id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
160634300|NCT01607398|580042699|FG000|Overall Study|Adverse Event|0|||
160634301|NCT01607398|580042700|FG001|Overall Study|Adverse Event|2|||
160634302|NCT01607398|580042699|FG000|Overall Study|Severe COPD|2|||
160634303|NCT01607398|580042700|FG001|Overall Study|Severe COPD|0|||
160634304|NCT02675426|580042701|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
160634305|NCT02675426|580042702|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
160634306|NCT02675426|580042703|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
160634307|NCT02675426|580042704|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
160634308|NCT02675426|580042701|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
160634309|NCT02675426|580042702|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
160634310|NCT02675426|580042703|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
160634311|NCT02675426|580042704|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
160634312|NCT02675426|580042701|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
160634313|NCT02675426|580042702|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
160634314|NCT02675426|580042703|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
160634315|NCT02675426|580042704|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
160634316|NCT02675426|580042701|FG000|Period 1: Week 1 to Week 12|Other|2|||
160634317|NCT02675426|580042702|FG001|Period 1: Week 1 to Week 12|Other|1|||
160634318|NCT02675426|580042703|FG002|Period 1: Week 1 to Week 12|Other|0|||
160634319|NCT02675426|580042704|FG003|Period 1: Week 1 to Week 12|Other|2|||
160634320|NCT02675426|580042701|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
160634321|NCT02675426|580042702|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
160634322|NCT02675426|580042703|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
160520073|NCT00604279|579634915|FG000|Overall Study|Lack of Efficacy|22|||
160634323|NCT02675426|580042704|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
160634324|NCT02675426|580042701|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
160634325|NCT02675426|580042702|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
160634326|NCT02675426|580042703|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
160634327|NCT02675426|580042704|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
160634328|NCT02675426|580042701|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
160634329|NCT02675426|580042702|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
160634330|NCT02675426|580042703|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
160634331|NCT02675426|580042704|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
160634332|NCT02675426|580042701|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
160634333|NCT02675426|580042702|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
160634334|NCT02675426|580042703|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
160634335|NCT02675426|580042704|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
160634336|NCT02675426|580042701|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
160634337|NCT02675426|580042702|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
160634338|NCT02675426|580042703|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
160634339|NCT02675426|580042704|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
160634340|NCT02675426|580042701|FG000|Period 2: Week 12 to Week 260|Other|8|||
160634341|NCT02675426|580042702|FG001|Period 2: Week 12 to Week 260|Other|12|||
160634342|NCT02675426|580042703|FG002|Period 2: Week 12 to Week 260|Other|23|||
160634343|NCT02675426|580042704|FG003|Period 2: Week 12 to Week 260|Other|15|||
160634344|NCT01784419|580042705|FG000|Overall Study|Adverse Event|3|||
160634345|NCT02237118|580042706|FG000|Overall Study|Protocol Violation|0|||
160634346|NCT02237118|580042707|FG001|Overall Study|Protocol Violation|1|||
160634347|NCT02237118|580042706|FG000|Overall Study|consent withdrawn|1|||
160634348|NCT02237118|580042707|FG001|Overall Study|consent withdrawn|0|||
160634349|NCT00080288|580042708|FG000|Overall Study|Adverse Event|7|||
160634350|NCT00080288|580042709|FG001|Overall Study|Adverse Event|4|||
160634351|NCT00080288|580042708|FG000|Overall Study|Lost to Follow-up|3|||
160634352|NCT00080288|580042709|FG001|Overall Study|Lost to Follow-up|5|||
160634353|NCT00080288|580042708|FG000|Overall Study|Physician Decision|6|||
160634354|NCT00080288|580042709|FG001|Overall Study|Physician Decision|2|||
160634355|NCT00080288|580042708|FG000|Overall Study|Withdrawal by Subject|3|||
160634356|NCT00080288|580042709|FG001|Overall Study|Withdrawal by Subject|16|||
160634357|NCT00080288|580042708|FG000|Overall Study|Miscellaneous|11|||
160634358|NCT00080288|580042709|FG001|Overall Study|Miscellaneous|11|||
160634359|NCT03044431|580042712|FG000|Overall Study|Lost to Follow-up|59|||
160634360|NCT00569231|580042713|FG000|Overall Study|Study unrelated surgery|1|||
160634361|NCT00569231|580042713|FG000|Overall Study|Airfare expense|2|||
160634362|NCT00569231|580042713|FG000|Overall Study|Withdrawal by Subject|1|||
160634363|NCT00569231|580042713|FG000|Overall Study|Car accident injury|1|||
160634364|NCT00569231|580042713|FG000|Overall Study|Non-compliance|2|||
160634365|NCT03456726|580042714|FG000|Overall Study|Disease Progression|6|||
160634366|NCT03456726|580042715|FG001|Overall Study|Disease Progression|1|||
160634367|NCT03456726|580042714|FG000|Overall Study|Adverse Event|4|||
160634368|NCT03456726|580042715|FG001|Overall Study|Adverse Event|2|||
160634369|NCT03456726|580042714|FG000|Overall Study|Withdrawal by Subject|1|||
160634370|NCT03456726|580042715|FG001|Overall Study|Withdrawal by Subject|0|||
160748892|NCT03091738|580467865|FG000|Overall Study|Adverse Event|1|||
160634371|NCT03456726|580042714|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
160634372|NCT03456726|580042715|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
160634373|NCT04470622|580042716|FG000|Overall Study|Withdrawal by Subject|0|||
160634374|NCT04470622|580042717|FG001|Overall Study|Withdrawal by Subject|1|||
160634375|NCT04470622|580042716|FG000|Overall Study|Screen Failure|0|||
160634376|NCT04470622|580042717|FG001|Overall Study|Screen Failure|1|||
160634377|NCT04470622|580042716|FG000|Overall Study|Death|0|||
160634378|NCT04470622|580042717|FG001|Overall Study|Death|1|||
160634379|NCT02576054|580042720|FG000|Overall Study|Withdrawal by Subject|1|||
160634380|NCT03978117|580042721|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
160634381|NCT03978117|580042722|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
160634382|NCT03978117|580042721|FG000|Overall Study|Lost to Follow-up|4|||
160634383|NCT03978117|580042722|FG001|Overall Study|Lost to Follow-up|4|||
160634384|NCT00791154|580042723|FG000|Overall Study|Noncompliance|0|||
160634385|NCT00791154|580042724|FG001|Overall Study|Noncompliance|1|||
160634386|NCT00791154|580042725|FG002|Overall Study|Noncompliance|0|||
160634387|NCT00791154|580042726|FG003|Overall Study|Noncompliance|0|||
160634388|NCT00791154|580042727|FG004|Overall Study|Noncompliance|1|||
160634389|NCT00791154|580042728|FG005|Overall Study|Noncompliance|1|||
160634390|NCT00791154|580042729|FG006|Overall Study|Noncompliance|1|||
160634391|NCT00791154|580042723|FG000|Overall Study|Adverse Event|0|||
160634392|NCT00791154|580042724|FG001|Overall Study|Adverse Event|0|||
160634393|NCT00791154|580042725|FG002|Overall Study|Adverse Event|0|||
160634394|NCT00791154|580042726|FG003|Overall Study|Adverse Event|0|||
160634395|NCT00791154|580042727|FG004|Overall Study|Adverse Event|2|||
160634396|NCT00791154|580042728|FG005|Overall Study|Adverse Event|0|||
160634397|NCT00791154|580042729|FG006|Overall Study|Adverse Event|1|||
160634398|NCT00791154|580042723|FG000|Overall Study|Full Consent withdrawn|1|||
160634399|NCT00791154|580042724|FG001|Overall Study|Full Consent withdrawn|3|||
160634400|NCT00791154|580042725|FG002|Overall Study|Full Consent withdrawn|0|||
160634401|NCT00791154|580042726|FG003|Overall Study|Full Consent withdrawn|0|||
160634402|NCT00791154|580042727|FG004|Overall Study|Full Consent withdrawn|1|||
160634403|NCT00791154|580042728|FG005|Overall Study|Full Consent withdrawn|3|||
160634404|NCT00791154|580042729|FG006|Overall Study|Full Consent withdrawn|1|||
160634405|NCT00791154|580042723|FG000|Overall Study|Lost to Follow-up|0|||
160634406|NCT00791154|580042724|FG001|Overall Study|Lost to Follow-up|0|||
160634407|NCT00791154|580042725|FG002|Overall Study|Lost to Follow-up|0|||
160634408|NCT00791154|580042726|FG003|Overall Study|Lost to Follow-up|1|||
160634409|NCT00791154|580042727|FG004|Overall Study|Lost to Follow-up|2|||
160634410|NCT00791154|580042728|FG005|Overall Study|Lost to Follow-up|0|||
160634411|NCT00791154|580042729|FG006|Overall Study|Lost to Follow-up|4|||
160634412|NCT00791154|580042723|FG000|Overall Study|Death|5|||
160634413|NCT00791154|580042724|FG001|Overall Study|Death|4|||
160634414|NCT00791154|580042725|FG002|Overall Study|Death|4|||
160634415|NCT00791154|580042726|FG003|Overall Study|Death|7|||
160634416|NCT00791154|580042727|FG004|Overall Study|Death|54|||
160634417|NCT00791154|580042728|FG005|Overall Study|Death|54|||
160634418|NCT00791154|580042729|FG006|Overall Study|Death|52|||
160634419|NCT00791154|580042723|FG000|Overall Study|Other event|0|||
160634420|NCT00791154|580042724|FG001|Overall Study|Other event|0|||
160634421|NCT00791154|580042725|FG002|Overall Study|Other event|2|||
160634422|NCT00791154|580042726|FG003|Overall Study|Other event|0|||
160634423|NCT00791154|580042727|FG004|Overall Study|Other event|2|||
160634424|NCT00791154|580042728|FG005|Overall Study|Other event|4|||
160634425|NCT00791154|580042729|FG006|Overall Study|Other event|2|||
160634426|NCT00953927|580042730|FG000|Overall Study|Lost to Follow-up|61|||
160634427|NCT00953927|580042731|FG001|Overall Study|Lost to Follow-up|65|||
160634428|NCT00953927|580042730|FG000|Overall Study|Withdrawal by Subject|36|||
160634429|NCT00953927|580042731|FG001|Overall Study|Withdrawal by Subject|25|||
160863404|NCT03312634|580894724|FG000|Overall Study|Adverse Event|11|||
160863405|NCT03312634|580894725|FG001|Overall Study|Adverse Event|0|||
160863406|NCT03312634|580894724|FG000|Overall Study|Sponsor request|2|||
160863407|NCT03312634|580894725|FG001|Overall Study|Sponsor request|0|||
160863408|NCT03312634|580894724|FG000|Overall Study|Withdrawal by Subject|31|||
160520074|NCT00604279|579634916|FG001|Overall Study|Lack of Efficacy|9|||
160520075|NCT00604279|579634915|FG000|Overall Study|Lost to Follow-up|9|||
160520076|NCT00604279|579634916|FG001|Overall Study|Lost to Follow-up|14|||
160520077|NCT00604279|579634915|FG000|Overall Study|Pregnancy|2|||
160520078|NCT00604279|579634916|FG001|Overall Study|Pregnancy|0|||
160520079|NCT00604279|579634915|FG000|Overall Study|Protocol Violation|3|||
160520080|NCT00604279|579634916|FG001|Overall Study|Protocol Violation|1|||
160520081|NCT00604279|579634915|FG000|Overall Study|Withdrawal by Subject|16|||
160520082|NCT00604279|579634916|FG001|Overall Study|Withdrawal by Subject|5|||
160520083|NCT00604279|579634915|FG000|Overall Study|Adverse Event|4|||
160520084|NCT00604279|579634916|FG001|Overall Study|Adverse Event|5|||
160520085|NCT00604279|579634915|FG000|Overall Study|Other|8|||
160520086|NCT00604279|579634916|FG001|Overall Study|Other|4|||
160634430|NCT00953927|580042730|FG000|Overall Study|Death|7|||
160634431|NCT00953927|580042731|FG001|Overall Study|Death|4|||
160634432|NCT00953927|580042730|FG000|Overall Study|Other study discontinuation|1|||
160634433|NCT00953927|580042731|FG001|Overall Study|Other study discontinuation|1|||
160634434|NCT01396161|580042732|FG000|Overall Study|Withdrawal by Subject|0|||
160634435|NCT01396161|580042733|FG001|Overall Study|Withdrawal by Subject|0|||
160634436|NCT01396161|580042734|FG002|Overall Study|Withdrawal by Subject|0|||
160634437|NCT01396161|580042735|FG003|Overall Study|Withdrawal by Subject|0|||
160634438|NCT01396161|580042736|FG004|Overall Study|Withdrawal by Subject|1|||
160634439|NCT01396161|580042737|FG005|Overall Study|Withdrawal by Subject|0|||
160634440|NCT01396161|580042738|FG006|Overall Study|Withdrawal by Subject|0|||
160520087|NCT03938545|579634917|FG000|Overall Study|Lost to Follow-up|0|||
160520088|NCT03938545|579634918|FG001|Overall Study|Lost to Follow-up|0|||
160520089|NCT03938545|579634919|FG002|Overall Study|Lost to Follow-up|0|||
160520090|NCT03938545|579634920|FG003|Overall Study|Lost to Follow-up|1|||
160520091|NCT03938545|579634917|FG000|Overall Study|Non-compliance with study drug|0|||
160520092|NCT03938545|579634918|FG001|Overall Study|Non-compliance with study drug|0|||
160634441|NCT01396161|580042732|FG000|Overall Study|Other|0|||
160634442|NCT01396161|580042733|FG001|Overall Study|Other|0|||
160634443|NCT01396161|580042734|FG002|Overall Study|Other|0|||
160520093|NCT03938545|579634919|FG002|Overall Study|Non-compliance with study drug|1|||
160520094|NCT03938545|579634920|FG003|Overall Study|Non-compliance with study drug|0|||
160520095|NCT03938545|579634917|FG000|Overall Study|Pregnancy|1|||
160520096|NCT03938545|579634918|FG001|Overall Study|Pregnancy|0|||
160520097|NCT03938545|579634919|FG002|Overall Study|Pregnancy|0|||
160520098|NCT03938545|579634920|FG003|Overall Study|Pregnancy|0|||
160520099|NCT03938545|579634917|FG000|Overall Study|Study terminated by sponsor|6|||
160520100|NCT03938545|579634918|FG001|Overall Study|Study terminated by sponsor|4|||
160520101|NCT03938545|579634919|FG002|Overall Study|Study terminated by sponsor|2|||
160520102|NCT03938545|579634920|FG003|Overall Study|Study terminated by sponsor|4|||
160520103|NCT03938545|579634917|FG000|Overall Study|Withdrawal by Subject|0|||
160520104|NCT03938545|579634918|FG001|Overall Study|Withdrawal by Subject|1|||
160520105|NCT03938545|579634919|FG002|Overall Study|Withdrawal by Subject|0|||
160520106|NCT03938545|579634920|FG003|Overall Study|Withdrawal by Subject|0|||
160520107|NCT03938545|579634917|FG000|Overall Study|Adverse Event|1|||
160520108|NCT03938545|579634918|FG001|Overall Study|Adverse Event|0|||
160520109|NCT03938545|579634919|FG002|Overall Study|Adverse Event|0|||
160520110|NCT03938545|579634920|FG003|Overall Study|Adverse Event|0|||
160520111|NCT00355056|579634921|FG000|Randomization Period|Early Termination|4|||
160520112|NCT00355056|579634922|FG001|Randomization Period|Early Termination|6|||
160520113|NCT01060540|579634923|FG000|Overall Study|Withdrawal by Subject|10|||
160520114|NCT01060540|579634924|FG001|Overall Study|Withdrawal by Subject|20|||
160520115|NCT01060540|579634923|FG000|Overall Study|Lost to Follow-up|52|||
160520116|NCT01060540|579634924|FG001|Overall Study|Lost to Follow-up|43|||
160634444|NCT01396161|580042735|FG003|Overall Study|Other|0|||
160634445|NCT01396161|580042736|FG004|Overall Study|Other|0|||
160634446|NCT01396161|580042737|FG005|Overall Study|Other|0|||
160520117|NCT01060540|579634923|FG000|Overall Study|Death|2|||
160520118|NCT01060540|579634924|FG001|Overall Study|Death|1|||
160520119|NCT01060540|579634923|FG000|Overall Study|Physician Decision|0|||
160520120|NCT01060540|579634924|FG001|Overall Study|Physician Decision|1|||
160520121|NCT00816400|579634928|FG000|Overall Study|Death|2|||
160520122|NCT00816400|579634929|FG001|Overall Study|Death|3|||
160520123|NCT00816400|579634930|FG002|Overall Study|Death|3|||
160520124|NCT00816400|579634931|FG003|Overall Study|Death|3|||
160520125|NCT00816400|579634932|FG004|Overall Study|Death|2|||
160520126|NCT00816400|579634933|FG005|Overall Study|Death|3|||
160520127|NCT00816400|579634934|FG006|Overall Study|Death|2|||
160520128|NCT00816400|579634935|FG007|Overall Study|Death|5|||
160520129|NCT00816400|579634936|FG008|Overall Study|Death|6|||
160520130|NCT00816400|579634928|FG000|Overall Study|In hospice care at the end of the study|0|||
160520131|NCT00816400|579634929|FG001|Overall Study|In hospice care at the end of the study|0|||
160520132|NCT00816400|579634930|FG002|Overall Study|In hospice care at the end of the study|2|||
160520133|NCT00816400|579634931|FG003|Overall Study|In hospice care at the end of the study|0|||
160520134|NCT00816400|579634932|FG004|Overall Study|In hospice care at the end of the study|0|||
160634447|NCT01396161|580042738|FG006|Overall Study|Other|1|||
160634448|NCT02962739|580042739|FG000|Overall Study|Withdrawal by Subject|0|||
160634449|NCT02962739|580042740|FG001|Overall Study|Withdrawal by Subject|1|||
160520135|NCT00816400|579634933|FG005|Overall Study|In hospice care at the end of the study|0|||
160520136|NCT00816400|579634934|FG006|Overall Study|In hospice care at the end of the study|0|||
160520137|NCT00816400|579634935|FG007|Overall Study|In hospice care at the end of the study|0|||
160520138|NCT00816400|579634936|FG008|Overall Study|In hospice care at the end of the study|0|||
160634450|NCT02962739|580042741|FG002|Overall Study|Withdrawal by Subject|0|||
160634451|NCT02962739|580042742|FG003|Overall Study|Withdrawal by Subject|0|||
160863409|NCT03312634|580894725|FG001|Overall Study|Withdrawal by Subject|9|||
160634452|NCT02962739|580042743|FG004|Overall Study|Withdrawal by Subject|0|||
160520139|NCT02647320|579634940|FG000|Overall Study|Adverse Event|0|||
160520140|NCT02647320|579634941|FG001|Overall Study|Adverse Event|1|||
160520141|NCT02647320|579634942|FG002|Overall Study|Adverse Event|3|||
160520142|NCT02647320|579634943|FG003|Overall Study|Adverse Event|2|||
160520143|NCT02647320|579634944|FG004|Overall Study|Adverse Event|1|||
160520144|NCT02647320|579634940|FG000|Overall Study|Protocol Violation|0|||
160520145|NCT02647320|579634941|FG001|Overall Study|Protocol Violation|0|||
160634453|NCT02962739|580042744|FG005|Overall Study|Withdrawal by Subject|0|||
160634454|NCT02962739|580042739|FG000|Overall Study|Protocol Violation|0|||
160520146|NCT02647320|579634942|FG002|Overall Study|Protocol Violation|3|||
160520147|NCT02647320|579634943|FG003|Overall Study|Protocol Violation|0|||
160520148|NCT02647320|579634944|FG004|Overall Study|Protocol Violation|0|||
160520149|NCT02647320|579634940|FG000|Overall Study|Withdrawal by Subject|7|||
160520150|NCT02647320|579634941|FG001|Overall Study|Withdrawal by Subject|4|||
160520151|NCT02647320|579634942|FG002|Overall Study|Withdrawal by Subject|2|||
160520152|NCT02647320|579634943|FG003|Overall Study|Withdrawal by Subject|2|||
160520153|NCT02647320|579634944|FG004|Overall Study|Withdrawal by Subject|7|||
160520154|NCT02647320|579634940|FG000|Overall Study|Persistent hyperglycemia|0|||
160520155|NCT02647320|579634941|FG001|Overall Study|Persistent hyperglycemia|1|||
160520156|NCT02647320|579634942|FG002|Overall Study|Persistent hyperglycemia|1|||
160634455|NCT02962739|580042740|FG001|Overall Study|Protocol Violation|0|||
160634456|NCT02962739|580042741|FG002|Overall Study|Protocol Violation|1|||
160634457|NCT02962739|580042742|FG003|Overall Study|Protocol Violation|0|||
160634458|NCT02962739|580042743|FG004|Overall Study|Protocol Violation|1|||
160634459|NCT02962739|580042744|FG005|Overall Study|Protocol Violation|0|||
160634460|NCT00414011|580042745|FG000|Overall Study|Physician Decision|3|||
160634461|NCT00414011|580042745|FG000|Overall Study|Withdrawal by Subject|2|||
160634462|NCT04056299|580042746|FG000|Overall Study|Sponsor discontinued study|3|||
160634463|NCT04056299|580042747|FG001|Overall Study|Sponsor discontinued study|3|||
160634464|NCT01227954|580042752|FG000|Overall Study|Protocol Violation|6|||
160634465|NCT01227954|580042752|FG000|Overall Study|No protocol treatment|7|||
160634466|NCT00078312|580042753|FG000|Overall Study|Adverse Event|43|||
160634467|NCT00078312|580042753|FG000|Overall Study|Lack of Efficacy|15|||
160634468|NCT00078312|580042753|FG000|Overall Study|Lost to Follow-up|41|||
160634469|NCT00078312|580042753|FG000|Overall Study|Physician Decision|9|||
160634470|NCT00078312|580042753|FG000|Overall Study|Protocol Violation|3|||
160634471|NCT00078312|580042753|FG000|Overall Study|Withdrawal by Subject|33|||
160634472|NCT00078312|580042753|FG000|Overall Study|Miscellaneous|33|||
160634473|NCT00756652|580042758|FG000|Original Phase|Withdrawal by Subject|864|||
160634474|NCT00756652|580042759|FG001|Original Phase|Withdrawal by Subject|23|||
160634475|NCT00756652|580042758|FG000|Original Phase|Lost to Follow-up|601|||
160634476|NCT00756652|580042759|FG001|Original Phase|Lost to Follow-up|0|||
160634477|NCT00756652|580042758|FG000|Original Phase|Other Discontinuation|797|||
160634478|NCT00756652|580042759|FG001|Original Phase|Other Discontinuation|5|||
160634479|NCT00756652|580042758|FG000|Original Phase|Participant Noncompliance|18622|||
160634480|NCT00756652|580042759|FG001|Original Phase|Participant Noncompliance|424|||
160634481|NCT00756652|580042758|FG000|Original Phase|Unknown Discontinuation Reason|2|||
160634482|NCT00756652|580042759|FG001|Original Phase|Unknown Discontinuation Reason|0|||
160634483|NCT00756652|580042758|FG000|Original Phase|Participants without data|3259|||
160634484|NCT00756652|580042759|FG001|Original Phase|Participants without data|466|||
160634485|NCT00756652|580042758|FG000|Original Phase|Death|168|||
160634486|NCT00756652|580042759|FG001|Original Phase|Death|1|||
160634487|NCT00756652|580042758|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
160634488|NCT00756652|580042759|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
160634489|NCT00756652|580042758|FG000|Re-Op Phase|Withdrawal by Subject|62|||
160634490|NCT00756652|580042759|FG001|Re-Op Phase|Withdrawal by Subject|0|||
160634491|NCT00756652|580042758|FG000|Re-Op Phase|Death|6|||
160634492|NCT00756652|580042759|FG001|Re-Op Phase|Death|0|||
160634493|NCT00756652|580042758|FG000|Re-Op Phase|Lost to Follow-up|340|||
160634494|NCT00756652|580042759|FG001|Re-Op Phase|Lost to Follow-up|0|||
160634495|NCT00756652|580042758|FG000|Re-Op Phase|Site Closed|2454|||
160634496|NCT00756652|580042759|FG001|Re-Op Phase|Site Closed|0|||
160634497|NCT00756652|580042758|FG000|Re-Op Phase|Withdrawn after explant|14|||
160634498|NCT00756652|580042759|FG001|Re-Op Phase|Withdrawn after explant|0|||
160520157|NCT02647320|579634943|FG003|Overall Study|Persistent hyperglycemia|1|||
160520158|NCT02647320|579634944|FG004|Overall Study|Persistent hyperglycemia|1|||
160520159|NCT02647320|579634940|FG000|Overall Study|Study terminated by sponsor|1|||
160520160|NCT02647320|579634941|FG001|Overall Study|Study terminated by sponsor|1|||
160520161|NCT02647320|579634942|FG002|Overall Study|Study terminated by sponsor|1|||
160520162|NCT02647320|579634943|FG003|Overall Study|Study terminated by sponsor|1|||
160634499|NCT00038467|580042764|FG000|Overall Study|Adverse Event|170|||
160634500|NCT00038467|580042765|FG001|Overall Study|Adverse Event|145|||
160634501|NCT00038467|580042764|FG000|Overall Study|Withdrawal by Subject|150|||
160520163|NCT02647320|579634944|FG004|Overall Study|Study terminated by sponsor|2|||
160520164|NCT02647320|579634940|FG000|Overall Study|Reason not provided|0|||
160520165|NCT02647320|579634941|FG001|Overall Study|Reason not provided|0|||
160520166|NCT02647320|579634942|FG002|Overall Study|Reason not provided|1|||
160520167|NCT02647320|579634943|FG003|Overall Study|Reason not provided|0|||
160634502|NCT00038467|580042765|FG001|Overall Study|Withdrawal by Subject|107|||
160634503|NCT00038467|580042764|FG000|Overall Study|Protocol Violation|19|||
160634504|NCT00038467|580042765|FG001|Overall Study|Protocol Violation|22|||
160634505|NCT00038467|580042764|FG000|Overall Study|Death|22|||
160634506|NCT00038467|580042765|FG001|Overall Study|Death|16|||
160634507|NCT00038467|580042764|FG000|Overall Study|Lost to Follow-up|15|||
160634508|NCT00038467|580042765|FG001|Overall Study|Lost to Follow-up|10|||
160634509|NCT00038467|580042764|FG000|Overall Study|Recurrence|109|||
160634510|NCT00038467|580042765|FG001|Overall Study|Recurrence|179|||
160634511|NCT00038467|580042764|FG000|Overall Study|Randomized, but not treated|31|||
160634512|NCT00038467|580042765|FG001|Overall Study|Randomized, but not treated|35|||
160634513|NCT00038467|580042764|FG000|Overall Study|Other|26|||
160634514|NCT00038467|580042765|FG001|Overall Study|Other|28|||
160634515|NCT04732728|580042766|FG000|Overall Study|Death|12|||
160634516|NCT04732728|580042766|FG000|Overall Study|Withdrawn|136|||
160634517|NCT05349188|580042767|FG000|Overall Study|Withdrawal by Subject|1|||
160634518|NCT05349188|580042768|FG001|Overall Study|Withdrawal by Subject|0|||
160634519|NCT00481871|580042769|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
160634520|NCT00481871|580042770|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
160634521|NCT00481871|580042771|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
160634522|NCT00481871|580042772|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
160634523|NCT00481871|580042773|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
160634524|NCT00644228|580042783|FG000|Randomization & Eligibility|Ineligible|31|||
160634525|NCT00644228|580042784|FG001|Randomization & Eligibility|Ineligible|21|||
160634526|NCT00644228|580042783|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
160634527|NCT00644228|580042784|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
160634528|NCT00644228|580042783|FG000|Randomization & Eligibility|Invalid Consent|0|||
160634529|NCT00644228|580042784|FG001|Randomization & Eligibility|Invalid Consent|1|||
160634530|NCT00644228|580042783|FG000|Induction Therapy|Adverse Event|22|||
160634531|NCT00644228|580042784|FG001|Induction Therapy|Adverse Event|55|||
160634532|NCT00644228|580042783|FG000|Induction Therapy|Withdrawal by Subject|10|||
160634533|NCT00644228|580042784|FG001|Induction Therapy|Withdrawal by Subject|3|||
160634534|NCT00644228|580042783|FG000|Induction Therapy|Progression/Relapse|24|||
160634535|NCT00644228|580042784|FG001|Induction Therapy|Progression/Relapse|12|||
160634536|NCT00644228|580042783|FG000|Induction Therapy|Death|3|||
160634537|NCT00644228|580042784|FG001|Induction Therapy|Death|7|||
160634538|NCT00644228|580042783|FG000|Induction Therapy|Not Protocol-Specified|24|||
160634539|NCT00644228|580042784|FG001|Induction Therapy|Not Protocol-Specified|28|||
160634540|NCT00644228|580042783|FG000|Maintenance|Adverse Event|27|||
160634541|NCT00644228|580042784|FG001|Maintenance|Adverse Event|31|||
160634542|NCT00644228|580042783|FG000|Maintenance|Withdrawal by Subject|6|||
160634543|NCT00644228|580042784|FG001|Maintenance|Withdrawal by Subject|4|||
160634544|NCT00644228|580042783|FG000|Maintenance|Progression/Relapse|67|||
160634545|NCT00644228|580042784|FG001|Maintenance|Progression/Relapse|42|||
160634546|NCT00644228|580042783|FG000|Maintenance|Death|3|||
160634547|NCT00644228|580042784|FG001|Maintenance|Death|3|||
160634548|NCT00644228|580042783|FG000|Maintenance|Not Protocol-Specified|14|||
160634549|NCT00644228|580042784|FG001|Maintenance|Not Protocol-Specified|15|||
160634550|NCT00644228|580042783|FG000|Maintenance|On Treatment|26|||
160634551|NCT00644228|580042784|FG001|Maintenance|On Treatment|40|||
160634552|NCT06078124|580042785|FG000|Overall Study|Lost to Follow-up|14|||
160634553|NCT06078124|580042786|FG001|Overall Study|Lost to Follow-up|14|||
160634554|NCT04050293|580042787|FG000|Overall Study|Lost to Follow-up|1|||
160634555|NCT04050293|580042788|FG001|Overall Study|Lost to Follow-up|2|||
160634556|NCT04050293|580042787|FG000|Overall Study|Withdrawal by Subject|2|||
160520168|NCT02647320|579634944|FG004|Overall Study|Reason not provided|2|||
160634557|NCT04050293|580042788|FG001|Overall Study|Withdrawal by Subject|0|||
160634558|NCT03868059|580042789|FG000|Overall Study|Adverse Event|3|||
160634559|NCT03868059|580042789|FG000|Overall Study|Lost to Follow-up|3|||
160634560|NCT03868059|580042789|FG000|Overall Study|Withdrawal by Subject|6|||
160634561|NCT05838755|580042795|FG000|Overall Study|Adverse Event|1|||
160634562|NCT05838755|580042796|FG001|Overall Study|Adverse Event|0|||
160634563|NCT05838755|580042797|FG002|Overall Study|Adverse Event|0|||
160634564|NCT05838755|580042795|FG000|Overall Study|Lack of Efficacy|1|||
160634565|NCT05838755|580042796|FG001|Overall Study|Lack of Efficacy|0|||
160634566|NCT05838755|580042797|FG002|Overall Study|Lack of Efficacy|1|||
160634567|NCT05838755|580042795|FG000|Overall Study|Lost to Follow-up|0|||
160634568|NCT05838755|580042796|FG001|Overall Study|Lost to Follow-up|1|||
160634569|NCT05838755|580042797|FG002|Overall Study|Lost to Follow-up|4|||
160634570|NCT05838755|580042795|FG000|Overall Study|Withdrawal by Subject|0|||
160520169|NCT02647320|579634940|FG000|Overall Study|Lost to Follow-up|1|||
160634571|NCT05838755|580042796|FG001|Overall Study|Withdrawal by Subject|2|||
160634572|NCT05838755|580042797|FG002|Overall Study|Withdrawal by Subject|0|||
160634573|NCT05838755|580042795|FG000|Overall Study|Study terminated by sponsor|26|||
160634574|NCT05838755|580042796|FG001|Overall Study|Study terminated by sponsor|27|||
160634575|NCT05838755|580042797|FG002|Overall Study|Study terminated by sponsor|26|||
160634576|NCT05838755|580042795|FG000|Overall Study|Randomized, not treated|2|||
160863410|NCT03312634|580894724|FG000|Overall Study|Enrolled in an interventional study|0|||
160977803|NCT03864926|581310077|FG000|Overall Study|Death|0|||
160634577|NCT05838755|580042796|FG001|Overall Study|Randomized, not treated|0|||
160634578|NCT05838755|580042797|FG002|Overall Study|Randomized, not treated|1|||
160634579|NCT05838755|580042795|FG000|Overall Study|Pregnancy|0|||
160634580|NCT05838755|580042796|FG001|Overall Study|Pregnancy|1|||
160634581|NCT05838755|580042797|FG002|Overall Study|Pregnancy|0|||
160634582|NCT00096031|580042798|FG000|Overall Study|Adverse Event|3|||
160634583|NCT00096031|580042798|FG000|Overall Study|Lack of Efficacy|42|||
160634584|NCT00096031|580042798|FG000|Overall Study|Death|4|||
160634585|NCT00096031|580042798|FG000|Overall Study|Withdrawal by Subject|1|||
160634586|NCT00096031|580042798|FG000|Overall Study|Ineligible|8|||
160634587|NCT00096031|580042798|FG000|Overall Study|Not protocol specified|5|||
160634588|NCT01283282|580042799|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
160634589|NCT01283282|580042800|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
160634590|NCT01283282|580042799|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
160634591|NCT01283282|580042800|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
160634592|NCT01283282|580042799|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
160634593|NCT01283282|580042800|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
160634594|NCT00483717|580042801|FG000|Overall Study|Protocol Violation|5|||
160634595|NCT00483717|580042802|FG001|Overall Study|Protocol Violation|7|||
160634596|NCT00483717|580042801|FG000|Overall Study|Time of dosing missing|1|||
160634597|NCT00483717|580042802|FG001|Overall Study|Time of dosing missing|1|||
160634598|NCT00483717|580042801|FG000|Overall Study|No treatment for migraine|16|||
160634599|NCT00483717|580042802|FG001|Overall Study|No treatment for migraine|13|||
160634600|NCT00483717|580042801|FG000|Overall Study|Lost to Follow-up|1|||
160634601|NCT00483717|580042802|FG001|Overall Study|Lost to Follow-up|0|||
160634602|NCT00483717|580042801|FG000|Overall Study|Withdrawal by Subject|1|||
160634603|NCT00483717|580042802|FG001|Overall Study|Withdrawal by Subject|0|||
160634604|NCT00083226|580042803|FG000|Overall Study|Lack of Efficacy|19|||
160634605|NCT00083226|580042803|FG000|Overall Study|Adverse Event|9|||
160634606|NCT00083226|580042803|FG000|Overall Study|Death|4|||
160634607|NCT00083226|580042803|FG000|Overall Study|Withdrawal by Subject|4|||
160634608|NCT00083226|580042803|FG000|Overall Study|Other|2|||
160634609|NCT00083226|580042803|FG000|Overall Study|ineligible or not receiving treatment|4|||
160634610|NCT00909857|580042804|FG000|Overall Study|Withdrawal by Subject|6|||
160634611|NCT00909857|580042805|FG001|Overall Study|Withdrawal by Subject|10|||
160634612|NCT00909857|580042804|FG000|Overall Study|Adverse Event|5|||
160634613|NCT00909857|580042805|FG001|Overall Study|Adverse Event|5|||
160634614|NCT00909857|580042804|FG000|Overall Study|Lost to Follow-up|2|||
160634615|NCT00909857|580042805|FG001|Overall Study|Lost to Follow-up|5|||
160520170|NCT02647320|579634941|FG001|Overall Study|Lost to Follow-up|1|||
160520171|NCT02647320|579634942|FG002|Overall Study|Lost to Follow-up|0|||
160520172|NCT02647320|579634943|FG003|Overall Study|Lost to Follow-up|0|||
160520173|NCT02647320|579634944|FG004|Overall Study|Lost to Follow-up|0|||
160520174|NCT02647320|579634940|FG000|Overall Study|Develop anemia|1|||
160520175|NCT02647320|579634941|FG001|Overall Study|Develop anemia|0|||
160520176|NCT02647320|579634942|FG002|Overall Study|Develop anemia|0|||
160520177|NCT02647320|579634943|FG003|Overall Study|Develop anemia|0|||
160634616|NCT00909857|580042804|FG000|Overall Study|Protocol Violation|2|||
160634617|NCT00909857|580042805|FG001|Overall Study|Protocol Violation|1|||
160634618|NCT00909857|580042804|FG000|Overall Study|Pregnancy|1|||
160634619|NCT00909857|580042805|FG001|Overall Study|Pregnancy|0|||
160634620|NCT00909857|580042804|FG000|Overall Study|Other|1|||
160520178|NCT02647320|579634944|FG004|Overall Study|Develop anemia|0|||
160520179|NCT02647320|579634940|FG000|Overall Study|Lack of Efficacy|0|||
160520180|NCT02647320|579634941|FG001|Overall Study|Lack of Efficacy|0|||
160520181|NCT02647320|579634942|FG002|Overall Study|Lack of Efficacy|0|||
160520182|NCT02647320|579634943|FG003|Overall Study|Lack of Efficacy|1|||
160520183|NCT02647320|579634944|FG004|Overall Study|Lack of Efficacy|0|||
160520184|NCT02647320|579634940|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
160520185|NCT02647320|579634941|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
160520186|NCT02647320|579634942|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
160520187|NCT02647320|579634943|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
160520188|NCT02647320|579634944|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
160520189|NCT00596427|579634945|FG000|Overall Study|Withdrawal by Subject|2|||
160520190|NCT00596427|579634946|FG001|Overall Study|Withdrawal by Subject|2|||
160520191|NCT00596427|579634945|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
160520192|NCT00596427|579634946|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
160520193|NCT00596427|579634945|FG000|Overall Study|Protocol Violation|1|||
160520194|NCT00596427|579634946|FG001|Overall Study|Protocol Violation|0|||
160520195|NCT02401867|579634947|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
160520196|NCT02401867|579634947|FG000|Analysis|Cervical assay could not be conducted|9|||
160634621|NCT00909857|580042805|FG001|Overall Study|Other|0|||
160634622|NCT00909857|580042804|FG000|Overall Study|Did not receive study medication|19|||
160634623|NCT00909857|580042805|FG001|Overall Study|Did not receive study medication|24|||
160520197|NCT01650246|579634948|FG000|Overall Study|Adverse Event|23|||
160520198|NCT01650246|579634948|FG000|Overall Study|Protocol Violation|5|||
160520199|NCT01650246|579634948|FG000|Overall Study|Sponsor terminated study|53|||
160520200|NCT01650246|579634948|FG000|Overall Study|Lost to Follow-up|5|||
160520201|NCT01650246|579634948|FG000|Overall Study|Withdrawal by Subject|26|||
160520202|NCT01650246|579634948|FG000|Overall Study|Death|1|||
160520203|NCT01650246|579634948|FG000|Overall Study|Lack of Efficacy|30|||
160634624|NCT03878108|580042806|FG000|Overall Study|Adverse Event|1|||
160634625|NCT03878108|580042807|FG001|Overall Study|Adverse Event|0|||
160520204|NCT00081770|579634949|FG000|Overall Study|Adverse Event|130|||
160520205|NCT00081770|579634950|FG001|Overall Study|Adverse Event|98|||
160520206|NCT00081770|579634951|FG002|Overall Study|Adverse Event|136|||
160520207|NCT00081770|579634949|FG000|Overall Study|Lack of Efficacy|262|||
160520208|NCT00081770|579634950|FG001|Overall Study|Lack of Efficacy|357|||
160520209|NCT00081770|579634951|FG002|Overall Study|Lack of Efficacy|211|||
160520210|NCT00081770|579634949|FG000|Overall Study|Lost to Follow-up|45|||
160520211|NCT00081770|579634950|FG001|Overall Study|Lost to Follow-up|34|||
160520212|NCT00081770|579634951|FG002|Overall Study|Lost to Follow-up|45|||
160520213|NCT00081770|579634949|FG000|Overall Study|Protocol Violation|15|||
160520214|NCT00081770|579634950|FG001|Overall Study|Protocol Violation|10|||
160520215|NCT00081770|579634951|FG002|Overall Study|Protocol Violation|10|||
160520216|NCT00081770|579634949|FG000|Overall Study|Withdrawal by Subject|45|||
160520217|NCT00081770|579634950|FG001|Overall Study|Withdrawal by Subject|40|||
160520218|NCT00081770|579634951|FG002|Overall Study|Withdrawal by Subject|42|||
160520219|NCT00081770|579634949|FG000|Overall Study|Did not meet protocol eligibility|2|||
160520220|NCT00081770|579634950|FG001|Overall Study|Did not meet protocol eligibility|0|||
160520221|NCT00081770|579634951|FG002|Overall Study|Did not meet protocol eligibility|3|||
160520222|NCT00081770|579634949|FG000|Overall Study|Administrative|1|||
160520223|NCT00081770|579634950|FG001|Overall Study|Administrative|0|||
160520224|NCT00081770|579634951|FG002|Overall Study|Administrative|1|||
160520225|NCT00081770|579634949|FG000|Overall Study|Other|2|||
160520226|NCT00081770|579634950|FG001|Overall Study|Other|7|||
160520227|NCT00081770|579634951|FG002|Overall Study|Other|8|||
160520228|NCT03435497|579634953|FG000|Overall Study|Lost to Follow-up|1|||
160520229|NCT03435497|579634954|FG001|Overall Study|Lost to Follow-up|0|||
160634626|NCT00604175|580042814|FG000|Entry Through Week 28|Death|2|||
160634627|NCT00604175|580042815|FG001|Entry Through Week 28|Death|0|||
160634628|NCT00604175|580042816|FG002|Entry Through Week 28|Death|0|||
160634629|NCT00604175|580042814|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
160634630|NCT00604175|580042815|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
160634631|NCT00604175|580042816|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
160634632|NCT00604175|580042814|FG000|Entry Through Week 28|Lost to Follow-up|4|||
160634633|NCT00604175|580042815|FG001|Entry Through Week 28|Lost to Follow-up|3|||
160634634|NCT00604175|580042816|FG002|Entry Through Week 28|Lost to Follow-up|0|||
160634635|NCT00604175|580042814|FG000|Entry Through Week 28|Ineligible|1|||
160634636|NCT00604175|580042815|FG001|Entry Through Week 28|Ineligible|0|||
160520230|NCT03435497|579634953|FG000|Overall Study|Death|1|||
160520231|NCT03435497|579634954|FG001|Overall Study|Death|0|||
160520232|NCT03435497|579634953|FG000|Overall Study|Withdrawal by Subject|0|||
160520233|NCT03435497|579634954|FG001|Overall Study|Withdrawal by Subject|4|||
160520234|NCT03435497|579634953|FG000|Overall Study|Wrong survey administered|0|||
160520235|NCT03435497|579634954|FG001|Overall Study|Wrong survey administered|2|||
160520236|NCT01072877|579634955|FG000|Overall Study|Lost to Follow-up|1|||
160520237|NCT01072877|579634956|FG001|Overall Study|Lost to Follow-up|1|||
160520238|NCT01072877|579634957|FG002|Overall Study|Lost to Follow-up|0|||
160520239|NCT01072877|579634958|FG003|Overall Study|Lost to Follow-up|2|||
160520240|NCT01072877|579634959|FG004|Overall Study|Lost to Follow-up|0|||
160520241|NCT00601419|579634960|FG000|Overall Study|Lost to Follow-up|3|||
160520242|NCT00601419|579634960|FG000|Overall Study|Missed Visits|1|||
160520243|NCT01217957|579634971|FG000|Phase 1|Withdrawal by Patient|1|||
160520244|NCT01217957|579634972|FG001|Phase 1|Withdrawal by Patient|0|||
160520245|NCT01217957|579634973|FG002|Phase 1|Withdrawal by Patient|1|||
160520246|NCT01217957|579634974|FG003|Phase 1|Withdrawal by Patient|1|||
160520247|NCT01217957|579634975|FG004|Phase 1|Withdrawal by Patient|0|||
160520248|NCT01217957|579634971|FG000|Phase 2|Withdrawal by Patient|0|||
160520249|NCT01217957|579634972|FG001|Phase 2|Withdrawal by Patient|0|||
160520250|NCT01217957|579634973|FG002|Phase 2|Withdrawal by Patient|0|||
160520251|NCT01217957|579634974|FG003|Phase 2|Withdrawal by Patient|0|||
160520252|NCT01217957|579634975|FG004|Phase 2|Withdrawal by Patient|1|||
160520253|NCT00971932|579634976|FG000|Overall Study|Withdrawal by Subject|1|||
160520254|NCT00971932|579634976|FG000|Overall Study|Investigator's decision|2|||
160520255|NCT00971932|579634976|FG000|Overall Study|Ongoing|4|||
160520256|NCT01640054|579634977|FG000|Overall Study|Study-specific disc criteria|1|||
160520257|NCT01640054|579634977|FG000|Overall Study|Lack of Efficacy|3|||
160520258|NCT01640054|579634977|FG000|Overall Study|Adverse Event|2|||
160520259|NCT01206777|579634979|FG000|Overall Study|Death|1|||
160520260|NCT01206777|579634979|FG000|Overall Study|Adverse Event|1|||
160520261|NCT02382016|579634980|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
160520262|NCT02382016|579634981|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
160520263|NCT02382016|579634980|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
160520264|NCT02382016|579634981|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
160520265|NCT02382016|579634980|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
160520266|NCT02382016|579634981|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
160520267|NCT02382016|579634980|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
160520268|NCT02382016|579634981|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
160520269|NCT02382016|579634980|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
160520270|NCT02382016|579634981|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
160520271|NCT02382016|579634980|FG000|Open-label (OL) Treatment Period|Death|4|||
160520272|NCT02382016|579634981|FG001|Open-label (OL) Treatment Period|Death|0|||
160520273|NCT02382016|579634980|FG000|OL Extension Period|Physician Decision|3|||
160520274|NCT02382016|579634981|FG001|OL Extension Period|Physician Decision|0|||
160520275|NCT02382016|579634980|FG000|OL Extension Period|Death|2|||
160520276|NCT02382016|579634981|FG001|OL Extension Period|Death|0|||
160634637|NCT00604175|580042816|FG002|Entry Through Week 28|Ineligible|0|||
160634638|NCT00604175|580042814|FG000|Entry Through Week 28|Did not start intervention|2|||
160634639|NCT00604175|580042815|FG001|Entry Through Week 28|Did not start intervention|0|||
160634640|NCT00604175|580042816|FG002|Entry Through Week 28|Did not start intervention|1|||
160634641|NCT00604175|580042814|FG000|Week 29 Through Week 72|Death|0|||
160634642|NCT00604175|580042815|FG001|Week 29 Through Week 72|Death|0|||
160634643|NCT00604175|580042816|FG002|Week 29 Through Week 72|Death|1|||
160634644|NCT00604175|580042814|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
160634645|NCT00604175|580042815|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
160634646|NCT00604175|580042816|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
160634647|NCT00604175|580042814|FG000|Week 29 Through Week 72|Site closure|0|||
160634648|NCT00604175|580042815|FG001|Week 29 Through Week 72|Site closure|1|||
160634649|NCT00604175|580042816|FG002|Week 29 Through Week 72|Site closure|0|||
160634650|NCT00604175|580042814|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
160634651|NCT00604175|580042815|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
160634652|NCT00604175|580042816|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
160634653|NCT01682681|580042817|FG000|Overall Study|Lack of Efficacy|62|||
160634654|NCT01682681|580042817|FG000|Overall Study|Withdrawal by Subject|1|||
160634655|NCT01682681|580042817|FG000|Overall Study|Moved to other hospital|10|||
160634656|NCT01682681|580042817|FG000|Overall Study|Lost to Follow-up|174|||
160634657|NCT01682681|580042817|FG000|Overall Study|Adverse Event|46|||
160634658|NCT01682681|580042817|FG000|Overall Study|tapering of topiramate|5|||
160634659|NCT01682681|580042817|FG000|Overall Study|Other|21|||
160634660|NCT01682681|580042817|FG000|Overall Study|Low compliance|13|||
160634661|NCT03353415|580042820|FG000|Masked CGM Wear|Lost to Follow-up|2|||
160634662|NCT03353415|580042820|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
160634663|NCT03205163|580042821|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
160634664|NCT03205163|580042822|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
160634665|NCT00005879|580042823|FG000|Overall Study|Withdrawal by Subject|8|||
160634666|NCT00005879|580042824|FG001|Overall Study|Withdrawal by Subject|10|||
160634667|NCT01238172|580042825|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
160634668|NCT01238172|580042826|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
160634669|NCT01238172|580042825|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
160634670|NCT01238172|580042826|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
160634671|NCT05022121|580042827|FG000|Overall Study|Lack of Efficacy|1|||
160634672|NCT05022121|580042828|FG001|Overall Study|Lack of Efficacy|0|||
160634673|NCT05022121|580042827|FG000|Overall Study|Lost to Follow-up|0|||
160634674|NCT05022121|580042828|FG001|Overall Study|Lost to Follow-up|2|||
160863411|NCT03312634|580894725|FG001|Overall Study|Enrolled in an interventional study|52|||
160863412|NCT03312634|580894724|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
160863413|NCT03312634|580894725|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
160863414|NCT03312634|580894724|FG000|Overall Study|Death|0|||
160863415|NCT03312634|580894725|FG001|Overall Study|Death|1|||
160863416|NCT03312634|580894724|FG000|Overall Study|Non-compliance|0|||
160863417|NCT03312634|580894725|FG001|Overall Study|Non-compliance|2|||
160863418|NCT03312634|580894724|FG000|Overall Study|Lost to Follow-up|0|||
160863419|NCT03312634|580894725|FG001|Overall Study|Lost to Follow-up|1|||
160863420|NCT03312634|580894724|FG000|Overall Study|Enrolled into non-interventional study|0|||
160863421|NCT03312634|580894725|FG001|Overall Study|Enrolled into non-interventional study|5|||
160863422|NCT03312634|580894724|FG000|Overall Study|Worsening clinical condition|0|||
160863423|NCT03312634|580894725|FG001|Overall Study|Worsening clinical condition|1|||
160863424|NCT03312634|580894724|FG000|Overall Study|Participant did not want to travel|0|||
160863425|NCT03312634|580894725|FG001|Overall Study|Participant did not want to travel|1|||
160863426|NCT03312634|580894724|FG000|Overall Study|Physician Decision|1|||
160863427|NCT03312634|580894725|FG001|Overall Study|Physician Decision|0|||
160863428|NCT03312634|580894724|FG000|Overall Study|Other|13|||
160863429|NCT03312634|580894725|FG001|Overall Study|Other|0|||
160863430|NCT01148979|580894734|FG000|Overall Study|Lost to Follow-up|0|||
160863431|NCT01148979|580894735|FG001|Overall Study|Lost to Follow-up|1|||
160520277|NCT02382016|579634980|FG000|OL Extension Period|Withdrawal by Subject|1|||
160520278|NCT02382016|579634981|FG001|OL Extension Period|Withdrawal by Subject|0|||
160634675|NCT00131937|580042829|FG000|Overall Study|Adverse Event|3|||
160634676|NCT00131937|580042829|FG000|Overall Study|Withdrawal by Subject|2|||
160634677|NCT00131937|580042829|FG000|Overall Study|Physician Decision|1|||
160634678|NCT00131937|580042829|FG000|Overall Study|Disease Progression|7|||
160634679|NCT00131937|580042829|FG000|Overall Study|Alternative therapy|1|||
160634680|NCT04647253|580042836|FG000|Overall Study|Death ≤ 365 Days|16|||
160634681|NCT04647253|580042837|FG001|Overall Study|Death ≤ 365 Days|7|||
160863432|NCT00777153|580894736|FG000|Overall Study|Lost to Follow-up|1|||
160863433|NCT00777153|580894737|FG001|Overall Study|Lost to Follow-up|1|||
160863434|NCT00777153|580894738|FG002|Overall Study|Lost to Follow-up|0|||
160863435|NCT00777153|580894736|FG000|Overall Study|Death|85|||
160863436|NCT00777153|580894737|FG001|Overall Study|Death|73|||
160863437|NCT00777153|580894738|FG002|Overall Study|Death|33|||
160863438|NCT00777153|580894736|FG000|Overall Study|Withdrawal by Subject|3|||
160863439|NCT00777153|580894737|FG001|Overall Study|Withdrawal by Subject|4|||
160863440|NCT00777153|580894738|FG002|Overall Study|Withdrawal by Subject|3|||
160863441|NCT00777153|580894736|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
160863442|NCT00777153|580894737|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
160863443|NCT00777153|580894738|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
160863444|NCT02079246|580894739|FG000|OLEX|Withdrawal before treatment|1|||
160863445|NCT02079246|580894740|FG001|OLEX|Withdrawal before treatment|0|||
160863446|NCT02079246|580894739|FG000|OLEX|Death|11|||
160863447|NCT02079246|580894740|FG001|OLEX|Death|0|||
160863448|NCT02079246|580894739|FG000|OLEX|Adverse Event|66|||
160863449|NCT02079246|580894740|FG001|OLEX|Adverse Event|0|||
160863450|NCT02079246|580894739|FG000|OLEX|Withdrawal by Subject|60|||
160863451|NCT02079246|580894740|FG001|OLEX|Withdrawal by Subject|0|||
160863452|NCT02079246|580894739|FG000|OLEX|Lost to Follow-up|6|||
160863453|NCT02079246|580894740|FG001|OLEX|Lost to Follow-up|0|||
160863454|NCT02079246|580894739|FG000|OLEX|Protocol Violation|6|||
160863455|NCT02079246|580894740|FG001|OLEX|Protocol Violation|0|||
160863456|NCT02079246|580894739|FG000|OLEX|Lack of Efficacy|3|||
160863457|NCT02079246|580894740|FG001|OLEX|Lack of Efficacy|0|||
160863458|NCT02079246|580894739|FG000|OLEX|Results of the lead-in studies|58|||
160863459|NCT02079246|580894740|FG001|OLEX|Results of the lead-in studies|0|||
160863460|NCT02079246|580894739|FG000|OLEX|Other: Disallowed medication|8|||
160634682|NCT04647253|580042836|FG000|Overall Study|Physician Decision|0|||
160634683|NCT04647253|580042837|FG001|Overall Study|Physician Decision|1|||
160634684|NCT04647253|580042836|FG000|Overall Study|Withdrawal by Subject|7|||
160634685|NCT04647253|580042837|FG001|Overall Study|Withdrawal by Subject|2|||
160634686|NCT04647253|580042836|FG000|Overall Study|Missed 12-Month Visit|9|||
160634687|NCT04647253|580042837|FG001|Overall Study|Missed 12-Month Visit|7|||
160634688|NCT04647253|580042836|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
160634689|NCT04647253|580042837|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
160634690|NCT01211613|580044203|FG000|Overall Study|Lost to Follow-up|2|||
160634691|NCT01211613|580044204|FG001|Overall Study|Lost to Follow-up|2|||
160634692|NCT01211613|580044205|FG002|Overall Study|Lost to Follow-up|2|||
160634693|NCT01211613|580044203|FG000|Overall Study|Withdrawal by Subject|1|||
160634694|NCT01211613|580044204|FG001|Overall Study|Withdrawal by Subject|0|||
160634695|NCT01211613|580044205|FG002|Overall Study|Withdrawal by Subject|0|||
160634696|NCT01020773|580044206|FG000|Overall Study|Withdrawal by Subject|4|||
160634697|NCT01020773|580044207|FG001|Overall Study|Withdrawal by Subject|3|||
160634698|NCT03853213|580044208|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
160634699|NCT03853213|580044209|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
160634700|NCT03853213|580044208|FG000|Overall Study|Other (e.g., too busy)|0|||
160634701|NCT03853213|580044209|FG001|Overall Study|Other (e.g., too busy)|2|||
160634702|NCT03302299|580044210|FG000|Overall Study|Protocol Violation|1|||
160634703|NCT01458132|580044211|FG000|Overall Study|Other|15|||
160634704|NCT01458132|580044212|FG001|Overall Study|Other|3|||
160634705|NCT00819091|580044222|FG000|Overall Study|Adverse Event|3|||
160634706|NCT00819091|580044223|FG001|Overall Study|Adverse Event|5|||
160634707|NCT00819091|580044222|FG000|Overall Study|Protocol Violation|0|||
160634708|NCT00819091|580044223|FG001|Overall Study|Protocol Violation|1|||
160634709|NCT00819091|580044222|FG000|Overall Study|Lost to Follow-up|2|||
160634710|NCT00819091|580044223|FG001|Overall Study|Lost to Follow-up|0|||
160634711|NCT00819091|580044222|FG000|Overall Study|Withdrawal by Subject|1|||
160634712|NCT00819091|580044223|FG001|Overall Study|Withdrawal by Subject|2|||
160634713|NCT00819091|580044222|FG000|Overall Study|Other|1|||
160634714|NCT00819091|580044223|FG001|Overall Study|Other|2|||
160634715|NCT01788163|580044225|FG000|Overall Study|Other|53|||
160634716|NCT01788163|580044226|FG001|Overall Study|Other|0|||
160634717|NCT01788163|580044227|FG002|Overall Study|Other|0|||
160634718|NCT01788163|580044228|FG003|Overall Study|Other|0|||
160634719|NCT01788163|580044229|FG004|Overall Study|Other|0|||
160634720|NCT01788163|580044230|FG005|Overall Study|Other|7|||
160863461|NCT02079246|580894740|FG001|OLEX|Other: Disallowed medication|0|||
160863462|NCT02079246|580894739|FG000|OLEX|Other: Insufficient compliance|2|||
160634721|NCT01788163|580044231|FG006|Overall Study|Other|1|||
160634722|NCT01788163|580044232|FG007|Overall Study|Other|48|||
160863463|NCT02079246|580894740|FG001|OLEX|Other: Insufficient compliance|0|||
160634723|NCT01788163|580044233|FG008|Overall Study|Other|15|||
160634724|NCT01788163|580044225|FG000|Overall Study|Withdrawal by Subject|2|||
160634725|NCT01788163|580044226|FG001|Overall Study|Withdrawal by Subject|0|||
160634726|NCT01788163|580044227|FG002|Overall Study|Withdrawal by Subject|0|||
160634727|NCT01788163|580044228|FG003|Overall Study|Withdrawal by Subject|0|||
160863464|NCT02079246|580894739|FG000|OLEX|Other: Caregiver unavailable|3|||
160634728|NCT01788163|580044229|FG004|Overall Study|Withdrawal by Subject|0|||
160634729|NCT01788163|580044230|FG005|Overall Study|Withdrawal by Subject|0|||
160634730|NCT01788163|580044231|FG006|Overall Study|Withdrawal by Subject|0|||
160634731|NCT01788163|580044232|FG007|Overall Study|Withdrawal by Subject|0|||
160634732|NCT01788163|580044233|FG008|Overall Study|Withdrawal by Subject|1|||
160634733|NCT00545441|580044234|FG000|Overall Study|Fistula draining at 6 months|2|||
160634734|NCT00545441|580044235|FG001|Overall Study|Fistula draining at 6 months|4|||
160634735|NCT00545441|580044234|FG000|Overall Study|Lost to Follow-up|9|||
160634736|NCT00545441|580044235|FG001|Overall Study|Lost to Follow-up|5|||
160634737|NCT00545441|580044234|FG000|Overall Study|Technical failure|0|||
160863465|NCT02079246|580894740|FG001|OLEX|Other: Caregiver unavailable|0|||
160863466|NCT02079246|580894739|FG000|OLEX|Other: Coordinator decision|1|||
160863467|NCT02079246|580894740|FG001|OLEX|Other: Coordinator decision|0|||
160863468|NCT02079246|580894739|FG000|OLEX|Other: Worsening of condition|1|||
160863469|NCT02079246|580894740|FG001|OLEX|Other: Worsening of condition|0|||
160863470|NCT02079246|580894739|FG000|OLEX|Other: Moved to nursing home|1|||
160863471|NCT02079246|580894740|FG001|OLEX|Other: Moved to nursing home|0|||
160863472|NCT02079246|580894739|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
160863473|NCT02079246|580894740|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
160863474|NCT02079246|580894739|FG000|OLEX-MEM|Adverse Event|0|||
160863475|NCT02079246|580894740|FG001|OLEX-MEM|Adverse Event|6|||
160863476|NCT02079246|580894739|FG000|OLEX-MEM|Withdrawal by Subject|0|||
160863477|NCT02079246|580894740|FG001|OLEX-MEM|Withdrawal by Subject|7|||
160863478|NCT02079246|580894739|FG000|OLEX-MEM|Protocol Violation|0|||
160863479|NCT02079246|580894740|FG001|OLEX-MEM|Protocol Violation|2|||
160863480|NCT02079246|580894739|FG000|OLEX-MEM|Lost to Follow-up|0|||
160863481|NCT02079246|580894740|FG001|OLEX-MEM|Lost to Follow-up|1|||
160863482|NCT02079246|580894739|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
160863483|NCT02079246|580894740|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
160863484|NCT03591406|580894745|FG000|Overall Study|Adverse Event|5|||
160863485|NCT03591406|580894746|FG001|Overall Study|Adverse Event|3|||
160863486|NCT03591406|580894745|FG000|Overall Study|Protocol Violation|2|||
160863487|NCT03591406|580894746|FG001|Overall Study|Protocol Violation|1|||
160863488|NCT03591406|580894745|FG000|Overall Study|Withdrawal by Subject|0|||
160863489|NCT03591406|580894746|FG001|Overall Study|Withdrawal by Subject|5|||
160863490|NCT01389596|580894747|FG000|Overall Study|Protocol Violation|3|||
160863491|NCT01389596|580894748|FG001|Overall Study|Protocol Violation|4|||
160863492|NCT01389596|580894749|FG002|Overall Study|Protocol Violation|3|||
160863493|NCT01389596|580894747|FG000|Overall Study|Withdrawal by Subject|1|||
160863494|NCT01389596|580894748|FG001|Overall Study|Withdrawal by Subject|2|||
160863495|NCT01389596|580894749|FG002|Overall Study|Withdrawal by Subject|2|||
160863496|NCT01389596|580894747|FG000|Overall Study|Insufficient Clinical Response|3|||
160863497|NCT01389596|580894748|FG001|Overall Study|Insufficient Clinical Response|4|||
160863498|NCT01389596|580894749|FG002|Overall Study|Insufficient Clinical Response|5|||
160863499|NCT01389596|580894747|FG000|Overall Study|Adverse Event|1|||
160863500|NCT01389596|580894748|FG001|Overall Study|Adverse Event|4|||
160863501|NCT01389596|580894749|FG002|Overall Study|Adverse Event|0|||
160863502|NCT01389596|580894747|FG000|Overall Study|Death|0|||
160863503|NCT01389596|580894748|FG001|Overall Study|Death|1|||
160863504|NCT01389596|580894749|FG002|Overall Study|Death|0|||
160634738|NCT00545441|580044235|FG001|Overall Study|Technical failure|1|||
160863505|NCT01389596|580894747|FG000|Overall Study|Other Unspecified|2|||
160863506|NCT01389596|580894748|FG001|Overall Study|Other Unspecified|1|||
160863507|NCT01389596|580894749|FG002|Overall Study|Other Unspecified|0|||
160863508|NCT01709084|580894750|FG000|Overall Study|Lost to Follow-up|4|||
160863509|NCT01709084|580894751|FG001|Overall Study|Lost to Follow-up|7|||
160863510|NCT01709084|580894750|FG000|Overall Study|Withdrawal by Subject|2|||
160863511|NCT01709084|580894751|FG001|Overall Study|Withdrawal by Subject|2|||
160863512|NCT01709084|580894750|FG000|Overall Study|Adverse Event|5|||
160863513|NCT01709084|580894751|FG001|Overall Study|Adverse Event|0|||
160863514|NCT01709084|580894750|FG000|Overall Study|Other|5|||
160863515|NCT01709084|580894751|FG001|Overall Study|Other|3|||
160863516|NCT01709084|580894750|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
160863517|NCT01709084|580894751|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
160863518|NCT01709084|580894750|FG000|Overall Study|Not Treated|0|||
160863519|NCT01709084|580894751|FG001|Overall Study|Not Treated|2|||
160863520|NCT00214201|580894752|FG000|Overall Study|Withdrawal by Subject|2|||
160863521|NCT00214201|580894753|FG001|Overall Study|Withdrawal by Subject|0|||
160863522|NCT00214201|580894752|FG000|Overall Study|Death|0|||
160863523|NCT00214201|580894753|FG001|Overall Study|Death|2|||
160863524|NCT01357850|580894759|FG000|Overall Study|Lost to Follow-up|1|||
160863525|NCT01357850|580894760|FG001|Overall Study|Lost to Follow-up|0|||
160863526|NCT01357850|580894761|FG002|Overall Study|Lost to Follow-up|0|||
160863527|NCT01357850|580894762|FG003|Overall Study|Lost to Follow-up|0|||
160863528|NCT04610281|580894763|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
160863529|NCT04610281|580894764|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
160863530|NCT01942837|580894765|FG000|Overall Study|Death|1|||
160977804|NCT03864926|581310078|FG001|Overall Study|Death|2|||
160863531|NCT01942837|580894765|FG000|Overall Study|Symptomatic or radiographic progression|49|||
160863532|NCT01942837|580894765|FG000|Overall Study|Adverse Event|6|||
160863533|NCT01942837|580894765|FG000|Overall Study|Physician Decision|3|||
160863534|NCT01942837|580894765|FG000|Overall Study|Withdrawal by Subject|2|||
160863535|NCT01942837|580894765|FG000|Overall Study|Intercurrent Illness|1|||
160863536|NCT01942837|580894765|FG000|Overall Study|On treatment|3|||
160863537|NCT01942837|580894765|FG000|Overall Study|Never initiate the treatment|2|||
160634739|NCT00545441|580044234|FG000|Overall Study|Withdrawal by Subject|1|||
160634740|NCT00545441|580044235|FG001|Overall Study|Withdrawal by Subject|1|||
160634741|NCT00545441|580044234|FG000|Overall Study|Persistence or recurrence of fistula|5|||
160634742|NCT00545441|580044235|FG001|Overall Study|Persistence or recurrence of fistula|2|||
160863538|NCT01298648|580894766|FG000|Overall Study|Withdrawal by Subject|2|||
160863539|NCT01298648|580894766|FG000|Overall Study|Lost to Follow-up|21|||
160863540|NCT02351856|580894772|FG000|Overall Study|Adverse Event|2|||
160863541|NCT02351856|580894772|FG000|Overall Study|Physician Decision|5|||
160863542|NCT02351856|580894772|FG000|Overall Study|Study terminated by sponsor|1|||
160863543|NCT01458392|580894777|FG000|Overall Study|Death|2|||
160863544|NCT01458392|580894778|FG001|Overall Study|Death|11|||
160863545|NCT01458392|580894779|FG002|Overall Study|Death|22|||
160863546|NCT01458392|580894777|FG000|Overall Study|At the discretion of the sponsor|0|||
160863547|NCT01458392|580894778|FG001|Overall Study|At the discretion of the sponsor|2|||
160863548|NCT01458392|580894779|FG002|Overall Study|At the discretion of the sponsor|7|||
160863549|NCT01458392|580894777|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
160863550|NCT01458392|580894778|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
160863551|NCT01458392|580894779|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
160863552|NCT03038100|580894788|FG000|Overall Study|Death|289|||
160863553|NCT03038100|580894789|FG001|Overall Study|Death|272|||
160863554|NCT03038100|580894788|FG000|Overall Study|Lost to Follow-up|9|||
160863555|NCT03038100|580894789|FG001|Overall Study|Lost to Follow-up|10|||
160863556|NCT03038100|580894788|FG000|Overall Study|Protocol Deviation|1|||
160863557|NCT03038100|580894789|FG001|Overall Study|Protocol Deviation|4|||
160863558|NCT03038100|580894788|FG000|Overall Study|Withdrawal by Subject|45|||
160863559|NCT03038100|580894789|FG001|Overall Study|Withdrawal by Subject|51|||
160863560|NCT03038100|580894788|FG000|Overall Study|Study Terminated By Sponsor|305|||
160863561|NCT03038100|580894789|FG001|Overall Study|Study Terminated By Sponsor|311|||
160863562|NCT03038100|580894788|FG000|Overall Study|Physician Decision|1|||
160863563|NCT03038100|580894789|FG001|Overall Study|Physician Decision|3|||
160863564|NCT00918255|580894790|FG000|Overall Study|Adverse Event|1|||
160863565|NCT00918255|580894791|FG001|Overall Study|Adverse Event|0|||
160863566|NCT00918255|580894792|FG002|Overall Study|Adverse Event|0|||
160863567|NCT00918255|580894790|FG000|Overall Study|Withdrawal by Subject|1|||
160863568|NCT00918255|580894791|FG001|Overall Study|Withdrawal by Subject|0|||
160863569|NCT00918255|580894792|FG002|Overall Study|Withdrawal by Subject|2|||
160863570|NCT00918255|580894790|FG000|Overall Study|Lack of Efficacy|1|||
160863571|NCT00918255|580894791|FG001|Overall Study|Lack of Efficacy|0|||
160863572|NCT00918255|580894792|FG002|Overall Study|Lack of Efficacy|0|||
160863573|NCT00918255|580894790|FG000|Overall Study|Lost to Follow-up|1|||
160863574|NCT00918255|580894791|FG001|Overall Study|Lost to Follow-up|0|||
160863575|NCT00918255|580894792|FG002|Overall Study|Lost to Follow-up|2|||
160863576|NCT00918255|580894790|FG000|Overall Study|Exceeded allowed number of interventions|0|||
160863577|NCT00918255|580894791|FG001|Overall Study|Exceeded allowed number of interventions|0|||
160863578|NCT00918255|580894792|FG002|Overall Study|Exceeded allowed number of interventions|1|||
160863579|NCT00918255|580894790|FG000|Overall Study|Non-compliance|1|||
160863580|NCT00918255|580894791|FG001|Overall Study|Non-compliance|0|||
160863581|NCT00918255|580894792|FG002|Overall Study|Non-compliance|0|||
160863582|NCT00918255|580894790|FG000|Overall Study|Investigator discretion|1|||
160863583|NCT00918255|580894791|FG001|Overall Study|Investigator discretion|0|||
160863584|NCT00918255|580894792|FG002|Overall Study|Investigator discretion|0|||
160863585|NCT02038933|580894793|FG000|Overall Study|Disease progression|104|||
160863586|NCT02038933|580894793|FG000|Overall Study|Study drug toxicity|6|||
160863587|NCT02038933|580894793|FG000|Overall Study|Adverse event unrelated to study drug|6|||
160863588|NCT02038933|580894793|FG000|Overall Study|Participant request to discontinue treatment|2|||
160863589|NCT02038933|580894793|FG000|Overall Study|Lost to Follow-up|1|||
160863590|NCT02038933|580894793|FG000|Overall Study|Other reasons|2|||
160863591|NCT03250273|580894826|FG000|Overall Study|Disease Progression|2|||
160863592|NCT03250273|580894827|FG001|Overall Study|Disease Progression|11|||
160863593|NCT03250273|580894826|FG000|Overall Study|Death|0|||
160863594|NCT03250273|580894827|FG001|Overall Study|Death|1|||
160863595|NCT04154904|580894828|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
160863596|NCT04154904|580894829|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
160863597|NCT04154904|580894830|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
160863598|NCT02392624|580894831|FG000|Overall Study|Withdrawal by Subject|15|||
160634743|NCT00545441|580044234|FG000|Overall Study|Patients were not treated|1|||
160863599|NCT02392624|580894832|FG001|Overall Study|Withdrawal by Subject|12|||
160863600|NCT02392624|580894833|FG002|Overall Study|Withdrawal by Subject|9|||
160863601|NCT02392624|580894831|FG000|Overall Study|Adverse Event|4|||
160634744|NCT00545441|580044235|FG001|Overall Study|Patients were not treated|3|||
160634745|NCT00424515|580044236|FG000|Overall Study|Progressive Disease|10|||
160634746|NCT00424515|580044237|FG001|Overall Study|Progressive Disease|11|||
160634747|NCT00424515|580044236|FG000|Overall Study|Adverse Event|0|||
160634748|NCT00424515|580044237|FG001|Overall Study|Adverse Event|1|||
160634749|NCT00424515|580044236|FG000|Overall Study|Intercurrent Illness|0|||
160634750|NCT00424515|580044237|FG001|Overall Study|Intercurrent Illness|1|||
160634751|NCT00424515|580044236|FG000|Overall Study|Withdrawal by Subject|1|||
160634752|NCT00424515|580044237|FG001|Overall Study|Withdrawal by Subject|0|||
160634753|NCT04071366|580044238|FG000|Part 1: Open-label (29 Days)|Death|4|||
160634754|NCT04071366|580044239|FG001|Part 1: Open-label (29 Days)|Death|2|||
160634755|NCT04071366|580044240|FG002|Part 1: Open-label (29 Days)|Death|8|||
160634756|NCT04071366|580044241|FG003|Part 1: Open-label (29 Days)|Death|0|||
160634757|NCT04071366|580044242|FG004|Part 1: Open-label (29 Days)|Death|0|||
160634758|NCT04071366|580044238|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
160634759|NCT04071366|580044239|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
160634760|NCT04071366|580044240|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
160634761|NCT04071366|580044241|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
160634762|NCT04071366|580044242|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
160634763|NCT04071366|580044238|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
160634764|NCT04071366|580044239|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
160634765|NCT04071366|580044240|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
160634766|NCT04071366|580044241|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
160634767|NCT04071366|580044242|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
160634768|NCT04071366|580044238|FG000|Part 2: Randomized (29 Days)|Death|0|||
160634769|NCT04071366|580044239|FG001|Part 2: Randomized (29 Days)|Death|0|||
160634770|NCT04071366|580044240|FG002|Part 2: Randomized (29 Days)|Death|0|||
160634771|NCT04071366|580044241|FG003|Part 2: Randomized (29 Days)|Death|2|||
160634772|NCT04071366|580044242|FG004|Part 2: Randomized (29 Days)|Death|2|||
160634773|NCT04071366|580044238|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
160634774|NCT04071366|580044239|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
160634775|NCT04071366|580044240|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
160634776|NCT04071366|580044241|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
160634777|NCT04071366|580044242|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
160634778|NCT04071366|580044238|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
160634779|NCT04071366|580044239|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
160634780|NCT04071366|580044240|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
160634781|NCT04071366|580044241|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
160634782|NCT04071366|580044242|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
160634783|NCT04071366|580044238|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
160634784|NCT04071366|580044239|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
160634785|NCT04071366|580044240|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
160634786|NCT04071366|580044241|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
160634787|NCT04071366|580044242|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
160634788|NCT04071366|580044238|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
160634789|NCT04071366|580044239|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
160634790|NCT04071366|580044240|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
160634791|NCT04071366|580044241|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
160634792|NCT04071366|580044242|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
160634793|NCT04071366|580044238|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
160634794|NCT04071366|580044239|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
160634795|NCT04071366|580044240|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
160634796|NCT04071366|580044241|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
160634797|NCT04071366|580044242|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
160634798|NCT04071366|580044238|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
160634799|NCT04071366|580044239|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
160634800|NCT04071366|580044240|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
160634801|NCT04071366|580044241|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
160634802|NCT04071366|580044242|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
160634803|NCT02239692|580044243|FG000|Overall Study|Incomplete colonoscopy|1|||
160634804|NCT02239692|580044244|FG001|Overall Study|Incomplete colonoscopy|2|||
160520279|NCT00730171|579634986|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
160634805|NCT02239692|580044243|FG000|Overall Study|Adverse Event|0|||
160634806|NCT02239692|580044244|FG001|Overall Study|Adverse Event|1|||
160634807|NCT02239692|580044243|FG000|Overall Study|Physician Decision|0|||
160634808|NCT02239692|580044244|FG001|Overall Study|Physician Decision|1|||
160634809|NCT02239692|580044243|FG000|Overall Study|Lost to Follow-up|1|||
160634810|NCT02239692|580044244|FG001|Overall Study|Lost to Follow-up|4|||
160634811|NCT02239692|580044243|FG000|Overall Study|Withdrawal by Subject|3|||
160634812|NCT02239692|580044244|FG001|Overall Study|Withdrawal by Subject|5|||
160520280|NCT00730171|579634986|FG000|Overall Study|Adverse Event|193|||
160863602|NCT02392624|580894832|FG001|Overall Study|Adverse Event|1|||
160863603|NCT02392624|580894833|FG002|Overall Study|Adverse Event|2|||
160863604|NCT02392624|580894831|FG000|Overall Study|Pregnancy|1|||
160863605|NCT02392624|580894832|FG001|Overall Study|Pregnancy|0|||
160863606|NCT02392624|580894833|FG002|Overall Study|Pregnancy|0|||
160863607|NCT02392624|580894831|FG000|Overall Study|Protocol Violation|0|||
160863608|NCT02392624|580894832|FG001|Overall Study|Protocol Violation|0|||
160863609|NCT02392624|580894833|FG002|Overall Study|Protocol Violation|1|||
160863610|NCT02392624|580894831|FG000|Overall Study|Sponsor/Investigator Decision|2|||
160863611|NCT02392624|580894832|FG001|Overall Study|Sponsor/Investigator Decision|1|||
160863612|NCT02392624|580894833|FG002|Overall Study|Sponsor/Investigator Decision|0|||
160863613|NCT02392624|580894831|FG000|Overall Study|Other|49|||
160863614|NCT02392624|580894832|FG001|Overall Study|Other|1|||
160863615|NCT02392624|580894833|FG002|Overall Study|Other|1|||
160863616|NCT00936715|580894834|FG000|Overall Study|Investigators Discretion|1|||
160863617|NCT00936715|580894834|FG000|Overall Study|Protocol Violation|1|||
160863618|NCT00936715|580894834|FG000|Overall Study|Safety or Tolerability Reasons|4|||
160863619|NCT03841604|580894837|FG000|Overall Study|Withdrawal by Subject|3|||
160863620|NCT03841604|580894838|FG001|Overall Study|Withdrawal by Subject|1|||
160863621|NCT03841604|580894837|FG000|Overall Study|Adverse Event|4|||
160863622|NCT03841604|580894838|FG001|Overall Study|Adverse Event|2|||
160863623|NCT03841604|580894837|FG000|Overall Study|Physician Decision|1|||
160863624|NCT03841604|580894838|FG001|Overall Study|Physician Decision|0|||
160863625|NCT01337960|580894839|FG000|Overall Study|Lost to Follow-up|1|||
160863626|NCT01337960|580894840|FG001|Overall Study|Lost to Follow-up|0|||
160863627|NCT01337960|580894841|FG002|Overall Study|Lost to Follow-up|0|||
160863628|NCT01337960|580894839|FG000|Overall Study|Withdrawal by Subject|1|||
160863629|NCT01337960|580894840|FG001|Overall Study|Withdrawal by Subject|0|||
160863630|NCT01337960|580894841|FG002|Overall Study|Withdrawal by Subject|0|||
160863631|NCT03763877|580894843|FG000|Overall Study|Withdrawal by Subject|3|||
160863632|NCT03763877|580894844|FG001|Overall Study|Withdrawal by Subject|1|||
160863633|NCT03763877|580894845|FG002|Overall Study|Withdrawal by Subject|3|||
160863634|NCT03763877|580894846|FG003|Overall Study|Withdrawal by Subject|4|||
160863635|NCT03763877|580894843|FG000|Overall Study|Adverse Event|1|||
160863636|NCT03763877|580894844|FG001|Overall Study|Adverse Event|1|||
160863637|NCT03763877|580894845|FG002|Overall Study|Adverse Event|3|||
160863638|NCT03763877|580894846|FG003|Overall Study|Adverse Event|1|||
160863639|NCT03763877|580894843|FG000|Overall Study|Protocol Violation|1|||
160863640|NCT03763877|580894844|FG001|Overall Study|Protocol Violation|1|||
160863641|NCT03763877|580894845|FG002|Overall Study|Protocol Violation|0|||
160863642|NCT03763877|580894846|FG003|Overall Study|Protocol Violation|0|||
160863643|NCT03763877|580894843|FG000|Overall Study|Lost to Follow-up|0|||
160863644|NCT03763877|580894844|FG001|Overall Study|Lost to Follow-up|1|||
160863645|NCT03763877|580894845|FG002|Overall Study|Lost to Follow-up|1|||
160863646|NCT03763877|580894846|FG003|Overall Study|Lost to Follow-up|0|||
160863647|NCT01774721|580894850|FG000|Overall Study|Death|133|||
160863648|NCT01774721|580894851|FG001|Overall Study|Death|152|||
160863649|NCT01774721|580894850|FG000|Overall Study|Withdrawal by Subject|20|||
160863650|NCT01774721|580894851|FG001|Overall Study|Withdrawal by Subject|14|||
160863651|NCT01774721|580894850|FG000|Overall Study|Lost to Follow-up|6|||
160863652|NCT01774721|580894851|FG001|Overall Study|Lost to Follow-up|7|||
160863653|NCT01774721|580894850|FG000|Overall Study|Did not meet eligibility criteria|0|||
160863654|NCT01774721|580894851|FG001|Overall Study|Did not meet eligibility criteria|3|||
160863655|NCT01774721|580894850|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
160863656|NCT01774721|580894851|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
160863657|NCT01774721|580894850|FG000|Overall Study|Study terminated by sponsor|5|||
160863658|NCT01774721|580894851|FG001|Overall Study|Study terminated by sponsor|0|||
160863659|NCT01774721|580894850|FG000|Overall Study|Disease progression|5|||
160863660|NCT01774721|580894851|FG001|Overall Study|Disease progression|0|||
160863661|NCT00084136|580894861|FG000|PI Comparison|Death|10|||
160863662|NCT00084136|580894862|FG001|PI Comparison|Death|9|||
160863663|NCT00084136|580894863|FG002|PI Comparison|Death|0|||
160863664|NCT00084136|580894861|FG000|PI Comparison|Lost to Follow-up|11|||
160863665|NCT00084136|580894862|FG001|PI Comparison|Lost to Follow-up|8|||
160863666|NCT00084136|580894863|FG002|PI Comparison|Lost to Follow-up|0|||
160863667|NCT00084136|580894861|FG000|PI Comparison|Withdrawal by Subject|33|||
160863668|NCT00084136|580894862|FG001|PI Comparison|Withdrawal by Subject|30|||
160863669|NCT00084136|580894863|FG002|PI Comparison|Withdrawal by Subject|0|||
160863670|NCT00084136|580894861|FG000|PI Comparison|Clinic site closed|1|||
160863671|NCT00084136|580894862|FG001|PI Comparison|Clinic site closed|0|||
160863672|NCT00084136|580894863|FG002|PI Comparison|Clinic site closed|0|||
160863673|NCT00084136|580894861|FG000|NRTI Comparison|Death|20|||
160863674|NCT00084136|580894862|FG001|NRTI Comparison|Death|0|||
160863675|NCT00084136|580894863|FG002|NRTI Comparison|Death|18|||
160863676|NCT00084136|580894861|FG000|NRTI Comparison|Lost to Follow-up|14|||
160863677|NCT00084136|580894862|FG001|NRTI Comparison|Lost to Follow-up|0|||
160863678|NCT00084136|580894863|FG002|NRTI Comparison|Lost to Follow-up|12|||
160863679|NCT00084136|580894861|FG000|NRTI Comparison|Withdrawal by Subject|54|||
160863680|NCT00084136|580894862|FG001|NRTI Comparison|Withdrawal by Subject|0|||
160863681|NCT00084136|580894863|FG002|NRTI Comparison|Withdrawal by Subject|38|||
160863682|NCT00084136|580894861|FG000|NRTI Comparison|Clinic site closed|12|||
160863683|NCT00084136|580894862|FG001|NRTI Comparison|Clinic site closed|0|||
160863684|NCT00084136|580894863|FG002|NRTI Comparison|Clinic site closed|14|||
160863685|NCT00084136|580894861|FG000|NRTI Comparison|Not reason above|1|||
160863686|NCT00084136|580894862|FG001|NRTI Comparison|Not reason above|0|||
160863687|NCT00084136|580894863|FG002|NRTI Comparison|Not reason above|0|||
160863688|NCT03938259|580894867|FG000|Overall Study|unable to establish baseline for ventilation|1|||
160863689|NCT03938259|580894868|FG001|Overall Study|unable to establish baseline for ventilation|1|||
160863690|NCT01213472|580894869|FG000|Overall Study|Recurrence/Progressive disease|25|||
160863691|NCT01213472|580894869|FG000|Overall Study|Withdrawal by Subject|1|||
160863692|NCT01213472|580894869|FG000|Overall Study|Physician Decision|1|||
160863693|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
160863694|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
160863695|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
160863696|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
160863697|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
160863698|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
160863699|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
160863700|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
160863701|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
160863702|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
160863703|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
160863704|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
160863705|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
160863706|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
160863707|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
160863708|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
160863709|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
160863710|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
160863711|NCT03773978|580894880|FG000|DBW Period|Adverse Event|2|||
160863712|NCT03773978|580894881|FG001|DBW Period|Adverse Event|2|||
160863713|NCT03773978|580894880|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
160863714|NCT03773978|580894881|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
160863715|NCT03773978|580894880|FG000|DBW Period|Withdrawal by Subject|2|||
160863716|NCT03773978|580894881|FG001|DBW Period|Withdrawal by Subject|1|||
160863717|NCT03773978|580894880|FG000|DBW Period|Due to epidemic or pandemic|5|||
160863718|NCT03773978|580894881|FG001|DBW Period|Due to epidemic or pandemic|6|||
160863719|NCT03773978|580894880|FG000|DBW Period|Study team decision|1|||
160863720|NCT03773978|580894881|FG001|DBW Period|Study team decision|0|||
160863721|NCT03777982|580894882|FG000|Overall Study|Physician Decision|0|||
160863722|NCT03777982|580894883|FG001|Overall Study|Physician Decision|1|||
160863723|NCT00198822|580894884|FG000|Overall Study|Lost to Follow-up|14|||
160863724|NCT00198822|580894885|FG001|Overall Study|Lost to Follow-up|20|||
160863725|NCT00198822|580894886|FG002|Overall Study|Lost to Follow-up|21|||
160863726|NCT00453206|580894888|FG000|Overall Study|Death|1|||
160863727|NCT03866577|580894891|FG000|Overall Study|Protocol Violation|0|||
160863728|NCT03866577|580894892|FG001|Overall Study|Protocol Violation|0|||
160863729|NCT03866577|580894893|FG002|Overall Study|Protocol Violation|0|||
160863730|NCT03866577|580894894|FG003|Overall Study|Protocol Violation|0|||
160863731|NCT03866577|580894895|FG004|Overall Study|Protocol Violation|0|||
160863732|NCT03866577|580894896|FG005|Overall Study|Protocol Violation|0|||
160863733|NCT03866577|580894897|FG006|Overall Study|Protocol Violation|0|||
160863734|NCT03866577|580894898|FG007|Overall Study|Protocol Violation|0|||
160863735|NCT03866577|580894899|FG008|Overall Study|Protocol Violation|0|||
160863736|NCT03866577|580894900|FG009|Overall Study|Protocol Violation|0|||
160863737|NCT03866577|580894901|FG010|Overall Study|Protocol Violation|0|||
160863738|NCT03866577|580894902|FG011|Overall Study|Protocol Violation|1|||
160863739|NCT03866577|580894903|FG012|Overall Study|Protocol Violation|0|||
160863740|NCT03866577|580894891|FG000|Overall Study|Withdrawal by Subject|0|||
160863741|NCT03866577|580894892|FG001|Overall Study|Withdrawal by Subject|0|||
160863742|NCT03866577|580894893|FG002|Overall Study|Withdrawal by Subject|0|||
160863743|NCT03866577|580894894|FG003|Overall Study|Withdrawal by Subject|0|||
160863744|NCT03866577|580894895|FG004|Overall Study|Withdrawal by Subject|0|||
160863745|NCT03866577|580894896|FG005|Overall Study|Withdrawal by Subject|0|||
160863746|NCT03866577|580894897|FG006|Overall Study|Withdrawal by Subject|0|||
160863747|NCT03866577|580894898|FG007|Overall Study|Withdrawal by Subject|0|||
160863748|NCT03866577|580894899|FG008|Overall Study|Withdrawal by Subject|1|||
160863749|NCT03866577|580894900|FG009|Overall Study|Withdrawal by Subject|1|||
160634813|NCT02239692|580044243|FG000|Overall Study|Other reason|1|||
160634814|NCT02239692|580044244|FG001|Overall Study|Other reason|0|||
160863750|NCT03866577|580894901|FG010|Overall Study|Withdrawal by Subject|0|||
160863751|NCT03866577|580894902|FG011|Overall Study|Withdrawal by Subject|0|||
160863752|NCT03866577|580894903|FG012|Overall Study|Withdrawal by Subject|0|||
160863753|NCT03866577|580894891|FG000|Overall Study|Not qualified for IVIg infusion|0|||
160863754|NCT03866577|580894892|FG001|Overall Study|Not qualified for IVIg infusion|0|||
160863755|NCT03866577|580894893|FG002|Overall Study|Not qualified for IVIg infusion|0|||
160863756|NCT03866577|580894894|FG003|Overall Study|Not qualified for IVIg infusion|0|||
160863757|NCT03866577|580894895|FG004|Overall Study|Not qualified for IVIg infusion|0|||
160863758|NCT03866577|580894896|FG005|Overall Study|Not qualified for IVIg infusion|0|||
160863759|NCT03866577|580894897|FG006|Overall Study|Not qualified for IVIg infusion|0|||
160863760|NCT03866577|580894898|FG007|Overall Study|Not qualified for IVIg infusion|0|||
160863761|NCT03866577|580894899|FG008|Overall Study|Not qualified for IVIg infusion|0|||
160863762|NCT03866577|580894900|FG009|Overall Study|Not qualified for IVIg infusion|1|||
160863763|NCT03866577|580894901|FG010|Overall Study|Not qualified for IVIg infusion|0|||
160863764|NCT03866577|580894902|FG011|Overall Study|Not qualified for IVIg infusion|0|||
160863765|NCT03866577|580894903|FG012|Overall Study|Not qualified for IVIg infusion|0|||
160863766|NCT03818256|580894904|FG000|Overall Study|Withdrawal by Subject|2|||
160863767|NCT03818256|580894905|FG001|Overall Study|Withdrawal by Subject|2|||
160863768|NCT03818256|580894904|FG000|Overall Study|Adverse Event|3|||
160863769|NCT03818256|580894905|FG001|Overall Study|Adverse Event|1|||
160863770|NCT03818256|580894904|FG000|Overall Study|Lost to Follow-up|0|||
160863771|NCT03818256|580894905|FG001|Overall Study|Lost to Follow-up|5|||
160863772|NCT03818256|580894904|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
160863773|NCT03818256|580894905|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
160863774|NCT03818256|580894904|FG000|Overall Study|Not reporting for scheduled visits|1|||
160863775|NCT03818256|580894905|FG001|Overall Study|Not reporting for scheduled visits|0|||
160863776|NCT03818256|580894904|FG000|Overall Study|Non-compliant with investigational product|1|||
160863777|NCT03818256|580894905|FG001|Overall Study|Non-compliant with investigational product|0|||
160863778|NCT01342211|580894906|FG000|Overall Study|Lost to Follow-up|0|||
160863779|NCT01342211|580894907|FG001|Overall Study|Lost to Follow-up|0|||
160863780|NCT01342211|580894908|FG002|Overall Study|Lost to Follow-up|0|||
160863781|NCT01342211|580894909|FG003|Overall Study|Lost to Follow-up|1|||
160863782|NCT01342211|580894910|FG004|Overall Study|Lost to Follow-up|0|||
160863783|NCT01342211|580894906|FG000|Overall Study|Adverse Event|0|||
160863784|NCT01342211|580894907|FG001|Overall Study|Adverse Event|0|||
160863785|NCT01342211|580894908|FG002|Overall Study|Adverse Event|0|||
160863786|NCT01342211|580894909|FG003|Overall Study|Adverse Event|0|||
160863787|NCT01342211|580894910|FG004|Overall Study|Adverse Event|1|||
160863788|NCT01342211|580894906|FG000|Overall Study|Withdrawal by Subject|0|||
160863789|NCT01342211|580894907|FG001|Overall Study|Withdrawal by Subject|0|||
160863790|NCT01342211|580894908|FG002|Overall Study|Withdrawal by Subject|0|||
160863791|NCT01342211|580894909|FG003|Overall Study|Withdrawal by Subject|1|||
160863792|NCT01342211|580894910|FG004|Overall Study|Withdrawal by Subject|0|||
160863793|NCT01342211|580894906|FG000|Overall Study|Randomized, but not Treated|0|||
160863794|NCT01342211|580894907|FG001|Overall Study|Randomized, but not Treated|2|||
160863795|NCT01342211|580894908|FG002|Overall Study|Randomized, but not Treated|0|||
160863796|NCT01342211|580894909|FG003|Overall Study|Randomized, but not Treated|0|||
160863797|NCT01342211|580894910|FG004|Overall Study|Randomized, but not Treated|1|||
160863798|NCT02749422|580894913|FG000|Overall Study|Lost to Follow-up|0|||
160863799|NCT02749422|580894914|FG001|Overall Study|Lost to Follow-up|2|||
160863800|NCT02749422|580894913|FG000|Overall Study|Ineligible|0|||
160863801|NCT02749422|580894914|FG001|Overall Study|Ineligible|1|||
160863802|NCT01824836|580894915|FG000|Overall Study|Adverse Event|48|||
160863803|NCT01824836|580894915|FG000|Overall Study|Withdrawal by Subject|63|||
160863804|NCT01824836|580894915|FG000|Overall Study|Other complicating disease|116|||
160863805|NCT01824836|580894915|FG000|Overall Study|Disease progression|5|||
160863806|NCT01824836|580894915|FG000|Overall Study|Alternative therapy|2|||
160863807|NCT01824836|580894915|FG000|Overall Study|Depression|1|||
160863808|NCT01824836|580894915|FG000|Overall Study|Non-compliance|3|||
160863809|NCT01824836|580894915|FG000|Overall Study|Patient regained ovarian function|3|||
160863810|NCT01824836|580894915|FG000|Overall Study|Lost to Follow-up|8|||
160863811|NCT01824836|580894915|FG000|Overall Study|Physician Decision|2|||
160863812|NCT01824836|580894915|FG000|Overall Study|Research office was closed|3|||
160863813|NCT01824836|580894915|FG000|Overall Study|Relocation|3|||
160863814|NCT01824836|580894915|FG000|Overall Study|Insurance-related issue|1|||
160863815|NCT01824836|580894915|FG000|Overall Study|Transportation issue|1|||
160863816|NCT01824836|580894915|FG000|Overall Study|Patient transferred care|1|||
160863817|NCT01824836|580894915|FG000|Overall Study|Unknown reasons|4|||
160863818|NCT01824836|580894915|FG000|Overall Study|Never started treatment|16|||
160863819|NCT05530252|580894916|FG000|Overall Study|Lost to Follow-up|1|||
160520281|NCT00730171|579634986|FG000|Overall Study|Protocol Violation|48|||
160520282|NCT00730171|579634986|FG000|Overall Study|Withdrawal by Subject|202|||
160520283|NCT00730171|579634986|FG000|Overall Study|Lost to Follow-up|121|||
160520284|NCT00730171|579634986|FG000|Overall Study|Insufficient Therapeutic Response|141|||
160863820|NCT05530252|580894917|FG001|Overall Study|Lost to Follow-up|1|||
160863821|NCT05530252|580894918|FG002|Overall Study|Lost to Follow-up|1|||
160863822|NCT01350999|580894919|FG000|Overall Study|Adverse Event|4|||
160863823|NCT01350999|580894920|FG001|Overall Study|Adverse Event|9|||
160863824|NCT01350999|580894921|FG002|Overall Study|Adverse Event|10|||
160863825|NCT01350999|580894919|FG000|Overall Study|Voluntary withdrawal|3|||
160863826|NCT01350999|580894920|FG001|Overall Study|Voluntary withdrawal|4|||
160863827|NCT01350999|580894921|FG002|Overall Study|Voluntary withdrawal|6|||
160863828|NCT01350999|580894919|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
160863829|NCT01350999|580894920|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
160863830|NCT01350999|580894921|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
160917859|NCT03510884|581094127|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
160917860|NCT03510884|581094128|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
160917861|NCT03510884|581094129|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
160917862|NCT03510884|581094130|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
160917863|NCT03510884|581094127|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
160917864|NCT03510884|581094128|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
160917865|NCT03510884|581094129|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
160917866|NCT03510884|581094130|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
160917867|NCT03510884|581094127|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
160917868|NCT03510884|581094128|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
160917869|NCT03510884|581094129|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
160917870|NCT03510884|581094130|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
160917871|NCT03510884|581094127|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
160917872|NCT03510884|581094128|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
160917873|NCT03510884|581094129|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
160917874|NCT03510884|581094130|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
160917875|NCT03510884|581094127|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
160917876|NCT03510884|581094128|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
160917877|NCT03510884|581094129|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
160917878|NCT03510884|581094130|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
160917879|NCT03510884|581094127|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
160917880|NCT03510884|581094128|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
160917881|NCT03510884|581094129|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
160917882|NCT03510884|581094130|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
160917883|NCT00715078|581094131|FG000|Overall Study|Death|29|||
160917884|NCT00715078|581094132|FG001|Overall Study|Death|36|||
160917885|NCT00715078|581094133|FG002|Overall Study|Death|36|||
160917886|NCT00715078|581094131|FG000|Overall Study|Withdrawal by Subject|1|||
160917887|NCT00715078|581094132|FG001|Overall Study|Withdrawal by Subject|0|||
160917888|NCT00715078|581094133|FG002|Overall Study|Withdrawal by Subject|1|||
160917889|NCT00715078|581094131|FG000|Overall Study|Unable to start due to disease prog.|0|||
160917890|NCT00715078|581094132|FG001|Overall Study|Unable to start due to disease prog.|0|||
160917891|NCT00715078|581094133|FG002|Overall Study|Unable to start due to disease prog.|1|||
160917892|NCT00157950|581094134|FG000|Overall Study|Death|1|||
160917893|NCT00157950|581094135|FG001|Overall Study|Death|0|||
160917894|NCT02892760|581094139|FG000|Overall Study|Withdrawal by Subject|3|||
160917895|NCT01500629|581094140|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
160917896|NCT01500629|581094141|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
160917897|NCT00588848|581094142|FG000|Overall Study|Physician Decision|0|||
160917898|NCT00588848|581094143|FG001|Overall Study|Physician Decision|3|||
160917899|NCT01499667|581094144|FG000|Overall Study|administrative problems|4|||
160917900|NCT01499667|581094145|FG001|Overall Study|administrative problems|5|||
160917901|NCT01499667|581094146|FG002|Overall Study|administrative problems|5|||
160917902|NCT01499667|581094144|FG000|Overall Study|Protocol Violation|1|||
160917903|NCT01499667|581094145|FG001|Overall Study|Protocol Violation|3|||
160917904|NCT01499667|581094146|FG002|Overall Study|Protocol Violation|2|||
160917905|NCT01499667|581094144|FG000|Overall Study|Adverse Event|0|||
160917906|NCT01499667|581094145|FG001|Overall Study|Adverse Event|2|||
160917907|NCT01499667|581094146|FG002|Overall Study|Adverse Event|2|||
160917908|NCT01499667|581094144|FG000|Overall Study|Withdrawal by Subject|2|||
160917909|NCT01499667|581094145|FG001|Overall Study|Withdrawal by Subject|1|||
160917910|NCT01499667|581094146|FG002|Overall Study|Withdrawal by Subject|1|||
160917911|NCT01499667|581094144|FG000|Overall Study|Lack of Efficacy|2|||
160917912|NCT01499667|581094145|FG001|Overall Study|Lack of Efficacy|0|||
160917913|NCT01499667|581094146|FG002|Overall Study|Lack of Efficacy|0|||
160520285|NCT00730171|579634986|FG000|Overall Study|Other|61|||
160917914|NCT02902965|581094147|FG000|Overall Study|Withdrawal by Subject|10|||
160917915|NCT02673489|581094148|FG000|Treatment Period|Lost to Follow-up|3|||
160917916|NCT02673489|581094149|FG001|Treatment Period|Lost to Follow-up|0|||
160917917|NCT02673489|581094148|FG000|Treatment Period|Participant request to discontinue|1|||
160917918|NCT02673489|581094149|FG001|Treatment Period|Participant request to discontinue|1|||
160917919|NCT02673489|581094148|FG000|Treatment Period|Participant moved to another province|1|||
160917920|NCT02673489|581094149|FG001|Treatment Period|Participant moved to another province|0|||
160520286|NCT01729156|579634987|FG000|Overall Study|Withdrawal by Subject|1|||
160917921|NCT02673489|581094148|FG000|Treatment Period|Participant was incarcerated|0|||
160863831|NCT02144610|580896656|FG000|Overall Study|Physician Decision|1|||
160863832|NCT02144610|580896657|FG001|Overall Study|Physician Decision|0|||
160863833|NCT02144610|580896656|FG000|Overall Study|Withdrawal by Subject|1|||
160863834|NCT02144610|580896657|FG001|Overall Study|Withdrawal by Subject|5|||
160863835|NCT02144610|580896656|FG000|Overall Study|Death|2|||
160863836|NCT02144610|580896657|FG001|Overall Study|Death|2|||
160863837|NCT02144610|580896656|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
160863838|NCT02144610|580896657|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
160863839|NCT02144610|580896656|FG000|Overall Study|Other|0|||
160863840|NCT02144610|580896657|FG001|Overall Study|Other|1|||
160863841|NCT01354899|580896658|FG000|Overall Study|discharge from the hospital|2|||
160863842|NCT01354899|580896658|FG000|Overall Study|Protocol Violation|1|||
160863843|NCT00463567|580896661|FG000|Overall Study|Adverse Event|29|||
160863844|NCT00463567|580896662|FG001|Overall Study|Adverse Event|26|||
160863845|NCT00463567|580896663|FG002|Overall Study|Adverse Event|17|||
160863846|NCT00463567|580896664|FG003|Overall Study|Adverse Event|46|||
160863847|NCT00463567|580896665|FG004|Overall Study|Adverse Event|10|||
160863848|NCT00463567|580896666|FG005|Overall Study|Adverse Event|10|||
160863849|NCT00463567|580896667|FG006|Overall Study|Adverse Event|4|||
160863850|NCT00463567|580896661|FG000|Overall Study|Withdrawal by Subject|29|||
160863851|NCT00463567|580896662|FG001|Overall Study|Withdrawal by Subject|22|||
160863852|NCT00463567|580896663|FG002|Overall Study|Withdrawal by Subject|20|||
160863853|NCT00463567|580896664|FG003|Overall Study|Withdrawal by Subject|37|||
160863854|NCT00463567|580896665|FG004|Overall Study|Withdrawal by Subject|6|||
160863855|NCT00463567|580896666|FG005|Overall Study|Withdrawal by Subject|5|||
160863856|NCT00463567|580896667|FG006|Overall Study|Withdrawal by Subject|1|||
160863857|NCT00463567|580896661|FG000|Overall Study|Protocol Deviation|13|||
160863858|NCT00463567|580896662|FG001|Overall Study|Protocol Deviation|9|||
160863859|NCT00463567|580896663|FG002|Overall Study|Protocol Deviation|14|||
160863860|NCT00463567|580896664|FG003|Overall Study|Protocol Deviation|11|||
160863861|NCT00463567|580896665|FG004|Overall Study|Protocol Deviation|1|||
160863862|NCT00463567|580896666|FG005|Overall Study|Protocol Deviation|1|||
160863863|NCT00463567|580896667|FG006|Overall Study|Protocol Deviation|2|||
160863864|NCT00463567|580896661|FG000|Overall Study|Lost to Follow-up|12|||
160863865|NCT00463567|580896662|FG001|Overall Study|Lost to Follow-up|6|||
160863866|NCT00463567|580896663|FG002|Overall Study|Lost to Follow-up|13|||
160863867|NCT00463567|580896664|FG003|Overall Study|Lost to Follow-up|8|||
160863868|NCT00463567|580896665|FG004|Overall Study|Lost to Follow-up|1|||
160863869|NCT00463567|580896666|FG005|Overall Study|Lost to Follow-up|1|||
160863870|NCT00463567|580896667|FG006|Overall Study|Lost to Follow-up|1|||
160977805|NCT00445601|581310079|FG000|Overall Study|Withdrawal by Subject|11|||
160977806|NCT00445601|581310080|FG001|Overall Study|Withdrawal by Subject|11|||
160977807|NCT00445601|581310079|FG000|Overall Study|TURBT Complication|12|||
160977808|NCT00445601|581310080|FG001|Overall Study|TURBT Complication|8|||
160977809|NCT00445601|581310079|FG000|Overall Study|Incorrect Disease Status|6|||
160977810|NCT00445601|581310080|FG001|Overall Study|Incorrect Disease Status|6|||
160977811|NCT00445601|581310079|FG000|Overall Study|Drug Delivery Issue|2|||
160977812|NCT00445601|581310080|FG001|Overall Study|Drug Delivery Issue|2|||
160977813|NCT00445601|581310079|FG000|Overall Study|Adverse Event|2|||
160977814|NCT00445601|581310080|FG001|Overall Study|Adverse Event|0|||
160977815|NCT00445601|581310079|FG000|Overall Study|Death prior to TURBT|0|||
160977816|NCT00445601|581310080|FG001|Overall Study|Death prior to TURBT|1|||
160977817|NCT00619476|581310081|FG000|Overall Study|Adverse Event|12|||
160977818|NCT00619476|581310082|FG001|Overall Study|Adverse Event|6|||
160520287|NCT01729156|579634988|FG001|Overall Study|Withdrawal by Subject|0|||
160520288|NCT01729156|579634989|FG002|Overall Study|Withdrawal by Subject|0|||
160863871|NCT00463567|580896661|FG000|Overall Study|Administrative problems|5|||
160863872|NCT00463567|580896662|FG001|Overall Study|Administrative problems|3|||
160863873|NCT00463567|580896663|FG002|Overall Study|Administrative problems|6|||
160863874|NCT00463567|580896664|FG003|Overall Study|Administrative problems|9|||
160977819|NCT00619476|581310083|FG002|Overall Study|Adverse Event|12|||
160977820|NCT00619476|581310084|FG003|Overall Study|Adverse Event|16|||
160977821|NCT00619476|581310081|FG000|Overall Study|Lack of Efficacy|6|||
160977822|NCT00619476|581310082|FG001|Overall Study|Lack of Efficacy|1|||
160977823|NCT00619476|581310083|FG002|Overall Study|Lack of Efficacy|1|||
160977824|NCT00619476|581310084|FG003|Overall Study|Lack of Efficacy|4|||
160977825|NCT00619476|581310081|FG000|Overall Study|Protocol Violation|5|||
160977826|NCT00619476|581310082|FG001|Overall Study|Protocol Violation|4|||
160520289|NCT01256658|579634992|FG000|Period 1|Lost to Follow-up|837|||
160863875|NCT00463567|580896665|FG004|Overall Study|Administrative problems|3|||
160863876|NCT00463567|580896666|FG005|Overall Study|Administrative problems|2|||
160977827|NCT00619476|581310083|FG002|Overall Study|Protocol Violation|4|||
160977828|NCT00619476|581310084|FG003|Overall Study|Protocol Violation|9|||
160863877|NCT00463567|580896667|FG006|Overall Study|Administrative problems|2|||
160863878|NCT00463567|580896661|FG000|Overall Study|Lack of Efficacy|4|||
160863879|NCT00463567|580896662|FG001|Overall Study|Lack of Efficacy|9|||
160863880|NCT00463567|580896663|FG002|Overall Study|Lack of Efficacy|9|||
160863881|NCT00463567|580896664|FG003|Overall Study|Lack of Efficacy|17|||
160977829|NCT00619476|581310081|FG000|Overall Study|Lost to Follow-up|1|||
160520290|NCT01256658|579634993|FG001|Period 1|Lost to Follow-up|661|||
160520291|NCT01256658|579634992|FG000|Period 1|Withdrawal by Subject|35|||
160520292|NCT01256658|579634993|FG001|Period 1|Withdrawal by Subject|43|||
160520293|NCT01256658|579634992|FG000|Period 1|Death|48|||
160520294|NCT01256658|579634993|FG001|Period 1|Death|44|||
160520295|NCT00719563|579634994|FG000|Overall Study|Adverse Event|16|||
160520296|NCT00719563|579634995|FG001|Overall Study|Adverse Event|13|||
160520297|NCT00719563|579634994|FG000|Overall Study|Medical condition changed|3|||
160520298|NCT00719563|579634995|FG001|Overall Study|Medical condition changed|5|||
160520299|NCT00719563|579634994|FG000|Overall Study|Lack of Efficacy|3|||
160520300|NCT00719563|579634995|FG001|Overall Study|Lack of Efficacy|7|||
160520301|NCT00719563|579634994|FG000|Overall Study|Personal reasons|6|||
160520302|NCT00719563|579634995|FG001|Overall Study|Personal reasons|7|||
160520303|NCT00719563|579634994|FG000|Overall Study|Unknown reasons|4|||
160520304|NCT00719563|579634995|FG001|Overall Study|Unknown reasons|6|||
160520305|NCT00719563|579634994|FG000|Overall Study|Noncompliant|1|||
160520306|NCT00719563|579634995|FG001|Overall Study|Noncompliant|1|||
160520307|NCT00719563|579634994|FG000|Overall Study|Lost to Follow-up|5|||
160520308|NCT00719563|579634995|FG001|Overall Study|Lost to Follow-up|3|||
160520309|NCT01386788|579634998|FG000|Overall Study|Lost to Follow-up|2|||
160520310|NCT00462865|579635001|FG000|Overall Study|Adverse Event|1|||
160520311|NCT02120625|579635002|FG000|Overall Study|Physician Decision|2|||
160520312|NCT04142450|579635003|FG000|Overall Study|Screen Failure|1|||
160520313|NCT04142450|579635003|FG000|Overall Study|Lost to Follow-up|1|||
160520314|NCT00120406|579635004|FG000|Overall Study|Death|9|||
160520315|NCT00120406|579635005|FG001|Overall Study|Death|4|||
160520316|NCT00120406|579635004|FG000|Overall Study|Withdrawal by Subject|5|||
160977830|NCT00619476|581310082|FG001|Overall Study|Lost to Follow-up|2|||
160977831|NCT00619476|581310083|FG002|Overall Study|Lost to Follow-up|0|||
160977832|NCT00619476|581310084|FG003|Overall Study|Lost to Follow-up|1|||
160977833|NCT00619476|581310081|FG000|Overall Study|Investigator Discretion|2|||
160977834|NCT00619476|581310082|FG001|Overall Study|Investigator Discretion|2|||
160977835|NCT00619476|581310083|FG002|Overall Study|Investigator Discretion|2|||
160977836|NCT00619476|581310084|FG003|Overall Study|Investigator Discretion|0|||
160977837|NCT00619476|581310081|FG000|Overall Study|Withdrawal by Subject|5|||
160977838|NCT00619476|581310082|FG001|Overall Study|Withdrawal by Subject|7|||
160977839|NCT00619476|581310083|FG002|Overall Study|Withdrawal by Subject|5|||
160977840|NCT00619476|581310084|FG003|Overall Study|Withdrawal by Subject|4|||
160977841|NCT01091428|581310085|FG000|Phase 1|Progressive Disease|24|||
160977842|NCT01091428|581310086|FG001|Phase 1|Progressive Disease|8|||
160977843|NCT01091428|581310087|FG002|Phase 1|Progressive Disease|0|||
160977844|NCT01091428|581310088|FG003|Phase 1|Progressive Disease|0|||
160977845|NCT01091428|581310085|FG000|Phase 1|Symptomatic Deterioration|3|||
160977846|NCT01091428|581310086|FG001|Phase 1|Symptomatic Deterioration|2|||
160977847|NCT01091428|581310087|FG002|Phase 1|Symptomatic Deterioration|0|||
160977848|NCT01091428|581310088|FG003|Phase 1|Symptomatic Deterioration|0|||
160977849|NCT01091428|581310085|FG000|Phase 1|Adverse Event|2|||
160977850|NCT01091428|581310086|FG001|Phase 1|Adverse Event|0|||
160977851|NCT01091428|581310087|FG002|Phase 1|Adverse Event|0|||
160977852|NCT01091428|581310088|FG003|Phase 1|Adverse Event|0|||
160977853|NCT01091428|581310085|FG000|Phase 1|Withdrawal by Subject|7|||
160977854|NCT01091428|581310086|FG001|Phase 1|Withdrawal by Subject|0|||
160977855|NCT01091428|581310087|FG002|Phase 1|Withdrawal by Subject|0|||
160977856|NCT01091428|581310088|FG003|Phase 1|Withdrawal by Subject|0|||
160977857|NCT01091428|581310085|FG000|Phase 1|Reason not specified|0|||
160977858|NCT01091428|581310086|FG001|Phase 1|Reason not specified|1|||
160977859|NCT01091428|581310087|FG002|Phase 1|Reason not specified|0|||
160977860|NCT01091428|581310088|FG003|Phase 1|Reason not specified|0|||
160977861|NCT01091428|581310085|FG000|Phase 1|Single-Patient IND|2|||
160863882|NCT00463567|580896665|FG004|Overall Study|Lack of Efficacy|1|||
160863883|NCT00463567|580896666|FG005|Overall Study|Lack of Efficacy|0|||
160863884|NCT00463567|580896667|FG006|Overall Study|Lack of Efficacy|1|||
160863885|NCT00463567|580896661|FG000|Overall Study|Abnormal lab value(s)|1|||
160863886|NCT00463567|580896662|FG001|Overall Study|Abnormal lab value(s)|1|||
160977862|NCT01091428|581310086|FG001|Phase 1|Single-Patient IND|0|||
160977863|NCT01091428|581310087|FG002|Phase 1|Single-Patient IND|0|||
160977864|NCT01091428|581310088|FG003|Phase 1|Single-Patient IND|0|||
160520317|NCT00120406|579635005|FG001|Overall Study|Withdrawal by Subject|7|||
160520318|NCT00120406|579635004|FG000|Overall Study|Lost to Follow-up|5|||
160520319|NCT00120406|579635005|FG001|Overall Study|Lost to Follow-up|2|||
160520320|NCT00120406|579635004|FG000|Overall Study|received non-study stent|0|||
160977865|NCT01091428|581310085|FG000|Phase 2|Progressive Disease|0|||
160520321|NCT00120406|579635005|FG001|Overall Study|received non-study stent|2|||
160520322|NCT00120406|579635004|FG000|Overall Study|patient moved but has not withdrawn|0|||
160520323|NCT00120406|579635005|FG001|Overall Study|patient moved but has not withdrawn|1|||
160520324|NCT06336603|579635006|FG000|Overall Study|Withdrawal by Subject|1|||
160520325|NCT06336603|579635006|FG000|Overall Study|Lost to Follow-up|2|||
160520326|NCT00762970|579635014|FG000|Overall Study|Withdrawal by Subject|7|||
160977866|NCT01091428|581310086|FG001|Phase 2|Progressive Disease|0|||
160977867|NCT01091428|581310087|FG002|Phase 2|Progressive Disease|44|||
160977868|NCT01091428|581310088|FG003|Phase 2|Progressive Disease|46|||
160977869|NCT01091428|581310085|FG000|Phase 2|Symptomatic Deterioration|0|||
160977870|NCT01091428|581310086|FG001|Phase 2|Symptomatic Deterioration|0|||
160977871|NCT01091428|581310087|FG002|Phase 2|Symptomatic Deterioration|1|||
160977872|NCT01091428|581310088|FG003|Phase 2|Symptomatic Deterioration|6|||
160977873|NCT01091428|581310085|FG000|Phase 2|Adverse Event|0|||
160977874|NCT01091428|581310086|FG001|Phase 2|Adverse Event|0|||
160977875|NCT01091428|581310087|FG002|Phase 2|Adverse Event|12|||
160977876|NCT01091428|581310088|FG003|Phase 2|Adverse Event|5|||
160977877|NCT01091428|581310085|FG000|Phase 2|Withdrawal by Subject|0|||
160977878|NCT01091428|581310086|FG001|Phase 2|Withdrawal by Subject|0|||
160977879|NCT01091428|581310087|FG002|Phase 2|Withdrawal by Subject|9|||
160977880|NCT01091428|581310088|FG003|Phase 2|Withdrawal by Subject|8|||
160977881|NCT01091428|581310085|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
160977882|NCT01091428|581310086|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
160977883|NCT01091428|581310087|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
160977884|NCT01091428|581310088|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
160863887|NCT00463567|580896663|FG002|Overall Study|Abnormal lab value(s)|2|||
160863888|NCT00463567|580896664|FG003|Overall Study|Abnormal lab value(s)|1|||
160863889|NCT00463567|580896665|FG004|Overall Study|Abnormal lab value(s)|1|||
160863890|NCT00463567|580896666|FG005|Overall Study|Abnormal lab value(s)|0|||
160863891|NCT00463567|580896667|FG006|Overall Study|Abnormal lab value(s)|0|||
160863892|NCT00463567|580896661|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160977885|NCT01091428|581310085|FG000|Phase 2|Reason not specified|0|||
160977886|NCT01091428|581310086|FG001|Phase 2|Reason not specified|0|||
160977887|NCT01091428|581310087|FG002|Phase 2|Reason not specified|4|||
160977888|NCT01091428|581310088|FG003|Phase 2|Reason not specified|3|||
160977889|NCT01091428|581310085|FG000|Phase 2|Physician Decision|0|||
160977890|NCT01091428|581310086|FG001|Phase 2|Physician Decision|0|||
160977891|NCT01091428|581310087|FG002|Phase 2|Physician Decision|2|||
160977892|NCT01091428|581310088|FG003|Phase 2|Physician Decision|0|||
160977893|NCT01625910|581310093|FG000|Overall Study|Lost to Follow-up|3|||
160977894|NCT01625910|581310094|FG001|Overall Study|Lost to Follow-up|4|||
160977895|NCT02959138|581310095|FG000|Overall Study|Enrolled but Never Treated|0|||
160977896|NCT02959138|581310096|FG001|Overall Study|Enrolled but Never Treated|1|||
160977897|NCT02959138|581310097|FG002|Overall Study|Enrolled but Never Treated|0|||
160977898|NCT02391038|581310098|FG000|Overall Study|Progressive disease|3|||
160977899|NCT02391038|581310099|FG001|Overall Study|Progressive disease|3|||
160977900|NCT02391038|581310100|FG002|Overall Study|Progressive disease|6|||
160863893|NCT00463567|580896662|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160863894|NCT00463567|580896663|FG002|Overall Study|Abnormal test procedure result(s)|6|||
160863895|NCT00463567|580896664|FG003|Overall Study|Abnormal test procedure result(s)|2|||
160863896|NCT00463567|580896665|FG004|Overall Study|Abnormal test procedure result(s)|0|||
160863897|NCT00463567|580896666|FG005|Overall Study|Abnormal test procedure result(s)|2|||
160863898|NCT00463567|580896667|FG006|Overall Study|Abnormal test procedure result(s)|0|||
160863899|NCT00463567|580896661|FG000|Overall Study|Death|1|||
160863900|NCT00463567|580896662|FG001|Overall Study|Death|0|||
160863901|NCT00463567|580896663|FG002|Overall Study|Death|2|||
160863902|NCT00463567|580896664|FG003|Overall Study|Death|0|||
160520327|NCT00762970|579635015|FG001|Overall Study|Withdrawal by Subject|4|||
160520328|NCT00762970|579635016|FG002|Overall Study|Withdrawal by Subject|0|||
160863903|NCT00463567|580896665|FG004|Overall Study|Death|0|||
160863904|NCT00463567|580896666|FG005|Overall Study|Death|0|||
160863905|NCT00463567|580896667|FG006|Overall Study|Death|0|||
160863906|NCT00641667|580896670|FG000|Overall Study|Withdrawal by Subject|1|||
160520329|NCT00762970|579635014|FG000|Overall Study|Protocol Violation|3|||
160520330|NCT00762970|579635015|FG001|Overall Study|Protocol Violation|1|||
160863907|NCT00641667|580896670|FG000|Overall Study|Adverse Event|1|||
160863908|NCT00641667|580896670|FG000|Overall Study|Physician Decision|1|||
160863909|NCT00641667|580896670|FG000|Overall Study|Worsening of underlying disease|3|||
160863910|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
160863911|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
160863912|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
160863913|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
160863914|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
160863915|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
160863916|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
160863917|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
160863918|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
160520331|NCT00762970|579635016|FG002|Overall Study|Protocol Violation|1|||
160520332|NCT00762970|579635014|FG000|Overall Study|Lost to Follow-up|1|||
160520333|NCT00762970|579635015|FG001|Overall Study|Lost to Follow-up|2|||
160863919|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
160977901|NCT04213989|581310106|FG000|Overall Study|Withdrawal by Subject|3|||
160977902|NCT04213989|581310107|FG001|Overall Study|Withdrawal by Subject|2|||
160977903|NCT04213989|581310106|FG000|Overall Study|Physician Decision|1|||
160863920|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
160863921|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
160863922|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
160863923|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
160863924|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
160863925|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
160863926|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
160863927|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
160863928|NCT01235741|580896671|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
160863929|NCT01235741|580896672|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
160863930|NCT01235741|580896673|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
160863931|NCT01235741|580896671|FG000|Randomized to Treatment|Adverse Event|0|||
160863932|NCT01235741|580896672|FG001|Randomized to Treatment|Adverse Event|1|||
160863933|NCT01235741|580896673|FG002|Randomized to Treatment|Adverse Event|1|||
160863934|NCT01235741|580896671|FG000|Randomized to Treatment|Sponsor terminated study|0|||
160863935|NCT01235741|580896672|FG001|Randomized to Treatment|Sponsor terminated study|35|||
160977904|NCT04213989|581310107|FG001|Overall Study|Physician Decision|0|||
160977905|NCT04213989|581310106|FG000|Overall Study|Lost to Follow-up|0|||
160977906|NCT04213989|581310107|FG001|Overall Study|Lost to Follow-up|4|||
160863936|NCT01235741|580896673|FG002|Randomized to Treatment|Sponsor terminated study|34|||
160977907|NCT01327547|581310108|FG000|Overall Study|Adverse Event|4|||
160977908|NCT01327547|581310109|FG001|Overall Study|Adverse Event|1|||
160977909|NCT01327547|581310108|FG000|Overall Study|Death|1|||
160977910|NCT01327547|581310109|FG001|Overall Study|Death|2|||
160977911|NCT01327547|581310108|FG000|Overall Study|Lost to Follow-up|6|||
160977912|NCT01327547|581310109|FG001|Overall Study|Lost to Follow-up|6|||
160977913|NCT01327547|581310108|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
160977914|NCT01327547|581310109|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
160977915|NCT01327547|581310108|FG000|Overall Study|Withdrawal by Subject|3|||
160977916|NCT01327547|581310109|FG001|Overall Study|Withdrawal by Subject|7|||
160977917|NCT01327547|581310108|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
160977918|NCT01327547|581310109|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
160977919|NCT01327547|581310108|FG000|Overall Study|Protocol Violation|1|||
160977920|NCT01327547|581310109|FG001|Overall Study|Protocol Violation|0|||
160977921|NCT01327547|581310108|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
160977922|NCT01327547|581310109|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
160977923|NCT01327547|581310108|FG000|Overall Study|Required prohibited medication|2|||
160977924|NCT01327547|581310109|FG001|Overall Study|Required prohibited medication|0|||
160977925|NCT01327547|581310108|FG000|Overall Study|Non-compliance with study procedures|1|||
160977926|NCT01327547|581310109|FG001|Overall Study|Non-compliance with study procedures|0|||
160977927|NCT01327547|581310108|FG000|Overall Study|By investigator in subject's interest|0|||
160977928|NCT01327547|581310109|FG001|Overall Study|By investigator in subject's interest|1|||
160977929|NCT03918239|581310112|FG000|Overall Study|Lost to Follow-up|3|||
160977930|NCT03918239|581310113|FG001|Overall Study|Lost to Follow-up|1|||
160977931|NCT03918239|581310112|FG000|Overall Study|Pregnancy|0|||
160977932|NCT03918239|581310113|FG001|Overall Study|Pregnancy|2|||
160977933|NCT03918239|581310112|FG000|Overall Study|Withdrawal by Subject|3|||
160977934|NCT03918239|581310113|FG001|Overall Study|Withdrawal by Subject|3|||
160977935|NCT03918239|581310112|FG000|Overall Study|positive urine drug screening results|4|||
160977936|NCT03918239|581310113|FG001|Overall Study|positive urine drug screening results|1|||
160977937|NCT01984424|581310118|FG000|Overall Study|Withdrawal by Subject|3|||
160977938|NCT01984424|581310119|FG001|Overall Study|Withdrawal by Subject|5|||
160977939|NCT01984424|581310118|FG000|Overall Study|Sponsor Decision|0|||
160977940|NCT01984424|581310119|FG001|Overall Study|Sponsor Decision|1|||
160977941|NCT01984424|581310118|FG000|Overall Study|Lost to Follow-up|0|||
160977942|NCT01984424|581310119|FG001|Overall Study|Lost to Follow-up|1|||
160977943|NCT01807221|581310122|FG000|Overall Study|Progressive disease|1|||
160977944|NCT01807221|581310123|FG001|Overall Study|Progressive disease|0|||
160977945|NCT01807221|581310124|FG002|Overall Study|Progressive disease|1|||
160977946|NCT01807221|581310125|FG003|Overall Study|Progressive disease|0|||
160977947|NCT01807221|581310126|FG004|Overall Study|Progressive disease|0|||
160977948|NCT01807221|581310127|FG005|Overall Study|Progressive disease|0|||
160977949|NCT01807221|581310122|FG000|Overall Study|Death|7|||
160634815|NCT01901146|580044245|FG000|Neoadjuvant Phase|Death|1|||
160977950|NCT01807221|581310123|FG001|Overall Study|Death|9|||
160977951|NCT01807221|581310124|FG002|Overall Study|Death|4|||
160977952|NCT01807221|581310125|FG003|Overall Study|Death|2|||
160977953|NCT01807221|581310126|FG004|Overall Study|Death|1|||
160977954|NCT01807221|581310127|FG005|Overall Study|Death|6|||
160977955|NCT01807221|581310122|FG000|Overall Study|Physician Decision|2|||
160977956|NCT01807221|581310123|FG001|Overall Study|Physician Decision|1|||
160977957|NCT01807221|581310124|FG002|Overall Study|Physician Decision|0|||
160977958|NCT01807221|581310125|FG003|Overall Study|Physician Decision|0|||
160977959|NCT01807221|581310126|FG004|Overall Study|Physician Decision|0|||
160634816|NCT01901146|580044246|FG001|Neoadjuvant Phase|Death|2|||
160977960|NCT01807221|581310127|FG005|Overall Study|Physician Decision|0|||
160977961|NCT01807221|581310122|FG000|Overall Study|Adverse Event|33|||
160977962|NCT01807221|581310123|FG001|Overall Study|Adverse Event|22|||
160977963|NCT01807221|581310124|FG002|Overall Study|Adverse Event|26|||
160977964|NCT01807221|581310125|FG003|Overall Study|Adverse Event|25|||
160977965|NCT01807221|581310126|FG004|Overall Study|Adverse Event|18|||
160977966|NCT01807221|581310127|FG005|Overall Study|Adverse Event|21|||
160977967|NCT01807221|581310122|FG000|Overall Study|Protocol Violation|0|||
160977968|NCT01807221|581310123|FG001|Overall Study|Protocol Violation|2|||
160977969|NCT01807221|581310124|FG002|Overall Study|Protocol Violation|1|||
160977970|NCT01807221|581310125|FG003|Overall Study|Protocol Violation|2|||
160977971|NCT01807221|581310126|FG004|Overall Study|Protocol Violation|0|||
160977972|NCT01807221|581310127|FG005|Overall Study|Protocol Violation|1|||
160977973|NCT01807221|581310122|FG000|Overall Study|Non-compliance|1|||
160977974|NCT01807221|581310123|FG001|Overall Study|Non-compliance|2|||
160977975|NCT01807221|581310124|FG002|Overall Study|Non-compliance|0|||
160977976|NCT01807221|581310125|FG003|Overall Study|Non-compliance|1|||
160977977|NCT01807221|581310126|FG004|Overall Study|Non-compliance|0|||
160977978|NCT01807221|581310127|FG005|Overall Study|Non-compliance|0|||
160977979|NCT01807221|581310122|FG000|Overall Study|Logistical difficulties|0|||
160977980|NCT01807221|581310123|FG001|Overall Study|Logistical difficulties|1|||
160977981|NCT01807221|581310124|FG002|Overall Study|Logistical difficulties|0|||
160977982|NCT01807221|581310125|FG003|Overall Study|Logistical difficulties|0|||
160977983|NCT01807221|581310126|FG004|Overall Study|Logistical difficulties|1|||
160977984|NCT01807221|581310127|FG005|Overall Study|Logistical difficulties|0|||
160977985|NCT01807221|581310122|FG000|Overall Study|Withdrawal by Subject|33|||
160977986|NCT01807221|581310123|FG001|Overall Study|Withdrawal by Subject|15|||
160977987|NCT01807221|581310124|FG002|Overall Study|Withdrawal by Subject|8|||
160977988|NCT01807221|581310125|FG003|Overall Study|Withdrawal by Subject|14|||
160977989|NCT01807221|581310126|FG004|Overall Study|Withdrawal by Subject|16|||
160977990|NCT01807221|581310127|FG005|Overall Study|Withdrawal by Subject|13|||
160977991|NCT01807221|581310122|FG000|Overall Study|Sponsor decision|2|||
160977992|NCT01807221|581310123|FG001|Overall Study|Sponsor decision|0|||
160977993|NCT01807221|581310124|FG002|Overall Study|Sponsor decision|1|||
160977994|NCT01807221|581310125|FG003|Overall Study|Sponsor decision|1|||
160977995|NCT01807221|581310126|FG004|Overall Study|Sponsor decision|0|||
160977996|NCT01807221|581310127|FG005|Overall Study|Sponsor decision|0|||
160977997|NCT01807221|581310122|FG000|Overall Study|Lost to Follow-up|1|||
160977998|NCT01807221|581310123|FG001|Overall Study|Lost to Follow-up|0|||
160977999|NCT01807221|581310124|FG002|Overall Study|Lost to Follow-up|2|||
160978000|NCT01807221|581310125|FG003|Overall Study|Lost to Follow-up|1|||
160978001|NCT01807221|581310126|FG004|Overall Study|Lost to Follow-up|0|||
160978002|NCT01807221|581310127|FG005|Overall Study|Lost to Follow-up|0|||
160978003|NCT00594906|581310130|FG000|Overall Study|Physician Decision|1|||
160978004|NCT00594906|581310131|FG001|Overall Study|Physician Decision|0|||
160978005|NCT00594906|581310130|FG000|Overall Study|Physician Decision|0|||
160978006|NCT00594906|581310131|FG001|Overall Study|Physician Decision|1|||
160978007|NCT00594906|581310130|FG000|Overall Study|Death|0|||
160978008|NCT00594906|581310131|FG001|Overall Study|Death|1|||
160978009|NCT03772314|581310139|FG000|Overall Study|Adverse Event|7|||
160978010|NCT03772314|581310140|FG001|Overall Study|Adverse Event|2|||
160978011|NCT01613027|581310141|FG000|Overall Study|Lost to Follow-up|5|||
160978012|NCT01613027|581310141|FG000|Overall Study|Switched Physician|1|||
160978013|NCT01613027|581310141|FG000|Overall Study|Lack of Efficacy|1|||
160978014|NCT01613027|581310141|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
160978015|NCT04267614|581310144|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
160978016|NCT04267614|581310144|FG000|Overall Study|Lost to Follow-up|115|||
160978017|NCT03881059|581310150|FG000|Treatment Period - Part A|Adverse Event|1|||
160978018|NCT03881059|581310151|FG001|Treatment Period - Part A|Adverse Event|3|||
160978019|NCT03881059|581310152|FG002|Treatment Period - Part A|Adverse Event|4|||
160978020|NCT03881059|581310150|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
160978021|NCT03881059|581310151|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
160978022|NCT03881059|581310152|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
160978023|NCT03881059|581310150|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
160978024|NCT03881059|581310151|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
160978025|NCT03881059|581310152|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
160978026|NCT03881059|581310150|FG000|Treatment Period - Part A|Other reasons|2|||
160978027|NCT03881059|581310151|FG001|Treatment Period - Part A|Other reasons|1|||
160978028|NCT03881059|581310152|FG002|Treatment Period - Part A|Other reasons|0|||
160978029|NCT03881059|581310150|FG000|Treatment Period - Part B|Adverse Event|0|||
160978030|NCT03881059|581310151|FG001|Treatment Period - Part B|Adverse Event|0|||
160978031|NCT03881059|581310152|FG002|Treatment Period - Part B|Adverse Event|3|||
160978032|NCT03881059|581310150|FG000|Treatment Period - Part B|Death|0|||
160978033|NCT03881059|581310151|FG001|Treatment Period - Part B|Death|1|||
160978034|NCT03881059|581310152|FG002|Treatment Period - Part B|Death|1|||
160978035|NCT03881059|581310150|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
160453929|NCT00592852|579393967|FG000|Overall Study|Found ineligible|1|||
160978036|NCT03881059|581310151|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
160978037|NCT03881059|581310152|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
160978038|NCT03881059|581310150|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
160978039|NCT03881059|581310151|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
160978040|NCT03881059|581310152|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
160978041|NCT03881059|581310150|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
160978042|NCT03881059|581310151|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
160978043|NCT03881059|581310152|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
160978044|NCT03881059|581310150|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
160978045|NCT03881059|581310151|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
160978046|NCT03881059|581310152|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
160978047|NCT03881059|581310150|FG000|Treatment Period - Part B|Other reasons|4|||
160978048|NCT03881059|581310151|FG001|Treatment Period - Part B|Other reasons|3|||
160978049|NCT03881059|581310152|FG002|Treatment Period - Part B|Other reasons|3|||
160978050|NCT02065570|581310153|FG000|Induction Study|Adverse Event|5|||
160978051|NCT02065570|581310154|FG001|Induction Study|Adverse Event|12|||
160978052|NCT02065570|581310155|FG002|Induction Study|Adverse Event|0|||
160978053|NCT02065570|581310156|FG003|Induction Study|Adverse Event|0|||
160520334|NCT00762970|579635016|FG002|Overall Study|Lost to Follow-up|0|||
160520335|NCT00762970|579635014|FG000|Overall Study|Difficulty of handling lens|1|||
160520336|NCT00762970|579635015|FG001|Overall Study|Difficulty of handling lens|2|||
160520337|NCT00762970|579635016|FG002|Overall Study|Difficulty of handling lens|0|||
160520338|NCT01480674|579635017|FG000|Overall Study|Death|23|||
160520339|NCT01480674|579635017|FG000|Overall Study|Lost to Follow-up|2|||
160520340|NCT01480674|579635017|FG000|Overall Study|visit not done|10|||
160978054|NCT02065570|581310153|FG000|Induction Study|Withdrawal by Subject|2|||
160978055|NCT02065570|581310154|FG001|Induction Study|Withdrawal by Subject|3|||
160978056|NCT02065570|581310155|FG002|Induction Study|Withdrawal by Subject|0|||
160978057|NCT02065570|581310156|FG003|Induction Study|Withdrawal by Subject|0|||
160978058|NCT02065570|581310153|FG000|Induction Study|Lost to Follow-up|1|||
160978059|NCT02065570|581310154|FG001|Induction Study|Lost to Follow-up|1|||
160978060|NCT02065570|581310155|FG002|Induction Study|Lost to Follow-up|0|||
160978061|NCT02065570|581310156|FG003|Induction Study|Lost to Follow-up|0|||
160978062|NCT02065570|581310153|FG000|Induction Study|Other, Not Specified|6|||
160978063|NCT02065570|581310154|FG001|Induction Study|Other, Not Specified|5|||
160978064|NCT02065570|581310155|FG002|Induction Study|Other, Not Specified|0|||
160978065|NCT02065570|581310156|FG003|Induction Study|Other, Not Specified|0|||
160978066|NCT02065570|581310153|FG000|Maintenance Study|Adverse Event|0|||
160978067|NCT02065570|581310154|FG001|Maintenance Study|Adverse Event|0|||
160978068|NCT02065570|581310155|FG002|Maintenance Study|Adverse Event|8|||
160978069|NCT02065570|581310156|FG003|Maintenance Study|Adverse Event|8|||
160978070|NCT02065570|581310153|FG000|Maintenance Study|Withdrawal by Subject|0|||
160978071|NCT02065570|581310154|FG001|Maintenance Study|Withdrawal by Subject|0|||
160978072|NCT02065570|581310155|FG002|Maintenance Study|Withdrawal by Subject|1|||
160978073|NCT02065570|581310156|FG003|Maintenance Study|Withdrawal by Subject|4|||
160978074|NCT02065570|581310153|FG000|Maintenance Study|Lost to Follow-up|0|||
160978075|NCT02065570|581310154|FG001|Maintenance Study|Lost to Follow-up|0|||
160978076|NCT02065570|581310155|FG002|Maintenance Study|Lost to Follow-up|2|||
160520341|NCT00975507|579635018|FG000|Overall Study|Adverse Event|1|||
160520342|NCT00975507|579635019|FG001|Overall Study|Adverse Event|0|||
160520343|NCT00975507|579635018|FG000|Overall Study|Lost to Follow-up|7|||
160520344|NCT00975507|579635019|FG001|Overall Study|Lost to Follow-up|1|||
160520345|NCT00975507|579635018|FG000|Overall Study|Protocol Violation|2|||
160520346|NCT00975507|579635019|FG001|Overall Study|Protocol Violation|0|||
160520347|NCT00975507|579635018|FG000|Overall Study|Withdrawal by Subject|10|||
160520348|NCT00975507|579635019|FG001|Overall Study|Withdrawal by Subject|3|||
160978077|NCT02065570|581310156|FG003|Maintenance Study|Lost to Follow-up|2|||
160978078|NCT02065570|581310153|FG000|Maintenance Study|Other, Not Specified|0|||
160520349|NCT01295034|579635020|FG000|Overall Study|Lost to Follow-up|5|||
160520350|NCT01295034|579635021|FG001|Overall Study|Lost to Follow-up|5|||
160520351|NCT03249714|579635022|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
160978079|NCT02065570|581310154|FG001|Maintenance Study|Other, Not Specified|0|||
160978080|NCT02065570|581310155|FG002|Maintenance Study|Other, Not Specified|11|||
160978081|NCT02065570|581310156|FG003|Maintenance Study|Other, Not Specified|5|||
160978082|NCT02743793|581310157|FG000|Overall Study|Death|1|||
160978083|NCT02743793|581310158|FG001|Overall Study|Death|1|||
160978084|NCT02743793|581310157|FG000|Overall Study|Withdrawal by Subject|0|||
160978085|NCT02743793|581310158|FG001|Overall Study|Withdrawal by Subject|1|||
160978086|NCT02743793|581310157|FG000|Overall Study|Screen Failure|4|||
160978087|NCT02743793|581310158|FG001|Overall Study|Screen Failure|0|||
160978088|NCT02743793|581310157|FG000|Overall Study|No Primary Care Physician|0|||
160520352|NCT03249714|579635023|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
160520353|NCT03249714|579635022|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
160520354|NCT03249714|579635023|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
160520355|NCT03249714|579635022|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
160978089|NCT02743793|581310158|FG001|Overall Study|No Primary Care Physician|1|||
160978090|NCT02743793|581310157|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
160520356|NCT03249714|579635023|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
160520357|NCT03249714|579635022|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
160520358|NCT03249714|579635023|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
160520359|NCT00824161|579635026|FG000|Overall Study|Withdrawal by Subject|1|||
160520360|NCT00824161|579635026|FG000|Overall Study|Screen Failure|1|||
160520361|NCT00879762|579635027|FG000|Overall Study|Lost to Follow-up|3|||
160520362|NCT00879762|579635028|FG001|Overall Study|Lost to Follow-up|1|||
160520363|NCT04754477|579635031|FG000|Overall Study|Withdrawal by Subject|1|||
160520364|NCT03575143|579635032|FG000|Overall Study|Lost to Follow-up|0|||
160520365|NCT03575143|579635033|FG001|Overall Study|Lost to Follow-up|0|||
160520366|NCT03575143|579635034|FG002|Overall Study|Lost to Follow-up|4|||
160520367|NCT03575143|579635032|FG000|Overall Study|Withdrawal by Subject|0|||
160520368|NCT03575143|579635033|FG001|Overall Study|Withdrawal by Subject|0|||
160520369|NCT03575143|579635034|FG002|Overall Study|Withdrawal by Subject|5|||
160520370|NCT03575143|579635032|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
160520371|NCT03575143|579635033|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
160520372|NCT03575143|579635034|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
160520373|NCT00899548|579635039|FG000|Overall Study|Physician Decision|3|||
160520374|NCT00551460|579635040|FG000|Overall Study|Adverse Event|1|||
160520375|NCT00551460|579635040|FG000|Overall Study|Withdrawal by Subject|1|||
160520376|NCT00551460|579635040|FG000|Overall Study|Physician Decision|1|||
160520377|NCT00551460|579635040|FG000|Overall Study|Death|7|||
160520378|NCT00551460|579635040|FG000|Overall Study|Ineligible|4|||
160520379|NCT00551460|579635040|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
160520380|NCT04781387|579635041|FG000|Overall Study|Withdrawal by Subject|1|||
160520381|NCT04781387|579635042|FG001|Overall Study|Withdrawal by Subject|0|||
160520382|NCT04781387|579635043|FG002|Overall Study|Withdrawal by Subject|1|||
160520383|NCT04781387|579635041|FG000|Overall Study|Lost to Follow-up|1|||
160520384|NCT04781387|579635042|FG001|Overall Study|Lost to Follow-up|0|||
160520385|NCT04781387|579635043|FG002|Overall Study|Lost to Follow-up|0|||
160520386|NCT01636960|579635044|FG000|Induction Phase|Adverse Event|2|||
160520387|NCT01636960|579635044|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
160520388|NCT01636960|579635044|FG000|Maintenance Phase|Adverse Event|3|||
160520389|NCT01636960|579635044|FG000|Maintenance Phase|Progressive disease|1|||
160520390|NCT01209780|579635045|FG000|Overall Study|Adverse Event|0|||
160520391|NCT01209780|579635046|FG001|Overall Study|Adverse Event|1|||
160520392|NCT01209780|579635047|FG002|Overall Study|Adverse Event|0|||
160520393|NCT01209780|579635048|FG003|Overall Study|Adverse Event|0|||
160520394|NCT01209780|579635049|FG004|Overall Study|Adverse Event|0|||
160520395|NCT01209780|579635045|FG000|Overall Study|Withdrawal by Subject|9|||
160520396|NCT01209780|579635046|FG001|Overall Study|Withdrawal by Subject|2|||
160520397|NCT01209780|579635047|FG002|Overall Study|Withdrawal by Subject|1|||
160520398|NCT01209780|579635048|FG003|Overall Study|Withdrawal by Subject|1|||
160520399|NCT01209780|579635049|FG004|Overall Study|Withdrawal by Subject|0|||
160520400|NCT01209780|579635045|FG000|Overall Study|Lost to Follow-up|17|||
160520401|NCT01209780|579635046|FG001|Overall Study|Lost to Follow-up|12|||
160520402|NCT01209780|579635047|FG002|Overall Study|Lost to Follow-up|3|||
160520403|NCT01209780|579635048|FG003|Overall Study|Lost to Follow-up|9|||
160520404|NCT01209780|579635049|FG004|Overall Study|Lost to Follow-up|4|||
160520405|NCT01209780|579635045|FG000|Overall Study|Protocol Violation|0|||
160520406|NCT01209780|579635046|FG001|Overall Study|Protocol Violation|1|||
160520407|NCT01209780|579635047|FG002|Overall Study|Protocol Violation|0|||
160520408|NCT01209780|579635048|FG003|Overall Study|Protocol Violation|0|||
160520409|NCT01209780|579635049|FG004|Overall Study|Protocol Violation|0|||
160520410|NCT01209780|579635045|FG000|Overall Study|Inappropriate enrollment|0|||
160520411|NCT01209780|579635046|FG001|Overall Study|Inappropriate enrollment|2|||
160520412|NCT01209780|579635047|FG002|Overall Study|Inappropriate enrollment|0|||
160520413|NCT01209780|579635048|FG003|Overall Study|Inappropriate enrollment|0|||
160520414|NCT01209780|579635049|FG004|Overall Study|Inappropriate enrollment|1|||
160978091|NCT02743793|581310158|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
160520415|NCT00903682|579635051|FG000|Overall Study|Adverse Event|6|||
160520416|NCT00903682|579635052|FG001|Overall Study|Adverse Event|13|||
160520417|NCT00903682|579635051|FG000|Overall Study|Lost to Follow-up|1|||
160520418|NCT00903682|579635052|FG001|Overall Study|Lost to Follow-up|0|||
160520419|NCT00903682|579635051|FG000|Overall Study|Withdrawal by Subject|5|||
160520420|NCT00903682|579635052|FG001|Overall Study|Withdrawal by Subject|0|||
160520421|NCT00903682|579635051|FG000|Overall Study|Pregnancy|0|||
160520422|NCT00903682|579635052|FG001|Overall Study|Pregnancy|1|||
160520423|NCT00903682|579635051|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
160520424|NCT00903682|579635052|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
160520425|NCT00903682|579635051|FG000|Overall Study|Subject Non-Compliant|1|||
160520426|NCT00903682|579635052|FG001|Overall Study|Subject Non-Compliant|0|||
160748893|NCT03091738|580467865|FG000|Overall Study|Lost to Follow-up|1|||
160520427|NCT00903682|579635051|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
160520428|NCT00903682|579635052|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
160520429|NCT00903682|579635051|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
160520430|NCT00903682|579635052|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
160520431|NCT03075410|579635053|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
160520432|NCT03075410|579635054|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
160520433|NCT03075410|579635055|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
160520434|NCT03075410|579635056|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
160520435|NCT03075410|579635057|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
160520436|NCT03075410|579635058|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
160520437|NCT03075410|579635059|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
160520438|NCT03075410|579635060|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
160520439|NCT03075410|579635061|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
160520440|NCT03075410|579635053|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
160520441|NCT03075410|579635054|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
160520442|NCT03075410|579635055|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
160520443|NCT03075410|579635056|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
160520444|NCT03075410|579635057|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
160520445|NCT03075410|579635058|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
160520446|NCT03075410|579635059|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
160520447|NCT03075410|579635060|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
160520448|NCT03075410|579635061|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
160520449|NCT03756129|579635062|FG000|Overall Study|Adverse Event|1|||
160520450|NCT03756129|579635063|FG001|Overall Study|Adverse Event|1|||
160520451|NCT03756129|579635064|FG002|Overall Study|Adverse Event|0|||
160520452|NCT03756129|579635065|FG003|Overall Study|Adverse Event|2|||
160520453|NCT03756129|579635066|FG004|Overall Study|Adverse Event|0|||
160520454|NCT03756129|579635067|FG005|Overall Study|Adverse Event|0|||
160520455|NCT03756129|579635062|FG000|Overall Study|Withdrawal by Subject|2|||
160520456|NCT03756129|579635063|FG001|Overall Study|Withdrawal by Subject|1|||
160520457|NCT03756129|579635064|FG002|Overall Study|Withdrawal by Subject|3|||
160520458|NCT03756129|579635065|FG003|Overall Study|Withdrawal by Subject|1|||
160520459|NCT03756129|579635066|FG004|Overall Study|Withdrawal by Subject|1|||
160520460|NCT03756129|579635067|FG005|Overall Study|Withdrawal by Subject|3|||
160520461|NCT03756129|579635062|FG000|Overall Study|Lost to Follow-up|0|||
160520462|NCT03756129|579635063|FG001|Overall Study|Lost to Follow-up|0|||
160520463|NCT03756129|579635064|FG002|Overall Study|Lost to Follow-up|0|||
160520464|NCT03756129|579635065|FG003|Overall Study|Lost to Follow-up|0|||
160520465|NCT03756129|579635066|FG004|Overall Study|Lost to Follow-up|0|||
160520466|NCT03756129|579635067|FG005|Overall Study|Lost to Follow-up|1|||
160520467|NCT03756129|579635062|FG000|Overall Study|Physician Decision|0|||
160520468|NCT03756129|579635063|FG001|Overall Study|Physician Decision|0|||
160520469|NCT03756129|579635064|FG002|Overall Study|Physician Decision|0|||
160520470|NCT03756129|579635065|FG003|Overall Study|Physician Decision|0|||
160520471|NCT03756129|579635066|FG004|Overall Study|Physician Decision|0|||
160520472|NCT03756129|579635067|FG005|Overall Study|Physician Decision|1|||
160520473|NCT03464097|579635068|FG000|Overall Study|Withdrawal by Subject|15|||
160520474|NCT03464097|579635069|FG001|Overall Study|Withdrawal by Subject|13|||
160520475|NCT03464097|579635070|FG002|Overall Study|Withdrawal by Subject|11|||
160520476|NCT03464097|579635068|FG000|Overall Study|Study terminated by sponsor|47|||
160520477|NCT03464097|579635069|FG001|Overall Study|Study terminated by sponsor|44|||
160520478|NCT03464097|579635070|FG002|Overall Study|Study terminated by sponsor|40|||
160520479|NCT03464097|579635068|FG000|Overall Study|Pregnancy|0|||
160520480|NCT03464097|579635069|FG001|Overall Study|Pregnancy|1|||
160520481|NCT03464097|579635070|FG002|Overall Study|Pregnancy|0|||
160520482|NCT03464097|579635068|FG000|Overall Study|Other reasons|5|||
160520483|NCT03464097|579635069|FG001|Overall Study|Other reasons|12|||
160520484|NCT03464097|579635070|FG002|Overall Study|Other reasons|14|||
160520485|NCT03464097|579635068|FG000|Overall Study|Lost to Follow-up|0|||
160520486|NCT03464097|579635069|FG001|Overall Study|Lost to Follow-up|1|||
160520487|NCT03464097|579635070|FG002|Overall Study|Lost to Follow-up|1|||
160520488|NCT03464097|579635068|FG000|Overall Study|Lack of Efficacy|11|||
160520489|NCT03464097|579635069|FG001|Overall Study|Lack of Efficacy|18|||
160520490|NCT03464097|579635070|FG002|Overall Study|Lack of Efficacy|30|||
160863937|NCT01235741|580896671|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
160520491|NCT03464097|579635068|FG000|Overall Study|Death|1|||
160520492|NCT03464097|579635069|FG001|Overall Study|Death|0|||
160520493|NCT03464097|579635070|FG002|Overall Study|Death|0|||
160520494|NCT03464097|579635068|FG000|Overall Study|Adverse Event|13|||
160863938|NCT01235741|580896672|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
160520495|NCT03464097|579635069|FG001|Overall Study|Adverse Event|6|||
160520496|NCT03464097|579635070|FG002|Overall Study|Adverse Event|8|||
160520497|NCT03432260|579635071|FG000|Overall Study|Lost to Follow-up|1|||
160863939|NCT01235741|580896673|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
160520498|NCT03432260|579635072|FG001|Overall Study|Lost to Follow-up|1|||
160520499|NCT03432260|579635073|FG002|Overall Study|Lost to Follow-up|0|||
160520500|NCT03432260|579635074|FG003|Overall Study|Lost to Follow-up|0|||
160978092|NCT02743793|581310157|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
160978093|NCT02743793|581310158|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
160520501|NCT03432260|579635075|FG004|Overall Study|Lost to Follow-up|1|||
160520502|NCT02186847|579635076|FG000|Overall Study|Protocol Violation|3|||
160520503|NCT02186847|579635077|FG001|Overall Study|Protocol Violation|0|||
160520504|NCT03319849|579635078|FG000|Overall Study|Adverse Event|1|||
160520505|NCT03319849|579635079|FG001|Overall Study|Adverse Event|0|||
160520506|NCT03319849|579635078|FG000|Overall Study|Physician Decision|0|||
160520507|NCT03319849|579635079|FG001|Overall Study|Physician Decision|1|||
160520508|NCT03319849|579635078|FG000|Overall Study|Withdrawal by Subject|0|||
160520509|NCT03319849|579635079|FG001|Overall Study|Withdrawal by Subject|1|||
160520510|NCT03319849|579635078|FG000|Overall Study|COVID-19|0|||
160520511|NCT03319849|579635079|FG001|Overall Study|COVID-19|1|||
160520512|NCT03319849|579635078|FG000|Overall Study|Other|1|||
160520513|NCT03319849|579635079|FG001|Overall Study|Other|2|||
160520514|NCT03319849|579635078|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
160520515|NCT03319849|579635079|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
160520516|NCT03319849|579635078|FG000|Overall Study|Lost to Follow-up|0|||
160520517|NCT03319849|579635079|FG001|Overall Study|Lost to Follow-up|2|||
160520518|NCT00112047|579635080|FG000|Randomized Phase|Lost to Follow-up|26|||
160520519|NCT00112047|579635081|FG001|Randomized Phase|Lost to Follow-up|33|||
160520520|NCT00112047|579635080|FG000|Randomized Phase|Adverse Event|10|||
160520521|NCT00112047|579635081|FG001|Randomized Phase|Adverse Event|10|||
160520522|NCT00112047|579635080|FG000|Randomized Phase|Withrawal of consent|10|||
160520523|NCT00112047|579635081|FG001|Randomized Phase|Withrawal of consent|18|||
160520524|NCT00112047|579635080|FG000|Randomized Phase|Sub-optimal virological response|3|||
160520525|NCT00112047|579635081|FG001|Randomized Phase|Sub-optimal virological response|13|||
160520526|NCT00112047|579635080|FG000|Randomized Phase|Noncompliance|8|||
160520527|NCT00112047|579635081|FG001|Randomized Phase|Noncompliance|4|||
160520528|NCT00112047|579635080|FG000|Randomized Phase|Protocol Violation|2|||
160520529|NCT00112047|579635081|FG001|Randomized Phase|Protocol Violation|0|||
160520530|NCT00112047|579635080|FG000|Randomized Phase|Pregnancy|3|||
160520531|NCT00112047|579635081|FG001|Randomized Phase|Pregnancy|1|||
160520532|NCT00112047|579635080|FG000|Randomized Phase|Death|1|||
160520533|NCT00112047|579635081|FG001|Randomized Phase|Death|3|||
160520534|NCT00112047|579635080|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
160520535|NCT00112047|579635081|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
160520536|NCT00112047|579635080|FG000|Randomized Phase|Inability to swallow pills|0|||
160520537|NCT00112047|579635081|FG001|Randomized Phase|Inability to swallow pills|1|||
160520538|NCT00112047|579635080|FG000|Randomized Phase|Incarceration|3|||
160520539|NCT00112047|579635081|FG001|Randomized Phase|Incarceration|2|||
160520540|NCT00112047|579635080|FG000|Randomized Phase|Moved out of State|0|||
160520541|NCT00112047|579635081|FG001|Randomized Phase|Moved out of State|1|||
160520542|NCT00112047|579635080|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
160520543|NCT00112047|579635081|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
160520544|NCT00112047|579635080|FG000|Randomized Phase|High Hepatitis B DNA|0|||
160520545|NCT00112047|579635081|FG001|Randomized Phase|High Hepatitis B DNA|1|||
160520546|NCT00112047|579635080|FG000|Atripla Phase|Adverse Event|2|||
160520547|NCT00112047|579635081|FG001|Atripla Phase|Adverse Event|1|||
160520548|NCT00112047|579635080|FG000|Atripla Phase|Lost to Follow-up|5|||
160520549|NCT00112047|579635081|FG001|Atripla Phase|Lost to Follow-up|7|||
160520550|NCT00112047|579635080|FG000|Atripla Phase|Pregnancy|0|||
160520551|NCT00112047|579635081|FG001|Atripla Phase|Pregnancy|1|||
160520552|NCT00112047|579635080|FG000|Atripla Phase|Death|0|||
160520553|NCT00112047|579635081|FG001|Atripla Phase|Death|2|||
160520554|NCT00112047|579635080|FG000|Atripla Phase|Withdrew consent|7|||
160520555|NCT00112047|579635081|FG001|Atripla Phase|Withdrew consent|7|||
160520556|NCT00112047|579635080|FG000|Atripla Phase|Sub-optimal virological response|0|||
160520557|NCT00112047|579635081|FG001|Atripla Phase|Sub-optimal virological response|1|||
160520558|NCT00112047|579635080|FG000|Atripla Phase|Non-compliance|1|||
160520559|NCT00112047|579635081|FG001|Atripla Phase|Non-compliance|0|||
160520560|NCT00112047|579635080|FG000|Atripla Phase|Other|3|||
160520561|NCT00112047|579635081|FG001|Atripla Phase|Other|1|||
160520562|NCT01307579|579635082|FG000|Overall Study|Death|3|||
160520563|NCT01307579|579635083|FG001|Overall Study|Death|6|||
160520564|NCT01307579|579635082|FG000|Overall Study|Physician Decision|26|||
160978094|NCT00786474|581310161|FG000|Overall Study|Death|5|||
160520565|NCT01307579|579635083|FG001|Overall Study|Physician Decision|29|||
160520566|NCT01307579|579635082|FG000|Overall Study|Withdrawal by Subject|7|||
160520567|NCT01307579|579635083|FG001|Overall Study|Withdrawal by Subject|3|||
160520568|NCT01307579|579635082|FG000|Overall Study|Institutional diagnosis of IFD|21|||
160520569|NCT01307579|579635083|FG001|Overall Study|Institutional diagnosis of IFD|36|||
160520570|NCT01307579|579635082|FG000|Overall Study|Begin conditioning for HSCT|42|||
160520571|NCT01307579|579635083|FG001|Overall Study|Begin conditioning for HSCT|44|||
160520572|NCT01307579|579635082|FG000|Overall Study|Refractory or relapsed AML|38|||
160520573|NCT01307579|579635083|FG001|Overall Study|Refractory or relapsed AML|23|||
160520574|NCT01307579|579635082|FG000|Overall Study|Ineligible|3|||
160520575|NCT01307579|579635083|FG001|Overall Study|Ineligible|4|||
160748894|NCT01826981|580467868|FG000|Overall Study|Lack of Efficacy|0|||
160748895|NCT01826981|580467869|FG001|Overall Study|Lack of Efficacy|1|||
160748896|NCT01826981|580467870|FG002|Overall Study|Lack of Efficacy|0|||
160748897|NCT01826981|580467871|FG003|Overall Study|Lack of Efficacy|0|||
160571765|NCT01254344|579816830|FG000|Overall Study|Adverse Event|2|||
160571766|NCT01254344|579816831|FG001|Overall Study|Adverse Event|5|||
160571767|NCT01254344|579816830|FG000|Overall Study|Physician Decision|7|||
160571768|NCT01254344|579816831|FG001|Overall Study|Physician Decision|4|||
160571769|NCT01254344|579816830|FG000|Overall Study|Protocol Violation|1|||
160571770|NCT01254344|579816831|FG001|Overall Study|Protocol Violation|4|||
160571771|NCT01254344|579816830|FG000|Overall Study|Withdrawal by Subject|3|||
160571772|NCT01254344|579816831|FG001|Overall Study|Withdrawal by Subject|6|||
160571773|NCT00467649|579816832|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
160571774|NCT00467649|579816833|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
160571775|NCT00467649|579816834|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
160571776|NCT00467649|579816835|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
160571777|NCT00467649|579816836|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
160571778|NCT00467649|579816837|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
160571779|NCT00467649|579816832|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
160571780|NCT00467649|579816833|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
160571781|NCT00467649|579816834|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
160571782|NCT00467649|579816835|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
160571783|NCT00467649|579816836|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
160571784|NCT00467649|579816837|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
160571785|NCT00467649|579816832|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
160571786|NCT00467649|579816833|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
160571787|NCT00467649|579816834|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
160571788|NCT00467649|579816835|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
160571789|NCT00467649|579816836|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
160571790|NCT00467649|579816837|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
160571791|NCT00467649|579816832|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
160571792|NCT00467649|579816833|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
160571793|NCT00467649|579816834|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
160571794|NCT00467649|579816835|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
160571795|NCT00467649|579816836|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
160571796|NCT00467649|579816837|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
160571797|NCT00467649|579816832|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
160571798|NCT00467649|579816833|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
160571799|NCT00467649|579816834|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
160571800|NCT00467649|579816835|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
160571801|NCT00467649|579816836|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
160571802|NCT00467649|579816837|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
160571803|NCT00467649|579816832|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
160571804|NCT00467649|579816833|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
160571805|NCT00467649|579816834|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
160571806|NCT00467649|579816835|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
160571807|NCT00467649|579816836|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
160571808|NCT00467649|579816837|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
160571809|NCT00467649|579816832|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
160571810|NCT00467649|579816833|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
160571811|NCT00467649|579816834|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
160571812|NCT00467649|579816835|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
160571813|NCT00467649|579816836|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
160571814|NCT00467649|579816837|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
160571815|NCT01633060|579816838|FG000|Randomization Phase|Protocol deviation|1|||
160571816|NCT01633060|579816839|FG001|Randomization Phase|Protocol deviation|2|||
160571817|NCT01633060|579816838|FG000|Randomization Phase|Technical problem|0|||
160571818|NCT01633060|579816839|FG001|Randomization Phase|Technical problem|1|||
160571819|NCT01633060|579816838|FG000|Treatment Phase|Adverse Event|24|||
160571820|NCT01633060|579816839|FG001|Treatment Phase|Adverse Event|3|||
160571821|NCT01633060|579816838|FG000|Treatment Phase|Lost to Follow-up|1|||
160571822|NCT01633060|579816839|FG001|Treatment Phase|Lost to Follow-up|0|||
160571823|NCT01633060|579816838|FG000|Treatment Phase|Physician Decision|16|||
160571824|NCT01633060|579816839|FG001|Treatment Phase|Physician Decision|7|||
160571825|NCT01633060|579816838|FG000|Treatment Phase|Progressive Disease|210|||
160571826|NCT01633060|579816839|FG001|Treatment Phase|Progressive Disease|120|||
160571827|NCT01633060|579816838|FG000|Treatment Phase|Protocol Deviation|1|||
160571828|NCT01633060|579816839|FG001|Treatment Phase|Protocol Deviation|0|||
160520576|NCT05677893|579636657|FG000|Overall Study|Withdrawal by Subject|0|||
160520577|NCT05677893|579636658|FG001|Overall Study|Withdrawal by Subject|0|||
160520578|NCT05677893|579636659|FG002|Overall Study|Withdrawal by Subject|0|||
160520579|NCT05677893|579636660|FG003|Overall Study|Withdrawal by Subject|0|||
160520580|NCT05677893|579636661|FG004|Overall Study|Withdrawal by Subject|1|||
160520581|NCT05677893|579636662|FG005|Overall Study|Withdrawal by Subject|1|||
160520582|NCT05677893|579636663|FG006|Overall Study|Withdrawal by Subject|0|||
160520583|NCT05677893|579636657|FG000|Overall Study|Others|1|||
160520584|NCT05677893|579636658|FG001|Overall Study|Others|0|||
160520585|NCT05677893|579636659|FG002|Overall Study|Others|0|||
160520586|NCT05677893|579636660|FG003|Overall Study|Others|0|||
160520587|NCT05677893|579636661|FG004|Overall Study|Others|0|||
160520588|NCT05677893|579636662|FG005|Overall Study|Others|0|||
160520589|NCT05677893|579636663|FG006|Overall Study|Others|0|||
160520590|NCT03217266|579636664|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
160520591|NCT03217266|579636665|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
160520592|NCT03217266|579636666|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
160520593|NCT03217266|579636667|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
160520594|NCT03217266|579636664|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
160520595|NCT03217266|579636665|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
160520596|NCT03217266|579636666|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
160520597|NCT03217266|579636667|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
160520598|NCT03217266|579636664|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
160520599|NCT03217266|579636665|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
160520600|NCT03217266|579636666|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
160520601|NCT03217266|579636667|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
160520602|NCT02101034|579636668|FG000|Overall Study|Enrolled but did not start treatment|0|||
160634817|NCT01901146|580044247|FG002|Neoadjuvant Phase|Death|0|||
160634818|NCT01901146|580044248|FG003|Neoadjuvant Phase|Death|0|||
160634819|NCT01901146|580044249|FG004|Neoadjuvant Phase|Death|0|||
160634820|NCT01901146|580044245|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
160634821|NCT01901146|580044246|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
160634822|NCT01901146|580044247|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
160634823|NCT01901146|580044248|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
160634824|NCT01901146|580044249|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
160634825|NCT01901146|580044245|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
160634826|NCT01901146|580044246|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
160634827|NCT01901146|580044247|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
160634828|NCT01901146|580044248|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
160634829|NCT01901146|580044249|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
160634830|NCT01901146|580044245|FG000|Neoadjuvant Phase|Physician Decision|1|||
160863940|NCT01235741|580896671|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
160634831|NCT01901146|580044246|FG001|Neoadjuvant Phase|Physician Decision|2|||
160634832|NCT01901146|580044247|FG002|Neoadjuvant Phase|Physician Decision|0|||
160634833|NCT01901146|580044248|FG003|Neoadjuvant Phase|Physician Decision|0|||
160634834|NCT01901146|580044249|FG004|Neoadjuvant Phase|Physician Decision|0|||
160634835|NCT01901146|580044245|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
160634836|NCT01901146|580044246|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
160634837|NCT01901146|580044247|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
160634838|NCT01901146|580044248|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
160634839|NCT01901146|580044249|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
160634840|NCT01901146|580044245|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
160634841|NCT01901146|580044246|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
160634842|NCT01901146|580044247|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
160634843|NCT01901146|580044248|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
160634844|NCT01901146|580044249|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
160634845|NCT01901146|580044245|FG000|Adjuvant Phase|Other|0|||
160634846|NCT01901146|580044246|FG001|Adjuvant Phase|Other|0|||
160634847|NCT01901146|580044247|FG002|Adjuvant Phase|Other|1|||
160634848|NCT01901146|580044248|FG003|Adjuvant Phase|Other|0|||
160634849|NCT01901146|580044249|FG004|Adjuvant Phase|Other|0|||
160634850|NCT01901146|580044245|FG000|Adjuvant Phase|Death|0|||
160634851|NCT01901146|580044246|FG001|Adjuvant Phase|Death|0|||
160634852|NCT01901146|580044247|FG002|Adjuvant Phase|Death|0|||
160634853|NCT01901146|580044248|FG003|Adjuvant Phase|Death|0|||
160634854|NCT01901146|580044249|FG004|Adjuvant Phase|Death|3|||
160634855|NCT01901146|580044245|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
160863941|NCT01235741|580896672|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
160520603|NCT02101034|579636669|FG001|Overall Study|Enrolled but did not start treatment|0|||
160520604|NCT02101034|579636670|FG002|Overall Study|Enrolled but did not start treatment|1|||
160520605|NCT02101034|579636671|FG003|Overall Study|Enrolled but did not start treatment|0|||
160634856|NCT01901146|580044246|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
160634857|NCT01901146|580044247|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
160634858|NCT01901146|580044248|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
160634859|NCT01901146|580044249|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
160634860|NCT01901146|580044245|FG000|Adjuvant Phase|Physician Decision|0|||
160634861|NCT01901146|580044246|FG001|Adjuvant Phase|Physician Decision|0|||
160634862|NCT01901146|580044247|FG002|Adjuvant Phase|Physician Decision|9|||
160634863|NCT01901146|580044248|FG003|Adjuvant Phase|Physician Decision|2|||
160634864|NCT01901146|580044249|FG004|Adjuvant Phase|Physician Decision|4|||
160634865|NCT01901146|580044245|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
160634866|NCT01901146|580044246|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
160634867|NCT01901146|580044247|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
160634868|NCT01901146|580044248|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
160634869|NCT01901146|580044249|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
160634870|NCT00297492|580044250|FG000|Set Quit Date|Lost to Follow-up|7|||
160634871|NCT00297492|580044251|FG001|Set Quit Date|Lost to Follow-up|13|||
160634872|NCT00297492|580044252|FG002|Set Quit Date|Lost to Follow-up|5|||
160634873|NCT00297492|580044250|FG000|6 Month Follow-up|Lost to Follow-up|63|||
160634874|NCT00297492|580044251|FG001|6 Month Follow-up|Lost to Follow-up|49|||
160520606|NCT02101034|579636672|FG004|Overall Study|Enrolled but did not start treatment|0|||
160520607|NCT01101477|579636674|FG000|Overall Study|Protocol Violation|5|||
160520608|NCT01101477|579636675|FG001|Overall Study|Protocol Violation|3|||
160520609|NCT01101477|579636676|FG002|Overall Study|Protocol Violation|1|||
160520610|NCT01222507|579636677|FG000|Overall Study|Physician Decision|1|||
160520611|NCT01222507|579636677|FG000|Overall Study|Withdrawal by Subject|1|||
160520612|NCT01786174|579636682|FG000|Overall Study|Discontinued Study Drug|2|||
160520613|NCT01786174|579636683|FG001|Overall Study|Discontinued Study Drug|0|||
160520614|NCT00995020|579636684|FG000|Overall Study|margin analysis not performed|2|||
160520615|NCT00995020|579636685|FG001|Overall Study|margin analysis not performed|5|||
160520616|NCT00995020|579636684|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
160520617|NCT00995020|579636685|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
160520618|NCT01614197|579636686|FG000|Overall Study|Withdrawal by Subject|0|||
160520619|NCT01614197|579636687|FG001|Overall Study|Withdrawal by Subject|1|||
160520620|NCT01614197|579636688|FG002|Overall Study|Withdrawal by Subject|0|||
160520621|NCT01614197|579636689|FG003|Overall Study|Withdrawal by Subject|0|||
160520622|NCT03442985|579636690|FG000|Overall Study|Sponsor Request|55|||
160520623|NCT03442985|579636691|FG001|Overall Study|Sponsor Request|60|||
160520624|NCT03442985|579636692|FG002|Overall Study|Sponsor Request|54|||
160520625|NCT03442985|579636690|FG000|Overall Study|Lost to Follow-up|5|||
160520626|NCT03442985|579636691|FG001|Overall Study|Lost to Follow-up|2|||
160520627|NCT03442985|579636692|FG002|Overall Study|Lost to Follow-up|7|||
160520628|NCT03442985|579636690|FG000|Overall Study|Withdrawal by Subject|2|||
160520629|NCT03442985|579636691|FG001|Overall Study|Withdrawal by Subject|3|||
160520630|NCT03442985|579636692|FG002|Overall Study|Withdrawal by Subject|4|||
160520631|NCT03442985|579636690|FG000|Overall Study|Adverse Event|0|||
160520632|NCT03442985|579636691|FG001|Overall Study|Adverse Event|1|||
160520633|NCT03442985|579636692|FG002|Overall Study|Adverse Event|0|||
160520634|NCT00876694|579636694|FG000|Overall Study|Adverse Event|10|||
160520635|NCT00876694|579636695|FG001|Overall Study|Adverse Event|7|||
160520636|NCT00876694|579636694|FG000|Overall Study|Subject withdrew consent|6|||
160520637|NCT00876694|579636695|FG001|Overall Study|Subject withdrew consent|4|||
160520638|NCT00876694|579636694|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160520639|NCT00876694|579636695|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160520640|NCT00876694|579636694|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160520641|NCT00876694|579636695|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160520642|NCT00876694|579636694|FG000|Overall Study|Administrative problems|1|||
160520643|NCT00876694|579636695|FG001|Overall Study|Administrative problems|1|||
160520644|NCT00876694|579636694|FG000|Overall Study|Death|1|||
160634875|NCT00297492|580044252|FG002|6 Month Follow-up|Lost to Follow-up|27|||
160634876|NCT01296152|580044257|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
160634877|NCT01268683|580044258|FG000|Overall Study|Lost to Follow-up|1|||
160634878|NCT01268683|580044258|FG000|Overall Study|Death|1|||
160634879|NCT04256759|580044259|FG000|Overall Study|Physician Decision|1|||
160634880|NCT04256759|580044259|FG000|Overall Study|Lack of Efficacy|1|||
160634881|NCT03981614|580044264|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
160634882|NCT03981614|580044265|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
160634883|NCT03981614|580044266|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
160634884|NCT04971226|580044267|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
160634885|NCT04971226|580044268|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
160634886|NCT04971226|580044269|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
160634887|NCT04971226|580044270|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
160634888|NCT04971226|580044267|FG000|Overall Study|Adverse Event|6|||
160634889|NCT04971226|580044268|FG001|Overall Study|Adverse Event|5|||
160634890|NCT04971226|580044269|FG002|Overall Study|Adverse Event|11|||
160634891|NCT04971226|580044270|FG003|Overall Study|Adverse Event|10|||
160634892|NCT04971226|580044267|FG000|Overall Study|Progressive disease|2|||
160634893|NCT04971226|580044268|FG001|Overall Study|Progressive disease|0|||
160520645|NCT00876694|579636695|FG001|Overall Study|Death|0|||
160520646|NCT00288509|579636696|FG000|Treatment Cycle 1|Adverse Event|1|||
160520647|NCT00288509|579636696|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
160520648|NCT00288509|579636696|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
160520649|NCT00288509|579636696|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
160520650|NCT00288509|579636696|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
160520651|NCT00288509|579636696|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
160520652|NCT00288509|579636696|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
160520653|NCT00288509|579636696|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
160520654|NCT00288509|579636696|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
160520655|NCT00288509|579636696|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
160520656|NCT00288509|579636696|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
160520657|NCT00288509|579636696|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
160520658|NCT00288509|579636696|FG000|Treatment Cycle 4|Physician Decision|4|||
160520659|NCT00288509|579636696|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
160520660|NCT00084266|579636697|FG000|Overall Study|Death|42|||
160634894|NCT04971226|580044269|FG002|Overall Study|Progressive disease|3|||
160634895|NCT04971226|580044270|FG003|Overall Study|Progressive disease|1|||
160634896|NCT04971226|580044267|FG000|Overall Study|Protocol Deviation|1|||
160634897|NCT04971226|580044268|FG001|Overall Study|Protocol Deviation|0|||
160634898|NCT04971226|580044269|FG002|Overall Study|Protocol Deviation|1|||
160634899|NCT04971226|580044270|FG003|Overall Study|Protocol Deviation|1|||
160634900|NCT04971226|580044267|FG000|Overall Study|Subject Decision|0|||
160634901|NCT04971226|580044268|FG001|Overall Study|Subject Decision|1|||
160520661|NCT00084266|579636698|FG001|Overall Study|Death|39|||
160520662|NCT00084266|579636697|FG000|Overall Study|Adverse Event|8|||
160520663|NCT00084266|579636698|FG001|Overall Study|Adverse Event|5|||
160520664|NCT00084266|579636697|FG000|Overall Study|Lack of Efficacy|2|||
160520665|NCT00084266|579636698|FG001|Overall Study|Lack of Efficacy|4|||
160520666|NCT00084266|579636697|FG000|Overall Study|Lost to Follow-up|5|||
160520667|NCT00084266|579636698|FG001|Overall Study|Lost to Follow-up|3|||
160520668|NCT00084266|579636697|FG000|Overall Study|Participant not willing to participate|3|||
160520669|NCT00084266|579636698|FG001|Overall Study|Participant not willing to participate|8|||
160520670|NCT00084266|579636697|FG000|Overall Study|Other|360|||
160634902|NCT04971226|580044269|FG002|Overall Study|Subject Decision|1|||
160634903|NCT04971226|580044270|FG003|Overall Study|Subject Decision|1|||
160634904|NCT04971226|580044267|FG000|Overall Study|Pregnancy|0|||
160634905|NCT04971226|580044268|FG001|Overall Study|Pregnancy|0|||
160634906|NCT04971226|580044269|FG002|Overall Study|Pregnancy|0|||
160634907|NCT04971226|580044270|FG003|Overall Study|Pregnancy|1|||
160634908|NCT04971226|580044267|FG000|Overall Study|Participants not treated|1|||
160634909|NCT04971226|580044268|FG001|Overall Study|Participants not treated|0|||
160634910|NCT04971226|580044269|FG002|Overall Study|Participants not treated|2|||
160634911|NCT04971226|580044270|FG003|Overall Study|Participants not treated|1|||
160634912|NCT04439149|580044273|FG000|Overall Study|Ineligible|1|||
160634913|NCT04439149|580044273|FG000|Overall Study|Never start protocol therapy|1|||
160634914|NCT04439149|580044273|FG000|Overall Study|Adverse Event|4|||
160634915|NCT04439149|580044273|FG000|Overall Study|Disease Progression|14|||
160634916|NCT04439149|580044273|FG000|Overall Study|Complicating disease|1|||
160634917|NCT04439149|580044273|FG000|Overall Study|Withdrawal by Subject|3|||
160634918|NCT05264506|580044276|FG000|Overall Study|Adverse Event|59|||
160634919|NCT05264506|580044276|FG000|Overall Study|Lost to Follow-up|204|||
160634920|NCT05264506|580044276|FG000|Overall Study|Protocol Violation|185|||
160634921|NCT05264506|580044276|FG000|Overall Study|Pregnancy|60|||
160634922|NCT05264506|580044276|FG000|Overall Study|Physician Decision|6|||
160634923|NCT05264506|580044276|FG000|Overall Study|Non-compliance with Study Drug|29|||
160634924|NCT05264506|580044276|FG000|Overall Study|Study termination|677|||
160634925|NCT05264506|580044276|FG000|Overall Study|Withdrawal by Subject|208|||
160634926|NCT05264506|580044276|FG000|Overall Study|Discontinued prior treatment|89|||
160520671|NCT00084266|579636698|FG001|Overall Study|Other|344|||
160520672|NCT00084266|579636697|FG000|Overall Study|Randomized not treated|21|||
160520673|NCT00084266|579636698|FG001|Overall Study|Randomized not treated|20|||
160520674|NCT01215422|579636699|FG000|Overall Study|Relocation|1|||
160520675|NCT01215422|579636700|FG001|Overall Study|Relocation|0|||
160520676|NCT01215422|579636701|FG002|Overall Study|Relocation|0|||
160520677|NCT01215422|579636702|FG003|Overall Study|Relocation|0|||
160520678|NCT01215422|579636699|FG000|Overall Study|Failed intubations|0|||
160520679|NCT01215422|579636700|FG001|Overall Study|Failed intubations|0|||
160520680|NCT01215422|579636701|FG002|Overall Study|Failed intubations|3|||
160520681|NCT01215422|579636702|FG003|Overall Study|Failed intubations|8|||
160520682|NCT01215422|579636699|FG000|Overall Study|Did not complete all intubations|7|||
160520683|NCT01215422|579636700|FG001|Overall Study|Did not complete all intubations|0|||
160520684|NCT01215422|579636701|FG002|Overall Study|Did not complete all intubations|0|||
160520685|NCT01215422|579636702|FG003|Overall Study|Did not complete all intubations|0|||
160634927|NCT02032823|580044278|FG000|Overall Study|Death|75|||
160634928|NCT02032823|580044279|FG001|Overall Study|Death|109|||
160634929|NCT02032823|580044278|FG000|Overall Study|Lost to Follow-up|18|||
160634930|NCT02032823|580044279|FG001|Overall Study|Lost to Follow-up|17|||
160634931|NCT02032823|580044278|FG000|Overall Study|Withdrawal by Subject|70|||
160634932|NCT02032823|580044279|FG001|Overall Study|Withdrawal by Subject|53|||
160520686|NCT01313637|579636712|FG000|Overall Study|Adverse Event|17|||
160520687|NCT01313637|579636713|FG001|Overall Study|Adverse Event|24|||
160634933|NCT02032823|580044278|FG000|Overall Study|Ongoing study at data cut-off|755|||
160634934|NCT02032823|580044279|FG001|Overall Study|Ongoing study at data cut-off|731|||
160634935|NCT02032823|580044278|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
160634936|NCT02032823|580044279|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
160634937|NCT06065176|580044280|FG000|Overall Study|Lost to Follow-up|11|||
160634938|NCT06065176|580044281|FG001|Overall Study|Lost to Follow-up|11|||
160634939|NCT06065176|580044282|FG002|Overall Study|Lost to Follow-up|10|||
160634940|NCT06065176|580044280|FG000|Overall Study|Withdrawal by Subject|1|||
160634941|NCT06065176|580044281|FG001|Overall Study|Withdrawal by Subject|1|||
160634942|NCT06065176|580044282|FG002|Overall Study|Withdrawal by Subject|2|||
160634943|NCT06065176|580044280|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
160634944|NCT06065176|580044281|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
160634945|NCT06065176|580044282|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
160634946|NCT04521608|580044283|FG000|Overall Study|Death|8|||
160634947|NCT04521608|580044284|FG001|Overall Study|Death|9|||
160634948|NCT04521608|580044283|FG000|Overall Study|Withdrawal by Subject|25|||
160634949|NCT04521608|580044284|FG001|Overall Study|Withdrawal by Subject|18|||
160634950|NCT04521608|580044283|FG000|Overall Study|Disease Progression|3|||
160634951|NCT04521608|580044284|FG001|Overall Study|Disease Progression|10|||
160634952|NCT04521608|580044283|FG000|Overall Study|Complicating Disease|6|||
160634953|NCT04521608|580044284|FG001|Overall Study|Complicating Disease|3|||
160634954|NCT04521608|580044283|FG000|Overall Study|Lost Contact|25|||
160634955|NCT04521608|580044284|FG001|Overall Study|Lost Contact|27|||
160634956|NCT04521608|580044283|FG000|Overall Study|Ineligible|1|||
160634957|NCT04521608|580044284|FG001|Overall Study|Ineligible|0|||
160634958|NCT04521608|580044283|FG000|Overall Study|Refused Further Study Participation|13|||
160634959|NCT04521608|580044284|FG001|Overall Study|Refused Further Study Participation|7|||
160634960|NCT04083378|580044287|FG000|Overall Study|Death|18|||
160634961|NCT04083378|580044288|FG001|Overall Study|Death|4|||
160634962|NCT04083378|580044287|FG000|Overall Study|Lost to Follow-up|4|||
160634963|NCT04083378|580044288|FG001|Overall Study|Lost to Follow-up|0|||
160634964|NCT05824273|580044289|FG000|Overall Study|Lost to Follow-up|16|||
160634965|NCT05824273|580044290|FG001|Overall Study|Lost to Follow-up|13|||
160634966|NCT00285012|580044291|FG000|Assigned to Study Treatment (Tx)|Other|2|||
160634967|NCT00285012|580044292|FG001|Assigned to Study Treatment (Tx)|Other|3|||
160634968|NCT00285012|580044291|FG000|Received Study Tx|Death|2|||
160634969|NCT00285012|580044292|FG001|Received Study Tx|Death|1|||
160634970|NCT00285012|580044291|FG000|Received Study Tx|Adverse Event|5|||
160634971|NCT00285012|580044292|FG001|Received Study Tx|Adverse Event|11|||
160634972|NCT00285012|580044291|FG000|Received Study Tx|Lack of Efficacy|0|||
160634973|NCT00285012|580044292|FG001|Received Study Tx|Lack of Efficacy|3|||
160634974|NCT00285012|580044291|FG000|Received Study Tx|Lost to Follow-up|29|||
160634975|NCT00285012|580044292|FG001|Received Study Tx|Lost to Follow-up|31|||
160634976|NCT00285012|580044291|FG000|Received Study Tx|Withdrawal by Subject|31|||
160634977|NCT00285012|580044292|FG001|Received Study Tx|Withdrawal by Subject|43|||
160634978|NCT00285012|580044291|FG000|Received Study Tx|Other|5|||
160634979|NCT00285012|580044292|FG001|Received Study Tx|Other|5|||
160634980|NCT04223193|580044304|FG000|Overall Study|Adverse Event|6|||
160634981|NCT04223193|580044305|FG001|Overall Study|Adverse Event|36|||
160634982|NCT04223193|580044304|FG000|Overall Study|Lack of Efficacy|2|||
160634983|NCT04223193|580044305|FG001|Overall Study|Lack of Efficacy|2|||
160634984|NCT04223193|580044304|FG000|Overall Study|Lost to Follow-up|1|||
160634985|NCT04223193|580044305|FG001|Overall Study|Lost to Follow-up|1|||
160634986|NCT04223193|580044304|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
160634987|NCT04223193|580044305|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
160634988|NCT04223193|580044304|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
160634989|NCT04223193|580044305|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
160634990|NCT04223193|580044304|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160634991|NCT04223193|580044305|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160634992|NCT04223193|580044304|FG000|Overall Study|Physician Decision|0|||
160634993|NCT04223193|580044305|FG001|Overall Study|Physician Decision|1|||
160634994|NCT04223193|580044304|FG000|Overall Study|Protocol Violation|1|||
160634995|NCT04223193|580044305|FG001|Overall Study|Protocol Violation|1|||
160634996|NCT04223193|580044304|FG000|Overall Study|Site Terminated by Sponsor|1|||
160634997|NCT04223193|580044305|FG001|Overall Study|Site Terminated by Sponsor|3|||
160634998|NCT04223193|580044304|FG000|Overall Study|Withdrawal by Subject|5|||
160634999|NCT04223193|580044305|FG001|Overall Study|Withdrawal by Subject|6|||
160635000|NCT04223193|580044304|FG000|Overall Study|Other|3|||
160635001|NCT04223193|580044305|FG001|Overall Study|Other|6|||
160635002|NCT03732677|580044306|FG000|Overall Study|Terminated the study|154|||
160635003|NCT03732677|580044307|FG001|Overall Study|Terminated the study|197|||
160635004|NCT03732677|580044306|FG000|Overall Study|Continuing study off treatment|379|||
160635005|NCT03732677|580044307|FG001|Overall Study|Continuing study off treatment|333|||
160520688|NCT01313637|579636714|FG002|Overall Study|Adverse Event|25|||
160520689|NCT01313637|579636715|FG003|Overall Study|Adverse Event|18|||
160520690|NCT01313637|579636712|FG000|Overall Study|Lack of Efficacy|44|||
160520691|NCT01313637|579636713|FG001|Overall Study|Lack of Efficacy|38|||
160520692|NCT01313637|579636714|FG002|Overall Study|Lack of Efficacy|37|||
160520693|NCT01313637|579636715|FG003|Overall Study|Lack of Efficacy|24|||
160520694|NCT01313637|579636712|FG000|Overall Study|Protocol Violation|4|||
160520695|NCT01313637|579636713|FG001|Overall Study|Protocol Violation|3|||
160520696|NCT01313637|579636714|FG002|Overall Study|Protocol Violation|11|||
160520697|NCT01313637|579636715|FG003|Overall Study|Protocol Violation|5|||
160520698|NCT01313637|579636712|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
160520699|NCT01313637|579636713|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
160520700|NCT01313637|579636714|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
160520701|NCT01313637|579636715|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
160520702|NCT01313637|579636712|FG000|Overall Study|Lost to Follow-up|0|||
160520703|NCT01313637|579636713|FG001|Overall Study|Lost to Follow-up|2|||
160520704|NCT01313637|579636714|FG002|Overall Study|Lost to Follow-up|1|||
160520705|NCT01313637|579636715|FG003|Overall Study|Lost to Follow-up|3|||
160520706|NCT01313637|579636712|FG000|Overall Study|Withdrawal by Subject|11|||
160520707|NCT01313637|579636713|FG001|Overall Study|Withdrawal by Subject|13|||
160520708|NCT01313637|579636714|FG002|Overall Study|Withdrawal by Subject|18|||
160520709|NCT01313637|579636715|FG003|Overall Study|Withdrawal by Subject|15|||
160520710|NCT00795951|579636718|FG000|Overall Study|Lost to Follow-up|1|||
160520711|NCT00795951|579636718|FG000|Overall Study|Withdrawal by Subject|1|||
160520712|NCT03548987|579636720|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
160520713|NCT03548987|579636721|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
160520714|NCT03548987|579636720|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
160520715|NCT03548987|579636721|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
160520716|NCT03548987|579636720|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
160520717|NCT03548987|579636721|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
160520718|NCT03548987|579636720|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
160520719|NCT03548987|579636721|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
160520720|NCT03548987|579636720|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
160520721|NCT03548987|579636721|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
160520722|NCT03548987|579636720|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
160520723|NCT03548987|579636721|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
160520724|NCT03548987|579636720|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
160520725|NCT03548987|579636721|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
160520726|NCT03548987|579636720|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
160520727|NCT03548987|579636721|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
160520728|NCT03548987|579636720|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
160520729|NCT03548987|579636721|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
160520730|NCT03548987|579636720|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
160520731|NCT03548987|579636721|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
160520732|NCT03548987|579636720|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
160520733|NCT03548987|579636721|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
160520734|NCT03548987|579636720|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
160520735|NCT03548987|579636721|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
160520736|NCT03548987|579636720|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
160520737|NCT03548987|579636721|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
160520738|NCT03548987|579636720|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
160520739|NCT03548987|579636721|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
160520740|NCT04572841|579636722|FG000|Overall Study|Adverse Event|1|||
160520741|NCT04572841|579636723|FG001|Overall Study|Adverse Event|1|||
160520742|NCT04572841|579636722|FG000|Overall Study|Withdrawal by Subject|2|||
160520743|NCT04572841|579636723|FG001|Overall Study|Withdrawal by Subject|1|||
160520744|NCT01323647|579636728|FG000|Overall Study|Migrated/moved from study area|2|||
160520745|NCT01323647|579636729|FG001|Overall Study|Migrated/moved from study area|0|||
160520746|NCT01323647|579636728|FG000|Overall Study|Withdrawal by Subject|5|||
160520747|NCT01323647|579636729|FG001|Overall Study|Withdrawal by Subject|0|||
160520748|NCT01323647|579636728|FG000|Overall Study|Lost to Follow-up|2|||
160520749|NCT01323647|579636729|FG001|Overall Study|Lost to Follow-up|0|||
160520750|NCT00712673|579636730|FG000|Overall Study|Adverse Event|3|||
160520751|NCT00712673|579636731|FG001|Overall Study|Adverse Event|3|||
160520752|NCT00712673|579636732|FG002|Overall Study|Adverse Event|21|||
160635006|NCT04644237|580044308|FG000|Overall Study|Death|4|||
160635007|NCT04644237|580044309|FG001|Overall Study|Death|2|||
160635008|NCT04644237|580044308|FG000|Overall Study|Adverse Event|18|||
160635009|NCT04644237|580044309|FG001|Overall Study|Adverse Event|19|||
160635010|NCT04644237|580044308|FG000|Overall Study|Progressive Disease|61|||
160635011|NCT04644237|580044309|FG001|Overall Study|Progressive Disease|23|||
160635012|NCT04644237|580044308|FG000|Overall Study|Clinical Progression|4|||
160635013|NCT04644237|580044309|FG001|Overall Study|Clinical Progression|1|||
160635014|NCT04644237|580044308|FG000|Overall Study|Withdrawal by Subject|4|||
160635015|NCT04644237|580044309|FG001|Overall Study|Withdrawal by Subject|2|||
160635016|NCT04644237|580044308|FG000|Overall Study|Physician Decision|4|||
160635017|NCT04644237|580044309|FG001|Overall Study|Physician Decision|0|||
160635018|NCT04644237|580044308|FG000|Overall Study|Other|6|||
160635019|NCT04644237|580044309|FG001|Overall Study|Other|3|||
160635020|NCT04644237|580044308|FG000|Overall Study|Randomized but not Treated|1|||
160635021|NCT04644237|580044309|FG001|Overall Study|Randomized but not Treated|0|||
160635022|NCT03131817|580044310|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
160635023|NCT02061293|580044312|FG000|Overall Study|Elevated Blood Pressure|1|||
160635024|NCT02061293|580044313|FG001|Overall Study|Elevated Blood Pressure|1|||
160635025|NCT04066894|580044315|FG000|Overall Study|Lack of Efficacy|1|||
160635026|NCT04066894|580044315|FG000|Overall Study|Screen Failure|1|||
160635027|NCT03494816|580044316|FG000|Overall Study|Protocol Violation|2|||
160635028|NCT03494816|580044316|FG000|Overall Study|Physician Decision|2|||
160635029|NCT03494816|580044316|FG000|Overall Study|Did not start trial treatment|1|||
160635030|NCT03494816|580044316|FG000|Overall Study|Adverse Event|1|||
160635031|NCT01500434|580044317|FG000|Overall Study|Death|1|||
160635032|NCT01500434|580044317|FG000|Overall Study|Withdrawal by Subject|1|||
160635033|NCT01500434|580044317|FG000|Overall Study|Missed 12-month follow-up|5|||
160635034|NCT00633217|580044318|FG000|Overall Study|Adverse Event|5|||
160635035|NCT00633217|580044319|FG001|Overall Study|Adverse Event|9|||
160635036|NCT00633217|580044318|FG000|Overall Study|Lack of Efficacy|0|||
160635037|NCT00633217|580044319|FG001|Overall Study|Lack of Efficacy|2|||
160635038|NCT00633217|580044318|FG000|Overall Study|Protocol Violation|3|||
160635039|NCT00633217|580044319|FG001|Overall Study|Protocol Violation|7|||
160635040|NCT00633217|580044318|FG000|Overall Study|Lost to Follow-up|2|||
160635041|NCT00633217|580044319|FG001|Overall Study|Lost to Follow-up|2|||
160635042|NCT00633217|580044318|FG000|Overall Study|Investigator Discretion|2|||
160635043|NCT00633217|580044319|FG001|Overall Study|Investigator Discretion|0|||
160635044|NCT00633217|580044318|FG000|Overall Study|Withdrew Consent|3|||
160635045|NCT00633217|580044319|FG001|Overall Study|Withdrew Consent|3|||
160635046|NCT04502862|580044320|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
160635047|NCT04502862|580044321|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
160635048|NCT04502862|580044320|FG000|Overall Study|Withdrawal by Subject|1|||
160635049|NCT04502862|580044321|FG001|Overall Study|Withdrawal by Subject|0|||
160635050|NCT04502862|580044320|FG000|Overall Study|Adverse Event|1|||
160635051|NCT04502862|580044321|FG001|Overall Study|Adverse Event|1|||
160653355|NCT04634409|580110521|FG021|Overall Study|Withdrawal by Subject|0|||
160653356|NCT04634409|580110522|FG022|Overall Study|Withdrawal by Subject|0|||
160653357|NCT04634409|580110523|FG023|Overall Study|Withdrawal by Subject|1|||
160653358|NCT04634409|580110524|FG024|Overall Study|Withdrawal by Subject|0|||
160653359|NCT04634409|580110525|FG025|Overall Study|Withdrawal by Subject|0|||
160653360|NCT04634409|580110526|FG026|Overall Study|Withdrawal by Subject|0|||
160653361|NCT04634409|580110500|FG000|Overall Study|Other - As reported by Investigator|1|||
160653362|NCT04634409|580110501|FG001|Overall Study|Other - As reported by Investigator|0|||
160653363|NCT04634409|580110502|FG002|Overall Study|Other - As reported by Investigator|0|||
160653364|NCT04634409|580110503|FG003|Overall Study|Other - As reported by Investigator|0|||
160653365|NCT04634409|580110504|FG004|Overall Study|Other - As reported by Investigator|0|||
160653366|NCT04634409|580110505|FG005|Overall Study|Other - As reported by Investigator|0|||
160653367|NCT04634409|580110506|FG006|Overall Study|Other - As reported by Investigator|0|||
160653368|NCT04634409|580110507|FG007|Overall Study|Other - As reported by Investigator|6|||
160653369|NCT04634409|580110508|FG008|Overall Study|Other - As reported by Investigator|4|||
160653370|NCT04634409|580110509|FG009|Overall Study|Other - As reported by Investigator|0|||
160653371|NCT04634409|580110510|FG010|Overall Study|Other - As reported by Investigator|1|||
160653372|NCT04634409|580110511|FG011|Overall Study|Other - As reported by Investigator|2|||
160653373|NCT04634409|580110512|FG012|Overall Study|Other - As reported by Investigator|2|||
160653374|NCT04634409|580110513|FG013|Overall Study|Other - As reported by Investigator|1|||
160653375|NCT04634409|580110514|FG014|Overall Study|Other - As reported by Investigator|0|||
160863942|NCT01235741|580896673|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
160863943|NCT01235741|580896671|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
160863944|NCT01235741|580896672|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
160863945|NCT01235741|580896673|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
160863946|NCT01124006|580896674|FG000|Overall Study|Withdrawal by Subject|2|||
160863947|NCT01124006|580896675|FG001|Overall Study|Withdrawal by Subject|2|||
160863948|NCT01124006|580896676|FG002|Overall Study|Withdrawal by Subject|0|||
160653376|NCT04634409|580110515|FG015|Overall Study|Other - As reported by Investigator|0|||
160863949|NCT01124006|580896674|FG000|Overall Study|Lost to Follow-up|1|||
160653377|NCT04634409|580110516|FG016|Overall Study|Other - As reported by Investigator|0|||
160653378|NCT04634409|580110517|FG017|Overall Study|Other - As reported by Investigator|0|||
160653379|NCT04634409|580110518|FG018|Overall Study|Other - As reported by Investigator|0|||
160653380|NCT04634409|580110519|FG019|Overall Study|Other - As reported by Investigator|0|||
160653381|NCT04634409|580110520|FG020|Overall Study|Other - As reported by Investigator|0|||
160863950|NCT01124006|580896675|FG001|Overall Study|Lost to Follow-up|0|||
160635052|NCT02038959|580046018|FG000|Overall Study|Withdrawal by Subject|6|||
160635053|NCT02038959|580046019|FG001|Overall Study|Withdrawal by Subject|8|||
160635054|NCT03911960|580046020|FG000|Overall Study|Lost to Follow-up|5|||
160635055|NCT03911960|580046021|FG001|Overall Study|Lost to Follow-up|3|||
160635056|NCT00265239|580046022|FG000|Overall Study|Adverse Event|2|||
160635057|NCT00265239|580046023|FG001|Overall Study|Adverse Event|1|||
160635058|NCT02803138|580046026|FG000|Overall Study|Failure to return|38|||
160635059|NCT02803138|580046026|FG000|Overall Study|Insufficient virological response|2|||
160635060|NCT02803138|580046026|FG000|Overall Study|Withdrawn consent|1|||
160635061|NCT02803138|580046026|FG000|Overall Study|Death|1|||
160635062|NCT02803138|580046026|FG000|Overall Study|Other, not specified|28|||
160635063|NCT04318535|580046027|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
160635064|NCT04318535|580046028|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
160635065|NCT04318535|580046029|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
160635066|NCT00021229|580046034|FG000|Overall Study|Adverse Event|10|||
160635067|NCT00021229|580046035|FG001|Overall Study|Adverse Event|5|||
160635068|NCT00021229|580046036|FG002|Overall Study|Adverse Event|2|||
160635069|NCT00021229|580046034|FG000|Overall Study|Death|0|||
160635070|NCT00021229|580046035|FG001|Overall Study|Death|1|||
160635071|NCT00021229|580046036|FG002|Overall Study|Death|0|||
160635072|NCT00021229|580046034|FG000|Overall Study|Withdrawal by Subject|7|||
160635073|NCT00021229|580046035|FG001|Overall Study|Withdrawal by Subject|7|||
160635074|NCT00021229|580046036|FG002|Overall Study|Withdrawal by Subject|1|||
160635075|NCT00021229|580046034|FG000|Overall Study|Progressive Disease|15|||
160635076|NCT00021229|580046035|FG001|Overall Study|Progressive Disease|19|||
160635077|NCT00021229|580046036|FG002|Overall Study|Progressive Disease|12|||
160635078|NCT00021229|580046034|FG000|Overall Study|Protocol Violation|1|||
160635079|NCT00021229|580046035|FG001|Overall Study|Protocol Violation|1|||
160635080|NCT00021229|580046036|FG002|Overall Study|Protocol Violation|0|||
160635081|NCT00021229|580046034|FG000|Overall Study|Physician Decision|0|||
160635082|NCT00021229|580046035|FG001|Overall Study|Physician Decision|0|||
160635083|NCT00021229|580046036|FG002|Overall Study|Physician Decision|1|||
160635084|NCT00021229|580046034|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
160635085|NCT00021229|580046035|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
160863951|NCT01124006|580896676|FG002|Overall Study|Lost to Follow-up|1|||
160635086|NCT00021229|580046036|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
160635087|NCT02156466|580046040|FG000|Overall Study|Adverse Event|0|||
160635088|NCT02156466|580046041|FG001|Overall Study|Adverse Event|0|||
160635089|NCT02156466|580046042|FG002|Overall Study|Adverse Event|1|||
160635090|NCT02156466|580046043|FG003|Overall Study|Adverse Event|1|||
160635091|NCT02156466|580046044|FG004|Overall Study|Adverse Event|0|||
160635092|NCT02156466|580046040|FG000|Overall Study|Quantiferon Positivity|0|||
160635093|NCT02156466|580046041|FG001|Overall Study|Quantiferon Positivity|0|||
160635094|NCT02156466|580046042|FG002|Overall Study|Quantiferon Positivity|0|||
160635095|NCT02156466|580046043|FG003|Overall Study|Quantiferon Positivity|1|||
160635096|NCT02156466|580046044|FG004|Overall Study|Quantiferon Positivity|0|||
160635097|NCT03724968|580046045|FG000|Overall Study|Insurance issues|0|||
160635098|NCT03724968|580046046|FG001|Overall Study|Insurance issues|1|||
160635099|NCT03724968|580046045|FG000|Overall Study|Study closed|0|||
160635100|NCT03724968|580046046|FG001|Overall Study|Study closed|1|||
160635101|NCT00399490|580046049|FG000|Overall Study|Adverse Event|19|||
160635102|NCT00399490|580046049|FG000|Overall Study|Lack of Efficacy|31|||
160635103|NCT00399490|580046049|FG000|Overall Study|Lost to Follow-up|5|||
160635104|NCT00399490|580046049|FG000|Overall Study|Withdrawal by Subject|18|||
160635105|NCT00399490|580046049|FG000|Overall Study|Other|25|||
160635106|NCT02437890|580046050|FG000|Overall Study|Non-compliance to study drug|0|||
160635107|NCT02437890|580046051|FG001|Overall Study|Non-compliance to study drug|1|||
160635108|NCT02437890|580046052|FG002|Overall Study|Non-compliance to study drug|0|||
160635109|NCT02437890|580046053|FG003|Overall Study|Non-compliance to study drug|0|||
160635110|NCT02437890|580046054|FG004|Overall Study|Non-compliance to study drug|1|||
160635111|NCT02437890|580046050|FG000|Overall Study|Sponsor's decision|1|||
160635112|NCT02437890|580046051|FG001|Overall Study|Sponsor's decision|1|||
160635113|NCT02437890|580046052|FG002|Overall Study|Sponsor's decision|4|||
160635114|NCT02437890|580046053|FG003|Overall Study|Sponsor's decision|0|||
160635115|NCT02437890|580046054|FG004|Overall Study|Sponsor's decision|2|||
160635116|NCT02437890|580046050|FG000|Overall Study|Physician Decision|0|||
160635117|NCT02437890|580046051|FG001|Overall Study|Physician Decision|0|||
160635118|NCT02437890|580046052|FG002|Overall Study|Physician Decision|0|||
160635119|NCT02437890|580046053|FG003|Overall Study|Physician Decision|1|||
160635120|NCT02437890|580046054|FG004|Overall Study|Physician Decision|0|||
160863952|NCT01124006|580896674|FG000|Overall Study|Other|0|||
160978095|NCT00786474|581310162|FG001|Overall Study|Death|4|||
160635121|NCT02437890|580046050|FG000|Overall Study|Unable to attend visit(s)|1|||
160635122|NCT02437890|580046051|FG001|Overall Study|Unable to attend visit(s)|0|||
160635123|NCT02437890|580046052|FG002|Overall Study|Unable to attend visit(s)|0|||
160863953|NCT01124006|580896675|FG001|Overall Study|Other|0|||
160863954|NCT01124006|580896676|FG002|Overall Study|Other|1|||
160863955|NCT01712399|580896679|FG000|Overall Study|Lost to Follow-up|1|||
160635124|NCT02437890|580046053|FG003|Overall Study|Unable to attend visit(s)|0|||
160635125|NCT02437890|580046054|FG004|Overall Study|Unable to attend visit(s)|0|||
160635126|NCT02437890|580046050|FG000|Overall Study|Lack of Efficacy|1|||
160635127|NCT02437890|580046051|FG001|Overall Study|Lack of Efficacy|3|||
160635128|NCT02437890|580046052|FG002|Overall Study|Lack of Efficacy|0|||
160635129|NCT02437890|580046053|FG003|Overall Study|Lack of Efficacy|3|||
160635130|NCT02437890|580046054|FG004|Overall Study|Lack of Efficacy|1|||
160635131|NCT02437890|580046050|FG000|Overall Study|Adverse Event|4|||
160635132|NCT02437890|580046051|FG001|Overall Study|Adverse Event|9|||
160635133|NCT02437890|580046052|FG002|Overall Study|Adverse Event|5|||
160635134|NCT02437890|580046053|FG003|Overall Study|Adverse Event|11|||
160635135|NCT02437890|580046054|FG004|Overall Study|Adverse Event|7|||
160635136|NCT02437890|580046050|FG000|Overall Study|Withdrawal by Subject|1|||
160635137|NCT02437890|580046051|FG001|Overall Study|Withdrawal by Subject|2|||
160635138|NCT02437890|580046052|FG002|Overall Study|Withdrawal by Subject|6|||
160635139|NCT02437890|580046053|FG003|Overall Study|Withdrawal by Subject|5|||
160635140|NCT02437890|580046054|FG004|Overall Study|Withdrawal by Subject|5|||
160635141|NCT02437890|580046050|FG000|Overall Study|Death|0|||
160635142|NCT02437890|580046051|FG001|Overall Study|Death|0|||
160635143|NCT02437890|580046052|FG002|Overall Study|Death|0|||
160635144|NCT02437890|580046053|FG003|Overall Study|Death|2|||
160635145|NCT02437890|580046054|FG004|Overall Study|Death|0|||
160635146|NCT02328547|580046055|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
160635147|NCT02328547|580046056|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
160635148|NCT02328547|580046055|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
160635149|NCT02328547|580046056|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
160635150|NCT00344305|580046057|FG000|Overall Study|Lost to Follow-up|2|||
160635151|NCT00344305|580046058|FG001|Overall Study|Lost to Follow-up|0|||
160635152|NCT00344305|580046057|FG000|Overall Study|Participant was not contacted in window|0|||
160635153|NCT00344305|580046058|FG001|Overall Study|Participant was not contacted in window|1|||
160635154|NCT04723173|580046060|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
160635155|NCT00306852|580046067|FG000|Overall Study|Death|14|||
160635156|NCT00306852|580046068|FG001|Overall Study|Death|14|||
160635157|NCT00306852|580046067|FG000|Overall Study|Lost to Follow-up|15|||
160635158|NCT00306852|580046068|FG001|Overall Study|Lost to Follow-up|24|||
160635159|NCT00817778|580046070|FG000|Overall Study|Adverse Event|1|||
160635160|NCT00817778|580046071|FG001|Overall Study|Adverse Event|0|||
160635161|NCT00817778|580046070|FG000|Overall Study|Withdrawal by Subject|1|||
160635162|NCT00817778|580046071|FG001|Overall Study|Withdrawal by Subject|1|||
160635163|NCT00817778|580046070|FG000|Overall Study|Protocol Violation|0|||
160635164|NCT00817778|580046071|FG001|Overall Study|Protocol Violation|1|||
160635165|NCT00817778|580046070|FG000|Overall Study|Study-specific discontinuation criteria|0|||
160635166|NCT00817778|580046071|FG001|Overall Study|Study-specific discontinuation criteria|1|||
160635167|NCT00817778|580046070|FG000|Overall Study|Poor venous access|1|||
160635168|NCT00817778|580046071|FG001|Overall Study|Poor venous access|0|||
160635169|NCT00883740|580046072|FG000|First Intervention|Lost to Follow-up|1|||
160635170|NCT00883740|580046073|FG001|First Intervention|Lost to Follow-up|0|||
160635171|NCT00883740|580046072|FG000|First Intervention|No longer willing to participate|2|||
160635172|NCT00883740|580046073|FG001|First Intervention|No longer willing to participate|0|||
160635173|NCT00883740|580046072|FG000|First Intervention|Protocol Violation|3|||
160635174|NCT00883740|580046073|FG001|First Intervention|Protocol Violation|6|||
160635175|NCT00883740|580046072|FG000|First Intervention|Adverse Event|1|||
160635176|NCT00883740|580046073|FG001|First Intervention|Adverse Event|2|||
160635177|NCT00883740|580046072|FG000|Second Intervention|Protocol Violation|1|||
160635178|NCT00883740|580046073|FG001|Second Intervention|Protocol Violation|0|||
160635179|NCT00883740|580046072|FG000|Second Intervention|No longer willing to participate|0|||
160635180|NCT00883740|580046073|FG001|Second Intervention|No longer willing to participate|1|||
160635181|NCT01286207|580046074|FG000|Overall Study|Adverse Event|27|||
160635182|NCT01286207|580046075|FG001|Overall Study|Adverse Event|41|||
160635183|NCT01286207|580046076|FG002|Overall Study|Adverse Event|8|||
160635184|NCT01286207|580046074|FG000|Overall Study|Lost to Follow-up|49|||
160635185|NCT01286207|580046075|FG001|Overall Study|Lost to Follow-up|43|||
160635186|NCT01286207|580046076|FG002|Overall Study|Lost to Follow-up|20|||
160635187|NCT01286207|580046074|FG000|Overall Study|Withdrawal by Subject|93|||
160635188|NCT01286207|580046075|FG001|Overall Study|Withdrawal by Subject|79|||
160635189|NCT01286207|580046076|FG002|Overall Study|Withdrawal by Subject|41|||
160635190|NCT01286207|580046074|FG000|Overall Study|Lack of Response|92|||
160635191|NCT01286207|580046075|FG001|Overall Study|Lack of Response|38|||
160635192|NCT01286207|580046076|FG002|Overall Study|Lack of Response|8|||
160635193|NCT01286207|580046074|FG000|Overall Study|Other|37|||
160635194|NCT01286207|580046075|FG001|Overall Study|Other|47|||
160635195|NCT01286207|580046076|FG002|Overall Study|Other|13|||
160635196|NCT02923115|580046077|FG000|Overall Study|Lost to Follow-up|0|||
160635197|NCT02923115|580046078|FG001|Overall Study|Lost to Follow-up|0|||
160635198|NCT02923115|580046079|FG002|Overall Study|Lost to Follow-up|0|||
160635199|NCT02923115|580046080|FG003|Overall Study|Lost to Follow-up|1|||
160635200|NCT02923115|580046081|FG004|Overall Study|Lost to Follow-up|0|||
160635201|NCT02923115|580046082|FG005|Overall Study|Lost to Follow-up|0|||
160635202|NCT02923115|580046077|FG000|Overall Study|Withdrawal by Subject|0|||
160635203|NCT02923115|580046078|FG001|Overall Study|Withdrawal by Subject|1|||
160635204|NCT02923115|580046079|FG002|Overall Study|Withdrawal by Subject|0|||
160635205|NCT02923115|580046080|FG003|Overall Study|Withdrawal by Subject|0|||
160635206|NCT02923115|580046081|FG004|Overall Study|Withdrawal by Subject|0|||
160635207|NCT02923115|580046082|FG005|Overall Study|Withdrawal by Subject|0|||
160635208|NCT02923115|580046077|FG000|Overall Study|Randomized, but not dosed|0|||
160635209|NCT02923115|580046078|FG001|Overall Study|Randomized, but not dosed|0|||
160635210|NCT02923115|580046079|FG002|Overall Study|Randomized, but not dosed|3|||
160635211|NCT02923115|580046080|FG003|Overall Study|Randomized, but not dosed|1|||
160635212|NCT02923115|580046081|FG004|Overall Study|Randomized, but not dosed|5|||
160635213|NCT02923115|580046082|FG005|Overall Study|Randomized, but not dosed|0|||
160635214|NCT01875991|580046087|FG000|Overall Study|Withdrawal by Subject|6|||
160635215|NCT01875991|580046088|FG001|Overall Study|Withdrawal by Subject|6|||
160635216|NCT01875991|580046087|FG000|Overall Study|Sponsor Decision|1|||
160635217|NCT01875991|580046088|FG001|Overall Study|Sponsor Decision|0|||
160635218|NCT04840901|580046089|FG000|Overall Study|Lost to Follow-up|3|||
160635219|NCT04840901|580046090|FG001|Overall Study|Lost to Follow-up|1|||
160635220|NCT04840901|580046089|FG000|Overall Study|Moved|1|||
160635221|NCT04840901|580046090|FG001|Overall Study|Moved|0|||
160635222|NCT04840901|580046089|FG000|Overall Study|Unable to comply with study schedule|0|||
160635223|NCT04840901|580046090|FG001|Overall Study|Unable to comply with study schedule|1|||
160635224|NCT04840901|580046089|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
160635225|NCT04840901|580046090|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
160635226|NCT03224234|580046091|FG000|Main Study|Lost to Follow-up|5|||
160635227|NCT03224234|580046092|FG001|Main Study|Lost to Follow-up|5|||
160635228|NCT02610842|580046093|FG000|Overall Study|Lost to Follow-up|5|||
160635229|NCT01783483|580046094|FG000|Overall Study|Death|3|||
160635230|NCT01783483|580046095|FG001|Overall Study|Death|3|||
160635231|NCT01783483|580046094|FG000|Overall Study|Lost to Follow-up|14|||
160635232|NCT01783483|580046095|FG001|Overall Study|Lost to Follow-up|10|||
160635233|NCT01783483|580046094|FG000|Overall Study|Withdrawal by Subject|2|||
160635234|NCT01783483|580046095|FG001|Overall Study|Withdrawal by Subject|1|||
160635235|NCT01783483|580046094|FG000|Overall Study|Physician Decision|1|||
160635236|NCT01783483|580046095|FG001|Overall Study|Physician Decision|1|||
160635237|NCT02268045|580046096|FG000|Overall Study|Death|4|||
160635238|NCT02268045|580046097|FG001|Overall Study|Death|4|||
160635239|NCT02268045|580046096|FG000|Overall Study|Disease Progression|2|||
160635240|NCT02268045|580046097|FG001|Overall Study|Disease Progression|1|||
160635241|NCT02268045|580046096|FG000|Overall Study|Adverse Event|7|||
160635242|NCT02268045|580046097|FG001|Overall Study|Adverse Event|7|||
160635243|NCT02268045|580046096|FG000|Overall Study|Withdrawal by Subject|2|||
160635244|NCT02268045|580046097|FG001|Overall Study|Withdrawal by Subject|6|||
160635245|NCT02268045|580046096|FG000|Overall Study|Physician Decision|0|||
160635246|NCT02268045|580046097|FG001|Overall Study|Physician Decision|1|||
160635247|NCT02268045|580046096|FG000|Overall Study|Protocol Violation|1|||
160635248|NCT02268045|580046097|FG001|Overall Study|Protocol Violation|1|||
160635249|NCT03151707|580046098|FG000|Overall Study|Lost to Follow-up|6|||
160635250|NCT01308762|580046100|FG000|Overall Study|Protocol Violation|0|||
160635251|NCT01308762|580046101|FG001|Overall Study|Protocol Violation|1|||
160635252|NCT01308762|580046102|FG002|Overall Study|Protocol Violation|0|||
160635253|NCT02617446|580046103|FG000|Overall Study|Withdrawal by Subject|0|||
160635254|NCT02617446|580046104|FG001|Overall Study|Withdrawal by Subject|2|||
160635255|NCT02617446|580046105|FG002|Overall Study|Withdrawal by Subject|0|||
160635256|NCT02617446|580046103|FG000|Overall Study|Adverse Event|1|||
160635257|NCT02617446|580046104|FG001|Overall Study|Adverse Event|0|||
160635258|NCT02617446|580046105|FG002|Overall Study|Adverse Event|5|||
160635259|NCT02617446|580046103|FG000|Overall Study|Lost to Follow-up|3|||
160635260|NCT02617446|580046104|FG001|Overall Study|Lost to Follow-up|0|||
160635261|NCT02617446|580046105|FG002|Overall Study|Lost to Follow-up|0|||
160635262|NCT02617446|580046103|FG000|Overall Study|Death|0|||
160863956|NCT01712399|580896679|FG000|Overall Study|Withdrawal by Subject|39|||
160635263|NCT02617446|580046104|FG001|Overall Study|Death|0|||
160635264|NCT02617446|580046105|FG002|Overall Study|Death|2|||
160635265|NCT01556490|580046114|FG000|Randomized Patients Summary|Protocol Violation|22|||
160635266|NCT01556490|580046115|FG001|Randomized Patients Summary|Protocol Violation|23|||
160635267|NCT01556490|580046114|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
160635268|NCT01556490|580046115|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
160635269|NCT05631093|580046117|FG000|Overall Study|Death|0|||
160635270|NCT05631093|580046118|FG001|Overall Study|Death|1|||
160635271|NCT05631093|580046117|FG000|Overall Study|Lost to Follow-up|1|||
160635272|NCT05631093|580046118|FG001|Overall Study|Lost to Follow-up|2|||
160635273|NCT05631093|580046117|FG000|Overall Study|Physician Decision|1|||
160635274|NCT05631093|580046118|FG001|Overall Study|Physician Decision|0|||
160635275|NCT05631093|580046117|FG000|Overall Study|Withdrawal by Subject|4|||
160863957|NCT01712399|580896679|FG000|Overall Study|Death|1|||
160863958|NCT01712399|580896679|FG000|Overall Study|Adverse Event|11|||
160635276|NCT05631093|580046118|FG001|Overall Study|Withdrawal by Subject|1|||
160635277|NCT05631093|580046117|FG000|Overall Study|Ongoing|353|||
160635278|NCT05631093|580046118|FG001|Overall Study|Ongoing|177|||
160635279|NCT05631093|580046117|FG000|Overall Study|Adverse Event|0|||
160635280|NCT05631093|580046118|FG001|Overall Study|Adverse Event|1|||
160635281|NCT02873195|580046119|FG000|Overall Study|Ineligible|5|||
160635282|NCT02873195|580046120|FG001|Overall Study|Ineligible|0|||
160863959|NCT01712399|580896679|FG000|Overall Study|Study closure|345|||
160978096|NCT00786474|581310161|FG000|Overall Study|Withdrawal by Subject|23|||
160635283|NCT03107715|580046121|FG000|Overall Study|did not deliver at the home hospital|4|||
160635284|NCT03107715|580046122|FG001|Overall Study|did not deliver at the home hospital|6|||
160635285|NCT03107715|580046121|FG000|Overall Study|infant stillborn|0|||
160635286|NCT03107715|580046122|FG001|Overall Study|infant stillborn|1|||
160635287|NCT03252756|580046125|FG000|Overall Study|Protocol Violation|2|||
160635288|NCT03252756|580046126|FG001|Overall Study|Protocol Violation|4|||
160635289|NCT03252756|580046125|FG000|Overall Study|COVID-19 Pandemic|1|||
160635290|NCT03252756|580046126|FG001|Overall Study|COVID-19 Pandemic|1|||
160635291|NCT03252756|580046125|FG000|Overall Study|Study Drug Expiration|0|||
160635292|NCT03252756|580046126|FG001|Overall Study|Study Drug Expiration|1|||
160635293|NCT03594175|580046127|FG000|Overall Study|Not treated|8|||
160635294|NCT03594175|580046128|FG001|Overall Study|Not treated|1|||
160635295|NCT03594175|580046129|FG002|Overall Study|Not treated|5|||
160635296|NCT03594175|580046127|FG000|Overall Study|Adverse Event|3|||
160635297|NCT03594175|580046128|FG001|Overall Study|Adverse Event|0|||
160635298|NCT03594175|580046129|FG002|Overall Study|Adverse Event|0|||
160635299|NCT03594175|580046127|FG000|Overall Study|Withdrawal by Subject|3|||
160635300|NCT03594175|580046128|FG001|Overall Study|Withdrawal by Subject|0|||
160635301|NCT03594175|580046129|FG002|Overall Study|Withdrawal by Subject|0|||
160635302|NCT03594175|580046127|FG000|Overall Study|Protocol Violation|2|||
160635303|NCT03594175|580046128|FG001|Overall Study|Protocol Violation|2|||
160635304|NCT03594175|580046129|FG002|Overall Study|Protocol Violation|2|||
160635305|NCT04822701|580046130|FG000|Overall Study|Not treated|2|||
160635306|NCT04822701|580046131|FG001|Overall Study|Not treated|0|||
160635307|NCT04822701|580046130|FG000|Overall Study|Lost to Follow-up|1|||
160635308|NCT04822701|580046131|FG001|Overall Study|Lost to Follow-up|0|||
160635309|NCT04822701|580046130|FG000|Overall Study|Withdrawal by Subject|1|||
160635310|NCT04822701|580046131|FG001|Overall Study|Withdrawal by Subject|0|||
160635311|NCT02706353|580046132|FG000|Dose Level 1|Disease Progression|1|||
160635312|NCT02706353|580046133|FG001|Dose Level 1|Disease Progression|0|||
160635313|NCT02706353|580046134|FG002|Dose Level 1|Disease Progression|0|||
160635314|NCT02706353|580046135|FG003|Dose Level 1|Disease Progression|0|||
160635315|NCT02706353|580046136|FG004|Dose Level 1|Disease Progression|0|||
160635316|NCT02706353|580046137|FG005|Dose Level 1|Disease Progression|0|||
160635317|NCT02706353|580046132|FG000|Dose Level 3|Disease Progression|0|||
160635318|NCT02706353|580046133|FG001|Dose Level 3|Disease Progression|0|||
160635319|NCT02706353|580046134|FG002|Dose Level 3|Disease Progression|2|||
160635320|NCT02706353|580046135|FG003|Dose Level 3|Disease Progression|0|||
160635321|NCT02706353|580046136|FG004|Dose Level 3|Disease Progression|0|||
160635322|NCT02706353|580046137|FG005|Dose Level 3|Disease Progression|0|||
160635323|NCT02706353|580046132|FG000|Dose Level 4|Disease Progression|0|||
160635324|NCT02706353|580046133|FG001|Dose Level 4|Disease Progression|0|||
160635325|NCT02706353|580046134|FG002|Dose Level 4|Disease Progression|0|||
160635326|NCT02706353|580046135|FG003|Dose Level 4|Disease Progression|1|||
160635327|NCT02706353|580046136|FG004|Dose Level 4|Disease Progression|0|||
160635328|NCT02706353|580046137|FG005|Dose Level 4|Disease Progression|0|||
160635329|NCT02706353|580046132|FG000|Dose Level 4|Toxicity|0|||
160635330|NCT02706353|580046133|FG001|Dose Level 4|Toxicity|0|||
160635331|NCT02706353|580046134|FG002|Dose Level 4|Toxicity|0|||
160635332|NCT02706353|580046135|FG003|Dose Level 4|Toxicity|1|||
160635333|NCT02706353|580046136|FG004|Dose Level 4|Toxicity|0|||
160748898|NCT01826981|580467872|FG004|Overall Study|Lack of Efficacy|5|||
160635334|NCT02706353|580046137|FG005|Dose Level 4|Toxicity|0|||
160635335|NCT02706353|580046132|FG000|Dose Level 4|Death|0|||
160978097|NCT00786474|581310162|FG001|Overall Study|Withdrawal by Subject|31|||
160978098|NCT00786474|581310161|FG000|Overall Study|Lost to Follow-up|3|||
160635336|NCT02706353|580046133|FG001|Dose Level 4|Death|0|||
160635337|NCT02706353|580046134|FG002|Dose Level 4|Death|0|||
160635338|NCT02706353|580046135|FG003|Dose Level 4|Death|1|||
160635339|NCT02706353|580046136|FG004|Dose Level 4|Death|0|||
160635340|NCT02706353|580046137|FG005|Dose Level 4|Death|0|||
160635341|NCT02706353|580046132|FG000|Dose Level 5|Toxicity|0|||
160635342|NCT02706353|580046133|FG001|Dose Level 5|Toxicity|0|||
160635343|NCT02706353|580046134|FG002|Dose Level 5|Toxicity|0|||
160635344|NCT02706353|580046135|FG003|Dose Level 5|Toxicity|0|||
160635345|NCT02706353|580046136|FG004|Dose Level 5|Toxicity|1|||
160635346|NCT02706353|580046137|FG005|Dose Level 5|Toxicity|0|||
160635347|NCT02706353|580046132|FG000|Dose Level 5|Disease Progression|0|||
160635348|NCT02706353|580046133|FG001|Dose Level 5|Disease Progression|0|||
160635349|NCT02706353|580046134|FG002|Dose Level 5|Disease Progression|0|||
160635350|NCT02706353|580046135|FG003|Dose Level 5|Disease Progression|0|||
160635351|NCT02706353|580046136|FG004|Dose Level 5|Disease Progression|3|||
160635352|NCT02706353|580046137|FG005|Dose Level 5|Disease Progression|2|||
160635353|NCT02706353|580046132|FG000|Dose Level 5|Death|0|||
160635354|NCT02706353|580046133|FG001|Dose Level 5|Death|0|||
160635355|NCT02706353|580046134|FG002|Dose Level 5|Death|0|||
160635356|NCT02706353|580046135|FG003|Dose Level 5|Death|0|||
160635357|NCT02706353|580046136|FG004|Dose Level 5|Death|1|||
160635358|NCT02706353|580046137|FG005|Dose Level 5|Death|6|||
160635359|NCT02706353|580046132|FG000|Dose Level 5|Withdrawal by Subject|0|||
160635360|NCT02706353|580046133|FG001|Dose Level 5|Withdrawal by Subject|0|||
160635361|NCT02706353|580046134|FG002|Dose Level 5|Withdrawal by Subject|0|||
160635362|NCT02706353|580046135|FG003|Dose Level 5|Withdrawal by Subject|0|||
160635363|NCT02706353|580046136|FG004|Dose Level 5|Withdrawal by Subject|0|||
160635364|NCT02706353|580046137|FG005|Dose Level 5|Withdrawal by Subject|2|||
160635365|NCT03560466|580046138|FG000|Overall Study|Adverse Event|1|||
160635366|NCT03560466|580046139|FG001|Overall Study|Adverse Event|2|||
160635367|NCT03560466|580046140|FG002|Overall Study|Adverse Event|0|||
160635368|NCT03560466|580046138|FG000|Overall Study|Poor Compliance to Protocol|0|||
160635369|NCT03560466|580046139|FG001|Overall Study|Poor Compliance to Protocol|2|||
160635370|NCT03560466|580046140|FG002|Overall Study|Poor Compliance to Protocol|0|||
160635371|NCT03560466|580046138|FG000|Overall Study|Other|6|||
160635372|NCT03560466|580046139|FG001|Overall Study|Other|8|||
160635373|NCT03560466|580046140|FG002|Overall Study|Other|1|||
160635374|NCT01858558|580047441|FG000|Overall Study|Death|1|||
160635375|NCT01858558|580047442|FG001|Overall Study|Death|1|||
160635376|NCT01858558|580047441|FG000|Overall Study|Lost to Follow-up|1|||
160635377|NCT01858558|580047442|FG001|Overall Study|Lost to Follow-up|0|||
160635378|NCT01858558|580047441|FG000|Overall Study|Disease progression|3|||
160635379|NCT01858558|580047442|FG001|Overall Study|Disease progression|1|||
160635380|NCT01858558|580047441|FG000|Overall Study|Product contamination|2|||
160635381|NCT01858558|580047442|FG001|Overall Study|Product contamination|0|||
160635382|NCT01858558|580047441|FG000|Overall Study|Failed expansion of cell product|2|||
160635383|NCT01858558|580047442|FG001|Overall Study|Failed expansion of cell product|0|||
160635384|NCT01336608|580047443|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
160635385|NCT01336608|580047444|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160635386|NCT01336608|580047445|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160635387|NCT01336608|580047446|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160635388|NCT01336608|580047443|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
160635389|NCT01336608|580047444|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160635390|NCT01336608|580047445|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160635391|NCT01336608|580047446|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160635392|NCT01336608|580047443|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
160635393|NCT01336608|580047444|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
160635394|NCT01336608|580047445|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
160635395|NCT01336608|580047446|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
160635396|NCT01336608|580047443|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
160635397|NCT01336608|580047444|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
160635398|NCT01336608|580047445|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
160635399|NCT01336608|580047446|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
160635400|NCT01336608|580047443|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
160635401|NCT01336608|580047444|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160635402|NCT01336608|580047445|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160635403|NCT01336608|580047446|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160635404|NCT01336608|580047443|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
160635405|NCT01336608|580047444|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
160635406|NCT01336608|580047445|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
160635407|NCT01336608|580047446|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
160635408|NCT01336608|580047443|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160635409|NCT01336608|580047444|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
160635410|NCT01336608|580047445|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160635411|NCT01336608|580047446|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160635412|NCT01336608|580047443|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
160635413|NCT01336608|580047444|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
160635414|NCT01336608|580047445|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
160635415|NCT01336608|580047446|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
160635416|NCT01336608|580047443|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
160635417|NCT01336608|580047444|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
160635418|NCT01336608|580047445|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
160635419|NCT01336608|580047446|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
160635420|NCT01336608|580047443|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
160635421|NCT01336608|580047444|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
160748899|NCT01826981|580467873|FG005|Overall Study|Lack of Efficacy|0|||
160520753|NCT00712673|579636733|FG003|Overall Study|Adverse Event|26|||
160520754|NCT00712673|579636730|FG000|Overall Study|Lack of Efficacy|2|||
160520755|NCT00712673|579636731|FG001|Overall Study|Lack of Efficacy|8|||
160520756|NCT00712673|579636732|FG002|Overall Study|Lack of Efficacy|8|||
160520757|NCT00712673|579636733|FG003|Overall Study|Lack of Efficacy|6|||
160520758|NCT00712673|579636730|FG000|Overall Study|Poor Compliance to Protocol|3|||
160520759|NCT00712673|579636731|FG001|Overall Study|Poor Compliance to Protocol|3|||
160520760|NCT00712673|579636732|FG002|Overall Study|Poor Compliance to Protocol|4|||
160520761|NCT00712673|579636733|FG003|Overall Study|Poor Compliance to Protocol|16|||
160520762|NCT00712673|579636730|FG000|Overall Study|Lost to Follow-up|1|||
160520763|NCT00712673|579636731|FG001|Overall Study|Lost to Follow-up|0|||
160520764|NCT00712673|579636732|FG002|Overall Study|Lost to Follow-up|2|||
160520765|NCT00712673|579636733|FG003|Overall Study|Lost to Follow-up|0|||
160520766|NCT00712673|579636730|FG000|Overall Study|Withdrawal by Subject|6|||
160520767|NCT00712673|579636731|FG001|Overall Study|Withdrawal by Subject|7|||
160520768|NCT00712673|579636732|FG002|Overall Study|Withdrawal by Subject|15|||
160520769|NCT00712673|579636733|FG003|Overall Study|Withdrawal by Subject|20|||
160520770|NCT00712673|579636730|FG000|Overall Study|Familial and Personal Reasons|5|||
160520771|NCT00712673|579636731|FG001|Overall Study|Familial and Personal Reasons|0|||
160520772|NCT00712673|579636732|FG002|Overall Study|Familial and Personal Reasons|5|||
160520773|NCT00712673|579636733|FG003|Overall Study|Familial and Personal Reasons|2|||
160520774|NCT00712673|579636730|FG000|Overall Study|Investigator's Decision|1|||
160520775|NCT00712673|579636731|FG001|Overall Study|Investigator's Decision|0|||
160520776|NCT00712673|579636732|FG002|Overall Study|Investigator's Decision|0|||
160520777|NCT00712673|579636733|FG003|Overall Study|Investigator's Decision|0|||
160520778|NCT00712673|579636730|FG000|Overall Study|Protocol Violation|0|||
160520779|NCT00712673|579636731|FG001|Overall Study|Protocol Violation|0|||
160520780|NCT00712673|579636732|FG002|Overall Study|Protocol Violation|2|||
160520781|NCT00712673|579636733|FG003|Overall Study|Protocol Violation|0|||
160520782|NCT02768870|579636736|FG000|Overall Study|Death|1|||
160520783|NCT02768870|579636736|FG000|Overall Study|Reoperation|6|||
160520784|NCT02768870|579636736|FG000|Overall Study|Lost to Follow-up|1|||
160520785|NCT02768870|579636736|FG000|Overall Study|Exit|4|||
160520786|NCT02963610|579636737|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
160520787|NCT01774110|579636738|FG000|Overall Study|Lost to Follow-up|7|||
160520788|NCT00063154|579636739|FG000|Overall Study|Disease progression|27|||
160520789|NCT00063154|579636739|FG000|Overall Study|Adverse Event|2|||
160520790|NCT00063154|579636739|FG000|Overall Study|Physician Decision|10|||
160520791|NCT00063154|579636739|FG000|Overall Study|Death|3|||
160520792|NCT00063154|579636739|FG000|Overall Study|Reason unspecified|1|||
160520793|NCT00063154|579636739|FG000|Overall Study|Did not receive treatment|8|||
160520794|NCT02203695|579636740|FG000|Overall Study|Patient withdrew consent|1|||
160520795|NCT02203695|579636741|FG001|Overall Study|Patient withdrew consent|1|||
160520796|NCT02203695|579636740|FG000|Overall Study|Started non-study treatment|1|||
160520797|NCT02203695|579636741|FG001|Overall Study|Started non-study treatment|0|||
160520798|NCT02699983|579636743|FG000|Overall Study|Withdrawal by Subject|1|||
160520799|NCT02699983|579636744|FG001|Overall Study|Withdrawal by Subject|0|||
160520800|NCT01259726|579636745|FG000|Overall Study|Death|1|||
160520801|NCT01259726|579636746|FG001|Overall Study|Death|0|||
160520802|NCT01259726|579636747|FG002|Overall Study|Death|0|||
160520803|NCT01259726|579636748|FG003|Overall Study|Death|0|||
160520804|NCT01259726|579636745|FG000|Overall Study|Physician Decision|2|||
160520805|NCT01259726|579636746|FG001|Overall Study|Physician Decision|0|||
160520806|NCT01259726|579636747|FG002|Overall Study|Physician Decision|1|||
160520807|NCT01259726|579636748|FG003|Overall Study|Physician Decision|1|||
160520808|NCT01259726|579636745|FG000|Overall Study|Withdrawal by Subject|1|||
160520809|NCT01259726|579636746|FG001|Overall Study|Withdrawal by Subject|3|||
160520810|NCT01259726|579636747|FG002|Overall Study|Withdrawal by Subject|2|||
160520811|NCT01259726|579636748|FG003|Overall Study|Withdrawal by Subject|1|||
160520812|NCT01259726|579636745|FG000|Overall Study|Lost to Follow-up|1|||
160520813|NCT01259726|579636746|FG001|Overall Study|Lost to Follow-up|1|||
160520814|NCT01259726|579636747|FG002|Overall Study|Lost to Follow-up|1|||
160520815|NCT01259726|579636748|FG003|Overall Study|Lost to Follow-up|3|||
160520816|NCT01211197|579636750|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160520817|NCT01211197|579636751|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160520818|NCT01211197|579636752|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
160520819|NCT01211197|579636753|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160520820|NCT01211197|579636754|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160520821|NCT01211197|579636755|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160520822|NCT01211197|579636750|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
160520823|NCT01211197|579636751|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
160520824|NCT01211197|579636752|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
160520825|NCT01211197|579636753|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
160520826|NCT01211197|579636754|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
160520827|NCT01211197|579636755|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
160520828|NCT00261846|579636756|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
160520829|NCT00261846|579636757|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
160635422|NCT01336608|580047445|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
160635423|NCT01336608|580047446|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
160635424|NCT01336608|580047443|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160635425|NCT01336608|580047444|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
160635426|NCT01336608|580047445|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160635427|NCT01336608|580047446|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160635428|NCT01336608|580047443|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
160635429|NCT01336608|580047444|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
160635430|NCT01336608|580047445|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
160635431|NCT01336608|580047446|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
160635432|NCT01336608|580047443|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
160635433|NCT01336608|580047444|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
160635434|NCT01336608|580047445|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
160635435|NCT01336608|580047446|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
160635436|NCT01190098|580047451|FG000|Overall Study|Adverse Event|2|||
160635437|NCT01190098|580047452|FG001|Overall Study|Adverse Event|0|||
160635438|NCT01190098|580047451|FG000|Overall Study|Patient coomorbidity|0|||
160635439|NCT01190098|580047452|FG001|Overall Study|Patient coomorbidity|1|||
160635440|NCT01190098|580047451|FG000|Overall Study|Lack of transportation|1|||
160635441|NCT01190098|580047452|FG001|Overall Study|Lack of transportation|0|||
160635442|NCT01190098|580047451|FG000|Overall Study|Other|0|||
160635443|NCT01190098|580047452|FG001|Overall Study|Other|1|||
160635444|NCT02996448|580047457|FG000|Overall Study|Study terminated due to adverse effects|3|||
160635445|NCT01422720|580047458|FG000|Overall Study|Adverse Event|16|||
160635446|NCT01422720|580047458|FG000|Overall Study|Lack of Efficacy|1|||
160635447|NCT01422720|580047458|FG000|Overall Study|Withdrawal by Subject|4|||
160635448|NCT01422720|580047458|FG000|Overall Study|Ineligibility|1|||
160635449|NCT00606801|580047459|FG000|Intervention|Protocol Violation|3|||
160635450|NCT00606801|580047460|FG001|Intervention|Protocol Violation|3|||
160635451|NCT02082262|580047461|FG000|Overall Study|Withdrawal by Subject|3|||
160635452|NCT02082262|580047461|FG000|Overall Study|Adverse Event|48|||
160635453|NCT01726335|580047466|FG000|Overall Study|Lost to Follow-up|2|||
160635454|NCT01726335|580047466|FG000|Overall Study|Withdrawal by Subject|15|||
160635455|NCT01726335|580047466|FG000|Overall Study|Adverse Event|4|||
160635456|NCT01726335|580047466|FG000|Overall Study|Lost to Follow-up|2|||
160863960|NCT01705509|580896685|FG000|Inclusion CPET|Screen Failure|5|||
160863961|NCT01705509|580896685|FG000|Inclusion CPET|Withdrawal by Subject|2|||
160863962|NCT01705509|580896685|FG000|CPET w/ Ranexa|Screen Failure|2|||
160863963|NCT00904033|580896686|FG000|Overall Study|Withdrawal by Subject|1|||
160863964|NCT00904033|580896687|FG001|Overall Study|Withdrawal by Subject|1|||
160863965|NCT00904033|580896688|FG002|Overall Study|Withdrawal by Subject|0|||
160863966|NCT00904033|580896689|FG003|Overall Study|Withdrawal by Subject|0|||
160863967|NCT00904033|580896686|FG000|Overall Study|Physician Decision|0|||
160863968|NCT00904033|580896687|FG001|Overall Study|Physician Decision|0|||
160863969|NCT00904033|580896688|FG002|Overall Study|Physician Decision|1|||
160863970|NCT00904033|580896689|FG003|Overall Study|Physician Decision|0|||
160863971|NCT00904033|580896686|FG000|Overall Study|Unable to obtain final blood draw|0|||
160863972|NCT00904033|580896687|FG001|Overall Study|Unable to obtain final blood draw|0|||
160863973|NCT00904033|580896688|FG002|Overall Study|Unable to obtain final blood draw|0|||
160863974|NCT00904033|580896689|FG003|Overall Study|Unable to obtain final blood draw|2|||
160863975|NCT02736890|580896690|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
160863976|NCT02736890|580896691|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
160863977|NCT02736890|580896690|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
160863978|NCT02736890|580896691|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
160863979|NCT01803607|580896693|FG000|Overall Study|Adverse Event|5|||
160863980|NCT01803607|580896694|FG001|Overall Study|Adverse Event|3|||
160863981|NCT01803607|580896693|FG000|Overall Study|Lack of Efficacy|0|||
160863982|NCT01803607|580896694|FG001|Overall Study|Lack of Efficacy|1|||
160863983|NCT01803607|580896693|FG000|Overall Study|Protocol Violation|3|||
160863984|NCT01803607|580896694|FG001|Overall Study|Protocol Violation|2|||
160863985|NCT01803607|580896693|FG000|Overall Study|Study terminated by sponsor|54|||
160863986|NCT01803607|580896694|FG001|Overall Study|Study terminated by sponsor|56|||
160863987|NCT01803607|580896693|FG000|Overall Study|Withdrawal by Subject|6|||
160863988|NCT01803607|580896694|FG001|Overall Study|Withdrawal by Subject|5|||
160863989|NCT03077412|580896695|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
160863990|NCT03077412|580896696|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
160863991|NCT03077412|580896697|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
160635457|NCT01726335|580047466|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
160863992|NCT03077412|580896695|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
160863993|NCT03077412|580896696|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
160863994|NCT03077412|580896697|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
160863995|NCT03077412|580896695|FG000|Overall Study|Adverse Event|1|||
160863996|NCT03077412|580896696|FG001|Overall Study|Adverse Event|2|||
160863997|NCT03077412|580896697|FG002|Overall Study|Adverse Event|2|||
160863998|NCT03077412|580896695|FG000|Overall Study|Investigator's Discretion|0|||
160863999|NCT03077412|580896696|FG001|Overall Study|Investigator's Discretion|1|||
160864000|NCT03077412|580896697|FG002|Overall Study|Investigator's Discretion|1|||
160864001|NCT03077412|580896695|FG000|Overall Study|Withdrew Consent|0|||
160864002|NCT03077412|580896696|FG001|Overall Study|Withdrew Consent|2|||
160864003|NCT03077412|580896697|FG002|Overall Study|Withdrew Consent|0|||
160864004|NCT01936870|580896698|FG000|Overall Study|No Visit After Treatment|176|||
160864005|NCT01936870|580896698|FG000|Overall Study|Protocol Violation|12|||
160864006|NCT01936870|580896698|FG000|Overall Study|No Drug Administration|1|||
160864007|NCT00248040|580896699|FG000|Overall Study|transplantectomy|2|||
160864008|NCT00248040|580896700|FG001|Overall Study|transplantectomy|1|||
160864009|NCT00248040|580896701|FG002|Overall Study|transplantectomy|3|||
160864010|NCT00248040|580896699|FG000|Overall Study|transplant cancelled post treat start|1|||
160864011|NCT00248040|580896700|FG001|Overall Study|transplant cancelled post treat start|0|||
160864012|NCT00248040|580896701|FG002|Overall Study|transplant cancelled post treat start|0|||
160864013|NCT00248040|580896699|FG000|Overall Study|Death|0|||
160864014|NCT00248040|580896700|FG001|Overall Study|Death|0|||
160864015|NCT00248040|580896701|FG002|Overall Study|Death|1|||
160864016|NCT00118417|580896702|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
160864017|NCT00118417|580896703|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
160864018|NCT00118417|580896702|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
160864019|NCT00118417|580896703|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
160864020|NCT00118417|580896702|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
160864021|NCT00118417|580896703|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
160864022|NCT00118417|580896702|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
160864023|NCT00118417|580896703|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
160864024|NCT00118417|580896702|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
160864025|NCT00118417|580896703|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
160864026|NCT02978781|580896704|FG000|Part A|Adverse Event|1|||
160864027|NCT02978781|580896705|FG001|Part A|Adverse Event|1|||
160864028|NCT02978781|580896706|FG002|Part A|Adverse Event|0|||
160864029|NCT02978781|580896707|FG003|Part A|Adverse Event|0|||
160864030|NCT02978781|580896708|FG004|Part A|Adverse Event|0|||
160864031|NCT02978781|580896704|FG000|Part A|Withdrawal by Subject|0|||
160864032|NCT02978781|580896705|FG001|Part A|Withdrawal by Subject|1|||
160864033|NCT02978781|580896706|FG002|Part A|Withdrawal by Subject|0|||
160864034|NCT02978781|580896707|FG003|Part A|Withdrawal by Subject|0|||
160864035|NCT02978781|580896708|FG004|Part A|Withdrawal by Subject|0|||
160864036|NCT02978781|580896704|FG000|Part B|Withdrawal by Subject|0|||
160864037|NCT02978781|580896705|FG001|Part B|Withdrawal by Subject|0|||
160864038|NCT02978781|580896706|FG002|Part B|Withdrawal by Subject|0|||
160864039|NCT02978781|580896707|FG003|Part B|Withdrawal by Subject|1|||
160864040|NCT02978781|580896708|FG004|Part B|Withdrawal by Subject|0|||
160864041|NCT02978781|580896704|FG000|Part C|Adverse Event|0|||
160864042|NCT02978781|580896705|FG001|Part C|Adverse Event|0|||
160864043|NCT02978781|580896706|FG002|Part C|Adverse Event|0|||
160864044|NCT02978781|580896707|FG003|Part C|Adverse Event|0|||
160635458|NCT01586624|580047467|FG000|Overall Study|Adverse Event|3|||
160635459|NCT01586624|580047468|FG001|Overall Study|Adverse Event|0|||
160635460|NCT01586624|580047469|FG002|Overall Study|Adverse Event|2|||
160635461|NCT01586624|580047470|FG003|Overall Study|Adverse Event|1|||
160635462|NCT01586624|580047471|FG004|Overall Study|Adverse Event|3|||
160635463|NCT01586624|580047472|FG005|Overall Study|Adverse Event|3|||
160635464|NCT01586624|580047473|FG006|Overall Study|Adverse Event|2|||
160635465|NCT01586624|580047474|FG007|Overall Study|Adverse Event|3|||
160635466|NCT01586624|580047467|FG000|Overall Study|Physician Decision|0|||
160635467|NCT01586624|580047468|FG001|Overall Study|Physician Decision|1|||
160635468|NCT01586624|580047469|FG002|Overall Study|Physician Decision|1|||
160635469|NCT01586624|580047470|FG003|Overall Study|Physician Decision|0|||
160635470|NCT01586624|580047471|FG004|Overall Study|Physician Decision|2|||
160635471|NCT01586624|580047472|FG005|Overall Study|Physician Decision|0|||
160635472|NCT01586624|580047473|FG006|Overall Study|Physician Decision|1|||
160635473|NCT01586624|580047474|FG007|Overall Study|Physician Decision|1|||
160864045|NCT02978781|580896708|FG004|Part C|Adverse Event|2|||
160864046|NCT02978781|580896704|FG000|Part C|Withdrawal by Subject|0|||
160864047|NCT02978781|580896705|FG001|Part C|Withdrawal by Subject|0|||
160864048|NCT02978781|580896706|FG002|Part C|Withdrawal by Subject|0|||
160864049|NCT02978781|580896707|FG003|Part C|Withdrawal by Subject|0|||
160864050|NCT02978781|580896708|FG004|Part C|Withdrawal by Subject|1|||
160864051|NCT02978781|580896704|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
160864052|NCT02978781|580896705|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
160864053|NCT02978781|580896706|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
160864054|NCT02978781|580896707|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
160864055|NCT02978781|580896708|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
160864056|NCT01383356|580896709|FG000|Period 1|Adverse Event|5|||
160635474|NCT01586624|580047467|FG000|Overall Study|Withdrawal by Subject|0|||
160635475|NCT01586624|580047468|FG001|Overall Study|Withdrawal by Subject|0|||
160635476|NCT01586624|580047469|FG002|Overall Study|Withdrawal by Subject|0|||
160635477|NCT01586624|580047470|FG003|Overall Study|Withdrawal by Subject|1|||
160635478|NCT01586624|580047471|FG004|Overall Study|Withdrawal by Subject|0|||
160635479|NCT01586624|580047472|FG005|Overall Study|Withdrawal by Subject|0|||
160635480|NCT01586624|580047473|FG006|Overall Study|Withdrawal by Subject|0|||
160635481|NCT01586624|580047474|FG007|Overall Study|Withdrawal by Subject|0|||
160635482|NCT01586624|580047467|FG000|Overall Study|Evidence of disease progression|1|||
160635483|NCT01586624|580047468|FG001|Overall Study|Evidence of disease progression|3|||
160635484|NCT01586624|580047469|FG002|Overall Study|Evidence of disease progression|2|||
160635485|NCT01586624|580047470|FG003|Overall Study|Evidence of disease progression|5|||
160635486|NCT01586624|580047471|FG004|Overall Study|Evidence of disease progression|3|||
160635487|NCT01586624|580047472|FG005|Overall Study|Evidence of disease progression|5|||
160635488|NCT01586624|580047473|FG006|Overall Study|Evidence of disease progression|4|||
160635489|NCT01586624|580047474|FG007|Overall Study|Evidence of disease progression|6|||
160635490|NCT01586624|580047467|FG000|Overall Study|Screen failure (no treatment received)|0|||
160635491|NCT01586624|580047468|FG001|Overall Study|Screen failure (no treatment received)|0|||
160635492|NCT01586624|580047469|FG002|Overall Study|Screen failure (no treatment received)|0|||
160635493|NCT01586624|580047470|FG003|Overall Study|Screen failure (no treatment received)|0|||
160635494|NCT01586624|580047471|FG004|Overall Study|Screen failure (no treatment received)|0|||
160635495|NCT01586624|580047472|FG005|Overall Study|Screen failure (no treatment received)|0|||
160635496|NCT01586624|580047473|FG006|Overall Study|Screen failure (no treatment received)|1|||
160635497|NCT01586624|580047474|FG007|Overall Study|Screen failure (no treatment received)|0|||
160635498|NCT01796860|580047479|FG000|Overall Study|Withdrawal by Subject|3|||
160635499|NCT01537549|580047480|FG000|Overall Study|Lost to Follow-up|1|||
160635500|NCT01537549|580047480|FG000|Overall Study|Withdrawal by Subject|2|||
160635501|NCT00103259|580047481|FG000|Overall Study|Death|3|||
160635502|NCT00103259|580047482|FG001|Overall Study|Death|2|||
160635503|NCT00103259|580047481|FG000|Overall Study|Withdrawal by Subject|2|||
160635504|NCT00103259|580047482|FG001|Overall Study|Withdrawal by Subject|3|||
160635505|NCT00103259|580047481|FG000|Overall Study|alternative therapy|1|||
160635506|NCT00103259|580047482|FG001|Overall Study|alternative therapy|0|||
160635507|NCT00103259|580047481|FG000|Overall Study|other (reasons were not specified)|2|||
160635508|NCT00103259|580047482|FG001|Overall Study|other (reasons were not specified)|1|||
160635509|NCT00103259|580047481|FG000|Overall Study|ineligible/no protocol therapy|4|||
160635510|NCT00103259|580047482|FG001|Overall Study|ineligible/no protocol therapy|6|||
160635511|NCT02494583|580047485|FG000|Overall Study|Death|224|||
160635512|NCT02494583|580047486|FG001|Overall Study|Death|214|||
160635513|NCT02494583|580047487|FG002|Overall Study|Death|225|||
160635514|NCT02494583|580047485|FG000|Overall Study|Lost to Follow-up|1|||
160635515|NCT02494583|580047486|FG001|Overall Study|Lost to Follow-up|0|||
160748900|NCT01826981|580467874|FG006|Overall Study|Lack of Efficacy|0|||
160748901|NCT01826981|580467875|FG007|Overall Study|Lack of Efficacy|8|||
160748902|NCT01826981|580467876|FG008|Overall Study|Lack of Efficacy|7|||
160748903|NCT01826981|580467877|FG009|Overall Study|Lack of Efficacy|0|||
160748904|NCT01826981|580467878|FG010|Overall Study|Lack of Efficacy|1|||
160748905|NCT01826981|580467879|FG011|Overall Study|Lack of Efficacy|0|||
160748906|NCT01826981|580467880|FG012|Overall Study|Lack of Efficacy|0|||
160748907|NCT01826981|580467881|FG013|Overall Study|Lack of Efficacy|3|||
160748908|NCT01826981|580467882|FG014|Overall Study|Lack of Efficacy|0|||
160748909|NCT01826981|580467868|FG000|Overall Study|Lost to Follow-up|0|||
160748910|NCT01826981|580467869|FG001|Overall Study|Lost to Follow-up|0|||
160748911|NCT01826981|580467870|FG002|Overall Study|Lost to Follow-up|0|||
160748912|NCT01826981|580467871|FG003|Overall Study|Lost to Follow-up|0|||
160748913|NCT01826981|580467872|FG004|Overall Study|Lost to Follow-up|1|||
160748914|NCT01826981|580467873|FG005|Overall Study|Lost to Follow-up|1|||
160748915|NCT01826981|580467874|FG006|Overall Study|Lost to Follow-up|0|||
160748916|NCT01826981|580467875|FG007|Overall Study|Lost to Follow-up|1|||
160748917|NCT01826981|580467876|FG008|Overall Study|Lost to Follow-up|0|||
160748918|NCT01826981|580467877|FG009|Overall Study|Lost to Follow-up|1|||
160748919|NCT01826981|580467878|FG010|Overall Study|Lost to Follow-up|1|||
160748920|NCT01826981|580467879|FG011|Overall Study|Lost to Follow-up|1|||
160748921|NCT01826981|580467880|FG012|Overall Study|Lost to Follow-up|1|||
160748922|NCT01826981|580467881|FG013|Overall Study|Lost to Follow-up|0|||
160748923|NCT01826981|580467882|FG014|Overall Study|Lost to Follow-up|0|||
160748924|NCT01826981|580467868|FG000|Overall Study|Withdrew Consent|0|||
160748925|NCT01826981|580467869|FG001|Overall Study|Withdrew Consent|0|||
160748926|NCT01826981|580467870|FG002|Overall Study|Withdrew Consent|0|||
160748927|NCT01826981|580467871|FG003|Overall Study|Withdrew Consent|0|||
160748928|NCT01826981|580467872|FG004|Overall Study|Withdrew Consent|0|||
160748929|NCT01826981|580467873|FG005|Overall Study|Withdrew Consent|0|||
160748930|NCT01826981|580467874|FG006|Overall Study|Withdrew Consent|1|||
160748931|NCT01826981|580467875|FG007|Overall Study|Withdrew Consent|1|||
160748932|NCT01826981|580467876|FG008|Overall Study|Withdrew Consent|0|||
160748933|NCT01826981|580467877|FG009|Overall Study|Withdrew Consent|0|||
160748934|NCT01826981|580467878|FG010|Overall Study|Withdrew Consent|0|||
160748935|NCT01826981|580467879|FG011|Overall Study|Withdrew Consent|1|||
160748936|NCT01826981|580467880|FG012|Overall Study|Withdrew Consent|0|||
160748937|NCT01826981|580467881|FG013|Overall Study|Withdrew Consent|1|||
160748938|NCT01826981|580467882|FG014|Overall Study|Withdrew Consent|0|||
160748939|NCT01826981|580467868|FG000|Overall Study|Adverse Event|0|||
160748940|NCT01826981|580467869|FG001|Overall Study|Adverse Event|0|||
160748941|NCT01826981|580467870|FG002|Overall Study|Adverse Event|0|||
160748942|NCT01826981|580467871|FG003|Overall Study|Adverse Event|0|||
160520830|NCT00261846|579636758|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
160748943|NCT01826981|580467872|FG004|Overall Study|Adverse Event|1|||
160748944|NCT01826981|580467873|FG005|Overall Study|Adverse Event|0|||
160748945|NCT01826981|580467874|FG006|Overall Study|Adverse Event|0|||
160748946|NCT01826981|580467875|FG007|Overall Study|Adverse Event|0|||
160748947|NCT01826981|580467876|FG008|Overall Study|Adverse Event|0|||
160748948|NCT01826981|580467877|FG009|Overall Study|Adverse Event|0|||
160748949|NCT01826981|580467878|FG010|Overall Study|Adverse Event|0|||
160748950|NCT01826981|580467879|FG011|Overall Study|Adverse Event|0|||
160748951|NCT01826981|580467880|FG012|Overall Study|Adverse Event|0|||
160748952|NCT01826981|580467881|FG013|Overall Study|Adverse Event|0|||
160748953|NCT01826981|580467882|FG014|Overall Study|Adverse Event|0|||
160748954|NCT01826981|580467868|FG000|Overall Study|Upper G-I Haemorrhage|0|||
160748955|NCT01826981|580467869|FG001|Overall Study|Upper G-I Haemorrhage|0|||
160748956|NCT01826981|580467870|FG002|Overall Study|Upper G-I Haemorrhage|0|||
160748957|NCT01826981|580467871|FG003|Overall Study|Upper G-I Haemorrhage|0|||
160748958|NCT01826981|580467872|FG004|Overall Study|Upper G-I Haemorrhage|0|||
160748959|NCT01826981|580467873|FG005|Overall Study|Upper G-I Haemorrhage|0|||
160748960|NCT01826981|580467874|FG006|Overall Study|Upper G-I Haemorrhage|0|||
160748961|NCT01826981|580467875|FG007|Overall Study|Upper G-I Haemorrhage|0|||
160748962|NCT01826981|580467876|FG008|Overall Study|Upper G-I Haemorrhage|0|||
160748963|NCT01826981|580467877|FG009|Overall Study|Upper G-I Haemorrhage|0|||
160748964|NCT01826981|580467878|FG010|Overall Study|Upper G-I Haemorrhage|0|||
160748965|NCT01826981|580467879|FG011|Overall Study|Upper G-I Haemorrhage|0|||
160748966|NCT01826981|580467880|FG012|Overall Study|Upper G-I Haemorrhage|0|||
160748967|NCT01826981|580467881|FG013|Overall Study|Upper G-I Haemorrhage|1|||
160748968|NCT01826981|580467882|FG014|Overall Study|Upper G-I Haemorrhage|0|||
160748969|NCT01826981|580467868|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748970|NCT01826981|580467869|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748971|NCT01826981|580467870|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748972|NCT01826981|580467871|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748973|NCT01826981|580467872|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748974|NCT01826981|580467873|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748975|NCT01826981|580467874|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
160520831|NCT00261846|579636759|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
160520832|NCT00261846|579636760|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
160748976|NCT01826981|580467875|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
160748977|NCT01826981|580467876|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748978|NCT01826981|580467877|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748979|NCT01826981|580467878|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748980|NCT01826981|580467879|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748981|NCT01826981|580467880|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748982|NCT01826981|580467881|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748983|NCT01826981|580467882|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
160748984|NCT03746405|580467887|FG000|Overall Study|Withdrawal by Subject|3|||
160748985|NCT03746405|580467888|FG001|Overall Study|Withdrawal by Subject|0|||
160748986|NCT03746405|580467887|FG000|Overall Study|technical difficulties|0|||
160748987|NCT03746405|580467888|FG001|Overall Study|technical difficulties|2|||
160748988|NCT03479008|580467889|FG000|Overall Study|Withdrawal by Subject|3|||
160748989|NCT00412932|580467890|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
160748990|NCT00412932|580467890|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
160748991|NCT00412932|580467890|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
160748992|NCT00412932|580467890|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
160748993|NCT00412932|580467890|FG000|Olmesartan (Olm) 20 mg|Other|1|||
160748994|NCT00412932|580467890|FG000|Olmesartan 40 mg|Adverse Event|4|||
160748995|NCT00412932|580467890|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
160748996|NCT00412932|580467890|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
160748997|NCT00412932|580467890|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
160748998|NCT00412932|580467890|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
160748999|NCT00412932|580467890|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
160749000|NCT00412932|580467890|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
160749001|NCT00667563|580467891|FG000|Overall Study|Protocol Violation|24|||
160749002|NCT02384538|580467908|FG000|Overall Study|Adverse Event|1|||
160749003|NCT02384538|580467909|FG001|Overall Study|Adverse Event|4|||
160749004|NCT02384538|580467908|FG000|Overall Study|Lack of Efficacy|4|||
160749005|NCT02384538|580467909|FG001|Overall Study|Lack of Efficacy|4|||
160749006|NCT02384538|580467908|FG000|Overall Study|Withdrew Consent|0|||
160749007|NCT02384538|580467909|FG001|Overall Study|Withdrew Consent|4|||
160749008|NCT02384538|580467908|FG000|Overall Study|Other|1|||
160749009|NCT02384538|580467909|FG001|Overall Study|Other|3|||
160749010|NCT04446429|580467912|FG000|Overall Study|Lost to Follow-up|6|||
160749011|NCT04446429|580467913|FG001|Overall Study|Lost to Follow-up|0|||
160749012|NCT05205005|580467914|FG000|Overall Study|Withdrawal by Subject|1|||
160749013|NCT05205005|580467915|FG001|Overall Study|Withdrawal by Subject|0|||
160749014|NCT05205005|580467914|FG000|Overall Study|Adverse Event|1|||
160749015|NCT05205005|580467915|FG001|Overall Study|Adverse Event|0|||
160749016|NCT03042910|580467916|FG000|Overall Study|Adverse Event|1|||
160749017|NCT03042910|580467916|FG000|Overall Study|Disease Progression|2|||
160749018|NCT03042910|580467916|FG000|Overall Study|Withdrawal by Subject|3|||
160749019|NCT03042910|580467916|FG000|Overall Study|Enrolled but not treated|1|||
160749020|NCT02187861|580467917|FG000|Overall Study|Adverse Event|2|||
160749021|NCT02187861|580467918|FG001|Overall Study|Adverse Event|1|||
160749022|NCT02187861|580467919|FG002|Overall Study|Adverse Event|2|||
160749023|NCT02187861|580467920|FG003|Overall Study|Adverse Event|1|||
160749024|NCT02187861|580467917|FG000|Overall Study|Death|0|||
160749025|NCT02187861|580467918|FG001|Overall Study|Death|3|||
160864057|NCT01383356|580896710|FG001|Period 1|Adverse Event|3|||
160864058|NCT01383356|580896709|FG000|Period 1|Non-compliance|3|||
160864059|NCT01383356|580896710|FG001|Period 1|Non-compliance|0|||
160864060|NCT01383356|580896709|FG000|Period 1|Out of Range Mid-study-Test|0|||
160864061|NCT01383356|580896710|FG001|Period 1|Out of Range Mid-study-Test|1|||
160864062|NCT01383356|580896709|FG000|Period 1|Personal|0|||
160864063|NCT01383356|580896710|FG001|Period 1|Personal|2|||
160864064|NCT02054104|580896712|FG000|Overall Study|Did not want to continue due to college classes|1|||
160864065|NCT02054104|580896713|FG001|Overall Study|Did not want to continue due to college classes|0|||
160864066|NCT02054104|580896712|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
160864067|NCT02054104|580896713|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
160864068|NCT02054104|580896712|FG000|Overall Study|No evidence of immunologic response|2|||
160864069|NCT02054104|580896713|FG001|Overall Study|No evidence of immunologic response|2|||
160864070|NCT02054104|580896712|FG000|Overall Study|Disease Progression On Study|4|||
160864071|NCT02054104|580896713|FG001|Overall Study|Disease Progression On Study|5|||
160864072|NCT02054104|580896712|FG000|Overall Study|Diagnosis of lymphoma|0|||
160864073|NCT02054104|580896713|FG001|Overall Study|Diagnosis of lymphoma|1|||
160864074|NCT02054104|580896712|FG000|Overall Study|Inconclusive response|0|||
160864075|NCT02054104|580896713|FG001|Overall Study|Inconclusive response|1|||
160864076|NCT00836693|580896718|FG000|Overall Study|Adverse Event|4|||
160864077|NCT00836693|580896719|FG001|Overall Study|Adverse Event|1|||
160864078|NCT00836693|580896718|FG000|Overall Study|Sponsor Decision|0|||
160864079|NCT00836693|580896719|FG001|Overall Study|Sponsor Decision|1|||
160864080|NCT00836693|580896718|FG000|Overall Study|Physician Decision|2|||
160864081|NCT00836693|580896719|FG001|Overall Study|Physician Decision|0|||
160864082|NCT00836693|580896718|FG000|Overall Study|Withdrawal by Subject|9|||
160864083|NCT00836693|580896719|FG001|Overall Study|Withdrawal by Subject|4|||
160864084|NCT00836693|580896718|FG000|Overall Study|Protocol Violation|1|||
160864085|NCT00836693|580896719|FG001|Overall Study|Protocol Violation|0|||
160864086|NCT00836693|580896718|FG000|Overall Study|Lost to Follow-up|1|||
160864087|NCT00836693|580896719|FG001|Overall Study|Lost to Follow-up|0|||
160864088|NCT02612779|580896720|FG000|Overall Study|Administrative reason by sponsor|4|||
160864089|NCT02612779|580896721|FG001|Overall Study|Administrative reason by sponsor|1|||
160864090|NCT02612779|580896720|FG000|Overall Study|No longer meet study criteria|0|||
160864091|NCT02612779|580896721|FG001|Overall Study|No longer meet study criteria|1|||
160864092|NCT02612779|580896720|FG000|Overall Study|Disease progression|29|||
160864093|NCT02612779|580896721|FG001|Overall Study|Disease progression|2|||
160749026|NCT02187861|580467919|FG002|Overall Study|Death|1|||
160749027|NCT02187861|580467920|FG003|Overall Study|Death|2|||
160864094|NCT02612779|580896720|FG000|Overall Study|Study drug toxicity|10|||
160864095|NCT02612779|580896721|FG001|Overall Study|Study drug toxicity|1|||
160864096|NCT02612779|580896720|FG000|Overall Study|Death|1|||
160864097|NCT02612779|580896721|FG001|Overall Study|Death|0|||
160864098|NCT02612779|580896720|FG000|Overall Study|Adverse event unrelated to study drug|5|||
160864099|NCT02612779|580896721|FG001|Overall Study|Adverse event unrelated to study drug|0|||
160864100|NCT02612779|580896720|FG000|Overall Study|Participant withdrew consent|4|||
160864101|NCT02612779|580896721|FG001|Overall Study|Participant withdrew consent|0|||
160864102|NCT02612779|580896720|FG000|Overall Study|Lost to Follow-up|1|||
160864103|NCT02612779|580896721|FG001|Overall Study|Lost to Follow-up|0|||
160864104|NCT02612779|580896720|FG000|Overall Study|Maximum clinical benefit|10|||
160864105|NCT02612779|580896721|FG001|Overall Study|Maximum clinical benefit|1|||
160864106|NCT02612779|580896720|FG000|Overall Study|Other reasons|4|||
160864107|NCT02612779|580896721|FG001|Overall Study|Other reasons|0|||
160864108|NCT02633306|580896724|FG000|Overall Study|Withdrawal by Subject|3|||
160864109|NCT00129402|580896741|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
160864110|NCT00129402|580896742|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
160749028|NCT02187861|580467917|FG000|Overall Study|Physician Decision|0|||
160749029|NCT02187861|580467918|FG001|Overall Study|Physician Decision|1|||
160749030|NCT02187861|580467919|FG002|Overall Study|Physician Decision|0|||
160864111|NCT00129402|580896743|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
160864112|NCT00129402|580896744|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
160864113|NCT00129402|580896745|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
160864114|NCT00129402|580896746|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
160864115|NCT00129402|580896747|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
160864116|NCT00129402|580896741|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864117|NCT00129402|580896742|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864118|NCT00129402|580896743|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864119|NCT00129402|580896744|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864120|NCT00129402|580896745|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864121|NCT00129402|580896746|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
160864122|NCT00129402|580896747|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864123|NCT00129402|580896741|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864124|NCT00129402|580896742|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864125|NCT00129402|580896743|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864126|NCT00129402|580896744|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
160864127|NCT00129402|580896745|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864128|NCT00129402|580896746|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864129|NCT00129402|580896747|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864130|NCT00129402|580896741|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
160864131|NCT00129402|580896742|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
160864132|NCT00129402|580896743|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
160864133|NCT00129402|580896744|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
160864134|NCT00129402|580896745|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
160864135|NCT00129402|580896746|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
160864136|NCT00129402|580896747|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
160864137|NCT00129402|580896741|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864138|NCT00129402|580896742|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864139|NCT00129402|580896743|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
160864140|NCT00129402|580896744|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864141|NCT00129402|580896745|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864142|NCT00129402|580896746|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864143|NCT00129402|580896747|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864144|NCT00129402|580896741|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
160864145|NCT00129402|580896742|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
160864146|NCT00129402|580896743|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
160864147|NCT00129402|580896744|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
160864148|NCT00129402|580896745|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
160864149|NCT00129402|580896746|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
160864150|NCT00129402|580896747|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
160864151|NCT00129402|580896741|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864152|NCT00129402|580896742|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864153|NCT00129402|580896743|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
160864154|NCT00129402|580896744|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864155|NCT00129402|580896745|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864156|NCT00129402|580896746|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864157|NCT00129402|580896747|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864158|NCT00129402|580896741|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
160864159|NCT00129402|580896742|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
160864160|NCT00129402|580896743|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
160864161|NCT00129402|580896744|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
160864162|NCT00129402|580896745|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
160864163|NCT00129402|580896746|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
160864164|NCT00129402|580896747|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
160864165|NCT00129402|580896741|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
160864166|NCT00129402|580896742|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
160864167|NCT00129402|580896743|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
160864168|NCT00129402|580896744|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
160864169|NCT00129402|580896745|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
160864170|NCT00129402|580896746|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
160864171|NCT00129402|580896747|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
160864172|NCT00129402|580896741|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864173|NCT00129402|580896742|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864174|NCT00129402|580896743|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864175|NCT00129402|580896744|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864176|NCT00129402|580896745|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864177|NCT00129402|580896746|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864178|NCT00129402|580896747|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
160864179|NCT00129402|580896741|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864180|NCT00129402|580896742|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864181|NCT00129402|580896743|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864182|NCT00129402|580896744|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864183|NCT00129402|580896745|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864184|NCT00129402|580896746|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864185|NCT00129402|580896747|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
160864186|NCT00129402|580896741|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864187|NCT00129402|580896742|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864188|NCT00129402|580896743|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864189|NCT00129402|580896744|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864190|NCT00129402|580896745|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864191|NCT00129402|580896746|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864192|NCT00129402|580896747|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
160864193|NCT00129402|580896741|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864194|NCT00129402|580896742|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864195|NCT00129402|580896743|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864196|NCT00129402|580896744|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864197|NCT00129402|580896745|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864198|NCT00129402|580896746|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864199|NCT00129402|580896747|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
160864200|NCT00763035|580896748|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
160864201|NCT00763035|580896749|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
160864202|NCT00763035|580896748|FG000|First Intervention|Adverse Event|0|||
160864203|NCT00763035|580896749|FG001|First Intervention|Adverse Event|1|||
160864204|NCT00763035|580896748|FG000|Second Intervention|Adverse Event|1|||
160864205|NCT00763035|580896749|FG001|Second Intervention|Adverse Event|0|||
160864206|NCT00763035|580896748|FG000|Second Intervention|Physician Decision|2|||
160864207|NCT00763035|580896749|FG001|Second Intervention|Physician Decision|0|||
160864208|NCT02131259|580896750|FG000|Overall Study|Progressive disease|751|||
160864209|NCT02131259|580896750|FG000|Overall Study|Adverse Event|341|||
160864210|NCT02131259|580896750|FG000|Overall Study|Lost to Follow-up|7|||
160864211|NCT02131259|580896750|FG000|Overall Study|Relocation|32|||
160864212|NCT02131259|580896750|FG000|Overall Study|Other|63|||
160864213|NCT02131259|580896750|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
160864214|NCT02131259|580896750|FG000|Overall Study|Progressive disease/relocation|1|||
160864215|NCT02131259|580896750|FG000|Overall Study|Progressive disease/other|2|||
160864216|NCT02131259|580896750|FG000|Overall Study|AE/lost to follow-up|1|||
160864217|NCT02131259|580896750|FG000|Overall Study|AE/other|1|||
160864218|NCT02131259|580896750|FG000|Overall Study|Progressive disease/AE/other|1|||
160864219|NCT02131259|580896750|FG000|Overall Study|Missing|3|||
160864220|NCT01472289|580896757|FG000|Overall Study|Death|2|||
160864221|NCT00907335|580896758|FG000|Overall Study|Withdrawal by Subject|2|||
160864222|NCT00907335|580896759|FG001|Overall Study|Withdrawal by Subject|0|||
160864223|NCT00907335|580896758|FG000|Overall Study|Adverse Event|4|||
160864224|NCT00907335|580896759|FG001|Overall Study|Adverse Event|1|||
160864225|NCT00907335|580896758|FG000|Overall Study|Lost to Follow-up|2|||
160864226|NCT00907335|580896759|FG001|Overall Study|Lost to Follow-up|0|||
160864227|NCT03879772|580896760|FG000|Overall Study|Adverse Event|2|||
160864228|NCT03879772|580896761|FG001|Overall Study|Adverse Event|2|||
160864229|NCT03879772|580896762|FG002|Overall Study|Adverse Event|3|||
160864230|NCT03879772|580896763|FG003|Overall Study|Adverse Event|4|||
160864231|NCT03879772|580896764|FG004|Overall Study|Adverse Event|3|||
160864232|NCT03879772|580896760|FG000|Overall Study|Treatment Failure|1|||
160864233|NCT03879772|580896761|FG001|Overall Study|Treatment Failure|0|||
160864234|NCT03879772|580896762|FG002|Overall Study|Treatment Failure|0|||
160864235|NCT03879772|580896763|FG003|Overall Study|Treatment Failure|2|||
160864236|NCT03879772|580896764|FG004|Overall Study|Treatment Failure|1|||
160864237|NCT03879772|580896760|FG000|Overall Study|Lost to Follow-up|0|||
160520833|NCT00261846|579636761|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
160864238|NCT03879772|580896761|FG001|Overall Study|Lost to Follow-up|0|||
160864239|NCT03879772|580896762|FG002|Overall Study|Lost to Follow-up|0|||
160864240|NCT03879772|580896763|FG003|Overall Study|Lost to Follow-up|0|||
160864241|NCT03879772|580896764|FG004|Overall Study|Lost to Follow-up|1|||
160864242|NCT03879772|580896760|FG000|Overall Study|Withdrawal by Subject|0|||
160864243|NCT03879772|580896761|FG001|Overall Study|Withdrawal by Subject|1|||
160864244|NCT03879772|580896762|FG002|Overall Study|Withdrawal by Subject|3|||
160864245|NCT03879772|580896763|FG003|Overall Study|Withdrawal by Subject|1|||
160864246|NCT03879772|580896764|FG004|Overall Study|Withdrawal by Subject|1|||
160864247|NCT03879772|580896760|FG000|Overall Study|Protocol Violation|0|||
160864248|NCT03879772|580896761|FG001|Overall Study|Protocol Violation|0|||
160864249|NCT03879772|580896762|FG002|Overall Study|Protocol Violation|3|||
160864250|NCT03879772|580896763|FG003|Overall Study|Protocol Violation|1|||
160864251|NCT03879772|580896764|FG004|Overall Study|Protocol Violation|2|||
160864252|NCT03879772|580896760|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
160864253|NCT03879772|580896761|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
160864254|NCT03879772|580896762|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
160864255|NCT03879772|580896763|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
160864256|NCT03879772|580896764|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
160864257|NCT00389610|580896776|FG000|Overall Study|Disease Progression|0|||
160864258|NCT00389610|580896777|FG001|Overall Study|Disease Progression|19|||
160864259|NCT00389610|580896776|FG000|Overall Study|Death|0|||
160864260|NCT00389610|580896777|FG001|Overall Study|Death|1|||
160864261|NCT00389610|580896776|FG000|Overall Study|Physician Decision|0|||
160864262|NCT00389610|580896777|FG001|Overall Study|Physician Decision|1|||
160864263|NCT00389610|580896776|FG000|Overall Study|Withdrawal by Subject|0|||
160864264|NCT00389610|580896777|FG001|Overall Study|Withdrawal by Subject|1|||
160864265|NCT00887809|580896778|FG000|Overall Study|Patient Not Treated|3|||
160864266|NCT00887809|580896779|FG001|Overall Study|Patient Not Treated|0|||
160864267|NCT00887809|580896778|FG000|Overall Study|Death|1|||
160864268|NCT00887809|580896779|FG001|Overall Study|Death|0|||
160864269|NCT03131570|580896780|FG000|Overall Study|Adverse Event|1|||
160864270|NCT03131570|580896781|FG001|Overall Study|Adverse Event|0|||
160864271|NCT04596267|580896782|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
160864272|NCT04596267|580896783|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
160864273|NCT04596267|580896782|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
160864274|NCT04596267|580896783|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
160864275|NCT00071058|580896784|FG000|Overall Study|brain tumor-removed from study|1|||
160864276|NCT04189952|580896792|FG000|Follow-up Period|Death|1|||
160864277|NCT04189952|580896792|FG000|Follow-up Period|Withdrawal by Subject|1|||
160864278|NCT00870740|580896793|FG000|Overall Study|Adverse Event|2|||
160864279|NCT00870740|580896794|FG001|Overall Study|Adverse Event|1|||
160864280|NCT00870740|580896795|FG002|Overall Study|Adverse Event|3|||
160864281|NCT00870740|580896796|FG003|Overall Study|Adverse Event|2|||
160864282|NCT00870740|580896797|FG004|Overall Study|Adverse Event|1|||
160864283|NCT00870740|580896798|FG005|Overall Study|Adverse Event|6|||
160864284|NCT00870740|580896793|FG000|Overall Study|Consent Withdrawn|6|||
160864285|NCT00870740|580896794|FG001|Overall Study|Consent Withdrawn|3|||
160864286|NCT00870740|580896795|FG002|Overall Study|Consent Withdrawn|4|||
160864287|NCT00870740|580896796|FG003|Overall Study|Consent Withdrawn|6|||
160864288|NCT00870740|580896797|FG004|Overall Study|Consent Withdrawn|6|||
160864289|NCT00870740|580896798|FG005|Overall Study|Consent Withdrawn|5|||
160864290|NCT00870740|580896793|FG000|Overall Study|Investigator Decision|2|||
160864291|NCT00870740|580896794|FG001|Overall Study|Investigator Decision|0|||
160864292|NCT00870740|580896795|FG002|Overall Study|Investigator Decision|1|||
160864293|NCT00870740|580896796|FG003|Overall Study|Investigator Decision|0|||
160864294|NCT00870740|580896797|FG004|Overall Study|Investigator Decision|0|||
160864295|NCT00870740|580896798|FG005|Overall Study|Investigator Decision|0|||
160864296|NCT00870740|580896793|FG000|Overall Study|Subject Non-compliance|0|||
160864297|NCT00870740|580896794|FG001|Overall Study|Subject Non-compliance|0|||
160864298|NCT00870740|580896795|FG002|Overall Study|Subject Non-compliance|0|||
160864299|NCT00870740|580896796|FG003|Overall Study|Subject Non-compliance|0|||
160864300|NCT00870740|580896797|FG004|Overall Study|Subject Non-compliance|0|||
160864301|NCT00870740|580896798|FG005|Overall Study|Subject Non-compliance|1|||
160864302|NCT00870740|580896793|FG000|Overall Study|Death|0|||
160864303|NCT00870740|580896794|FG001|Overall Study|Death|0|||
160864304|NCT00870740|580896795|FG002|Overall Study|Death|0|||
160864305|NCT00870740|580896796|FG003|Overall Study|Death|0|||
160864306|NCT00870740|580896797|FG004|Overall Study|Death|1|||
160864307|NCT00870740|580896798|FG005|Overall Study|Death|0|||
160864308|NCT00870740|580896793|FG000|Overall Study|Other|2|||
160864309|NCT00870740|580896794|FG001|Overall Study|Other|5|||
160864310|NCT00870740|580896795|FG002|Overall Study|Other|2|||
160864311|NCT00870740|580896796|FG003|Overall Study|Other|4|||
160864312|NCT00870740|580896797|FG004|Overall Study|Other|3|||
160864313|NCT00870740|580896798|FG005|Overall Study|Other|5|||
160864314|NCT04298697|580896806|FG000|Overall Study|Lost to Follow-up|5|||
160864315|NCT04298697|580896807|FG001|Overall Study|Lost to Follow-up|5|||
160864316|NCT04298697|580896808|FG002|Overall Study|Lost to Follow-up|1|||
160864317|NCT04298697|580896809|FG003|Overall Study|Lost to Follow-up|0|||
160864318|NCT04298697|580896806|FG000|Overall Study|Withdrawal by Subject|0|||
160864319|NCT04298697|580896807|FG001|Overall Study|Withdrawal by Subject|3|||
160864320|NCT04298697|580896808|FG002|Overall Study|Withdrawal by Subject|2|||
160864321|NCT04298697|580896809|FG003|Overall Study|Withdrawal by Subject|3|||
160864322|NCT03995368|580896810|FG000|Overall Study|Lost to Follow-up|1|||
160864323|NCT03995368|580896811|FG001|Overall Study|Lost to Follow-up|4|||
160864324|NCT03995368|580896812|FG002|Overall Study|Lost to Follow-up|1|||
160864325|NCT03995368|580896810|FG000|Overall Study|Did not meet inclusion criteria|1|||
160864326|NCT03995368|580896811|FG001|Overall Study|Did not meet inclusion criteria|6|||
160864327|NCT03995368|580896812|FG002|Overall Study|Did not meet inclusion criteria|3|||
160864328|NCT03995368|580896810|FG000|Overall Study|Withdrawal by Subject|0|||
160864329|NCT03995368|580896811|FG001|Overall Study|Withdrawal by Subject|1|||
160864330|NCT03995368|580896812|FG002|Overall Study|Withdrawal by Subject|1|||
160864331|NCT04322526|580896813|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
160864332|NCT04322526|580896814|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
160864333|NCT04322526|580896813|FG000|Washout (1 Week)|Lost to Follow-up|1|||
160864334|NCT04322526|580896814|FG001|Washout (1 Week)|Lost to Follow-up|2|||
160864335|NCT03205423|580896815|FG000|Overall Study|Personal|1|||
160864336|NCT03205423|580896816|FG001|Overall Study|Personal|1|||
160864337|NCT03205423|580896815|FG000|Overall Study|Physician Decision|0|||
160864338|NCT03205423|580896816|FG001|Overall Study|Physician Decision|2|||
160864339|NCT02594124|580896817|FG000|Overall Study|Adverse Event|0|||
160864340|NCT02594124|580896818|FG001|Overall Study|Adverse Event|5|||
160864341|NCT02594124|580896819|FG002|Overall Study|Adverse Event|8|||
160864342|NCT02594124|580896820|FG003|Overall Study|Adverse Event|1|||
160864343|NCT02594124|580896821|FG004|Overall Study|Adverse Event|0|||
160864344|NCT02594124|580896822|FG005|Overall Study|Adverse Event|0|||
160864345|NCT02594124|580896823|FG006|Overall Study|Adverse Event|2|||
160864346|NCT02594124|580896824|FG007|Overall Study|Adverse Event|2|||
160864347|NCT02594124|580896825|FG008|Overall Study|Adverse Event|0|||
160864348|NCT02594124|580896817|FG000|Overall Study|Withdrawal by Subject|2|||
160864349|NCT02594124|580896818|FG001|Overall Study|Withdrawal by Subject|3|||
160864350|NCT02594124|580896819|FG002|Overall Study|Withdrawal by Subject|5|||
160864351|NCT02594124|580896820|FG003|Overall Study|Withdrawal by Subject|1|||
160864352|NCT02594124|580896821|FG004|Overall Study|Withdrawal by Subject|8|||
160864353|NCT02594124|580896822|FG005|Overall Study|Withdrawal by Subject|4|||
160864354|NCT02594124|580896823|FG006|Overall Study|Withdrawal by Subject|13|||
160864355|NCT02594124|580896824|FG007|Overall Study|Withdrawal by Subject|19|||
160864356|NCT02594124|580896825|FG008|Overall Study|Withdrawal by Subject|0|||
160864357|NCT02594124|580896817|FG000|Overall Study|Physician Decision|0|||
160864358|NCT02594124|580896818|FG001|Overall Study|Physician Decision|2|||
160864359|NCT02594124|580896819|FG002|Overall Study|Physician Decision|0|||
160864360|NCT02594124|580896820|FG003|Overall Study|Physician Decision|0|||
160864361|NCT02594124|580896821|FG004|Overall Study|Physician Decision|0|||
160864362|NCT02594124|580896822|FG005|Overall Study|Physician Decision|0|||
160864363|NCT02594124|580896823|FG006|Overall Study|Physician Decision|0|||
160864364|NCT02594124|580896824|FG007|Overall Study|Physician Decision|1|||
160864365|NCT02594124|580896825|FG008|Overall Study|Physician Decision|0|||
160864366|NCT02594124|580896817|FG000|Overall Study|Commercial drug|0|||
160864367|NCT02594124|580896818|FG001|Overall Study|Commercial drug|1|||
160864368|NCT02594124|580896819|FG002|Overall Study|Commercial drug|6|||
160864369|NCT02594124|580896820|FG003|Overall Study|Commercial drug|3|||
160864370|NCT02594124|580896821|FG004|Overall Study|Commercial drug|0|||
160978099|NCT00786474|581310162|FG001|Overall Study|Lost to Follow-up|3|||
160978100|NCT00786474|581310161|FG000|Overall Study|Physician Decision|2|||
160978101|NCT00786474|581310162|FG001|Overall Study|Physician Decision|1|||
160978102|NCT00786474|581310161|FG000|Overall Study|Other|4|||
160978103|NCT00786474|581310162|FG001|Overall Study|Other|4|||
160978104|NCT04276090|581310163|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
160978105|NCT04276090|581310164|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
160978106|NCT04642469|581310166|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
160978107|NCT04642469|581310167|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
160978108|NCT04642469|581310166|FG000|Overall Study|Death|1|||
160978109|NCT04642469|581310167|FG001|Overall Study|Death|2|||
160978110|NCT04642469|581310166|FG000|Overall Study|Study/site closed following amendment 1|11|||
160978111|NCT04642469|581310167|FG001|Overall Study|Study/site closed following amendment 1|11|||
160978112|NCT04642469|581310166|FG000|Overall Study|Other|1|||
160978113|NCT04642469|581310167|FG001|Overall Study|Other|1|||
160978114|NCT04642469|581310166|FG000|Overall Study|Withdrawal by Subject|1|||
160978115|NCT04642469|581310167|FG001|Overall Study|Withdrawal by Subject|0|||
160978116|NCT01088529|581310169|FG000|Overall Study|Did not receive study treatment|0|||
160978117|NCT01088529|581310170|FG001|Overall Study|Did not receive study treatment|1|||
160978118|NCT02838628|581310172|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
160864371|NCT02594124|580896822|FG005|Overall Study|Commercial drug|0|||
160864372|NCT02594124|580896823|FG006|Overall Study|Commercial drug|7|||
160864373|NCT02594124|580896824|FG007|Overall Study|Commercial drug|11|||
160864374|NCT02594124|580896825|FG008|Overall Study|Commercial drug|2|||
160864375|NCT02594124|580896817|FG000|Overall Study|Reason Not Specified|1|||
160864376|NCT02594124|580896818|FG001|Overall Study|Reason Not Specified|3|||
160864377|NCT02594124|580896819|FG002|Overall Study|Reason Not Specified|4|||
160864378|NCT02594124|580896820|FG003|Overall Study|Reason Not Specified|0|||
160864379|NCT02594124|580896821|FG004|Overall Study|Reason Not Specified|0|||
160864380|NCT02594124|580896822|FG005|Overall Study|Reason Not Specified|1|||
160864381|NCT02594124|580896823|FG006|Overall Study|Reason Not Specified|1|||
160864382|NCT02594124|580896824|FG007|Overall Study|Reason Not Specified|6|||
160864383|NCT02594124|580896825|FG008|Overall Study|Reason Not Specified|1|||
160864384|NCT05523089|580896826|FG000|Overall Study|Withdrawal by Subject|1|||
160864385|NCT05523089|580896827|FG001|Overall Study|Withdrawal by Subject|0|||
160864386|NCT05523089|580896828|FG002|Overall Study|Withdrawal by Subject|0|||
160864387|NCT05523089|580896826|FG000|Overall Study|Lost to Follow-up|1|||
160864388|NCT05523089|580896827|FG001|Overall Study|Lost to Follow-up|0|||
160864389|NCT05523089|580896828|FG002|Overall Study|Lost to Follow-up|0|||
160864390|NCT00554216|580898835|FG000|Overall Study|Lost to Follow-up|92|||
160864391|NCT00554216|580898836|FG001|Overall Study|Lost to Follow-up|31|||
160864392|NCT00554216|580898837|FG002|Overall Study|Lost to Follow-up|63|||
160864393|NCT00554216|580898835|FG000|Overall Study|Adverse Event|16|||
160864394|NCT00554216|580898836|FG001|Overall Study|Adverse Event|16|||
160864395|NCT00554216|580898837|FG002|Overall Study|Adverse Event|36|||
160864396|NCT00554216|580898835|FG000|Overall Study|Withdrawal by Subject|92|||
160864397|NCT00554216|580898836|FG001|Overall Study|Withdrawal by Subject|31|||
160864398|NCT00554216|580898837|FG002|Overall Study|Withdrawal by Subject|43|||
160864399|NCT00554216|580898835|FG000|Overall Study|Non compliance|10|||
160864400|NCT00554216|580898836|FG001|Overall Study|Non compliance|4|||
160864401|NCT00554216|580898837|FG002|Overall Study|Non compliance|5|||
160864402|NCT00554216|580898835|FG000|Overall Study|Pregnancy|2|||
160864403|NCT00554216|580898836|FG001|Overall Study|Pregnancy|1|||
160864404|NCT00554216|580898837|FG002|Overall Study|Pregnancy|14|||
160864405|NCT00554216|580898835|FG000|Overall Study|Restricted med|3|||
160864406|NCT00554216|580898836|FG001|Overall Study|Restricted med|1|||
160864407|NCT00554216|580898837|FG002|Overall Study|Restricted med|1|||
160864408|NCT00554216|580898835|FG000|Overall Study|Other|12|||
160864409|NCT00554216|580898836|FG001|Overall Study|Other|7|||
160864410|NCT00554216|580898837|FG002|Overall Study|Other|10|||
160864411|NCT00554216|580898835|FG000|Overall Study|Lack of Efficacy|15|||
160864412|NCT00554216|580898836|FG001|Overall Study|Lack of Efficacy|3|||
160864413|NCT00554216|580898837|FG002|Overall Study|Lack of Efficacy|0|||
160978119|NCT02838628|581310173|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
160978120|NCT02838628|581310172|FG000|Recurrence Follow-up Period|Adverse Event|1|||
160978121|NCT02838628|581310173|FG001|Recurrence Follow-up Period|Adverse Event|0|||
160978122|NCT02838628|581310172|FG000|Recurrence Follow-up Period|Non-compliance|0|||
160978123|NCT02838628|581310173|FG001|Recurrence Follow-up Period|Non-compliance|1|||
160978124|NCT02838628|581310172|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
160978125|NCT02838628|581310173|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
160978126|NCT02838628|581310172|FG000|Recurrence Follow-up Period|Other un-specified|1|||
160978127|NCT02838628|581310173|FG001|Recurrence Follow-up Period|Other un-specified|1|||
160978128|NCT02303626|581310175|FG000|Overall Study|Lack of Efficacy|1|||
160978129|NCT02303626|581310176|FG001|Overall Study|Lack of Efficacy|0|||
160978130|NCT02303626|581310177|FG002|Overall Study|Lack of Efficacy|1|||
160978131|NCT02303626|581310175|FG000|Overall Study|Adverse Event|0|||
160978132|NCT02303626|581310176|FG001|Overall Study|Adverse Event|2|||
160978133|NCT02303626|581310177|FG002|Overall Study|Adverse Event|0|||
160978134|NCT02303626|581310175|FG000|Overall Study|Protocol Violation|0|||
160978135|NCT02303626|581310176|FG001|Overall Study|Protocol Violation|1|||
160978136|NCT02303626|581310177|FG002|Overall Study|Protocol Violation|0|||
160978137|NCT02303626|581310175|FG000|Overall Study|Pregnancy|0|||
160978138|NCT02303626|581310176|FG001|Overall Study|Pregnancy|0|||
160978139|NCT02303626|581310177|FG002|Overall Study|Pregnancy|1|||
160978140|NCT02303626|581310175|FG000|Overall Study|Subject Non-Compliance|0|||
160978141|NCT02303626|581310176|FG001|Overall Study|Subject Non-Compliance|0|||
160978142|NCT02303626|581310177|FG002|Overall Study|Subject Non-Compliance|1|||
160978143|NCT05832437|581310178|FG000|Overall Study|time off work|1|||
160978144|NCT05832437|581310179|FG001|Overall Study|time off work|0|||
160978145|NCT05832437|581310180|FG002|Overall Study|time off work|0|||
160978146|NCT05832437|581310181|FG003|Overall Study|time off work|0|||
160978147|NCT04159415|581310182|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978148|NCT04159415|581310183|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978149|NCT04159415|581310184|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978150|NCT04159415|581310185|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160864414|NCT05291520|580898838|FG000|Overall Study|Lost to Follow-up|0|||
160864415|NCT05291520|580898839|FG001|Overall Study|Lost to Follow-up|0|||
160864416|NCT05291520|580898840|FG002|Overall Study|Lost to Follow-up|1|||
160864417|NCT01347112|580898841|FG000|Overall Study|Withdrawal by Subject|1|||
160864418|NCT01347112|580898842|FG001|Overall Study|Withdrawal by Subject|7|||
160864419|NCT01347112|580898841|FG000|Overall Study|Lost to Follow-up|3|||
160864420|NCT01347112|580898842|FG001|Overall Study|Lost to Follow-up|5|||
160864421|NCT05462756|580898859|FG000|Treatment Period|Adverse Event|3|||
160864422|NCT05462756|580898860|FG001|Treatment Period|Adverse Event|0|||
160864423|NCT05462756|580898859|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
160864424|NCT05462756|580898860|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
160864425|NCT05462756|580898859|FG000|Treatment Period|Death|0|||
160864426|NCT05462756|580898860|FG001|Treatment Period|Death|1|||
160864427|NCT05462756|580898859|FG000|Treatment Period|Lost to Follow-up|2|||
160864428|NCT05462756|580898860|FG001|Treatment Period|Lost to Follow-up|1|||
160864429|NCT05462756|580898859|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
160864430|NCT05462756|580898860|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
160864431|NCT05462756|580898859|FG000|Treatment Period|Physician Decision|2|||
160864432|NCT05462756|580898860|FG001|Treatment Period|Physician Decision|0|||
160864433|NCT05462756|580898859|FG000|Treatment Period|Protocol Violation|0|||
160864434|NCT05462756|580898860|FG001|Treatment Period|Protocol Violation|1|||
160864435|NCT05462756|580898859|FG000|Treatment Period|Withdrawal by Subject|5|||
160864436|NCT05462756|580898860|FG001|Treatment Period|Withdrawal by Subject|12|||
160864437|NCT05462756|580898859|FG000|Follow-Up Period|Adverse Event|1|||
160864438|NCT05462756|580898860|FG001|Follow-Up Period|Adverse Event|0|||
160864439|NCT05462756|580898859|FG000|Follow-Up Period|Death|1|||
160864440|NCT05462756|580898860|FG001|Follow-Up Period|Death|0|||
160864441|NCT05462756|580898859|FG000|Follow-Up Period|Lost to Follow-up|3|||
160864442|NCT05462756|580898860|FG001|Follow-Up Period|Lost to Follow-up|1|||
160864443|NCT05462756|580898859|FG000|Follow-Up Period|Withdrawal by Subject|0|||
160864444|NCT05462756|580898860|FG001|Follow-Up Period|Withdrawal by Subject|4|||
160864445|NCT01432730|580898865|FG000|Period 1|Adverse Event|2|||
160864446|NCT01432730|580898866|FG001|Period 1|Adverse Event|0|||
160864447|NCT01432730|580898865|FG000|Period 2|Adverse Event|0|||
160864448|NCT01432730|580898866|FG001|Period 2|Adverse Event|4|||
160864449|NCT01421719|580898867|FG000|Overall Study|Withdrawal by Subject|4|||
160864450|NCT01281124|580898872|FG000|Overall Study|Death|1|||
160864451|NCT01198795|580898873|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
160864452|NCT01198795|580898873|FG000|Overall Study|Withdrawal by Subject|17|||
160864453|NCT01198795|580898873|FG000|Overall Study|Lost to Follow-up|15|||
160864454|NCT01198795|580898873|FG000|Overall Study|Adverse Event|9|||
160864455|NCT01198795|580898873|FG000|Overall Study|Lack of Efficacy|5|||
160864456|NCT01198795|580898873|FG000|Overall Study|Protocol Violation|2|||
160864457|NCT01198795|580898873|FG000|Overall Study|Other Reason|4|||
160864458|NCT00706238|580898874|FG000|Overall Study|Disease progression|4|||
160864459|NCT00706238|580898874|FG000|Overall Study|Other|1|||
160864460|NCT04226742|580898875|FG000|Overall Study|Lost to Follow-up|16|||
160864461|NCT04226742|580898876|FG001|Overall Study|Lost to Follow-up|13|||
160864462|NCT04226742|580898875|FG000|Overall Study|Withdrawal by Subject|5|||
160864463|NCT04226742|580898876|FG001|Overall Study|Withdrawal by Subject|3|||
160864464|NCT05097963|580898879|FG000|Overall Study|Protocol Violation|13|||
160864465|NCT05097963|580898879|FG000|Overall Study|Withdrawal by Subject|21|||
160864466|NCT02492763|580898880|FG000|Overall Study|Withdrawal by Subject|0|||
160864467|NCT02492763|580898881|FG001|Overall Study|Withdrawal by Subject|2|||
160864468|NCT02492763|580898882|FG002|Overall Study|Withdrawal by Subject|1|||
160864469|NCT02492763|580898883|FG003|Overall Study|Withdrawal by Subject|0|||
160864470|NCT02492763|580898880|FG000|Overall Study|Adverse Event|3|||
160864471|NCT02492763|580898881|FG001|Overall Study|Adverse Event|1|||
160864472|NCT02492763|580898882|FG002|Overall Study|Adverse Event|1|||
160864473|NCT02492763|580898883|FG003|Overall Study|Adverse Event|2|||
160864474|NCT02492763|580898880|FG000|Overall Study|Death|0|||
160864475|NCT02492763|580898881|FG001|Overall Study|Death|0|||
160864476|NCT02492763|580898882|FG002|Overall Study|Death|1|||
160864477|NCT02492763|580898883|FG003|Overall Study|Death|0|||
160864478|NCT02492763|580898880|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
160864479|NCT02492763|580898881|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
160864480|NCT02492763|580898882|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
160864481|NCT02492763|580898883|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
160864482|NCT02492763|580898880|FG000|Overall Study|Lost to Follow-up|0|||
160864483|NCT02492763|580898881|FG001|Overall Study|Lost to Follow-up|0|||
160864484|NCT02492763|580898882|FG002|Overall Study|Lost to Follow-up|1|||
160864485|NCT02492763|580898883|FG003|Overall Study|Lost to Follow-up|0|||
160864486|NCT02492763|580898880|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160864487|NCT02492763|580898881|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160864488|NCT02492763|580898882|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160864489|NCT02492763|580898883|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160864490|NCT02492763|580898880|FG000|Overall Study|Screen Failure|0|||
160864491|NCT02492763|580898881|FG001|Overall Study|Screen Failure|0|||
160864492|NCT02492763|580898882|FG002|Overall Study|Screen Failure|0|||
160749031|NCT02187861|580467920|FG003|Overall Study|Physician Decision|3|||
160864493|NCT02492763|580898883|FG003|Overall Study|Screen Failure|1|||
160864494|NCT02492763|580898880|FG000|Overall Study|Study Terminated by Sponsor|13|||
160996802|NCT03536884|581373708|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160864495|NCT02492763|580898881|FG001|Overall Study|Study Terminated by Sponsor|10|||
160864496|NCT02492763|580898882|FG002|Overall Study|Study Terminated by Sponsor|6|||
160864497|NCT02492763|580898883|FG003|Overall Study|Study Terminated by Sponsor|10|||
160864498|NCT01193244|580898884|FG000|Overall Study|Withdrawal by Subject|79|||
160864499|NCT01193244|580898885|FG001|Overall Study|Withdrawal by Subject|97|||
160864500|NCT01193244|580898884|FG000|Overall Study|Other|303|||
160864501|NCT01193244|580898885|FG001|Overall Study|Other|278|||
160864502|NCT01193244|580898884|FG000|Overall Study|Lost to Follow-up|6|||
160864503|NCT01193244|580898885|FG001|Overall Study|Lost to Follow-up|15|||
160864504|NCT02395471|580898895|FG000|Overall Study|Lost to Follow-up|2|||
160864505|NCT02395471|580898896|FG001|Overall Study|Lost to Follow-up|0|||
160864506|NCT02395471|580898895|FG000|Overall Study|Withdrawal by Subject|2|||
160864507|NCT02395471|580898896|FG001|Overall Study|Withdrawal by Subject|1|||
160864508|NCT02395471|580898895|FG000|Overall Study|Physician Decision|1|||
160864509|NCT02395471|580898896|FG001|Overall Study|Physician Decision|0|||
160864510|NCT02395471|580898895|FG000|Overall Study|Protocol Violation|0|||
160864511|NCT02395471|580898896|FG001|Overall Study|Protocol Violation|1|||
160864512|NCT02395471|580898895|FG000|Overall Study|Failure to swollow sponge twice|1|||
160864513|NCT02395471|580898896|FG001|Overall Study|Failure to swollow sponge twice|0|||
160864514|NCT02395471|580898895|FG000|Overall Study|Patient did not return for procedure|0|||
160864515|NCT02395471|580898896|FG001|Overall Study|Patient did not return for procedure|1|||
160864516|NCT02395471|580898895|FG000|Overall Study|Subject not eligible|1|||
160864517|NCT02395471|580898896|FG001|Overall Study|Subject not eligible|0|||
160864518|NCT03847896|580898897|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
160864519|NCT03847896|580898898|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
160864520|NCT03847896|580898899|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
160864521|NCT03847896|580898900|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
160864522|NCT03847896|580898901|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
160864523|NCT03847896|580898897|FG000|Overall Study|Withdrawal by Subject|2|||
160864524|NCT03847896|580898898|FG001|Overall Study|Withdrawal by Subject|10|||
160864525|NCT03847896|580898899|FG002|Overall Study|Withdrawal by Subject|5|||
160864526|NCT03847896|580898900|FG003|Overall Study|Withdrawal by Subject|9|||
160864527|NCT03847896|580898901|FG004|Overall Study|Withdrawal by Subject|8|||
160864528|NCT03847896|580898897|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160864529|NCT03847896|580898898|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160864530|NCT03847896|580898899|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160864531|NCT03847896|580898900|FG003|Overall Study|Withdrawal by parent/guardian|0|||
160864532|NCT03847896|580898901|FG004|Overall Study|Withdrawal by parent/guardian|0|||
160864533|NCT03847896|580898897|FG000|Overall Study|Adverse Event|2|||
160864534|NCT03847896|580898898|FG001|Overall Study|Adverse Event|1|||
160864535|NCT03847896|580898899|FG002|Overall Study|Adverse Event|3|||
160864536|NCT03847896|580898900|FG003|Overall Study|Adverse Event|2|||
160864537|NCT03847896|580898901|FG004|Overall Study|Adverse Event|4|||
160864538|NCT03847896|580898897|FG000|Overall Study|A severe exacerbation event|0|||
160864539|NCT03847896|580898898|FG001|Overall Study|A severe exacerbation event|0|||
160864540|NCT03847896|580898899|FG002|Overall Study|A severe exacerbation event|0|||
160864541|NCT03847896|580898900|FG003|Overall Study|A severe exacerbation event|0|||
160864542|NCT03847896|580898901|FG004|Overall Study|A severe exacerbation event|3|||
160864543|NCT03847896|580898897|FG000|Overall Study|Protocol Violation|0|||
160864544|NCT03847896|580898898|FG001|Overall Study|Protocol Violation|2|||
160864545|NCT03847896|580898899|FG002|Overall Study|Protocol Violation|1|||
160864546|NCT03847896|580898900|FG003|Overall Study|Protocol Violation|0|||
160864547|NCT03847896|580898901|FG004|Overall Study|Protocol Violation|2|||
160864548|NCT03847896|580898897|FG000|Overall Study|Lost to Follow-up|0|||
160864549|NCT03847896|580898898|FG001|Overall Study|Lost to Follow-up|0|||
160864550|NCT03847896|580898899|FG002|Overall Study|Lost to Follow-up|0|||
160864551|NCT03847896|580898900|FG003|Overall Study|Lost to Follow-up|1|||
160864552|NCT03847896|580898901|FG004|Overall Study|Lost to Follow-up|0|||
160864553|NCT03847896|580898897|FG000|Overall Study|Condition under investigation worsened|0|||
160864554|NCT03847896|580898898|FG001|Overall Study|Condition under investigation worsened|0|||
160864555|NCT03847896|580898899|FG002|Overall Study|Condition under investigation worsened|0|||
160864556|NCT03847896|580898900|FG003|Overall Study|Condition under investigation worsened|1|||
160864557|NCT03847896|580898901|FG004|Overall Study|Condition under investigation worsened|1|||
160864558|NCT03847896|580898897|FG000|Overall Study|Lack of Efficacy|0|||
160864559|NCT03847896|580898898|FG001|Overall Study|Lack of Efficacy|0|||
160864560|NCT03847896|580898899|FG002|Overall Study|Lack of Efficacy|0|||
160864561|NCT03847896|580898900|FG003|Overall Study|Lack of Efficacy|2|||
160864562|NCT03847896|580898901|FG004|Overall Study|Lack of Efficacy|2|||
160864563|NCT03847896|580898897|FG000|Overall Study|Other reasons|3|||
160864564|NCT03847896|580898898|FG001|Overall Study|Other reasons|3|||
160864565|NCT03847896|580898899|FG002|Overall Study|Other reasons|1|||
160978151|NCT04159415|581310186|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160864566|NCT03847896|580898900|FG003|Overall Study|Other reasons|2|||
160864567|NCT03847896|580898901|FG004|Overall Study|Other reasons|1|||
160864568|NCT01039376|580898902|FG000|Overall Study|Lost to Follow-up|5|||
160864569|NCT01039376|580898903|FG001|Overall Study|Lost to Follow-up|12|||
160864570|NCT01039376|580898902|FG000|Overall Study|Physician Decision|15|||
160864571|NCT01039376|580898903|FG001|Overall Study|Physician Decision|10|||
160864572|NCT01039376|580898902|FG000|Overall Study|Withdrawal by Subject|20|||
160864573|NCT01039376|580898903|FG001|Overall Study|Withdrawal by Subject|32|||
160864574|NCT01039376|580898902|FG000|Overall Study|Study terminated by Sponsor|90|||
160864575|NCT01039376|580898903|FG001|Overall Study|Study terminated by Sponsor|72|||
160864576|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
160864577|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
160864578|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Adverse Event|31|||
160864579|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Adverse Event|21|||
160864580|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
160864581|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
160864582|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
160864583|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
160864584|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
160864585|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
160864586|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
160864587|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
160864588|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Administrative problems|3|||
160864589|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Administrative problems|3|||
160864590|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Death|5|||
160864591|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Death|8|||
160864592|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Disease progression|139|||
160864593|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Disease progression|119|||
160864594|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
160864595|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
160864596|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
160864597|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
160864598|NCT00785785|580898904|FG000|Optional Extension Phase|Adverse Event|4|||
160864599|NCT00785785|580898905|FG001|Optional Extension Phase|Adverse Event|5|||
160864600|NCT00785785|580898904|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
160864601|NCT00785785|580898905|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
160864602|NCT00785785|580898904|FG000|Optional Extension Phase|Lost to Follow-up|1|||
160864603|NCT00785785|580898905|FG001|Optional Extension Phase|Lost to Follow-up|0|||
160864604|NCT00785785|580898904|FG000|Optional Extension Phase|Administrative problems|2|||
160864605|NCT00785785|580898905|FG001|Optional Extension Phase|Administrative problems|0|||
160864606|NCT00785785|580898904|FG000|Optional Extension Phase|Death|1|||
160864607|NCT00785785|580898905|FG001|Optional Extension Phase|Death|5|||
160864608|NCT00785785|580898904|FG000|Optional Extension Phase|Disease progression|22|||
160864609|NCT00785785|580898905|FG001|Optional Extension Phase|Disease progression|70|||
160864610|NCT00785785|580898904|FG000|Optional Extension Phase|Protocol deviation|0|||
160864611|NCT00785785|580898905|FG001|Optional Extension Phase|Protocol deviation|2|||
160864612|NCT00785785|580898904|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
160864613|NCT00785785|580898905|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
160864614|NCT03252925|580898906|FG000|Overall Study|Withdrawal by Subject|1|||
160864615|NCT03252925|580898907|FG001|Overall Study|Withdrawal by Subject|0|||
160864616|NCT03252925|580898906|FG000|Overall Study|Protocol Violation|6|||
160864617|NCT03252925|580898907|FG001|Overall Study|Protocol Violation|0|||
160864618|NCT03252925|580898906|FG000|Overall Study|Adverse Event|1|||
160864619|NCT03252925|580898907|FG001|Overall Study|Adverse Event|0|||
160864620|NCT03252925|580898906|FG000|Overall Study|Lost to Follow-up|6|||
160864621|NCT03252925|580898907|FG001|Overall Study|Lost to Follow-up|6|||
160864622|NCT01244893|580898908|FG000|Baseline|Protocol Violation|0|||
160864623|NCT01244893|580898909|FG001|Baseline|Protocol Violation|1|||
160864624|NCT01244893|580898908|FG000|1-Week Follow Up|Lost to Follow-up|1|||
160864625|NCT01244893|580898909|FG001|1-Week Follow Up|Lost to Follow-up|0|||
160864626|NCT00357552|580898910|FG000|Screening|Did not meet eligibility criteria|84|||
160864627|NCT00357552|580898910|FG000|Weeks 0 to 24|Death|1|||
160864628|NCT00357552|580898910|FG000|Weeks 24 to 104|Death|3|||
160864629|NCT00357552|580898910|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
160864630|NCT00521404|580898913|FG000|Overall Study|Adverse Event|13|||
160864631|NCT00521404|580898913|FG000|Overall Study|Disease Progression|33|||
160864632|NCT00521404|580898913|FG000|Overall Study|Investigator decision|5|||
160864633|NCT00521404|580898913|FG000|Overall Study|Withdrawal of consent|3|||
160978152|NCT04159415|581310187|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978153|NCT04159415|581310188|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
160978154|NCT04159415|581310189|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
160978155|NCT04159415|581310190|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978156|NCT04159415|581310191|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978157|NCT04159415|581310182|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978158|NCT04159415|581310183|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978159|NCT04159415|581310184|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978160|NCT04159415|581310185|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160864634|NCT00521404|580898913|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
160864635|NCT00521404|580898913|FG000|Overall Study|Other|7|||
160864636|NCT04555616|580898916|FG000|Overall Study|Death|1|||
160864637|NCT04555616|580898917|FG001|Overall Study|Death|0|||
160864638|NCT04555616|580898918|FG002|Overall Study|Death|1|||
160864639|NCT04555616|580898916|FG000|Overall Study|Withdrawal by Subject|2|||
160864640|NCT04555616|580898917|FG001|Overall Study|Withdrawal by Subject|1|||
160864641|NCT04555616|580898918|FG002|Overall Study|Withdrawal by Subject|0|||
160864642|NCT00882557|580898919|FG000|Overall Study|Withdrawal by Subject|1|||
160864643|NCT00882557|580898920|FG001|Overall Study|Withdrawal by Subject|0|||
160864644|NCT00882557|580898919|FG000|Overall Study|Trouble with Vein Access|1|||
160864645|NCT00882557|580898920|FG001|Overall Study|Trouble with Vein Access|0|||
160864646|NCT00882557|580898919|FG000|Overall Study|Randomized Not Treated|0|||
160864647|NCT00882557|580898920|FG001|Overall Study|Randomized Not Treated|1|||
160864648|NCT02282605|580898921|FG000|Overall Study|negative SA result on Day -1|3|||
160864649|NCT02282605|580898922|FG001|Overall Study|negative SA result on Day -1|0|||
160864650|NCT02282605|580898923|FG002|Overall Study|negative SA result on Day -1|0|||
160864651|NCT00711191|580898924|FG000|Overall Study|Adverse Event|1|||
160864652|NCT00711191|580898925|FG001|Overall Study|Adverse Event|1|||
160864653|NCT00711191|580898926|FG002|Overall Study|Adverse Event|2|||
160864654|NCT00711191|580898924|FG000|Overall Study|Objective progression or relapse|2|||
160864655|NCT00711191|580898925|FG001|Overall Study|Objective progression or relapse|3|||
160864656|NCT00711191|580898926|FG002|Overall Study|Objective progression or relapse|7|||
160864657|NCT00711191|580898924|FG000|Overall Study|Withdrawal by Subject|0|||
160864658|NCT00711191|580898925|FG001|Overall Study|Withdrawal by Subject|1|||
160864659|NCT00711191|580898926|FG002|Overall Study|Withdrawal by Subject|3|||
160864660|NCT02035267|580898927|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
160864661|NCT02035267|580898928|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
160864662|NCT02035267|580898929|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
160864663|NCT02035267|580898930|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
160864664|NCT02035267|580898927|FG000|Overall Study|Adverse Event|0|||
160864665|NCT02035267|580898928|FG001|Overall Study|Adverse Event|0|||
160864666|NCT02035267|580898929|FG002|Overall Study|Adverse Event|1|||
160864667|NCT02035267|580898930|FG003|Overall Study|Adverse Event|0|||
160864668|NCT02035267|580898927|FG000|Overall Study|Lost to Follow-up|0|||
160864669|NCT02035267|580898928|FG001|Overall Study|Lost to Follow-up|0|||
160864670|NCT02035267|580898929|FG002|Overall Study|Lost to Follow-up|0|||
160864671|NCT02035267|580898930|FG003|Overall Study|Lost to Follow-up|1|||
160864672|NCT02035267|580898927|FG000|Overall Study|Other unspecified|0|||
160864673|NCT02035267|580898928|FG001|Overall Study|Other unspecified|1|||
160864674|NCT02035267|580898929|FG002|Overall Study|Other unspecified|0|||
160864675|NCT02035267|580898930|FG003|Overall Study|Other unspecified|0|||
160864676|NCT03038880|580898936|FG000|Overall Study|Death|1|||
160864677|NCT03038880|580898937|FG001|Overall Study|Death|2|||
160864678|NCT03038880|580898938|FG002|Overall Study|Death|0|||
160864679|NCT03038880|580898936|FG000|Overall Study|Physician Decision|2|||
160864680|NCT03038880|580898937|FG001|Overall Study|Physician Decision|1|||
160864681|NCT03038880|580898938|FG002|Overall Study|Physician Decision|0|||
160864682|NCT03926611|580898943|FG000|Overall Study|Adverse Event|0|||
160864683|NCT03926611|580898944|FG001|Overall Study|Adverse Event|0|||
160864684|NCT03926611|580898945|FG002|Overall Study|Adverse Event|0|||
160864685|NCT03926611|580898946|FG003|Overall Study|Adverse Event|3|||
160864686|NCT03926611|580898947|FG004|Overall Study|Adverse Event|1|||
160864687|NCT03926611|580898948|FG005|Overall Study|Adverse Event|3|||
160864688|NCT03926611|580898949|FG006|Overall Study|Adverse Event|0|||
160864689|NCT03926611|580898943|FG000|Overall Study|Lack of Efficacy|1|||
160864690|NCT03926611|580898944|FG001|Overall Study|Lack of Efficacy|2|||
160864691|NCT03926611|580898945|FG002|Overall Study|Lack of Efficacy|0|||
160864692|NCT03926611|580898946|FG003|Overall Study|Lack of Efficacy|0|||
160864693|NCT03926611|580898947|FG004|Overall Study|Lack of Efficacy|1|||
160864694|NCT03926611|580898948|FG005|Overall Study|Lack of Efficacy|0|||
160864695|NCT03926611|580898949|FG006|Overall Study|Lack of Efficacy|1|||
160864696|NCT03926611|580898943|FG000|Overall Study|Physician Decision|0|||
160864697|NCT03926611|580898944|FG001|Overall Study|Physician Decision|0|||
160864698|NCT03926611|580898945|FG002|Overall Study|Physician Decision|0|||
160864699|NCT03926611|580898946|FG003|Overall Study|Physician Decision|0|||
160864700|NCT03926611|580898947|FG004|Overall Study|Physician Decision|0|||
160864701|NCT03926611|580898948|FG005|Overall Study|Physician Decision|1|||
160864702|NCT03926611|580898949|FG006|Overall Study|Physician Decision|0|||
160864703|NCT03926611|580898943|FG000|Overall Study|Protocol Violation|1|||
160864704|NCT03926611|580898944|FG001|Overall Study|Protocol Violation|0|||
160864705|NCT03926611|580898945|FG002|Overall Study|Protocol Violation|0|||
160864706|NCT03926611|580898946|FG003|Overall Study|Protocol Violation|1|||
160864707|NCT03926611|580898947|FG004|Overall Study|Protocol Violation|1|||
160864708|NCT03926611|580898948|FG005|Overall Study|Protocol Violation|1|||
160864709|NCT03926611|580898949|FG006|Overall Study|Protocol Violation|1|||
160864710|NCT03926611|580898943|FG000|Overall Study|Technical problems|0|||
160864711|NCT03926611|580898944|FG001|Overall Study|Technical problems|0|||
160864712|NCT03926611|580898945|FG002|Overall Study|Technical problems|0|||
160864713|NCT03926611|580898946|FG003|Overall Study|Technical problems|0|||
160864714|NCT03926611|580898947|FG004|Overall Study|Technical problems|0|||
160864715|NCT03926611|580898948|FG005|Overall Study|Technical problems|1|||
160864716|NCT03926611|580898949|FG006|Overall Study|Technical problems|0|||
160864717|NCT03926611|580898943|FG000|Overall Study|Withdrawal by Subject|1|||
160864718|NCT03926611|580898944|FG001|Overall Study|Withdrawal by Subject|1|||
160864719|NCT03926611|580898945|FG002|Overall Study|Withdrawal by Subject|1|||
160864720|NCT03926611|580898946|FG003|Overall Study|Withdrawal by Subject|0|||
160864721|NCT03926611|580898947|FG004|Overall Study|Withdrawal by Subject|0|||
160864722|NCT03926611|580898948|FG005|Overall Study|Withdrawal by Subject|1|||
160864723|NCT03926611|580898949|FG006|Overall Study|Withdrawal by Subject|3|||
160864724|NCT03926611|580898943|FG000|Overall Study|Covid-19 pandemic|0|||
160864725|NCT03926611|580898944|FG001|Overall Study|Covid-19 pandemic|0|||
160864726|NCT03926611|580898945|FG002|Overall Study|Covid-19 pandemic|1|||
160864727|NCT03926611|580898946|FG003|Overall Study|Covid-19 pandemic|0|||
160864728|NCT03926611|580898947|FG004|Overall Study|Covid-19 pandemic|1|||
160864729|NCT03926611|580898948|FG005|Overall Study|Covid-19 pandemic|2|||
160864730|NCT03926611|580898949|FG006|Overall Study|Covid-19 pandemic|0|||
160864731|NCT01657019|580898950|FG000|Overall Study|Withdrawal by Subject|65|||
160864732|NCT01657019|580898950|FG000|Overall Study|Adverse Event|55|||
160864733|NCT01657019|580898950|FG000|Overall Study|Lost to Follow-up|48|||
160864734|NCT01657019|580898950|FG000|Overall Study|Protocol Violation|6|||
160864735|NCT01657019|580898950|FG000|Overall Study|Lack of Efficacy|3|||
160864736|NCT01657019|580898950|FG000|Overall Study|Other|58|||
160864737|NCT01744977|580898951|FG000|Overall Study|Withdrawal by Subject|1|||
160864738|NCT01744977|580898952|FG001|Overall Study|Withdrawal by Subject|2|||
160864739|NCT01744977|580898951|FG000|Overall Study|Death|2|||
160864740|NCT01744977|580898952|FG001|Overall Study|Death|3|||
160864741|NCT01744977|580898951|FG000|Overall Study|Lost to Follow-up|2|||
160864742|NCT01744977|580898952|FG001|Overall Study|Lost to Follow-up|0|||
160864743|NCT01744977|580898951|FG000|Overall Study|No longer meets inclusion|6|||
160864744|NCT01744977|580898952|FG001|Overall Study|No longer meets inclusion|0|||
160864745|NCT01750229|580898955|FG000|Randomized Crossover Phase|Adverse Event|1|||
160864746|NCT01750229|580898955|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
160864747|NCT01750229|580898955|FG000|Long-term Follow-up Phase|Adverse Event|2|||
160864748|NCT01750229|580898955|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
160864749|NCT03774576|580898956|FG000|Period 2|Adverse Event|1|||
160864750|NCT02796170|580898957|FG000|Overall Study|Lost to Follow-up|3|||
160864751|NCT02796170|580898958|FG001|Overall Study|Lost to Follow-up|0|||
160864752|NCT01527370|580898959|FG000|Overall Study|Withdrawal by Subject|4|||
160864753|NCT01527370|580898959|FG000|Overall Study|Physician Decision|1|||
160864754|NCT01527370|580898959|FG000|Overall Study|Death|1|||
160864755|NCT00912808|580898960|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
160864756|NCT00912808|580898961|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
160864757|NCT00912808|580898960|FG000|Washout|Withdrawal by Subject|0|||
160864758|NCT00912808|580898961|FG001|Washout|Withdrawal by Subject|1|||
160864759|NCT00912808|580898960|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
160864760|NCT00912808|580898961|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
160864761|NCT00912808|580898960|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
160864762|NCT00912808|580898961|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
160864763|NCT00702221|580898962|FG000|Overall Study|Adverse Event|4|||
160864764|NCT00702221|580898963|FG001|Overall Study|Adverse Event|3|||
160864765|NCT02900378|580898964|FG000|Randomization (Visit 2)|Adverse Event|14|||
160864766|NCT02900378|580898965|FG001|Randomization (Visit 2)|Adverse Event|11|||
160864767|NCT02900378|580898964|FG000|Randomization (Visit 2)|Death|1|||
160864768|NCT02900378|580898965|FG001|Randomization (Visit 2)|Death|4|||
160864769|NCT02900378|580898964|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
160864770|NCT02900378|580898965|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
160864771|NCT02900378|580898964|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
160864772|NCT02900378|580898965|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
160864773|NCT02900378|580898964|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
160864774|NCT02900378|580898965|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
160864775|NCT02900378|580898964|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
160864776|NCT02900378|580898965|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
160864777|NCT02900378|580898964|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
160978161|NCT04159415|581310186|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978162|NCT04159415|581310187|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160864778|NCT02900378|580898965|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
160864779|NCT01134055|580898968|FG000|Overall Study|Adverse Event|5|||
160864780|NCT01134055|580898969|FG001|Overall Study|Adverse Event|2|||
160864781|NCT01134055|580898970|FG002|Overall Study|Adverse Event|2|||
160864782|NCT01134055|580898971|FG003|Overall Study|Adverse Event|2|||
160864783|NCT01134055|580898972|FG004|Overall Study|Adverse Event|5|||
160864784|NCT01134055|580898973|FG005|Overall Study|Adverse Event|7|||
160864785|NCT01134055|580898974|FG006|Overall Study|Adverse Event|2|||
160864786|NCT01134055|580898968|FG000|Overall Study|Lost to Follow-up|0|||
160978163|NCT04159415|581310188|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978164|NCT04159415|581310189|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
160978165|NCT04159415|581310190|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978166|NCT04159415|581310191|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978167|NCT04159415|581310182|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978168|NCT04159415|581310183|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978169|NCT04159415|581310184|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978170|NCT04159415|581310185|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978171|NCT04159415|581310186|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978172|NCT04159415|581310187|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978173|NCT04159415|581310188|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978174|NCT04159415|581310189|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
160978175|NCT04159415|581310190|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978176|NCT04159415|581310191|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978177|NCT04159415|581310182|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978178|NCT04159415|581310183|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978179|NCT04159415|581310184|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978180|NCT04159415|581310185|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978181|NCT04159415|581310186|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978182|NCT04159415|581310187|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978183|NCT04159415|581310188|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978184|NCT04159415|581310189|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978185|NCT04159415|581310190|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978186|NCT04159415|581310191|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
160978187|NCT05407311|581310192|FG000|Overall Study|Withdrawal by Subject|5|||
160978188|NCT05407311|581310192|FG000|Overall Study|Protocol Violation|3|||
160978189|NCT05407311|581310192|FG000|Overall Study|Physician Decision|1|||
160978190|NCT05407311|581310192|FG000|Overall Study|Non-compliance|1|||
160978191|NCT00337662|581310193|FG000|Study Period II|Lost to Follow-up|0|||
160978192|NCT00337662|581310194|FG001|Study Period II|Lost to Follow-up|0|||
160978193|NCT00337662|581310195|FG002|Study Period II|Lost to Follow-up|0|||
160978194|NCT00337662|581310196|FG003|Study Period II|Lost to Follow-up|35|||
160978195|NCT00337662|581310193|FG000|Study Period II|Withdrawal by Subject|0|||
160978196|NCT00337662|581310194|FG001|Study Period II|Withdrawal by Subject|0|||
160978197|NCT00337662|581310195|FG002|Study Period II|Withdrawal by Subject|0|||
160978198|NCT00337662|581310196|FG003|Study Period II|Withdrawal by Subject|20|||
160978199|NCT00337662|581310193|FG000|Study Period II|Adverse Event|0|||
160978200|NCT00337662|581310194|FG001|Study Period II|Adverse Event|0|||
160978201|NCT00337662|581310195|FG002|Study Period II|Adverse Event|0|||
160978202|NCT00337662|581310196|FG003|Study Period II|Adverse Event|16|||
160978203|NCT00337662|581310193|FG000|Study Period II|Physician Decision|0|||
160978204|NCT00337662|581310194|FG001|Study Period II|Physician Decision|0|||
160978205|NCT00337662|581310195|FG002|Study Period II|Physician Decision|0|||
160978206|NCT00337662|581310196|FG003|Study Period II|Physician Decision|13|||
160978207|NCT00337662|581310193|FG000|Study Period II|Entry Criteria Not Met|0|||
160978208|NCT00337662|581310194|FG001|Study Period II|Entry Criteria Not Met|0|||
160978209|NCT00337662|581310195|FG002|Study Period II|Entry Criteria Not Met|0|||
160978210|NCT00337662|581310196|FG003|Study Period II|Entry Criteria Not Met|6|||
160978211|NCT00337662|581310193|FG000|Study Period II|Protocol Violation|0|||
160978212|NCT00337662|581310194|FG001|Study Period II|Protocol Violation|0|||
160453930|NCT00592852|579393967|FG000|Overall Study|Withdrawal by Subject|1|||
160453931|NCT02589795|579393971|FG000|Overall Study|Lost to Follow-up|1|||
160453932|NCT02589795|579393972|FG001|Overall Study|Lost to Follow-up|0|||
160453933|NCT02589795|579393973|FG002|Overall Study|Lost to Follow-up|0|||
160453934|NCT02589795|579393971|FG000|Overall Study|Withdrawal by Subject|0|||
160453935|NCT02589795|579393972|FG001|Overall Study|Withdrawal by Subject|0|||
160453936|NCT02589795|579393973|FG002|Overall Study|Withdrawal by Subject|2|||
160453937|NCT02589795|579393971|FG000|Overall Study|Protocol Violation|0|||
160453938|NCT02589795|579393972|FG001|Overall Study|Protocol Violation|0|||
160453939|NCT02589795|579393973|FG002|Overall Study|Protocol Violation|1|||
160453940|NCT02505984|579393977|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
160453941|NCT02505984|579393978|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
160453942|NCT02505984|579393977|FG000|Overall Study|Unreliable self-report data|1|||
160453943|NCT02505984|579393978|FG001|Overall Study|Unreliable self-report data|0|||
160978213|NCT00337662|581310195|FG002|Study Period II|Protocol Violation|0|||
160978214|NCT00337662|581310196|FG003|Study Period II|Protocol Violation|6|||
160978215|NCT00337662|581310193|FG000|Study Period II|Lack of Efficacy|0|||
160978216|NCT00337662|581310194|FG001|Study Period II|Lack of Efficacy|0|||
160978217|NCT00337662|581310195|FG002|Study Period II|Lack of Efficacy|0|||
160978218|NCT00337662|581310196|FG003|Study Period II|Lack of Efficacy|7|||
160978219|NCT00337662|581310193|FG000|Study Period II|Sponsor Decision|0|||
160978220|NCT00337662|581310194|FG001|Study Period II|Sponsor Decision|0|||
160978221|NCT00337662|581310195|FG002|Study Period II|Sponsor Decision|0|||
160978222|NCT00337662|581310196|FG003|Study Period II|Sponsor Decision|2|||
160978223|NCT00337662|581310193|FG000|Study Period II|Parent/Caregiver Decision|0|||
160978224|NCT00337662|581310194|FG001|Study Period II|Parent/Caregiver Decision|0|||
160978225|NCT00337662|581310195|FG002|Study Period II|Parent/Caregiver Decision|0|||
160978226|NCT00337662|581310196|FG003|Study Period II|Parent/Caregiver Decision|1|||
160978227|NCT00337662|581310193|FG000|Study Period III|Lost to Follow-up|14|||
160978228|NCT00337662|581310194|FG001|Study Period III|Lost to Follow-up|16|||
160978229|NCT00337662|581310195|FG002|Study Period III|Lost to Follow-up|14|||
160978230|NCT00337662|581310196|FG003|Study Period III|Lost to Follow-up|0|||
160978231|NCT00337662|581310193|FG000|Study Period III|Withdrawal by Subject|18|||
160978232|NCT00337662|581310194|FG001|Study Period III|Withdrawal by Subject|14|||
160978233|NCT00337662|581310195|FG002|Study Period III|Withdrawal by Subject|12|||
160978234|NCT00337662|581310196|FG003|Study Period III|Withdrawal by Subject|0|||
160978235|NCT00337662|581310193|FG000|Study Period III|Adverse Event|9|||
160978236|NCT00337662|581310194|FG001|Study Period III|Adverse Event|10|||
160978237|NCT00337662|581310195|FG002|Study Period III|Adverse Event|8|||
160978238|NCT00337662|581310196|FG003|Study Period III|Adverse Event|0|||
160978239|NCT00337662|581310193|FG000|Study Period III|Protocol Violation|3|||
160978240|NCT00337662|581310194|FG001|Study Period III|Protocol Violation|8|||
160978241|NCT00337662|581310195|FG002|Study Period III|Protocol Violation|2|||
160978242|NCT00337662|581310196|FG003|Study Period III|Protocol Violation|0|||
160978243|NCT00337662|581310193|FG000|Study Period III|Physician Decision|6|||
160978244|NCT00337662|581310194|FG001|Study Period III|Physician Decision|5|||
160978245|NCT00337662|581310195|FG002|Study Period III|Physician Decision|0|||
160978246|NCT00337662|581310196|FG003|Study Period III|Physician Decision|0|||
160978247|NCT00337662|581310193|FG000|Study Period III|Entry Criteria Not Met|4|||
160978248|NCT00337662|581310194|FG001|Study Period III|Entry Criteria Not Met|1|||
160978249|NCT00337662|581310195|FG002|Study Period III|Entry Criteria Not Met|3|||
160978250|NCT00337662|581310196|FG003|Study Period III|Entry Criteria Not Met|0|||
160978251|NCT00337662|581310193|FG000|Study Period III|Lack of Efficacy|4|||
160978252|NCT00337662|581310194|FG001|Study Period III|Lack of Efficacy|4|||
160978253|NCT00337662|581310195|FG002|Study Period III|Lack of Efficacy|2|||
160749032|NCT02187861|580467917|FG000|Overall Study|Progressive Disease|4|||
160978254|NCT00337662|581310196|FG003|Study Period III|Lack of Efficacy|0|||
160978255|NCT00337662|581310193|FG000|Study Period III|Parent/Caregiver Decision|0|||
160978256|NCT00337662|581310194|FG001|Study Period III|Parent/Caregiver Decision|0|||
160978257|NCT00337662|581310195|FG002|Study Period III|Parent/Caregiver Decision|2|||
160978258|NCT00337662|581310196|FG003|Study Period III|Parent/Caregiver Decision|0|||
160978259|NCT00337662|581310193|FG000|Study Period III|Sponsor Decision|1|||
160978260|NCT00337662|581310194|FG001|Study Period III|Sponsor Decision|0|||
160978261|NCT00337662|581310195|FG002|Study Period III|Sponsor Decision|1|||
160978262|NCT00337662|581310196|FG003|Study Period III|Sponsor Decision|0|||
160978263|NCT00337662|581310193|FG000|Study Period III|Clinical Relapse|1|||
160978264|NCT00337662|581310194|FG001|Study Period III|Clinical Relapse|0|||
160978265|NCT00337662|581310195|FG002|Study Period III|Clinical Relapse|0|||
160978266|NCT00337662|581310196|FG003|Study Period III|Clinical Relapse|0|||
160978267|NCT01265823|581310197|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
160978268|NCT01265823|581310197|FG000|Overall Study|Failure to Return|4|||
160978269|NCT01265823|581310197|FG000|Overall Study|Protocol Violation|1|||
160978270|NCT01265823|581310197|FG000|Overall Study|Participant Request|1|||
160978271|NCT01263106|581310198|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
160978272|NCT01263106|581310199|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
160978273|NCT00882921|581310200|FG000|Overall Study|Death|2|||
160978274|NCT00882921|581310200|FG000|Overall Study|Other|3|||
160978275|NCT00882921|581310200|FG000|Overall Study|Lost to Follow-up|2|||
160978276|NCT00882921|581310200|FG000|Overall Study|Termination By Investigator|3|||
160978277|NCT00882921|581310200|FG000|Overall Study|Withdrawal Of Consent|1|||
160978278|NCT05027074|581310218|FG000|Overall Study|Death|47|||
160978279|NCT05027074|581310219|FG001|Overall Study|Death|42|||
160978280|NCT05027074|581310220|FG002|Overall Study|Death|39|||
160978281|NCT05027074|581310218|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160978282|NCT05027074|581310219|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160978283|NCT05027074|581310220|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160978284|NCT05027074|581310218|FG000|Overall Study|Site Terminated By Sponsor|3|||
160978285|NCT05027074|581310219|FG001|Overall Study|Site Terminated By Sponsor|0|||
160978286|NCT05027074|581310220|FG002|Overall Study|Site Terminated By Sponsor|2|||
160978287|NCT05027074|581310218|FG000|Overall Study|Withdrawal by Subject|13|||
160978288|NCT05027074|581310219|FG001|Overall Study|Withdrawal by Subject|8|||
160978289|NCT05027074|581310220|FG002|Overall Study|Withdrawal by Subject|10|||
160978290|NCT05027074|581310218|FG000|Overall Study|Lost to Follow-up|2|||
160978291|NCT05027074|581310219|FG001|Overall Study|Lost to Follow-up|4|||
160978292|NCT05027074|581310220|FG002|Overall Study|Lost to Follow-up|3|||
160978293|NCT05027074|581310218|FG000|Overall Study|Status Not Recorded|0|||
160978294|NCT05027074|581310219|FG001|Overall Study|Status Not Recorded|0|||
160978295|NCT05027074|581310220|FG002|Overall Study|Status Not Recorded|1|||
160978296|NCT02180438|581310226|FG000|Overall Study|Lost to Follow-up|1|||
160978297|NCT00785707|581310227|FG000|Overall Study|Lost to Follow-up|7|||
160978298|NCT05569954|581310232|FG000|Overall Study|Lost to Follow-up|3|||
160978299|NCT05569954|581310233|FG001|Overall Study|Lost to Follow-up|4|||
160978300|NCT05569954|581310232|FG000|Overall Study|Protocol Violation|1|||
160978301|NCT05569954|581310233|FG001|Overall Study|Protocol Violation|2|||
160978302|NCT05569954|581310232|FG000|Overall Study|Withdrawal by Subject|4|||
160978303|NCT05569954|581310233|FG001|Overall Study|Withdrawal by Subject|2|||
160978304|NCT03857841|581310243|FG000|Overall Study|Death|1|||
160978305|NCT03857841|581310244|FG001|Overall Study|Death|0|||
160978306|NCT03857841|581310245|FG002|Overall Study|Death|0|||
160978307|NCT03857841|581310246|FG003|Overall Study|Death|0|||
160978308|NCT03857841|581310243|FG000|Overall Study|Study Terminated by Sponsor|1|||
160978309|NCT03857841|581310244|FG001|Overall Study|Study Terminated by Sponsor|0|||
160978310|NCT03857841|581310245|FG002|Overall Study|Study Terminated by Sponsor|0|||
160978311|NCT03857841|581310246|FG003|Overall Study|Study Terminated by Sponsor|0|||
160978312|NCT00384059|581310247|FG000|Infant Series|Not consented|2|||
160978313|NCT00384059|581310248|FG001|Infant Series|Not consented|6|||
160978314|NCT00384059|581310247|FG000|Infant Series|Withdrawal by Subject|2|||
160978315|NCT00384059|581310248|FG001|Infant Series|Withdrawal by Subject|2|||
160978316|NCT00384059|581310247|FG000|Infant Series|Adverse Event|1|||
160978317|NCT00384059|581310248|FG001|Infant Series|Adverse Event|2|||
160978318|NCT00384059|581310247|FG000|Infant Series|Protocol Violation|1|||
160978319|NCT00384059|581310248|FG001|Infant Series|Protocol Violation|2|||
160978320|NCT00384059|581310247|FG000|Infant Series|Lost to Follow-up|0|||
160978321|NCT00384059|581310248|FG001|Infant Series|Lost to Follow-up|1|||
160978322|NCT00384059|581310247|FG000|After Infant Series|Protocol Violation|2|||
160978323|NCT00384059|581310248|FG001|After Infant Series|Protocol Violation|3|||
160978324|NCT00384059|581310247|FG000|After Infant Series|Withdrawal by Subject|2|||
160978325|NCT00384059|581310248|FG001|After Infant Series|Withdrawal by Subject|2|||
160978326|NCT00384059|581310247|FG000|After Infant Series|Failed to Return|0|||
160978327|NCT00384059|581310248|FG001|After Infant Series|Failed to Return|2|||
160978328|NCT00384059|581310247|FG000|After Infant Series|Adverse Event|0|||
160978329|NCT00384059|581310248|FG001|After Infant Series|Adverse Event|1|||
160978330|NCT00384059|581310247|FG000|After Infant Series|Physician Decision|0|||
160978331|NCT00384059|581310248|FG001|After Infant Series|Physician Decision|1|||
160978332|NCT00384059|581310247|FG000|After Infant Series|Lost to Follow-up|0|||
160978333|NCT00384059|581310248|FG001|After Infant Series|Lost to Follow-up|1|||
160978334|NCT00384059|581310247|FG000|Toddler Dose|Lost to Follow-up|1|||
160978335|NCT00384059|581310248|FG001|Toddler Dose|Lost to Follow-up|1|||
160978336|NCT00384059|581310247|FG000|Toddler Dose|Failed to return|0|||
160978337|NCT00384059|581310248|FG001|Toddler Dose|Failed to return|1|||
160978338|NCT00381641|581310251|FG000|Overall Study|Withdrawal by Subject|0|||
160978339|NCT00381641|581310252|FG001|Overall Study|Withdrawal by Subject|2|||
160996803|NCT03536884|581373709|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996804|NCT03536884|581373698|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996805|NCT03536884|581373699|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996806|NCT03536884|581373700|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
160996807|NCT03536884|581373701|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
160996808|NCT03536884|581373702|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
160996809|NCT03536884|581373703|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996810|NCT03536884|581373704|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996811|NCT03536884|581373705|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996812|NCT03536884|581373706|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996813|NCT03536884|581373707|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996814|NCT03536884|581373708|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996815|NCT03536884|581373709|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996816|NCT03536884|581373698|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996817|NCT03536884|581373699|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996818|NCT03536884|581373700|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
160996819|NCT03536884|581373701|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
160996820|NCT03536884|581373702|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
160996821|NCT03536884|581373703|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996822|NCT03536884|581373704|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996823|NCT03536884|581373705|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996824|NCT03536884|581373706|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996825|NCT03536884|581373707|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160978340|NCT00802737|581311850|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
160978341|NCT00802737|581311851|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
160978342|NCT00802737|581311852|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
160978343|NCT00802737|581311850|FG000|Overall Study|Death|6|||
160978344|NCT00802737|581311851|FG001|Overall Study|Death|5|||
160978345|NCT00802737|581311852|FG002|Overall Study|Death|1|||
160978346|NCT00802737|581311850|FG000|Overall Study|Adverse Event|1|||
160978347|NCT00802737|581311851|FG001|Overall Study|Adverse Event|0|||
160978348|NCT00802737|581311852|FG002|Overall Study|Adverse Event|0|||
160978349|NCT00802737|581311850|FG000|Overall Study|Received Prohibited Therapy|1|||
160978350|NCT00802737|581311851|FG001|Overall Study|Received Prohibited Therapy|0|||
160978351|NCT00802737|581311852|FG002|Overall Study|Received Prohibited Therapy|0|||
160978352|NCT00802737|581311850|FG000|Overall Study|Ongoing CLL-Treatment|0|||
160978353|NCT00802737|581311851|FG001|Overall Study|Ongoing CLL-Treatment|1|||
160978354|NCT00802737|581311852|FG002|Overall Study|Ongoing CLL-Treatment|0|||
160978355|NCT00802737|581311850|FG000|Overall Study|Participant too Unwell|0|||
160978356|NCT00802737|581311851|FG001|Overall Study|Participant too Unwell|2|||
160978357|NCT00802737|581311852|FG002|Overall Study|Participant too Unwell|0|||
160978358|NCT03390036|581311853|FG000|Overall Study|Lost to Follow-up|1|||
160978359|NCT03390036|581311854|FG001|Overall Study|Lost to Follow-up|0|||
160978360|NCT03390036|581311855|FG002|Overall Study|Lost to Follow-up|0|||
160978361|NCT03390036|581311853|FG000|Overall Study|Lack of Efficacy|1|||
160978362|NCT03390036|581311854|FG001|Overall Study|Lack of Efficacy|0|||
160978363|NCT03390036|581311855|FG002|Overall Study|Lack of Efficacy|0|||
160978364|NCT01681368|581311858|FG000|Overall Study|Refused further treatment|1|||
160978365|NCT01681368|581311858|FG000|Overall Study|Refused further follow up|1|||
160978366|NCT06017999|581311861|FG000|Overall Study|Withdrawal by Subject|0|||
160978367|NCT06017999|581311862|FG001|Overall Study|Withdrawal by Subject|4|||
160978368|NCT06017999|581311863|FG002|Overall Study|Withdrawal by Subject|3|||
160978369|NCT06017999|581311861|FG000|Overall Study|Adverse Event|2|||
160978370|NCT06017999|581311862|FG001|Overall Study|Adverse Event|1|||
160978371|NCT06017999|581311863|FG002|Overall Study|Adverse Event|1|||
160978372|NCT06017999|581311861|FG000|Overall Study|Lost to Follow-up|0|||
160978373|NCT06017999|581311862|FG001|Overall Study|Lost to Follow-up|0|||
160978374|NCT06017999|581311863|FG002|Overall Study|Lost to Follow-up|1|||
160978375|NCT06017999|581311861|FG000|Overall Study|Physician Decision|1|||
160520834|NCT00261846|579636762|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
160520835|NCT00261846|579636763|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
160520836|NCT00261846|579636764|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
160520837|NCT00261846|579636765|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
160520838|NCT00261846|579636766|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
160520839|NCT00261846|579636767|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
160520840|NCT00261846|579636756|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
160520841|NCT00261846|579636757|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
160520842|NCT00261846|579636758|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
160520843|NCT00261846|579636759|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
160520844|NCT00261846|579636760|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
160520845|NCT00261846|579636761|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
160520846|NCT00261846|579636762|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
160520847|NCT00261846|579636763|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
160520848|NCT00261846|579636764|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
160520849|NCT00261846|579636765|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
160978376|NCT06017999|581311862|FG001|Overall Study|Physician Decision|1|||
160978377|NCT06017999|581311863|FG002|Overall Study|Physician Decision|0|||
160978378|NCT06017999|581311861|FG000|Overall Study|Non-Compliance|0|||
160978379|NCT06017999|581311862|FG001|Overall Study|Non-Compliance|0|||
160978380|NCT06017999|581311863|FG002|Overall Study|Non-Compliance|1|||
160978381|NCT06017999|581311861|FG000|Overall Study|Lack of Efficacy|1|||
160978382|NCT06017999|581311862|FG001|Overall Study|Lack of Efficacy|0|||
160978383|NCT06017999|581311863|FG002|Overall Study|Lack of Efficacy|7|||
160978384|NCT06017999|581311861|FG000|Overall Study|COVID Positive|0|||
160978385|NCT06017999|581311862|FG001|Overall Study|COVID Positive|1|||
160978386|NCT06017999|581311863|FG002|Overall Study|COVID Positive|0|||
160978387|NCT06017999|581311861|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
160520850|NCT00261846|579636766|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
160520851|NCT00261846|579636767|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
160978388|NCT06017999|581311862|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
160978389|NCT06017999|581311863|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
160978390|NCT01155388|581311864|FG000|Overall Study|Adverse Event|1|||
160978391|NCT01155388|581311865|FG001|Overall Study|Adverse Event|0|||
160978392|NCT03943589|581311866|FG000|Overall Study|Death|1|||
160978393|NCT03943589|581311866|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
160978394|NCT04329104|581311867|FG000|Efficacy Study|Withdrawal by Subject|0|||
160978395|NCT04329104|581311868|FG001|Efficacy Study|Withdrawal by Subject|0|||
160978396|NCT04329104|581311869|FG002|Efficacy Study|Withdrawal by Subject|0|||
160978397|NCT04329104|581311870|FG003|Efficacy Study|Withdrawal by Subject|5|||
160978398|NCT04329104|581311871|FG004|Efficacy Study|Withdrawal by Subject|6|||
160978399|NCT04329104|581311872|FG005|Efficacy Study|Withdrawal by Subject|8|||
160978400|NCT03884231|581311873|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
160978401|NCT03884231|581311873|FG000|Overall Study|Subject Withdrew Consent|1|||
160978402|NCT03884231|581311873|FG000|Overall Study|MRI Scan Not Performed|1|||
160978403|NCT00900627|581311874|FG000|Overall Study|Condition under investigation worsened|4|||
160978404|NCT00900627|581311875|FG001|Overall Study|Condition under investigation worsened|0|||
160978405|NCT00900627|581311876|FG002|Overall Study|Condition under investigation worsened|5|||
160978406|NCT00900627|581311877|FG003|Overall Study|Condition under investigation worsened|3|||
160978407|NCT00900627|581311878|FG004|Overall Study|Condition under investigation worsened|0|||
160978408|NCT00900627|581311879|FG005|Overall Study|Condition under investigation worsened|0|||
160978409|NCT00900627|581311874|FG000|Overall Study|Withdrawal by Subject|1|||
160978410|NCT00900627|581311875|FG001|Overall Study|Withdrawal by Subject|0|||
160978411|NCT00900627|581311876|FG002|Overall Study|Withdrawal by Subject|1|||
160978412|NCT00900627|581311877|FG003|Overall Study|Withdrawal by Subject|0|||
160978413|NCT00900627|581311878|FG004|Overall Study|Withdrawal by Subject|1|||
160978414|NCT00900627|581311879|FG005|Overall Study|Withdrawal by Subject|2|||
160978415|NCT00900627|581311874|FG000|Overall Study|Adverse Event|1|||
160978416|NCT00900627|581311875|FG001|Overall Study|Adverse Event|2|||
160978417|NCT00900627|581311876|FG002|Overall Study|Adverse Event|0|||
160978418|NCT00900627|581311877|FG003|Overall Study|Adverse Event|3|||
160978419|NCT00900627|581311878|FG004|Overall Study|Adverse Event|0|||
160978420|NCT00900627|581311879|FG005|Overall Study|Adverse Event|0|||
160978421|NCT00900627|581311874|FG000|Overall Study|Death|0|||
160978422|NCT00900627|581311875|FG001|Overall Study|Death|0|||
160978423|NCT00900627|581311876|FG002|Overall Study|Death|0|||
160978424|NCT00900627|581311877|FG003|Overall Study|Death|0|||
160978425|NCT00900627|581311878|FG004|Overall Study|Death|28|||
160978426|NCT00900627|581311879|FG005|Overall Study|Death|24|||
160978427|NCT00373295|581311880|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
160978428|NCT00373295|581311881|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
160520852|NCT00261846|579636756|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
160520853|NCT00261846|579636757|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
160978429|NCT00373295|581311882|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
160978430|NCT00373295|581311883|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
160978431|NCT00373295|581311884|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
160978432|NCT00373295|581311885|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
160978433|NCT00830947|581311886|FG000|Overall Study|Lost to Follow-up|4|||
160978434|NCT00830947|581311887|FG001|Overall Study|Lost to Follow-up|4|||
160978435|NCT01474512|581311899|FG000|Induction Period|Adverse Event|6|||
160978436|NCT01474512|581311900|FG001|Induction Period|Adverse Event|10|||
160978437|NCT01474512|581311901|FG002|Induction Period|Adverse Event|10|||
160978438|NCT01474512|581311902|FG003|Induction Period|Adverse Event|0|||
160978439|NCT01474512|581311903|FG004|Induction Period|Adverse Event|0|||
160978440|NCT01474512|581311904|FG005|Induction Period|Adverse Event|0|||
160978441|NCT01474512|581311905|FG006|Induction Period|Adverse Event|0|||
160978442|NCT01474512|581311906|FG007|Induction Period|Adverse Event|0|||
160978443|NCT01474512|581311907|FG008|Induction Period|Adverse Event|0|||
160978444|NCT01474512|581311908|FG009|Induction Period|Adverse Event|0|||
160978445|NCT01474512|581311909|FG010|Induction Period|Adverse Event|0|||
160978446|NCT01474512|581311910|FG011|Induction Period|Adverse Event|0|||
160978447|NCT01474512|581311911|FG012|Induction Period|Adverse Event|0|||
160978448|NCT01474512|581311912|FG013|Induction Period|Adverse Event|0|||
160978449|NCT01474512|581311913|FG014|Induction Period|Adverse Event|0|||
160978450|NCT01474512|581311914|FG015|Induction Period|Adverse Event|0|||
160978451|NCT01474512|581311915|FG016|Induction Period|Adverse Event|0|||
160978452|NCT01474512|581311916|FG017|Induction Period|Adverse Event|0|||
160978453|NCT01474512|581311899|FG000|Induction Period|Lack of Efficacy|7|||
160978454|NCT01474512|581311900|FG001|Induction Period|Lack of Efficacy|1|||
160978455|NCT01474512|581311901|FG002|Induction Period|Lack of Efficacy|0|||
160978456|NCT01474512|581311902|FG003|Induction Period|Lack of Efficacy|0|||
160978457|NCT01474512|581311903|FG004|Induction Period|Lack of Efficacy|0|||
160978458|NCT01474512|581311904|FG005|Induction Period|Lack of Efficacy|0|||
160978459|NCT01474512|581311905|FG006|Induction Period|Lack of Efficacy|0|||
160978460|NCT01474512|581311906|FG007|Induction Period|Lack of Efficacy|0|||
160978461|NCT01474512|581311907|FG008|Induction Period|Lack of Efficacy|0|||
160978462|NCT01474512|581311908|FG009|Induction Period|Lack of Efficacy|0|||
160978463|NCT01474512|581311909|FG010|Induction Period|Lack of Efficacy|0|||
160978464|NCT01474512|581311910|FG011|Induction Period|Lack of Efficacy|0|||
160978465|NCT01474512|581311911|FG012|Induction Period|Lack of Efficacy|0|||
160978466|NCT01474512|581311912|FG013|Induction Period|Lack of Efficacy|0|||
160635516|NCT02494583|580047487|FG002|Overall Study|Lost to Follow-up|0|||
160978467|NCT01474512|581311913|FG014|Induction Period|Lack of Efficacy|0|||
160978468|NCT01474512|581311914|FG015|Induction Period|Lack of Efficacy|0|||
160978469|NCT01474512|581311915|FG016|Induction Period|Lack of Efficacy|0|||
160978470|NCT01474512|581311916|FG017|Induction Period|Lack of Efficacy|0|||
160520854|NCT00261846|579636758|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
160520855|NCT00261846|579636759|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
160520856|NCT00261846|579636760|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
160520857|NCT00261846|579636761|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
160520858|NCT00261846|579636762|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
160520859|NCT00261846|579636763|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
160520860|NCT00261846|579636764|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
160520861|NCT00261846|579636765|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
160978471|NCT01474512|581311899|FG000|Induction Period|Withdrawal by Subject|6|||
160978472|NCT01474512|581311900|FG001|Induction Period|Withdrawal by Subject|6|||
160978473|NCT01474512|581311901|FG002|Induction Period|Withdrawal by Subject|5|||
160978474|NCT01474512|581311902|FG003|Induction Period|Withdrawal by Subject|0|||
160978475|NCT01474512|581311903|FG004|Induction Period|Withdrawal by Subject|0|||
160978476|NCT01474512|581311904|FG005|Induction Period|Withdrawal by Subject|0|||
160978477|NCT01474512|581311905|FG006|Induction Period|Withdrawal by Subject|0|||
160978478|NCT01474512|581311906|FG007|Induction Period|Withdrawal by Subject|0|||
160978479|NCT01474512|581311907|FG008|Induction Period|Withdrawal by Subject|0|||
160978480|NCT01474512|581311908|FG009|Induction Period|Withdrawal by Subject|0|||
160978481|NCT01474512|581311909|FG010|Induction Period|Withdrawal by Subject|0|||
160978482|NCT01474512|581311910|FG011|Induction Period|Withdrawal by Subject|0|||
160978483|NCT01474512|581311911|FG012|Induction Period|Withdrawal by Subject|0|||
160978484|NCT01474512|581311912|FG013|Induction Period|Withdrawal by Subject|0|||
160978485|NCT01474512|581311913|FG014|Induction Period|Withdrawal by Subject|0|||
160978486|NCT01474512|581311914|FG015|Induction Period|Withdrawal by Subject|0|||
160978487|NCT01474512|581311915|FG016|Induction Period|Withdrawal by Subject|0|||
160978488|NCT01474512|581311916|FG017|Induction Period|Withdrawal by Subject|0|||
160520862|NCT00261846|579636766|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
160520863|NCT00261846|579636767|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
160520864|NCT00261846|579636756|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
160520865|NCT00261846|579636757|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
160520866|NCT00261846|579636758|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
160520867|NCT00261846|579636759|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
160520868|NCT00261846|579636760|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
160520869|NCT00261846|579636761|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
160520870|NCT00261846|579636762|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
160520871|NCT00261846|579636763|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
160520872|NCT00261846|579636764|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
160520873|NCT00261846|579636765|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
160520874|NCT00261846|579636766|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
160520875|NCT00261846|579636767|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
160520876|NCT00261846|579636756|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
160520877|NCT00261846|579636757|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
160520878|NCT00261846|579636758|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
160978489|NCT01474512|581311899|FG000|Induction Period|Protocol Violation|3|||
160520879|NCT00261846|579636759|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
160520880|NCT00261846|579636760|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
160520881|NCT00261846|579636761|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
160520882|NCT00261846|579636762|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
160520883|NCT00261846|579636763|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
160520884|NCT00261846|579636764|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
160520885|NCT00261846|579636765|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
160520886|NCT00261846|579636766|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
160520887|NCT00261846|579636767|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
160978490|NCT01474512|581311900|FG001|Induction Period|Protocol Violation|6|||
160978491|NCT01474512|581311901|FG002|Induction Period|Protocol Violation|0|||
160978492|NCT01474512|581311902|FG003|Induction Period|Protocol Violation|0|||
160978493|NCT01474512|581311903|FG004|Induction Period|Protocol Violation|0|||
160978494|NCT01474512|581311904|FG005|Induction Period|Protocol Violation|0|||
160978495|NCT01474512|581311905|FG006|Induction Period|Protocol Violation|0|||
160978496|NCT01474512|581311906|FG007|Induction Period|Protocol Violation|0|||
160978497|NCT01474512|581311907|FG008|Induction Period|Protocol Violation|0|||
160978498|NCT01474512|581311908|FG009|Induction Period|Protocol Violation|0|||
160978499|NCT01474512|581311909|FG010|Induction Period|Protocol Violation|0|||
160520888|NCT00261846|579636756|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
160520889|NCT00261846|579636757|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
160520890|NCT00261846|579636758|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
160520891|NCT00261846|579636759|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
160520892|NCT00261846|579636760|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
160978500|NCT01474512|581311910|FG011|Induction Period|Protocol Violation|0|||
160978501|NCT01474512|581311911|FG012|Induction Period|Protocol Violation|0|||
160978502|NCT01474512|581311912|FG013|Induction Period|Protocol Violation|0|||
160978503|NCT01474512|581311913|FG014|Induction Period|Protocol Violation|0|||
160978504|NCT01474512|581311914|FG015|Induction Period|Protocol Violation|0|||
160978505|NCT01474512|581311915|FG016|Induction Period|Protocol Violation|0|||
160978506|NCT01474512|581311916|FG017|Induction Period|Protocol Violation|0|||
160978507|NCT01474512|581311899|FG000|Induction Period|Sponsor Decision|1|||
160978508|NCT01474512|581311900|FG001|Induction Period|Sponsor Decision|1|||
160978509|NCT01474512|581311901|FG002|Induction Period|Sponsor Decision|1|||
160978510|NCT01474512|581311902|FG003|Induction Period|Sponsor Decision|0|||
160978511|NCT01474512|581311903|FG004|Induction Period|Sponsor Decision|0|||
160978512|NCT01474512|581311904|FG005|Induction Period|Sponsor Decision|0|||
160978513|NCT01474512|581311905|FG006|Induction Period|Sponsor Decision|0|||
160978514|NCT01474512|581311906|FG007|Induction Period|Sponsor Decision|0|||
160978515|NCT01474512|581311907|FG008|Induction Period|Sponsor Decision|0|||
160978516|NCT01474512|581311908|FG009|Induction Period|Sponsor Decision|0|||
160978517|NCT01474512|581311909|FG010|Induction Period|Sponsor Decision|0|||
160978518|NCT01474512|581311910|FG011|Induction Period|Sponsor Decision|0|||
160978519|NCT01474512|581311911|FG012|Induction Period|Sponsor Decision|0|||
160978520|NCT01474512|581311912|FG013|Induction Period|Sponsor Decision|0|||
160978521|NCT01474512|581311913|FG014|Induction Period|Sponsor Decision|0|||
160978522|NCT01474512|581311914|FG015|Induction Period|Sponsor Decision|0|||
160978523|NCT01474512|581311915|FG016|Induction Period|Sponsor Decision|0|||
160978524|NCT01474512|581311916|FG017|Induction Period|Sponsor Decision|0|||
160978525|NCT01474512|581311899|FG000|Induction Period|Lost to Follow-up|1|||
160978526|NCT01474512|581311900|FG001|Induction Period|Lost to Follow-up|0|||
160978527|NCT01474512|581311901|FG002|Induction Period|Lost to Follow-up|2|||
160978528|NCT01474512|581311902|FG003|Induction Period|Lost to Follow-up|0|||
160978529|NCT01474512|581311903|FG004|Induction Period|Lost to Follow-up|0|||
160978530|NCT01474512|581311904|FG005|Induction Period|Lost to Follow-up|0|||
160978531|NCT01474512|581311905|FG006|Induction Period|Lost to Follow-up|0|||
160978532|NCT01474512|581311906|FG007|Induction Period|Lost to Follow-up|0|||
160978533|NCT01474512|581311907|FG008|Induction Period|Lost to Follow-up|0|||
160978534|NCT01474512|581311908|FG009|Induction Period|Lost to Follow-up|0|||
160978535|NCT01474512|581311909|FG010|Induction Period|Lost to Follow-up|0|||
160978536|NCT01474512|581311910|FG011|Induction Period|Lost to Follow-up|0|||
160978537|NCT01474512|581311911|FG012|Induction Period|Lost to Follow-up|0|||
160978538|NCT01474512|581311912|FG013|Induction Period|Lost to Follow-up|0|||
160978539|NCT01474512|581311913|FG014|Induction Period|Lost to Follow-up|0|||
160978540|NCT01474512|581311914|FG015|Induction Period|Lost to Follow-up|0|||
160978541|NCT01474512|581311915|FG016|Induction Period|Lost to Follow-up|0|||
160978542|NCT01474512|581311916|FG017|Induction Period|Lost to Follow-up|0|||
160978543|NCT01474512|581311899|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978544|NCT01474512|581311900|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978545|NCT01474512|581311901|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978546|NCT01474512|581311902|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
160978547|NCT01474512|581311903|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
160978548|NCT01474512|581311904|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
160978549|NCT01474512|581311905|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
160978550|NCT01474512|581311906|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978551|NCT01474512|581311907|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978552|NCT01474512|581311908|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978553|NCT01474512|581311909|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978554|NCT01474512|581311910|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978555|NCT01474512|581311911|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978556|NCT01474512|581311912|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978557|NCT01474512|581311913|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978558|NCT01474512|581311914|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978559|NCT01474512|581311915|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978560|NCT01474512|581311916|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978561|NCT01474512|581311899|FG000|Maintenance Period|Adverse Event|0|||
160978562|NCT01474512|581311900|FG001|Maintenance Period|Adverse Event|0|||
160978563|NCT01474512|581311901|FG002|Maintenance Period|Adverse Event|0|||
160978564|NCT01474512|581311902|FG003|Maintenance Period|Adverse Event|4|||
160978565|NCT01474512|581311903|FG004|Maintenance Period|Adverse Event|2|||
160978566|NCT01474512|581311904|FG005|Maintenance Period|Adverse Event|7|||
160520893|NCT00261846|579636761|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
160520894|NCT00261846|579636762|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
160978567|NCT01474512|581311905|FG006|Maintenance Period|Adverse Event|0|||
160978568|NCT01474512|581311906|FG007|Maintenance Period|Adverse Event|19|||
160978569|NCT01474512|581311907|FG008|Maintenance Period|Adverse Event|1|||
160978570|NCT01474512|581311908|FG009|Maintenance Period|Adverse Event|3|||
160978571|NCT01474512|581311909|FG010|Maintenance Period|Adverse Event|0|||
160978572|NCT01474512|581311910|FG011|Maintenance Period|Adverse Event|0|||
160978573|NCT01474512|581311911|FG012|Maintenance Period|Adverse Event|0|||
160978574|NCT01474512|581311912|FG013|Maintenance Period|Adverse Event|0|||
160978575|NCT01474512|581311913|FG014|Maintenance Period|Adverse Event|0|||
160978576|NCT01474512|581311914|FG015|Maintenance Period|Adverse Event|0|||
160978577|NCT01474512|581311915|FG016|Maintenance Period|Adverse Event|0|||
160978578|NCT01474512|581311916|FG017|Maintenance Period|Adverse Event|0|||
160978579|NCT01474512|581311899|FG000|Maintenance Period|Withdrawal by Subject|0|||
160978580|NCT01474512|581311900|FG001|Maintenance Period|Withdrawal by Subject|0|||
160978581|NCT01474512|581311901|FG002|Maintenance Period|Withdrawal by Subject|0|||
160978582|NCT01474512|581311902|FG003|Maintenance Period|Withdrawal by Subject|6|||
160978583|NCT01474512|581311903|FG004|Maintenance Period|Withdrawal by Subject|2|||
160978584|NCT01474512|581311904|FG005|Maintenance Period|Withdrawal by Subject|3|||
160978585|NCT01474512|581311905|FG006|Maintenance Period|Withdrawal by Subject|1|||
160978586|NCT01474512|581311906|FG007|Maintenance Period|Withdrawal by Subject|6|||
160978587|NCT01474512|581311907|FG008|Maintenance Period|Withdrawal by Subject|3|||
160978588|NCT01474512|581311908|FG009|Maintenance Period|Withdrawal by Subject|1|||
160978589|NCT01474512|581311909|FG010|Maintenance Period|Withdrawal by Subject|0|||
160978590|NCT01474512|581311910|FG011|Maintenance Period|Withdrawal by Subject|0|||
160978591|NCT01474512|581311911|FG012|Maintenance Period|Withdrawal by Subject|0|||
160978592|NCT01474512|581311912|FG013|Maintenance Period|Withdrawal by Subject|0|||
160978593|NCT01474512|581311913|FG014|Maintenance Period|Withdrawal by Subject|0|||
160978594|NCT01474512|581311914|FG015|Maintenance Period|Withdrawal by Subject|0|||
160978595|NCT01474512|581311915|FG016|Maintenance Period|Withdrawal by Subject|0|||
160978596|NCT01474512|581311916|FG017|Maintenance Period|Withdrawal by Subject|0|||
160978597|NCT01474512|581311899|FG000|Maintenance Period|Lost to Follow-up|0|||
160978598|NCT01474512|581311900|FG001|Maintenance Period|Lost to Follow-up|0|||
160520895|NCT00261846|579636763|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
160520896|NCT00261846|579636764|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
160520897|NCT00261846|579636765|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
160520898|NCT00261846|579636766|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
160520899|NCT00261846|579636767|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
160520900|NCT00261846|579636756|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
160520901|NCT00261846|579636757|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
160520902|NCT00261846|579636758|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
160520903|NCT00261846|579636759|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
160520904|NCT00261846|579636760|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
160520905|NCT00261846|579636761|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
160520906|NCT00261846|579636762|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
160520907|NCT00261846|579636763|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
160520908|NCT00261846|579636764|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
160520909|NCT00261846|579636765|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
160520910|NCT00261846|579636766|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
160520911|NCT00261846|579636767|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
160520912|NCT01776424|579636768|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
160520913|NCT01776424|579636769|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
160520914|NCT01776424|579636770|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
160520915|NCT01776424|579636768|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
160520916|NCT01776424|579636769|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
160520917|NCT01776424|579636770|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
160520918|NCT01776424|579636768|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
160520919|NCT01776424|579636769|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
160520920|NCT01776424|579636770|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
160520921|NCT01776424|579636768|FG000|LTOLE Part (Open Label)|Refused|5|||
160520922|NCT01776424|579636769|FG001|LTOLE Part (Open Label)|Refused|2|||
160520923|NCT01776424|579636770|FG002|LTOLE Part (Open Label)|Refused|11|||
160520924|NCT01776424|579636768|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
160520925|NCT01776424|579636769|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
160520926|NCT01776424|579636770|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
160520927|NCT02294227|579636775|FG000|Overall Study|Death|0|||
160520928|NCT02294227|579636776|FG001|Overall Study|Death|0|||
160520929|NCT02294227|579636777|FG002|Overall Study|Death|1|||
160520930|NCT02294227|579636775|FG000|Overall Study|Subject/Guardian Decision|6|||
160520931|NCT02294227|579636776|FG001|Overall Study|Subject/Guardian Decision|3|||
160520932|NCT02294227|579636777|FG002|Overall Study|Subject/Guardian Decision|7|||
160520933|NCT02294227|579636775|FG000|Overall Study|Physician Decision|1|||
160520934|NCT02294227|579636776|FG001|Overall Study|Physician Decision|2|||
160520935|NCT02294227|579636777|FG002|Overall Study|Physician Decision|1|||
160520936|NCT02294227|579636775|FG000|Overall Study|Lost to Follow-up|1|||
160520937|NCT02294227|579636776|FG001|Overall Study|Lost to Follow-up|0|||
160520938|NCT02294227|579636777|FG002|Overall Study|Lost to Follow-up|0|||
160520939|NCT02294227|579636775|FG000|Overall Study|Lack of Efficacy|11|||
160520940|NCT02294227|579636776|FG001|Overall Study|Lack of Efficacy|12|||
160520941|NCT02294227|579636777|FG002|Overall Study|Lack of Efficacy|8|||
160520942|NCT02294227|579636775|FG000|Overall Study|Adverse Event|6|||
160749033|NCT02187861|580467918|FG001|Overall Study|Progressive Disease|42|||
160978599|NCT01474512|581311901|FG002|Maintenance Period|Lost to Follow-up|0|||
160978600|NCT01474512|581311902|FG003|Maintenance Period|Lost to Follow-up|3|||
160978601|NCT01474512|581311903|FG004|Maintenance Period|Lost to Follow-up|3|||
160978602|NCT01474512|581311904|FG005|Maintenance Period|Lost to Follow-up|0|||
160978603|NCT01474512|581311905|FG006|Maintenance Period|Lost to Follow-up|0|||
160978604|NCT01474512|581311906|FG007|Maintenance Period|Lost to Follow-up|2|||
160520943|NCT02294227|579636776|FG001|Overall Study|Adverse Event|8|||
160749034|NCT02187861|580467919|FG002|Overall Study|Progressive Disease|19|||
160978605|NCT01474512|581311907|FG008|Maintenance Period|Lost to Follow-up|1|||
160978606|NCT01474512|581311908|FG009|Maintenance Period|Lost to Follow-up|1|||
160978607|NCT01474512|581311909|FG010|Maintenance Period|Lost to Follow-up|0|||
160978608|NCT01474512|581311910|FG011|Maintenance Period|Lost to Follow-up|0|||
160978609|NCT01474512|581311911|FG012|Maintenance Period|Lost to Follow-up|0|||
160978610|NCT01474512|581311912|FG013|Maintenance Period|Lost to Follow-up|0|||
160978611|NCT01474512|581311913|FG014|Maintenance Period|Lost to Follow-up|0|||
160978612|NCT01474512|581311914|FG015|Maintenance Period|Lost to Follow-up|0|||
160978613|NCT01474512|581311915|FG016|Maintenance Period|Lost to Follow-up|0|||
160978614|NCT01474512|581311916|FG017|Maintenance Period|Lost to Follow-up|0|||
160978615|NCT01474512|581311899|FG000|Maintenance Period|Death|0|||
160520944|NCT02294227|579636777|FG002|Overall Study|Adverse Event|2|||
160520945|NCT00887432|579636778|FG000|Overall Study|Start Excluded Therapy|3|||
160520946|NCT00887432|579636779|FG001|Overall Study|Start Excluded Therapy|0|||
160520947|NCT00887432|579636778|FG000|Overall Study|Did not complete treatment|6|||
160520948|NCT00887432|579636779|FG001|Overall Study|Did not complete treatment|8|||
160520949|NCT00887432|579636778|FG000|Overall Study|Protocol Violation|2|||
160520950|NCT00887432|579636779|FG001|Overall Study|Protocol Violation|3|||
160520951|NCT00887432|579636778|FG000|Overall Study|Withdrawal by Subject|3|||
160520952|NCT00887432|579636779|FG001|Overall Study|Withdrawal by Subject|2|||
160520953|NCT00887432|579636778|FG000|Overall Study|Lost to Follow-up|1|||
160520954|NCT00887432|579636779|FG001|Overall Study|Lost to Follow-up|0|||
160520955|NCT00887432|579636778|FG000|Overall Study|No reason provided|0|||
160520956|NCT00887432|579636779|FG001|Overall Study|No reason provided|1|||
160520957|NCT01745848|579636780|FG000|Overall Study|Adverse Event|6|||
160520958|NCT00448123|579636782|FG000|Overall Study|Lost to Follow-up|9|||
160520959|NCT00448123|579636783|FG001|Overall Study|Lost to Follow-up|6|||
160520960|NCT00448123|579636782|FG000|Overall Study|Physician Decision|6|||
160520961|NCT00448123|579636783|FG001|Overall Study|Physician Decision|6|||
160520962|NCT02318797|579636784|FG000|Overall Study|Death|3|||
160520963|NCT02318797|579636785|FG001|Overall Study|Death|6|||
160520964|NCT02318797|579636784|FG000|Overall Study|Lost to Follow-up|85|||
160520965|NCT02318797|579636785|FG001|Overall Study|Lost to Follow-up|96|||
160520966|NCT00940108|579636788|FG000|Overall Study|Adverse Event|2|||
160520967|NCT00940108|579636789|FG001|Overall Study|Adverse Event|4|||
160520968|NCT00940108|579636790|FG002|Overall Study|Adverse Event|0|||
160520969|NCT00940108|579636791|FG003|Overall Study|Adverse Event|2|||
160520970|NCT00940108|579636788|FG000|Overall Study|Withdrew Consent|2|||
160520971|NCT00940108|579636789|FG001|Overall Study|Withdrew Consent|1|||
160520972|NCT00940108|579636790|FG002|Overall Study|Withdrew Consent|0|||
160520973|NCT00940108|579636791|FG003|Overall Study|Withdrew Consent|1|||
160520974|NCT00940108|579636788|FG000|Overall Study|Dose 2 contraindicated|1|||
160520975|NCT00940108|579636789|FG001|Overall Study|Dose 2 contraindicated|1|||
160520976|NCT00940108|579636790|FG002|Overall Study|Dose 2 contraindicated|0|||
160520977|NCT00940108|579636791|FG003|Overall Study|Dose 2 contraindicated|1|||
160520978|NCT00940108|579636788|FG000|Overall Study|Declined further vaccination|0|||
160520979|NCT00940108|579636789|FG001|Overall Study|Declined further vaccination|1|||
160520980|NCT00940108|579636790|FG002|Overall Study|Declined further vaccination|3|||
160520981|NCT00940108|579636791|FG003|Overall Study|Declined further vaccination|0|||
160520982|NCT00940108|579636788|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
160520983|NCT00940108|579636789|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
160520984|NCT00940108|579636790|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
160520985|NCT00940108|579636791|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
160520986|NCT00940108|579636788|FG000|Overall Study|Viral illness after Dose 1|0|||
160520987|NCT00940108|579636789|FG001|Overall Study|Viral illness after Dose 1|1|||
160749035|NCT02187861|580467920|FG003|Overall Study|Progressive Disease|22|||
160749036|NCT02187861|580467917|FG000|Overall Study|Withdrawal by Subject|0|||
160749037|NCT02187861|580467918|FG001|Overall Study|Withdrawal by Subject|0|||
160749038|NCT02187861|580467919|FG002|Overall Study|Withdrawal by Subject|3|||
160749039|NCT02187861|580467920|FG003|Overall Study|Withdrawal by Subject|3|||
160749040|NCT02187861|580467917|FG000|Overall Study|Other|0|||
160749041|NCT02187861|580467918|FG001|Overall Study|Other|1|||
160749042|NCT02187861|580467919|FG002|Overall Study|Other|7|||
160749043|NCT02187861|580467920|FG003|Overall Study|Other|1|||
160749044|NCT01491841|580467922|FG000|Overall Study|Screen Failure|10|||
160749045|NCT01491841|580467922|FG000|Overall Study|Withdrawal by Subject|1|||
160749046|NCT02087943|580467925|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
160749047|NCT02087943|580467926|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
160749048|NCT02087943|580467927|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
160749049|NCT02087943|580467928|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
160749050|NCT02087943|580467929|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
160749051|NCT02087943|580467925|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
160749052|NCT02087943|580467926|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
160749053|NCT02087943|580467927|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
160978616|NCT01474512|581311900|FG001|Maintenance Period|Death|0|||
160978617|NCT01474512|581311901|FG002|Maintenance Period|Death|0|||
160749054|NCT02087943|580467928|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
160749055|NCT02087943|580467929|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
160520988|NCT00940108|579636790|FG002|Overall Study|Viral illness after Dose 1|0|||
160520989|NCT00940108|579636791|FG003|Overall Study|Viral illness after Dose 1|0|||
160520990|NCT00940108|579636788|FG000|Overall Study|Diagnosed with H1N1|0|||
160520991|NCT00940108|579636789|FG001|Overall Study|Diagnosed with H1N1|0|||
160520992|NCT00940108|579636790|FG002|Overall Study|Diagnosed with H1N1|0|||
160520993|NCT00940108|579636791|FG003|Overall Study|Diagnosed with H1N1|1|||
160520994|NCT00928447|579636792|FG000|Overall Study|Withdrawal by Subject|1|||
160520995|NCT00928447|579636792|FG000|Overall Study|Investigator's decision|1|||
160520996|NCT03581825|579636797|FG000|Period 1|Lens Discomfort|1|||
160520997|NCT03581825|579636798|FG001|Period 1|Lens Discomfort|0|||
160520998|NCT03581825|579636797|FG000|Period 2|Unsatisfactory Vision to Test|0|||
160520999|NCT03581825|579636798|FG001|Period 2|Unsatisfactory Vision to Test|1|||
160521000|NCT04469270|579636799|FG000|Overall Study|Adverse Event|2|||
160521001|NCT04469270|579636800|FG001|Overall Study|Adverse Event|0|||
160521002|NCT04469270|579636799|FG000|Overall Study|Lost to Follow-up|4|||
160521003|NCT04469270|579636800|FG001|Overall Study|Lost to Follow-up|3|||
160521004|NCT04469270|579636799|FG000|Overall Study|Withdrawal by Subject|7|||
160521005|NCT04469270|579636800|FG001|Overall Study|Withdrawal by Subject|3|||
160521006|NCT04469270|579636799|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
160521007|NCT04469270|579636800|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
160521008|NCT04469270|579636799|FG000|Overall Study|missing|1|||
160521009|NCT04469270|579636800|FG001|Overall Study|missing|0|||
160521010|NCT05572021|579636801|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
160521011|NCT05572021|579636802|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
160521012|NCT04873232|579636804|FG000|Overall Study|Lost to Follow-up|1|||
160521013|NCT04873232|579636805|FG001|Overall Study|Lost to Follow-up|4|||
160521014|NCT04873232|579636804|FG000|Overall Study|Withdrawal by Subject|1|||
160521015|NCT04873232|579636805|FG001|Overall Study|Withdrawal by Subject|0|||
160521016|NCT01390181|579638824|FG000|Overall Study|Lost to Follow-up|1|||
160521017|NCT01390181|579638824|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
160521018|NCT00720941|579638829|FG000|Overall Study|Protocol Violation|1|||
160521019|NCT00720941|579638830|FG001|Overall Study|Protocol Violation|2|||
160521020|NCT00720941|579638829|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
160521021|NCT00720941|579638830|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
160521022|NCT00720941|579638829|FG000|Overall Study|Lost to Follow-up|20|||
160521023|NCT00720941|579638830|FG001|Overall Study|Lost to Follow-up|15|||
160521024|NCT00720941|579638829|FG000|Overall Study|Physician Decision|14|||
160521025|NCT00720941|579638830|FG001|Overall Study|Physician Decision|12|||
160521026|NCT00720941|579638829|FG000|Overall Study|Withdrawal by Subject|29|||
160521027|NCT00720941|579638830|FG001|Overall Study|Withdrawal by Subject|36|||
160521028|NCT03628898|579638831|FG000|Overall Study|Device deficiency|1|||
160521029|NCT02598557|579638834|FG000|Overall Study|Withdrawal by Subject|1|||
160521030|NCT02598557|579638835|FG001|Overall Study|Withdrawal by Subject|0|||
160521031|NCT02598557|579638836|FG002|Overall Study|Withdrawal by Subject|1|||
160521032|NCT02598557|579638834|FG000|Overall Study|Participant did not start treatment|2|||
160521033|NCT02598557|579638835|FG001|Overall Study|Participant did not start treatment|1|||
160521034|NCT02598557|579638836|FG002|Overall Study|Participant did not start treatment|1|||
160521035|NCT02598557|579638834|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
160521036|NCT02598557|579638835|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
160521037|NCT02598557|579638836|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
160521038|NCT02598557|579638834|FG000|Overall Study|Adverse Event|1|||
160521039|NCT02598557|579638835|FG001|Overall Study|Adverse Event|1|||
160521040|NCT02598557|579638836|FG002|Overall Study|Adverse Event|0|||
160521041|NCT02986334|579638837|FG000|Overall Study|Withdrawal by Subject|0|||
160521042|NCT02986334|579638838|FG001|Overall Study|Withdrawal by Subject|1|||
160521043|NCT02986334|579638839|FG002|Overall Study|Withdrawal by Subject|2|||
160521044|NCT02986334|579638837|FG000|Overall Study|Lost to Follow-up|1|||
160521045|NCT02986334|579638838|FG001|Overall Study|Lost to Follow-up|2|||
160521046|NCT02986334|579638839|FG002|Overall Study|Lost to Follow-up|1|||
160521047|NCT02986334|579638837|FG000|Overall Study|Adverse Event|0|||
160521048|NCT02986334|579638838|FG001|Overall Study|Adverse Event|2|||
160978618|NCT01474512|581311902|FG003|Maintenance Period|Death|0|||
160978619|NCT01474512|581311903|FG004|Maintenance Period|Death|0|||
160978620|NCT01474512|581311904|FG005|Maintenance Period|Death|2|||
160978621|NCT01474512|581311905|FG006|Maintenance Period|Death|0|||
160978622|NCT01474512|581311906|FG007|Maintenance Period|Death|0|||
160978623|NCT01474512|581311907|FG008|Maintenance Period|Death|0|||
160978624|NCT01474512|581311908|FG009|Maintenance Period|Death|0|||
160978625|NCT01474512|581311909|FG010|Maintenance Period|Death|0|||
160978626|NCT01474512|581311910|FG011|Maintenance Period|Death|0|||
160978627|NCT01474512|581311911|FG012|Maintenance Period|Death|0|||
160978628|NCT01474512|581311912|FG013|Maintenance Period|Death|0|||
160978629|NCT01474512|581311913|FG014|Maintenance Period|Death|0|||
160978630|NCT01474512|581311914|FG015|Maintenance Period|Death|0|||
160978631|NCT01474512|581311915|FG016|Maintenance Period|Death|0|||
160978632|NCT01474512|581311916|FG017|Maintenance Period|Death|0|||
160978633|NCT01474512|581311899|FG000|Maintenance Period|Physician Decision|0|||
160978634|NCT01474512|581311900|FG001|Maintenance Period|Physician Decision|0|||
160978635|NCT01474512|581311901|FG002|Maintenance Period|Physician Decision|0|||
160521049|NCT02986334|579638839|FG002|Overall Study|Adverse Event|1|||
160521050|NCT02986334|579638837|FG000|Overall Study|non compliance in phone ratings|2|||
160521051|NCT02986334|579638838|FG001|Overall Study|non compliance in phone ratings|1|||
160521052|NCT02986334|579638839|FG002|Overall Study|non compliance in phone ratings|2|||
160521053|NCT02986334|579638837|FG000|Overall Study|undisclosed comorbidities|0|||
160521054|NCT02986334|579638838|FG001|Overall Study|undisclosed comorbidities|1|||
160521055|NCT02986334|579638839|FG002|Overall Study|undisclosed comorbidities|1|||
160521056|NCT00655863|579638840|FG000|Overall Study|Lost to Follow-up|0|||
160521057|NCT00655863|579638841|FG001|Overall Study|Lost to Follow-up|0|||
160521058|NCT00655863|579638842|FG002|Overall Study|Lost to Follow-up|1|||
160521059|NCT01138007|579638843|FG000|Overall Study|Adverse Event|4|||
160521060|NCT01138007|579638844|FG001|Overall Study|Adverse Event|12|||
160521061|NCT01138007|579638845|FG002|Overall Study|Adverse Event|9|||
160521062|NCT01138007|579638843|FG000|Overall Study|Lack of Efficacy|2|||
160521063|NCT01138007|579638844|FG001|Overall Study|Lack of Efficacy|0|||
160521064|NCT01138007|579638845|FG002|Overall Study|Lack of Efficacy|6|||
160521065|NCT01138007|579638843|FG000|Overall Study|Protocol Violation|2|||
160521066|NCT01138007|579638844|FG001|Overall Study|Protocol Violation|3|||
160521067|NCT01138007|579638845|FG002|Overall Study|Protocol Violation|2|||
160521068|NCT01138007|579638843|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
160521069|NCT01138007|579638844|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
160521070|NCT01138007|579638845|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
160521071|NCT01138007|579638843|FG000|Overall Study|Lost to Follow-up|3|||
160521072|NCT01138007|579638844|FG001|Overall Study|Lost to Follow-up|3|||
160521073|NCT01138007|579638845|FG002|Overall Study|Lost to Follow-up|5|||
160521074|NCT01138007|579638843|FG000|Overall Study|Physician Decision|0|||
160521075|NCT01138007|579638844|FG001|Overall Study|Physician Decision|5|||
160521076|NCT01138007|579638845|FG002|Overall Study|Physician Decision|3|||
160521077|NCT01138007|579638843|FG000|Overall Study|Withdrawal by Subject|5|||
160521078|NCT01138007|579638844|FG001|Overall Study|Withdrawal by Subject|6|||
160521079|NCT01138007|579638845|FG002|Overall Study|Withdrawal by Subject|15|||
160521080|NCT04661878|579638846|FG000|Overall Study|Lost to Follow-up|6|||
160521081|NCT04661878|579638847|FG001|Overall Study|Lost to Follow-up|5|||
160521082|NCT03603028|579638848|FG000|Overall Study|Withdrawal by Subject|1|||
160521083|NCT00640016|579638851|FG000|Overall Study|Withdrawal by Subject|0|||
160521084|NCT00640016|579638852|FG001|Overall Study|Withdrawal by Subject|1|||
160521085|NCT00640016|579638853|FG002|Overall Study|Withdrawal by Subject|0|||
160521086|NCT00640016|579638854|FG003|Overall Study|Withdrawal by Subject|0|||
160521087|NCT00640016|579638851|FG000|Overall Study|Study termination|2|||
160521088|NCT00640016|579638852|FG001|Overall Study|Study termination|1|||
160521089|NCT00640016|579638853|FG002|Overall Study|Study termination|3|||
160521090|NCT00640016|579638854|FG003|Overall Study|Study termination|2|||
160521091|NCT00640016|579638851|FG000|Overall Study|Adverse Event|0|||
160521092|NCT00640016|579638852|FG001|Overall Study|Adverse Event|0|||
160521093|NCT00640016|579638853|FG002|Overall Study|Adverse Event|0|||
160521094|NCT00640016|579638854|FG003|Overall Study|Adverse Event|1|||
160521095|NCT00846391|579638855|FG000|Overall Study|Physician Decision|0|||
160521096|NCT00846391|579638856|FG001|Overall Study|Physician Decision|0|||
160521097|NCT00846391|579638857|FG002|Overall Study|Physician Decision|1|||
160978636|NCT01474512|581311902|FG003|Maintenance Period|Physician Decision|0|||
160978637|NCT01474512|581311903|FG004|Maintenance Period|Physician Decision|0|||
160978638|NCT01474512|581311904|FG005|Maintenance Period|Physician Decision|1|||
160978639|NCT01474512|581311905|FG006|Maintenance Period|Physician Decision|0|||
160978640|NCT01474512|581311906|FG007|Maintenance Period|Physician Decision|2|||
160978641|NCT01474512|581311907|FG008|Maintenance Period|Physician Decision|0|||
160978642|NCT01474512|581311908|FG009|Maintenance Period|Physician Decision|0|||
160978643|NCT01474512|581311909|FG010|Maintenance Period|Physician Decision|0|||
160978644|NCT01474512|581311910|FG011|Maintenance Period|Physician Decision|0|||
160978645|NCT01474512|581311911|FG012|Maintenance Period|Physician Decision|0|||
160978646|NCT01474512|581311912|FG013|Maintenance Period|Physician Decision|0|||
160978647|NCT01474512|581311913|FG014|Maintenance Period|Physician Decision|0|||
160978648|NCT01474512|581311914|FG015|Maintenance Period|Physician Decision|0|||
160978649|NCT01474512|581311915|FG016|Maintenance Period|Physician Decision|0|||
160521098|NCT00846391|579638855|FG000|Overall Study|Study Terminated by Sponsor|1|||
160521099|NCT00846391|579638856|FG001|Overall Study|Study Terminated by Sponsor|2|||
160521100|NCT00846391|579638857|FG002|Overall Study|Study Terminated by Sponsor|2|||
160749056|NCT02087943|580467925|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
160978650|NCT01474512|581311916|FG017|Maintenance Period|Physician Decision|0|||
160978651|NCT01474512|581311899|FG000|Maintenance Period|Clinical Relapse|0|||
160978652|NCT01474512|581311900|FG001|Maintenance Period|Clinical Relapse|0|||
160978653|NCT01474512|581311901|FG002|Maintenance Period|Clinical Relapse|0|||
160521101|NCT01287065|579638858|FG000|Treatment Period 1|Adverse Event|0|||
160521102|NCT01287065|579638859|FG001|Treatment Period 1|Adverse Event|0|||
160978654|NCT01474512|581311902|FG003|Maintenance Period|Clinical Relapse|1|||
160978655|NCT01474512|581311903|FG004|Maintenance Period|Clinical Relapse|0|||
160978656|NCT01474512|581311904|FG005|Maintenance Period|Clinical Relapse|0|||
160978657|NCT01474512|581311905|FG006|Maintenance Period|Clinical Relapse|0|||
160978658|NCT01474512|581311906|FG007|Maintenance Period|Clinical Relapse|0|||
160978659|NCT01474512|581311907|FG008|Maintenance Period|Clinical Relapse|0|||
160978660|NCT01474512|581311908|FG009|Maintenance Period|Clinical Relapse|0|||
160978661|NCT01474512|581311909|FG010|Maintenance Period|Clinical Relapse|0|||
160978662|NCT01474512|581311910|FG011|Maintenance Period|Clinical Relapse|0|||
160978663|NCT01474512|581311911|FG012|Maintenance Period|Clinical Relapse|0|||
160978664|NCT01474512|581311912|FG013|Maintenance Period|Clinical Relapse|0|||
160978665|NCT01474512|581311913|FG014|Maintenance Period|Clinical Relapse|0|||
160978666|NCT01474512|581311914|FG015|Maintenance Period|Clinical Relapse|0|||
160978667|NCT01474512|581311915|FG016|Maintenance Period|Clinical Relapse|0|||
160978668|NCT01474512|581311916|FG017|Maintenance Period|Clinical Relapse|0|||
160978669|NCT01474512|581311899|FG000|Maintenance Period|Lack of Efficacy|0|||
160521103|NCT01287065|579638860|FG002|Treatment Period 1|Adverse Event|0|||
160521104|NCT01287065|579638861|FG003|Treatment Period 1|Adverse Event|0|||
160521105|NCT01287065|579638862|FG004|Treatment Period 1|Adverse Event|1|||
160521106|NCT01287065|579638863|FG005|Treatment Period 1|Adverse Event|0|||
160521107|NCT01287065|579638858|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160521108|NCT01287065|579638859|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160521109|NCT01287065|579638860|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160521110|NCT01287065|579638861|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160521111|NCT01287065|579638862|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160521112|NCT01287065|579638863|FG005|Treatment Period 1|Withdrawal by Subject|1|||
160521113|NCT01580969|579638868|FG000|Overall Study|Physician Decision|3|||
160521114|NCT01580969|579638869|FG001|Overall Study|Physician Decision|0|||
160521115|NCT01580969|579638870|FG002|Overall Study|Physician Decision|0|||
160521116|NCT00511472|579638874|FG000|Overall Study|Clinical Adverse Event|1|||
160521117|NCT00511472|579638875|FG001|Overall Study|Clinical Adverse Event|2|||
160521118|NCT00511472|579638874|FG000|Overall Study|Laboratory Adverse Event|0|||
160521119|NCT00511472|579638875|FG001|Overall Study|Laboratory Adverse Event|2|||
160521120|NCT00511472|579638874|FG000|Overall Study|Not reported|2|||
160521121|NCT00511472|579638875|FG001|Overall Study|Not reported|2|||
160521122|NCT02019927|579638876|FG000|Overall Study|Lost to Follow-up|2|||
160521123|NCT02019927|579638877|FG001|Overall Study|Lost to Follow-up|4|||
160521124|NCT02019927|579638878|FG002|Overall Study|Lost to Follow-up|1|||
160521125|NCT02019927|579638879|FG003|Overall Study|Lost to Follow-up|2|||
160521126|NCT02019927|579638880|FG004|Overall Study|Lost to Follow-up|3|||
160521127|NCT02019927|579638881|FG005|Overall Study|Lost to Follow-up|1|||
160521128|NCT03181451|579638888|FG000|Overall Study|Adverse Event|0|||
160521129|NCT03181451|579638889|FG001|Overall Study|Adverse Event|1|||
160521130|NCT03181451|579638890|FG002|Overall Study|Adverse Event|0|||
160521131|NCT03181451|579638888|FG000|Overall Study|Withdrawal by Subject|0|||
160521132|NCT03181451|579638889|FG001|Overall Study|Withdrawal by Subject|1|||
160521133|NCT03181451|579638890|FG002|Overall Study|Withdrawal by Subject|0|||
160521134|NCT00069238|579638891|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
160521135|NCT00069238|579638892|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
160521136|NCT00069238|579638893|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
160521137|NCT00069238|579638891|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
160521138|NCT00069238|579638892|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
160521139|NCT00069238|579638893|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
160521140|NCT00069238|579638891|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
160521141|NCT00069238|579638892|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
160521142|NCT00069238|579638893|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
160521143|NCT01001832|579638894|FG000|Short-term Period|Adverse Event|2|||
160521144|NCT01001832|579638895|FG001|Short-term Period|Adverse Event|3|||
160521145|NCT01001832|579638894|FG000|Long-term Period|Adverse Event|2|||
160521146|NCT01001832|579638895|FG001|Long-term Period|Adverse Event|1|||
160521147|NCT01001832|579638894|FG000|Long-term Period|Withdrawal by Subject|1|||
160521148|NCT01001832|579638895|FG001|Long-term Period|Withdrawal by Subject|0|||
160978670|NCT01474512|581311900|FG001|Maintenance Period|Lack of Efficacy|0|||
160978671|NCT01474512|581311901|FG002|Maintenance Period|Lack of Efficacy|0|||
160521149|NCT01001832|579638894|FG000|Long-term Period|Lack of Efficacy|0|||
160521150|NCT01001832|579638895|FG001|Long-term Period|Lack of Efficacy|2|||
160521151|NCT01001832|579638894|FG000|Long-term Period|Other|1|||
160521152|NCT01001832|579638895|FG001|Long-term Period|Other|2|||
160521153|NCT01001832|579638894|FG000|Follow-up Period|Withdrawal by Subject|1|||
160521154|NCT01001832|579638895|FG001|Follow-up Period|Withdrawal by Subject|0|||
160521155|NCT01001832|579638894|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
160521156|NCT01001832|579638895|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
160521157|NCT01001832|579638894|FG000|Follow-up Period|Other|2|||
160635517|NCT02494583|580047485|FG000|Overall Study|Protocol Violation|1|||
160978672|NCT01474512|581311902|FG003|Maintenance Period|Lack of Efficacy|1|||
160978673|NCT01474512|581311903|FG004|Maintenance Period|Lack of Efficacy|0|||
160978674|NCT01474512|581311904|FG005|Maintenance Period|Lack of Efficacy|0|||
160978675|NCT01474512|581311905|FG006|Maintenance Period|Lack of Efficacy|0|||
160978676|NCT01474512|581311906|FG007|Maintenance Period|Lack of Efficacy|11|||
160978677|NCT01474512|581311907|FG008|Maintenance Period|Lack of Efficacy|11|||
160978678|NCT01474512|581311908|FG009|Maintenance Period|Lack of Efficacy|12|||
160978679|NCT01474512|581311909|FG010|Maintenance Period|Lack of Efficacy|0|||
160978680|NCT01474512|581311910|FG011|Maintenance Period|Lack of Efficacy|0|||
160978681|NCT01474512|581311911|FG012|Maintenance Period|Lack of Efficacy|0|||
160978682|NCT01474512|581311912|FG013|Maintenance Period|Lack of Efficacy|0|||
160978683|NCT01474512|581311913|FG014|Maintenance Period|Lack of Efficacy|0|||
160978684|NCT01474512|581311914|FG015|Maintenance Period|Lack of Efficacy|0|||
160978685|NCT01474512|581311915|FG016|Maintenance Period|Lack of Efficacy|0|||
160978686|NCT01474512|581311916|FG017|Maintenance Period|Lack of Efficacy|0|||
160978687|NCT01474512|581311899|FG000|Maintenance Period|Protocol Violation|0|||
160978688|NCT01474512|581311900|FG001|Maintenance Period|Protocol Violation|0|||
160978689|NCT01474512|581311901|FG002|Maintenance Period|Protocol Violation|0|||
160978690|NCT01474512|581311902|FG003|Maintenance Period|Protocol Violation|1|||
160978691|NCT01474512|581311903|FG004|Maintenance Period|Protocol Violation|0|||
160978692|NCT01474512|581311904|FG005|Maintenance Period|Protocol Violation|0|||
160978693|NCT01474512|581311905|FG006|Maintenance Period|Protocol Violation|0|||
160978694|NCT01474512|581311906|FG007|Maintenance Period|Protocol Violation|1|||
160978695|NCT01474512|581311907|FG008|Maintenance Period|Protocol Violation|0|||
160978696|NCT01474512|581311908|FG009|Maintenance Period|Protocol Violation|1|||
160978697|NCT01474512|581311909|FG010|Maintenance Period|Protocol Violation|0|||
160978698|NCT01474512|581311910|FG011|Maintenance Period|Protocol Violation|0|||
160978699|NCT01474512|581311911|FG012|Maintenance Period|Protocol Violation|0|||
160978700|NCT01474512|581311912|FG013|Maintenance Period|Protocol Violation|0|||
160978701|NCT01474512|581311913|FG014|Maintenance Period|Protocol Violation|0|||
160978702|NCT01474512|581311914|FG015|Maintenance Period|Protocol Violation|0|||
160978703|NCT01474512|581311915|FG016|Maintenance Period|Protocol Violation|0|||
160978704|NCT01474512|581311916|FG017|Maintenance Period|Protocol Violation|0|||
160978705|NCT01474512|581311899|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
160978706|NCT01474512|581311900|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
160978707|NCT01474512|581311901|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
160978708|NCT01474512|581311902|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
160978709|NCT01474512|581311903|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
160978710|NCT01474512|581311904|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
160978711|NCT01474512|581311905|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
160978712|NCT01474512|581311906|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
160978713|NCT01474512|581311907|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
160978714|NCT01474512|581311908|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
160978715|NCT01474512|581311909|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
160978716|NCT01474512|581311910|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
160978717|NCT01474512|581311911|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
160978718|NCT01474512|581311912|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
160978719|NCT01474512|581311913|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
160978720|NCT01474512|581311914|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
160978721|NCT01474512|581311915|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
160978722|NCT01474512|581311916|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
160978723|NCT01474512|581311899|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
160978724|NCT01474512|581311900|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
160978725|NCT01474512|581311901|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
160978726|NCT01474512|581311902|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
160978727|NCT01474512|581311903|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
160978728|NCT01474512|581311904|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
160978729|NCT01474512|581311905|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
160978730|NCT01474512|581311906|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
160978731|NCT01474512|581311907|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
160978732|NCT01474512|581311908|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
160978733|NCT01474512|581311909|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
160978734|NCT01474512|581311910|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
160978735|NCT01474512|581311911|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
160978736|NCT01474512|581311912|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
160978737|NCT01474512|581311913|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
160978738|NCT01474512|581311914|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
160978739|NCT01474512|581311915|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
160978740|NCT01474512|581311916|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
160978741|NCT01474512|581311899|FG000|Long-Term Extension Period|Adverse Event|0|||
160978742|NCT01474512|581311900|FG001|Long-Term Extension Period|Adverse Event|0|||
160978743|NCT01474512|581311901|FG002|Long-Term Extension Period|Adverse Event|0|||
160978744|NCT01474512|581311902|FG003|Long-Term Extension Period|Adverse Event|0|||
160978745|NCT01474512|581311903|FG004|Long-Term Extension Period|Adverse Event|0|||
160978746|NCT01474512|581311904|FG005|Long-Term Extension Period|Adverse Event|0|||
160978747|NCT01474512|581311905|FG006|Long-Term Extension Period|Adverse Event|0|||
160978748|NCT01474512|581311906|FG007|Long-Term Extension Period|Adverse Event|0|||
160978749|NCT01474512|581311907|FG008|Long-Term Extension Period|Adverse Event|0|||
160978750|NCT01474512|581311908|FG009|Long-Term Extension Period|Adverse Event|0|||
160978751|NCT01474512|581311909|FG010|Long-Term Extension Period|Adverse Event|0|||
160978752|NCT01474512|581311910|FG011|Long-Term Extension Period|Adverse Event|1|||
160978753|NCT01474512|581311911|FG012|Long-Term Extension Period|Adverse Event|57|||
160978754|NCT01474512|581311912|FG013|Long-Term Extension Period|Adverse Event|58|||
160978755|NCT01474512|581311913|FG014|Long-Term Extension Period|Adverse Event|0|||
160978756|NCT01474512|581311914|FG015|Long-Term Extension Period|Adverse Event|0|||
160978757|NCT01474512|581311915|FG016|Long-Term Extension Period|Adverse Event|0|||
160978758|NCT01474512|581311916|FG017|Long-Term Extension Period|Adverse Event|0|||
160978759|NCT01474512|581311899|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
160978760|NCT01474512|581311900|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
160978761|NCT01474512|581311901|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
160978762|NCT01474512|581311902|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
160978763|NCT01474512|581311903|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
160978764|NCT01474512|581311904|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
160978765|NCT01474512|581311905|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
160978766|NCT01474512|581311906|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
160978767|NCT01474512|581311907|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
160978768|NCT01474512|581311908|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
160978769|NCT01474512|581311909|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
160978770|NCT01474512|581311910|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
160978771|NCT01474512|581311911|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
160978772|NCT01474512|581311912|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
160978773|NCT01474512|581311913|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
160978774|NCT01474512|581311914|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
160978775|NCT01474512|581311915|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
160978776|NCT01474512|581311916|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
160978777|NCT01474512|581311899|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
160978778|NCT01474512|581311900|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
160978779|NCT01474512|581311901|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
160978780|NCT01474512|581311902|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
160978781|NCT01474512|581311903|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
160978782|NCT01474512|581311904|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
160978783|NCT01474512|581311905|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
160978784|NCT01474512|581311906|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
160978785|NCT01474512|581311907|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
160978786|NCT01474512|581311908|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
160978787|NCT01474512|581311909|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
160978788|NCT01474512|581311910|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
160978789|NCT01474512|581311911|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
160978790|NCT01474512|581311912|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
160978791|NCT01474512|581311913|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
160978792|NCT01474512|581311914|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
160978793|NCT01474512|581311915|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
160978794|NCT01474512|581311916|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
160978795|NCT01474512|581311899|FG000|Long-Term Extension Period|Physician Decision|0|||
160978796|NCT01474512|581311900|FG001|Long-Term Extension Period|Physician Decision|0|||
160978797|NCT01474512|581311901|FG002|Long-Term Extension Period|Physician Decision|0|||
160978798|NCT01474512|581311902|FG003|Long-Term Extension Period|Physician Decision|0|||
160978799|NCT01474512|581311903|FG004|Long-Term Extension Period|Physician Decision|0|||
160978800|NCT01474512|581311904|FG005|Long-Term Extension Period|Physician Decision|0|||
160978801|NCT01474512|581311905|FG006|Long-Term Extension Period|Physician Decision|0|||
160978802|NCT01474512|581311906|FG007|Long-Term Extension Period|Physician Decision|0|||
160978803|NCT01474512|581311907|FG008|Long-Term Extension Period|Physician Decision|0|||
160978804|NCT01474512|581311908|FG009|Long-Term Extension Period|Physician Decision|0|||
160978805|NCT01474512|581311909|FG010|Long-Term Extension Period|Physician Decision|0|||
160978806|NCT01474512|581311910|FG011|Long-Term Extension Period|Physician Decision|0|||
160978807|NCT01474512|581311911|FG012|Long-Term Extension Period|Physician Decision|21|||
160978808|NCT01474512|581311912|FG013|Long-Term Extension Period|Physician Decision|21|||
160978809|NCT01474512|581311913|FG014|Long-Term Extension Period|Physician Decision|0|||
160978810|NCT01474512|581311914|FG015|Long-Term Extension Period|Physician Decision|0|||
160978811|NCT01474512|581311915|FG016|Long-Term Extension Period|Physician Decision|0|||
160978812|NCT01474512|581311916|FG017|Long-Term Extension Period|Physician Decision|0|||
160978813|NCT01474512|581311899|FG000|Long-Term Extension Period|Clinical Relapse|0|||
160978814|NCT01474512|581311900|FG001|Long-Term Extension Period|Clinical Relapse|0|||
160978815|NCT01474512|581311901|FG002|Long-Term Extension Period|Clinical Relapse|0|||
160978816|NCT01474512|581311902|FG003|Long-Term Extension Period|Clinical Relapse|0|||
160978817|NCT01474512|581311903|FG004|Long-Term Extension Period|Clinical Relapse|0|||
160978818|NCT01474512|581311904|FG005|Long-Term Extension Period|Clinical Relapse|0|||
160978819|NCT01474512|581311905|FG006|Long-Term Extension Period|Clinical Relapse|0|||
160978820|NCT01474512|581311906|FG007|Long-Term Extension Period|Clinical Relapse|0|||
160978821|NCT01474512|581311907|FG008|Long-Term Extension Period|Clinical Relapse|0|||
160978822|NCT01474512|581311908|FG009|Long-Term Extension Period|Clinical Relapse|0|||
160978823|NCT01474512|581311909|FG010|Long-Term Extension Period|Clinical Relapse|0|||
160978824|NCT01474512|581311910|FG011|Long-Term Extension Period|Clinical Relapse|0|||
160978825|NCT01474512|581311911|FG012|Long-Term Extension Period|Clinical Relapse|9|||
160978826|NCT01474512|581311912|FG013|Long-Term Extension Period|Clinical Relapse|9|||
160978827|NCT01474512|581311913|FG014|Long-Term Extension Period|Clinical Relapse|0|||
160978828|NCT01474512|581311914|FG015|Long-Term Extension Period|Clinical Relapse|0|||
160978829|NCT01474512|581311915|FG016|Long-Term Extension Period|Clinical Relapse|0|||
160978830|NCT01474512|581311916|FG017|Long-Term Extension Period|Clinical Relapse|0|||
160978831|NCT01474512|581311899|FG000|Long-Term Extension Period|Death|0|||
160978832|NCT01474512|581311900|FG001|Long-Term Extension Period|Death|0|||
160978833|NCT01474512|581311901|FG002|Long-Term Extension Period|Death|0|||
160978834|NCT01474512|581311902|FG003|Long-Term Extension Period|Death|0|||
160978835|NCT01474512|581311903|FG004|Long-Term Extension Period|Death|0|||
160978836|NCT01474512|581311904|FG005|Long-Term Extension Period|Death|0|||
160978837|NCT01474512|581311905|FG006|Long-Term Extension Period|Death|0|||
160978838|NCT01474512|581311906|FG007|Long-Term Extension Period|Death|0|||
160978839|NCT01474512|581311907|FG008|Long-Term Extension Period|Death|0|||
160978840|NCT01474512|581311908|FG009|Long-Term Extension Period|Death|0|||
160978841|NCT01474512|581311909|FG010|Long-Term Extension Period|Death|0|||
160978842|NCT01474512|581311910|FG011|Long-Term Extension Period|Death|0|||
160978843|NCT01474512|581311911|FG012|Long-Term Extension Period|Death|9|||
160978844|NCT01474512|581311912|FG013|Long-Term Extension Period|Death|9|||
160978845|NCT01474512|581311913|FG014|Long-Term Extension Period|Death|0|||
160978846|NCT01474512|581311914|FG015|Long-Term Extension Period|Death|0|||
160978847|NCT01474512|581311915|FG016|Long-Term Extension Period|Death|0|||
160978848|NCT01474512|581311916|FG017|Long-Term Extension Period|Death|0|||
160978849|NCT01474512|581311899|FG000|Long-Term Extension Period|Sponsor Decision|0|||
160978850|NCT01474512|581311900|FG001|Long-Term Extension Period|Sponsor Decision|0|||
160978851|NCT01474512|581311901|FG002|Long-Term Extension Period|Sponsor Decision|0|||
160978852|NCT01474512|581311902|FG003|Long-Term Extension Period|Sponsor Decision|0|||
160978853|NCT01474512|581311903|FG004|Long-Term Extension Period|Sponsor Decision|0|||
160978854|NCT01474512|581311904|FG005|Long-Term Extension Period|Sponsor Decision|0|||
160978855|NCT01474512|581311905|FG006|Long-Term Extension Period|Sponsor Decision|0|||
160978856|NCT01474512|581311906|FG007|Long-Term Extension Period|Sponsor Decision|0|||
160978857|NCT01474512|581311907|FG008|Long-Term Extension Period|Sponsor Decision|0|||
160978858|NCT01474512|581311908|FG009|Long-Term Extension Period|Sponsor Decision|0|||
160978859|NCT01474512|581311909|FG010|Long-Term Extension Period|Sponsor Decision|0|||
160978860|NCT01474512|581311910|FG011|Long-Term Extension Period|Sponsor Decision|0|||
160978861|NCT01474512|581311911|FG012|Long-Term Extension Period|Sponsor Decision|6|||
160978862|NCT01474512|581311912|FG013|Long-Term Extension Period|Sponsor Decision|6|||
160978863|NCT01474512|581311913|FG014|Long-Term Extension Period|Sponsor Decision|0|||
160978864|NCT01474512|581311914|FG015|Long-Term Extension Period|Sponsor Decision|0|||
160978865|NCT01474512|581311915|FG016|Long-Term Extension Period|Sponsor Decision|0|||
160978866|NCT01474512|581311916|FG017|Long-Term Extension Period|Sponsor Decision|0|||
160978867|NCT01474512|581311899|FG000|Long-Term Extension Period|Protocol Violation|0|||
160978868|NCT01474512|581311900|FG001|Long-Term Extension Period|Protocol Violation|0|||
160978869|NCT01474512|581311901|FG002|Long-Term Extension Period|Protocol Violation|0|||
160978870|NCT01474512|581311902|FG003|Long-Term Extension Period|Protocol Violation|0|||
160978871|NCT01474512|581311903|FG004|Long-Term Extension Period|Protocol Violation|0|||
160978872|NCT01474512|581311904|FG005|Long-Term Extension Period|Protocol Violation|0|||
160978873|NCT01474512|581311905|FG006|Long-Term Extension Period|Protocol Violation|0|||
160978874|NCT01474512|581311906|FG007|Long-Term Extension Period|Protocol Violation|0|||
160978875|NCT01474512|581311907|FG008|Long-Term Extension Period|Protocol Violation|0|||
160978876|NCT01474512|581311908|FG009|Long-Term Extension Period|Protocol Violation|0|||
160978877|NCT01474512|581311909|FG010|Long-Term Extension Period|Protocol Violation|0|||
160978878|NCT01474512|581311910|FG011|Long-Term Extension Period|Protocol Violation|0|||
160978879|NCT01474512|581311911|FG012|Long-Term Extension Period|Protocol Violation|5|||
160978880|NCT01474512|581311912|FG013|Long-Term Extension Period|Protocol Violation|5|||
160978881|NCT01474512|581311913|FG014|Long-Term Extension Period|Protocol Violation|0|||
160978882|NCT01474512|581311914|FG015|Long-Term Extension Period|Protocol Violation|0|||
160978883|NCT01474512|581311915|FG016|Long-Term Extension Period|Protocol Violation|0|||
160978884|NCT01474512|581311916|FG017|Long-Term Extension Period|Protocol Violation|0|||
160978885|NCT01474512|581311899|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978886|NCT01474512|581311900|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978887|NCT01474512|581311901|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160521158|NCT01001832|579638895|FG001|Follow-up Period|Other|1|||
160521159|NCT00926211|579638899|FG000|Overall Study|Lost to Follow-up|1|||
160521160|NCT00511901|579638902|FG000|Overall Study|Withdrawal by Subject|1|||
160521161|NCT00511901|579638903|FG001|Overall Study|Withdrawal by Subject|3|||
160521162|NCT03562247|579638907|FG000|Overall Study|Lost to Follow-up|3|||
160521163|NCT03562247|579638908|FG001|Overall Study|Lost to Follow-up|1|||
160521164|NCT03562247|579638909|FG002|Overall Study|Lost to Follow-up|1|||
160521165|NCT00983931|579638910|FG000|14 Day Washout Period|Physician Decision|1|||
160521166|NCT01281969|579638911|FG000|Overall Study|not randomized didn't meet criteria|0|||
160521167|NCT01281969|579638912|FG001|Overall Study|not randomized didn't meet criteria|0|||
160521168|NCT01281969|579638913|FG002|Overall Study|not randomized didn't meet criteria|7|||
160521169|NCT01281969|579638911|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
160521170|NCT01281969|579638912|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
160521171|NCT01281969|579638913|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
160521172|NCT01281969|579638911|FG000|Overall Study|not randomized, child consent not given|0|||
160521173|NCT01281969|579638912|FG001|Overall Study|not randomized, child consent not given|0|||
160521174|NCT01281969|579638913|FG002|Overall Study|not randomized, child consent not given|2|||
160521175|NCT02409368|579638918|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
160521176|NCT02409368|579638919|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
160521177|NCT02409368|579638920|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
160521178|NCT02409368|579638921|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
160521179|NCT02409368|579638918|FG000|ECOG Reclassification|Death|1|||
160521180|NCT02409368|579638919|FG001|ECOG Reclassification|Death|5|||
160521181|NCT02409368|579638920|FG002|ECOG Reclassification|Death|0|||
160521182|NCT02409368|579638921|FG003|ECOG Reclassification|Death|0|||
160521183|NCT02409368|579638918|FG000|ECOG Reclassification|Disease Progression|113|||
160521184|NCT02409368|579638919|FG001|ECOG Reclassification|Disease Progression|382|||
160521185|NCT02409368|579638920|FG002|ECOG Reclassification|Disease Progression|70|||
160521186|NCT02409368|579638921|FG003|ECOG Reclassification|Disease Progression|1|||
160521187|NCT02409368|579638918|FG000|ECOG Reclassification|Lost to Follow-up|1|||
160521188|NCT02409368|579638919|FG001|ECOG Reclassification|Lost to Follow-up|5|||
160521189|NCT02409368|579638920|FG002|ECOG Reclassification|Lost to Follow-up|0|||
160521190|NCT02409368|579638921|FG003|ECOG Reclassification|Lost to Follow-up|0|||
160521191|NCT02409368|579638918|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
160521192|NCT02409368|579638919|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
160521193|NCT02409368|579638920|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
160521194|NCT02409368|579638921|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
160521195|NCT02409368|579638918|FG000|ECOG Reclassification|Poor/non-compliance|0|||
160521196|NCT02409368|579638919|FG001|ECOG Reclassification|Poor/non-compliance|3|||
160521197|NCT02409368|579638920|FG002|ECOG Reclassification|Poor/non-compliance|2|||
160521198|NCT02409368|579638921|FG003|ECOG Reclassification|Poor/non-compliance|0|||
160521199|NCT02409368|579638918|FG000|ECOG Reclassification|Study drug toxicity|17|||
160521200|NCT02409368|579638919|FG001|ECOG Reclassification|Study drug toxicity|42|||
160521201|NCT02409368|579638920|FG002|ECOG Reclassification|Study drug toxicity|7|||
160521202|NCT02409368|579638921|FG003|ECOG Reclassification|Study drug toxicity|0|||
160521203|NCT02409368|579638918|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
160521204|NCT02409368|579638919|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
160521205|NCT02409368|579638920|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
160521206|NCT02409368|579638921|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
160521207|NCT02409368|579638918|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
160521208|NCT02409368|579638919|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
160521209|NCT02409368|579638920|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
160521210|NCT02409368|579638921|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
160521211|NCT02409368|579638918|FG000|ECOG Reclassification|Participant withdrew consent|2|||
160521212|NCT02409368|579638919|FG001|ECOG Reclassification|Participant withdrew consent|3|||
160521213|NCT02409368|579638920|FG002|ECOG Reclassification|Participant withdrew consent|4|||
160521214|NCT02409368|579638921|FG003|ECOG Reclassification|Participant withdrew consent|0|||
160521215|NCT02409368|579638918|FG000|ECOG Reclassification|Other Reasons|5|||
160521216|NCT02409368|579638919|FG001|ECOG Reclassification|Other Reasons|26|||
160521217|NCT02409368|579638920|FG002|ECOG Reclassification|Other Reasons|2|||
160521218|NCT02409368|579638921|FG003|ECOG Reclassification|Other Reasons|0|||
160521219|NCT02409368|579638918|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
160521220|NCT02409368|579638919|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
160521221|NCT02409368|579638920|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
160521222|NCT02409368|579638921|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
160521223|NCT01296347|579638922|FG000|Allocation|Withdrawal by Subject|1|||
160521224|NCT01296347|579638923|FG001|Allocation|Withdrawal by Subject|2|||
160521225|NCT01296347|579638922|FG000|Allocation|Lack of Efficacy|1|||
160521226|NCT01296347|579638923|FG001|Allocation|Lack of Efficacy|2|||
160521227|NCT01296347|579638922|FG000|Allocation|not received infusion|1|||
160521228|NCT01296347|579638923|FG001|Allocation|not received infusion|0|||
160521229|NCT01296347|579638922|FG000|6 Week Follow up|Death|0|||
160521230|NCT01296347|579638923|FG001|6 Week Follow up|Death|1|||
160521231|NCT01296347|579638922|FG000|3 Month Follow up|Death|1|||
160521232|NCT01296347|579638923|FG001|3 Month Follow up|Death|0|||
160521233|NCT01296347|579638922|FG000|3 Month Follow up|Lost to Follow-up|0|||
160521234|NCT01296347|579638923|FG001|3 Month Follow up|Lost to Follow-up|1|||
160521235|NCT01296347|579638922|FG000|6 Month Follow up|Death|2|||
160521236|NCT01296347|579638923|FG001|6 Month Follow up|Death|1|||
160521237|NCT01296347|579638922|FG000|6 Month Follow up|Lost to Follow-up|0|||
160521238|NCT01296347|579638923|FG001|6 Month Follow up|Lost to Follow-up|1|||
160521239|NCT01296347|579638922|FG000|12 Month Follow up|Lost to Follow-up|3|||
160521240|NCT01296347|579638923|FG001|12 Month Follow up|Lost to Follow-up|1|||
160521241|NCT01296347|579638922|FG000|12 Month Follow up|Death|1|||
160521242|NCT01296347|579638923|FG001|12 Month Follow up|Death|1|||
160521243|NCT01296347|579638922|FG000|12 Month Follow up|Withdrawal by Subject|0|||
160521244|NCT01296347|579638923|FG001|12 Month Follow up|Withdrawal by Subject|1|||
160521245|NCT02240693|579638924|FG000|Overall Study|Adverse Event|0|||
160521246|NCT02240693|579638925|FG001|Overall Study|Adverse Event|0|||
160521247|NCT02240693|579638926|FG002|Overall Study|Adverse Event|0|||
160521248|NCT02240693|579638927|FG003|Overall Study|Adverse Event|0|||
160521249|NCT02240693|579638928|FG004|Overall Study|Adverse Event|1|||
160521250|NCT02240693|579638924|FG000|Overall Study|Withdrawal by Subject|0|||
160521251|NCT02240693|579638925|FG001|Overall Study|Withdrawal by Subject|0|||
160978888|NCT01474512|581311902|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978889|NCT01474512|581311903|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978890|NCT01474512|581311904|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978891|NCT01474512|581311905|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978892|NCT01474512|581311906|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978893|NCT01474512|581311907|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978894|NCT01474512|581311908|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978895|NCT01474512|581311909|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978896|NCT01474512|581311910|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978897|NCT01474512|581311911|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
160978898|NCT01474512|581311912|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
160978899|NCT01474512|581311913|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978900|NCT01474512|581311914|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978901|NCT01474512|581311915|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978902|NCT01474512|581311916|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160521252|NCT02240693|579638926|FG002|Overall Study|Withdrawal by Subject|2|||
160521253|NCT02240693|579638927|FG003|Overall Study|Withdrawal by Subject|1|||
160521254|NCT02240693|579638928|FG004|Overall Study|Withdrawal by Subject|0|||
160521255|NCT02240693|579638924|FG000|Overall Study|Other than specified|0|||
160521256|NCT02240693|579638925|FG001|Overall Study|Other than specified|0|||
160521257|NCT02240693|579638926|FG002|Overall Study|Other than specified|2|||
160521258|NCT02240693|579638927|FG003|Overall Study|Other than specified|0|||
160521259|NCT02240693|579638928|FG004|Overall Study|Other than specified|0|||
160521260|NCT03343301|579638929|FG000|Overall Study|Withdrawal by Subject|1|||
160521261|NCT03343301|579638930|FG001|Overall Study|Withdrawal by Subject|1|||
160521262|NCT03343301|579638929|FG000|Overall Study|Death|0|||
160521263|NCT03343301|579638930|FG001|Overall Study|Death|2|||
160521264|NCT03343301|579638929|FG000|Overall Study|Other|0|||
160521265|NCT03343301|579638930|FG001|Overall Study|Other|6|||
160521266|NCT03343301|579638929|FG000|Overall Study|Missing|2|||
160521267|NCT03343301|579638930|FG001|Overall Study|Missing|0|||
160978903|NCT01474512|581311899|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978904|NCT01474512|581311900|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978905|NCT01474512|581311901|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160521268|NCT02668185|579638933|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
160521269|NCT02668185|579638934|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
160521270|NCT02668185|579638933|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
160521271|NCT02668185|579638934|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
160521272|NCT02668185|579638933|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
160521273|NCT02668185|579638934|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
160521274|NCT02668185|579638933|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
160521275|NCT02668185|579638934|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
160521276|NCT01013597|579638935|FG000|Overall Study|Withdrawal by Subject|1|||
160521277|NCT00427895|579638936|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
160521278|NCT00427895|579638937|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
160521279|NCT00427895|579638938|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
160521280|NCT00427895|579638939|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
160521281|NCT00427895|579638940|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
160521282|NCT00427895|579638941|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
160521283|NCT00427895|579638942|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
160521284|NCT00427895|579638943|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
160521285|NCT00427895|579638936|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
160521286|NCT00427895|579638937|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
160521287|NCT00427895|579638938|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
160521288|NCT00427895|579638939|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
160521289|NCT00427895|579638940|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
160521290|NCT00427895|579638941|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
160521291|NCT00427895|579638942|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
160521292|NCT00427895|579638943|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
160521293|NCT00427895|579638936|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
160521294|NCT00427895|579638937|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
160521295|NCT00427895|579638938|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
160521296|NCT00427895|579638939|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
160521297|NCT00427895|579638940|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
160521298|NCT00427895|579638941|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
160521299|NCT00427895|579638942|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
160521300|NCT00427895|579638943|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
160521301|NCT00427895|579638936|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
160521302|NCT00427895|579638937|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
160521303|NCT00427895|579638938|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
160521304|NCT00427895|579638939|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
160521305|NCT00427895|579638940|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
160521306|NCT00427895|579638941|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
160521307|NCT00427895|579638942|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
160521308|NCT00427895|579638943|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
160521309|NCT00427895|579638936|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
160521310|NCT00427895|579638937|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
160521311|NCT00427895|579638938|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
160521312|NCT00427895|579638939|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
160521313|NCT00427895|579638940|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
160521314|NCT00427895|579638941|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
160521315|NCT00427895|579638942|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
160521316|NCT00427895|579638943|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
160521317|NCT00427895|579638936|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
160521318|NCT00427895|579638937|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
160521319|NCT00427895|579638938|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
160521320|NCT00427895|579638939|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
160521321|NCT00427895|579638940|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
160521322|NCT00427895|579638941|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
160521323|NCT00427895|579638942|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
160521324|NCT00427895|579638943|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
160521325|NCT00427895|579638936|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
160521326|NCT00427895|579638937|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
160521327|NCT00427895|579638938|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
160521328|NCT00427895|579638939|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
160521329|NCT00427895|579638940|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
160521330|NCT00427895|579638941|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
160521331|NCT00427895|579638942|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
160521332|NCT00427895|579638943|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
160521333|NCT00427895|579638936|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
160521334|NCT00427895|579638937|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
160635518|NCT02494583|580047486|FG001|Overall Study|Protocol Violation|2|||
160635519|NCT02494583|580047487|FG002|Overall Study|Protocol Violation|0|||
160521335|NCT00427895|579638938|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
160521336|NCT00427895|579638939|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
160521337|NCT00427895|579638940|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
160521338|NCT00427895|579638941|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
160521339|NCT00427895|579638942|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
160521340|NCT00427895|579638943|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
160521341|NCT00427895|579638936|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
160521342|NCT00427895|579638937|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
160521343|NCT00427895|579638938|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
160521344|NCT00427895|579638939|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
160521345|NCT00427895|579638940|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
160521346|NCT00427895|579638941|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
160521347|NCT00427895|579638942|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
160521348|NCT00427895|579638943|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
160521349|NCT00427895|579638936|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
160521350|NCT00427895|579638937|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
160521351|NCT00427895|579638938|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
160521352|NCT00427895|579638939|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
160521353|NCT00427895|579638940|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
160521354|NCT00427895|579638941|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
160521355|NCT00427895|579638942|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
160521356|NCT00427895|579638943|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
160521357|NCT00427895|579638936|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
160521358|NCT00427895|579638937|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
160521359|NCT00427895|579638938|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
160521360|NCT00427895|579638939|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
160521361|NCT00427895|579638940|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
160521362|NCT00427895|579638941|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
160521363|NCT00427895|579638942|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
160521364|NCT00427895|579638943|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
160521365|NCT00427895|579638936|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
160521366|NCT00427895|579638937|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
160521367|NCT00427895|579638938|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
160521368|NCT00427895|579638939|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
160521369|NCT00427895|579638940|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
160521370|NCT00427895|579638941|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
160521371|NCT00427895|579638942|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
160521372|NCT00427895|579638943|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
160521373|NCT00427895|579638936|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
160521374|NCT00427895|579638937|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
160521375|NCT00427895|579638938|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
160521376|NCT00427895|579638939|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
160521377|NCT00427895|579638940|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
160521378|NCT00427895|579638941|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
160521379|NCT00427895|579638942|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
160521380|NCT00427895|579638943|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
160521381|NCT00427895|579638936|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
160521382|NCT00427895|579638937|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
160521383|NCT00427895|579638938|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
160521384|NCT00427895|579638939|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
160521385|NCT00427895|579638940|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
160521386|NCT00427895|579638941|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
160521387|NCT00427895|579638942|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
160521388|NCT00427895|579638943|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
160521389|NCT00427895|579638936|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
160521390|NCT00427895|579638937|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
160521391|NCT00427895|579638938|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
160521392|NCT00427895|579638939|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
160521393|NCT00427895|579638940|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
160521394|NCT00427895|579638941|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
160521395|NCT00427895|579638942|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
160521396|NCT00427895|579638943|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
160521397|NCT00427895|579638936|FG000|Vax 1/Year 1 Follow-up|Death|1|||
160521398|NCT00427895|579638937|FG001|Vax 1/Year 1 Follow-up|Death|0|||
160521399|NCT00427895|579638938|FG002|Vax 1/Year 1 Follow-up|Death|0|||
160521400|NCT00427895|579638939|FG003|Vax 1/Year 1 Follow-up|Death|0|||
160521401|NCT00427895|579638940|FG004|Vax 1/Year 1 Follow-up|Death|0|||
160521402|NCT00427895|579638941|FG005|Vax 1/Year 1 Follow-up|Death|0|||
160521403|NCT00427895|579638942|FG006|Vax 1/Year 1 Follow-up|Death|0|||
160521404|NCT00427895|579638943|FG007|Vax 1/Year 1 Follow-up|Death|0|||
160521405|NCT00427895|579638936|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
160521406|NCT00427895|579638937|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
160521407|NCT00427895|579638938|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
160521408|NCT00427895|579638939|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
160521409|NCT00427895|579638940|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
160521410|NCT00427895|579638941|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
160521411|NCT00427895|579638942|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
160521412|NCT00427895|579638943|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
160521413|NCT00427895|579638936|FG000|Vax 1/Year 1 Follow-up|Other|0|||
160521414|NCT00427895|579638937|FG001|Vax 1/Year 1 Follow-up|Other|0|||
160521415|NCT00427895|579638938|FG002|Vax 1/Year 1 Follow-up|Other|0|||
160521416|NCT00427895|579638939|FG003|Vax 1/Year 1 Follow-up|Other|2|||
160521417|NCT00427895|579638940|FG004|Vax 1/Year 1 Follow-up|Other|0|||
160521418|NCT00427895|579638941|FG005|Vax 1/Year 1 Follow-up|Other|0|||
160521419|NCT00427895|579638942|FG006|Vax 1/Year 1 Follow-up|Other|0|||
160521420|NCT00427895|579638943|FG007|Vax 1/Year 1 Follow-up|Other|0|||
160521421|NCT00427895|579638936|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
160521422|NCT00427895|579638937|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
160521423|NCT00427895|579638938|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
160521424|NCT00427895|579638939|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
160521425|NCT00427895|579638940|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
160521426|NCT00427895|579638941|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
160521427|NCT00427895|579638942|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
160978906|NCT01474512|581311902|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978907|NCT01474512|581311903|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978908|NCT01474512|581311904|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978909|NCT01474512|581311905|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978910|NCT01474512|581311906|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978911|NCT01474512|581311907|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978912|NCT01474512|581311908|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978913|NCT01474512|581311909|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978914|NCT01474512|581311910|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
160978915|NCT01474512|581311911|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978916|NCT01474512|581311912|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978917|NCT01474512|581311913|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978918|NCT01474512|581311914|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978919|NCT01474512|581311915|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978920|NCT01474512|581311916|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160521428|NCT00427895|579638943|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
160978921|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
160978922|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
160978923|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
160978924|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
160978925|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
160978926|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
160978927|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
160978928|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
160978929|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
160978930|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
160978931|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
160978932|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
160978933|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
160978934|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
160978935|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
160978936|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
160978937|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
160978938|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
160978939|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978940|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978941|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978942|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978943|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978944|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978945|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160521429|NCT02678247|579638944|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
160521430|NCT02678247|579638945|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
160521431|NCT02678247|579638944|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
160521432|NCT02678247|579638945|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
160521433|NCT02678247|579638944|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
160978946|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978947|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978948|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160521434|NCT02678247|579638945|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
160521435|NCT02678247|579638944|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
160521436|NCT02678247|579638945|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
160521437|NCT02678247|579638944|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
160521438|NCT02678247|579638945|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
160521439|NCT02678247|579638944|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
160521440|NCT02678247|579638945|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
160521441|NCT00585195|579638947|FG000|Overall Study|Adverse Event|0|||
160521442|NCT00585195|579638948|FG001|Overall Study|Adverse Event|0|||
160521443|NCT00585195|579638949|FG002|Overall Study|Adverse Event|0|||
160521444|NCT00585195|579638950|FG003|Overall Study|Adverse Event|0|||
160521445|NCT00585195|579638951|FG004|Overall Study|Adverse Event|2|||
160521446|NCT00585195|579638952|FG005|Overall Study|Adverse Event|1|||
160521447|NCT00585195|579638953|FG006|Overall Study|Adverse Event|0|||
160521448|NCT00585195|579638954|FG007|Overall Study|Adverse Event|1|||
160521449|NCT00585195|579638955|FG008|Overall Study|Adverse Event|0|||
160521450|NCT00585195|579638956|FG009|Overall Study|Adverse Event|0|||
160521451|NCT00585195|579638957|FG010|Overall Study|Adverse Event|3|||
160749057|NCT02087943|580467926|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
160749058|NCT02087943|580467927|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
160749059|NCT02087943|580467928|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
160749060|NCT02087943|580467929|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
160978949|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978950|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978951|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978952|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978953|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
160978954|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
160978955|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
160978956|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
160978957|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978958|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978959|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978960|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978961|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978962|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978963|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978964|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978965|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978966|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978967|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978968|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978969|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978970|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978971|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
160978972|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
160978973|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
160978974|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
160978975|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978976|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978977|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978978|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978979|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978980|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978981|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978982|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978983|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978984|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978985|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978986|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978987|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978988|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978989|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978990|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978991|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
160749061|NCT02087943|580467925|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
160749062|NCT02087943|580467926|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
160749063|NCT02087943|580467927|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
160749064|NCT02087943|580467928|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
160749065|NCT02087943|580467929|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
160749066|NCT02087943|580467925|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
160749067|NCT02087943|580467926|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
160978992|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
160978993|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
160978994|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
160978995|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
160978996|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
160978997|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
160978998|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
160978999|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
160979000|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
160979001|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
160979002|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
160979003|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
160979004|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
160979005|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
160979006|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
160979007|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
160979008|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
160979009|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
160979010|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
160521452|NCT00585195|579638958|FG011|Overall Study|Adverse Event|0|||
160521453|NCT00585195|579638959|FG012|Overall Study|Adverse Event|8|||
160521454|NCT00585195|579638960|FG013|Overall Study|Adverse Event|6|||
160521455|NCT00585195|579638961|FG014|Overall Study|Adverse Event|4|||
160521456|NCT00585195|579638962|FG015|Overall Study|Adverse Event|1|||
160521457|NCT00585195|579638963|FG016|Overall Study|Adverse Event|14|||
160521458|NCT00585195|579638964|FG017|Overall Study|Adverse Event|9|||
160521459|NCT00585195|579638965|FG018|Overall Study|Adverse Event|2|||
160521460|NCT00585195|579638966|FG019|Overall Study|Adverse Event|3|||
160521461|NCT00585195|579638967|FG020|Overall Study|Adverse Event|1|||
160521462|NCT00585195|579638947|FG000|Overall Study|Progressive Disease|2|||
160521463|NCT00585195|579638948|FG001|Overall Study|Progressive Disease|2|||
160521464|NCT00585195|579638949|FG002|Overall Study|Progressive Disease|5|||
160521465|NCT00585195|579638950|FG003|Overall Study|Progressive Disease|4|||
160521466|NCT00585195|579638951|FG004|Overall Study|Progressive Disease|6|||
160521467|NCT00585195|579638952|FG005|Overall Study|Progressive Disease|4|||
160521468|NCT00585195|579638953|FG006|Overall Study|Progressive Disease|6|||
160521469|NCT00585195|579638954|FG007|Overall Study|Progressive Disease|3|||
160521470|NCT00585195|579638955|FG008|Overall Study|Progressive Disease|0|||
160521471|NCT00585195|579638956|FG009|Overall Study|Progressive Disease|5|||
160521472|NCT00585195|579638957|FG010|Overall Study|Progressive Disease|2|||
160521473|NCT00585195|579638958|FG011|Overall Study|Progressive Disease|25|||
160521474|NCT00585195|579638959|FG012|Overall Study|Progressive Disease|29|||
160521475|NCT00585195|579638960|FG013|Overall Study|Progressive Disease|26|||
160521476|NCT00585195|579638961|FG014|Overall Study|Progressive Disease|21|||
160521477|NCT00585195|579638962|FG015|Overall Study|Progressive Disease|12|||
160521478|NCT00585195|579638963|FG016|Overall Study|Progressive Disease|94|||
160521479|NCT00585195|579638964|FG017|Overall Study|Progressive Disease|42|||
160521480|NCT00585195|579638965|FG018|Overall Study|Progressive Disease|4|||
160521481|NCT00585195|579638966|FG019|Overall Study|Progressive Disease|9|||
160521482|NCT00585195|579638967|FG020|Overall Study|Progressive Disease|8|||
160521483|NCT00585195|579638947|FG000|Overall Study|Withdrawal by Subject|1|||
160521484|NCT00585195|579638948|FG001|Overall Study|Withdrawal by Subject|1|||
160635520|NCT02494583|580047485|FG000|Overall Study|Screen Failure|0|||
160635521|NCT02494583|580047486|FG001|Overall Study|Screen Failure|1|||
160749068|NCT02087943|580467927|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
160749069|NCT02087943|580467928|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
160749070|NCT02087943|580467929|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
160749071|NCT02087943|580467925|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
160749072|NCT02087943|580467926|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
160749073|NCT02087943|580467927|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
160749074|NCT02087943|580467928|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
160749075|NCT02087943|580467929|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
160521485|NCT00585195|579638949|FG002|Overall Study|Withdrawal by Subject|2|||
160521486|NCT00585195|579638950|FG003|Overall Study|Withdrawal by Subject|2|||
160521487|NCT00585195|579638951|FG004|Overall Study|Withdrawal by Subject|0|||
160521488|NCT00585195|579638952|FG005|Overall Study|Withdrawal by Subject|0|||
160521489|NCT00585195|579638953|FG006|Overall Study|Withdrawal by Subject|0|||
160521490|NCT00585195|579638954|FG007|Overall Study|Withdrawal by Subject|1|||
160521491|NCT00585195|579638955|FG008|Overall Study|Withdrawal by Subject|0|||
160521492|NCT00585195|579638956|FG009|Overall Study|Withdrawal by Subject|0|||
160521493|NCT00585195|579638957|FG010|Overall Study|Withdrawal by Subject|3|||
160521494|NCT00585195|579638958|FG011|Overall Study|Withdrawal by Subject|8|||
160521495|NCT00585195|579638959|FG012|Overall Study|Withdrawal by Subject|15|||
160521496|NCT00585195|579638960|FG013|Overall Study|Withdrawal by Subject|0|||
160521497|NCT00585195|579638961|FG014|Overall Study|Withdrawal by Subject|3|||
160521498|NCT00585195|579638962|FG015|Overall Study|Withdrawal by Subject|0|||
160521499|NCT00585195|579638963|FG016|Overall Study|Withdrawal by Subject|7|||
160521500|NCT00585195|579638964|FG017|Overall Study|Withdrawal by Subject|1|||
160521501|NCT00585195|579638965|FG018|Overall Study|Withdrawal by Subject|2|||
160521502|NCT00585195|579638966|FG019|Overall Study|Withdrawal by Subject|2|||
160521503|NCT00585195|579638967|FG020|Overall Study|Withdrawal by Subject|0|||
160521504|NCT00585195|579638947|FG000|Overall Study|Other|0|||
160521505|NCT00585195|579638948|FG001|Overall Study|Other|1|||
160749076|NCT02087943|580467925|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
160521506|NCT00585195|579638949|FG002|Overall Study|Other|1|||
160521507|NCT00585195|579638950|FG003|Overall Study|Other|1|||
160521508|NCT00585195|579638951|FG004|Overall Study|Other|0|||
160521509|NCT00585195|579638952|FG005|Overall Study|Other|1|||
160521510|NCT00585195|579638953|FG006|Overall Study|Other|0|||
160521511|NCT00585195|579638954|FG007|Overall Study|Other|0|||
160521512|NCT00585195|579638955|FG008|Overall Study|Other|2|||
160521513|NCT00585195|579638956|FG009|Overall Study|Other|1|||
160521514|NCT00585195|579638957|FG010|Overall Study|Other|0|||
160521515|NCT00585195|579638958|FG011|Overall Study|Other|19|||
160521516|NCT00585195|579638959|FG012|Overall Study|Other|24|||
160521517|NCT00585195|579638960|FG013|Overall Study|Other|7|||
160521518|NCT00585195|579638961|FG014|Overall Study|Other|11|||
160521519|NCT00585195|579638962|FG015|Overall Study|Other|3|||
160521520|NCT00585195|579638963|FG016|Overall Study|Other|28|||
160521521|NCT00585195|579638964|FG017|Overall Study|Other|12|||
160521522|NCT00585195|579638965|FG018|Overall Study|Other|10|||
160521523|NCT00585195|579638966|FG019|Overall Study|Other|4|||
160521524|NCT00585195|579638967|FG020|Overall Study|Other|2|||
160521525|NCT00585195|579638947|FG000|Overall Study|Randomized not treated|0|||
160521526|NCT00585195|579638948|FG001|Overall Study|Randomized not treated|0|||
160521527|NCT00585195|579638949|FG002|Overall Study|Randomized not treated|1|||
160521528|NCT00585195|579638950|FG003|Overall Study|Randomized not treated|0|||
160521529|NCT00585195|579638951|FG004|Overall Study|Randomized not treated|1|||
160521530|NCT00585195|579638952|FG005|Overall Study|Randomized not treated|0|||
160521531|NCT00585195|579638953|FG006|Overall Study|Randomized not treated|1|||
160521532|NCT00585195|579638954|FG007|Overall Study|Randomized not treated|0|||
160521533|NCT00585195|579638955|FG008|Overall Study|Randomized not treated|0|||
160521534|NCT00585195|579638956|FG009|Overall Study|Randomized not treated|0|||
160521535|NCT00585195|579638957|FG010|Overall Study|Randomized not treated|2|||
160521536|NCT00585195|579638958|FG011|Overall Study|Randomized not treated|0|||
160521537|NCT00585195|579638959|FG012|Overall Study|Randomized not treated|0|||
160521538|NCT00585195|579638960|FG013|Overall Study|Randomized not treated|0|||
160521539|NCT00585195|579638961|FG014|Overall Study|Randomized not treated|0|||
160521540|NCT00585195|579638962|FG015|Overall Study|Randomized not treated|1|||
160521541|NCT00585195|579638963|FG016|Overall Study|Randomized not treated|0|||
160521542|NCT00585195|579638964|FG017|Overall Study|Randomized not treated|1|||
160521543|NCT00585195|579638965|FG018|Overall Study|Randomized not treated|3|||
160521544|NCT00585195|579638966|FG019|Overall Study|Randomized not treated|0|||
160521545|NCT00585195|579638967|FG020|Overall Study|Randomized not treated|2|||
160521546|NCT00585195|579638947|FG000|Overall Study|Death|0|||
160521547|NCT00585195|579638948|FG001|Overall Study|Death|0|||
160521548|NCT00585195|579638949|FG002|Overall Study|Death|0|||
160521549|NCT00585195|579638950|FG003|Overall Study|Death|0|||
160521550|NCT00585195|579638951|FG004|Overall Study|Death|0|||
160521551|NCT00585195|579638952|FG005|Overall Study|Death|0|||
160521552|NCT00585195|579638953|FG006|Overall Study|Death|0|||
160521553|NCT00585195|579638954|FG007|Overall Study|Death|0|||
160521554|NCT00585195|579638955|FG008|Overall Study|Death|1|||
160521555|NCT00585195|579638956|FG009|Overall Study|Death|0|||
160521556|NCT00585195|579638957|FG010|Overall Study|Death|1|||
160521557|NCT00585195|579638958|FG011|Overall Study|Death|1|||
160521558|NCT00585195|579638959|FG012|Overall Study|Death|7|||
160521559|NCT00585195|579638960|FG013|Overall Study|Death|2|||
160521560|NCT00585195|579638961|FG014|Overall Study|Death|8|||
160521561|NCT00585195|579638962|FG015|Overall Study|Death|2|||
160521562|NCT00585195|579638963|FG016|Overall Study|Death|11|||
160521563|NCT00585195|579638964|FG017|Overall Study|Death|0|||
160749077|NCT02087943|580467926|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
160521564|NCT00585195|579638965|FG018|Overall Study|Death|0|||
160521565|NCT00585195|579638966|FG019|Overall Study|Death|0|||
160521566|NCT00585195|579638967|FG020|Overall Study|Death|1|||
160521567|NCT00585195|579638947|FG000|Overall Study|Lost to Follow-up|0|||
160521568|NCT00585195|579638948|FG001|Overall Study|Lost to Follow-up|0|||
160521569|NCT00585195|579638949|FG002|Overall Study|Lost to Follow-up|0|||
160521570|NCT00585195|579638950|FG003|Overall Study|Lost to Follow-up|0|||
160521571|NCT00585195|579638951|FG004|Overall Study|Lost to Follow-up|0|||
160521572|NCT00585195|579638952|FG005|Overall Study|Lost to Follow-up|0|||
160521573|NCT00585195|579638953|FG006|Overall Study|Lost to Follow-up|0|||
160521574|NCT00585195|579638954|FG007|Overall Study|Lost to Follow-up|0|||
160521575|NCT00585195|579638955|FG008|Overall Study|Lost to Follow-up|0|||
160521576|NCT00585195|579638956|FG009|Overall Study|Lost to Follow-up|0|||
160521577|NCT00585195|579638957|FG010|Overall Study|Lost to Follow-up|0|||
160521578|NCT00585195|579638958|FG011|Overall Study|Lost to Follow-up|0|||
160521579|NCT00585195|579638959|FG012|Overall Study|Lost to Follow-up|1|||
160749078|NCT02087943|580467927|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
160521580|NCT00585195|579638960|FG013|Overall Study|Lost to Follow-up|0|||
160749079|NCT02087943|580467928|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
160521581|NCT00585195|579638961|FG014|Overall Study|Lost to Follow-up|0|||
160521582|NCT00585195|579638962|FG015|Overall Study|Lost to Follow-up|0|||
160521583|NCT00585195|579638963|FG016|Overall Study|Lost to Follow-up|0|||
160521584|NCT00585195|579638964|FG017|Overall Study|Lost to Follow-up|2|||
160521585|NCT00585195|579638965|FG018|Overall Study|Lost to Follow-up|0|||
160521586|NCT00585195|579638966|FG019|Overall Study|Lost to Follow-up|0|||
160521587|NCT00585195|579638967|FG020|Overall Study|Lost to Follow-up|0|||
160521588|NCT00585195|579638947|FG000|Overall Study|Site Terminated by Sponsor|0|||
160521589|NCT00585195|579638948|FG001|Overall Study|Site Terminated by Sponsor|0|||
160521590|NCT00585195|579638949|FG002|Overall Study|Site Terminated by Sponsor|0|||
160521591|NCT00585195|579638950|FG003|Overall Study|Site Terminated by Sponsor|0|||
160521592|NCT00585195|579638951|FG004|Overall Study|Site Terminated by Sponsor|0|||
160521593|NCT00585195|579638952|FG005|Overall Study|Site Terminated by Sponsor|0|||
160521594|NCT00585195|579638953|FG006|Overall Study|Site Terminated by Sponsor|0|||
160521595|NCT00585195|579638954|FG007|Overall Study|Site Terminated by Sponsor|0|||
160521596|NCT00585195|579638955|FG008|Overall Study|Site Terminated by Sponsor|0|||
160521597|NCT00585195|579638956|FG009|Overall Study|Site Terminated by Sponsor|0|||
160521598|NCT00585195|579638957|FG010|Overall Study|Site Terminated by Sponsor|0|||
160521599|NCT00585195|579638958|FG011|Overall Study|Site Terminated by Sponsor|0|||
160521600|NCT00585195|579638959|FG012|Overall Study|Site Terminated by Sponsor|1|||
160521601|NCT00585195|579638960|FG013|Overall Study|Site Terminated by Sponsor|0|||
160521602|NCT00585195|579638961|FG014|Overall Study|Site Terminated by Sponsor|0|||
160521603|NCT00585195|579638962|FG015|Overall Study|Site Terminated by Sponsor|0|||
160521604|NCT00585195|579638963|FG016|Overall Study|Site Terminated by Sponsor|0|||
160521605|NCT00585195|579638964|FG017|Overall Study|Site Terminated by Sponsor|0|||
160521606|NCT00585195|579638965|FG018|Overall Study|Site Terminated by Sponsor|0|||
160521607|NCT00585195|579638966|FG019|Overall Study|Site Terminated by Sponsor|0|||
160521608|NCT00585195|579638967|FG020|Overall Study|Site Terminated by Sponsor|0|||
160749080|NCT02087943|580467929|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
160749081|NCT02087943|580467925|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
160749082|NCT02087943|580467926|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
160749083|NCT02087943|580467927|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
160749084|NCT02087943|580467928|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
160749085|NCT02087943|580467929|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
160749086|NCT02087943|580467925|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
160749087|NCT02087943|580467926|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
160749088|NCT02087943|580467927|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
160749089|NCT02087943|580467928|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
160749090|NCT02087943|580467929|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
160749091|NCT02087943|580467925|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
160749092|NCT02087943|580467926|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
160749093|NCT02087943|580467927|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
160749094|NCT02087943|580467928|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
160749095|NCT02087943|580467929|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
160749096|NCT01690299|580467930|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
160749097|NCT01690299|580467931|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
160749098|NCT01690299|580467932|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
160749099|NCT01690299|580467933|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
160749100|NCT01690299|580467934|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
160749101|NCT01690299|580467935|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
160749102|NCT01690299|580467930|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
160749103|NCT01690299|580467931|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160749104|NCT01690299|580467932|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160749105|NCT01690299|580467933|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160749106|NCT01690299|580467934|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160749107|NCT01690299|580467935|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160749108|NCT01690299|580467930|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
160749109|NCT01690299|580467931|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
160749110|NCT01690299|580467932|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160749111|NCT01690299|580467933|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160749112|NCT01690299|580467934|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160749113|NCT01690299|580467935|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160749114|NCT01690299|580467930|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
160749115|NCT01690299|580467931|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
160749116|NCT01690299|580467932|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
160749117|NCT01690299|580467933|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
160749118|NCT01690299|580467934|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
160749119|NCT01690299|580467935|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
160749120|NCT01690299|580467930|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
160749121|NCT01690299|580467931|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
160749122|NCT01690299|580467932|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
160864787|NCT01134055|580898969|FG001|Overall Study|Lost to Follow-up|1|||
160521609|NCT00585195|579638947|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
160521610|NCT00585195|579638948|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
160521611|NCT00585195|579638949|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
160521612|NCT00585195|579638950|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
160521613|NCT00585195|579638951|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
160521614|NCT00585195|579638952|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
160521615|NCT00585195|579638953|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
160521616|NCT00585195|579638954|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
160521617|NCT00585195|579638955|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
160521618|NCT00585195|579638956|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
160521619|NCT00585195|579638957|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
160521620|NCT00585195|579638958|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
160521621|NCT00585195|579638959|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
160521622|NCT00585195|579638960|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
160521623|NCT00585195|579638961|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
160521624|NCT00585195|579638962|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
160521625|NCT00585195|579638963|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
160521626|NCT00585195|579638964|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
160521627|NCT00585195|579638965|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
160521628|NCT00585195|579638966|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
160521629|NCT00585195|579638967|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
160521630|NCT00770341|579638968|FG000|Overall Study|Did not meet eligibility criteria|1|||
160521631|NCT00770341|579638969|FG001|Overall Study|Did not meet eligibility criteria|0|||
160521632|NCT00770341|579638970|FG002|Overall Study|Did not meet eligibility criteria|0|||
160521633|NCT00770341|579638968|FG000|Overall Study|Withdrawal by Subject|0|||
160521634|NCT00770341|579638969|FG001|Overall Study|Withdrawal by Subject|1|||
160521635|NCT00770341|579638970|FG002|Overall Study|Withdrawal by Subject|0|||
160521636|NCT00770341|579638968|FG000|Overall Study|Clinical Adverse Event|3|||
160521637|NCT00770341|579638969|FG001|Overall Study|Clinical Adverse Event|1|||
160521638|NCT00770341|579638970|FG002|Overall Study|Clinical Adverse Event|2|||
160521639|NCT00770341|579638968|FG000|Overall Study|Laboratory adverse event|3|||
160521640|NCT00770341|579638969|FG001|Overall Study|Laboratory adverse event|3|||
160521641|NCT00770341|579638970|FG002|Overall Study|Laboratory adverse event|0|||
160521642|NCT00770341|579638968|FG000|Overall Study|Lack of Efficacy|3|||
160521643|NCT00770341|579638969|FG001|Overall Study|Lack of Efficacy|0|||
160521644|NCT00770341|579638970|FG002|Overall Study|Lack of Efficacy|1|||
160521645|NCT00770341|579638968|FG000|Overall Study|Other|1|||
160521646|NCT00770341|579638969|FG001|Overall Study|Other|0|||
160521647|NCT00770341|579638970|FG002|Overall Study|Other|0|||
160521648|NCT00770341|579638968|FG000|Overall Study|Not treated|1|||
160521649|NCT00770341|579638969|FG001|Overall Study|Not treated|0|||
160521650|NCT00770341|579638970|FG002|Overall Study|Not treated|0|||
160521651|NCT02796560|579638976|FG000|Overall Study|Adverse Event|2|||
160521652|NCT02796560|579638977|FG001|Overall Study|Adverse Event|0|||
160521653|NCT02796560|579638976|FG000|Overall Study|Withdrawal by Subject|2|||
160521654|NCT02796560|579638977|FG001|Overall Study|Withdrawal by Subject|2|||
160521655|NCT02739360|579638978|FG000|Overall Study|Adverse Event|1|||
160521656|NCT02739360|579638978|FG000|Overall Study|Study terminated by Sponsor|2|||
160521657|NCT02533570|579638979|FG000|Overall Study|Adverse Event|0|||
160521658|NCT02533570|579638980|FG001|Overall Study|Adverse Event|1|||
160749123|NCT01690299|580467933|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
160749124|NCT01690299|580467934|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
160749125|NCT01690299|580467935|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
160521659|NCT02533570|579638981|FG002|Overall Study|Adverse Event|1|||
160521660|NCT01163916|579638983|FG000|Overall Study|Withdrawal by Subject|2|||
160521661|NCT01163916|579638984|FG001|Overall Study|Withdrawal by Subject|0|||
160749126|NCT01690299|580467930|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
160749127|NCT01690299|580467931|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
160749128|NCT01690299|580467932|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
160749129|NCT01690299|580467933|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
160749130|NCT01690299|580467934|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
160749131|NCT01690299|580467935|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
160749132|NCT01690299|580467930|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
160749133|NCT01690299|580467931|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
160749134|NCT01690299|580467932|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
160749135|NCT01690299|580467933|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
160749136|NCT01690299|580467934|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
160749137|NCT01690299|580467935|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
160749138|NCT01690299|580467930|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
160749139|NCT01690299|580467931|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
160749140|NCT01690299|580467932|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
160749141|NCT01690299|580467933|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
160749142|NCT01690299|580467934|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
160749143|NCT01690299|580467935|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
160749144|NCT01690299|580467930|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
160749145|NCT01690299|580467931|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
160749146|NCT01690299|580467932|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
160749147|NCT01690299|580467933|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
160749148|NCT01690299|580467934|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
160749149|NCT01690299|580467935|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
160749150|NCT01690299|580467930|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
160749151|NCT01690299|580467931|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
160749152|NCT01690299|580467932|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
160749153|NCT01690299|580467933|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
160749154|NCT01690299|580467934|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
160749155|NCT01690299|580467935|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
160749156|NCT04318132|580467940|FG000|Overall Study|Protocol Violation|0|||
160749157|NCT04318132|580467941|FG001|Overall Study|Protocol Violation|0|||
160749158|NCT04318132|580467942|FG002|Overall Study|Protocol Violation|3|||
160749159|NCT04318132|580467943|FG003|Overall Study|Protocol Violation|0|||
160749160|NCT00621517|580467944|FG000|Overall Study|Lost to Follow-up|3|||
160749161|NCT00621517|580467945|FG001|Overall Study|Lost to Follow-up|3|||
160749162|NCT00621517|580467944|FG000|Overall Study|Withdrawal by Subject|3|||
160749163|NCT00621517|580467945|FG001|Overall Study|Withdrawal by Subject|4|||
160749164|NCT00621517|580467944|FG000|Overall Study|Adverse Event|1|||
160749165|NCT00621517|580467945|FG001|Overall Study|Adverse Event|0|||
160749166|NCT00073008|580467946|FG000|Overall Study|Missing|6|||
160749167|NCT00073008|580467947|FG001|Overall Study|Missing|6|||
160749168|NCT00073008|580467946|FG000|Overall Study|Withdrawal by Subject|2|||
160749169|NCT00073008|580467947|FG001|Overall Study|Withdrawal by Subject|2|||
160749170|NCT00073008|580467946|FG000|Overall Study|Lost to Follow-up|1|||
160749171|NCT00073008|580467947|FG001|Overall Study|Lost to Follow-up|3|||
160749172|NCT00073008|580467946|FG000|Overall Study|Death|46|||
160749173|NCT00073008|580467947|FG001|Overall Study|Death|47|||
160749174|NCT00073008|580467946|FG000|Overall Study|"Other selected on Case Report Form"|7|||
160749175|NCT00073008|580467947|FG001|Overall Study|"Other selected on Case Report Form"|5|||
160749176|NCT01778751|580467957|FG000|Overall Study|Lost to Follow-up|1|||
160749177|NCT01778751|580467958|FG001|Overall Study|Lost to Follow-up|0|||
160749178|NCT01778751|580467957|FG000|Overall Study|Withdrawal by Subject|0|||
160749179|NCT01778751|580467958|FG001|Overall Study|Withdrawal by Subject|2|||
160749180|NCT01778751|580467957|FG000|Overall Study|Transfered care|1|||
160749181|NCT01778751|580467958|FG001|Overall Study|Transfered care|0|||
160749182|NCT03337048|580467959|FG000|Overall Study|Withdrawal by Subject|2|||
160749183|NCT03337048|580467960|FG001|Overall Study|Withdrawal by Subject|0|||
160749184|NCT03337048|580467961|FG002|Overall Study|Withdrawal by Subject|0|||
160749185|NCT02669667|580467962|FG000|Overall Study|Lost to Follow-up|0|||
160749186|NCT02669667|580467963|FG001|Overall Study|Lost to Follow-up|0|||
160749187|NCT02669667|580467964|FG002|Overall Study|Lost to Follow-up|0|||
160749188|NCT02669667|580467965|FG003|Overall Study|Lost to Follow-up|0|||
160749189|NCT02669667|580467966|FG004|Overall Study|Lost to Follow-up|0|||
160749190|NCT02669667|580467967|FG005|Overall Study|Lost to Follow-up|1|||
160749191|NCT02669667|580467968|FG006|Overall Study|Lost to Follow-up|0|||
160749192|NCT00636961|580467984|FG000|Period 1|Administrative problems|1|||
160749193|NCT00636961|580467985|FG001|Period 1|Administrative problems|1|||
160749194|NCT00636961|580467984|FG000|Period 2|Adverse Event|1|||
160749195|NCT00636961|580467985|FG001|Period 2|Adverse Event|0|||
160749196|NCT01428115|580467987|FG000|Overall Study|Lack of Efficacy|3|||
160749197|NCT01428115|580467987|FG000|Overall Study|Lost to Follow-up|10|||
160749198|NCT01428115|580467987|FG000|Overall Study|Pregnancy|1|||
160749199|NCT01428115|580467987|FG000|Overall Study|Protocol Violation|3|||
160749200|NCT01428115|580467987|FG000|Overall Study|Withdrawal by Subject|4|||
160749201|NCT00856843|580467988|FG000|Overall Study|Withdrawal by Subject|1|||
160749202|NCT00856843|580467989|FG001|Overall Study|Withdrawal by Subject|5|||
160749203|NCT00856843|580467988|FG000|Overall Study|Lack of Efficacy|1|||
160749204|NCT00856843|580467989|FG001|Overall Study|Lack of Efficacy|0|||
160749205|NCT03755518|580467990|FG000|Overall Study|Lack of Efficacy|10|||
160749206|NCT03755518|580467990|FG000|Overall Study|Adverse Event|7|||
160749207|NCT03755518|580467990|FG000|Overall Study|Study Terminated by Sponsor|5|||
160749208|NCT03755518|580467990|FG000|Overall Study|Death|1|||
160521662|NCT01163916|579638985|FG002|Overall Study|Withdrawal by Subject|2|||
160521663|NCT01163916|579638983|FG000|Overall Study|Adverse Event|2|||
160521664|NCT01163916|579638984|FG001|Overall Study|Adverse Event|0|||
160521665|NCT01163916|579638985|FG002|Overall Study|Adverse Event|1|||
160521666|NCT01163916|579638983|FG000|Overall Study|Lack of Efficacy|2|||
160521667|NCT01163916|579638984|FG001|Overall Study|Lack of Efficacy|0|||
160749209|NCT03755518|580467990|FG000|Overall Study|Withdrawal by Subject|3|||
160749210|NCT03755518|580467990|FG000|Overall Study|Progressive Disease|4|||
160749211|NCT03755518|580467990|FG000|Overall Study|Bone Marrow Transplant|4|||
160749212|NCT03755518|580467990|FG000|Overall Study|Physicians Decision|1|||
160749213|NCT03755518|580467990|FG000|Overall Study|Relapse|1|||
160749214|NCT03755518|580467990|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
160521668|NCT01163916|579638985|FG002|Overall Study|Lack of Efficacy|1|||
160521669|NCT01163916|579638983|FG000|Overall Study|Other|24|||
160521670|NCT01163916|579638984|FG001|Overall Study|Other|4|||
160521671|NCT01163916|579638985|FG002|Overall Study|Other|16|||
160521672|NCT00529958|579638987|FG000|2-Year Follow-up|Lost to Follow-up|1|||
160521673|NCT00529958|579638988|FG001|2-Year Follow-up|Lost to Follow-up|2|||
160521674|NCT00529958|579638989|FG002|2-Year Follow-up|Lost to Follow-up|2|||
160521675|NCT00529958|579638987|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
160521676|NCT00529958|579638988|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
160521677|NCT00529958|579638989|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
160521678|NCT00529958|579638987|FG000|5-Year Follow-up|Lost to Follow-up|2|||
160749215|NCT03755518|580467990|FG000|Overall Study|Withdrawal by PI|1|||
160749216|NCT03172364|580467991|FG000|Overall Study|Adverse Event|1|||
160749217|NCT03172364|580467992|FG001|Overall Study|Adverse Event|1|||
160749218|NCT03172364|580467991|FG000|Overall Study|Protocol Violation|1|||
160749219|NCT03172364|580467992|FG001|Overall Study|Protocol Violation|0|||
160749220|NCT01714609|580467993|FG000|Overall Study|Protocol Violation|1|||
160749221|NCT01714609|580467994|FG001|Overall Study|Protocol Violation|0|||
160749222|NCT00583102|580467995|FG000|Overall Study|Adverse Event|3|||
160749223|NCT03403621|580467996|FG000|Overall Study|Withdrawal by Subject|2|||
160749224|NCT03403621|580467997|FG001|Overall Study|Withdrawal by Subject|2|||
160749225|NCT00395642|580467998|FG000|Overall Study|Death|4|||
160749226|NCT00395642|580467998|FG000|Overall Study|Lost to Follow-up|1|||
160749227|NCT00395642|580467998|FG000|Overall Study|Physician Decision|7|||
160749228|NCT00395642|580467998|FG000|Overall Study|Withdrawal by Subject|1|||
160749229|NCT00628927|580468009|FG000|Overall Study|Problems performing blood draw|6|||
160749230|NCT00628927|580468010|FG001|Overall Study|Problems performing blood draw|0|||
160749231|NCT00628927|580468009|FG000|Overall Study|Lost to Follow-up|1|||
160749232|NCT00628927|580468010|FG001|Overall Study|Lost to Follow-up|0|||
160749233|NCT00628927|580468009|FG000|Overall Study|Equipment failure|1|||
160749234|NCT00628927|580468010|FG001|Overall Study|Equipment failure|0|||
160749235|NCT02483572|580468011|FG000|Overall Study|Withdrawal by Subject|1|||
160749236|NCT02483572|580468012|FG001|Overall Study|Withdrawal by Subject|0|||
160749237|NCT02483572|580468011|FG000|Overall Study|Lost to Follow-up|1|||
160749238|NCT02483572|580468012|FG001|Overall Study|Lost to Follow-up|0|||
160749239|NCT02483572|580468011|FG000|Overall Study|Physician Decision|0|||
160749240|NCT02483572|580468012|FG001|Overall Study|Physician Decision|1|||
160749241|NCT01298141|580468016|FG000|Overall Study|Adverse Event|3|||
160749242|NCT01298141|580468016|FG000|Overall Study|Refusal of Required Study Procedures|1|||
160521679|NCT00529958|579638988|FG001|5-Year Follow-up|Lost to Follow-up|3|||
160521680|NCT00529958|579638989|FG002|5-Year Follow-up|Lost to Follow-up|1|||
160521681|NCT00529958|579638987|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
160521682|NCT00529958|579638988|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
160521683|NCT00529958|579638989|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
160521684|NCT03816332|579638990|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
160521685|NCT03816332|579638990|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
160521686|NCT05330312|579638991|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
160749243|NCT01298141|580468016|FG000|Overall Study|Withdrawal by Subject|6|||
160749244|NCT01298141|580468016|FG000|Overall Study|Termination of Study by the Investigator|5|||
160749245|NCT01298141|580468016|FG000|Overall Study|Other|5|||
160749246|NCT01298141|580468016|FG000|Overall Study|Lost to Follow-up|1|||
160749247|NCT01298141|580468016|FG000|Overall Study|Death|6|||
160749248|NCT01298141|580468016|FG000|Overall Study|Not treated|4|||
160749249|NCT00528372|580468017|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
160749250|NCT00528372|580468018|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
160749251|NCT00528372|580468019|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
160749252|NCT00528372|580468020|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
160749253|NCT00528372|580468021|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
160749254|NCT00528372|580468022|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
160749255|NCT00528372|580468023|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
160749256|NCT00528372|580468024|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
160749257|NCT00528372|580468025|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
160749258|NCT00528372|580468017|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
160749259|NCT00528372|580468018|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
160749260|NCT00528372|580468019|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
160749261|NCT00528372|580468020|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
160749262|NCT00528372|580468021|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
160749263|NCT00528372|580468022|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
160749264|NCT00528372|580468023|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
160749265|NCT00528372|580468024|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
160749266|NCT00528372|580468025|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
160749267|NCT00528372|580468017|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
160749268|NCT00528372|580468018|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
160749269|NCT00528372|580468019|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
160749270|NCT00528372|580468020|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
160749271|NCT00528372|580468021|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
160749272|NCT00528372|580468022|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
160749273|NCT00528372|580468023|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
160749274|NCT00528372|580468024|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
160749275|NCT00528372|580468025|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
160749276|NCT00528372|580468017|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
160749277|NCT00528372|580468018|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
160749278|NCT00528372|580468019|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
160749279|NCT00528372|580468020|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
160749280|NCT00528372|580468021|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
160749281|NCT00528372|580468022|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
160749282|NCT00528372|580468023|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
160749283|NCT00528372|580468024|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
160749284|NCT00528372|580468025|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
160749285|NCT00528372|580468017|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
160749286|NCT00528372|580468018|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
160749287|NCT00528372|580468019|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
160749288|NCT00528372|580468020|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
160749289|NCT00528372|580468021|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
160749290|NCT00528372|580468022|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
160749291|NCT00528372|580468023|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
160749292|NCT00528372|580468024|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
160749293|NCT00528372|580468025|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
160749294|NCT00528372|580468017|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
160749295|NCT00528372|580468018|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
160749296|NCT00528372|580468019|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
160749297|NCT00528372|580468020|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
160749298|NCT00528372|580468021|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
160749299|NCT00528372|580468022|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
160749300|NCT00528372|580468023|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
160749301|NCT00528372|580468024|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
160749302|NCT00528372|580468025|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
160749303|NCT00528372|580468017|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
160749304|NCT00528372|580468018|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
160749305|NCT00528372|580468019|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
160749306|NCT00528372|580468020|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
160749307|NCT00528372|580468021|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
160749308|NCT00528372|580468022|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
160749309|NCT00528372|580468023|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
160749310|NCT00528372|580468024|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
160749311|NCT00528372|580468025|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
160749312|NCT00528372|580468017|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
160749313|NCT00528372|580468018|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
160749314|NCT00528372|580468019|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
160749315|NCT00528372|580468020|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
160749316|NCT00528372|580468021|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
160749317|NCT00528372|580468022|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
160749318|NCT00528372|580468023|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
160749319|NCT00528372|580468024|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
160749320|NCT00528372|580468025|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
160749321|NCT00528372|580468017|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
160749322|NCT00528372|580468018|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
160749323|NCT00528372|580468019|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
160749324|NCT00528372|580468020|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
160749325|NCT00528372|580468021|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
160749326|NCT00528372|580468022|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
160749327|NCT00528372|580468023|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
160749328|NCT00528372|580468024|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
160749329|NCT00528372|580468025|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
160749330|NCT00528372|580468017|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
160749331|NCT00528372|580468018|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
160749332|NCT00528372|580468019|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
160749333|NCT00528372|580468020|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
160749334|NCT00528372|580468021|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
160749335|NCT00528372|580468022|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
160749336|NCT00528372|580468023|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
160749337|NCT00528372|580468024|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
160749338|NCT00528372|580468025|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
160749339|NCT00528372|580468017|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
160749340|NCT00528372|580468018|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
160749341|NCT00528372|580468019|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
160749342|NCT00528372|580468020|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
160749343|NCT00528372|580468021|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
160749344|NCT00528372|580468022|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
160749345|NCT00528372|580468023|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
160749346|NCT00528372|580468024|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
160749347|NCT00528372|580468025|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
160749348|NCT00528372|580468017|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
160749349|NCT00528372|580468018|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
160749350|NCT00528372|580468019|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
160749351|NCT00528372|580468020|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
160749352|NCT00528372|580468021|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
160749353|NCT00528372|580468022|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
160749354|NCT00528372|580468023|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
160749355|NCT00528372|580468024|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
160749356|NCT00528372|580468025|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
160749357|NCT00528372|580468017|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
160749358|NCT00528372|580468018|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
160749359|NCT00528372|580468019|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
160749360|NCT00528372|580468020|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
160749361|NCT00528372|580468021|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
160749362|NCT00528372|580468022|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
160749363|NCT00528372|580468023|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
160749364|NCT00528372|580468024|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
160749365|NCT00528372|580468025|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
160749366|NCT00528372|580468017|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
160749367|NCT00528372|580468018|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
160749368|NCT00528372|580468019|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
160749369|NCT00528372|580468020|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
160749370|NCT00528372|580468021|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
160861850|NCT02531802|580887846|FG001|Received Vaccination 2|Adverse Event|0|||
160749371|NCT00528372|580468022|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
160749372|NCT00528372|580468023|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
160749373|NCT00528372|580468024|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
160749374|NCT00528372|580468025|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
160749375|NCT00528372|580468017|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
160749376|NCT00528372|580468018|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
160749377|NCT00528372|580468019|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
160749378|NCT00528372|580468020|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
160749379|NCT00528372|580468021|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
160749380|NCT00528372|580468022|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
160749381|NCT00528372|580468023|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
160749382|NCT00528372|580468024|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
160749383|NCT00528372|580468025|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
160749384|NCT01289574|580468026|FG000|Overall Study|Lack of Efficacy|4|||
160749385|NCT01289574|580468027|FG001|Overall Study|Lack of Efficacy|0|||
160749386|NCT01289574|580468028|FG002|Overall Study|Lack of Efficacy|1|||
160749387|NCT01289574|580468026|FG000|Overall Study|Lost to Follow-up|2|||
160749388|NCT01289574|580468027|FG001|Overall Study|Lost to Follow-up|0|||
160749389|NCT01289574|580468028|FG002|Overall Study|Lost to Follow-up|1|||
160749390|NCT01289574|580468026|FG000|Overall Study|Withdrawal by Subject|1|||
160749391|NCT01289574|580468027|FG001|Overall Study|Withdrawal by Subject|1|||
160749392|NCT01289574|580468028|FG002|Overall Study|Withdrawal by Subject|1|||
160749393|NCT01289574|580468026|FG000|Overall Study|Adverse Event|0|||
160749394|NCT01289574|580468027|FG001|Overall Study|Adverse Event|1|||
160749395|NCT01289574|580468028|FG002|Overall Study|Adverse Event|0|||
160749396|NCT01289574|580468026|FG000|Overall Study|Subject wanted alternate treatment|0|||
160749397|NCT01289574|580468027|FG001|Overall Study|Subject wanted alternate treatment|1|||
160749398|NCT01289574|580468028|FG002|Overall Study|Subject wanted alternate treatment|0|||
160749399|NCT02432144|580468029|FG000|Overall Study|Participant Non-Compliance|1|||
160749400|NCT00262002|580468030|FG000|Overall Study|Adverse Event|2|||
160749401|NCT00262002|580468031|FG001|Overall Study|Adverse Event|1|||
160749402|NCT00262002|580468032|FG002|Overall Study|Adverse Event|0|||
160749403|NCT00262002|580468033|FG003|Overall Study|Adverse Event|0|||
160749404|NCT00262002|580468034|FG004|Overall Study|Adverse Event|0|||
160749405|NCT00262002|580468035|FG005|Overall Study|Adverse Event|1|||
160749406|NCT00262002|580468036|FG006|Overall Study|Adverse Event|0|||
160749407|NCT00262002|580468030|FG000|Overall Study|Withdrawal by Subject|4|||
160749408|NCT00262002|580468031|FG001|Overall Study|Withdrawal by Subject|2|||
160749409|NCT00262002|580468032|FG002|Overall Study|Withdrawal by Subject|0|||
160749410|NCT00262002|580468033|FG003|Overall Study|Withdrawal by Subject|1|||
160749411|NCT00262002|580468034|FG004|Overall Study|Withdrawal by Subject|2|||
160749412|NCT00262002|580468035|FG005|Overall Study|Withdrawal by Subject|2|||
160749413|NCT00262002|580468036|FG006|Overall Study|Withdrawal by Subject|2|||
160749414|NCT00262002|580468030|FG000|Overall Study|Lost to Follow-up|2|||
160749415|NCT00262002|580468031|FG001|Overall Study|Lost to Follow-up|0|||
160749416|NCT00262002|580468032|FG002|Overall Study|Lost to Follow-up|0|||
160749417|NCT00262002|580468033|FG003|Overall Study|Lost to Follow-up|2|||
160749418|NCT00262002|580468034|FG004|Overall Study|Lost to Follow-up|0|||
160749419|NCT00262002|580468035|FG005|Overall Study|Lost to Follow-up|1|||
160749420|NCT00262002|580468036|FG006|Overall Study|Lost to Follow-up|0|||
160749421|NCT00262002|580468030|FG000|Overall Study|Inapropriate enrollment|0|||
160749422|NCT00262002|580468031|FG001|Overall Study|Inapropriate enrollment|1|||
160749423|NCT00262002|580468032|FG002|Overall Study|Inapropriate enrollment|0|||
160749424|NCT00262002|580468033|FG003|Overall Study|Inapropriate enrollment|0|||
160749425|NCT00262002|580468034|FG004|Overall Study|Inapropriate enrollment|0|||
160749426|NCT00262002|580468035|FG005|Overall Study|Inapropriate enrollment|0|||
160749427|NCT00262002|580468036|FG006|Overall Study|Inapropriate enrollment|0|||
160749428|NCT00262002|580468030|FG000|Overall Study|Protocol Violation|3|||
160749429|NCT00262002|580468031|FG001|Overall Study|Protocol Violation|2|||
160749430|NCT00262002|580468032|FG002|Overall Study|Protocol Violation|0|||
160749431|NCT00262002|580468033|FG003|Overall Study|Protocol Violation|2|||
160749432|NCT00262002|580468034|FG004|Overall Study|Protocol Violation|5|||
160749433|NCT00262002|580468035|FG005|Overall Study|Protocol Violation|3|||
160749434|NCT00262002|580468036|FG006|Overall Study|Protocol Violation|2|||
160749435|NCT00262002|580468030|FG000|Overall Study|Unable to classify|0|||
160749436|NCT00262002|580468031|FG001|Overall Study|Unable to classify|0|||
160749437|NCT00262002|580468032|FG002|Overall Study|Unable to classify|0|||
160749438|NCT00262002|580468033|FG003|Overall Study|Unable to classify|0|||
160749439|NCT00262002|580468034|FG004|Overall Study|Unable to classify|0|||
160749440|NCT00262002|580468035|FG005|Overall Study|Unable to classify|0|||
160749441|NCT00262002|580468036|FG006|Overall Study|Unable to classify|2|||
160749442|NCT01451554|580468037|FG000|Overall Study|Withdrawal by Subject|14|||
160749443|NCT01451554|580468038|FG001|Overall Study|Withdrawal by Subject|9|||
160749444|NCT02749799|580468039|FG000|Overall Study|Adverse Event|2|||
160749445|NCT02749799|580468039|FG000|Overall Study|Lost to Follow-up|4|||
160749446|NCT02749799|580468039|FG000|Overall Study|Protocol Violation|1|||
160749447|NCT02749799|580468039|FG000|Overall Study|Withdrawal by Subject|1|||
160749448|NCT02070978|580468040|FG000|Overall Study|Adverse Event|6|||
160749449|NCT02070978|580468041|FG001|Overall Study|Adverse Event|2|||
160749450|NCT02070978|580468042|FG002|Overall Study|Adverse Event|0|||
160749451|NCT02070978|580468040|FG000|Overall Study|Lost to Follow-up|1|||
160749452|NCT02070978|580468041|FG001|Overall Study|Lost to Follow-up|3|||
160749453|NCT02070978|580468042|FG002|Overall Study|Lost to Follow-up|4|||
160749454|NCT02070978|580468040|FG000|Overall Study|Withdrawal by Subject|3|||
160749455|NCT02070978|580468041|FG001|Overall Study|Withdrawal by Subject|5|||
160749456|NCT02070978|580468042|FG002|Overall Study|Withdrawal by Subject|3|||
160749457|NCT02070978|580468040|FG000|Overall Study|Protocol Violation|1|||
160749458|NCT02070978|580468041|FG001|Overall Study|Protocol Violation|0|||
160749459|NCT02070978|580468042|FG002|Overall Study|Protocol Violation|3|||
160749460|NCT02070978|580468040|FG000|Overall Study|Lack of Efficacy|0|||
160749461|NCT02070978|580468041|FG001|Overall Study|Lack of Efficacy|1|||
160749462|NCT02070978|580468042|FG002|Overall Study|Lack of Efficacy|0|||
160749463|NCT02070978|580468040|FG000|Overall Study|Death|0|||
160749464|NCT02070978|580468041|FG001|Overall Study|Death|0|||
160749465|NCT02070978|580468042|FG002|Overall Study|Death|2|||
160749466|NCT02070978|580468040|FG000|Overall Study|Un-specified|3|||
160749467|NCT02070978|580468041|FG001|Overall Study|Un-specified|2|||
160749468|NCT02070978|580468042|FG002|Overall Study|Un-specified|2|||
160749469|NCT02070978|580468040|FG000|Overall Study|Terminated by Sponsor|33|||
160749470|NCT02070978|580468041|FG001|Overall Study|Terminated by Sponsor|40|||
160749471|NCT02070978|580468042|FG002|Overall Study|Terminated by Sponsor|39|||
160749472|NCT03951753|580468043|FG000|Overall Study|Adverse Event|1|||
160749473|NCT03951753|580468044|FG001|Overall Study|Adverse Event|0|||
160749474|NCT03951753|580468045|FG002|Overall Study|Adverse Event|3|||
160749475|NCT03951753|580468043|FG000|Overall Study|Withdrawal by Subject|3|||
160749476|NCT03951753|580468044|FG001|Overall Study|Withdrawal by Subject|1|||
160749477|NCT03951753|580468045|FG002|Overall Study|Withdrawal by Subject|0|||
160749478|NCT03951753|580468043|FG000|Overall Study|Lost to Follow-up|0|||
160749479|NCT03951753|580468044|FG001|Overall Study|Lost to Follow-up|0|||
160749480|NCT03951753|580468045|FG002|Overall Study|Lost to Follow-up|1|||
160749481|NCT01905592|580468048|FG000|Overall Study|Disease Progression|51|||
160749482|NCT01905592|580468049|FG001|Overall Study|Disease Progression|110|||
160749483|NCT01905592|580468048|FG000|Overall Study|Toxicity|1|||
160749484|NCT01905592|580468049|FG001|Overall Study|Toxicity|16|||
160749485|NCT01905592|580468048|FG000|Overall Study|Physician Decision|0|||
160749486|NCT01905592|580468049|FG001|Overall Study|Physician Decision|2|||
160749487|NCT01905592|580468048|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
160749488|NCT01905592|580468049|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
160749489|NCT01905592|580468048|FG000|Overall Study|Protocol Violation|0|||
160749490|NCT01905592|580468049|FG001|Overall Study|Protocol Violation|1|||
160749491|NCT01905592|580468048|FG000|Overall Study|Sponsor's decision|1|||
160749492|NCT01905592|580468049|FG001|Overall Study|Sponsor's decision|1|||
160749493|NCT01905592|580468048|FG000|Overall Study|Not treated|7|||
160749494|NCT01905592|580468049|FG001|Overall Study|Not treated|3|||
160749495|NCT01905592|580468048|FG000|Overall Study|Withdrawal by Subject|10|||
160749496|NCT01905592|580468049|FG001|Overall Study|Withdrawal by Subject|2|||
160749497|NCT02669043|580468050|FG000|Overall Study|Didn't meet I/E criteria|4|||
160749498|NCT01483599|580468051|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
160749499|NCT01483599|580468052|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
160749500|NCT01483599|580468053|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
160749501|NCT01483599|580468054|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
160749502|NCT01483599|580468055|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
160749503|NCT01483599|580468056|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
160749504|NCT01483599|580468057|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
160749505|NCT01483599|580468058|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
160749506|NCT01483599|580468059|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
160749507|NCT01483599|580468060|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
160749508|NCT01483599|580468061|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
160749509|NCT01483599|580468062|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
160749510|NCT01483599|580468063|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
160521687|NCT05330312|579638992|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
160749511|NCT01483599|580468064|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
160749512|NCT01483599|580468051|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160749513|NCT01483599|580468052|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
160749514|NCT01483599|580468053|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160749515|NCT01483599|580468054|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
160749516|NCT01483599|580468055|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160749517|NCT01483599|580468056|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160864788|NCT01134055|580898970|FG002|Overall Study|Lost to Follow-up|0|||
160749518|NCT01483599|580468057|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
160749519|NCT01483599|580468058|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160749520|NCT01483599|580468059|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160749521|NCT01483599|580468060|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160749522|NCT01483599|580468061|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160749523|NCT01483599|580468062|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160749524|NCT01483599|580468063|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160749525|NCT01483599|580468064|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
160749526|NCT01483599|580468051|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
160749527|NCT01483599|580468052|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749528|NCT01483599|580468053|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749529|NCT01483599|580468054|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749530|NCT01483599|580468055|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749531|NCT01483599|580468056|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749532|NCT01483599|580468057|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749533|NCT01483599|580468058|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749534|NCT01483599|580468059|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749535|NCT01483599|580468060|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749536|NCT01483599|580468061|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749537|NCT01483599|580468062|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749538|NCT01483599|580468063|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749539|NCT01483599|580468064|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
160749540|NCT01483599|580468051|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
160749541|NCT01483599|580468052|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
160749542|NCT01483599|580468053|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
160749543|NCT01483599|580468054|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
160749544|NCT01483599|580468055|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
160749545|NCT01483599|580468056|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
160749546|NCT01483599|580468057|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
160749547|NCT01483599|580468058|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
160749548|NCT01483599|580468059|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
160749549|NCT01483599|580468060|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
160749550|NCT01483599|580468061|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
160749551|NCT01483599|580468062|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
160749552|NCT01483599|580468063|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
160749553|NCT01483599|580468064|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
160749554|NCT01483599|580468051|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
160749555|NCT01483599|580468052|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
160749556|NCT01483599|580468053|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
160749557|NCT01483599|580468054|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
160749558|NCT01483599|580468055|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
160749559|NCT01483599|580468056|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
160749560|NCT01483599|580468057|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
160749561|NCT01483599|580468058|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
160864789|NCT01134055|580898971|FG003|Overall Study|Lost to Follow-up|1|||
160864790|NCT01134055|580898972|FG004|Overall Study|Lost to Follow-up|0|||
160864791|NCT01134055|580898973|FG005|Overall Study|Lost to Follow-up|0|||
160864792|NCT01134055|580898974|FG006|Overall Study|Lost to Follow-up|0|||
160864793|NCT01134055|580898968|FG000|Overall Study|Withdrawal by Subject|3|||
160864794|NCT01134055|580898969|FG001|Overall Study|Withdrawal by Subject|3|||
160864795|NCT01134055|580898970|FG002|Overall Study|Withdrawal by Subject|1|||
160864796|NCT01134055|580898971|FG003|Overall Study|Withdrawal by Subject|2|||
160864797|NCT01134055|580898972|FG004|Overall Study|Withdrawal by Subject|0|||
160864798|NCT01134055|580898973|FG005|Overall Study|Withdrawal by Subject|0|||
160864799|NCT01134055|580898974|FG006|Overall Study|Withdrawal by Subject|8|||
160864800|NCT01134055|580898968|FG000|Overall Study|Protocol Violation|0|||
160864801|NCT01134055|580898969|FG001|Overall Study|Protocol Violation|0|||
160864802|NCT01134055|580898970|FG002|Overall Study|Protocol Violation|0|||
160864803|NCT01134055|580898971|FG003|Overall Study|Protocol Violation|1|||
160864804|NCT01134055|580898972|FG004|Overall Study|Protocol Violation|1|||
160864805|NCT01134055|580898973|FG005|Overall Study|Protocol Violation|0|||
160864806|NCT01134055|580898974|FG006|Overall Study|Protocol Violation|0|||
160864807|NCT01134055|580898968|FG000|Overall Study|Physician Decision|0|||
160521688|NCT05330312|579638993|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
160749562|NCT01483599|580468059|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
160749563|NCT01483599|580468060|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
160749564|NCT01483599|580468061|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
160749565|NCT01483599|580468062|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
160749566|NCT01483599|580468063|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
160864808|NCT01134055|580898969|FG001|Overall Study|Physician Decision|0|||
160864809|NCT01134055|580898970|FG002|Overall Study|Physician Decision|0|||
160864810|NCT01134055|580898971|FG003|Overall Study|Physician Decision|0|||
160864811|NCT01134055|580898972|FG004|Overall Study|Physician Decision|0|||
160521689|NCT05330312|579638991|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
160521690|NCT05330312|579638992|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
160521691|NCT05330312|579638993|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
160521692|NCT05330312|579638991|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
160521693|NCT05330312|579638992|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
160521694|NCT05330312|579638993|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
160521695|NCT05330312|579638991|FG000|Pivotal Investigation - Part 2|Death|1|||
160521696|NCT05330312|579638992|FG001|Pivotal Investigation - Part 2|Death|4|||
160521697|NCT05330312|579638993|FG002|Pivotal Investigation - Part 2|Death|0|||
160521698|NCT03534284|579638994|FG000|Overall Study|Death|2|||
160521699|NCT03534284|579638995|FG001|Overall Study|Death|3|||
160521700|NCT03534284|579638996|FG002|Overall Study|Death|3|||
160521701|NCT03534284|579638994|FG000|Overall Study|Withdrawal by Subject|5|||
160521702|NCT03534284|579638995|FG001|Overall Study|Withdrawal by Subject|0|||
160521703|NCT03534284|579638996|FG002|Overall Study|Withdrawal by Subject|0|||
160521704|NCT03316300|579638997|FG000|Overall Study|Withdrawal by Subject|3|||
160521705|NCT03316300|579638998|FG001|Overall Study|Withdrawal by Subject|2|||
160521706|NCT03316300|579638997|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
160521707|NCT03316300|579638998|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
160521708|NCT03316300|579638997|FG000|Overall Study|Adverse Event|1|||
160521709|NCT03316300|579638998|FG001|Overall Study|Adverse Event|0|||
160521710|NCT03316300|579638997|FG000|Overall Study|COVID-19|0|||
160521711|NCT03316300|579638998|FG001|Overall Study|COVID-19|1|||
160521712|NCT00423930|579638999|FG000|Overall Study|Withdrawal by Subject|2|||
160521713|NCT04002401|579639000|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
160521714|NCT04002401|579639000|FG000|Overall Study|Death|10|||
160521715|NCT04002401|579639000|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
160521716|NCT04002401|579639000|FG000|Overall Study|Enrolled but Never Treated|1|||
160521717|NCT04002401|579639000|FG000|Overall Study|Lost to Follow-up|1|||
160521718|NCT02337751|579639001|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
160521719|NCT02337751|579639002|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
160521720|NCT02337751|579639001|FG000|Overall Study|Voluntary Withdrawal|6|||
160521721|NCT02337751|579639002|FG001|Overall Study|Voluntary Withdrawal|8|||
160521722|NCT02337751|579639001|FG000|Overall Study|Lack of Efficacy|2|||
160521723|NCT02337751|579639002|FG001|Overall Study|Lack of Efficacy|5|||
160521724|NCT02337751|579639001|FG000|Overall Study|Investigator's Judgement|1|||
160521725|NCT02337751|579639002|FG001|Overall Study|Investigator's Judgement|0|||
160521726|NCT01340651|579639003|FG000|Overall Study|Adverse Event|3|||
160521727|NCT01340651|579639003|FG000|Overall Study|Consent Withdrawn|2|||
160521728|NCT01340651|579639003|FG000|Overall Study|Commercial Supply per Sponsor|12|||
160521729|NCT01315353|579639004|FG000|Overall Study|Death|2|||
160521730|NCT01315353|579639005|FG001|Overall Study|Death|1|||
160521731|NCT01315353|579639006|FG002|Overall Study|Death|0|||
160521732|NCT01315353|579639004|FG000|Overall Study|Withdrawal by Subject|2|||
160521733|NCT01315353|579639005|FG001|Overall Study|Withdrawal by Subject|6|||
160521734|NCT01315353|579639006|FG002|Overall Study|Withdrawal by Subject|1|||
160521735|NCT01315353|579639004|FG000|Overall Study|Lost to Follow-up|13|||
160521736|NCT01315353|579639005|FG001|Overall Study|Lost to Follow-up|6|||
160521737|NCT01315353|579639006|FG002|Overall Study|Lost to Follow-up|6|||
160521738|NCT01315353|579639004|FG000|Overall Study|Unwilling to adhere to requirements|5|||
160521739|NCT01315353|579639005|FG001|Overall Study|Unwilling to adhere to requirements|5|||
160521740|NCT01315353|579639006|FG002|Overall Study|Unwilling to adhere to requirements|4|||
160521741|NCT01315353|579639004|FG000|Overall Study|Site closing|7|||
160521742|NCT01315353|579639005|FG001|Overall Study|Site closing|4|||
160521743|NCT01315353|579639006|FG002|Overall Study|Site closing|0|||
160521744|NCT01315353|579639004|FG000|Overall Study|Taken off study by site in error|0|||
160521745|NCT01315353|579639005|FG001|Overall Study|Taken off study by site in error|1|||
160521746|NCT01315353|579639006|FG002|Overall Study|Taken off study by site in error|0|||
160635522|NCT02494583|580047487|FG002|Overall Study|Screen Failure|0|||
160749567|NCT01483599|580468064|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
160749568|NCT01483599|580468051|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
160749569|NCT01483599|580468052|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
160749570|NCT01483599|580468053|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
160749571|NCT01483599|580468054|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
160749572|NCT01483599|580468055|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
160749573|NCT01483599|580468056|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
160749574|NCT01483599|580468057|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
160749575|NCT01483599|580468058|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
160749576|NCT01483599|580468059|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
160749577|NCT01483599|580468060|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
160749578|NCT01483599|580468061|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
160749579|NCT01483599|580468062|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
160864812|NCT01134055|580898973|FG005|Overall Study|Physician Decision|0|||
160864813|NCT01134055|580898974|FG006|Overall Study|Physician Decision|1|||
160864814|NCT03345784|580898977|FG000|Overall Study|Withdrawal by Subject|2|||
160864815|NCT03345784|580898978|FG001|Overall Study|Withdrawal by Subject|1|||
160864816|NCT04798196|580898980|FG000|Overall Study|Lost to Follow-up|3|||
160864817|NCT04798196|580898981|FG001|Overall Study|Lost to Follow-up|1|||
160864818|NCT04798196|580898982|FG002|Overall Study|Lost to Follow-up|3|||
160864819|NCT00001959|580898990|FG000|Overall Study|newly diagnosed colon cancer|1|||
160864820|NCT00001959|580898990|FG000|Overall Study|disabling sedation|1|||
160864821|NCT00001959|580898990|FG000|Overall Study|non-compliance|1|||
160749580|NCT01483599|580468063|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
160749581|NCT01483599|580468064|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
160749582|NCT01483599|580468051|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160864822|NCT03592186|580898991|FG000|Overall Study|Withdrawal by Subject|1|||
160864823|NCT03592186|580898992|FG001|Overall Study|Withdrawal by Subject|0|||
160864824|NCT03592186|580898991|FG000|Overall Study|Lost to Follow-up|16|||
160864825|NCT03592186|580898992|FG001|Overall Study|Lost to Follow-up|11|||
160864826|NCT03755934|580898993|FG000|Overall Study|Adverse Event|4|||
160864827|NCT03755934|580898994|FG001|Overall Study|Adverse Event|1|||
160864828|NCT03755934|580898995|FG002|Overall Study|Adverse Event|1|||
160864829|NCT03755934|580898996|FG003|Overall Study|Adverse Event|3|||
160864830|NCT03755934|580898993|FG000|Overall Study|Physician Decision|2|||
160864831|NCT03755934|580898994|FG001|Overall Study|Physician Decision|0|||
160864832|NCT03755934|580898995|FG002|Overall Study|Physician Decision|0|||
160864833|NCT03755934|580898996|FG003|Overall Study|Physician Decision|1|||
160864834|NCT03755934|580898993|FG000|Overall Study|Withdrawal by Subject|5|||
160864835|NCT03755934|580898994|FG001|Overall Study|Withdrawal by Subject|0|||
160864836|NCT03755934|580898995|FG002|Overall Study|Withdrawal by Subject|0|||
160864837|NCT03755934|580898996|FG003|Overall Study|Withdrawal by Subject|1|||
160864838|NCT03755934|580898993|FG000|Overall Study|Other|3|||
160864839|NCT03755934|580898994|FG001|Overall Study|Other|1|||
160864840|NCT03755934|580898995|FG002|Overall Study|Other|3|||
160864841|NCT03755934|580898996|FG003|Overall Study|Other|1|||
160864842|NCT01498068|580898997|FG000|Overall Study|Withdrawal by Subject|1|||
160864843|NCT01498068|580898998|FG001|Overall Study|Withdrawal by Subject|1|||
160864844|NCT00361296|580899001|FG000|Overall Study|Physician Decision|1|||
160864845|NCT00361296|580899001|FG000|Overall Study|Lack of Efficacy|2|||
160864846|NCT00904982|580899003|FG000|Overall Study|Withdrawal by Subject|2|||
160864847|NCT00904982|580899004|FG001|Overall Study|Withdrawal by Subject|0|||
160864848|NCT00904982|580899005|FG002|Overall Study|Withdrawal by Subject|0|||
160864849|NCT00904982|580899006|FG003|Overall Study|Withdrawal by Subject|0|||
160864850|NCT01353898|580899009|FG000|Overall Study|Study site terminated|0|||
160864851|NCT01353898|580899010|FG001|Overall Study|Study site terminated|0|||
160864852|NCT01353898|580899011|FG002|Overall Study|Study site terminated|0|||
160864853|NCT01353898|580899012|FG003|Overall Study|Study site terminated|0|||
160864854|NCT01353898|580899013|FG004|Overall Study|Study site terminated|0|||
160864855|NCT01353898|580899014|FG005|Overall Study|Study site terminated|1|||
160864856|NCT02072668|580899015|FG000|Second Intervention|Lost to Follow-up|1|||
160864857|NCT02072668|580899016|FG001|Second Intervention|Lost to Follow-up|0|||
160864858|NCT02668653|580899017|FG000|Overall Study|Refractory disease|41|||
160864859|NCT02668653|580899018|FG001|Overall Study|Refractory disease|70|||
160864860|NCT02668653|580899017|FG000|Overall Study|Relapse|44|||
160864861|NCT02668653|580899018|FG001|Overall Study|Relapse|65|||
160864862|NCT02668653|580899017|FG000|Overall Study|Adverse Event|58|||
160864863|NCT02668653|580899018|FG001|Overall Study|Adverse Event|23|||
160521747|NCT01315353|579639004|FG000|Overall Study|Inadvertent randomization/assignment|0|||
160864864|NCT02668653|580899017|FG000|Overall Study|Subject decision to stop study drug|25|||
160864865|NCT02668653|580899018|FG001|Overall Study|Subject decision to stop study drug|23|||
160864866|NCT02668653|580899017|FG000|Overall Study|Other reasons not specified|16|||
160864867|NCT02668653|580899018|FG001|Overall Study|Other reasons not specified|11|||
160864868|NCT02668653|580899017|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
160864869|NCT02668653|580899018|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
160864870|NCT02668653|580899017|FG000|Overall Study|Investigator decision|10|||
160864871|NCT02668653|580899018|FG001|Overall Study|Investigator decision|7|||
160864872|NCT02668653|580899017|FG000|Overall Study|Failure to meet continuation criteria|5|||
160864873|NCT02668653|580899018|FG001|Overall Study|Failure to meet continuation criteria|12|||
160864874|NCT02668653|580899017|FG000|Overall Study|Lost to Follow-up|1|||
160864875|NCT02668653|580899018|FG001|Overall Study|Lost to Follow-up|0|||
160864876|NCT02668653|580899017|FG000|Overall Study|Pregnancy|0|||
160864877|NCT02668653|580899018|FG001|Overall Study|Pregnancy|1|||
160864878|NCT02668653|580899017|FG000|Overall Study|Death|0|||
160864879|NCT02668653|580899018|FG001|Overall Study|Death|1|||
160864880|NCT01352793|580899024|FG000|Overall Study|Lost to Follow-up|289|||
160864881|NCT01352793|580899025|FG001|Overall Study|Lost to Follow-up|125|||
160864882|NCT01352793|580899024|FG000|Overall Study|Withdrawal by Subject|120|||
160864883|NCT01352793|580899025|FG001|Overall Study|Withdrawal by Subject|55|||
160864884|NCT01352793|580899024|FG000|Overall Study|Protocol Violation|44|||
160864885|NCT01352793|580899025|FG001|Overall Study|Protocol Violation|23|||
160864886|NCT01352793|580899024|FG000|Overall Study|Adverse Event|44|||
160864887|NCT01352793|580899025|FG001|Overall Study|Adverse Event|10|||
160749583|NCT01483599|580468052|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160749584|NCT01483599|580468053|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160749585|NCT01483599|580468054|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160749586|NCT01483599|580468055|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160749587|NCT01483599|580468056|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160749588|NCT01483599|580468057|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160749589|NCT01483599|580468058|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160749590|NCT01483599|580468059|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
160749591|NCT01483599|580468060|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160749592|NCT01483599|580468061|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160749593|NCT01483599|580468062|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
160864888|NCT01352793|580899024|FG000|Overall Study|Physician Decision|1|||
160864889|NCT01352793|580899025|FG001|Overall Study|Physician Decision|0|||
160864890|NCT01352793|580899024|FG000|Overall Study|Pregnancy|26|||
160864891|NCT01352793|580899025|FG001|Overall Study|Pregnancy|8|||
160864892|NCT01352793|580899024|FG000|Overall Study|Other|25|||
160864893|NCT01352793|580899025|FG001|Overall Study|Other|7|||
160864894|NCT01352793|580899024|FG000|Overall Study|Medication error|2|||
160864895|NCT01352793|580899025|FG001|Overall Study|Medication error|2|||
160864896|NCT01352793|580899024|FG000|Overall Study|Death|1|||
160864897|NCT01352793|580899025|FG001|Overall Study|Death|0|||
160749594|NCT01483599|580468063|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
160749595|NCT01483599|580468064|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
160749596|NCT01483599|580468051|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749597|NCT01483599|580468052|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749598|NCT01483599|580468053|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749599|NCT01483599|580468054|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749600|NCT01483599|580468055|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749601|NCT01483599|580468056|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749602|NCT01483599|580468057|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749603|NCT01483599|580468058|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749604|NCT01483599|580468059|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
160749605|NCT01483599|580468060|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749606|NCT01483599|580468061|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
160749607|NCT01483599|580468062|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749608|NCT01483599|580468063|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
160749609|NCT01483599|580468064|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
160749610|NCT01483599|580468051|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160749611|NCT01483599|580468052|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160749612|NCT01483599|580468053|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160864898|NCT01352793|580899024|FG000|Overall Study|Randomized but not vaccinated|8|||
160864899|NCT01352793|580899025|FG001|Overall Study|Randomized but not vaccinated|0|||
160864900|NCT01352793|580899024|FG000|Overall Study|No longer meets eligibility criteria|25|||
160864901|NCT01352793|580899025|FG001|Overall Study|No longer meets eligibility criteria|15|||
160864902|NCT02083354|580901179|FG000|Overall Study|Withdrawal by Subject|9|||
160864903|NCT02083354|580901179|FG000|Overall Study|Lost to Follow-up|1|||
160521748|NCT01315353|579639005|FG001|Overall Study|Inadvertent randomization/assignment|0|||
160864904|NCT02083354|580901179|FG000|Overall Study|Adverse Event|3|||
160864905|NCT02083354|580901179|FG000|Overall Study|Disease progression|46|||
160864906|NCT02083354|580901179|FG000|Overall Study|Study closed/terminated|5|||
160864907|NCT01987453|580901180|FG000|Overall Study|Death|0|||
160864908|NCT01987453|580901181|FG001|Overall Study|Death|0|||
160864909|NCT01987453|580901182|FG002|Overall Study|Death|1|||
160864910|NCT01987453|580901180|FG000|Overall Study|Lack of Efficacy|1|||
160864911|NCT01987453|580901181|FG001|Overall Study|Lack of Efficacy|12|||
160864912|NCT01987453|580901182|FG002|Overall Study|Lack of Efficacy|0|||
160864913|NCT04040933|580901186|FG000|Overall Study|Protocol Violation|1|||
160864914|NCT04040933|580901186|FG000|Overall Study|Withdrawal by Subject|2|||
160864915|NCT02066181|580901187|FG000|Overall Study|Withdrawal by Subject|1|||
160864916|NCT02066181|580901188|FG001|Overall Study|Withdrawal by Subject|1|||
160864917|NCT00775190|580901193|FG000|Overall Study|Lost to Follow-up|2|||
160864918|NCT00775190|580901194|FG001|Overall Study|Lost to Follow-up|3|||
160864919|NCT00775190|580901193|FG000|Overall Study|Withdrawal by Subject|1|||
160864920|NCT00775190|580901194|FG001|Overall Study|Withdrawal by Subject|2|||
160864921|NCT00775190|580901193|FG000|Overall Study|Protocol Violation|1|||
160864922|NCT00775190|580901194|FG001|Overall Study|Protocol Violation|0|||
160864923|NCT02141295|580901195|FG000|Overall Study|Adverse Event|1|||
160864924|NCT02141295|580901196|FG001|Overall Study|Adverse Event|18|||
160864925|NCT02141295|580901197|FG002|Overall Study|Adverse Event|11|||
160864926|NCT02141295|580901195|FG000|Overall Study|Physician Decision|2|||
160864927|NCT02141295|580901196|FG001|Overall Study|Physician Decision|19|||
160864928|NCT02141295|580901197|FG002|Overall Study|Physician Decision|14|||
160864929|NCT02141295|580901195|FG000|Overall Study|Study terminated by sponsor|0|||
160864930|NCT02141295|580901196|FG001|Overall Study|Study terminated by sponsor|6|||
160864931|NCT02141295|580901197|FG002|Overall Study|Study terminated by sponsor|6|||
160864932|NCT02141295|580901195|FG000|Overall Study|Non-compliance|0|||
160864933|NCT02141295|580901196|FG001|Overall Study|Non-compliance|1|||
160864934|NCT02141295|580901197|FG002|Overall Study|Non-compliance|0|||
160864935|NCT02141295|580901195|FG000|Overall Study|Progressive disease|3|||
160864936|NCT02141295|580901196|FG001|Overall Study|Progressive disease|32|||
160864937|NCT02141295|580901197|FG002|Overall Study|Progressive disease|50|||
160864938|NCT02141295|580901195|FG000|Overall Study|Reason not specified|0|||
160864939|NCT02141295|580901196|FG001|Overall Study|Reason not specified|9|||
160864940|NCT02141295|580901197|FG002|Overall Study|Reason not specified|10|||
160864941|NCT02141295|580901195|FG000|Overall Study|Withdrawal by Subject|0|||
160864942|NCT02141295|580901196|FG001|Overall Study|Withdrawal by Subject|9|||
160864943|NCT02141295|580901197|FG002|Overall Study|Withdrawal by Subject|4|||
160864944|NCT01710501|580901198|FG000|Overall Study|Lost to Follow-up|2|||
160864945|NCT01710501|580901199|FG001|Overall Study|Lost to Follow-up|0|||
160864946|NCT01710501|580901200|FG002|Overall Study|Lost to Follow-up|0|||
160864947|NCT02536976|580901201|FG000|Overall Study|Physician Decision|0|||
160864948|NCT02536976|580901202|FG001|Overall Study|Physician Decision|1|||
160864949|NCT01671319|580901205|FG000|Overall Study|Withdrawal by Subject|1|||
160864950|NCT01376804|580901206|FG000|Treatment Period|Withdrawal by Subject|1|||
160864951|NCT01376804|580901206|FG000|Treatment Period|Adverse Event|6|||
160864952|NCT01376804|580901206|FG000|Treatment Period|Patient did not receive study drug|1|||
160864953|NCT02904954|580901211|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
160864954|NCT02904954|580901212|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
160864955|NCT02904954|580901211|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
160864956|NCT02904954|580901212|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
160864957|NCT02904954|580901211|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
160864958|NCT02904954|580901212|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
160864959|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Recurrence|2|||
160864960|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Recurrence|0|||
160864961|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Adverse Event|2|||
160864962|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Adverse Event|6|||
160864963|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Participant wishes|12|||
160864964|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Participant wishes|7|||
160864965|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Physician Decision|2|||
160864966|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Physician Decision|1|||
160864967|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
160864968|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
160864969|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Death|0|||
160864970|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Death|1|||
160864971|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
160864972|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
160864973|NCT00753506|580901213|FG000|Overall Study|Withdrawal by Subject|4|||
160864974|NCT00753506|580901214|FG001|Overall Study|Withdrawal by Subject|1|||
160864975|NCT00753506|580901213|FG000|Overall Study|Lost to Follow-up|2|||
160864976|NCT00753506|580901214|FG001|Overall Study|Lost to Follow-up|0|||
160864977|NCT00753506|580901213|FG000|Overall Study|Other reason|1|||
160864978|NCT00753506|580901214|FG001|Overall Study|Other reason|1|||
160864979|NCT03819114|580901215|FG000|Overall Study|Protocol Violation|0|||
160864980|NCT03819114|580901216|FG001|Overall Study|Protocol Violation|1|||
160864981|NCT03819114|580901217|FG002|Overall Study|Protocol Violation|1|||
160864982|NCT03819114|580901218|FG003|Overall Study|Protocol Violation|0|||
160864983|NCT03819114|580901215|FG000|Overall Study|Lost to Follow-up|0|||
160864984|NCT03819114|580901216|FG001|Overall Study|Lost to Follow-up|0|||
160864985|NCT03819114|580901217|FG002|Overall Study|Lost to Follow-up|1|||
160864986|NCT03819114|580901218|FG003|Overall Study|Lost to Follow-up|0|||
160864987|NCT00628108|580901219|FG000|Overall Study|Adverse Event|0|||
160864988|NCT00628108|580901220|FG001|Overall Study|Adverse Event|3|||
160864989|NCT00628108|580901219|FG000|Overall Study|Withdrawal by Subject|1|||
160864990|NCT00628108|580901220|FG001|Overall Study|Withdrawal by Subject|0|||
160864991|NCT03848832|580901221|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
160864992|NCT03848832|580901222|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
160864993|NCT03848832|580901223|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
160864994|NCT03848832|580901221|FG000|Overall Study|Withdrawal by Subject|0|||
160864995|NCT03848832|580901222|FG001|Overall Study|Withdrawal by Subject|0|||
160864996|NCT03848832|580901223|FG002|Overall Study|Withdrawal by Subject|1|||
160864997|NCT03848832|580901221|FG000|Overall Study|Withdrawal (Covid-19)|0|||
160864998|NCT03848832|580901222|FG001|Overall Study|Withdrawal (Covid-19)|2|||
160864999|NCT03848832|580901223|FG002|Overall Study|Withdrawal (Covid-19)|0|||
160865000|NCT03848832|580901221|FG000|Overall Study|Physician Decision|2|||
160865001|NCT03848832|580901222|FG001|Overall Study|Physician Decision|1|||
160865002|NCT03848832|580901223|FG002|Overall Study|Physician Decision|3|||
160865003|NCT03848832|580901221|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
160865004|NCT03848832|580901222|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
160865005|NCT03848832|580901223|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
160865006|NCT03848832|580901221|FG000|Overall Study|Adverse Event|1|||
160865007|NCT03848832|580901222|FG001|Overall Study|Adverse Event|0|||
160865008|NCT03848832|580901223|FG002|Overall Study|Adverse Event|0|||
160865009|NCT00865566|580901224|FG000|Overall Study|Death|1|||
160865010|NCT00865566|580901225|FG001|Overall Study|Death|11|||
160865011|NCT00865566|580901224|FG000|Overall Study|Lost to Follow-up|314|||
160865012|NCT00865566|580901225|FG001|Overall Study|Lost to Follow-up|315|||
160865013|NCT00865566|580901224|FG000|Overall Study|Withdrawal by Subject|45|||
160865014|NCT00865566|580901225|FG001|Overall Study|Withdrawal by Subject|65|||
160865015|NCT00865566|580901224|FG000|Overall Study|Physician Decision|0|||
160865016|NCT00865566|580901225|FG001|Overall Study|Physician Decision|1|||
160865017|NCT00865566|580901224|FG000|Overall Study|Participant relocated|78|||
160865018|NCT00865566|580901225|FG001|Overall Study|Participant relocated|107|||
160865019|NCT00865566|580901224|FG000|Overall Study|Participant unable to adhere|27|||
160865020|NCT00865566|580901225|FG001|Overall Study|Participant unable to adhere|42|||
160865021|NCT00865566|580901224|FG000|Overall Study|Other; N=245 due to early study closure|154|||
160865022|NCT00865566|580901225|FG001|Overall Study|Other; N=245 due to early study closure|139|||
160865023|NCT00865566|580901224|FG000|Overall Study|HIV infection|5|||
160865024|NCT00865566|580901225|FG001|Overall Study|HIV infection|7|||
160865025|NCT02453321|580901226|FG000|Overall Study|Weakness|1|||
160865026|NCT02453321|580901227|FG001|Overall Study|Weakness|1|||
160865027|NCT02453321|580901228|FG002|Overall Study|Weakness|2|||
160865028|NCT02453321|580901226|FG000|Overall Study|Deep Venous Thrombosis|0|||
160865029|NCT02453321|580901227|FG001|Overall Study|Deep Venous Thrombosis|1|||
160865030|NCT02453321|580901228|FG002|Overall Study|Deep Venous Thrombosis|0|||
160865031|NCT02404025|580901229|FG000|Overall Study|Adverse Event|1|||
160865032|NCT02404025|580901229|FG000|Overall Study|Lack of Efficacy|3|||
160865033|NCT00098813|580901230|FG000|Overall Study|Death|8|||
160865034|NCT00098813|580901230|FG000|Overall Study|Protocol Violation|1|||
160865035|NCT00098813|580901230|FG000|Overall Study|Withdrawal by Subject|7|||
160865036|NCT00098813|580901230|FG000|Overall Study|Progression of Disease|1|||
160865037|NCT00098813|580901230|FG000|Overall Study|Other complicating disease|1|||
160865038|NCT00098813|580901230|FG000|Overall Study|Reversal of RAI resistance|1|||
160865039|NCT02230670|580901232|FG000|Overall Study|Adverse Event|1|||
160865040|NCT02230670|580901233|FG001|Overall Study|Adverse Event|2|||
160865041|NCT02230670|580901232|FG000|Overall Study|Withdrawal by Subject|2|||
160865042|NCT02230670|580901233|FG001|Overall Study|Withdrawal by Subject|2|||
160865043|NCT02230670|580901232|FG000|Overall Study|Physician Decision|0|||
160865044|NCT02230670|580901233|FG001|Overall Study|Physician Decision|1|||
160865045|NCT02230670|580901232|FG000|Overall Study|Protocol Violation|0|||
160865046|NCT02230670|580901233|FG001|Overall Study|Protocol Violation|1|||
160865047|NCT02230670|580901232|FG000|Overall Study|Progression to Child-Pugh C|1|||
160865048|NCT02230670|580901233|FG001|Overall Study|Progression to Child-Pugh C|2|||
160865049|NCT01907854|580901238|FG000|Overall Study|Protocol Violation|1|||
160865050|NCT01907854|580901239|FG001|Overall Study|Protocol Violation|1|||
160865051|NCT01907854|580901238|FG000|Overall Study|Withdrawal by Subject|9|||
160865052|NCT01907854|580901239|FG001|Overall Study|Withdrawal by Subject|7|||
160865053|NCT01907854|580901238|FG000|Overall Study|Lost to Follow-up|2|||
160865054|NCT01907854|580901239|FG001|Overall Study|Lost to Follow-up|2|||
160865055|NCT01907854|580901238|FG000|Overall Study|Unclassified|4|||
160865056|NCT01907854|580901239|FG001|Overall Study|Unclassified|3|||
160865057|NCT02215252|580901240|FG000|Overall Study|Adverse Event|1|||
160865058|NCT02215252|580901241|FG001|Overall Study|Adverse Event|5|||
160865059|NCT02215252|580901242|FG002|Overall Study|Adverse Event|2|||
160865060|NCT02215252|580901240|FG000|Overall Study|Lost to Follow-up|0|||
160865061|NCT02215252|580901241|FG001|Overall Study|Lost to Follow-up|0|||
160865062|NCT02215252|580901242|FG002|Overall Study|Lost to Follow-up|1|||
160865063|NCT02215252|580901240|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
160865064|NCT02215252|580901241|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
160865065|NCT02215252|580901242|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
160865066|NCT02215252|580901240|FG000|Overall Study|Protocol Violation|0|||
160865067|NCT02215252|580901241|FG001|Overall Study|Protocol Violation|1|||
160865068|NCT02215252|580901242|FG002|Overall Study|Protocol Violation|0|||
160865069|NCT02215252|580901240|FG000|Overall Study|Withdrawal by Subject|1|||
160865070|NCT02215252|580901241|FG001|Overall Study|Withdrawal by Subject|0|||
160865071|NCT02215252|580901242|FG002|Overall Study|Withdrawal by Subject|0|||
160865072|NCT02215252|580901240|FG000|Overall Study|Other|0|||
160865073|NCT02215252|580901241|FG001|Overall Study|Other|1|||
160865074|NCT02215252|580901242|FG002|Overall Study|Other|1|||
160865075|NCT00892099|580901244|FG000|Overall Study|Death|1|||
160865076|NCT00892099|580901245|FG001|Overall Study|Death|0|||
160865077|NCT00892099|580901246|FG002|Overall Study|Death|1|||
160865078|NCT00892099|580901244|FG000|Overall Study|Adverse Event|1|||
160865079|NCT00892099|580901245|FG001|Overall Study|Adverse Event|0|||
160865080|NCT00892099|580901246|FG002|Overall Study|Adverse Event|0|||
160865081|NCT00892099|580901244|FG000|Overall Study|replocated|1|||
160865082|NCT00892099|580901245|FG001|Overall Study|replocated|0|||
160865083|NCT00892099|580901246|FG002|Overall Study|replocated|2|||
160865084|NCT00892099|580901244|FG000|Overall Study|Prolonged hospitalization|1|||
160865085|NCT00892099|580901245|FG001|Overall Study|Prolonged hospitalization|0|||
160865086|NCT00892099|580901246|FG002|Overall Study|Prolonged hospitalization|1|||
160865087|NCT00892099|580901244|FG000|Overall Study|no further details|1|||
160865088|NCT00892099|580901245|FG001|Overall Study|no further details|0|||
160865089|NCT00892099|580901246|FG002|Overall Study|no further details|1|||
160865090|NCT00892099|580901244|FG000|Overall Study|kidney function recovered|0|||
160865091|NCT00892099|580901245|FG001|Overall Study|kidney function recovered|1|||
160865092|NCT00892099|580901246|FG002|Overall Study|kidney function recovered|0|||
160865093|NCT00892099|580901244|FG000|Overall Study|investigator decision|0|||
160865094|NCT00892099|580901245|FG001|Overall Study|investigator decision|0|||
160865095|NCT00892099|580901246|FG002|Overall Study|investigator decision|1|||
160865096|NCT00892099|580901244|FG000|Overall Study|Lost to Follow-up|0|||
160865097|NCT00892099|580901245|FG001|Overall Study|Lost to Follow-up|0|||
160865098|NCT00892099|580901246|FG002|Overall Study|Lost to Follow-up|1|||
160865099|NCT01746901|580901247|FG000|Naloxone Challenge Phase|Adverse Event|2|||
160865100|NCT01746901|580901248|FG001|Naloxone Challenge Phase|Adverse Event|0|||
160865101|NCT01746901|580901249|FG002|Naloxone Challenge Phase|Adverse Event|0|||
160865102|NCT01746901|580901250|FG003|Naloxone Challenge Phase|Adverse Event|0|||
160865103|NCT01746901|580901251|FG004|Naloxone Challenge Phase|Adverse Event|0|||
160865104|NCT01746901|580901252|FG005|Naloxone Challenge Phase|Adverse Event|0|||
160865105|NCT01746901|580901253|FG006|Naloxone Challenge Phase|Adverse Event|0|||
160865106|NCT01746901|580901254|FG007|Naloxone Challenge Phase|Adverse Event|0|||
160865107|NCT01746901|580901255|FG008|Naloxone Challenge Phase|Adverse Event|0|||
160865108|NCT01746901|580901247|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
160865109|NCT01746901|580901248|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865110|NCT01746901|580901249|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865111|NCT01746901|580901250|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865112|NCT01746901|580901251|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865113|NCT01746901|580901252|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865114|NCT01746901|580901253|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865115|NCT01746901|580901254|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865116|NCT01746901|580901255|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865117|NCT01746901|580901247|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865118|NCT01746901|580901248|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
160865119|NCT01746901|580901249|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865120|NCT01746901|580901250|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865121|NCT01746901|580901251|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865122|NCT01746901|580901252|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865123|NCT01746901|580901253|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865124|NCT01746901|580901254|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865125|NCT01746901|580901255|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865126|NCT01746901|580901247|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865127|NCT01746901|580901248|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
160865128|NCT01746901|580901249|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
160865129|NCT01746901|580901250|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865130|NCT01746901|580901251|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865131|NCT01746901|580901252|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865132|NCT01746901|580901253|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865133|NCT01746901|580901254|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865134|NCT01746901|580901255|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865135|NCT01746901|580901247|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865136|NCT01746901|580901248|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
160865137|NCT01746901|580901249|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
160865138|NCT01746901|580901250|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865139|NCT01746901|580901251|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865140|NCT01746901|580901252|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865141|NCT01746901|580901253|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865142|NCT01746901|580901254|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865143|NCT01746901|580901255|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865144|NCT01746901|580901247|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865145|NCT01746901|580901248|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
160865146|NCT01746901|580901249|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
160865147|NCT01746901|580901250|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865148|NCT01746901|580901251|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160749613|NCT01483599|580468054|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160749614|NCT01483599|580468055|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160749615|NCT01483599|580468056|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160749616|NCT01483599|580468057|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160749617|NCT01483599|580468058|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160749618|NCT01483599|580468059|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
160749619|NCT01483599|580468060|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160749620|NCT01483599|580468061|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160749621|NCT01483599|580468062|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
160749622|NCT01483599|580468063|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
160749623|NCT01483599|580468064|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
160749624|NCT01483599|580468051|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
160749625|NCT01483599|580468052|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
160749626|NCT01483599|580468053|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
160749627|NCT01483599|580468054|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
160749628|NCT01483599|580468055|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
160749629|NCT01483599|580468056|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
160749630|NCT01483599|580468057|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
160749631|NCT01483599|580468058|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
160749632|NCT01483599|580468059|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
160749633|NCT01483599|580468060|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
160749634|NCT01483599|580468061|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
160749635|NCT01483599|580468062|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
160749636|NCT01483599|580468063|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
160749637|NCT01483599|580468064|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
160749638|NCT02109445|580468066|FG000|Overall Study|Symptomatic deterioration|2|||
160749639|NCT02109445|580468066|FG000|Overall Study|Adverse Event|1|||
160749640|NCT00966355|580468071|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
160749641|NCT00966355|580468072|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
160749642|NCT00966355|580468073|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
160749643|NCT00966355|580468071|FG000|Overall Study|newly diagnosed advanced HCC|11|||
160749644|NCT00966355|580468072|FG001|Overall Study|newly diagnosed advanced HCC|12|||
160749645|NCT00966355|580468073|FG002|Overall Study|newly diagnosed advanced HCC|10|||
160749646|NCT00966355|580468071|FG000|Overall Study|Lost to Follow-up|5|||
160865149|NCT01746901|580901252|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865150|NCT01746901|580901253|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865151|NCT01746901|580901254|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865152|NCT01746901|580901255|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865153|NCT01746901|580901247|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
160865154|NCT01746901|580901248|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
160749647|NCT00966355|580468072|FG001|Overall Study|Lost to Follow-up|4|||
160749648|NCT00966355|580468073|FG002|Overall Study|Lost to Follow-up|3|||
160749649|NCT01048944|580469633|FG000|Overall Study|Protocol Violation|8|||
160749650|NCT01048944|580469634|FG001|Overall Study|Protocol Violation|10|||
160749651|NCT01048944|580469635|FG002|Overall Study|Protocol Violation|10|||
160749652|NCT01048944|580469636|FG003|Overall Study|Protocol Violation|2|||
160749653|NCT01962948|580469637|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
160749654|NCT01962948|580469638|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
160749655|NCT01962948|580469639|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
160861851|NCT02531802|580887847|FG002|Received Vaccination 2|Adverse Event|0|||
160865155|NCT01746901|580901249|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
160865156|NCT01746901|580901250|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
160865157|NCT01746901|580901251|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
160979011|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979012|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979013|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979014|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979015|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979016|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979017|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979018|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979019|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979020|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979021|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979022|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979023|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979024|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979025|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979026|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979027|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
160979028|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
160979029|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
160979030|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
160979031|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
160979032|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
160979033|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
160979034|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
160979035|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
160979036|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
160979037|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
160979038|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
160979039|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
160979040|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
160979041|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
160979042|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
160979043|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
160979044|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
160979045|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
160979046|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
160979047|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979048|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979049|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979050|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979051|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979052|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979053|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979054|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979055|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979056|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979057|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979058|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979059|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979060|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979061|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
160979062|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
160865158|NCT01746901|580901252|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
160865159|NCT01746901|580901253|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
160865160|NCT01746901|580901254|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
160865161|NCT01746901|580901255|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
160865162|NCT01746901|580901247|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865163|NCT01746901|580901248|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865164|NCT01746901|580901249|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865165|NCT01746901|580901250|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865166|NCT01746901|580901251|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865167|NCT01746901|580901252|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865168|NCT01746901|580901253|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865169|NCT01746901|580901254|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
160865170|NCT01746901|580901255|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865171|NCT01746901|580901247|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865172|NCT01746901|580901248|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865173|NCT01746901|580901249|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865174|NCT01746901|580901250|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865175|NCT01746901|580901251|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865176|NCT01746901|580901252|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
160865177|NCT01746901|580901253|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
160865178|NCT01746901|580901254|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865179|NCT01746901|580901255|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865180|NCT01746901|580901247|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865181|NCT01746901|580901248|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865182|NCT01746901|580901249|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865183|NCT01746901|580901250|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
160865184|NCT01746901|580901251|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865185|NCT01746901|580901252|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865186|NCT01746901|580901253|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865187|NCT01746901|580901254|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865188|NCT01746901|580901255|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865189|NCT01746901|580901247|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865190|NCT01746901|580901248|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865191|NCT01746901|580901249|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865192|NCT01746901|580901250|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865193|NCT01746901|580901251|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865194|NCT01746901|580901252|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
160865195|NCT01746901|580901253|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865196|NCT01746901|580901254|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865197|NCT01746901|580901255|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
160865198|NCT01746901|580901247|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865199|NCT01746901|580901248|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865200|NCT01746901|580901249|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865201|NCT01746901|580901250|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865202|NCT01746901|580901251|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865203|NCT01746901|580901252|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865204|NCT01746901|580901253|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
160865205|NCT01746901|580901254|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865206|NCT01746901|580901255|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
160865207|NCT04455815|580901256|FG000|Randomisation Phase|Adverse Event|1|||
160865208|NCT04455815|580901257|FG001|Randomisation Phase|Adverse Event|0|||
160865209|NCT04455815|580901256|FG000|Treatment Phase|Adverse Event|0|||
160865210|NCT04455815|580901257|FG001|Treatment Phase|Adverse Event|1|||
160865211|NCT04455815|580901256|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
160865212|NCT04455815|580901257|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
160865213|NCT04455815|580901256|FG000|Treatment Phase|Withdrawal by Subject|1|||
160865214|NCT04455815|580901257|FG001|Treatment Phase|Withdrawal by Subject|1|||
160865215|NCT02106390|580901258|FG000|Overall Study|Withdrawal by Subject|15|||
160865216|NCT02106390|580901259|FG001|Overall Study|Withdrawal by Subject|16|||
160865217|NCT02106390|580901260|FG002|Overall Study|Withdrawal by Subject|15|||
160865218|NCT02106390|580901258|FG000|Overall Study|Lost to Follow-up|25|||
160865219|NCT02106390|580901259|FG001|Overall Study|Lost to Follow-up|20|||
160865220|NCT02106390|580901260|FG002|Overall Study|Lost to Follow-up|13|||
160865221|NCT02106390|580901258|FG000|Overall Study|Other: Administrative Reason|8|||
160865222|NCT02106390|580901259|FG001|Overall Study|Other: Administrative Reason|5|||
160865223|NCT02106390|580901260|FG002|Overall Study|Other: Administrative Reason|12|||
160865224|NCT02106390|580901258|FG000|Overall Study|Other: Unspecified|1|||
160865225|NCT02106390|580901259|FG001|Overall Study|Other: Unspecified|4|||
160865226|NCT02106390|580901260|FG002|Overall Study|Other: Unspecified|2|||
160865227|NCT02106390|580901258|FG000|Overall Study|Adverse Event|0|||
160865228|NCT02106390|580901259|FG001|Overall Study|Adverse Event|2|||
160865229|NCT02106390|580901260|FG002|Overall Study|Adverse Event|1|||
160865230|NCT02106390|580901258|FG000|Overall Study|Protocol Violation|0|||
160865231|NCT02106390|580901259|FG001|Overall Study|Protocol Violation|1|||
160865232|NCT02106390|580901260|FG002|Overall Study|Protocol Violation|0|||
160865233|NCT03594110|580901261|FG000|Interventional Part|Participant concerned about study treatment|23|||
160865234|NCT03594110|580901262|FG001|Interventional Part|Participant concerned about study treatment|28|||
160865235|NCT03594110|580901261|FG000|Interventional Part|Doctor advice|38|||
160865236|NCT03594110|580901262|FG001|Interventional Part|Doctor advice|40|||
160865237|NCT03594110|580901261|FG000|Interventional Part|Participants' wish|89|||
160865238|NCT03594110|580901262|FG001|Interventional Part|Participants' wish|68|||
160865239|NCT03594110|580901261|FG000|Interventional Part|Adverse event-non-fatal events|119|||
160865240|NCT03594110|580901262|FG001|Interventional Part|Adverse event-non-fatal events|116|||
160865241|NCT03594110|580901261|FG000|Interventional Part|Study drug stopped, reason missing|336|||
160865242|NCT03594110|580901262|FG001|Interventional Part|Study drug stopped, reason missing|294|||
160865243|NCT03594110|580901261|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
160865244|NCT03594110|580901262|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
160865245|NCT03594110|580901261|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
160865246|NCT03594110|580901262|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
160865247|NCT03594110|580901261|FG000|Interventional Part|Contraindicated drug started|32|||
160865248|NCT03594110|580901262|FG001|Interventional Part|Contraindicated drug started|18|||
160865249|NCT03594110|580901261|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
160865250|NCT03594110|580901262|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
160865251|NCT03594110|580901261|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
160865252|NCT03594110|580901262|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
160865253|NCT03594110|580901261|FG000|Non-interventional Part|Withdrawal by Subject|3|||
160865254|NCT03594110|580901262|FG001|Non-interventional Part|Withdrawal by Subject|4|||
160865255|NCT03594110|580901261|FG000|Non-interventional Part|Lost to Follow-up|45|||
160865256|NCT03594110|580901262|FG001|Non-interventional Part|Lost to Follow-up|41|||
160865257|NCT03041038|580901263|FG000|Overall Study|Withdrawal by Subject|4|||
160865258|NCT03041038|580901264|FG001|Overall Study|Withdrawal by Subject|0|||
160865259|NCT03041038|580901263|FG000|Overall Study|Lost to Follow-up|1|||
160865260|NCT03041038|580901264|FG001|Overall Study|Lost to Follow-up|1|||
160865261|NCT03041038|580901263|FG000|Overall Study|Protocol Violation|1|||
160865262|NCT03041038|580901264|FG001|Overall Study|Protocol Violation|1|||
160865263|NCT00803569|580901265|FG000|Overall Study|Progressive Disease|3|||
160865264|NCT00803569|580901265|FG000|Overall Study|Noncompliance|1|||
160865265|NCT02177032|580901266|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
160865266|NCT02177032|580901267|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
160865267|NCT02177032|580901268|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
160865268|NCT02177032|580901269|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
160865269|NCT02177032|580901266|FG000|Overall Study|Lost to Follow-up|0|||
160865270|NCT02177032|580901267|FG001|Overall Study|Lost to Follow-up|2|||
160865271|NCT02177032|580901268|FG002|Overall Study|Lost to Follow-up|0|||
160865272|NCT02177032|580901269|FG003|Overall Study|Lost to Follow-up|0|||
160865273|NCT02177032|580901266|FG000|Overall Study|OTHER|2|||
160865274|NCT02177032|580901267|FG001|Overall Study|OTHER|0|||
160865275|NCT02177032|580901268|FG002|Overall Study|OTHER|1|||
160865276|NCT02177032|580901269|FG003|Overall Study|OTHER|0|||
160865277|NCT02177032|580901266|FG000|Overall Study|Withdrawal by Subject|1|||
160865278|NCT02177032|580901267|FG001|Overall Study|Withdrawal by Subject|0|||
160865279|NCT02177032|580901268|FG002|Overall Study|Withdrawal by Subject|1|||
160865280|NCT02177032|580901269|FG003|Overall Study|Withdrawal by Subject|0|||
160865281|NCT00930046|580901270|FG000|Overall Study|Wound catheter malfunctioned|1|||
160865282|NCT00930046|580901271|FG001|Overall Study|Wound catheter malfunctioned|2|||
160865283|NCT01598532|580901272|FG000|Overall Study|Lost to Follow-up|3|||
160865284|NCT01598532|580901272|FG000|Overall Study|Did not meet inclusion criteria|8|||
160865285|NCT01249261|580901273|FG000|Overall Study|Withdrawal by Subject|1|||
160865286|NCT01249261|580901274|FG001|Overall Study|Withdrawal by Subject|0|||
160865287|NCT01967940|580901279|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
160865288|NCT01967940|580901280|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
160865289|NCT01967940|580901281|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
160865290|NCT01967940|580901282|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
160865291|NCT01967940|580901279|FG000|Part 2|Adverse Event|0|||
160865292|NCT01967940|580901280|FG001|Part 2|Adverse Event|0|||
160865293|NCT01967940|580901281|FG002|Part 2|Adverse Event|0|||
160865294|NCT01967940|580901282|FG003|Part 2|Adverse Event|1|||
160865295|NCT01967940|580901279|FG000|Part 2|Unknown Reason|0|||
160865296|NCT01967940|580901280|FG001|Part 2|Unknown Reason|0|||
160865297|NCT01967940|580901281|FG002|Part 2|Unknown Reason|0|||
160865298|NCT01967940|580901282|FG003|Part 2|Unknown Reason|1|||
160865299|NCT04109547|580901283|FG000|Overall Study|Withdrawal by Subject|3|||
160865300|NCT04109547|580901284|FG001|Overall Study|Withdrawal by Subject|2|||
160865301|NCT04109547|580901285|FG002|Overall Study|Withdrawal by Subject|6|||
160865302|NCT04109547|580901286|FG003|Overall Study|Withdrawal by Subject|6|||
160865303|NCT04109547|580901283|FG000|Overall Study|Lost to Follow-up|0|||
160865304|NCT04109547|580901284|FG001|Overall Study|Lost to Follow-up|0|||
160865305|NCT04109547|580901285|FG002|Overall Study|Lost to Follow-up|0|||
160865306|NCT04109547|580901286|FG003|Overall Study|Lost to Follow-up|1|||
160865307|NCT04109547|580901283|FG000|Overall Study|Physician Decision|1|||
160865308|NCT04109547|580901284|FG001|Overall Study|Physician Decision|2|||
160865309|NCT04109547|580901285|FG002|Overall Study|Physician Decision|0|||
160865310|NCT04109547|580901286|FG003|Overall Study|Physician Decision|0|||
160865311|NCT01550003|580901287|FG000|Overall Study|Adverse Event|0|||
160865312|NCT01550003|580901288|FG001|Overall Study|Adverse Event|9|||
160865313|NCT01550003|580901289|FG002|Overall Study|Adverse Event|15|||
160865314|NCT01550003|580901287|FG000|Overall Study|Lack of Efficacy|4|||
160865315|NCT01550003|580901288|FG001|Overall Study|Lack of Efficacy|11|||
160865316|NCT01550003|580901289|FG002|Overall Study|Lack of Efficacy|15|||
160865317|NCT01550003|580901287|FG000|Overall Study|Protocol Violation|0|||
160865318|NCT01550003|580901288|FG001|Overall Study|Protocol Violation|3|||
160865319|NCT01550003|580901289|FG002|Overall Study|Protocol Violation|2|||
160865320|NCT01550003|580901287|FG000|Overall Study|Lost to Follow-up|1|||
160865321|NCT01550003|580901288|FG001|Overall Study|Lost to Follow-up|4|||
160865322|NCT01550003|580901289|FG002|Overall Study|Lost to Follow-up|8|||
160865323|NCT01550003|580901287|FG000|Overall Study|Consent withdrawn|2|||
160865324|NCT01550003|580901288|FG001|Overall Study|Consent withdrawn|11|||
160865325|NCT01550003|580901289|FG002|Overall Study|Consent withdrawn|23|||
160865326|NCT01550003|580901287|FG000|Overall Study|Missing|1|||
160865327|NCT01550003|580901288|FG001|Overall Study|Missing|0|||
160865328|NCT01550003|580901289|FG002|Overall Study|Missing|2|||
160865329|NCT01550003|580901287|FG000|Overall Study|Study closure as announced by sponsor|7|||
160865330|NCT01550003|580901288|FG001|Overall Study|Study closure as announced by sponsor|6|||
160865331|NCT01550003|580901289|FG002|Overall Study|Study closure as announced by sponsor|24|||
160865332|NCT01550003|580901287|FG000|Overall Study|Protocol Noncompliance|1|||
160865333|NCT01550003|580901288|FG001|Overall Study|Protocol Noncompliance|0|||
160865334|NCT01550003|580901289|FG002|Overall Study|Protocol Noncompliance|0|||
160865335|NCT01550003|580901287|FG000|Overall Study|Study closure|0|||
160865336|NCT01550003|580901288|FG001|Overall Study|Study closure|1|||
160865337|NCT01550003|580901289|FG002|Overall Study|Study closure|1|||
160865338|NCT01550003|580901287|FG000|Overall Study|Patient reached adulthood|0|||
160865339|NCT01550003|580901288|FG001|Overall Study|Patient reached adulthood|1|||
160865340|NCT01550003|580901289|FG002|Overall Study|Patient reached adulthood|0|||
160865341|NCT01550003|580901287|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
160865342|NCT01550003|580901288|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
160865343|NCT01550003|580901289|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
160865344|NCT01550003|580901287|FG000|Overall Study|Sponsor's order|0|||
160865345|NCT01550003|580901288|FG001|Overall Study|Sponsor's order|3|||
160865346|NCT01550003|580901289|FG002|Overall Study|Sponsor's order|3|||
160865347|NCT01550003|580901287|FG000|Overall Study|Sponsor's decision|1|||
160865348|NCT01550003|580901288|FG001|Overall Study|Sponsor's decision|5|||
160865349|NCT01550003|580901289|FG002|Overall Study|Sponsor's decision|4|||
160865350|NCT01550003|580901287|FG000|Overall Study|Subject mother passed away|0|||
160865351|NCT01550003|580901288|FG001|Overall Study|Subject mother passed away|1|||
160865352|NCT01550003|580901289|FG002|Overall Study|Subject mother passed away|0|||
160865353|NCT01550003|580901287|FG000|Overall Study|Discontinuation|0|||
160865354|NCT01550003|580901288|FG001|Overall Study|Discontinuation|1|||
160865355|NCT01550003|580901289|FG002|Overall Study|Discontinuation|0|||
160865356|NCT01550003|580901287|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
160865357|NCT01550003|580901288|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
160865358|NCT01550003|580901289|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
160865359|NCT01550003|580901287|FG000|Overall Study|Site closure|0|||
160865360|NCT01550003|580901288|FG001|Overall Study|Site closure|2|||
160865361|NCT01550003|580901289|FG002|Overall Study|Site closure|0|||
160865362|NCT01550003|580901287|FG000|Overall Study|Pregnancy|0|||
160865363|NCT01550003|580901288|FG001|Overall Study|Pregnancy|1|||
160865364|NCT01550003|580901289|FG002|Overall Study|Pregnancy|0|||
160865365|NCT01550003|580901287|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
160865366|NCT01550003|580901288|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
160865367|NCT01550003|580901289|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
160865368|NCT01550003|580901287|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
160865369|NCT01550003|580901288|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
160865370|NCT01550003|580901289|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
160865371|NCT01550003|580901287|FG000|Overall Study|Switching to adult rheumatologist|0|||
160865372|NCT01550003|580901288|FG001|Overall Study|Switching to adult rheumatologist|0|||
160865373|NCT01550003|580901289|FG002|Overall Study|Switching to adult rheumatologist|1|||
160865374|NCT01550003|580901287|FG000|Overall Study|Patient transition to adult care|0|||
160865375|NCT01550003|580901288|FG001|Overall Study|Patient transition to adult care|0|||
160865376|NCT01550003|580901289|FG002|Overall Study|Patient transition to adult care|1|||
160865377|NCT01550003|580901287|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
160865378|NCT01550003|580901288|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
160865379|NCT01550003|580901289|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
160865380|NCT01550003|580901287|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
160865381|NCT01550003|580901288|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
160865382|NCT01550003|580901289|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
160865383|NCT01550003|580901287|FG000|Overall Study|Per Sponsor request|1|||
160865384|NCT01550003|580901288|FG001|Overall Study|Per Sponsor request|0|||
160865385|NCT01550003|580901289|FG002|Overall Study|Per Sponsor request|1|||
160865386|NCT01550003|580901287|FG000|Overall Study|Patient not compliance|0|||
160865387|NCT01550003|580901288|FG001|Overall Study|Patient not compliance|0|||
160865388|NCT01550003|580901289|FG002|Overall Study|Patient not compliance|1|||
160865389|NCT01550003|580901287|FG000|Overall Study|Non-compliance|0|||
160865390|NCT01550003|580901288|FG001|Overall Study|Non-compliance|0|||
160865391|NCT01550003|580901289|FG002|Overall Study|Non-compliance|1|||
160865392|NCT01550003|580901287|FG000|Overall Study|Study closed|0|||
160865393|NCT01550003|580901288|FG001|Overall Study|Study closed|1|||
160865394|NCT01550003|580901289|FG002|Overall Study|Study closed|0|||
160865395|NCT01550003|580901287|FG000|Overall Study|Transitioned to adult rheumatology|0|||
160865396|NCT01550003|580901288|FG001|Overall Study|Transitioned to adult rheumatology|0|||
160865397|NCT01550003|580901289|FG002|Overall Study|Transitioned to adult rheumatology|1|||
160865398|NCT05567783|580901290|FG000|Overall Study|Death|2|||
160865399|NCT05567783|580901291|FG001|Overall Study|Death|3|||
160865400|NCT05567783|580901292|FG002|Overall Study|Death|0|||
160865401|NCT05567783|580901290|FG000|Overall Study|Lost to Follow-up|25|||
160865402|NCT05567783|580901291|FG001|Overall Study|Lost to Follow-up|19|||
160865403|NCT05567783|580901292|FG002|Overall Study|Lost to Follow-up|17|||
160865404|NCT05567783|580901290|FG000|Overall Study|Physician Decision|10|||
160865405|NCT05567783|580901291|FG001|Overall Study|Physician Decision|7|||
160865406|NCT05567783|580901292|FG002|Overall Study|Physician Decision|9|||
160865407|NCT05567783|580901290|FG000|Overall Study|Study Terminated by Sponsor|924|||
160865408|NCT05567783|580901291|FG001|Overall Study|Study Terminated by Sponsor|937|||
160865409|NCT05567783|580901292|FG002|Overall Study|Study Terminated by Sponsor|941|||
160865410|NCT05567783|580901290|FG000|Overall Study|Withdrawal by Subject|23|||
160865411|NCT05567783|580901291|FG001|Overall Study|Withdrawal by Subject|27|||
160865412|NCT05567783|580901292|FG002|Overall Study|Withdrawal by Subject|24|||
160865413|NCT05567783|580901290|FG000|Overall Study|Incarcerated|1|||
160865414|NCT05567783|580901291|FG001|Overall Study|Incarcerated|0|||
160865415|NCT05567783|580901292|FG002|Overall Study|Incarcerated|0|||
160865416|NCT05567783|580901290|FG000|Overall Study|Participant randomized in error|4|||
160865417|NCT05567783|580901291|FG001|Overall Study|Participant randomized in error|2|||
160865418|NCT05567783|580901292|FG002|Overall Study|Participant randomized in error|2|||
160865419|NCT03675126|580901295|FG000|Overall Study|Study Terminated by Sponsor|9|||
160865420|NCT03675126|580901295|FG000|Overall Study|Death|2|||
160865421|NCT03675126|580901295|FG000|Overall Study|Withdrawal by Subject|4|||
160865422|NCT01929317|580901299|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
160865423|NCT01929317|580901300|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
160865424|NCT01929317|580901299|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
160865425|NCT01929317|580901300|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
160865426|NCT01929317|580901299|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
160865427|NCT01929317|580901300|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
160865428|NCT01929317|580901299|FG000|Long-term Phase|Adverse Event|5|||
160865429|NCT01929317|580901300|FG001|Long-term Phase|Adverse Event|1|||
160865430|NCT01929317|580901299|FG000|Long-term Phase|Physician Decision|3|||
160865431|NCT01929317|580901300|FG001|Long-term Phase|Physician Decision|0|||
160865432|NCT01929317|580901299|FG000|Long-term Phase|Withdrawal by Subject|4|||
160865433|NCT01929317|580901300|FG001|Long-term Phase|Withdrawal by Subject|0|||
160865434|NCT01929317|580901299|FG000|Long-term Phase|Protocol Violation|1|||
160865435|NCT01929317|580901300|FG001|Long-term Phase|Protocol Violation|0|||
160865436|NCT01929317|580901299|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
160865437|NCT01929317|580901300|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
160865438|NCT01929317|580901299|FG000|Long-term Phase|Study Closed/Terminated|5|||
160865439|NCT01929317|580901300|FG001|Long-term Phase|Study Closed/Terminated|3|||
160865440|NCT00993967|580901306|FG000|Overall Study|Adverse Event|8|||
160865441|NCT00993967|580901306|FG000|Overall Study|Death|1|||
160865442|NCT00993967|580901306|FG000|Overall Study|Lost to Follow-up|14|||
160865443|NCT00993967|580901306|FG000|Overall Study|Withdrawal by Subject|36|||
160865444|NCT00993967|580901306|FG000|Overall Study|Protocol Violation|2|||
160865445|NCT03815929|580901307|FG000|Overall Study|Lost to Follow-up|2|||
160865446|NCT03815929|580901308|FG001|Overall Study|Lost to Follow-up|1|||
160865447|NCT03815929|580901309|FG002|Overall Study|Lost to Follow-up|0|||
160865448|NCT03815929|580901307|FG000|Overall Study|Physician Decision|2|||
160865449|NCT03815929|580901308|FG001|Overall Study|Physician Decision|2|||
160865450|NCT03815929|580901309|FG002|Overall Study|Physician Decision|0|||
160865451|NCT03815929|580901307|FG000|Overall Study|Withdrawal by Subject|0|||
160865452|NCT03815929|580901308|FG001|Overall Study|Withdrawal by Subject|0|||
160865453|NCT03815929|580901309|FG002|Overall Study|Withdrawal by Subject|1|||
160865454|NCT02205736|580901310|FG000|Overall Study|Lost to Follow-up|106|||
160865455|NCT02638220|580901318|FG000|Overall Study|Lost to Follow-up|6|||
160865456|NCT02638220|580901318|FG000|Overall Study|Withdrawal by Subject|3|||
160865457|NCT02638220|580901318|FG000|Overall Study|Physician Decision|1|||
160865458|NCT02638220|580901318|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
160865459|NCT04323124|580901319|FG000|Overall Study|Adverse Event|0|||
160865460|NCT04323124|580901320|FG001|Overall Study|Adverse Event|0|||
160865461|NCT04323124|580901321|FG002|Overall Study|Adverse Event|0|||
160865462|NCT04323124|580901322|FG003|Overall Study|Adverse Event|0|||
160865463|NCT04323124|580901323|FG004|Overall Study|Adverse Event|0|||
160865464|NCT04323124|580901324|FG005|Overall Study|Adverse Event|1|||
160865465|NCT04323124|580901325|FG006|Overall Study|Adverse Event|0|||
160865466|NCT04323124|580901326|FG007|Overall Study|Adverse Event|1|||
160865467|NCT04323124|580901327|FG008|Overall Study|Adverse Event|1|||
160865468|NCT04323124|580901328|FG009|Overall Study|Adverse Event|0|||
160865469|NCT04323124|580901329|FG010|Overall Study|Adverse Event|0|||
160865470|NCT04323124|580901330|FG011|Overall Study|Adverse Event|0|||
160865471|NCT04323124|580901331|FG012|Overall Study|Adverse Event|0|||
160865472|NCT04323124|580901332|FG013|Overall Study|Adverse Event|0|||
160865473|NCT04323124|580901333|FG014|Overall Study|Adverse Event|0|||
160865474|NCT04323124|580901319|FG000|Overall Study|Other|0|||
160865475|NCT04323124|580901320|FG001|Overall Study|Other|0|||
160865476|NCT04323124|580901321|FG002|Overall Study|Other|0|||
160865477|NCT04323124|580901322|FG003|Overall Study|Other|0|||
160865478|NCT04323124|580901323|FG004|Overall Study|Other|1|||
160865479|NCT04323124|580901324|FG005|Overall Study|Other|0|||
160865480|NCT04323124|580901325|FG006|Overall Study|Other|0|||
160865481|NCT04323124|580901326|FG007|Overall Study|Other|0|||
160865482|NCT04323124|580901327|FG008|Overall Study|Other|1|||
160865483|NCT04323124|580901328|FG009|Overall Study|Other|0|||
160865484|NCT04323124|580901329|FG010|Overall Study|Other|0|||
160865485|NCT04323124|580901330|FG011|Overall Study|Other|0|||
160865486|NCT04323124|580901331|FG012|Overall Study|Other|0|||
160865487|NCT04323124|580901332|FG013|Overall Study|Other|0|||
160865488|NCT04323124|580901333|FG014|Overall Study|Other|0|||
160865489|NCT04323124|580901319|FG000|Overall Study|Coming from a red zone (COVID)|0|||
160865490|NCT04323124|580901320|FG001|Overall Study|Coming from a red zone (COVID)|0|||
160865491|NCT04323124|580901321|FG002|Overall Study|Coming from a red zone (COVID)|0|||
160865492|NCT04323124|580901322|FG003|Overall Study|Coming from a red zone (COVID)|0|||
160865493|NCT04323124|580901323|FG004|Overall Study|Coming from a red zone (COVID)|1|||
160865494|NCT04323124|580901324|FG005|Overall Study|Coming from a red zone (COVID)|1|||
160865495|NCT04323124|580901325|FG006|Overall Study|Coming from a red zone (COVID)|0|||
160865496|NCT04323124|580901326|FG007|Overall Study|Coming from a red zone (COVID)|0|||
160865497|NCT04323124|580901327|FG008|Overall Study|Coming from a red zone (COVID)|0|||
160865498|NCT04323124|580901328|FG009|Overall Study|Coming from a red zone (COVID)|0|||
160865499|NCT04323124|580901329|FG010|Overall Study|Coming from a red zone (COVID)|0|||
160865500|NCT04323124|580901330|FG011|Overall Study|Coming from a red zone (COVID)|0|||
160865501|NCT04323124|580901331|FG012|Overall Study|Coming from a red zone (COVID)|0|||
160865502|NCT04323124|580901332|FG013|Overall Study|Coming from a red zone (COVID)|0|||
160865503|NCT04323124|580901333|FG014|Overall Study|Coming from a red zone (COVID)|0|||
160865504|NCT04323124|580901319|FG000|Overall Study|No longer meets eligibility criteria|0|||
160865505|NCT04323124|580901320|FG001|Overall Study|No longer meets eligibility criteria|0|||
160865506|NCT04323124|580901321|FG002|Overall Study|No longer meets eligibility criteria|0|||
160865507|NCT04323124|580901322|FG003|Overall Study|No longer meets eligibility criteria|0|||
160865508|NCT04323124|580901323|FG004|Overall Study|No longer meets eligibility criteria|0|||
160865509|NCT04323124|580901324|FG005|Overall Study|No longer meets eligibility criteria|0|||
160865510|NCT04323124|580901325|FG006|Overall Study|No longer meets eligibility criteria|0|||
160865511|NCT04323124|580901326|FG007|Overall Study|No longer meets eligibility criteria|1|||
160865512|NCT04323124|580901327|FG008|Overall Study|No longer meets eligibility criteria|0|||
160865513|NCT04323124|580901328|FG009|Overall Study|No longer meets eligibility criteria|0|||
160865514|NCT04323124|580901329|FG010|Overall Study|No longer meets eligibility criteria|0|||
160865515|NCT04323124|580901330|FG011|Overall Study|No longer meets eligibility criteria|0|||
160865516|NCT04323124|580901331|FG012|Overall Study|No longer meets eligibility criteria|0|||
160865517|NCT04323124|580901332|FG013|Overall Study|No longer meets eligibility criteria|1|||
160865518|NCT04323124|580901333|FG014|Overall Study|No longer meets eligibility criteria|1|||
160865519|NCT04323124|580901319|FG000|Overall Study|Study terminated by sponsor|0|||
160865520|NCT04323124|580901320|FG001|Overall Study|Study terminated by sponsor|0|||
160865521|NCT04323124|580901321|FG002|Overall Study|Study terminated by sponsor|0|||
160865522|NCT04323124|580901322|FG003|Overall Study|Study terminated by sponsor|0|||
160865523|NCT04323124|580901323|FG004|Overall Study|Study terminated by sponsor|0|||
160865524|NCT04323124|580901324|FG005|Overall Study|Study terminated by sponsor|0|||
160865525|NCT04323124|580901325|FG006|Overall Study|Study terminated by sponsor|0|||
160865526|NCT04323124|580901326|FG007|Overall Study|Study terminated by sponsor|0|||
160865527|NCT04323124|580901327|FG008|Overall Study|Study terminated by sponsor|0|||
160865528|NCT04323124|580901328|FG009|Overall Study|Study terminated by sponsor|0|||
160865529|NCT04323124|580901329|FG010|Overall Study|Study terminated by sponsor|0|||
160865530|NCT04323124|580901330|FG011|Overall Study|Study terminated by sponsor|2|||
160865531|NCT04323124|580901331|FG012|Overall Study|Study terminated by sponsor|1|||
160865532|NCT04323124|580901332|FG013|Overall Study|Study terminated by sponsor|0|||
160865533|NCT04323124|580901333|FG014|Overall Study|Study terminated by sponsor|0|||
160865534|NCT02968004|580902896|FG000|Main Study Phase|Adverse Event|1|||
160865535|NCT02968004|580902897|FG001|Main Study Phase|Adverse Event|0|||
160865536|NCT02968004|580902896|FG000|Main Study Phase|Withdrawal by Subject|0|||
160865537|NCT02968004|580902897|FG001|Main Study Phase|Withdrawal by Subject|1|||
160865538|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
160865539|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
160865540|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
160865541|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
160865542|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
160865543|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
160865544|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
160865545|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
160865546|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
160865547|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
160865548|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
160865549|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
160865550|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
160865551|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
160865552|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
160865553|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
160865554|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
160865555|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
160865556|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
160865557|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
160865558|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
160865559|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
160865560|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
160865561|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
160865562|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
160865563|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
160865564|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
160865565|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
160865566|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
160865567|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
160865568|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
160865569|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
160865570|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
160865571|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
160865572|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
160865573|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
160865574|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
160865575|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
160865576|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
160865577|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
160865578|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
160865579|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
160865580|NCT03722238|580902902|FG000|Overall Study|Protocol Violation|1|||
160865581|NCT03722238|580902903|FG001|Overall Study|Protocol Violation|0|||
160865582|NCT03722238|580902902|FG000|Overall Study|Physician Decision|1|||
160979063|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
160979064|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979065|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979066|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979067|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979068|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979069|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979070|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979071|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979072|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160865583|NCT03722238|580902903|FG001|Overall Study|Physician Decision|0|||
160865584|NCT03722238|580902902|FG000|Overall Study|Death|1|||
160865585|NCT03722238|580902903|FG001|Overall Study|Death|0|||
160865586|NCT03722238|580902902|FG000|Overall Study|Lost to Follow-up|6|||
160979073|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979074|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979075|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979076|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979077|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160865587|NCT03722238|580902903|FG001|Overall Study|Lost to Follow-up|0|||
160865588|NCT03722238|580902902|FG000|Overall Study|Partial missing data|44|||
160865589|NCT03722238|580902903|FG001|Overall Study|Partial missing data|1|||
160865590|NCT03722238|580902902|FG000|Overall Study|Withdrawal by Subject|2|||
160865591|NCT03722238|580902903|FG001|Overall Study|Withdrawal by Subject|0|||
160979078|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979079|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
160979080|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979081|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979082|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
160979083|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Death|0|||
160979084|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Death|0|||
160865592|NCT03722238|580902902|FG000|Overall Study|Other|4|||
160865593|NCT03722238|580902903|FG001|Overall Study|Other|0|||
160865594|NCT03722238|580902902|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
160865595|NCT03722238|580902903|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
160865596|NCT03722238|580902902|FG000|Overall Study|Did not meet risk classification group criteria|90|||
160865597|NCT03722238|580902903|FG001|Overall Study|Did not meet risk classification group criteria|0|||
160865598|NCT03722238|580902902|FG000|Overall Study|Did not sign consent|17|||
160865599|NCT03722238|580902903|FG001|Overall Study|Did not sign consent|0|||
160865600|NCT03722238|580902902|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
160865601|NCT03722238|580902903|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
160865602|NCT03722238|580902902|FG000|Overall Study|Not willing to purchase study medication|142|||
160865603|NCT03722238|580902903|FG001|Overall Study|Not willing to purchase study medication|0|||
160865604|NCT03722238|580902902|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
160865605|NCT03722238|580902903|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
160865606|NCT02085460|580902904|FG000|Overall Study|Adverse Event|2|||
160865607|NCT02085460|580902905|FG001|Overall Study|Adverse Event|2|||
160865608|NCT02085460|580902906|FG002|Overall Study|Adverse Event|1|||
160865609|NCT02085460|580902904|FG000|Overall Study|Physician Decision|1|||
160865610|NCT02085460|580902905|FG001|Overall Study|Physician Decision|1|||
160865611|NCT02085460|580902906|FG002|Overall Study|Physician Decision|2|||
160865612|NCT02085460|580902904|FG000|Overall Study|Withdrawal by Subject|11|||
160865613|NCT02085460|580902905|FG001|Overall Study|Withdrawal by Subject|5|||
160865614|NCT02085460|580902906|FG002|Overall Study|Withdrawal by Subject|7|||
160865615|NCT02606643|580902907|FG000|Overall Study|did not meet inclusion criteria|1|||
160979085|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Death|0|||
160979086|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Death|0|||
160979087|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Death|0|||
160979088|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Death|0|||
160979089|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Death|0|||
160979090|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Death|0|||
160979091|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Death|0|||
160979092|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Death|0|||
160979093|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Death|0|||
160979094|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Death|0|||
160979095|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Death|0|||
160979096|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Death|0|||
160979097|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Death|0|||
160979098|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Death|0|||
160979099|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Death|1|||
160979100|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Death|0|||
160979101|NCT01118962|581311919|FG000|Overall Study|Adverse Event|2|||
160979102|NCT01118962|581311919|FG000|Overall Study|Lack of Efficacy|1|||
160979103|NCT01118962|581311919|FG000|Overall Study|Protocol Violation|1|||
160979104|NCT01118962|581311919|FG000|Overall Study|Withdrawal by Subject|4|||
160979105|NCT01118962|581311919|FG000|Overall Study|Pregnancy|1|||
160979106|NCT01118962|581311919|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
160979107|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
160979108|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
160979109|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
160979110|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
160979111|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
160979112|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
160979113|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
160979114|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
160979115|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
160979116|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
160979117|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
160979118|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
160979119|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
160979120|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
160979121|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
160979122|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
160979123|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
160979124|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
160979125|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
160979126|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
160979127|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
160979128|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
160979129|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
160979130|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
160979131|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
160979132|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
160979133|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
160979134|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
160979135|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
160979136|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
160979137|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
160979138|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
160979139|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
160979140|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
160979141|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
160979142|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
160979143|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
160979144|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
160979145|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
160979146|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
160979147|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
160979148|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
160979149|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
160979150|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
160979151|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
160979152|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
160979153|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
160979154|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
160979155|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
160979156|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
160979157|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
160979158|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
160979159|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
160979160|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
160979161|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
160979162|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
160979163|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
160979164|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
160979165|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
160979166|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
160979167|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
160979168|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
160979169|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
160979170|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
160979171|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
160979172|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
160979173|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
160979174|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
160979175|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
160979176|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
160979177|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
160979178|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
160979179|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
160979180|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
160979181|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
160979182|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
160979183|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
160979184|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
160979185|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
160979186|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
160979187|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
160979188|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
160979189|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
160979190|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
160979191|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
160979192|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
160979193|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
160979194|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
160979195|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
160979196|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
160979197|NCT01702428|581311928|FG000|Overall Study|Adverse Event|2|||
160979198|NCT01702428|581311929|FG001|Overall Study|Adverse Event|0|||
160979199|NCT01702428|581311930|FG002|Overall Study|Adverse Event|0|||
160979200|NCT01702428|581311931|FG003|Overall Study|Adverse Event|0|||
160979201|NCT01702428|581311928|FG000|Overall Study|Lost to Follow-up|33|||
160979202|NCT01702428|581311929|FG001|Overall Study|Lost to Follow-up|41|||
160979203|NCT01702428|581311930|FG002|Overall Study|Lost to Follow-up|37|||
160979204|NCT01702428|581311931|FG003|Overall Study|Lost to Follow-up|44|||
160979205|NCT01702428|581311928|FG000|Overall Study|Parents cannot assist to site|1|||
160979206|NCT01702428|581311929|FG001|Overall Study|Parents cannot assist to site|0|||
160979207|NCT01702428|581311930|FG002|Overall Study|Parents cannot assist to site|1|||
160979208|NCT01702428|581311931|FG003|Overall Study|Parents cannot assist to site|0|||
160979209|NCT01702428|581311928|FG000|Overall Study|Lost Coverage|0|||
160979210|NCT01702428|581311929|FG001|Overall Study|Lost Coverage|0|||
160979211|NCT01702428|581311930|FG002|Overall Study|Lost Coverage|0|||
160979212|NCT01702428|581311931|FG003|Overall Study|Lost Coverage|1|||
160979213|NCT01702428|581311928|FG000|Overall Study|Lost Health Plan|3|||
160979214|NCT01702428|581311929|FG001|Overall Study|Lost Health Plan|5|||
160979215|NCT01702428|581311930|FG002|Overall Study|Lost Health Plan|0|||
160979216|NCT01702428|581311931|FG003|Overall Study|Lost Health Plan|2|||
160979217|NCT01702428|581311928|FG000|Overall Study|Mother transferred care|0|||
160979218|NCT01702428|581311929|FG001|Overall Study|Mother transferred care|1|||
160979219|NCT01702428|581311930|FG002|Overall Study|Mother transferred care|0|||
160979220|NCT01702428|581311931|FG003|Overall Study|Mother transferred care|0|||
160979221|NCT01702428|581311928|FG000|Overall Study|Parents too busy|1|||
160979222|NCT01702428|581311929|FG001|Overall Study|Parents too busy|0|||
160979223|NCT01702428|581311930|FG002|Overall Study|Parents too busy|0|||
160979224|NCT01702428|581311931|FG003|Overall Study|Parents too busy|0|||
160979225|NCT01702428|581311928|FG000|Overall Study|Protocol Violation|3|||
160979226|NCT01702428|581311929|FG001|Overall Study|Protocol Violation|0|||
160979227|NCT01702428|581311930|FG002|Overall Study|Protocol Violation|1|||
160979228|NCT01702428|581311931|FG003|Overall Study|Protocol Violation|0|||
160979229|NCT01702428|581311928|FG000|Overall Study|Withdrawal by Subject|21|||
160979230|NCT01702428|581311929|FG001|Overall Study|Withdrawal by Subject|23|||
160979231|NCT01702428|581311930|FG002|Overall Study|Withdrawal by Subject|14|||
160979232|NCT01702428|581311931|FG003|Overall Study|Withdrawal by Subject|10|||
160979233|NCT02091869|581311932|FG000|Overall Study|Withdrawal by Subject|0|||
160979234|NCT02091869|581311933|FG001|Overall Study|Withdrawal by Subject|3|||
160979235|NCT03685708|581311937|FG000|Overall Study|Withdrawal by Subject|0|||
160979236|NCT03685708|581311938|FG001|Overall Study|Withdrawal by Subject|0|||
160979237|NCT03685708|581311939|FG002|Overall Study|Withdrawal by Subject|1|||
160979238|NCT03685708|581311937|FG000|Overall Study|Screen Fail|0|||
160979239|NCT03685708|581311938|FG001|Overall Study|Screen Fail|1|||
160979240|NCT03685708|581311939|FG002|Overall Study|Screen Fail|1|||
160979241|NCT03685708|581311937|FG000|Overall Study|COVID 19 Pandemic|1|||
160979242|NCT03685708|581311938|FG001|Overall Study|COVID 19 Pandemic|1|||
160979243|NCT03685708|581311939|FG002|Overall Study|COVID 19 Pandemic|6|||
160979244|NCT03685708|581311937|FG000|Overall Study|Disease Progression|0|||
160979245|NCT03685708|581311938|FG001|Overall Study|Disease Progression|0|||
160979246|NCT03685708|581311939|FG002|Overall Study|Disease Progression|1|||
160979247|NCT02771210|581311941|FG000|Period 1|Adverse Event|5|||
160979248|NCT02771210|581311942|FG001|Period 1|Adverse Event|3|||
160979249|NCT02771210|581311941|FG000|Period 1|Lack of Efficacy|3|||
160979250|NCT02771210|581311942|FG001|Period 1|Lack of Efficacy|6|||
160979251|NCT02771210|581311941|FG000|Period 1|Lost to Follow-up|2|||
160979252|NCT02771210|581311942|FG001|Period 1|Lost to Follow-up|0|||
160979253|NCT02771210|581311941|FG000|Period 1|Physician Decision|0|||
160979254|NCT02771210|581311942|FG001|Period 1|Physician Decision|1|||
160979255|NCT02771210|581311941|FG000|Period 1|Withdrawal by Subject|0|||
160979256|NCT02771210|581311942|FG001|Period 1|Withdrawal by Subject|3|||
160979257|NCT02771210|581311941|FG000|Period 1|Withdrawal of informed consent|1|||
160979258|NCT02771210|581311942|FG001|Period 1|Withdrawal of informed consent|5|||
160979259|NCT02771210|581311941|FG000|Period 2|Adverse Event|1|||
160979260|NCT02771210|581311942|FG001|Period 2|Adverse Event|0|||
160979261|NCT02771210|581311941|FG000|Period 2|Lack of Efficacy|0|||
160979262|NCT02771210|581311942|FG001|Period 2|Lack of Efficacy|1|||
160979263|NCT02771210|581311941|FG000|Period 2|Withdrawal by Subject|1|||
160979264|NCT02771210|581311942|FG001|Period 2|Withdrawal by Subject|0|||
160979265|NCT02771210|581311941|FG000|Period 2|Withdrawal of informed consent|0|||
160979266|NCT02771210|581311942|FG001|Period 2|Withdrawal of informed consent|2|||
160979267|NCT04397523|581311943|FG000|Overall Study|Lost to Follow-up|3|||
160979268|NCT04397523|581311943|FG000|Overall Study|Transfer from/to other hospital|8|||
160979269|NCT01275196|581311944|FG000|Overall Study|Adverse Event|3|||
160979270|NCT01275196|581311945|FG001|Overall Study|Adverse Event|5|||
160979271|NCT01275196|581311944|FG000|Overall Study|Withdrawal by Subject|4|||
160979272|NCT01275196|581311945|FG001|Overall Study|Withdrawal by Subject|5|||
160979273|NCT01275196|581311944|FG000|Overall Study|Lost to Follow-up|1|||
160979274|NCT01275196|581311945|FG001|Overall Study|Lost to Follow-up|0|||
160979275|NCT01275196|581311944|FG000|Overall Study|Disease Progression|6|||
160979276|NCT01275196|581311945|FG001|Overall Study|Disease Progression|5|||
160979277|NCT01275196|581311944|FG000|Overall Study|Protocol Violation|1|||
160979278|NCT01275196|581311945|FG001|Overall Study|Protocol Violation|0|||
160979279|NCT01275196|581311944|FG000|Overall Study|Suboptimal response/treatment failure|5|||
160979280|NCT01275196|581311945|FG001|Overall Study|Suboptimal response/treatment failure|6|||
160979281|NCT02222896|581311948|FG000|Abdomen|Did not qualify|34|||
160979282|NCT02222896|581311949|FG001|Abdomen|Did not qualify|10|||
160979283|NCT02222896|581311950|FG002|Abdomen|Did not qualify|32|||
160979284|NCT02222896|581311948|FG000|Groin|Did not qualify|43|||
160979285|NCT02222896|581311949|FG001|Groin|Did not qualify|9|||
160979286|NCT02222896|581311950|FG002|Groin|Did not qualify|40|||
160979287|NCT01744496|581311951|FG000|Titration Period|Adverse Event|2|||
160979288|NCT01744496|581311952|FG001|Titration Period|Adverse Event|1|||
160979289|NCT01744496|581311951|FG000|Titration Period|Personal reasons|0|||
160979290|NCT01744496|581311952|FG001|Titration Period|Personal reasons|1|||
160979291|NCT01744496|581311951|FG000|Maintenance Period|Adverse Event|1|||
160979292|NCT01744496|581311952|FG001|Maintenance Period|Adverse Event|3|||
160979293|NCT01744496|581311951|FG000|Maintenance Period|Protocol Violation|1|||
160979294|NCT01744496|581311952|FG001|Maintenance Period|Protocol Violation|0|||
160979295|NCT01744496|581311951|FG000|Maintenance Period|Withdrawal by Subject|1|||
160979296|NCT01744496|581311952|FG001|Maintenance Period|Withdrawal by Subject|1|||
160979297|NCT01744496|581311951|FG000|Maintenance Period|Subject left town|1|||
160979298|NCT01744496|581311952|FG001|Maintenance Period|Subject left town|0|||
160979299|NCT01865617|581311956|FG000|Overall Study|Death|27|||
160979300|NCT01865617|581311957|FG001|Overall Study|Death|3|||
160979301|NCT01865617|581311958|FG002|Overall Study|Death|1|||
160979302|NCT01865617|581311959|FG003|Overall Study|Death|1|||
160979303|NCT01865617|581311960|FG004|Overall Study|Death|5|||
160979304|NCT01865617|581311961|FG005|Overall Study|Death|1|||
160979305|NCT01865617|581311962|FG006|Overall Study|Death|11|||
160979306|NCT01865617|581311963|FG007|Overall Study|Death|1|||
160979307|NCT01865617|581311964|FG008|Overall Study|Death|11|||
160979308|NCT01865617|581311965|FG009|Overall Study|Death|3|||
160979309|NCT01865617|581311966|FG010|Overall Study|Death|32|||
160979310|NCT01865617|581311967|FG011|Overall Study|Death|6|||
160979311|NCT01865617|581311968|FG012|Overall Study|Death|13|||
160979312|NCT01865617|581311956|FG000|Overall Study|Lost to Follow-up|2|||
160979313|NCT01865617|581311957|FG001|Overall Study|Lost to Follow-up|0|||
160979314|NCT01865617|581311958|FG002|Overall Study|Lost to Follow-up|0|||
160979315|NCT01865617|581311959|FG003|Overall Study|Lost to Follow-up|0|||
160979316|NCT01865617|581311960|FG004|Overall Study|Lost to Follow-up|0|||
160979317|NCT01865617|581311961|FG005|Overall Study|Lost to Follow-up|0|||
160979318|NCT01865617|581311962|FG006|Overall Study|Lost to Follow-up|0|||
160979319|NCT01865617|581311963|FG007|Overall Study|Lost to Follow-up|0|||
160979320|NCT01865617|581311964|FG008|Overall Study|Lost to Follow-up|0|||
160979321|NCT01865617|581311965|FG009|Overall Study|Lost to Follow-up|0|||
160979322|NCT01865617|581311966|FG010|Overall Study|Lost to Follow-up|0|||
160979323|NCT01865617|581311967|FG011|Overall Study|Lost to Follow-up|0|||
160979324|NCT01865617|581311968|FG012|Overall Study|Lost to Follow-up|0|||
160979325|NCT01865617|581311956|FG000|Overall Study|Withdrawal by Subject|1|||
160979326|NCT01865617|581311957|FG001|Overall Study|Withdrawal by Subject|0|||
160979327|NCT01865617|581311958|FG002|Overall Study|Withdrawal by Subject|0|||
160979328|NCT01865617|581311959|FG003|Overall Study|Withdrawal by Subject|0|||
160979329|NCT01865617|581311960|FG004|Overall Study|Withdrawal by Subject|0|||
160979330|NCT01865617|581311961|FG005|Overall Study|Withdrawal by Subject|0|||
160979331|NCT01865617|581311962|FG006|Overall Study|Withdrawal by Subject|0|||
160979332|NCT01865617|581311963|FG007|Overall Study|Withdrawal by Subject|0|||
160979333|NCT01865617|581311964|FG008|Overall Study|Withdrawal by Subject|0|||
160979334|NCT01865617|581311965|FG009|Overall Study|Withdrawal by Subject|0|||
160979335|NCT01865617|581311966|FG010|Overall Study|Withdrawal by Subject|0|||
160979336|NCT01865617|581311967|FG011|Overall Study|Withdrawal by Subject|0|||
160979337|NCT01865617|581311968|FG012|Overall Study|Withdrawal by Subject|0|||
160979338|NCT01865617|581311956|FG000|Overall Study|Patient proceeded to new therapy|0|||
160979339|NCT01865617|581311957|FG001|Overall Study|Patient proceeded to new therapy|0|||
160979340|NCT01865617|581311958|FG002|Overall Study|Patient proceeded to new therapy|0|||
160979341|NCT01865617|581311959|FG003|Overall Study|Patient proceeded to new therapy|0|||
160979342|NCT01865617|581311960|FG004|Overall Study|Patient proceeded to new therapy|2|||
160979343|NCT01865617|581311961|FG005|Overall Study|Patient proceeded to new therapy|0|||
160979344|NCT01865617|581311962|FG006|Overall Study|Patient proceeded to new therapy|0|||
160979345|NCT01865617|581311963|FG007|Overall Study|Patient proceeded to new therapy|0|||
160979346|NCT01865617|581311964|FG008|Overall Study|Patient proceeded to new therapy|0|||
160979347|NCT01865617|581311965|FG009|Overall Study|Patient proceeded to new therapy|0|||
160979348|NCT01865617|581311966|FG010|Overall Study|Patient proceeded to new therapy|0|||
160979349|NCT01865617|581311967|FG011|Overall Study|Patient proceeded to new therapy|0|||
160979350|NCT01865617|581311968|FG012|Overall Study|Patient proceeded to new therapy|0|||
160979351|NCT01865617|581311956|FG000|Overall Study|Other|0|||
160979352|NCT01865617|581311957|FG001|Overall Study|Other|0|||
160979353|NCT01865617|581311958|FG002|Overall Study|Other|0|||
160979354|NCT01865617|581311959|FG003|Overall Study|Other|0|||
160979355|NCT01865617|581311960|FG004|Overall Study|Other|0|||
160979356|NCT01865617|581311961|FG005|Overall Study|Other|0|||
160979357|NCT01865617|581311962|FG006|Overall Study|Other|1|||
160979358|NCT01865617|581311963|FG007|Overall Study|Other|0|||
160979359|NCT01865617|581311964|FG008|Overall Study|Other|0|||
160979360|NCT01865617|581311965|FG009|Overall Study|Other|0|||
160979361|NCT01865617|581311966|FG010|Overall Study|Other|0|||
160979362|NCT01865617|581311967|FG011|Overall Study|Other|0|||
160979363|NCT01865617|581311968|FG012|Overall Study|Other|0|||
160979364|NCT02500979|581311969|FG000|Period 1|Hyperglycemia|1|||
160979365|NCT02500979|581311970|FG001|Period 1|Hyperglycemia|0|||
160979366|NCT02500979|581311969|FG000|Period 1|Severe non-compliance to protocol|0|||
160979367|NCT02500979|581311970|FG001|Period 1|Severe non-compliance to protocol|1|||
160979368|NCT02500979|581311969|FG000|Period 1|Adverse Event|1|||
160979369|NCT02500979|581311970|FG001|Period 1|Adverse Event|0|||
160979370|NCT02500979|581311969|FG000|Period 1|Subject decision|2|||
160979371|NCT02500979|581311970|FG001|Period 1|Subject decision|0|||
160979372|NCT02500979|581311969|FG000|Period 2|Change in risk|1|||
160979373|NCT02500979|581311970|FG001|Period 2|Change in risk|0|||
160979374|NCT02796963|581311971|FG000|Overall Study|Lost to Follow-up|89|||
160979375|NCT02796963|581311972|FG001|Overall Study|Lost to Follow-up|76|||
160979376|NCT02796963|581311973|FG002|Overall Study|Lost to Follow-up|69|||
160979377|NCT02796963|581311974|FG003|Overall Study|Lost to Follow-up|72|||
160979378|NCT03192215|581311975|FG000|Overall Study|Death|28|||
160979379|NCT03192215|581311976|FG001|Overall Study|Death|23|||
160979380|NCT03192215|581311975|FG000|Overall Study|Lost to Follow-up|10|||
160979381|NCT03192215|581311976|FG001|Overall Study|Lost to Follow-up|15|||
160979382|NCT03192215|581311975|FG000|Overall Study|Withdrawal by Subject|49|||
160979383|NCT03192215|581311976|FG001|Overall Study|Withdrawal by Subject|48|||
160979384|NCT03192215|581311975|FG000|Overall Study|Other as reported in analysis|4|||
160979385|NCT03192215|581311976|FG001|Overall Study|Other as reported in analysis|1|||
160865616|NCT02606643|580902908|FG001|Overall Study|did not meet inclusion criteria|3|||
160865617|NCT02158546|580902916|FG000|Overall Study|Physician Decision|0|||
160865618|NCT02158546|580902917|FG001|Overall Study|Physician Decision|1|||
160865619|NCT02158546|580902918|FG002|Overall Study|Physician Decision|0|||
160865620|NCT02158546|580902919|FG003|Overall Study|Physician Decision|0|||
160865621|NCT02158546|580902916|FG000|Overall Study|Non-compliance|0|||
160865622|NCT02158546|580902917|FG001|Overall Study|Non-compliance|1|||
160865623|NCT02158546|580902918|FG002|Overall Study|Non-compliance|0|||
160865624|NCT02158546|580902919|FG003|Overall Study|Non-compliance|1|||
160865625|NCT02158546|580902916|FG000|Overall Study|Failure to meet eligibility criteria|0|||
160865626|NCT02158546|580902917|FG001|Overall Study|Failure to meet eligibility criteria|1|||
160865627|NCT02158546|580902918|FG002|Overall Study|Failure to meet eligibility criteria|0|||
160865628|NCT02158546|580902919|FG003|Overall Study|Failure to meet eligibility criteria|0|||
160865629|NCT02158546|580902916|FG000|Overall Study|Lack of Efficacy|1|||
160865630|NCT02158546|580902917|FG001|Overall Study|Lack of Efficacy|1|||
160865631|NCT02158546|580902918|FG002|Overall Study|Lack of Efficacy|0|||
160865632|NCT02158546|580902919|FG003|Overall Study|Lack of Efficacy|0|||
160865633|NCT02158546|580902916|FG000|Overall Study|Adverse Event|2|||
160865634|NCT02158546|580902917|FG001|Overall Study|Adverse Event|2|||
160865635|NCT02158546|580902918|FG002|Overall Study|Adverse Event|0|||
160865636|NCT02158546|580902919|FG003|Overall Study|Adverse Event|0|||
160865637|NCT02158546|580902916|FG000|Overall Study|Withdrawal by Subject|6|||
160865638|NCT02158546|580902917|FG001|Overall Study|Withdrawal by Subject|2|||
160865639|NCT02158546|580902918|FG002|Overall Study|Withdrawal by Subject|1|||
160865640|NCT02158546|580902919|FG003|Overall Study|Withdrawal by Subject|0|||
160865641|NCT02158546|580902916|FG000|Overall Study|Lost to Follow-up|5|||
160865642|NCT02158546|580902917|FG001|Overall Study|Lost to Follow-up|4|||
160865643|NCT02158546|580902918|FG002|Overall Study|Lost to Follow-up|0|||
160865644|NCT02158546|580902919|FG003|Overall Study|Lost to Follow-up|1|||
160865645|NCT02158546|580902916|FG000|Overall Study|Site Excluded|5|||
160865646|NCT02158546|580902917|FG001|Overall Study|Site Excluded|5|||
160865647|NCT02158546|580902918|FG002|Overall Study|Site Excluded|3|||
160865648|NCT02158546|580902919|FG003|Overall Study|Site Excluded|4|||
160865649|NCT00891904|580902924|FG000|Overall Study|Death|1|||
160865650|NCT00891904|580902924|FG000|Overall Study|Adverse Event|1|||
160865651|NCT01046396|580902925|FG000|Overall Study|Withdrawal by Subject|5|||
160865652|NCT01605799|580902936|FG000|Overall Study|Withdrawal by Subject|2|||
160865653|NCT01605799|580902937|FG001|Overall Study|Withdrawal by Subject|1|||
160865654|NCT01055197|580902942|FG000|Overall Study|Protocol Violation|7|||
160865655|NCT01055197|580902943|FG001|Overall Study|Protocol Violation|2|||
160635523|NCT02494583|580047485|FG000|Overall Study|Transferred to Extension Study|15|||
160979386|NCT00119262|581311977|FG000|Overall Study|Lack of Efficacy|0|||
160521749|NCT01315353|579639006|FG002|Overall Study|Inadvertent randomization/assignment|2|||
160979387|NCT00119262|581311978|FG001|Overall Study|Lack of Efficacy|3|||
160979388|NCT00119262|581311977|FG000|Overall Study|Withdrawal by Subject|12|||
160979389|NCT00119262|581311978|FG001|Overall Study|Withdrawal by Subject|11|||
160979390|NCT00119262|581311977|FG000|Overall Study|Adverse Event|33|||
160979391|NCT00119262|581311978|FG001|Overall Study|Adverse Event|35|||
160979392|NCT00119262|581311977|FG000|Overall Study|other disease|0|||
160979393|NCT00119262|581311978|FG001|Overall Study|other disease|2|||
160979394|NCT00119262|581311977|FG000|Overall Study|ineligble|1|||
160979395|NCT00119262|581311978|FG001|Overall Study|ineligble|2|||
160979396|NCT00119262|581311977|FG000|Overall Study|others|0|||
160979397|NCT00119262|581311978|FG001|Overall Study|others|5|||
160979398|NCT03853317|581311979|FG000|Overall Study|Progressive Disease|5|||
160979399|NCT03853317|581311979|FG000|Overall Study|Adverse Event|1|||
160979400|NCT03853317|581311979|FG000|Overall Study|Death|1|||
160979401|NCT03853317|581311979|FG000|Overall Study|other event|2|||
160979402|NCT01551303|581311988|FG000|Overall Study|failed awareness check on vision test|4|||
160979403|NCT01551303|581311989|FG001|Overall Study|failed awareness check on vision test|7|||
160979404|NCT01927731|581311995|FG000|Overall Study|Graft Failure|1|||
160979405|NCT01927731|581311996|FG001|Overall Study|Graft Failure|2|||
160979406|NCT01927731|581311995|FG000|Overall Study|Physician Decision|2|||
160979407|NCT01927731|581311996|FG001|Overall Study|Physician Decision|3|||
160979408|NCT01927731|581311995|FG000|Overall Study|Withdrawal by Subject|0|||
160979409|NCT01927731|581311996|FG001|Overall Study|Withdrawal by Subject|2|||
160979410|NCT01927731|581311995|FG000|Overall Study|Death|0|||
160979411|NCT01927731|581311996|FG001|Overall Study|Death|3|||
160979412|NCT02589392|581312001|FG000|Overall Study|Adverse Event|1|||
160979413|NCT02589392|581312002|FG001|Overall Study|Adverse Event|1|||
160979414|NCT02589392|581312001|FG000|Overall Study|Withdrawal by Subject|1|||
160979415|NCT02589392|581312002|FG001|Overall Study|Withdrawal by Subject|2|||
160979416|NCT02589392|581312001|FG000|Overall Study|Protocol Violation|1|||
160979417|NCT02589392|581312002|FG001|Overall Study|Protocol Violation|1|||
160979418|NCT02589392|581312001|FG000|Overall Study|Lost to Follow-up|2|||
160979419|NCT02589392|581312002|FG001|Overall Study|Lost to Follow-up|2|||
160979420|NCT02589392|581312001|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
160979421|NCT02589392|581312002|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
160979422|NCT00322374|581312004|FG000|Starting Dose|Physician Decision|2|||
160979423|NCT00322374|581312005|FG001|Starting Dose|Physician Decision|0|||
160979424|NCT00322374|581312006|FG002|Starting Dose|Physician Decision|0|||
160979425|NCT00322374|581312007|FG003|Starting Dose|Physician Decision|0|||
160979426|NCT00322374|581312004|FG000|Starting Dose|Study Drug Toxicity|4|||
160979427|NCT00322374|581312005|FG001|Starting Dose|Study Drug Toxicity|0|||
160979428|NCT00322374|581312006|FG002|Starting Dose|Study Drug Toxicity|0|||
160979429|NCT00322374|581312007|FG003|Starting Dose|Study Drug Toxicity|0|||
160979430|NCT00322374|581312004|FG000|First Escalation|Documented Disease Progression|0|||
160979431|NCT00322374|581312005|FG001|First Escalation|Documented Disease Progression|6|||
160979432|NCT00322374|581312006|FG002|First Escalation|Documented Disease Progression|0|||
160979433|NCT00322374|581312007|FG003|First Escalation|Documented Disease Progression|0|||
160979434|NCT00322374|581312004|FG000|First Escalation|Physician Decision|0|||
160979435|NCT00322374|581312005|FG001|First Escalation|Physician Decision|12|||
160979436|NCT00322374|581312006|FG002|First Escalation|Physician Decision|0|||
160979437|NCT00322374|581312007|FG003|First Escalation|Physician Decision|0|||
160979438|NCT00322374|581312004|FG000|First Escalation|Study Drug Toxicity|0|||
160979439|NCT00322374|581312005|FG001|First Escalation|Study Drug Toxicity|11|||
160979440|NCT00322374|581312006|FG002|First Escalation|Study Drug Toxicity|0|||
160979441|NCT00322374|581312007|FG003|First Escalation|Study Drug Toxicity|0|||
160979442|NCT00322374|581312004|FG000|First Escalation|Participant Request|0|||
160979443|NCT00322374|581312005|FG001|First Escalation|Participant Request|1|||
160979444|NCT00322374|581312006|FG002|First Escalation|Participant Request|0|||
160979445|NCT00322374|581312007|FG003|First Escalation|Participant Request|0|||
160979446|NCT00322374|581312004|FG000|Second Escalation|Physician Decision|0|||
160979447|NCT00322374|581312005|FG001|Second Escalation|Physician Decision|0|||
160979448|NCT00322374|581312006|FG002|Second Escalation|Physician Decision|5|||
160979449|NCT00322374|581312007|FG003|Second Escalation|Physician Decision|0|||
160979450|NCT00322374|581312004|FG000|Second Escalation|Study Drug Toxicity|0|||
160979451|NCT00322374|581312005|FG001|Second Escalation|Study Drug Toxicity|0|||
160979452|NCT00322374|581312006|FG002|Second Escalation|Study Drug Toxicity|1|||
160979453|NCT00322374|581312007|FG003|Second Escalation|Study Drug Toxicity|0|||
160979454|NCT03382600|581312008|FG000|Overall Study|Adverse Event|3|||
160979455|NCT03382600|581312009|FG001|Overall Study|Adverse Event|3|||
160979456|NCT03382600|581312008|FG000|Overall Study|Clinical Disease Progression|2|||
160979457|NCT03382600|581312009|FG001|Overall Study|Clinical Disease Progression|4|||
160979458|NCT03382600|581312008|FG000|Overall Study|Radiological Progression|40|||
160979459|NCT03382600|581312009|FG001|Overall Study|Radiological Progression|31|||
160979460|NCT03382600|581312008|FG000|Overall Study|Withdrawal by Subject|0|||
160979461|NCT03382600|581312009|FG001|Overall Study|Withdrawal by Subject|1|||
160979462|NCT03382600|581312008|FG000|Overall Study|Other|9|||
160979463|NCT03382600|581312009|FG001|Overall Study|Other|7|||
160979464|NCT02269943|581312010|FG000|Treatment Period|Death|0|||
160979465|NCT02269943|581312011|FG001|Treatment Period|Death|1|||
160979466|NCT02269943|581312010|FG000|Treatment Period|Adverse Event|1|||
160979467|NCT02269943|581312011|FG001|Treatment Period|Adverse Event|10|||
160979468|NCT02269943|581312010|FG000|Treatment Period|Progressive Disease|5|||
160979469|NCT02269943|581312011|FG001|Treatment Period|Progressive Disease|17|||
160979470|NCT02269943|581312010|FG000|Treatment Period|Symptomatic Deterioration|0|||
160979471|NCT02269943|581312011|FG001|Treatment Period|Symptomatic Deterioration|2|||
160979472|NCT02269943|581312010|FG000|Follow-Up Survival Period|Death|3|||
160979473|NCT02269943|581312011|FG001|Follow-Up Survival Period|Death|16|||
160979474|NCT02269943|581312010|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
160979475|NCT02269943|581312011|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
160979476|NCT02269943|581312010|FG000|Follow-Up Survival Period|Alive|2|||
160979477|NCT02269943|581312011|FG001|Follow-Up Survival Period|Alive|8|||
160979478|NCT02733042|581312012|FG000|Overall Study|Adverse Event|1|||
160979479|NCT02733042|581312013|FG001|Overall Study|Adverse Event|0|||
160979480|NCT02733042|581312014|FG002|Overall Study|Adverse Event|1|||
160979481|NCT02733042|581312015|FG003|Overall Study|Adverse Event|1|||
160979482|NCT02733042|581312016|FG004|Overall Study|Adverse Event|0|||
160979483|NCT02733042|581312017|FG005|Overall Study|Adverse Event|0|||
160979484|NCT02733042|581312018|FG006|Overall Study|Adverse Event|0|||
160979485|NCT02733042|581312019|FG007|Overall Study|Adverse Event|0|||
160979486|NCT02733042|581312020|FG008|Overall Study|Adverse Event|0|||
160979487|NCT02733042|581312021|FG009|Overall Study|Adverse Event|0|||
160979488|NCT02733042|581312022|FG010|Overall Study|Adverse Event|2|||
160979489|NCT02733042|581312023|FG011|Overall Study|Adverse Event|2|||
160979490|NCT02733042|581312024|FG012|Overall Study|Adverse Event|0|||
160979491|NCT02733042|581312025|FG013|Overall Study|Adverse Event|2|||
160979492|NCT02733042|581312026|FG014|Overall Study|Adverse Event|0|||
160979493|NCT02733042|581312027|FG015|Overall Study|Adverse Event|0|||
160979494|NCT02733042|581312028|FG016|Overall Study|Adverse Event|0|||
160979495|NCT02733042|581312029|FG017|Overall Study|Adverse Event|1|||
160979496|NCT02733042|581312030|FG018|Overall Study|Adverse Event|0|||
160979497|NCT02733042|581312012|FG000|Overall Study|Progressive Disease|2|||
160979498|NCT02733042|581312013|FG001|Overall Study|Progressive Disease|1|||
160979499|NCT02733042|581312014|FG002|Overall Study|Progressive Disease|3|||
160979500|NCT02733042|581312015|FG003|Overall Study|Progressive Disease|1|||
160979501|NCT02733042|581312016|FG004|Overall Study|Progressive Disease|2|||
160979502|NCT02733042|581312017|FG005|Overall Study|Progressive Disease|3|||
160979503|NCT02733042|581312018|FG006|Overall Study|Progressive Disease|0|||
160979504|NCT02733042|581312019|FG007|Overall Study|Progressive Disease|3|||
160979505|NCT02733042|581312020|FG008|Overall Study|Progressive Disease|3|||
160979506|NCT02733042|581312021|FG009|Overall Study|Progressive Disease|2|||
160979507|NCT02733042|581312022|FG010|Overall Study|Progressive Disease|2|||
160979508|NCT02733042|581312023|FG011|Overall Study|Progressive Disease|2|||
160979509|NCT02733042|581312024|FG012|Overall Study|Progressive Disease|8|||
160979510|NCT02733042|581312025|FG013|Overall Study|Progressive Disease|1|||
160979511|NCT02733042|581312026|FG014|Overall Study|Progressive Disease|4|||
160979512|NCT02733042|581312027|FG015|Overall Study|Progressive Disease|7|||
160979513|NCT02733042|581312028|FG016|Overall Study|Progressive Disease|2|||
160979514|NCT02733042|581312029|FG017|Overall Study|Progressive Disease|3|||
160979515|NCT02733042|581312030|FG018|Overall Study|Progressive Disease|4|||
160979516|NCT02733042|581312012|FG000|Overall Study|Withdrawal by Subject|0|||
160979517|NCT02733042|581312013|FG001|Overall Study|Withdrawal by Subject|1|||
160979518|NCT02733042|581312014|FG002|Overall Study|Withdrawal by Subject|2|||
160979519|NCT02733042|581312015|FG003|Overall Study|Withdrawal by Subject|1|||
160979520|NCT02733042|581312016|FG004|Overall Study|Withdrawal by Subject|1|||
160979521|NCT02733042|581312017|FG005|Overall Study|Withdrawal by Subject|0|||
160979522|NCT02733042|581312018|FG006|Overall Study|Withdrawal by Subject|0|||
160979523|NCT02733042|581312019|FG007|Overall Study|Withdrawal by Subject|0|||
160979524|NCT02733042|581312020|FG008|Overall Study|Withdrawal by Subject|1|||
160979525|NCT02733042|581312021|FG009|Overall Study|Withdrawal by Subject|1|||
160979526|NCT02733042|581312022|FG010|Overall Study|Withdrawal by Subject|0|||
160979527|NCT02733042|581312023|FG011|Overall Study|Withdrawal by Subject|2|||
160979528|NCT02733042|581312024|FG012|Overall Study|Withdrawal by Subject|1|||
160979529|NCT02733042|581312025|FG013|Overall Study|Withdrawal by Subject|1|||
160979530|NCT02733042|581312026|FG014|Overall Study|Withdrawal by Subject|0|||
160979531|NCT02733042|581312027|FG015|Overall Study|Withdrawal by Subject|0|||
160979532|NCT02733042|581312028|FG016|Overall Study|Withdrawal by Subject|0|||
160979533|NCT02733042|581312029|FG017|Overall Study|Withdrawal by Subject|0|||
160979534|NCT02733042|581312030|FG018|Overall Study|Withdrawal by Subject|0|||
160979535|NCT02733042|581312012|FG000|Overall Study|Other Reasons|0|||
160979536|NCT02733042|581312013|FG001|Overall Study|Other Reasons|0|||
160979537|NCT02733042|581312014|FG002|Overall Study|Other Reasons|1|||
160979538|NCT02733042|581312015|FG003|Overall Study|Other Reasons|0|||
160979539|NCT02733042|581312016|FG004|Overall Study|Other Reasons|0|||
160979540|NCT02733042|581312017|FG005|Overall Study|Other Reasons|0|||
160979541|NCT02733042|581312018|FG006|Overall Study|Other Reasons|0|||
160979542|NCT02733042|581312019|FG007|Overall Study|Other Reasons|0|||
160979543|NCT02733042|581312020|FG008|Overall Study|Other Reasons|0|||
160979544|NCT02733042|581312021|FG009|Overall Study|Other Reasons|1|||
160979545|NCT02733042|581312022|FG010|Overall Study|Other Reasons|1|||
160979546|NCT02733042|581312023|FG011|Overall Study|Other Reasons|0|||
160979547|NCT02733042|581312024|FG012|Overall Study|Other Reasons|0|||
160979548|NCT02733042|581312025|FG013|Overall Study|Other Reasons|0|||
160521750|NCT01009580|579639007|FG000|Overall Study|Adverse Event|4|||
160979549|NCT02733042|581312026|FG014|Overall Study|Other Reasons|0|||
160979550|NCT02733042|581312027|FG015|Overall Study|Other Reasons|1|||
160979551|NCT02733042|581312028|FG016|Overall Study|Other Reasons|0|||
160979552|NCT02733042|581312029|FG017|Overall Study|Other Reasons|1|||
160979553|NCT02733042|581312030|FG018|Overall Study|Other Reasons|0|||
160979554|NCT02733042|581312012|FG000|Overall Study|Death|0|||
160979555|NCT02733042|581312013|FG001|Overall Study|Death|0|||
160979556|NCT02733042|581312014|FG002|Overall Study|Death|0|||
160979557|NCT02733042|581312015|FG003|Overall Study|Death|0|||
160979558|NCT02733042|581312016|FG004|Overall Study|Death|0|||
160979559|NCT02733042|581312017|FG005|Overall Study|Death|0|||
160979560|NCT02733042|581312018|FG006|Overall Study|Death|1|||
160979561|NCT02733042|581312019|FG007|Overall Study|Death|0|||
160979562|NCT02733042|581312020|FG008|Overall Study|Death|1|||
160979563|NCT02733042|581312021|FG009|Overall Study|Death|0|||
160979564|NCT02733042|581312022|FG010|Overall Study|Death|1|||
160979565|NCT02733042|581312023|FG011|Overall Study|Death|0|||
160979566|NCT02733042|581312024|FG012|Overall Study|Death|0|||
160979567|NCT02733042|581312025|FG013|Overall Study|Death|0|||
160979568|NCT02733042|581312026|FG014|Overall Study|Death|1|||
160979569|NCT02733042|581312027|FG015|Overall Study|Death|2|||
160979570|NCT02733042|581312028|FG016|Overall Study|Death|0|||
160979571|NCT02733042|581312029|FG017|Overall Study|Death|0|||
160979572|NCT02733042|581312030|FG018|Overall Study|Death|0|||
160979573|NCT02066532|581312035|FG000|Phase II|Withdrawal by Subject|1|||
160979574|NCT02066532|581312036|FG001|Phase II|Withdrawal by Subject|0|||
160979575|NCT02066532|581312037|FG002|Phase II|Withdrawal by Subject|0|||
160979576|NCT02066532|581312038|FG003|Phase II|Withdrawal by Subject|0|||
160979577|NCT05033080|581312039|FG000|Overall Study|Adverse Event|4|||
160979578|NCT05033080|581312040|FG001|Overall Study|Adverse Event|4|||
160979579|NCT05033080|581312039|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
160979580|NCT05033080|581312040|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
160979581|NCT05033080|581312039|FG000|Overall Study|Lost to Follow-up|1|||
160979582|NCT05033080|581312040|FG001|Overall Study|Lost to Follow-up|0|||
160979583|NCT05033080|581312039|FG000|Overall Study|Other non-compliance|0|||
160979584|NCT05033080|581312040|FG001|Overall Study|Other non-compliance|1|||
160979585|NCT05033080|581312039|FG000|Overall Study|Physician Decision|0|||
160979586|NCT05033080|581312040|FG001|Overall Study|Physician Decision|1|||
160979587|NCT05033080|581312039|FG000|Overall Study|Other|1|||
160979588|NCT05033080|581312040|FG001|Overall Study|Other|1|||
160979589|NCT01233609|581312041|FG000|Overall Study|Death|1|||
160979590|NCT01233609|581312042|FG001|Overall Study|Death|0|||
160979591|NCT01233609|581312041|FG000|Overall Study|Lost to Follow-up|3|||
160979592|NCT01233609|581312042|FG001|Overall Study|Lost to Follow-up|1|||
160979593|NCT01233609|581312041|FG000|Overall Study|Adverse Event|2|||
160979594|NCT01233609|581312042|FG001|Overall Study|Adverse Event|1|||
160979595|NCT01233609|581312041|FG000|Overall Study|Withdrawal by Subject|3|||
160979596|NCT01233609|581312042|FG001|Overall Study|Withdrawal by Subject|0|||
160979597|NCT03391960|581312043|FG000|Overall Study|Protocol Violation|0|||
160979598|NCT03391960|581312044|FG001|Overall Study|Protocol Violation|0|||
160979599|NCT04076020|581313313|FG000|Overall Study|Death|4|||
160979600|NCT04076020|581313314|FG001|Overall Study|Death|6|||
160979601|NCT04076020|581313313|FG000|Overall Study|Withdrawal by Subject|12|||
160979602|NCT04076020|581313314|FG001|Overall Study|Withdrawal by Subject|8|||
160979603|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
160979604|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
160979605|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
160979606|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
160979607|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
160979608|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
160979609|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
160979610|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
160979611|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
160979612|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
160979613|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
160979614|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
160979615|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
160979616|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
160979617|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
160979618|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
160979619|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
160979620|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
160979621|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
160996826|NCT03536884|581373708|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160979622|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
160979623|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
160979624|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
160979625|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
160979626|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
160979627|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
160979628|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
160979629|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
160979630|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
160979631|NCT03230864|581313316|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
160979632|NCT03230864|581313317|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
160979633|NCT03230864|581313318|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
160979634|NCT03230864|581313319|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
160979635|NCT03230864|581313316|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
160979636|NCT03230864|581313317|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
160979637|NCT03230864|581313318|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
160979638|NCT03230864|581313319|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
160979639|NCT03230864|581313316|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
160979640|NCT03230864|581313317|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
160979641|NCT03230864|581313318|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
160979642|NCT03230864|581313319|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
160979643|NCT03537261|581313329|FG000|Overall Study|Lost to Follow-up|4|||
160979644|NCT03537261|581313330|FG001|Overall Study|Lost to Follow-up|5|||
160979645|NCT03537261|581313329|FG000|Overall Study|Withdrawal by Subject|4|||
160979646|NCT03537261|581313330|FG001|Overall Study|Withdrawal by Subject|6|||
160979647|NCT03537261|581313329|FG000|Overall Study|Did not return study questionnaires|0|||
160979648|NCT03537261|581313330|FG001|Overall Study|Did not return study questionnaires|1|||
160979649|NCT00502996|581313333|FG000|Overall Study|Lost to Follow-up|9|||
160979650|NCT00502996|581313333|FG000|Overall Study|Protocol Violation|2|||
160979651|NCT00502996|581313333|FG000|Overall Study|Treatment failure|25|||
160979652|NCT00502996|581313333|FG000|Overall Study|Withdrawal Informed Consent|6|||
160979653|NCT00502996|581313333|FG000|Overall Study|Adverse Event|2|||
160979654|NCT01729728|581313334|FG000|Overall Study|Adverse Event|0|||
160979655|NCT01729728|581313335|FG001|Overall Study|Adverse Event|6|||
160979656|NCT01729728|581313336|FG002|Overall Study|Adverse Event|0|||
160979657|NCT01729728|581313334|FG000|Overall Study|Protocol Violation|1|||
160979658|NCT01729728|581313335|FG001|Overall Study|Protocol Violation|0|||
160979659|NCT01729728|581313336|FG002|Overall Study|Protocol Violation|1|||
160979660|NCT01316692|581313337|FG000|Overall Study|Adverse Event|5|||
160979661|NCT01316692|581313337|FG000|Overall Study|Disease Progression|7|||
160979662|NCT02001974|581313350|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
160979663|NCT02001974|581313351|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
160979664|NCT02001974|581313352|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
160979665|NCT02001974|581313350|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
160979666|NCT02001974|581313351|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
160979667|NCT02001974|581313352|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
160979668|NCT02001974|581313350|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
160979669|NCT02001974|581313351|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
160979670|NCT02001974|581313352|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
160979671|NCT02001974|581313350|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
160979672|NCT02001974|581313351|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
160979673|NCT02001974|581313352|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
160979674|NCT00993317|581313353|FG000|Overall Study|Adverse Event|2|||
160979675|NCT00993317|581313354|FG001|Overall Study|Adverse Event|4|||
160979676|NCT00993317|581313353|FG000|Overall Study|Lack of Efficacy|18|||
160979677|NCT00993317|581313354|FG001|Overall Study|Lack of Efficacy|18|||
160979678|NCT00993317|581313353|FG000|Overall Study|Withdrawal by Subject|0|||
160979679|NCT00993317|581313354|FG001|Overall Study|Withdrawal by Subject|2|||
160979680|NCT00993317|581313353|FG000|Overall Study|Investigator's opinion|0|||
160979681|NCT00993317|581313354|FG001|Overall Study|Investigator's opinion|1|||
160979682|NCT00993317|581313353|FG000|Overall Study|Early study termination at the site|1|||
160979683|NCT00993317|581313354|FG001|Overall Study|Early study termination at the site|0|||
160979684|NCT01380990|581313355|FG000|Overall Study|Treatment Failure|1|||
160979685|NCT01380990|581313356|FG001|Overall Study|Treatment Failure|0|||
160979686|NCT01380990|581313355|FG000|Overall Study|Death|0|||
160979687|NCT01380990|581313356|FG001|Overall Study|Death|1|||
160979688|NCT00672958|581313357|FG000|Overall Study|Adverse Event|11|||
160979689|NCT00672958|581313358|FG001|Overall Study|Adverse Event|9|||
160979690|NCT00672958|581313357|FG000|Overall Study|Lack of Efficacy|6|||
160979691|NCT00672958|581313358|FG001|Overall Study|Lack of Efficacy|11|||
160979692|NCT00672958|581313357|FG000|Overall Study|Non-compliance with study drug|2|||
160979693|NCT00672958|581313358|FG001|Overall Study|Non-compliance with study drug|3|||
160979694|NCT00672958|581313357|FG000|Overall Study|Protocol deviations|11|||
160979695|NCT00672958|581313358|FG001|Overall Study|Protocol deviations|5|||
160979696|NCT00672958|581313357|FG000|Overall Study|Voluntary withdrawal|12|||
160979697|NCT00672958|581313358|FG001|Overall Study|Voluntary withdrawal|8|||
160979698|NCT00672958|581313357|FG000|Overall Study|Lost to Follow-up|22|||
160979699|NCT00672958|581313358|FG001|Overall Study|Lost to Follow-up|17|||
160979700|NCT00672958|581313357|FG000|Overall Study|Reason not specified|0|||
160979701|NCT00672958|581313358|FG001|Overall Study|Reason not specified|3|||
160979702|NCT04422639|581313359|FG000|Overall Study|Death|1|||
160979703|NCT04422639|581313360|FG001|Overall Study|Death|0|||
160979704|NCT04422639|581313359|FG000|Overall Study|study closed prior to completion of FU visits|0|||
160979705|NCT04422639|581313360|FG001|Overall Study|study closed prior to completion of FU visits|2|||
160979706|NCT01964521|581313361|FG000|Overall Study|Lost to Follow-up|4|||
160979707|NCT02374593|581313362|FG000|Overall Study|non-compliant|2|||
160979708|NCT02374593|581313363|FG001|Overall Study|non-compliant|0|||
160979709|NCT01463293|581313365|FG000|Overall Study|Lost to Follow-up|1|||
160979710|NCT01463293|581313366|FG001|Overall Study|Lost to Follow-up|4|||
160979711|NCT01463293|581313367|FG002|Overall Study|Lost to Follow-up|5|||
160979712|NCT01463293|581313365|FG000|Overall Study|Adverse Event|1|||
160979713|NCT01463293|581313366|FG001|Overall Study|Adverse Event|2|||
160979714|NCT01463293|581313367|FG002|Overall Study|Adverse Event|0|||
160979715|NCT01463293|581313365|FG000|Overall Study|Withdrawal by Subject|4|||
160979716|NCT01463293|581313366|FG001|Overall Study|Withdrawal by Subject|10|||
160979717|NCT01463293|581313367|FG002|Overall Study|Withdrawal by Subject|5|||
160979718|NCT01463293|581313365|FG000|Overall Study|Other|0|||
160979719|NCT01463293|581313366|FG001|Overall Study|Other|0|||
160979720|NCT01463293|581313367|FG002|Overall Study|Other|2|||
160979721|NCT01284140|581313368|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
160979722|NCT01284140|581313369|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
160979723|NCT01284140|581313368|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
160979724|NCT01284140|581313369|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
160979725|NCT05376371|581313375|FG000|Overall Study|change in release date|10|||
160979726|NCT03560245|581313377|FG000|Overall Study|Withdrawal by Subject|3|||
160979727|NCT03560245|581313378|FG001|Overall Study|Withdrawal by Subject|2|||
160979728|NCT03560245|581313377|FG000|Overall Study|Adverse Event|1|||
160979729|NCT03560245|581313378|FG001|Overall Study|Adverse Event|1|||
160979730|NCT03560245|581313377|FG000|Overall Study|Protocol Violation|1|||
160979731|NCT03560245|581313378|FG001|Overall Study|Protocol Violation|0|||
160979732|NCT03560245|581313377|FG000|Overall Study|Death|0|||
160979733|NCT03560245|581313378|FG001|Overall Study|Death|1|||
160979734|NCT03560245|581313377|FG000|Overall Study|Lost to Follow-up|0|||
160979735|NCT03560245|581313378|FG001|Overall Study|Lost to Follow-up|1|||
160979736|NCT03560245|581313377|FG000|Overall Study|Physician Decision|0|||
160979737|NCT03560245|581313378|FG001|Overall Study|Physician Decision|1|||
160979738|NCT03560245|581313377|FG000|Overall Study|Other|0|||
160979739|NCT03560245|581313378|FG001|Overall Study|Other|1|||
160979740|NCT00960752|581313385|FG000|Overall Study|Adverse Event|0|||
160979741|NCT00960752|581313386|FG001|Overall Study|Adverse Event|0|||
160979742|NCT00960752|581313387|FG002|Overall Study|Adverse Event|1|||
160979743|NCT00960752|581313385|FG000|Overall Study|Progression|0|||
160979744|NCT00960752|581313386|FG001|Overall Study|Progression|0|||
160979745|NCT00960752|581313387|FG002|Overall Study|Progression|1|||
160979746|NCT02058290|581313391|FG000|Overall Study|Protocol Violation|2|||
160979747|NCT02058290|581313392|FG001|Overall Study|Protocol Violation|1|||
160979748|NCT02058290|581313391|FG000|Overall Study|Physician Decision|1|||
160979749|NCT02058290|581313392|FG001|Overall Study|Physician Decision|0|||
160979750|NCT02058290|581313391|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
160979751|NCT02058290|581313392|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
160979752|NCT02058290|581313391|FG000|Overall Study|Withdrawal by Subject|0|||
160979753|NCT02058290|581313392|FG001|Overall Study|Withdrawal by Subject|1|||
160979754|NCT00105586|581313396|FG000|Overall Study|Adverse Event|4|||
160979755|NCT00105586|581313397|FG001|Overall Study|Adverse Event|3|||
160979756|NCT00105586|581313396|FG000|Overall Study|Physician Decision|13|||
160979757|NCT00105586|581313397|FG001|Overall Study|Physician Decision|13|||
160979758|NCT02262260|581313400|FG000|Overall Study|Adverse Event|4|||
160979759|NCT02262260|581313401|FG001|Overall Study|Adverse Event|1|||
160979760|NCT02262260|581313400|FG000|Overall Study|Withdrawal of consent|4|||
160979761|NCT02262260|581313401|FG001|Overall Study|Withdrawal of consent|2|||
160979762|NCT02262260|581313400|FG000|Overall Study|Lost to Follow-up|1|||
160979763|NCT02262260|581313401|FG001|Overall Study|Lost to Follow-up|2|||
160979764|NCT02262260|581313400|FG000|Overall Study|Protocol deviation|2|||
160979765|NCT02262260|581313401|FG001|Overall Study|Protocol deviation|5|||
160979766|NCT01794117|581313402|FG000|Overall Study|Adverse Event|1|||
160979767|NCT01794117|581313403|FG001|Overall Study|Adverse Event|0|||
160979768|NCT01794117|581313404|FG002|Overall Study|Adverse Event|0|||
160979769|NCT01794117|581313405|FG003|Overall Study|Adverse Event|0|||
160979770|NCT01794117|581313402|FG000|Overall Study|Participant noncompliance|0|||
160979771|NCT01794117|581313403|FG001|Overall Study|Participant noncompliance|1|||
160979772|NCT01794117|581313404|FG002|Overall Study|Participant noncompliance|0|||
160979773|NCT01794117|581313405|FG003|Overall Study|Participant noncompliance|0|||
160979774|NCT01794117|581313402|FG000|Overall Study|Refused further treatment|0|||
160979775|NCT01794117|581313403|FG001|Overall Study|Refused further treatment|2|||
160979776|NCT01794117|581313404|FG002|Overall Study|Refused further treatment|0|||
160979777|NCT01794117|581313405|FG003|Overall Study|Refused further treatment|0|||
160979794|NCT03406702|581313408|FG000|Overall Study|Missed Day 27 Dosing|1|||
160979795|NCT00735644|581313411|FG000|Overall Study|Did not receive study vaccine|0|||
160979796|NCT00735644|581313412|FG001|Overall Study|Did not receive study vaccine|1|||
160979797|NCT00735644|581313413|FG002|Overall Study|Did not receive study vaccine|0|||
160979798|NCT00735644|581313414|FG003|Overall Study|Did not receive study vaccine|0|||
160979799|NCT00735644|581313415|FG004|Overall Study|Did not receive study vaccine|0|||
160979800|NCT00735644|581313411|FG000|Overall Study|Withdrawal by Subject|0|||
160979801|NCT00735644|581313412|FG001|Overall Study|Withdrawal by Subject|1|||
160979802|NCT00735644|581313413|FG002|Overall Study|Withdrawal by Subject|1|||
160979803|NCT00735644|581313414|FG003|Overall Study|Withdrawal by Subject|1|||
160979804|NCT00735644|581313415|FG004|Overall Study|Withdrawal by Subject|0|||
160979805|NCT01040780|581315022|FG000|Overall Study|Protocol Violation|1|||
160979806|NCT01040780|581315023|FG001|Overall Study|Protocol Violation|3|||
160979807|NCT03681639|581315024|FG000|Overall Study|Death|4|||
160979808|NCT03681639|581315024|FG000|Overall Study|Lost to Follow-up|2|||
160979809|NCT03681639|581315024|FG000|Overall Study|Withdrawal by Subject|1|||
160979810|NCT03681639|581315024|FG000|Overall Study|Adverse Event|2|||
160979811|NCT00654940|581315025|FG000|Period 1|Adverse Event|0|||
160979812|NCT00654940|581315026|FG001|Period 1|Adverse Event|1|||
160979813|NCT00654940|581315025|FG000|Period 1|Intolerable Pain Level|1|||
160979814|NCT00654940|581315026|FG001|Period 1|Intolerable Pain Level|0|||
160979815|NCT00581113|581315032|FG000|Overall Study|Withdrawal by Subject|0|||
160979816|NCT00581113|581315033|FG001|Overall Study|Withdrawal by Subject|1|||
160979817|NCT01818141|581315034|FG000|Overall Study|Withdrawal by Subject|2|||
160979818|NCT01818141|581315035|FG001|Overall Study|Withdrawal by Subject|0|||
160979819|NCT01818141|581315034|FG000|Overall Study|No baseline C.diff colonies|1|||
160979820|NCT01818141|581315035|FG001|Overall Study|No baseline C.diff colonies|1|||
160979821|NCT01818141|581315034|FG000|Overall Study|Lost to Follow-up|0|||
160979822|NCT01818141|581315035|FG001|Overall Study|Lost to Follow-up|2|||
160979823|NCT04834362|581315038|FG000|Overall Study|Death|1|||
160979824|NCT04834362|581315039|FG001|Overall Study|Death|2|||
160979825|NCT00329719|581315042|FG000|Overall Study|Lost to Follow-up|0|||
160979826|NCT00329719|581315043|FG001|Overall Study|Lost to Follow-up|0|||
160979827|NCT00329719|581315044|FG002|Overall Study|Lost to Follow-up|0|||
160979828|NCT00329719|581315045|FG003|Overall Study|Lost to Follow-up|1|||
160979829|NCT01809210|581315048|FG000|Overall Study|Withdrawal by Subject|0|||
160979830|NCT01809210|581315049|FG001|Overall Study|Withdrawal by Subject|0|||
160979831|NCT01809210|581315050|FG002|Overall Study|Withdrawal by Subject|1|||
160979832|NCT01809210|581315051|FG003|Overall Study|Withdrawal by Subject|1|||
160979833|NCT01809210|581315052|FG004|Overall Study|Withdrawal by Subject|1|||
160979834|NCT01809210|581315053|FG005|Overall Study|Withdrawal by Subject|0|||
160979835|NCT01809210|581315054|FG006|Overall Study|Withdrawal by Subject|4|||
160979836|NCT01809210|581315048|FG000|Overall Study|Death|1|||
160979837|NCT01809210|581315049|FG001|Overall Study|Death|1|||
160979838|NCT01809210|581315050|FG002|Overall Study|Death|2|||
160979839|NCT01809210|581315051|FG003|Overall Study|Death|0|||
160979840|NCT01809210|581315052|FG004|Overall Study|Death|1|||
160979841|NCT01809210|581315053|FG005|Overall Study|Death|3|||
160979842|NCT01809210|581315054|FG006|Overall Study|Death|1|||
160979843|NCT01668147|581315055|FG000|Overall Study|Withdrawal by Subject|6|||
160979844|NCT01115998|581315058|FG000|Overall Study|Lost to Follow-up|6|||
160979845|NCT01115998|581315059|FG001|Overall Study|Lost to Follow-up|6|||
160979846|NCT00224133|581315060|FG000|Overall Study|Adverse Event|93|||
160979847|NCT00224133|581315060|FG000|Overall Study|Protocol Violation|6|||
160979848|NCT00224133|581315060|FG000|Overall Study|Withdrawal by Subject|33|||
160979849|NCT00224133|581315060|FG000|Overall Study|Lack of Efficacy|58|||
160979850|NCT00224133|581315060|FG000|Overall Study|Lost to Follow-up|21|||
160979851|NCT00224133|581315060|FG000|Overall Study|Physician Decision|1|||
160979852|NCT00224133|581315060|FG000|Overall Study|Other|14|||
160979853|NCT01238575|581315064|FG000|Overall Study|Lack of Efficacy|2|||
160979854|NCT01238575|581315065|FG001|Overall Study|Lack of Efficacy|4|||
160979855|NCT01238575|581315064|FG000|Overall Study|Adverse Event|2|||
160979856|NCT01238575|581315065|FG001|Overall Study|Adverse Event|0|||
160979857|NCT00593554|581315067|FG000|Overall Study|Death|1|||
160979858|NCT00593554|581315068|FG001|Overall Study|Death|2|||
160979859|NCT00593554|581315067|FG000|Overall Study|Physician Decision|0|||
160979860|NCT00593554|581315068|FG001|Overall Study|Physician Decision|1|||
160979861|NCT00593554|581315067|FG000|Overall Study|Withdrawal by Subject|1|||
160979862|NCT00593554|581315068|FG001|Overall Study|Withdrawal by Subject|0|||
160979863|NCT00593554|581315067|FG000|Overall Study|Disease Progression|1|||
160979864|NCT00593554|581315068|FG001|Overall Study|Disease Progression|2|||
160979865|NCT00795132|581315071|FG000|Overall Study|Death|1|||
160979866|NCT00795132|581315071|FG000|Overall Study|Relapse|2|||
160979867|NCT00358150|581315076|FG000|Overall Study|Adverse Event|3|||
160979868|NCT00358150|581315076|FG000|Overall Study|Withdrawal by Subject|1|||
160979869|NCT00358150|581315076|FG000|Overall Study|Undefined|3|||
160979870|NCT04747275|581315077|FG000|Overall Study|Study terminated|0|||
160979871|NCT04747275|581315078|FG001|Overall Study|Study terminated|1|||
160979872|NCT03268590|581315081|FG000|Overall Study|Previously unknown exclusion criteria|1|||
160979873|NCT00531011|581315082|FG000|Overall Study|Withdrawal by Subject|2|||
160979874|NCT00531011|581315083|FG001|Overall Study|Withdrawal by Subject|4|||
160979875|NCT00531011|581315082|FG000|Overall Study|Death|1|||
160979876|NCT00531011|581315083|FG001|Overall Study|Death|0|||
160979877|NCT00531011|581315082|FG000|Overall Study|Lost to Follow-up|1|||
160979878|NCT00531011|581315083|FG001|Overall Study|Lost to Follow-up|0|||
160979879|NCT00531011|581315082|FG000|Overall Study|Physician Decision|0|||
160979880|NCT00531011|581315083|FG001|Overall Study|Physician Decision|3|||
160979881|NCT04254679|581315108|FG000|Overall Study|Protocol Violation|1|||
160979882|NCT04254679|581315109|FG001|Overall Study|Protocol Violation|1|||
160979883|NCT04254679|581315108|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
160979884|NCT04254679|581315109|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
160979885|NCT02823964|581315110|FG000|Overall Study|Adverse Event|2|||
160979886|NCT02823964|581315110|FG000|Overall Study|Physician Decision|1|||
160979887|NCT02823964|581315110|FG000|Overall Study|Lack of Efficacy|1|||
160979888|NCT02823964|581315110|FG000|Overall Study|Withdrawal by Subject|1|||
160979889|NCT00610675|581315113|FG000|Overall Study|Untreated|4|||
160979890|NCT00610675|581315113|FG000|Overall Study|Adverse Event|67|||
160979891|NCT00610675|581315113|FG000|Overall Study|Insufficient Effect|31|||
160979892|NCT00610675|581315113|FG000|Overall Study|Withdrawal by Subject|28|||
160979893|NCT00610675|581315113|FG000|Overall Study|Reasons unrelated to trial|27|||
160979894|NCT00610675|581315113|FG000|Overall Study|Lack of Compliance|7|||
160979895|NCT00610675|581315113|FG000|Overall Study|Lost to Follow-up|31|||
160979896|NCT00610675|581315113|FG000|Overall Study|Other reason (not specified)|25|||
160979897|NCT04844918|581315118|FG000|Overall Study|Adverse Event|7|||
160979898|NCT04844918|581315119|FG001|Overall Study|Adverse Event|8|||
160979899|NCT04844918|581315120|FG002|Overall Study|Adverse Event|5|||
160979900|NCT04844918|581315118|FG000|Overall Study|Physician Decision|0|||
160979901|NCT04844918|581315119|FG001|Overall Study|Physician Decision|1|||
160979902|NCT04844918|581315120|FG002|Overall Study|Physician Decision|0|||
160979903|NCT04844918|581315118|FG000|Overall Study|Withdrawal by Subject|6|||
160979904|NCT04844918|581315119|FG001|Overall Study|Withdrawal by Subject|3|||
160979905|NCT04844918|581315120|FG002|Overall Study|Withdrawal by Subject|3|||
160979906|NCT04844918|581315118|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
160979907|NCT04844918|581315119|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
160979908|NCT04844918|581315120|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
160979909|NCT01009047|581315121|FG000|Overall Study|Adverse Event|5|||
160979910|NCT01009047|581315122|FG001|Overall Study|Adverse Event|0|||
160979911|NCT01009047|581315121|FG000|Overall Study|Lost to Follow-up|0|||
160979912|NCT01009047|581315122|FG001|Overall Study|Lost to Follow-up|2|||
160979913|NCT01009047|581315121|FG000|Overall Study|Lack of Efficacy|4|||
160979914|NCT01009047|581315122|FG001|Overall Study|Lack of Efficacy|11|||
160979915|NCT01009047|581315121|FG000|Overall Study|Withdrawal by consent|16|||
160979916|NCT01009047|581315122|FG001|Overall Study|Withdrawal by consent|11|||
160979917|NCT01009047|581315121|FG000|Overall Study|Other|3|||
160979918|NCT01009047|581315122|FG001|Overall Study|Other|2|||
160979919|NCT01630590|581315126|FG000|Overall Study|Adverse Event|9|||
160979920|NCT01630590|581315126|FG000|Overall Study|Lack of Efficacy|37|||
160979921|NCT01630590|581315126|FG000|Overall Study|Withdrawal by Subject|4|||
160979922|NCT01630590|581315126|FG000|Overall Study|2nd primary tumor|2|||
160979923|NCT01630590|581315126|FG000|Overall Study|Automobile accident|1|||
160979924|NCT01630590|581315126|FG000|Overall Study|Maximum benefit|4|||
160979925|NCT02366936|581315127|FG000|Overall Study|Withdrawal by Subject|2|||
160979926|NCT02366936|581315127|FG000|Overall Study|Lost to Follow-up|4|||
160979927|NCT02366936|581315127|FG000|Overall Study|Physician Decision|2|||
160979928|NCT01751113|581315128|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
160979929|NCT01751113|581315129|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
160979930|NCT01751113|581315130|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
160979931|NCT01751113|581315131|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
160979932|NCT01751113|581315132|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
160979933|NCT01751113|581315133|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
160979934|NCT01751113|581315128|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
160979935|NCT01751113|581315129|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
160979936|NCT01751113|581315130|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
160979937|NCT01751113|581315131|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
160979938|NCT01751113|581315132|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
160979939|NCT01751113|581315133|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
160979940|NCT02878213|581315134|FG000|Overall Study|Withdrawal by Subject|2|||
160979941|NCT02878213|581315134|FG000|Overall Study|Adverse Event|1|||
160979942|NCT00363896|581315135|FG000|Overall Study|Withdrawal by Subject|29|||
160979943|NCT00363896|581315136|FG001|Overall Study|Withdrawal by Subject|16|||
160979944|NCT00363896|581315135|FG000|Overall Study|Adverse Event|24|||
160979945|NCT00363896|581315136|FG001|Overall Study|Adverse Event|13|||
160979946|NCT00363896|581315135|FG000|Overall Study|COPD exacerbation|13|||
160979947|NCT00363896|581315136|FG001|Overall Study|COPD exacerbation|7|||
160979948|NCT00363896|581315135|FG000|Overall Study|Lack of Efficacy|12|||
160979949|NCT00363896|581315136|FG001|Overall Study|Lack of Efficacy|8|||
160979950|NCT00363896|581315135|FG000|Overall Study|Protocol Violation|6|||
160979951|NCT00363896|581315136|FG001|Overall Study|Protocol Violation|1|||
160979952|NCT00363896|581315135|FG000|Overall Study|Lost to Follow-up|3|||
160979953|NCT00363896|581315136|FG001|Overall Study|Lost to Follow-up|0|||
160979954|NCT00363896|581315135|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
160979955|NCT00363896|581315136|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
160979956|NCT00363896|581315135|FG000|Overall Study|Other|1|||
160979957|NCT00363896|581315136|FG001|Overall Study|Other|2|||
160979958|NCT01558674|581315137|FG000|Part 1|Study Terminated by Sponsor|10|||
160979959|NCT01558674|581315138|FG001|Part 1|Study Terminated by Sponsor|0|||
160979960|NCT01558674|581315137|FG000|Part 1|Withdrawal by Subject|1|||
160979961|NCT01558674|581315138|FG001|Part 1|Withdrawal by Subject|0|||
160979962|NCT01555021|581315143|FG000|Overall Study|Lost to Follow-up|1|||
160979963|NCT01555021|581315144|FG001|Overall Study|Lost to Follow-up|2|||
160979964|NCT02471404|581315148|FG000|Overall Study|Adverse Event|7|||
160979965|NCT02471404|581315149|FG001|Overall Study|Adverse Event|1|||
160979966|NCT02471404|581315150|FG002|Overall Study|Adverse Event|2|||
160979967|NCT02471404|581315148|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
160979968|NCT02471404|581315149|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
160979969|NCT02471404|581315150|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
160979970|NCT02471404|581315148|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
160979971|NCT02471404|581315149|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
160979972|NCT02471404|581315150|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
160979973|NCT02471404|581315148|FG000|Overall Study|Lost to Follow-up|1|||
160979974|NCT02471404|581315149|FG001|Overall Study|Lost to Follow-up|1|||
160979975|NCT02471404|581315150|FG002|Overall Study|Lost to Follow-up|3|||
160979976|NCT02471404|581315148|FG000|Overall Study|Protocol Violation|1|||
160979977|NCT02471404|581315149|FG001|Overall Study|Protocol Violation|0|||
160979978|NCT02471404|581315150|FG002|Overall Study|Protocol Violation|0|||
160979979|NCT02471404|581315148|FG000|Overall Study|Withdrawal by Subject|8|||
160979980|NCT02471404|581315149|FG001|Overall Study|Withdrawal by Subject|4|||
160979981|NCT02471404|581315150|FG002|Overall Study|Withdrawal by Subject|5|||
160979982|NCT02471404|581315148|FG000|Overall Study|Other reasons not specified|10|||
160979983|NCT02471404|581315149|FG001|Overall Study|Other reasons not specified|7|||
160979984|NCT02471404|581315150|FG002|Overall Study|Other reasons not specified|12|||
160979985|NCT01388530|581315151|FG000|Overall Study|Lost to Follow-up|5|||
160979986|NCT02204293|581315152|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
160979987|NCT02204293|581315153|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
160979988|NCT02204293|581315154|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
160979989|NCT02204293|581315155|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
160979990|NCT02204293|581315156|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
160979991|NCT02204293|581315157|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
160979992|NCT02204293|581315152|FG000|Core Study Part I|Adverse Event|1|||
160979993|NCT02204293|581315153|FG001|Core Study Part I|Adverse Event|0|||
160979994|NCT02204293|581315154|FG002|Core Study Part I|Adverse Event|0|||
160979995|NCT02204293|581315155|FG003|Core Study Part I|Adverse Event|0|||
160979996|NCT02204293|581315156|FG004|Core Study Part I|Adverse Event|0|||
160979997|NCT02204293|581315157|FG005|Core Study Part I|Adverse Event|0|||
160979998|NCT02204293|581315152|FG000|Core Study Part I|Physician Decision|0|||
160979999|NCT02204293|581315153|FG001|Core Study Part I|Physician Decision|3|||
160980000|NCT02204293|581315154|FG002|Core Study Part I|Physician Decision|0|||
160980001|NCT02204293|581315155|FG003|Core Study Part I|Physician Decision|0|||
160980002|NCT02204293|581315156|FG004|Core Study Part I|Physician Decision|0|||
160980003|NCT02204293|581315157|FG005|Core Study Part I|Physician Decision|0|||
160980004|NCT02204293|581315152|FG000|LTE Phase|Study Suspended|0|||
160980005|NCT02204293|581315153|FG001|LTE Phase|Study Suspended|0|||
160980006|NCT02204293|581315154|FG002|LTE Phase|Study Suspended|0|||
160980007|NCT02204293|581315155|FG003|LTE Phase|Study Suspended|0|||
160980008|NCT02204293|581315156|FG004|LTE Phase|Study Suspended|0|||
160980009|NCT02204293|581315157|FG005|LTE Phase|Study Suspended|7|||
160980010|NCT02420327|581315158|FG000|Overall Study|Adverse Event|7|||
160980011|NCT02420327|581315158|FG000|Overall Study|Pregnancy|1|||
160980012|NCT02420327|581315158|FG000|Overall Study|Withdrawal by Subject|6|||
160980013|NCT02420327|581315158|FG000|Overall Study|Lost to Follow-up|1|||
160980014|NCT02420327|581315158|FG000|Overall Study|Protocol Violation|1|||
160980015|NCT01225835|581315161|FG000|Overall Study|Completed protocol|2|||
160980016|NCT01225835|581315162|FG001|Overall Study|Completed protocol|1|||
160980017|NCT01225835|581315161|FG000|Overall Study|Did not meet hCG criterion|2|||
160980018|NCT01225835|581315162|FG001|Overall Study|Did not meet hCG criterion|0|||
160980019|NCT01225835|581315161|FG000|Overall Study|Adverse Event|2|||
160980020|NCT01225835|581315162|FG001|Overall Study|Adverse Event|1|||
160980021|NCT01225835|581315161|FG000|Overall Study|Other|1|||
160980022|NCT01225835|581315162|FG001|Overall Study|Other|1|||
160980023|NCT01146574|581315163|FG000|Overall Study|Death|0|||
160980024|NCT01146574|581315164|FG001|Overall Study|Death|1|||
160980025|NCT01146574|581315165|FG002|Overall Study|Death|1|||
160980026|NCT01146574|581315166|FG003|Overall Study|Death|0|||
160980027|NCT01146574|581315167|FG004|Overall Study|Death|0|||
160980028|NCT01146574|581315168|FG005|Overall Study|Death|0|||
160980029|NCT01146574|581315169|FG006|Overall Study|Death|0|||
160980030|NCT01146574|581315163|FG000|Overall Study|Other reasons|0|||
160980031|NCT01146574|581315164|FG001|Overall Study|Other reasons|0|||
160980032|NCT01146574|581315165|FG002|Overall Study|Other reasons|3|||
160980033|NCT01146574|581315166|FG003|Overall Study|Other reasons|0|||
160980034|NCT01146574|581315167|FG004|Overall Study|Other reasons|0|||
160980035|NCT01146574|581315168|FG005|Overall Study|Other reasons|0|||
160980036|NCT01146574|581315169|FG006|Overall Study|Other reasons|0|||
160980037|NCT01146574|581315163|FG000|Overall Study|Kidney transplant|0|||
160980038|NCT01146574|581315164|FG001|Overall Study|Kidney transplant|0|||
160980039|NCT01146574|581315165|FG002|Overall Study|Kidney transplant|1|||
160980040|NCT01146574|581315166|FG003|Overall Study|Kidney transplant|1|||
160980041|NCT01146574|581315167|FG004|Overall Study|Kidney transplant|0|||
160980042|NCT01146574|581315168|FG005|Overall Study|Kidney transplant|0|||
160980043|NCT01146574|581315169|FG006|Overall Study|Kidney transplant|0|||
160980044|NCT01146574|581315163|FG000|Overall Study|Withdrew consent|0|||
160980045|NCT01146574|581315164|FG001|Overall Study|Withdrew consent|0|||
160980046|NCT01146574|581315165|FG002|Overall Study|Withdrew consent|1|||
160980047|NCT01146574|581315166|FG003|Overall Study|Withdrew consent|1|||
160980048|NCT01146574|581315167|FG004|Overall Study|Withdrew consent|2|||
160980049|NCT01146574|581315168|FG005|Overall Study|Withdrew consent|1|||
160980050|NCT01146574|581315169|FG006|Overall Study|Withdrew consent|1|||
160980051|NCT03051659|581315170|FG000|Treatment Period|Withdrawal by Subject|0|||
160980052|NCT03051659|581315171|FG001|Treatment Period|Withdrawal by Subject|2|||
160980053|NCT03051659|581315170|FG000|Survival Follow-up|Lost to Follow-up|23|||
160980054|NCT03051659|581315171|FG001|Survival Follow-up|Lost to Follow-up|22|||
160980055|NCT01266993|581315172|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
160980056|NCT01266993|581315173|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
160980057|NCT01266993|581315172|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
160980058|NCT01266993|581315173|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
160980059|NCT04779242|581315174|FG000|Overall Study|Adverse Event|1|||
160980060|NCT04779242|581315175|FG001|Overall Study|Adverse Event|1|||
160980061|NCT04779242|581315174|FG000|Overall Study|Lost to Follow-up|2|||
160980062|NCT04779242|581315175|FG001|Overall Study|Lost to Follow-up|4|||
160980063|NCT04779242|581315174|FG000|Overall Study|Withdrawal by Subject|7|||
160980064|NCT04779242|581315175|FG001|Overall Study|Withdrawal by Subject|9|||
160980065|NCT04779242|581315174|FG000|Overall Study|Death|6|||
160980066|NCT04779242|581315175|FG001|Overall Study|Death|6|||
160980067|NCT04779242|581315174|FG000|Overall Study|COVID-19 related reasons|2|||
160980068|NCT04779242|581315175|FG001|Overall Study|COVID-19 related reasons|1|||
160980069|NCT04779242|581315174|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
160521751|NCT01009580|579639008|FG001|Overall Study|Adverse Event|4|||
160980070|NCT04779242|581315175|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
160980071|NCT04779242|581315174|FG000|Overall Study|Martial Law in Ukraine|2|||
160980072|NCT04779242|581315175|FG001|Overall Study|Martial Law in Ukraine|3|||
160980073|NCT00849680|581315180|FG000|Overall Study|Adverse Event|0|||
160980074|NCT00849680|581315181|FG001|Overall Study|Adverse Event|0|||
160980075|NCT00849680|581315182|FG002|Overall Study|Adverse Event|0|||
160980076|NCT00849680|581315183|FG003|Overall Study|Adverse Event|0|||
160980077|NCT00849680|581315184|FG004|Overall Study|Adverse Event|0|||
160980078|NCT00849680|581315185|FG005|Overall Study|Adverse Event|0|||
160980079|NCT00849680|581315186|FG006|Overall Study|Adverse Event|2|||
160980080|NCT00849680|581315187|FG007|Overall Study|Adverse Event|0|||
160980081|NCT00849680|581315180|FG000|Overall Study|Lost to Follow-up|7|||
160980082|NCT00849680|581315181|FG001|Overall Study|Lost to Follow-up|3|||
160980083|NCT00849680|581315182|FG002|Overall Study|Lost to Follow-up|12|||
160980084|NCT00849680|581315183|FG003|Overall Study|Lost to Follow-up|11|||
160980085|NCT00849680|581315184|FG004|Overall Study|Lost to Follow-up|8|||
160980086|NCT00849680|581315185|FG005|Overall Study|Lost to Follow-up|11|||
160980087|NCT00849680|581315186|FG006|Overall Study|Lost to Follow-up|12|||
160980088|NCT00849680|581315187|FG007|Overall Study|Lost to Follow-up|5|||
160980089|NCT00849680|581315180|FG000|Overall Study|Subject moved|1|||
160980090|NCT00849680|581315181|FG001|Overall Study|Subject moved|0|||
160980091|NCT00849680|581315182|FG002|Overall Study|Subject moved|3|||
160980092|NCT00849680|581315183|FG003|Overall Study|Subject moved|1|||
160980093|NCT00849680|581315184|FG004|Overall Study|Subject moved|0|||
160980094|NCT00849680|581315185|FG005|Overall Study|Subject moved|2|||
160980095|NCT00849680|581315186|FG006|Overall Study|Subject moved|2|||
160980096|NCT00849680|581315187|FG007|Overall Study|Subject moved|2|||
160980097|NCT00849680|581315180|FG000|Overall Study|Withdrawal by Subject|2|||
160980098|NCT00849680|581315181|FG001|Overall Study|Withdrawal by Subject|0|||
160980099|NCT00849680|581315182|FG002|Overall Study|Withdrawal by Subject|0|||
160980100|NCT00849680|581315183|FG003|Overall Study|Withdrawal by Subject|2|||
160980101|NCT00849680|581315184|FG004|Overall Study|Withdrawal by Subject|2|||
160980102|NCT00849680|581315185|FG005|Overall Study|Withdrawal by Subject|2|||
160980103|NCT00849680|581315186|FG006|Overall Study|Withdrawal by Subject|1|||
160980104|NCT00849680|581315187|FG007|Overall Study|Withdrawal by Subject|1|||
160980105|NCT00849680|581315180|FG000|Overall Study|Subject unable to comply with protocol|1|||
160980106|NCT00849680|581315181|FG001|Overall Study|Subject unable to comply with protocol|0|||
160980107|NCT00849680|581315182|FG002|Overall Study|Subject unable to comply with protocol|0|||
160980108|NCT00849680|581315183|FG003|Overall Study|Subject unable to comply with protocol|0|||
160980109|NCT00849680|581315184|FG004|Overall Study|Subject unable to comply with protocol|0|||
160980110|NCT00849680|581315185|FG005|Overall Study|Subject unable to comply with protocol|0|||
160980111|NCT00849680|581315186|FG006|Overall Study|Subject unable to comply with protocol|0|||
160980112|NCT00849680|581315187|FG007|Overall Study|Subject unable to comply with protocol|0|||
160980113|NCT04285229|581315188|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
160980114|NCT04285229|581315189|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160980115|NCT04285229|581315190|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160980116|NCT04285229|581315191|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160980117|NCT04285229|581315192|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160980118|NCT04285229|581315193|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160980119|NCT04285229|581315188|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
160980120|NCT04285229|581315189|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
160980121|NCT04285229|581315190|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
160980122|NCT04285229|581315191|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
160980123|NCT04285229|581315192|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
160980124|NCT04285229|581315193|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
160980125|NCT04285229|581315188|FG000|Extended Treatment Period|Adverse Event|0|||
160980126|NCT04285229|581315189|FG001|Extended Treatment Period|Adverse Event|0|||
160980127|NCT04285229|581315190|FG002|Extended Treatment Period|Adverse Event|0|||
160980128|NCT04285229|581315191|FG003|Extended Treatment Period|Adverse Event|1|||
160980129|NCT04285229|581315192|FG004|Extended Treatment Period|Adverse Event|0|||
160980130|NCT04285229|581315193|FG005|Extended Treatment Period|Adverse Event|0|||
160980131|NCT04285229|581315188|FG000|Extended Treatment Period|Physician Decision|0|||
160980132|NCT04285229|581315189|FG001|Extended Treatment Period|Physician Decision|0|||
160980133|NCT04285229|581315190|FG002|Extended Treatment Period|Physician Decision|1|||
160980134|NCT04285229|581315191|FG003|Extended Treatment Period|Physician Decision|0|||
160980135|NCT04285229|581315192|FG004|Extended Treatment Period|Physician Decision|0|||
160980136|NCT04285229|581315193|FG005|Extended Treatment Period|Physician Decision|0|||
160980137|NCT04285229|581315188|FG000|Follow-up Period|Adverse Event|0|||
160980138|NCT04285229|581315189|FG001|Follow-up Period|Adverse Event|0|||
160980139|NCT04285229|581315190|FG002|Follow-up Period|Adverse Event|0|||
160980140|NCT04285229|581315191|FG003|Follow-up Period|Adverse Event|0|||
160980141|NCT04285229|581315192|FG004|Follow-up Period|Adverse Event|1|||
160980142|NCT04285229|581315193|FG005|Follow-up Period|Adverse Event|4|||
160980143|NCT04285229|581315188|FG000|Follow-up Period|Withdrawal by Subject|0|||
160980144|NCT04285229|581315189|FG001|Follow-up Period|Withdrawal by Subject|0|||
160980145|NCT04285229|581315190|FG002|Follow-up Period|Withdrawal by Subject|0|||
160980146|NCT04285229|581315191|FG003|Follow-up Period|Withdrawal by Subject|0|||
160980147|NCT04285229|581315192|FG004|Follow-up Period|Withdrawal by Subject|0|||
160980148|NCT04285229|581315193|FG005|Follow-up Period|Withdrawal by Subject|5|||
160980149|NCT04285229|581315188|FG000|Follow-up Period|Covid-19|0|||
160980150|NCT04285229|581315189|FG001|Follow-up Period|Covid-19|0|||
160980151|NCT04285229|581315190|FG002|Follow-up Period|Covid-19|0|||
160980152|NCT04285229|581315191|FG003|Follow-up Period|Covid-19|0|||
160980153|NCT04285229|581315192|FG004|Follow-up Period|Covid-19|0|||
160980154|NCT04285229|581315193|FG005|Follow-up Period|Covid-19|2|||
160980155|NCT04285229|581315188|FG000|Follow-up Period|Physician Decision|0|||
160980156|NCT04285229|581315189|FG001|Follow-up Period|Physician Decision|0|||
160980157|NCT04285229|581315190|FG002|Follow-up Period|Physician Decision|0|||
160980158|NCT04285229|581315191|FG003|Follow-up Period|Physician Decision|0|||
160980159|NCT04285229|581315192|FG004|Follow-up Period|Physician Decision|0|||
160980160|NCT04285229|581315193|FG005|Follow-up Period|Physician Decision|1|||
160980161|NCT00655551|581315194|FG000|All Periods Combined|Adverse Event|0|||
160980162|NCT00655551|581315195|FG001|All Periods Combined|Adverse Event|3|||
160980163|NCT00655551|581315196|FG002|All Periods Combined|Adverse Event|4|||
160980164|NCT00655551|581315194|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
160980165|NCT00655551|581315195|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
160980166|NCT00655551|581315196|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
160980167|NCT00655551|581315194|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
160980168|NCT00655551|581315195|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
160980169|NCT00655551|581315196|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
160980170|NCT00655551|581315194|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
160980171|NCT00655551|581315195|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
160980172|NCT00655551|581315196|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
160980173|NCT02049710|581315202|FG000|Overall Study|Lost to Follow-up|319|||
160980174|NCT02049710|581315203|FG001|Overall Study|Lost to Follow-up|324|||
160980175|NCT00003458|581315204|FG000|Overall Study|Not evaluable|4|||
160980176|NCT06385483|581315208|FG000|Overall Study|Withdrawal by Subject|2|||
160980177|NCT06385483|581315208|FG000|Overall Study|Never start protocol therapy|2|||
160980178|NCT06385483|581315208|FG000|Overall Study|Disease progression|15|||
160980179|NCT01216293|581315209|FG000|Main Study|Adverse Event|1|||
160980180|NCT01216293|581315210|FG001|Main Study|Adverse Event|4|||
160980181|NCT01216293|581315211|FG002|Main Study|Adverse Event|2|||
160980182|NCT01216293|581315209|FG000|Main Study|Major Protocol Deviation|1|||
160980183|NCT01216293|581315210|FG001|Main Study|Major Protocol Deviation|0|||
160980184|NCT01216293|581315211|FG002|Main Study|Major Protocol Deviation|1|||
160980185|NCT01216293|581315209|FG000|Main Study|Lost to Follow-up|3|||
160980186|NCT01216293|581315210|FG001|Main Study|Lost to Follow-up|1|||
160980187|NCT01216293|581315211|FG002|Main Study|Lost to Follow-up|0|||
160980188|NCT01216293|581315209|FG000|Main Study|Voluntary Withdrawal|2|||
160980189|NCT01216293|581315210|FG001|Main Study|Voluntary Withdrawal|2|||
160980190|NCT01216293|581315211|FG002|Main Study|Voluntary Withdrawal|2|||
160980191|NCT01216293|581315209|FG000|Main Study|Other Reason Not Specified|0|||
160980192|NCT01216293|581315210|FG001|Main Study|Other Reason Not Specified|1|||
160980193|NCT01216293|581315211|FG002|Main Study|Other Reason Not Specified|1|||
160980194|NCT01216293|581315209|FG000|Main Study|Randomized, Not Treated|1|||
160980195|NCT01216293|581315210|FG001|Main Study|Randomized, Not Treated|0|||
160980196|NCT01216293|581315211|FG002|Main Study|Randomized, Not Treated|0|||
160980197|NCT01216293|581315209|FG000|Calcium Absorption Substudy|Adverse Event|0|||
160980198|NCT01216293|581315210|FG001|Calcium Absorption Substudy|Adverse Event|2|||
160980199|NCT01216293|581315211|FG002|Calcium Absorption Substudy|Adverse Event|0|||
160980200|NCT01216293|581315209|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
160980201|NCT01216293|581315210|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
160980202|NCT01216293|581315211|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
160980203|NCT01216293|581315209|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
160980204|NCT01216293|581315210|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
160980205|NCT01216293|581315211|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
160980206|NCT02169830|581317384|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
160980207|NCT02169830|581317385|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
160980208|NCT02169830|581317386|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
160980209|NCT02169830|581317384|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
160980210|NCT02169830|581317385|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
160980211|NCT02169830|581317386|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
160980212|NCT02169830|581317384|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
160980213|NCT02169830|581317385|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
160980214|NCT02169830|581317386|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
160980215|NCT02169830|581317384|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
160980216|NCT02169830|581317385|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
160980217|NCT02169830|581317386|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
160980218|NCT02169830|581317384|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
160980219|NCT02169830|581317385|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
160980220|NCT02169830|581317386|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
160980221|NCT03204695|581317387|FG000|Overall Study|Death|1|||
160980222|NCT03204695|581317387|FG000|Overall Study|Participant was treated with another device|1|||
160980223|NCT03204695|581317387|FG000|Overall Study|Physician Decision|2|||
160980224|NCT04781647|581317391|FG000|Overall Study|Study terminated by Sponsor|11|||
160980225|NCT04781647|581317392|FG001|Overall Study|Study terminated by Sponsor|9|||
160980226|NCT04781647|581317393|FG002|Overall Study|Study terminated by Sponsor|9|||
160980227|NCT04781647|581317391|FG000|Overall Study|Withdrawal by Subject|1|||
160980228|NCT04781647|581317392|FG001|Overall Study|Withdrawal by Subject|2|||
160980229|NCT04781647|581317393|FG002|Overall Study|Withdrawal by Subject|0|||
160980230|NCT04781647|581317391|FG000|Overall Study|Adverse Event|0|||
160980231|NCT04781647|581317392|FG001|Overall Study|Adverse Event|1|||
160980232|NCT04781647|581317393|FG002|Overall Study|Adverse Event|1|||
160980233|NCT04781647|581317391|FG000|Overall Study|Protocol Violation|1|||
160980234|NCT04781647|581317392|FG001|Overall Study|Protocol Violation|0|||
160980235|NCT04781647|581317393|FG002|Overall Study|Protocol Violation|0|||
160980236|NCT04781647|581317391|FG000|Overall Study|Pregnancy|0|||
160980237|NCT04781647|581317392|FG001|Overall Study|Pregnancy|0|||
160980238|NCT04781647|581317393|FG002|Overall Study|Pregnancy|1|||
160980239|NCT04781647|581317391|FG000|Overall Study|Virology rebounded|1|||
160980240|NCT04781647|581317392|FG001|Overall Study|Virology rebounded|0|||
160980241|NCT04781647|581317393|FG002|Overall Study|Virology rebounded|0|||
160980242|NCT00777803|581317394|FG000|Overall Study|Lost to Follow-up|12|||
160980243|NCT00777803|581317395|FG001|Overall Study|Lost to Follow-up|5|||
160980244|NCT00777803|581317394|FG000|Overall Study|Adverse Event|1|||
160980245|NCT00777803|581317395|FG001|Overall Study|Adverse Event|0|||
160980246|NCT00777803|581317394|FG000|Overall Study|Non-compliance|2|||
160980247|NCT00777803|581317395|FG001|Overall Study|Non-compliance|2|||
160980248|NCT01755689|581317396|FG000|Overall Study|Withdrawal by Subject|1|||
160980249|NCT01755689|581317397|FG001|Overall Study|Withdrawal by Subject|3|||
160980250|NCT01755689|581317398|FG002|Overall Study|Withdrawal by Subject|2|||
160980251|NCT01755689|581317399|FG003|Overall Study|Withdrawal by Subject|1|||
160980252|NCT01755689|581317400|FG004|Overall Study|Withdrawal by Subject|1|||
160980253|NCT01755689|581317396|FG000|Overall Study|Migrated/moved from study area|0|||
160980254|NCT01755689|581317397|FG001|Overall Study|Migrated/moved from study area|1|||
160980255|NCT01755689|581317398|FG002|Overall Study|Migrated/moved from study area|1|||
160980256|NCT01755689|581317399|FG003|Overall Study|Migrated/moved from study area|1|||
160980257|NCT01755689|581317400|FG004|Overall Study|Migrated/moved from study area|1|||
160980258|NCT01755689|581317396|FG000|Overall Study|Lost to Follow-up|1|||
160980259|NCT01755689|581317397|FG001|Overall Study|Lost to Follow-up|0|||
160980260|NCT01755689|581317398|FG002|Overall Study|Lost to Follow-up|1|||
160980261|NCT01755689|581317399|FG003|Overall Study|Lost to Follow-up|0|||
160980262|NCT01755689|581317400|FG004|Overall Study|Lost to Follow-up|2|||
160980263|NCT01755689|581317396|FG000|Overall Study|Pregnancy|1|||
160980264|NCT01755689|581317397|FG001|Overall Study|Pregnancy|1|||
160980265|NCT01755689|581317398|FG002|Overall Study|Pregnancy|2|||
160980266|NCT01755689|581317399|FG003|Overall Study|Pregnancy|4|||
160980267|NCT01755689|581317400|FG004|Overall Study|Pregnancy|2|||
160980268|NCT02930122|581317403|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
160980269|NCT02930122|581317404|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
160980270|NCT01995357|581317405|FG000|Period 5|Lack of Efficacy|1|||
160980271|NCT01995357|581317406|FG001|Period 5|Lack of Efficacy|0|||
160980272|NCT01995357|581317407|FG002|Period 5|Lack of Efficacy|0|||
160980273|NCT01995357|581317408|FG003|Period 5|Lack of Efficacy|0|||
160980274|NCT01995357|581317409|FG004|Period 5|Lack of Efficacy|0|||
160980275|NCT01995357|581317410|FG005|Period 5|Lack of Efficacy|0|||
160980276|NCT01995357|581317405|FG000|Period 5|Adverse Event|1|||
160980277|NCT01995357|581317406|FG001|Period 5|Adverse Event|0|||
160980278|NCT01995357|581317407|FG002|Period 5|Adverse Event|1|||
160980279|NCT01995357|581317408|FG003|Period 5|Adverse Event|0|||
160980280|NCT01995357|581317409|FG004|Period 5|Adverse Event|0|||
160980281|NCT01995357|581317410|FG005|Period 5|Adverse Event|0|||
160980282|NCT02609659|581317411|FG000|Overall Study|Adverse Event|1|||
160980283|NCT02609659|581317411|FG000|Overall Study|Lost to Follow-up|6|||
160980284|NCT02609659|581317411|FG000|Overall Study|Other|1|||
160980285|NCT01004250|581317414|FG000|Induction Therapy Period|Adverse Event|10|||
160980286|NCT01004250|581317414|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
160980287|NCT01004250|581317414|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
160980288|NCT01004250|581317414|FG000|Induction Therapy Period|Physician Decision|2|||
160980289|NCT01004250|581317414|FG000|Maintenance Therapy Period|Adverse Event|15|||
160980290|NCT01004250|581317414|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
160980291|NCT01004250|581317414|FG000|Maintenance Therapy Period|Protocol Violation|1|||
160980292|NCT01004250|581317414|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
160980293|NCT01004250|581317414|FG000|Maintenance Therapy Period|Physician Decision|4|||
160980294|NCT01004250|581317414|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
160980295|NCT01853254|581317415|FG000|Overall Study|Abnormal Laboratory Test|1|||
160980296|NCT01853254|581317415|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
160980297|NCT01853254|581317415|FG000|Overall Study|Death|1|||
160980298|NCT01853254|581317415|FG000|Overall Study|Failure to Return|43|||
160980299|NCT01853254|581317415|FG000|Overall Study|Insufficient Therapeutic Response|22|||
160980300|NCT01853254|581317415|FG000|Overall Study|Refusal of Treatment|1|||
160980301|NCT01853254|581317415|FG000|Overall Study|Other Protocol Violation|1|||
160980302|NCT01853254|581317415|FG000|Overall Study|Withdrawal of Consent|16|||
160980303|NCT01853254|581317415|FG000|Overall Study|Administrative/Other|16|||
160980304|NCT02462083|581317416|FG000|Overall Study|Sponsor request|39|||
160980305|NCT02462083|581317416|FG000|Overall Study|Withdrawal by Subject|87|||
160980306|NCT02462083|581317416|FG000|Overall Study|Lost to Follow-up|41|||
160980307|NCT02462083|581317416|FG000|Overall Study|Lack of Efficacy|151|||
160980308|NCT02462083|581317416|FG000|Overall Study|Pregnancy|1|||
160980309|NCT02462083|581317416|FG000|Overall Study|Protocol Violation|6|||
160980310|NCT02462083|581317416|FG000|Overall Study|Adverse Event|33|||
160980311|NCT02462083|581317416|FG000|Overall Study|Worsening condition|16|||
160980312|NCT02462083|581317416|FG000|Overall Study|Other than specified|45|||
160980313|NCT02711995|581317419|FG000|Washout (90 Days)|Conflicting medication|1|||
160980314|NCT01383993|581317425|FG000|Overall Study|Adverse Event|1|||
160980315|NCT01383993|581317426|FG001|Overall Study|Adverse Event|1|||
160980316|NCT01383993|581317427|FG002|Overall Study|Adverse Event|0|||
160980317|NCT01383993|581317425|FG000|Overall Study|Withdrawal by Subject|0|||
160980318|NCT01383993|581317426|FG001|Overall Study|Withdrawal by Subject|0|||
160980319|NCT01383993|581317427|FG002|Overall Study|Withdrawal by Subject|1|||
160980320|NCT01383993|581317425|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
160980321|NCT01383993|581317426|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
160980322|NCT01383993|581317427|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
160980323|NCT01489020|581317432|FG000|Overall Study|Withdrawal by Subject|1|||
160980324|NCT01489020|581317433|FG001|Overall Study|Withdrawal by Subject|0|||
160980325|NCT01489020|581317434|FG002|Overall Study|Withdrawal by Subject|0|||
160980326|NCT01489020|581317435|FG003|Overall Study|Withdrawal by Subject|0|||
160980327|NCT01489020|581317436|FG004|Overall Study|Withdrawal by Subject|0|||
160980328|NCT01489020|581317437|FG005|Overall Study|Withdrawal by Subject|0|||
160980329|NCT01489020|581317432|FG000|Overall Study|Adverse Event|0|||
160980330|NCT01489020|581317433|FG001|Overall Study|Adverse Event|0|||
160980331|NCT01489020|581317434|FG002|Overall Study|Adverse Event|3|||
160980332|NCT01489020|581317435|FG003|Overall Study|Adverse Event|0|||
160980333|NCT01489020|581317436|FG004|Overall Study|Adverse Event|3|||
160980334|NCT01489020|581317437|FG005|Overall Study|Adverse Event|0|||
160980335|NCT01489020|581317432|FG000|Overall Study|Concomitant disease|0|||
160980336|NCT01489020|581317433|FG001|Overall Study|Concomitant disease|0|||
160980337|NCT01489020|581317434|FG002|Overall Study|Concomitant disease|0|||
160980338|NCT01489020|581317435|FG003|Overall Study|Concomitant disease|0|||
160980339|NCT01489020|581317436|FG004|Overall Study|Concomitant disease|3|||
160980340|NCT01489020|581317437|FG005|Overall Study|Concomitant disease|0|||
160980341|NCT02451930|581317439|FG000|Overall Study|Death|0|||
160521752|NCT01009580|579639007|FG000|Overall Study|Lack of Efficacy|0|||
160980342|NCT02451930|581317440|FG001|Overall Study|Death|15|||
160980343|NCT02451930|581317439|FG000|Overall Study|Lost to Follow-up|0|||
160980344|NCT02451930|581317440|FG001|Overall Study|Lost to Follow-up|3|||
160980345|NCT02451930|581317439|FG000|Overall Study|Sponsor Decision|2|||
160980346|NCT02451930|581317440|FG001|Overall Study|Sponsor Decision|10|||
160980347|NCT02451930|581317439|FG000|Overall Study|Withdrawal by Subject|0|||
160980348|NCT02451930|581317440|FG001|Overall Study|Withdrawal by Subject|1|||
160980349|NCT02451930|581317439|FG000|Overall Study|Other|0|||
160980350|NCT02451930|581317440|FG001|Overall Study|Other|1|||
160980351|NCT00962585|581317441|FG000|Overall Study|Adverse Event|0|||
160980352|NCT00962585|581317442|FG001|Overall Study|Adverse Event|2|||
160980353|NCT00962585|581317443|FG002|Overall Study|Adverse Event|1|||
160980354|NCT00962585|581317444|FG003|Overall Study|Adverse Event|0|||
160980355|NCT00962585|581317441|FG000|Overall Study|Lost to Follow-up|3|||
160980356|NCT00962585|581317442|FG001|Overall Study|Lost to Follow-up|0|||
160980357|NCT00962585|581317443|FG002|Overall Study|Lost to Follow-up|1|||
160980358|NCT00962585|581317444|FG003|Overall Study|Lost to Follow-up|0|||
160980359|NCT00962585|581317441|FG000|Overall Study|Protocol Violation|0|||
160980360|NCT00962585|581317442|FG001|Overall Study|Protocol Violation|0|||
160980361|NCT00962585|581317443|FG002|Overall Study|Protocol Violation|1|||
160980362|NCT00962585|581317444|FG003|Overall Study|Protocol Violation|0|||
160980363|NCT00962585|581317441|FG000|Overall Study|Withdrawal by Subject|1|||
160980364|NCT00962585|581317442|FG001|Overall Study|Withdrawal by Subject|0|||
160980365|NCT00962585|581317443|FG002|Overall Study|Withdrawal by Subject|0|||
160980366|NCT00962585|581317444|FG003|Overall Study|Withdrawal by Subject|0|||
160980367|NCT00962585|581317441|FG000|Overall Study|Withdrew Consent|2|||
160980368|NCT00962585|581317442|FG001|Overall Study|Withdrew Consent|0|||
160980369|NCT00962585|581317443|FG002|Overall Study|Withdrew Consent|0|||
160980370|NCT00962585|581317444|FG003|Overall Study|Withdrew Consent|0|||
160980371|NCT00262743|581317445|FG000|Overall Study|Adverse Event|0|||
160980372|NCT00262743|581317446|FG001|Overall Study|Adverse Event|9|||
160749656|NCT01962948|580469640|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
160749657|NCT00376532|580469641|FG000|Overall Study|Lack sufficient blood sample|6|||
160749658|NCT00376532|580469642|FG001|Overall Study|Lack sufficient blood sample|6|||
160749659|NCT01844817|580469643|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
160749660|NCT01844817|580469644|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
160749661|NCT01844817|580469643|FG000|Treatment|Progressive Disease|27|||
160749662|NCT01844817|580469644|FG001|Treatment|Progressive Disease|36|||
160749663|NCT01844817|580469643|FG000|Treatment|Adverse Event|17|||
160749664|NCT01844817|580469644|FG001|Treatment|Adverse Event|9|||
160749665|NCT01844817|580469643|FG000|Treatment|Withdrawal by Subject|10|||
160749666|NCT01844817|580469644|FG001|Treatment|Withdrawal by Subject|6|||
160749667|NCT01844817|580469643|FG000|Treatment|Death|10|||
160749668|NCT01844817|580469644|FG001|Treatment|Death|8|||
160749669|NCT01844817|580469643|FG000|Treatment|Lost to Follow-up|0|||
160749670|NCT01844817|580469644|FG001|Treatment|Lost to Follow-up|1|||
160749671|NCT01844817|580469643|FG000|Treatment|Other|0|||
160749672|NCT01844817|580469644|FG001|Treatment|Other|3|||
160749673|NCT01133704|580469645|FG000|Overall Study|Death|44|||
160749674|NCT01133704|580469646|FG001|Overall Study|Death|26|||
160749675|NCT01133704|580469645|FG000|Overall Study|Patient refused to continue|4|||
160749676|NCT01133704|580469646|FG001|Overall Study|Patient refused to continue|0|||
160749677|NCT01133704|580469645|FG000|Overall Study|Study Closure|1|||
160749678|NCT01133704|580469646|FG001|Overall Study|Study Closure|0|||
160749679|NCT02849704|580469647|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
160749680|NCT02849704|580469648|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
160749681|NCT02849704|580469647|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
160749682|NCT02849704|580469648|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
160749683|NCT02849704|580469647|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
160749684|NCT02849704|580469648|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
160749685|NCT02362425|580469654|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
160749686|NCT02362425|580469655|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
160749687|NCT02362425|580469656|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
160749688|NCT02362425|580469657|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
160749689|NCT02362425|580469654|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
160749690|NCT02362425|580469655|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
160749691|NCT02362425|580469656|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
160749692|NCT02362425|580469657|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
160749693|NCT02362425|580469654|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
160749694|NCT02362425|580469655|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
160749695|NCT02362425|580469656|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
160749696|NCT02362425|580469657|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
160749697|NCT02362425|580469654|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
160749698|NCT02362425|580469655|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
160749699|NCT02362425|580469656|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
160749700|NCT02362425|580469657|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
160749701|NCT02362425|580469654|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
160749702|NCT02362425|580469655|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
160749703|NCT02362425|580469656|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
160749704|NCT02362425|580469657|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
160749705|NCT02362425|580469654|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
160749706|NCT02362425|580469655|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
160980373|NCT00262743|581317445|FG000|Overall Study|Disease progression|0|||
160980374|NCT00262743|581317446|FG001|Overall Study|Disease progression|3|||
160980375|NCT02485353|581317447|FG000|Overall Study|Death|1|||
160980376|NCT02485353|581317447|FG000|Overall Study|Disease Progression|1|||
160980377|NCT04430335|581317456|FG000|Overall Study|Withdrawal by Subject|1|||
160980378|NCT00179010|581317459|FG000|Overall Study|Muscle probe defective|1|||
160980379|NCT00179010|581317460|FG001|Overall Study|Muscle probe defective|1|||
160980380|NCT00179010|581317459|FG000|Overall Study|Failure to place arterial line|0|||
160980381|NCT00179010|581317460|FG001|Overall Study|Failure to place arterial line|1|||
160980382|NCT03249376|581317478|FG000|Overall Study|Adverse Event|11|||
160980383|NCT03249376|581317479|FG001|Overall Study|Adverse Event|5|||
160980384|NCT03249376|581317478|FG000|Overall Study|Lack of Efficacy|2|||
160980385|NCT03249376|581317479|FG001|Overall Study|Lack of Efficacy|4|||
160980386|NCT03249376|581317478|FG000|Overall Study|Protocol Violation|3|||
160980387|NCT03249376|581317479|FG001|Overall Study|Protocol Violation|2|||
160980388|NCT03249376|581317478|FG000|Overall Study|Physician Decision|0|||
160980389|NCT03249376|581317479|FG001|Overall Study|Physician Decision|2|||
160980390|NCT03249376|581317478|FG000|Overall Study|Withdrawal by Subject|3|||
160980391|NCT03249376|581317479|FG001|Overall Study|Withdrawal by Subject|9|||
160980392|NCT03249376|581317478|FG000|Overall Study|LTFU|2|||
160980393|NCT03249376|581317479|FG001|Overall Study|LTFU|1|||
160980394|NCT00627042|581317480|FG000|Overall Study|Withdrawal by Subject|2|||
160980395|NCT00794820|581317488|FG000|Overall Study|Adverse Event|11|||
160980396|NCT00794820|581317488|FG000|Overall Study|Secondary Malignancies|2|||
160980397|NCT00794820|581317488|FG000|Overall Study|Resistant Disease|2|||
160980398|NCT00794820|581317488|FG000|Overall Study|Ineligible/Screen Failure|1|||
160980399|NCT00432679|581317492|FG000|Overall Study|Adverse Event|2|||
160980400|NCT00432679|581317493|FG001|Overall Study|Adverse Event|1|||
160980401|NCT00432679|581317492|FG000|Overall Study|Withdrawal by Subject|3|||
160980402|NCT00432679|581317493|FG001|Overall Study|Withdrawal by Subject|2|||
160980403|NCT00280293|581317495|FG000|Overall Study|Protocol Violation|3|||
160980404|NCT00280293|581317496|FG001|Overall Study|Protocol Violation|0|||
160980405|NCT00280293|581317495|FG000|Overall Study|Physician Decision|5|||
160980406|NCT00280293|581317496|FG001|Overall Study|Physician Decision|4|||
160980407|NCT00280293|581317495|FG000|Overall Study|Lost to Follow-up|14|||
160980408|NCT00280293|581317496|FG001|Overall Study|Lost to Follow-up|12|||
160521753|NCT01009580|579639008|FG001|Overall Study|Lack of Efficacy|1|||
160980409|NCT00280293|581317495|FG000|Overall Study|Withdrawal by Subject|3|||
160980410|NCT00280293|581317496|FG001|Overall Study|Withdrawal by Subject|5|||
160980411|NCT00280293|581317495|FG000|Overall Study|Incarceration/Legal Reasons|1|||
160980412|NCT00280293|581317496|FG001|Overall Study|Incarceration/Legal Reasons|1|||
160980413|NCT00280293|581317495|FG000|Overall Study|Adverse Event|0|||
160980414|NCT00280293|581317496|FG001|Overall Study|Adverse Event|1|||
160980415|NCT01177813|581317497|FG000|Overall Study|Adverse Event|8|||
160980416|NCT01177813|581317498|FG001|Overall Study|Adverse Event|2|||
160980417|NCT01177813|581317499|FG002|Overall Study|Adverse Event|4|||
160980418|NCT01177813|581317500|FG003|Overall Study|Adverse Event|6|||
160980419|NCT01177813|581317501|FG004|Overall Study|Adverse Event|3|||
160980420|NCT01177813|581317497|FG000|Overall Study|Lack of Efficacy|1|||
160521754|NCT01009580|579639007|FG000|Overall Study|Protocol Violation|2|||
160521755|NCT01009580|579639008|FG001|Overall Study|Protocol Violation|3|||
160749707|NCT02362425|580469656|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
160980421|NCT01177813|581317498|FG001|Overall Study|Lack of Efficacy|0|||
160980422|NCT01177813|581317499|FG002|Overall Study|Lack of Efficacy|0|||
160980423|NCT01177813|581317500|FG003|Overall Study|Lack of Efficacy|0|||
160980424|NCT01177813|581317501|FG004|Overall Study|Lack of Efficacy|0|||
160980425|NCT01177813|581317497|FG000|Overall Study|Protocol Violation|3|||
160980426|NCT01177813|581317498|FG001|Overall Study|Protocol Violation|2|||
160980427|NCT01177813|581317499|FG002|Overall Study|Protocol Violation|2|||
160980428|NCT01177813|581317500|FG003|Overall Study|Protocol Violation|0|||
160980429|NCT01177813|581317501|FG004|Overall Study|Protocol Violation|1|||
160980430|NCT01177813|581317497|FG000|Overall Study|Lost to Follow-up|12|||
160980431|NCT01177813|581317498|FG001|Overall Study|Lost to Follow-up|5|||
160980432|NCT01177813|581317499|FG002|Overall Study|Lost to Follow-up|6|||
160980433|NCT01177813|581317500|FG003|Overall Study|Lost to Follow-up|3|||
160980434|NCT01177813|581317501|FG004|Overall Study|Lost to Follow-up|0|||
160521756|NCT01009580|579639007|FG000|Overall Study|Withdrawal Criteria|4|||
160980435|NCT01177813|581317497|FG000|Overall Study|Withdrawal by Subject|12|||
160980436|NCT01177813|581317498|FG001|Overall Study|Withdrawal by Subject|7|||
160980437|NCT01177813|581317499|FG002|Overall Study|Withdrawal by Subject|6|||
160980438|NCT01177813|581317500|FG003|Overall Study|Withdrawal by Subject|5|||
160980439|NCT01177813|581317501|FG004|Overall Study|Withdrawal by Subject|3|||
160980440|NCT01177813|581317497|FG000|Overall Study|Other reason not defined above|5|||
160980441|NCT01177813|581317498|FG001|Overall Study|Other reason not defined above|2|||
160980442|NCT01177813|581317499|FG002|Overall Study|Other reason not defined above|2|||
160980443|NCT01177813|581317500|FG003|Overall Study|Other reason not defined above|3|||
160980444|NCT01177813|581317501|FG004|Overall Study|Other reason not defined above|2|||
160980445|NCT02056119|581317506|FG000|Overall Study|Death|1|||
160980446|NCT02056119|581317507|FG001|Overall Study|Death|2|||
160980447|NCT02056119|581317506|FG000|Overall Study|Intubated for less than 24 hrs|2|||
160980448|NCT02056119|581317507|FG001|Overall Study|Intubated for less than 24 hrs|7|||
160980449|NCT02056119|581317506|FG000|Overall Study|No aerosol treatments were given.|3|||
160980450|NCT02056119|581317507|FG001|Overall Study|No aerosol treatments were given.|2|||
160980451|NCT02056119|581317506|FG000|Overall Study|Received Metaneb treatment|0|||
160980452|NCT02056119|581317507|FG001|Overall Study|Received Metaneb treatment|2|||
160980453|NCT02056119|581317506|FG000|Overall Study|Protocol Violation|4|||
160980454|NCT02056119|581317507|FG001|Overall Study|Protocol Violation|7|||
160980455|NCT00983619|581317508|FG000|Overall Study|Lost to Follow-up|0|||
160980456|NCT00983619|581317509|FG001|Overall Study|Lost to Follow-up|1|||
160980457|NCT00983619|581317510|FG002|Overall Study|Lost to Follow-up|0|||
160980458|NCT00983619|581317511|FG003|Overall Study|Lost to Follow-up|0|||
160980459|NCT00983619|581317512|FG004|Overall Study|Lost to Follow-up|0|||
160980460|NCT00983619|581317513|FG005|Overall Study|Lost to Follow-up|2|||
160980461|NCT00983619|581317514|FG006|Overall Study|Lost to Follow-up|0|||
160980462|NCT00983619|581317515|FG007|Overall Study|Lost to Follow-up|0|||
160980463|NCT00983619|581317516|FG008|Overall Study|Lost to Follow-up|0|||
160980464|NCT00983619|581317517|FG009|Overall Study|Lost to Follow-up|0|||
160980465|NCT00983619|581317518|FG010|Overall Study|Lost to Follow-up|0|||
160980466|NCT00983619|581317519|FG011|Overall Study|Lost to Follow-up|2|||
160980467|NCT00983619|581317508|FG000|Overall Study|Withdrawal by Subject|2|||
160980468|NCT00983619|581317509|FG001|Overall Study|Withdrawal by Subject|1|||
160980469|NCT00983619|581317510|FG002|Overall Study|Withdrawal by Subject|1|||
160980470|NCT00983619|581317511|FG003|Overall Study|Withdrawal by Subject|3|||
160980471|NCT00983619|581317512|FG004|Overall Study|Withdrawal by Subject|1|||
160980472|NCT00983619|581317513|FG005|Overall Study|Withdrawal by Subject|23|||
160980473|NCT00983619|581317514|FG006|Overall Study|Withdrawal by Subject|0|||
160980474|NCT00983619|581317515|FG007|Overall Study|Withdrawal by Subject|0|||
160980475|NCT00983619|581317516|FG008|Overall Study|Withdrawal by Subject|0|||
160980476|NCT00983619|581317517|FG009|Overall Study|Withdrawal by Subject|0|||
160980477|NCT00983619|581317518|FG010|Overall Study|Withdrawal by Subject|1|||
160980478|NCT00983619|581317519|FG011|Overall Study|Withdrawal by Subject|1|||
160980479|NCT00983619|581317508|FG000|Overall Study|Death|0|||
160980480|NCT00983619|581317509|FG001|Overall Study|Death|2|||
160980481|NCT00983619|581317510|FG002|Overall Study|Death|2|||
160980482|NCT00983619|581317511|FG003|Overall Study|Death|1|||
160980483|NCT00983619|581317512|FG004|Overall Study|Death|2|||
160980484|NCT00983619|581317513|FG005|Overall Study|Death|30|||
160980485|NCT00983619|581317514|FG006|Overall Study|Death|1|||
160980486|NCT00983619|581317515|FG007|Overall Study|Death|0|||
160980487|NCT00983619|581317516|FG008|Overall Study|Death|1|||
160980488|NCT00983619|581317517|FG009|Overall Study|Death|2|||
160980489|NCT00983619|581317518|FG010|Overall Study|Death|9|||
160980490|NCT00983619|581317519|FG011|Overall Study|Death|8|||
160980491|NCT00983619|581317508|FG000|Overall Study|Other|1|||
160980492|NCT00983619|581317509|FG001|Overall Study|Other|0|||
160980493|NCT00983619|581317510|FG002|Overall Study|Other|0|||
160980494|NCT00983619|581317511|FG003|Overall Study|Other|1|||
160980495|NCT00983619|581317512|FG004|Overall Study|Other|0|||
160980496|NCT00983619|581317513|FG005|Overall Study|Other|12|||
160980497|NCT00983619|581317514|FG006|Overall Study|Other|2|||
160980498|NCT00983619|581317515|FG007|Overall Study|Other|2|||
160980499|NCT00983619|581317516|FG008|Overall Study|Other|0|||
160980500|NCT00983619|581317517|FG009|Overall Study|Other|1|||
160980501|NCT00983619|581317518|FG010|Overall Study|Other|1|||
160980502|NCT00983619|581317519|FG011|Overall Study|Other|0|||
160980503|NCT04716881|581317520|FG000|Overall Study|Adverse Event|1|||
160980504|NCT04716881|581317520|FG000|Overall Study|Lost to Follow-up|1|||
160980505|NCT02443103|581317521|FG000|Overall Study|Adverse Event|2|||
160980506|NCT02443103|581317521|FG000|Overall Study|Noncompliance|1|||
160980507|NCT04147260|581317522|FG000|Overall Study|Adverse Event|1|||
160980508|NCT04147260|581317523|FG001|Overall Study|Adverse Event|0|||
160980509|NCT04147260|581317524|FG002|Overall Study|Adverse Event|1|||
160980510|NCT04147260|581317525|FG003|Overall Study|Adverse Event|2|||
160980511|NCT04147260|581317526|FG004|Overall Study|Adverse Event|0|||
160980512|NCT04147260|581317522|FG000|Overall Study|Withdrawal by Subject|0|||
160980513|NCT04147260|581317523|FG001|Overall Study|Withdrawal by Subject|0|||
160980514|NCT04147260|581317524|FG002|Overall Study|Withdrawal by Subject|1|||
160980515|NCT04147260|581317525|FG003|Overall Study|Withdrawal by Subject|1|||
160980516|NCT04147260|581317526|FG004|Overall Study|Withdrawal by Subject|0|||
160980517|NCT01313923|581317529|FG000|Overall Study|Physician Decision|3|||
160980518|NCT00785538|581317532|FG000|Treatment Period|Adverse Event|1|||
160980519|NCT00785538|581317533|FG001|Treatment Period|Adverse Event|2|||
160521757|NCT01009580|579639008|FG001|Overall Study|Withdrawal Criteria|6|||
160521758|NCT01009580|579639007|FG000|Overall Study|Unclassified|17|||
160980520|NCT00785538|581317534|FG002|Treatment Period|Adverse Event|2|||
160980521|NCT00785538|581317535|FG003|Treatment Period|Adverse Event|0|||
160980522|NCT00785538|581317532|FG000|Treatment Period|Withdrawal by Subject|0|||
160980523|NCT00785538|581317533|FG001|Treatment Period|Withdrawal by Subject|0|||
160980524|NCT00785538|581317534|FG002|Treatment Period|Withdrawal by Subject|0|||
160980525|NCT00785538|581317535|FG003|Treatment Period|Withdrawal by Subject|1|||
160980526|NCT01680458|581317540|FG000|Overall Study|Protocol Violation|3|||
160980527|NCT02138747|581317541|FG000|Treatment Period 1|Adverse Event|10|||
160980528|NCT02138747|581317542|FG001|Treatment Period 1|Adverse Event|14|||
160980529|NCT02138747|581317543|FG002|Treatment Period 1|Adverse Event|2|||
160980530|NCT02138747|581317544|FG003|Treatment Period 1|Adverse Event|1|||
160980531|NCT02138747|581317541|FG000|Treatment Period 1|Lost to Follow-up|0|||
160980532|NCT02138747|581317542|FG001|Treatment Period 1|Lost to Follow-up|1|||
160980533|NCT02138747|581317543|FG002|Treatment Period 1|Lost to Follow-up|1|||
160980534|NCT02138747|581317544|FG003|Treatment Period 1|Lost to Follow-up|0|||
160980535|NCT02138747|581317541|FG000|Treatment Period 1|Protocol Violation|0|||
160980536|NCT02138747|581317542|FG001|Treatment Period 1|Protocol Violation|2|||
160980537|NCT02138747|581317543|FG002|Treatment Period 1|Protocol Violation|0|||
160980538|NCT02138747|581317544|FG003|Treatment Period 1|Protocol Violation|0|||
160980539|NCT02138747|581317541|FG000|Treatment Period 1|Withdrawal by Subject|8|||
160980540|NCT02138747|581317542|FG001|Treatment Period 1|Withdrawal by Subject|4|||
160980541|NCT02138747|581317543|FG002|Treatment Period 1|Withdrawal by Subject|1|||
160980542|NCT02138747|581317544|FG003|Treatment Period 1|Withdrawal by Subject|3|||
160980543|NCT02138747|581317541|FG000|Treatment Period 1|Other - Miscellaneous|2|||
160980544|NCT02138747|581317542|FG001|Treatment Period 1|Other - Miscellaneous|4|||
160980545|NCT02138747|581317543|FG002|Treatment Period 1|Other - Miscellaneous|0|||
160980546|NCT02138747|581317544|FG003|Treatment Period 1|Other - Miscellaneous|0|||
160980547|NCT02138747|581317541|FG000|Treatment Period 2|Adverse Event|6|||
160980548|NCT02138747|581317542|FG001|Treatment Period 2|Adverse Event|3|||
160980549|NCT02138747|581317543|FG002|Treatment Period 2|Adverse Event|1|||
160980550|NCT02138747|581317544|FG003|Treatment Period 2|Adverse Event|1|||
160980551|NCT02138747|581317541|FG000|Treatment Period 2|Lost to Follow-up|2|||
160980552|NCT02138747|581317542|FG001|Treatment Period 2|Lost to Follow-up|0|||
160980553|NCT02138747|581317543|FG002|Treatment Period 2|Lost to Follow-up|0|||
160980554|NCT02138747|581317544|FG003|Treatment Period 2|Lost to Follow-up|0|||
160980555|NCT02138747|581317541|FG000|Treatment Period 2|Protocol Violation|1|||
160980556|NCT02138747|581317542|FG001|Treatment Period 2|Protocol Violation|0|||
160980557|NCT02138747|581317543|FG002|Treatment Period 2|Protocol Violation|0|||
160980558|NCT02138747|581317544|FG003|Treatment Period 2|Protocol Violation|0|||
160980559|NCT02138747|581317541|FG000|Treatment Period 2|Withdrawal by Subject|5|||
160980560|NCT02138747|581317542|FG001|Treatment Period 2|Withdrawal by Subject|4|||
160980561|NCT02138747|581317543|FG002|Treatment Period 2|Withdrawal by Subject|1|||
160980562|NCT02138747|581317544|FG003|Treatment Period 2|Withdrawal by Subject|2|||
160980563|NCT02138747|581317541|FG000|Treatment Period 2|Other - Miscellaneous|3|||
160980564|NCT02138747|581317542|FG001|Treatment Period 2|Other - Miscellaneous|0|||
160980565|NCT02138747|581317543|FG002|Treatment Period 2|Other - Miscellaneous|0|||
160980566|NCT02138747|581317544|FG003|Treatment Period 2|Other - Miscellaneous|0|||
160980567|NCT02302066|581317548|FG000|Overall Study|Adverse Event|1|||
160980568|NCT02302066|581317549|FG001|Overall Study|Adverse Event|1|||
160980569|NCT02302066|581317550|FG002|Overall Study|Adverse Event|3|||
160980570|NCT02302066|581317551|FG003|Overall Study|Adverse Event|0|||
160980571|NCT02302066|581317548|FG000|Overall Study|Lost to Follow-up|4|||
160980572|NCT02302066|581317549|FG001|Overall Study|Lost to Follow-up|5|||
160980573|NCT02302066|581317550|FG002|Overall Study|Lost to Follow-up|24|||
160980574|NCT02302066|581317551|FG003|Overall Study|Lost to Follow-up|7|||
160980575|NCT02302066|581317548|FG000|Overall Study|Withdrawal by Subject|25|||
160980576|NCT02302066|581317549|FG001|Overall Study|Withdrawal by Subject|58|||
160980577|NCT02302066|581317550|FG002|Overall Study|Withdrawal by Subject|124|||
160980578|NCT02302066|581317551|FG003|Overall Study|Withdrawal by Subject|33|||
160980579|NCT02302066|581317548|FG000|Overall Study|Pregnancy|2|||
160980580|NCT02302066|581317549|FG001|Overall Study|Pregnancy|10|||
160980581|NCT02302066|581317550|FG002|Overall Study|Pregnancy|12|||
160980582|NCT02302066|581317551|FG003|Overall Study|Pregnancy|0|||
160980583|NCT02302066|581317548|FG000|Overall Study|Reason Not Specified|1|||
160980584|NCT02302066|581317549|FG001|Overall Study|Reason Not Specified|1|||
160980585|NCT02302066|581317550|FG002|Overall Study|Reason Not Specified|9|||
160980586|NCT02302066|581317551|FG003|Overall Study|Reason Not Specified|1|||
160980587|NCT02696902|581317556|FG000|Overall Study|Lost to Follow-up|0|||
160980588|NCT02696902|581317557|FG001|Overall Study|Lost to Follow-up|1|||
160980589|NCT02696902|581317558|FG002|Overall Study|Lost to Follow-up|1|||
160980590|NCT02696902|581317556|FG000|Overall Study|Withdrawal by Subject|0|||
160980591|NCT02696902|581317557|FG001|Overall Study|Withdrawal by Subject|0|||
160980592|NCT02696902|581317558|FG002|Overall Study|Withdrawal by Subject|1|||
160980593|NCT02696902|581317556|FG000|Overall Study|Death|19|||
160980594|NCT02696902|581317557|FG001|Overall Study|Death|3|||
160980595|NCT02696902|581317558|FG002|Overall Study|Death|24|||
160521759|NCT01009580|579639008|FG001|Overall Study|Unclassified|21|||
160521760|NCT04576455|579639011|FG000|Overall Study|Ongoing in the Study|48|||
160521761|NCT04576455|579639012|FG001|Overall Study|Ongoing in the Study|58|||
160521762|NCT04576455|579639011|FG000|Overall Study|Death|83|||
160521763|NCT04576455|579639012|FG001|Overall Study|Death|77|||
160521764|NCT04576455|579639011|FG000|Overall Study|Lost to Follow-up|4|||
160521765|NCT04576455|579639012|FG001|Overall Study|Lost to Follow-up|5|||
160521766|NCT04576455|579639011|FG000|Overall Study|Withdrawal by Subject|16|||
160521767|NCT04576455|579639012|FG001|Overall Study|Withdrawal by Subject|12|||
160521768|NCT00345293|579639013|FG000|Overall Study|Unable to access line for sample|1|||
160521769|NCT00345293|579639014|FG001|Overall Study|Unable to access line for sample|0|||
160521770|NCT00345293|579639013|FG000|Overall Study|Withdrawal by Subject|1|||
160521771|NCT00345293|579639014|FG001|Overall Study|Withdrawal by Subject|0|||
160521772|NCT00294554|579640379|FG000|Overall Study|Lack of Efficacy|0|||
160521773|NCT00294554|579640380|FG001|Overall Study|Lack of Efficacy|1|||
160521774|NCT00294554|579640379|FG000|Overall Study|Physician Decision|0|||
160521775|NCT00294554|579640380|FG001|Overall Study|Physician Decision|1|||
160521776|NCT01717989|579640381|FG000|Overall Study|Ineligibility determined|6|||
160521777|NCT01717989|579640381|FG000|Overall Study|Protocol deviation|6|||
160521778|NCT01717989|579640381|FG000|Overall Study|Withdrawal by Subject|11|||
160521779|NCT01717989|579640381|FG000|Overall Study|Physician Decision|2|||
160521780|NCT01717989|579640381|FG000|Overall Study|Lost to Follow-up|11|||
160521781|NCT01717989|579640381|FG000|Overall Study|Death|439|||
160521782|NCT01717989|579640381|FG000|Overall Study|Protocol-specified criteria|551|||
160521783|NCT01717989|579640381|FG000|Overall Study|Other|40|||
160521784|NCT03224325|579640382|FG000|Overall Study|Adverse Event|1|||
160521785|NCT03224325|579640383|FG001|Overall Study|Adverse Event|0|||
160521786|NCT03224325|579640384|FG002|Overall Study|Adverse Event|0|||
160521787|NCT03224325|579640385|FG003|Overall Study|Adverse Event|0|||
160521788|NCT03224325|579640386|FG004|Overall Study|Adverse Event|0|||
160521789|NCT03224325|579640387|FG005|Overall Study|Adverse Event|0|||
160521790|NCT03224325|579640388|FG006|Overall Study|Adverse Event|1|||
160521791|NCT03224325|579640382|FG000|Overall Study|Withdrawal by Subject|0|||
160521792|NCT03224325|579640383|FG001|Overall Study|Withdrawal by Subject|0|||
160521793|NCT03224325|579640384|FG002|Overall Study|Withdrawal by Subject|0|||
160521794|NCT03224325|579640385|FG003|Overall Study|Withdrawal by Subject|1|||
160521795|NCT03224325|579640386|FG004|Overall Study|Withdrawal by Subject|0|||
160521796|NCT03224325|579640387|FG005|Overall Study|Withdrawal by Subject|0|||
160521797|NCT03224325|579640388|FG006|Overall Study|Withdrawal by Subject|0|||
160521798|NCT02864381|579640389|FG000|Overall Study|Death|58|||
160521799|NCT02864381|579640390|FG001|Overall Study|Death|61|||
160521800|NCT02864381|579640389|FG000|Overall Study|Withdrew Consent|5|||
160521801|NCT02864381|579640390|FG001|Overall Study|Withdrew Consent|6|||
160521802|NCT02864381|579640389|FG000|Overall Study|Reason Unknown|7|||
160521803|NCT02864381|579640390|FG001|Overall Study|Reason Unknown|3|||
160521804|NCT02864381|579640389|FG000|Overall Study|Lost to Follow-up|1|||
160521805|NCT02864381|579640390|FG001|Overall Study|Lost to Follow-up|1|||
160521806|NCT02864381|579640389|FG000|Overall Study|Investigator's Discretion|1|||
160521807|NCT02864381|579640390|FG001|Overall Study|Investigator's Discretion|0|||
160521808|NCT02864381|579640389|FG000|Overall Study|Protocol Violation|0|||
160521809|NCT02864381|579640390|FG001|Overall Study|Protocol Violation|1|||
160521810|NCT00667355|579640395|FG000|Overall Study|Adverse Event|5|||
160980596|NCT02696902|581317556|FG000|Overall Study|Participant not fit post-randomization|0|||
160980597|NCT02696902|581317557|FG001|Overall Study|Participant not fit post-randomization|0|||
160980598|NCT02696902|581317558|FG002|Overall Study|Participant not fit post-randomization|1|||
160980599|NCT02696902|581317556|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
160980600|NCT02696902|581317557|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
160980601|NCT02696902|581317558|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
160980602|NCT02696902|581317556|FG000|Overall Study|Principal investigator's decision|1|||
160980603|NCT02696902|581317557|FG001|Overall Study|Principal investigator's decision|0|||
160980604|NCT02696902|581317558|FG002|Overall Study|Principal investigator's decision|0|||
160980605|NCT02696902|581317556|FG000|Overall Study|Sponsor's decision|1|||
160980606|NCT02696902|581317557|FG001|Overall Study|Sponsor's decision|0|||
160980607|NCT02696902|581317558|FG002|Overall Study|Sponsor's decision|0|||
160980608|NCT02696902|581317556|FG000|Overall Study|Transferred to other hospital|1|||
160980609|NCT02696902|581317557|FG001|Overall Study|Transferred to other hospital|0|||
160980610|NCT02696902|581317558|FG002|Overall Study|Transferred to other hospital|0|||
160980611|NCT01857622|581317560|FG000|Overall Study|Adverse Event|5|||
160980612|NCT01857622|581317561|FG001|Overall Study|Adverse Event|0|||
160980613|NCT01857622|581317562|FG002|Overall Study|Adverse Event|2|||
160980614|NCT01857622|581317560|FG000|Overall Study|Physician Decision|1|||
160980615|NCT01857622|581317561|FG001|Overall Study|Physician Decision|0|||
160980616|NCT01857622|581317562|FG002|Overall Study|Physician Decision|0|||
160980617|NCT01857622|581317560|FG000|Overall Study|Protocol Violation|4|||
160980618|NCT01857622|581317561|FG001|Overall Study|Protocol Violation|1|||
160980619|NCT01857622|581317562|FG002|Overall Study|Protocol Violation|0|||
160980620|NCT01857622|581317560|FG000|Overall Study|Withdrawal by Subject|1|||
160980621|NCT01857622|581317561|FG001|Overall Study|Withdrawal by Subject|0|||
160980622|NCT01857622|581317562|FG002|Overall Study|Withdrawal by Subject|0|||
160980623|NCT00514046|581317571|FG000|Overall Study|transferred to another protocol|2|||
160980624|NCT00514046|581317572|FG001|Overall Study|transferred to another protocol|1|||
160980625|NCT00514046|581317573|FG002|Overall Study|transferred to another protocol|3|||
160980626|NCT00514046|581317574|FG003|Overall Study|transferred to another protocol|0|||
160980627|NCT00514046|581317575|FG004|Overall Study|transferred to another protocol|1|||
160980628|NCT00514046|581317576|FG005|Overall Study|transferred to another protocol|0|||
160980629|NCT00514046|581317577|FG006|Overall Study|transferred to another protocol|0|||
160980630|NCT00514046|581317578|FG007|Overall Study|transferred to another protocol|0|||
160980631|NCT00514046|581317579|FG008|Overall Study|transferred to another protocol|0|||
160980632|NCT00514046|581317571|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
160980633|NCT00514046|581317572|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
160980634|NCT00514046|581317573|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
160980635|NCT00514046|581317574|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
160980636|NCT00514046|581317575|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
160980637|NCT00514046|581317576|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
160980638|NCT00514046|581317577|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
160980639|NCT00514046|581317578|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
160980640|NCT00514046|581317579|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
160980641|NCT00514046|581317571|FG000|Overall Study|Disease progression on study|0|||
160980642|NCT00514046|581317572|FG001|Overall Study|Disease progression on study|0|||
160980643|NCT00514046|581317573|FG002|Overall Study|Disease progression on study|2|||
160980644|NCT00514046|581317574|FG003|Overall Study|Disease progression on study|0|||
160980645|NCT00514046|581317575|FG004|Overall Study|Disease progression on study|0|||
160980646|NCT00514046|581317576|FG005|Overall Study|Disease progression on study|1|||
160980647|NCT00514046|581317577|FG006|Overall Study|Disease progression on study|0|||
160980648|NCT00514046|581317578|FG007|Overall Study|Disease progression on study|0|||
160980649|NCT00514046|581317579|FG008|Overall Study|Disease progression on study|0|||
160980650|NCT02855164|581317580|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
160980651|NCT02855164|581317581|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
160980652|NCT02855164|581317582|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
160980653|NCT02855164|581317583|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
160980654|NCT02855164|581317584|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
160980655|NCT02855164|581317585|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
160980656|NCT02855164|581317586|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
160980657|NCT02855164|581317587|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
160980658|NCT02855164|581317580|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
160980659|NCT02855164|581317581|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
160980660|NCT02855164|581317582|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
160980661|NCT02855164|581317583|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
160980662|NCT02855164|581317584|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
160980663|NCT02855164|581317585|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
160980664|NCT02855164|581317586|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
160521811|NCT00667355|579640395|FG000|Overall Study|Lost to Follow-up|1|||
160980665|NCT02855164|581317587|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
160980666|NCT02855164|581317580|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
160980667|NCT02855164|581317581|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
160980668|NCT02855164|581317582|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
160980669|NCT02855164|581317583|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
160980670|NCT02855164|581317584|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
160980671|NCT02855164|581317585|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
160521812|NCT00667355|579640395|FG000|Overall Study|Other reason was not specified|5|||
160980672|NCT02855164|581317586|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
160980673|NCT02855164|581317587|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
160980674|NCT02855164|581317580|FG000|Part C (Randomized Set)|Adverse Event|0|||
160980675|NCT02855164|581317581|FG001|Part C (Randomized Set)|Adverse Event|0|||
160980676|NCT02855164|581317582|FG002|Part C (Randomized Set)|Adverse Event|0|||
160980677|NCT02855164|581317583|FG003|Part C (Randomized Set)|Adverse Event|0|||
160980678|NCT02855164|581317584|FG004|Part C (Randomized Set)|Adverse Event|0|||
160980679|NCT02855164|581317585|FG005|Part C (Randomized Set)|Adverse Event|5|||
160980680|NCT02855164|581317586|FG006|Part C (Randomized Set)|Adverse Event|9|||
160980681|NCT02855164|581317587|FG007|Part C (Randomized Set)|Adverse Event|2|||
160980682|NCT02855164|581317580|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
160980683|NCT02855164|581317581|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
160980684|NCT02855164|581317582|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
160980685|NCT02855164|581317583|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
160980686|NCT02855164|581317584|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
160980687|NCT02855164|581317585|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
160980688|NCT02855164|581317586|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
160980689|NCT02855164|581317587|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
160980690|NCT02855164|581317580|FG000|Part C (Randomized Set)|Physician Decision|0|||
160980691|NCT02855164|581317581|FG001|Part C (Randomized Set)|Physician Decision|0|||
160980692|NCT02855164|581317582|FG002|Part C (Randomized Set)|Physician Decision|0|||
160980693|NCT02855164|581317583|FG003|Part C (Randomized Set)|Physician Decision|0|||
160980694|NCT02855164|581317584|FG004|Part C (Randomized Set)|Physician Decision|0|||
160980695|NCT02855164|581317585|FG005|Part C (Randomized Set)|Physician Decision|1|||
160980696|NCT02855164|581317586|FG006|Part C (Randomized Set)|Physician Decision|0|||
160980697|NCT02855164|581317587|FG007|Part C (Randomized Set)|Physician Decision|1|||
160980698|NCT02855164|581317580|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
160980699|NCT02855164|581317581|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
160980700|NCT02855164|581317582|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
160980701|NCT02855164|581317583|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
160980702|NCT02855164|581317584|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
160980703|NCT02855164|581317585|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
160980704|NCT02855164|581317586|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
160980705|NCT02855164|581317587|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
160980706|NCT00876460|581317588|FG000|Combination Therapy Phase|Progressive disease|2|||
160980707|NCT00876460|581317589|FG001|Combination Therapy Phase|Progressive disease|3|||
160980708|NCT00876460|581317590|FG002|Combination Therapy Phase|Progressive disease|3|||
160980709|NCT00876460|581317591|FG003|Combination Therapy Phase|Progressive disease|3|||
160980710|NCT00876460|581317592|FG004|Combination Therapy Phase|Progressive disease|3|||
160980711|NCT00876460|581317593|FG005|Combination Therapy Phase|Progressive disease|1|||
160980712|NCT00876460|581317594|FG006|Combination Therapy Phase|Progressive disease|1|||
160980713|NCT00876460|581317595|FG007|Combination Therapy Phase|Progressive disease|1|||
160980714|NCT00876460|581317588|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
160980715|NCT00876460|581317589|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
160980716|NCT00876460|581317590|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
160980717|NCT00876460|581317591|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
160980718|NCT00876460|581317592|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
160980719|NCT00876460|581317593|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
160980720|NCT00876460|581317594|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
160980721|NCT00876460|581317595|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
160980722|NCT00876460|581317588|FG000|Combination Therapy Phase|Adverse Event|0|||
160980723|NCT00876460|581317589|FG001|Combination Therapy Phase|Adverse Event|2|||
160980724|NCT00876460|581317590|FG002|Combination Therapy Phase|Adverse Event|0|||
160980725|NCT00876460|581317591|FG003|Combination Therapy Phase|Adverse Event|2|||
160980726|NCT00876460|581317592|FG004|Combination Therapy Phase|Adverse Event|2|||
160980727|NCT00876460|581317593|FG005|Combination Therapy Phase|Adverse Event|0|||
160980728|NCT00876460|581317594|FG006|Combination Therapy Phase|Adverse Event|3|||
160980729|NCT00876460|581317595|FG007|Combination Therapy Phase|Adverse Event|2|||
160980730|NCT00876460|581317588|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
160980731|NCT00876460|581317589|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
160980732|NCT00876460|581317590|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
160980733|NCT00876460|581317591|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
160980734|NCT00876460|581317592|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
160980735|NCT00876460|581317593|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
160980736|NCT00876460|581317594|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
160980737|NCT00876460|581317595|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
160980738|NCT00876460|581317588|FG000|Combination Therapy Phase|Other reason not defined above|0|||
160980739|NCT00876460|581317589|FG001|Combination Therapy Phase|Other reason not defined above|0|||
160980740|NCT00876460|581317590|FG002|Combination Therapy Phase|Other reason not defined above|0|||
160980741|NCT00876460|581317591|FG003|Combination Therapy Phase|Other reason not defined above|0|||
160980742|NCT00876460|581317592|FG004|Combination Therapy Phase|Other reason not defined above|0|||
160980743|NCT00876460|581317593|FG005|Combination Therapy Phase|Other reason not defined above|0|||
160980744|NCT00876460|581317594|FG006|Combination Therapy Phase|Other reason not defined above|1|||
160980745|NCT00876460|581317595|FG007|Combination Therapy Phase|Other reason not defined above|2|||
160980746|NCT00876460|581317588|FG000|Combination Therapy Phase|Not treated|0|||
160980747|NCT00876460|581317589|FG001|Combination Therapy Phase|Not treated|0|||
160980748|NCT00876460|581317590|FG002|Combination Therapy Phase|Not treated|0|||
160980749|NCT00876460|581317591|FG003|Combination Therapy Phase|Not treated|0|||
160980750|NCT00876460|581317592|FG004|Combination Therapy Phase|Not treated|0|||
160980751|NCT00876460|581317593|FG005|Combination Therapy Phase|Not treated|0|||
160980752|NCT00876460|581317594|FG006|Combination Therapy Phase|Not treated|1|||
160980753|NCT00876460|581317595|FG007|Combination Therapy Phase|Not treated|0|||
160980754|NCT00876460|581317588|FG000|Mono Therapy Phase|Progressive disease|0|||
160980755|NCT00876460|581317589|FG001|Mono Therapy Phase|Progressive disease|0|||
160980756|NCT00876460|581317590|FG002|Mono Therapy Phase|Progressive disease|0|||
160980757|NCT00876460|581317591|FG003|Mono Therapy Phase|Progressive disease|0|||
160980758|NCT00876460|581317592|FG004|Mono Therapy Phase|Progressive disease|2|||
160980759|NCT00876460|581317593|FG005|Mono Therapy Phase|Progressive disease|0|||
160980760|NCT00876460|581317594|FG006|Mono Therapy Phase|Progressive disease|1|||
160980761|NCT00876460|581317595|FG007|Mono Therapy Phase|Progressive disease|3|||
160980762|NCT00876460|581317588|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
160980763|NCT00876460|581317589|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
160980764|NCT00876460|581317590|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
160980765|NCT00876460|581317591|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
160980766|NCT00876460|581317592|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
160980767|NCT00876460|581317593|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
160980768|NCT00876460|581317594|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
160980769|NCT00876460|581317595|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
160980770|NCT00876460|581317588|FG000|Mono Therapy Phase|Adverse Event|0|||
160980771|NCT00876460|581317589|FG001|Mono Therapy Phase|Adverse Event|0|||
160980772|NCT00876460|581317590|FG002|Mono Therapy Phase|Adverse Event|0|||
160980773|NCT00876460|581317591|FG003|Mono Therapy Phase|Adverse Event|1|||
160980774|NCT00876460|581317592|FG004|Mono Therapy Phase|Adverse Event|0|||
160980775|NCT00876460|581317593|FG005|Mono Therapy Phase|Adverse Event|0|||
160980776|NCT00876460|581317594|FG006|Mono Therapy Phase|Adverse Event|0|||
160980777|NCT00876460|581317595|FG007|Mono Therapy Phase|Adverse Event|0|||
160980778|NCT00383240|581317596|FG000|Overall Study|Adverse Event|4|||
160980779|NCT00383240|581317597|FG001|Overall Study|Adverse Event|6|||
160980780|NCT00383240|581317598|FG002|Overall Study|Adverse Event|9|||
160980781|NCT00383240|581317599|FG003|Overall Study|Adverse Event|7|||
160980782|NCT00383240|581317596|FG000|Overall Study|Treatment Failure|8|||
160980783|NCT00383240|581317597|FG001|Overall Study|Treatment Failure|13|||
160980784|NCT00383240|581317598|FG002|Overall Study|Treatment Failure|47|||
160980785|NCT00383240|581317599|FG003|Overall Study|Treatment Failure|46|||
160980786|NCT00383240|581317596|FG000|Overall Study|Lost to Follow-up|3|||
160980787|NCT00383240|581317597|FG001|Overall Study|Lost to Follow-up|0|||
160980788|NCT00383240|581317598|FG002|Overall Study|Lost to Follow-up|0|||
160980789|NCT00383240|581317599|FG003|Overall Study|Lost to Follow-up|2|||
160980790|NCT00383240|581317596|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
160980791|NCT00383240|581317597|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
160980792|NCT00383240|581317598|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
160980793|NCT00383240|581317599|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
160980794|NCT00383240|581317596|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
160980795|NCT00383240|581317597|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
160980796|NCT00383240|581317598|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
160980797|NCT00383240|581317599|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
160980798|NCT00383240|581317596|FG000|Overall Study|Protocol Violation|4|||
160980799|NCT00383240|581317597|FG001|Overall Study|Protocol Violation|5|||
160980800|NCT00383240|581317598|FG002|Overall Study|Protocol Violation|9|||
160980801|NCT00383240|581317599|FG003|Overall Study|Protocol Violation|6|||
160980802|NCT00383240|581317596|FG000|Overall Study|Did not meet protocol eligibility|9|||
160980803|NCT00383240|581317597|FG001|Overall Study|Did not meet protocol eligibility|4|||
160980804|NCT00383240|581317598|FG002|Overall Study|Did not meet protocol eligibility|9|||
160980805|NCT00383240|581317599|FG003|Overall Study|Did not meet protocol eligibility|3|||
160980806|NCT00383240|581317596|FG000|Overall Study|Administrative|1|||
160980807|NCT00383240|581317597|FG001|Overall Study|Administrative|1|||
160980808|NCT00383240|581317598|FG002|Overall Study|Administrative|0|||
160980809|NCT00383240|581317599|FG003|Overall Study|Administrative|0|||
160980810|NCT01349829|581319789|FG000|Overall Study|Lost to Follow-up|4|||
160980811|NCT01349829|581319790|FG001|Overall Study|Lost to Follow-up|8|||
160980812|NCT01349829|581319789|FG000|Overall Study|Consent withdrawal|3|||
160980813|NCT01349829|581319790|FG001|Overall Study|Consent withdrawal|8|||
160980814|NCT01349829|581319789|FG000|Overall Study|Migrated/moved|2|||
160980815|NCT01349829|581319790|FG001|Overall Study|Migrated/moved|7|||
160980816|NCT02555371|581319791|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
160980817|NCT02555371|581319792|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
160980818|NCT02555371|581319793|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
160980819|NCT02555371|581319794|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
160980820|NCT02555371|581319795|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
160980821|NCT02555371|581319791|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
160980822|NCT02555371|581319792|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
160980823|NCT02555371|581319793|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
160980824|NCT02555371|581319794|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
160980825|NCT02555371|581319795|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
160980826|NCT02555371|581319791|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
160980827|NCT02555371|581319792|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
160980828|NCT02555371|581319793|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
160980829|NCT02555371|581319794|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
160980830|NCT02555371|581319795|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
160980831|NCT02555371|581319791|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
160980832|NCT02555371|581319792|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
160980833|NCT02555371|581319793|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
160980834|NCT02555371|581319794|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
160980835|NCT02555371|581319795|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
160980836|NCT02555371|581319791|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
160980837|NCT02555371|581319792|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
160980838|NCT02555371|581319793|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
160980839|NCT02555371|581319794|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
160980840|NCT02555371|581319795|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
160980841|NCT02555371|581319791|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
160980842|NCT02555371|581319792|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
160980843|NCT02555371|581319793|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
160980844|NCT02555371|581319794|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
160980845|NCT02555371|581319795|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
160980846|NCT02555371|581319791|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
160980847|NCT02555371|581319792|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
160980848|NCT02555371|581319793|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
160980849|NCT02555371|581319794|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
160980850|NCT02555371|581319795|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
160980851|NCT02555371|581319791|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
160980852|NCT02555371|581319792|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
160980853|NCT02555371|581319793|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
160980854|NCT02555371|581319794|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
160980855|NCT02555371|581319795|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
160980856|NCT02555371|581319791|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
160980857|NCT02555371|581319792|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
160980858|NCT02555371|581319793|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
160980859|NCT02555371|581319794|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
160980860|NCT02555371|581319795|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
160980861|NCT02555371|581319791|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
160980862|NCT02555371|581319792|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
160980863|NCT02555371|581319793|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
160980864|NCT02555371|581319794|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
160980865|NCT02555371|581319795|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
160980866|NCT02555371|581319791|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
160980867|NCT02555371|581319792|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
160980868|NCT02555371|581319793|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
160980869|NCT02555371|581319794|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
160980870|NCT02555371|581319795|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
160980871|NCT02555371|581319791|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
160980872|NCT02555371|581319792|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
160980873|NCT02555371|581319793|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
160521813|NCT01607554|579640397|FG000|Overall Study|Disease progression|2|||
160749708|NCT02362425|580469657|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
160749709|NCT02362425|580469654|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
160749710|NCT02362425|580469655|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
160980874|NCT02555371|581319794|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
160980875|NCT02555371|581319795|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
160980876|NCT02555371|581319791|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
160980877|NCT02555371|581319792|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
160980878|NCT02555371|581319793|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
160980879|NCT02555371|581319794|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
160980880|NCT02555371|581319795|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
160980881|NCT02555371|581319791|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
160980882|NCT02555371|581319792|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
160980883|NCT02555371|581319793|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
160980884|NCT02555371|581319794|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
160980885|NCT02555371|581319795|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
160980886|NCT03095599|581319796|FG000|Overall Study|Withdrawal by Subject|1|||
160980887|NCT03095599|581319797|FG001|Overall Study|Withdrawal by Subject|0|||
160980888|NCT03095599|581319796|FG000|Overall Study|Lost to Follow-up|1|||
160980889|NCT03095599|581319797|FG001|Overall Study|Lost to Follow-up|0|||
160980890|NCT03095599|581319796|FG000|Overall Study|Withdrawal prior to vaccination|1|||
160980891|NCT03095599|581319797|FG001|Overall Study|Withdrawal prior to vaccination|0|||
160980892|NCT00742885|581319799|FG000|Overall Study|Lost to Follow-up|1|||
160980893|NCT00742885|581319800|FG001|Overall Study|Lost to Follow-up|0|||
160980894|NCT03615482|581319803|FG000|Overall Study|Death|1|||
160980895|NCT03615482|581319804|FG001|Overall Study|Death|0|||
160980896|NCT03615482|581319803|FG000|Overall Study|Lost to Follow-up|7|||
160980897|NCT03615482|581319804|FG001|Overall Study|Lost to Follow-up|7|||
160980898|NCT03615482|581319803|FG000|Overall Study|Physician Decision|2|||
160980899|NCT03615482|581319804|FG001|Overall Study|Physician Decision|3|||
160980900|NCT03615482|581319803|FG000|Overall Study|Withdrawal by Subject|7|||
160980901|NCT03615482|581319804|FG001|Overall Study|Withdrawal by Subject|7|||
160980902|NCT00322868|581319805|FG000|Overall Study|disease progression|1|||
160980903|NCT01642186|581319810|FG000|Overall Study|Death|0|||
160980904|NCT01642186|581319811|FG001|Overall Study|Death|2|||
160980905|NCT01642186|581319812|FG002|Overall Study|Death|2|||
160980906|NCT01642186|581319810|FG000|Overall Study|Lost to Follow-up|0|||
160980907|NCT01642186|581319811|FG001|Overall Study|Lost to Follow-up|0|||
160980908|NCT01642186|581319812|FG002|Overall Study|Lost to Follow-up|1|||
160980909|NCT00163215|581319813|FG000|Overall Study|Lack of Efficacy|3|||
160980910|NCT00163215|581319813|FG000|Overall Study|Withdrawal by Subject|5|||
160980911|NCT00163215|581319813|FG000|Overall Study|Other|7|||
160980912|NCT01023308|581319814|FG000|Overall Study|Abnormal test proceedure results|3|||
160980913|NCT01023308|581319815|FG001|Overall Study|Abnormal test proceedure results|8|||
160980914|NCT01023308|581319814|FG000|Overall Study|Administrative problems|2|||
160980915|NCT01023308|581319815|FG001|Overall Study|Administrative problems|1|||
160980916|NCT01023308|581319814|FG000|Overall Study|Adverse Event|130|||
160980917|NCT01023308|581319815|FG001|Overall Study|Adverse Event|66|||
160980918|NCT01023308|581319814|FG000|Overall Study|Death|21|||
160980919|NCT01023308|581319815|FG001|Overall Study|Death|17|||
160980920|NCT01023308|581319814|FG000|Overall Study|Disease progression|82|||
160980921|NCT01023308|581319815|FG001|Overall Study|Disease progression|153|||
160980922|NCT01023308|581319814|FG000|Overall Study|New Cancer therapy|4|||
160980923|NCT01023308|581319815|FG001|Overall Study|New Cancer therapy|7|||
160980924|NCT01023308|581319814|FG000|Overall Study|Protocol Violation|3|||
160980925|NCT01023308|581319815|FG001|Overall Study|Protocol Violation|4|||
160980926|NCT01023308|581319814|FG000|Overall Study|Untreated|5|||
160980927|NCT01023308|581319815|FG001|Overall Study|Untreated|5|||
160980928|NCT01023308|581319814|FG000|Overall Study|Lost to Follow-up|1|||
160980929|NCT01023308|581319815|FG001|Overall Study|Lost to Follow-up|0|||
160980930|NCT01023308|581319814|FG000|Overall Study|Withdrawal by Subject|34|||
160980931|NCT01023308|581319815|FG001|Overall Study|Withdrawal by Subject|18|||
160980932|NCT02254421|581319824|FG000|Overall Study|Randomized but Not Treated|1|||
160980933|NCT02254421|581319825|FG001|Overall Study|Randomized but Not Treated|0|||
160980934|NCT02254421|581319824|FG000|Overall Study|Death|0|||
160980935|NCT02254421|581319825|FG001|Overall Study|Death|2|||
160980936|NCT02254421|581319824|FG000|Overall Study|Withdrew Consent|1|||
160980937|NCT02254421|581319825|FG001|Overall Study|Withdrew Consent|1|||
160980938|NCT00867490|581319828|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
160980939|NCT00867490|581319828|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
160980940|NCT00867490|581319828|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
160980941|NCT00867490|581319828|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
160980942|NCT00867490|581319828|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
160980943|NCT01950273|581319829|FG000|Overall Study|Protocol Violation|1|||
160980944|NCT01950273|581319830|FG001|Overall Study|Protocol Violation|0|||
160980945|NCT01950273|581319829|FG000|Overall Study|Withdrawal by Subject|2|||
160980946|NCT01950273|581319830|FG001|Overall Study|Withdrawal by Subject|0|||
160980947|NCT01950273|581319829|FG000|Overall Study|Other not defined above|1|||
160980948|NCT01950273|581319830|FG001|Overall Study|Other not defined above|0|||
160980949|NCT01154036|581319839|FG000|Phase I|Physician Decision|0|||
160980950|NCT01154036|581319840|FG001|Phase I|Physician Decision|1|||
160980951|NCT01154036|581319841|FG002|Phase I|Physician Decision|0|||
160980952|NCT01154036|581319842|FG003|Phase I|Physician Decision|0|||
160980953|NCT01154036|581319843|FG004|Phase I|Physician Decision|0|||
160980954|NCT01154036|581319844|FG005|Phase I|Physician Decision|0|||
160980955|NCT01154036|581319845|FG006|Phase I|Physician Decision|0|||
160980956|NCT01154036|581319846|FG007|Phase I|Physician Decision|0|||
160980957|NCT01154036|581319839|FG000|Phase I|Lost to Follow-up|0|||
160980958|NCT01154036|581319840|FG001|Phase I|Lost to Follow-up|3|||
160980959|NCT01154036|581319841|FG002|Phase I|Lost to Follow-up|6|||
160980960|NCT01154036|581319842|FG003|Phase I|Lost to Follow-up|0|||
160980961|NCT01154036|581319843|FG004|Phase I|Lost to Follow-up|0|||
160980962|NCT01154036|581319844|FG005|Phase I|Lost to Follow-up|0|||
160980963|NCT01154036|581319845|FG006|Phase I|Lost to Follow-up|0|||
160980964|NCT01154036|581319846|FG007|Phase I|Lost to Follow-up|0|||
160980965|NCT01154036|581319839|FG000|Phase I|Protocol Violation|0|||
160980966|NCT01154036|581319840|FG001|Phase I|Protocol Violation|3|||
160980967|NCT01154036|581319841|FG002|Phase I|Protocol Violation|9|||
160980968|NCT01154036|581319842|FG003|Phase I|Protocol Violation|0|||
160980969|NCT01154036|581319843|FG004|Phase I|Protocol Violation|0|||
160980970|NCT01154036|581319844|FG005|Phase I|Protocol Violation|0|||
160980971|NCT01154036|581319845|FG006|Phase I|Protocol Violation|0|||
160980972|NCT01154036|581319846|FG007|Phase I|Protocol Violation|0|||
160980973|NCT01154036|581319839|FG000|Phase I|Withdrawal by Subject|2|||
160980974|NCT01154036|581319840|FG001|Phase I|Withdrawal by Subject|10|||
160980975|NCT01154036|581319841|FG002|Phase I|Withdrawal by Subject|29|||
160980976|NCT01154036|581319842|FG003|Phase I|Withdrawal by Subject|0|||
160980977|NCT01154036|581319843|FG004|Phase I|Withdrawal by Subject|0|||
160980978|NCT01154036|581319844|FG005|Phase I|Withdrawal by Subject|0|||
160980979|NCT01154036|581319845|FG006|Phase I|Withdrawal by Subject|0|||
160980980|NCT01154036|581319846|FG007|Phase I|Withdrawal by Subject|0|||
160980981|NCT01154036|581319839|FG000|Phase I|Adverse Event|1|||
160980982|NCT01154036|581319840|FG001|Phase I|Adverse Event|11|||
160980983|NCT01154036|581319841|FG002|Phase I|Adverse Event|12|||
160980984|NCT01154036|581319842|FG003|Phase I|Adverse Event|0|||
160980985|NCT01154036|581319843|FG004|Phase I|Adverse Event|0|||
160980986|NCT01154036|581319844|FG005|Phase I|Adverse Event|0|||
160980987|NCT01154036|581319845|FG006|Phase I|Adverse Event|0|||
160980988|NCT01154036|581319846|FG007|Phase I|Adverse Event|0|||
160980989|NCT01154036|581319839|FG000|Phase II|Adverse Event|0|||
160980990|NCT01154036|581319840|FG001|Phase II|Adverse Event|0|||
160980991|NCT01154036|581319841|FG002|Phase II|Adverse Event|0|||
160980992|NCT01154036|581319842|FG003|Phase II|Adverse Event|0|||
160980993|NCT01154036|581319843|FG004|Phase II|Adverse Event|1|||
160980994|NCT01154036|581319844|FG005|Phase II|Adverse Event|1|||
160980995|NCT01154036|581319845|FG006|Phase II|Adverse Event|1|||
160980996|NCT01154036|581319846|FG007|Phase II|Adverse Event|1|||
160980997|NCT01154036|581319839|FG000|Phase II|Physician Decision|0|||
160980998|NCT01154036|581319840|FG001|Phase II|Physician Decision|0|||
160980999|NCT01154036|581319841|FG002|Phase II|Physician Decision|0|||
160981000|NCT01154036|581319842|FG003|Phase II|Physician Decision|0|||
160981001|NCT01154036|581319843|FG004|Phase II|Physician Decision|0|||
160981002|NCT01154036|581319844|FG005|Phase II|Physician Decision|0|||
160981003|NCT01154036|581319845|FG006|Phase II|Physician Decision|1|||
160981004|NCT01154036|581319846|FG007|Phase II|Physician Decision|0|||
160981005|NCT01154036|581319839|FG000|Phase II|Lost to Follow-up|0|||
160981006|NCT01154036|581319840|FG001|Phase II|Lost to Follow-up|0|||
160981007|NCT01154036|581319841|FG002|Phase II|Lost to Follow-up|0|||
160981008|NCT01154036|581319842|FG003|Phase II|Lost to Follow-up|1|||
160981009|NCT01154036|581319843|FG004|Phase II|Lost to Follow-up|2|||
160981010|NCT01154036|581319844|FG005|Phase II|Lost to Follow-up|0|||
160981011|NCT01154036|581319845|FG006|Phase II|Lost to Follow-up|2|||
160981012|NCT01154036|581319846|FG007|Phase II|Lost to Follow-up|1|||
160981013|NCT01154036|581319839|FG000|Phase II|Protocol Violation|0|||
160981014|NCT01154036|581319840|FG001|Phase II|Protocol Violation|0|||
160981015|NCT01154036|581319841|FG002|Phase II|Protocol Violation|0|||
160981016|NCT01154036|581319842|FG003|Phase II|Protocol Violation|0|||
160981017|NCT01154036|581319843|FG004|Phase II|Protocol Violation|1|||
160981018|NCT01154036|581319844|FG005|Phase II|Protocol Violation|2|||
160981019|NCT01154036|581319845|FG006|Phase II|Protocol Violation|0|||
160981020|NCT01154036|581319846|FG007|Phase II|Protocol Violation|0|||
160981021|NCT01154036|581319839|FG000|Phase II|Withdrawal by Subject|0|||
160981022|NCT01154036|581319840|FG001|Phase II|Withdrawal by Subject|0|||
160981023|NCT01154036|581319841|FG002|Phase II|Withdrawal by Subject|0|||
160981024|NCT01154036|581319842|FG003|Phase II|Withdrawal by Subject|0|||
160981025|NCT01154036|581319843|FG004|Phase II|Withdrawal by Subject|4|||
160981026|NCT01154036|581319844|FG005|Phase II|Withdrawal by Subject|2|||
160981027|NCT01154036|581319845|FG006|Phase II|Withdrawal by Subject|5|||
160981028|NCT01154036|581319846|FG007|Phase II|Withdrawal by Subject|4|||
160981029|NCT02264574|581319847|FG000|Overall Study|Death|21|||
160981030|NCT02264574|581319848|FG001|Overall Study|Death|21|||
160981031|NCT02264574|581319847|FG000|Overall Study|Withdrawal by Subject|8|||
160981032|NCT02264574|581319848|FG001|Overall Study|Withdrawal by Subject|6|||
160981033|NCT02264574|581319847|FG000|Overall Study|Other, Not Specified|0|||
160981034|NCT02264574|581319848|FG001|Overall Study|Other, Not Specified|3|||
160981035|NCT02080520|581319849|FG000|Overall Study|Self-reported symptoms|5|||
160981036|NCT02080520|581319850|FG001|Overall Study|Self-reported symptoms|6|||
160981037|NCT02080520|581319849|FG000|Overall Study|Unable to contact|2|||
160981038|NCT02080520|581319850|FG001|Overall Study|Unable to contact|1|||
160981039|NCT02080520|581319849|FG000|Overall Study|Initiated aspirin|2|||
160981040|NCT02080520|581319850|FG001|Overall Study|Initiated aspirin|0|||
160981041|NCT02080520|581319849|FG000|Overall Study|Atrial fibrillation|1|||
160981042|NCT02080520|581319850|FG001|Overall Study|Atrial fibrillation|1|||
160981043|NCT02080520|581319849|FG000|Overall Study|Cancer|1|||
160981044|NCT02080520|581319850|FG001|Overall Study|Cancer|2|||
160981045|NCT02080520|581319849|FG000|Overall Study|Not interested in study|1|||
160981046|NCT02080520|581319850|FG001|Overall Study|Not interested in study|3|||
160981047|NCT02080520|581319849|FG000|Overall Study|Too busy|1|||
160981048|NCT02080520|581319850|FG001|Overall Study|Too busy|1|||
160981049|NCT02080520|581319849|FG000|Overall Study|Work-related injury|1|||
160981050|NCT02080520|581319850|FG001|Overall Study|Work-related injury|0|||
160521814|NCT03952806|579640401|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
160521815|NCT03952806|579640402|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
160521816|NCT03952806|579640401|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
160521817|NCT03952806|579640402|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
160521818|NCT03952806|579640401|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
160521819|NCT03952806|579640402|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
160521820|NCT03952806|579640401|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
160521821|NCT03952806|579640402|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
160521822|NCT03952806|579640401|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
160521823|NCT03952806|579640402|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
160521824|NCT03952806|579640401|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
160521825|NCT03952806|579640402|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
160521826|NCT03952806|579640401|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
160521827|NCT03952806|579640402|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
160521828|NCT03952806|579640401|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
160521829|NCT03952806|579640402|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
160521830|NCT03952806|579640401|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
160521831|NCT03952806|579640402|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
160521832|NCT03952806|579640401|FG000|OLE Phase (48 Weeks)|Other|16|||
160521833|NCT03952806|579640402|FG001|OLE Phase (48 Weeks)|Other|13|||
160521834|NCT05580588|579640403|FG000|Overall Study|Lack of Efficacy|12|||
160521835|NCT00756470|579640408|FG000|Overall Study|Withdrawal by Subject|1|||
160521836|NCT00756470|579640408|FG000|Overall Study|Adverse Event|4|||
160521837|NCT02875977|579640409|FG000|Overall Study|Lost to Follow-up|42|||
160521838|NCT02875977|579640410|FG001|Overall Study|Lost to Follow-up|29|||
160521839|NCT01079741|579640411|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
160521840|NCT01079741|579640412|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
160521841|NCT01079741|579640413|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
160521842|NCT01079741|579640414|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
160521843|NCT01079741|579640415|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
160521844|NCT01079741|579640411|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
160521845|NCT01079741|579640412|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
160521846|NCT01079741|579640413|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
160521847|NCT01079741|579640414|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
160521848|NCT01079741|579640415|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
160521849|NCT00446992|579640416|FG000|Overall Study|Adverse Event|11|||
160521850|NCT00446992|579640416|FG000|Overall Study|Lost to Follow-up|5|||
160521851|NCT00406653|579640417|FG000|Induction Period|Adverse Event|1|||
160521852|NCT00406653|579640418|FG001|Induction Period|Adverse Event|10|||
160521853|NCT00406653|579640419|FG002|Induction Period|Adverse Event|4|||
160521854|NCT00406653|579640420|FG003|Induction Period|Adverse Event|11|||
160521855|NCT00406653|579640421|FG004|Induction Period|Adverse Event|0|||
160521856|NCT00406653|579640422|FG005|Induction Period|Adverse Event|0|||
160521857|NCT00406653|579640423|FG006|Induction Period|Adverse Event|0|||
160521858|NCT00406653|579640417|FG000|Induction Period|Lack of Efficacy|11|||
160521859|NCT00406653|579640418|FG001|Induction Period|Lack of Efficacy|14|||
160521860|NCT00406653|579640419|FG002|Induction Period|Lack of Efficacy|8|||
160521861|NCT00406653|579640420|FG003|Induction Period|Lack of Efficacy|10|||
160521862|NCT00406653|579640421|FG004|Induction Period|Lack of Efficacy|0|||
160521863|NCT00406653|579640422|FG005|Induction Period|Lack of Efficacy|0|||
160521864|NCT00406653|579640423|FG006|Induction Period|Lack of Efficacy|0|||
160521865|NCT00406653|579640417|FG000|Induction Period|Lost to Follow-up|0|||
160521866|NCT00406653|579640418|FG001|Induction Period|Lost to Follow-up|2|||
160521867|NCT00406653|579640419|FG002|Induction Period|Lost to Follow-up|0|||
160521868|NCT00406653|579640420|FG003|Induction Period|Lost to Follow-up|0|||
160521869|NCT00406653|579640421|FG004|Induction Period|Lost to Follow-up|0|||
160521870|NCT00406653|579640422|FG005|Induction Period|Lost to Follow-up|0|||
160521871|NCT00406653|579640423|FG006|Induction Period|Lost to Follow-up|0|||
160521872|NCT00406653|579640417|FG000|Induction Period|Withdrawal of Consent|2|||
160521873|NCT00406653|579640418|FG001|Induction Period|Withdrawal of Consent|5|||
160521874|NCT00406653|579640419|FG002|Induction Period|Withdrawal of Consent|1|||
160521875|NCT00406653|579640420|FG003|Induction Period|Withdrawal of Consent|2|||
160521876|NCT00406653|579640421|FG004|Induction Period|Withdrawal of Consent|0|||
160521877|NCT00406653|579640422|FG005|Induction Period|Withdrawal of Consent|0|||
160521878|NCT00406653|579640423|FG006|Induction Period|Withdrawal of Consent|0|||
160521879|NCT00406653|579640417|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
160521880|NCT00406653|579640418|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
160521881|NCT00406653|579640419|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
160521882|NCT00406653|579640420|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
160521883|NCT00406653|579640421|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
160521884|NCT00406653|579640422|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
160749711|NCT02362425|580469656|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
160521885|NCT00406653|579640423|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
160521886|NCT00406653|579640417|FG000|Induction Period|Pregnancy|1|||
160521887|NCT00406653|579640418|FG001|Induction Period|Pregnancy|0|||
160521888|NCT00406653|579640419|FG002|Induction Period|Pregnancy|0|||
160521889|NCT00406653|579640420|FG003|Induction Period|Pregnancy|0|||
160521890|NCT00406653|579640421|FG004|Induction Period|Pregnancy|0|||
160521891|NCT00406653|579640422|FG005|Induction Period|Pregnancy|0|||
160521892|NCT00406653|579640423|FG006|Induction Period|Pregnancy|0|||
160521893|NCT00406653|579640417|FG000|Induction Period|Declined participation but followup done|0|||
160521894|NCT00406653|579640418|FG001|Induction Period|Declined participation but followup done|2|||
160521895|NCT00406653|579640419|FG002|Induction Period|Declined participation but followup done|1|||
160521896|NCT00406653|579640420|FG003|Induction Period|Declined participation but followup done|1|||
160521897|NCT00406653|579640421|FG004|Induction Period|Declined participation but followup done|0|||
160521898|NCT00406653|579640422|FG005|Induction Period|Declined participation but followup done|0|||
160521899|NCT00406653|579640423|FG006|Induction Period|Declined participation but followup done|0|||
160521900|NCT00406653|579640417|FG000|Induction Period|Given prohibited drug|0|||
160521901|NCT00406653|579640418|FG001|Induction Period|Given prohibited drug|1|||
160521902|NCT00406653|579640419|FG002|Induction Period|Given prohibited drug|2|||
160521903|NCT00406653|579640420|FG003|Induction Period|Given prohibited drug|0|||
160521904|NCT00406653|579640421|FG004|Induction Period|Given prohibited drug|0|||
160521905|NCT00406653|579640422|FG005|Induction Period|Given prohibited drug|0|||
160521906|NCT00406653|579640423|FG006|Induction Period|Given prohibited drug|0|||
160521907|NCT00406653|579640417|FG000|Induction Period|Incarcerated|0|||
160521908|NCT00406653|579640418|FG001|Induction Period|Incarcerated|0|||
160521909|NCT00406653|579640419|FG002|Induction Period|Incarcerated|1|||
160521910|NCT00406653|579640420|FG003|Induction Period|Incarcerated|0|||
160521911|NCT00406653|579640421|FG004|Induction Period|Incarcerated|0|||
160521912|NCT00406653|579640422|FG005|Induction Period|Incarcerated|0|||
160521913|NCT00406653|579640423|FG006|Induction Period|Incarcerated|0|||
160521914|NCT00406653|579640417|FG000|Induction Period|Patient relocated|0|||
160521915|NCT00406653|579640418|FG001|Induction Period|Patient relocated|0|||
160521916|NCT00406653|579640419|FG002|Induction Period|Patient relocated|1|||
160521917|NCT00406653|579640420|FG003|Induction Period|Patient relocated|0|||
160521918|NCT00406653|579640421|FG004|Induction Period|Patient relocated|0|||
160521919|NCT00406653|579640422|FG005|Induction Period|Patient relocated|0|||
160521920|NCT00406653|579640423|FG006|Induction Period|Patient relocated|0|||
160521921|NCT00406653|579640417|FG000|Maintenance Period|Adverse Event|0|||
160981051|NCT02080520|581319849|FG000|Overall Study|Personal reasons|0|||
160981052|NCT02080520|581319850|FG001|Overall Study|Personal reasons|3|||
160981053|NCT00390455|581319851|FG000|Overall Study|Adverse Event|17|||
160981054|NCT00390455|581319852|FG001|Overall Study|Adverse Event|3|||
160981055|NCT00390455|581319851|FG000|Overall Study|Withdrawal by Subject|8|||
160981056|NCT00390455|581319852|FG001|Overall Study|Withdrawal by Subject|8|||
160981057|NCT00390455|581319851|FG000|Overall Study|Alternate Treatment|0|||
160981058|NCT00390455|581319852|FG001|Overall Study|Alternate Treatment|1|||
160981059|NCT00390455|581319851|FG000|Overall Study|Other Medical Reasons|7|||
160981060|NCT00390455|581319852|FG001|Overall Study|Other Medical Reasons|11|||
160981061|NCT01591460|581319855|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
160981062|NCT01591460|581319855|FG000|Overall Study|Futility Rule (Week 12)|7|||
160981063|NCT01591460|581319855|FG000|Overall Study|Futility Rule (Week 24)|3|||
160981064|NCT01591460|581319855|FG000|Overall Study|Rebound or Breakthrough|3|||
160981065|NCT01591460|581319855|FG000|Overall Study|Treatment Discontinued by Error|1|||
160981066|NCT01591460|581319855|FG000|Overall Study|Lost to Follow-up|1|||
160981067|NCT01591460|581319855|FG000|Overall Study|Noncompliance|1|||
160521922|NCT00406653|579640418|FG001|Maintenance Period|Adverse Event|0|||
160521923|NCT00406653|579640419|FG002|Maintenance Period|Adverse Event|0|||
160521924|NCT00406653|579640420|FG003|Maintenance Period|Adverse Event|0|||
160521925|NCT00406653|579640421|FG004|Maintenance Period|Adverse Event|1|||
160521926|NCT00406653|579640422|FG005|Maintenance Period|Adverse Event|1|||
160521927|NCT00406653|579640423|FG006|Maintenance Period|Adverse Event|0|||
160521928|NCT00406653|579640417|FG000|Maintenance Period|Lack of Efficacy|0|||
160521929|NCT00406653|579640418|FG001|Maintenance Period|Lack of Efficacy|0|||
160521930|NCT00406653|579640419|FG002|Maintenance Period|Lack of Efficacy|0|||
160981068|NCT01591460|581319855|FG000|Overall Study|Participant Refusal|3|||
160981069|NCT01591460|581319855|FG000|Overall Study|Withdrawal by Subject|1|||
160981070|NCT01591460|581319855|FG000|Overall Study|Protocol Violation|1|||
160981071|NCT04102540|581319860|FG000|Overall Study|Withdrawn by PI|2|||
160981072|NCT04102540|581319860|FG000|Overall Study|Lost to Follow-up|6|||
160981073|NCT03405662|581319861|FG000|Overall Study|COVID-19 restriction|1|||
160981074|NCT03405662|581319862|FG001|Overall Study|COVID-19 restriction|0|||
160981075|NCT03405662|581319861|FG000|Overall Study|unblinding|0|||
160521931|NCT00406653|579640420|FG003|Maintenance Period|Lack of Efficacy|0|||
160521932|NCT00406653|579640421|FG004|Maintenance Period|Lack of Efficacy|20|||
160521933|NCT00406653|579640422|FG005|Maintenance Period|Lack of Efficacy|26|||
160521934|NCT00406653|579640423|FG006|Maintenance Period|Lack of Efficacy|0|||
160981076|NCT03405662|581319862|FG001|Overall Study|unblinding|1|||
160521935|NCT00406653|579640417|FG000|Maintenance Period|Lost to Follow-up|0|||
160521936|NCT00406653|579640418|FG001|Maintenance Period|Lost to Follow-up|0|||
160521937|NCT00406653|579640419|FG002|Maintenance Period|Lost to Follow-up|0|||
160521938|NCT00406653|579640420|FG003|Maintenance Period|Lost to Follow-up|0|||
160521939|NCT00406653|579640421|FG004|Maintenance Period|Lost to Follow-up|2|||
160521940|NCT00406653|579640422|FG005|Maintenance Period|Lost to Follow-up|1|||
160521941|NCT00406653|579640423|FG006|Maintenance Period|Lost to Follow-up|0|||
160521942|NCT00406653|579640417|FG000|Maintenance Period|Withdrawal of Consent|0|||
160521943|NCT00406653|579640418|FG001|Maintenance Period|Withdrawal of Consent|0|||
160521944|NCT00406653|579640419|FG002|Maintenance Period|Withdrawal of Consent|0|||
160521945|NCT00406653|579640420|FG003|Maintenance Period|Withdrawal of Consent|0|||
160521946|NCT00406653|579640421|FG004|Maintenance Period|Withdrawal of Consent|2|||
160521947|NCT00406653|579640422|FG005|Maintenance Period|Withdrawal of Consent|0|||
160521948|NCT00406653|579640423|FG006|Maintenance Period|Withdrawal of Consent|0|||
160521949|NCT00406653|579640417|FG000|Maintenance Period|Pregnancy|0|||
160521950|NCT00406653|579640418|FG001|Maintenance Period|Pregnancy|0|||
160521951|NCT00406653|579640419|FG002|Maintenance Period|Pregnancy|0|||
160521952|NCT00406653|579640420|FG003|Maintenance Period|Pregnancy|0|||
160521953|NCT00406653|579640421|FG004|Maintenance Period|Pregnancy|0|||
160521954|NCT00406653|579640422|FG005|Maintenance Period|Pregnancy|1|||
160521955|NCT00406653|579640423|FG006|Maintenance Period|Pregnancy|0|||
160521956|NCT00406653|579640417|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
160521957|NCT00406653|579640418|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
160521958|NCT00406653|579640419|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
160521959|NCT00406653|579640420|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
160521960|NCT00406653|579640421|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
160521961|NCT00406653|579640422|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
160521962|NCT00406653|579640423|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
160521963|NCT00406653|579640417|FG000|Maintenance Period|Error in disease score evaluation|0|||
160521964|NCT00406653|579640418|FG001|Maintenance Period|Error in disease score evaluation|0|||
160981077|NCT03405662|581319861|FG000|Overall Study|placement in memory care facility|0|||
160981078|NCT03405662|581319862|FG001|Overall Study|placement in memory care facility|2|||
160521965|NCT00406653|579640419|FG002|Maintenance Period|Error in disease score evaluation|0|||
160521966|NCT00406653|579640420|FG003|Maintenance Period|Error in disease score evaluation|0|||
160521967|NCT00406653|579640421|FG004|Maintenance Period|Error in disease score evaluation|1|||
160981079|NCT01458249|581319863|FG000|Overall Study|Not treated|1|||
160981080|NCT01458249|581319863|FG000|Overall Study|Adverse Event|4|||
160981081|NCT01458249|581319863|FG000|Overall Study|Other|2|||
160981082|NCT01458249|581319863|FG000|Overall Study|Ongoing|1|||
160981083|NCT01348854|581319864|FG000|Overall Study|Lost to Follow-up|2|||
160981084|NCT01348854|581319865|FG001|Overall Study|Lost to Follow-up|1|||
160981085|NCT01348854|581319864|FG000|Overall Study|Withdrawal by Subject|1|||
160981086|NCT01348854|581319865|FG001|Overall Study|Withdrawal by Subject|0|||
160981087|NCT03220737|581319866|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
160981088|NCT03220737|581319867|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
160981089|NCT03220737|581319868|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
160981090|NCT03220737|581319869|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
160981091|NCT03220737|581319870|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
160981092|NCT03220737|581319871|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
160981093|NCT03220737|581319872|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
160981094|NCT03220737|581319866|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
160981095|NCT03220737|581319867|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
160981096|NCT03220737|581319868|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
160981097|NCT03220737|581319869|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
160981098|NCT03220737|581319870|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
160981099|NCT03220737|581319871|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
160981100|NCT03220737|581319872|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
160981101|NCT03220737|581319866|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
160981102|NCT03220737|581319867|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
160981103|NCT03220737|581319868|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
160981104|NCT03220737|581319869|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
160981105|NCT03220737|581319870|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
160981106|NCT03220737|581319871|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
160981107|NCT03220737|581319872|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
160981108|NCT03220737|581319866|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
160981109|NCT03220737|581319867|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
160521968|NCT00406653|579640422|FG005|Maintenance Period|Error in disease score evaluation|0|||
160521969|NCT00406653|579640423|FG006|Maintenance Period|Error in disease score evaluation|0|||
160521970|NCT00406653|579640417|FG000|Open-Label Period|Death|0|||
160521971|NCT00406653|579640418|FG001|Open-Label Period|Death|0|||
160981110|NCT03220737|581319868|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
160981111|NCT03220737|581319869|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
160981112|NCT03220737|581319870|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
160981113|NCT03220737|581319871|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
160981114|NCT03220737|581319872|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
160981115|NCT03220737|581319866|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981116|NCT03220737|581319867|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981117|NCT03220737|581319868|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981118|NCT03220737|581319869|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981119|NCT03220737|581319870|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
160981120|NCT03220737|581319871|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981121|NCT03220737|581319872|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981122|NCT03220737|581319866|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
160981123|NCT03220737|581319867|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981124|NCT03220737|581319868|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981125|NCT03220737|581319869|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981126|NCT03220737|581319870|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981127|NCT03220737|581319871|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981128|NCT03220737|581319872|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981129|NCT03220737|581319866|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
160981130|NCT03220737|581319867|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981131|NCT03220737|581319868|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981132|NCT03220737|581319869|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981133|NCT03220737|581319870|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981134|NCT03220737|581319871|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981135|NCT03220737|581319872|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981136|NCT03220737|581319866|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
160981137|NCT03220737|581319867|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981138|NCT03220737|581319868|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981139|NCT03220737|581319869|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981140|NCT03220737|581319870|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981141|NCT03220737|581319871|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981142|NCT03220737|581319872|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981143|NCT04011384|581319880|FG000|Overall Study|Withdrawal by Subject|2|||
160981144|NCT04011384|581319881|FG001|Overall Study|Withdrawal by Subject|0|||
160981145|NCT01686932|581319882|FG000|Period 1|Adverse Event|1|||
160981146|NCT01686932|581319883|FG001|Period 1|Adverse Event|1|||
160981147|NCT04827134|581319886|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
160981148|NCT04827134|581319887|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
160981149|NCT04827134|581319888|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
160981150|NCT04827134|581319889|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
160981151|NCT00924469|581319899|FG000|Overall Study|Adverse Event|2|||
160981152|NCT00924469|581319900|FG001|Overall Study|Adverse Event|0|||
160981153|NCT00924469|581319899|FG000|Overall Study|Withdrawal by Subject|0|||
160521972|NCT00406653|579640419|FG002|Open-Label Period|Death|0|||
160521973|NCT00406653|579640420|FG003|Open-Label Period|Death|0|||
160521974|NCT00406653|579640421|FG004|Open-Label Period|Death|0|||
160521975|NCT00406653|579640422|FG005|Open-Label Period|Death|0|||
160521976|NCT00406653|579640423|FG006|Open-Label Period|Death|1|||
160521977|NCT00406653|579640417|FG000|Open-Label Period|Adverse Event|0|||
160521978|NCT00406653|579640418|FG001|Open-Label Period|Adverse Event|0|||
160521979|NCT00406653|579640419|FG002|Open-Label Period|Adverse Event|0|||
160521980|NCT00406653|579640420|FG003|Open-Label Period|Adverse Event|0|||
160521981|NCT00406653|579640421|FG004|Open-Label Period|Adverse Event|0|||
160521982|NCT00406653|579640422|FG005|Open-Label Period|Adverse Event|0|||
160521983|NCT00406653|579640423|FG006|Open-Label Period|Adverse Event|18|||
160521984|NCT00406653|579640417|FG000|Open-Label Period|Lack of Efficacy|0|||
160521985|NCT00406653|579640418|FG001|Open-Label Period|Lack of Efficacy|0|||
160521986|NCT00406653|579640419|FG002|Open-Label Period|Lack of Efficacy|0|||
160521987|NCT00406653|579640420|FG003|Open-Label Period|Lack of Efficacy|0|||
160521988|NCT00406653|579640421|FG004|Open-Label Period|Lack of Efficacy|0|||
160521989|NCT00406653|579640422|FG005|Open-Label Period|Lack of Efficacy|0|||
160521990|NCT00406653|579640423|FG006|Open-Label Period|Lack of Efficacy|160|||
160521991|NCT00406653|579640417|FG000|Open-Label Period|Lost to Follow-up|0|||
160521992|NCT00406653|579640418|FG001|Open-Label Period|Lost to Follow-up|0|||
160521993|NCT00406653|579640419|FG002|Open-Label Period|Lost to Follow-up|0|||
160521994|NCT00406653|579640420|FG003|Open-Label Period|Lost to Follow-up|0|||
160521995|NCT00406653|579640421|FG004|Open-Label Period|Lost to Follow-up|0|||
160521996|NCT00406653|579640422|FG005|Open-Label Period|Lost to Follow-up|0|||
160521997|NCT00406653|579640423|FG006|Open-Label Period|Lost to Follow-up|6|||
160521998|NCT00406653|579640417|FG000|Open-Label Period|Withdrawal of Consent|0|||
160521999|NCT00406653|579640418|FG001|Open-Label Period|Withdrawal of Consent|0|||
160522000|NCT00406653|579640419|FG002|Open-Label Period|Withdrawal of Consent|0|||
160522001|NCT00406653|579640420|FG003|Open-Label Period|Withdrawal of Consent|0|||
160522002|NCT00406653|579640421|FG004|Open-Label Period|Withdrawal of Consent|0|||
160522003|NCT00406653|579640422|FG005|Open-Label Period|Withdrawal of Consent|0|||
160522004|NCT00406653|579640423|FG006|Open-Label Period|Withdrawal of Consent|11|||
160522005|NCT00406653|579640417|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
160522006|NCT00406653|579640418|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
160522007|NCT00406653|579640419|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
160522008|NCT00406653|579640420|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
160981154|NCT00924469|581319900|FG001|Overall Study|Withdrawal by Subject|1|||
160981155|NCT00924469|581319899|FG000|Overall Study|Lost to Follow-up|0|||
160981156|NCT00924469|581319900|FG001|Overall Study|Lost to Follow-up|1|||
160981157|NCT01651936|581319901|FG000|Base Study|Adverse Event|3|||
160981158|NCT01651936|581319902|FG001|Base Study|Adverse Event|0|||
160981159|NCT01651936|581319903|FG002|Base Study|Adverse Event|0|||
160981160|NCT01651936|581319901|FG000|Base Study|Withdrawal by Subject|1|||
160981161|NCT01651936|581319902|FG001|Base Study|Withdrawal by Subject|1|||
160981162|NCT01651936|581319903|FG002|Base Study|Withdrawal by Subject|0|||
160981163|NCT01651936|581319901|FG000|Base Study|Early Escape|2|||
160981164|NCT01651936|581319902|FG001|Base Study|Early Escape|8|||
160981165|NCT01651936|581319903|FG002|Base Study|Early Escape|0|||
160981166|NCT01651936|581319901|FG000|Base Study|Study terminated by sponsor|21|||
160981167|NCT01651936|581319902|FG001|Base Study|Study terminated by sponsor|16|||
160981168|NCT01651936|581319903|FG002|Base Study|Study terminated by sponsor|0|||
160981169|NCT01651936|581319901|FG000|Extension Study|Lack of Efficacy|0|||
160981170|NCT01651936|581319902|FG001|Extension Study|Lack of Efficacy|0|||
160981171|NCT01651936|581319903|FG002|Extension Study|Lack of Efficacy|1|||
160981172|NCT01651936|581319901|FG000|Extension Study|Study terminated by sponsor|0|||
160981173|NCT01651936|581319902|FG001|Extension Study|Study terminated by sponsor|0|||
160981174|NCT01651936|581319903|FG002|Extension Study|Study terminated by sponsor|13|||
160981175|NCT03044353|581319904|FG000|Overall Study|Adverse Event|0|||
160981176|NCT03044353|581319905|FG001|Overall Study|Adverse Event|1|||
160522009|NCT00406653|579640421|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
160522010|NCT00406653|579640422|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
160522011|NCT00406653|579640423|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
160522012|NCT00406653|579640417|FG000|Open-Label Period|Pregnancy|0|||
160981177|NCT03044353|581319906|FG002|Overall Study|Adverse Event|0|||
160981178|NCT03358329|581319907|FG000|Overall Study|Lost to Follow-up|2|||
160981179|NCT03358329|581319907|FG000|Overall Study|Withdrawal by Subject|2|||
160981180|NCT03875911|581319908|FG000|Overall Study|Lost to Follow-up|3|||
160981181|NCT03875911|581319909|FG001|Overall Study|Lost to Follow-up|6|||
160981182|NCT03875911|581319910|FG002|Overall Study|Lost to Follow-up|2|||
160981183|NCT03875911|581319908|FG000|Overall Study|Surgery cancelled|1|||
160981184|NCT03875911|581319909|FG001|Overall Study|Surgery cancelled|0|||
160981185|NCT03875911|581319910|FG002|Overall Study|Surgery cancelled|1|||
160981186|NCT03875911|581319908|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
160981187|NCT03875911|581319909|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
160981188|NCT03875911|581319910|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
160981189|NCT05284019|581319911|FG000|Overall Study|Study terminated|2|||
160981190|NCT05284019|581319912|FG001|Overall Study|Study terminated|2|||
160981191|NCT05284019|581319913|FG002|Overall Study|Study terminated|2|||
160522013|NCT00406653|579640418|FG001|Open-Label Period|Pregnancy|0|||
160522014|NCT00406653|579640419|FG002|Open-Label Period|Pregnancy|0|||
160522015|NCT00406653|579640420|FG003|Open-Label Period|Pregnancy|0|||
160522016|NCT00406653|579640421|FG004|Open-Label Period|Pregnancy|0|||
160522017|NCT00406653|579640422|FG005|Open-Label Period|Pregnancy|0|||
160522018|NCT00406653|579640423|FG006|Open-Label Period|Pregnancy|2|||
160522019|NCT00406653|579640417|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
160522020|NCT00406653|579640418|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
160522021|NCT00406653|579640419|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
160522022|NCT00406653|579640420|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
160522023|NCT00406653|579640421|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
160522024|NCT00406653|579640422|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
160522025|NCT00406653|579640423|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
160522026|NCT00406653|579640417|FG000|Open-Label Period|Declined participation but followup done|0|||
160522027|NCT00406653|579640418|FG001|Open-Label Period|Declined participation but followup done|0|||
160522028|NCT00406653|579640419|FG002|Open-Label Period|Declined participation but followup done|0|||
160522029|NCT00406653|579640420|FG003|Open-Label Period|Declined participation but followup done|0|||
160522030|NCT00406653|579640421|FG004|Open-Label Period|Declined participation but followup done|0|||
160522031|NCT00406653|579640422|FG005|Open-Label Period|Declined participation but followup done|0|||
160522032|NCT00406653|579640423|FG006|Open-Label Period|Declined participation but followup done|8|||
160522033|NCT00406653|579640417|FG000|Open-Label Period|Discontinued by Sponsor|0|||
160522034|NCT00406653|579640418|FG001|Open-Label Period|Discontinued by Sponsor|0|||
160522035|NCT00406653|579640419|FG002|Open-Label Period|Discontinued by Sponsor|0|||
160522036|NCT00406653|579640420|FG003|Open-Label Period|Discontinued by Sponsor|0|||
160522037|NCT00406653|579640421|FG004|Open-Label Period|Discontinued by Sponsor|0|||
160522038|NCT00406653|579640422|FG005|Open-Label Period|Discontinued by Sponsor|0|||
160522039|NCT00406653|579640423|FG006|Open-Label Period|Discontinued by Sponsor|1|||
160522040|NCT00406653|579640417|FG000|Open-Label Period|Refused followup|0|||
160522041|NCT00406653|579640418|FG001|Open-Label Period|Refused followup|0|||
160522042|NCT00406653|579640419|FG002|Open-Label Period|Refused followup|0|||
160522043|NCT00406653|579640420|FG003|Open-Label Period|Refused followup|0|||
160522044|NCT00406653|579640421|FG004|Open-Label Period|Refused followup|0|||
160522045|NCT00406653|579640422|FG005|Open-Label Period|Refused followup|0|||
160522046|NCT00406653|579640423|FG006|Open-Label Period|Refused followup|1|||
160522047|NCT00731120|579640424|FG000|Overall Study|Adverse Event|7|||
160522048|NCT00731120|579640425|FG001|Overall Study|Adverse Event|6|||
160522049|NCT00731120|579640426|FG002|Overall Study|Adverse Event|8|||
160522050|NCT00731120|579640424|FG000|Overall Study|Lack of Efficacy|4|||
160522051|NCT00731120|579640425|FG001|Overall Study|Lack of Efficacy|5|||
160522052|NCT00731120|579640426|FG002|Overall Study|Lack of Efficacy|4|||
160522053|NCT00731120|579640424|FG000|Overall Study|Noncompliance with Study Drug|3|||
160522054|NCT00731120|579640425|FG001|Overall Study|Noncompliance with Study Drug|3|||
160522055|NCT00731120|579640426|FG002|Overall Study|Noncompliance with Study Drug|1|||
160522056|NCT00731120|579640424|FG000|Overall Study|Protocol Deviations|1|||
160981192|NCT05284019|581319914|FG003|Overall Study|Study terminated|5|||
160981193|NCT05284019|581319915|FG004|Overall Study|Study terminated|15|||
160522057|NCT00731120|579640425|FG001|Overall Study|Protocol Deviations|6|||
160522058|NCT00731120|579640426|FG002|Overall Study|Protocol Deviations|1|||
160522059|NCT00731120|579640424|FG000|Overall Study|Withdrawal of Consent|13|||
160981194|NCT05284019|581319911|FG000|Overall Study|Withdrawal by Subject|0|||
160522060|NCT00731120|579640425|FG001|Overall Study|Withdrawal of Consent|8|||
160522061|NCT00731120|579640426|FG002|Overall Study|Withdrawal of Consent|4|||
160522062|NCT00731120|579640424|FG000|Overall Study|Lost to Follow-up|10|||
160522063|NCT00731120|579640425|FG001|Overall Study|Lost to Follow-up|15|||
160522064|NCT00731120|579640426|FG002|Overall Study|Lost to Follow-up|17|||
160522065|NCT00731120|579640424|FG000|Overall Study|Other|4|||
160522066|NCT00731120|579640425|FG001|Overall Study|Other|0|||
160522067|NCT00731120|579640426|FG002|Overall Study|Other|1|||
160522068|NCT02434939|579640429|FG000|Overall Study|Lack of Efficacy|34|||
160522069|NCT02434939|579640430|FG001|Overall Study|Lack of Efficacy|48|||
160522070|NCT02434939|579640429|FG000|Overall Study|Withdrawal by Subject|3|||
160522071|NCT02434939|579640430|FG001|Overall Study|Withdrawal by Subject|0|||
160522072|NCT02434939|579640429|FG000|Overall Study|Adverse Event|0|||
160522073|NCT02434939|579640430|FG001|Overall Study|Adverse Event|1|||
160522074|NCT01259284|579640437|FG000|Overall Study|Study Termination|2|||
160522075|NCT01259284|579640438|FG001|Overall Study|Study Termination|0|||
160522076|NCT01259284|579640439|FG002|Overall Study|Study Termination|0|||
160522077|NCT01326533|579640441|FG000|Overall Study|Lost to Follow-up|2|||
160522078|NCT01326533|579640442|FG001|Overall Study|Lost to Follow-up|0|||
160522079|NCT01326533|579640441|FG000|Overall Study|Withdrawal by Subject|1|||
160522080|NCT01326533|579640442|FG001|Overall Study|Withdrawal by Subject|0|||
160522081|NCT01326533|579640441|FG000|Overall Study|Adverse Event|1|||
160522082|NCT01326533|579640442|FG001|Overall Study|Adverse Event|0|||
160522083|NCT04079803|579640443|FG000|Overall Study|Withdrawal by Subject|0|||
160522084|NCT04079803|579640444|FG001|Overall Study|Withdrawal by Subject|0|||
160522085|NCT04079803|579640445|FG002|Overall Study|Withdrawal by Subject|1|||
160522086|NCT01032382|579640447|FG000|Overall Study|Disease dissemination|1|||
160522087|NCT01032382|579640448|FG001|Overall Study|Disease dissemination|1|||
160522088|NCT01032382|579640447|FG000|Overall Study|Treatment failure|3|||
160522089|NCT01032382|579640448|FG001|Overall Study|Treatment failure|1|||
160522090|NCT01032382|579640447|FG000|Overall Study|Index lesion relapse|1|||
160522091|NCT01032382|579640448|FG001|Overall Study|Index lesion relapse|3|||
160522092|NCT01012713|579640449|FG000|Overall Study|Lack of Efficacy|3|||
160522093|NCT01242800|579640450|FG000|Overall Study|Patient refusal|0|||
160522094|NCT01242800|579640451|FG001|Overall Study|Patient refusal|10|||
160522095|NCT01242800|579640450|FG000|Overall Study|Physician Decision|0|||
160522096|NCT01242800|579640451|FG001|Overall Study|Physician Decision|1|||
160522097|NCT01242800|579640450|FG000|Overall Study|Disease progression|0|||
160522098|NCT01242800|579640451|FG001|Overall Study|Disease progression|3|||
160522099|NCT01242800|579640450|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
160522100|NCT01242800|579640451|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
160522101|NCT01242800|579640450|FG000|Overall Study|Reasons not reported|0|||
160522102|NCT01242800|579640451|FG001|Overall Study|Reasons not reported|4|||
160522103|NCT04508023|579640453|FG000|Overall Study|Withdrawal by Subject|1|||
160522104|NCT04508023|579640454|FG001|Overall Study|Withdrawal by Subject|2|||
160522105|NCT01668667|579640462|FG000|Overall Study|Adverse Event|3|||
160522106|NCT01668667|579640463|FG001|Overall Study|Adverse Event|6|||
160522107|NCT01668667|579640464|FG002|Overall Study|Adverse Event|4|||
160522108|NCT01668667|579640465|FG003|Overall Study|Adverse Event|4|||
160522109|NCT01668667|579640462|FG000|Overall Study|Lack of Efficacy|3|||
160522110|NCT01668667|579640463|FG001|Overall Study|Lack of Efficacy|2|||
160522111|NCT01668667|579640464|FG002|Overall Study|Lack of Efficacy|2|||
160522112|NCT01668667|579640465|FG003|Overall Study|Lack of Efficacy|3|||
160522113|NCT01668667|579640462|FG000|Overall Study|Protocol Violation|6|||
160522114|NCT01668667|579640463|FG001|Overall Study|Protocol Violation|10|||
160522115|NCT01668667|579640464|FG002|Overall Study|Protocol Violation|12|||
160522116|NCT01668667|579640465|FG003|Overall Study|Protocol Violation|5|||
160522117|NCT01668667|579640462|FG000|Overall Study|Lost to Follow-up|9|||
160522118|NCT01668667|579640463|FG001|Overall Study|Lost to Follow-up|4|||
160522119|NCT01668667|579640464|FG002|Overall Study|Lost to Follow-up|7|||
160522120|NCT01668667|579640465|FG003|Overall Study|Lost to Follow-up|6|||
160981195|NCT05284019|581319912|FG001|Overall Study|Withdrawal by Subject|0|||
160981196|NCT05284019|581319913|FG002|Overall Study|Withdrawal by Subject|0|||
160981197|NCT05284019|581319914|FG003|Overall Study|Withdrawal by Subject|1|||
160981198|NCT05284019|581319915|FG004|Overall Study|Withdrawal by Subject|1|||
160981199|NCT05284019|581319911|FG000|Overall Study|Lost to Follow-up|1|||
160981200|NCT05284019|581319912|FG001|Overall Study|Lost to Follow-up|0|||
160981201|NCT05284019|581319913|FG002|Overall Study|Lost to Follow-up|0|||
160981202|NCT05284019|581319914|FG003|Overall Study|Lost to Follow-up|2|||
160981203|NCT05284019|581319915|FG004|Overall Study|Lost to Follow-up|1|||
160981204|NCT01990300|581319916|FG000|Overall Study|Case Report Forms Uncollected|89|||
160981205|NCT01990300|581319916|FG000|Overall Study|Protocol Deviation|53|||
160981206|NCT01231503|581319917|FG000|Overall Study|Adverse Event|0|||
160981207|NCT01231503|581319918|FG001|Overall Study|Adverse Event|0|||
160981208|NCT01231503|581319919|FG002|Overall Study|Adverse Event|0|||
160981209|NCT01231503|581319920|FG003|Overall Study|Adverse Event|0|||
160981210|NCT01231503|581319921|FG004|Overall Study|Adverse Event|0|||
160981211|NCT01231503|581319922|FG005|Overall Study|Adverse Event|1|||
160981212|NCT01231503|581319923|FG006|Overall Study|Adverse Event|0|||
160981213|NCT01231503|581319924|FG007|Overall Study|Adverse Event|0|||
160981214|NCT01231503|581319917|FG000|Overall Study|Adverse event, serious fatal|0|||
160981215|NCT01231503|581319918|FG001|Overall Study|Adverse event, serious fatal|0|||
160981216|NCT01231503|581319919|FG002|Overall Study|Adverse event, serious fatal|1|||
160981217|NCT01231503|581319920|FG003|Overall Study|Adverse event, serious fatal|1|||
160981218|NCT01231503|581319921|FG004|Overall Study|Adverse event, serious fatal|0|||
160981219|NCT01231503|581319922|FG005|Overall Study|Adverse event, serious fatal|1|||
160981220|NCT01231503|581319923|FG006|Overall Study|Adverse event, serious fatal|0|||
160981221|NCT01231503|581319924|FG007|Overall Study|Adverse event, serious fatal|0|||
160981222|NCT01231503|581319917|FG000|Overall Study|Withdrawal by Subject|6|||
160981223|NCT01231503|581319918|FG001|Overall Study|Withdrawal by Subject|3|||
160981224|NCT01231503|581319919|FG002|Overall Study|Withdrawal by Subject|3|||
160981225|NCT01231503|581319920|FG003|Overall Study|Withdrawal by Subject|1|||
160981226|NCT01231503|581319921|FG004|Overall Study|Withdrawal by Subject|3|||
160981227|NCT01231503|581319922|FG005|Overall Study|Withdrawal by Subject|5|||
160981228|NCT01231503|581319923|FG006|Overall Study|Withdrawal by Subject|1|||
160981229|NCT01231503|581319924|FG007|Overall Study|Withdrawal by Subject|2|||
160981230|NCT01231503|581319917|FG000|Overall Study|Lost to Follow-up|8|||
160981231|NCT01231503|581319918|FG001|Overall Study|Lost to Follow-up|10|||
160981232|NCT01231503|581319919|FG002|Overall Study|Lost to Follow-up|8|||
160981233|NCT01231503|581319920|FG003|Overall Study|Lost to Follow-up|5|||
160981234|NCT01231503|581319921|FG004|Overall Study|Lost to Follow-up|7|||
160981235|NCT01231503|581319922|FG005|Overall Study|Lost to Follow-up|9|||
160981236|NCT01231503|581319923|FG006|Overall Study|Lost to Follow-up|6|||
160981237|NCT01231503|581319924|FG007|Overall Study|Lost to Follow-up|6|||
160981238|NCT01231503|581319917|FG000|Overall Study|Protocol Violation|0|||
160981239|NCT01231503|581319918|FG001|Overall Study|Protocol Violation|0|||
160981240|NCT01231503|581319919|FG002|Overall Study|Protocol Violation|0|||
160981241|NCT01231503|581319920|FG003|Overall Study|Protocol Violation|1|||
160981242|NCT01231503|581319921|FG004|Overall Study|Protocol Violation|0|||
160981243|NCT01231503|581319922|FG005|Overall Study|Protocol Violation|0|||
160981244|NCT01231503|581319923|FG006|Overall Study|Protocol Violation|0|||
160981245|NCT01231503|581319924|FG007|Overall Study|Protocol Violation|0|||
160981246|NCT02293837|581319925|FG000|Overall Study|Lost to Follow-up|0|||
160981247|NCT02293837|581319926|FG001|Overall Study|Lost to Follow-up|2|||
160981248|NCT02293837|581319927|FG002|Overall Study|Lost to Follow-up|1|||
160981249|NCT02293837|581319928|FG003|Overall Study|Lost to Follow-up|0|||
160981250|NCT02293837|581319925|FG000|Overall Study|Withdrawal by Subject|2|||
160981251|NCT02293837|581319926|FG001|Overall Study|Withdrawal by Subject|1|||
160981252|NCT02293837|581319927|FG002|Overall Study|Withdrawal by Subject|2|||
160981253|NCT02293837|581319928|FG003|Overall Study|Withdrawal by Subject|1|||
160981254|NCT02293837|581319925|FG000|Overall Study|COVID-19 Related|1|||
160981255|NCT02293837|581319926|FG001|Overall Study|COVID-19 Related|1|||
160981256|NCT02293837|581319927|FG002|Overall Study|COVID-19 Related|0|||
160981257|NCT02293837|581319928|FG003|Overall Study|COVID-19 Related|0|||
160981258|NCT02293837|581319925|FG000|Overall Study|Participant ill and could not be infused|0|||
160981259|NCT02293837|581319926|FG001|Overall Study|Participant ill and could not be infused|0|||
160981260|NCT02293837|581319927|FG002|Overall Study|Participant ill and could not be infused|1|||
160981261|NCT02293837|581319928|FG003|Overall Study|Participant ill and could not be infused|0|||
160981262|NCT03285113|581319929|FG000|Overall Study|Unable to implant leads|2|||
160522121|NCT01668667|579640462|FG000|Overall Study|Physician Decision|3|||
160981263|NCT01076088|581319930|FG000|Overall Study|Adverse Event|1|||
160981264|NCT01076088|581319931|FG001|Overall Study|Adverse Event|6|||
160981265|NCT01076088|581319932|FG002|Overall Study|Adverse Event|3|||
160981266|NCT01076088|581319933|FG003|Overall Study|Adverse Event|2|||
160981267|NCT01076088|581319934|FG004|Overall Study|Adverse Event|3|||
160981268|NCT01076088|581319935|FG005|Overall Study|Adverse Event|3|||
160981269|NCT01076088|581319930|FG000|Overall Study|Lost to Follow-up|1|||
160981270|NCT01076088|581319931|FG001|Overall Study|Lost to Follow-up|1|||
160981271|NCT01076088|581319932|FG002|Overall Study|Lost to Follow-up|0|||
160981272|NCT01076088|581319933|FG003|Overall Study|Lost to Follow-up|1|||
160981273|NCT01076088|581319934|FG004|Overall Study|Lost to Follow-up|1|||
160981274|NCT01076088|581319935|FG005|Overall Study|Lost to Follow-up|2|||
160981275|NCT01076088|581319930|FG000|Overall Study|Non-compliance with study drug|0|||
160981276|NCT01076088|581319931|FG001|Overall Study|Non-compliance with study drug|0|||
160981277|NCT01076088|581319932|FG002|Overall Study|Non-compliance with study drug|0|||
160981278|NCT01076088|581319933|FG003|Overall Study|Non-compliance with study drug|1|||
160981279|NCT01076088|581319934|FG004|Overall Study|Non-compliance with study drug|0|||
160981280|NCT01076088|581319935|FG005|Overall Study|Non-compliance with study drug|0|||
160981281|NCT01076088|581319930|FG000|Overall Study|Physician Decision|1|||
160981282|NCT01076088|581319931|FG001|Overall Study|Physician Decision|3|||
160981283|NCT01076088|581319932|FG002|Overall Study|Physician Decision|0|||
160981284|NCT01076088|581319933|FG003|Overall Study|Physician Decision|1|||
160981285|NCT01076088|581319934|FG004|Overall Study|Physician Decision|1|||
160981286|NCT01076088|581319935|FG005|Overall Study|Physician Decision|0|||
160981287|NCT01076088|581319930|FG000|Overall Study|Withdrawal by Subject|8|||
160981288|NCT01076088|581319931|FG001|Overall Study|Withdrawal by Subject|8|||
160981289|NCT01076088|581319932|FG002|Overall Study|Withdrawal by Subject|14|||
160981290|NCT01076088|581319933|FG003|Overall Study|Withdrawal by Subject|10|||
160981291|NCT01076088|581319934|FG004|Overall Study|Withdrawal by Subject|11|||
160981292|NCT01076088|581319935|FG005|Overall Study|Withdrawal by Subject|17|||
160981293|NCT01076088|581319930|FG000|Overall Study|Other protocol specified criteria|0|||
160981294|NCT01076088|581319931|FG001|Overall Study|Other protocol specified criteria|0|||
160981295|NCT01076088|581319932|FG002|Overall Study|Other protocol specified criteria|0|||
160981296|NCT01076088|581319933|FG003|Overall Study|Other protocol specified criteria|0|||
160981297|NCT01076088|581319934|FG004|Overall Study|Other protocol specified criteria|0|||
160981298|NCT01076088|581319935|FG005|Overall Study|Other protocol specified criteria|1|||
160981299|NCT03053492|581319936|FG000|Overall Study|Adverse Event|1|||
160981300|NCT03053492|581319937|FG001|Overall Study|Adverse Event|1|||
160981301|NCT03053492|581319936|FG000|Overall Study|Withdrawal by Subject|7|||
160981302|NCT03053492|581319937|FG001|Overall Study|Withdrawal by Subject|5|||
160981303|NCT02207374|581319942|FG000|Overall Study|Withdrawal by Subject|5|||
160981304|NCT02207374|581319943|FG001|Overall Study|Withdrawal by Subject|9|||
160981305|NCT02207374|581319944|FG002|Overall Study|Withdrawal by Subject|4|||
160981306|NCT02207374|581319942|FG000|Overall Study|Death|1|||
160981307|NCT02207374|581319943|FG001|Overall Study|Death|0|||
160981308|NCT02207374|581319944|FG002|Overall Study|Death|1|||
160981309|NCT02207374|581319942|FG000|Overall Study|Missing follow-up information|0|||
160981310|NCT02207374|581319943|FG001|Overall Study|Missing follow-up information|1|||
160981311|NCT02207374|581319944|FG002|Overall Study|Missing follow-up information|1|||
160981312|NCT02087150|581319945|FG000|Overall Study|Death|0|||
160981313|NCT02087150|581319946|FG001|Overall Study|Death|1|||
160981314|NCT02087150|581319947|FG002|Overall Study|Death|0|||
160981315|NCT02087150|581319945|FG000|Overall Study|Lost to Follow-up|6|||
160981316|NCT02087150|581319946|FG001|Overall Study|Lost to Follow-up|13|||
160981317|NCT02087150|581319947|FG002|Overall Study|Lost to Follow-up|7|||
160981318|NCT02087150|581319945|FG000|Overall Study|Withdrawal by Subject|2|||
160981319|NCT02087150|581319946|FG001|Overall Study|Withdrawal by Subject|5|||
160981320|NCT02087150|581319947|FG002|Overall Study|Withdrawal by Subject|3|||
160981321|NCT02087150|581319945|FG000|Overall Study|Physician Decision|0|||
160981322|NCT02087150|581319946|FG001|Overall Study|Physician Decision|1|||
160981323|NCT02087150|581319947|FG002|Overall Study|Physician Decision|0|||
160981324|NCT02087150|581319945|FG000|Overall Study|Procedure not done|1|||
160981325|NCT02087150|581319946|FG001|Overall Study|Procedure not done|13|||
160981326|NCT02087150|581319947|FG002|Overall Study|Procedure not done|0|||
160981327|NCT02087150|581319945|FG000|Overall Study|F/U not completed w/in study window|0|||
160981328|NCT02087150|581319946|FG001|Overall Study|F/U not completed w/in study window|0|||
160981329|NCT02087150|581319947|FG002|Overall Study|F/U not completed w/in study window|1|||
160981330|NCT02087150|581319945|FG000|Overall Study|Other|1|||
160981331|NCT02087150|581319946|FG001|Overall Study|Other|0|||
160981332|NCT02087150|581319947|FG002|Overall Study|Other|0|||
160981333|NCT02087150|581319945|FG000|Overall Study|Pt moved out of town|0|||
160981334|NCT02087150|581319946|FG001|Overall Study|Pt moved out of town|1|||
160981335|NCT02087150|581319947|FG002|Overall Study|Pt moved out of town|0|||
160981336|NCT00683449|581319948|FG000|Overall Study|Lost to Follow-up|0|||
160981337|NCT00683449|581319949|FG001|Overall Study|Lost to Follow-up|1|||
160981338|NCT00683449|581319950|FG002|Overall Study|Lost to Follow-up|0|||
160981339|NCT00683449|581319951|FG003|Overall Study|Lost to Follow-up|0|||
160981340|NCT00683449|581319952|FG004|Overall Study|Lost to Follow-up|0|||
160981341|NCT01000376|581319957|FG000|Cycle 1 Day 1|Adverse Event|1|||
160981342|NCT01000376|581319958|FG001|Cycle 1 Day 1|Adverse Event|0|||
160981343|NCT01000376|581319957|FG000|Cycle 1 Day 1|Progressive Disease|1|||
160981344|NCT01000376|581319958|FG001|Cycle 1 Day 1|Progressive Disease|0|||
160981345|NCT00507026|581319959|FG000|Overall Study|Lack of Efficacy|6|||
160981346|NCT00507026|581319960|FG001|Overall Study|Lack of Efficacy|4|||
160981347|NCT00507026|581319961|FG002|Overall Study|Lack of Efficacy|21|||
160981348|NCT00507026|581319959|FG000|Overall Study|Withdrawal by Subject|2|||
160522122|NCT01668667|579640463|FG001|Overall Study|Physician Decision|0|||
160522123|NCT01668667|579640464|FG002|Overall Study|Physician Decision|1|||
160522124|NCT01668667|579640465|FG003|Overall Study|Physician Decision|0|||
160522125|NCT01668667|579640462|FG000|Overall Study|Withdrawal by Subject|7|||
160522126|NCT01668667|579640463|FG001|Overall Study|Withdrawal by Subject|4|||
160522127|NCT01668667|579640464|FG002|Overall Study|Withdrawal by Subject|5|||
160522128|NCT01668667|579640465|FG003|Overall Study|Withdrawal by Subject|5|||
160522129|NCT02988622|579640466|FG000|Overall Study|Lost to Follow-up|17|||
160522130|NCT02447172|579640467|FG000|Overall Study|Adverse Event|11|||
160522131|NCT02447172|579640468|FG001|Overall Study|Adverse Event|8|||
160522132|NCT02447172|579640469|FG002|Overall Study|Adverse Event|7|||
160522133|NCT02447172|579640467|FG000|Overall Study|Death|3|||
160522134|NCT02447172|579640468|FG001|Overall Study|Death|1|||
160522135|NCT02447172|579640469|FG002|Overall Study|Death|0|||
160522136|NCT02447172|579640467|FG000|Overall Study|Protocol Violation|2|||
160522137|NCT02447172|579640468|FG001|Overall Study|Protocol Violation|1|||
160522138|NCT02447172|579640469|FG002|Overall Study|Protocol Violation|2|||
160522139|NCT02447172|579640467|FG000|Overall Study|Lost to Follow-up|7|||
160522140|NCT02447172|579640468|FG001|Overall Study|Lost to Follow-up|4|||
160522141|NCT02447172|579640469|FG002|Overall Study|Lost to Follow-up|4|||
160522142|NCT02447172|579640467|FG000|Overall Study|Withdrawal by Subject|5|||
160522143|NCT02447172|579640468|FG001|Overall Study|Withdrawal by Subject|1|||
160522144|NCT02447172|579640469|FG002|Overall Study|Withdrawal by Subject|3|||
160522145|NCT02447172|579640467|FG000|Overall Study|protocol specific treatment unrelated|3|||
160522146|NCT02447172|579640468|FG001|Overall Study|protocol specific treatment unrelated|0|||
160522147|NCT02447172|579640469|FG002|Overall Study|protocol specific treatment unrelated|2|||
160522148|NCT01204398|579640470|FG000|Overall Study|Adverse Event|1|||
160522149|NCT03261700|579640471|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
160522150|NCT03261700|579640472|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
160522151|NCT01910181|579640482|FG000|Overall Study|Death|37|||
160522152|NCT01910181|579640482|FG000|Overall Study|Lost to Follow-up|3|||
160522153|NCT01910181|579640482|FG000|Overall Study|Study Terminated by Sponsor|6|||
160522154|NCT05269355|579640484|FG000|Overall Study|Progressive Disease|104|||
160522155|NCT05269355|579640485|FG001|Overall Study|Progressive Disease|68|||
160522156|NCT05269355|579640484|FG000|Overall Study|Study Terminated by Sponsor|87|||
160522157|NCT05269355|579640485|FG001|Overall Study|Study Terminated by Sponsor|29|||
160522158|NCT05269355|579640484|FG000|Overall Study|Adverse Event|15|||
160522159|NCT05269355|579640485|FG001|Overall Study|Adverse Event|8|||
160981349|NCT00507026|581319960|FG001|Overall Study|Withdrawal by Subject|0|||
160981350|NCT00507026|581319961|FG002|Overall Study|Withdrawal by Subject|0|||
160981351|NCT00507026|581319959|FG000|Overall Study|Investigator Decision|1|||
160981352|NCT00507026|581319960|FG001|Overall Study|Investigator Decision|0|||
160981353|NCT00507026|581319961|FG002|Overall Study|Investigator Decision|0|||
160981354|NCT00507026|581319959|FG000|Overall Study|Adverse Event|2|||
160981355|NCT00507026|581319960|FG001|Overall Study|Adverse Event|0|||
160981356|NCT00507026|581319961|FG002|Overall Study|Adverse Event|0|||
160981357|NCT00507026|581319959|FG000|Overall Study|Protocol Violation|1|||
160981358|NCT00507026|581319960|FG001|Overall Study|Protocol Violation|0|||
160981359|NCT00507026|581319961|FG002|Overall Study|Protocol Violation|0|||
160981360|NCT00507026|581319959|FG000|Overall Study|Other|1|||
160981361|NCT00507026|581319960|FG001|Overall Study|Other|0|||
160981362|NCT00507026|581319961|FG002|Overall Study|Other|0|||
160981363|NCT04230980|581319962|FG000|Overall Study|Lost to Follow-up|1|||
160981364|NCT04230980|581319963|FG001|Overall Study|Lost to Follow-up|2|||
160981365|NCT04230980|581319962|FG000|Overall Study|Adverse Event|0|||
160522160|NCT05269355|579640484|FG000|Overall Study|Withdrawal by Subject|18|||
160522161|NCT05269355|579640485|FG001|Overall Study|Withdrawal by Subject|5|||
160522162|NCT05269355|579640484|FG000|Overall Study|Physician Decision|6|||
160522163|NCT05269355|579640485|FG001|Overall Study|Physician Decision|4|||
160522164|NCT05269355|579640484|FG000|Overall Study|Death|3|||
160522165|NCT05269355|579640485|FG001|Overall Study|Death|5|||
160522166|NCT05269355|579640484|FG000|Overall Study|Other Than Specified|5|||
160522167|NCT05269355|579640485|FG001|Overall Study|Other Than Specified|1|||
160981366|NCT04230980|581319963|FG001|Overall Study|Adverse Event|1|||
160981367|NCT04793464|581319965|FG000|Overall Study|Lost to Follow-up|458|||
160981368|NCT04793464|581319966|FG001|Overall Study|Lost to Follow-up|168|||
160981369|NCT04793464|581319967|FG002|Overall Study|Lost to Follow-up|5|||
160981370|NCT04793464|581319965|FG000|Overall Study|Withdrawal by Subject|43|||
160981371|NCT04793464|581319966|FG001|Overall Study|Withdrawal by Subject|15|||
160981372|NCT04793464|581319967|FG002|Overall Study|Withdrawal by Subject|0|||
160981373|NCT00845871|581319973|FG000|Assessment Period|Adverse Event|2|||
160981374|NCT00845871|581319973|FG000|Assessment Period|Abnormal laboratory values|1|||
160981375|NCT00845871|581319973|FG000|Assessment Period|Abnormal test procedure results|1|||
160981376|NCT00845871|581319973|FG000|Assessment Period|Patient withdrew consent|3|||
160981377|NCT01291225|581319975|FG000|Overall Study|Lost to Follow-up|85|||
160981378|NCT01291225|581319976|FG001|Overall Study|Lost to Follow-up|39|||
160981379|NCT04318093|581319977|FG000|Overall Study|Adverse Event|2|||
160981380|NCT04318093|581319978|FG001|Overall Study|Adverse Event|2|||
160981381|NCT04318093|581319977|FG000|Overall Study|Participant withdrew consent|1|||
160981382|NCT04318093|581319978|FG001|Overall Study|Participant withdrew consent|0|||
160981383|NCT04318093|581319977|FG000|Overall Study|Other reasons|0|||
160981384|NCT04318093|581319978|FG001|Overall Study|Other reasons|1|||
160981385|NCT01734434|581319979|FG000|Overall Study|Death Infant|3|||
160981386|NCT01734434|581319980|FG001|Overall Study|Death Infant|1|||
160981387|NCT01734434|581319981|FG002|Overall Study|Death Infant|17|||
160981388|NCT01734434|581319982|FG003|Overall Study|Death Infant|5|||
160981389|NCT01734434|581319979|FG000|Overall Study|Lost to Follow-up|2|||
160981390|NCT01734434|581319980|FG001|Overall Study|Lost to Follow-up|9|||
160981391|NCT01734434|581319981|FG002|Overall Study|Lost to Follow-up|67|||
160981392|NCT01734434|581319982|FG003|Overall Study|Lost to Follow-up|11|||
160981393|NCT01734434|581319979|FG000|Overall Study|No Live Birth|1|||
160981394|NCT01734434|581319980|FG001|Overall Study|No Live Birth|2|||
160981395|NCT01734434|581319981|FG002|Overall Study|No Live Birth|32|||
160981396|NCT01734434|581319982|FG003|Overall Study|No Live Birth|6|||
160981397|NCT01734434|581319979|FG000|Overall Study|Withdrawal by Subject|4|||
160981398|NCT01734434|581319980|FG001|Overall Study|Withdrawal by Subject|0|||
160981399|NCT01734434|581319981|FG002|Overall Study|Withdrawal by Subject|8|||
160981400|NCT01734434|581319982|FG003|Overall Study|Withdrawal by Subject|1|||
160981401|NCT01734434|581319979|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
160981402|NCT01734434|581319980|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
160981403|NCT01734434|581319981|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
160749712|NCT02362425|580469657|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
160749713|NCT02362425|580469654|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
160749714|NCT02362425|580469655|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
160749715|NCT02362425|580469656|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
160749716|NCT02362425|580469657|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
160749717|NCT00314808|580469665|FG000|Overall Study|Disease Progression without AE|4|||
160749718|NCT00314808|580469665|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
160749719|NCT02688764|580469672|FG000|Overall Study|Adverse Event|3|||
160749720|NCT02688764|580469673|FG001|Overall Study|Adverse Event|3|||
160749721|NCT02688764|580469672|FG000|Overall Study|AE/Kidney transplant|1|||
160749722|NCT02688764|580469673|FG001|Overall Study|AE/Kidney transplant|0|||
160749723|NCT02688764|580469672|FG000|Overall Study|AE/Lack of efficacy|1|||
160749724|NCT02688764|580469673|FG001|Overall Study|AE/Lack of efficacy|0|||
160981404|NCT01734434|581319982|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
160981405|NCT01734434|581319979|FG000|Overall Study|Subject Not Reachable|0|||
160981406|NCT01734434|581319980|FG001|Overall Study|Subject Not Reachable|0|||
160981407|NCT01734434|581319981|FG002|Overall Study|Subject Not Reachable|1|||
160981408|NCT01734434|581319982|FG003|Overall Study|Subject Not Reachable|0|||
160981409|NCT01734434|581319979|FG000|Overall Study|Treatment Defaulter|0|||
160981410|NCT01734434|581319980|FG001|Overall Study|Treatment Defaulter|0|||
160981411|NCT01734434|581319981|FG002|Overall Study|Treatment Defaulter|1|||
160981412|NCT01734434|581319982|FG003|Overall Study|Treatment Defaulter|0|||
160981413|NCT01734434|581319979|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
160981414|NCT01734434|581319980|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
160981415|NCT01734434|581319981|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
160981416|NCT01734434|581319982|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
160981417|NCT01734434|581319979|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
160981418|NCT01734434|581319980|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
160981419|NCT01734434|581319981|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
160981420|NCT01734434|581319982|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
160981421|NCT01370603|581319983|FG000|Period 1|Adverse Event|5|||
160981422|NCT01370603|581319984|FG001|Period 1|Adverse Event|3|||
160981423|NCT01370603|581319983|FG000|Period 1|Lost to Follow-up|2|||
160981424|NCT01370603|581319984|FG001|Period 1|Lost to Follow-up|0|||
160981425|NCT01370603|581319983|FG000|Period 1|Protocol Violation|2|||
160981426|NCT01370603|581319984|FG001|Period 1|Protocol Violation|2|||
160981427|NCT01370603|581319983|FG000|Period 1|Withdrawal by Subject|5|||
160981428|NCT01370603|581319984|FG001|Period 1|Withdrawal by Subject|5|||
160522168|NCT05269355|579640484|FG000|Overall Study|Randomized But Not Treated|1|||
160522169|NCT05269355|579640485|FG001|Overall Study|Randomized But Not Treated|0|||
160522170|NCT01050790|579640486|FG000|Overall Study|Adverse Event|1|||
160522171|NCT01439360|579640487|FG000|Overall Study|Adverse Event|4|||
160522172|NCT01439360|579640488|FG001|Overall Study|Adverse Event|16|||
160522173|NCT01439360|579640487|FG000|Overall Study|Lost to Follow-up|43|||
160522174|NCT01439360|579640488|FG001|Overall Study|Lost to Follow-up|58|||
160522175|NCT01439360|579640487|FG000|Overall Study|Others|10|||
160522176|NCT01439360|579640488|FG001|Overall Study|Others|5|||
160522177|NCT01439360|579640487|FG000|Overall Study|Protocol Violation|1|||
160522178|NCT01439360|579640488|FG001|Overall Study|Protocol Violation|0|||
160522179|NCT01439360|579640487|FG000|Overall Study|Withdrawal by Subject|140|||
160522180|NCT01439360|579640488|FG001|Overall Study|Withdrawal by Subject|129|||
160522181|NCT02390245|579640490|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
160981429|NCT01370603|581319983|FG000|Crossover Washout|Adverse Event|2|||
160522182|NCT02390245|579640491|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
160522183|NCT02390245|579640492|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
160522184|NCT02390245|579640490|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
160522185|NCT02390245|579640491|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
160522186|NCT02390245|579640492|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
160522187|NCT03511053|579642671|FG000|Overall Study|Withdrawal by Subject|1|||
160522188|NCT02425644|579642672|FG000|Overall Study|Lost to Follow-up|2|||
160522189|NCT02425644|579642673|FG001|Overall Study|Lost to Follow-up|3|||
160522190|NCT02425644|579642672|FG000|Overall Study|Withdrawal by Subject|41|||
160522191|NCT02425644|579642673|FG001|Overall Study|Withdrawal by Subject|36|||
160522192|NCT02425644|579642672|FG000|Overall Study|Lack of Efficacy|3|||
160522193|NCT02425644|579642673|FG001|Overall Study|Lack of Efficacy|10|||
160522194|NCT02425644|579642672|FG000|Overall Study|Adverse Event|13|||
160522195|NCT02425644|579642673|FG001|Overall Study|Adverse Event|3|||
160522196|NCT02425644|579642672|FG000|Overall Study|Death|0|||
160522197|NCT02425644|579642673|FG001|Overall Study|Death|2|||
160522198|NCT02425644|579642672|FG000|Overall Study|Other|18|||
160522199|NCT02425644|579642673|FG001|Overall Study|Other|17|||
160522200|NCT02720536|579642674|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
160522201|NCT02720536|579642674|FG000|Overall Study|PR - pregnancy|2|||
160522202|NCT02720536|579642674|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
160981430|NCT01370603|581319984|FG001|Crossover Washout|Adverse Event|1|||
160981431|NCT01370603|581319983|FG000|Crossover Washout|Lost to Follow-up|2|||
160981432|NCT01370603|581319984|FG001|Crossover Washout|Lost to Follow-up|0|||
160981433|NCT01370603|581319983|FG000|Crossover Washout|Protocol Violation|1|||
160981434|NCT01370603|581319984|FG001|Crossover Washout|Protocol Violation|0|||
160981435|NCT01370603|581319983|FG000|Crossover Washout|Withdrawal by Subject|4|||
160981436|NCT01370603|581319984|FG001|Crossover Washout|Withdrawal by Subject|1|||
160981437|NCT01370603|581319983|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
160981438|NCT01370603|581319984|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
160981439|NCT01370603|581319983|FG000|Period 2|Adverse Event|1|||
160981440|NCT01370603|581319984|FG001|Period 2|Adverse Event|4|||
160981441|NCT01370603|581319983|FG000|Period 2|Lost to Follow-up|1|||
160981442|NCT01370603|581319984|FG001|Period 2|Lost to Follow-up|0|||
160981443|NCT01370603|581319983|FG000|Period 2|Withdrawal by Subject|1|||
160981444|NCT01370603|581319984|FG001|Period 2|Withdrawal by Subject|0|||
160981445|NCT04714216|581321674|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
160981446|NCT04714216|581321674|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
160981447|NCT00513019|581321675|FG000|Overall Study|Adverse Event|1|||
160981448|NCT00513019|581321676|FG001|Overall Study|Adverse Event|0|||
160981449|NCT00513019|581321675|FG000|Overall Study|Withdrawal by Subject|4|||
160981450|NCT00513019|581321676|FG001|Overall Study|Withdrawal by Subject|5|||
160981451|NCT04129580|581321677|FG000|Overall Study|Lost to Follow-up|14|||
160981452|NCT04129580|581321678|FG001|Overall Study|Lost to Follow-up|25|||
160981453|NCT01852162|581321679|FG000|Overall Study|Adverse Event|1|||
160981454|NCT01852162|581321680|FG001|Overall Study|Adverse Event|0|||
160981455|NCT01852162|581321679|FG000|Overall Study|Withdrawal by Subject|3|||
160981456|NCT01852162|581321680|FG001|Overall Study|Withdrawal by Subject|1|||
160981457|NCT01500226|581321683|FG000|Overall Study|Adverse Event|31|||
160981458|NCT01500226|581321684|FG001|Overall Study|Adverse Event|38|||
160981459|NCT01500226|581321683|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
160981460|NCT01500226|581321684|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
160981461|NCT01500226|581321683|FG000|Overall Study|Withdrawal by Subject|93|||
160522203|NCT02720536|579642674|FG000|Overall Study|PR - death|1|||
160522204|NCT02720536|579642674|FG000|Overall Study|PR - adverse event|1|||
160522205|NCT02720536|579642674|FG000|Overall Study|PR - abnormal lab value(s)|1|||
160522206|NCT02720536|579642674|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
160522207|NCT01028222|579642675|FG000|Overall Study|Protocol deviation|1|||
160522208|NCT01028222|579642676|FG001|Overall Study|Protocol deviation|0|||
160981462|NCT01500226|581321684|FG001|Overall Study|Withdrawal by Subject|96|||
160981463|NCT01500226|581321683|FG000|Overall Study|Death|12|||
160981464|NCT01500226|581321684|FG001|Overall Study|Death|4|||
160522209|NCT01028222|579642675|FG000|Overall Study|Disease progression|33|||
160522210|NCT01028222|579642676|FG001|Overall Study|Disease progression|9|||
160522211|NCT01028222|579642675|FG000|Overall Study|Administrative problems|1|||
160522212|NCT01028222|579642676|FG001|Overall Study|Administrative problems|1|||
160522213|NCT01028222|579642675|FG000|Overall Study|Lost to Follow-up|0|||
160522214|NCT01028222|579642676|FG001|Overall Study|Lost to Follow-up|1|||
160522215|NCT01028222|579642675|FG000|Overall Study|Withdrawal by Subject|1|||
160522216|NCT01028222|579642676|FG001|Overall Study|Withdrawal by Subject|0|||
160522217|NCT01028222|579642675|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
160522218|NCT01028222|579642676|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
160522219|NCT01028222|579642675|FG000|Overall Study|Adverse Event|2|||
160522220|NCT01028222|579642676|FG001|Overall Study|Adverse Event|0|||
160522221|NCT00146328|579642677|FG000|Overall Study|Adverse Event|39|||
160522222|NCT00146328|579642678|FG001|Overall Study|Adverse Event|48|||
160522223|NCT00146328|579642679|FG002|Overall Study|Adverse Event|79|||
160981465|NCT01500226|581321683|FG000|Overall Study|Disease Progression|16|||
160981466|NCT01500226|581321684|FG001|Overall Study|Disease Progression|14|||
160981467|NCT01500226|581321683|FG000|Overall Study|Protocol Violation|53|||
160981468|NCT01500226|581321684|FG001|Overall Study|Protocol Violation|39|||
160981469|NCT01500226|581321683|FG000|Overall Study|Physician Decision|17|||
160981470|NCT01500226|581321684|FG001|Overall Study|Physician Decision|15|||
160981471|NCT01500226|581321683|FG000|Overall Study|Lack of Efficacy|14|||
160981472|NCT01500226|581321684|FG001|Overall Study|Lack of Efficacy|30|||
160981473|NCT01500226|581321683|FG000|Overall Study|Lost to Follow-up|9|||
160981474|NCT01500226|581321684|FG001|Overall Study|Lost to Follow-up|5|||
160981475|NCT01500226|581321683|FG000|Overall Study|Other Reasons|19|||
160522224|NCT00146328|579642677|FG000|Overall Study|Protocol Violation|11|||
160981476|NCT01500226|581321684|FG001|Overall Study|Other Reasons|16|||
160522225|NCT00146328|579642678|FG001|Overall Study|Protocol Violation|6|||
160522226|NCT00146328|579642679|FG002|Overall Study|Protocol Violation|12|||
160522227|NCT00146328|579642677|FG000|Overall Study|Lost to Follow-up|7|||
160522228|NCT00146328|579642678|FG001|Overall Study|Lost to Follow-up|4|||
160522229|NCT00146328|579642679|FG002|Overall Study|Lost to Follow-up|7|||
160522230|NCT00146328|579642677|FG000|Overall Study|Withdrawal by Subject|16|||
160522231|NCT00146328|579642678|FG001|Overall Study|Withdrawal by Subject|16|||
160522232|NCT00146328|579642679|FG002|Overall Study|Withdrawal by Subject|22|||
160981477|NCT02955277|581321685|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
160981478|NCT02955277|581321686|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
160981479|NCT02955277|581321685|FG000|Post to Follow-up|Lost to Follow-up|8|||
160981480|NCT02955277|581321686|FG001|Post to Follow-up|Lost to Follow-up|11|||
160522233|NCT00146328|579642677|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
160522234|NCT00146328|579642678|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
160522235|NCT00146328|579642679|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
160522236|NCT00146328|579642677|FG000|Overall Study|Trial ended/site closed|8|||
160522237|NCT00146328|579642678|FG001|Overall Study|Trial ended/site closed|2|||
160522238|NCT00146328|579642679|FG002|Overall Study|Trial ended/site closed|19|||
160522239|NCT00146328|579642677|FG000|Overall Study|Patient decision to end|0|||
160522240|NCT00146328|579642678|FG001|Overall Study|Patient decision to end|1|||
160522241|NCT00146328|579642679|FG002|Overall Study|Patient decision to end|6|||
160522242|NCT00146328|579642677|FG000|Overall Study|Enroll into other trial|2|||
160522243|NCT00146328|579642678|FG001|Overall Study|Enroll into other trial|4|||
160522244|NCT00146328|579642679|FG002|Overall Study|Enroll into other trial|2|||
160522245|NCT00146328|579642677|FG000|Overall Study|Death|0|||
160522246|NCT00146328|579642678|FG001|Overall Study|Death|1|||
160522247|NCT00146328|579642679|FG002|Overall Study|Death|1|||
160522248|NCT00146328|579642677|FG000|Overall Study|Moved|2|||
160522249|NCT00146328|579642678|FG001|Overall Study|Moved|0|||
160522250|NCT00146328|579642679|FG002|Overall Study|Moved|0|||
160522251|NCT00146328|579642677|FG000|Overall Study|Interaction with other medication|2|||
160522252|NCT00146328|579642678|FG001|Overall Study|Interaction with other medication|0|||
160522253|NCT00146328|579642679|FG002|Overall Study|Interaction with other medication|1|||
160981481|NCT04212169|581321689|FG000|Overall Study|Adverse Event|0|||
160981482|NCT04212169|581321690|FG001|Overall Study|Adverse Event|0|||
160522254|NCT00300781|579642680|FG000|Overall Study|Disease Progression|55|||
160522255|NCT00300781|579642681|FG001|Overall Study|Disease Progression|52|||
160522256|NCT00300781|579642680|FG000|Overall Study|Adverse Event|5|||
160522257|NCT00300781|579642681|FG001|Overall Study|Adverse Event|6|||
160522258|NCT00300781|579642680|FG000|Overall Study|Withdrawal by Subject|1|||
160522259|NCT00300781|579642681|FG001|Overall Study|Withdrawal by Subject|2|||
160522260|NCT00300781|579642680|FG000|Overall Study|Physician Decision|1|||
160522261|NCT00300781|579642681|FG001|Overall Study|Physician Decision|0|||
160522262|NCT00300781|579642680|FG000|Overall Study|Not Recorded|0|||
160522263|NCT00300781|579642681|FG001|Overall Study|Not Recorded|1|||
160522264|NCT00300781|579642680|FG000|Overall Study|Symptomatic Deterioration|1|||
160522265|NCT00300781|579642681|FG001|Overall Study|Symptomatic Deterioration|0|||
160522266|NCT00300781|579642680|FG000|Overall Study|Lost to Follow-up|0|||
160522267|NCT00300781|579642681|FG001|Overall Study|Lost to Follow-up|1|||
160522268|NCT00567268|579642682|FG000|Overall Study|Protocol Violation|7|||
160522269|NCT00567268|579642682|FG000|Overall Study|Lost to Follow-up|36|||
160522270|NCT00567268|579642682|FG000|Overall Study|No Visit After First Day of Treatment|2|||
160522271|NCT00567268|579642682|FG000|Overall Study|No Drug Administration|4|||
160522272|NCT00567268|579642682|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
160522273|NCT02525861|579642685|FG000|Overall Study|Adverse Event|1|||
160522274|NCT02525861|579642686|FG001|Overall Study|Adverse Event|0|||
160522275|NCT02525861|579642685|FG000|Overall Study|Withdrawal by Subject|0|||
160522276|NCT02525861|579642686|FG001|Overall Study|Withdrawal by Subject|1|||
160522277|NCT02525861|579642685|FG000|Overall Study|Physician Decision|0|||
160522278|NCT02525861|579642686|FG001|Overall Study|Physician Decision|1|||
160522279|NCT01117454|579642689|FG000|Overall Study|Pregnancy|0|||
160522280|NCT01117454|579642690|FG001|Overall Study|Pregnancy|1|||
160522281|NCT00888433|579642691|FG000|Overall Study|Withdrawal by Subject|1|||
160522282|NCT00888433|579642692|FG001|Overall Study|Withdrawal by Subject|2|||
160522283|NCT00888433|579642691|FG000|Overall Study|Missed Visit|2|||
160981483|NCT04212169|581321691|FG002|Overall Study|Adverse Event|0|||
160981484|NCT04212169|581321692|FG003|Overall Study|Adverse Event|2|||
160522284|NCT00888433|579642692|FG001|Overall Study|Missed Visit|1|||
160522285|NCT02544217|579642695|FG000|Overall Study|Withdrawal by Subject|1|||
160522286|NCT02544217|579642696|FG001|Overall Study|Withdrawal by Subject|1|||
160522287|NCT02544217|579642697|FG002|Overall Study|Withdrawal by Subject|0|||
160522288|NCT02544217|579642698|FG003|Overall Study|Withdrawal by Subject|0|||
160522289|NCT02544217|579642699|FG004|Overall Study|Withdrawal by Subject|0|||
160522290|NCT02544217|579642700|FG005|Overall Study|Withdrawal by Subject|0|||
160522291|NCT02027701|579642702|FG000|Overall Study|Adverse Event|3|||
160522292|NCT02027701|579642702|FG000|Overall Study|Lack of Efficacy|8|||
160522293|NCT02027701|579642702|FG000|Overall Study|Physician Decision|2|||
160981485|NCT04212169|581321689|FG000|Overall Study|Lost to Follow-up|1|||
160981486|NCT04212169|581321690|FG001|Overall Study|Lost to Follow-up|0|||
160981487|NCT04212169|581321691|FG002|Overall Study|Lost to Follow-up|0|||
160981488|NCT04212169|581321692|FG003|Overall Study|Lost to Follow-up|2|||
160981489|NCT04212169|581321689|FG000|Overall Study|Withdrawal by Subject|10|||
160981490|NCT04212169|581321690|FG001|Overall Study|Withdrawal by Subject|2|||
160981491|NCT04212169|581321691|FG002|Overall Study|Withdrawal by Subject|5|||
160981492|NCT04212169|581321692|FG003|Overall Study|Withdrawal by Subject|7|||
160981493|NCT04212169|581321689|FG000|Overall Study|Other reason, unspecified|3|||
160981494|NCT04212169|581321690|FG001|Overall Study|Other reason, unspecified|1|||
160981495|NCT04212169|581321691|FG002|Overall Study|Other reason, unspecified|0|||
160981496|NCT04212169|581321692|FG003|Overall Study|Other reason, unspecified|2|||
160981497|NCT02176928|581321693|FG000|Overall Study|Lost to Follow-up|2|||
160522294|NCT02027701|579642702|FG000|Overall Study|Withdrawal by Subject|3|||
160522295|NCT00820027|579642703|FG000|Overall Study|Adverse Event|15|||
160522296|NCT00820027|579642704|FG001|Overall Study|Adverse Event|8|||
160522297|NCT00820027|579642705|FG002|Overall Study|Adverse Event|10|||
160522298|NCT00820027|579642706|FG003|Overall Study|Adverse Event|5|||
160522299|NCT00820027|579642703|FG000|Overall Study|Lack of Efficacy|2|||
160522300|NCT00820027|579642704|FG001|Overall Study|Lack of Efficacy|1|||
160522301|NCT00820027|579642705|FG002|Overall Study|Lack of Efficacy|2|||
160522302|NCT00820027|579642706|FG003|Overall Study|Lack of Efficacy|2|||
160522303|NCT00820027|579642703|FG000|Overall Study|Physician Decision|0|||
160522304|NCT00820027|579642704|FG001|Overall Study|Physician Decision|1|||
160522305|NCT00820027|579642705|FG002|Overall Study|Physician Decision|1|||
160522306|NCT00820027|579642706|FG003|Overall Study|Physician Decision|0|||
160522307|NCT00820027|579642703|FG000|Overall Study|Protocol Violation|3|||
160522308|NCT00820027|579642704|FG001|Overall Study|Protocol Violation|0|||
160981498|NCT02176928|581321694|FG001|Overall Study|Lost to Follow-up|4|||
160522309|NCT00820027|579642705|FG002|Overall Study|Protocol Violation|4|||
160522310|NCT00820027|579642706|FG003|Overall Study|Protocol Violation|0|||
160522311|NCT00820027|579642703|FG000|Overall Study|Withdrawal by Subject|6|||
160522312|NCT00820027|579642704|FG001|Overall Study|Withdrawal by Subject|4|||
160522313|NCT00820027|579642705|FG002|Overall Study|Withdrawal by Subject|4|||
160522314|NCT00820027|579642706|FG003|Overall Study|Withdrawal by Subject|6|||
160522315|NCT02604433|579642707|FG000|Overall Study|Withdrawal by Subject|37|||
160522316|NCT02604433|579642708|FG001|Overall Study|Withdrawal by Subject|16|||
160522317|NCT02604433|579642707|FG000|Overall Study|Adverse Event|4|||
160522318|NCT02604433|579642708|FG001|Overall Study|Adverse Event|0|||
160522319|NCT02604433|579642707|FG000|Overall Study|Other reasons|3|||
160522320|NCT02604433|579642708|FG001|Overall Study|Other reasons|5|||
160522321|NCT02604433|579642707|FG000|Overall Study|Death|4|||
160522322|NCT02604433|579642708|FG001|Overall Study|Death|1|||
160522323|NCT02604433|579642707|FG000|Overall Study|Transition to Rollover Protocol|169|||
160522324|NCT02604433|579642708|FG001|Overall Study|Transition to Rollover Protocol|82|||
160522325|NCT02604433|579642707|FG000|Overall Study|Physician Decision|1|||
160522326|NCT02604433|579642708|FG001|Overall Study|Physician Decision|1|||
160522327|NCT02604433|579642707|FG000|Overall Study|Lack of Efficacy|0|||
160522328|NCT02604433|579642708|FG001|Overall Study|Lack of Efficacy|1|||
160522329|NCT00887679|579642709|FG000|Overall Study|Withdrawal by Subject|1|||
160522330|NCT00887679|579642709|FG000|Overall Study|Lost to Follow-up|4|||
160522331|NCT00887679|579642709|FG000|Overall Study|Physician Decision|5|||
160522332|NCT02683941|579642710|FG000|Double-blind Phase|Adverse Event|0|||
160522333|NCT02683941|579642711|FG001|Double-blind Phase|Adverse Event|1|||
160522334|NCT02683941|579642710|FG000|Double-blind Phase|Withdrawal by Subject|4|||
160522335|NCT02683941|579642711|FG001|Double-blind Phase|Withdrawal by Subject|2|||
160522336|NCT02683941|579642710|FG000|Double-blind Phase|Lost to Follow-up|1|||
160522337|NCT02683941|579642711|FG001|Double-blind Phase|Lost to Follow-up|0|||
160522338|NCT02683941|579642710|FG000|Double-blind Phase|Disease Progression|5|||
160522339|NCT02683941|579642711|FG001|Double-blind Phase|Disease Progression|2|||
160522340|NCT02683941|579642710|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
160522341|NCT02683941|579642711|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
160522342|NCT02683941|579642710|FG000|Open-label Treatment Phase|Disease Progression|1|||
160522343|NCT02683941|579642711|FG001|Open-label Treatment Phase|Disease Progression|2|||
160522344|NCT02683941|579642710|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
160522345|NCT02683941|579642711|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
160522346|NCT02683941|579642710|FG000|Open-label Treatment Phase|Other|1|||
160522347|NCT02683941|579642711|FG001|Open-label Treatment Phase|Other|0|||
160522348|NCT02683941|579642710|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
160522349|NCT02683941|579642711|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
160522350|NCT02683941|579642710|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
160749725|NCT02688764|580469672|FG000|Overall Study|AE/Non-compl.|1|||
160522351|NCT02683941|579642711|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
160522352|NCT02683941|579642710|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
160522353|NCT02683941|579642711|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
160522354|NCT02683941|579642710|FG000|Open-label Follow-up Phase|Other|8|||
160522355|NCT02683941|579642711|FG001|Open-label Follow-up Phase|Other|1|||
160522356|NCT00325039|579642712|FG000|Overall Study|Lost to Follow-up|18|||
160522357|NCT00325039|579642713|FG001|Overall Study|Lost to Follow-up|14|||
160522358|NCT00892723|579642717|FG000|Overall Study|Lost to Follow-up|1|||
160522359|NCT00892723|579642718|FG001|Overall Study|Lost to Follow-up|3|||
160522360|NCT00892723|579642719|FG002|Overall Study|Lost to Follow-up|1|||
160522361|NCT00892723|579642717|FG000|Overall Study|Withdrawal by Subject|1|||
160522362|NCT00892723|579642718|FG001|Overall Study|Withdrawal by Subject|1|||
160522363|NCT00892723|579642719|FG002|Overall Study|Withdrawal by Subject|1|||
160522364|NCT02974088|579642720|FG000|Overall Study|Lost to Follow-up|0|||
160522365|NCT02974088|579642721|FG001|Overall Study|Lost to Follow-up|2|||
160522366|NCT02974088|579642720|FG000|Overall Study|Adverse Event|0|||
160522367|NCT02974088|579642721|FG001|Overall Study|Adverse Event|1|||
160522368|NCT02075541|579642723|FG000|Overall Study|Serious Adverse Event|1|||
160522369|NCT02075541|579642724|FG001|Overall Study|Serious Adverse Event|4|||
160522370|NCT02075541|579642723|FG000|Overall Study|Protocol Violation|1|||
160522371|NCT02075541|579642724|FG001|Overall Study|Protocol Violation|0|||
160522372|NCT02075541|579642723|FG000|Overall Study|Withdrawal by Subject|1|||
160522373|NCT02075541|579642724|FG001|Overall Study|Withdrawal by Subject|3|||
160522374|NCT02075541|579642723|FG000|Overall Study|Sponsor study termination|0|||
160522375|NCT02075541|579642724|FG001|Overall Study|Sponsor study termination|1|||
160522376|NCT02075541|579642723|FG000|Overall Study|Other- unable to perform study procedure|1|||
160522377|NCT02075541|579642724|FG001|Overall Study|Other- unable to perform study procedure|0|||
160522378|NCT03353350|579642727|FG000|30-week Core Treatment Period|Protocol Violation|1|||
160522379|NCT03353350|579642728|FG001|30-week Core Treatment Period|Protocol Violation|1|||
160522380|NCT03353350|579642729|FG002|30-week Core Treatment Period|Protocol Violation|1|||
160522381|NCT03353350|579642730|FG003|30-week Core Treatment Period|Protocol Violation|0|||
160522382|NCT03353350|579642727|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
160522383|NCT03353350|579642728|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
160522384|NCT03353350|579642729|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
160522385|NCT03353350|579642730|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
160522386|NCT03353350|579642727|FG000|30-week Core Treatment Period|Adverse Event|0|||
160522387|NCT03353350|579642728|FG001|30-week Core Treatment Period|Adverse Event|4|||
160522388|NCT03353350|579642729|FG002|30-week Core Treatment Period|Adverse Event|2|||
160522389|NCT03353350|579642730|FG003|30-week Core Treatment Period|Adverse Event|3|||
160522390|NCT03353350|579642727|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
160522391|NCT03353350|579642728|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
160522392|NCT03353350|579642729|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
160522393|NCT03353350|579642730|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
160522394|NCT03353350|579642727|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
160522395|NCT03353350|579642728|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
160522396|NCT03353350|579642729|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
160522397|NCT03353350|579642730|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
160522398|NCT03353350|579642727|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
160522399|NCT03353350|579642728|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
160522400|NCT03353350|579642729|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
160522401|NCT03353350|579642730|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
160522402|NCT03353350|579642727|FG000|26-week Treatment Extension Period|Adverse Event|1|||
160522403|NCT03353350|579642728|FG001|26-week Treatment Extension Period|Adverse Event|0|||
160522404|NCT03353350|579642729|FG002|26-week Treatment Extension Period|Adverse Event|0|||
160522405|NCT03353350|579642730|FG003|26-week Treatment Extension Period|Adverse Event|1|||
160522406|NCT03353350|579642727|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
160522407|NCT03353350|579642728|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
160522408|NCT03353350|579642729|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
160522409|NCT03353350|579642730|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
160522410|NCT00807235|579642735|FG000|Overall Study|Adverse Event|1|||
160522411|NCT00807235|579642736|FG001|Overall Study|Adverse Event|0|||
160522412|NCT00985153|579642739|FG000|Overall Study|Lost to Follow-up|16|||
160522413|NCT00985153|579642740|FG001|Overall Study|Lost to Follow-up|19|||
160522414|NCT00985153|579642741|FG002|Overall Study|Lost to Follow-up|17|||
160522415|NCT00985153|579642742|FG003|Overall Study|Lost to Follow-up|20|||
160522416|NCT00985153|579642739|FG000|Overall Study|Protocol Violation|3|||
160522417|NCT00985153|579642740|FG001|Overall Study|Protocol Violation|2|||
160522418|NCT00985153|579642741|FG002|Overall Study|Protocol Violation|4|||
160522419|NCT00985153|579642742|FG003|Overall Study|Protocol Violation|3|||
160522420|NCT00985153|579642739|FG000|Overall Study|Withdrawal by Subject|6|||
160522421|NCT00985153|579642740|FG001|Overall Study|Withdrawal by Subject|11|||
160522422|NCT00985153|579642741|FG002|Overall Study|Withdrawal by Subject|11|||
160522423|NCT00985153|579642742|FG003|Overall Study|Withdrawal by Subject|10|||
160522424|NCT00985153|579642739|FG000|Overall Study|Missed One or More Bleeds|7|||
160522425|NCT00985153|579642740|FG001|Overall Study|Missed One or More Bleeds|7|||
160522426|NCT00985153|579642741|FG002|Overall Study|Missed One or More Bleeds|8|||
160522427|NCT00985153|579642742|FG003|Overall Study|Missed One or More Bleeds|10|||
160522428|NCT00985153|579642739|FG000|Overall Study|Incomplete Safety Follow-up|3|||
160522429|NCT00985153|579642740|FG001|Overall Study|Incomplete Safety Follow-up|5|||
160522430|NCT00985153|579642741|FG002|Overall Study|Incomplete Safety Follow-up|4|||
160522431|NCT00985153|579642742|FG003|Overall Study|Incomplete Safety Follow-up|4|||
160522432|NCT01679405|579642743|FG000|Overall Study|Death|2|||
160522433|NCT01679405|579642744|FG001|Overall Study|Death|5|||
160522434|NCT04677179|579642745|FG000|Induction Treatment Period|Adverse Event|1|||
160522435|NCT04677179|579642746|FG001|Induction Treatment Period|Adverse Event|0|||
160522436|NCT04677179|579642747|FG002|Induction Treatment Period|Adverse Event|0|||
160522437|NCT04677179|579642748|FG003|Induction Treatment Period|Adverse Event|0|||
160635524|NCT02494583|580047486|FG001|Overall Study|Transferred to Extension Study|15|||
160635525|NCT02494583|580047487|FG002|Overall Study|Transferred to Extension Study|6|||
160522438|NCT04677179|579642749|FG004|Induction Treatment Period|Adverse Event|0|||
160522439|NCT04677179|579642750|FG005|Induction Treatment Period|Adverse Event|0|||
160522440|NCT04677179|579642751|FG006|Induction Treatment Period|Adverse Event|0|||
160522441|NCT04677179|579642752|FG007|Induction Treatment Period|Adverse Event|0|||
160522442|NCT04677179|579642753|FG008|Induction Treatment Period|Adverse Event|0|||
160522443|NCT04677179|579642754|FG009|Induction Treatment Period|Adverse Event|0|||
160522444|NCT04677179|579642745|FG000|Induction Treatment Period|Physician Decision|1|||
160522445|NCT04677179|579642746|FG001|Induction Treatment Period|Physician Decision|0|||
160522446|NCT04677179|579642747|FG002|Induction Treatment Period|Physician Decision|1|||
160522447|NCT04677179|579642748|FG003|Induction Treatment Period|Physician Decision|0|||
160522448|NCT04677179|579642749|FG004|Induction Treatment Period|Physician Decision|0|||
160522449|NCT04677179|579642750|FG005|Induction Treatment Period|Physician Decision|0|||
160522450|NCT04677179|579642751|FG006|Induction Treatment Period|Physician Decision|0|||
160522451|NCT04677179|579642752|FG007|Induction Treatment Period|Physician Decision|0|||
160522452|NCT04677179|579642753|FG008|Induction Treatment Period|Physician Decision|0|||
160522453|NCT04677179|579642754|FG009|Induction Treatment Period|Physician Decision|0|||
160522454|NCT04677179|579642745|FG000|Induction Treatment Period|Protocol Violation|0|||
160522455|NCT04677179|579642746|FG001|Induction Treatment Period|Protocol Violation|1|||
160522456|NCT04677179|579642747|FG002|Induction Treatment Period|Protocol Violation|0|||
160522457|NCT04677179|579642748|FG003|Induction Treatment Period|Protocol Violation|0|||
160522458|NCT04677179|579642749|FG004|Induction Treatment Period|Protocol Violation|0|||
160522459|NCT04677179|579642750|FG005|Induction Treatment Period|Protocol Violation|0|||
160522460|NCT04677179|579642751|FG006|Induction Treatment Period|Protocol Violation|0|||
160522461|NCT04677179|579642752|FG007|Induction Treatment Period|Protocol Violation|0|||
160522462|NCT04677179|579642753|FG008|Induction Treatment Period|Protocol Violation|0|||
160522463|NCT04677179|579642754|FG009|Induction Treatment Period|Protocol Violation|0|||
160522464|NCT04677179|579642745|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
160522465|NCT04677179|579642746|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
160522466|NCT04677179|579642747|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
160522467|NCT04677179|579642748|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
160522468|NCT04677179|579642749|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
160522469|NCT04677179|579642750|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
160522470|NCT04677179|579642751|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
160522471|NCT04677179|579642752|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
160522472|NCT04677179|579642753|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
160522473|NCT04677179|579642754|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
160522474|NCT04677179|579642745|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
160522475|NCT04677179|579642746|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
160522476|NCT04677179|579642747|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
160522477|NCT04677179|579642748|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
160522478|NCT04677179|579642749|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
160522479|NCT04677179|579642750|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
160522480|NCT04677179|579642751|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
160522481|NCT04677179|579642752|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
160522482|NCT04677179|579642753|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
160522483|NCT04677179|579642754|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
160522484|NCT04677179|579642745|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
160522485|NCT04677179|579642746|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
160522486|NCT04677179|579642747|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
160522487|NCT04677179|579642748|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
160749726|NCT02688764|580469673|FG001|Overall Study|AE/Non-compl.|0|||
160522488|NCT04677179|579642749|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
160522489|NCT04677179|579642750|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
160522490|NCT04677179|579642751|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
160522491|NCT04677179|579642752|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
160522492|NCT04677179|579642753|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
160522493|NCT04677179|579642754|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
160522494|NCT04677179|579642745|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
160522495|NCT04677179|579642746|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
160522496|NCT04677179|579642747|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
160522497|NCT04677179|579642748|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
160522498|NCT04677179|579642749|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
160522499|NCT04677179|579642750|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
160522500|NCT04677179|579642751|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
160522501|NCT04677179|579642752|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
160522502|NCT04677179|579642753|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
160522503|NCT04677179|579642754|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
160522504|NCT04677179|579642745|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
160522505|NCT04677179|579642746|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
160522506|NCT04677179|579642747|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
160522507|NCT04677179|579642748|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
160522508|NCT04677179|579642749|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
160522509|NCT04677179|579642750|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
160522510|NCT04677179|579642751|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
160522511|NCT04677179|579642752|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
160522512|NCT04677179|579642753|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
160522513|NCT04677179|579642754|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
160522514|NCT04677179|579642745|FG000|Extension Treatment Period|Lack of Efficacy|0|||
160522515|NCT04677179|579642746|FG001|Extension Treatment Period|Lack of Efficacy|0|||
160522516|NCT04677179|579642747|FG002|Extension Treatment Period|Lack of Efficacy|0|||
160522517|NCT04677179|579642748|FG003|Extension Treatment Period|Lack of Efficacy|0|||
160522518|NCT04677179|579642749|FG004|Extension Treatment Period|Lack of Efficacy|0|||
160522519|NCT04677179|579642750|FG005|Extension Treatment Period|Lack of Efficacy|0|||
160522520|NCT04677179|579642751|FG006|Extension Treatment Period|Lack of Efficacy|6|||
160522521|NCT04677179|579642752|FG007|Extension Treatment Period|Lack of Efficacy|0|||
160522522|NCT04677179|579642753|FG008|Extension Treatment Period|Lack of Efficacy|0|||
160522523|NCT04677179|579642754|FG009|Extension Treatment Period|Lack of Efficacy|0|||
160522524|NCT04677179|579642745|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
160522525|NCT04677179|579642746|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
160522526|NCT04677179|579642747|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
160522527|NCT04677179|579642748|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
160522528|NCT04677179|579642749|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
160522529|NCT04677179|579642750|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
160522530|NCT04677179|579642751|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
160522531|NCT04677179|579642752|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
160522532|NCT04677179|579642753|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
160522533|NCT04677179|579642754|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
160522534|NCT04677179|579642745|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
160522535|NCT04677179|579642746|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
160522536|NCT04677179|579642747|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
160522537|NCT04677179|579642748|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
160522538|NCT04677179|579642749|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
160522539|NCT04677179|579642750|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
160522540|NCT04677179|579642751|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
160522541|NCT04677179|579642752|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
160522542|NCT04677179|579642753|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
160522543|NCT04677179|579642754|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
160522544|NCT04677179|579642745|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
160522545|NCT04677179|579642746|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
160522546|NCT04677179|579642747|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
160522547|NCT04677179|579642748|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
160522548|NCT04677179|579642749|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
160522549|NCT04677179|579642750|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
160522550|NCT04677179|579642751|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
160522551|NCT04677179|579642752|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
160522552|NCT04677179|579642753|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
160522553|NCT04677179|579642754|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
160522554|NCT04677179|579642745|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
160522555|NCT04677179|579642746|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
160522556|NCT04677179|579642747|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
160522557|NCT04677179|579642748|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
160522558|NCT04677179|579642749|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
160522559|NCT04677179|579642750|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
160522560|NCT04677179|579642751|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
160522561|NCT04677179|579642752|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
160522562|NCT04677179|579642753|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
160522563|NCT04677179|579642754|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
160522564|NCT04677179|579642745|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160522565|NCT04677179|579642746|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160522566|NCT04677179|579642747|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160522567|NCT04677179|579642748|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160522568|NCT04677179|579642749|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160522569|NCT04677179|579642750|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160522570|NCT04677179|579642751|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160522571|NCT04677179|579642752|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
160522572|NCT04677179|579642753|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160522573|NCT04677179|579642754|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160522574|NCT04677179|579642745|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160522575|NCT04677179|579642746|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160522576|NCT04677179|579642747|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160522577|NCT04677179|579642748|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160522578|NCT04677179|579642749|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160522579|NCT04677179|579642750|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160522580|NCT04677179|579642751|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160522581|NCT04677179|579642752|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
160522582|NCT04677179|579642753|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
160522583|NCT04677179|579642754|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160522584|NCT04677179|579642745|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
160522585|NCT04677179|579642746|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
160522586|NCT04677179|579642747|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
160522587|NCT04677179|579642748|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
160522588|NCT04677179|579642749|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
160522589|NCT04677179|579642750|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
160522590|NCT04677179|579642751|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
160522591|NCT04677179|579642752|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
160522592|NCT04677179|579642753|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
160522593|NCT04677179|579642754|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
160522594|NCT01536015|579642755|FG000|Overall Study|Adverse Event|1|||
160522595|NCT01536015|579642756|FG001|Overall Study|Adverse Event|4|||
160522596|NCT01536015|579642755|FG000|Overall Study|Lost to Follow-up|0|||
160522597|NCT01536015|579642756|FG001|Overall Study|Lost to Follow-up|1|||
160522598|NCT01536015|579642755|FG000|Overall Study|Inclusion Criterion not met|2|||
160522599|NCT01536015|579642756|FG001|Overall Study|Inclusion Criterion not met|0|||
160522600|NCT01536015|579642755|FG000|Overall Study|Study closure|5|||
160522601|NCT01536015|579642756|FG001|Overall Study|Study closure|5|||
160522602|NCT01723254|579642759|FG000|Overall Study|Conflict with work schedule|0|||
160522603|NCT01723254|579642760|FG001|Overall Study|Conflict with work schedule|0|||
160522604|NCT01723254|579642761|FG002|Overall Study|Conflict with work schedule|0|||
160522605|NCT01723254|579642762|FG003|Overall Study|Conflict with work schedule|0|||
160522606|NCT01723254|579642763|FG004|Overall Study|Conflict with work schedule|0|||
160522607|NCT01723254|579642764|FG005|Overall Study|Conflict with work schedule|0|||
160522608|NCT01723254|579642765|FG006|Overall Study|Conflict with work schedule|0|||
160522609|NCT01723254|579642766|FG007|Overall Study|Conflict with work schedule|1|||
160522610|NCT01723254|579642759|FG000|Overall Study|Personal issues|0|||
160522611|NCT01723254|579642760|FG001|Overall Study|Personal issues|0|||
160522612|NCT01723254|579642761|FG002|Overall Study|Personal issues|0|||
160522613|NCT01723254|579642762|FG003|Overall Study|Personal issues|0|||
160522614|NCT01723254|579642763|FG004|Overall Study|Personal issues|0|||
160522615|NCT01723254|579642764|FG005|Overall Study|Personal issues|1|||
160522616|NCT01723254|579642765|FG006|Overall Study|Personal issues|0|||
160522617|NCT01723254|579642766|FG007|Overall Study|Personal issues|0|||
160522618|NCT01723254|579642759|FG000|Overall Study|No longer have time to participate|0|||
160522619|NCT01723254|579642760|FG001|Overall Study|No longer have time to participate|0|||
160522620|NCT01723254|579642761|FG002|Overall Study|No longer have time to participate|0|||
160522621|NCT01723254|579642762|FG003|Overall Study|No longer have time to participate|1|||
160522622|NCT01723254|579642763|FG004|Overall Study|No longer have time to participate|0|||
160522623|NCT01723254|579642764|FG005|Overall Study|No longer have time to participate|0|||
160635526|NCT02494583|580047485|FG000|Overall Study|Did Not Continue on Extension Study|8|||
160522624|NCT01723254|579642765|FG006|Overall Study|No longer have time to participate|0|||
160522625|NCT01723254|579642766|FG007|Overall Study|No longer have time to participate|0|||
160522626|NCT01723254|579642759|FG000|Overall Study|Move/Left to another country/city|0|||
160522627|NCT01723254|579642760|FG001|Overall Study|Move/Left to another country/city|0|||
160522628|NCT01723254|579642761|FG002|Overall Study|Move/Left to another country/city|2|||
160522629|NCT01723254|579642762|FG003|Overall Study|Move/Left to another country/city|1|||
160522630|NCT01723254|579642763|FG004|Overall Study|Move/Left to another country/city|1|||
160522631|NCT01723254|579642764|FG005|Overall Study|Move/Left to another country/city|0|||
160522632|NCT01723254|579642765|FG006|Overall Study|Move/Left to another country/city|0|||
160522633|NCT01723254|579642766|FG007|Overall Study|Move/Left to another country/city|0|||
160522634|NCT01723254|579642759|FG000|Overall Study|Protocol Violation|0|||
160522635|NCT01723254|579642760|FG001|Overall Study|Protocol Violation|1|||
160522636|NCT01723254|579642761|FG002|Overall Study|Protocol Violation|0|||
160522637|NCT01723254|579642762|FG003|Overall Study|Protocol Violation|0|||
160522638|NCT01723254|579642763|FG004|Overall Study|Protocol Violation|0|||
160522639|NCT01723254|579642764|FG005|Overall Study|Protocol Violation|0|||
160522640|NCT01723254|579642765|FG006|Overall Study|Protocol Violation|0|||
160522641|NCT01723254|579642766|FG007|Overall Study|Protocol Violation|0|||
160522642|NCT01723254|579642759|FG000|Overall Study|Withdrawal by Subject|1|||
160522643|NCT01723254|579642760|FG001|Overall Study|Withdrawal by Subject|2|||
160522644|NCT01723254|579642761|FG002|Overall Study|Withdrawal by Subject|1|||
160522645|NCT01723254|579642762|FG003|Overall Study|Withdrawal by Subject|0|||
160522646|NCT01723254|579642763|FG004|Overall Study|Withdrawal by Subject|1|||
160522647|NCT01723254|579642764|FG005|Overall Study|Withdrawal by Subject|1|||
160522648|NCT01723254|579642765|FG006|Overall Study|Withdrawal by Subject|1|||
160522649|NCT01723254|579642766|FG007|Overall Study|Withdrawal by Subject|2|||
160522650|NCT01201265|579642767|FG000|Overall Study|Death|14|||
160522651|NCT01201265|579642767|FG000|Overall Study|Insufficient Therapeutic Response|3|||
160522652|NCT01201265|579642767|FG000|Overall Study|Lost to Follow-up|10|||
160522653|NCT01201265|579642767|FG000|Overall Study|Withdrawal by Subject|7|||
160522654|NCT01201265|579642767|FG000|Overall Study|Disease Progression|4|||
160522655|NCT04640077|579642768|FG000|Period 1|Withdrawal by Subject|4|||
160522656|NCT04640077|579642769|FG001|Period 1|Withdrawal by Subject|5|||
160522657|NCT04640077|579642770|FG002|Period 1|Withdrawal by Subject|0|||
160522658|NCT04640077|579642768|FG000|Period 1|Adverse Event|1|||
160522659|NCT04640077|579642769|FG001|Period 1|Adverse Event|1|||
160522660|NCT04640077|579642770|FG002|Period 1|Adverse Event|0|||
160522661|NCT04640077|579642768|FG000|Period 1|Screen Failure|2|||
160522662|NCT04640077|579642769|FG001|Period 1|Screen Failure|0|||
160522663|NCT04640077|579642770|FG002|Period 1|Screen Failure|0|||
160522664|NCT04640077|579642768|FG000|Period 2|Withdrawal by Subject|0|||
160522665|NCT04640077|579642769|FG001|Period 2|Withdrawal by Subject|0|||
160522666|NCT04640077|579642770|FG002|Period 2|Withdrawal by Subject|18|||
160522667|NCT04640077|579642768|FG000|Period 2|Adverse Event|0|||
160522668|NCT04640077|579642769|FG001|Period 2|Adverse Event|0|||
160522669|NCT04640077|579642770|FG002|Period 2|Adverse Event|6|||
160522670|NCT04640077|579642768|FG000|Period 2|Lost to Follow-up|0|||
160522671|NCT04640077|579642769|FG001|Period 2|Lost to Follow-up|0|||
160522672|NCT04640077|579642770|FG002|Period 2|Lost to Follow-up|2|||
160522673|NCT04640077|579642768|FG000|Period 2|Death|0|||
160522674|NCT04640077|579642769|FG001|Period 2|Death|0|||
160522675|NCT04640077|579642770|FG002|Period 2|Death|2|||
160522676|NCT04640077|579642768|FG000|Period 2|Progressive Disease|0|||
160522677|NCT04640077|579642769|FG001|Period 2|Progressive Disease|0|||
160522678|NCT04640077|579642770|FG002|Period 2|Progressive Disease|1|||
160522679|NCT04640077|579642768|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
160522680|NCT04640077|579642769|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
160522681|NCT04640077|579642770|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
160522682|NCT01257425|579642771|FG000|Overall Study|Lack of Efficacy|3|||
160522683|NCT01257425|579642772|FG001|Overall Study|Lack of Efficacy|3|||
160522684|NCT01257425|579642771|FG000|Overall Study|Adverse Event|1|||
160522685|NCT01257425|579642772|FG001|Overall Study|Adverse Event|1|||
160522686|NCT01257425|579642771|FG000|Overall Study|Protocol Violation|1|||
160522687|NCT01257425|579642772|FG001|Overall Study|Protocol Violation|1|||
160522688|NCT01257425|579642771|FG000|Overall Study|Withdrawal by Subject|0|||
160522689|NCT01257425|579642772|FG001|Overall Study|Withdrawal by Subject|1|||
160522690|NCT01257425|579642771|FG000|Overall Study|Death|1|||
160522691|NCT01257425|579642772|FG001|Overall Study|Death|0|||
160522692|NCT02041520|579642774|FG000|Overall Study|Adverse Event|2|||
160522693|NCT02041520|579642775|FG001|Overall Study|Adverse Event|1|||
160522694|NCT02041520|579642774|FG000|Overall Study|Withdrawal by Subject|3|||
160522695|NCT02041520|579642775|FG001|Overall Study|Withdrawal by Subject|4|||
160522696|NCT02041520|579642774|FG000|Overall Study|Protocol Violation|1|||
160522697|NCT02041520|579642775|FG001|Overall Study|Protocol Violation|0|||
160522698|NCT02041520|579642774|FG000|Overall Study|Lost to Follow-up|0|||
160522699|NCT02041520|579642775|FG001|Overall Study|Lost to Follow-up|1|||
160522700|NCT02041520|579642774|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
160522701|NCT02041520|579642775|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
160522702|NCT00413972|579642776|FG000|Overall Study|Adverse Event|2|||
160522703|NCT00413972|579642777|FG001|Overall Study|Adverse Event|1|||
160522704|NCT00413972|579642778|FG002|Overall Study|Adverse Event|0|||
160522705|NCT00413972|579642779|FG003|Overall Study|Adverse Event|0|||
160522706|NCT00413972|579642776|FG000|Overall Study|Lost to Follow-up|1|||
160522707|NCT00413972|579642777|FG001|Overall Study|Lost to Follow-up|2|||
160522708|NCT00413972|579642778|FG002|Overall Study|Lost to Follow-up|1|||
160522709|NCT00413972|579642779|FG003|Overall Study|Lost to Follow-up|0|||
160522710|NCT00413972|579642776|FG000|Overall Study|Withdrawal by Subject|4|||
160522711|NCT00413972|579642777|FG001|Overall Study|Withdrawal by Subject|5|||
160522712|NCT00413972|579642778|FG002|Overall Study|Withdrawal by Subject|7|||
160522713|NCT00413972|579642779|FG003|Overall Study|Withdrawal by Subject|2|||
160522714|NCT00413972|579642776|FG000|Overall Study|Protocol Violation|0|||
160522715|NCT00413972|579642777|FG001|Overall Study|Protocol Violation|0|||
160522716|NCT00413972|579642778|FG002|Overall Study|Protocol Violation|2|||
160522717|NCT00413972|579642779|FG003|Overall Study|Protocol Violation|0|||
160522718|NCT00413972|579642776|FG000|Overall Study|Other|0|||
160522719|NCT00413972|579642777|FG001|Overall Study|Other|0|||
160522720|NCT00413972|579642778|FG002|Overall Study|Other|0|||
160522721|NCT00413972|579642779|FG003|Overall Study|Other|1|||
160522722|NCT03164564|579642785|FG000|Overall Study|Death|3|||
160522723|NCT03164564|579642786|FG001|Overall Study|Death|0|||
160522724|NCT03164564|579642785|FG000|Overall Study|Withdrawal by Subject|20|||
160522725|NCT03164564|579642786|FG001|Overall Study|Withdrawal by Subject|15|||
160522726|NCT03164564|579642785|FG000|Overall Study|Lost to Follow-up|2|||
160522727|NCT03164564|579642786|FG001|Overall Study|Lost to Follow-up|0|||
160522728|NCT03164564|579642785|FG000|Overall Study|Physician Decision|0|||
160522729|NCT03164564|579642786|FG001|Overall Study|Physician Decision|1|||
160522730|NCT03164564|579642785|FG000|Overall Study|Adverse Event|0|||
160522731|NCT03164564|579642786|FG001|Overall Study|Adverse Event|1|||
160522732|NCT03164564|579642785|FG000|Overall Study|Ongoing|1586|||
160522733|NCT03164564|579642786|FG001|Overall Study|Ongoing|1586|||
160522734|NCT02656823|579642787|FG000|Overall Study|Adverse Event|3|||
160522735|NCT02656823|579642787|FG000|Overall Study|Lost to Follow-up|2|||
160522736|NCT03567434|579642791|FG000|Overall Study|Lost to Follow-up|1|||
160522737|NCT03567434|579642792|FG001|Overall Study|Lost to Follow-up|3|||
160522738|NCT02881957|579642798|FG000|Overall Study|Comfort care|0|||
160522739|NCT02881957|579642799|FG001|Overall Study|Comfort care|1|||
160522740|NCT02881957|579642798|FG000|Overall Study|Concurrent trial enrollment|0|||
160522741|NCT02881957|579642799|FG001|Overall Study|Concurrent trial enrollment|1|||
160522742|NCT02881957|579642798|FG000|Overall Study|Discharged within 48 hours|0|||
160522743|NCT02881957|579642799|FG001|Overall Study|Discharged within 48 hours|1|||
160522744|NCT02881957|579642798|FG000|Overall Study|Withdrawal by Subject|2|||
160522745|NCT02881957|579642799|FG001|Overall Study|Withdrawal by Subject|1|||
160522746|NCT02881957|579642798|FG000|Overall Study|Protocol Violation|1|||
160522747|NCT02881957|579642799|FG001|Overall Study|Protocol Violation|0|||
160522748|NCT03705832|579642804|FG000|Overall Study|Physician Decision|0|||
160522749|NCT03705832|579642805|FG001|Overall Study|Physician Decision|1|||
160522750|NCT03705832|579642804|FG000|Overall Study|Withdrawal by Subject|1|||
160522751|NCT03705832|579642805|FG001|Overall Study|Withdrawal by Subject|0|||
160522752|NCT01880528|579642806|FG000|Overall Study|Other|1|||
160522753|NCT01880528|579642807|FG001|Overall Study|Other|1|||
160522754|NCT00081497|579642808|FG000|Overall Study|Adverse Event|2|||
160522755|NCT00081497|579642809|FG001|Overall Study|Adverse Event|0|||
160522756|NCT00081497|579642808|FG000|Overall Study|Death|0|||
160522757|NCT00081497|579642809|FG001|Overall Study|Death|1|||
160522758|NCT00081497|579642808|FG000|Overall Study|Withdrawal by Subject|1|||
160522759|NCT00081497|579642809|FG001|Overall Study|Withdrawal by Subject|0|||
160522760|NCT00081497|579642808|FG000|Overall Study|Non-compliance|0|||
160522761|NCT00081497|579642809|FG001|Overall Study|Non-compliance|1|||
160522762|NCT02254278|579642810|FG000|Overall Study|Protocol Violation|1|||
160522763|NCT02254278|579642811|FG001|Overall Study|Protocol Violation|1|||
160522764|NCT05437510|579642815|FG000|Overall Study|Adverse Event|2|||
160522765|NCT05437510|579642816|FG001|Overall Study|Adverse Event|1|||
160522766|NCT05437510|579642815|FG000|Overall Study|Protocol Deviation|1|||
160522767|NCT05437510|579642816|FG001|Overall Study|Protocol Deviation|6|||
160522768|NCT05437510|579642815|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
160522769|NCT05437510|579642816|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
160522770|NCT05437510|579642815|FG000|Overall Study|Lost to Follow-up|265|||
160522771|NCT05437510|579642816|FG001|Overall Study|Lost to Follow-up|358|||
160522772|NCT00826111|579644624|FG000|Overall Study|Lost to Follow-up|0|||
160522773|NCT00826111|579644625|FG001|Overall Study|Lost to Follow-up|1|||
160522774|NCT00826111|579644624|FG000|Overall Study|Protocol Violation|1|||
160522775|NCT00826111|579644625|FG001|Overall Study|Protocol Violation|0|||
160522776|NCT00826111|579644624|FG000|Overall Study|Withdrawal by Subject|5|||
160522777|NCT00826111|579644625|FG001|Overall Study|Withdrawal by Subject|0|||
160522778|NCT00826111|579644624|FG000|Overall Study|Physician Decision|1|||
160522779|NCT00826111|579644625|FG001|Overall Study|Physician Decision|1|||
160522780|NCT02805725|579644626|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
160522781|NCT02805725|579644627|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
160522782|NCT02805725|579644628|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
160522783|NCT02805725|579644629|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
160522784|NCT02805725|579644630|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
160522785|NCT02805725|579644626|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
160522786|NCT02805725|579644627|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
160522787|NCT02805725|579644628|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
160522788|NCT02805725|579644629|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
160522789|NCT02805725|579644630|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
160522790|NCT02805725|579644626|FG000|Phase II|Protocol Violation|0|||
160522791|NCT02805725|579644627|FG001|Phase II|Protocol Violation|0|||
160522792|NCT02805725|579644628|FG002|Phase II|Protocol Violation|0|||
160522793|NCT02805725|579644629|FG003|Phase II|Protocol Violation|0|||
160522794|NCT02805725|579644630|FG004|Phase II|Protocol Violation|6|||
160522795|NCT01195545|579644631|FG000|Overall Study|Protocol Violation|4|||
160522796|NCT00985166|579644632|FG000|Overall Study|Lost to Follow-up|3|||
160522797|NCT00985166|579644633|FG001|Overall Study|Lost to Follow-up|2|||
160522798|NCT00985166|579644634|FG002|Overall Study|Lost to Follow-up|2|||
160522799|NCT00985166|579644632|FG000|Overall Study|Withdrawal by Subject|3|||
160522800|NCT00985166|579644633|FG001|Overall Study|Withdrawal by Subject|2|||
160522801|NCT00985166|579644634|FG002|Overall Study|Withdrawal by Subject|0|||
160522802|NCT00985166|579644632|FG000|Overall Study|Test not done|2|||
160522803|NCT00985166|579644633|FG001|Overall Study|Test not done|0|||
160522804|NCT00985166|579644634|FG002|Overall Study|Test not done|4|||
160522805|NCT00985166|579644632|FG000|Overall Study|Other|1|||
160522806|NCT00985166|579644633|FG001|Overall Study|Other|0|||
160522807|NCT00985166|579644634|FG002|Overall Study|Other|1|||
160522808|NCT00792805|579644635|FG000|Overall Study|Adverse Event|12|||
160522809|NCT00792805|579644636|FG001|Overall Study|Adverse Event|10|||
160522810|NCT00792805|579644637|FG002|Overall Study|Adverse Event|10|||
160522811|NCT00792805|579644635|FG000|Overall Study|Subject withdrew consent|5|||
160522812|NCT00792805|579644636|FG001|Overall Study|Subject withdrew consent|6|||
160522813|NCT00792805|579644637|FG002|Overall Study|Subject withdrew consent|5|||
160522814|NCT00792805|579644635|FG000|Overall Study|Administrative problems|2|||
160522815|NCT00792805|579644636|FG001|Overall Study|Administrative problems|0|||
160522816|NCT00792805|579644637|FG002|Overall Study|Administrative problems|4|||
160522817|NCT00792805|579644635|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160522818|NCT00792805|579644636|FG001|Overall Study|Abnormal test procedure result(s)|2|||
160522819|NCT00792805|579644637|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160522820|NCT00792805|579644635|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160522821|NCT00792805|579644636|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
160522822|NCT00792805|579644637|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
160522823|NCT00792805|579644635|FG000|Overall Study|Lost to Follow-up|1|||
160522824|NCT00792805|579644636|FG001|Overall Study|Lost to Follow-up|1|||
160522825|NCT00792805|579644637|FG002|Overall Study|Lost to Follow-up|6|||
160522826|NCT00792805|579644635|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160522827|NCT00792805|579644636|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160522828|NCT00792805|579644637|FG002|Overall Study|Abnormal laboratory value(s)|1|||
160522829|NCT00792805|579644635|FG000|Overall Study|Protocol deviation|0|||
160522830|NCT00792805|579644636|FG001|Overall Study|Protocol deviation|1|||
160522831|NCT00792805|579644637|FG002|Overall Study|Protocol deviation|1|||
160522832|NCT02072434|579644638|FG000|Overall Study|Protocol Violation|10|||
160522833|NCT02072434|579644639|FG001|Overall Study|Protocol Violation|9|||
160522834|NCT02072434|579644638|FG000|Overall Study|Physician Decision|5|||
160522835|NCT02072434|579644639|FG001|Overall Study|Physician Decision|10|||
160522836|NCT02072434|579644638|FG000|Overall Study|Adverse event, serious fatal|1|||
160522837|NCT02072434|579644639|FG001|Overall Study|Adverse event, serious fatal|6|||
160522838|NCT02072434|579644638|FG000|Overall Study|Adverse Event|7|||
160522839|NCT02072434|579644639|FG001|Overall Study|Adverse Event|6|||
160522840|NCT02072434|579644638|FG000|Overall Study|Withdrawal by Subject|17|||
160522841|NCT02072434|579644639|FG001|Overall Study|Withdrawal by Subject|29|||
160522842|NCT02072434|579644638|FG000|Overall Study|Other|14|||
160522843|NCT02072434|579644639|FG001|Overall Study|Other|29|||
160522844|NCT02072434|579644638|FG000|Overall Study|Lost to Follow-up|0|||
160522845|NCT02072434|579644639|FG001|Overall Study|Lost to Follow-up|1|||
160522846|NCT02276872|579644640|FG000|Overall Study|Adverse Event|1|||
160522847|NCT02276872|579644641|FG001|Overall Study|Adverse Event|0|||
160522848|NCT02276872|579644642|FG002|Overall Study|Adverse Event|0|||
160522849|NCT04175808|579644643|FG000|Part A|Miscellaneous|2|||
160522850|NCT04175808|579644644|FG001|Part A|Miscellaneous|0|||
160522851|NCT04175808|579644645|FG002|Part A|Miscellaneous|0|||
160522852|NCT04175808|579644646|FG003|Part A|Miscellaneous|0|||
160522853|NCT04175808|579644647|FG004|Part A|Miscellaneous|0|||
160522854|NCT04175808|579644648|FG005|Part A|Miscellaneous|0|||
160522855|NCT04175808|579644649|FG006|Part A|Miscellaneous|0|||
160522856|NCT00402363|579644651|FG000|Overall Study|Adverse Event|9|||
160522857|NCT00402363|579644652|FG001|Overall Study|Adverse Event|14|||
160522858|NCT00402363|579644653|FG002|Overall Study|Adverse Event|2|||
160522859|NCT00402363|579644654|FG003|Overall Study|Adverse Event|2|||
160522860|NCT00402363|579644651|FG000|Overall Study|Withdrew Consent|10|||
160522861|NCT00402363|579644652|FG001|Overall Study|Withdrew Consent|5|||
160522862|NCT00402363|579644653|FG002|Overall Study|Withdrew Consent|2|||
160522863|NCT00402363|579644654|FG003|Overall Study|Withdrew Consent|1|||
160522864|NCT00402363|579644651|FG000|Overall Study|Protocol Violation|3|||
160522865|NCT00402363|579644652|FG001|Overall Study|Protocol Violation|5|||
160522866|NCT00402363|579644653|FG002|Overall Study|Protocol Violation|0|||
160522867|NCT00402363|579644654|FG003|Overall Study|Protocol Violation|3|||
160522868|NCT00402363|579644651|FG000|Overall Study|Lost to Follow-up|5|||
160522869|NCT00402363|579644652|FG001|Overall Study|Lost to Follow-up|4|||
160522870|NCT00402363|579644653|FG002|Overall Study|Lost to Follow-up|0|||
160522871|NCT00402363|579644654|FG003|Overall Study|Lost to Follow-up|2|||
160522872|NCT00402363|579644651|FG000|Overall Study|"Captured as Other"|6|||
160522873|NCT00402363|579644652|FG001|Overall Study|"Captured as Other"|2|||
160522874|NCT00402363|579644653|FG002|Overall Study|"Captured as Other"|2|||
160522875|NCT00402363|579644654|FG003|Overall Study|"Captured as Other"|2|||
160522876|NCT00937833|579644663|FG000|Overall Study|Protocol Violation|1|||
160522877|NCT00937833|579644664|FG001|Overall Study|Protocol Violation|2|||
160522878|NCT00937833|579644663|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
160522879|NCT00937833|579644664|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
160522880|NCT00937833|579644663|FG000|Overall Study|Lost to Follow-up|10|||
160522881|NCT00937833|579644664|FG001|Overall Study|Lost to Follow-up|8|||
160522882|NCT00937833|579644663|FG000|Overall Study|Withdrawal by Subject|4|||
160522883|NCT00937833|579644664|FG001|Overall Study|Withdrawal by Subject|6|||
160522884|NCT03278106|579644666|FG000|Overall Study|No protocol treatment|1|||
160522885|NCT02175004|579644667|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
160522886|NCT02175004|579644668|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
160522887|NCT02175004|579644667|FG000|Overall Study|Investigator Judgment|1|||
160522888|NCT02175004|579644668|FG001|Overall Study|Investigator Judgment|4|||
160522889|NCT02175004|579644667|FG000|Overall Study|Voluntary Withdrawal|6|||
160522890|NCT02175004|579644668|FG001|Overall Study|Voluntary Withdrawal|19|||
160522891|NCT02175004|579644667|FG000|Overall Study|Liver Transplant|1|||
160522892|NCT02175004|579644668|FG001|Overall Study|Liver Transplant|0|||
160522893|NCT02175004|579644667|FG000|Overall Study|Disease Progression|1|||
160522894|NCT02175004|579644668|FG001|Overall Study|Disease Progression|0|||
160522895|NCT02175004|579644667|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
160522896|NCT02175004|579644668|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
160522897|NCT00162032|579644669|FG000|Overall Study|Lost to Follow-up|4|||
160522898|NCT00162032|579644670|FG001|Overall Study|Lost to Follow-up|2|||
160522899|NCT00162032|579644669|FG000|Overall Study|Reason not specified|1|||
160522900|NCT00162032|579644670|FG001|Overall Study|Reason not specified|0|||
160522901|NCT01137955|579644671|FG000|Overall Study|Withdrawal by Subject|5|||
160522902|NCT01137955|579644672|FG001|Overall Study|Withdrawal by Subject|4|||
160749727|NCT02688764|580469672|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
160749728|NCT02688764|580469673|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
160749729|NCT02688764|580469672|FG000|Overall Study|AE/Other|0|||
160749730|NCT02688764|580469673|FG001|Overall Study|AE/Other|1|||
160749731|NCT02688764|580469672|FG000|Overall Study|AE/Physician decision|1|||
160749732|NCT02688764|580469673|FG001|Overall Study|AE/Physician decision|0|||
160749733|NCT02688764|580469672|FG000|Overall Study|AE/Withd. parent|3|||
160749734|NCT02688764|580469673|FG001|Overall Study|AE/Withd. parent|0|||
160749735|NCT02688764|580469672|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
160749736|NCT02688764|580469673|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
160749737|NCT02688764|580469672|FG000|Overall Study|AE/Withd. subject|1|||
160749738|NCT02688764|580469673|FG001|Overall Study|AE/Withd. subject|0|||
160749739|NCT02688764|580469672|FG000|Overall Study|Kidney transplant|10|||
160749740|NCT02688764|580469673|FG001|Overall Study|Kidney transplant|4|||
160749741|NCT02688764|580469672|FG000|Overall Study|Lack of Efficacy|3|||
160749742|NCT02688764|580469673|FG001|Overall Study|Lack of Efficacy|2|||
160749743|NCT02688764|580469672|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
160749744|NCT02688764|580469673|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
160749745|NCT02688764|580469672|FG000|Overall Study|Non-compliance with study drug|4|||
160749746|NCT02688764|580469673|FG001|Overall Study|Non-compliance with study drug|0|||
160749747|NCT02688764|580469672|FG000|Overall Study|Non-compl./Physician decision|2|||
160749748|NCT02688764|580469673|FG001|Overall Study|Non-compl./Physician decision|0|||
160749749|NCT02688764|580469672|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
160749750|NCT02688764|580469673|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
160749751|NCT02688764|580469672|FG000|Overall Study|Non-compl./Withd. subject|0|||
160749752|NCT02688764|580469673|FG001|Overall Study|Non-compl./Withd. subject|2|||
160749753|NCT02688764|580469672|FG000|Overall Study|Phosphorus level outside safe range|0|||
160749754|NCT02688764|580469673|FG001|Overall Study|Phosphorus level outside safe range|1|||
160749755|NCT02688764|580469672|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
160749756|NCT02688764|580469673|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
160749757|NCT02688764|580469672|FG000|Overall Study|Study drug taste/Withd. parent|1|||
160749758|NCT02688764|580469673|FG001|Overall Study|Study drug taste/Withd. parent|0|||
160749759|NCT02688764|580469672|FG000|Overall Study|Subject moving out|2|||
160749760|NCT02688764|580469673|FG001|Overall Study|Subject moving out|0|||
160749761|NCT02688764|580469672|FG000|Overall Study|Subject taken off dialysis|1|||
160749762|NCT02688764|580469673|FG001|Overall Study|Subject taken off dialysis|0|||
160749763|NCT02688764|580469672|FG000|Overall Study|Withdrawal by parent|3|||
160749764|NCT02688764|580469673|FG001|Overall Study|Withdrawal by parent|0|||
160749765|NCT02579382|580469674|FG000|Main Study Phase|Lost to Follow-up|0|||
160749766|NCT02579382|580469675|FG001|Main Study Phase|Lost to Follow-up|0|||
160749767|NCT02579382|580469676|FG002|Main Study Phase|Lost to Follow-up|2|||
160749768|NCT02579382|580469677|FG003|Main Study Phase|Lost to Follow-up|0|||
160749769|NCT02579382|580469674|FG000|Main Study Phase|Withdrew Consent|0|||
160749770|NCT02579382|580469675|FG001|Main Study Phase|Withdrew Consent|0|||
160749771|NCT02579382|580469676|FG002|Main Study Phase|Withdrew Consent|0|||
160749772|NCT02579382|580469677|FG003|Main Study Phase|Withdrew Consent|2|||
160749773|NCT02579382|580469674|FG000|Main Study Phase|Lack of Efficacy|0|||
160749774|NCT02579382|580469675|FG001|Main Study Phase|Lack of Efficacy|0|||
160749775|NCT02579382|580469676|FG002|Main Study Phase|Lack of Efficacy|0|||
160749776|NCT02579382|580469677|FG003|Main Study Phase|Lack of Efficacy|1|||
160749777|NCT02579382|580469674|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
160749778|NCT02579382|580469675|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
160749779|NCT02579382|580469676|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
160749780|NCT02579382|580469677|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
160749781|NCT02579382|580469674|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
160749782|NCT02579382|580469675|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
160749783|NCT02579382|580469676|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
160749784|NCT02579382|580469677|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
160749785|NCT02579382|580469674|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
160749786|NCT02579382|580469675|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
160749787|NCT02579382|580469676|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
160749788|NCT02579382|580469677|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
160749789|NCT02579382|580469674|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
160749790|NCT02579382|580469675|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
160749791|NCT02579382|580469676|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
160749792|NCT02579382|580469677|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
160749793|NCT02579382|580469674|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
160749794|NCT02579382|580469675|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
160749795|NCT02579382|580469676|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
160749796|NCT02579382|580469677|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
160749797|NCT02579382|580469674|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
160749798|NCT02579382|580469675|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
160749799|NCT02579382|580469676|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
160749800|NCT02579382|580469677|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
160749801|NCT01775787|580469678|FG000|First 7-10 Days|Adverse Event|0|||
160749802|NCT01775787|580469679|FG001|First 7-10 Days|Adverse Event|1|||
160749803|NCT01775787|580469678|FG000|First 7-10 Days|family emergency|0|||
160749804|NCT01775787|580469679|FG001|First 7-10 Days|family emergency|1|||
160749805|NCT01775787|580469678|FG000|First 7-10 Days|time commitment|0|||
160749806|NCT01775787|580469679|FG001|First 7-10 Days|time commitment|2|||
160749807|NCT01775787|580469678|FG000|First 7-10 Days|concerns with using IV|1|||
160749808|NCT01775787|580469679|FG001|First 7-10 Days|concerns with using IV|2|||
160749809|NCT01775787|580469678|FG000|Second 7-10 Days|time commitment|0|||
160749810|NCT01775787|580469679|FG001|Second 7-10 Days|time commitment|1|||
160749811|NCT01775787|580469678|FG000|Second 7-10 Days|concerns with using IV|0|||
160749812|NCT01775787|580469679|FG001|Second 7-10 Days|concerns with using IV|1|||
160749813|NCT03026283|580469680|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
160749814|NCT03026283|580469681|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
160749815|NCT03026283|580469682|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
160749816|NCT03026283|580469683|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
160522903|NCT04263909|579644673|FG000|Overall Study|Physician Decision|1|||
160522904|NCT04263909|579644674|FG001|Overall Study|Physician Decision|0|||
160522905|NCT04263909|579644675|FG002|Overall Study|Physician Decision|0|||
160522906|NCT04263909|579644673|FG000|Overall Study|Adverse Event|3|||
160522907|NCT04263909|579644674|FG001|Overall Study|Adverse Event|0|||
160522908|NCT04263909|579644675|FG002|Overall Study|Adverse Event|0|||
160522909|NCT04263909|579644673|FG000|Overall Study|Protocol Violation|5|||
160522910|NCT04263909|579644674|FG001|Overall Study|Protocol Violation|0|||
160522911|NCT04263909|579644675|FG002|Overall Study|Protocol Violation|0|||
160522912|NCT00068588|579644676|FG000|Overall Study|Adverse Event|0|||
160522913|NCT00068588|579644677|FG001|Overall Study|Adverse Event|0|||
160522914|NCT00068588|579644678|FG002|Overall Study|Adverse Event|2|||
160522915|NCT00068588|579644676|FG000|Overall Study|Withdrawal by Subject|0|||
160522916|NCT00068588|579644677|FG001|Overall Study|Withdrawal by Subject|0|||
160522917|NCT00068588|579644678|FG002|Overall Study|Withdrawal by Subject|1|||
160522918|NCT00068588|579644676|FG000|Overall Study|Poor KPS|0|||
160522919|NCT00068588|579644677|FG001|Overall Study|Poor KPS|0|||
160522920|NCT00068588|579644678|FG002|Overall Study|Poor KPS|1|||
160522921|NCT03840486|579644679|FG000|Overall Study|Withdrawal by Subject|0|||
160522922|NCT03840486|579644680|FG001|Overall Study|Withdrawal by Subject|1|||
160522923|NCT03840486|579644681|FG002|Overall Study|Withdrawal by Subject|0|||
160522924|NCT03840486|579644682|FG003|Overall Study|Withdrawal by Subject|0|||
160522925|NCT03840486|579644683|FG004|Overall Study|Withdrawal by Subject|0|||
160522926|NCT03840486|579644684|FG005|Overall Study|Withdrawal by Subject|0|||
160522927|NCT03840486|579644685|FG006|Overall Study|Withdrawal by Subject|0|||
160522928|NCT03840486|579644686|FG007|Overall Study|Withdrawal by Subject|0|||
160522929|NCT03840486|579644687|FG008|Overall Study|Withdrawal by Subject|0|||
160522930|NCT03840486|579644688|FG009|Overall Study|Withdrawal by Subject|0|||
160522931|NCT03840486|579644689|FG010|Overall Study|Withdrawal by Subject|0|||
160522932|NCT03840486|579644690|FG011|Overall Study|Withdrawal by Subject|0|||
160522933|NCT03285178|579644691|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
160522934|NCT03285178|579644692|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
160522935|NCT03285178|579644693|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
160522936|NCT03285178|579644694|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
160522937|NCT03285178|579644695|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
160522938|NCT03285178|579644696|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
160522939|NCT03285178|579644697|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
160522940|NCT03285178|579644691|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
160522941|NCT03285178|579644692|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
160522942|NCT03285178|579644693|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
160522943|NCT03285178|579644694|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
160522944|NCT03285178|579644695|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
160522945|NCT03285178|579644696|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
160522946|NCT03285178|579644697|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
160522947|NCT03285178|579644691|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
160522948|NCT03285178|579644692|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
160522949|NCT03285178|579644693|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
160522950|NCT03285178|579644694|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
160522951|NCT03285178|579644695|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
160522952|NCT03285178|579644696|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
160522953|NCT03285178|579644697|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
160522954|NCT03285178|579644691|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
160522955|NCT03285178|579644692|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
160522956|NCT03285178|579644693|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
160522957|NCT03285178|579644694|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
160522958|NCT03285178|579644695|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
160522959|NCT03285178|579644696|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
160522960|NCT03285178|579644697|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
160522961|NCT03285178|579644691|FG000|Single-Blind Run-In Period|Physician Decision|2|||
160522962|NCT03285178|579644692|FG001|Single-Blind Run-In Period|Physician Decision|0|||
160522963|NCT03285178|579644693|FG002|Single-Blind Run-In Period|Physician Decision|0|||
160522964|NCT03285178|579644694|FG003|Single-Blind Run-In Period|Physician Decision|0|||
160522965|NCT03285178|579644695|FG004|Single-Blind Run-In Period|Physician Decision|0|||
160522966|NCT03285178|579644696|FG005|Single-Blind Run-In Period|Physician Decision|0|||
160522967|NCT03285178|579644697|FG006|Single-Blind Run-In Period|Physician Decision|0|||
160522968|NCT03285178|579644691|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
160522969|NCT03285178|579644692|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
160522970|NCT03285178|579644693|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
160522971|NCT03285178|579644694|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
160522972|NCT03285178|579644695|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
160522973|NCT03285178|579644696|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
160749817|NCT03026283|580469684|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
160522974|NCT03285178|579644697|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
160522975|NCT03285178|579644691|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160522976|NCT03285178|579644692|FG001|Double-Blind Treatment Period|Adverse Event|0|||
160522977|NCT03285178|579644693|FG002|Double-Blind Treatment Period|Adverse Event|0|||
160522978|NCT03285178|579644694|FG003|Double-Blind Treatment Period|Adverse Event|0|||
160522979|NCT03285178|579644695|FG004|Double-Blind Treatment Period|Adverse Event|0|||
160522980|NCT03285178|579644696|FG005|Double-Blind Treatment Period|Adverse Event|0|||
160522981|NCT03285178|579644697|FG006|Double-Blind Treatment Period|Adverse Event|2|||
160522982|NCT03285178|579644691|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160522983|NCT03285178|579644692|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
160522984|NCT03285178|579644693|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
160522985|NCT03285178|579644694|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
160522986|NCT03285178|579644695|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
160522987|NCT03285178|579644696|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
160749818|NCT03026283|580469685|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
160749819|NCT03026283|580469686|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
160522988|NCT03285178|579644697|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
160522989|NCT03285178|579644691|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160522990|NCT03285178|579644692|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160522991|NCT03285178|579644693|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160522992|NCT03285178|579644694|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160522993|NCT03285178|579644695|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160522994|NCT03285178|579644696|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
160522995|NCT03285178|579644697|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160522996|NCT03285178|579644691|FG000|Double-Blind Treatment Period|COVID-19|0|||
160522997|NCT03285178|579644692|FG001|Double-Blind Treatment Period|COVID-19|0|||
160522998|NCT03285178|579644693|FG002|Double-Blind Treatment Period|COVID-19|1|||
160522999|NCT03285178|579644694|FG003|Double-Blind Treatment Period|COVID-19|0|||
160523000|NCT03285178|579644695|FG004|Double-Blind Treatment Period|COVID-19|0|||
160523001|NCT03285178|579644696|FG005|Double-Blind Treatment Period|COVID-19|0|||
160523002|NCT03285178|579644697|FG006|Double-Blind Treatment Period|COVID-19|0|||
160523003|NCT01128894|579644698|FG000|Overall Study|Adverse Event|31|||
160523004|NCT01128894|579644699|FG001|Overall Study|Adverse Event|41|||
160523005|NCT01128894|579644698|FG000|Overall Study|Protocol Violation|2|||
160523006|NCT01128894|579644699|FG001|Overall Study|Protocol Violation|1|||
160523007|NCT01128894|579644698|FG000|Overall Study|Noncompliance|4|||
160523008|NCT01128894|579644699|FG001|Overall Study|Noncompliance|5|||
160523009|NCT01128894|579644698|FG000|Overall Study|Lost to Follow-up|8|||
160523010|NCT01128894|579644699|FG001|Overall Study|Lost to Follow-up|8|||
160523011|NCT01128894|579644698|FG000|Overall Study|Withdrawal by Subject|10|||
160749820|NCT03026283|580469687|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
160749821|NCT03026283|580469680|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
160749822|NCT03026283|580469681|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
160749823|NCT03026283|580469682|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
160749824|NCT03026283|580469683|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
160749825|NCT03026283|580469684|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
160749826|NCT03026283|580469685|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
160749827|NCT03026283|580469686|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
160749828|NCT03026283|580469687|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
160749829|NCT03026283|580469680|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
160749830|NCT03026283|580469681|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
160749831|NCT03026283|580469682|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
160749832|NCT03026283|580469683|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
160749833|NCT03026283|580469684|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
160749834|NCT03026283|580469685|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
160523012|NCT01128894|579644699|FG001|Overall Study|Withdrawal by Subject|12|||
160523013|NCT01128894|579644698|FG000|Overall Study|Physician Decision|2|||
160523014|NCT01128894|579644699|FG001|Overall Study|Physician Decision|1|||
160523015|NCT01128894|579644698|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
160523016|NCT01128894|579644699|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
160523026|NCT01128738|579644703|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
160523027|NCT01128738|579644704|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
160523028|NCT01128738|579644703|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
160523029|NCT01128738|579644704|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
160523030|NCT01128738|579644703|FG000|Second TP|Lost to Follow-up|0|||
160523031|NCT01128738|579644704|FG001|Second TP|Lost to Follow-up|1|||
160523032|NCT01128738|579644703|FG000|Second TP|Withdrawal by Subject|0|||
160523033|NCT01128738|579644704|FG001|Second TP|Withdrawal by Subject|2|||
160523034|NCT00973362|579644705|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
160523035|NCT00973362|579644706|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
160523036|NCT00973362|579644705|FG000|Baseline Evaluation|No colposcopy visit|62|||
160523037|NCT00973362|579644706|FG001|Baseline Evaluation|No colposcopy visit|0|||
160523038|NCT00973362|579644705|FG000|Baseline Evaluation|Inevaluable|686|||
160523039|NCT00973362|579644706|FG001|Baseline Evaluation|Inevaluable|223|||
160523040|NCT00973362|579644705|FG000|3-Year Follow-up|Lost to Follow-up|17|||
160523041|NCT00973362|579644706|FG001|3-Year Follow-up|Lost to Follow-up|0|||
160523042|NCT05116046|579644711|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160523043|NCT05116046|579644712|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160523044|NCT05116046|579644713|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160523045|NCT05116046|579644711|FG000|Overall Study|Study terminated by sponsor|14|||
160523046|NCT05116046|579644712|FG001|Overall Study|Study terminated by sponsor|16|||
160523047|NCT05116046|579644713|FG002|Overall Study|Study terminated by sponsor|1|||
160523048|NCT01009203|579644716|FG000|Overall Study|Withdrawal by Subject|1|||
160523049|NCT01009203|579644716|FG000|Overall Study|Adverse Event|5|||
160523050|NCT01009203|579644716|FG000|Overall Study|Treatment-unrelated death|1|||
160523051|NCT00150969|579644719|FG000|24 Month Main Study|Adverse Event|3|||
160523052|NCT00150969|579644720|FG001|24 Month Main Study|Adverse Event|4|||
160523053|NCT00150969|579644719|FG000|24 Month Main Study|Death|1|||
160523054|NCT00150969|579644720|FG001|24 Month Main Study|Death|1|||
160523055|NCT00150969|579644719|FG000|24 Month Main Study|Lack of Efficacy|1|||
160523056|NCT00150969|579644720|FG001|24 Month Main Study|Lack of Efficacy|8|||
160523057|NCT00150969|579644719|FG000|24 Month Main Study|Lost to Follow-up|3|||
160523058|NCT00150969|579644720|FG001|24 Month Main Study|Lost to Follow-up|2|||
160523059|NCT00150969|579644719|FG000|24 Month Main Study|Protocol Violation|4|||
160523060|NCT00150969|579644720|FG001|24 Month Main Study|Protocol Violation|2|||
160523061|NCT00150969|579644719|FG000|24 Month Main Study|Withdrawal by Subject|7|||
160523062|NCT00150969|579644720|FG001|24 Month Main Study|Withdrawal by Subject|4|||
160523063|NCT00150969|579644719|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
160523064|NCT00150969|579644720|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
160523065|NCT00150969|579644719|FG000|24-48 Month Extension|Lack of Efficacy|0|||
160523066|NCT00150969|579644720|FG001|24-48 Month Extension|Lack of Efficacy|1|||
160523067|NCT00150969|579644719|FG000|24-48 Month Extension|Adverse Event|1|||
160523068|NCT00150969|579644720|FG001|24-48 Month Extension|Adverse Event|3|||
160523069|NCT00150969|579644719|FG000|24-48 Month Extension|Other Reason|81|||
160523070|NCT00150969|579644720|FG001|24-48 Month Extension|Other Reason|91|||
160523071|NCT00146757|579644721|FG000|Overall Study|Death|1|||
160523072|NCT00146757|579644722|FG001|Overall Study|Death|0|||
160523073|NCT00146757|579644721|FG000|Overall Study|Adverse Event|1|||
160523074|NCT00146757|579644722|FG001|Overall Study|Adverse Event|0|||
160523075|NCT00615836|579644723|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
160523076|NCT00615836|579644724|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
160523077|NCT00615836|579644725|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
160523078|NCT00615836|579644726|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
160523079|NCT00615836|579644727|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
160523080|NCT00615836|579644723|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
160523081|NCT00615836|579644724|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
160523082|NCT00615836|579644725|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
160523083|NCT00615836|579644726|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
160523084|NCT00615836|579644727|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
160523085|NCT00615836|579644723|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
160523086|NCT00615836|579644724|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
160523087|NCT00615836|579644725|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
160523088|NCT00615836|579644726|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
160523089|NCT00615836|579644727|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
160523090|NCT00615836|579644723|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
160523091|NCT00615836|579644724|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
160523092|NCT00615836|579644725|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
160523093|NCT00615836|579644726|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
160523094|NCT00615836|579644727|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
160523095|NCT00615836|579644723|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
160523096|NCT00615836|579644724|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
160523097|NCT00615836|579644725|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
160523098|NCT00615836|579644726|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
160523099|NCT00615836|579644727|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
160523100|NCT00615836|579644723|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
160523101|NCT00615836|579644724|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
160523102|NCT00615836|579644725|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
160523103|NCT00615836|579644726|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
160523104|NCT00615836|579644727|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
160523105|NCT00615836|579644723|FG000|Extension Study (FE992026 CS31)|Other|10|||
160523106|NCT00615836|579644724|FG001|Extension Study (FE992026 CS31)|Other|7|||
160523107|NCT00615836|579644725|FG002|Extension Study (FE992026 CS31)|Other|8|||
160523108|NCT00615836|579644726|FG003|Extension Study (FE992026 CS31)|Other|8|||
160523109|NCT00615836|579644727|FG004|Extension Study (FE992026 CS31)|Other|0|||
160523110|NCT00615836|579644723|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
160523111|NCT00615836|579644724|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
160523112|NCT00615836|579644725|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
160523113|NCT00615836|579644726|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
160523114|NCT00615836|579644727|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
160523115|NCT00615836|579644723|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
160523116|NCT00615836|579644724|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
160523117|NCT00615836|579644725|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
160523118|NCT00615836|579644726|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
160523119|NCT00615836|579644727|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
160523120|NCT01630434|579644728|FG000|Overall Study|Donor lungs turned down|1|||
160523121|NCT01630434|579644729|FG001|Overall Study|Donor lungs turned down|0|||
160523122|NCT01630434|579644728|FG000|Overall Study|Protocol Violation|9|||
160523123|NCT01630434|579644729|FG001|Overall Study|Protocol Violation|4|||
160523124|NCT01630434|579644728|FG000|Overall Study|Death|20|||
160523125|NCT01630434|579644729|FG001|Overall Study|Death|26|||
160523126|NCT00687973|579644730|FG000|Overall Study|Adverse Event|18|||
160865656|NCT01055197|580902942|FG000|Overall Study|Withdrawal by Subject|2|||
160523127|NCT00687973|579644731|FG001|Overall Study|Adverse Event|28|||
160523128|NCT00687973|579644730|FG000|Overall Study|Lack of Efficacy|2|||
160523129|NCT00687973|579644731|FG001|Overall Study|Lack of Efficacy|3|||
160523130|NCT00687973|579644730|FG000|Overall Study|Protocol Violation|1|||
160523131|NCT00687973|579644731|FG001|Overall Study|Protocol Violation|2|||
160523132|NCT00687973|579644730|FG000|Overall Study|Administrative Reasons|0|||
160523133|NCT00687973|579644731|FG001|Overall Study|Administrative Reasons|2|||
160523134|NCT00687973|579644730|FG000|Overall Study|Withdrawal by Subject|3|||
160523135|NCT00687973|579644731|FG001|Overall Study|Withdrawal by Subject|3|||
160523136|NCT02349360|579644732|FG000|Overall Study|Withdrawal by Subject|0|||
160523137|NCT02349360|579644733|FG001|Overall Study|Withdrawal by Subject|1|||
160523138|NCT01054846|579644734|FG000|Overall Study|Lost to Follow-up|76|||
160523139|NCT01054846|579644735|FG001|Overall Study|Lost to Follow-up|17|||
160523140|NCT00394953|579644736|FG000|First Treatment Period|Adverse Event|1|||
160523141|NCT00394953|579644737|FG001|First Treatment Period|Adverse Event|2|||
160523142|NCT00394953|579644736|FG000|First Treatment Period|Death|6|||
160523143|NCT00394953|579644737|FG001|First Treatment Period|Death|7|||
160523144|NCT00394953|579644736|FG000|First Treatment Period|Lack of Efficacy|1|||
160523145|NCT00394953|579644737|FG001|First Treatment Period|Lack of Efficacy|1|||
160523146|NCT00394953|579644736|FG000|First Treatment Period|Withdrawal by Subject|6|||
160523147|NCT00394953|579644737|FG001|First Treatment Period|Withdrawal by Subject|3|||
160523148|NCT00394953|579644736|FG000|First Treatment Period|Lost to Follow-up|0|||
160523149|NCT00394953|579644737|FG001|First Treatment Period|Lost to Follow-up|1|||
160523150|NCT00394953|579644736|FG000|First Treatment Period|Renal transplant|11|||
160523151|NCT00394953|579644737|FG001|First Treatment Period|Renal transplant|7|||
160523152|NCT00394953|579644736|FG000|First Treatment Period|Not defined|4|||
160523153|NCT00394953|579644737|FG001|First Treatment Period|Not defined|1|||
160523154|NCT00394953|579644736|FG000|Second Treatment Period|Adverse Event|2|||
160523155|NCT00394953|579644737|FG001|Second Treatment Period|Adverse Event|5|||
160523156|NCT00394953|579644736|FG000|Second Treatment Period|Death|8|||
160523157|NCT00394953|579644737|FG001|Second Treatment Period|Death|4|||
160523158|NCT00394953|579644736|FG000|Second Treatment Period|Lack of Efficacy|9|||
160523159|NCT00394953|579644737|FG001|Second Treatment Period|Lack of Efficacy|47|||
160523160|NCT00394953|579644736|FG000|Second Treatment Period|Withdrawal by Subject|3|||
160523161|NCT00394953|579644737|FG001|Second Treatment Period|Withdrawal by Subject|3|||
160523162|NCT00394953|579644736|FG000|Second Treatment Period|Lost to Follow-up|0|||
160523163|NCT00394953|579644737|FG001|Second Treatment Period|Lost to Follow-up|1|||
160523164|NCT00394953|579644736|FG000|Second Treatment Period|Renal transplant|4|||
160523165|NCT00394953|579644737|FG001|Second Treatment Period|Renal transplant|6|||
160523166|NCT00394953|579644736|FG000|Second Treatment Period|Not defined|3|||
160523167|NCT00394953|579644737|FG001|Second Treatment Period|Not defined|8|||
160523168|NCT02446886|579644744|FG000|Overall Study|Adverse Event|1|||
160523169|NCT02446886|579644745|FG001|Overall Study|Adverse Event|3|||
160523170|NCT02446886|579644744|FG000|Overall Study|Withdrawal by Subject|1|||
160523171|NCT02446886|579644745|FG001|Overall Study|Withdrawal by Subject|1|||
160523172|NCT03021954|579644753|FG000|Overall Study|Lost to Follow-up|10|||
160523173|NCT03021954|579644754|FG001|Overall Study|Lost to Follow-up|43|||
160523174|NCT03021954|579644753|FG000|Overall Study|Subjects had avulsion trauma|4|||
160523175|NCT03021954|579644754|FG001|Overall Study|Subjects had avulsion trauma|1|||
160523176|NCT02196714|579644757|FG000|Overall Study|Protocol Violation|0|||
160523177|NCT02196714|579644758|FG001|Overall Study|Protocol Violation|0|||
160523178|NCT02196714|579644759|FG002|Overall Study|Protocol Violation|1|||
160523179|NCT02196714|579644760|FG003|Overall Study|Protocol Violation|0|||
160523180|NCT01592864|579644762|FG000|Overall Study|Withdrawal by Subject|0|||
160523181|NCT01592864|579644763|FG001|Overall Study|Withdrawal by Subject|1|||
160523182|NCT00307125|579644770|FG000|Screening Phase|Adverse Event|1|||
160523183|NCT00307125|579644771|FG001|Screening Phase|Adverse Event|0|||
160523184|NCT00307125|579644772|FG002|Screening Phase|Adverse Event|0|||
160523185|NCT00307125|579644770|FG000|Screening Phase|Protocol Violation|27|||
160523186|NCT00307125|579644771|FG001|Screening Phase|Protocol Violation|0|||
160523187|NCT00307125|579644772|FG002|Screening Phase|Protocol Violation|0|||
160523188|NCT00307125|579644770|FG000|Screening Phase|Lost to Follow-up|87|||
160523189|NCT00307125|579644771|FG001|Screening Phase|Lost to Follow-up|0|||
160523190|NCT00307125|579644772|FG002|Screening Phase|Lost to Follow-up|0|||
160523191|NCT00307125|579644770|FG000|Screening Phase|Death|10|||
160523192|NCT00307125|579644771|FG001|Screening Phase|Death|0|||
160523193|NCT00307125|579644772|FG002|Screening Phase|Death|0|||
160523194|NCT00307125|579644770|FG000|Screening Phase|Withdrawal by Subject|77|||
160523195|NCT00307125|579644771|FG001|Screening Phase|Withdrawal by Subject|0|||
160523196|NCT00307125|579644772|FG002|Screening Phase|Withdrawal by Subject|0|||
160523197|NCT00307125|579644770|FG000|Screening Phase|Physician Decision|26|||
160523198|NCT00307125|579644771|FG001|Screening Phase|Physician Decision|0|||
160523199|NCT00307125|579644772|FG002|Screening Phase|Physician Decision|0|||
160523200|NCT00307125|579644770|FG000|Screening Phase|Sponsor Decision|4|||
160523201|NCT00307125|579644771|FG001|Screening Phase|Sponsor Decision|0|||
160523202|NCT00307125|579644772|FG002|Screening Phase|Sponsor Decision|0|||
160523203|NCT00307125|579644770|FG000|Screening Phase|Study Terminated|17|||
160523204|NCT00307125|579644771|FG001|Screening Phase|Study Terminated|0|||
160523205|NCT00307125|579644772|FG002|Screening Phase|Study Terminated|0|||
160523206|NCT00307125|579644770|FG000|Screening Phase|Graft Loss|3|||
160523207|NCT00307125|579644771|FG001|Screening Phase|Graft Loss|0|||
160523208|NCT00307125|579644772|FG002|Screening Phase|Graft Loss|0|||
160523209|NCT00307125|579644770|FG000|Screening Phase|Graft Failure|8|||
160523210|NCT00307125|579644771|FG001|Screening Phase|Graft Failure|0|||
160523211|NCT00307125|579644772|FG002|Screening Phase|Graft Failure|0|||
160523212|NCT00307125|579644770|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
160523213|NCT00307125|579644771|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
160523214|NCT00307125|579644772|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
160523215|NCT00307125|579644770|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
160523216|NCT00307125|579644771|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
160523217|NCT00307125|579644772|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
160523218|NCT00307125|579644770|FG000|Screening Phase|Moved or transferred facilities|34|||
160523219|NCT00307125|579644771|FG001|Screening Phase|Moved or transferred facilities|0|||
160523220|NCT00307125|579644772|FG002|Screening Phase|Moved or transferred facilities|0|||
160523221|NCT00307125|579644770|FG000|Screening Phase|Received Pancreas Transplant|8|||
160523222|NCT00307125|579644771|FG001|Screening Phase|Received Pancreas Transplant|0|||
160523223|NCT00307125|579644772|FG002|Screening Phase|Received Pancreas Transplant|0|||
160523224|NCT00307125|579644770|FG000|Screening Phase|Ineligible for pilot|4|||
160523225|NCT00307125|579644771|FG001|Screening Phase|Ineligible for pilot|0|||
160523226|NCT00307125|579644772|FG002|Screening Phase|Ineligible for pilot|0|||
160523227|NCT00307125|579644770|FG000|Screening Phase|Try to get pregnant|1|||
160523228|NCT00307125|579644771|FG001|Screening Phase|Try to get pregnant|0|||
160523229|NCT00307125|579644772|FG002|Screening Phase|Try to get pregnant|0|||
160523230|NCT00307125|579644770|FG000|Screening Phase|Developed acute leukemia|1|||
160523231|NCT00307125|579644771|FG001|Screening Phase|Developed acute leukemia|0|||
160523232|NCT00307125|579644772|FG002|Screening Phase|Developed acute leukemia|0|||
160523233|NCT00307125|579644770|FG000|Screening Phase|Metastatic colon cancer|1|||
160523234|NCT00307125|579644771|FG001|Screening Phase|Metastatic colon cancer|0|||
160523235|NCT00307125|579644772|FG002|Screening Phase|Metastatic colon cancer|0|||
160523236|NCT00307125|579644770|FG000|Screening Phase|Malignancy|1|||
160523237|NCT00307125|579644771|FG001|Screening Phase|Malignancy|0|||
160523238|NCT00307125|579644772|FG002|Screening Phase|Malignancy|0|||
160523239|NCT00307125|579644770|FG000|Screening Phase|PAK|1|||
160523240|NCT00307125|579644771|FG001|Screening Phase|PAK|0|||
160523241|NCT00307125|579644772|FG002|Screening Phase|PAK|0|||
160523242|NCT00307125|579644770|FG000|Screening Phase|Ineligible|1|||
160523243|NCT00307125|579644771|FG001|Screening Phase|Ineligible|0|||
160523244|NCT00307125|579644772|FG002|Screening Phase|Ineligible|0|||
160523245|NCT00307125|579644770|FG000|Screening Phase|Screen Error|1|||
160523246|NCT00307125|579644771|FG001|Screening Phase|Screen Error|0|||
160523247|NCT00307125|579644772|FG002|Screening Phase|Screen Error|0|||
160523248|NCT00307125|579644770|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
160523249|NCT00307125|579644771|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
160523250|NCT00307125|579644772|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
160523251|NCT00307125|579644770|FG000|Screening Phase|AMR and treated with rituximab|1|||
160523252|NCT00307125|579644771|FG001|Screening Phase|AMR and treated with rituximab|0|||
160523253|NCT00307125|579644772|FG002|Screening Phase|AMR and treated with rituximab|0|||
160523254|NCT00307125|579644770|FG000|Screening Phase|Coronary artery bypass|1|||
160523255|NCT00307125|579644771|FG001|Screening Phase|Coronary artery bypass|0|||
160523256|NCT00307125|579644772|FG002|Screening Phase|Coronary artery bypass|0|||
160523257|NCT00307125|579644770|FG000|Pilot Phase|Lost to Follow-up|0|||
160523258|NCT00307125|579644771|FG001|Pilot Phase|Lost to Follow-up|1|||
160523259|NCT00307125|579644772|FG002|Pilot Phase|Lost to Follow-up|0|||
160523260|NCT00307125|579644770|FG000|Pilot Phase|Withdrawal by Subject|0|||
160523261|NCT00307125|579644771|FG001|Pilot Phase|Withdrawal by Subject|1|||
160523262|NCT00307125|579644772|FG002|Pilot Phase|Withdrawal by Subject|1|||
160523263|NCT02571049|579644773|FG000|Screening|Did not meet entry criteria|2|||
160523264|NCT02571049|579644774|FG001|Screening|Did not meet entry criteria|2|||
160523265|NCT02571049|579644773|FG000|Randomization|No migraine attack|0|||
160523266|NCT02571049|579644774|FG001|Randomization|No migraine attack|1|||
160523267|NCT02571049|579644773|FG000|Randomization|Adverse Event|0|||
160523268|NCT02571049|579644774|FG001|Randomization|Adverse Event|1|||
160523269|NCT01055262|579644777|FG000|Overall Study|Adverse Event|5|||
160523270|NCT01055262|579644777|FG000|Overall Study|Protocol Violation|3|||
160523271|NCT01055262|579644777|FG000|Overall Study|Uncooperativeness|1|||
160523272|NCT03370471|579644779|FG000|Overall Study|Withdrawal by Subject|6|||
160523273|NCT03370471|579644780|FG001|Overall Study|Withdrawal by Subject|1|||
160523274|NCT03370471|579644779|FG000|Overall Study|Unable to access veins for blood draw|0|||
160523275|NCT03370471|579644780|FG001|Overall Study|Unable to access veins for blood draw|1|||
160523276|NCT03370471|579644779|FG000|Overall Study|Screen fail|1|||
160523277|NCT03370471|579644780|FG001|Overall Study|Screen fail|0|||
160523278|NCT00561951|579644782|FG000|Overall Study|Adverse Event|11|||
160523279|NCT00561951|579644783|FG001|Overall Study|Adverse Event|14|||
160523280|NCT00561951|579644784|FG002|Overall Study|Adverse Event|14|||
160523281|NCT00561951|579644782|FG000|Overall Study|Lack of Efficacy|5|||
160523282|NCT00561951|579644783|FG001|Overall Study|Lack of Efficacy|3|||
160523283|NCT00561951|579644784|FG002|Overall Study|Lack of Efficacy|2|||
160523284|NCT00561951|579644782|FG000|Overall Study|Lost to Follow-up|1|||
160523285|NCT00561951|579644783|FG001|Overall Study|Lost to Follow-up|1|||
160523286|NCT00561951|579644784|FG002|Overall Study|Lost to Follow-up|0|||
160523287|NCT00561951|579644782|FG000|Overall Study|Withdrawal by Subject|10|||
160523288|NCT00561951|579644783|FG001|Overall Study|Withdrawal by Subject|9|||
160523289|NCT00561951|579644784|FG002|Overall Study|Withdrawal by Subject|10|||
160523290|NCT00561951|579644782|FG000|Overall Study|Protocol Violation|4|||
160523291|NCT00561951|579644783|FG001|Overall Study|Protocol Violation|3|||
160523292|NCT00561951|579644784|FG002|Overall Study|Protocol Violation|4|||
160523293|NCT00561951|579644782|FG000|Overall Study|Physician Decision|1|||
160523294|NCT00561951|579644783|FG001|Overall Study|Physician Decision|0|||
160523295|NCT00561951|579644784|FG002|Overall Study|Physician Decision|0|||
160523296|NCT00561951|579644782|FG000|Overall Study|Pregnancy|0|||
160523297|NCT00561951|579644783|FG001|Overall Study|Pregnancy|1|||
160523298|NCT00561951|579644784|FG002|Overall Study|Pregnancy|0|||
160523299|NCT00561951|579644782|FG000|Overall Study|Meet Withdrawal Criterion|0|||
160523300|NCT00561951|579644783|FG001|Overall Study|Meet Withdrawal Criterion|1|||
160523301|NCT00561951|579644784|FG002|Overall Study|Meet Withdrawal Criterion|1|||
160523302|NCT00561951|579644782|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
160523303|NCT00561951|579644783|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
160523304|NCT00561951|579644784|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
160523305|NCT01765179|579644785|FG000|Overall Study|Adverse Event|3|||
160523306|NCT01765179|579644785|FG000|Overall Study|Lost to Follow-up|5|||
160523307|NCT01765179|579644785|FG000|Overall Study|Non-compliance with study drug|2|||
160523308|NCT01765179|579644785|FG000|Overall Study|Protocol Violation|1|||
160523309|NCT01765179|579644785|FG000|Overall Study|Withdrawal by Subject|8|||
160523310|NCT01765179|579644785|FG000|Overall Study|Hematocrit >54%|3|||
160523311|NCT01765179|579644785|FG000|Overall Study|prohibited med|1|||
160523312|NCT01765179|579644785|FG000|Overall Study|Out of country unable to finish study|1|||
160523313|NCT01765179|579644785|FG000|Overall Study|lack of venous access|1|||
160523314|NCT01765179|579644785|FG000|Overall Study|work conflict|1|||
160523315|NCT01765179|579644785|FG000|Overall Study|Ca elevated 10.6|1|||
160523316|NCT02640157|579644786|FG000|Overall Study|Adverse Event|2|||
160523317|NCT02640157|579644787|FG001|Overall Study|Adverse Event|2|||
160523318|NCT02640157|579644788|FG002|Overall Study|Adverse Event|1|||
160523319|NCT02640157|579644786|FG000|Overall Study|Withdrew consent|2|||
160523320|NCT02640157|579644787|FG001|Overall Study|Withdrew consent|0|||
160523321|NCT02640157|579644788|FG002|Overall Study|Withdrew consent|2|||
160523322|NCT02640157|579644786|FG000|Overall Study|Lost to Follow-up|9|||
160523323|NCT02640157|579644787|FG001|Overall Study|Lost to Follow-up|2|||
160523324|NCT02640157|579644788|FG002|Overall Study|Lost to Follow-up|7|||
160523325|NCT02640157|579644786|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
160523326|NCT02640157|579644787|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
160523327|NCT02640157|579644788|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
160523328|NCT01596621|579644789|FG000|Overall Study|Death|4|||
160523329|NCT01596621|579644789|FG000|Overall Study|Withdrawal by Subject|9|||
160523330|NCT01596621|579644789|FG000|Overall Study|Disease Progression|49|||
160523331|NCT01596621|579644789|FG000|Overall Study|Lost to Follow-up|3|||
160523332|NCT01596621|579644789|FG000|Overall Study|Other than specified|13|||
160523333|NCT00710021|579644790|FG000|Overall Study|Lost to Follow-up|1|||
160523334|NCT00710021|579644791|FG001|Overall Study|Lost to Follow-up|0|||
160523335|NCT00710021|579644792|FG002|Overall Study|Lost to Follow-up|0|||
160523336|NCT00710021|579644790|FG000|Overall Study|Subject's Decision|0|||
160523337|NCT00710021|579644791|FG001|Overall Study|Subject's Decision|1|||
160523338|NCT00710021|579644792|FG002|Overall Study|Subject's Decision|0|||
160523339|NCT00710021|579644790|FG000|Overall Study|Subject misrandomized|0|||
160523340|NCT00710021|579644791|FG001|Overall Study|Subject misrandomized|1|||
160523341|NCT00710021|579644792|FG002|Overall Study|Subject misrandomized|1|||
160523342|NCT00710021|579644790|FG000|Overall Study|Physician Decision|0|||
160523343|NCT00710021|579644791|FG001|Overall Study|Physician Decision|1|||
160523344|NCT00710021|579644792|FG002|Overall Study|Physician Decision|0|||
160523345|NCT01898923|579644795|FG000|Overall Study|Lack of Efficacy|5|||
160523346|NCT01898923|579644796|FG001|Overall Study|Lack of Efficacy|6|||
160523347|NCT01898923|579644795|FG000|Overall Study|Adverse Event|3|||
160523348|NCT01898923|579644796|FG001|Overall Study|Adverse Event|1|||
160523349|NCT01898923|579644795|FG000|Overall Study|Lost to Follow-up|0|||
160523350|NCT01898923|579644796|FG001|Overall Study|Lost to Follow-up|1|||
160523351|NCT01898923|579644795|FG000|Overall Study|Withdrawal by Subject|4|||
160523352|NCT01898923|579644796|FG001|Overall Study|Withdrawal by Subject|7|||
160523353|NCT01898923|579644795|FG000|Overall Study|Physician Decision|3|||
160523354|NCT01898923|579644796|FG001|Overall Study|Physician Decision|4|||
160523355|NCT01898923|579644795|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
160523356|NCT01898923|579644796|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
160523357|NCT00723021|579644797|FG000|Intervention Period 4|Adverse Event|0|||
160523358|NCT00723021|579644798|FG001|Intervention Period 4|Adverse Event|0|||
160523359|NCT00723021|579644799|FG002|Intervention Period 4|Adverse Event|0|||
160523360|NCT00723021|579644800|FG003|Intervention Period 4|Adverse Event|0|||
160523361|NCT00723021|579644801|FG004|Intervention Period 4|Adverse Event|1|||
160523362|NCT03573401|579644805|FG000|Overall Study|Withdrawal by Subject|2|||
160523363|NCT03573401|579644806|FG001|Overall Study|Withdrawal by Subject|0|||
160523364|NCT03573401|579644805|FG000|Overall Study|Subject non-compliance with study schedule|1|||
160523365|NCT03573401|579644806|FG001|Overall Study|Subject non-compliance with study schedule|0|||
160523366|NCT03573401|579644805|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
160523367|NCT03573401|579644806|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
160523368|NCT03573401|579644805|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
160523369|NCT03573401|579644806|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
160523370|NCT03769181|579646005|FG000|Overall Study|Adverse Event|1|||
160523371|NCT03769181|579646006|FG001|Overall Study|Adverse Event|0|||
160523372|NCT03769181|579646007|FG002|Overall Study|Adverse Event|2|||
160523373|NCT03769181|579646008|FG003|Overall Study|Adverse Event|4|||
160523374|NCT03769181|579646005|FG000|Overall Study|Withdrawal by Subject|1|||
160523375|NCT03769181|579646006|FG001|Overall Study|Withdrawal by Subject|0|||
160523376|NCT03769181|579646007|FG002|Overall Study|Withdrawal by Subject|2|||
160523377|NCT03769181|579646008|FG003|Overall Study|Withdrawal by Subject|1|||
160523378|NCT03769181|579646005|FG000|Overall Study|Progressive disease|9|||
160523379|NCT03769181|579646006|FG001|Overall Study|Progressive disease|7|||
160523380|NCT03769181|579646007|FG002|Overall Study|Progressive disease|13|||
160523381|NCT03769181|579646008|FG003|Overall Study|Progressive disease|6|||
160523382|NCT03769181|579646005|FG000|Overall Study|Other - Unspecified|2|||
160523383|NCT03769181|579646006|FG001|Overall Study|Other - Unspecified|1|||
160523384|NCT03769181|579646007|FG002|Overall Study|Other - Unspecified|0|||
160523385|NCT03769181|579646008|FG003|Overall Study|Other - Unspecified|0|||
160523386|NCT03338192|579646009|FG000|Year One to Year Two|High Blood Pressure|7|||
160523387|NCT03338192|579646010|FG001|Year One to Year Two|High Blood Pressure|1|||
160523388|NCT03338192|579646009|FG000|Year One to Year Two|HIV +|1|||
160523389|NCT03338192|579646010|FG001|Year One to Year Two|HIV +|0|||
160523390|NCT03338192|579646009|FG000|Year Two to Year Four|High Blood Pressure|1|||
160523391|NCT03338192|579646010|FG001|Year Two to Year Four|High Blood Pressure|0|||
160523392|NCT03338192|579646009|FG000|Year Two to Year Four|HIV +|2|||
160523393|NCT03338192|579646010|FG001|Year Two to Year Four|HIV +|0|||
160523394|NCT03338192|579646009|FG000|Year Four to Year Six|High Blood Pressure|2|||
160523395|NCT03338192|579646010|FG001|Year Four to Year Six|High Blood Pressure|1|||
160523396|NCT01376349|579646014|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
160523397|NCT01376349|579646015|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
160523398|NCT01376349|579646016|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
160523399|NCT01376349|579646014|FG000|Raondomized Treatment|Adverse Event|13|||
160523400|NCT01376349|579646015|FG001|Raondomized Treatment|Adverse Event|17|||
160523401|NCT01376349|579646016|FG002|Raondomized Treatment|Adverse Event|14|||
160523402|NCT01376349|579646014|FG000|Raondomized Treatment|Unkown|1|||
160523403|NCT01376349|579646015|FG001|Raondomized Treatment|Unkown|2|||
160523404|NCT01376349|579646016|FG002|Raondomized Treatment|Unkown|1|||
160523405|NCT01376349|579646014|FG000|Raondomized Treatment|Alternative Treatment|0|||
160523406|NCT01376349|579646015|FG001|Raondomized Treatment|Alternative Treatment|0|||
160523407|NCT01376349|579646016|FG002|Raondomized Treatment|Alternative Treatment|1|||
160523408|NCT00718640|579646017|FG000|Overall Study|Adverse Event|4|||
160523409|NCT00718640|579646017|FG000|Overall Study|Death|1|||
160523410|NCT00718640|579646017|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
160523411|NCT05193500|579646018|FG000|Overall Study|Withdrawal by Subject|7|||
160523412|NCT05193500|579646019|FG001|Overall Study|Withdrawal by Subject|4|||
160523413|NCT05193500|579646020|FG002|Overall Study|Withdrawal by Subject|3|||
160523414|NCT05193500|579646021|FG003|Overall Study|Withdrawal by Subject|5|||
160523415|NCT01978262|579646022|FG000|Overall Study|Withdrawal by Subject|9|||
160523416|NCT01978262|579646022|FG000|Overall Study|Lost to Follow-up|2|||
160523417|NCT02202551|579646023|FG000|Overall Study|Adverse Event|8|||
160523418|NCT02202551|579646024|FG001|Overall Study|Adverse Event|19|||
160523419|NCT02202551|579646025|FG002|Overall Study|Adverse Event|5|||
160523420|NCT02202551|579646026|FG003|Overall Study|Adverse Event|9|||
160749835|NCT03026283|580469686|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
160749836|NCT03026283|580469687|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
160523421|NCT02202551|579646023|FG000|Overall Study|Death|3|||
160523422|NCT02202551|579646024|FG001|Overall Study|Death|2|||
160523423|NCT02202551|579646025|FG002|Overall Study|Death|1|||
160523424|NCT02202551|579646026|FG003|Overall Study|Death|1|||
160523425|NCT02202551|579646023|FG000|Overall Study|Lost to Follow-up|0|||
160523426|NCT02202551|579646024|FG001|Overall Study|Lost to Follow-up|1|||
160523427|NCT02202551|579646025|FG002|Overall Study|Lost to Follow-up|0|||
160523428|NCT02202551|579646026|FG003|Overall Study|Lost to Follow-up|1|||
160523429|NCT02202551|579646023|FG000|Overall Study|Needed to take excluded medication|0|||
160523430|NCT02202551|579646024|FG001|Overall Study|Needed to take excluded medication|2|||
160523431|NCT02202551|579646025|FG002|Overall Study|Needed to take excluded medication|0|||
160523432|NCT02202551|579646026|FG003|Overall Study|Needed to take excluded medication|1|||
160523433|NCT02202551|579646023|FG000|Overall Study|Subject moved away|0|||
160523434|NCT02202551|579646024|FG001|Overall Study|Subject moved away|1|||
160523435|NCT02202551|579646025|FG002|Overall Study|Subject moved away|0|||
160523436|NCT02202551|579646026|FG003|Overall Study|Subject moved away|0|||
160523437|NCT02202551|579646023|FG000|Overall Study|DBS surgery|3|||
160523438|NCT02202551|579646024|FG001|Overall Study|DBS surgery|0|||
160523439|NCT02202551|579646025|FG002|Overall Study|DBS surgery|0|||
160523440|NCT02202551|579646026|FG003|Overall Study|DBS surgery|0|||
160523441|NCT02202551|579646023|FG000|Overall Study|Dyskinesia upon taper|1|||
160523442|NCT02202551|579646024|FG001|Overall Study|Dyskinesia upon taper|0|||
160523443|NCT02202551|579646025|FG002|Overall Study|Dyskinesia upon taper|0|||
160523444|NCT02202551|579646026|FG003|Overall Study|Dyskinesia upon taper|0|||
160523445|NCT02202551|579646023|FG000|Overall Study|Lack of Efficacy|0|||
160523446|NCT02202551|579646024|FG001|Overall Study|Lack of Efficacy|1|||
160523447|NCT02202551|579646025|FG002|Overall Study|Lack of Efficacy|0|||
160523448|NCT02202551|579646026|FG003|Overall Study|Lack of Efficacy|0|||
160523449|NCT02202551|579646023|FG000|Overall Study|Physician Decision|1|||
160523450|NCT02202551|579646024|FG001|Overall Study|Physician Decision|0|||
160523451|NCT02202551|579646025|FG002|Overall Study|Physician Decision|0|||
160523452|NCT02202551|579646026|FG003|Overall Study|Physician Decision|0|||
160523453|NCT02202551|579646023|FG000|Overall Study|Site closure|3|||
160523454|NCT02202551|579646024|FG001|Overall Study|Site closure|0|||
160523455|NCT02202551|579646025|FG002|Overall Study|Site closure|0|||
160523456|NCT02202551|579646026|FG003|Overall Study|Site closure|1|||
160523457|NCT02202551|579646023|FG000|Overall Study|Unable to complete visits per protocol|1|||
160523458|NCT02202551|579646024|FG001|Overall Study|Unable to complete visits per protocol|0|||
160523459|NCT02202551|579646025|FG002|Overall Study|Unable to complete visits per protocol|0|||
160523460|NCT02202551|579646026|FG003|Overall Study|Unable to complete visits per protocol|0|||
160523461|NCT02202551|579646023|FG000|Overall Study|Worsening Dyskinesia|0|||
160523462|NCT02202551|579646024|FG001|Overall Study|Worsening Dyskinesia|0|||
160523463|NCT02202551|579646025|FG002|Overall Study|Worsening Dyskinesia|0|||
160523464|NCT02202551|579646026|FG003|Overall Study|Worsening Dyskinesia|1|||
160523465|NCT02202551|579646023|FG000|Overall Study|Protocol Violation|0|||
160523466|NCT02202551|579646024|FG001|Overall Study|Protocol Violation|1|||
160523467|NCT02202551|579646025|FG002|Overall Study|Protocol Violation|0|||
160523468|NCT02202551|579646026|FG003|Overall Study|Protocol Violation|0|||
160523469|NCT02202551|579646023|FG000|Overall Study|Sponsor's decision|2|||
160523470|NCT02202551|579646024|FG001|Overall Study|Sponsor's decision|0|||
160523471|NCT02202551|579646025|FG002|Overall Study|Sponsor's decision|0|||
160523472|NCT02202551|579646026|FG003|Overall Study|Sponsor's decision|0|||
160523473|NCT02202551|579646023|FG000|Overall Study|Subject unwilling to proceed|1|||
160523474|NCT02202551|579646024|FG001|Overall Study|Subject unwilling to proceed|5|||
160523475|NCT02202551|579646025|FG002|Overall Study|Subject unwilling to proceed|3|||
160523476|NCT02202551|579646026|FG003|Overall Study|Subject unwilling to proceed|5|||
160523477|NCT02202551|579646023|FG000|Overall Study|Subject consent withdrawn|0|||
160523478|NCT02202551|579646024|FG001|Overall Study|Subject consent withdrawn|3|||
160523479|NCT02202551|579646025|FG002|Overall Study|Subject consent withdrawn|1|||
160523480|NCT02202551|579646026|FG003|Overall Study|Subject consent withdrawn|2|||
160523481|NCT02202551|579646023|FG000|Overall Study|eGFR<50mL/min/m2|2|||
160523482|NCT02202551|579646024|FG001|Overall Study|eGFR<50mL/min/m2|2|||
160523483|NCT02202551|579646025|FG002|Overall Study|eGFR<50mL/min/m2|0|||
160523484|NCT02202551|579646026|FG003|Overall Study|eGFR<50mL/min/m2|1|||
160523485|NCT00343252|579646040|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
160523486|NCT00343252|579646041|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
160523487|NCT00343252|579646040|FG000|6 Months (All Treated Participants)|Death|0|||
160523488|NCT00343252|579646041|FG001|6 Months (All Treated Participants)|Death|2|||
160523489|NCT00343252|579646040|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
160523490|NCT00343252|579646041|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
160523491|NCT00343252|579646040|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
160523492|NCT00343252|579646041|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
160523493|NCT00343252|579646040|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
160523494|NCT00343252|579646041|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
160523495|NCT00343252|579646040|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
160749837|NCT03026283|580469680|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
160523496|NCT00343252|579646041|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
160523497|NCT00343252|579646040|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
160523498|NCT00343252|579646041|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
160523499|NCT00343252|579646040|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
160749838|NCT03026283|580469681|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
160523500|NCT00343252|579646041|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
160523501|NCT00343252|579646040|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
160523502|NCT00343252|579646041|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
160523503|NCT00343252|579646040|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
160523504|NCT00343252|579646041|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
160523505|NCT00343252|579646040|FG000|12 Months (All Treated Participants)|Death|3|||
160523506|NCT00343252|579646041|FG001|12 Months (All Treated Participants)|Death|3|||
160523507|NCT00343252|579646040|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
160523508|NCT00343252|579646041|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
160523509|NCT00343252|579646040|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
160523510|NCT00343252|579646041|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
160523511|NCT00343252|579646040|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
160523512|NCT00343252|579646041|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
160523513|NCT00343252|579646040|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
160523514|NCT00343252|579646041|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
160523515|NCT00343252|579646040|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
160523516|NCT00343252|579646041|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
160523517|NCT00343252|579646040|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
160523518|NCT00343252|579646041|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
160523519|NCT00343252|579646040|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
160523520|NCT00343252|579646041|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
160523521|NCT00343252|579646040|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
160523522|NCT00343252|579646041|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
160523523|NCT00343252|579646040|FG000|18 Months (All Treated Participants)|Death|4|||
160523524|NCT00343252|579646041|FG001|18 Months (All Treated Participants)|Death|5|||
160523525|NCT00343252|579646040|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
160523526|NCT00343252|579646041|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
160523527|NCT00343252|579646040|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
160523528|NCT00343252|579646041|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
160523529|NCT00343252|579646040|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
160523530|NCT00343252|579646041|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
160523531|NCT00343252|579646040|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
160523532|NCT00343252|579646041|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
160523533|NCT00343252|579646040|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
160523534|NCT00343252|579646041|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
160523535|NCT00343252|579646040|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
160523536|NCT00343252|579646041|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
160523537|NCT00343252|579646040|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
160523538|NCT00343252|579646041|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
160523539|NCT02076178|579646042|FG000|Oral Phase|Adverse Event|0|||
160523540|NCT02076178|579646043|FG001|Oral Phase|Adverse Event|7|||
160523541|NCT02076178|579646042|FG000|Oral Phase|Withdrawal by Subject|0|||
160523542|NCT02076178|579646043|FG001|Oral Phase|Withdrawal by Subject|4|||
160523543|NCT02076178|579646042|FG000|Oral Phase|Physician Decision|0|||
160523544|NCT02076178|579646043|FG001|Oral Phase|Physician Decision|1|||
160523545|NCT02076178|579646042|FG000|Injection Phase|Protocol defined stopping criteria|1|||
160523546|NCT02076178|579646043|FG001|Injection Phase|Protocol defined stopping criteria|0|||
160523547|NCT02076178|579646042|FG000|Injection Phase|Withdrawal by Subject|0|||
160523548|NCT02076178|579646043|FG001|Injection Phase|Withdrawal by Subject|3|||
160523549|NCT02076178|579646042|FG000|Injection Phase|Physician Decision|0|||
160523550|NCT02076178|579646043|FG001|Injection Phase|Physician Decision|3|||
160523551|NCT02076178|579646042|FG000|Injection Phase|Lost to Follow-up|0|||
160523552|NCT02076178|579646043|FG001|Injection Phase|Lost to Follow-up|1|||
160523553|NCT01026454|579646044|FG000|Second Intervention|Pregnancy|1|||
160523554|NCT01026454|579646045|FG001|Second Intervention|Pregnancy|1|||
160523555|NCT02893930|579646046|FG000|Overall Study|Adverse Event|3|||
160523556|NCT02893930|579646046|FG000|Overall Study|Death|1|||
160523557|NCT02893930|579646046|FG000|Overall Study|Disease progression|5|||
160523558|NCT02893930|579646046|FG000|Overall Study|Withdrawal by Subject|2|||
160523559|NCT02893930|579646046|FG000|Overall Study|Physician Decision|1|||
160523560|NCT02893930|579646046|FG000|Overall Study|Ineligible|1|||
160523561|NCT01971203|579646055|FG000|Overall Study|Protocol Violation|3|||
160523562|NCT01971203|579646056|FG001|Overall Study|Protocol Violation|2|||
160523563|NCT01971203|579646055|FG000|Overall Study|Withdrawal by Subject|5|||
160523564|NCT01971203|579646056|FG001|Overall Study|Withdrawal by Subject|6|||
160523565|NCT01971203|579646055|FG000|Overall Study|Adverse Event|1|||
160523566|NCT01971203|579646056|FG001|Overall Study|Adverse Event|0|||
160523567|NCT03037619|579646057|FG000|Overall Study|Lost to Follow-up|0|||
160523568|NCT03037619|579646058|FG001|Overall Study|Lost to Follow-up|1|||
160523569|NCT01294683|579646061|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
160523570|NCT01294683|579646062|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
160523571|NCT01294683|579646061|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
160865657|NCT01055197|580902943|FG001|Overall Study|Withdrawal by Subject|0|||
160523572|NCT01294683|579646062|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
160523573|NCT01294683|579646061|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
160523574|NCT01294683|579646062|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
160523575|NCT01294683|579646061|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
160523576|NCT01294683|579646062|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
160523577|NCT01294683|579646061|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
160523578|NCT01294683|579646062|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
160523579|NCT01294683|579646061|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
160523580|NCT01294683|579646062|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
160523581|NCT01294683|579646061|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
160523582|NCT01294683|579646062|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
160523583|NCT01294683|579646061|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
160523584|NCT01294683|579646062|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
160523585|NCT01294683|579646061|FG000|Post Crossover (Period III)|Adverse Event|6|||
160523586|NCT01294683|579646062|FG001|Post Crossover (Period III)|Adverse Event|6|||
160523587|NCT01294683|579646061|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
160523588|NCT01294683|579646062|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
160523589|NCT01294683|579646061|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
160523590|NCT01294683|579646062|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
160523591|NCT01294683|579646061|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
160523592|NCT01294683|579646062|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
160523593|NCT01794923|579646063|FG000|Overall Study|Adverse Event|0|||
160523594|NCT01794923|579646064|FG001|Overall Study|Adverse Event|0|||
160523595|NCT01794923|579646065|FG002|Overall Study|Adverse Event|1|||
160523596|NCT01881750|579646066|FG000|Overall Study|Changes in concomitant therapies|2|||
160523597|NCT01881750|579646067|FG001|Overall Study|Changes in concomitant therapies|3|||
160523598|NCT01881750|579646066|FG000|Overall Study|Lost to Follow-up|0|||
160523599|NCT01881750|579646067|FG001|Overall Study|Lost to Follow-up|1|||
160523600|NCT00051363|579646068|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
160523601|NCT00051363|579646069|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
160523602|NCT00051363|579646068|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
160523603|NCT00051363|579646069|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
160523604|NCT00051363|579646068|FG000|Overall Study|Death|2|||
160523605|NCT00051363|579646069|FG001|Overall Study|Death|2|||
160523606|NCT00051363|579646068|FG000|Overall Study|Excluded Pre-Randomization|2|||
160523607|NCT00051363|579646069|FG001|Overall Study|Excluded Pre-Randomization|5|||
160523608|NCT00421707|579646072|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
160523609|NCT00421707|579646073|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
160523610|NCT00421707|579646072|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
160523611|NCT00421707|579646073|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
160523612|NCT00421707|579646072|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
160523613|NCT00421707|579646073|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
160523614|NCT00421707|579646072|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
160523615|NCT00421707|579646073|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
160523616|NCT00421707|579646072|FG000|Period 2: Washout|Adverse Event|1|||
160523617|NCT00421707|579646073|FG001|Period 2: Washout|Adverse Event|1|||
160523618|NCT00421707|579646072|FG000|Period 2: Washout|Withdrawal by Subject|0|||
160523619|NCT00421707|579646073|FG001|Period 2: Washout|Withdrawal by Subject|1|||
160523620|NCT00421707|579646072|FG000|Period 2: Washout|Lost to Follow-up|0|||
160749839|NCT03026283|580469682|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
160523621|NCT00421707|579646073|FG001|Period 2: Washout|Lost to Follow-up|1|||
160523622|NCT00421707|579646072|FG000|Period 2: Washout|Other: Pregnancy|0|||
160523623|NCT00421707|579646073|FG001|Period 2: Washout|Other: Pregnancy|1|||
160523624|NCT00421707|579646072|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
160523625|NCT00421707|579646073|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
160523626|NCT00421707|579646072|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
160523627|NCT00421707|579646073|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
160523628|NCT00421707|579646072|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
160523629|NCT00421707|579646073|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
160523630|NCT00026208|579646076|FG000|Overall Study|Complications of auto accident|1|||
160523631|NCT00026208|579646077|FG001|Overall Study|Complications of auto accident|0|||
160523632|NCT03282240|579646078|FG000|Overall Study|Adverse Event|2|||
160523633|NCT03282240|579646079|FG001|Overall Study|Adverse Event|2|||
160523634|NCT03282240|579646080|FG002|Overall Study|Adverse Event|0|||
160523635|NCT03282240|579646078|FG000|Overall Study|Lost to Follow-up|3|||
160523636|NCT03282240|579646079|FG001|Overall Study|Lost to Follow-up|0|||
160523637|NCT03282240|579646080|FG002|Overall Study|Lost to Follow-up|0|||
160523638|NCT03282240|579646078|FG000|Overall Study|Protocol Deviation|4|||
160523639|NCT03282240|579646079|FG001|Overall Study|Protocol Deviation|1|||
160523640|NCT03282240|579646080|FG002|Overall Study|Protocol Deviation|2|||
160523641|NCT03282240|579646078|FG000|Overall Study|Withdrawal by Subject|1|||
160523642|NCT03282240|579646079|FG001|Overall Study|Withdrawal by Subject|0|||
160523643|NCT03282240|579646080|FG002|Overall Study|Withdrawal by Subject|1|||
160523644|NCT01675479|579646081|FG000|Overall Study|Lost to Follow-up|11|||
160523645|NCT02910739|579646082|FG000|Overall Study|Adverse Event|1|||
160523646|NCT02910739|579646083|FG001|Overall Study|Adverse Event|0|||
160523647|NCT02910739|579646084|FG002|Overall Study|Adverse Event|0|||
160523648|NCT02910739|579646085|FG003|Overall Study|Adverse Event|0|||
160523649|NCT01572922|579646088|FG000|Overall Study|Adverse Event|1|||
160523650|NCT01572922|579646088|FG000|Overall Study|Protocol Violation|1|||
160523651|NCT01572922|579646088|FG000|Overall Study|Death|1|||
160523652|NCT02903368|579646090|FG000|Part 1|Adverse Event|3|||
160523653|NCT02903368|579646091|FG001|Part 1|Adverse Event|0|||
160523654|NCT02903368|579646092|FG002|Part 1|Adverse Event|0|||
160523655|NCT02903368|579646093|FG003|Part 1|Adverse Event|0|||
160523656|NCT02903368|579646090|FG000|Part 1|Withdrawal by Subject|1|||
160523657|NCT02903368|579646091|FG001|Part 1|Withdrawal by Subject|0|||
160523658|NCT02903368|579646092|FG002|Part 1|Withdrawal by Subject|0|||
160523659|NCT02903368|579646093|FG003|Part 1|Withdrawal by Subject|0|||
160523660|NCT02903368|579646090|FG000|Part 2|Adverse Event|0|||
160523661|NCT02903368|579646091|FG001|Part 2|Adverse Event|0|||
160523662|NCT02903368|579646092|FG002|Part 2|Adverse Event|5|||
160523663|NCT02903368|579646093|FG003|Part 2|Adverse Event|0|||
160523664|NCT02903368|579646090|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
160523665|NCT02903368|579646091|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
160523666|NCT02903368|579646092|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
160523667|NCT02903368|579646093|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
160523668|NCT02903368|579646090|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
160523669|NCT02903368|579646091|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
160523670|NCT02903368|579646092|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
160523671|NCT02903368|579646093|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
160523672|NCT02903368|579646090|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
160523673|NCT02903368|579646091|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
160523674|NCT02903368|579646092|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
160523675|NCT02903368|579646093|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
160523676|NCT00147823|579646096|FG000|Overall Study|Lost to Follow-up|6|||
160523677|NCT00147823|579646097|FG001|Overall Study|Lost to Follow-up|12|||
160523678|NCT00147823|579646096|FG000|Overall Study|Physician Decision|1|||
160523679|NCT00147823|579646097|FG001|Overall Study|Physician Decision|0|||
160523680|NCT00147823|579646096|FG000|Overall Study|Withdrawal by Subject|0|||
160523681|NCT00147823|579646097|FG001|Overall Study|Withdrawal by Subject|1|||
160523682|NCT00147823|579646096|FG000|Overall Study|Did not receive vitoss due to infection|6|||
160523683|NCT00147823|579646097|FG001|Overall Study|Did not receive vitoss due to infection|2|||
160523684|NCT04751656|579647938|FG000|Overall Study|Lost to Follow-up|1|||
160523685|NCT01485354|579647944|FG000|Overall Study|Withdrawal by Subject|5|||
160523686|NCT03566810|579647945|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
160523687|NCT03566810|579647946|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
160523688|NCT03566810|579647947|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
160523689|NCT03566810|579647948|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
160523690|NCT01444651|579647951|FG000|Overall Study|Adverse Event|3|||
160523691|NCT01444651|579647952|FG001|Overall Study|Adverse Event|2|||
160523692|NCT01444651|579647951|FG000|Overall Study|Lost to Follow-up|5|||
160523693|NCT01444651|579647952|FG001|Overall Study|Lost to Follow-up|5|||
160523694|NCT01444651|579647951|FG000|Overall Study|Non-fasting|2|||
160523695|NCT01444651|579647952|FG001|Overall Study|Non-fasting|1|||
160523696|NCT01444651|579647951|FG000|Overall Study|Missing data|1|||
160523697|NCT01444651|579647952|FG001|Overall Study|Missing data|1|||
160523698|NCT01929980|579647955|FG000|Overall Study|Physician Decision|1|||
160523699|NCT03236246|579647956|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
160523700|NCT03236246|579647957|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
160523701|NCT03236246|579647956|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
160523702|NCT03236246|579647957|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
160523703|NCT03236246|579647956|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
160523704|NCT03236246|579647957|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
160523705|NCT03236246|579647956|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
160523706|NCT03236246|579647957|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
160523707|NCT03236246|579647956|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
160523708|NCT03236246|579647957|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
160523709|NCT03236246|579647956|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
160523710|NCT03236246|579647957|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
160523711|NCT03236246|579647956|FG000|24-Week Dose Titration Period|Death|3|||
160523712|NCT03236246|579647957|FG001|24-Week Dose Titration Period|Death|1|||
160523713|NCT03236246|579647956|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
160523714|NCT03236246|579647957|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
160523715|NCT03236246|579647956|FG000|24-Week Dose Titration Period|Adverse Event|7|||
160523716|NCT03236246|579647957|FG001|24-Week Dose Titration Period|Adverse Event|8|||
160523717|NCT03236246|579647956|FG000|24-Week Dose Titration Period|Captured as Other|1|||
160523718|NCT03236246|579647957|FG001|24-Week Dose Titration Period|Captured as Other|2|||
160523719|NCT03236246|579647956|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
160523720|NCT03236246|579647957|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
160523721|NCT03236246|579647956|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
160523722|NCT03236246|579647957|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
160523723|NCT03236246|579647956|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
160523724|NCT03236246|579647957|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
160523725|NCT03236246|579647956|FG000|24-Week Dose Maintenance Period|Death|0|||
160523726|NCT03236246|579647957|FG001|24-Week Dose Maintenance Period|Death|1|||
160523727|NCT03236246|579647956|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
160523728|NCT03236246|579647957|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
160523729|NCT02952001|579647958|FG000|Overall Study|Adverse Event|3|||
160523730|NCT02952001|579647959|FG001|Overall Study|Adverse Event|0|||
160523731|NCT02952001|579647958|FG000|Overall Study|Prohibited therapy|10|||
160523732|NCT02952001|579647959|FG001|Overall Study|Prohibited therapy|3|||
160523733|NCT02952001|579647958|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
160523734|NCT02952001|579647959|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
160523735|NCT01681628|579647962|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
160523736|NCT01681628|579647963|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
160523737|NCT01681628|579647962|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
160523738|NCT01681628|579647963|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
160523739|NCT01681628|579647962|FG000|19 Months Follow-up|Death|1|||
160523740|NCT01681628|579647963|FG001|19 Months Follow-up|Death|0|||
160523741|NCT01681628|579647962|FG000|19 Months Follow-up|Lost to Follow-up|61|||
160523742|NCT01681628|579647963|FG001|19 Months Follow-up|Lost to Follow-up|43|||
160523743|NCT01794520|579647964|FG000|Overall Study|Adverse events- related to progression|0|||
160523744|NCT01794520|579647965|FG001|Overall Study|Adverse events- related to progression|0|||
160523745|NCT01794520|579647966|FG002|Overall Study|Adverse events- related to progression|1|||
160523746|NCT01794520|579647967|FG003|Overall Study|Adverse events- related to progression|2|||
160523747|NCT01794520|579647968|FG004|Overall Study|Adverse events- related to progression|0|||
160523748|NCT01794520|579647969|FG005|Overall Study|Adverse events- related to progression|1|||
160523749|NCT01794520|579647970|FG006|Overall Study|Adverse events- related to progression|0|||
160523750|NCT01794520|579647964|FG000|Overall Study|Adverse event- not related to progression|1|||
160523751|NCT01794520|579647965|FG001|Overall Study|Adverse event- not related to progression|1|||
160523752|NCT01794520|579647966|FG002|Overall Study|Adverse event- not related to progression|0|||
160523753|NCT01794520|579647967|FG003|Overall Study|Adverse event- not related to progression|0|||
160523754|NCT01794520|579647968|FG004|Overall Study|Adverse event- not related to progression|2|||
160523755|NCT01794520|579647969|FG005|Overall Study|Adverse event- not related to progression|0|||
160523756|NCT01794520|579647970|FG006|Overall Study|Adverse event- not related to progression|0|||
160523757|NCT01794520|579647964|FG000|Overall Study|Progressive disease|5|||
160523758|NCT01794520|579647965|FG001|Overall Study|Progressive disease|6|||
160523759|NCT01794520|579647966|FG002|Overall Study|Progressive disease|2|||
160523760|NCT01794520|579647967|FG003|Overall Study|Progressive disease|5|||
160523761|NCT01794520|579647968|FG004|Overall Study|Progressive disease|27|||
160523762|NCT01794520|579647969|FG005|Overall Study|Progressive disease|18|||
160523763|NCT01794520|579647970|FG006|Overall Study|Progressive disease|0|||
160523764|NCT01794520|579647964|FG000|Overall Study|Withdrew consent|0|||
160523765|NCT01794520|579647965|FG001|Overall Study|Withdrew consent|0|||
160523766|NCT01794520|579647966|FG002|Overall Study|Withdrew consent|1|||
160523767|NCT01794520|579647967|FG003|Overall Study|Withdrew consent|1|||
160523768|NCT01794520|579647968|FG004|Overall Study|Withdrew consent|0|||
160523769|NCT01794520|579647969|FG005|Overall Study|Withdrew consent|0|||
160523770|NCT01794520|579647970|FG006|Overall Study|Withdrew consent|0|||
160523771|NCT01794520|579647964|FG000|Overall Study|Lost to Follow-up|0|||
160523772|NCT01794520|579647965|FG001|Overall Study|Lost to Follow-up|0|||
160523773|NCT01794520|579647966|FG002|Overall Study|Lost to Follow-up|0|||
160523774|NCT01794520|579647967|FG003|Overall Study|Lost to Follow-up|0|||
160523775|NCT01794520|579647968|FG004|Overall Study|Lost to Follow-up|1|||
160523776|NCT01794520|579647969|FG005|Overall Study|Lost to Follow-up|0|||
160523777|NCT01794520|579647970|FG006|Overall Study|Lost to Follow-up|0|||
160523778|NCT01794520|579647964|FG000|Overall Study|Toxicity|0|||
160523779|NCT01794520|579647965|FG001|Overall Study|Toxicity|2|||
160523780|NCT01794520|579647966|FG002|Overall Study|Toxicity|0|||
160523781|NCT01794520|579647967|FG003|Overall Study|Toxicity|0|||
160523782|NCT01794520|579647968|FG004|Overall Study|Toxicity|0|||
160523783|NCT01794520|579647969|FG005|Overall Study|Toxicity|0|||
160523784|NCT01794520|579647970|FG006|Overall Study|Toxicity|0|||
160523785|NCT01794520|579647964|FG000|Overall Study|Study terminated by sponsor|0|||
160523786|NCT01794520|579647965|FG001|Overall Study|Study terminated by sponsor|0|||
160523787|NCT01794520|579647966|FG002|Overall Study|Study terminated by sponsor|1|||
160523788|NCT01794520|579647967|FG003|Overall Study|Study terminated by sponsor|0|||
160523789|NCT01794520|579647968|FG004|Overall Study|Study terminated by sponsor|1|||
160523790|NCT01794520|579647969|FG005|Overall Study|Study terminated by sponsor|0|||
160523791|NCT01794520|579647970|FG006|Overall Study|Study terminated by sponsor|7|||
160523792|NCT01794520|579647964|FG000|Overall Study|Death|0|||
160523793|NCT01794520|579647965|FG001|Overall Study|Death|0|||
160523794|NCT01794520|579647966|FG002|Overall Study|Death|0|||
160523795|NCT01794520|579647967|FG003|Overall Study|Death|0|||
160523796|NCT01794520|579647968|FG004|Overall Study|Death|1|||
160523797|NCT01794520|579647969|FG005|Overall Study|Death|0|||
160523798|NCT01794520|579647970|FG006|Overall Study|Death|22|||
160523799|NCT01794520|579647964|FG000|Overall Study|Other, not specified|0|||
160523800|NCT01794520|579647965|FG001|Overall Study|Other, not specified|0|||
160523801|NCT01794520|579647966|FG002|Overall Study|Other, not specified|1|||
160523802|NCT01794520|579647967|FG003|Overall Study|Other, not specified|1|||
160523803|NCT01794520|579647968|FG004|Overall Study|Other, not specified|4|||
160523804|NCT01794520|579647969|FG005|Overall Study|Other, not specified|1|||
160523805|NCT01794520|579647970|FG006|Overall Study|Other, not specified|2|||
160523806|NCT01177787|579647974|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
160523807|NCT01177787|579647974|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
160523808|NCT01177787|579647974|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
160523809|NCT01676909|579647979|FG000|Overall Study|Withdrawal by Subject|3|||
160523810|NCT01676909|579647980|FG001|Overall Study|Withdrawal by Subject|5|||
160523811|NCT01676909|579647979|FG000|Overall Study|Lost to Follow-up|15|||
160523812|NCT01676909|579647980|FG001|Overall Study|Lost to Follow-up|9|||
160523813|NCT04615247|579647981|FG000|Overall Study|Adverse Event|0|||
160523814|NCT04615247|579647982|FG001|Overall Study|Adverse Event|2|||
160523815|NCT04615247|579647981|FG000|Overall Study|Withdrawal by Subject|1|||
160523816|NCT04615247|579647982|FG001|Overall Study|Withdrawal by Subject|1|||
160523817|NCT00823901|579647985|FG000|Overall Study|Adverse Event|1|||
160523818|NCT00823901|579647986|FG001|Overall Study|Adverse Event|1|||
160523819|NCT00823901|579647985|FG000|Overall Study|Lack of Efficacy|1|||
160523820|NCT00823901|579647986|FG001|Overall Study|Lack of Efficacy|0|||
160523821|NCT00823901|579647985|FG000|Overall Study|Lost to Follow-up|2|||
160523822|NCT00823901|579647986|FG001|Overall Study|Lost to Follow-up|1|||
160523823|NCT01369511|579647987|FG000|Overall Study|Adverse Event|1|||
160523824|NCT01369511|579647988|FG001|Overall Study|Adverse Event|1|||
160523825|NCT01369511|579647989|FG002|Overall Study|Adverse Event|5|||
160523826|NCT01369511|579647990|FG003|Overall Study|Adverse Event|0|||
160523827|NCT01369511|579647987|FG000|Overall Study|Entry criteria not met|2|||
160523828|NCT01369511|579647988|FG001|Overall Study|Entry criteria not met|0|||
160523829|NCT01369511|579647989|FG002|Overall Study|Entry criteria not met|0|||
160523830|NCT01369511|579647990|FG003|Overall Study|Entry criteria not met|1|||
160523831|NCT01369511|579647987|FG000|Overall Study|Lost to Follow-up|0|||
160523832|NCT01369511|579647988|FG001|Overall Study|Lost to Follow-up|1|||
160523833|NCT01369511|579647989|FG002|Overall Study|Lost to Follow-up|1|||
160523834|NCT01369511|579647990|FG003|Overall Study|Lost to Follow-up|2|||
160523835|NCT01369511|579647987|FG000|Overall Study|Protocol Violation|0|||
160523836|NCT01369511|579647988|FG001|Overall Study|Protocol Violation|1|||
160523837|NCT01369511|579647989|FG002|Overall Study|Protocol Violation|0|||
160523838|NCT01369511|579647990|FG003|Overall Study|Protocol Violation|2|||
160523839|NCT01369511|579647987|FG000|Overall Study|Physician Decision|3|||
160523840|NCT01369511|579647988|FG001|Overall Study|Physician Decision|4|||
160523841|NCT01369511|579647989|FG002|Overall Study|Physician Decision|0|||
160523842|NCT01369511|579647990|FG003|Overall Study|Physician Decision|0|||
160523843|NCT01369511|579647987|FG000|Overall Study|Sponsor decision|2|||
160523844|NCT01369511|579647988|FG001|Overall Study|Sponsor decision|0|||
160523845|NCT01369511|579647989|FG002|Overall Study|Sponsor decision|1|||
160523846|NCT01369511|579647990|FG003|Overall Study|Sponsor decision|0|||
160523847|NCT01369511|579647987|FG000|Overall Study|Withdrawal by Subject|5|||
160523848|NCT01369511|579647988|FG001|Overall Study|Withdrawal by Subject|6|||
160523849|NCT01369511|579647989|FG002|Overall Study|Withdrawal by Subject|4|||
160523850|NCT01369511|579647990|FG003|Overall Study|Withdrawal by Subject|6|||
160523851|NCT00818389|579647991|FG000|Overall Study|Death|1|||
160523852|NCT00818389|579647992|FG001|Overall Study|Death|3|||
160523853|NCT00818389|579647991|FG000|Overall Study|ALS Disease Progression|1|||
160523854|NCT00818389|579647992|FG001|Overall Study|ALS Disease Progression|0|||
160523855|NCT00818389|579647991|FG000|Overall Study|Withdrawal by Subject|2|||
160523856|NCT00818389|579647992|FG001|Overall Study|Withdrawal by Subject|2|||
160523857|NCT00818389|579647991|FG000|Overall Study|Adverse Event|0|||
160523858|NCT00818389|579647992|FG001|Overall Study|Adverse Event|1|||
160523859|NCT04658186|579647995|FG000|Overall Study|Adverse Event|4|||
160523860|NCT04658186|579647996|FG001|Overall Study|Adverse Event|18|||
160523861|NCT04658186|579647997|FG002|Overall Study|Adverse Event|15|||
160523862|NCT04658186|579647995|FG000|Overall Study|Lack of Efficacy|1|||
160523863|NCT04658186|579647996|FG001|Overall Study|Lack of Efficacy|1|||
160523864|NCT04658186|579647997|FG002|Overall Study|Lack of Efficacy|0|||
160523865|NCT04658186|579647995|FG000|Overall Study|Protocol Violation|0|||
160523866|NCT04658186|579647996|FG001|Overall Study|Protocol Violation|0|||
160523867|NCT04658186|579647997|FG002|Overall Study|Protocol Violation|1|||
160523868|NCT04658186|579647995|FG000|Overall Study|Lost to Follow-up|0|||
160523869|NCT04658186|579647996|FG001|Overall Study|Lost to Follow-up|0|||
160523870|NCT04658186|579647997|FG002|Overall Study|Lost to Follow-up|2|||
160523871|NCT04658186|579647995|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
160523872|NCT04658186|579647996|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
160523873|NCT04658186|579647997|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
160523874|NCT04658186|579647995|FG000|Overall Study|Participant is Moving in Another Province|0|||
160523875|NCT04658186|579647996|FG001|Overall Study|Participant is Moving in Another Province|1|||
160523876|NCT04658186|579647997|FG002|Overall Study|Participant is Moving in Another Province|0|||
160523877|NCT04658186|579647995|FG000|Overall Study|Non-Compliance|0|||
160523878|NCT04658186|579647996|FG001|Overall Study|Non-Compliance|1|||
160523879|NCT04658186|579647997|FG002|Overall Study|Non-Compliance|1|||
160523880|NCT04658186|579647995|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
160523881|NCT04658186|579647996|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
160523882|NCT04658186|579647997|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
160523883|NCT04658186|579647995|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
160523884|NCT04658186|579647996|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
160523885|NCT04658186|579647997|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
160523886|NCT04658186|579647995|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
160523887|NCT04658186|579647996|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
160523888|NCT04658186|579647997|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
160523889|NCT04658186|579647995|FG000|Overall Study|PI Decision due to Participant Safety|0|||
160523890|NCT04658186|579647996|FG001|Overall Study|PI Decision due to Participant Safety|0|||
160523891|NCT04658186|579647997|FG002|Overall Study|PI Decision due to Participant Safety|1|||
160523892|NCT04658186|579647995|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
160523893|NCT04658186|579647996|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
160523894|NCT04658186|579647997|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
160523895|NCT04098068|579647998|FG000|Overall Study|Disease Progression|7|||
160523896|NCT04098068|579647998|FG000|Overall Study|Withdrawal by Subject|2|||
160523897|NCT04098068|579647998|FG000|Overall Study|New Cancer Diagnosis|1|||
160523898|NCT03871829|579647999|FG000|Overall Study|Lost to Follow-up|0|||
160523899|NCT03871829|579648000|FG001|Overall Study|Lost to Follow-up|1|||
160523900|NCT03871829|579647999|FG000|Overall Study|Withdrawal by Subject|1|||
160523901|NCT03871829|579648000|FG001|Overall Study|Withdrawal by Subject|1|||
160523902|NCT03871829|579647999|FG000|Overall Study|Death|12|||
160523903|NCT03871829|579648000|FG001|Overall Study|Death|8|||
160523904|NCT03871829|579647999|FG000|Overall Study|Study terminated by sponsor|31|||
160523905|NCT03871829|579648000|FG001|Overall Study|Study terminated by sponsor|34|||
160523906|NCT02993523|579648001|FG000|Overall Study|Withdrew Consent|0|||
160523907|NCT02993523|579648002|FG001|Overall Study|Withdrew Consent|0|||
160523908|NCT02993523|579648003|FG002|Overall Study|Withdrew Consent|2|||
160523909|NCT02993523|579648004|FG003|Overall Study|Withdrew Consent|9|||
160523910|NCT02993523|579648005|FG004|Overall Study|Withdrew Consent|0|||
160523911|NCT02993523|579648001|FG000|Overall Study|Lost to Follow-up|0|||
160523912|NCT02993523|579648002|FG001|Overall Study|Lost to Follow-up|0|||
160523913|NCT02993523|579648003|FG002|Overall Study|Lost to Follow-up|3|||
160523914|NCT02993523|579648004|FG003|Overall Study|Lost to Follow-up|6|||
160523915|NCT02993523|579648005|FG004|Overall Study|Lost to Follow-up|0|||
160523916|NCT02993523|579648001|FG000|Overall Study|Death|1|||
160523917|NCT02993523|579648002|FG001|Overall Study|Death|1|||
160523918|NCT02993523|579648003|FG002|Overall Study|Death|138|||
160523919|NCT02993523|579648004|FG003|Overall Study|Death|222|||
160523920|NCT02993523|579648005|FG004|Overall Study|Death|6|||
160523921|NCT02993523|579648001|FG000|Overall Study|Reason not Specified|0|||
160523922|NCT02993523|579648002|FG001|Overall Study|Reason not Specified|0|||
160523923|NCT02993523|579648003|FG002|Overall Study|Reason not Specified|1|||
160523924|NCT02993523|579648004|FG003|Overall Study|Reason not Specified|1|||
160523925|NCT02993523|579648005|FG004|Overall Study|Reason not Specified|0|||
160523926|NCT03694418|579648006|FG000|Overall Study|Lost to Follow-up|115|||
160523927|NCT03694418|579648007|FG001|Overall Study|Lost to Follow-up|23|||
160523928|NCT03694418|579648008|FG002|Overall Study|Lost to Follow-up|12|||
160523929|NCT03694418|579648009|FG003|Overall Study|Lost to Follow-up|12|||
160523930|NCT03694418|579648010|FG004|Overall Study|Lost to Follow-up|13|||
160523931|NCT04288778|579648013|FG000|Overall Study|Withdrawal by Subject|2|||
160523932|NCT04288778|579648013|FG000|Overall Study|Adverse Event|5|||
160523933|NCT04288778|579648013|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160523934|NCT04288778|579648013|FG000|Overall Study|Other|1|||
160523935|NCT04288778|579648013|FG000|Overall Study|Started but not treated|2|||
160523936|NCT04442737|579648014|FG000|Overall Study|Lost to Follow-up|1|||
160523937|NCT04442737|579648015|FG001|Overall Study|Lost to Follow-up|3|||
160523938|NCT04442737|579648014|FG000|Overall Study|Withdrawal by Subject|3|||
160523939|NCT04442737|579648015|FG001|Overall Study|Withdrawal by Subject|2|||
160523940|NCT04442737|579648014|FG000|Overall Study|Adverse Event|3|||
160523941|NCT04442737|579648015|FG001|Overall Study|Adverse Event|2|||
160523942|NCT04442737|579648014|FG000|Overall Study|Death|0|||
160523943|NCT04442737|579648015|FG001|Overall Study|Death|1|||
160523944|NCT04442737|579648014|FG000|Overall Study|Protocol Violation|0|||
160523945|NCT04442737|579648015|FG001|Overall Study|Protocol Violation|2|||
160523946|NCT04442737|579648014|FG000|Overall Study|Other|1|||
160523947|NCT04442737|579648015|FG001|Overall Study|Other|1|||
160523948|NCT01139021|579648016|FG000|Overall Study|Adverse Event|0|||
160523949|NCT01139021|579648017|FG001|Overall Study|Adverse Event|0|||
160523950|NCT01139021|579648018|FG002|Overall Study|Adverse Event|0|||
160523951|NCT01139021|579648019|FG003|Overall Study|Adverse Event|0|||
160523952|NCT01139021|579648020|FG004|Overall Study|Adverse Event|1|||
160523953|NCT01139021|579648021|FG005|Overall Study|Adverse Event|0|||
160523954|NCT01139021|579648016|FG000|Overall Study|Lost to Follow-up|0|||
160523955|NCT01139021|579648017|FG001|Overall Study|Lost to Follow-up|0|||
160523956|NCT01139021|579648018|FG002|Overall Study|Lost to Follow-up|0|||
160523957|NCT01139021|579648019|FG003|Overall Study|Lost to Follow-up|0|||
160523958|NCT01139021|579648020|FG004|Overall Study|Lost to Follow-up|2|||
160523959|NCT01139021|579648021|FG005|Overall Study|Lost to Follow-up|0|||
160523960|NCT01139021|579648016|FG000|Overall Study|Protocol Violation|1|||
160523961|NCT01139021|579648017|FG001|Overall Study|Protocol Violation|0|||
160523962|NCT01139021|579648018|FG002|Overall Study|Protocol Violation|0|||
160523963|NCT01139021|579648019|FG003|Overall Study|Protocol Violation|0|||
160523964|NCT01139021|579648020|FG004|Overall Study|Protocol Violation|2|||
160523965|NCT01139021|579648021|FG005|Overall Study|Protocol Violation|0|||
160523966|NCT01139021|579648016|FG000|Overall Study|Withdrawal by Subject|0|||
160523967|NCT01139021|579648017|FG001|Overall Study|Withdrawal by Subject|0|||
160523968|NCT01139021|579648018|FG002|Overall Study|Withdrawal by Subject|0|||
160523969|NCT01139021|579648019|FG003|Overall Study|Withdrawal by Subject|1|||
160523970|NCT01139021|579648020|FG004|Overall Study|Withdrawal by Subject|4|||
160523971|NCT01139021|579648021|FG005|Overall Study|Withdrawal by Subject|0|||
160523972|NCT00784693|579648026|FG000|Overall Study|Lost to Follow-up|0|||
160523973|NCT00784693|579648027|FG001|Overall Study|Lost to Follow-up|1|||
160523974|NCT00784693|579648026|FG000|Overall Study|Lack of Efficacy|1|||
160523975|NCT00784693|579648027|FG001|Overall Study|Lack of Efficacy|1|||
160523976|NCT00784693|579648026|FG000|Overall Study|Withdrawal by Subject|0|||
160523977|NCT00784693|579648027|FG001|Overall Study|Withdrawal by Subject|4|||
160523978|NCT00784693|579648026|FG000|Overall Study|Randomized but not Treated|1|||
160523979|NCT00784693|579648027|FG001|Overall Study|Randomized but not Treated|0|||
160523980|NCT00784693|579648026|FG000|Overall Study|Other|1|||
160523981|NCT00784693|579648027|FG001|Overall Study|Other|0|||
160523982|NCT05458479|579648028|FG000|Overall Study|Lost to Follow-up|1|||
160523983|NCT02982187|579648029|FG000|Overall Study|Withdrawal by Subject|0|||
160523984|NCT02982187|579648030|FG001|Overall Study|Withdrawal by Subject|0|||
160523985|NCT02982187|579648031|FG002|Overall Study|Withdrawal by Subject|0|||
160523986|NCT02982187|579648032|FG003|Overall Study|Withdrawal by Subject|0|||
160523987|NCT02982187|579648033|FG004|Overall Study|Withdrawal by Subject|0|||
160523988|NCT02982187|579648034|FG005|Overall Study|Withdrawal by Subject|0|||
160523989|NCT02982187|579648035|FG006|Overall Study|Withdrawal by Subject|1|||
160523990|NCT02982187|579648036|FG007|Overall Study|Withdrawal by Subject|0|||
160523991|NCT02349451|579648040|FG000|Overall Study|Withdrawal by Subject|0|||
160523992|NCT02349451|579648041|FG001|Overall Study|Withdrawal by Subject|1|||
160523993|NCT02349451|579648042|FG002|Overall Study|Withdrawal by Subject|2|||
160523994|NCT02349451|579648043|FG003|Overall Study|Withdrawal by Subject|1|||
160523995|NCT02168842|579648044|FG000|Overall Study|Withdrawal by Subject|5|||
160523996|NCT02168842|579648045|FG001|Overall Study|Withdrawal by Subject|3|||
160523997|NCT02168842|579648044|FG000|Overall Study|Lost to Follow-up|0|||
160523998|NCT02168842|579648045|FG001|Overall Study|Lost to Follow-up|2|||
160523999|NCT02168842|579648044|FG000|Overall Study|Death|2|||
160524000|NCT02168842|579648045|FG001|Overall Study|Death|1|||
160524001|NCT02168842|579648044|FG000|Overall Study|Physician Decision|1|||
160524002|NCT02168842|579648045|FG001|Overall Study|Physician Decision|2|||
160524003|NCT02147353|579648046|FG000|Overall Study|Lost to Follow-up|2|||
160524004|NCT02147353|579648047|FG001|Overall Study|Lost to Follow-up|0|||
160524005|NCT02147353|579648046|FG000|Overall Study|unable to make visits|4|||
160524006|NCT02147353|579648047|FG001|Overall Study|unable to make visits|0|||
160524007|NCT02147353|579648046|FG000|Overall Study|medication noncompliance|3|||
160524008|NCT02147353|579648047|FG001|Overall Study|medication noncompliance|0|||
160524009|NCT02121834|579648054|FG000|Overall Study|Protocol Violation|0|||
160524010|NCT02121834|579648055|FG001|Overall Study|Protocol Violation|1|||
160524011|NCT02121834|579648056|FG002|Overall Study|Protocol Violation|0|||
160524012|NCT02121834|579648057|FG003|Overall Study|Protocol Violation|0|||
160524013|NCT02121834|579648058|FG004|Overall Study|Protocol Violation|0|||
160524014|NCT02121834|579648059|FG005|Overall Study|Protocol Violation|0|||
160524015|NCT02121834|579648060|FG006|Overall Study|Protocol Violation|0|||
160524016|NCT02121834|579648054|FG000|Overall Study|Withdrawal by Subject|0|||
160524017|NCT02121834|579648055|FG001|Overall Study|Withdrawal by Subject|1|||
160524018|NCT02121834|579648056|FG002|Overall Study|Withdrawal by Subject|1|||
160524019|NCT02121834|579648057|FG003|Overall Study|Withdrawal by Subject|0|||
160524020|NCT02121834|579648058|FG004|Overall Study|Withdrawal by Subject|0|||
160524021|NCT02121834|579648059|FG005|Overall Study|Withdrawal by Subject|0|||
160524022|NCT02121834|579648060|FG006|Overall Study|Withdrawal by Subject|0|||
160524023|NCT02121834|579648054|FG000|Overall Study|Lost to Follow-up|0|||
160524024|NCT02121834|579648055|FG001|Overall Study|Lost to Follow-up|0|||
160524025|NCT02121834|579648056|FG002|Overall Study|Lost to Follow-up|1|||
160524026|NCT02121834|579648057|FG003|Overall Study|Lost to Follow-up|0|||
160524027|NCT02121834|579648058|FG004|Overall Study|Lost to Follow-up|0|||
160524028|NCT02121834|579648059|FG005|Overall Study|Lost to Follow-up|0|||
160524029|NCT02121834|579648060|FG006|Overall Study|Lost to Follow-up|0|||
160524030|NCT02578862|579648061|FG000|Overall Study|Withdrawal by Subject|0|||
160524031|NCT02578862|579648062|FG001|Overall Study|Withdrawal by Subject|1|||
160524032|NCT02578862|579648061|FG000|Overall Study|Unplanned unilateral procedure|0|||
160524033|NCT02578862|579648062|FG001|Overall Study|Unplanned unilateral procedure|1|||
160524034|NCT01142596|579648067|FG000|Overall Study|Withdrawal by Subject|9|||
160524035|NCT01142596|579648068|FG001|Overall Study|Withdrawal by Subject|35|||
160524036|NCT01142596|579648067|FG000|Overall Study|Adverse Event|8|||
160524037|NCT01142596|579648068|FG001|Overall Study|Adverse Event|35|||
160524038|NCT01142596|579648067|FG000|Overall Study|Lack of Efficacy|5|||
160524039|NCT01142596|579648068|FG001|Overall Study|Lack of Efficacy|9|||
160524040|NCT01142596|579648067|FG000|Overall Study|Lost to Follow-up|2|||
160524041|NCT01142596|579648068|FG001|Overall Study|Lost to Follow-up|3|||
160524042|NCT01142596|579648067|FG000|Overall Study|Other reason (not specified)|5|||
160524043|NCT01142596|579648068|FG001|Overall Study|Other reason (not specified)|4|||
160524044|NCT01290601|579648069|FG000|Overall Study|Adverse Event|0|||
160524045|NCT01290601|579648070|FG001|Overall Study|Adverse Event|2|||
160524046|NCT01290601|579648071|FG002|Overall Study|Adverse Event|0|||
160524047|NCT01290601|579648072|FG003|Overall Study|Adverse Event|0|||
160524048|NCT01290601|579648069|FG000|Overall Study|Lack of Efficacy|2|||
160524049|NCT01290601|579648070|FG001|Overall Study|Lack of Efficacy|1|||
160524050|NCT01290601|579648071|FG002|Overall Study|Lack of Efficacy|0|||
160524051|NCT01290601|579648072|FG003|Overall Study|Lack of Efficacy|0|||
160524052|NCT01290601|579648069|FG000|Overall Study|Lost to Follow-up|7|||
160524053|NCT01290601|579648070|FG001|Overall Study|Lost to Follow-up|2|||
160524054|NCT01290601|579648071|FG002|Overall Study|Lost to Follow-up|0|||
160524055|NCT01290601|579648072|FG003|Overall Study|Lost to Follow-up|0|||
160524056|NCT01290601|579648069|FG000|Overall Study|Other|1|||
160524057|NCT01290601|579648070|FG001|Overall Study|Other|0|||
160524058|NCT01290601|579648071|FG002|Overall Study|Other|0|||
160524059|NCT01290601|579648072|FG003|Overall Study|Other|0|||
160524060|NCT01290601|579648069|FG000|Overall Study|Protocol Violation|1|||
160524061|NCT01290601|579648070|FG001|Overall Study|Protocol Violation|0|||
160524062|NCT01290601|579648071|FG002|Overall Study|Protocol Violation|0|||
160524063|NCT01290601|579648072|FG003|Overall Study|Protocol Violation|0|||
160524064|NCT00775450|579648073|FG000|Overall Study|Serious Adverse Event|2|||
160524065|NCT00775450|579648074|FG001|Overall Study|Serious Adverse Event|0|||
160524066|NCT00775450|579648075|FG002|Overall Study|Serious Adverse Event|0|||
160524067|NCT00775450|579648076|FG003|Overall Study|Serious Adverse Event|0|||
160524068|NCT00775450|579648077|FG004|Overall Study|Serious Adverse Event|0|||
160524069|NCT00775450|579648073|FG000|Overall Study|Protocol Violation|0|||
160524070|NCT00775450|579648074|FG001|Overall Study|Protocol Violation|0|||
160524071|NCT00775450|579648075|FG002|Overall Study|Protocol Violation|0|||
160524072|NCT00775450|579648076|FG003|Overall Study|Protocol Violation|0|||
160524073|NCT00775450|579648077|FG004|Overall Study|Protocol Violation|1|||
160524074|NCT00775450|579648073|FG000|Overall Study|Withdrawal by Subject|1|||
160524075|NCT00775450|579648074|FG001|Overall Study|Withdrawal by Subject|0|||
160524076|NCT00775450|579648075|FG002|Overall Study|Withdrawal by Subject|0|||
160524077|NCT00775450|579648076|FG003|Overall Study|Withdrawal by Subject|0|||
160524078|NCT00775450|579648077|FG004|Overall Study|Withdrawal by Subject|1|||
160524079|NCT01749540|579648085|FG000|Overall Study|Protocol Violation|0|||
160524080|NCT01749540|579648086|FG001|Overall Study|Protocol Violation|0|||
160524081|NCT01749540|579648087|FG002|Overall Study|Protocol Violation|0|||
160524082|NCT01749540|579648088|FG003|Overall Study|Protocol Violation|0|||
160524083|NCT01749540|579648089|FG004|Overall Study|Protocol Violation|0|||
160524084|NCT01749540|579648090|FG005|Overall Study|Protocol Violation|1|||
160524085|NCT01749540|579648091|FG006|Overall Study|Protocol Violation|1|||
160524086|NCT01749540|579648085|FG000|Overall Study|Withdrawal by Subject|0|||
160524087|NCT01749540|579648086|FG001|Overall Study|Withdrawal by Subject|0|||
160524088|NCT01749540|579648087|FG002|Overall Study|Withdrawal by Subject|0|||
160524089|NCT01749540|579648088|FG003|Overall Study|Withdrawal by Subject|1|||
160524090|NCT01749540|579648089|FG004|Overall Study|Withdrawal by Subject|0|||
160524091|NCT01749540|579648090|FG005|Overall Study|Withdrawal by Subject|0|||
160524092|NCT01749540|579648091|FG006|Overall Study|Withdrawal by Subject|0|||
160524093|NCT01749540|579648085|FG000|Overall Study|Initiated into extension study A536-06|0|||
160524094|NCT01749540|579648086|FG001|Overall Study|Initiated into extension study A536-06|0|||
160524095|NCT01749540|579648087|FG002|Overall Study|Initiated into extension study A536-06|0|||
160524096|NCT01749540|579648088|FG003|Overall Study|Initiated into extension study A536-06|0|||
160524097|NCT01749540|579648089|FG004|Overall Study|Initiated into extension study A536-06|0|||
160524098|NCT01749540|579648090|FG005|Overall Study|Initiated into extension study A536-06|2|||
160524099|NCT01749540|579648091|FG006|Overall Study|Initiated into extension study A536-06|24|||
160524100|NCT05056987|579648092|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
160524101|NCT05056987|579648093|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
160524102|NCT05056987|579648092|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
160524103|NCT05056987|579648093|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
160524104|NCT01182194|579648094|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
160524105|NCT01182194|579648095|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
160524106|NCT01948908|579648096|FG000|Overall Study|Protocol Violation|1|||
160524107|NCT01948908|579648097|FG001|Overall Study|Protocol Violation|0|||
160524108|NCT01948908|579648098|FG002|Overall Study|Protocol Violation|2|||
160524109|NCT01585987|579648099|FG000|Randomized|Withdrawal by Subject|0|||
160524110|NCT01585987|579648100|FG001|Randomized|Withdrawal by Subject|4|||
160524111|NCT01585987|579648099|FG000|Randomized|No longer met criteria|0|||
160524112|NCT01585987|579648100|FG001|Randomized|No longer met criteria|2|||
160524113|NCT01585987|579648099|FG000|Treated|Disease Progression|39|||
160524114|NCT01585987|579648100|FG001|Treated|Disease Progression|36|||
160524115|NCT01585987|579648099|FG000|Treated|Study Drug Toxicity|9|||
160524116|NCT01585987|579648100|FG001|Treated|Study Drug Toxicity|5|||
160524117|NCT01585987|579648099|FG000|Treated|Adverse Event|3|||
160524118|NCT01585987|579648100|FG001|Treated|Adverse Event|0|||
160524119|NCT01585987|579648099|FG000|Treated|Withdrawal by Subject|1|||
160524120|NCT01585987|579648100|FG001|Treated|Withdrawal by Subject|2|||
160524121|NCT01585987|579648099|FG000|Treated|Death|1|||
160524122|NCT01585987|579648100|FG001|Treated|Death|0|||
160524123|NCT01585987|579648099|FG000|Treated|Lost to Follow-up|0|||
160524124|NCT01585987|579648100|FG001|Treated|Lost to Follow-up|1|||
160524125|NCT01585987|579648099|FG000|Treated|Maximum Clinical Benefit|0|||
160524126|NCT01585987|579648100|FG001|Treated|Maximum Clinical Benefit|1|||
160524127|NCT01585987|579648099|FG000|Treated|Non-Specified|1|||
160524128|NCT01585987|579648100|FG001|Treated|Non-Specified|2|||
160524129|NCT01585987|579648099|FG000|Treated|Subject Request|0|||
160524130|NCT01585987|579648100|FG001|Treated|Subject Request|1|||
160524131|NCT01585987|579648099|FG000|Treated|Poor/Non-Compliance|0|||
160524132|NCT01585987|579648100|FG001|Treated|Poor/Non-Compliance|1|||
160524133|NCT03291587|579648101|FG000|Overall Study|Lost to Follow-up|62|||
160524134|NCT03291587|579648102|FG001|Overall Study|Lost to Follow-up|43|||
160524135|NCT03291587|579648101|FG000|Overall Study|Refused to Answer|5|||
160524136|NCT03291587|579648102|FG001|Overall Study|Refused to Answer|2|||
160524137|NCT03291587|579648101|FG000|Overall Study|Death|2|||
160524138|NCT03291587|579648102|FG001|Overall Study|Death|4|||
160524139|NCT03291587|579648101|FG000|Overall Study|Not interested in participating|8|||
160524140|NCT03291587|579648102|FG001|Overall Study|Not interested in participating|6|||
160524141|NCT03291587|579648101|FG000|Overall Study|Too busy to participate|4|||
160524142|NCT03291587|579648102|FG001|Overall Study|Too busy to participate|2|||
160524143|NCT00796120|579648103|FG000|Overall Study|Death|3|||
160524144|NCT00796120|579648104|FG001|Overall Study|Death|0|||
160524145|NCT00796120|579648103|FG000|Overall Study|Adverse Event|11|||
160524146|NCT00796120|579648104|FG001|Overall Study|Adverse Event|6|||
160524147|NCT00796120|579648103|FG000|Overall Study|Progressive disease|22|||
160524148|NCT00796120|579648104|FG001|Overall Study|Progressive disease|13|||
160524149|NCT00796120|579648103|FG000|Overall Study|Participant refusal|3|||
160524150|NCT00796120|579648104|FG001|Overall Study|Participant refusal|4|||
160524151|NCT00796120|579648103|FG000|Overall Study|Other|6|||
160524152|NCT00796120|579648104|FG001|Overall Study|Other|17|||
160524153|NCT00796120|579648103|FG000|Overall Study|Physician Decision|16|||
160524154|NCT00796120|579648104|FG001|Overall Study|Physician Decision|17|||
160524155|NCT00796120|579648103|FG000|Overall Study|Randomized but not treated|0|||
160524156|NCT00796120|579648104|FG001|Overall Study|Randomized but not treated|3|||
160524157|NCT01411839|579648109|FG000|Overall Study|Lost to Follow-up|4|||
160524158|NCT01411839|579648110|FG001|Overall Study|Lost to Follow-up|3|||
160524159|NCT01103245|579649973|FG000|Overall Study|Withdrawal by Subject|1|||
160524160|NCT01103245|579649974|FG001|Overall Study|Withdrawal by Subject|0|||
160524161|NCT01103245|579649975|FG002|Overall Study|Withdrawal by Subject|3|||
160524162|NCT01103245|579649976|FG003|Overall Study|Withdrawal by Subject|0|||
160524163|NCT01103245|579649973|FG000|Overall Study|Inadequate IV access|1|||
160524164|NCT01103245|579649974|FG001|Overall Study|Inadequate IV access|0|||
160524165|NCT01103245|579649975|FG002|Overall Study|Inadequate IV access|0|||
160524166|NCT01103245|579649976|FG003|Overall Study|Inadequate IV access|0|||
160524167|NCT01103245|579649973|FG000|Overall Study|Adverse Event|0|||
160524168|NCT01103245|579649974|FG001|Overall Study|Adverse Event|2|||
160524169|NCT01103245|579649975|FG002|Overall Study|Adverse Event|1|||
160524170|NCT01103245|579649976|FG003|Overall Study|Adverse Event|0|||
160524171|NCT01103245|579649973|FG000|Overall Study|Physician Decision|1|||
160524172|NCT01103245|579649974|FG001|Overall Study|Physician Decision|0|||
160524173|NCT01103245|579649975|FG002|Overall Study|Physician Decision|0|||
160524174|NCT01103245|579649976|FG003|Overall Study|Physician Decision|0|||
160524175|NCT03078907|579649977|FG000|Overall Study|Adverse Event|2|||
160524176|NCT03078907|579649978|FG001|Overall Study|Adverse Event|0|||
160524177|NCT03078907|579649977|FG000|Overall Study|Other|1|||
160524178|NCT03078907|579649978|FG001|Overall Study|Other|0|||
160524179|NCT03078907|579649977|FG000|Overall Study|Protocol Violation|0|||
160524180|NCT03078907|579649978|FG001|Overall Study|Protocol Violation|1|||
160524181|NCT01955122|579649979|FG000|Overall Study|Physician Decision|5|||
160524182|NCT01955122|579649980|FG001|Overall Study|Physician Decision|5|||
160524183|NCT01672788|579649981|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
160524184|NCT01672788|579649982|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
160524185|NCT01672788|579649983|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
160524186|NCT01672788|579649984|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
160524187|NCT02464228|579649987|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
160524188|NCT02464228|579649988|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
160524189|NCT02464228|579649989|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
160524190|NCT02464228|579649990|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
160524191|NCT02464228|579649987|FG000|Overall Study|Physician Decision|2|||
160524192|NCT02464228|579649988|FG001|Overall Study|Physician Decision|0|||
160524193|NCT02464228|579649989|FG002|Overall Study|Physician Decision|1|||
160524194|NCT02464228|579649990|FG003|Overall Study|Physician Decision|0|||
160524195|NCT02464228|579649987|FG000|Overall Study|Miscellaneous|1|||
160524196|NCT02464228|579649988|FG001|Overall Study|Miscellaneous|0|||
160524197|NCT02464228|579649989|FG002|Overall Study|Miscellaneous|1|||
160524198|NCT02464228|579649990|FG003|Overall Study|Miscellaneous|0|||
160524199|NCT02464228|579649987|FG000|Overall Study|Adverse Event|9|||
160524200|NCT02464228|579649988|FG001|Overall Study|Adverse Event|0|||
160524201|NCT02464228|579649989|FG002|Overall Study|Adverse Event|3|||
160524202|NCT02464228|579649990|FG003|Overall Study|Adverse Event|0|||
160524203|NCT02464228|579649987|FG000|Overall Study|Withdrawal by Subject|1|||
160524204|NCT02464228|579649988|FG001|Overall Study|Withdrawal by Subject|1|||
160524205|NCT02464228|579649989|FG002|Overall Study|Withdrawal by Subject|1|||
160524206|NCT02464228|579649990|FG003|Overall Study|Withdrawal by Subject|0|||
160524207|NCT02464228|579649987|FG000|Overall Study|Disease Progression|22|||
160524208|NCT02464228|579649988|FG001|Overall Study|Disease Progression|12|||
160524209|NCT02464228|579649989|FG002|Overall Study|Disease Progression|5|||
160524210|NCT02464228|579649990|FG003|Overall Study|Disease Progression|2|||
160524211|NCT04796896|579649993|FG000|Overall Study|Adverse Event|1|||
160524212|NCT04796896|579649994|FG001|Overall Study|Adverse Event|0|||
160524213|NCT04796896|579649995|FG002|Overall Study|Adverse Event|0|||
160524214|NCT04796896|579649996|FG003|Overall Study|Adverse Event|0|||
160524215|NCT04796896|579649997|FG004|Overall Study|Adverse Event|0|||
160524216|NCT04796896|579649998|FG005|Overall Study|Adverse Event|1|||
160524217|NCT04796896|579649999|FG006|Overall Study|Adverse Event|1|||
160524218|NCT04796896|579650000|FG007|Overall Study|Adverse Event|0|||
160524219|NCT04796896|579650001|FG008|Overall Study|Adverse Event|1|||
160524220|NCT04796896|579650002|FG009|Overall Study|Adverse Event|1|||
160524221|NCT04796896|579650003|FG010|Overall Study|Adverse Event|1|||
160524222|NCT04796896|579650004|FG011|Overall Study|Adverse Event|0|||
160524223|NCT04796896|579649993|FG000|Overall Study|Lost to Follow-up|24|||
160524224|NCT04796896|579649994|FG001|Overall Study|Lost to Follow-up|15|||
160524225|NCT04796896|579649995|FG002|Overall Study|Lost to Follow-up|6|||
160524226|NCT04796896|579649996|FG003|Overall Study|Lost to Follow-up|4|||
160524227|NCT04796896|579649997|FG004|Overall Study|Lost to Follow-up|21|||
160524228|NCT04796896|579649998|FG005|Overall Study|Lost to Follow-up|55|||
160524229|NCT04796896|579649999|FG006|Overall Study|Lost to Follow-up|237|||
160524230|NCT04796896|579650000|FG007|Overall Study|Lost to Follow-up|52|||
160524231|NCT04796896|579650001|FG008|Overall Study|Lost to Follow-up|221|||
160524232|NCT04796896|579650002|FG009|Overall Study|Lost to Follow-up|43|||
160524233|NCT04796896|579650003|FG010|Overall Study|Lost to Follow-up|142|||
160524234|NCT04796896|579650004|FG011|Overall Study|Lost to Follow-up|18|||
160524235|NCT04796896|579649993|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
160524236|NCT04796896|579649994|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
160524237|NCT04796896|579649995|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
160524238|NCT04796896|579649996|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
160524239|NCT04796896|579649997|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
160524240|NCT04796896|579649998|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
160524241|NCT04796896|579649999|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
160524242|NCT04796896|579650000|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
160524243|NCT04796896|579650001|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
160524244|NCT04796896|579650002|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
160524245|NCT04796896|579650003|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
160524246|NCT04796896|579650004|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
160524247|NCT04796896|579649993|FG000|Overall Study|Physician Decision|1|||
160524248|NCT04796896|579649994|FG001|Overall Study|Physician Decision|0|||
160524249|NCT04796896|579649995|FG002|Overall Study|Physician Decision|0|||
160524250|NCT04796896|579649996|FG003|Overall Study|Physician Decision|0|||
160524251|NCT04796896|579649997|FG004|Overall Study|Physician Decision|0|||
160524252|NCT04796896|579649998|FG005|Overall Study|Physician Decision|3|||
160524253|NCT04796896|579649999|FG006|Overall Study|Physician Decision|18|||
160524254|NCT04796896|579650000|FG007|Overall Study|Physician Decision|1|||
160524255|NCT04796896|579650001|FG008|Overall Study|Physician Decision|7|||
160524256|NCT04796896|579650002|FG009|Overall Study|Physician Decision|0|||
160524257|NCT04796896|579650003|FG010|Overall Study|Physician Decision|5|||
160524258|NCT04796896|579650004|FG011|Overall Study|Physician Decision|0|||
160524259|NCT04796896|579649993|FG000|Overall Study|Withdrawal by Subject|36|||
160524260|NCT04796896|579649994|FG001|Overall Study|Withdrawal by Subject|31|||
160524261|NCT04796896|579649995|FG002|Overall Study|Withdrawal by Subject|11|||
160524262|NCT04796896|579649996|FG003|Overall Study|Withdrawal by Subject|8|||
160524263|NCT04796896|579649997|FG004|Overall Study|Withdrawal by Subject|16|||
160524264|NCT04796896|579649998|FG005|Overall Study|Withdrawal by Subject|162|||
160524265|NCT04796896|579649999|FG006|Overall Study|Withdrawal by Subject|299|||
160524266|NCT04796896|579650000|FG007|Overall Study|Withdrawal by Subject|149|||
160524267|NCT04796896|579650001|FG008|Overall Study|Withdrawal by Subject|303|||
160524268|NCT04796896|579650002|FG009|Overall Study|Withdrawal by Subject|94|||
160524269|NCT04796896|579650003|FG010|Overall Study|Withdrawal by Subject|192|||
160524270|NCT04796896|579650004|FG011|Overall Study|Withdrawal by Subject|16|||
160524271|NCT04796896|579649993|FG000|Overall Study|Other Than Specified|6|||
160524272|NCT04796896|579649994|FG001|Overall Study|Other Than Specified|5|||
160524273|NCT04796896|579649995|FG002|Overall Study|Other Than Specified|3|||
160524274|NCT04796896|579649996|FG003|Overall Study|Other Than Specified|2|||
160524275|NCT04796896|579649997|FG004|Overall Study|Other Than Specified|6|||
160524276|NCT04796896|579649998|FG005|Overall Study|Other Than Specified|31|||
160524277|NCT04796896|579649999|FG006|Overall Study|Other Than Specified|86|||
160524278|NCT04796896|579650000|FG007|Overall Study|Other Than Specified|66|||
160524279|NCT04796896|579650001|FG008|Overall Study|Other Than Specified|388|||
160524280|NCT04796896|579650002|FG009|Overall Study|Other Than Specified|48|||
160524281|NCT04796896|579650003|FG010|Overall Study|Other Than Specified|258|||
160524282|NCT04796896|579650004|FG011|Overall Study|Other Than Specified|4|||
160524283|NCT04796896|579649993|FG000|Overall Study|Protocol Deviation|0|||
160524284|NCT04796896|579649994|FG001|Overall Study|Protocol Deviation|0|||
160524285|NCT04796896|579649995|FG002|Overall Study|Protocol Deviation|0|||
160524286|NCT04796896|579649996|FG003|Overall Study|Protocol Deviation|1|||
160524287|NCT04796896|579649997|FG004|Overall Study|Protocol Deviation|1|||
160524288|NCT04796896|579649998|FG005|Overall Study|Protocol Deviation|2|||
160524289|NCT04796896|579649999|FG006|Overall Study|Protocol Deviation|2|||
160524290|NCT04796896|579650000|FG007|Overall Study|Protocol Deviation|2|||
160524291|NCT04796896|579650001|FG008|Overall Study|Protocol Deviation|2|||
160524292|NCT04796896|579650002|FG009|Overall Study|Protocol Deviation|1|||
160524293|NCT04796896|579650003|FG010|Overall Study|Protocol Deviation|0|||
160524294|NCT04796896|579650004|FG011|Overall Study|Protocol Deviation|0|||
160524295|NCT04796896|579649993|FG000|Overall Study|Missing|0|||
160524296|NCT04796896|579649994|FG001|Overall Study|Missing|0|||
160524297|NCT04796896|579649995|FG002|Overall Study|Missing|0|||
160524298|NCT04796896|579649996|FG003|Overall Study|Missing|0|||
160524299|NCT04796896|579649997|FG004|Overall Study|Missing|0|||
160524300|NCT04796896|579649998|FG005|Overall Study|Missing|0|||
160524301|NCT04796896|579649999|FG006|Overall Study|Missing|2|||
160524302|NCT04796896|579650000|FG007|Overall Study|Missing|1|||
160524303|NCT04796896|579650001|FG008|Overall Study|Missing|2|||
160524304|NCT04796896|579650002|FG009|Overall Study|Missing|1|||
160524305|NCT04796896|579650003|FG010|Overall Study|Missing|1|||
160524306|NCT04796896|579650004|FG011|Overall Study|Missing|0|||
160524307|NCT04796896|579649993|FG000|Overall Study|Death|0|||
160524308|NCT04796896|579649994|FG001|Overall Study|Death|0|||
160524309|NCT04796896|579649995|FG002|Overall Study|Death|0|||
160524310|NCT04796896|579649996|FG003|Overall Study|Death|0|||
160524311|NCT04796896|579649997|FG004|Overall Study|Death|0|||
160524312|NCT04796896|579649998|FG005|Overall Study|Death|0|||
160524313|NCT04796896|579649999|FG006|Overall Study|Death|0|||
160524314|NCT04796896|579650000|FG007|Overall Study|Death|0|||
160749840|NCT03026283|580469683|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
160749841|NCT03026283|580469684|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
160749842|NCT03026283|580469685|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
160749843|NCT03026283|580469686|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
160749844|NCT03026283|580469687|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
160749845|NCT03026283|580469680|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
160749846|NCT03026283|580469681|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
160749847|NCT03026283|580469682|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
160749848|NCT03026283|580469683|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
160749849|NCT03026283|580469684|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
160749850|NCT03026283|580469685|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
160749851|NCT03026283|580469686|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
160749852|NCT03026283|580469687|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
160749853|NCT03026283|580469680|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
160749854|NCT03026283|580469681|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
160749855|NCT03026283|580469682|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
160749856|NCT03026283|580469683|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
160749857|NCT03026283|580469684|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
160749858|NCT03026283|580469685|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
160749859|NCT03026283|580469686|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
160749860|NCT03026283|580469687|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
160749861|NCT03026283|580469680|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
160749862|NCT03026283|580469681|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
160749863|NCT03026283|580469682|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
160749864|NCT03026283|580469683|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
160749865|NCT03026283|580469684|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
160749866|NCT03026283|580469685|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
160749867|NCT03026283|580469686|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
160749868|NCT03026283|580469687|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
160749869|NCT03026283|580469680|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
160749870|NCT03026283|580469681|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
160749871|NCT03026283|580469682|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
160749872|NCT03026283|580469683|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
160749873|NCT03026283|580469684|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
160865658|NCT00734539|580902944|FG000|Main Study|Death|33|||
160524315|NCT04796896|579650001|FG008|Overall Study|Death|1|||
160524316|NCT04796896|579650002|FG009|Overall Study|Death|0|||
160524317|NCT04796896|579650003|FG010|Overall Study|Death|0|||
160524318|NCT04796896|579650004|FG011|Overall Study|Death|0|||
160524319|NCT02021292|579650005|FG000|Overall Study|Physician Decision|0|||
160524320|NCT02021292|579650006|FG001|Overall Study|Physician Decision|1|||
160524321|NCT02021292|579650005|FG000|Overall Study|Lost to Follow-up|0|||
160524322|NCT02021292|579650006|FG001|Overall Study|Lost to Follow-up|1|||
160524323|NCT02021292|579650005|FG000|Overall Study|Death|0|||
160524324|NCT02021292|579650006|FG001|Overall Study|Death|1|||
160524325|NCT04356183|579650007|FG000|Overall Study|Lost to Follow-up|1|||
160524326|NCT04356183|579650008|FG001|Overall Study|Lost to Follow-up|0|||
160524327|NCT04356183|579650007|FG000|Overall Study|Withdrawal by Subject|1|||
160524328|NCT04356183|579650008|FG001|Overall Study|Withdrawal by Subject|1|||
160524329|NCT05972733|579650009|FG000|Overall Study|Lost to Follow-up|2|||
160524330|NCT05972733|579650009|FG000|Overall Study|Withdrawal by Subject|1|||
160524331|NCT01637623|579650010|FG000|Overall Study|Lost to Follow-up|0|||
160524332|NCT01637623|579650011|FG001|Overall Study|Lost to Follow-up|0|||
160524333|NCT01637623|579650012|FG002|Overall Study|Lost to Follow-up|2|||
160524334|NCT01637623|579650010|FG000|Overall Study|Physician Decision|1|||
160524335|NCT01637623|579650011|FG001|Overall Study|Physician Decision|0|||
160524336|NCT01637623|579650012|FG002|Overall Study|Physician Decision|1|||
160524337|NCT02824263|579650013|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
160524338|NCT02824263|579650014|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
160524339|NCT02824263|579650013|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
160524340|NCT02824263|579650014|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
160524341|NCT00568321|579650015|FG000|Overall Study|Adverse Event|1|||
160524342|NCT00568321|579650016|FG001|Overall Study|Adverse Event|0|||
160524343|NCT00568321|579650017|FG002|Overall Study|Adverse Event|0|||
160524344|NCT00568321|579650015|FG000|Overall Study|Lack of Efficacy|8|||
160524345|NCT00568321|579650016|FG001|Overall Study|Lack of Efficacy|5|||
160524346|NCT00568321|579650017|FG002|Overall Study|Lack of Efficacy|6|||
160524347|NCT00568321|579650015|FG000|Overall Study|Lost to Follow-up|0|||
160524348|NCT00568321|579650016|FG001|Overall Study|Lost to Follow-up|0|||
160524349|NCT00568321|579650017|FG002|Overall Study|Lost to Follow-up|1|||
160524350|NCT00568321|579650015|FG000|Overall Study|Withdrawal by Subject|2|||
160524351|NCT00568321|579650016|FG001|Overall Study|Withdrawal by Subject|0|||
160524352|NCT00568321|579650017|FG002|Overall Study|Withdrawal by Subject|0|||
160524353|NCT00568321|579650015|FG000|Overall Study|Protocol Violation|0|||
160524354|NCT00568321|579650016|FG001|Overall Study|Protocol Violation|0|||
160524355|NCT00568321|579650017|FG002|Overall Study|Protocol Violation|1|||
160524356|NCT00568321|579650015|FG000|Overall Study|Randomized, not treated|2|||
160524357|NCT00568321|579650016|FG001|Overall Study|Randomized, not treated|0|||
160524358|NCT00568321|579650017|FG002|Overall Study|Randomized, not treated|1|||
160524359|NCT01230788|579650024|FG000|Overall Study|Prescribed exclusion drug|1|||
160524360|NCT00323297|579650025|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
160524361|NCT00323297|579650026|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
160524362|NCT00323297|579650025|FG000|Part A (Double Blind Randomized)|Death|0|||
160524363|NCT00323297|579650026|FG001|Part A (Double Blind Randomized)|Death|1|||
160524364|NCT00323297|579650025|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
160524365|NCT00323297|579650026|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
160524366|NCT00323297|579650025|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
160524367|NCT00323297|579650026|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
160524368|NCT00323297|579650025|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
160524369|NCT00323297|579650026|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
160524370|NCT00323297|579650025|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
160524371|NCT00323297|579650026|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
160524372|NCT00323297|579650025|FG000|Part B (Open-label)|Death|0|||
160524373|NCT00323297|579650026|FG001|Part B (Open-label)|Death|1|||
160524374|NCT00323297|579650025|FG000|Part B (Open-label)|Reason unspecified|0|||
160524375|NCT00323297|579650026|FG001|Part B (Open-label)|Reason unspecified|1|||
160524376|NCT00323297|579650025|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
160524377|NCT00323297|579650026|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
160524378|NCT00323297|579650025|FG000|Part B (Open-label)|Lack of Efficacy|3|||
160524379|NCT00323297|579650026|FG001|Part B (Open-label)|Lack of Efficacy|1|||
160524380|NCT00323297|579650025|FG000|Part B (Open-label)|Adverse Event|5|||
160524381|NCT00323297|579650026|FG001|Part B (Open-label)|Adverse Event|5|||
160524382|NCT00323297|579650025|FG000|Part B (Open-label)|Protocol Violation|0|||
160524383|NCT00323297|579650026|FG001|Part B (Open-label)|Protocol Violation|1|||
160524384|NCT01176773|579650027|FG000|Overall Study|Screen Failure|2|||
160524385|NCT01176773|579650027|FG000|Overall Study|Withdrew consent|1|||
160524386|NCT01498289|579650032|FG000|Overall Study|Adverse Event|16|||
160524387|NCT01498289|579650033|FG001|Overall Study|Adverse Event|18|||
160524388|NCT01498289|579650032|FG000|Overall Study|Death|6|||
160524389|NCT01498289|579650033|FG001|Overall Study|Death|8|||
160524390|NCT01498289|579650032|FG000|Overall Study|Withdrawal unrelated to AE|16|||
160524391|NCT01498289|579650033|FG001|Overall Study|Withdrawal unrelated to AE|16|||
160524392|NCT01498289|579650032|FG000|Overall Study|Progression/relapse|53|||
160524393|NCT01498289|579650033|FG001|Overall Study|Progression/relapse|59|||
160524394|NCT01498289|579650032|FG000|Overall Study|Not protocol specified|7|||
160524395|NCT01498289|579650033|FG001|Overall Study|Not protocol specified|2|||
160524396|NCT01498289|579650032|FG000|Overall Study|Reason under review|0|||
160524397|NCT01498289|579650033|FG001|Overall Study|Reason under review|1|||
160524398|NCT01423253|579650034|FG000|Overall Study|Adverse Event|2|||
160524399|NCT01423253|579650034|FG000|Overall Study|Lack of Efficacy|2|||
160524400|NCT01423253|579650034|FG000|Overall Study|Lost to Follow-up|1|||
160524401|NCT01423253|579650034|FG000|Overall Study|Protocol Violation|2|||
160524402|NCT01423253|579650034|FG000|Overall Study|Withdrawal by Subject|2|||
160524403|NCT00752622|579650048|FG000|Induction Phase|Adverse Event|3|||
160524404|NCT00752622|579650048|FG000|Induction Phase|Other|3|||
160524405|NCT00752622|579650048|FG000|Induction Phase|Non-responder|14|||
160524406|NCT00752622|579650048|FG000|Induction Phase|Withdrawal by Subject|1|||
160524407|NCT00752622|579650048|FG000|Induction Phase|Premature study termination|14|||
160524408|NCT00752622|579650048|FG000|Observational Phase|Premature Study Termination|36|||
160524409|NCT00752622|579650048|FG000|Observational Phase|Non-responder|2|||
160524410|NCT00752622|579650048|FG000|Observational Phase|Withdrawal by Subject|2|||
160524411|NCT00752622|579650048|FG000|Observational Phase|Adverse Event|1|||
160524412|NCT00752622|579650048|FG000|Observational Phase|Other|2|||
160524413|NCT00752622|579650048|FG000|Interventional Phase|Non-responder|2|||
160524414|NCT00752622|579650048|FG000|Interventional Phase|Physician Decision|1|||
160524415|NCT00752622|579650048|FG000|Interventional Phase|Premature Study Termination|5|||
160524416|NCT00576836|579650049|FG000|Overall Study|Death|0|||
160524417|NCT00576836|579650050|FG001|Overall Study|Death|1|||
160524418|NCT00576836|579650049|FG000|Overall Study|Physician Decision|0|||
160524419|NCT00576836|579650050|FG001|Overall Study|Physician Decision|1|||
160524420|NCT00392327|579650053|FG000|Overall Study|Death|1|||
160524421|NCT00392327|579650054|FG001|Overall Study|Death|0|||
160524422|NCT00392327|579650055|FG002|Overall Study|Death|1|||
160524423|NCT00392327|579650056|FG003|Overall Study|Death|0|||
160524424|NCT00392327|579650057|FG004|Overall Study|Death|0|||
160524425|NCT00392327|579650058|FG005|Overall Study|Death|0|||
160524426|NCT00392327|579650059|FG006|Overall Study|Death|0|||
160524427|NCT00392327|579650060|FG007|Overall Study|Death|0|||
160524428|NCT00392327|579650053|FG000|Overall Study|Lack of Efficacy|8|||
160524429|NCT00392327|579650054|FG001|Overall Study|Lack of Efficacy|8|||
160524430|NCT00392327|579650055|FG002|Overall Study|Lack of Efficacy|9|||
160524431|NCT00392327|579650056|FG003|Overall Study|Lack of Efficacy|6|||
160524432|NCT00392327|579650057|FG004|Overall Study|Lack of Efficacy|3|||
160524433|NCT00392327|579650058|FG005|Overall Study|Lack of Efficacy|3|||
160524434|NCT00392327|579650059|FG006|Overall Study|Lack of Efficacy|3|||
160524435|NCT00392327|579650060|FG007|Overall Study|Lack of Efficacy|3|||
160524436|NCT00392327|579650053|FG000|Overall Study|Physician Decision|3|||
160524437|NCT00392327|579650054|FG001|Overall Study|Physician Decision|5|||
160524438|NCT00392327|579650055|FG002|Overall Study|Physician Decision|2|||
160524439|NCT00392327|579650056|FG003|Overall Study|Physician Decision|2|||
160524440|NCT00392327|579650057|FG004|Overall Study|Physician Decision|0|||
160524441|NCT00392327|579650058|FG005|Overall Study|Physician Decision|1|||
160524442|NCT00392327|579650059|FG006|Overall Study|Physician Decision|5|||
160524443|NCT00392327|579650060|FG007|Overall Study|Physician Decision|3|||
160524444|NCT00392327|579650053|FG000|Overall Study|Protocol Violation|0|||
160524445|NCT00392327|579650054|FG001|Overall Study|Protocol Violation|0|||
160524446|NCT00392327|579650055|FG002|Overall Study|Protocol Violation|1|||
160524447|NCT00392327|579650056|FG003|Overall Study|Protocol Violation|0|||
160524448|NCT00392327|579650057|FG004|Overall Study|Protocol Violation|0|||
160524449|NCT00392327|579650058|FG005|Overall Study|Protocol Violation|0|||
160524450|NCT00392327|579650059|FG006|Overall Study|Protocol Violation|0|||
160524451|NCT00392327|579650060|FG007|Overall Study|Protocol Violation|0|||
160524452|NCT00392327|579650053|FG000|Overall Study|Withdrawal by Subject|3|||
160524453|NCT00392327|579650054|FG001|Overall Study|Withdrawal by Subject|2|||
160524454|NCT00392327|579650055|FG002|Overall Study|Withdrawal by Subject|4|||
160524455|NCT00392327|579650056|FG003|Overall Study|Withdrawal by Subject|6|||
160524456|NCT00392327|579650057|FG004|Overall Study|Withdrawal by Subject|0|||
160524457|NCT00392327|579650058|FG005|Overall Study|Withdrawal by Subject|1|||
160524458|NCT00392327|579650059|FG006|Overall Study|Withdrawal by Subject|1|||
160524459|NCT00392327|579650060|FG007|Overall Study|Withdrawal by Subject|5|||
160524460|NCT00392327|579650053|FG000|Overall Study|Ineligible|0|||
160524461|NCT00392327|579650054|FG001|Overall Study|Ineligible|4|||
160524462|NCT00392327|579650055|FG002|Overall Study|Ineligible|3|||
160524463|NCT00392327|579650056|FG003|Overall Study|Ineligible|2|||
160524464|NCT00392327|579650057|FG004|Overall Study|Ineligible|0|||
160524465|NCT00392327|579650058|FG005|Overall Study|Ineligible|0|||
160524466|NCT00392327|579650059|FG006|Overall Study|Ineligible|0|||
160524467|NCT00392327|579650060|FG007|Overall Study|Ineligible|0|||
160635527|NCT02494583|580047486|FG001|Overall Study|Did Not Continue on Extension Study|10|||
160635528|NCT02494583|580047487|FG002|Overall Study|Did Not Continue on Extension Study|4|||
160635529|NCT02494583|580047485|FG000|Overall Study|Withdrawal by Subject|7|||
160635530|NCT02494583|580047486|FG001|Overall Study|Withdrawal by Subject|15|||
160635531|NCT02494583|580047487|FG002|Overall Study|Withdrawal by Subject|15|||
160635532|NCT00627458|580047490|FG000|Overall Study|Migrated from study area|1|||
160635533|NCT00627458|580047491|FG001|Overall Study|Migrated from study area|0|||
160635534|NCT00627458|580047492|FG002|Overall Study|Migrated from study area|1|||
160635535|NCT00627458|580047490|FG000|Overall Study|Withdrawal by Subject|2|||
160635536|NCT00627458|580047491|FG001|Overall Study|Withdrawal by Subject|6|||
160635537|NCT00627458|580047492|FG002|Overall Study|Withdrawal by Subject|5|||
160635538|NCT00627458|580047490|FG000|Overall Study|Lost to Follow-up|1|||
160635539|NCT00627458|580047491|FG001|Overall Study|Lost to Follow-up|1|||
160635540|NCT00627458|580047492|FG002|Overall Study|Lost to Follow-up|0|||
160635541|NCT03891875|580047493|FG000|Overall Study|Withdrawal by Subject|20|||
160635542|NCT03891875|580047494|FG001|Overall Study|Withdrawal by Subject|3|||
160635543|NCT03891875|580047493|FG000|Overall Study|Adverse Event|10|||
160635544|NCT03891875|580047494|FG001|Overall Study|Adverse Event|4|||
160635545|NCT03891875|580047493|FG000|Overall Study|Physician Decision|1|||
160635546|NCT03891875|580047494|FG001|Overall Study|Physician Decision|1|||
160635547|NCT03891875|580047493|FG000|Overall Study|Protocol Violation|1|||
160635548|NCT03891875|580047494|FG001|Overall Study|Protocol Violation|0|||
160635549|NCT03891875|580047493|FG000|Overall Study|Lost to Follow-up|1|||
160635550|NCT03891875|580047494|FG001|Overall Study|Lost to Follow-up|0|||
160635551|NCT03891875|580047493|FG000|Overall Study|COVID-19 infection|1|||
160635552|NCT03891875|580047494|FG001|Overall Study|COVID-19 infection|0|||
160635553|NCT00835068|580047499|FG000|Overall Study|Death|1|||
160635554|NCT00835068|580047500|FG001|Overall Study|Death|0|||
160635555|NCT00835068|580047499|FG000|Overall Study|Adverse Event|0|||
160635556|NCT00835068|580047500|FG001|Overall Study|Adverse Event|1|||
160635557|NCT00835068|580047499|FG000|Overall Study|Other|8|||
160635558|NCT00835068|580047500|FG001|Overall Study|Other|0|||
160635559|NCT00835068|580047499|FG000|Overall Study|Withdrawal by Subject|1|||
160635560|NCT00835068|580047500|FG001|Overall Study|Withdrawal by Subject|0|||
160635561|NCT00646282|580047501|FG000|Overall Study|Protocol terminated|4|||
160635562|NCT00646282|580047502|FG001|Overall Study|Protocol terminated|4|||
160635563|NCT00530088|580047503|FG000|Overall Study|Disease Progression|4|||
160635564|NCT00530088|580047503|FG000|Overall Study|Physician Decision|4|||
160635565|NCT00530088|580047503|FG000|Overall Study|Other Not Specified|2|||
160635566|NCT02058368|580047508|FG000|Overall Study|Adverse Event|15|||
160635567|NCT02058368|580047509|FG001|Overall Study|Adverse Event|20|||
160635568|NCT02058368|580047508|FG000|Overall Study|Lack of Efficacy|0|||
160635569|NCT02058368|580047509|FG001|Overall Study|Lack of Efficacy|1|||
160635570|NCT02058368|580047508|FG000|Overall Study|Protocol Violation|0|||
160635571|NCT02058368|580047509|FG001|Overall Study|Protocol Violation|4|||
160635572|NCT02058368|580047508|FG000|Overall Study|Lost to Follow-up|2|||
160635573|NCT02058368|580047509|FG001|Overall Study|Lost to Follow-up|0|||
160635574|NCT02058368|580047508|FG000|Overall Study|Physician Decision|2|||
160635575|NCT02058368|580047509|FG001|Overall Study|Physician Decision|3|||
160635576|NCT02058368|580047508|FG000|Overall Study|Withdrawal by Subject|22|||
160635577|NCT02058368|580047509|FG001|Overall Study|Withdrawal by Subject|26|||
160635578|NCT02181842|580047510|FG000|Overall Study|Case Report Forms Uncollected|2|||
160635579|NCT01652872|580047511|FG000|Overall Study|Death|36|||
160635580|NCT01652872|580047512|FG001|Overall Study|Death|39|||
160635581|NCT01652872|580047511|FG000|Overall Study|Lost to Follow-up|28|||
160635582|NCT01652872|580047512|FG001|Overall Study|Lost to Follow-up|23|||
160635583|NCT01652872|580047511|FG000|Overall Study|Decision by sponsor|5|||
160635584|NCT01652872|580047512|FG001|Overall Study|Decision by sponsor|7|||
160635585|NCT01652872|580047511|FG000|Overall Study|Withdrawal by Subject|76|||
160635586|NCT01652872|580047512|FG001|Overall Study|Withdrawal by Subject|84|||
160635587|NCT00758706|580047513|FG000|Overall Study|Adverse Event|4|||
160635588|NCT00758706|580047514|FG001|Overall Study|Adverse Event|4|||
160635589|NCT03985293|580047530|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
160635590|NCT03985293|580047531|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
160635591|NCT03985293|580047532|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
160635592|NCT03985293|580047533|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
160635593|NCT03985293|580047534|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
160635594|NCT03985293|580047535|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
160635595|NCT03985293|580047530|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
160635596|NCT03985293|580047531|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
160635597|NCT03985293|580047532|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
160635598|NCT03985293|580047533|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
160635599|NCT03985293|580047534|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
160635600|NCT03985293|580047535|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
160635601|NCT03985293|580047530|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
160635602|NCT03985293|580047531|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
160635603|NCT03985293|580047532|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
160635604|NCT03985293|580047533|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
160635605|NCT03985293|580047534|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
160635606|NCT03985293|580047535|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
160635607|NCT03985293|580047530|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
160635608|NCT03985293|580047531|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
160635609|NCT03985293|580047532|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
160635610|NCT03985293|580047533|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
160635611|NCT03985293|580047534|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
160635612|NCT03985293|580047535|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
160635613|NCT03985293|580047530|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
160635614|NCT03985293|580047531|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
160635615|NCT03985293|580047532|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
160635616|NCT03985293|580047533|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
160635617|NCT03985293|580047534|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
160524468|NCT00894686|579650061|FG000|Overall Study|Withdrawal by Subject|50|||
160524469|NCT00894686|579650061|FG000|Overall Study|Physician Decision|1|||
160524470|NCT00894686|579650061|FG000|Overall Study|Other|5|||
160524471|NCT03267940|579650062|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
160524472|NCT03267940|579650063|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
160524473|NCT03267940|579650064|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
160524474|NCT03267940|579650065|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
160524475|NCT03267940|579650066|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
160524476|NCT03267940|579650067|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
160524477|NCT03267940|579650062|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
160524478|NCT03267940|579650063|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
160524479|NCT03267940|579650064|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
160524480|NCT03267940|579650065|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
160524481|NCT03267940|579650066|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
160524482|NCT03267940|579650067|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
160524483|NCT03267940|579650062|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
160524484|NCT03267940|579650063|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
160524485|NCT03267940|579650064|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
160524486|NCT03267940|579650065|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
160524487|NCT03267940|579650066|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
160524488|NCT03267940|579650067|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
160524489|NCT03267940|579650062|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
160524490|NCT03267940|579650063|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
160524491|NCT03267940|579650064|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
160524492|NCT03267940|579650065|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
160524493|NCT03267940|579650066|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
160524494|NCT03267940|579650067|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
160524495|NCT03267940|579650062|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
160524496|NCT03267940|579650063|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
160524497|NCT03267940|579650064|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
160524498|NCT03267940|579650065|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
160524499|NCT03267940|579650066|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
160524500|NCT03267940|579650067|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
160524501|NCT03267940|579650062|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
160524502|NCT03267940|579650063|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
160524503|NCT03267940|579650064|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
160524504|NCT03267940|579650065|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
160524505|NCT03267940|579650066|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
160524506|NCT03267940|579650067|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
160524507|NCT03267940|579650062|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
160524508|NCT03267940|579650063|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
160524509|NCT03267940|579650064|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
160524510|NCT03267940|579650065|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
160524511|NCT03267940|579650066|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
160524512|NCT03267940|579650067|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
160635618|NCT03985293|580047535|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
160635619|NCT03985293|580047530|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
160635620|NCT03985293|580047531|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
160635621|NCT03985293|580047532|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
160635622|NCT03985293|580047533|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
160635623|NCT03985293|580047534|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
160635624|NCT03985293|580047535|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
160635625|NCT03985293|580047530|FG000|FOLLOW-UP|Lost to Follow-up|0|||
160635626|NCT03985293|580047531|FG001|FOLLOW-UP|Lost to Follow-up|0|||
160635627|NCT03985293|580047532|FG002|FOLLOW-UP|Lost to Follow-up|1|||
160635628|NCT03985293|580047533|FG003|FOLLOW-UP|Lost to Follow-up|0|||
160635629|NCT03985293|580047534|FG004|FOLLOW-UP|Lost to Follow-up|0|||
160635630|NCT03985293|580047535|FG005|FOLLOW-UP|Lost to Follow-up|0|||
160635631|NCT02588651|580047536|FG000|Overall Study|Adverse Event|1|||
160635632|NCT02588651|580047536|FG000|Overall Study|Withdrawal by Subject|2|||
160635633|NCT02588651|580047536|FG000|Overall Study|Death|1|||
160635634|NCT02588651|580047536|FG000|Overall Study|Lack of Efficacy|13|||
160635635|NCT02588651|580047536|FG000|Overall Study|Lost to Follow-up|1|||
160635636|NCT02588651|580047536|FG000|Overall Study|Physician Decision|1|||
160635637|NCT02588651|580047536|FG000|Overall Study|Disease progression|2|||
160635638|NCT05899218|580047537|FG000|Overall Study|Lost to Follow-up|2|||
160635639|NCT05899218|580047538|FG001|Overall Study|Lost to Follow-up|2|||
160635640|NCT05899218|580047537|FG000|Overall Study|deemed ineligible out of country|1|||
160635641|NCT05899218|580047538|FG001|Overall Study|deemed ineligible out of country|0|||
160635642|NCT02587325|580047543|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
160635643|NCT02587325|580047544|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
160635644|NCT02587325|580047545|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
160635645|NCT02587325|580047546|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
160635646|NCT02587325|580047547|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
160635647|NCT02587325|580047543|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
160635648|NCT02587325|580047544|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
160635649|NCT02587325|580047545|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
160635650|NCT02587325|580047546|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
160635651|NCT02587325|580047547|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
160635652|NCT02587325|580047543|FG000|32-Week Optional Extension Part|Adverse Event|0|||
160635653|NCT02587325|580047544|FG001|32-Week Optional Extension Part|Adverse Event|0|||
160635654|NCT02587325|580047545|FG002|32-Week Optional Extension Part|Adverse Event|1|||
160635655|NCT02587325|580047546|FG003|32-Week Optional Extension Part|Adverse Event|0|||
160635656|NCT02587325|580047547|FG004|32-Week Optional Extension Part|Adverse Event|0|||
160635657|NCT02587325|580047543|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
160635658|NCT02587325|580047544|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
160635659|NCT02587325|580047545|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
160635660|NCT02587325|580047546|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
160635661|NCT02587325|580047547|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
160635662|NCT00390572|580047548|FG000|Overall Study|Lost to Follow-up|8|||
160635663|NCT00390572|580047549|FG001|Overall Study|Lost to Follow-up|4|||
160635664|NCT00390572|580047548|FG000|Overall Study|health condition|0|||
160635665|NCT00390572|580047549|FG001|Overall Study|health condition|1|||
160635666|NCT03078192|580047580|FG000|Overall Study|Withdrawal by Subject|2|||
160635667|NCT03078192|580047581|FG001|Overall Study|Withdrawal by Subject|1|||
160635668|NCT03078192|580047580|FG000|Overall Study|screen failure|0|||
160635669|NCT03078192|580047581|FG001|Overall Study|screen failure|3|||
160635670|NCT01408576|580049287|FG000|Overall Study|Lack of Efficacy|17|||
160635671|NCT01408576|580049288|FG001|Overall Study|Lack of Efficacy|30|||
160635672|NCT01408576|580049289|FG002|Overall Study|Lack of Efficacy|48|||
160635673|NCT01408576|580049287|FG000|Overall Study|Protocol Violation|1|||
160635674|NCT01408576|580049288|FG001|Overall Study|Protocol Violation|2|||
160635675|NCT01408576|580049289|FG002|Overall Study|Protocol Violation|2|||
160635676|NCT01408576|580049287|FG000|Overall Study|Lost to Follow-up|10|||
160635677|NCT01408576|580049288|FG001|Overall Study|Lost to Follow-up|9|||
160635678|NCT01408576|580049289|FG002|Overall Study|Lost to Follow-up|17|||
160635679|NCT01408576|580049287|FG000|Overall Study|Withdrawal by Subject|34|||
160635680|NCT01408576|580049288|FG001|Overall Study|Withdrawal by Subject|60|||
160635681|NCT01408576|580049289|FG002|Overall Study|Withdrawal by Subject|66|||
160635682|NCT01408576|580049287|FG000|Overall Study|Sponsor terminated study|89|||
160635683|NCT01408576|580049288|FG001|Overall Study|Sponsor terminated study|333|||
160635684|NCT01408576|580049289|FG002|Overall Study|Sponsor terminated study|330|||
160635685|NCT01408576|580049287|FG000|Overall Study|AE, serious fatal|4|||
160635686|NCT01408576|580049288|FG001|Overall Study|AE, serious fatal|4|||
160635687|NCT01408576|580049289|FG002|Overall Study|AE, serious fatal|1|||
160635688|NCT01408576|580049287|FG000|Overall Study|SAE, non-fatal|11|||
160635689|NCT01408576|580049288|FG001|Overall Study|SAE, non-fatal|23|||
160635690|NCT01408576|580049289|FG002|Overall Study|SAE, non-fatal|14|||
160635691|NCT01408576|580049287|FG000|Overall Study|AE, non-serious non-fatal|12|||
160635692|NCT01408576|580049288|FG001|Overall Study|AE, non-serious non-fatal|19|||
160635693|NCT01408576|580049289|FG002|Overall Study|AE, non-serious non-fatal|11|||
160635694|NCT01408576|580049287|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
160635695|NCT01408576|580049288|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160635696|NCT01408576|580049289|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160635697|NCT01408576|580049287|FG000|Overall Study|AE, unknown type|0|||
160635698|NCT01408576|580049288|FG001|Overall Study|AE, unknown type|1|||
160635699|NCT01408576|580049289|FG002|Overall Study|AE, unknown type|0|||
160635700|NCT01408576|580049287|FG000|Overall Study|Other|10|||
160635701|NCT01408576|580049288|FG001|Overall Study|Other|16|||
160635702|NCT01408576|580049289|FG002|Overall Study|Other|18|||
160635703|NCT02016755|580049290|FG000|Overall Study|Major amputation of index limb|2|||
160635704|NCT02016755|580049290|FG000|Overall Study|Adverse Event|2|||
160635705|NCT02016755|580049290|FG000|Overall Study|Physician Decision|1|||
160635706|NCT02016755|580049290|FG000|Overall Study|Death|2|||
160635707|NCT02476851|580049291|FG000|Overall Study|Protocol Violation|1|||
160635708|NCT02476851|580049292|FG001|Overall Study|Protocol Violation|1|||
160635709|NCT00647426|580049302|FG000|Overall Study|Withdrawal by Subject|2|||
160635710|NCT02360397|580049308|FG000|Overall Study|Incomplete screening|3|||
160635711|NCT02360397|580049308|FG000|Overall Study|Adverse Event|1|||
160635712|NCT03543046|580049315|FG000|Overall Study|Adverse Event|1|||
160635713|NCT03543046|580049316|FG001|Overall Study|Adverse Event|1|||
160635714|NCT03543046|580049315|FG000|Overall Study|Physician Decision|1|||
160635715|NCT03543046|580049316|FG001|Overall Study|Physician Decision|1|||
160635716|NCT03543046|580049315|FG000|Overall Study|Protocol Violation|1|||
160635717|NCT03543046|580049316|FG001|Overall Study|Protocol Violation|0|||
160635718|NCT02748616|580049324|FG000|Overall Study|Lost to Follow-up|1|||
160635719|NCT02748616|580049324|FG000|Overall Study|Withdrawal by Subject|2|||
160635720|NCT02748616|580049324|FG000|Overall Study|Physician Decision|2|||
160635721|NCT02748616|580049324|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
160635722|NCT00068406|580049327|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
160635723|NCT00068406|580049327|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
160635724|NCT02018042|580049331|FG000|Overall Study|Withdrawal by Subject|1|||
160635725|NCT00589693|580049332|FG000|Overall Study|randomized in error|12|||
160635726|NCT00589693|580049333|FG001|Overall Study|randomized in error|6|||
160635727|NCT00589693|580049332|FG000|Overall Study|Adverse Event|4|||
160635728|NCT00589693|580049333|FG001|Overall Study|Adverse Event|4|||
160635729|NCT00589693|580049332|FG000|Overall Study|Death|26|||
160635730|NCT00589693|580049333|FG001|Overall Study|Death|16|||
160635731|NCT00589693|580049332|FG000|Overall Study|Lack of Efficacy|0|||
160635732|NCT00589693|580049333|FG001|Overall Study|Lack of Efficacy|1|||
160635733|NCT00589693|580049332|FG000|Overall Study|Lost to Follow-up|1|||
160635734|NCT00589693|580049333|FG001|Overall Study|Lost to Follow-up|0|||
160635735|NCT00589693|580049332|FG000|Overall Study|Physician Decision|0|||
160635736|NCT00589693|580049333|FG001|Overall Study|Physician Decision|1|||
160635737|NCT00589693|580049332|FG000|Overall Study|Protocol Violation|1|||
160635738|NCT00589693|580049333|FG001|Overall Study|Protocol Violation|1|||
160635739|NCT03231709|580049334|FG000|Treatment Period 1|Reason not Specified|0|||
160635740|NCT03231709|580049335|FG001|Treatment Period 1|Reason not Specified|1|||
160749874|NCT03026283|580469685|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
160749875|NCT03026283|580469686|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
160749876|NCT03026283|580469687|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
160749877|NCT03026283|580469680|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
160749878|NCT03026283|580469681|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
160749879|NCT03026283|580469682|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
160749880|NCT03026283|580469683|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
160749881|NCT03026283|580469684|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
160749882|NCT03026283|580469685|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
160749883|NCT03026283|580469686|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
160749884|NCT03026283|580469687|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
160749885|NCT00824655|580469688|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
160749886|NCT00824655|580469689|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
160749887|NCT00824655|580469688|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
160749888|NCT00824655|580469689|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
160749889|NCT02630563|580469692|FG000|Overall Study|Administrative|1|||
160749890|NCT01301079|580469694|FG000|Overall Study|Lost to Follow-up|2|||
160749891|NCT01301079|580469695|FG001|Overall Study|Lost to Follow-up|2|||
160749892|NCT00313586|580469696|FG000|Overall Study|Disease progression|14|||
160749893|NCT00313586|580469697|FG001|Overall Study|Disease progression|19|||
160749894|NCT00313586|580469698|FG002|Overall Study|Disease progression|10|||
160749895|NCT00313586|580469699|FG003|Overall Study|Disease progression|3|||
160749896|NCT00313586|580469696|FG000|Overall Study|Adverse Event|12|||
160749897|NCT00313586|580469697|FG001|Overall Study|Adverse Event|18|||
160749898|NCT00313586|580469698|FG002|Overall Study|Adverse Event|3|||
160749899|NCT00313586|580469699|FG003|Overall Study|Adverse Event|10|||
160749900|NCT00313586|580469696|FG000|Overall Study|Death|11|||
160749901|NCT00313586|580469697|FG001|Overall Study|Death|8|||
160635741|NCT03231709|580049334|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
160635742|NCT03231709|580049335|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
160635743|NCT02609178|580049336|FG000|First Crown|Withdrawal by Subject|0|||
160635744|NCT02609178|580049337|FG001|First Crown|Withdrawal by Subject|0|||
160749902|NCT00313586|580469698|FG002|Overall Study|Death|1|||
160749903|NCT00313586|580469699|FG003|Overall Study|Death|7|||
160749904|NCT00313586|580469696|FG000|Overall Study|Withdrawal by Subject|13|||
160749905|NCT00313586|580469697|FG001|Overall Study|Withdrawal by Subject|6|||
160749906|NCT00313586|580469698|FG002|Overall Study|Withdrawal by Subject|6|||
160749907|NCT00313586|580469699|FG003|Overall Study|Withdrawal by Subject|2|||
160749908|NCT00313586|580469696|FG000|Overall Study|Alternative therapy|3|||
160749909|NCT00313586|580469697|FG001|Overall Study|Alternative therapy|6|||
160749910|NCT00313586|580469698|FG002|Overall Study|Alternative therapy|2|||
160749911|NCT00313586|580469699|FG003|Overall Study|Alternative therapy|0|||
160749912|NCT00313586|580469696|FG000|Overall Study|Other complicating disease|2|||
160749913|NCT00313586|580469697|FG001|Overall Study|Other complicating disease|2|||
160749914|NCT00313586|580469698|FG002|Overall Study|Other complicating disease|0|||
160749915|NCT00313586|580469699|FG003|Overall Study|Other complicating disease|0|||
160749916|NCT00313586|580469696|FG000|Overall Study|Did not achieve HI-major/better response|10|||
160749917|NCT00313586|580469697|FG001|Overall Study|Did not achieve HI-major/better response|7|||
160749918|NCT00313586|580469698|FG002|Overall Study|Did not achieve HI-major/better response|2|||
160749919|NCT00313586|580469699|FG003|Overall Study|Did not achieve HI-major/better response|1|||
160749920|NCT00313586|580469696|FG000|Overall Study|Physician Decision|2|||
160749921|NCT00313586|580469697|FG001|Overall Study|Physician Decision|1|||
160749922|NCT00313586|580469698|FG002|Overall Study|Physician Decision|0|||
160749923|NCT00313586|580469699|FG003|Overall Study|Physician Decision|0|||
160749924|NCT00313586|580469696|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
160749925|NCT00313586|580469697|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
160749926|NCT00313586|580469698|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
160749927|NCT00313586|580469699|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
160749928|NCT00313586|580469696|FG000|Overall Study|Lost insurance|0|||
160749929|NCT00313586|580469697|FG001|Overall Study|Lost insurance|1|||
160749930|NCT00313586|580469698|FG002|Overall Study|Lost insurance|0|||
160749931|NCT00313586|580469699|FG003|Overall Study|Lost insurance|0|||
160749932|NCT00313586|580469696|FG000|Overall Study|Moved|0|||
160749933|NCT00313586|580469697|FG001|Overall Study|Moved|1|||
160749934|NCT00313586|580469698|FG002|Overall Study|Moved|0|||
160749935|NCT00313586|580469699|FG003|Overall Study|Moved|0|||
160749936|NCT00313586|580469696|FG000|Overall Study|Death before starting treatment|1|||
160749937|NCT00313586|580469697|FG001|Overall Study|Death before starting treatment|0|||
160749938|NCT00313586|580469698|FG002|Overall Study|Death before starting treatment|0|||
160749939|NCT00313586|580469699|FG003|Overall Study|Death before starting treatment|0|||
160749940|NCT01639703|580469700|FG000|Overall Study|Withdrawal by Subject|5|||
160749941|NCT01639703|580469700|FG000|Overall Study|Other reason|7|||
160749942|NCT00264290|580469701|FG000|Intervention (8 Weeks)|Adverse Event|1|||
160749943|NCT00264290|580469702|FG001|Intervention (8 Weeks)|Adverse Event|0|||
160524513|NCT03267940|579650062|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
160749944|NCT04472494|580469703|FG000|Pre-treatment|Other reasons|2|||
160749945|NCT04472494|580469704|FG001|Pre-treatment|Other reasons|0|||
160749946|NCT04472494|580469703|FG000|Treatment|Death|5|||
160749947|NCT04472494|580469704|FG001|Treatment|Death|2|||
160749948|NCT04472494|580469703|FG000|Treatment|Hospital discharge|1|||
160749949|NCT04472494|580469704|FG001|Treatment|Hospital discharge|1|||
160749950|NCT03519919|580469705|FG000|Overall Study|Withdrawal by Subject|1|||
160749951|NCT03519919|580469705|FG000|Overall Study|Lack of Efficacy|1|||
160749952|NCT03519919|580469705|FG000|Overall Study|Screen Failure|1|||
160749953|NCT03076996|580469706|FG000|Overall Study|Withdrawal by Subject|2|||
160749954|NCT03076996|580469706|FG000|Overall Study|Lost to Follow-up|3|||
160749955|NCT03076996|580469706|FG000|Overall Study|Literacy precluded participation|1|||
160749956|NCT00587795|580469711|FG000|Overall Study|Withdrawal by Subject|1|||
160749957|NCT00587795|580469712|FG001|Overall Study|Withdrawal by Subject|0|||
160749958|NCT02144077|580469713|FG000|Overall Study|Withdrawal by Subject|3|||
160749959|NCT02144077|580469714|FG001|Overall Study|Withdrawal by Subject|3|||
160749960|NCT02144077|580469713|FG000|Overall Study|Adverse Event|2|||
160749961|NCT02144077|580469714|FG001|Overall Study|Adverse Event|3|||
160749962|NCT02144077|580469713|FG000|Overall Study|Lost to Follow-up|2|||
160749963|NCT02144077|580469714|FG001|Overall Study|Lost to Follow-up|2|||
160749964|NCT02144077|580469713|FG000|Overall Study|Protocol Violation|1|||
160749965|NCT02144077|580469714|FG001|Overall Study|Protocol Violation|2|||
160749966|NCT02144077|580469713|FG000|Overall Study|Death|0|||
160749967|NCT02144077|580469714|FG001|Overall Study|Death|1|||
160749968|NCT02144077|580469713|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
160749969|NCT02144077|580469714|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
160749970|NCT01869777|580469715|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
160749971|NCT01951573|580469716|FG000|Washout Period|Adverse Event|0|||
160749972|NCT01951573|580469717|FG001|Washout Period|Adverse Event|1|||
160749973|NCT00943592|580469718|FG000|Overall Study|Death|3|||
160749974|NCT01909973|580469719|FG000|Overall Study|Lost to Follow-up|1|||
160749975|NCT01909973|580469720|FG001|Overall Study|Lost to Follow-up|0|||
160749976|NCT02438280|580469724|FG000|Overall Study|Physician Decision|1|||
160749977|NCT02438280|580469725|FG001|Overall Study|Physician Decision|0|||
160749978|NCT02982863|580469726|FG000|Overall Study|Not eligible patients|809|||
160749979|NCT02982863|580469727|FG001|Overall Study|Not eligible patients|4261|||
160749980|NCT02982863|580469728|FG002|Overall Study|Not eligible patients|1852|||
160749981|NCT02982863|580469729|FG003|Overall Study|Not eligible patients|1400|||
160749982|NCT02982863|580469730|FG004|Overall Study|Not eligible patients|492|||
160749983|NCT03739710|580469731|FG000|Overall Study|Screen Failed|81|||
160749984|NCT01753115|580469732|FG000|Overall Study|Lost to Follow-up|3|||
160749985|NCT01753115|580469733|FG001|Overall Study|Lost to Follow-up|6|||
160749986|NCT01753115|580469734|FG002|Overall Study|Lost to Follow-up|8|||
160749987|NCT01753115|580469732|FG000|Overall Study|Withdrawal by Subject|6|||
160749988|NCT01753115|580469733|FG001|Overall Study|Withdrawal by Subject|5|||
160749989|NCT01753115|580469734|FG002|Overall Study|Withdrawal by Subject|6|||
160749990|NCT01753115|580469732|FG000|Overall Study|Subject non-compliant|3|||
160749991|NCT01753115|580469733|FG001|Overall Study|Subject non-compliant|3|||
160749992|NCT01753115|580469734|FG002|Overall Study|Subject non-compliant|0|||
160749993|NCT01753115|580469732|FG000|Overall Study|Used excluded drug|0|||
160749994|NCT01753115|580469733|FG001|Overall Study|Used excluded drug|1|||
160749995|NCT01753115|580469734|FG002|Overall Study|Used excluded drug|0|||
160749996|NCT04313400|580469740|FG000|Overall Study|Withdrawal by Subject|0|||
160749997|NCT04313400|580469741|FG001|Overall Study|Withdrawal by Subject|0|||
160749998|NCT04313400|580469742|FG002|Overall Study|Withdrawal by Subject|0|||
160749999|NCT04313400|580469743|FG003|Overall Study|Withdrawal by Subject|0|||
160750000|NCT04313400|580469744|FG004|Overall Study|Withdrawal by Subject|0|||
160750001|NCT04313400|580469745|FG005|Overall Study|Withdrawal by Subject|4|||
160750002|NCT04313400|580469746|FG006|Overall Study|Withdrawal by Subject|1|||
160750003|NCT04313400|580469740|FG000|Overall Study|Adverse Event|0|||
160750004|NCT04313400|580469741|FG001|Overall Study|Adverse Event|0|||
160750005|NCT04313400|580469742|FG002|Overall Study|Adverse Event|0|||
160750006|NCT04313400|580469743|FG003|Overall Study|Adverse Event|0|||
160750007|NCT04313400|580469744|FG004|Overall Study|Adverse Event|0|||
160750008|NCT04313400|580469745|FG005|Overall Study|Adverse Event|1|||
160750009|NCT04313400|580469746|FG006|Overall Study|Adverse Event|0|||
160750010|NCT04313400|580469740|FG000|Overall Study|Lost to Follow-up|0|||
160750011|NCT04313400|580469741|FG001|Overall Study|Lost to Follow-up|0|||
160750012|NCT04313400|580469742|FG002|Overall Study|Lost to Follow-up|0|||
160750013|NCT04313400|580469743|FG003|Overall Study|Lost to Follow-up|0|||
160750014|NCT04313400|580469744|FG004|Overall Study|Lost to Follow-up|0|||
160635745|NCT02609178|580049338|FG002|First Crown|Withdrawal by Subject|1|||
160635746|NCT02609178|580049339|FG003|First Crown|Withdrawal by Subject|1|||
160635747|NCT02609178|580049340|FG004|First Crown|Withdrawal by Subject|0|||
160635748|NCT02609178|580049341|FG005|First Crown|Withdrawal by Subject|0|||
160635749|NCT02419469|580049342|FG000|Overall Study|Withdrawal by Subject|1|||
160635750|NCT01377233|580049343|FG000|Open-label|Adverse Event|1|||
160635751|NCT01377233|580049344|FG001|Open-label|Adverse Event|0|||
160635752|NCT01377233|580049345|FG002|Open-label|Adverse Event|0|||
160635753|NCT01377233|580049346|FG003|Open-label|Adverse Event|0|||
160635754|NCT01377233|580049347|FG004|Open-label|Adverse Event|0|||
160635755|NCT01377233|580049343|FG000|Open-label|Withdrawal by Subject|3|||
160635756|NCT01377233|580049344|FG001|Open-label|Withdrawal by Subject|0|||
160635757|NCT01377233|580049345|FG002|Open-label|Withdrawal by Subject|0|||
160635758|NCT01377233|580049346|FG003|Open-label|Withdrawal by Subject|0|||
160635759|NCT01377233|580049347|FG004|Open-label|Withdrawal by Subject|0|||
160635760|NCT01377233|580049343|FG000|Double-blind|Adverse Event|0|||
160635761|NCT01377233|580049344|FG001|Double-blind|Adverse Event|1|||
160635762|NCT01377233|580049345|FG002|Double-blind|Adverse Event|2|||
160635763|NCT01377233|580049346|FG003|Double-blind|Adverse Event|2|||
160635764|NCT01377233|580049347|FG004|Double-blind|Adverse Event|0|||
160635765|NCT01377233|580049343|FG000|Double-blind|Protocol Violation|0|||
160635766|NCT01377233|580049344|FG001|Double-blind|Protocol Violation|0|||
160635767|NCT01377233|580049345|FG002|Double-blind|Protocol Violation|0|||
160635768|NCT01377233|580049346|FG003|Double-blind|Protocol Violation|0|||
160635769|NCT01377233|580049347|FG004|Double-blind|Protocol Violation|1|||
160635770|NCT01377233|580049343|FG000|Double-blind|Withdrawal by Subject|0|||
160635771|NCT01377233|580049344|FG001|Double-blind|Withdrawal by Subject|0|||
160635772|NCT01377233|580049345|FG002|Double-blind|Withdrawal by Subject|0|||
160635773|NCT01377233|580049346|FG003|Double-blind|Withdrawal by Subject|1|||
160635774|NCT01377233|580049347|FG004|Double-blind|Withdrawal by Subject|0|||
160635775|NCT01377233|580049343|FG000|Double-blind|Administrative or other|0|||
160635776|NCT01377233|580049344|FG001|Double-blind|Administrative or other|0|||
160635777|NCT01377233|580049345|FG002|Double-blind|Administrative or other|0|||
160750015|NCT04313400|580469745|FG005|Overall Study|Lost to Follow-up|1|||
160750016|NCT04313400|580469746|FG006|Overall Study|Lost to Follow-up|0|||
160750017|NCT02091414|580469749|FG000|Overall Study|Withdrawal by Subject|2|||
160750018|NCT02091414|580469749|FG000|Overall Study|Death|2|||
160865659|NCT00734539|580902945|FG001|Main Study|Death|32|||
160635778|NCT01377233|580049346|FG003|Double-blind|Administrative or other|1|||
160635779|NCT01377233|580049347|FG004|Double-blind|Administrative or other|1|||
160635780|NCT01785875|580049348|FG000|Overall Study|Withdrawal by Subject|41|||
160635781|NCT01785875|580049349|FG001|Overall Study|Withdrawal by Subject|34|||
160635782|NCT01785875|580049350|FG002|Overall Study|Withdrawal by Subject|36|||
160635783|NCT01785875|580049348|FG000|Overall Study|Lost to Follow-up|19|||
160635784|NCT01785875|580049349|FG001|Overall Study|Lost to Follow-up|22|||
160635785|NCT01785875|580049350|FG002|Overall Study|Lost to Follow-up|6|||
160635786|NCT01785875|580049348|FG000|Overall Study|Death|27|||
160635787|NCT01785875|580049349|FG001|Overall Study|Death|16|||
160635788|NCT01785875|580049350|FG002|Overall Study|Death|7|||
160635789|NCT01785875|580049348|FG000|Overall Study|Sponsor Decision|0|||
160635790|NCT01785875|580049349|FG001|Overall Study|Sponsor Decision|2|||
160635791|NCT01785875|580049350|FG002|Overall Study|Sponsor Decision|0|||
160635792|NCT01785875|580049348|FG000|Overall Study|Protocol Specified Criteria|207|||
160635793|NCT01785875|580049349|FG001|Overall Study|Protocol Specified Criteria|214|||
160635794|NCT01785875|580049350|FG002|Overall Study|Protocol Specified Criteria|55|||
160635795|NCT01785875|580049348|FG000|Overall Study|Missing|0|||
160635796|NCT01785875|580049349|FG001|Overall Study|Missing|1|||
160635797|NCT01785875|580049350|FG002|Overall Study|Missing|3|||
160635798|NCT01414062|580049353|FG000|Overall Study|Lost to Follow-up|3|||
160635799|NCT01414062|580049354|FG001|Overall Study|Lost to Follow-up|2|||
160635800|NCT01414062|580049353|FG000|Overall Study|Left Country|1|||
160635801|NCT01414062|580049354|FG001|Overall Study|Left Country|1|||
160635802|NCT01414062|580049353|FG000|Overall Study|Family Disapproval|1|||
160635803|NCT01414062|580049354|FG001|Overall Study|Family Disapproval|0|||
160635804|NCT01414062|580049353|FG000|Overall Study|Withdrawal by Subject|0|||
160635805|NCT01414062|580049354|FG001|Overall Study|Withdrawal by Subject|1|||
160635806|NCT04075292|580049355|FG000|Overall Study|Withdrawal by Subject|1|||
160635807|NCT04075292|580049356|FG001|Overall Study|Withdrawal by Subject|9|||
160635808|NCT04075292|580049355|FG000|Overall Study|Death|2|||
160635809|NCT04075292|580049356|FG001|Overall Study|Death|5|||
160635810|NCT04075292|580049355|FG000|Overall Study|Remained on study at time of DCO|74|||
160635811|NCT04075292|580049356|FG001|Overall Study|Remained on study at time of DCO|64|||
160635812|NCT00902265|580049359|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
160635813|NCT00902265|580049359|FG000|Overall Study|Adverse Event|2|||
160635814|NCT00902265|580049359|FG000|Overall Study|Lack of Efficacy|2|||
160635815|NCT00902265|580049359|FG000|Overall Study|Protocol Violation|1|||
160635816|NCT02866695|580049361|FG000|Overall Study|Adverse Event|1|||
160635817|NCT02866695|580049361|FG000|Overall Study|Lost to Follow-up|1|||
160635818|NCT05016765|580049362|FG000|Overall Study|Lost to Follow-up|4|||
160635819|NCT01988493|580049365|FG000|Overall Study|Randomized but not treated|0|||
160635820|NCT01988493|580049366|FG001|Overall Study|Randomized but not treated|0|||
160635821|NCT01988493|580049367|FG002|Overall Study|Randomized but not treated|0|||
160635822|NCT01988493|580049368|FG003|Overall Study|Randomized but not treated|0|||
160635823|NCT01988493|580049369|FG004|Overall Study|Randomized but not treated|1|||
160635824|NCT03087773|580049374|FG000|Overall Study|Withdrawal by Subject|8|||
160635825|NCT03087773|580049375|FG001|Overall Study|Withdrawal by Subject|4|||
160635826|NCT03087773|580049374|FG000|Overall Study|Lost to Follow-up|12|||
160635827|NCT03087773|580049375|FG001|Overall Study|Lost to Follow-up|8|||
160635828|NCT00185731|580049376|FG000|Overall Study|Withdrawal by Subject|1|||
160635829|NCT00185731|580049376|FG000|Overall Study|Not Eligible|1|||
160635830|NCT05144477|580049379|FG000|Overall Study|Withdrawal by Subject|1|||
160635831|NCT05144477|580049380|FG001|Overall Study|Withdrawal by Subject|1|||
160635832|NCT01787188|580049383|FG000|Overall Study|Adverse Event|2|||
160635833|NCT01787188|580049384|FG001|Overall Study|Adverse Event|4|||
160635834|NCT01787188|580049385|FG002|Overall Study|Adverse Event|6|||
160635835|NCT01787188|580049383|FG000|Overall Study|Lack of Efficacy|7|||
160635836|NCT01787188|580049384|FG001|Overall Study|Lack of Efficacy|3|||
160635837|NCT01787188|580049385|FG002|Overall Study|Lack of Efficacy|5|||
160635838|NCT01787188|580049383|FG000|Overall Study|Non-compliance with Study Drug|0|||
160635839|NCT01787188|580049384|FG001|Overall Study|Non-compliance with Study Drug|1|||
160635840|NCT01787188|580049385|FG002|Overall Study|Non-compliance with Study Drug|0|||
160635841|NCT01787188|580049383|FG000|Overall Study|Withdrawal by Subject|4|||
160635842|NCT01787188|580049384|FG001|Overall Study|Withdrawal by Subject|3|||
160635843|NCT01787188|580049385|FG002|Overall Study|Withdrawal by Subject|2|||
160635844|NCT01787188|580049383|FG000|Overall Study|Protocol Violation|3|||
160635845|NCT01787188|580049384|FG001|Overall Study|Protocol Violation|2|||
160750019|NCT02782377|580469750|FG000|Overall Study|Physician Decision|5|||
160750020|NCT02521792|580469751|FG000|Overall Study|Study Terminated|6|||
160635846|NCT01787188|580049385|FG002|Overall Study|Protocol Violation|3|||
160635847|NCT01787188|580049383|FG000|Overall Study|Lost to Follow-up|1|||
160635848|NCT01787188|580049384|FG001|Overall Study|Lost to Follow-up|2|||
160635849|NCT01787188|580049385|FG002|Overall Study|Lost to Follow-up|2|||
160635850|NCT01787188|580049383|FG000|Overall Study|Other, including patient moved|0|||
160750021|NCT01188668|580469752|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
160635851|NCT01787188|580049384|FG001|Overall Study|Other, including patient moved|3|||
160635852|NCT01787188|580049385|FG002|Overall Study|Other, including patient moved|0|||
160635853|NCT00854607|580049386|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
160635854|NCT00965263|580049392|FG000|Overall Study|Physician Decision|2|||
160635855|NCT00965263|580049393|FG001|Overall Study|Physician Decision|0|||
160635856|NCT00965263|580049392|FG000|Overall Study|Family emergency|0|||
160635857|NCT00965263|580049393|FG001|Overall Study|Family emergency|1|||
160635858|NCT00965263|580049392|FG000|Overall Study|Protocol Violation|0|||
160635859|NCT00965263|580049393|FG001|Overall Study|Protocol Violation|2|||
160635860|NCT03959137|580049394|FG000|Overall Study|Protocol Violation|6|||
160635861|NCT02756078|580049395|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
160635862|NCT02756078|580049396|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
160635863|NCT02756078|580049395|FG000|Period 1|Lost to Follow-up|0|||
160635864|NCT02756078|580049396|FG001|Period 1|Lost to Follow-up|2|||
160635865|NCT02756078|580049395|FG000|Period 1|Protocol Violation|0|||
160635866|NCT02756078|580049396|FG001|Period 1|Protocol Violation|1|||
160635867|NCT02756078|580049395|FG000|Period 1|Adverse Event|1|||
160635868|NCT02756078|580049396|FG001|Period 1|Adverse Event|10|||
160635869|NCT02756078|580049395|FG000|Period 1|Withdrawal by Subject|6|||
160635870|NCT02756078|580049396|FG001|Period 1|Withdrawal by Subject|6|||
160635871|NCT02756078|580049395|FG000|Period 1|Lens Discomfort|2|||
160635872|NCT02756078|580049396|FG001|Period 1|Lens Discomfort|2|||
160635873|NCT02756078|580049395|FG000|Period 2|Adverse Event|3|||
160635874|NCT02756078|580049396|FG001|Period 2|Adverse Event|5|||
160635875|NCT02756078|580049395|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
160635876|NCT02756078|580049396|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
160635877|NCT02756078|580049395|FG000|Period 2|Withdrawal by Subject|3|||
160635878|NCT02756078|580049396|FG001|Period 2|Withdrawal by Subject|1|||
160635879|NCT00810615|580049397|FG000|Overall Study|Withdrawal by Subject|1|||
160635880|NCT00810615|580049398|FG001|Overall Study|Withdrawal by Subject|1|||
160635881|NCT01766310|580049400|FG000|Overall Study|Lost to Follow-up|1|||
160635882|NCT01766310|580049401|FG001|Overall Study|Lost to Follow-up|3|||
160635883|NCT02125734|580049402|FG000|Period 2|Adverse Event|0|||
160635884|NCT02125734|580049403|FG001|Period 2|Adverse Event|1|||
160635885|NCT01591499|580049404|FG000|Baseline Visit|Withdrawal by Subject|0|||
160635886|NCT01591499|580049405|FG001|Baseline Visit|Withdrawal by Subject|2|||
160635887|NCT01591499|580049406|FG002|Baseline Visit|Withdrawal by Subject|0|||
160635888|NCT01591499|580049407|FG003|Baseline Visit|Withdrawal by Subject|2|||
160635889|NCT01591499|580049404|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
160635890|NCT01591499|580049405|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
160635891|NCT01591499|580049406|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
160635892|NCT01591499|580049407|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
160635893|NCT01591499|580049404|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
160635894|NCT01591499|580049405|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
160635895|NCT01591499|580049406|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
160635896|NCT01591499|580049407|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
160635897|NCT02441179|580049410|FG000|Overall Study|Withdrawal by Subject|1|||
160635898|NCT02441179|580049411|FG001|Overall Study|Withdrawal by Subject|1|||
160635899|NCT03454672|580049412|FG000|Overall Study|Adverse Event|1|||
160635900|NCT03454672|580049413|FG001|Overall Study|Adverse Event|1|||
160635901|NCT03454672|580049412|FG000|Overall Study|Lost to Follow-up|1|||
160635902|NCT03454672|580049413|FG001|Overall Study|Lost to Follow-up|3|||
160635903|NCT03454672|580049412|FG000|Overall Study|painful|1|||
160635904|NCT03454672|580049413|FG001|Overall Study|painful|2|||
160635905|NCT03454672|580049412|FG000|Overall Study|Non-compliance|2|||
160635906|NCT03454672|580049413|FG001|Overall Study|Non-compliance|4|||
160635907|NCT03454672|580049412|FG000|Overall Study|personal reasons|3|||
160635908|NCT03454672|580049413|FG001|Overall Study|personal reasons|2|||
160635909|NCT03454672|580049412|FG000|Overall Study|Withdrawal by Subject|1|||
160635910|NCT03454672|580049413|FG001|Overall Study|Withdrawal by Subject|0|||
160635911|NCT02139306|580049414|FG000|Overall Study|Withdrawal by Subject|4|||
160635912|NCT02139306|580049415|FG001|Overall Study|Withdrawal by Subject|6|||
160635913|NCT02139306|580049414|FG000|Overall Study|Adverse Event|3|||
160635914|NCT02139306|580049415|FG001|Overall Study|Adverse Event|4|||
160635915|NCT02139306|580049414|FG000|Overall Study|Physician Decision|0|||
160635916|NCT02139306|580049415|FG001|Overall Study|Physician Decision|1|||
160635917|NCT02139306|580049414|FG000|Overall Study|Other Unspecified|2|||
160635918|NCT02139306|580049415|FG001|Overall Study|Other Unspecified|3|||
160635919|NCT02139306|580049414|FG000|Overall Study|Protocol Violation|4|||
160635920|NCT02139306|580049415|FG001|Overall Study|Protocol Violation|0|||
160635921|NCT01220128|580049416|FG000|Overall Study|Progressive disease|0|||
160635922|NCT01220128|580049417|FG001|Overall Study|Progressive disease|0|||
160635923|NCT01220128|580049418|FG002|Overall Study|Progressive disease|2|||
160635924|NCT01220128|580049419|FG003|Overall Study|Progressive disease|0|||
160635925|NCT01220128|580049420|FG004|Overall Study|Progressive disease|0|||
160635926|NCT01220128|580049421|FG005|Overall Study|Progressive disease|0|||
160750022|NCT01188668|580469752|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
160635927|NCT01220128|580049422|FG006|Overall Study|Progressive disease|0|||
160635928|NCT01220128|580049416|FG000|Overall Study|Sponsor study termination|0|||
160635929|NCT01220128|580049417|FG001|Overall Study|Sponsor study termination|1|||
160635930|NCT01220128|580049418|FG002|Overall Study|Sponsor study termination|0|||
160635931|NCT01220128|580049419|FG003|Overall Study|Sponsor study termination|0|||
160635932|NCT01220128|580049420|FG004|Overall Study|Sponsor study termination|0|||
160635933|NCT01220128|580049421|FG005|Overall Study|Sponsor study termination|0|||
160750023|NCT01188668|580469752|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
160750024|NCT00902746|580469753|FG000|Overall Study|Protocol Violation|7|||
160750025|NCT00902746|580469753|FG000|Overall Study|Withdrawal by Subject|16|||
160750026|NCT00902746|580469753|FG000|Overall Study|Adverse Event|8|||
160750027|NCT00902746|580469753|FG000|Overall Study|Lost to Follow-up|3|||
160750028|NCT00902746|580469753|FG000|Overall Study|Physician Decision|2|||
160750029|NCT02081001|580469755|FG000|Overall Study|Adverse Event|0|||
160750030|NCT02081001|580469756|FG001|Overall Study|Adverse Event|0|||
160750031|NCT02081001|580469757|FG002|Overall Study|Adverse Event|0|||
160750032|NCT02081001|580469758|FG003|Overall Study|Adverse Event|0|||
160750033|NCT02081001|580469759|FG004|Overall Study|Adverse Event|1|||
160750034|NCT02081001|580469760|FG005|Overall Study|Adverse Event|0|||
160750035|NCT02081001|580469761|FG006|Overall Study|Adverse Event|0|||
160750036|NCT02081001|580469762|FG007|Overall Study|Adverse Event|0|||
160750037|NCT02081001|580469763|FG008|Overall Study|Adverse Event|0|||
160750038|NCT02081001|580469764|FG009|Overall Study|Adverse Event|0|||
160750039|NCT02081001|580469765|FG010|Overall Study|Adverse Event|0|||
160750040|NCT02081001|580469766|FG011|Overall Study|Adverse Event|0|||
160750041|NCT02937636|580469771|FG000|Overall Study|Other (Not specified)|3|||
160750042|NCT02937636|580469772|FG001|Overall Study|Other (Not specified)|2|||
160750043|NCT00359294|580469773|FG000|Overall Study|Progressive disease|1|||
160750044|NCT00359294|580469774|FG001|Overall Study|Progressive disease|1|||
160635934|NCT01220128|580049422|FG006|Overall Study|Sponsor study termination|1|||
160635935|NCT01220128|580049416|FG000|Overall Study|Adverse event, serious fatal|2|||
160635936|NCT01220128|580049417|FG001|Overall Study|Adverse event, serious fatal|0|||
160635937|NCT01220128|580049418|FG002|Overall Study|Adverse event, serious fatal|0|||
160635938|NCT01220128|580049419|FG003|Overall Study|Adverse event, serious fatal|0|||
160635939|NCT01220128|580049420|FG004|Overall Study|Adverse event, serious fatal|0|||
160750045|NCT00359294|580469775|FG002|Overall Study|Progressive disease|2|||
160635940|NCT01220128|580049421|FG005|Overall Study|Adverse event, serious fatal|0|||
160635941|NCT01220128|580049422|FG006|Overall Study|Adverse event, serious fatal|1|||
160635942|NCT01220128|580049416|FG000|Overall Study|Adverse event, non-fatal|1|||
160635943|NCT01220128|580049417|FG001|Overall Study|Adverse event, non-fatal|0|||
160750046|NCT00359294|580469776|FG003|Overall Study|Progressive disease|3|||
160750047|NCT00359294|580469777|FG004|Overall Study|Progressive disease|2|||
160750048|NCT00359294|580469773|FG000|Overall Study|Withdrawal by Subject|0|||
160750049|NCT00359294|580469774|FG001|Overall Study|Withdrawal by Subject|0|||
160750050|NCT00359294|580469775|FG002|Overall Study|Withdrawal by Subject|0|||
160750051|NCT00359294|580469776|FG003|Overall Study|Withdrawal by Subject|0|||
160750052|NCT00359294|580469777|FG004|Overall Study|Withdrawal by Subject|1|||
160750053|NCT00359294|580469773|FG000|Overall Study|Not treated|0|||
160750054|NCT00359294|580469774|FG001|Overall Study|Not treated|0|||
160750055|NCT00359294|580469775|FG002|Overall Study|Not treated|0|||
160750056|NCT00359294|580469776|FG003|Overall Study|Not treated|1|||
160750057|NCT00359294|580469777|FG004|Overall Study|Not treated|0|||
160750058|NCT00359294|580469773|FG000|Overall Study|Physician Decision|0|||
160750059|NCT00359294|580469774|FG001|Overall Study|Physician Decision|0|||
160750060|NCT00359294|580469775|FG002|Overall Study|Physician Decision|1|||
160750061|NCT00359294|580469776|FG003|Overall Study|Physician Decision|0|||
160750062|NCT00359294|580469777|FG004|Overall Study|Physician Decision|0|||
160750063|NCT04208412|580469780|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
160750064|NCT04208412|580469781|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
160750065|NCT04208412|580469780|FG000|Overall Study|Withdrawal by Subject|1|||
160750066|NCT04208412|580469781|FG001|Overall Study|Withdrawal by Subject|0|||
160750067|NCT04208412|580469780|FG000|Overall Study|Lost to Follow-up|0|||
160750068|NCT04208412|580469781|FG001|Overall Study|Lost to Follow-up|1|||
160750069|NCT00435188|580469787|FG000|Overall Study|Death|1|||
160750070|NCT00435188|580469788|FG001|Overall Study|Death|6|||
160750071|NCT00435188|580469787|FG000|Overall Study|Withdrawal by Subject|16|||
160750072|NCT00435188|580469788|FG001|Overall Study|Withdrawal by Subject|11|||
160750073|NCT00435188|580469787|FG000|Overall Study|Lost to Follow-up|5|||
160750074|NCT00435188|580469788|FG001|Overall Study|Lost to Follow-up|6|||
160750075|NCT01915771|580469789|FG000|Day 1|Withdrawal by Subject|1|||
160750076|NCT01915771|580469789|FG000|Day 15|Withdrawal by Subject|1|||
160750077|NCT02912455|580469790|FG000|Overall Study|Withdrawal by Subject|0|||
160750078|NCT02912455|580469791|FG001|Overall Study|Withdrawal by Subject|1|||
160750079|NCT02912455|580469790|FG000|Overall Study|Lack of Efficacy|0|||
160750080|NCT02912455|580469791|FG001|Overall Study|Lack of Efficacy|1|||
160750081|NCT02912455|580469790|FG000|Overall Study|Lost to Follow-up|2|||
160750082|NCT02912455|580469791|FG001|Overall Study|Lost to Follow-up|1|||
160861852|NCT02531802|580887848|FG003|Received Vaccination 2|Adverse Event|0|||
160861853|NCT02531802|580887849|FG004|Received Vaccination 2|Adverse Event|0|||
160635944|NCT01220128|580049418|FG002|Overall Study|Adverse event, non-fatal|0|||
160635945|NCT01220128|580049419|FG003|Overall Study|Adverse event, non-fatal|0|||
160861854|NCT02531802|580887850|FG005|Received Vaccination 2|Adverse Event|2|||
160861855|NCT02531802|580887851|FG006|Received Vaccination 2|Adverse Event|0|||
160861856|NCT02531802|580887852|FG007|Received Vaccination 2|Adverse Event|0|||
160750083|NCT00401193|580472223|FG000|Overall Study|Adverse Event|1|||
160750084|NCT00401193|580472224|FG001|Overall Study|Adverse Event|3|||
160750085|NCT00401193|580472225|FG002|Overall Study|Adverse Event|1|||
160750086|NCT00401193|580472223|FG000|Overall Study|Protocol Violation|3|||
160750087|NCT00401193|580472224|FG001|Overall Study|Protocol Violation|1|||
160750088|NCT00401193|580472225|FG002|Overall Study|Protocol Violation|1|||
160750089|NCT00401193|580472223|FG000|Overall Study|Lost to Follow-up|6|||
160750090|NCT00401193|580472224|FG001|Overall Study|Lost to Follow-up|5|||
160750091|NCT00401193|580472225|FG002|Overall Study|Lost to Follow-up|1|||
160750092|NCT00401193|580472223|FG000|Overall Study|Withdrawal by Subject|2|||
160750093|NCT00401193|580472224|FG001|Overall Study|Withdrawal by Subject|0|||
160750094|NCT00401193|580472225|FG002|Overall Study|Withdrawal by Subject|1|||
160750095|NCT00401193|580472223|FG000|Overall Study|Other Event|3|||
160750096|NCT00401193|580472224|FG001|Overall Study|Other Event|2|||
160750097|NCT00401193|580472225|FG002|Overall Study|Other Event|2|||
160750098|NCT04378569|580472229|FG000|Overall Study|Adverse Event|0|||
160750099|NCT04378569|580472230|FG001|Overall Study|Adverse Event|0|||
160750100|NCT04378569|580472231|FG002|Overall Study|Adverse Event|2|||
160750101|NCT04378569|580472232|FG003|Overall Study|Adverse Event|0|||
160750102|NCT04378569|580472233|FG004|Overall Study|Adverse Event|3|||
160750103|NCT04378569|580472234|FG005|Overall Study|Adverse Event|3|||
160750104|NCT04378569|580472229|FG000|Overall Study|Lost to Follow-up|0|||
160750105|NCT04378569|580472230|FG001|Overall Study|Lost to Follow-up|3|||
160750106|NCT04378569|580472231|FG002|Overall Study|Lost to Follow-up|1|||
160750107|NCT04378569|580472232|FG003|Overall Study|Lost to Follow-up|0|||
160750108|NCT04378569|580472233|FG004|Overall Study|Lost to Follow-up|1|||
160750109|NCT04378569|580472234|FG005|Overall Study|Lost to Follow-up|1|||
160750110|NCT04378569|580472229|FG000|Overall Study|Protocol Violation|0|||
160750111|NCT04378569|580472230|FG001|Overall Study|Protocol Violation|0|||
160750112|NCT04378569|580472231|FG002|Overall Study|Protocol Violation|0|||
160750113|NCT04378569|580472232|FG003|Overall Study|Protocol Violation|0|||
160750114|NCT04378569|580472233|FG004|Overall Study|Protocol Violation|0|||
160750115|NCT04378569|580472234|FG005|Overall Study|Protocol Violation|1|||
160750116|NCT04378569|580472229|FG000|Overall Study|Withdrawal by Subject|0|||
160750117|NCT04378569|580472230|FG001|Overall Study|Withdrawal by Subject|6|||
160750118|NCT04378569|580472231|FG002|Overall Study|Withdrawal by Subject|7|||
160750119|NCT04378569|580472232|FG003|Overall Study|Withdrawal by Subject|4|||
160750120|NCT04378569|580472233|FG004|Overall Study|Withdrawal by Subject|5|||
160750121|NCT04378569|580472234|FG005|Overall Study|Withdrawal by Subject|4|||
160750122|NCT04378569|580472229|FG000|Overall Study|Lack of response|0|||
160750123|NCT04378569|580472230|FG001|Overall Study|Lack of response|0|||
160750124|NCT04378569|580472231|FG002|Overall Study|Lack of response|1|||
160750125|NCT04378569|580472232|FG003|Overall Study|Lack of response|0|||
160750126|NCT04378569|580472233|FG004|Overall Study|Lack of response|1|||
160750127|NCT04378569|580472234|FG005|Overall Study|Lack of response|1|||
160750128|NCT03638466|580472236|FG000|Overall Study|Early Termination|0|||
160750129|NCT03638466|580472237|FG001|Overall Study|Early Termination|1|||
160750130|NCT02576977|580472238|FG000|Overall Study|Adverse Event|13|||
160750131|NCT02576977|580472239|FG001|Overall Study|Adverse Event|2|||
160750132|NCT02576977|580472238|FG000|Overall Study|Death|73|||
160750133|NCT02576977|580472239|FG001|Overall Study|Death|60|||
160750134|NCT02576977|580472238|FG000|Overall Study|Screen failure|1|||
160750135|NCT02576977|580472239|FG001|Overall Study|Screen failure|0|||
160750136|NCT02576977|580472238|FG000|Overall Study|Study Terminated at Selected Sites|27|||
160750137|NCT02576977|580472239|FG001|Overall Study|Study Terminated at Selected Sites|50|||
160750138|NCT02576977|580472238|FG000|Overall Study|Withdrawal by Subject|11|||
160750139|NCT02576977|580472239|FG001|Overall Study|Withdrawal by Subject|11|||
160750140|NCT02576977|580472238|FG000|Overall Study|Final Disposition Unknown|0|||
160750141|NCT02576977|580472239|FG001|Overall Study|Final Disposition Unknown|1|||
160750142|NCT02576977|580472238|FG000|Overall Study|Lost to Follow-up|1|||
160750143|NCT02576977|580472239|FG001|Overall Study|Lost to Follow-up|0|||
160750144|NCT02576977|580472238|FG000|Overall Study|Progressive Disease|0|||
160750145|NCT02576977|580472239|FG001|Overall Study|Progressive Disease|1|||
160750146|NCT02447328|580472244|FG000|Overall Study|Withdrawal by Subject|1|||
160750147|NCT02906579|580472253|FG000|Overall Study|Adverse Event|1|||
160750148|NCT02906579|580472253|FG000|Overall Study|Physician Decision|1|||
160750149|NCT00759655|580472254|FG000|Overall Study|Termination of the study by sponsor|1|||
160750150|NCT02753816|580472255|FG000|Overall Study|Protocol Violation|0|||
160750151|NCT02753816|580472256|FG001|Overall Study|Protocol Violation|1|||
160750152|NCT02753816|580472257|FG002|Overall Study|Protocol Violation|0|||
160750153|NCT01473940|580472258|FG000|Induction Therapy|Death|0|||
160750154|NCT01473940|580472259|FG001|Induction Therapy|Death|0|||
160750155|NCT01473940|580472260|FG002|Induction Therapy|Death|1|||
160750156|NCT01473940|580472261|FG003|Induction Therapy|Death|1|||
160750157|NCT01473940|580472258|FG000|Induction Therapy|Progressive Disease|0|||
160750158|NCT01473940|580472259|FG001|Induction Therapy|Progressive Disease|1|||
160750159|NCT01473940|580472260|FG002|Induction Therapy|Progressive Disease|1|||
160750160|NCT01473940|580472261|FG003|Induction Therapy|Progressive Disease|0|||
160750161|NCT01473940|580472258|FG000|Maintenance Therapy|Progressive Disease|1|||
160750162|NCT01473940|580472259|FG001|Maintenance Therapy|Progressive Disease|2|||
160524514|NCT03267940|579650063|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
160865660|NCT00734539|580902944|FG000|Main Study|Physician Decision|2|||
160750163|NCT01473940|580472260|FG002|Maintenance Therapy|Progressive Disease|1|||
160750164|NCT01473940|580472261|FG003|Maintenance Therapy|Progressive Disease|4|||
160750165|NCT00534248|580472262|FG000|Overall Study|Adverse Event|19|||
160750166|NCT00534248|580472263|FG001|Overall Study|Adverse Event|29|||
160750167|NCT00534248|580472262|FG000|Overall Study|Lost to Follow-up|353|||
160750168|NCT00534248|580472263|FG001|Overall Study|Lost to Follow-up|375|||
160750169|NCT00534248|580472262|FG000|Overall Study|Other protocol specified criteria|13|||
160750170|NCT00534248|580472263|FG001|Overall Study|Other protocol specified criteria|3|||
160750171|NCT00534248|580472262|FG000|Overall Study|Physician Decision|10|||
160750172|NCT00534248|580472263|FG001|Overall Study|Physician Decision|7|||
160750173|NCT00534248|580472262|FG000|Overall Study|Protocol Violation|3|||
160750174|NCT00534248|580472263|FG001|Overall Study|Protocol Violation|4|||
160750175|NCT00534248|580472262|FG000|Overall Study|Withdrawal by Subject|263|||
160750176|NCT00534248|580472263|FG001|Overall Study|Withdrawal by Subject|255|||
160750177|NCT02849171|580472264|FG000|Overall Study|Withdrawal by Subject|1|||
160750178|NCT02849171|580472264|FG000|Overall Study|Not treated|1|||
160750179|NCT03084302|580472271|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
160750180|NCT03084302|580472271|FG000|Overall Study|No valid objective monitor data|6|||
160750181|NCT00929994|580472272|FG000|Overall Study|Withdrawal by Subject|1|||
160750182|NCT00929994|580472272|FG000|Overall Study|medical issue unrelated to intervention|4|||
160750183|NCT00929994|580472272|FG000|Overall Study|employment|1|||
160750184|NCT02061813|580472273|FG000|Overall Study|Withdrawal by Subject|1|||
160750185|NCT02061813|580472273|FG000|Overall Study|Protocol Violation|2|||
160750186|NCT01705080|580472274|FG000|Overall Study|Missed visit|10|||
160750187|NCT01705080|580472275|FG001|Overall Study|Missed visit|4|||
160750188|NCT01705080|580472276|FG002|Overall Study|Missed visit|1|||
160750189|NCT01705080|580472274|FG000|Overall Study|Death|4|||
160750190|NCT01705080|580472275|FG001|Overall Study|Death|4|||
160750191|NCT01705080|580472276|FG002|Overall Study|Death|6|||
160750192|NCT01705080|580472274|FG000|Overall Study|Withdrawal by Subject|61|||
160750193|NCT01705080|580472275|FG001|Overall Study|Withdrawal by Subject|44|||
160750194|NCT01705080|580472276|FG002|Overall Study|Withdrawal by Subject|9|||
160750195|NCT01704755|580472281|FG000|Overall Study|Adverse Event|4|||
160750196|NCT01704755|580472282|FG001|Overall Study|Adverse Event|1|||
160750197|NCT01704755|580472281|FG000|Overall Study|Lost to Follow-up|3|||
160750198|NCT01704755|580472282|FG001|Overall Study|Lost to Follow-up|4|||
160750199|NCT01704755|580472281|FG000|Overall Study|Withdrew consent|1|||
160750200|NCT01704755|580472282|FG001|Overall Study|Withdrew consent|1|||
160750201|NCT01704755|580472281|FG000|Overall Study|Other (not specified)|3|||
160750202|NCT01704755|580472282|FG001|Overall Study|Other (not specified)|1|||
160750203|NCT01704755|580472281|FG000|Overall Study|Withdrew consent and personal issues|1|||
160750204|NCT01704755|580472282|FG001|Overall Study|Withdrew consent and personal issues|0|||
160750205|NCT02075008|580472289|FG000|Overall Study|Technical problems|1|||
160750206|NCT02075008|580472289|FG000|Overall Study|Pregnancy|1|||
160750207|NCT02075008|580472289|FG000|Overall Study|Physician Decision|1|||
160750208|NCT02075008|580472289|FG000|Overall Study|Lost to Follow-up|1|||
160750209|NCT02075008|580472289|FG000|Overall Study|Lack of Efficacy|1|||
160750210|NCT02075008|580472289|FG000|Overall Study|Death|1|||
160750211|NCT02075008|580472289|FG000|Overall Study|Adverse Event|5|||
160750212|NCT02075008|580472289|FG000|Overall Study|Withdrawal by Subject|6|||
160750213|NCT02075008|580472289|FG000|Overall Study|Study terminated by Sponsor|159|||
160524515|NCT03267940|579650064|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
160524516|NCT03267940|579650065|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
160750214|NCT03130959|580472290|FG000|Overall Study|Disease progression|19|||
160750215|NCT03130959|580472291|FG001|Overall Study|Disease progression|7|||
160750216|NCT03130959|580472292|FG002|Overall Study|Disease progression|12|||
160750217|NCT03130959|580472293|FG003|Overall Study|Disease progression|7|||
160750218|NCT03130959|580472294|FG004|Overall Study|Disease progression|12|||
160750219|NCT03130959|580472295|FG005|Overall Study|Disease progression|3|||
160750220|NCT03130959|580472296|FG006|Overall Study|Disease progression|6|||
160750221|NCT03130959|580472297|FG007|Overall Study|Disease progression|3|||
160750222|NCT03130959|580472298|FG008|Overall Study|Disease progression|15|||
160750223|NCT03130959|580472299|FG009|Overall Study|Disease progression|8|||
160750224|NCT03130959|580472290|FG000|Overall Study|Study drug toxicity|2|||
160865661|NCT00734539|580902945|FG001|Main Study|Physician Decision|0|||
160750225|NCT03130959|580472291|FG001|Overall Study|Study drug toxicity|2|||
160750226|NCT03130959|580472292|FG002|Overall Study|Study drug toxicity|1|||
160750227|NCT03130959|580472293|FG003|Overall Study|Study drug toxicity|2|||
160750228|NCT03130959|580472294|FG004|Overall Study|Study drug toxicity|1|||
160750229|NCT03130959|580472295|FG005|Overall Study|Study drug toxicity|1|||
160750230|NCT03130959|580472296|FG006|Overall Study|Study drug toxicity|3|||
160750231|NCT03130959|580472297|FG007|Overall Study|Study drug toxicity|0|||
160750232|NCT03130959|580472298|FG008|Overall Study|Study drug toxicity|3|||
160750233|NCT03130959|580472299|FG009|Overall Study|Study drug toxicity|3|||
160750234|NCT03130959|580472290|FG000|Overall Study|Other reasons|0|||
160750235|NCT03130959|580472291|FG001|Overall Study|Other reasons|0|||
160750236|NCT03130959|580472292|FG002|Overall Study|Other reasons|0|||
160750237|NCT03130959|580472293|FG003|Overall Study|Other reasons|0|||
160750238|NCT03130959|580472294|FG004|Overall Study|Other reasons|0|||
160750239|NCT03130959|580472295|FG005|Overall Study|Other reasons|1|||
160750240|NCT03130959|580472296|FG006|Overall Study|Other reasons|1|||
160750241|NCT03130959|580472297|FG007|Overall Study|Other reasons|0|||
160750242|NCT03130959|580472298|FG008|Overall Study|Other reasons|0|||
160750243|NCT03130959|580472299|FG009|Overall Study|Other reasons|0|||
160750244|NCT03130959|580472290|FG000|Overall Study|Subject request to discontinue therapy|0|||
160750245|NCT03130959|580472291|FG001|Overall Study|Subject request to discontinue therapy|0|||
160750246|NCT03130959|580472292|FG002|Overall Study|Subject request to discontinue therapy|1|||
160750247|NCT03130959|580472293|FG003|Overall Study|Subject request to discontinue therapy|1|||
160750248|NCT03130959|580472294|FG004|Overall Study|Subject request to discontinue therapy|0|||
160750249|NCT03130959|580472295|FG005|Overall Study|Subject request to discontinue therapy|0|||
160750250|NCT03130959|580472296|FG006|Overall Study|Subject request to discontinue therapy|1|||
160750251|NCT03130959|580472297|FG007|Overall Study|Subject request to discontinue therapy|1|||
160750252|NCT03130959|580472298|FG008|Overall Study|Subject request to discontinue therapy|0|||
160750253|NCT03130959|580472299|FG009|Overall Study|Subject request to discontinue therapy|0|||
160750254|NCT03130959|580472290|FG000|Overall Study|Not reported|0|||
160750255|NCT03130959|580472291|FG001|Overall Study|Not reported|0|||
160750256|NCT03130959|580472292|FG002|Overall Study|Not reported|0|||
160750257|NCT03130959|580472293|FG003|Overall Study|Not reported|1|||
160750258|NCT03130959|580472294|FG004|Overall Study|Not reported|0|||
160750259|NCT03130959|580472295|FG005|Overall Study|Not reported|1|||
160750260|NCT03130959|580472296|FG006|Overall Study|Not reported|0|||
160750261|NCT03130959|580472297|FG007|Overall Study|Not reported|0|||
160750262|NCT03130959|580472298|FG008|Overall Study|Not reported|0|||
160750263|NCT03130959|580472299|FG009|Overall Study|Not reported|1|||
160750264|NCT03130959|580472290|FG000|Overall Study|Adverse Event unrelated to drug|0|||
160750265|NCT03130959|580472291|FG001|Overall Study|Adverse Event unrelated to drug|0|||
160750266|NCT03130959|580472292|FG002|Overall Study|Adverse Event unrelated to drug|1|||
160750267|NCT03130959|580472293|FG003|Overall Study|Adverse Event unrelated to drug|1|||
160750268|NCT03130959|580472294|FG004|Overall Study|Adverse Event unrelated to drug|1|||
160750269|NCT03130959|580472295|FG005|Overall Study|Adverse Event unrelated to drug|0|||
160750270|NCT03130959|580472296|FG006|Overall Study|Adverse Event unrelated to drug|1|||
160750271|NCT03130959|580472297|FG007|Overall Study|Adverse Event unrelated to drug|0|||
160750272|NCT03130959|580472298|FG008|Overall Study|Adverse Event unrelated to drug|1|||
160750273|NCT03130959|580472299|FG009|Overall Study|Adverse Event unrelated to drug|1|||
160750274|NCT03130959|580472290|FG000|Overall Study|Participant withdrew consent|0|||
160750275|NCT03130959|580472291|FG001|Overall Study|Participant withdrew consent|1|||
160750276|NCT03130959|580472292|FG002|Overall Study|Participant withdrew consent|0|||
160750277|NCT03130959|580472293|FG003|Overall Study|Participant withdrew consent|2|||
160750278|NCT03130959|580472294|FG004|Overall Study|Participant withdrew consent|1|||
160750279|NCT03130959|580472295|FG005|Overall Study|Participant withdrew consent|0|||
160750280|NCT03130959|580472296|FG006|Overall Study|Participant withdrew consent|0|||
160750281|NCT03130959|580472297|FG007|Overall Study|Participant withdrew consent|0|||
160750282|NCT03130959|580472298|FG008|Overall Study|Participant withdrew consent|0|||
160750283|NCT03130959|580472299|FG009|Overall Study|Participant withdrew consent|2|||
160750284|NCT03130959|580472290|FG000|Overall Study|Administrative reason by sponsor|1|||
160750285|NCT03130959|580472291|FG001|Overall Study|Administrative reason by sponsor|0|||
160750286|NCT03130959|580472292|FG002|Overall Study|Administrative reason by sponsor|1|||
160750287|NCT03130959|580472293|FG003|Overall Study|Administrative reason by sponsor|0|||
160750288|NCT03130959|580472294|FG004|Overall Study|Administrative reason by sponsor|0|||
160750289|NCT03130959|580472295|FG005|Overall Study|Administrative reason by sponsor|0|||
160750290|NCT03130959|580472296|FG006|Overall Study|Administrative reason by sponsor|0|||
160750291|NCT03130959|580472297|FG007|Overall Study|Administrative reason by sponsor|0|||
160750292|NCT03130959|580472298|FG008|Overall Study|Administrative reason by sponsor|0|||
160750293|NCT03130959|580472299|FG009|Overall Study|Administrative reason by sponsor|0|||
160750294|NCT03130959|580472290|FG000|Overall Study|Lost to Follow-up|1|||
160750295|NCT03130959|580472291|FG001|Overall Study|Lost to Follow-up|0|||
160750296|NCT03130959|580472292|FG002|Overall Study|Lost to Follow-up|0|||
160750297|NCT03130959|580472293|FG003|Overall Study|Lost to Follow-up|0|||
160750298|NCT03130959|580472294|FG004|Overall Study|Lost to Follow-up|0|||
160750299|NCT03130959|580472295|FG005|Overall Study|Lost to Follow-up|0|||
160750300|NCT03130959|580472296|FG006|Overall Study|Lost to Follow-up|0|||
160750301|NCT03130959|580472297|FG007|Overall Study|Lost to Follow-up|0|||
160750302|NCT03130959|580472298|FG008|Overall Study|Lost to Follow-up|0|||
160750303|NCT03130959|580472299|FG009|Overall Study|Lost to Follow-up|0|||
160750304|NCT02821416|580472300|FG000|Overall Study|Adverse Event|0|||
160750305|NCT02821416|580472301|FG001|Overall Study|Adverse Event|1|||
160750306|NCT02821416|580472300|FG000|Overall Study|Withdrawal by Subject|2|||
160750307|NCT02821416|580472301|FG001|Overall Study|Withdrawal by Subject|0|||
160750308|NCT02821416|580472300|FG000|Overall Study|Lost to Follow-up|1|||
160750309|NCT02821416|580472301|FG001|Overall Study|Lost to Follow-up|0|||
160750310|NCT01763203|580472308|FG000|Overall Study|Death|4|||
160750311|NCT01763203|580472309|FG001|Overall Study|Death|7|||
160750312|NCT01763203|580472308|FG000|Overall Study|Lost to Follow-up|12|||
160750313|NCT01763203|580472309|FG001|Overall Study|Lost to Follow-up|12|||
160750314|NCT01763203|580472308|FG000|Overall Study|Withdrawal by Subject|8|||
160750315|NCT01763203|580472309|FG001|Overall Study|Withdrawal by Subject|12|||
160750316|NCT01763203|580472308|FG000|Overall Study|Moved out of study region|7|||
160750317|NCT01763203|580472309|FG001|Overall Study|Moved out of study region|10|||
160750318|NCT01763203|580472308|FG000|Overall Study|Physician Decision|2|||
160750319|NCT01763203|580472309|FG001|Overall Study|Physician Decision|1|||
160750320|NCT02256917|580472310|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
160750321|NCT02256917|580472310|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
160750322|NCT02256917|580472310|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
160750323|NCT02256917|580472310|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
160750324|NCT02256917|580472310|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
160750325|NCT02756819|580472311|FG000|Overall Study|Lost for observation|23|||
160750326|NCT02756819|580472311|FG000|Overall Study|Patient's unwillingness|16|||
160750327|NCT02756819|580472311|FG000|Overall Study|Insufficient efficacy|2|||
160750328|NCT02756819|580472311|FG000|Overall Study|Adverse Event|2|||
160750329|NCT02756819|580472311|FG000|Overall Study|Reason not Specified|9|||
160750330|NCT02933528|580472312|FG000|Overall Study|Lost to Follow-up|2|||
160750331|NCT00741598|580472313|FG000|Overall Study|Lost to Follow-up|3|||
160750332|NCT00741598|580472314|FG001|Overall Study|Lost to Follow-up|4|||
160750333|NCT00741598|580472313|FG000|Overall Study|Lack of Efficacy|1|||
160750334|NCT00741598|580472314|FG001|Overall Study|Lack of Efficacy|2|||
160750335|NCT00741598|580472313|FG000|Overall Study|Physician Decision|1|||
160750336|NCT00741598|580472314|FG001|Overall Study|Physician Decision|1|||
160750337|NCT00741598|580472313|FG000|Overall Study|Pregnancy|1|||
160750338|NCT00741598|580472314|FG001|Overall Study|Pregnancy|0|||
160750339|NCT00741598|580472313|FG000|Overall Study|Withdrawal by Subject|3|||
160750340|NCT00741598|580472314|FG001|Overall Study|Withdrawal by Subject|2|||
160750341|NCT04676724|580472319|FG000|Overall Study|Adverse Event|2|||
160750342|NCT04676724|580472320|FG001|Overall Study|Adverse Event|0|||
160750343|NCT04676724|580472319|FG000|Overall Study|Lost to Follow-up|1|||
160750344|NCT04676724|580472320|FG001|Overall Study|Lost to Follow-up|0|||
160750345|NCT04676724|580472319|FG000|Overall Study|Physician Decision|0|||
160750346|NCT04676724|580472320|FG001|Overall Study|Physician Decision|1|||
160750347|NCT04676724|580472319|FG000|Overall Study|Withdrawal by Subject|3|||
160750348|NCT04676724|580472320|FG001|Overall Study|Withdrawal by Subject|2|||
160750349|NCT00398047|580472326|FG000|Overall Study|all patient progressed before completion|3|||
160750350|NCT02588092|580472333|FG000|Overall Study|Death|4|||
160750351|NCT02588092|580472334|FG001|Overall Study|Death|3|||
160750352|NCT02588092|580472335|FG002|Overall Study|Death|3|||
160750353|NCT02588092|580472336|FG003|Overall Study|Death|3|||
160750354|NCT02588092|580472337|FG004|Overall Study|Death|2|||
160750355|NCT02588092|580472338|FG005|Overall Study|Death|2|||
160750356|NCT02588092|580472339|FG006|Overall Study|Death|2|||
160750357|NCT02588092|580472340|FG007|Overall Study|Death|1|||
160750358|NCT02588092|580472341|FG008|Overall Study|Death|5|||
160750359|NCT02588092|580472342|FG009|Overall Study|Death|2|||
160750360|NCT02588092|580472333|FG000|Overall Study|Withdrawal by Subject|0|||
160750361|NCT02588092|580472334|FG001|Overall Study|Withdrawal by Subject|0|||
160750362|NCT02588092|580472335|FG002|Overall Study|Withdrawal by Subject|0|||
160750363|NCT02588092|580472336|FG003|Overall Study|Withdrawal by Subject|0|||
160750364|NCT02588092|580472337|FG004|Overall Study|Withdrawal by Subject|0|||
160750365|NCT02588092|580472338|FG005|Overall Study|Withdrawal by Subject|1|||
160750366|NCT02588092|580472339|FG006|Overall Study|Withdrawal by Subject|1|||
160750367|NCT02588092|580472340|FG007|Overall Study|Withdrawal by Subject|2|||
160750368|NCT02588092|580472341|FG008|Overall Study|Withdrawal by Subject|0|||
160750369|NCT02588092|580472342|FG009|Overall Study|Withdrawal by Subject|0|||
160750370|NCT02588092|580472333|FG000|Overall Study|Started Another Treatment|0|||
160750371|NCT02588092|580472334|FG001|Overall Study|Started Another Treatment|0|||
160750372|NCT02588092|580472335|FG002|Overall Study|Started Another Treatment|0|||
160750373|NCT02588092|580472336|FG003|Overall Study|Started Another Treatment|0|||
160750374|NCT02588092|580472337|FG004|Overall Study|Started Another Treatment|1|||
160750375|NCT02588092|580472338|FG005|Overall Study|Started Another Treatment|0|||
160750376|NCT02588092|580472339|FG006|Overall Study|Started Another Treatment|0|||
160750377|NCT02588092|580472340|FG007|Overall Study|Started Another Treatment|1|||
160750378|NCT02588092|580472341|FG008|Overall Study|Started Another Treatment|0|||
160750379|NCT02588092|580472342|FG009|Overall Study|Started Another Treatment|0|||
160750380|NCT02588092|580472333|FG000|Overall Study|Sponsor Decision|0|||
160750381|NCT02588092|580472334|FG001|Overall Study|Sponsor Decision|0|||
160750382|NCT02588092|580472335|FG002|Overall Study|Sponsor Decision|0|||
160750383|NCT02588092|580472336|FG003|Overall Study|Sponsor Decision|0|||
160750384|NCT02588092|580472337|FG004|Overall Study|Sponsor Decision|0|||
160750385|NCT02588092|580472338|FG005|Overall Study|Sponsor Decision|0|||
160750386|NCT02588092|580472339|FG006|Overall Study|Sponsor Decision|0|||
160750387|NCT02588092|580472340|FG007|Overall Study|Sponsor Decision|0|||
160750388|NCT02588092|580472341|FG008|Overall Study|Sponsor Decision|1|||
160750389|NCT02588092|580472342|FG009|Overall Study|Sponsor Decision|1|||
160750390|NCT01348100|580472343|FG000|Overall Study|Subject Withdrew Consent|0|||
160750391|NCT01348100|580472344|FG001|Overall Study|Subject Withdrew Consent|0|||
160750392|NCT01348100|580472345|FG002|Overall Study|Subject Withdrew Consent|2|||
160750393|NCT01348100|580472346|FG003|Overall Study|Subject Withdrew Consent|0|||
160750394|NCT01348100|580472347|FG004|Overall Study|Subject Withdrew Consent|1|||
160750395|NCT01348100|580472348|FG005|Overall Study|Subject Withdrew Consent|0|||
160750396|NCT01348100|580472349|FG006|Overall Study|Subject Withdrew Consent|1|||
160750397|NCT01348100|580472343|FG000|Overall Study|Protocol Deviation|0|||
160750398|NCT01348100|580472344|FG001|Overall Study|Protocol Deviation|0|||
160750399|NCT01348100|580472345|FG002|Overall Study|Protocol Deviation|0|||
160750400|NCT01348100|580472346|FG003|Overall Study|Protocol Deviation|1|||
160750401|NCT01348100|580472347|FG004|Overall Study|Protocol Deviation|0|||
160750402|NCT01348100|580472348|FG005|Overall Study|Protocol Deviation|0|||
160750403|NCT01348100|580472349|FG006|Overall Study|Protocol Deviation|0|||
160750404|NCT01348100|580472343|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160750405|NCT01348100|580472344|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160750406|NCT01348100|580472345|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160750407|NCT01348100|580472346|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160750408|NCT01348100|580472347|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160750409|NCT01348100|580472348|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
160750410|NCT01348100|580472349|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160750411|NCT01348100|580472343|FG000|Overall Study|Lost to Follow-up|0|||
160750412|NCT01348100|580472344|FG001|Overall Study|Lost to Follow-up|0|||
160750413|NCT01348100|580472345|FG002|Overall Study|Lost to Follow-up|0|||
160750414|NCT01348100|580472346|FG003|Overall Study|Lost to Follow-up|0|||
160750415|NCT01348100|580472347|FG004|Overall Study|Lost to Follow-up|0|||
160750416|NCT01348100|580472348|FG005|Overall Study|Lost to Follow-up|0|||
160750417|NCT01348100|580472349|FG006|Overall Study|Lost to Follow-up|1|||
160750418|NCT01348100|580472343|FG000|Overall Study|Administrative Problems|0|||
160750419|NCT01348100|580472344|FG001|Overall Study|Administrative Problems|0|||
160750420|NCT01348100|580472345|FG002|Overall Study|Administrative Problems|0|||
160750421|NCT01348100|580472346|FG003|Overall Study|Administrative Problems|0|||
160750422|NCT01348100|580472347|FG004|Overall Study|Administrative Problems|0|||
160750423|NCT01348100|580472348|FG005|Overall Study|Administrative Problems|1|||
160750424|NCT01348100|580472349|FG006|Overall Study|Administrative Problems|1|||
160750425|NCT03882957|580472352|FG000|Overall Study|Did not complete all three arms|1|||
160750426|NCT03762681|580472354|FG000|Part 1|Withdrawal by Subject|0|||
160750427|NCT03762681|580472355|FG001|Part 1|Withdrawal by Subject|0|||
160750428|NCT03762681|580472356|FG002|Part 1|Withdrawal by Subject|0|||
160750429|NCT03762681|580472357|FG003|Part 1|Withdrawal by Subject|1|||
160750430|NCT03762681|580472358|FG004|Part 1|Withdrawal by Subject|0|||
160750431|NCT03762681|580472359|FG005|Part 1|Withdrawal by Subject|0|||
160750432|NCT03762681|580472360|FG006|Part 1|Withdrawal by Subject|0|||
160750433|NCT03762681|580472361|FG007|Part 1|Withdrawal by Subject|0|||
160750434|NCT03762681|580472354|FG000|Part 2a|Pandemic Travel Restrictions|0|||
160750435|NCT03762681|580472355|FG001|Part 2a|Pandemic Travel Restrictions|0|||
160750436|NCT03762681|580472356|FG002|Part 2a|Pandemic Travel Restrictions|0|||
160750437|NCT03762681|580472357|FG003|Part 2a|Pandemic Travel Restrictions|0|||
160750438|NCT03762681|580472358|FG004|Part 2a|Pandemic Travel Restrictions|0|||
160750439|NCT03762681|580472359|FG005|Part 2a|Pandemic Travel Restrictions|0|||
160750440|NCT03762681|580472360|FG006|Part 2a|Pandemic Travel Restrictions|0|||
160750441|NCT03762681|580472361|FG007|Part 2a|Pandemic Travel Restrictions|1|||
160750442|NCT03148067|580472362|FG000|Overall Study|Lost to Follow-up|3|||
160750443|NCT03148067|580472362|FG000|Overall Study|Death|1|||
160750444|NCT00524680|580472364|FG000|Overall Study|progression|0|||
160750445|NCT00524680|580472365|FG001|Overall Study|progression|0|||
160750446|NCT00524680|580472366|FG002|Overall Study|progression|0|||
160750447|NCT00524680|580472367|FG003|Overall Study|progression|1|||
160750448|NCT00524680|580472364|FG000|Overall Study|Adverse Event|2|||
160750449|NCT00524680|580472365|FG001|Overall Study|Adverse Event|0|||
160750450|NCT00524680|580472366|FG002|Overall Study|Adverse Event|0|||
160750451|NCT00524680|580472367|FG003|Overall Study|Adverse Event|1|||
160750452|NCT00524680|580472364|FG000|Overall Study|Other|0|||
160750453|NCT00524680|580472365|FG001|Overall Study|Other|1|||
160750454|NCT00524680|580472366|FG002|Overall Study|Other|2|||
160750455|NCT00524680|580472367|FG003|Overall Study|Other|3|||
160750456|NCT00524680|580472364|FG000|Overall Study|Withdrawal by Subject|1|||
160750457|NCT00524680|580472365|FG001|Overall Study|Withdrawal by Subject|0|||
160750458|NCT00524680|580472366|FG002|Overall Study|Withdrawal by Subject|1|||
160750459|NCT00524680|580472367|FG003|Overall Study|Withdrawal by Subject|1|||
160750460|NCT01146561|580472368|FG000|Overall Study|Withdrawal by Subject|1|||
160750461|NCT01146561|580472368|FG000|Overall Study|Lost to Follow-up|1|||
160750462|NCT01416155|580472376|FG000|Overall Study|Adverse Event|8|||
160750463|NCT01416155|580472376|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
160750464|NCT01416155|580472376|FG000|Overall Study|Withdrawal by Subject|33|||
160750465|NCT01416155|580472376|FG000|Overall Study|Investigator decision|8|||
160750466|NCT01416155|580472376|FG000|Overall Study|Other|7|||
160750467|NCT00382109|580472377|FG000|Overall Study|Adverse Event|3|||
160750468|NCT00382109|580472378|FG001|Overall Study|Adverse Event|0|||
160750469|NCT00382109|580472377|FG000|Overall Study|Physician Decision|6|||
160750470|NCT00382109|580472378|FG001|Overall Study|Physician Decision|1|||
160750471|NCT00382109|580472377|FG000|Overall Study|Withdrawal by Subject|1|||
160750472|NCT00382109|580472378|FG001|Overall Study|Withdrawal by Subject|0|||
160750473|NCT00382109|580472377|FG000|Overall Study|ineligible|2|||
160750474|NCT00382109|580472378|FG001|Overall Study|ineligible|0|||
160750475|NCT00382109|580472377|FG000|Overall Study|Other|0|||
160750476|NCT00382109|580472378|FG001|Overall Study|Other|2|||
160750477|NCT00382109|580472377|FG000|Overall Study|consent withdrawal|0|||
160750478|NCT00382109|580472378|FG001|Overall Study|consent withdrawal|1|||
160750479|NCT02772809|580472381|FG000|Overall Study|not completed some tasks|6|||
160750480|NCT02774005|580472382|FG000|Overall Study|Adverse Event|8|||
160750481|NCT02774005|580472382|FG000|Overall Study|Withdrawal by Subject|23|||
160750482|NCT02774005|580472382|FG000|Overall Study|Lost to Follow-up|7|||
160750483|NCT02774005|580472382|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
160750484|NCT02774005|580472382|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
160750485|NCT02774005|580472382|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
160750486|NCT02774005|580472382|FG000|Overall Study|Death|1|||
160750487|NCT02774005|580472382|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
160750488|NCT02774005|580472382|FG000|Overall Study|Lack of compliance with study medication|4|||
160750489|NCT02774005|580472382|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
160750490|NCT02774005|580472382|FG000|Overall Study|another study|1|||
160750491|NCT02774005|580472382|FG000|Overall Study|cardiologist imposed travel restriction|1|||
160750492|NCT00534105|580472383|FG000|Overall Study|Lost to Follow-up|23|||
160750493|NCT00534105|580472384|FG001|Overall Study|Lost to Follow-up|39|||
160750494|NCT00723697|580472385|FG000|Overall Study|Physician questionnaires not received|2|||
160750495|NCT00723697|580472385|FG000|Overall Study|Missing Informed Consent Form|10|||
160750496|NCT00723697|580472385|FG000|Overall Study|Other exclusion criteria applied|6|||
160750497|NCT03275389|580472388|FG000|Overall Study|Lost to Follow-up|10|||
160750498|NCT03275389|580472389|FG001|Overall Study|Lost to Follow-up|10|||
160750499|NCT03275389|580472390|FG002|Overall Study|Lost to Follow-up|19|||
160750500|NCT03275389|580472391|FG003|Overall Study|Lost to Follow-up|12|||
160750501|NCT03275389|580472392|FG004|Overall Study|Lost to Follow-up|11|||
160750502|NCT03275389|580472393|FG005|Overall Study|Lost to Follow-up|12|||
160750503|NCT03275389|580472394|FG006|Overall Study|Lost to Follow-up|21|||
160750504|NCT03275389|580472395|FG007|Overall Study|Lost to Follow-up|15|||
160750505|NCT03275389|580472396|FG008|Overall Study|Lost to Follow-up|12|||
160750506|NCT03275389|580472397|FG009|Overall Study|Lost to Follow-up|14|||
160750507|NCT03275389|580472388|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
160750508|NCT03275389|580472389|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
160750509|NCT03275389|580472390|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
160750510|NCT03275389|580472391|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
160750511|NCT03275389|580472392|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
160750512|NCT03275389|580472393|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
160750513|NCT03275389|580472394|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
160750514|NCT03275389|580472395|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
160750515|NCT03275389|580472396|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
160750516|NCT03275389|580472397|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
160750517|NCT03275389|580472388|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
160750518|NCT03275389|580472389|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160750519|NCT03275389|580472390|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160750520|NCT03275389|580472391|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
160750521|NCT03275389|580472392|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
160750522|NCT03275389|580472393|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
160750523|NCT03275389|580472394|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
160750524|NCT03275389|580472395|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
160750525|NCT03275389|580472396|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
160750526|NCT03275389|580472397|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
160750527|NCT03275389|580472388|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160750528|NCT03275389|580472389|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
160750529|NCT03275389|580472390|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160750530|NCT03275389|580472391|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
160750531|NCT03275389|580472392|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160750532|NCT03275389|580472393|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160750533|NCT03275389|580472394|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160750534|NCT03275389|580472395|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160750535|NCT03275389|580472396|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160750536|NCT03275389|580472397|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160750537|NCT03275389|580472388|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
160750538|NCT03275389|580472389|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
160750539|NCT03275389|580472390|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
160750540|NCT03275389|580472391|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
160750541|NCT03275389|580472392|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
160750542|NCT03275389|580472393|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
160750543|NCT03275389|580472394|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
160750544|NCT03275389|580472395|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
160750545|NCT03275389|580472396|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
160750546|NCT03275389|580472397|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
160750547|NCT03275389|580472388|FG000|Overall Study|Other|0|||
160750548|NCT03275389|580472389|FG001|Overall Study|Other|4|||
160750549|NCT03275389|580472390|FG002|Overall Study|Other|3|||
160750550|NCT03275389|580472391|FG003|Overall Study|Other|2|||
160750551|NCT03275389|580472392|FG004|Overall Study|Other|2|||
160750552|NCT03275389|580472393|FG005|Overall Study|Other|2|||
160750553|NCT03275389|580472394|FG006|Overall Study|Other|0|||
160750554|NCT03275389|580472395|FG007|Overall Study|Other|0|||
160750555|NCT03275389|580472396|FG008|Overall Study|Other|1|||
160750556|NCT03275389|580472397|FG009|Overall Study|Other|0|||
160750557|NCT00978341|580472400|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
160750558|NCT00978341|580472401|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
160750559|NCT03885999|580472402|FG000|Overall Study|Adverse Event|1|||
160750560|NCT02452554|580472403|FG000|Overall Study|Death|2|||
160750561|NCT02452554|580472404|FG001|Overall Study|Death|1|||
160750562|NCT02452554|580472405|FG002|Overall Study|Death|0|||
160750563|NCT02452554|580472406|FG003|Overall Study|Death|0|||
160750564|NCT02452554|580472407|FG004|Overall Study|Death|0|||
160750565|NCT02452554|580472408|FG005|Overall Study|Death|0|||
160750566|NCT02452554|580472403|FG000|Overall Study|Lack of Efficacy|13|||
160750567|NCT02452554|580472404|FG001|Overall Study|Lack of Efficacy|14|||
160750568|NCT02452554|580472405|FG002|Overall Study|Lack of Efficacy|9|||
160750569|NCT02452554|580472406|FG003|Overall Study|Lack of Efficacy|1|||
160750570|NCT02452554|580472407|FG004|Overall Study|Lack of Efficacy|5|||
160750571|NCT02452554|580472408|FG005|Overall Study|Lack of Efficacy|8|||
160750572|NCT02452554|580472403|FG000|Overall Study|Physician Decision|0|||
160750573|NCT02452554|580472404|FG001|Overall Study|Physician Decision|1|||
160750574|NCT02452554|580472405|FG002|Overall Study|Physician Decision|0|||
160750575|NCT02452554|580472406|FG003|Overall Study|Physician Decision|0|||
160750576|NCT02452554|580472407|FG004|Overall Study|Physician Decision|0|||
160750577|NCT02452554|580472408|FG005|Overall Study|Physician Decision|0|||
160750578|NCT02452554|580472403|FG000|Overall Study|Withdrawal by Subject|1|||
160750579|NCT02452554|580472404|FG001|Overall Study|Withdrawal by Subject|0|||
160750580|NCT02452554|580472405|FG002|Overall Study|Withdrawal by Subject|2|||
160865662|NCT00734539|580902944|FG000|Main Study|Withdrawal by Subject|1|||
160750581|NCT02452554|580472406|FG003|Overall Study|Withdrawal by Subject|0|||
160750582|NCT02452554|580472407|FG004|Overall Study|Withdrawal by Subject|0|||
160750583|NCT02452554|580472408|FG005|Overall Study|Withdrawal by Subject|1|||
160750584|NCT02452554|580472403|FG000|Overall Study|Ineligible|0|||
160750585|NCT02452554|580472404|FG001|Overall Study|Ineligible|1|||
160750586|NCT02452554|580472405|FG002|Overall Study|Ineligible|0|||
160750587|NCT02452554|580472406|FG003|Overall Study|Ineligible|0|||
160750588|NCT02452554|580472407|FG004|Overall Study|Ineligible|0|||
160750589|NCT02452554|580472408|FG005|Overall Study|Ineligible|0|||
160750590|NCT02452554|580472403|FG000|Overall Study|Never Received Treatment|1|||
160750591|NCT02452554|580472404|FG001|Overall Study|Never Received Treatment|0|||
160750592|NCT02452554|580472405|FG002|Overall Study|Never Received Treatment|0|||
160750593|NCT02452554|580472406|FG003|Overall Study|Never Received Treatment|0|||
160750594|NCT02452554|580472407|FG004|Overall Study|Never Received Treatment|0|||
160750595|NCT02452554|580472408|FG005|Overall Study|Never Received Treatment|0|||
160750596|NCT01790516|580472409|FG000|Overall Study|Physician Decision|1|||
160750597|NCT01790516|580472410|FG001|Overall Study|Physician Decision|0|||
160750598|NCT01085084|580472411|FG000|Overall Study|Withdrawal by Subject|1|||
160750599|NCT01085084|580472412|FG001|Overall Study|Withdrawal by Subject|0|||
160750600|NCT01085084|580472413|FG002|Overall Study|Withdrawal by Subject|0|||
160750601|NCT01085084|580472411|FG000|Overall Study|Lost to Follow-up|2|||
160750602|NCT01085084|580472412|FG001|Overall Study|Lost to Follow-up|1|||
160750603|NCT01085084|580472413|FG002|Overall Study|Lost to Follow-up|1|||
160750604|NCT01085084|580472411|FG000|Overall Study|Adverse Event|4|||
160750605|NCT01085084|580472412|FG001|Overall Study|Adverse Event|3|||
160750606|NCT01085084|580472413|FG002|Overall Study|Adverse Event|6|||
160750607|NCT01085084|580472411|FG000|Overall Study|Treatment Failure|0|||
160750608|NCT01085084|580472412|FG001|Overall Study|Treatment Failure|1|||
160750609|NCT01085084|580472413|FG002|Overall Study|Treatment Failure|2|||
160750610|NCT03034135|580472414|FG000|Overall Study|Withdrawal by Subject|2|||
160750611|NCT00520767|580472415|FG000|Overall Study|Death|2|||
160750612|NCT03251482|580475164|FG000|Overall Study|Withdrawal by Subject|0|||
160750613|NCT03251482|580475165|FG001|Overall Study|Withdrawal by Subject|1|||
160750614|NCT03251482|580475166|FG002|Overall Study|Withdrawal by Subject|0|||
160750615|NCT03251482|580475167|FG003|Overall Study|Withdrawal by Subject|0|||
160750616|NCT03251482|580475168|FG004|Overall Study|Withdrawal by Subject|0|||
160750617|NCT04530838|580475169|FG000|Overall Study|Other|2|||
160750618|NCT04530838|580475170|FG001|Overall Study|Other|1|||
160750619|NCT04530838|580475171|FG002|Overall Study|Other|0|||
160750620|NCT04530838|580475169|FG000|Overall Study|Physician Decision|0|||
160750621|NCT04530838|580475170|FG001|Overall Study|Physician Decision|0|||
160750622|NCT04530838|580475171|FG002|Overall Study|Physician Decision|1|||
160750623|NCT04530838|580475169|FG000|Overall Study|Death|0|||
160750624|NCT04530838|580475170|FG001|Overall Study|Death|0|||
160750625|NCT04530838|580475171|FG002|Overall Study|Death|1|||
160750626|NCT04530838|580475169|FG000|Overall Study|Adverse Event|0|||
160750627|NCT04530838|580475170|FG001|Overall Study|Adverse Event|1|||
160750628|NCT04530838|580475171|FG002|Overall Study|Adverse Event|0|||
160750629|NCT04530838|580475169|FG000|Overall Study|No longer meets eligibility criteria|1|||
160750630|NCT04530838|580475170|FG001|Overall Study|No longer meets eligibility criteria|0|||
160750631|NCT04530838|580475171|FG002|Overall Study|No longer meets eligibility criteria|2|||
160750632|NCT04530838|580475169|FG000|Overall Study|Withdrawal by parent/guardian|5|||
160750633|NCT04530838|580475170|FG001|Overall Study|Withdrawal by parent/guardian|2|||
160750634|NCT04530838|580475171|FG002|Overall Study|Withdrawal by parent/guardian|2|||
160750635|NCT02501161|580475172|FG000|Overall Study|Adverse Event|2|||
160750636|NCT02501161|580475173|FG001|Overall Study|Adverse Event|6|||
160750637|NCT02501161|580475172|FG000|Overall Study|Lost to Follow-up|7|||
160750638|NCT02501161|580475173|FG001|Overall Study|Lost to Follow-up|4|||
160750639|NCT02501161|580475172|FG000|Overall Study|Withdrawal by Subject|10|||
160750640|NCT02501161|580475173|FG001|Overall Study|Withdrawal by Subject|15|||
160750641|NCT02501161|580475172|FG000|Overall Study|Other|3|||
160750642|NCT02501161|580475173|FG001|Overall Study|Other|0|||
160750643|NCT04336475|580475174|FG000|Overall Study|pain|1|||
160750644|NCT04336475|580475175|FG001|Overall Study|pain|0|||
160750645|NCT04336475|580475174|FG000|Overall Study|upper respiratory infection|1|||
160750646|NCT04336475|580475175|FG001|Overall Study|upper respiratory infection|0|||
160750647|NCT04336475|580475174|FG000|Overall Study|Lost to Follow-up|0|||
160750648|NCT04336475|580475175|FG001|Overall Study|Lost to Follow-up|2|||
160750649|NCT02030119|580475178|FG000|Overall Study|Withdrawal by Subject|3|||
160750650|NCT02030119|580475179|FG001|Overall Study|Withdrawal by Subject|1|||
160750651|NCT02030119|580475180|FG002|Overall Study|Withdrawal by Subject|5|||
160750652|NCT02030119|580475181|FG003|Overall Study|Withdrawal by Subject|3|||
160750653|NCT02030119|580475178|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
160750654|NCT02030119|580475179|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
160750655|NCT02030119|580475180|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
160750656|NCT02030119|580475181|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
160750657|NCT02213380|580475187|FG000|Underwent Randomization|Withdrawal by Subject|2|||
160750658|NCT02213380|580475188|FG001|Underwent Randomization|Withdrawal by Subject|0|||
160750659|NCT02213380|580475187|FG000|Underwent Randomization|Not treated|3|||
160750660|NCT02213380|580475188|FG001|Underwent Randomization|Not treated|3|||
160750661|NCT02213380|580475187|FG000|Per-protocol Analysis|Protocol Violation|32|||
160750662|NCT02213380|580475188|FG001|Per-protocol Analysis|Protocol Violation|36|||
160750663|NCT01465230|580475196|FG000|Overall Study|Withdrawal by Subject|2|||
160750664|NCT00905567|580475197|FG000|Washout|Withdrawal by Subject|0|||
160750665|NCT00905567|580475198|FG001|Washout|Withdrawal by Subject|1|||
160750666|NCT01738919|580475200|FG000|Overall Study|Lost to Follow-up|1|||
160750667|NCT01738919|580475201|FG001|Overall Study|Lost to Follow-up|0|||
160750668|NCT01738919|580475200|FG000|Overall Study|Immigrated|0|||
160524517|NCT03267940|579650066|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
160524518|NCT03267940|579650067|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
160750669|NCT01738919|580475201|FG001|Overall Study|Immigrated|1|||
160750670|NCT01738919|580475200|FG000|Overall Study|Withdrawal by Subject|0|||
160865663|NCT00734539|580902945|FG001|Main Study|Withdrawal by Subject|3|||
160750671|NCT01738919|580475201|FG001|Overall Study|Withdrawal by Subject|1|||
160750672|NCT01738919|580475200|FG000|Overall Study|Not treated in accordance to guidelines|0|||
160750673|NCT01738919|580475201|FG001|Overall Study|Not treated in accordance to guidelines|1|||
160750674|NCT02532257|580475202|FG000|Overall Study|Adverse Event|2|||
160750675|NCT02532257|580475202|FG000|Overall Study|Physician Decision|4|||
160750676|NCT02532257|580475202|FG000|Overall Study|Withdrawal by Subject|3|||
160750677|NCT02532257|580475202|FG000|Overall Study|Progressive Disease|10|||
160750678|NCT02259400|580475203|FG000|Overall Study|Death|0|||
160750679|NCT02259400|580475204|FG001|Overall Study|Death|2|||
160750680|NCT03498313|580475208|FG000|Experimental Period 1|Adverse Event|1|||
160750681|NCT03498313|580475209|FG001|Experimental Period 1|Adverse Event|0|||
160750682|NCT03498313|580475210|FG002|Experimental Period 1|Adverse Event|0|||
160750683|NCT03498313|580475211|FG003|Experimental Period 1|Adverse Event|1|||
160750684|NCT03498313|580475212|FG004|Experimental Period 1|Adverse Event|0|||
160750685|NCT03498313|580475213|FG005|Experimental Period 1|Adverse Event|0|||
160750686|NCT03498313|580475208|FG000|Experimental Period 1|Withdrawal by Subject|0|||
160750687|NCT03498313|580475209|FG001|Experimental Period 1|Withdrawal by Subject|1|||
160750688|NCT03498313|580475210|FG002|Experimental Period 1|Withdrawal by Subject|0|||
160750689|NCT03498313|580475211|FG003|Experimental Period 1|Withdrawal by Subject|0|||
160750690|NCT03498313|580475212|FG004|Experimental Period 1|Withdrawal by Subject|0|||
160750691|NCT03498313|580475213|FG005|Experimental Period 1|Withdrawal by Subject|0|||
160750692|NCT03498313|580475208|FG000|Washout Period 1|Anovulation|1|||
160750693|NCT03498313|580475209|FG001|Washout Period 1|Anovulation|0|||
160750694|NCT03498313|580475210|FG002|Washout Period 1|Anovulation|0|||
160750695|NCT03498313|580475211|FG003|Washout Period 1|Anovulation|0|||
160750696|NCT03498313|580475212|FG004|Washout Period 1|Anovulation|0|||
160750697|NCT03498313|580475213|FG005|Washout Period 1|Anovulation|0|||
160750698|NCT03498313|580475208|FG000|Washout Period 1|Withdrawal by Subject|0|||
160750699|NCT03498313|580475209|FG001|Washout Period 1|Withdrawal by Subject|3|||
160750700|NCT03498313|580475210|FG002|Washout Period 1|Withdrawal by Subject|0|||
160750701|NCT03498313|580475211|FG003|Washout Period 1|Withdrawal by Subject|1|||
160750702|NCT03498313|580475212|FG004|Washout Period 1|Withdrawal by Subject|0|||
160750703|NCT03498313|580475213|FG005|Washout Period 1|Withdrawal by Subject|1|||
160750704|NCT03498313|580475208|FG000|Experimental Period 2|Adverse Event|0|||
160750705|NCT03498313|580475209|FG001|Experimental Period 2|Adverse Event|0|||
160750706|NCT03498313|580475210|FG002|Experimental Period 2|Adverse Event|0|||
160750707|NCT03498313|580475211|FG003|Experimental Period 2|Adverse Event|0|||
160750708|NCT03498313|580475212|FG004|Experimental Period 2|Adverse Event|1|||
160750709|NCT03498313|580475213|FG005|Experimental Period 2|Adverse Event|2|||
160750710|NCT03498313|580475208|FG000|Washout Period 2|Physician Decision|1|||
160750711|NCT03498313|580475209|FG001|Washout Period 2|Physician Decision|0|||
160750712|NCT03498313|580475210|FG002|Washout Period 2|Physician Decision|0|||
160750713|NCT03498313|580475211|FG003|Washout Period 2|Physician Decision|1|||
160750714|NCT03498313|580475212|FG004|Washout Period 2|Physician Decision|0|||
160750715|NCT03498313|580475213|FG005|Washout Period 2|Physician Decision|1|||
160750716|NCT03498313|580475208|FG000|Washout Period 2|Withdrawal by Subject|3|||
160750717|NCT03498313|580475209|FG001|Washout Period 2|Withdrawal by Subject|2|||
160750718|NCT03498313|580475210|FG002|Washout Period 2|Withdrawal by Subject|0|||
160750719|NCT03498313|580475211|FG003|Washout Period 2|Withdrawal by Subject|0|||
160750720|NCT03498313|580475212|FG004|Washout Period 2|Withdrawal by Subject|2|||
160750721|NCT03498313|580475213|FG005|Washout Period 2|Withdrawal by Subject|0|||
160750722|NCT03498313|580475208|FG000|Washout Period 2|Anovulation|0|||
160750723|NCT03498313|580475209|FG001|Washout Period 2|Anovulation|0|||
160750724|NCT03498313|580475210|FG002|Washout Period 2|Anovulation|0|||
160750725|NCT03498313|580475211|FG003|Washout Period 2|Anovulation|0|||
160750726|NCT03498313|580475212|FG004|Washout Period 2|Anovulation|0|||
160750727|NCT03498313|580475213|FG005|Washout Period 2|Anovulation|1|||
160750728|NCT02372383|580475217|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
160750729|NCT02372383|580475218|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
160750730|NCT02372383|580475219|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
160750731|NCT00621257|580475220|FG000|Overall Study|Lost to Follow-up|4|||
160750732|NCT00621257|580475221|FG001|Overall Study|Lost to Follow-up|0|||
160750733|NCT00621257|580475222|FG002|Overall Study|Lost to Follow-up|2|||
160750734|NCT00621257|580475223|FG003|Overall Study|Lost to Follow-up|4|||
160750735|NCT00621257|580475224|FG004|Overall Study|Lost to Follow-up|7|||
160750736|NCT00621257|580475220|FG000|Overall Study|Adverse Event|0|||
160750737|NCT00621257|580475221|FG001|Overall Study|Adverse Event|1|||
160750738|NCT00621257|580475222|FG002|Overall Study|Adverse Event|1|||
160750739|NCT00621257|580475223|FG003|Overall Study|Adverse Event|0|||
160750740|NCT00621257|580475224|FG004|Overall Study|Adverse Event|0|||
160750741|NCT00621257|580475220|FG000|Overall Study|Physician Decision|0|||
160750742|NCT00621257|580475221|FG001|Overall Study|Physician Decision|2|||
160750743|NCT00621257|580475222|FG002|Overall Study|Physician Decision|0|||
160750744|NCT00621257|580475223|FG003|Overall Study|Physician Decision|1|||
160750745|NCT00621257|580475224|FG004|Overall Study|Physician Decision|1|||
160750746|NCT00621257|580475220|FG000|Overall Study|Withdrawal by Subject|0|||
160750747|NCT00621257|580475221|FG001|Overall Study|Withdrawal by Subject|0|||
160750748|NCT00621257|580475222|FG002|Overall Study|Withdrawal by Subject|0|||
160750749|NCT00621257|580475223|FG003|Overall Study|Withdrawal by Subject|1|||
160750750|NCT00621257|580475224|FG004|Overall Study|Withdrawal by Subject|1|||
160750751|NCT01255904|580475225|FG000|Overall Study|Physician Decision|1|||
160750752|NCT01255904|580475226|FG001|Overall Study|Physician Decision|4|||
160750753|NCT00184002|580475227|FG000|Overall Study|Adverse Event|9|||
160750754|NCT00184002|580475227|FG000|Overall Study|Death|3|||
160750755|NCT00184002|580475227|FG000|Overall Study|Physician Decision|1|||
160750756|NCT00184002|580475227|FG000|Overall Study|Withdrawal by Subject|4|||
160750757|NCT00694356|580475234|FG000|Overall Study|Adverse Event|1|||
160750758|NCT00694356|580475235|FG001|Overall Study|Adverse Event|0|||
160750759|NCT00694356|580475236|FG002|Overall Study|Adverse Event|0|||
160750760|NCT00694356|580475234|FG000|Overall Study|Progressive Disease|2|||
160750761|NCT00694356|580475235|FG001|Overall Study|Progressive Disease|6|||
160750762|NCT00694356|580475236|FG002|Overall Study|Progressive Disease|6|||
160750763|NCT02087670|580475239|FG000|Overall Study|Withdrawal by Subject|3|||
160750764|NCT02087670|580475240|FG001|Overall Study|Withdrawal by Subject|2|||
160750765|NCT01247350|580475242|FG000|Overall Study|Adverse Event|0|||
160750766|NCT01247350|580475243|FG001|Overall Study|Adverse Event|0|||
160750767|NCT01247350|580475244|FG002|Overall Study|Adverse Event|1|||
160750768|NCT01247350|580475245|FG003|Overall Study|Adverse Event|0|||
160750769|NCT01247350|580475246|FG004|Overall Study|Adverse Event|0|||
160750770|NCT01247350|580475242|FG000|Overall Study|Withdrawal by Subject|0|||
160750771|NCT01247350|580475243|FG001|Overall Study|Withdrawal by Subject|0|||
160750772|NCT01247350|580475244|FG002|Overall Study|Withdrawal by Subject|0|||
160750773|NCT01247350|580475245|FG003|Overall Study|Withdrawal by Subject|1|||
160750774|NCT01247350|580475246|FG004|Overall Study|Withdrawal by Subject|0|||
160750775|NCT01247350|580475242|FG000|Overall Study|Entry criteria not met|0|||
160750776|NCT01247350|580475243|FG001|Overall Study|Entry criteria not met|0|||
160750777|NCT01247350|580475244|FG002|Overall Study|Entry criteria not met|0|||
160750778|NCT01247350|580475245|FG003|Overall Study|Entry criteria not met|0|||
160750779|NCT01247350|580475246|FG004|Overall Study|Entry criteria not met|1|||
160750780|NCT00169104|580475247|FG000|Overall Study|Withdrawal by Subject|2|||
160750781|NCT00169104|580475248|FG001|Overall Study|Withdrawal by Subject|0|||
160750782|NCT00169104|580475247|FG000|Overall Study|Protocol Violation|0|||
160750783|NCT00169104|580475248|FG001|Overall Study|Protocol Violation|1|||
160750784|NCT00169104|580475247|FG000|Overall Study|Physician Decision|0|||
160750785|NCT00169104|580475248|FG001|Overall Study|Physician Decision|1|||
160750786|NCT00715299|580475254|FG000|Overall Study|Withdrawal by Subject|1|||
160750787|NCT00715299|580475254|FG000|Overall Study|Adverse Event|3|||
160750788|NCT00715299|580475254|FG000|Overall Study|failed the pre-screen exercise test|2|||
160750789|NCT02020889|580475255|FG000|Overall Study|Adverse Event|0|||
160750790|NCT02020889|580475256|FG001|Overall Study|Adverse Event|1|||
160750791|NCT02020889|580475255|FG000|Overall Study|Lack of Efficacy|1|||
160750792|NCT02020889|580475256|FG001|Overall Study|Lack of Efficacy|0|||
160750793|NCT02020889|580475255|FG000|Overall Study|Lost to Follow-up|1|||
160750794|NCT02020889|580475256|FG001|Overall Study|Lost to Follow-up|0|||
160750795|NCT02020889|580475255|FG000|Overall Study|Physician Decision|2|||
160750796|NCT02020889|580475256|FG001|Overall Study|Physician Decision|0|||
160750797|NCT02020889|580475255|FG000|Overall Study|Withdrawal by Subject|3|||
160750798|NCT02020889|580475256|FG001|Overall Study|Withdrawal by Subject|2|||
160750799|NCT01540981|580475257|FG000|Overall Study|Withdrawal by Subject|1|||
160750800|NCT01540981|580475258|FG001|Overall Study|Withdrawal by Subject|0|||
160750801|NCT00809094|580475259|FG000|Overall Study|Lost to Follow-up|0|||
160750802|NCT00809094|580475260|FG001|Overall Study|Lost to Follow-up|1|||
160750803|NCT00232557|580475261|FG000|Overall Study|Lost to Follow-up|3|||
160750804|NCT00232557|580475262|FG001|Overall Study|Lost to Follow-up|5|||
160750805|NCT04819438|580475267|FG000|Overall Study|Withdrawal by Subject|1|||
160750806|NCT04819438|580475268|FG001|Overall Study|Withdrawal by Subject|0|||
160750807|NCT04819438|580475267|FG000|Overall Study|Adverse Event|0|||
160750808|NCT04819438|580475268|FG001|Overall Study|Adverse Event|1|||
160750809|NCT04819438|580475267|FG000|Overall Study|Protocol Violation|0|||
160750810|NCT04819438|580475268|FG001|Overall Study|Protocol Violation|1|||
160750811|NCT03836209|580475269|FG000|Overall Study|Adverse Event|5|||
160750812|NCT03836209|580475270|FG001|Overall Study|Adverse Event|2|||
160750813|NCT03836209|580475269|FG000|Overall Study|Death|4|||
160750814|NCT03836209|580475270|FG001|Overall Study|Death|1|||
160750815|NCT03836209|580475269|FG000|Overall Study|Lack of Efficacy|7|||
160750816|NCT03836209|580475270|FG001|Overall Study|Lack of Efficacy|10|||
160750817|NCT03836209|580475269|FG000|Overall Study|Physician Decision|7|||
160750818|NCT03836209|580475270|FG001|Overall Study|Physician Decision|11|||
160750819|NCT03836209|580475269|FG000|Overall Study|Protocol Violation|0|||
160750820|NCT03836209|580475270|FG001|Overall Study|Protocol Violation|3|||
160750821|NCT03836209|580475269|FG000|Overall Study|Withdrawal by Subject|2|||
160750822|NCT03836209|580475270|FG001|Overall Study|Withdrawal by Subject|10|||
160750823|NCT03836209|580475269|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
160750824|NCT03836209|580475270|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
160750825|NCT05980013|580475271|FG000|Overall Study|Withdrawal by Subject|0|||
160750826|NCT05980013|580475272|FG001|Overall Study|Withdrawal by Subject|1|||
160750827|NCT05980013|580475271|FG000|Overall Study|Device Error|0|||
160750828|NCT05980013|580475272|FG001|Overall Study|Device Error|1|||
160750829|NCT02328937|580475276|FG000|Period 1|Lost to Follow-up|0|||
160750830|NCT02328937|580475277|FG001|Period 1|Lost to Follow-up|0|||
160750831|NCT02328937|580475278|FG002|Period 1|Lost to Follow-up|0|||
160750832|NCT02328937|580475279|FG003|Period 1|Lost to Follow-up|1|||
160750833|NCT02328937|580475280|FG004|Period 1|Lost to Follow-up|0|||
160750834|NCT02328937|580475281|FG005|Period 1|Lost to Follow-up|0|||
160750835|NCT02328937|580475276|FG000|Period 2|Adverse Event|0|||
160750836|NCT02328937|580475277|FG001|Period 2|Adverse Event|0|||
160750837|NCT02328937|580475278|FG002|Period 2|Adverse Event|1|||
160750838|NCT02328937|580475279|FG003|Period 2|Adverse Event|0|||
160750839|NCT02328937|580475280|FG004|Period 2|Adverse Event|0|||
160750840|NCT02328937|580475281|FG005|Period 2|Adverse Event|0|||
160750841|NCT00435461|580475282|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
160750842|NCT00435461|580475283|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
160750843|NCT00435461|580475284|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
160750844|NCT00435461|580475282|FG000|Overall Study|Protocol Violation|6|||
160750845|NCT00435461|580475283|FG001|Overall Study|Protocol Violation|9|||
160750846|NCT00435461|580475284|FG002|Overall Study|Protocol Violation|10|||
160750847|NCT00435461|580475282|FG000|Overall Study|Participant randomized(inadequate score)|1|||
160524519|NCT03267940|579650062|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
160524520|NCT03267940|579650063|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
160750848|NCT00435461|580475283|FG001|Overall Study|Participant randomized(inadequate score)|0|||
160750849|NCT00435461|580475284|FG002|Overall Study|Participant randomized(inadequate score)|0|||
160750850|NCT00435461|580475282|FG000|Overall Study|Compliance less than 80 percent|1|||
160750851|NCT00435461|580475283|FG001|Overall Study|Compliance less than 80 percent|0|||
160750852|NCT00435461|580475284|FG002|Overall Study|Compliance less than 80 percent|0|||
160750853|NCT00435461|580475282|FG000|Overall Study|In error, two study medications switched|1|||
160750854|NCT00435461|580475283|FG001|Overall Study|In error, two study medications switched|0|||
160750855|NCT00435461|580475284|FG002|Overall Study|In error, two study medications switched|0|||
160750856|NCT00435461|580475282|FG000|Overall Study|Lack of Efficacy|2|||
160750857|NCT00435461|580475283|FG001|Overall Study|Lack of Efficacy|1|||
160750858|NCT00435461|580475284|FG002|Overall Study|Lack of Efficacy|0|||
160750859|NCT00435461|580475282|FG000|Overall Study|Withdrawal by Subject|1|||
160750860|NCT00435461|580475283|FG001|Overall Study|Withdrawal by Subject|0|||
160750861|NCT00435461|580475284|FG002|Overall Study|Withdrawal by Subject|2|||
160750862|NCT00435461|580475282|FG000|Overall Study|Randomized in error|1|||
160750863|NCT00435461|580475283|FG001|Overall Study|Randomized in error|0|||
160750864|NCT00435461|580475284|FG002|Overall Study|Randomized in error|0|||
160750865|NCT00435461|580475282|FG000|Overall Study|Participant could not tolerate symptoms|0|||
160750866|NCT00435461|580475283|FG001|Overall Study|Participant could not tolerate symptoms|0|||
160750867|NCT00435461|580475284|FG002|Overall Study|Participant could not tolerate symptoms|1|||
160750868|NCT00435461|580475282|FG000|Overall Study|Participant could not swallow capsule|0|||
160750869|NCT00435461|580475283|FG001|Overall Study|Participant could not swallow capsule|0|||
160750870|NCT00435461|580475284|FG002|Overall Study|Participant could not swallow capsule|1|||
160750871|NCT00435461|580475282|FG000|Overall Study|Pregnancy|2|||
160750872|NCT00435461|580475283|FG001|Overall Study|Pregnancy|0|||
160750873|NCT00435461|580475284|FG002|Overall Study|Pregnancy|0|||
160750874|NCT00435461|580475282|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
160750875|NCT00435461|580475283|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
160750876|NCT00435461|580475284|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
160750877|NCT00435461|580475282|FG000|Overall Study|Participant ended study one day early|1|||
160750878|NCT00435461|580475283|FG001|Overall Study|Participant ended study one day early|0|||
160750879|NCT00435461|580475284|FG002|Overall Study|Participant ended study one day early|0|||
160750880|NCT00435461|580475282|FG000|Overall Study|Noncompliance with study requirements|1|||
160750881|NCT00435461|580475283|FG001|Overall Study|Noncompliance with study requirements|1|||
160750882|NCT00435461|580475284|FG002|Overall Study|Noncompliance with study requirements|1|||
160750883|NCT00435461|580475282|FG000|Overall Study|Adverse Event|1|||
160750884|NCT00435461|580475283|FG001|Overall Study|Adverse Event|2|||
160750885|NCT00435461|580475284|FG002|Overall Study|Adverse Event|6|||
160750886|NCT00435461|580475282|FG000|Overall Study|Non-Compliance of diary|2|||
160750887|NCT00435461|580475283|FG001|Overall Study|Non-Compliance of diary|0|||
160750888|NCT00435461|580475284|FG002|Overall Study|Non-Compliance of diary|1|||
160750889|NCT00435461|580475282|FG000|Overall Study|Lost to Follow-up|1|||
160750890|NCT00435461|580475283|FG001|Overall Study|Lost to Follow-up|1|||
160750891|NCT00435461|580475284|FG002|Overall Study|Lost to Follow-up|2|||
160750892|NCT00531947|580475285|FG000|Overall Study|Adverse Event|5|||
160750893|NCT00531947|580475286|FG001|Overall Study|Adverse Event|10|||
160750894|NCT00531947|580475285|FG000|Overall Study|Lost to Follow-up|12|||
160750895|NCT00531947|580475286|FG001|Overall Study|Lost to Follow-up|9|||
160750896|NCT00531947|580475285|FG000|Overall Study|Withdrawal by Subject|14|||
160750897|NCT00531947|580475286|FG001|Overall Study|Withdrawal by Subject|19|||
160750898|NCT00531947|580475285|FG000|Overall Study|Protocol Violation|2|||
160750899|NCT00531947|580475286|FG001|Overall Study|Protocol Violation|1|||
160750900|NCT00531947|580475285|FG000|Overall Study|Non-Compliance|4|||
160750901|NCT00531947|580475286|FG001|Overall Study|Non-Compliance|7|||
160750902|NCT00531947|580475285|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
160750903|NCT00531947|580475286|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
160750904|NCT02383355|580475289|FG000|Overall Study|Adverse Event|2|||
160750905|NCT02383355|580475290|FG001|Overall Study|Adverse Event|0|||
160750906|NCT03092791|580475291|FG000|Overall Study|Lost to Follow-up|0|||
160750907|NCT03092791|580475292|FG001|Overall Study|Lost to Follow-up|0|||
160750908|NCT03092791|580475293|FG002|Overall Study|Lost to Follow-up|0|||
160750909|NCT03092791|580475294|FG003|Overall Study|Lost to Follow-up|0|||
160750910|NCT03092791|580475295|FG004|Overall Study|Lost to Follow-up|0|||
160750911|NCT03092791|580475296|FG005|Overall Study|Lost to Follow-up|0|||
160750912|NCT03092791|580475297|FG006|Overall Study|Lost to Follow-up|1|||
160750913|NCT03092791|580475298|FG007|Overall Study|Lost to Follow-up|0|||
160750914|NCT03092791|580475291|FG000|Overall Study|Withdrawal of Consent|0|||
160750915|NCT03092791|580475292|FG001|Overall Study|Withdrawal of Consent|0|||
160750916|NCT03092791|580475293|FG002|Overall Study|Withdrawal of Consent|0|||
160750917|NCT03092791|580475294|FG003|Overall Study|Withdrawal of Consent|0|||
160750918|NCT03092791|580475295|FG004|Overall Study|Withdrawal of Consent|4|||
160750919|NCT03092791|580475296|FG005|Overall Study|Withdrawal of Consent|12|||
160750920|NCT03092791|580475297|FG006|Overall Study|Withdrawal of Consent|6|||
160750921|NCT03092791|580475298|FG007|Overall Study|Withdrawal of Consent|4|||
160750922|NCT03092791|580475291|FG000|Overall Study|Study Termination|0|||
160750923|NCT03092791|580475292|FG001|Overall Study|Study Termination|0|||
160750924|NCT03092791|580475293|FG002|Overall Study|Study Termination|0|||
160750925|NCT03092791|580475294|FG003|Overall Study|Study Termination|0|||
160750926|NCT03092791|580475295|FG004|Overall Study|Study Termination|55|||
160750927|NCT03092791|580475296|FG005|Overall Study|Study Termination|46|||
160750928|NCT03092791|580475297|FG006|Overall Study|Study Termination|53|||
160750929|NCT03092791|580475298|FG007|Overall Study|Study Termination|55|||
160750930|NCT03092791|580475291|FG000|Overall Study|Death|0|||
160750931|NCT03092791|580475292|FG001|Overall Study|Death|0|||
160750932|NCT03092791|580475293|FG002|Overall Study|Death|0|||
160750933|NCT03092791|580475294|FG003|Overall Study|Death|0|||
160750934|NCT03092791|580475295|FG004|Overall Study|Death|0|||
160750935|NCT03092791|580475296|FG005|Overall Study|Death|1|||
160750936|NCT03092791|580475297|FG006|Overall Study|Death|0|||
160750937|NCT03092791|580475298|FG007|Overall Study|Death|1|||
160750938|NCT03092791|580475291|FG000|Overall Study|Reason Not Specified|0|||
160750939|NCT03092791|580475292|FG001|Overall Study|Reason Not Specified|0|||
160750940|NCT03092791|580475293|FG002|Overall Study|Reason Not Specified|0|||
160750941|NCT03092791|580475294|FG003|Overall Study|Reason Not Specified|0|||
160750942|NCT03092791|580475295|FG004|Overall Study|Reason Not Specified|1|||
160750943|NCT03092791|580475296|FG005|Overall Study|Reason Not Specified|1|||
160750944|NCT03092791|580475297|FG006|Overall Study|Reason Not Specified|0|||
160750945|NCT03092791|580475298|FG007|Overall Study|Reason Not Specified|0|||
160750946|NCT02182830|580475302|FG000|Overall Study|Not Treated|1|||
160750947|NCT02182830|580475303|FG001|Overall Study|Not Treated|1|||
160750948|NCT02182830|580475302|FG000|Overall Study|Trial stopped, reason missing|3|||
160750949|NCT02182830|580475303|FG001|Overall Study|Trial stopped, reason missing|3|||
160750950|NCT02182830|580475302|FG000|Overall Study|Consent withdrawn|8|||
160750951|NCT02182830|580475303|FG001|Overall Study|Consent withdrawn|8|||
160750952|NCT02182830|580475302|FG000|Overall Study|Lost to Follow-up|3|||
160750953|NCT02182830|580475303|FG001|Overall Study|Lost to Follow-up|3|||
160750954|NCT00334295|580475305|FG000|Overall Study|Patients received fewer than 3 injection|5|||
160750955|NCT00586898|580475306|FG000|Overall Study|Adverse Event|1|||
160750956|NCT00586898|580475306|FG000|Overall Study|Patiemt Non-compliance|1|||
160750957|NCT00586898|580475306|FG000|Overall Study|Evaluable for Toxicity Only|5|||
160750958|NCT00893971|580475307|FG000|Overall Study|Physician Decision|3|||
160750959|NCT01588405|580475308|FG000|Overall Study|Adverse Event|1|||
160750960|NCT01588405|580475308|FG000|Overall Study|Clinical Worsening|1|||
160750961|NCT00492232|580475309|FG000|Placebo Run-in|Adverse Event|0|||
160750962|NCT00492232|580475310|FG001|Placebo Run-in|Adverse Event|2|||
160750963|NCT00492232|580475309|FG000|Placebo Run-in|Protocol Violation|0|||
160750964|NCT00492232|580475310|FG001|Placebo Run-in|Protocol Violation|3|||
160750965|NCT00492232|580475309|FG000|Placebo Run-in|Lost to Follow-up|0|||
160750966|NCT00492232|580475310|FG001|Placebo Run-in|Lost to Follow-up|3|||
160750967|NCT00492232|580475309|FG000|Placebo Run-in|Withdrawal by Subject|0|||
160750968|NCT00492232|580475310|FG001|Placebo Run-in|Withdrawal by Subject|8|||
160750969|NCT00492232|580475309|FG000|Placebo Run-in|Pregnancy|0|||
160750970|NCT00492232|580475310|FG001|Placebo Run-in|Pregnancy|1|||
160750971|NCT00492232|580475309|FG000|Placebo Run-in|Entrance criteria not met|0|||
160750972|NCT00492232|580475310|FG001|Placebo Run-in|Entrance criteria not met|45|||
160750973|NCT00492232|580475309|FG000|Placebo Run-in|Other|0|||
160750974|NCT00492232|580475310|FG001|Placebo Run-in|Other|6|||
160750975|NCT00492232|580475309|FG000|Placebo Run-in|Missing|0|||
160750976|NCT00492232|580475310|FG001|Placebo Run-in|Missing|2|||
160750977|NCT00492232|580475309|FG000|Double-Blind Treatment|Adverse Event|1|||
160750978|NCT00492232|580475310|FG001|Double-Blind Treatment|Adverse Event|2|||
160750979|NCT00492232|580475309|FG000|Double-Blind Treatment|Protocol Violation|3|||
160750980|NCT00492232|580475310|FG001|Double-Blind Treatment|Protocol Violation|7|||
160750981|NCT00492232|580475309|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
160750982|NCT00492232|580475310|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
160750983|NCT00492232|580475309|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
160750984|NCT00492232|580475310|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
160750985|NCT00492232|580475309|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
160750986|NCT00492232|580475310|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
160750987|NCT00492232|580475309|FG000|Double-Blind Treatment|Other|6|||
160750988|NCT00492232|580475310|FG001|Double-Blind Treatment|Other|5|||
160750989|NCT00492232|580475309|FG000|Double-Blind Treatment|Randomized not treated|1|||
160750990|NCT00492232|580475310|FG001|Double-Blind Treatment|Randomized not treated|0|||
160750991|NCT00492232|580475309|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
160750992|NCT00492232|580475310|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
160750993|NCT00829829|580475315|FG000|Overall Study|Protocol Violation|0|||
160750994|NCT00829829|580475316|FG001|Overall Study|Protocol Violation|3|||
160750995|NCT00829829|580475317|FG002|Overall Study|Protocol Violation|0|||
160750996|NCT00829829|580475315|FG000|Overall Study|Adverse Event|4|||
160750997|NCT00829829|580475316|FG001|Overall Study|Adverse Event|4|||
160750998|NCT00829829|580475317|FG002|Overall Study|Adverse Event|3|||
160750999|NCT00829829|580475315|FG000|Overall Study|Withdrawal by Subject|8|||
160751000|NCT00829829|580475316|FG001|Overall Study|Withdrawal by Subject|4|||
160751001|NCT00829829|580475317|FG002|Overall Study|Withdrawal by Subject|2|||
160751002|NCT00829829|580475315|FG000|Overall Study|Decision by the Sponsor|1|||
160751003|NCT00829829|580475316|FG001|Overall Study|Decision by the Sponsor|0|||
160751004|NCT00829829|580475317|FG002|Overall Study|Decision by the Sponsor|2|||
160751005|NCT00829829|580475315|FG000|Overall Study|Lost to Follow-up|7|||
160751006|NCT00829829|580475316|FG001|Overall Study|Lost to Follow-up|3|||
160751007|NCT00829829|580475317|FG002|Overall Study|Lost to Follow-up|3|||
160751008|NCT00829829|580475315|FG000|Overall Study|Other than specified above|2|||
160751009|NCT00829829|580475316|FG001|Overall Study|Other than specified above|2|||
160751010|NCT00829829|580475317|FG002|Overall Study|Other than specified above|1|||
160751011|NCT04811664|580475318|FG000|Overall Study|Lost to Follow-up|78|||
160751012|NCT04811664|580475319|FG001|Overall Study|Lost to Follow-up|125|||
160751013|NCT04811664|580475320|FG002|Overall Study|Lost to Follow-up|46|||
160751014|NCT04811664|580475318|FG000|Overall Study|Withdrawal by Subject|39|||
160751015|NCT04811664|580475319|FG001|Overall Study|Withdrawal by Subject|76|||
160751016|NCT04811664|580475320|FG002|Overall Study|Withdrawal by Subject|12|||
160751017|NCT04811664|580475318|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
160751018|NCT04811664|580475319|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
160751019|NCT04811664|580475320|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
160751020|NCT04811664|580475318|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
160751021|NCT04811664|580475319|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
160751022|NCT04811664|580475320|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
160751023|NCT04811664|580475318|FG000|Overall Study|Protocol Violation|0|||
160751024|NCT04811664|580475319|FG001|Overall Study|Protocol Violation|5|||
160751025|NCT04811664|580475320|FG002|Overall Study|Protocol Violation|11|||
160751026|NCT04811664|580475318|FG000|Overall Study|Study Terminated by Sponsor|4|||
160751027|NCT04811664|580475319|FG001|Overall Study|Study Terminated by Sponsor|3|||
160751028|NCT04811664|580475320|FG002|Overall Study|Study Terminated by Sponsor|34|||
160751029|NCT04811664|580475318|FG000|Overall Study|Early Study Closure|3|||
160751030|NCT04811664|580475319|FG001|Overall Study|Early Study Closure|7|||
160751031|NCT04811664|580475320|FG002|Overall Study|Early Study Closure|79|||
160751032|NCT04811664|580475318|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
160751033|NCT04811664|580475319|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
160751034|NCT04811664|580475320|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
160751035|NCT02717442|580475321|FG000|Overall Study|Study Terminated by Sponsor|31|||
160751036|NCT02717442|580475322|FG001|Overall Study|Study Terminated by Sponsor|29|||
160751037|NCT02717442|580475321|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
160751038|NCT02717442|580475322|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
160751039|NCT02717442|580475321|FG000|Overall Study|Other - Not Specified|2|||
160751040|NCT02717442|580475322|FG001|Overall Study|Other - Not Specified|0|||
160751041|NCT05052697|580475323|FG000|Substudy A|Lost to Follow-up|0|||
160751042|NCT05052697|580475324|FG001|Substudy A|Lost to Follow-up|0|||
160751043|NCT05052697|580475325|FG002|Substudy A|Lost to Follow-up|0|||
160751044|NCT05052697|580475326|FG003|Substudy A|Lost to Follow-up|0|||
160751045|NCT05052697|580475327|FG004|Substudy A|Lost to Follow-up|0|||
160751046|NCT05052697|580475328|FG005|Substudy A|Lost to Follow-up|1|||
160751047|NCT05052697|580475329|FG006|Substudy A|Lost to Follow-up|0|||
160751048|NCT05052697|580475330|FG007|Substudy A|Lost to Follow-up|0|||
160751049|NCT05052697|580475331|FG008|Substudy A|Lost to Follow-up|0|||
160751050|NCT05052697|580475332|FG009|Substudy A|Lost to Follow-up|0|||
160751051|NCT05052697|580475333|FG010|Substudy A|Lost to Follow-up|0|||
160751052|NCT05052697|580475334|FG011|Substudy A|Lost to Follow-up|0|||
160751053|NCT05052697|580475335|FG012|Substudy A|Lost to Follow-up|0|||
160751054|NCT05052697|580475336|FG013|Substudy A|Lost to Follow-up|0|||
160751055|NCT05052697|580475337|FG014|Substudy A|Lost to Follow-up|0|||
160751056|NCT05052697|580475338|FG015|Substudy A|Lost to Follow-up|2|||
160751057|NCT05052697|580475339|FG016|Substudy A|Lost to Follow-up|0|||
160751058|NCT05052697|580475340|FG017|Substudy A|Lost to Follow-up|0|||
160751059|NCT05052697|580475341|FG018|Substudy A|Lost to Follow-up|0|||
160751060|NCT05052697|580475342|FG019|Substudy A|Lost to Follow-up|0|||
160751061|NCT05052697|580475343|FG020|Substudy A|Lost to Follow-up|0|||
160751062|NCT05052697|580475344|FG021|Substudy A|Lost to Follow-up|0|||
160751063|NCT05052697|580475345|FG022|Substudy A|Lost to Follow-up|0|||
160751064|NCT05052697|580475346|FG023|Substudy A|Lost to Follow-up|0|||
160751065|NCT05052697|580475347|FG024|Substudy A|Lost to Follow-up|0|||
160751066|NCT05052697|580475348|FG025|Substudy A|Lost to Follow-up|0|||
160751067|NCT05052697|580475349|FG026|Substudy A|Lost to Follow-up|0|||
160751068|NCT05052697|580475350|FG027|Substudy A|Lost to Follow-up|0|||
160751069|NCT05052697|580475351|FG028|Substudy A|Lost to Follow-up|0|||
160751070|NCT05052697|580475352|FG029|Substudy A|Lost to Follow-up|0|||
160751071|NCT05052697|580475353|FG030|Substudy A|Lost to Follow-up|0|||
160751072|NCT05052697|580475354|FG031|Substudy A|Lost to Follow-up|0|||
160751073|NCT05052697|580475355|FG032|Substudy A|Lost to Follow-up|0|||
160751074|NCT05052697|580475356|FG033|Substudy A|Lost to Follow-up|0|||
160751075|NCT05052697|580475323|FG000|Substudy A|No longer met eligibility criteria|0|||
160751076|NCT05052697|580475324|FG001|Substudy A|No longer met eligibility criteria|0|||
160751077|NCT05052697|580475325|FG002|Substudy A|No longer met eligibility criteria|0|||
160751078|NCT05052697|580475326|FG003|Substudy A|No longer met eligibility criteria|0|||
160751079|NCT05052697|580475327|FG004|Substudy A|No longer met eligibility criteria|0|||
160751080|NCT05052697|580475328|FG005|Substudy A|No longer met eligibility criteria|0|||
160751081|NCT05052697|580475329|FG006|Substudy A|No longer met eligibility criteria|0|||
160751082|NCT05052697|580475330|FG007|Substudy A|No longer met eligibility criteria|0|||
160751083|NCT05052697|580475331|FG008|Substudy A|No longer met eligibility criteria|0|||
160751084|NCT05052697|580475332|FG009|Substudy A|No longer met eligibility criteria|0|||
160751085|NCT05052697|580475333|FG010|Substudy A|No longer met eligibility criteria|0|||
160751086|NCT05052697|580475334|FG011|Substudy A|No longer met eligibility criteria|0|||
160751087|NCT05052697|580475335|FG012|Substudy A|No longer met eligibility criteria|0|||
160751088|NCT05052697|580475336|FG013|Substudy A|No longer met eligibility criteria|1|||
160751089|NCT05052697|580475337|FG014|Substudy A|No longer met eligibility criteria|0|||
160751090|NCT05052697|580475338|FG015|Substudy A|No longer met eligibility criteria|0|||
160751091|NCT05052697|580475339|FG016|Substudy A|No longer met eligibility criteria|0|||
160751092|NCT05052697|580475340|FG017|Substudy A|No longer met eligibility criteria|0|||
160751093|NCT05052697|580475341|FG018|Substudy A|No longer met eligibility criteria|0|||
160751094|NCT05052697|580475342|FG019|Substudy A|No longer met eligibility criteria|0|||
160865664|NCT00734539|580902944|FG000|Main Study|Enrolled in error; ineligible|1|||
160751095|NCT05052697|580475343|FG020|Substudy A|No longer met eligibility criteria|0|||
160751096|NCT05052697|580475344|FG021|Substudy A|No longer met eligibility criteria|0|||
160751097|NCT05052697|580475345|FG022|Substudy A|No longer met eligibility criteria|0|||
160751098|NCT05052697|580475346|FG023|Substudy A|No longer met eligibility criteria|0|||
160751099|NCT05052697|580475347|FG024|Substudy A|No longer met eligibility criteria|0|||
160751100|NCT05052697|580475348|FG025|Substudy A|No longer met eligibility criteria|0|||
160751101|NCT05052697|580475349|FG026|Substudy A|No longer met eligibility criteria|0|||
160751102|NCT05052697|580475350|FG027|Substudy A|No longer met eligibility criteria|0|||
160751103|NCT05052697|580475351|FG028|Substudy A|No longer met eligibility criteria|0|||
160751104|NCT05052697|580475352|FG029|Substudy A|No longer met eligibility criteria|0|||
160751105|NCT05052697|580475353|FG030|Substudy A|No longer met eligibility criteria|0|||
160751106|NCT05052697|580475354|FG031|Substudy A|No longer met eligibility criteria|0|||
160751107|NCT05052697|580475355|FG032|Substudy A|No longer met eligibility criteria|0|||
160751108|NCT05052697|580475356|FG033|Substudy A|No longer met eligibility criteria|0|||
160751109|NCT05052697|580475323|FG000|Substudy A|Not vaccinated|0|||
160751110|NCT05052697|580475324|FG001|Substudy A|Not vaccinated|0|||
160751111|NCT05052697|580475325|FG002|Substudy A|Not vaccinated|0|||
160751112|NCT05052697|580475326|FG003|Substudy A|Not vaccinated|1|||
160751113|NCT05052697|580475327|FG004|Substudy A|Not vaccinated|0|||
160751114|NCT05052697|580475328|FG005|Substudy A|Not vaccinated|0|||
160751115|NCT05052697|580475329|FG006|Substudy A|Not vaccinated|0|||
160751116|NCT05052697|580475330|FG007|Substudy A|Not vaccinated|0|||
160751117|NCT05052697|580475331|FG008|Substudy A|Not vaccinated|1|||
160751118|NCT05052697|580475332|FG009|Substudy A|Not vaccinated|0|||
160751119|NCT05052697|580475333|FG010|Substudy A|Not vaccinated|0|||
160751120|NCT05052697|580475334|FG011|Substudy A|Not vaccinated|0|||
160751121|NCT05052697|580475335|FG012|Substudy A|Not vaccinated|0|||
160751122|NCT05052697|580475336|FG013|Substudy A|Not vaccinated|0|||
160751123|NCT05052697|580475337|FG014|Substudy A|Not vaccinated|0|||
160751124|NCT05052697|580475338|FG015|Substudy A|Not vaccinated|0|||
160751125|NCT05052697|580475339|FG016|Substudy A|Not vaccinated|0|||
160751126|NCT05052697|580475340|FG017|Substudy A|Not vaccinated|0|||
160751127|NCT05052697|580475341|FG018|Substudy A|Not vaccinated|0|||
160751128|NCT05052697|580475342|FG019|Substudy A|Not vaccinated|0|||
160751129|NCT05052697|580475343|FG020|Substudy A|Not vaccinated|0|||
160751130|NCT05052697|580475344|FG021|Substudy A|Not vaccinated|0|||
160751131|NCT05052697|580475345|FG022|Substudy A|Not vaccinated|0|||
160751132|NCT05052697|580475346|FG023|Substudy A|Not vaccinated|0|||
160751133|NCT05052697|580475347|FG024|Substudy A|Not vaccinated|0|||
160751134|NCT05052697|580475348|FG025|Substudy A|Not vaccinated|0|||
160751135|NCT05052697|580475349|FG026|Substudy A|Not vaccinated|0|||
160751136|NCT05052697|580475350|FG027|Substudy A|Not vaccinated|0|||
160751137|NCT05052697|580475351|FG028|Substudy A|Not vaccinated|0|||
160751138|NCT05052697|580475352|FG029|Substudy A|Not vaccinated|0|||
160751139|NCT05052697|580475353|FG030|Substudy A|Not vaccinated|0|||
160751140|NCT05052697|580475354|FG031|Substudy A|Not vaccinated|0|||
160751141|NCT05052697|580475355|FG032|Substudy A|Not vaccinated|0|||
160751142|NCT05052697|580475356|FG033|Substudy A|Not vaccinated|0|||
160751143|NCT05052697|580475323|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751144|NCT05052697|580475324|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751145|NCT05052697|580475325|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751146|NCT05052697|580475326|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751147|NCT05052697|580475327|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751148|NCT05052697|580475328|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751149|NCT05052697|580475329|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751150|NCT05052697|580475330|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751151|NCT05052697|580475331|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751152|NCT05052697|580475332|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751153|NCT05052697|580475333|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751154|NCT05052697|580475334|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751155|NCT05052697|580475335|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751156|NCT05052697|580475336|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751157|NCT05052697|580475337|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751158|NCT05052697|580475338|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751159|NCT05052697|580475339|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751160|NCT05052697|580475340|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751161|NCT05052697|580475341|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
160751162|NCT05052697|580475342|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
160751163|NCT05052697|580475343|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751164|NCT05052697|580475344|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
160751165|NCT05052697|580475345|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
160751166|NCT05052697|580475346|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751167|NCT05052697|580475347|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751168|NCT05052697|580475348|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160865665|NCT00734539|580902945|FG001|Main Study|Enrolled in error; ineligible|0|||
160751169|NCT05052697|580475349|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751170|NCT05052697|580475350|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751171|NCT05052697|580475351|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751172|NCT05052697|580475352|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751173|NCT05052697|580475353|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751174|NCT05052697|580475354|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751175|NCT05052697|580475355|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751176|NCT05052697|580475356|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
160751177|NCT05052697|580475323|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751178|NCT05052697|580475324|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751179|NCT05052697|580475325|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751180|NCT05052697|580475326|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751181|NCT05052697|580475327|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751182|NCT05052697|580475328|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751183|NCT05052697|580475329|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751184|NCT05052697|580475330|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751185|NCT05052697|580475331|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751186|NCT05052697|580475332|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751187|NCT05052697|580475333|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751188|NCT05052697|580475334|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751189|NCT05052697|580475335|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751190|NCT05052697|580475336|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751191|NCT05052697|580475337|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751192|NCT05052697|580475338|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751193|NCT05052697|580475339|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751194|NCT05052697|580475340|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
160751195|NCT05052697|580475341|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751196|NCT05052697|580475342|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751197|NCT05052697|580475343|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751198|NCT05052697|580475344|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751199|NCT05052697|580475345|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751200|NCT05052697|580475346|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751201|NCT05052697|580475347|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751202|NCT05052697|580475348|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751203|NCT05052697|580475349|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751204|NCT05052697|580475350|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751205|NCT05052697|580475351|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751206|NCT05052697|580475352|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751207|NCT05052697|580475353|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751208|NCT05052697|580475354|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751209|NCT05052697|580475355|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751210|NCT05052697|580475356|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
160751211|NCT05052697|580475323|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751212|NCT05052697|580475324|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751213|NCT05052697|580475325|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751214|NCT05052697|580475326|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751215|NCT05052697|580475327|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751216|NCT05052697|580475328|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751217|NCT05052697|580475329|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751218|NCT05052697|580475330|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751219|NCT05052697|580475331|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751220|NCT05052697|580475332|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751221|NCT05052697|580475333|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751222|NCT05052697|580475334|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751223|NCT05052697|580475335|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751224|NCT05052697|580475336|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751225|NCT05052697|580475337|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751226|NCT05052697|580475338|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751227|NCT05052697|580475339|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751228|NCT05052697|580475340|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751229|NCT05052697|580475341|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751230|NCT05052697|580475342|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
160751231|NCT05052697|580475343|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751232|NCT05052697|580475344|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751233|NCT05052697|580475345|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751234|NCT05052697|580475346|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751235|NCT05052697|580475347|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751236|NCT05052697|580475348|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751237|NCT05052697|580475349|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751238|NCT05052697|580475350|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751239|NCT05052697|580475351|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751240|NCT05052697|580475352|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751241|NCT05052697|580475353|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751242|NCT05052697|580475354|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751243|NCT05052697|580475355|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751244|NCT05052697|580475356|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
160751245|NCT05052697|580475323|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751246|NCT05052697|580475324|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751247|NCT05052697|580475325|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751248|NCT05052697|580475326|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751249|NCT05052697|580475327|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751250|NCT05052697|580475328|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751251|NCT05052697|580475329|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751252|NCT05052697|580475330|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751253|NCT05052697|580475331|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751254|NCT05052697|580475332|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751255|NCT05052697|580475333|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751256|NCT05052697|580475334|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751257|NCT05052697|580475335|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751258|NCT05052697|580475336|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751259|NCT05052697|580475337|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751260|NCT05052697|580475338|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751261|NCT05052697|580475339|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751262|NCT05052697|580475340|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
160751263|NCT05052697|580475341|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751264|NCT05052697|580475342|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751265|NCT05052697|580475343|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751266|NCT05052697|580475344|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751267|NCT05052697|580475345|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751268|NCT05052697|580475346|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751269|NCT05052697|580475347|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751270|NCT05052697|580475348|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
160751271|NCT05052697|580475349|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751272|NCT05052697|580475350|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
160751273|NCT05052697|580475351|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751274|NCT05052697|580475352|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751275|NCT05052697|580475353|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751276|NCT05052697|580475354|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751277|NCT05052697|580475355|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751278|NCT05052697|580475356|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
160751279|NCT05052697|580475323|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751280|NCT05052697|580475324|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751281|NCT05052697|580475325|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751282|NCT05052697|580475326|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751283|NCT05052697|580475327|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751284|NCT05052697|580475328|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751285|NCT05052697|580475329|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751286|NCT05052697|580475330|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751287|NCT05052697|580475331|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751288|NCT05052697|580475332|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751289|NCT05052697|580475333|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751290|NCT05052697|580475334|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751291|NCT05052697|580475335|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751292|NCT05052697|580475336|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751293|NCT05052697|580475337|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160865666|NCT02504151|580902946|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
160751294|NCT05052697|580475338|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751295|NCT05052697|580475339|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751296|NCT05052697|580475340|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751297|NCT05052697|580475341|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751298|NCT05052697|580475342|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751299|NCT05052697|580475343|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751300|NCT05052697|580475344|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751301|NCT05052697|580475345|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751302|NCT05052697|580475346|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751303|NCT05052697|580475347|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751304|NCT05052697|580475348|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751305|NCT05052697|580475349|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751306|NCT05052697|580475350|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751307|NCT05052697|580475351|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
160751308|NCT05052697|580475352|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751309|NCT05052697|580475353|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
160751310|NCT05052697|580475354|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
160751311|NCT05052697|580475355|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
160751312|NCT05052697|580475356|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
160751313|NCT05052697|580475323|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751314|NCT05052697|580475324|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751315|NCT05052697|580475325|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751316|NCT05052697|580475326|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751317|NCT05052697|580475327|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751318|NCT05052697|580475328|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751319|NCT05052697|580475329|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751320|NCT05052697|580475330|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751321|NCT05052697|580475331|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751322|NCT05052697|580475332|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751323|NCT05052697|580475333|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751324|NCT05052697|580475334|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751325|NCT05052697|580475335|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751326|NCT05052697|580475336|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751327|NCT05052697|580475337|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751328|NCT05052697|580475338|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751329|NCT05052697|580475339|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751330|NCT05052697|580475340|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751331|NCT05052697|580475341|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751332|NCT05052697|580475342|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751333|NCT05052697|580475343|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751334|NCT05052697|580475344|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751335|NCT05052697|580475345|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751336|NCT05052697|580475346|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751337|NCT05052697|580475347|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751338|NCT05052697|580475348|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751339|NCT05052697|580475349|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751340|NCT05052697|580475350|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751341|NCT05052697|580475351|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
160751342|NCT05052697|580475352|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
160751343|NCT05052697|580475353|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
160751344|NCT05052697|580475354|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
160751345|NCT05052697|580475355|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
160751346|NCT05052697|580475356|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
160751347|NCT05052697|580475323|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751348|NCT05052697|580475324|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751349|NCT05052697|580475325|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751350|NCT05052697|580475326|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751351|NCT05052697|580475327|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751352|NCT05052697|580475328|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751353|NCT05052697|580475329|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751354|NCT05052697|580475330|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751355|NCT05052697|580475331|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751356|NCT05052697|580475332|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751357|NCT05052697|580475333|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751358|NCT05052697|580475334|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751359|NCT05052697|580475335|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751360|NCT05052697|580475336|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751361|NCT05052697|580475337|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751362|NCT05052697|580475338|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751363|NCT05052697|580475339|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751364|NCT05052697|580475340|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160524521|NCT03267940|579650064|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
160524522|NCT03267940|579650065|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
160524523|NCT03267940|579650066|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
160524524|NCT03267940|579650067|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
160751365|NCT05052697|580475341|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751366|NCT05052697|580475342|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751367|NCT05052697|580475343|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751368|NCT05052697|580475344|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751369|NCT05052697|580475345|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751370|NCT05052697|580475346|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751371|NCT05052697|580475347|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751372|NCT05052697|580475348|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751373|NCT05052697|580475349|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751374|NCT05052697|580475350|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751375|NCT05052697|580475351|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751376|NCT05052697|580475352|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751377|NCT05052697|580475353|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751378|NCT05052697|580475354|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751379|NCT05052697|580475355|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
160751380|NCT05052697|580475356|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
160751381|NCT05052697|580475323|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751382|NCT05052697|580475324|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751383|NCT05052697|580475325|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751384|NCT05052697|580475326|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751385|NCT05052697|580475327|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751386|NCT05052697|580475328|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751387|NCT05052697|580475329|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751388|NCT05052697|580475330|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751389|NCT05052697|580475331|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751390|NCT05052697|580475332|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751391|NCT05052697|580475333|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751392|NCT05052697|580475334|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751393|NCT05052697|580475335|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751394|NCT05052697|580475336|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751395|NCT05052697|580475337|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751396|NCT05052697|580475338|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751397|NCT05052697|580475339|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751398|NCT05052697|580475340|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751399|NCT05052697|580475341|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751400|NCT05052697|580475342|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751401|NCT05052697|580475343|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751402|NCT05052697|580475344|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751403|NCT05052697|580475345|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751404|NCT05052697|580475346|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751405|NCT05052697|580475347|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751406|NCT05052697|580475348|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751407|NCT05052697|580475349|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751408|NCT05052697|580475350|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751409|NCT05052697|580475351|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
160751410|NCT05052697|580475352|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
160751411|NCT05052697|580475353|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
160751412|NCT05052697|580475354|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751413|NCT05052697|580475355|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751414|NCT05052697|580475356|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160751415|NCT01249833|580475357|FG000|Overall Study|Lost to Follow-up|0|||
160751416|NCT01249833|580475358|FG001|Overall Study|Lost to Follow-up|1|||
160751417|NCT03796676|580475359|FG000|Overall Study|Adverse Event|2|||
160751418|NCT03796676|580475360|FG001|Overall Study|Adverse Event|1|||
160751419|NCT03796676|580475361|FG002|Overall Study|Adverse Event|2|||
160751420|NCT03796676|580475359|FG000|Overall Study|Lost to Follow-up|2|||
160751421|NCT03796676|580475360|FG001|Overall Study|Lost to Follow-up|1|||
160751422|NCT03796676|580475361|FG002|Overall Study|Lost to Follow-up|0|||
160751423|NCT03796676|580475359|FG000|Overall Study|Protocol Violation|0|||
160751424|NCT03796676|580475360|FG001|Overall Study|Protocol Violation|0|||
160751425|NCT03796676|580475361|FG002|Overall Study|Protocol Violation|1|||
160751426|NCT03796676|580475359|FG000|Overall Study|Withdrawal by Subject|1|||
160751427|NCT03796676|580475360|FG001|Overall Study|Withdrawal by Subject|1|||
160751428|NCT03796676|580475361|FG002|Overall Study|Withdrawal by Subject|0|||
160751429|NCT03796676|580475359|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
160751430|NCT03796676|580475360|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
160751431|NCT03796676|580475361|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
160751432|NCT01900899|580475365|FG000|Overall Study|Withdrawal by Subject|7|||
160751433|NCT01900899|580475366|FG001|Overall Study|Withdrawal by Subject|1|||
160751434|NCT01900899|580475365|FG000|Overall Study|Migrated from study area|2|||
160751435|NCT01900899|580475366|FG001|Overall Study|Migrated from study area|0|||
160751436|NCT03035916|580475370|FG000|Overall Study|Puncture failed|0|||
160751437|NCT03035916|580475371|FG001|Overall Study|Puncture failed|2|||
160751438|NCT03035916|580475372|FG002|Overall Study|Puncture failed|0|||
160751439|NCT01402986|580475373|FG000|Overall Study|Withdrawal by Subject|7|||
160751440|NCT01402986|580475374|FG001|Overall Study|Withdrawal by Subject|10|||
160751441|NCT01402986|580475375|FG002|Overall Study|Withdrawal by Subject|7|||
160751442|NCT01402986|580475376|FG003|Overall Study|Withdrawal by Subject|13|||
160751443|NCT01402986|580475373|FG000|Overall Study|Death|0|||
160751444|NCT01402986|580475374|FG001|Overall Study|Death|0|||
160751445|NCT01402986|580475375|FG002|Overall Study|Death|0|||
160751446|NCT01402986|580475376|FG003|Overall Study|Death|2|||
160751447|NCT01402986|580475373|FG000|Overall Study|Lost to Follow-up|0|||
160751448|NCT01402986|580475374|FG001|Overall Study|Lost to Follow-up|0|||
160751449|NCT01402986|580475375|FG002|Overall Study|Lost to Follow-up|0|||
160751450|NCT01402986|580475376|FG003|Overall Study|Lost to Follow-up|1|||
160751451|NCT01402986|580475373|FG000|Overall Study|Other|2|||
160751452|NCT01402986|580475374|FG001|Overall Study|Other|5|||
160751453|NCT01402986|580475375|FG002|Overall Study|Other|1|||
160751454|NCT01402986|580475376|FG003|Overall Study|Other|6|||
160751455|NCT03749109|580475377|FG000|Overall Study|Adverse Event|2|||
160751456|NCT03749109|580475378|FG001|Overall Study|Adverse Event|0|||
160751457|NCT03178851|580475379|FG000|Overall Study|Death|48|||
160751458|NCT03178851|580475380|FG001|Overall Study|Death|2|||
160751459|NCT03178851|580475381|FG002|Overall Study|Death|25|||
160751460|NCT03178851|580475379|FG000|Overall Study|Withdrawal by Subject|8|||
160751461|NCT03178851|580475380|FG001|Overall Study|Withdrawal by Subject|0|||
160751462|NCT03178851|580475381|FG002|Overall Study|Withdrawal by Subject|0|||
160751463|NCT03178851|580475379|FG000|Overall Study|Lost to Follow-up|5|||
160751464|NCT03178851|580475380|FG001|Overall Study|Lost to Follow-up|2|||
160751465|NCT03178851|580475381|FG002|Overall Study|Lost to Follow-up|0|||
160751466|NCT03178851|580475379|FG000|Overall Study|Adverse Event|0|||
160751467|NCT03178851|580475380|FG001|Overall Study|Adverse Event|0|||
160751468|NCT03178851|580475381|FG002|Overall Study|Adverse Event|1|||
160751469|NCT03178851|580475379|FG000|Overall Study|Study Termination by Sponsor|31|||
160751470|NCT03178851|580475380|FG001|Overall Study|Study Termination by Sponsor|7|||
160751471|NCT03178851|580475381|FG002|Overall Study|Study Termination by Sponsor|26|||
160751472|NCT00803712|580477204|FG000|Overall Study|Noncompliance|3|||
160751473|NCT00803712|580477205|FG001|Overall Study|Noncompliance|0|||
160751474|NCT00803712|580477204|FG000|Overall Study|Adverse Event|5|||
160751475|NCT00803712|580477205|FG001|Overall Study|Adverse Event|0|||
160751476|NCT00803712|580477204|FG000|Overall Study|Death|8|||
160751477|NCT00803712|580477205|FG001|Overall Study|Death|7|||
160751478|NCT00803712|580477204|FG000|Overall Study|Lost to Follow-up|3|||
160751479|NCT00803712|580477205|FG001|Overall Study|Lost to Follow-up|1|||
160751480|NCT00803712|580477204|FG000|Overall Study|Withdrawal by Subject|2|||
160751481|NCT00803712|580477205|FG001|Overall Study|Withdrawal by Subject|4|||
160751482|NCT00803712|580477204|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
160751483|NCT00803712|580477205|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
160751484|NCT00803712|580477204|FG000|Overall Study|Protocol criteria (other)|0|||
160751485|NCT00803712|580477205|FG001|Overall Study|Protocol criteria (other)|2|||
160751486|NCT00803712|580477204|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
160751487|NCT00803712|580477205|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
160751488|NCT00803712|580477204|FG000|Overall Study|Administrative decision|2|||
160751489|NCT00803712|580477205|FG001|Overall Study|Administrative decision|3|||
160751490|NCT00803712|580477204|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
160751491|NCT00803712|580477205|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
160751492|NCT02823470|580477210|FG000|Overall Study|Adverse Event|1|||
160751493|NCT02823470|580477211|FG001|Overall Study|Adverse Event|0|||
160751494|NCT02823470|580477210|FG000|Overall Study|Study terminated by sponsor|8|||
160751495|NCT02823470|580477211|FG001|Overall Study|Study terminated by sponsor|15|||
160751496|NCT02155309|580477212|FG000|Overall Study|Protocol Violation|0|||
160751497|NCT02155309|580477213|FG001|Overall Study|Protocol Violation|0|||
160751498|NCT02155309|580477214|FG002|Overall Study|Protocol Violation|1|||
160751499|NCT01310127|580477216|FG000|Overall Study|Protocol Violation|1|||
160751500|NCT01310127|580477217|FG001|Overall Study|Protocol Violation|1|||
160751501|NCT01310127|580477216|FG000|Overall Study|advanced psc cataract outlier|1|||
160751502|NCT01310127|580477217|FG001|Overall Study|advanced psc cataract outlier|0|||
160751503|NCT01490840|580477218|FG000|Phase 1|Lost to Follow-up|1|||
160751504|NCT01490840|580477219|FG001|Phase 1|Lost to Follow-up|0|||
160751505|NCT01490840|580477218|FG000|Phase 1|Adverse Event|2|||
160751506|NCT01490840|580477219|FG001|Phase 1|Adverse Event|1|||
160751507|NCT01490840|580477218|FG000|Phase 1|Withdrawal by Subject|6|||
160751508|NCT01490840|580477219|FG001|Phase 1|Withdrawal by Subject|5|||
160751509|NCT01490840|580477218|FG000|Phase 1|Visit 6a omitted|1|||
160751510|NCT01490840|580477219|FG001|Phase 1|Visit 6a omitted|0|||
160751511|NCT01490840|580477218|FG000|Phase 2|Withdrawal by Subject|4|||
160751512|NCT01490840|580477219|FG001|Phase 2|Withdrawal by Subject|3|||
160751513|NCT01490840|580477218|FG000|Phase 2|Permanent interruption of fingolimod|0|||
160751514|NCT01490840|580477219|FG001|Phase 2|Permanent interruption of fingolimod|1|||
160751515|NCT01490840|580477218|FG000|Phase 2|Lost to Follow-up|1|||
160751516|NCT01490840|580477219|FG001|Phase 2|Lost to Follow-up|1|||
160751517|NCT01490840|580477218|FG000|Phase 2|Adverse Event|1|||
160751518|NCT01490840|580477219|FG001|Phase 2|Adverse Event|1|||
160751519|NCT01042392|580477224|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
160751520|NCT01042392|580477225|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
160751521|NCT01042392|580477226|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
160751522|NCT01042392|580477227|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
160751523|NCT01042392|580477224|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
160751524|NCT01042392|580477225|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
160751525|NCT01042392|580477226|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
160751526|NCT01042392|580477227|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
160751527|NCT01042392|580477224|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
160751528|NCT01042392|580477225|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
160751529|NCT01042392|580477226|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
160751530|NCT01042392|580477227|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
160751531|NCT01042392|580477224|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
160751532|NCT01042392|580477225|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
160751533|NCT01042392|580477226|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
160751534|NCT01042392|580477227|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
160751535|NCT01042392|580477224|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
160751536|NCT01042392|580477225|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
160751537|NCT01042392|580477226|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
160751538|NCT01042392|580477227|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
160751539|NCT01042392|580477224|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
160751540|NCT01042392|580477225|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
160751541|NCT01042392|580477226|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
160751542|NCT01042392|580477227|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
160751543|NCT01042392|580477224|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
160751544|NCT01042392|580477225|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
160751545|NCT01042392|580477226|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
160751546|NCT01042392|580477227|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
160751547|NCT01042392|580477224|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
160751548|NCT01042392|580477225|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
160751549|NCT01042392|580477226|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
160751550|NCT01042392|580477227|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
160751551|NCT01042392|580477224|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
160751552|NCT01042392|580477225|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
160751553|NCT01042392|580477226|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
160751554|NCT01042392|580477227|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
160751555|NCT03117361|580477228|FG000|Overall Study|Progressive disease|5|||
160751556|NCT03117361|580477228|FG000|Overall Study|Death|1|||
160751557|NCT03117361|580477228|FG000|Overall Study|Physician Decision|2|||
160751558|NCT03117361|580477228|FG000|Overall Study|On study treatment at the end of study|1|||
160751559|NCT03117361|580477228|FG000|Overall Study|Treatment-related adverse event|1|||
160751560|NCT00878800|580477229|FG000|Overall Study|Adverse Event|0|||
160751561|NCT00878800|580477230|FG001|Overall Study|Adverse Event|0|||
160751562|NCT00878800|580477231|FG002|Overall Study|Adverse Event|2|||
160751563|NCT00878800|580477232|FG003|Overall Study|Adverse Event|0|||
160751564|NCT00878800|580477233|FG004|Overall Study|Adverse Event|1|||
160751565|NCT00878800|580477229|FG000|Overall Study|Progressive disease|1|||
160751566|NCT00878800|580477230|FG001|Overall Study|Progressive disease|5|||
160751567|NCT00878800|580477231|FG002|Overall Study|Progressive disease|6|||
160751568|NCT00878800|580477232|FG003|Overall Study|Progressive disease|5|||
160751569|NCT00878800|580477233|FG004|Overall Study|Progressive disease|13|||
160751570|NCT00878800|580477229|FG000|Overall Study|Withdrew consent|1|||
160751571|NCT00878800|580477230|FG001|Overall Study|Withdrew consent|1|||
160751572|NCT00878800|580477231|FG002|Overall Study|Withdrew consent|0|||
160751573|NCT00878800|580477232|FG003|Overall Study|Withdrew consent|1|||
160751574|NCT00878800|580477233|FG004|Overall Study|Withdrew consent|1|||
160751575|NCT00878800|580477229|FG000|Overall Study|Death|0|||
160751576|NCT00878800|580477230|FG001|Overall Study|Death|0|||
160751577|NCT00878800|580477231|FG002|Overall Study|Death|1|||
160751578|NCT00878800|580477232|FG003|Overall Study|Death|0|||
160751579|NCT00878800|580477233|FG004|Overall Study|Death|0|||
160751580|NCT00878800|580477229|FG000|Overall Study|Other|1|||
160751581|NCT00878800|580477230|FG001|Overall Study|Other|1|||
160751582|NCT00878800|580477231|FG002|Overall Study|Other|0|||
160751583|NCT00878800|580477232|FG003|Overall Study|Other|0|||
160751584|NCT00878800|580477233|FG004|Overall Study|Other|1|||
160751585|NCT02072941|580477234|FG000|Overall Study|Withdrawal by Subject|29|||
160751586|NCT02072941|580477235|FG001|Overall Study|Withdrawal by Subject|21|||
160751587|NCT02072941|580477234|FG000|Overall Study|Lost to Follow-up|4|||
160751588|NCT02072941|580477235|FG001|Overall Study|Lost to Follow-up|4|||
160751589|NCT02072941|580477234|FG000|Overall Study|Death|3|||
160751590|NCT02072941|580477235|FG001|Overall Study|Death|2|||
160751591|NCT02072941|580477234|FG000|Overall Study|Removed by Study Staff|2|||
160751592|NCT02072941|580477235|FG001|Overall Study|Removed by Study Staff|2|||
160751593|NCT02457195|580477240|FG000|Overall Study|Adverse Event|3|||
160751594|NCT02457195|580477240|FG000|Overall Study|Protocol Violation|2|||
160751595|NCT02457195|580477240|FG000|Overall Study|Withdrawal by Subject|4|||
160751596|NCT05359952|580477242|FG000|Overall Study|Lost to Follow-up|1|||
160751597|NCT05359952|580477243|FG001|Overall Study|Lost to Follow-up|0|||
160751598|NCT04892446|580477244|FG000|Overall Study|Death|4|||
160751599|NCT04892446|580477245|FG001|Overall Study|Death|4|||
160751600|NCT04892446|580477246|FG002|Overall Study|Death|0|||
160751601|NCT04892446|580477244|FG000|Overall Study|Withdrew consent|3|||
160751602|NCT04892446|580477245|FG001|Overall Study|Withdrew consent|0|||
160751603|NCT04892446|580477246|FG002|Overall Study|Withdrew consent|1|||
160751604|NCT04892446|580477244|FG000|Overall Study|Investigator's discretion|1|||
160751605|NCT04892446|580477245|FG001|Overall Study|Investigator's discretion|1|||
160751606|NCT04892446|580477246|FG002|Overall Study|Investigator's discretion|0|||
160751607|NCT04892446|580477244|FG000|Overall Study|Study terminated by sponsor|0|||
160751608|NCT04892446|580477245|FG001|Overall Study|Study terminated by sponsor|0|||
160751609|NCT04892446|580477246|FG002|Overall Study|Study terminated by sponsor|2|||
160751610|NCT01768559|580477247|FG000|Overall Study|Randomized but not treated|0|||
160751611|NCT01768559|580477248|FG001|Overall Study|Randomized but not treated|0|||
160751612|NCT01768559|580477249|FG002|Overall Study|Randomized but not treated|1|||
160751613|NCT01768559|580477247|FG000|Overall Study|Adverse Event|15|||
160751614|NCT01768559|580477248|FG001|Overall Study|Adverse Event|2|||
160751615|NCT01768559|580477249|FG002|Overall Study|Adverse Event|5|||
160751616|NCT01768559|580477247|FG000|Overall Study|Lack of Efficacy|6|||
160751617|NCT01768559|580477248|FG001|Overall Study|Lack of Efficacy|4|||
160751618|NCT01768559|580477249|FG002|Overall Study|Lack of Efficacy|0|||
160751619|NCT01768559|580477247|FG000|Overall Study|Poor compliance to protocol|0|||
160751620|NCT01768559|580477248|FG001|Overall Study|Poor compliance to protocol|3|||
160751621|NCT01768559|580477249|FG002|Overall Study|Poor compliance to protocol|2|||
160751622|NCT01768559|580477247|FG000|Overall Study|Other than specified|9|||
160751623|NCT01768559|580477248|FG001|Overall Study|Other than specified|8|||
160751624|NCT01768559|580477249|FG002|Overall Study|Other than specified|5|||
160751625|NCT00237692|580477252|FG000|Overall Study|Lost to Follow-up|9|||
160751626|NCT00237692|580477253|FG001|Overall Study|Lost to Follow-up|3|||
160751627|NCT00237692|580477254|FG002|Overall Study|Lost to Follow-up|5|||
160751628|NCT00237692|580477255|FG003|Overall Study|Lost to Follow-up|3|||
160751629|NCT00237692|580477252|FG000|Overall Study|Death|1|||
160751630|NCT00237692|580477253|FG001|Overall Study|Death|2|||
160751631|NCT00237692|580477254|FG002|Overall Study|Death|2|||
160751632|NCT00237692|580477255|FG003|Overall Study|Death|3|||
160751633|NCT00237692|580477252|FG000|Overall Study|Excluded - did not meet criteria|4|||
160751634|NCT00237692|580477253|FG001|Overall Study|Excluded - did not meet criteria|3|||
160751635|NCT00237692|580477254|FG002|Overall Study|Excluded - did not meet criteria|5|||
160751636|NCT00237692|580477255|FG003|Overall Study|Excluded - did not meet criteria|9|||
160751637|NCT00237692|580477252|FG000|Overall Study|Withdrawal by Subject|4|||
160751638|NCT00237692|580477253|FG001|Overall Study|Withdrawal by Subject|6|||
160751639|NCT00237692|580477254|FG002|Overall Study|Withdrawal by Subject|10|||
160751640|NCT00237692|580477255|FG003|Overall Study|Withdrawal by Subject|4|||
160524525|NCT00178126|579650074|FG000|Overall Study|Lost to Follow-up|21|||
160524526|NCT00178126|579650075|FG001|Overall Study|Lost to Follow-up|21|||
160524527|NCT00178126|579650074|FG000|Overall Study|did not receive intervention|4|||
160751641|NCT01737879|580477256|FG000|Overall Study|Death|1|||
160751642|NCT01737879|580477256|FG000|Overall Study|Sponsor decision|40|||
160751643|NCT00685360|580477257|FG000|Overall Study|Lost to Follow-up|0|||
160751644|NCT00685360|580477258|FG001|Overall Study|Lost to Follow-up|1|||
160751645|NCT00685360|580477259|FG002|Overall Study|Lost to Follow-up|2|||
160751646|NCT00685360|580477257|FG000|Overall Study|Adverse Event|4|||
160751647|NCT00685360|580477258|FG001|Overall Study|Adverse Event|6|||
160751648|NCT00685360|580477259|FG002|Overall Study|Adverse Event|4|||
160751649|NCT00685360|580477257|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
160751650|NCT00685360|580477258|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
160751651|NCT00685360|580477259|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
160751652|NCT00685360|580477257|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
160524528|NCT00178126|579650075|FG001|Overall Study|did not receive intervention|6|||
160751653|NCT00685360|580477258|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
160751654|NCT00685360|580477259|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
160751655|NCT00685360|580477257|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
160751656|NCT00685360|580477258|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
160751657|NCT00685360|580477259|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
160751658|NCT00685360|580477257|FG000|Overall Study|Protocol Deviation|0|||
160751659|NCT00685360|580477258|FG001|Overall Study|Protocol Deviation|1|||
160751660|NCT00685360|580477259|FG002|Overall Study|Protocol Deviation|1|||
160751661|NCT01386944|580477266|FG000|Overall Study|Adverse Event|26|||
160751662|NCT01386944|580477266|FG000|Overall Study|Lack of Efficacy|14|||
160751663|NCT01386944|580477266|FG000|Overall Study|Lost to Follow-up|8|||
160751664|NCT01386944|580477266|FG000|Overall Study|Unspecified reason|8|||
160751665|NCT03853291|580477267|FG000|Overall Study|Lost to Follow-up|1|||
160751666|NCT03853291|580477268|FG001|Overall Study|Lost to Follow-up|2|||
160751667|NCT03853291|580477269|FG002|Overall Study|Lost to Follow-up|0|||
160751668|NCT03853291|580477270|FG003|Overall Study|Lost to Follow-up|0|||
160751669|NCT03853291|580477271|FG004|Overall Study|Lost to Follow-up|0|||
160751670|NCT03853291|580477272|FG005|Overall Study|Lost to Follow-up|0|||
160751671|NCT03853291|580477267|FG000|Overall Study|Determined to be ineligible|1|||
160751672|NCT03853291|580477268|FG001|Overall Study|Determined to be ineligible|1|||
160751673|NCT03853291|580477269|FG002|Overall Study|Determined to be ineligible|0|||
160751674|NCT03853291|580477270|FG003|Overall Study|Determined to be ineligible|0|||
160751675|NCT03853291|580477271|FG004|Overall Study|Determined to be ineligible|0|||
160751676|NCT03853291|580477272|FG005|Overall Study|Determined to be ineligible|0|||
160751677|NCT03883477|580477273|FG000|Overall Study|Death|1|||
160751678|NCT03883477|580477274|FG001|Overall Study|Death|0|||
160751679|NCT03883477|580477273|FG000|Overall Study|Protocol Violation|0|||
160751680|NCT03883477|580477274|FG001|Overall Study|Protocol Violation|1|||
160751681|NCT04186221|580477275|FG000|Overall Study|Death|1|||
160751682|NCT00972283|580477281|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
160751683|NCT00972283|580477282|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
160751684|NCT00972283|580477281|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
160751685|NCT00972283|580477282|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
160751686|NCT00972283|580477281|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
160751687|NCT00972283|580477282|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
160751688|NCT00972283|580477281|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
160751689|NCT00972283|580477282|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
160751690|NCT00972283|580477281|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
160751691|NCT00972283|580477282|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
160751692|NCT00972283|580477281|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
160751693|NCT00972283|580477282|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
160751694|NCT00972283|580477281|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
160751695|NCT00972283|580477282|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
160751696|NCT00972283|580477281|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
160751697|NCT00972283|580477282|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
160751698|NCT00972283|580477281|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
160751699|NCT00972283|580477282|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
160751700|NCT00972283|580477281|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
160751701|NCT00972283|580477282|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
160751702|NCT03124537|580477283|FG000|Overall Study|Lost to Follow-up|3|||
160751703|NCT03124537|580477284|FG001|Overall Study|Lost to Follow-up|5|||
160751704|NCT03124537|580477283|FG000|Overall Study|App Crash, Incomplete Data|7|||
160751705|NCT03124537|580477284|FG001|Overall Study|App Crash, Incomplete Data|8|||
160751706|NCT00830518|580477287|FG000|Overall Study|Progressive Disease|18|||
160751707|NCT00830518|580477288|FG001|Overall Study|Progressive Disease|8|||
160751708|NCT00830518|580477287|FG000|Overall Study|Symptomatic Deterioration|4|||
160751709|NCT00830518|580477288|FG001|Overall Study|Symptomatic Deterioration|1|||
160751710|NCT00830518|580477287|FG000|Overall Study|Adverse Event|14|||
160751711|NCT00830518|580477288|FG001|Overall Study|Adverse Event|1|||
160751712|NCT00830518|580477287|FG000|Overall Study|Withdrawal by Patient|2|||
160751713|NCT00830518|580477288|FG001|Overall Study|Withdrawal by Patient|0|||
160751714|NCT00830518|580477287|FG000|Overall Study|Reason not Specified|8|||
160751715|NCT00830518|580477288|FG001|Overall Study|Reason not Specified|1|||
160751716|NCT01990768|580477289|FG000|Intervention Started|Found to be ineligible|14|||
160751717|NCT01990768|580477290|FG001|Intervention Started|Found to be ineligible|13|||
160751718|NCT01990768|580477291|FG002|Intervention Started|Found to be ineligible|11|||
160751719|NCT01990768|580477289|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
160751720|NCT01990768|580477290|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
160751721|NCT01990768|580477291|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
160751722|NCT01990768|580477289|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
160751723|NCT01990768|580477290|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
160751724|NCT01990768|580477291|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
160751725|NCT01990768|580477289|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
160751726|NCT01990768|580477290|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
160751727|NCT01990768|580477291|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
160751728|NCT01990768|580477289|FG000|Intervention Started|Patient care priority|1|||
160751729|NCT01990768|580477290|FG001|Intervention Started|Patient care priority|2|||
160751730|NCT01990768|580477291|FG002|Intervention Started|Patient care priority|3|||
160751731|NCT01990768|580477289|FG000|Intervention Started|IV lost|2|||
160751732|NCT01990768|580477290|FG001|Intervention Started|IV lost|2|||
160751733|NCT01990768|580477291|FG002|Intervention Started|IV lost|2|||
160751734|NCT01990768|580477289|FG000|Intervention Started|Required CPR|1|||
160751735|NCT01990768|580477290|FG001|Intervention Started|Required CPR|1|||
160751736|NCT01990768|580477291|FG002|Intervention Started|Required CPR|0|||
160751737|NCT01990768|580477289|FG000|Intervention Started|Seizure or hx of seizure|0|||
160751738|NCT01990768|580477290|FG001|Intervention Started|Seizure or hx of seizure|0|||
160751739|NCT01990768|580477291|FG002|Intervention Started|Seizure or hx of seizure|2|||
160751740|NCT01990768|580477289|FG000|Intervention Started|Discovered to be pregnant|0|||
160751741|NCT01990768|580477290|FG001|Intervention Started|Discovered to be pregnant|1|||
160751742|NCT01990768|580477291|FG002|Intervention Started|Discovered to be pregnant|0|||
160751743|NCT01990768|580477289|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
160751744|NCT01990768|580477290|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
160751745|NCT01990768|580477291|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
160751746|NCT01990768|580477289|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
160751747|NCT01990768|580477290|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
160751748|NCT01990768|580477291|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
160751749|NCT01990768|580477289|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
160751750|NCT01990768|580477290|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
160751751|NCT01990768|580477291|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
160751752|NCT01990768|580477289|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
160751753|NCT01990768|580477290|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
160751754|NCT01990768|580477291|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
160751755|NCT01990768|580477289|FG000|Prehospital Study Drug Infusion|Death|3|||
160751756|NCT01990768|580477290|FG001|Prehospital Study Drug Infusion|Death|1|||
160751757|NCT01990768|580477291|FG002|Prehospital Study Drug Infusion|Death|1|||
160751758|NCT01990768|580477289|FG000|Prehospital Study Drug Infusion|Discharged|2|||
160751759|NCT01990768|580477290|FG001|Prehospital Study Drug Infusion|Discharged|1|||
160751760|NCT01990768|580477291|FG002|Prehospital Study Drug Infusion|Discharged|0|||
160751761|NCT01990768|580477289|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
160751762|NCT01990768|580477290|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
160751763|NCT01990768|580477291|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
160751764|NCT01990768|580477289|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
160751765|NCT01990768|580477290|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
160751766|NCT01990768|580477291|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
160751767|NCT01990768|580477289|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
160751768|NCT01990768|580477290|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
160751769|NCT01990768|580477291|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
160751770|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
160751771|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
160751772|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
160751773|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
160751774|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
160751775|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
160751776|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
160751777|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
160751778|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
160751779|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
160751780|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
160751781|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
160751782|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
160751783|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
160751784|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
160751785|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
160751786|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
160751787|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
160751788|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
160751789|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
160751790|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
160751791|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
160751792|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
160751793|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
160751794|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
160751795|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
160751796|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
160751797|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
160751798|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
160751799|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
160751800|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
160751801|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
160751802|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
160751803|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
160751804|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
160751805|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
160751806|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
160751807|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
160751808|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
160751809|NCT01990768|580477289|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
160751810|NCT01990768|580477290|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
160751811|NCT01990768|580477291|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
160751812|NCT01990768|580477289|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
160751813|NCT01990768|580477290|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
160751814|NCT01990768|580477291|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
160751815|NCT01990768|580477289|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
160751816|NCT01990768|580477290|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
160751817|NCT01990768|580477291|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
160751818|NCT01990768|580477289|FG000|6-Month Follow-up|No contact information|5|||
160751819|NCT01990768|580477290|FG001|6-Month Follow-up|No contact information|6|||
160751820|NCT01990768|580477291|FG002|6-Month Follow-up|No contact information|5|||
160751821|NCT01990768|580477289|FG000|6-Month Follow-up|Homeless|4|||
160751822|NCT01990768|580477290|FG001|6-Month Follow-up|Homeless|3|||
160751823|NCT01990768|580477291|FG002|6-Month Follow-up|Homeless|6|||
160751824|NCT01990768|580477289|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
160751825|NCT01990768|580477290|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
160751826|NCT01990768|580477291|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
160751827|NCT01990768|580477289|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
160751828|NCT01990768|580477290|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
160751829|NCT01990768|580477291|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
160751830|NCT01990768|580477289|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
160751831|NCT01990768|580477290|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
160751832|NCT01990768|580477291|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
160751833|NCT02348008|580477292|FG000|Overall Study|Adverse Event|2|||
160751834|NCT02348008|580477293|FG001|Overall Study|Adverse Event|3|||
160751835|NCT02348008|580477294|FG002|Overall Study|Adverse Event|3|||
160751836|NCT02348008|580477292|FG000|Overall Study|Disease Progression|1|||
160751837|NCT02348008|580477293|FG001|Overall Study|Disease Progression|5|||
160751838|NCT02348008|580477294|FG002|Overall Study|Disease Progression|16|||
160751839|NCT02348008|580477292|FG000|Overall Study|Withdrawal by Subject|0|||
160751840|NCT02348008|580477293|FG001|Overall Study|Withdrawal by Subject|1|||
160751841|NCT02348008|580477294|FG002|Overall Study|Withdrawal by Subject|0|||
160751842|NCT02348008|580477292|FG000|Overall Study|Symptomatic Deterioration|0|||
160751843|NCT02348008|580477293|FG001|Overall Study|Symptomatic Deterioration|1|||
160751844|NCT02348008|580477294|FG002|Overall Study|Symptomatic Deterioration|0|||
160751845|NCT04399538|580477295|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
160751846|NCT04399538|580477296|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
160751847|NCT04399538|580477297|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
160751848|NCT04399538|580477298|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
160751849|NCT04399538|580477299|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
160751850|NCT04399538|580477295|FG000|Double-Blind Treatment|Adverse Event|0|||
160751851|NCT04399538|580477296|FG001|Double-Blind Treatment|Adverse Event|0|||
160751852|NCT04399538|580477297|FG002|Double-Blind Treatment|Adverse Event|0|||
160751853|NCT04399538|580477298|FG003|Double-Blind Treatment|Adverse Event|0|||
160751854|NCT04399538|580477299|FG004|Double-Blind Treatment|Adverse Event|1|||
160751855|NCT04399538|580477295|FG000|Follow-Up|Adverse Event|0|||
160751856|NCT04399538|580477296|FG001|Follow-Up|Adverse Event|0|||
160751857|NCT04399538|580477297|FG002|Follow-Up|Adverse Event|0|||
160751858|NCT04399538|580477298|FG003|Follow-Up|Adverse Event|0|||
160751859|NCT04399538|580477299|FG004|Follow-Up|Adverse Event|1|||
160751860|NCT04399538|580477295|FG000|Follow-Up|Withdrawal by Subject|0|||
160751861|NCT04399538|580477296|FG001|Follow-Up|Withdrawal by Subject|0|||
160751862|NCT04399538|580477297|FG002|Follow-Up|Withdrawal by Subject|0|||
160751863|NCT04399538|580477298|FG003|Follow-Up|Withdrawal by Subject|2|||
160751864|NCT04399538|580477299|FG004|Follow-Up|Withdrawal by Subject|0|||
160751865|NCT03268005|580477304|FG000|Overall Study|Death|2|||
160751866|NCT03268005|580477305|FG001|Overall Study|Death|1|||
160751867|NCT03268005|580477304|FG000|Overall Study|Lost to Follow-up|2|||
160751868|NCT03268005|580477305|FG001|Overall Study|Lost to Follow-up|2|||
160751869|NCT03268005|580477304|FG000|Overall Study|Withdrawal by Subject|11|||
160751870|NCT03268005|580477305|FG001|Overall Study|Withdrawal by Subject|11|||
160751871|NCT01926197|580477307|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
160751872|NCT01926197|580477308|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
160751873|NCT01926197|580477307|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
160751874|NCT01926197|580477308|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
160751875|NCT00980655|580477310|FG000|Overall Study|Adverse Event|13|||
160751876|NCT00980655|580477311|FG001|Overall Study|Adverse Event|31|||
160751877|NCT00980655|580477310|FG000|Overall Study|Death|0|||
160751878|NCT00980655|580477311|FG001|Overall Study|Death|7|||
160751879|NCT00980655|580477310|FG000|Overall Study|Protocol Violation|2|||
160751880|NCT00980655|580477311|FG001|Overall Study|Protocol Violation|7|||
160751881|NCT00980655|580477310|FG000|Overall Study|Withdrawal by Subject|0|||
160751882|NCT00980655|580477311|FG001|Overall Study|Withdrawal by Subject|4|||
160751883|NCT00980655|580477310|FG000|Overall Study|Lost to Follow-up|0|||
160751884|NCT00980655|580477311|FG001|Overall Study|Lost to Follow-up|1|||
160751885|NCT00980655|580477310|FG000|Overall Study|Parent/legal guardian request|1|||
160751886|NCT00980655|580477311|FG001|Overall Study|Parent/legal guardian request|0|||
160751887|NCT00980655|580477310|FG000|Overall Study|Other|0|||
160751888|NCT00980655|580477311|FG001|Overall Study|Other|1|||
160751889|NCT04162795|580477315|FG000|Overall Study|Other|16|||
160751890|NCT04162795|580477315|FG000|Overall Study|Screen failures|10|||
160751891|NCT02029274|580477316|FG000|Overall Study|Adverse Event|1|||
160751892|NCT02029274|580477317|FG001|Overall Study|Adverse Event|0|||
160751893|NCT02029274|580477318|FG002|Overall Study|Adverse Event|2|||
160751894|NCT02029274|580477319|FG003|Overall Study|Adverse Event|2|||
160751895|NCT00845676|580477322|FG000|Overall Study|Virologic breakthrough at week 20|1|||
160751896|NCT00845676|580477322|FG000|Overall Study|Adverse Event|1|||
160751897|NCT02756364|580477323|FG000|Overall Study|Site Terminated by Sponsor|24|||
160751898|NCT02756364|580477324|FG001|Overall Study|Site Terminated by Sponsor|30|||
160751899|NCT02756364|580477325|FG002|Overall Study|Site Terminated by Sponsor|21|||
160751900|NCT02756364|580477323|FG000|Overall Study|Death|20|||
160751901|NCT02756364|580477324|FG001|Overall Study|Death|15|||
160751902|NCT02756364|580477325|FG002|Overall Study|Death|18|||
160751903|NCT02756364|580477323|FG000|Overall Study|Withdrawal by Patient|2|||
160751904|NCT02756364|580477324|FG001|Overall Study|Withdrawal by Patient|1|||
160751905|NCT02756364|580477325|FG002|Overall Study|Withdrawal by Patient|8|||
160751906|NCT02756364|580477323|FG000|Overall Study|Lost to Follow-up|0|||
160751907|NCT02756364|580477324|FG001|Overall Study|Lost to Follow-up|1|||
160751908|NCT02756364|580477325|FG002|Overall Study|Lost to Follow-up|1|||
160751909|NCT02223364|580477326|FG000|Overall Study|Protocol Violation|3|||
160751910|NCT02223364|580477327|FG001|Overall Study|Protocol Violation|0|||
160751911|NCT02223364|580477328|FG002|Overall Study|Protocol Violation|3|||
160751912|NCT02223364|580477326|FG000|Overall Study|subject expired before surgery|1|||
160751913|NCT02223364|580477327|FG001|Overall Study|subject expired before surgery|0|||
160751914|NCT02223364|580477328|FG002|Overall Study|subject expired before surgery|0|||
160751915|NCT02223364|580477326|FG000|Overall Study|Physician Decision|1|||
160751916|NCT02223364|580477327|FG001|Overall Study|Physician Decision|0|||
160751917|NCT02223364|580477328|FG002|Overall Study|Physician Decision|0|||
160751918|NCT02984267|580477329|FG000|Overall Study|Protocol Violation|1|||
160751919|NCT02984267|580477330|FG001|Overall Study|Protocol Violation|0|||
160751920|NCT02984267|580477329|FG000|Overall Study|Withdrawal by Subject|0|||
160751921|NCT02984267|580477330|FG001|Overall Study|Withdrawal by Subject|1|||
160751922|NCT02685072|580477331|FG000|Treatment Period|Lost to Follow-up|12|||
160751923|NCT02685072|580477332|FG001|Treatment Period|Lost to Follow-up|6|||
160751924|NCT02685072|580477331|FG000|Treatment Period|Withdrawal by Subject|1|||
160751925|NCT02685072|580477332|FG001|Treatment Period|Withdrawal by Subject|3|||
160751926|NCT02685072|580477331|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
160751927|NCT02685072|580477332|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
160751928|NCT01994902|580477333|FG000|Test Period 1|Withdrawal by Subject|3|||
160751929|NCT01994902|580477334|FG001|Test Period 1|Withdrawal by Subject|0|||
160751930|NCT01994902|580477333|FG000|Test Period 1|device deficiency with adverse event|0|||
160751931|NCT01994902|580477334|FG001|Test Period 1|device deficiency with adverse event|1|||
160751932|NCT01994902|580477333|FG000|Test Period 1|Adverse Event|2|||
160751933|NCT01994902|580477334|FG001|Test Period 1|Adverse Event|1|||
160751934|NCT01994902|580477333|FG000|Test Period 1|Lack of Efficacy|0|||
160751935|NCT01994902|580477334|FG001|Test Period 1|Lack of Efficacy|1|||
160751936|NCT01994902|580477333|FG000|Test Period 1|bag too small|1|||
160751937|NCT01994902|580477334|FG001|Test Period 1|bag too small|0|||
160751938|NCT01994902|580477333|FG000|Test Period 2|Withdrawal by Subject|0|||
160751939|NCT01994902|580477334|FG001|Test Period 2|Withdrawal by Subject|2|||
160751940|NCT01994902|580477333|FG000|Test Period 2|Lack of Efficacy|0|||
160751941|NCT01994902|580477334|FG001|Test Period 2|Lack of Efficacy|1|||
160751942|NCT01994902|580477333|FG000|Test Period 2|Other|0|||
160751943|NCT01994902|580477334|FG001|Test Period 2|Other|3|||
160751944|NCT03597139|580477336|FG000|Overall Study|Adverse Event|3|||
160751945|NCT03597139|580477337|FG001|Overall Study|Adverse Event|0|||
160751946|NCT03597139|580477336|FG000|Overall Study|Protocol Non-compliance|1|||
160751947|NCT03597139|580477337|FG001|Overall Study|Protocol Non-compliance|0|||
160751948|NCT00248833|580477340|FG000|Overall Study|Adverse Event|2|||
160751949|NCT00248833|580477341|FG001|Overall Study|Adverse Event|0|||
160751950|NCT00248833|580477342|FG002|Overall Study|Adverse Event|0|||
160751951|NCT00248833|580477340|FG000|Overall Study|Withdrawal by Subject|0|||
160751952|NCT00248833|580477341|FG001|Overall Study|Withdrawal by Subject|1|||
160751953|NCT00248833|580477342|FG002|Overall Study|Withdrawal by Subject|1|||
160751954|NCT00248833|580477340|FG000|Overall Study|Lost to Follow-up|1|||
160751955|NCT00248833|580477341|FG001|Overall Study|Lost to Follow-up|1|||
160751956|NCT00248833|580477342|FG002|Overall Study|Lost to Follow-up|1|||
160751957|NCT00248833|580477340|FG000|Overall Study|Other|0|||
160751958|NCT00248833|580477341|FG001|Overall Study|Other|1|||
160751959|NCT00248833|580477342|FG002|Overall Study|Other|0|||
160751960|NCT02427802|580477343|FG000|Overall Study|Adverse Event|11|||
160751961|NCT02427802|580477344|FG001|Overall Study|Adverse Event|3|||
160751962|NCT02427802|580477345|FG002|Overall Study|Adverse Event|7|||
160751963|NCT02427802|580477343|FG000|Overall Study|Death|0|||
160751964|NCT02427802|580477344|FG001|Overall Study|Death|4|||
160751965|NCT02427802|580477345|FG002|Overall Study|Death|1|||
160751966|NCT02427802|580477343|FG000|Overall Study|Lost to Follow-up|13|||
160751967|NCT02427802|580477344|FG001|Overall Study|Lost to Follow-up|8|||
160751968|NCT02427802|580477345|FG002|Overall Study|Lost to Follow-up|8|||
160751969|NCT02427802|580477343|FG000|Overall Study|Physician Decision|4|||
160751970|NCT02427802|580477344|FG001|Overall Study|Physician Decision|2|||
160751971|NCT02427802|580477345|FG002|Overall Study|Physician Decision|4|||
160751972|NCT02427802|580477343|FG000|Overall Study|Withdrawal by Subject|10|||
160751973|NCT02427802|580477344|FG001|Overall Study|Withdrawal by Subject|5|||
160751974|NCT02427802|580477345|FG002|Overall Study|Withdrawal by Subject|11|||
160751975|NCT02427802|580477343|FG000|Overall Study|Protocol Violation|3|||
160751976|NCT02427802|580477344|FG001|Overall Study|Protocol Violation|1|||
160751977|NCT02427802|580477345|FG002|Overall Study|Protocol Violation|1|||
160751978|NCT02427802|580477343|FG000|Overall Study|protocol specific treatment unrelated|18|||
160751979|NCT02427802|580477344|FG001|Overall Study|protocol specific treatment unrelated|11|||
160751980|NCT02427802|580477345|FG002|Overall Study|protocol specific treatment unrelated|11|||
160751981|NCT02226120|580477346|FG000|Overall Study|Adverse Event|60|||
160751982|NCT02226120|580477346|FG000|Overall Study|Death|172|||
160751983|NCT02226120|580477346|FG000|Overall Study|Study terminated by sponsor|1|||
160751984|NCT02226120|580477346|FG000|Overall Study|Technical problems|4|||
160751985|NCT02226120|580477346|FG000|Overall Study|Lost to Follow-up|13|||
160751986|NCT02226120|580477346|FG000|Overall Study|Physician Decision|21|||
160751987|NCT02226120|580477346|FG000|Overall Study|Withdrawal by parent/guardian|36|||
160751988|NCT02226120|580477346|FG000|Overall Study|Non-compliance with study drug|10|||
160751989|NCT02226120|580477346|FG000|Overall Study|Protocol deviation|1|||
160751990|NCT02226120|580477346|FG000|Overall Study|missing treatment disposition pages|2|||
160751991|NCT00467558|580477348|FG000|Overall Study|Lost to Follow-up|2|||
160751992|NCT00467558|580477349|FG001|Overall Study|Lost to Follow-up|0|||
160751993|NCT02636439|580477351|FG000|Overall Study|Adverse Event|2|||
160751994|NCT02636439|580477352|FG001|Overall Study|Adverse Event|2|||
160751995|NCT02636439|580477351|FG000|Overall Study|Lost to Follow-up|1|||
160751996|NCT02636439|580477352|FG001|Overall Study|Lost to Follow-up|0|||
160751997|NCT02636439|580477351|FG000|Overall Study|Non-compliance|1|||
160751998|NCT02636439|580477352|FG001|Overall Study|Non-compliance|1|||
160751999|NCT02636439|580477351|FG000|Overall Study|Personal reasons|2|||
160752000|NCT02636439|580477352|FG001|Overall Study|Personal reasons|0|||
160752001|NCT02494401|580477353|FG000|Overall Study|Lost to Follow-up|22|||
160752002|NCT02494401|580477354|FG001|Overall Study|Lost to Follow-up|25|||
160752003|NCT02494401|580477353|FG000|Overall Study|Withdrawal by Subject|3|||
160752004|NCT02494401|580477354|FG001|Overall Study|Withdrawal by Subject|2|||
160752005|NCT05188729|580477355|FG000|Overall Study|Withdrawal by Subject|0|||
160752006|NCT05188729|580477356|FG001|Overall Study|Withdrawal by Subject|0|||
160752007|NCT05188729|580477357|FG002|Overall Study|Withdrawal by Subject|0|||
160752008|NCT05188729|580477358|FG003|Overall Study|Withdrawal by Subject|0|||
160752009|NCT05188729|580477359|FG004|Overall Study|Withdrawal by Subject|0|||
160752010|NCT05188729|580477360|FG005|Overall Study|Withdrawal by Subject|0|||
160752011|NCT05188729|580477361|FG006|Overall Study|Withdrawal by Subject|0|||
160752012|NCT05188729|580477362|FG007|Overall Study|Withdrawal by Subject|0|||
160752013|NCT05188729|580477363|FG008|Overall Study|Withdrawal by Subject|0|||
160752014|NCT05188729|580477364|FG009|Overall Study|Withdrawal by Subject|1|||
160752015|NCT05188729|580477365|FG010|Overall Study|Withdrawal by Subject|0|||
160752016|NCT05188729|580477366|FG011|Overall Study|Withdrawal by Subject|0|||
160752017|NCT05188729|580477367|FG012|Overall Study|Withdrawal by Subject|0|||
160752018|NCT05188729|580477355|FG000|Overall Study|Lost to Follow-up|0|||
160752019|NCT05188729|580477356|FG001|Overall Study|Lost to Follow-up|0|||
160752020|NCT05188729|580477357|FG002|Overall Study|Lost to Follow-up|0|||
160752021|NCT05188729|580477358|FG003|Overall Study|Lost to Follow-up|0|||
160752022|NCT05188729|580477359|FG004|Overall Study|Lost to Follow-up|0|||
160752023|NCT05188729|580477360|FG005|Overall Study|Lost to Follow-up|0|||
160752024|NCT05188729|580477361|FG006|Overall Study|Lost to Follow-up|0|||
160752025|NCT05188729|580477362|FG007|Overall Study|Lost to Follow-up|0|||
160752026|NCT05188729|580477363|FG008|Overall Study|Lost to Follow-up|0|||
160752027|NCT05188729|580477364|FG009|Overall Study|Lost to Follow-up|0|||
160752028|NCT05188729|580477365|FG010|Overall Study|Lost to Follow-up|1|||
160752029|NCT05188729|580477366|FG011|Overall Study|Lost to Follow-up|1|||
160752030|NCT05188729|580477367|FG012|Overall Study|Lost to Follow-up|0|||
160752031|NCT01073163|580478646|FG000|Overall Study|Adverse Event|1|||
160752032|NCT01073163|580478646|FG000|Overall Study|Disease Progression|1|||
160752033|NCT01073163|580478646|FG000|Overall Study|Early termination|1|||
160752034|NCT00802672|580478647|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
160752035|NCT00802672|580478648|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
160752036|NCT00802672|580478649|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
160752037|NCT00802672|580478647|FG000|Overall Study|Adverse Event|1|||
160752038|NCT00802672|580478648|FG001|Overall Study|Adverse Event|1|||
160752039|NCT00802672|580478649|FG002|Overall Study|Adverse Event|1|||
160752040|NCT00802672|580478647|FG000|Overall Study|Protocol Violation|2|||
160752041|NCT00802672|580478648|FG001|Overall Study|Protocol Violation|1|||
160752042|NCT00802672|580478649|FG002|Overall Study|Protocol Violation|1|||
160752043|NCT00802672|580478647|FG000|Overall Study|Lost to Follow-up|5|||
160752044|NCT00802672|580478648|FG001|Overall Study|Lost to Follow-up|5|||
160752045|NCT00802672|580478649|FG002|Overall Study|Lost to Follow-up|3|||
160752046|NCT00802672|580478647|FG000|Overall Study|Withdrawal by Subject|1|||
160752047|NCT00802672|580478648|FG001|Overall Study|Withdrawal by Subject|1|||
160752048|NCT00802672|580478649|FG002|Overall Study|Withdrawal by Subject|2|||
160752049|NCT00802672|580478647|FG000|Overall Study|other|3|||
160752050|NCT00802672|580478648|FG001|Overall Study|other|1|||
160752051|NCT00802672|580478649|FG002|Overall Study|other|2|||
160752052|NCT00703677|580478650|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
160752053|NCT03859648|580478657|FG000|Overall Study|Lost to Follow-up|1|||
160752054|NCT03859648|580478657|FG000|Overall Study|Adverse Event|1|||
160752055|NCT02793947|580478667|FG000|Overall Study|Death|1|||
160752056|NCT02793947|580478668|FG001|Overall Study|Death|0|||
160752057|NCT02793947|580478667|FG000|Overall Study|Physician Decision|1|||
160752058|NCT02793947|580478668|FG001|Overall Study|Physician Decision|5|||
160752059|NCT01025284|580478672|FG000|Overall Study|Investigator Decision|0|||
160752060|NCT01025284|580478673|FG001|Overall Study|Investigator Decision|1|||
160752061|NCT01025284|580478674|FG002|Overall Study|Investigator Decision|0|||
160752062|NCT01025284|580478672|FG000|Overall Study|Withdrawal by Subject|0|||
160752063|NCT01025284|580478673|FG001|Overall Study|Withdrawal by Subject|1|||
160752064|NCT01025284|580478674|FG002|Overall Study|Withdrawal by Subject|0|||
160752065|NCT02542397|580478675|FG000|Overall Study|Death|2|||
160752066|NCT02542397|580478675|FG000|Overall Study|Physician Decision|6|||
160752067|NCT02542397|580478675|FG000|Overall Study|Withdrawal by Subject|6|||
160752068|NCT02542397|580478675|FG000|Overall Study|Lost to Follow-up|2|||
160752069|NCT00305227|580478676|FG000|Overall Study|Lost to Follow-up|7|||
160752070|NCT00305227|580478677|FG001|Overall Study|Lost to Follow-up|6|||
160752071|NCT00632125|580478679|FG000|Overall Study|Death|82|||
160752072|NCT00632125|580478679|FG000|Overall Study|Withdrawal by Subject|44|||
160752073|NCT00632125|580478679|FG000|Overall Study|Adverse Event|36|||
160752074|NCT00632125|580478679|FG000|Overall Study|Renal transplantation|17|||
160752075|NCT00632125|580478679|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
160752076|NCT00632125|580478679|FG000|Overall Study|Non-compliance|8|||
160752077|NCT00632125|580478679|FG000|Overall Study|Development of uncontrolled hypertension|5|||
160752078|NCT00632125|580478679|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
160752079|NCT05133323|580478680|FG000|Overall Study|Lack of Efficacy|0|||
160752080|NCT05133323|580478681|FG001|Overall Study|Lack of Efficacy|0|||
160752081|NCT05133323|580478682|FG002|Overall Study|Lack of Efficacy|1|||
160752082|NCT05133323|580478680|FG000|Overall Study|Withdrawal by Subject|2|||
160752083|NCT05133323|580478681|FG001|Overall Study|Withdrawal by Subject|1|||
160752084|NCT05133323|580478682|FG002|Overall Study|Withdrawal by Subject|0|||
160752085|NCT00577772|580478691|FG000|Overall Study|Lost to Follow-up|0|||
160752086|NCT00577772|580478692|FG001|Overall Study|Lost to Follow-up|1|||
160752087|NCT04152083|580478699|FG000|Overall Study|Lost to Follow-up|2|||
160752088|NCT04152083|580478700|FG001|Overall Study|Lost to Follow-up|1|||
160752089|NCT04152083|580478699|FG000|Overall Study|Adverse Event|1|||
160752090|NCT04152083|580478700|FG001|Overall Study|Adverse Event|0|||
160752091|NCT04152083|580478699|FG000|Overall Study|Randomized but not treated|3|||
160752092|NCT04152083|580478700|FG001|Overall Study|Randomized but not treated|2|||
160752093|NCT00540644|580478701|FG000|Overall Study|Adverse Event|3|||
160752094|NCT00540644|580478702|FG001|Overall Study|Adverse Event|1|||
160752095|NCT00540644|580478701|FG000|Overall Study|Disease Progression|3|||
160752096|NCT00540644|580478702|FG001|Overall Study|Disease Progression|1|||
160752097|NCT00540644|580478701|FG000|Overall Study|Physician Decision|0|||
160752098|NCT00540644|580478702|FG001|Overall Study|Physician Decision|5|||
160752099|NCT00540644|580478701|FG000|Overall Study|Withdrawal by Subject|2|||
160752100|NCT00540644|580478702|FG001|Overall Study|Withdrawal by Subject|2|||
160752101|NCT00540644|580478701|FG000|Overall Study|Noncomplilance|1|||
160752102|NCT00540644|580478702|FG001|Overall Study|Noncomplilance|0|||
160752103|NCT00105989|580478703|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
160752104|NCT00105989|580478704|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
160752105|NCT00105989|580478703|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
160752106|NCT00105989|580478704|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
160752107|NCT00105989|580478703|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
160752108|NCT00105989|580478704|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
160752109|NCT00105989|580478703|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
160752110|NCT00105989|580478704|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
160752111|NCT00105989|580478703|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
160752112|NCT00105989|580478704|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
160752113|NCT00105989|580478703|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
160752114|NCT00105989|580478704|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
160752115|NCT00105989|580478703|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
160752116|NCT00105989|580478704|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
160752117|NCT00105989|580478703|FG000|Acute - Open Label: Week 0-10|Death|1|||
160752118|NCT00105989|580478704|FG001|Acute - Open Label: Week 0-10|Death|0|||
160752119|NCT00105989|580478703|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
160752120|NCT00105989|580478704|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
160752121|NCT00105989|580478703|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
160752122|NCT00105989|580478704|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
160752123|NCT00105989|580478703|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
160752124|NCT00105989|580478704|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
160752125|NCT00105989|580478703|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
160752126|NCT00105989|580478704|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
160752127|NCT00105989|580478703|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
160752128|NCT00105989|580478704|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
160752129|NCT00105989|580478703|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
160752130|NCT00105989|580478704|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
160752131|NCT00105989|580478703|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
160752132|NCT00105989|580478704|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
160752133|NCT00105989|580478703|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
160752134|NCT00105989|580478704|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
160752135|NCT00105989|580478703|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
160752136|NCT00105989|580478704|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
160752137|NCT00105989|580478703|FG000|Continuation - Open Label:Week 10-34|Death|0|||
160752138|NCT00105989|580478704|FG001|Continuation - Open Label:Week 10-34|Death|0|||
160752139|NCT00105989|580478703|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
160752140|NCT00105989|580478704|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
160752141|NCT00105989|580478703|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
160752142|NCT00105989|580478704|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
160752143|NCT00105989|580478703|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
160752144|NCT00105989|580478704|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
160752145|NCT00105989|580478703|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
160752146|NCT00105989|580478704|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
160752147|NCT00105989|580478703|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
160752148|NCT00105989|580478704|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
160752149|NCT00105989|580478703|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
160752150|NCT00105989|580478704|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
160752151|NCT00105989|580478703|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
160752152|NCT00105989|580478704|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
160752153|NCT00105989|580478703|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
160752154|NCT00105989|580478704|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
160752155|NCT00105989|580478703|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
160752156|NCT00105989|580478704|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
160752157|NCT00105989|580478703|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
160752158|NCT00105989|580478704|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
160752159|NCT00105989|580478703|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
160752160|NCT00105989|580478704|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
160752161|NCT00105989|580478703|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
160752162|NCT00105989|580478704|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
160752163|NCT03318003|580478705|FG000|Overall Study|Withdrawal by Subject|1|||
160752164|NCT03318003|580478706|FG001|Overall Study|Withdrawal by Subject|1|||
160752165|NCT03318003|580478705|FG000|Overall Study|fetal loss|0|||
160752166|NCT03318003|580478706|FG001|Overall Study|fetal loss|1|||
160752167|NCT01716663|580478707|FG000|Overall Study|Withdrawn prior to procedure|4|||
160752168|NCT01716663|580478707|FG000|Overall Study|Treated with non-study catheter|2|||
160752169|NCT01806168|580478711|FG000|Overall Study|Adverse Event|1|||
160752170|NCT01806168|580478712|FG001|Overall Study|Adverse Event|0|||
160752171|NCT01806168|580478713|FG002|Overall Study|Adverse Event|0|||
160752172|NCT01806168|580478711|FG000|Overall Study|Withdrawal by Subject|0|||
160752173|NCT01806168|580478712|FG001|Overall Study|Withdrawal by Subject|1|||
160752174|NCT01806168|580478713|FG002|Overall Study|Withdrawal by Subject|2|||
160752175|NCT01806168|580478711|FG000|Overall Study|Protocol Violation|0|||
160752176|NCT01806168|580478712|FG001|Overall Study|Protocol Violation|0|||
160752177|NCT01806168|580478713|FG002|Overall Study|Protocol Violation|1|||
160752178|NCT00614874|580478714|FG000|Overall Study|Protocol Violation|1|||
160752179|NCT00614874|580478714|FG000|Overall Study|Withdrawal by Subject|1|||
160752180|NCT04435808|580478715|FG000|Overall Study|Study stopped by DSMB|0|||
160752181|NCT04435808|580478716|FG001|Overall Study|Study stopped by DSMB|1|||
160752182|NCT00807612|580478719|FG000|Overall Study|Death|8|||
160752183|NCT00807612|580478719|FG000|Overall Study|Study early termination|5|||
160752184|NCT00807612|580478719|FG000|Overall Study|Withdrawal by Subject|1|||
160752185|NCT02768792|580478720|FG000|Overall Study|Adverse Event|1|||
160752186|NCT04607135|580478722|FG000|Overall Study|Physician Decision|1|||
160752187|NCT04607135|580478722|FG000|Overall Study|Withdrawal by Subject|1|||
160752188|NCT04607135|580478722|FG000|Overall Study|Equipment not working|3|||
160752189|NCT03465709|580478723|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
160752190|NCT03465709|580478723|FG000|Overall Study|Withdrawal by Subject|3|||
160752191|NCT00705341|580478724|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
160752192|NCT00705341|580478725|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
160752193|NCT00705341|580478726|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
160752194|NCT00705341|580478727|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
160752195|NCT00705341|580478724|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
160752196|NCT00705341|580478725|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
160752197|NCT00705341|580478726|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
160752198|NCT00705341|580478727|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
160752199|NCT03173456|580478730|FG000|Baseline|Medication dispensing system malfunction'|0|||
160752200|NCT03173456|580478731|FG001|Baseline|Medication dispensing system malfunction'|1|||
160752201|NCT03173456|580478732|FG002|Baseline|Medication dispensing system malfunction'|0|||
160752202|NCT03173456|580478733|FG003|Baseline|Medication dispensing system malfunction'|0|||
160752203|NCT03173456|580478734|FG004|Baseline|Medication dispensing system malfunction'|2|||
160752204|NCT03173456|580478730|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
160752205|NCT03173456|580478731|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
160752206|NCT03173456|580478732|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
160752207|NCT03173456|580478733|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
160752208|NCT03173456|580478734|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
160752209|NCT01733121|580478735|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
160752210|NCT01733121|580478736|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
160752211|NCT01733121|580478735|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
160752212|NCT01733121|580478736|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
160752213|NCT01733121|580478735|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
160752214|NCT01733121|580478736|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
160752215|NCT01733121|580478735|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
160752216|NCT01733121|580478736|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
160752217|NCT04978337|580478739|FG000|Overall Study|Withdrawal by Subject|0|||
160752218|NCT04978337|580478740|FG001|Overall Study|Withdrawal by Subject|1|||
160752219|NCT01436227|580478746|FG000|Overall Study|Adverse Event|7|||
160752220|NCT01436227|580478746|FG000|Overall Study|Death|1|||
160752221|NCT01436227|580478746|FG000|Overall Study|Lack of Efficacy|1|||
160752222|NCT01436227|580478746|FG000|Overall Study|Lost to Follow-up|3|||
160752223|NCT01436227|580478746|FG000|Overall Study|Physician Decision|1|||
160752224|NCT01436227|580478746|FG000|Overall Study|Withdrawal by Subject|7|||
160752225|NCT01436227|580478746|FG000|Overall Study|Disease progression, relapse|6|||
160752226|NCT04865419|580478749|FG000|Overall Study|Other|1|||
160752227|NCT04865419|580478750|FG001|Overall Study|Other|2|||
160752228|NCT04865419|580478751|FG002|Overall Study|Other|2|||
160752229|NCT04865419|580478752|FG003|Overall Study|Other|1|||
160752230|NCT04865419|580478753|FG004|Overall Study|Other|3|||
160752231|NCT04865419|580478754|FG005|Overall Study|Other|0|||
160752232|NCT04865419|580478755|FG006|Overall Study|Other|0|||
160752233|NCT04865419|580478756|FG007|Overall Study|Other|1|||
160752234|NCT04865419|580478757|FG008|Overall Study|Other|0|||
160752235|NCT04865419|580478758|FG009|Overall Study|Other|0|||
160752236|NCT04865419|580478759|FG010|Overall Study|Other|0|||
160752237|NCT04865419|580478749|FG000|Overall Study|Withdrawal by Subject|0|||
160752238|NCT04865419|580478750|FG001|Overall Study|Withdrawal by Subject|1|||
160752239|NCT04865419|580478751|FG002|Overall Study|Withdrawal by Subject|1|||
160752240|NCT04865419|580478752|FG003|Overall Study|Withdrawal by Subject|0|||
160752241|NCT04865419|580478753|FG004|Overall Study|Withdrawal by Subject|0|||
160752242|NCT04865419|580478754|FG005|Overall Study|Withdrawal by Subject|0|||
160752243|NCT04865419|580478755|FG006|Overall Study|Withdrawal by Subject|0|||
160752244|NCT04865419|580478756|FG007|Overall Study|Withdrawal by Subject|1|||
160752245|NCT04865419|580478757|FG008|Overall Study|Withdrawal by Subject|2|||
160752246|NCT04865419|580478758|FG009|Overall Study|Withdrawal by Subject|1|||
160752247|NCT04865419|580478759|FG010|Overall Study|Withdrawal by Subject|0|||
160752248|NCT04865419|580478749|FG000|Overall Study|Study terminated by Sponsor|0|||
160752249|NCT04865419|580478750|FG001|Overall Study|Study terminated by Sponsor|0|||
160752250|NCT04865419|580478751|FG002|Overall Study|Study terminated by Sponsor|0|||
160752251|NCT04865419|580478752|FG003|Overall Study|Study terminated by Sponsor|2|||
160752252|NCT04865419|580478753|FG004|Overall Study|Study terminated by Sponsor|2|||
160752253|NCT04865419|580478754|FG005|Overall Study|Study terminated by Sponsor|0|||
160752254|NCT04865419|580478755|FG006|Overall Study|Study terminated by Sponsor|0|||
160752255|NCT04865419|580478756|FG007|Overall Study|Study terminated by Sponsor|0|||
160752256|NCT04865419|580478757|FG008|Overall Study|Study terminated by Sponsor|0|||
160752257|NCT04865419|580478758|FG009|Overall Study|Study terminated by Sponsor|0|||
160752258|NCT04865419|580478759|FG010|Overall Study|Study terminated by Sponsor|1|||
160752259|NCT04865419|580478749|FG000|Overall Study|Death|3|||
160752260|NCT04865419|580478750|FG001|Overall Study|Death|1|||
160752261|NCT04865419|580478751|FG002|Overall Study|Death|4|||
160752262|NCT04865419|580478752|FG003|Overall Study|Death|2|||
160752263|NCT04865419|580478753|FG004|Overall Study|Death|5|||
160752264|NCT04865419|580478754|FG005|Overall Study|Death|2|||
160752265|NCT04865419|580478755|FG006|Overall Study|Death|1|||
160752266|NCT04865419|580478756|FG007|Overall Study|Death|1|||
160752267|NCT04865419|580478757|FG008|Overall Study|Death|2|||
160752268|NCT04865419|580478758|FG009|Overall Study|Death|2|||
160752269|NCT04865419|580478759|FG010|Overall Study|Death|1|||
160752270|NCT04865419|580478749|FG000|Overall Study|Lost to Follow-up|0|||
160752271|NCT04865419|580478750|FG001|Overall Study|Lost to Follow-up|0|||
160752272|NCT04865419|580478751|FG002|Overall Study|Lost to Follow-up|0|||
160752273|NCT04865419|580478752|FG003|Overall Study|Lost to Follow-up|0|||
160752274|NCT04865419|580478753|FG004|Overall Study|Lost to Follow-up|0|||
160752275|NCT04865419|580478754|FG005|Overall Study|Lost to Follow-up|0|||
160752276|NCT04865419|580478755|FG006|Overall Study|Lost to Follow-up|0|||
160752277|NCT04865419|580478756|FG007|Overall Study|Lost to Follow-up|0|||
160752278|NCT04865419|580478757|FG008|Overall Study|Lost to Follow-up|0|||
160752279|NCT04865419|580478758|FG009|Overall Study|Lost to Follow-up|1|||
160752280|NCT04865419|580478759|FG010|Overall Study|Lost to Follow-up|0|||
160752281|NCT05446142|580478760|FG000|Period 2|Adverse Event|1|||
160752282|NCT05446142|580478761|FG001|Period 2|Adverse Event|0|||
160752283|NCT05446142|580478762|FG002|Period 2|Adverse Event|0|||
160752284|NCT05446142|580478763|FG003|Period 2|Adverse Event|0|||
160752285|NCT05446142|580478764|FG004|Period 2|Adverse Event|0|||
160752286|NCT05446142|580478765|FG005|Period 2|Adverse Event|0|||
160752287|NCT00547157|580478770|FG000|Overall Study|Other|1|||
160752288|NCT00547157|580478771|FG001|Overall Study|Other|0|||
160752289|NCT00547157|580478770|FG000|Overall Study|Death|38|||
160752290|NCT00547157|580478771|FG001|Overall Study|Death|18|||
160752291|NCT00547157|580478770|FG000|Overall Study|Withdrawal by Subject|3|||
160752292|NCT00547157|580478771|FG001|Overall Study|Withdrawal by Subject|1|||
160752293|NCT00547157|580478770|FG000|Overall Study|Administrative decision|3|||
160752294|NCT00547157|580478771|FG001|Overall Study|Administrative decision|2|||
160752295|NCT00547157|580478770|FG000|Overall Study|Lost to Follow-up|4|||
160752296|NCT00547157|580478771|FG001|Overall Study|Lost to Follow-up|2|||
160752297|NCT01151345|580478773|FG000|First Intervention Period|Protocol Violation|0|||
160752298|NCT01151345|580478774|FG001|First Intervention Period|Protocol Violation|1|||
160752299|NCT01765569|580478775|FG000|Period B|Withdrawal by Subject|1|||
160752300|NCT01765569|580478775|FG000|Period C|Death|1|||
160752301|NCT05415462|580478776|FG000|Overall Study|Death|18|||
160752302|NCT05415462|580478777|FG001|Overall Study|Death|10|||
160752303|NCT05415462|580478776|FG000|Overall Study|Lost to Follow-up|72|||
160752304|NCT05415462|580478777|FG001|Overall Study|Lost to Follow-up|64|||
160752305|NCT05415462|580478776|FG000|Overall Study|Physician Decision|5|||
160752306|NCT05415462|580478777|FG001|Overall Study|Physician Decision|5|||
160752307|NCT05415462|580478776|FG000|Overall Study|Protocol Deviation|1|||
160752308|NCT05415462|580478777|FG001|Overall Study|Protocol Deviation|0|||
160752309|NCT05415462|580478776|FG000|Overall Study|Withdrawal by Subject|129|||
160752310|NCT05415462|580478777|FG001|Overall Study|Withdrawal by Subject|101|||
160752311|NCT05415462|580478776|FG000|Overall Study|Other Than Specified|8|||
160752312|NCT05415462|580478777|FG001|Overall Study|Other Than Specified|8|||
160752313|NCT01030718|580478778|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
160752314|NCT01030718|580478779|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
160752315|NCT01030718|580478780|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
160752316|NCT01030718|580478778|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
160752317|NCT01030718|580478779|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
160752318|NCT01030718|580478780|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
160752319|NCT01030718|580478778|FG000|Studies CA180-031 and -036 Combined|Death|0|||
160752320|NCT01030718|580478779|FG001|Studies CA180-031 and -036 Combined|Death|1|||
160752321|NCT01030718|580478780|FG002|Studies CA180-031 and -036 Combined|Death|0|||
160752322|NCT01030718|580478778|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
160752323|NCT01030718|580478779|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
160752324|NCT01030718|580478780|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
160752325|NCT01030718|580478778|FG000|Study CA180-036 Only|insufficient effect|1|||
160752326|NCT01030718|580478779|FG001|Study CA180-036 Only|insufficient effect|1|||
160752327|NCT01030718|580478780|FG002|Study CA180-036 Only|insufficient effect|5|||
160752328|NCT01030718|580478778|FG000|Study CA180-036 Only|Adverse Event|2|||
160752329|NCT01030718|580478779|FG001|Study CA180-036 Only|Adverse Event|3|||
160752330|NCT01030718|580478780|FG002|Study CA180-036 Only|Adverse Event|0|||
160752331|NCT01030718|580478778|FG000|Study CA180-036 Only|Death|0|||
160752332|NCT01030718|580478779|FG001|Study CA180-036 Only|Death|1|||
160752333|NCT01030718|580478780|FG002|Study CA180-036 Only|Death|0|||
160752334|NCT01030718|580478778|FG000|Study CA180-036 Only|Other Reasons|0|||
160752335|NCT01030718|580478779|FG001|Study CA180-036 Only|Other Reasons|2|||
160752336|NCT01030718|580478780|FG002|Study CA180-036 Only|Other Reasons|0|||
160752337|NCT00423813|580478781|FG000|Overall Study|Adverse Event|11|||
160752338|NCT00423813|580478782|FG001|Overall Study|Adverse Event|30|||
160752339|NCT00423813|580478783|FG002|Overall Study|Adverse Event|40|||
160752340|NCT00423813|580478781|FG000|Overall Study|Withdrawal by Subject|6|||
160752341|NCT00423813|580478782|FG001|Overall Study|Withdrawal by Subject|8|||
160752342|NCT00423813|580478783|FG002|Overall Study|Withdrawal by Subject|5|||
160752343|NCT00423813|580478781|FG000|Overall Study|Lost to Follow-up|5|||
160752344|NCT00423813|580478782|FG001|Overall Study|Lost to Follow-up|4|||
160752345|NCT00423813|580478783|FG002|Overall Study|Lost to Follow-up|4|||
160752346|NCT00423813|580478781|FG000|Overall Study|Lack of Efficacy|23|||
160752347|NCT00423813|580478782|FG001|Overall Study|Lack of Efficacy|18|||
160752348|NCT00423813|580478783|FG002|Overall Study|Lack of Efficacy|19|||
160752349|NCT00423813|580478781|FG000|Overall Study|Physician Decision|2|||
160752350|NCT00423813|580478782|FG001|Overall Study|Physician Decision|0|||
160752351|NCT00423813|580478783|FG002|Overall Study|Physician Decision|0|||
160752352|NCT00423813|580478781|FG000|Overall Study|Sponsor Decision|0|||
160752353|NCT00423813|580478782|FG001|Overall Study|Sponsor Decision|1|||
160752354|NCT00423813|580478783|FG002|Overall Study|Sponsor Decision|0|||
160752355|NCT00423813|580478781|FG000|Overall Study|Protocol Violation|9|||
160752356|NCT00423813|580478782|FG001|Overall Study|Protocol Violation|4|||
160752357|NCT00423813|580478783|FG002|Overall Study|Protocol Violation|4|||
160752358|NCT00423813|580478781|FG000|Overall Study|Pregnancy|0|||
160752359|NCT00423813|580478782|FG001|Overall Study|Pregnancy|0|||
160752360|NCT00423813|580478783|FG002|Overall Study|Pregnancy|1|||
160752361|NCT00423813|580478781|FG000|Overall Study|Subject started night shift work|1|||
160752362|NCT00423813|580478782|FG001|Overall Study|Subject started night shift work|0|||
160752363|NCT00423813|580478783|FG002|Overall Study|Subject started night shift work|0|||
160752364|NCT00423813|580478781|FG000|Overall Study|Will start exclusionary medications|0|||
160752365|NCT00423813|580478782|FG001|Overall Study|Will start exclusionary medications|1|||
160752366|NCT00423813|580478783|FG002|Overall Study|Will start exclusionary medications|0|||
160752367|NCT00423813|580478781|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
160752368|NCT00423813|580478782|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
160752369|NCT00423813|580478783|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
160752370|NCT02998996|580478787|FG000|Overall Study|Lost to Follow-up|0|||
160752371|NCT02998996|580478788|FG001|Overall Study|Lost to Follow-up|0|||
160752372|NCT02998996|580478789|FG002|Overall Study|Lost to Follow-up|1|||
160752373|NCT02998996|580478790|FG003|Overall Study|Lost to Follow-up|0|||
160752374|NCT02998996|580478791|FG004|Overall Study|Lost to Follow-up|0|||
160752375|NCT02998996|580478792|FG005|Overall Study|Lost to Follow-up|0|||
160752376|NCT02998996|580478787|FG000|Overall Study|Pregnancy|0|||
160752377|NCT02998996|580478788|FG001|Overall Study|Pregnancy|1|||
160752378|NCT02998996|580478789|FG002|Overall Study|Pregnancy|0|||
160752379|NCT02998996|580478790|FG003|Overall Study|Pregnancy|0|||
160752380|NCT02998996|580478791|FG004|Overall Study|Pregnancy|0|||
160752381|NCT02998996|580478792|FG005|Overall Study|Pregnancy|0|||
160752382|NCT02998996|580478787|FG000|Overall Study|Family reasons|0|||
160752383|NCT02998996|580478788|FG001|Overall Study|Family reasons|0|||
160752384|NCT02998996|580478789|FG002|Overall Study|Family reasons|0|||
160752385|NCT02998996|580478790|FG003|Overall Study|Family reasons|0|||
160752386|NCT02998996|580478791|FG004|Overall Study|Family reasons|1|||
160752387|NCT02998996|580478792|FG005|Overall Study|Family reasons|0|||
160752388|NCT01087203|580478793|FG000|Overall Study|Lost to Follow-up|2|||
160752389|NCT01087203|580478794|FG001|Overall Study|Lost to Follow-up|0|||
160752390|NCT01087203|580478793|FG000|Overall Study|Withdrawal by Subject|2|||
160752391|NCT01087203|580478794|FG001|Overall Study|Withdrawal by Subject|6|||
160752392|NCT01087203|580478793|FG000|Overall Study|Lack of Efficacy|1|||
160752393|NCT01087203|580478794|FG001|Overall Study|Lack of Efficacy|2|||
160752394|NCT01087203|580478793|FG000|Overall Study|Study terminated by sponsor|27|||
160752395|NCT01087203|580478794|FG001|Overall Study|Study terminated by sponsor|27|||
160752396|NCT00913770|580478801|FG000|Overall Study|Unable to contact|24|||
160752397|NCT00913770|580478802|FG001|Overall Study|Unable to contact|19|||
160752398|NCT00913770|580478803|FG002|Overall Study|Unable to contact|13|||
160752399|NCT00913770|580478801|FG000|Overall Study|Refused|11|||
160752400|NCT00913770|580478802|FG001|Overall Study|Refused|10|||
160752401|NCT00913770|580478803|FG002|Overall Study|Refused|8|||
160752402|NCT02634983|580478804|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
160752403|NCT02634983|580478805|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
160752404|NCT04441788|580480566|FG000|Overall Study|Voluntary Withdrawl|0|||
160752405|NCT04441788|580480567|FG001|Overall Study|Voluntary Withdrawl|1|||
160752406|NCT04441788|580480568|FG002|Overall Study|Voluntary Withdrawl|0|||
160752407|NCT04441788|580480566|FG000|Overall Study|Ineligibility|1|||
160752408|NCT04441788|580480567|FG001|Overall Study|Ineligibility|0|||
160752409|NCT04441788|580480568|FG002|Overall Study|Ineligibility|0|||
160752410|NCT04441788|580480566|FG000|Overall Study|Adverse Event|0|||
160752411|NCT04441788|580480567|FG001|Overall Study|Adverse Event|0|||
160752412|NCT04441788|580480568|FG002|Overall Study|Adverse Event|4|||
160752413|NCT04441788|580480566|FG000|Overall Study|Study Terminated by Sponsor|16|||
160752414|NCT04441788|580480567|FG001|Overall Study|Study Terminated by Sponsor|16|||
160752415|NCT04441788|580480568|FG002|Overall Study|Study Terminated by Sponsor|12|||
160752416|NCT02315664|580480571|FG000|Overall Study|Lost to Follow-up|1|||
160752417|NCT02315664|580480572|FG001|Overall Study|Lost to Follow-up|1|||
160752418|NCT02315664|580480571|FG000|Overall Study|Withdrawal by Subject|0|||
160752419|NCT02315664|580480572|FG001|Overall Study|Withdrawal by Subject|3|||
160752420|NCT01677182|580480573|FG000|Overall Study|Adverse Event|2|||
160752421|NCT01677182|580480574|FG001|Overall Study|Adverse Event|1|||
160752422|NCT01677182|580480575|FG002|Overall Study|Adverse Event|8|||
160752423|NCT01677182|580480573|FG000|Overall Study|Protocol Violation|5|||
160752424|NCT01677182|580480574|FG001|Overall Study|Protocol Violation|1|||
160752425|NCT01677182|580480575|FG002|Overall Study|Protocol Violation|4|||
160752426|NCT01677182|580480573|FG000|Overall Study|Lost to Follow-up|4|||
160752427|NCT01677182|580480574|FG001|Overall Study|Lost to Follow-up|0|||
160752428|NCT01677182|580480575|FG002|Overall Study|Lost to Follow-up|3|||
160752429|NCT01677182|580480573|FG000|Overall Study|Withdrawal by Subject|7|||
160752430|NCT01677182|580480574|FG001|Overall Study|Withdrawal by Subject|12|||
160752431|NCT01677182|580480575|FG002|Overall Study|Withdrawal by Subject|10|||
160752432|NCT01677182|580480573|FG000|Overall Study|Study termination|12|||
160752433|NCT01677182|580480574|FG001|Overall Study|Study termination|9|||
160752434|NCT01677182|580480575|FG002|Overall Study|Study termination|11|||
160752435|NCT01677182|580480573|FG000|Overall Study|Lack of Efficacy|3|||
160752436|NCT01677182|580480574|FG001|Overall Study|Lack of Efficacy|0|||
160752437|NCT01677182|580480575|FG002|Overall Study|Lack of Efficacy|1|||
160752438|NCT01677182|580480573|FG000|Overall Study|Other reasons|1|||
160752439|NCT01677182|580480574|FG001|Overall Study|Other reasons|5|||
160752440|NCT01677182|580480575|FG002|Overall Study|Other reasons|2|||
160752441|NCT00667992|580480578|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
160752442|NCT00667992|580480579|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
160752443|NCT00667992|580480578|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
160752444|NCT00667992|580480579|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
160752445|NCT00667992|580480578|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
160752446|NCT00667992|580480579|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
160752447|NCT00667992|580480578|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
160752448|NCT00667992|580480579|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
160752449|NCT00667992|580480578|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
160752450|NCT00667992|580480579|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
160752451|NCT00667992|580480578|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
160752452|NCT00667992|580480579|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
160752453|NCT00667992|580480578|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
160752454|NCT00667992|580480579|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
160752455|NCT00667992|580480578|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
160752456|NCT00667992|580480579|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
160752457|NCT00667992|580480578|FG000|Wash-out|Not within one doubling dilution|4|||
160752458|NCT00667992|580480579|FG001|Wash-out|Not within one doubling dilution|3|||
160752459|NCT00667992|580480578|FG000|Wash-out|Failure to wash-out|2|||
160752460|NCT00667992|580480579|FG001|Wash-out|Failure to wash-out|2|||
160752461|NCT00667992|580480578|FG000|Wash-out|Withdrawal by Subject|1|||
160752462|NCT00667992|580480579|FG001|Wash-out|Withdrawal by Subject|0|||
160752463|NCT00667992|580480578|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
160752464|NCT00667992|580480579|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
160752465|NCT00667992|580480578|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
160752466|NCT00667992|580480579|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
160752467|NCT00762762|580480580|FG000|Overall Study|Did not return for appointments|6|||
160752468|NCT00762762|580480581|FG001|Overall Study|Did not return for appointments|8|||
160752469|NCT02489448|580480582|FG000|Overall Study|Death|3|||
160752470|NCT02489448|580480582|FG000|Overall Study|Withdrawal by Subject|2|||
160752471|NCT02748057|580480583|FG000|Overall Study|Adverse Event|1|||
160752472|NCT02748057|580480584|FG001|Overall Study|Adverse Event|0|||
160752473|NCT02748057|580480583|FG000|Overall Study|Physician Decision|0|||
160752474|NCT02748057|580480584|FG001|Overall Study|Physician Decision|1|||
160752475|NCT02748057|580480583|FG000|Overall Study|Protocol Violation|2|||
160752476|NCT02748057|580480584|FG001|Overall Study|Protocol Violation|1|||
160752477|NCT02748057|580480583|FG000|Overall Study|Participant Moved|1|||
160752478|NCT02748057|580480584|FG001|Overall Study|Participant Moved|0|||
160752479|NCT02748057|580480583|FG000|Overall Study|Withdrawal by Subject|1|||
160752480|NCT02748057|580480584|FG001|Overall Study|Withdrawal by Subject|0|||
160752481|NCT01990573|580480585|FG000|Overall Study|Physician Decision|0|||
160752482|NCT01990573|580480586|FG001|Overall Study|Physician Decision|0|||
160752483|NCT01990573|580480587|FG002|Overall Study|Physician Decision|1|||
160752484|NCT00547248|580480600|FG000|Overall Study|Protocol Violation|0|||
160752485|NCT00547248|580480601|FG001|Overall Study|Protocol Violation|0|||
160752486|NCT00547248|580480602|FG002|Overall Study|Protocol Violation|1|||
160752487|NCT00547248|580480603|FG003|Overall Study|Protocol Violation|1|||
160752488|NCT00547248|580480600|FG000|Overall Study|Migrated/moved from study area|0|||
160752489|NCT00547248|580480601|FG001|Overall Study|Migrated/moved from study area|0|||
160752490|NCT00547248|580480602|FG002|Overall Study|Migrated/moved from study area|2|||
160752491|NCT00547248|580480603|FG003|Overall Study|Migrated/moved from study area|0|||
160752492|NCT00547248|580480600|FG000|Overall Study|Withdrawal by Subject|0|||
160752493|NCT00547248|580480601|FG001|Overall Study|Withdrawal by Subject|0|||
160752494|NCT00547248|580480602|FG002|Overall Study|Withdrawal by Subject|7|||
160752495|NCT00547248|580480603|FG003|Overall Study|Withdrawal by Subject|1|||
160752496|NCT02090283|580480606|FG000|Overall Study|Withdrawal by Subject|6|||
160752497|NCT02090283|580480607|FG001|Overall Study|Withdrawal by Subject|6|||
160752498|NCT02090283|580480608|FG002|Overall Study|Withdrawal by Subject|6|||
160752499|NCT02090283|580480606|FG000|Overall Study|Sponsor Terminated Study|6|||
160752500|NCT02090283|580480607|FG001|Overall Study|Sponsor Terminated Study|6|||
160752501|NCT02090283|580480608|FG002|Overall Study|Sponsor Terminated Study|1|||
160752502|NCT02090283|580480606|FG000|Overall Study|Lost to Follow-up|2|||
160752503|NCT02090283|580480607|FG001|Overall Study|Lost to Follow-up|2|||
160752504|NCT02090283|580480608|FG002|Overall Study|Lost to Follow-up|3|||
160752505|NCT02090283|580480606|FG000|Overall Study|Adverse Event|1|||
160752506|NCT02090283|580480607|FG001|Overall Study|Adverse Event|1|||
160752507|NCT02090283|580480608|FG002|Overall Study|Adverse Event|0|||
160752508|NCT02090283|580480606|FG000|Overall Study|Protocol Violation|2|||
160752509|NCT02090283|580480607|FG001|Overall Study|Protocol Violation|0|||
160752510|NCT02090283|580480608|FG002|Overall Study|Protocol Violation|0|||
160752511|NCT00697593|580480611|FG000|Overall Study|Adverse Event|3|||
160752512|NCT00697593|580480611|FG000|Overall Study|Protocol Violation|1|||
160752513|NCT00697593|580480611|FG000|Overall Study|Lack of Efficacy|3|||
160752514|NCT00697593|580480611|FG000|Overall Study|Suspension of the study by sponsor|12|||
160752515|NCT02609386|580480616|FG000|Overall Study|Withdrawal by Subject|6|||
160752516|NCT02609386|580480617|FG001|Overall Study|Withdrawal by Subject|1|||
160752517|NCT02609386|580480616|FG000|Overall Study|Lost to Follow-up|3|||
160752518|NCT02609386|580480617|FG001|Overall Study|Lost to Follow-up|5|||
160752519|NCT02609386|580480616|FG000|Overall Study|Death|19|||
160752520|NCT02609386|580480617|FG001|Overall Study|Death|9|||
160752521|NCT02609386|580480616|FG000|Overall Study|Physician Decision|0|||
160752522|NCT02609386|580480617|FG001|Overall Study|Physician Decision|2|||
160752523|NCT00610168|580480619|FG000|Overall Study|Withdrawal by Subject|2|||
160752524|NCT00610168|580480620|FG001|Overall Study|Withdrawal by Subject|0|||
160752525|NCT00411450|580480621|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
160752526|NCT01029262|580480624|FG000|Overall Study|Adverse Event|9|||
160752527|NCT01029262|580480625|FG001|Overall Study|Adverse Event|52|||
160752528|NCT01029262|580480624|FG000|Overall Study|Lack of therapeutic effect|57|||
160752529|NCT01029262|580480625|FG001|Overall Study|Lack of therapeutic effect|76|||
160752530|NCT01029262|580480624|FG000|Overall Study|Withdrawal by Subject|10|||
160752531|NCT01029262|580480625|FG001|Overall Study|Withdrawal by Subject|17|||
160752532|NCT01029262|580480624|FG000|Overall Study|Protocol Violation|2|||
160752533|NCT01029262|580480625|FG001|Overall Study|Protocol Violation|3|||
160752534|NCT01029262|580480624|FG000|Overall Study|Miscellaneous|1|||
160752535|NCT01029262|580480625|FG001|Overall Study|Miscellaneous|9|||
160752536|NCT01029262|580480624|FG000|Overall Study|Death|0|||
160752537|NCT01029262|580480625|FG001|Overall Study|Death|3|||
160752538|NCT03904420|580480626|FG000|Overall Study|Study terminated|2|||
160752539|NCT03904420|580480627|FG001|Overall Study|Study terminated|2|||
160752540|NCT02364388|580480634|FG000|Overall Study|Protocol Violation|1|||
160752541|NCT02364388|580480634|FG000|Overall Study|Technical Failure|3|||
160752542|NCT02364388|580480634|FG000|Overall Study|No OA/US data|2|||
160752543|NCT02364388|580480634|FG000|Overall Study|No Biopsy|2|||
160752544|NCT00837967|580480635|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
160752545|NCT00837967|580480636|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
160752546|NCT03061188|580480638|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
160752547|NCT03061188|580480639|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
160752548|NCT03061188|580480640|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
160752549|NCT03061188|580480641|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
160752550|NCT03061188|580480638|FG000|On Follow-up for 3 Years|Death|0|||
160752551|NCT03061188|580480639|FG001|On Follow-up for 3 Years|Death|3|||
160752552|NCT03061188|580480640|FG002|On Follow-up for 3 Years|Death|5|||
160752553|NCT03061188|580480641|FG003|On Follow-up for 3 Years|Death|4|||
160752554|NCT03061188|580480638|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
160752555|NCT03061188|580480639|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
160752556|NCT03061188|580480640|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
160752557|NCT03061188|580480641|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
160752558|NCT02306850|580480647|FG000|Overall Study|Lack of Efficacy|2|||
160752559|NCT02420262|580480648|FG000|Overall Study|Adverse Event|1|||
160752560|NCT02420262|580480649|FG001|Overall Study|Adverse Event|0|||
160752561|NCT02420262|580480648|FG000|Overall Study|Withdrawal by Subject|1|||
160752562|NCT02420262|580480649|FG001|Overall Study|Withdrawal by Subject|4|||
160752563|NCT02420262|580480648|FG000|Overall Study|Unclassified|0|||
160752564|NCT02420262|580480649|FG001|Overall Study|Unclassified|1|||
160752565|NCT01210222|580480650|FG000|Overall Study|Ineligible|2|||
160752566|NCT01210222|580480650|FG000|Overall Study|Never treated|1|||
160752567|NCT00941304|580480651|FG000|Overall Study|Lost to Follow-up|1|||
160752568|NCT00941304|580480652|FG001|Overall Study|Lost to Follow-up|0|||
160752569|NCT00941304|580480653|FG002|Overall Study|Lost to Follow-up|0|||
160752570|NCT00941304|580480654|FG003|Overall Study|Lost to Follow-up|0|||
160752571|NCT00941304|580480655|FG004|Overall Study|Lost to Follow-up|0|||
160752572|NCT02098395|580480658|FG000|Overall Study|Protocol Violation|2|||
160752573|NCT02098395|580480659|FG001|Overall Study|Protocol Violation|2|||
160752574|NCT02098395|580480660|FG002|Overall Study|Protocol Violation|0|||
160752575|NCT02098395|580480661|FG003|Overall Study|Protocol Violation|7|||
160752576|NCT02098395|580480658|FG000|Overall Study|Withdrawal by Subject|10|||
160752577|NCT02098395|580480659|FG001|Overall Study|Withdrawal by Subject|10|||
160752578|NCT02098395|580480660|FG002|Overall Study|Withdrawal by Subject|5|||
160752579|NCT02098395|580480661|FG003|Overall Study|Withdrawal by Subject|13|||
160752580|NCT02098395|580480658|FG000|Overall Study|Adverse Event|12|||
160752581|NCT02098395|580480659|FG001|Overall Study|Adverse Event|19|||
160752582|NCT02098395|580480660|FG002|Overall Study|Adverse Event|34|||
160752583|NCT02098395|580480661|FG003|Overall Study|Adverse Event|2|||
160752584|NCT02098395|580480658|FG000|Overall Study|Lost to Follow-up|2|||
160752585|NCT02098395|580480659|FG001|Overall Study|Lost to Follow-up|1|||
160752586|NCT02098395|580480660|FG002|Overall Study|Lost to Follow-up|0|||
160752587|NCT02098395|580480661|FG003|Overall Study|Lost to Follow-up|3|||
160752588|NCT02098395|580480658|FG000|Overall Study|Unclassified|0|||
160752589|NCT02098395|580480659|FG001|Overall Study|Unclassified|0|||
160752590|NCT02098395|580480660|FG002|Overall Study|Unclassified|3|||
160752591|NCT02098395|580480661|FG003|Overall Study|Unclassified|2|||
160752592|NCT01904032|580480670|FG000|Overall Study|Adverse Event|3|||
160752593|NCT01904032|580480671|FG001|Overall Study|Adverse Event|1|||
160752594|NCT01904032|580480670|FG000|Overall Study|Lost to Follow-up|4|||
160752595|NCT01904032|580480671|FG001|Overall Study|Lost to Follow-up|2|||
160752596|NCT01658904|580480672|FG000|Overall Study|Principal Investigator discretion|2|||
160752597|NCT01658904|580480673|FG001|Overall Study|Principal Investigator discretion|0|||
160752598|NCT01658904|580480674|FG002|Overall Study|Principal Investigator discretion|0|||
160752599|NCT04074330|580480676|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
160752600|NCT04074330|580480677|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
160752601|NCT04074330|580480678|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
160752602|NCT04074330|580480679|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
160752603|NCT04074330|580480680|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
160752604|NCT04074330|580480681|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
160752605|NCT04074330|580480682|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
160752606|NCT04074330|580480683|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
160752607|NCT04074330|580480684|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
160752608|NCT04074330|580480685|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
160752609|NCT04074330|580480676|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
160752610|NCT04074330|580480677|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
160752611|NCT04074330|580480678|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
160752612|NCT04074330|580480679|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
160752613|NCT04074330|580480680|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
160752614|NCT04074330|580480681|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
160752615|NCT04074330|580480682|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
160752616|NCT04074330|580480683|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
160752617|NCT04074330|580480684|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
160752618|NCT04074330|580480685|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
160752619|NCT04074330|580480676|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
160752620|NCT04074330|580480677|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
160752621|NCT04074330|580480678|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
160752622|NCT04074330|580480679|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
160752623|NCT04074330|580480680|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
160752624|NCT04074330|580480681|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
160752625|NCT04074330|580480682|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
160752626|NCT04074330|580480683|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
160752627|NCT04074330|580480684|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
160752628|NCT04074330|580480685|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
160752629|NCT04074330|580480676|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
160752630|NCT04074330|580480677|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
160752631|NCT04074330|580480678|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
160752632|NCT04074330|580480679|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
160752633|NCT04074330|580480680|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
160752634|NCT04074330|580480681|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
160752635|NCT04074330|580480682|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
160752636|NCT04074330|580480683|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
160752637|NCT04074330|580480684|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
160752638|NCT04074330|580480685|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
160752639|NCT04074330|580480676|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
160752640|NCT04074330|580480677|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
160752641|NCT04074330|580480678|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
160752642|NCT04074330|580480679|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
160752643|NCT04074330|580480680|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
160752644|NCT04074330|580480681|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
160752645|NCT04074330|580480682|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
160752646|NCT04074330|580480683|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
160752647|NCT04074330|580480684|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
160752648|NCT04074330|580480685|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
160752649|NCT04074330|580480676|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
160752650|NCT04074330|580480677|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
160752651|NCT04074330|580480678|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
160752652|NCT04074330|580480679|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
160752653|NCT04074330|580480680|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
160752654|NCT04074330|580480681|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
160752655|NCT04074330|580480682|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
160752656|NCT04074330|580480683|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
160752657|NCT04074330|580480684|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
160752658|NCT04074330|580480685|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
160752659|NCT04074330|580480676|FG000|Dose Expansion (up to 42 Months)|Death|0|||
160752660|NCT04074330|580480677|FG001|Dose Expansion (up to 42 Months)|Death|0|||
160752661|NCT04074330|580480678|FG002|Dose Expansion (up to 42 Months)|Death|0|||
160752662|NCT04074330|580480679|FG003|Dose Expansion (up to 42 Months)|Death|0|||
160752663|NCT04074330|580480680|FG004|Dose Expansion (up to 42 Months)|Death|0|||
160752664|NCT04074330|580480681|FG005|Dose Expansion (up to 42 Months)|Death|0|||
160752665|NCT04074330|580480682|FG006|Dose Expansion (up to 42 Months)|Death|0|||
160524529|NCT01074216|579650076|FG000|Overall Study|Physician Decision|1|||
160752666|NCT04074330|580480683|FG007|Dose Expansion (up to 42 Months)|Death|0|||
160752667|NCT04074330|580480684|FG008|Dose Expansion (up to 42 Months)|Death|1|||
160752668|NCT04074330|580480685|FG009|Dose Expansion (up to 42 Months)|Death|0|||
160752669|NCT04074330|580480676|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
160752670|NCT04074330|580480677|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
160752671|NCT04074330|580480678|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
160752672|NCT04074330|580480679|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
160752673|NCT04074330|580480680|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
160752674|NCT04074330|580480681|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
160752675|NCT04074330|580480682|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
160752676|NCT04074330|580480683|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
160752677|NCT04074330|580480684|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
160752678|NCT04074330|580480685|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
160752679|NCT01429298|580480686|FG000|Overall Study|Protocol Violation|4|||
160752680|NCT01429298|580480687|FG001|Overall Study|Protocol Violation|6|||
160752681|NCT02903420|580480690|FG000|Overall Study|Death|3|||
160752682|NCT00181883|580480693|FG000|Overall Study|Lack of Efficacy|2|||
160752683|NCT00181883|580480693|FG000|Overall Study|Treatment Limiting AEs|3|||
160752684|NCT00181883|580480693|FG000|Overall Study|Withdrawal by Subject|4|||
160752685|NCT00181883|580480693|FG000|Overall Study|Lost to Follow-up|1|||
160752686|NCT05305989|580480694|FG000|Overall Study|Other|3|||
160752687|NCT05305989|580480695|FG001|Overall Study|Other|2|||
160752688|NCT05305989|580480696|FG002|Overall Study|Other|0|||
160752689|NCT05305989|580480694|FG000|Overall Study|Sponsor decision|2|||
160752690|NCT05305989|580480695|FG001|Overall Study|Sponsor decision|1|||
160752691|NCT05305989|580480696|FG002|Overall Study|Sponsor decision|0|||
160752692|NCT05305989|580480694|FG000|Overall Study|Protocol Violation|0|||
160752693|NCT05305989|580480695|FG001|Overall Study|Protocol Violation|1|||
160752694|NCT05305989|580480696|FG002|Overall Study|Protocol Violation|0|||
160752695|NCT05305989|580480694|FG000|Overall Study|Investigator decision|1|||
160752696|NCT05305989|580480695|FG001|Overall Study|Investigator decision|2|||
160752697|NCT05305989|580480696|FG002|Overall Study|Investigator decision|0|||
160752698|NCT05305989|580480694|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
160752699|NCT05305989|580480695|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
160752700|NCT05305989|580480696|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
160752701|NCT05305989|580480694|FG000|Overall Study|Adverse Event|1|||
160752702|NCT05305989|580480695|FG001|Overall Study|Adverse Event|1|||
160752703|NCT05305989|580480696|FG002|Overall Study|Adverse Event|0|||
160752704|NCT05305989|580480694|FG000|Overall Study|Enrolled but never dosed|3|||
160752705|NCT05305989|580480695|FG001|Overall Study|Enrolled but never dosed|2|||
160752706|NCT05305989|580480696|FG002|Overall Study|Enrolled but never dosed|1|||
160752707|NCT03162328|580480697|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
160752708|NCT03162328|580480698|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
160752709|NCT03162328|580480699|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
160752710|NCT03162328|580480697|FG000|Screening Period|Withdrawal by Subject|1|||
160752711|NCT03162328|580480698|FG001|Screening Period|Withdrawal by Subject|0|||
160752712|NCT03162328|580480699|FG002|Screening Period|Withdrawal by Subject|0|||
160752713|NCT03162328|580480697|FG000|Study Period|Withdrawal by Subject|0|||
160752714|NCT03162328|580480698|FG001|Study Period|Withdrawal by Subject|0|||
160752715|NCT03162328|580480699|FG002|Study Period|Withdrawal by Subject|1|||
160752716|NCT01066871|580480703|FG000|Overall Study|Lost to Follow-up|0|||
160752717|NCT01066871|580480704|FG001|Overall Study|Lost to Follow-up|2|||
160752718|NCT01066871|580480705|FG002|Overall Study|Lost to Follow-up|2|||
160752719|NCT01066871|580480706|FG003|Overall Study|Lost to Follow-up|0|||
160752720|NCT01066871|580480703|FG000|Overall Study|Protocol Violation|1|||
160752721|NCT01066871|580480704|FG001|Overall Study|Protocol Violation|0|||
160752722|NCT01066871|580480705|FG002|Overall Study|Protocol Violation|3|||
160752723|NCT01066871|580480706|FG003|Overall Study|Protocol Violation|2|||
160752724|NCT01066871|580480703|FG000|Overall Study|Lack of Efficacy|0|||
160752725|NCT01066871|580480704|FG001|Overall Study|Lack of Efficacy|0|||
160752726|NCT01066871|580480705|FG002|Overall Study|Lack of Efficacy|0|||
160752727|NCT01066871|580480706|FG003|Overall Study|Lack of Efficacy|1|||
160752728|NCT01066871|580480703|FG000|Overall Study|Withdrawal by Subject|3|||
160752729|NCT01066871|580480704|FG001|Overall Study|Withdrawal by Subject|1|||
160752730|NCT01066871|580480705|FG002|Overall Study|Withdrawal by Subject|0|||
160752731|NCT01066871|580480706|FG003|Overall Study|Withdrawal by Subject|0|||
160752732|NCT01066871|580480703|FG000|Overall Study|Other|0|||
160752733|NCT01066871|580480704|FG001|Overall Study|Other|2|||
160752734|NCT01066871|580480705|FG002|Overall Study|Other|1|||
160752735|NCT01066871|580480706|FG003|Overall Study|Other|2|||
160752736|NCT03373461|580480710|FG000|Part 2|Adverse Event|0|||
160752737|NCT03373461|580480711|FG001|Part 2|Adverse Event|1|||
160752738|NCT03373461|580480712|FG002|Part 2|Adverse Event|0|||
160752739|NCT03373461|580480713|FG003|Part 2|Adverse Event|0|||
160752740|NCT03373461|580480714|FG004|Part 2|Adverse Event|1|||
160752741|NCT01366638|580480715|FG000|Overall Study|Withdrawal by Subject|0|||
160752742|NCT01366638|580480716|FG001|Overall Study|Withdrawal by Subject|0|||
160752743|NCT01366638|580480717|FG002|Overall Study|Withdrawal by Subject|6|||
160752744|NCT01366638|580480715|FG000|Overall Study|Other|1|||
160752745|NCT01366638|580480716|FG001|Overall Study|Other|0|||
160752746|NCT01366638|580480717|FG002|Overall Study|Other|0|||
160752747|NCT01554163|580480719|FG000|Overall Study|Adverse Event|3|||
160752748|NCT01554163|580480720|FG001|Overall Study|Adverse Event|0|||
160752749|NCT01554163|580480719|FG000|Overall Study|Lack of Efficacy|1|||
160752750|NCT01554163|580480720|FG001|Overall Study|Lack of Efficacy|0|||
160524530|NCT01074216|579650076|FG000|Overall Study|Not Treated|12|||
160752751|NCT01554163|580480719|FG000|Overall Study|Lost to Follow-up|1|||
160752752|NCT01554163|580480720|FG001|Overall Study|Lost to Follow-up|0|||
160752753|NCT01554163|580480719|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160752754|NCT01554163|580480720|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160752755|NCT01554163|580480719|FG000|Overall Study|Protocol Violation|0|||
160752756|NCT01554163|580480720|FG001|Overall Study|Protocol Violation|4|||
160752757|NCT01554163|580480719|FG000|Overall Study|Withdrawal by Subject|1|||
160752758|NCT01554163|580480720|FG001|Overall Study|Withdrawal by Subject|5|||
160752759|NCT01554163|580480719|FG000|Overall Study|Not Treated|1|||
160752760|NCT01554163|580480720|FG001|Overall Study|Not Treated|0|||
160752761|NCT01941537|580480721|FG000|Overall Study|Lack of Efficacy|1|||
160752762|NCT01941537|580480722|FG001|Overall Study|Lack of Efficacy|2|||
160752763|NCT01941537|580480721|FG000|Overall Study|Lost to Follow-up|1|||
160752764|NCT01941537|580480722|FG001|Overall Study|Lost to Follow-up|0|||
160752765|NCT01941537|580480721|FG000|Overall Study|Pregnancy|1|||
160752766|NCT01941537|580480722|FG001|Overall Study|Pregnancy|0|||
160752767|NCT01941537|580480721|FG000|Overall Study|Adverse Event|1|||
160752768|NCT01941537|580480722|FG001|Overall Study|Adverse Event|0|||
160752769|NCT01941537|580480721|FG000|Overall Study|Withdrawal by Subject|0|||
160752770|NCT01941537|580480722|FG001|Overall Study|Withdrawal by Subject|1|||
160752771|NCT01243177|580480724|FG000|Overall Study|Lack of Efficacy|47|||
160752772|NCT01243177|580480725|FG001|Overall Study|Lack of Efficacy|31|||
160752773|NCT01243177|580480724|FG000|Overall Study|Protocol Violation|11|||
160752774|NCT01243177|580480725|FG001|Overall Study|Protocol Violation|10|||
160752775|NCT01243177|580480724|FG000|Overall Study|Lost to Follow-up|15|||
160752776|NCT01243177|580480725|FG001|Overall Study|Lost to Follow-up|18|||
160752777|NCT01243177|580480724|FG000|Overall Study|Withdrawal by Subject|46|||
160752778|NCT01243177|580480725|FG001|Overall Study|Withdrawal by Subject|38|||
160752779|NCT01243177|580480724|FG000|Overall Study|AE, serious fatal|0|||
160752780|NCT01243177|580480725|FG001|Overall Study|AE, serious fatal|1|||
160752781|NCT01243177|580480724|FG000|Overall Study|SAE, non-fatal|7|||
160752782|NCT01243177|580480725|FG001|Overall Study|SAE, non-fatal|9|||
160752783|NCT01243177|580480724|FG000|Overall Study|AE, non-serious non-fatal|40|||
160752784|NCT01243177|580480725|FG001|Overall Study|AE, non-serious non-fatal|58|||
160752785|NCT01243177|580480724|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
160752786|NCT01243177|580480725|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
160752787|NCT01243177|580480724|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
160752788|NCT01243177|580480725|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
160752789|NCT01243177|580480724|FG000|Overall Study|Other Reason|11|||
160752790|NCT01243177|580480725|FG001|Overall Study|Other Reason|12|||
160752791|NCT00463801|580482416|FG000|Overall Study|Protocol Violation|1|||
160752792|NCT00463801|580482416|FG000|Overall Study|Lack of Efficacy|2|||
160752793|NCT00463801|580482416|FG000|Overall Study|Adverse Event|4|||
160752794|NCT00463801|580482416|FG000|Overall Study|Lost to Follow-up|5|||
160752795|NCT00463801|580482416|FG000|Overall Study|No longer require therapy|1|||
160752796|NCT00669318|580482417|FG000|Overall Study|Withdrawal by Subject|2|||
160752797|NCT03335813|580482423|FG000|Overall Study|Withdrawal by Subject|1|||
160752798|NCT02861664|580482424|FG000|Overall Study|Withdrawal of Consent|0|||
160524531|NCT01323634|579650077|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
160752799|NCT02861664|580482425|FG001|Overall Study|Withdrawal of Consent|1|||
160752800|NCT03512353|580482426|FG000|Overall Study|Sponsor Decision|3|||
160752801|NCT03512353|580482426|FG000|Overall Study|Death|1|||
160752802|NCT01639144|580482427|FG000|Overall Study|Withdrawal by Subject|4|||
160752803|NCT01639144|580482428|FG001|Overall Study|Withdrawal by Subject|2|||
160752804|NCT01639144|580482427|FG000|Overall Study|Physician Decision|2|||
160752805|NCT01639144|580482428|FG001|Overall Study|Physician Decision|0|||
160752806|NCT01639144|580482427|FG000|Overall Study|Met postoperative exclusion criteria|4|||
160752807|NCT01639144|580482428|FG001|Overall Study|Met postoperative exclusion criteria|3|||
160752808|NCT01000974|580482429|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
160752809|NCT01000974|580482430|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
160752810|NCT01000974|580482431|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
160635946|NCT01220128|580049420|FG004|Overall Study|Adverse event, non-fatal|0|||
160635947|NCT01220128|580049421|FG005|Overall Study|Adverse event, non-fatal|0|||
160635948|NCT01220128|580049422|FG006|Overall Study|Adverse event, non-fatal|3|||
160635949|NCT01220128|580049416|FG000|Overall Study|Other|0|||
160635950|NCT01220128|580049417|FG001|Overall Study|Other|0|||
160635951|NCT01220128|580049418|FG002|Overall Study|Other|1|||
160635952|NCT01220128|580049419|FG003|Overall Study|Other|0|||
160635953|NCT01220128|580049420|FG004|Overall Study|Other|0|||
160635954|NCT01220128|580049421|FG005|Overall Study|Other|0|||
160635955|NCT01220128|580049422|FG006|Overall Study|Other|0|||
160635956|NCT01220128|580049416|FG000|Overall Study|Consent withdrawn by subject|1|||
160635957|NCT01220128|580049417|FG001|Overall Study|Consent withdrawn by subject|0|||
160635958|NCT01220128|580049418|FG002|Overall Study|Consent withdrawn by subject|0|||
160635959|NCT01220128|580049419|FG003|Overall Study|Consent withdrawn by subject|0|||
160635960|NCT01220128|580049420|FG004|Overall Study|Consent withdrawn by subject|0|||
160635961|NCT01220128|580049421|FG005|Overall Study|Consent withdrawn by subject|0|||
160635962|NCT01220128|580049422|FG006|Overall Study|Consent withdrawn by subject|0|||
160635963|NCT02913261|580049423|FG000|Overall Study|Technical problems|0|||
160635964|NCT02913261|580049424|FG001|Overall Study|Technical problems|1|||
160635965|NCT02913261|580049423|FG000|Overall Study|Lack of Efficacy|32|||
160635966|NCT02913261|580049424|FG001|Overall Study|Lack of Efficacy|69|||
160635967|NCT02913261|580049423|FG000|Overall Study|Adverse Event|27|||
160635968|NCT02913261|580049424|FG001|Overall Study|Adverse Event|5|||
160635969|NCT02913261|580049423|FG000|Overall Study|Death|25|||
160635970|NCT02913261|580049424|FG001|Overall Study|Death|22|||
160635971|NCT02913261|580049423|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
160635972|NCT02913261|580049424|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
160635973|NCT02913261|580049423|FG000|Overall Study|Disease relapse|8|||
160635974|NCT02913261|580049424|FG001|Overall Study|Disease relapse|13|||
160635975|NCT02913261|580049423|FG000|Overall Study|Physician Decision|8|||
160635976|NCT02913261|580049424|FG001|Overall Study|Physician Decision|9|||
160635977|NCT02913261|580049423|FG000|Overall Study|Subject/guardian decision|4|||
160635978|NCT02913261|580049424|FG001|Overall Study|Subject/guardian decision|6|||
160635979|NCT02913261|580049423|FG000|Overall Study|Graft loss|2|||
160635980|NCT02913261|580049424|FG001|Overall Study|Graft loss|0|||
160635981|NCT02304302|580049425|FG000|Overall Study|Adverse Event|2|||
160635982|NCT02304302|580049426|FG001|Overall Study|Adverse Event|3|||
160635983|NCT02304302|580049425|FG000|Overall Study|Lost to Follow-up|1|||
160635984|NCT02304302|580049426|FG001|Overall Study|Lost to Follow-up|4|||
160635985|NCT02304302|580049425|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
160635986|NCT02304302|580049426|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
160635987|NCT00391118|580049427|FG000|Overall Study|Adverse Event|3|||
160635988|NCT00391118|580049428|FG001|Overall Study|Adverse Event|10|||
160635989|NCT00391118|580049429|FG002|Overall Study|Adverse Event|7|||
160635990|NCT00391118|580049427|FG000|Overall Study|Lost to Follow-up|0|||
160524532|NCT01323634|579650078|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
160524533|NCT01323634|579650079|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
160524534|NCT01323634|579650077|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
160524535|NCT01323634|579650078|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
160524536|NCT01323634|579650079|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
160524537|NCT01323634|579650077|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
160524538|NCT01323634|579650078|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
160524539|NCT01323634|579650079|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
160524540|NCT01323634|579650077|FG000|2-week Run-in Period|Physician Decision|5|||
160524541|NCT01323634|579650078|FG001|2-week Run-in Period|Physician Decision|0|||
160524542|NCT01323634|579650079|FG002|2-week Run-in Period|Physician Decision|0|||
160524543|NCT01323634|579650077|FG000|2-week Run-in Period|Protocol Violation|1|||
160524544|NCT01323634|579650078|FG001|2-week Run-in Period|Protocol Violation|0|||
160524545|NCT01323634|579650079|FG002|2-week Run-in Period|Protocol Violation|0|||
160524546|NCT01323634|579650077|FG000|2-week Run-in Period|Adverse Event|1|||
160524547|NCT01323634|579650078|FG001|2-week Run-in Period|Adverse Event|0|||
160524548|NCT01323634|579650079|FG002|2-week Run-in Period|Adverse Event|0|||
160524549|NCT01323634|579650077|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160524550|NCT01323634|579650078|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
160524551|NCT01323634|579650079|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
160524552|NCT01323634|579650077|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160524553|NCT01323634|579650078|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160524554|NCT01323634|579650079|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
160524555|NCT01323634|579650077|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160524556|NCT01323634|579650078|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
160524557|NCT01323634|579650079|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
160524558|NCT01323634|579650077|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160524559|NCT01323634|579650078|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
160524560|NCT01323634|579650079|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
160524561|NCT01323634|579650077|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
160524562|NCT01323634|579650078|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
160524563|NCT01323634|579650079|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
160524564|NCT01323634|579650077|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160524565|NCT01323634|579650078|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
160524566|NCT01323634|579650079|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
160524567|NCT01323634|579650077|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
160524568|NCT01323634|579650078|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
160524569|NCT01323634|579650079|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
160524570|NCT01575028|579650080|FG000|Overall Study|Physician Decision|0|||
160524571|NCT01575028|579650081|FG001|Overall Study|Physician Decision|1|||
160524572|NCT01759407|579650084|FG000|Overall Study|Protocol Violation|0|||
160524573|NCT01759407|579650085|FG001|Overall Study|Protocol Violation|2|||
160524574|NCT02520284|579650086|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
160524575|NCT02520284|579650087|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
160524576|NCT02520284|579650088|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
160524577|NCT02520284|579650086|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
160524578|NCT02520284|579650087|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
160524579|NCT02520284|579650088|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
160524580|NCT02520284|579650086|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
160524581|NCT02520284|579650087|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
160524582|NCT02520284|579650088|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
160524583|NCT02520284|579650086|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
160524584|NCT02520284|579650087|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
160524585|NCT02520284|579650088|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
160524586|NCT02520284|579650086|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
160524587|NCT02520284|579650087|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
160524588|NCT02520284|579650088|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
160524589|NCT02520284|579650086|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
160635991|NCT00391118|580049428|FG001|Overall Study|Lost to Follow-up|2|||
160752811|NCT01000974|580482429|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
160752812|NCT01000974|580482430|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
160752813|NCT01000974|580482431|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
160752814|NCT01000974|580482429|FG000|Primary Vaccination Phase|Protocol Violation|40|||
160752815|NCT01000974|580482430|FG001|Primary Vaccination Phase|Protocol Violation|3|||
160752816|NCT01000974|580482431|FG002|Primary Vaccination Phase|Protocol Violation|2|||
160752817|NCT01000974|580482429|FG000|Primary Vaccination Phase|Adverse Event|14|||
160752818|NCT01000974|580482430|FG001|Primary Vaccination Phase|Adverse Event|2|||
160752819|NCT01000974|580482431|FG002|Primary Vaccination Phase|Adverse Event|2|||
160752820|NCT01000974|580482429|FG000|Primary Vaccination Phase|Other|4|||
160752821|NCT01000974|580482430|FG001|Primary Vaccination Phase|Other|9|||
160752822|NCT01000974|580482431|FG002|Primary Vaccination Phase|Other|12|||
160752823|NCT01000974|580482429|FG000|Booster Vaccination Phase|Protocol Violation|0|||
160752824|NCT01000974|580482430|FG001|Booster Vaccination Phase|Protocol Violation|0|||
160752825|NCT01000974|580482431|FG002|Booster Vaccination Phase|Protocol Violation|2|||
160752826|NCT01000974|580482429|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
160752827|NCT01000974|580482430|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
160752828|NCT01000974|580482431|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
160752829|NCT01000974|580482429|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
160752830|NCT01000974|580482430|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
160752831|NCT01000974|580482431|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
160752832|NCT01000974|580482429|FG000|Booster Vaccination Phase|Other|24|||
160752833|NCT01000974|580482430|FG001|Booster Vaccination Phase|Other|6|||
160752834|NCT01000974|580482431|FG002|Booster Vaccination Phase|Other|4|||
160752835|NCT02171429|580482433|FG000|Overall Study|Other|0|||
160752836|NCT02171429|580482434|FG001|Overall Study|Other|1|||
160752837|NCT02171429|580482435|FG002|Overall Study|Other|1|||
160752838|NCT02171429|580482433|FG000|Overall Study|Non-Compliance|0|||
160752839|NCT02171429|580482434|FG001|Overall Study|Non-Compliance|0|||
160752840|NCT02171429|580482435|FG002|Overall Study|Non-Compliance|1|||
160752841|NCT02171429|580482433|FG000|Overall Study|Physician Decision|0|||
160752842|NCT02171429|580482434|FG001|Overall Study|Physician Decision|0|||
160752843|NCT02171429|580482435|FG002|Overall Study|Physician Decision|1|||
160752844|NCT02171429|580482433|FG000|Overall Study|Withdrawal by Subject|1|||
160752845|NCT02171429|580482434|FG001|Overall Study|Withdrawal by Subject|1|||
160752846|NCT02171429|580482435|FG002|Overall Study|Withdrawal by Subject|1|||
160752847|NCT02171429|580482433|FG000|Overall Study|Lost to Follow-up|0|||
160752848|NCT02171429|580482434|FG001|Overall Study|Lost to Follow-up|1|||
160752849|NCT02171429|580482435|FG002|Overall Study|Lost to Follow-up|0|||
160752850|NCT02171429|580482433|FG000|Overall Study|Death|0|||
160752851|NCT02171429|580482434|FG001|Overall Study|Death|0|||
160752852|NCT02171429|580482435|FG002|Overall Study|Death|1|||
160752853|NCT00493012|580482436|FG000|Overall Study|Lost to Follow-up|18|||
160752854|NCT00493012|580482437|FG001|Overall Study|Lost to Follow-up|17|||
160752855|NCT01724177|580482438|FG000|Overall Study|Adverse Event|8|||
160752856|NCT01724177|580482438|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
160752857|NCT01724177|580482438|FG000|Overall Study|Nervous participant|1|||
160752858|NCT01724177|580482438|FG000|Overall Study|Serious Adverse Event Related|1|||
160752859|NCT00327340|580482443|FG000|Overall Study|Withdrawal by Subject|1|||
160752860|NCT00327340|580482444|FG001|Overall Study|Withdrawal by Subject|5|||
160752861|NCT00327340|580482443|FG000|Overall Study|Physician Decision|1|||
160752862|NCT00327340|580482444|FG001|Overall Study|Physician Decision|1|||
160752863|NCT00327340|580482443|FG000|Overall Study|Disease Progression|10|||
160752864|NCT00327340|580482444|FG001|Overall Study|Disease Progression|19|||
160752865|NCT00327340|580482443|FG000|Overall Study|Symptomatic Disease|0|||
160752866|NCT00327340|580482444|FG001|Overall Study|Symptomatic Disease|2|||
160752867|NCT00327340|580482443|FG000|Overall Study|Adverse Event|3|||
160752868|NCT00327340|580482444|FG001|Overall Study|Adverse Event|3|||
160752869|NCT04085601|580482447|FG000|Overall Study|Lost to Follow-up|1|||
160752870|NCT04085601|580482448|FG001|Overall Study|Lost to Follow-up|0|||
160752871|NCT04085601|580482447|FG000|Overall Study|Death|1|||
160752872|NCT04085601|580482448|FG001|Overall Study|Death|1|||
160752873|NCT00206427|580482449|FG000|Overall Study|Adverse Event|2|||
160752874|NCT03492437|580482450|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160752875|NCT03492437|580482451|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160752876|NCT03872843|580482453|FG000|Overall Study|Lost to Follow-up|5|||
160752877|NCT03872843|580482454|FG001|Overall Study|Lost to Follow-up|7|||
160752878|NCT00281697|580482455|FG000|Overall Study|> 60 days since last dose of study drug|4|||
160752879|NCT00281697|580482456|FG001|Overall Study|> 60 days since last dose of study drug|4|||
160752880|NCT00281697|580482455|FG000|Overall Study|Adverse Event|54|||
160752881|NCT00281697|580482456|FG001|Overall Study|Adverse Event|15|||
160752882|NCT00281697|580482455|FG000|Overall Study|Death|8|||
160752883|NCT00281697|580482456|FG001|Overall Study|Death|3|||
160752884|NCT00281697|580482455|FG000|Overall Study|Disease progression|279|||
160752885|NCT00281697|580482456|FG001|Overall Study|Disease progression|149|||
160752886|NCT00281697|580482455|FG000|Overall Study|Other|5|||
160752887|NCT00281697|580482456|FG001|Overall Study|Other|6|||
160752888|NCT00281697|580482455|FG000|Overall Study|Physician's decision to withdraw|15|||
160752889|NCT00281697|580482456|FG001|Overall Study|Physician's decision to withdraw|12|||
160752890|NCT00281697|580482455|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
160752891|NCT00281697|580482456|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
160752892|NCT00281697|580482455|FG000|Overall Study|Did not receive study drug|3|||
160752893|NCT00281697|580482456|FG001|Overall Study|Did not receive study drug|2|||
160752894|NCT03280056|580482459|FG000|Overall Study|Withdrawal by Subject|12|||
160752895|NCT03280056|580482460|FG001|Overall Study|Withdrawal by Subject|14|||
160752896|NCT03280056|580482459|FG000|Overall Study|Death|9|||
160752897|NCT03280056|580482460|FG001|Overall Study|Death|2|||
160752898|NCT03280056|580482459|FG000|Overall Study|Adverse Event|1|||
160752899|NCT03280056|580482460|FG001|Overall Study|Adverse Event|3|||
160752900|NCT03280056|580482459|FG000|Overall Study|Lost to Follow-up|1|||
160752901|NCT03280056|580482460|FG001|Overall Study|Lost to Follow-up|1|||
160752902|NCT03280056|580482459|FG000|Overall Study|Physician Decision|0|||
160752903|NCT03280056|580482460|FG001|Overall Study|Physician Decision|1|||
160752904|NCT03280056|580482459|FG000|Overall Study|Early Discontinuation|1|||
160752905|NCT03280056|580482460|FG001|Overall Study|Early Discontinuation|0|||
160752906|NCT01059773|580482461|FG000|Overall Study|Adverse Event|2|||
160752907|NCT01059773|580482462|FG001|Overall Study|Adverse Event|2|||
160752908|NCT01059773|580482461|FG000|Overall Study|Withdrawal by Subject|1|||
160752909|NCT01059773|580482462|FG001|Overall Study|Withdrawal by Subject|5|||
160752910|NCT01059773|580482461|FG000|Overall Study|Lost to Follow-up|1|||
160752911|NCT01059773|580482462|FG001|Overall Study|Lost to Follow-up|1|||
160752912|NCT01059773|580482461|FG000|Overall Study|Pregnancy|1|||
160752913|NCT01059773|580482462|FG001|Overall Study|Pregnancy|1|||
160752914|NCT01059773|580482461|FG000|Overall Study|Protocol Violation|6|||
160752915|NCT01059773|580482462|FG001|Overall Study|Protocol Violation|2|||
160752916|NCT01059773|580482461|FG000|Overall Study|Physician Decision|5|||
160752917|NCT01059773|580482462|FG001|Overall Study|Physician Decision|4|||
160752918|NCT01059773|580482461|FG000|Overall Study|Lack of Efficacy|3|||
160752919|NCT01059773|580482462|FG001|Overall Study|Lack of Efficacy|3|||
160752920|NCT01059773|580482461|FG000|Overall Study|Death|0|||
160752921|NCT01059773|580482462|FG001|Overall Study|Death|1|||
160752922|NCT01059773|580482461|FG000|Overall Study|Malignancy including squamous cell skin|0|||
160752923|NCT01059773|580482462|FG001|Overall Study|Malignancy including squamous cell skin|1|||
160752924|NCT01059773|580482461|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
160752925|NCT01059773|580482462|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
160752926|NCT01059773|580482461|FG000|Overall Study|Other|1|||
160752927|NCT01059773|580482462|FG001|Overall Study|Other|3|||
160752928|NCT01468454|580482463|FG000|Overall Study|Did not have surgery after PET|9|||
160752929|NCT02620787|580482464|FG000|Overall Study|Adverse Event|1|||
160752930|NCT02620787|580482465|FG001|Overall Study|Adverse Event|0|||
160752931|NCT02620787|580482464|FG000|Overall Study|Eligibility Criteria Not Met|1|||
160752932|NCT02620787|580482465|FG001|Overall Study|Eligibility Criteria Not Met|0|||
160752933|NCT03060291|580482466|FG000|3-month Follow-up|Declined to respond|8|||
160752934|NCT03060291|580482467|FG001|3-month Follow-up|Declined to respond|10|||
160752935|NCT03060291|580482468|FG002|3-month Follow-up|Declined to respond|2|||
160524590|NCT02520284|579650087|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
160752936|NCT03060291|580482466|FG000|6-month Follow-up|Declined to respond|7|||
160752937|NCT03060291|580482467|FG001|6-month Follow-up|Declined to respond|13|||
160752938|NCT03060291|580482468|FG002|6-month Follow-up|Declined to respond|4|||
160752939|NCT03060291|580482466|FG000|12-month Follow-up|Declined to respond|7|||
160752940|NCT03060291|580482467|FG001|12-month Follow-up|Declined to respond|16|||
160752941|NCT03060291|580482468|FG002|12-month Follow-up|Declined to respond|6|||
160752942|NCT01509664|580482469|FG000|Overall Study|Lost to Follow-up|15|||
160752943|NCT01509664|580482470|FG001|Overall Study|Lost to Follow-up|21|||
160752944|NCT03665077|580482471|FG000|Overall Study|Lost to Follow-up|2|||
160752945|NCT03665077|580482471|FG000|Overall Study|Physician Decision|2|||
160752946|NCT02959918|580482472|FG000|Overall Study|Adverse Event|1|||
160752947|NCT02959918|580482473|FG001|Overall Study|Adverse Event|1|||
160752948|NCT02959918|580482474|FG002|Overall Study|Adverse Event|2|||
160752949|NCT02959918|580482475|FG003|Overall Study|Adverse Event|0|||
160752950|NCT02959918|580482476|FG004|Overall Study|Adverse Event|0|||
160752951|NCT02959918|580482477|FG005|Overall Study|Adverse Event|2|||
160752952|NCT02959918|580482478|FG006|Overall Study|Adverse Event|2|||
160752953|NCT02959918|580482479|FG007|Overall Study|Adverse Event|1|||
160752954|NCT02959918|580482480|FG008|Overall Study|Adverse Event|2|||
160752955|NCT02959918|580482481|FG009|Overall Study|Adverse Event|1|||
160752956|NCT02959918|580482482|FG010|Overall Study|Adverse Event|1|||
160752957|NCT02959918|580482483|FG011|Overall Study|Adverse Event|3|||
160752958|NCT02959918|580482484|FG012|Overall Study|Adverse Event|2|||
160752959|NCT02959918|580482485|FG013|Overall Study|Adverse Event|4|||
160752960|NCT02959918|580482472|FG000|Overall Study|Lost to Follow-up|0|||
160752961|NCT02959918|580482473|FG001|Overall Study|Lost to Follow-up|0|||
160752962|NCT02959918|580482474|FG002|Overall Study|Lost to Follow-up|0|||
160752963|NCT02959918|580482475|FG003|Overall Study|Lost to Follow-up|0|||
160752964|NCT02959918|580482476|FG004|Overall Study|Lost to Follow-up|0|||
160752965|NCT02959918|580482477|FG005|Overall Study|Lost to Follow-up|0|||
160752966|NCT02959918|580482478|FG006|Overall Study|Lost to Follow-up|0|||
160752967|NCT02959918|580482479|FG007|Overall Study|Lost to Follow-up|0|||
160752968|NCT02959918|580482480|FG008|Overall Study|Lost to Follow-up|0|||
160752969|NCT02959918|580482481|FG009|Overall Study|Lost to Follow-up|1|||
160752970|NCT02959918|580482482|FG010|Overall Study|Lost to Follow-up|0|||
160752971|NCT02959918|580482483|FG011|Overall Study|Lost to Follow-up|0|||
160752972|NCT02959918|580482484|FG012|Overall Study|Lost to Follow-up|1|||
160752973|NCT02959918|580482485|FG013|Overall Study|Lost to Follow-up|0|||
160752974|NCT02959918|580482472|FG000|Overall Study|Withdrawal by Subject|0|||
160752975|NCT02959918|580482473|FG001|Overall Study|Withdrawal by Subject|0|||
160752976|NCT02959918|580482474|FG002|Overall Study|Withdrawal by Subject|1|||
160752977|NCT02959918|580482475|FG003|Overall Study|Withdrawal by Subject|2|||
160752978|NCT02959918|580482476|FG004|Overall Study|Withdrawal by Subject|0|||
160752979|NCT02959918|580482477|FG005|Overall Study|Withdrawal by Subject|0|||
160752980|NCT02959918|580482478|FG006|Overall Study|Withdrawal by Subject|1|||
160752981|NCT02959918|580482479|FG007|Overall Study|Withdrawal by Subject|0|||
160752982|NCT02959918|580482480|FG008|Overall Study|Withdrawal by Subject|1|||
160752983|NCT02959918|580482481|FG009|Overall Study|Withdrawal by Subject|1|||
160752984|NCT02959918|580482482|FG010|Overall Study|Withdrawal by Subject|2|||
160752985|NCT02959918|580482483|FG011|Overall Study|Withdrawal by Subject|3|||
160752986|NCT02959918|580482484|FG012|Overall Study|Withdrawal by Subject|1|||
160752987|NCT02959918|580482485|FG013|Overall Study|Withdrawal by Subject|1|||
160752988|NCT02959918|580482472|FG000|Overall Study|Protocol Violation|0|||
160752989|NCT02959918|580482473|FG001|Overall Study|Protocol Violation|0|||
160752990|NCT02959918|580482474|FG002|Overall Study|Protocol Violation|1|||
160752991|NCT02959918|580482475|FG003|Overall Study|Protocol Violation|0|||
160752992|NCT02959918|580482476|FG004|Overall Study|Protocol Violation|0|||
160752993|NCT02959918|580482477|FG005|Overall Study|Protocol Violation|1|||
160752994|NCT02959918|580482478|FG006|Overall Study|Protocol Violation|0|||
160752995|NCT02959918|580482479|FG007|Overall Study|Protocol Violation|0|||
160752996|NCT02959918|580482480|FG008|Overall Study|Protocol Violation|2|||
160752997|NCT02959918|580482481|FG009|Overall Study|Protocol Violation|1|||
160752998|NCT02959918|580482482|FG010|Overall Study|Protocol Violation|0|||
160752999|NCT02959918|580482483|FG011|Overall Study|Protocol Violation|1|||
160753000|NCT02959918|580482484|FG012|Overall Study|Protocol Violation|1|||
160753001|NCT02959918|580482485|FG013|Overall Study|Protocol Violation|0|||
160753002|NCT02959918|580482472|FG000|Overall Study|Stopping Rule Met|1|||
160753003|NCT02959918|580482473|FG001|Overall Study|Stopping Rule Met|0|||
160753004|NCT02959918|580482474|FG002|Overall Study|Stopping Rule Met|3|||
160753005|NCT02959918|580482475|FG003|Overall Study|Stopping Rule Met|4|||
160753006|NCT02959918|580482476|FG004|Overall Study|Stopping Rule Met|5|||
160753007|NCT02959918|580482477|FG005|Overall Study|Stopping Rule Met|3|||
160753008|NCT02959918|580482478|FG006|Overall Study|Stopping Rule Met|2|||
160753009|NCT02959918|580482479|FG007|Overall Study|Stopping Rule Met|4|||
160753010|NCT02959918|580482480|FG008|Overall Study|Stopping Rule Met|1|||
160753011|NCT02959918|580482481|FG009|Overall Study|Stopping Rule Met|1|||
160753012|NCT02959918|580482482|FG010|Overall Study|Stopping Rule Met|3|||
160753013|NCT02959918|580482483|FG011|Overall Study|Stopping Rule Met|5|||
160753014|NCT02959918|580482484|FG012|Overall Study|Stopping Rule Met|2|||
160753015|NCT02959918|580482485|FG013|Overall Study|Stopping Rule Met|1|||
160753016|NCT02959918|580482472|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
160753017|NCT02959918|580482473|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
160753018|NCT02959918|580482474|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
160753019|NCT02959918|580482475|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
160753020|NCT02959918|580482476|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
160753021|NCT02959918|580482477|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
160753022|NCT02959918|580482478|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
160753023|NCT02959918|580482479|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
160753024|NCT02959918|580482480|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
160753025|NCT02959918|580482481|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
160753026|NCT02959918|580482482|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
160753027|NCT02959918|580482483|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
160753028|NCT02959918|580482484|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
160753029|NCT02959918|580482485|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
160753030|NCT02959918|580482472|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753031|NCT02959918|580482473|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753032|NCT02959918|580482474|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753033|NCT02959918|580482475|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753034|NCT02959918|580482476|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753035|NCT02959918|580482477|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753036|NCT02959918|580482478|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753037|NCT02959918|580482479|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
160753038|NCT02959918|580482480|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753039|NCT02959918|580482481|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753040|NCT02959918|580482482|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753041|NCT02959918|580482483|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753042|NCT02959918|580482484|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753043|NCT02959918|580482485|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
160753044|NCT02959918|580482472|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753045|NCT02959918|580482473|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753046|NCT02959918|580482474|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753047|NCT02959918|580482475|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753048|NCT02959918|580482476|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753049|NCT02959918|580482477|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753050|NCT02959918|580482478|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753051|NCT02959918|580482479|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753052|NCT02959918|580482480|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
160753053|NCT02959918|580482481|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753054|NCT02959918|580482482|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753055|NCT02959918|580482483|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753056|NCT02959918|580482484|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160753057|NCT02959918|580482485|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
160861857|NCT02531802|580887853|FG008|Received Vaccination 2|Adverse Event|0|||
160753058|NCT02959918|580482472|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753059|NCT02959918|580482473|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753060|NCT02959918|580482474|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753061|NCT02959918|580482475|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753062|NCT02959918|580482476|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753063|NCT02959918|580482477|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753064|NCT02959918|580482478|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753065|NCT02959918|580482479|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753066|NCT02959918|580482480|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753067|NCT02959918|580482481|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
160753068|NCT02959918|580482482|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753069|NCT02959918|580482483|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753070|NCT02959918|580482484|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753071|NCT02959918|580482485|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
160753072|NCT02504320|580482486|FG000|Treatment Period 1|Positive Drug Screen|0|||
160753073|NCT02504320|580482487|FG001|Treatment Period 1|Positive Drug Screen|0|||
160753074|NCT02504320|580482488|FG002|Treatment Period 1|Positive Drug Screen|1|||
160753075|NCT02504320|580482489|FG003|Treatment Period 1|Positive Drug Screen|0|||
160753076|NCT02504320|580482486|FG000|Treatment Period 2|Positive Drug Screen|0|||
160753077|NCT02504320|580482487|FG001|Treatment Period 2|Positive Drug Screen|1|||
160753078|NCT02504320|580482488|FG002|Treatment Period 2|Positive Drug Screen|0|||
160753079|NCT02504320|580482489|FG003|Treatment Period 2|Positive Drug Screen|0|||
160753080|NCT02504320|580482486|FG000|Treatment Period 3|Positive Drug Screen|0|||
160753081|NCT02504320|580482487|FG001|Treatment Period 3|Positive Drug Screen|0|||
160753082|NCT02504320|580482488|FG002|Treatment Period 3|Positive Drug Screen|0|||
160753083|NCT02504320|580482489|FG003|Treatment Period 3|Positive Drug Screen|1|||
160753084|NCT02504320|580482486|FG000|Treatment Period 3|Adverse Event|0|||
160753085|NCT02504320|580482487|FG001|Treatment Period 3|Adverse Event|0|||
160753086|NCT02504320|580482488|FG002|Treatment Period 3|Adverse Event|1|||
160753087|NCT02504320|580482489|FG003|Treatment Period 3|Adverse Event|0|||
160753088|NCT03293394|580482490|FG000|Follow-up (6 Months)|Adverse Event|4|||
160753089|NCT03293394|580482491|FG001|Follow-up (6 Months)|Adverse Event|2|||
160753090|NCT02497404|580482492|FG000|Overall Study|Adverse Event|1|||
160753091|NCT01408901|580482493|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
160753092|NCT01408901|580482494|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
160753093|NCT01408901|580482495|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
160753094|NCT01408901|580482496|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
160753095|NCT01408901|580482493|FG000|6-Week Follow-Up|Death|1|||
160753096|NCT01408901|580482494|FG001|6-Week Follow-Up|Death|0|||
160753097|NCT01408901|580482495|FG002|6-Week Follow-Up|Death|0|||
160753098|NCT01408901|580482496|FG003|6-Week Follow-Up|Death|0|||
160753099|NCT01408901|580482493|FG000|6-Week Follow-Up|Cancelled visit|0|||
160753100|NCT01408901|580482494|FG001|6-Week Follow-Up|Cancelled visit|1|||
160753101|NCT01408901|580482495|FG002|6-Week Follow-Up|Cancelled visit|0|||
160753102|NCT01408901|580482496|FG003|6-Week Follow-Up|Cancelled visit|2|||
160753103|NCT01408901|580482493|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
160753104|NCT01408901|580482494|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
160753105|NCT01408901|580482495|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
160753106|NCT01408901|580482496|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
160753107|NCT01408901|580482493|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
160753108|NCT01408901|580482494|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
160753109|NCT01408901|580482495|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
160753110|NCT01408901|580482496|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
160753111|NCT01408901|580482493|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
160753112|NCT01408901|580482494|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
160753113|NCT01408901|580482495|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
160753114|NCT01408901|580482496|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
160753115|NCT01408901|580482493|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
160753116|NCT01408901|580482494|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
160753117|NCT01408901|580482495|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
160753118|NCT01408901|580482496|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
160753119|NCT01408901|580482493|FG000|26-Week Follow-Up|Death|0|||
160753120|NCT01408901|580482494|FG001|26-Week Follow-Up|Death|1|||
160753121|NCT01408901|580482495|FG002|26-Week Follow-Up|Death|0|||
160753122|NCT01408901|580482496|FG003|26-Week Follow-Up|Death|0|||
160753123|NCT00110357|580482500|FG000|Overall Study|Deterioration without progression|2|||
160753124|NCT00110357|580482501|FG001|Overall Study|Deterioration without progression|0|||
160753125|NCT00110357|580482500|FG000|Overall Study|Disease progression/relapse|20|||
160753126|NCT00110357|580482501|FG001|Overall Study|Disease progression/relapse|15|||
160753127|NCT00110357|580482500|FG000|Overall Study|Study Closure|1|||
160753128|NCT00110357|580482501|FG001|Overall Study|Study Closure|0|||
160753129|NCT00110357|580482500|FG000|Overall Study|Study Drug Toxicity|1|||
160753130|NCT00110357|580482501|FG001|Overall Study|Study Drug Toxicity|3|||
160753131|NCT00110357|580482500|FG000|Overall Study|Withdrawal by Subject|3|||
160753132|NCT00110357|580482501|FG001|Overall Study|Withdrawal by Subject|1|||
160753133|NCT05285787|580482502|FG000|Overall Study|Withdrawal by Subject|1|||
160753134|NCT04004260|580482506|FG000|Overall Study|Withdrawal by Subject|7|||
160753135|NCT04004260|580482507|FG001|Overall Study|Withdrawal by Subject|3|||
160753136|NCT04004260|580482506|FG000|Overall Study|Lost to Follow-up|22|||
160753137|NCT04004260|580482507|FG001|Overall Study|Lost to Follow-up|12|||
160753138|NCT04004260|580482506|FG000|Overall Study|Did not engage in intervention|13|||
160753139|NCT04004260|580482507|FG001|Overall Study|Did not engage in intervention|17|||
160753140|NCT02360280|580482511|FG000|Overall Study|Withdrawal by Subject|2|||
160753141|NCT02360280|580482512|FG001|Overall Study|Withdrawal by Subject|0|||
160753142|NCT02360280|580482511|FG000|Overall Study|Adverse Event|0|||
160753143|NCT02360280|580482512|FG001|Overall Study|Adverse Event|1|||
160753144|NCT02360280|580482511|FG000|Overall Study|Lost to Follow-up|1|||
160753145|NCT02360280|580482512|FG001|Overall Study|Lost to Follow-up|0|||
160753146|NCT00320788|580482513|FG000|Overall Study|Adverse Event|0|||
160753147|NCT00320788|580482514|FG001|Overall Study|Adverse Event|0|||
160753148|NCT00320788|580482515|FG002|Overall Study|Adverse Event|0|||
160753149|NCT00320788|580482516|FG003|Overall Study|Adverse Event|1|||
160753150|NCT00320788|580482517|FG004|Overall Study|Adverse Event|0|||
160753151|NCT00320788|580482513|FG000|Overall Study|Death|0|||
160753152|NCT00320788|580482514|FG001|Overall Study|Death|0|||
160753153|NCT00320788|580482515|FG002|Overall Study|Death|1|||
160753154|NCT00320788|580482516|FG003|Overall Study|Death|0|||
160753155|NCT00320788|580482517|FG004|Overall Study|Death|1|||
160753156|NCT00320788|580482513|FG000|Overall Study|Lost to Follow-up|0|||
160753157|NCT00320788|580482514|FG001|Overall Study|Lost to Follow-up|2|||
160753158|NCT00320788|580482515|FG002|Overall Study|Lost to Follow-up|1|||
160753159|NCT00320788|580482516|FG003|Overall Study|Lost to Follow-up|0|||
160753160|NCT00320788|580482517|FG004|Overall Study|Lost to Follow-up|0|||
160753161|NCT00320788|580482513|FG000|Overall Study|Decision by the Sponsor|1|||
160753162|NCT00320788|580482514|FG001|Overall Study|Decision by the Sponsor|1|||
160753163|NCT00320788|580482515|FG002|Overall Study|Decision by the Sponsor|0|||
160753164|NCT00320788|580482516|FG003|Overall Study|Decision by the Sponsor|0|||
160753165|NCT00320788|580482517|FG004|Overall Study|Decision by the Sponsor|1|||
160753166|NCT00320788|580482513|FG000|Overall Study|Other|1|||
160753167|NCT00320788|580482514|FG001|Overall Study|Other|2|||
160753168|NCT00320788|580482515|FG002|Overall Study|Other|1|||
160753169|NCT00320788|580482516|FG003|Overall Study|Other|1|||
160753170|NCT00320788|580482517|FG004|Overall Study|Other|1|||
160753171|NCT00320788|580482513|FG000|Overall Study|Physician Decision|1|||
160753172|NCT00320788|580482514|FG001|Overall Study|Physician Decision|1|||
160753173|NCT00320788|580482515|FG002|Overall Study|Physician Decision|0|||
160753174|NCT00320788|580482516|FG003|Overall Study|Physician Decision|0|||
160753175|NCT00320788|580482517|FG004|Overall Study|Physician Decision|0|||
160753176|NCT00320788|580482513|FG000|Overall Study|Protocol Violation|0|||
160753177|NCT00320788|580482514|FG001|Overall Study|Protocol Violation|0|||
160753178|NCT00320788|580482515|FG002|Overall Study|Protocol Violation|0|||
160753179|NCT00320788|580482516|FG003|Overall Study|Protocol Violation|0|||
160753180|NCT00320788|580482517|FG004|Overall Study|Protocol Violation|1|||
160753181|NCT00320788|580482513|FG000|Overall Study|Withdrawal by Subject|3|||
160753182|NCT00320788|580482514|FG001|Overall Study|Withdrawal by Subject|0|||
160753183|NCT00320788|580482515|FG002|Overall Study|Withdrawal by Subject|0|||
160753184|NCT00320788|580482516|FG003|Overall Study|Withdrawal by Subject|3|||
160753185|NCT00320788|580482517|FG004|Overall Study|Withdrawal by Subject|1|||
160753186|NCT04633226|580482518|FG000|Overall Study|Withdrawal by parent/guardian|4|||
160753187|NCT04633226|580482518|FG000|Overall Study|Randomized by mistake without study treatment|1|||
160753188|NCT01398358|580482532|FG000|Overall Study|Lost to Follow-up|11|||
160753189|NCT01398358|580482533|FG001|Overall Study|Lost to Follow-up|21|||
160753190|NCT01398358|580482534|FG002|Overall Study|Lost to Follow-up|18|||
160753191|NCT01398358|580482532|FG000|Overall Study|Withdrawal by Subject|3|||
160753192|NCT01398358|580482533|FG001|Overall Study|Withdrawal by Subject|2|||
160753193|NCT01398358|580482534|FG002|Overall Study|Withdrawal by Subject|2|||
160753194|NCT01398358|580482532|FG000|Overall Study|no longer eligible|1|||
160753195|NCT01398358|580482533|FG001|Overall Study|no longer eligible|0|||
160753196|NCT01398358|580482534|FG002|Overall Study|no longer eligible|1|||
160753197|NCT00003896|580482537|FG000|Overall Study|Adverse Event|16|||
160753198|NCT00003896|580482537|FG000|Overall Study|Withdrawal by Subject|1|||
160753199|NCT00003896|580482537|FG000|Overall Study|Lack of Efficacy|1|||
160753200|NCT00003896|580482537|FG000|Overall Study|Death|3|||
160753201|NCT00003896|580482537|FG000|Overall Study|not protocol specified|3|||
160753202|NCT00003896|580482537|FG000|Overall Study|ineligible|5|||
160753203|NCT02559570|580482540|FG000|Overall Study|Adverse Event|0|||
160753204|NCT02559570|580482541|FG001|Overall Study|Adverse Event|2|||
160753205|NCT02559570|580482542|FG002|Overall Study|Adverse Event|0|||
160753206|NCT02559570|580482543|FG003|Overall Study|Adverse Event|1|||
160753207|NCT02559570|580482544|FG004|Overall Study|Adverse Event|0|||
160753208|NCT02559570|580482540|FG000|Overall Study|Withdrawal of Consent|0|||
160753209|NCT02559570|580482541|FG001|Overall Study|Withdrawal of Consent|0|||
160753210|NCT02559570|580482542|FG002|Overall Study|Withdrawal of Consent|1|||
160753211|NCT02559570|580482543|FG003|Overall Study|Withdrawal of Consent|2|||
160753212|NCT02559570|580482544|FG004|Overall Study|Withdrawal of Consent|1|||
160753213|NCT02559570|580482540|FG000|Overall Study|Lost to Follow-up|1|||
160753214|NCT02559570|580482541|FG001|Overall Study|Lost to Follow-up|0|||
160753215|NCT02559570|580482542|FG002|Overall Study|Lost to Follow-up|0|||
160753216|NCT02559570|580482543|FG003|Overall Study|Lost to Follow-up|0|||
160753217|NCT02559570|580482544|FG004|Overall Study|Lost to Follow-up|0|||
160753218|NCT02559570|580482540|FG000|Overall Study|Protocol Violation|1|||
160753219|NCT02559570|580482541|FG001|Overall Study|Protocol Violation|0|||
160753220|NCT02559570|580482542|FG002|Overall Study|Protocol Violation|0|||
160753221|NCT02559570|580482543|FG003|Overall Study|Protocol Violation|0|||
160753222|NCT02559570|580482544|FG004|Overall Study|Protocol Violation|1|||
160753223|NCT02559570|580482540|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160753224|NCT02559570|580482541|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160753225|NCT02559570|580482542|FG002|Overall Study|Other Miscellaneous Reasons|1|||
160753226|NCT02559570|580482543|FG003|Overall Study|Other Miscellaneous Reasons|0|||
160753227|NCT02559570|580482544|FG004|Overall Study|Other Miscellaneous Reasons|0|||
160753228|NCT00184093|580482550|FG000|Overall Study|Adverse Event|3|||
160753229|NCT00184093|580482550|FG000|Overall Study|Lost to Follow-up|3|||
160753230|NCT00184093|580482550|FG000|Overall Study|Physician Decision|1|||
160753231|NCT00184093|580482550|FG000|Overall Study|Withdrawal by Subject|2|||
160753232|NCT01903993|580482553|FG000|Overall Study|Death|118|||
160753233|NCT01903993|580482554|FG001|Overall Study|Death|121|||
160753234|NCT01903993|580482553|FG000|Overall Study|Withdrawal by Subject|15|||
160753235|NCT01903993|580482554|FG001|Overall Study|Withdrawal by Subject|4|||
160753236|NCT01903993|580482553|FG000|Overall Study|Lost to Follow-up|2|||
160753237|NCT01903993|580482554|FG001|Overall Study|Lost to Follow-up|3|||
160753238|NCT01903993|580482553|FG000|Overall Study|Study Terminated by Sponsor|8|||
160753239|NCT01903993|580482554|FG001|Overall Study|Study Terminated by Sponsor|14|||
160753240|NCT01903993|580482553|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
160753241|NCT01903993|580482554|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
160753242|NCT03283930|580482556|FG000|Overall Study|Scheduling conflict|8|||
160753243|NCT03283930|580482557|FG001|Overall Study|Scheduling conflict|10|||
160753244|NCT03283930|580482556|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
160753245|NCT03283930|580482557|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
160753246|NCT03283930|580482556|FG000|Overall Study|Technical software issue|2|||
160753247|NCT03283930|580482557|FG001|Overall Study|Technical software issue|2|||
160753248|NCT02588664|580482560|FG000|Overall Study|Death|56|||
160753249|NCT02588664|580482561|FG001|Overall Study|Death|55|||
160753250|NCT02588664|580482560|FG000|Overall Study|Lost to Follow-up|1305|||
160753251|NCT02588664|580482561|FG001|Overall Study|Lost to Follow-up|990|||
160753252|NCT03681184|580482562|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
160753253|NCT03681184|580482563|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
160753254|NCT02500719|580482566|FG000|Overall Study|Lost to Follow-up|2|||
160753255|NCT02500719|580482567|FG001|Overall Study|Lost to Follow-up|3|||
160753256|NCT02500719|580482566|FG000|Overall Study|Trauma history|1|||
160753257|NCT02500719|580482567|FG001|Overall Study|Trauma history|0|||
160753258|NCT02500719|580482566|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
160753259|NCT02500719|580482567|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
160753260|NCT02500719|580482566|FG000|Overall Study|Did not meet criteria for PTSD|0|||
160753261|NCT02500719|580482567|FG001|Overall Study|Did not meet criteria for PTSD|1|||
160753262|NCT02500719|580482566|FG000|Overall Study|Claustrophobia|0|||
160753263|NCT02500719|580482567|FG001|Overall Study|Claustrophobia|1|||
160753264|NCT02500719|580482566|FG000|Overall Study|History of head trauma|0|||
160753265|NCT02500719|580482567|FG001|Overall Study|History of head trauma|1|||
160524591|NCT02520284|579650088|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
160753266|NCT02787083|580482568|FG000|Overall Study|Adverse Event|1|||
160753267|NCT02787083|580482569|FG001|Overall Study|Adverse Event|0|||
160753268|NCT02787083|580482568|FG000|Overall Study|Withdrawal by Subject|2|||
160753269|NCT02787083|580482569|FG001|Overall Study|Withdrawal by Subject|2|||
160753270|NCT02710084|580482570|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
160753271|NCT02710084|580482571|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
160753272|NCT00154375|580482572|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
160753273|NCT00154375|580482573|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
160753274|NCT00154375|580482572|FG000|Overall Study|Adverse Event|18|||
160753275|NCT00154375|580482573|FG001|Overall Study|Adverse Event|20|||
160753276|NCT00154375|580482572|FG000|Overall Study|Withdrawal by Subject|14|||
160753277|NCT00154375|580482573|FG001|Overall Study|Withdrawal by Subject|10|||
160753278|NCT00154375|580482572|FG000|Overall Study|Death|5|||
160753279|NCT00154375|580482573|FG001|Overall Study|Death|13|||
160753280|NCT00154375|580482572|FG000|Overall Study|Study drug no longer required|5|||
160753281|NCT00154375|580482573|FG001|Overall Study|Study drug no longer required|3|||
160753282|NCT00154375|580482572|FG000|Overall Study|Lost to Follow-up|2|||
160753283|NCT00154375|580482573|FG001|Overall Study|Lost to Follow-up|1|||
160753284|NCT00154375|580482572|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160753285|NCT00154375|580482573|FG001|Overall Study|Abnormal laboratory value(s)|2|||
160753286|NCT00154375|580482572|FG000|Overall Study|Protocol Violation|0|||
160753287|NCT00154375|580482573|FG001|Overall Study|Protocol Violation|1|||
160753288|NCT00154375|580482572|FG000|Overall Study|Suspected progression of disease|44|||
160753289|NCT00154375|580482573|FG001|Overall Study|Suspected progression of disease|30|||
160753290|NCT00792116|580482578|FG000|Overall Study|Lost to Follow-up|0|||
160753291|NCT00792116|580482579|FG001|Overall Study|Lost to Follow-up|1|||
160753292|NCT00792116|580482578|FG000|Overall Study|Discontnued intervention|1|||
160753293|NCT00792116|580482579|FG001|Overall Study|Discontnued intervention|0|||
160753294|NCT02453256|580482580|FG000|Double Blind Period|Death|1|||
160753295|NCT02453256|580482581|FG001|Double Blind Period|Death|1|||
160753296|NCT02453256|580482580|FG000|Double Blind Period|Adverse Event|3|||
160753297|NCT02453256|580482581|FG001|Double Blind Period|Adverse Event|2|||
160753298|NCT02453256|580482580|FG000|Double Blind Period|Withdrawal by Subject|9|||
160753299|NCT02453256|580482581|FG001|Double Blind Period|Withdrawal by Subject|5|||
160753300|NCT02453256|580482580|FG000|Double Blind Period|Other|0|||
160753301|NCT02453256|580482581|FG001|Double Blind Period|Other|1|||
160753302|NCT02453256|580482580|FG000|Open Label Period|Adverse Event|1|||
160753303|NCT02453256|580482581|FG001|Open Label Period|Adverse Event|3|||
160753304|NCT02453256|580482580|FG000|Open Label Period|Death|0|||
160753305|NCT02453256|580482581|FG001|Open Label Period|Death|1|||
160753306|NCT02453256|580482580|FG000|Open Label Period|Lost to Follow-up|1|||
160753307|NCT02453256|580482581|FG001|Open Label Period|Lost to Follow-up|0|||
160753308|NCT02453256|580482580|FG000|Open Label Period|Other|0|||
160753309|NCT02453256|580482581|FG001|Open Label Period|Other|2|||
160753310|NCT02453256|580482580|FG000|Open Label Period|Withdrawal by Subject|5|||
160753311|NCT02453256|580482581|FG001|Open Label Period|Withdrawal by Subject|1|||
160753312|NCT05259163|580484520|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
160753313|NCT05259163|580484521|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
160635992|NCT00391118|580049429|FG002|Overall Study|Lost to Follow-up|3|||
160753314|NCT05251233|580484522|FG000|Overall Study|Disease progression - did not start treatment|0|||
160753315|NCT05251233|580484523|FG001|Overall Study|Disease progression - did not start treatment|0|||
160753316|NCT05251233|580484524|FG002|Overall Study|Disease progression - did not start treatment|5|||
160753317|NCT05251233|580484522|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
160753318|NCT05251233|580484523|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
160753319|NCT05251233|580484524|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
160753320|NCT05251233|580484522|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
160753321|NCT05251233|580484523|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
160753322|NCT05251233|580484524|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
160753323|NCT05251233|580484522|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
160753324|NCT05251233|580484523|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
160753325|NCT05251233|580484524|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
160753326|NCT05251233|580484522|FG000|Overall Study|Death - did not start treatment|3|||
160753327|NCT05251233|580484523|FG001|Overall Study|Death - did not start treatment|0|||
160753328|NCT05251233|580484524|FG002|Overall Study|Death - did not start treatment|0|||
160753329|NCT05251233|580484522|FG000|Overall Study|Withdrawal by Subject|2|||
160753330|NCT05251233|580484523|FG001|Overall Study|Withdrawal by Subject|2|||
160753331|NCT05251233|580484524|FG002|Overall Study|Withdrawal by Subject|0|||
160753332|NCT05251233|580484522|FG000|Overall Study|Other complicating disease|2|||
160753333|NCT05251233|580484523|FG001|Overall Study|Other complicating disease|1|||
160753334|NCT05251233|580484524|FG002|Overall Study|Other complicating disease|0|||
160753335|NCT05251233|580484522|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
160753336|NCT05251233|580484523|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
160753337|NCT05251233|580484524|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
160753338|NCT05251233|580484522|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
160753339|NCT05251233|580484523|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
160753340|NCT05251233|580484524|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
160753341|NCT00452439|580484526|FG000|Overall Study|Lost to Follow-up|1|||
160753342|NCT00452439|580484527|FG001|Overall Study|Lost to Follow-up|1|||
160753343|NCT00452439|580484526|FG000|Overall Study|Refused Treatment|4|||
160753344|NCT00452439|580484527|FG001|Overall Study|Refused Treatment|3|||
160753345|NCT00452439|580484526|FG000|Overall Study|Death|3|||
160753346|NCT00452439|580484527|FG001|Overall Study|Death|1|||
160753347|NCT00452439|580484526|FG000|Overall Study|Bone Marrow Transplant|0|||
160753348|NCT00452439|580484527|FG001|Overall Study|Bone Marrow Transplant|1|||
160753349|NCT00452439|580484526|FG000|Overall Study|Too Ill to Continue|0|||
160753350|NCT00452439|580484527|FG001|Overall Study|Too Ill to Continue|1|||
160753351|NCT00452439|580484526|FG000|Overall Study|Failed to achieve complete response|2|||
160753352|NCT00452439|580484527|FG001|Overall Study|Failed to achieve complete response|0|||
160753353|NCT00452439|580484526|FG000|Overall Study|Relapse|3|||
160753354|NCT00452439|580484527|FG001|Overall Study|Relapse|0|||
160753355|NCT00452439|580484526|FG000|Overall Study|Fracture|1|||
160753356|NCT00452439|580484527|FG001|Overall Study|Fracture|0|||
160753357|NCT01381926|580484530|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
160753358|NCT01381926|580484531|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
160753359|NCT01381926|580484530|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
160753360|NCT01381926|580484531|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
160753361|NCT02624947|580484536|FG000|Maternal Participants|Adverse Event|5|||
160753362|NCT02624947|580484537|FG001|Maternal Participants|Adverse Event|0|||
160753363|NCT02624947|580484536|FG000|Maternal Participants|Investigator Decision|5|||
160753364|NCT02624947|580484537|FG001|Maternal Participants|Investigator Decision|3|||
160753365|NCT02624947|580484536|FG000|Maternal Participants|Lost to Follow-up|54|||
160753366|NCT02624947|580484537|FG001|Maternal Participants|Lost to Follow-up|24|||
160753367|NCT02624947|580484536|FG000|Maternal Participants|Non Compliance|8|||
160753368|NCT02624947|580484537|FG001|Maternal Participants|Non Compliance|5|||
160753369|NCT02624947|580484536|FG000|Maternal Participants|Sponsor Request|1|||
160753370|NCT02624947|580484537|FG001|Maternal Participants|Sponsor Request|1|||
160753371|NCT02624947|580484536|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
160753372|NCT02624947|580484537|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
160753373|NCT02624947|580484536|FG000|Maternal Participants|Miscellaneous|23|||
160753374|NCT02624947|580484537|FG001|Maternal Participants|Miscellaneous|15|||
160753375|NCT02624947|580484536|FG000|Infant Participants|Adverse Event|18|||
160753376|NCT02624947|580484537|FG001|Infant Participants|Adverse Event|11|||
160753377|NCT02624947|580484536|FG000|Infant Participants|Investigator Decision|5|||
160753378|NCT02624947|580484537|FG001|Infant Participants|Investigator Decision|4|||
160753379|NCT02624947|580484536|FG000|Infant Participants|Lost to Follow-up|93|||
160753380|NCT02624947|580484537|FG001|Infant Participants|Lost to Follow-up|58|||
160753381|NCT02624947|580484536|FG000|Infant Participants|Non Compliance|17|||
160753382|NCT02624947|580484537|FG001|Infant Participants|Non Compliance|7|||
160524592|NCT02520284|579650086|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
160524593|NCT02520284|579650087|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
160524594|NCT02520284|579650088|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
160524595|NCT02520284|579650086|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
160524596|NCT02520284|579650087|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
160524597|NCT02520284|579650088|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
160524598|NCT02520284|579650086|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
160524599|NCT02520284|579650087|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
160524600|NCT02520284|579650088|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
160524601|NCT02520284|579650086|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
160524602|NCT02520284|579650087|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
160524603|NCT02520284|579650088|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
160524604|NCT02520284|579650086|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
160524605|NCT02520284|579650087|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
160524606|NCT02520284|579650088|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
160524607|NCT03737474|579650089|FG000|Overall Study|Adverse Event|18|||
160524608|NCT03737474|579650090|FG001|Overall Study|Adverse Event|48|||
160524609|NCT03737474|579650089|FG000|Overall Study|Lack of Efficacy|1|||
160524610|NCT03737474|579650090|FG001|Overall Study|Lack of Efficacy|3|||
160524611|NCT03737474|579650089|FG000|Overall Study|Protocol Violation|0|||
160524612|NCT03737474|579650090|FG001|Overall Study|Protocol Violation|8|||
160524613|NCT03737474|579650089|FG000|Overall Study|Withdrawal by Subject|5|||
160524614|NCT03737474|579650090|FG001|Overall Study|Withdrawal by Subject|20|||
160524615|NCT03737474|579650089|FG000|Overall Study|Non-compliance With Study Drug|0|||
160524616|NCT03737474|579650090|FG001|Overall Study|Non-compliance With Study Drug|1|||
160524617|NCT03737474|579650089|FG000|Overall Study|Physician Decision|1|||
160524618|NCT03737474|579650090|FG001|Overall Study|Physician Decision|4|||
160524619|NCT02513745|579650093|FG000|Overall Study|Criteria at time of surgery not met.|3|||
160524620|NCT02513745|579650094|FG001|Overall Study|Criteria at time of surgery not met.|3|||
160524621|NCT01139658|579650095|FG000|Overall Study|Adverse Event|10|||
160524622|NCT01139658|579650096|FG001|Overall Study|Adverse Event|27|||
160524623|NCT01139658|579650095|FG000|Overall Study|Lack of Efficacy|15|||
160524624|NCT01139658|579650096|FG001|Overall Study|Lack of Efficacy|7|||
160524625|NCT01139658|579650095|FG000|Overall Study|Withdrawal by Subject|2|||
160524626|NCT01139658|579650096|FG001|Overall Study|Withdrawal by Subject|4|||
160524627|NCT01139658|579650095|FG000|Overall Study|No documentation of treatment|1|||
160524628|NCT01139658|579650096|FG001|Overall Study|No documentation of treatment|0|||
160524629|NCT01139658|579650095|FG000|Overall Study|Other|28|||
160524630|NCT01139658|579650096|FG001|Overall Study|Other|75|||
160524631|NCT00753272|579650101|FG000|Overall Study|Adverse Event|878|||
160524632|NCT00753272|579650102|FG001|Overall Study|Adverse Event|869|||
160524633|NCT00753272|579650101|FG000|Overall Study|Protocol Violation|28|||
160524634|NCT00753272|579650102|FG001|Overall Study|Protocol Violation|46|||
160524635|NCT00753272|579650101|FG000|Overall Study|Withdrawal by Subject|2481|||
160524636|NCT00753272|579650102|FG001|Overall Study|Withdrawal by Subject|2407|||
160524637|NCT00753272|579650101|FG000|Overall Study|Lost to Follow-up|491|||
160524638|NCT00753272|579650102|FG001|Overall Study|Lost to Follow-up|497|||
160524639|NCT00753272|579650101|FG000|Overall Study|Other|1104|||
160524640|NCT00753272|579650102|FG001|Overall Study|Other|1088|||
160524641|NCT00803270|579650103|FG000|Overall Study|Lost to Follow-up|1|||
160524642|NCT00803270|579650104|FG001|Overall Study|Lost to Follow-up|2|||
160524643|NCT02092220|579650108|FG000|Period 1|Unrelated Illness|0|||
160524644|NCT02092220|579650109|FG001|Period 1|Unrelated Illness|2|||
160524645|NCT02092220|579650108|FG000|Period 2|Severe Hypoglycaemia|1|||
160524646|NCT02092220|579650109|FG001|Period 2|Severe Hypoglycaemia|0|||
160524647|NCT02092220|579650108|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
160524648|NCT02092220|579650109|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
160524649|NCT00960531|579650110|FG000|Overall Study|Lack of Efficacy|1|||
160524650|NCT00960531|579650111|FG001|Overall Study|Lack of Efficacy|0|||
160524651|NCT00960531|579650112|FG002|Overall Study|Lack of Efficacy|0|||
160524652|NCT00960531|579650113|FG003|Overall Study|Lack of Efficacy|0|||
160524653|NCT00960531|579650114|FG004|Overall Study|Lack of Efficacy|0|||
160524654|NCT00960531|579650115|FG005|Overall Study|Lack of Efficacy|0|||
160524655|NCT00960531|579650116|FG006|Overall Study|Lack of Efficacy|0|||
160524656|NCT00960531|579650117|FG007|Overall Study|Lack of Efficacy|0|||
160524657|NCT00960531|579650118|FG008|Overall Study|Lack of Efficacy|0|||
160524658|NCT00960531|579650119|FG009|Overall Study|Lack of Efficacy|0|||
160524659|NCT00960531|579650110|FG000|Overall Study|Withdrawal by Subject|1|||
160524660|NCT00960531|579650111|FG001|Overall Study|Withdrawal by Subject|0|||
160524661|NCT00960531|579650112|FG002|Overall Study|Withdrawal by Subject|5|||
160524662|NCT00960531|579650113|FG003|Overall Study|Withdrawal by Subject|2|||
160524663|NCT00960531|579650114|FG004|Overall Study|Withdrawal by Subject|0|||
160524664|NCT00960531|579650115|FG005|Overall Study|Withdrawal by Subject|0|||
160524665|NCT00960531|579650116|FG006|Overall Study|Withdrawal by Subject|2|||
160753383|NCT02624947|580484536|FG000|Infant Participants|Sponsor Request|0|||
160753384|NCT02624947|580484537|FG001|Infant Participants|Sponsor Request|1|||
160753385|NCT02624947|580484536|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
160753386|NCT02624947|580484537|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
160753387|NCT02624947|580484536|FG000|Infant Participants|Miscellaneous|50|||
160753388|NCT02624947|580484537|FG001|Infant Participants|Miscellaneous|26|||
160753389|NCT03654729|580484548|FG000|Overall Study|Death|9|||
160753390|NCT03654729|580484549|FG001|Overall Study|Death|9|||
160753391|NCT03654729|580484550|FG002|Overall Study|Death|16|||
160753392|NCT03654729|580484548|FG000|Overall Study|Withdrawal by Subject|8|||
160753393|NCT03654729|580484549|FG001|Overall Study|Withdrawal by Subject|6|||
160753394|NCT03654729|580484550|FG002|Overall Study|Withdrawal by Subject|4|||
160753395|NCT03654729|580484548|FG000|Overall Study|Study terminated by Sponsor|3|||
160753396|NCT03654729|580484549|FG001|Overall Study|Study terminated by Sponsor|5|||
160753397|NCT03654729|580484550|FG002|Overall Study|Study terminated by Sponsor|4|||
160753398|NCT03654729|580484548|FG000|Overall Study|Not reported|2|||
160753399|NCT03654729|580484549|FG001|Overall Study|Not reported|4|||
160753400|NCT03654729|580484550|FG002|Overall Study|Not reported|5|||
160753401|NCT03654729|580484548|FG000|Overall Study|Progressive disease|3|||
160753402|NCT03654729|580484549|FG001|Overall Study|Progressive disease|0|||
160753403|NCT03654729|580484550|FG002|Overall Study|Progressive disease|0|||
160753404|NCT03654729|580484548|FG000|Overall Study|Lost to Follow-up|2|||
160753405|NCT03654729|580484549|FG001|Overall Study|Lost to Follow-up|0|||
160753406|NCT03654729|580484550|FG002|Overall Study|Lost to Follow-up|0|||
160753407|NCT03654729|580484548|FG000|Overall Study|Physician Decision|2|||
160753408|NCT03654729|580484549|FG001|Overall Study|Physician Decision|0|||
160753409|NCT03654729|580484550|FG002|Overall Study|Physician Decision|0|||
160753410|NCT03654729|580484548|FG000|Overall Study|Protocol Violation|1|||
160753411|NCT03654729|580484549|FG001|Overall Study|Protocol Violation|1|||
160753412|NCT03654729|580484550|FG002|Overall Study|Protocol Violation|0|||
160753413|NCT03654729|580484548|FG000|Overall Study|Non-compliance with study drug|0|||
160753414|NCT03654729|580484549|FG001|Overall Study|Non-compliance with study drug|1|||
160753415|NCT03654729|580484550|FG002|Overall Study|Non-compliance with study drug|0|||
160753416|NCT03654729|580484548|FG000|Overall Study|Site terminated by Sponsor|1|||
160753417|NCT03654729|580484549|FG001|Overall Study|Site terminated by Sponsor|0|||
160753418|NCT03654729|580484550|FG002|Overall Study|Site terminated by Sponsor|0|||
160753419|NCT00588146|580484558|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
160753420|NCT00588146|580484559|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
160753421|NCT00215644|580484562|FG000|Overall Study|Disease Progression|28|||
160753422|NCT00215644|580484563|FG001|Overall Study|Disease Progression|10|||
160753423|NCT00215644|580484562|FG000|Overall Study|Adverse Event|2|||
160753424|NCT00215644|580484563|FG001|Overall Study|Adverse Event|9|||
160753425|NCT00215644|580484562|FG000|Overall Study|Death|1|||
160753426|NCT00215644|580484563|FG001|Overall Study|Death|2|||
160753427|NCT00215644|580484562|FG000|Overall Study|Withdrawal by Subject|1|||
160753428|NCT00215644|580484563|FG001|Overall Study|Withdrawal by Subject|0|||
160753429|NCT00215644|580484562|FG000|Overall Study|Other|3|||
160753430|NCT00215644|580484563|FG001|Overall Study|Other|15|||
160753431|NCT00215644|580484562|FG000|Overall Study|Randomized but Not Treated|1|||
160753432|NCT00215644|580484563|FG001|Overall Study|Randomized but Not Treated|0|||
160753433|NCT01239394|580484566|FG000|Overall Study|Adverse Event|1|||
160753434|NCT00905632|580484568|FG000|Overall Study|Adverse Event|0|||
160753435|NCT00905632|580484569|FG001|Overall Study|Adverse Event|0|||
160753436|NCT00905632|580484570|FG002|Overall Study|Adverse Event|0|||
160753437|NCT00905632|580484571|FG003|Overall Study|Adverse Event|0|||
160753438|NCT00905632|580484572|FG004|Overall Study|Adverse Event|0|||
160753439|NCT00905632|580484573|FG005|Overall Study|Adverse Event|1|||
160753440|NCT00905632|580484574|FG006|Overall Study|Adverse Event|4|||
160524666|NCT00960531|579650117|FG007|Overall Study|Withdrawal by Subject|0|||
160524667|NCT00960531|579650118|FG008|Overall Study|Withdrawal by Subject|1|||
160524668|NCT00960531|579650119|FG009|Overall Study|Withdrawal by Subject|0|||
160524669|NCT00960531|579650110|FG000|Overall Study|Caregiver Request|2|||
160524670|NCT00960531|579650111|FG001|Overall Study|Caregiver Request|0|||
160524671|NCT00960531|579650112|FG002|Overall Study|Caregiver Request|6|||
160524672|NCT00960531|579650113|FG003|Overall Study|Caregiver Request|5|||
160524673|NCT00960531|579650114|FG004|Overall Study|Caregiver Request|0|||
160524674|NCT00960531|579650115|FG005|Overall Study|Caregiver Request|2|||
160524675|NCT00960531|579650116|FG006|Overall Study|Caregiver Request|3|||
160524676|NCT00960531|579650117|FG007|Overall Study|Caregiver Request|1|||
160524677|NCT00960531|579650118|FG008|Overall Study|Caregiver Request|3|||
160524678|NCT00960531|579650119|FG009|Overall Study|Caregiver Request|0|||
160524679|NCT00960531|579650110|FG000|Overall Study|Investigator Request|0|||
160524680|NCT00960531|579650111|FG001|Overall Study|Investigator Request|0|||
160524681|NCT00960531|579650112|FG002|Overall Study|Investigator Request|1|||
160524682|NCT00960531|579650113|FG003|Overall Study|Investigator Request|0|||
160524683|NCT00960531|579650114|FG004|Overall Study|Investigator Request|0|||
160524684|NCT00960531|579650115|FG005|Overall Study|Investigator Request|0|||
160524685|NCT00960531|579650116|FG006|Overall Study|Investigator Request|0|||
160524686|NCT00960531|579650117|FG007|Overall Study|Investigator Request|0|||
160524687|NCT00960531|579650118|FG008|Overall Study|Investigator Request|0|||
160524688|NCT00960531|579650119|FG009|Overall Study|Investigator Request|0|||
160524689|NCT00960531|579650110|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
160524690|NCT00960531|579650111|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
160524691|NCT00960531|579650112|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
160524692|NCT00960531|579650113|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
160524693|NCT00960531|579650114|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
160524694|NCT00960531|579650115|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
160524695|NCT00960531|579650116|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
160524696|NCT00960531|579650117|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
160524697|NCT00960531|579650118|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
160524698|NCT00960531|579650119|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
160524699|NCT00960531|579650110|FG000|Overall Study|Lost to Follow-up|0|||
160524700|NCT00960531|579650111|FG001|Overall Study|Lost to Follow-up|0|||
160524701|NCT00960531|579650112|FG002|Overall Study|Lost to Follow-up|1|||
160524702|NCT00960531|579650113|FG003|Overall Study|Lost to Follow-up|0|||
160524703|NCT00960531|579650114|FG004|Overall Study|Lost to Follow-up|0|||
160524704|NCT00960531|579650115|FG005|Overall Study|Lost to Follow-up|0|||
160524705|NCT00960531|579650116|FG006|Overall Study|Lost to Follow-up|1|||
160524706|NCT00960531|579650117|FG007|Overall Study|Lost to Follow-up|0|||
160524707|NCT00960531|579650118|FG008|Overall Study|Lost to Follow-up|0|||
160524708|NCT00960531|579650119|FG009|Overall Study|Lost to Follow-up|0|||
160524709|NCT00960531|579650110|FG000|Overall Study|Failed to Return|2|||
160524710|NCT00960531|579650111|FG001|Overall Study|Failed to Return|0|||
160524711|NCT00960531|579650112|FG002|Overall Study|Failed to Return|0|||
160524712|NCT00960531|579650113|FG003|Overall Study|Failed to Return|0|||
160524713|NCT00960531|579650114|FG004|Overall Study|Failed to Return|0|||
160524714|NCT00960531|579650115|FG005|Overall Study|Failed to Return|0|||
160524715|NCT00960531|579650116|FG006|Overall Study|Failed to Return|0|||
160524716|NCT00960531|579650117|FG007|Overall Study|Failed to Return|2|||
160524717|NCT00960531|579650118|FG008|Overall Study|Failed to Return|0|||
160524718|NCT00960531|579650119|FG009|Overall Study|Failed to Return|0|||
160524719|NCT00960531|579650110|FG000|Overall Study|Adverse Event (AE)|2|||
160524720|NCT00960531|579650111|FG001|Overall Study|Adverse Event (AE)|0|||
160524721|NCT00960531|579650112|FG002|Overall Study|Adverse Event (AE)|0|||
160524722|NCT00960531|579650113|FG003|Overall Study|Adverse Event (AE)|0|||
160524723|NCT00960531|579650114|FG004|Overall Study|Adverse Event (AE)|0|||
160524724|NCT00960531|579650115|FG005|Overall Study|Adverse Event (AE)|1|||
160524725|NCT00960531|579650116|FG006|Overall Study|Adverse Event (AE)|2|||
160524726|NCT00960531|579650117|FG007|Overall Study|Adverse Event (AE)|0|||
160524727|NCT00960531|579650118|FG008|Overall Study|Adverse Event (AE)|2|||
160524728|NCT00960531|579650119|FG009|Overall Study|Adverse Event (AE)|0|||
160524729|NCT00960531|579650110|FG000|Overall Study|Reason not Specified|2|||
160524730|NCT00960531|579650111|FG001|Overall Study|Reason not Specified|1|||
160524731|NCT00960531|579650112|FG002|Overall Study|Reason not Specified|13|||
160524732|NCT00960531|579650113|FG003|Overall Study|Reason not Specified|1|||
160524733|NCT00960531|579650114|FG004|Overall Study|Reason not Specified|2|||
160524734|NCT00960531|579650115|FG005|Overall Study|Reason not Specified|0|||
160524735|NCT00960531|579650116|FG006|Overall Study|Reason not Specified|16|||
160524736|NCT00960531|579650117|FG007|Overall Study|Reason not Specified|0|||
160524737|NCT00960531|579650118|FG008|Overall Study|Reason not Specified|8|||
160524738|NCT00960531|579650119|FG009|Overall Study|Reason not Specified|1|||
160524739|NCT00593957|579650120|FG000|Overall Study|Physician Decision|0|||
160524740|NCT00593957|579650121|FG001|Overall Study|Physician Decision|1|||
160524741|NCT00593957|579650122|FG002|Overall Study|Physician Decision|2|||
160524742|NCT02411578|579650123|FG000|Crossover Trial Phase|Pregnancy|0|||
160524743|NCT02411578|579650124|FG001|Crossover Trial Phase|Pregnancy|1|||
160753441|NCT03569098|580484575|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
160753442|NCT03569098|580484576|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
160753443|NCT03569098|580484577|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
160753444|NCT03569098|580484575|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
160753445|NCT03569098|580484576|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
160753446|NCT03569098|580484577|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
160753447|NCT03569098|580484575|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
160753448|NCT03569098|580484576|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
160753449|NCT03569098|580484577|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
160753450|NCT03569098|580484575|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
160753451|NCT03569098|580484576|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
160753452|NCT03569098|580484577|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
160753453|NCT03569098|580484575|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
160753454|NCT03569098|580484576|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
160753455|NCT03569098|580484577|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
160753456|NCT03569098|580484575|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
160753457|NCT03569098|580484576|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
160753458|NCT03569098|580484577|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
160753459|NCT03569098|580484575|FG000|Double-Blind Treatment Cycle 1|Other|1|||
160753460|NCT03569098|580484576|FG001|Double-Blind Treatment Cycle 1|Other|0|||
160753461|NCT03569098|580484577|FG002|Double-Blind Treatment Cycle 1|Other|1|||
160753462|NCT03569098|580484575|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
160753463|NCT03569098|580484576|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
160753464|NCT03569098|580484577|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
160753465|NCT03569098|580484575|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
160753466|NCT03569098|580484576|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
160753467|NCT03569098|580484577|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
160753468|NCT03569098|580484575|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
160753469|NCT03569098|580484576|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
160753470|NCT03569098|580484577|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
160753471|NCT03569098|580484575|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
160753472|NCT03569098|580484576|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
160524744|NCT00494481|579650125|FG000|Overall Study|Condition under investigation worsened|11|||
160753473|NCT03569098|580484577|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
160753474|NCT03569098|580484575|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
160753475|NCT03569098|580484576|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
160753476|NCT03569098|580484577|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
160753477|NCT03569098|580484575|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
160524745|NCT00494481|579650126|FG001|Overall Study|Condition under investigation worsened|13|||
160524746|NCT00494481|579650125|FG000|Overall Study|Adverse Event|15|||
160753478|NCT03569098|580484576|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
160753479|NCT03569098|580484577|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
160753480|NCT02581488|580484582|FG000|Overall Study|Adverse Event|6|||
160753481|NCT02581488|580484583|FG001|Overall Study|Adverse Event|7|||
160753482|NCT02581488|580484582|FG000|Overall Study|Lost to Follow-up|1|||
160753483|NCT02581488|580484583|FG001|Overall Study|Lost to Follow-up|0|||
160753484|NCT02581488|580484582|FG000|Overall Study|Withdrawal by Subject|1|||
160753485|NCT02581488|580484583|FG001|Overall Study|Withdrawal by Subject|0|||
160753486|NCT02581488|580484582|FG000|Overall Study|Non-Compliance|1|||
160753487|NCT02581488|580484583|FG001|Overall Study|Non-Compliance|0|||
160753488|NCT02581488|580484582|FG000|Overall Study|Protocol Violation|0|||
160753489|NCT02581488|580484583|FG001|Overall Study|Protocol Violation|4|||
160753490|NCT03365934|580484587|FG000|Overall Study|Adverse Event|1|||
160753491|NCT03365934|580484587|FG000|Overall Study|Withdrawal by Subject|1|||
160753492|NCT01307891|580484588|FG000|Overall Study|Progressive Disease|3|||
160753493|NCT01307891|580484589|FG001|Overall Study|Progressive Disease|1|||
160753494|NCT02937740|580484590|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
160753495|NCT02937740|580484591|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
160753496|NCT02937740|580484590|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
160753497|NCT02937740|580484591|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
160753498|NCT02937740|580484590|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
160753499|NCT02937740|580484591|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
160753500|NCT02937740|580484590|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
160753501|NCT02937740|580484591|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
160753502|NCT02937740|580484590|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
160753503|NCT02937740|580484591|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
160753504|NCT02937740|580484590|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
160753505|NCT02937740|580484591|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
160753506|NCT02964338|580484596|FG000|Overall Study|Sponsor terminated study for futility|12|||
160753507|NCT02964338|580484597|FG001|Overall Study|Sponsor terminated study for futility|15|||
160753508|NCT02964338|580484598|FG002|Overall Study|Sponsor terminated study for futility|14|||
160524747|NCT00494481|579650126|FG001|Overall Study|Adverse Event|11|||
160753509|NCT02964338|580484596|FG000|Overall Study|Lack of Efficacy|0|||
160753510|NCT02964338|580484597|FG001|Overall Study|Lack of Efficacy|3|||
160753511|NCT02964338|580484598|FG002|Overall Study|Lack of Efficacy|0|||
160753512|NCT02964338|580484596|FG000|Overall Study|Lost to Follow-up|1|||
160753513|NCT02964338|580484597|FG001|Overall Study|Lost to Follow-up|0|||
160753514|NCT02964338|580484598|FG002|Overall Study|Lost to Follow-up|3|||
160524748|NCT00494481|579650125|FG000|Overall Study|Other|1|||
160753515|NCT02964338|580484596|FG000|Overall Study|Protocol Violation|0|||
160753516|NCT02964338|580484597|FG001|Overall Study|Protocol Violation|1|||
160753517|NCT02964338|580484598|FG002|Overall Study|Protocol Violation|0|||
160753518|NCT02964338|580484596|FG000|Overall Study|Withdrawal by Subject|1|||
160753519|NCT02964338|580484597|FG001|Overall Study|Withdrawal by Subject|3|||
160753520|NCT02964338|580484598|FG002|Overall Study|Withdrawal by Subject|1|||
160753521|NCT02964338|580484596|FG000|Overall Study|Adverse Event|2|||
160753522|NCT02964338|580484597|FG001|Overall Study|Adverse Event|1|||
160753523|NCT02964338|580484598|FG002|Overall Study|Adverse Event|1|||
160753524|NCT02964338|580484596|FG000|Overall Study|Non-compliant with e-diary|0|||
160753525|NCT02964338|580484597|FG001|Overall Study|Non-compliant with e-diary|1|||
160753526|NCT02964338|580484598|FG002|Overall Study|Non-compliant with e-diary|0|||
160753527|NCT02964338|580484596|FG000|Overall Study|Did not meet criteria|1|||
160753528|NCT02964338|580484597|FG001|Overall Study|Did not meet criteria|0|||
160753529|NCT02964338|580484598|FG002|Overall Study|Did not meet criteria|0|||
160753530|NCT02239640|580484599|FG000|Overall Study|Withdrawal by Subject|3|||
160753531|NCT02239640|580484599|FG000|Overall Study|Lost to Follow-up|72|||
160753532|NCT02239640|580484599|FG000|Overall Study|Death|142|||
160753533|NCT02291029|580484607|FG000|Overall Study|Withdrawal by Subject|0|||
160753534|NCT02291029|580484608|FG001|Overall Study|Withdrawal by Subject|0|||
160753535|NCT02291029|580484609|FG002|Overall Study|Withdrawal by Subject|1|||
160753536|NCT02291029|580484610|FG003|Overall Study|Withdrawal by Subject|0|||
160753537|NCT02291029|580484611|FG004|Overall Study|Withdrawal by Subject|0|||
160753538|NCT02291029|580484612|FG005|Overall Study|Withdrawal by Subject|0|||
160753539|NCT02291029|580484607|FG000|Overall Study|Adverse Event|0|||
160753540|NCT02291029|580484608|FG001|Overall Study|Adverse Event|1|||
160753541|NCT02291029|580484609|FG002|Overall Study|Adverse Event|0|||
160753542|NCT02291029|580484610|FG003|Overall Study|Adverse Event|0|||
160753543|NCT02291029|580484611|FG004|Overall Study|Adverse Event|0|||
160753544|NCT02291029|580484612|FG005|Overall Study|Adverse Event|0|||
160753545|NCT04147247|580484613|FG000|Overall Study|Progressive disease|3|||
160753546|NCT04147247|580484614|FG001|Overall Study|Progressive disease|3|||
160753547|NCT04147247|580484615|FG002|Overall Study|Progressive disease|4|||
160753548|NCT04147247|580484616|FG003|Overall Study|Progressive disease|4|||
160753549|NCT04147247|580484617|FG004|Overall Study|Progressive disease|3|||
160753550|NCT04147247|580484613|FG000|Overall Study|Physician Decision|0|||
160753551|NCT04147247|580484614|FG001|Overall Study|Physician Decision|1|||
160753552|NCT04147247|580484615|FG002|Overall Study|Physician Decision|0|||
160753553|NCT04147247|580484616|FG003|Overall Study|Physician Decision|0|||
160753554|NCT04147247|580484617|FG004|Overall Study|Physician Decision|0|||
160753555|NCT04147247|580484613|FG000|Overall Study|Clinical Disease Progression|0|||
160753556|NCT04147247|580484614|FG001|Overall Study|Clinical Disease Progression|0|||
160753557|NCT04147247|580484615|FG002|Overall Study|Clinical Disease Progression|0|||
160753558|NCT04147247|580484616|FG003|Overall Study|Clinical Disease Progression|0|||
160753559|NCT04147247|580484617|FG004|Overall Study|Clinical Disease Progression|1|||
160753560|NCT04147247|580484613|FG000|Overall Study|Adverse Event|0|||
160753561|NCT04147247|580484614|FG001|Overall Study|Adverse Event|0|||
160753562|NCT04147247|580484615|FG002|Overall Study|Adverse Event|1|||
160753563|NCT04147247|580484616|FG003|Overall Study|Adverse Event|0|||
160753564|NCT04147247|580484617|FG004|Overall Study|Adverse Event|1|||
160753565|NCT02915159|580484619|FG000|Overall Study|Participant no longer meets criteria|2|||
160753566|NCT02915159|580484620|FG001|Overall Study|Participant no longer meets criteria|0|||
160753567|NCT02915159|580484619|FG000|Overall Study|poor/non-compliance|1|||
160753568|NCT02915159|580484620|FG001|Overall Study|poor/non-compliance|0|||
160753569|NCT02915159|580484619|FG000|Overall Study|Participant withdrew consent|5|||
160753570|NCT02915159|580484620|FG001|Overall Study|Participant withdrew consent|1|||
160753571|NCT02915159|580484619|FG000|Overall Study|Request to discontinue treatment|1|||
160753572|NCT02915159|580484620|FG001|Overall Study|Request to discontinue treatment|2|||
160753573|NCT02915159|580484619|FG000|Overall Study|Adverse Event|2|||
160753574|NCT02915159|580484620|FG001|Overall Study|Adverse Event|2|||
160753575|NCT02915159|580484619|FG000|Overall Study|Lack of Efficacy|0|||
160753576|NCT02915159|580484620|FG001|Overall Study|Lack of Efficacy|3|||
160753577|NCT04534517|580484621|FG000|Overall Study|Adverse Event|1|||
160753578|NCT04534517|580484621|FG000|Overall Study|Withdrawal by Subject|1|||
160753579|NCT04534517|580484621|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
160753580|NCT04534517|580484621|FG000|Overall Study|COVID-19 Related|1|||
160753581|NCT02121795|580484622|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
160753582|NCT02121795|580484623|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
160753583|NCT02121795|580484622|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
160753584|NCT02121795|580484623|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
160753585|NCT02121795|580484622|FG000|Double-Blind Phase|Lost to Follow-up|7|||
160753586|NCT02121795|580484623|FG001|Double-Blind Phase|Lost to Follow-up|4|||
160753587|NCT02121795|580484622|FG000|Double-Blind Phase|Physician Decision|2|||
160753588|NCT02121795|580484623|FG001|Double-Blind Phase|Physician Decision|5|||
160753589|NCT02121795|580484622|FG000|Double-Blind Phase|Adverse Event|5|||
160753590|NCT02121795|580484623|FG001|Double-Blind Phase|Adverse Event|0|||
160753591|NCT02121795|580484622|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
160753592|NCT02121795|580484623|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
160753593|NCT02121795|580484622|FG000|Double-Blind Phase|Protocol Violation|0|||
160753594|NCT02121795|580484623|FG001|Double-Blind Phase|Protocol Violation|3|||
160753595|NCT02121795|580484622|FG000|Double-Blind Phase|Death|1|||
160753596|NCT02121795|580484623|FG001|Double-Blind Phase|Death|1|||
160753597|NCT02121795|580484622|FG000|Open-Label Phase|Physician Decision|8|||
160753598|NCT02121795|580484623|FG001|Open-Label Phase|Physician Decision|8|||
160753599|NCT02121795|580484622|FG000|Open-Label Phase|Withdrawal by Subject|3|||
160753600|NCT02121795|580484623|FG001|Open-Label Phase|Withdrawal by Subject|2|||
160753601|NCT02121795|580484622|FG000|Open-Label Phase|Lost to Follow-up|1|||
160753602|NCT02121795|580484623|FG001|Open-Label Phase|Lost to Follow-up|0|||
160753603|NCT00572455|580484624|FG000|Stage I (14 Days)|Adverse Event|0|||
160524749|NCT00494481|579650126|FG001|Overall Study|Other|0|||
160524750|NCT00494481|579650125|FG000|Overall Study|Never received IP|2|||
160524751|NCT00494481|579650126|FG001|Overall Study|Never received IP|0|||
160524752|NCT00332189|579650127|FG000|Overall Study|Adverse Event|3|||
160524753|NCT00332189|579650127|FG000|Overall Study|Uncooperative/Noncompliant|3|||
160524754|NCT00332189|579650127|FG000|Overall Study|Withdrawal by Subject|9|||
160524755|NCT00332189|579650127|FG000|Overall Study|Lack of Efficacy|4|||
160524756|NCT00332189|579650127|FG000|Overall Study|Moved out of country|2|||
160524757|NCT02225353|579650130|FG000|Overall Study|Lost to Follow-up|0|||
160524758|NCT02225353|579650131|FG001|Overall Study|Lost to Follow-up|1|||
160524759|NCT02225353|579650132|FG002|Overall Study|Lost to Follow-up|3|||
160524760|NCT02225353|579650130|FG000|Overall Study|Protocol Violation|4|||
160524761|NCT02225353|579650131|FG001|Overall Study|Protocol Violation|5|||
160524762|NCT02225353|579650132|FG002|Overall Study|Protocol Violation|12|||
160524763|NCT01193920|579650133|FG000|Overall Study|Withdrawal by Subject|1|||
160524764|NCT01193920|579650134|FG001|Overall Study|Withdrawal by Subject|0|||
160524765|NCT01193920|579650135|FG002|Overall Study|Withdrawal by Subject|5|||
160524766|NCT01193920|579650136|FG003|Overall Study|Withdrawal by Subject|1|||
160524767|NCT01193920|579650137|FG004|Overall Study|Withdrawal by Subject|3|||
160524768|NCT01193920|579650138|FG005|Overall Study|Withdrawal by Subject|1|||
160524769|NCT01193920|579650139|FG006|Overall Study|Withdrawal by Subject|3|||
160524770|NCT01193920|579650140|FG007|Overall Study|Withdrawal by Subject|0|||
160524771|NCT01193920|579650141|FG008|Overall Study|Withdrawal by Subject|1|||
160524772|NCT01193920|579650142|FG009|Overall Study|Withdrawal by Subject|0|||
160524773|NCT01193920|579650133|FG000|Overall Study|Lost to Follow-up|1|||
160524774|NCT01193920|579650134|FG001|Overall Study|Lost to Follow-up|0|||
160524775|NCT01193920|579650135|FG002|Overall Study|Lost to Follow-up|1|||
160524776|NCT01193920|579650136|FG003|Overall Study|Lost to Follow-up|1|||
160524777|NCT01193920|579650137|FG004|Overall Study|Lost to Follow-up|3|||
160524778|NCT01193920|579650138|FG005|Overall Study|Lost to Follow-up|3|||
160524779|NCT01193920|579650139|FG006|Overall Study|Lost to Follow-up|1|||
160524780|NCT01193920|579650140|FG007|Overall Study|Lost to Follow-up|0|||
160524781|NCT01193920|579650141|FG008|Overall Study|Lost to Follow-up|2|||
160524782|NCT01193920|579650142|FG009|Overall Study|Lost to Follow-up|3|||
160524783|NCT01193920|579650133|FG000|Overall Study|Protocol Violation|1|||
160524784|NCT01193920|579650134|FG001|Overall Study|Protocol Violation|0|||
160524785|NCT01193920|579650135|FG002|Overall Study|Protocol Violation|0|||
160524786|NCT01193920|579650136|FG003|Overall Study|Protocol Violation|0|||
160524787|NCT01193920|579650137|FG004|Overall Study|Protocol Violation|0|||
160524788|NCT01193920|579650138|FG005|Overall Study|Protocol Violation|0|||
160524789|NCT01193920|579650139|FG006|Overall Study|Protocol Violation|0|||
160524790|NCT01193920|579650140|FG007|Overall Study|Protocol Violation|0|||
160524791|NCT01193920|579650141|FG008|Overall Study|Protocol Violation|0|||
160524792|NCT01193920|579650142|FG009|Overall Study|Protocol Violation|0|||
160524793|NCT01193920|579650133|FG000|Overall Study|Death|0|||
160524794|NCT01193920|579650134|FG001|Overall Study|Death|0|||
160524795|NCT01193920|579650135|FG002|Overall Study|Death|0|||
160524796|NCT01193920|579650136|FG003|Overall Study|Death|1|||
160524797|NCT01193920|579650137|FG004|Overall Study|Death|0|||
160524798|NCT01193920|579650138|FG005|Overall Study|Death|0|||
160524799|NCT01193920|579650139|FG006|Overall Study|Death|2|||
160524800|NCT01193920|579650140|FG007|Overall Study|Death|3|||
160753604|NCT00572455|580484625|FG001|Stage I (14 Days)|Adverse Event|0|||
160753605|NCT00572455|580484626|FG002|Stage I (14 Days)|Adverse Event|0|||
160524801|NCT01193920|579650141|FG008|Overall Study|Death|2|||
160524802|NCT01193920|579650142|FG009|Overall Study|Death|4|||
160524803|NCT01193920|579650133|FG000|Overall Study|Unable to classify|0|||
160524804|NCT01193920|579650134|FG001|Overall Study|Unable to classify|0|||
160524805|NCT01193920|579650135|FG002|Overall Study|Unable to classify|0|||
160524806|NCT01193920|579650136|FG003|Overall Study|Unable to classify|1|||
160524807|NCT01193920|579650137|FG004|Overall Study|Unable to classify|0|||
160524808|NCT01193920|579650138|FG005|Overall Study|Unable to classify|0|||
160524809|NCT01193920|579650139|FG006|Overall Study|Unable to classify|0|||
160524810|NCT01193920|579650140|FG007|Overall Study|Unable to classify|1|||
160524811|NCT01193920|579650141|FG008|Overall Study|Unable to classify|0|||
160753606|NCT00572455|580484627|FG003|Stage I (14 Days)|Adverse Event|0|||
160753607|NCT00572455|580484628|FG004|Stage I (14 Days)|Adverse Event|0|||
160753608|NCT00572455|580484629|FG005|Stage I (14 Days)|Adverse Event|3|||
160753609|NCT00572455|580484630|FG006|Stage I (14 Days)|Adverse Event|0|||
160753610|NCT00572455|580484631|FG007|Stage I (14 Days)|Adverse Event|0|||
160753611|NCT00572455|580484632|FG008|Stage I (14 Days)|Adverse Event|0|||
160753612|NCT00572455|580484633|FG009|Stage I (14 Days)|Adverse Event|0|||
160753613|NCT00572455|580484634|FG010|Stage I (14 Days)|Adverse Event|0|||
160753614|NCT00572455|580484635|FG011|Stage I (14 Days)|Adverse Event|0|||
160753615|NCT00572455|580484636|FG012|Stage I (14 Days)|Adverse Event|0|||
160753616|NCT00572455|580484637|FG013|Stage I (14 Days)|Adverse Event|0|||
160753617|NCT00572455|580484624|FG000|Stage I (14 Days)|Other|0|||
160753618|NCT00572455|580484625|FG001|Stage I (14 Days)|Other|0|||
160753619|NCT00572455|580484626|FG002|Stage I (14 Days)|Other|0|||
160753620|NCT00572455|580484627|FG003|Stage I (14 Days)|Other|0|||
160753621|NCT00572455|580484628|FG004|Stage I (14 Days)|Other|1|||
160753622|NCT00572455|580484629|FG005|Stage I (14 Days)|Other|0|||
160753623|NCT00572455|580484630|FG006|Stage I (14 Days)|Other|0|||
160753624|NCT00572455|580484631|FG007|Stage I (14 Days)|Other|0|||
160753625|NCT00572455|580484632|FG008|Stage I (14 Days)|Other|0|||
160753626|NCT00572455|580484633|FG009|Stage I (14 Days)|Other|0|||
160753627|NCT00572455|580484634|FG010|Stage I (14 Days)|Other|0|||
160753628|NCT00572455|580484635|FG011|Stage I (14 Days)|Other|0|||
160753629|NCT00572455|580484636|FG012|Stage I (14 Days)|Other|0|||
160753630|NCT00572455|580484637|FG013|Stage I (14 Days)|Other|0|||
160753631|NCT00572455|580484624|FG000|Stage II (28 Days)|Adverse Event|0|||
160753632|NCT00572455|580484625|FG001|Stage II (28 Days)|Adverse Event|0|||
160753633|NCT00572455|580484626|FG002|Stage II (28 Days)|Adverse Event|0|||
160753634|NCT00572455|580484627|FG003|Stage II (28 Days)|Adverse Event|0|||
160753635|NCT00572455|580484628|FG004|Stage II (28 Days)|Adverse Event|0|||
160753636|NCT00572455|580484629|FG005|Stage II (28 Days)|Adverse Event|0|||
160753637|NCT00572455|580484630|FG006|Stage II (28 Days)|Adverse Event|0|||
160753638|NCT00572455|580484631|FG007|Stage II (28 Days)|Adverse Event|0|||
160753639|NCT00572455|580484632|FG008|Stage II (28 Days)|Adverse Event|1|||
160753640|NCT00572455|580484633|FG009|Stage II (28 Days)|Adverse Event|3|||
160753641|NCT00572455|580484634|FG010|Stage II (28 Days)|Adverse Event|3|||
160753642|NCT00572455|580484635|FG011|Stage II (28 Days)|Adverse Event|4|||
160753643|NCT00572455|580484636|FG012|Stage II (28 Days)|Adverse Event|5|||
160753644|NCT00572455|580484637|FG013|Stage II (28 Days)|Adverse Event|1|||
160753645|NCT00572455|580484624|FG000|Stage II (28 Days)|Death|0|||
160753646|NCT00572455|580484625|FG001|Stage II (28 Days)|Death|0|||
160753647|NCT00572455|580484626|FG002|Stage II (28 Days)|Death|0|||
160753648|NCT00572455|580484627|FG003|Stage II (28 Days)|Death|0|||
160753649|NCT00572455|580484628|FG004|Stage II (28 Days)|Death|0|||
160753650|NCT00572455|580484629|FG005|Stage II (28 Days)|Death|0|||
160753651|NCT00572455|580484630|FG006|Stage II (28 Days)|Death|0|||
160753652|NCT00572455|580484631|FG007|Stage II (28 Days)|Death|0|||
160753653|NCT00572455|580484632|FG008|Stage II (28 Days)|Death|1|||
160753654|NCT00572455|580484633|FG009|Stage II (28 Days)|Death|0|||
160753655|NCT00572455|580484634|FG010|Stage II (28 Days)|Death|0|||
160753656|NCT00572455|580484635|FG011|Stage II (28 Days)|Death|0|||
160753657|NCT00572455|580484636|FG012|Stage II (28 Days)|Death|0|||
160753658|NCT00572455|580484637|FG013|Stage II (28 Days)|Death|0|||
160753659|NCT00572455|580484624|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
160753660|NCT00572455|580484625|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
160753661|NCT00572455|580484626|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
160753662|NCT00572455|580484627|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
160753663|NCT00572455|580484628|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
160753664|NCT00572455|580484629|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
160753665|NCT00572455|580484630|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
160753666|NCT00572455|580484631|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
160753667|NCT00572455|580484632|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
160753668|NCT00572455|580484633|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
160753669|NCT00572455|580484634|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
160753670|NCT00572455|580484635|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
160753671|NCT00572455|580484636|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
160753672|NCT00572455|580484637|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
160753673|NCT00572455|580484624|FG000|Stage II (28 Days)|Other|0|||
160753674|NCT00572455|580484625|FG001|Stage II (28 Days)|Other|0|||
160753675|NCT00572455|580484626|FG002|Stage II (28 Days)|Other|0|||
160753676|NCT00572455|580484627|FG003|Stage II (28 Days)|Other|0|||
160753677|NCT00572455|580484628|FG004|Stage II (28 Days)|Other|0|||
160753678|NCT00572455|580484629|FG005|Stage II (28 Days)|Other|0|||
160753679|NCT00572455|580484630|FG006|Stage II (28 Days)|Other|0|||
160753680|NCT00572455|580484631|FG007|Stage II (28 Days)|Other|0|||
160753681|NCT00572455|580484632|FG008|Stage II (28 Days)|Other|1|||
160753682|NCT00572455|580484633|FG009|Stage II (28 Days)|Other|0|||
160753683|NCT00572455|580484634|FG010|Stage II (28 Days)|Other|0|||
160753684|NCT00572455|580484635|FG011|Stage II (28 Days)|Other|0|||
160753685|NCT00572455|580484636|FG012|Stage II (28 Days)|Other|0|||
160753686|NCT00572455|580484637|FG013|Stage II (28 Days)|Other|0|||
160753687|NCT00572455|580484624|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
160753688|NCT00572455|580484625|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
160753689|NCT00572455|580484626|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
160753690|NCT00572455|580484627|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
160753691|NCT00572455|580484628|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
160524812|NCT01193920|579650142|FG009|Overall Study|Unable to classify|0|||
160524813|NCT00883051|579650143|FG000|Overall Study|Lost to Follow-up|0|||
160524814|NCT00883051|579650144|FG001|Overall Study|Lost to Follow-up|0|||
160524815|NCT00883051|579650145|FG002|Overall Study|Lost to Follow-up|0|||
160524816|NCT00883051|579650146|FG003|Overall Study|Lost to Follow-up|0|||
160753692|NCT00572455|580484629|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
160753693|NCT00572455|580484630|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
160753694|NCT00572455|580484631|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
160753695|NCT00572455|580484632|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
160753696|NCT00572455|580484633|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
160753697|NCT00572455|580484634|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
160753698|NCT00572455|580484635|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
160753699|NCT00572455|580484636|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
160753700|NCT00572455|580484637|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
160753701|NCT00856999|580484638|FG000|Overall Study|Withdrawal by Subject|5|||
160753702|NCT02465437|580484639|FG000|Overall Study|Physician Decision|0|||
160753703|NCT02465437|580484640|FG001|Overall Study|Physician Decision|0|||
160753704|NCT02465437|580484641|FG002|Overall Study|Physician Decision|1|||
160753705|NCT02465437|580484642|FG003|Overall Study|Physician Decision|0|||
160753706|NCT02465437|580484639|FG000|Overall Study|Withdrawal by Subject|1|||
160753707|NCT02465437|580484640|FG001|Overall Study|Withdrawal by Subject|0|||
160753708|NCT02465437|580484641|FG002|Overall Study|Withdrawal by Subject|0|||
160753709|NCT02465437|580484642|FG003|Overall Study|Withdrawal by Subject|1|||
160753710|NCT02465437|580484639|FG000|Overall Study|Adverse Event|0|||
160753711|NCT02465437|580484640|FG001|Overall Study|Adverse Event|1|||
160753712|NCT02465437|580484641|FG002|Overall Study|Adverse Event|0|||
160753713|NCT02465437|580484642|FG003|Overall Study|Adverse Event|0|||
160753714|NCT00003483|580484643|FG000|Overall Study|Not evaluable|1|||
160753715|NCT01308463|580484644|FG000|Overall Study|Study Discontinued|23|||
160753716|NCT01308463|580484644|FG000|Overall Study|Death|4|||
160753717|NCT01308463|580484644|FG000|Overall Study|Revision|2|||
160753718|NCT00103662|580484645|FG000|Overall Study|Entered Rescue Procedure|0|||
160753719|NCT00103662|580484646|FG001|Overall Study|Entered Rescue Procedure|7|||
160753720|NCT00103662|580484645|FG000|Overall Study|Death|7|||
160753721|NCT00103662|580484646|FG001|Overall Study|Death|7|||
160753722|NCT00103662|580484645|FG000|Overall Study|Elective Withdrawal|5|||
160753723|NCT00103662|580484646|FG001|Overall Study|Elective Withdrawal|5|||
160753724|NCT00103662|580484645|FG000|Overall Study|Lost to Follow-up|0|||
160753725|NCT00103662|580484646|FG001|Overall Study|Lost to Follow-up|1|||
160753726|NCT00103662|580484645|FG000|Overall Study|Other|6|||
160753727|NCT00103662|580484646|FG001|Overall Study|Other|9|||
160753728|NCT00103662|580484645|FG000|Overall Study|Failed mobilization|0|||
160753729|NCT00103662|580484646|FG001|Overall Study|Failed mobilization|4|||
160753730|NCT00103662|580484645|FG000|Overall Study|Intercurrent illness|1|||
160753731|NCT00103662|580484646|FG001|Overall Study|Intercurrent illness|0|||
160753732|NCT03373760|580484647|FG000|Overall Study|Adverse Event|8|||
160753733|NCT03373760|580484647|FG000|Overall Study|Disease Progression|46|||
160753734|NCT03373760|580484647|FG000|Overall Study|Death|4|||
160753735|NCT01135524|580484660|FG000|Overall Study|Withdrawal by Subject|14|||
160753736|NCT01135524|580484660|FG000|Overall Study|Adverse Event|20|||
160753737|NCT01135524|580484660|FG000|Overall Study|Lost to Follow-up|3|||
160753738|NCT01135524|580484660|FG000|Overall Study|Administrative|151|||
160753739|NCT01135524|580484660|FG000|Overall Study|Lack of Efficacy|8|||
160753740|NCT00613821|580484661|FG000|Overall Study|Withdrawal by Subject|1|||
160753741|NCT00613821|580484662|FG001|Overall Study|Withdrawal by Subject|0|||
160753742|NCT00613821|580484661|FG000|Overall Study|Physician Decision|1|||
160753743|NCT00613821|580484662|FG001|Overall Study|Physician Decision|1|||
160753744|NCT01266824|580484664|FG000|Overall Study|Study terminated prior to completion|2|||
160753745|NCT01266824|580484665|FG001|Overall Study|Study terminated prior to completion|3|||
160753746|NCT00397189|580484666|FG000|3 Weeks Period|Lost to Follow-up|5|||
160753747|NCT00397189|580484667|FG001|3 Weeks Period|Lost to Follow-up|4|||
160753748|NCT00397189|580484666|FG000|3 Weeks Period|Adverse Event|3|||
160753749|NCT00397189|580484667|FG001|3 Weeks Period|Adverse Event|2|||
160753750|NCT00397189|580484666|FG000|3 Weeks Period|Withdrawal by Subject|13|||
160753751|NCT00397189|580484667|FG001|3 Weeks Period|Withdrawal by Subject|9|||
160753752|NCT00397189|580484666|FG000|3 Weeks Period|Physician Decision|0|||
160753753|NCT00397189|580484667|FG001|3 Weeks Period|Physician Decision|2|||
160753754|NCT00397189|580484666|FG000|3 Weeks Period|Protocol Violation|0|||
160753755|NCT00397189|580484667|FG001|3 Weeks Period|Protocol Violation|3|||
160753756|NCT00397189|580484666|FG000|3 Weeks Period|Other|0|||
160753757|NCT00397189|580484667|FG001|3 Weeks Period|Other|2|||
160753758|NCT00141518|580484670|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
160753759|NCT00141518|580484671|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
160635993|NCT00391118|580049427|FG000|Overall Study|Withdrawal by Subject|0|||
160753760|NCT00141518|580484672|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
160753761|NCT00141518|580484670|FG000|Overall Study|Adverse Event|7|||
160753762|NCT00141518|580484671|FG001|Overall Study|Adverse Event|5|||
160753763|NCT00141518|580484672|FG002|Overall Study|Adverse Event|2|||
160753764|NCT00141518|580484670|FG000|Overall Study|Withdrawal by Subject|2|||
160753765|NCT00141518|580484671|FG001|Overall Study|Withdrawal by Subject|0|||
160753766|NCT00141518|580484672|FG002|Overall Study|Withdrawal by Subject|2|||
160753767|NCT00141518|580484670|FG000|Overall Study|Protocol Violation|1|||
160753768|NCT00141518|580484671|FG001|Overall Study|Protocol Violation|1|||
160753769|NCT00141518|580484672|FG002|Overall Study|Protocol Violation|2|||
160753770|NCT00141518|580484670|FG000|Overall Study|Lack of Efficacy|5|||
160753771|NCT00141518|580484671|FG001|Overall Study|Lack of Efficacy|0|||
160753772|NCT00141518|580484672|FG002|Overall Study|Lack of Efficacy|0|||
160753773|NCT02896569|580484677|FG000|Overall Study|Lost to Follow-up|2|||
160753774|NCT02896569|580484678|FG001|Overall Study|Lost to Follow-up|1|||
160753775|NCT02896569|580484677|FG000|Overall Study|Physician Decision|1|||
160635994|NCT00391118|580049428|FG001|Overall Study|Withdrawal by Subject|9|||
160753776|NCT02896569|580484678|FG001|Overall Study|Physician Decision|3|||
160753777|NCT02896569|580484677|FG000|Overall Study|Adverse Event|0|||
160753778|NCT02896569|580484678|FG001|Overall Study|Adverse Event|1|||
160753779|NCT02896569|580484677|FG000|Overall Study|Withdrawal by Subject|1|||
160635995|NCT00391118|580049429|FG002|Overall Study|Withdrawal by Subject|1|||
160635996|NCT00391118|580049427|FG000|Overall Study|Death|0|||
160635997|NCT00391118|580049428|FG001|Overall Study|Death|1|||
160635998|NCT00391118|580049429|FG002|Overall Study|Death|0|||
160635999|NCT00391118|580049427|FG000|Overall Study|Physician Decision|0|||
160636000|NCT00391118|580049428|FG001|Overall Study|Physician Decision|3|||
160636001|NCT00391118|580049429|FG002|Overall Study|Physician Decision|0|||
160636002|NCT00391118|580049427|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
160636003|NCT00391118|580049428|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
160636004|NCT00391118|580049429|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
160636005|NCT00391118|580049427|FG000|Overall Study|Progressive Disease|7|||
160636006|NCT00391118|580049428|FG001|Overall Study|Progressive Disease|26|||
160636007|NCT00391118|580049429|FG002|Overall Study|Progressive Disease|43|||
160636008|NCT00391118|580049427|FG000|Overall Study|Sponsor Decision|0|||
160636009|NCT00391118|580049428|FG001|Overall Study|Sponsor Decision|1|||
160636010|NCT00391118|580049429|FG002|Overall Study|Sponsor Decision|3|||
160636011|NCT00391118|580049427|FG000|Overall Study|Protocol Violation|1|||
160636012|NCT00391118|580049428|FG001|Overall Study|Protocol Violation|0|||
160636013|NCT00391118|580049429|FG002|Overall Study|Protocol Violation|0|||
160636014|NCT00314262|580049430|FG000|Overall Study|Adverse Event|2|||
160524817|NCT00883051|579650147|FG004|Overall Study|Lost to Follow-up|1|||
160524818|NCT00883051|579650143|FG000|Overall Study|Did not use study medication|24|||
160524819|NCT00883051|579650144|FG001|Overall Study|Did not use study medication|22|||
160524820|NCT00883051|579650145|FG002|Overall Study|Did not use study medication|29|||
160524821|NCT00883051|579650146|FG003|Overall Study|Did not use study medication|29|||
160524822|NCT00883051|579650147|FG004|Overall Study|Did not use study medication|17|||
160524823|NCT03144804|579650148|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
160524824|NCT00959647|579650149|FG000|Overall Study|Adverse Event|2|||
160524825|NCT00959647|579650149|FG000|Overall Study|Progressive disease|6|||
160524826|NCT00959647|579650149|FG000|Overall Study|Study terminated by sponsor|4|||
160524827|NCT00959647|579650149|FG000|Overall Study|Withdrawal by Subject|7|||
160524828|NCT04223856|579650150|FG000|Overall Study|Progressive disease|153|||
160524829|NCT04223856|579650151|FG001|Overall Study|Progressive disease|73|||
160524830|NCT04223856|579650150|FG000|Overall Study|Adverse Event|97|||
160524831|NCT04223856|579650151|FG001|Overall Study|Adverse Event|62|||
160524832|NCT04223856|579650150|FG000|Overall Study|Physician Decision|9|||
160753780|NCT02896569|580484678|FG001|Overall Study|Withdrawal by Subject|0|||
160753781|NCT01462630|580484679|FG000|Overall Study|Did not initiate therapy|3|||
160753782|NCT01462630|580484679|FG000|Overall Study|Death|1|||
160753783|NCT01462630|580484679|FG000|Overall Study|Protocol Violation|2|||
160753784|NCT01462630|580484679|FG000|Overall Study|Adverse Event|1|||
160753785|NCT01411852|580484685|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
160753786|NCT01411852|580484686|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
160753787|NCT01411852|580484685|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
160753788|NCT01411852|580484686|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
160753789|NCT01411852|580484685|FG000|Prehospital Intervention Phase|Found to be under age|0|||
160753790|NCT01411852|580484686|FG001|Prehospital Intervention Phase|Found to be under age|1|||
160753791|NCT01411852|580484685|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
160753792|NCT01411852|580484686|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
160753793|NCT01411852|580484685|FG000|Hospital Intervention Phase|Severe head injury|5|||
160753794|NCT01411852|580484686|FG001|Hospital Intervention Phase|Severe head injury|4|||
160753795|NCT01411852|580484685|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
160753796|NCT01411852|580484686|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
160753797|NCT01411852|580484685|FG000|Hospital Intervention Phase|Miscommunication error|1|||
160753798|NCT01411852|580484686|FG001|Hospital Intervention Phase|Miscommunication error|2|||
160753799|NCT01411852|580484685|FG000|Hospital Intervention Phase|CPR administered|3|||
160753800|NCT01411852|580484686|FG001|Hospital Intervention Phase|CPR administered|1|||
160753801|NCT01411852|580484685|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
160753802|NCT01411852|580484686|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
160753803|NCT01411852|580484685|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
160753804|NCT01411852|580484686|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
160753805|NCT01411852|580484685|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
160753806|NCT01411852|580484686|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
160753807|NCT01411852|580484685|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
160753808|NCT01411852|580484686|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
160753809|NCT01411852|580484685|FG000|Hospital Intervention Phase|Other ineligible|2|||
160753810|NCT01411852|580484686|FG001|Hospital Intervention Phase|Other ineligible|2|||
160753811|NCT01411852|580484685|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
160753812|NCT01411852|580484686|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
160753813|NCT01411852|580484685|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
160753814|NCT01411852|580484686|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
160753815|NCT01411852|580484685|FG000|Hospital Intervention Phase|Vascular access failed|1|||
160753816|NCT01411852|580484686|FG001|Hospital Intervention Phase|Vascular access failed|0|||
160753817|NCT05095311|580484688|FG000|Overall Study|Lost to Follow-up|7|||
160753818|NCT05095311|580484689|FG001|Overall Study|Lost to Follow-up|0|||
160753819|NCT05095311|580484690|FG002|Overall Study|Lost to Follow-up|0|||
160753820|NCT00805129|580484694|FG000|Overall Study|Not treated|1|||
160753821|NCT00571662|580484695|FG000|Overall Study|Withdrawal by Subject|2|||
160753822|NCT00571662|580484695|FG000|Overall Study|psychiatric instability|1|||
160753823|NCT00571662|580484695|FG000|Overall Study|Adverse Event|5|||
160753824|NCT00103285|580486611|FG000|Induction|Adverse Event|14|||
160753825|NCT00103285|580486612|FG001|Induction|Adverse Event|0|||
160753826|NCT00103285|580486613|FG002|Induction|Adverse Event|0|||
160753827|NCT00103285|580486614|FG003|Induction|Adverse Event|0|||
160753828|NCT00103285|580486615|FG004|Induction|Adverse Event|0|||
160753829|NCT00103285|580486616|FG005|Induction|Adverse Event|0|||
160753830|NCT00103285|580486617|FG006|Induction|Adverse Event|0|||
160753831|NCT00103285|580486618|FG007|Induction|Adverse Event|0|||
160753832|NCT00103285|580486611|FG000|Induction|Death|24|||
160753833|NCT00103285|580486612|FG001|Induction|Death|0|||
160753834|NCT00103285|580486613|FG002|Induction|Death|0|||
160753835|NCT00103285|580486614|FG003|Induction|Death|0|||
160753836|NCT00103285|580486615|FG004|Induction|Death|0|||
160753837|NCT00103285|580486616|FG005|Induction|Death|0|||
160753838|NCT00103285|580486617|FG006|Induction|Death|0|||
160753839|NCT00103285|580486618|FG007|Induction|Death|0|||
160753840|NCT00103285|580486611|FG000|Induction|Physician Decision|103|||
160753841|NCT00103285|580486612|FG001|Induction|Physician Decision|0|||
160753842|NCT00103285|580486613|FG002|Induction|Physician Decision|0|||
160753843|NCT00103285|580486614|FG003|Induction|Physician Decision|0|||
160753844|NCT00103285|580486615|FG004|Induction|Physician Decision|0|||
160753845|NCT00103285|580486616|FG005|Induction|Physician Decision|0|||
160753846|NCT00103285|580486617|FG006|Induction|Physician Decision|0|||
160753847|NCT00103285|580486618|FG007|Induction|Physician Decision|0|||
160753848|NCT00103285|580486611|FG000|Induction|Withdrawal by Subject|1|||
160753849|NCT00103285|580486612|FG001|Induction|Withdrawal by Subject|0|||
160753850|NCT00103285|580486613|FG002|Induction|Withdrawal by Subject|0|||
160753851|NCT00103285|580486614|FG003|Induction|Withdrawal by Subject|0|||
160753852|NCT00103285|580486615|FG004|Induction|Withdrawal by Subject|0|||
160753853|NCT00103285|580486616|FG005|Induction|Withdrawal by Subject|0|||
160753854|NCT00103285|580486617|FG006|Induction|Withdrawal by Subject|0|||
160753855|NCT00103285|580486618|FG007|Induction|Withdrawal by Subject|0|||
160753856|NCT00103285|580486611|FG000|Induction|Ineligible|43|||
160753857|NCT00103285|580486612|FG001|Induction|Ineligible|0|||
160753858|NCT00103285|580486613|FG002|Induction|Ineligible|0|||
160753859|NCT00103285|580486614|FG003|Induction|Ineligible|0|||
160753860|NCT00103285|580486615|FG004|Induction|Ineligible|0|||
160753861|NCT00103285|580486616|FG005|Induction|Ineligible|0|||
160753862|NCT00103285|580486617|FG006|Induction|Ineligible|0|||
160753863|NCT00103285|580486618|FG007|Induction|Ineligible|0|||
160753864|NCT00103285|580486611|FG000|Induction|Refusal|906|||
160753865|NCT00103285|580486612|FG001|Induction|Refusal|0|||
160753866|NCT00103285|580486613|FG002|Induction|Refusal|0|||
160753867|NCT00103285|580486614|FG003|Induction|Refusal|0|||
160753868|NCT00103285|580486615|FG004|Induction|Refusal|0|||
160753869|NCT00103285|580486616|FG005|Induction|Refusal|0|||
160753870|NCT00103285|580486617|FG006|Induction|Refusal|0|||
160753871|NCT00103285|580486618|FG007|Induction|Refusal|0|||
160753872|NCT00103285|580486611|FG000|Induction|Other|258|||
160753873|NCT00103285|580486612|FG001|Induction|Other|0|||
160753874|NCT00103285|580486613|FG002|Induction|Other|0|||
160753875|NCT00103285|580486614|FG003|Induction|Other|0|||
160753876|NCT00103285|580486615|FG004|Induction|Other|0|||
160753877|NCT00103285|580486616|FG005|Induction|Other|0|||
160753878|NCT00103285|580486617|FG006|Induction|Other|0|||
160753879|NCT00103285|580486618|FG007|Induction|Other|0|||
160753880|NCT00103285|580486611|FG000|Response Assignment|Adverse Event|0|||
160753881|NCT00103285|580486612|FG001|Response Assignment|Adverse Event|8|||
160753882|NCT00103285|580486613|FG002|Response Assignment|Adverse Event|3|||
160524833|NCT04223856|579650151|FG001|Overall Study|Physician Decision|28|||
160753883|NCT00103285|580486614|FG003|Response Assignment|Adverse Event|2|||
160753884|NCT00103285|580486615|FG004|Response Assignment|Adverse Event|3|||
160753885|NCT00103285|580486616|FG005|Response Assignment|Adverse Event|1|||
160753886|NCT00103285|580486617|FG006|Response Assignment|Adverse Event|1|||
160753887|NCT00103285|580486618|FG007|Response Assignment|Adverse Event|2|||
160753888|NCT00103285|580486611|FG000|Response Assignment|Death|0|||
160753889|NCT00103285|580486612|FG001|Response Assignment|Death|5|||
160753890|NCT00103285|580486613|FG002|Response Assignment|Death|2|||
160753891|NCT00103285|580486614|FG003|Response Assignment|Death|2|||
160753892|NCT00103285|580486615|FG004|Response Assignment|Death|3|||
160753893|NCT00103285|580486616|FG005|Response Assignment|Death|1|||
160753894|NCT00103285|580486617|FG006|Response Assignment|Death|0|||
160753895|NCT00103285|580486618|FG007|Response Assignment|Death|8|||
160753896|NCT00103285|580486611|FG000|Response Assignment|Lost to Follow-up|0|||
160753897|NCT00103285|580486612|FG001|Response Assignment|Lost to Follow-up|9|||
160753898|NCT00103285|580486613|FG002|Response Assignment|Lost to Follow-up|5|||
160524834|NCT04223856|579650150|FG000|Overall Study|Withdrawal by Subject|22|||
160524835|NCT04223856|579650151|FG001|Overall Study|Withdrawal by Subject|24|||
160524836|NCT04223856|579650150|FG000|Overall Study|Other|7|||
160753899|NCT00103285|580486614|FG003|Response Assignment|Lost to Follow-up|5|||
160753900|NCT00103285|580486615|FG004|Response Assignment|Lost to Follow-up|1|||
160753901|NCT00103285|580486616|FG005|Response Assignment|Lost to Follow-up|2|||
160524837|NCT04223856|579650151|FG001|Overall Study|Other|2|||
160753902|NCT00103285|580486617|FG006|Response Assignment|Lost to Follow-up|2|||
160753903|NCT00103285|580486618|FG007|Response Assignment|Lost to Follow-up|5|||
160753904|NCT00103285|580486611|FG000|Response Assignment|Physician Decision|0|||
160753905|NCT00103285|580486612|FG001|Response Assignment|Physician Decision|13|||
160753906|NCT00103285|580486613|FG002|Response Assignment|Physician Decision|14|||
160753907|NCT00103285|580486614|FG003|Response Assignment|Physician Decision|9|||
160753908|NCT00103285|580486615|FG004|Response Assignment|Physician Decision|13|||
160753909|NCT00103285|580486616|FG005|Response Assignment|Physician Decision|7|||
160753910|NCT00103285|580486617|FG006|Response Assignment|Physician Decision|4|||
160753911|NCT00103285|580486618|FG007|Response Assignment|Physician Decision|35|||
160524838|NCT04223856|579650150|FG000|Overall Study|Randomized but not treated|2|||
160524839|NCT04223856|579650151|FG001|Overall Study|Randomized but not treated|11|||
160753912|NCT00103285|580486611|FG000|Response Assignment|Protocol Violation|0|||
160753913|NCT00103285|580486612|FG001|Response Assignment|Protocol Violation|2|||
160753914|NCT00103285|580486613|FG002|Response Assignment|Protocol Violation|0|||
160753915|NCT00103285|580486614|FG003|Response Assignment|Protocol Violation|0|||
160753916|NCT00103285|580486615|FG004|Response Assignment|Protocol Violation|0|||
160753917|NCT00103285|580486616|FG005|Response Assignment|Protocol Violation|0|||
160753918|NCT00103285|580486617|FG006|Response Assignment|Protocol Violation|0|||
160753919|NCT00103285|580486618|FG007|Response Assignment|Protocol Violation|0|||
160753920|NCT00103285|580486611|FG000|Response Assignment|Withdrawal by Subject|0|||
160753921|NCT00103285|580486612|FG001|Response Assignment|Withdrawal by Subject|4|||
160753922|NCT00103285|580486613|FG002|Response Assignment|Withdrawal by Subject|1|||
160753923|NCT00103285|580486614|FG003|Response Assignment|Withdrawal by Subject|1|||
160753924|NCT00103285|580486615|FG004|Response Assignment|Withdrawal by Subject|2|||
160753925|NCT00103285|580486616|FG005|Response Assignment|Withdrawal by Subject|2|||
160753926|NCT00103285|580486617|FG006|Response Assignment|Withdrawal by Subject|0|||
160753927|NCT00103285|580486618|FG007|Response Assignment|Withdrawal by Subject|2|||
160753928|NCT00103285|580486611|FG000|Response Assignment|Ineligible|0|||
160753929|NCT00103285|580486612|FG001|Response Assignment|Ineligible|8|||
160753930|NCT00103285|580486613|FG002|Response Assignment|Ineligible|6|||
160753931|NCT00103285|580486614|FG003|Response Assignment|Ineligible|2|||
160753932|NCT00103285|580486615|FG004|Response Assignment|Ineligible|0|||
160753933|NCT00103285|580486616|FG005|Response Assignment|Ineligible|3|||
160753934|NCT00103285|580486617|FG006|Response Assignment|Ineligible|1|||
160753935|NCT00103285|580486618|FG007|Response Assignment|Ineligible|5|||
160753936|NCT00103285|580486611|FG000|Response Assignment|Refusal|0|||
160753937|NCT00103285|580486612|FG001|Response Assignment|Refusal|53|||
160524840|NCT04223856|579650150|FG000|Overall Study|On-treatment|144|||
160753938|NCT00103285|580486613|FG002|Response Assignment|Refusal|5|||
160524841|NCT04223856|579650151|FG001|Overall Study|On-treatment|0|||
160524842|NCT06515483|579650154|FG000|Overall Study|Subject withdraw due to family issues|1|||
160524843|NCT06515483|579650155|FG001|Overall Study|Subject withdraw due to family issues|0|||
160524844|NCT01128361|579651701|FG000|Overall Study|Lost to Follow-up|0|||
160524845|NCT01128361|579651702|FG001|Overall Study|Lost to Follow-up|1|||
160524846|NCT01128361|579651701|FG000|Overall Study|Withdrawal by Subject|5|||
160524847|NCT01128361|579651702|FG001|Overall Study|Withdrawal by Subject|2|||
160636015|NCT00314262|580049430|FG000|Overall Study|Withdrawal by Subject|2|||
160636016|NCT00314262|580049430|FG000|Overall Study|Physician Decision|1|||
160636017|NCT00532779|580049431|FG000|Overall Study|Adverse Event|122|||
160636018|NCT00532779|580049432|FG001|Overall Study|Adverse Event|112|||
160636019|NCT00532779|580049433|FG002|Overall Study|Adverse Event|56|||
160753939|NCT00103285|580486614|FG003|Response Assignment|Refusal|3|||
160753940|NCT00103285|580486615|FG004|Response Assignment|Refusal|25|||
160753941|NCT00103285|580486616|FG005|Response Assignment|Refusal|15|||
160753942|NCT00103285|580486617|FG006|Response Assignment|Refusal|30|||
160753943|NCT00103285|580486618|FG007|Response Assignment|Refusal|10|||
160753944|NCT00103285|580486611|FG000|Response Assignment|Other|0|||
160753945|NCT00103285|580486612|FG001|Response Assignment|Other|30|||
160753946|NCT00103285|580486613|FG002|Response Assignment|Other|48|||
160753947|NCT00103285|580486614|FG003|Response Assignment|Other|38|||
160753948|NCT00103285|580486615|FG004|Response Assignment|Other|37|||
160636020|NCT00532779|580049431|FG000|Overall Study|Lost to Follow-up|76|||
160524848|NCT05736211|579651719|FG000|Overall Study|Lost to Follow-up|6|||
160524849|NCT05736211|579651720|FG001|Overall Study|Lost to Follow-up|0|||
160524850|NCT01180998|579651724|FG000|Overall Study|Poor Vision|0|||
160524851|NCT01180998|579651725|FG001|Overall Study|Poor Vision|2|||
160753949|NCT00103285|580486616|FG005|Response Assignment|Other|17|||
160753950|NCT00103285|580486617|FG006|Response Assignment|Other|11|||
160753951|NCT00103285|580486618|FG007|Response Assignment|Other|53|||
160753952|NCT00391872|580486619|FG000|Overall Study|Protocol Violation|7|||
160636021|NCT00532779|580049432|FG001|Overall Study|Lost to Follow-up|65|||
160753953|NCT00391872|580486620|FG001|Overall Study|Protocol Violation|2|||
160753954|NCT00391872|580486619|FG000|Overall Study|Withdrawal by Subject|296|||
160753955|NCT00391872|580486620|FG001|Overall Study|Withdrawal by Subject|249|||
160753956|NCT00391872|580486619|FG000|Overall Study|Reason unknown|2|||
160753957|NCT00391872|580486620|FG001|Overall Study|Reason unknown|4|||
160524852|NCT01180998|579651726|FG002|Overall Study|Poor Vision|2|||
160524853|NCT01180998|579651724|FG000|Overall Study|Lost to Follow-up|0|||
160753958|NCT00391872|580486619|FG000|Overall Study|Lost to Follow-up|2|||
160636022|NCT00532779|580049433|FG002|Overall Study|Lost to Follow-up|66|||
160636023|NCT00532779|580049431|FG000|Overall Study|Withdrawal by Subject|63|||
160636024|NCT00532779|580049432|FG001|Overall Study|Withdrawal by Subject|60|||
160636025|NCT00532779|580049433|FG002|Overall Study|Withdrawal by Subject|90|||
160636026|NCT00532779|580049431|FG000|Overall Study|Lack of Efficacy|12|||
160636027|NCT00532779|580049432|FG001|Overall Study|Lack of Efficacy|12|||
160636028|NCT00532779|580049433|FG002|Overall Study|Lack of Efficacy|40|||
160636029|NCT00532779|580049431|FG000|Overall Study|Protocol Violation|5|||
160636030|NCT00532779|580049432|FG001|Overall Study|Protocol Violation|9|||
160636031|NCT00532779|580049433|FG002|Overall Study|Protocol Violation|7|||
160636032|NCT00532779|580049431|FG000|Overall Study|Pregnancy|2|||
160636033|NCT00532779|580049432|FG001|Overall Study|Pregnancy|5|||
160636034|NCT00532779|580049433|FG002|Overall Study|Pregnancy|3|||
160636035|NCT00532779|580049431|FG000|Overall Study|Death|0|||
160636036|NCT00532779|580049432|FG001|Overall Study|Death|1|||
160636037|NCT00532779|580049433|FG002|Overall Study|Death|0|||
160636038|NCT00532779|580049431|FG000|Overall Study|Drug noncompliance, moved, other|14|||
160636039|NCT00532779|580049432|FG001|Overall Study|Drug noncompliance, moved, other|23|||
160753959|NCT00391872|580486620|FG001|Overall Study|Lost to Follow-up|0|||
160753960|NCT04826484|580486621|FG000|Overall Study|Lost to Follow-up|2|||
160524854|NCT01180998|579651725|FG001|Overall Study|Lost to Follow-up|0|||
160753961|NCT04826484|580486622|FG001|Overall Study|Lost to Follow-up|0|||
160753962|NCT00823264|580486624|FG000|Overall Study|Protocol Violation|2|||
160753963|NCT00823264|580486625|FG001|Overall Study|Protocol Violation|0|||
160753964|NCT01914393|580486626|FG000|Overall Study|Protocol Violation|11|||
160753965|NCT01914393|580486627|FG001|Overall Study|Protocol Violation|3|||
160753966|NCT01914393|580486628|FG002|Overall Study|Protocol Violation|19|||
160753967|NCT01914393|580486626|FG000|Overall Study|Lack of Efficacy|11|||
160753968|NCT01914393|580486627|FG001|Overall Study|Lack of Efficacy|16|||
160753969|NCT01914393|580486628|FG002|Overall Study|Lack of Efficacy|5|||
160753970|NCT01914393|580486626|FG000|Overall Study|no reason given|14|||
160753971|NCT01914393|580486627|FG001|Overall Study|no reason given|8|||
160753972|NCT01914393|580486628|FG002|Overall Study|no reason given|16|||
160753973|NCT01914393|580486626|FG000|Overall Study|Adverse Event|29|||
160753974|NCT01914393|580486627|FG001|Overall Study|Adverse Event|18|||
160753975|NCT01914393|580486628|FG002|Overall Study|Adverse Event|31|||
160753976|NCT01914393|580486626|FG000|Overall Study|Withdrawal by Subject|38|||
160753977|NCT01914393|580486627|FG001|Overall Study|Withdrawal by Subject|20|||
160753978|NCT01914393|580486628|FG002|Overall Study|Withdrawal by Subject|47|||
160753979|NCT01914393|580486626|FG000|Overall Study|Lost to Follow-up|12|||
160753980|NCT01914393|580486627|FG001|Overall Study|Lost to Follow-up|6|||
160753981|NCT01914393|580486628|FG002|Overall Study|Lost to Follow-up|19|||
160753982|NCT01914393|580486626|FG000|Overall Study|subject never dosed|0|||
160753983|NCT01914393|580486627|FG001|Overall Study|subject never dosed|0|||
160753984|NCT01914393|580486628|FG002|Overall Study|subject never dosed|1|||
160753985|NCT02907463|580486633|FG000|Overall Study|Lost to Follow-up|17|||
160753986|NCT02907463|580486633|FG000|Overall Study|Death|10|||
160753987|NCT02907463|580486633|FG000|Overall Study|Withdrawal by Subject|4|||
160753988|NCT02907463|580486633|FG000|Overall Study|MIS Approach was not used|2|||
160753989|NCT02907463|580486633|FG000|Overall Study|Not Implanted with Study Device|2|||
160753990|NCT02907463|580486633|FG000|Overall Study|Device Explanted|1|||
160753991|NCT02907463|580486633|FG000|Overall Study|Missing Exit Form|1|||
160753992|NCT02302846|580486634|FG000|Overall Study|Withdrawal by Subject|1|||
160753993|NCT01447407|580486637|FG000|Overall Study|Withdrawal by Subject|2|||
160753994|NCT01447407|580486638|FG001|Overall Study|Withdrawal by Subject|0|||
160753995|NCT01447407|580486639|FG002|Overall Study|Withdrawal by Subject|0|||
160753996|NCT01447407|580486640|FG003|Overall Study|Withdrawal by Subject|1|||
160753997|NCT01447407|580486637|FG000|Overall Study|Physician Decision|0|||
160753998|NCT01447407|580486638|FG001|Overall Study|Physician Decision|0|||
160753999|NCT01447407|580486639|FG002|Overall Study|Physician Decision|1|||
160754000|NCT01447407|580486640|FG003|Overall Study|Physician Decision|1|||
160754001|NCT00872521|580486643|FG000|Completed PAD Induction|Patient choice|0|||
160754002|NCT00872521|580486644|FG001|Completed PAD Induction|Patient choice|1|||
160754003|NCT00872521|580486645|FG002|Completed PAD Induction|Patient choice|0|||
160754004|NCT00872521|580486643|FG000|Completed PAD Induction|Disease progression|0|||
160754005|NCT00872521|580486644|FG001|Completed PAD Induction|Disease progression|2|||
160754006|NCT00872521|580486645|FG002|Completed PAD Induction|Disease progression|0|||
160754007|NCT00872521|580486643|FG000|Completed PAD Induction|Adverse Event|4|||
160754008|NCT00872521|580486644|FG001|Completed PAD Induction|Adverse Event|0|||
160754009|NCT00872521|580486645|FG002|Completed PAD Induction|Adverse Event|0|||
160754010|NCT00872521|580486643|FG000|Completed PAD Induction|Death|1|||
160754011|NCT00872521|580486644|FG001|Completed PAD Induction|Death|1|||
160754012|NCT00872521|580486645|FG002|Completed PAD Induction|Death|0|||
160754013|NCT00872521|580486643|FG000|Primary Endpoint Analysis|Other|1|||
160754014|NCT00872521|580486644|FG001|Primary Endpoint Analysis|Other|2|||
160754015|NCT00872521|580486645|FG002|Primary Endpoint Analysis|Other|0|||
160754016|NCT00872521|580486643|FG000|Primary Endpoint Analysis|Patient choice|0|||
160754017|NCT00872521|580486644|FG001|Primary Endpoint Analysis|Patient choice|1|||
160754018|NCT00872521|580486645|FG002|Primary Endpoint Analysis|Patient choice|0|||
160754019|NCT00872521|580486643|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
160754020|NCT00872521|580486644|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
160754021|NCT00872521|580486645|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
160754022|NCT00872521|580486643|FG000|Primary Endpoint Analysis|Patient response missing|0|||
160754023|NCT00872521|580486644|FG001|Primary Endpoint Analysis|Patient response missing|0|||
160754024|NCT00872521|580486645|FG002|Primary Endpoint Analysis|Patient response missing|1|||
160754025|NCT00872521|580486643|FG000|Completed 3-month Follow up|Other|0|||
160754026|NCT00872521|580486644|FG001|Completed 3-month Follow up|Other|2|||
160754027|NCT00872521|580486645|FG002|Completed 3-month Follow up|Other|0|||
160754028|NCT00872521|580486643|FG000|Completed 3-month Follow up|Physician Decision|0|||
160524855|NCT01180998|579651726|FG002|Overall Study|Lost to Follow-up|1|||
160754029|NCT00872521|580486644|FG001|Completed 3-month Follow up|Physician Decision|1|||
160754030|NCT00872521|580486645|FG002|Completed 3-month Follow up|Physician Decision|0|||
160754031|NCT00872521|580486643|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
160754032|NCT00872521|580486644|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
160754033|NCT00872521|580486645|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
160754034|NCT05225558|580486646|FG000|Overall Study|Withdrawal by Subject|4|||
160754035|NCT05225558|580486647|FG001|Overall Study|Withdrawal by Subject|3|||
160754036|NCT05225558|580486646|FG000|Overall Study|Adverse Event|1|||
160754037|NCT05225558|580486647|FG001|Overall Study|Adverse Event|0|||
160754038|NCT05225558|580486646|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
160754039|NCT05225558|580486647|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
160754040|NCT05225558|580486646|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
160754041|NCT05225558|580486647|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
160754042|NCT01001910|580486648|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
160754043|NCT01089127|580486649|FG000|Overall Study|Adverse Event|5|||
160754044|NCT01089127|580486650|FG001|Overall Study|Adverse Event|1|||
160754045|NCT01089127|580486651|FG002|Overall Study|Adverse Event|1|||
160754046|NCT01089127|580486652|FG003|Overall Study|Adverse Event|0|||
160754047|NCT01089127|580486653|FG004|Overall Study|Adverse Event|0|||
160754048|NCT01089127|580486654|FG005|Overall Study|Adverse Event|1|||
160754049|NCT01089127|580486649|FG000|Overall Study|Subject withdrew consent|0|||
160754050|NCT01089127|580486650|FG001|Overall Study|Subject withdrew consent|1|||
160754051|NCT01089127|580486651|FG002|Overall Study|Subject withdrew consent|1|||
160754052|NCT01089127|580486652|FG003|Overall Study|Subject withdrew consent|1|||
160754053|NCT01089127|580486653|FG004|Overall Study|Subject withdrew consent|0|||
160754054|NCT01089127|580486654|FG005|Overall Study|Subject withdrew consent|2|||
160754055|NCT01089127|580486649|FG000|Overall Study|Abnormal test procedure result(s)|2|||
160754056|NCT01089127|580486650|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160754057|NCT01089127|580486651|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160754058|NCT01089127|580486652|FG003|Overall Study|Abnormal test procedure result(s)|0|||
160754059|NCT01089127|580486653|FG004|Overall Study|Abnormal test procedure result(s)|0|||
160754060|NCT01089127|580486654|FG005|Overall Study|Abnormal test procedure result(s)|0|||
160754061|NCT01089127|580486649|FG000|Overall Study|Lost to Follow-up|1|||
160754062|NCT01089127|580486650|FG001|Overall Study|Lost to Follow-up|1|||
160754063|NCT01089127|580486651|FG002|Overall Study|Lost to Follow-up|0|||
160754064|NCT01089127|580486652|FG003|Overall Study|Lost to Follow-up|0|||
160754065|NCT01089127|580486653|FG004|Overall Study|Lost to Follow-up|1|||
160754066|NCT01089127|580486654|FG005|Overall Study|Lost to Follow-up|0|||
160754067|NCT01089127|580486649|FG000|Overall Study|Protocol deviation|0|||
160754068|NCT01089127|580486650|FG001|Overall Study|Protocol deviation|1|||
160754069|NCT01089127|580486651|FG002|Overall Study|Protocol deviation|0|||
160754070|NCT01089127|580486652|FG003|Overall Study|Protocol deviation|0|||
160754071|NCT01089127|580486653|FG004|Overall Study|Protocol deviation|1|||
160754072|NCT01089127|580486654|FG005|Overall Study|Protocol deviation|0|||
160754073|NCT03200548|580486655|FG000|Overall Study|Withdrawal by Subject|5|||
160754074|NCT03200548|580486656|FG001|Overall Study|Withdrawal by Subject|11|||
160754075|NCT03200548|580486657|FG002|Overall Study|Withdrawal by Subject|7|||
160754076|NCT03200548|580486658|FG003|Overall Study|Withdrawal by Subject|6|||
160754077|NCT00875563|580486660|FG000|Overall Study|Death|4|||
160754078|NCT00875563|580486660|FG000|Overall Study|Withdrawal by Subject|7|||
160754079|NCT00875563|580486660|FG000|Overall Study|No long-term (3-5 year) consent|6|||
160754080|NCT00875563|580486660|FG000|Overall Study|Still be eligible for follow-up|7|||
160754081|NCT00511810|580486663|FG000|Overall Study|Lost to Follow-up|1|||
160754082|NCT00511810|580486664|FG001|Overall Study|Lost to Follow-up|2|||
160754083|NCT00511810|580486663|FG000|Overall Study|Lack of Efficacy|0|||
160754084|NCT00511810|580486664|FG001|Overall Study|Lack of Efficacy|2|||
160754085|NCT00511810|580486663|FG000|Overall Study|Refused second scn|0|||
160754086|NCT00511810|580486664|FG001|Overall Study|Refused second scn|1|||
160524856|NCT01180998|579651724|FG000|Overall Study|Protocol Violation|1|||
160754087|NCT00313846|580486665|FG000|Overall Study|Withdrawal by Subject|2|||
160754088|NCT00313846|580486666|FG001|Overall Study|Withdrawal by Subject|0|||
160754089|NCT00313846|580486665|FG000|Overall Study|Adverse Event|1|||
160754090|NCT00313846|580486666|FG001|Overall Study|Adverse Event|8|||
160754091|NCT00313846|580486665|FG000|Overall Study|Administrative|2|||
160524857|NCT01180998|579651725|FG001|Overall Study|Protocol Violation|2|||
160754092|NCT00313846|580486666|FG001|Overall Study|Administrative|3|||
160754093|NCT01896193|580486669|FG000|Overall Study|Lack of Efficacy|20|||
160754094|NCT01896193|580486670|FG001|Overall Study|Lack of Efficacy|11|||
160754095|NCT01896193|580486669|FG000|Overall Study|Protocol Violation|0|||
160754096|NCT01896193|580486670|FG001|Overall Study|Protocol Violation|1|||
160754097|NCT01896193|580486669|FG000|Overall Study|Withdrew Consent|1|||
160754098|NCT01896193|580486670|FG001|Overall Study|Withdrew Consent|0|||
160754099|NCT02592447|580486671|FG000|Overall Study|Lost to Follow-up|1|||
160754100|NCT02592447|580486672|FG001|Overall Study|Lost to Follow-up|0|||
160754101|NCT02592447|580486671|FG000|Overall Study|Ineligible after randomization|1|||
160754102|NCT02592447|580486672|FG001|Overall Study|Ineligible after randomization|0|||
160754103|NCT02592447|580486671|FG000|Overall Study|Withdrawal by Subject|0|||
160754104|NCT02592447|580486672|FG001|Overall Study|Withdrawal by Subject|1|||
160754105|NCT03428100|580486673|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
160754106|NCT03428100|580486674|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754107|NCT03428100|580486675|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
160754108|NCT03428100|580486676|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
160754109|NCT03428100|580486677|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754110|NCT03428100|580486678|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754111|NCT03428100|580486679|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754112|NCT03428100|580486680|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754113|NCT03428100|580486681|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754114|NCT03428100|580486682|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754115|NCT03428100|580486683|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754116|NCT03428100|580486684|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754117|NCT03428100|580486685|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754118|NCT03428100|580486686|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754119|NCT03428100|580486687|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754120|NCT03428100|580486688|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754121|NCT03428100|580486689|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754122|NCT03428100|580486690|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754123|NCT03428100|580486691|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
160754124|NCT03428100|580486673|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
160754125|NCT03428100|580486674|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
160754126|NCT03428100|580486675|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
160754127|NCT03428100|580486676|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
160754128|NCT03428100|580486677|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754129|NCT03428100|580486678|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754130|NCT03428100|580486679|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754131|NCT03428100|580486680|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754132|NCT03428100|580486681|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754133|NCT03428100|580486682|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754134|NCT03428100|580486683|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754135|NCT03428100|580486684|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754136|NCT03428100|580486685|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754137|NCT03428100|580486686|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754138|NCT03428100|580486687|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754139|NCT03428100|580486688|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754140|NCT03428100|580486689|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754141|NCT03428100|580486690|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754142|NCT03428100|580486691|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
160754143|NCT03428100|580486673|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754144|NCT03428100|580486674|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
160754145|NCT03428100|580486675|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
160754146|NCT03428100|580486676|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754147|NCT03428100|580486677|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754148|NCT03428100|580486678|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754149|NCT03428100|580486679|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754150|NCT03428100|580486680|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754151|NCT03428100|580486681|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754152|NCT03428100|580486682|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754153|NCT03428100|580486683|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754154|NCT03428100|580486684|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754155|NCT03428100|580486685|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160524858|NCT01180998|579651726|FG002|Overall Study|Protocol Violation|0|||
160524859|NCT01180998|579651724|FG000|Overall Study|Withdrawal by Subject|0|||
160524860|NCT01180998|579651725|FG001|Overall Study|Withdrawal by Subject|0|||
160524861|NCT01180998|579651726|FG002|Overall Study|Withdrawal by Subject|1|||
160524862|NCT01180998|579651724|FG000|Overall Study|Poor comfort|3|||
160524863|NCT01180998|579651725|FG001|Overall Study|Poor comfort|0|||
160524864|NCT01180998|579651726|FG002|Overall Study|Poor comfort|4|||
160524865|NCT01180998|579651724|FG000|Overall Study|Poor lens handling|0|||
160524866|NCT01180998|579651725|FG001|Overall Study|Poor lens handling|0|||
160524867|NCT01180998|579651726|FG002|Overall Study|Poor lens handling|2|||
160524868|NCT01176968|579651727|FG000|Overall Study|Adverse Event|10|||
160524869|NCT01176968|579651728|FG001|Overall Study|Adverse Event|11|||
160524870|NCT01176968|579651727|FG000|Overall Study|Death|2|||
160524871|NCT01176968|579651728|FG001|Overall Study|Death|3|||
160524872|NCT01176968|579651727|FG000|Overall Study|Lack of Efficacy|0|||
160524873|NCT01176968|579651728|FG001|Overall Study|Lack of Efficacy|1|||
160524874|NCT01176968|579651727|FG000|Overall Study|Lost to Follow-up|16|||
160524875|NCT01176968|579651728|FG001|Overall Study|Lost to Follow-up|14|||
160524876|NCT01176968|579651727|FG000|Overall Study|Withdrawal by Subject|48|||
160524877|NCT01176968|579651728|FG001|Overall Study|Withdrawal by Subject|48|||
160524878|NCT01176968|579651727|FG000|Overall Study|Protocol Violation|2|||
160524879|NCT01176968|579651728|FG001|Overall Study|Protocol Violation|1|||
160524880|NCT01176968|579651727|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
160524881|NCT01176968|579651728|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
160524882|NCT01176968|579651727|FG000|Overall Study|Study terminated by sponsor|0|||
160524883|NCT01176968|579651728|FG001|Overall Study|Study terminated by sponsor|1|||
160524884|NCT01176968|579651727|FG000|Overall Study|Reason not defined|5|||
160524885|NCT01176968|579651728|FG001|Overall Study|Reason not defined|3|||
160524886|NCT04485104|579651743|FG000|Overall Study|Physician Decision|2|||
160524887|NCT04485104|579651744|FG001|Overall Study|Physician Decision|0|||
160524888|NCT04485104|579651743|FG000|Overall Study|Decision by sponsor|0|||
160524889|NCT04485104|579651744|FG001|Overall Study|Decision by sponsor|1|||
160524890|NCT00744523|579651745|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
160524891|NCT00744523|579651746|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
160524892|NCT05057247|579651747|FG000|Overall Study|Death|4|||
160524893|NCT05057247|579651747|FG000|Overall Study|Physician Decision|3|||
160524894|NCT05057247|579651747|FG000|Overall Study|Progressive Disease|7|||
160524895|NCT05057247|579651747|FG000|Overall Study|Withdrawal by Subject|3|||
160524896|NCT05057247|579651747|FG000|Overall Study|Adverse Event|6|||
160524897|NCT05057247|579651747|FG000|Overall Study|Subject Non-Compliance|1|||
160524898|NCT05057247|579651747|FG000|Overall Study|On treatment|2|||
160524899|NCT03588728|579651751|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
160524900|NCT03588728|579651752|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
160524901|NCT03588728|579651753|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
160524902|NCT03588728|579651754|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
160524903|NCT03588728|579651751|FG000|Overall Study|Lab shut down due to COVID-19|0|||
160524904|NCT03588728|579651752|FG001|Overall Study|Lab shut down due to COVID-19|0|||
160524905|NCT03588728|579651753|FG002|Overall Study|Lab shut down due to COVID-19|0|||
160524906|NCT03588728|579651754|FG003|Overall Study|Lab shut down due to COVID-19|1|||
160524907|NCT03588728|579651751|FG000|Overall Study|multiple technical issues|1|||
160524908|NCT03588728|579651752|FG001|Overall Study|multiple technical issues|0|||
160524909|NCT03588728|579651753|FG002|Overall Study|multiple technical issues|0|||
160524910|NCT03588728|579651754|FG003|Overall Study|multiple technical issues|0|||
160524911|NCT03588728|579651751|FG000|Overall Study|Hospitalized for COVID|1|||
160524912|NCT03588728|579651752|FG001|Overall Study|Hospitalized for COVID|0|||
160524913|NCT03588728|579651753|FG002|Overall Study|Hospitalized for COVID|0|||
160524914|NCT03588728|579651754|FG003|Overall Study|Hospitalized for COVID|0|||
160524915|NCT03588728|579651751|FG000|Overall Study|Schedule change unable to attend sessions|1|||
160524916|NCT03588728|579651752|FG001|Overall Study|Schedule change unable to attend sessions|0|||
160524917|NCT03588728|579651753|FG002|Overall Study|Schedule change unable to attend sessions|0|||
160524918|NCT03588728|579651754|FG003|Overall Study|Schedule change unable to attend sessions|0|||
160754156|NCT03428100|580486686|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160524919|NCT01388790|579651755|FG000|Overall Study|Ongoing at data cut-off date|8|||
160524920|NCT03153137|579651756|FG000|Overall Study|Lost to Follow-up|1|||
160524921|NCT03153137|579651757|FG001|Overall Study|Lost to Follow-up|0|||
160524922|NCT03153137|579651756|FG000|Overall Study|Withdrawal by Subject|2|||
160524923|NCT03153137|579651757|FG001|Overall Study|Withdrawal by Subject|1|||
160524924|NCT03153137|579651756|FG000|Overall Study|Physician Decision|0|||
160524925|NCT03153137|579651757|FG001|Overall Study|Physician Decision|3|||
160524926|NCT00195507|579651758|FG000|Overall Study|Adverse Event|24|||
160524927|NCT00195507|579651759|FG001|Overall Study|Adverse Event|13|||
160524928|NCT00195507|579651758|FG000|Overall Study|Death|0|||
160524929|NCT00195507|579651759|FG001|Overall Study|Death|1|||
160524930|NCT00195507|579651758|FG000|Overall Study|Failed to Return|4|||
160524931|NCT00195507|579651759|FG001|Overall Study|Failed to Return|3|||
160524932|NCT00195507|579651758|FG000|Overall Study|Physician Decision|1|||
160524933|NCT00195507|579651759|FG001|Overall Study|Physician Decision|2|||
160754157|NCT03428100|580486687|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754158|NCT03428100|580486688|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754159|NCT03428100|580486689|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754160|NCT03428100|580486690|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754161|NCT03428100|580486691|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
160754162|NCT03428100|580486673|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
160754163|NCT03428100|580486674|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754164|NCT03428100|580486675|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754165|NCT03428100|580486676|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754166|NCT03428100|580486677|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754167|NCT03428100|580486678|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754168|NCT03428100|580486679|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754169|NCT03428100|580486680|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754170|NCT03428100|580486681|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754171|NCT03428100|580486682|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754172|NCT03428100|580486683|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754173|NCT03428100|580486684|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754174|NCT03428100|580486685|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754175|NCT03428100|580486686|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754176|NCT03428100|580486687|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754177|NCT03428100|580486688|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754178|NCT03428100|580486689|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754179|NCT03428100|580486690|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754180|NCT03428100|580486691|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
160754181|NCT03428100|580486673|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754182|NCT03428100|580486674|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
160754183|NCT03428100|580486675|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754184|NCT03428100|580486676|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754185|NCT03428100|580486677|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754186|NCT03428100|580486678|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754187|NCT03428100|580486679|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754188|NCT03428100|580486680|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754189|NCT03428100|580486681|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754190|NCT03428100|580486682|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754191|NCT03428100|580486683|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754192|NCT03428100|580486684|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754193|NCT03428100|580486685|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754194|NCT03428100|580486686|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754195|NCT03428100|580486687|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754196|NCT03428100|580486688|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754197|NCT03428100|580486689|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754198|NCT03428100|580486690|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754199|NCT03428100|580486691|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
160754200|NCT03428100|580486673|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
160754201|NCT03428100|580486674|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
160754202|NCT03428100|580486675|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
160754203|NCT03428100|580486676|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
160754204|NCT03428100|580486677|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
160754205|NCT03428100|580486678|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
160754206|NCT03428100|580486679|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
160754207|NCT03428100|580486680|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
160754208|NCT03428100|580486681|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
160754209|NCT03428100|580486682|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
160754210|NCT03428100|580486683|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
160754211|NCT03428100|580486684|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
160754212|NCT03428100|580486685|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
160754213|NCT03428100|580486686|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
160754214|NCT03428100|580486687|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
160754215|NCT03428100|580486688|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
160754216|NCT03428100|580486689|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
160754217|NCT03428100|580486690|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
160754218|NCT03428100|580486691|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
160754219|NCT03428100|580486673|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
160754220|NCT03428100|580486674|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
160754221|NCT03428100|580486675|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
160754222|NCT03428100|580486676|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
160754223|NCT03428100|580486677|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
160754224|NCT03428100|580486678|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
160754225|NCT03428100|580486679|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
160754226|NCT03428100|580486680|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
160754227|NCT03428100|580486681|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
160754228|NCT03428100|580486682|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
160754229|NCT03428100|580486683|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
160754230|NCT03428100|580486684|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
160754231|NCT03428100|580486685|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
160754232|NCT03428100|580486686|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
160754233|NCT03428100|580486687|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
160754234|NCT03428100|580486688|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
160754235|NCT03428100|580486689|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
160754236|NCT03428100|580486690|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
160754237|NCT03428100|580486691|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
160754238|NCT03428100|580486673|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
160754239|NCT03428100|580486674|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
160754240|NCT03428100|580486675|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
160754241|NCT03428100|580486676|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
160754242|NCT03428100|580486677|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
160754243|NCT03428100|580486678|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
160754244|NCT03428100|580486679|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
160754245|NCT03428100|580486680|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
160754246|NCT03428100|580486681|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
160754247|NCT03428100|580486682|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
160754248|NCT03428100|580486683|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
160754249|NCT03428100|580486684|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
160754250|NCT03428100|580486685|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
160754251|NCT03428100|580486686|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
160754252|NCT03428100|580486687|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
160754253|NCT03428100|580486688|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
160754254|NCT03428100|580486689|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
160754255|NCT03428100|580486690|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
160754256|NCT03428100|580486691|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
160754257|NCT03428100|580486673|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754258|NCT03428100|580486674|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754259|NCT03428100|580486675|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754260|NCT03428100|580486676|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754261|NCT03428100|580486677|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754262|NCT03428100|580486678|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754263|NCT03428100|580486679|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754264|NCT03428100|580486680|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
160754265|NCT03428100|580486681|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754266|NCT03428100|580486682|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754267|NCT03428100|580486683|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754268|NCT03428100|580486684|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
160754269|NCT03428100|580486685|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
160754270|NCT03428100|580486686|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754271|NCT03428100|580486687|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
160754272|NCT03428100|580486688|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754273|NCT03428100|580486689|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754274|NCT03428100|580486690|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
160754275|NCT03428100|580486691|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160754276|NCT03428100|580486673|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
160754277|NCT03428100|580486674|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
160754278|NCT03428100|580486675|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
160754279|NCT03428100|580486676|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
160754280|NCT03428100|580486677|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
160754281|NCT03428100|580486678|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
160754282|NCT03428100|580486679|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
160754283|NCT03428100|580486680|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
160754284|NCT03428100|580486681|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
160754285|NCT03428100|580486682|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
160754286|NCT03428100|580486683|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
160754287|NCT03428100|580486684|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
160754288|NCT03428100|580486685|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
160754289|NCT03428100|580486686|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
160754290|NCT03428100|580486687|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
160754291|NCT03428100|580486688|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
160754292|NCT03428100|580486689|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
160754293|NCT03428100|580486690|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
160754294|NCT03428100|580486691|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
160754295|NCT03428100|580486673|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754296|NCT03428100|580486674|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754297|NCT03428100|580486675|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754298|NCT03428100|580486676|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754299|NCT03428100|580486677|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754300|NCT03428100|580486678|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754301|NCT03428100|580486679|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
160754302|NCT03428100|580486680|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754303|NCT03428100|580486681|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754304|NCT03428100|580486682|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754305|NCT03428100|580486683|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754306|NCT03428100|580486684|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754307|NCT03428100|580486685|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754308|NCT03428100|580486686|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754309|NCT03428100|580486687|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754310|NCT03428100|580486688|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754311|NCT03428100|580486689|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754312|NCT03428100|580486690|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160754313|NCT03428100|580486691|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
160754314|NCT03428100|580486673|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
160754315|NCT03428100|580486674|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
160754316|NCT03428100|580486675|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
160754317|NCT03428100|580486676|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
160754318|NCT03428100|580486677|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
160754319|NCT03428100|580486678|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
160754320|NCT03428100|580486679|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
160754321|NCT03428100|580486680|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
160754322|NCT03428100|580486681|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
160754323|NCT03428100|580486682|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
160754324|NCT03428100|580486683|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
160754325|NCT03428100|580486684|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
160754326|NCT03428100|580486685|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
160754327|NCT03428100|580486686|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
160754328|NCT03428100|580486687|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
160754329|NCT03428100|580486688|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
160754330|NCT03428100|580486689|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
160754331|NCT03428100|580486690|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
160754332|NCT03428100|580486691|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
160754333|NCT03428100|580486673|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
160754334|NCT03428100|580486674|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
160754335|NCT03428100|580486675|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
160754336|NCT03428100|580486676|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
160754337|NCT03428100|580486677|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
160754338|NCT03428100|580486678|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
160754339|NCT03428100|580486679|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
160754340|NCT03428100|580486680|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
160754341|NCT03428100|580486681|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
160754342|NCT03428100|580486682|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
160754343|NCT03428100|580486683|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
160754344|NCT03428100|580486684|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
160754345|NCT03428100|580486685|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
160754346|NCT03428100|580486686|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
160754347|NCT03428100|580486687|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
160754348|NCT03428100|580486688|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
160754349|NCT03428100|580486689|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
160754350|NCT03428100|580486690|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
160754351|NCT03428100|580486691|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
160754352|NCT01048541|580486695|FG000|Overall Study|Withdrawal by Subject|1|||
160754353|NCT01048541|580486696|FG001|Overall Study|Withdrawal by Subject|0|||
160754354|NCT01300247|580486697|FG000|Overall Study|Death|1|||
160754355|NCT01300247|580486698|FG001|Overall Study|Death|1|||
160754356|NCT01300247|580486697|FG000|Overall Study|Lost to Follow-up|2|||
160754357|NCT01300247|580486698|FG001|Overall Study|Lost to Follow-up|0|||
160754358|NCT01300247|580486697|FG000|Overall Study|Withdrawal by Subject|1|||
160754359|NCT01300247|580486698|FG001|Overall Study|Withdrawal by Subject|0|||
160754360|NCT01300247|580486697|FG000|Overall Study|Non-Compliance|0|||
160754361|NCT01300247|580486698|FG001|Overall Study|Non-Compliance|1|||
160754362|NCT00922116|580486699|FG000|Overall Study|Adverse Event|4|||
160754363|NCT00922116|580486699|FG000|Overall Study|Death|1|||
160754364|NCT00922116|580486699|FG000|Overall Study|Lost to Follow-up|1|||
160754365|NCT00922116|580486699|FG000|Overall Study|Withdrawal by Subject|4|||
160754366|NCT00922116|580486699|FG000|Overall Study|Other|5|||
160754367|NCT02258659|580486700|FG000|Overall Study|Withdrawal by Subject|1|||
160754368|NCT03990051|580486701|FG000|Masked Period|Lost to Follow-up|1|||
160754369|NCT03990051|580486702|FG001|Masked Period|Lost to Follow-up|0|||
160754370|NCT03990051|580486701|FG000|Long Term Period|Death|1|||
160754371|NCT03990051|580486702|FG001|Long Term Period|Death|1|||
160754372|NCT03990051|580486701|FG000|Long Term Period|Lost to Follow-up|7|||
160754373|NCT03990051|580486702|FG001|Long Term Period|Lost to Follow-up|2|||
160754374|NCT00272844|580486703|FG000|Overall Study|Withdrawal by Subject|5|||
160754375|NCT00618826|580486704|FG000|Overall Study|Adverse Event|1|||
160754376|NCT03193047|580486705|FG000|Overall Study|Physician Decision|1|||
160754377|NCT03193047|580486706|FG001|Overall Study|Physician Decision|0|||
160754378|NCT03193047|580486705|FG000|Overall Study|Participant Left State|1|||
160754379|NCT03193047|580486706|FG001|Overall Study|Participant Left State|0|||
160754380|NCT03743025|580486710|FG000|Overall Study|Surgery was cancelled|2|||
160754381|NCT03743025|580486711|FG001|Overall Study|Surgery was cancelled|1|||
160754382|NCT00791700|580486712|FG000|Overall Study|Insufficient clinical response|1|||
160754383|NCT00791700|580486713|FG001|Overall Study|Insufficient clinical response|4|||
160754384|NCT00791700|580486714|FG002|Overall Study|Insufficient clinical response|1|||
160754385|NCT00791700|580486715|FG003|Overall Study|Insufficient clinical response|8|||
160754386|NCT00791700|580486712|FG000|Overall Study|No longer willing to participate|1|||
160754387|NCT00791700|580486713|FG001|Overall Study|No longer willing to participate|1|||
160754388|NCT00791700|580486714|FG002|Overall Study|No longer willing to participate|0|||
160754389|NCT00791700|580486715|FG003|Overall Study|No longer willing to participate|8|||
160754390|NCT00791700|580486712|FG000|Overall Study|Non-compliance with study treatment|0|||
160754391|NCT00791700|580486713|FG001|Overall Study|Non-compliance with study treatment|2|||
160754392|NCT00791700|580486714|FG002|Overall Study|Non-compliance with study treatment|0|||
160754393|NCT00791700|580486715|FG003|Overall Study|Non-compliance with study treatment|4|||
160754394|NCT00791700|580486712|FG000|Overall Study|Withdrawn due to pregnancy|0|||
160754395|NCT00791700|580486713|FG001|Overall Study|Withdrawn due to pregnancy|0|||
160754396|NCT00791700|580486714|FG002|Overall Study|Withdrawn due to pregnancy|0|||
160754397|NCT00791700|580486715|FG003|Overall Study|Withdrawn due to pregnancy|1|||
160754398|NCT00791700|580486712|FG000|Overall Study|Other|0|||
160754399|NCT00791700|580486713|FG001|Overall Study|Other|1|||
160754400|NCT00791700|580486714|FG002|Overall Study|Other|0|||
160754401|NCT00791700|580486715|FG003|Overall Study|Other|1|||
160754402|NCT00791700|580486712|FG000|Overall Study|Death|0|||
160754403|NCT00791700|580486713|FG001|Overall Study|Death|0|||
160754404|NCT00791700|580486714|FG002|Overall Study|Death|0|||
160754405|NCT00791700|580486715|FG003|Overall Study|Death|1|||
160754406|NCT00791700|580486712|FG000|Overall Study|Lost to Follow-up|4|||
160754407|NCT00791700|580486713|FG001|Overall Study|Lost to Follow-up|3|||
160754408|NCT00791700|580486714|FG002|Overall Study|Lost to Follow-up|4|||
160754409|NCT00791700|580486715|FG003|Overall Study|Lost to Follow-up|6|||
160754410|NCT00791700|580486712|FG000|Overall Study|Adverse Event|0|||
160754411|NCT00791700|580486713|FG001|Overall Study|Adverse Event|0|||
160754412|NCT00791700|580486714|FG002|Overall Study|Adverse Event|1|||
160754413|NCT00791700|580486715|FG003|Overall Study|Adverse Event|1|||
160754414|NCT01720524|580486718|FG000|Part A|Insufficient Clinical Response|2|||
160754415|NCT01720524|580486719|FG001|Part A|Insufficient Clinical Response|4|||
160754416|NCT01720524|580486718|FG000|Part A|Adverse Event|2|||
160754417|NCT01720524|580486719|FG001|Part A|Adverse Event|2|||
160754418|NCT01720524|580486718|FG000|Part A|Death|2|||
160754419|NCT01720524|580486719|FG001|Part A|Death|1|||
160754420|NCT01720524|580486718|FG000|Part A|Lost to Follow-up|0|||
160754421|NCT01720524|580486719|FG001|Part A|Lost to Follow-up|1|||
160754422|NCT01720524|580486718|FG000|Part A|Missed 28 day follow-up visit|1|||
160754423|NCT01720524|580486719|FG001|Part A|Missed 28 day follow-up visit|1|||
160754424|NCT01720524|580486718|FG000|Part A|Withdrawal by Subject|0|||
160754425|NCT01720524|580486719|FG001|Part A|Withdrawal by Subject|1|||
160754426|NCT01720524|580486718|FG000|Part A|Other|0|||
160754427|NCT01720524|580486719|FG001|Part A|Other|1|||
160754428|NCT01720524|580486718|FG000|Part A|Lost to Follow-up|0|||
160754429|NCT01720524|580486719|FG001|Part A|Lost to Follow-up|1|||
160754430|NCT01720524|580486718|FG000|Part B|No longer willing to participate in study|1|||
160754431|NCT01720524|580486719|FG001|Part B|No longer willing to participate in study|4|||
160754432|NCT01720524|580486718|FG000|Part B|Other|2|||
160754433|NCT01720524|580486719|FG001|Part B|Other|0|||
160754434|NCT01720524|580486718|FG000|Part B|Lost to Follow-up|2|||
160754435|NCT01720524|580486719|FG001|Part B|Lost to Follow-up|3|||
160754436|NCT01720524|580486718|FG000|Part B|Death|0|||
160754437|NCT01720524|580486719|FG001|Part B|Death|2|||
160754438|NCT00996034|580486720|FG000|Overall Study|Lost to Follow-up|2|||
160754439|NCT00996034|580486720|FG000|Overall Study|withdrawn by PI|1|||
160754440|NCT00158262|580486724|FG000|Overall Study|Lost to Follow-up|1|||
160754441|NCT00158262|580486725|FG001|Overall Study|Lost to Follow-up|1|||
160754442|NCT00527826|580486726|FG000|Overall Study|Adverse Event|10|||
160754443|NCT00527826|580486727|FG001|Overall Study|Adverse Event|10|||
160754444|NCT00527826|580486726|FG000|Overall Study|Lost to Follow-up|3|||
160754445|NCT00527826|580486727|FG001|Overall Study|Lost to Follow-up|2|||
160754446|NCT00527826|580486726|FG000|Overall Study|Withdrawal by Subject|5|||
160754447|NCT00527826|580486727|FG001|Overall Study|Withdrawal by Subject|8|||
160524934|NCT00195507|579651758|FG000|Overall Study|Lost to Follow-up|3|||
160524935|NCT00195507|579651759|FG001|Overall Study|Lost to Follow-up|2|||
160754448|NCT00527826|580486726|FG000|Overall Study|Inclusion Criteria Not Met|3|||
160524936|NCT00195507|579651758|FG000|Overall Study|Protocol Violation|5|||
160524937|NCT00195507|579651759|FG001|Overall Study|Protocol Violation|4|||
160524938|NCT00195507|579651758|FG000|Overall Study|Lack of Efficacy|40|||
160524939|NCT00195507|579651759|FG001|Overall Study|Lack of Efficacy|67|||
160524940|NCT00195507|579651758|FG000|Overall Study|Withdrawal by Subject|16|||
160524941|NCT00195507|579651759|FG001|Overall Study|Withdrawal by Subject|23|||
160524942|NCT00195507|579651758|FG000|Overall Study|Protocol Deviation|6|||
160524943|NCT00195507|579651759|FG001|Overall Study|Protocol Deviation|3|||
160524944|NCT00528866|579651760|FG000|Overall Study|Protocol Violation|6|||
160524945|NCT00993915|579651761|FG000|Overall Study|Insufficient clinical response|3|||
160524946|NCT00993915|579651761|FG000|Overall Study|Withdrawal by Subject|2|||
160524947|NCT00993915|579651761|FG000|Overall Study|Other|1|||
160524948|NCT00993915|579651761|FG000|Overall Study|Ongoing|3|||
160524949|NCT01386658|579651762|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
160524950|NCT01386658|579651763|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
160754449|NCT00527826|580486727|FG001|Overall Study|Inclusion Criteria Not Met|3|||
160524951|NCT01386658|579651762|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
160524952|NCT01386658|579651763|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
160524953|NCT02465463|579651764|FG000|Overall Study|Lost to Follow-up|2|||
160754450|NCT00527826|580486726|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
160754451|NCT00527826|580486727|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
160754452|NCT00527826|580486726|FG000|Overall Study|Additional Intake of Viani forte|0|||
160754453|NCT00527826|580486727|FG001|Overall Study|Additional Intake of Viani forte|1|||
160754454|NCT00527826|580486726|FG000|Overall Study|Participant moved away|0|||
160754455|NCT00527826|580486727|FG001|Overall Study|Participant moved away|1|||
160754456|NCT02080364|580486731|FG000|Baseline Period|Protocol Violation|2|||
160754457|NCT02080364|580486732|FG001|Baseline Period|Protocol Violation|1|||
160754458|NCT02080364|580486733|FG002|Baseline Period|Protocol Violation|0|||
160754459|NCT02080364|580486734|FG003|Baseline Period|Protocol Violation|0|||
160754460|NCT02080364|580486731|FG000|Baseline Period|Other|0|||
160754461|NCT02080364|580486732|FG001|Baseline Period|Other|1|||
160754462|NCT02080364|580486733|FG002|Baseline Period|Other|1|||
160754463|NCT02080364|580486734|FG003|Baseline Period|Other|0|||
160754464|NCT02080364|580486731|FG000|Treatment Period|Adverse Event|10|||
160754465|NCT02080364|580486732|FG001|Treatment Period|Adverse Event|15|||
160754466|NCT02080364|580486733|FG002|Treatment Period|Adverse Event|11|||
160754467|NCT02080364|580486734|FG003|Treatment Period|Adverse Event|14|||
160754468|NCT02080364|580486731|FG000|Treatment Period|Lost to Follow-up|2|||
160754469|NCT02080364|580486732|FG001|Treatment Period|Lost to Follow-up|3|||
160754470|NCT02080364|580486733|FG002|Treatment Period|Lost to Follow-up|5|||
160754471|NCT02080364|580486734|FG003|Treatment Period|Lost to Follow-up|0|||
160754472|NCT02080364|580486731|FG000|Treatment Period|Protocol Violation|5|||
160754473|NCT02080364|580486732|FG001|Treatment Period|Protocol Violation|3|||
160754474|NCT02080364|580486733|FG002|Treatment Period|Protocol Violation|5|||
160754475|NCT02080364|580486734|FG003|Treatment Period|Protocol Violation|1|||
160754476|NCT02080364|580486731|FG000|Treatment Period|Withdrawal by Subject|16|||
160754477|NCT02080364|580486732|FG001|Treatment Period|Withdrawal by Subject|16|||
160754478|NCT02080364|580486733|FG002|Treatment Period|Withdrawal by Subject|15|||
160754479|NCT02080364|580486734|FG003|Treatment Period|Withdrawal by Subject|10|||
160754480|NCT02080364|580486731|FG000|Treatment Period|Study Terminated by Sponsor|0|||
160754481|NCT02080364|580486732|FG001|Treatment Period|Study Terminated by Sponsor|0|||
160754482|NCT02080364|580486733|FG002|Treatment Period|Study Terminated by Sponsor|180|||
160754483|NCT02080364|580486734|FG003|Treatment Period|Study Terminated by Sponsor|183|||
160754484|NCT02080364|580486731|FG000|Treatment Period|Other|14|||
160754485|NCT02080364|580486732|FG001|Treatment Period|Other|12|||
160754486|NCT02080364|580486733|FG002|Treatment Period|Other|21|||
160754487|NCT02080364|580486734|FG003|Treatment Period|Other|16|||
160754488|NCT00784719|580486735|FG000|Overall Study|Adverse Event|0|||
160754489|NCT00784719|580486736|FG001|Overall Study|Adverse Event|2|||
160754490|NCT00784719|580486737|FG002|Overall Study|Adverse Event|0|||
160754491|NCT00784719|580486738|FG003|Overall Study|Adverse Event|0|||
160754492|NCT00784719|580486739|FG004|Overall Study|Adverse Event|1|||
160754493|NCT00784719|580486740|FG005|Overall Study|Adverse Event|1|||
160754494|NCT00784719|580486741|FG006|Overall Study|Adverse Event|1|||
160754495|NCT00784719|580486735|FG000|Overall Study|Lost to Follow-up|0|||
160754496|NCT00784719|580486736|FG001|Overall Study|Lost to Follow-up|0|||
160754497|NCT00784719|580486737|FG002|Overall Study|Lost to Follow-up|0|||
160754498|NCT00784719|580486738|FG003|Overall Study|Lost to Follow-up|0|||
160754499|NCT00784719|580486739|FG004|Overall Study|Lost to Follow-up|1|||
160754500|NCT00784719|580486740|FG005|Overall Study|Lost to Follow-up|1|||
160754501|NCT00784719|580486741|FG006|Overall Study|Lost to Follow-up|0|||
160754502|NCT00784719|580486735|FG000|Overall Study|Other|2|||
160754503|NCT00784719|580486736|FG001|Overall Study|Other|1|||
160754504|NCT00784719|580486737|FG002|Overall Study|Other|1|||
160754505|NCT00784719|580486738|FG003|Overall Study|Other|0|||
160754506|NCT00784719|580486739|FG004|Overall Study|Other|2|||
160754507|NCT00784719|580486740|FG005|Overall Study|Other|1|||
160754508|NCT00784719|580486741|FG006|Overall Study|Other|3|||
160754509|NCT00784719|580486735|FG000|Overall Study|Withdrawal by Subject|1|||
160754510|NCT00784719|580486736|FG001|Overall Study|Withdrawal by Subject|0|||
160754511|NCT00784719|580486737|FG002|Overall Study|Withdrawal by Subject|0|||
160754512|NCT00784719|580486738|FG003|Overall Study|Withdrawal by Subject|0|||
160754513|NCT00784719|580486739|FG004|Overall Study|Withdrawal by Subject|2|||
160754514|NCT00784719|580486740|FG005|Overall Study|Withdrawal by Subject|0|||
160754515|NCT00784719|580486741|FG006|Overall Study|Withdrawal by Subject|1|||
160754516|NCT01189461|580486744|FG000|Overall Study|Lack of Efficacy|13|||
160754517|NCT01189461|580486744|FG000|Overall Study|Lost to Follow-up|1|||
160754518|NCT01189461|580486744|FG000|Overall Study|Withdrawal by Subject|6|||
160754519|NCT01189461|580486744|FG000|Overall Study|Protocol Violation|1|||
160754520|NCT01189461|580486744|FG000|Overall Study|Adverse Event|2|||
160754521|NCT01189461|580486744|FG000|Overall Study|Did not meet entrance criteria|3|||
160754522|NCT01189461|580486744|FG000|Overall Study|Other|8|||
160754523|NCT00420628|580486746|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
160754524|NCT00420628|580486747|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
160754525|NCT00420628|580486746|FG000|Overall Study|Lost to Follow-up|3|||
160754526|NCT00420628|580486747|FG001|Overall Study|Lost to Follow-up|2|||
160754527|NCT00420628|580486746|FG000|Overall Study|Adverse Event|1|||
160754528|NCT00420628|580486747|FG001|Overall Study|Adverse Event|0|||
160754529|NCT02716584|580486748|FG000|Overall Study|Lost to Follow-up|8|||
160754530|NCT02716584|580486749|FG001|Overall Study|Lost to Follow-up|5|||
160754531|NCT00282152|580486757|FG000|Overall Study|Withdrawal by Subject|1|||
160754532|NCT00282152|580486758|FG001|Overall Study|Withdrawal by Subject|0|||
160754533|NCT03301831|580486759|FG000|Overall Study|Lost to Follow-up|5|||
160754534|NCT03301831|580486760|FG001|Overall Study|Lost to Follow-up|3|||
160754535|NCT03301831|580486759|FG000|Overall Study|Protocol Violation|4|||
160754536|NCT03301831|580486760|FG001|Overall Study|Protocol Violation|0|||
160754537|NCT03301831|580486759|FG000|Overall Study|Withdrawal by Subject|11|||
160754538|NCT03301831|580486760|FG001|Overall Study|Withdrawal by Subject|0|||
160754539|NCT00585325|580486761|FG000|Overall Study|Withdrawal by Subject|1|||
160754540|NCT00585325|580486762|FG001|Overall Study|Withdrawal by Subject|1|||
160754541|NCT03538691|580486763|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
160754542|NCT03538691|580486764|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
160754543|NCT03538691|580486765|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
160754544|NCT03538691|580486766|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
160754545|NCT03538691|580486763|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
160636040|NCT00532779|580049433|FG002|Overall Study|Drug noncompliance, moved, other|29|||
160636041|NCT02662556|580049434|FG000|Overall Study|Adverse Event|4|||
160636042|NCT02662556|580049434|FG000|Overall Study|Lack of Efficacy|4|||
160636043|NCT02787746|580049443|FG000|Overall Study|Adverse Event|42|||
160636044|NCT02787746|580049443|FG000|Overall Study|Withdrawal by Subject|65|||
160636045|NCT02787746|580049443|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
160636046|NCT01142466|580051422|FG000|Overall Study|Adverse Event|2|||
160636047|NCT01142466|580051423|FG001|Overall Study|Adverse Event|1|||
160636048|NCT01142466|580051422|FG000|Overall Study|Withdrawal by Subject|1|||
160636049|NCT01142466|580051423|FG001|Overall Study|Withdrawal by Subject|1|||
160636050|NCT00700310|580051428|FG000|Overall Study|Adverse Event|6|||
160636051|NCT00700310|580051429|FG001|Overall Study|Adverse Event|10|||
160636052|NCT00700310|580051430|FG002|Overall Study|Adverse Event|5|||
160636053|NCT00700310|580051431|FG003|Overall Study|Adverse Event|11|||
160636054|NCT00700310|580051428|FG000|Overall Study|Lost to Follow-up|4|||
160636055|NCT00700310|580051429|FG001|Overall Study|Lost to Follow-up|1|||
160636056|NCT00700310|580051430|FG002|Overall Study|Lost to Follow-up|0|||
160636057|NCT00700310|580051431|FG003|Overall Study|Lost to Follow-up|1|||
160636058|NCT00700310|580051428|FG000|Overall Study|Withdrawal by Subject|8|||
160636059|NCT00700310|580051429|FG001|Overall Study|Withdrawal by Subject|9|||
160636060|NCT00700310|580051430|FG002|Overall Study|Withdrawal by Subject|8|||
160636061|NCT00700310|580051431|FG003|Overall Study|Withdrawal by Subject|8|||
160636062|NCT00700310|580051428|FG000|Overall Study|Lack of Efficacy|0|||
160636063|NCT00700310|580051429|FG001|Overall Study|Lack of Efficacy|3|||
160636064|NCT00700310|580051430|FG002|Overall Study|Lack of Efficacy|0|||
160636065|NCT00700310|580051431|FG003|Overall Study|Lack of Efficacy|1|||
160636066|NCT00700310|580051428|FG000|Overall Study|Administrative/Other|1|||
160636067|NCT00700310|580051429|FG001|Overall Study|Administrative/Other|3|||
160636068|NCT00700310|580051430|FG002|Overall Study|Administrative/Other|1|||
160636069|NCT00700310|580051431|FG003|Overall Study|Administrative/Other|3|||
160636070|NCT00700310|580051428|FG000|Overall Study|Randomized, Not Treated|2|||
160636071|NCT00700310|580051429|FG001|Overall Study|Randomized, Not Treated|0|||
160636072|NCT00700310|580051430|FG002|Overall Study|Randomized, Not Treated|2|||
160636073|NCT00700310|580051431|FG003|Overall Study|Randomized, Not Treated|2|||
160636074|NCT02414854|580051432|FG000|Overall Study|Adverse Event|9|||
160636075|NCT02414854|580051433|FG001|Overall Study|Adverse Event|7|||
160636076|NCT02414854|580051434|FG002|Overall Study|Adverse Event|1|||
160636077|NCT02414854|580051435|FG003|Overall Study|Adverse Event|12|||
160636078|NCT02414854|580051432|FG000|Overall Study|Poor compliance to protocol|1|||
160636079|NCT02414854|580051433|FG001|Overall Study|Poor compliance to protocol|1|||
160636080|NCT02414854|580051434|FG002|Overall Study|Poor compliance to protocol|2|||
160636081|NCT02414854|580051435|FG003|Overall Study|Poor compliance to protocol|2|||
160636082|NCT02414854|580051432|FG000|Overall Study|Other than specified above|12|||
160636083|NCT02414854|580051433|FG001|Overall Study|Other than specified above|37|||
160636084|NCT02414854|580051434|FG002|Overall Study|Other than specified above|17|||
160636085|NCT02414854|580051435|FG003|Overall Study|Other than specified above|37|||
160636086|NCT01355523|580051436|FG000|Overall Study|Withdrawal by Subject|1|||
160636087|NCT01355523|580051437|FG001|Overall Study|Withdrawal by Subject|4|||
160636088|NCT01355523|580051436|FG000|Overall Study|Lost to Follow-up|0|||
160636089|NCT01355523|580051437|FG001|Overall Study|Lost to Follow-up|2|||
160636090|NCT01355523|580051436|FG000|Overall Study|Protocol Violation|0|||
160636091|NCT01355523|580051437|FG001|Overall Study|Protocol Violation|2|||
160636092|NCT01355523|580051436|FG000|Overall Study|Adverse Event|0|||
160636093|NCT01355523|580051437|FG001|Overall Study|Adverse Event|2|||
160636094|NCT00303316|580051438|FG000|Overall Study|Protocol Violation|1|||
160636095|NCT00303316|580051439|FG001|Overall Study|Protocol Violation|0|||
160636096|NCT00303316|580051438|FG000|Overall Study|Lost to Follow-up|0|||
160636097|NCT00303316|580051439|FG001|Overall Study|Lost to Follow-up|1|||
160636098|NCT00303316|580051438|FG000|Overall Study|Withdrawal by Subject|1|||
160636099|NCT00303316|580051439|FG001|Overall Study|Withdrawal by Subject|2|||
160636100|NCT01074307|580051440|FG000|Overall Study|No primary endpoint evaluation|14|||
160636101|NCT01074307|580051441|FG001|Overall Study|No primary endpoint evaluation|6|||
160636102|NCT01074307|580051440|FG000|Overall Study|Exclusion criterion|0|||
160636103|NCT01074307|580051441|FG001|Overall Study|Exclusion criterion|1|||
160636104|NCT01074307|580051440|FG000|Overall Study|Protocol Violation|8|||
160636105|NCT01074307|580051441|FG001|Overall Study|Protocol Violation|5|||
160636106|NCT02162511|580051447|FG000|Overall Study|Lack of Efficacy|0|||
160636107|NCT02162511|580051448|FG001|Overall Study|Lack of Efficacy|0|||
160636108|NCT02162511|580051449|FG002|Overall Study|Lack of Efficacy|2|||
160636109|NCT01160198|580051450|FG000|Overall Study|Withdrawal by Subject|2|||
160636110|NCT01160198|580051451|FG001|Overall Study|Withdrawal by Subject|1|||
160636111|NCT01160198|580051452|FG002|Overall Study|Withdrawal by Subject|0|||
160636112|NCT01160198|580051450|FG000|Overall Study|Adverse Event|0|||
160636113|NCT01160198|580051451|FG001|Overall Study|Adverse Event|1|||
160636114|NCT01160198|580051452|FG002|Overall Study|Adverse Event|0|||
160636115|NCT01160198|580051450|FG000|Overall Study|Lost to Follow-up|0|||
160636116|NCT01160198|580051451|FG001|Overall Study|Lost to Follow-up|1|||
160754546|NCT03538691|580486764|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
160754547|NCT03538691|580486765|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
160754548|NCT03538691|580486766|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
160754549|NCT03538691|580486763|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
160754550|NCT03538691|580486764|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
160754551|NCT03538691|580486765|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
160754552|NCT03538691|580486766|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
160754553|NCT03538691|580486763|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
160754554|NCT03538691|580486764|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
160754555|NCT03538691|580486765|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
160754556|NCT03538691|580486766|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
160754557|NCT03538691|580486763|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
160754558|NCT03538691|580486764|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
160754559|NCT03538691|580486765|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
160754560|NCT03538691|580486766|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
160754561|NCT03538691|580486763|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
160754562|NCT03538691|580486764|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
160754563|NCT03538691|580486765|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
160754564|NCT03538691|580486766|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
160754565|NCT03538691|580486763|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
160754566|NCT03538691|580486764|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
160754567|NCT03538691|580486765|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
160754568|NCT03538691|580486766|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
160754569|NCT03538691|580486763|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
160754570|NCT03538691|580486764|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
160636117|NCT01160198|580051452|FG002|Overall Study|Lost to Follow-up|0|||
160636118|NCT01160198|580051450|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
160636119|NCT01160198|580051451|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
160636120|NCT01160198|580051452|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
160636121|NCT00802529|580051453|FG000|Overall Study|Lost to Follow-up|0|||
160636122|NCT00802529|580051454|FG001|Overall Study|Lost to Follow-up|1|||
160636123|NCT02703454|580051458|FG000|Overall Study|Not treated|1|||
160636124|NCT02703454|580051459|FG001|Overall Study|Not treated|3|||
160636125|NCT02703454|580051458|FG000|Overall Study|Withdrawal by Subject|4|||
160636126|NCT02703454|580051459|FG001|Overall Study|Withdrawal by Subject|3|||
160636127|NCT02703454|580051458|FG000|Overall Study|Lost to Follow-up|1|||
160636128|NCT02703454|580051459|FG001|Overall Study|Lost to Follow-up|2|||
160636129|NCT02703454|580051458|FG000|Overall Study|Study discontinuation|5|||
160636130|NCT02703454|580051459|FG001|Overall Study|Study discontinuation|8|||
160636131|NCT02284373|580051460|FG000|Overall Study|Withdrawal by Subject|0|||
160636132|NCT02284373|580051461|FG001|Overall Study|Withdrawal by Subject|1|||
160636133|NCT02284373|580051462|FG002|Overall Study|Withdrawal by Subject|0|||
160636134|NCT02284373|580051460|FG000|Overall Study|Other|0|||
160636135|NCT02284373|580051461|FG001|Overall Study|Other|1|||
160636136|NCT02284373|580051462|FG002|Overall Study|Other|0|||
160636137|NCT02284373|580051460|FG000|Overall Study|Lost to Follow-up|0|||
160636138|NCT02284373|580051461|FG001|Overall Study|Lost to Follow-up|1|||
160636139|NCT02284373|580051462|FG002|Overall Study|Lost to Follow-up|0|||
160636140|NCT00552617|580051464|FG000|Overall Study|Not Treated|0|||
160636141|NCT00552617|580051465|FG001|Overall Study|Not Treated|0|||
160636142|NCT00552617|580051466|FG002|Overall Study|Not Treated|1|||
160636143|NCT00552617|580051467|FG003|Overall Study|Not Treated|0|||
160636144|NCT00552617|580051468|FG004|Overall Study|Not Treated|0|||
160636145|NCT00552617|580051469|FG005|Overall Study|Not Treated|0|||
160636146|NCT00552617|580051470|FG006|Overall Study|Not Treated|0|||
160636147|NCT00552617|580051471|FG007|Overall Study|Not Treated|0|||
160636148|NCT00552617|580051472|FG008|Overall Study|Not Treated|0|||
160636149|NCT00552617|580051473|FG009|Overall Study|Not Treated|1|||
160636150|NCT00552617|580051464|FG000|Overall Study|Lost to Follow-up|0|||
160636151|NCT00552617|580051465|FG001|Overall Study|Lost to Follow-up|0|||
160636152|NCT00552617|580051466|FG002|Overall Study|Lost to Follow-up|0|||
160636153|NCT00552617|580051467|FG003|Overall Study|Lost to Follow-up|1|||
160636154|NCT00552617|580051468|FG004|Overall Study|Lost to Follow-up|0|||
160636155|NCT00552617|580051469|FG005|Overall Study|Lost to Follow-up|2|||
160636156|NCT00552617|580051470|FG006|Overall Study|Lost to Follow-up|0|||
160636157|NCT00552617|580051471|FG007|Overall Study|Lost to Follow-up|0|||
160636158|NCT00552617|580051472|FG008|Overall Study|Lost to Follow-up|2|||
160636159|NCT00552617|580051473|FG009|Overall Study|Lost to Follow-up|0|||
160636160|NCT04651218|580051474|FG000|Overall Study|Withdrawal by Subject|0|||
160636161|NCT04651218|580051475|FG001|Overall Study|Withdrawal by Subject|2|||
160636162|NCT01399125|580051478|FG000|Overall Study|Adverse Event|32|||
160636163|NCT01399125|580051479|FG001|Overall Study|Adverse Event|30|||
160636164|NCT01399125|580051478|FG000|Overall Study|Abnormal Lab values|0|||
160754571|NCT03538691|580486765|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
160754572|NCT03538691|580486766|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
160754573|NCT03538691|580486763|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
160754574|NCT03538691|580486764|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
160754575|NCT03538691|580486765|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
160754576|NCT03538691|580486766|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
160754577|NCT03538691|580486763|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
160754578|NCT03538691|580486764|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
160754579|NCT03538691|580486765|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
160754580|NCT03538691|580486766|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
160754581|NCT03538691|580486763|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
160754582|NCT03538691|580486764|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
160754583|NCT03538691|580486765|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
160754584|NCT03538691|580486766|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
160754585|NCT03538691|580486763|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
160754586|NCT03538691|580486764|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
160754587|NCT03538691|580486765|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
160754588|NCT03538691|580486766|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
160754589|NCT03538691|580486763|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
160754590|NCT03538691|580486764|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
160754591|NCT03538691|580486765|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
160754592|NCT03538691|580486766|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
160754593|NCT03538691|580486763|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
160754594|NCT03538691|580486764|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
160754595|NCT03538691|580486765|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
160754596|NCT03538691|580486766|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
160754597|NCT03538691|580486763|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
160754598|NCT03538691|580486764|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
160754599|NCT03538691|580486765|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
160754600|NCT03538691|580486766|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
160754601|NCT03538691|580486763|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
160754602|NCT03538691|580486764|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
160754603|NCT03538691|580486765|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
160754604|NCT03538691|580486766|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
160754605|NCT03538691|580486763|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
160754606|NCT03538691|580486764|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
160754607|NCT03538691|580486765|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
160754608|NCT03538691|580486766|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
160754609|NCT03538691|580486763|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
160754610|NCT03538691|580486764|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
160754611|NCT03538691|580486765|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
160754612|NCT03538691|580486766|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
160754613|NCT03538691|580486763|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
160754614|NCT03538691|580486764|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
160754615|NCT03538691|580486765|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
160754616|NCT03538691|580486766|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
160754617|NCT03538691|580486763|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
160754618|NCT03538691|580486764|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
160754619|NCT03538691|580486765|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
160754620|NCT03538691|580486766|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
160754621|NCT03538691|580486763|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
160754622|NCT03538691|580486764|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
160754623|NCT03538691|580486765|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
160754624|NCT03538691|580486766|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
160754625|NCT03538691|580486763|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
160754626|NCT03538691|580486764|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
160754627|NCT03538691|580486765|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
160754628|NCT03538691|580486766|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
160754629|NCT03538691|580486763|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
160754630|NCT03538691|580486764|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
160754631|NCT03538691|580486765|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
160754632|NCT03538691|580486766|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
160754633|NCT03538691|580486763|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
160754634|NCT03538691|580486764|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
160754635|NCT03538691|580486765|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
160754636|NCT03538691|580486766|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
160754637|NCT03538691|580486763|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
160754638|NCT03538691|580486764|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
160754639|NCT03538691|580486765|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
160754640|NCT03538691|580486766|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
160754641|NCT03538691|580486763|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
160754642|NCT03538691|580486764|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
160754643|NCT03538691|580486765|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
160754644|NCT03538691|580486766|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
160754645|NCT03538691|580486763|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
160754646|NCT03538691|580486764|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
160754647|NCT03538691|580486765|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
160754648|NCT03538691|580486766|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
160754649|NCT03538691|580486763|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
160754650|NCT03538691|580486764|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
160754651|NCT03538691|580486765|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
160754652|NCT03538691|580486766|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
160754653|NCT01972464|580486767|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
160754654|NCT01972464|580486768|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
160754655|NCT01972464|580486767|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
160754656|NCT01972464|580486768|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
160754657|NCT01972464|580486767|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
160754658|NCT01972464|580486768|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
160754659|NCT01972464|580486767|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
160754660|NCT01972464|580486768|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
160754661|NCT02100839|580488254|FG000|Multiple Ascending Dose|Adverse Event|2|||
160754662|NCT02100839|580488255|FG001|Multiple Ascending Dose|Adverse Event|0|||
160754663|NCT02100839|580488254|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
160754664|NCT02100839|580488255|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
160754665|NCT03272347|580488256|FG000|Overall Study|Death|0|||
160754666|NCT03272347|580488257|FG001|Overall Study|Death|0|||
160754667|NCT03272347|580488258|FG002|Overall Study|Death|0|||
160754668|NCT03272347|580488259|FG003|Overall Study|Death|1|||
160754669|NCT03272347|580488256|FG000|Overall Study|Lost to Follow-up|1|||
160754670|NCT03272347|580488257|FG001|Overall Study|Lost to Follow-up|3|||
160754671|NCT03272347|580488258|FG002|Overall Study|Lost to Follow-up|5|||
160754672|NCT03272347|580488259|FG003|Overall Study|Lost to Follow-up|1|||
160754673|NCT03272347|580488256|FG000|Overall Study|Physician Decision|4|||
160754674|NCT03272347|580488257|FG001|Overall Study|Physician Decision|2|||
160754675|NCT03272347|580488258|FG002|Overall Study|Physician Decision|5|||
160754676|NCT03272347|580488259|FG003|Overall Study|Physician Decision|4|||
160754677|NCT03272347|580488256|FG000|Overall Study|Screen Failure|1|||
160754678|NCT03272347|580488257|FG001|Overall Study|Screen Failure|0|||
160754679|NCT03272347|580488258|FG002|Overall Study|Screen Failure|0|||
160754680|NCT03272347|580488259|FG003|Overall Study|Screen Failure|0|||
160754681|NCT03272347|580488256|FG000|Overall Study|Withdrawal by Subject|5|||
160754682|NCT03272347|580488257|FG001|Overall Study|Withdrawal by Subject|1|||
160754683|NCT03272347|580488258|FG002|Overall Study|Withdrawal by Subject|2|||
160754684|NCT03272347|580488259|FG003|Overall Study|Withdrawal by Subject|1|||
160754685|NCT01971567|580488260|FG000|Overall Study|Withdrawal by Subject|3|||
160754686|NCT01971567|580488261|FG001|Overall Study|Withdrawal by Subject|2|||
160754687|NCT01971567|580488260|FG000|Overall Study|Lost to Follow-up|1|||
160754688|NCT01971567|580488261|FG001|Overall Study|Lost to Follow-up|0|||
160754689|NCT00522548|580488262|FG000|Overall Study|Adverse Event|2|||
160754690|NCT00522548|580488263|FG001|Overall Study|Adverse Event|2|||
160754691|NCT00522548|580488262|FG000|Overall Study|Withdrawal by Subject|0|||
160754692|NCT00522548|580488263|FG001|Overall Study|Withdrawal by Subject|2|||
160754693|NCT04668209|580488265|FG000|Overall Study|Withdrawal by Subject|2|||
160754694|NCT04668209|580488266|FG001|Overall Study|Withdrawal by Subject|2|||
160754695|NCT04668209|580488265|FG000|Overall Study|Lost to Follow-up|3|||
160754696|NCT04668209|580488266|FG001|Overall Study|Lost to Follow-up|4|||
160754697|NCT04668209|580488265|FG000|Overall Study|Subject Expired|2|||
160754698|NCT04668209|580488266|FG001|Overall Study|Subject Expired|0|||
160754699|NCT04668209|580488265|FG000|Overall Study|Withdrawn from study|0|||
160754700|NCT04668209|580488266|FG001|Overall Study|Withdrawn from study|1|||
160754701|NCT04668209|580488265|FG000|Overall Study|Adverse Event|0|||
160754702|NCT04668209|580488266|FG001|Overall Study|Adverse Event|1|||
160754703|NCT01096160|580488269|FG000|Overall Study|Adverse Event|0|||
160754704|NCT01096160|580488270|FG001|Overall Study|Adverse Event|0|||
160754705|NCT01096160|580488271|FG002|Overall Study|Adverse Event|1|||
160754706|NCT01096160|580488272|FG003|Overall Study|Adverse Event|0|||
160754707|NCT01096160|580488273|FG004|Overall Study|Adverse Event|0|||
160754708|NCT01096160|580488274|FG005|Overall Study|Adverse Event|0|||
160754709|NCT01096160|580488275|FG006|Overall Study|Adverse Event|0|||
160754710|NCT01096160|580488276|FG007|Overall Study|Adverse Event|0|||
160754711|NCT01096160|580488277|FG008|Overall Study|Adverse Event|0|||
160754712|NCT01096160|580488278|FG009|Overall Study|Adverse Event|1|||
160754713|NCT01096160|580488269|FG000|Overall Study|Met stopping criteria per protocol|0|||
160754714|NCT01096160|580488270|FG001|Overall Study|Met stopping criteria per protocol|0|||
160754715|NCT01096160|580488271|FG002|Overall Study|Met stopping criteria per protocol|0|||
160754716|NCT01096160|580488272|FG003|Overall Study|Met stopping criteria per protocol|0|||
160754717|NCT01096160|580488273|FG004|Overall Study|Met stopping criteria per protocol|1|||
160754718|NCT01096160|580488274|FG005|Overall Study|Met stopping criteria per protocol|0|||
160754719|NCT01096160|580488275|FG006|Overall Study|Met stopping criteria per protocol|2|||
160754720|NCT01096160|580488276|FG007|Overall Study|Met stopping criteria per protocol|0|||
160754721|NCT01096160|580488277|FG008|Overall Study|Met stopping criteria per protocol|2|||
160754722|NCT01096160|580488278|FG009|Overall Study|Met stopping criteria per protocol|0|||
160754723|NCT02028507|580488279|FG000|Overall Study|Progressive Disease|122|||
160754724|NCT02028507|580488280|FG001|Overall Study|Progressive Disease|90|||
160754725|NCT02028507|580488281|FG002|Overall Study|Progressive Disease|102|||
160754726|NCT02028507|580488282|FG003|Overall Study|Progressive Disease|89|||
160754727|NCT02028507|580488279|FG000|Overall Study|Adverse Event|8|||
160754728|NCT02028507|580488280|FG001|Overall Study|Adverse Event|25|||
160754729|NCT02028507|580488281|FG002|Overall Study|Adverse Event|3|||
160754730|NCT02028507|580488282|FG003|Overall Study|Adverse Event|16|||
160754731|NCT02028507|580488279|FG000|Overall Study|Withdrawal by Subject|6|||
160754732|NCT02028507|580488280|FG001|Overall Study|Withdrawal by Subject|8|||
160754733|NCT02028507|580488281|FG002|Overall Study|Withdrawal by Subject|5|||
160754734|NCT02028507|580488282|FG003|Overall Study|Withdrawal by Subject|9|||
160754735|NCT02028507|580488279|FG000|Overall Study|Protocol Violation|2|||
160754736|NCT02028507|580488280|FG001|Overall Study|Protocol Violation|4|||
160754737|NCT02028507|580488281|FG002|Overall Study|Protocol Violation|1|||
160754738|NCT02028507|580488282|FG003|Overall Study|Protocol Violation|3|||
160754739|NCT02028507|580488279|FG000|Overall Study|Physician Decision|0|||
160754740|NCT02028507|580488280|FG001|Overall Study|Physician Decision|4|||
160754741|NCT02028507|580488281|FG002|Overall Study|Physician Decision|0|||
160754742|NCT02028507|580488282|FG003|Overall Study|Physician Decision|0|||
160754743|NCT02028507|580488279|FG000|Overall Study|Death|1|||
160754744|NCT02028507|580488280|FG001|Overall Study|Death|0|||
160754745|NCT02028507|580488281|FG002|Overall Study|Death|1|||
160754746|NCT02028507|580488282|FG003|Overall Study|Death|3|||
160754747|NCT02028507|580488279|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
160754748|NCT02028507|580488280|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
160754749|NCT02028507|580488281|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
160754750|NCT02028507|580488282|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
160754751|NCT02028507|580488279|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
160754752|NCT02028507|580488280|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
160754753|NCT02028507|580488281|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
160754754|NCT02028507|580488282|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
160754755|NCT02028507|580488279|FG000|Overall Study|Randomized But Not Treated|3|||
160754756|NCT02028507|580488280|FG001|Overall Study|Randomized But Not Treated|6|||
160754757|NCT02028507|580488281|FG002|Overall Study|Randomized But Not Treated|0|||
160754758|NCT02028507|580488282|FG003|Overall Study|Randomized But Not Treated|4|||
160754759|NCT02028507|580488279|FG000|Overall Study|Enzyme defect|0|||
160754760|NCT02028507|580488280|FG001|Overall Study|Enzyme defect|0|||
160754761|NCT02028507|580488281|FG002|Overall Study|Enzyme defect|0|||
160754762|NCT02028507|580488282|FG003|Overall Study|Enzyme defect|1|||
160754763|NCT02028507|580488279|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
160754764|NCT02028507|580488280|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
160754765|NCT02028507|580488281|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
160754766|NCT02028507|580488282|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
160754767|NCT02028507|580488279|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
160754768|NCT02028507|580488280|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
160754769|NCT02028507|580488281|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
160754770|NCT02028507|580488282|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
160754771|NCT01556932|580488283|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
160754772|NCT01556932|580488284|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
160754773|NCT02105285|580488285|FG000|Overall Study|Adverse Event|1|||
160754774|NCT02105285|580488286|FG001|Overall Study|Adverse Event|1|||
160754775|NCT02105285|580488287|FG002|Overall Study|Adverse Event|0|||
160754776|NCT02105285|580488285|FG000|Overall Study|Protocol Violation|0|||
160754777|NCT02105285|580488286|FG001|Overall Study|Protocol Violation|1|||
160754778|NCT02105285|580488287|FG002|Overall Study|Protocol Violation|0|||
160754779|NCT02105285|580488285|FG000|Overall Study|Withdrawal by Subject|1|||
160754780|NCT02105285|580488286|FG001|Overall Study|Withdrawal by Subject|0|||
160754781|NCT02105285|580488287|FG002|Overall Study|Withdrawal by Subject|0|||
160754782|NCT01421641|580488288|FG000|Overall Study|Protocol Violation|2|||
160754783|NCT01421641|580488289|FG001|Overall Study|Protocol Violation|2|||
160754784|NCT02420119|580488290|FG000|Overall Study|insufficient laboratory data|5|||
160754785|NCT03231306|580488291|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
160754786|NCT03231306|580488291|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
160754787|NCT03231306|580488291|FG000|Overall Study|Treatment delay > 21 days|2|||
160754788|NCT03231306|580488291|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
160754789|NCT03231306|580488291|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
160754790|NCT03231306|580488291|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
160754791|NCT03231306|580488291|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
160754792|NCT03231306|580488291|FG000|Overall Study|More than 1 Reason|2|||
160754793|NCT01808261|580488292|FG000|Overall Study|Physician Decision|0|||
160754794|NCT01808261|580488293|FG001|Overall Study|Physician Decision|2|||
160754795|NCT01808261|580488292|FG000|Overall Study|Study Closed/Terminated|25|||
160754796|NCT01808261|580488293|FG001|Overall Study|Study Closed/Terminated|23|||
160754797|NCT01808261|580488292|FG000|Overall Study|Adverse event, non-fatal|2|||
160754798|NCT01808261|580488293|FG001|Overall Study|Adverse event, non-fatal|0|||
160754799|NCT01808261|580488292|FG000|Overall Study|Consent withdrawn by subject|6|||
160754800|NCT01808261|580488293|FG001|Overall Study|Consent withdrawn by subject|7|||
160754801|NCT01808261|580488292|FG000|Overall Study|Lost to Follow-up|3|||
160754802|NCT01808261|580488293|FG001|Overall Study|Lost to Follow-up|1|||
160754803|NCT02585713|580488296|FG000|Overall Study|Withdrew prior to treatment|2|||
160754804|NCT02585713|580488297|FG001|Overall Study|Withdrew prior to treatment|7|||
160754805|NCT02585713|580488296|FG000|Overall Study|Other|3|||
160754806|NCT02585713|580488297|FG001|Overall Study|Other|1|||
160754807|NCT04501952|580488302|FG000|Overall Study|Adverse Event|0|||
160754808|NCT04501952|580488303|FG001|Overall Study|Adverse Event|3|||
160754809|NCT04501952|580488302|FG000|Overall Study|Investigator's Discretion|0|||
160754810|NCT04501952|580488303|FG001|Overall Study|Investigator's Discretion|1|||
160754811|NCT04501952|580488302|FG000|Overall Study|Protocol Violation|1|||
160754812|NCT04501952|580488303|FG001|Overall Study|Protocol Violation|1|||
160754813|NCT04501952|580488302|FG000|Overall Study|Withdrew Consent|5|||
160754814|NCT04501952|580488303|FG001|Overall Study|Withdrew Consent|4|||
160754815|NCT04501952|580488302|FG000|Overall Study|Lost to Follow-up|7|||
160754816|NCT04501952|580488303|FG001|Overall Study|Lost to Follow-up|2|||
160754817|NCT04501952|580488302|FG000|Overall Study|Randomized and Never Treated|13|||
160754818|NCT04501952|580488303|FG001|Overall Study|Randomized and Never Treated|9|||
160754819|NCT02609984|580488305|FG000|Overall Study|Death|29|||
160754820|NCT02609984|580488306|FG001|Overall Study|Death|26|||
160754821|NCT02609984|580488305|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
160754822|NCT02609984|580488306|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
160754823|NCT02609984|580488305|FG000|Overall Study|Lost to Follow-up|1|||
160754824|NCT02609984|580488306|FG001|Overall Study|Lost to Follow-up|2|||
160754825|NCT02609984|580488305|FG000|Overall Study|Withdrawal by Subject|0|||
160754826|NCT02609984|580488306|FG001|Overall Study|Withdrawal by Subject|1|||
160754827|NCT02609984|580488305|FG000|Overall Study|Disease Progression|2|||
160754828|NCT02609984|580488306|FG001|Overall Study|Disease Progression|0|||
160754829|NCT02256839|580488308|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
160754830|NCT02256839|580488309|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
160754831|NCT01843803|580488310|FG000|Overall Study|not a Veteran, did not see provider|1|||
160754832|NCT01843803|580488311|FG001|Overall Study|not a Veteran, did not see provider|3|||
160754833|NCT00436826|580488317|FG000|Double Blind Period (DBP)|Adverse Event|2|||
160754834|NCT00436826|580488318|FG001|Double Blind Period (DBP)|Adverse Event|0|||
160754835|NCT00436826|580488319|FG002|Double Blind Period (DBP)|Adverse Event|0|||
160754836|NCT00436826|580488320|FG003|Double Blind Period (DBP)|Adverse Event|0|||
160754837|NCT00436826|580488321|FG004|Double Blind Period (DBP)|Adverse Event|0|||
160754838|NCT00436826|580488322|FG005|Double Blind Period (DBP)|Adverse Event|0|||
160754839|NCT00436826|580488317|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
160754840|NCT00436826|580488318|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
160754841|NCT00436826|580488319|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
160754842|NCT00436826|580488320|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
160754843|NCT00436826|580488321|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
160754844|NCT00436826|580488322|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
160754845|NCT00436826|580488317|FG000|Double Blind Period (DBP)|Other|10|||
160754846|NCT00436826|580488318|FG001|Double Blind Period (DBP)|Other|11|||
160754847|NCT00436826|580488319|FG002|Double Blind Period (DBP)|Other|0|||
160754848|NCT00436826|580488320|FG003|Double Blind Period (DBP)|Other|0|||
160754849|NCT00436826|580488321|FG004|Double Blind Period (DBP)|Other|0|||
160754850|NCT00436826|580488322|FG005|Double Blind Period (DBP)|Other|0|||
160754851|NCT00436826|580488317|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
160754852|NCT00436826|580488318|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
160754853|NCT00436826|580488319|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
160754854|NCT00436826|580488320|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
160754855|NCT00436826|580488321|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
160754856|NCT00436826|580488322|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
160754857|NCT00436826|580488317|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
160754858|NCT00436826|580488318|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
160754859|NCT00436826|580488319|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
160754860|NCT00436826|580488320|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
160754861|NCT00436826|580488321|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
160754862|NCT00436826|580488322|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
160754863|NCT00436826|580488317|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
160754864|NCT00436826|580488318|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
160754865|NCT00436826|580488319|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
160754866|NCT00436826|580488320|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
160754867|NCT00436826|580488321|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
160754868|NCT00436826|580488322|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
160754869|NCT03382418|580488325|FG000|Overall Study|Withdrawal by Subject|1|||
160754870|NCT03382418|580488326|FG001|Overall Study|Withdrawal by Subject|0|||
160754871|NCT03382418|580488327|FG002|Overall Study|Withdrawal by Subject|0|||
160754872|NCT03382418|580488325|FG000|Overall Study|Lost to Follow-up|2|||
160754873|NCT03382418|580488326|FG001|Overall Study|Lost to Follow-up|3|||
160754874|NCT03382418|580488327|FG002|Overall Study|Lost to Follow-up|0|||
160754875|NCT02472886|580488335|FG000|Overall Study|Lack of Efficacy|0|||
160754876|NCT02472886|580488336|FG001|Overall Study|Lack of Efficacy|2|||
160754877|NCT02472886|580488337|FG002|Overall Study|Lack of Efficacy|1|||
160754878|NCT01051817|580488338|FG000|Overall Study|Adverse Event|0|||
160754879|NCT01051817|580488339|FG001|Overall Study|Adverse Event|2|||
160754880|NCT01051817|580488338|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
160754881|NCT01051817|580488339|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
160754882|NCT01051817|580488338|FG000|Overall Study|Withdrawal by Subject|3|||
160754883|NCT01051817|580488339|FG001|Overall Study|Withdrawal by Subject|5|||
160754884|NCT01051817|580488338|FG000|Overall Study|Protocol Violation|0|||
160754885|NCT01051817|580488339|FG001|Overall Study|Protocol Violation|1|||
160754886|NCT04346199|580488341|FG000|Overall Study|Death|8|||
160754887|NCT04346199|580488342|FG001|Overall Study|Death|9|||
160754888|NCT04346199|580488341|FG000|Overall Study|Lost to Follow-up|0|||
160754889|NCT04346199|580488342|FG001|Overall Study|Lost to Follow-up|1|||
160754890|NCT04346199|580488341|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
160754891|NCT04346199|580488342|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
160754892|NCT04346199|580488341|FG000|Overall Study|Withdrawal by Subject|5|||
160754893|NCT04346199|580488342|FG001|Overall Study|Withdrawal by Subject|1|||
160754894|NCT00627926|580488343|FG000|Overall Study|Adverse Event|26|||
160754895|NCT00627926|580488344|FG001|Overall Study|Adverse Event|37|||
160754896|NCT00627926|580488345|FG002|Overall Study|Adverse Event|36|||
160754897|NCT00627926|580488343|FG000|Overall Study|Death|1|||
160754898|NCT00627926|580488344|FG001|Overall Study|Death|0|||
160754899|NCT00627926|580488345|FG002|Overall Study|Death|0|||
160754900|NCT00627926|580488343|FG000|Overall Study|Lost to Follow-up|4|||
160754901|NCT00627926|580488344|FG001|Overall Study|Lost to Follow-up|3|||
160754902|NCT00627926|580488345|FG002|Overall Study|Lost to Follow-up|4|||
160754903|NCT00627926|580488343|FG000|Overall Study|Withdrawal by Subject|2|||
160754904|NCT00627926|580488344|FG001|Overall Study|Withdrawal by Subject|1|||
160754905|NCT00627926|580488345|FG002|Overall Study|Withdrawal by Subject|0|||
160754906|NCT00627926|580488343|FG000|Overall Study|Lack of Efficacy|118|||
160754907|NCT00627926|580488344|FG001|Overall Study|Lack of Efficacy|40|||
160754908|NCT00627926|580488345|FG002|Overall Study|Lack of Efficacy|38|||
160754909|NCT00627926|580488343|FG000|Overall Study|Noncompliance/unspecified|8|||
160754910|NCT00627926|580488344|FG001|Overall Study|Noncompliance/unspecified|23|||
160754911|NCT00627926|580488345|FG002|Overall Study|Noncompliance/unspecified|17|||
160754912|NCT03414229|580488346|FG000|Overall Study|Adverse Event|1|||
160754913|NCT03414229|580488347|FG001|Overall Study|Adverse Event|0|||
160754914|NCT03414229|580488348|FG002|Overall Study|Adverse Event|2|||
160754915|NCT03414229|580488349|FG003|Overall Study|Adverse Event|1|||
160754916|NCT03414229|580488346|FG000|Overall Study|Lack of Efficacy|7|||
160754917|NCT03414229|580488347|FG001|Overall Study|Lack of Efficacy|4|||
160754918|NCT03414229|580488348|FG002|Overall Study|Lack of Efficacy|1|||
160754919|NCT03414229|580488349|FG003|Overall Study|Lack of Efficacy|9|||
160754920|NCT03414229|580488346|FG000|Overall Study|Change in therapy|1|||
160754921|NCT03414229|580488347|FG001|Overall Study|Change in therapy|0|||
160754922|NCT03414229|580488348|FG002|Overall Study|Change in therapy|0|||
160754923|NCT03414229|580488349|FG003|Overall Study|Change in therapy|0|||
160754924|NCT03414229|580488346|FG000|Overall Study|Pregnancy|0|||
160754925|NCT03414229|580488347|FG001|Overall Study|Pregnancy|0|||
160754926|NCT03414229|580488348|FG002|Overall Study|Pregnancy|1|||
160754927|NCT03414229|580488349|FG003|Overall Study|Pregnancy|0|||
160754928|NCT03414229|580488346|FG000|Overall Study|Withdrawal by Subject|0|||
160754929|NCT03414229|580488347|FG001|Overall Study|Withdrawal by Subject|1|||
160754930|NCT03414229|580488348|FG002|Overall Study|Withdrawal by Subject|1|||
160754931|NCT03414229|580488349|FG003|Overall Study|Withdrawal by Subject|0|||
160754932|NCT01118663|580488358|FG000|Overall Study|Adverse Event|2|||
160754933|NCT01118663|580488359|FG001|Overall Study|Adverse Event|1|||
160754934|NCT01118663|580488358|FG000|Overall Study|Withdrawal by Subject|0|||
160754935|NCT01118663|580488359|FG001|Overall Study|Withdrawal by Subject|1|||
160754936|NCT03046953|580488366|FG000|Overall Study|Relapse/progressive disease|21|||
160754937|NCT03046953|580488366|FG000|Overall Study|Death|2|||
160754938|NCT03046953|580488366|FG000|Overall Study|Withdrawal by Subject|3|||
160754939|NCT04039204|580488368|FG000|Overall Study|Withdrawal by Subject|0|||
160754940|NCT04039204|580488369|FG001|Overall Study|Withdrawal by Subject|2|||
160754941|NCT00396383|580488374|FG000|Overall Study|Death|2|||
160754942|NCT00396383|580488374|FG000|Overall Study|Lost to Follow-up|1|||
160754943|NCT02385110|580488377|FG000|Overall Study|Early Death|1|||
160754944|NCT02385110|580488378|FG001|Overall Study|Early Death|0|||
160754945|NCT00534638|580488379|FG000|Overall Study|Withdrawal by Subject|3|||
160754946|NCT00534638|580488380|FG001|Overall Study|Withdrawal by Subject|4|||
160754947|NCT00534638|580488379|FG000|Overall Study|Migrated/moved from study area|13|||
160754948|NCT00534638|580488380|FG001|Overall Study|Migrated/moved from study area|11|||
160754949|NCT00534638|580488379|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
160754950|NCT00534638|580488380|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
160754951|NCT00534638|580488379|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
160754952|NCT00534638|580488380|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
160754953|NCT00534638|580488379|FG000|Overall Study|Other|1685|||
160754954|NCT00534638|580488380|FG001|Overall Study|Other|902|||
160754955|NCT01124292|580488382|FG000|Overall Study|Lost to Follow-up|2|||
160754956|NCT01124292|580488383|FG001|Overall Study|Lost to Follow-up|4|||
160754957|NCT01124292|580488384|FG002|Overall Study|Lost to Follow-up|3|||
160754958|NCT01124292|580488382|FG000|Overall Study|Physician Decision|0|||
160754959|NCT01124292|580488383|FG001|Overall Study|Physician Decision|3|||
160754960|NCT01124292|580488384|FG002|Overall Study|Physician Decision|2|||
160754961|NCT01124292|580488382|FG000|Overall Study|Withdrawal by Subject|0|||
160754962|NCT01124292|580488383|FG001|Overall Study|Withdrawal by Subject|6|||
160754963|NCT01124292|580488384|FG002|Overall Study|Withdrawal by Subject|2|||
160754964|NCT01124292|580488382|FG000|Overall Study|medical issue unrelated to the study|0|||
160754965|NCT01124292|580488383|FG001|Overall Study|medical issue unrelated to the study|0|||
160754966|NCT01124292|580488384|FG002|Overall Study|medical issue unrelated to the study|2|||
160754967|NCT01124292|580488382|FG000|Overall Study|piercing track closed|0|||
160754968|NCT01124292|580488383|FG001|Overall Study|piercing track closed|2|||
160754969|NCT01124292|580488384|FG002|Overall Study|piercing track closed|1|||
160754970|NCT00481767|580488385|FG000|Overall Study|Withdrawal by Subject|16|||
160754971|NCT00481767|580488386|FG001|Overall Study|Withdrawal by Subject|11|||
160754972|NCT00481767|580488385|FG000|Overall Study|Lost to Follow-up|16|||
160754973|NCT00481767|580488386|FG001|Overall Study|Lost to Follow-up|10|||
160754974|NCT00636636|580488387|FG000|Overall Study|Other reason|4|||
160754975|NCT00636636|580488388|FG001|Overall Study|Other reason|6|||
160754976|NCT00636636|580488387|FG000|Overall Study|Adverse Event|19|||
160754977|NCT00636636|580488388|FG001|Overall Study|Adverse Event|8|||
160754978|NCT00636636|580488387|FG000|Overall Study|Lack of Efficacy|7|||
160754979|NCT00636636|580488388|FG001|Overall Study|Lack of Efficacy|12|||
160754980|NCT00636636|580488387|FG000|Overall Study|Protocol Violation|2|||
160754981|NCT00636636|580488388|FG001|Overall Study|Protocol Violation|2|||
160754982|NCT00636636|580488387|FG000|Overall Study|Lost to Follow-up|0|||
160754983|NCT00636636|580488388|FG001|Overall Study|Lost to Follow-up|1|||
160754984|NCT00636636|580488387|FG000|Overall Study|Death|0|||
160754985|NCT00636636|580488388|FG001|Overall Study|Death|1|||
160754986|NCT00636636|580488387|FG000|Overall Study|Withdrawal by Subject|4|||
160754987|NCT00636636|580488388|FG001|Overall Study|Withdrawal by Subject|9|||
160754988|NCT00524173|580488389|FG000|Overall Study|Lost to Follow-up|0|||
160754989|NCT00524173|580488390|FG001|Overall Study|Lost to Follow-up|1|||
160754990|NCT00524173|580488389|FG000|Overall Study|Death|1|||
160754991|NCT00524173|580488390|FG001|Overall Study|Death|0|||
160754992|NCT00524173|580488389|FG000|Overall Study|Had not reached endpoint at study close|4|||
160754993|NCT00524173|580488390|FG001|Overall Study|Had not reached endpoint at study close|1|||
160524954|NCT02465463|579651765|FG001|Overall Study|Lost to Follow-up|1|||
160524955|NCT02465463|579651764|FG000|Overall Study|Death|1|||
160524956|NCT02465463|579651765|FG001|Overall Study|Death|0|||
160524957|NCT02465463|579651764|FG000|Overall Study|Protocol Violation|1|||
160636165|NCT01399125|580051479|FG001|Overall Study|Abnormal Lab values|1|||
160636166|NCT01399125|580051478|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160636167|NCT01399125|580051479|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
160636168|NCT01399125|580051478|FG000|Overall Study|Withdrawal by Subject|5|||
160636169|NCT01399125|580051479|FG001|Overall Study|Withdrawal by Subject|8|||
160636170|NCT01399125|580051478|FG000|Overall Study|Lost to Follow-up|2|||
160636171|NCT01399125|580051479|FG001|Overall Study|Lost to Follow-up|3|||
160636172|NCT01399125|580051478|FG000|Overall Study|Administrative Problems|7|||
160636173|NCT01399125|580051479|FG001|Overall Study|Administrative Problems|11|||
160636174|NCT01399125|580051478|FG000|Overall Study|Death|0|||
160636175|NCT01399125|580051479|FG001|Overall Study|Death|1|||
160636176|NCT01399125|580051478|FG000|Overall Study|Protocol Deviation|5|||
160636177|NCT01399125|580051479|FG001|Overall Study|Protocol Deviation|2|||
160636178|NCT01902134|580051480|FG000|Overall Study|Adverse Event|3|||
160636179|NCT01902134|580051481|FG001|Overall Study|Adverse Event|1|||
160636180|NCT01902134|580051482|FG002|Overall Study|Adverse Event|2|||
160636181|NCT01902134|580051483|FG003|Overall Study|Adverse Event|1|||
160636182|NCT01902134|580051484|FG004|Overall Study|Adverse Event|1|||
160636183|NCT01902134|580051485|FG005|Overall Study|Adverse Event|3|||
160636184|NCT01902134|580051480|FG000|Overall Study|Lack of Efficacy|0|||
160636185|NCT01902134|580051481|FG001|Overall Study|Lack of Efficacy|0|||
160636186|NCT01902134|580051482|FG002|Overall Study|Lack of Efficacy|2|||
160636187|NCT01902134|580051483|FG003|Overall Study|Lack of Efficacy|0|||
160524958|NCT02465463|579651765|FG001|Overall Study|Protocol Violation|0|||
160524959|NCT01067326|579651770|FG000|Overall Study|Adverse Event|0|||
160524960|NCT01067326|579651771|FG001|Overall Study|Adverse Event|2|||
160524961|NCT01067326|579651770|FG000|Overall Study|Withdrawal by Subject|1|||
160524962|NCT01067326|579651771|FG001|Overall Study|Withdrawal by Subject|0|||
160524963|NCT01067326|579651770|FG000|Overall Study|Early Study Termination|1|||
160524964|NCT01067326|579651771|FG001|Overall Study|Early Study Termination|1|||
160524965|NCT03026127|579651780|FG000|CRISP R61|Adverse Event|5|||
160524966|NCT03026127|579651781|FG001|CRISP R61|Adverse Event|0|||
160524967|NCT03026127|579651782|FG002|CRISP R61|Adverse Event|0|||
160524968|NCT03026127|579651780|FG000|CRISP R61|Lost to Follow-up|2|||
160524969|NCT03026127|579651781|FG001|CRISP R61|Lost to Follow-up|0|||
160524970|NCT03026127|579651782|FG002|CRISP R61|Lost to Follow-up|0|||
160524971|NCT03026127|579651780|FG000|CRISP R61|Dropped before therapy|5|||
160524972|NCT03026127|579651781|FG001|CRISP R61|Dropped before therapy|0|||
160524973|NCT03026127|579651782|FG002|CRISP R61|Dropped before therapy|0|||
160524974|NCT03026127|579651780|FG000|CRISP R33|Lost to Follow-up|0|||
160524975|NCT03026127|579651781|FG001|CRISP R33|Lost to Follow-up|5|||
160524976|NCT03026127|579651782|FG002|CRISP R33|Lost to Follow-up|4|||
160524977|NCT03026127|579651780|FG000|CRISP R33|Adverse Event|0|||
160524978|NCT03026127|579651781|FG001|CRISP R33|Adverse Event|9|||
160524979|NCT03026127|579651782|FG002|CRISP R33|Adverse Event|5|||
160524980|NCT03026127|579651780|FG000|CRISP R33|Withdrawal by Subject|0|||
160524981|NCT03026127|579651781|FG001|CRISP R33|Withdrawal by Subject|9|||
160524982|NCT03026127|579651782|FG002|CRISP R33|Withdrawal by Subject|1|||
160524983|NCT03026127|579651780|FG000|CRISP R33|Lack of Efficacy|0|||
160524984|NCT03026127|579651781|FG001|CRISP R33|Lack of Efficacy|3|||
160524985|NCT03026127|579651782|FG002|CRISP R33|Lack of Efficacy|2|||
160524986|NCT03026127|579651780|FG000|CRISP R33|Physician Decision|0|||
160524987|NCT03026127|579651781|FG001|CRISP R33|Physician Decision|3|||
160524988|NCT03026127|579651782|FG002|CRISP R33|Physician Decision|1|||
160524989|NCT03026127|579651780|FG000|CRISP R33|Transportation|0|||
160524990|NCT03026127|579651781|FG001|CRISP R33|Transportation|2|||
160524991|NCT03026127|579651782|FG002|CRISP R33|Transportation|1|||
160524992|NCT00564018|579651784|FG000|Overall Study|Withdrawal by Subject|2|||
160524993|NCT00564018|579651785|FG001|Overall Study|Withdrawal by Subject|3|||
160524994|NCT00564018|579651786|FG002|Overall Study|Withdrawal by Subject|1|||
160524995|NCT01209143|579651789|FG000|Overall Study|Adverse Event|2|||
160524996|NCT01209143|579651790|FG001|Overall Study|Adverse Event|1|||
160524997|NCT01209143|579651789|FG000|Overall Study|Death|0|||
160524998|NCT01209143|579651790|FG001|Overall Study|Death|1|||
160524999|NCT01209143|579651789|FG000|Overall Study|Physician Decision|3|||
160525000|NCT01209143|579651790|FG001|Overall Study|Physician Decision|1|||
160525001|NCT01209143|579651789|FG000|Overall Study|Lost to Follow-up|1|||
160525002|NCT01209143|579651790|FG001|Overall Study|Lost to Follow-up|0|||
160525003|NCT01209143|579651789|FG000|Overall Study|Withdrawal by Subject|2|||
160525004|NCT01209143|579651790|FG001|Overall Study|Withdrawal by Subject|1|||
160636188|NCT01902134|580051484|FG004|Overall Study|Lack of Efficacy|0|||
160636189|NCT01902134|580051485|FG005|Overall Study|Lack of Efficacy|1|||
160525005|NCT01209143|579651789|FG000|Overall Study|Disease progression|11|||
160525006|NCT01209143|579651790|FG001|Overall Study|Disease progression|16|||
160525007|NCT00381303|579651791|FG000|Overall Study|Lost to Follow-up|25|||
160525008|NCT00381303|579651792|FG001|Overall Study|Lost to Follow-up|9|||
160525009|NCT00381303|579651791|FG000|Overall Study|AE/HIV-related event|22|||
160754994|NCT03300180|580488391|FG000|Baseline|Withdrawal by Subject|4|||
160754995|NCT03300180|580488392|FG001|Baseline|Withdrawal by Subject|6|||
160754996|NCT03300180|580488393|FG002|Baseline|Withdrawal by Subject|4|||
160754997|NCT03300180|580488391|FG000|6 Month Outcome|Withdrawal by Subject|12|||
160754998|NCT03300180|580488392|FG001|6 Month Outcome|Withdrawal by Subject|12|||
160754999|NCT03300180|580488393|FG002|6 Month Outcome|Withdrawal by Subject|19|||
160755000|NCT03300180|580488391|FG000|6 Month Outcome|Death|2|||
160755001|NCT03300180|580488392|FG001|6 Month Outcome|Death|4|||
160755002|NCT03300180|580488393|FG002|6 Month Outcome|Death|3|||
160755003|NCT03300180|580488391|FG000|6 Month Outcome|Missed Assessment|43|||
160755004|NCT03300180|580488392|FG001|6 Month Outcome|Missed Assessment|52|||
160755005|NCT03300180|580488393|FG002|6 Month Outcome|Missed Assessment|46|||
160755006|NCT03300180|580488391|FG000|12 Month Outcome|Withdrawal by Subject|3|||
160755007|NCT03300180|580488392|FG001|12 Month Outcome|Withdrawal by Subject|6|||
160755008|NCT03300180|580488393|FG002|12 Month Outcome|Withdrawal by Subject|6|||
160755009|NCT03300180|580488391|FG000|12 Month Outcome|Death|9|||
160755010|NCT03300180|580488392|FG001|12 Month Outcome|Death|6|||
160755011|NCT03300180|580488393|FG002|12 Month Outcome|Death|6|||
160755012|NCT03300180|580488391|FG000|12 Month Outcome|Missed Assessment|62|||
160755013|NCT03300180|580488392|FG001|12 Month Outcome|Missed Assessment|59|||
160755014|NCT03300180|580488393|FG002|12 Month Outcome|Missed Assessment|58|||
160755015|NCT03300180|580488391|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
160755016|NCT03300180|580488392|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
160755017|NCT03300180|580488393|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
160755018|NCT03300180|580488391|FG000|18 Month Outcome Assessment|Death|8|||
160755019|NCT03300180|580488392|FG001|18 Month Outcome Assessment|Death|5|||
160755020|NCT03300180|580488393|FG002|18 Month Outcome Assessment|Death|5|||
160755021|NCT03300180|580488391|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
160755022|NCT03300180|580488392|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
160755023|NCT03300180|580488393|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
160755024|NCT03300180|580488391|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
160755025|NCT03300180|580488392|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
160755026|NCT03300180|580488393|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
160755027|NCT03300180|580488391|FG000|24 Month Outcome Assessment|Death|13|||
160755028|NCT03300180|580488392|FG001|24 Month Outcome Assessment|Death|13|||
160755029|NCT03300180|580488393|FG002|24 Month Outcome Assessment|Death|3|||
160755030|NCT03300180|580488391|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
160755031|NCT03300180|580488392|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
160755032|NCT03300180|580488393|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
160755033|NCT02557516|580488396|FG000|Overall Study|Adverse Event|1|||
160755034|NCT02557516|580488397|FG001|Overall Study|Adverse Event|0|||
160755035|NCT02557516|580488398|FG002|Overall Study|Adverse Event|2|||
160755036|NCT02557516|580488399|FG003|Overall Study|Adverse Event|1|||
160755037|NCT02557516|580488396|FG000|Overall Study|Disease progression|0|||
160755038|NCT02557516|580488397|FG001|Overall Study|Disease progression|2|||
160755039|NCT02557516|580488398|FG002|Overall Study|Disease progression|0|||
160755040|NCT02557516|580488399|FG003|Overall Study|Disease progression|0|||
160755041|NCT02557516|580488396|FG000|Overall Study|Physician Decision|0|||
160755042|NCT02557516|580488397|FG001|Overall Study|Physician Decision|2|||
160755043|NCT02557516|580488398|FG002|Overall Study|Physician Decision|0|||
160755044|NCT02557516|580488399|FG003|Overall Study|Physician Decision|0|||
160755045|NCT02557516|580488396|FG000|Overall Study|Sponsor decision|0|||
160755046|NCT02557516|580488397|FG001|Overall Study|Sponsor decision|1|||
160755047|NCT02557516|580488398|FG002|Overall Study|Sponsor decision|2|||
160755048|NCT02557516|580488399|FG003|Overall Study|Sponsor decision|8|||
160755049|NCT01919164|580490180|FG000|Overall Study|Adverse Event|6|||
160755050|NCT01919164|580490181|FG001|Overall Study|Adverse Event|4|||
160755051|NCT01919164|580490182|FG002|Overall Study|Adverse Event|9|||
160755052|NCT01919164|580490183|FG003|Overall Study|Adverse Event|3|||
160755053|NCT01919164|580490184|FG004|Overall Study|Adverse Event|2|||
160755054|NCT01919164|580490180|FG000|Overall Study|Lost to Follow-up|2|||
160755055|NCT01919164|580490181|FG001|Overall Study|Lost to Follow-up|2|||
160755056|NCT01919164|580490182|FG002|Overall Study|Lost to Follow-up|2|||
160755057|NCT01919164|580490183|FG003|Overall Study|Lost to Follow-up|0|||
160755058|NCT01919164|580490184|FG004|Overall Study|Lost to Follow-up|4|||
160755059|NCT01919164|580490180|FG000|Overall Study|Death|1|||
160755060|NCT01919164|580490181|FG001|Overall Study|Death|0|||
160755061|NCT01919164|580490182|FG002|Overall Study|Death|0|||
160755062|NCT01919164|580490183|FG003|Overall Study|Death|0|||
160755063|NCT01919164|580490184|FG004|Overall Study|Death|0|||
160755064|NCT01919164|580490180|FG000|Overall Study|Protocol Violation|6|||
160755065|NCT01919164|580490181|FG001|Overall Study|Protocol Violation|0|||
160755066|NCT01919164|580490182|FG002|Overall Study|Protocol Violation|3|||
160755067|NCT01919164|580490183|FG003|Overall Study|Protocol Violation|2|||
160755068|NCT01919164|580490184|FG004|Overall Study|Protocol Violation|2|||
160755069|NCT01919164|580490180|FG000|Overall Study|Disease progression|2|||
160755070|NCT01919164|580490181|FG001|Overall Study|Disease progression|2|||
160755071|NCT01919164|580490182|FG002|Overall Study|Disease progression|1|||
160755072|NCT01919164|580490183|FG003|Overall Study|Disease progression|2|||
160755073|NCT01919164|580490184|FG004|Overall Study|Disease progression|1|||
160755074|NCT01919164|580490180|FG000|Overall Study|Withdrew consent|13|||
160755075|NCT01919164|580490181|FG001|Overall Study|Withdrew consent|13|||
160755076|NCT01919164|580490182|FG002|Overall Study|Withdrew consent|14|||
160755077|NCT01919164|580490183|FG003|Overall Study|Withdrew consent|14|||
160755078|NCT01919164|580490184|FG004|Overall Study|Withdrew consent|9|||
160755079|NCT01919164|580490180|FG000|Overall Study|Other Un-specified|13|||
160755080|NCT01919164|580490181|FG001|Overall Study|Other Un-specified|9|||
160755081|NCT01919164|580490182|FG002|Overall Study|Other Un-specified|8|||
160755082|NCT01919164|580490183|FG003|Overall Study|Other Un-specified|7|||
160755083|NCT01919164|580490184|FG004|Overall Study|Other Un-specified|15|||
160755084|NCT00940888|580490188|FG000|Overall Study|Unsuccessful Implant|4|||
160755085|NCT00940888|580490188|FG000|Overall Study|Death|461|||
160755086|NCT00940888|580490188|FG000|Overall Study|Withdrawn - Non-Death|364|||
160755087|NCT00940888|580490188|FG000|Overall Study|Lost to Follow-up|6|||
160755088|NCT01409915|580490192|FG000|Overall Study|Adverse Event|0|||
160755089|NCT01409915|580490193|FG001|Overall Study|Adverse Event|2|||
160755090|NCT01409915|580490192|FG000|Overall Study|Withdrawal by Subject|0|||
160755091|NCT01409915|580490193|FG001|Overall Study|Withdrawal by Subject|1|||
160755092|NCT01409915|580490192|FG000|Overall Study|Protocol Violation|1|||
160755093|NCT01409915|580490193|FG001|Overall Study|Protocol Violation|0|||
160755094|NCT02250300|580490197|FG000|Expansion Phase|Death|6|||
160755095|NCT02250300|580490198|FG001|Expansion Phase|Death|7|||
160755096|NCT02250300|580490199|FG002|Expansion Phase|Death|0|||
160755097|NCT02250300|580490200|FG003|Expansion Phase|Death|0|||
160755098|NCT01845597|580490202|FG000|Overall Study|Death|8|||
160755099|NCT01845597|580490202|FG000|Overall Study|Lost to Follow-up|22|||
160755100|NCT00715559|580490203|FG000|Overall Study|medication not tolerated - nausea|1|||
160755101|NCT01516736|580490207|FG000|Overall Study|Withdrawal by Subject|10|||
160755102|NCT01516736|580490208|FG001|Overall Study|Withdrawal by Subject|4|||
160755103|NCT01516736|580490207|FG000|Overall Study|Adverse Event|4|||
160755104|NCT01516736|580490208|FG001|Overall Study|Adverse Event|5|||
160755105|NCT01516736|580490207|FG000|Overall Study|Death|3|||
160755106|NCT01516736|580490208|FG001|Overall Study|Death|1|||
160755107|NCT01516736|580490207|FG000|Overall Study|Physician Decision|2|||
160755108|NCT01516736|580490208|FG001|Overall Study|Physician Decision|1|||
160755109|NCT01516736|580490207|FG000|Overall Study|Lack of Efficacy|1|||
160755110|NCT01516736|580490208|FG001|Overall Study|Lack of Efficacy|0|||
160755111|NCT01516736|580490207|FG000|Overall Study|Protocol Violation|0|||
160755112|NCT01516736|580490208|FG001|Overall Study|Protocol Violation|1|||
160755113|NCT01516736|580490207|FG000|Overall Study|Other (not specified)|0|||
160755114|NCT01516736|580490208|FG001|Overall Study|Other (not specified)|1|||
160755115|NCT00524771|580490211|FG000|Overall Study|Protocol Violation|220|||
160755116|NCT00524771|580490212|FG001|Overall Study|Protocol Violation|585|||
160755117|NCT02781818|580490213|FG000|Overall Study|Lost to Follow-up|4|||
160755118|NCT02781818|580490214|FG001|Overall Study|Lost to Follow-up|2|||
160755119|NCT02781818|580490215|FG002|Overall Study|Lost to Follow-up|1|||
160755120|NCT01877668|580490216|FG000|Overall Study|Death|0|||
160755121|NCT01877668|580490217|FG001|Overall Study|Death|0|||
160755122|NCT01877668|580490218|FG002|Overall Study|Death|0|||
160755123|NCT01877668|580490219|FG003|Overall Study|Death|1|||
160755124|NCT01877668|580490220|FG004|Overall Study|Death|0|||
160755125|NCT01877668|580490216|FG000|Overall Study|No longer met study criteria|1|||
160755126|NCT01877668|580490217|FG001|Overall Study|No longer met study criteria|0|||
160755127|NCT01877668|580490218|FG002|Overall Study|No longer met study criteria|1|||
160755128|NCT01877668|580490219|FG003|Overall Study|No longer met study criteria|0|||
160755129|NCT01877668|580490220|FG004|Overall Study|No longer met study criteria|0|||
160755130|NCT01877668|580490216|FG000|Overall Study|Insufficient clinical response|0|||
160755131|NCT01877668|580490217|FG001|Overall Study|Insufficient clinical response|1|||
160755132|NCT01877668|580490218|FG002|Overall Study|Insufficient clinical response|2|||
160755133|NCT01877668|580490219|FG003|Overall Study|Insufficient clinical response|2|||
160755134|NCT01877668|580490220|FG004|Overall Study|Insufficient clinical response|0|||
160755135|NCT01877668|580490216|FG000|Overall Study|Lost to Follow-up|0|||
160755136|NCT01877668|580490217|FG001|Overall Study|Lost to Follow-up|2|||
160755137|NCT01877668|580490218|FG002|Overall Study|Lost to Follow-up|1|||
160755138|NCT01877668|580490219|FG003|Overall Study|Lost to Follow-up|0|||
160755139|NCT01877668|580490220|FG004|Overall Study|Lost to Follow-up|0|||
160755140|NCT01877668|580490216|FG000|Overall Study|Withdrawal by Subject|2|||
160755141|NCT01877668|580490217|FG001|Overall Study|Withdrawal by Subject|0|||
160755142|NCT01877668|580490218|FG002|Overall Study|Withdrawal by Subject|3|||
160755143|NCT01877668|580490219|FG003|Overall Study|Withdrawal by Subject|2|||
160755144|NCT01877668|580490220|FG004|Overall Study|Withdrawal by Subject|2|||
160755145|NCT01877668|580490216|FG000|Overall Study|Other|1|||
160755146|NCT01877668|580490217|FG001|Overall Study|Other|1|||
160755147|NCT01877668|580490218|FG002|Overall Study|Other|1|||
160755148|NCT01877668|580490219|FG003|Overall Study|Other|1|||
160755149|NCT01877668|580490220|FG004|Overall Study|Other|3|||
160755150|NCT01877668|580490216|FG000|Overall Study|Protocol Violation|1|||
160755151|NCT01877668|580490217|FG001|Overall Study|Protocol Violation|1|||
160755152|NCT01877668|580490218|FG002|Overall Study|Protocol Violation|0|||
160755153|NCT01877668|580490219|FG003|Overall Study|Protocol Violation|0|||
160755154|NCT01877668|580490220|FG004|Overall Study|Protocol Violation|3|||
160755155|NCT01877668|580490216|FG000|Overall Study|Adverse event related to study drug|2|||
160755156|NCT01877668|580490217|FG001|Overall Study|Adverse event related to study drug|2|||
160755157|NCT01877668|580490218|FG002|Overall Study|Adverse event related to study drug|2|||
160755158|NCT01877668|580490219|FG003|Overall Study|Adverse event related to study drug|2|||
160755159|NCT01877668|580490220|FG004|Overall Study|Adverse event related to study drug|1|||
160755160|NCT01877668|580490216|FG000|Overall Study|Adverse event unrelated to study drug|4|||
160755161|NCT01877668|580490217|FG001|Overall Study|Adverse event unrelated to study drug|1|||
160755162|NCT01877668|580490218|FG002|Overall Study|Adverse event unrelated to study drug|2|||
160755163|NCT01877668|580490219|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160755164|NCT01877668|580490220|FG004|Overall Study|Adverse event unrelated to study drug|1|||
160755165|NCT02317991|580490221|FG000|Overall Study|Adverse Event|12|||
160755166|NCT02317991|580490221|FG000|Overall Study|Death|4|||
160755167|NCT02317991|580490221|FG000|Overall Study|Withdrawal by Subject|8|||
160755168|NCT02317991|580490221|FG000|Overall Study|Progressive Disease|41|||
160755169|NCT01223404|580490222|FG000|First Intervention (1 Day)|Adverse Event|0|||
160755170|NCT01223404|580490223|FG001|First Intervention (1 Day)|Adverse Event|0|||
160755171|NCT01223404|580490224|FG002|First Intervention (1 Day)|Adverse Event|0|||
160755172|NCT01223404|580490225|FG003|First Intervention (1 Day)|Adverse Event|1|||
160755173|NCT01223404|580490226|FG004|First Intervention (1 Day)|Adverse Event|0|||
160755174|NCT01223404|580490227|FG005|First Intervention (1 Day)|Adverse Event|0|||
160755175|NCT01223404|580490222|FG000|Second Intervention (1 Day)|Adverse Event|1|||
160755176|NCT01223404|580490223|FG001|Second Intervention (1 Day)|Adverse Event|0|||
160755177|NCT01223404|580490224|FG002|Second Intervention (1 Day)|Adverse Event|0|||
160755178|NCT01223404|580490225|FG003|Second Intervention (1 Day)|Adverse Event|0|||
160755179|NCT01223404|580490226|FG004|Second Intervention (1 Day)|Adverse Event|0|||
160755180|NCT01223404|580490227|FG005|Second Intervention (1 Day)|Adverse Event|0|||
160755181|NCT01223404|580490222|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
160755182|NCT01223404|580490223|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
160755183|NCT01223404|580490224|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
160755184|NCT01223404|580490225|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
160755185|NCT01223404|580490226|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
160755186|NCT01223404|580490227|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
160755187|NCT02492165|580490228|FG000|Overall Study|Withdrawal by Subject|0|||
160755188|NCT02492165|580490229|FG001|Overall Study|Withdrawal by Subject|1|||
160755189|NCT02492165|580490230|FG002|Overall Study|Withdrawal by Subject|0|||
160755190|NCT02492165|580490231|FG003|Overall Study|Withdrawal by Subject|0|||
160755191|NCT00707057|580490232|FG000|Overall Study|Withdrawal by Subject|8|||
160755192|NCT00707057|580490233|FG001|Overall Study|Withdrawal by Subject|3|||
160755193|NCT00707057|580490232|FG000|Overall Study|Dosed incorrectly|0|||
160755194|NCT00707057|580490233|FG001|Overall Study|Dosed incorrectly|1|||
160755195|NCT01697800|580490234|FG000|Overall Study|Death|0|||
160755196|NCT01697800|580490235|FG001|Overall Study|Death|1|||
160755197|NCT00954122|580490236|FG000|Overall Study|Withdrawal by Subject|5|||
160755198|NCT00954122|580490236|FG000|Overall Study|Adverse Event|1|||
160755199|NCT00954122|580490236|FG000|Overall Study|Safety Reason|1|||
160755200|NCT01957579|580490241|FG000|Overall Study|Withdrawal of concent|0|||
160755201|NCT01957579|580490242|FG001|Overall Study|Withdrawal of concent|1|||
160755202|NCT01957579|580490243|FG002|Overall Study|Withdrawal of concent|0|||
160755203|NCT01957579|580490244|FG003|Overall Study|Withdrawal of concent|0|||
160755204|NCT01957579|580490241|FG000|Overall Study|Death|0|||
160755205|NCT01957579|580490242|FG001|Overall Study|Death|0|||
160755206|NCT01957579|580490243|FG002|Overall Study|Death|2|||
160755207|NCT01957579|580490244|FG003|Overall Study|Death|0|||
160755208|NCT02019550|580490245|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
160755209|NCT02019550|580490246|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
160755210|NCT02750332|580490248|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160755211|NCT02750332|580490249|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160755212|NCT04194489|580490250|FG000|Overall Study|Withdrawal by Subject|5|||
160755213|NCT04194489|580490250|FG000|Overall Study|Lost to Follow-up|48|||
160755214|NCT02485483|580490254|FG000|Overall Study|Depression at baseline|15|||
160755215|NCT02485483|580490255|FG001|Overall Study|Depression at baseline|0|||
160755216|NCT02485483|580490254|FG000|Overall Study|Discontinued after baseline|39|||
160755217|NCT02485483|580490255|FG001|Overall Study|Discontinued after baseline|0|||
160755218|NCT00377637|580490256|FG000|Induction Phase|Adverse Event|12|||
160755219|NCT00377637|580490257|FG001|Induction Phase|Adverse Event|21|||
160755220|NCT00377637|580490258|FG002|Induction Phase|Adverse Event|0|||
160755221|NCT00377637|580490259|FG003|Induction Phase|Adverse Event|0|||
160755222|NCT00377637|580490256|FG000|Induction Phase|Deterioration/serum creatinine|2|||
160755223|NCT00377637|580490257|FG001|Induction Phase|Deterioration/serum creatinine|0|||
160755224|NCT00377637|580490258|FG002|Induction Phase|Deterioration/serum creatinine|0|||
160755225|NCT00377637|580490259|FG003|Induction Phase|Deterioration/serum creatinine|0|||
160755226|NCT00377637|580490256|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
160755227|NCT00377637|580490257|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
160755228|NCT00377637|580490258|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
160755229|NCT00377637|580490259|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
160755230|NCT00377637|580490256|FG000|Induction Phase|Lost to Follow-up|2|||
160755231|NCT00377637|580490257|FG001|Induction Phase|Lost to Follow-up|1|||
160755232|NCT00377637|580490258|FG002|Induction Phase|Lost to Follow-up|0|||
160755233|NCT00377637|580490259|FG003|Induction Phase|Lost to Follow-up|0|||
160755234|NCT00377637|580490256|FG000|Induction Phase|Death|1|||
160755235|NCT00377637|580490257|FG001|Induction Phase|Death|3|||
160755236|NCT00377637|580490258|FG002|Induction Phase|Death|0|||
160755237|NCT00377637|580490259|FG003|Induction Phase|Death|0|||
160755238|NCT00377637|580490256|FG000|Induction Phase|Withdrawal by Subject|5|||
160755239|NCT00377637|580490257|FG001|Induction Phase|Withdrawal by Subject|6|||
160755240|NCT00377637|580490258|FG002|Induction Phase|Withdrawal by Subject|0|||
160755241|NCT00377637|580490259|FG003|Induction Phase|Withdrawal by Subject|0|||
160755242|NCT00377637|580490256|FG000|Induction Phase|Physician Decision|3|||
160755243|NCT00377637|580490257|FG001|Induction Phase|Physician Decision|1|||
160755244|NCT00377637|580490258|FG002|Induction Phase|Physician Decision|0|||
160755245|NCT00377637|580490259|FG003|Induction Phase|Physician Decision|0|||
160755246|NCT00377637|580490256|FG000|Induction Phase|Sponsor decision|1|||
160755247|NCT00377637|580490257|FG001|Induction Phase|Sponsor decision|2|||
160755248|NCT00377637|580490258|FG002|Induction Phase|Sponsor decision|0|||
160755249|NCT00377637|580490259|FG003|Induction Phase|Sponsor decision|0|||
160755250|NCT00377637|580490256|FG000|Induction Phase|Non-Compliance|1|||
160755251|NCT00377637|580490257|FG001|Induction Phase|Non-Compliance|0|||
160755252|NCT00377637|580490258|FG002|Induction Phase|Non-Compliance|0|||
160755253|NCT00377637|580490259|FG003|Induction Phase|Non-Compliance|0|||
160755254|NCT00377637|580490256|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
160755255|NCT00377637|580490257|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
160755256|NCT00377637|580490258|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
160755257|NCT00377637|580490259|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
160755258|NCT00377637|580490256|FG000|Maintenance Phase|Adverse Event|0|||
160755259|NCT00377637|580490257|FG001|Maintenance Phase|Adverse Event|0|||
160755260|NCT00377637|580490258|FG002|Maintenance Phase|Adverse Event|29|||
160755261|NCT00377637|580490259|FG003|Maintenance Phase|Adverse Event|43|||
160755262|NCT00377637|580490256|FG000|Maintenance Phase|Physician Decision|0|||
160755263|NCT00377637|580490257|FG001|Maintenance Phase|Physician Decision|0|||
160755264|NCT00377637|580490258|FG002|Maintenance Phase|Physician Decision|5|||
160755265|NCT00377637|580490259|FG003|Maintenance Phase|Physician Decision|4|||
160755266|NCT00377637|580490256|FG000|Maintenance Phase|Lost to Follow-up|0|||
160755267|NCT00377637|580490257|FG001|Maintenance Phase|Lost to Follow-up|0|||
160755268|NCT00377637|580490258|FG002|Maintenance Phase|Lost to Follow-up|3|||
160755269|NCT00377637|580490259|FG003|Maintenance Phase|Lost to Follow-up|1|||
160755270|NCT00377637|580490256|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160755271|NCT00377637|580490257|FG001|Maintenance Phase|Withdrawal by Subject|0|||
160755272|NCT00377637|580490258|FG002|Maintenance Phase|Withdrawal by Subject|3|||
160755273|NCT00377637|580490259|FG003|Maintenance Phase|Withdrawal by Subject|3|||
160755274|NCT00377637|580490256|FG000|Maintenance Phase|Sponsor decision|0|||
160755275|NCT00377637|580490257|FG001|Maintenance Phase|Sponsor decision|0|||
160755276|NCT00377637|580490258|FG002|Maintenance Phase|Sponsor decision|2|||
160755277|NCT00377637|580490259|FG003|Maintenance Phase|Sponsor decision|3|||
160755278|NCT00377637|580490256|FG000|Maintenance Phase|Non-compliance|0|||
160755279|NCT00377637|580490257|FG001|Maintenance Phase|Non-compliance|0|||
160525010|NCT00381303|579651792|FG001|Overall Study|AE/HIV-related event|6|||
160525011|NCT00381303|579651791|FG000|Overall Study|Non-Adherence|13|||
160525012|NCT00381303|579651792|FG001|Overall Study|Non-Adherence|6|||
160525013|NCT00381303|579651791|FG000|Overall Study|Withdrawal by Subject|13|||
160525014|NCT00381303|579651792|FG001|Overall Study|Withdrawal by Subject|6|||
160525015|NCT00381303|579651791|FG000|Overall Study|Virologic failure|6|||
160525016|NCT00381303|579651792|FG001|Overall Study|Virologic failure|4|||
160525017|NCT00381303|579651791|FG000|Overall Study|Ineligible to continue the trial|2|||
160525018|NCT00381303|579651792|FG001|Overall Study|Ineligible to continue the trial|1|||
160525019|NCT00381303|579651791|FG000|Overall Study|Pregnancy|2|||
160755280|NCT00377637|580490258|FG002|Maintenance Phase|Non-compliance|1|||
160755281|NCT00377637|580490259|FG003|Maintenance Phase|Non-compliance|1|||
160755282|NCT00377637|580490256|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
160755283|NCT00377637|580490257|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
160755284|NCT00377637|580490258|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
160755285|NCT00377637|580490259|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
160755286|NCT00377637|580490256|FG000|Maintenance Phase|Death|0|||
160755287|NCT00377637|580490257|FG001|Maintenance Phase|Death|0|||
160755288|NCT00377637|580490258|FG002|Maintenance Phase|Death|0|||
160755289|NCT00377637|580490259|FG003|Maintenance Phase|Death|1|||
160755290|NCT02922153|580490260|FG000|Overall Study|Death|8|||
160755291|NCT02922153|580490261|FG001|Overall Study|Death|1|||
160755292|NCT02922153|580490260|FG000|Overall Study|Lost to Follow-up|1|||
160755293|NCT02922153|580490261|FG001|Overall Study|Lost to Follow-up|0|||
160755294|NCT02922153|580490260|FG000|Overall Study|Physician Decision|1|||
160755295|NCT02922153|580490261|FG001|Overall Study|Physician Decision|1|||
160755296|NCT03506438|580490262|FG000|Overall Study|Lost to Follow-up|8|||
160755297|NCT03506438|580490263|FG001|Overall Study|Lost to Follow-up|7|||
160755298|NCT03506438|580490264|FG002|Overall Study|Lost to Follow-up|8|||
160755299|NCT03506438|580490265|FG003|Overall Study|Lost to Follow-up|7|||
160755300|NCT03506438|580490266|FG004|Overall Study|Lost to Follow-up|0|||
160755301|NCT03506438|580490267|FG005|Overall Study|Lost to Follow-up|0|||
160755302|NCT01128296|580490268|FG000|Overall Study|Physician Decision|0|||
160755303|NCT01128296|580490269|FG001|Overall Study|Physician Decision|0|||
160755304|NCT01128296|580490270|FG002|Overall Study|Physician Decision|0|||
160755305|NCT01128296|580490271|FG003|Overall Study|Physician Decision|0|||
160755306|NCT01128296|580490272|FG004|Overall Study|Physician Decision|0|||
160755307|NCT01128296|580490273|FG005|Overall Study|Physician Decision|3|||
160755308|NCT01128296|580490268|FG000|Overall Study|Withdrawal by Subject|0|||
160755309|NCT01128296|580490269|FG001|Overall Study|Withdrawal by Subject|0|||
160755310|NCT01128296|580490270|FG002|Overall Study|Withdrawal by Subject|0|||
160755311|NCT01128296|580490271|FG003|Overall Study|Withdrawal by Subject|0|||
160755312|NCT01128296|580490272|FG004|Overall Study|Withdrawal by Subject|0|||
160755313|NCT01128296|580490273|FG005|Overall Study|Withdrawal by Subject|2|||
160755314|NCT04155463|580490274|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
160755315|NCT04155463|580490275|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
160755316|NCT00113295|580490276|FG000|Overall Study|Adverse Event|4|||
160755317|NCT00113295|580490277|FG001|Overall Study|Adverse Event|1|||
160755318|NCT00113295|580490276|FG000|Overall Study|Unrelated Medical Illness|1|||
160755319|NCT00113295|580490277|FG001|Overall Study|Unrelated Medical Illness|0|||
160755320|NCT01714544|580490278|FG000|Overall Study|Lost to Follow-up|1|||
160755321|NCT01714544|580490278|FG000|Overall Study|Physician Decision|1|||
160755322|NCT01714544|580490278|FG000|Overall Study|Withdrawal by Subject|1|||
160755323|NCT01053741|580490279|FG000|2nd Study Intervention|Physician Decision|0|||
160755324|NCT01053741|580490280|FG001|2nd Study Intervention|Physician Decision|1|||
160755325|NCT00666211|580490281|FG000|Overall Study|Withdrawal by Subject|10|||
160755326|NCT00666211|580490282|FG001|Overall Study|Withdrawal by Subject|13|||
160755327|NCT00666211|580490281|FG000|Overall Study|went off medication, no more pain|1|||
160755328|NCT00666211|580490282|FG001|Overall Study|went off medication, no more pain|0|||
160755329|NCT00666211|580490281|FG000|Overall Study|patient non-compliant|6|||
160755330|NCT00666211|580490282|FG001|Overall Study|patient non-compliant|6|||
160755331|NCT00666211|580490281|FG000|Overall Study|disease progression|1|||
160755332|NCT00666211|580490282|FG001|Overall Study|disease progression|8|||
160755333|NCT00666211|580490281|FG000|Overall Study|Lost to Follow-up|2|||
160755334|NCT00666211|580490282|FG001|Overall Study|Lost to Follow-up|0|||
160755335|NCT00666211|580490281|FG000|Overall Study|toxicity|0|||
160755336|NCT00666211|580490282|FG001|Overall Study|toxicity|2|||
160755337|NCT00666211|580490281|FG000|Overall Study|hospital admission|0|||
160755338|NCT00666211|580490282|FG001|Overall Study|hospital admission|5|||
160755339|NCT00666211|580490281|FG000|Overall Study|Death|0|||
160755340|NCT00666211|580490282|FG001|Overall Study|Death|2|||
160755341|NCT00666211|580490281|FG000|Overall Study|off tx for other complicating disease|0|||
160755342|NCT00666211|580490282|FG001|Overall Study|off tx for other complicating disease|1|||
160755343|NCT00666211|580490281|FG000|Overall Study|Physician Decision|0|||
160755344|NCT00666211|580490282|FG001|Overall Study|Physician Decision|1|||
160755345|NCT02806713|580490283|FG000|Overall Study|Urethral injury during procedure|1|||
160755346|NCT02806713|580490284|FG001|Overall Study|Urethral injury during procedure|0|||
160755347|NCT02806713|580490283|FG000|Overall Study|cancelled surgery|1|||
160755348|NCT02806713|580490284|FG001|Overall Study|cancelled surgery|2|||
160755349|NCT00003537|580490294|FG000|Overall Study|Not evalauable|1|||
160755350|NCT01001520|580490295|FG000|Medication Period 1|Withdrawal by Subject|2|||
160755351|NCT01001520|580490296|FG001|Medication Period 1|Withdrawal by Subject|2|||
160755352|NCT01001520|580490295|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
160755353|NCT01001520|580490296|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
160755354|NCT01001520|580490295|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
160755355|NCT01001520|580490296|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
160755356|NCT01001520|580490295|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
160755357|NCT01001520|580490296|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
160755358|NCT01001520|580490295|FG000|Washout Period|Withdrawal by Subject|2|||
160755359|NCT01001520|580490296|FG001|Washout Period|Withdrawal by Subject|1|||
160755360|NCT01001520|580490295|FG000|Medication Period 2|Withdrawal by Subject|0|||
160981499|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
160755361|NCT01001520|580490296|FG001|Medication Period 2|Withdrawal by Subject|3|||
160755362|NCT01004978|580490299|FG000|Overall Study|Disease progression|31|||
160755363|NCT01004978|580490300|FG001|Overall Study|Disease progression|48|||
160755364|NCT01004978|580490299|FG000|Overall Study|Adverse Event|42|||
160755365|NCT01004978|580490300|FG001|Overall Study|Adverse Event|22|||
160755366|NCT01004978|580490299|FG000|Overall Study|Death|3|||
160755367|NCT01004978|580490300|FG001|Overall Study|Death|2|||
160755368|NCT01004978|580490299|FG000|Overall Study|Withdrawal by Subject|16|||
160755369|NCT01004978|580490300|FG001|Overall Study|Withdrawal by Subject|16|||
160755370|NCT01004978|580490299|FG000|Overall Study|Alternative therapy|4|||
160755371|NCT01004978|580490300|FG001|Overall Study|Alternative therapy|8|||
160755372|NCT01004978|580490299|FG000|Overall Study|Physician Decision|6|||
160755373|NCT01004978|580490300|FG001|Overall Study|Physician Decision|3|||
160755374|NCT01004978|580490299|FG000|Overall Study|Other complicating disease|2|||
160755375|NCT01004978|580490300|FG001|Overall Study|Other complicating disease|2|||
160755376|NCT01004978|580490299|FG000|Overall Study|Protocol Violation|2|||
160755377|NCT01004978|580490300|FG001|Overall Study|Protocol Violation|3|||
160755378|NCT01004978|580490299|FG000|Overall Study|Non-compliance|3|||
160755379|NCT01004978|580490300|FG001|Overall Study|Non-compliance|2|||
160755380|NCT01004978|580490299|FG000|Overall Study|Ineligible|1|||
160755381|NCT01004978|580490300|FG001|Overall Study|Ineligible|0|||
160755382|NCT01004978|580490299|FG000|Overall Study|Unblinded|0|||
160755383|NCT01004978|580490300|FG001|Overall Study|Unblinded|1|||
160755384|NCT01004978|580490299|FG000|Overall Study|Performance status worsening|0|||
160755385|NCT01004978|580490300|FG001|Overall Study|Performance status worsening|1|||
160755386|NCT01004978|580490299|FG000|Overall Study|Never started treatment|8|||
160755387|NCT01004978|580490300|FG001|Overall Study|Never started treatment|9|||
160755388|NCT00369915|580490301|FG000|Overall Study|expected side effects|2|||
160755389|NCT00369915|580490302|FG001|Overall Study|expected side effects|1|||
160755390|NCT00369915|580490301|FG000|Overall Study|Withdrawal by Subject|4|||
160755391|NCT00369915|580490302|FG001|Overall Study|Withdrawal by Subject|1|||
160755392|NCT00369915|580490301|FG000|Overall Study|W/drawl by investigators|0|||
160755393|NCT00369915|580490302|FG001|Overall Study|W/drawl by investigators|1|||
160755394|NCT00268983|580490309|FG000|Overall Study|Death|3|||
160755395|NCT00268983|580490310|FG001|Overall Study|Death|0|||
160755396|NCT01719380|580490311|FG000|Overall Study|Adverse Event|0|||
160755397|NCT01719380|580490312|FG001|Overall Study|Adverse Event|0|||
160755398|NCT01719380|580490313|FG002|Overall Study|Adverse Event|1|||
160755399|NCT01719380|580490314|FG003|Overall Study|Adverse Event|2|||
160755400|NCT01719380|580490315|FG004|Overall Study|Adverse Event|0|||
160755401|NCT01719380|580490316|FG005|Overall Study|Adverse Event|1|||
160755402|NCT01719380|580490317|FG006|Overall Study|Adverse Event|0|||
160755403|NCT01719380|580490318|FG007|Overall Study|Adverse Event|1|||
160755404|NCT01719380|580490319|FG008|Overall Study|Adverse Event|4|||
160755405|NCT01719380|580490320|FG009|Overall Study|Adverse Event|3|||
160755406|NCT01719380|580490311|FG000|Overall Study|Death|0|||
160755407|NCT01719380|580490312|FG001|Overall Study|Death|1|||
160755408|NCT01719380|580490313|FG002|Overall Study|Death|0|||
160755409|NCT01719380|580490314|FG003|Overall Study|Death|0|||
160755410|NCT01719380|580490315|FG004|Overall Study|Death|0|||
160755411|NCT01719380|580490316|FG005|Overall Study|Death|0|||
160755412|NCT01719380|580490317|FG006|Overall Study|Death|0|||
160755413|NCT01719380|580490318|FG007|Overall Study|Death|0|||
160755414|NCT01719380|580490319|FG008|Overall Study|Death|3|||
160755415|NCT01719380|580490320|FG009|Overall Study|Death|3|||
160755416|NCT01719380|580490311|FG000|Overall Study|Participant/Guardian Decision|0|||
160755417|NCT01719380|580490312|FG001|Overall Study|Participant/Guardian Decision|0|||
160755418|NCT01719380|580490313|FG002|Overall Study|Participant/Guardian Decision|1|||
160755419|NCT01719380|580490314|FG003|Overall Study|Participant/Guardian Decision|0|||
160755420|NCT01719380|580490315|FG004|Overall Study|Participant/Guardian Decision|0|||
160755421|NCT01719380|580490316|FG005|Overall Study|Participant/Guardian Decision|0|||
160755422|NCT01719380|580490317|FG006|Overall Study|Participant/Guardian Decision|0|||
160755423|NCT01719380|580490318|FG007|Overall Study|Participant/Guardian Decision|0|||
160755424|NCT01719380|580490319|FG008|Overall Study|Participant/Guardian Decision|2|||
160755425|NCT01719380|580490320|FG009|Overall Study|Participant/Guardian Decision|2|||
160755426|NCT01719380|580490311|FG000|Overall Study|Physician Decision|0|||
160755427|NCT01719380|580490312|FG001|Overall Study|Physician Decision|0|||
160755428|NCT01719380|580490313|FG002|Overall Study|Physician Decision|2|||
160755429|NCT01719380|580490314|FG003|Overall Study|Physician Decision|0|||
160755430|NCT01719380|580490315|FG004|Overall Study|Physician Decision|0|||
160755431|NCT01719380|580490316|FG005|Overall Study|Physician Decision|0|||
160755432|NCT01719380|580490317|FG006|Overall Study|Physician Decision|0|||
160755433|NCT01719380|580490318|FG007|Overall Study|Physician Decision|0|||
160755434|NCT01719380|580490319|FG008|Overall Study|Physician Decision|1|||
160755435|NCT01719380|580490320|FG009|Overall Study|Physician Decision|1|||
160755436|NCT01719380|580490311|FG000|Overall Study|Lack of Efficacy|2|||
160755437|NCT01719380|580490312|FG001|Overall Study|Lack of Efficacy|6|||
160755438|NCT01719380|580490313|FG002|Overall Study|Lack of Efficacy|5|||
160755439|NCT01719380|580490314|FG003|Overall Study|Lack of Efficacy|6|||
160755440|NCT01719380|580490315|FG004|Overall Study|Lack of Efficacy|3|||
160755441|NCT01719380|580490316|FG005|Overall Study|Lack of Efficacy|7|||
160755442|NCT01719380|580490317|FG006|Overall Study|Lack of Efficacy|10|||
160755443|NCT01719380|580490318|FG007|Overall Study|Lack of Efficacy|6|||
160755444|NCT01719380|580490319|FG008|Overall Study|Lack of Efficacy|39|||
160755445|NCT01719380|580490320|FG009|Overall Study|Lack of Efficacy|42|||
160755446|NCT01719380|580490311|FG000|Overall Study|Progressive Disease|0|||
160755447|NCT01719380|580490312|FG001|Overall Study|Progressive Disease|0|||
160755448|NCT01719380|580490313|FG002|Overall Study|Progressive Disease|0|||
160755449|NCT01719380|580490314|FG003|Overall Study|Progressive Disease|0|||
160755450|NCT01719380|580490315|FG004|Overall Study|Progressive Disease|0|||
160755451|NCT01719380|580490316|FG005|Overall Study|Progressive Disease|0|||
160755452|NCT01719380|580490317|FG006|Overall Study|Progressive Disease|0|||
160755453|NCT01719380|580490318|FG007|Overall Study|Progressive Disease|0|||
160755454|NCT01719380|580490319|FG008|Overall Study|Progressive Disease|1|||
160755455|NCT01719380|580490320|FG009|Overall Study|Progressive Disease|0|||
160755456|NCT03478371|580490321|FG000|Overall Study|non-compliance|1|||
160755457|NCT03478371|580490321|FG000|Overall Study|Lost to Follow-up|4|||
160755458|NCT04533438|580490325|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
160755459|NCT04533438|580490326|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
160755460|NCT05568797|580490327|FG000|Overall Study|Adverse Event|0|||
160755461|NCT05568797|580490328|FG001|Overall Study|Adverse Event|8|||
160755462|NCT05568797|580490327|FG000|Overall Study|Lost to Follow-up|2|||
160755463|NCT05568797|580490328|FG001|Overall Study|Lost to Follow-up|3|||
160755464|NCT05568797|580490327|FG000|Overall Study|Withdrawal by Subject|1|||
160755465|NCT05568797|580490328|FG001|Overall Study|Withdrawal by Subject|10|||
160755466|NCT05568797|580490327|FG000|Overall Study|Other|2|||
160755467|NCT05568797|580490328|FG001|Overall Study|Other|2|||
160755468|NCT00099632|580490329|FG000|Overall Study|Lost to Follow-up|1|||
160755469|NCT00099632|580490330|FG001|Overall Study|Lost to Follow-up|0|||
160755470|NCT00099632|580490331|FG002|Overall Study|Lost to Follow-up|3|||
160755471|NCT00099632|580490332|FG003|Overall Study|Lost to Follow-up|1|||
160755472|NCT00099632|580490333|FG004|Overall Study|Lost to Follow-up|1|||
160755473|NCT00099632|580490334|FG005|Overall Study|Lost to Follow-up|0|||
160755474|NCT00099632|580490329|FG000|Overall Study|Withdrawal by Subject|0|||
160755475|NCT00099632|580490330|FG001|Overall Study|Withdrawal by Subject|1|||
160755476|NCT00099632|580490331|FG002|Overall Study|Withdrawal by Subject|0|||
160755477|NCT00099632|580490332|FG003|Overall Study|Withdrawal by Subject|0|||
160755478|NCT00099632|580490333|FG004|Overall Study|Withdrawal by Subject|0|||
160755479|NCT00099632|580490334|FG005|Overall Study|Withdrawal by Subject|1|||
160755480|NCT00099632|580490329|FG000|Overall Study|Protocol Violation|0|||
160755481|NCT00099632|580490330|FG001|Overall Study|Protocol Violation|0|||
160755482|NCT00099632|580490331|FG002|Overall Study|Protocol Violation|0|||
160755483|NCT00099632|580490332|FG003|Overall Study|Protocol Violation|0|||
160755484|NCT00099632|580490333|FG004|Overall Study|Protocol Violation|0|||
160755485|NCT00099632|580490334|FG005|Overall Study|Protocol Violation|1|||
160755486|NCT03131687|580490355|FG000|Overall Study|Adverse Event|0|||
160755487|NCT03131687|580490356|FG001|Overall Study|Adverse Event|1|||
160755488|NCT03131687|580490357|FG002|Overall Study|Adverse Event|0|||
160755489|NCT03131687|580490358|FG003|Overall Study|Adverse Event|1|||
160755490|NCT03131687|580490359|FG004|Overall Study|Adverse Event|2|||
160755491|NCT03131687|580490360|FG005|Overall Study|Adverse Event|2|||
160755492|NCT03131687|580490355|FG000|Overall Study|Death|1|||
160755493|NCT03131687|580490356|FG001|Overall Study|Death|0|||
160755494|NCT03131687|580490357|FG002|Overall Study|Death|0|||
160755495|NCT03131687|580490358|FG003|Overall Study|Death|0|||
160755496|NCT03131687|580490359|FG004|Overall Study|Death|0|||
160755497|NCT03131687|580490360|FG005|Overall Study|Death|0|||
160755498|NCT03131687|580490355|FG000|Overall Study|Withdrawal by Subject|3|||
160755499|NCT03131687|580490356|FG001|Overall Study|Withdrawal by Subject|3|||
160755500|NCT03131687|580490357|FG002|Overall Study|Withdrawal by Subject|3|||
160755501|NCT03131687|580490358|FG003|Overall Study|Withdrawal by Subject|1|||
160755502|NCT03131687|580490359|FG004|Overall Study|Withdrawal by Subject|2|||
160755503|NCT03131687|580490360|FG005|Overall Study|Withdrawal by Subject|1|||
160755504|NCT03131687|580490355|FG000|Overall Study|Lost to Follow-up|1|||
160755505|NCT03131687|580490356|FG001|Overall Study|Lost to Follow-up|4|||
160755506|NCT03131687|580490357|FG002|Overall Study|Lost to Follow-up|0|||
160755507|NCT03131687|580490358|FG003|Overall Study|Lost to Follow-up|1|||
160755508|NCT03131687|580490359|FG004|Overall Study|Lost to Follow-up|4|||
160755509|NCT03131687|580490360|FG005|Overall Study|Lost to Follow-up|2|||
160755510|NCT03131687|580490355|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
160755511|NCT03131687|580490356|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
160755512|NCT03131687|580490357|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
160755513|NCT03131687|580490358|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
160755514|NCT03131687|580490359|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
160755515|NCT03131687|580490360|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
160755516|NCT03131687|580490355|FG000|Overall Study|Principle Investigator Decision|0|||
160755517|NCT03131687|580490356|FG001|Overall Study|Principle Investigator Decision|1|||
160755518|NCT03131687|580490357|FG002|Overall Study|Principle Investigator Decision|0|||
160755519|NCT03131687|580490358|FG003|Overall Study|Principle Investigator Decision|0|||
160755520|NCT03131687|580490359|FG004|Overall Study|Principle Investigator Decision|0|||
160755521|NCT03131687|580490360|FG005|Overall Study|Principle Investigator Decision|0|||
160755522|NCT03131687|580490355|FG000|Overall Study|Inadvertent Enrollment|0|||
160755523|NCT03131687|580490356|FG001|Overall Study|Inadvertent Enrollment|0|||
160755524|NCT03131687|580490357|FG002|Overall Study|Inadvertent Enrollment|0|||
160755525|NCT03131687|580490358|FG003|Overall Study|Inadvertent Enrollment|1|||
160755526|NCT03131687|580490359|FG004|Overall Study|Inadvertent Enrollment|0|||
160755527|NCT03131687|580490360|FG005|Overall Study|Inadvertent Enrollment|0|||
160755528|NCT02797678|580490361|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
160755529|NCT02797678|580490362|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
160755530|NCT02797678|580490363|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
160755531|NCT02797678|580490364|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
160755532|NCT02797678|580490361|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
160755533|NCT02797678|580490362|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
160755534|NCT02797678|580490363|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
160755535|NCT02797678|580490364|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
160755536|NCT02797678|580490361|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
160755537|NCT02797678|580490362|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
160755538|NCT02797678|580490363|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
160755539|NCT02797678|580490364|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
160755540|NCT02401035|580490365|FG000|Overall Study|Withdrawal by Subject|1|||
160755541|NCT02401035|580490366|FG001|Overall Study|Withdrawal by Subject|0|||
160755542|NCT00869128|580490367|FG000|Overall Study|lack of Compliance|6|||
160755543|NCT00869128|580490368|FG001|Overall Study|lack of Compliance|6|||
160755544|NCT02137226|580490369|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
160755545|NCT02137226|580490370|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
160755546|NCT02137226|580490371|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
160755547|NCT02137226|580490372|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
160755548|NCT02137226|580490373|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
160755549|NCT02137226|580490369|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
160755550|NCT02137226|580490370|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
160755551|NCT02137226|580490371|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
160755552|NCT02137226|580490372|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
160755553|NCT02137226|580490373|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
160755554|NCT02137226|580490369|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
160755555|NCT02137226|580490370|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
160755556|NCT02137226|580490371|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
160755557|NCT02137226|580490372|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
160755558|NCT02137226|580490373|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
160755559|NCT02137226|580490369|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
160755560|NCT02137226|580490370|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
160755561|NCT02137226|580490371|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
160755562|NCT02137226|580490372|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
160755563|NCT02137226|580490373|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
160755564|NCT02137226|580490369|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
160755565|NCT02137226|580490370|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
160755566|NCT02137226|580490371|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
160755567|NCT02137226|580490372|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
160755568|NCT02137226|580490373|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
160755569|NCT02137226|580490369|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
160755570|NCT02137226|580490370|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
160755571|NCT02137226|580490371|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
160755572|NCT02137226|580490372|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
160755573|NCT02137226|580490373|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
160755574|NCT02137226|580490369|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
160755575|NCT02137226|580490370|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
160755576|NCT02137226|580490371|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
160755577|NCT02137226|580490372|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
160755578|NCT02137226|580490373|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
160755579|NCT02137226|580490369|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
160755580|NCT02137226|580490370|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
160755581|NCT02137226|580490371|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
160755582|NCT02137226|580490372|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
160755583|NCT02137226|580490373|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
160755584|NCT02137226|580490369|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
160755585|NCT02137226|580490370|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
160755586|NCT02137226|580490371|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
160755587|NCT02137226|580490372|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
160755588|NCT02137226|580490373|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
160755589|NCT02137226|580490369|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
160755590|NCT02137226|580490370|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
160755591|NCT02137226|580490371|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
160755592|NCT02137226|580490372|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
160755593|NCT02137226|580490373|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
160755594|NCT02137226|580490369|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
160755595|NCT02137226|580490370|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
160755596|NCT02137226|580490371|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
160755597|NCT02137226|580490372|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
160755598|NCT02137226|580490373|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
160755599|NCT02137226|580490369|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
160755600|NCT02137226|580490370|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
160755601|NCT02137226|580490371|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
160755602|NCT02137226|580490372|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
160755603|NCT02137226|580490373|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
160755604|NCT00985686|580490375|FG000|Overall Study|Lost to Follow-up|1|||
160755605|NCT00985686|580490376|FG001|Overall Study|Lost to Follow-up|1|||
160755606|NCT00985686|580490377|FG002|Overall Study|Lost to Follow-up|0|||
160755607|NCT00985686|580490378|FG003|Overall Study|Lost to Follow-up|2|||
160755608|NCT03134911|580490379|FG000|Overall Study|Screen failure|31|||
160755609|NCT03134911|580490379|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
160755610|NCT01237327|580490380|FG000|Overall Study|Protocol Violation: Core Study|1|||
160755611|NCT01237327|580490381|FG001|Overall Study|Protocol Violation: Core Study|0|||
160755612|NCT01237327|580490380|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
160755613|NCT01237327|580490381|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
160755614|NCT01237327|580490380|FG000|Overall Study|Progression of Disease: Core Study|18|||
160755615|NCT01237327|580490381|FG001|Overall Study|Progression of Disease: Core Study|22|||
160755616|NCT01237327|580490380|FG000|Overall Study|Progression of Disease: Extension Study|15|||
160755617|NCT01237327|580490381|FG001|Overall Study|Progression of Disease: Extension Study|13|||
160755618|NCT01237327|580490380|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
160755619|NCT01237327|580490381|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
160755620|NCT01237327|580490380|FG000|Overall Study|Withdrawal by Subject|1|||
160755621|NCT01237327|580490381|FG001|Overall Study|Withdrawal by Subject|3|||
160755622|NCT01237327|580490380|FG000|Overall Study|Lost to Follow-up|3|||
160755623|NCT01237327|580490381|FG001|Overall Study|Lost to Follow-up|0|||
160755624|NCT02358031|580492382|FG000|Overall Study|Death|253|||
160755625|NCT02358031|580492383|FG001|Overall Study|Death|237|||
160755626|NCT02358031|580492384|FG002|Overall Study|Death|266|||
160755627|NCT02358031|580492382|FG000|Overall Study|Lost to Follow-up|1|||
160755628|NCT02358031|580492383|FG001|Overall Study|Lost to Follow-up|1|||
160755629|NCT02358031|580492384|FG002|Overall Study|Lost to Follow-up|0|||
160755630|NCT02358031|580492382|FG000|Overall Study|Withdrawal by Subject|19|||
160755631|NCT02358031|580492383|FG001|Overall Study|Withdrawal by Subject|14|||
160755632|NCT02358031|580492384|FG002|Overall Study|Withdrawal by Subject|18|||
160755633|NCT02358031|580492382|FG000|Overall Study|Sponsor Decision|26|||
160755634|NCT02358031|580492383|FG001|Overall Study|Sponsor Decision|28|||
160755635|NCT02358031|580492384|FG002|Overall Study|Sponsor Decision|16|||
160755636|NCT04980014|580492389|FG000|Overall Study|Participants who are Duplicated|1|||
160755637|NCT04980014|580492389|FG000|Overall Study|Follow-up Failure|13|||
160755638|NCT04980014|580492389|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
160755639|NCT04980014|580492389|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
160755640|NCT04980014|580492389|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
160755641|NCT00758498|580492390|FG000|Overall Study|Adverse Event|2|||
160755642|NCT00758498|580492391|FG001|Overall Study|Adverse Event|2|||
160755643|NCT00758498|580492392|FG002|Overall Study|Adverse Event|3|||
160755644|NCT00758498|580492390|FG000|Overall Study|Subject legally detained out of state|1|||
160755645|NCT00758498|580492391|FG001|Overall Study|Subject legally detained out of state|0|||
160755646|NCT00758498|580492392|FG002|Overall Study|Subject legally detained out of state|0|||
160755647|NCT00758498|580492390|FG000|Overall Study|Withdrawal by Subject|0|||
160755648|NCT00758498|580492391|FG001|Overall Study|Withdrawal by Subject|0|||
160755649|NCT00758498|580492392|FG002|Overall Study|Withdrawal by Subject|1|||
160755650|NCT00758498|580492390|FG000|Overall Study|Noncompliance to study procedures|0|||
160755651|NCT00758498|580492391|FG001|Overall Study|Noncompliance to study procedures|0|||
160755652|NCT00758498|580492392|FG002|Overall Study|Noncompliance to study procedures|1|||
160755653|NCT02999789|580492393|FG000|Overall Study|Withdrawal by Subject|0|||
160755654|NCT02999789|580492394|FG001|Overall Study|Withdrawal by Subject|1|||
160755655|NCT02999789|580492393|FG000|Overall Study|Became ineligible|1|||
160755656|NCT02999789|580492394|FG001|Overall Study|Became ineligible|2|||
160755657|NCT02824224|580492395|FG000|Overall Study|Discontinued, IUS expulsion|0|||
160755658|NCT02824224|580492396|FG001|Overall Study|Discontinued, IUS expulsion|1|||
160755659|NCT02824224|580492395|FG000|Overall Study|Did not show up for allocation visit|2|||
160755660|NCT02824224|580492396|FG001|Overall Study|Did not show up for allocation visit|0|||
160755661|NCT00368108|580492397|FG000|Overall Study|Adverse Event|38|||
160755662|NCT00368108|580492398|FG001|Overall Study|Adverse Event|26|||
160755663|NCT00368108|580492399|FG002|Overall Study|Adverse Event|44|||
160755664|NCT00368108|580492397|FG000|Overall Study|Abnormal Laboratory Value|0|||
160755665|NCT00368108|580492398|FG001|Overall Study|Abnormal Laboratory Value|0|||
160755666|NCT00368108|580492399|FG002|Overall Study|Abnormal Laboratory Value|3|||
160755667|NCT00368108|580492397|FG000|Overall Study|Protocol Violation|5|||
160755668|NCT00368108|580492398|FG001|Overall Study|Protocol Violation|9|||
160755669|NCT00368108|580492399|FG002|Overall Study|Protocol Violation|9|||
160755670|NCT00368108|580492397|FG000|Overall Study|Withdrawal by Subject|9|||
160755671|NCT00368108|580492398|FG001|Overall Study|Withdrawal by Subject|3|||
160755672|NCT00368108|580492399|FG002|Overall Study|Withdrawal by Subject|5|||
160755673|NCT00368108|580492397|FG000|Overall Study|Lack of Efficacy|7|||
160755674|NCT00368108|580492398|FG001|Overall Study|Lack of Efficacy|8|||
160755675|NCT00368108|580492399|FG002|Overall Study|Lack of Efficacy|5|||
160755676|NCT00368108|580492397|FG000|Overall Study|Physician Decision|2|||
160755677|NCT00368108|580492398|FG001|Overall Study|Physician Decision|0|||
160755678|NCT00368108|580492399|FG002|Overall Study|Physician Decision|1|||
160755679|NCT00368108|580492397|FG000|Overall Study|Other|3|||
160755680|NCT00368108|580492398|FG001|Overall Study|Other|7|||
160755681|NCT00368108|580492399|FG002|Overall Study|Other|1|||
160755682|NCT02299388|580492404|FG000|Overall Study|Withdrawal by Subject|0|||
160755683|NCT02299388|580492405|FG001|Overall Study|Withdrawal by Subject|1|||
160755684|NCT01093586|580492410|FG000|Overall Study|Failed to engraft|3|||
160755685|NCT03442088|580492411|FG000|Overall Study|Adverse Event|1|||
160755686|NCT03442088|580492411|FG000|Overall Study|Lack of Efficacy|2|||
160755687|NCT03442088|580492411|FG000|Overall Study|Lost to Follow-up|2|||
160755688|NCT00357877|580492412|FG000|Overall Study|Death|2|||
160755689|NCT00357877|580492413|FG001|Overall Study|Death|1|||
160755690|NCT00357877|580492412|FG000|Overall Study|Lost to Follow-up|20|||
160755691|NCT00357877|580492413|FG001|Overall Study|Lost to Follow-up|23|||
160755692|NCT00357877|580492412|FG000|Overall Study|Withdrawal by Subject|3|||
160755693|NCT00357877|580492413|FG001|Overall Study|Withdrawal by Subject|3|||
160755694|NCT00357877|580492412|FG000|Overall Study|Administrative withdrawal|1|||
160755695|NCT00357877|580492413|FG001|Overall Study|Administrative withdrawal|1|||
160755696|NCT00357877|580492412|FG000|Overall Study|Other|0|||
160755697|NCT00357877|580492413|FG001|Overall Study|Other|2|||
160755698|NCT01051557|580492416|FG000|Overall Study|Physician Decision|1|||
160755699|NCT01051557|580492417|FG001|Overall Study|Physician Decision|0|||
160755700|NCT01051557|580492418|FG002|Overall Study|Physician Decision|0|||
160755701|NCT01051557|580492419|FG003|Overall Study|Physician Decision|0|||
160755702|NCT01051557|580492420|FG004|Overall Study|Physician Decision|0|||
160755703|NCT01051557|580492421|FG005|Overall Study|Physician Decision|0|||
160755704|NCT01051557|580492422|FG006|Overall Study|Physician Decision|0|||
160755705|NCT01051557|580492416|FG000|Overall Study|disease progression|3|||
160755706|NCT01051557|580492417|FG001|Overall Study|disease progression|3|||
160755707|NCT01051557|580492418|FG002|Overall Study|disease progression|5|||
160755708|NCT01051557|580492419|FG003|Overall Study|disease progression|2|||
160755709|NCT01051557|580492420|FG004|Overall Study|disease progression|4|||
160755710|NCT01051557|580492421|FG005|Overall Study|disease progression|3|||
160755711|NCT01051557|580492422|FG006|Overall Study|disease progression|1|||
160755712|NCT01051557|580492416|FG000|Overall Study|Withdrawal by Subject|0|||
160755713|NCT01051557|580492417|FG001|Overall Study|Withdrawal by Subject|0|||
160755714|NCT01051557|580492418|FG002|Overall Study|Withdrawal by Subject|1|||
160755715|NCT01051557|580492419|FG003|Overall Study|Withdrawal by Subject|0|||
160755716|NCT01051557|580492420|FG004|Overall Study|Withdrawal by Subject|2|||
160755717|NCT01051557|580492421|FG005|Overall Study|Withdrawal by Subject|0|||
160755718|NCT01051557|580492422|FG006|Overall Study|Withdrawal by Subject|1|||
160755719|NCT01051557|580492416|FG000|Overall Study|Adverse Event|0|||
160755720|NCT01051557|580492417|FG001|Overall Study|Adverse Event|0|||
160755721|NCT01051557|580492418|FG002|Overall Study|Adverse Event|0|||
160755722|NCT01051557|580492419|FG003|Overall Study|Adverse Event|1|||
160755723|NCT01051557|580492420|FG004|Overall Study|Adverse Event|1|||
160755724|NCT01051557|580492421|FG005|Overall Study|Adverse Event|3|||
160755725|NCT01051557|580492422|FG006|Overall Study|Adverse Event|4|||
160755726|NCT00613366|580492429|FG000|Overall Study|Withdrawal by Subject|3|||
160755727|NCT00613366|580492430|FG001|Overall Study|Withdrawal by Subject|2|||
160755728|NCT00943397|580492431|FG000|Overall Study|Adverse Event|0|||
160755729|NCT00943397|580492432|FG001|Overall Study|Adverse Event|6|||
160755730|NCT00943397|580492431|FG000|Overall Study|Lost to Follow-up|0|||
160755731|NCT00943397|580492432|FG001|Overall Study|Lost to Follow-up|4|||
160755732|NCT00943397|580492431|FG000|Overall Study|Protocol Violation|2|||
160755733|NCT00943397|580492432|FG001|Overall Study|Protocol Violation|5|||
160755734|NCT00943397|580492431|FG000|Overall Study|Withdrawal by Subject|1|||
160755735|NCT00943397|580492432|FG001|Overall Study|Withdrawal by Subject|1|||
160755736|NCT00943397|580492431|FG000|Overall Study|Site terminated and other|12|||
160755737|NCT00943397|580492432|FG001|Overall Study|Site terminated and other|56|||
160755738|NCT04878055|580492433|FG000|Overall Study|Patient transferred in another department|0|||
160755739|NCT04878055|580492434|FG001|Overall Study|Patient transferred in another department|2|||
160755740|NCT04878055|580492433|FG000|Overall Study|Physician Decision|1|||
160755741|NCT04878055|580492434|FG001|Overall Study|Physician Decision|1|||
160755742|NCT04878055|580492433|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
160755743|NCT04878055|580492434|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
160755744|NCT04878055|580492433|FG000|Overall Study|Adverse Event|12|||
160755745|NCT04878055|580492434|FG001|Overall Study|Adverse Event|7|||
160755746|NCT04878055|580492433|FG000|Overall Study|Other|5|||
160755747|NCT04878055|580492434|FG001|Overall Study|Other|0|||
160755748|NCT04878055|580492433|FG000|Overall Study|Withdrawal by Subject|7|||
160755749|NCT04878055|580492434|FG001|Overall Study|Withdrawal by Subject|3|||
160755750|NCT04878055|580492433|FG000|Overall Study|Lost to Follow-up|10|||
160755751|NCT04878055|580492434|FG001|Overall Study|Lost to Follow-up|1|||
160755752|NCT01968811|580492435|FG000|Overall Study|Protocol Violation|4|||
160755753|NCT01968811|580492435|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
160755754|NCT01178125|580492436|FG000|Overall Study|Lost to Follow-up|397|||
160755755|NCT01178125|580492436|FG000|Overall Study|Adverse Event|244|||
160755756|NCT01178125|580492436|FG000|Overall Study|Withdrawal by Subject|209|||
160755757|NCT01178125|580492436|FG000|Overall Study|Noncompliance|184|||
160755758|NCT01178125|580492436|FG000|Overall Study|Pregnancy|55|||
160755759|NCT01178125|580492436|FG000|Overall Study|Other Reason|39|||
160755760|NCT01178125|580492436|FG000|Overall Study|Sponsor Decision|28|||
160755761|NCT01178125|580492436|FG000|Overall Study|Protocol Violation|17|||
160755762|NCT01178125|580492436|FG000|Overall Study|Investigator Decision|5|||
160755763|NCT02532374|580492437|FG000|Overall Study|Withdrawal by Subject|1|||
160755764|NCT02532374|580492437|FG000|Overall Study|Physician Decision|1|||
160755765|NCT02762084|580492440|FG000|Overall Study|Withdrawal by Subject|1|||
160755766|NCT02762084|580492441|FG001|Overall Study|Withdrawal by Subject|0|||
160755767|NCT02762084|580492442|FG002|Overall Study|Withdrawal by Subject|0|||
160755768|NCT02762084|580492440|FG000|Overall Study|Adverse Event|0|||
160755769|NCT02762084|580492441|FG001|Overall Study|Adverse Event|0|||
160755770|NCT02762084|580492442|FG002|Overall Study|Adverse Event|1|||
160755771|NCT01348139|580492443|FG000|Period 1|Adverse Event|1|||
160755772|NCT01348139|580492444|FG001|Period 1|Adverse Event|0|||
160755773|NCT01348139|580492445|FG002|Period 1|Adverse Event|0|||
160755774|NCT01348139|580492446|FG003|Period 1|Adverse Event|0|||
160755775|NCT01348139|580492447|FG004|Period 1|Adverse Event|0|||
160755776|NCT01348139|580492448|FG005|Period 1|Adverse Event|0|||
160755777|NCT02254772|580492449|FG000|Overall Study|Ineligible|1|||
160755778|NCT02254772|580492449|FG000|Overall Study|Withdrawal by Subject|1|||
160755779|NCT03006562|580492450|FG000|Overall Study|Lost to Follow-up|0|||
160755780|NCT03006562|580492451|FG001|Overall Study|Lost to Follow-up|1|||
160755781|NCT02427841|580492460|FG000|Overall Study|Lack of Efficacy|5|||
160755782|NCT02427841|580492460|FG000|Overall Study|Physician Decision|2|||
160755783|NCT02427841|580492460|FG000|Overall Study|Withdrawal by Subject|1|||
160755784|NCT01765296|580492461|FG000|Overall Study|Protocol Violation|0|||
160755785|NCT01765296|580492462|FG001|Overall Study|Protocol Violation|5|||
160755786|NCT01765296|580492463|FG002|Overall Study|Protocol Violation|4|||
160755787|NCT01765296|580492461|FG000|Overall Study|Withdrawal by Subject|4|||
160755788|NCT01765296|580492462|FG001|Overall Study|Withdrawal by Subject|2|||
160755789|NCT01765296|580492463|FG002|Overall Study|Withdrawal by Subject|2|||
160755790|NCT01765296|580492461|FG000|Overall Study|Adverse Event|1|||
160755791|NCT01765296|580492462|FG001|Overall Study|Adverse Event|13|||
160755792|NCT01765296|580492463|FG002|Overall Study|Adverse Event|5|||
160755793|NCT01765296|580492461|FG000|Overall Study|Lack of Efficacy|0|||
160755794|NCT01765296|580492462|FG001|Overall Study|Lack of Efficacy|0|||
160755795|NCT01765296|580492463|FG002|Overall Study|Lack of Efficacy|2|||
160755796|NCT03257436|580492464|FG000|Overall Study|Withdrawal by Subject|76|||
160755797|NCT03257436|580492464|FG000|Overall Study|Death|19|||
160755798|NCT01619852|580492465|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
160755799|NCT01619852|580492466|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
160755800|NCT01619852|580492465|FG000|3 Month Follow up|Lost to Follow-up|31|||
160755801|NCT01619852|580492466|FG001|3 Month Follow up|Lost to Follow-up|34|||
160755802|NCT00970489|580492467|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
160755803|NCT00970489|580492468|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
160755804|NCT02659943|580492469|FG000|Overall Study|Switched to alternative treatment|1|||
160755805|NCT02659943|580492470|FG001|Overall Study|Switched to alternative treatment|1|||
160525020|NCT00381303|579651792|FG001|Overall Study|Pregnancy|0|||
160755806|NCT02659943|580492471|FG002|Overall Study|Switched to alternative treatment|0|||
160755807|NCT02659943|580492472|FG003|Overall Study|Switched to alternative treatment|2|||
160755808|NCT02659943|580492473|FG004|Overall Study|Switched to alternative treatment|1|||
160755809|NCT02659943|580492474|FG005|Overall Study|Switched to alternative treatment|0|||
160755810|NCT02659943|580492475|FG006|Overall Study|Switched to alternative treatment|1|||
160755811|NCT02659943|580492469|FG000|Overall Study|Disease progression on study|0|||
160755812|NCT02659943|580492470|FG001|Overall Study|Disease progression on study|1|||
160755813|NCT02659943|580492471|FG002|Overall Study|Disease progression on study|1|||
160755814|NCT02659943|580492472|FG003|Overall Study|Disease progression on study|1|||
160755815|NCT02659943|580492473|FG004|Overall Study|Disease progression on study|1|||
160755816|NCT02659943|580492474|FG005|Overall Study|Disease progression on study|4|||
160755817|NCT02659943|580492475|FG006|Overall Study|Disease progression on study|0|||
160755818|NCT02659943|580492469|FG000|Overall Study|Patient's condition per principal investigator|0|||
160755819|NCT02659943|580492470|FG001|Overall Study|Patient's condition per principal investigator|0|||
160755820|NCT02659943|580492471|FG002|Overall Study|Patient's condition per principal investigator|0|||
160755821|NCT02659943|580492472|FG003|Overall Study|Patient's condition per principal investigator|0|||
160755822|NCT02659943|580492473|FG004|Overall Study|Patient's condition per principal investigator|0|||
160755823|NCT02659943|580492474|FG005|Overall Study|Patient's condition per principal investigator|1|||
160755824|NCT02659943|580492475|FG006|Overall Study|Patient's condition per principal investigator|0|||
160755825|NCT02659943|580492469|FG000|Overall Study|Ineligible|0|||
160755826|NCT02659943|580492470|FG001|Overall Study|Ineligible|0|||
160755827|NCT02659943|580492471|FG002|Overall Study|Ineligible|0|||
160755828|NCT02659943|580492472|FG003|Overall Study|Ineligible|0|||
160755829|NCT02659943|580492473|FG004|Overall Study|Ineligible|0|||
160755830|NCT02659943|580492474|FG005|Overall Study|Ineligible|0|||
160755831|NCT02659943|580492475|FG006|Overall Study|Ineligible|1|||
160755832|NCT02659943|580492469|FG000|Overall Study|No longer meets eligibility|0|||
160755833|NCT02659943|580492470|FG001|Overall Study|No longer meets eligibility|0|||
160755834|NCT02659943|580492471|FG002|Overall Study|No longer meets eligibility|0|||
160755835|NCT02659943|580492472|FG003|Overall Study|No longer meets eligibility|0|||
160755836|NCT02659943|580492473|FG004|Overall Study|No longer meets eligibility|0|||
160755837|NCT02659943|580492474|FG005|Overall Study|No longer meets eligibility|0|||
160755838|NCT02659943|580492475|FG006|Overall Study|No longer meets eligibility|1|||
160755839|NCT02659943|580492469|FG000|Overall Study|No treatment, per protocol|0|||
160755840|NCT02659943|580492470|FG001|Overall Study|No treatment, per protocol|0|||
160755841|NCT02659943|580492471|FG002|Overall Study|No treatment, per protocol|0|||
160755842|NCT02659943|580492472|FG003|Overall Study|No treatment, per protocol|0|||
160755843|NCT02659943|580492473|FG004|Overall Study|No treatment, per protocol|0|||
160755844|NCT02659943|580492474|FG005|Overall Study|No treatment, per protocol|0|||
160755845|NCT02659943|580492475|FG006|Overall Study|No treatment, per protocol|3|||
160755846|NCT00627497|580492479|FG000|Overall Study|Lost to Follow-up|1|||
160755847|NCT00627497|580492480|FG001|Overall Study|Lost to Follow-up|1|||
160755848|NCT00627497|580492481|FG002|Overall Study|Lost to Follow-up|0|||
160755849|NCT00627497|580492482|FG003|Overall Study|Lost to Follow-up|0|||
160755850|NCT03361306|580492485|FG000|Overall Study|Death|6|||
160755851|NCT04767373|580492490|FG000|Overall Study|Death|6|||
160755852|NCT04767373|580492491|FG001|Overall Study|Death|3|||
160755853|NCT04767373|580492490|FG000|Overall Study|Lost to Follow-up|67|||
160755854|NCT04767373|580492491|FG001|Overall Study|Lost to Follow-up|35|||
160755855|NCT04767373|580492490|FG000|Overall Study|Physician Decision|15|||
160755856|NCT04767373|580492491|FG001|Overall Study|Physician Decision|4|||
160755857|NCT04767373|580492490|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160755858|NCT04767373|580492491|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160755859|NCT04767373|580492490|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
160755860|NCT04767373|580492491|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
160755861|NCT04767373|580492490|FG000|Overall Study|Other|1|||
160755862|NCT04767373|580492491|FG001|Overall Study|Other|2|||
160755863|NCT01502033|580492492|FG000|Overall Study|1 participant had scalp discomfort|1|||
160755864|NCT01502033|580492492|FG000|Overall Study|1 participant had worsening depression|1|||
160755865|NCT01502033|580492492|FG000|Overall Study|1 participant went back to school|1|||
160755866|NCT02983045|580492493|FG000|Overall Study|Withdrawal by Subject|0|||
160755867|NCT02983045|580492494|FG001|Overall Study|Withdrawal by Subject|1|||
160755868|NCT02983045|580492495|FG002|Overall Study|Withdrawal by Subject|0|||
160755869|NCT02983045|580492496|FG003|Overall Study|Withdrawal by Subject|5|||
160755870|NCT02983045|580492497|FG004|Overall Study|Withdrawal by Subject|0|||
160755871|NCT02983045|580492498|FG005|Overall Study|Withdrawal by Subject|72|||
160755872|NCT02983045|580492499|FG006|Overall Study|Withdrawal by Subject|0|||
160755873|NCT02983045|580492500|FG007|Overall Study|Withdrawal by Subject|0|||
160755874|NCT02983045|580492501|FG008|Overall Study|Withdrawal by Subject|0|||
160755875|NCT02983045|580492502|FG009|Overall Study|Withdrawal by Subject|2|||
160755876|NCT02983045|580492493|FG000|Overall Study|Lost to Follow-up|0|||
160755877|NCT02983045|580492494|FG001|Overall Study|Lost to Follow-up|0|||
160755878|NCT02983045|580492495|FG002|Overall Study|Lost to Follow-up|0|||
160755879|NCT02983045|580492496|FG003|Overall Study|Lost to Follow-up|0|||
160755880|NCT02983045|580492497|FG004|Overall Study|Lost to Follow-up|0|||
160755881|NCT02983045|580492498|FG005|Overall Study|Lost to Follow-up|10|||
160755882|NCT02983045|580492499|FG006|Overall Study|Lost to Follow-up|0|||
160755883|NCT02983045|580492500|FG007|Overall Study|Lost to Follow-up|0|||
160525021|NCT00381303|579651791|FG000|Overall Study|Physician Decision|1|||
160755884|NCT02983045|580492501|FG008|Overall Study|Lost to Follow-up|0|||
160755885|NCT02983045|580492502|FG009|Overall Study|Lost to Follow-up|0|||
160755886|NCT00991289|580492503|FG000|Overall Study|Adverse Event|1|||
160755887|NCT00991289|580492503|FG000|Overall Study|Physician Decision|2|||
160755888|NCT00991289|580492503|FG000|Overall Study|Withdrawal by Subject|3|||
160755889|NCT00991289|580492503|FG000|Overall Study|Lost to Follow-up|4|||
160755890|NCT00991289|580492503|FG000|Overall Study|Protocol Violation|2|||
160755891|NCT05464420|580492519|FG000|Overall Study|Death|0|||
160755892|NCT05464420|580492520|FG001|Overall Study|Death|0|||
160755893|NCT05464420|580492521|FG002|Overall Study|Death|0|||
160755894|NCT05464420|580492522|FG003|Overall Study|Death|1|||
160755895|NCT05464420|580492519|FG000|Overall Study|Lost to Follow-up|16|||
160755896|NCT05464420|580492520|FG001|Overall Study|Lost to Follow-up|11|||
160755897|NCT05464420|580492521|FG002|Overall Study|Lost to Follow-up|11|||
160755898|NCT05464420|580492522|FG003|Overall Study|Lost to Follow-up|11|||
160755899|NCT05464420|580492519|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
160755900|NCT05464420|580492520|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
160755901|NCT05464420|580492521|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
160755902|NCT05464420|580492522|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
160755903|NCT05464420|580492519|FG000|Overall Study|Withdrawal by Subject|4|||
160755904|NCT05464420|580492520|FG001|Overall Study|Withdrawal by Subject|8|||
160755905|NCT05464420|580492521|FG002|Overall Study|Withdrawal by Subject|3|||
160755906|NCT05464420|580492522|FG003|Overall Study|Withdrawal by Subject|1|||
160755907|NCT05464420|580492519|FG000|Overall Study|Protocol Violation|0|||
160755908|NCT05464420|580492520|FG001|Overall Study|Protocol Violation|0|||
160755909|NCT05464420|580492521|FG002|Overall Study|Protocol Violation|1|||
160755910|NCT05464420|580492522|FG003|Overall Study|Protocol Violation|1|||
160755911|NCT05464420|580492519|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
160755912|NCT05464420|580492520|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
160755913|NCT05464420|580492521|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
160755914|NCT05464420|580492522|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
160755915|NCT01383018|580492523|FG000|Overall Study|Adverse Event|14|||
160755916|NCT01383018|580492523|FG000|Overall Study|Death|10|||
160755917|NCT01383018|580492523|FG000|Overall Study|Lost to Follow-up|5|||
160755918|NCT01383018|580492523|FG000|Overall Study|Physician Decision|5|||
160755919|NCT01383018|580492523|FG000|Overall Study|Withdrawal by Subject|9|||
160755920|NCT01383018|580492523|FG000|Overall Study|Subject not implanted|76|||
160755921|NCT01383018|580492523|FG000|Overall Study|Missed Visit|247|||
160755922|NCT01383018|580492523|FG000|Overall Study|Site closed early-not compliance related|7|||
160755923|NCT01383018|580492523|FG000|Overall Study|Patient moved away from site|1|||
160755924|NCT01383018|580492523|FG000|Overall Study|Subject Incarcerated|1|||
160755925|NCT01598610|580492524|FG000|Overall Study|Adverse Event|1|||
160755926|NCT03066830|580492525|FG000|Overall Study|At the Participant's own Request|16|||
160755927|NCT03066830|580492526|FG001|Overall Study|At the Participant's own Request|17|||
160755928|NCT03066830|580492525|FG000|Overall Study|Other|3|||
160755929|NCT03066830|580492526|FG001|Overall Study|Other|0|||
160755930|NCT03066830|580492525|FG000|Overall Study|Poor Compliance to Protocol|1|||
160755931|NCT03066830|580492526|FG001|Overall Study|Poor Compliance to Protocol|0|||
160755932|NCT03066830|580492525|FG000|Overall Study|Adverse Event|2|||
160755933|NCT03066830|580492526|FG001|Overall Study|Adverse Event|2|||
160755934|NCT03066830|580492525|FG000|Overall Study|Lost to Follow-up|11|||
160755935|NCT03066830|580492526|FG001|Overall Study|Lost to Follow-up|3|||
160755936|NCT00656175|580492531|FG000|Overall Study|Adverse Event|1|||
160755937|NCT00656175|580492532|FG001|Overall Study|Adverse Event|0|||
160755938|NCT00656175|580492531|FG000|Overall Study|Transportation issues|0|||
160755939|NCT00656175|580492532|FG001|Overall Study|Transportation issues|1|||
160755940|NCT02149264|580492538|FG000|Overall Study|Withdrawal by Subject|9|||
160755941|NCT02149264|580492538|FG000|Overall Study|Adverse Event|7|||
160755942|NCT02149264|580492538|FG000|Overall Study|Physician Decision|3|||
160755943|NCT02149264|580492538|FG000|Overall Study|Protocol Violation|1|||
160755944|NCT00672633|580492542|FG000|Overall Study|Withdrawal by Subject|0|||
160755945|NCT00672633|580492543|FG001|Overall Study|Withdrawal by Subject|1|||
160755946|NCT02824627|580492544|FG000|Overall Study|Adverse Event|1|||
160755947|NCT02824627|580492545|FG001|Overall Study|Adverse Event|2|||
160755948|NCT02824627|580492544|FG000|Overall Study|Lost to Follow-up|2|||
160755949|NCT02824627|580492545|FG001|Overall Study|Lost to Follow-up|1|||
160755950|NCT01938846|580492546|FG000|Overall Study|Progressive disease|26|||
160755951|NCT01938846|580492547|FG001|Overall Study|Progressive disease|18|||
160755952|NCT01938846|580492548|FG002|Overall Study|Progressive disease|16|||
160755953|NCT01938846|580492546|FG000|Overall Study|Adverse Event|8|||
160755954|NCT01938846|580492547|FG001|Overall Study|Adverse Event|4|||
160755955|NCT01938846|580492548|FG002|Overall Study|Adverse Event|3|||
160755956|NCT01938846|580492546|FG000|Overall Study|Withdrawal by Subject|2|||
160755957|NCT01938846|580492547|FG001|Overall Study|Withdrawal by Subject|2|||
160755958|NCT01938846|580492548|FG002|Overall Study|Withdrawal by Subject|1|||
160755959|NCT01938846|580492546|FG000|Overall Study|Other than listed|5|||
160755960|NCT01938846|580492547|FG001|Overall Study|Other than listed|1|||
160755961|NCT01938846|580492548|FG002|Overall Study|Other than listed|4|||
160755962|NCT02499120|580492552|FG000|Overall Study|Death|52|||
160755963|NCT02499120|580492553|FG001|Overall Study|Death|43|||
160755964|NCT02499120|580492552|FG000|Overall Study|Lost to Follow-up|1|||
160755965|NCT02499120|580492553|FG001|Overall Study|Lost to Follow-up|2|||
160755966|NCT02499120|580492552|FG000|Overall Study|Participant refused further follow-up|1|||
160755967|NCT02499120|580492553|FG001|Overall Study|Participant refused further follow-up|0|||
160525022|NCT00381303|579651792|FG001|Overall Study|Physician Decision|0|||
160755968|NCT02499120|580492552|FG000|Overall Study|Withdrawal by Subject|2|||
160755969|NCT02499120|580492553|FG001|Overall Study|Withdrawal by Subject|5|||
160755970|NCT02499120|580492552|FG000|Overall Study|Other|9|||
160755971|NCT02499120|580492553|FG001|Overall Study|Other|10|||
160755972|NCT01868165|580492556|FG000|Overall Study|Withdrawal by Subject|36|||
160755973|NCT01868165|580492556|FG000|Overall Study|Physician Decision|2|||
160755974|NCT01868165|580492556|FG000|Overall Study|Lost to Follow-up|3|||
160755975|NCT01868165|580492556|FG000|Overall Study|Death|4|||
160755976|NCT02282163|580492557|FG000|Overall Study|Protocol Violation|1|||
160755977|NCT01839916|580492558|FG000|Overall Study|Death|9|||
160755978|NCT01839916|580492558|FG000|Overall Study|Physician Decision|17|||
160755979|NCT01839916|580492558|FG000|Overall Study|Relapse|12|||
160755980|NCT01839916|580492558|FG000|Overall Study|GVHD|2|||
160755981|NCT01839916|580492558|FG000|Overall Study|Graft Failure|1|||
160755982|NCT03472521|580492559|FG000|Overall Study|Lost to Follow-up|3|||
160755983|NCT03472521|580492560|FG001|Overall Study|Lost to Follow-up|2|||
160755984|NCT03472521|580492559|FG000|Overall Study|Discontinued intervention|3|||
160755985|NCT03472521|580492560|FG001|Overall Study|Discontinued intervention|1|||
160755986|NCT01603407|580492561|FG000|Overall Study|Adverse Event|1|||
160755987|NCT01603407|580492562|FG001|Overall Study|Adverse Event|1|||
160755988|NCT01603407|580492563|FG002|Overall Study|Adverse Event|1|||
160755989|NCT01603407|580492561|FG000|Overall Study|Protocol Violation|2|||
160755990|NCT01603407|580492562|FG001|Overall Study|Protocol Violation|2|||
160755991|NCT01603407|580492563|FG002|Overall Study|Protocol Violation|0|||
160755992|NCT01603407|580492561|FG000|Overall Study|Withdrawal by Subject|8|||
160755993|NCT01603407|580492562|FG001|Overall Study|Withdrawal by Subject|5|||
160755994|NCT01603407|580492563|FG002|Overall Study|Withdrawal by Subject|7|||
160755995|NCT01603407|580492561|FG000|Overall Study|Lost to Follow-up|0|||
160755996|NCT01603407|580492562|FG001|Overall Study|Lost to Follow-up|3|||
160755997|NCT01603407|580492563|FG002|Overall Study|Lost to Follow-up|2|||
160755998|NCT00823134|580493857|FG000|Overall Study|Invalid measurement|1|||
160755999|NCT01325350|580493864|FG000|Overall Study|Adverse Event|3|||
160756000|NCT01325350|580493865|FG001|Overall Study|Adverse Event|3|||
160756001|NCT01325350|580493866|FG002|Overall Study|Adverse Event|3|||
160756002|NCT01325350|580493867|FG003|Overall Study|Adverse Event|1|||
160756003|NCT01325350|580493868|FG004|Overall Study|Adverse Event|2|||
160756004|NCT01325350|580493864|FG000|Overall Study|Pregnancy|0|||
160756005|NCT01325350|580493865|FG001|Overall Study|Pregnancy|0|||
160756006|NCT01325350|580493866|FG002|Overall Study|Pregnancy|1|||
160756007|NCT01325350|580493867|FG003|Overall Study|Pregnancy|0|||
160756008|NCT01325350|580493868|FG004|Overall Study|Pregnancy|1|||
160756009|NCT01325350|580493864|FG000|Overall Study|Lost to Follow-up|1|||
160756010|NCT01325350|580493865|FG001|Overall Study|Lost to Follow-up|0|||
160756011|NCT01325350|580493866|FG002|Overall Study|Lost to Follow-up|5|||
160756012|NCT01325350|580493867|FG003|Overall Study|Lost to Follow-up|1|||
160756013|NCT01325350|580493868|FG004|Overall Study|Lost to Follow-up|5|||
160756014|NCT01325350|580493864|FG000|Overall Study|Personal Reasons|2|||
160756015|NCT01325350|580493865|FG001|Overall Study|Personal Reasons|1|||
160756016|NCT01325350|580493866|FG002|Overall Study|Personal Reasons|6|||
160756017|NCT01325350|580493867|FG003|Overall Study|Personal Reasons|5|||
160756018|NCT01325350|580493868|FG004|Overall Study|Personal Reasons|3|||
160756019|NCT01325350|580493864|FG000|Overall Study|Protocol Violation|0|||
160756020|NCT01325350|580493865|FG001|Overall Study|Protocol Violation|0|||
160756021|NCT01325350|580493866|FG002|Overall Study|Protocol Violation|0|||
160756022|NCT01325350|580493867|FG003|Overall Study|Protocol Violation|1|||
160756023|NCT01325350|580493868|FG004|Overall Study|Protocol Violation|0|||
160756024|NCT01325350|580493864|FG000|Overall Study|Withdrawal by Subject|0|||
160756025|NCT01325350|580493865|FG001|Overall Study|Withdrawal by Subject|0|||
160756026|NCT01325350|580493866|FG002|Overall Study|Withdrawal by Subject|1|||
160756027|NCT01325350|580493867|FG003|Overall Study|Withdrawal by Subject|1|||
160756028|NCT01325350|580493868|FG004|Overall Study|Withdrawal by Subject|0|||
160756029|NCT01325350|580493864|FG000|Overall Study|Did Not Receive Treatment|0|||
160756030|NCT01325350|580493865|FG001|Overall Study|Did Not Receive Treatment|1|||
160756031|NCT01325350|580493866|FG002|Overall Study|Did Not Receive Treatment|1|||
160756032|NCT01325350|580493867|FG003|Overall Study|Did Not Receive Treatment|0|||
160756033|NCT01325350|580493868|FG004|Overall Study|Did Not Receive Treatment|1|||
160756034|NCT02692586|580493869|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
160756035|NCT02692586|580493869|FG000|Overall Study|Received adjunctive thrombolytics|2|||
160756036|NCT00956839|580493870|FG000|Overall Study|Lost to Follow-up|3|||
160756037|NCT00956839|580493871|FG001|Overall Study|Lost to Follow-up|0|||
160756038|NCT00956839|580493872|FG002|Overall Study|Lost to Follow-up|3|||
160756039|NCT03316586|580493880|FG000|Overall Study|Adverse Event|2|||
160756040|NCT03316586|580493880|FG000|Overall Study|Physician Decision|3|||
160756041|NCT03316586|580493880|FG000|Overall Study|Lack of Efficacy|10|||
160756042|NCT03316586|580493880|FG000|Overall Study|still on treatment|1|||
160756043|NCT03316586|580493880|FG000|Overall Study|Patient needed radiation therapy|1|||
160756044|NCT03316586|580493880|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
160756045|NCT00994110|580493881|FG000|Overall Study|Withdrawal by Subject|9|||
160756046|NCT00994110|580493882|FG001|Overall Study|Withdrawal by Subject|9|||
160756047|NCT00994110|580493881|FG000|Overall Study|Not Treated|4|||
160756048|NCT00994110|580493882|FG001|Overall Study|Not Treated|8|||
160756049|NCT00994110|580493881|FG000|Overall Study|Adverse Event|1|||
160756050|NCT00994110|580493882|FG001|Overall Study|Adverse Event|0|||
160756051|NCT00994110|580493881|FG000|Overall Study|Patient not resected|41|||
160756052|NCT00994110|580493882|FG001|Overall Study|Patient not resected|52|||
160756053|NCT00994110|580493881|FG000|Overall Study|Pt not eligible|10|||
160756054|NCT00994110|580493882|FG001|Overall Study|Pt not eligible|5|||
160756055|NCT00619827|580493883|FG000|Overall Study|Adverse Event|1|||
160756056|NCT00619827|580493884|FG001|Overall Study|Adverse Event|2|||
160756057|NCT00619827|580493883|FG000|Overall Study|Withdrawal by Subject|2|||
160756058|NCT00619827|580493884|FG001|Overall Study|Withdrawal by Subject|2|||
160756059|NCT02163395|580493885|FG000|Overall Study|Withdrawal by Subject|1|||
160756060|NCT02163395|580493885|FG000|Overall Study|Lost to Follow-up|3|||
160756061|NCT02163395|580493885|FG000|Overall Study|Adverse Event|1|||
160756062|NCT01111565|580493886|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
160756063|NCT01111565|580493887|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
160756064|NCT01111565|580493888|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
160756065|NCT01111565|580493889|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
160756066|NCT01111565|580493890|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
160756067|NCT01111565|580493886|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
160756068|NCT01111565|580493887|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
160756069|NCT01111565|580493888|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
160756070|NCT01111565|580493889|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
160756071|NCT01111565|580493890|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
160756072|NCT01111565|580493886|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
160756073|NCT01111565|580493887|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
160756074|NCT01111565|580493888|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
160756075|NCT01111565|580493889|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
160756076|NCT01111565|580493890|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
160756077|NCT01111565|580493886|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
160756078|NCT01111565|580493887|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
160756079|NCT01111565|580493888|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
160756080|NCT01111565|580493889|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
160756081|NCT01111565|580493890|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
160756082|NCT01111565|580493886|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
160756083|NCT01111565|580493887|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
160756084|NCT01111565|580493888|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
160756085|NCT01111565|580493889|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
160756086|NCT01111565|580493890|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
160756087|NCT01111565|580493886|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
160756088|NCT01111565|580493887|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
160756089|NCT01111565|580493888|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
160756090|NCT01111565|580493889|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
160756091|NCT01111565|580493890|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
160756092|NCT01111565|580493886|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
160756093|NCT01111565|580493887|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
160756094|NCT01111565|580493888|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
160756095|NCT01111565|580493889|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
160756096|NCT01111565|580493890|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
160756097|NCT01111565|580493886|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
160756098|NCT01111565|580493887|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
160756099|NCT01111565|580493888|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
160756100|NCT01111565|580493889|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
160756101|NCT01111565|580493890|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
160756102|NCT01111565|580493886|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160756103|NCT01111565|580493887|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160756104|NCT01111565|580493888|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
160756105|NCT01111565|580493889|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160756106|NCT01111565|580493890|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160756107|NCT01111565|580493886|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
160756108|NCT01111565|580493887|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
160756109|NCT01111565|580493888|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
160756110|NCT01111565|580493889|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
160756111|NCT01111565|580493890|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
160756112|NCT01111565|580493886|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
160756113|NCT01111565|580493887|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
160525023|NCT00381303|579651791|FG000|Overall Study|Physician's decision to close the site|3|||
160636190|NCT01902134|580051480|FG000|Overall Study|Physician Decision|0|||
160756114|NCT01111565|580493888|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
160756115|NCT01111565|580493889|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
160756116|NCT01111565|580493890|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
160756117|NCT01111565|580493886|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
160756118|NCT01111565|580493887|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
160756119|NCT01111565|580493888|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
160756120|NCT01111565|580493889|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
160756121|NCT01111565|580493890|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
160756122|NCT03150082|580493893|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
160756123|NCT03150082|580493894|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
160756124|NCT04131712|580493895|FG000|Overall Study|COVID related|0|||
160756125|NCT04131712|580493896|FG001|Overall Study|COVID related|0|||
160756126|NCT04131712|580493897|FG002|Overall Study|COVID related|2|||
160756127|NCT04131712|580493898|FG003|Overall Study|COVID related|0|||
160756128|NCT04131712|580493895|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
160756129|NCT04131712|580493896|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
160756130|NCT04131712|580493897|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
160756131|NCT04131712|580493898|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
160756132|NCT03334188|580493899|FG000|Overall Study|Withdrawal by Subject|0|||
160756133|NCT03334188|580493900|FG001|Overall Study|Withdrawal by Subject|1|||
160756134|NCT03334188|580493899|FG000|Overall Study|Death|1|||
160756135|NCT03334188|580493900|FG001|Overall Study|Death|0|||
160756136|NCT03334188|580493899|FG000|Overall Study|Never had qualifying clinic visit|7|||
160756137|NCT03334188|580493900|FG001|Overall Study|Never had qualifying clinic visit|7|||
160756138|NCT00766597|580493904|FG000|Overall Study|Unexpected closure of study|4|||
160756139|NCT00766597|580493904|FG000|Overall Study|Without CCR5-tropic virus|5|||
160756140|NCT01254656|580493905|FG000|Overall Study|Discontinued due to termination of study|40|||
160756141|NCT01254656|580493906|FG001|Overall Study|Discontinued due to termination of study|39|||
160756142|NCT01254656|580493907|FG002|Overall Study|Discontinued due to termination of study|13|||
160756143|NCT01254656|580493905|FG000|Overall Study|Lack of Efficacy|3|||
160756144|NCT01254656|580493906|FG001|Overall Study|Lack of Efficacy|0|||
160756145|NCT01254656|580493907|FG002|Overall Study|Lack of Efficacy|0|||
160756146|NCT01254656|580493905|FG000|Overall Study|Lost to Follow-up|1|||
160756147|NCT01254656|580493906|FG001|Overall Study|Lost to Follow-up|0|||
160756148|NCT01254656|580493907|FG002|Overall Study|Lost to Follow-up|2|||
160756149|NCT01254656|580493905|FG000|Overall Study|Withdrawal by Subject|2|||
160756150|NCT01254656|580493906|FG001|Overall Study|Withdrawal by Subject|2|||
160756151|NCT01254656|580493907|FG002|Overall Study|Withdrawal by Subject|1|||
160756152|NCT01254656|580493905|FG000|Overall Study|Pregnancy|0|||
160756153|NCT01254656|580493906|FG001|Overall Study|Pregnancy|0|||
160756154|NCT01254656|580493907|FG002|Overall Study|Pregnancy|2|||
160756155|NCT01254656|580493905|FG000|Overall Study|Adverse Event|1|||
160756156|NCT01254656|580493906|FG001|Overall Study|Adverse Event|1|||
160756157|NCT01254656|580493907|FG002|Overall Study|Adverse Event|0|||
160756158|NCT01254656|580493905|FG000|Overall Study|Death|0|||
160756159|NCT01254656|580493906|FG001|Overall Study|Death|1|||
160756160|NCT01254656|580493907|FG002|Overall Study|Death|0|||
160756161|NCT00249873|580493915|FG000|Overall Study|Not treated|7|||
160756162|NCT00249873|580493916|FG001|Overall Study|Not treated|8|||
160756163|NCT00249873|580493915|FG000|Overall Study|Significant thrombocytopenia|9|||
160756164|NCT00249873|580493916|FG001|Overall Study|Significant thrombocytopenia|8|||
160756165|NCT00249873|580493915|FG000|Overall Study|Severe allergic reaction|8|||
160756166|NCT00249873|580493916|FG001|Overall Study|Severe allergic reaction|1|||
160756167|NCT00249873|580493915|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
160756168|NCT00249873|580493916|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
160756169|NCT00249873|580493915|FG000|Overall Study|Other Serious Adverse Event|86|||
160756170|NCT00249873|580493916|FG001|Overall Study|Other Serious Adverse Event|97|||
160756171|NCT00249873|580493915|FG000|Overall Study|Qualifying condition not present|20|||
160756172|NCT00249873|580493916|FG001|Overall Study|Qualifying condition not present|23|||
160756173|NCT00249873|580493915|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
160756174|NCT00249873|580493916|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
160756175|NCT00249873|580493915|FG000|Overall Study|Withdrawal by Subject|504|||
160756176|NCT00249873|580493916|FG001|Overall Study|Withdrawal by Subject|466|||
160756177|NCT00249873|580493915|FG000|Overall Study|Lost to Follow-up|4|||
160756178|NCT00249873|580493916|FG001|Overall Study|Lost to Follow-up|7|||
160756179|NCT00249873|580493915|FG000|Overall Study|Minor bleeding|99|||
160756180|NCT00249873|580493916|FG001|Overall Study|Minor bleeding|37|||
160756181|NCT00249873|580493915|FG000|Overall Study|Non-compliance|41|||
160756182|NCT00249873|580493916|FG001|Overall Study|Non-compliance|46|||
160756183|NCT00249873|580493915|FG000|Overall Study|Other non serious Adverse Event|112|||
160756184|NCT00249873|580493916|FG001|Overall Study|Other non serious Adverse Event|108|||
160756185|NCT00249873|580493915|FG000|Overall Study|Other contraindicated medication|1|||
160756186|NCT00249873|580493916|FG001|Overall Study|Other contraindicated medication|0|||
160756187|NCT00249873|580493915|FG000|Overall Study|Patient not wish to continue after May08|3|||
160756188|NCT00249873|580493916|FG001|Overall Study|Patient not wish to continue after May08|4|||
160756189|NCT00249873|580493915|FG000|Overall Study|Physician withdrew consent|59|||
160756190|NCT00249873|580493916|FG001|Overall Study|Physician withdrew consent|60|||
160756191|NCT00249873|580493915|FG000|Overall Study|Open label clopidogrel required|31|||
160756192|NCT00249873|580493916|FG001|Overall Study|Open label clopidogrel required|42|||
160756193|NCT00249873|580493915|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
160756194|NCT00249873|580493916|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
160756195|NCT00249873|580493915|FG000|Overall Study|Oral anticoagulant required|159|||
160756196|NCT00249873|580493916|FG001|Overall Study|Oral anticoagulant required|157|||
160756197|NCT00249873|580493915|FG000|Overall Study|Study drug intolerance|5|||
160756198|NCT00249873|580493916|FG001|Overall Study|Study drug intolerance|0|||
160756199|NCT00249873|580493915|FG000|Overall Study|Surgery/ procedure|9|||
160756200|NCT00249873|580493916|FG001|Overall Study|Surgery/ procedure|9|||
160756201|NCT00249873|580493915|FG000|Overall Study|Event related to cardiac condition|12|||
160756202|NCT00249873|580493916|FG001|Overall Study|Event related to cardiac condition|21|||
160756203|NCT00249873|580493915|FG000|Overall Study|Thromboembolic/outcome event|82|||
160756204|NCT00249873|580493916|FG001|Overall Study|Thromboembolic/outcome event|122|||
160756205|NCT00447772|580493917|FG000|Overall Study|Lack of Efficacy|3|||
160756206|NCT00447772|580493917|FG000|Overall Study|Insufficient compliance|6|||
160756207|NCT00447772|580493917|FG000|Overall Study|Discontinuation of drug therapy|1|||
160756208|NCT00447772|580493917|FG000|Overall Study|Lost to Follow-up|9|||
160756209|NCT00447772|580493917|FG000|Overall Study|Withdrawal by Subject|1|||
160756210|NCT00447772|580493917|FG000|Overall Study|Unable to attend all study visits|2|||
160756211|NCT00447772|580493917|FG000|Overall Study|Adverse Event|1|||
160756212|NCT00447772|580493917|FG000|Overall Study|Patient relocated|1|||
160756213|NCT00447772|580493917|FG000|Overall Study|Incomplete documentation at visit 1|1|||
160756214|NCT00447772|580493917|FG000|Overall Study|Chemotherapy for lung cancer|1|||
160756215|NCT00447772|580493917|FG000|Overall Study|Premature re-injection required|1|||
160756216|NCT01610037|580493922|FG000|All Patients|Adverse Event|27|||
160756217|NCT01610037|580493923|FG001|All Patients|Adverse Event|22|||
160756218|NCT01610037|580493924|FG002|All Patients|Adverse Event|26|||
160756219|NCT01610037|580493922|FG000|All Patients|Withdrawal by Subject|12|||
160756220|NCT01610037|580493923|FG001|All Patients|Withdrawal by Subject|10|||
160756221|NCT01610037|580493924|FG002|All Patients|Withdrawal by Subject|20|||
160756222|NCT01610037|580493922|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
160756223|NCT01610037|580493923|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
160756224|NCT01610037|580493924|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
160756225|NCT01610037|580493922|FG000|All Patients|Death|4|||
160756226|NCT01610037|580493923|FG001|All Patients|Death|2|||
160756227|NCT01610037|580493924|FG002|All Patients|Death|1|||
160756228|NCT01610037|580493922|FG000|All Patients|Protocol deviation|4|||
160756229|NCT01610037|580493923|FG001|All Patients|Protocol deviation|3|||
160756230|NCT01610037|580493924|FG002|All Patients|Protocol deviation|3|||
160756231|NCT01610037|580493922|FG000|All Patients|Abnormal laboratory value|1|||
160756232|NCT01610037|580493923|FG001|All Patients|Abnormal laboratory value|1|||
160756233|NCT01610037|580493924|FG002|All Patients|Abnormal laboratory value|0|||
160756234|NCT01610037|580493922|FG000|All Patients|Administrative problems|1|||
160756235|NCT01610037|580493923|FG001|All Patients|Administrative problems|4|||
160756236|NCT01610037|580493924|FG002|All Patients|Administrative problems|4|||
160756237|NCT01610037|580493922|FG000|All Patients|Lost to Follow-up|1|||
160756238|NCT01610037|580493923|FG001|All Patients|Lost to Follow-up|0|||
160756239|NCT01610037|580493924|FG002|All Patients|Lost to Follow-up|0|||
160756240|NCT01610037|580493922|FG000|All Patients|Abnormal test procedure result(s)|0|||
160756241|NCT01610037|580493923|FG001|All Patients|Abnormal test procedure result(s)|1|||
160756242|NCT01610037|580493924|FG002|All Patients|Abnormal test procedure result(s)|3|||
160756243|NCT01610037|580493922|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
160756244|NCT01610037|580493923|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
160756245|NCT01610037|580493924|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
160756246|NCT01610037|580493922|FG000|Treatment and Follow up Period|Death|10|||
160756247|NCT01610037|580493923|FG001|Treatment and Follow up Period|Death|5|||
160756248|NCT01610037|580493924|FG002|Treatment and Follow up Period|Death|4|||
160756249|NCT01610037|580493922|FG000|Treatment and Follow up Period|Administrative problems|1|||
160756250|NCT01610037|580493923|FG001|Treatment and Follow up Period|Administrative problems|3|||
160756251|NCT01610037|580493924|FG002|Treatment and Follow up Period|Administrative problems|2|||
160756252|NCT01610037|580493922|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
160756253|NCT01610037|580493923|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
160756254|NCT01610037|580493924|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
160756255|NCT00274742|580493925|FG000|Overall Study|Adverse Event|0|||
160756256|NCT00274742|580493926|FG001|Overall Study|Adverse Event|4|||
160756257|NCT00274742|580493927|FG002|Overall Study|Adverse Event|1|||
160756258|NCT00274742|580493928|FG003|Overall Study|Adverse Event|4|||
160756259|NCT00274742|580493929|FG004|Overall Study|Adverse Event|12|||
160756260|NCT00274742|580493930|FG005|Overall Study|Adverse Event|3|||
160756261|NCT00274742|580493925|FG000|Overall Study|Lost to Follow-up|0|||
160756262|NCT00274742|580493926|FG001|Overall Study|Lost to Follow-up|0|||
160756263|NCT00274742|580493927|FG002|Overall Study|Lost to Follow-up|0|||
160756264|NCT00274742|580493928|FG003|Overall Study|Lost to Follow-up|0|||
160756265|NCT00274742|580493929|FG004|Overall Study|Lost to Follow-up|1|||
160756266|NCT00274742|580493930|FG005|Overall Study|Lost to Follow-up|0|||
160756267|NCT00274742|580493925|FG000|Overall Study|End of Study|0|||
160756268|NCT00274742|580493926|FG001|Overall Study|End of Study|0|||
160756269|NCT00274742|580493927|FG002|Overall Study|End of Study|0|||
160756270|NCT00274742|580493928|FG003|Overall Study|End of Study|1|||
160756271|NCT00274742|580493929|FG004|Overall Study|End of Study|0|||
160756272|NCT00274742|580493930|FG005|Overall Study|End of Study|0|||
160756273|NCT00274742|580493925|FG000|Overall Study|Disease Progression|0|||
160756274|NCT00274742|580493926|FG001|Overall Study|Disease Progression|1|||
160756275|NCT00274742|580493927|FG002|Overall Study|Disease Progression|1|||
160756276|NCT00274742|580493928|FG003|Overall Study|Disease Progression|0|||
160756277|NCT00274742|580493929|FG004|Overall Study|Disease Progression|1|||
160756278|NCT00274742|580493930|FG005|Overall Study|Disease Progression|0|||
160756279|NCT00274742|580493925|FG000|Overall Study|Other|0|||
160756280|NCT00274742|580493926|FG001|Overall Study|Other|3|||
160756281|NCT00274742|580493927|FG002|Overall Study|Other|0|||
160756282|NCT00274742|580493928|FG003|Overall Study|Other|0|||
160756283|NCT00274742|580493929|FG004|Overall Study|Other|2|||
160756284|NCT00274742|580493930|FG005|Overall Study|Other|0|||
160756285|NCT03489343|580493936|FG000|Overall Study|Documented progressive disease|1|||
160756286|NCT03489343|580493937|FG001|Overall Study|Documented progressive disease|0|||
160756287|NCT03489343|580493938|FG002|Overall Study|Documented progressive disease|3|||
160756288|NCT03489343|580493939|FG003|Overall Study|Documented progressive disease|1|||
160756289|NCT03489343|580493940|FG004|Overall Study|Documented progressive disease|3|||
160756290|NCT03489343|580493941|FG005|Overall Study|Documented progressive disease|5|||
160756291|NCT03489343|580493942|FG006|Overall Study|Documented progressive disease|4|||
160756292|NCT03489343|580493936|FG000|Overall Study|Adverse Event|0|||
160756293|NCT03489343|580493937|FG001|Overall Study|Adverse Event|1|||
160756294|NCT03489343|580493938|FG002|Overall Study|Adverse Event|0|||
160756295|NCT03489343|580493939|FG003|Overall Study|Adverse Event|0|||
160756296|NCT03489343|580493940|FG004|Overall Study|Adverse Event|0|||
160756297|NCT03489343|580493941|FG005|Overall Study|Adverse Event|1|||
160756298|NCT03489343|580493942|FG006|Overall Study|Adverse Event|0|||
160756299|NCT03489343|580493936|FG000|Overall Study|Withdrawal by Subject|0|||
160756300|NCT03489343|580493937|FG001|Overall Study|Withdrawal by Subject|0|||
160756301|NCT03489343|580493938|FG002|Overall Study|Withdrawal by Subject|0|||
160756302|NCT03489343|580493939|FG003|Overall Study|Withdrawal by Subject|1|||
160756303|NCT03489343|580493940|FG004|Overall Study|Withdrawal by Subject|0|||
160756304|NCT03489343|580493941|FG005|Overall Study|Withdrawal by Subject|1|||
160756305|NCT03489343|580493942|FG006|Overall Study|Withdrawal by Subject|1|||
160756306|NCT03489343|580493936|FG000|Overall Study|Clinical progression|0|||
160756307|NCT03489343|580493937|FG001|Overall Study|Clinical progression|0|||
160756308|NCT03489343|580493938|FG002|Overall Study|Clinical progression|0|||
160756309|NCT03489343|580493939|FG003|Overall Study|Clinical progression|1|||
160756310|NCT03489343|580493940|FG004|Overall Study|Clinical progression|0|||
160756311|NCT03489343|580493941|FG005|Overall Study|Clinical progression|0|||
160756312|NCT03489343|580493942|FG006|Overall Study|Clinical progression|1|||
160756313|NCT00327717|580493943|FG000|Overall Study|Adverse Event|6|||
160756314|NCT00327717|580493944|FG001|Overall Study|Adverse Event|6|||
160756315|NCT00327717|580493943|FG000|Overall Study|Lack of Efficacy|0|||
160756316|NCT00327717|580493944|FG001|Overall Study|Lack of Efficacy|1|||
160756317|NCT00327717|580493943|FG000|Overall Study|Withdrawal by Subject|3|||
160756318|NCT00327717|580493944|FG001|Overall Study|Withdrawal by Subject|7|||
160756319|NCT01630135|580493946|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
160756320|NCT01630135|580493947|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
160756321|NCT02658669|580493949|FG000|Overall Study|Lost to Follow-up|7|||
160756322|NCT02658669|580493950|FG001|Overall Study|Lost to Follow-up|5|||
160756323|NCT00838097|580493959|FG000|Overall Study|Ineligibility determined|6|||
160756324|NCT00838097|580493959|FG000|Overall Study|Adverse Event|2|||
160756325|NCT00838097|580493959|FG000|Overall Study|Withdrawal by Subject|3|||
160756326|NCT00838097|580493959|FG000|Overall Study|Requirement for alternative therapy|2|||
160756327|NCT00838097|580493959|FG000|Overall Study|Physician Decision|4|||
160756328|NCT00838097|580493959|FG000|Overall Study|Lost to Follow-up|11|||
160756329|NCT00838097|580493959|FG000|Overall Study|Death|6|||
160756330|NCT00838097|580493959|FG000|Overall Study|Protocol-specified criteria|142|||
160756331|NCT03311841|580493960|FG000|14-day Wash-out|Adverse Event|0|||
160756332|NCT03311841|580493961|FG001|14-day Wash-out|Adverse Event|1|||
160756333|NCT03311841|580493962|FG002|14-day Wash-out|Adverse Event|0|||
160756334|NCT03311841|580493963|FG003|14-day Wash-out|Adverse Event|0|||
160756335|NCT03311841|580493964|FG004|14-day Wash-out|Adverse Event|0|||
160756336|NCT03311841|580493960|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
160756337|NCT03311841|580493961|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
160756338|NCT03311841|580493962|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
160756339|NCT03311841|580493963|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
160756340|NCT03311841|580493964|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
160756341|NCT00977613|580493967|FG000|Overall Study|Lost to Follow-up|16|||
160756342|NCT02989402|580493979|FG000|Overall Study|Adverse event, or serious adverse event|4|||
160756343|NCT02989402|580493979|FG000|Overall Study|Death|2|||
160756344|NCT02989402|580493979|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
160756345|NCT02989402|580493979|FG000|Overall Study|Lost to Follow-up|8|||
160756346|NCT02989402|580493979|FG000|Overall Study|Patient no longer on monotherapy|1|||
160756347|NCT02989402|580493979|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
160756348|NCT02989402|580493979|FG000|Overall Study|Withdrawal by Subject|7|||
160756349|NCT02989402|580493979|FG000|Overall Study|Other|2|||
160756350|NCT02039778|580493982|FG000|Overall Study|Death|2|||
160756351|NCT02039778|580493982|FG000|Overall Study|Withdrawal by Subject|1|||
160756352|NCT02039778|580493982|FG000|Overall Study|Never started the protocol treatment|1|||
160756353|NCT01210482|580493992|FG000|Overall Study|Protocol Violation|1|||
160756354|NCT01210482|580493992|FG000|Overall Study|Case Report Forms were not collected|18|||
160756355|NCT01210482|580493992|FG000|Overall Study|Duplicated|2|||
160756356|NCT01210482|580493992|FG000|Overall Study|No Drug Administration|28|||
160756357|NCT03284853|580493993|FG000|Overall Study|Adverse Event|40|||
160756358|NCT03284853|580493994|FG001|Overall Study|Adverse Event|4|||
160756359|NCT03284853|580493993|FG000|Overall Study|Withdrawal by Subject|5|||
160756360|NCT03284853|580493994|FG001|Overall Study|Withdrawal by Subject|1|||
160756361|NCT03284853|580493993|FG000|Overall Study|Lost to Follow-up|1|||
160756362|NCT03284853|580493994|FG001|Overall Study|Lost to Follow-up|0|||
160756363|NCT03284853|580493993|FG000|Overall Study|Lack of Efficacy|1|||
160756364|NCT03284853|580493994|FG001|Overall Study|Lack of Efficacy|0|||
160756365|NCT03284853|580493993|FG000|Overall Study|Disallowed Concurrent Medication|1|||
160756366|NCT03284853|580493994|FG001|Overall Study|Disallowed Concurrent Medication|1|||
160756367|NCT03284853|580493993|FG000|Overall Study|Protocol Violation|3|||
160756368|NCT03284853|580493994|FG001|Overall Study|Protocol Violation|3|||
160756369|NCT03284853|580493993|FG000|Overall Study|Death|0|||
160756370|NCT03284853|580493994|FG001|Overall Study|Death|1|||
160756371|NCT03284853|580493993|FG000|Overall Study|Other - Reason not reported in CSR|4|||
160756372|NCT03284853|580493994|FG001|Overall Study|Other - Reason not reported in CSR|3|||
160756373|NCT02143024|580493995|FG000|Overall Study|Lost to Follow-up|1|||
160756374|NCT02143024|580493996|FG001|Overall Study|Lost to Follow-up|1|||
160756375|NCT02143024|580493995|FG000|Overall Study|Withdrawal by Subject|1|||
160756376|NCT02143024|580493996|FG001|Overall Study|Withdrawal by Subject|0|||
160756377|NCT01216332|580494000|FG000|Overall Study|Withdrawal by Subject|4|||
160756378|NCT01216332|580494001|FG001|Overall Study|Withdrawal by Subject|0|||
160756379|NCT03677869|580494002|FG000|Overall Study|Withdrawal by Subject|1|||
160756380|NCT05219968|580494003|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
160756381|NCT05219968|580494004|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
160756382|NCT05219968|580494005|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
160756383|NCT05219968|580494006|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
160756384|NCT05219968|580494007|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
160756385|NCT05219968|580494003|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
160756386|NCT05219968|580494004|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
160756387|NCT05219968|580494005|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
160756388|NCT05219968|580494006|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
160756389|NCT05219968|580494007|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
160756390|NCT05219968|580494003|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
160756391|NCT05219968|580494004|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
160756392|NCT05219968|580494005|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
160756393|NCT05219968|580494006|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
160756394|NCT05219968|580494007|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
160756395|NCT05219968|580494003|FG000|Week 24 Treatment Period|Adverse Event|3|||
160756396|NCT05219968|580494004|FG001|Week 24 Treatment Period|Adverse Event|0|||
160756397|NCT05219968|580494005|FG002|Week 24 Treatment Period|Adverse Event|0|||
160756398|NCT05219968|580494006|FG003|Week 24 Treatment Period|Adverse Event|0|||
160756399|NCT05219968|580494007|FG004|Week 24 Treatment Period|Adverse Event|0|||
160756400|NCT05219968|580494003|FG000|Week 24 Treatment Period|Physician Decision|0|||
160756401|NCT05219968|580494004|FG001|Week 24 Treatment Period|Physician Decision|1|||
160756402|NCT05219968|580494005|FG002|Week 24 Treatment Period|Physician Decision|0|||
160756403|NCT05219968|580494006|FG003|Week 24 Treatment Period|Physician Decision|0|||
160756404|NCT05219968|580494007|FG004|Week 24 Treatment Period|Physician Decision|0|||
160756405|NCT05219968|580494003|FG000|Week 24 Treatment Period|Other, not specified|3|||
160756406|NCT05219968|580494004|FG001|Week 24 Treatment Period|Other, not specified|0|||
160756407|NCT05219968|580494005|FG002|Week 24 Treatment Period|Other, not specified|0|||
160756408|NCT05219968|580494006|FG003|Week 24 Treatment Period|Other, not specified|0|||
160756409|NCT05219968|580494007|FG004|Week 24 Treatment Period|Other, not specified|0|||
160756410|NCT05219968|580494003|FG000|Safety Extension Period|Treatment administration failure|0|||
160756411|NCT05219968|580494004|FG001|Safety Extension Period|Treatment administration failure|0|||
160756412|NCT05219968|580494005|FG002|Safety Extension Period|Treatment administration failure|0|||
160756413|NCT05219968|580494006|FG003|Safety Extension Period|Treatment administration failure|1|||
160756414|NCT05219968|580494007|FG004|Safety Extension Period|Treatment administration failure|4|||
160756415|NCT05219968|580494003|FG000|Safety Extension Period|Bilateral dislodgement|0|||
160756416|NCT05219968|580494004|FG001|Safety Extension Period|Bilateral dislodgement|0|||
160756417|NCT05219968|580494005|FG002|Safety Extension Period|Bilateral dislodgement|4|||
160756418|NCT05219968|580494006|FG003|Safety Extension Period|Bilateral dislodgement|0|||
160756419|NCT05219968|580494007|FG004|Safety Extension Period|Bilateral dislodgement|1|||
160756420|NCT05219968|580494003|FG000|Safety Extension Period|Withdrawal by Subject|0|||
160756421|NCT05219968|580494004|FG001|Safety Extension Period|Withdrawal by Subject|0|||
160756422|NCT05219968|580494005|FG002|Safety Extension Period|Withdrawal by Subject|2|||
160756423|NCT05219968|580494006|FG003|Safety Extension Period|Withdrawal by Subject|0|||
160756424|NCT05219968|580494007|FG004|Safety Extension Period|Withdrawal by Subject|4|||
160756425|NCT05219968|580494003|FG000|Safety Extension Period|Adverse Event|0|||
160756426|NCT05219968|580494004|FG001|Safety Extension Period|Adverse Event|0|||
160756427|NCT05219968|580494005|FG002|Safety Extension Period|Adverse Event|2|||
160756428|NCT05219968|580494006|FG003|Safety Extension Period|Adverse Event|1|||
160756429|NCT05219968|580494007|FG004|Safety Extension Period|Adverse Event|1|||
160756430|NCT05219968|580494003|FG000|Safety Extension Period|Lost to Follow-up|0|||
160756431|NCT05219968|580494004|FG001|Safety Extension Period|Lost to Follow-up|0|||
160756432|NCT05219968|580494005|FG002|Safety Extension Period|Lost to Follow-up|0|||
160756433|NCT05219968|580494006|FG003|Safety Extension Period|Lost to Follow-up|1|||
160756434|NCT05219968|580494007|FG004|Safety Extension Period|Lost to Follow-up|0|||
160756435|NCT04587336|580494010|FG000|Overall Study|Lost to Follow-up|1|||
160756436|NCT04587336|580494011|FG001|Overall Study|Lost to Follow-up|0|||
160756437|NCT01716806|580495893|FG000|Overall Study|Patient withdrawal of consent|4|||
160756438|NCT01716806|580495894|FG001|Overall Study|Patient withdrawal of consent|2|||
160756439|NCT01716806|580495895|FG002|Overall Study|Patient withdrawal of consent|4|||
160756440|NCT01716806|580495896|FG003|Overall Study|Patient withdrawal of consent|3|||
160756441|NCT01716806|580495897|FG004|Overall Study|Patient withdrawal of consent|2|||
160756442|NCT01716806|580495898|FG005|Overall Study|Patient withdrawal of consent|0|||
160756443|NCT01716806|580495893|FG000|Overall Study|Lost to Follow-up|3|||
160756444|NCT01716806|580495894|FG001|Overall Study|Lost to Follow-up|3|||
160756445|NCT01716806|580495895|FG002|Overall Study|Lost to Follow-up|0|||
160756446|NCT01716806|580495896|FG003|Overall Study|Lost to Follow-up|2|||
160756447|NCT01716806|580495897|FG004|Overall Study|Lost to Follow-up|1|||
160756448|NCT01716806|580495898|FG005|Overall Study|Lost to Follow-up|0|||
160756449|NCT01716806|580495893|FG000|Overall Study|Death|13|||
160756450|NCT01716806|580495894|FG001|Overall Study|Death|9|||
160756451|NCT01716806|580495895|FG002|Overall Study|Death|12|||
160756452|NCT01716806|580495896|FG003|Overall Study|Death|4|||
160756453|NCT01716806|580495897|FG004|Overall Study|Death|10|||
160756454|NCT01716806|580495898|FG005|Overall Study|Death|5|||
160756455|NCT01716806|580495893|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
160756456|NCT01716806|580495894|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
160756457|NCT01716806|580495895|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
160756458|NCT01716806|580495896|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
160756459|NCT01716806|580495897|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
160756460|NCT01716806|580495898|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
160756461|NCT01716806|580495893|FG000|Overall Study|PI decision|0|||
160756462|NCT01716806|580495894|FG001|Overall Study|PI decision|0|||
160756463|NCT01716806|580495895|FG002|Overall Study|PI decision|0|||
160756464|NCT01716806|580495896|FG003|Overall Study|PI decision|0|||
160756465|NCT01716806|580495897|FG004|Overall Study|PI decision|1|||
160756466|NCT01716806|580495898|FG005|Overall Study|PI decision|0|||
160756467|NCT01716806|580495893|FG000|Overall Study|Change in performance status|1|||
160756468|NCT01716806|580495894|FG001|Overall Study|Change in performance status|0|||
160756469|NCT01716806|580495895|FG002|Overall Study|Change in performance status|0|||
160756470|NCT01716806|580495896|FG003|Overall Study|Change in performance status|0|||
160756471|NCT01716806|580495897|FG004|Overall Study|Change in performance status|0|||
160756472|NCT01716806|580495898|FG005|Overall Study|Change in performance status|0|||
160525024|NCT00381303|579651792|FG001|Overall Study|Physician's decision to close the site|1|||
160525025|NCT00381303|579651791|FG000|Overall Study|Subject moved out of state|2|||
160756473|NCT01716806|580495893|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
160756474|NCT01716806|580495894|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
160756475|NCT01716806|580495895|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
160756476|NCT01716806|580495896|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
160756477|NCT01716806|580495897|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
160756478|NCT01716806|580495898|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
160756479|NCT01716806|580495893|FG000|Overall Study|Sponsor direction|7|||
160756480|NCT01716806|580495894|FG001|Overall Study|Sponsor direction|8|||
160756481|NCT01716806|580495895|FG002|Overall Study|Sponsor direction|5|||
160756482|NCT01716806|580495896|FG003|Overall Study|Sponsor direction|12|||
160756483|NCT01716806|580495897|FG004|Overall Study|Sponsor direction|16|||
160756484|NCT01716806|580495898|FG005|Overall Study|Sponsor direction|1|||
160756485|NCT03934216|580495901|FG000|Overall Study|Other Reasons|5|||
160756486|NCT03934216|580495902|FG001|Overall Study|Other Reasons|5|||
160756487|NCT03934216|580495901|FG000|Overall Study|Adverse Event|22|||
160756488|NCT03934216|580495902|FG001|Overall Study|Adverse Event|11|||
160756489|NCT03934216|580495901|FG000|Overall Study|Lack of Efficacy|8|||
160756490|NCT03934216|580495902|FG001|Overall Study|Lack of Efficacy|7|||
160756491|NCT03934216|580495901|FG000|Overall Study|Lost to Follow-up|2|||
160756492|NCT03934216|580495902|FG001|Overall Study|Lost to Follow-up|0|||
160756493|NCT03934216|580495901|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160756494|NCT03934216|580495902|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160756495|NCT03934216|580495901|FG000|Overall Study|Pregnancy|1|||
160756496|NCT03934216|580495902|FG001|Overall Study|Pregnancy|0|||
160756497|NCT03934216|580495901|FG000|Overall Study|Withdrawal by Subject|18|||
160756498|NCT03934216|580495902|FG001|Overall Study|Withdrawal by Subject|6|||
160756499|NCT03934216|580495901|FG000|Overall Study|Randomized but not treated|1|||
160756500|NCT03934216|580495902|FG001|Overall Study|Randomized but not treated|1|||
160756501|NCT01396083|580495908|FG000|Overall Study|Adverse Event|2|||
160756502|NCT01396083|580495909|FG001|Overall Study|Adverse Event|28|||
160756503|NCT01396083|580495908|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160756504|NCT01396083|580495909|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
160756505|NCT01396083|580495908|FG000|Overall Study|Consent withdrawn|4|||
160756506|NCT01396083|580495909|FG001|Overall Study|Consent withdrawn|5|||
160756507|NCT01396083|580495908|FG000|Overall Study|Protocol deviation(s)|0|||
160756508|NCT01396083|580495909|FG001|Overall Study|Protocol deviation(s)|1|||
160756509|NCT01396083|580495908|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160756510|NCT01396083|580495909|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160756511|NCT01396083|580495908|FG000|Overall Study|Administrative problems|1|||
160756512|NCT01396083|580495909|FG001|Overall Study|Administrative problems|0|||
160756513|NCT01396083|580495908|FG000|Overall Study|Lost to Follow-up|1|||
160756514|NCT01396083|580495909|FG001|Overall Study|Lost to Follow-up|0|||
160756515|NCT01063855|580495911|FG000|Overall Study|Adverse Event|4|||
160756516|NCT01063855|580495912|FG001|Overall Study|Adverse Event|4|||
160756517|NCT01063855|580495911|FG000|Overall Study|Death|0|||
160756518|NCT01063855|580495912|FG001|Overall Study|Death|1|||
160756519|NCT01063855|580495911|FG000|Overall Study|Lost to Follow-up|8|||
160756520|NCT01063855|580495912|FG001|Overall Study|Lost to Follow-up|4|||
160756521|NCT01063855|580495911|FG000|Overall Study|Pregnancy|1|||
160756522|NCT01063855|580495912|FG001|Overall Study|Pregnancy|0|||
160756523|NCT01063855|580495911|FG000|Overall Study|Lack of Efficacy|0|||
160756524|NCT01063855|580495912|FG001|Overall Study|Lack of Efficacy|1|||
160756525|NCT01063855|580495911|FG000|Overall Study|Withdrawal by Subject|11|||
160756526|NCT01063855|580495912|FG001|Overall Study|Withdrawal by Subject|8|||
160756527|NCT01063855|580495911|FG000|Overall Study|Reason not specified|13|||
160756528|NCT01063855|580495912|FG001|Overall Study|Reason not specified|11|||
160756529|NCT00735709|580495913|FG000|Overall Study|Adverse Event|2|||
160756530|NCT00735709|580495914|FG001|Overall Study|Adverse Event|3|||
160756531|NCT00735709|580495915|FG002|Overall Study|Adverse Event|1|||
160756532|NCT00735709|580495916|FG003|Overall Study|Adverse Event|5|||
160756533|NCT00735709|580495913|FG000|Overall Study|Lack of Efficacy|8|||
160756534|NCT00735709|580495914|FG001|Overall Study|Lack of Efficacy|4|||
160756535|NCT00735709|580495915|FG002|Overall Study|Lack of Efficacy|2|||
160756536|NCT00735709|580495916|FG003|Overall Study|Lack of Efficacy|3|||
160756537|NCT00735709|580495913|FG000|Overall Study|Noncompliance|0|||
160756538|NCT00735709|580495914|FG001|Overall Study|Noncompliance|0|||
160756539|NCT00735709|580495915|FG002|Overall Study|Noncompliance|1|||
160756540|NCT00735709|580495916|FG003|Overall Study|Noncompliance|0|||
160756541|NCT00735709|580495913|FG000|Overall Study|Protocol deviations|1|||
160756542|NCT00735709|580495914|FG001|Overall Study|Protocol deviations|2|||
160756543|NCT00735709|580495915|FG002|Overall Study|Protocol deviations|1|||
160525026|NCT00381303|579651792|FG001|Overall Study|Subject moved out of state|0|||
160756544|NCT00735709|580495916|FG003|Overall Study|Protocol deviations|1|||
160756545|NCT00735709|580495913|FG000|Overall Study|Voluntary Withdrawal|1|||
160756546|NCT00735709|580495914|FG001|Overall Study|Voluntary Withdrawal|3|||
160756547|NCT00735709|580495915|FG002|Overall Study|Voluntary Withdrawal|5|||
160756548|NCT00735709|580495916|FG003|Overall Study|Voluntary Withdrawal|7|||
160756549|NCT00735709|580495913|FG000|Overall Study|Lost to Follow-up|0|||
160525027|NCT00381303|579651791|FG000|Overall Study|Subject taking too many different meds|1|||
160756550|NCT00735709|580495914|FG001|Overall Study|Lost to Follow-up|1|||
160756551|NCT00735709|580495915|FG002|Overall Study|Lost to Follow-up|1|||
160636191|NCT01902134|580051481|FG001|Overall Study|Physician Decision|1|||
160756552|NCT00735709|580495916|FG003|Overall Study|Lost to Follow-up|1|||
160756553|NCT00735709|580495913|FG000|Overall Study|Excluded medication|1|||
160756554|NCT00735709|580495914|FG001|Overall Study|Excluded medication|0|||
160756555|NCT00735709|580495915|FG002|Overall Study|Excluded medication|0|||
160756556|NCT00735709|580495916|FG003|Overall Study|Excluded medication|1|||
160756557|NCT01165307|580495918|FG000|Overall Study|Lost to Follow-up|11|||
160756558|NCT01165307|580495919|FG001|Overall Study|Lost to Follow-up|3|||
160756559|NCT01165307|580495918|FG000|Overall Study|Withdrawal by Subject|2|||
160756560|NCT01165307|580495919|FG001|Overall Study|Withdrawal by Subject|0|||
160756561|NCT01165307|580495918|FG000|Overall Study|Subject not available for contact|1|||
160756562|NCT01165307|580495919|FG001|Overall Study|Subject not available for contact|0|||
160756563|NCT03234036|580495920|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
160756564|NCT03234036|580495921|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
160756565|NCT03234036|580495922|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
160756566|NCT03234036|580495923|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
160756567|NCT01718483|580495926|FG000|Overall Study|Withdrawal by Subject|14|||
160756568|NCT01718483|580495927|FG001|Overall Study|Withdrawal by Subject|12|||
160756569|NCT01718483|580495926|FG000|Overall Study|Adverse Event|5|||
160756570|NCT01718483|580495927|FG001|Overall Study|Adverse Event|12|||
160756571|NCT01718483|580495926|FG000|Overall Study|Lost to Follow-up|8|||
160756572|NCT01718483|580495927|FG001|Overall Study|Lost to Follow-up|3|||
160756573|NCT01718483|580495926|FG000|Overall Study|Protocol Violation|4|||
160756574|NCT01718483|580495927|FG001|Overall Study|Protocol Violation|2|||
160756575|NCT01718483|580495926|FG000|Overall Study|Other|1|||
160756576|NCT01718483|580495927|FG001|Overall Study|Other|4|||
160756577|NCT01718483|580495926|FG000|Overall Study|Pregnancy|1|||
160756578|NCT01718483|580495927|FG001|Overall Study|Pregnancy|1|||
160756579|NCT01718483|580495926|FG000|Overall Study|Lack of Efficacy|1|||
160756580|NCT01718483|580495927|FG001|Overall Study|Lack of Efficacy|0|||
160756581|NCT02119299|580495930|FG000|Overall Study|Withdrawal by Subject|7|||
160756582|NCT02119299|580495930|FG000|Overall Study|Lack of Efficacy|1|||
160756583|NCT02119299|580495930|FG000|Overall Study|Pregnancy|1|||
160756584|NCT04613739|580495931|FG000|Overall Study|Lost to Follow-up|6|||
160756585|NCT04613739|580495932|FG001|Overall Study|Lost to Follow-up|9|||
160756586|NCT04613739|580495931|FG000|Overall Study|potentially duplicative/fraudulent|1|||
160756587|NCT04613739|580495932|FG001|Overall Study|potentially duplicative/fraudulent|3|||
160756588|NCT00130689|580495933|FG000|Overall Study|Progressive Disease|29|||
160756589|NCT00130689|580495933|FG000|Overall Study|Death|1|||
160756590|NCT00130689|580495933|FG000|Overall Study|Clinical Deterioration|4|||
160756591|NCT00130689|580495933|FG000|Overall Study|Withdrawal by Subject|3|||
160756592|NCT00130689|580495933|FG000|Overall Study|Ineligible|6|||
160756593|NCT00048035|580495934|FG000|Core Period|Early Withdrawals|4|||
160756594|NCT00048035|580495935|FG001|Core Period|Early Withdrawals|2|||
160756595|NCT00048035|580495936|FG002|Core Period|Early Withdrawals|1|||
160756596|NCT00048035|580495937|FG003|Core Period|Early Withdrawals|1|||
160756597|NCT00048035|580495938|FG004|Core Period|Early Withdrawals|1|||
160756598|NCT00048035|580495939|FG005|Core Period|Early Withdrawals|1|||
160756599|NCT00048035|580495940|FG006|Core Period|Early Withdrawals|0|||
160756600|NCT00048035|580495941|FG007|Core Period|Early Withdrawals|0|||
160756601|NCT00048035|580495934|FG000|Extension Year 1|Early Withdrawals|0|||
160756602|NCT00048035|580495935|FG001|Extension Year 1|Early Withdrawals|0|||
160756603|NCT00048035|580495936|FG002|Extension Year 1|Early Withdrawals|0|||
160756604|NCT00048035|580495937|FG003|Extension Year 1|Early Withdrawals|0|||
160756605|NCT00048035|580495938|FG004|Extension Year 1|Early Withdrawals|0|||
160756606|NCT00048035|580495939|FG005|Extension Year 1|Early Withdrawals|0|||
160756607|NCT00048035|580495940|FG006|Extension Year 1|Early Withdrawals|11|||
160756608|NCT00048035|580495941|FG007|Extension Year 1|Early Withdrawals|11|||
160756609|NCT00048035|580495934|FG000|Extension Year 2|Early Withdrawals|0|||
160756610|NCT00048035|580495935|FG001|Extension Year 2|Early Withdrawals|0|||
160756611|NCT00048035|580495936|FG002|Extension Year 2|Early Withdrawals|0|||
160756612|NCT00048035|580495937|FG003|Extension Year 2|Early Withdrawals|0|||
160756613|NCT00048035|580495938|FG004|Extension Year 2|Early Withdrawals|0|||
160756614|NCT00048035|580495939|FG005|Extension Year 2|Early Withdrawals|0|||
160756615|NCT00048035|580495940|FG006|Extension Year 2|Early Withdrawals|3|||
160756616|NCT00048035|580495941|FG007|Extension Year 2|Early Withdrawals|3|||
160756617|NCT05137717|580495942|FG000|Overall Study|Death|2|||
160756618|NCT05137717|580495942|FG000|Overall Study|Withdrawal by Subject|6|||
160756619|NCT02619617|580495943|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
160756620|NCT02619617|580495944|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
160756621|NCT02619617|580495943|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
160756622|NCT02619617|580495944|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
160756623|NCT00509899|580495945|FG000|Overall Study|Progressive disease|1|||
160756624|NCT00509899|580495946|FG001|Overall Study|Progressive disease|3|||
160756625|NCT00509899|580495947|FG002|Overall Study|Progressive disease|5|||
160756626|NCT00509899|580495948|FG003|Overall Study|Progressive disease|1|||
160756627|NCT00509899|580495949|FG004|Overall Study|Progressive disease|0|||
160756628|NCT00509899|580495950|FG005|Overall Study|Progressive disease|1|||
160756629|NCT00509899|580495951|FG006|Overall Study|Progressive disease|0|||
160756630|NCT00509899|580495952|FG007|Overall Study|Progressive disease|0|||
160756631|NCT00509899|580495945|FG000|Overall Study|Unacceptable Toxicity|1|||
160756632|NCT00509899|580495946|FG001|Overall Study|Unacceptable Toxicity|0|||
160756633|NCT00509899|580495947|FG002|Overall Study|Unacceptable Toxicity|0|||
160756634|NCT00509899|580495948|FG003|Overall Study|Unacceptable Toxicity|2|||
160756635|NCT00509899|580495949|FG004|Overall Study|Unacceptable Toxicity|0|||
160756636|NCT00509899|580495950|FG005|Overall Study|Unacceptable Toxicity|0|||
160756637|NCT00509899|580495951|FG006|Overall Study|Unacceptable Toxicity|0|||
160756638|NCT00509899|580495952|FG007|Overall Study|Unacceptable Toxicity|0|||
160756639|NCT00509899|580495945|FG000|Overall Study|Withdrawal by Subject|6|||
160756640|NCT00509899|580495946|FG001|Overall Study|Withdrawal by Subject|2|||
160756641|NCT00509899|580495947|FG002|Overall Study|Withdrawal by Subject|3|||
160756642|NCT00509899|580495948|FG003|Overall Study|Withdrawal by Subject|0|||
160756643|NCT00509899|580495949|FG004|Overall Study|Withdrawal by Subject|3|||
160756644|NCT00509899|580495950|FG005|Overall Study|Withdrawal by Subject|2|||
160756645|NCT00509899|580495951|FG006|Overall Study|Withdrawal by Subject|0|||
160756646|NCT00509899|580495952|FG007|Overall Study|Withdrawal by Subject|0|||
160756647|NCT00509899|580495945|FG000|Overall Study|Physician Decision|4|||
160756648|NCT00509899|580495946|FG001|Overall Study|Physician Decision|2|||
160756649|NCT00509899|580495947|FG002|Overall Study|Physician Decision|7|||
160756650|NCT00509899|580495948|FG003|Overall Study|Physician Decision|0|||
160756651|NCT00509899|580495949|FG004|Overall Study|Physician Decision|1|||
160756652|NCT00509899|580495950|FG005|Overall Study|Physician Decision|4|||
160756653|NCT00509899|580495951|FG006|Overall Study|Physician Decision|0|||
160756654|NCT00509899|580495952|FG007|Overall Study|Physician Decision|0|||
160756655|NCT00509899|580495945|FG000|Overall Study|Intercurrent Illness|1|||
160756656|NCT00509899|580495946|FG001|Overall Study|Intercurrent Illness|0|||
160756657|NCT00509899|580495947|FG002|Overall Study|Intercurrent Illness|0|||
160756658|NCT00509899|580495948|FG003|Overall Study|Intercurrent Illness|1|||
160756659|NCT00509899|580495949|FG004|Overall Study|Intercurrent Illness|0|||
160756660|NCT00509899|580495950|FG005|Overall Study|Intercurrent Illness|1|||
160756661|NCT00509899|580495951|FG006|Overall Study|Intercurrent Illness|0|||
160756662|NCT00509899|580495952|FG007|Overall Study|Intercurrent Illness|0|||
160756663|NCT00509899|580495945|FG000|Overall Study|Death|2|||
160756664|NCT00509899|580495946|FG001|Overall Study|Death|2|||
160756665|NCT00509899|580495947|FG002|Overall Study|Death|3|||
160756666|NCT00509899|580495948|FG003|Overall Study|Death|0|||
160756667|NCT00509899|580495949|FG004|Overall Study|Death|1|||
160756668|NCT00509899|580495950|FG005|Overall Study|Death|1|||
160756669|NCT00509899|580495951|FG006|Overall Study|Death|1|||
160756670|NCT00509899|580495952|FG007|Overall Study|Death|1|||
160756671|NCT00509899|580495945|FG000|Overall Study|Lack of Efficacy|1|||
160756672|NCT00509899|580495946|FG001|Overall Study|Lack of Efficacy|0|||
160756673|NCT00509899|580495947|FG002|Overall Study|Lack of Efficacy|2|||
160756674|NCT00509899|580495948|FG003|Overall Study|Lack of Efficacy|0|||
160756675|NCT00509899|580495949|FG004|Overall Study|Lack of Efficacy|0|||
160756676|NCT00509899|580495950|FG005|Overall Study|Lack of Efficacy|1|||
160756677|NCT00509899|580495951|FG006|Overall Study|Lack of Efficacy|0|||
160756678|NCT00509899|580495952|FG007|Overall Study|Lack of Efficacy|0|||
160756679|NCT02948829|580495953|FG000|Overall Study|Lost to Follow-up|2|||
160756680|NCT02948829|580495953|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
160756681|NCT02948829|580495953|FG000|Overall Study|Pregnancy|1|||
160756682|NCT02948829|580495953|FG000|Overall Study|Other: Reason not Specified|8|||
160756683|NCT02326272|580495954|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756684|NCT02326272|580495955|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
160756685|NCT02326272|580495956|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
160756686|NCT02326272|580495957|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756687|NCT02326272|580495958|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756688|NCT02326272|580495959|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756689|NCT02326272|580495960|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756690|NCT02326272|580495961|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756691|NCT02326272|580495962|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756692|NCT02326272|580495963|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756693|NCT02326272|580495964|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756694|NCT02326272|580495965|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756695|NCT02326272|580495966|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756696|NCT02326272|580495967|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756697|NCT02326272|580495968|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160756698|NCT02326272|580495954|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
160756699|NCT02326272|580495955|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
160756700|NCT02326272|580495956|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756701|NCT02326272|580495957|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756702|NCT02326272|580495958|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756703|NCT02326272|580495959|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756704|NCT02326272|580495960|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756705|NCT02326272|580495961|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756706|NCT02326272|580495962|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756707|NCT02326272|580495963|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756708|NCT02326272|580495964|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756709|NCT02326272|580495965|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756710|NCT02326272|580495966|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756711|NCT02326272|580495967|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756712|NCT02326272|580495968|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160756713|NCT02326272|580495954|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
160756714|NCT02326272|580495955|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
160756715|NCT02326272|580495956|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
160756716|NCT02326272|580495957|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756717|NCT02326272|580495958|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756718|NCT02326272|580495959|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756719|NCT02326272|580495960|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756720|NCT02326272|580495961|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756721|NCT02326272|580495962|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756722|NCT02326272|580495963|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756723|NCT02326272|580495964|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756724|NCT02326272|580495965|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756725|NCT02326272|580495966|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756726|NCT02326272|580495967|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756727|NCT02326272|580495968|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160756728|NCT02326272|580495954|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756729|NCT02326272|580495955|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756730|NCT02326272|580495956|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
160756731|NCT02326272|580495957|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756732|NCT02326272|580495958|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756733|NCT02326272|580495959|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756734|NCT02326272|580495960|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756735|NCT02326272|580495961|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756736|NCT02326272|580495962|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756737|NCT02326272|580495963|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756738|NCT02326272|580495964|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756739|NCT02326272|580495965|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756740|NCT02326272|580495966|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756741|NCT02326272|580495967|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756742|NCT02326272|580495968|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160756743|NCT02326272|580495954|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756744|NCT02326272|580495955|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756745|NCT02326272|580495956|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
160756746|NCT02326272|580495957|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756747|NCT02326272|580495958|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756748|NCT02326272|580495959|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756749|NCT02326272|580495960|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756750|NCT02326272|580495961|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756751|NCT02326272|580495962|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756752|NCT02326272|580495963|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756753|NCT02326272|580495964|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756754|NCT02326272|580495965|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756755|NCT02326272|580495966|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756756|NCT02326272|580495967|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756757|NCT02326272|580495968|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
160756758|NCT02326272|580495954|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756759|NCT02326272|580495955|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756760|NCT02326272|580495956|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
160756761|NCT02326272|580495957|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756762|NCT02326272|580495958|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756763|NCT02326272|580495959|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756764|NCT02326272|580495960|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756765|NCT02326272|580495961|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756766|NCT02326272|580495962|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756767|NCT02326272|580495963|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160636192|NCT01902134|580051482|FG002|Overall Study|Physician Decision|0|||
160636193|NCT01902134|580051483|FG003|Overall Study|Physician Decision|0|||
160636194|NCT01902134|580051484|FG004|Overall Study|Physician Decision|0|||
160636195|NCT01902134|580051485|FG005|Overall Study|Physician Decision|0|||
160636196|NCT01902134|580051480|FG000|Overall Study|Protocol Violation|0|||
160636197|NCT01902134|580051481|FG001|Overall Study|Protocol Violation|0|||
160636198|NCT01902134|580051482|FG002|Overall Study|Protocol Violation|0|||
160636199|NCT01902134|580051483|FG003|Overall Study|Protocol Violation|0|||
160636200|NCT01902134|580051484|FG004|Overall Study|Protocol Violation|0|||
160636201|NCT01902134|580051485|FG005|Overall Study|Protocol Violation|1|||
160636202|NCT01902134|580051480|FG000|Overall Study|Withdrawal by Subject|4|||
160636203|NCT01902134|580051481|FG001|Overall Study|Withdrawal by Subject|8|||
160636204|NCT01902134|580051482|FG002|Overall Study|Withdrawal by Subject|9|||
160636205|NCT01902134|580051483|FG003|Overall Study|Withdrawal by Subject|1|||
160636206|NCT01902134|580051484|FG004|Overall Study|Withdrawal by Subject|5|||
160636207|NCT01902134|580051485|FG005|Overall Study|Withdrawal by Subject|4|||
160636208|NCT01902134|580051480|FG000|Overall Study|no compliance|1|||
160636209|NCT01902134|580051481|FG001|Overall Study|no compliance|0|||
160636210|NCT01902134|580051482|FG002|Overall Study|no compliance|0|||
160636211|NCT01902134|580051483|FG003|Overall Study|no compliance|0|||
160636212|NCT01902134|580051484|FG004|Overall Study|no compliance|0|||
160636213|NCT01902134|580051485|FG005|Overall Study|no compliance|0|||
160636214|NCT01902134|580051480|FG000|Overall Study|Other|0|||
160636215|NCT01902134|580051481|FG001|Overall Study|Other|1|||
160636216|NCT01902134|580051482|FG002|Overall Study|Other|2|||
160636217|NCT01902134|580051483|FG003|Overall Study|Other|0|||
160636218|NCT01902134|580051484|FG004|Overall Study|Other|1|||
160636219|NCT01902134|580051485|FG005|Overall Study|Other|0|||
160636220|NCT00305110|580051486|FG000|Overall Study|Missing data|29|||
160636221|NCT00337129|580051487|FG000|Overall Study|Adverse Event|4|||
160636222|NCT00337129|580051487|FG000|Overall Study|Withdrawal by Subject|1|||
160636223|NCT00337129|580051487|FG000|Overall Study|Lack of Efficacy|32|||
160636224|NCT00337129|580051487|FG000|Overall Study|Death|2|||
160636225|NCT00337129|580051487|FG000|Overall Study|not protocol specified|1|||
160636226|NCT00563524|580051492|FG000|Overall Study|Adverse Event|0|||
160636227|NCT00563524|580051493|FG001|Overall Study|Adverse Event|1|||
160636228|NCT00563524|580051494|FG002|Overall Study|Adverse Event|0|||
160636229|NCT00563524|580051495|FG003|Overall Study|Adverse Event|0|||
160636230|NCT00563524|580051496|FG004|Overall Study|Adverse Event|2|||
160636231|NCT00563524|580051497|FG005|Overall Study|Adverse Event|0|||
160636232|NCT00563524|580051492|FG000|Overall Study|Lost to Follow-up|1|||
160636233|NCT00563524|580051493|FG001|Overall Study|Lost to Follow-up|0|||
160636234|NCT00563524|580051494|FG002|Overall Study|Lost to Follow-up|0|||
160636235|NCT00563524|580051495|FG003|Overall Study|Lost to Follow-up|0|||
160636236|NCT00563524|580051496|FG004|Overall Study|Lost to Follow-up|0|||
160636237|NCT00563524|580051497|FG005|Overall Study|Lost to Follow-up|0|||
160636238|NCT00563524|580051492|FG000|Overall Study|Protocol Violation|0|||
160636239|NCT00563524|580051493|FG001|Overall Study|Protocol Violation|1|||
160636240|NCT00563524|580051494|FG002|Overall Study|Protocol Violation|0|||
160636241|NCT00563524|580051495|FG003|Overall Study|Protocol Violation|0|||
160636242|NCT00563524|580051496|FG004|Overall Study|Protocol Violation|0|||
160636243|NCT00563524|580051497|FG005|Overall Study|Protocol Violation|0|||
160636244|NCT00563524|580051492|FG000|Overall Study|Withdrawal by Subject|1|||
160636245|NCT00563524|580051493|FG001|Overall Study|Withdrawal by Subject|1|||
160636246|NCT00563524|580051494|FG002|Overall Study|Withdrawal by Subject|3|||
160636247|NCT00563524|580051495|FG003|Overall Study|Withdrawal by Subject|0|||
160636248|NCT00563524|580051496|FG004|Overall Study|Withdrawal by Subject|0|||
160636249|NCT00563524|580051497|FG005|Overall Study|Withdrawal by Subject|1|||
160636250|NCT01272193|580051499|FG000|Overall Study|Adverse Event|1|||
160636251|NCT01272193|580051500|FG001|Overall Study|Adverse Event|1|||
160636252|NCT01272193|580051499|FG000|Overall Study|Lack of Efficacy|0|||
160636253|NCT01272193|580051500|FG001|Overall Study|Lack of Efficacy|3|||
160636254|NCT01272193|580051499|FG000|Overall Study|Withdrawal Criteria|1|||
160636255|NCT01272193|580051500|FG001|Overall Study|Withdrawal Criteria|1|||
160636256|NCT01272193|580051499|FG000|Overall Study|Unclassified|8|||
160636257|NCT01272193|580051500|FG001|Overall Study|Unclassified|7|||
160636258|NCT02626182|580051501|FG000|Overall Study|Adverse Event|2|||
160636259|NCT02626182|580051502|FG001|Overall Study|Adverse Event|0|||
160636260|NCT03578276|580051503|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
160636261|NCT03578276|580051504|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
160636262|NCT01084603|580051512|FG000|Baseline|Withdrawal by Subject|2|||
160636263|NCT01084603|580051512|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
160636264|NCT01084603|580051512|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
160636265|NCT01084603|580051512|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
160636266|NCT01084603|580051512|FG000|Washout Period 4|Adverse Event|1|||
160636267|NCT01508325|580051516|FG000|Overall Study|Withdrawal by Subject|8|||
160636268|NCT01508325|580051517|FG001|Overall Study|Withdrawal by Subject|9|||
160636269|NCT01508325|580051516|FG000|Overall Study|Protocol Violation|0|||
160636270|NCT01508325|580051517|FG001|Overall Study|Protocol Violation|3|||
160756768|NCT02326272|580495964|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756769|NCT02326272|580495965|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756770|NCT02326272|580495966|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756771|NCT02326272|580495967|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756772|NCT02326272|580495968|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160756773|NCT02326272|580495954|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756774|NCT02326272|580495955|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756775|NCT02326272|580495956|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
160756776|NCT02326272|580495957|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756777|NCT02326272|580495958|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756778|NCT02326272|580495959|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756779|NCT02326272|580495960|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756780|NCT02326272|580495961|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756781|NCT02326272|580495962|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756782|NCT02326272|580495963|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756783|NCT02326272|580495964|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756784|NCT02326272|580495965|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756785|NCT02326272|580495966|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756786|NCT02326272|580495967|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756787|NCT02326272|580495968|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
160756788|NCT02326272|580495954|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160756789|NCT02326272|580495955|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160756790|NCT02326272|580495956|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160756791|NCT02326272|580495957|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160756792|NCT02326272|580495958|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
160756793|NCT02326272|580495959|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
160756794|NCT02326272|580495960|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
160756795|NCT02326272|580495961|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
160756796|NCT02326272|580495962|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
160756797|NCT02326272|580495963|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160756798|NCT02326272|580495964|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160756799|NCT02326272|580495965|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160756800|NCT02326272|580495966|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160756801|NCT02326272|580495967|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160756802|NCT02326272|580495968|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160756803|NCT02326272|580495954|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756804|NCT02326272|580495955|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756805|NCT02326272|580495956|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756806|NCT02326272|580495957|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756807|NCT02326272|580495958|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756808|NCT02326272|580495959|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
160756809|NCT02326272|580495960|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
160756810|NCT02326272|580495961|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756811|NCT02326272|580495962|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
160756812|NCT02326272|580495963|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
160756813|NCT02326272|580495964|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756814|NCT02326272|580495965|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756815|NCT02326272|580495966|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756816|NCT02326272|580495967|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756817|NCT02326272|580495968|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160756818|NCT02326272|580495954|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756819|NCT02326272|580495955|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756820|NCT02326272|580495956|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756821|NCT02326272|580495957|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756822|NCT02326272|580495958|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756823|NCT02326272|580495959|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
160756824|NCT02326272|580495960|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756825|NCT02326272|580495961|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
160756826|NCT02326272|580495962|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756827|NCT02326272|580495963|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756828|NCT02326272|580495964|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756829|NCT02326272|580495965|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756830|NCT02326272|580495966|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756831|NCT02326272|580495967|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756832|NCT02326272|580495968|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160756833|NCT02326272|580495954|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160756834|NCT02326272|580495955|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160756835|NCT02326272|580495956|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160756836|NCT02326272|580495957|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160756837|NCT02326272|580495958|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160756838|NCT02326272|580495959|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
160756839|NCT02326272|580495960|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160756840|NCT02326272|580495961|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160756841|NCT02326272|580495962|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160756842|NCT02326272|580495963|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160756843|NCT02326272|580495964|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160756844|NCT02326272|580495965|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160756845|NCT02326272|580495966|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160756846|NCT02326272|580495967|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160756847|NCT02326272|580495968|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160756848|NCT02326272|580495954|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756849|NCT02326272|580495955|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756850|NCT02326272|580495956|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756851|NCT02326272|580495957|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756852|NCT02326272|580495958|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756853|NCT02326272|580495959|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756854|NCT02326272|580495960|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756855|NCT02326272|580495961|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
160756856|NCT02326272|580495962|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756857|NCT02326272|580495963|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756858|NCT02326272|580495964|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756859|NCT02326272|580495965|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756860|NCT02326272|580495966|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756861|NCT02326272|580495967|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756862|NCT02326272|580495968|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160756863|NCT02326272|580495954|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756864|NCT02326272|580495955|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756865|NCT02326272|580495956|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756866|NCT02326272|580495957|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756867|NCT02326272|580495958|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756868|NCT02326272|580495959|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756869|NCT02326272|580495960|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
160756870|NCT02326272|580495961|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756871|NCT02326272|580495962|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756872|NCT02326272|580495963|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756873|NCT02326272|580495964|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756874|NCT02326272|580495965|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756875|NCT02326272|580495966|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756876|NCT02326272|580495967|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756877|NCT02326272|580495968|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160756878|NCT02326272|580495954|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756879|NCT02326272|580495955|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756880|NCT02326272|580495956|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756881|NCT02326272|580495957|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756882|NCT02326272|580495958|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756883|NCT02326272|580495959|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756884|NCT02326272|580495960|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756885|NCT02326272|580495961|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756886|NCT02326272|580495962|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
160756887|NCT02326272|580495963|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756888|NCT02326272|580495964|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756889|NCT02326272|580495965|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756890|NCT02326272|580495966|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756891|NCT02326272|580495967|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756892|NCT02326272|580495968|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
160756893|NCT02326272|580495954|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756894|NCT02326272|580495955|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756895|NCT02326272|580495956|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756896|NCT02326272|580495957|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756897|NCT02326272|580495958|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756898|NCT02326272|580495959|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
160756899|NCT02326272|580495960|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
160756900|NCT02326272|580495961|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
160756901|NCT02326272|580495962|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
160756902|NCT02326272|580495963|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756903|NCT02326272|580495964|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756904|NCT02326272|580495965|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756905|NCT02326272|580495966|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756906|NCT02326272|580495967|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756907|NCT02326272|580495968|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160756908|NCT02326272|580495954|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756909|NCT02326272|580495955|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756910|NCT02326272|580495956|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756911|NCT02326272|580495957|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756912|NCT02326272|580495958|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756913|NCT02326272|580495959|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
160756914|NCT02326272|580495960|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756915|NCT02326272|580495961|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756916|NCT02326272|580495962|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756917|NCT02326272|580495963|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756918|NCT02326272|580495964|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756919|NCT02326272|580495965|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756920|NCT02326272|580495966|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756921|NCT02326272|580495967|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756922|NCT02326272|580495968|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160756923|NCT02326272|580495954|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756924|NCT02326272|580495955|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756925|NCT02326272|580495956|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756926|NCT02326272|580495957|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756927|NCT02326272|580495958|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756928|NCT02326272|580495959|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756929|NCT02326272|580495960|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
160756930|NCT02326272|580495961|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756931|NCT02326272|580495962|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756932|NCT02326272|580495963|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756933|NCT02326272|580495964|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756934|NCT02326272|580495965|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756935|NCT02326272|580495966|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756936|NCT02326272|580495967|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756937|NCT02326272|580495968|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
160756938|NCT02326272|580495954|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
160756939|NCT02326272|580495955|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
160756940|NCT02326272|580495956|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
160756941|NCT02326272|580495957|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
160756942|NCT02326272|580495958|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
160756943|NCT02326272|580495959|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
160756944|NCT02326272|580495960|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
160756945|NCT02326272|580495961|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
160756946|NCT02326272|580495962|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
160756947|NCT02326272|580495963|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
160756948|NCT02326272|580495964|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
160756949|NCT02326272|580495965|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
160756950|NCT02326272|580495966|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
160756951|NCT02326272|580495967|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
160756952|NCT02326272|580495968|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
160756953|NCT02326272|580495954|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756954|NCT02326272|580495955|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756955|NCT02326272|580495956|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756956|NCT02326272|580495957|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756957|NCT02326272|580495958|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756958|NCT02326272|580495959|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756959|NCT02326272|580495960|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756960|NCT02326272|580495961|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756961|NCT02326272|580495962|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756962|NCT02326272|580495963|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756963|NCT02326272|580495964|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
160756964|NCT02326272|580495965|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
160756965|NCT02326272|580495966|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
160756966|NCT02326272|580495967|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160756967|NCT02326272|580495968|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
160756968|NCT02326272|580495954|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756969|NCT02326272|580495955|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756970|NCT02326272|580495956|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756971|NCT02326272|580495957|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756972|NCT02326272|580495958|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756973|NCT02326272|580495959|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756974|NCT02326272|580495960|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756975|NCT02326272|580495961|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756976|NCT02326272|580495962|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756977|NCT02326272|580495963|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756978|NCT02326272|580495964|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
160756979|NCT02326272|580495965|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756980|NCT02326272|580495966|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
160756981|NCT02326272|580495967|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756982|NCT02326272|580495968|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160756983|NCT02326272|580495954|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756984|NCT02326272|580495955|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756985|NCT02326272|580495956|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756986|NCT02326272|580495957|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756987|NCT02326272|580495958|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756988|NCT02326272|580495959|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756989|NCT02326272|580495960|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756990|NCT02326272|580495961|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756991|NCT02326272|580495962|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756992|NCT02326272|580495963|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756993|NCT02326272|580495964|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756994|NCT02326272|580495965|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
160756995|NCT02326272|580495966|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756996|NCT02326272|580495967|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756997|NCT02326272|580495968|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160756998|NCT02326272|580495954|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160756999|NCT02326272|580495955|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757000|NCT02326272|580495956|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757001|NCT02326272|580495957|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757002|NCT02326272|580495958|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757003|NCT02326272|580495959|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757004|NCT02326272|580495960|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757005|NCT02326272|580495961|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757006|NCT02326272|580495962|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757007|NCT02326272|580495963|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757008|NCT02326272|580495964|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
160757009|NCT02326272|580495965|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757010|NCT02326272|580495966|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
160757011|NCT02326272|580495967|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160757012|NCT02326272|580495968|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
160757013|NCT02326272|580495954|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757014|NCT02326272|580495955|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757015|NCT02326272|580495956|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757016|NCT02326272|580495957|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757017|NCT02326272|580495958|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757018|NCT02326272|580495959|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757019|NCT02326272|580495960|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757020|NCT02326272|580495961|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757021|NCT02326272|580495962|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757022|NCT02326272|580495963|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757023|NCT02326272|580495964|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757024|NCT02326272|580495965|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
160757025|NCT02326272|580495966|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757026|NCT02326272|580495967|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160757027|NCT02326272|580495968|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
160757028|NCT02326272|580495954|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757029|NCT02326272|580495955|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757030|NCT02326272|580495956|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757031|NCT02326272|580495957|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757032|NCT02326272|580495958|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757033|NCT02326272|580495959|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757034|NCT02326272|580495960|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757035|NCT02326272|580495961|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757036|NCT02326272|580495962|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757037|NCT02326272|580495963|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757038|NCT02326272|580495964|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757039|NCT02326272|580495965|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
160757040|NCT02326272|580495966|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
160757041|NCT02326272|580495967|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160757042|NCT02326272|580495968|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
160757043|NCT02326272|580495954|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757044|NCT02326272|580495955|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757045|NCT02326272|580495956|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757046|NCT02326272|580495957|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757047|NCT02326272|580495958|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757048|NCT02326272|580495959|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757049|NCT02326272|580495960|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757050|NCT02326272|580495961|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757051|NCT02326272|580495962|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757052|NCT02326272|580495963|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757053|NCT02326272|580495964|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757054|NCT02326272|580495965|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
160757055|NCT02326272|580495966|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757056|NCT02326272|580495967|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757057|NCT02326272|580495968|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
160757058|NCT02326272|580495954|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757059|NCT02326272|580495955|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757060|NCT02326272|580495956|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757061|NCT02326272|580495957|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757062|NCT02326272|580495958|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757063|NCT02326272|580495959|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757064|NCT02326272|580495960|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757065|NCT02326272|580495961|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757066|NCT02326272|580495962|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757067|NCT02326272|580495963|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757068|NCT02326272|580495964|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757069|NCT02326272|580495965|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757070|NCT02326272|580495966|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
160757071|NCT02326272|580495967|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757072|NCT02326272|580495968|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160757073|NCT01265394|580495985|FG000|Overall Study|Subjects withdrawn|37|||
160757074|NCT00928434|580495990|FG000|Overall Study|Adverse Event|14|||
160757075|NCT00928434|580495991|FG001|Overall Study|Adverse Event|5|||
160757076|NCT00928434|580495992|FG002|Overall Study|Adverse Event|18|||
160757077|NCT00928434|580495990|FG000|Overall Study|Protocol Violation|5|||
160757078|NCT00928434|580495991|FG001|Overall Study|Protocol Violation|0|||
160757079|NCT00928434|580495992|FG002|Overall Study|Protocol Violation|8|||
160757080|NCT00928434|580495990|FG000|Overall Study|Physician Decision|2|||
160757081|NCT00928434|580495991|FG001|Overall Study|Physician Decision|0|||
160757082|NCT00928434|580495992|FG002|Overall Study|Physician Decision|3|||
160757083|NCT00928434|580495990|FG000|Overall Study|Lost to Follow-up|1|||
160757084|NCT00928434|580495991|FG001|Overall Study|Lost to Follow-up|0|||
160757085|NCT00928434|580495992|FG002|Overall Study|Lost to Follow-up|3|||
160757086|NCT00928434|580495990|FG000|Overall Study|Withdrawal by Subject|5|||
160757087|NCT00928434|580495991|FG001|Overall Study|Withdrawal by Subject|3|||
160757088|NCT00928434|580495992|FG002|Overall Study|Withdrawal by Subject|2|||
160757089|NCT00928434|580495990|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
160757090|NCT00928434|580495991|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
160757091|NCT00928434|580495992|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
160757092|NCT00928434|580495990|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
160757093|NCT00928434|580495991|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
160757094|NCT00928434|580495992|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
160757095|NCT00928434|580495990|FG000|Overall Study|Other (not meeting above criteria)|5|||
160757096|NCT00928434|580495991|FG001|Overall Study|Other (not meeting above criteria)|1|||
160757097|NCT00928434|580495992|FG002|Overall Study|Other (not meeting above criteria)|2|||
160757098|NCT00716456|580495993|FG000|Overall Study|Adverse Event|0|||
160757099|NCT00716456|580495994|FG001|Overall Study|Adverse Event|2|||
160757100|NCT00716456|580495995|FG002|Overall Study|Adverse Event|0|||
160757101|NCT05417412|580495997|FG000|Overall Study|Lost to Follow-up|2|||
160757102|NCT01576575|580495998|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
160757103|NCT01576575|580495998|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
160757104|NCT01576575|580495998|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
160757105|NCT01723072|580496003|FG000|Overall Study|Withdrawal by Subject|7|||
160757106|NCT01723072|580496004|FG001|Overall Study|Withdrawal by Subject|13|||
160757107|NCT01723072|580496003|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
160757108|NCT01723072|580496004|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
160757109|NCT01723072|580496003|FG000|Overall Study|Other|4|||
160757110|NCT01723072|580496004|FG001|Overall Study|Other|3|||
160757111|NCT01841970|580496005|FG000|Overall Study|Withdrawal by Subject|1|||
160757112|NCT01841970|580496005|FG000|Overall Study|Physician Decision|2|||
160757113|NCT01841970|580496005|FG000|Overall Study|Lost to Follow-up|8|||
160757114|NCT01443858|580496019|FG000|Overall Study|Withdrawal by Subject|9|||
160757115|NCT01443858|580496020|FG001|Overall Study|Withdrawal by Subject|8|||
160757116|NCT01443858|580496021|FG002|Overall Study|Withdrawal by Subject|5|||
160757117|NCT01443858|580496019|FG000|Overall Study|Lack of Efficacy|1|||
160757118|NCT01443858|580496020|FG001|Overall Study|Lack of Efficacy|0|||
160757119|NCT01443858|580496021|FG002|Overall Study|Lack of Efficacy|0|||
160757120|NCT01443858|580496019|FG000|Overall Study|Lost to Follow-up|5|||
160757121|NCT01443858|580496020|FG001|Overall Study|Lost to Follow-up|5|||
160757122|NCT01443858|580496021|FG002|Overall Study|Lost to Follow-up|2|||
160757123|NCT06060496|580496022|FG000|Overall Study|Withdrawal by Subject|2|||
160757124|NCT06060496|580496022|FG000|Overall Study|Lost to Follow-up|2|||
160757125|NCT00149396|580496026|FG000|Overall Study|Death|15|||
160757126|NCT00149396|580496026|FG000|Overall Study|Withdrawal by Subject|1|||
160757127|NCT00149396|580496026|FG000|Overall Study|Subject noncompliance|2|||
160757128|NCT00149396|580496026|FG000|Overall Study|other treatment|5|||
160757129|NCT00807885|580496027|FG000|Overall Study|Lost to Follow-up|0|||
160757130|NCT00807885|580496028|FG001|Overall Study|Lost to Follow-up|0|||
160757131|NCT00807885|580496029|FG002|Overall Study|Lost to Follow-up|0|||
160757132|NCT00807885|580496030|FG003|Overall Study|Lost to Follow-up|0|||
160757133|NCT00807885|580496031|FG004|Overall Study|Lost to Follow-up|0|||
160757134|NCT00807885|580496032|FG005|Overall Study|Lost to Follow-up|1|||
160757135|NCT00807885|580496033|FG006|Overall Study|Lost to Follow-up|0|||
160757136|NCT00807885|580496034|FG007|Overall Study|Lost to Follow-up|0|||
160757137|NCT00807885|580496035|FG008|Overall Study|Lost to Follow-up|0|||
160757138|NCT01670045|580496039|FG000|Overall Study|Withdrawal by Subject|3|||
160757139|NCT01670045|580496039|FG000|Overall Study|Adverse Event|1|||
160757140|NCT01670045|580496039|FG000|Overall Study|Death|1|||
160757141|NCT01670045|580496039|FG000|Overall Study|Lost to Follow-up|11|||
160757142|NCT00753675|580496040|FG000|Overall Study|other reason|11|||
160757143|NCT00753675|580496041|FG001|Overall Study|other reason|12|||
160757144|NCT00753675|580496042|FG002|Overall Study|other reason|13|||
160757145|NCT00753675|580496040|FG000|Overall Study|Death|1|||
160757146|NCT00753675|580496041|FG001|Overall Study|Death|2|||
160757147|NCT00753675|580496042|FG002|Overall Study|Death|4|||
160757148|NCT00753675|580496040|FG000|Overall Study|Adverse Event|11|||
160757149|NCT00753675|580496041|FG001|Overall Study|Adverse Event|9|||
160757150|NCT00753675|580496042|FG002|Overall Study|Adverse Event|4|||
160757151|NCT00753675|580496040|FG000|Overall Study|Objective progression of disease|35|||
160757152|NCT00753675|580496041|FG001|Overall Study|Objective progression of disease|35|||
160757153|NCT00753675|580496042|FG002|Overall Study|Objective progression of disease|35|||
160757154|NCT00753675|580496040|FG000|Overall Study|Withdrawal by Subject|0|||
160757155|NCT00753675|580496041|FG001|Overall Study|Withdrawal by Subject|1|||
160757156|NCT00753675|580496042|FG002|Overall Study|Withdrawal by Subject|0|||
160757157|NCT00753675|580496040|FG000|Overall Study|Lost to Follow-up|1|||
160757158|NCT00753675|580496041|FG001|Overall Study|Lost to Follow-up|0|||
160757159|NCT00753675|580496042|FG002|Overall Study|Lost to Follow-up|0|||
160757160|NCT00069823|580496048|FG000|Overall Study|Did not have follow-up diary cards|6|||
160757161|NCT00069823|580496049|FG001|Overall Study|Did not have follow-up diary cards|3|||
160757162|NCT01801111|580496050|FG000|Overall Study|Adverse Event|12|||
160757163|NCT01801111|580496050|FG000|Overall Study|Death|8|||
160757164|NCT01801111|580496050|FG000|Overall Study|Physician Decision|5|||
160757165|NCT01801111|580496050|FG000|Overall Study|Other|1|||
160757166|NCT01801111|580496050|FG000|Overall Study|Withdrawal by Subject|4|||
160757167|NCT01801111|580496050|FG000|Overall Study|Study Terminated by Sponsor|27|||
160757168|NCT01801111|580496050|FG000|Overall Study|Progressive Disease|81|||
160757169|NCT01223937|580496051|FG000|Overall Study|Withdrawal by Subject|3|||
160757170|NCT01223937|580496052|FG001|Overall Study|Withdrawal by Subject|2|||
160757171|NCT01223937|580496051|FG000|Overall Study|Lost to Follow-up|1|||
160757172|NCT01223937|580496052|FG001|Overall Study|Lost to Follow-up|4|||
160757173|NCT01223937|580496051|FG000|Overall Study|Adverse Event|1|||
160757174|NCT01223937|580496052|FG001|Overall Study|Adverse Event|4|||
160757175|NCT01223937|580496051|FG000|Overall Study|Protocol Violation|8|||
160757176|NCT01223937|580496052|FG001|Overall Study|Protocol Violation|7|||
160757177|NCT01223937|580496051|FG000|Overall Study|Other|4|||
160757178|NCT01223937|580496052|FG001|Overall Study|Other|1|||
160757179|NCT05176717|580496053|FG000|Overall Study|Sponsor Decision|1|||
160757180|NCT05176717|580496054|FG001|Overall Study|Sponsor Decision|2|||
160757181|NCT05176717|580496055|FG002|Overall Study|Sponsor Decision|2|||
160757182|NCT00765817|580496057|FG000|Overall Study|Adverse Event|13|||
160757183|NCT00765817|580496058|FG001|Overall Study|Adverse Event|1|||
160757184|NCT00765817|580496057|FG000|Overall Study|Death|0|||
160757185|NCT00765817|580496058|FG001|Overall Study|Death|1|||
160757186|NCT00765817|580496057|FG000|Overall Study|Entry criteria not met|2|||
160757187|NCT00765817|580496058|FG001|Overall Study|Entry criteria not met|2|||
160757188|NCT00765817|580496057|FG000|Overall Study|Loss of glucose control|0|||
160757189|NCT00765817|580496058|FG001|Overall Study|Loss of glucose control|2|||
160757190|NCT00765817|580496057|FG000|Overall Study|Lost to Follow-up|1|||
160757191|NCT00765817|580496058|FG001|Overall Study|Lost to Follow-up|3|||
160757192|NCT00765817|580496057|FG000|Overall Study|Physician Decision|2|||
160757193|NCT00765817|580496058|FG001|Overall Study|Physician Decision|1|||
160757194|NCT00765817|580496057|FG000|Overall Study|Protocol Violation|1|||
160757195|NCT00765817|580496058|FG001|Overall Study|Protocol Violation|1|||
160757196|NCT00765817|580496057|FG000|Overall Study|Subject decision|7|||
160757197|NCT00765817|580496058|FG001|Overall Study|Subject decision|11|||
160757198|NCT02058589|580496059|FG000|Overall Study|Serious Adverse Event|1|||
160757199|NCT02058589|580496060|FG001|Overall Study|Serious Adverse Event|1|||
160757200|NCT02058589|580496059|FG000|Overall Study|Non-Serious Adverse Event|1|||
160757201|NCT02058589|580496060|FG001|Overall Study|Non-Serious Adverse Event|0|||
160757202|NCT02058589|580496059|FG000|Overall Study|Withdrawal by Subject|0|||
160757203|NCT02058589|580496060|FG001|Overall Study|Withdrawal by Subject|1|||
160757204|NCT02308228|580496061|FG000|Overall Study|Adverse Event|3|||
160757205|NCT02308228|580496062|FG001|Overall Study|Adverse Event|4|||
160757206|NCT02308228|580496061|FG000|Overall Study|Withdrawal by Subject|5|||
160757207|NCT02308228|580496062|FG001|Overall Study|Withdrawal by Subject|3|||
160757208|NCT06597084|580496063|FG000|Overall Study|Withdrawal by Subject|4|||
160757209|NCT06597084|580496064|FG001|Overall Study|Withdrawal by Subject|9|||
160757210|NCT06597084|580496063|FG000|Overall Study|Consent was not given by the patient until V2|0|||
160757211|NCT06597084|580496064|FG001|Overall Study|Consent was not given by the patient until V2|3|||
160757212|NCT06597084|580496063|FG000|Overall Study|Physician Decision|1|||
160757213|NCT06597084|580496064|FG001|Overall Study|Physician Decision|0|||
160757214|NCT06597084|580496063|FG000|Overall Study|Adverse Event|3|||
160757215|NCT06597084|580496064|FG001|Overall Study|Adverse Event|2|||
160757216|NCT06597084|580496063|FG000|Overall Study|Death|4|||
160757217|NCT06597084|580496064|FG001|Overall Study|Death|0|||
160757218|NCT06597084|580496063|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
160757219|NCT06597084|580496064|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
160757220|NCT06597084|580496063|FG000|Overall Study|Lost to Follow-up|4|||
160757221|NCT06597084|580496064|FG001|Overall Study|Lost to Follow-up|2|||
160757222|NCT06597084|580496063|FG000|Overall Study|Other. Not specified|1|||
160757223|NCT06597084|580496064|FG001|Overall Study|Other. Not specified|0|||
160757224|NCT00490971|580496067|FG000|Acute/Continuation|Adverse Event|62|||
160757225|NCT00490971|580496068|FG001|Acute/Continuation|Adverse Event|13|||
160757226|NCT00490971|580496069|FG002|Acute/Continuation|Adverse Event|0|||
160757227|NCT00490971|580496070|FG003|Acute/Continuation|Adverse Event|0|||
160757228|NCT00490971|580496071|FG004|Acute/Continuation|Adverse Event|0|||
160757229|NCT00490971|580496067|FG000|Acute/Continuation|Death|2|||
160757230|NCT00490971|580496068|FG001|Acute/Continuation|Death|0|||
160757231|NCT00490971|580496069|FG002|Acute/Continuation|Death|0|||
160757232|NCT00490971|580496070|FG003|Acute/Continuation|Death|0|||
160757233|NCT00490971|580496071|FG004|Acute/Continuation|Death|0|||
160757234|NCT00490971|580496067|FG000|Acute/Continuation|Lack of Efficacy|106|||
160757235|NCT00490971|580496068|FG001|Acute/Continuation|Lack of Efficacy|12|||
160757236|NCT00490971|580496069|FG002|Acute/Continuation|Lack of Efficacy|0|||
160757237|NCT00490971|580496070|FG003|Acute/Continuation|Lack of Efficacy|0|||
160757238|NCT00490971|580496071|FG004|Acute/Continuation|Lack of Efficacy|0|||
160757239|NCT00490971|580496067|FG000|Acute/Continuation|Lost to Follow-up|23|||
160757240|NCT00490971|580496068|FG001|Acute/Continuation|Lost to Follow-up|7|||
160757241|NCT00490971|580496069|FG002|Acute/Continuation|Lost to Follow-up|0|||
160757242|NCT00490971|580496070|FG003|Acute/Continuation|Lost to Follow-up|0|||
160757243|NCT00490971|580496071|FG004|Acute/Continuation|Lost to Follow-up|0|||
160757244|NCT00490971|580496067|FG000|Acute/Continuation|Protocol Violation|10|||
160757245|NCT00490971|580496068|FG001|Acute/Continuation|Protocol Violation|2|||
160757246|NCT00490971|580496069|FG002|Acute/Continuation|Protocol Violation|0|||
160757247|NCT00490971|580496070|FG003|Acute/Continuation|Protocol Violation|0|||
160757248|NCT00490971|580496071|FG004|Acute/Continuation|Protocol Violation|0|||
160757249|NCT00490971|580496067|FG000|Acute/Continuation|Withdrawal by Subject|92|||
160757250|NCT00490971|580496068|FG001|Acute/Continuation|Withdrawal by Subject|24|||
160757251|NCT00490971|580496069|FG002|Acute/Continuation|Withdrawal by Subject|0|||
160757252|NCT00490971|580496070|FG003|Acute/Continuation|Withdrawal by Subject|0|||
160757253|NCT00490971|580496071|FG004|Acute/Continuation|Withdrawal by Subject|0|||
160757254|NCT00490971|580496067|FG000|Acute/Continuation|Other|11|||
160757255|NCT00490971|580496068|FG001|Acute/Continuation|Other|4|||
160757256|NCT00490971|580496069|FG002|Acute/Continuation|Other|0|||
160757257|NCT00490971|580496070|FG003|Acute/Continuation|Other|0|||
160757258|NCT00490971|580496071|FG004|Acute/Continuation|Other|0|||
160757259|NCT00490971|580496067|FG000|Maintenance|Adverse Event|0|||
160757260|NCT00490971|580496068|FG001|Maintenance|Adverse Event|0|||
160757261|NCT00490971|580496069|FG002|Maintenance|Adverse Event|4|||
160757262|NCT00490971|580496070|FG003|Maintenance|Adverse Event|5|||
160757263|NCT00490971|580496071|FG004|Maintenance|Adverse Event|7|||
160757264|NCT00490971|580496067|FG000|Maintenance|Death|0|||
160757265|NCT00490971|580496068|FG001|Maintenance|Death|0|||
160757266|NCT00490971|580496069|FG002|Maintenance|Death|0|||
160757267|NCT00490971|580496070|FG003|Maintenance|Death|2|||
160757268|NCT00490971|580496071|FG004|Maintenance|Death|0|||
160757269|NCT00490971|580496067|FG000|Maintenance|Lost to Follow-up|0|||
160757270|NCT00490971|580496068|FG001|Maintenance|Lost to Follow-up|0|||
160757271|NCT00490971|580496069|FG002|Maintenance|Lost to Follow-up|5|||
160757272|NCT00490971|580496070|FG003|Maintenance|Lost to Follow-up|8|||
160757273|NCT00490971|580496071|FG004|Maintenance|Lost to Follow-up|10|||
160757274|NCT00490971|580496067|FG000|Maintenance|Pregnancy|0|||
160757275|NCT00490971|580496068|FG001|Maintenance|Pregnancy|0|||
160757276|NCT00490971|580496069|FG002|Maintenance|Pregnancy|1|||
160757277|NCT00490971|580496070|FG003|Maintenance|Pregnancy|0|||
160757278|NCT00490971|580496071|FG004|Maintenance|Pregnancy|0|||
160757279|NCT00490971|580496067|FG000|Maintenance|Protocol Violation|0|||
160757280|NCT00490971|580496068|FG001|Maintenance|Protocol Violation|0|||
160757281|NCT00490971|580496069|FG002|Maintenance|Protocol Violation|4|||
160757282|NCT00490971|580496070|FG003|Maintenance|Protocol Violation|1|||
160757283|NCT00490971|580496071|FG004|Maintenance|Protocol Violation|1|||
160757284|NCT00490971|580496067|FG000|Maintenance|Withdrawal by Subject|0|||
160757285|NCT00490971|580496068|FG001|Maintenance|Withdrawal by Subject|0|||
160757286|NCT00490971|580496069|FG002|Maintenance|Withdrawal by Subject|26|||
160757287|NCT00490971|580496070|FG003|Maintenance|Withdrawal by Subject|28|||
160757288|NCT00490971|580496071|FG004|Maintenance|Withdrawal by Subject|18|||
160757289|NCT00490971|580496067|FG000|Maintenance|Other|0|||
160757290|NCT00490971|580496068|FG001|Maintenance|Other|0|||
160757291|NCT00490971|580496069|FG002|Maintenance|Other|11|||
160757292|NCT00490971|580496070|FG003|Maintenance|Other|9|||
160757293|NCT00490971|580496071|FG004|Maintenance|Other|3|||
160757294|NCT03999749|580496077|FG000|Overall Study|Toxicity|16|||
160757295|NCT03999749|580496077|FG000|Overall Study|Withdrawal by Subject|3|||
160757296|NCT03999749|580496077|FG000|Overall Study|Disease progression|26|||
160757297|NCT03999749|580496077|FG000|Overall Study|Physician Decision|4|||
160757298|NCT03999749|580496077|FG000|Overall Study|Death|5|||
160757299|NCT03999749|580496077|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
160757300|NCT00255164|580496078|FG000|Overall Study|Adverse Event|10|||
160757301|NCT00255164|580496079|FG001|Overall Study|Adverse Event|6|||
160757302|NCT00255164|580496080|FG002|Overall Study|Adverse Event|9|||
160757303|NCT00255164|580496078|FG000|Overall Study|Lost to Follow-up|4|||
160757304|NCT00255164|580496079|FG001|Overall Study|Lost to Follow-up|3|||
160757305|NCT00255164|580496080|FG002|Overall Study|Lost to Follow-up|4|||
160757306|NCT00255164|580496078|FG000|Overall Study|Withdrawal by Subject|18|||
160757307|NCT00255164|580496079|FG001|Overall Study|Withdrawal by Subject|17|||
160757308|NCT00255164|580496080|FG002|Overall Study|Withdrawal by Subject|8|||
160757309|NCT00255164|580496078|FG000|Overall Study|Noncompliance|0|||
160757310|NCT00255164|580496079|FG001|Overall Study|Noncompliance|1|||
160757311|NCT00255164|580496080|FG002|Overall Study|Noncompliance|2|||
160757312|NCT00255164|580496078|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
160757313|NCT00255164|580496079|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
160757314|NCT00255164|580496080|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
160757315|NCT00255164|580496078|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
160757316|NCT00255164|580496079|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
160757317|NCT00255164|580496080|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
160757318|NCT00255164|580496078|FG000|Overall Study|Possible Barrett's Esophagus|1|||
160757319|NCT00255164|580496079|FG001|Overall Study|Possible Barrett's Esophagus|3|||
160757320|NCT00255164|580496080|FG002|Overall Study|Possible Barrett's Esophagus|8|||
160757321|NCT00255164|580496078|FG000|Overall Study|Esophageal Stricture|0|||
160757322|NCT00255164|580496079|FG001|Overall Study|Esophageal Stricture|0|||
160757323|NCT00255164|580496080|FG002|Overall Study|Esophageal Stricture|1|||
160757324|NCT00255164|580496078|FG000|Overall Study|Therapeutic Failure|11|||
160757325|NCT00255164|580496079|FG001|Overall Study|Therapeutic Failure|2|||
160757326|NCT00255164|580496080|FG002|Overall Study|Therapeutic Failure|3|||
160757327|NCT03877224|580496081|FG000|Overall Study|Death|3|||
160757328|NCT03877224|580496082|FG001|Overall Study|Death|2|||
160757329|NCT03877224|580496081|FG000|Overall Study|Withdrawal by Subject|1|||
160757330|NCT03877224|580496082|FG001|Overall Study|Withdrawal by Subject|6|||
160757331|NCT03877224|580496081|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
160757332|NCT03877224|580496082|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
160757333|NCT04754542|580496085|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
160757334|NCT04754542|580496086|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
160757335|NCT01212094|580497757|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
160757336|NCT01212094|580497758|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
160757337|NCT01212094|580497759|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
160757338|NCT01212094|580497757|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
160757339|NCT01212094|580497758|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
160757340|NCT01212094|580497759|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
160757341|NCT01212094|580497757|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
160757342|NCT01212094|580497758|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
160757343|NCT01212094|580497759|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
160757344|NCT01212094|580497757|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
160757345|NCT01212094|580497758|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
160757346|NCT01212094|580497759|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
160757347|NCT01212094|580497757|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
160757348|NCT01212094|580497758|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
160757349|NCT01212094|580497759|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
160757350|NCT01212094|580497757|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
160757351|NCT01212094|580497758|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
160757352|NCT01212094|580497759|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
160757353|NCT05664581|580497762|FG000|Overall Study|Withdrawal by Subject|2|||
160757354|NCT01317641|580497766|FG000|Overall Study|Not treated|0|||
160757355|NCT01317641|580497767|FG001|Overall Study|Not treated|0|||
160757356|NCT01317641|580497768|FG002|Overall Study|Not treated|0|||
160757357|NCT01317641|580497769|FG003|Overall Study|Not treated|0|||
160757358|NCT01317641|580497770|FG004|Overall Study|Not treated|0|||
160757359|NCT01317641|580497771|FG005|Overall Study|Not treated|0|||
160757360|NCT01317641|580497772|FG006|Overall Study|Not treated|0|||
160757361|NCT01317641|580497773|FG007|Overall Study|Not treated|1|||
160757362|NCT01317641|580497774|FG008|Overall Study|Not treated|1|||
160757363|NCT01317641|580497766|FG000|Overall Study|Adverse Event|0|||
160757364|NCT01317641|580497767|FG001|Overall Study|Adverse Event|1|||
160757365|NCT01317641|580497768|FG002|Overall Study|Adverse Event|0|||
160757366|NCT01317641|580497769|FG003|Overall Study|Adverse Event|1|||
160757367|NCT01317641|580497770|FG004|Overall Study|Adverse Event|0|||
160757368|NCT01317641|580497771|FG005|Overall Study|Adverse Event|0|||
160757369|NCT01317641|580497772|FG006|Overall Study|Adverse Event|2|||
160757370|NCT01317641|580497773|FG007|Overall Study|Adverse Event|1|||
160757371|NCT01317641|580497774|FG008|Overall Study|Adverse Event|0|||
160757372|NCT01317641|580497766|FG000|Overall Study|Protocol Violation|1|||
160757373|NCT01317641|580497767|FG001|Overall Study|Protocol Violation|0|||
160757374|NCT01317641|580497768|FG002|Overall Study|Protocol Violation|0|||
160757375|NCT01317641|580497769|FG003|Overall Study|Protocol Violation|0|||
160757376|NCT01317641|580497770|FG004|Overall Study|Protocol Violation|0|||
160757377|NCT01317641|580497771|FG005|Overall Study|Protocol Violation|0|||
160757378|NCT01317641|580497772|FG006|Overall Study|Protocol Violation|0|||
160757379|NCT01317641|580497773|FG007|Overall Study|Protocol Violation|0|||
160757380|NCT01317641|580497774|FG008|Overall Study|Protocol Violation|0|||
160757381|NCT01317641|580497766|FG000|Overall Study|Disease progression|0|||
160757382|NCT01317641|580497767|FG001|Overall Study|Disease progression|0|||
160757383|NCT01317641|580497768|FG002|Overall Study|Disease progression|0|||
160757384|NCT01317641|580497769|FG003|Overall Study|Disease progression|0|||
160757385|NCT01317641|580497770|FG004|Overall Study|Disease progression|0|||
160757386|NCT01317641|580497771|FG005|Overall Study|Disease progression|0|||
160757387|NCT01317641|580497772|FG006|Overall Study|Disease progression|0|||
160757388|NCT01317641|580497773|FG007|Overall Study|Disease progression|3|||
160757389|NCT01317641|580497774|FG008|Overall Study|Disease progression|4|||
160757390|NCT01317641|580497766|FG000|Overall Study|Withdrawal by Subject|0|||
160757391|NCT01317641|580497767|FG001|Overall Study|Withdrawal by Subject|0|||
160757392|NCT01317641|580497768|FG002|Overall Study|Withdrawal by Subject|0|||
160757393|NCT01317641|580497769|FG003|Overall Study|Withdrawal by Subject|0|||
160757394|NCT01317641|580497770|FG004|Overall Study|Withdrawal by Subject|0|||
160757395|NCT01317641|580497771|FG005|Overall Study|Withdrawal by Subject|0|||
160757396|NCT01317641|580497772|FG006|Overall Study|Withdrawal by Subject|1|||
160757397|NCT01317641|580497773|FG007|Overall Study|Withdrawal by Subject|0|||
160757398|NCT01317641|580497774|FG008|Overall Study|Withdrawal by Subject|0|||
160757399|NCT01302418|580497775|FG000|Overall Study|Protocol Violation|9|||
160757400|NCT01302418|580497775|FG000|Overall Study|Non-evaluable|9|||
160757401|NCT02787304|580497780|FG000|Overall Study|Adverse Event|9|||
160757402|NCT02787304|580497781|FG001|Overall Study|Adverse Event|3|||
160757403|NCT02787304|580497782|FG002|Overall Study|Adverse Event|8|||
160757404|NCT02787304|580497783|FG003|Overall Study|Adverse Event|1|||
160757405|NCT02787304|580497780|FG000|Overall Study|Withdrawal by Subject|1|||
160757406|NCT02787304|580497781|FG001|Overall Study|Withdrawal by Subject|4|||
160757407|NCT02787304|580497782|FG002|Overall Study|Withdrawal by Subject|0|||
160757408|NCT02787304|580497783|FG003|Overall Study|Withdrawal by Subject|0|||
160757409|NCT02787304|580497780|FG000|Overall Study|Lost to Follow-up|1|||
160757410|NCT02787304|580497781|FG001|Overall Study|Lost to Follow-up|0|||
160757411|NCT02787304|580497782|FG002|Overall Study|Lost to Follow-up|0|||
160757412|NCT02787304|580497783|FG003|Overall Study|Lost to Follow-up|1|||
160757413|NCT02787304|580497780|FG000|Overall Study|Noncompliance with study drug|0|||
160757414|NCT02787304|580497781|FG001|Overall Study|Noncompliance with study drug|0|||
160757415|NCT02787304|580497782|FG002|Overall Study|Noncompliance with study drug|1|||
160757416|NCT02787304|580497783|FG003|Overall Study|Noncompliance with study drug|0|||
160757417|NCT02787304|580497780|FG000|Overall Study|Physician Decision|0|||
160757418|NCT02787304|580497781|FG001|Overall Study|Physician Decision|0|||
160757419|NCT02787304|580497782|FG002|Overall Study|Physician Decision|1|||
160757420|NCT02787304|580497783|FG003|Overall Study|Physician Decision|0|||
160757421|NCT02787304|580497780|FG000|Overall Study|Study terminated by sponsor|25|||
160757422|NCT02787304|580497781|FG001|Overall Study|Study terminated by sponsor|31|||
160757423|NCT02787304|580497782|FG002|Overall Study|Study terminated by sponsor|31|||
160757424|NCT02787304|580497783|FG003|Overall Study|Study terminated by sponsor|32|||
160757425|NCT04771013|580497788|FG000|Overall Study|Withdrawal by Subject|2|||
160757426|NCT04771013|580497789|FG001|Overall Study|Withdrawal by Subject|0|||
160757427|NCT04771013|580497788|FG000|Overall Study|Death|0|||
160525028|NCT00381303|579651792|FG001|Overall Study|Subject taking too many different meds|0|||
160757428|NCT04771013|580497789|FG001|Overall Study|Death|5|||
160757429|NCT04771013|580497788|FG000|Overall Study|Referred to another hospital before day 20|0|||
160757430|NCT04771013|580497789|FG001|Overall Study|Referred to another hospital before day 20|1|||
160757431|NCT00419757|580497790|FG000|Overall Study|Adverse Event|1|||
160757432|NCT00419757|580497791|FG001|Overall Study|Adverse Event|4|||
160757433|NCT00419757|580497790|FG000|Overall Study|Lost to Follow-up|1|||
160757434|NCT00419757|580497791|FG001|Overall Study|Lost to Follow-up|4|||
160757435|NCT00419757|580497790|FG000|Overall Study|Withdrawal by Subject|7|||
160757436|NCT00419757|580497791|FG001|Overall Study|Withdrawal by Subject|1|||
160757437|NCT00419757|580497790|FG000|Overall Study|Protocol Violation|2|||
160525029|NCT00381303|579651791|FG000|Overall Study|No virologic response by week 12|1|||
160525030|NCT00381303|579651792|FG001|Overall Study|No virologic response by week 12|0|||
160525031|NCT00381303|579651791|FG000|Overall Study|Subject was too busy for appointments|1|||
160525032|NCT00381303|579651792|FG001|Overall Study|Subject was too busy for appointments|0|||
160757438|NCT00419757|580497791|FG001|Overall Study|Protocol Violation|3|||
160757439|NCT00419757|580497790|FG000|Overall Study|Study specific discontinuation criteria|4|||
160757440|NCT00419757|580497791|FG001|Overall Study|Study specific discontinuation criteria|8|||
160757441|NCT00419757|580497790|FG000|Overall Study|Multiple reasons|3|||
160757442|NCT00419757|580497791|FG001|Overall Study|Multiple reasons|1|||
160757443|NCT01051921|580497792|FG000|Overall Study|Physician Decision|9|||
160757444|NCT01051921|580497792|FG000|Overall Study|Adverse Event|8|||
160757445|NCT01051921|580497792|FG000|Overall Study|Withdrawal by Subject|7|||
160757446|NCT01051921|580497792|FG000|Overall Study|Lost to Follow-up|4|||
160757447|NCT01051921|580497792|FG000|Overall Study|virological failure|1|||
160757448|NCT01051921|580497792|FG000|Overall Study|patient moved|1|||
160757449|NCT00379834|580497796|FG000|Overall Study|Time constraints|2|||
160757450|NCT01519817|580497797|FG000|Overall Study|Withdrawal by Subject|1|||
160757451|NCT01519817|580497798|FG001|Overall Study|Withdrawal by Subject|0|||
160757452|NCT01519817|580497799|FG002|Overall Study|Withdrawal by Subject|0|||
160757453|NCT01519817|580497800|FG003|Overall Study|Withdrawal by Subject|0|||
160757454|NCT01519817|580497797|FG000|Overall Study|Off study due to infection|0|||
160757455|NCT01519817|580497798|FG001|Overall Study|Off study due to infection|0|||
160757456|NCT01519817|580497799|FG002|Overall Study|Off study due to infection|0|||
160757457|NCT01519817|580497800|FG003|Overall Study|Off study due to infection|1|||
160757458|NCT02683239|580497820|FG000|Overall Study|Protocol Violation|35|||
160757459|NCT02683239|580497821|FG001|Overall Study|Protocol Violation|23|||
160757460|NCT02683239|580497822|FG002|Overall Study|Protocol Violation|26|||
160757461|NCT02683239|580497823|FG003|Overall Study|Protocol Violation|4|||
160757462|NCT02683239|580497824|FG004|Overall Study|Protocol Violation|35|||
160757463|NCT02683239|580497825|FG005|Overall Study|Protocol Violation|4|||
160757464|NCT02683239|580497826|FG006|Overall Study|Protocol Violation|5|||
160757465|NCT02683239|580497820|FG000|Overall Study|Adverse Event|64|||
160757466|NCT02683239|580497821|FG001|Overall Study|Adverse Event|39|||
160757467|NCT02683239|580497822|FG002|Overall Study|Adverse Event|42|||
160757468|NCT02683239|580497823|FG003|Overall Study|Adverse Event|16|||
160757469|NCT02683239|580497824|FG004|Overall Study|Adverse Event|189|||
160757470|NCT02683239|580497825|FG005|Overall Study|Adverse Event|9|||
160757471|NCT02683239|580497826|FG006|Overall Study|Adverse Event|9|||
160757472|NCT02683239|580497820|FG000|Overall Study|Physician Decision|38|||
160757473|NCT02683239|580497821|FG001|Overall Study|Physician Decision|19|||
160757474|NCT02683239|580497822|FG002|Overall Study|Physician Decision|14|||
160757475|NCT02683239|580497823|FG003|Overall Study|Physician Decision|73|||
160757476|NCT02683239|580497824|FG004|Overall Study|Physician Decision|143|||
160757477|NCT02683239|580497825|FG005|Overall Study|Physician Decision|14|||
160757478|NCT02683239|580497826|FG006|Overall Study|Physician Decision|15|||
160757479|NCT02683239|580497820|FG000|Overall Study|Withdrawal by Subject|187|||
160757480|NCT02683239|580497821|FG001|Overall Study|Withdrawal by Subject|99|||
160757481|NCT02683239|580497822|FG002|Overall Study|Withdrawal by Subject|91|||
160757482|NCT02683239|580497823|FG003|Overall Study|Withdrawal by Subject|18|||
160757483|NCT02683239|580497824|FG004|Overall Study|Withdrawal by Subject|248|||
160757484|NCT02683239|580497825|FG005|Overall Study|Withdrawal by Subject|22|||
160757485|NCT02683239|580497826|FG006|Overall Study|Withdrawal by Subject|28|||
160757486|NCT02683239|580497820|FG000|Overall Study|Lost to Follow-up|77|||
160757487|NCT02683239|580497821|FG001|Overall Study|Lost to Follow-up|24|||
160525033|NCT00381303|579651791|FG000|Overall Study|Subject did not continue visits|1|||
160757488|NCT02683239|580497822|FG002|Overall Study|Lost to Follow-up|25|||
160757489|NCT02683239|580497823|FG003|Overall Study|Lost to Follow-up|7|||
160757490|NCT02683239|580497824|FG004|Overall Study|Lost to Follow-up|88|||
160757491|NCT02683239|580497825|FG005|Overall Study|Lost to Follow-up|8|||
160757492|NCT02683239|580497826|FG006|Overall Study|Lost to Follow-up|11|||
160757493|NCT02683239|580497820|FG000|Overall Study|Death|9|||
160757494|NCT02683239|580497821|FG001|Overall Study|Death|5|||
160757495|NCT02683239|580497822|FG002|Overall Study|Death|8|||
160757496|NCT02683239|580497823|FG003|Overall Study|Death|0|||
160757497|NCT02683239|580497824|FG004|Overall Study|Death|12|||
160757498|NCT02683239|580497825|FG005|Overall Study|Death|1|||
160757499|NCT02683239|580497826|FG006|Overall Study|Death|0|||
160757500|NCT02683239|580497820|FG000|Overall Study|Lack of Efficacy|50|||
160757501|NCT02683239|580497821|FG001|Overall Study|Lack of Efficacy|23|||
160757502|NCT02683239|580497822|FG002|Overall Study|Lack of Efficacy|12|||
160757503|NCT02683239|580497823|FG003|Overall Study|Lack of Efficacy|2|||
160757504|NCT02683239|580497824|FG004|Overall Study|Lack of Efficacy|29|||
160757505|NCT02683239|580497825|FG005|Overall Study|Lack of Efficacy|2|||
160757506|NCT02683239|580497826|FG006|Overall Study|Lack of Efficacy|3|||
160757507|NCT02683239|580497820|FG000|Overall Study|Missing data|0|||
160757508|NCT02683239|580497821|FG001|Overall Study|Missing data|1|||
160757509|NCT02683239|580497822|FG002|Overall Study|Missing data|1|||
160757510|NCT02683239|580497823|FG003|Overall Study|Missing data|0|||
160757511|NCT02683239|580497824|FG004|Overall Study|Missing data|1|||
160757512|NCT02683239|580497825|FG005|Overall Study|Missing data|0|||
160757513|NCT02683239|580497826|FG006|Overall Study|Missing data|0|||
160757514|NCT00521365|580497829|FG000|Overall Study|Adverse Event|3|||
160757515|NCT00521365|580497829|FG000|Overall Study|Lost to Follow-up|6|||
160757516|NCT00521365|580497829|FG000|Overall Study|Protocol deviation|2|||
160757517|NCT00521365|580497829|FG000|Overall Study|Drug compliance|3|||
160757518|NCT00521365|580497829|FG000|Overall Study|Usage of not allowed drugs|6|||
160757519|NCT03627832|580497830|FG000|Overall Study|Withdrawal by Subject|10|||
160757520|NCT03627832|580497831|FG001|Overall Study|Withdrawal by Subject|1|||
160757521|NCT01711983|580497837|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
160757522|NCT01711983|580497837|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
160757523|NCT01711983|580497837|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
160757524|NCT01711983|580497837|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
160757525|NCT00737100|580497838|FG000|Overall Study|Adverse Event|6|||
160757526|NCT00737100|580497839|FG001|Overall Study|Adverse Event|5|||
160757527|NCT00737100|580497840|FG002|Overall Study|Adverse Event|3|||
160757528|NCT00737100|580497838|FG000|Overall Study|Lost to Follow-up|0|||
160757529|NCT00737100|580497839|FG001|Overall Study|Lost to Follow-up|1|||
160757530|NCT00737100|580497840|FG002|Overall Study|Lost to Follow-up|0|||
160757531|NCT00737100|580497838|FG000|Overall Study|Withdrawal by Subject|0|||
160757532|NCT00737100|580497839|FG001|Overall Study|Withdrawal by Subject|0|||
160757533|NCT00737100|580497840|FG002|Overall Study|Withdrawal by Subject|3|||
160757534|NCT00737100|580497838|FG000|Overall Study|Reason discontinued not explained above|1|||
160757535|NCT00737100|580497839|FG001|Overall Study|Reason discontinued not explained above|1|||
160757536|NCT00737100|580497840|FG002|Overall Study|Reason discontinued not explained above|1|||
160757537|NCT00735943|580497845|FG000|Overall Study|Lost to Follow-up|1|||
160757538|NCT00735943|580497845|FG000|Overall Study|Adverse Event|1|||
160757539|NCT02515630|580497848|FG000|Overall Study|Withdrawal by Subject|5|||
160757540|NCT02515630|580497848|FG000|Overall Study|Adverse Event|4|||
160757541|NCT02515630|580497848|FG000|Overall Study|Physician Decision|4|||
160757542|NCT02515630|580497848|FG000|Overall Study|Death|2|||
160757543|NCT02515630|580497848|FG000|Overall Study|Disease Progression|1|||
160757544|NCT01064414|580497849|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
160757545|NCT01064414|580497850|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
160757546|NCT01064414|580497851|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
160757547|NCT01064414|580497849|FG000|Core Period: Baseline to Week 26|Death|0|||
160757548|NCT01064414|580497850|FG001|Core Period: Baseline to Week 26|Death|1|||
160757549|NCT01064414|580497851|FG002|Core Period: Baseline to Week 26|Death|0|||
160757550|NCT01064414|580497849|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
160757551|NCT01064414|580497850|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
160757552|NCT01064414|580497851|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
160757553|NCT01064414|580497849|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
160757554|NCT01064414|580497850|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
160757555|NCT01064414|580497851|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
160757556|NCT01064414|580497849|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
160757557|NCT01064414|580497850|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
160757558|NCT01064414|580497851|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
160757559|NCT01064414|580497849|FG000|Core Period: Baseline to Week 26|Other|4|||
160757560|NCT01064414|580497850|FG001|Core Period: Baseline to Week 26|Other|7|||
160757561|NCT01064414|580497851|FG002|Core Period: Baseline to Week 26|Other|2|||
160757562|NCT01064414|580497849|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
160757563|NCT01064414|580497850|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
160757564|NCT01064414|580497851|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
160757565|NCT01064414|580497849|FG000|Extension Period: Week 26 to Week 52|Death|0|||
160757566|NCT01064414|580497850|FG001|Extension Period: Week 26 to Week 52|Death|1|||
160757567|NCT01064414|580497851|FG002|Extension Period: Week 26 to Week 52|Death|0|||
160757568|NCT01064414|580497849|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
160757569|NCT01064414|580497850|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
160757570|NCT01064414|580497851|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
160757571|NCT01064414|580497849|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
160757572|NCT01064414|580497850|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
160757573|NCT01064414|580497851|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
160757574|NCT01064414|580497849|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
160757575|NCT01064414|580497850|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
160757576|NCT01064414|580497851|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
160757577|NCT01064414|580497849|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
160757578|NCT01064414|580497850|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
160757579|NCT01064414|580497851|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
160757580|NCT01064414|580497849|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
160757581|NCT01064414|580497850|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
160757582|NCT01064414|580497851|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
160525034|NCT00381303|579651792|FG001|Overall Study|Subject did not continue visits|0|||
160525035|NCT00381303|579651791|FG000|Overall Study|Subject primary physician's decision|1|||
160757583|NCT01064414|580497849|FG000|Extension Period: Week 26 to Week 52|Other|5|||
160757584|NCT01064414|580497850|FG001|Extension Period: Week 26 to Week 52|Other|2|||
160757585|NCT01064414|580497851|FG002|Extension Period: Week 26 to Week 52|Other|1|||
160757586|NCT00974311|580497852|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
160757587|NCT00974311|580497853|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
160757588|NCT00974311|580497852|FG000|DB Phase (up to 24 Months)|Death|561|||
160757589|NCT00974311|580497853|FG001|DB Phase (up to 24 Months)|Death|298|||
160757590|NCT00974311|580497852|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
160757591|NCT00974311|580497853|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
160757592|NCT00974311|580497852|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
160757593|NCT00974311|580497853|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
160757594|NCT00974311|580497852|FG000|DB Phase (up to 24 Months)|Other|1|||
160757595|NCT00974311|580497853|FG001|DB Phase (up to 24 Months)|Other|0|||
160757596|NCT00974311|580497852|FG000|OLE Phase (up to 77 Months)|Death|14|||
160757597|NCT00974311|580497853|FG001|OLE Phase (up to 77 Months)|Death|21|||
160757598|NCT00974311|580497852|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
160757599|NCT00974311|580497853|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
160757600|NCT00974311|580497852|FG000|OLE Phase (up to 77 Months)|Other|15|||
160757601|NCT00974311|580497853|FG001|OLE Phase (up to 77 Months)|Other|2|||
160757602|NCT00974311|580497852|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
160757603|NCT00974311|580497853|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
160757604|NCT02595502|580497854|FG000|Period 1|Adverse Event|0|||
160757605|NCT02595502|580497855|FG001|Period 1|Adverse Event|1|||
160757606|NCT02595502|580497854|FG000|Period 1|Withdrawal by Subject|1|||
160757607|NCT02595502|580497855|FG001|Period 1|Withdrawal by Subject|0|||
160757608|NCT02595502|580497854|FG000|Period 1|Lost to Follow-up|0|||
160757609|NCT02595502|580497855|FG001|Period 1|Lost to Follow-up|1|||
160757610|NCT02595502|580497854|FG000|Period 2|Adverse Event|1|||
160757611|NCT02595502|580497855|FG001|Period 2|Adverse Event|1|||
160757612|NCT02595502|580497854|FG000|Period 2|Received incorrect lens at Period 1|0|||
160757613|NCT02595502|580497855|FG001|Period 2|Received incorrect lens at Period 1|1|||
160757614|NCT02595502|580497854|FG000|Period 3|Protocol Violation|0|||
160757615|NCT02595502|580497855|FG001|Period 3|Protocol Violation|1|||
160757616|NCT02595502|580497854|FG000|Period 3|Lost to Follow-up|1|||
160757617|NCT02595502|580497855|FG001|Period 3|Lost to Follow-up|0|||
160757618|NCT02595502|580497854|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
160757619|NCT02595502|580497855|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
160757620|NCT03286218|580497856|FG000|Qualification Phase Period 1|Adverse Event|1|||
160757621|NCT03286218|580497857|FG001|Qualification Phase Period 1|Adverse Event|0|||
160757622|NCT03286218|580497858|FG002|Qualification Phase Period 1|Adverse Event|0|||
160757623|NCT03286218|580497859|FG003|Qualification Phase Period 1|Adverse Event|0|||
160757624|NCT03286218|580497860|FG004|Qualification Phase Period 1|Adverse Event|0|||
160757625|NCT03286218|580497861|FG005|Qualification Phase Period 1|Adverse Event|0|||
160757626|NCT03286218|580497862|FG006|Qualification Phase Period 1|Adverse Event|0|||
160757627|NCT03286218|580497863|FG007|Qualification Phase Period 1|Adverse Event|0|||
160757628|NCT03286218|580497864|FG008|Qualification Phase Period 1|Adverse Event|0|||
160757629|NCT03286218|580497865|FG009|Qualification Phase Period 1|Adverse Event|0|||
160757630|NCT03286218|580497866|FG010|Qualification Phase Period 1|Adverse Event|0|||
160757631|NCT03286218|580497867|FG011|Qualification Phase Period 1|Adverse Event|0|||
160757632|NCT03286218|580497856|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757633|NCT03286218|580497857|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
160757634|NCT03286218|580497858|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757635|NCT03286218|580497859|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757636|NCT03286218|580497860|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757637|NCT03286218|580497861|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757638|NCT03286218|580497862|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757639|NCT03286218|580497863|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757640|NCT03286218|580497864|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757641|NCT03286218|580497865|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757642|NCT03286218|580497866|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757643|NCT03286218|580497867|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
160757644|NCT03286218|580497856|FG000|Qualification Phase Period 2|Adverse Event|0|||
160757645|NCT03286218|580497857|FG001|Qualification Phase Period 2|Adverse Event|1|||
160757646|NCT03286218|580497858|FG002|Qualification Phase Period 2|Adverse Event|0|||
160757647|NCT03286218|580497859|FG003|Qualification Phase Period 2|Adverse Event|0|||
160757648|NCT03286218|580497860|FG004|Qualification Phase Period 2|Adverse Event|0|||
160757649|NCT03286218|580497861|FG005|Qualification Phase Period 2|Adverse Event|0|||
160757650|NCT03286218|580497862|FG006|Qualification Phase Period 2|Adverse Event|0|||
160757651|NCT03286218|580497863|FG007|Qualification Phase Period 2|Adverse Event|0|||
160757652|NCT03286218|580497864|FG008|Qualification Phase Period 2|Adverse Event|0|||
160757653|NCT03286218|580497865|FG009|Qualification Phase Period 2|Adverse Event|0|||
160757654|NCT03286218|580497866|FG010|Qualification Phase Period 2|Adverse Event|0|||
160757655|NCT03286218|580497867|FG011|Qualification Phase Period 2|Adverse Event|0|||
160757656|NCT03286218|580497856|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
160525036|NCT00381303|579651792|FG001|Overall Study|Subject primary physician's decision|0|||
160525037|NCT01116882|579651793|FG000|30-day|Lost to Follow-up|50|||
160525038|NCT01116882|579651794|FG001|30-day|Lost to Follow-up|21|||
160525039|NCT01116882|579651793|FG000|30-day|Withdrawal by Subject|2|||
160757657|NCT03286218|580497857|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
160757658|NCT03286218|580497858|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
160757659|NCT03286218|580497859|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
160757660|NCT03286218|580497860|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
160757661|NCT03286218|580497861|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
160757662|NCT03286218|580497862|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
160757663|NCT03286218|580497863|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
160757664|NCT03286218|580497864|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
160757665|NCT03286218|580497865|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
160757666|NCT03286218|580497866|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
160757667|NCT03286218|580497867|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
160757668|NCT03286218|580497856|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
160757669|NCT03286218|580497857|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
160757670|NCT03286218|580497858|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
160757671|NCT03286218|580497859|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
160757672|NCT03286218|580497860|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
160757673|NCT03286218|580497861|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
160757674|NCT03286218|580497862|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
160757675|NCT03286218|580497863|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
160757676|NCT03286218|580497864|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
160757677|NCT03286218|580497865|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
160757678|NCT03286218|580497866|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
160757679|NCT03286218|580497867|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
160757680|NCT03286218|580497856|FG000|Qualification Phase Period 2|Protocol Violation|2|||
160757681|NCT03286218|580497857|FG001|Qualification Phase Period 2|Protocol Violation|0|||
160757682|NCT03286218|580497858|FG002|Qualification Phase Period 2|Protocol Violation|0|||
160757683|NCT03286218|580497859|FG003|Qualification Phase Period 2|Protocol Violation|0|||
160757684|NCT03286218|580497860|FG004|Qualification Phase Period 2|Protocol Violation|0|||
160757685|NCT03286218|580497861|FG005|Qualification Phase Period 2|Protocol Violation|0|||
160757686|NCT03286218|580497862|FG006|Qualification Phase Period 2|Protocol Violation|0|||
160757687|NCT03286218|580497863|FG007|Qualification Phase Period 2|Protocol Violation|0|||
160757688|NCT03286218|580497864|FG008|Qualification Phase Period 2|Protocol Violation|0|||
160757689|NCT03286218|580497865|FG009|Qualification Phase Period 2|Protocol Violation|0|||
160757690|NCT03286218|580497866|FG010|Qualification Phase Period 2|Protocol Violation|0|||
160757691|NCT03286218|580497867|FG011|Qualification Phase Period 2|Protocol Violation|0|||
160757692|NCT03286218|580497856|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
160757693|NCT03286218|580497857|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
160757694|NCT03286218|580497858|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
160757695|NCT03286218|580497859|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
160757696|NCT03286218|580497860|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
160757697|NCT03286218|580497861|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
160757698|NCT03286218|580497862|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
160757699|NCT03286218|580497863|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
160757700|NCT03286218|580497864|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
160757701|NCT03286218|580497865|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
160757702|NCT03286218|580497866|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
160757703|NCT03286218|580497867|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
160757704|NCT03286218|580497856|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
160757705|NCT03286218|580497857|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
160757706|NCT03286218|580497858|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
160757707|NCT03286218|580497859|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
160757708|NCT03286218|580497860|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
160757709|NCT03286218|580497861|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
160525040|NCT01116882|579651794|FG001|30-day|Withdrawal by Subject|4|||
160757710|NCT03286218|580497862|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
160757711|NCT03286218|580497863|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
160757712|NCT03286218|580497864|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
160757713|NCT03286218|580497865|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
160757714|NCT03286218|580497866|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
160757715|NCT03286218|580497867|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
160757716|NCT03286218|580497856|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
160757717|NCT03286218|580497857|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
160757718|NCT03286218|580497858|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
160757719|NCT03286218|580497859|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
160757720|NCT03286218|580497860|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
160757721|NCT03286218|580497861|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
160525041|NCT01116882|579651793|FG000|30-day|Other Reasons|16|||
160525042|NCT01116882|579651794|FG001|30-day|Other Reasons|6|||
160757722|NCT03286218|580497862|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
160757723|NCT03286218|580497863|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
160757724|NCT03286218|580497864|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
160757725|NCT03286218|580497865|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
160757726|NCT03286218|580497866|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
160757727|NCT03286218|580497867|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
160757728|NCT02346708|580497868|FG000|Overall Study|Adverse Event|2|||
160757729|NCT02346708|580497869|FG001|Overall Study|Adverse Event|0|||
160757730|NCT02346708|580497868|FG000|Overall Study|Protocol Violation|0|||
160757731|NCT02346708|580497869|FG001|Overall Study|Protocol Violation|1|||
160757732|NCT00483652|580497870|FG000|Double-blind Treatment Period|Protocol Violation|2|||
160757733|NCT00483652|580497871|FG001|Double-blind Treatment Period|Protocol Violation|1|||
160757734|NCT00483652|580497870|FG000|Double-blind Treatment Period|Adverse Event|3|||
160757735|NCT00483652|580497871|FG001|Double-blind Treatment Period|Adverse Event|4|||
160757736|NCT00483652|580497870|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
160757737|NCT00483652|580497871|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
160757738|NCT00483652|580497870|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
160757739|NCT00483652|580497871|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
160757740|NCT01781962|580497874|FG000|Overall Study|Other Miscellaneous Reasons|5|||
160757741|NCT02154139|580497879|FG000|Overall Study|Injection not administered|2|||
160757742|NCT02154139|580497879|FG000|Overall Study|Other|2|||
160757743|NCT02154139|580497879|FG000|Overall Study|Investigator transferred|3|||
160757744|NCT00891813|580497880|FG000|Overall Study|Adverse Event|3|||
160757745|NCT00891813|580497880|FG000|Overall Study|Withdrawal by Subject|1|||
160757746|NCT00891813|580497880|FG000|Overall Study|Patient Noncompliance|6|||
160757747|NCT00891813|580497880|FG000|Overall Study|Protocol Violation|2|||
160757748|NCT03075267|580497884|FG000|Overall Study|Protocol Violation|1|||
160757749|NCT03075267|580497885|FG001|Overall Study|Protocol Violation|0|||
160757750|NCT03075267|580497886|FG002|Overall Study|Protocol Violation|0|||
160757751|NCT03874013|580497887|FG000|Overall Study|Adverse Event|0|||
160757752|NCT03874013|580497888|FG001|Overall Study|Adverse Event|1|||
160757753|NCT03360019|580497889|FG000|Overall Study|Withdrawal by Subject|2|||
160757754|NCT03360019|580497890|FG001|Overall Study|Withdrawal by Subject|0|||
160757755|NCT03360019|580497891|FG002|Overall Study|Withdrawal by Subject|0|||
160757756|NCT03360019|580497889|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
160757757|NCT03360019|580497890|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
160757758|NCT03360019|580497891|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
160757759|NCT01462110|580497894|FG000|Overall Study|Adverse Event|1|||
160757760|NCT01462110|580497895|FG001|Overall Study|Adverse Event|0|||
160757761|NCT05279131|580497896|FG000|Overall Study|Lost to Follow-up|1|||
160757762|NCT05279131|580497896|FG000|Overall Study|Death|1|||
160757763|NCT05279131|580497896|FG000|Overall Study|Physician Decision|1|||
160757764|NCT00964028|580497898|FG000|Overall Study|Withdrawal by Subject|0|||
160757765|NCT00964028|580497899|FG001|Overall Study|Withdrawal by Subject|1|||
160757766|NCT02106351|580497900|FG000|Treatment Cycle 1|Adverse Event|2|||
160757767|NCT02106351|580497901|FG001|Treatment Cycle 1|Adverse Event|0|||
160757768|NCT02106351|580497902|FG002|Treatment Cycle 1|Adverse Event|0|||
160757769|NCT02106351|580497900|FG000|Treatment Cycle 1|Consent withdrawn|1|||
160757770|NCT02106351|580497901|FG001|Treatment Cycle 1|Consent withdrawn|0|||
160757771|NCT02106351|580497902|FG002|Treatment Cycle 1|Consent withdrawn|2|||
160757772|NCT02106351|580497900|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
160757773|NCT02106351|580497901|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
160757774|NCT02106351|580497902|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
160757775|NCT02106351|580497900|FG000|Treatment Cycle 1|Other|0|||
160757776|NCT02106351|580497901|FG001|Treatment Cycle 1|Other|3|||
160757777|NCT02106351|580497902|FG002|Treatment Cycle 1|Other|1|||
160757778|NCT02106351|580497900|FG000|Treatment Cycle 1|Randomised but not treated|1|||
160757779|NCT02106351|580497901|FG001|Treatment Cycle 1|Randomised but not treated|0|||
160757780|NCT02106351|580497902|FG002|Treatment Cycle 1|Randomised but not treated|1|||
160757781|NCT02106351|580497900|FG000|Treatment Cycle 2|Adverse Event|0|||
160757782|NCT02106351|580497901|FG001|Treatment Cycle 2|Adverse Event|2|||
160757783|NCT02106351|580497902|FG002|Treatment Cycle 2|Adverse Event|0|||
160757784|NCT02106351|580497900|FG000|Treatment Cycle 2|Consent withdrawn|0|||
160757785|NCT02106351|580497901|FG001|Treatment Cycle 2|Consent withdrawn|1|||
160757786|NCT02106351|580497902|FG002|Treatment Cycle 2|Consent withdrawn|1|||
160757787|NCT02106351|580497900|FG000|Treatment Cycle 2|Other|0|||
160757788|NCT02106351|580497901|FG001|Treatment Cycle 2|Other|2|||
160757789|NCT02106351|580497902|FG002|Treatment Cycle 2|Other|2|||
160757790|NCT02106351|580497900|FG000|Treatment Cycle 3|Adverse Event|0|||
160757791|NCT02106351|580497901|FG001|Treatment Cycle 3|Adverse Event|1|||
160757792|NCT02106351|580497902|FG002|Treatment Cycle 3|Adverse Event|0|||
160757793|NCT02106351|580497900|FG000|Treatment Cycle 3|Consent withdrawn|0|||
160757794|NCT02106351|580497901|FG001|Treatment Cycle 3|Consent withdrawn|0|||
160757795|NCT02106351|580497902|FG002|Treatment Cycle 3|Consent withdrawn|2|||
160757796|NCT02106351|580497900|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
160757797|NCT02106351|580497901|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
160757798|NCT02106351|580497902|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
160757799|NCT02106351|580497900|FG000|Treatment Cycle 3|Other|0|||
160757800|NCT02106351|580497901|FG001|Treatment Cycle 3|Other|2|||
160525043|NCT01116882|579651793|FG000|12-month|Lost to Follow-up|111|||
160757801|NCT02106351|580497902|FG002|Treatment Cycle 3|Other|3|||
160757802|NCT02106351|580497900|FG000|Treatment Cycle 4|Consent withdrawn|0|||
160757803|NCT02106351|580497901|FG001|Treatment Cycle 4|Consent withdrawn|0|||
160757804|NCT02106351|580497902|FG002|Treatment Cycle 4|Consent withdrawn|2|||
160757805|NCT02106351|580497900|FG000|Treatment Cycle 4|Other|0|||
160757806|NCT02106351|580497901|FG001|Treatment Cycle 4|Other|1|||
160757807|NCT02106351|580497902|FG002|Treatment Cycle 4|Other|0|||
160757808|NCT03101150|580499532|FG000|Overall Study|Lost to Follow-up|2|||
160757809|NCT03101150|580499533|FG001|Overall Study|Lost to Follow-up|4|||
160757810|NCT03101150|580499532|FG000|Overall Study|Miscarriage|3|||
160757811|NCT03101150|580499533|FG001|Overall Study|Miscarriage|6|||
160757812|NCT00329108|580499534|FG000|Overall Study|Adverse Event|2|||
160757813|NCT00329108|580499535|FG001|Overall Study|Adverse Event|2|||
160757814|NCT00329108|580499534|FG000|Overall Study|Lack of Efficacy|3|||
160757815|NCT00329108|580499535|FG001|Overall Study|Lack of Efficacy|3|||
160757816|NCT00329108|580499534|FG000|Overall Study|Withdrawal by Subject|0|||
160757817|NCT00329108|580499535|FG001|Overall Study|Withdrawal by Subject|2|||
160757818|NCT00329108|580499534|FG000|Overall Study|symptomatic deterioration|1|||
160757819|NCT00329108|580499535|FG001|Overall Study|symptomatic deterioration|1|||
160757820|NCT00329108|580499534|FG000|Overall Study|Subject no longer willing to participate|2|||
160757821|NCT00329108|580499535|FG001|Overall Study|Subject no longer willing to participate|2|||
160757822|NCT00329108|580499534|FG000|Overall Study|study terminated by sponsor|1|||
160757823|NCT00329108|580499535|FG001|Overall Study|study terminated by sponsor|0|||
160757824|NCT00329108|580499534|FG000|Overall Study|withdrew patient after SAE resolved|1|||
160757825|NCT00329108|580499535|FG001|Overall Study|withdrew patient after SAE resolved|0|||
160757826|NCT00329108|580499534|FG000|Overall Study|Protocol Violation|0|||
160757827|NCT00329108|580499535|FG001|Overall Study|Protocol Violation|2|||
160757828|NCT02498678|580499538|FG000|Overall Study|interference from the surgical team|0|||
160757829|NCT02498678|580499539|FG001|Overall Study|interference from the surgical team|2|||
160757830|NCT01145482|580499541|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
160757831|NCT01145482|580499542|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
160757832|NCT04547140|580499543|FG000|Overall Study|Adverse Event|0|||
160757833|NCT04547140|580499544|FG001|Overall Study|Adverse Event|1|||
160757834|NCT04547140|580499543|FG000|Overall Study|Withdrawal by Subject|0|||
160757835|NCT04547140|580499544|FG001|Overall Study|Withdrawal by Subject|1|||
160757836|NCT04547140|580499543|FG000|Overall Study|Lost to Follow-up|3|||
160757837|NCT04547140|580499544|FG001|Overall Study|Lost to Follow-up|1|||
160757838|NCT04547140|580499543|FG000|Overall Study|Death|2|||
160757839|NCT04547140|580499544|FG001|Overall Study|Death|1|||
160757840|NCT04547140|580499543|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
160757841|NCT04547140|580499544|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
160757842|NCT04547140|580499543|FG000|Overall Study|Pregnancy|1|||
160757843|NCT04547140|580499544|FG001|Overall Study|Pregnancy|0|||
160757844|NCT04547140|580499543|FG000|Overall Study|Reason Not Specified|4|||
160757845|NCT04547140|580499544|FG001|Overall Study|Reason Not Specified|1|||
160757846|NCT00873730|580499545|FG000|Overall Study|Protocol Deviation|5|||
160525044|NCT01116882|579651794|FG001|12-month|Lost to Follow-up|42|||
160757847|NCT00873730|580499546|FG001|Overall Study|Protocol Deviation|2|||
160757848|NCT00873730|580499545|FG000|Overall Study|Adverse Event|0|||
160757849|NCT00873730|580499546|FG001|Overall Study|Adverse Event|2|||
160757850|NCT00873730|580499545|FG000|Overall Study|Withdrawal by Subject|0|||
160757851|NCT00873730|580499546|FG001|Overall Study|Withdrawal by Subject|1|||
160757852|NCT00873730|580499545|FG000|Overall Study|Sponsor decision|1|||
160757853|NCT00873730|580499546|FG001|Overall Study|Sponsor decision|0|||
160757854|NCT04110314|580499549|FG000|Overall Study|Did not meet inclusion criteria|35255|||
160525045|NCT01116882|579651793|FG000|12-month|Other Reasons|151|||
160757855|NCT04110314|580499550|FG001|Overall Study|Did not meet inclusion criteria|35104|||
160757856|NCT04110314|580499551|FG002|Overall Study|Did not meet inclusion criteria|35636|||
160757857|NCT04110314|580499552|FG003|Overall Study|Did not meet inclusion criteria|35135|||
160757858|NCT04110314|580499553|FG004|Overall Study|Did not meet inclusion criteria|35247|||
160757859|NCT04110314|580499554|FG005|Overall Study|Did not meet inclusion criteria|35727|||
160525046|NCT01116882|579651794|FG001|12-month|Other Reasons|49|||
160525047|NCT01116882|579651793|FG000|12-month|Withdrawal by Subject|5|||
160525048|NCT01116882|579651794|FG001|12-month|Withdrawal by Subject|8|||
160525049|NCT00547365|579651795|FG000|Overall Study|Physician Decision|1|||
160525050|NCT00547365|579651795|FG000|Overall Study|Lost to Follow-up|1|||
160525051|NCT00547365|579651795|FG000|Overall Study|Protocol Violation|2|||
160757860|NCT00115778|580499560|FG000|Overall Study|Withdrawal by Subject|0|||
160525052|NCT00547365|579651795|FG000|Overall Study|death (not related to study)|4|||
160525053|NCT01777269|579651796|FG000|Overall Study|Adverse Event|24|||
160525054|NCT01777269|579651797|FG001|Overall Study|Adverse Event|33|||
160525055|NCT01777269|579651796|FG000|Overall Study|Lack of Efficacy|8|||
160525056|NCT01777269|579651797|FG001|Overall Study|Lack of Efficacy|10|||
160525057|NCT01777269|579651796|FG000|Overall Study|Protocol Violation|4|||
160525058|NCT01777269|579651797|FG001|Overall Study|Protocol Violation|4|||
160525059|NCT01777269|579651796|FG000|Overall Study|Participants reached stopping criteria|1|||
160525060|NCT01777269|579651797|FG001|Overall Study|Participants reached stopping criteria|1|||
160525061|NCT01777269|579651796|FG000|Overall Study|Lost to Follow-up|4|||
160525062|NCT01777269|579651797|FG001|Overall Study|Lost to Follow-up|0|||
160525063|NCT01777269|579651796|FG000|Overall Study|Physician Decision|5|||
160525064|NCT01777269|579651797|FG001|Overall Study|Physician Decision|2|||
160525065|NCT01777269|579651796|FG000|Overall Study|Withdrawal by Subject|9|||
160525066|NCT01777269|579651797|FG001|Overall Study|Withdrawal by Subject|9|||
160525067|NCT00504881|579651798|FG000|Overall Study|Lack of Efficacy|1|||
160525068|NCT00504881|579651799|FG001|Overall Study|Lack of Efficacy|5|||
160525069|NCT00504881|579651798|FG000|Overall Study|Lost to Follow-up|0|||
160525070|NCT00504881|579651799|FG001|Overall Study|Lost to Follow-up|2|||
160525071|NCT00504881|579651798|FG000|Overall Study|Withdrawal by Subject|1|||
160525072|NCT00504881|579651799|FG001|Overall Study|Withdrawal by Subject|4|||
160525073|NCT00504881|579651798|FG000|Overall Study|Non-Compliance|1|||
160525074|NCT00504881|579651799|FG001|Overall Study|Non-Compliance|0|||
160525075|NCT00504881|579651798|FG000|Overall Study|No Birth Control|0|||
160525076|NCT00504881|579651799|FG001|Overall Study|No Birth Control|1|||
160525077|NCT00504881|579651798|FG000|Overall Study|Safety Visit not performed|0|||
160525078|NCT00504881|579651799|FG001|Overall Study|Safety Visit not performed|1|||
160525079|NCT00504881|579651798|FG000|Overall Study|AE, serious fatal|0|||
160525080|NCT00504881|579651799|FG001|Overall Study|AE, serious fatal|1|||
160525081|NCT00504881|579651798|FG000|Overall Study|SAE, non-fatal|2|||
160525082|NCT00504881|579651799|FG001|Overall Study|SAE, non-fatal|6|||
160525083|NCT00504881|579651798|FG000|Overall Study|AE, non-serious non-fatal|4|||
160525084|NCT00504881|579651799|FG001|Overall Study|AE, non-serious non-fatal|14|||
160525085|NCT00504881|579651798|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
160525086|NCT00504881|579651799|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
160525087|NCT00504881|579651798|FG000|Overall Study|AE of unknown type|1|||
160525088|NCT00504881|579651799|FG001|Overall Study|AE of unknown type|0|||
160525089|NCT01966471|579651805|FG000|Overall Study|Death|44|||
160525090|NCT01966471|579651806|FG001|Overall Study|Death|56|||
160525091|NCT01966471|579651805|FG000|Overall Study|Lost to Follow-up|46|||
160525092|NCT01966471|579651806|FG001|Overall Study|Lost to Follow-up|39|||
160525093|NCT01966471|579651805|FG000|Overall Study|Various reasons|4|||
160525094|NCT01966471|579651806|FG001|Overall Study|Various reasons|4|||
160525095|NCT01966471|579651805|FG000|Overall Study|Physician Decision|7|||
160525096|NCT01966471|579651806|FG001|Overall Study|Physician Decision|5|||
160525097|NCT01966471|579651805|FG000|Overall Study|Study Terminated By Sponsor|758|||
160525098|NCT01966471|579651806|FG001|Overall Study|Study Terminated By Sponsor|773|||
160525099|NCT01966471|579651805|FG000|Overall Study|Withdrawal by Subject|59|||
160525100|NCT01966471|579651806|FG001|Overall Study|Withdrawal by Subject|51|||
160525101|NCT01030198|579651810|FG000|Overall Study|Could not measure efficacy accurately|0|||
160525102|NCT01030198|579651811|FG001|Overall Study|Could not measure efficacy accurately|7|||
160525103|NCT02370043|579651812|FG000|Overall Study|Withdrawal by Subject|0|||
160525104|NCT02370043|579651813|FG001|Overall Study|Withdrawal by Subject|0|||
160525105|NCT02370043|579651814|FG002|Overall Study|Withdrawal by Subject|0|||
160525106|NCT02370043|579651815|FG003|Overall Study|Withdrawal by Subject|0|||
160525107|NCT02370043|579651816|FG004|Overall Study|Withdrawal by Subject|1|||
160525108|NCT02370043|579651817|FG005|Overall Study|Withdrawal by Subject|1|||
160525109|NCT01231516|579651818|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
160525110|NCT01231516|579651819|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
160525111|NCT01231516|579651818|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
160525112|NCT01231516|579651819|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
160525113|NCT01231516|579651818|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
160525114|NCT01231516|579651819|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
160525115|NCT01231516|579651818|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
160525116|NCT01231516|579651819|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
160525117|NCT01231516|579651818|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
160525118|NCT01231516|579651819|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
160525119|NCT01231516|579651818|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
160525120|NCT01231516|579651819|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
160525121|NCT01231516|579651818|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
160525122|NCT01231516|579651819|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
160525123|NCT01231516|579651818|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
160525124|NCT01231516|579651819|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
160525125|NCT01231516|579651818|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
160525126|NCT01231516|579651819|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
160525127|NCT01231516|579651818|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
160525128|NCT01231516|579651819|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
160525129|NCT01231516|579651818|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
160525130|NCT01231516|579651819|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
160525131|NCT01231516|579651818|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
160525132|NCT01231516|579651819|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
160525133|NCT01231516|579651818|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
160525134|NCT01231516|579651819|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
160525135|NCT01231516|579651818|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
160525136|NCT01231516|579651819|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
160525137|NCT01231516|579651818|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
160525138|NCT01231516|579651819|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
160525139|NCT01231516|579651818|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
160525140|NCT01231516|579651819|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
160525141|NCT05266586|579651820|FG000|Overall Study|Adverse Event|2|||
160525142|NCT05266586|579651821|FG001|Overall Study|Adverse Event|2|||
160525143|NCT05266586|579651822|FG002|Overall Study|Adverse Event|1|||
160525144|NCT05266586|579651820|FG000|Overall Study|Withdrawal by Subject|1|||
160525145|NCT05266586|579651821|FG001|Overall Study|Withdrawal by Subject|0|||
160525146|NCT05266586|579651822|FG002|Overall Study|Withdrawal by Subject|1|||
160525147|NCT05266586|579651820|FG000|Overall Study|Non-compliance with study drug|0|||
160525148|NCT05266586|579651821|FG001|Overall Study|Non-compliance with study drug|1|||
160525149|NCT05266586|579651822|FG002|Overall Study|Non-compliance with study drug|0|||
160757861|NCT00115778|580499561|FG001|Overall Study|Withdrawal by Subject|1|||
160757862|NCT01607593|580499562|FG000|Overall Study|Adverse Event|15|||
160757863|NCT01607593|580499562|FG000|Overall Study|Lack of Efficacy|16|||
160757864|NCT01607593|580499562|FG000|Overall Study|Lost to Follow-up|25|||
160757865|NCT01607593|580499562|FG000|Overall Study|Continuation|33|||
160757866|NCT01607593|580499562|FG000|Overall Study|Other|4|||
160757867|NCT03713684|580499565|FG000|Overall Study|Adverse Event|1|||
160757868|NCT03713684|580499566|FG001|Overall Study|Adverse Event|3|||
160757869|NCT03713684|580499567|FG002|Overall Study|Adverse Event|1|||
160757870|NCT03713684|580499568|FG003|Overall Study|Adverse Event|0|||
160757871|NCT03713684|580499565|FG000|Overall Study|Poor compliance to protocol|2|||
160757872|NCT03713684|580499566|FG001|Overall Study|Poor compliance to protocol|1|||
160757873|NCT03713684|580499567|FG002|Overall Study|Poor compliance to protocol|0|||
160757874|NCT03713684|580499568|FG003|Overall Study|Poor compliance to protocol|1|||
160757875|NCT03713684|580499565|FG000|Overall Study|Withdrawal by Subject|14|||
160757876|NCT03713684|580499566|FG001|Overall Study|Withdrawal by Subject|6|||
160757877|NCT03713684|580499567|FG002|Overall Study|Withdrawal by Subject|14|||
160757878|NCT03713684|580499568|FG003|Overall Study|Withdrawal by Subject|16|||
160757879|NCT03713684|580499565|FG000|Overall Study|Other than specified|69|||
160757880|NCT03713684|580499566|FG001|Overall Study|Other than specified|77|||
160757881|NCT03713684|580499567|FG002|Overall Study|Other than specified|73|||
160757882|NCT03713684|580499568|FG003|Overall Study|Other than specified|70|||
160757883|NCT00458003|580499571|FG000|Overall Study|Non protocol spinal anesthesia|1|||
160757884|NCT00458003|580499572|FG001|Overall Study|Non protocol spinal anesthesia|1|||
160757885|NCT03131167|580499573|FG000|Overall Study|Other (Unspecified)|0|||
160757886|NCT03131167|580499574|FG001|Overall Study|Other (Unspecified)|0|||
160757887|NCT03131167|580499575|FG002|Overall Study|Other (Unspecified)|0|||
160757888|NCT03131167|580499576|FG003|Overall Study|Other (Unspecified)|0|||
160757889|NCT03131167|580499577|FG004|Overall Study|Other (Unspecified)|0|||
160757890|NCT03131167|580499578|FG005|Overall Study|Other (Unspecified)|1|||
160757891|NCT03131167|580499579|FG006|Overall Study|Other (Unspecified)|0|||
160757892|NCT03131167|580499580|FG007|Overall Study|Other (Unspecified)|0|||
160757893|NCT03131167|580499581|FG008|Overall Study|Other (Unspecified)|0|||
160757894|NCT03131167|580499582|FG009|Overall Study|Other (Unspecified)|0|||
160757895|NCT03131167|580499583|FG010|Overall Study|Other (Unspecified)|0|||
160757896|NCT03131167|580499584|FG011|Overall Study|Other (Unspecified)|0|||
160757897|NCT03131167|580499585|FG012|Overall Study|Other (Unspecified)|0|||
160757898|NCT00165503|580499590|FG000|Overall Study|Death|1|||
160757899|NCT00165503|580499590|FG000|Overall Study|Lost to Follow-up|12|||
160757900|NCT00165503|580499590|FG000|Overall Study|Unresectable|3|||
160757901|NCT00643201|580499591|FG000|Randomized, Completed 6 Months of Study|Death|20|||
160757902|NCT00643201|580499592|FG001|Randomized, Completed 6 Months of Study|Death|26|||
160757903|NCT00643201|580499591|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
160757904|NCT00643201|580499592|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
160757905|NCT00643201|580499591|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
160757906|NCT00643201|580499592|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
160757907|NCT00643201|580499591|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
160757908|NCT00643201|580499592|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
160757909|NCT00643201|580499591|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
160757910|NCT00643201|580499592|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
160757911|NCT00643201|580499591|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
160757912|NCT00643201|580499592|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
160757913|NCT00643201|580499591|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
160757914|NCT00643201|580499592|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
160757915|NCT00643201|580499591|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
160757916|NCT00643201|580499592|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
160757917|NCT00643201|580499591|FG000|Randomized, Completed 6 Months of Study|Other|107|||
160757918|NCT00643201|580499592|FG001|Randomized, Completed 6 Months of Study|Other|107|||
160757919|NCT00643201|580499591|FG000|Completed Study Follow Up|Death|28|||
160757920|NCT00643201|580499592|FG001|Completed Study Follow Up|Death|34|||
160757921|NCT00643201|580499591|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
160757922|NCT00643201|580499592|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
160757923|NCT00643201|580499591|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
160757924|NCT00643201|580499592|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
160757925|NCT00643201|580499591|FG000|Completed Study Follow Up|non-specified|1|||
160757926|NCT00643201|580499592|FG001|Completed Study Follow Up|non-specified|0|||
160757927|NCT04556760|580499595|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
160757928|NCT04556760|580499596|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
160757929|NCT04556760|580499597|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
160757930|NCT04556760|580499598|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
160757931|NCT04556760|580499599|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
160525150|NCT05266586|579651820|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
160571829|NCT01633060|579816838|FG000|Treatment Phase|Study Terminated by sponsor|7|||
160757932|NCT04556760|580499600|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
160757933|NCT04556760|580499595|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
160757934|NCT04556760|580499596|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
160757935|NCT04556760|580499597|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
160757936|NCT04556760|580499598|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
160757937|NCT04556760|580499599|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
160757938|NCT04556760|580499600|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
160757939|NCT02849743|580499601|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
160757940|NCT02849743|580499602|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
160757941|NCT02849743|580499601|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
160757942|NCT02849743|580499602|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
160757943|NCT02168491|580499605|FG000|Overall Study|Withdrawal by Subject|1|||
160757944|NCT00809445|580499606|FG000|1 Month Follow-up|Lost contact|1|||
160757945|NCT00809445|580499607|FG001|1 Month Follow-up|Lost contact|2|||
160757946|NCT00809445|580499608|FG002|1 Month Follow-up|Lost contact|1|||
160757947|NCT00809445|580499606|FG000|1 Month Follow-up|Withdrew consent|1|||
160757948|NCT00809445|580499607|FG001|1 Month Follow-up|Withdrew consent|1|||
160757949|NCT00809445|580499608|FG002|1 Month Follow-up|Withdrew consent|1|||
160757950|NCT00809445|580499606|FG000|1 Month Follow-up|Death|0|||
160757951|NCT00809445|580499607|FG001|1 Month Follow-up|Death|1|||
160757952|NCT00809445|580499608|FG002|1 Month Follow-up|Death|1|||
160757953|NCT00809445|580499606|FG000|1 Month Follow-up|Incarcerated|0|||
160757954|NCT00809445|580499607|FG001|1 Month Follow-up|Incarcerated|0|||
160757955|NCT00809445|580499608|FG002|1 Month Follow-up|Incarcerated|1|||
160757956|NCT00809445|580499606|FG000|6 Month Follow-up|Lost contact|16|||
160757957|NCT00809445|580499607|FG001|6 Month Follow-up|Lost contact|14|||
160757958|NCT00809445|580499608|FG002|6 Month Follow-up|Lost contact|14|||
160757959|NCT00809445|580499606|FG000|6 Month Follow-up|Death|2|||
160757960|NCT00809445|580499607|FG001|6 Month Follow-up|Death|1|||
160757961|NCT00809445|580499608|FG002|6 Month Follow-up|Death|1|||
160757962|NCT00809445|580499606|FG000|6 Month Follow-up|Incarcerated|6|||
160757963|NCT00809445|580499607|FG001|6 Month Follow-up|Incarcerated|8|||
160757964|NCT00809445|580499608|FG002|6 Month Follow-up|Incarcerated|8|||
160757965|NCT00809445|580499606|FG000|6 Month Follow-up|Withdrew consent|0|||
160757966|NCT00809445|580499607|FG001|6 Month Follow-up|Withdrew consent|0|||
160757967|NCT00809445|580499608|FG002|6 Month Follow-up|Withdrew consent|1|||
160757968|NCT04919317|580499609|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
160757969|NCT04919317|580499610|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
160757970|NCT04919317|580499609|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
160757971|NCT04919317|580499610|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
160757972|NCT01566604|580499611|FG000|Overall Study|Patient's inability to use the device|1|||
160757973|NCT01566604|580499612|FG001|Overall Study|Patient's inability to use the device|0|||
160757974|NCT01566604|580499611|FG000|Overall Study|Administrative problems|1|||
160757975|NCT01566604|580499612|FG001|Overall Study|Administrative problems|0|||
160757976|NCT01566604|580499611|FG000|Overall Study|Lack of Efficacy|1|||
160757977|NCT01566604|580499612|FG001|Overall Study|Lack of Efficacy|2|||
160757978|NCT01566604|580499611|FG000|Overall Study|Protocol deviation|2|||
160757979|NCT01566604|580499612|FG001|Overall Study|Protocol deviation|0|||
160757980|NCT01566604|580499611|FG000|Overall Study|Abnormal laboratory value|2|||
160757981|NCT01566604|580499612|FG001|Overall Study|Abnormal laboratory value|0|||
160757982|NCT01566604|580499611|FG000|Overall Study|Death|4|||
160757983|NCT01566604|580499612|FG001|Overall Study|Death|1|||
160757984|NCT01566604|580499611|FG000|Overall Study|Adverse Event|4|||
160757985|NCT01566604|580499612|FG001|Overall Study|Adverse Event|2|||
160757986|NCT01566604|580499611|FG000|Overall Study|Withdrawal by Subject|9|||
160757987|NCT01566604|580499612|FG001|Overall Study|Withdrawal by Subject|6|||
160757988|NCT00661089|580499617|FG000|Overall Study|1 subject withdrawal|0|||
160757989|NCT00661089|580499618|FG001|Overall Study|1 subject withdrawal|1|||
160757990|NCT00661089|580499617|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
160757991|NCT00661089|580499618|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
160525151|NCT05266586|579651821|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
160525152|NCT05266586|579651822|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
160525153|NCT03707925|579651823|FG000|Overall Study|Inevaluable|1|||
160757992|NCT00186485|580499624|FG000|Overall Study|Lost to Follow-up|3|||
160525154|NCT01117857|579651827|FG000|Overall Study|Lost to Follow-up|4|||
160757993|NCT00905424|580499625|FG000|Overall Study|Lost to Follow-up|3|||
160757994|NCT00905424|580499626|FG001|Overall Study|Lost to Follow-up|3|||
160757995|NCT00905424|580499625|FG000|Overall Study|Withdrawal by Subject|1|||
160757996|NCT00905424|580499626|FG001|Overall Study|Withdrawal by Subject|2|||
160757997|NCT00905424|580499625|FG000|Overall Study|Adverse Event|4|||
160757998|NCT00905424|580499626|FG001|Overall Study|Adverse Event|2|||
160757999|NCT00905424|580499625|FG000|Overall Study|Non-compliance with study medication|2|||
160758000|NCT00905424|580499626|FG001|Overall Study|Non-compliance with study medication|0|||
160758001|NCT00905424|580499625|FG000|Overall Study|Sponsor decision|1|||
160758002|NCT00905424|580499626|FG001|Overall Study|Sponsor decision|0|||
160758003|NCT00905424|580499625|FG000|Overall Study|Positive urine drug screen|0|||
160758004|NCT00905424|580499626|FG001|Overall Study|Positive urine drug screen|1|||
160758005|NCT00905424|580499625|FG000|Overall Study|Non-adherence to visit schedule|0|||
160758006|NCT00905424|580499626|FG001|Overall Study|Non-adherence to visit schedule|1|||
160758007|NCT00426764|580499627|FG000|Overall Study|Protocol Violation|1|||
160758008|NCT00426764|580499627|FG000|Overall Study|Withdrawal by Subject|4|||
160758009|NCT00426764|580499627|FG000|Overall Study|Physician Decision|6|||
160758010|NCT00426764|580499627|FG000|Overall Study|Compassionate Use|1|||
160758011|NCT00426764|580499627|FG000|Overall Study|Progressive Disease|83|||
160758012|NCT00426764|580499627|FG000|Overall Study|Adverse Event|24|||
160758013|NCT00426764|580499627|FG000|Overall Study|Other|1|||
160758014|NCT00426764|580499627|FG000|Overall Study|Death|1|||
160758015|NCT00426764|580499627|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
160758016|NCT01922258|580499628|FG000|Overall Study|Lost to Follow-up|1|||
160758017|NCT01922258|580499629|FG001|Overall Study|Lost to Follow-up|1|||
160758018|NCT01922258|580499628|FG000|Overall Study|Adverse Event|9|||
160758019|NCT01922258|580499629|FG001|Overall Study|Adverse Event|2|||
160758020|NCT01922258|580499628|FG000|Overall Study|Met Withdrawal Criteria|0|||
160758021|NCT01922258|580499629|FG001|Overall Study|Met Withdrawal Criteria|4|||
160758022|NCT01922258|580499628|FG000|Overall Study|Withdrawn by the Investigator|1|||
160758023|NCT01922258|580499629|FG001|Overall Study|Withdrawn by the Investigator|4|||
160758024|NCT01922258|580499628|FG000|Overall Study|Withdrawal by participant|5|||
160758025|NCT01922258|580499629|FG001|Overall Study|Withdrawal by participant|5|||
160758026|NCT01166750|580499630|FG000|Overall Study|Lost to Follow-up|1|||
160758027|NCT01166750|580499631|FG001|Overall Study|Lost to Follow-up|0|||
160758028|NCT05225389|580499632|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
160758029|NCT02417753|580499633|FG000|Overall Study|Death|1|||
160758030|NCT03113968|580499634|FG000|Overall Study|Withdrawal by Subject|31|||
160758031|NCT03113968|580499635|FG001|Overall Study|Withdrawal by Subject|4|||
160758032|NCT04805671|580499636|FG000|Overall Study|Death|2|||
160758033|NCT04805671|580499637|FG001|Overall Study|Death|7|||
160758034|NCT04805671|580499636|FG000|Overall Study|Lost to Follow-up|1|||
160758035|NCT04805671|580499637|FG001|Overall Study|Lost to Follow-up|0|||
160758036|NCT04805671|580499636|FG000|Overall Study|Withdrawal by Subject|9|||
160758037|NCT04805671|580499637|FG001|Overall Study|Withdrawal by Subject|7|||
160758038|NCT04805671|580499636|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
160758039|NCT04805671|580499637|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
160758040|NCT00901342|580499638|FG000|Overall Study|Adverse Event|1|||
160758041|NCT00901342|580499638|FG000|Overall Study|Death|4|||
160758042|NCT00901342|580499638|FG000|Overall Study|Disease progression|1|||
160525155|NCT01117857|579651827|FG000|Overall Study|Withdrawal by Subject|4|||
160525156|NCT01117857|579651827|FG000|Overall Study|Physician Decision|1|||
160525157|NCT02876835|579651828|FG000|Treatment Period (51.1 Month)|Other|1|||
160525158|NCT02876835|579651829|FG001|Treatment Period (51.1 Month)|Other|0|||
160525159|NCT02876835|579651828|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
160525160|NCT02876835|579651829|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
160525161|NCT02876835|579651828|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
160636271|NCT01508325|580051516|FG000|Overall Study|Physician Decision|2|||
160758043|NCT00901342|580499638|FG000|Overall Study|Withdrawal by Subject|9|||
160636272|NCT01508325|580051517|FG001|Overall Study|Physician Decision|1|||
160636273|NCT01508325|580051516|FG000|Overall Study|Adverse Event|1|||
160758044|NCT03804268|580499639|FG000|Overall Study|Adverse Event|2|||
160525162|NCT02876835|579651829|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
160525163|NCT02876835|579651828|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
160525164|NCT02876835|579651829|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
160525165|NCT00954421|579651830|FG000|Screening|screen failures|3|||
160525166|NCT00954421|579651830|FG000|6 Months of DBS|Withdrawal by Subject|1|||
160525167|NCT00954421|579651830|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
160525168|NCT04683731|579651833|FG000|Overall Study|Withdrawal by Subject|1|||
160525169|NCT04683731|579651834|FG001|Overall Study|Withdrawal by Subject|0|||
160636274|NCT01508325|580051517|FG001|Overall Study|Adverse Event|0|||
160525170|NCT04683731|579651835|FG002|Overall Study|Withdrawal by Subject|3|||
160636275|NCT01508325|580051516|FG000|Overall Study|Lost to Follow-up|5|||
160636276|NCT01508325|580051517|FG001|Overall Study|Lost to Follow-up|6|||
160636277|NCT01508325|580051516|FG000|Overall Study|Other|2|||
160525171|NCT04683731|579651836|FG003|Overall Study|Withdrawal by Subject|2|||
160525172|NCT04683731|579651833|FG000|Overall Study|Determined patient was not eligible|3|||
160525173|NCT04683731|579651834|FG001|Overall Study|Determined patient was not eligible|3|||
160525174|NCT04683731|579651835|FG002|Overall Study|Determined patient was not eligible|12|||
160525175|NCT04683731|579651836|FG003|Overall Study|Determined patient was not eligible|3|||
160525176|NCT01335009|579651837|FG000|Overall Study|Too ill to travel to study sites|1|||
160525177|NCT01335009|579651838|FG001|Overall Study|Too ill to travel to study sites|0|||
160525178|NCT01335009|579651837|FG000|Overall Study|Death|28|||
160525179|NCT01335009|579651838|FG001|Overall Study|Death|32|||
160525180|NCT01335009|579651837|FG000|Overall Study|Withdrawal by Subject|1|||
160525181|NCT01335009|579651838|FG001|Overall Study|Withdrawal by Subject|1|||
160525182|NCT01335009|579651837|FG000|Overall Study|Lost to Follow-up|1|||
160525183|NCT01335009|579651838|FG001|Overall Study|Lost to Follow-up|0|||
160525184|NCT04824521|579651839|FG000|Overall Study|Lost to Follow-up|1|||
160525185|NCT01598311|579651840|FG000|Overall Study|Physician Decision|4|||
160525186|NCT01598311|579651841|FG001|Overall Study|Physician Decision|5|||
160525187|NCT01598311|579651840|FG000|Overall Study|Adverse Event|9|||
160525188|NCT01598311|579651841|FG001|Overall Study|Adverse Event|13|||
160525189|NCT01598311|579651840|FG000|Overall Study|Lost to Follow-up|7|||
160525190|NCT01598311|579651841|FG001|Overall Study|Lost to Follow-up|12|||
160525191|NCT01598311|579651840|FG000|Overall Study|Withdrawal by Subject|9|||
160525192|NCT01598311|579651841|FG001|Overall Study|Withdrawal by Subject|13|||
160525193|NCT01598311|579651840|FG000|Overall Study|No reason provided.|0|||
160525194|NCT01598311|579651841|FG001|Overall Study|No reason provided.|5|||
160525195|NCT01598311|579651840|FG000|Overall Study|Randomized but never treated|8|||
160525196|NCT01598311|579651841|FG001|Overall Study|Randomized but never treated|5|||
160525197|NCT01598311|579651840|FG000|Overall Study|Treated but no confirmed CDAD|9|||
160525198|NCT01598311|579651841|FG001|Overall Study|Treated but no confirmed CDAD|8|||
160525199|NCT01598311|579651840|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
160525200|NCT01598311|579651841|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
160525201|NCT04641299|579653674|FG000|Overall Study|Adverse Event|0|||
160525202|NCT04641299|579653675|FG001|Overall Study|Adverse Event|0|||
160525203|NCT04641299|579653676|FG002|Overall Study|Adverse Event|2|||
160758045|NCT03804268|580499640|FG001|Overall Study|Adverse Event|2|||
160758046|NCT03804268|580499639|FG000|Overall Study|Withdrawal by Subject|2|||
160758047|NCT03804268|580499640|FG001|Overall Study|Withdrawal by Subject|0|||
160758048|NCT03804268|580499639|FG000|Overall Study|Lost to Follow-up|1|||
160758049|NCT03804268|580499640|FG001|Overall Study|Lost to Follow-up|0|||
160758050|NCT03804268|580499639|FG000|Overall Study|Physician Decision|2|||
160525204|NCT04641299|579653677|FG003|Overall Study|Adverse Event|0|||
160525205|NCT04641299|579653674|FG000|Overall Study|Lost to Follow-up|0|||
160758051|NCT03804268|580499640|FG001|Overall Study|Physician Decision|0|||
160758052|NCT02849587|580499641|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
160758053|NCT02849587|580499642|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
160758054|NCT02849587|580499643|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
160758055|NCT02849587|580499641|FG000|Overall Study|Withdrawal by Subject|0|||
160758056|NCT02849587|580499642|FG001|Overall Study|Withdrawal by Subject|1|||
160758057|NCT02849587|580499643|FG002|Overall Study|Withdrawal by Subject|0|||
160758058|NCT03380377|580499644|FG000|Overall Study|Physician Decision|1|||
160758059|NCT03380377|580499644|FG000|Overall Study|Withdrawal by Subject|1|||
160758060|NCT03421379|580499645|FG000|Period 1|Withdrawal by Subject|0|||
160758061|NCT03421379|580499646|FG001|Period 1|Withdrawal by Subject|1|||
160758062|NCT03421379|580499645|FG000|Period 1|Physician Decision|1|||
160758063|NCT03421379|580499646|FG001|Period 1|Physician Decision|1|||
160758064|NCT03421379|580499645|FG000|Period 1|Did not receive treatment|1|||
160758065|NCT03421379|580499646|FG001|Period 1|Did not receive treatment|2|||
160758066|NCT01951417|580499648|FG000|Overall Study|Withdrawal by Subject|1|||
160758067|NCT01951417|580499648|FG000|Overall Study|Protocol Violation|2|||
160758068|NCT01951417|580499648|FG000|Overall Study|Lost to Follow-up|6|||
160758069|NCT04010461|580499649|FG000|Overall Study|COVID based withdrawal|5|||
160758070|NCT04010461|580499649|FG000|Overall Study|Withdrawal by Subject|5|||
160758071|NCT04010461|580499649|FG000|Overall Study|Adverse Event|1|||
160758072|NCT04010461|580499649|FG000|Overall Study|No Motor Threshold obtainable|1|||
160758073|NCT04010461|580499649|FG000|Overall Study|Physician Decision|1|||
160758074|NCT03771963|580499650|FG000|Overall Study|Lost to Follow-up|22|||
160758075|NCT03771963|580499650|FG000|Overall Study|Withdrawal of Consent|10|||
160758076|NCT01026948|580499651|FG000|Overall Study|Physician Decision|8|||
160758077|NCT01275144|580499652|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
160758078|NCT01275144|580499653|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
160758079|NCT05116202|580499654|FG000|Overall Study|Study Terminated by Sponsor|21|||
160758080|NCT05116202|580499655|FG001|Overall Study|Study Terminated by Sponsor|38|||
160758081|NCT05116202|580499656|FG002|Overall Study|Study Terminated by Sponsor|17|||
160758082|NCT05116202|580499657|FG003|Overall Study|Study Terminated by Sponsor|18|||
160758083|NCT05116202|580499658|FG004|Overall Study|Study Terminated by Sponsor|0|||
160758084|NCT05116202|580499654|FG000|Overall Study|Withdrawal by Subject|0|||
160758085|NCT05116202|580499655|FG001|Overall Study|Withdrawal by Subject|1|||
160758086|NCT05116202|580499656|FG002|Overall Study|Withdrawal by Subject|1|||
160758087|NCT05116202|580499657|FG003|Overall Study|Withdrawal by Subject|1|||
160758088|NCT05116202|580499658|FG004|Overall Study|Withdrawal by Subject|1|||
160758089|NCT05116202|580499654|FG000|Overall Study|Lost to Follow-up|0|||
160758090|NCT05116202|580499655|FG001|Overall Study|Lost to Follow-up|0|||
160758091|NCT05116202|580499656|FG002|Overall Study|Lost to Follow-up|0|||
160758092|NCT05116202|580499657|FG003|Overall Study|Lost to Follow-up|0|||
160758093|NCT05116202|580499658|FG004|Overall Study|Lost to Follow-up|2|||
160758094|NCT05116202|580499654|FG000|Overall Study|Death|1|||
160758095|NCT05116202|580499655|FG001|Overall Study|Death|1|||
160758096|NCT05116202|580499656|FG002|Overall Study|Death|2|||
160758097|NCT05116202|580499657|FG003|Overall Study|Death|1|||
160758098|NCT05116202|580499658|FG004|Overall Study|Death|5|||
160758099|NCT00096538|580499665|FG000|Overall Study|Withdrawal by Subject|1|||
160758100|NCT02324361|580499671|FG000|Overall Study|Lost to Follow-up|5|||
160758101|NCT02324361|580499672|FG001|Overall Study|Lost to Follow-up|2|||
160758102|NCT00715403|580499680|FG000|Overall Study|Progressive disease|0|||
160758103|NCT00715403|580499681|FG001|Overall Study|Progressive disease|1|||
160758104|NCT00715403|580499682|FG002|Overall Study|Progressive disease|3|||
160758105|NCT00715403|580499683|FG003|Overall Study|Progressive disease|9|||
160758106|NCT00715403|580499684|FG004|Overall Study|Progressive disease|5|||
160758107|NCT00715403|580499685|FG005|Overall Study|Progressive disease|14|||
160758108|NCT00715403|580499686|FG006|Overall Study|Progressive disease|1|||
160758109|NCT00715403|580499680|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
160758110|NCT00715403|580499681|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
160758111|NCT00715403|580499682|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
160758112|NCT00715403|580499683|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
160758113|NCT00715403|580499684|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
160758114|NCT00715403|580499685|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
160758115|NCT00715403|580499686|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
160758116|NCT00715403|580499680|FG000|Overall Study|Other Adverse Event than DLT|1|||
160758117|NCT00715403|580499681|FG001|Overall Study|Other Adverse Event than DLT|0|||
160758118|NCT00715403|580499682|FG002|Overall Study|Other Adverse Event than DLT|0|||
160758119|NCT00715403|580499683|FG003|Overall Study|Other Adverse Event than DLT|0|||
160758120|NCT00715403|580499684|FG004|Overall Study|Other Adverse Event than DLT|0|||
160758121|NCT00715403|580499685|FG005|Overall Study|Other Adverse Event than DLT|2|||
160758122|NCT00715403|580499686|FG006|Overall Study|Other Adverse Event than DLT|0|||
160758123|NCT00715403|580499680|FG000|Overall Study|Protocol Violation|0|||
160758124|NCT00715403|580499681|FG001|Overall Study|Protocol Violation|0|||
160758125|NCT00715403|580499682|FG002|Overall Study|Protocol Violation|0|||
160758126|NCT00715403|580499683|FG003|Overall Study|Protocol Violation|0|||
160758127|NCT00715403|580499684|FG004|Overall Study|Protocol Violation|0|||
160758128|NCT00715403|580499685|FG005|Overall Study|Protocol Violation|1|||
160758129|NCT00715403|580499686|FG006|Overall Study|Protocol Violation|0|||
160758130|NCT00715403|580499680|FG000|Overall Study|Other reason not defined above|0|||
160758131|NCT00715403|580499681|FG001|Overall Study|Other reason not defined above|0|||
160758132|NCT00715403|580499682|FG002|Overall Study|Other reason not defined above|1|||
160758133|NCT00715403|580499683|FG003|Overall Study|Other reason not defined above|0|||
160758134|NCT00715403|580499684|FG004|Overall Study|Other reason not defined above|1|||
160758135|NCT00715403|580499685|FG005|Overall Study|Other reason not defined above|1|||
160758136|NCT00715403|580499686|FG006|Overall Study|Other reason not defined above|0|||
160758137|NCT00520039|580499689|FG000|Overall Study|Exclusion criteria met at first visit|7|||
160758138|NCT00520039|580499690|FG001|Overall Study|Exclusion criteria met at first visit|5|||
160758139|NCT03560869|580499691|FG000|Overall Study|Withdrawal by Subject|3|||
160758140|NCT03560869|580499692|FG001|Overall Study|Withdrawal by Subject|4|||
160758141|NCT03560869|580499691|FG000|Overall Study|Screening failure|4|||
160758142|NCT03560869|580499692|FG001|Overall Study|Screening failure|4|||
160758143|NCT03560869|580499691|FG000|Overall Study|Withdrawal by PI|0|||
160758144|NCT03560869|580499692|FG001|Overall Study|Withdrawal by PI|1|||
160758145|NCT01386606|580501401|FG000|Overall Study|Adverse Event|0|||
160758146|NCT01386606|580501402|FG001|Overall Study|Adverse Event|1|||
160758147|NCT01386606|580501403|FG002|Overall Study|Adverse Event|0|||
160758148|NCT01386606|580501404|FG003|Overall Study|Adverse Event|0|||
160758149|NCT01386606|580501401|FG000|Overall Study|Withdrawal by Subject|0|||
160758150|NCT01386606|580501402|FG001|Overall Study|Withdrawal by Subject|1|||
160758151|NCT01386606|580501403|FG002|Overall Study|Withdrawal by Subject|1|||
160758152|NCT01386606|580501404|FG003|Overall Study|Withdrawal by Subject|0|||
160758153|NCT01386606|580501401|FG000|Overall Study|Protocol Violation|1|||
160758154|NCT01386606|580501402|FG001|Overall Study|Protocol Violation|0|||
160758155|NCT01386606|580501403|FG002|Overall Study|Protocol Violation|1|||
160758156|NCT01386606|580501404|FG003|Overall Study|Protocol Violation|1|||
160758157|NCT01386606|580501401|FG000|Overall Study|Lost to Follow-up|2|||
160758158|NCT01386606|580501402|FG001|Overall Study|Lost to Follow-up|0|||
160758159|NCT01386606|580501403|FG002|Overall Study|Lost to Follow-up|0|||
160758160|NCT01386606|580501404|FG003|Overall Study|Lost to Follow-up|0|||
160758161|NCT01386606|580501401|FG000|Overall Study|Subject incarcerated|0|||
160758162|NCT01386606|580501402|FG001|Overall Study|Subject incarcerated|1|||
160758163|NCT01386606|580501403|FG002|Overall Study|Subject incarcerated|0|||
160758164|NCT01386606|580501404|FG003|Overall Study|Subject incarcerated|0|||
160758165|NCT01386606|580501401|FG000|Overall Study|Unable to draw PK|1|||
160758166|NCT01386606|580501402|FG001|Overall Study|Unable to draw PK|0|||
160758167|NCT01386606|580501403|FG002|Overall Study|Unable to draw PK|0|||
160758168|NCT01386606|580501404|FG003|Overall Study|Unable to draw PK|0|||
160758169|NCT01386606|580501401|FG000|Overall Study|T levels too high|0|||
160758170|NCT01386606|580501402|FG001|Overall Study|T levels too high|1|||
160758171|NCT01386606|580501403|FG002|Overall Study|T levels too high|1|||
160758172|NCT01386606|580501404|FG003|Overall Study|T levels too high|0|||
160758173|NCT00593814|580501406|FG000|Overall Study|Death|7|||
160758174|NCT00593814|580501407|FG001|Overall Study|Death|0|||
160758175|NCT00593814|580501406|FG000|Overall Study|Withdrawal by Subject|7|||
160758176|NCT00593814|580501407|FG001|Overall Study|Withdrawal by Subject|0|||
160758177|NCT00593814|580501406|FG000|Overall Study|Lost to Follow-up|7|||
160758178|NCT00593814|580501407|FG001|Overall Study|Lost to Follow-up|0|||
160758179|NCT00593814|580501406|FG000|Overall Study|Physician Decision|3|||
160758180|NCT00593814|580501407|FG001|Overall Study|Physician Decision|0|||
160758181|NCT03110354|580501408|FG000|Overall Study|Death|1|||
160758182|NCT03110354|580501409|FG001|Overall Study|Death|0|||
160758183|NCT03110354|580501410|FG002|Overall Study|Death|0|||
160758184|NCT03110354|580501411|FG003|Overall Study|Death|1|||
160758185|NCT03110354|580501412|FG004|Overall Study|Death|0|||
160758186|NCT03110354|580501408|FG000|Overall Study|Start of new therapy|0|||
160758187|NCT03110354|580501409|FG001|Overall Study|Start of new therapy|0|||
160758188|NCT03110354|580501410|FG002|Overall Study|Start of new therapy|0|||
160758189|NCT03110354|580501411|FG003|Overall Study|Start of new therapy|0|||
160758190|NCT03110354|580501412|FG004|Overall Study|Start of new therapy|1|||
160758191|NCT03110354|580501408|FG000|Overall Study|Failure to achieve response|2|||
160758192|NCT03110354|580501409|FG001|Overall Study|Failure to achieve response|3|||
160758193|NCT03110354|580501410|FG002|Overall Study|Failure to achieve response|0|||
160758194|NCT03110354|580501411|FG003|Overall Study|Failure to achieve response|2|||
160758195|NCT03110354|580501412|FG004|Overall Study|Failure to achieve response|1|||
160758196|NCT03110354|580501408|FG000|Overall Study|Progressive disease|1|||
160758197|NCT03110354|580501409|FG001|Overall Study|Progressive disease|1|||
160758198|NCT03110354|580501410|FG002|Overall Study|Progressive disease|3|||
160758199|NCT03110354|580501411|FG003|Overall Study|Progressive disease|4|||
160758200|NCT03110354|580501412|FG004|Overall Study|Progressive disease|2|||
160758201|NCT03110354|580501408|FG000|Overall Study|Adverse Event|0|||
160758202|NCT03110354|580501409|FG001|Overall Study|Adverse Event|0|||
160758203|NCT03110354|580501410|FG002|Overall Study|Adverse Event|0|||
160758204|NCT03110354|580501411|FG003|Overall Study|Adverse Event|2|||
160758205|NCT03110354|580501412|FG004|Overall Study|Adverse Event|2|||
160758206|NCT03110354|580501408|FG000|Overall Study|Other|0|||
160758207|NCT03110354|580501409|FG001|Overall Study|Other|0|||
160758208|NCT03110354|580501410|FG002|Overall Study|Other|0|||
160758209|NCT03110354|580501411|FG003|Overall Study|Other|1|||
160758210|NCT03110354|580501412|FG004|Overall Study|Other|1|||
160758211|NCT01965327|580501415|FG000|Overall Study|Physician Decision|2|||
160758212|NCT00528424|580501416|FG000|Overall Study|Lost to Follow-up|13|||
160758213|NCT00528424|580501416|FG000|Overall Study|Withdrew consent|2|||
160758214|NCT00528424|580501416|FG000|Overall Study|Administrative reason|2|||
160758215|NCT00528424|580501416|FG000|Overall Study|Other|12|||
160758216|NCT02185417|580501417|FG000|Overall Study|Death|448|||
160758217|NCT02185417|580501418|FG001|Overall Study|Death|446|||
160758218|NCT02185417|580501419|FG002|Overall Study|Death|0|||
160758219|NCT02185417|580501417|FG000|Overall Study|Withdrawal by Subject|7|||
160758220|NCT02185417|580501418|FG001|Overall Study|Withdrawal by Subject|12|||
160758221|NCT02185417|580501419|FG002|Overall Study|Withdrawal by Subject|0|||
160758222|NCT02976519|580501422|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
160758223|NCT02976519|580501423|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
160758224|NCT02976519|580501424|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
160758225|NCT02976519|580501425|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
160758226|NCT02976519|580501426|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
160758227|NCT02976519|580501427|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
160758228|NCT02976519|580501428|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
160758229|NCT02976519|580501422|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
160758230|NCT02976519|580501423|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
160758231|NCT02976519|580501424|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
160758232|NCT02976519|580501425|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
160758233|NCT02976519|580501426|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
160758234|NCT02976519|580501427|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
160758235|NCT02976519|580501428|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
160758236|NCT02976519|580501422|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
160758237|NCT02976519|580501423|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
160758238|NCT02976519|580501424|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
160758239|NCT02976519|580501425|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
160758240|NCT02976519|580501426|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
160758241|NCT02976519|580501427|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
160758242|NCT02976519|580501428|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
160758243|NCT02976519|580501422|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
160758244|NCT02976519|580501423|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
160758245|NCT02976519|580501424|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
160758246|NCT02976519|580501425|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
160758247|NCT02976519|580501426|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
160758248|NCT02976519|580501427|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
160758249|NCT02976519|580501428|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
160758250|NCT02976519|580501422|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
160758251|NCT02976519|580501423|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
160758252|NCT02976519|580501424|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
160758253|NCT02976519|580501425|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
160758254|NCT02976519|580501426|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
160758255|NCT02976519|580501427|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
160758256|NCT02976519|580501428|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
160758257|NCT01278342|580501429|FG000|Overall Study|Physician Decision|0|||
160758258|NCT01278342|580501430|FG001|Overall Study|Physician Decision|1|||
160758259|NCT01278342|580501431|FG002|Overall Study|Physician Decision|0|||
160758260|NCT01278342|580501429|FG000|Overall Study|Lost to Follow-up|1|||
160758261|NCT01278342|580501430|FG001|Overall Study|Lost to Follow-up|0|||
160758262|NCT01278342|580501431|FG002|Overall Study|Lost to Follow-up|0|||
160758263|NCT01278342|580501429|FG000|Overall Study|Administrative problems|2|||
160758264|NCT01278342|580501430|FG001|Overall Study|Administrative problems|0|||
160758265|NCT01278342|580501431|FG002|Overall Study|Administrative problems|0|||
160758266|NCT01278342|580501429|FG000|Overall Study|Other|1|||
160758267|NCT01278342|580501430|FG001|Overall Study|Other|0|||
160758268|NCT01278342|580501431|FG002|Overall Study|Other|0|||
160758269|NCT00473655|580501439|FG000|Overall Study|Lost to Follow-up|9|||
160758270|NCT00473655|580501440|FG001|Overall Study|Lost to Follow-up|5|||
160758271|NCT00473655|580501441|FG002|Overall Study|Lost to Follow-up|8|||
160758272|NCT02513550|580501449|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
160758273|NCT02513550|580501450|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
160758274|NCT02513550|580501451|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
160758275|NCT02513550|580501452|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
160758276|NCT02513550|580501453|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
160758277|NCT02513550|580501454|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
160758278|NCT02513550|580501449|FG000|Double Blind Treatment Period|Adverse Event|5|||
160758279|NCT02513550|580501450|FG001|Double Blind Treatment Period|Adverse Event|13|||
160758280|NCT02513550|580501451|FG002|Double Blind Treatment Period|Adverse Event|17|||
160758281|NCT02513550|580501452|FG003|Double Blind Treatment Period|Adverse Event|0|||
160758282|NCT02513550|580501453|FG004|Double Blind Treatment Period|Adverse Event|1|||
160758283|NCT02513550|580501454|FG005|Double Blind Treatment Period|Adverse Event|0|||
160758284|NCT02513550|580501449|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
160758285|NCT02513550|580501450|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
160758286|NCT02513550|580501451|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
160758287|NCT02513550|580501452|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
160758288|NCT02513550|580501453|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
160758289|NCT02513550|580501454|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
160758290|NCT02513550|580501449|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
160758291|NCT02513550|580501450|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
160758292|NCT02513550|580501451|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
160758293|NCT02513550|580501452|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
160758294|NCT02513550|580501453|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
160758295|NCT02513550|580501454|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
160758296|NCT02513550|580501449|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160758297|NCT02513550|580501450|FG001|Double Blind Treatment Period|Protocol Violation|1|||
160758298|NCT02513550|580501451|FG002|Double Blind Treatment Period|Protocol Violation|4|||
160758299|NCT02513550|580501452|FG003|Double Blind Treatment Period|Protocol Violation|0|||
160758300|NCT02513550|580501453|FG004|Double Blind Treatment Period|Protocol Violation|0|||
160758301|NCT02513550|580501454|FG005|Double Blind Treatment Period|Protocol Violation|0|||
160758302|NCT02513550|580501449|FG000|Double Blind Treatment Period|Physician Decision|2|||
160758303|NCT02513550|580501450|FG001|Double Blind Treatment Period|Physician Decision|0|||
160758304|NCT02513550|580501451|FG002|Double Blind Treatment Period|Physician Decision|4|||
160758305|NCT02513550|580501452|FG003|Double Blind Treatment Period|Physician Decision|0|||
160758306|NCT02513550|580501453|FG004|Double Blind Treatment Period|Physician Decision|0|||
160758307|NCT02513550|580501454|FG005|Double Blind Treatment Period|Physician Decision|0|||
160758308|NCT02513550|580501449|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
160758309|NCT02513550|580501450|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
160758310|NCT02513550|580501451|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
160758311|NCT02513550|580501452|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
160758312|NCT02513550|580501453|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
160758313|NCT02513550|580501454|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
160758314|NCT02513550|580501449|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
160758315|NCT02513550|580501450|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
160758316|NCT02513550|580501451|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
160758317|NCT02513550|580501452|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
160758318|NCT02513550|580501453|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
160758319|NCT02513550|580501454|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
160758320|NCT02513550|580501449|FG000|Double Blind Treatment Period|Due to personal business|2|||
160758321|NCT02513550|580501450|FG001|Double Blind Treatment Period|Due to personal business|0|||
160758322|NCT02513550|580501451|FG002|Double Blind Treatment Period|Due to personal business|1|||
160758323|NCT02513550|580501452|FG003|Double Blind Treatment Period|Due to personal business|0|||
160758324|NCT02513550|580501453|FG004|Double Blind Treatment Period|Due to personal business|0|||
160758325|NCT02513550|580501454|FG005|Double Blind Treatment Period|Due to personal business|0|||
160758326|NCT02513550|580501449|FG000|Double Blind Treatment Period|Death|1|||
160758327|NCT02513550|580501450|FG001|Double Blind Treatment Period|Death|0|||
160758328|NCT02513550|580501451|FG002|Double Blind Treatment Period|Death|2|||
160758329|NCT02513550|580501452|FG003|Double Blind Treatment Period|Death|0|||
160758330|NCT02513550|580501453|FG004|Double Blind Treatment Period|Death|0|||
160758331|NCT02513550|580501454|FG005|Double Blind Treatment Period|Death|0|||
160758332|NCT02513550|580501449|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
160758333|NCT02513550|580501450|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
160758334|NCT02513550|580501451|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
160758335|NCT02513550|580501452|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160758336|NCT02513550|580501453|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160758337|NCT02513550|580501454|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
160758338|NCT02513550|580501449|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
160758339|NCT02513550|580501450|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
160758340|NCT02513550|580501451|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
160758341|NCT02513550|580501452|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
160758342|NCT02513550|580501453|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
160758343|NCT02513550|580501454|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
160758344|NCT02513550|580501449|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
160758345|NCT02513550|580501450|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
160758346|NCT02513550|580501451|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
160758347|NCT02513550|580501452|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160758348|NCT02513550|580501453|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160758349|NCT02513550|580501454|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
160758350|NCT02513550|580501449|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
160758351|NCT02513550|580501450|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
160758352|NCT02513550|580501451|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
160758353|NCT02513550|580501452|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
160758354|NCT02513550|580501453|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
160758355|NCT02513550|580501454|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
160758356|NCT02513550|580501449|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
160758357|NCT02513550|580501450|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
160758358|NCT02513550|580501451|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
160758359|NCT02513550|580501452|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
160758360|NCT02513550|580501453|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
160758361|NCT02513550|580501454|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
160758362|NCT02513550|580501449|FG000|Post-Treatment Follow-up Period|Death|0|||
160758363|NCT02513550|580501450|FG001|Post-Treatment Follow-up Period|Death|0|||
160758364|NCT02513550|580501451|FG002|Post-Treatment Follow-up Period|Death|1|||
160758365|NCT02513550|580501452|FG003|Post-Treatment Follow-up Period|Death|0|||
160758366|NCT02513550|580501453|FG004|Post-Treatment Follow-up Period|Death|0|||
160758367|NCT02513550|580501454|FG005|Post-Treatment Follow-up Period|Death|0|||
160758368|NCT02513550|580501449|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
160758369|NCT02513550|580501450|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
160758370|NCT02513550|580501451|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
160758371|NCT02513550|580501452|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
160758372|NCT02513550|580501453|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
160758373|NCT02513550|580501454|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
160758374|NCT02513550|580501449|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
160758375|NCT02513550|580501450|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
160758376|NCT02513550|580501451|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
160758377|NCT02513550|580501452|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
160758378|NCT02513550|580501453|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
160758379|NCT02513550|580501454|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
160758380|NCT02513550|580501449|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
160758381|NCT02513550|580501450|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
160758382|NCT02513550|580501451|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
160758383|NCT02513550|580501452|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
160758384|NCT02513550|580501453|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
160758385|NCT02513550|580501454|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
160758386|NCT00243919|580501455|FG000|Overall Study|Death|3|||
160758387|NCT00243919|580501456|FG001|Overall Study|Death|4|||
160758388|NCT00243919|580501457|FG002|Overall Study|Death|6|||
160758389|NCT00243919|580501455|FG000|Overall Study|Withdrawal by Subject|6|||
160758390|NCT00243919|580501456|FG001|Overall Study|Withdrawal by Subject|6|||
160758391|NCT00243919|580501457|FG002|Overall Study|Withdrawal by Subject|2|||
160758392|NCT00243919|580501455|FG000|Overall Study|Lost to Follow-up|6|||
160758393|NCT00243919|580501456|FG001|Overall Study|Lost to Follow-up|7|||
160758394|NCT00243919|580501457|FG002|Overall Study|Lost to Follow-up|3|||
160758395|NCT00243919|580501455|FG000|Overall Study|Administrative Error|1|||
160525206|NCT04641299|579653675|FG001|Overall Study|Lost to Follow-up|1|||
160758396|NCT00243919|580501456|FG001|Overall Study|Administrative Error|0|||
160758397|NCT00243919|580501457|FG002|Overall Study|Administrative Error|0|||
160758398|NCT00243919|580501455|FG000|Overall Study|Physician Decision|1|||
160758399|NCT00243919|580501456|FG001|Overall Study|Physician Decision|1|||
160758400|NCT00243919|580501457|FG002|Overall Study|Physician Decision|0|||
160758401|NCT00321906|580501458|FG000|Overall Study|Adverse Event|36|||
160758402|NCT00321906|580501459|FG001|Overall Study|Adverse Event|44|||
160758403|NCT00321906|580501458|FG000|Overall Study|Death|9|||
160758404|NCT00321906|580501459|FG001|Overall Study|Death|6|||
160758405|NCT00321906|580501458|FG000|Overall Study|Lost to Follow-up|1|||
160758406|NCT00321906|580501459|FG001|Overall Study|Lost to Follow-up|2|||
160758407|NCT00321906|580501458|FG000|Overall Study|Withdrawal by Subject|0|||
160758408|NCT00321906|580501459|FG001|Overall Study|Withdrawal by Subject|4|||
160758409|NCT02221648|580501462|FG000|Overall Study|Withdrawal by Subject|3|||
160758410|NCT02221648|580501463|FG001|Overall Study|Withdrawal by Subject|3|||
160758411|NCT00810069|580501465|FG000|Lead-in Period I|Adverse Event|43|||
160758412|NCT00810069|580501466|FG001|Lead-in Period I|Adverse Event|0|||
160758413|NCT00810069|580501467|FG002|Lead-in Period I|Adverse Event|0|||
160758414|NCT00810069|580501465|FG000|Lead-in Period I|Lack of Efficacy|1|||
160758415|NCT00810069|580501466|FG001|Lead-in Period I|Lack of Efficacy|0|||
160758416|NCT00810069|580501467|FG002|Lead-in Period I|Lack of Efficacy|0|||
160758417|NCT00810069|580501465|FG000|Lead-in Period I|Lost to Follow-up|19|||
160758418|NCT00810069|580501466|FG001|Lead-in Period I|Lost to Follow-up|0|||
160758419|NCT00810069|580501467|FG002|Lead-in Period I|Lost to Follow-up|0|||
160758420|NCT00810069|580501465|FG000|Lead-in Period I|Physician Decision|1|||
160758421|NCT00810069|580501466|FG001|Lead-in Period I|Physician Decision|0|||
160758422|NCT00810069|580501467|FG002|Lead-in Period I|Physician Decision|0|||
160758423|NCT00810069|580501465|FG000|Lead-in Period I|Protocol Violation|1|||
160758424|NCT00810069|580501466|FG001|Lead-in Period I|Protocol Violation|0|||
160758425|NCT00810069|580501467|FG002|Lead-in Period I|Protocol Violation|0|||
160758426|NCT00810069|580501465|FG000|Lead-in Period I|Withdrawal by Subject|46|||
160758427|NCT00810069|580501466|FG001|Lead-in Period I|Withdrawal by Subject|0|||
160758428|NCT00810069|580501467|FG002|Lead-in Period I|Withdrawal by Subject|0|||
160758429|NCT00810069|580501465|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
160758430|NCT00810069|580501466|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
160758431|NCT00810069|580501467|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
160758432|NCT00810069|580501465|FG000|Lead-in Period I|Randomization criteria not met|158|||
160758433|NCT00810069|580501466|FG001|Lead-in Period I|Randomization criteria not met|0|||
160758434|NCT00810069|580501467|FG002|Lead-in Period I|Randomization criteria not met|0|||
160758435|NCT00810069|580501465|FG000|Double-Blind Period II|Adverse Event|0|||
160758436|NCT00810069|580501466|FG001|Double-Blind Period II|Adverse Event|9|||
160758437|NCT00810069|580501467|FG002|Double-Blind Period II|Adverse Event|8|||
160525207|NCT04641299|579653676|FG002|Overall Study|Lost to Follow-up|0|||
160525208|NCT04641299|579653677|FG003|Overall Study|Lost to Follow-up|0|||
160525209|NCT04641299|579653674|FG000|Overall Study|Withdrawal by Subject|1|||
160525210|NCT04641299|579653675|FG001|Overall Study|Withdrawal by Subject|0|||
160525211|NCT04641299|579653676|FG002|Overall Study|Withdrawal by Subject|0|||
160758438|NCT00810069|580501465|FG000|Double-Blind Period II|Lack of Efficacy|0|||
160758439|NCT00810069|580501466|FG001|Double-Blind Period II|Lack of Efficacy|7|||
160758440|NCT00810069|580501467|FG002|Double-Blind Period II|Lack of Efficacy|12|||
160758441|NCT00810069|580501465|FG000|Double-Blind Period II|Lost to Follow-up|0|||
160758442|NCT00810069|580501466|FG001|Double-Blind Period II|Lost to Follow-up|9|||
160758443|NCT00810069|580501467|FG002|Double-Blind Period II|Lost to Follow-up|9|||
160758444|NCT00810069|580501465|FG000|Double-Blind Period II|Physician Decision|0|||
160758445|NCT00810069|580501466|FG001|Double-Blind Period II|Physician Decision|0|||
160758446|NCT00810069|580501467|FG002|Double-Blind Period II|Physician Decision|1|||
160758447|NCT00810069|580501465|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
160758448|NCT00810069|580501466|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
160758449|NCT00810069|580501467|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
160758450|NCT00810069|580501465|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
160758451|NCT00810069|580501466|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
160758452|NCT00810069|580501467|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
160758453|NCT00810069|580501465|FG000|Double-Blind Period II|Clinical relapse|0|||
160758454|NCT00810069|580501466|FG001|Double-Blind Period II|Clinical relapse|3|||
160758455|NCT00810069|580501467|FG002|Double-Blind Period II|Clinical relapse|0|||
160758456|NCT00810069|580501465|FG000|Double-Blind Period II|Protocol Violation|0|||
160758457|NCT00810069|580501466|FG001|Double-Blind Period II|Protocol Violation|7|||
160758458|NCT00810069|580501467|FG002|Double-Blind Period II|Protocol Violation|6|||
160525212|NCT04641299|579653677|FG003|Overall Study|Withdrawal by Subject|0|||
160525213|NCT04641299|579653674|FG000|Overall Study|Reason not given|1|||
160525214|NCT04641299|579653675|FG001|Overall Study|Reason not given|0|||
160525215|NCT04641299|579653676|FG002|Overall Study|Reason not given|0|||
160525216|NCT04641299|579653677|FG003|Overall Study|Reason not given|0|||
160525217|NCT01890148|579653681|FG000|Overall Study|Adverse Event|1|||
160525218|NCT05104476|579653682|FG000|Overall Study|Randomized But Not Treated|1|||
160525219|NCT05104476|579653683|FG001|Overall Study|Randomized But Not Treated|2|||
160525220|NCT05104476|579653682|FG000|Overall Study|Adverse Event|2|||
160525221|NCT05104476|579653683|FG001|Overall Study|Adverse Event|2|||
160525222|NCT05104476|579653682|FG000|Overall Study|Withdrawal by Subject|3|||
160525223|NCT05104476|579653683|FG001|Overall Study|Withdrawal by Subject|3|||
160525224|NCT05104476|579653682|FG000|Overall Study|Other Than Specified|0|||
160525225|NCT05104476|579653683|FG001|Overall Study|Other Than Specified|3|||
160525226|NCT00992511|579653686|FG000|Overall Study|Migrated/moved from study area|1|||
160525227|NCT00992511|579653687|FG001|Overall Study|Migrated/moved from study area|0|||
160525228|NCT00992511|579653688|FG002|Overall Study|Migrated/moved from study area|1|||
160525229|NCT00992511|579653689|FG003|Overall Study|Migrated/moved from study area|2|||
160525230|NCT00992511|579653686|FG000|Overall Study|Lost to Follow-up|1|||
160525231|NCT00992511|579653687|FG001|Overall Study|Lost to Follow-up|0|||
160525232|NCT00992511|579653688|FG002|Overall Study|Lost to Follow-up|0|||
160525233|NCT00992511|579653689|FG003|Overall Study|Lost to Follow-up|2|||
160525234|NCT00992511|579653686|FG000|Overall Study|Withdrawal by Subject|0|||
160525235|NCT00992511|579653687|FG001|Overall Study|Withdrawal by Subject|0|||
160525236|NCT00992511|579653688|FG002|Overall Study|Withdrawal by Subject|1|||
160525237|NCT00992511|579653689|FG003|Overall Study|Withdrawal by Subject|1|||
160525238|NCT00908232|579653693|FG000|Cycle 1 to 4|Death|5|||
160525239|NCT00908232|579653694|FG001|Cycle 1 to 4|Death|0|||
160525240|NCT00908232|579653695|FG002|Cycle 1 to 4|Death|0|||
160525241|NCT00908232|579653696|FG003|Cycle 1 to 4|Death|0|||
160525242|NCT00908232|579653693|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
160525243|NCT00908232|579653694|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
160525244|NCT00908232|579653695|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
160525245|NCT00908232|579653696|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
160525246|NCT00908232|579653693|FG000|Cycle 1 to 4|Progressive Disease|6|||
160525247|NCT00908232|579653694|FG001|Cycle 1 to 4|Progressive Disease|0|||
160525248|NCT00908232|579653695|FG002|Cycle 1 to 4|Progressive Disease|0|||
160525249|NCT00908232|579653696|FG003|Cycle 1 to 4|Progressive Disease|0|||
160525250|NCT00908232|579653693|FG000|Cycle 1 to 4|Adverse Event|12|||
160525251|NCT00908232|579653694|FG001|Cycle 1 to 4|Adverse Event|0|||
160525252|NCT00908232|579653695|FG002|Cycle 1 to 4|Adverse Event|0|||
160758459|NCT02899065|580501470|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
160758460|NCT02899065|580501471|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
160758461|NCT02899065|580501470|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
160758462|NCT02899065|580501471|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
160758463|NCT02899065|580501470|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
160758464|NCT02899065|580501471|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
160758465|NCT00379899|580501479|FG000|Overall Study|Adverse Event|7|||
160758466|NCT00379899|580501480|FG001|Overall Study|Adverse Event|3|||
160758467|NCT00379899|580501479|FG000|Overall Study|Death|10|||
160758468|NCT00379899|580501480|FG001|Overall Study|Death|10|||
160758469|NCT00379899|580501479|FG000|Overall Study|Lost to Follow-up|2|||
160758470|NCT00379899|580501480|FG001|Overall Study|Lost to Follow-up|4|||
160758471|NCT00379899|580501479|FG000|Overall Study|Physician Decision|3|||
160525253|NCT00908232|579653696|FG003|Cycle 1 to 4|Adverse Event|0|||
160525254|NCT00908232|579653693|FG000|Cycle 1 to 4|Other|1|||
160525255|NCT00908232|579653694|FG001|Cycle 1 to 4|Other|0|||
160525256|NCT00908232|579653695|FG002|Cycle 1 to 4|Other|0|||
160525257|NCT00908232|579653696|FG003|Cycle 1 to 4|Other|0|||
160758472|NCT00379899|580501480|FG001|Overall Study|Physician Decision|4|||
160758473|NCT00379899|580501479|FG000|Overall Study|Withdrawal by Subject|5|||
160758474|NCT00379899|580501480|FG001|Overall Study|Withdrawal by Subject|5|||
160758475|NCT00379899|580501479|FG000|Overall Study|Ineligibility determined|0|||
160758476|NCT00379899|580501480|FG001|Overall Study|Ineligibility determined|1|||
160758477|NCT00379899|580501479|FG000|Overall Study|Noncompliance|1|||
160758478|NCT00379899|580501480|FG001|Overall Study|Noncompliance|1|||
160758479|NCT00379899|580501479|FG000|Overall Study|Parathyroidectomy|0|||
160758480|NCT00379899|580501480|FG001|Overall Study|Parathyroidectomy|2|||
160758481|NCT00379899|580501479|FG000|Overall Study|Renal transplantation|5|||
160758482|NCT00379899|580501480|FG001|Overall Study|Renal transplantation|4|||
160758483|NCT00379899|580501479|FG000|Overall Study|Coronary artery bypass graft|1|||
160758484|NCT00379899|580501480|FG001|Overall Study|Coronary artery bypass graft|1|||
160758485|NCT00379899|580501479|FG000|Overall Study|Other protocol-specified criteria|3|||
160758486|NCT00379899|580501480|FG001|Overall Study|Other protocol-specified criteria|4|||
160758487|NCT00379899|580501479|FG000|Overall Study|Other|3|||
160758488|NCT00379899|580501480|FG001|Overall Study|Other|1|||
160758489|NCT02716779|580501483|FG000|Monotherapy|Adverse Event|0|||
160758490|NCT02716779|580501484|FG001|Monotherapy|Adverse Event|1|||
160758491|NCT02716779|580501485|FG002|Monotherapy|Adverse Event|1|||
160758492|NCT02716779|580501483|FG000|Combination Therapy|Adverse Event|0|||
160758493|NCT02716779|580501484|FG001|Combination Therapy|Adverse Event|2|||
160758494|NCT02716779|580501485|FG002|Combination Therapy|Adverse Event|1|||
160758495|NCT00385918|580501490|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
160758496|NCT00385918|580501491|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
160758497|NCT00385918|580501492|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
160758498|NCT00385918|580501490|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
160758499|NCT00385918|580501491|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
160758500|NCT00385918|580501492|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
160758501|NCT00385918|580501490|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
160758502|NCT00385918|580501491|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
160758503|NCT00385918|580501492|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
160758504|NCT00385918|580501490|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
160758505|NCT00385918|580501491|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
160758506|NCT00385918|580501492|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
160758507|NCT00385918|580501490|FG000|Intervention Phase After Randomization|Physician Decision|1|||
160758508|NCT00385918|580501491|FG001|Intervention Phase After Randomization|Physician Decision|0|||
160758509|NCT00385918|580501492|FG002|Intervention Phase After Randomization|Physician Decision|0|||
160758510|NCT00385918|580501490|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
160758511|NCT00385918|580501491|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
160758512|NCT00385918|580501492|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
160758513|NCT00128661|580501493|FG000|Overall Study|Adverse Event|14|||
160758514|NCT00128661|580501494|FG001|Overall Study|Adverse Event|11|||
160758515|NCT00128661|580501493|FG000|Overall Study|Lost to Follow-up|10|||
160758516|NCT00128661|580501494|FG001|Overall Study|Lost to Follow-up|7|||
160758517|NCT00128661|580501493|FG000|Overall Study|Withdrawal by Subject|243|||
160758518|NCT00128661|580501494|FG001|Overall Study|Withdrawal by Subject|232|||
160758519|NCT00128661|580501493|FG000|Overall Study|Other|7|||
160758520|NCT00128661|580501494|FG001|Overall Study|Other|8|||
160758521|NCT00102596|580501495|FG000|Part A|Screen failures|6|||
160758522|NCT00102596|580501496|FG001|Part A|Screen failures|0|||
160758523|NCT00102596|580501495|FG000|Part A|Adverse Event|1|||
160758524|NCT00102596|580501496|FG001|Part A|Adverse Event|0|||
160758525|NCT01705977|580501497|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
160758526|NCT01705977|580501498|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
160758527|NCT01705977|580501497|FG000|Treatment Period (Year 1)|Adverse Event|57|||
160758528|NCT01705977|580501498|FG001|Treatment Period (Year 1)|Adverse Event|49|||
160758529|NCT01705977|580501497|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
160758530|NCT01705977|580501498|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
160758531|NCT01705977|580501497|FG000|Treatment Period (Year 1)|Site closure|3|||
160758532|NCT01705977|580501498|FG001|Treatment Period (Year 1)|Site closure|2|||
160758533|NCT01705977|580501497|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
160758534|NCT01705977|580501498|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
160758535|NCT01705977|580501497|FG000|Treatment Period (Year 1)|Physician Decision|48|||
160758536|NCT01705977|580501498|FG001|Treatment Period (Year 1)|Physician Decision|38|||
160758537|NCT01705977|580501497|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
160758538|NCT01705977|580501498|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
160758539|NCT01705977|580501497|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
160758540|NCT01705977|580501498|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
160758541|NCT01705977|580501497|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
160758542|NCT01705977|580501498|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
160758543|NCT01705977|580501497|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
160758544|NCT01705977|580501498|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
160758545|NCT01705977|580501497|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
160758546|NCT01705977|580501498|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
160758547|NCT01705977|580501497|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
160758548|NCT01705977|580501498|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
160758549|NCT05067972|580501499|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
160758550|NCT05067972|580501500|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
160758551|NCT05067972|580501501|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
160758552|NCT05067972|580501502|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
160758553|NCT05067972|580501503|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
160758554|NCT05067972|580501504|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
160758555|NCT05067972|580501505|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
160758556|NCT05067972|580501499|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
160758557|NCT05067972|580501500|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
160758558|NCT05067972|580501501|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
160758559|NCT05067972|580501502|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
160758560|NCT05067972|580501503|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
160758561|NCT05067972|580501504|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
160758562|NCT05067972|580501505|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
160758563|NCT05067972|580501499|FG000|Part 1: Treatment|Progressive Disease|3|||
160758564|NCT05067972|580501500|FG001|Part 1: Treatment|Progressive Disease|3|||
160758565|NCT05067972|580501501|FG002|Part 1: Treatment|Progressive Disease|4|||
160758566|NCT05067972|580501502|FG003|Part 1: Treatment|Progressive Disease|2|||
160758567|NCT05067972|580501503|FG004|Part 1: Treatment|Progressive Disease|3|||
160758568|NCT05067972|580501504|FG005|Part 1: Treatment|Progressive Disease|0|||
160758569|NCT05067972|580501505|FG006|Part 1: Treatment|Progressive Disease|2|||
160758570|NCT05067972|580501499|FG000|Part 1: Treatment|Physician Decision|0|||
160758571|NCT05067972|580501500|FG001|Part 1: Treatment|Physician Decision|0|||
160758572|NCT05067972|580501501|FG002|Part 1: Treatment|Physician Decision|0|||
160758573|NCT05067972|580501502|FG003|Part 1: Treatment|Physician Decision|1|||
160758574|NCT05067972|580501503|FG004|Part 1: Treatment|Physician Decision|0|||
160758575|NCT05067972|580501504|FG005|Part 1: Treatment|Physician Decision|0|||
160758576|NCT05067972|580501505|FG006|Part 1: Treatment|Physician Decision|0|||
160758577|NCT05067972|580501499|FG000|Part 1: Treatment|Death|0|||
160758578|NCT05067972|580501500|FG001|Part 1: Treatment|Death|0|||
160758579|NCT05067972|580501501|FG002|Part 1: Treatment|Death|0|||
160758580|NCT05067972|580501502|FG003|Part 1: Treatment|Death|2|||
160758581|NCT05067972|580501503|FG004|Part 1: Treatment|Death|0|||
160758582|NCT05067972|580501504|FG005|Part 1: Treatment|Death|0|||
160758583|NCT05067972|580501505|FG006|Part 1: Treatment|Death|0|||
160758584|NCT05067972|580501499|FG000|Part 1: Treatment|Adverse Event|0|||
160758585|NCT05067972|580501500|FG001|Part 1: Treatment|Adverse Event|0|||
160758586|NCT05067972|580501501|FG002|Part 1: Treatment|Adverse Event|0|||
160758587|NCT05067972|580501502|FG003|Part 1: Treatment|Adverse Event|0|||
160758588|NCT05067972|580501503|FG004|Part 1: Treatment|Adverse Event|0|||
160758589|NCT05067972|580501504|FG005|Part 1: Treatment|Adverse Event|2|||
160758590|NCT05067972|580501505|FG006|Part 1: Treatment|Adverse Event|1|||
160758591|NCT05067972|580501499|FG000|Part 1: Follow-up|Adverse Event|0|||
160758592|NCT05067972|580501500|FG001|Part 1: Follow-up|Adverse Event|0|||
160758593|NCT05067972|580501501|FG002|Part 1: Follow-up|Adverse Event|0|||
160758594|NCT05067972|580501502|FG003|Part 1: Follow-up|Adverse Event|0|||
160758595|NCT05067972|580501503|FG004|Part 1: Follow-up|Adverse Event|0|||
160758596|NCT05067972|580501504|FG005|Part 1: Follow-up|Adverse Event|1|||
160758597|NCT05067972|580501505|FG006|Part 1: Follow-up|Adverse Event|0|||
160758598|NCT05067972|580501499|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
160758599|NCT05067972|580501500|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
160758600|NCT05067972|580501501|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
160758601|NCT05067972|580501502|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
160758602|NCT05067972|580501503|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
160758603|NCT05067972|580501504|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
160758604|NCT05067972|580501505|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
160758605|NCT05067972|580501499|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
160758606|NCT05067972|580501500|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
160758607|NCT05067972|580501501|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
160758608|NCT05067972|580501502|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
160758609|NCT05067972|580501503|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
160758610|NCT05067972|580501504|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
160758611|NCT05067972|580501505|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
160758612|NCT05067972|580501499|FG000|Part 1: Follow-up|Physician Decision|0|||
160758613|NCT05067972|580501500|FG001|Part 1: Follow-up|Physician Decision|0|||
160636278|NCT01508325|580051517|FG001|Overall Study|Other|2|||
160758614|NCT05067972|580501501|FG002|Part 1: Follow-up|Physician Decision|0|||
160758615|NCT05067972|580501502|FG003|Part 1: Follow-up|Physician Decision|1|||
160758616|NCT05067972|580501503|FG004|Part 1: Follow-up|Physician Decision|0|||
160758617|NCT05067972|580501504|FG005|Part 1: Follow-up|Physician Decision|0|||
160758618|NCT05067972|580501505|FG006|Part 1: Follow-up|Physician Decision|0|||
160758619|NCT05067972|580501499|FG000|Part 1: Follow-up|Death|1|||
160758620|NCT05067972|580501500|FG001|Part 1: Follow-up|Death|2|||
160758621|NCT05067972|580501501|FG002|Part 1: Follow-up|Death|1|||
160758622|NCT05067972|580501502|FG003|Part 1: Follow-up|Death|0|||
160758623|NCT05067972|580501503|FG004|Part 1: Follow-up|Death|1|||
160758624|NCT05067972|580501504|FG005|Part 1: Follow-up|Death|0|||
160758625|NCT05067972|580501505|FG006|Part 1: Follow-up|Death|1|||
160758626|NCT00810199|580501513|FG000|Overall Study|Adverse Event|24|||
160758627|NCT00810199|580501514|FG001|Overall Study|Adverse Event|26|||
160758628|NCT00810199|580501513|FG000|Overall Study|Death|4|||
160758629|NCT00810199|580501514|FG001|Overall Study|Death|6|||
160758630|NCT00810199|580501513|FG000|Overall Study|Withdrew consent|9|||
160758631|NCT00810199|580501514|FG001|Overall Study|Withdrew consent|12|||
160758632|NCT00810199|580501513|FG000|Overall Study|Insufficient therapeutic response|5|||
160758633|NCT00810199|580501514|FG001|Overall Study|Insufficient therapeutic response|14|||
160758634|NCT00810199|580501513|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
160758635|NCT00810199|580501514|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
160758636|NCT00810199|580501513|FG000|Overall Study|Administrative/Other|5|||
160758637|NCT00810199|580501514|FG001|Overall Study|Administrative/Other|6|||
160758638|NCT00810199|580501513|FG000|Overall Study|Protocol Violation|2|||
160758639|NCT00810199|580501514|FG001|Overall Study|Protocol Violation|6|||
160758640|NCT00810199|580501513|FG000|Overall Study|Failure to return|1|||
160758641|NCT00810199|580501514|FG001|Overall Study|Failure to return|4|||
160758642|NCT00810199|580501513|FG000|Overall Study|Did not receive study drug|2|||
160758643|NCT00810199|580501514|FG001|Overall Study|Did not receive study drug|1|||
160758644|NCT02864407|580501516|FG000|Overall Study|Protocol Violation|3|||
160758645|NCT02864407|580501516|FG000|Overall Study|Lost to Follow-up|115|||
160758646|NCT02864407|580501516|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
160758647|NCT02864407|580501516|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
160758648|NCT02864407|580501516|FG000|Overall Study|Consent prior to the contract date|1|||
160758649|NCT02686164|580501524|FG000|Overall Study|Adverse Event|1|||
160758650|NCT02686164|580501524|FG000|Overall Study|Withdrawal of consent|1|||
160758651|NCT02686164|580501524|FG000|Overall Study|Clinical progression|1|||
160758652|NCT01827592|580501527|FG000|Overall Study|Adverse Event|11|||
160758653|NCT01827592|580501528|FG001|Overall Study|Adverse Event|9|||
160758654|NCT01827592|580501529|FG002|Overall Study|Adverse Event|2|||
160758655|NCT01827592|580501527|FG000|Overall Study|Physician Decision|0|||
160525258|NCT00908232|579653693|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
160525259|NCT00908232|579653694|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
160525260|NCT00908232|579653695|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
160758656|NCT01827592|580501528|FG001|Overall Study|Physician Decision|2|||
160758657|NCT01827592|580501529|FG002|Overall Study|Physician Decision|1|||
160758658|NCT01827592|580501527|FG000|Overall Study|Protocol Violation|2|||
160758659|NCT01827592|580501528|FG001|Overall Study|Protocol Violation|1|||
160758660|NCT01827592|580501529|FG002|Overall Study|Protocol Violation|0|||
160758661|NCT01827592|580501527|FG000|Overall Study|Lost to Follow-up|1|||
160758662|NCT01827592|580501528|FG001|Overall Study|Lost to Follow-up|2|||
160758663|NCT01827592|580501529|FG002|Overall Study|Lost to Follow-up|2|||
160758664|NCT01827592|580501527|FG000|Overall Study|Withdrawal by Subject|12|||
160758665|NCT01827592|580501528|FG001|Overall Study|Withdrawal by Subject|11|||
160758666|NCT01827592|580501529|FG002|Overall Study|Withdrawal by Subject|11|||
160758667|NCT01827592|580501527|FG000|Overall Study|Patient's substantial non-compliance|1|||
160758668|NCT01827592|580501528|FG001|Overall Study|Patient's substantial non-compliance|1|||
160758669|NCT01827592|580501529|FG002|Overall Study|Patient's substantial non-compliance|6|||
160758670|NCT01827592|580501527|FG000|Overall Study|Trial terminated by Sponsor|47|||
160758671|NCT01827592|580501528|FG001|Overall Study|Trial terminated by Sponsor|53|||
160758672|NCT01827592|580501529|FG002|Overall Study|Trial terminated by Sponsor|51|||
160758673|NCT01827592|580501527|FG000|Overall Study|Others|0|||
160758674|NCT01827592|580501528|FG001|Overall Study|Others|1|||
160758675|NCT01827592|580501529|FG002|Overall Study|Others|3|||
160758676|NCT00003471|580501537|FG000|Overall Study|Not evaluable|4|||
160758677|NCT00101868|580501545|FG000|Overall Study|Death|10|||
160758678|NCT00101868|580501546|FG001|Overall Study|Death|10|||
160758679|NCT00101868|580501545|FG000|Overall Study|Withdrawal by Subject|8|||
160758680|NCT00101868|580501546|FG001|Overall Study|Withdrawal by Subject|9|||
160758681|NCT00101868|580501545|FG000|Overall Study|Protocol Violation|3|||
160758682|NCT00101868|580501546|FG001|Overall Study|Protocol Violation|0|||
160758683|NCT00101868|580501545|FG000|Overall Study|Lost to Follow-up|8|||
160758684|NCT00101868|580501546|FG001|Overall Study|Lost to Follow-up|13|||
160758685|NCT04001803|580501547|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
160525261|NCT00908232|579653696|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
160525262|NCT00908232|579653693|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
160758686|NCT04001803|580501547|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
160758687|NCT04001803|580501547|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
160758688|NCT04001803|580501547|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
160758689|NCT04001803|580501547|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
160758690|NCT04001803|580501547|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
160758691|NCT04001803|580501547|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
160758692|NCT04001803|580501547|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
160758693|NCT04001803|580501547|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
160758694|NCT04001803|580501547|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
160758695|NCT01931397|580501550|FG000|Overall Study|Physician Decision|2|||
160758696|NCT01931397|580501550|FG000|Overall Study|Withdrawal by Subject|8|||
160758697|NCT01931397|580501550|FG000|Overall Study|moved out of state|1|||
160758698|NCT02329327|580501554|FG000|Overall Study|Death|78|||
160758699|NCT02329327|580501555|FG001|Overall Study|Death|0|||
160758700|NCT02329327|580501554|FG000|Overall Study|Withdrawal by Subject|3|||
160758701|NCT02329327|580501555|FG001|Overall Study|Withdrawal by Subject|0|||
160758702|NCT02329327|580501554|FG000|Overall Study|Lost to Follow-up|4|||
160758703|NCT02329327|580501555|FG001|Overall Study|Lost to Follow-up|0|||
160758704|NCT01367249|580501556|FG000|Overall Study|Withdrawal by Subject|6|||
160758705|NCT01367249|580501557|FG001|Overall Study|Withdrawal by Subject|6|||
160758706|NCT01367249|580501556|FG000|Overall Study|Other|3|||
160758707|NCT01367249|580501557|FG001|Overall Study|Other|10|||
160758708|NCT02493517|580501558|FG000|Overall Study|Protocol Violation|1|||
160758709|NCT02493517|580501559|FG001|Overall Study|Protocol Violation|2|||
160758710|NCT02493517|580501558|FG000|Overall Study|Withdrawal by Subject|1|||
160758711|NCT02493517|580501559|FG001|Overall Study|Withdrawal by Subject|2|||
160758712|NCT02493517|580501558|FG000|Overall Study|Adverse Event|0|||
160758713|NCT02493517|580501559|FG001|Overall Study|Adverse Event|2|||
160758714|NCT02493517|580501558|FG000|Overall Study|Missed study visit|0|||
160758715|NCT02493517|580501559|FG001|Overall Study|Missed study visit|1|||
160758716|NCT03718429|580501560|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
160758717|NCT03718429|580501561|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
160758718|NCT03718429|580501562|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
160758719|NCT03718429|580501563|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
160758720|NCT05404711|580501564|FG000|Completed Study Visit|Withdrawal by Subject|1|||
160758721|NCT05404711|580501564|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
160758722|NCT05404711|580501564|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
160758723|NCT05404711|580501564|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
160758724|NCT05404711|580501564|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
160758725|NCT05404711|580501564|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
160758726|NCT00325819|580501565|FG000|Overall Study|Study product lost in mail|2|||
160758727|NCT00325819|580501566|FG001|Overall Study|Study product lost in mail|1|||
160758728|NCT00325819|580501565|FG000|Overall Study|Did not take a dose of study product|4|||
160758729|NCT00325819|580501566|FG001|Overall Study|Did not take a dose of study product|9|||
160758730|NCT00325819|580501565|FG000|Overall Study|Lost to Follow-up|3|||
160758731|NCT00325819|580501566|FG001|Overall Study|Lost to Follow-up|3|||
160758732|NCT02346877|580501567|FG000|Overall Study|Adverse Event|1|||
160758733|NCT02346877|580501568|FG001|Overall Study|Adverse Event|0|||
160758734|NCT02346877|580501567|FG000|Overall Study|Administrative Decision|1|||
160525263|NCT00908232|579653694|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
160525264|NCT00908232|579653695|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
160758735|NCT02346877|580501568|FG001|Overall Study|Administrative Decision|0|||
160758736|NCT02346877|580501567|FG000|Overall Study|Sponsor Decision|12|||
160758737|NCT02346877|580501568|FG001|Overall Study|Sponsor Decision|0|||
160758738|NCT02346877|580501567|FG000|Overall Study|Missing|5|||
160758739|NCT02346877|580501568|FG001|Overall Study|Missing|0|||
160758740|NCT01683604|580501575|FG000|Overall Study|Adverse Event|2|||
160758741|NCT01683604|580501575|FG000|Overall Study|Lack of Efficacy|1|||
160758742|NCT01683604|580501575|FG000|Overall Study|Other|2|||
160758743|NCT03430856|580501576|FG000|Overall Study|Adverse Event|0|||
160758744|NCT03430856|580501577|FG001|Overall Study|Adverse Event|1|||
160758745|NCT03430856|580501578|FG002|Overall Study|Adverse Event|0|||
160758746|NCT03430856|580501576|FG000|Overall Study|Rescue criteria|1|||
160758747|NCT03430856|580501577|FG001|Overall Study|Rescue criteria|1|||
160758748|NCT03430856|580501578|FG002|Overall Study|Rescue criteria|0|||
160758749|NCT03430856|580501576|FG000|Overall Study|Voluntary withdrawal of consent|1|||
160758750|NCT03430856|580501577|FG001|Overall Study|Voluntary withdrawal of consent|1|||
160758751|NCT03430856|580501578|FG002|Overall Study|Voluntary withdrawal of consent|1|||
160758752|NCT02481050|580503850|FG000|Overall Study|Adverse Event|1|||
160758753|NCT02481050|580503850|FG000|Overall Study|Disease Progression|47|||
160758754|NCT02481050|580503850|FG000|Overall Study|Withdrawal by Subject|7|||
160758755|NCT02481050|580503850|FG000|Overall Study|Other|3|||
160758756|NCT00611806|580503854|FG000|Overall Study|Withdrawal by Subject|8|||
160758757|NCT00611806|580503855|FG001|Overall Study|Withdrawal by Subject|2|||
160758758|NCT00611806|580503854|FG000|Overall Study|Adverse Event|2|||
160758759|NCT00611806|580503855|FG001|Overall Study|Adverse Event|1|||
160758760|NCT00611806|580503854|FG000|Overall Study|Lost to Follow-up|6|||
160758761|NCT00611806|580503855|FG001|Overall Study|Lost to Follow-up|0|||
160758762|NCT04152200|580503856|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
160758763|NCT04152200|580503857|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
160758764|NCT04969289|580503858|FG000|Overall Study|Lost to Follow-up|13|||
160758765|NCT04969289|580503859|FG001|Overall Study|Lost to Follow-up|9|||
160758766|NCT02699996|580503860|FG000|Overall Study|Withdrawal by Subject|5|||
160758767|NCT02699996|580503861|FG001|Overall Study|Withdrawal by Subject|2|||
160758768|NCT01921517|580503862|FG000|Overall Study|Lost to Follow-up|5|||
160758769|NCT01921517|580503863|FG001|Overall Study|Lost to Follow-up|0|||
160758770|NCT01921517|580503862|FG000|Overall Study|Newly diagnosed health concern|2|||
160758771|NCT01921517|580503863|FG001|Overall Study|Newly diagnosed health concern|0|||
160758772|NCT01921517|580503862|FG000|Overall Study|Physician Decision|0|||
160758773|NCT01921517|580503863|FG001|Overall Study|Physician Decision|2|||
160758774|NCT01921517|580503862|FG000|Overall Study|Withdrawal by Subject|7|||
160758775|NCT01921517|580503863|FG001|Overall Study|Withdrawal by Subject|3|||
160758776|NCT01921517|580503862|FG000|Overall Study|Subject missed final imaging|1|||
160758777|NCT01921517|580503863|FG001|Overall Study|Subject missed final imaging|4|||
160758778|NCT04069715|580503866|FG000|Overall Study|Lost to Follow-up|1|||
160758779|NCT04069715|580503867|FG001|Overall Study|Lost to Follow-up|1|||
160758780|NCT04069715|580503866|FG000|Overall Study|Physician Decision|1|||
160758781|NCT04069715|580503867|FG001|Overall Study|Physician Decision|1|||
160758782|NCT04069715|580503866|FG000|Overall Study|Withdrawal by Subject|3|||
160758783|NCT04069715|580503867|FG001|Overall Study|Withdrawal by Subject|3|||
160758784|NCT03205150|580503868|FG000|Overall Study|Protocol deviation|1|||
160758785|NCT03205150|580503869|FG001|Overall Study|Protocol deviation|3|||
160758786|NCT03205150|580503870|FG002|Overall Study|Protocol deviation|0|||
160525265|NCT00908232|579653696|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
160525266|NCT00908232|579653693|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
160758787|NCT03205150|580503868|FG000|Overall Study|Patient/guardian decision|0|||
160758788|NCT03205150|580503869|FG001|Overall Study|Patient/guardian decision|3|||
160758789|NCT03205150|580503870|FG002|Overall Study|Patient/guardian decision|0|||
160758790|NCT03205150|580503868|FG000|Overall Study|Adverse Event|1|||
160758791|NCT03205150|580503869|FG001|Overall Study|Adverse Event|1|||
160758792|NCT03205150|580503870|FG002|Overall Study|Adverse Event|1|||
160758793|NCT03205150|580503868|FG000|Overall Study|Lost to Follow-up|0|||
160758794|NCT03205150|580503869|FG001|Overall Study|Lost to Follow-up|0|||
160758795|NCT03205150|580503870|FG002|Overall Study|Lost to Follow-up|1|||
160758796|NCT02723188|580503871|FG000|Overall Study|Withdrawal by Subject|1|||
160758797|NCT02723188|580503872|FG001|Overall Study|Withdrawal by Subject|0|||
160758798|NCT02723188|580503873|FG002|Overall Study|Withdrawal by Subject|0|||
160758799|NCT01095835|580503874|FG000|Overall Study|Adverse Event|8|||
160758800|NCT01095835|580503875|FG001|Overall Study|Adverse Event|6|||
160758801|NCT01095835|580503876|FG002|Overall Study|Adverse Event|6|||
160758802|NCT01095835|580503874|FG000|Overall Study|Lack of Efficacy|0|||
160758803|NCT01095835|580503875|FG001|Overall Study|Lack of Efficacy|1|||
160758804|NCT01095835|580503876|FG002|Overall Study|Lack of Efficacy|0|||
160758805|NCT01095835|580503874|FG000|Overall Study|Physician Decision|0|||
160758806|NCT01095835|580503875|FG001|Overall Study|Physician Decision|0|||
160758807|NCT01095835|580503876|FG002|Overall Study|Physician Decision|1|||
160758808|NCT01095835|580503874|FG000|Overall Study|Withdrawal by Subject|1|||
160758809|NCT01095835|580503875|FG001|Overall Study|Withdrawal by Subject|3|||
160758810|NCT01095835|580503876|FG002|Overall Study|Withdrawal by Subject|0|||
160758811|NCT01095835|580503874|FG000|Overall Study|Non study compliance|0|||
160758812|NCT01095835|580503875|FG001|Overall Study|Non study compliance|0|||
160758813|NCT01095835|580503876|FG002|Overall Study|Non study compliance|1|||
160758814|NCT01095835|580503874|FG000|Overall Study|Protocol Violation|1|||
160758815|NCT01095835|580503875|FG001|Overall Study|Protocol Violation|2|||
160758816|NCT01095835|580503876|FG002|Overall Study|Protocol Violation|0|||
160758817|NCT02486692|580503882|FG000|Overall Study|did not login for randomization|4|||
160758818|NCT02486692|580503883|FG001|Overall Study|did not login for randomization|7|||
160758819|NCT03028142|580503884|FG000|Overall Study|Adverse Event|1|||
160758820|NCT03028142|580503885|FG001|Overall Study|Adverse Event|1|||
160758821|NCT03028142|580503886|FG002|Overall Study|Adverse Event|0|||
160758822|NCT03028142|580503887|FG003|Overall Study|Adverse Event|0|||
160758823|NCT03028142|580503888|FG004|Overall Study|Adverse Event|0|||
160758824|NCT03028142|580503889|FG005|Overall Study|Adverse Event|1|||
160758825|NCT03028142|580503884|FG000|Overall Study|Withdrawal by Subject|0|||
160758826|NCT03028142|580503885|FG001|Overall Study|Withdrawal by Subject|0|||
160758827|NCT03028142|580503886|FG002|Overall Study|Withdrawal by Subject|0|||
160758828|NCT03028142|580503887|FG003|Overall Study|Withdrawal by Subject|0|||
160758829|NCT03028142|580503888|FG004|Overall Study|Withdrawal by Subject|1|||
160758830|NCT03028142|580503889|FG005|Overall Study|Withdrawal by Subject|0|||
160758831|NCT01198002|580503894|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
160758832|NCT01198002|580503895|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
160758833|NCT01198002|580503896|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
160758834|NCT01198002|580503894|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
160758835|NCT01198002|580503895|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
160758836|NCT01198002|580503896|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
160758837|NCT01198002|580503894|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
160758838|NCT01198002|580503895|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
160758839|NCT01198002|580503896|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
160758840|NCT01198002|580503894|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
160758841|NCT01198002|580503895|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
160758842|NCT01198002|580503896|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
160758843|NCT01198002|580503894|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
160758844|NCT01198002|580503895|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
160758845|NCT01198002|580503896|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
160758846|NCT01198002|580503894|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
160758847|NCT01198002|580503895|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
160758848|NCT01198002|580503896|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
160758849|NCT01198002|580503894|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
160758850|NCT01198002|580503895|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
160758851|NCT01198002|580503896|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
160758852|NCT01198002|580503894|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
160758853|NCT01198002|580503895|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
160758854|NCT01198002|580503896|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
160758855|NCT01198002|580503894|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
160758856|NCT01198002|580503895|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
160758857|NCT01198002|580503896|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
160758858|NCT01198002|580503894|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
160758859|NCT01198002|580503895|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
160758860|NCT01198002|580503896|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
160758861|NCT01198002|580503894|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
160758862|NCT01198002|580503895|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
160758863|NCT01198002|580503896|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
160758864|NCT01198002|580503894|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
160758865|NCT01198002|580503895|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
160758866|NCT01198002|580503896|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
160758867|NCT01198002|580503894|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
160758868|NCT01198002|580503895|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
160758869|NCT01198002|580503896|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
160758870|NCT01198002|580503894|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
160758871|NCT01198002|580503895|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
160758872|NCT01198002|580503896|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
160758873|NCT01198002|580503894|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
160758874|NCT01198002|580503895|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
160758875|NCT01198002|580503896|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
160758876|NCT00116688|580503900|FG000|Overall Study|Protocol deviation|1|||
160758877|NCT00116688|580503901|FG001|Overall Study|Protocol deviation|0|||
160758878|NCT00116688|580503900|FG000|Overall Study|Noncompliance|3|||
160758879|NCT00116688|580503901|FG001|Overall Study|Noncompliance|1|||
160758880|NCT00116688|580503900|FG000|Overall Study|Adverse Event|11|||
160758881|NCT00116688|580503901|FG001|Overall Study|Adverse Event|0|||
160758882|NCT00116688|580503900|FG000|Overall Study|Withdrawal by Subject|26|||
160758883|NCT00116688|580503901|FG001|Overall Study|Withdrawal by Subject|2|||
160758884|NCT00116688|580503900|FG000|Overall Study|Requirement for alternative therapy|11|||
160758885|NCT00116688|580503901|FG001|Overall Study|Requirement for alternative therapy|1|||
160758886|NCT00116688|580503900|FG000|Overall Study|Physician Decision|7|||
160758887|NCT00116688|580503901|FG001|Overall Study|Physician Decision|0|||
160758888|NCT00116688|580503900|FG000|Overall Study|Lost to Follow-up|3|||
160758889|NCT00116688|580503901|FG001|Overall Study|Lost to Follow-up|0|||
160758890|NCT00116688|580503900|FG000|Overall Study|Death|15|||
160758891|NCT00116688|580503901|FG001|Overall Study|Death|0|||
160758892|NCT00116688|580503900|FG000|Overall Study|Protocol-specified criteria|3|||
160758893|NCT00116688|580503901|FG001|Overall Study|Protocol-specified criteria|0|||
160758894|NCT00116688|580503900|FG000|Overall Study|Pregnancy|1|||
160758895|NCT00116688|580503901|FG001|Overall Study|Pregnancy|0|||
160758896|NCT00116688|580503900|FG000|Overall Study|Other|11|||
160758897|NCT00116688|580503901|FG001|Overall Study|Other|0|||
160758898|NCT01775670|580503907|FG000|Overall Study|Lost to Follow-up|1|||
160758899|NCT01775670|580503908|FG001|Overall Study|Lost to Follow-up|1|||
160758900|NCT01298700|580503909|FG000|Overall Study|Adverse Event|50|||
160758901|NCT01298700|580503910|FG001|Overall Study|Adverse Event|51|||
160758902|NCT01298700|580503909|FG000|Overall Study|Lack of Efficacy|9|||
160758903|NCT01298700|580503910|FG001|Overall Study|Lack of Efficacy|14|||
160758904|NCT01298700|580503909|FG000|Overall Study|Lost to Follow-up|5|||
160758905|NCT01298700|580503910|FG001|Overall Study|Lost to Follow-up|2|||
160758906|NCT01298700|580503909|FG000|Overall Study|Withdrawal by Subject|12|||
160758907|NCT01298700|580503910|FG001|Overall Study|Withdrawal by Subject|9|||
160758908|NCT01298700|580503909|FG000|Overall Study|Protocol Violation|6|||
160758909|NCT01298700|580503910|FG001|Overall Study|Protocol Violation|4|||
160758910|NCT01298700|580503909|FG000|Overall Study|Other Miscellaneous Reasons|16|||
160758911|NCT01298700|580503910|FG001|Overall Study|Other Miscellaneous Reasons|15|||
160758912|NCT01298700|580503909|FG000|Overall Study|Did not Receive Study Drug|3|||
160758913|NCT01298700|580503910|FG001|Overall Study|Did not Receive Study Drug|5|||
160758914|NCT04006145|580503913|FG000|Overall Study|Lost to Follow-up|0|||
160758915|NCT04006145|580503914|FG001|Overall Study|Lost to Follow-up|1|||
160758916|NCT04006145|580503913|FG000|Overall Study|Other|1|||
160758917|NCT04006145|580503914|FG001|Overall Study|Other|2|||
160758918|NCT01001429|580503915|FG000|Overall Study|surgery cancelled|0|||
160758919|NCT01001429|580503916|FG001|Overall Study|surgery cancelled|1|||
160758920|NCT00010257|580503919|FG000|Overall Study|Withdrawal by Subject|1|||
160758921|NCT00010257|580503920|FG001|Overall Study|Withdrawal by Subject|0|||
160758922|NCT02812186|580503921|FG000|Period 1|Post randomization screen failure|5|||
160758923|NCT02812186|580503922|FG001|Period 1|Post randomization screen failure|9|||
160758924|NCT02812186|580503921|FG000|Period 1|nonevaluable data sets|6|||
160758925|NCT02812186|580503922|FG001|Period 1|nonevaluable data sets|6|||
160758926|NCT00643760|580503925|FG000|Overall Study|Adverse Event|11|||
160758927|NCT00643760|580503926|FG001|Overall Study|Adverse Event|5|||
160758928|NCT00643760|580503927|FG002|Overall Study|Adverse Event|12|||
160758929|NCT00643760|580503928|FG003|Overall Study|Adverse Event|21|||
160758930|NCT00643760|580503929|FG004|Overall Study|Adverse Event|6|||
160758931|NCT00643760|580503925|FG000|Overall Study|Lack of Efficacy|3|||
160758932|NCT00643760|580503926|FG001|Overall Study|Lack of Efficacy|1|||
160758933|NCT00643760|580503927|FG002|Overall Study|Lack of Efficacy|0|||
160758934|NCT00643760|580503928|FG003|Overall Study|Lack of Efficacy|4|||
160758935|NCT00643760|580503929|FG004|Overall Study|Lack of Efficacy|3|||
160758936|NCT00643760|580503925|FG000|Overall Study|Protocol Violation|7|||
160758937|NCT00643760|580503926|FG001|Overall Study|Protocol Violation|6|||
160758938|NCT00643760|580503927|FG002|Overall Study|Protocol Violation|4|||
160758939|NCT00643760|580503928|FG003|Overall Study|Protocol Violation|4|||
160758940|NCT00643760|580503929|FG004|Overall Study|Protocol Violation|6|||
160758941|NCT00643760|580503925|FG000|Overall Study|Lost to Follow-up|6|||
160758942|NCT00643760|580503926|FG001|Overall Study|Lost to Follow-up|2|||
160758943|NCT00643760|580503927|FG002|Overall Study|Lost to Follow-up|1|||
160758944|NCT00643760|580503928|FG003|Overall Study|Lost to Follow-up|3|||
160758945|NCT00643760|580503929|FG004|Overall Study|Lost to Follow-up|3|||
160758946|NCT00643760|580503925|FG000|Overall Study|Investigator Discretion|0|||
160758947|NCT00643760|580503926|FG001|Overall Study|Investigator Discretion|0|||
160758948|NCT00643760|580503927|FG002|Overall Study|Investigator Discretion|0|||
160758949|NCT00643760|580503928|FG003|Overall Study|Investigator Discretion|2|||
160758950|NCT00643760|580503929|FG004|Overall Study|Investigator Discretion|0|||
160758951|NCT00643760|580503925|FG000|Overall Study|Withdrawal by Subject|3|||
160758952|NCT00643760|580503926|FG001|Overall Study|Withdrawal by Subject|1|||
160758953|NCT00643760|580503927|FG002|Overall Study|Withdrawal by Subject|2|||
160758954|NCT00643760|580503928|FG003|Overall Study|Withdrawal by Subject|4|||
160758955|NCT00643760|580503929|FG004|Overall Study|Withdrawal by Subject|1|||
160758956|NCT02063672|580503933|FG000|Overall Study|Ongoing Follow-up|27|||
160758957|NCT02063672|580503934|FG001|Overall Study|Ongoing Follow-up|14|||
160758958|NCT02063672|580503933|FG000|Overall Study|Death|5|||
160758959|NCT02063672|580503934|FG001|Overall Study|Death|3|||
160758960|NCT02063672|580503933|FG000|Overall Study|Lost to Follow-up|1|||
160758961|NCT02063672|580503934|FG001|Overall Study|Lost to Follow-up|3|||
160758962|NCT02063672|580503933|FG000|Overall Study|Withdrawal by Subject|2|||
160758963|NCT02063672|580503934|FG001|Overall Study|Withdrawal by Subject|2|||
160758964|NCT01307787|580503935|FG000|Overall Study|Withdrawal by Subject|2|||
160758965|NCT01307787|580503936|FG001|Overall Study|Withdrawal by Subject|0|||
160758966|NCT03353792|580503941|FG000|Overall Study|Lost to Follow-up|1|||
160758967|NCT03353792|580503942|FG001|Overall Study|Lost to Follow-up|0|||
160758968|NCT03353792|580503941|FG000|Overall Study|Participant Unable to Manage Device|1|||
160758969|NCT03353792|580503942|FG001|Overall Study|Participant Unable to Manage Device|0|||
160758970|NCT04176939|580503951|FG000|Overall Study|Withdrawal by Subject|5|||
160758971|NCT04176939|580503951|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
160758972|NCT04176939|580503951|FG000|Overall Study|Lost to Follow-up|2|||
160758973|NCT04176939|580503951|FG000|Overall Study|Unspecified reason|4|||
160758974|NCT04176939|580503951|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
160758975|NCT02157519|580503952|FG000|Overall Study|Death|3|||
160758976|NCT02157519|580503953|FG001|Overall Study|Death|1|||
160758977|NCT02157519|580503952|FG000|Overall Study|Withdrawal by Subject|7|||
160758978|NCT02157519|580503953|FG001|Overall Study|Withdrawal by Subject|0|||
160758979|NCT02157519|580503952|FG000|Overall Study|Lost to Follow-up|1|||
160758980|NCT02157519|580503953|FG001|Overall Study|Lost to Follow-up|0|||
160758981|NCT01656395|580503954|FG000|Overall Study|Adverse Event|1|||
160758982|NCT01656395|580503955|FG001|Overall Study|Adverse Event|14|||
160758983|NCT01656395|580503956|FG002|Overall Study|Adverse Event|5|||
160758984|NCT01656395|580503957|FG003|Overall Study|Adverse Event|4|||
160758985|NCT01656395|580503958|FG004|Overall Study|Adverse Event|5|||
160758986|NCT01656395|580503959|FG005|Overall Study|Adverse Event|7|||
160758987|NCT01656395|580503960|FG006|Overall Study|Adverse Event|0|||
160758988|NCT01656395|580503961|FG007|Overall Study|Adverse Event|0|||
160758989|NCT01656395|580503954|FG000|Overall Study|Lack of Efficacy|1|||
160758990|NCT01656395|580503955|FG001|Overall Study|Lack of Efficacy|8|||
160758991|NCT01656395|580503956|FG002|Overall Study|Lack of Efficacy|6|||
160758992|NCT01656395|580503957|FG003|Overall Study|Lack of Efficacy|1|||
160758993|NCT01656395|580503958|FG004|Overall Study|Lack of Efficacy|1|||
160758994|NCT01656395|580503959|FG005|Overall Study|Lack of Efficacy|6|||
160758995|NCT01656395|580503960|FG006|Overall Study|Lack of Efficacy|0|||
160758996|NCT01656395|580503961|FG007|Overall Study|Lack of Efficacy|0|||
160758997|NCT01656395|580503954|FG000|Overall Study|Lost to Follow-up|1|||
160758998|NCT01656395|580503955|FG001|Overall Study|Lost to Follow-up|0|||
160758999|NCT01656395|580503956|FG002|Overall Study|Lost to Follow-up|0|||
160759000|NCT01656395|580503957|FG003|Overall Study|Lost to Follow-up|0|||
160759001|NCT01656395|580503958|FG004|Overall Study|Lost to Follow-up|0|||
160759002|NCT01656395|580503959|FG005|Overall Study|Lost to Follow-up|0|||
160759003|NCT01656395|580503960|FG006|Overall Study|Lost to Follow-up|0|||
160759004|NCT01656395|580503961|FG007|Overall Study|Lost to Follow-up|0|||
160759005|NCT01656395|580503954|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160759006|NCT01656395|580503955|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160759007|NCT01656395|580503956|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160759008|NCT01656395|580503957|FG003|Overall Study|Non-Compliance with Study Drug|0|||
160759009|NCT01656395|580503958|FG004|Overall Study|Non-Compliance with Study Drug|1|||
160759010|NCT01656395|580503959|FG005|Overall Study|Non-Compliance with Study Drug|1|||
160759011|NCT01656395|580503960|FG006|Overall Study|Non-Compliance with Study Drug|0|||
160759012|NCT01656395|580503961|FG007|Overall Study|Non-Compliance with Study Drug|0|||
160759013|NCT01656395|580503954|FG000|Overall Study|Other|0|||
160759014|NCT01656395|580503955|FG001|Overall Study|Other|0|||
160759015|NCT01656395|580503956|FG002|Overall Study|Other|1|||
160759016|NCT01656395|580503957|FG003|Overall Study|Other|0|||
160759017|NCT01656395|580503958|FG004|Overall Study|Other|0|||
160759018|NCT01656395|580503959|FG005|Overall Study|Other|1|||
160759019|NCT01656395|580503960|FG006|Overall Study|Other|0|||
160759020|NCT01656395|580503961|FG007|Overall Study|Other|0|||
160759021|NCT01656395|580503954|FG000|Overall Study|Physician Decision|2|||
160759022|NCT01656395|580503955|FG001|Overall Study|Physician Decision|3|||
160759023|NCT01656395|580503956|FG002|Overall Study|Physician Decision|3|||
160759024|NCT01656395|580503957|FG003|Overall Study|Physician Decision|2|||
160759025|NCT01656395|580503958|FG004|Overall Study|Physician Decision|3|||
160759026|NCT01656395|580503959|FG005|Overall Study|Physician Decision|3|||
160759027|NCT01656395|580503960|FG006|Overall Study|Physician Decision|0|||
160759028|NCT01656395|580503961|FG007|Overall Study|Physician Decision|0|||
160759029|NCT01656395|580503954|FG000|Overall Study|Pregnancy|0|||
160759030|NCT01656395|580503955|FG001|Overall Study|Pregnancy|0|||
160759031|NCT01656395|580503956|FG002|Overall Study|Pregnancy|1|||
160759032|NCT01656395|580503957|FG003|Overall Study|Pregnancy|0|||
160759033|NCT01656395|580503958|FG004|Overall Study|Pregnancy|0|||
160759034|NCT01656395|580503959|FG005|Overall Study|Pregnancy|0|||
160759035|NCT01656395|580503960|FG006|Overall Study|Pregnancy|0|||
160759036|NCT01656395|580503961|FG007|Overall Study|Pregnancy|0|||
160759037|NCT01656395|580503954|FG000|Overall Study|Progressive Disease|0|||
160759038|NCT01656395|580503955|FG001|Overall Study|Progressive Disease|0|||
160759039|NCT01656395|580503956|FG002|Overall Study|Progressive Disease|0|||
160759040|NCT01656395|580503957|FG003|Overall Study|Progressive Disease|0|||
160759041|NCT01656395|580503958|FG004|Overall Study|Progressive Disease|0|||
160759042|NCT01656395|580503959|FG005|Overall Study|Progressive Disease|1|||
160759043|NCT01656395|580503960|FG006|Overall Study|Progressive Disease|0|||
160759044|NCT01656395|580503961|FG007|Overall Study|Progressive Disease|0|||
160759045|NCT01656395|580503954|FG000|Overall Study|Protocol Violation|6|||
160759046|NCT01656395|580503955|FG001|Overall Study|Protocol Violation|6|||
160759047|NCT01656395|580503956|FG002|Overall Study|Protocol Violation|9|||
160759048|NCT01656395|580503957|FG003|Overall Study|Protocol Violation|2|||
160759049|NCT01656395|580503958|FG004|Overall Study|Protocol Violation|4|||
160759050|NCT01656395|580503959|FG005|Overall Study|Protocol Violation|10|||
160759051|NCT01656395|580503960|FG006|Overall Study|Protocol Violation|0|||
160759052|NCT01656395|580503961|FG007|Overall Study|Protocol Violation|0|||
160759053|NCT01656395|580503954|FG000|Overall Study|Screen Failure|2|||
160759054|NCT01656395|580503955|FG001|Overall Study|Screen Failure|1|||
160759055|NCT01656395|580503956|FG002|Overall Study|Screen Failure|7|||
160759056|NCT01656395|580503957|FG003|Overall Study|Screen Failure|1|||
160759057|NCT01656395|580503958|FG004|Overall Study|Screen Failure|0|||
160759058|NCT01656395|580503959|FG005|Overall Study|Screen Failure|8|||
160759059|NCT01656395|580503960|FG006|Overall Study|Screen Failure|0|||
160759060|NCT01656395|580503961|FG007|Overall Study|Screen Failure|0|||
160759061|NCT01656395|580503954|FG000|Overall Study|Withdrawal by Subject|3|||
160759062|NCT01656395|580503955|FG001|Overall Study|Withdrawal by Subject|1|||
160759063|NCT01656395|580503956|FG002|Overall Study|Withdrawal by Subject|4|||
160759064|NCT01656395|580503957|FG003|Overall Study|Withdrawal by Subject|2|||
160759065|NCT01656395|580503958|FG004|Overall Study|Withdrawal by Subject|0|||
160759066|NCT01656395|580503959|FG005|Overall Study|Withdrawal by Subject|3|||
160759067|NCT01656395|580503960|FG006|Overall Study|Withdrawal by Subject|0|||
160759068|NCT01656395|580503961|FG007|Overall Study|Withdrawal by Subject|0|||
160759069|NCT00230048|580503966|FG000|Overall Study|Lost to Follow-up|13|||
160759070|NCT00230048|580503967|FG001|Overall Study|Lost to Follow-up|18|||
160759071|NCT00676403|580503968|FG000|Overall Study|Adverse Event|1|||
160759072|NCT00676403|580503969|FG001|Overall Study|Adverse Event|2|||
160759073|NCT00676403|580503970|FG002|Overall Study|Adverse Event|0|||
160759074|NCT00676403|580503971|FG003|Overall Study|Adverse Event|5|||
160759075|NCT00676403|580503972|FG004|Overall Study|Adverse Event|1|||
160759076|NCT00676403|580503973|FG005|Overall Study|Adverse Event|2|||
160759077|NCT00676403|580503968|FG000|Overall Study|Lost to Follow-up|0|||
160759078|NCT00676403|580503969|FG001|Overall Study|Lost to Follow-up|0|||
160759079|NCT00676403|580503970|FG002|Overall Study|Lost to Follow-up|0|||
160759080|NCT00676403|580503971|FG003|Overall Study|Lost to Follow-up|0|||
160759081|NCT00676403|580503972|FG004|Overall Study|Lost to Follow-up|0|||
160759082|NCT00676403|580503973|FG005|Overall Study|Lost to Follow-up|1|||
160759083|NCT00676403|580503968|FG000|Overall Study|Reason Unspecified|1|||
160759084|NCT00676403|580503969|FG001|Overall Study|Reason Unspecified|0|||
160759085|NCT00676403|580503970|FG002|Overall Study|Reason Unspecified|1|||
160759086|NCT00676403|580503971|FG003|Overall Study|Reason Unspecified|0|||
160759087|NCT00676403|580503972|FG004|Overall Study|Reason Unspecified|0|||
160759088|NCT00676403|580503973|FG005|Overall Study|Reason Unspecified|1|||
160759089|NCT00676403|580503968|FG000|Overall Study|Withdrawal by Subject|0|||
160759090|NCT00676403|580503969|FG001|Overall Study|Withdrawal by Subject|0|||
160759091|NCT00676403|580503970|FG002|Overall Study|Withdrawal by Subject|0|||
160759092|NCT00676403|580503971|FG003|Overall Study|Withdrawal by Subject|0|||
160759093|NCT00676403|580503972|FG004|Overall Study|Withdrawal by Subject|0|||
160759094|NCT00676403|580503973|FG005|Overall Study|Withdrawal by Subject|1|||
160759095|NCT03225170|580503974|FG000|Overall Study|Lost to Follow-up|4|||
160759096|NCT03225170|580503975|FG001|Overall Study|Lost to Follow-up|4|||
160759097|NCT03225170|580503976|FG002|Overall Study|Lost to Follow-up|0|||
160759098|NCT03225170|580503974|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
160759099|NCT03225170|580503975|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
160759100|NCT03225170|580503976|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
160759101|NCT01272908|580503977|FG000|Initial Treatment Period|Adverse Event|1|||
160759102|NCT01272908|580503977|FG000|Initial Treatment Period|Lack of Efficacy|5|||
160759103|NCT01272908|580503977|FG000|Initial Treatment Period|Protocol Violation|1|||
160759104|NCT01272908|580503977|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
160759105|NCT01272908|580503977|FG000|Re-Treatment Period|Adverse Event|2|||
160759106|NCT01272908|580503977|FG000|Re-Treatment Period|Lack of Efficacy|3|||
160759107|NCT01272908|580503977|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
160759108|NCT00971867|580503978|FG000|Overall Study|Adverse Event|4|||
160759109|NCT00971867|580503978|FG000|Overall Study|Participant Withdrew Consent|1|||
160759110|NCT00971867|580503978|FG000|Overall Study|Disease Progression|6|||
160759111|NCT01261390|580503982|FG000|Overall Study|Significant Concurrent Illness|1|||
160759112|NCT01261390|580503983|FG001|Overall Study|Significant Concurrent Illness|0|||
160759113|NCT01261390|580503984|FG002|Overall Study|Significant Concurrent Illness|1|||
160759114|NCT01261390|580503985|FG003|Overall Study|Significant Concurrent Illness|0|||
160759115|NCT01261390|580503982|FG000|Overall Study|Dissatisfaction with Treatment|2|||
160759116|NCT01261390|580503983|FG001|Overall Study|Dissatisfaction with Treatment|1|||
160759117|NCT01261390|580503984|FG002|Overall Study|Dissatisfaction with Treatment|1|||
160759118|NCT01261390|580503985|FG003|Overall Study|Dissatisfaction with Treatment|2|||
160759119|NCT01261390|580503982|FG000|Overall Study|Relocation|0|||
160759120|NCT01261390|580503983|FG001|Overall Study|Relocation|1|||
160759121|NCT01261390|580503984|FG002|Overall Study|Relocation|0|||
160759122|NCT01261390|580503985|FG003|Overall Study|Relocation|0|||
160759123|NCT01261390|580503982|FG000|Overall Study|Loss of Interest in the Study|3|||
160759124|NCT01261390|580503983|FG001|Overall Study|Loss of Interest in the Study|1|||
160759125|NCT01261390|580503984|FG002|Overall Study|Loss of Interest in the Study|0|||
160759126|NCT01261390|580503985|FG003|Overall Study|Loss of Interest in the Study|0|||
160759127|NCT01261390|580503982|FG000|Overall Study|Lost to Follow-up|1|||
160759128|NCT01261390|580503983|FG001|Overall Study|Lost to Follow-up|6|||
160759129|NCT01261390|580503984|FG002|Overall Study|Lost to Follow-up|5|||
160759130|NCT01261390|580503985|FG003|Overall Study|Lost to Follow-up|6|||
160759131|NCT02782741|580503987|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
160759132|NCT02782741|580503988|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
160759133|NCT02782741|580503989|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
160759134|NCT02782741|580503987|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
160759135|NCT02782741|580503988|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
160759136|NCT02782741|580503989|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
160759137|NCT02782741|580503987|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
160759138|NCT02782741|580503988|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
160759139|NCT02782741|580503989|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
160759140|NCT02782741|580503987|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
160759141|NCT02782741|580503988|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
160759142|NCT02782741|580503989|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
160759143|NCT02782741|580503987|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
160759144|NCT02782741|580503988|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
160759145|NCT02782741|580503989|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
160759146|NCT04157088|580503990|FG000|Overall Study|Study terminated by sponsor|23|||
160759147|NCT04157088|580503990|FG000|Overall Study|Withdrawal by Subject|4|||
160759148|NCT04157088|580503990|FG000|Overall Study|Lost to Follow-up|2|||
160759149|NCT04157088|580503990|FG000|Overall Study|Death|1|||
160759150|NCT02421419|580503991|FG000|Overall Study|Physician Decision|0|||
160759151|NCT02421419|580503992|FG001|Overall Study|Physician Decision|0|||
160759152|NCT02421419|580503993|FG002|Overall Study|Physician Decision|1|||
160759153|NCT01747499|580503994|FG000|Overall Study|Steroid refractory aGvHD|1|||
160759154|NCT01747499|580503995|FG001|Overall Study|Steroid refractory aGvHD|0|||
160759155|NCT01747499|580503996|FG002|Overall Study|Steroid refractory aGvHD|0|||
160759156|NCT01747499|580503997|FG003|Overall Study|Steroid refractory aGvHD|1|||
160759157|NCT01747499|580503998|FG004|Overall Study|Steroid refractory aGvHD|4|||
160759158|NCT01747499|580503994|FG000|Overall Study|Physician Decision|0|||
160759159|NCT01747499|580503995|FG001|Overall Study|Physician Decision|1|||
160759160|NCT01747499|580503996|FG002|Overall Study|Physician Decision|0|||
160759161|NCT01747499|580503997|FG003|Overall Study|Physician Decision|0|||
160759162|NCT01747499|580503998|FG004|Overall Study|Physician Decision|2|||
160759163|NCT01747499|580503994|FG000|Overall Study|Death|0|||
160759164|NCT01747499|580503995|FG001|Overall Study|Death|0|||
160759165|NCT01747499|580503996|FG002|Overall Study|Death|0|||
160759166|NCT01747499|580503997|FG003|Overall Study|Death|1|||
160759167|NCT01747499|580503998|FG004|Overall Study|Death|1|||
160759168|NCT01747499|580503994|FG000|Overall Study|Withdrawal by Subject|0|||
160759169|NCT01747499|580503995|FG001|Overall Study|Withdrawal by Subject|0|||
160759170|NCT01747499|580503996|FG002|Overall Study|Withdrawal by Subject|0|||
160759171|NCT01747499|580503997|FG003|Overall Study|Withdrawal by Subject|0|||
160759172|NCT01747499|580503998|FG004|Overall Study|Withdrawal by Subject|6|||
160759173|NCT01747499|580503994|FG000|Overall Study|Developed AML and death|0|||
160759174|NCT01747499|580503995|FG001|Overall Study|Developed AML and death|0|||
160759175|NCT01747499|580503996|FG002|Overall Study|Developed AML and death|0|||
160759176|NCT01747499|580503997|FG003|Overall Study|Developed AML and death|0|||
160759177|NCT01747499|580503998|FG004|Overall Study|Developed AML and death|1|||
160759178|NCT01747499|580503994|FG000|Overall Study|Determined not to be eligible|0|||
160759179|NCT01747499|580503995|FG001|Overall Study|Determined not to be eligible|0|||
160759180|NCT01747499|580503996|FG002|Overall Study|Determined not to be eligible|0|||
160759181|NCT01747499|580503997|FG003|Overall Study|Determined not to be eligible|0|||
160759182|NCT01747499|580503998|FG004|Overall Study|Determined not to be eligible|1|||
160759183|NCT01676701|580503999|FG000|Overall Study|Protocol Violation|1|||
160759184|NCT01676701|580504000|FG001|Overall Study|Protocol Violation|0|||
160759185|NCT01676701|580503999|FG000|Overall Study|Sponsor Decision|3|||
160759186|NCT01676701|580504000|FG001|Overall Study|Sponsor Decision|4|||
160759187|NCT00196105|580504002|FG000|Overall Study|Lost to Follow-up|4|||
160759188|NCT00196105|580504003|FG001|Overall Study|Lost to Follow-up|5|||
160759189|NCT00196105|580504004|FG002|Overall Study|Lost to Follow-up|7|||
160759190|NCT01497067|580504005|FG000|Overall Study|Lost to Follow-up|56|||
160759191|NCT01497067|580504005|FG000|Overall Study|Adverse Event|3|||
160759192|NCT01497067|580504005|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
160759193|NCT01497067|580504005|FG000|Overall Study|Other|13|||
160759194|NCT02227784|580504009|FG000|Double-Blind Phase|Adverse Event|3|||
160525267|NCT00908232|579653694|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
160525268|NCT00908232|579653695|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
160525269|NCT00908232|579653696|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
160525270|NCT00908232|579653693|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
160525271|NCT00908232|579653694|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
160525272|NCT00908232|579653695|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
160525273|NCT00908232|579653696|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
160525274|NCT00908232|579653693|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
160525275|NCT00908232|579653694|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
160525276|NCT00908232|579653695|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
160759195|NCT02227784|580504010|FG001|Double-Blind Phase|Adverse Event|2|||
160759196|NCT02227784|580504011|FG002|Double-Blind Phase|Adverse Event|1|||
160759197|NCT02227784|580504012|FG003|Double-Blind Phase|Adverse Event|3|||
160759198|NCT02227784|580504013|FG004|Double-Blind Phase|Adverse Event|0|||
160759199|NCT02227784|580504009|FG000|Double-Blind Phase|Physician Decision|1|||
160759200|NCT02227784|580504010|FG001|Double-Blind Phase|Physician Decision|0|||
160759201|NCT02227784|580504011|FG002|Double-Blind Phase|Physician Decision|0|||
160759202|NCT02227784|580504012|FG003|Double-Blind Phase|Physician Decision|1|||
160759203|NCT02227784|580504013|FG004|Double-Blind Phase|Physician Decision|0|||
160759204|NCT02227784|580504009|FG000|Double-Blind Phase|Protocol Violation|0|||
160759205|NCT02227784|580504010|FG001|Double-Blind Phase|Protocol Violation|0|||
160759206|NCT02227784|580504011|FG002|Double-Blind Phase|Protocol Violation|1|||
160759207|NCT02227784|580504012|FG003|Double-Blind Phase|Protocol Violation|1|||
160759208|NCT02227784|580504013|FG004|Double-Blind Phase|Protocol Violation|0|||
160759209|NCT02227784|580504009|FG000|Double-Blind Phase|Sponsor Decision|34|||
160759210|NCT02227784|580504010|FG001|Double-Blind Phase|Sponsor Decision|15|||
160759211|NCT02227784|580504011|FG002|Double-Blind Phase|Sponsor Decision|14|||
160759212|NCT02227784|580504012|FG003|Double-Blind Phase|Sponsor Decision|32|||
160759213|NCT02227784|580504013|FG004|Double-Blind Phase|Sponsor Decision|0|||
160759214|NCT02227784|580504009|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
160759215|NCT02227784|580504010|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
160759216|NCT02227784|580504011|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
160759217|NCT02227784|580504012|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
160759218|NCT02227784|580504013|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
160759219|NCT02227784|580504009|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
160759220|NCT02227784|580504010|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
160759221|NCT02227784|580504011|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
160759222|NCT02227784|580504012|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
160759223|NCT02227784|580504013|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
160759224|NCT02227784|580504009|FG000|Open-Label Extension Phase (OLE)|Death|0|||
160759225|NCT02227784|580504010|FG001|Open-Label Extension Phase (OLE)|Death|0|||
160759226|NCT02227784|580504011|FG002|Open-Label Extension Phase (OLE)|Death|0|||
160759227|NCT02227784|580504012|FG003|Open-Label Extension Phase (OLE)|Death|0|||
160759228|NCT02227784|580504013|FG004|Open-Label Extension Phase (OLE)|Death|1|||
160759229|NCT02227784|580504009|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
160759230|NCT02227784|580504010|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
160759231|NCT02227784|580504011|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
160759232|NCT02227784|580504012|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
160759233|NCT02227784|580504013|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
160759234|NCT02227784|580504009|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
160759235|NCT02227784|580504010|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
160759236|NCT02227784|580504011|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
160759237|NCT02227784|580504012|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
160759238|NCT02227784|580504013|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
160759239|NCT04058028|580504014|FG000|Overall Study|Withdrawal of Consent from Study|12|||
160759240|NCT04058028|580504015|FG001|Overall Study|Withdrawal of Consent from Study|8|||
160759241|NCT04058028|580504016|FG002|Overall Study|Withdrawal of Consent from Study|6|||
160759242|NCT04058028|580504017|FG003|Overall Study|Withdrawal of Consent from Study|7|||
160759243|NCT04058028|580504014|FG000|Overall Study|Decision by Sponsor|13|||
160759244|NCT04058028|580504015|FG001|Overall Study|Decision by Sponsor|4|||
160759245|NCT04058028|580504016|FG002|Overall Study|Decision by Sponsor|1|||
160759246|NCT04058028|580504017|FG003|Overall Study|Decision by Sponsor|35|||
160759247|NCT04058028|580504014|FG000|Overall Study|Lost to Follow-up|1|||
160759248|NCT04058028|580504015|FG001|Overall Study|Lost to Follow-up|1|||
160759249|NCT04058028|580504016|FG002|Overall Study|Lost to Follow-up|1|||
160759250|NCT04058028|580504017|FG003|Overall Study|Lost to Follow-up|0|||
160759251|NCT04058028|580504014|FG000|Overall Study|Death|0|||
160759252|NCT04058028|580504015|FG001|Overall Study|Death|1|||
160759253|NCT04058028|580504016|FG002|Overall Study|Death|0|||
160759254|NCT04058028|580504017|FG003|Overall Study|Death|0|||
160759255|NCT00248651|580504020|FG000|Overall Study|Withdrawal by Subject|28|||
160759256|NCT00248651|580504021|FG001|Overall Study|Withdrawal by Subject|40|||
160759257|NCT00248651|580504022|FG002|Overall Study|Withdrawal by Subject|32|||
160759258|NCT00828113|580504023|FG000|Overall Study|Withdrawal by Subject|27|||
160759259|NCT00828113|580504024|FG001|Overall Study|Withdrawal by Subject|26|||
160759260|NCT00828113|580504023|FG000|Overall Study|Lost to Follow-up|3|||
160759261|NCT00828113|580504024|FG001|Overall Study|Lost to Follow-up|5|||
160759262|NCT01365130|580504025|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
160759263|NCT05607576|580504027|FG000|Overall Study|immediate sensor error|2|||
160759264|NCT05607576|580504027|FG000|Overall Study|Physician Decision|2|||
160759265|NCT05616013|580504028|FG000|Overall Study|Adverse Event|6|||
160759266|NCT05616013|580504029|FG001|Overall Study|Adverse Event|12|||
160759267|NCT05616013|580504030|FG002|Overall Study|Adverse Event|8|||
160759268|NCT05616013|580504031|FG003|Overall Study|Adverse Event|4|||
160759269|NCT05616013|580504032|FG004|Overall Study|Adverse Event|6|||
160759270|NCT05616013|580504033|FG005|Overall Study|Adverse Event|8|||
160759271|NCT05616013|580504034|FG006|Overall Study|Adverse Event|3|||
160759272|NCT05616013|580504035|FG007|Overall Study|Adverse Event|6|||
160759273|NCT05616013|580504036|FG008|Overall Study|Adverse Event|1|||
160759274|NCT05616013|580504028|FG000|Overall Study|Lost to Follow-up|5|||
160759275|NCT05616013|580504029|FG001|Overall Study|Lost to Follow-up|4|||
160759276|NCT05616013|580504030|FG002|Overall Study|Lost to Follow-up|3|||
160759277|NCT05616013|580504031|FG003|Overall Study|Lost to Follow-up|2|||
160759278|NCT05616013|580504032|FG004|Overall Study|Lost to Follow-up|0|||
160759279|NCT05616013|580504033|FG005|Overall Study|Lost to Follow-up|5|||
160759280|NCT05616013|580504034|FG006|Overall Study|Lost to Follow-up|2|||
160759281|NCT05616013|580504035|FG007|Overall Study|Lost to Follow-up|1|||
160759282|NCT05616013|580504036|FG008|Overall Study|Lost to Follow-up|2|||
160759283|NCT05616013|580504028|FG000|Overall Study|Non-compliance with study requirements|2|||
160759284|NCT05616013|580504029|FG001|Overall Study|Non-compliance with study requirements|2|||
160759285|NCT05616013|580504030|FG002|Overall Study|Non-compliance with study requirements|2|||
160759286|NCT05616013|580504031|FG003|Overall Study|Non-compliance with study requirements|3|||
160759287|NCT05616013|580504032|FG004|Overall Study|Non-compliance with study requirements|0|||
160759288|NCT05616013|580504033|FG005|Overall Study|Non-compliance with study requirements|2|||
160759289|NCT05616013|580504034|FG006|Overall Study|Non-compliance with study requirements|1|||
160759290|NCT05616013|580504035|FG007|Overall Study|Non-compliance with study requirements|1|||
160759291|NCT05616013|580504036|FG008|Overall Study|Non-compliance with study requirements|4|||
160759292|NCT05616013|580504028|FG000|Overall Study|Withdrawal by Subject|11|||
160759293|NCT05616013|580504029|FG001|Overall Study|Withdrawal by Subject|9|||
160759294|NCT05616013|580504030|FG002|Overall Study|Withdrawal by Subject|8|||
160759295|NCT05616013|580504031|FG003|Overall Study|Withdrawal by Subject|6|||
160759296|NCT05616013|580504032|FG004|Overall Study|Withdrawal by Subject|3|||
160759297|NCT05616013|580504033|FG005|Overall Study|Withdrawal by Subject|4|||
160759298|NCT05616013|580504034|FG006|Overall Study|Withdrawal by Subject|6|||
160759299|NCT05616013|580504035|FG007|Overall Study|Withdrawal by Subject|5|||
160759300|NCT05616013|580504036|FG008|Overall Study|Withdrawal by Subject|4|||
160759301|NCT05616013|580504028|FG000|Overall Study|Physician Decision|0|||
160525277|NCT00908232|579653696|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
160525278|NCT00908232|579653693|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
160525279|NCT00908232|579653694|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
160525280|NCT00908232|579653695|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
160525281|NCT00908232|579653696|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
160525282|NCT00908232|579653693|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
160525283|NCT00908232|579653694|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
160525284|NCT00908232|579653695|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
160525285|NCT00908232|579653696|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
160759302|NCT05616013|580504029|FG001|Overall Study|Physician Decision|0|||
160759303|NCT05616013|580504030|FG002|Overall Study|Physician Decision|1|||
160759304|NCT05616013|580504031|FG003|Overall Study|Physician Decision|0|||
160759305|NCT05616013|580504032|FG004|Overall Study|Physician Decision|0|||
160759306|NCT05616013|580504033|FG005|Overall Study|Physician Decision|1|||
160759307|NCT05616013|580504034|FG006|Overall Study|Physician Decision|3|||
160759308|NCT05616013|580504035|FG007|Overall Study|Physician Decision|0|||
160759309|NCT05616013|580504036|FG008|Overall Study|Physician Decision|0|||
160759310|NCT05616013|580504028|FG000|Overall Study|Protocol Violation|0|||
160759311|NCT05616013|580504029|FG001|Overall Study|Protocol Violation|0|||
160759312|NCT05616013|580504030|FG002|Overall Study|Protocol Violation|0|||
160759313|NCT05616013|580504031|FG003|Overall Study|Protocol Violation|0|||
160759314|NCT05616013|580504032|FG004|Overall Study|Protocol Violation|0|||
160759315|NCT05616013|580504033|FG005|Overall Study|Protocol Violation|0|||
160759316|NCT05616013|580504034|FG006|Overall Study|Protocol Violation|1|||
160759317|NCT05616013|580504035|FG007|Overall Study|Protocol Violation|0|||
160759318|NCT05616013|580504036|FG008|Overall Study|Protocol Violation|2|||
160759319|NCT05616013|580504028|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
160759320|NCT05616013|580504029|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
160759321|NCT05616013|580504030|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
160759322|NCT05616013|580504031|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
160759323|NCT05616013|580504032|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
160759324|NCT05616013|580504033|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
160759325|NCT05616013|580504034|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
160759326|NCT05616013|580504035|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
160759327|NCT05616013|580504036|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
160759328|NCT05616013|580504028|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
160759329|NCT05616013|580504029|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
160759330|NCT05616013|580504030|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
160759331|NCT05616013|580504031|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
160759332|NCT05616013|580504032|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
160759333|NCT05616013|580504033|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
160759334|NCT05616013|580504034|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
160759335|NCT05616013|580504035|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
160759336|NCT05616013|580504036|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
160525286|NCT00908232|579653693|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
160525287|NCT00908232|579653694|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
160525288|NCT00908232|579653695|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
160525289|NCT00908232|579653696|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
160525290|NCT00769860|579653705|FG000|Overall Study|Withdrawal by Subject|2|||
160525291|NCT00769860|579653706|FG001|Overall Study|Withdrawal by Subject|0|||
160525292|NCT00448435|579653709|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
160525293|NCT00448435|579653710|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
160525294|NCT02804178|579653715|FG000|Overall Study|Adverse Event|1|||
160525295|NCT00412971|579653716|FG000|Overall Study|Lost to Follow-up|17|||
160525296|NCT00412971|579653717|FG001|Overall Study|Lost to Follow-up|9|||
160525297|NCT00412971|579653716|FG000|Overall Study|Protocol Violation|13|||
160525298|NCT00412971|579653717|FG001|Overall Study|Protocol Violation|1|||
160759337|NCT05616013|580504028|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
160759338|NCT05616013|580504029|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
160759339|NCT05616013|580504030|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
160759340|NCT05616013|580504031|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
160759341|NCT05616013|580504032|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
160525299|NCT01774084|579653718|FG000|Overall Study|Personal reasons|1|||
160759342|NCT05616013|580504033|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
160759343|NCT05616013|580504034|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
160759344|NCT05616013|580504035|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
160759345|NCT05616013|580504036|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
160759346|NCT05616013|580504028|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
160759347|NCT05616013|580504029|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
160759348|NCT05616013|580504030|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
160759349|NCT05616013|580504031|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
160759350|NCT05616013|580504032|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
160759351|NCT05616013|580504033|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
160759352|NCT05616013|580504034|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
160759353|NCT05616013|580504035|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
160759354|NCT05616013|580504036|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
160759355|NCT05616013|580504028|FG000|Overall Study|Participant Decision, Time Constraints|0|||
160759356|NCT05616013|580504029|FG001|Overall Study|Participant Decision, Time Constraints|1|||
160759357|NCT05616013|580504030|FG002|Overall Study|Participant Decision, Time Constraints|0|||
160759358|NCT05616013|580504031|FG003|Overall Study|Participant Decision, Time Constraints|0|||
160759359|NCT05616013|580504032|FG004|Overall Study|Participant Decision, Time Constraints|0|||
160759360|NCT05616013|580504033|FG005|Overall Study|Participant Decision, Time Constraints|0|||
160759361|NCT05616013|580504034|FG006|Overall Study|Participant Decision, Time Constraints|0|||
160759362|NCT05616013|580504035|FG007|Overall Study|Participant Decision, Time Constraints|0|||
160759363|NCT05616013|580504036|FG008|Overall Study|Participant Decision, Time Constraints|0|||
160759364|NCT05616013|580504028|FG000|Overall Study|Prohibited Concomitant Medication|0|||
160759365|NCT05616013|580504029|FG001|Overall Study|Prohibited Concomitant Medication|0|||
160759366|NCT05616013|580504030|FG002|Overall Study|Prohibited Concomitant Medication|1|||
160759367|NCT05616013|580504031|FG003|Overall Study|Prohibited Concomitant Medication|0|||
160759368|NCT05616013|580504032|FG004|Overall Study|Prohibited Concomitant Medication|0|||
160759369|NCT05616013|580504033|FG005|Overall Study|Prohibited Concomitant Medication|0|||
160759370|NCT05616013|580504034|FG006|Overall Study|Prohibited Concomitant Medication|0|||
160759371|NCT05616013|580504035|FG007|Overall Study|Prohibited Concomitant Medication|0|||
160759372|NCT05616013|580504036|FG008|Overall Study|Prohibited Concomitant Medication|0|||
160759373|NCT05616013|580504028|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
160759374|NCT05616013|580504029|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
160759375|NCT05616013|580504030|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
160759376|NCT05616013|580504031|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
160759377|NCT05616013|580504032|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
160759378|NCT05616013|580504033|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
160759379|NCT05616013|580504034|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
160759380|NCT05616013|580504035|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
160759381|NCT05616013|580504036|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
160759382|NCT05616013|580504028|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
160759383|NCT05616013|580504029|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
160759384|NCT05616013|580504030|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
160759385|NCT05616013|580504031|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
160759386|NCT05616013|580504032|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
160759387|NCT05616013|580504033|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
160759388|NCT05616013|580504034|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
160759389|NCT05616013|580504035|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
160759390|NCT05616013|580504036|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
160759391|NCT05616013|580504028|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
160759392|NCT05616013|580504029|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
160759393|NCT05616013|580504030|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
160759394|NCT05616013|580504031|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
160759395|NCT05616013|580504032|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
160759396|NCT05616013|580504033|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
160759397|NCT05616013|580504034|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
160759398|NCT05616013|580504035|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
160759399|NCT05616013|580504036|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
160759400|NCT05616013|580504028|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
160759401|NCT05616013|580504029|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
160759402|NCT05616013|580504030|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
160759403|NCT05616013|580504031|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
160759404|NCT05616013|580504032|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
160759405|NCT05616013|580504033|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
160759406|NCT05616013|580504034|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
160759407|NCT05616013|580504035|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
160759408|NCT05616013|580504036|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
160759409|NCT05616013|580504028|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
160759410|NCT05616013|580504029|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
160759411|NCT05616013|580504030|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
160759412|NCT05616013|580504031|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
160759413|NCT05616013|580504032|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
160759414|NCT05616013|580504033|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
160759415|NCT05616013|580504034|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
160759416|NCT05616013|580504035|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
160759417|NCT05616013|580504036|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
160759418|NCT01548599|580505750|FG000|Overall Study|Lost to Follow-up|0|||
160759419|NCT01548599|580505751|FG001|Overall Study|Lost to Follow-up|1|||
160759420|NCT01548599|580505750|FG000|Overall Study|Withdrawal by Subject|4|||
160759421|NCT01548599|580505751|FG001|Overall Study|Withdrawal by Subject|0|||
160759422|NCT01548599|580505750|FG000|Overall Study|Death|2|||
160759423|NCT01548599|580505751|FG001|Overall Study|Death|1|||
160759424|NCT02188160|580505752|FG000|Overall Study|Adverse Event|1|||
160759425|NCT02188160|580505753|FG001|Overall Study|Adverse Event|0|||
160759426|NCT02188160|580505752|FG000|Overall Study|Use of an excluded medication|0|||
160759427|NCT02188160|580505753|FG001|Overall Study|Use of an excluded medication|1|||
160759428|NCT01022203|580505758|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
160759429|NCT01022203|580505759|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
160759430|NCT01022203|580505758|FG000|Post Treatment Assessment|Physician Decision|2|||
160759431|NCT01022203|580505759|FG001|Post Treatment Assessment|Physician Decision|0|||
160759432|NCT01022203|580505758|FG000|Post Treatment Assessment|Adverse Event|0|||
160759433|NCT01022203|580505759|FG001|Post Treatment Assessment|Adverse Event|2|||
160759434|NCT01022203|580505758|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
160759435|NCT01022203|580505759|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
160759436|NCT03638128|580505760|FG000|Overall Study|Withdrawal by Subject|1|||
160759437|NCT03638128|580505761|FG001|Overall Study|Withdrawal by Subject|7|||
160759438|NCT03638128|580505762|FG002|Overall Study|Withdrawal by Subject|6|||
160759439|NCT03638128|580505760|FG000|Overall Study|Sponsor Decision|15|||
160759440|NCT03638128|580505761|FG001|Overall Study|Sponsor Decision|12|||
160759441|NCT03638128|580505762|FG002|Overall Study|Sponsor Decision|19|||
160759442|NCT03638128|580505760|FG000|Overall Study|Lost to Follow-up|0|||
160759443|NCT03638128|580505761|FG001|Overall Study|Lost to Follow-up|0|||
160759444|NCT03638128|580505762|FG002|Overall Study|Lost to Follow-up|1|||
160759445|NCT03163446|580505763|FG000|Overall Study|Unable to return for Day 180 visit|2|||
160759446|NCT03163446|580505764|FG001|Overall Study|Unable to return for Day 180 visit|0|||
160759447|NCT03163446|580505763|FG000|Overall Study|Withdrawal by Subject|2|||
160759448|NCT03163446|580505764|FG001|Overall Study|Withdrawal by Subject|6|||
160759449|NCT03163446|580505763|FG000|Overall Study|Death|16|||
160759450|NCT03163446|580505764|FG001|Overall Study|Death|5|||
160759451|NCT03163446|580505763|FG000|Overall Study|Lost to Follow-up|6|||
160759452|NCT03163446|580505764|FG001|Overall Study|Lost to Follow-up|5|||
160759453|NCT03163446|580505763|FG000|Overall Study|Physician Decision|1|||
160759454|NCT03163446|580505764|FG001|Overall Study|Physician Decision|1|||
160759455|NCT03163446|580505763|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
160759456|NCT03163446|580505764|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
160525300|NCT01774084|579653719|FG001|Overall Study|Personal reasons|0|||
160525301|NCT01106404|579653720|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
160759457|NCT00903201|580505765|FG000|Overall Study|Adverse Event|1|||
160865667|NCT02504151|580902947|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
160865668|NCT02504151|580902946|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
160525302|NCT01106404|579653721|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
160525303|NCT01106404|579653720|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
160525304|NCT01106404|579653721|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
160865669|NCT02504151|580902947|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
160865670|NCT02504151|580902946|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
160865671|NCT02504151|580902947|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160759458|NCT00903201|580505766|FG001|Overall Study|Adverse Event|4|||
160759459|NCT00903201|580505767|FG002|Overall Study|Adverse Event|0|||
160759460|NCT00903201|580505765|FG000|Overall Study|Protocol Violation|2|||
160759461|NCT00903201|580505766|FG001|Overall Study|Protocol Violation|1|||
160759462|NCT00903201|580505767|FG002|Overall Study|Protocol Violation|0|||
160759463|NCT00903201|580505765|FG000|Overall Study|Lost to Follow-up|0|||
160759464|NCT00903201|580505766|FG001|Overall Study|Lost to Follow-up|1|||
160759465|NCT00903201|580505767|FG002|Overall Study|Lost to Follow-up|0|||
160759466|NCT00903201|580505765|FG000|Overall Study|Physician Decision|1|||
160759467|NCT00903201|580505766|FG001|Overall Study|Physician Decision|0|||
160759468|NCT00903201|580505767|FG002|Overall Study|Physician Decision|1|||
160759469|NCT00903201|580505765|FG000|Overall Study|Withdrawal by Subject|1|||
160759470|NCT00903201|580505766|FG001|Overall Study|Withdrawal by Subject|0|||
160759471|NCT00903201|580505767|FG002|Overall Study|Withdrawal by Subject|1|||
160759472|NCT01094288|580505770|FG000|Overall Study|Adverse Event|0|||
160759473|NCT01094288|580505771|FG001|Overall Study|Adverse Event|3|||
160759474|NCT01094288|580505772|FG002|Overall Study|Adverse Event|1|||
160759475|NCT01094288|580505773|FG003|Overall Study|Adverse Event|1|||
160759476|NCT01094288|580505774|FG004|Overall Study|Adverse Event|0|||
160759477|NCT01094288|580505775|FG005|Overall Study|Adverse Event|0|||
160759478|NCT01094288|580505776|FG006|Overall Study|Adverse Event|0|||
160759479|NCT01094288|580505777|FG007|Overall Study|Adverse Event|0|||
160759480|NCT01094288|580505770|FG000|Overall Study|Withdrawal by Subject|0|||
160759481|NCT01094288|580505771|FG001|Overall Study|Withdrawal by Subject|1|||
160759482|NCT01094288|580505772|FG002|Overall Study|Withdrawal by Subject|2|||
160759483|NCT01094288|580505773|FG003|Overall Study|Withdrawal by Subject|0|||
160759484|NCT01094288|580505774|FG004|Overall Study|Withdrawal by Subject|0|||
160759485|NCT01094288|580505775|FG005|Overall Study|Withdrawal by Subject|0|||
160759486|NCT01094288|580505776|FG006|Overall Study|Withdrawal by Subject|0|||
160759487|NCT01094288|580505777|FG007|Overall Study|Withdrawal by Subject|2|||
160759488|NCT01094288|580505770|FG000|Overall Study|Initiation of Alternative Therapy|0|||
160759489|NCT01094288|580505771|FG001|Overall Study|Initiation of Alternative Therapy|0|||
160759490|NCT01094288|580505772|FG002|Overall Study|Initiation of Alternative Therapy|1|||
160759491|NCT01094288|580505773|FG003|Overall Study|Initiation of Alternative Therapy|0|||
160759492|NCT01094288|580505774|FG004|Overall Study|Initiation of Alternative Therapy|0|||
160759493|NCT01094288|580505775|FG005|Overall Study|Initiation of Alternative Therapy|0|||
160759494|NCT01094288|580505776|FG006|Overall Study|Initiation of Alternative Therapy|0|||
160759495|NCT01094288|580505777|FG007|Overall Study|Initiation of Alternative Therapy|0|||
160759496|NCT01094288|580505770|FG000|Overall Study|Reason not Specified|2|||
160759497|NCT01094288|580505771|FG001|Overall Study|Reason not Specified|3|||
160759498|NCT01094288|580505772|FG002|Overall Study|Reason not Specified|0|||
160759499|NCT01094288|580505773|FG003|Overall Study|Reason not Specified|1|||
160759500|NCT01094288|580505774|FG004|Overall Study|Reason not Specified|0|||
160759501|NCT01094288|580505775|FG005|Overall Study|Reason not Specified|0|||
160759502|NCT01094288|580505776|FG006|Overall Study|Reason not Specified|0|||
160759503|NCT01094288|580505777|FG007|Overall Study|Reason not Specified|0|||
160759504|NCT01094288|580505770|FG000|Overall Study|Ongoing Participants|0|||
160759505|NCT01094288|580505771|FG001|Overall Study|Ongoing Participants|3|||
160759506|NCT01094288|580505772|FG002|Overall Study|Ongoing Participants|0|||
160759507|NCT01094288|580505773|FG003|Overall Study|Ongoing Participants|0|||
160759508|NCT01094288|580505774|FG004|Overall Study|Ongoing Participants|0|||
160759509|NCT01094288|580505775|FG005|Overall Study|Ongoing Participants|0|||
160759510|NCT01094288|580505776|FG006|Overall Study|Ongoing Participants|0|||
160759511|NCT01094288|580505777|FG007|Overall Study|Ongoing Participants|0|||
160759512|NCT01228591|580505778|FG000|Baseline|Lack of Efficacy|1|||
160759513|NCT01228591|580505779|FG001|Baseline|Lack of Efficacy|2|||
160759514|NCT02611882|580505780|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
160759515|NCT02611882|580505781|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
160759516|NCT02611882|580505782|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
160759517|NCT01389232|580505783|FG000|Overall Study|Had scaffold removed|15|||
160759518|NCT01389232|580505783|FG000|Overall Study|Personal reasons|2|||
160759519|NCT01389232|580505783|FG000|Overall Study|Adverse Event|1|||
160759520|NCT01389232|580505783|FG000|Overall Study|Death|1|||
160759521|NCT01317940|580505784|FG000|Overall Study|Death|1|||
160759522|NCT01317940|580505785|FG001|Overall Study|Death|0|||
160759523|NCT01317940|580505786|FG002|Overall Study|Death|1|||
160759524|NCT01317940|580505787|FG003|Overall Study|Death|0|||
160759525|NCT01317940|580505788|FG004|Overall Study|Death|0|||
160759526|NCT01317940|580505789|FG005|Overall Study|Death|0|||
160759527|NCT01317940|580505784|FG000|Overall Study|Lost to Follow-up|0|||
160759528|NCT01317940|580505785|FG001|Overall Study|Lost to Follow-up|0|||
160759529|NCT01317940|580505786|FG002|Overall Study|Lost to Follow-up|1|||
160759530|NCT01317940|580505787|FG003|Overall Study|Lost to Follow-up|1|||
160759531|NCT01317940|580505788|FG004|Overall Study|Lost to Follow-up|1|||
160759532|NCT01317940|580505789|FG005|Overall Study|Lost to Follow-up|0|||
160759533|NCT01317940|580505784|FG000|Overall Study|Change in therapy plan|0|||
160759534|NCT01317940|580505785|FG001|Overall Study|Change in therapy plan|0|||
160525305|NCT01106404|579653720|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
160525306|NCT01106404|579653721|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
160525307|NCT01106404|579653720|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
160525308|NCT01106404|579653721|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
160525309|NCT01387230|579653722|FG000|Overall Study|Adverse Event|0|||
160525310|NCT01387230|579653723|FG001|Overall Study|Adverse Event|1|||
160525311|NCT01387230|579653724|FG002|Overall Study|Adverse Event|3|||
160525312|NCT01387230|579653722|FG000|Overall Study|Lack of Efficacy|8|||
160525313|NCT01387230|579653723|FG001|Overall Study|Lack of Efficacy|5|||
160525314|NCT01387230|579653724|FG002|Overall Study|Lack of Efficacy|4|||
160525315|NCT01387230|579653722|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
160525316|NCT01387230|579653723|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
160525317|NCT01387230|579653724|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
160525318|NCT01387230|579653722|FG000|Overall Study|Lost to Follow-up|0|||
160525319|NCT01387230|579653723|FG001|Overall Study|Lost to Follow-up|0|||
160525320|NCT01387230|579653724|FG002|Overall Study|Lost to Follow-up|1|||
160525321|NCT01387230|579653722|FG000|Overall Study|Withdrawal by Subject|4|||
160525322|NCT01387230|579653723|FG001|Overall Study|Withdrawal by Subject|1|||
160525323|NCT01387230|579653724|FG002|Overall Study|Withdrawal by Subject|0|||
160525324|NCT03027557|579653728|FG000|Overall Study|Adverse Event|1|||
160525325|NCT03027557|579653729|FG001|Overall Study|Adverse Event|0|||
160525326|NCT03027557|579653730|FG002|Overall Study|Adverse Event|0|||
160525327|NCT02430051|579653733|FG000|Overall Study|Withdrawal by Subject|6|||
160525328|NCT02430051|579653734|FG001|Overall Study|Withdrawal by Subject|3|||
160525329|NCT02430051|579653733|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
160525330|NCT02430051|579653734|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
160525331|NCT02430051|579653733|FG000|Overall Study|Protocol Violation|1|||
160525332|NCT02430051|579653734|FG001|Overall Study|Protocol Violation|0|||
160525333|NCT02030405|579653739|FG000|Overall Study|Withdrawal by Subject|1|||
160525334|NCT02030405|579653739|FG000|Overall Study|Lost to Follow-up|1|||
160525335|NCT00132496|579653740|FG000|Overall Study|Withdrawal by Subject|1|||
160525336|NCT00132496|579653741|FG001|Overall Study|Withdrawal by Subject|2|||
160525337|NCT00132496|579653740|FG000|Overall Study|Physician Decision|1|||
160525338|NCT00132496|579653741|FG001|Overall Study|Physician Decision|0|||
160525339|NCT00986440|579653744|FG000|Overall Study|Progressive disease|27|||
160525340|NCT00986440|579653745|FG001|Overall Study|Progressive disease|37|||
160525341|NCT00986440|579653744|FG000|Overall Study|Serious adverse event or adverse event|9|||
160525342|NCT00986440|579653745|FG001|Overall Study|Serious adverse event or adverse event|2|||
160525343|NCT00986440|579653744|FG000|Overall Study|Withdrawal by Subject|1|||
160525344|NCT00986440|579653745|FG001|Overall Study|Withdrawal by Subject|2|||
160525345|NCT00986440|579653744|FG000|Overall Study|Screen failure (not dosed)|4|||
160525346|NCT00986440|579653745|FG001|Overall Study|Screen failure (not dosed)|2|||
160525347|NCT00388154|579653746|FG000|Overall Study|Withdrawal by Subject|1|||
160525348|NCT04526197|579653752|FG000|Period 1|Adverse Event|0|||
160525349|NCT04526197|579653753|FG001|Period 1|Adverse Event|1|||
160525350|NCT04526197|579653752|FG000|Period 1|Withdrawal by Subject|1|||
160525351|NCT04526197|579653753|FG001|Period 1|Withdrawal by Subject|0|||
160525352|NCT04526197|579653752|FG000|Period 2|Adverse Event|0|||
160525353|NCT04526197|579653753|FG001|Period 2|Adverse Event|1|||
160525354|NCT04526197|579653752|FG000|Period 2|Withdrawal by Subject|0|||
160525355|NCT04526197|579653753|FG001|Period 2|Withdrawal by Subject|1|||
160525356|NCT01136811|579653756|FG000|Overall Study|Physician Decision|11|||
160525357|NCT01145755|579653757|FG000|Overall Study|Adverse Event|2|||
160525358|NCT01145755|579653758|FG001|Overall Study|Adverse Event|4|||
160525359|NCT01145755|579653759|FG002|Overall Study|Adverse Event|2|||
160525360|NCT01145755|579653757|FG000|Overall Study|Withdrawal by Subject|2|||
160525361|NCT01145755|579653758|FG001|Overall Study|Withdrawal by Subject|2|||
160525362|NCT01145755|579653759|FG002|Overall Study|Withdrawal by Subject|2|||
160525363|NCT01145755|579653757|FG000|Overall Study|Lost to Follow-up|2|||
160759535|NCT01317940|580505786|FG002|Overall Study|Change in therapy plan|3|||
160759536|NCT01317940|580505787|FG003|Overall Study|Change in therapy plan|0|||
160759537|NCT01317940|580505788|FG004|Overall Study|Change in therapy plan|0|||
160759538|NCT01317940|580505789|FG005|Overall Study|Change in therapy plan|0|||
160759539|NCT00945243|580505791|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
160759540|NCT02371616|580505792|FG000|Overall Study|Protocol Violation|2|||
160759541|NCT02371616|580505793|FG001|Overall Study|Protocol Violation|1|||
160525364|NCT01145755|579653758|FG001|Overall Study|Lost to Follow-up|3|||
160525365|NCT01145755|579653759|FG002|Overall Study|Lost to Follow-up|1|||
160525366|NCT01145755|579653757|FG000|Overall Study|Protocol Violation|0|||
160525367|NCT01145755|579653758|FG001|Overall Study|Protocol Violation|3|||
160525368|NCT01145755|579653759|FG002|Overall Study|Protocol Violation|1|||
160759542|NCT02371616|580505792|FG000|Overall Study|Adverse Event|0|||
160759543|NCT02371616|580505793|FG001|Overall Study|Adverse Event|1|||
160525369|NCT01145755|579653757|FG000|Overall Study|Study Closure|14|||
160525370|NCT01145755|579653758|FG001|Overall Study|Study Closure|14|||
160525371|NCT01145755|579653759|FG002|Overall Study|Study Closure|17|||
160525372|NCT01145755|579653757|FG000|Overall Study|Lack of Efficacy|0|||
160525373|NCT01145755|579653758|FG001|Overall Study|Lack of Efficacy|1|||
160525374|NCT01145755|579653759|FG002|Overall Study|Lack of Efficacy|0|||
160525375|NCT01145755|579653757|FG000|Overall Study|Patient could not swollow medication|0|||
160525376|NCT01145755|579653758|FG001|Overall Study|Patient could not swollow medication|0|||
160525377|NCT01145755|579653759|FG002|Overall Study|Patient could not swollow medication|1|||
160525378|NCT01145755|579653757|FG000|Overall Study|Withdrawal by Subject|0|||
160525379|NCT01145755|579653758|FG001|Overall Study|Withdrawal by Subject|0|||
160525380|NCT01145755|579653759|FG002|Overall Study|Withdrawal by Subject|1|||
160525381|NCT01145755|579653757|FG000|Overall Study|Positive urine ethanol|0|||
160525382|NCT01145755|579653758|FG001|Overall Study|Positive urine ethanol|1|||
160525383|NCT01145755|579653759|FG002|Overall Study|Positive urine ethanol|0|||
160525384|NCT01211522|579653761|FG000|Overall Study|Withdrawal by Subject|3|||
160525385|NCT01211522|579653762|FG001|Overall Study|Withdrawal by Subject|7|||
160525386|NCT01211522|579653763|FG002|Overall Study|Withdrawal by Subject|5|||
160525387|NCT03431857|579653769|FG000|Overall Study|Death|6|||
160759544|NCT02371616|580505792|FG000|Overall Study|Withdrawal of Consent|1|||
160759545|NCT02371616|580505793|FG001|Overall Study|Withdrawal of Consent|0|||
160759546|NCT02371616|580505792|FG000|Overall Study|Other (Not specified)|1|||
160759547|NCT02371616|580505793|FG001|Overall Study|Other (Not specified)|5|||
160759548|NCT00754741|580505796|FG000|Overall Study|Died or disenrolled|57|||
160759549|NCT00754741|580505797|FG001|Overall Study|Died or disenrolled|69|||
160759550|NCT00754741|580505798|FG002|Overall Study|Died or disenrolled|54|||
160759551|NCT00789321|580505799|FG000|Overall Study|Adverse Event|0|||
160759552|NCT00789321|580505800|FG001|Overall Study|Adverse Event|1|||
160759553|NCT00104052|580505801|FG000|Overall Study|Adverse Event|1|||
160759554|NCT00104052|580505801|FG000|Overall Study|Lack of Efficacy|26|||
160759555|NCT00104052|580505801|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
160759556|NCT01162343|580505802|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
160759557|NCT01162343|580505802|FG000|Overall Study|Refused psychiatrist assessment|12|||
160759558|NCT01294423|580505807|FG000|Overall Study|Adverse Event|1|||
160759559|NCT01294423|580505808|FG001|Overall Study|Adverse Event|2|||
160759560|NCT01294423|580505809|FG002|Overall Study|Adverse Event|3|||
160759561|NCT01294423|580505807|FG000|Overall Study|Withdrawal by Subject|1|||
160759562|NCT01294423|580505808|FG001|Overall Study|Withdrawal by Subject|2|||
160759563|NCT01294423|580505809|FG002|Overall Study|Withdrawal by Subject|2|||
160759564|NCT01294423|580505807|FG000|Overall Study|subject no longer meets study criteria|2|||
160759565|NCT01294423|580505808|FG001|Overall Study|subject no longer meets study criteria|5|||
160759566|NCT01294423|580505809|FG002|Overall Study|subject no longer meets study criteria|2|||
160759567|NCT01294423|580505807|FG000|Overall Study|poor/non-compliance|1|||
160759568|NCT01294423|580505808|FG001|Overall Study|poor/non-compliance|0|||
160759569|NCT01294423|580505809|FG002|Overall Study|poor/non-compliance|1|||
160759570|NCT01241279|580505810|FG000|Overall Study|Lost to Follow-up|0|||
160759571|NCT01241279|580505811|FG001|Overall Study|Lost to Follow-up|1|||
160759572|NCT01484951|580505812|FG000|Overall Study|Adverse Event|3|||
160759573|NCT01484951|580505812|FG000|Overall Study|Personal Reasons|1|||
160759574|NCT01484951|580505812|FG000|Overall Study|Non-Compliance|1|||
160759575|NCT02452047|580505814|FG000|Overall Study|Adverse Event|0|||
160759576|NCT02452047|580505815|FG001|Overall Study|Adverse Event|1|||
160759577|NCT02452047|580505816|FG002|Overall Study|Adverse Event|1|||
160759578|NCT02452047|580505814|FG000|Overall Study|Death|1|||
160759579|NCT02452047|580505815|FG001|Overall Study|Death|3|||
160759580|NCT02452047|580505816|FG002|Overall Study|Death|1|||
160759581|NCT02452047|580505814|FG000|Overall Study|Physician Decision|1|||
160759582|NCT02452047|580505815|FG001|Overall Study|Physician Decision|0|||
160759583|NCT02452047|580505816|FG002|Overall Study|Physician Decision|0|||
160759584|NCT02452047|580505814|FG000|Overall Study|Lost to Follow-up|1|||
160759585|NCT02452047|580505815|FG001|Overall Study|Lost to Follow-up|1|||
160759586|NCT02452047|580505816|FG002|Overall Study|Lost to Follow-up|0|||
160759587|NCT02452047|580505814|FG000|Overall Study|Withdrawal by Subject|1|||
160759588|NCT02452047|580505815|FG001|Overall Study|Withdrawal by Subject|0|||
160759589|NCT02452047|580505816|FG002|Overall Study|Withdrawal by Subject|0|||
160759590|NCT02026141|580505818|FG000|Overall Study|Protocol Violation|0|||
160759591|NCT02026141|580505819|FG001|Overall Study|Protocol Violation|1|||
160759592|NCT02169505|580505820|FG000|Overall Study|Withdrawal by Subject|1|||
160759593|NCT01248455|580505821|FG000|Overall Study|switched to alternate treatment|1|||
160759594|NCT02735980|580505822|FG000|Overall Study|Adverse Event|0|||
160759595|NCT02735980|580505823|FG001|Overall Study|Adverse Event|4|||
160759596|NCT02735980|580505824|FG002|Overall Study|Adverse Event|1|||
160759597|NCT02735980|580505822|FG000|Overall Study|Death|5|||
160759598|NCT02735980|580505823|FG001|Overall Study|Death|4|||
160525388|NCT03431857|579653769|FG000|Overall Study|Lost to Follow-up|41|||
160759599|NCT02735980|580505824|FG002|Overall Study|Death|0|||
160759600|NCT02735980|580505822|FG000|Overall Study|Physician Decision|3|||
160759601|NCT02735980|580505823|FG001|Overall Study|Physician Decision|1|||
160759602|NCT02735980|580505824|FG002|Overall Study|Physician Decision|0|||
160525389|NCT03431857|579653769|FG000|Overall Study|Adverse Event|6|||
160525390|NCT03431857|579653769|FG000|Overall Study|Withdrawal by Subject|1|||
160759603|NCT02735980|580505822|FG000|Overall Study|Screen failure|1|||
160759604|NCT02735980|580505823|FG001|Overall Study|Screen failure|0|||
160759605|NCT02735980|580505824|FG002|Overall Study|Screen failure|0|||
160759606|NCT02735980|580505822|FG000|Overall Study|Withdrawal by Subject|1|||
160759607|NCT02735980|580505823|FG001|Overall Study|Withdrawal by Subject|2|||
160759608|NCT02735980|580505824|FG002|Overall Study|Withdrawal by Subject|0|||
160759609|NCT00917124|580505828|FG000|Overall Study|Protocol Violation|4|||
160759610|NCT00917124|580505829|FG001|Overall Study|Protocol Violation|6|||
160759611|NCT01783743|580505830|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
160759612|NCT01783743|580505831|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
160759613|NCT01783743|580505830|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
160759614|NCT01783743|580505831|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
160759615|NCT01783743|580505830|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
160759616|NCT01783743|580505831|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
160759617|NCT00126594|580505848|FG000|Overall Study|Ineligible|2|||
160759618|NCT00126594|580505849|FG001|Overall Study|Ineligible|0|||
160525391|NCT01323621|579653770|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
160525392|NCT01323621|579653771|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
160525393|NCT01323621|579653772|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
160525394|NCT01323621|579653770|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
160525395|NCT01323621|579653771|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
160525396|NCT01323621|579653772|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
160525397|NCT01323621|579653770|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
160525398|NCT01323621|579653771|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
160525399|NCT01323621|579653772|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
160525400|NCT01323621|579653770|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
160525401|NCT01323621|579653771|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
160525402|NCT01323621|579653772|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
160525403|NCT01323621|579653770|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
160525404|NCT01323621|579653771|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
160759619|NCT00126594|580505848|FG000|Overall Study|Withdrawal by Subject|0|||
160759620|NCT00126594|580505849|FG001|Overall Study|Withdrawal by Subject|4|||
160759621|NCT00126594|580505848|FG000|Overall Study|Physician Decision|1|||
160759622|NCT00126594|580505849|FG001|Overall Study|Physician Decision|3|||
160759623|NCT00126594|580505848|FG000|Overall Study|Adverse Event|7|||
160759624|NCT00126594|580505849|FG001|Overall Study|Adverse Event|5|||
160759625|NCT00126594|580505848|FG000|Overall Study|Non-compliance|0|||
160759626|NCT00126594|580505849|FG001|Overall Study|Non-compliance|1|||
160759627|NCT00126594|580505848|FG000|Overall Study|Disease Progression|29|||
160759628|NCT00126594|580505849|FG001|Overall Study|Disease Progression|24|||
160759629|NCT02631941|580505856|FG000|Overall Study|Physician Decision|0|||
160759630|NCT02631941|580505857|FG001|Overall Study|Physician Decision|1|||
160759631|NCT02631941|580505858|FG002|Overall Study|Physician Decision|0|||
160759632|NCT02631941|580505859|FG003|Overall Study|Physician Decision|0|||
160759633|NCT02631941|580505860|FG004|Overall Study|Physician Decision|0|||
160759634|NCT02631941|580505861|FG005|Overall Study|Physician Decision|0|||
160759635|NCT02631941|580505862|FG006|Overall Study|Physician Decision|0|||
160759636|NCT02631941|580505863|FG007|Overall Study|Physician Decision|0|||
160759637|NCT02631941|580505864|FG008|Overall Study|Physician Decision|0|||
160759638|NCT02631941|580505865|FG009|Overall Study|Physician Decision|0|||
160759639|NCT02631941|580505856|FG000|Overall Study|Adverse Event|0|||
160759640|NCT02631941|580505857|FG001|Overall Study|Adverse Event|1|||
160759641|NCT02631941|580505858|FG002|Overall Study|Adverse Event|0|||
160525405|NCT01323621|579653772|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
160525406|NCT01323621|579653770|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
160525407|NCT01323621|579653771|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
160525408|NCT01323621|579653772|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
160525409|NCT01323621|579653770|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
160525410|NCT01323621|579653771|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
160525411|NCT01323621|579653772|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
160525412|NCT01323621|579653770|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
160525413|NCT01323621|579653771|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
160525414|NCT01323621|579653772|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
160525415|NCT01323621|579653770|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
160525416|NCT01323621|579653771|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
160525417|NCT01323621|579653772|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
160525418|NCT01323621|579653770|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160525419|NCT01323621|579653771|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
160759642|NCT02631941|580505859|FG003|Overall Study|Adverse Event|0|||
160759643|NCT02631941|580505860|FG004|Overall Study|Adverse Event|0|||
160759644|NCT02631941|580505861|FG005|Overall Study|Adverse Event|0|||
160865672|NCT02504151|580902946|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
160759645|NCT02631941|580505862|FG006|Overall Study|Adverse Event|0|||
160759646|NCT02631941|580505863|FG007|Overall Study|Adverse Event|0|||
160759647|NCT02631941|580505864|FG008|Overall Study|Adverse Event|0|||
160759648|NCT02631941|580505865|FG009|Overall Study|Adverse Event|0|||
160759649|NCT02631941|580505856|FG000|Overall Study|Withdrawal by Subject|0|||
160759650|NCT02631941|580505857|FG001|Overall Study|Withdrawal by Subject|0|||
160759651|NCT02631941|580505858|FG002|Overall Study|Withdrawal by Subject|0|||
160759652|NCT02631941|580505859|FG003|Overall Study|Withdrawal by Subject|0|||
160759653|NCT02631941|580505860|FG004|Overall Study|Withdrawal by Subject|1|||
160759654|NCT02631941|580505861|FG005|Overall Study|Withdrawal by Subject|0|||
160759655|NCT02631941|580505862|FG006|Overall Study|Withdrawal by Subject|0|||
160759656|NCT02631941|580505863|FG007|Overall Study|Withdrawal by Subject|1|||
160759657|NCT02631941|580505864|FG008|Overall Study|Withdrawal by Subject|0|||
160759658|NCT02631941|580505865|FG009|Overall Study|Withdrawal by Subject|0|||
160759659|NCT02631941|580505856|FG000|Overall Study|Lost to Follow-up|0|||
160759660|NCT02631941|580505857|FG001|Overall Study|Lost to Follow-up|0|||
160759661|NCT02631941|580505858|FG002|Overall Study|Lost to Follow-up|0|||
160759662|NCT02631941|580505859|FG003|Overall Study|Lost to Follow-up|0|||
160759663|NCT02631941|580505860|FG004|Overall Study|Lost to Follow-up|0|||
160525420|NCT01323621|579653772|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160759664|NCT02631941|580505861|FG005|Overall Study|Lost to Follow-up|0|||
160759665|NCT02631941|580505862|FG006|Overall Study|Lost to Follow-up|0|||
160759666|NCT02631941|580505863|FG007|Overall Study|Lost to Follow-up|0|||
160759667|NCT02631941|580505864|FG008|Overall Study|Lost to Follow-up|1|||
160759668|NCT02631941|580505865|FG009|Overall Study|Lost to Follow-up|0|||
160759669|NCT01158261|580505873|FG000|Overall Study|Lost to Follow-up|9|||
160759670|NCT01158261|580505873|FG000|Overall Study|Death|7|||
160759671|NCT01158261|580505873|FG000|Overall Study|Withdrawal by Subject|1|||
160759672|NCT03727841|580505876|FG000|Overall Study|Physician Decision|3|||
160759673|NCT03727841|580505877|FG001|Overall Study|Physician Decision|1|||
160759674|NCT01601496|580505878|FG000|Overall Study|Physician Decision|1|||
160759675|NCT01601496|580505878|FG000|Overall Study|Withdrawal by Subject|1|||
160759676|NCT01601496|580505878|FG000|Overall Study|Lost to Follow-up|6|||
160759677|NCT01601496|580505878|FG000|Overall Study|Death|4|||
160759678|NCT01601496|580505878|FG000|Overall Study|Other: patient refusal to continue|3|||
160759679|NCT03126786|580505879|FG000|Overall Study|Adverse Event|3|||
160759680|NCT03126786|580505880|FG001|Overall Study|Adverse Event|0|||
160759681|NCT03126786|580505879|FG000|Overall Study|Lost to Follow-up|0|||
160759682|NCT03126786|580505880|FG001|Overall Study|Lost to Follow-up|1|||
160759683|NCT03126786|580505879|FG000|Overall Study|Withdrawal by Subject|3|||
160759684|NCT03126786|580505880|FG001|Overall Study|Withdrawal by Subject|1|||
160759685|NCT03243305|580505881|FG000|Overall Study|Lost to Follow-up|250|||
160759686|NCT03243305|580505881|FG000|Overall Study|Withdrawal by Subject|170|||
160759687|NCT03243305|580505881|FG000|Overall Study|Pregnancy|104|||
160759688|NCT03243305|580505881|FG000|Overall Study|Non-Compliance with Study Drug|38|||
160759689|NCT03243305|580505881|FG000|Overall Study|Adverse Event|23|||
160759690|NCT03243305|580505881|FG000|Overall Study|No sexually active|26|||
160759691|NCT03243305|580505881|FG000|Overall Study|Physician Decision|22|||
160759692|NCT03243305|580505881|FG000|Overall Study|Protocol Violation|22|||
160759693|NCT03243305|580505881|FG000|Overall Study|Study method no longer primary method|12|||
160759694|NCT03243305|580505881|FG000|Overall Study|Study Terminated by Sponsor|1|||
160759695|NCT03243305|580505881|FG000|Overall Study|Early terminations|267|||
160759696|NCT02689804|580505882|FG000|Overall Study|Withdrawal by Subject|2|||
160759697|NCT02689804|580505883|FG001|Overall Study|Withdrawal by Subject|0|||
160759698|NCT00227539|580505884|FG000|Overall Study|Protocol Violation|1|||
160759699|NCT00673257|580505885|FG000|Overall Study|Withdrawal by Subject|4|||
160759700|NCT00673257|580505885|FG000|Overall Study|Unable to obtain specimen|1|||
160759701|NCT01585246|580505892|FG000|Overall Study|Lost to Follow-up|0|||
160759702|NCT01585246|580505893|FG001|Overall Study|Lost to Follow-up|0|||
160759703|NCT01585246|580505894|FG002|Overall Study|Lost to Follow-up|2|||
160759704|NCT01585246|580505895|FG003|Overall Study|Lost to Follow-up|1|||
160759705|NCT01585246|580505896|FG004|Overall Study|Lost to Follow-up|0|||
160759706|NCT01585246|580505892|FG000|Overall Study|Protocol Violation|0|||
160759707|NCT01585246|580505893|FG001|Overall Study|Protocol Violation|0|||
160759708|NCT01585246|580505894|FG002|Overall Study|Protocol Violation|0|||
160759709|NCT01585246|580505895|FG003|Overall Study|Protocol Violation|0|||
160759710|NCT01585246|580505896|FG004|Overall Study|Protocol Violation|1|||
160759711|NCT01585246|580505892|FG000|Overall Study|Withdrawal by Subject|0|||
160759712|NCT01585246|580505893|FG001|Overall Study|Withdrawal by Subject|0|||
160759713|NCT01585246|580505894|FG002|Overall Study|Withdrawal by Subject|1|||
160759714|NCT01585246|580505895|FG003|Overall Study|Withdrawal by Subject|2|||
160759715|NCT01585246|580505896|FG004|Overall Study|Withdrawal by Subject|1|||
160525421|NCT01323621|579653770|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
160759716|NCT01585246|580505892|FG000|Overall Study|Other|0|||
160759717|NCT01585246|580505893|FG001|Overall Study|Other|1|||
160759718|NCT01585246|580505894|FG002|Overall Study|Other|1|||
160759719|NCT01585246|580505895|FG003|Overall Study|Other|1|||
160759720|NCT01585246|580505896|FG004|Overall Study|Other|0|||
160759721|NCT04396626|580505897|FG000|Overall Study|Premature termination of study|975|||
160525422|NCT01323621|579653771|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
160525423|NCT01323621|579653772|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
160525424|NCT01323621|579653770|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
160525425|NCT01323621|579653771|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
160525426|NCT01323621|579653772|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
160525427|NCT01119001|579653773|FG000|Overall Study|Withdrawal by Subject|2|||
160525428|NCT03951220|579653774|FG000|Overall Study|Withdrawal by Subject|9|||
160525429|NCT03951220|579653775|FG001|Overall Study|Withdrawal by Subject|2|||
160525430|NCT03951220|579653776|FG002|Overall Study|Withdrawal by Subject|0|||
160525431|NCT05245097|579653777|FG000|Overall Study|Adverse Event|13|||
160525432|NCT05245097|579653778|FG001|Overall Study|Adverse Event|2|||
160525433|NCT05245097|579653777|FG000|Overall Study|Protocol Violation|8|||
160525434|NCT05245097|579653778|FG001|Overall Study|Protocol Violation|6|||
160525435|NCT05245097|579653777|FG000|Overall Study|Withdrawal by Subject|18|||
160525436|NCT05245097|579653778|FG001|Overall Study|Withdrawal by Subject|0|||
160525437|NCT05245097|579653777|FG000|Overall Study|Death|6|||
160525438|NCT05245097|579653778|FG001|Overall Study|Death|7|||
160525439|NCT05245097|579653777|FG000|Overall Study|Physician Decision|6|||
160525440|NCT05245097|579653778|FG001|Overall Study|Physician Decision|0|||
160525441|NCT05245097|579653777|FG000|Overall Study|Relocation|4|||
160525442|NCT05245097|579653778|FG001|Overall Study|Relocation|3|||
160525443|NCT03604523|579653783|FG000|Overall Study|Physician Decision|1|||
160525444|NCT03604523|579653784|FG001|Overall Study|Physician Decision|0|||
160525445|NCT00458341|579653785|FG000|Cycle 1|Adverse Event|1|||
160525446|NCT00458341|579653786|FG001|Cycle 1|Adverse Event|0|||
160525447|NCT05461794|579653787|FG000|Overall Study|Withdrawal by Subject|1|||
160525448|NCT05461794|579653788|FG001|Overall Study|Withdrawal by Subject|1|||
160525449|NCT05461794|579653789|FG002|Overall Study|Withdrawal by Subject|3|||
160525450|NCT05461794|579653787|FG000|Overall Study|Study Terminated By Sponsor|18|||
160525451|NCT05461794|579653788|FG001|Overall Study|Study Terminated By Sponsor|13|||
160525452|NCT05461794|579653789|FG002|Overall Study|Study Terminated By Sponsor|16|||
160525453|NCT05461794|579653787|FG000|Overall Study|Death|20|||
160525454|NCT05461794|579653788|FG001|Overall Study|Death|5|||
160525455|NCT05461794|579653789|FG002|Overall Study|Death|19|||
160525456|NCT00810394|579653796|FG000|Overall Study|Withdrawal by Subject|3|||
160525457|NCT00467285|579653799|FG000|Overall Study|Lost to Follow-up|4|||
160525458|NCT00467285|579653800|FG001|Overall Study|Lost to Follow-up|4|||
160525459|NCT03891524|579653801|FG000|Overall Study|Death|0|||
160525460|NCT03891524|579653802|FG001|Overall Study|Death|0|||
160525461|NCT03891524|579653803|FG002|Overall Study|Death|0|||
160525462|NCT03891524|579653804|FG003|Overall Study|Death|0|||
160525463|NCT03891524|579653805|FG004|Overall Study|Death|0|||
160525464|NCT03891524|579653806|FG005|Overall Study|Death|0|||
160525465|NCT03891524|579653807|FG006|Overall Study|Death|0|||
160525466|NCT03891524|579653808|FG007|Overall Study|Death|1|||
160525467|NCT03891524|579653801|FG000|Overall Study|Withdrawal by Subject|0|||
160525468|NCT03891524|579653802|FG001|Overall Study|Withdrawal by Subject|1|||
160525469|NCT03891524|579653803|FG002|Overall Study|Withdrawal by Subject|2|||
160525470|NCT03891524|579653804|FG003|Overall Study|Withdrawal by Subject|1|||
160525471|NCT03891524|579653805|FG004|Overall Study|Withdrawal by Subject|2|||
160525472|NCT03891524|579653806|FG005|Overall Study|Withdrawal by Subject|2|||
160525473|NCT03891524|579653807|FG006|Overall Study|Withdrawal by Subject|2|||
160525474|NCT03891524|579653808|FG007|Overall Study|Withdrawal by Subject|1|||
160759722|NCT02111174|580505900|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
160525475|NCT02958267|579653810|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
160525476|NCT02958267|579653811|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
160525477|NCT02958267|579653810|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
160525478|NCT02958267|579653811|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
160525479|NCT02958267|579653810|FG000|Follow-up Visits|Additional treatment pursued|2|||
160525480|NCT02958267|579653811|FG001|Follow-up Visits|Additional treatment pursued|1|||
160525481|NCT01079130|579653812|FG000|Overall Study|Adverse Event|1|||
160759723|NCT02111174|580505901|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
160759724|NCT02111174|580505900|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
160525482|NCT01079130|579653813|FG001|Overall Study|Adverse Event|1|||
160525483|NCT01079130|579653814|FG002|Overall Study|Adverse Event|0|||
160525484|NCT01079130|579653815|FG003|Overall Study|Adverse Event|1|||
160525485|NCT01079130|579653816|FG004|Overall Study|Adverse Event|5|||
160525486|NCT01079130|579653817|FG005|Overall Study|Adverse Event|1|||
160525487|NCT01079130|579653812|FG000|Overall Study|Administrative problems|1|||
160525488|NCT01079130|579653813|FG001|Overall Study|Administrative problems|3|||
160759725|NCT02111174|580505901|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
160759726|NCT02111174|580505900|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
160759727|NCT02111174|580505901|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
160525489|NCT01079130|579653814|FG002|Overall Study|Administrative problems|0|||
160525490|NCT01079130|579653815|FG003|Overall Study|Administrative problems|0|||
160525491|NCT01079130|579653816|FG004|Overall Study|Administrative problems|0|||
160525492|NCT01079130|579653817|FG005|Overall Study|Administrative problems|1|||
160525493|NCT01079130|579653812|FG000|Overall Study|Withdrawal by Subject|0|||
160525494|NCT01079130|579653813|FG001|Overall Study|Withdrawal by Subject|1|||
160525495|NCT01079130|579653814|FG002|Overall Study|Withdrawal by Subject|0|||
160525496|NCT01079130|579653815|FG003|Overall Study|Withdrawal by Subject|0|||
160525497|NCT01079130|579653816|FG004|Overall Study|Withdrawal by Subject|1|||
160525498|NCT01079130|579653817|FG005|Overall Study|Withdrawal by Subject|3|||
160525499|NCT01079130|579653812|FG000|Overall Study|Protocol deviation|0|||
160525500|NCT01079130|579653813|FG001|Overall Study|Protocol deviation|2|||
160525501|NCT01079130|579653814|FG002|Overall Study|Protocol deviation|1|||
160525502|NCT01079130|579653815|FG003|Overall Study|Protocol deviation|2|||
160525503|NCT01079130|579653816|FG004|Overall Study|Protocol deviation|0|||
160525504|NCT01079130|579653817|FG005|Overall Study|Protocol deviation|0|||
160525505|NCT01079130|579653812|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160525506|NCT01079130|579653813|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160525507|NCT01079130|579653814|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160525508|NCT01079130|579653815|FG003|Overall Study|Abnormal test procedure result(s)|0|||
160525509|NCT01079130|579653816|FG004|Overall Study|Abnormal test procedure result(s)|1|||
160525510|NCT01079130|579653817|FG005|Overall Study|Abnormal test procedure result(s)|0|||
160525511|NCT01079130|579653812|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160525512|NCT01079130|579653813|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160525513|NCT01079130|579653814|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160525514|NCT01079130|579653815|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
160525515|NCT01079130|579653816|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
160525516|NCT01079130|579653817|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
160525517|NCT01079130|579653812|FG000|Overall Study|Lost to Follow-up|0|||
160525518|NCT01079130|579653813|FG001|Overall Study|Lost to Follow-up|0|||
160525519|NCT01079130|579653814|FG002|Overall Study|Lost to Follow-up|0|||
160525520|NCT01079130|579653815|FG003|Overall Study|Lost to Follow-up|0|||
160525521|NCT01079130|579653816|FG004|Overall Study|Lost to Follow-up|1|||
160525522|NCT01079130|579653817|FG005|Overall Study|Lost to Follow-up|0|||
160525523|NCT00475033|579653824|FG000|Infant Series|Failed to return|3|||
160525524|NCT00475033|579653825|FG001|Infant Series|Failed to return|4|||
160525525|NCT00475033|579653824|FG000|Infant Series|Parent or legal guardian request|1|||
160525526|NCT00475033|579653825|FG001|Infant Series|Parent or legal guardian request|5|||
160525527|NCT00475033|579653824|FG000|Infant Series|Protocol Violation|1|||
160525528|NCT00475033|579653825|FG001|Infant Series|Protocol Violation|2|||
160525529|NCT00475033|579653824|FG000|Infant Series|Lost to Follow-up|2|||
160525530|NCT00475033|579653825|FG001|Infant Series|Lost to Follow-up|0|||
160525531|NCT00475033|579653824|FG000|Infant Series|Adverse Event|0|||
160525532|NCT00475033|579653825|FG001|Infant Series|Adverse Event|2|||
160525533|NCT00475033|579653824|FG000|After the Infant Series|Adverse Event|0|||
160525534|NCT00475033|579653825|FG001|After the Infant Series|Adverse Event|4|||
160525535|NCT00475033|579653824|FG000|After the Infant Series|Parent or legal guardian request|2|||
160525536|NCT00475033|579653825|FG001|After the Infant Series|Parent or legal guardian request|2|||
160525537|NCT00475033|579653824|FG000|After the Infant Series|Failed to return|2|||
160525538|NCT00475033|579653825|FG001|After the Infant Series|Failed to return|1|||
160759728|NCT02111174|580505900|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
160525539|NCT00475033|579653824|FG000|After the Infant Series|Protocol Violation|1|||
160525540|NCT00475033|579653825|FG001|After the Infant Series|Protocol Violation|0|||
160525541|NCT00475033|579653824|FG000|After the Infant Series|Lost to Follow-up|1|||
160525542|NCT00475033|579653825|FG001|After the Infant Series|Lost to Follow-up|0|||
160525543|NCT00475033|579653824|FG000|After the Infant Series|Other|0|||
160525544|NCT00475033|579653825|FG001|After the Infant Series|Other|1|||
160525545|NCT00475033|579653824|FG000|Toddler Dose|Parent or legal guardian request|2|||
160525546|NCT00475033|579653825|FG001|Toddler Dose|Parent or legal guardian request|0|||
160525547|NCT00475033|579653824|FG000|Toddler Dose|Failed to return|1|||
160525548|NCT00475033|579653825|FG001|Toddler Dose|Failed to return|0|||
160525549|NCT00475033|579653824|FG000|Toddler Dose|Lost to Follow-up|1|||
160525550|NCT00475033|579653825|FG001|Toddler Dose|Lost to Follow-up|0|||
160525551|NCT04484831|579653826|FG000|Overall Study|Withdrawal by Subject|1|||
160759729|NCT02111174|580505901|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
160759730|NCT04552132|580505902|FG000|Overall Study|Lost to Follow-up|4|||
160759731|NCT04552132|580505903|FG001|Overall Study|Lost to Follow-up|3|||
160759732|NCT04552132|580505902|FG000|Overall Study|Protocol Violation|1|||
160759733|NCT04552132|580505903|FG001|Overall Study|Protocol Violation|0|||
160759734|NCT01657162|580505904|FG000|Overall Study|Adverse Event|26|||
160759735|NCT01657162|580505905|FG001|Overall Study|Adverse Event|36|||
160759736|NCT01657162|580505904|FG000|Overall Study|Withdrawal by Subject|13|||
160759737|NCT01657162|580505905|FG001|Overall Study|Withdrawal by Subject|13|||
160759738|NCT01657162|580505904|FG000|Overall Study|Continuing Significant Deterioration|9|||
160759739|NCT01657162|580505905|FG001|Overall Study|Continuing Significant Deterioration|3|||
160759740|NCT01657162|580505904|FG000|Overall Study|Refusal of Treatment|4|||
160525552|NCT04484831|579653827|FG001|Overall Study|Withdrawal by Subject|0|||
160525553|NCT03471871|579653828|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
160525554|NCT03471871|579653829|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
160525555|NCT03471871|579653830|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
160525556|NCT03471871|579653831|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
160525557|NCT03471871|579653832|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
160525558|NCT03471871|579653828|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
160525559|NCT03471871|579653829|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
160525560|NCT03471871|579653830|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
160525561|NCT03471871|579653831|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
160525562|NCT03471871|579653832|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
160525563|NCT03471871|579653828|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
160525564|NCT03471871|579653829|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
160525565|NCT03471871|579653830|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
160525566|NCT03471871|579653831|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
160525567|NCT03471871|579653832|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
160525568|NCT03471871|579653828|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
160525569|NCT03471871|579653829|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
160525570|NCT03471871|579653830|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
160525571|NCT03471871|579653831|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
160525572|NCT03471871|579653832|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
160525573|NCT03471871|579653828|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
160525574|NCT03471871|579653829|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
160525575|NCT03471871|579653830|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
160525576|NCT03471871|579653831|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
160525577|NCT03471871|579653832|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
160525578|NCT00047320|579653833|FG000|Overall Study|Lack of Efficacy|8|||
160525579|NCT00047320|579653833|FG000|Overall Study|Lost to Follow-up|1|||
160525580|NCT00047320|579653833|FG000|Overall Study|Physician Decision|8|||
160525581|NCT00047320|579653833|FG000|Overall Study|Withdrawal by Subject|9|||
160525582|NCT00047320|579653833|FG000|Overall Study|Ineligible|2|||
160525583|NCT00658684|579653834|FG000|Overall Study|Adverse Event|10|||
160525584|NCT00658684|579653835|FG001|Overall Study|Adverse Event|8|||
160525585|NCT00658684|579653836|FG002|Overall Study|Adverse Event|2|||
160525586|NCT00658684|579653837|FG003|Overall Study|Adverse Event|0|||
160525587|NCT00658684|579653834|FG000|Overall Study|Withdrawal by Subject|6|||
160525588|NCT00658684|579653835|FG001|Overall Study|Withdrawal by Subject|4|||
160525589|NCT00658684|579653836|FG002|Overall Study|Withdrawal by Subject|1|||
160525590|NCT00658684|579653837|FG003|Overall Study|Withdrawal by Subject|1|||
160525591|NCT00658684|579653834|FG000|Overall Study|Lack of Efficacy|1|||
160525592|NCT00658684|579653835|FG001|Overall Study|Lack of Efficacy|1|||
160525593|NCT00658684|579653836|FG002|Overall Study|Lack of Efficacy|0|||
160525594|NCT00658684|579653837|FG003|Overall Study|Lack of Efficacy|0|||
160525595|NCT00658684|579653834|FG000|Overall Study|Protocol Violation|1|||
160525596|NCT00658684|579653835|FG001|Overall Study|Protocol Violation|1|||
160525597|NCT00658684|579653836|FG002|Overall Study|Protocol Violation|0|||
160525598|NCT00658684|579653837|FG003|Overall Study|Protocol Violation|0|||
160525599|NCT00658684|579653834|FG000|Overall Study|Pregnancy|1|||
160525600|NCT00658684|579653835|FG001|Overall Study|Pregnancy|1|||
160525601|NCT00658684|579653836|FG002|Overall Study|Pregnancy|0|||
160525602|NCT00658684|579653837|FG003|Overall Study|Pregnancy|0|||
160525603|NCT00688103|579653838|FG000|Overall Study|Adverse Event|4|||
160525604|NCT00688103|579653839|FG001|Overall Study|Adverse Event|1|||
160525605|NCT00688103|579653838|FG000|Overall Study|Lack of Efficacy|11|||
160525606|NCT00688103|579653839|FG001|Overall Study|Lack of Efficacy|1|||
160525607|NCT00688103|579653838|FG000|Overall Study|Withdrawal by Subject|4|||
160525608|NCT00688103|579653839|FG001|Overall Study|Withdrawal by Subject|2|||
160525609|NCT00688103|579653838|FG000|Overall Study|complex reasons|11|||
160525610|NCT00688103|579653839|FG001|Overall Study|complex reasons|9|||
160525611|NCT05959629|579653843|FG000|Overall Study|partially necrotic/technical issues|2|||
160525612|NCT05959629|579653844|FG001|Overall Study|partially necrotic/technical issues|2|||
160525613|NCT00523718|579655702|FG000|Overall Study|Withdrawal by Subject|1|||
160525614|NCT00523718|579655703|FG001|Overall Study|Withdrawal by Subject|0|||
160525615|NCT00523718|579655702|FG000|Overall Study|Protocol Violation|2|||
160525616|NCT00523718|579655703|FG001|Overall Study|Protocol Violation|0|||
160525617|NCT01306890|579655704|FG000|Overall Study|Adverse Event|2|||
160525618|NCT01306890|579655704|FG000|Overall Study|Death|1223|||
160525619|NCT01306890|579655704|FG000|Overall Study|Lost to Follow-up|58|||
160525620|NCT01306890|579655704|FG000|Overall Study|Withdrawal by Subject|88|||
160525621|NCT01306890|579655704|FG000|Overall Study|Unspecified reasons|104|||
160525622|NCT01306890|579655704|FG000|Overall Study|Study Termination|3|||
160525623|NCT01306890|579655704|FG000|Overall Study|No discontinuation documentation|41|||
160525624|NCT02217436|579655705|FG000|Overall Study|Protocol Violation|1|||
160525625|NCT02217436|579655706|FG001|Overall Study|Protocol Violation|1|||
160525626|NCT02217436|579655705|FG000|Overall Study|Incomplete data|0|||
160759741|NCT01657162|580505905|FG001|Overall Study|Refusal of Treatment|6|||
160759742|NCT01657162|580505904|FG000|Overall Study|Lost to Follow-up|3|||
160759743|NCT01657162|580505905|FG001|Overall Study|Lost to Follow-up|4|||
160759744|NCT01657162|580505904|FG000|Overall Study|Death|2|||
160759745|NCT01657162|580505905|FG001|Overall Study|Death|3|||
160759746|NCT01657162|580505904|FG000|Overall Study|Inability to Complete Study Procedures|1|||
160759747|NCT01657162|580505905|FG001|Overall Study|Inability to Complete Study Procedures|7|||
160759748|NCT01657162|580505904|FG000|Overall Study|Protocol Violation|1|||
160759749|NCT01657162|580505905|FG001|Overall Study|Protocol Violation|0|||
160759750|NCT01657162|580505904|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
160759751|NCT01657162|580505905|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
160759752|NCT01657162|580505904|FG000|Overall Study|Other than Specified|0|||
160759753|NCT01657162|580505905|FG001|Overall Study|Other than Specified|2|||
160759754|NCT02600923|580505908|FG000|Overall Study|Death|10|||
160759755|NCT02600923|580505908|FG000|Overall Study|Adverse Event|3|||
160759756|NCT02600923|580505908|FG000|Overall Study|Global deterioration of health status|2|||
160759757|NCT02600923|580505908|FG000|Overall Study|Insufficient clinical response|6|||
160759758|NCT02600923|580505908|FG000|Overall Study|Lost to Follow-up|1|||
160759759|NCT02600923|580505908|FG000|Overall Study|Withdrawal by Subject|5|||
160759760|NCT02600923|580505908|FG000|Overall Study|Objective progression or relapse|50|||
160759761|NCT02600923|580505908|FG000|Overall Study|Study terminated by Sponsor|53|||
160759762|NCT02600923|580505908|FG000|Overall Study|Not treated|1|||
160759763|NCT00792909|580505909|FG000|Overall Study|Withdrawal by Subject|0|||
160759764|NCT00792909|580505910|FG001|Overall Study|Withdrawal by Subject|1|||
160759765|NCT00792909|580505911|FG002|Overall Study|Withdrawal by Subject|0|||
160759766|NCT04391842|580505917|FG000|Overall Study|Withdrawal by Subject|2|||
160759767|NCT00992017|580505918|FG000|Overall Study|Lost to Follow-up|2|||
160759768|NCT00992017|580505918|FG000|Overall Study|Withdrawal by Subject|2|||
160759769|NCT00992017|580505918|FG000|Overall Study|Unable to get to clinic|5|||
160759770|NCT00992017|580505918|FG000|Overall Study|Not adhere to study requirements|1|||
160759771|NCT01691378|580505919|FG000|Overall Study|Withdrawal by Subject|2|||
160759772|NCT01691378|580505920|FG001|Overall Study|Withdrawal by Subject|0|||
160759773|NCT01691378|580505919|FG000|Overall Study|Lost to Follow-up|5|||
160759774|NCT01691378|580505920|FG001|Overall Study|Lost to Follow-up|2|||
160759775|NCT04888494|580505921|FG000|Overall Study|Lost to Follow-up|2|||
160759776|NCT04888494|580505922|FG001|Overall Study|Lost to Follow-up|3|||
160759777|NCT04888494|580505921|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
160759778|NCT04888494|580505922|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
160759779|NCT02357459|580507943|FG000|Overall Study|Adverse Event|0|||
160759780|NCT02357459|580507944|FG001|Overall Study|Adverse Event|1|||
160759781|NCT02357459|580507945|FG002|Overall Study|Adverse Event|1|||
160759782|NCT02357459|580507943|FG000|Overall Study|Withdrawal by Subject|5|||
160759783|NCT02357459|580507944|FG001|Overall Study|Withdrawal by Subject|3|||
160759784|NCT02357459|580507945|FG002|Overall Study|Withdrawal by Subject|3|||
160759785|NCT02357459|580507943|FG000|Overall Study|Physician Decision|0|||
160759786|NCT02357459|580507944|FG001|Overall Study|Physician Decision|2|||
160759787|NCT02357459|580507945|FG002|Overall Study|Physician Decision|0|||
160759788|NCT02357459|580507943|FG000|Overall Study|Protocol Violation|1|||
160759789|NCT02357459|580507944|FG001|Overall Study|Protocol Violation|1|||
160759790|NCT02357459|580507945|FG002|Overall Study|Protocol Violation|0|||
160759791|NCT02357459|580507943|FG000|Overall Study|Lost to Follow-up|1|||
160759792|NCT02357459|580507944|FG001|Overall Study|Lost to Follow-up|3|||
160759793|NCT02357459|580507945|FG002|Overall Study|Lost to Follow-up|0|||
160759794|NCT02357459|580507943|FG000|Overall Study|Lack of Efficacy|7|||
160759795|NCT02357459|580507944|FG001|Overall Study|Lack of Efficacy|4|||
160759796|NCT02357459|580507945|FG002|Overall Study|Lack of Efficacy|4|||
160759797|NCT02357459|580507943|FG000|Overall Study|Patient Relocated|2|||
160759798|NCT02357459|580507944|FG001|Overall Study|Patient Relocated|0|||
160759799|NCT02357459|580507945|FG002|Overall Study|Patient Relocated|0|||
160759800|NCT02357459|580507943|FG000|Overall Study|Instruction from PCP|1|||
160759801|NCT02357459|580507944|FG001|Overall Study|Instruction from PCP|0|||
160759802|NCT02357459|580507945|FG002|Overall Study|Instruction from PCP|0|||
160759803|NCT02357459|580507943|FG000|Overall Study|Incarceration|0|||
160759804|NCT02357459|580507944|FG001|Overall Study|Incarceration|0|||
160759805|NCT02357459|580507945|FG002|Overall Study|Incarceration|1|||
160759806|NCT02357459|580507943|FG000|Overall Study|Pre-planned Knee surgery|0|||
160759807|NCT02357459|580507944|FG001|Overall Study|Pre-planned Knee surgery|0|||
160759808|NCT02357459|580507945|FG002|Overall Study|Pre-planned Knee surgery|2|||
160759809|NCT02357459|580507943|FG000|Overall Study|Job Commitments|0|||
160759810|NCT02357459|580507944|FG001|Overall Study|Job Commitments|0|||
160759811|NCT02357459|580507945|FG002|Overall Study|Job Commitments|1|||
160759812|NCT03246347|580507946|FG000|Overall Study|On Study|23|||
160759813|NCT00916578|580507947|FG000|Overall Study|Physician Decision|2|||
160759814|NCT00916578|580507947|FG000|Overall Study|Withdrawal by Subject|3|||
160759815|NCT00916578|580507947|FG000|Overall Study|Insurance Denial|2|||
160759816|NCT03652818|580507950|FG000|Overall Study|Adverse Event|1|||
160759817|NCT03652818|580507951|FG001|Overall Study|Adverse Event|0|||
160525627|NCT02217436|579655706|FG001|Overall Study|Incomplete data|1|||
160525628|NCT00234494|579655711|FG000|Overall Study|Protocol Violation|2|||
160525629|NCT02634346|579655717|FG000|Overall Study|Withdrawal by Subject|8|||
160525630|NCT02634346|579655718|FG001|Overall Study|Withdrawal by Subject|9|||
160525631|NCT02634346|579655719|FG002|Overall Study|Withdrawal by Subject|8|||
160525632|NCT02634346|579655717|FG000|Overall Study|Adverse Event|2|||
160525633|NCT02634346|579655718|FG001|Overall Study|Adverse Event|2|||
160525634|NCT02634346|579655719|FG002|Overall Study|Adverse Event|7|||
160525635|NCT02634346|579655717|FG000|Overall Study|Lack of Efficacy|1|||
160525636|NCT02634346|579655718|FG001|Overall Study|Lack of Efficacy|2|||
160525637|NCT02634346|579655719|FG002|Overall Study|Lack of Efficacy|8|||
160525638|NCT02634346|579655717|FG000|Overall Study|Lost to Follow-up|1|||
160525639|NCT02634346|579655718|FG001|Overall Study|Lost to Follow-up|0|||
160525640|NCT02634346|579655719|FG002|Overall Study|Lost to Follow-up|0|||
160525641|NCT02634346|579655717|FG000|Overall Study|Protocol Violation|0|||
160525642|NCT02634346|579655718|FG001|Overall Study|Protocol Violation|1|||
160525643|NCT02634346|579655719|FG002|Overall Study|Protocol Violation|0|||
160525644|NCT02170389|579655720|FG000|Overall Study|Study terminated prior to start of treat|1|||
160525645|NCT02076113|579655723|FG000|Overall Study|Lost to Follow-up|4|||
160525646|NCT02076113|579655724|FG001|Overall Study|Lost to Follow-up|1|||
160525647|NCT02076113|579655723|FG000|Overall Study|Withdrawal by Subject|2|||
160525648|NCT02076113|579655724|FG001|Overall Study|Withdrawal by Subject|3|||
160525649|NCT02076113|579655723|FG000|Overall Study|Death|1|||
160525650|NCT02076113|579655724|FG001|Overall Study|Death|3|||
160525651|NCT01862640|579655729|FG000|Overall Study|Adverse Event|4|||
160525652|NCT01862640|579655730|FG001|Overall Study|Adverse Event|10|||
160525653|NCT01862640|579655731|FG002|Overall Study|Adverse Event|6|||
160525654|NCT01862640|579655732|FG003|Overall Study|Adverse Event|8|||
160525655|NCT01862640|579655729|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
160525656|NCT01862640|579655730|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
160525657|NCT01862640|579655731|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
160525658|NCT01862640|579655732|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
160525659|NCT01862640|579655729|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
160525660|NCT01862640|579655730|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
160525661|NCT01862640|579655731|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
160525662|NCT01862640|579655732|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
160525663|NCT01862640|579655729|FG000|Overall Study|Withdrawal by Subject|2|||
160525664|NCT01862640|579655730|FG001|Overall Study|Withdrawal by Subject|4|||
160525665|NCT01862640|579655731|FG002|Overall Study|Withdrawal by Subject|8|||
160525666|NCT01862640|579655732|FG003|Overall Study|Withdrawal by Subject|5|||
160525667|NCT01862640|579655729|FG000|Overall Study|Protocol Deviation|0|||
160525668|NCT01862640|579655730|FG001|Overall Study|Protocol Deviation|0|||
160525669|NCT01862640|579655731|FG002|Overall Study|Protocol Deviation|1|||
160525670|NCT01862640|579655732|FG003|Overall Study|Protocol Deviation|0|||
160525671|NCT05085665|579655735|FG000|Overall Study|Physician Decision|2|||
160525672|NCT01717768|579655736|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525673|NCT01717768|579655737|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
160525674|NCT01717768|579655738|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525675|NCT01717768|579655739|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525676|NCT01717768|579655740|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525677|NCT01717768|579655741|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525678|NCT01717768|579655742|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525679|NCT01717768|579655743|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525680|NCT01717768|579655744|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525681|NCT01717768|579655745|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525682|NCT01717768|579655746|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525683|NCT01717768|579655747|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
160525684|NCT01717768|579655736|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525685|NCT01717768|579655737|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525686|NCT01717768|579655738|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525687|NCT01717768|579655739|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525688|NCT01717768|579655740|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525689|NCT01717768|579655741|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525690|NCT01717768|579655742|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525691|NCT01717768|579655743|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525692|NCT01717768|579655744|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525693|NCT01717768|579655745|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525694|NCT01717768|579655746|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
160525695|NCT01717768|579655747|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
160525696|NCT01717768|579655736|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160525697|NCT01717768|579655737|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160525698|NCT01717768|579655738|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160759818|NCT03652818|580507952|FG002|Overall Study|Adverse Event|0|||
160525699|NCT01717768|579655739|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160525700|NCT01717768|579655740|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160525701|NCT01717768|579655741|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160525702|NCT01717768|579655742|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160525703|NCT01717768|579655743|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
160525704|NCT01717768|579655744|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160525705|NCT01717768|579655745|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160525706|NCT01717768|579655746|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160525707|NCT01717768|579655747|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
160525708|NCT01717768|579655736|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525709|NCT01717768|579655737|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525710|NCT01717768|579655738|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525711|NCT01717768|579655739|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525712|NCT01717768|579655740|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525713|NCT01717768|579655741|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525714|NCT01717768|579655742|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525715|NCT01717768|579655743|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525716|NCT01717768|579655744|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525717|NCT01717768|579655745|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
160525718|NCT01717768|579655746|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525719|NCT01717768|579655747|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
160525720|NCT00372385|579655748|FG000|Overall Study|Adverse Event|6|||
160525721|NCT00372385|579655749|FG001|Overall Study|Adverse Event|11|||
160525722|NCT00372385|579655750|FG002|Overall Study|Adverse Event|9|||
160525723|NCT00372385|579655751|FG003|Overall Study|Adverse Event|7|||
160525724|NCT00372385|579655748|FG000|Overall Study|Noncompliance|0|||
160525725|NCT00372385|579655749|FG001|Overall Study|Noncompliance|1|||
160525726|NCT00372385|579655750|FG002|Overall Study|Noncompliance|1|||
160525727|NCT00372385|579655751|FG003|Overall Study|Noncompliance|1|||
160525728|NCT00372385|579655748|FG000|Overall Study|Physician Decision|1|||
160525729|NCT00372385|579655749|FG001|Overall Study|Physician Decision|0|||
160525730|NCT00372385|579655750|FG002|Overall Study|Physician Decision|0|||
160525731|NCT00372385|579655751|FG003|Overall Study|Physician Decision|0|||
160525732|NCT00372385|579655748|FG000|Overall Study|Lost to Follow-up|2|||
160525733|NCT00372385|579655749|FG001|Overall Study|Lost to Follow-up|0|||
160525734|NCT00372385|579655750|FG002|Overall Study|Lost to Follow-up|0|||
160525735|NCT00372385|579655751|FG003|Overall Study|Lost to Follow-up|0|||
160525736|NCT00372385|579655748|FG000|Overall Study|Withdrawal by Subject|2|||
160525737|NCT00372385|579655749|FG001|Overall Study|Withdrawal by Subject|1|||
160525738|NCT00372385|579655750|FG002|Overall Study|Withdrawal by Subject|0|||
160525739|NCT00372385|579655751|FG003|Overall Study|Withdrawal by Subject|0|||
160525740|NCT00372385|579655748|FG000|Overall Study|Refusal of Treatment|3|||
160525741|NCT00372385|579655749|FG001|Overall Study|Refusal of Treatment|6|||
160525742|NCT00372385|579655750|FG002|Overall Study|Refusal of Treatment|0|||
160525743|NCT00372385|579655751|FG003|Overall Study|Refusal of Treatment|0|||
160525744|NCT00372385|579655748|FG000|Overall Study|No Response|1|||
160525745|NCT00372385|579655749|FG001|Overall Study|No Response|1|||
160525746|NCT00372385|579655750|FG002|Overall Study|No Response|0|||
160525747|NCT00372385|579655751|FG003|Overall Study|No Response|0|||
160525748|NCT00372385|579655748|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
160525749|NCT00372385|579655749|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
160525750|NCT00372385|579655750|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
160759819|NCT03652818|580507953|FG003|Overall Study|Adverse Event|0|||
160759820|NCT03652818|580507954|FG004|Overall Study|Adverse Event|0|||
160759821|NCT03652818|580507950|FG000|Overall Study|Physician Decision|1|||
160759822|NCT03652818|580507951|FG001|Overall Study|Physician Decision|0|||
160759823|NCT03652818|580507952|FG002|Overall Study|Physician Decision|0|||
160759824|NCT03652818|580507953|FG003|Overall Study|Physician Decision|0|||
160759825|NCT03652818|580507954|FG004|Overall Study|Physician Decision|0|||
160759826|NCT03652818|580507950|FG000|Overall Study|Lost to Follow-up|0|||
160759827|NCT03652818|580507951|FG001|Overall Study|Lost to Follow-up|1|||
160525751|NCT00372385|579655751|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
160525752|NCT00372385|579655748|FG000|Overall Study|Virologic Stopping Rule|17|||
160525753|NCT00372385|579655749|FG001|Overall Study|Virologic Stopping Rule|0|||
160759828|NCT03652818|580507952|FG002|Overall Study|Lost to Follow-up|2|||
160759829|NCT03652818|580507953|FG003|Overall Study|Lost to Follow-up|1|||
160525754|NCT00372385|579655750|FG002|Overall Study|Virologic Stopping Rule|0|||
160525755|NCT00372385|579655751|FG003|Overall Study|Virologic Stopping Rule|0|||
160525756|NCT01009554|579655754|FG000|Overall Study|Adverse Event|1|||
160525757|NCT01009554|579655755|FG001|Overall Study|Adverse Event|1|||
160759830|NCT03652818|580507954|FG004|Overall Study|Lost to Follow-up|1|||
160861858|NCT02531802|580887854|FG009|Received Vaccination 2|Adverse Event|0|||
160525758|NCT01009554|579655754|FG000|Overall Study|Withdrawal by Subject|1|||
160525759|NCT01009554|579655755|FG001|Overall Study|Withdrawal by Subject|3|||
160525760|NCT01009554|579655754|FG000|Overall Study|Noncompliant with Study Product|0|||
160525761|NCT01009554|579655755|FG001|Overall Study|Noncompliant with Study Product|3|||
160759831|NCT01239797|580507955|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
160759832|NCT01239797|580507956|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
160759833|NCT01239797|580507955|FG000|Randomized Participants|Participant withdrew consent|1|||
160525762|NCT02973048|579655758|FG000|Overall Study|Epidural catheter insertion failure|1|||
160525763|NCT02973048|579655759|FG001|Overall Study|Epidural catheter insertion failure|0|||
160525764|NCT02973048|579655758|FG000|Overall Study|Withdrawal by Subject|0|||
160525765|NCT02973048|579655759|FG001|Overall Study|Withdrawal by Subject|3|||
160525766|NCT04427501|579655762|FG000|Overall Study|Death|0|||
160525767|NCT04427501|579655763|FG001|Overall Study|Death|0|||
160525768|NCT04427501|579655764|FG002|Overall Study|Death|0|||
160525769|NCT04427501|579655765|FG003|Overall Study|Death|0|||
160525770|NCT04427501|579655766|FG004|Overall Study|Death|0|||
160525771|NCT04427501|579655767|FG005|Overall Study|Death|15|||
160525772|NCT04427501|579655768|FG006|Overall Study|Death|0|||
160525773|NCT04427501|579655769|FG007|Overall Study|Death|0|||
160525774|NCT04427501|579655770|FG008|Overall Study|Death|0|||
160525775|NCT04427501|579655771|FG009|Overall Study|Death|0|||
160525776|NCT04427501|579655772|FG010|Overall Study|Death|0|||
160525777|NCT04427501|579655773|FG011|Overall Study|Death|0|||
160525778|NCT04427501|579655762|FG000|Overall Study|Lost to Follow-up|5|||
160525779|NCT04427501|579655763|FG001|Overall Study|Lost to Follow-up|1|||
160525780|NCT04427501|579655764|FG002|Overall Study|Lost to Follow-up|2|||
160525781|NCT04427501|579655765|FG003|Overall Study|Lost to Follow-up|0|||
160525782|NCT04427501|579655766|FG004|Overall Study|Lost to Follow-up|2|||
160525783|NCT04427501|579655767|FG005|Overall Study|Lost to Follow-up|11|||
160525784|NCT04427501|579655768|FG006|Overall Study|Lost to Follow-up|10|||
160525785|NCT04427501|579655769|FG007|Overall Study|Lost to Follow-up|10|||
160525786|NCT04427501|579655770|FG008|Overall Study|Lost to Follow-up|2|||
160525787|NCT04427501|579655771|FG009|Overall Study|Lost to Follow-up|5|||
160525788|NCT04427501|579655772|FG010|Overall Study|Lost to Follow-up|2|||
160525789|NCT04427501|579655773|FG011|Overall Study|Lost to Follow-up|0|||
160525790|NCT04427501|579655762|FG000|Overall Study|Physician Decision|0|||
160525791|NCT04427501|579655763|FG001|Overall Study|Physician Decision|3|||
160525792|NCT04427501|579655764|FG002|Overall Study|Physician Decision|0|||
160525793|NCT04427501|579655765|FG003|Overall Study|Physician Decision|0|||
160525794|NCT04427501|579655766|FG004|Overall Study|Physician Decision|0|||
160525795|NCT04427501|579655767|FG005|Overall Study|Physician Decision|0|||
160525796|NCT04427501|579655768|FG006|Overall Study|Physician Decision|2|||
160525797|NCT04427501|579655769|FG007|Overall Study|Physician Decision|0|||
160525798|NCT04427501|579655770|FG008|Overall Study|Physician Decision|0|||
160759834|NCT01239797|580507956|FG001|Randomized Participants|Participant withdrew consent|7|||
160759835|NCT01239797|580507955|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
160759836|NCT01239797|580507956|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
160759837|NCT01239797|580507955|FG000|Treated Participants|Disease progression|185|||
160759838|NCT01239797|580507956|FG001|Treated Participants|Disease progression|185|||
160759839|NCT01239797|580507955|FG000|Treated Participants|Study drug toxicity|39|||
160759840|NCT01239797|580507956|FG001|Treated Participants|Study drug toxicity|45|||
160759841|NCT01239797|580507955|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
160759842|NCT01239797|580507956|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
160759843|NCT01239797|580507955|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
160759844|NCT01239797|580507956|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
160759845|NCT01239797|580507955|FG000|Treated Participants|Administrative reason by sponsor|13|||
160759846|NCT01239797|580507956|FG001|Treated Participants|Administrative reason by sponsor|4|||
160759847|NCT01239797|580507955|FG000|Treated Participants|Other reasons|14|||
160759848|NCT01239797|580507956|FG001|Treated Participants|Other reasons|14|||
160759849|NCT01239797|580507955|FG000|Treated Participants|Participant withdrew consent|6|||
160759850|NCT01239797|580507956|FG001|Treated Participants|Participant withdrew consent|11|||
160759851|NCT01239797|580507955|FG000|Treated Participants|Death|1|||
160759852|NCT01239797|580507956|FG001|Treated Participants|Death|1|||
160759853|NCT01239797|580507955|FG000|Treated Participants|Participant no longer meets study criteria|1|||
160759854|NCT01239797|580507956|FG001|Treated Participants|Participant no longer meets study criteria|1|||
160525799|NCT04427501|579655771|FG009|Overall Study|Physician Decision|0|||
160525800|NCT04427501|579655772|FG010|Overall Study|Physician Decision|0|||
160525801|NCT04427501|579655773|FG011|Overall Study|Physician Decision|0|||
160525802|NCT04427501|579655762|FG000|Overall Study|Withdrawal by Subject|9|||
160525803|NCT04427501|579655763|FG001|Overall Study|Withdrawal by Subject|2|||
160525804|NCT04427501|579655764|FG002|Overall Study|Withdrawal by Subject|2|||
160525805|NCT04427501|579655765|FG003|Overall Study|Withdrawal by Subject|3|||
160525806|NCT04427501|579655766|FG004|Overall Study|Withdrawal by Subject|7|||
160525807|NCT04427501|579655767|FG005|Overall Study|Withdrawal by Subject|25|||
160525808|NCT04427501|579655768|FG006|Overall Study|Withdrawal by Subject|15|||
160525809|NCT04427501|579655769|FG007|Overall Study|Withdrawal by Subject|7|||
160525810|NCT04427501|579655770|FG008|Overall Study|Withdrawal by Subject|4|||
160525811|NCT04427501|579655771|FG009|Overall Study|Withdrawal by Subject|1|||
160525812|NCT04427501|579655772|FG010|Overall Study|Withdrawal by Subject|4|||
160525813|NCT04427501|579655773|FG011|Overall Study|Withdrawal by Subject|0|||
160525814|NCT04427501|579655762|FG000|Overall Study|Other - as reported by the investigator|1|||
160525815|NCT04427501|579655763|FG001|Overall Study|Other - as reported by the investigator|0|||
160525816|NCT04427501|579655764|FG002|Overall Study|Other - as reported by the investigator|0|||
160525817|NCT04427501|579655765|FG003|Overall Study|Other - as reported by the investigator|0|||
160525818|NCT04427501|579655766|FG004|Overall Study|Other - as reported by the investigator|0|||
160525819|NCT04427501|579655767|FG005|Overall Study|Other - as reported by the investigator|6|||
160525820|NCT04427501|579655768|FG006|Overall Study|Other - as reported by the investigator|6|||
160525821|NCT04427501|579655769|FG007|Overall Study|Other - as reported by the investigator|0|||
160525822|NCT04427501|579655770|FG008|Overall Study|Other - as reported by the investigator|0|||
160525823|NCT04427501|579655771|FG009|Overall Study|Other - as reported by the investigator|0|||
160525824|NCT04427501|579655772|FG010|Overall Study|Other - as reported by the investigator|0|||
160525825|NCT04427501|579655773|FG011|Overall Study|Other - as reported by the investigator|0|||
160525826|NCT04427501|579655762|FG000|Overall Study|Other|0|||
160525827|NCT04427501|579655763|FG001|Overall Study|Other|0|||
160759855|NCT01239797|580507955|FG000|Treated Participants|Poor/non-compliance|0|||
160759856|NCT01239797|580507956|FG001|Treated Participants|Poor/non-compliance|1|||
160759857|NCT00853762|580507959|FG000|Overall Study|Premature Termination|16|||
160759858|NCT00853762|580507960|FG001|Overall Study|Premature Termination|15|||
160759859|NCT00853762|580507961|FG002|Overall Study|Premature Termination|14|||
160759860|NCT00853762|580507962|FG003|Overall Study|Premature Termination|21|||
160759861|NCT00853762|580507959|FG000|Overall Study|Protocol Violation|0|||
160759862|NCT00853762|580507960|FG001|Overall Study|Protocol Violation|0|||
160759863|NCT00853762|580507961|FG002|Overall Study|Protocol Violation|0|||
160759864|NCT00853762|580507962|FG003|Overall Study|Protocol Violation|1|||
160759865|NCT00853762|580507959|FG000|Overall Study|Withdrawal by Subject|0|||
160759866|NCT00853762|580507960|FG001|Overall Study|Withdrawal by Subject|0|||
160759867|NCT00853762|580507961|FG002|Overall Study|Withdrawal by Subject|1|||
160759868|NCT00853762|580507962|FG003|Overall Study|Withdrawal by Subject|0|||
160759869|NCT00853762|580507959|FG000|Overall Study|Other|0|||
160759870|NCT00853762|580507960|FG001|Overall Study|Other|2|||
160759871|NCT00853762|580507961|FG002|Overall Study|Other|0|||
160759872|NCT00853762|580507962|FG003|Overall Study|Other|0|||
160759873|NCT00853762|580507959|FG000|Overall Study|Randomised but not Treated|0|||
160759874|NCT00853762|580507960|FG001|Overall Study|Randomised but not Treated|2|||
160759875|NCT00853762|580507961|FG002|Overall Study|Randomised but not Treated|2|||
160759876|NCT00853762|580507962|FG003|Overall Study|Randomised but not Treated|0|||
160759877|NCT02000921|580507963|FG000|Overall Study|Withdrawal by Subject|3|||
160759878|NCT02000921|580507964|FG001|Overall Study|Withdrawal by Subject|10|||
160759879|NCT02000921|580507965|FG002|Overall Study|Withdrawal by Subject|5|||
160759880|NCT02000921|580507963|FG000|Overall Study|Lost to Follow-up|2|||
160759881|NCT02000921|580507964|FG001|Overall Study|Lost to Follow-up|4|||
160759882|NCT02000921|580507965|FG002|Overall Study|Lost to Follow-up|5|||
160525828|NCT04427501|579655764|FG002|Overall Study|Other|0|||
160525829|NCT04427501|579655765|FG003|Overall Study|Other|0|||
160525830|NCT04427501|579655766|FG004|Overall Study|Other|0|||
160525831|NCT04427501|579655767|FG005|Overall Study|Other|0|||
160525832|NCT04427501|579655768|FG006|Overall Study|Other|0|||
160525833|NCT04427501|579655769|FG007|Overall Study|Other|0|||
160525834|NCT04427501|579655770|FG008|Overall Study|Other|0|||
160525835|NCT04427501|579655771|FG009|Overall Study|Other|0|||
160525836|NCT04427501|579655772|FG010|Overall Study|Other|0|||
160525837|NCT04427501|579655773|FG011|Overall Study|Other|1|||
160525838|NCT03170154|579655774|FG000|Overall Study|Lost to Follow-up|4|||
160525839|NCT03170154|579655774|FG000|Overall Study|Death|2|||
160525840|NCT03170154|579655774|FG000|Overall Study|Withdrawal by Subject|2|||
160525841|NCT01906346|579655775|FG000|Overall Study|AEs|1|||
160759883|NCT02000921|580507963|FG000|Overall Study|Physician Decision|0|||
160759884|NCT02000921|580507964|FG001|Overall Study|Physician Decision|2|||
160759885|NCT02000921|580507965|FG002|Overall Study|Physician Decision|0|||
160759886|NCT03933449|580507968|FG000|Overall Study|Adverse Event|6|||
160759887|NCT03933449|580507969|FG001|Overall Study|Adverse Event|4|||
160759888|NCT03933449|580507968|FG000|Overall Study|Death|55|||
160759889|NCT03933449|580507969|FG001|Overall Study|Death|57|||
160759890|NCT03933449|580507968|FG000|Overall Study|Sponsor Decision|1|||
160759891|NCT03933449|580507969|FG001|Overall Study|Sponsor Decision|0|||
160759892|NCT02087774|580507972|FG000|Overall Study|Were absent day of data collection|8|||
160759893|NCT02087774|580507973|FG001|Overall Study|Were absent day of data collection|20|||
160759894|NCT00719901|580507974|FG000|Overall Study|Adverse Event|5|||
160759895|NCT00719901|580507974|FG000|Overall Study|Withdrawal by Subject|1|||
160525842|NCT02279862|579655778|FG000|Overall Study|Study drug toxicity|3|||
160525843|NCT02279862|579655779|FG001|Overall Study|Study drug toxicity|6|||
160759896|NCT00719901|580507974|FG000|Overall Study|Alternate Treatment|1|||
160759897|NCT00719901|580507974|FG000|Overall Study|Disease Progression|3|||
160525844|NCT02279862|579655778|FG000|Overall Study|No longer meets criteria|0|||
160525845|NCT02279862|579655779|FG001|Overall Study|No longer meets criteria|1|||
160525846|NCT02279862|579655778|FG000|Overall Study|Administrative reason by sponsor|0|||
160525847|NCT02279862|579655779|FG001|Overall Study|Administrative reason by sponsor|1|||
160525848|NCT02279862|579655778|FG000|Overall Study|Disease progression|5|||
160525849|NCT02279862|579655779|FG001|Overall Study|Disease progression|2|||
160525850|NCT02279862|579655778|FG000|Overall Study|Study closed by sponsor|16|||
160525851|NCT02279862|579655779|FG001|Overall Study|Study closed by sponsor|13|||
160525852|NCT02279862|579655778|FG000|Overall Study|Other|1|||
160525853|NCT02279862|579655779|FG001|Overall Study|Other|2|||
160525854|NCT02279862|579655778|FG000|Overall Study|Withdrawal by Subject|1|||
160525855|NCT02279862|579655779|FG001|Overall Study|Withdrawal by Subject|0|||
160525856|NCT04226833|579655780|FG000|Overall Study|Death|0|||
160525857|NCT04226833|579655781|FG001|Overall Study|Death|0|||
160525858|NCT04226833|579655782|FG002|Overall Study|Death|1|||
160525859|NCT04226833|579655783|FG003|Overall Study|Death|0|||
160525860|NCT01163721|579655786|FG000|Overall Study|Adverse Event|5|||
160525861|NCT01163721|579655787|FG001|Overall Study|Adverse Event|6|||
160525862|NCT01163721|579655786|FG000|Overall Study|Withdrawal by Subject|3|||
160525863|NCT01163721|579655787|FG001|Overall Study|Withdrawal by Subject|4|||
160525864|NCT01163721|579655786|FG000|Overall Study|Lost to Follow-up|0|||
160525865|NCT01163721|579655787|FG001|Overall Study|Lost to Follow-up|1|||
160525866|NCT01163721|579655786|FG000|Overall Study|Physician Decision|0|||
160525867|NCT01163721|579655787|FG001|Overall Study|Physician Decision|1|||
160525868|NCT01050205|579655788|FG000|Overall Study|Lost to Follow-up|7|||
160525869|NCT01050205|579655789|FG001|Overall Study|Lost to Follow-up|1|||
160525870|NCT01050205|579655788|FG000|Overall Study|Withdrawal by Subject|1|||
160525871|NCT01050205|579655789|FG001|Overall Study|Withdrawal by Subject|1|||
160525872|NCT01050205|579655788|FG000|Overall Study|Relocated from area|1|||
160525873|NCT01050205|579655789|FG001|Overall Study|Relocated from area|2|||
160525874|NCT01050205|579655788|FG000|Overall Study|Discontinued Intervention|2|||
160525875|NCT01050205|579655789|FG001|Overall Study|Discontinued Intervention|0|||
160525876|NCT00403754|579655790|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
160525877|NCT00403754|579655791|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
160525878|NCT00403754|579655792|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
160525879|NCT00403754|579655793|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
160525880|NCT00403754|579655790|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
160525881|NCT00403754|579655791|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
160525882|NCT00403754|579655792|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
160525883|NCT00403754|579655793|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
160525884|NCT04343248|579655794|FG000|Overall Study|Withdrawal by Subject|5|||
160525885|NCT04343248|579655795|FG001|Overall Study|Withdrawal by Subject|6|||
160525886|NCT04343248|579655794|FG000|Overall Study|Death|1|||
160525887|NCT04343248|579655795|FG001|Overall Study|Death|2|||
160525888|NCT04343248|579655794|FG000|Overall Study|Lost to Follow-up|9|||
160525889|NCT04343248|579655795|FG001|Overall Study|Lost to Follow-up|6|||
160525890|NCT04343248|579655794|FG000|Overall Study|Physician Decision|0|||
160525891|NCT04343248|579655795|FG001|Overall Study|Physician Decision|1|||
160525892|NCT04343248|579655794|FG000|Overall Study|Adverse Event|1|||
160525893|NCT04343248|579655795|FG001|Overall Study|Adverse Event|0|||
160525894|NCT02708095|579655796|FG000|Overall Study|Adverse Event|4|||
160525895|NCT02708095|579655797|FG001|Overall Study|Adverse Event|10|||
160525896|NCT02708095|579655798|FG002|Overall Study|Adverse Event|11|||
160525897|NCT02708095|579655796|FG000|Overall Study|Lack of Efficacy|9|||
160525898|NCT02708095|579655797|FG001|Overall Study|Lack of Efficacy|3|||
160525899|NCT02708095|579655798|FG002|Overall Study|Lack of Efficacy|0|||
160525900|NCT02708095|579655796|FG000|Overall Study|Lost to Follow-up|2|||
160525901|NCT02708095|579655797|FG001|Overall Study|Lost to Follow-up|0|||
160525902|NCT02708095|579655798|FG002|Overall Study|Lost to Follow-up|0|||
160525903|NCT02708095|579655796|FG000|Overall Study|Physician Decision|2|||
160525904|NCT02708095|579655797|FG001|Overall Study|Physician Decision|3|||
160525905|NCT02708095|579655798|FG002|Overall Study|Physician Decision|2|||
160525906|NCT02708095|579655796|FG000|Overall Study|Protocol Violation|0|||
160525907|NCT02708095|579655797|FG001|Overall Study|Protocol Violation|0|||
160525908|NCT02708095|579655798|FG002|Overall Study|Protocol Violation|1|||
160525909|NCT02708095|579655796|FG000|Overall Study|Withdrawal by Subject|5|||
160525910|NCT02708095|579655797|FG001|Overall Study|Withdrawal by Subject|3|||
160525911|NCT02708095|579655798|FG002|Overall Study|Withdrawal by Subject|4|||
160525912|NCT02730598|579655817|FG000|Overall Study|Withdrawal by Subject|3|||
160525913|NCT02730598|579655818|FG001|Overall Study|Withdrawal by Subject|3|||
160525914|NCT02730598|579655817|FG000|Overall Study|Protocol Violation|0|||
160525915|NCT02730598|579655818|FG001|Overall Study|Protocol Violation|1|||
160525916|NCT02730598|579655817|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
160525917|NCT02730598|579655818|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
160525918|NCT03254485|579655819|FG000|Overall Study|Adverse Event|3|||
160525919|NCT03254485|579655820|FG001|Overall Study|Adverse Event|0|||
160525920|NCT03254485|579655821|FG002|Overall Study|Adverse Event|0|||
160636279|NCT01392170|580051518|FG000|Overall Study|Withdrawal by Subject|1|||
160636280|NCT01392170|580051518|FG000|Overall Study|Ineligible|1|||
160759898|NCT00719901|580507974|FG000|Overall Study|Availability of Study Drug|1|||
160759899|NCT04456686|580507977|FG000|Overall Study|Adverse Event|2|||
160759900|NCT04456686|580507978|FG001|Overall Study|Adverse Event|1|||
160759901|NCT04456686|580507977|FG000|Overall Study|Lack of Efficacy|3|||
160759902|NCT04456686|580507978|FG001|Overall Study|Lack of Efficacy|1|||
160759903|NCT04456686|580507977|FG000|Overall Study|Withdrew consent|3|||
160636281|NCT03174925|580051526|FG000|Overall Study|Elastographic images not retrievable|2|||
160759904|NCT04456686|580507978|FG001|Overall Study|Withdrew consent|1|||
160759905|NCT04456686|580507977|FG000|Overall Study|Physician Decision|2|||
160636282|NCT03174925|580051526|FG000|Overall Study|Elastography image not interpretable|1|||
160636283|NCT00520494|580051527|FG000|Overall Study|Withdrawal by Subject|1|||
160636284|NCT04247594|580051528|FG000|Overall Study|Withdrawal by Subject|4|||
160636285|NCT04440163|580051530|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
160636286|NCT04440163|580051531|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
160636287|NCT04440163|580051532|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
160636288|NCT04440163|580051533|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
160636289|NCT04440163|580051534|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
160636290|NCT04440163|580051535|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
160636291|NCT04440163|580051536|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
160636292|NCT04440163|580051537|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
160636293|NCT04440163|580051530|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
160636294|NCT04440163|580051531|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
160636295|NCT04440163|580051532|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
160636296|NCT04440163|580051533|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
160636297|NCT04440163|580051534|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
160636298|NCT04440163|580051535|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
160636299|NCT04440163|580051536|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
160636300|NCT04440163|580051537|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
160636301|NCT04440163|580051530|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
160636302|NCT04440163|580051531|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
160636303|NCT04440163|580051532|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
160636304|NCT04440163|580051533|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
160636305|NCT04440163|580051534|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
160636306|NCT04440163|580051535|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
160636307|NCT04440163|580051536|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
160636308|NCT04440163|580051537|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
160636309|NCT04440163|580051530|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
160636310|NCT04440163|580051531|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
160636311|NCT04440163|580051532|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
160636312|NCT04440163|580051533|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
160636313|NCT04440163|580051534|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
160636314|NCT04440163|580051535|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
160636315|NCT04440163|580051536|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
160636316|NCT04440163|580051537|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
160636317|NCT04440163|580051530|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
160636318|NCT04440163|580051531|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
160636319|NCT04440163|580051532|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
160636320|NCT04440163|580051533|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
160636321|NCT04440163|580051534|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
160636322|NCT04440163|580051535|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
160636323|NCT04440163|580051536|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
160636324|NCT04440163|580051537|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
160636325|NCT04440163|580051530|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
160636326|NCT04440163|580051531|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
160636327|NCT04440163|580051532|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
160636328|NCT04440163|580051533|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
160636329|NCT04440163|580051534|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
160636330|NCT04440163|580051535|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
160636331|NCT04440163|580051536|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
160636332|NCT04440163|580051537|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
160636333|NCT04440163|580051530|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
160636334|NCT04440163|580051531|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
160636335|NCT04440163|580051532|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
160636336|NCT04440163|580051533|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
160636337|NCT04440163|580051534|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
160759906|NCT04456686|580507978|FG001|Overall Study|Physician Decision|2|||
160759907|NCT04456686|580507977|FG000|Overall Study|Withdrawal by Subject|5|||
160759908|NCT04456686|580507978|FG001|Overall Study|Withdrawal by Subject|1|||
160759909|NCT04456686|580507977|FG000|Overall Study|Protocol Violation|0|||
160759910|NCT04456686|580507978|FG001|Overall Study|Protocol Violation|1|||
160759911|NCT02858401|580507981|FG000|Overall Study|Withdrew Consent|0|||
160759912|NCT02858401|580507982|FG001|Overall Study|Withdrew Consent|0|||
160759913|NCT02858401|580507983|FG002|Overall Study|Withdrew Consent|0|||
160759914|NCT02858401|580507984|FG003|Overall Study|Withdrew Consent|0|||
160759915|NCT02858401|580507985|FG004|Overall Study|Withdrew Consent|0|||
160759916|NCT02858401|580507986|FG005|Overall Study|Withdrew Consent|1|||
160759917|NCT02858401|580507987|FG006|Overall Study|Withdrew Consent|0|||
160759918|NCT02858401|580507981|FG000|Overall Study|Lost to Follow-up|0|||
160759919|NCT02858401|580507982|FG001|Overall Study|Lost to Follow-up|1|||
160759920|NCT02858401|580507983|FG002|Overall Study|Lost to Follow-up|0|||
160759921|NCT02858401|580507984|FG003|Overall Study|Lost to Follow-up|0|||
160759922|NCT02858401|580507985|FG004|Overall Study|Lost to Follow-up|0|||
160759923|NCT02858401|580507986|FG005|Overall Study|Lost to Follow-up|0|||
160759924|NCT02858401|580507987|FG006|Overall Study|Lost to Follow-up|0|||
160759925|NCT03722576|580507988|FG000|Overall Study|Withdrawal by Subject|3|||
160759926|NCT03722576|580507988|FG000|Overall Study|Adverse Event|2|||
160759927|NCT03722576|580507988|FG000|Overall Study|Physician Decision|1|||
160759928|NCT03722576|580507988|FG000|Overall Study|Lost to Follow-up|1|||
160759929|NCT02059239|580507992|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
160759930|NCT02059239|580507993|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
160759931|NCT02059239|580507992|FG000|Overall Study|Physician Decision|1|||
160759932|NCT02059239|580507993|FG001|Overall Study|Physician Decision|0|||
160759933|NCT01408706|580507995|FG000|Overall Study|Physician Decision|1|||
160759934|NCT01408706|580507996|FG001|Overall Study|Physician Decision|0|||
160759935|NCT00888654|580507998|FG000|Overall Study|Problems swallowing oral meds.|1|||
160759936|NCT00888654|580507998|FG000|Overall Study|Not enough oral meds before surgery|3|||
160759937|NCT00888654|580507998|FG000|Overall Study|Surgery aborted|2|||
160759938|NCT00888654|580507998|FG000|Overall Study|Withdrawal by Subject|1|||
160759939|NCT00888654|580507998|FG000|Overall Study|Inelig. due to contraindication of med|1|||
160759940|NCT00888654|580507998|FG000|Overall Study|Change in surg date|1|||
160759941|NCT00888654|580507998|FG000|Overall Study|Stopped meds due to headaches|1|||
160759942|NCT01418339|580507999|FG000|Overall Study|Adverse Event|5|||
160759943|NCT01418339|580508000|FG001|Overall Study|Adverse Event|2|||
160759944|NCT01418339|580507999|FG000|Overall Study|Subject Withdrew Consent|1|||
160759945|NCT01418339|580508000|FG001|Overall Study|Subject Withdrew Consent|2|||
160759946|NCT01418339|580507999|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
160759947|NCT01418339|580508000|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
160759948|NCT02204917|580508005|FG000|Overall Study|Protocol Violation|1|||
160759949|NCT02869789|580508006|FG000|Overall Study|Disease progression|184|||
160759950|NCT02869789|580508007|FG001|Overall Study|Disease progression|109|||
160759951|NCT02869789|580508008|FG002|Overall Study|Disease progression|260|||
160759952|NCT02869789|580508009|FG003|Overall Study|Disease progression|19|||
160759953|NCT02869789|580508006|FG000|Overall Study|Study drug toxicity|90|||
160759954|NCT02869789|580508007|FG001|Overall Study|Study drug toxicity|32|||
160759955|NCT02869789|580508008|FG002|Overall Study|Study drug toxicity|55|||
160759956|NCT02869789|580508009|FG003|Overall Study|Study drug toxicity|14|||
160759957|NCT02869789|580508006|FG000|Overall Study|Death|7|||
160759958|NCT02869789|580508007|FG001|Overall Study|Death|3|||
160759959|NCT02869789|580508008|FG002|Overall Study|Death|5|||
160759960|NCT02869789|580508009|FG003|Overall Study|Death|1|||
160759961|NCT02869789|580508006|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
160759962|NCT02869789|580508007|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
160759963|NCT02869789|580508008|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
160759964|NCT02869789|580508009|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
160759965|NCT02869789|580508006|FG000|Overall Study|Participant request to discontinue study treatment|10|||
160759966|NCT02869789|580508007|FG001|Overall Study|Participant request to discontinue study treatment|5|||
160759967|NCT02869789|580508008|FG002|Overall Study|Participant request to discontinue study treatment|5|||
160759968|NCT02869789|580508009|FG003|Overall Study|Participant request to discontinue study treatment|3|||
160759969|NCT02869789|580508006|FG000|Overall Study|Withdrawal by Subject|5|||
160759970|NCT02869789|580508007|FG001|Overall Study|Withdrawal by Subject|2|||
160759971|NCT02869789|580508008|FG002|Overall Study|Withdrawal by Subject|7|||
160759972|NCT02869789|580508009|FG003|Overall Study|Withdrawal by Subject|2|||
160525921|NCT03254485|579655822|FG003|Overall Study|Adverse Event|6|||
160759973|NCT02869789|580508006|FG000|Overall Study|Lost to Follow-up|0|||
160759974|NCT02869789|580508007|FG001|Overall Study|Lost to Follow-up|0|||
160759975|NCT02869789|580508008|FG002|Overall Study|Lost to Follow-up|2|||
160759976|NCT02869789|580508009|FG003|Overall Study|Lost to Follow-up|0|||
160759977|NCT02869789|580508006|FG000|Overall Study|Maximum clinical benefit|5|||
160759978|NCT02869789|580508007|FG001|Overall Study|Maximum clinical benefit|2|||
160759979|NCT02869789|580508008|FG002|Overall Study|Maximum clinical benefit|1|||
160759980|NCT02869789|580508009|FG003|Overall Study|Maximum clinical benefit|0|||
160525922|NCT03254485|579655819|FG000|Overall Study|Protocol Violation|6|||
160525923|NCT03254485|579655820|FG001|Overall Study|Protocol Violation|0|||
160525924|NCT03254485|579655821|FG002|Overall Study|Protocol Violation|0|||
160525925|NCT03254485|579655822|FG003|Overall Study|Protocol Violation|2|||
160525926|NCT03254485|579655819|FG000|Overall Study|Withdrawal by Subject|1|||
160525927|NCT03254485|579655820|FG001|Overall Study|Withdrawal by Subject|0|||
160525928|NCT03254485|579655821|FG002|Overall Study|Withdrawal by Subject|0|||
160525929|NCT03254485|579655822|FG003|Overall Study|Withdrawal by Subject|4|||
160525930|NCT03254485|579655819|FG000|Overall Study|Death|0|||
160525931|NCT03254485|579655820|FG001|Overall Study|Death|0|||
160525932|NCT03254485|579655821|FG002|Overall Study|Death|0|||
160525933|NCT03254485|579655822|FG003|Overall Study|Death|1|||
160525934|NCT03254485|579655819|FG000|Overall Study|Lost to Follow-up|1|||
160525935|NCT03254485|579655820|FG001|Overall Study|Lost to Follow-up|0|||
160525936|NCT03254485|579655821|FG002|Overall Study|Lost to Follow-up|0|||
160525937|NCT03254485|579655822|FG003|Overall Study|Lost to Follow-up|0|||
160525938|NCT03254485|579655819|FG000|Overall Study|Other|1|||
160525939|NCT03254485|579655820|FG001|Overall Study|Other|0|||
160525940|NCT03254485|579655821|FG002|Overall Study|Other|0|||
160525941|NCT03254485|579655822|FG003|Overall Study|Other|2|||
160525942|NCT03153111|579655823|FG000|Overall Study|Death|2|||
160525943|NCT03153111|579655824|FG001|Overall Study|Death|5|||
160525944|NCT03153111|579655823|FG000|Overall Study|Lost to Follow-up|1|||
160525945|NCT03153111|579655824|FG001|Overall Study|Lost to Follow-up|0|||
160525946|NCT03153111|579655823|FG000|Overall Study|Physician Decision|5|||
160525947|NCT03153111|579655824|FG001|Overall Study|Physician Decision|1|||
160525948|NCT03153111|579655823|FG000|Overall Study|Withdrawal by Subject|3|||
160525949|NCT03153111|579655824|FG001|Overall Study|Withdrawal by Subject|3|||
160525950|NCT01210118|579655825|FG000|Overall Study|Lost to Follow-up|1|||
160525951|NCT01210118|579655826|FG001|Overall Study|Lost to Follow-up|1|||
160525952|NCT01210118|579655825|FG000|Overall Study|Protocol Violation|1|||
160525953|NCT01210118|579655826|FG001|Overall Study|Protocol Violation|1|||
160525954|NCT01210118|579655825|FG000|Overall Study|Spontaneous abortion|1|||
160525955|NCT01210118|579655826|FG001|Overall Study|Spontaneous abortion|3|||
160525956|NCT01696942|579655830|FG000|Overall Study|Withdrawal by Subject|1|||
160525957|NCT01696942|579655831|FG001|Overall Study|Withdrawal by Subject|0|||
160525958|NCT01696942|579655830|FG000|Overall Study|Protocol Violation|1|||
160525959|NCT01696942|579655831|FG001|Overall Study|Protocol Violation|2|||
160525960|NCT01696942|579655830|FG000|Overall Study|screen failure|0|||
160525961|NCT01696942|579655831|FG001|Overall Study|screen failure|1|||
160525962|NCT01422850|579655832|FG000|Overall Study|Physician Decision|3|||
160525963|NCT02244996|579655834|FG000|Overall Study|Lack of Efficacy|2|||
160525964|NCT02244996|579655835|FG001|Overall Study|Lack of Efficacy|6|||
160525965|NCT00174265|579655836|FG000|Overall Study|Adverse Event|7|||
160525966|NCT00174265|579655837|FG001|Overall Study|Adverse Event|4|||
160525967|NCT00174265|579655836|FG000|Overall Study|Lack of Efficacy|2|||
160525968|NCT00174265|579655837|FG001|Overall Study|Lack of Efficacy|2|||
160525969|NCT00174265|579655836|FG000|Overall Study|Withdrawal by Subject|3|||
160525970|NCT00174265|579655837|FG001|Overall Study|Withdrawal by Subject|5|||
160525971|NCT00174265|579655836|FG000|Overall Study|Lost to Follow-up|1|||
160525972|NCT00174265|579655837|FG001|Overall Study|Lost to Follow-up|0|||
160525973|NCT00174265|579655836|FG000|Overall Study|Other (Not specified)|16|||
160525974|NCT00174265|579655837|FG001|Overall Study|Other (Not specified)|10|||
160525975|NCT03231943|579655839|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525976|NCT03231943|579655840|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
160525977|NCT03231943|579655841|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
160525978|NCT03231943|579655842|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525979|NCT03231943|579655843|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525980|NCT03231943|579655844|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525981|NCT03231943|579655845|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525982|NCT03231943|579655846|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525983|NCT03231943|579655847|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525984|NCT03231943|579655848|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525985|NCT03231943|579655849|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525986|NCT03231943|579655850|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525987|NCT03231943|579655851|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
160525988|NCT03231943|579655839|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160525989|NCT03231943|579655840|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
160525990|NCT03231943|579655841|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160525991|NCT03231943|579655842|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160525992|NCT03231943|579655843|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160525993|NCT03231943|579655844|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160525994|NCT03231943|579655845|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160525995|NCT03231943|579655846|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160525996|NCT03231943|579655847|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160759981|NCT02869789|580508006|FG000|Overall Study|Poor/Non-compliance|0|||
160759982|NCT02869789|580508007|FG001|Overall Study|Poor/Non-compliance|2|||
160759983|NCT02869789|580508008|FG002|Overall Study|Poor/Non-compliance|1|||
160759984|NCT02869789|580508009|FG003|Overall Study|Poor/Non-compliance|0|||
160759985|NCT02869789|580508006|FG000|Overall Study|Participant no longer meets study criteria|0|||
160759986|NCT02869789|580508007|FG001|Overall Study|Participant no longer meets study criteria|1|||
160759987|NCT02869789|580508008|FG002|Overall Study|Participant no longer meets study criteria|1|||
160759988|NCT02869789|580508009|FG003|Overall Study|Participant no longer meets study criteria|0|||
160759989|NCT02869789|580508006|FG000|Overall Study|Administrative reason by sponsor|0|||
160759990|NCT02869789|580508007|FG001|Overall Study|Administrative reason by sponsor|0|||
160759991|NCT02869789|580508008|FG002|Overall Study|Administrative reason by sponsor|1|||
160759992|NCT02869789|580508009|FG003|Overall Study|Administrative reason by sponsor|0|||
160759993|NCT02869789|580508006|FG000|Overall Study|Other reasons|4|||
160759994|NCT02869789|580508007|FG001|Overall Study|Other reasons|8|||
160759995|NCT02869789|580508008|FG002|Overall Study|Other reasons|6|||
160759996|NCT02869789|580508009|FG003|Overall Study|Other reasons|0|||
160759997|NCT00297648|580508011|FG000|Overall Study|Adverse Event|13|||
160759998|NCT00297648|580508011|FG000|Overall Study|Lack of Efficacy|18|||
160759999|NCT00297648|580508011|FG000|Overall Study|Lost to Follow-up|1|||
160760000|NCT00297648|580508011|FG000|Overall Study|Withdrawal by Subject|3|||
160760001|NCT00297648|580508011|FG000|Overall Study|Other: Incompliance|1|||
160760002|NCT02048722|580508012|FG000|2 Cycles of Treatment|Adverse Event|2|||
160760003|NCT02048722|580508012|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
160760004|NCT02048722|580508012|FG000|2 Cycles of Treatment|Progressive Disease|2|||
160760005|NCT02048722|580508012|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
160760006|NCT02048722|580508012|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
160760007|NCT02048722|580508012|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
160760008|NCT00705757|580508013|FG000|Overall Study|Lack of Efficacy|5|||
160760009|NCT00705757|580508014|FG001|Overall Study|Lack of Efficacy|1|||
160760010|NCT00705757|580508015|FG002|Overall Study|Lack of Efficacy|3|||
160760011|NCT00705757|580508013|FG000|Overall Study|Lost to Follow-up|7|||
160760012|NCT00705757|580508014|FG001|Overall Study|Lost to Follow-up|6|||
160760013|NCT00705757|580508015|FG002|Overall Study|Lost to Follow-up|6|||
160760014|NCT00705757|580508013|FG000|Overall Study|Withdrawal by Subject|1|||
160760015|NCT00705757|580508014|FG001|Overall Study|Withdrawal by Subject|1|||
160760016|NCT00705757|580508015|FG002|Overall Study|Withdrawal by Subject|2|||
160760017|NCT01529606|580508016|FG000|Overall Study|Lost to Follow-up|21|||
160760018|NCT01529606|580508017|FG001|Overall Study|Lost to Follow-up|18|||
160760019|NCT01746862|580508018|FG000|Overall Study|Withdrawal by Subject|1|||
160760020|NCT01746862|580508019|FG001|Overall Study|Withdrawal by Subject|1|||
160760021|NCT01746862|580508018|FG000|Overall Study|Protocol Violation|1|||
160760022|NCT01746862|580508019|FG001|Overall Study|Protocol Violation|0|||
160760023|NCT01746862|580508018|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
160760024|NCT01746862|580508019|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
160760025|NCT01746862|580508018|FG000|Overall Study|Entered puberty during the study|1|||
160760026|NCT01746862|580508019|FG001|Overall Study|Entered puberty during the study|0|||
160760027|NCT04742673|580508020|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
160760028|NCT04742673|580508021|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
160760029|NCT00731822|580508032|FG000|Overall Study|Adverse Event|2|||
160760030|NCT00731822|580508033|FG001|Overall Study|Adverse Event|1|||
160760031|NCT00731822|580508032|FG000|Overall Study|Protocol Violation|1|||
160760032|NCT00731822|580508033|FG001|Overall Study|Protocol Violation|0|||
160760033|NCT00731822|580508032|FG000|Overall Study|Lost to Follow-up|1|||
160760034|NCT00731822|580508033|FG001|Overall Study|Lost to Follow-up|0|||
160760035|NCT05209880|580508037|FG000|1-Month Follow-up|Spoke with Doctor|5|||
160760036|NCT05209880|580508038|FG001|1-Month Follow-up|Spoke with Doctor|5|||
160760037|NCT05209880|580508037|FG000|1-Month Follow-up|Lost to Follow-up|7|||
160760038|NCT05209880|580508038|FG001|1-Month Follow-up|Lost to Follow-up|9|||
160760039|NCT05209880|580508037|FG000|1-Month Follow-up|Discontinued|0|||
160760040|NCT05209880|580508038|FG001|1-Month Follow-up|Discontinued|1|||
160760041|NCT05209880|580508037|FG000|3-Month Follow-up|Spoke with Doctor|17|||
160760042|NCT05209880|580508038|FG001|3-Month Follow-up|Spoke with Doctor|7|||
160760043|NCT05209880|580508037|FG000|3-Month Follow-up|Lost to Follow-up|8|||
160760044|NCT05209880|580508038|FG001|3-Month Follow-up|Lost to Follow-up|10|||
160760045|NCT05209880|580508037|FG000|3-Month Follow-up|Discontinued|1|||
160760046|NCT05209880|580508038|FG001|3-Month Follow-up|Discontinued|3|||
160760047|NCT05209880|580508037|FG000|6-Month Follow-up|Spoke with Doctor|25|||
160760048|NCT05209880|580508038|FG001|6-Month Follow-up|Spoke with Doctor|14|||
160760049|NCT05209880|580508037|FG000|6-Month Follow-up|Lost to Follow-up|9|||
160760050|NCT05209880|580508038|FG001|6-Month Follow-up|Lost to Follow-up|14|||
160760051|NCT05209880|580508037|FG000|6-Month Follow-up|Discontinued|1|||
160760052|NCT05209880|580508038|FG001|6-Month Follow-up|Discontinued|3|||
160760053|NCT02127658|580508039|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
160760054|NCT02127658|580508040|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
160760055|NCT02127658|580508039|FG000|Overall Study|Withdrawal by Subject|0|||
160760056|NCT02127658|580508040|FG001|Overall Study|Withdrawal by Subject|2|||
160760057|NCT02127658|580508039|FG000|Overall Study|Physician Decision|0|||
160760058|NCT02127658|580508040|FG001|Overall Study|Physician Decision|1|||
160760059|NCT03834493|580508041|FG000|Overall Study|Participants Ongoing|311|||
160760060|NCT03834493|580508042|FG001|Overall Study|Participants Ongoing|324|||
160760061|NCT03834493|580508041|FG000|Overall Study|Withdrawal by Subject|20|||
160760062|NCT03834493|580508042|FG001|Overall Study|Withdrawal by Subject|17|||
160760063|NCT03834493|580508041|FG000|Overall Study|Physician Decision|1|||
160760064|NCT03834493|580508042|FG001|Overall Study|Physician Decision|0|||
160760065|NCT03834493|580508041|FG000|Overall Study|Death|289|||
160760066|NCT03834493|580508042|FG001|Overall Study|Death|282|||
160760067|NCT04003103|580508043|FG000|Overall Study|Death|1|||
160760068|NCT04003103|580508044|FG001|Overall Study|Death|0|||
160760069|NCT04003103|580508045|FG002|Overall Study|Death|0|||
160760070|NCT04003103|580508043|FG000|Overall Study|Lost to Follow-up|4|||
160760071|NCT04003103|580508044|FG001|Overall Study|Lost to Follow-up|3|||
160760072|NCT04003103|580508045|FG002|Overall Study|Lost to Follow-up|2|||
160760073|NCT04003103|580508043|FG000|Overall Study|Withdrawal by Subject|10|||
160760074|NCT04003103|580508044|FG001|Overall Study|Withdrawal by Subject|1|||
160760075|NCT04003103|580508045|FG002|Overall Study|Withdrawal by Subject|1|||
160760076|NCT04003103|580508043|FG000|Overall Study|Status not recorded|0|||
160760077|NCT04003103|580508044|FG001|Overall Study|Status not recorded|2|||
160760078|NCT04003103|580508045|FG002|Overall Study|Status not recorded|0|||
160525997|NCT03231943|579655848|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160525998|NCT03231943|579655849|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160525999|NCT03231943|579655850|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160526000|NCT03231943|579655851|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
160526001|NCT03231943|579655839|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
160526002|NCT03231943|579655840|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526003|NCT03231943|579655841|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526004|NCT03231943|579655842|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526005|NCT03231943|579655843|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526006|NCT03231943|579655844|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526007|NCT03231943|579655845|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526008|NCT03231943|579655846|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526009|NCT03231943|579655847|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526010|NCT03231943|579655848|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526011|NCT03231943|579655849|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526012|NCT03231943|579655850|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526013|NCT03231943|579655851|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
160526014|NCT03231943|579655839|FG000|Part 2|Adverse Event|0|||
160526015|NCT03231943|579655840|FG001|Part 2|Adverse Event|0|||
160526016|NCT03231943|579655841|FG002|Part 2|Adverse Event|0|||
160526017|NCT03231943|579655842|FG003|Part 2|Adverse Event|0|||
160526018|NCT03231943|579655843|FG004|Part 2|Adverse Event|0|||
160526019|NCT03231943|579655844|FG005|Part 2|Adverse Event|0|||
160526020|NCT03231943|579655845|FG006|Part 2|Adverse Event|0|||
160526021|NCT03231943|579655846|FG007|Part 2|Adverse Event|0|||
160526022|NCT03231943|579655847|FG008|Part 2|Adverse Event|0|||
160526023|NCT03231943|579655848|FG009|Part 2|Adverse Event|0|||
160526024|NCT03231943|579655849|FG010|Part 2|Adverse Event|1|||
160526025|NCT03231943|579655850|FG011|Part 2|Adverse Event|0|||
160526026|NCT03231943|579655851|FG012|Part 2|Adverse Event|0|||
160526027|NCT03231943|579655839|FG000|Part 2|Withdrawal by Subject|0|||
160526028|NCT03231943|579655840|FG001|Part 2|Withdrawal by Subject|0|||
160526029|NCT03231943|579655841|FG002|Part 2|Withdrawal by Subject|0|||
160526030|NCT03231943|579655842|FG003|Part 2|Withdrawal by Subject|0|||
160526031|NCT03231943|579655843|FG004|Part 2|Withdrawal by Subject|0|||
160526032|NCT03231943|579655844|FG005|Part 2|Withdrawal by Subject|0|||
160526033|NCT03231943|579655845|FG006|Part 2|Withdrawal by Subject|0|||
160526034|NCT03231943|579655846|FG007|Part 2|Withdrawal by Subject|0|||
160526035|NCT03231943|579655847|FG008|Part 2|Withdrawal by Subject|0|||
160526036|NCT03231943|579655848|FG009|Part 2|Withdrawal by Subject|0|||
160526037|NCT03231943|579655849|FG010|Part 2|Withdrawal by Subject|0|||
160526038|NCT03231943|579655850|FG011|Part 2|Withdrawal by Subject|1|||
160526039|NCT03231943|579655851|FG012|Part 2|Withdrawal by Subject|0|||
160526040|NCT03040622|579655852|FG000|Overall Study|unable to implant device|3|||
160526041|NCT02818920|579655853|FG000|Overall Study|Unresectable|4|||
160526042|NCT02818920|579655853|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
160760079|NCT04073303|580508047|FG000|Overall Study|Adverse Event|0|||
160760080|NCT04073303|580508048|FG001|Overall Study|Adverse Event|2|||
160760081|NCT04073303|580508047|FG000|Overall Study|Withdrawal by Subject|16|||
160760082|NCT04073303|580508048|FG001|Overall Study|Withdrawal by Subject|36|||
160760083|NCT04073303|580508047|FG000|Overall Study|Lost to Follow-up|6|||
160760084|NCT04073303|580508048|FG001|Overall Study|Lost to Follow-up|1|||
160760085|NCT04073303|580508047|FG000|Overall Study|Protocol Deviation|0|||
160760086|NCT04073303|580508048|FG001|Overall Study|Protocol Deviation|4|||
160760087|NCT04073303|580508047|FG000|Overall Study|Other|1|||
160760088|NCT04073303|580508048|FG001|Overall Study|Other|1|||
160760089|NCT02277028|580508051|FG000|Overall Study|Lost to Follow-up|1|||
160760090|NCT02277028|580508052|FG001|Overall Study|Lost to Follow-up|0|||
160760091|NCT02277028|580508051|FG000|Overall Study|Withdrawal by Subject|0|||
160760092|NCT02277028|580508052|FG001|Overall Study|Withdrawal by Subject|1|||
160760093|NCT02718911|580508053|FG000|Overall Study|Adverse Event|0|||
160760094|NCT02718911|580508054|FG001|Overall Study|Adverse Event|0|||
160760095|NCT02718911|580508055|FG002|Overall Study|Adverse Event|0|||
160760096|NCT02718911|580508056|FG003|Overall Study|Adverse Event|0|||
160760097|NCT02718911|580508057|FG004|Overall Study|Adverse Event|0|||
160760098|NCT02718911|580508058|FG005|Overall Study|Adverse Event|0|||
160760099|NCT02718911|580508059|FG006|Overall Study|Adverse Event|0|||
160760100|NCT02718911|580508060|FG007|Overall Study|Adverse Event|0|||
160760101|NCT02718911|580508061|FG008|Overall Study|Adverse Event|0|||
160760102|NCT02718911|580508062|FG009|Overall Study|Adverse Event|2|||
160760103|NCT02718911|580508053|FG000|Overall Study|Death|2|||
160760104|NCT02718911|580508054|FG001|Overall Study|Death|3|||
160760105|NCT02718911|580508055|FG002|Overall Study|Death|1|||
160760106|NCT02718911|580508056|FG003|Overall Study|Death|0|||
160760107|NCT02718911|580508057|FG004|Overall Study|Death|1|||
160760108|NCT02718911|580508058|FG005|Overall Study|Death|3|||
160760109|NCT02718911|580508059|FG006|Overall Study|Death|1|||
160760110|NCT02718911|580508060|FG007|Overall Study|Death|1|||
160760111|NCT02718911|580508061|FG008|Overall Study|Death|4|||
160760112|NCT02718911|580508062|FG009|Overall Study|Death|3|||
160760113|NCT02718911|580508053|FG000|Overall Study|Lost to Follow-up|0|||
160760114|NCT02718911|580508054|FG001|Overall Study|Lost to Follow-up|0|||
160760115|NCT02718911|580508055|FG002|Overall Study|Lost to Follow-up|0|||
160760116|NCT02718911|580508056|FG003|Overall Study|Lost to Follow-up|0|||
160760117|NCT02718911|580508057|FG004|Overall Study|Lost to Follow-up|0|||
160760118|NCT02718911|580508058|FG005|Overall Study|Lost to Follow-up|0|||
160760119|NCT02718911|580508059|FG006|Overall Study|Lost to Follow-up|0|||
160760120|NCT02718911|580508060|FG007|Overall Study|Lost to Follow-up|0|||
160760121|NCT02718911|580508061|FG008|Overall Study|Lost to Follow-up|1|||
160760122|NCT02718911|580508062|FG009|Overall Study|Lost to Follow-up|0|||
160760123|NCT02718911|580508053|FG000|Overall Study|Physician Decision|2|||
160760124|NCT02718911|580508054|FG001|Overall Study|Physician Decision|0|||
160760125|NCT02718911|580508055|FG002|Overall Study|Physician Decision|1|||
160760126|NCT02718911|580508056|FG003|Overall Study|Physician Decision|1|||
160760127|NCT02718911|580508057|FG004|Overall Study|Physician Decision|0|||
160760128|NCT02718911|580508058|FG005|Overall Study|Physician Decision|0|||
160526043|NCT02818920|579655853|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
160526044|NCT02818920|579655853|FG000|Overall Study|Adverse Event|3|||
160526045|NCT02818920|579655853|FG000|Overall Study|Developed Other Disease|1|||
160526046|NCT02818920|579655853|FG000|Overall Study|Refused Further Treatment|1|||
160526047|NCT00445068|579655854|FG000|Overall Study|Disease progression|26|||
160526048|NCT00445068|579655854|FG000|Overall Study|Adverse Event|5|||
160526049|NCT00445068|579655854|FG000|Overall Study|Abnormal laboratory value|2|||
160526050|NCT00445068|579655854|FG000|Overall Study|Withdrawal by Subject|2|||
160526051|NCT00445068|579655854|FG000|Overall Study|Death|1|||
160526052|NCT02673619|579655855|FG000|Overall Study|Lost to Follow-up|1|||
160526053|NCT02673619|579655856|FG001|Overall Study|Lost to Follow-up|0|||
160526054|NCT02673619|579655857|FG002|Overall Study|Lost to Follow-up|0|||
160526055|NCT02673619|579655858|FG003|Overall Study|Lost to Follow-up|0|||
160526056|NCT02673619|579655855|FG000|Overall Study|Withdrawal by Subject|1|||
160526057|NCT02673619|579655856|FG001|Overall Study|Withdrawal by Subject|1|||
160526058|NCT02673619|579655857|FG002|Overall Study|Withdrawal by Subject|1|||
160526059|NCT02673619|579655858|FG003|Overall Study|Withdrawal by Subject|0|||
160526060|NCT02673619|579655855|FG000|Overall Study|Adverse Event|0|||
160526061|NCT02673619|579655856|FG001|Overall Study|Adverse Event|0|||
160526062|NCT02673619|579655857|FG002|Overall Study|Adverse Event|1|||
160526063|NCT02673619|579655858|FG003|Overall Study|Adverse Event|0|||
160526064|NCT02673619|579655855|FG000|Overall Study|Lack of Efficacy|0|||
160526065|NCT02673619|579655856|FG001|Overall Study|Lack of Efficacy|0|||
160526066|NCT02673619|579655857|FG002|Overall Study|Lack of Efficacy|1|||
160526067|NCT02673619|579655858|FG003|Overall Study|Lack of Efficacy|0|||
160526068|NCT03444324|579655859|FG000|Overall Study|Withdrawal by Subject|0|||
160526069|NCT03444324|579655860|FG001|Overall Study|Withdrawal by Subject|1|||
160526070|NCT03444324|579655859|FG000|Overall Study|Lost to Follow-up|4|||
160526071|NCT03444324|579655860|FG001|Overall Study|Lost to Follow-up|2|||
160526072|NCT03444324|579655859|FG000|Overall Study|Protocol Violation|0|||
160526073|NCT03444324|579655860|FG001|Overall Study|Protocol Violation|1|||
160526074|NCT03444324|579655859|FG000|Overall Study|Lack of Trial Compliance|1|||
160526075|NCT03444324|579655860|FG001|Overall Study|Lack of Trial Compliance|1|||
160526076|NCT03444324|579655859|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
160526077|NCT03444324|579655860|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
160526078|NCT06071754|579655862|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
160526079|NCT03226275|579655863|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
160526080|NCT03226275|579655864|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
160526081|NCT03226275|579655865|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
160526082|NCT03226275|579655866|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
160526083|NCT03226275|579655863|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
160526084|NCT03226275|579655864|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
160526085|NCT03226275|579655865|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
160526086|NCT03226275|579655866|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
160526087|NCT01436071|579657318|FG000|Overall Study|Adverse Event|1|||
160526088|NCT01436071|579657319|FG001|Overall Study|Adverse Event|0|||
160526089|NCT01436071|579657318|FG000|Overall Study|Lack of Efficacy|16|||
160526090|NCT01436071|579657319|FG001|Overall Study|Lack of Efficacy|7|||
160526091|NCT01436071|579657318|FG000|Overall Study|Protocol Violation|0|||
160526092|NCT01436071|579657319|FG001|Overall Study|Protocol Violation|1|||
160526093|NCT01436071|579657318|FG000|Overall Study|Lost to Follow-up|3|||
160526094|NCT01436071|579657319|FG001|Overall Study|Lost to Follow-up|1|||
160526095|NCT01436071|579657318|FG000|Overall Study|Physician Decision|1|||
160526096|NCT01436071|579657319|FG001|Overall Study|Physician Decision|0|||
160526097|NCT01436071|579657318|FG000|Overall Study|Withdrawal by Subject|2|||
160526098|NCT01436071|579657319|FG001|Overall Study|Withdrawal by Subject|2|||
160526099|NCT01436071|579657318|FG000|Overall Study|Did Not Receive Trial Medication|3|||
160526100|NCT01436071|579657319|FG001|Overall Study|Did Not Receive Trial Medication|3|||
160526101|NCT00833911|579657320|FG000|Titration|Adverse Event|18|||
160526102|NCT00833911|579657320|FG000|Titration|Withdrawal by Subject|3|||
160526103|NCT00833911|579657320|FG000|Maintenance Phase I|Adverse Event|73|||
160526104|NCT00833911|579657320|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
160526105|NCT00833911|579657320|FG000|Maintenance Phase I|Physician Decision|10|||
160526106|NCT00833911|579657320|FG000|Maintenance Phase I|Lack of Efficacy|4|||
160526107|NCT00833911|579657320|FG000|Maintenance Phase II|Adverse Event|6|||
160526108|NCT00833911|579657320|FG000|Maintenance Phase II|Physician Decision|2|||
160526109|NCT00833911|579657320|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
160526110|NCT00833911|579657320|FG000|Maintenance Phase II|Lack of Efficacy|1|||
160526111|NCT03942406|579657321|FG000|Overall Study|Lost to Follow-up|4|||
160526112|NCT03942406|579657322|FG001|Overall Study|Lost to Follow-up|5|||
160526113|NCT03942406|579657323|FG002|Overall Study|Lost to Follow-up|3|||
160526114|NCT03942406|579657324|FG003|Overall Study|Lost to Follow-up|7|||
160526115|NCT03942406|579657325|FG004|Overall Study|Lost to Follow-up|1|||
160526116|NCT03942406|579657326|FG005|Overall Study|Lost to Follow-up|0|||
160526117|NCT03942406|579657327|FG006|Overall Study|Lost to Follow-up|0|||
160526118|NCT03942406|579657321|FG000|Overall Study|Withdrawal by Subject|3|||
160526119|NCT03942406|579657322|FG001|Overall Study|Withdrawal by Subject|1|||
160526120|NCT03942406|579657323|FG002|Overall Study|Withdrawal by Subject|1|||
160526121|NCT03942406|579657324|FG003|Overall Study|Withdrawal by Subject|3|||
160526122|NCT03942406|579657325|FG004|Overall Study|Withdrawal by Subject|0|||
160526123|NCT03942406|579657326|FG005|Overall Study|Withdrawal by Subject|0|||
160526124|NCT03942406|579657327|FG006|Overall Study|Withdrawal by Subject|0|||
160526125|NCT03942406|579657321|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
160526126|NCT03942406|579657322|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
160526127|NCT03942406|579657323|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
160526128|NCT03942406|579657324|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
160526129|NCT03942406|579657325|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
160526130|NCT03942406|579657326|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
160526131|NCT03942406|579657327|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
160526132|NCT02748018|579657328|FG000|Study Period|Adverse Event|1|||
160526133|NCT02748018|579657329|FG001|Study Period|Adverse Event|3|||
160526134|NCT02748018|579657330|FG002|Study Period|Adverse Event|4|||
160526135|NCT02748018|579657331|FG003|Study Period|Adverse Event|0|||
160526136|NCT02748018|579657332|FG004|Study Period|Adverse Event|3|||
160526137|NCT02748018|579657333|FG005|Study Period|Adverse Event|3|||
160526138|NCT02748018|579657328|FG000|Study Period|Withdrawal by Subject|7|||
160526139|NCT02748018|579657329|FG001|Study Period|Withdrawal by Subject|4|||
160526140|NCT02748018|579657330|FG002|Study Period|Withdrawal by Subject|4|||
160526141|NCT02748018|579657331|FG003|Study Period|Withdrawal by Subject|11|||
160526142|NCT02748018|579657332|FG004|Study Period|Withdrawal by Subject|12|||
160526143|NCT02748018|579657333|FG005|Study Period|Withdrawal by Subject|10|||
160526144|NCT02748018|579657328|FG000|Study Period|Pregnancy|0|||
160526145|NCT02748018|579657329|FG001|Study Period|Pregnancy|1|||
160526146|NCT02748018|579657330|FG002|Study Period|Pregnancy|0|||
160526147|NCT02748018|579657331|FG003|Study Period|Pregnancy|0|||
160526148|NCT02748018|579657332|FG004|Study Period|Pregnancy|1|||
160526149|NCT02748018|579657333|FG005|Study Period|Pregnancy|0|||
160526150|NCT02748018|579657328|FG000|Study Period|Physician Decision|2|||
160526151|NCT02748018|579657329|FG001|Study Period|Physician Decision|2|||
160526152|NCT02748018|579657330|FG002|Study Period|Physician Decision|1|||
160526153|NCT02748018|579657331|FG003|Study Period|Physician Decision|0|||
160526154|NCT02748018|579657332|FG004|Study Period|Physician Decision|2|||
160526155|NCT02748018|579657333|FG005|Study Period|Physician Decision|0|||
160526156|NCT02748018|579657328|FG000|Study Period|Lost to Follow-up|0|||
160526157|NCT02748018|579657329|FG001|Study Period|Lost to Follow-up|0|||
160526158|NCT02748018|579657330|FG002|Study Period|Lost to Follow-up|0|||
160526159|NCT02748018|579657331|FG003|Study Period|Lost to Follow-up|2|||
160526160|NCT02748018|579657332|FG004|Study Period|Lost to Follow-up|0|||
160526161|NCT02748018|579657333|FG005|Study Period|Lost to Follow-up|1|||
160526162|NCT02748018|579657328|FG000|Continuation Period|Adverse Event|2|||
160526163|NCT02748018|579657329|FG001|Continuation Period|Adverse Event|0|||
160526164|NCT02748018|579657330|FG002|Continuation Period|Adverse Event|1|||
160526165|NCT02748018|579657331|FG003|Continuation Period|Adverse Event|1|||
160526166|NCT02748018|579657332|FG004|Continuation Period|Adverse Event|1|||
160526167|NCT02748018|579657333|FG005|Continuation Period|Adverse Event|4|||
160526168|NCT02748018|579657328|FG000|Continuation Period|Withdrawal by Subject|3|||
160526169|NCT02748018|579657329|FG001|Continuation Period|Withdrawal by Subject|5|||
160526170|NCT02748018|579657330|FG002|Continuation Period|Withdrawal by Subject|3|||
160526171|NCT02748018|579657331|FG003|Continuation Period|Withdrawal by Subject|9|||
160526172|NCT02748018|579657332|FG004|Continuation Period|Withdrawal by Subject|11|||
160526173|NCT02748018|579657333|FG005|Continuation Period|Withdrawal by Subject|1|||
160526174|NCT02748018|579657328|FG000|Continuation Period|Lost to Follow-up|0|||
160526175|NCT02748018|579657329|FG001|Continuation Period|Lost to Follow-up|2|||
160526176|NCT02748018|579657330|FG002|Continuation Period|Lost to Follow-up|1|||
160526177|NCT02748018|579657331|FG003|Continuation Period|Lost to Follow-up|0|||
160526178|NCT02748018|579657332|FG004|Continuation Period|Lost to Follow-up|1|||
160526179|NCT02748018|579657333|FG005|Continuation Period|Lost to Follow-up|0|||
160526180|NCT02748018|579657328|FG000|Continuation Period|Pregnancy|1|||
160526181|NCT02748018|579657329|FG001|Continuation Period|Pregnancy|2|||
160526182|NCT02748018|579657330|FG002|Continuation Period|Pregnancy|0|||
160526183|NCT02748018|579657331|FG003|Continuation Period|Pregnancy|0|||
160526184|NCT02748018|579657332|FG004|Continuation Period|Pregnancy|0|||
160526185|NCT02748018|579657333|FG005|Continuation Period|Pregnancy|0|||
160526186|NCT02748018|579657328|FG000|Continuation Period|Physician Decision|0|||
160526187|NCT02748018|579657329|FG001|Continuation Period|Physician Decision|1|||
160526188|NCT02748018|579657330|FG002|Continuation Period|Physician Decision|2|||
160526189|NCT02748018|579657331|FG003|Continuation Period|Physician Decision|0|||
160526190|NCT02748018|579657332|FG004|Continuation Period|Physician Decision|2|||
160526191|NCT02748018|579657333|FG005|Continuation Period|Physician Decision|1|||
160526192|NCT02748018|579657328|FG000|Continuation Period|Protocol Violation|0|||
160526193|NCT02748018|579657329|FG001|Continuation Period|Protocol Violation|1|||
160526194|NCT02748018|579657330|FG002|Continuation Period|Protocol Violation|0|||
160526195|NCT02748018|579657331|FG003|Continuation Period|Protocol Violation|0|||
160526196|NCT02748018|579657332|FG004|Continuation Period|Protocol Violation|0|||
160526197|NCT02748018|579657333|FG005|Continuation Period|Protocol Violation|0|||
160526198|NCT03801902|579657334|FG000|Overall Study|Did not receive protocol treatment.|1|||
160526199|NCT03801902|579657335|FG001|Overall Study|Did not receive protocol treatment.|0|||
160526200|NCT03801902|579657336|FG002|Overall Study|Did not receive protocol treatment.|0|||
160526201|NCT03801902|579657337|FG003|Overall Study|Did not receive protocol treatment.|0|||
160526202|NCT04704336|579657343|FG000|Overall Study|Death|2|||
160526203|NCT04704336|579657344|FG001|Overall Study|Death|2|||
160526204|NCT04704336|579657343|FG000|Overall Study|Lost to Follow-up|33|||
160526205|NCT04704336|579657344|FG001|Overall Study|Lost to Follow-up|40|||
160526206|NCT02260882|579657345|FG000|Overall Study|Protocol Violation|0|||
160526207|NCT02260882|579657346|FG001|Overall Study|Protocol Violation|1|||
160526208|NCT02119325|579657347|FG000|Washout Period 1|Adverse Event|0|||
160526209|NCT02119325|579657348|FG001|Washout Period 1|Adverse Event|1|||
160526210|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
160526211|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
160526212|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
160760129|NCT02718911|580508059|FG006|Overall Study|Physician Decision|0|||
160760130|NCT02718911|580508060|FG007|Overall Study|Physician Decision|1|||
160760131|NCT02718911|580508061|FG008|Overall Study|Physician Decision|2|||
160760132|NCT02718911|580508062|FG009|Overall Study|Physician Decision|1|||
160760133|NCT02718911|580508053|FG000|Overall Study|Withdrawal by Subject|0|||
160760134|NCT02718911|580508054|FG001|Overall Study|Withdrawal by Subject|0|||
160760135|NCT02718911|580508055|FG002|Overall Study|Withdrawal by Subject|0|||
160760136|NCT02718911|580508056|FG003|Overall Study|Withdrawal by Subject|0|||
160760137|NCT02718911|580508057|FG004|Overall Study|Withdrawal by Subject|1|||
160760138|NCT02718911|580508058|FG005|Overall Study|Withdrawal by Subject|0|||
160760139|NCT02718911|580508059|FG006|Overall Study|Withdrawal by Subject|0|||
160760140|NCT02718911|580508060|FG007|Overall Study|Withdrawal by Subject|0|||
160760141|NCT02718911|580508061|FG008|Overall Study|Withdrawal by Subject|1|||
160760142|NCT02718911|580508062|FG009|Overall Study|Withdrawal by Subject|4|||
160760143|NCT02718911|580508053|FG000|Overall Study|Reason Not Collected|0|||
160760144|NCT02718911|580508054|FG001|Overall Study|Reason Not Collected|0|||
160526213|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
160760145|NCT02718911|580508055|FG002|Overall Study|Reason Not Collected|1|||
160526214|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
160526215|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
160526216|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
160526217|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
160526218|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Death|1|||
160526219|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Death|1|||
160526220|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
160526221|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
160526222|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
160526223|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
160526224|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
160526225|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
160526226|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
160526227|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
160526228|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
160526229|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
160526230|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
160526231|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
160526232|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
160526233|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
160526234|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
160526235|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
160526236|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
160526237|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
160526238|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
160526239|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
160526240|NCT00559585|579657351|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
160526241|NCT00559585|579657352|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
160526242|NCT00559585|579657351|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
160526243|NCT00559585|579657352|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
160526244|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
160526245|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
160760146|NCT02718911|580508056|FG003|Overall Study|Reason Not Collected|0|||
160760147|NCT02718911|580508057|FG004|Overall Study|Reason Not Collected|0|||
160760148|NCT02718911|580508058|FG005|Overall Study|Reason Not Collected|0|||
160760149|NCT02718911|580508059|FG006|Overall Study|Reason Not Collected|2|||
160760150|NCT02718911|580508060|FG007|Overall Study|Reason Not Collected|1|||
160760151|NCT02718911|580508061|FG008|Overall Study|Reason Not Collected|4|||
160760152|NCT02718911|580508062|FG009|Overall Study|Reason Not Collected|9|||
160760153|NCT04817332|580508063|FG000|Overall Study|Lost to Follow-up|3|||
160760154|NCT04817332|580508064|FG001|Overall Study|Lost to Follow-up|3|||
160760155|NCT04817332|580508063|FG000|Overall Study|Protocol Violation|2|||
160760156|NCT04817332|580508064|FG001|Overall Study|Protocol Violation|0|||
160760157|NCT01867008|580508067|FG000|Overall Study|Withdrawal by Subject|1|||
160760158|NCT00983372|580508068|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
160760159|NCT00983372|580508068|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
160760160|NCT00983372|580508068|FG000|Diltiazem ER Alone|Adverse Event|1|||
160760161|NCT05635045|580508069|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
160760162|NCT05635045|580508070|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
160760163|NCT05635045|580508071|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
160760164|NCT05635045|580508072|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
160760165|NCT03143101|580508081|FG000|Overall Study|Withdrawal by Subject|0|||
160760166|NCT03143101|580508082|FG001|Overall Study|Withdrawal by Subject|1|||
160760167|NCT03143101|580508083|FG002|Overall Study|Withdrawal by Subject|0|||
160760168|NCT03143101|580508081|FG000|Overall Study|Lost to Follow-up|2|||
160760169|NCT03143101|580508082|FG001|Overall Study|Lost to Follow-up|2|||
160760170|NCT03143101|580508083|FG002|Overall Study|Lost to Follow-up|0|||
160760171|NCT05227118|580508084|FG000|Overall Study|Adverse Event|0|||
160760172|NCT05227118|580508085|FG001|Overall Study|Adverse Event|0|||
160760173|NCT05227118|580508086|FG002|Overall Study|Adverse Event|1|||
160760174|NCT05227118|580508087|FG003|Overall Study|Adverse Event|0|||
160760175|NCT05227118|580508084|FG000|Overall Study|Withdrawal by Subject|0|||
160760176|NCT05227118|580508085|FG001|Overall Study|Withdrawal by Subject|0|||
160760177|NCT05227118|580508086|FG002|Overall Study|Withdrawal by Subject|2|||
160760178|NCT05227118|580508087|FG003|Overall Study|Withdrawal by Subject|0|||
160760179|NCT01435759|580508088|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
160760180|NCT01435759|580508089|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
160760181|NCT01435759|580508090|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
160760182|NCT01435759|580508091|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
160760183|NCT01435759|580508092|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
160760184|NCT01435759|580508093|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
160760185|NCT01435759|580508088|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
160760186|NCT01435759|580508089|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
160760187|NCT01435759|580508090|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
160760188|NCT01435759|580508091|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
160760189|NCT01435759|580508092|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
160760190|NCT01435759|580508093|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
160760191|NCT01435759|580508088|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
160760192|NCT01435759|580508089|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
160760193|NCT01435759|580508090|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
160760194|NCT01435759|580508091|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
160760195|NCT01435759|580508092|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
160760196|NCT01435759|580508093|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
160760197|NCT01435759|580508088|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
160760198|NCT01435759|580508089|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
160760199|NCT01435759|580508090|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
160760200|NCT01435759|580508091|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
160760201|NCT01435759|580508092|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
160760202|NCT01435759|580508093|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
160760203|NCT01435759|580508088|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
160760204|NCT01435759|580508089|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
160760205|NCT01435759|580508090|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
160760206|NCT01435759|580508091|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
160760207|NCT01435759|580508092|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
160526246|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
160526247|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
160526248|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
160526249|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
160526250|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
160526251|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
160526252|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
160526253|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
160526254|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
160526255|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
160526256|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
160526257|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
160526258|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
160526259|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
160526260|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
160526261|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
160526262|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
160526263|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
160526264|NCT00559585|579657351|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
160526265|NCT00559585|579657352|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
160526266|NCT04209621|579657353|FG000|Overall Study|Death|1|||
160526267|NCT04209621|579657353|FG000|Overall Study|Study Terminated Early|2|||
160526268|NCT02249767|579657354|FG000|Overall Study|Did not use medication|8|||
160526269|NCT02249767|579657355|FG001|Overall Study|Did not use medication|9|||
160526270|NCT02249767|579657356|FG002|Overall Study|Did not use medication|8|||
160526271|NCT01372410|579657357|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
160526272|NCT01372410|579657358|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
160526273|NCT01372410|579657359|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
160526274|NCT01372410|579657360|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
160526275|NCT01372410|579657361|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
160526276|NCT01372410|579657362|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
160526277|NCT01372410|579657363|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
160526278|NCT01372410|579657364|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
160526279|NCT01372410|579657357|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
160526280|NCT01372410|579657358|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
160526281|NCT01372410|579657359|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
160526282|NCT01372410|579657360|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
160526283|NCT01372410|579657361|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
160526284|NCT01372410|579657362|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
160526285|NCT01372410|579657363|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
160526286|NCT01372410|579657364|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
160526287|NCT01372410|579657357|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160526288|NCT01372410|579657358|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160526289|NCT01372410|579657359|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160526290|NCT01372410|579657360|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160526291|NCT01372410|579657361|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
160526292|NCT01372410|579657362|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160526293|NCT01372410|579657363|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160526294|NCT01372410|579657364|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160526295|NCT01372410|579657357|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
160526296|NCT01372410|579657358|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
160526297|NCT01372410|579657359|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
160526298|NCT01372410|579657360|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
160526299|NCT01372410|579657361|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
160526300|NCT01372410|579657362|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
160526301|NCT01372410|579657363|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
160526302|NCT01372410|579657364|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
160526303|NCT01372410|579657357|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
160526304|NCT01372410|579657358|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
160526305|NCT01372410|579657359|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
160526306|NCT01372410|579657360|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
160526307|NCT01372410|579657361|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
160526308|NCT01372410|579657362|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
160526309|NCT01372410|579657363|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
160526310|NCT01372410|579657364|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
160526311|NCT01372410|579657357|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
160526312|NCT01372410|579657358|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
160526313|NCT01372410|579657359|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
160526314|NCT01372410|579657360|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
160526315|NCT01372410|579657361|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
160526316|NCT01372410|579657362|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
160526317|NCT01372410|579657363|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
160526318|NCT01372410|579657364|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
160526319|NCT01372410|579657357|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
160526320|NCT01372410|579657358|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
160526321|NCT01372410|579657359|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
160526322|NCT01372410|579657360|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
160526323|NCT01372410|579657361|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
160526324|NCT01372410|579657362|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
160526325|NCT01372410|579657363|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
160526326|NCT01372410|579657364|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
160526327|NCT01372410|579657357|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
160526328|NCT01372410|579657358|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
160526329|NCT01372410|579657359|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
160526330|NCT01372410|579657360|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
160526331|NCT01372410|579657361|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
160526332|NCT01372410|579657362|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
160526333|NCT01372410|579657363|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
160526334|NCT01372410|579657364|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
160526335|NCT01372410|579657357|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
160526336|NCT01372410|579657358|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
160526337|NCT01372410|579657359|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
160526338|NCT01372410|579657360|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
160526339|NCT01372410|579657361|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
160526340|NCT01372410|579657362|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
160526341|NCT01372410|579657363|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
160526342|NCT01372410|579657364|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
160526343|NCT01372410|579657357|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
160526344|NCT01372410|579657358|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
160526345|NCT01372410|579657359|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
160526346|NCT01372410|579657360|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
160526347|NCT01372410|579657361|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
160526348|NCT01372410|579657362|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
160636338|NCT04440163|580051535|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
160636339|NCT04440163|580051536|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
160636340|NCT04440163|580051537|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
160526349|NCT01372410|579657363|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
160526350|NCT01372410|579657364|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
160526351|NCT04585646|579657365|FG000|First Intervention|Physician Decision|1|||
160526352|NCT04585646|579657366|FG001|First Intervention|Physician Decision|0|||
160526353|NCT04585646|579657365|FG000|First Intervention|Lost to Follow-up|0|||
160526354|NCT04585646|579657366|FG001|First Intervention|Lost to Follow-up|3|||
160526355|NCT04585646|579657365|FG000|First Intervention|Withdrawal by Subject|0|||
160526356|NCT04585646|579657366|FG001|First Intervention|Withdrawal by Subject|1|||
160526357|NCT04614662|579657369|FG000|Overall Study|Withdrawal by Subject|0|||
160526358|NCT04614662|579657370|FG001|Overall Study|Withdrawal by Subject|1|||
160526359|NCT02178553|579657376|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
160526360|NCT02178553|579657377|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
160526361|NCT02178553|579657376|FG000|Overall Study|Physician Decision|0|||
160526362|NCT02178553|579657377|FG001|Overall Study|Physician Decision|4|||
160526363|NCT02178553|579657376|FG000|Overall Study|Technical problem with injection|1|||
160526364|NCT02178553|579657377|FG001|Overall Study|Technical problem with injection|3|||
160526365|NCT03294109|579657378|FG000|Overall Study|Withdrawal by Subject|6|||
160526366|NCT03294109|579657379|FG001|Overall Study|Withdrawal by Subject|5|||
160526367|NCT01182766|579657380|FG000|Overall Study|Lost to Follow-up|32|||
160526368|NCT01182766|579657381|FG001|Overall Study|Lost to Follow-up|36|||
160526369|NCT01182766|579657382|FG002|Overall Study|Lost to Follow-up|29|||
160526370|NCT01182766|579657380|FG000|Overall Study|Withdrawal by Subject|14|||
160526371|NCT01182766|579657381|FG001|Overall Study|Withdrawal by Subject|3|||
160526372|NCT01182766|579657382|FG002|Overall Study|Withdrawal by Subject|6|||
160526373|NCT01182766|579657380|FG000|Overall Study|Physician Decision|1|||
160526374|NCT01182766|579657381|FG001|Overall Study|Physician Decision|0|||
160526375|NCT01182766|579657382|FG002|Overall Study|Physician Decision|0|||
160526376|NCT01182766|579657380|FG000|Overall Study|Non-compliance|1|||
160526377|NCT01182766|579657381|FG001|Overall Study|Non-compliance|1|||
160526378|NCT01182766|579657382|FG002|Overall Study|Non-compliance|1|||
160526379|NCT01605253|579657383|FG000|Overall Study|Physician Decision|3|||
160526380|NCT01605253|579657384|FG001|Overall Study|Physician Decision|2|||
160526381|NCT01605253|579657383|FG000|Overall Study|Lost to Follow-up|3|||
160526382|NCT01605253|579657384|FG001|Overall Study|Lost to Follow-up|1|||
160526383|NCT02554903|579657385|FG000|Overall Study|Death|1|||
160526384|NCT02554903|579657386|FG001|Overall Study|Death|1|||
160526385|NCT02554903|579657385|FG000|Overall Study|Physician Decision|2|||
160526386|NCT02554903|579657386|FG001|Overall Study|Physician Decision|2|||
160526387|NCT02554903|579657385|FG000|Overall Study|Heart Transplant|1|||
160526388|NCT02554903|579657386|FG001|Overall Study|Heart Transplant|2|||
160526389|NCT04936841|579657389|FG000|Overall Study|Death|1|||
160526390|NCT00364156|579657397|FG000|Overall Study|Withdrawal by Subject|73|||
160526391|NCT00364156|579657398|FG001|Overall Study|Withdrawal by Subject|80|||
160526392|NCT00364156|579657397|FG000|Overall Study|Protocol Violation|6|||
160526393|NCT00364156|579657398|FG001|Overall Study|Protocol Violation|1|||
160526394|NCT01472380|579657399|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
160526395|NCT01472380|579657399|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
160526396|NCT01295281|579657402|FG000|First Intervention (7 Days)|Death|0|||
160526397|NCT01295281|579657403|FG001|First Intervention (7 Days)|Death|1|||
160760208|NCT01435759|580508093|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
160760209|NCT01435759|580508088|FG000|Antidepressant Lead-in Phase|Other|119|||
160760210|NCT01435759|580508089|FG001|Antidepressant Lead-in Phase|Other|0|||
160760211|NCT01435759|580508090|FG002|Antidepressant Lead-in Phase|Other|0|||
160760212|NCT01435759|580508091|FG003|Antidepressant Lead-in Phase|Other|0|||
160760213|NCT01435759|580508092|FG004|Antidepressant Lead-in Phase|Other|0|||
160760214|NCT01435759|580508093|FG005|Antidepressant Lead-in Phase|Other|0|||
160760215|NCT01435759|580508088|FG000|Double-blind Phase|Adverse Event|7|||
160760216|NCT01435759|580508089|FG001|Double-blind Phase|Adverse Event|0|||
160760217|NCT01435759|580508090|FG002|Double-blind Phase|Adverse Event|1|||
160760218|NCT01435759|580508091|FG003|Double-blind Phase|Adverse Event|1|||
160760219|NCT01435759|580508092|FG004|Double-blind Phase|Adverse Event|1|||
160760220|NCT01435759|580508093|FG005|Double-blind Phase|Adverse Event|3|||
160760221|NCT01435759|580508088|FG000|Double-blind Phase|Protocol Violation|2|||
160760222|NCT01435759|580508089|FG001|Double-blind Phase|Protocol Violation|0|||
160760223|NCT01435759|580508090|FG002|Double-blind Phase|Protocol Violation|1|||
160760224|NCT01435759|580508091|FG003|Double-blind Phase|Protocol Violation|2|||
160760225|NCT01435759|580508092|FG004|Double-blind Phase|Protocol Violation|0|||
160760226|NCT01435759|580508093|FG005|Double-blind Phase|Protocol Violation|1|||
160760227|NCT01435759|580508088|FG000|Double-blind Phase|Withdrawal by Subject|17|||
160760228|NCT01435759|580508089|FG001|Double-blind Phase|Withdrawal by Subject|4|||
160760229|NCT01435759|580508090|FG002|Double-blind Phase|Withdrawal by Subject|3|||
160760230|NCT01435759|580508091|FG003|Double-blind Phase|Withdrawal by Subject|4|||
160760231|NCT01435759|580508092|FG004|Double-blind Phase|Withdrawal by Subject|2|||
160760232|NCT01435759|580508093|FG005|Double-blind Phase|Withdrawal by Subject|2|||
160760233|NCT01435759|580508088|FG000|Double-blind Phase|Lost to Follow-up|31|||
160760234|NCT01435759|580508089|FG001|Double-blind Phase|Lost to Follow-up|1|||
160760235|NCT01435759|580508090|FG002|Double-blind Phase|Lost to Follow-up|2|||
160760236|NCT01435759|580508091|FG003|Double-blind Phase|Lost to Follow-up|0|||
160760237|NCT01435759|580508092|FG004|Double-blind Phase|Lost to Follow-up|3|||
160760238|NCT01435759|580508093|FG005|Double-blind Phase|Lost to Follow-up|3|||
160760239|NCT01435759|580508088|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
160760240|NCT01435759|580508089|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
160760241|NCT01435759|580508090|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
160760242|NCT01435759|580508091|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
160760243|NCT01435759|580508092|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
160760244|NCT01435759|580508093|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
160760245|NCT01435759|580508088|FG000|Double-blind Phase|Other|8|||
160760246|NCT01435759|580508089|FG001|Double-blind Phase|Other|2|||
160760247|NCT01435759|580508090|FG002|Double-blind Phase|Other|0|||
160760248|NCT01435759|580508091|FG003|Double-blind Phase|Other|2|||
160760249|NCT01435759|580508092|FG004|Double-blind Phase|Other|0|||
160760250|NCT01435759|580508093|FG005|Double-blind Phase|Other|0|||
160760251|NCT01710020|580508094|FG000|Period 1|Protocol Violation|1|||
160760252|NCT00427908|580508095|FG000|Primary Phase|Lost to Follow-up|4|||
160760253|NCT00427908|580508096|FG001|Primary Phase|Lost to Follow-up|0|||
160760254|NCT00427908|580508097|FG002|Primary Phase|Lost to Follow-up|2|||
160760255|NCT00427908|580508098|FG003|Primary Phase|Lost to Follow-up|0|||
160760256|NCT00427908|580508095|FG000|Primary Phase|Withdrawal by Subject|1|||
160760257|NCT00427908|580508096|FG001|Primary Phase|Withdrawal by Subject|2|||
160760258|NCT00427908|580508097|FG002|Primary Phase|Withdrawal by Subject|1|||
160760259|NCT00427908|580508098|FG003|Primary Phase|Withdrawal by Subject|0|||
160760260|NCT00427908|580508095|FG000|Primary Phase|Adverse Event|0|||
160760261|NCT00427908|580508096|FG001|Primary Phase|Adverse Event|1|||
160760262|NCT00427908|580508097|FG002|Primary Phase|Adverse Event|0|||
160760263|NCT00427908|580508098|FG003|Primary Phase|Adverse Event|0|||
160760264|NCT02115607|580508099|FG000|Overall Study|Withdrawal by Subject|1|||
160760265|NCT04863872|580508102|FG000|Overall Study|Withdrawal by Subject|4|||
160760266|NCT04863872|580508103|FG001|Overall Study|Withdrawal by Subject|15|||
160760267|NCT04863872|580508102|FG000|Overall Study|Death|5|||
160760268|NCT04863872|580508103|FG001|Overall Study|Death|2|||
160760269|NCT04863872|580508102|FG000|Overall Study|Lost to Follow-up|2|||
160760270|NCT04863872|580508103|FG001|Overall Study|Lost to Follow-up|1|||
160760271|NCT00735007|580508104|FG000|Overall Study|Adverse Event|4|||
160760272|NCT00735007|580508104|FG000|Overall Study|Protocol Violation|1|||
160760273|NCT03839394|580508107|FG000|Overall Study|Lost to Follow-up|6|||
160760274|NCT03839394|580508108|FG001|Overall Study|Lost to Follow-up|8|||
160760275|NCT03839394|580508107|FG000|Overall Study|Withdrawal by Subject|0|||
160760276|NCT03839394|580508108|FG001|Overall Study|Withdrawal by Subject|2|||
160760277|NCT00565604|580508116|FG000|Overall Study|Failure to treat|2|||
160760278|NCT00565604|580508116|FG000|Overall Study|Lost to Follow-up|2|||
160760279|NCT05630196|580510751|FG000|Overall Study|Adverse Event|2|||
160760280|NCT05630196|580510752|FG001|Overall Study|Adverse Event|1|||
160760281|NCT05630196|580510751|FG000|Overall Study|Lost to Follow-up|1|||
160760282|NCT05630196|580510752|FG001|Overall Study|Lost to Follow-up|1|||
160760283|NCT05630196|580510751|FG000|Overall Study|Protocol Violation|2|||
160760284|NCT05630196|580510752|FG001|Overall Study|Protocol Violation|3|||
160760285|NCT05630196|580510751|FG000|Overall Study|Physician Decision|1|||
160760286|NCT05630196|580510752|FG001|Overall Study|Physician Decision|0|||
160760287|NCT05630196|580510751|FG000|Overall Study|Withdrawal by Subject|3|||
160760288|NCT05630196|580510752|FG001|Overall Study|Withdrawal by Subject|4|||
160760289|NCT03973996|580510753|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160760290|NCT03973996|580510754|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160760291|NCT03973996|580510755|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160760292|NCT03973996|580510756|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
160760293|NCT04070989|580510757|FG000|Overall Study|Death|1|||
160760294|NCT04070989|580510758|FG001|Overall Study|Death|0|||
160760295|NCT04070989|580510759|FG002|Overall Study|Death|0|||
160760296|NCT04070989|580510757|FG000|Overall Study|Study Terminated by Sponsor|7|||
160760297|NCT04070989|580510758|FG001|Overall Study|Study Terminated by Sponsor|8|||
160760298|NCT04070989|580510759|FG002|Overall Study|Study Terminated by Sponsor|23|||
160760299|NCT04070989|580510757|FG000|Overall Study|Withdrawal by Subject|0|||
160760300|NCT04070989|580510758|FG001|Overall Study|Withdrawal by Subject|1|||
160760301|NCT04070989|580510759|FG002|Overall Study|Withdrawal by Subject|0|||
160760302|NCT04070989|580510757|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
160865673|NCT02504151|580902947|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
160526398|NCT00292461|579657404|FG000|Overall Study|Adverse Event|4|||
160526399|NCT00292461|579657405|FG001|Overall Study|Adverse Event|2|||
160526400|NCT00292461|579657404|FG000|Overall Study|Lack of Efficacy|1|||
160526401|NCT00292461|579657405|FG001|Overall Study|Lack of Efficacy|0|||
160526402|NCT00292461|579657404|FG000|Overall Study|Withdrawal by Subject|0|||
160526403|NCT00292461|579657405|FG001|Overall Study|Withdrawal by Subject|1|||
160526404|NCT00292461|579657404|FG000|Overall Study|Protocol Violation|4|||
160526405|NCT00292461|579657405|FG001|Overall Study|Protocol Violation|3|||
160526406|NCT00292461|579657404|FG000|Overall Study|Lost to Follow-up|1|||
160526407|NCT00292461|579657405|FG001|Overall Study|Lost to Follow-up|0|||
160526408|NCT00633061|579657409|FG000|Overall Study|Study closed|86|||
160526409|NCT00633061|579657410|FG001|Overall Study|Study closed|0|||
160526410|NCT02000427|579657411|FG000|Overall Study|Death|22|||
160526411|NCT02146326|579657416|FG000|Overall Study|Lost to Follow-up|3|||
160526412|NCT02146326|579657417|FG001|Overall Study|Lost to Follow-up|3|||
160526413|NCT02146326|579657418|FG002|Overall Study|Lost to Follow-up|11|||
160526414|NCT02146326|579657419|FG003|Overall Study|Lost to Follow-up|19|||
160526415|NCT02146326|579657416|FG000|Overall Study|Withdrawal by Subject|2|||
160526416|NCT02146326|579657417|FG001|Overall Study|Withdrawal by Subject|1|||
160526417|NCT02146326|579657418|FG002|Overall Study|Withdrawal by Subject|15|||
160526418|NCT02146326|579657419|FG003|Overall Study|Withdrawal by Subject|11|||
160526419|NCT02146326|579657416|FG000|Overall Study|Separated from mental health center|23|||
160526420|NCT02146326|579657417|FG001|Overall Study|Separated from mental health center|33|||
160526421|NCT02146326|579657418|FG002|Overall Study|Separated from mental health center|0|||
160526422|NCT02146326|579657419|FG003|Overall Study|Separated from mental health center|0|||
160526423|NCT02146326|579657416|FG000|Overall Study|Incarcerated|0|||
160526424|NCT02146326|579657417|FG001|Overall Study|Incarcerated|0|||
160526425|NCT02146326|579657418|FG002|Overall Study|Incarcerated|3|||
160526426|NCT02146326|579657419|FG003|Overall Study|Incarcerated|8|||
160526427|NCT02146326|579657416|FG000|Overall Study|Death|0|||
160526428|NCT02146326|579657417|FG001|Overall Study|Death|0|||
160526429|NCT02146326|579657418|FG002|Overall Study|Death|4|||
160526430|NCT02146326|579657419|FG003|Overall Study|Death|4|||
160526431|NCT02146326|579657416|FG000|Overall Study|Unable to complete interview|0|||
160526432|NCT02146326|579657417|FG001|Overall Study|Unable to complete interview|0|||
160526433|NCT02146326|579657418|FG002|Overall Study|Unable to complete interview|10|||
160526434|NCT02146326|579657419|FG003|Overall Study|Unable to complete interview|6|||
160526435|NCT00777946|579657422|FG000|Overall Study|Adverse Event|11|||
160526436|NCT00777946|579657423|FG001|Overall Study|Adverse Event|1|||
160526437|NCT00777946|579657424|FG002|Overall Study|Adverse Event|3|||
160526438|NCT00777946|579657422|FG000|Overall Study|Lack of Efficacy|0|||
160526439|NCT00777946|579657423|FG001|Overall Study|Lack of Efficacy|0|||
160526440|NCT00777946|579657424|FG002|Overall Study|Lack of Efficacy|9|||
160526441|NCT00777946|579657422|FG000|Overall Study|Condition no longer required study drug|1|||
160526442|NCT00777946|579657423|FG001|Overall Study|Condition no longer required study drug|0|||
160526443|NCT00777946|579657424|FG002|Overall Study|Condition no longer required study drug|0|||
160526444|NCT00777946|579657422|FG000|Overall Study|Patient withdrew consent|3|||
160526445|NCT00777946|579657423|FG001|Overall Study|Patient withdrew consent|2|||
160526446|NCT00777946|579657424|FG002|Overall Study|Patient withdrew consent|3|||
160526447|NCT00777946|579657422|FG000|Overall Study|Lost to Follow-up|3|||
160526448|NCT00777946|579657423|FG001|Overall Study|Lost to Follow-up|1|||
160526449|NCT00777946|579657424|FG002|Overall Study|Lost to Follow-up|0|||
160526450|NCT00777946|579657422|FG000|Overall Study|Protocol deviation|2|||
160526451|NCT00777946|579657423|FG001|Overall Study|Protocol deviation|1|||
160526452|NCT00777946|579657424|FG002|Overall Study|Protocol deviation|1|||
160526453|NCT00777946|579657422|FG000|Overall Study|Randomized in error|1|||
160526454|NCT00777946|579657423|FG001|Overall Study|Randomized in error|1|||
160526455|NCT00777946|579657424|FG002|Overall Study|Randomized in error|0|||
160526456|NCT02684357|579657425|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
160526457|NCT02684357|579657426|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
160526458|NCT02684357|579657427|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
160526459|NCT02684357|579657428|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
160526460|NCT02684357|579657429|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
160526461|NCT02684357|579657430|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
160526462|NCT02684357|579657425|FG000|Part A|Lost to Follow-up|0|||
160526463|NCT02684357|579657426|FG001|Part A|Lost to Follow-up|2|||
160526464|NCT02684357|579657427|FG002|Part A|Lost to Follow-up|2|||
160526465|NCT02684357|579657428|FG003|Part A|Lost to Follow-up|0|||
160526466|NCT02684357|579657429|FG004|Part A|Lost to Follow-up|0|||
160526467|NCT02684357|579657430|FG005|Part A|Lost to Follow-up|0|||
160526468|NCT02684357|579657425|FG000|Part A|Withdrawal by Subject|3|||
160526469|NCT02684357|579657426|FG001|Part A|Withdrawal by Subject|0|||
160526470|NCT02684357|579657427|FG002|Part A|Withdrawal by Subject|0|||
160526471|NCT02684357|579657428|FG003|Part A|Withdrawal by Subject|0|||
160526472|NCT02684357|579657429|FG004|Part A|Withdrawal by Subject|0|||
160526473|NCT02684357|579657430|FG005|Part A|Withdrawal by Subject|0|||
160526474|NCT02684357|579657425|FG000|Part A|Other|0|||
160526475|NCT02684357|579657426|FG001|Part A|Other|1|||
160526476|NCT02684357|579657427|FG002|Part A|Other|0|||
160526477|NCT02684357|579657428|FG003|Part A|Other|0|||
160526478|NCT02684357|579657429|FG004|Part A|Other|0|||
160526479|NCT02684357|579657430|FG005|Part A|Other|0|||
160526480|NCT02684357|579657425|FG000|Part B|Adverse Event (Other)|0|||
160526481|NCT02684357|579657426|FG001|Part B|Adverse Event (Other)|0|||
160526482|NCT02684357|579657427|FG002|Part B|Adverse Event (Other)|0|||
160526483|NCT02684357|579657428|FG003|Part B|Adverse Event (Other)|1|||
160526484|NCT02684357|579657429|FG004|Part B|Adverse Event (Other)|1|||
160526485|NCT02684357|579657430|FG005|Part B|Adverse Event (Other)|1|||
160526486|NCT02684357|579657425|FG000|Part B|Lost to Follow-up|0|||
160526487|NCT02684357|579657426|FG001|Part B|Lost to Follow-up|0|||
160526488|NCT02684357|579657427|FG002|Part B|Lost to Follow-up|0|||
160526489|NCT02684357|579657428|FG003|Part B|Lost to Follow-up|1|||
160526490|NCT02684357|579657429|FG004|Part B|Lost to Follow-up|1|||
160526491|NCT02684357|579657430|FG005|Part B|Lost to Follow-up|7|||
160526492|NCT02684357|579657425|FG000|Part B|Withdrawal by Subject|0|||
160526493|NCT02684357|579657426|FG001|Part B|Withdrawal by Subject|0|||
160526494|NCT02684357|579657427|FG002|Part B|Withdrawal by Subject|0|||
160526495|NCT02684357|579657428|FG003|Part B|Withdrawal by Subject|0|||
160526496|NCT02684357|579657429|FG004|Part B|Withdrawal by Subject|2|||
160526497|NCT02684357|579657430|FG005|Part B|Withdrawal by Subject|4|||
160526498|NCT02684357|579657425|FG000|Part B|Other|0|||
160526499|NCT02684357|579657426|FG001|Part B|Other|0|||
160526500|NCT02684357|579657427|FG002|Part B|Other|0|||
160526501|NCT02684357|579657428|FG003|Part B|Other|1|||
160526502|NCT02684357|579657429|FG004|Part B|Other|0|||
160526503|NCT02684357|579657430|FG005|Part B|Other|1|||
160526504|NCT05066724|579657431|FG000|Overall Study|Adverse Event|1|||
160526505|NCT05066724|579657431|FG000|Overall Study|Non-Compliance With Study Drug|5|||
160526506|NCT05066724|579657431|FG000|Overall Study|Withdrawal by Subject|6|||
160526507|NCT05066724|579657431|FG000|Overall Study|Physician Decision|2|||
160526508|NCT04821869|579657443|FG000|Overall Study|Adverse Event|4|||
160526509|NCT04821869|579657443|FG000|Overall Study|Withdrawal by Subject|2|||
160526510|NCT04821869|579657443|FG000|Overall Study|Did not meet FEV1 criteria|1|||
160526511|NCT01313117|579657447|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
160526512|NCT01313117|579657447|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
160526513|NCT03602261|579657452|FG000|Overall Study|Adverse Event|5|||
160526514|NCT03602261|579657453|FG001|Overall Study|Adverse Event|1|||
160526515|NCT03602261|579657452|FG000|Overall Study|Physician Decision|1|||
160526516|NCT03602261|579657453|FG001|Overall Study|Physician Decision|0|||
160526517|NCT03602261|579657452|FG000|Overall Study|Withdrawal by Subject|1|||
160526518|NCT03602261|579657453|FG001|Overall Study|Withdrawal by Subject|1|||
160526519|NCT03602261|579657452|FG000|Overall Study|Lack of Efficacy|0|||
160526520|NCT03602261|579657453|FG001|Overall Study|Lack of Efficacy|1|||
160526521|NCT03602261|579657452|FG000|Overall Study|Subject moving out of state|1|||
160526522|NCT03602261|579657453|FG001|Overall Study|Subject moving out of state|0|||
160526523|NCT03442114|579657454|FG000|Overall Study|Lost to Follow-up|13|||
160526524|NCT03442114|579657455|FG001|Overall Study|Lost to Follow-up|13|||
160526525|NCT03442114|579657454|FG000|Overall Study|Physician Decision|2|||
160526526|NCT03442114|579657455|FG001|Overall Study|Physician Decision|2|||
160526527|NCT03442114|579657454|FG000|Overall Study|Protocol Violation|0|||
160526528|NCT03442114|579657455|FG001|Overall Study|Protocol Violation|2|||
160526529|NCT03442114|579657454|FG000|Overall Study|Withdrawal by Subject|1|||
160526530|NCT03442114|579657455|FG001|Overall Study|Withdrawal by Subject|3|||
160526531|NCT03442114|579657454|FG000|Overall Study|Guardianship Change|0|||
160526532|NCT03442114|579657455|FG001|Overall Study|Guardianship Change|1|||
160526533|NCT00352885|579659108|FG000|Overall Study|Withdrawal by Subject|0|||
160526534|NCT00352885|579659109|FG001|Overall Study|Withdrawal by Subject|3|||
160526535|NCT00352885|579659108|FG000|Overall Study|Development of major depression|0|||
160526536|NCT00352885|579659109|FG001|Overall Study|Development of major depression|1|||
160526537|NCT00352885|579659108|FG000|Overall Study|Progression of metastatic melanoma|5|||
160526538|NCT00352885|579659109|FG001|Overall Study|Progression of metastatic melanoma|3|||
160526539|NCT00352885|579659108|FG000|Overall Study|Side effects of IL-2 administration|1|||
160526540|NCT00352885|579659109|FG001|Overall Study|Side effects of IL-2 administration|0|||
160526541|NCT01920594|579659110|FG000|Overall Study|Adverse Event|4|||
160526542|NCT01920594|579659111|FG001|Overall Study|Adverse Event|2|||
160526543|NCT01920594|579659110|FG000|Overall Study|Lost to Follow-up|1|||
160526544|NCT01920594|579659111|FG001|Overall Study|Lost to Follow-up|0|||
160526545|NCT01920594|579659110|FG000|Overall Study|Recovery|2|||
160526546|NCT01920594|579659111|FG001|Overall Study|Recovery|0|||
160526547|NCT01920594|579659110|FG000|Overall Study|Investigator discretion|0|||
160526548|NCT01920594|579659111|FG001|Overall Study|Investigator discretion|1|||
160526549|NCT04906616|579659112|FG000|Overall Study|Divorce|3|||
160526550|NCT04906616|579659113|FG001|Overall Study|Divorce|2|||
160526551|NCT01521897|579659114|FG000|Overall Study|Protocol Violation|18|||
160526552|NCT01521897|579659114|FG000|Overall Study|Lost to Follow-up|5|||
160526553|NCT00385203|579659115|FG000|Overall Study|Adverse Event|5|||
160526554|NCT00385203|579659116|FG001|Overall Study|Adverse Event|4|||
160526555|NCT00385203|579659115|FG000|Overall Study|Death|1|||
160526556|NCT00385203|579659116|FG001|Overall Study|Death|0|||
160526557|NCT00385203|579659115|FG000|Overall Study|Condition under investigation worsened|18|||
160526558|NCT00385203|579659116|FG001|Overall Study|Condition under investigation worsened|3|||
160526559|NCT00385203|579659115|FG000|Overall Study|Incorrect enrollment|2|||
160526560|NCT00385203|579659116|FG001|Overall Study|Incorrect enrollment|0|||
160526561|NCT02194062|579659117|FG000|Overall Study|Lost to Follow-up|2|||
160526562|NCT02194062|579659118|FG001|Overall Study|Lost to Follow-up|2|||
160526563|NCT02194062|579659119|FG002|Overall Study|Lost to Follow-up|5|||
160760303|NCT04070989|580510758|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
160526564|NCT03422172|579659120|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
160526565|NCT03422172|579659120|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
160526566|NCT03422172|579659120|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
160526567|NCT04147234|579659121|FG000|Overall Study|Clinical deterioration|0|||
160526568|NCT04147234|579659122|FG001|Overall Study|Clinical deterioration|0|||
160760304|NCT04070989|580510759|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
160760305|NCT04070989|580510757|FG000|Overall Study|Other|1|||
160760306|NCT04070989|580510758|FG001|Overall Study|Other|1|||
160526569|NCT04147234|579659123|FG002|Overall Study|Clinical deterioration|1|||
160526570|NCT04147234|579659124|FG003|Overall Study|Clinical deterioration|0|||
160526571|NCT04147234|579659125|FG004|Overall Study|Clinical deterioration|0|||
160526572|NCT04147234|579659126|FG005|Overall Study|Clinical deterioration|0|||
160526573|NCT04147234|579659127|FG006|Overall Study|Clinical deterioration|0|||
160526574|NCT04147234|579659121|FG000|Overall Study|Withdrawal by Subject|0|||
160526575|NCT04147234|579659122|FG001|Overall Study|Withdrawal by Subject|1|||
160526576|NCT04147234|579659123|FG002|Overall Study|Withdrawal by Subject|1|||
160526577|NCT04147234|579659124|FG003|Overall Study|Withdrawal by Subject|0|||
160526578|NCT04147234|579659125|FG004|Overall Study|Withdrawal by Subject|0|||
160526579|NCT04147234|579659126|FG005|Overall Study|Withdrawal by Subject|0|||
160526580|NCT04147234|579659127|FG006|Overall Study|Withdrawal by Subject|0|||
160526581|NCT04147234|579659121|FG000|Overall Study|Clinical disease progression|1|||
160526582|NCT04147234|579659122|FG001|Overall Study|Clinical disease progression|3|||
160526583|NCT04147234|579659123|FG002|Overall Study|Clinical disease progression|1|||
160526584|NCT04147234|579659124|FG003|Overall Study|Clinical disease progression|1|||
160526585|NCT04147234|579659125|FG004|Overall Study|Clinical disease progression|0|||
160526586|NCT04147234|579659126|FG005|Overall Study|Clinical disease progression|1|||
160526587|NCT04147234|579659127|FG006|Overall Study|Clinical disease progression|0|||
160526588|NCT04147234|579659121|FG000|Overall Study|Objective disease progression|6|||
160760307|NCT04070989|580510759|FG002|Overall Study|Other|0|||
160526589|NCT04147234|579659122|FG001|Overall Study|Objective disease progression|4|||
160526590|NCT04147234|579659123|FG002|Overall Study|Objective disease progression|3|||
160526591|NCT04147234|579659124|FG003|Overall Study|Objective disease progression|3|||
160526592|NCT04147234|579659125|FG004|Overall Study|Objective disease progression|5|||
160526593|NCT04147234|579659126|FG005|Overall Study|Objective disease progression|2|||
160526594|NCT04147234|579659127|FG006|Overall Study|Objective disease progression|3|||
160760308|NCT06088784|580510760|FG000|Overall Study|Adverse Event|0|||
160760309|NCT06088784|580510761|FG001|Overall Study|Adverse Event|0|||
160760310|NCT06088784|580510762|FG002|Overall Study|Adverse Event|0|||
160760311|NCT06088784|580510763|FG003|Overall Study|Adverse Event|0|||
160760312|NCT06088784|580510764|FG004|Overall Study|Adverse Event|0|||
160760313|NCT06088784|580510765|FG005|Overall Study|Adverse Event|0|||
160526595|NCT04147234|579659121|FG000|Overall Study|Adverse Event|0|||
160526596|NCT04147234|579659122|FG001|Overall Study|Adverse Event|0|||
160760314|NCT06088784|580510766|FG006|Overall Study|Adverse Event|3|||
160760315|NCT06088784|580510767|FG007|Overall Study|Adverse Event|0|||
160760316|NCT06088784|580510768|FG008|Overall Study|Adverse Event|0|||
160760317|NCT06088784|580510769|FG009|Overall Study|Adverse Event|0|||
160760318|NCT06088784|580510770|FG010|Overall Study|Adverse Event|0|||
160526597|NCT04147234|579659123|FG002|Overall Study|Adverse Event|0|||
160526598|NCT04147234|579659124|FG003|Overall Study|Adverse Event|0|||
160526599|NCT04147234|579659125|FG004|Overall Study|Adverse Event|1|||
160526600|NCT04147234|579659126|FG005|Overall Study|Adverse Event|0|||
160526601|NCT04147234|579659127|FG006|Overall Study|Adverse Event|0|||
160526602|NCT00293722|579659136|FG000|Overall Study|Other|427|||
160526603|NCT04498169|579659139|FG000|Study Completion|Adverse Event|1|||
160526604|NCT04498169|579659140|FG001|Study Completion|Adverse Event|1|||
160526605|NCT01754857|579659141|FG000|Overall Study|Adverse Event|7|||
160526606|NCT01754857|579659141|FG000|Overall Study|Disease progression|3|||
160526607|NCT01754857|579659141|FG000|Overall Study|Physician Decision|2|||
160526608|NCT01754857|579659141|FG000|Overall Study|Withdrawal by Subject|3|||
160526609|NCT01754857|579659141|FG000|Overall Study|other complicating disease|1|||
160526610|NCT01754857|579659141|FG000|Overall Study|ineligible to continue onto maintenance|1|||
160526611|NCT01754857|579659141|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
160526612|NCT01754857|579659141|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
160526613|NCT04964960|579659142|FG000|Overall Study|Withdrawal by Subject|1|||
160526614|NCT04964960|579659142|FG000|Overall Study|Did not complete cycles|1|||
160526615|NCT02960854|579659145|FG000|Overall Study|Not Disclosed|2|||
160526616|NCT02960854|579659146|FG001|Overall Study|Not Disclosed|2|||
160526617|NCT02960854|579659145|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
160526618|NCT02960854|579659146|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
160526619|NCT02960854|579659145|FG000|Overall Study|Subject Withdrew Consent|0|||
160526620|NCT02960854|579659146|FG001|Overall Study|Subject Withdrew Consent|1|||
160526621|NCT02960854|579659145|FG000|Overall Study|Death|4|||
160526622|NCT02960854|579659146|FG001|Overall Study|Death|6|||
160526623|NCT01383161|579659148|FG000|Overall Study|Adverse Event|5|||
160526624|NCT01383161|579659149|FG001|Overall Study|Adverse Event|1|||
160526625|NCT01383161|579659148|FG000|Overall Study|Withdrawal by Subject|0|||
160526626|NCT01383161|579659149|FG001|Overall Study|Withdrawal by Subject|2|||
160526627|NCT01383161|579659148|FG000|Overall Study|Lack of Efficacy|0|||
160526628|NCT01383161|579659149|FG001|Overall Study|Lack of Efficacy|1|||
160526629|NCT01423812|579659156|FG000|Overall Study|Lost to Follow-up|2|||
160526630|NCT01423812|579659157|FG001|Overall Study|Lost to Follow-up|2|||
160526631|NCT01423812|579659156|FG000|Overall Study|Withdrawal by Subject|1|||
160526632|NCT01423812|579659157|FG001|Overall Study|Withdrawal by Subject|2|||
160526633|NCT01207596|579659158|FG000|Overall Study|Physician Decision|4|||
160526634|NCT01207596|579659158|FG000|Overall Study|Lack of Efficacy|1|||
160526635|NCT01207596|579659158|FG000|Overall Study|Adverse Event|3|||
160526636|NCT01207596|579659158|FG000|Overall Study|Withdrawal by Subject|1|||
160526637|NCT00216203|579659159|FG000|Overall Study|Withdrawal by Subject|2|||
160526638|NCT02596620|579659171|FG000|Overall Study|Lost to Follow-up|1|||
160526639|NCT02596620|579659172|FG001|Overall Study|Lost to Follow-up|1|||
160526640|NCT01054144|579659173|FG000|Overall Study|Death|2|||
160526641|NCT02616614|579659174|FG000|Overall Study|Withdrawal by Subject|10|||
160526642|NCT02616614|579659175|FG001|Overall Study|Withdrawal by Subject|5|||
160526643|NCT02616614|579659176|FG002|Overall Study|Withdrawal by Subject|6|||
160526644|NCT02616614|579659174|FG000|Overall Study|Physician Decision|2|||
160526645|NCT02616614|579659175|FG001|Overall Study|Physician Decision|1|||
160526646|NCT02616614|579659176|FG002|Overall Study|Physician Decision|0|||
160526647|NCT02616614|579659174|FG000|Overall Study|Adverse Event|1|||
160526648|NCT02616614|579659175|FG001|Overall Study|Adverse Event|4|||
160526649|NCT02616614|579659176|FG002|Overall Study|Adverse Event|1|||
160526650|NCT02616614|579659174|FG000|Overall Study|Protocol Violation|0|||
160526651|NCT02616614|579659175|FG001|Overall Study|Protocol Violation|3|||
160526652|NCT02616614|579659176|FG002|Overall Study|Protocol Violation|1|||
160526653|NCT02616614|579659174|FG000|Overall Study|Prohibited Medication|12|||
160526654|NCT02616614|579659175|FG001|Overall Study|Prohibited Medication|9|||
160526655|NCT02616614|579659176|FG002|Overall Study|Prohibited Medication|5|||
160526656|NCT02616614|579659174|FG000|Overall Study|More than 3 applications missed|6|||
160526657|NCT02616614|579659175|FG001|Overall Study|More than 3 applications missed|8|||
160526658|NCT02616614|579659176|FG002|Overall Study|More than 3 applications missed|1|||
160760319|NCT06088784|580510771|FG011|Overall Study|Adverse Event|0|||
160760320|NCT06088784|580510760|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160760321|NCT06088784|580510761|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160526659|NCT02616614|579659174|FG000|Overall Study|Lost to Follow-up|31|||
160526660|NCT02616614|579659175|FG001|Overall Study|Lost to Follow-up|28|||
160760322|NCT06088784|580510762|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160760323|NCT06088784|580510763|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160526661|NCT02616614|579659176|FG002|Overall Study|Lost to Follow-up|13|||
160526662|NCT02616614|579659174|FG000|Overall Study|Pregnancy|2|||
160526663|NCT02616614|579659175|FG001|Overall Study|Pregnancy|0|||
160526664|NCT02616614|579659176|FG002|Overall Study|Pregnancy|1|||
160526665|NCT02616614|579659174|FG000|Overall Study|Other|1|||
160526666|NCT02616614|579659175|FG001|Overall Study|Other|2|||
160526667|NCT02616614|579659176|FG002|Overall Study|Other|1|||
160526668|NCT06069778|579659177|FG000|Overall Study|Withdrawal by Subject|1|||
160526669|NCT03118674|579659178|FG000|Overall Study|Lost to Follow-up|2|||
160526670|NCT03118674|579659178|FG000|Overall Study|Screen Faliure|8|||
160526671|NCT03118674|579659178|FG000|Overall Study|Withdrawal by Subject|5|||
160526672|NCT00954174|579659185|FG000|Overall Study|Adverse Event|28|||
160526673|NCT00954174|579659186|FG001|Overall Study|Adverse Event|23|||
160526674|NCT00954174|579659187|FG002|Overall Study|Adverse Event|4|||
160526675|NCT00954174|579659188|FG003|Overall Study|Adverse Event|9|||
160526676|NCT00954174|579659185|FG000|Overall Study|Death|4|||
160526677|NCT00954174|579659186|FG001|Overall Study|Death|2|||
160526678|NCT00954174|579659187|FG002|Overall Study|Death|0|||
160526679|NCT00954174|579659188|FG003|Overall Study|Death|0|||
160526680|NCT00954174|579659185|FG000|Overall Study|Lack of Efficacy|32|||
160526681|NCT00954174|579659186|FG001|Overall Study|Lack of Efficacy|22|||
160526682|NCT00954174|579659187|FG002|Overall Study|Lack of Efficacy|8|||
160526683|NCT00954174|579659188|FG003|Overall Study|Lack of Efficacy|6|||
160526684|NCT00954174|579659185|FG000|Overall Study|Withdrawal by Subject|14|||
160526685|NCT00954174|579659186|FG001|Overall Study|Withdrawal by Subject|10|||
160526686|NCT00954174|579659187|FG002|Overall Study|Withdrawal by Subject|4|||
160526687|NCT00954174|579659188|FG003|Overall Study|Withdrawal by Subject|3|||
160526688|NCT00954174|579659185|FG000|Overall Study|Medical Reason|4|||
160526689|NCT00954174|579659186|FG001|Overall Study|Medical Reason|2|||
160526690|NCT00954174|579659187|FG002|Overall Study|Medical Reason|1|||
160526691|NCT00954174|579659188|FG003|Overall Study|Medical Reason|0|||
160526692|NCT00954174|579659185|FG000|Overall Study|Ineligible|40|||
160526693|NCT00954174|579659186|FG001|Overall Study|Ineligible|47|||
160526694|NCT00954174|579659187|FG002|Overall Study|Ineligible|7|||
160526695|NCT00954174|579659188|FG003|Overall Study|Ineligible|4|||
160526696|NCT00954174|579659185|FG000|Overall Study|Never Treated|4|||
160526697|NCT00954174|579659186|FG001|Overall Study|Never Treated|17|||
160526698|NCT00954174|579659187|FG002|Overall Study|Never Treated|0|||
160526699|NCT00954174|579659188|FG003|Overall Study|Never Treated|3|||
160526700|NCT02234323|579659189|FG000|All Enrolled|Not Treated: Completed study in database|2|||
160526701|NCT02234323|579659189|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
160526702|NCT02234323|579659189|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
160526703|NCT02234323|579659189|FG000|All Treated|Death|1|||
160526704|NCT02234323|579659189|FG000|All Treated|Physician Decision|5|||
160526705|NCT02234323|579659189|FG000|All Treated|Lack of Efficacy|3|||
160526706|NCT02234323|579659189|FG000|All Treated|Exceeded lab value limit|2|||
160526707|NCT02234323|579659189|FG000|All Treated|Other|7|||
160526708|NCT02644941|579659190|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
160526709|NCT02644941|579659191|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
160526710|NCT00867113|579659192|FG000|Treatment Period|Adverse Event|15|||
160526711|NCT00867113|579659192|FG000|Treatment Period|Death|2|||
160526712|NCT00867113|579659192|FG000|Treatment Period|Withdrawal by Subject|19|||
160526713|NCT00867113|579659192|FG000|Treatment Period|Lost to Follow-up|3|||
160526714|NCT00867113|579659192|FG000|Treatment Period|Administrative problems|1|||
160526715|NCT00867113|579659192|FG000|Treatment Period|Disease progression/relapse|1|||
160526716|NCT00867113|579659192|FG000|Treatment Period|Protocol Violation|4|||
160526717|NCT00867113|579659192|FG000|Post Treatment After Survival Follow-up|Death|1|||
160526718|NCT00867113|579659192|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
160526719|NCT00867113|579659192|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
160526720|NCT00867113|579659192|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
160526721|NCT01145495|579659193|FG000|Overall Study|Adverse Event|6|||
160526722|NCT01145495|579659193|FG000|Overall Study|Withdrawal by Subject|6|||
160526723|NCT01145495|579659193|FG000|Overall Study|Disease progression after respone|2|||
160526724|NCT01886313|579659196|FG000|Overall Study|Adverse Event|1|||
160526725|NCT01886313|579659197|FG001|Overall Study|Adverse Event|1|||
160526726|NCT01603082|579659202|FG000|Overall Study|Adverse Event|0|||
160526727|NCT01603082|579659203|FG001|Overall Study|Adverse Event|1|||
160526728|NCT01603082|579659202|FG000|Overall Study|Withdrawal by Subject|1|||
160526729|NCT01603082|579659203|FG001|Overall Study|Withdrawal by Subject|0|||
160526730|NCT01603082|579659202|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
160526731|NCT01603082|579659203|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
160526732|NCT01641809|579659207|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
160636341|NCT04440163|580051530|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
160760324|NCT06088784|580510764|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160760325|NCT06088784|580510765|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160760326|NCT06088784|580510766|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
160526733|NCT01641809|579659208|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
160526734|NCT01641809|579659209|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
160526735|NCT01641809|579659210|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
160526736|NCT01641809|579659207|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
160526737|NCT01641809|579659208|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
160526738|NCT01641809|579659209|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
160526739|NCT01641809|579659210|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
160526740|NCT01641809|579659207|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
160526741|NCT01641809|579659208|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
160760327|NCT06088784|580510767|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160760328|NCT06088784|580510768|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160760329|NCT06088784|580510769|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160760330|NCT06088784|580510770|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160760331|NCT06088784|580510771|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
160760332|NCT05556616|580510774|FG000|Overall Study|Withdrawal by Subject|1|||
160760333|NCT05556616|580510775|FG001|Overall Study|Withdrawal by Subject|0|||
160760334|NCT05556616|580510776|FG002|Overall Study|Withdrawal by Subject|0|||
160760335|NCT05556616|580510777|FG003|Overall Study|Withdrawal by Subject|0|||
160760336|NCT05556616|580510778|FG004|Overall Study|Withdrawal by Subject|0|||
160760337|NCT05556616|580510779|FG005|Overall Study|Withdrawal by Subject|0|||
160760338|NCT05556616|580510780|FG006|Overall Study|Withdrawal by Subject|0|||
160760339|NCT05556616|580510774|FG000|Overall Study|Death|0|||
160760340|NCT05556616|580510775|FG001|Overall Study|Death|0|||
160760341|NCT05556616|580510776|FG002|Overall Study|Death|2|||
160760342|NCT05556616|580510777|FG003|Overall Study|Death|1|||
160760343|NCT05556616|580510778|FG004|Overall Study|Death|0|||
160760344|NCT05556616|580510779|FG005|Overall Study|Death|0|||
160760345|NCT05556616|580510780|FG006|Overall Study|Death|0|||
160760346|NCT05556616|580510774|FG000|Overall Study|Study Terminated by Sponsor|0|||
160760347|NCT05556616|580510775|FG001|Overall Study|Study Terminated by Sponsor|3|||
160760348|NCT05556616|580510776|FG002|Overall Study|Study Terminated by Sponsor|0|||
160760349|NCT05556616|580510777|FG003|Overall Study|Study Terminated by Sponsor|0|||
160760350|NCT05556616|580510778|FG004|Overall Study|Study Terminated by Sponsor|0|||
160760351|NCT05556616|580510779|FG005|Overall Study|Study Terminated by Sponsor|0|||
160760352|NCT05556616|580510780|FG006|Overall Study|Study Terminated by Sponsor|0|||
160760353|NCT03256578|580510781|FG000|Overall Study|Excluded Post Randomization|66|||
160760354|NCT03256578|580510782|FG001|Overall Study|Excluded Post Randomization|56|||
160760355|NCT05428436|580510783|FG000|Period 1 - 2 washout|Adverse Event|1|||
160760356|NCT05428436|580510784|FG001|Period 1 - 2 washout|Adverse Event|0|||
160760357|NCT05428436|580510785|FG002|Period 1 - 2 washout|Adverse Event|0|||
160760358|NCT03964207|580510786|FG000|First Treatment|Withdrawal by Subject|1|||
160760359|NCT03964207|580510787|FG001|First Treatment|Withdrawal by Subject|2|||
160760360|NCT03964207|580510786|FG000|First Treatment|Protocol Violation|1|||
160760361|NCT03964207|580510787|FG001|First Treatment|Protocol Violation|0|||
160760362|NCT03964207|580510786|FG000|First Treatment|Lost to Follow-up|1|||
160760363|NCT03964207|580510787|FG001|First Treatment|Lost to Follow-up|0|||
160760364|NCT03964207|580510786|FG000|Second Treatment|Lost to Follow-up|0|||
160760365|NCT03964207|580510787|FG001|Second Treatment|Lost to Follow-up|1|||
160760366|NCT03964207|580510786|FG000|Second Treatment|Adverse Event|1|||
160760367|NCT03964207|580510787|FG001|Second Treatment|Adverse Event|2|||
160760368|NCT01130272|580510788|FG000|Overall Study|Adverse Event|2|||
160760369|NCT01130272|580510789|FG001|Overall Study|Adverse Event|5|||
160760370|NCT01130272|580510790|FG002|Overall Study|Adverse Event|6|||
160760371|NCT01130272|580510791|FG003|Overall Study|Adverse Event|22|||
160760372|NCT01130272|580510792|FG004|Overall Study|Adverse Event|7|||
160760373|NCT01130272|580510788|FG000|Overall Study|IVRS-confirmed constipation|0|||
160760374|NCT01130272|580510789|FG001|Overall Study|IVRS-confirmed constipation|1|||
160760375|NCT01130272|580510790|FG002|Overall Study|IVRS-confirmed constipation|1|||
160760376|NCT01130272|580510791|FG003|Overall Study|IVRS-confirmed constipation|2|||
160760377|NCT01130272|580510792|FG004|Overall Study|IVRS-confirmed constipation|0|||
160760378|NCT01130272|580510788|FG000|Overall Study|Rescue medications due to diarrhea|3|||
160760379|NCT01130272|580510789|FG001|Overall Study|Rescue medications due to diarrhea|5|||
160760380|NCT01130272|580510790|FG002|Overall Study|Rescue medications due to diarrhea|8|||
160760381|NCT01130272|580510791|FG003|Overall Study|Rescue medications due to diarrhea|8|||
160760382|NCT01130272|580510792|FG004|Overall Study|Rescue medications due to diarrhea|6|||
160760383|NCT01130272|580510788|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
160760384|NCT01130272|580510789|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
160760385|NCT01130272|580510790|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
160760386|NCT01130272|580510791|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
160760387|NCT01130272|580510792|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
160760388|NCT01130272|580510788|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
160760389|NCT01130272|580510789|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
160760390|NCT01130272|580510790|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
160760391|NCT01130272|580510791|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
160760392|NCT01130272|580510792|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
160760393|NCT01130272|580510788|FG000|Overall Study|Protocol Violation|0|||
160760394|NCT01130272|580510789|FG001|Overall Study|Protocol Violation|0|||
160760395|NCT01130272|580510790|FG002|Overall Study|Protocol Violation|3|||
160760396|NCT01130272|580510791|FG003|Overall Study|Protocol Violation|5|||
160760397|NCT01130272|580510792|FG004|Overall Study|Protocol Violation|5|||
160760398|NCT01130272|580510788|FG000|Overall Study|Lost to Follow-up|4|||
160526742|NCT01641809|579659209|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
160526743|NCT01641809|579659210|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
160760399|NCT01130272|580510789|FG001|Overall Study|Lost to Follow-up|3|||
160760400|NCT01130272|580510790|FG002|Overall Study|Lost to Follow-up|4|||
160760401|NCT01130272|580510791|FG003|Overall Study|Lost to Follow-up|7|||
160760402|NCT01130272|580510792|FG004|Overall Study|Lost to Follow-up|6|||
160760403|NCT01130272|580510788|FG000|Overall Study|Withdrawal by Subject|4|||
160760404|NCT01130272|580510789|FG001|Overall Study|Withdrawal by Subject|11|||
160760405|NCT01130272|580510790|FG002|Overall Study|Withdrawal by Subject|10|||
160760406|NCT01130272|580510791|FG003|Overall Study|Withdrawal by Subject|9|||
160760407|NCT01130272|580510792|FG004|Overall Study|Withdrawal by Subject|8|||
160760408|NCT01130272|580510788|FG000|Overall Study|Physician Decision|1|||
160760409|NCT01130272|580510789|FG001|Overall Study|Physician Decision|1|||
160760410|NCT01130272|580510790|FG002|Overall Study|Physician Decision|0|||
160760411|NCT01130272|580510791|FG003|Overall Study|Physician Decision|1|||
160760412|NCT01130272|580510792|FG004|Overall Study|Physician Decision|2|||
160760413|NCT01130272|580510788|FG000|Overall Study|Sponsor decision|6|||
160760414|NCT01130272|580510789|FG001|Overall Study|Sponsor decision|15|||
160760415|NCT01130272|580510790|FG002|Overall Study|Sponsor decision|16|||
160760416|NCT01130272|580510791|FG003|Overall Study|Sponsor decision|13|||
160760417|NCT01130272|580510792|FG004|Overall Study|Sponsor decision|16|||
160760418|NCT01130272|580510788|FG000|Overall Study|Study arm discontinued|38|||
160760419|NCT01130272|580510789|FG001|Overall Study|Study arm discontinued|0|||
160760420|NCT01130272|580510790|FG002|Overall Study|Study arm discontinued|0|||
160760421|NCT01130272|580510791|FG003|Overall Study|Study arm discontinued|0|||
160760422|NCT01130272|580510792|FG004|Overall Study|Study arm discontinued|0|||
160760423|NCT01405560|580510793|FG000|Overall Study|Physician Decision|1|||
160760424|NCT01699750|580510798|FG000|Overall Study|Withdrew Consent|0|||
160760425|NCT01699750|580510799|FG001|Overall Study|Withdrew Consent|1|||
160760426|NCT01699750|580510798|FG000|Overall Study|Other|0|||
160760427|NCT01699750|580510799|FG001|Overall Study|Other|2|||
160760428|NCT01868646|580510801|FG000|Overall Study|Do not meet inclusion criteria|3|||
160760429|NCT01868646|580510802|FG001|Overall Study|Do not meet inclusion criteria|5|||
160760430|NCT01831427|580510803|FG000|Overall Study|Adverse Event|0|||
160760431|NCT01831427|580510804|FG001|Overall Study|Adverse Event|1|||
160760432|NCT01831427|580510805|FG002|Overall Study|Adverse Event|0|||
160760433|NCT01831427|580510806|FG003|Overall Study|Adverse Event|0|||
160760434|NCT01831427|580510807|FG004|Overall Study|Adverse Event|0|||
160760435|NCT01831427|580510808|FG005|Overall Study|Adverse Event|1|||
160760436|NCT01831427|580510809|FG006|Overall Study|Adverse Event|0|||
160760437|NCT01831427|580510810|FG007|Overall Study|Adverse Event|1|||
160760438|NCT01831427|580510811|FG008|Overall Study|Adverse Event|0|||
160760439|NCT01831427|580510812|FG009|Overall Study|Adverse Event|0|||
160760440|NCT01831427|580510813|FG010|Overall Study|Adverse Event|2|||
160760441|NCT01831427|580510803|FG000|Overall Study|Investigator's Discretion|0|||
160760442|NCT01831427|580510804|FG001|Overall Study|Investigator's Discretion|0|||
160760443|NCT01831427|580510805|FG002|Overall Study|Investigator's Discretion|0|||
160760444|NCT01831427|580510806|FG003|Overall Study|Investigator's Discretion|1|||
160760445|NCT01831427|580510807|FG004|Overall Study|Investigator's Discretion|0|||
160760446|NCT01831427|580510808|FG005|Overall Study|Investigator's Discretion|0|||
160760447|NCT01831427|580510809|FG006|Overall Study|Investigator's Discretion|0|||
160760448|NCT01831427|580510810|FG007|Overall Study|Investigator's Discretion|0|||
160760449|NCT01831427|580510811|FG008|Overall Study|Investigator's Discretion|0|||
160760450|NCT01831427|580510812|FG009|Overall Study|Investigator's Discretion|0|||
160760451|NCT01831427|580510813|FG010|Overall Study|Investigator's Discretion|0|||
160760452|NCT01831427|580510803|FG000|Overall Study|Withdrew Consent|0|||
160760453|NCT01831427|580510804|FG001|Overall Study|Withdrew Consent|0|||
160760454|NCT01831427|580510805|FG002|Overall Study|Withdrew Consent|0|||
160760455|NCT01831427|580510806|FG003|Overall Study|Withdrew Consent|0|||
160760456|NCT01831427|580510807|FG004|Overall Study|Withdrew Consent|0|||
160760457|NCT01831427|580510808|FG005|Overall Study|Withdrew Consent|0|||
160760458|NCT01831427|580510809|FG006|Overall Study|Withdrew Consent|2|||
160760459|NCT01831427|580510810|FG007|Overall Study|Withdrew Consent|0|||
160760460|NCT01831427|580510811|FG008|Overall Study|Withdrew Consent|0|||
160760461|NCT01831427|580510812|FG009|Overall Study|Withdrew Consent|1|||
160760462|NCT01831427|580510813|FG010|Overall Study|Withdrew Consent|1|||
160760463|NCT01249417|580510816|FG000|Randomised Population|Study treatment not received|0|||
160760464|NCT01249417|580510817|FG001|Randomised Population|Study treatment not received|0|||
160760465|NCT01249417|580510818|FG002|Randomised Population|Study treatment not received|2|||
160760466|NCT01249417|580510816|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
160760467|NCT01249417|580510817|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
160760468|NCT01249417|580510818|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
160760469|NCT01249417|580510816|FG000|Treatment Phase - ITT Population|Other|0|||
160760470|NCT01249417|580510817|FG001|Treatment Phase - ITT Population|Other|0|||
160760471|NCT01249417|580510818|FG002|Treatment Phase - ITT Population|Other|1|||
160760472|NCT01249417|580510816|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
160760473|NCT01249417|580510817|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
160760474|NCT01249417|580510818|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
160760475|NCT01249417|580510816|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
160760476|NCT01249417|580510817|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
160760477|NCT01249417|580510818|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
160760478|NCT01249417|580510816|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
160760479|NCT01249417|580510817|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
160760480|NCT01249417|580510818|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
160760481|NCT02035553|580510819|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
160760482|NCT02035553|580510820|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
160760483|NCT02035553|580510819|FG000|Overall Study|Adverse Event|10|||
160760484|NCT02035553|580510820|FG001|Overall Study|Adverse Event|6|||
160760485|NCT02035553|580510819|FG000|Overall Study|Physician Decision|3|||
160760486|NCT02035553|580510820|FG001|Overall Study|Physician Decision|2|||
160760487|NCT02035553|580510819|FG000|Overall Study|Lack of Efficacy|1|||
160760488|NCT02035553|580510820|FG001|Overall Study|Lack of Efficacy|1|||
160760489|NCT02035553|580510819|FG000|Overall Study|Withdrawal by Subject|4|||
160760490|NCT02035553|580510820|FG001|Overall Study|Withdrawal by Subject|7|||
160760491|NCT02035553|580510819|FG000|Overall Study|Non-compliance with Study Drug|0|||
160760492|NCT02035553|580510820|FG001|Overall Study|Non-compliance with Study Drug|1|||
160760493|NCT02035553|580510819|FG000|Overall Study|Lost to Follow-up|0|||
160760494|NCT02035553|580510820|FG001|Overall Study|Lost to Follow-up|1|||
160760495|NCT02035553|580510819|FG000|Overall Study|Other Reason|0|||
160760496|NCT02035553|580510820|FG001|Overall Study|Other Reason|4|||
160760497|NCT04539964|580510821|FG000|Overall Study|device malfunction|1|||
160760498|NCT04539964|580510822|FG001|Overall Study|device malfunction|0|||
160760499|NCT04539964|580510821|FG000|Overall Study|Withdrawal by Subject|1|||
160760500|NCT04539964|580510822|FG001|Overall Study|Withdrawal by Subject|2|||
160760501|NCT04539964|580510821|FG000|Overall Study|Adverse Event|0|||
160760502|NCT04539964|580510822|FG001|Overall Study|Adverse Event|2|||
160760503|NCT01854697|580510823|FG000|Overall Study|Adverse Event|1|||
160760504|NCT01854697|580510824|FG001|Overall Study|Adverse Event|0|||
160760505|NCT01854697|580510825|FG002|Overall Study|Adverse Event|0|||
160760506|NCT01854697|580510826|FG003|Overall Study|Adverse Event|0|||
160760507|NCT01854697|580510827|FG004|Overall Study|Adverse Event|1|||
160760508|NCT01854697|580510823|FG000|Overall Study|Lost to Follow-up|4|||
160760509|NCT01854697|580510824|FG001|Overall Study|Lost to Follow-up|1|||
160760510|NCT01854697|580510825|FG002|Overall Study|Lost to Follow-up|1|||
160760511|NCT01854697|580510826|FG003|Overall Study|Lost to Follow-up|2|||
160760512|NCT01854697|580510827|FG004|Overall Study|Lost to Follow-up|0|||
160760513|NCT01854697|580510823|FG000|Overall Study|To enter another AbbVie study|1|||
160760514|NCT01854697|580510824|FG001|Overall Study|To enter another AbbVie study|0|||
160760515|NCT01854697|580510825|FG002|Overall Study|To enter another AbbVie study|0|||
160760516|NCT01854697|580510826|FG003|Overall Study|To enter another AbbVie study|0|||
160760517|NCT01854697|580510827|FG004|Overall Study|To enter another AbbVie study|1|||
160760518|NCT01854697|580510823|FG000|Overall Study|Withdrew Consent|0|||
160760519|NCT01854697|580510824|FG001|Overall Study|Withdrew Consent|1|||
160760520|NCT01854697|580510825|FG002|Overall Study|Withdrew Consent|0|||
160760521|NCT01854697|580510826|FG003|Overall Study|Withdrew Consent|1|||
160760522|NCT01854697|580510827|FG004|Overall Study|Withdrew Consent|0|||
160760523|NCT01854697|580510823|FG000|Overall Study|Other|0|||
160760524|NCT01854697|580510824|FG001|Overall Study|Other|1|||
160760525|NCT01854697|580510825|FG002|Overall Study|Other|1|||
160760526|NCT01854697|580510826|FG003|Overall Study|Other|0|||
160760527|NCT01854697|580510827|FG004|Overall Study|Other|0|||
160760528|NCT02771275|580510832|FG000|Overall Study|Reoperation|3|||
160760529|NCT02771275|580510832|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
160760530|NCT05556148|580510833|FG000|Overall Study|Early Termination|29|||
160760531|NCT05556148|580510833|FG000|Overall Study|Baseline Tasks Expired|4|||
160760532|NCT05556148|580510833|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
160760533|NCT05556148|580510833|FG000|Overall Study|No Longer Wished to Participate|1|||
160760534|NCT05556148|580510833|FG000|Overall Study|Bacterial Conjunctivitis|1|||
160760535|NCT01171898|580510834|FG000|Overall Study|Death|0|||
160760536|NCT01171898|580510835|FG001|Overall Study|Death|0|||
160760537|NCT01171898|580510836|FG002|Overall Study|Death|2|||
160760538|NCT01171898|580510837|FG003|Overall Study|Death|0|||
160760539|NCT01171898|580510834|FG000|Overall Study|Lost to Follow-up|0|||
160760540|NCT01171898|580510835|FG001|Overall Study|Lost to Follow-up|1|||
160760541|NCT01171898|580510836|FG002|Overall Study|Lost to Follow-up|1|||
160760542|NCT01171898|580510837|FG003|Overall Study|Lost to Follow-up|1|||
160760543|NCT01171898|580510834|FG000|Overall Study|Withdrawal by Subject|1|||
160760544|NCT01171898|580510835|FG001|Overall Study|Withdrawal by Subject|4|||
160760545|NCT01171898|580510836|FG002|Overall Study|Withdrawal by Subject|6|||
160760546|NCT01171898|580510837|FG003|Overall Study|Withdrawal by Subject|3|||
160760547|NCT01171898|580510834|FG000|Overall Study|Terminated by Sponsor|1|||
160760548|NCT01171898|580510835|FG001|Overall Study|Terminated by Sponsor|0|||
160760549|NCT01171898|580510836|FG002|Overall Study|Terminated by Sponsor|0|||
160760550|NCT01171898|580510837|FG003|Overall Study|Terminated by Sponsor|0|||
160760551|NCT01171898|580510834|FG000|Overall Study|Ongoing|1|||
160760552|NCT01171898|580510835|FG001|Overall Study|Ongoing|9|||
160760553|NCT01171898|580510836|FG002|Overall Study|Ongoing|3|||
160760554|NCT01171898|580510837|FG003|Overall Study|Ongoing|0|||
160760555|NCT01171898|580510834|FG000|Overall Study|Other|1|||
160760556|NCT01171898|580510835|FG001|Overall Study|Other|5|||
160760557|NCT01171898|580510836|FG002|Overall Study|Other|0|||
160760558|NCT01171898|580510837|FG003|Overall Study|Other|2|||
160760559|NCT03191799|580510838|FG000|Overall Study|Withdrawal by Subject|4|||
160760560|NCT03191799|580510838|FG000|Overall Study|Physician Decision|2|||
160760561|NCT03191799|580510838|FG000|Overall Study|Lost to Follow-up|1|||
160760562|NCT03191799|580510838|FG000|Overall Study|Death|2|||
160760563|NCT00902577|580510839|FG000|Overall Study|Withdrawal by Subject|6|||
160760564|NCT00902577|580510839|FG000|Overall Study|FMISO production failure|2|||
160760565|NCT01232790|580510842|FG000|Randomization|Withdrawal by Subject|2|||
160760566|NCT01232790|580510843|FG001|Randomization|Withdrawal by Subject|0|||
160760567|NCT01232790|580510842|FG000|Randomization|Protocol Violation|0|||
160760568|NCT01232790|580510843|FG001|Randomization|Protocol Violation|1|||
160760569|NCT01232790|580510842|FG000|Randomization|Physician Decision|0|||
160760570|NCT01232790|580510843|FG001|Randomization|Physician Decision|1|||
160760571|NCT01232790|580510842|FG000|Initial Assessment|Withdrawal by Subject|0|||
160760572|NCT01232790|580510843|FG001|Initial Assessment|Withdrawal by Subject|1|||
160760573|NCT01232790|580510842|FG000|First Crossover|Withdrawal by Subject|1|||
160760574|NCT01232790|580510843|FG001|First Crossover|Withdrawal by Subject|0|||
160760575|NCT01232790|580510842|FG000|Second Crossover|Withdrawal by Subject|1|||
160760576|NCT01232790|580510843|FG001|Second Crossover|Withdrawal by Subject|2|||
160760577|NCT03769649|580510844|FG000|Overall Study|Lost to Follow-up|4|||
160760578|NCT03322293|580510845|FG000|Overall Study|Lost to Follow-up|0|||
160760579|NCT03322293|580510846|FG001|Overall Study|Lost to Follow-up|0|||
160760580|NCT03322293|580510847|FG002|Overall Study|Lost to Follow-up|1|||
160760581|NCT00083915|580510850|FG000|Overall Study|Death|6|||
160760582|NCT00083915|580510851|FG001|Overall Study|Death|3|||
160760583|NCT00083915|580510850|FG000|Overall Study|Physician Decision|11|||
160760584|NCT00083915|580510851|FG001|Overall Study|Physician Decision|6|||
160760585|NCT00083915|580510850|FG000|Overall Study|Withdrawal by Subject|8|||
160760586|NCT00083915|580510851|FG001|Overall Study|Withdrawal by Subject|3|||
160760587|NCT00083915|580510850|FG000|Overall Study|disease progression|18|||
160760588|NCT00083915|580510851|FG001|Overall Study|disease progression|23|||
160760589|NCT00083915|580510850|FG000|Overall Study|Failure to collect|3|||
160760590|NCT00083915|580510851|FG001|Overall Study|Failure to collect|0|||
160760591|NCT00083915|580510850|FG000|Overall Study|No response|3|||
160760592|NCT00083915|580510851|FG001|Overall Study|No response|1|||
160760593|NCT00083915|580510850|FG000|Overall Study|Insurance issues|1|||
160760594|NCT00083915|580510851|FG001|Overall Study|Insurance issues|1|||
160760595|NCT01290718|580510853|FG000|Overall Study|Early termination of the study|4|||
160760596|NCT01268267|580510854|FG000|Overall Study|Protocol Violation|1|||
160760597|NCT01222104|580510855|FG000|Overall Study|Lost to Follow-up|37|||
160760598|NCT01222104|580510855|FG000|Overall Study|Death|10|||
160760599|NCT02219685|580510856|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
160760600|NCT02219685|580510857|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
160760601|NCT02219685|580510856|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
160760602|NCT02219685|580510857|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
160760603|NCT04144322|580510859|FG000|Overall Study|Lack of Efficacy|2|||
160760604|NCT04144322|580510860|FG001|Overall Study|Lack of Efficacy|2|||
160760605|NCT00570401|580510866|FG000|Overall Study|Adverse Event|2|||
160760606|NCT01764841|580510867|FG000|Overall Study|Logistical Difficulties|0|||
160760607|NCT01764841|580510868|FG001|Overall Study|Logistical Difficulties|1|||
160760608|NCT01764841|580510869|FG002|Overall Study|Logistical Difficulties|0|||
160760609|NCT01764841|580510870|FG003|Overall Study|Logistical Difficulties|0|||
160760610|NCT01764841|580510867|FG000|Overall Study|Death|3|||
160760611|NCT01764841|580510868|FG001|Overall Study|Death|0|||
160760612|NCT01764841|580510869|FG002|Overall Study|Death|1|||
160760613|NCT01764841|580510870|FG003|Overall Study|Death|4|||
160760614|NCT01764841|580510867|FG000|Overall Study|No Follow Up|1|||
160760615|NCT01764841|580510868|FG001|Overall Study|No Follow Up|0|||
160760616|NCT01764841|580510869|FG002|Overall Study|No Follow Up|1|||
160760617|NCT01764841|580510870|FG003|Overall Study|No Follow Up|0|||
160760618|NCT01764841|580510867|FG000|Overall Study|Protocol Violation|0|||
160760619|NCT01764841|580510868|FG001|Overall Study|Protocol Violation|1|||
160760620|NCT01764841|580510869|FG002|Overall Study|Protocol Violation|0|||
160760621|NCT01764841|580510870|FG003|Overall Study|Protocol Violation|0|||
160760622|NCT01764841|580510867|FG000|Overall Study|Withdrawal by Subject|16|||
160760623|NCT01764841|580510868|FG001|Overall Study|Withdrawal by Subject|24|||
160760624|NCT01764841|580510869|FG002|Overall Study|Withdrawal by Subject|11|||
160760625|NCT01764841|580510870|FG003|Overall Study|Withdrawal by Subject|15|||
160760626|NCT01764841|580510867|FG000|Overall Study|Lost to Follow-up|3|||
160760627|NCT01764841|580510868|FG001|Overall Study|Lost to Follow-up|0|||
160760628|NCT01764841|580510869|FG002|Overall Study|Lost to Follow-up|1|||
160760629|NCT01764841|580510870|FG003|Overall Study|Lost to Follow-up|0|||
160760630|NCT00549549|580510871|FG000|Overall Study|Adverse Event|5|||
160760631|NCT00549549|580510872|FG001|Overall Study|Adverse Event|3|||
160760632|NCT00549549|580510873|FG002|Overall Study|Adverse Event|1|||
160760633|NCT00549549|580510874|FG003|Overall Study|Adverse Event|9|||
160760634|NCT00549549|580510871|FG000|Overall Study|Lack of Efficacy|9|||
160760635|NCT00549549|580510872|FG001|Overall Study|Lack of Efficacy|6|||
160760636|NCT00549549|580510873|FG002|Overall Study|Lack of Efficacy|4|||
160760637|NCT00549549|580510874|FG003|Overall Study|Lack of Efficacy|2|||
160760638|NCT00549549|580510871|FG000|Overall Study|Lost to Follow-up|1|||
160760639|NCT00549549|580510872|FG001|Overall Study|Lost to Follow-up|0|||
160760640|NCT00549549|580510873|FG002|Overall Study|Lost to Follow-up|1|||
160760641|NCT00549549|580510874|FG003|Overall Study|Lost to Follow-up|2|||
160760642|NCT00549549|580510871|FG000|Overall Study|Withdrawal by Subject|0|||
160760643|NCT00549549|580510872|FG001|Overall Study|Withdrawal by Subject|4|||
160760644|NCT00549549|580510873|FG002|Overall Study|Withdrawal by Subject|1|||
160760645|NCT00549549|580510874|FG003|Overall Study|Withdrawal by Subject|0|||
160760646|NCT00549549|580510871|FG000|Overall Study|Other|9|||
160760647|NCT00549549|580510872|FG001|Overall Study|Other|9|||
160760648|NCT00549549|580510873|FG002|Overall Study|Other|9|||
160760649|NCT00549549|580510874|FG003|Overall Study|Other|11|||
160760650|NCT00549549|580510871|FG000|Overall Study|Randomized but not treated|0|||
160760651|NCT00549549|580510872|FG001|Overall Study|Randomized but not treated|0|||
160760652|NCT00549549|580510873|FG002|Overall Study|Randomized but not treated|1|||
160760653|NCT00549549|580510874|FG003|Overall Study|Randomized but not treated|1|||
160760654|NCT02155699|580510875|FG000|Overall Study|Withdrawal by Subject|0|||
160760655|NCT02155699|580510876|FG001|Overall Study|Withdrawal by Subject|3|||
160760656|NCT02155699|580510877|FG002|Overall Study|Withdrawal by Subject|6|||
160760657|NCT02155699|580510878|FG003|Overall Study|Withdrawal by Subject|1|||
160760658|NCT02155699|580510875|FG000|Overall Study|Lost to Follow-up|0|||
160760659|NCT02155699|580510876|FG001|Overall Study|Lost to Follow-up|0|||
160760660|NCT02155699|580510877|FG002|Overall Study|Lost to Follow-up|0|||
160760661|NCT02155699|580510878|FG003|Overall Study|Lost to Follow-up|3|||
160760662|NCT02155699|580510875|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
160760663|NCT02155699|580510876|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
160760664|NCT02155699|580510877|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
160760665|NCT02155699|580510878|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
160760666|NCT05547386|580510879|FG000|Overall Study|Withdrawal by Subject|7|||
160760667|NCT02573259|580510888|FG000|Overall Study|Death|1|||
160760668|NCT02573259|580510889|FG001|Overall Study|Death|6|||
160760669|NCT02573259|580510890|FG002|Overall Study|Death|5|||
160760670|NCT02573259|580510891|FG003|Overall Study|Death|6|||
160760671|NCT02573259|580510892|FG004|Overall Study|Death|9|||
160760672|NCT02573259|580510893|FG005|Overall Study|Death|32|||
160760673|NCT02573259|580510894|FG006|Overall Study|Death|21|||
160760674|NCT02573259|580510888|FG000|Overall Study|Lost to Follow-up|0|||
160760675|NCT02573259|580510889|FG001|Overall Study|Lost to Follow-up|0|||
160760676|NCT02573259|580510890|FG002|Overall Study|Lost to Follow-up|0|||
160760677|NCT02573259|580510891|FG003|Overall Study|Lost to Follow-up|0|||
160760678|NCT02573259|580510892|FG004|Overall Study|Lost to Follow-up|0|||
160760679|NCT02573259|580510893|FG005|Overall Study|Lost to Follow-up|2|||
160760680|NCT02573259|580510894|FG006|Overall Study|Lost to Follow-up|1|||
160760681|NCT02573259|580510888|FG000|Overall Study|Participant refused further follow-up|0|||
160760682|NCT02573259|580510889|FG001|Overall Study|Participant refused further follow-up|2|||
160760683|NCT02573259|580510890|FG002|Overall Study|Participant refused further follow-up|1|||
160760684|NCT02573259|580510891|FG003|Overall Study|Participant refused further follow-up|0|||
160760685|NCT02573259|580510892|FG004|Overall Study|Participant refused further follow-up|3|||
160760686|NCT02573259|580510893|FG005|Overall Study|Participant refused further follow-up|20|||
160760687|NCT02573259|580510894|FG006|Overall Study|Participant refused further follow-up|7|||
160760688|NCT02573259|580510888|FG000|Overall Study|Other|0|||
160760689|NCT02573259|580510889|FG001|Overall Study|Other|0|||
160760690|NCT02573259|580510890|FG002|Overall Study|Other|0|||
160760691|NCT02573259|580510891|FG003|Overall Study|Other|0|||
160760692|NCT02573259|580510892|FG004|Overall Study|Other|1|||
160760693|NCT02573259|580510893|FG005|Overall Study|Other|4|||
160760694|NCT02573259|580510894|FG006|Overall Study|Other|5|||
160760695|NCT00751140|580510895|FG000|Overall Study|benign angioma excluded from analysis|1|||
160760696|NCT03160716|580510896|FG000|Overall Study|Lost to Follow-up|1|||
160760697|NCT01628848|580510897|FG000|Overall Study|Adverse Event|9|||
160760698|NCT01628848|580510898|FG001|Overall Study|Adverse Event|7|||
160760699|NCT01628848|580510897|FG000|Overall Study|Lack of Efficacy|0|||
160760700|NCT01628848|580510898|FG001|Overall Study|Lack of Efficacy|4|||
160760701|NCT01628848|580510897|FG000|Overall Study|Withdrawal by Subject|0|||
160760702|NCT01628848|580510898|FG001|Overall Study|Withdrawal by Subject|2|||
160760703|NCT01628848|580510897|FG000|Overall Study|Physician Decision|3|||
160760704|NCT01628848|580510898|FG001|Overall Study|Physician Decision|1|||
160760705|NCT00689338|580510900|FG000|Overall Study|Death|65|||
160760706|NCT00689338|580510900|FG000|Overall Study|Adverse Event|13|||
160760707|NCT00689338|580510900|FG000|Overall Study|Insufficient Clinical Response|1|||
160760708|NCT00689338|580510900|FG000|Overall Study|Lack of Efficacy|6|||
160760709|NCT00689338|580510900|FG000|Overall Study|Other|8|||
160760710|NCT00689338|580510900|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
160760711|NCT00689338|580510900|FG000|Overall Study|Lost to Follow-up|5|||
160760712|NCT00689338|580510900|FG000|Overall Study|Withdrawal by Subject|3|||
160760713|NCT00689338|580510900|FG000|Overall Study|Protocol Violation|15|||
160760714|NCT00808067|580510901|FG000|Overall Study|Major/minor bleed|30|||
160760715|NCT00808067|580510902|FG001|Overall Study|Major/minor bleed|44|||
160760716|NCT00808067|580510901|FG000|Overall Study|Outcome event - other|33|||
160760717|NCT00808067|580510902|FG001|Overall Study|Outcome event - other|25|||
160760718|NCT00808067|580510901|FG000|Overall Study|Adverse Event|111|||
160760719|NCT00808067|580510902|FG001|Overall Study|Adverse Event|121|||
160760720|NCT00808067|580510901|FG000|Overall Study|Hospitalization (not including surgery)|18|||
160760721|NCT00808067|580510902|FG001|Overall Study|Hospitalization (not including surgery)|17|||
160760722|NCT00808067|580510901|FG000|Overall Study|Hospitalization due to surgery|37|||
160760723|NCT00808067|580510902|FG001|Overall Study|Hospitalization due to surgery|40|||
160760724|NCT00808067|580510901|FG000|Overall Study|Reduced creatinine clearance|53|||
160760725|NCT00808067|580510902|FG001|Overall Study|Reduced creatinine clearance|55|||
160760726|NCT00808067|580510901|FG000|Overall Study|Elevated LFT results|7|||
160760727|NCT00808067|580510902|FG001|Overall Study|Elevated LFT results|3|||
160760728|NCT00808067|580510901|FG000|Overall Study|Patient refused to take study medication|65|||
160760729|NCT00808067|580510902|FG001|Overall Study|Patient refused to take study medication|76|||
160760730|NCT00808067|580510901|FG000|Overall Study|Missing|1|||
160760731|NCT00808067|580510902|FG001|Overall Study|Missing|0|||
160760732|NCT00808067|580510901|FG000|Overall Study|Death|1|||
160760733|NCT00808067|580510902|FG001|Overall Study|Death|1|||
160760734|NCT00808067|580510901|FG000|Overall Study|Procedure|6|||
160760735|NCT00808067|580510902|FG001|Overall Study|Procedure|7|||
160760736|NCT00808067|580510901|FG000|Overall Study|Withdrawal by Subject|21|||
160760737|NCT00808067|580510902|FG001|Overall Study|Withdrawal by Subject|25|||
160760738|NCT00808067|580510901|FG000|Overall Study|Site closed|4|||
160760739|NCT00808067|580510902|FG001|Overall Study|Site closed|3|||
160760740|NCT00808067|580510901|FG000|Overall Study|Physician Decision|47|||
160760741|NCT00808067|580510902|FG001|Overall Study|Physician Decision|38|||
160760742|NCT00808067|580510901|FG000|Overall Study|Protocol Violation|3|||
160760743|NCT00808067|580510902|FG001|Overall Study|Protocol Violation|11|||
160760744|NCT00808067|580510901|FG000|Overall Study|Patient elected|7|||
160760745|NCT00808067|580510902|FG001|Overall Study|Patient elected|9|||
160760746|NCT00808067|580510901|FG000|Overall Study|Site closed for cause|19|||
160760747|NCT00808067|580510902|FG001|Overall Study|Site closed for cause|19|||
160760748|NCT00808067|580510901|FG000|Overall Study|Other reason not defined above|5|||
160760749|NCT00808067|580510902|FG001|Overall Study|Other reason not defined above|5|||
160760750|NCT00808067|580510901|FG000|Overall Study|Excluded from analysis|13|||
160760751|NCT00808067|580510902|FG001|Overall Study|Excluded from analysis|19|||
160760752|NCT01939314|580510903|FG000|Overall Study|Withdrawal by Subject|3|||
160760753|NCT01939314|580510904|FG001|Overall Study|Withdrawal by Subject|1|||
160760754|NCT01939314|580510903|FG000|Overall Study|Protocol Violation|1|||
160760755|NCT01939314|580510904|FG001|Overall Study|Protocol Violation|0|||
160760756|NCT01939314|580510903|FG000|Overall Study|Pregnancy|0|||
160760757|NCT01939314|580510904|FG001|Overall Study|Pregnancy|1|||
160760758|NCT01939314|580510903|FG000|Overall Study|Lost to Follow-up|5|||
160760759|NCT01939314|580510904|FG001|Overall Study|Lost to Follow-up|6|||
160760760|NCT02104895|580510907|FG000|Overall Study|Withdrawal by Subject|0|||
160760761|NCT02104895|580510908|FG001|Overall Study|Withdrawal by Subject|14|||
160760762|NCT00969228|580510913|FG000|Overall Study|Adverse Event|1|||
160760763|NCT00969228|580510914|FG001|Overall Study|Adverse Event|0|||
160760764|NCT00969228|580510913|FG000|Overall Study|Withdrawal by Subject|4|||
160760765|NCT00969228|580510914|FG001|Overall Study|Withdrawal by Subject|0|||
160760766|NCT00969228|580510913|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
160760767|NCT00969228|580510914|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
160760768|NCT01107925|580510916|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
160760769|NCT01107925|580510917|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
160760770|NCT01107925|580510918|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
160760771|NCT01107925|580510919|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
160760772|NCT01107925|580510920|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
160760773|NCT01107925|580510921|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
160760774|NCT01107925|580510916|FG000|Period 2|Withdrawal by Subject|0|||
160760775|NCT01107925|580510917|FG001|Period 2|Withdrawal by Subject|1|||
160760776|NCT01107925|580510918|FG002|Period 2|Withdrawal by Subject|0|||
160760777|NCT01107925|580510919|FG003|Period 2|Withdrawal by Subject|0|||
160760778|NCT01107925|580510920|FG004|Period 2|Withdrawal by Subject|0|||
160760779|NCT01107925|580510921|FG005|Period 2|Withdrawal by Subject|1|||
160760780|NCT03311945|580510922|FG000|Overall Study|Adverse Event|2|||
160760781|NCT03311945|580510922|FG000|Overall Study|Lack of Efficacy|1|||
160760782|NCT04235504|580510923|FG000|Study Phase|Withdrawal by Subject|5|||
160760783|NCT04235504|580510924|FG001|Study Phase|Withdrawal by Subject|2|||
160760784|NCT04235504|580510925|FG002|Study Phase|Withdrawal by Subject|0|||
160760785|NCT04235504|580510926|FG003|Study Phase|Withdrawal by Subject|0|||
160760786|NCT04235504|580510923|FG000|Continuation Phase|Withdrawal by Subject|0|||
160760787|NCT04235504|580510924|FG001|Continuation Phase|Withdrawal by Subject|4|||
160526744|NCT01641809|579659207|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
160526745|NCT01641809|579659208|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
160526746|NCT01641809|579659209|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
160526747|NCT01641809|579659210|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
160526748|NCT01641809|579659207|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
160526749|NCT01641809|579659208|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
160526750|NCT01641809|579659209|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
160526751|NCT01641809|579659210|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
160526752|NCT01641809|579659207|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
160526753|NCT01641809|579659208|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
160526754|NCT01641809|579659209|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
160526755|NCT01641809|579659210|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
160526756|NCT01641809|579659207|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
160526757|NCT01641809|579659208|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
160526758|NCT01641809|579659209|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
160526759|NCT01641809|579659210|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
160526760|NCT01641809|579659207|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
160526761|NCT01641809|579659208|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
160526762|NCT01641809|579659209|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
160526763|NCT01641809|579659210|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
160526764|NCT01641809|579659207|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
160526765|NCT01641809|579659208|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
160760788|NCT04235504|580510925|FG002|Continuation Phase|Withdrawal by Subject|0|||
160760789|NCT04235504|580510926|FG003|Continuation Phase|Withdrawal by Subject|0|||
160760790|NCT04235504|580510923|FG000|Continuation Phase|Adverse Event|0|||
160760791|NCT04235504|580510924|FG001|Continuation Phase|Adverse Event|1|||
160760792|NCT04235504|580510925|FG002|Continuation Phase|Adverse Event|0|||
160760793|NCT04235504|580510926|FG003|Continuation Phase|Adverse Event|0|||
160760794|NCT04235504|580510923|FG000|Continuation Phase|Physician Decision|1|||
160760795|NCT04235504|580510924|FG001|Continuation Phase|Physician Decision|2|||
160760796|NCT04235504|580510925|FG002|Continuation Phase|Physician Decision|1|||
160760797|NCT04235504|580510926|FG003|Continuation Phase|Physician Decision|0|||
160760798|NCT04877990|580510927|FG000|Treatment|Other reasons|3|||
160760799|NCT04877990|580510928|FG001|Treatment|Other reasons|1|||
160760800|NCT04877990|580510927|FG000|Treatment|Administrative reasons by sponsor|17|||
160760801|NCT04877990|580510928|FG001|Treatment|Administrative reasons by sponsor|33|||
160760802|NCT04877990|580510927|FG000|Treatment|Withdrawal by Subject|2|||
160760803|NCT04877990|580510928|FG001|Treatment|Withdrawal by Subject|6|||
160760804|NCT04877990|580510927|FG000|Treatment|Adverse Event|2|||
160760805|NCT04877990|580510928|FG001|Treatment|Adverse Event|1|||
160760806|NCT02895295|580510929|FG000|Overall Study|Survey Non-response|71|||
160760807|NCT02895295|580510930|FG001|Overall Study|Survey Non-response|94|||
160760808|NCT02895295|580510931|FG002|Overall Study|Survey Non-response|92|||
160760809|NCT02532283|580510939|FG000|Overall Study|Adverse Event|0|||
160760810|NCT02532283|580510940|FG001|Overall Study|Adverse Event|1|||
160760811|NCT02532283|580510939|FG000|Overall Study|Death|1|||
160760812|NCT02532283|580510940|FG001|Overall Study|Death|0|||
160760813|NCT02532283|580510939|FG000|Overall Study|Lost to Follow-up|0|||
160526766|NCT01641809|579659209|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
160526767|NCT01641809|579659210|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
160760814|NCT02532283|580510940|FG001|Overall Study|Lost to Follow-up|1|||
160760815|NCT02532283|580510939|FG000|Overall Study|Withdrawal by Subject|8|||
160760816|NCT02532283|580510940|FG001|Overall Study|Withdrawal by Subject|3|||
160760817|NCT01945944|580510941|FG000|Overall Study|Adverse Event|0|||
160760818|NCT01945944|580510942|FG001|Overall Study|Adverse Event|2|||
160760819|NCT01945944|580510941|FG000|Overall Study|Physician Decision|1|||
160760820|NCT01945944|580510942|FG001|Overall Study|Physician Decision|0|||
160760821|NCT01945944|580510941|FG000|Overall Study|Withdrawal by Subject|0|||
160760822|NCT01945944|580510942|FG001|Overall Study|Withdrawal by Subject|1|||
160760823|NCT01817075|580510943|FG000|Overall Study|Adverse Event|7|||
160760824|NCT01817075|580510944|FG001|Overall Study|Adverse Event|5|||
160526768|NCT01641809|579659207|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
160526769|NCT01641809|579659208|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
160526770|NCT01641809|579659209|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
160526771|NCT01641809|579659210|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
160526772|NCT01641809|579659207|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
160526773|NCT01641809|579659208|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
160526774|NCT01641809|579659209|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
160760825|NCT01817075|580510943|FG000|Overall Study|Physician Decision|9|||
160760826|NCT01817075|580510944|FG001|Overall Study|Physician Decision|12|||
160760827|NCT01817075|580510943|FG000|Overall Study|Withdrawal by Subject|31|||
160760828|NCT01817075|580510944|FG001|Overall Study|Withdrawal by Subject|15|||
160760829|NCT01817075|580510943|FG000|Overall Study|Received Sorafenib after enrollment|0|||
160760830|NCT01817075|580510944|FG001|Overall Study|Received Sorafenib after enrollment|1|||
160760831|NCT01817075|580510943|FG000|Overall Study|Ineligible|0|||
160760832|NCT01817075|580510944|FG001|Overall Study|Ineligible|2|||
160760833|NCT04376515|580510945|FG000|Overall Study|Found to have been vaccinated before study start|6|||
160760834|NCT04376515|580510946|FG001|Overall Study|Found to have been vaccinated before study start|6|||
160760835|NCT03811821|580510947|FG000|Overall Study|Adverse Event|1|||
160760836|NCT03811821|580510948|FG001|Overall Study|Adverse Event|1|||
160760837|NCT03811821|580510947|FG000|Overall Study|Withdrawal by Subject|5|||
160760838|NCT03811821|580510948|FG001|Overall Study|Withdrawal by Subject|4|||
160760839|NCT03811821|580510947|FG000|Overall Study|Lost to Follow-up|2|||
160760840|NCT03811821|580510948|FG001|Overall Study|Lost to Follow-up|2|||
160760841|NCT03811821|580510947|FG000|Overall Study|Contraindication for treatment|0|||
160760842|NCT03811821|580510948|FG001|Overall Study|Contraindication for treatment|1|||
160760843|NCT03811821|580510947|FG000|Overall Study|Tolerability|0|||
160760844|NCT03811821|580510948|FG001|Overall Study|Tolerability|3|||
160760845|NCT03811821|580510947|FG000|Overall Study|Comorbidities|0|||
160760846|NCT03811821|580510948|FG001|Overall Study|Comorbidities|2|||
160760847|NCT04157517|580510949|FG000|Overall Study|Death|1|||
160760848|NCT04157517|580510950|FG001|Overall Study|Death|2|||
160760849|NCT04157517|580510951|FG002|Overall Study|Death|2|||
160760850|NCT04157517|580510952|FG003|Overall Study|Death|3|||
160760851|NCT04157517|580510953|FG004|Overall Study|Death|3|||
160760852|NCT04157517|580510954|FG005|Overall Study|Death|4|||
160760853|NCT04157517|580510955|FG006|Overall Study|Death|1|||
160760854|NCT04157517|580510956|FG007|Overall Study|Death|2|||
160760855|NCT04157517|580510957|FG008|Overall Study|Death|4|||
160760856|NCT04157517|580510958|FG009|Overall Study|Death|0|||
160760857|NCT04157517|580510949|FG000|Overall Study|Withdrawal by Subject|1|||
160760858|NCT04157517|580510950|FG001|Overall Study|Withdrawal by Subject|1|||
160760859|NCT04157517|580510951|FG002|Overall Study|Withdrawal by Subject|1|||
160760860|NCT04157517|580510952|FG003|Overall Study|Withdrawal by Subject|0|||
160760861|NCT04157517|580510953|FG004|Overall Study|Withdrawal by Subject|0|||
160760862|NCT04157517|580510954|FG005|Overall Study|Withdrawal by Subject|1|||
160760863|NCT04157517|580510955|FG006|Overall Study|Withdrawal by Subject|0|||
160760864|NCT04157517|580510956|FG007|Overall Study|Withdrawal by Subject|0|||
160760865|NCT04157517|580510957|FG008|Overall Study|Withdrawal by Subject|1|||
160760866|NCT04157517|580510958|FG009|Overall Study|Withdrawal by Subject|0|||
160760867|NCT04157517|580510949|FG000|Overall Study|Other|1|||
160760868|NCT04157517|580510950|FG001|Overall Study|Other|0|||
160760869|NCT04157517|580510951|FG002|Overall Study|Other|0|||
160760870|NCT04157517|580510952|FG003|Overall Study|Other|0|||
160760871|NCT04157517|580510953|FG004|Overall Study|Other|0|||
160760872|NCT04157517|580510954|FG005|Overall Study|Other|1|||
160760873|NCT04157517|580510955|FG006|Overall Study|Other|2|||
160760874|NCT04157517|580510956|FG007|Overall Study|Other|7|||
160760875|NCT04157517|580510957|FG008|Overall Study|Other|7|||
160760876|NCT04157517|580510958|FG009|Overall Study|Other|0|||
160760877|NCT03433898|580510961|FG000|Overall Study|Progressive disease|6|||
160760878|NCT03433898|580510962|FG001|Overall Study|Progressive disease|3|||
160526775|NCT01641809|579659210|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
160526776|NCT01641809|579659207|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
160526777|NCT01641809|579659208|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
160760879|NCT03433898|580510963|FG002|Overall Study|Progressive disease|3|||
160760880|NCT03433898|580510964|FG003|Overall Study|Progressive disease|2|||
160760881|NCT03433898|580510965|FG004|Overall Study|Progressive disease|30|||
160760882|NCT03433898|580510966|FG005|Overall Study|Progressive disease|29|||
160760883|NCT03433898|580510967|FG006|Overall Study|Progressive disease|17|||
160760884|NCT03433898|580510968|FG007|Overall Study|Progressive disease|30|||
160760885|NCT03433898|580510961|FG000|Overall Study|Not treated|1|||
160760886|NCT03433898|580510962|FG001|Overall Study|Not treated|0|||
160760887|NCT03433898|580510963|FG002|Overall Study|Not treated|0|||
160760888|NCT03433898|580510964|FG003|Overall Study|Not treated|0|||
160760889|NCT03433898|580510965|FG004|Overall Study|Not treated|1|||
160760890|NCT03433898|580510966|FG005|Overall Study|Not treated|0|||
160760891|NCT03433898|580510967|FG006|Overall Study|Not treated|0|||
160760892|NCT03433898|580510968|FG007|Overall Study|Not treated|0|||
160760893|NCT03433898|580510961|FG000|Overall Study|Death|0|||
160760894|NCT03433898|580510962|FG001|Overall Study|Death|0|||
160760895|NCT03433898|580510963|FG002|Overall Study|Death|0|||
160760896|NCT03433898|580510964|FG003|Overall Study|Death|0|||
160760897|NCT03433898|580510965|FG004|Overall Study|Death|0|||
160760898|NCT03433898|580510966|FG005|Overall Study|Death|0|||
160760899|NCT03433898|580510967|FG006|Overall Study|Death|1|||
160760900|NCT03433898|580510968|FG007|Overall Study|Death|1|||
160526778|NCT01641809|579659209|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
160526779|NCT01641809|579659210|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
160526780|NCT01641809|579659207|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
160526781|NCT01641809|579659208|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
160526782|NCT01641809|579659209|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
160526783|NCT01641809|579659210|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
160526784|NCT01641809|579659207|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
160526785|NCT01641809|579659208|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
160526786|NCT01641809|579659209|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
160526787|NCT01641809|579659210|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
160526788|NCT01641809|579659207|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
160526789|NCT01641809|579659208|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
160526790|NCT01641809|579659209|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
160526791|NCT01641809|579659210|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
160526792|NCT01641809|579659207|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
160526793|NCT01641809|579659208|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
160526794|NCT01641809|579659209|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
160526795|NCT01641809|579659210|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
160526796|NCT01641809|579659207|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
160526797|NCT01641809|579659208|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
160526798|NCT01641809|579659209|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
160526799|NCT01641809|579659210|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
160526800|NCT01641809|579659207|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
160526801|NCT01641809|579659208|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
160526802|NCT01641809|579659209|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
160526803|NCT01641809|579659210|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
160526804|NCT04195581|579659211|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
160526805|NCT04195581|579659211|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
160526806|NCT04195581|579659211|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
160526807|NCT04195581|579659211|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
160526808|NCT04195581|579659211|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
160526809|NCT04195581|579659211|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
160526810|NCT00821431|579659212|FG000|Overall Study|Adverse Event|6|||
160526811|NCT00821431|579659213|FG001|Overall Study|Adverse Event|3|||
160526812|NCT00821431|579659212|FG000|Overall Study|Withdrawal by Subject|5|||
160526813|NCT00821431|579659213|FG001|Overall Study|Withdrawal by Subject|0|||
160526814|NCT00821431|579659212|FG000|Overall Study|Lost to Follow-up|1|||
160526815|NCT00821431|579659213|FG001|Overall Study|Lost to Follow-up|0|||
160526816|NCT00821431|579659212|FG000|Overall Study|Protocol Violation|3|||
160526817|NCT00821431|579659213|FG001|Overall Study|Protocol Violation|1|||
160526818|NCT00821431|579659212|FG000|Overall Study|Physician Decision|0|||
160526819|NCT00821431|579659213|FG001|Overall Study|Physician Decision|1|||
160526820|NCT01699789|579659217|FG000|Overall Study|Withdrawal by Subject|18|||
160526821|NCT01699789|579659218|FG001|Overall Study|Withdrawal by Subject|23|||
160526822|NCT01699789|579659217|FG000|Overall Study|Death|1|||
160526823|NCT01699789|579659218|FG001|Overall Study|Death|2|||
160526824|NCT01699789|579659217|FG000|Overall Study|Lost to Follow-up|83|||
160526825|NCT01699789|579659218|FG001|Overall Study|Lost to Follow-up|101|||
160526826|NCT00639223|579659220|FG000|Overall Study|Lost to Follow-up|0|||
160526827|NCT00639223|579659221|FG001|Overall Study|Lost to Follow-up|2|||
160526828|NCT02511678|579659222|FG000|Overall Study|Withdrawal by Subject|2|||
160526829|NCT02511678|579659222|FG000|Overall Study|Lost to Follow-up|4|||
160526830|NCT02511678|579659222|FG000|Overall Study|Death|19|||
160526831|NCT02511678|579659222|FG000|Overall Study|Adverse Event|1|||
160526832|NCT02511678|579659222|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
160526833|NCT02511678|579659222|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
160526834|NCT02511678|579659222|FG000|Overall Study|Required Radiofrequency Ablation|1|||
160526835|NCT02511678|579659222|FG000|Overall Study|Biopsy was Negative|1|||
160526836|NCT02511678|579659222|FG000|Overall Study|Protocol Violation|1|||
160526837|NCT02511678|579659222|FG000|Overall Study|Received Radiation Treatment|1|||
160526838|NCT05125679|579659227|FG000|Overall Study|Study Terminated by Sponsor|2|||
160526839|NCT05125679|579659228|FG001|Overall Study|Study Terminated by Sponsor|5|||
160526840|NCT06268288|579659231|FG000|Overall Study|Withdrawal by Subject|1|||
160526841|NCT06268288|579659232|FG001|Overall Study|Withdrawal by Subject|2|||
160526842|NCT03049735|579659235|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
160526843|NCT03049735|579659236|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
160526844|NCT03049735|579659237|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
160526845|NCT03049735|579659235|FG000|Overall Study|Other|5|||
160526846|NCT03049735|579659236|FG001|Overall Study|Other|3|||
160526847|NCT03049735|579659237|FG002|Overall Study|Other|1|||
160526848|NCT03049735|579659235|FG000|Overall Study|Lack of Efficacy|4|||
160526849|NCT03049735|579659236|FG001|Overall Study|Lack of Efficacy|0|||
160526850|NCT03049735|579659237|FG002|Overall Study|Lack of Efficacy|3|||
160526851|NCT03049735|579659235|FG000|Overall Study|Protocol deviation|1|||
160526852|NCT03049735|579659236|FG001|Overall Study|Protocol deviation|0|||
160526853|NCT03049735|579659237|FG002|Overall Study|Protocol deviation|0|||
160760901|NCT03433898|580510961|FG000|Overall Study|Withdrawal by Subject|0|||
160760902|NCT03433898|580510962|FG001|Overall Study|Withdrawal by Subject|0|||
160760903|NCT03433898|580510963|FG002|Overall Study|Withdrawal by Subject|0|||
160760904|NCT03433898|580510964|FG003|Overall Study|Withdrawal by Subject|0|||
160760905|NCT03433898|580510965|FG004|Overall Study|Withdrawal by Subject|2|||
160760906|NCT03433898|580510966|FG005|Overall Study|Withdrawal by Subject|0|||
160760907|NCT03433898|580510967|FG006|Overall Study|Withdrawal by Subject|0|||
160760908|NCT03433898|580510968|FG007|Overall Study|Withdrawal by Subject|0|||
160760909|NCT03433898|580510961|FG000|Overall Study|Adverse Event|0|||
160760910|NCT03433898|580510962|FG001|Overall Study|Adverse Event|0|||
160760911|NCT03433898|580510963|FG002|Overall Study|Adverse Event|0|||
160760912|NCT03433898|580510964|FG003|Overall Study|Adverse Event|0|||
160760913|NCT03433898|580510965|FG004|Overall Study|Adverse Event|0|||
160760914|NCT03433898|580510966|FG005|Overall Study|Adverse Event|5|||
160760915|NCT03433898|580510967|FG006|Overall Study|Adverse Event|2|||
160760916|NCT03433898|580510968|FG007|Overall Study|Adverse Event|2|||
160760917|NCT03433898|580510961|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
160760918|NCT03433898|580510962|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
160760919|NCT03433898|580510963|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
160760920|NCT03433898|580510964|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
160760921|NCT03433898|580510965|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
160760922|NCT03433898|580510966|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
160760923|NCT03433898|580510967|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
160760924|NCT03433898|580510968|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
160760925|NCT01395810|580510973|FG000|Overall Study|Adverse Event|0|||
160760926|NCT01395810|580510974|FG001|Overall Study|Adverse Event|1|||
160760927|NCT01395810|580510975|FG002|Overall Study|Adverse Event|0|||
160760928|NCT01395810|580510976|FG003|Overall Study|Adverse Event|0|||
160760929|NCT01395810|580510973|FG000|Overall Study|Lack of Efficacy|0|||
160760930|NCT01395810|580510974|FG001|Overall Study|Lack of Efficacy|1|||
160760931|NCT01395810|580510975|FG002|Overall Study|Lack of Efficacy|0|||
160760932|NCT01395810|580510976|FG003|Overall Study|Lack of Efficacy|0|||
160760933|NCT01395810|580510973|FG000|Overall Study|Withdrawal criteria|0|||
160760934|NCT01395810|580510974|FG001|Overall Study|Withdrawal criteria|2|||
160760935|NCT01395810|580510975|FG002|Overall Study|Withdrawal criteria|0|||
160760936|NCT01395810|580510976|FG003|Overall Study|Withdrawal criteria|0|||
160760937|NCT01395810|580510973|FG000|Overall Study|Unclassified|2|||
160760938|NCT01395810|580510974|FG001|Overall Study|Unclassified|0|||
160760939|NCT01395810|580510975|FG002|Overall Study|Unclassified|0|||
160760940|NCT01395810|580510976|FG003|Overall Study|Unclassified|0|||
160760941|NCT01496976|580512050|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
160760942|NCT04579380|580512051|FG000|Overall Study|Death|9|||
160760943|NCT04579380|580512052|FG001|Overall Study|Death|22|||
160760944|NCT04579380|580512053|FG002|Overall Study|Death|22|||
160760945|NCT04579380|580512054|FG003|Overall Study|Death|17|||
160760946|NCT04579380|580512055|FG004|Overall Study|Death|6|||
160760947|NCT04579380|580512056|FG005|Overall Study|Death|21|||
160760948|NCT04579380|580512057|FG006|Overall Study|Death|10|||
160760949|NCT04579380|580512058|FG007|Overall Study|Death|11|||
160760950|NCT04579380|580512059|FG008|Overall Study|Death|25|||
160760951|NCT04579380|580512051|FG000|Overall Study|Withdrawal by Subject|0|||
160760952|NCT04579380|580512052|FG001|Overall Study|Withdrawal by Subject|3|||
160760953|NCT04579380|580512053|FG002|Overall Study|Withdrawal by Subject|4|||
160760954|NCT04579380|580512054|FG003|Overall Study|Withdrawal by Subject|0|||
160760955|NCT04579380|580512055|FG004|Overall Study|Withdrawal by Subject|1|||
160526854|NCT03049735|579659235|FG000|Overall Study|Pregnancy|0|||
160526855|NCT03049735|579659236|FG001|Overall Study|Pregnancy|0|||
160526856|NCT03049735|579659237|FG002|Overall Study|Pregnancy|1|||
160526857|NCT03049735|579659235|FG000|Overall Study|Adverse Event|7|||
160526858|NCT03049735|579659236|FG001|Overall Study|Adverse Event|18|||
160526859|NCT03049735|579659237|FG002|Overall Study|Adverse Event|5|||
160526860|NCT03049735|579659235|FG000|Overall Study|Withdrawal by Subject|10|||
160526861|NCT03049735|579659236|FG001|Overall Study|Withdrawal by Subject|3|||
160760956|NCT04579380|580512056|FG005|Overall Study|Withdrawal by Subject|2|||
160760957|NCT04579380|580512057|FG006|Overall Study|Withdrawal by Subject|0|||
160760958|NCT04579380|580512058|FG007|Overall Study|Withdrawal by Subject|1|||
160760959|NCT04579380|580512059|FG008|Overall Study|Withdrawal by Subject|2|||
160760960|NCT04579380|580512051|FG000|Overall Study|Ongoing|2|||
160526862|NCT03049735|579659237|FG002|Overall Study|Withdrawal by Subject|7|||
160526863|NCT03049735|579659235|FG000|Overall Study|Lost to Follow-up|1|||
160760961|NCT04579380|580512052|FG001|Overall Study|Ongoing|6|||
160760962|NCT04579380|580512053|FG002|Overall Study|Ongoing|4|||
160760963|NCT04579380|580512054|FG003|Overall Study|Ongoing|8|||
160760964|NCT04579380|580512055|FG004|Overall Study|Ongoing|5|||
160760965|NCT04579380|580512056|FG005|Overall Study|Ongoing|8|||
160760966|NCT04579380|580512057|FG006|Overall Study|Ongoing|3|||
160760967|NCT04579380|580512058|FG007|Overall Study|Ongoing|19|||
160760968|NCT04579380|580512059|FG008|Overall Study|Ongoing|6|||
160760969|NCT04113694|580512061|FG000|Overall Study|Adverse Event|2|||
160760970|NCT04113694|580512061|FG000|Overall Study|Lost to Follow-up|2|||
160760971|NCT04113694|580512061|FG000|Overall Study|Withdrawal by Subject|6|||
160760972|NCT04113694|580512061|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
160760973|NCT00830219|580512067|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
160760974|NCT00830219|580512068|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
160760975|NCT00641056|580512069|FG000|Overall Study|Adverse Event|12|||
160760976|NCT00641056|580512070|FG001|Overall Study|Adverse Event|2|||
160760977|NCT00641056|580512069|FG000|Overall Study|Lost to Follow-up|2|||
160760978|NCT00641056|580512070|FG001|Overall Study|Lost to Follow-up|1|||
160760979|NCT00641056|580512069|FG000|Overall Study|Physician Decision|3|||
160760980|NCT00641056|580512070|FG001|Overall Study|Physician Decision|1|||
160760981|NCT00641056|580512069|FG000|Overall Study|Protocol Violation|2|||
160760982|NCT00641056|580512070|FG001|Overall Study|Protocol Violation|0|||
160760983|NCT00641056|580512069|FG000|Overall Study|Entry Criteria Not Met|3|||
160760984|NCT00641056|580512070|FG001|Overall Study|Entry Criteria Not Met|0|||
160760985|NCT00641056|580512069|FG000|Overall Study|Subject Decision|6|||
160760986|NCT00641056|580512070|FG001|Overall Study|Subject Decision|19|||
160760987|NCT00641056|580512069|FG000|Overall Study|Sponsor Decision|1|||
160760988|NCT00641056|580512070|FG001|Overall Study|Sponsor Decision|2|||
160760989|NCT00239720|580512074|FG000|Overall Study|Adverse Event|1|||
160760990|NCT00239720|580512075|FG001|Overall Study|Adverse Event|0|||
160760991|NCT00239720|580512074|FG000|Overall Study|Lost to Follow-up|0|||
160760992|NCT00239720|580512075|FG001|Overall Study|Lost to Follow-up|1|||
160760993|NCT01811732|580512078|FG000|Overall Study|Lost to Follow-up|24|||
160760994|NCT01811732|580512079|FG001|Overall Study|Lost to Follow-up|30|||
160760995|NCT01811732|580512078|FG000|Overall Study|Withdrawal by Subject|16|||
160760996|NCT01811732|580512079|FG001|Overall Study|Withdrawal by Subject|10|||
160760997|NCT01811732|580512078|FG000|Overall Study|Adverse Event|3|||
160760998|NCT01811732|580512079|FG001|Overall Study|Adverse Event|9|||
160760999|NCT01811732|580512078|FG000|Overall Study|Lack of Efficacy|3|||
160761000|NCT01811732|580512079|FG001|Overall Study|Lack of Efficacy|1|||
160761001|NCT01811732|580512078|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
160761002|NCT01811732|580512079|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
160761003|NCT01811732|580512078|FG000|Overall Study|Physician Decision|2|||
160761004|NCT01811732|580512079|FG001|Overall Study|Physician Decision|0|||
160761005|NCT01811732|580512078|FG000|Overall Study|Death|1|||
160761006|NCT01811732|580512079|FG001|Overall Study|Death|1|||
160761007|NCT01811732|580512078|FG000|Overall Study|Insufficient venous access|0|||
160761008|NCT01811732|580512079|FG001|Overall Study|Insufficient venous access|1|||
160761009|NCT01811732|580512078|FG000|Overall Study|Protocol Violation|0|||
160761010|NCT01811732|580512079|FG001|Overall Study|Protocol Violation|1|||
160761011|NCT01811732|580512078|FG000|Overall Study|Subject incarcerated|1|||
160761012|NCT01811732|580512079|FG001|Overall Study|Subject incarcerated|2|||
160761013|NCT01811732|580512078|FG000|Overall Study|Admitted to another facility|1|||
160761014|NCT01811732|580512079|FG001|Overall Study|Admitted to another facility|0|||
160761015|NCT01811732|580512078|FG000|Overall Study|Correct study drug not available on site|1|||
160761016|NCT01811732|580512079|FG001|Overall Study|Correct study drug not available on site|0|||
160761017|NCT00896493|580512080|FG000|Overall Study|Early disease relapse|3|||
160761018|NCT00536510|580512081|FG000|Overall Study|Adverse Event|27|||
160761019|NCT00536510|580512082|FG001|Overall Study|Adverse Event|4|||
160761020|NCT00536510|580512081|FG000|Overall Study|Lost to Follow-up|11|||
160761021|NCT00536510|580512082|FG001|Overall Study|Lost to Follow-up|8|||
160761022|NCT00536510|580512081|FG000|Overall Study|Protocol Violation|4|||
160761023|NCT00536510|580512082|FG001|Overall Study|Protocol Violation|5|||
160761024|NCT00536510|580512081|FG000|Overall Study|Withdrawal by Subject|16|||
160761025|NCT00536510|580512082|FG001|Overall Study|Withdrawal by Subject|9|||
160761026|NCT00536510|580512081|FG000|Overall Study|Flushing with Product|20|||
160761027|NCT00536510|580512082|FG001|Overall Study|Flushing with Product|0|||
160761028|NCT00536510|580512081|FG000|Overall Study|Laboratory Adverse Event|2|||
160761029|NCT00536510|580512082|FG001|Overall Study|Laboratory Adverse Event|1|||
160761030|NCT00536510|580512081|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
160761031|NCT00536510|580512082|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
160761032|NCT01674725|580512083|FG000|Overall Study|Adverse Event|1|||
160761033|NCT01674725|580512084|FG001|Overall Study|Adverse Event|0|||
160761034|NCT01674725|580512083|FG000|Overall Study|Did not receive study drug|1|||
160761035|NCT01674725|580512084|FG001|Overall Study|Did not receive study drug|0|||
160761036|NCT01674725|580512083|FG000|Overall Study|Withdrawal by Subject|1|||
160761037|NCT01674725|580512084|FG001|Overall Study|Withdrawal by Subject|0|||
160761038|NCT01674725|580512083|FG000|Overall Study|Lost to Follow-up|0|||
160761039|NCT01674725|580512084|FG001|Overall Study|Lost to Follow-up|1|||
160761040|NCT03074695|580512085|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
160761041|NCT03074695|580512086|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
160761042|NCT03074695|580512085|FG000|Overall Study|Research staff not available|1|||
160761043|NCT03074695|580512086|FG001|Overall Study|Research staff not available|2|||
160761044|NCT03074695|580512085|FG000|Overall Study|Did not receive neuraxial block|2|||
160761045|NCT03074695|580512086|FG001|Overall Study|Did not receive neuraxial block|2|||
160761046|NCT00468585|580512087|FG000|Overall Study|Patient not treated|1|||
160761047|NCT00468585|580512088|FG001|Overall Study|Patient not treated|0|||
160761048|NCT00468585|580512089|FG002|Overall Study|Patient not treated|1|||
160761049|NCT00468585|580512090|FG003|Overall Study|Patient not treated|0|||
160761050|NCT00468585|580512087|FG000|Overall Study|Patient found to be ineligible|0|||
160761051|NCT00468585|580512088|FG001|Overall Study|Patient found to be ineligible|0|||
160761052|NCT00468585|580512089|FG002|Overall Study|Patient found to be ineligible|1|||
160761053|NCT00468585|580512090|FG003|Overall Study|Patient found to be ineligible|0|||
160761054|NCT00468585|580512087|FG000|Overall Study|Adverse Event|0|||
160761055|NCT00468585|580512088|FG001|Overall Study|Adverse Event|0|||
160761056|NCT00468585|580512089|FG002|Overall Study|Adverse Event|1|||
160761057|NCT00468585|580512090|FG003|Overall Study|Adverse Event|0|||
160761058|NCT00468585|580512087|FG000|Overall Study|Withdrawal by Subject|0|||
160761059|NCT00468585|580512088|FG001|Overall Study|Withdrawal by Subject|0|||
160761060|NCT00468585|580512089|FG002|Overall Study|Withdrawal by Subject|2|||
160761061|NCT00468585|580512090|FG003|Overall Study|Withdrawal by Subject|1|||
160761062|NCT00748241|580512092|FG000|Overall Study|Implant failure|1|||
160761063|NCT00748241|580512092|FG000|Overall Study|Lost to Follow-up|5|||
160761064|NCT00748241|580512092|FG000|Overall Study|Death|2|||
160761065|NCT01240382|580512093|FG000|Overall Study|Adverse Event|2|||
160761066|NCT01240382|580512094|FG001|Overall Study|Adverse Event|1|||
160761067|NCT01240382|580512093|FG000|Overall Study|Lack of Efficacy|0|||
160761068|NCT01240382|580512094|FG001|Overall Study|Lack of Efficacy|2|||
160761069|NCT01240382|580512093|FG000|Overall Study|Fear of adverse events|0|||
160761070|NCT01240382|580512094|FG001|Overall Study|Fear of adverse events|1|||
160761071|NCT02643693|580512095|FG000|Overall Study|Physician Decision|0|||
160761072|NCT02643693|580512096|FG001|Overall Study|Physician Decision|1|||
160761073|NCT02643693|580512097|FG002|Overall Study|Physician Decision|0|||
160761074|NCT02643693|580512098|FG003|Overall Study|Physician Decision|0|||
160761075|NCT02643693|580512099|FG004|Overall Study|Physician Decision|0|||
160761076|NCT02643693|580512100|FG005|Overall Study|Physician Decision|0|||
160761077|NCT02643693|580512095|FG000|Overall Study|Withdrawal by Subject|0|||
160761078|NCT02643693|580512096|FG001|Overall Study|Withdrawal by Subject|1|||
160761079|NCT02643693|580512097|FG002|Overall Study|Withdrawal by Subject|0|||
160761080|NCT02643693|580512098|FG003|Overall Study|Withdrawal by Subject|0|||
160761081|NCT02643693|580512099|FG004|Overall Study|Withdrawal by Subject|0|||
160761082|NCT02643693|580512100|FG005|Overall Study|Withdrawal by Subject|0|||
160761083|NCT02643693|580512095|FG000|Overall Study|Protocol Adherence Issues|2|||
160761084|NCT02643693|580512096|FG001|Overall Study|Protocol Adherence Issues|0|||
160761085|NCT02643693|580512097|FG002|Overall Study|Protocol Adherence Issues|1|||
160761086|NCT02643693|580512098|FG003|Overall Study|Protocol Adherence Issues|0|||
160761087|NCT02643693|580512099|FG004|Overall Study|Protocol Adherence Issues|0|||
160761088|NCT02643693|580512100|FG005|Overall Study|Protocol Adherence Issues|1|||
160761089|NCT01319565|580512101|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
160761090|NCT01319565|580512102|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
160761091|NCT01319565|580512103|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
160865674|NCT00538902|580902948|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
160526864|NCT03049735|579659236|FG001|Overall Study|Lost to Follow-up|5|||
160761092|NCT00698815|580512105|FG000|Overall Study|Death|1|||
160761093|NCT00698815|580512106|FG001|Overall Study|Death|2|||
160761094|NCT00698815|580512107|FG002|Overall Study|Death|4|||
160761095|NCT00698815|580512105|FG000|Overall Study|Withdrawal by Subject|6|||
160761096|NCT00698815|580512106|FG001|Overall Study|Withdrawal by Subject|3|||
160761097|NCT00698815|580512107|FG002|Overall Study|Withdrawal by Subject|2|||
160761098|NCT00698815|580512105|FG000|Overall Study|MD discretion|2|||
160761099|NCT00698815|580512106|FG001|Overall Study|MD discretion|7|||
160761100|NCT00698815|580512107|FG002|Overall Study|MD discretion|2|||
160761101|NCT00698815|580512105|FG000|Overall Study|Did not receive protocol treatment|1|||
160761102|NCT00698815|580512106|FG001|Overall Study|Did not receive protocol treatment|2|||
160761103|NCT00698815|580512107|FG002|Overall Study|Did not receive protocol treatment|2|||
160526865|NCT03049735|579659237|FG002|Overall Study|Lost to Follow-up|5|||
160526866|NCT01853982|579659238|FG000|Overall Study|Withdrawal by Subject|1|||
160761104|NCT03575702|580512108|FG000|Overall Study|Withdrawal by Subject|1|||
160761105|NCT03575702|580512109|FG001|Overall Study|Withdrawal by Subject|1|||
160761106|NCT03575702|580512108|FG000|Overall Study|Lost to Follow-up|1|||
160761107|NCT03575702|580512109|FG001|Overall Study|Lost to Follow-up|2|||
160636342|NCT04440163|580051531|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
160761108|NCT03575702|580512108|FG000|Overall Study|Protocol Violation|0|||
160761109|NCT03575702|580512109|FG001|Overall Study|Protocol Violation|1|||
160761110|NCT03575702|580512108|FG000|Overall Study|Patient non compliance|4|||
160761111|NCT03575702|580512109|FG001|Overall Study|Patient non compliance|0|||
160761112|NCT00490035|580512114|FG000|Overall Study|AE, non-serious non-fatal|3|||
160761113|NCT00490035|580512115|FG001|Overall Study|AE, non-serious non-fatal|4|||
160761114|NCT00490035|580512116|FG002|Overall Study|AE, non-serious non-fatal|4|||
160761115|NCT00490035|580512117|FG003|Overall Study|AE, non-serious non-fatal|5|||
160761116|NCT00490035|580512114|FG000|Overall Study|Lost to Follow-up|2|||
160761117|NCT00490035|580512115|FG001|Overall Study|Lost to Follow-up|0|||
160761118|NCT00490035|580512116|FG002|Overall Study|Lost to Follow-up|1|||
160761119|NCT00490035|580512117|FG003|Overall Study|Lost to Follow-up|0|||
160761120|NCT00490035|580512114|FG000|Overall Study|Withdrawal by Subject|2|||
160761121|NCT00490035|580512115|FG001|Overall Study|Withdrawal by Subject|1|||
160761122|NCT00490035|580512116|FG002|Overall Study|Withdrawal by Subject|1|||
160761123|NCT00490035|580512117|FG003|Overall Study|Withdrawal by Subject|0|||
160761124|NCT00490035|580512114|FG000|Overall Study|Other reason|0|||
160761125|NCT00490035|580512115|FG001|Overall Study|Other reason|1|||
160761126|NCT00490035|580512116|FG002|Overall Study|Other reason|3|||
160761127|NCT00490035|580512117|FG003|Overall Study|Other reason|1|||
160761128|NCT00490035|580512114|FG000|Overall Study|AE, serious fatal|1|||
160761129|NCT00490035|580512115|FG001|Overall Study|AE, serious fatal|0|||
160761130|NCT00490035|580512116|FG002|Overall Study|AE, serious fatal|0|||
160761131|NCT00490035|580512117|FG003|Overall Study|AE, serious fatal|0|||
160761132|NCT00490035|580512114|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
160761133|NCT00490035|580512115|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
160761134|NCT00490035|580512116|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
160761135|NCT00490035|580512117|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
160761136|NCT00490035|580512114|FG000|Overall Study|AE of unknown type|0|||
160761137|NCT00490035|580512115|FG001|Overall Study|AE of unknown type|0|||
160761138|NCT00490035|580512116|FG002|Overall Study|AE of unknown type|2|||
160761139|NCT00490035|580512117|FG003|Overall Study|AE of unknown type|0|||
160761140|NCT05559905|580512118|FG000|Overall Study|Withdrawal by Subject|1|||
160761141|NCT05559905|580512119|FG001|Overall Study|Withdrawal by Subject|0|||
160761142|NCT05559905|580512120|FG002|Overall Study|Withdrawal by Subject|0|||
160761143|NCT05559905|580512118|FG000|Overall Study|Not Reported|1|||
160761144|NCT05559905|580512119|FG001|Overall Study|Not Reported|0|||
160761145|NCT05559905|580512120|FG002|Overall Study|Not Reported|0|||
160761146|NCT05276973|580512121|FG000|Overall Study|Treated and DLT unevaluable|1|||
160761147|NCT05276973|580512122|FG001|Overall Study|Treated and DLT unevaluable|1|||
160761148|NCT05276973|580512123|FG002|Overall Study|Treated and DLT unevaluable|0|||
160761149|NCT02131064|580512126|FG000|Overall Study|Death|5|||
160761150|NCT02131064|580512127|FG001|Overall Study|Death|6|||
160761151|NCT02131064|580512126|FG000|Overall Study|Lost to Follow-up|4|||
160761152|NCT02131064|580512127|FG001|Overall Study|Lost to Follow-up|8|||
160761153|NCT02131064|580512126|FG000|Overall Study|Withdrawal by Subject|14|||
160761154|NCT02131064|580512127|FG001|Overall Study|Withdrawal by Subject|18|||
160761155|NCT02131064|580512126|FG000|Overall Study|Other|2|||
160761156|NCT02131064|580512127|FG001|Overall Study|Other|2|||
160761157|NCT00593918|580512128|FG000|Overall Study|Withdrawal by Subject|5|||
160761158|NCT00593918|580512129|FG001|Overall Study|Withdrawal by Subject|24|||
160761159|NCT00871234|580512139|FG000|Overall Study|Adverse Event|2|||
160761160|NCT00871234|580512139|FG000|Overall Study|Lost to Follow-up|3|||
160761161|NCT04344301|580512140|FG000|Overall Study|Withdrawal by Subject|1|||
160761162|NCT04344301|580512141|FG001|Overall Study|Withdrawal by Subject|0|||
160761163|NCT04344301|580512140|FG000|Overall Study|Death|0|||
160761164|NCT04344301|580512141|FG001|Overall Study|Death|1|||
160761165|NCT00072410|580512142|FG000|Overall Study|Progressive disease|0|||
160761166|NCT00072410|580512143|FG001|Overall Study|Progressive disease|3|||
160761167|NCT05590377|580512144|FG000|Overall Study|Death|1|||
160761168|NCT05590377|580512145|FG001|Overall Study|Death|1|||
160761169|NCT05590377|580512146|FG002|Overall Study|Death|2|||
160761170|NCT05590377|580512147|FG003|Overall Study|Death|0|||
160761171|NCT05590377|580512148|FG004|Overall Study|Death|0|||
160761172|NCT05590377|580512144|FG000|Overall Study|Study Terminated by Sponsor|1|||
160761173|NCT05590377|580512145|FG001|Overall Study|Study Terminated by Sponsor|5|||
160761174|NCT05590377|580512146|FG002|Overall Study|Study Terminated by Sponsor|4|||
160761175|NCT05590377|580512147|FG003|Overall Study|Study Terminated by Sponsor|0|||
160761176|NCT05590377|580512148|FG004|Overall Study|Study Terminated by Sponsor|0|||
160761177|NCT05590377|580512144|FG000|Overall Study|Withdrawal by Subject|1|||
160761178|NCT05590377|580512145|FG001|Overall Study|Withdrawal by Subject|0|||
160761179|NCT05590377|580512146|FG002|Overall Study|Withdrawal by Subject|0|||
160761180|NCT05590377|580512147|FG003|Overall Study|Withdrawal by Subject|0|||
160761181|NCT05590377|580512148|FG004|Overall Study|Withdrawal by Subject|0|||
160761182|NCT03389620|580512149|FG000|Overall Study|Lost to Follow-up|5|||
160761183|NCT03389620|580512150|FG001|Overall Study|Lost to Follow-up|1|||
160761184|NCT04414787|580512152|FG000|Overall Study|Patient Death|18|||
160761185|NCT04414787|580512153|FG001|Overall Study|Patient Death|18|||
160761186|NCT04414787|580512154|FG002|Overall Study|Patient Death|15|||
160761187|NCT04414787|580512155|FG003|Overall Study|Patient Death|15|||
160761188|NCT04414787|580512152|FG000|Overall Study|Patient Hospitalization|1|||
160761189|NCT04414787|580512153|FG001|Overall Study|Patient Hospitalization|1|||
160761190|NCT04414787|580512154|FG002|Overall Study|Patient Hospitalization|2|||
160761191|NCT04414787|580512155|FG003|Overall Study|Patient Hospitalization|2|||
160761192|NCT04414787|580512152|FG000|Overall Study|Lost to Follow-up|7|||
160761193|NCT04414787|580512153|FG001|Overall Study|Lost to Follow-up|7|||
160761194|NCT04414787|580512154|FG002|Overall Study|Lost to Follow-up|5|||
160761195|NCT04414787|580512155|FG003|Overall Study|Lost to Follow-up|5|||
160761196|NCT04414787|580512152|FG000|Overall Study|Residence in post-acute care facility|3|||
160761197|NCT04414787|580512153|FG001|Overall Study|Residence in post-acute care facility|3|||
160761198|NCT04414787|580512154|FG002|Overall Study|Residence in post-acute care facility|5|||
160761199|NCT04414787|580512155|FG003|Overall Study|Residence in post-acute care facility|5|||
160761200|NCT05069259|580512159|FG000|Overall Study|Withdrawal by Subject|1|||
160761201|NCT05069259|580512159|FG000|Overall Study|Sponsor decision|1|||
160761202|NCT00922636|580514054|FG000|Overall Study|Adverse Event|3|||
160761203|NCT00922636|580514055|FG001|Overall Study|Adverse Event|3|||
160761204|NCT00922636|580514056|FG002|Overall Study|Adverse Event|2|||
160761205|NCT00922636|580514057|FG003|Overall Study|Adverse Event|3|||
160761206|NCT00922636|580514058|FG004|Overall Study|Adverse Event|2|||
160761207|NCT00922636|580514054|FG000|Overall Study|Lack of Efficacy|1|||
160761208|NCT00922636|580514055|FG001|Overall Study|Lack of Efficacy|7|||
160761209|NCT00922636|580514056|FG002|Overall Study|Lack of Efficacy|3|||
160761210|NCT00922636|580514057|FG003|Overall Study|Lack of Efficacy|2|||
160761211|NCT00922636|580514058|FG004|Overall Study|Lack of Efficacy|4|||
160761212|NCT00922636|580514054|FG000|Overall Study|Sponsor Decision|0|||
160761213|NCT00922636|580514055|FG001|Overall Study|Sponsor Decision|0|||
160761214|NCT00922636|580514056|FG002|Overall Study|Sponsor Decision|2|||
160761215|NCT00922636|580514057|FG003|Overall Study|Sponsor Decision|0|||
160761216|NCT00922636|580514058|FG004|Overall Study|Sponsor Decision|0|||
160761217|NCT00922636|580514054|FG000|Overall Study|Withdrawal by Subject|0|||
160761218|NCT00922636|580514055|FG001|Overall Study|Withdrawal by Subject|0|||
160761219|NCT00922636|580514056|FG002|Overall Study|Withdrawal by Subject|5|||
160761220|NCT00922636|580514057|FG003|Overall Study|Withdrawal by Subject|2|||
160761221|NCT00922636|580514058|FG004|Overall Study|Withdrawal by Subject|4|||
160761222|NCT00922636|580514054|FG000|Overall Study|Protocol Violation|0|||
160761223|NCT00922636|580514055|FG001|Overall Study|Protocol Violation|0|||
160761224|NCT00922636|580514056|FG002|Overall Study|Protocol Violation|2|||
160761225|NCT00922636|580514057|FG003|Overall Study|Protocol Violation|2|||
160761226|NCT00922636|580514058|FG004|Overall Study|Protocol Violation|0|||
160761227|NCT00922636|580514054|FG000|Overall Study|Entry Criteria Not Met|0|||
160761228|NCT00922636|580514055|FG001|Overall Study|Entry Criteria Not Met|0|||
160761229|NCT00922636|580514056|FG002|Overall Study|Entry Criteria Not Met|1|||
160761230|NCT00922636|580514057|FG003|Overall Study|Entry Criteria Not Met|1|||
160761231|NCT00922636|580514058|FG004|Overall Study|Entry Criteria Not Met|0|||
160761232|NCT00922636|580514054|FG000|Overall Study|Parent/Caregiver Decision|2|||
160761233|NCT00922636|580514055|FG001|Overall Study|Parent/Caregiver Decision|4|||
160761234|NCT00922636|580514056|FG002|Overall Study|Parent/Caregiver Decision|3|||
160761235|NCT00922636|580514057|FG003|Overall Study|Parent/Caregiver Decision|5|||
160761236|NCT00922636|580514058|FG004|Overall Study|Parent/Caregiver Decision|2|||
160761237|NCT00922636|580514054|FG000|Overall Study|Lost to Follow-up|1|||
160761238|NCT00922636|580514055|FG001|Overall Study|Lost to Follow-up|2|||
160761239|NCT00922636|580514056|FG002|Overall Study|Lost to Follow-up|2|||
160761240|NCT00922636|580514057|FG003|Overall Study|Lost to Follow-up|2|||
160761241|NCT00922636|580514058|FG004|Overall Study|Lost to Follow-up|4|||
160761242|NCT00870727|580514059|FG000|Overall Study|Lost to Follow-up|0|||
160761243|NCT00870727|580514060|FG001|Overall Study|Lost to Follow-up|1|||
160761244|NCT00870727|580514059|FG000|Overall Study|Lack of Efficacy|1|||
160761245|NCT00870727|580514060|FG001|Overall Study|Lack of Efficacy|3|||
160761246|NCT00870727|580514059|FG000|Overall Study|Adverse Event|0|||
160761247|NCT00870727|580514060|FG001|Overall Study|Adverse Event|1|||
160761248|NCT01117870|580514064|FG000|Overall Study|Inability to place needle|1|||
160761249|NCT01117870|580514065|FG001|Overall Study|Inability to place needle|0|||
160761250|NCT01309386|580514066|FG000|Overall Study|Other|2|||
160761251|NCT01309386|580514067|FG001|Overall Study|Other|0|||
160761252|NCT01309386|580514066|FG000|Overall Study|Withdrawal by Subject|2|||
160761253|NCT01309386|580514067|FG001|Overall Study|Withdrawal by Subject|0|||
160761254|NCT01309386|580514066|FG000|Overall Study|Progressive disease|9|||
160761255|NCT01309386|580514067|FG001|Overall Study|Progressive disease|11|||
160761256|NCT01309386|580514066|FG000|Overall Study|Physician Decision|1|||
160761257|NCT01309386|580514067|FG001|Overall Study|Physician Decision|1|||
160761258|NCT01309386|580514066|FG000|Overall Study|Lack of Efficacy|3|||
160761259|NCT01309386|580514067|FG001|Overall Study|Lack of Efficacy|1|||
160761260|NCT01309386|580514066|FG000|Overall Study|Adverse Event|5|||
160761261|NCT01309386|580514067|FG001|Overall Study|Adverse Event|8|||
160761262|NCT03102762|580514068|FG000|Overall Study|Lost to Follow-up|1|||
160761263|NCT03102762|580514069|FG001|Overall Study|Lost to Follow-up|0|||
160761264|NCT02709746|580514070|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
160761265|NCT02709746|580514071|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
160761266|NCT02709746|580514072|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
160761267|NCT02709746|580514073|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
160761268|NCT02709746|580514074|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
160761269|NCT02709746|580514070|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
160761270|NCT02709746|580514071|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
160761271|NCT02709746|580514072|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
160761272|NCT02709746|580514073|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
160761273|NCT02709746|580514074|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
160761274|NCT02709746|580514070|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
160761275|NCT02709746|580514071|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
160761276|NCT02709746|580514072|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
160761277|NCT02709746|580514073|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
160761278|NCT02709746|580514074|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
160761279|NCT02709746|580514070|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
160761280|NCT02709746|580514071|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
160761281|NCT02709746|580514072|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
160761282|NCT02709746|580514073|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
160761283|NCT02709746|580514074|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
160761284|NCT02709746|580514070|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
160761285|NCT02709746|580514071|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
160761286|NCT02709746|580514072|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
160761287|NCT02709746|580514073|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
160761288|NCT02709746|580514074|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
160761289|NCT02709746|580514070|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
160761290|NCT02709746|580514071|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
160761291|NCT02709746|580514072|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
160761292|NCT02709746|580514073|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
160761293|NCT02709746|580514074|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
160761294|NCT02709746|580514070|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
160761295|NCT02709746|580514071|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
160761296|NCT02709746|580514072|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
160761297|NCT02709746|580514073|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
160761298|NCT02709746|580514074|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
160526867|NCT01853982|579659239|FG001|Overall Study|Withdrawal by Subject|0|||
160761299|NCT02709746|580514070|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
160526868|NCT01853982|579659238|FG000|Overall Study|Death|1|||
160526869|NCT01853982|579659239|FG001|Overall Study|Death|0|||
160526870|NCT01853982|579659238|FG000|Overall Study|Lost to Follow-up|0|||
160526871|NCT01853982|579659239|FG001|Overall Study|Lost to Follow-up|1|||
160526872|NCT00390910|579659240|FG000|Overall Study|Adverse Event|1|||
160526873|NCT00390910|579659241|FG001|Overall Study|Adverse Event|0|||
160526874|NCT00390910|579659242|FG002|Overall Study|Adverse Event|0|||
160526875|NCT00390910|579659240|FG000|Overall Study|Lost to Follow-up|0|||
160526876|NCT00390910|579659241|FG001|Overall Study|Lost to Follow-up|1|||
160526877|NCT00390910|579659242|FG002|Overall Study|Lost to Follow-up|5|||
160526878|NCT00390910|579659240|FG000|Overall Study|Withdrawal by Subject|1|||
160526879|NCT00390910|579659241|FG001|Overall Study|Withdrawal by Subject|3|||
160526880|NCT00390910|579659242|FG002|Overall Study|Withdrawal by Subject|2|||
160526881|NCT00390910|579659240|FG000|Overall Study|Migrated/moved from study area|0|||
160526882|NCT00390910|579659241|FG001|Overall Study|Migrated/moved from study area|0|||
160526883|NCT00390910|579659242|FG002|Overall Study|Migrated/moved from study area|3|||
160526884|NCT03808688|579660808|FG000|Overall Study|Adverse Event|13|||
160526885|NCT03808688|579660809|FG001|Overall Study|Adverse Event|17|||
160526886|NCT03808688|579660808|FG000|Overall Study|Lack of Efficacy|2|||
160526887|NCT03808688|579660809|FG001|Overall Study|Lack of Efficacy|0|||
160526888|NCT03808688|579660808|FG000|Overall Study|Lost to Follow-up|0|||
160526889|NCT03808688|579660809|FG001|Overall Study|Lost to Follow-up|2|||
160526890|NCT03808688|579660808|FG000|Overall Study|Withdrawal by Subject|1|||
160526891|NCT03808688|579660809|FG001|Overall Study|Withdrawal by Subject|0|||
160526892|NCT03808688|579660808|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
160526893|NCT03808688|579660809|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
160526894|NCT03808688|579660808|FG000|Overall Study|IOP Too High|1|||
160526895|NCT03808688|579660809|FG001|Overall Study|IOP Too High|1|||
160526896|NCT03808688|579660808|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
160761300|NCT02709746|580514071|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
160761301|NCT02709746|580514072|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
160761302|NCT02709746|580514073|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
160761303|NCT02709746|580514074|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
160761304|NCT02709746|580514070|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
160761305|NCT02709746|580514071|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
160761306|NCT02709746|580514072|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
160761307|NCT02709746|580514073|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
160761308|NCT02709746|580514074|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
160761309|NCT02709746|580514070|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
160761310|NCT02709746|580514071|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
160761311|NCT02709746|580514072|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
160761312|NCT02709746|580514073|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
160761313|NCT02709746|580514074|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
160761314|NCT02709746|580514070|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
160761315|NCT02709746|580514071|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
160761316|NCT02709746|580514072|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
160761317|NCT02709746|580514073|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
160761318|NCT02709746|580514074|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
160761319|NCT02709746|580514070|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
160761320|NCT02709746|580514071|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
160761321|NCT02709746|580514072|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
160761322|NCT02709746|580514073|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
160761323|NCT02709746|580514074|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
160761324|NCT02709746|580514070|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
160761325|NCT02709746|580514071|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
160761326|NCT02709746|580514072|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
160761327|NCT02709746|580514073|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
160761328|NCT02709746|580514074|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
160761329|NCT02709746|580514070|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
160526897|NCT03808688|579660809|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
160526898|NCT03808688|579660808|FG000|Overall Study|Visit Out of Window|0|||
160526899|NCT03808688|579660809|FG001|Overall Study|Visit Out of Window|1|||
160526900|NCT03808688|579660808|FG000|Overall Study|Medication Non-Compliance|0|||
160526901|NCT03808688|579660809|FG001|Overall Study|Medication Non-Compliance|1|||
160526902|NCT01215175|579660813|FG000|Overall Study|Lost to Follow-up|0|||
160526903|NCT01215175|579660814|FG001|Overall Study|Lost to Follow-up|1|||
160526904|NCT01215175|579660815|FG002|Overall Study|Lost to Follow-up|0|||
160526905|NCT01215175|579660816|FG003|Overall Study|Lost to Follow-up|1|||
160526906|NCT01215175|579660817|FG004|Overall Study|Lost to Follow-up|0|||
160761330|NCT02709746|580514071|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
160761331|NCT02709746|580514072|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
160761332|NCT02709746|580514073|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
160761333|NCT02709746|580514074|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
160761334|NCT02709746|580514070|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
160761335|NCT02709746|580514071|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
160761336|NCT02709746|580514072|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
160761337|NCT02709746|580514073|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
160761338|NCT02709746|580514074|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
160761339|NCT02709746|580514070|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
160761340|NCT02709746|580514071|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
160761341|NCT02709746|580514072|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
160761342|NCT02709746|580514073|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
160761343|NCT02709746|580514074|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
160761344|NCT02709746|580514070|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
160761345|NCT02709746|580514071|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
160761346|NCT02709746|580514072|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
160761347|NCT02709746|580514073|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
160761348|NCT02709746|580514074|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
160761349|NCT01774981|580514079|FG000|Overall Study|Adverse Event|0|||
160761350|NCT01774981|580514080|FG001|Overall Study|Adverse Event|0|||
160761351|NCT01774981|580514081|FG002|Overall Study|Adverse Event|0|||
160761352|NCT01774981|580514082|FG003|Overall Study|Adverse Event|0|||
160761353|NCT01774981|580514083|FG004|Overall Study|Adverse Event|0|||
160761354|NCT01774981|580514084|FG005|Overall Study|Adverse Event|1|||
160761355|NCT01774981|580514085|FG006|Overall Study|Adverse Event|0|||
160761356|NCT01774981|580514086|FG007|Overall Study|Adverse Event|0|||
160761357|NCT01774981|580514079|FG000|Overall Study|Withdrawal by Subject|0|||
160761358|NCT01774981|580514080|FG001|Overall Study|Withdrawal by Subject|0|||
160761359|NCT01774981|580514081|FG002|Overall Study|Withdrawal by Subject|0|||
160761360|NCT01774981|580514082|FG003|Overall Study|Withdrawal by Subject|0|||
160761361|NCT01774981|580514083|FG004|Overall Study|Withdrawal by Subject|0|||
160761362|NCT01774981|580514084|FG005|Overall Study|Withdrawal by Subject|0|||
160761363|NCT01774981|580514085|FG006|Overall Study|Withdrawal by Subject|0|||
160761364|NCT01774981|580514086|FG007|Overall Study|Withdrawal by Subject|1|||
160761365|NCT01774981|580514079|FG000|Overall Study|Death|0|||
160761366|NCT01774981|580514080|FG001|Overall Study|Death|0|||
160526907|NCT01016964|579660818|FG000|Overall Study|Lost to Follow-up|3|||
160761367|NCT01774981|580514081|FG002|Overall Study|Death|0|||
160761368|NCT01774981|580514082|FG003|Overall Study|Death|0|||
160761369|NCT01774981|580514083|FG004|Overall Study|Death|1|||
160761370|NCT01774981|580514084|FG005|Overall Study|Death|0|||
160761371|NCT01774981|580514085|FG006|Overall Study|Death|0|||
160761372|NCT01774981|580514086|FG007|Overall Study|Death|0|||
160761373|NCT00001566|580514089|FG000|Overall Study|patients' choice to discontinue protocol|3|||
160761374|NCT00001566|580514089|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
160761375|NCT00001566|580514089|FG000|Overall Study|Death|13|||
160761376|NCT00001566|580514089|FG000|Overall Study|Lost to Follow-up|1|||
160761377|NCT00001566|580514089|FG000|Overall Study|unable to complete initial apheresis|1|||
160761378|NCT02915835|580514090|FG000|Overall Study|Physician Decision|1|||
160761379|NCT02915835|580514091|FG001|Overall Study|Physician Decision|0|||
160761380|NCT02915835|580514090|FG000|Overall Study|Withdrawal by Subject|0|||
160761381|NCT02915835|580514091|FG001|Overall Study|Withdrawal by Subject|1|||
160761382|NCT00433836|580514092|FG000|Overall Study|Adverse Event|7|||
160761383|NCT00433836|580514093|FG001|Overall Study|Adverse Event|0|||
160761384|NCT00433836|580514092|FG000|Overall Study|Lost to Follow-up|3|||
160761385|NCT00433836|580514093|FG001|Overall Study|Lost to Follow-up|0|||
160761386|NCT00433836|580514092|FG000|Overall Study|Withdrawal by Subject|2|||
160761387|NCT00433836|580514093|FG001|Overall Study|Withdrawal by Subject|1|||
160761388|NCT00433836|580514092|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160761389|NCT00433836|580514093|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160761390|NCT00433836|580514092|FG000|Overall Study|Protocol Violation|0|||
160761391|NCT00433836|580514093|FG001|Overall Study|Protocol Violation|2|||
160761392|NCT00433836|580514092|FG000|Overall Study|Condition no longer requires study drug|0|||
160761393|NCT00433836|580514093|FG001|Overall Study|Condition no longer requires study drug|1|||
160865675|NCT00538902|580902949|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
160526908|NCT01016964|579660819|FG001|Overall Study|Lost to Follow-up|3|||
160526909|NCT03872453|579660820|FG000|Overall Study|Adverse Event|1|||
160526910|NCT03872453|579660821|FG001|Overall Study|Adverse Event|1|||
160526911|NCT03872453|579660822|FG002|Overall Study|Adverse Event|0|||
160526912|NCT03872453|579660823|FG003|Overall Study|Adverse Event|0|||
160526913|NCT03872453|579660820|FG000|Overall Study|Lost to Follow-up|8|||
160526914|NCT03872453|579660821|FG001|Overall Study|Lost to Follow-up|7|||
160526915|NCT03872453|579660822|FG002|Overall Study|Lost to Follow-up|4|||
160526916|NCT03872453|579660823|FG003|Overall Study|Lost to Follow-up|4|||
160526917|NCT03872453|579660820|FG000|Overall Study|Never Treated Migraine|19|||
160526918|NCT03872453|579660821|FG001|Overall Study|Never Treated Migraine|17|||
160526919|NCT03872453|579660822|FG002|Overall Study|Never Treated Migraine|13|||
160526920|NCT03872453|579660823|FG003|Overall Study|Never Treated Migraine|12|||
160526921|NCT03872453|579660820|FG000|Overall Study|Pregnancy|1|||
160526922|NCT03872453|579660821|FG001|Overall Study|Pregnancy|0|||
160526923|NCT03872453|579660822|FG002|Overall Study|Pregnancy|0|||
160526924|NCT03872453|579660823|FG003|Overall Study|Pregnancy|0|||
160526925|NCT03872453|579660820|FG000|Overall Study|Protocol Deviation|2|||
160526926|NCT03872453|579660821|FG001|Overall Study|Protocol Deviation|0|||
160526927|NCT03872453|579660822|FG002|Overall Study|Protocol Deviation|0|||
160526928|NCT03872453|579660823|FG003|Overall Study|Protocol Deviation|2|||
160526929|NCT03872453|579660820|FG000|Overall Study|Withdrawal by Subject|0|||
160761394|NCT00433836|580514092|FG000|Overall Study|Abnormal laboratory values|0|||
160761395|NCT00433836|580514093|FG001|Overall Study|Abnormal laboratory values|1|||
160761396|NCT00113607|580514094|FG000|Overall Study|Adverse Event|40|||
160761397|NCT00113607|580514095|FG001|Overall Study|Adverse Event|71|||
160761398|NCT00113607|580514094|FG000|Overall Study|Death|8|||
160761399|NCT00113607|580514095|FG001|Overall Study|Death|8|||
160526930|NCT03872453|579660821|FG001|Overall Study|Withdrawal by Subject|1|||
160526931|NCT03872453|579660822|FG002|Overall Study|Withdrawal by Subject|2|||
160526932|NCT03872453|579660823|FG003|Overall Study|Withdrawal by Subject|0|||
160526933|NCT03872453|579660820|FG000|Overall Study|Other Than Specified|1|||
160526934|NCT03872453|579660821|FG001|Overall Study|Other Than Specified|0|||
160526935|NCT03872453|579660822|FG002|Overall Study|Other Than Specified|0|||
160526936|NCT03872453|579660823|FG003|Overall Study|Other Than Specified|0|||
160526937|NCT01678209|579660824|FG000|Overall Study|could not scan twice|1|||
160526938|NCT01678209|579660825|FG001|Overall Study|could not scan twice|1|||
160526939|NCT01678209|579660826|FG002|Overall Study|could not scan twice|1|||
160526940|NCT01678209|579660824|FG000|Overall Study|scheduling conflicts|0|||
160526941|NCT01678209|579660825|FG001|Overall Study|scheduling conflicts|0|||
160526942|NCT01678209|579660826|FG002|Overall Study|scheduling conflicts|1|||
160526943|NCT01678209|579660824|FG000|Overall Study|screen fail|16|||
160526944|NCT01678209|579660825|FG001|Overall Study|screen fail|17|||
160526945|NCT01678209|579660826|FG002|Overall Study|screen fail|16|||
160526946|NCT03756350|579660831|FG000|Overall Study|Lost to Follow-up|1|||
160526947|NCT00702845|579660835|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
160526948|NCT00702845|579660836|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
160526949|NCT00702845|579660835|FG000|Overall Study|Too high ovarian response|5|||
160526950|NCT00702845|579660836|FG001|Overall Study|Too high ovarian response|1|||
160526951|NCT00702845|579660835|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
160526952|NCT00702845|579660836|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
160526953|NCT00702845|579660835|FG000|Overall Study|Insufficient ovarian response|1|||
160526954|NCT00702845|579660836|FG001|Overall Study|Insufficient ovarian response|0|||
160526955|NCT00702845|579660835|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
160526956|NCT00702845|579660836|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
160526957|NCT00702845|579660835|FG000|Overall Study|No or abnormal fertilization|4|||
160526958|NCT00702845|579660836|FG001|Overall Study|No or abnormal fertilization|2|||
160526959|NCT00702845|579660835|FG000|Overall Study|Patient's decision|2|||
160526960|NCT00702845|579660836|FG001|Overall Study|Patient's decision|1|||
160526961|NCT00702845|579660835|FG000|Overall Study|Not randomized|0|||
160526962|NCT00702845|579660836|FG001|Overall Study|Not randomized|1|||
160526963|NCT00440700|579660837|FG000|Overall Study|Withdrawal by Subject|8|||
160526964|NCT00440700|579660838|FG001|Overall Study|Withdrawal by Subject|8|||
160526965|NCT00440700|579660839|FG002|Overall Study|Withdrawal by Subject|4|||
160526966|NCT00928564|579660840|FG000|Overall Study|Lost to Follow-up|6|||
160526967|NCT00928564|579660841|FG001|Overall Study|Lost to Follow-up|0|||
160526968|NCT01096342|579660844|FG000|Overall Study|Protocol Violation|1|||
160526969|NCT03434353|579660845|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
160526970|NCT03434353|579660846|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
160526971|NCT03434353|579660847|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
160526972|NCT03434353|579660848|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
160526973|NCT03434353|579660849|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
160761400|NCT00113607|580514094|FG000|Overall Study|Withdrawal by Subject|50|||
160761401|NCT00113607|580514095|FG001|Overall Study|Withdrawal by Subject|58|||
160761402|NCT00113607|580514094|FG000|Overall Study|Lost to Follow-up|0|||
160761403|NCT00113607|580514095|FG001|Overall Study|Lost to Follow-up|2|||
160636343|NCT04440163|580051532|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
160636344|NCT04440163|580051533|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
160636345|NCT04440163|580051534|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
160636346|NCT04440163|580051535|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
160761404|NCT00113607|580514094|FG000|Overall Study|Disease Progression|180|||
160636347|NCT04440163|580051536|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
160636348|NCT04440163|580051537|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
160636349|NCT04440163|580051530|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
160636350|NCT04440163|580051531|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
160636351|NCT04440163|580051532|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
160636352|NCT04440163|580051533|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
160636353|NCT04440163|580051534|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
160636354|NCT04440163|580051535|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
160636355|NCT04440163|580051536|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
160636356|NCT04440163|580051537|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
160636357|NCT04440163|580051530|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
160636358|NCT04440163|580051531|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
160636359|NCT04440163|580051532|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
160636360|NCT04440163|580051533|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
160636361|NCT04440163|580051534|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
160636362|NCT04440163|580051535|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
160636363|NCT04440163|580051536|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
160636364|NCT04440163|580051537|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
160636365|NCT04440163|580051530|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
160636366|NCT04440163|580051531|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
160636367|NCT04440163|580051532|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
160636368|NCT04440163|580051533|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
160636369|NCT04440163|580051534|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
160636370|NCT04440163|580051535|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
160636371|NCT04440163|580051536|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
160636372|NCT04440163|580051537|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
160636373|NCT04440163|580051530|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
160636374|NCT04440163|580051531|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
160636375|NCT04440163|580051532|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
160636376|NCT04440163|580051533|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
160636377|NCT04440163|580051534|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
160636378|NCT04440163|580051535|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
160636379|NCT04440163|580051536|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
160636380|NCT04440163|580051537|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
160636381|NCT01128153|580051538|FG000|Overall Study|Adverse Event|1|||
160636382|NCT01128153|580051539|FG001|Overall Study|Adverse Event|3|||
160636383|NCT01128153|580051538|FG000|Overall Study|Condition under investigation worsened|8|||
160636384|NCT01128153|580051539|FG001|Overall Study|Condition under investigation worsened|7|||
160636385|NCT01128153|580051538|FG000|Overall Study|Withdrawal by Subject|2|||
160636386|NCT01128153|580051539|FG001|Overall Study|Withdrawal by Subject|3|||
160636387|NCT01128153|580051538|FG000|Overall Study|Incorrect enrolment to study|2|||
160636388|NCT01128153|580051539|FG001|Overall Study|Incorrect enrolment to study|1|||
160636389|NCT01128153|580051538|FG000|Overall Study|Protocol Violation|2|||
160636390|NCT01128153|580051539|FG001|Overall Study|Protocol Violation|0|||
160636391|NCT01128153|580051538|FG000|Overall Study|Developed discontinuation criteria|1|||
160636392|NCT01128153|580051539|FG001|Overall Study|Developed discontinuation criteria|1|||
160636393|NCT01954082|580051540|FG000|Overall Study|Study Suspension|42|||
160636394|NCT01954082|580051541|FG001|Overall Study|Study Suspension|36|||
160636395|NCT01954082|580051540|FG000|Overall Study|Adverse Event|10|||
160526974|NCT03434353|579660845|FG000|Overall Study|Withdrew consent|1|||
160526975|NCT03434353|579660846|FG001|Overall Study|Withdrew consent|0|||
160526976|NCT03434353|579660847|FG002|Overall Study|Withdrew consent|3|||
160526977|NCT03434353|579660848|FG003|Overall Study|Withdrew consent|0|||
160761405|NCT00113607|580514095|FG001|Overall Study|Disease Progression|142|||
160761406|NCT00113607|580514094|FG000|Overall Study|Complete Response (Confirmed)|14|||
160761407|NCT00113607|580514095|FG001|Overall Study|Complete Response (Confirmed)|24|||
160761408|NCT00113607|580514094|FG000|Overall Study|Other|43|||
160761409|NCT00113607|580514095|FG001|Overall Study|Other|32|||
160761410|NCT03669549|580514096|FG000|Overall Study|Adverse Event|4|||
160761411|NCT03669549|580514096|FG000|Overall Study|Withdrawal by Subject|1|||
160761412|NCT03669549|580514096|FG000|Overall Study|Study terminated by the Sponsor|1|||
160761413|NCT00909844|580514097|FG000|Overall Study|Adverse Event|1|||
160761414|NCT00909844|580514097|FG000|Overall Study|Withdrawal by Subject|1|||
160761415|NCT00909844|580514097|FG000|Overall Study|Lost to Follow-up|2|||
160761416|NCT00706004|580514098|FG000|Overall Study|Did not meet eligibility criteria|2|||
160761417|NCT02674516|580514099|FG000|Overall Study|Lost to Follow-up|3|||
160761418|NCT02674516|580514100|FG001|Overall Study|Lost to Follow-up|0|||
160761419|NCT02674516|580514099|FG000|Overall Study|Protocol Violation|0|||
160761420|NCT02674516|580514100|FG001|Overall Study|Protocol Violation|4|||
160761421|NCT02674516|580514099|FG000|Overall Study|Knowledge of study hypothesis|1|||
160761422|NCT02674516|580514100|FG001|Overall Study|Knowledge of study hypothesis|0|||
160761423|NCT01064479|580514101|FG000|Overall Study|Death|10|||
160761424|NCT01064479|580514102|FG001|Overall Study|Death|11|||
160761425|NCT01064479|580514101|FG000|Overall Study|Withdrawal by Subject|2|||
160761426|NCT01064479|580514102|FG001|Overall Study|Withdrawal by Subject|2|||
160761427|NCT01064479|580514101|FG000|Overall Study|Disease progression|1|||
160761428|NCT01064479|580514102|FG001|Overall Study|Disease progression|1|||
160761429|NCT01064479|580514101|FG000|Overall Study|Toxicity|1|||
160761430|NCT01064479|580514102|FG001|Overall Study|Toxicity|1|||
160761431|NCT01064479|580514101|FG000|Overall Study|Other|1|||
160526978|NCT03434353|579660849|FG004|Overall Study|Withdrew consent|0|||
160526979|NCT03434353|579660845|FG000|Overall Study|Adverse Event|1|||
160761432|NCT01064479|580514102|FG001|Overall Study|Other|2|||
160761433|NCT00749398|580514104|FG000|Overall Study|Lack of Efficacy|7|||
160761434|NCT00749398|580514104|FG000|Overall Study|Adverse Event|4|||
160761435|NCT00749398|580514104|FG000|Overall Study|Serious adverse event|11|||
160761436|NCT00749398|580514104|FG000|Overall Study|Withdrawal by Subject|17|||
160761437|NCT00749398|580514104|FG000|Overall Study|Lost to Follow-up|11|||
160761438|NCT00749398|580514104|FG000|Overall Study|Reason not specified|2|||
160761439|NCT00749398|580514104|FG000|Overall Study|Unknown reason|1|||
160761440|NCT05696392|580514110|FG000|Overall Study|Lost to Follow-up|3|||
160761441|NCT05696392|580514110|FG000|Overall Study|Protocol Violation|1|||
160761442|NCT05696392|580514110|FG000|Overall Study|Withdrawal by Subject|1|||
160761443|NCT03180736|580514111|FG000|Overall Study|Adverse Event|3|||
160761444|NCT03180736|580514112|FG001|Overall Study|Adverse Event|4|||
160526980|NCT03434353|579660846|FG001|Overall Study|Adverse Event|0|||
160526981|NCT03434353|579660847|FG002|Overall Study|Adverse Event|0|||
160526982|NCT03434353|579660848|FG003|Overall Study|Adverse Event|0|||
160526983|NCT03434353|579660849|FG004|Overall Study|Adverse Event|1|||
160526984|NCT03434353|579660845|FG000|Overall Study|Lost to Follow-up|2|||
160526985|NCT03434353|579660846|FG001|Overall Study|Lost to Follow-up|0|||
160526986|NCT03434353|579660847|FG002|Overall Study|Lost to Follow-up|0|||
160526987|NCT03434353|579660848|FG003|Overall Study|Lost to Follow-up|0|||
160526988|NCT03434353|579660849|FG004|Overall Study|Lost to Follow-up|0|||
160526989|NCT03739762|579660850|FG000|Overall Study|Lost to Follow-up|1|||
160526990|NCT03739762|579660851|FG001|Overall Study|Lost to Follow-up|1|||
160526991|NCT03739762|579660850|FG000|Overall Study|Withdrawal by Subject|2|||
160526992|NCT03739762|579660851|FG001|Overall Study|Withdrawal by Subject|6|||
160526993|NCT00607880|579660852|FG000|Overall Study|Unable to place port due to occlusion|1|||
160526994|NCT00607880|579660853|FG001|Overall Study|Unable to place port due to occlusion|0|||
160526995|NCT01990534|579660854|FG000|Overall Study|Death|22|||
160526996|NCT01990534|579660854|FG000|Overall Study|Progressive disease|3|||
160526997|NCT01990534|579660854|FG000|Overall Study|Protocol Violation|1|||
160526998|NCT01990534|579660854|FG000|Overall Study|Withdrawal of Informed Consent|2|||
160526999|NCT01990534|579660854|FG000|Overall Study|Symptomatic Deterioration|1|||
160527000|NCT01990534|579660854|FG000|Overall Study|Withdrawal by Subject|3|||
160527001|NCT01990534|579660854|FG000|Overall Study|Reason not Specified|2|||
160527002|NCT01990534|579660854|FG000|Overall Study|Lost to Follow-up|1|||
160527003|NCT01831544|579660855|FG000|Overall Study|Death|1|||
160527004|NCT01831544|579660855|FG000|Overall Study|Still on original MVAD device|2|||
160527005|NCT03308942|579660858|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
160527006|NCT03308942|579660859|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
160527007|NCT03308942|579660860|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
160527008|NCT03308942|579660861|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
160761445|NCT03180736|580514111|FG000|Overall Study|Death|10|||
160761446|NCT03180736|580514112|FG001|Overall Study|Death|7|||
160761447|NCT03180736|580514111|FG000|Overall Study|Withdrawal by Subject|5|||
160761448|NCT03180736|580514112|FG001|Overall Study|Withdrawal by Subject|12|||
160761449|NCT03180736|580514111|FG000|Overall Study|Lost to Follow-up|1|||
160761450|NCT03180736|580514112|FG001|Overall Study|Lost to Follow-up|0|||
160761451|NCT03180736|580514111|FG000|Overall Study|Lack of Efficacy|66|||
160761452|NCT03180736|580514112|FG001|Overall Study|Lack of Efficacy|87|||
160761453|NCT03180736|580514111|FG000|Overall Study|Physician Decision|4|||
160761454|NCT03180736|580514112|FG001|Overall Study|Physician Decision|7|||
160761455|NCT03180736|580514111|FG000|Overall Study|randomized but not treated|2|||
160761456|NCT03180736|580514112|FG001|Overall Study|randomized but not treated|3|||
160761457|NCT03258593|580514113|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
160761458|NCT03258593|580514114|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
160761459|NCT03258593|580514115|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
160761460|NCT03258593|580514116|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
160761461|NCT03258593|580514113|FG000|Run-In Maintenance Phase|Disease progression|3|||
160761462|NCT03258593|580514114|FG001|Run-In Maintenance Phase|Disease progression|0|||
160761463|NCT03258593|580514115|FG002|Run-In Maintenance Phase|Disease progression|0|||
160761464|NCT03258593|580514116|FG003|Run-In Maintenance Phase|Disease progression|0|||
160761465|NCT03258593|580514113|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
160761466|NCT03258593|580514114|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
160761467|NCT03258593|580514115|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
160761468|NCT03258593|580514116|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
160761469|NCT03258593|580514113|FG000|Expansion Maintenance Phase|Physician Decision|0|||
160761470|NCT03258593|580514114|FG001|Expansion Maintenance Phase|Physician Decision|1|||
160761471|NCT03258593|580514115|FG002|Expansion Maintenance Phase|Physician Decision|0|||
160761472|NCT03258593|580514116|FG003|Expansion Maintenance Phase|Physician Decision|0|||
160761473|NCT05457257|580514124|FG000|Overall Study|Withdrawal by Subject|0|||
160761474|NCT05457257|580514125|FG001|Overall Study|Withdrawal by Subject|2|||
160761475|NCT05457257|580514124|FG000|Overall Study|Death|10|||
160527009|NCT03308942|579660862|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
160527010|NCT03308942|579660858|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
160527011|NCT03308942|579660859|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
160527012|NCT03308942|579660860|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
160761476|NCT05457257|580514125|FG001|Overall Study|Death|3|||
160761477|NCT05457257|580514124|FG000|Overall Study|Ongoing|19|||
160761478|NCT05457257|580514125|FG001|Overall Study|Ongoing|9|||
160527013|NCT03308942|579660861|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
160527014|NCT03308942|579660862|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
160527015|NCT03308942|579660858|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
160527016|NCT03308942|579660859|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
160761479|NCT04464707|580514131|FG000|Overall Study|Adverse Event|1|||
160761480|NCT04464707|580514132|FG001|Overall Study|Adverse Event|0|||
160761481|NCT04464707|580514133|FG002|Overall Study|Adverse Event|0|||
160761482|NCT04464707|580514131|FG000|Overall Study|Withdrawal by Subject|0|||
160636396|NCT01954082|580051541|FG001|Overall Study|Adverse Event|4|||
160761483|NCT04464707|580514132|FG001|Overall Study|Withdrawal by Subject|0|||
160761484|NCT04464707|580514133|FG002|Overall Study|Withdrawal by Subject|2|||
160761485|NCT04464707|580514131|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160761486|NCT04464707|580514132|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160761487|NCT04464707|580514133|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160761488|NCT04464707|580514131|FG000|Overall Study|Protocol Deviation|1|||
160761489|NCT04464707|580514132|FG001|Overall Study|Protocol Deviation|0|||
160761490|NCT04464707|580514133|FG002|Overall Study|Protocol Deviation|0|||
160761491|NCT04464707|580514131|FG000|Overall Study|Lost to Follow-up|2|||
160761492|NCT04464707|580514132|FG001|Overall Study|Lost to Follow-up|0|||
160761493|NCT04464707|580514133|FG002|Overall Study|Lost to Follow-up|1|||
160761494|NCT04831138|580514136|FG000|Overall Study|Lost to Follow-up|2|||
160761495|NCT04831138|580514137|FG001|Overall Study|Lost to Follow-up|0|||
160761496|NCT04202497|580514143|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
160761497|NCT04202497|580514144|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
160761498|NCT04202497|580514145|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
160761499|NCT04202497|580514146|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
160761500|NCT04782180|580514155|FG000|Overall Study|Withdrawal by Subject|2|||
160761501|NCT04782180|580514155|FG000|Overall Study|Lost to Follow-up|2|||
160761502|NCT05852353|580514156|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
160761503|NCT05852353|580514156|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
160761504|NCT05852353|580514156|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
160761505|NCT05852353|580514156|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
160761506|NCT03509467|580514157|FG000|Overall Study|Withdrawal by Subject|5|||
160761507|NCT03509467|580514158|FG001|Overall Study|Withdrawal by Subject|1|||
160761508|NCT03509467|580514159|FG002|Overall Study|Withdrawal by Subject|6|||
160761509|NCT03509467|580514160|FG003|Overall Study|Withdrawal by Subject|7|||
160761510|NCT03509467|580514161|FG004|Overall Study|Withdrawal by Subject|10|||
160761511|NCT03509467|580514162|FG005|Overall Study|Withdrawal by Subject|10|||
160761512|NCT03509467|580514163|FG006|Overall Study|Withdrawal by Subject|10|||
160761513|NCT03509467|580514164|FG007|Overall Study|Withdrawal by Subject|10|||
160761514|NCT03509467|580514157|FG000|Overall Study|Death|0|||
160761515|NCT03509467|580514158|FG001|Overall Study|Death|0|||
160761516|NCT03509467|580514159|FG002|Overall Study|Death|2|||
160761517|NCT03509467|580514160|FG003|Overall Study|Death|2|||
160761518|NCT03509467|580514161|FG004|Overall Study|Death|1|||
160761519|NCT03509467|580514162|FG005|Overall Study|Death|0|||
160761520|NCT03509467|580514163|FG006|Overall Study|Death|1|||
160761521|NCT03509467|580514164|FG007|Overall Study|Death|0|||
160761522|NCT03509467|580514157|FG000|Overall Study|Proxy Withdrawal|0|||
160761523|NCT03509467|580514158|FG001|Overall Study|Proxy Withdrawal|0|||
160761524|NCT03509467|580514159|FG002|Overall Study|Proxy Withdrawal|0|||
160761525|NCT03509467|580514160|FG003|Overall Study|Proxy Withdrawal|0|||
160761526|NCT03509467|580514161|FG004|Overall Study|Proxy Withdrawal|0|||
160761527|NCT03509467|580514162|FG005|Overall Study|Proxy Withdrawal|0|||
160761528|NCT03509467|580514163|FG006|Overall Study|Proxy Withdrawal|0|||
160761529|NCT03509467|580514164|FG007|Overall Study|Proxy Withdrawal|1|||
160761530|NCT01005745|580514165|FG000|Overall Study|No TIL growth|1|||
160761531|NCT01005745|580514165|FG000|Overall Study|Disease progressed during TIL growth|3|||
160761532|NCT01005745|580514165|FG000|Overall Study|Death prior to treatment|1|||
160761533|NCT01005745|580514165|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
160761534|NCT06077773|580514166|FG000|Overall Study|Withdrawal by Subject|1|||
160761535|NCT06077773|580514167|FG001|Overall Study|Withdrawal by Subject|0|||
160761536|NCT06077773|580514168|FG002|Overall Study|Withdrawal by Subject|1|||
160761537|NCT06077773|580514166|FG000|Overall Study|Lost to Follow-up|0|||
160761538|NCT06077773|580514167|FG001|Overall Study|Lost to Follow-up|1|||
160761539|NCT06077773|580514168|FG002|Overall Study|Lost to Follow-up|0|||
160761540|NCT06077773|580514166|FG000|Overall Study|Adverse Event|0|||
160761541|NCT06077773|580514167|FG001|Overall Study|Adverse Event|0|||
160761542|NCT06077773|580514168|FG002|Overall Study|Adverse Event|2|||
160761543|NCT03834506|580514169|FG000|Overall Study|Death|336|||
160761544|NCT03834506|580514170|FG001|Overall Study|Death|326|||
160761545|NCT03834506|580514169|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160761546|NCT03834506|580514170|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160761547|NCT03834506|580514169|FG000|Overall Study|Withdrawal by Subject|10|||
160761548|NCT03834506|580514170|FG001|Overall Study|Withdrawal by Subject|8|||
160761549|NCT03834506|580514169|FG000|Overall Study|Sponsor decision|165|||
160761550|NCT03834506|580514170|FG001|Overall Study|Sponsor decision|178|||
160761551|NCT03834506|580514169|FG000|Overall Study|Physician Decision|3|||
160761552|NCT03834506|580514170|FG001|Overall Study|Physician Decision|1|||
160761553|NCT03834506|580514169|FG000|Overall Study|Lost to Follow-up|0|||
160761554|NCT03834506|580514170|FG001|Overall Study|Lost to Follow-up|1|||
160761555|NCT02287038|580514173|FG000|Overall Study|Stopped attending appointments|3|||
160761556|NCT02287038|580514174|FG001|Overall Study|Stopped attending appointments|2|||
160761557|NCT02287038|580514173|FG000|Overall Study|Anxiety after starting medication|0|||
160761558|NCT02287038|580514174|FG001|Overall Study|Anxiety after starting medication|1|||
160761559|NCT02287038|580514173|FG000|Overall Study|Nausea after starting medication|1|||
160761560|NCT02287038|580514174|FG001|Overall Study|Nausea after starting medication|0|||
160761561|NCT02287038|580514173|FG000|Overall Study|Abnormal ECG after starting medication|1|||
160761562|NCT02287038|580514174|FG001|Overall Study|Abnormal ECG after starting medication|0|||
160761563|NCT05502302|580514180|FG000|Overall Study|Lost to Follow-up|6|||
160761564|NCT05502302|580514180|FG000|Overall Study|Death|2|||
160761565|NCT02998151|580514181|FG000|Overall Study|Withdrawal by Subject|3|||
160761566|NCT02998151|580514181|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
160636397|NCT01954082|580051540|FG000|Overall Study|Intolerance|0|||
160527017|NCT03308942|579660860|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
160527018|NCT03308942|579660861|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
160761567|NCT02998151|580514181|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
160761568|NCT02667301|580514182|FG000|Overall Study|Adverse Event|1|||
160761569|NCT02667301|580514182|FG000|Overall Study|Lack of Efficacy|1|||
160527019|NCT03308942|579660862|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
160527020|NCT03308942|579660858|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
160761570|NCT01619878|580514185|FG000|6 Week Follow-up Phase|Adverse Event|1|||
160761571|NCT01619878|580514185|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
160761572|NCT01619878|580514185|FG000|Follow-up at 12 Months of Age|Death|2|||
160761573|NCT05093933|580514186|FG000|Overall Study|Death|372|||
160761574|NCT05093933|580514187|FG001|Overall Study|Death|434|||
160761575|NCT05093933|580514186|FG000|Overall Study|Lost to Follow-up|13|||
160761576|NCT05093933|580514187|FG001|Overall Study|Lost to Follow-up|16|||
160761577|NCT05093933|580514186|FG000|Overall Study|Physician Decision|0|||
160761578|NCT05093933|580514187|FG001|Overall Study|Physician Decision|2|||
160761579|NCT05093933|580514186|FG000|Overall Study|Sponsor Decision|1|||
160761580|NCT05093933|580514187|FG001|Overall Study|Sponsor Decision|3|||
160761581|NCT05093933|580514186|FG000|Overall Study|Withdrawal by Guardian|1|||
160761582|NCT05093933|580514187|FG001|Overall Study|Withdrawal by Guardian|1|||
160761583|NCT05093933|580514186|FG000|Overall Study|Withdrawal by Subject|18|||
160761584|NCT05093933|580514187|FG001|Overall Study|Withdrawal by Subject|25|||
160761585|NCT04037358|580514188|FG000|Overall Study|Patient withdrew before intervention|1|||
160761586|NCT04037358|580514189|FG001|Overall Study|Patient withdrew before intervention|0|||
160761587|NCT05027815|580514192|FG000|Overall Study|Death|2|||
160761588|NCT05027815|580514193|FG001|Overall Study|Death|1|||
160761589|NCT01655901|580515697|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
160761590|NCT01655901|580515698|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
160761591|NCT01655901|580515699|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
160761592|NCT01655901|580515700|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
160761593|NCT01655901|580515701|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
160761594|NCT01655901|580515702|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
160761595|NCT02997163|580515703|FG000|Overall Study|Adverse Event|1|||
160761596|NCT02997163|580515704|FG001|Overall Study|Adverse Event|0|||
160761597|NCT02997163|580515705|FG002|Overall Study|Adverse Event|0|||
160761598|NCT02997163|580515706|FG003|Overall Study|Adverse Event|1|||
160761599|NCT01712516|580515707|FG000|Overall Study|Technical problems|0|||
160761600|NCT01712516|580515708|FG001|Overall Study|Technical problems|0|||
160761601|NCT01712516|580515709|FG002|Overall Study|Technical problems|0|||
160761602|NCT01712516|580515710|FG003|Overall Study|Technical problems|2|||
160761603|NCT01712516|580515707|FG000|Overall Study|Lost to Follow-up|0|||
160761604|NCT01712516|580515708|FG001|Overall Study|Lost to Follow-up|0|||
160761605|NCT01712516|580515709|FG002|Overall Study|Lost to Follow-up|2|||
160761606|NCT01712516|580515710|FG003|Overall Study|Lost to Follow-up|1|||
160761607|NCT01712516|580515707|FG000|Overall Study|Death|0|||
160761608|NCT01712516|580515708|FG001|Overall Study|Death|1|||
160761609|NCT01712516|580515709|FG002|Overall Study|Death|0|||
160761610|NCT01712516|580515710|FG003|Overall Study|Death|0|||
160761611|NCT01712516|580515707|FG000|Overall Study|Protocol deviation|1|||
160761612|NCT01712516|580515708|FG001|Overall Study|Protocol deviation|0|||
160761613|NCT01712516|580515709|FG002|Overall Study|Protocol deviation|1|||
160761614|NCT01712516|580515710|FG003|Overall Study|Protocol deviation|0|||
160761615|NCT01712516|580515707|FG000|Overall Study|Physician Decision|2|||
160761616|NCT01712516|580515708|FG001|Overall Study|Physician Decision|0|||
160761617|NCT01712516|580515709|FG002|Overall Study|Physician Decision|0|||
160761618|NCT01712516|580515710|FG003|Overall Study|Physician Decision|1|||
160761619|NCT01712516|580515707|FG000|Overall Study|Withdrawal by Subject|3|||
160761620|NCT01712516|580515708|FG001|Overall Study|Withdrawal by Subject|9|||
160761621|NCT01712516|580515709|FG002|Overall Study|Withdrawal by Subject|3|||
160761622|NCT01712516|580515710|FG003|Overall Study|Withdrawal by Subject|9|||
160761623|NCT01251952|580515711|FG000|Overall Study|Adverse Event|1|||
160527021|NCT03308942|579660859|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
160761624|NCT00496769|580515712|FG000|Double Blind|>=1 reason assigned per patient|558|||
160761625|NCT00496769|580515713|FG001|Double Blind|>=1 reason assigned per patient|649|||
160527022|NCT03308942|579660860|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
160527023|NCT03308942|579660861|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
160527024|NCT03308942|579660862|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
160761626|NCT00496769|580515714|FG002|Double Blind|>=1 reason assigned per patient|0|||
160761627|NCT00496769|580515712|FG000|Open Label|>=1 reason assigned per patient|0|||
160761628|NCT00496769|580515713|FG001|Open Label|>=1 reason assigned per patient|0|||
160761629|NCT00496769|580515714|FG002|Open Label|>=1 reason assigned per patient|1011|||
160761630|NCT02308046|580515715|FG000|Overall Study|Negative yeast culture at Baseline|32|||
160636398|NCT01954082|580051541|FG001|Overall Study|Intolerance|1|||
160761631|NCT02308046|580515716|FG001|Overall Study|Negative yeast culture at Baseline|33|||
160761632|NCT02308046|580515715|FG000|Overall Study|Positive for STD at Baseline|1|||
160761633|NCT02308046|580515716|FG001|Overall Study|Positive for STD at Baseline|2|||
160527025|NCT03308942|579660858|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
160527026|NCT03308942|579660859|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
160527027|NCT03308942|579660860|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
160527028|NCT03308942|579660861|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
160527029|NCT03308942|579660862|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
160527030|NCT03308942|579660858|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
160527031|NCT03308942|579660859|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
160527032|NCT03308942|579660860|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
160761634|NCT02308046|580515715|FG000|Overall Study|Lost to Follow-up|1|||
160761635|NCT02308046|580515716|FG001|Overall Study|Lost to Follow-up|3|||
160761636|NCT02224625|580515722|FG000|Irritation|Adverse Event|6|||
160761637|NCT02224625|580515722|FG000|Sensitization|Adverse Event|55|||
160761638|NCT01181167|580515723|FG000|Overall Study|Adverse Event|11|||
160761639|NCT01181167|580515724|FG001|Overall Study|Adverse Event|21|||
160761640|NCT01181167|580515723|FG000|Overall Study|Lost to Follow-up|1|||
160761641|NCT01181167|580515724|FG001|Overall Study|Lost to Follow-up|0|||
160761642|NCT01181167|580515723|FG000|Overall Study|Physician Decision|2|||
160761643|NCT01181167|580515724|FG001|Overall Study|Physician Decision|3|||
160761644|NCT01181167|580515723|FG000|Overall Study|Protocol Violation|3|||
160761645|NCT01181167|580515724|FG001|Overall Study|Protocol Violation|0|||
160761646|NCT01181167|580515723|FG000|Overall Study|Withdrawal by Subject|6|||
160761647|NCT01181167|580515724|FG001|Overall Study|Withdrawal by Subject|8|||
160761648|NCT01433159|580515728|FG000|Overall Study|Adverse Event|1|||
160761649|NCT01433159|580515729|FG001|Overall Study|Adverse Event|0|||
160761650|NCT01433159|580515728|FG000|Overall Study|Physician Decision|1|||
160761651|NCT01433159|580515729|FG001|Overall Study|Physician Decision|0|||
160761652|NCT01433159|580515728|FG000|Overall Study|Protocol Violation|0|||
160761653|NCT01433159|580515729|FG001|Overall Study|Protocol Violation|1|||
160761654|NCT01100853|580515730|FG000|Overall Study|Lost to Follow-up|11|||
160761655|NCT01100853|580515731|FG001|Overall Study|Lost to Follow-up|6|||
160761656|NCT01100853|580515730|FG000|Overall Study|Received <4 study injections|10|||
160761657|NCT01100853|580515731|FG001|Overall Study|Received <4 study injections|13|||
160761658|NCT01100853|580515730|FG000|Overall Study|Withdrawal by Subject|6|||
160761659|NCT01100853|580515731|FG001|Overall Study|Withdrawal by Subject|4|||
160761660|NCT01384877|580515732|FG000|Treatment 2|Lost to Follow-up|2|||
160761661|NCT01384877|580515733|FG001|Treatment 2|Lost to Follow-up|2|||
160761662|NCT01548404|580515746|FG000|Overall Study|Adverse Event|3|||
160761663|NCT01548404|580515747|FG001|Overall Study|Adverse Event|1|||
160761664|NCT01548404|580515746|FG000|Overall Study|Physician Decision|2|||
160761665|NCT01548404|580515747|FG001|Overall Study|Physician Decision|1|||
160761666|NCT01548404|580515746|FG000|Overall Study|Inadequate response to study treatment|23|||
160761667|NCT01548404|580515747|FG001|Overall Study|Inadequate response to study treatment|7|||
160761668|NCT01548404|580515746|FG000|Overall Study|Lost to Follow-up|2|||
160761669|NCT01548404|580515747|FG001|Overall Study|Lost to Follow-up|0|||
160761670|NCT01548404|580515746|FG000|Overall Study|Withdrawal by Subject|0|||
160761671|NCT01548404|580515747|FG001|Overall Study|Withdrawal by Subject|3|||
160761672|NCT01548404|580515746|FG000|Overall Study|Other than specified above|0|||
160761673|NCT01548404|580515747|FG001|Overall Study|Other than specified above|2|||
160761674|NCT00883181|580515748|FG000|Overall Study|Hematological Adverse Event|26|||
160761675|NCT00883181|580515748|FG000|Overall Study|Non-hematological Adverse Event|55|||
160761676|NCT00883181|580515748|FG000|Overall Study|Disease Progression|94|||
160761677|NCT00883181|580515748|FG000|Overall Study|Administrative Reason|24|||
160761678|NCT00883181|580515748|FG000|Overall Study|Withdrawal by Subject|4|||
160761679|NCT00883181|580515748|FG000|Overall Study|Death|31|||
160761680|NCT00883181|580515748|FG000|Overall Study|Other|38|||
160761681|NCT00883181|580515748|FG000|Overall Study|Protocol Deviation|3|||
160761682|NCT00883181|580515748|FG000|Overall Study|Noncompliance|3|||
160761683|NCT04040439|580515749|FG000|Overall Study|Invalid registration|11|||
160761684|NCT04040439|580515749|FG000|Overall Study|No IC* on publication of study results|2|||
160761685|NCT00426270|580515750|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
160761686|NCT00426270|580515750|FG000|Overall Study|Adverse Event|5|||
160761687|NCT01450813|580515751|FG000|Overall Study|Physician Decision|1|||
160761688|NCT01450813|580515752|FG001|Overall Study|Physician Decision|1|||
160761689|NCT01450813|580515753|FG002|Overall Study|Physician Decision|0|||
160761690|NCT01450813|580515754|FG003|Overall Study|Physician Decision|3|||
160761691|NCT02062437|580515757|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
160761692|NCT02062437|580515757|FG000|Overall Study|Patient not available for the 2y visit|18|||
160761693|NCT02062437|580515757|FG000|Overall Study|Death|2|||
160761694|NCT02062437|580515757|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
160761695|NCT01324102|580515758|FG000|Overall Study|illness|1|||
160761696|NCT01324102|580515759|FG001|Overall Study|illness|6|||
160761697|NCT00728494|580515760|FG000|Overall Study|Adverse Event|7|||
160761698|NCT00728494|580515761|FG001|Overall Study|Adverse Event|0|||
160761699|NCT00728494|580515760|FG000|Overall Study|Withdrawal by Subject|0|||
160761700|NCT00728494|580515761|FG001|Overall Study|Withdrawal by Subject|2|||
160527033|NCT03308942|579660861|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
160761701|NCT00728494|580515760|FG000|Overall Study|Lack of Efficacy|2|||
160761702|NCT00728494|580515761|FG001|Overall Study|Lack of Efficacy|4|||
160761703|NCT00728494|580515760|FG000|Overall Study|No data available|0|||
160761704|NCT00728494|580515761|FG001|Overall Study|No data available|1|||
160761705|NCT02089347|580515762|FG000|Overall Study|Protocol Violation|1|||
160761706|NCT02089347|580515763|FG001|Overall Study|Protocol Violation|0|||
160761707|NCT01225549|580515764|FG000|Period 4 - Washout|Disallowed medication|0|||
160761708|NCT01225549|580515765|FG001|Period 4 - Washout|Disallowed medication|1|||
160761709|NCT01225549|580515766|FG002|Period 4 - Washout|Disallowed medication|0|||
160761710|NCT01225549|580515767|FG003|Period 4 - Washout|Disallowed medication|0|||
160761711|NCT01225549|580515768|FG004|Period 4 - Washout|Disallowed medication|0|||
160761712|NCT01225549|580515769|FG005|Period 4 - Washout|Disallowed medication|0|||
160761713|NCT01225549|580515770|FG006|Period 4 - Washout|Disallowed medication|0|||
160761714|NCT01225549|580515771|FG007|Period 4 - Washout|Disallowed medication|0|||
160761715|NCT01225549|580515772|FG008|Period 4 - Washout|Disallowed medication|0|||
160761716|NCT01225549|580515773|FG009|Period 4 - Washout|Disallowed medication|0|||
160761717|NCT01225549|580515764|FG000|Period 6 - Washout|Disallowed medication|0|||
160761718|NCT01225549|580515765|FG001|Period 6 - Washout|Disallowed medication|0|||
160761719|NCT01225549|580515766|FG002|Period 6 - Washout|Disallowed medication|0|||
160761720|NCT01225549|580515767|FG003|Period 6 - Washout|Disallowed medication|1|||
160761721|NCT01225549|580515768|FG004|Period 6 - Washout|Disallowed medication|0|||
160761722|NCT01225549|580515769|FG005|Period 6 - Washout|Disallowed medication|0|||
160761723|NCT01225549|580515770|FG006|Period 6 - Washout|Disallowed medication|0|||
160761724|NCT01225549|580515771|FG007|Period 6 - Washout|Disallowed medication|0|||
160761725|NCT01225549|580515772|FG008|Period 6 - Washout|Disallowed medication|0|||
160761726|NCT01225549|580515773|FG009|Period 6 - Washout|Disallowed medication|0|||
160761727|NCT03426345|580515774|FG000|Overall Study|Adverse Event|4|||
160761728|NCT03426345|580515775|FG001|Overall Study|Adverse Event|4|||
160761729|NCT03426345|580515774|FG000|Overall Study|Lack of Efficacy|1|||
160761730|NCT03426345|580515775|FG001|Overall Study|Lack of Efficacy|0|||
160761731|NCT03426345|580515774|FG000|Overall Study|Withdrawal by Subject|5|||
160761732|NCT03426345|580515775|FG001|Overall Study|Withdrawal by Subject|6|||
160761733|NCT03426345|580515774|FG000|Overall Study|Lost to Follow-up|3|||
160761734|NCT03426345|580515775|FG001|Overall Study|Lost to Follow-up|1|||
160761735|NCT03426345|580515774|FG000|Overall Study|Protocol Deviation|3|||
160761736|NCT03426345|580515775|FG001|Overall Study|Protocol Deviation|4|||
160761737|NCT03426345|580515774|FG000|Overall Study|Reason Not Specified|1|||
160761738|NCT03426345|580515775|FG001|Overall Study|Reason Not Specified|2|||
160761739|NCT03426345|580515774|FG000|Overall Study|Missing Completion Status|1|||
160761740|NCT03426345|580515775|FG001|Overall Study|Missing Completion Status|0|||
160761741|NCT02456727|580515776|FG000|Overall Study|Lost to Follow-up|63|||
160761742|NCT02456727|580515777|FG001|Overall Study|Lost to Follow-up|65|||
160761743|NCT02456727|580515776|FG000|Overall Study|Death|2|||
160761744|NCT02456727|580515777|FG001|Overall Study|Death|1|||
160761745|NCT02456727|580515776|FG000|Overall Study|Withdrawal by Subject|1|||
160761746|NCT02456727|580515777|FG001|Overall Study|Withdrawal by Subject|10|||
160761747|NCT02456727|580515776|FG000|Overall Study|Never Initiated Treatment|43|||
160761748|NCT02456727|580515777|FG001|Overall Study|Never Initiated Treatment|30|||
160761749|NCT00492297|580515778|FG000|Treatment|Death|2|||
160527034|NCT03308942|579660862|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
160761750|NCT00492297|580515778|FG000|Treatment|Study terminated by sponsor|3|||
160761751|NCT00492297|580515778|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
160761752|NCT00492297|580515778|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
160761753|NCT00492297|580515778|FG000|Survival Only Follow-up|Death|46|||
160761754|NCT00492297|580515778|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
160761755|NCT00492297|580515778|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
160761756|NCT02974868|580515779|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
160761757|NCT02974868|580515780|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
160761758|NCT02974868|580515781|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
160761759|NCT02974868|580515782|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
160761760|NCT02974868|580515779|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
160761761|NCT02974868|580515780|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
160761762|NCT02974868|580515781|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
160761763|NCT02974868|580515782|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
160761764|NCT02974868|580515779|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
160761765|NCT02974868|580515780|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
160761766|NCT02974868|580515781|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
160761767|NCT02974868|580515782|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
160761768|NCT02974868|580515779|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
160761769|NCT02974868|580515780|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
160761770|NCT02974868|580515781|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
160761771|NCT02974868|580515782|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
160761772|NCT01663402|580515783|FG000|Overall Study|Randomized but not treated|19|||
160761773|NCT01663402|580515784|FG001|Overall Study|Randomized but not treated|11|||
160761774|NCT01663402|580515783|FG000|Overall Study|Adverse Event|347|||
160761775|NCT01663402|580515784|FG001|Overall Study|Adverse Event|362|||
160761776|NCT01663402|580515783|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
160761777|NCT01663402|580515784|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
160761778|NCT01663402|580515783|FG000|Overall Study|Poor compliance to protocol|529|||
160761779|NCT01663402|580515784|FG001|Overall Study|Poor compliance to protocol|454|||
160761780|NCT01663402|580515783|FG000|Overall Study|Physician Decision|77|||
160761781|NCT01663402|580515784|FG001|Overall Study|Physician Decision|62|||
160761782|NCT01663402|580515783|FG000|Overall Study|Site terminated by sponsor|1|||
160761783|NCT01663402|580515784|FG001|Overall Study|Site terminated by sponsor|3|||
160761784|NCT01663402|580515783|FG000|Overall Study|Participant moved|139|||
160761785|NCT01663402|580515784|FG001|Overall Study|Participant moved|104|||
160761786|NCT01663402|580515783|FG000|Overall Study|Withdrawal by Subject|118|||
160761787|NCT01663402|580515784|FG001|Overall Study|Withdrawal by Subject|91|||
160761788|NCT01663402|580515783|FG000|Overall Study|Related to study drug administration|96|||
160761789|NCT01663402|580515784|FG001|Overall Study|Related to study drug administration|105|||
160761790|NCT01663402|580515783|FG000|Overall Study|Lost to Follow-up|17|||
160761791|NCT01663402|580515784|FG001|Overall Study|Lost to Follow-up|15|||
160761792|NCT01663402|580515783|FG000|Overall Study|Other than specified above|172|||
160761793|NCT01663402|580515784|FG001|Overall Study|Other than specified above|147|||
160761794|NCT01900444|580515787|FG000|Overall Study|Protocol Violation|2|||
160761795|NCT01900444|580515787|FG000|Overall Study|Lost to Follow-up|1|||
160761796|NCT00072384|580515788|FG000|Overall Study|Physician Decision|1|||
160761797|NCT00072384|580515788|FG000|Overall Study|Ineligible|8|||
160761798|NCT01825200|580515789|FG000|Overall Study|Lost to Follow-up|5|||
160865676|NCT00538902|580902950|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
160761799|NCT01825200|580515790|FG001|Overall Study|Lost to Follow-up|6|||
160761800|NCT01825200|580515789|FG000|Overall Study|Withdrawal by Subject|0|||
160761801|NCT01825200|580515790|FG001|Overall Study|Withdrawal by Subject|1|||
160761802|NCT06058390|580515791|FG000|Overall Study|Lost to Follow-up|0|||
160761803|NCT06058390|580515792|FG001|Overall Study|Lost to Follow-up|0|||
160761804|NCT06058390|580515793|FG002|Overall Study|Lost to Follow-up|2|||
160761805|NCT06058390|580515794|FG003|Overall Study|Lost to Follow-up|1|||
160761806|NCT06058390|580515791|FG000|Overall Study|Physician Decision|0|||
160761807|NCT06058390|580515792|FG001|Overall Study|Physician Decision|0|||
160761808|NCT06058390|580515793|FG002|Overall Study|Physician Decision|0|||
160761809|NCT06058390|580515794|FG003|Overall Study|Physician Decision|1|||
160761810|NCT06058390|580515791|FG000|Overall Study|Participants did not receive any study intervention|0|||
160761811|NCT06058390|580515792|FG001|Overall Study|Participants did not receive any study intervention|0|||
160761812|NCT06058390|580515793|FG002|Overall Study|Participants did not receive any study intervention|0|||
160761813|NCT06058390|580515794|FG003|Overall Study|Participants did not receive any study intervention|1|||
160761814|NCT03585270|580515797|FG000|Overall Study|Withdrawal by Subject|2|||
160761815|NCT03585270|580515798|FG001|Overall Study|Withdrawal by Subject|6|||
160761816|NCT03585270|580515797|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
160761817|NCT03585270|580515798|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
160761818|NCT03585270|580515797|FG000|Overall Study|Adverse Event|5|||
160761819|NCT03585270|580515798|FG001|Overall Study|Adverse Event|2|||
160761820|NCT03585270|580515797|FG000|Overall Study|Lost to Follow-up|1|||
160761821|NCT03585270|580515798|FG001|Overall Study|Lost to Follow-up|4|||
160761822|NCT03585270|580515797|FG000|Overall Study|Death|5|||
160761823|NCT03585270|580515798|FG001|Overall Study|Death|3|||
160761824|NCT03585270|580515797|FG000|Overall Study|Other reasons|2|||
160761825|NCT03585270|580515798|FG001|Overall Study|Other reasons|2|||
160761826|NCT05953363|580515799|FG000|Overall Study|Screen Failure|2|||
160761827|NCT05953363|580515799|FG000|Overall Study|Withdrawal by Subject|3|||
160761828|NCT05953363|580515799|FG000|Overall Study|Surgery cancelled|2|||
160761829|NCT05953363|580515799|FG000|Overall Study|Adverse Event|1|||
160761830|NCT01701674|580515800|FG000|Overall Study|Unable to safely complete treatment|1|||
160761831|NCT03904693|580515802|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
160761832|NCT03904693|580515803|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
160761833|NCT03904693|580515804|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
160761834|NCT03904693|580515805|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
160761835|NCT03904693|580515806|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
160761836|NCT03904693|580515807|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
160761837|NCT03904693|580515802|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
160761838|NCT03904693|580515803|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
160761839|NCT03904693|580515804|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
160761840|NCT03904693|580515805|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
160761841|NCT03904693|580515806|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
160761842|NCT03904693|580515807|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
160761843|NCT03904693|580515802|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
160761844|NCT03904693|580515803|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
160761845|NCT03904693|580515804|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
160761846|NCT03904693|580515805|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
160761847|NCT03904693|580515806|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
160761848|NCT03904693|580515807|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
160761849|NCT03904693|580515802|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
160761850|NCT03904693|580515803|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
160761851|NCT03904693|580515804|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
160761852|NCT03904693|580515805|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
160761853|NCT03904693|580515806|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
160761854|NCT03904693|580515807|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
160761855|NCT03904693|580515802|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
160761856|NCT03904693|580515803|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
160761857|NCT03904693|580515804|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
160761858|NCT03904693|580515805|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
160761859|NCT03904693|580515806|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
160761860|NCT03904693|580515807|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
160761861|NCT03904693|580515802|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
160761862|NCT03904693|580515803|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
160761863|NCT03904693|580515804|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
160761864|NCT03904693|580515805|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
160761865|NCT03904693|580515806|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
160761866|NCT03904693|580515807|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
160761867|NCT03904693|580515802|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
160761868|NCT03904693|580515803|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
160761869|NCT03904693|580515804|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
160761870|NCT03904693|580515805|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
160761871|NCT03904693|580515806|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
160761872|NCT03904693|580515807|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
160761873|NCT03904693|580515802|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
160761874|NCT03904693|580515803|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
160761875|NCT03904693|580515804|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
160761876|NCT03904693|580515805|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
160636399|NCT01954082|580051540|FG000|Overall Study|Non-compliance|6|||
160761877|NCT03904693|580515806|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
160761878|NCT03904693|580515807|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
160761879|NCT03904693|580515802|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
160761880|NCT03904693|580515803|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
160761881|NCT03904693|580515804|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
160761882|NCT03904693|580515805|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
160761883|NCT03904693|580515806|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
160761884|NCT03904693|580515807|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
160761885|NCT03904693|580515802|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
160761886|NCT03904693|580515803|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
160761887|NCT03904693|580515804|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
160761888|NCT03904693|580515805|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
160761889|NCT03904693|580515806|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
160761890|NCT03904693|580515807|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
160761891|NCT03904693|580515802|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
160761892|NCT03904693|580515803|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
160761893|NCT03904693|580515804|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
160761894|NCT03904693|580515805|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
160761895|NCT03904693|580515806|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
160761896|NCT03904693|580515807|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
160761897|NCT04275973|580515808|FG000|Overall Study|Withdrawal by Subject|2|||
160761898|NCT04275973|580515809|FG001|Overall Study|Withdrawal by Subject|1|||
160761899|NCT06110754|580515810|FG000|Overall Study|Withdrawal by Subject|0|||
160761900|NCT06110754|580515811|FG001|Overall Study|Withdrawal by Subject|0|||
160761901|NCT06110754|580515812|FG002|Overall Study|Withdrawal by Subject|1|||
160761902|NCT06110754|580515813|FG003|Overall Study|Withdrawal by Subject|0|||
160761903|NCT02499146|580515816|FG000|Overall Study|Global deterioration of health status|1|||
160761904|NCT02499146|580515816|FG000|Overall Study|Objective progression or relapse|20|||
160761905|NCT02499146|580515816|FG000|Overall Study|Other|2|||
160761906|NCT02499146|580515816|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
160761907|NCT04325828|580515817|FG000|Overall Study|Ongoing|26|||
160761908|NCT05115630|580515818|FG000|Overall Study|Due to COVID19|1|||
160761909|NCT05115630|580515818|FG000|Overall Study|Due to Bacteremia|1|||
160761910|NCT05115630|580515818|FG000|Overall Study|Due to viral infection|1|||
160761911|NCT04577794|580515819|FG000|Overall Study|Adverse Event|1|||
160761912|NCT04577794|580515820|FG001|Overall Study|Adverse Event|1|||
160761913|NCT00846586|580515829|FG000|Overall Study|Adverse Event|20|||
160761914|NCT00846586|580515830|FG001|Overall Study|Adverse Event|10|||
160761915|NCT00846586|580515829|FG000|Overall Study|Subject withdrew consent|8|||
160761916|NCT00846586|580515830|FG001|Overall Study|Subject withdrew consent|10|||
160761917|NCT00846586|580515829|FG000|Overall Study|Administrative problems|5|||
160761918|NCT00846586|580515830|FG001|Overall Study|Administrative problems|4|||
160761919|NCT00846586|580515829|FG000|Overall Study|Death|2|||
160761920|NCT00846586|580515830|FG001|Overall Study|Death|0|||
160761921|NCT00846586|580515829|FG000|Overall Study|Protocol deviation|2|||
160761922|NCT00846586|580515830|FG001|Overall Study|Protocol deviation|6|||
160761923|NCT00846586|580515829|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160761924|NCT00846586|580515830|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160761925|NCT00846586|580515829|FG000|Overall Study|Lost to Follow-up|1|||
160761926|NCT00846586|580515830|FG001|Overall Study|Lost to Follow-up|4|||
160761927|NCT00846586|580515829|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160761928|NCT00846586|580515830|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160761929|NCT01883895|580515833|FG000|Overall Study|Lost to Follow-up|2|||
160761930|NCT00447902|580515834|FG000|Overall Study|Adverse Event|0|||
160761931|NCT00447902|580515835|FG001|Overall Study|Adverse Event|3|||
160761932|NCT00447902|580515834|FG000|Overall Study|Protocol Violation|1|||
160761933|NCT00447902|580515835|FG001|Overall Study|Protocol Violation|0|||
160761934|NCT00447902|580515834|FG000|Overall Study|Withdrawal by Subject|0|||
160761935|NCT00447902|580515835|FG001|Overall Study|Withdrawal by Subject|1|||
160761936|NCT00447902|580515834|FG000|Overall Study|included patients who discontinued|1|||
160761937|NCT00447902|580515835|FG001|Overall Study|included patients who discontinued|1|||
160761938|NCT00447902|580515834|FG000|Overall Study|Lack of Efficacy|2|||
160761939|NCT00447902|580515835|FG001|Overall Study|Lack of Efficacy|1|||
160761940|NCT00352118|580517550|FG000|Overall Study|Physician Decision|4|||
160761941|NCT01573000|580517558|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
160761942|NCT01573000|580517559|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
160761943|NCT01573000|580517558|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
160761944|NCT01573000|580517559|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
160761945|NCT01573000|580517558|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
160761946|NCT01573000|580517559|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
160761947|NCT01573000|580517558|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
160761948|NCT01573000|580517559|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
160761949|NCT01573000|580517558|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
160761950|NCT01573000|580517559|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
160761951|NCT01573000|580517558|FG000|Crossover Phase|Lack of Efficacy|0|||
160761952|NCT01573000|580517559|FG001|Crossover Phase|Lack of Efficacy|13|||
160761953|NCT01573000|580517558|FG000|Crossover Phase|Lost to Follow-up|0|||
160761954|NCT01573000|580517559|FG001|Crossover Phase|Lost to Follow-up|2|||
160761955|NCT01573000|580517558|FG000|Crossover Phase|Death|0|||
160761956|NCT01573000|580517559|FG001|Crossover Phase|Death|3|||
160761957|NCT01573000|580517558|FG000|Long-Term Follow-Up|Death|3|||
160761958|NCT01573000|580517559|FG001|Long-Term Follow-Up|Death|0|||
160761959|NCT01573000|580517558|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
160761960|NCT01573000|580517559|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
160761961|NCT03342001|580517562|FG000|Overall Study|Adverse Event|1|||
160761962|NCT03342001|580517562|FG000|Overall Study|Lost to Follow-up|1|||
160761963|NCT01930539|580517565|FG000|Overall Study|Withdrawal by Subject|2|||
160761964|NCT01930539|580517566|FG001|Overall Study|Withdrawal by Subject|2|||
160761965|NCT00960193|580517567|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
160761966|NCT00975416|580517568|FG000|Overall Study|early discharge from tx|3|||
160761967|NCT00975416|580517569|FG001|Overall Study|early discharge from tx|5|||
160761968|NCT01249131|580517570|FG000|Washout Period of 10 Days|Adverse Event|0|||
160761969|NCT01249131|580517571|FG001|Washout Period of 10 Days|Adverse Event|0|||
160761970|NCT01249131|580517572|FG002|Washout Period of 10 Days|Adverse Event|0|||
160636400|NCT01954082|580051541|FG001|Overall Study|Non-compliance|4|||
160761971|NCT01249131|580517573|FG003|Washout Period of 10 Days|Adverse Event|0|||
160761972|NCT01249131|580517574|FG004|Washout Period of 10 Days|Adverse Event|1|||
160761973|NCT01249131|580517575|FG005|Washout Period of 10 Days|Adverse Event|0|||
160761974|NCT01245101|580517576|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
160761975|NCT01245101|580517577|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
160761976|NCT01245101|580517576|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
160761977|NCT01245101|580517577|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
160761978|NCT01245101|580517576|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
160761979|NCT01245101|580517577|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
160761980|NCT02446691|580517586|FG000|Overall Study|Withdrawal by Subject|2|||
160761981|NCT02446691|580517586|FG000|Overall Study|Lost to Follow-up|8|||
160761982|NCT02446691|580517586|FG000|Overall Study|Protocol Violation|1|||
160761983|NCT00192114|580517587|FG000|Overall Study|Objective Tumor Progression|19|||
160761984|NCT00192114|580517587|FG000|Overall Study|Adverse Event|2|||
160761985|NCT00192114|580517587|FG000|Overall Study|Clinical Progression|2|||
160865677|NCT00538902|580902948|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
160865678|NCT00538902|580902949|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
160865679|NCT00538902|580902950|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
160865680|NCT00538902|580902948|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
160865681|NCT00538902|580902949|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
160865682|NCT00538902|580902950|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
160865683|NCT00538902|580902948|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
160865684|NCT00538902|580902949|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
160865685|NCT00538902|580902950|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
160865686|NCT00538902|580902948|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
160865687|NCT00538902|580902949|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
160865688|NCT00538902|580902950|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
160865689|NCT00538902|580902948|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
160865690|NCT00538902|580902949|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
160865691|NCT00538902|580902950|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
160865692|NCT00538902|580902948|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
160865693|NCT00538902|580902949|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
160865694|NCT00538902|580902950|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
160865695|NCT00538902|580902948|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
160865696|NCT00538902|580902949|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
160865697|NCT00538902|580902950|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
160865698|NCT01454102|580902951|FG000|Overall Study|Continuing in the treatment period|0|||
160865699|NCT01454102|580902952|FG001|Overall Study|Continuing in the treatment period|0|||
160865700|NCT01454102|580902953|FG002|Overall Study|Continuing in the treatment period|0|||
160865701|NCT01454102|580902954|FG003|Overall Study|Continuing in the treatment period|0|||
160865702|NCT01454102|580902955|FG004|Overall Study|Continuing in the treatment period|3|||
160865703|NCT01454102|580902956|FG005|Overall Study|Continuing in the treatment period|3|||
160865704|NCT01454102|580902957|FG006|Overall Study|Continuing in the treatment period|2|||
160865705|NCT01454102|580902958|FG007|Overall Study|Continuing in the treatment period|0|||
160865706|NCT01454102|580902959|FG008|Overall Study|Continuing in the treatment period|1|||
160865707|NCT01454102|580902960|FG009|Overall Study|Continuing in the treatment period|0|||
160865708|NCT01454102|580902961|FG010|Overall Study|Continuing in the treatment period|0|||
160865709|NCT01454102|580902962|FG011|Overall Study|Continuing in the treatment period|4|||
160865710|NCT01454102|580902963|FG012|Overall Study|Continuing in the treatment period|7|||
160865711|NCT01454102|580902964|FG013|Overall Study|Continuing in the treatment period|4|||
160865712|NCT01454102|580902965|FG014|Overall Study|Continuing in the treatment period|3|||
160865713|NCT01454102|580902966|FG015|Overall Study|Continuing in the treatment period|1|||
160865714|NCT00705016|580902967|FG000|Overall Study|Adverse Event|6|||
160865715|NCT00705016|580902968|FG001|Overall Study|Adverse Event|11|||
160865716|NCT00705016|580902969|FG002|Overall Study|Adverse Event|10|||
160865717|NCT00705016|580902967|FG000|Overall Study|Death|5|||
160761986|NCT00192114|580517587|FG000|Overall Study|Death|1|||
160761987|NCT03885908|580517588|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
160761988|NCT03885908|580517589|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
160761989|NCT03885908|580517588|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
160865718|NCT00705016|580902968|FG001|Overall Study|Death|7|||
160761990|NCT03885908|580517589|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
160761991|NCT03885908|580517588|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
160761992|NCT03885908|580517589|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
160761993|NCT03885908|580517588|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
160761994|NCT03885908|580517589|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
160761995|NCT03903172|580517596|FG000|Overall Study|screen fail|4|||
160761996|NCT03903172|580517597|FG001|Overall Study|screen fail|1|||
160761997|NCT01545388|580517598|FG000|Overall Study|Adverse Event|2|||
160761998|NCT01545388|580517599|FG001|Overall Study|Adverse Event|4|||
160761999|NCT01545388|580517600|FG002|Overall Study|Adverse Event|1|||
160762000|NCT01545388|580517598|FG000|Overall Study|Lack of Efficacy|3|||
160762001|NCT01545388|580517599|FG001|Overall Study|Lack of Efficacy|2|||
160865719|NCT00705016|580902969|FG002|Overall Study|Death|5|||
160865720|NCT00705016|580902967|FG000|Overall Study|Protocol Violation|0|||
160865721|NCT00705016|580902968|FG001|Overall Study|Protocol Violation|1|||
160865722|NCT00705016|580902969|FG002|Overall Study|Protocol Violation|1|||
160762002|NCT01545388|580517600|FG002|Overall Study|Lack of Efficacy|5|||
160762003|NCT01545388|580517598|FG000|Overall Study|Participant moved or relocated|1|||
160762004|NCT01545388|580517599|FG001|Overall Study|Participant moved or relocated|0|||
160762005|NCT01545388|580517600|FG002|Overall Study|Participant moved or relocated|0|||
160762006|NCT01545388|580517598|FG000|Overall Study|Withdrawal by Subject|1|||
160762007|NCT01545388|580517599|FG001|Overall Study|Withdrawal by Subject|4|||
160762008|NCT01545388|580517600|FG002|Overall Study|Withdrawal by Subject|2|||
160762009|NCT01545388|580517598|FG000|Overall Study|Other|1|||
160762010|NCT01545388|580517599|FG001|Overall Study|Other|1|||
160762011|NCT01545388|580517600|FG002|Overall Study|Other|0|||
160762012|NCT01474486|580517603|FG000|Overall Study|Death|2|||
160762013|NCT01474486|580517603|FG000|Overall Study|Withdrawal by Subject|4|||
160762014|NCT01474486|580517603|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
160762015|NCT04219189|580517605|FG000|Overall Study|Withdrawal by Subject|1|||
160762016|NCT04219189|580517606|FG001|Overall Study|Withdrawal by Subject|2|||
160762017|NCT04219189|580517605|FG000|Overall Study|Protocol Violation|0|||
160762018|NCT04219189|580517606|FG001|Overall Study|Protocol Violation|1|||
160762019|NCT04219189|580517605|FG000|Overall Study|Lost to Follow-up|0|||
160762020|NCT04219189|580517606|FG001|Overall Study|Lost to Follow-up|1|||
160762021|NCT04219189|580517605|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
160762022|NCT04219189|580517606|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
160762023|NCT02495389|580517607|FG000|Overall Study|Withdrawal by Subject|40|||
160762024|NCT03292016|580517610|FG000|Second Washout|Adverse Event|0|||
160762025|NCT03292016|580517611|FG001|Second Washout|Adverse Event|1|||
160762026|NCT03292016|580517612|FG002|Second Washout|Adverse Event|0|||
160762027|NCT03292016|580517613|FG003|Second Washout|Adverse Event|0|||
160762028|NCT03292016|580517614|FG004|Second Washout|Adverse Event|0|||
160762029|NCT03292016|580517615|FG005|Second Washout|Adverse Event|0|||
160762030|NCT05002972|580517616|FG000|Overall Study|Withdrawal by Subject|2|||
160762031|NCT01172873|580517617|FG000|Overall Study|Withdrawal by Subject|3|||
160762032|NCT01172873|580517618|FG001|Overall Study|Withdrawal by Subject|2|||
160762033|NCT05518539|580517619|FG000|Overall Study|Lost to Follow-up|6|||
160762034|NCT04613518|580517620|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
160762035|NCT04613518|580517621|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
160762036|NCT04613518|580517622|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
160762037|NCT04613518|580517620|FG000|Double-Blind Treatment Period|Adverse Event|2|||
160762038|NCT04613518|580517621|FG001|Double-Blind Treatment Period|Adverse Event|0|||
160762039|NCT04613518|580517622|FG002|Double-Blind Treatment Period|Adverse Event|1|||
160762040|NCT04613518|580517620|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
160762041|NCT04613518|580517621|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
160762042|NCT04613518|580517622|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
160762043|NCT04613518|580517620|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
160762044|NCT04613518|580517621|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
160762045|NCT04613518|580517622|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
160762046|NCT04613518|580517620|FG000|Double-Blind Treatment Period|Other Reasons|2|||
160527035|NCT03308942|579660858|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
160527036|NCT03308942|579660859|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
160527037|NCT03308942|579660860|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
160527038|NCT03308942|579660861|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
160527039|NCT03308942|579660862|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
160527040|NCT01131351|579660863|FG000|Overall Study|Adverse Event|0|||
160527041|NCT01131351|579660864|FG001|Overall Study|Adverse Event|2|||
160527042|NCT01131351|579660863|FG000|Overall Study|Protocol Deviation|0|||
160527043|NCT01131351|579660864|FG001|Overall Study|Protocol Deviation|1|||
160527044|NCT00221195|579660868|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
160527045|NCT00221195|579660869|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
160527046|NCT00221195|579660868|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
160527047|NCT00221195|579660869|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
160527048|NCT00221195|579660868|FG000|Washout Period (Months 7-9)|Death|0|||
160527049|NCT00221195|579660869|FG001|Washout Period (Months 7-9)|Death|1|||
160527050|NCT00221195|579660868|FG000|Therapy 2 (Months 10-15)|Death|1|||
160527051|NCT00221195|579660869|FG001|Therapy 2 (Months 10-15)|Death|0|||
160636401|NCT01954082|580051540|FG000|Overall Study|Physician Decision|2|||
160762047|NCT04613518|580517621|FG001|Double-Blind Treatment Period|Other Reasons|0|||
160762048|NCT04613518|580517622|FG002|Double-Blind Treatment Period|Other Reasons|0|||
160762049|NCT04613518|580517620|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
160762050|NCT04613518|580517621|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
160762051|NCT04613518|580517622|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
160762052|NCT04613518|580517620|FG000|Open-Label Treatment Period|Adverse Event|1|||
160762053|NCT04613518|580517621|FG001|Open-Label Treatment Period|Adverse Event|0|||
160762054|NCT04613518|580517622|FG002|Open-Label Treatment Period|Adverse Event|3|||
160762055|NCT04613518|580517620|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
160762056|NCT04613518|580517621|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
160762057|NCT04613518|580517622|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
160762058|NCT04613518|580517620|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
160762059|NCT04613518|580517621|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
160762060|NCT04613518|580517622|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
160762061|NCT04613518|580517620|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
160762062|NCT04613518|580517621|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
160762063|NCT04613518|580517622|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
160762064|NCT04613518|580517620|FG000|Open-Label Treatment Period|Other reasons|1|||
160762065|NCT04613518|580517621|FG001|Open-Label Treatment Period|Other reasons|0|||
160762066|NCT04613518|580517622|FG002|Open-Label Treatment Period|Other reasons|0|||
160762067|NCT03589807|580517623|FG000|Overall Study|Lost to Follow-up|0|||
160762068|NCT03589807|580517624|FG001|Overall Study|Lost to Follow-up|2|||
160762069|NCT03589807|580517625|FG002|Overall Study|Lost to Follow-up|2|||
160762070|NCT03589807|580517626|FG003|Overall Study|Lost to Follow-up|3|||
160762071|NCT03589807|580517627|FG004|Overall Study|Lost to Follow-up|1|||
160762072|NCT03589807|580517628|FG005|Overall Study|Lost to Follow-up|1|||
160762073|NCT03589807|580517623|FG000|Overall Study|Withdrawal by Subject|0|||
160762074|NCT03589807|580517624|FG001|Overall Study|Withdrawal by Subject|5|||
160762075|NCT03589807|580517625|FG002|Overall Study|Withdrawal by Subject|0|||
160762076|NCT03589807|580517626|FG003|Overall Study|Withdrawal by Subject|0|||
160762077|NCT03589807|580517627|FG004|Overall Study|Withdrawal by Subject|0|||
160762078|NCT03589807|580517628|FG005|Overall Study|Withdrawal by Subject|0|||
160762079|NCT03589807|580517623|FG000|Overall Study|Protocol Violation|0|||
160762080|NCT03589807|580517624|FG001|Overall Study|Protocol Violation|0|||
160762081|NCT03589807|580517625|FG002|Overall Study|Protocol Violation|0|||
160762082|NCT03589807|580517626|FG003|Overall Study|Protocol Violation|1|||
160762083|NCT03589807|580517627|FG004|Overall Study|Protocol Violation|0|||
160762084|NCT03589807|580517628|FG005|Overall Study|Protocol Violation|0|||
160762085|NCT03589807|580517623|FG000|Overall Study|Enrolled but treatment not administered|0|||
160762086|NCT03589807|580517624|FG001|Overall Study|Enrolled but treatment not administered|0|||
160762087|NCT03589807|580517625|FG002|Overall Study|Enrolled but treatment not administered|0|||
160762088|NCT03589807|580517626|FG003|Overall Study|Enrolled but treatment not administered|0|||
160762089|NCT03589807|580517627|FG004|Overall Study|Enrolled but treatment not administered|1|||
160762090|NCT03589807|580517628|FG005|Overall Study|Enrolled but treatment not administered|0|||
160762091|NCT01076543|580517629|FG000|Overall Study|Withdrawal by Subject|2|||
160762092|NCT01076543|580517630|FG001|Overall Study|Withdrawal by Subject|0|||
160762093|NCT01076543|580517631|FG002|Overall Study|Withdrawal by Subject|0|||
160762094|NCT01076543|580517632|FG003|Overall Study|Withdrawal by Subject|0|||
160762095|NCT01076543|580517633|FG004|Overall Study|Withdrawal by Subject|0|||
160762096|NCT01076543|580517634|FG005|Overall Study|Withdrawal by Subject|0|||
160762097|NCT00338741|580517635|FG000|Overall Study|Lost to Follow-up|2|||
160762098|NCT00338741|580517636|FG001|Overall Study|Lost to Follow-up|0|||
160762099|NCT01534273|580517637|FG000|Period 1|Physician Decision|0|||
160762100|NCT01534273|580517638|FG001|Period 1|Physician Decision|0|||
160636402|NCT01954082|580051541|FG001|Overall Study|Physician Decision|0|||
160865723|NCT00705016|580902967|FG000|Overall Study|Withdrawal by Subject|4|||
160865724|NCT00705016|580902968|FG001|Overall Study|Withdrawal by Subject|3|||
160865725|NCT00705016|580902969|FG002|Overall Study|Withdrawal by Subject|2|||
160865726|NCT00705016|580902967|FG000|Overall Study|Progressive Disease|33|||
160865727|NCT00705016|580902968|FG001|Overall Study|Progressive Disease|29|||
160865728|NCT00705016|580902969|FG002|Overall Study|Progressive Disease|33|||
160865729|NCT00705016|580902967|FG000|Overall Study|Symptomatic Deterioration|3|||
160865730|NCT00705016|580902968|FG001|Overall Study|Symptomatic Deterioration|1|||
160865731|NCT00705016|580902969|FG002|Overall Study|Symptomatic Deterioration|1|||
160865732|NCT00705016|580902967|FG000|Overall Study|Other|9|||
160865733|NCT00705016|580902968|FG001|Overall Study|Other|6|||
160865734|NCT00705016|580902969|FG002|Overall Study|Other|6|||
160865735|NCT00942604|580902972|FG000|Overall Study|Protocol Violation|1|||
160865736|NCT00942604|580902973|FG001|Overall Study|Protocol Violation|1|||
160865737|NCT00942604|580902972|FG000|Overall Study|Adverse Event|0|||
160865738|NCT00942604|580902973|FG001|Overall Study|Adverse Event|1|||
160865739|NCT00942604|580902972|FG000|Overall Study|Withdrawal by Subject|0|||
160865740|NCT00942604|580902973|FG001|Overall Study|Withdrawal by Subject|1|||
160865741|NCT00942604|580902972|FG000|Overall Study|Patient relocation|1|||
160865742|NCT00942604|580902973|FG001|Overall Study|Patient relocation|1|||
160865743|NCT01188343|580902974|FG000|Overall Study|Not vaccinated|0|||
160865744|NCT01188343|580902975|FG001|Overall Study|Not vaccinated|2|||
160865745|NCT01188343|580902976|FG002|Overall Study|Not vaccinated|1|||
160865746|NCT01188343|580902974|FG000|Overall Study|Withdrawal by Subject|1|||
160865747|NCT01188343|580902975|FG001|Overall Study|Withdrawal by Subject|24|||
160865748|NCT01188343|580902976|FG002|Overall Study|Withdrawal by Subject|0|||
160865749|NCT01663103|580902977|FG000|Overall Study|Withdrawal by Subject|1|||
160865750|NCT01663103|580902978|FG001|Overall Study|Withdrawal by Subject|2|||
160865751|NCT01663103|580902977|FG000|Overall Study|Adverse Event|1|||
160527052|NCT00221195|579660868|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
160527053|NCT00221195|579660869|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
160865752|NCT01663103|580902978|FG001|Overall Study|Adverse Event|0|||
160865753|NCT01663103|580902977|FG000|Overall Study|dog bite|1|||
160865754|NCT01663103|580902978|FG001|Overall Study|dog bite|0|||
160865755|NCT04634253|580902983|FG000|Overall Study|Adverse Event|1|||
160865756|NCT04634253|580902984|FG001|Overall Study|Adverse Event|1|||
160865757|NCT04634253|580902985|FG002|Overall Study|Adverse Event|0|||
160865758|NCT04634253|580902983|FG000|Overall Study|Physician Decision|0|||
160865759|NCT04634253|580902984|FG001|Overall Study|Physician Decision|1|||
160865760|NCT04634253|580902985|FG002|Overall Study|Physician Decision|0|||
160865761|NCT04634253|580902983|FG000|Overall Study|Withdrawal by Subject|1|||
160865762|NCT04634253|580902984|FG001|Overall Study|Withdrawal by Subject|0|||
160865763|NCT04634253|580902985|FG002|Overall Study|Withdrawal by Subject|3|||
160865764|NCT01721044|580902986|FG000|Treatment Period|Adverse Event|7|||
160865765|NCT01721044|580902987|FG001|Treatment Period|Adverse Event|7|||
160865766|NCT01721044|580902988|FG002|Treatment Period|Adverse Event|10|||
160865767|NCT01721044|580902986|FG000|Treatment Period|Death|0|||
160865768|NCT01721044|580902987|FG001|Treatment Period|Death|0|||
160865769|NCT01721044|580902988|FG002|Treatment Period|Death|1|||
160762101|NCT01534273|580517639|FG002|Period 1|Physician Decision|0|||
160762102|NCT01534273|580517640|FG003|Period 1|Physician Decision|1|||
160762103|NCT01534273|580517641|FG004|Period 1|Physician Decision|0|||
160762104|NCT01534273|580517642|FG005|Period 1|Physician Decision|0|||
160762105|NCT01534273|580517643|FG006|Period 1|Physician Decision|0|||
160762106|NCT01619865|580517644|FG000|Overall Study|Adverse Event|1|||
160762107|NCT01619865|580517644|FG000|Overall Study|Death|2|||
160762108|NCT01619865|580517644|FG000|Overall Study|subject not able to comply|1|||
160762109|NCT03586050|580517645|FG000|Overall Study|Death|3|||
160762110|NCT03586050|580517645|FG000|Overall Study|Withdrawal by Subject|2|||
160762111|NCT01494818|580517646|FG000|Overall Study|Relocation|1|||
160762112|NCT01494818|580517647|FG001|Overall Study|Relocation|2|||
160762113|NCT01494818|580517646|FG000|Overall Study|Lost to Follow-up|1|||
160762114|NCT01494818|580517647|FG001|Overall Study|Lost to Follow-up|0|||
160762115|NCT01211145|580517648|FG000|Overall Study|Reason not specified|3|||
160762116|NCT01211145|580517649|FG001|Overall Study|Reason not specified|2|||
160762117|NCT01211145|580517650|FG002|Overall Study|Reason not specified|2|||
160762118|NCT01211145|580517651|FG003|Overall Study|Reason not specified|1|||
160762119|NCT01211145|580517648|FG000|Overall Study|Lost to Follow-up|3|||
160762120|NCT01211145|580517649|FG001|Overall Study|Lost to Follow-up|2|||
160762121|NCT01211145|580517650|FG002|Overall Study|Lost to Follow-up|1|||
160762122|NCT01211145|580517651|FG003|Overall Study|Lost to Follow-up|2|||
160762123|NCT01211145|580517648|FG000|Overall Study|Study-specific withdrawal criteria|1|||
160762124|NCT01211145|580517649|FG001|Overall Study|Study-specific withdrawal criteria|0|||
160762125|NCT01211145|580517650|FG002|Overall Study|Study-specific withdrawal criteria|0|||
160762126|NCT01211145|580517651|FG003|Overall Study|Study-specific withdrawal criteria|0|||
160762127|NCT01211145|580517648|FG000|Overall Study|Severe noncompliance to protocol|1|||
160762128|NCT01211145|580517649|FG001|Overall Study|Severe noncompliance to protocol|0|||
160762129|NCT01211145|580517650|FG002|Overall Study|Severe noncompliance to protocol|0|||
160762130|NCT01211145|580517651|FG003|Overall Study|Severe noncompliance to protocol|0|||
160762131|NCT01211145|580517648|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
160762132|NCT01211145|580517649|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
160762133|NCT01211145|580517650|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
160762134|NCT01211145|580517651|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
160762135|NCT01211145|580517648|FG000|Overall Study|Patient decision|2|||
160762136|NCT01211145|580517649|FG001|Overall Study|Patient decision|1|||
160762137|NCT01211145|580517650|FG002|Overall Study|Patient decision|0|||
160762138|NCT01211145|580517651|FG003|Overall Study|Patient decision|2|||
160762139|NCT00617357|580517654|FG000|Overall Study|Lost to Follow-up|7|||
160762140|NCT00617357|580517654|FG000|Overall Study|Death|5|||
160762141|NCT00617357|580517654|FG000|Overall Study|insurance concerns|2|||
160762142|NCT00617357|580517654|FG000|Overall Study|Withdrawal by Subject|1|||
160762143|NCT00617357|580517654|FG000|Overall Study|Physician Decision|1|||
160762144|NCT01946204|580517657|FG000|Overall Study|Death|38|||
160865770|NCT01721044|580902986|FG000|Treatment Period|Lack of Efficacy|16|||
160865771|NCT01721044|580902987|FG001|Treatment Period|Lack of Efficacy|4|||
160865772|NCT01721044|580902988|FG002|Treatment Period|Lack of Efficacy|4|||
160527054|NCT03083847|579660870|FG000|Main|Physician Decision|0|||
160527055|NCT03083847|579660871|FG001|Main|Physician Decision|0|||
160527056|NCT03083847|579660872|FG002|Main|Physician Decision|0|||
160527057|NCT03083847|579660873|FG003|Main|Physician Decision|0|||
160527058|NCT03083847|579660874|FG004|Main|Physician Decision|0|||
160527059|NCT03083847|579660875|FG005|Main|Physician Decision|1|||
160527060|NCT03083847|579660876|FG006|Main|Physician Decision|0|||
160527061|NCT03083847|579660877|FG007|Main|Physician Decision|0|||
160527062|NCT03083847|579660878|FG008|Main|Physician Decision|0|||
160527063|NCT03083847|579660879|FG009|Main|Physician Decision|0|||
160527064|NCT03083847|579660870|FG000|Main|Pregnancy|0|||
160527065|NCT03083847|579660871|FG001|Main|Pregnancy|0|||
160762145|NCT01946204|580517658|FG001|Overall Study|Death|59|||
160762146|NCT01946204|580517657|FG000|Overall Study|Withdrawal by Subject|37|||
160762147|NCT01946204|580517658|FG001|Overall Study|Withdrawal by Subject|50|||
160762148|NCT01946204|580517657|FG000|Overall Study|Lost to Follow-up|3|||
160762149|NCT01946204|580517658|FG001|Overall Study|Lost to Follow-up|7|||
160762150|NCT01946204|580517657|FG000|Overall Study|Ongoing|316|||
160762151|NCT01946204|580517658|FG001|Overall Study|Ongoing|687|||
160762152|NCT01946204|580517657|FG000|Overall Study|Other|7|||
160762153|NCT01946204|580517658|FG001|Overall Study|Other|3|||
160762154|NCT00086190|580517659|FG000|Overall Study|Adverse Event|6|||
160762155|NCT00086190|580517660|FG001|Overall Study|Adverse Event|2|||
160762156|NCT00086190|580517661|FG002|Overall Study|Adverse Event|2|||
160762157|NCT00086190|580517659|FG000|Overall Study|Withdrawal by Subject|0|||
160762158|NCT00086190|580517660|FG001|Overall Study|Withdrawal by Subject|2|||
160762159|NCT00086190|580517661|FG002|Overall Study|Withdrawal by Subject|2|||
160762160|NCT00086190|580517659|FG000|Overall Study|Protocol Violation|1|||
160762161|NCT00086190|580517660|FG001|Overall Study|Protocol Violation|0|||
160762162|NCT00086190|580517661|FG002|Overall Study|Protocol Violation|0|||
160762163|NCT00086190|580517659|FG000|Overall Study|Moved|1|||
160762164|NCT00086190|580517660|FG001|Overall Study|Moved|0|||
160762165|NCT00086190|580517661|FG002|Overall Study|Moved|0|||
160762166|NCT00086190|580517659|FG000|Overall Study|Worsening depression|0|||
160762167|NCT00086190|580517660|FG001|Overall Study|Worsening depression|0|||
160762168|NCT00086190|580517661|FG002|Overall Study|Worsening depression|2|||
160762169|NCT00249834|580517662|FG000|Overall Study|Ovarian stimulation failed|1|||
160762170|NCT00249834|580517663|FG001|Overall Study|Ovarian stimulation failed|0|||
160762171|NCT00249834|580517664|FG002|Overall Study|Ovarian stimulation failed|0|||
160762172|NCT00249834|580517665|FG003|Overall Study|Ovarian stimulation failed|0|||
160762173|NCT00249834|580517666|FG004|Overall Study|Ovarian stimulation failed|0|||
160762174|NCT00249834|580517667|FG005|Overall Study|Ovarian stimulation failed|0|||
160762175|NCT00249834|580517668|FG006|Overall Study|Ovarian stimulation failed|0|||
160762176|NCT00249834|580517669|FG007|Overall Study|Ovarian stimulation failed|0|||
160762177|NCT00249834|580517662|FG000|Overall Study|Failure of down-regulation|0|||
160762178|NCT00249834|580517663|FG001|Overall Study|Failure of down-regulation|0|||
160762179|NCT00249834|580517664|FG002|Overall Study|Failure of down-regulation|0|||
160762180|NCT00249834|580517665|FG003|Overall Study|Failure of down-regulation|0|||
160762181|NCT00249834|580517666|FG004|Overall Study|Failure of down-regulation|0|||
160762182|NCT00249834|580517667|FG005|Overall Study|Failure of down-regulation|0|||
160762183|NCT00249834|580517668|FG006|Overall Study|Failure of down-regulation|1|||
160762184|NCT00249834|580517669|FG007|Overall Study|Failure of down-regulation|0|||
160762185|NCT00249834|580517662|FG000|Overall Study|Protocol Violation|0|||
160762186|NCT00249834|580517663|FG001|Overall Study|Protocol Violation|19|||
160762187|NCT00249834|580517664|FG002|Overall Study|Protocol Violation|14|||
160762188|NCT00249834|580517665|FG003|Overall Study|Protocol Violation|8|||
160762189|NCT00249834|580517666|FG004|Overall Study|Protocol Violation|5|||
160762190|NCT00249834|580517667|FG005|Overall Study|Protocol Violation|2|||
160762191|NCT00249834|580517668|FG006|Overall Study|Protocol Violation|0|||
160527066|NCT03083847|579660872|FG002|Main|Pregnancy|0|||
160762192|NCT00249834|580517669|FG007|Overall Study|Protocol Violation|0|||
160762193|NCT02688933|580517672|FG000|Overall Study|Adverse Event|3|||
160762194|NCT02688933|580517673|FG001|Overall Study|Adverse Event|1|||
160762195|NCT02688933|580517672|FG000|Overall Study|Lack of Efficacy|2|||
160762196|NCT02688933|580517673|FG001|Overall Study|Lack of Efficacy|2|||
160762197|NCT02688933|580517672|FG000|Overall Study|Poor compliance to protocol|7|||
160762198|NCT02688933|580517673|FG001|Overall Study|Poor compliance to protocol|4|||
160527067|NCT03083847|579660873|FG003|Main|Pregnancy|0|||
160762199|NCT02688933|580517672|FG000|Overall Study|Hypoglycemia|2|||
160762200|NCT02688933|580517673|FG001|Overall Study|Hypoglycemia|0|||
160527068|NCT03083847|579660874|FG004|Main|Pregnancy|0|||
160762201|NCT02688933|580517672|FG000|Overall Study|Other than Specified|14|||
160762202|NCT02688933|580517673|FG001|Overall Study|Other than Specified|25|||
160865773|NCT01721044|580902986|FG000|Treatment Period|Lost to Follow-up|0|||
160527069|NCT03083847|579660875|FG005|Main|Pregnancy|0|||
160527070|NCT03083847|579660876|FG006|Main|Pregnancy|0|||
160527071|NCT03083847|579660877|FG007|Main|Pregnancy|1|||
160762203|NCT02688933|580517672|FG000|Overall Study|Lost to Follow-up|1|||
160865774|NCT01721044|580902987|FG001|Treatment Period|Lost to Follow-up|0|||
160865775|NCT01721044|580902988|FG002|Treatment Period|Lost to Follow-up|1|||
160865776|NCT01721044|580902986|FG000|Treatment Period|Physician Decision|1|||
160865777|NCT01721044|580902987|FG001|Treatment Period|Physician Decision|0|||
160865778|NCT01721044|580902988|FG002|Treatment Period|Physician Decision|2|||
160865779|NCT01721044|580902986|FG000|Treatment Period|Protocol Violation|1|||
160865780|NCT01721044|580902987|FG001|Treatment Period|Protocol Violation|0|||
160865781|NCT01721044|580902988|FG002|Treatment Period|Protocol Violation|0|||
160865782|NCT01721044|580902986|FG000|Treatment Period|Withdrawal by Subject|7|||
160865783|NCT01721044|580902987|FG001|Treatment Period|Withdrawal by Subject|6|||
160865784|NCT01721044|580902988|FG002|Treatment Period|Withdrawal by Subject|1|||
160865785|NCT01499355|580902992|FG000|Run-In Period|Study Termination|15|||
160865786|NCT01499355|580902993|FG001|Run-In Period|Study Termination|0|||
160865787|NCT01499355|580902994|FG002|Run-In Period|Study Termination|0|||
160865788|NCT01499355|580902995|FG003|Run-In Period|Study Termination|0|||
160865789|NCT01499355|580902992|FG000|Run-In Period|Other|3|||
160865790|NCT01499355|580902993|FG001|Run-In Period|Other|0|||
160865791|NCT01499355|580902994|FG002|Run-In Period|Other|0|||
160865792|NCT01499355|580902995|FG003|Run-In Period|Other|0|||
160865793|NCT01499355|580902992|FG000|Run-In Period|Death|2|||
160865794|NCT01499355|580902993|FG001|Run-In Period|Death|0|||
160865795|NCT01499355|580902994|FG002|Run-In Period|Death|0|||
160865796|NCT01499355|580902995|FG003|Run-In Period|Death|0|||
160865797|NCT01499355|580902992|FG000|Run-In Period|Investigator Decision|2|||
160865798|NCT01499355|580902993|FG001|Run-In Period|Investigator Decision|0|||
160762204|NCT02688933|580517673|FG001|Overall Study|Lost to Follow-up|5|||
160762205|NCT01949142|580517691|FG000|Overall Study|Withdrawal of consent|1|||
160762206|NCT01949142|580517692|FG001|Overall Study|Withdrawal of consent|0|||
160762207|NCT01949142|580517691|FG000|Overall Study|Lost to Follow-up|1|||
160762208|NCT01949142|580517692|FG001|Overall Study|Lost to Follow-up|1|||
160762209|NCT01949142|580517691|FG000|Overall Study|Parent changed their mind|1|||
160762210|NCT01949142|580517692|FG001|Overall Study|Parent changed their mind|0|||
160762211|NCT04802161|580517694|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
160762212|NCT04802161|580517695|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
160762213|NCT04802161|580517696|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
160762214|NCT04802161|580517697|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
160762215|NCT04802161|580517694|FG000|Overall Study|Clinical Instability|0|||
160762216|NCT04802161|580517695|FG001|Overall Study|Clinical Instability|0|||
160762217|NCT04802161|580517696|FG002|Overall Study|Clinical Instability|1|||
160762218|NCT04802161|580517697|FG003|Overall Study|Clinical Instability|0|||
160762219|NCT04802161|580517694|FG000|Overall Study|Adverse Event|0|||
160762220|NCT04802161|580517695|FG001|Overall Study|Adverse Event|0|||
160762221|NCT04802161|580517696|FG002|Overall Study|Adverse Event|1|||
160762222|NCT04802161|580517697|FG003|Overall Study|Adverse Event|0|||
160762223|NCT04802161|580517694|FG000|Overall Study|Death|0|||
160762224|NCT04802161|580517695|FG001|Overall Study|Death|0|||
160762225|NCT04802161|580517696|FG002|Overall Study|Death|1|||
160762226|NCT04802161|580517697|FG003|Overall Study|Death|0|||
160762227|NCT00557466|580519303|FG000|Overall Study|Adverse Event|3|||
160762228|NCT00557466|580519304|FG001|Overall Study|Adverse Event|1|||
160762229|NCT00557466|580519305|FG002|Overall Study|Adverse Event|4|||
160762230|NCT00557466|580519306|FG003|Overall Study|Adverse Event|1|||
160762231|NCT00557466|580519307|FG004|Overall Study|Adverse Event|2|||
160762232|NCT00557466|580519308|FG005|Overall Study|Adverse Event|4|||
160762233|NCT00557466|580519303|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160762234|NCT00557466|580519304|FG001|Overall Study|Abnormal laboratory value(s)|2|||
160762235|NCT00557466|580519305|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160762236|NCT00557466|580519306|FG003|Overall Study|Abnormal laboratory value(s)|0|||
160762237|NCT00557466|580519307|FG004|Overall Study|Abnormal laboratory value(s)|0|||
160762238|NCT00557466|580519308|FG005|Overall Study|Abnormal laboratory value(s)|0|||
160762239|NCT00557466|580519303|FG000|Overall Study|Protocol deviation|0|||
160762240|NCT00557466|580519304|FG001|Overall Study|Protocol deviation|1|||
160865799|NCT01499355|580902994|FG002|Run-In Period|Investigator Decision|0|||
160865800|NCT01499355|580902995|FG003|Run-In Period|Investigator Decision|0|||
160865801|NCT01499355|580902992|FG000|Run-In Period|Consent Withdrawn|1|||
160762241|NCT00557466|580519305|FG002|Overall Study|Protocol deviation|0|||
160762242|NCT00557466|580519306|FG003|Overall Study|Protocol deviation|2|||
160762243|NCT00557466|580519307|FG004|Overall Study|Protocol deviation|0|||
160762244|NCT00557466|580519308|FG005|Overall Study|Protocol deviation|0|||
160762245|NCT00557466|580519303|FG000|Overall Study|Subject withdrew consent|0|||
160762246|NCT00557466|580519304|FG001|Overall Study|Subject withdrew consent|0|||
160762247|NCT00557466|580519305|FG002|Overall Study|Subject withdrew consent|0|||
160762248|NCT00557466|580519306|FG003|Overall Study|Subject withdrew consent|0|||
160762249|NCT00557466|580519307|FG004|Overall Study|Subject withdrew consent|1|||
160762250|NCT00557466|580519308|FG005|Overall Study|Subject withdrew consent|2|||
160762251|NCT00557466|580519303|FG000|Overall Study|Administrative problems|0|||
160762252|NCT00557466|580519304|FG001|Overall Study|Administrative problems|1|||
160762253|NCT00557466|580519305|FG002|Overall Study|Administrative problems|1|||
160762254|NCT00557466|580519306|FG003|Overall Study|Administrative problems|0|||
160762255|NCT00557466|580519307|FG004|Overall Study|Administrative problems|0|||
160762256|NCT00557466|580519308|FG005|Overall Study|Administrative problems|0|||
160762257|NCT00557466|580519303|FG000|Overall Study|Abnormal test procedure results|0|||
160762258|NCT00557466|580519304|FG001|Overall Study|Abnormal test procedure results|0|||
160762259|NCT00557466|580519305|FG002|Overall Study|Abnormal test procedure results|1|||
160762260|NCT00557466|580519306|FG003|Overall Study|Abnormal test procedure results|0|||
160762261|NCT00557466|580519307|FG004|Overall Study|Abnormal test procedure results|0|||
160762262|NCT00557466|580519308|FG005|Overall Study|Abnormal test procedure results|0|||
160762263|NCT00557466|580519303|FG000|Overall Study|Lost to Follow-up|0|||
160762264|NCT00557466|580519304|FG001|Overall Study|Lost to Follow-up|0|||
160762265|NCT00557466|580519305|FG002|Overall Study|Lost to Follow-up|0|||
160762266|NCT00557466|580519306|FG003|Overall Study|Lost to Follow-up|1|||
160762267|NCT00557466|580519307|FG004|Overall Study|Lost to Follow-up|0|||
160762268|NCT00557466|580519308|FG005|Overall Study|Lost to Follow-up|0|||
160762269|NCT00752089|580519309|FG000|Overall Study|Adverse Event|1|||
160762270|NCT00752089|580519309|FG000|Overall Study|Protocol Deviation|2|||
160762271|NCT00752089|580519309|FG000|Overall Study|Could not attend visit 9|1|||
160762272|NCT00752089|580519309|FG000|Overall Study|Not capable of wearing partial denture|1|||
160762273|NCT00752089|580519309|FG000|Overall Study|Cannot continue the study|1|||
160762274|NCT00386334|580519312|FG000|Double Blind Period|Adverse Event|9|||
160762275|NCT00386334|580519313|FG001|Double Blind Period|Adverse Event|14|||
160762276|NCT00386334|580519312|FG000|Double Blind Period|Protocol Violation|1|||
160762277|NCT00386334|580519313|FG001|Double Blind Period|Protocol Violation|1|||
160762278|NCT00386334|580519312|FG000|Double Blind Period|Withdrawal by Subject|9|||
160762279|NCT00386334|580519313|FG001|Double Blind Period|Withdrawal by Subject|13|||
160762280|NCT00386334|580519312|FG000|Double Blind Period|Lack of Efficacy|20|||
160762281|NCT00386334|580519313|FG001|Double Blind Period|Lack of Efficacy|11|||
160762282|NCT00386334|580519312|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
160762283|NCT00386334|580519313|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
160762284|NCT00386334|580519312|FG000|Double Blind Period|Other|3|||
160762285|NCT00386334|580519313|FG001|Double Blind Period|Other|3|||
160762286|NCT00386334|580519312|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
160762287|NCT00386334|580519313|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
160762288|NCT03238417|580519314|FG000|Overall|non-response|955|||
160762289|NCT03238417|580519315|FG001|Overall|non-response|1920|||
160762290|NCT03238417|580519314|FG000|Overall|partial completion|48|||
160762291|NCT03238417|580519315|FG001|Overall|partial completion|68|||
160762292|NCT03238417|580519314|FG000|Baseline|Partial completion|17|||
160762293|NCT03238417|580519315|FG001|Baseline|Partial completion|48|||
160762294|NCT03238417|580519314|FG000|Baseline|non-response|372|||
160762295|NCT03238417|580519315|FG001|Baseline|non-response|669|||
160762296|NCT03238417|580519314|FG000|12-month|non-response|296|||
160762297|NCT03238417|580519315|FG001|12-month|non-response|669|||
160762298|NCT03238417|580519314|FG000|12-month|partial completion|23|||
160762299|NCT03238417|580519315|FG001|12-month|partial completion|37|||
160762300|NCT03238417|580519314|FG000|24-month|non-response|287|||
160762301|NCT03238417|580519315|FG001|24-month|non-response|594|||
160762302|NCT03238417|580519314|FG000|24-month|partial completion|8|||
160762303|NCT03238417|580519315|FG001|24-month|partial completion|31|||
160762304|NCT02914834|580519319|FG000|Overall Study|Study halted due to COVID|1|||
160762305|NCT02914834|580519320|FG001|Overall Study|Study halted due to COVID|1|||
160762306|NCT02914834|580519319|FG000|Overall Study|1 subject withdrew|0|||
160762307|NCT02914834|580519320|FG001|Overall Study|1 subject withdrew|1|||
160762308|NCT00473083|580519327|FG000|Overall Study|Adverse Event|1|||
160762309|NCT00473083|580519328|FG001|Overall Study|Adverse Event|0|||
160762310|NCT00473083|580519329|FG002|Overall Study|Adverse Event|0|||
160762311|NCT01184872|580519330|FG000|Overall Study|Adverse Event|3|||
160762312|NCT01184872|580519331|FG001|Overall Study|Adverse Event|4|||
160762313|NCT01184872|580519330|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
160762314|NCT01184872|580519331|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160762315|NCT01184872|580519330|FG000|Overall Study|Withdrawal by Subject|2|||
160762316|NCT01184872|580519331|FG001|Overall Study|Withdrawal by Subject|0|||
160762317|NCT01184872|580519330|FG000|Overall Study|Lost to Follow-up|0|||
160762318|NCT01184872|580519331|FG001|Overall Study|Lost to Follow-up|1|||
160762319|NCT01184872|580519330|FG000|Overall Study|Administrative problems|1|||
160762320|NCT01184872|580519331|FG001|Overall Study|Administrative problems|1|||
160762321|NCT01184872|580519330|FG000|Overall Study|Protocol deviation|1|||
160762322|NCT01184872|580519331|FG001|Overall Study|Protocol deviation|0|||
160762323|NCT01255163|580519335|FG000|Overall Study|Withdrawal by Subject|1|||
160762324|NCT01255163|580519336|FG001|Overall Study|Withdrawal by Subject|0|||
160762325|NCT01255163|580519335|FG000|Overall Study|Lost to Follow-up|2|||
160762326|NCT01255163|580519336|FG001|Overall Study|Lost to Follow-up|0|||
160762327|NCT01255163|580519335|FG000|Overall Study|Adverse Event|0|||
160762328|NCT01255163|580519336|FG001|Overall Study|Adverse Event|2|||
160762329|NCT01255163|580519335|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
160762330|NCT01255163|580519336|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
160762331|NCT01924533|580519337|FG000|Overall Study|Death|181|||
160762332|NCT01924533|580519338|FG001|Overall Study|Death|200|||
160762333|NCT01924533|580519337|FG000|Overall Study|Lost to Follow-up|0|||
160762334|NCT01924533|580519338|FG001|Overall Study|Lost to Follow-up|1|||
160762335|NCT01924533|580519337|FG000|Overall Study|Withdrawal by Subject|7|||
160762336|NCT01924533|580519338|FG001|Overall Study|Withdrawal by Subject|3|||
160762337|NCT01924533|580519337|FG000|Overall Study|Other Eligibility criteria|1|||
160762338|NCT01924533|580519338|FG001|Overall Study|Other Eligibility criteria|1|||
160762339|NCT05817669|580519339|FG000|Overall Study|Prohibited medication used|1|||
160762340|NCT05817669|580519340|FG001|Overall Study|Prohibited medication used|2|||
160762341|NCT05817669|580519339|FG000|Overall Study|Adverse Event|1|||
160762342|NCT05817669|580519340|FG001|Overall Study|Adverse Event|0|||
160762343|NCT05817669|580519339|FG000|Overall Study|Withdrawal by Subject|1|||
160762344|NCT05817669|580519340|FG001|Overall Study|Withdrawal by Subject|2|||
160762345|NCT04233879|580519341|FG000|Overall Study|Death|2|||
160762346|NCT04233879|580519342|FG001|Overall Study|Death|0|||
160762347|NCT04233879|580519341|FG000|Overall Study|Lost to Follow-up|3|||
160762348|NCT04233879|580519342|FG001|Overall Study|Lost to Follow-up|8|||
160762349|NCT04233879|580519341|FG000|Overall Study|Physician Decision|4|||
160527072|NCT03083847|579660878|FG008|Main|Pregnancy|0|||
160762350|NCT04233879|580519342|FG001|Overall Study|Physician Decision|4|||
160762351|NCT04233879|580519341|FG000|Overall Study|Withdrawal by Subject|7|||
160762352|NCT04233879|580519342|FG001|Overall Study|Withdrawal by Subject|10|||
160762353|NCT04233879|580519341|FG000|Overall Study|Other|281|||
160762354|NCT04233879|580519342|FG001|Overall Study|Other|279|||
160762355|NCT01802385|580519344|FG000|Overall Study|Death|106|||
160762356|NCT01802385|580519345|FG001|Overall Study|Death|120|||
160762357|NCT03810183|580519346|FG000|Overall Study|Study terminated by Sponsor|2|||
160762358|NCT03810183|580519347|FG001|Overall Study|Study terminated by Sponsor|1|||
160762359|NCT00323063|580519349|FG000|Overall Study|Adverse Event|1|||
160762360|NCT00323063|580519350|FG001|Overall Study|Adverse Event|0|||
160762361|NCT00323063|580519349|FG000|Overall Study|brain mets discovered prior to treatment|1|||
160762362|NCT00323063|580519350|FG001|Overall Study|brain mets discovered prior to treatment|0|||
160762363|NCT01664091|580519352|FG000|Overall Study|Death|1|||
160762364|NCT01664091|580519352|FG000|Overall Study|Disease Progression|2|||
160762365|NCT01664091|580519352|FG000|Overall Study|Lost to Follow-up|2|||
160527073|NCT03083847|579660879|FG009|Main|Pregnancy|0|||
160527074|NCT03083847|579660870|FG000|Main|Adverse Event|0|||
160527075|NCT03083847|579660871|FG001|Main|Adverse Event|0|||
160527076|NCT03083847|579660872|FG002|Main|Adverse Event|0|||
160527077|NCT03083847|579660873|FG003|Main|Adverse Event|0|||
160527078|NCT03083847|579660874|FG004|Main|Adverse Event|0|||
160527079|NCT03083847|579660875|FG005|Main|Adverse Event|0|||
160527080|NCT03083847|579660876|FG006|Main|Adverse Event|0|||
160527081|NCT03083847|579660877|FG007|Main|Adverse Event|2|||
160527082|NCT03083847|579660878|FG008|Main|Adverse Event|0|||
160527083|NCT03083847|579660879|FG009|Main|Adverse Event|0|||
160527084|NCT03083847|579660870|FG000|Main|Withdrawal by Subject|0|||
160527085|NCT03083847|579660871|FG001|Main|Withdrawal by Subject|0|||
160527086|NCT03083847|579660872|FG002|Main|Withdrawal by Subject|0|||
160527087|NCT03083847|579660873|FG003|Main|Withdrawal by Subject|0|||
160527088|NCT03083847|579660874|FG004|Main|Withdrawal by Subject|0|||
160527089|NCT03083847|579660875|FG005|Main|Withdrawal by Subject|0|||
160527090|NCT03083847|579660876|FG006|Main|Withdrawal by Subject|1|||
160527091|NCT03083847|579660877|FG007|Main|Withdrawal by Subject|1|||
160527092|NCT03083847|579660878|FG008|Main|Withdrawal by Subject|0|||
160527093|NCT03083847|579660879|FG009|Main|Withdrawal by Subject|0|||
160527094|NCT03155373|579660880|FG000|Overall Study|No longer required surgery|1|||
160527095|NCT03155373|579660880|FG000|Overall Study|Protocol Violation|1|||
160527096|NCT03155373|579660880|FG000|Overall Study|Death|2|||
160527097|NCT03155373|579660880|FG000|Overall Study|Withdrawal by Subject|3|||
160527098|NCT02856893|579660881|FG000|Overall Study|Lack of Efficacy|27|||
160527099|NCT02856893|579660882|FG001|Overall Study|Lack of Efficacy|15|||
160527100|NCT02856893|579660883|FG002|Overall Study|Lack of Efficacy|19|||
160527101|NCT02856893|579660881|FG000|Overall Study|Death|1|||
160527102|NCT02856893|579660882|FG001|Overall Study|Death|0|||
160527103|NCT02856893|579660883|FG002|Overall Study|Death|0|||
160527104|NCT02856893|579660881|FG000|Overall Study|Adverse Event|2|||
160527105|NCT02856893|579660882|FG001|Overall Study|Adverse Event|0|||
160527106|NCT02856893|579660883|FG002|Overall Study|Adverse Event|0|||
160527107|NCT02856893|579660881|FG000|Overall Study|Physician Decision|0|||
160527108|NCT02856893|579660882|FG001|Overall Study|Physician Decision|2|||
160527109|NCT02856893|579660883|FG002|Overall Study|Physician Decision|3|||
160527110|NCT02856893|579660881|FG000|Overall Study|Withdrawal by Subject|1|||
160527111|NCT02856893|579660882|FG001|Overall Study|Withdrawal by Subject|1|||
160636403|NCT01954082|580051540|FG000|Overall Study|Parent Decision|1|||
160762366|NCT01664091|580519352|FG000|Overall Study|Withdrawal by Subject|1|||
160527112|NCT02856893|579660883|FG002|Overall Study|Withdrawal by Subject|0|||
160527113|NCT02856893|579660881|FG000|Overall Study|Other reasons|2|||
160527114|NCT02856893|579660882|FG001|Overall Study|Other reasons|1|||
160527115|NCT02856893|579660883|FG002|Overall Study|Other reasons|2|||
160527116|NCT02310672|579660884|FG000|Overall Study|Death|1|||
160762367|NCT02053493|580519355|FG000|Overall Study|Withdrawal by Subject|1|||
160762368|NCT02053493|580519356|FG001|Overall Study|Withdrawal by Subject|1|||
160762369|NCT00791999|580519359|FG000|Overall Study|Protocol planed withdrawal|14|||
160762370|NCT00791999|580519360|FG001|Overall Study|Protocol planed withdrawal|11|||
160762371|NCT00791999|580519361|FG002|Overall Study|Protocol planed withdrawal|11|||
160762372|NCT00791999|580519362|FG003|Overall Study|Protocol planed withdrawal|45|||
160762373|NCT00791999|580519359|FG000|Overall Study|Withdrawal by Subject|0|||
160762374|NCT00791999|580519360|FG001|Overall Study|Withdrawal by Subject|1|||
160762375|NCT00791999|580519361|FG002|Overall Study|Withdrawal by Subject|0|||
160762376|NCT00791999|580519362|FG003|Overall Study|Withdrawal by Subject|2|||
160762377|NCT00791999|580519359|FG000|Overall Study|Protocol Violation|3|||
160762378|NCT00791999|580519360|FG001|Overall Study|Protocol Violation|0|||
160762379|NCT00791999|580519361|FG002|Overall Study|Protocol Violation|1|||
160762380|NCT00791999|580519362|FG003|Overall Study|Protocol Violation|0|||
160762381|NCT00791999|580519359|FG000|Overall Study|Adverse Event|3|||
160762382|NCT00791999|580519360|FG001|Overall Study|Adverse Event|3|||
160762383|NCT00791999|580519361|FG002|Overall Study|Adverse Event|7|||
160762384|NCT00791999|580519362|FG003|Overall Study|Adverse Event|3|||
160762385|NCT00791999|580519359|FG000|Overall Study|Lack of Efficacy|0|||
160762386|NCT00791999|580519360|FG001|Overall Study|Lack of Efficacy|1|||
160762387|NCT00791999|580519361|FG002|Overall Study|Lack of Efficacy|0|||
160762388|NCT00791999|580519362|FG003|Overall Study|Lack of Efficacy|2|||
160762389|NCT00791999|580519359|FG000|Overall Study|Reason other than those above|1|||
160762390|NCT00791999|580519360|FG001|Overall Study|Reason other than those above|0|||
160762391|NCT00791999|580519361|FG002|Overall Study|Reason other than those above|1|||
160762392|NCT00791999|580519362|FG003|Overall Study|Reason other than those above|0|||
160762393|NCT02153918|580519367|FG000|Overall Study|Refused further treatment|1|||
160762394|NCT03327324|580519368|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762395|NCT03327324|580519369|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
160762396|NCT03327324|580519370|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762397|NCT03327324|580519371|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
160762398|NCT03327324|580519372|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762399|NCT03327324|580519373|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
160762400|NCT03327324|580519368|FG000|Baseline (Month 0-Month 3)|Refused|0|||
160762401|NCT03327324|580519369|FG001|Baseline (Month 0-Month 3)|Refused|0|||
160762402|NCT03327324|580519370|FG002|Baseline (Month 0-Month 3)|Refused|0|||
160762403|NCT03327324|580519371|FG003|Baseline (Month 0-Month 3)|Refused|0|||
160762404|NCT03327324|580519372|FG004|Baseline (Month 0-Month 3)|Refused|1|||
160762405|NCT03327324|580519373|FG005|Baseline (Month 0-Month 3)|Refused|0|||
160762406|NCT03327324|580519368|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
160762407|NCT03327324|580519369|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
160762408|NCT03327324|580519370|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
160762409|NCT03327324|580519371|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
160762410|NCT03327324|580519372|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
160762411|NCT03327324|580519373|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
160762412|NCT03327324|580519368|FG000|Baseline (Month 0-Month 3)|Death|0|||
160762413|NCT03327324|580519369|FG001|Baseline (Month 0-Month 3)|Death|0|||
160762414|NCT03327324|580519370|FG002|Baseline (Month 0-Month 3)|Death|0|||
160762415|NCT03327324|580519371|FG003|Baseline (Month 0-Month 3)|Death|0|||
160762416|NCT03327324|580519372|FG004|Baseline (Month 0-Month 3)|Death|1|||
160762417|NCT03327324|580519373|FG005|Baseline (Month 0-Month 3)|Death|0|||
160762418|NCT03327324|580519368|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762419|NCT03327324|580519369|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762420|NCT03327324|580519370|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762421|NCT03327324|580519371|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762422|NCT03327324|580519372|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762423|NCT03327324|580519373|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
160762424|NCT03327324|580519368|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762425|NCT03327324|580519369|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762426|NCT03327324|580519370|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
160762427|NCT03327324|580519371|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762428|NCT03327324|580519372|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160861859|NCT02531802|580887855|FG010|Received Vaccination 2|Adverse Event|0|||
160861860|NCT02531802|580887856|FG011|Received Vaccination 2|Adverse Event|0|||
160865802|NCT01499355|580902993|FG001|Run-In Period|Consent Withdrawn|0|||
160865803|NCT01499355|580902994|FG002|Run-In Period|Consent Withdrawn|0|||
160865804|NCT01499355|580902995|FG003|Run-In Period|Consent Withdrawn|0|||
160865805|NCT01499355|580902992|FG000|Run-In Period|Adverse Event|8|||
160865806|NCT01499355|580902993|FG001|Run-In Period|Adverse Event|0|||
160865807|NCT01499355|580902994|FG002|Run-In Period|Adverse Event|0|||
160865808|NCT01499355|580902995|FG003|Run-In Period|Adverse Event|0|||
160865809|NCT01499355|580902992|FG000|Double-Blind Period|Adverse Event|0|||
160865810|NCT01499355|580902993|FG001|Double-Blind Period|Adverse Event|2|||
160865811|NCT01499355|580902994|FG002|Double-Blind Period|Adverse Event|3|||
160865812|NCT01499355|580902995|FG003|Double-Blind Period|Adverse Event|2|||
160865813|NCT01499355|580902992|FG000|Double-Blind Period|Study Termination|0|||
160865814|NCT01499355|580902993|FG001|Double-Blind Period|Study Termination|18|||
160865815|NCT01499355|580902994|FG002|Double-Blind Period|Study Termination|16|||
160865816|NCT01499355|580902995|FG003|Double-Blind Period|Study Termination|14|||
160865817|NCT01499355|580902992|FG000|Double-Blind Period|Other|0|||
160865818|NCT01499355|580902993|FG001|Double-Blind Period|Other|1|||
160865819|NCT01499355|580902994|FG002|Double-Blind Period|Other|2|||
160865820|NCT01499355|580902995|FG003|Double-Blind Period|Other|2|||
160865821|NCT01499355|580902992|FG000|Double-Blind Period|Death|0|||
160865822|NCT01499355|580902993|FG001|Double-Blind Period|Death|1|||
160865823|NCT01499355|580902994|FG002|Double-Blind Period|Death|0|||
160865824|NCT01499355|580902995|FG003|Double-Blind Period|Death|0|||
160865825|NCT01499355|580902992|FG000|Double-Blind Period|Investigator Decision|0|||
160865826|NCT01499355|580902993|FG001|Double-Blind Period|Investigator Decision|0|||
160865827|NCT01499355|580902994|FG002|Double-Blind Period|Investigator Decision|3|||
160865828|NCT01499355|580902995|FG003|Double-Blind Period|Investigator Decision|3|||
160865829|NCT01499355|580902992|FG000|Double-Blind Period|Consent Withdrawn|0|||
160865830|NCT01499355|580902993|FG001|Double-Blind Period|Consent Withdrawn|0|||
160865831|NCT01499355|580902994|FG002|Double-Blind Period|Consent Withdrawn|1|||
160865832|NCT01499355|580902995|FG003|Double-Blind Period|Consent Withdrawn|2|||
160865833|NCT01499355|580902992|FG000|Double-Blind Period|Lost to Follow-up|0|||
160865834|NCT01499355|580902993|FG001|Double-Blind Period|Lost to Follow-up|1|||
160865835|NCT01499355|580902994|FG002|Double-Blind Period|Lost to Follow-up|0|||
160865836|NCT01499355|580902995|FG003|Double-Blind Period|Lost to Follow-up|0|||
160865837|NCT01457703|580903002|FG000|Overall Study|Screen Failure|5|||
160865838|NCT01457703|580903003|FG001|Overall Study|Screen Failure|7|||
160865839|NCT01457703|580903002|FG000|Overall Study|Withdrawal by Subject|1|||
160762429|NCT03327324|580519373|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762430|NCT03327324|580519368|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
160762431|NCT03327324|580519369|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
160762432|NCT03327324|580519370|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
160762433|NCT03327324|580519371|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
160762434|NCT03327324|580519372|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
160762435|NCT03327324|580519373|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
160762436|NCT03327324|580519368|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
160762437|NCT03327324|580519369|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
160762438|NCT03327324|580519370|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
160762439|NCT03327324|580519371|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
160762440|NCT03327324|580519372|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
160762441|NCT03327324|580519373|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
160762442|NCT03327324|580519368|FG000|Intervention (Month 3-Month 6)|Death|1|||
160762443|NCT03327324|580519369|FG001|Intervention (Month 3-Month 6)|Death|0|||
160762444|NCT03327324|580519370|FG002|Intervention (Month 3-Month 6)|Death|1|||
160762445|NCT03327324|580519371|FG003|Intervention (Month 3-Month 6)|Death|1|||
160762446|NCT03327324|580519372|FG004|Intervention (Month 3-Month 6)|Death|1|||
160762447|NCT03327324|580519373|FG005|Intervention (Month 3-Month 6)|Death|0|||
160762448|NCT03327324|580519368|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762449|NCT03327324|580519369|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762450|NCT03327324|580519370|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762451|NCT03327324|580519371|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762452|NCT03327324|580519372|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762453|NCT03327324|580519373|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
160762454|NCT03327324|580519368|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
160762455|NCT03327324|580519369|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762456|NCT03327324|580519370|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762457|NCT03327324|580519371|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762458|NCT03327324|580519372|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762459|NCT03327324|580519373|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160762460|NCT03327324|580519368|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
160762461|NCT03327324|580519369|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
160762462|NCT03327324|580519370|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
160762463|NCT03327324|580519371|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
160762464|NCT03327324|580519372|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
160762465|NCT03327324|580519373|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
160762466|NCT03327324|580519368|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
160762467|NCT03327324|580519369|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
160762468|NCT03327324|580519370|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
160762469|NCT03327324|580519371|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
160762470|NCT03327324|580519372|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
160762471|NCT03327324|580519373|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
160762472|NCT03327324|580519368|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762473|NCT03327324|580519369|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762474|NCT03327324|580519370|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762475|NCT03327324|580519371|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
160762476|NCT03327324|580519372|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
160762477|NCT03327324|580519373|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160762478|NCT03327324|580519368|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
160762479|NCT03327324|580519369|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
160762480|NCT03327324|580519370|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
160762481|NCT03327324|580519371|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
160762482|NCT03327324|580519372|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
160762483|NCT03327324|580519373|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
160762484|NCT03327324|580519368|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
160865840|NCT01457703|580903003|FG001|Overall Study|Withdrawal by Subject|4|||
160865841|NCT01658436|580903004|FG000|Overall Study|Adverse Event|6|||
160865842|NCT01658436|580903005|FG001|Overall Study|Adverse Event|5|||
160865843|NCT01658436|580903004|FG000|Overall Study|Physician Decision|1|||
160865844|NCT01658436|580903005|FG001|Overall Study|Physician Decision|0|||
160865845|NCT01658436|580903004|FG000|Overall Study|Progressive disease|12|||
160865846|NCT01658436|580903005|FG001|Overall Study|Progressive disease|4|||
160865847|NCT01658436|580903004|FG000|Overall Study|Study terminated by sponsor|0|||
160865848|NCT01658436|580903005|FG001|Overall Study|Study terminated by sponsor|1|||
160865849|NCT01658436|580903004|FG000|Overall Study|Subject/guardian decision|0|||
160865850|NCT01658436|580903005|FG001|Overall Study|Subject/guardian decision|1|||
160865851|NCT01658436|580903004|FG000|Overall Study|Death|1|||
160865852|NCT01658436|580903005|FG001|Overall Study|Death|0|||
160865853|NCT00686712|580903006|FG000|Overall Study|Protocol Violation|8|||
160865854|NCT00686712|580903007|FG001|Overall Study|Protocol Violation|8|||
160865855|NCT00686712|580903008|FG002|Overall Study|Protocol Violation|10|||
160865856|NCT00686712|580903006|FG000|Overall Study|Lost to Follow-up|1|||
160865857|NCT00686712|580903007|FG001|Overall Study|Lost to Follow-up|2|||
160865858|NCT00686712|580903008|FG002|Overall Study|Lost to Follow-up|3|||
160865859|NCT00686712|580903006|FG000|Overall Study|Adverse Event|1|||
160865860|NCT00686712|580903007|FG001|Overall Study|Adverse Event|1|||
160865861|NCT00686712|580903008|FG002|Overall Study|Adverse Event|0|||
160865862|NCT01318915|580903009|FG000|Overall Study|Lost to Follow-up|1|||
160865863|NCT04119414|580903010|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
160865864|NCT03313037|580903026|FG000|Overall Study|Protocol Violation|4|||
160865865|NCT03313037|580903027|FG001|Overall Study|Protocol Violation|1|||
160865866|NCT03313037|580903026|FG000|Overall Study|Other|1|||
160865867|NCT03313037|580903027|FG001|Overall Study|Other|1|||
160865868|NCT03313037|580903026|FG000|Overall Study|Withdrawal by Subject|4|||
160865869|NCT03313037|580903027|FG001|Overall Study|Withdrawal by Subject|3|||
160865870|NCT03313037|580903026|FG000|Overall Study|No longer meets eligibility criteria|1|||
160865871|NCT03313037|580903027|FG001|Overall Study|No longer meets eligibility criteria|7|||
160865872|NCT03313037|580903026|FG000|Overall Study|Lost to Follow-up|9|||
160865873|NCT03313037|580903027|FG001|Overall Study|Lost to Follow-up|8|||
160865874|NCT03313037|580903026|FG000|Overall Study|Randomized but not treated|1|||
160865875|NCT03313037|580903027|FG001|Overall Study|Randomized but not treated|0|||
160865876|NCT02760498|580903028|FG000|Overall Study|Adverse Event|3|||
160865877|NCT02760498|580903029|FG001|Overall Study|Adverse Event|3|||
160865878|NCT02760498|580903030|FG002|Overall Study|Adverse Event|1|||
160865879|NCT02760498|580903031|FG003|Overall Study|Adverse Event|1|||
160865880|NCT02760498|580903032|FG004|Overall Study|Adverse Event|0|||
160865881|NCT02760498|580903033|FG005|Overall Study|Adverse Event|6|||
160865882|NCT02760498|580903028|FG000|Overall Study|Death|7|||
160865883|NCT02760498|580903029|FG001|Overall Study|Death|5|||
160865884|NCT02760498|580903030|FG002|Overall Study|Death|5|||
160865885|NCT02760498|580903031|FG003|Overall Study|Death|7|||
160865886|NCT02760498|580903032|FG004|Overall Study|Death|0|||
160865887|NCT02760498|580903033|FG005|Overall Study|Death|23|||
160865888|NCT02760498|580903028|FG000|Overall Study|Lost to Follow-up|0|||
160865889|NCT02760498|580903029|FG001|Overall Study|Lost to Follow-up|0|||
160865890|NCT02760498|580903030|FG002|Overall Study|Lost to Follow-up|0|||
160865891|NCT02760498|580903031|FG003|Overall Study|Lost to Follow-up|0|||
160865892|NCT02760498|580903032|FG004|Overall Study|Lost to Follow-up|0|||
160865893|NCT02760498|580903033|FG005|Overall Study|Lost to Follow-up|3|||
160865894|NCT02760498|580903028|FG000|Overall Study|Non-compliance with study drug|0|||
160865895|NCT02760498|580903029|FG001|Overall Study|Non-compliance with study drug|2|||
160865896|NCT02760498|580903030|FG002|Overall Study|Non-compliance with study drug|0|||
160865897|NCT02760498|580903031|FG003|Overall Study|Non-compliance with study drug|0|||
160865898|NCT02760498|580903032|FG004|Overall Study|Non-compliance with study drug|0|||
160865899|NCT02760498|580903033|FG005|Overall Study|Non-compliance with study drug|0|||
160865900|NCT02760498|580903028|FG000|Overall Study|Participant decision|1|||
160865901|NCT02760498|580903029|FG001|Overall Study|Participant decision|4|||
160865902|NCT02760498|580903030|FG002|Overall Study|Participant decision|2|||
160865903|NCT02760498|580903031|FG003|Overall Study|Participant decision|2|||
160865904|NCT02760498|580903032|FG004|Overall Study|Participant decision|1|||
160865905|NCT02760498|580903033|FG005|Overall Study|Participant decision|6|||
160865906|NCT02760498|580903028|FG000|Overall Study|Sponsor decision|0|||
160865907|NCT02760498|580903029|FG001|Overall Study|Sponsor decision|0|||
160865908|NCT02760498|580903030|FG002|Overall Study|Sponsor decision|0|||
160865909|NCT02760498|580903031|FG003|Overall Study|Sponsor decision|3|||
160865910|NCT02760498|580903032|FG004|Overall Study|Sponsor decision|0|||
160865911|NCT02760498|580903033|FG005|Overall Study|Sponsor decision|0|||
160865912|NCT02760498|580903028|FG000|Overall Study|Physician Decision|3|||
160865913|NCT02760498|580903029|FG001|Overall Study|Physician Decision|4|||
160865914|NCT02760498|580903030|FG002|Overall Study|Physician Decision|1|||
160865915|NCT02760498|580903031|FG003|Overall Study|Physician Decision|4|||
160865916|NCT02760498|580903032|FG004|Overall Study|Physician Decision|0|||
160865917|NCT02760498|580903033|FG005|Overall Study|Physician Decision|2|||
160865918|NCT02760498|580903028|FG000|Overall Study|Disease progression|21|||
160865919|NCT02760498|580903029|FG001|Overall Study|Disease progression|19|||
160865920|NCT02760498|580903030|FG002|Overall Study|Disease progression|20|||
160865921|NCT02760498|580903031|FG003|Overall Study|Disease progression|18|||
160865922|NCT02760498|580903032|FG004|Overall Study|Disease progression|4|||
160865923|NCT02760498|580903033|FG005|Overall Study|Disease progression|55|||
160865924|NCT02760498|580903028|FG000|Overall Study|Withdrawal by Subject|4|||
160865925|NCT02760498|580903029|FG001|Overall Study|Withdrawal by Subject|7|||
160865926|NCT02760498|580903030|FG002|Overall Study|Withdrawal by Subject|5|||
160865927|NCT02760498|580903031|FG003|Overall Study|Withdrawal by Subject|1|||
160865928|NCT02760498|580903032|FG004|Overall Study|Withdrawal by Subject|0|||
160865929|NCT02760498|580903033|FG005|Overall Study|Withdrawal by Subject|6|||
160865930|NCT02760498|580903028|FG000|Overall Study|Other than specified|1|||
160865931|NCT02760498|580903029|FG001|Overall Study|Other than specified|6|||
160865932|NCT02760498|580903030|FG002|Overall Study|Other than specified|0|||
160865933|NCT02760498|580903031|FG003|Overall Study|Other than specified|3|||
160865934|NCT02760498|580903032|FG004|Overall Study|Other than specified|1|||
160865935|NCT02760498|580903033|FG005|Overall Study|Other than specified|0|||
160865936|NCT02760498|580903028|FG000|Overall Study|Not treated|0|||
160865937|NCT02760498|580903029|FG001|Overall Study|Not treated|0|||
160865938|NCT02760498|580903030|FG002|Overall Study|Not treated|0|||
160865939|NCT02760498|580903031|FG003|Overall Study|Not treated|0|||
160865940|NCT02760498|580903032|FG004|Overall Study|Not treated|0|||
160865941|NCT02760498|580903033|FG005|Overall Study|Not treated|2|||
160865942|NCT03067077|580903034|FG000|Overall Study|Did not receive surgery|4|||
160865943|NCT03067077|580903035|FG001|Overall Study|Did not receive surgery|5|||
160865944|NCT03067077|580903034|FG000|Overall Study|Lost to Follow-up|3|||
160865945|NCT03067077|580903035|FG001|Overall Study|Lost to Follow-up|2|||
160865946|NCT01198977|580903043|FG000|Overall Study|Lost to Follow-up|1|||
160865947|NCT01198977|580903044|FG001|Overall Study|Lost to Follow-up|0|||
160865948|NCT01588522|580903050|FG000|Overall Study|Withdrawal by Subject|1|||
160865949|NCT01588522|580903051|FG001|Overall Study|Withdrawal by Subject|5|||
160865950|NCT01588522|580903052|FG002|Overall Study|Withdrawal by Subject|3|||
160865951|NCT01588522|580903053|FG003|Overall Study|Withdrawal by Subject|1|||
160865952|NCT01588522|580903054|FG004|Overall Study|Withdrawal by Subject|2|||
160865953|NCT01588522|580903055|FG005|Overall Study|Withdrawal by Subject|0|||
160865954|NCT01588522|580903050|FG000|Overall Study|Lack of Efficacy|0|||
160865955|NCT01588522|580903051|FG001|Overall Study|Lack of Efficacy|0|||
160865956|NCT01588522|580903052|FG002|Overall Study|Lack of Efficacy|0|||
160865957|NCT01588522|580903053|FG003|Overall Study|Lack of Efficacy|0|||
160865958|NCT01588522|580903054|FG004|Overall Study|Lack of Efficacy|1|||
160865959|NCT01588522|580903055|FG005|Overall Study|Lack of Efficacy|0|||
160865960|NCT01588522|580903050|FG000|Overall Study|Adverse Event|0|||
160865961|NCT01588522|580903051|FG001|Overall Study|Adverse Event|0|||
160865962|NCT01588522|580903052|FG002|Overall Study|Adverse Event|0|||
160865963|NCT01588522|580903053|FG003|Overall Study|Adverse Event|1|||
160865964|NCT01588522|580903054|FG004|Overall Study|Adverse Event|0|||
160865965|NCT01588522|580903055|FG005|Overall Study|Adverse Event|0|||
160865966|NCT01588522|580903050|FG000|Overall Study|Grade 2 alopecia|1|||
160865967|NCT01588522|580903051|FG001|Overall Study|Grade 2 alopecia|0|||
160865968|NCT01588522|580903052|FG002|Overall Study|Grade 2 alopecia|0|||
160865969|NCT01588522|580903053|FG003|Overall Study|Grade 2 alopecia|0|||
160527117|NCT02310672|579660884|FG000|Overall Study|Lost to Follow-up|1|||
160527118|NCT02310672|579660884|FG000|Overall Study|Withdrawal by Subject|1|||
160527119|NCT02310672|579660884|FG000|Overall Study|Sponsor's decision|12|||
160527120|NCT01214187|579660888|FG000|Overall Study|Adverse Event|6|||
160527121|NCT01214187|579660889|FG001|Overall Study|Adverse Event|2|||
160527122|NCT01214187|579660888|FG000|Overall Study|Death|1|||
160527123|NCT01214187|579660889|FG001|Overall Study|Death|1|||
160527124|NCT01214187|579660888|FG000|Overall Study|Withdrawal by Subject|0|||
160527125|NCT01214187|579660889|FG001|Overall Study|Withdrawal by Subject|3|||
160527126|NCT02308007|579660898|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
160527127|NCT02308007|579660899|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
160527128|NCT02308007|579660900|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
160527129|NCT02308007|579660898|FG000|Overall Study|Positive for STD at Baseline|7|||
160527130|NCT02308007|579660899|FG001|Overall Study|Positive for STD at Baseline|11|||
160527131|NCT02308007|579660900|FG002|Overall Study|Positive for STD at Baseline|7|||
160527132|NCT02308007|579660898|FG000|Overall Study|Lost to Follow-up|3|||
160762485|NCT03327324|580519369|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
160762486|NCT03327324|580519370|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
160762487|NCT03327324|580519371|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
160762488|NCT03327324|580519372|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
160762489|NCT03327324|580519373|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
160762490|NCT01791985|580519374|FG000|Overall Study|Adverse Event|7|||
160762491|NCT01791985|580519374|FG000|Overall Study|Withdrawal by Subject|1|||
160762492|NCT01103323|580519375|FG000|Without/Before Drug Switch|Adverse Event|50|||
160762493|NCT01103323|580519376|FG001|Without/Before Drug Switch|Adverse Event|7|||
160762494|NCT01103323|580519375|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
160762495|NCT01103323|580519376|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
160762496|NCT01103323|580519375|FG000|Without/Before Drug Switch|Protocol Violation|2|||
160762497|NCT01103323|580519376|FG001|Without/Before Drug Switch|Protocol Violation|0|||
160762498|NCT01103323|580519375|FG000|Without/Before Drug Switch|Physician Decision|2|||
160762499|NCT01103323|580519376|FG001|Without/Before Drug Switch|Physician Decision|0|||
160762500|NCT01103323|580519375|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
160762501|NCT01103323|580519376|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
160762502|NCT01103323|580519375|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
160762503|NCT01103323|580519376|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
160762504|NCT01103323|580519375|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
160762505|NCT01103323|580519376|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
160762506|NCT03797898|580519382|FG000|Overall Study|Lost to Follow-up|60|||
160762507|NCT03797898|580519383|FG001|Overall Study|Lost to Follow-up|69|||
160762508|NCT03797898|580519382|FG000|Overall Study|Withdrawal by Subject|9|||
160762509|NCT03797898|580519383|FG001|Overall Study|Withdrawal by Subject|7|||
160762510|NCT03797898|580519382|FG000|Overall Study|Became ineligible|5|||
160762511|NCT03797898|580519383|FG001|Overall Study|Became ineligible|2|||
160762512|NCT00485069|580519384|FG000|Overall Study|Adverse Event|10|||
160762513|NCT00485069|580519385|FG001|Overall Study|Adverse Event|4|||
160762514|NCT00485069|580519384|FG000|Overall Study|Lack of Efficacy|2|||
160762515|NCT00485069|580519385|FG001|Overall Study|Lack of Efficacy|1|||
160762516|NCT00485069|580519384|FG000|Overall Study|Protocol Violation|0|||
160762517|NCT00485069|580519385|FG001|Overall Study|Protocol Violation|1|||
160762518|NCT00485069|580519384|FG000|Overall Study|Withdrawal by Subject|6|||
160762519|NCT00485069|580519385|FG001|Overall Study|Withdrawal by Subject|6|||
160762520|NCT03217591|580519386|FG000|Overall Study|Adverse Event|1|||
160762521|NCT03217591|580519387|FG001|Overall Study|Adverse Event|2|||
160762522|NCT03217591|580519388|FG002|Overall Study|Adverse Event|6|||
160762523|NCT03217591|580519386|FG000|Overall Study|Withdrawal by Subject|0|||
160762524|NCT03217591|580519387|FG001|Overall Study|Withdrawal by Subject|1|||
160762525|NCT03217591|580519388|FG002|Overall Study|Withdrawal by Subject|3|||
160762526|NCT03217591|580519386|FG000|Overall Study|Lost to Follow-up|1|||
160762527|NCT03217591|580519387|FG001|Overall Study|Lost to Follow-up|0|||
160762528|NCT03217591|580519388|FG002|Overall Study|Lost to Follow-up|0|||
160762529|NCT03217591|580519386|FG000|Overall Study|Protocol Violation|1|||
160762530|NCT03217591|580519387|FG001|Overall Study|Protocol Violation|0|||
160762531|NCT03217591|580519388|FG002|Overall Study|Protocol Violation|1|||
160762532|NCT03902613|580519390|FG000|Overall Study|Physician Decision|1|||
160762533|NCT01091246|580519392|FG000|Overall Study|Lost to Follow-up|23|||
160762534|NCT01091246|580519393|FG001|Overall Study|Lost to Follow-up|11|||
160762535|NCT01091246|580519394|FG002|Overall Study|Lost to Follow-up|7|||
160762536|NCT01091246|580519392|FG000|Overall Study|Adverse Event|1|||
160762537|NCT01091246|580519393|FG001|Overall Study|Adverse Event|0|||
160762538|NCT01091246|580519394|FG002|Overall Study|Adverse Event|1|||
160527133|NCT02308007|579660899|FG001|Overall Study|Lost to Follow-up|0|||
160527134|NCT02308007|579660900|FG002|Overall Study|Lost to Follow-up|1|||
160762539|NCT01091246|580519392|FG000|Overall Study|Withdrawal by Subject|9|||
160762540|NCT01091246|580519393|FG001|Overall Study|Withdrawal by Subject|5|||
160762541|NCT01091246|580519394|FG002|Overall Study|Withdrawal by Subject|4|||
160762542|NCT01091246|580519392|FG000|Overall Study|Subject not dosed|2|||
160865970|NCT01588522|580903054|FG004|Overall Study|Grade 2 alopecia|0|||
160865971|NCT01588522|580903055|FG005|Overall Study|Grade 2 alopecia|0|||
160865972|NCT01588522|580903050|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
160865973|NCT01588522|580903051|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
160865974|NCT01588522|580903052|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
160865975|NCT01588522|580903053|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
160865976|NCT01588522|580903054|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
160865977|NCT01588522|580903055|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
160865978|NCT01588522|580903050|FG000|Overall Study|Taken off taxane-based regimen|0|||
160865979|NCT01588522|580903051|FG001|Overall Study|Taken off taxane-based regimen|0|||
160865980|NCT01588522|580903052|FG002|Overall Study|Taken off taxane-based regimen|0|||
160865981|NCT01588522|580903053|FG003|Overall Study|Taken off taxane-based regimen|1|||
160865982|NCT01588522|580903054|FG004|Overall Study|Taken off taxane-based regimen|0|||
160865983|NCT01588522|580903055|FG005|Overall Study|Taken off taxane-based regimen|0|||
160865984|NCT01588522|580903050|FG000|Overall Study|Did not initiate chemotherapy|0|||
160865985|NCT01588522|580903051|FG001|Overall Study|Did not initiate chemotherapy|0|||
160865986|NCT01588522|580903052|FG002|Overall Study|Did not initiate chemotherapy|0|||
160865987|NCT01588522|580903053|FG003|Overall Study|Did not initiate chemotherapy|0|||
160865988|NCT01588522|580903054|FG004|Overall Study|Did not initiate chemotherapy|1|||
160865989|NCT01588522|580903055|FG005|Overall Study|Did not initiate chemotherapy|0|||
160865990|NCT02855125|580903060|FG000|Overall Study|Withdrawal by Subject|2|||
160865991|NCT02855125|580903061|FG001|Overall Study|Withdrawal by Subject|2|||
160865992|NCT02855125|580903060|FG000|Overall Study|Clinical Disease Progression|5|||
160865993|NCT02855125|580903061|FG001|Overall Study|Clinical Disease Progression|4|||
160865994|NCT02855125|580903060|FG000|Overall Study|Radiologic Disease Progression|36|||
160865995|NCT02855125|580903061|FG001|Overall Study|Radiologic Disease Progression|39|||
160865996|NCT02855125|580903060|FG000|Overall Study|Adverse Event|11|||
160865997|NCT02855125|580903061|FG001|Overall Study|Adverse Event|7|||
160865998|NCT02855125|580903060|FG000|Overall Study|Physician Decision|1|||
160865999|NCT02855125|580903061|FG001|Overall Study|Physician Decision|0|||
160866000|NCT02855125|580903060|FG000|Overall Study|On Treatment|9|||
160866001|NCT02855125|580903061|FG001|Overall Study|On Treatment|11|||
160866002|NCT02855125|580903060|FG000|Overall Study|Randomized but not treated|0|||
160866003|NCT02855125|580903061|FG001|Overall Study|Randomized but not treated|1|||
160866004|NCT04467905|580903062|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
160866005|NCT04467905|580903063|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
160866006|NCT04467905|580903064|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
160866007|NCT04467905|580903062|FG000|Overall Study|Conversion to SR|0|||
160866008|NCT04467905|580903063|FG001|Overall Study|Conversion to SR|0|||
160866009|NCT04467905|580903064|FG002|Overall Study|Conversion to SR|3|||
160866010|NCT04467905|580903062|FG000|Overall Study|Technical issue with Holter ECG|0|||
160866011|NCT04467905|580903063|FG001|Overall Study|Technical issue with Holter ECG|0|||
160866012|NCT04467905|580903064|FG002|Overall Study|Technical issue with Holter ECG|3|||
160866013|NCT04467905|580903062|FG000|Overall Study|Hemodynamic instability|0|||
160866014|NCT04467905|580903063|FG001|Overall Study|Hemodynamic instability|0|||
160866015|NCT04467905|580903064|FG002|Overall Study|Hemodynamic instability|1|||
160866016|NCT04467905|580903062|FG000|Overall Study|Site misinterpretation of protocol|0|||
160866017|NCT04467905|580903063|FG001|Overall Study|Site misinterpretation of protocol|0|||
160866018|NCT04467905|580903064|FG002|Overall Study|Site misinterpretation of protocol|1|||
160866019|NCT02514083|580903070|FG000|Overall Study|Adverse Event|1|||
160866020|NCT02017405|580903071|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
160866021|NCT02017405|580903072|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
160866022|NCT02017405|580903073|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
160866023|NCT02017405|580903074|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
160866024|NCT02017405|580903075|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
160866025|NCT02017405|580903076|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
160866026|NCT02017405|580903071|FG000|Open-label Phase|Adverse Event|1|||
160866027|NCT02017405|580903072|FG001|Open-label Phase|Adverse Event|1|||
160866028|NCT02017405|580903073|FG002|Open-label Phase|Adverse Event|0|||
160866029|NCT02017405|580903074|FG003|Open-label Phase|Adverse Event|0|||
160866030|NCT02017405|580903075|FG004|Open-label Phase|Adverse Event|0|||
160866031|NCT02017405|580903076|FG005|Open-label Phase|Adverse Event|0|||
160866032|NCT01899040|580903077|FG000|Overall Study|Randomized in error|0|||
160866033|NCT01899040|580903078|FG001|Overall Study|Randomized in error|1|||
160866034|NCT01899040|580903079|FG002|Overall Study|Randomized in error|1|||
160866035|NCT01899040|580903077|FG000|Overall Study|Adverse Event|3|||
160866036|NCT01899040|580903078|FG001|Overall Study|Adverse Event|1|||
160866037|NCT01899040|580903079|FG002|Overall Study|Adverse Event|2|||
160866038|NCT01899040|580903077|FG000|Overall Study|Unspecified reasons|4|||
160866039|NCT01899040|580903078|FG001|Overall Study|Unspecified reasons|4|||
160866040|NCT01899040|580903079|FG002|Overall Study|Unspecified reasons|0|||
160866041|NCT01899040|580903077|FG000|Overall Study|Compliance issues|1|||
160866042|NCT01899040|580903078|FG001|Overall Study|Compliance issues|2|||
160866043|NCT01899040|580903079|FG002|Overall Study|Compliance issues|0|||
160866044|NCT04586205|580903088|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
160866045|NCT04586205|580903089|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
160866046|NCT02202759|580904899|FG000|Overall Study|Study Terminated by Sponsor|3|||
160866047|NCT02202759|580904900|FG001|Overall Study|Study Terminated by Sponsor|3|||
160866048|NCT02202759|580904901|FG002|Overall Study|Study Terminated by Sponsor|3|||
160866049|NCT02202759|580904899|FG000|Overall Study|Withdrawal by Subject|2|||
160866050|NCT02202759|580904900|FG001|Overall Study|Withdrawal by Subject|1|||
160866051|NCT02202759|580904901|FG002|Overall Study|Withdrawal by Subject|1|||
160866052|NCT02202759|580904899|FG000|Overall Study|Reason not Specified|4|||
160866053|NCT02202759|580904900|FG001|Overall Study|Reason not Specified|11|||
160866054|NCT02202759|580904901|FG002|Overall Study|Reason not Specified|10|||
160866055|NCT01590888|580904902|FG000|Overall Study|Adverse Event|3|||
160866056|NCT01590888|580904903|FG001|Overall Study|Adverse Event|0|||
160866057|NCT01590888|580904904|FG002|Overall Study|Adverse Event|1|||
160866058|NCT01590888|580904902|FG000|Overall Study|Lost to Follow-up|1|||
160866059|NCT01590888|580904903|FG001|Overall Study|Lost to Follow-up|0|||
160866060|NCT01590888|580904904|FG002|Overall Study|Lost to Follow-up|0|||
160866061|NCT04953728|580904905|FG000|Overall Study|Withdrawal by Subject|3|||
160866062|NCT04953728|580904905|FG000|Overall Study|Physician Decision|1|||
160866063|NCT01646125|580904906|FG000|Overall Study|Untreated|2|||
160866064|NCT01646125|580904907|FG001|Overall Study|Untreated|5|||
160866065|NCT01646125|580904906|FG000|Overall Study|Adverse Event|2|||
160866066|NCT01646125|580904907|FG001|Overall Study|Adverse Event|1|||
160866067|NCT01646125|580904906|FG000|Overall Study|Death|1|||
160866068|NCT01646125|580904907|FG001|Overall Study|Death|1|||
160866069|NCT01646125|580904906|FG000|Overall Study|Physician Decision|1|||
160866070|NCT01646125|580904907|FG001|Overall Study|Physician Decision|3|||
160866071|NCT01646125|580904906|FG000|Overall Study|Progressive disease|22|||
160866072|NCT01646125|580904907|FG001|Overall Study|Progressive disease|16|||
160866073|NCT01646125|580904906|FG000|Overall Study|Study terminated by sponsor|2|||
160866074|NCT01646125|580904907|FG001|Overall Study|Study terminated by sponsor|1|||
160866075|NCT01646125|580904906|FG000|Overall Study|Subject/Guardian decision|1|||
160866076|NCT01646125|580904907|FG001|Overall Study|Subject/Guardian decision|1|||
160866077|NCT02105662|580904908|FG000|Overall Study|Lost to Follow-up|5|||
160866078|NCT02105662|580904908|FG000|Overall Study|Withdrawal by Subject|1|||
160866079|NCT01417377|580904911|FG000|Overall Study|Lost to Follow-up|12|||
160866080|NCT01417377|580904911|FG000|Overall Study|Enrolled, but not treated|1|||
160866081|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
160866082|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
160866083|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
160866084|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
160866085|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
160866086|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
160866087|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
160866088|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
160866089|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
160866090|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
160866091|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
160866092|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
160866093|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
160866094|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
160866095|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
160866096|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
160527135|NCT01233869|579660901|FG000|Initial Treatment Period (24 Months)|Death|1|||
160527136|NCT01233869|579660902|FG001|Initial Treatment Period (24 Months)|Death|0|||
160866097|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
160866098|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
160866099|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
160866100|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
160866101|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
160866102|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
160866103|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
160866104|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
160866105|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
160866106|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
160866107|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
160866108|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
160866109|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866110|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866111|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866112|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866113|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866114|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866115|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
160866116|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866117|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866118|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866119|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866120|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866121|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866122|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866123|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Transplant|0|||
160866124|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Transplant|1|||
160866125|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Transplant|0|||
160866126|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Transplant|0|||
160866127|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Transplant|0|||
160866128|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Transplant|1|||
160866129|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Transplant|0|||
160866130|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Transplant|0|||
160866131|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Transplant|0|||
160866132|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Transplant|0|||
160866133|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Transplant|0|||
160866134|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Transplant|0|||
160866135|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Transplant|0|||
160866136|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Transplant|0|||
160866137|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
160866138|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
160866139|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
160866140|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
160866141|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
160866142|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
160866143|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
160866144|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
160866145|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
160866146|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
160866147|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
160866148|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
160866149|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
160866150|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
160866151|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
160866152|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
160866153|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
160866154|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
160866155|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
160866156|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
160866157|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
160866158|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
160866159|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
160866160|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
160866161|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
160866162|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
160866163|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
160866164|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
160866165|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
160866166|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
160866167|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
160866168|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
160866169|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
160866170|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
160866171|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
160866172|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
160866173|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
160866174|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
160866175|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
160866176|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
160866177|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
160866178|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
160866179|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
160866180|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
160866181|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
160866182|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
160866183|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
160866184|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
160866185|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
160866186|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
160866187|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
160866188|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
160866189|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
160866190|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
160866191|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
160866192|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
160866193|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866194|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866195|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866196|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866197|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866198|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866199|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866200|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
160866201|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866202|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
160866203|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
160866204|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866205|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866206|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866207|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866208|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866209|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866210|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866211|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866212|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866213|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866214|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
160866215|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866216|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
160866217|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866218|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866219|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866220|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866221|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866222|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866223|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866224|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866225|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866226|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866227|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866228|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
160866229|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866230|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866231|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866232|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866233|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866234|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866235|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Transplant|0|||
160866236|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Transplant|0|||
160866237|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Transplant|0|||
160866238|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Transplant|0|||
160866239|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Transplant|0|||
160527137|NCT01233869|579660903|FG002|Initial Treatment Period (24 Months)|Death|0|||
160527138|NCT01233869|579660904|FG003|Initial Treatment Period (24 Months)|Death|0|||
160527139|NCT01233869|579660901|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
160527140|NCT01233869|579660902|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
160866240|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Transplant|0|||
160866241|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Transplant|0|||
160866242|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Transplant|0|||
160866243|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Transplant|0|||
160866244|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Transplant|4|||
160866245|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Transplant|2|||
160866246|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Transplant|0|||
160866247|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Transplant|0|||
160866248|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Transplant|0|||
160866249|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
160866250|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
160866251|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
160866252|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
160866253|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
160866254|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
160866255|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
160866256|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
160866257|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
160866258|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
160866259|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
160866260|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
160866261|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
160866262|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
160866263|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
160866264|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
160866265|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
160866266|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
160866267|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
160866268|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
160866269|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
160866270|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
160866271|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
160866272|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
160866273|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
160866274|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
160866275|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
160866276|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
160866277|NCT02113982|580904912|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866278|NCT02113982|580904913|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866279|NCT02113982|580904914|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866280|NCT02113982|580904915|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866281|NCT02113982|580904916|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866282|NCT02113982|580904917|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866283|NCT02113982|580904918|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866284|NCT02113982|580904919|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866285|NCT02113982|580904920|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866286|NCT02113982|580904921|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866287|NCT02113982|580904922|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866288|NCT02113982|580904923|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
160866289|NCT02113982|580904924|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866290|NCT02113982|580904925|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866291|NCT02113982|580904912|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866292|NCT02113982|580904913|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866293|NCT02113982|580904914|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866294|NCT02113982|580904915|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866295|NCT02113982|580904916|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866296|NCT02113982|580904917|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866297|NCT02113982|580904918|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866298|NCT02113982|580904919|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866299|NCT02113982|580904920|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866300|NCT02113982|580904921|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866301|NCT02113982|580904922|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866302|NCT02113982|580904923|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
160866303|NCT02113982|580904924|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866304|NCT02113982|580904925|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866305|NCT02113982|580904912|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866306|NCT02113982|580904913|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866307|NCT02113982|580904914|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866308|NCT02113982|580904915|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866309|NCT02113982|580904916|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866310|NCT02113982|580904917|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160636404|NCT01954082|580051541|FG001|Overall Study|Parent Decision|0|||
160762543|NCT01091246|580519393|FG001|Overall Study|Subject not dosed|0|||
160762544|NCT01091246|580519394|FG002|Overall Study|Subject not dosed|1|||
160762545|NCT01676012|580519395|FG000|Overall Study|Adverse Event|2|||
160762546|NCT01676012|580519395|FG000|Overall Study|incomplete set of videos|1|||
160762547|NCT02155985|580519404|FG000|Overall Study|Withdrawal by Subject|0|||
160762548|NCT02155985|580519405|FG001|Overall Study|Withdrawal by Subject|0|||
160762549|NCT02155985|580519406|FG002|Overall Study|Withdrawal by Subject|1|||
160762550|NCT02155985|580519404|FG000|Overall Study|Lost to Follow-up|1|||
160762551|NCT02155985|580519405|FG001|Overall Study|Lost to Follow-up|0|||
160762552|NCT02155985|580519406|FG002|Overall Study|Lost to Follow-up|0|||
160762553|NCT04460326|580519407|FG000|Completed at Least 4 Meals|Early discharge|5|||
160762554|NCT04460326|580519408|FG001|Completed at Least 4 Meals|Early discharge|5|||
160762555|NCT04460326|580519407|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
160762556|NCT04460326|580519408|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
160762557|NCT04460326|580519407|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
160762558|NCT04460326|580519408|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
160762559|NCT04460326|580519407|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
160762560|NCT04460326|580519408|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
160866311|NCT02113982|580904918|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866312|NCT02113982|580904919|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866313|NCT02113982|580904920|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866314|NCT02113982|580904921|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866315|NCT02113982|580904922|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866316|NCT02113982|580904923|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
160866317|NCT02113982|580904924|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866318|NCT02113982|580904925|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866319|NCT02113982|580904912|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
160866320|NCT02113982|580904913|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
160866321|NCT02113982|580904914|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
160866322|NCT02113982|580904915|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
160866323|NCT02113982|580904916|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
160866324|NCT02113982|580904917|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
160866325|NCT02113982|580904918|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
160866326|NCT02113982|580904919|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
160866327|NCT02113982|580904920|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
160866328|NCT02113982|580904921|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
160866329|NCT02113982|580904922|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
160866330|NCT02113982|580904923|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
160866331|NCT02113982|580904924|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
160866332|NCT02113982|580904925|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
160866333|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866334|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866335|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866336|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866337|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866338|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866339|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866340|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866341|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866342|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866343|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866344|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866345|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
160866346|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866347|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866348|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866349|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866350|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866351|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866352|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866353|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866354|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866355|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866356|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866357|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866358|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866359|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
160866360|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
160866361|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866362|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866363|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866364|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866365|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866366|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866367|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866368|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866369|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866370|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866371|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866372|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866373|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
160866374|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
160866375|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866376|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866377|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866378|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866379|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866380|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866381|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866382|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866383|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866384|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866385|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866386|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866387|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
160866388|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
160866389|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866390|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866391|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866392|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866393|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866394|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866395|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866396|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866397|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866398|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866399|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866400|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866401|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
160866402|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866403|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866404|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866405|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866406|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866407|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866408|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866409|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866410|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866411|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866412|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866413|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866414|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866415|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
160866416|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866417|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866418|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866419|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866420|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866421|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866422|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866423|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866424|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866425|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866426|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866427|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866428|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866429|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
160866430|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866431|NCT01772316|580904926|FG000|Overall Study|Serious adverse event|1|||
160866432|NCT01772316|580904926|FG000|Overall Study|Inform consent withdrawn|1|||
160866433|NCT01772316|580904926|FG000|Overall Study|Withdrawn by sponsor decision|5|||
160866434|NCT02085161|580904928|FG000|Overall Study|Not Treated|1|||
160866435|NCT02085161|580904929|FG001|Overall Study|Not Treated|0|||
160866436|NCT02085161|580904930|FG002|Overall Study|Not Treated|0|||
160866437|NCT02085161|580904931|FG003|Overall Study|Not Treated|0|||
160866438|NCT02085161|580904928|FG000|Overall Study|Adverse Event|8|||
160866439|NCT02085161|580904929|FG001|Overall Study|Adverse Event|5|||
160866440|NCT02085161|580904930|FG002|Overall Study|Adverse Event|4|||
160866441|NCT02085161|580904931|FG003|Overall Study|Adverse Event|5|||
160866442|NCT02085161|580904928|FG000|Overall Study|Protocol Violation|0|||
160866443|NCT02085161|580904929|FG001|Overall Study|Protocol Violation|1|||
160866444|NCT02085161|580904930|FG002|Overall Study|Protocol Violation|0|||
160866445|NCT02085161|580904931|FG003|Overall Study|Protocol Violation|1|||
160636405|NCT01954082|580051540|FG000|Overall Study|Withdrawal by Subject|0|||
160866446|NCT02085161|580904928|FG000|Overall Study|Withdrawal by Subject|2|||
160866447|NCT02085161|580904929|FG001|Overall Study|Withdrawal by Subject|4|||
160866448|NCT02085161|580904930|FG002|Overall Study|Withdrawal by Subject|0|||
160866449|NCT02085161|580904931|FG003|Overall Study|Withdrawal by Subject|3|||
160866450|NCT02085161|580904928|FG000|Overall Study|Other Reason|1|||
160866451|NCT02085161|580904929|FG001|Overall Study|Other Reason|0|||
160866452|NCT02085161|580904930|FG002|Overall Study|Other Reason|1|||
160866453|NCT02085161|580904931|FG003|Overall Study|Other Reason|1|||
160866454|NCT00068692|580904942|FG000|Step 1: Registration|Disese progression/relapse|5|||
160866455|NCT00068692|580904943|FG001|Step 1: Registration|Disese progression/relapse|0|||
160866456|NCT00068692|580904944|FG002|Step 1: Registration|Disese progression/relapse|0|||
160866457|NCT00068692|580904945|FG003|Step 1: Registration|Disese progression/relapse|0|||
160866458|NCT00068692|580904946|FG004|Step 1: Registration|Disese progression/relapse|0|||
160866459|NCT00068692|580904947|FG005|Step 1: Registration|Disese progression/relapse|0|||
160866460|NCT00068692|580904948|FG006|Step 1: Registration|Disese progression/relapse|0|||
160866461|NCT00068692|580904949|FG007|Step 1: Registration|Disese progression/relapse|0|||
160866462|NCT00068692|580904942|FG000|Step 1: Registration|Adverse Event|7|||
160866463|NCT00068692|580904943|FG001|Step 1: Registration|Adverse Event|0|||
160866464|NCT00068692|580904944|FG002|Step 1: Registration|Adverse Event|0|||
160866465|NCT00068692|580904945|FG003|Step 1: Registration|Adverse Event|0|||
160866466|NCT00068692|580904946|FG004|Step 1: Registration|Adverse Event|0|||
160866467|NCT00068692|580904947|FG005|Step 1: Registration|Adverse Event|0|||
160866468|NCT00068692|580904948|FG006|Step 1: Registration|Adverse Event|0|||
160866469|NCT00068692|580904949|FG007|Step 1: Registration|Adverse Event|0|||
160866470|NCT00068692|580904942|FG000|Step 1: Registration|Death|1|||
160866471|NCT00068692|580904943|FG001|Step 1: Registration|Death|0|||
160866472|NCT00068692|580904944|FG002|Step 1: Registration|Death|0|||
160866473|NCT00068692|580904945|FG003|Step 1: Registration|Death|0|||
160866474|NCT00068692|580904946|FG004|Step 1: Registration|Death|0|||
160866475|NCT00068692|580904947|FG005|Step 1: Registration|Death|0|||
160866476|NCT00068692|580904948|FG006|Step 1: Registration|Death|0|||
160866477|NCT00068692|580904949|FG007|Step 1: Registration|Death|0|||
160866478|NCT00068692|580904942|FG000|Step 1: Registration|Withdrawal by Subject|11|||
160866479|NCT00068692|580904943|FG001|Step 1: Registration|Withdrawal by Subject|0|||
160866480|NCT00068692|580904944|FG002|Step 1: Registration|Withdrawal by Subject|0|||
160866481|NCT00068692|580904945|FG003|Step 1: Registration|Withdrawal by Subject|0|||
160866482|NCT00068692|580904946|FG004|Step 1: Registration|Withdrawal by Subject|0|||
160866483|NCT00068692|580904947|FG005|Step 1: Registration|Withdrawal by Subject|0|||
160866484|NCT00068692|580904948|FG006|Step 1: Registration|Withdrawal by Subject|0|||
160453944|NCT02505984|579393977|FG000|Overall Study|Study blind opened during assessment|0|||
160866485|NCT00068692|580904949|FG007|Step 1: Registration|Withdrawal by Subject|0|||
160866486|NCT00068692|580904942|FG000|Step 1: Registration|Alternative therapy|2|||
160981500|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
160762561|NCT04460326|580519407|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
160762562|NCT04460326|580519408|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
160762563|NCT04460326|580519407|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
160762564|NCT04460326|580519408|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
160762565|NCT03372798|580519409|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
160762566|NCT03372798|580519410|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
160762567|NCT03372798|580519409|FG000|Overall Study|Failure of imaging probe|0|||
160762568|NCT03372798|580519410|FG001|Overall Study|Failure of imaging probe|1|||
160762569|NCT04794751|580519411|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
160762570|NCT04794751|580519412|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
160762571|NCT04794751|580519411|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
160762572|NCT04794751|580519412|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
160762573|NCT04794751|580519411|FG000|Period 1|Protocol Violation|0|||
160762574|NCT04794751|580519412|FG001|Period 1|Protocol Violation|2|||
160762575|NCT04794751|580519411|FG000|Period 1|Withdrawal by Subject|0|||
160762576|NCT04794751|580519412|FG001|Period 1|Withdrawal by Subject|1|||
160762577|NCT04794751|580519411|FG000|Period 2|Withdrawal by Subject|0|||
160762578|NCT04794751|580519412|FG001|Period 2|Withdrawal by Subject|1|||
160762579|NCT04794751|580519411|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
160762580|NCT04794751|580519412|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
160762581|NCT04794751|580519411|FG000|Period 2|Protocol Violation|1|||
160762582|NCT04794751|580519412|FG001|Period 2|Protocol Violation|0|||
160762583|NCT01405898|580519413|FG000|Overall Study|Withdrawal by Subject|2|||
160762584|NCT01405898|580519414|FG001|Overall Study|Withdrawal by Subject|2|||
160762585|NCT01687218|580519415|FG000|Overall Study|Withdrawal by Subject|2|||
160762586|NCT01687218|580519416|FG001|Overall Study|Withdrawal by Subject|3|||
160762587|NCT01687218|580519417|FG002|Overall Study|Withdrawal by Subject|0|||
160762588|NCT01687218|580519418|FG003|Overall Study|Withdrawal by Subject|1|||
160762589|NCT01687218|580519419|FG004|Overall Study|Withdrawal by Subject|1|||
160762590|NCT01687218|580519420|FG005|Overall Study|Withdrawal by Subject|0|||
160762591|NCT01687218|580519415|FG000|Overall Study|Relocated, no follow-up planned|1|||
160762592|NCT01687218|580519416|FG001|Overall Study|Relocated, no follow-up planned|0|||
160762593|NCT01687218|580519417|FG002|Overall Study|Relocated, no follow-up planned|1|||
160762594|NCT01687218|580519418|FG003|Overall Study|Relocated, no follow-up planned|1|||
160762595|NCT01687218|580519419|FG004|Overall Study|Relocated, no follow-up planned|0|||
160762596|NCT01687218|580519420|FG005|Overall Study|Relocated, no follow-up planned|0|||
160762597|NCT03528551|580519427|FG000|Overall Study|Lost to Follow-up|0|||
160762598|NCT03528551|580519428|FG001|Overall Study|Lost to Follow-up|1|||
160762599|NCT03528551|580519429|FG002|Overall Study|Lost to Follow-up|0|||
160762600|NCT03528551|580519427|FG000|Overall Study|Transferred to other arm/group|2|||
160762601|NCT03528551|580519428|FG001|Overall Study|Transferred to other arm/group|3|||
160762602|NCT03528551|580519429|FG002|Overall Study|Transferred to other arm/group|0|||
160762603|NCT03528551|580519427|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160762604|NCT03528551|580519428|FG001|Overall Study|Withdrawal by parent/guardian|5|||
160762605|NCT03528551|580519429|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160762606|NCT03528551|580519427|FG000|Overall Study|Protocol Violation|0|||
160762607|NCT03528551|580519428|FG001|Overall Study|Protocol Violation|3|||
160762608|NCT03528551|580519429|FG002|Overall Study|Protocol Violation|0|||
160762609|NCT03528551|580519427|FG000|Overall Study|Withdrawal by Subject|0|||
160762610|NCT03528551|580519428|FG001|Overall Study|Withdrawal by Subject|7|||
160762611|NCT03528551|580519429|FG002|Overall Study|Withdrawal by Subject|0|||
160762612|NCT01789047|580519430|FG000|Overall Study|Adverse Event|3|||
160762613|NCT01789047|580519431|FG001|Overall Study|Adverse Event|2|||
160762614|NCT01789047|580519430|FG000|Overall Study|Withdrawal by Subject|1|||
160762615|NCT01789047|580519431|FG001|Overall Study|Withdrawal by Subject|2|||
160762616|NCT03644017|580519432|FG000|Overall Study|Access Abandonment|5|||
160762617|NCT03644017|580519432|FG000|Overall Study|Kidney Transplant|2|||
160762618|NCT02700048|580519433|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
160762619|NCT02700048|580519434|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
160762620|NCT01204671|580519435|FG000|Overall Study|Adverse Event|4|||
160762621|NCT01204671|580519436|FG001|Overall Study|Adverse Event|3|||
160762622|NCT01204671|580519437|FG002|Overall Study|Adverse Event|3|||
160762623|NCT01204671|580519438|FG003|Overall Study|Adverse Event|3|||
160762624|NCT01204671|580519439|FG004|Overall Study|Adverse Event|1|||
160762625|NCT01204671|580519435|FG000|Overall Study|Withdrawal by Subject|2|||
160762626|NCT01204671|580519436|FG001|Overall Study|Withdrawal by Subject|3|||
160762627|NCT01204671|580519437|FG002|Overall Study|Withdrawal by Subject|4|||
160762628|NCT01204671|580519438|FG003|Overall Study|Withdrawal by Subject|5|||
160762629|NCT01204671|580519439|FG004|Overall Study|Withdrawal by Subject|3|||
160762630|NCT01204671|580519435|FG000|Overall Study|Lost to Follow-up|7|||
160762631|NCT01204671|580519436|FG001|Overall Study|Lost to Follow-up|8|||
160762632|NCT01204671|580519437|FG002|Overall Study|Lost to Follow-up|6|||
160762633|NCT01204671|580519438|FG003|Overall Study|Lost to Follow-up|4|||
160762634|NCT01204671|580519439|FG004|Overall Study|Lost to Follow-up|0|||
160762635|NCT01204671|580519435|FG000|Overall Study|Unknown Completion Status|1|||
160762636|NCT01204671|580519436|FG001|Overall Study|Unknown Completion Status|1|||
160762637|NCT01204671|580519437|FG002|Overall Study|Unknown Completion Status|0|||
160762638|NCT01204671|580519438|FG003|Overall Study|Unknown Completion Status|0|||
160762639|NCT01204671|580519439|FG004|Overall Study|Unknown Completion Status|0|||
160762640|NCT01204671|580519435|FG000|Overall Study|Physician Decision|0|||
160762641|NCT01204671|580519436|FG001|Overall Study|Physician Decision|0|||
160762642|NCT01204671|580519437|FG002|Overall Study|Physician Decision|0|||
160762643|NCT01204671|580519438|FG003|Overall Study|Physician Decision|1|||
160762644|NCT01204671|580519439|FG004|Overall Study|Physician Decision|0|||
160762645|NCT02175225|580519440|FG000|Overall Study|Withdrawal by Subject|1|||
160762646|NCT02175225|580519441|FG001|Overall Study|Withdrawal by Subject|2|||
160762647|NCT02175225|580519440|FG000|Overall Study|Lost to Follow-up|6|||
160762648|NCT02175225|580519441|FG001|Overall Study|Lost to Follow-up|7|||
160762649|NCT02175225|580519440|FG000|Overall Study|Study drug not administered|1|||
160762650|NCT02175225|580519441|FG001|Overall Study|Study drug not administered|2|||
160762651|NCT02340000|580519442|FG000|Time Period 1|Withdrawal by Subject|6|||
160762652|NCT02340000|580519443|FG001|Time Period 1|Withdrawal by Subject|8|||
160762653|NCT02340000|580519442|FG000|Time Period 1|Lost to Follow-up|6|||
160762654|NCT02340000|580519443|FG001|Time Period 1|Lost to Follow-up|7|||
160762655|NCT02340000|580519442|FG000|Time Period 2|Withdrawal by Subject|9|||
160762656|NCT02340000|580519443|FG001|Time Period 2|Withdrawal by Subject|7|||
160762657|NCT02340000|580519442|FG000|Time Period 2|Lost to Follow-up|10|||
160762658|NCT02340000|580519443|FG001|Time Period 2|Lost to Follow-up|8|||
160762659|NCT02668640|580519444|FG000|Overall Study|Lost to Follow-up|13|||
160762660|NCT02668640|580519444|FG000|Overall Study|Other, not specified|1|||
160762661|NCT00919633|580519454|FG000|Overall Study|Adverse Event|1|||
160762662|NCT00919633|580519455|FG001|Overall Study|Adverse Event|9|||
160762663|NCT00919633|580519456|FG002|Overall Study|Adverse Event|12|||
160762664|NCT00919633|580519457|FG003|Overall Study|Adverse Event|10|||
160762665|NCT00919633|580519454|FG000|Overall Study|Death|0|||
160762666|NCT00919633|580519455|FG001|Overall Study|Death|0|||
160762667|NCT00919633|580519456|FG002|Overall Study|Death|2|||
160762668|NCT00919633|580519457|FG003|Overall Study|Death|0|||
160762669|NCT00919633|580519454|FG000|Overall Study|Lack of Efficacy|17|||
160762670|NCT00919633|580519455|FG001|Overall Study|Lack of Efficacy|3|||
160762671|NCT00919633|580519456|FG002|Overall Study|Lack of Efficacy|2|||
160762672|NCT00919633|580519457|FG003|Overall Study|Lack of Efficacy|3|||
160762673|NCT00919633|580519454|FG000|Overall Study|Withdrawal by Subject|1|||
160762674|NCT00919633|580519455|FG001|Overall Study|Withdrawal by Subject|2|||
160762675|NCT00919633|580519456|FG002|Overall Study|Withdrawal by Subject|4|||
160762676|NCT00919633|580519457|FG003|Overall Study|Withdrawal by Subject|3|||
160762677|NCT00919633|580519454|FG000|Overall Study|Lost to Follow-up|3|||
160762678|NCT00919633|580519455|FG001|Overall Study|Lost to Follow-up|1|||
160762679|NCT00919633|580519456|FG002|Overall Study|Lost to Follow-up|0|||
160762680|NCT00919633|580519457|FG003|Overall Study|Lost to Follow-up|2|||
160762681|NCT00919633|580519454|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
160762682|NCT00919633|580519455|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
160762683|NCT00919633|580519456|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
160762684|NCT00919633|580519457|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
160762685|NCT00919633|580519454|FG000|Overall Study|Protocol Violation|0|||
160762686|NCT00919633|580519455|FG001|Overall Study|Protocol Violation|0|||
160762687|NCT00919633|580519456|FG002|Overall Study|Protocol Violation|0|||
160762688|NCT00919633|580519457|FG003|Overall Study|Protocol Violation|1|||
160762689|NCT00919633|580519454|FG000|Overall Study|Physician Decision|0|||
160762690|NCT00919633|580519455|FG001|Overall Study|Physician Decision|0|||
160762691|NCT00919633|580519456|FG002|Overall Study|Physician Decision|0|||
160762692|NCT00919633|580519457|FG003|Overall Study|Physician Decision|1|||
160762693|NCT00919633|580519454|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
160762694|NCT00919633|580519455|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
160762695|NCT00919633|580519456|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
160762696|NCT00919633|580519457|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
160762697|NCT00919633|580519454|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
160762698|NCT00919633|580519455|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
160762699|NCT00919633|580519456|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
160762700|NCT00919633|580519457|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
160762701|NCT01526785|580519458|FG000|Overall Study|Study Terminated by Sponsor|8|||
160762702|NCT01526785|580519458|FG000|Overall Study|Death|2|||
160762703|NCT01526785|580519458|FG000|Overall Study|Physician Decision|1|||
160762704|NCT01526785|580519458|FG000|Overall Study|Withdrawal by Subject|2|||
160762705|NCT01121263|580519461|FG000|Overall Study|Death|3|||
160762706|NCT01121263|580519462|FG001|Overall Study|Death|2|||
160762707|NCT01121263|580519461|FG000|Overall Study|Lost to Follow-up|22|||
160762708|NCT01121263|580519462|FG001|Overall Study|Lost to Follow-up|12|||
160762709|NCT01121263|580519461|FG000|Overall Study|Withdrawal by Subject|0|||
160762710|NCT01121263|580519462|FG001|Overall Study|Withdrawal by Subject|1|||
160866487|NCT00068692|580904943|FG001|Step 1: Registration|Alternative therapy|0|||
160866488|NCT00068692|580904944|FG002|Step 1: Registration|Alternative therapy|0|||
160866489|NCT00068692|580904945|FG003|Step 1: Registration|Alternative therapy|0|||
160866490|NCT00068692|580904946|FG004|Step 1: Registration|Alternative therapy|0|||
160762711|NCT02873689|580521092|FG000|Overall Study|Lack of Efficacy|1|||
160762712|NCT02873689|580521093|FG001|Overall Study|Lack of Efficacy|0|||
160762713|NCT02873689|580521092|FG000|Overall Study|Withdrawal by Subject|2|||
160762714|NCT02873689|580521093|FG001|Overall Study|Withdrawal by Subject|2|||
160762715|NCT02873689|580521092|FG000|Overall Study|Protocol Violation|1|||
160762716|NCT02873689|580521093|FG001|Overall Study|Protocol Violation|0|||
160762717|NCT02873689|580521092|FG000|Overall Study|Adverse Event|2|||
160762718|NCT02873689|580521093|FG001|Overall Study|Adverse Event|2|||
160762719|NCT02873689|580521092|FG000|Overall Study|Randomized but not Treated|1|||
160762720|NCT02873689|580521093|FG001|Overall Study|Randomized but not Treated|1|||
160762721|NCT00434252|580521097|FG000|Overall Study|Lack of Efficacy|50|||
160762722|NCT00434252|580521098|FG001|Overall Study|Lack of Efficacy|100|||
160762723|NCT00434252|580521097|FG000|Overall Study|Adverse Event|6|||
160762724|NCT00434252|580521098|FG001|Overall Study|Adverse Event|13|||
160762725|NCT00434252|580521097|FG000|Overall Study|Death|1|||
160762726|NCT00434252|580521098|FG001|Overall Study|Death|2|||
160762727|NCT00434252|580521097|FG000|Overall Study|Lost to Follow-up|0|||
160762728|NCT00434252|580521098|FG001|Overall Study|Lost to Follow-up|1|||
160762729|NCT00434252|580521097|FG000|Overall Study|Physician Decision|4|||
160762730|NCT00434252|580521098|FG001|Overall Study|Physician Decision|8|||
160762731|NCT00434252|580521097|FG000|Overall Study|Withdrawal by Subject|3|||
160762732|NCT00434252|580521098|FG001|Overall Study|Withdrawal by Subject|7|||
160762733|NCT02337764|580521099|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
160762734|NCT02337764|580521099|FG000|Overall Study|Voluntary Withdrawal|12|||
160762735|NCT02337764|580521099|FG000|Overall Study|Lack of Efficacy|2|||
160762736|NCT02990000|580521100|FG000|Overall Study|Failed to provide data beyond baseline|36|||
160762737|NCT02990000|580521101|FG001|Overall Study|Failed to provide data beyond baseline|34|||
160762738|NCT02810418|580521108|FG000|Arm A Dose Escalation|Adverse Event|2|||
160762739|NCT02810418|580521109|FG001|Arm A Dose Escalation|Adverse Event|1|||
160762740|NCT02810418|580521110|FG002|Arm A Dose Escalation|Adverse Event|0|||
160762741|NCT02810418|580521111|FG003|Arm A Dose Escalation|Adverse Event|0|||
160762742|NCT02810418|580521112|FG004|Arm A Dose Escalation|Adverse Event|0|||
160762743|NCT02810418|580521113|FG005|Arm A Dose Escalation|Adverse Event|0|||
160762744|NCT02810418|580521114|FG006|Arm A Dose Escalation|Adverse Event|0|||
160762745|NCT02810418|580521108|FG000|Dose Expansion|Adverse Event|0|||
160762746|NCT02810418|580521109|FG001|Dose Expansion|Adverse Event|1|||
160762747|NCT02810418|580521110|FG002|Dose Expansion|Adverse Event|1|||
160762748|NCT02810418|580521111|FG003|Dose Expansion|Adverse Event|0|||
160762749|NCT02810418|580521112|FG004|Dose Expansion|Adverse Event|0|||
160762750|NCT02810418|580521113|FG005|Dose Expansion|Adverse Event|0|||
160762751|NCT02810418|580521114|FG006|Dose Expansion|Adverse Event|0|||
160762752|NCT02810418|580521108|FG000|Dose Expansion|Physician Decision|0|||
160762753|NCT02810418|580521109|FG001|Dose Expansion|Physician Decision|0|||
160762754|NCT02810418|580521110|FG002|Dose Expansion|Physician Decision|2|||
160762755|NCT02810418|580521111|FG003|Dose Expansion|Physician Decision|0|||
160762756|NCT02810418|580521112|FG004|Dose Expansion|Physician Decision|0|||
160762757|NCT02810418|580521113|FG005|Dose Expansion|Physician Decision|0|||
160762758|NCT02810418|580521114|FG006|Dose Expansion|Physician Decision|0|||
160762759|NCT02810418|580521108|FG000|Arm B Dose Escalation|Adverse Event|0|||
160762760|NCT02810418|580521109|FG001|Arm B Dose Escalation|Adverse Event|0|||
160762761|NCT02810418|580521110|FG002|Arm B Dose Escalation|Adverse Event|0|||
160762762|NCT02810418|580521111|FG003|Arm B Dose Escalation|Adverse Event|0|||
160762763|NCT02810418|580521112|FG004|Arm B Dose Escalation|Adverse Event|1|||
160762764|NCT02810418|580521113|FG005|Arm B Dose Escalation|Adverse Event|2|||
160762765|NCT02810418|580521114|FG006|Arm B Dose Escalation|Adverse Event|0|||
160762766|NCT03103503|580521115|FG000|Overall Study|Death|64|||
160762767|NCT03103503|580521115|FG000|Overall Study|Physician Decision|57|||
160762768|NCT03103503|580521115|FG000|Overall Study|Withdrawal by Subject|10|||
160762769|NCT03103503|580521115|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
160762770|NCT03103503|580521115|FG000|Overall Study|Lost to Follow-up|3|||
160762771|NCT03103503|580521115|FG000|Overall Study|Study Closure|757|||
160762772|NCT04161391|580521120|FG000|Overall Study|Adverse Event|0|||
160762773|NCT04161391|580521121|FG001|Overall Study|Adverse Event|1|||
160762774|NCT04161391|580521122|FG002|Overall Study|Adverse Event|0|||
160762775|NCT04161391|580521123|FG003|Overall Study|Adverse Event|1|||
160866491|NCT00068692|580904947|FG005|Step 1: Registration|Alternative therapy|0|||
160866492|NCT00068692|580904948|FG006|Step 1: Registration|Alternative therapy|0|||
160762776|NCT04161391|580521124|FG004|Overall Study|Adverse Event|0|||
160762777|NCT04161391|580521125|FG005|Overall Study|Adverse Event|0|||
160762778|NCT04161391|580521126|FG006|Overall Study|Adverse Event|0|||
160762779|NCT04161391|580521127|FG007|Overall Study|Adverse Event|3|||
160762780|NCT04161391|580521128|FG008|Overall Study|Adverse Event|0|||
160762781|NCT04161391|580521120|FG000|Overall Study|Death|0|||
160762782|NCT04161391|580521121|FG001|Overall Study|Death|0|||
160866493|NCT00068692|580904949|FG007|Step 1: Registration|Alternative therapy|0|||
160866494|NCT00068692|580904942|FG000|Step 1: Registration|Complicating disease|2|||
160866495|NCT00068692|580904943|FG001|Step 1: Registration|Complicating disease|0|||
160866496|NCT00068692|580904944|FG002|Step 1: Registration|Complicating disease|0|||
160866497|NCT00068692|580904945|FG003|Step 1: Registration|Complicating disease|0|||
160866498|NCT00068692|580904946|FG004|Step 1: Registration|Complicating disease|0|||
160866499|NCT00068692|580904947|FG005|Step 1: Registration|Complicating disease|0|||
160866500|NCT00068692|580904948|FG006|Step 1: Registration|Complicating disease|0|||
160866501|NCT00068692|580904949|FG007|Step 1: Registration|Complicating disease|0|||
160866502|NCT00068692|580904942|FG000|Step 1: Registration|Protocol Violation|1|||
160866503|NCT00068692|580904943|FG001|Step 1: Registration|Protocol Violation|0|||
160866504|NCT00068692|580904944|FG002|Step 1: Registration|Protocol Violation|0|||
160866505|NCT00068692|580904945|FG003|Step 1: Registration|Protocol Violation|0|||
160866506|NCT00068692|580904946|FG004|Step 1: Registration|Protocol Violation|0|||
160866507|NCT00068692|580904947|FG005|Step 1: Registration|Protocol Violation|0|||
160866508|NCT00068692|580904948|FG006|Step 1: Registration|Protocol Violation|0|||
160866509|NCT00068692|580904949|FG007|Step 1: Registration|Protocol Violation|0|||
160866510|NCT00068692|580904942|FG000|Step 1: Registration|Not eligible|6|||
160866511|NCT00068692|580904943|FG001|Step 1: Registration|Not eligible|0|||
160866512|NCT00068692|580904944|FG002|Step 1: Registration|Not eligible|0|||
160866513|NCT00068692|580904945|FG003|Step 1: Registration|Not eligible|0|||
160866514|NCT00068692|580904946|FG004|Step 1: Registration|Not eligible|0|||
160866515|NCT00068692|580904947|FG005|Step 1: Registration|Not eligible|0|||
160866516|NCT00068692|580904948|FG006|Step 1: Registration|Not eligible|0|||
160866517|NCT00068692|580904949|FG007|Step 1: Registration|Not eligible|0|||
160866518|NCT00068692|580904942|FG000|Step 1: Registration|Other|2|||
160866519|NCT00068692|580904943|FG001|Step 1: Registration|Other|0|||
160866520|NCT00068692|580904944|FG002|Step 1: Registration|Other|0|||
160866521|NCT00068692|580904945|FG003|Step 1: Registration|Other|0|||
160866522|NCT00068692|580904946|FG004|Step 1: Registration|Other|0|||
160866523|NCT00068692|580904947|FG005|Step 1: Registration|Other|0|||
160866524|NCT00068692|580904948|FG006|Step 1: Registration|Other|0|||
160866525|NCT00068692|580904949|FG007|Step 1: Registration|Other|0|||
160866526|NCT00068692|580904942|FG000|Step 1: Registration|Not start protocol therapy|3|||
160866527|NCT00068692|580904943|FG001|Step 1: Registration|Not start protocol therapy|0|||
160866528|NCT00068692|580904944|FG002|Step 1: Registration|Not start protocol therapy|0|||
160866529|NCT00068692|580904945|FG003|Step 1: Registration|Not start protocol therapy|0|||
160866530|NCT00068692|580904946|FG004|Step 1: Registration|Not start protocol therapy|0|||
160866531|NCT00068692|580904947|FG005|Step 1: Registration|Not start protocol therapy|0|||
160866532|NCT00068692|580904948|FG006|Step 1: Registration|Not start protocol therapy|0|||
160866533|NCT00068692|580904949|FG007|Step 1: Registration|Not start protocol therapy|0|||
160866534|NCT00068692|580904942|FG000|Step 1: Registration|Registered but not randomized|0|||
160866535|NCT00068692|580904943|FG001|Step 1: Registration|Registered but not randomized|1|||
160866536|NCT00068692|580904944|FG002|Step 1: Registration|Registered but not randomized|0|||
160866537|NCT00068692|580904945|FG003|Step 1: Registration|Registered but not randomized|0|||
160866538|NCT00068692|580904946|FG004|Step 1: Registration|Registered but not randomized|0|||
160866539|NCT00068692|580904947|FG005|Step 1: Registration|Registered but not randomized|0|||
160866540|NCT00068692|580904948|FG006|Step 1: Registration|Registered but not randomized|0|||
160866541|NCT00068692|580904949|FG007|Step 1: Registration|Registered but not randomized|0|||
160866542|NCT00068692|580904942|FG000|Step 2: Randomization|Disesae progression/replase|0|||
160866543|NCT00068692|580904943|FG001|Step 2: Randomization|Disesae progression/replase|0|||
160866544|NCT00068692|580904944|FG002|Step 2: Randomization|Disesae progression/replase|1|||
160866545|NCT00068692|580904945|FG003|Step 2: Randomization|Disesae progression/replase|1|||
160866546|NCT00068692|580904946|FG004|Step 2: Randomization|Disesae progression/replase|0|||
160866547|NCT00068692|580904947|FG005|Step 2: Randomization|Disesae progression/replase|0|||
160866548|NCT00068692|580904948|FG006|Step 2: Randomization|Disesae progression/replase|0|||
160866549|NCT00068692|580904949|FG007|Step 2: Randomization|Disesae progression/replase|0|||
160866550|NCT00068692|580904942|FG000|Step 2: Randomization|Adverse Event|0|||
160866551|NCT00068692|580904943|FG001|Step 2: Randomization|Adverse Event|0|||
160866552|NCT00068692|580904944|FG002|Step 2: Randomization|Adverse Event|4|||
160866553|NCT00068692|580904945|FG003|Step 2: Randomization|Adverse Event|2|||
160527141|NCT01233869|579660903|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
160866554|NCT00068692|580904946|FG004|Step 2: Randomization|Adverse Event|2|||
160866555|NCT00068692|580904947|FG005|Step 2: Randomization|Adverse Event|3|||
160866556|NCT00068692|580904948|FG006|Step 2: Randomization|Adverse Event|4|||
160866557|NCT00068692|580904949|FG007|Step 2: Randomization|Adverse Event|4|||
160866558|NCT00068692|580904942|FG000|Step 2: Randomization|Death|0|||
160866559|NCT00068692|580904943|FG001|Step 2: Randomization|Death|0|||
160866560|NCT00068692|580904944|FG002|Step 2: Randomization|Death|0|||
160866561|NCT00068692|580904945|FG003|Step 2: Randomization|Death|0|||
160866562|NCT00068692|580904946|FG004|Step 2: Randomization|Death|1|||
160866563|NCT00068692|580904947|FG005|Step 2: Randomization|Death|0|||
160866564|NCT00068692|580904948|FG006|Step 2: Randomization|Death|0|||
160866565|NCT00068692|580904949|FG007|Step 2: Randomization|Death|1|||
160866566|NCT00068692|580904942|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
160866567|NCT00068692|580904943|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
160866568|NCT00068692|580904944|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
160866569|NCT00068692|580904945|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
160866570|NCT00068692|580904946|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
160866571|NCT00068692|580904947|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
160866572|NCT00068692|580904948|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
160866573|NCT00068692|580904949|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
160866574|NCT00068692|580904942|FG000|Step 2: Randomization|alternative therapy|0|||
160866575|NCT00068692|580904943|FG001|Step 2: Randomization|alternative therapy|0|||
160866576|NCT00068692|580904944|FG002|Step 2: Randomization|alternative therapy|0|||
160866577|NCT00068692|580904945|FG003|Step 2: Randomization|alternative therapy|1|||
160866578|NCT00068692|580904946|FG004|Step 2: Randomization|alternative therapy|1|||
160866579|NCT00068692|580904947|FG005|Step 2: Randomization|alternative therapy|0|||
160866580|NCT00068692|580904948|FG006|Step 2: Randomization|alternative therapy|0|||
160866581|NCT00068692|580904949|FG007|Step 2: Randomization|alternative therapy|0|||
160762783|NCT04161391|580521122|FG002|Overall Study|Death|0|||
160762784|NCT04161391|580521123|FG003|Overall Study|Death|0|||
160762785|NCT04161391|580521124|FG004|Overall Study|Death|0|||
160762786|NCT04161391|580521125|FG005|Overall Study|Death|0|||
160762787|NCT04161391|580521126|FG006|Overall Study|Death|0|||
160762788|NCT04161391|580521127|FG007|Overall Study|Death|1|||
160762789|NCT04161391|580521128|FG008|Overall Study|Death|0|||
160762790|NCT04161391|580521120|FG000|Overall Study|Physician Decision|0|||
160762791|NCT04161391|580521121|FG001|Overall Study|Physician Decision|0|||
160762792|NCT04161391|580521122|FG002|Overall Study|Physician Decision|1|||
160762793|NCT04161391|580521123|FG003|Overall Study|Physician Decision|2|||
160762794|NCT04161391|580521124|FG004|Overall Study|Physician Decision|0|||
160762795|NCT04161391|580521125|FG005|Overall Study|Physician Decision|0|||
160762796|NCT04161391|580521126|FG006|Overall Study|Physician Decision|2|||
160762797|NCT04161391|580521127|FG007|Overall Study|Physician Decision|0|||
160762798|NCT04161391|580521128|FG008|Overall Study|Physician Decision|0|||
160762799|NCT04161391|580521120|FG000|Overall Study|Progressive Disease|4|||
160762800|NCT04161391|580521121|FG001|Overall Study|Progressive Disease|3|||
160762801|NCT04161391|580521122|FG002|Overall Study|Progressive Disease|3|||
160762802|NCT04161391|580521123|FG003|Overall Study|Progressive Disease|5|||
160762803|NCT04161391|580521124|FG004|Overall Study|Progressive Disease|3|||
160762804|NCT04161391|580521125|FG005|Overall Study|Progressive Disease|3|||
160762805|NCT04161391|580521126|FG006|Overall Study|Progressive Disease|5|||
160762806|NCT04161391|580521127|FG007|Overall Study|Progressive Disease|2|||
160762807|NCT04161391|580521128|FG008|Overall Study|Progressive Disease|2|||
160762808|NCT02579629|580521134|FG000|Overall Study|Withdrawal by Subject|0|||
160762809|NCT02579629|580521135|FG001|Overall Study|Withdrawal by Subject|1|||
160762810|NCT02579629|580521136|FG002|Overall Study|Withdrawal by Subject|0|||
160762811|NCT02579629|580521134|FG000|Overall Study|Screen Failure|2|||
160762812|NCT02579629|580521135|FG001|Overall Study|Screen Failure|0|||
160762813|NCT02579629|580521136|FG002|Overall Study|Screen Failure|2|||
160762814|NCT00737048|580521137|FG000|Overall Study|Physician Decision|0|||
160762815|NCT00737048|580521138|FG001|Overall Study|Physician Decision|0|||
160762816|NCT00737048|580521139|FG002|Overall Study|Physician Decision|1|||
160762817|NCT00737048|580521137|FG000|Overall Study|Adverse Event|0|||
160762818|NCT00737048|580521138|FG001|Overall Study|Adverse Event|1|||
160762819|NCT00737048|580521139|FG002|Overall Study|Adverse Event|0|||
160762820|NCT00737048|580521137|FG000|Overall Study|Worsening of the symptoms|3|||
160762821|NCT00737048|580521138|FG001|Overall Study|Worsening of the symptoms|5|||
160762822|NCT00737048|580521139|FG002|Overall Study|Worsening of the symptoms|3|||
160762823|NCT01739335|580521140|FG000|Overall Study|Lost to Follow-up|7|||
160762824|NCT01739335|580521141|FG001|Overall Study|Lost to Follow-up|4|||
160762825|NCT01739335|580521140|FG000|Overall Study|Ineligible patient randomized|0|||
160762826|NCT01739335|580521141|FG001|Overall Study|Ineligible patient randomized|1|||
160762827|NCT01863771|580521143|FG000|Induction Phase|Adverse Event|9|||
160762828|NCT01863771|580521144|FG001|Induction Phase|Adverse Event|0|||
160762829|NCT01863771|580521145|FG002|Induction Phase|Adverse Event|0|||
160762830|NCT01863771|580521146|FG003|Induction Phase|Adverse Event|0|||
160762831|NCT01863771|580521143|FG000|Induction Phase|Lack of Efficacy|10|||
160762832|NCT01863771|580521144|FG001|Induction Phase|Lack of Efficacy|0|||
160762833|NCT01863771|580521145|FG002|Induction Phase|Lack of Efficacy|0|||
160866582|NCT00068692|580904942|FG000|Step 2: Randomization|Physician Decision|0|||
160866583|NCT00068692|580904943|FG001|Step 2: Randomization|Physician Decision|0|||
160866584|NCT00068692|580904944|FG002|Step 2: Randomization|Physician Decision|0|||
160762834|NCT01863771|580521146|FG003|Induction Phase|Lack of Efficacy|0|||
160762835|NCT01863771|580521143|FG000|Induction Phase|Withdrawal by Subject|2|||
160762836|NCT01863771|580521144|FG001|Induction Phase|Withdrawal by Subject|0|||
160762837|NCT01863771|580521145|FG002|Induction Phase|Withdrawal by Subject|0|||
160762838|NCT01863771|580521146|FG003|Induction Phase|Withdrawal by Subject|0|||
160762839|NCT01863771|580521143|FG000|Maintenance Phase|Adverse Event|0|||
160762840|NCT01863771|580521144|FG001|Maintenance Phase|Adverse Event|0|||
160762841|NCT01863771|580521145|FG002|Maintenance Phase|Adverse Event|1|||
160866585|NCT00068692|580904945|FG003|Step 2: Randomization|Physician Decision|1|||
160866586|NCT00068692|580904946|FG004|Step 2: Randomization|Physician Decision|1|||
160866587|NCT00068692|580904947|FG005|Step 2: Randomization|Physician Decision|0|||
160866588|NCT00068692|580904948|FG006|Step 2: Randomization|Physician Decision|0|||
160866589|NCT00068692|580904949|FG007|Step 2: Randomization|Physician Decision|0|||
160866590|NCT00068692|580904942|FG000|Step 2: Randomization|Other|0|||
160866591|NCT00068692|580904943|FG001|Step 2: Randomization|Other|0|||
160866592|NCT00068692|580904944|FG002|Step 2: Randomization|Other|0|||
160866593|NCT00068692|580904945|FG003|Step 2: Randomization|Other|1|||
160866594|NCT00068692|580904946|FG004|Step 2: Randomization|Other|0|||
160866595|NCT00068692|580904947|FG005|Step 2: Randomization|Other|1|||
160866596|NCT00068692|580904948|FG006|Step 2: Randomization|Other|0|||
160866597|NCT00068692|580904949|FG007|Step 2: Randomization|Other|0|||
160866598|NCT00068692|580904942|FG000|Step 2: Randomization|never start protocol therapy|0|||
160866599|NCT00068692|580904943|FG001|Step 2: Randomization|never start protocol therapy|0|||
160866600|NCT00068692|580904944|FG002|Step 2: Randomization|never start protocol therapy|1|||
160866601|NCT00068692|580904945|FG003|Step 2: Randomization|never start protocol therapy|0|||
160866602|NCT00068692|580904946|FG004|Step 2: Randomization|never start protocol therapy|1|||
160866603|NCT00068692|580904947|FG005|Step 2: Randomization|never start protocol therapy|0|||
160866604|NCT00068692|580904948|FG006|Step 2: Randomization|never start protocol therapy|0|||
160762842|NCT01863771|580521146|FG003|Maintenance Phase|Adverse Event|1|||
160762843|NCT01863771|580521143|FG000|Maintenance Phase|Lack of Efficacy|0|||
160762844|NCT01863771|580521144|FG001|Maintenance Phase|Lack of Efficacy|3|||
160762845|NCT01863771|580521145|FG002|Maintenance Phase|Lack of Efficacy|7|||
160762846|NCT01863771|580521146|FG003|Maintenance Phase|Lack of Efficacy|38|||
160762847|NCT01863771|580521143|FG000|Maintenance Phase|Physician Decision|0|||
160762848|NCT01863771|580521144|FG001|Maintenance Phase|Physician Decision|0|||
160762849|NCT01863771|580521145|FG002|Maintenance Phase|Physician Decision|2|||
160762850|NCT01863771|580521146|FG003|Maintenance Phase|Physician Decision|1|||
160762851|NCT01863771|580521143|FG000|Maintenance Phase|Pregnancy|0|||
160762852|NCT01863771|580521144|FG001|Maintenance Phase|Pregnancy|1|||
160762853|NCT01863771|580521145|FG002|Maintenance Phase|Pregnancy|0|||
160762854|NCT01863771|580521146|FG003|Maintenance Phase|Pregnancy|0|||
160762855|NCT01863771|580521143|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160762856|NCT01863771|580521144|FG001|Maintenance Phase|Withdrawal by Subject|1|||
160762857|NCT01863771|580521145|FG002|Maintenance Phase|Withdrawal by Subject|2|||
160762858|NCT01863771|580521146|FG003|Maintenance Phase|Withdrawal by Subject|3|||
160762859|NCT02666222|580521154|FG000|Overall Study|Death|2|||
160762860|NCT03504917|580521158|FG000|Blinded Treatment Period|Protocol Violation|1|||
160762861|NCT03504917|580521159|FG001|Blinded Treatment Period|Protocol Violation|0|||
160762862|NCT03504917|580521158|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
160762863|NCT03504917|580521159|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
160762864|NCT03504917|580521158|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
160762865|NCT03504917|580521159|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
160762866|NCT03504917|580521158|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
160762867|NCT03504917|580521159|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
160762868|NCT03504917|580521158|FG000|Blinded Treatment Period|Adverse Event|4|||
160762869|NCT03504917|580521159|FG001|Blinded Treatment Period|Adverse Event|4|||
160762870|NCT03504917|580521158|FG000|Blinded Treatment Period|Physician Decision|1|||
160762871|NCT03504917|580521159|FG001|Blinded Treatment Period|Physician Decision|0|||
160762872|NCT03504917|580521158|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
160762873|NCT03504917|580521159|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
160762874|NCT03504917|580521158|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
160762875|NCT03504917|580521159|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
160762876|NCT03504917|580521158|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
160762877|NCT03504917|580521159|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
160762878|NCT03504917|580521158|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
160762879|NCT03504917|580521159|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
160762880|NCT03504917|580521158|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
160762881|NCT03504917|580521159|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
160762882|NCT03504917|580521158|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
160866605|NCT00068692|580904949|FG007|Step 2: Randomization|never start protocol therapy|0|||
160866606|NCT01600716|580904951|FG000|Overall Study|Other Reasons|3|||
160866607|NCT01600716|580904952|FG001|Overall Study|Other Reasons|1|||
160866608|NCT01600716|580904951|FG000|Overall Study|Personal Reasons|0|||
160866609|NCT01600716|580904952|FG001|Overall Study|Personal Reasons|2|||
160866610|NCT01600716|580904951|FG000|Overall Study|Lost to Follow-up|0|||
160866611|NCT01600716|580904952|FG001|Overall Study|Lost to Follow-up|2|||
160866612|NCT01600716|580904951|FG000|Overall Study|Pregnancy|1|||
160866613|NCT01600716|580904952|FG001|Overall Study|Pregnancy|0|||
160866614|NCT01600716|580904951|FG000|Overall Study|Lack of Efficacy|2|||
160866615|NCT01600716|580904952|FG001|Overall Study|Lack of Efficacy|1|||
160866616|NCT01600716|580904951|FG000|Overall Study|Adverse Event|1|||
160866617|NCT01600716|580904952|FG001|Overall Study|Adverse Event|1|||
160866618|NCT03557034|580904955|FG000|Overall Study|Withdrawal by Subject|1|||
160866619|NCT03557034|580904956|FG001|Overall Study|Withdrawal by Subject|0|||
160866620|NCT03349034|580904959|FG000|Overall Study|catheters dislodged during transport|2|||
160866621|NCT03349034|580904960|FG001|Overall Study|catheters dislodged during transport|0|||
160866622|NCT03349034|580904959|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
160866623|NCT03349034|580904960|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
160866624|NCT03349034|580904959|FG000|Overall Study|soft tissue flap used|1|||
160866625|NCT03349034|580904960|FG001|Overall Study|soft tissue flap used|0|||
160866626|NCT03349034|580904959|FG000|Overall Study|Other|0|||
160866627|NCT03349034|580904960|FG001|Overall Study|Other|1|||
160866628|NCT01759446|580904961|FG000|Overall Study|Protocol Violation|1|||
160866629|NCT01759446|580904962|FG001|Overall Study|Protocol Violation|0|||
160866630|NCT01759446|580904963|FG002|Overall Study|Protocol Violation|1|||
160866631|NCT01759446|580904964|FG003|Overall Study|Protocol Violation|0|||
160866632|NCT01759446|580904965|FG004|Overall Study|Protocol Violation|0|||
160866633|NCT01759446|580904961|FG000|Overall Study|Withdrawal by Subject|0|||
160866634|NCT01759446|580904962|FG001|Overall Study|Withdrawal by Subject|1|||
160866635|NCT01759446|580904963|FG002|Overall Study|Withdrawal by Subject|0|||
160866636|NCT01759446|580904964|FG003|Overall Study|Withdrawal by Subject|1|||
160866637|NCT01759446|580904965|FG004|Overall Study|Withdrawal by Subject|0|||
160866638|NCT01760733|580904966|FG000|Waiting List|Death|18|||
160866639|NCT01760733|580904966|FG000|Waiting List|Removed from waiting list|41|||
160866640|NCT01760733|580904966|FG000|Waiting List|Not received a transplant yet|13|||
160866641|NCT01760733|580904966|FG000|Transplanted|Not reached 10 years post transplant|184|||
160866642|NCT01760733|580904966|FG000|Transplanted|Death|26|||
160866643|NCT01760733|580904966|FG000|Transplanted|Graft loss|7|||
160866644|NCT00815659|580904969|FG000|Overall Study|Adverse Event|9|||
160866645|NCT00815659|580904969|FG000|Overall Study|Withdrawal by Subject|9|||
160866646|NCT00815659|580904969|FG000|Overall Study|Lost to Follow-up|4|||
160866647|NCT00815659|580904969|FG000|Overall Study|Protocol Violation|1|||
160866648|NCT00719472|580904970|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
160866649|NCT00719472|580904970|FG000|Enrolled in Study|Subject decision to withdraw|8|||
160866650|NCT00719472|580904970|FG000|Enrolled in Study|Various Reasons|17|||
160866651|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
160866652|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Death|5|||
160866653|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
160866654|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
160866655|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
160866656|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
160866657|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
160866658|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Death|6|||
160866659|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Disease progression|3|||
160866660|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
160866661|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
160866662|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
160866663|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
160866664|NCT00123422|580904971|FG000|Overall Study|Physician Decision|2|||
160866665|NCT00123422|580904972|FG001|Overall Study|Physician Decision|2|||
160866666|NCT00123422|580904973|FG002|Overall Study|Physician Decision|6|||
160866667|NCT00123422|580904971|FG000|Overall Study|Withdrawal by Subject|1|||
160866668|NCT00123422|580904972|FG001|Overall Study|Withdrawal by Subject|2|||
160866669|NCT00123422|580904973|FG002|Overall Study|Withdrawal by Subject|2|||
160866670|NCT00123422|580904971|FG000|Overall Study|Lost to Follow-up|1|||
160866671|NCT00123422|580904972|FG001|Overall Study|Lost to Follow-up|2|||
160866672|NCT00123422|580904973|FG002|Overall Study|Lost to Follow-up|2|||
160866673|NCT03584789|580904981|FG000|Overall Study|refused EHR permission|19|||
160866674|NCT03584789|580904982|FG001|Overall Study|refused EHR permission|28|||
160866675|NCT03584789|580904983|FG002|Overall Study|refused EHR permission|23|||
160866676|NCT03584789|580904981|FG000|Overall Study|patients tied to a provider who retired|0|||
160866677|NCT03584789|580904982|FG001|Overall Study|patients tied to a provider who retired|0|||
160866678|NCT03584789|580904983|FG002|Overall Study|patients tied to a provider who retired|3|||
160866679|NCT04646044|580904985|FG000|Overall Study|Lost to Follow-up|0|||
160527142|NCT01233869|579660904|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
160527143|NCT01233869|579660901|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
160527144|NCT01233869|579660902|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
160762883|NCT03504917|580521159|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
160762884|NCT03504917|580521158|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
160762885|NCT03504917|580521159|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
160762886|NCT03504917|580521158|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
160762887|NCT03504917|580521159|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
160762888|NCT03504917|580521158|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
160762889|NCT03504917|580521159|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
160762890|NCT03504917|580521158|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
160762891|NCT03504917|580521159|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
160762892|NCT03863353|580521160|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
160762893|NCT03863353|580521161|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
160762894|NCT04079790|580521165|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
160762895|NCT04079790|580521166|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
160762896|NCT04079790|580521167|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
160762897|NCT04079790|580521168|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
160762898|NCT04079790|580521165|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
160762899|NCT04079790|580521166|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
160762900|NCT04079790|580521167|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
160762901|NCT04079790|580521168|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
160762902|NCT04079790|580521165|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
160762903|NCT04079790|580521166|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
160762904|NCT04079790|580521167|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
160762905|NCT04079790|580521168|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
160762906|NCT04275336|580521172|FG000|Overall Study|First venipuncture failed|4|||
160762907|NCT04275336|580521173|FG001|Overall Study|First venipuncture failed|6|||
160762908|NCT04275336|580521174|FG002|Overall Study|First venipuncture failed|5|||
160762909|NCT04275336|580521172|FG000|Overall Study|Unscheduled venipuncture|9|||
160762910|NCT04275336|580521173|FG001|Overall Study|Unscheduled venipuncture|13|||
160762911|NCT04275336|580521174|FG002|Overall Study|Unscheduled venipuncture|7|||
160762912|NCT04275336|580521172|FG000|Overall Study|Failed specimen of saliva|4|||
160762913|NCT04275336|580521173|FG001|Overall Study|Failed specimen of saliva|3|||
160762914|NCT04275336|580521174|FG002|Overall Study|Failed specimen of saliva|4|||
160762915|NCT03055936|580521175|FG000|Overall Study|Adverse Event|0|||
160762916|NCT03055936|580521176|FG001|Overall Study|Adverse Event|1|||
160762917|NCT03055936|580521177|FG002|Overall Study|Adverse Event|1|||
160762918|NCT03055936|580521178|FG003|Overall Study|Adverse Event|1|||
160762919|NCT03055936|580521175|FG000|Overall Study|Personal reason|2|||
160762920|NCT03055936|580521176|FG001|Overall Study|Personal reason|0|||
160762921|NCT03055936|580521177|FG002|Overall Study|Personal reason|1|||
160762922|NCT03055936|580521178|FG003|Overall Study|Personal reason|0|||
160762923|NCT01909804|580521185|FG000|Overall Study|Randomized but Never Treated|0|||
160762924|NCT01909804|580521186|FG001|Overall Study|Randomized but Never Treated|0|||
160762925|NCT01909804|580521187|FG002|Overall Study|Randomized but Never Treated|0|||
160762926|NCT01909804|580521188|FG003|Overall Study|Randomized but Never Treated|0|||
160762927|NCT01909804|580521189|FG004|Overall Study|Randomized but Never Treated|0|||
160762928|NCT01909804|580521190|FG005|Overall Study|Randomized but Never Treated|0|||
160762929|NCT01909804|580521191|FG006|Overall Study|Randomized but Never Treated|1|||
160762930|NCT01909804|580521192|FG007|Overall Study|Randomized but Never Treated|0|||
160762931|NCT01909804|580521193|FG008|Overall Study|Randomized but Never Treated|0|||
160762932|NCT01909804|580521194|FG009|Overall Study|Randomized but Never Treated|0|||
160762933|NCT01909804|580521195|FG010|Overall Study|Randomized but Never Treated|0|||
160762934|NCT01909804|580521196|FG011|Overall Study|Randomized but Never Treated|1|||
160762935|NCT01909804|580521185|FG000|Overall Study|Death|0|||
160762936|NCT01909804|580521186|FG001|Overall Study|Death|0|||
160762937|NCT01909804|580521187|FG002|Overall Study|Death|0|||
160762938|NCT01909804|580521188|FG003|Overall Study|Death|0|||
160762939|NCT01909804|580521189|FG004|Overall Study|Death|0|||
160762940|NCT01909804|580521190|FG005|Overall Study|Death|0|||
160762941|NCT01909804|580521191|FG006|Overall Study|Death|0|||
160762942|NCT01909804|580521192|FG007|Overall Study|Death|0|||
160762943|NCT01909804|580521193|FG008|Overall Study|Death|0|||
160762944|NCT01909804|580521194|FG009|Overall Study|Death|0|||
160762945|NCT01909804|580521195|FG010|Overall Study|Death|1|||
160762946|NCT01909804|580521196|FG011|Overall Study|Death|0|||
160762947|NCT01909804|580521185|FG000|Overall Study|Lack of Efficacy|4|||
160762948|NCT01909804|580521186|FG001|Overall Study|Lack of Efficacy|1|||
160762949|NCT01909804|580521187|FG002|Overall Study|Lack of Efficacy|0|||
160762950|NCT01909804|580521188|FG003|Overall Study|Lack of Efficacy|0|||
160762951|NCT01909804|580521189|FG004|Overall Study|Lack of Efficacy|7|||
160866680|NCT04646044|580904986|FG001|Overall Study|Lost to Follow-up|0|||
160866681|NCT04646044|580904987|FG002|Overall Study|Lost to Follow-up|1|||
160866682|NCT04646044|580904988|FG003|Overall Study|Lost to Follow-up|0|||
160866683|NCT04646044|580904985|FG000|Overall Study|Withdrawal by Subject|0|||
160866684|NCT04646044|580904986|FG001|Overall Study|Withdrawal by Subject|1|||
160866685|NCT04646044|580904987|FG002|Overall Study|Withdrawal by Subject|0|||
160866686|NCT04646044|580904988|FG003|Overall Study|Withdrawal by Subject|0|||
160866687|NCT00602472|580904989|FG000|Overall Study|Adverse Event|5|||
160866688|NCT00602472|580904990|FG001|Overall Study|Adverse Event|23|||
160866689|NCT00602472|580904989|FG000|Overall Study|Protocol Violation|4|||
160866690|NCT00602472|580904990|FG001|Overall Study|Protocol Violation|19|||
160866691|NCT00602472|580904989|FG000|Overall Study|Withdrawal by Subject|8|||
160866692|NCT00602472|580904990|FG001|Overall Study|Withdrawal by Subject|14|||
160866693|NCT00602472|580904989|FG000|Overall Study|Other incl. lack of efficacy|4|||
160866694|NCT00602472|580904990|FG001|Overall Study|Other incl. lack of efficacy|2|||
160866695|NCT01938716|580904991|FG000|Overall Study|Physician Decision|2|||
160866696|NCT01938716|580904991|FG000|Overall Study|Withdrawal by Subject|2|||
160866697|NCT01908803|580904992|FG000|Overall Study|Adverse Event|1|||
160866698|NCT01908803|580904993|FG001|Overall Study|Adverse Event|0|||
160866699|NCT01908803|580904992|FG000|Overall Study|Physician Decision|0|||
160866700|NCT01908803|580904993|FG001|Overall Study|Physician Decision|1|||
160866701|NCT01908803|580904992|FG000|Overall Study|Withdrawal by Subject|1|||
160866702|NCT01908803|580904993|FG001|Overall Study|Withdrawal by Subject|0|||
160866703|NCT01908803|580904992|FG000|Overall Study|Randomization Error|1|||
160866704|NCT01908803|580904993|FG001|Overall Study|Randomization Error|0|||
160866705|NCT01908803|580904992|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
160866706|NCT01908803|580904993|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
160866707|NCT00823615|580904994|FG000|Period 2|Lost to Follow-up|2|||
160866708|NCT00823615|580904995|FG001|Period 2|Lost to Follow-up|0|||
160866709|NCT00823615|580904994|FG000|Period 2|Time/Job Conflict|1|||
160866710|NCT00823615|580904995|FG001|Period 2|Time/Job Conflict|2|||
160866711|NCT00433004|580904996|FG000|Overall Study|Lost to Follow-up|5|||
160866712|NCT00433004|580904997|FG001|Overall Study|Lost to Follow-up|7|||
160866713|NCT00742235|580904998|FG000|Overall Study|Lost to Follow-up|0|||
160866714|NCT00742235|580904999|FG001|Overall Study|Lost to Follow-up|31|||
160866715|NCT03910244|580905001|FG000|Overall Study|Adverse Event|14|||
160866716|NCT03910244|580905002|FG001|Overall Study|Adverse Event|0|||
160866717|NCT03910244|580905001|FG000|Overall Study|Death|1|||
160866718|NCT03910244|580905002|FG001|Overall Study|Death|0|||
160866719|NCT03910244|580905001|FG000|Overall Study|Lost to Follow-up|0|||
160866720|NCT03910244|580905002|FG001|Overall Study|Lost to Follow-up|2|||
160866721|NCT03910244|580905001|FG000|Overall Study|Joint withdrawal decision|1|||
160866722|NCT03910244|580905002|FG001|Overall Study|Joint withdrawal decision|0|||
160866723|NCT03910244|580905001|FG000|Overall Study|Study Terminated by Sponsor|7|||
160866724|NCT03910244|580905002|FG001|Overall Study|Study Terminated by Sponsor|4|||
160866725|NCT03910244|580905001|FG000|Overall Study|Physician Decision|1|||
160866726|NCT03910244|580905002|FG001|Overall Study|Physician Decision|0|||
160866727|NCT03910244|580905001|FG000|Overall Study|Protocol Violation|1|||
160866728|NCT03910244|580905002|FG001|Overall Study|Protocol Violation|0|||
160866729|NCT03910244|580905001|FG000|Overall Study|Withdrawal by Subject|7|||
160866730|NCT03910244|580905002|FG001|Overall Study|Withdrawal by Subject|2|||
160866731|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
160866732|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
160866733|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
160762952|NCT01909804|580521190|FG005|Overall Study|Lack of Efficacy|3|||
160762953|NCT01909804|580521191|FG006|Overall Study|Lack of Efficacy|1|||
160762954|NCT01909804|580521192|FG007|Overall Study|Lack of Efficacy|1|||
160762955|NCT01909804|580521193|FG008|Overall Study|Lack of Efficacy|0|||
160762956|NCT01909804|580521194|FG009|Overall Study|Lack of Efficacy|1|||
160762957|NCT01909804|580521195|FG010|Overall Study|Lack of Efficacy|0|||
160762958|NCT01909804|580521196|FG011|Overall Study|Lack of Efficacy|1|||
160762959|NCT01909804|580521185|FG000|Overall Study|Withdrew Consent|0|||
160762960|NCT01909804|580521186|FG001|Overall Study|Withdrew Consent|0|||
160762961|NCT01909804|580521187|FG002|Overall Study|Withdrew Consent|0|||
160762962|NCT01909804|580521188|FG003|Overall Study|Withdrew Consent|0|||
160762963|NCT01909804|580521189|FG004|Overall Study|Withdrew Consent|1|||
160762964|NCT01909804|580521190|FG005|Overall Study|Withdrew Consent|1|||
160762965|NCT01909804|580521191|FG006|Overall Study|Withdrew Consent|0|||
160762966|NCT01909804|580521192|FG007|Overall Study|Withdrew Consent|0|||
160762967|NCT01909804|580521193|FG008|Overall Study|Withdrew Consent|0|||
160762968|NCT01909804|580521194|FG009|Overall Study|Withdrew Consent|0|||
160762969|NCT01909804|580521195|FG010|Overall Study|Withdrew Consent|0|||
160762970|NCT01909804|580521196|FG011|Overall Study|Withdrew Consent|0|||
160762971|NCT01909804|580521185|FG000|Overall Study|Protocol Violation|0|||
160762972|NCT01909804|580521186|FG001|Overall Study|Protocol Violation|0|||
160866734|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
160866735|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
160866736|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
160866737|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
160866738|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
160866739|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
160866740|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
160866741|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
160866742|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
160866743|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
160866744|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
160866745|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
160866746|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
160866747|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
160866748|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
160866749|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
160866750|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
160866751|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
160866752|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
160866753|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
160762973|NCT01909804|580521187|FG002|Overall Study|Protocol Violation|0|||
160762974|NCT01909804|580521188|FG003|Overall Study|Protocol Violation|0|||
160762975|NCT01909804|580521189|FG004|Overall Study|Protocol Violation|0|||
160762976|NCT01909804|580521190|FG005|Overall Study|Protocol Violation|0|||
160762977|NCT01909804|580521191|FG006|Overall Study|Protocol Violation|0|||
160762978|NCT01909804|580521192|FG007|Overall Study|Protocol Violation|0|||
160762979|NCT01909804|580521193|FG008|Overall Study|Protocol Violation|0|||
160762980|NCT01909804|580521194|FG009|Overall Study|Protocol Violation|0|||
160762981|NCT01909804|580521195|FG010|Overall Study|Protocol Violation|0|||
160762982|NCT01909804|580521196|FG011|Overall Study|Protocol Violation|1|||
160762983|NCT01077323|580521200|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
160762984|NCT01077323|580521201|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
160762985|NCT01077323|580521202|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
160762986|NCT01077323|580521200|FG000|Overall Study|Dispensing of drug in baseline period|0|||
160762987|NCT01077323|580521201|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
160762988|NCT01077323|580521202|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
160762989|NCT01077323|580521200|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
160762990|NCT01077323|580521201|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
160762991|NCT01077323|580521202|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
160762992|NCT04622969|580521203|FG000|Overall Study|Withdrawal by Subject|2|||
160762993|NCT04622969|580521204|FG001|Overall Study|Withdrawal by Subject|3|||
160762994|NCT04467515|580521205|FG000|Overall Study|Lost to Follow-up|1|||
160762995|NCT04467515|580521206|FG001|Overall Study|Lost to Follow-up|0|||
160762996|NCT04467515|580521207|FG002|Overall Study|Lost to Follow-up|0|||
160762997|NCT04467515|580521205|FG000|Overall Study|Withdrawal by Subject|1|||
160762998|NCT04467515|580521206|FG001|Overall Study|Withdrawal by Subject|0|||
160762999|NCT04467515|580521207|FG002|Overall Study|Withdrawal by Subject|1|||
160763000|NCT04467515|580521205|FG000|Overall Study|Progressive Disease|0|||
160763001|NCT04467515|580521206|FG001|Overall Study|Progressive Disease|1|||
160763002|NCT04467515|580521207|FG002|Overall Study|Progressive Disease|3|||
160763003|NCT04467515|580521205|FG000|Overall Study|Death|0|||
160763004|NCT04467515|580521206|FG001|Overall Study|Death|1|||
160763005|NCT04467515|580521207|FG002|Overall Study|Death|0|||
160763006|NCT04249427|580521210|FG000|Overall Study|Adverse Event|3|||
160763007|NCT04249427|580521211|FG001|Overall Study|Adverse Event|1|||
160763008|NCT04249427|580521210|FG000|Overall Study|Lack of Efficacy|0|||
160763009|NCT04249427|580521211|FG001|Overall Study|Lack of Efficacy|1|||
160763010|NCT04249427|580521210|FG000|Overall Study|Withdrawal by Subject|1|||
160763011|NCT04249427|580521211|FG001|Overall Study|Withdrawal by Subject|2|||
160763012|NCT02848664|580521215|FG000|Overall Study|Withdrawal by Subject|2|||
160763013|NCT02848664|580521215|FG000|Overall Study|Adverse Event|1|||
160763014|NCT02848664|580521215|FG000|Overall Study|no assistance for device training|1|||
160763015|NCT02849080|580521216|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
160763016|NCT02849080|580521217|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
160763017|NCT02849080|580521218|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
160763018|NCT02849080|580521219|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
160763019|NCT02849080|580521216|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
160763020|NCT02849080|580521217|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
160763021|NCT02849080|580521218|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
160763022|NCT02849080|580521219|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
160866754|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
160866755|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Other|10|||
160866756|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Other|2|||
160866757|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Other|6|||
160866758|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
160866759|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
160866760|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
160866761|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
160866762|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
160866763|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
160866764|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
160866765|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
160866766|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
160866767|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
160866768|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
160866769|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
160866770|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
160866771|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
160866772|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
160866773|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Other|8|||
160866774|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Other|3|||
160866775|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Other|4|||
160866776|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
160866777|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
160866778|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
160866779|NCT02346721|580905006|FG000|Overall Study|Withdrew Consent|3|||
160866780|NCT02346721|580905006|FG000|Overall Study|Lack of Efficacy|1|||
160763023|NCT02849080|580521216|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
160763024|NCT02849080|580521217|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
160763025|NCT02849080|580521218|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
160763026|NCT02849080|580521219|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
160763027|NCT02849080|580521216|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
160763028|NCT02849080|580521217|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
160763029|NCT02849080|580521218|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
160763030|NCT02849080|580521219|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
160763031|NCT02849080|580521216|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
160763032|NCT02849080|580521217|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
160763033|NCT02849080|580521218|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
160763034|NCT02849080|580521219|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
160763035|NCT02849080|580521216|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
160763036|NCT02849080|580521217|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
160763037|NCT02849080|580521218|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
160763038|NCT02849080|580521219|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
160763039|NCT01819727|580521222|FG000|Overall Study|Adverse Event|8|||
160763040|NCT01819727|580521223|FG001|Overall Study|Adverse Event|9|||
160763041|NCT01819727|580521222|FG000|Overall Study|Death|1|||
160763042|NCT01819727|580521223|FG001|Overall Study|Death|0|||
160763043|NCT01819727|580521222|FG000|Overall Study|Lost to Follow-up|1|||
160763044|NCT01819727|580521223|FG001|Overall Study|Lost to Follow-up|1|||
160763045|NCT01819727|580521222|FG000|Overall Study|Physician Decision|3|||
160763046|NCT01819727|580521223|FG001|Overall Study|Physician Decision|2|||
160763047|NCT01819727|580521222|FG000|Overall Study|Pregnancy|1|||
160763048|NCT01819727|580521223|FG001|Overall Study|Pregnancy|0|||
160763049|NCT01819727|580521222|FG000|Overall Study|Protocol Violation|0|||
160763050|NCT01819727|580521223|FG001|Overall Study|Protocol Violation|2|||
160763051|NCT01819727|580521222|FG000|Overall Study|Study Terminated by Sponsor|0|||
160763052|NCT01819727|580521223|FG001|Overall Study|Study Terminated by Sponsor|1|||
160763053|NCT01819727|580521222|FG000|Overall Study|Withdrawal by Subject|6|||
160763054|NCT01819727|580521223|FG001|Overall Study|Withdrawal by Subject|11|||
160763055|NCT01819727|580521222|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
160763056|NCT01819727|580521223|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
160763057|NCT01819727|580521222|FG000|Overall Study|Quit due to lack of health benifits|0|||
160763058|NCT01819727|580521223|FG001|Overall Study|Quit due to lack of health benifits|1|||
160763059|NCT00402727|580521226|FG000|Overall Study|Adverse Event|10|||
160763060|NCT00402727|580521227|FG001|Overall Study|Adverse Event|6|||
160763061|NCT00402727|580521226|FG000|Overall Study|Death|1|||
160527145|NCT01233869|579660903|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
160763062|NCT00402727|580521227|FG001|Overall Study|Death|0|||
160763063|NCT00402727|580521226|FG000|Overall Study|Lack of Efficacy|1|||
160763064|NCT00402727|580521227|FG001|Overall Study|Lack of Efficacy|3|||
160763065|NCT00402727|580521226|FG000|Overall Study|Lost to Follow-up|24|||
160763066|NCT00402727|580521227|FG001|Overall Study|Lost to Follow-up|11|||
160763067|NCT00402727|580521226|FG000|Overall Study|Physician Decision|1|||
160763068|NCT00402727|580521227|FG001|Overall Study|Physician Decision|1|||
160763069|NCT00402727|580521226|FG000|Overall Study|Protocol Violation|0|||
160866781|NCT03219528|580905016|FG000|Overall Study|Lost to Follow-up|5|||
160866782|NCT03219528|580905017|FG001|Overall Study|Lost to Follow-up|4|||
160866783|NCT03219528|580905016|FG000|Overall Study|Withdrawal by Subject|4|||
160866784|NCT03219528|580905017|FG001|Overall Study|Withdrawal by Subject|4|||
160866785|NCT03809104|580905018|FG000|Overall Study|Withdrawal by Subject|3|||
160866786|NCT00790842|580905019|FG000|Dose Level 1|Adverse Event|1|||
160866787|NCT00790842|580905020|FG001|Dose Level 1|Adverse Event|0|||
160866788|NCT00790842|580905021|FG002|Dose Level 1|Adverse Event|0|||
160866789|NCT00790842|580905022|FG003|Dose Level 1|Adverse Event|2|||
160866790|NCT00790842|580905023|FG004|Dose Level 1|Adverse Event|0|||
160866791|NCT00790842|580905024|FG005|Dose Level 1|Adverse Event|0|||
160866792|NCT00790842|580905025|FG006|Dose Level 1|Adverse Event|0|||
160866793|NCT00790842|580905026|FG007|Dose Level 1|Adverse Event|1|||
160866794|NCT00790842|580905027|FG008|Dose Level 1|Adverse Event|0|||
160866795|NCT00790842|580905028|FG009|Dose Level 1|Adverse Event|0|||
160866796|NCT00790842|580905029|FG010|Dose Level 1|Adverse Event|0|||
160866797|NCT00790842|580905019|FG000|Dose Level 1|Physician Decision|1|||
160866798|NCT00790842|580905020|FG001|Dose Level 1|Physician Decision|0|||
160866799|NCT00790842|580905021|FG002|Dose Level 1|Physician Decision|0|||
160866800|NCT00790842|580905022|FG003|Dose Level 1|Physician Decision|0|||
160866801|NCT00790842|580905023|FG004|Dose Level 1|Physician Decision|0|||
160866802|NCT00790842|580905024|FG005|Dose Level 1|Physician Decision|0|||
160866803|NCT00790842|580905025|FG006|Dose Level 1|Physician Decision|0|||
160866804|NCT00790842|580905026|FG007|Dose Level 1|Physician Decision|1|||
160866805|NCT00790842|580905027|FG008|Dose Level 1|Physician Decision|0|||
160866806|NCT00790842|580905028|FG009|Dose Level 1|Physician Decision|0|||
160866807|NCT00790842|580905029|FG010|Dose Level 1|Physician Decision|0|||
160866808|NCT00790842|580905019|FG000|Dose Level 1|Withdrawal by Subject|1|||
160866809|NCT00790842|580905020|FG001|Dose Level 1|Withdrawal by Subject|0|||
160866810|NCT00790842|580905021|FG002|Dose Level 1|Withdrawal by Subject|0|||
160866811|NCT00790842|580905022|FG003|Dose Level 1|Withdrawal by Subject|0|||
160866812|NCT00790842|580905023|FG004|Dose Level 1|Withdrawal by Subject|0|||
160866813|NCT00790842|580905024|FG005|Dose Level 1|Withdrawal by Subject|0|||
160866814|NCT00790842|580905025|FG006|Dose Level 1|Withdrawal by Subject|0|||
160866815|NCT00790842|580905026|FG007|Dose Level 1|Withdrawal by Subject|0|||
160866816|NCT00790842|580905027|FG008|Dose Level 1|Withdrawal by Subject|0|||
160866817|NCT00790842|580905028|FG009|Dose Level 1|Withdrawal by Subject|0|||
160866818|NCT00790842|580905029|FG010|Dose Level 1|Withdrawal by Subject|0|||
160866819|NCT00790842|580905019|FG000|Dose Level 2|Death|0|||
160866820|NCT00790842|580905020|FG001|Dose Level 2|Death|1|||
160866821|NCT00790842|580905021|FG002|Dose Level 2|Death|0|||
160866822|NCT00790842|580905022|FG003|Dose Level 2|Death|0|||
160866823|NCT00790842|580905023|FG004|Dose Level 2|Death|1|||
160866824|NCT00790842|580905024|FG005|Dose Level 2|Death|0|||
160866825|NCT00790842|580905025|FG006|Dose Level 2|Death|0|||
160866826|NCT00790842|580905026|FG007|Dose Level 2|Death|0|||
160866827|NCT00790842|580905027|FG008|Dose Level 2|Death|0|||
160866828|NCT00790842|580905028|FG009|Dose Level 2|Death|0|||
160866829|NCT00790842|580905029|FG010|Dose Level 2|Death|0|||
160866830|NCT00790842|580905019|FG000|Dose Level 2|Physician Decision|0|||
160866831|NCT00790842|580905020|FG001|Dose Level 2|Physician Decision|1|||
160866832|NCT00790842|580905021|FG002|Dose Level 2|Physician Decision|0|||
160866833|NCT00790842|580905022|FG003|Dose Level 2|Physician Decision|0|||
160866834|NCT00790842|580905023|FG004|Dose Level 2|Physician Decision|0|||
160866835|NCT00790842|580905024|FG005|Dose Level 2|Physician Decision|0|||
160866836|NCT00790842|580905025|FG006|Dose Level 2|Physician Decision|0|||
160866837|NCT00790842|580905026|FG007|Dose Level 2|Physician Decision|0|||
160866838|NCT00790842|580905027|FG008|Dose Level 2|Physician Decision|0|||
160866839|NCT00790842|580905028|FG009|Dose Level 2|Physician Decision|0|||
160866840|NCT00790842|580905029|FG010|Dose Level 2|Physician Decision|0|||
160866841|NCT00790842|580905019|FG000|Dose Level 2|Withdrawal by Subject|0|||
160866842|NCT00790842|580905020|FG001|Dose Level 2|Withdrawal by Subject|1|||
160866843|NCT00790842|580905021|FG002|Dose Level 2|Withdrawal by Subject|0|||
160866844|NCT00790842|580905022|FG003|Dose Level 2|Withdrawal by Subject|0|||
160866845|NCT00790842|580905023|FG004|Dose Level 2|Withdrawal by Subject|0|||
160866846|NCT00790842|580905024|FG005|Dose Level 2|Withdrawal by Subject|0|||
160866847|NCT00790842|580905025|FG006|Dose Level 2|Withdrawal by Subject|0|||
160866848|NCT00790842|580905026|FG007|Dose Level 2|Withdrawal by Subject|0|||
160866849|NCT00790842|580905027|FG008|Dose Level 2|Withdrawal by Subject|0|||
160866850|NCT00790842|580905028|FG009|Dose Level 2|Withdrawal by Subject|0|||
160866851|NCT00790842|580905029|FG010|Dose Level 2|Withdrawal by Subject|0|||
160866852|NCT00790842|580905019|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866853|NCT00790842|580905020|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866854|NCT00790842|580905021|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866855|NCT00790842|580905022|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866856|NCT00790842|580905023|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866857|NCT00790842|580905024|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866858|NCT00790842|580905025|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866859|NCT00790842|580905026|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866860|NCT00790842|580905027|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
160866861|NCT00790842|580905028|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866862|NCT00790842|580905029|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866863|NCT00790842|580905019|FG000|Dose Level 3|Adverse Event|0|||
160866864|NCT00790842|580905020|FG001|Dose Level 3|Adverse Event|0|||
160866865|NCT00790842|580905021|FG002|Dose Level 3|Adverse Event|1|||
160866866|NCT00790842|580905022|FG003|Dose Level 3|Adverse Event|0|||
160866867|NCT00790842|580905023|FG004|Dose Level 3|Adverse Event|0|||
160866868|NCT00790842|580905024|FG005|Dose Level 3|Adverse Event|0|||
160866869|NCT00790842|580905025|FG006|Dose Level 3|Adverse Event|0|||
160866870|NCT00790842|580905026|FG007|Dose Level 3|Adverse Event|0|||
160866871|NCT00790842|580905027|FG008|Dose Level 3|Adverse Event|0|||
160866872|NCT00790842|580905028|FG009|Dose Level 3|Adverse Event|0|||
160866873|NCT00790842|580905029|FG010|Dose Level 3|Adverse Event|0|||
160866874|NCT00790842|580905019|FG000|Dose Level 3|Withdrawal by Subject|0|||
160866875|NCT00790842|580905020|FG001|Dose Level 3|Withdrawal by Subject|0|||
160866876|NCT00790842|580905021|FG002|Dose Level 3|Withdrawal by Subject|3|||
160866877|NCT00790842|580905022|FG003|Dose Level 3|Withdrawal by Subject|0|||
160866878|NCT00790842|580905023|FG004|Dose Level 3|Withdrawal by Subject|0|||
160866879|NCT00790842|580905024|FG005|Dose Level 3|Withdrawal by Subject|0|||
160866880|NCT00790842|580905025|FG006|Dose Level 3|Withdrawal by Subject|0|||
160866881|NCT00790842|580905026|FG007|Dose Level 3|Withdrawal by Subject|0|||
160866882|NCT00790842|580905027|FG008|Dose Level 3|Withdrawal by Subject|0|||
160866883|NCT00790842|580905028|FG009|Dose Level 3|Withdrawal by Subject|2|||
160866884|NCT00790842|580905029|FG010|Dose Level 3|Withdrawal by Subject|0|||
160866885|NCT00790842|580905019|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866886|NCT00790842|580905020|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866887|NCT00790842|580905021|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866888|NCT00790842|580905022|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866889|NCT00790842|580905023|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866890|NCT00790842|580905024|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
160866891|NCT00790842|580905025|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866892|NCT00790842|580905026|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866893|NCT00790842|580905027|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866894|NCT00790842|580905028|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866895|NCT00790842|580905029|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866896|NCT00790842|580905019|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866897|NCT00790842|580905020|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866898|NCT00790842|580905021|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
160866899|NCT00790842|580905022|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866900|NCT00790842|580905023|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866901|NCT00790842|580905024|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866902|NCT00790842|580905025|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866903|NCT00790842|580905026|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866904|NCT00790842|580905027|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866905|NCT00790842|580905028|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866906|NCT00790842|580905029|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866907|NCT00790842|580905019|FG000|Dose Level 4|Adverse Event|0|||
160866908|NCT00790842|580905020|FG001|Dose Level 4|Adverse Event|0|||
160866909|NCT00790842|580905021|FG002|Dose Level 4|Adverse Event|0|||
160866910|NCT00790842|580905022|FG003|Dose Level 4|Adverse Event|0|||
160866911|NCT00790842|580905023|FG004|Dose Level 4|Adverse Event|0|||
160866912|NCT00790842|580905024|FG005|Dose Level 4|Adverse Event|0|||
160866913|NCT00790842|580905025|FG006|Dose Level 4|Adverse Event|1|||
160866914|NCT00790842|580905026|FG007|Dose Level 4|Adverse Event|0|||
160866915|NCT00790842|580905027|FG008|Dose Level 4|Adverse Event|0|||
160866916|NCT00790842|580905028|FG009|Dose Level 4|Adverse Event|0|||
160866917|NCT00790842|580905029|FG010|Dose Level 4|Adverse Event|0|||
160866918|NCT00790842|580905019|FG000|Dose Level 4|Physician Decision|0|||
160866919|NCT00790842|580905020|FG001|Dose Level 4|Physician Decision|0|||
160866920|NCT00790842|580905021|FG002|Dose Level 4|Physician Decision|0|||
160866921|NCT00790842|580905022|FG003|Dose Level 4|Physician Decision|0|||
160866922|NCT00790842|580905023|FG004|Dose Level 4|Physician Decision|0|||
160866923|NCT00790842|580905024|FG005|Dose Level 4|Physician Decision|0|||
160866924|NCT00790842|580905025|FG006|Dose Level 4|Physician Decision|1|||
160866925|NCT00790842|580905026|FG007|Dose Level 4|Physician Decision|0|||
160866926|NCT00790842|580905027|FG008|Dose Level 4|Physician Decision|0|||
160866927|NCT00790842|580905028|FG009|Dose Level 4|Physician Decision|0|||
160866928|NCT00790842|580905029|FG010|Dose Level 4|Physician Decision|1|||
160866929|NCT00790842|580905019|FG000|Dose Level 4|Withdrawal by Subject|0|||
160866930|NCT00790842|580905020|FG001|Dose Level 4|Withdrawal by Subject|0|||
160866931|NCT00790842|580905021|FG002|Dose Level 4|Withdrawal by Subject|0|||
160866932|NCT00790842|580905022|FG003|Dose Level 4|Withdrawal by Subject|0|||
160866933|NCT00790842|580905023|FG004|Dose Level 4|Withdrawal by Subject|0|||
160866934|NCT00790842|580905024|FG005|Dose Level 4|Withdrawal by Subject|0|||
160763070|NCT00402727|580521227|FG001|Overall Study|Protocol Violation|4|||
160763071|NCT00402727|580521226|FG000|Overall Study|Withdrawal by Subject|3|||
160763072|NCT00402727|580521227|FG001|Overall Study|Withdrawal by Subject|7|||
160763073|NCT00402727|580521226|FG000|Overall Study|supply problems|2|||
160763074|NCT00402727|580521227|FG001|Overall Study|supply problems|1|||
160763075|NCT00402727|580521226|FG000|Overall Study|non-compliance|0|||
160763076|NCT00402727|580521227|FG001|Overall Study|non-compliance|1|||
160763077|NCT00732069|580521228|FG000|Washout After First Study Drug|Adverse Event|1|||
160763078|NCT00732069|580521229|FG001|Washout After First Study Drug|Adverse Event|0|||
160763079|NCT00732069|580521230|FG002|Washout After First Study Drug|Adverse Event|0|||
160763080|NCT00732069|580521231|FG003|Washout After First Study Drug|Adverse Event|0|||
160763081|NCT00732069|580521232|FG004|Washout After First Study Drug|Adverse Event|0|||
160763082|NCT00732069|580521233|FG005|Washout After First Study Drug|Adverse Event|0|||
160763083|NCT00577317|580521234|FG000|Overall Study|Study Terminated|0|||
160763084|NCT00577317|580521235|FG001|Overall Study|Study Terminated|2|||
160763085|NCT02283658|580521239|FG000|Overall Study|Withdrawal by Subject|1|||
160763086|NCT03608826|580521241|FG000|Overall Study|Death|3|||
160763087|NCT03608826|580521241|FG000|Overall Study|Heart Transplant|3|||
160763088|NCT03608826|580521241|FG000|Overall Study|Physician Decision|4|||
160763089|NCT00875810|580521250|FG000|Overall Study|Withdrawal by Subject|1|||
160763090|NCT00875810|580521250|FG000|Overall Study|Physician Decision|3|||
160763091|NCT00875810|580521250|FG000|Overall Study|Lost to Follow-up|39|||
160763092|NCT00875810|580521250|FG000|Overall Study|Patient enroled but not implanted|2|||
160763093|NCT00875810|580521250|FG000|Overall Study|Device explanted|1|||
160763094|NCT01061606|580521251|FG000|Overall Study|Adverse Event|1|||
160763095|NCT01061606|580521251|FG000|Overall Study|Death|1|||
160763096|NCT01061606|580521251|FG000|Overall Study|Disease Progression|4|||
160763097|NCT01061606|580521251|FG000|Overall Study|alternative therapy|2|||
160763098|NCT01305564|580521252|FG000|Overall Study|Death|21|||
160763099|NCT01305564|580521252|FG000|Overall Study|Lost to Follow-up|12|||
160763100|NCT01305564|580521252|FG000|Overall Study|Withdrawal by Subject|1|||
160763101|NCT01305564|580521252|FG000|Overall Study|Physician Decision|3|||
160763102|NCT02322749|580521253|FG000|Period 2|Adverse Event|0|||
160763103|NCT02322749|580521254|FG001|Period 2|Adverse Event|0|||
160763104|NCT02322749|580521255|FG002|Period 2|Adverse Event|0|||
160763105|NCT02322749|580521256|FG003|Period 2|Adverse Event|1|||
160763106|NCT02322749|580521257|FG004|Period 2|Adverse Event|0|||
160763107|NCT02322749|580521258|FG005|Period 2|Adverse Event|0|||
160763108|NCT02322749|580521253|FG000|Period 2|Withdrawal by Subject|0|||
160763109|NCT02322749|580521254|FG001|Period 2|Withdrawal by Subject|0|||
160763110|NCT02322749|580521255|FG002|Period 2|Withdrawal by Subject|0|||
160763111|NCT02322749|580521256|FG003|Period 2|Withdrawal by Subject|1|||
160763112|NCT02322749|580521257|FG004|Period 2|Withdrawal by Subject|0|||
160763113|NCT02322749|580521258|FG005|Period 2|Withdrawal by Subject|0|||
160763114|NCT02322749|580521253|FG000|Period 3|Withdrawal by Subject|0|||
160763115|NCT02322749|580521254|FG001|Period 3|Withdrawal by Subject|0|||
160763116|NCT02322749|580521255|FG002|Period 3|Withdrawal by Subject|1|||
160763117|NCT02322749|580521256|FG003|Period 3|Withdrawal by Subject|0|||
160763118|NCT02322749|580521257|FG004|Period 3|Withdrawal by Subject|0|||
160763119|NCT02322749|580521258|FG005|Period 3|Withdrawal by Subject|0|||
160763120|NCT07116759|580521263|FG000|Overall Study|Incompatibility with the RHMC device|2|||
160763121|NCT00350545|580522879|FG000|Overall Study|Withdrawal by Subject|2|||
160763122|NCT01190891|580522880|FG000|Overall Study|Protocol Violation|1|||
160763123|NCT01190891|580522881|FG001|Overall Study|Protocol Violation|0|||
160763124|NCT01190891|580522880|FG000|Overall Study|Withdrawal by Subject|5|||
160763125|NCT01190891|580522881|FG001|Overall Study|Withdrawal by Subject|0|||
160763126|NCT00301834|580522882|FG000|Overall Study|Death|1|||
160763127|NCT02737358|580522883|FG000|Overall Study|Withdrawal by Subject|7|||
160763128|NCT02737358|580522884|FG001|Overall Study|Withdrawal by Subject|12|||
160763129|NCT02737358|580522883|FG000|Overall Study|Lost to Follow-up|2|||
160763130|NCT02737358|580522884|FG001|Overall Study|Lost to Follow-up|3|||
160763131|NCT00744939|580522885|FG000|Overall Study|Withdrawal by Subject|9|||
160763132|NCT00744939|580522885|FG000|Overall Study|Protocol Violation|13|||
160763133|NCT00744939|580522885|FG000|Overall Study|Death|24|||
160763134|NCT00744939|580522885|FG000|Overall Study|distance|4|||
160763135|NCT00744939|580522885|FG000|Overall Study|Lost to Follow-up|12|||
160763136|NCT00744939|580522885|FG000|Overall Study|Medical history exclusionary|1|||
160763137|NCT00744939|580522885|FG000|Overall Study|Did not receive Magnevist|7|||
160763138|NCT00744939|580522885|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
160763139|NCT00744939|580522885|FG000|Overall Study|coma|1|||
160763140|NCT00744939|580522885|FG000|Overall Study|incorrect race|1|||
160763141|NCT00183430|580522886|FG000|Overall Study|Adverse Event|1|||
160763142|NCT00183430|580522887|FG001|Overall Study|Adverse Event|0|||
160763143|NCT00183430|580522886|FG000|Overall Study|Lost to Follow-up|3|||
160763144|NCT00183430|580522887|FG001|Overall Study|Lost to Follow-up|0|||
160763145|NCT00183430|580522886|FG000|Overall Study|did not meet inclusion criteria|1|||
160763146|NCT00183430|580522887|FG001|Overall Study|did not meet inclusion criteria|0|||
160763147|NCT00183430|580522886|FG000|Overall Study|Withdrawal by Subject|1|||
160763148|NCT00183430|580522887|FG001|Overall Study|Withdrawal by Subject|0|||
160866935|NCT00790842|580905025|FG006|Dose Level 4|Withdrawal by Subject|0|||
160866936|NCT00790842|580905026|FG007|Dose Level 4|Withdrawal by Subject|0|||
160866937|NCT00790842|580905027|FG008|Dose Level 4|Withdrawal by Subject|0|||
160866938|NCT00790842|580905028|FG009|Dose Level 4|Withdrawal by Subject|0|||
160866939|NCT00790842|580905029|FG010|Dose Level 4|Withdrawal by Subject|1|||
160866940|NCT00790842|580905019|FG000|Expansion Cohort|Adverse Event|0|||
160866941|NCT00790842|580905020|FG001|Expansion Cohort|Adverse Event|0|||
160866942|NCT00790842|580905021|FG002|Expansion Cohort|Adverse Event|0|||
160866943|NCT00790842|580905022|FG003|Expansion Cohort|Adverse Event|0|||
160866944|NCT00790842|580905023|FG004|Expansion Cohort|Adverse Event|0|||
160866945|NCT00790842|580905024|FG005|Expansion Cohort|Adverse Event|0|||
160866946|NCT00790842|580905025|FG006|Expansion Cohort|Adverse Event|1|||
160866947|NCT00790842|580905026|FG007|Expansion Cohort|Adverse Event|0|||
160866948|NCT00790842|580905027|FG008|Expansion Cohort|Adverse Event|0|||
160866949|NCT00790842|580905028|FG009|Expansion Cohort|Adverse Event|0|||
160866950|NCT00790842|580905029|FG010|Expansion Cohort|Adverse Event|0|||
160866951|NCT00790842|580905019|FG000|Expansion Cohort|Death|0|||
160866952|NCT00790842|580905020|FG001|Expansion Cohort|Death|0|||
160866953|NCT00790842|580905021|FG002|Expansion Cohort|Death|2|||
160866954|NCT00790842|580905022|FG003|Expansion Cohort|Death|0|||
160866955|NCT00790842|580905023|FG004|Expansion Cohort|Death|0|||
160866956|NCT00790842|580905024|FG005|Expansion Cohort|Death|0|||
160866957|NCT00790842|580905025|FG006|Expansion Cohort|Death|0|||
160866958|NCT00790842|580905026|FG007|Expansion Cohort|Death|0|||
160866959|NCT00790842|580905027|FG008|Expansion Cohort|Death|0|||
160866960|NCT00790842|580905028|FG009|Expansion Cohort|Death|0|||
160866961|NCT00790842|580905029|FG010|Expansion Cohort|Death|0|||
160866962|NCT00790842|580905019|FG000|Expansion Cohort|Physician Decision|0|||
160866963|NCT00790842|580905020|FG001|Expansion Cohort|Physician Decision|0|||
160866964|NCT00790842|580905021|FG002|Expansion Cohort|Physician Decision|1|||
160866965|NCT00790842|580905022|FG003|Expansion Cohort|Physician Decision|0|||
160866966|NCT00790842|580905023|FG004|Expansion Cohort|Physician Decision|0|||
160866967|NCT00790842|580905024|FG005|Expansion Cohort|Physician Decision|0|||
160866968|NCT00790842|580905025|FG006|Expansion Cohort|Physician Decision|0|||
160866969|NCT00790842|580905026|FG007|Expansion Cohort|Physician Decision|0|||
160866970|NCT00790842|580905027|FG008|Expansion Cohort|Physician Decision|0|||
160866971|NCT00790842|580905028|FG009|Expansion Cohort|Physician Decision|0|||
160866972|NCT00790842|580905029|FG010|Expansion Cohort|Physician Decision|0|||
160866973|NCT00790842|580905019|FG000|Expansion Cohort|Withdrawal by Subject|0|||
160866974|NCT00790842|580905020|FG001|Expansion Cohort|Withdrawal by Subject|0|||
160866975|NCT00790842|580905021|FG002|Expansion Cohort|Withdrawal by Subject|3|||
160866976|NCT00790842|580905022|FG003|Expansion Cohort|Withdrawal by Subject|0|||
160866977|NCT00790842|580905023|FG004|Expansion Cohort|Withdrawal by Subject|0|||
160866978|NCT00790842|580905024|FG005|Expansion Cohort|Withdrawal by Subject|0|||
160866979|NCT00790842|580905025|FG006|Expansion Cohort|Withdrawal by Subject|0|||
160866980|NCT00790842|580905026|FG007|Expansion Cohort|Withdrawal by Subject|0|||
160866981|NCT00790842|580905027|FG008|Expansion Cohort|Withdrawal by Subject|0|||
160866982|NCT00790842|580905028|FG009|Expansion Cohort|Withdrawal by Subject|0|||
160866983|NCT00790842|580905029|FG010|Expansion Cohort|Withdrawal by Subject|0|||
160866984|NCT00790842|580905019|FG000|Expansion Cohort|Study Closure|0|||
160866985|NCT00790842|580905020|FG001|Expansion Cohort|Study Closure|0|||
160866986|NCT00790842|580905021|FG002|Expansion Cohort|Study Closure|1|||
160866987|NCT00790842|580905022|FG003|Expansion Cohort|Study Closure|0|||
160866988|NCT00790842|580905023|FG004|Expansion Cohort|Study Closure|0|||
160866989|NCT00790842|580905024|FG005|Expansion Cohort|Study Closure|0|||
160866990|NCT00790842|580905025|FG006|Expansion Cohort|Study Closure|0|||
160866991|NCT00790842|580905026|FG007|Expansion Cohort|Study Closure|0|||
160866992|NCT00790842|580905027|FG008|Expansion Cohort|Study Closure|0|||
160866993|NCT00790842|580905028|FG009|Expansion Cohort|Study Closure|0|||
160866994|NCT00790842|580905029|FG010|Expansion Cohort|Study Closure|0|||
160866995|NCT05029362|580905030|FG000|Overall Study|Lost to Follow-up|9|||
160866996|NCT00419952|580905032|FG000|Overall Study|Adverse Event|8|||
160866997|NCT00419952|580905033|FG001|Overall Study|Adverse Event|10|||
160866998|NCT00419952|580905032|FG000|Overall Study|Withdrawal by Subject|44|||
160866999|NCT00419952|580905033|FG001|Overall Study|Withdrawal by Subject|43|||
160867000|NCT00419952|580905032|FG000|Overall Study|Lost to Follow-up|43|||
160867001|NCT00419952|580905033|FG001|Overall Study|Lost to Follow-up|34|||
160867002|NCT00419952|580905032|FG000|Overall Study|Protocol Violation|32|||
160867003|NCT00419952|580905033|FG001|Overall Study|Protocol Violation|24|||
160867004|NCT00419952|580905032|FG000|Overall Study|Pregnancy|4|||
160867005|NCT00419952|580905033|FG001|Overall Study|Pregnancy|2|||
160867006|NCT00419952|580905032|FG000|Overall Study|Physician Decision|1|||
160867007|NCT00419952|580905033|FG001|Overall Study|Physician Decision|3|||
160867008|NCT00419952|580905032|FG000|Overall Study|Incorrectly enrolled|10|||
160867009|NCT00419952|580905033|FG001|Overall Study|Incorrectly enrolled|3|||
160867010|NCT00419952|580905032|FG000|Overall Study|Intake of prohibited medication|2|||
160867011|NCT00419952|580905033|FG001|Overall Study|Intake of prohibited medication|2|||
160867012|NCT00419952|580905032|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
160867013|NCT00419952|580905033|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
160867014|NCT00419952|580905032|FG000|Overall Study|Diary or medication non-compliance|2|||
160867015|NCT00419952|580905033|FG001|Overall Study|Diary or medication non-compliance|4|||
160867016|NCT00419952|580905032|FG000|Overall Study|Abnormal ECG|1|||
160867017|NCT00419952|580905033|FG001|Overall Study|Abnormal ECG|0|||
160867018|NCT03126591|580905038|FG000|Overall Study|Death|6|||
160867019|NCT03126591|580905039|FG001|Overall Study|Death|3|||
160867020|NCT03126591|580905040|FG002|Overall Study|Death|17|||
160867021|NCT03126591|580905038|FG000|Overall Study|Progressive Disease|0|||
160867022|NCT03126591|580905039|FG001|Overall Study|Progressive Disease|1|||
160867023|NCT03126591|580905040|FG002|Overall Study|Progressive Disease|2|||
160867024|NCT03126591|580905038|FG000|Overall Study|Terminated by Sponsor|0|||
160867025|NCT03126591|580905039|FG001|Overall Study|Terminated by Sponsor|1|||
160867026|NCT03126591|580905040|FG002|Overall Study|Terminated by Sponsor|4|||
160867027|NCT03126591|580905038|FG000|Overall Study|Withdrawal by Subject|1|||
160867028|NCT03126591|580905039|FG001|Overall Study|Withdrawal by Subject|1|||
160867029|NCT03126591|580905040|FG002|Overall Study|Withdrawal by Subject|4|||
160867030|NCT01285323|580905041|FG000|Overall Study|Adverse Event|9|||
160867031|NCT01285323|580905042|FG001|Overall Study|Adverse Event|8|||
160867032|NCT01285323|580905041|FG000|Overall Study|Lack of Efficacy|4|||
160867033|NCT01285323|580905042|FG001|Overall Study|Lack of Efficacy|2|||
160867034|NCT01285323|580905041|FG000|Overall Study|Withdrawal by Subject|15|||
160867035|NCT01285323|580905042|FG001|Overall Study|Withdrawal by Subject|11|||
160867036|NCT01285323|580905041|FG000|Overall Study|Protocol Violation|1|||
160867037|NCT01285323|580905042|FG001|Overall Study|Protocol Violation|2|||
160867038|NCT01285323|580905041|FG000|Overall Study|Non-compliance with study procedures|2|||
160867039|NCT01285323|580905042|FG001|Overall Study|Non-compliance with study procedures|3|||
160867040|NCT01285323|580905041|FG000|Overall Study|Lost to Follow-up|1|||
160867041|NCT01285323|580905042|FG001|Overall Study|Lost to Follow-up|1|||
160867042|NCT01285323|580905041|FG000|Overall Study|Other|1|||
160867043|NCT01285323|580905042|FG001|Overall Study|Other|3|||
160867044|NCT02351817|580905043|FG000|Period 1|Adverse Event|1|||
160867045|NCT02351817|580905044|FG001|Period 1|Adverse Event|2|||
160867046|NCT02351817|580905043|FG000|Period 1|Lack of Efficacy|0|||
160867047|NCT02351817|580905044|FG001|Period 1|Lack of Efficacy|1|||
160867048|NCT02351817|580905043|FG000|Period 2|Adverse Event|0|||
160867049|NCT02351817|580905044|FG001|Period 2|Adverse Event|2|||
160867050|NCT02351817|580905043|FG000|Period 2|Protocol Violation|1|||
160867051|NCT02351817|580905044|FG001|Period 2|Protocol Violation|0|||
160867052|NCT02488915|580905047|FG000|Overall Study|Death|21|||
160867053|NCT02488915|580905047|FG000|Overall Study|Lost to Follow-up|4|||
160867054|NCT02488915|580905047|FG000|Overall Study|Withdrawal by Subject|1|||
160867055|NCT01208207|580905051|FG000|Part I|Adverse Event|19|||
160867056|NCT01208207|580905052|FG001|Part I|Adverse Event|2|||
160867057|NCT01208207|580905053|FG002|Part I|Adverse Event|6|||
160867058|NCT01208207|580905054|FG003|Part I|Adverse Event|0|||
160867059|NCT01208207|580905055|FG004|Part I|Adverse Event|0|||
160867060|NCT01208207|580905056|FG005|Part I|Adverse Event|0|||
160867061|NCT01208207|580905057|FG006|Part I|Adverse Event|0|||
160867062|NCT01208207|580905051|FG000|Part I|Lack of Efficacy|21|||
160867063|NCT01208207|580905052|FG001|Part I|Lack of Efficacy|3|||
160867064|NCT01208207|580905053|FG002|Part I|Lack of Efficacy|2|||
160867065|NCT01208207|580905054|FG003|Part I|Lack of Efficacy|0|||
160867066|NCT01208207|580905055|FG004|Part I|Lack of Efficacy|0|||
160867067|NCT01208207|580905056|FG005|Part I|Lack of Efficacy|0|||
160867068|NCT01208207|580905057|FG006|Part I|Lack of Efficacy|0|||
160867069|NCT01208207|580905051|FG000|Part I|Lost to Follow-up|6|||
160867070|NCT01208207|580905052|FG001|Part I|Lost to Follow-up|1|||
160867071|NCT01208207|580905053|FG002|Part I|Lost to Follow-up|0|||
160867072|NCT01208207|580905054|FG003|Part I|Lost to Follow-up|0|||
160867073|NCT01208207|580905055|FG004|Part I|Lost to Follow-up|0|||
160527146|NCT01233869|579660904|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
160527147|NCT01233869|579660901|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
160527148|NCT01233869|579660902|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
160527149|NCT01233869|579660903|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
160527150|NCT01233869|579660904|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
160867074|NCT01208207|580905056|FG005|Part I|Lost to Follow-up|0|||
160867075|NCT01208207|580905057|FG006|Part I|Lost to Follow-up|0|||
160867076|NCT01208207|580905051|FG000|Part I|Non-Compliance With Study Drug|1|||
160867077|NCT01208207|580905052|FG001|Part I|Non-Compliance With Study Drug|0|||
160867078|NCT01208207|580905053|FG002|Part I|Non-Compliance With Study Drug|1|||
160867079|NCT01208207|580905054|FG003|Part I|Non-Compliance With Study Drug|0|||
160867080|NCT01208207|580905055|FG004|Part I|Non-Compliance With Study Drug|0|||
160867081|NCT01208207|580905056|FG005|Part I|Non-Compliance With Study Drug|0|||
160867082|NCT01208207|580905057|FG006|Part I|Non-Compliance With Study Drug|0|||
160867083|NCT01208207|580905051|FG000|Part I|Physician Decision|0|||
160867084|NCT01208207|580905052|FG001|Part I|Physician Decision|1|||
160867085|NCT01208207|580905053|FG002|Part I|Physician Decision|0|||
160867086|NCT01208207|580905054|FG003|Part I|Physician Decision|0|||
160867087|NCT01208207|580905055|FG004|Part I|Physician Decision|0|||
160867088|NCT01208207|580905056|FG005|Part I|Physician Decision|0|||
160867089|NCT01208207|580905057|FG006|Part I|Physician Decision|0|||
160867090|NCT01208207|580905051|FG000|Part I|Progressive Disease|1|||
160867091|NCT01208207|580905052|FG001|Part I|Progressive Disease|0|||
160867092|NCT01208207|580905053|FG002|Part I|Progressive Disease|0|||
160867093|NCT01208207|580905054|FG003|Part I|Progressive Disease|0|||
160867094|NCT01208207|580905055|FG004|Part I|Progressive Disease|0|||
160867095|NCT01208207|580905056|FG005|Part I|Progressive Disease|0|||
160867096|NCT01208207|580905057|FG006|Part I|Progressive Disease|0|||
160867097|NCT01208207|580905051|FG000|Part I|Protocol Violation|8|||
160867098|NCT01208207|580905052|FG001|Part I|Protocol Violation|0|||
160867099|NCT01208207|580905053|FG002|Part I|Protocol Violation|2|||
160867100|NCT01208207|580905054|FG003|Part I|Protocol Violation|0|||
160867101|NCT01208207|580905055|FG004|Part I|Protocol Violation|0|||
160867102|NCT01208207|580905056|FG005|Part I|Protocol Violation|0|||
160867103|NCT01208207|580905057|FG006|Part I|Protocol Violation|0|||
160867104|NCT01208207|580905051|FG000|Part I|Withdrawal by Subject|14|||
160867105|NCT01208207|580905052|FG001|Part I|Withdrawal by Subject|4|||
160867106|NCT01208207|580905053|FG002|Part I|Withdrawal by Subject|4|||
160867107|NCT01208207|580905054|FG003|Part I|Withdrawal by Subject|0|||
160867108|NCT01208207|580905055|FG004|Part I|Withdrawal by Subject|0|||
160867109|NCT01208207|580905056|FG005|Part I|Withdrawal by Subject|0|||
160867110|NCT01208207|580905057|FG006|Part I|Withdrawal by Subject|0|||
160867111|NCT01208207|580905051|FG000|Part II|Withdrawal by Subject|0|||
160867112|NCT01208207|580905052|FG001|Part II|Withdrawal by Subject|0|||
160867113|NCT01208207|580905053|FG002|Part II|Withdrawal by Subject|0|||
160867114|NCT01208207|580905054|FG003|Part II|Withdrawal by Subject|10|||
160867115|NCT01208207|580905055|FG004|Part II|Withdrawal by Subject|9|||
160867116|NCT01208207|580905056|FG005|Part II|Withdrawal by Subject|3|||
160867117|NCT01208207|580905057|FG006|Part II|Withdrawal by Subject|5|||
160867118|NCT01208207|580905051|FG000|Part II|Adverse Event|0|||
160867119|NCT01208207|580905052|FG001|Part II|Adverse Event|0|||
160867120|NCT01208207|580905053|FG002|Part II|Adverse Event|0|||
160867121|NCT01208207|580905054|FG003|Part II|Adverse Event|5|||
160867122|NCT01208207|580905055|FG004|Part II|Adverse Event|9|||
160867123|NCT01208207|580905056|FG005|Part II|Adverse Event|4|||
160867124|NCT01208207|580905057|FG006|Part II|Adverse Event|2|||
160867125|NCT01208207|580905051|FG000|Part II|Lack of Efficacy|0|||
160867126|NCT01208207|580905052|FG001|Part II|Lack of Efficacy|0|||
160867127|NCT01208207|580905053|FG002|Part II|Lack of Efficacy|0|||
160867128|NCT01208207|580905054|FG003|Part II|Lack of Efficacy|6|||
160867129|NCT01208207|580905055|FG004|Part II|Lack of Efficacy|4|||
160867130|NCT01208207|580905056|FG005|Part II|Lack of Efficacy|3|||
160867131|NCT01208207|580905057|FG006|Part II|Lack of Efficacy|3|||
160867132|NCT01208207|580905051|FG000|Part II|Lost to Follow-up|0|||
160867133|NCT01208207|580905052|FG001|Part II|Lost to Follow-up|0|||
160867134|NCT01208207|580905053|FG002|Part II|Lost to Follow-up|0|||
160867135|NCT01208207|580905054|FG003|Part II|Lost to Follow-up|4|||
160867136|NCT01208207|580905055|FG004|Part II|Lost to Follow-up|0|||
160867137|NCT01208207|580905056|FG005|Part II|Lost to Follow-up|2|||
160867138|NCT01208207|580905057|FG006|Part II|Lost to Follow-up|1|||
160867139|NCT01208207|580905051|FG000|Part II|Non-Compliance With Study Drug|0|||
160867140|NCT01208207|580905052|FG001|Part II|Non-Compliance With Study Drug|0|||
160867141|NCT01208207|580905053|FG002|Part II|Non-Compliance With Study Drug|0|||
160867142|NCT01208207|580905054|FG003|Part II|Non-Compliance With Study Drug|4|||
160867143|NCT01208207|580905055|FG004|Part II|Non-Compliance With Study Drug|1|||
160867144|NCT01208207|580905056|FG005|Part II|Non-Compliance With Study Drug|1|||
160867145|NCT01208207|580905057|FG006|Part II|Non-Compliance With Study Drug|0|||
160867146|NCT01208207|580905051|FG000|Part II|Physician Decision|0|||
160867147|NCT01208207|580905052|FG001|Part II|Physician Decision|0|||
160867148|NCT01208207|580905053|FG002|Part II|Physician Decision|0|||
160867149|NCT01208207|580905054|FG003|Part II|Physician Decision|1|||
160867150|NCT01208207|580905055|FG004|Part II|Physician Decision|0|||
160867151|NCT01208207|580905056|FG005|Part II|Physician Decision|2|||
160867152|NCT01208207|580905057|FG006|Part II|Physician Decision|0|||
160867153|NCT01208207|580905051|FG000|Part II|Protocol Violation|0|||
160867154|NCT01208207|580905052|FG001|Part II|Protocol Violation|0|||
160867155|NCT01208207|580905053|FG002|Part II|Protocol Violation|0|||
160867156|NCT01208207|580905054|FG003|Part II|Protocol Violation|1|||
160867157|NCT01208207|580905055|FG004|Part II|Protocol Violation|0|||
160867158|NCT01208207|580905056|FG005|Part II|Protocol Violation|0|||
160867159|NCT01208207|580905057|FG006|Part II|Protocol Violation|0|||
160867160|NCT01208207|580905051|FG000|Part II|Technical Problems|0|||
160867161|NCT01208207|580905052|FG001|Part II|Technical Problems|0|||
160867162|NCT01208207|580905053|FG002|Part II|Technical Problems|0|||
160867163|NCT01208207|580905054|FG003|Part II|Technical Problems|1|||
160867164|NCT01208207|580905055|FG004|Part II|Technical Problems|0|||
160867165|NCT01208207|580905056|FG005|Part II|Technical Problems|1|||
160867166|NCT01208207|580905057|FG006|Part II|Technical Problems|0|||
160867167|NCT04041414|580905060|FG000|Overall Study|Lost to Follow-up|1|||
160867168|NCT04041414|580905061|FG001|Overall Study|Lost to Follow-up|2|||
160867169|NCT00665652|580905062|FG000|Overall Study|Adverse Event|4|||
160867170|NCT00665652|580905062|FG000|Overall Study|Death|1|||
160867171|NCT00665652|580905062|FG000|Overall Study|No longer met inclusion criteria.|1|||
160867172|NCT01782378|580905065|FG000|First Series|Lost to Follow-up|7|||
160867173|NCT01782378|580905066|FG001|First Series|Lost to Follow-up|8|||
160867174|NCT01782378|580905065|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
160867175|NCT01782378|580905066|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
160867176|NCT01782378|580905065|FG000|Second Series|Lost to Follow-up|8|||
160867177|NCT01782378|580905066|FG001|Second Series|Lost to Follow-up|7|||
160867178|NCT01782378|580905065|FG000|Second Series|Did not choose to complete S2 Optional|18|||
160867179|NCT01782378|580905066|FG001|Second Series|Did not choose to complete S2 Optional|0|||
160867180|NCT00830440|580905067|FG000|Overall Study|Protocol Violation|1|||
160867181|NCT00830440|580905068|FG001|Overall Study|Protocol Violation|0|||
160867182|NCT00830440|580905067|FG000|Overall Study|Withdrawal by Subject|1|||
160867183|NCT00830440|580905068|FG001|Overall Study|Withdrawal by Subject|0|||
160867184|NCT00830440|580905067|FG000|Overall Study|unsuccessful procedure|4|||
160867185|NCT00830440|580905068|FG001|Overall Study|unsuccessful procedure|0|||
160867186|NCT00830440|580905067|FG000|Overall Study|Adverse Event|2|||
160867187|NCT00830440|580905068|FG001|Overall Study|Adverse Event|0|||
160867188|NCT01656408|580905069|FG000|Overall Study|Adverse Event|0|||
160867189|NCT01656408|580905070|FG001|Overall Study|Adverse Event|0|||
160867190|NCT01656408|580905071|FG002|Overall Study|Adverse Event|1|||
160867191|NCT01656408|580905072|FG003|Overall Study|Adverse Event|0|||
160867192|NCT01656408|580905073|FG004|Overall Study|Adverse Event|0|||
160867193|NCT01656408|580905074|FG005|Overall Study|Adverse Event|1|||
160867194|NCT01656408|580905075|FG006|Overall Study|Adverse Event|1|||
160867195|NCT01656408|580905076|FG007|Overall Study|Adverse Event|0|||
160867196|NCT01656408|580905077|FG008|Overall Study|Adverse Event|1|||
160867197|NCT01656408|580905078|FG009|Overall Study|Adverse Event|0|||
160867198|NCT01656408|580905069|FG000|Overall Study|Physician Decision|1|||
160867199|NCT01656408|580905070|FG001|Overall Study|Physician Decision|0|||
160867200|NCT01656408|580905071|FG002|Overall Study|Physician Decision|1|||
160867201|NCT01656408|580905072|FG003|Overall Study|Physician Decision|0|||
160867202|NCT01656408|580905073|FG004|Overall Study|Physician Decision|1|||
160867203|NCT01656408|580905074|FG005|Overall Study|Physician Decision|1|||
160867204|NCT01656408|580905075|FG006|Overall Study|Physician Decision|0|||
160867205|NCT01656408|580905076|FG007|Overall Study|Physician Decision|1|||
160867206|NCT01656408|580905077|FG008|Overall Study|Physician Decision|1|||
160867207|NCT01656408|580905078|FG009|Overall Study|Physician Decision|3|||
160867208|NCT02420821|580905080|FG000|Overall Study|Lost to Follow-up|6|||
160867209|NCT02420821|580905081|FG001|Overall Study|Lost to Follow-up|6|||
160867210|NCT02420821|580905080|FG000|Overall Study|Non-compliance|0|||
160867211|NCT02420821|580905081|FG001|Overall Study|Non-compliance|2|||
160867212|NCT02420821|580905080|FG000|Overall Study|Physician Decision|6|||
160867213|NCT02420821|580905081|FG001|Overall Study|Physician Decision|2|||
160867214|NCT02420821|580905080|FG000|Overall Study|Withdrawal by Subject|32|||
160867215|NCT02420821|580905081|FG001|Overall Study|Withdrawal by Subject|25|||
160867216|NCT02420821|580905080|FG000|Overall Study|Death|270|||
160867217|NCT02420821|580905081|FG001|Overall Study|Death|263|||
160867218|NCT02420821|580905080|FG000|Overall Study|Study Terminated By Sponsor|145|||
160867219|NCT02420821|580905081|FG001|Overall Study|Study Terminated By Sponsor|149|||
160867220|NCT02420821|580905080|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
160867221|NCT02420821|580905081|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
160867222|NCT02420821|580905080|FG000|Overall Study|Adverse Event|0|||
160867223|NCT02420821|580905081|FG001|Overall Study|Adverse Event|1|||
160867224|NCT02420821|580905080|FG000|Overall Study|Protinuria|0|||
160867225|NCT02420821|580905081|FG001|Overall Study|Protinuria|1|||
160867226|NCT02420821|580905080|FG000|Overall Study|Progressive Disease|1|||
160867227|NCT02420821|580905081|FG001|Overall Study|Progressive Disease|1|||
160867228|NCT02420821|580905080|FG000|Overall Study|Disease Progression|0|||
160867229|NCT02420821|580905081|FG001|Overall Study|Disease Progression|1|||
160867230|NCT02420821|580905080|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
160867231|NCT02420821|580905081|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
160867232|NCT03987503|580905085|FG000|Overall Study|Lost to Follow-up|20|||
160867233|NCT03987503|580905085|FG000|Overall Study|Withdrawal by Subject|2|||
160867234|NCT00926237|580905086|FG000|Overall Study|Withdrawal by Subject|2|||
160867235|NCT00926237|580905087|FG001|Overall Study|Withdrawal by Subject|1|||
160867236|NCT02446899|580906812|FG000|Overall Study|Adverse Event|4|||
160867237|NCT02446899|580906813|FG001|Overall Study|Adverse Event|7|||
160867238|NCT02446899|580906812|FG000|Overall Study|Condition Under Investigation Worsened|1|||
160867239|NCT02446899|580906813|FG001|Overall Study|Condition Under Investigation Worsened|4|||
160867240|NCT02446899|580906812|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
160867241|NCT02446899|580906813|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
160867242|NCT02446899|580906812|FG000|Overall Study|Lack of Efficacy|2|||
160867243|NCT02446899|580906813|FG001|Overall Study|Lack of Efficacy|8|||
160867244|NCT02446899|580906812|FG000|Overall Study|Lost to Follow-up|1|||
160867245|NCT02446899|580906813|FG001|Overall Study|Lost to Follow-up|3|||
160867246|NCT02446899|580906812|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
160867247|NCT02446899|580906813|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
160527151|NCT01233869|579660901|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
160867248|NCT02446899|580906812|FG000|Overall Study|Withdrawal by Subject|11|||
160763149|NCT03636256|580522896|FG000|Overall Study|Lost to Follow-up|3|||
160763150|NCT03636256|580522897|FG001|Overall Study|Lost to Follow-up|0|||
160763151|NCT03636256|580522898|FG002|Overall Study|Lost to Follow-up|2|||
160763152|NCT03636256|580522899|FG003|Overall Study|Lost to Follow-up|1|||
160763153|NCT03636256|580522900|FG004|Overall Study|Lost to Follow-up|0|||
160763154|NCT03636256|580522901|FG005|Overall Study|Lost to Follow-up|4|||
160763155|NCT03636256|580522902|FG006|Overall Study|Lost to Follow-up|2|||
160763156|NCT03636256|580522903|FG007|Overall Study|Lost to Follow-up|0|||
160763157|NCT03636256|580522904|FG008|Overall Study|Lost to Follow-up|4|||
160763158|NCT03636256|580522896|FG000|Overall Study|Withdrawal by Subject|0|||
160763159|NCT03636256|580522897|FG001|Overall Study|Withdrawal by Subject|0|||
160763160|NCT03636256|580522898|FG002|Overall Study|Withdrawal by Subject|0|||
160763161|NCT03636256|580522899|FG003|Overall Study|Withdrawal by Subject|0|||
160763162|NCT03636256|580522900|FG004|Overall Study|Withdrawal by Subject|0|||
160763163|NCT03636256|580522901|FG005|Overall Study|Withdrawal by Subject|0|||
160763164|NCT03636256|580522902|FG006|Overall Study|Withdrawal by Subject|0|||
160763165|NCT03636256|580522903|FG007|Overall Study|Withdrawal by Subject|0|||
160763166|NCT03636256|580522904|FG008|Overall Study|Withdrawal by Subject|1|||
160763167|NCT01218308|580522905|FG000|Overall Study|Adverse Event|1|||
160763168|NCT01218308|580522906|FG001|Overall Study|Adverse Event|2|||
160763169|NCT01218308|580522905|FG000|Overall Study|Protocol Violation|0|||
160763170|NCT01218308|580522906|FG001|Overall Study|Protocol Violation|2|||
160763171|NCT01218308|580522905|FG000|Overall Study|Withdrawal by Subject|61|||
160763172|NCT01218308|580522906|FG001|Overall Study|Withdrawal by Subject|64|||
160763173|NCT01218308|580522905|FG000|Overall Study|Lost to Follow-up|27|||
160763174|NCT01218308|580522906|FG001|Overall Study|Lost to Follow-up|31|||
160763175|NCT01218308|580522905|FG000|Overall Study|Other|14|||
160763176|NCT01218308|580522906|FG001|Overall Study|Other|21|||
160763177|NCT05222880|580522909|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
160763178|NCT05222880|580522909|FG000|Overall Study|Withdrew Consent during Study|1|||
160763179|NCT05222880|580522909|FG000|Overall Study|COVID-19 Related|1|||
160763180|NCT05401565|580522910|FG000|Overall Study|Lost to Follow-up|1|||
160763181|NCT05401565|580522911|FG001|Overall Study|Lost to Follow-up|0|||
160763182|NCT05401565|580522910|FG000|Overall Study|Adverse Event|2|||
160763183|NCT05401565|580522911|FG001|Overall Study|Adverse Event|0|||
160763184|NCT02984982|580522912|FG000|Overall Study|Adverse Event|2|||
160763185|NCT02984982|580522913|FG001|Overall Study|Adverse Event|5|||
160763186|NCT02984982|580522912|FG000|Overall Study|Poor Compliance to Protocol|4|||
160763187|NCT02984982|580522913|FG001|Overall Study|Poor Compliance to Protocol|4|||
160763188|NCT02984982|580522912|FG000|Overall Study|Withdrawal by Subject|2|||
160763189|NCT02984982|580522913|FG001|Overall Study|Withdrawal by Subject|0|||
160763190|NCT02984982|580522912|FG000|Overall Study|Randomized but not treated|0|||
160763191|NCT02984982|580522913|FG001|Overall Study|Randomized but not treated|1|||
160763192|NCT02144701|580522914|FG000|Overall Study|development of relapse, GVHD or death|9|||
160763193|NCT02144701|580522915|FG001|Overall Study|development of relapse, GVHD or death|3|||
160763194|NCT02616783|580522916|FG000|Overall Study|Randomized but Not Treated|1|||
160763195|NCT02616783|580522917|FG001|Overall Study|Randomized but Not Treated|0|||
160763196|NCT02616783|580522916|FG000|Overall Study|Adverse Event|1|||
160763197|NCT02616783|580522917|FG001|Overall Study|Adverse Event|0|||
160763198|NCT02616783|580522916|FG000|Overall Study|Death|1|||
160763199|NCT02616783|580522917|FG001|Overall Study|Death|0|||
160763200|NCT02616783|580522916|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160763201|NCT02616783|580522917|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160763202|NCT02616783|580522916|FG000|Overall Study|Protocol Violation|1|||
160763203|NCT02616783|580522917|FG001|Overall Study|Protocol Violation|1|||
160763204|NCT02616783|580522916|FG000|Overall Study|Withdrew Consent|1|||
160763205|NCT02616783|580522917|FG001|Overall Study|Withdrew Consent|1|||
160763206|NCT00069264|580522933|FG000|Overall Study|Adverse Event|3|||
160763207|NCT00069264|580522933|FG000|Overall Study|Progressive Disease|23|||
160763208|NCT00069264|580522933|FG000|Overall Study|Withdrawal by Subject|3|||
160763209|NCT00069264|580522933|FG000|Overall Study|Discon Therapy|3|||
160763210|NCT03886272|580522934|FG000|Period 1|Withdrawal by Subject|0|||
160763211|NCT03886272|580522935|FG001|Period 1|Withdrawal by Subject|0|||
160763212|NCT03886272|580522936|FG002|Period 1|Withdrawal by Subject|0|||
160763213|NCT03886272|580522937|FG003|Period 1|Withdrawal by Subject|0|||
160763214|NCT03886272|580522938|FG004|Period 1|Withdrawal by Subject|0|||
160763215|NCT03886272|580522939|FG005|Period 1|Withdrawal by Subject|1|||
160763216|NCT03886272|580522940|FG006|Period 1|Withdrawal by Subject|0|||
160763217|NCT02895347|580522943|FG000|Overall Study|Withdrawal by Subject|3|||
160763218|NCT02895347|580522944|FG001|Overall Study|Withdrawal by Subject|1|||
160763219|NCT01673178|580522948|FG000|Overall Study|Lost to Follow-up|0|||
160763220|NCT01673178|580522949|FG001|Overall Study|Lost to Follow-up|1|||
160763221|NCT01673178|580522950|FG002|Overall Study|Lost to Follow-up|0|||
160763222|NCT01673178|580522951|FG003|Overall Study|Lost to Follow-up|0|||
160763223|NCT01673178|580522952|FG004|Overall Study|Lost to Follow-up|0|||
160763224|NCT01673178|580522948|FG000|Overall Study|Withdrawal by Subject|0|||
160763225|NCT01673178|580522949|FG001|Overall Study|Withdrawal by Subject|0|||
160763226|NCT01673178|580522950|FG002|Overall Study|Withdrawal by Subject|1|||
160867249|NCT02446899|580906813|FG001|Overall Study|Withdrawal by Subject|19|||
160867250|NCT02446899|580906812|FG000|Overall Study|Miscellaneous|5|||
160867251|NCT02446899|580906813|FG001|Overall Study|Miscellaneous|4|||
160867252|NCT02446899|580906812|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
160867253|NCT02446899|580906813|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
160867254|NCT01002339|580906814|FG000|Overall Study|Withdrawal by Subject|0|||
160867255|NCT01002339|580906815|FG001|Overall Study|Withdrawal by Subject|1|||
160867256|NCT01002339|580906816|FG002|Overall Study|Withdrawal by Subject|0|||
160867257|NCT01002339|580906814|FG000|Overall Study|Incorrect treatment assignment|0|||
160867258|NCT01002339|580906815|FG001|Overall Study|Incorrect treatment assignment|0|||
160867259|NCT01002339|580906816|FG002|Overall Study|Incorrect treatment assignment|1|||
160867260|NCT01002339|580906814|FG000|Overall Study|Protocol Violation|0|||
160867261|NCT01002339|580906815|FG001|Overall Study|Protocol Violation|0|||
160867262|NCT01002339|580906816|FG002|Overall Study|Protocol Violation|2|||
160867263|NCT01002339|580906814|FG000|Overall Study|Lung cancer detected before transplant|0|||
160867264|NCT01002339|580906815|FG001|Overall Study|Lung cancer detected before transplant|0|||
160867265|NCT01002339|580906816|FG002|Overall Study|Lung cancer detected before transplant|1|||
160867266|NCT01002339|580906814|FG000|Overall Study|Randomized. Not transplanted|0|||
160867267|NCT01002339|580906815|FG001|Overall Study|Randomized. Not transplanted|0|||
160867268|NCT01002339|580906816|FG002|Overall Study|Randomized. Not transplanted|1|||
160867269|NCT05661409|580906817|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
160867270|NCT05661409|580906818|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
160867271|NCT05661409|580906819|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
160867272|NCT05661409|580906820|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
160867273|NCT05661409|580906821|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
160867274|NCT05661409|580906822|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
160867275|NCT05661409|580906817|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
160867276|NCT05661409|580906818|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
160867277|NCT05661409|580906819|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
160867278|NCT05661409|580906820|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
160867279|NCT05661409|580906821|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
160867280|NCT05661409|580906822|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
160867281|NCT05661409|580906817|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
160867282|NCT05661409|580906818|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
160867283|NCT05661409|580906819|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
160867284|NCT05661409|580906820|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
160867285|NCT05661409|580906821|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
160867286|NCT05661409|580906822|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
160867287|NCT05661409|580906817|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
160867288|NCT05661409|580906818|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
160867289|NCT05661409|580906819|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
160867290|NCT05661409|580906820|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
160867291|NCT05661409|580906821|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
160867292|NCT05661409|580906822|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
160867293|NCT05661409|580906817|FG000|Overall Study|Miscommu-nication about administration|0|||
160867294|NCT05661409|580906818|FG001|Overall Study|Miscommu-nication about administration|0|||
160867295|NCT05661409|580906819|FG002|Overall Study|Miscommu-nication about administration|0|||
160867296|NCT05661409|580906820|FG003|Overall Study|Miscommu-nication about administration|0|||
160867297|NCT05661409|580906821|FG004|Overall Study|Miscommu-nication about administration|0|||
160867298|NCT05661409|580906822|FG005|Overall Study|Miscommu-nication about administration|1|||
160867299|NCT04730271|580906825|FG000|Overall Study|Adverse Event|0|||
160867300|NCT04730271|580906826|FG001|Overall Study|Adverse Event|2|||
160867301|NCT04730271|580906825|FG000|Overall Study|Withdrawal by Subject|1|||
160867302|NCT04730271|580906826|FG001|Overall Study|Withdrawal by Subject|1|||
160867303|NCT04730271|580906825|FG000|Overall Study|Protocol Violation|7|||
160867304|NCT04730271|580906826|FG001|Overall Study|Protocol Violation|13|||
160867305|NCT04730271|580906825|FG000|Overall Study|Lost to Follow-up|3|||
160867306|NCT04730271|580906826|FG001|Overall Study|Lost to Follow-up|3|||
160867307|NCT04730271|580906825|FG000|Overall Study|Death|1|||
160867308|NCT04730271|580906826|FG001|Overall Study|Death|0|||
160867309|NCT00998296|580906827|FG000|Overall Study|Progressive disease|0|||
160867310|NCT00998296|580906828|FG001|Overall Study|Progressive disease|1|||
160867311|NCT00998296|580906829|FG002|Overall Study|Progressive disease|0|||
160867312|NCT00998296|580906830|FG003|Overall Study|Progressive disease|0|||
160867313|NCT00998296|580906831|FG004|Overall Study|Progressive disease|0|||
160867314|NCT00998296|580906832|FG005|Overall Study|Progressive disease|0|||
160867315|NCT00998296|580906833|FG006|Overall Study|Progressive disease|1|||
160867316|NCT00998296|580906834|FG007|Overall Study|Progressive disease|0|||
160867317|NCT00998296|580906835|FG008|Overall Study|Progressive disease|0|||
160867318|NCT00998296|580906836|FG009|Overall Study|Progressive disease|14|||
160636406|NCT01954082|580051541|FG001|Overall Study|Withdrawal by Subject|1|||
160867319|NCT00998296|580906837|FG010|Overall Study|Progressive disease|5|||
160867320|NCT00998296|580906827|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867321|NCT00998296|580906828|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867322|NCT00998296|580906829|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867323|NCT00998296|580906830|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867324|NCT00998296|580906831|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
160867325|NCT00998296|580906832|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867326|NCT00998296|580906833|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867327|NCT00998296|580906834|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
160867328|NCT00998296|580906835|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
160867329|NCT00998296|580906836|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867330|NCT00998296|580906837|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867331|NCT00998296|580906827|FG000|Overall Study|Other adverse event|0|||
160867332|NCT00998296|580906828|FG001|Overall Study|Other adverse event|0|||
160867333|NCT00998296|580906829|FG002|Overall Study|Other adverse event|0|||
160867334|NCT00998296|580906830|FG003|Overall Study|Other adverse event|0|||
160867335|NCT00998296|580906831|FG004|Overall Study|Other adverse event|1|||
160867336|NCT00998296|580906832|FG005|Overall Study|Other adverse event|0|||
160867337|NCT00998296|580906833|FG006|Overall Study|Other adverse event|0|||
160867338|NCT00998296|580906834|FG007|Overall Study|Other adverse event|0|||
160867339|NCT00998296|580906835|FG008|Overall Study|Other adverse event|0|||
160867340|NCT00998296|580906836|FG009|Overall Study|Other adverse event|1|||
160867341|NCT00998296|580906837|FG010|Overall Study|Other adverse event|2|||
160867342|NCT00998296|580906827|FG000|Overall Study|Refused to continue taking trial med.|0|||
160867343|NCT00998296|580906828|FG001|Overall Study|Refused to continue taking trial med.|0|||
160867344|NCT00998296|580906829|FG002|Overall Study|Refused to continue taking trial med.|0|||
160867345|NCT00998296|580906830|FG003|Overall Study|Refused to continue taking trial med.|0|||
160867346|NCT00998296|580906831|FG004|Overall Study|Refused to continue taking trial med.|0|||
160867347|NCT00998296|580906832|FG005|Overall Study|Refused to continue taking trial med.|0|||
160867348|NCT00998296|580906833|FG006|Overall Study|Refused to continue taking trial med.|0|||
160867349|NCT00998296|580906834|FG007|Overall Study|Refused to continue taking trial med.|0|||
160867350|NCT00998296|580906835|FG008|Overall Study|Refused to continue taking trial med.|0|||
160867351|NCT00998296|580906836|FG009|Overall Study|Refused to continue taking trial med.|2|||
160867352|NCT00998296|580906837|FG010|Overall Study|Refused to continue taking trial med.|0|||
160867353|NCT00998296|580906827|FG000|Overall Study|Reason other than those specified above|0|||
160867354|NCT00998296|580906828|FG001|Overall Study|Reason other than those specified above|0|||
160867355|NCT00998296|580906829|FG002|Overall Study|Reason other than those specified above|0|||
160867356|NCT00998296|580906830|FG003|Overall Study|Reason other than those specified above|0|||
160867357|NCT00998296|580906831|FG004|Overall Study|Reason other than those specified above|0|||
160867358|NCT00998296|580906832|FG005|Overall Study|Reason other than those specified above|0|||
160867359|NCT00998296|580906833|FG006|Overall Study|Reason other than those specified above|0|||
160867360|NCT00998296|580906834|FG007|Overall Study|Reason other than those specified above|0|||
160867361|NCT00998296|580906835|FG008|Overall Study|Reason other than those specified above|0|||
160867362|NCT00998296|580906836|FG009|Overall Study|Reason other than those specified above|1|||
160867363|NCT00998296|580906837|FG010|Overall Study|Reason other than those specified above|0|||
160867364|NCT04396639|580906840|FG000|Overall Study|Withdrawal by Subject|1|||
160867365|NCT04396639|580906840|FG000|Overall Study|Other|1|||
160867366|NCT01544335|580906841|FG000|Overall Study|Lost to Follow-up|27|||
160867367|NCT01544335|580906841|FG000|Overall Study|Death|4|||
160867368|NCT01544335|580906841|FG000|Overall Study|Disease progression|3|||
160867369|NCT01544335|580906841|FG000|Overall Study|Baseline Measurements not Available|19|||
160867370|NCT01532986|580906842|FG000|Overall Study|Death|9|||
160867371|NCT01532986|580906843|FG001|Overall Study|Death|9|||
160867372|NCT01532986|580906842|FG000|Overall Study|Withdrawal by Subject|7|||
160867373|NCT01532986|580906843|FG001|Overall Study|Withdrawal by Subject|10|||
160867374|NCT01532986|580906842|FG000|Overall Study|Physician Decision|7|||
160867375|NCT01532986|580906843|FG001|Overall Study|Physician Decision|5|||
160867376|NCT00885170|580906846|FG000|Overall Study|Adverse Event|12|||
160867377|NCT00885170|580906847|FG001|Overall Study|Adverse Event|4|||
160867378|NCT00885170|580906846|FG000|Overall Study|Excessive bone loss|6|||
160867379|NCT00885170|580906847|FG001|Overall Study|Excessive bone loss|3|||
160867380|NCT00885170|580906846|FG000|Overall Study|Lost to Follow-up|2|||
160867381|NCT00885170|580906847|FG001|Overall Study|Lost to Follow-up|1|||
160867382|NCT00885170|580906846|FG000|Overall Study|Physician Decision|2|||
160867383|NCT00885170|580906847|FG001|Overall Study|Physician Decision|1|||
160867384|NCT00885170|580906846|FG000|Overall Study|Protocol Violation|3|||
160867385|NCT00885170|580906847|FG001|Overall Study|Protocol Violation|1|||
160867386|NCT00885170|580906846|FG000|Overall Study|Withdrawal by Subject|13|||
160867387|NCT00885170|580906847|FG001|Overall Study|Withdrawal by Subject|13|||
160867388|NCT03771664|580906848|FG000|Overall Study|Adverse Event|1|||
160867389|NCT03771664|580906849|FG001|Overall Study|Adverse Event|0|||
160867390|NCT03771664|580906848|FG000|Overall Study|Lost to Follow-up|1|||
160867391|NCT03771664|580906849|FG001|Overall Study|Lost to Follow-up|0|||
160867392|NCT03771664|580906848|FG000|Overall Study|Withdrawal by Participant|1|||
160867393|NCT03771664|580906849|FG001|Overall Study|Withdrawal by Participant|4|||
160867394|NCT03771664|580906848|FG000|Overall Study|Randomized but not Treated|0|||
160867395|NCT03771664|580906849|FG001|Overall Study|Randomized but not Treated|1|||
160867396|NCT02120898|580906850|FG000|Overall Study|Withdrawal by Subject|4|||
160867397|NCT02120898|580906851|FG001|Overall Study|Withdrawal by Subject|2|||
160867398|NCT02120898|580906852|FG002|Overall Study|Withdrawal by Subject|2|||
160867399|NCT02120898|580906850|FG000|Overall Study|Non-compliance with study drug|3|||
160867400|NCT02120898|580906851|FG001|Overall Study|Non-compliance with study drug|0|||
160867401|NCT02120898|580906852|FG002|Overall Study|Non-compliance with study drug|0|||
160867402|NCT02120898|580906850|FG000|Overall Study|Adverse Event|1|||
160867403|NCT02120898|580906851|FG001|Overall Study|Adverse Event|2|||
160867404|NCT02120898|580906852|FG002|Overall Study|Adverse Event|1|||
160867405|NCT02120898|580906850|FG000|Overall Study|Protocol Violation|1|||
160867406|NCT02120898|580906851|FG001|Overall Study|Protocol Violation|2|||
160867407|NCT02120898|580906852|FG002|Overall Study|Protocol Violation|0|||
160867408|NCT02120898|580906850|FG000|Overall Study|Lost to Follow-up|0|||
160867409|NCT02120898|580906851|FG001|Overall Study|Lost to Follow-up|0|||
160763227|NCT01673178|580522951|FG003|Overall Study|Withdrawal by Subject|4|||
160763228|NCT01673178|580522952|FG004|Overall Study|Withdrawal by Subject|2|||
160763229|NCT01673178|580522948|FG000|Overall Study|Protocol Violation|1|||
160763230|NCT01673178|580522949|FG001|Overall Study|Protocol Violation|1|||
160763231|NCT01673178|580522950|FG002|Overall Study|Protocol Violation|0|||
160763232|NCT01673178|580522951|FG003|Overall Study|Protocol Violation|1|||
160763233|NCT01673178|580522952|FG004|Overall Study|Protocol Violation|0|||
160763234|NCT01673178|580522948|FG000|Overall Study|Adverse Event|1|||
160763235|NCT01673178|580522949|FG001|Overall Study|Adverse Event|0|||
160763236|NCT01673178|580522950|FG002|Overall Study|Adverse Event|0|||
160763237|NCT01673178|580522951|FG003|Overall Study|Adverse Event|2|||
160763238|NCT01673178|580522952|FG004|Overall Study|Adverse Event|0|||
160763239|NCT01673178|580522948|FG000|Overall Study|Other|1|||
160763240|NCT01673178|580522949|FG001|Overall Study|Other|0|||
160763241|NCT01673178|580522950|FG002|Overall Study|Other|2|||
160763242|NCT01673178|580522951|FG003|Overall Study|Other|1|||
160763243|NCT01673178|580522952|FG004|Overall Study|Other|0|||
160763244|NCT03177148|580522953|FG000|Overall Study|Lost to Follow-up|50|||
160763245|NCT03177148|580522954|FG001|Overall Study|Lost to Follow-up|1|||
160763246|NCT03177148|580522953|FG000|Overall Study|Death|1|||
160763247|NCT03177148|580522954|FG001|Overall Study|Death|0|||
160763248|NCT02557399|580522955|FG000|Overall Study|Adverse Event|6|||
160763249|NCT02557399|580522956|FG001|Overall Study|Adverse Event|5|||
160763250|NCT02557399|580522955|FG000|Overall Study|Protocol Violation|0|||
160763251|NCT02557399|580522956|FG001|Overall Study|Protocol Violation|1|||
160763252|NCT02557399|580522955|FG000|Overall Study|Protocol-defined stopping criteria|0|||
160763253|NCT02557399|580522956|FG001|Overall Study|Protocol-defined stopping criteria|1|||
160763254|NCT02557399|580522955|FG000|Overall Study|Withdrawal by Subject|1|||
160763255|NCT02557399|580522956|FG001|Overall Study|Withdrawal by Subject|1|||
160763256|NCT00780975|580522972|FG000|Overall Study|Progressive disease|3|||
160763257|NCT00780975|580522972|FG000|Overall Study|Toxicity|5|||
160763258|NCT00887484|580522976|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
160763259|NCT00887484|580522976|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
160763260|NCT00887484|580522976|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
160763261|NCT03122171|580522977|FG000|Overall Study|Withdrawal by Subject|1|||
160763262|NCT03044314|580522978|FG000|Overall Study|Physician Decision|2|||
160763263|NCT03044314|580522978|FG000|Overall Study|Withdrawal by Subject|1|||
160763264|NCT03044314|580522978|FG000|Overall Study|Connector tubing not available|1|||
160763265|NCT01316224|580522979|FG000|Overall Study|Protocol Violation|3|||
160763266|NCT01316224|580522979|FG000|Overall Study|Adverse Event|3|||
160763267|NCT01316224|580522979|FG000|Overall Study|Lack of Efficacy|1|||
160763268|NCT01316224|580522979|FG000|Overall Study|Withdrawal by Subject|1|||
160763269|NCT01316224|580522979|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
160763270|NCT01316224|580522979|FG000|Overall Study|Other|1|||
160763271|NCT03106077|580522982|FG000|Overall Study|Screen Failure|94|||
160763272|NCT03106077|580522983|FG001|Overall Study|Screen Failure|0|||
160763273|NCT00449163|580522984|FG000|Overall Study|Physician Decision|3|||
160763274|NCT00606307|580522989|FG000|Overall Study|Adverse Event|2|||
160763275|NCT00606307|580522989|FG000|Overall Study|Withdrawal by Subject|2|||
160763276|NCT00606307|580522989|FG000|Overall Study|Disease progression|6|||
160763277|NCT00606307|580522989|FG000|Overall Study|QTc prolongation|1|||
160763278|NCT01274533|580522990|FG000|Overall Study|Withdrawal by Subject|1|||
160763279|NCT01274533|580522990|FG000|Overall Study|Non-compliance|1|||
160763280|NCT01274533|580522990|FG000|Overall Study|Disease progression|2|||
160763281|NCT03368807|580522991|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
160763282|NCT03368807|580522991|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
160763283|NCT03368807|580522991|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
160763284|NCT03368807|580522991|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
160867410|NCT02120898|580906852|FG002|Overall Study|Lost to Follow-up|1|||
160867411|NCT00561925|580906853|FG000|14 Day Lead-In Period|Adverse Event|38|||
160867412|NCT00561925|580906854|FG001|14 Day Lead-In Period|Adverse Event|0|||
160867413|NCT00561925|580906855|FG002|14 Day Lead-In Period|Adverse Event|0|||
160867414|NCT00561925|580906856|FG003|14 Day Lead-In Period|Adverse Event|0|||
160867415|NCT00561925|580906857|FG004|14 Day Lead-In Period|Adverse Event|0|||
160867416|NCT00561925|580906853|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
160867417|NCT00561925|580906854|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
160867418|NCT00561925|580906855|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
160867419|NCT00561925|580906856|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
160867420|NCT00561925|580906857|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
160867421|NCT00561925|580906853|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
160527152|NCT01233869|579660902|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
160527153|NCT01233869|579660903|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
160527154|NCT01233869|579660904|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
160527155|NCT01233869|579660901|FG000|Extended Treatment Period (46 Months)|Other|3|||
160527156|NCT01233869|579660902|FG001|Extended Treatment Period (46 Months)|Other|0|||
160527157|NCT01233869|579660903|FG002|Extended Treatment Period (46 Months)|Other|0|||
160867422|NCT00561925|580906854|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
160867423|NCT00561925|580906855|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
160867424|NCT00561925|580906856|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
160867425|NCT00561925|580906857|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
160867426|NCT00561925|580906853|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
160867427|NCT00561925|580906854|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
160867428|NCT00561925|580906855|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
160867429|NCT00561925|580906856|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
160867430|NCT00561925|580906857|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
160867431|NCT00561925|580906853|FG000|14 Day Lead-In Period|Other|5|||
160867432|NCT00561925|580906854|FG001|14 Day Lead-In Period|Other|0|||
160867433|NCT00561925|580906855|FG002|14 Day Lead-In Period|Other|0|||
160867434|NCT00561925|580906856|FG003|14 Day Lead-In Period|Other|0|||
160867435|NCT00561925|580906857|FG004|14 Day Lead-In Period|Other|0|||
160867436|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
160867437|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
160867438|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
160867439|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
160867440|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
160867441|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
160867442|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
160867443|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
160867444|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
160867445|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
160867446|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
160867447|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
160867448|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
160867449|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
160867450|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
160867451|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
160867452|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
160867453|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
160867454|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
160867455|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
160867456|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
160867457|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
160867458|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
160867459|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
160867460|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
160867461|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
160867462|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
160867463|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
160867464|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
160867465|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
160867466|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Death|0|||
160867467|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Death|6|||
160867468|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Death|3|||
160867469|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Death|0|||
160867470|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Death|0|||
160867471|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
160867472|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
160867473|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
160867474|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
160867475|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
160867476|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Other|0|||
160763285|NCT02563899|580522992|FG000|Overall Study|Protocol Violation|1|||
160763286|NCT02563899|580522993|FG001|Overall Study|Protocol Violation|0|||
160763287|NCT02563899|580522994|FG002|Overall Study|Protocol Violation|0|||
160763288|NCT02563899|580522995|FG003|Overall Study|Protocol Violation|0|||
160763289|NCT02563899|580522992|FG000|Overall Study|Withdrawal by Subject|0|||
160763290|NCT02563899|580522993|FG001|Overall Study|Withdrawal by Subject|0|||
160763291|NCT02563899|580522994|FG002|Overall Study|Withdrawal by Subject|1|||
160763292|NCT02563899|580522995|FG003|Overall Study|Withdrawal by Subject|0|||
160867477|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Other|8|||
160867478|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Other|11|||
160867479|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Other|0|||
160867480|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Other|0|||
160867481|NCT00561925|580906853|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
160867482|NCT00561925|580906854|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
160867483|NCT00561925|580906855|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
160867484|NCT00561925|580906856|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
160867485|NCT00561925|580906857|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
160867486|NCT00684021|580906858|FG000|Overall Study|MRI Contraindicated|1|||
160867487|NCT00684021|580906859|FG001|Overall Study|MRI Contraindicated|1|||
160867488|NCT00684021|580906860|FG002|Overall Study|MRI Contraindicated|1|||
160867489|NCT00684021|580906861|FG003|Overall Study|MRI Contraindicated|0|||
160867490|NCT00684021|580906858|FG000|Overall Study|MRI not performed|0|||
160867491|NCT00684021|580906859|FG001|Overall Study|MRI not performed|1|||
160867492|NCT00684021|580906860|FG002|Overall Study|MRI not performed|1|||
160867493|NCT00684021|580906861|FG003|Overall Study|MRI not performed|2|||
160867494|NCT00684021|580906858|FG000|Overall Study|Death|1|||
160867495|NCT00684021|580906859|FG001|Overall Study|Death|0|||
160867496|NCT00684021|580906860|FG002|Overall Study|Death|0|||
160867497|NCT00684021|580906861|FG003|Overall Study|Death|0|||
160867498|NCT02161016|580906865|FG000|Overall Study|withdrawn by IRB|1|||
160867499|NCT02556177|580906869|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
160867500|NCT02556177|580906870|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
160867501|NCT03818321|580906873|FG000|Overall Study|Withdrawal by Subject|1|||
160867502|NCT03818321|580906874|FG001|Overall Study|Withdrawal by Subject|2|||
160867503|NCT00275509|580906875|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
160867504|NCT00275509|580906876|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
160867505|NCT00380367|580906878|FG000|Overall Study|Lost to Follow-up|1|||
160867506|NCT00380367|580906878|FG000|Overall Study|Withdrawal by Subject|1|||
160867507|NCT01812252|580906886|FG000|Overall Study|Persistent Disease|1|||
160867508|NCT01812252|580906887|FG001|Overall Study|Persistent Disease|0|||
160867509|NCT01812252|580906886|FG000|Overall Study|Not transplanted|11|||
160867510|NCT01812252|580906887|FG001|Overall Study|Not transplanted|11|||
160867511|NCT01812252|580906886|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
160867512|NCT01812252|580906887|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
160867513|NCT01812252|580906886|FG000|Overall Study|Withdrawal by Subject|1|||
160763293|NCT03669588|580523009|FG000|Overall Study|Adverse Event|1|||
160763294|NCT03669588|580523010|FG001|Overall Study|Adverse Event|0|||
160763295|NCT03669588|580523009|FG000|Overall Study|Physician Decision|0|||
160763296|NCT03669588|580523010|FG001|Overall Study|Physician Decision|1|||
160867514|NCT01812252|580906887|FG001|Overall Study|Withdrawal by Subject|1|||
160867515|NCT01812252|580906886|FG000|Overall Study|Screen Failure|1|||
160867516|NCT01812252|580906887|FG001|Overall Study|Screen Failure|0|||
160867517|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
160867518|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
160867519|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
160867520|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
160636407|NCT01954082|580051540|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
160636408|NCT01954082|580051541|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
160636409|NCT01954082|580051540|FG000|Overall Study|Redirection of Care|0|||
160636410|NCT01954082|580051541|FG001|Overall Study|Redirection of Care|2|||
160636411|NCT01954082|580051540|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
160636412|NCT01954082|580051541|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
160636413|NCT01954082|580051540|FG000|Overall Study|Comfort Care|0|||
160763297|NCT03669588|580523009|FG000|Overall Study|Protocol Violation|1|||
160867521|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
160867522|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
160867523|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
160867524|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
160867525|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
160867526|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
160867527|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
160867528|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
160867529|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
160867530|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
160867531|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
160867532|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
160867533|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
160763298|NCT03669588|580523010|FG001|Overall Study|Protocol Violation|0|||
160763299|NCT03669588|580523009|FG000|Overall Study|Sponsor Decision|1|||
160763300|NCT03669588|580523010|FG001|Overall Study|Sponsor Decision|1|||
160763301|NCT03669588|580523009|FG000|Overall Study|Withdrawal by Subject|1|||
160763302|NCT03669588|580523010|FG001|Overall Study|Withdrawal by Subject|4|||
160763303|NCT03669588|580523009|FG000|Overall Study|Rescue Therapy Needed|0|||
160763304|NCT03669588|580523010|FG001|Overall Study|Rescue Therapy Needed|1|||
160763305|NCT02008526|580523011|FG000|Overall Study|Death|0|||
160763306|NCT02008526|580523012|FG001|Overall Study|Death|2|||
160763307|NCT02008526|580523013|FG002|Overall Study|Death|1|||
160763308|NCT02008526|580523011|FG000|Overall Study|Withdrawal by Subject|3|||
160763309|NCT02008526|580523012|FG001|Overall Study|Withdrawal by Subject|3|||
160763310|NCT02008526|580523013|FG002|Overall Study|Withdrawal by Subject|2|||
160763311|NCT02008526|580523011|FG000|Overall Study|Lost to Follow-up|5|||
160763312|NCT02008526|580523012|FG001|Overall Study|Lost to Follow-up|9|||
160763313|NCT02008526|580523013|FG002|Overall Study|Lost to Follow-up|6|||
160763314|NCT00369343|580523024|FG000|Double-blind Phase|Adverse Event|19|||
160763315|NCT00369343|580523025|FG001|Double-blind Phase|Adverse Event|4|||
160763316|NCT00369343|580523024|FG000|Double-blind Phase|Failed to return|2|||
160763317|NCT00369343|580523025|FG001|Double-blind Phase|Failed to return|0|||
160763318|NCT00369343|580523024|FG000|Double-blind Phase|Lost to Follow-up|9|||
160763319|NCT00369343|580523025|FG001|Double-blind Phase|Lost to Follow-up|2|||
160763320|NCT00369343|580523024|FG000|Double-blind Phase|Protocol Violation|2|||
160763321|NCT00369343|580523025|FG001|Double-blind Phase|Protocol Violation|0|||
160763322|NCT00369343|580523024|FG000|Double-blind Phase|Withdrawal by Subject|8|||
160763323|NCT00369343|580523025|FG001|Double-blind Phase|Withdrawal by Subject|6|||
160763324|NCT00369343|580523024|FG000|Double-blind Phase|Lack of Efficacy|0|||
160763325|NCT00369343|580523025|FG001|Double-blind Phase|Lack of Efficacy|4|||
160763326|NCT00369343|580523024|FG000|Double-blind Phase|Protocol deviation|4|||
160763327|NCT00369343|580523025|FG001|Double-blind Phase|Protocol deviation|0|||
160763328|NCT00369343|580523024|FG000|Open-label Phase|Adverse Event|19|||
160763329|NCT00369343|580523025|FG001|Open-label Phase|Adverse Event|7|||
160763330|NCT00369343|580523024|FG000|Open-label Phase|Failed to return|4|||
160763331|NCT00369343|580523025|FG001|Open-label Phase|Failed to return|0|||
160763332|NCT00369343|580523024|FG000|Open-label Phase|Physician Decision|2|||
160763333|NCT00369343|580523025|FG001|Open-label Phase|Physician Decision|0|||
160763334|NCT00369343|580523024|FG000|Open-label Phase|Lost to Follow-up|5|||
160763335|NCT00369343|580523025|FG001|Open-label Phase|Lost to Follow-up|3|||
160763336|NCT00369343|580523024|FG000|Open-label Phase|inadvertently reported study completers|3|||
160763337|NCT00369343|580523025|FG001|Open-label Phase|inadvertently reported study completers|2|||
160763338|NCT00369343|580523024|FG000|Open-label Phase|Protocol Violation|1|||
160763339|NCT00369343|580523025|FG001|Open-label Phase|Protocol Violation|3|||
160763340|NCT00369343|580523024|FG000|Open-label Phase|Withdrawal by Subject|15|||
160763341|NCT00369343|580523025|FG001|Open-label Phase|Withdrawal by Subject|6|||
160763342|NCT00369343|580523024|FG000|Open-label Phase|Lack of Efficacy|4|||
160763343|NCT00369343|580523025|FG001|Open-label Phase|Lack of Efficacy|3|||
160763344|NCT00369343|580523024|FG000|Open-label Phase|Lack of continuance tolerability|3|||
160763345|NCT00369343|580523025|FG001|Open-label Phase|Lack of continuance tolerability|4|||
160763346|NCT00369343|580523024|FG000|Open-label Phase|did not take study drug|1|||
160763347|NCT00369343|580523025|FG001|Open-label Phase|did not take study drug|2|||
160763348|NCT00073918|580523028|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
160763349|NCT00073918|580523028|FG000|Overall Study|Rapid disease progression|2|||
160867534|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
160867535|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
160763350|NCT00073918|580523028|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
160763351|NCT01190813|580523031|FG000|Overall Study|Lost to Follow-up|1|||
160763352|NCT01190813|580523032|FG001|Overall Study|Lost to Follow-up|2|||
160763353|NCT01190813|580523031|FG000|Overall Study|Withdrawal by Subject|2|||
160763354|NCT01190813|580523032|FG001|Overall Study|Withdrawal by Subject|1|||
160763355|NCT01190813|580523031|FG000|Overall Study|Refused study treatment after randomized|1|||
160763356|NCT01190813|580523032|FG001|Overall Study|Refused study treatment after randomized|0|||
160763357|NCT01190813|580523031|FG000|Overall Study|Adverse Event|0|||
160763358|NCT01190813|580523032|FG001|Overall Study|Adverse Event|1|||
160763359|NCT02033759|580523033|FG000|Overall Study|Withdrawal by Subject|2|||
160763360|NCT02033759|580523034|FG001|Overall Study|Withdrawal by Subject|1|||
160763361|NCT02033759|580523033|FG000|Overall Study|Protocol Violation|1|||
160763362|NCT02033759|580523034|FG001|Overall Study|Protocol Violation|1|||
160763363|NCT04821830|580523040|FG000|Overall Study|Withdrawal by Subject|1|||
160763364|NCT04821830|580523041|FG001|Overall Study|Withdrawal by Subject|0|||
160763365|NCT03810456|580523043|FG000|Treatment|Urgent Family Matters|3|||
160763366|NCT03810456|580523044|FG001|Treatment|Urgent Family Matters|0|||
160763367|NCT03810456|580523045|FG002|Treatment|Urgent Family Matters|0|||
160763368|NCT03810456|580523043|FG000|Treatment|Scheduling Conflicts|0|||
160763369|NCT03810456|580523044|FG001|Treatment|Scheduling Conflicts|11|||
160763370|NCT03810456|580523045|FG002|Treatment|Scheduling Conflicts|0|||
160763371|NCT03810456|580523043|FG000|Treatment|No Longer Interested|0|||
160763372|NCT03810456|580523044|FG001|Treatment|No Longer Interested|12|||
160763373|NCT03810456|580523045|FG002|Treatment|No Longer Interested|0|||
160763374|NCT03810456|580523043|FG000|Treatment|Transportation Issues|0|||
160763375|NCT03810456|580523044|FG001|Treatment|Transportation Issues|1|||
160763376|NCT03810456|580523045|FG002|Treatment|Transportation Issues|0|||
160763377|NCT03810456|580523043|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
160763378|NCT03810456|580523044|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
160763379|NCT03810456|580523045|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
160763380|NCT03810456|580523043|FG000|1 Month Follow-Up|Relocated to Different State|1|||
160763381|NCT03810456|580523044|FG001|1 Month Follow-Up|Relocated to Different State|0|||
160763382|NCT03810456|580523045|FG002|1 Month Follow-Up|Relocated to Different State|1|||
160763383|NCT03810456|580523043|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
160763384|NCT03810456|580523044|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
160763385|NCT03810456|580523045|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
160763386|NCT03810456|580523043|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
160763387|NCT03810456|580523044|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
160763388|NCT03810456|580523045|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
160763389|NCT03810456|580523043|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
160763390|NCT03810456|580523044|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
160763391|NCT03810456|580523045|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
160763392|NCT03810456|580523043|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
160763393|NCT03810456|580523044|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
160763394|NCT03810456|580523045|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
160763395|NCT03810456|580523043|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
160763396|NCT03810456|580523044|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
160763397|NCT03810456|580523045|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
160763398|NCT00490919|580523046|FG000|Open-label Run-in Period|Adverse Event|239|||
160763399|NCT00490919|580523047|FG001|Open-label Run-in Period|Adverse Event|0|||
160763400|NCT00490919|580523048|FG002|Open-label Run-in Period|Adverse Event|0|||
160763401|NCT00490919|580523046|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
160763402|NCT00490919|580523047|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
160763403|NCT00490919|580523048|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
160763404|NCT00490919|580523046|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
160763405|NCT00490919|580523047|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
160763406|NCT00490919|580523048|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
160763407|NCT00490919|580523046|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
160763408|NCT00490919|580523047|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
160763409|NCT00490919|580523048|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
160763410|NCT00490919|580523046|FG000|Open-label Run-in Period|Administrative|40|||
160763411|NCT00490919|580523047|FG001|Open-label Run-in Period|Administrative|0|||
160763412|NCT00490919|580523048|FG002|Open-label Run-in Period|Administrative|0|||
160763413|NCT00490919|580523046|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
160763414|NCT00490919|580523047|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
160763415|NCT00490919|580523048|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
160763416|NCT00490919|580523046|FG000|Double-blind Phase|Adverse Event|0|||
160763417|NCT00490919|580523047|FG001|Double-blind Phase|Adverse Event|40|||
160763418|NCT00490919|580523048|FG002|Double-blind Phase|Adverse Event|20|||
160763419|NCT00490919|580523046|FG000|Double-blind Phase|Withdrawal by Subject|0|||
160763420|NCT00490919|580523047|FG001|Double-blind Phase|Withdrawal by Subject|10|||
160763421|NCT00490919|580523048|FG002|Double-blind Phase|Withdrawal by Subject|11|||
160763422|NCT00490919|580523046|FG000|Double-blind Phase|Lost to Follow-up|0|||
160763423|NCT00490919|580523047|FG001|Double-blind Phase|Lost to Follow-up|8|||
160763424|NCT00490919|580523048|FG002|Double-blind Phase|Lost to Follow-up|11|||
160763425|NCT00490919|580523046|FG000|Double-blind Phase|Lack of Efficacy|0|||
160763426|NCT00490919|580523047|FG001|Double-blind Phase|Lack of Efficacy|22|||
160763427|NCT00490919|580523048|FG002|Double-blind Phase|Lack of Efficacy|36|||
160763428|NCT00490919|580523046|FG000|Double-blind Phase|Administrative|0|||
160867536|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
160867537|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
160527158|NCT01233869|579660904|FG003|Extended Treatment Period (46 Months)|Other|3|||
160527159|NCT01233869|579660901|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
160527160|NCT01233869|579660902|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
160527161|NCT01233869|579660903|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
160527162|NCT01233869|579660904|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
160763429|NCT00490919|580523047|FG001|Double-blind Phase|Administrative|6|||
160763430|NCT00490919|580523048|FG002|Double-blind Phase|Administrative|6|||
160763431|NCT04350827|580523053|FG000|Overall Study|Lost to Follow-up|1|||
160763432|NCT04350827|580523054|FG001|Overall Study|Lost to Follow-up|2|||
160763433|NCT04265261|580523055|FG000|Overall Study|Adverse Event|2|||
160763434|NCT04265261|580523056|FG001|Overall Study|Adverse Event|0|||
160763435|NCT04265261|580523057|FG002|Overall Study|Adverse Event|0|||
160763436|NCT04265261|580523055|FG000|Overall Study|Death|1|||
160763437|NCT04265261|580523056|FG001|Overall Study|Death|0|||
160763438|NCT04265261|580523057|FG002|Overall Study|Death|0|||
160763439|NCT04265261|580523055|FG000|Overall Study|Lost to Follow-up|4|||
160763440|NCT04265261|580523056|FG001|Overall Study|Lost to Follow-up|1|||
160763441|NCT04265261|580523057|FG002|Overall Study|Lost to Follow-up|3|||
160763442|NCT04265261|580523055|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160763443|NCT04265261|580523056|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160763444|NCT04265261|580523057|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160763445|NCT04265261|580523055|FG000|Overall Study|Physician Decision|0|||
160763446|NCT04265261|580523056|FG001|Overall Study|Physician Decision|0|||
160763447|NCT04265261|580523057|FG002|Overall Study|Physician Decision|1|||
160763448|NCT04265261|580523055|FG000|Overall Study|Protocol Deviation|0|||
160763449|NCT04265261|580523056|FG001|Overall Study|Protocol Deviation|2|||
160763450|NCT04265261|580523057|FG002|Overall Study|Protocol Deviation|0|||
160763451|NCT04265261|580523055|FG000|Overall Study|Withdrawal by Subject|2|||
160763452|NCT04265261|580523056|FG001|Overall Study|Withdrawal by Subject|1|||
160763453|NCT04265261|580523057|FG002|Overall Study|Withdrawal by Subject|4|||
160763454|NCT02337491|580524671|FG000|Overall Study|Death|1|||
160763455|NCT02337491|580524672|FG001|Overall Study|Death|1|||
160763456|NCT02337491|580524671|FG000|Overall Study|Adverse Event|0|||
160763457|NCT02337491|580524672|FG001|Overall Study|Adverse Event|1|||
160763458|NCT02337491|580524671|FG000|Overall Study|Withdrawal by Subject|3|||
160763459|NCT02337491|580524672|FG001|Overall Study|Withdrawal by Subject|0|||
160763460|NCT02337491|580524671|FG000|Overall Study|Progressive Disease|44|||
160763461|NCT02337491|580524672|FG001|Overall Study|Progressive Disease|28|||
160763462|NCT02337491|580524671|FG000|Overall Study|On Treatment|2|||
160763463|NCT02337491|580524672|FG001|Overall Study|On Treatment|0|||
160763464|NCT00723229|580524673|FG000|First Intervention|Lost to Follow-up|7|||
160763465|NCT00723229|580524674|FG001|First Intervention|Lost to Follow-up|3|||
160763466|NCT01432951|580524675|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
160763467|NCT02900352|580524676|FG000|Overall Study|Lost to Follow-up|28|||
160763468|NCT02900352|580524677|FG001|Overall Study|Lost to Follow-up|17|||
160763469|NCT00785356|580524679|FG000|Overall Study|Study prematurely terminated|8|||
160763470|NCT03712280|580524685|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
160763471|NCT03712280|580524686|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
160763472|NCT03712280|580524687|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
160763473|NCT03712280|580524688|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
160763474|NCT03712280|580524685|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
160763475|NCT03712280|580524686|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
160763476|NCT03712280|580524687|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
160763477|NCT03712280|580524688|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
160763478|NCT03712280|580524685|FG000|Overall Study|Adverse Event|0|||
160763479|NCT03712280|580524686|FG001|Overall Study|Adverse Event|0|||
160763480|NCT03712280|580524687|FG002|Overall Study|Adverse Event|1|||
160763481|NCT03712280|580524688|FG003|Overall Study|Adverse Event|0|||
160763482|NCT00106002|580524689|FG000|Overall Study|Did not take any study drug|1|||
160763483|NCT00106002|580524689|FG000|Overall Study|Ineligible after Registration|1|||
160763484|NCT01122173|580524694|FG000|Overall Study|Lost to Follow-up|3|||
160763485|NCT01122173|580524694|FG000|Overall Study|Withdrawal by Subject|3|||
160763486|NCT01122173|580524694|FG000|Overall Study|Left study for other reasons|3|||
160763487|NCT02265510|580524695|FG000|Overall Study|Withdrawal by Subject|1|||
160763488|NCT02265510|580524696|FG001|Overall Study|Withdrawal by Subject|1|||
160763489|NCT02265510|580524697|FG002|Overall Study|Withdrawal by Subject|2|||
160763490|NCT02265510|580524698|FG003|Overall Study|Withdrawal by Subject|1|||
160763491|NCT02265510|580524699|FG004|Overall Study|Withdrawal by Subject|0|||
160763492|NCT02265510|580524700|FG005|Overall Study|Withdrawal by Subject|2|||
160763493|NCT02265510|580524701|FG006|Overall Study|Withdrawal by Subject|0|||
160867538|NCT03739203|580906892|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
160763494|NCT02265510|580524702|FG007|Overall Study|Withdrawal by Subject|2|||
160636414|NCT01954082|580051541|FG001|Overall Study|Comfort Care|1|||
160763495|NCT02265510|580524703|FG008|Overall Study|Withdrawal by Subject|0|||
160763496|NCT02265510|580524704|FG009|Overall Study|Withdrawal by Subject|0|||
160763497|NCT02265510|580524705|FG010|Overall Study|Withdrawal by Subject|0|||
160763498|NCT02265510|580524706|FG011|Overall Study|Withdrawal by Subject|0|||
160763499|NCT02265510|580524707|FG012|Overall Study|Withdrawal by Subject|1|||
160763500|NCT02265510|580524708|FG013|Overall Study|Withdrawal by Subject|0|||
160763501|NCT02265510|580524695|FG000|Overall Study|Disease Progression|0|||
160763502|NCT02265510|580524696|FG001|Overall Study|Disease Progression|1|||
160763503|NCT02265510|580524697|FG002|Overall Study|Disease Progression|2|||
160763504|NCT02265510|580524698|FG003|Overall Study|Disease Progression|1|||
160763505|NCT02265510|580524699|FG004|Overall Study|Disease Progression|1|||
160763506|NCT02265510|580524700|FG005|Overall Study|Disease Progression|0|||
160763507|NCT02265510|580524701|FG006|Overall Study|Disease Progression|0|||
160763508|NCT02265510|580524702|FG007|Overall Study|Disease Progression|0|||
160763509|NCT02265510|580524703|FG008|Overall Study|Disease Progression|0|||
160763510|NCT02265510|580524704|FG009|Overall Study|Disease Progression|0|||
160763511|NCT02265510|580524705|FG010|Overall Study|Disease Progression|0|||
160763512|NCT02265510|580524706|FG011|Overall Study|Disease Progression|0|||
160763513|NCT02265510|580524707|FG012|Overall Study|Disease Progression|0|||
160763514|NCT02265510|580524708|FG013|Overall Study|Disease Progression|0|||
160763515|NCT02265510|580524695|FG000|Overall Study|Death|2|||
160867539|NCT03739203|580906893|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
160867540|NCT03739203|580906894|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
160867541|NCT03739203|580906892|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
160867542|NCT03739203|580906893|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
160867543|NCT03739203|580906894|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
160867544|NCT03739203|580906892|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
160867545|NCT03739203|580906893|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
160867546|NCT03739203|580906894|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
160867547|NCT03739203|580906892|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
160867548|NCT03739203|580906893|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
160867549|NCT03739203|580906894|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
160867550|NCT03023397|580906895|FG000|Run-In|Failed screening allergen challenge|1|||
160867551|NCT03023397|580906896|FG001|Run-In|Failed screening allergen challenge|0|||
160867552|NCT03023397|580906897|FG002|Run-In|Failed screening allergen challenge|0|||
160867553|NCT03023397|580906895|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
160867554|NCT03023397|580906896|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
160867555|NCT03023397|580906897|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
160867556|NCT01519921|580906901|FG000|Overall Study|Adverse Event|10|||
160867557|NCT01519921|580906902|FG001|Overall Study|Adverse Event|9|||
160867558|NCT01519921|580906901|FG000|Overall Study|Lack of Efficacy|4|||
160867559|NCT01519921|580906902|FG001|Overall Study|Lack of Efficacy|3|||
160867560|NCT01519921|580906901|FG000|Overall Study|Withdrawal by Subject|3|||
160867561|NCT01519921|580906902|FG001|Overall Study|Withdrawal by Subject|0|||
160867562|NCT01519921|580906901|FG000|Overall Study|Lost to Follow-up|2|||
160867563|NCT01519921|580906902|FG001|Overall Study|Lost to Follow-up|1|||
160867564|NCT01519921|580906901|FG000|Overall Study|Treatment refusal|2|||
160763516|NCT02265510|580524696|FG001|Overall Study|Death|0|||
160763517|NCT02265510|580524697|FG002|Overall Study|Death|2|||
160763518|NCT02265510|580524698|FG003|Overall Study|Death|2|||
160763519|NCT02265510|580524699|FG004|Overall Study|Death|1|||
160763520|NCT02265510|580524700|FG005|Overall Study|Death|3|||
160763521|NCT02265510|580524701|FG006|Overall Study|Death|2|||
160763522|NCT02265510|580524702|FG007|Overall Study|Death|1|||
160763523|NCT02265510|580524703|FG008|Overall Study|Death|3|||
160763524|NCT02265510|580524704|FG009|Overall Study|Death|3|||
160763525|NCT02265510|580524705|FG010|Overall Study|Death|4|||
160763526|NCT02265510|580524706|FG011|Overall Study|Death|12|||
160763527|NCT02265510|580524707|FG012|Overall Study|Death|7|||
160763528|NCT02265510|580524708|FG013|Overall Study|Death|6|||
160763529|NCT02265510|580524695|FG000|Overall Study|Lost to Follow-up|0|||
160763530|NCT02265510|580524696|FG001|Overall Study|Lost to Follow-up|0|||
160763531|NCT02265510|580524697|FG002|Overall Study|Lost to Follow-up|0|||
160763532|NCT02265510|580524698|FG003|Overall Study|Lost to Follow-up|0|||
160763533|NCT02265510|580524699|FG004|Overall Study|Lost to Follow-up|1|||
160763534|NCT02265510|580524700|FG005|Overall Study|Lost to Follow-up|0|||
160763535|NCT02265510|580524701|FG006|Overall Study|Lost to Follow-up|0|||
160763536|NCT02265510|580524702|FG007|Overall Study|Lost to Follow-up|0|||
160763537|NCT02265510|580524703|FG008|Overall Study|Lost to Follow-up|0|||
160763538|NCT02265510|580524704|FG009|Overall Study|Lost to Follow-up|2|||
160763539|NCT02265510|580524705|FG010|Overall Study|Lost to Follow-up|0|||
160763540|NCT02265510|580524706|FG011|Overall Study|Lost to Follow-up|0|||
160763541|NCT02265510|580524707|FG012|Overall Study|Lost to Follow-up|0|||
160763542|NCT02265510|580524708|FG013|Overall Study|Lost to Follow-up|2|||
160763543|NCT02265510|580524695|FG000|Overall Study|Other|0|||
160763544|NCT02265510|580524696|FG001|Overall Study|Other|1|||
160763545|NCT02265510|580524697|FG002|Overall Study|Other|0|||
160763546|NCT02265510|580524698|FG003|Overall Study|Other|0|||
160867565|NCT01519921|580906902|FG001|Overall Study|Treatment refusal|1|||
160867566|NCT01519921|580906901|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
160867567|NCT01519921|580906902|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
160867568|NCT00363480|580906903|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
160867569|NCT00363480|580906903|FG000|Overall Study|Adverse Event|4|||
160867570|NCT00363480|580906903|FG000|Overall Study|Lost to Follow-up|5|||
160867571|NCT00363480|580906903|FG000|Overall Study|Withdrawal by Subject|5|||
160867572|NCT00363480|580906903|FG000|Overall Study|Non-compliance of subject|1|||
160867573|NCT00363480|580906903|FG000|Overall Study|Participant discontinued on its own|1|||
160867574|NCT03133793|580906908|FG000|Overall Study|Withdrawal by Subject|0|||
160867575|NCT03133793|580906909|FG001|Overall Study|Withdrawal by Subject|4|||
160867576|NCT03133793|580906910|FG002|Overall Study|Withdrawal by Subject|2|||
160867577|NCT03133793|580906911|FG003|Overall Study|Withdrawal by Subject|4|||
160867578|NCT03133793|580906908|FG000|Overall Study|Lost to Follow-up|1|||
160867579|NCT03133793|580906909|FG001|Overall Study|Lost to Follow-up|0|||
160867580|NCT03133793|580906910|FG002|Overall Study|Lost to Follow-up|2|||
160867581|NCT03133793|580906911|FG003|Overall Study|Lost to Follow-up|0|||
160867582|NCT03133793|580906908|FG000|Overall Study|Death|0|||
160867583|NCT03133793|580906909|FG001|Overall Study|Death|0|||
160867584|NCT03133793|580906910|FG002|Overall Study|Death|0|||
160867585|NCT03133793|580906911|FG003|Overall Study|Death|1|||
160867586|NCT03486834|580906912|FG000|Overall Study|Withdrawal by Subject|46|||
160867587|NCT03486834|580906913|FG001|Overall Study|Withdrawal by Subject|46|||
160867588|NCT03486834|580906914|FG002|Overall Study|Withdrawal by Subject|52|||
160867589|NCT03486834|580906912|FG000|Overall Study|Adverse Event|8|||
160867590|NCT03486834|580906913|FG001|Overall Study|Adverse Event|7|||
160867591|NCT03486834|580906914|FG002|Overall Study|Adverse Event|0|||
160867592|NCT03486834|580906912|FG000|Overall Study|Lost to Follow-up|41|||
160867593|NCT03486834|580906913|FG001|Overall Study|Lost to Follow-up|24|||
160867594|NCT03486834|580906914|FG002|Overall Study|Lost to Follow-up|39|||
160867595|NCT03486834|580906912|FG000|Overall Study|Non-compliance with Study Drug|2|||
160867596|NCT03486834|580906913|FG001|Overall Study|Non-compliance with Study Drug|2|||
160867597|NCT03486834|580906914|FG002|Overall Study|Non-compliance with Study Drug|0|||
160867598|NCT03486834|580906912|FG000|Overall Study|Physician Decision|5|||
160867599|NCT03486834|580906913|FG001|Overall Study|Physician Decision|2|||
160867600|NCT03486834|580906914|FG002|Overall Study|Physician Decision|3|||
160867601|NCT03486834|580906912|FG000|Overall Study|Pregnancy|10|||
160867602|NCT03486834|580906913|FG001|Overall Study|Pregnancy|12|||
160867603|NCT03486834|580906914|FG002|Overall Study|Pregnancy|12|||
160867604|NCT03486834|580906912|FG000|Overall Study|Protocol Deviation|2|||
160867605|NCT03486834|580906913|FG001|Overall Study|Protocol Deviation|3|||
160867606|NCT03486834|580906914|FG002|Overall Study|Protocol Deviation|3|||
160867607|NCT03486834|580906912|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160867608|NCT03486834|580906913|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
160867609|NCT03486834|580906914|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
160867610|NCT03486834|580906912|FG000|Overall Study|Randomized but not treated|4|||
160867611|NCT03486834|580906913|FG001|Overall Study|Randomized but not treated|4|||
160867612|NCT03486834|580906914|FG002|Overall Study|Randomized but not treated|1|||
160867613|NCT00432172|580906916|FG000|Overall Study|Physician Decision|0|||
160867614|NCT00432172|580906917|FG001|Overall Study|Physician Decision|0|||
160867615|NCT00432172|580906918|FG002|Overall Study|Physician Decision|2|||
160867616|NCT00432172|580906919|FG003|Overall Study|Physician Decision|0|||
160867617|NCT00432172|580906916|FG000|Overall Study|Adverse Event|4|||
160867618|NCT00432172|580906917|FG001|Overall Study|Adverse Event|2|||
160867619|NCT00432172|580906918|FG002|Overall Study|Adverse Event|4|||
160867620|NCT00432172|580906919|FG003|Overall Study|Adverse Event|3|||
160867621|NCT00432172|580906916|FG000|Overall Study|Disease progression|0|||
160867622|NCT00432172|580906917|FG001|Overall Study|Disease progression|2|||
160867623|NCT00432172|580906918|FG002|Overall Study|Disease progression|5|||
160867624|NCT00432172|580906919|FG003|Overall Study|Disease progression|1|||
160867625|NCT00432172|580906916|FG000|Overall Study|Withdrawal by Subject|0|||
160867626|NCT00432172|580906917|FG001|Overall Study|Withdrawal by Subject|1|||
160867627|NCT00432172|580906918|FG002|Overall Study|Withdrawal by Subject|0|||
160867628|NCT00432172|580906919|FG003|Overall Study|Withdrawal by Subject|2|||
160867629|NCT00432172|580906916|FG000|Overall Study|No treatment received|2|||
160867630|NCT00432172|580906917|FG001|Overall Study|No treatment received|2|||
160867631|NCT00432172|580906918|FG002|Overall Study|No treatment received|0|||
160867632|NCT00432172|580906919|FG003|Overall Study|No treatment received|1|||
160867633|NCT02141204|580906920|FG000|Overall Study|Lost to Follow-up|2|||
160867634|NCT02141204|580906921|FG001|Overall Study|Lost to Follow-up|1|||
160867635|NCT02141204|580906920|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
160867636|NCT02141204|580906921|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
160867637|NCT02141204|580906920|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
160867638|NCT02141204|580906921|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
160867639|NCT02141204|580906920|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
160867640|NCT02141204|580906921|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
160763547|NCT02265510|580524699|FG004|Overall Study|Other|0|||
160763548|NCT02265510|580524700|FG005|Overall Study|Other|0|||
160763549|NCT02265510|580524701|FG006|Overall Study|Other|0|||
160763550|NCT02265510|580524702|FG007|Overall Study|Other|0|||
160763551|NCT02265510|580524703|FG008|Overall Study|Other|0|||
160763552|NCT02265510|580524704|FG009|Overall Study|Other|0|||
160763553|NCT02265510|580524705|FG010|Overall Study|Other|0|||
160763554|NCT02265510|580524706|FG011|Overall Study|Other|0|||
160763555|NCT02265510|580524707|FG012|Overall Study|Other|0|||
160763556|NCT02265510|580524708|FG013|Overall Study|Other|0|||
160763557|NCT02265510|580524695|FG000|Overall Study|Study Terminated by Sponsor|0|||
160763558|NCT02265510|580524696|FG001|Overall Study|Study Terminated by Sponsor|0|||
160763559|NCT02265510|580524697|FG002|Overall Study|Study Terminated by Sponsor|0|||
160763560|NCT02265510|580524698|FG003|Overall Study|Study Terminated by Sponsor|0|||
160763561|NCT02265510|580524699|FG004|Overall Study|Study Terminated by Sponsor|0|||
160763562|NCT02265510|580524700|FG005|Overall Study|Study Terminated by Sponsor|1|||
160763563|NCT02265510|580524701|FG006|Overall Study|Study Terminated by Sponsor|1|||
160763564|NCT02265510|580524702|FG007|Overall Study|Study Terminated by Sponsor|1|||
160763565|NCT02265510|580524703|FG008|Overall Study|Study Terminated by Sponsor|1|||
160763566|NCT02265510|580524704|FG009|Overall Study|Study Terminated by Sponsor|2|||
160763567|NCT02265510|580524705|FG010|Overall Study|Study Terminated by Sponsor|1|||
160763568|NCT02265510|580524706|FG011|Overall Study|Study Terminated by Sponsor|4|||
160763569|NCT02265510|580524707|FG012|Overall Study|Study Terminated by Sponsor|1|||
160763570|NCT02265510|580524708|FG013|Overall Study|Study Terminated by Sponsor|2|||
160763571|NCT02530385|580524709|FG000|Overall Study|Withdrawal by Subject|0|||
160763572|NCT02530385|580524710|FG001|Overall Study|Withdrawal by Subject|1|||
160763573|NCT00116142|580524711|FG000|Overall Study|Adverse Event|8|||
160763574|NCT00116142|580524712|FG001|Overall Study|Adverse Event|7|||
160763575|NCT00116142|580524711|FG000|Overall Study|Protocol Violation|2|||
160763576|NCT00116142|580524712|FG001|Overall Study|Protocol Violation|1|||
160763577|NCT00116142|580524711|FG000|Overall Study|Withdrawal by Subject|5|||
160763578|NCT00116142|580524712|FG001|Overall Study|Withdrawal by Subject|5|||
160763579|NCT00116142|580524711|FG000|Overall Study|Physician Decision|3|||
160763580|NCT00116142|580524712|FG001|Overall Study|Physician Decision|1|||
160763581|NCT00116142|580524711|FG000|Overall Study|Delayed Radiation Therapy|1|||
160763582|NCT00116142|580524712|FG001|Overall Study|Delayed Radiation Therapy|0|||
160763583|NCT00116142|580524711|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
160763584|NCT00116142|580524712|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
160763585|NCT00116142|580524711|FG000|Overall Study|Patient stopped due to depression|0|||
160763586|NCT00116142|580524712|FG001|Overall Study|Patient stopped due to depression|1|||
160763587|NCT00116142|580524711|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
160763588|NCT00116142|580524712|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
160763589|NCT00116142|580524711|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
160763590|NCT00116142|580524712|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
160763591|NCT00116142|580524711|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
160763592|NCT00116142|580524712|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
160763593|NCT03093181|580524714|FG000|Overall Study|Withdrawal by Subject|2|||
160763594|NCT03093181|580524715|FG001|Overall Study|Withdrawal by Subject|1|||
160763595|NCT03093181|580524716|FG002|Overall Study|Withdrawal by Subject|2|||
160763596|NCT03093181|580524714|FG000|Overall Study|Other (Not specified)|1|||
160763597|NCT03093181|580524715|FG001|Overall Study|Other (Not specified)|0|||
160763598|NCT03093181|580524716|FG002|Overall Study|Other (Not specified)|0|||
160763599|NCT03093181|580524714|FG000|Overall Study|Adverse Event|0|||
160763600|NCT03093181|580524715|FG001|Overall Study|Adverse Event|1|||
160763601|NCT03093181|580524716|FG002|Overall Study|Adverse Event|0|||
160763602|NCT03093181|580524714|FG000|Overall Study|Other (Protocol violation)|0|||
160763603|NCT03093181|580524715|FG001|Overall Study|Other (Protocol violation)|0|||
160763604|NCT03093181|580524716|FG002|Overall Study|Other (Protocol violation)|1|||
160763605|NCT04076917|580524717|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
160763606|NCT04076917|580524717|FG000|Overall Study|Study closure|13|||
160763607|NCT04076917|580524717|FG000|Overall Study|Physician Decision|3|||
160763608|NCT04076917|580524717|FG000|Overall Study|Death|1|||
160763609|NCT04076917|580524717|FG000|Overall Study|Lost to Follow-up|1|||
160763610|NCT04076917|580524717|FG000|Overall Study|Withdrawal by Subject|1|||
160763611|NCT04076917|580524717|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
160763612|NCT04210986|580524718|FG000|Overall Study|Lost to Follow-up|5|||
160763613|NCT04210986|580524719|FG001|Overall Study|Lost to Follow-up|2|||
160763614|NCT04210986|580524718|FG000|Overall Study|Withdrawal by Subject|3|||
160763615|NCT04210986|580524719|FG001|Overall Study|Withdrawal by Subject|1|||
160763616|NCT04210986|580524718|FG000|Overall Study|Protocol Violation|1|||
160763617|NCT04210986|580524719|FG001|Overall Study|Protocol Violation|1|||
160763618|NCT04210986|580524718|FG000|Overall Study|Physician Decision|0|||
160763619|NCT04210986|580524719|FG001|Overall Study|Physician Decision|1|||
160763620|NCT02378662|580524720|FG000|Overall Study|Early Discontinuation|2|||
160763621|NCT02378662|580524721|FG001|Overall Study|Early Discontinuation|0|||
160867641|NCT00515619|580906924|FG000|Overall Study|Adverse Event|34|||
160867642|NCT00515619|580906924|FG000|Overall Study|Lack of Efficacy|92|||
160867643|NCT00515619|580906924|FG000|Overall Study|Withdrawal by Subject|66|||
160867644|NCT00515619|580906924|FG000|Overall Study|Protocol Violation|3|||
160867645|NCT00515619|580906924|FG000|Overall Study|Lost to Follow-up|4|||
160867646|NCT00515619|580906924|FG000|Overall Study|Unsatisfactory compliance|6|||
160867647|NCT00515619|580906924|FG000|Overall Study|Other: Site discontinuing trials|2|||
160867648|NCT00515619|580906924|FG000|Overall Study|Other: Subject cannot attend visits|2|||
160867649|NCT00515619|580906924|FG000|Overall Study|Other: Subject required surgery|1|||
160867650|NCT00515619|580906924|FG000|Overall Study|Other: Subject moved to another country|1|||
160867651|NCT00515619|580906924|FG000|Overall Study|Other: Investigator decision|1|||
160867652|NCT00515619|580906924|FG000|Overall Study|Other: Subject became pregnant|1|||
160867653|NCT00515619|580906924|FG000|Overall Study|Other: Request from sponsor|1|||
160867654|NCT00515619|580906924|FG000|Overall Study|Other: Drug available on license|1|||
160867655|NCT00515619|580906924|FG000|Overall Study|Other: Subject interested in other AED|1|||
160867656|NCT02379091|580906925|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160867657|NCT02379091|580906926|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
160867658|NCT02379091|580906927|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
160867659|NCT02379091|580906928|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
160867660|NCT02379091|580906925|FG000|Overall Study|Principal Investigator Discretion|0|||
160867661|NCT02379091|580906926|FG001|Overall Study|Principal Investigator Discretion|1|||
160867662|NCT02379091|580906927|FG002|Overall Study|Principal Investigator Discretion|0|||
160867663|NCT02379091|580906928|FG003|Overall Study|Principal Investigator Discretion|0|||
160867664|NCT02379091|580906925|FG000|Overall Study|Lost to Follow-up|0|||
160867665|NCT02379091|580906926|FG001|Overall Study|Lost to Follow-up|0|||
160867666|NCT02379091|580906927|FG002|Overall Study|Lost to Follow-up|0|||
160867667|NCT02379091|580906928|FG003|Overall Study|Lost to Follow-up|1|||
160867668|NCT02379091|580906925|FG000|Overall Study|Voluntary Withdrawal|2|||
160867669|NCT02379091|580906926|FG001|Overall Study|Voluntary Withdrawal|5|||
160867670|NCT02379091|580906927|FG002|Overall Study|Voluntary Withdrawal|2|||
160867671|NCT02379091|580906928|FG003|Overall Study|Voluntary Withdrawal|4|||
160867672|NCT02379091|580906925|FG000|Overall Study|Study Termination|7|||
160867673|NCT02379091|580906926|FG001|Overall Study|Study Termination|2|||
160867674|NCT02379091|580906927|FG002|Overall Study|Study Termination|5|||
160867675|NCT02379091|580906928|FG003|Overall Study|Study Termination|8|||
160867676|NCT02379091|580906925|FG000|Overall Study|Lack of Efficacy|3|||
160867677|NCT02379091|580906926|FG001|Overall Study|Lack of Efficacy|0|||
160867678|NCT02379091|580906927|FG002|Overall Study|Lack of Efficacy|0|||
160867679|NCT02379091|580906928|FG003|Overall Study|Lack of Efficacy|0|||
160867680|NCT03326713|580906930|FG000|Overall Study|Death|2|||
160867681|NCT03326713|580906931|FG001|Overall Study|Death|1|||
160867682|NCT03326713|580906932|FG002|Overall Study|Death|0|||
160867683|NCT03326713|580906930|FG000|Overall Study|Lost to Follow-up|20|||
160867684|NCT03326713|580906931|FG001|Overall Study|Lost to Follow-up|21|||
160867685|NCT03326713|580906932|FG002|Overall Study|Lost to Follow-up|33|||
160867686|NCT03326713|580906930|FG000|Overall Study|Withdrawal by Subject|1|||
160867687|NCT03326713|580906931|FG001|Overall Study|Withdrawal by Subject|2|||
160867688|NCT03326713|580906932|FG002|Overall Study|Withdrawal by Subject|11|||
160867689|NCT03326713|580906930|FG000|Overall Study|Found Ineligible|11|||
160867690|NCT03326713|580906931|FG001|Overall Study|Found Ineligible|11|||
160867691|NCT03326713|580906932|FG002|Overall Study|Found Ineligible|8|||
160867692|NCT00771758|580906933|FG000|Overall Study|Adverse Event|2|||
160867693|NCT00771758|580906934|FG001|Overall Study|Adverse Event|8|||
160867694|NCT00771758|580906935|FG002|Overall Study|Adverse Event|1|||
160867695|NCT00771758|580906933|FG000|Overall Study|Lack of Efficacy|0|||
160867696|NCT00771758|580906934|FG001|Overall Study|Lack of Efficacy|2|||
160867697|NCT00771758|580906935|FG002|Overall Study|Lack of Efficacy|1|||
160867698|NCT00771758|580906933|FG000|Overall Study|Lost to Follow-up|1|||
160867699|NCT00771758|580906934|FG001|Overall Study|Lost to Follow-up|0|||
160867700|NCT00771758|580906935|FG002|Overall Study|Lost to Follow-up|0|||
160867701|NCT00771758|580906933|FG000|Overall Study|Protocol Violation|1|||
160867702|NCT00771758|580906934|FG001|Overall Study|Protocol Violation|0|||
160867703|NCT00771758|580906935|FG002|Overall Study|Protocol Violation|0|||
160867704|NCT00771758|580906933|FG000|Overall Study|Withdrawal by Subject|1|||
160867705|NCT00771758|580906934|FG001|Overall Study|Withdrawal by Subject|0|||
160867706|NCT00771758|580906935|FG002|Overall Study|Withdrawal by Subject|0|||
160867707|NCT00771758|580906933|FG000|Overall Study|Other|3|||
160867708|NCT00771758|580906934|FG001|Overall Study|Other|2|||
160867709|NCT00771758|580906935|FG002|Overall Study|Other|0|||
160867710|NCT00935584|580906936|FG000|Overall Study|Withdrawal by Subject|9|||
160867711|NCT00935584|580906937|FG001|Overall Study|Withdrawal by Subject|0|||
160867712|NCT00935584|580906936|FG000|Overall Study|Death|3|||
160867713|NCT00935584|580906937|FG001|Overall Study|Death|0|||
160867714|NCT00935584|580906936|FG000|Overall Study|Lost to Follow-up|8|||
160867715|NCT00935584|580906937|FG001|Overall Study|Lost to Follow-up|0|||
160867716|NCT00935584|580906936|FG000|Overall Study|No show|9|||
160867717|NCT00935584|580906937|FG001|Overall Study|No show|0|||
160867718|NCT00935584|580906936|FG000|Overall Study|Relocated|3|||
160867719|NCT00935584|580906937|FG001|Overall Study|Relocated|0|||
160867720|NCT00935584|580906936|FG000|Overall Study|Patient changed provider|3|||
160867721|NCT00935584|580906937|FG001|Overall Study|Patient changed provider|0|||
160867722|NCT00935584|580906936|FG000|Overall Study|Provider dropped out of study|14|||
160867723|NCT00935584|580906937|FG001|Overall Study|Provider dropped out of study|4|||
160867724|NCT00687193|580906938|FG000|Overall Study|Adverse Event|0|||
160867725|NCT00687193|580906939|FG001|Overall Study|Adverse Event|1|||
160867726|NCT00687193|580906940|FG002|Overall Study|Adverse Event|2|||
160867727|NCT00687193|580906941|FG003|Overall Study|Adverse Event|3|||
160867728|NCT00687193|580906942|FG004|Overall Study|Adverse Event|0|||
160867729|NCT00687193|580906943|FG005|Overall Study|Adverse Event|2|||
160867730|NCT00687193|580906938|FG000|Overall Study|Lack of Efficacy|1|||
160867731|NCT00687193|580906939|FG001|Overall Study|Lack of Efficacy|1|||
160867732|NCT00687193|580906940|FG002|Overall Study|Lack of Efficacy|0|||
160867733|NCT00687193|580906941|FG003|Overall Study|Lack of Efficacy|0|||
160867734|NCT00687193|580906942|FG004|Overall Study|Lack of Efficacy|0|||
160867735|NCT00687193|580906943|FG005|Overall Study|Lack of Efficacy|2|||
160867736|NCT00687193|580906938|FG000|Overall Study|Protocol Violation|1|||
160867737|NCT00687193|580906939|FG001|Overall Study|Protocol Violation|2|||
160867738|NCT00687193|580906940|FG002|Overall Study|Protocol Violation|0|||
160867739|NCT00687193|580906941|FG003|Overall Study|Protocol Violation|1|||
160867740|NCT00687193|580906942|FG004|Overall Study|Protocol Violation|2|||
160867741|NCT00687193|580906943|FG005|Overall Study|Protocol Violation|0|||
160867742|NCT02129699|580906944|FG000|Overall Study|Did not start treatment|3|||
160867743|NCT02129699|580906945|FG001|Overall Study|Did not start treatment|2|||
160867744|NCT01394016|580906946|FG000|Overall Study|Progressive Disease|2|||
160867745|NCT01394016|580906947|FG001|Overall Study|Progressive Disease|0|||
160867746|NCT01394016|580906948|FG002|Overall Study|Progressive Disease|0|||
160867747|NCT01394016|580906949|FG003|Overall Study|Progressive Disease|0|||
160867748|NCT01394016|580906950|FG004|Overall Study|Progressive Disease|0|||
160867749|NCT01394016|580906951|FG005|Overall Study|Progressive Disease|0|||
160867750|NCT01394016|580906952|FG006|Overall Study|Progressive Disease|0|||
160867751|NCT01394016|580906953|FG007|Overall Study|Progressive Disease|0|||
160867752|NCT01394016|580906954|FG008|Overall Study|Progressive Disease|0|||
160867753|NCT01394016|580906955|FG009|Overall Study|Progressive Disease|0|||
160867754|NCT01394016|580906956|FG010|Overall Study|Progressive Disease|0|||
160867755|NCT01394016|580906957|FG011|Overall Study|Progressive Disease|0|||
160867756|NCT01394016|580906958|FG012|Overall Study|Progressive Disease|0|||
160867757|NCT01394016|580906959|FG013|Overall Study|Progressive Disease|0|||
160867758|NCT01394016|580906960|FG014|Overall Study|Progressive Disease|0|||
160867759|NCT01394016|580906961|FG015|Overall Study|Progressive Disease|0|||
160867760|NCT01394016|580906962|FG016|Overall Study|Progressive Disease|0|||
160867761|NCT01394016|580906963|FG017|Overall Study|Progressive Disease|0|||
160867762|NCT01394016|580906964|FG018|Overall Study|Progressive Disease|0|||
160867763|NCT01394016|580906946|FG000|Overall Study|Withdrawal by Subject|0|||
160867764|NCT01394016|580906947|FG001|Overall Study|Withdrawal by Subject|0|||
160867765|NCT01394016|580906948|FG002|Overall Study|Withdrawal by Subject|0|||
160867766|NCT01394016|580906949|FG003|Overall Study|Withdrawal by Subject|0|||
160867767|NCT01394016|580906950|FG004|Overall Study|Withdrawal by Subject|0|||
160867768|NCT01394016|580906951|FG005|Overall Study|Withdrawal by Subject|0|||
160867769|NCT01394016|580906952|FG006|Overall Study|Withdrawal by Subject|0|||
160867770|NCT01394016|580906953|FG007|Overall Study|Withdrawal by Subject|1|||
160867771|NCT01394016|580906954|FG008|Overall Study|Withdrawal by Subject|1|||
160867772|NCT01394016|580906955|FG009|Overall Study|Withdrawal by Subject|1|||
160867773|NCT01394016|580906956|FG010|Overall Study|Withdrawal by Subject|4|||
160867774|NCT01394016|580906957|FG011|Overall Study|Withdrawal by Subject|0|||
160867775|NCT01394016|580906958|FG012|Overall Study|Withdrawal by Subject|0|||
160867776|NCT01394016|580906959|FG013|Overall Study|Withdrawal by Subject|3|||
160867777|NCT01394016|580906960|FG014|Overall Study|Withdrawal by Subject|1|||
160867778|NCT01394016|580906961|FG015|Overall Study|Withdrawal by Subject|3|||
160867779|NCT01394016|580906962|FG016|Overall Study|Withdrawal by Subject|1|||
160867780|NCT01394016|580906963|FG017|Overall Study|Withdrawal by Subject|1|||
160867781|NCT01394016|580906964|FG018|Overall Study|Withdrawal by Subject|2|||
160867782|NCT01394016|580906946|FG000|Overall Study|Adverse Event|0|||
160867783|NCT01394016|580906947|FG001|Overall Study|Adverse Event|0|||
160867784|NCT01394016|580906948|FG002|Overall Study|Adverse Event|0|||
160867785|NCT01394016|580906949|FG003|Overall Study|Adverse Event|0|||
160867786|NCT01394016|580906950|FG004|Overall Study|Adverse Event|0|||
160867787|NCT01394016|580906951|FG005|Overall Study|Adverse Event|0|||
160867788|NCT01394016|580906952|FG006|Overall Study|Adverse Event|0|||
160867789|NCT01394016|580906953|FG007|Overall Study|Adverse Event|0|||
160867790|NCT01394016|580906954|FG008|Overall Study|Adverse Event|0|||
160867791|NCT01394016|580906955|FG009|Overall Study|Adverse Event|1|||
160867792|NCT01394016|580906956|FG010|Overall Study|Adverse Event|0|||
160867793|NCT01394016|580906957|FG011|Overall Study|Adverse Event|0|||
160867794|NCT01394016|580906958|FG012|Overall Study|Adverse Event|0|||
160867795|NCT01394016|580906959|FG013|Overall Study|Adverse Event|0|||
160867796|NCT01394016|580906960|FG014|Overall Study|Adverse Event|0|||
160867797|NCT01394016|580906961|FG015|Overall Study|Adverse Event|0|||
160763622|NCT01774591|580524722|FG000|Overall Study|Physician Decision|1|||
160763623|NCT01774591|580524723|FG001|Overall Study|Physician Decision|1|||
160763624|NCT01774591|580524722|FG000|Overall Study|Withdrawal by Subject|0|||
160763625|NCT01774591|580524723|FG001|Overall Study|Withdrawal by Subject|1|||
160763626|NCT01774591|580524722|FG000|Overall Study|Adverse Event|0|||
160763627|NCT01774591|580524723|FG001|Overall Study|Adverse Event|2|||
160763628|NCT01159574|580524724|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
160763629|NCT01159574|580524724|FG000|Treatment Phase|Adverse Event|3|||
160763630|NCT01159574|580524724|FG000|Treatment Phase|Death|6|||
160763631|NCT01159574|580524724|FG000|Treatment Phase|Physician Decision|2|||
160763632|NCT01159574|580524724|FG000|Treatment Phase|Withdrawal by Subject|7|||
160763633|NCT01159574|580524724|FG000|Treatment Phase|still on treatment|2|||
160763634|NCT01159574|580524724|FG000|Follow Up Phase|Lost to Follow-up|2|||
160763635|NCT01159574|580524724|FG000|Follow Up Phase|still being followed for overall surviva|18|||
160763636|NCT00630916|580524725|FG000|Overall Study|Death|110|||
160763637|NCT00630916|580524725|FG000|Overall Study|Explant|8|||
160763638|NCT00630916|580524725|FG000|Overall Study|Lost to Follow-up|5|||
160763639|NCT00630916|580524725|FG000|Overall Study|Withdrawal by Subject|30|||
160763640|NCT00630916|580524725|FG000|Overall Study|Protocol Violation|7|||
160763641|NCT00630916|580524725|FG000|Overall Study|Physician Decision|47|||
160763642|NCT00630916|580524725|FG000|Overall Study|Lack of Efficacy|3|||
160763643|NCT02295644|580524726|FG000|Overall Study|Did not meet inclusion criterion|0|||
160763644|NCT02295644|580524727|FG001|Overall Study|Did not meet inclusion criterion|0|||
160763645|NCT02295644|580524728|FG002|Overall Study|Did not meet inclusion criterion|1|||
160763646|NCT02295644|580524729|FG003|Overall Study|Did not meet inclusion criterion|2|||
160763647|NCT00390689|580524730|FG000|Overall Study|Adverse Event|2|||
160763648|NCT00390689|580524731|FG001|Overall Study|Adverse Event|5|||
160763649|NCT00390689|580524732|FG002|Overall Study|Adverse Event|2|||
160763650|NCT00390689|580524730|FG000|Overall Study|Lack of Efficacy|0|||
160763651|NCT00390689|580524731|FG001|Overall Study|Lack of Efficacy|0|||
160763652|NCT00390689|580524732|FG002|Overall Study|Lack of Efficacy|1|||
160763653|NCT00390689|580524730|FG000|Overall Study|Protocol Violation|1|||
160763654|NCT00390689|580524731|FG001|Overall Study|Protocol Violation|0|||
160763655|NCT00390689|580524732|FG002|Overall Study|Protocol Violation|0|||
160763656|NCT00390689|580524730|FG000|Overall Study|Investigator's judgement|2|||
160763657|NCT00390689|580524731|FG001|Overall Study|Investigator's judgement|0|||
160763658|NCT00390689|580524732|FG002|Overall Study|Investigator's judgement|0|||
160763659|NCT03101020|580524734|FG000|Overall Study|Lack of time to participate|1|||
160763660|NCT03101020|580524735|FG001|Overall Study|Lack of time to participate|0|||
160763661|NCT03101020|580524734|FG000|Overall Study|Ran over by a car|0|||
160763662|NCT03101020|580524735|FG001|Overall Study|Ran over by a car|1|||
160763663|NCT03101020|580524734|FG000|Overall Study|Withdrawal by Subject|0|||
160763664|NCT03101020|580524735|FG001|Overall Study|Withdrawal by Subject|2|||
160763665|NCT03167242|580524737|FG000|Overall Study|Patient/Guardian Decision|0|||
160763666|NCT03167242|580524738|FG001|Overall Study|Patient/Guardian Decision|1|||
160763667|NCT03167242|580524739|FG002|Overall Study|Patient/Guardian Decision|2|||
160763668|NCT03167242|580524740|FG003|Overall Study|Patient/Guardian Decision|1|||
160763669|NCT03167242|580524741|FG004|Overall Study|Patient/Guardian Decision|1|||
160763670|NCT03167242|580524742|FG005|Overall Study|Patient/Guardian Decision|1|||
160763671|NCT03167242|580524743|FG006|Overall Study|Patient/Guardian Decision|0|||
160763672|NCT03167242|580524744|FG007|Overall Study|Patient/Guardian Decision|0|||
160763673|NCT03167242|580524745|FG008|Overall Study|Patient/Guardian Decision|0|||
160763674|NCT03167242|580524746|FG009|Overall Study|Patient/Guardian Decision|0|||
160763675|NCT03167242|580524747|FG010|Overall Study|Patient/Guardian Decision|1|||
160763676|NCT03167242|580524748|FG011|Overall Study|Patient/Guardian Decision|0|||
160763677|NCT03167242|580524737|FG000|Overall Study|Lost to Follow-up|0|||
160763678|NCT03167242|580524738|FG001|Overall Study|Lost to Follow-up|0|||
160763679|NCT03167242|580524739|FG002|Overall Study|Lost to Follow-up|1|||
160763680|NCT03167242|580524740|FG003|Overall Study|Lost to Follow-up|0|||
160763681|NCT03167242|580524741|FG004|Overall Study|Lost to Follow-up|0|||
160763682|NCT03167242|580524742|FG005|Overall Study|Lost to Follow-up|1|||
160763683|NCT03167242|580524743|FG006|Overall Study|Lost to Follow-up|2|||
160763684|NCT03167242|580524744|FG007|Overall Study|Lost to Follow-up|1|||
160763685|NCT03167242|580524745|FG008|Overall Study|Lost to Follow-up|0|||
160763686|NCT03167242|580524746|FG009|Overall Study|Lost to Follow-up|0|||
160763687|NCT03167242|580524747|FG010|Overall Study|Lost to Follow-up|1|||
160763688|NCT03167242|580524748|FG011|Overall Study|Lost to Follow-up|1|||
160763689|NCT03167242|580524737|FG000|Overall Study|Reason not provided|0|||
160763690|NCT03167242|580524738|FG001|Overall Study|Reason not provided|0|||
160763691|NCT03167242|580524739|FG002|Overall Study|Reason not provided|0|||
160763692|NCT03167242|580524740|FG003|Overall Study|Reason not provided|0|||
160763693|NCT03167242|580524741|FG004|Overall Study|Reason not provided|0|||
160763694|NCT03167242|580524742|FG005|Overall Study|Reason not provided|0|||
160763695|NCT03167242|580524743|FG006|Overall Study|Reason not provided|0|||
160763696|NCT03167242|580524744|FG007|Overall Study|Reason not provided|0|||
160763697|NCT03167242|580524745|FG008|Overall Study|Reason not provided|1|||
160763698|NCT03167242|580524746|FG009|Overall Study|Reason not provided|0|||
160763699|NCT03167242|580524747|FG010|Overall Study|Reason not provided|0|||
160867798|NCT01394016|580906962|FG016|Overall Study|Adverse Event|1|||
160867799|NCT01394016|580906963|FG017|Overall Study|Adverse Event|1|||
160867800|NCT01394016|580906964|FG018|Overall Study|Adverse Event|0|||
160867801|NCT01394016|580906946|FG000|Overall Study|Sponsor Decision|0|||
160867802|NCT01394016|580906947|FG001|Overall Study|Sponsor Decision|0|||
160867803|NCT01394016|580906948|FG002|Overall Study|Sponsor Decision|0|||
160867804|NCT01394016|580906949|FG003|Overall Study|Sponsor Decision|0|||
160867805|NCT01394016|580906950|FG004|Overall Study|Sponsor Decision|0|||
160867806|NCT01394016|580906951|FG005|Overall Study|Sponsor Decision|0|||
160867807|NCT01394016|580906952|FG006|Overall Study|Sponsor Decision|0|||
160867808|NCT01394016|580906953|FG007|Overall Study|Sponsor Decision|0|||
160867809|NCT01394016|580906954|FG008|Overall Study|Sponsor Decision|0|||
160867810|NCT01394016|580906955|FG009|Overall Study|Sponsor Decision|0|||
160867811|NCT01394016|580906956|FG010|Overall Study|Sponsor Decision|0|||
160867812|NCT01394016|580906957|FG011|Overall Study|Sponsor Decision|0|||
160867813|NCT01394016|580906958|FG012|Overall Study|Sponsor Decision|1|||
160867814|NCT01394016|580906959|FG013|Overall Study|Sponsor Decision|0|||
160867815|NCT01394016|580906960|FG014|Overall Study|Sponsor Decision|0|||
160867816|NCT01394016|580906961|FG015|Overall Study|Sponsor Decision|0|||
160867817|NCT01394016|580906962|FG016|Overall Study|Sponsor Decision|0|||
160867818|NCT01394016|580906963|FG017|Overall Study|Sponsor Decision|0|||
160867819|NCT01394016|580906964|FG018|Overall Study|Sponsor Decision|0|||
160867820|NCT01394016|580906946|FG000|Overall Study|Lost to Follow-up|0|||
160867821|NCT01394016|580906947|FG001|Overall Study|Lost to Follow-up|0|||
160867822|NCT01394016|580906948|FG002|Overall Study|Lost to Follow-up|0|||
160867823|NCT01394016|580906949|FG003|Overall Study|Lost to Follow-up|0|||
160867824|NCT01394016|580906950|FG004|Overall Study|Lost to Follow-up|0|||
160867825|NCT01394016|580906951|FG005|Overall Study|Lost to Follow-up|0|||
160867826|NCT01394016|580906952|FG006|Overall Study|Lost to Follow-up|0|||
160867827|NCT01394016|580906953|FG007|Overall Study|Lost to Follow-up|0|||
160867828|NCT01394016|580906954|FG008|Overall Study|Lost to Follow-up|0|||
160867829|NCT01394016|580906955|FG009|Overall Study|Lost to Follow-up|0|||
160867830|NCT01394016|580906956|FG010|Overall Study|Lost to Follow-up|0|||
160867831|NCT01394016|580906957|FG011|Overall Study|Lost to Follow-up|0|||
160867832|NCT01394016|580906958|FG012|Overall Study|Lost to Follow-up|0|||
160867833|NCT01394016|580906959|FG013|Overall Study|Lost to Follow-up|0|||
160867834|NCT01394016|580906960|FG014|Overall Study|Lost to Follow-up|0|||
160867835|NCT01394016|580906961|FG015|Overall Study|Lost to Follow-up|0|||
160867836|NCT01394016|580906962|FG016|Overall Study|Lost to Follow-up|0|||
160867837|NCT01394016|580906963|FG017|Overall Study|Lost to Follow-up|0|||
160867838|NCT01394016|580906964|FG018|Overall Study|Lost to Follow-up|1|||
160867839|NCT03534804|580906965|FG000|Overall Study|Withdrawal by Subject|1|||
160867840|NCT04161157|580906969|FG000|Overall Study|Lost to Follow-up|4|||
160867841|NCT04161157|580906969|FG000|Overall Study|Death|3|||
160867842|NCT04161157|580906969|FG000|Overall Study|Ineligible|2|||
160867843|NCT04161157|580906969|FG000|Overall Study|Withdrawal by Subject|4|||
160867844|NCT05786651|580906973|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
160867845|NCT02331277|580908128|FG000|Overall Study|Withdrawal by Subject|1|||
160763700|NCT03167242|580524748|FG011|Overall Study|Reason not provided|0|||
160763701|NCT03786380|580524750|FG000|Overall Study|Adverse Event|1|||
160763702|NCT03786380|580524751|FG001|Overall Study|Adverse Event|0|||
160763703|NCT03786380|580524752|FG002|Overall Study|Adverse Event|0|||
160763704|NCT03786380|580524753|FG003|Overall Study|Adverse Event|3|||
160763705|NCT03786380|580524754|FG004|Overall Study|Adverse Event|1|||
160763706|NCT03786380|580524750|FG000|Overall Study|Lack of Efficacy|0|||
160763707|NCT03786380|580524751|FG001|Overall Study|Lack of Efficacy|0|||
160763708|NCT03786380|580524752|FG002|Overall Study|Lack of Efficacy|0|||
160763709|NCT03786380|580524753|FG003|Overall Study|Lack of Efficacy|0|||
160763710|NCT03786380|580524754|FG004|Overall Study|Lack of Efficacy|1|||
160763711|NCT03786380|580524750|FG000|Overall Study|Withdrawal by Subject|1|||
160763712|NCT03786380|580524751|FG001|Overall Study|Withdrawal by Subject|2|||
160763713|NCT03786380|580524752|FG002|Overall Study|Withdrawal by Subject|2|||
160763714|NCT03786380|580524753|FG003|Overall Study|Withdrawal by Subject|1|||
160763715|NCT03786380|580524754|FG004|Overall Study|Withdrawal by Subject|2|||
160763716|NCT03786380|580524750|FG000|Overall Study|Lost to Follow-up|3|||
160867846|NCT02331277|580908129|FG001|Overall Study|Withdrawal by Subject|0|||
160867847|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
160867848|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
160867849|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Patient requirement|20|||
160867850|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Death|5|||
160867851|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Change of therapy|6|||
160867852|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
160867853|NCT01071798|580908131|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
160867854|NCT01071798|580908131|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
160867855|NCT01071798|580908131|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
160867856|NCT01071798|580908131|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
160867857|NCT01177397|580908135|FG000|Overall Study|Protocol Violation|0|||
160867858|NCT01177397|580908136|FG001|Overall Study|Protocol Violation|0|||
160867859|NCT01177397|580908137|FG002|Overall Study|Protocol Violation|0|||
160867860|NCT01177397|580908138|FG003|Overall Study|Protocol Violation|0|||
160867861|NCT01177397|580908139|FG004|Overall Study|Protocol Violation|0|||
160867862|NCT01177397|580908140|FG005|Overall Study|Protocol Violation|1|||
160867863|NCT01177397|580908141|FG006|Overall Study|Protocol Violation|0|||
160867864|NCT01177397|580908142|FG007|Overall Study|Protocol Violation|0|||
160867865|NCT01177397|580908143|FG008|Overall Study|Protocol Violation|0|||
160867866|NCT01177397|580908144|FG009|Overall Study|Protocol Violation|0|||
160867867|NCT01177397|580908145|FG010|Overall Study|Protocol Violation|0|||
160867868|NCT01177397|580908146|FG011|Overall Study|Protocol Violation|0|||
160867869|NCT01177397|580908135|FG000|Overall Study|Lost to Follow-up|0|||
160867870|NCT01177397|580908136|FG001|Overall Study|Lost to Follow-up|0|||
160867871|NCT01177397|580908137|FG002|Overall Study|Lost to Follow-up|0|||
160867872|NCT01177397|580908138|FG003|Overall Study|Lost to Follow-up|0|||
160867873|NCT01177397|580908139|FG004|Overall Study|Lost to Follow-up|1|||
160867874|NCT01177397|580908140|FG005|Overall Study|Lost to Follow-up|0|||
160867875|NCT01177397|580908141|FG006|Overall Study|Lost to Follow-up|0|||
160867876|NCT01177397|580908142|FG007|Overall Study|Lost to Follow-up|2|||
160867877|NCT01177397|580908143|FG008|Overall Study|Lost to Follow-up|0|||
160867878|NCT01177397|580908144|FG009|Overall Study|Lost to Follow-up|0|||
160867879|NCT01177397|580908145|FG010|Overall Study|Lost to Follow-up|0|||
160867880|NCT01177397|580908146|FG011|Overall Study|Lost to Follow-up|0|||
160867881|NCT01177397|580908135|FG000|Overall Study|Death|0|||
160867882|NCT01177397|580908136|FG001|Overall Study|Death|0|||
160867883|NCT01177397|580908137|FG002|Overall Study|Death|1|||
160867884|NCT01177397|580908138|FG003|Overall Study|Death|1|||
160867885|NCT01177397|580908139|FG004|Overall Study|Death|0|||
160867886|NCT01177397|580908140|FG005|Overall Study|Death|0|||
160867887|NCT01177397|580908141|FG006|Overall Study|Death|0|||
160867888|NCT01177397|580908142|FG007|Overall Study|Death|5|||
160867889|NCT01177397|580908143|FG008|Overall Study|Death|2|||
160867890|NCT01177397|580908144|FG009|Overall Study|Death|1|||
160867891|NCT01177397|580908145|FG010|Overall Study|Death|0|||
160867892|NCT01177397|580908146|FG011|Overall Study|Death|0|||
160867893|NCT01177397|580908135|FG000|Overall Study|Withdrawal by Subject|0|||
160867894|NCT01177397|580908136|FG001|Overall Study|Withdrawal by Subject|0|||
160867895|NCT01177397|580908137|FG002|Overall Study|Withdrawal by Subject|1|||
160867896|NCT01177397|580908138|FG003|Overall Study|Withdrawal by Subject|1|||
160867897|NCT01177397|580908139|FG004|Overall Study|Withdrawal by Subject|1|||
160867898|NCT01177397|580908140|FG005|Overall Study|Withdrawal by Subject|2|||
160867899|NCT01177397|580908141|FG006|Overall Study|Withdrawal by Subject|0|||
160867900|NCT01177397|580908142|FG007|Overall Study|Withdrawal by Subject|5|||
160867901|NCT01177397|580908143|FG008|Overall Study|Withdrawal by Subject|9|||
160867902|NCT01177397|580908144|FG009|Overall Study|Withdrawal by Subject|1|||
160867903|NCT01177397|580908145|FG010|Overall Study|Withdrawal by Subject|1|||
160867904|NCT01177397|580908146|FG011|Overall Study|Withdrawal by Subject|0|||
160867905|NCT01177397|580908135|FG000|Overall Study|Adverse Event|0|||
160867906|NCT01177397|580908136|FG001|Overall Study|Adverse Event|0|||
160867907|NCT01177397|580908137|FG002|Overall Study|Adverse Event|1|||
160867908|NCT01177397|580908138|FG003|Overall Study|Adverse Event|2|||
160867909|NCT01177397|580908139|FG004|Overall Study|Adverse Event|0|||
160867910|NCT01177397|580908140|FG005|Overall Study|Adverse Event|12|||
160867911|NCT01177397|580908141|FG006|Overall Study|Adverse Event|1|||
160867912|NCT01177397|580908142|FG007|Overall Study|Adverse Event|14|||
160867913|NCT01177397|580908143|FG008|Overall Study|Adverse Event|8|||
160867914|NCT01177397|580908144|FG009|Overall Study|Adverse Event|6|||
160867915|NCT01177397|580908145|FG010|Overall Study|Adverse Event|3|||
160867916|NCT01177397|580908146|FG011|Overall Study|Adverse Event|7|||
160867917|NCT01177397|580908135|FG000|Overall Study|Disease progression|1|||
160867918|NCT01177397|580908136|FG001|Overall Study|Disease progression|2|||
160867919|NCT01177397|580908137|FG002|Overall Study|Disease progression|5|||
160867920|NCT01177397|580908138|FG003|Overall Study|Disease progression|5|||
160867921|NCT01177397|580908139|FG004|Overall Study|Disease progression|4|||
160867922|NCT01177397|580908140|FG005|Overall Study|Disease progression|10|||
160867923|NCT01177397|580908141|FG006|Overall Study|Disease progression|10|||
160867924|NCT01177397|580908142|FG007|Overall Study|Disease progression|21|||
160867925|NCT01177397|580908143|FG008|Overall Study|Disease progression|18|||
160867926|NCT01177397|580908144|FG009|Overall Study|Disease progression|12|||
160867927|NCT01177397|580908145|FG010|Overall Study|Disease progression|10|||
160867928|NCT01177397|580908146|FG011|Overall Study|Disease progression|8|||
160867929|NCT01177397|580908135|FG000|Overall Study|Other reasons|0|||
160867930|NCT01177397|580908136|FG001|Overall Study|Other reasons|0|||
160867931|NCT01177397|580908137|FG002|Overall Study|Other reasons|1|||
160867932|NCT01177397|580908138|FG003|Overall Study|Other reasons|0|||
160867933|NCT01177397|580908139|FG004|Overall Study|Other reasons|1|||
160867934|NCT01177397|580908140|FG005|Overall Study|Other reasons|1|||
160867935|NCT01177397|580908141|FG006|Overall Study|Other reasons|2|||
160867936|NCT01177397|580908142|FG007|Overall Study|Other reasons|6|||
160867937|NCT01177397|580908143|FG008|Overall Study|Other reasons|10|||
160867938|NCT01177397|580908144|FG009|Overall Study|Other reasons|8|||
160867939|NCT01177397|580908145|FG010|Overall Study|Other reasons|0|||
160867940|NCT01177397|580908146|FG011|Overall Study|Other reasons|2|||
160867941|NCT01528969|580908147|FG000|Overall Study|absent from the school at baseline|2|||
160867942|NCT01528969|580908148|FG001|Overall Study|absent from the school at baseline|0|||
160867943|NCT03085797|580908149|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
160867944|NCT03085797|580908150|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
160867945|NCT03085797|580908149|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
160867946|NCT03085797|580908150|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
160867947|NCT03085797|580908149|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
160867948|NCT03085797|580908150|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
160867949|NCT04050202|580908155|FG000|Overall Study|Lost to Follow-up|2|||
160867950|NCT01554241|580908156|FG000|Overall Study|Death|3|||
160867951|NCT01554241|580908157|FG001|Overall Study|Death|1|||
160867952|NCT01554241|580908158|FG002|Overall Study|Death|1|||
160867953|NCT01554241|580908159|FG003|Overall Study|Death|0|||
160867954|NCT01554241|580908156|FG000|Overall Study|protocol specified renal stone|0|||
160867955|NCT01554241|580908157|FG001|Overall Study|protocol specified renal stone|0|||
160867956|NCT01554241|580908158|FG002|Overall Study|protocol specified renal stone|0|||
160867957|NCT01554241|580908159|FG003|Overall Study|protocol specified renal stone|1|||
160867958|NCT01554241|580908156|FG000|Overall Study|protocol specified change in eGFR|0|||
160867959|NCT01554241|580908157|FG001|Overall Study|protocol specified change in eGFR|0|||
160867960|NCT01554241|580908158|FG002|Overall Study|protocol specified change in eGFR|1|||
160867961|NCT01554241|580908159|FG003|Overall Study|protocol specified change in eGFR|0|||
160867962|NCT01554241|580908156|FG000|Overall Study|Withdrawal by Subject|0|||
160867963|NCT01554241|580908157|FG001|Overall Study|Withdrawal by Subject|0|||
160867964|NCT01554241|580908158|FG002|Overall Study|Withdrawal by Subject|2|||
160867965|NCT01554241|580908159|FG003|Overall Study|Withdrawal by Subject|0|||
160867966|NCT03198507|580908162|FG000|Overall Study|Withdrawal by Subject|1|||
160867967|NCT03198507|580908163|FG001|Overall Study|Withdrawal by Subject|0|||
160867968|NCT00724698|580908164|FG000|Overall Study|Adverse Event|9|||
160867969|NCT00724698|580908164|FG000|Overall Study|Failure of Therapy|4|||
160867970|NCT00724698|580908164|FG000|Overall Study|Poor Compliance|16|||
160867971|NCT00724698|580908164|FG000|Overall Study|Lost to Follow-up|36|||
160867972|NCT00724698|580908164|FG000|Overall Study|No Info|25|||
160867973|NCT01411891|580908167|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
160867974|NCT01411891|580908168|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
160867975|NCT01075685|580908169|FG000|Overall Study|Protocol Violation|9|||
160867976|NCT01075685|580908170|FG001|Overall Study|Protocol Violation|1|||
160867977|NCT01075685|580908169|FG000|Overall Study|Withdrawal by Subject|20|||
160867978|NCT01075685|580908170|FG001|Overall Study|Withdrawal by Subject|5|||
160867979|NCT01075685|580908169|FG000|Overall Study|Lost to Follow-up|563|||
160867980|NCT01075685|580908170|FG001|Overall Study|Lost to Follow-up|220|||
160867981|NCT03196349|580908173|FG000|Overall Study|Did not receive study drug|0|||
160867982|NCT03196349|580908174|FG001|Overall Study|Did not receive study drug|1|||
160867983|NCT03196349|580908175|FG002|Overall Study|Did not receive study drug|2|||
160867984|NCT03196349|580908173|FG000|Overall Study|No data entered|2|||
160867985|NCT03196349|580908174|FG001|Overall Study|No data entered|4|||
160867986|NCT03196349|580908175|FG002|Overall Study|No data entered|0|||
160867987|NCT03196349|580908173|FG000|Overall Study|Study Terminated early|15|||
160867988|NCT03196349|580908174|FG001|Overall Study|Study Terminated early|9|||
160867989|NCT03196349|580908175|FG002|Overall Study|Study Terminated early|11|||
160867990|NCT03388164|580908180|FG000|Overall Study|Withdrawal by Subject|3|||
160867991|NCT03388164|580908181|FG001|Overall Study|Withdrawal by Subject|1|||
160867992|NCT03967444|580908182|FG000|Overall Study|Lost to Follow-up|1|||
160867993|NCT03967444|580908183|FG001|Overall Study|Lost to Follow-up|2|||
160867994|NCT00499083|580908191|FG000|Overall Study|Not evaluable|3|||
160867995|NCT00686686|580908192|FG000|Overall Study|Non-compliance|1|||
160867996|NCT00686686|580908192|FG000|Overall Study|Adverse Event|2|||
160867997|NCT00686686|580908192|FG000|Overall Study|Lost to Follow-up|3|||
160867998|NCT00477386|580908193|FG000|Overall Study|Adverse Event|4|||
160867999|NCT00477386|580908194|FG001|Overall Study|Adverse Event|8|||
160868000|NCT00477386|580908193|FG000|Overall Study|Disease progression, relapse|3|||
160868001|NCT00477386|580908194|FG001|Overall Study|Disease progression, relapse|4|||
160868002|NCT00477386|580908193|FG000|Overall Study|Disease progression, refractory|1|||
160868003|NCT00477386|580908194|FG001|Overall Study|Disease progression, refractory|3|||
160868004|NCT00477386|580908193|FG000|Overall Study|Other|1|||
160868005|NCT00477386|580908194|FG001|Overall Study|Other|2|||
160868006|NCT00477386|580908193|FG000|Overall Study|Physician Decision|1|||
160868007|NCT00477386|580908194|FG001|Overall Study|Physician Decision|0|||
160868008|NCT00477386|580908193|FG000|Overall Study|Withdrawal by Subject|1|||
160763717|NCT03786380|580524751|FG001|Overall Study|Lost to Follow-up|0|||
160763718|NCT03786380|580524752|FG002|Overall Study|Lost to Follow-up|1|||
160763719|NCT03786380|580524753|FG003|Overall Study|Lost to Follow-up|2|||
160763720|NCT03786380|580524754|FG004|Overall Study|Lost to Follow-up|0|||
160763721|NCT03786380|580524750|FG000|Overall Study|Physician Decision|0|||
160763722|NCT03786380|580524751|FG001|Overall Study|Physician Decision|0|||
160763723|NCT03786380|580524752|FG002|Overall Study|Physician Decision|1|||
160763724|NCT03786380|580524753|FG003|Overall Study|Physician Decision|0|||
160763725|NCT03786380|580524754|FG004|Overall Study|Physician Decision|0|||
160763726|NCT03786380|580524750|FG000|Overall Study|Study Terminated by the Sponsor|30|||
160763727|NCT03786380|580524751|FG001|Overall Study|Study Terminated by the Sponsor|20|||
160763728|NCT03786380|580524752|FG002|Overall Study|Study Terminated by the Sponsor|50|||
160763729|NCT03786380|580524753|FG003|Overall Study|Study Terminated by the Sponsor|57|||
160763730|NCT03786380|580524754|FG004|Overall Study|Study Terminated by the Sponsor|23|||
160763731|NCT03786380|580524750|FG000|Overall Study|Reason Not Specified|0|||
160763732|NCT03786380|580524751|FG001|Overall Study|Reason Not Specified|0|||
160763733|NCT03786380|580524752|FG002|Overall Study|Reason Not Specified|0|||
160763734|NCT03786380|580524753|FG003|Overall Study|Reason Not Specified|0|||
160763735|NCT03786380|580524754|FG004|Overall Study|Reason Not Specified|1|||
160763736|NCT00467519|580524757|FG000|Overall Study|Protocol Violation|8|||
160763737|NCT00467519|580524758|FG001|Overall Study|Protocol Violation|4|||
160763738|NCT00467519|580524757|FG000|Overall Study|Lost to Follow-up|2|||
160763739|NCT00467519|580524758|FG001|Overall Study|Lost to Follow-up|9|||
160763740|NCT00467519|580524757|FG000|Overall Study|Withdrawal by Subject|4|||
160763741|NCT00467519|580524758|FG001|Overall Study|Withdrawal by Subject|10|||
160763742|NCT00372424|580524759|FG000|Overall Study|Adverse Event|2|||
160763743|NCT00372424|580524759|FG000|Overall Study|Withdrawal by Subject|1|||
160763744|NCT00372424|580524759|FG000|Overall Study|Death|1|||
160763745|NCT00372424|580524759|FG000|Overall Study|Objective Progression or Relapse|14|||
160763746|NCT00372424|580524759|FG000|Overall Study|Other|7|||
160763747|NCT00372424|580524759|FG000|Overall Study|Enrolled, Not Treated|1|||
160763748|NCT03080935|580524762|FG000|Overall Study|Death|34|||
160763749|NCT03080935|580524763|FG001|Overall Study|Death|50|||
160763750|NCT03080935|580524762|FG000|Overall Study|Lost to Follow-up|5|||
160763751|NCT03080935|580524763|FG001|Overall Study|Lost to Follow-up|4|||
160763752|NCT03080935|580524762|FG000|Overall Study|Withdrawal by Subject|11|||
160763753|NCT03080935|580524763|FG001|Overall Study|Withdrawal by Subject|15|||
160763754|NCT03118934|580524765|FG000|Overall Study|Adverse Event|0|||
160763755|NCT03118934|580524766|FG001|Overall Study|Adverse Event|0|||
160763756|NCT03118934|580524767|FG002|Overall Study|Adverse Event|0|||
160763757|NCT03118934|580524768|FG003|Overall Study|Adverse Event|0|||
160763758|NCT03118934|580524769|FG004|Overall Study|Adverse Event|0|||
160763759|NCT03118934|580524770|FG005|Overall Study|Adverse Event|1|||
160763760|NCT03118934|580524765|FG000|Overall Study|Physician Decision|0|||
160763761|NCT03118934|580524766|FG001|Overall Study|Physician Decision|0|||
160763762|NCT03118934|580524767|FG002|Overall Study|Physician Decision|0|||
160763763|NCT03118934|580524768|FG003|Overall Study|Physician Decision|0|||
160763764|NCT03118934|580524769|FG004|Overall Study|Physician Decision|0|||
160763765|NCT03118934|580524770|FG005|Overall Study|Physician Decision|1|||
160763766|NCT03118934|580524765|FG000|Overall Study|Discontinued prior to exposure|0|||
160763767|NCT03118934|580524766|FG001|Overall Study|Discontinued prior to exposure|1|||
160763768|NCT03118934|580524767|FG002|Overall Study|Discontinued prior to exposure|1|||
160763769|NCT03118934|580524768|FG003|Overall Study|Discontinued prior to exposure|1|||
160763770|NCT03118934|580524769|FG004|Overall Study|Discontinued prior to exposure|2|||
160763771|NCT03118934|580524770|FG005|Overall Study|Discontinued prior to exposure|0|||
160763772|NCT02175121|580524771|FG000|Overall Study|Lack of Efficacy|1|||
160763773|NCT02175121|580524772|FG001|Overall Study|Lack of Efficacy|0|||
160763774|NCT02175121|580524773|FG002|Overall Study|Lack of Efficacy|0|||
160763775|NCT02175121|580524774|FG003|Overall Study|Lack of Efficacy|0|||
160763776|NCT02175121|580524775|FG004|Overall Study|Lack of Efficacy|0|||
160763777|NCT02175121|580524771|FG000|Overall Study|Lost to Follow-up|0|||
160763778|NCT02175121|580524772|FG001|Overall Study|Lost to Follow-up|1|||
160763779|NCT02175121|580524773|FG002|Overall Study|Lost to Follow-up|0|||
160763780|NCT02175121|580524774|FG003|Overall Study|Lost to Follow-up|1|||
160763781|NCT02175121|580524775|FG004|Overall Study|Lost to Follow-up|0|||
160763782|NCT02175121|580524771|FG000|Overall Study|Personal emergency|0|||
160763783|NCT02175121|580524772|FG001|Overall Study|Personal emergency|0|||
160763784|NCT02175121|580524773|FG002|Overall Study|Personal emergency|0|||
160763785|NCT02175121|580524774|FG003|Overall Study|Personal emergency|0|||
160763786|NCT02175121|580524775|FG004|Overall Study|Personal emergency|1|||
160763787|NCT02175121|580524771|FG000|Overall Study|Schedule conflict|0|||
160763788|NCT02175121|580524772|FG001|Overall Study|Schedule conflict|0|||
160763789|NCT02175121|580524773|FG002|Overall Study|Schedule conflict|1|||
160763790|NCT02175121|580524774|FG003|Overall Study|Schedule conflict|0|||
160763791|NCT02175121|580524775|FG004|Overall Study|Schedule conflict|0|||
160763792|NCT02175121|580524771|FG000|Overall Study|Time issues|0|||
160763793|NCT02175121|580524772|FG001|Overall Study|Time issues|0|||
160763794|NCT02175121|580524773|FG002|Overall Study|Time issues|1|||
160763795|NCT02175121|580524774|FG003|Overall Study|Time issues|0|||
160868009|NCT00477386|580908194|FG001|Overall Study|Withdrawal by Subject|0|||
160868010|NCT01254422|580908195|FG000|Overall Study|Protocol Violation|1|||
160868011|NCT01254422|580908196|FG001|Overall Study|Protocol Violation|0|||
160868012|NCT01254422|580908195|FG000|Overall Study|Adverse Event|1|||
160868013|NCT01254422|580908196|FG001|Overall Study|Adverse Event|0|||
160868014|NCT01254422|580908195|FG000|Overall Study|Serious adverse event|0|||
160868015|NCT01254422|580908196|FG001|Overall Study|Serious adverse event|1|||
160868016|NCT01254422|580908195|FG000|Overall Study|Lost to Follow-up|1|||
160868017|NCT01254422|580908196|FG001|Overall Study|Lost to Follow-up|0|||
160868018|NCT00643162|580908197|FG000|Overall Study|Withdrawal by Subject|1|||
160868019|NCT00643162|580908198|FG001|Overall Study|Withdrawal by Subject|1|||
160868020|NCT05038982|580908199|FG000|Overall Study|Withdrawal by Subject|0|||
160868021|NCT05038982|580908200|FG001|Overall Study|Withdrawal by Subject|2|||
160868022|NCT02592798|580908203|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
160868023|NCT02592798|580908204|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
160868024|NCT02592798|580908203|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
160868025|NCT02592798|580908204|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
160868026|NCT02592798|580908203|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
160868027|NCT02592798|580908204|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
160868028|NCT02592798|580908203|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
160868029|NCT02592798|580908204|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
160868030|NCT02592798|580908203|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
160868031|NCT02592798|580908204|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
160868032|NCT02592798|580908203|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
160868033|NCT02592798|580908204|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
160868034|NCT02592798|580908203|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
160868035|NCT02592798|580908204|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
160868036|NCT02592798|580908203|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
160868037|NCT02592798|580908204|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
160868038|NCT02592798|580908203|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
160868039|NCT02592798|580908204|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
160868040|NCT02592798|580908203|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
160868041|NCT02592798|580908204|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
160868042|NCT02592798|580908203|FG000|Transition From DB2 to OLE|Other reasons|1|||
160868043|NCT02592798|580908204|FG001|Transition From DB2 to OLE|Other reasons|0|||
160868044|NCT02592798|580908203|FG000|Open Label Period (OLE)|Other reasons|0|||
160868045|NCT02592798|580908204|FG001|Open Label Period (OLE)|Other reasons|2|||
160868046|NCT02592798|580908203|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
160868047|NCT02592798|580908204|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
160868048|NCT02592798|580908203|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
160868049|NCT02592798|580908204|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
160868050|NCT02592798|580908203|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
160868051|NCT02592798|580908204|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
160868052|NCT02592798|580908203|FG000|Open Label Period (OLE)|Adverse Event|0|||
160868053|NCT02592798|580908204|FG001|Open Label Period (OLE)|Adverse Event|1|||
160868054|NCT01143246|580908205|FG000|Overall Study|Adverse Event|24|||
160868055|NCT01143246|580908206|FG001|Overall Study|Adverse Event|28|||
160868056|NCT01143246|580908205|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
160868057|NCT01143246|580908206|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
160868058|NCT01143246|580908205|FG000|Overall Study|Lost to Follow-up|0|||
160868059|NCT01143246|580908206|FG001|Overall Study|Lost to Follow-up|1|||
160868060|NCT01143246|580908205|FG000|Overall Study|Death|16|||
160868061|NCT01143246|580908206|FG001|Overall Study|Death|15|||
160868062|NCT01143246|580908205|FG000|Overall Study|Reason not Specified|3|||
160868063|NCT01143246|580908206|FG001|Overall Study|Reason not Specified|5|||
160868064|NCT01146795|580908207|FG000|Overall Study|Withdrawal by Subject|4|||
160868065|NCT01146795|580908207|FG000|Overall Study|Adverse Event|6|||
160527163|NCT01324323|579660905|FG000|Overall Study|Withdrawal by Subject|1|||
160527164|NCT00537485|579660906|FG000|Overall Study|Adverse Event|10|||
160868066|NCT01146795|580908207|FG000|Overall Study|Still in treatment at study closure|10|||
160868067|NCT05375760|580908208|FG000|Overall Study|Adverse Event|1|||
160868068|NCT05375760|580908209|FG001|Overall Study|Adverse Event|0|||
160868069|NCT05375760|580908208|FG000|Overall Study|Death|0|||
160527165|NCT00537485|579660907|FG001|Overall Study|Adverse Event|5|||
160868070|NCT05375760|580908209|FG001|Overall Study|Death|1|||
160868071|NCT05375760|580908208|FG000|Overall Study|Lost to Follow-up|6|||
160868072|NCT05375760|580908209|FG001|Overall Study|Lost to Follow-up|6|||
160868073|NCT05375760|580908208|FG000|Overall Study|Withdrawal by Subject|17|||
160868074|NCT05375760|580908209|FG001|Overall Study|Withdrawal by Subject|19|||
160868075|NCT05375760|580908208|FG000|Overall Study|Dosing halted by FDA|96|||
160868076|NCT05375760|580908209|FG001|Overall Study|Dosing halted by FDA|100|||
160868077|NCT05375760|580908208|FG000|Overall Study|Not compliant with study visit|2|||
160868078|NCT05375760|580908209|FG001|Overall Study|Not compliant with study visit|0|||
160868079|NCT05375760|580908208|FG000|Overall Study|Physician Decision|1|||
160763796|NCT02175121|580524775|FG004|Overall Study|Time issues|0|||
160763797|NCT03014206|580524782|FG000|Overall Study|Registration Violation|12|||
160763798|NCT03139552|580524786|FG000|Overall Study|unable to attend tasting due to schedule|3|||
160763799|NCT00264147|580524787|FG000|Treatment I Period|Adverse Event|3|||
160763800|NCT00264147|580524788|FG001|Treatment I Period|Adverse Event|6|||
160763801|NCT00264147|580524789|FG002|Treatment I Period|Adverse Event|3|||
160763802|NCT00264147|580524790|FG003|Treatment I Period|Adverse Event|5|||
160763803|NCT00264147|580524791|FG004|Treatment I Period|Adverse Event|7|||
160763804|NCT00264147|580524792|FG005|Treatment I Period|Adverse Event|0|||
160763805|NCT00264147|580524787|FG000|Treatment I Period|Laboratory Adverse Event|0|||
160763806|NCT00264147|580524788|FG001|Treatment I Period|Laboratory Adverse Event|0|||
160763807|NCT00264147|580524789|FG002|Treatment I Period|Laboratory Adverse Event|0|||
160763808|NCT00264147|580524790|FG003|Treatment I Period|Laboratory Adverse Event|1|||
160763809|NCT00264147|580524791|FG004|Treatment I Period|Laboratory Adverse Event|0|||
160763810|NCT00264147|580524792|FG005|Treatment I Period|Laboratory Adverse Event|0|||
160763811|NCT00264147|580524787|FG000|Treatment I Period|Lack of Efficacy|6|||
160763812|NCT00264147|580524788|FG001|Treatment I Period|Lack of Efficacy|2|||
160763813|NCT00264147|580524789|FG002|Treatment I Period|Lack of Efficacy|8|||
160763814|NCT00264147|580524790|FG003|Treatment I Period|Lack of Efficacy|0|||
160763815|NCT00264147|580524791|FG004|Treatment I Period|Lack of Efficacy|1|||
160763816|NCT00264147|580524792|FG005|Treatment I Period|Lack of Efficacy|0|||
160763817|NCT00264147|580524787|FG000|Treatment I Period|Lost to Follow-up|1|||
160763818|NCT00264147|580524788|FG001|Treatment I Period|Lost to Follow-up|0|||
160763819|NCT00264147|580524789|FG002|Treatment I Period|Lost to Follow-up|0|||
160763820|NCT00264147|580524790|FG003|Treatment I Period|Lost to Follow-up|1|||
160763821|NCT00264147|580524791|FG004|Treatment I Period|Lost to Follow-up|1|||
160763822|NCT00264147|580524792|FG005|Treatment I Period|Lost to Follow-up|0|||
160763823|NCT00264147|580524787|FG000|Treatment I Period|Protocol Violation|2|||
160763824|NCT00264147|580524788|FG001|Treatment I Period|Protocol Violation|2|||
160763825|NCT00264147|580524789|FG002|Treatment I Period|Protocol Violation|0|||
160763826|NCT00264147|580524790|FG003|Treatment I Period|Protocol Violation|0|||
160763827|NCT00264147|580524791|FG004|Treatment I Period|Protocol Violation|0|||
160763828|NCT00264147|580524792|FG005|Treatment I Period|Protocol Violation|0|||
160763829|NCT00264147|580524787|FG000|Treatment I Period|Withdrawal by Subject|2|||
160763830|NCT00264147|580524788|FG001|Treatment I Period|Withdrawal by Subject|0|||
160763831|NCT00264147|580524789|FG002|Treatment I Period|Withdrawal by Subject|0|||
160763832|NCT00264147|580524790|FG003|Treatment I Period|Withdrawal by Subject|2|||
160763833|NCT00264147|580524791|FG004|Treatment I Period|Withdrawal by Subject|2|||
160763834|NCT00264147|580524792|FG005|Treatment I Period|Withdrawal by Subject|0|||
160763835|NCT00264147|580524787|FG000|Treatment I Period|Patient out of town for an extended time|0|||
160763836|NCT00264147|580524788|FG001|Treatment I Period|Patient out of town for an extended time|1|||
160763837|NCT00264147|580524789|FG002|Treatment I Period|Patient out of town for an extended time|0|||
160763838|NCT00264147|580524790|FG003|Treatment I Period|Patient out of town for an extended time|0|||
160763839|NCT00264147|580524791|FG004|Treatment I Period|Patient out of town for an extended time|0|||
160763840|NCT00264147|580524792|FG005|Treatment I Period|Patient out of town for an extended time|0|||
160763841|NCT00264147|580524787|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
160763842|NCT00264147|580524788|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
160763843|NCT00264147|580524789|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
160763844|NCT00264147|580524790|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
160763845|NCT00264147|580524791|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
160763846|NCT00264147|580524792|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
160763847|NCT00264147|580524787|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
160763848|NCT00264147|580524788|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
160763849|NCT00264147|580524789|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
160763850|NCT00264147|580524790|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
160763851|NCT00264147|580524791|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
160763852|NCT00264147|580524792|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
160763853|NCT00264147|580524787|FG000|Treatment II Period|Adverse Event|0|||
160763854|NCT00264147|580524788|FG001|Treatment II Period|Adverse Event|0|||
160763855|NCT00264147|580524789|FG002|Treatment II Period|Adverse Event|0|||
160763856|NCT00264147|580524790|FG003|Treatment II Period|Adverse Event|0|||
160763857|NCT00264147|580524791|FG004|Treatment II Period|Adverse Event|9|||
160763858|NCT00264147|580524792|FG005|Treatment II Period|Adverse Event|9|||
160763859|NCT00264147|580524787|FG000|Treatment II Period|Laboratory Adverse Event|0|||
160453945|NCT02505984|579393978|FG001|Overall Study|Study blind opened during assessment|1|||
160763860|NCT00264147|580524788|FG001|Treatment II Period|Laboratory Adverse Event|0|||
160763861|NCT00264147|580524789|FG002|Treatment II Period|Laboratory Adverse Event|0|||
160763862|NCT00264147|580524790|FG003|Treatment II Period|Laboratory Adverse Event|0|||
160763863|NCT00264147|580524791|FG004|Treatment II Period|Laboratory Adverse Event|0|||
160763864|NCT00264147|580524792|FG005|Treatment II Period|Laboratory Adverse Event|1|||
160763865|NCT00264147|580524787|FG000|Treatment II Period|Lack of Efficacy|0|||
160763866|NCT00264147|580524788|FG001|Treatment II Period|Lack of Efficacy|0|||
160763867|NCT00264147|580524789|FG002|Treatment II Period|Lack of Efficacy|0|||
160763868|NCT00264147|580524790|FG003|Treatment II Period|Lack of Efficacy|0|||
160763869|NCT00264147|580524791|FG004|Treatment II Period|Lack of Efficacy|20|||
160763870|NCT00264147|580524792|FG005|Treatment II Period|Lack of Efficacy|19|||
160763871|NCT00264147|580524787|FG000|Treatment II Period|Lost to Follow-up|0|||
160763872|NCT00264147|580524788|FG001|Treatment II Period|Lost to Follow-up|0|||
160763873|NCT00264147|580524789|FG002|Treatment II Period|Lost to Follow-up|0|||
160763874|NCT00264147|580524790|FG003|Treatment II Period|Lost to Follow-up|0|||
160763875|NCT00264147|580524791|FG004|Treatment II Period|Lost to Follow-up|1|||
160763876|NCT00264147|580524792|FG005|Treatment II Period|Lost to Follow-up|1|||
160763877|NCT00264147|580524787|FG000|Treatment II Period|Withdrawal by Subject|0|||
160763878|NCT00264147|580524788|FG001|Treatment II Period|Withdrawal by Subject|0|||
160763879|NCT00264147|580524789|FG002|Treatment II Period|Withdrawal by Subject|0|||
160763880|NCT00264147|580524790|FG003|Treatment II Period|Withdrawal by Subject|0|||
160763881|NCT00264147|580524791|FG004|Treatment II Period|Withdrawal by Subject|3|||
160763882|NCT00264147|580524792|FG005|Treatment II Period|Withdrawal by Subject|2|||
160763883|NCT00264147|580524787|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
160763884|NCT00264147|580524788|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
160763885|NCT00264147|580524789|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
160763886|NCT00264147|580524790|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
160763887|NCT00264147|580524791|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
160763888|NCT00264147|580524792|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
160763889|NCT03234465|580524793|FG000|Overall Study|Adverse Event|4|||
160763890|NCT03234465|580524794|FG001|Overall Study|Adverse Event|2|||
160763891|NCT03234465|580524793|FG000|Overall Study|Death|0|||
160763892|NCT03234465|580524794|FG001|Overall Study|Death|1|||
160763893|NCT03234465|580524793|FG000|Overall Study|Lost to Follow-up|1|||
160763894|NCT03234465|580524794|FG001|Overall Study|Lost to Follow-up|1|||
160763895|NCT03234465|580524793|FG000|Overall Study|Withdrawal by Subject|12|||
160763896|NCT03234465|580524794|FG001|Overall Study|Withdrawal by Subject|27|||
160763897|NCT03234465|580524793|FG000|Overall Study|Symptomatic deterioration|0|||
160763898|NCT03234465|580524794|FG001|Overall Study|Symptomatic deterioration|1|||
160763899|NCT03234465|580524793|FG000|Overall Study|Non-compliance|2|||
160763900|NCT03234465|580524794|FG001|Overall Study|Non-compliance|0|||
160763901|NCT03234465|580524793|FG000|Overall Study|Other|14|||
160763902|NCT03234465|580524794|FG001|Overall Study|Other|8|||
160763903|NCT02949947|580524799|FG000|Overall Study|Non Compliance|0|||
160763904|NCT02949947|580524800|FG001|Overall Study|Non Compliance|1|||
160763905|NCT02949947|580524799|FG000|Overall Study|Insurance change|1|||
160763906|NCT02949947|580524800|FG001|Overall Study|Insurance change|0|||
160763907|NCT00794664|580524801|FG000|Treatment Period|Withdrawal by Subject|0|||
160763908|NCT00794664|580524802|FG001|Treatment Period|Withdrawal by Subject|2|||
160763909|NCT00794664|580524801|FG000|Treatment Period|Protocol non-compliance|0|||
160763910|NCT00794664|580524802|FG001|Treatment Period|Protocol non-compliance|1|||
160763911|NCT00794664|580524801|FG000|Treatment Period|Other|0|||
160763912|NCT00794664|580524802|FG001|Treatment Period|Other|1|||
160763913|NCT00794664|580524801|FG000|Treatment Period|Adverse Event|1|||
160763914|NCT00794664|580524802|FG001|Treatment Period|Adverse Event|8|||
160763915|NCT00794664|580524801|FG000|Follow-up Period|Other|1|||
160763916|NCT00794664|580524802|FG001|Follow-up Period|Other|2|||
160763917|NCT00794664|580524801|FG000|Follow-up Period|Withdrawal by Subject|0|||
160763918|NCT00794664|580524802|FG001|Follow-up Period|Withdrawal by Subject|2|||
160763919|NCT00794664|580524801|FG000|Follow-up Period|Protocol non-compliance|0|||
160763920|NCT00794664|580524802|FG001|Follow-up Period|Protocol non-compliance|1|||
160763921|NCT00720499|580524803|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
160763922|NCT00720499|580524804|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
160763923|NCT00720499|580524803|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
160763924|NCT00720499|580524804|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
160763925|NCT00720499|580524803|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
160763926|NCT00720499|580524804|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
160763927|NCT01973218|580524805|FG000|Overall Study|Adverse Event|1|||
160763928|NCT01973218|580524806|FG001|Overall Study|Adverse Event|0|||
160763929|NCT01973218|580524805|FG000|Overall Study|Withdrawal by Subject|1|||
160763930|NCT01973218|580524806|FG001|Overall Study|Withdrawal by Subject|0|||
160763931|NCT02247466|580524807|FG000|Overall Study|Procedure changed to open surgery|0|||
160763932|NCT02247466|580524808|FG001|Overall Study|Procedure changed to open surgery|3|||
160763933|NCT00492726|580524809|FG000|Overall Study|Adverse Event|10|||
160763934|NCT00492726|580524810|FG001|Overall Study|Adverse Event|6|||
160763935|NCT00492726|580524809|FG000|Overall Study|Death|7|||
160763936|NCT00492726|580524810|FG001|Overall Study|Death|2|||
160763937|NCT00492726|580524809|FG000|Overall Study|Lack of Efficacy|0|||
160763938|NCT00492726|580524810|FG001|Overall Study|Lack of Efficacy|2|||
160763939|NCT00492726|580524809|FG000|Overall Study|Lost to Follow-up|27|||
160763940|NCT00492726|580524810|FG001|Overall Study|Lost to Follow-up|19|||
160763941|NCT00492726|580524809|FG000|Overall Study|Physician Decision|0|||
160763942|NCT00492726|580524810|FG001|Overall Study|Physician Decision|1|||
160763943|NCT00492726|580524809|FG000|Overall Study|Withdrawal by Subject|6|||
160763944|NCT00492726|580524810|FG001|Overall Study|Withdrawal by Subject|3|||
160763945|NCT00492726|580524809|FG000|Overall Study|Non compliant with study medication|0|||
160763946|NCT00492726|580524810|FG001|Overall Study|Non compliant with study medication|3|||
160763947|NCT04386902|580524811|FG000|Overall Study|Withdrawal by Subject|5|||
160763948|NCT04386902|580524811|FG000|Overall Study|Technical problems in the recording|5|||
160763949|NCT01100502|580524812|FG000|Overall Study|Withdrawal by Subject|18|||
160763950|NCT01100502|580524813|FG001|Overall Study|Withdrawal by Subject|25|||
160763951|NCT01100502|580524812|FG000|Overall Study|Lost to Follow-up|13|||
160763952|NCT01100502|580524813|FG001|Overall Study|Lost to Follow-up|28|||
160763953|NCT01100502|580524812|FG000|Overall Study|Site request to end participation in study|0|||
160763954|NCT01100502|580524813|FG001|Overall Study|Site request to end participation in study|1|||
160763955|NCT01100502|580524812|FG000|Overall Study|Death|45|||
160763956|NCT01100502|580524813|FG001|Overall Study|Death|40|||
160763957|NCT04356937|580524821|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
160763958|NCT04356937|580524822|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
160763959|NCT00807365|580524823|FG000|Overall Study|Study Terminated|5|||
160763960|NCT00960804|580524824|FG000|Overall Study|Adverse Event|1|||
160763961|NCT00960804|580524825|FG001|Overall Study|Adverse Event|0|||
160763962|NCT00960804|580524826|FG002|Overall Study|Adverse Event|0|||
160763963|NCT00960804|580524824|FG000|Overall Study|Withdrawal by Subject|1|||
160763964|NCT00960804|580524825|FG001|Overall Study|Withdrawal by Subject|0|||
160763965|NCT00960804|580524826|FG002|Overall Study|Withdrawal by Subject|0|||
160763966|NCT00960804|580524824|FG000|Overall Study|Study terminated by the sponsor|5|||
160763967|NCT00960804|580524825|FG001|Overall Study|Study terminated by the sponsor|4|||
160763968|NCT00960804|580524826|FG002|Overall Study|Study terminated by the sponsor|10|||
160763969|NCT02007720|580524827|FG000|Overall Study|Withdrawal by Subject|9|||
160763970|NCT02007720|580524828|FG001|Overall Study|Withdrawal by Subject|11|||
160763971|NCT02007720|580524827|FG000|Overall Study|study terminated by sponsor|58|||
160763972|NCT02007720|580524828|FG001|Overall Study|study terminated by sponsor|54|||
160763973|NCT02007720|580524827|FG000|Overall Study|technical problem|4|||
160763974|NCT02007720|580524828|FG001|Overall Study|technical problem|2|||
160763975|NCT02007720|580524827|FG000|Overall Study|patient followd less than 165 days|11|||
160763976|NCT02007720|580524828|FG001|Overall Study|patient followd less than 165 days|5|||
160763977|NCT02100124|580524832|FG000|Overall Study|Lost to Follow-up|5|||
160763978|NCT02100124|580524833|FG001|Overall Study|Lost to Follow-up|11|||
160763979|NCT02100124|580524834|FG002|Overall Study|Lost to Follow-up|3|||
160763980|NCT02100124|580524832|FG000|Overall Study|Withdrawal by Subject|1|||
160763981|NCT02100124|580524833|FG001|Overall Study|Withdrawal by Subject|0|||
160763982|NCT02100124|580524834|FG002|Overall Study|Withdrawal by Subject|0|||
160763983|NCT02034006|580526248|FG000|Overall Study|Withdrawal by Subject|7|||
160763984|NCT02034006|580526248|FG000|Overall Study|Lost to Follow-up|5|||
160763985|NCT02034006|580526248|FG000|Overall Study|Death|1|||
160763986|NCT02034006|580526248|FG000|Overall Study|Pregnancy|1|||
160763987|NCT00161213|580526251|FG000|Overall Study|Withdrawal by Subject|1|||
160763988|NCT00161213|580526251|FG000|Overall Study|Evaluable for toxicity but not response|1|||
160763989|NCT01926028|580526252|FG000|Overall Study|Lost to Follow-up|7|||
160763990|NCT01926028|580526253|FG001|Overall Study|Lost to Follow-up|6|||
160763991|NCT01926028|580526254|FG002|Overall Study|Lost to Follow-up|0|||
160763992|NCT01926028|580526252|FG000|Overall Study|Physician Decision|1|||
160763993|NCT01926028|580526253|FG001|Overall Study|Physician Decision|5|||
160763994|NCT01926028|580526254|FG002|Overall Study|Physician Decision|0|||
160763995|NCT01926028|580526252|FG000|Overall Study|Withdrawal by Subject|9|||
160763996|NCT01926028|580526253|FG001|Overall Study|Withdrawal by Subject|9|||
160763997|NCT01926028|580526254|FG002|Overall Study|Withdrawal by Subject|2|||
160763998|NCT01926028|580526252|FG000|Overall Study|Non compliance or other reasons|4|||
160763999|NCT01926028|580526253|FG001|Overall Study|Non compliance or other reasons|2|||
160764000|NCT01926028|580526254|FG002|Overall Study|Non compliance or other reasons|0|||
160764001|NCT02351934|580526255|FG000|Allocation|POD weight<pre-op weight|3|||
160764002|NCT02351934|580526256|FG001|Allocation|POD weight<pre-op weight|0|||
160764003|NCT02351934|580526255|FG000|Allocation|Hypotension preventing administration|2|||
160764004|NCT02351934|580526256|FG001|Allocation|Hypotension preventing administration|0|||
160764005|NCT02351934|580526255|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
160764006|NCT02351934|580526256|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
160764007|NCT02351934|580526255|FG000|Follow-Up|POD weight<pre-op weight|3|||
160764008|NCT02351934|580526256|FG001|Follow-Up|POD weight<pre-op weight|0|||
160764009|NCT02351934|580526255|FG000|Follow-Up|Acute Kidney Injury|1|||
160764010|NCT02351934|580526256|FG001|Follow-Up|Acute Kidney Injury|0|||
160764011|NCT02351934|580526255|FG000|Follow-Up|Early dismissal|3|||
160764012|NCT02351934|580526256|FG001|Follow-Up|Early dismissal|0|||
160764013|NCT02351934|580526255|FG000|Follow-Up|Hypotension|3|||
160764014|NCT02351934|580526256|FG001|Follow-Up|Hypotension|0|||
160764015|NCT02351934|580526255|FG000|Follow-Up|No documentation|2|||
160764016|NCT02351934|580526256|FG001|Follow-Up|No documentation|0|||
160764017|NCT02351934|580526255|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
160764018|NCT02351934|580526256|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
160527166|NCT00537485|579660906|FG000|Overall Study|Withdrawal by Subject|3|||
160527167|NCT00537485|579660907|FG001|Overall Study|Withdrawal by Subject|2|||
160527168|NCT00537485|579660906|FG000|Overall Study|Withdrawal by Subject|1|||
160868080|NCT05375760|580908209|FG001|Overall Study|Physician Decision|0|||
160527169|NCT00537485|579660907|FG001|Overall Study|Withdrawal by Subject|3|||
160527170|NCT00537485|579660906|FG000|Overall Study|Physician Decision|1|||
160527171|NCT00537485|579660907|FG001|Overall Study|Physician Decision|0|||
160527172|NCT01601847|579660916|FG000|Overall Study|Death|1|||
160527173|NCT01601847|579660917|FG001|Overall Study|Death|0|||
160527174|NCT01601847|579660916|FG000|Overall Study|Withdrawal by Subject|11|||
160527175|NCT01601847|579660917|FG001|Overall Study|Withdrawal by Subject|7|||
160527176|NCT01601847|579660916|FG000|Overall Study|Lost to Follow-up|1|||
160527177|NCT01601847|579660917|FG001|Overall Study|Lost to Follow-up|3|||
160527178|NCT00631189|579660918|FG000|Initial Phase|Protocol Violation|347|||
160527179|NCT00631189|579660919|FG001|Initial Phase|Protocol Violation|0|||
160527180|NCT00631189|579660920|FG002|Initial Phase|Protocol Violation|0|||
160527181|NCT00631189|579660921|FG003|Initial Phase|Protocol Violation|0|||
160527182|NCT00631189|579660918|FG000|Initial Phase|Withdrawal by Subject|4|||
160527183|NCT00631189|579660919|FG001|Initial Phase|Withdrawal by Subject|0|||
160527184|NCT00631189|579660920|FG002|Initial Phase|Withdrawal by Subject|0|||
160527185|NCT00631189|579660921|FG003|Initial Phase|Withdrawal by Subject|0|||
160527186|NCT00631189|579660918|FG000|Treatment Phase|Withdrawal by Subject|0|||
160527187|NCT00631189|579660919|FG001|Treatment Phase|Withdrawal by Subject|2|||
160527188|NCT00631189|579660920|FG002|Treatment Phase|Withdrawal by Subject|1|||
160527189|NCT00631189|579660921|FG003|Treatment Phase|Withdrawal by Subject|1|||
160527190|NCT00631189|579660918|FG000|Treatment Phase|Protocol Violation|0|||
160527191|NCT00631189|579660919|FG001|Treatment Phase|Protocol Violation|1|||
160527192|NCT00631189|579660920|FG002|Treatment Phase|Protocol Violation|6|||
160527193|NCT00631189|579660921|FG003|Treatment Phase|Protocol Violation|2|||
160527194|NCT00631189|579660918|FG000|Treatment Phase|Adverse Event|0|||
160527195|NCT00631189|579660919|FG001|Treatment Phase|Adverse Event|3|||
160527196|NCT00631189|579660920|FG002|Treatment Phase|Adverse Event|2|||
160527197|NCT00631189|579660921|FG003|Treatment Phase|Adverse Event|4|||
160527198|NCT00631189|579660918|FG000|Treatment Phase|Lost to Follow-up|0|||
160527199|NCT00631189|579660919|FG001|Treatment Phase|Lost to Follow-up|1|||
160527200|NCT00631189|579660920|FG002|Treatment Phase|Lost to Follow-up|0|||
160527201|NCT00631189|579660921|FG003|Treatment Phase|Lost to Follow-up|0|||
160527202|NCT00631189|579660918|FG000|Treatment Phase|Pregnancy|0|||
160527203|NCT00631189|579660919|FG001|Treatment Phase|Pregnancy|0|||
160527204|NCT00631189|579660920|FG002|Treatment Phase|Pregnancy|1|||
160527205|NCT00631189|579660921|FG003|Treatment Phase|Pregnancy|0|||
160527206|NCT00631189|579660918|FG000|Treatment Phase|patient did not take pravastatin|0|||
160527207|NCT00631189|579660919|FG001|Treatment Phase|patient did not take pravastatin|0|||
160527208|NCT00631189|579660920|FG002|Treatment Phase|patient did not take pravastatin|1|||
160527209|NCT00631189|579660921|FG003|Treatment Phase|patient did not take pravastatin|0|||
160527210|NCT01284062|579660922|FG000|Overall Study|Adverse Event|4|||
160527211|NCT01284062|579660923|FG001|Overall Study|Adverse Event|5|||
160527212|NCT01284062|579660924|FG002|Overall Study|Adverse Event|0|||
160527213|NCT01284062|579660925|FG003|Overall Study|Adverse Event|5|||
160527214|NCT01284062|579660922|FG000|Overall Study|Lack of Efficacy|3|||
160527215|NCT01284062|579660923|FG001|Overall Study|Lack of Efficacy|2|||
160527216|NCT01284062|579660924|FG002|Overall Study|Lack of Efficacy|2|||
160527217|NCT01284062|579660925|FG003|Overall Study|Lack of Efficacy|1|||
160527218|NCT01284062|579660922|FG000|Overall Study|Medication error without adverse event|0|||
160527219|NCT01284062|579660923|FG001|Overall Study|Medication error without adverse event|0|||
160527220|NCT01284062|579660924|FG002|Overall Study|Medication error without adverse event|1|||
160527221|NCT01284062|579660925|FG003|Overall Study|Medication error without adverse event|0|||
160527222|NCT01284062|579660922|FG000|Overall Study|Protocol Violation|1|||
160527223|NCT01284062|579660923|FG001|Overall Study|Protocol Violation|0|||
160527224|NCT01284062|579660924|FG002|Overall Study|Protocol Violation|0|||
160527225|NCT01284062|579660925|FG003|Overall Study|Protocol Violation|2|||
160527226|NCT01284062|579660922|FG000|Overall Study|Withdrawal by Subject|3|||
160527227|NCT01284062|579660923|FG001|Overall Study|Withdrawal by Subject|1|||
160527228|NCT01284062|579660924|FG002|Overall Study|Withdrawal by Subject|2|||
160527229|NCT01284062|579660925|FG003|Overall Study|Withdrawal by Subject|5|||
160527230|NCT01284062|579660922|FG000|Overall Study|Other|0|||
160527231|NCT01284062|579660923|FG001|Overall Study|Other|0|||
160527232|NCT01284062|579660924|FG002|Overall Study|Other|0|||
160527233|NCT01284062|579660925|FG003|Overall Study|Other|1|||
160527234|NCT01284062|579660922|FG000|Overall Study|Site Closed|0|||
160527235|NCT01284062|579660923|FG001|Overall Study|Site Closed|0|||
160527236|NCT01284062|579660924|FG002|Overall Study|Site Closed|1|||
160527237|NCT01284062|579660925|FG003|Overall Study|Site Closed|0|||
160527238|NCT03189862|579660926|FG000|Overall Study|Withdrawal by Subject|1|||
160527239|NCT03189862|579660927|FG001|Overall Study|Withdrawal by Subject|0|||
160527240|NCT03189862|579660926|FG000|Overall Study|Lost to Follow-up|54|||
160527241|NCT03189862|579660927|FG001|Overall Study|Lost to Follow-up|62|||
160527242|NCT00931944|579660929|FG000|Overall Study|Adverse Event|4|||
160764019|NCT02351934|580526255|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
160764020|NCT02351934|580526256|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
160764021|NCT04635839|580526257|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
160764022|NCT04635839|580526258|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
160764023|NCT02870868|580526259|FG000|Overall Study|Withdrawal by Subject|2|||
160764024|NCT02870868|580526260|FG001|Overall Study|Withdrawal by Subject|1|||
160764025|NCT00288912|580526261|FG000|Overall Study|Developed exclusion criterion|4|||
160764026|NCT00288912|580526262|FG001|Overall Study|Developed exclusion criterion|6|||
160764027|NCT00288912|580526263|FG002|Overall Study|Developed exclusion criterion|7|||
160764028|NCT00288912|580526261|FG000|Overall Study|Lost to Follow-up|9|||
160764029|NCT00288912|580526262|FG001|Overall Study|Lost to Follow-up|6|||
160764030|NCT00288912|580526263|FG002|Overall Study|Lost to Follow-up|9|||
160764031|NCT00288912|580526261|FG000|Overall Study|Withdrawal by Subject|4|||
160764032|NCT00288912|580526262|FG001|Overall Study|Withdrawal by Subject|5|||
160764033|NCT00288912|580526263|FG002|Overall Study|Withdrawal by Subject|12|||
160764034|NCT02466399|580526264|FG000|Overall Study|Adverse Event|1|||
160764035|NCT02466399|580526265|FG001|Overall Study|Adverse Event|0|||
160764036|NCT02466399|580526264|FG000|Overall Study|Early exit due to family emergency|1|||
160764037|NCT02466399|580526265|FG001|Overall Study|Early exit due to family emergency|0|||
160764038|NCT02669849|580526270|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
160764039|NCT02669849|580526271|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
160764040|NCT02669849|580526272|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
160764041|NCT02669849|580526270|FG000|Overall Study|Lost to Follow-up|1|||
160764042|NCT02669849|580526271|FG001|Overall Study|Lost to Follow-up|0|||
160764043|NCT02669849|580526272|FG002|Overall Study|Lost to Follow-up|3|||
160764044|NCT02669849|580526270|FG000|Overall Study|Death|1|||
160764045|NCT02669849|580526271|FG001|Overall Study|Death|1|||
160764046|NCT02669849|580526272|FG002|Overall Study|Death|2|||
160764047|NCT02669849|580526270|FG000|Overall Study|Study terminated by sponsor|16|||
160764048|NCT02669849|580526271|FG001|Overall Study|Study terminated by sponsor|1|||
160764049|NCT02669849|580526272|FG002|Overall Study|Study terminated by sponsor|14|||
160764050|NCT02669849|580526270|FG000|Overall Study|Other|0|||
160764051|NCT02669849|580526271|FG001|Overall Study|Other|0|||
160764052|NCT02669849|580526272|FG002|Overall Study|Other|2|||
160764053|NCT03408899|580526273|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
160764054|NCT00606008|580526274|FG000|Overall Study|Adverse Event|1|||
160764055|NCT00606008|580526274|FG000|Overall Study|Withdrawal by Subject|4|||
160764056|NCT04745351|580526275|FG000|Overall Study|Death|51|||
160764057|NCT04745351|580526276|FG001|Overall Study|Death|25|||
160764058|NCT04745351|580526275|FG000|Overall Study|Lost to Follow-up|9|||
160764059|NCT04745351|580526276|FG001|Overall Study|Lost to Follow-up|3|||
160764060|NCT04745351|580526275|FG000|Overall Study|Randomized but Never Treated|3|||
160764061|NCT04745351|580526276|FG001|Overall Study|Randomized but Never Treated|3|||
160764062|NCT04745351|580526275|FG000|Overall Study|Adverse Event|4|||
160764063|NCT04745351|580526276|FG001|Overall Study|Adverse Event|0|||
160764064|NCT04745351|580526275|FG000|Overall Study|Withdrew Consent|1|||
160764065|NCT04745351|580526276|FG001|Overall Study|Withdrew Consent|2|||
160764066|NCT04745351|580526275|FG000|Overall Study|Investigator's Discretion|2|||
160764067|NCT04745351|580526276|FG001|Overall Study|Investigator's Discretion|0|||
160764068|NCT04745351|580526275|FG000|Overall Study|Protocol Violation|1|||
160764069|NCT04745351|580526276|FG001|Overall Study|Protocol Violation|0|||
160764070|NCT02014272|580526280|FG000|Intervention Period 1|Withdrawal by Subject|1|||
160764071|NCT02014272|580526281|FG001|Intervention Period 1|Withdrawal by Subject|0|||
160868081|NCT05375760|580908208|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
160527243|NCT00931944|579660929|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
160527244|NCT00931944|579660929|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
160527245|NCT00931944|579660929|FG000|Overall Study|Death|28|||
160527246|NCT00931944|579660929|FG000|Overall Study|Other|2|||
160527247|NCT04233164|579660932|FG000|Overall Study|Unable to obtain specimen|0|||
160527248|NCT04233164|579660933|FG001|Overall Study|Unable to obtain specimen|1|||
160527249|NCT04201821|579660936|FG000|Overall Study|Withdrawal by Subject|2|||
160527250|NCT00651157|579660937|FG000|Overall Study|Death|1|||
160527251|NCT00651157|579660937|FG000|Overall Study|Protocol Violation|1|||
160527252|NCT00688181|579660939|FG000|Overall Study|Lost to Follow-up|17|||
160527253|NCT00688181|579660939|FG000|Overall Study|Unknown Reason|4|||
160764072|NCT02014272|580526280|FG000|Intervention Period 1|Adverse Event|0|||
160764073|NCT02014272|580526281|FG001|Intervention Period 1|Adverse Event|1|||
160764074|NCT03499795|580526282|FG000|Overall Study|Adverse Event|1|||
160764075|NCT03499795|580526282|FG000|Overall Study|Lost to Follow-up|1|||
160764076|NCT00547339|580526283|FG000|Overall Study|Physician Decision|0|||
160764077|NCT00547339|580526284|FG001|Overall Study|Physician Decision|0|||
160764078|NCT00547339|580526285|FG002|Overall Study|Physician Decision|1|||
160764079|NCT00547339|580526286|FG003|Overall Study|Physician Decision|0|||
160764080|NCT02426684|580526287|FG000|Overall Study|Physician Decision|1|||
160764081|NCT03736967|580526288|FG000|Overall Study|Withdrawal by Subject|26|||
160764082|NCT03736967|580526289|FG001|Overall Study|Withdrawal by Subject|25|||
160764083|NCT03736967|580526290|FG002|Overall Study|Withdrawal by Subject|23|||
160764084|NCT03736967|580526291|FG003|Overall Study|Withdrawal by Subject|26|||
160764085|NCT03736967|580526288|FG000|Overall Study|Lost to Follow-up|3|||
160764086|NCT03736967|580526289|FG001|Overall Study|Lost to Follow-up|2|||
160764087|NCT03736967|580526290|FG002|Overall Study|Lost to Follow-up|1|||
160764088|NCT03736967|580526291|FG003|Overall Study|Lost to Follow-up|1|||
160764089|NCT03736967|580526288|FG000|Overall Study|Physician Decision|1|||
160764090|NCT03736967|580526289|FG001|Overall Study|Physician Decision|0|||
160764091|NCT03736967|580526290|FG002|Overall Study|Physician Decision|0|||
160764092|NCT03736967|580526291|FG003|Overall Study|Physician Decision|1|||
160764093|NCT03736967|580526288|FG000|Overall Study|Adverse Event|0|||
160764094|NCT03736967|580526289|FG001|Overall Study|Adverse Event|1|||
160764095|NCT03736967|580526290|FG002|Overall Study|Adverse Event|0|||
160764096|NCT03736967|580526291|FG003|Overall Study|Adverse Event|1|||
160764097|NCT03736967|580526288|FG000|Overall Study|Death|0|||
160764098|NCT03736967|580526289|FG001|Overall Study|Death|0|||
160764099|NCT03736967|580526290|FG002|Overall Study|Death|0|||
160764100|NCT03736967|580526291|FG003|Overall Study|Death|1|||
160764101|NCT03736967|580526288|FG000|Overall Study|Randomized but never treated|1|||
160764102|NCT03736967|580526289|FG001|Overall Study|Randomized but never treated|0|||
160764103|NCT03736967|580526290|FG002|Overall Study|Randomized but never treated|0|||
160764104|NCT03736967|580526291|FG003|Overall Study|Randomized but never treated|0|||
160764105|NCT01587885|580526292|FG000|Treatment Period 1|Failure to Return|0|||
160764106|NCT01587885|580526293|FG001|Treatment Period 1|Failure to Return|1|||
160764107|NCT01587885|580526292|FG000|Treatment Period 1|Protocol Violation|0|||
160764108|NCT01587885|580526293|FG001|Treatment Period 1|Protocol Violation|2|||
160764109|NCT01118299|580526295|FG000|Overall Study|Death|7|||
160764110|NCT01118299|580526296|FG001|Overall Study|Death|5|||
160764111|NCT01118299|580526295|FG000|Overall Study|Withdrawal by Subject|8|||
160764112|NCT01118299|580526296|FG001|Overall Study|Withdrawal by Subject|8|||
160764113|NCT01118299|580526295|FG000|Overall Study|Lost to Follow-up|2|||
160764114|NCT01118299|580526296|FG001|Overall Study|Lost to Follow-up|1|||
160764115|NCT01118299|580526295|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
160764116|NCT01118299|580526296|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
160764117|NCT01935089|580526297|FG000|Overall Study|Adverse Event|2|||
160764118|NCT01935089|580526297|FG000|Overall Study|Withdrawal by Subject|1|||
160764119|NCT02665117|580526300|FG000|Overall Study|Physician Decision|1|||
160764120|NCT02665117|580526301|FG001|Overall Study|Physician Decision|0|||
160764121|NCT00977197|580526305|FG000|Overall Study|Withdrawal by Subject|3|||
160764122|NCT00977197|580526306|FG001|Overall Study|Withdrawal by Subject|4|||
160764123|NCT00977197|580526305|FG000|Overall Study|Adverse Event|3|||
160764124|NCT00977197|580526306|FG001|Overall Study|Adverse Event|1|||
160764125|NCT00977197|580526305|FG000|Overall Study|Lack of Efficacy|1|||
160764126|NCT00977197|580526306|FG001|Overall Study|Lack of Efficacy|0|||
160764127|NCT00977197|580526305|FG000|Overall Study|Lost to Follow-up|1|||
160764128|NCT00977197|580526306|FG001|Overall Study|Lost to Follow-up|3|||
160764129|NCT00977197|580526305|FG000|Overall Study|Nonadherence|1|||
160764130|NCT00977197|580526306|FG001|Overall Study|Nonadherence|1|||
160764131|NCT01483118|580526307|FG000|Overall Study|Lost to Follow-up|12|||
160764132|NCT01483118|580526308|FG001|Overall Study|Lost to Follow-up|16|||
160764133|NCT01079780|580526310|FG000|Overall Study|Disease progression|43|||
160764134|NCT01079780|580526311|FG001|Overall Study|Disease progression|7|||
160764135|NCT01079780|580526312|FG002|Overall Study|Disease progression|31|||
160764136|NCT01079780|580526310|FG000|Overall Study|Adverse Event|13|||
160764137|NCT01079780|580526311|FG001|Overall Study|Adverse Event|5|||
160764138|NCT01079780|580526312|FG002|Overall Study|Adverse Event|7|||
160764139|NCT01079780|580526310|FG000|Overall Study|Death|2|||
160764140|NCT01079780|580526311|FG001|Overall Study|Death|0|||
160764141|NCT01079780|580526312|FG002|Overall Study|Death|2|||
160764142|NCT01079780|580526310|FG000|Overall Study|Withdrawal by Subject|6|||
160764143|NCT01079780|580526311|FG001|Overall Study|Withdrawal by Subject|4|||
160764144|NCT01079780|580526312|FG002|Overall Study|Withdrawal by Subject|4|||
160764145|NCT01079780|580526310|FG000|Overall Study|Alternative therapy|2|||
160764146|NCT01079780|580526311|FG001|Overall Study|Alternative therapy|0|||
160764147|NCT01079780|580526312|FG002|Overall Study|Alternative therapy|2|||
160764148|NCT01079780|580526310|FG000|Overall Study|Physician Decision|1|||
160764149|NCT01079780|580526311|FG001|Overall Study|Physician Decision|0|||
160868082|NCT05375760|580908209|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
160764150|NCT01079780|580526312|FG002|Overall Study|Physician Decision|1|||
160764151|NCT01079780|580526310|FG000|Overall Study|Error made in lesion measurement|1|||
160527254|NCT00688181|579660939|FG000|Overall Study|Non-clinical Reason|2|||
160527255|NCT01891721|579660940|FG000|Overall Study|Lost to Follow-up|10|||
160764152|NCT01079780|580526311|FG001|Overall Study|Error made in lesion measurement|0|||
160764153|NCT01079780|580526312|FG002|Overall Study|Error made in lesion measurement|0|||
160868083|NCT05375760|580908208|FG000|Overall Study|Participant moved|1|||
160764154|NCT01079780|580526310|FG000|Overall Study|Patient had surgery|1|||
160764155|NCT01079780|580526311|FG001|Overall Study|Patient had surgery|0|||
160764156|NCT01079780|580526312|FG002|Overall Study|Patient had surgery|0|||
160764157|NCT01079780|580526310|FG000|Overall Study|Treatment cycle delay|0|||
160764158|NCT01079780|580526311|FG001|Overall Study|Treatment cycle delay|0|||
160868084|NCT05375760|580908209|FG001|Overall Study|Participant moved|0|||
160868085|NCT03853109|580908210|FG000|Overall Study|Withdrawal by Subject|0|||
160868086|NCT03853109|580908211|FG001|Overall Study|Withdrawal by Subject|0|||
160868087|NCT03853109|580908212|FG002|Overall Study|Withdrawal by Subject|1|||
160868088|NCT03853109|580908213|FG003|Overall Study|Withdrawal by Subject|2|||
160868089|NCT03853109|580908214|FG004|Overall Study|Withdrawal by Subject|1|||
160868090|NCT03853109|580908215|FG005|Overall Study|Withdrawal by Subject|4|||
160868091|NCT03853109|580908216|FG006|Overall Study|Withdrawal by Subject|5|||
160868092|NCT03853109|580908217|FG007|Overall Study|Withdrawal by Subject|3|||
160868093|NCT03853109|580908210|FG000|Overall Study|Decision by Sponsor|0|||
160868094|NCT03853109|580908211|FG001|Overall Study|Decision by Sponsor|0|||
160868095|NCT03853109|580908212|FG002|Overall Study|Decision by Sponsor|1|||
160868096|NCT03853109|580908213|FG003|Overall Study|Decision by Sponsor|0|||
160868097|NCT03853109|580908214|FG004|Overall Study|Decision by Sponsor|1|||
160868098|NCT03853109|580908215|FG005|Overall Study|Decision by Sponsor|1|||
160868099|NCT03853109|580908216|FG006|Overall Study|Decision by Sponsor|10|||
160868100|NCT03853109|580908217|FG007|Overall Study|Decision by Sponsor|2|||
160868101|NCT03853109|580908210|FG000|Overall Study|Lost to Follow-up|0|||
160868102|NCT03853109|580908211|FG001|Overall Study|Lost to Follow-up|0|||
160868103|NCT03853109|580908212|FG002|Overall Study|Lost to Follow-up|0|||
160868104|NCT03853109|580908213|FG003|Overall Study|Lost to Follow-up|0|||
160868105|NCT03853109|580908214|FG004|Overall Study|Lost to Follow-up|1|||
160868106|NCT03853109|580908215|FG005|Overall Study|Lost to Follow-up|3|||
160868107|NCT03853109|580908216|FG006|Overall Study|Lost to Follow-up|0|||
160868108|NCT03853109|580908217|FG007|Overall Study|Lost to Follow-up|0|||
160868109|NCT03853109|580908210|FG000|Overall Study|Death|2|||
160868110|NCT03853109|580908211|FG001|Overall Study|Death|5|||
160868111|NCT03853109|580908212|FG002|Overall Study|Death|8|||
160868112|NCT03853109|580908213|FG003|Overall Study|Death|10|||
160868113|NCT03853109|580908214|FG004|Overall Study|Death|3|||
160868114|NCT03853109|580908215|FG005|Overall Study|Death|20|||
160868115|NCT03853109|580908216|FG006|Overall Study|Death|10|||
160868116|NCT03853109|580908217|FG007|Overall Study|Death|5|||
160868117|NCT02745119|580908222|FG000|Overall Study|Adverse Event|1|||
160868118|NCT02745119|580908223|FG001|Overall Study|Adverse Event|0|||
160868119|NCT02745119|580908224|FG002|Overall Study|Adverse Event|1|||
160868120|NCT02745119|580908225|FG003|Overall Study|Adverse Event|3|||
160868121|NCT02745119|580908222|FG000|Overall Study|Death|3|||
160868122|NCT02745119|580908223|FG001|Overall Study|Death|3|||
160868123|NCT02745119|580908224|FG002|Overall Study|Death|0|||
160868124|NCT02745119|580908225|FG003|Overall Study|Death|4|||
160868125|NCT02745119|580908222|FG000|Overall Study|Lost to Follow-up|0|||
160868126|NCT02745119|580908223|FG001|Overall Study|Lost to Follow-up|0|||
160868127|NCT02745119|580908224|FG002|Overall Study|Lost to Follow-up|0|||
160868128|NCT02745119|580908225|FG003|Overall Study|Lost to Follow-up|1|||
160868129|NCT02745119|580908222|FG000|Overall Study|Protocol Deviation|0|||
160868130|NCT02745119|580908223|FG001|Overall Study|Protocol Deviation|0|||
160764159|NCT01079780|580526312|FG002|Overall Study|Treatment cycle delay|1|||
160764160|NCT01079780|580526310|FG000|Overall Study|Never started treatment|1|||
160764161|NCT01079780|580526311|FG001|Overall Study|Never started treatment|0|||
160764162|NCT01079780|580526312|FG002|Overall Study|Never started treatment|2|||
160764163|NCT02783066|580526313|FG000|Overall Study|Withdrawal by Subject|13|||
160764164|NCT00551369|580526314|FG000|Overall Study|Protocol Violation|5|||
160764165|NCT00551369|580526314|FG000|Overall Study|Withdrawal by Subject|1|||
160764166|NCT00551369|580526314|FG000|Overall Study|Not treated per protocol and re|1|||
160764167|NCT05379920|580526317|FG000|Overall Study|Lost to Follow-up|0|||
160764168|NCT05379920|580526318|FG001|Overall Study|Lost to Follow-up|5|||
160764169|NCT05379920|580526319|FG002|Overall Study|Lost to Follow-up|0|||
160764170|NCT05379920|580526320|FG003|Overall Study|Lost to Follow-up|0|||
160764171|NCT03530293|580526323|FG000|Pre-randomization|Adverse Event|12|||
160764172|NCT03530293|580526324|FG001|Pre-randomization|Adverse Event|0|||
160764173|NCT03530293|580526325|FG002|Pre-randomization|Adverse Event|0|||
160764174|NCT03530293|580526323|FG000|Pre-randomization|Protocol Violation|2|||
160764175|NCT03530293|580526324|FG001|Pre-randomization|Protocol Violation|0|||
160764176|NCT03530293|580526325|FG002|Pre-randomization|Protocol Violation|0|||
160764177|NCT03530293|580526323|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
160764178|NCT03530293|580526324|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
160764179|NCT03530293|580526325|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
160868131|NCT02745119|580908224|FG002|Overall Study|Protocol Deviation|0|||
160764180|NCT03530293|580526323|FG000|Pre-randomization|Withdrawal by Subject|5|||
160764181|NCT03530293|580526324|FG001|Pre-randomization|Withdrawal by Subject|0|||
160868132|NCT02745119|580908225|FG003|Overall Study|Protocol Deviation|1|||
160868133|NCT02745119|580908222|FG000|Overall Study|Withdrawal by Subject|7|||
160868134|NCT02745119|580908223|FG001|Overall Study|Withdrawal by Subject|15|||
160868135|NCT02745119|580908224|FG002|Overall Study|Withdrawal by Subject|8|||
160868136|NCT02745119|580908225|FG003|Overall Study|Withdrawal by Subject|14|||
160868137|NCT02745119|580908222|FG000|Overall Study|Study Terminated by Sponsor|134|||
160868138|NCT02745119|580908223|FG001|Overall Study|Study Terminated by Sponsor|252|||
160868139|NCT02745119|580908224|FG002|Overall Study|Study Terminated by Sponsor|135|||
160868140|NCT02745119|580908225|FG003|Overall Study|Study Terminated by Sponsor|251|||
160868141|NCT02745119|580908222|FG000|Overall Study|Physician Decision|0|||
160868142|NCT02745119|580908223|FG001|Overall Study|Physician Decision|2|||
160868143|NCT02745119|580908224|FG002|Overall Study|Physician Decision|2|||
160868144|NCT02745119|580908225|FG003|Overall Study|Physician Decision|2|||
160868145|NCT02745119|580908222|FG000|Overall Study|Reason Not Specified|0|||
160868146|NCT02745119|580908223|FG001|Overall Study|Reason Not Specified|2|||
160868147|NCT02745119|580908224|FG002|Overall Study|Reason Not Specified|0|||
160527256|NCT01891721|579660941|FG001|Overall Study|Lost to Follow-up|5|||
160764182|NCT03530293|580526325|FG002|Pre-randomization|Withdrawal by Subject|0|||
160764183|NCT03530293|580526323|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
160764184|NCT03530293|580526324|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
160764185|NCT03530293|580526325|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
160764186|NCT03530293|580526323|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
160764187|NCT03530293|580526324|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
160764188|NCT03530293|580526325|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
160764189|NCT03530293|580526323|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
160764190|NCT03530293|580526324|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
160764191|NCT03530293|580526325|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
160764192|NCT03530293|580526323|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
160764193|NCT03530293|580526324|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
160764194|NCT03530293|580526325|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
160764195|NCT03530293|580526323|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
160764196|NCT03530293|580526324|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
160764197|NCT03530293|580526325|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
160764198|NCT01663623|580526327|FG000|Overall Study|Adverse Event|3|||
160764199|NCT01663623|580526328|FG001|Overall Study|Adverse Event|7|||
160764200|NCT01663623|580526327|FG000|Overall Study|Lack of Efficacy|5|||
160764201|NCT01663623|580526328|FG001|Overall Study|Lack of Efficacy|6|||
160764202|NCT01663623|580526327|FG000|Overall Study|Protocol Violation|0|||
160764203|NCT01663623|580526328|FG001|Overall Study|Protocol Violation|1|||
160764204|NCT01663623|580526327|FG000|Overall Study|Other-Study closed/terminated|1|||
160764205|NCT01663623|580526328|FG001|Overall Study|Other-Study closed/terminated|1|||
160764206|NCT01663623|580526327|FG000|Overall Study|Physician Decision|1|||
160764207|NCT01663623|580526328|FG001|Overall Study|Physician Decision|4|||
160764208|NCT01663623|580526327|FG000|Overall Study|Withdrawal by Subject|2|||
160764209|NCT01663623|580526328|FG001|Overall Study|Withdrawal by Subject|1|||
160764210|NCT01302899|580526329|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
160764211|NCT01302899|580526330|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
160764212|NCT01302899|580526329|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
160764213|NCT01302899|580526330|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
160764214|NCT02834975|580526331|FG000|Overall Study|Physician Decision|2|||
160764215|NCT02834975|580526331|FG000|Overall Study|Adverse Event|1|||
160764216|NCT02834975|580526331|FG000|Overall Study|Withdrawal by Subject|1|||
160764217|NCT02834975|580526331|FG000|Overall Study|Lack of Efficacy|1|||
160764218|NCT03482024|580526333|FG000|Overall Study|Physician Decision|1|||
160764219|NCT03482024|580526334|FG001|Overall Study|Physician Decision|0|||
160764220|NCT03482024|580526335|FG002|Overall Study|Physician Decision|0|||
160764221|NCT03482024|580526336|FG003|Overall Study|Physician Decision|0|||
160764222|NCT03482024|580526337|FG004|Overall Study|Physician Decision|0|||
160764223|NCT02497469|580526338|FG000|Overall Study|Randomized but not Treated|0|||
160764224|NCT02497469|580526339|FG001|Overall Study|Randomized but not Treated|2|||
160764225|NCT02497469|580526338|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
160764226|NCT02497469|580526339|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
160764227|NCT02497469|580526338|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
160764228|NCT02497469|580526339|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
160764229|NCT02497469|580526338|FG000|Overall Study|Significant Protocol Deviation|4|||
160764230|NCT02497469|580526339|FG001|Overall Study|Significant Protocol Deviation|5|||
160764231|NCT02497469|580526338|FG000|Overall Study|Lost to Follow-up|14|||
160764232|NCT02497469|580526339|FG001|Overall Study|Lost to Follow-up|4|||
160764233|NCT02497469|580526338|FG000|Overall Study|Voluntary Withdrawal|39|||
160764234|NCT02497469|580526339|FG001|Overall Study|Voluntary Withdrawal|41|||
160764235|NCT02497469|580526338|FG000|Overall Study|Pregnancy|1|||
160764236|NCT02497469|580526339|FG001|Overall Study|Pregnancy|1|||
160764237|NCT02497469|580526338|FG000|Overall Study|Lack of Efficacy|86|||
160764238|NCT02497469|580526339|FG001|Overall Study|Lack of Efficacy|40|||
160868148|NCT02745119|580908225|FG003|Overall Study|Reason Not Specified|1|||
160868149|NCT00960999|580908226|FG000|Overall Study|Withdrawal by Subject|1|||
160527257|NCT01891721|579660942|FG002|Overall Study|Lost to Follow-up|1|||
160868150|NCT00960999|580908227|FG001|Overall Study|Withdrawal by Subject|0|||
160868151|NCT00960999|580908226|FG000|Overall Study|Protocol Violation|5|||
160868152|NCT00960999|580908227|FG001|Overall Study|Protocol Violation|2|||
160868153|NCT00960999|580908226|FG000|Overall Study|RT dose constraints not met|2|||
160868154|NCT00960999|580908227|FG001|Overall Study|RT dose constraints not met|0|||
160868155|NCT00888940|580908228|FG000|Overall Study|Adverse Event|12|||
160868156|NCT00888940|580908229|FG001|Overall Study|Adverse Event|3|||
160868157|NCT00888940|580908228|FG000|Overall Study|Lost to Follow-up|5|||
160868158|NCT00888940|580908229|FG001|Overall Study|Lost to Follow-up|5|||
160868159|NCT00888940|580908228|FG000|Overall Study|Randomized Not Treated|11|||
160868160|NCT00888940|580908229|FG001|Overall Study|Randomized Not Treated|13|||
160868161|NCT02536963|580908230|FG000|Overall Study|Withdrawal by Subject|18|||
160868162|NCT02668393|580908231|FG000|Overall Study|Progressive disease|6|||
160868163|NCT02668393|580908232|FG001|Overall Study|Progressive disease|3|||
160868164|NCT02668393|580908231|FG000|Overall Study|Adverse Event|0|||
160868165|NCT02668393|580908232|FG001|Overall Study|Adverse Event|2|||
160868166|NCT02668393|580908231|FG000|Overall Study|Withdrawal from the trial|0|||
160868167|NCT02668393|580908232|FG001|Overall Study|Withdrawal from the trial|1|||
160868168|NCT02668393|580908231|FG000|Overall Study|Lack of benefit and side effects|1|||
160868169|NCT02668393|580908232|FG001|Overall Study|Lack of benefit and side effects|0|||
160868170|NCT00174187|580908233|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
160868171|NCT00174187|580908234|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
160868172|NCT00174187|580908235|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
160868173|NCT00174187|580908233|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
160868174|NCT00174187|580908234|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
160868175|NCT00174187|580908235|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
160868176|NCT00174187|580908233|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
160868177|NCT00174187|580908234|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
160868178|NCT00174187|580908235|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
160868179|NCT00174187|580908233|FG000|Period 1 (up to 3 Years)|Other|0|||
160868180|NCT00174187|580908234|FG001|Period 1 (up to 3 Years)|Other|1|||
160868181|NCT00174187|580908235|FG002|Period 1 (up to 3 Years)|Other|0|||
160868182|NCT00174187|580908233|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
160868183|NCT00174187|580908234|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
160868184|NCT00174187|580908235|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
160868185|NCT00174187|580908233|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
160868186|NCT00174187|580908234|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
160868187|NCT00174187|580908235|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
160868188|NCT00174187|580908233|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
160868189|NCT00174187|580908234|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
160868190|NCT00174187|580908235|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
160868191|NCT00174187|580908233|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
160868192|NCT00174187|580908234|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
160868193|NCT00174187|580908235|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
160868194|NCT00174187|580908233|FG000|Period 2 (After 3 Years)|Other|0|||
160868195|NCT00174187|580908234|FG001|Period 2 (After 3 Years)|Other|0|||
160868196|NCT00174187|580908235|FG002|Period 2 (After 3 Years)|Other|5|||
160868197|NCT01285557|580908236|FG000|Overall Study|Death|173|||
160868198|NCT01285557|580908237|FG001|Overall Study|Death|90|||
160868199|NCT01285557|580908236|FG000|Overall Study|Lost to Follow-up|6|||
160868200|NCT01285557|580908237|FG001|Overall Study|Lost to Follow-up|2|||
160868201|NCT01285557|580908236|FG000|Overall Study|Withdrew Consent|6|||
160868202|NCT01285557|580908237|FG001|Overall Study|Withdrew Consent|1|||
160868203|NCT01285557|580908236|FG000|Overall Study|Sponsor Study Termination|23|||
160868204|NCT01285557|580908237|FG001|Overall Study|Sponsor Study Termination|13|||
160868205|NCT01285557|580908236|FG000|Overall Study|Randomized but not treated|1|||
160868206|NCT01285557|580908237|FG001|Overall Study|Randomized but not treated|1|||
160868207|NCT01285557|580908236|FG000|Overall Study|Study follow-up ongoing|28|||
160868208|NCT01285557|580908237|FG001|Overall Study|Study follow-up ongoing|14|||
160868209|NCT01285557|580908236|FG000|Overall Study|Sponsor Decision|2|||
160981501|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
160981502|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
160636415|NCT01954082|580051540|FG000|Overall Study|Infant Moved|0|||
160868210|NCT01285557|580908237|FG001|Overall Study|Sponsor Decision|1|||
160868211|NCT02991768|580908243|FG000|Overall Study|Physician Decision|4|||
160868212|NCT02273596|580910300|FG000|24-Week Treatment Period|Adverse Event|3|||
160868213|NCT02273596|580910300|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
160868214|NCT02273596|580910300|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
160868215|NCT02273596|580910300|FG000|24-Week Treatment Period|Physician Decision|1|||
160868216|NCT02273596|580910300|FG000|24-Week Treatment Period|Protocol Deviation|1|||
160868217|NCT02273596|580910300|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
160868218|NCT02273596|580910300|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
160868219|NCT02273596|580910300|FG000|Extension Period|Lost to Follow-up|1|||
160868220|NCT02273596|580910300|FG000|Extension Period|Protocol Deviation|1|||
160868221|NCT02139592|580910302|FG000|Overall Study|Case Report Forms Uncollected|8|||
160868222|NCT02873702|580910306|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
160868223|NCT02873702|580910307|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
160868224|NCT02873702|580910308|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
160868225|NCT02873702|580910309|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
160868226|NCT02873702|580910306|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
160868227|NCT02873702|580910307|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
160868228|NCT02873702|580910308|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
160868229|NCT02873702|580910309|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
160868230|NCT02873702|580910306|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
160868231|NCT02873702|580910307|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
160868232|NCT02873702|580910308|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
160868233|NCT02873702|580910309|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
160868234|NCT02873702|580910306|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
160868235|NCT02873702|580910307|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
160868236|NCT02873702|580910308|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
160868237|NCT02873702|580910309|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
160868238|NCT02873702|580910306|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
160868239|NCT02873702|580910307|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
160868240|NCT02873702|580910308|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
160868241|NCT02873702|580910309|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
160868242|NCT02803580|580910310|FG000|Overall Study|Death|13|||
160868243|NCT02803580|580910310|FG000|Overall Study|Lost to Follow-up|19|||
160868244|NCT02803580|580910310|FG000|Overall Study|Withdrawal by Subject|3|||
160868245|NCT02803580|580910310|FG000|Overall Study|Inclusion in clinical trial|1|||
160764239|NCT02497469|580526338|FG000|Overall Study|Reason not Specified|6|||
160764240|NCT02497469|580526339|FG001|Overall Study|Reason not Specified|6|||
160764241|NCT03558516|580526340|FG000|Overall Study|Protocol Violation|2|||
160764242|NCT03558516|580526341|FG001|Overall Study|Protocol Violation|2|||
160764243|NCT02714153|580526342|FG000|Overall Study|Death|1|||
160764244|NCT02785939|580526345|FG000|Overall Study|Progression|25|||
160764245|NCT02785939|580526346|FG001|Overall Study|Progression|8|||
160764246|NCT02785939|580526345|FG000|Overall Study|Adverse Event|3|||
160764247|NCT02785939|580526346|FG001|Overall Study|Adverse Event|1|||
160764248|NCT02785939|580526345|FG000|Overall Study|Death|1|||
160764249|NCT02785939|580526346|FG001|Overall Study|Death|0|||
160764250|NCT02785939|580526345|FG000|Overall Study|Refusal|1|||
160764251|NCT02785939|580526346|FG001|Overall Study|Refusal|0|||
160764252|NCT02785939|580526345|FG000|Overall Study|Deteriorating health|1|||
160764253|NCT02785939|580526346|FG001|Overall Study|Deteriorating health|0|||
160764254|NCT02785939|580526345|FG000|Overall Study|Not protocol specified|0|||
160764255|NCT02785939|580526346|FG001|Overall Study|Not protocol specified|1|||
160764256|NCT04465422|580526347|FG000|Overall Study|Lost to Follow-up|0|||
160764257|NCT04465422|580526348|FG001|Overall Study|Lost to Follow-up|2|||
160764258|NCT01787552|580526349|FG000|Overall Study|Withdrawal by Subject|2|||
160764259|NCT01787552|580526350|FG001|Overall Study|Withdrawal by Subject|0|||
160764260|NCT01787552|580526351|FG002|Overall Study|Withdrawal by Subject|0|||
160764261|NCT01787552|580526352|FG003|Overall Study|Withdrawal by Subject|4|||
160764262|NCT01787552|580526349|FG000|Overall Study|Physician Decision|2|||
160764263|NCT01787552|580526350|FG001|Overall Study|Physician Decision|2|||
160764264|NCT01787552|580526351|FG002|Overall Study|Physician Decision|1|||
160764265|NCT01787552|580526352|FG003|Overall Study|Physician Decision|2|||
160764266|NCT01787552|580526349|FG000|Overall Study|Death|0|||
160764267|NCT01787552|580526350|FG001|Overall Study|Death|0|||
160527258|NCT03829319|579660943|FG000|Overall Study|Sponsor's Decision|4|||
160764268|NCT01787552|580526351|FG002|Overall Study|Death|0|||
160764269|NCT01787552|580526352|FG003|Overall Study|Death|1|||
160764270|NCT01787552|580526349|FG000|Overall Study|Adverse Event|2|||
160764271|NCT01787552|580526350|FG001|Overall Study|Adverse Event|5|||
160764272|NCT01787552|580526351|FG002|Overall Study|Adverse Event|2|||
160764273|NCT01787552|580526352|FG003|Overall Study|Adverse Event|16|||
160764274|NCT01787552|580526349|FG000|Overall Study|Study terminated by Sponsor|0|||
160764275|NCT01787552|580526350|FG001|Overall Study|Study terminated by Sponsor|0|||
160868246|NCT01358721|580910313|FG000|Overall Study|Withdrawal by Subject|0|||
160868247|NCT01358721|580910314|FG001|Overall Study|Withdrawal by Subject|0|||
160868248|NCT01358721|580910315|FG002|Overall Study|Withdrawal by Subject|0|||
160868249|NCT01358721|580910316|FG003|Overall Study|Withdrawal by Subject|1|||
160868250|NCT01358721|580910313|FG000|Overall Study|Death|0|||
160868251|NCT01358721|580910314|FG001|Overall Study|Death|2|||
160868252|NCT01358721|580910315|FG002|Overall Study|Death|0|||
160868253|NCT01358721|580910316|FG003|Overall Study|Death|0|||
160868254|NCT01358721|580910313|FG000|Overall Study|Study Drug Toxicity|1|||
160868255|NCT01358721|580910314|FG001|Overall Study|Study Drug Toxicity|3|||
160868256|NCT01358721|580910315|FG002|Overall Study|Study Drug Toxicity|4|||
160868257|NCT01358721|580910316|FG003|Overall Study|Study Drug Toxicity|5|||
160868258|NCT01358721|580910313|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
160868259|NCT01358721|580910314|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
160868260|NCT01358721|580910315|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
160868261|NCT01358721|580910316|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
160868262|NCT01358721|580910313|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
160868263|NCT01358721|580910314|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
160868264|NCT01358721|580910315|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
160868265|NCT01358721|580910316|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
160868266|NCT01358721|580910313|FG000|Overall Study|Adverse Event related to study drug|1|||
160868267|NCT01358721|580910314|FG001|Overall Study|Adverse Event related to study drug|0|||
160868268|NCT01358721|580910315|FG002|Overall Study|Adverse Event related to study drug|0|||
160868269|NCT01358721|580910316|FG003|Overall Study|Adverse Event related to study drug|1|||
160868270|NCT01358721|580910313|FG000|Overall Study|Disease Progression|19|||
160868271|NCT01358721|580910314|FG001|Overall Study|Disease Progression|15|||
160868272|NCT01358721|580910315|FG002|Overall Study|Disease Progression|17|||
160868273|NCT01358721|580910316|FG003|Overall Study|Disease Progression|15|||
160868274|NCT01358721|580910313|FG000|Overall Study|Out of State/Unmet Criteria|0|||
160868275|NCT01358721|580910314|FG001|Overall Study|Out of State/Unmet Criteria|0|||
160868276|NCT01358721|580910315|FG002|Overall Study|Out of State/Unmet Criteria|1|||
160868277|NCT01358721|580910316|FG003|Overall Study|Out of State/Unmet Criteria|0|||
160868278|NCT04614974|580910317|FG000|Overall Study|Lost to Follow-up|14|||
160868279|NCT04614974|580910318|FG001|Overall Study|Lost to Follow-up|11|||
160868280|NCT00658359|580910320|FG000|Overall Study|Death|3|||
160868281|NCT00658359|580910321|FG001|Overall Study|Death|1|||
160868282|NCT00658359|580910322|FG002|Overall Study|Death|2|||
160868283|NCT00658359|580910320|FG000|Overall Study|Adverse Event|13|||
160868284|NCT00658359|580910321|FG001|Overall Study|Adverse Event|6|||
160868285|NCT00658359|580910322|FG002|Overall Study|Adverse Event|9|||
160868286|NCT00658359|580910320|FG000|Overall Study|Protocol Violation|1|||
160868287|NCT00658359|580910321|FG001|Overall Study|Protocol Violation|0|||
160868288|NCT00658359|580910322|FG002|Overall Study|Protocol Violation|0|||
160868289|NCT00658359|580910320|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
160868290|NCT00658359|580910321|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
160868291|NCT00658359|580910322|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
160868292|NCT00658359|580910320|FG000|Overall Study|Withdrawal by Subject|7|||
160868293|NCT00658359|580910321|FG001|Overall Study|Withdrawal by Subject|4|||
160868294|NCT00658359|580910322|FG002|Overall Study|Withdrawal by Subject|2|||
160868295|NCT00658359|580910320|FG000|Overall Study|Lost to Follow-up|2|||
160868296|NCT00658359|580910321|FG001|Overall Study|Lost to Follow-up|2|||
160868297|NCT00658359|580910322|FG002|Overall Study|Lost to Follow-up|4|||
160868298|NCT00658359|580910320|FG000|Overall Study|Lack of Efficacy|0|||
160868299|NCT00658359|580910321|FG001|Overall Study|Lack of Efficacy|1|||
160868300|NCT00658359|580910322|FG002|Overall Study|Lack of Efficacy|0|||
160868301|NCT02754440|580910323|FG000|Overall Study|Protocol Violation|3|||
160868302|NCT02754440|580910324|FG001|Overall Study|Protocol Violation|2|||
160868303|NCT02754440|580910325|FG002|Overall Study|Protocol Violation|2|||
160868304|NCT02754440|580910326|FG003|Overall Study|Protocol Violation|6|||
160868305|NCT02754440|580910323|FG000|Overall Study|Adverse Event|3|||
160868306|NCT02754440|580910324|FG001|Overall Study|Adverse Event|1|||
160868307|NCT02754440|580910325|FG002|Overall Study|Adverse Event|0|||
160868308|NCT02754440|580910326|FG003|Overall Study|Adverse Event|9|||
160868309|NCT02754440|580910323|FG000|Overall Study|Withdrawal by Subject|0|||
160868310|NCT02754440|580910324|FG001|Overall Study|Withdrawal by Subject|0|||
160868311|NCT02754440|580910325|FG002|Overall Study|Withdrawal by Subject|0|||
160868312|NCT02754440|580910326|FG003|Overall Study|Withdrawal by Subject|1|||
160868313|NCT02754440|580910323|FG000|Overall Study|Equipment failure|0|||
160868314|NCT02754440|580910324|FG001|Overall Study|Equipment failure|5|||
160868315|NCT02754440|580910325|FG002|Overall Study|Equipment failure|5|||
160868316|NCT02754440|580910326|FG003|Overall Study|Equipment failure|7|||
160868317|NCT02754440|580910323|FG000|Overall Study|Subject issues not resulting in AE|0|||
160868318|NCT02754440|580910324|FG001|Overall Study|Subject issues not resulting in AE|0|||
160868319|NCT02754440|580910325|FG002|Overall Study|Subject issues not resulting in AE|0|||
160868320|NCT02754440|580910326|FG003|Overall Study|Subject issues not resulting in AE|12|||
160868321|NCT02560558|580910327|FG000|Overall Study|Adverse Event|1|||
160868322|NCT02560558|580910328|FG001|Overall Study|Adverse Event|0|||
160868323|NCT02560558|580910327|FG000|Overall Study|Death|0|||
160868324|NCT02560558|580910328|FG001|Overall Study|Death|2|||
160868325|NCT02560558|580910327|FG000|Overall Study|Lost to Follow-up|0|||
160868326|NCT02560558|580910328|FG001|Overall Study|Lost to Follow-up|4|||
160868327|NCT02560558|580910327|FG000|Overall Study|Protocol Violation|3|||
160868328|NCT02560558|580910328|FG001|Overall Study|Protocol Violation|0|||
160868329|NCT02560558|580910327|FG000|Overall Study|Withdrawal by Subject|3|||
160868330|NCT02560558|580910328|FG001|Overall Study|Withdrawal by Subject|0|||
160868331|NCT01189032|580910333|FG000|Overall Study|Adverse Event|1|||
160868332|NCT01189032|580910334|FG001|Overall Study|Adverse Event|3|||
160868333|NCT01189032|580910335|FG002|Overall Study|Adverse Event|4|||
160868334|NCT01189032|580910333|FG000|Overall Study|Lack of Efficacy|2|||
160868335|NCT01189032|580910334|FG001|Overall Study|Lack of Efficacy|3|||
160868336|NCT01189032|580910335|FG002|Overall Study|Lack of Efficacy|0|||
160868337|NCT01189032|580910333|FG000|Overall Study|Withdrawal by Subject|1|||
160868338|NCT01189032|580910334|FG001|Overall Study|Withdrawal by Subject|0|||
160868339|NCT01189032|580910335|FG002|Overall Study|Withdrawal by Subject|1|||
160868340|NCT01189032|580910333|FG000|Overall Study|Protocol Violation|1|||
160868341|NCT01189032|580910334|FG001|Overall Study|Protocol Violation|1|||
160868342|NCT01189032|580910335|FG002|Overall Study|Protocol Violation|1|||
160868343|NCT01995838|580910336|FG000|Overall Study|Lost to Follow-up|0|||
160868344|NCT01995838|580910337|FG001|Overall Study|Lost to Follow-up|1|||
160868345|NCT01995838|580910338|FG002|Overall Study|Lost to Follow-up|0|||
160868346|NCT01995838|580910339|FG003|Overall Study|Lost to Follow-up|0|||
160868347|NCT01995838|580910340|FG004|Overall Study|Lost to Follow-up|0|||
160868348|NCT01995838|580910341|FG005|Overall Study|Lost to Follow-up|0|||
160868349|NCT01995838|580910342|FG006|Overall Study|Lost to Follow-up|1|||
160868350|NCT01995838|580910336|FG000|Overall Study|Participant choice|2|||
160868351|NCT01995838|580910337|FG001|Overall Study|Participant choice|0|||
160868352|NCT01995838|580910338|FG002|Overall Study|Participant choice|0|||
160868353|NCT01995838|580910339|FG003|Overall Study|Participant choice|0|||
160868354|NCT01995838|580910340|FG004|Overall Study|Participant choice|0|||
160868355|NCT01995838|580910341|FG005|Overall Study|Participant choice|1|||
160868356|NCT01995838|580910342|FG006|Overall Study|Participant choice|1|||
160868357|NCT01995838|580910336|FG000|Overall Study|Adverse Event|0|||
160868358|NCT01995838|580910337|FG001|Overall Study|Adverse Event|0|||
160868359|NCT01995838|580910338|FG002|Overall Study|Adverse Event|0|||
160868360|NCT01995838|580910339|FG003|Overall Study|Adverse Event|0|||
160868361|NCT01995838|580910340|FG004|Overall Study|Adverse Event|0|||
160868362|NCT01995838|580910341|FG005|Overall Study|Adverse Event|0|||
160868363|NCT01995838|580910342|FG006|Overall Study|Adverse Event|1|||
160868364|NCT01995838|580910336|FG000|Overall Study|Withdrawal by Subject|0|||
160868365|NCT01995838|580910337|FG001|Overall Study|Withdrawal by Subject|0|||
160868366|NCT01995838|580910338|FG002|Overall Study|Withdrawal by Subject|0|||
160868367|NCT01995838|580910339|FG003|Overall Study|Withdrawal by Subject|0|||
160868368|NCT01995838|580910340|FG004|Overall Study|Withdrawal by Subject|1|||
160868369|NCT01995838|580910341|FG005|Overall Study|Withdrawal by Subject|0|||
160868370|NCT01995838|580910342|FG006|Overall Study|Withdrawal by Subject|0|||
160868371|NCT01995838|580910336|FG000|Overall Study|Other|3|||
160868372|NCT01995838|580910337|FG001|Overall Study|Other|1|||
160868373|NCT01995838|580910338|FG002|Overall Study|Other|0|||
160868374|NCT01995838|580910339|FG003|Overall Study|Other|2|||
160868375|NCT01995838|580910340|FG004|Overall Study|Other|1|||
160868376|NCT01995838|580910341|FG005|Overall Study|Other|1|||
160868377|NCT01995838|580910342|FG006|Overall Study|Other|2|||
160868378|NCT01967576|580910347|FG000|Overall Study|Withdrawal by Subject|3|||
160868379|NCT01967576|580910347|FG000|Overall Study|Progressed/Removed from treatment|1|||
160868380|NCT01967576|580910347|FG000|Overall Study|Study closing at site|1|||
160868381|NCT01967576|580910347|FG000|Overall Study|Adverse Event|1|||
160868382|NCT01967576|580910347|FG000|Overall Study|Refused further treatment|1|||
160868383|NCT02819804|580910348|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
160868384|NCT02858362|580910349|FG000|Overall Study|Protocol Violation|0|||
160868385|NCT02858362|580910350|FG001|Overall Study|Protocol Violation|1|||
160636416|NCT01954082|580051541|FG001|Overall Study|Infant Moved|1|||
160868386|NCT02858362|580910351|FG002|Overall Study|Protocol Violation|0|||
160868387|NCT02858362|580910349|FG000|Overall Study|Withdrawal by Subject|1|||
160868388|NCT02858362|580910350|FG001|Overall Study|Withdrawal by Subject|0|||
160868389|NCT02858362|580910351|FG002|Overall Study|Withdrawal by Subject|0|||
160868390|NCT02858362|580910349|FG000|Overall Study|Early Study Termination|0|||
160868391|NCT02858362|580910350|FG001|Overall Study|Early Study Termination|0|||
160868392|NCT02858362|580910351|FG002|Overall Study|Early Study Termination|3|||
160868393|NCT02858362|580910349|FG000|Overall Study|Lost to Follow-up|1|||
160868394|NCT02858362|580910350|FG001|Overall Study|Lost to Follow-up|0|||
160868395|NCT02858362|580910351|FG002|Overall Study|Lost to Follow-up|0|||
160868396|NCT01821118|580910352|FG000|Overall Study|Death|0|||
160868397|NCT01821118|580910353|FG001|Overall Study|Death|1|||
160868398|NCT00345358|580910354|FG000|Primary Vaccination Phase|Other|0|||
160868399|NCT00345358|580910355|FG001|Primary Vaccination Phase|Other|1|||
160868400|NCT00345358|580910356|FG002|Primary Vaccination Phase|Other|1|||
160868401|NCT00345358|580910357|FG003|Primary Vaccination Phase|Other|0|||
160868402|NCT00345358|580910354|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
160764276|NCT01787552|580526351|FG002|Overall Study|Study terminated by Sponsor|1|||
160764277|NCT01787552|580526352|FG003|Overall Study|Study terminated by Sponsor|3|||
160764278|NCT01787552|580526349|FG000|Overall Study|Progressive Disease|2|||
160764279|NCT01787552|580526350|FG001|Overall Study|Progressive Disease|2|||
160764280|NCT01787552|580526351|FG002|Overall Study|Progressive Disease|1|||
160764281|NCT01787552|580526352|FG003|Overall Study|Progressive Disease|1|||
160764282|NCT02147626|580526357|FG000|Overall Study|Lost to Follow-up|4|||
160764283|NCT02147626|580526358|FG001|Overall Study|Lost to Follow-up|4|||
160764284|NCT02147626|580526357|FG000|Overall Study|Pregnancy|1|||
160764285|NCT02147626|580526358|FG001|Overall Study|Pregnancy|2|||
160764286|NCT02147626|580526357|FG000|Overall Study|Withdrawal by Subject|0|||
160764287|NCT02147626|580526358|FG001|Overall Study|Withdrawal by Subject|1|||
160764288|NCT00324155|580526359|FG000|Enrolled and Randomized|No longer met study criteria|3|||
160764289|NCT00324155|580526360|FG001|Enrolled and Randomized|No longer met study criteria|0|||
160764290|NCT00324155|580526359|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
160764291|NCT00324155|580526360|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
160764292|NCT00324155|580526359|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
160764293|NCT00324155|580526360|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
160764294|NCT00324155|580526359|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
160764295|NCT00324155|580526360|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
160764296|NCT00324155|580526359|FG000|Received Treatment in Induction Phase|Death|8|||
160764297|NCT00324155|580526360|FG001|Received Treatment in Induction Phase|Death|15|||
160764298|NCT00324155|580526359|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
160764299|NCT00324155|580526360|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
160764300|NCT00324155|580526359|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
160764301|NCT00324155|580526360|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
160764302|NCT00324155|580526359|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
160764303|NCT00324155|580526360|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
160764304|NCT00324155|580526359|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
160764305|NCT00324155|580526360|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
160764306|NCT00324155|580526359|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
160764307|NCT00324155|580526360|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
160764308|NCT00324155|580526359|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
160764309|NCT00324155|580526360|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
160764310|NCT00324155|580526359|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
160868403|NCT00345358|580910355|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
160868404|NCT00345358|580910356|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
160868405|NCT00345358|580910357|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
160868406|NCT00345358|580910354|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
160868407|NCT00345358|580910355|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
160868408|NCT00345358|580910356|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
160868409|NCT00345358|580910357|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
160868410|NCT00345358|580910354|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
160868411|NCT00345358|580910355|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
160868412|NCT00345358|580910356|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
160868413|NCT00345358|580910357|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
160868414|NCT00345358|580910354|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
160868415|NCT00345358|580910355|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
160868416|NCT00345358|580910356|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
160868417|NCT00345358|580910357|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
160868418|NCT00345358|580910354|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
160868419|NCT00345358|580910355|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
160868420|NCT00345358|580910356|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
160868421|NCT00345358|580910357|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
160868422|NCT00346697|580910358|FG000|Overall Study|Lost to Follow-up|0|||
160868423|NCT00346697|580910359|FG001|Overall Study|Lost to Follow-up|1|||
160868424|NCT01012440|580910360|FG000|Overall Study|Withdrawal by Subject|2|||
160868425|NCT00131248|580910361|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
160868426|NCT00131248|580910362|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
160868427|NCT00318643|580910367|FG000|Overall Study|Adverse Event|0|||
160868428|NCT00318643|580910368|FG001|Overall Study|Adverse Event|0|||
160868429|NCT00318643|580910369|FG002|Overall Study|Adverse Event|0|||
160868430|NCT00318643|580910370|FG003|Overall Study|Adverse Event|0|||
160868431|NCT00318643|580910371|FG004|Overall Study|Adverse Event|1|||
160868432|NCT00318643|580910367|FG000|Overall Study|Participant's Decision|0|||
160868433|NCT00318643|580910368|FG001|Overall Study|Participant's Decision|0|||
160868434|NCT00318643|580910369|FG002|Overall Study|Participant's Decision|0|||
160868435|NCT00318643|580910370|FG003|Overall Study|Participant's Decision|0|||
160868436|NCT00318643|580910371|FG004|Overall Study|Participant's Decision|1|||
160868437|NCT00318643|580910367|FG000|Overall Study|Investigator's Decision|0|||
160868438|NCT00318643|580910368|FG001|Overall Study|Investigator's Decision|0|||
160868439|NCT00318643|580910369|FG002|Overall Study|Investigator's Decision|0|||
160868440|NCT00318643|580910370|FG003|Overall Study|Investigator's Decision|0|||
160868441|NCT00318643|580910371|FG004|Overall Study|Investigator's Decision|1|||
160868442|NCT02691507|580910374|FG000|Overall Study|Missed Visit 3|0|||
160868443|NCT02691507|580910375|FG001|Overall Study|Missed Visit 3|1|||
160868444|NCT02557139|580910376|FG000|Overall Study|Significant liver elevation|1|||
160868445|NCT02557139|580910377|FG001|Overall Study|Significant liver elevation|0|||
160868446|NCT02557139|580910378|FG002|Overall Study|Significant liver elevation|1|||
160868447|NCT02557139|580910376|FG000|Overall Study|Withdrawal by Subject|1|||
160868448|NCT02557139|580910377|FG001|Overall Study|Withdrawal by Subject|0|||
160868449|NCT02557139|580910378|FG002|Overall Study|Withdrawal by Subject|0|||
160868450|NCT02557139|580910376|FG000|Overall Study|Illness of prohibited medication|0|||
160868451|NCT02557139|580910377|FG001|Overall Study|Illness of prohibited medication|0|||
160868452|NCT02557139|580910378|FG002|Overall Study|Illness of prohibited medication|1|||
160868453|NCT02284243|580910379|FG000|Overall Study|Lack of Efficacy|3|||
160868454|NCT02284243|580910380|FG001|Overall Study|Lack of Efficacy|3|||
160868455|NCT02284243|580910379|FG000|Overall Study|Adverse Event|1|||
160868456|NCT02284243|580910380|FG001|Overall Study|Adverse Event|0|||
160868457|NCT01216189|580910381|FG000|Overall Study|Lost to Follow-up|21|||
160868458|NCT01216189|580910382|FG001|Overall Study|Lost to Follow-up|3|||
160868459|NCT01216189|580910381|FG000|Overall Study|Death|4|||
160868460|NCT01216189|580910382|FG001|Overall Study|Death|2|||
160868461|NCT04032093|580910383|FG000|Overall Study|Lost to Follow-up|7|||
160636417|NCT01954082|580051540|FG000|Overall Study|Randomized not Treated|4|||
160868462|NCT04032093|580910384|FG001|Overall Study|Lost to Follow-up|7|||
160868463|NCT04032093|580910385|FG002|Overall Study|Lost to Follow-up|6|||
160868464|NCT04032093|580910386|FG003|Overall Study|Lost to Follow-up|10|||
160868465|NCT04032093|580910387|FG004|Overall Study|Lost to Follow-up|13|||
160868466|NCT04032093|580910388|FG005|Overall Study|Lost to Follow-up|7|||
160868467|NCT04032093|580910389|FG006|Overall Study|Lost to Follow-up|7|||
160868468|NCT04032093|580910390|FG007|Overall Study|Lost to Follow-up|5|||
160868469|NCT04032093|580910391|FG008|Overall Study|Lost to Follow-up|9|||
160868470|NCT04032093|580910392|FG009|Overall Study|Lost to Follow-up|12|||
160868471|NCT04032093|580910383|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868472|NCT04032093|580910384|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868473|NCT04032093|580910385|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868474|NCT04032093|580910386|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
160868475|NCT04032093|580910387|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
160868476|NCT04032093|580910388|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868477|NCT04032093|580910389|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868478|NCT04032093|580910390|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868479|NCT04032093|580910391|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
160868480|NCT04032093|580910392|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
160868481|NCT04032093|580910383|FG000|Overall Study|Other|1|||
160868482|NCT04032093|580910384|FG001|Overall Study|Other|0|||
160868483|NCT04032093|580910385|FG002|Overall Study|Other|0|||
160868484|NCT04032093|580910386|FG003|Overall Study|Other|1|||
160868485|NCT04032093|580910387|FG004|Overall Study|Other|1|||
160868486|NCT04032093|580910388|FG005|Overall Study|Other|0|||
160868487|NCT04032093|580910389|FG006|Overall Study|Other|0|||
160868488|NCT04032093|580910390|FG007|Overall Study|Other|0|||
160868489|NCT04032093|580910391|FG008|Overall Study|Other|0|||
160868490|NCT04032093|580910392|FG009|Overall Study|Other|1|||
160868491|NCT04032093|580910383|FG000|Overall Study|Withdrawal by Subject|1|||
160868492|NCT04032093|580910384|FG001|Overall Study|Withdrawal by Subject|3|||
160868493|NCT04032093|580910385|FG002|Overall Study|Withdrawal by Subject|2|||
160868494|NCT04032093|580910386|FG003|Overall Study|Withdrawal by Subject|2|||
160868495|NCT04032093|580910387|FG004|Overall Study|Withdrawal by Subject|3|||
160868496|NCT04032093|580910388|FG005|Overall Study|Withdrawal by Subject|0|||
160868497|NCT04032093|580910389|FG006|Overall Study|Withdrawal by Subject|0|||
160868498|NCT04032093|580910390|FG007|Overall Study|Withdrawal by Subject|0|||
160868499|NCT04032093|580910391|FG008|Overall Study|Withdrawal by Subject|0|||
160868500|NCT04032093|580910392|FG009|Overall Study|Withdrawal by Subject|0|||
160868501|NCT04032093|580910383|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160868502|NCT04032093|580910384|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160868503|NCT04032093|580910385|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160868504|NCT04032093|580910386|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160868505|NCT04032093|580910387|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
160868506|NCT04032093|580910388|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
160868507|NCT04032093|580910389|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
160868508|NCT04032093|580910390|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
160868509|NCT04032093|580910391|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
160868510|NCT04032093|580910392|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
160868511|NCT04032093|580910383|FG000|Overall Study|Adverse Event|0|||
160868512|NCT04032093|580910384|FG001|Overall Study|Adverse Event|0|||
160868513|NCT04032093|580910385|FG002|Overall Study|Adverse Event|0|||
160868514|NCT04032093|580910386|FG003|Overall Study|Adverse Event|0|||
160868515|NCT04032093|580910387|FG004|Overall Study|Adverse Event|0|||
160868516|NCT04032093|580910388|FG005|Overall Study|Adverse Event|0|||
160868517|NCT04032093|580910389|FG006|Overall Study|Adverse Event|0|||
160868518|NCT04032093|580910390|FG007|Overall Study|Adverse Event|0|||
160527259|NCT03829319|579660944|FG001|Overall Study|Sponsor's Decision|90|||
160527260|NCT03829319|579660945|FG002|Overall Study|Sponsor's Decision|102|||
160527261|NCT03829319|579660943|FG000|Overall Study|Withdrawal by Subject|1|||
160527262|NCT03829319|579660944|FG001|Overall Study|Withdrawal by Subject|5|||
160527263|NCT03829319|579660945|FG002|Overall Study|Withdrawal by Subject|4|||
160527264|NCT03829319|579660943|FG000|Overall Study|Physician Decision|0|||
160527265|NCT03829319|579660944|FG001|Overall Study|Physician Decision|3|||
160527266|NCT03829319|579660945|FG002|Overall Study|Physician Decision|0|||
160527267|NCT03829319|579660943|FG000|Overall Study|Lost to Follow-up|0|||
160527268|NCT03829319|579660944|FG001|Overall Study|Lost to Follow-up|0|||
160527269|NCT03829319|579660945|FG002|Overall Study|Lost to Follow-up|1|||
160527270|NCT03829319|579660943|FG000|Overall Study|Death|8|||
160527271|NCT03829319|579660944|FG001|Overall Study|Death|277|||
160527272|NCT03829319|579660945|FG002|Overall Study|Death|266|||
160527273|NCT04484259|579660946|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
160527274|NCT04484259|579660947|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
160527275|NCT04484259|579660948|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
160527276|NCT04484259|579660949|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
160527277|NCT04484259|579660950|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
160868519|NCT04032093|580910391|FG008|Overall Study|Adverse Event|0|||
160868520|NCT04032093|580910392|FG009|Overall Study|Adverse Event|1|||
160527278|NCT04484259|579660946|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
160868521|NCT04032093|580910383|FG000|Overall Study|Physician Decision|0|||
160868522|NCT04032093|580910384|FG001|Overall Study|Physician Decision|0|||
160868523|NCT04032093|580910385|FG002|Overall Study|Physician Decision|0|||
160868524|NCT04032093|580910386|FG003|Overall Study|Physician Decision|0|||
160868525|NCT04032093|580910387|FG004|Overall Study|Physician Decision|0|||
160868526|NCT04032093|580910388|FG005|Overall Study|Physician Decision|1|||
160868527|NCT04032093|580910389|FG006|Overall Study|Physician Decision|0|||
160868528|NCT04032093|580910390|FG007|Overall Study|Physician Decision|0|||
160527279|NCT04484259|579660947|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
160527280|NCT04484259|579660948|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
160527281|NCT04484259|579660949|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
160868529|NCT04032093|580910391|FG008|Overall Study|Physician Decision|0|||
160868530|NCT04032093|580910392|FG009|Overall Study|Physician Decision|0|||
160868531|NCT02699749|580910395|FG000|Overall Study|Other|0|||
160868532|NCT02699749|580910396|FG001|Overall Study|Other|0|||
160868533|NCT02699749|580910397|FG002|Overall Study|Other|2|||
160868534|NCT02699749|580910398|FG003|Overall Study|Other|0|||
160868535|NCT02699749|580910399|FG004|Overall Study|Other|0|||
160868536|NCT02699749|580910400|FG005|Overall Study|Other|1|||
160868537|NCT02699749|580910401|FG006|Overall Study|Other|1|||
160868538|NCT02699749|580910402|FG007|Overall Study|Other|0|||
160868539|NCT02699749|580910403|FG008|Overall Study|Other|0|||
160868540|NCT02699749|580910404|FG009|Overall Study|Other|0|||
160868541|NCT02699749|580910405|FG010|Overall Study|Other|1|||
160868542|NCT02699749|580910406|FG011|Overall Study|Other|0|||
160868543|NCT02699749|580910407|FG012|Overall Study|Other|0|||
160868544|NCT02699749|580910408|FG013|Overall Study|Other|0|||
160868545|NCT02699749|580910395|FG000|Overall Study|Progressive Disease|3|||
160868546|NCT02699749|580910396|FG001|Overall Study|Progressive Disease|3|||
160868547|NCT02699749|580910397|FG002|Overall Study|Progressive Disease|14|||
160868548|NCT02699749|580910398|FG003|Overall Study|Progressive Disease|3|||
160868549|NCT02699749|580910399|FG004|Overall Study|Progressive Disease|3|||
160868550|NCT02699749|580910400|FG005|Overall Study|Progressive Disease|7|||
160868551|NCT02699749|580910401|FG006|Overall Study|Progressive Disease|5|||
160868552|NCT02699749|580910402|FG007|Overall Study|Progressive Disease|5|||
160868553|NCT02699749|580910403|FG008|Overall Study|Progressive Disease|6|||
160868554|NCT02699749|580910404|FG009|Overall Study|Progressive Disease|6|||
160868555|NCT02699749|580910405|FG010|Overall Study|Progressive Disease|5|||
160868556|NCT02699749|580910406|FG011|Overall Study|Progressive Disease|4|||
160868557|NCT02699749|580910407|FG012|Overall Study|Progressive Disease|3|||
160868558|NCT02699749|580910408|FG013|Overall Study|Progressive Disease|5|||
160868559|NCT02699749|580910395|FG000|Overall Study|Death|0|||
160868560|NCT02699749|580910396|FG001|Overall Study|Death|0|||
160868561|NCT02699749|580910397|FG002|Overall Study|Death|0|||
160868562|NCT02699749|580910398|FG003|Overall Study|Death|0|||
160868563|NCT02699749|580910399|FG004|Overall Study|Death|0|||
160868564|NCT02699749|580910400|FG005|Overall Study|Death|0|||
160868565|NCT02699749|580910401|FG006|Overall Study|Death|0|||
160868566|NCT02699749|580910402|FG007|Overall Study|Death|0|||
160868567|NCT02699749|580910403|FG008|Overall Study|Death|0|||
160868568|NCT02699749|580910404|FG009|Overall Study|Death|0|||
160868569|NCT02699749|580910405|FG010|Overall Study|Death|0|||
160868570|NCT02699749|580910406|FG011|Overall Study|Death|0|||
160868571|NCT02699749|580910407|FG012|Overall Study|Death|0|||
160868572|NCT02699749|580910408|FG013|Overall Study|Death|1|||
160868573|NCT02699749|580910395|FG000|Overall Study|Lost to Follow-up|0|||
160868574|NCT02699749|580910396|FG001|Overall Study|Lost to Follow-up|0|||
160868575|NCT02699749|580910397|FG002|Overall Study|Lost to Follow-up|0|||
160868576|NCT02699749|580910398|FG003|Overall Study|Lost to Follow-up|0|||
160868577|NCT02699749|580910399|FG004|Overall Study|Lost to Follow-up|0|||
160868578|NCT02699749|580910400|FG005|Overall Study|Lost to Follow-up|1|||
160868579|NCT02699749|580910401|FG006|Overall Study|Lost to Follow-up|0|||
160868580|NCT02699749|580910402|FG007|Overall Study|Lost to Follow-up|1|||
160868581|NCT02699749|580910403|FG008|Overall Study|Lost to Follow-up|0|||
160868582|NCT02699749|580910404|FG009|Overall Study|Lost to Follow-up|0|||
160868583|NCT02699749|580910405|FG010|Overall Study|Lost to Follow-up|0|||
160868584|NCT02699749|580910406|FG011|Overall Study|Lost to Follow-up|0|||
160868585|NCT02699749|580910407|FG012|Overall Study|Lost to Follow-up|0|||
160868586|NCT02699749|580910408|FG013|Overall Study|Lost to Follow-up|0|||
160868587|NCT02377817|580910410|FG000|Overall Study|Transportation/childcare barriers.|2|||
160868588|NCT02377817|580910411|FG001|Overall Study|Transportation/childcare barriers.|0|||
160868589|NCT02377817|580910410|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
160868590|NCT02377817|580910411|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
160868591|NCT04139018|580910412|FG000|Overall Study|Screen fail|1|||
160868592|NCT04139018|580910413|FG001|Overall Study|Screen fail|0|||
160868593|NCT04139018|580910412|FG000|Overall Study|Withdrawal by Subject|2|||
160868594|NCT04139018|580910413|FG001|Overall Study|Withdrawal by Subject|0|||
160868595|NCT04139018|580910412|FG000|Overall Study|Lost to Follow-up|0|||
160868596|NCT04139018|580910413|FG001|Overall Study|Lost to Follow-up|1|||
160868597|NCT02565108|580910414|FG000|Overall Study|Adverse Event|1|||
160868598|NCT02565108|580910415|FG001|Overall Study|Adverse Event|0|||
160868599|NCT02565108|580910414|FG000|Overall Study|Withdrew Consent|1|||
160764311|NCT00324155|580526360|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
160764312|NCT00324155|580526359|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
160764313|NCT00324155|580526360|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
160764314|NCT00324155|580526359|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
160764315|NCT00324155|580526360|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
160764316|NCT00324155|580526359|FG000|Follow-up Phase|On-going participants still on drug|11|||
160764317|NCT00324155|580526360|FG001|Follow-up Phase|On-going participants still on drug|6|||
160764318|NCT01253161|580526361|FG000|Overall Study|Adverse Event|1|||
160764319|NCT05412134|580526362|FG000|Overall Study|Lost to Follow-up|2|||
160764320|NCT05412134|580526363|FG001|Overall Study|Lost to Follow-up|0|||
160764321|NCT03444584|580526364|FG000|Overall Study|Withdrawal by Subject|0|||
160764322|NCT03444584|580526365|FG001|Overall Study|Withdrawal by Subject|1|||
160764323|NCT03444584|580526364|FG000|Overall Study|Other|0|||
160764324|NCT03444584|580526365|FG001|Overall Study|Other|1|||
160764325|NCT00423046|580526366|FG000|Overall Study|Other|340|||
160764326|NCT00423046|580526367|FG001|Overall Study|Other|345|||
160764327|NCT01038687|580526368|FG000|Overall Study|Adverse Event|0|||
160764328|NCT01038687|580526369|FG001|Overall Study|Adverse Event|2|||
160764329|NCT01038687|580526370|FG002|Overall Study|Adverse Event|1|||
160764330|NCT02783911|580526371|FG000|Overall Study|Lost to Follow-up|3|||
160764331|NCT02783911|580526372|FG001|Overall Study|Lost to Follow-up|32|||
160764332|NCT05214118|580526376|FG000|Overall Study|Lost to Follow-up|0|||
160764333|NCT05214118|580526377|FG001|Overall Study|Lost to Follow-up|2|||
160764334|NCT05214118|580526376|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
160764335|NCT05214118|580526377|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
160764336|NCT05214118|580526376|FG000|Overall Study|moved|1|||
160764337|NCT05214118|580526377|FG001|Overall Study|moved|0|||
160764338|NCT02314728|580526378|FG000|Overall Study|Protocol Violation|1|||
160764339|NCT02314728|580526379|FG001|Overall Study|Protocol Violation|0|||
160764340|NCT02314728|580526378|FG000|Overall Study|Lost to Follow-up|0|||
160636418|NCT01954082|580051541|FG001|Overall Study|Randomized not Treated|2|||
160764341|NCT02314728|580526379|FG001|Overall Study|Lost to Follow-up|1|||
160764342|NCT01614470|580526380|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
160764343|NCT01614470|580526381|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
160764344|NCT01614470|580526382|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
160868600|NCT02565108|580910415|FG001|Overall Study|Withdrew Consent|0|||
160868601|NCT01310075|580910432|FG000|Overall Study|Lost to Follow-up|1|||
160868602|NCT01310075|580910433|FG001|Overall Study|Lost to Follow-up|0|||
160868603|NCT01310075|580910432|FG000|Overall Study|Physician Decision|10|||
160868604|NCT01310075|580910433|FG001|Overall Study|Physician Decision|7|||
160868605|NCT01310075|580910432|FG000|Overall Study|Protocol Violation|2|||
160868606|NCT01310075|580910433|FG001|Overall Study|Protocol Violation|2|||
160868607|NCT01310075|580910432|FG000|Overall Study|Withdrawal by Subject|1|||
160868608|NCT01310075|580910433|FG001|Overall Study|Withdrawal by Subject|1|||
160868609|NCT01696188|580910435|FG000|Overall Study|Protocol Violation|1|||
160868610|NCT01696188|580910436|FG001|Overall Study|Protocol Violation|1|||
160868611|NCT02425943|580910437|FG000|Overall Study|Adverse Event|3|||
160868612|NCT02425943|580910438|FG001|Overall Study|Adverse Event|1|||
160868613|NCT02425943|580910437|FG000|Overall Study|Lost to Follow-up|59|||
160868614|NCT02425943|580910438|FG001|Overall Study|Lost to Follow-up|37|||
160868615|NCT02425943|580910437|FG000|Overall Study|Protocol Violation|4|||
160868616|NCT02425943|580910438|FG001|Overall Study|Protocol Violation|1|||
160868617|NCT02425943|580910437|FG000|Overall Study|Withdrawal by Subject|64|||
160868618|NCT02425943|580910438|FG001|Overall Study|Withdrawal by Subject|31|||
160868619|NCT02425943|580910437|FG000|Overall Study|Other|6|||
160868620|NCT02425943|580910438|FG001|Overall Study|Other|0|||
160764345|NCT01614470|580526380|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
160764346|NCT01614470|580526381|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
160764347|NCT01614470|580526382|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
160764348|NCT00931632|580526383|FG000|Overall Study|Withdrawal by Subject|2|||
160764349|NCT00931632|580526384|FG001|Overall Study|Withdrawal by Subject|3|||
160764350|NCT00931632|580526383|FG000|Overall Study|Adverse Event|19|||
160764351|NCT00931632|580526384|FG001|Overall Study|Adverse Event|15|||
160764352|NCT01419314|580526385|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
160764353|NCT01419314|580526386|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
160764354|NCT01419314|580526385|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
160764355|NCT01419314|580526386|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
160764356|NCT01419314|580526385|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
160764357|NCT01419314|580526386|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
160764358|NCT00721799|580526393|FG000|Overall Study|Withdrawal by Subject|7|||
160764359|NCT00721799|580526393|FG000|Overall Study|withdraw by subject after scan 1|1|||
160764360|NCT00750269|580528561|FG000|Overall Study|Protocol Violation|0|||
160764361|NCT00750269|580528562|FG001|Overall Study|Protocol Violation|1|||
160764362|NCT00750269|580528563|FG002|Overall Study|Protocol Violation|1|||
160764363|NCT00750269|580528564|FG003|Overall Study|Protocol Violation|2|||
160764364|NCT00750269|580528565|FG004|Overall Study|Protocol Violation|4|||
160764365|NCT00750269|580528561|FG000|Overall Study|Withdrawal by Subject|0|||
160764366|NCT00750269|580528562|FG001|Overall Study|Withdrawal by Subject|0|||
160764367|NCT00750269|580528563|FG002|Overall Study|Withdrawal by Subject|2|||
160764368|NCT00750269|580528564|FG003|Overall Study|Withdrawal by Subject|2|||
160764369|NCT00750269|580528565|FG004|Overall Study|Withdrawal by Subject|2|||
160764370|NCT00750269|580528561|FG000|Overall Study|Physician Decision|0|||
160764371|NCT00750269|580528562|FG001|Overall Study|Physician Decision|0|||
160764372|NCT00750269|580528563|FG002|Overall Study|Physician Decision|0|||
160764373|NCT00750269|580528564|FG003|Overall Study|Physician Decision|0|||
160764374|NCT00750269|580528565|FG004|Overall Study|Physician Decision|2|||
160764375|NCT00750269|580528561|FG000|Overall Study|Patient too large for positioning|0|||
160764376|NCT00750269|580528562|FG001|Overall Study|Patient too large for positioning|0|||
160764377|NCT00750269|580528563|FG002|Overall Study|Patient too large for positioning|1|||
160764378|NCT00750269|580528564|FG003|Overall Study|Patient too large for positioning|0|||
160764379|NCT00750269|580528565|FG004|Overall Study|Patient too large for positioning|0|||
160764380|NCT00750269|580528561|FG000|Overall Study|Site error|0|||
160764381|NCT00750269|580528562|FG001|Overall Study|Site error|0|||
160764382|NCT00750269|580528563|FG002|Overall Study|Site error|0|||
160764383|NCT00750269|580528564|FG003|Overall Study|Site error|1|||
160764384|NCT00750269|580528565|FG004|Overall Study|Site error|0|||
160764385|NCT00750269|580528561|FG000|Overall Study|SBRT plan could not be drawn|0|||
160764386|NCT00750269|580528562|FG001|Overall Study|SBRT plan could not be drawn|0|||
160764387|NCT00750269|580528563|FG002|Overall Study|SBRT plan could not be drawn|0|||
160764388|NCT00750269|580528564|FG003|Overall Study|SBRT plan could not be drawn|0|||
160764389|NCT00750269|580528565|FG004|Overall Study|SBRT plan could not be drawn|1|||
160764390|NCT00750269|580528561|FG000|Overall Study|Fiducials could not be placed|0|||
160764391|NCT00750269|580528562|FG001|Overall Study|Fiducials could not be placed|0|||
160764392|NCT00750269|580528563|FG002|Overall Study|Fiducials could not be placed|0|||
160764393|NCT00750269|580528564|FG003|Overall Study|Fiducials could not be placed|0|||
160764394|NCT00750269|580528565|FG004|Overall Study|Fiducials could not be placed|1|||
160764395|NCT03630393|580528566|FG000|Overall Study|Death|1|||
160764396|NCT03630393|580528567|FG001|Overall Study|Death|0|||
160764397|NCT00499122|580528569|FG000|Overall Study|Withdrawal by Subject|2|||
160764398|NCT03312738|580528570|FG000|Overall Study|Progressive disease|58|||
160764399|NCT03312738|580528571|FG001|Overall Study|Progressive disease|67|||
160764400|NCT03312738|580528570|FG000|Overall Study|Patient/guardian decision|13|||
160764401|NCT03312738|580528571|FG001|Overall Study|Patient/guardian decision|5|||
160764402|NCT03312738|580528570|FG000|Overall Study|Adverse Event|5|||
160764403|NCT03312738|580528571|FG001|Overall Study|Adverse Event|3|||
160636419|NCT01682512|580051542|FG000|Overall Study|Adverse Event|6|||
160636420|NCT01682512|580051543|FG001|Overall Study|Adverse Event|5|||
160764404|NCT03312738|580528570|FG000|Overall Study|Protocol deviation|2|||
160764405|NCT03312738|580528571|FG001|Overall Study|Protocol deviation|0|||
160764406|NCT03312738|580528570|FG000|Overall Study|Technical problems|0|||
160764407|NCT03312738|580528571|FG001|Overall Study|Technical problems|1|||
160764408|NCT03312738|580528570|FG000|Overall Study|Physician Decision|2|||
160764409|NCT03312738|580528571|FG001|Overall Study|Physician Decision|3|||
160764410|NCT04539275|580528580|FG000|Overall Study|Death|2|||
160764411|NCT04539275|580528581|FG001|Overall Study|Death|4|||
160764412|NCT04539275|580528580|FG000|Overall Study|Lost to Follow-up|1|||
160764413|NCT04539275|580528581|FG001|Overall Study|Lost to Follow-up|1|||
160764414|NCT04539275|580528580|FG000|Overall Study|Withdrawal by Subject|3|||
160764415|NCT04539275|580528581|FG001|Overall Study|Withdrawal by Subject|0|||
160764416|NCT00607893|580528582|FG000|Overall Study|Lost to Follow-up|4|||
160764417|NCT00607893|580528583|FG001|Overall Study|Lost to Follow-up|0|||
160764418|NCT00607893|580528582|FG000|Overall Study|withdrew due to loss of interest|0|||
160868621|NCT01106248|580910440|FG000|Overall Study|Adverse Event|1|||
160868622|NCT01106248|580910440|FG000|Overall Study|Administrative|2|||
160868623|NCT01209325|580910441|FG000|Overall Study|Lost to Follow-up|24|||
160868624|NCT01209325|580910441|FG000|Overall Study|Adverse Event|1|||
160868625|NCT01209325|580910441|FG000|Overall Study|Relocated|3|||
160868626|NCT01209325|580910441|FG000|Overall Study|Refusal after starting therapy|8|||
160868627|NCT01209325|580910441|FG000|Overall Study|Protocol Violation|4|||
160868628|NCT01209325|580910441|FG000|Overall Study|Refusal prior to therapy|1|||
160868629|NCT01209325|580910441|FG000|Overall Study|Incarceration|2|||
160868630|NCT01160822|580910442|FG000|Overall Study|Adverse Event|0|||
160868631|NCT01160822|580910443|FG001|Overall Study|Adverse Event|0|||
160868632|NCT01160822|580910444|FG002|Overall Study|Adverse Event|0|||
160868633|NCT01160822|580910445|FG003|Overall Study|Adverse Event|0|||
160868634|NCT01160822|580910446|FG004|Overall Study|Adverse Event|1|||
160868635|NCT01160822|580910447|FG005|Overall Study|Adverse Event|2|||
160868636|NCT01160822|580910448|FG006|Overall Study|Adverse Event|5|||
160868637|NCT01160822|580910442|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160868638|NCT01160822|580910443|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160868639|NCT01160822|580910444|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160868640|NCT01160822|580910445|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
160868641|NCT01160822|580910446|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
160868642|NCT01160822|580910447|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
160868643|NCT01160822|580910448|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
160868644|NCT01160822|580910442|FG000|Overall Study|Withdrawal by Subject|0|||
160868645|NCT01160822|580910443|FG001|Overall Study|Withdrawal by Subject|0|||
160868646|NCT01160822|580910444|FG002|Overall Study|Withdrawal by Subject|0|||
160868647|NCT01160822|580910445|FG003|Overall Study|Withdrawal by Subject|0|||
160868648|NCT01160822|580910446|FG004|Overall Study|Withdrawal by Subject|0|||
160868649|NCT01160822|580910447|FG005|Overall Study|Withdrawal by Subject|0|||
160868650|NCT01160822|580910448|FG006|Overall Study|Withdrawal by Subject|1|||
160868651|NCT01160822|580910442|FG000|Overall Study|Lost to Follow-up|0|||
160868652|NCT01160822|580910443|FG001|Overall Study|Lost to Follow-up|0|||
160868653|NCT01160822|580910444|FG002|Overall Study|Lost to Follow-up|0|||
160868654|NCT01160822|580910445|FG003|Overall Study|Lost to Follow-up|0|||
160868655|NCT01160822|580910446|FG004|Overall Study|Lost to Follow-up|1|||
160868656|NCT01160822|580910447|FG005|Overall Study|Lost to Follow-up|0|||
160868657|NCT01160822|580910448|FG006|Overall Study|Lost to Follow-up|0|||
160868658|NCT01160822|580910442|FG000|Overall Study|Administrative problems|0|||
160868659|NCT01160822|580910443|FG001|Overall Study|Administrative problems|0|||
160868660|NCT01160822|580910444|FG002|Overall Study|Administrative problems|0|||
160868661|NCT01160822|580910445|FG003|Overall Study|Administrative problems|0|||
160868662|NCT01160822|580910446|FG004|Overall Study|Administrative problems|1|||
160868663|NCT01160822|580910447|FG005|Overall Study|Administrative problems|0|||
160868664|NCT01160822|580910448|FG006|Overall Study|Administrative problems|0|||
160868665|NCT01160822|580910442|FG000|Overall Study|Protocol deviation|0|||
160868666|NCT01160822|580910443|FG001|Overall Study|Protocol deviation|0|||
160868667|NCT01160822|580910444|FG002|Overall Study|Protocol deviation|0|||
160868668|NCT01160822|580910445|FG003|Overall Study|Protocol deviation|0|||
160868669|NCT01160822|580910446|FG004|Overall Study|Protocol deviation|2|||
160868670|NCT01160822|580910447|FG005|Overall Study|Protocol deviation|0|||
160868671|NCT01160822|580910448|FG006|Overall Study|Protocol deviation|0|||
160868672|NCT01648751|580910461|FG000|Overall Study|Withdrawal by Subject|2|||
160868673|NCT01648751|580910462|FG001|Overall Study|Withdrawal by Subject|3|||
160868674|NCT03467750|580910464|FG000|Overall Study|Surgery canceled|1|||
160868675|NCT03467750|580910465|FG001|Overall Study|Surgery canceled|0|||
160868676|NCT03467750|580910464|FG000|Overall Study|Protocol Violation|1|||
160868677|NCT03467750|580910465|FG001|Overall Study|Protocol Violation|1|||
160868678|NCT03467750|580910464|FG000|Overall Study|Withdrawal by Subject|0|||
160868679|NCT03467750|580910465|FG001|Overall Study|Withdrawal by Subject|1|||
160527282|NCT04484259|579660950|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
160527283|NCT04484259|579660946|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
160868680|NCT05673876|580910466|FG000|Overall Study|Death|3|||
160868681|NCT05673876|580910467|FG001|Overall Study|Death|1|||
160868682|NCT05673876|580910466|FG000|Overall Study|Study Terminated by Sponsor|0|||
160868683|NCT05673876|580910467|FG001|Overall Study|Study Terminated by Sponsor|1|||
160868684|NCT05673876|580910466|FG000|Overall Study|Physician Decision|0|||
160868685|NCT05673876|580910467|FG001|Overall Study|Physician Decision|1|||
160868686|NCT03529422|580910468|FG000|Overall Study|Withdrawal by Subject|1|||
160868687|NCT03529422|580910468|FG000|Overall Study|Protocol Violation|1|||
160868688|NCT03529422|580910468|FG000|Overall Study|Disease progression|2|||
160868689|NCT02000115|580910471|FG000|Overall Study|Death|56|||
160868690|NCT02000115|580910472|FG001|Overall Study|Death|45|||
160868691|NCT02000115|580910473|FG002|Overall Study|Death|0|||
160868692|NCT02000115|580910474|FG003|Overall Study|Death|0|||
160868693|NCT02000115|580910471|FG000|Overall Study|Missed Visit|6|||
160868694|NCT02000115|580910472|FG001|Overall Study|Missed Visit|8|||
160868695|NCT02000115|580910473|FG002|Overall Study|Missed Visit|1|||
160868696|NCT02000115|580910474|FG003|Overall Study|Missed Visit|0|||
160868697|NCT02000115|580910471|FG000|Overall Study|Protocol Violation|2|||
160868698|NCT02000115|580910472|FG001|Overall Study|Protocol Violation|1|||
160868699|NCT02000115|580910473|FG002|Overall Study|Protocol Violation|0|||
160868700|NCT02000115|580910474|FG003|Overall Study|Protocol Violation|0|||
160868701|NCT02000115|580910471|FG000|Overall Study|Physician Decision|2|||
160868702|NCT02000115|580910472|FG001|Overall Study|Physician Decision|0|||
160868703|NCT02000115|580910473|FG002|Overall Study|Physician Decision|0|||
160868704|NCT02000115|580910474|FG003|Overall Study|Physician Decision|0|||
160868705|NCT02000115|580910471|FG000|Overall Study|Withdrawal by Subject|11|||
160868706|NCT02000115|580910472|FG001|Overall Study|Withdrawal by Subject|11|||
160868707|NCT02000115|580910473|FG002|Overall Study|Withdrawal by Subject|0|||
160868708|NCT02000115|580910474|FG003|Overall Study|Withdrawal by Subject|0|||
160868709|NCT02000115|580910471|FG000|Overall Study|Lost to Follow-up|0|||
160868710|NCT02000115|580910472|FG001|Overall Study|Lost to Follow-up|1|||
160868711|NCT02000115|580910473|FG002|Overall Study|Lost to Follow-up|0|||
160868712|NCT02000115|580910474|FG003|Overall Study|Lost to Follow-up|0|||
160868713|NCT02000115|580910471|FG000|Overall Study|Non-compliance|2|||
160868714|NCT02000115|580910472|FG001|Overall Study|Non-compliance|1|||
160868715|NCT02000115|580910473|FG002|Overall Study|Non-compliance|0|||
160868716|NCT02000115|580910474|FG003|Overall Study|Non-compliance|0|||
160868717|NCT02000115|580910471|FG000|Overall Study|Withdrawn on day of randomization|0|||
160868718|NCT02000115|580910472|FG001|Overall Study|Withdrawn on day of randomization|1|||
160868719|NCT02000115|580910473|FG002|Overall Study|Withdrawn on day of randomization|0|||
160868720|NCT02000115|580910474|FG003|Overall Study|Withdrawn on day of randomization|0|||
160868721|NCT02000115|580910471|FG000|Overall Study|Still on Study|0|||
160868722|NCT02000115|580910472|FG001|Overall Study|Still on Study|0|||
160868723|NCT02000115|580910473|FG002|Overall Study|Still on Study|0|||
160868724|NCT02000115|580910474|FG003|Overall Study|Still on Study|53|||
160868725|NCT05006573|580910477|FG000|Double-blind Treatment Period|Physician Decision|2|||
160868726|NCT05006573|580910478|FG001|Double-blind Treatment Period|Physician Decision|0|||
160868727|NCT05006573|580910477|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
160868728|NCT05006573|580910478|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
160868729|NCT05006573|580910477|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
160868730|NCT05006573|580910478|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
160868731|NCT05006573|580910477|FG000|Double-blind Treatment Period|Protocol Violation|2|||
160868732|NCT05006573|580910478|FG001|Double-blind Treatment Period|Protocol Violation|0|||
160868733|NCT05006573|580910477|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
160868734|NCT05006573|580910478|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
160868735|NCT05006573|580910477|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
160868736|NCT05006573|580910478|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
160868737|NCT01967238|580910479|FG000|Overall Study|Adverse Event|1|||
160868738|NCT01967238|580910480|FG001|Overall Study|Adverse Event|1|||
160868739|NCT01967238|580910481|FG002|Overall Study|Adverse Event|0|||
160868740|NCT01967238|580910479|FG000|Overall Study|Lost to Follow-up|1|||
160868741|NCT01967238|580910480|FG001|Overall Study|Lost to Follow-up|0|||
160868742|NCT01967238|580910481|FG002|Overall Study|Lost to Follow-up|1|||
160868743|NCT01967238|580910479|FG000|Overall Study|Withdrawal by Subject|0|||
160868744|NCT01967238|580910480|FG001|Overall Study|Withdrawal by Subject|0|||
160868745|NCT01967238|580910481|FG002|Overall Study|Withdrawal by Subject|1|||
160868746|NCT02484391|580910482|FG000|Overall Study|Lack of Efficacy|15|||
160868747|NCT02484391|580910483|FG001|Overall Study|Lack of Efficacy|14|||
160868748|NCT02484391|580910484|FG002|Overall Study|Lack of Efficacy|3|||
160868749|NCT02484391|580910482|FG000|Overall Study|Lost to Follow-up|0|||
160868750|NCT02484391|580910483|FG001|Overall Study|Lost to Follow-up|0|||
160868751|NCT02484391|580910484|FG002|Overall Study|Lost to Follow-up|2|||
160868752|NCT02484391|580910482|FG000|Overall Study|Physician Decision|1|||
160868753|NCT02484391|580910483|FG001|Overall Study|Physician Decision|3|||
160868754|NCT02484391|580910484|FG002|Overall Study|Physician Decision|0|||
160868755|NCT02484391|580910482|FG000|Overall Study|Went to Transplant|5|||
160868756|NCT02484391|580910483|FG001|Overall Study|Went to Transplant|3|||
160868757|NCT02484391|580910484|FG002|Overall Study|Went to Transplant|2|||
160868758|NCT04922216|580910488|FG000|Overall Study|Withdrawal by Subject|0|||
160868759|NCT04922216|580910489|FG001|Overall Study|Withdrawal by Subject|1|||
160868760|NCT04922216|580910490|FG002|Overall Study|Withdrawal by Subject|0|||
160868761|NCT04922216|580910491|FG003|Overall Study|Withdrawal by Subject|0|||
160868762|NCT04922216|580910492|FG004|Overall Study|Withdrawal by Subject|0|||
160868763|NCT04922216|580910493|FG005|Overall Study|Withdrawal by Subject|0|||
160868764|NCT04922216|580910494|FG006|Overall Study|Withdrawal by Subject|0|||
160868765|NCT04922216|580910495|FG007|Overall Study|Withdrawal by Subject|2|||
160868766|NCT04922216|580910496|FG008|Overall Study|Withdrawal by Subject|0|||
160868767|NCT04922216|580910497|FG009|Overall Study|Withdrawal by Subject|0|||
160868768|NCT04922216|580910498|FG010|Overall Study|Withdrawal by Subject|0|||
160868769|NCT04922216|580910499|FG011|Overall Study|Withdrawal by Subject|0|||
160527284|NCT04484259|579660947|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
160527285|NCT04484259|579660948|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
160527286|NCT04484259|579660949|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
160527287|NCT04484259|579660950|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
160527288|NCT04484259|579660946|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
160527289|NCT04484259|579660947|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
160527290|NCT04484259|579660948|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
160527291|NCT04484259|579660949|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
160636421|NCT01682512|580051544|FG002|Overall Study|Adverse Event|2|||
160764419|NCT00607893|580528583|FG001|Overall Study|withdrew due to loss of interest|1|||
160764420|NCT00607893|580528582|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
160764421|NCT00607893|580528583|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
160764422|NCT00607893|580528582|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
160764423|NCT00607893|580528583|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
160764424|NCT00607893|580528582|FG000|Overall Study|Declined to be treated|1|||
160764425|NCT00607893|580528583|FG001|Overall Study|Declined to be treated|0|||
160764426|NCT00607893|580528582|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
160764427|NCT00607893|580528583|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
160764428|NCT01799941|580528584|FG000|Overall Study|Adverse Event|34|||
160764429|NCT01799941|580528584|FG000|Overall Study|Withdrawal by Subject|21|||
160764430|NCT01799941|580528584|FG000|Overall Study|Death|2|||
160764431|NCT01799941|580528584|FG000|Overall Study|Investigator Decision|4|||
160764432|NCT01799941|580528584|FG000|Overall Study|Lack of Efficacy|3|||
160764433|NCT01799941|580528584|FG000|Overall Study|Lost to Follow-up|17|||
160764434|NCT01799941|580528584|FG000|Overall Study|Other|15|||
160764435|NCT02369653|580528585|FG000|Overall Study|Lost to Follow-up|0|||
160764436|NCT02369653|580528586|FG001|Overall Study|Lost to Follow-up|1|||
160764437|NCT02369653|580528585|FG000|Overall Study|Administrative reason by sponsor|0|||
160764438|NCT02369653|580528586|FG001|Overall Study|Administrative reason by sponsor|1|||
160764439|NCT02369653|580528585|FG000|Overall Study|Death|1|||
160764440|NCT02369653|580528586|FG001|Overall Study|Death|2|||
160764441|NCT02369653|580528585|FG000|Overall Study|Participant withdrew consent|13|||
160764442|NCT02369653|580528586|FG001|Overall Study|Participant withdrew consent|3|||
160764443|NCT03587636|580528587|FG000|Overall Study|Lost to Follow-up|2|||
160764444|NCT03587636|580528588|FG001|Overall Study|Lost to Follow-up|5|||
160764445|NCT01458587|580528589|FG000|Overall Study|Withdrawal by Subject|1|||
160764446|NCT01458587|580528590|FG001|Overall Study|Withdrawal by Subject|0|||
160764447|NCT01603602|580528591|FG000|Overall Study|Adverse Event|1|||
160764448|NCT01603602|580528592|FG001|Overall Study|Adverse Event|0|||
160764449|NCT01603602|580528593|FG002|Overall Study|Adverse Event|0|||
160764450|NCT01603602|580528591|FG000|Overall Study|Personal Reasons|1|||
160764451|NCT01603602|580528592|FG001|Overall Study|Personal Reasons|0|||
160764452|NCT01603602|580528593|FG002|Overall Study|Personal Reasons|1|||
160764453|NCT04748718|580528597|FG000|Overall Study|Lost to Follow-up|50|||
160764454|NCT00316004|580528598|FG000|Overall Study|Subject was not given study fluid.|14|||
160764455|NCT00316004|580528599|FG001|Overall Study|Subject was not given study fluid.|14|||
160764456|NCT00316004|580528600|FG002|Overall Study|Subject was not given study fluid.|21|||
160764457|NCT02932943|580528601|FG000|Overall Study|Lost to Follow-up|0|||
160764458|NCT02932943|580528602|FG001|Overall Study|Lost to Follow-up|2|||
160764459|NCT02932943|580528601|FG000|Overall Study|Adverse Event|2|||
160764460|NCT02932943|580528602|FG001|Overall Study|Adverse Event|2|||
160764461|NCT02932943|580528601|FG000|Overall Study|Withdrawal by Subject|3|||
160764462|NCT02932943|580528602|FG001|Overall Study|Withdrawal by Subject|3|||
160764463|NCT01178294|580528609|FG000|Overall Study|Adverse Event|4|||
160764464|NCT01178294|580528609|FG000|Overall Study|Lost to Follow-up|2|||
160764465|NCT01178294|580528609|FG000|Overall Study|Lack of Efficacy|1|||
160764466|NCT01178294|580528609|FG000|Overall Study|Death|1|||
160764467|NCT01178294|580528609|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
160764468|NCT01178294|580528609|FG000|Overall Study|Subject status is terminal|1|||
160764469|NCT01178294|580528609|FG000|Overall Study|Completion status could not be verified|1|||
160764470|NCT02251275|580528610|FG000|Overall Study|Adverse Event|23|||
160764471|NCT02251275|580528611|FG001|Overall Study|Adverse Event|60|||
160764472|NCT02251275|580528612|FG002|Overall Study|Adverse Event|28|||
160764473|NCT02251275|580528613|FG003|Overall Study|Adverse Event|0|||
160764474|NCT02251275|580528614|FG004|Overall Study|Adverse Event|0|||
160764475|NCT02251275|580528610|FG000|Overall Study|Lost to Follow-up|5|||
160764476|NCT02251275|580528611|FG001|Overall Study|Lost to Follow-up|6|||
160764477|NCT02251275|580528612|FG002|Overall Study|Lost to Follow-up|4|||
160764478|NCT02251275|580528613|FG003|Overall Study|Lost to Follow-up|0|||
160764479|NCT02251275|580528614|FG004|Overall Study|Lost to Follow-up|0|||
160764480|NCT02251275|580528610|FG000|Overall Study|Physician Decision|19|||
160764481|NCT02251275|580528611|FG001|Overall Study|Physician Decision|30|||
160764482|NCT02251275|580528612|FG002|Overall Study|Physician Decision|26|||
160764483|NCT02251275|580528613|FG003|Overall Study|Physician Decision|0|||
160764484|NCT02251275|580528614|FG004|Overall Study|Physician Decision|1|||
160636422|NCT01682512|580051542|FG000|Overall Study|Withdrawal by Subject|2|||
160764485|NCT02251275|580528610|FG000|Overall Study|Protocol Deviation|0|||
160764486|NCT02251275|580528611|FG001|Overall Study|Protocol Deviation|0|||
160764487|NCT02251275|580528612|FG002|Overall Study|Protocol Deviation|1|||
160764488|NCT02251275|580528613|FG003|Overall Study|Protocol Deviation|0|||
160764489|NCT02251275|580528614|FG004|Overall Study|Protocol Deviation|0|||
160764490|NCT02251275|580528610|FG000|Overall Study|Withdrawal by Subject|25|||
160764491|NCT02251275|580528611|FG001|Overall Study|Withdrawal by Subject|51|||
160764492|NCT02251275|580528612|FG002|Overall Study|Withdrawal by Subject|35|||
160764493|NCT02251275|580528613|FG003|Overall Study|Withdrawal by Subject|1|||
160764494|NCT02251275|580528614|FG004|Overall Study|Withdrawal by Subject|0|||
160764495|NCT01004614|580528618|FG000|Washout|Withdrawal by Subject|0|||
160764496|NCT01004614|580528619|FG001|Washout|Withdrawal by Subject|1|||
160764497|NCT01004614|580528620|FG002|Washout|Withdrawal by Subject|0|||
160764498|NCT01004614|580528621|FG003|Washout|Withdrawal by Subject|0|||
160764499|NCT01569022|580528623|FG000|First Intervention|Lost to Follow-up|2|||
160764500|NCT01569022|580528624|FG001|First Intervention|Lost to Follow-up|1|||
160764501|NCT01569022|580528623|FG000|Second Intervention|Lost to Follow-up|2|||
160764502|NCT01569022|580528624|FG001|Second Intervention|Lost to Follow-up|2|||
160764503|NCT02111083|580528629|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
160764504|NCT02111083|580528630|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
160764505|NCT00644059|580528631|FG000|Overall Study|Lost to Follow-up|37|||
160764506|NCT00644059|580528632|FG001|Overall Study|Lost to Follow-up|34|||
160764507|NCT00644059|580528633|FG002|Overall Study|Lost to Follow-up|16|||
160764508|NCT00644059|580528631|FG000|Overall Study|Withdrawal by Subject|52|||
160764509|NCT00644059|580528632|FG001|Overall Study|Withdrawal by Subject|60|||
160764510|NCT00644059|580528633|FG002|Overall Study|Withdrawal by Subject|30|||
160764511|NCT00644059|580528631|FG000|Overall Study|Adverse Event|8|||
160764512|NCT00644059|580528632|FG001|Overall Study|Adverse Event|5|||
160764513|NCT00644059|580528633|FG002|Overall Study|Adverse Event|1|||
160764514|NCT00644059|580528631|FG000|Overall Study|Inappropriate Enrollment|1|||
160764515|NCT00644059|580528632|FG001|Overall Study|Inappropriate Enrollment|3|||
160764516|NCT00644059|580528633|FG002|Overall Study|Inappropriate Enrollment|0|||
160764517|NCT00644059|580528631|FG000|Overall Study|Protocol Deviation/violation|20|||
160764518|NCT00644059|580528632|FG001|Overall Study|Protocol Deviation/violation|19|||
160764519|NCT00644059|580528633|FG002|Overall Study|Protocol Deviation/violation|15|||
160764520|NCT00644059|580528631|FG000|Overall Study|Unable to classify|6|||
160764521|NCT00644059|580528632|FG001|Overall Study|Unable to classify|2|||
160764522|NCT00644059|580528633|FG002|Overall Study|Unable to classify|3|||
160764523|NCT02133508|580528634|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
160764524|NCT02133508|580528634|FG000|Overall Study|Death|12|||
160764525|NCT02133508|580528634|FG000|Overall Study|Lost to Follow-up|2|||
160764526|NCT02152007|580528635|FG000|Overall Study|Withdrawal by Subject|1|||
160764527|NCT03363906|580528640|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
160764528|NCT03363906|580528641|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
160527292|NCT04484259|579660950|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
160527293|NCT04484259|579660946|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
160527294|NCT04484259|579660947|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
160764529|NCT03363906|580528640|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
160764530|NCT03363906|580528641|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
160764531|NCT03363906|580528640|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
160764532|NCT03363906|580528641|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
160764533|NCT03363906|580528640|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
160764534|NCT03363906|580528641|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
160764535|NCT00676143|580528642|FG000|Overall Study|Adverse Event|34|||
160764536|NCT00676143|580528643|FG001|Overall Study|Adverse Event|60|||
160764537|NCT00676143|580528642|FG000|Overall Study|Death|4|||
160764538|NCT00676143|580528643|FG001|Overall Study|Death|4|||
160764539|NCT00676143|580528642|FG000|Overall Study|Lack of Efficacy|0|||
160764540|NCT00676143|580528643|FG001|Overall Study|Lack of Efficacy|6|||
160764541|NCT00676143|580528642|FG000|Overall Study|Lost to Follow-up|0|||
160764542|NCT00676143|580528643|FG001|Overall Study|Lost to Follow-up|13|||
160764543|NCT00676143|580528642|FG000|Overall Study|Physician Decision|5|||
160764544|NCT00676143|580528643|FG001|Overall Study|Physician Decision|8|||
160764545|NCT00676143|580528642|FG000|Overall Study|Protocol Violation|4|||
160764546|NCT00676143|580528643|FG001|Overall Study|Protocol Violation|8|||
160764547|NCT00676143|580528642|FG000|Overall Study|Withdrawal by Subject|24|||
160764548|NCT00676143|580528643|FG001|Overall Study|Withdrawal by Subject|42|||
160764549|NCT00676143|580528642|FG000|Overall Study|Discontinuation of study by sponsor|65|||
160764550|NCT00676143|580528643|FG001|Overall Study|Discontinuation of study by sponsor|88|||
160764551|NCT00676143|580528642|FG000|Overall Study|Failed to return|2|||
160764552|NCT00676143|580528643|FG001|Overall Study|Failed to return|1|||
160764553|NCT00676143|580528642|FG000|Overall Study|Loss of caregiver|5|||
160764554|NCT00676143|580528643|FG001|Overall Study|Loss of caregiver|3|||
160764555|NCT00676143|580528642|FG000|Overall Study|Other|11|||
160764556|NCT00676143|580528643|FG001|Overall Study|Other|20|||
160764557|NCT00676143|580528642|FG000|Overall Study|Participant participation unknown|1|||
160764558|NCT00676143|580528643|FG001|Overall Study|Participant participation unknown|4|||
160764559|NCT00676143|580528642|FG000|Overall Study|Vasogenic edema recurrence|1|||
160764560|NCT00676143|580528643|FG001|Overall Study|Vasogenic edema recurrence|3|||
160764561|NCT00472420|580528644|FG000|Induction Treatment Period|Physician Decision|9|||
160764562|NCT00472420|580528644|FG000|Induction Treatment Period|Adverse Event|3|||
160764563|NCT00472420|580528644|FG000|Induction Treatment Period|Non-compliance|1|||
160764564|NCT00472420|580528644|FG000|Induction Treatment Period|Death|3|||
160764565|NCT00472420|580528644|FG000|Follow-up Period|Death|5|||
160764566|NCT00472420|580528644|FG000|Follow-up Period|Physician Decision|9|||
160764567|NCT00472420|580528644|FG000|Follow-up Period|Lost to Follow-up|2|||
160764568|NCT00472420|580528644|FG000|Follow-up Period|Protocol Violation|1|||
160764569|NCT00686972|580528646|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
160764570|NCT01901185|580528647|FG000|Overall Study|Withdrawal by Subject|2|||
160764571|NCT02065557|580528650|FG000|Induction Period|Withdrawal by Subject|2|||
160764572|NCT02065557|580528651|FG001|Induction Period|Withdrawal by Subject|1|||
160764573|NCT02065557|580528652|FG002|Induction Period|Withdrawal by Subject|0|||
160764574|NCT02065557|580528653|FG003|Induction Period|Withdrawal by Subject|0|||
160764575|NCT02065557|580528654|FG004|Induction Period|Withdrawal by Subject|0|||
160764576|NCT02065557|580528655|FG005|Induction Period|Withdrawal by Subject|0|||
160764577|NCT02065557|580528650|FG000|Induction Period|Lack of Efficacy|2|||
160764578|NCT02065557|580528651|FG001|Induction Period|Lack of Efficacy|1|||
160764579|NCT02065557|580528652|FG002|Induction Period|Lack of Efficacy|1|||
160764580|NCT02065557|580528653|FG003|Induction Period|Lack of Efficacy|0|||
160764581|NCT02065557|580528654|FG004|Induction Period|Lack of Efficacy|0|||
160764582|NCT02065557|580528655|FG005|Induction Period|Lack of Efficacy|0|||
160764583|NCT02065557|580528650|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
160764584|NCT02065557|580528651|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
160764585|NCT02065557|580528652|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
160764586|NCT02065557|580528653|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
160868770|NCT04922216|580910500|FG012|Overall Study|Withdrawal by Subject|1|||
160764587|NCT02065557|580528654|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
160764588|NCT02065557|580528655|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
160764589|NCT02065557|580528650|FG000|Induction Period|Non-Responder at Week 8|4|||
160764590|NCT02065557|580528651|FG001|Induction Period|Non-Responder at Week 8|4|||
160868771|NCT04922216|580910501|FG013|Overall Study|Withdrawal by Subject|1|||
160868772|NCT04922216|580910502|FG014|Overall Study|Withdrawal by Subject|1|||
160764591|NCT02065557|580528652|FG002|Induction Period|Non-Responder at Week 8|0|||
160764592|NCT02065557|580528653|FG003|Induction Period|Non-Responder at Week 8|0|||
160764593|NCT02065557|580528654|FG004|Induction Period|Non-Responder at Week 8|0|||
160764594|NCT02065557|580528655|FG005|Induction Period|Non-Responder at Week 8|0|||
160764595|NCT02065557|580528650|FG000|Induction Period|Adverse Event|1|||
160764596|NCT02065557|580528651|FG001|Induction Period|Adverse Event|1|||
160527295|NCT04484259|579660948|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
160527296|NCT04484259|579660949|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
160527297|NCT04484259|579660950|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
160527298|NCT04484259|579660946|FG000|Randomized Treatment|Withdrawal by Subject|1|||
160527299|NCT04484259|579660947|FG001|Randomized Treatment|Withdrawal by Subject|0|||
160527300|NCT04484259|579660948|FG002|Randomized Treatment|Withdrawal by Subject|0|||
160527301|NCT04484259|579660949|FG003|Randomized Treatment|Withdrawal by Subject|0|||
160764597|NCT02065557|580528652|FG002|Induction Period|Adverse Event|0|||
160764598|NCT02065557|580528653|FG003|Induction Period|Adverse Event|0|||
160764599|NCT02065557|580528654|FG004|Induction Period|Adverse Event|0|||
160764600|NCT02065557|580528655|FG005|Induction Period|Adverse Event|0|||
160764601|NCT02065557|580528650|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
160764602|NCT02065557|580528651|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
160764603|NCT02065557|580528652|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
160764604|NCT02065557|580528653|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
160764605|NCT02065557|580528654|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
160764606|NCT02065557|580528655|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
160764607|NCT02065557|580528650|FG000|Maintenance Period|Withdrawal by Subject|0|||
160764608|NCT02065557|580528651|FG001|Maintenance Period|Withdrawal by Subject|0|||
160764609|NCT02065557|580528652|FG002|Maintenance Period|Withdrawal by Subject|0|||
160764610|NCT02065557|580528653|FG003|Maintenance Period|Withdrawal by Subject|0|||
160764611|NCT02065557|580528654|FG004|Maintenance Period|Withdrawal by Subject|2|||
160764612|NCT02065557|580528655|FG005|Maintenance Period|Withdrawal by Subject|1|||
160764613|NCT02065557|580528650|FG000|Maintenance Period|Lack of Efficacy|0|||
160764614|NCT02065557|580528651|FG001|Maintenance Period|Lack of Efficacy|0|||
160764615|NCT02065557|580528652|FG002|Maintenance Period|Lack of Efficacy|0|||
160764616|NCT02065557|580528653|FG003|Maintenance Period|Lack of Efficacy|0|||
160764617|NCT02065557|580528654|FG004|Maintenance Period|Lack of Efficacy|5|||
160764618|NCT02065557|580528655|FG005|Maintenance Period|Lack of Efficacy|2|||
160764619|NCT02065557|580528650|FG000|Maintenance Period|Subject Non-Compliance|0|||
160764620|NCT02065557|580528651|FG001|Maintenance Period|Subject Non-Compliance|0|||
160764621|NCT02065557|580528652|FG002|Maintenance Period|Subject Non-Compliance|0|||
160764622|NCT02065557|580528653|FG003|Maintenance Period|Subject Non-Compliance|0|||
160764623|NCT02065557|580528654|FG004|Maintenance Period|Subject Non-Compliance|0|||
160764624|NCT02065557|580528655|FG005|Maintenance Period|Subject Non-Compliance|1|||
160764625|NCT01462942|580528659|FG000|Overall Study|Adverse Event|7|||
160764626|NCT01462942|580528660|FG001|Overall Study|Adverse Event|12|||
160764627|NCT01462942|580528661|FG002|Overall Study|Adverse Event|10|||
160764628|NCT01462942|580528662|FG003|Overall Study|Adverse Event|11|||
160764629|NCT01462942|580528663|FG004|Overall Study|Adverse Event|11|||
160764630|NCT01462942|580528659|FG000|Overall Study|Other, including COPD exacerbation|3|||
160764631|NCT01462942|580528660|FG001|Overall Study|Other, including COPD exacerbation|5|||
160764632|NCT01462942|580528661|FG002|Overall Study|Other, including COPD exacerbation|2|||
160764633|NCT01462942|580528662|FG003|Overall Study|Other, including COPD exacerbation|8|||
160764634|NCT01462942|580528663|FG004|Overall Study|Other, including COPD exacerbation|5|||
160764635|NCT01462942|580528659|FG000|Overall Study|Withdrawal by Subject|14|||
160764636|NCT01462942|580528660|FG001|Overall Study|Withdrawal by Subject|10|||
160764637|NCT01462942|580528661|FG002|Overall Study|Withdrawal by Subject|14|||
160764638|NCT01462942|580528662|FG003|Overall Study|Withdrawal by Subject|16|||
160764639|NCT01462942|580528663|FG004|Overall Study|Withdrawal by Subject|19|||
160764640|NCT01462942|580528659|FG000|Overall Study|Lack of Efficacy|6|||
160764641|NCT01462942|580528660|FG001|Overall Study|Lack of Efficacy|0|||
160764642|NCT01462942|580528661|FG002|Overall Study|Lack of Efficacy|4|||
160764643|NCT01462942|580528662|FG003|Overall Study|Lack of Efficacy|5|||
160764644|NCT01462942|580528663|FG004|Overall Study|Lack of Efficacy|3|||
160868773|NCT04922216|580910503|FG015|Overall Study|Withdrawal by Subject|0|||
160868774|NCT04922216|580910504|FG016|Overall Study|Withdrawal by Subject|0|||
160868775|NCT04922216|580910505|FG017|Overall Study|Withdrawal by Subject|1|||
160868776|NCT04922216|580910506|FG018|Overall Study|Withdrawal by Subject|1|||
160868777|NCT04922216|580910507|FG019|Overall Study|Withdrawal by Subject|1|||
160868778|NCT04922216|580910508|FG020|Overall Study|Withdrawal by Subject|1|||
160868779|NCT04922216|580910509|FG021|Overall Study|Withdrawal by Subject|0|||
160868780|NCT04922216|580910510|FG022|Overall Study|Withdrawal by Subject|0|||
160868781|NCT04922216|580910511|FG023|Overall Study|Withdrawal by Subject|2|||
160868782|NCT04922216|580910512|FG024|Overall Study|Withdrawal by Subject|0|||
160868783|NCT04922216|580910513|FG025|Overall Study|Withdrawal by Subject|0|||
160868784|NCT04922216|580910514|FG026|Overall Study|Withdrawal by Subject|1|||
160868785|NCT04922216|580910515|FG027|Overall Study|Withdrawal by Subject|0|||
160868786|NCT04922216|580910516|FG028|Overall Study|Withdrawal by Subject|0|||
160868787|NCT04922216|580910517|FG029|Overall Study|Withdrawal by Subject|0|||
160868788|NCT04922216|580910518|FG030|Overall Study|Withdrawal by Subject|1|||
160868789|NCT04922216|580910519|FG031|Overall Study|Withdrawal by Subject|0|||
160868790|NCT04922216|580910488|FG000|Overall Study|Lost to Follow-up|1|||
160868791|NCT04922216|580910489|FG001|Overall Study|Lost to Follow-up|0|||
160868792|NCT04922216|580910490|FG002|Overall Study|Lost to Follow-up|2|||
160868793|NCT04922216|580910491|FG003|Overall Study|Lost to Follow-up|0|||
160868794|NCT04922216|580910492|FG004|Overall Study|Lost to Follow-up|0|||
160868795|NCT04922216|580910493|FG005|Overall Study|Lost to Follow-up|2|||
160868796|NCT04922216|580910494|FG006|Overall Study|Lost to Follow-up|0|||
160868797|NCT04922216|580910495|FG007|Overall Study|Lost to Follow-up|1|||
160868798|NCT04922216|580910496|FG008|Overall Study|Lost to Follow-up|1|||
160868799|NCT04922216|580910497|FG009|Overall Study|Lost to Follow-up|2|||
160868800|NCT04922216|580910498|FG010|Overall Study|Lost to Follow-up|2|||
160868801|NCT04922216|580910499|FG011|Overall Study|Lost to Follow-up|1|||
160868802|NCT04922216|580910500|FG012|Overall Study|Lost to Follow-up|1|||
160868803|NCT04922216|580910501|FG013|Overall Study|Lost to Follow-up|0|||
160868804|NCT04922216|580910502|FG014|Overall Study|Lost to Follow-up|1|||
160868805|NCT04922216|580910503|FG015|Overall Study|Lost to Follow-up|0|||
160868806|NCT04922216|580910504|FG016|Overall Study|Lost to Follow-up|0|||
160868807|NCT04922216|580910505|FG017|Overall Study|Lost to Follow-up|2|||
160868808|NCT04922216|580910506|FG018|Overall Study|Lost to Follow-up|1|||
160868809|NCT04922216|580910507|FG019|Overall Study|Lost to Follow-up|0|||
160636423|NCT01682512|580051543|FG001|Overall Study|Withdrawal by Subject|6|||
160868810|NCT04922216|580910508|FG020|Overall Study|Lost to Follow-up|1|||
160868811|NCT04922216|580910509|FG021|Overall Study|Lost to Follow-up|0|||
160868812|NCT04922216|580910510|FG022|Overall Study|Lost to Follow-up|2|||
160868813|NCT04922216|580910511|FG023|Overall Study|Lost to Follow-up|1|||
160868814|NCT04922216|580910512|FG024|Overall Study|Lost to Follow-up|0|||
160868815|NCT04922216|580910513|FG025|Overall Study|Lost to Follow-up|2|||
160868816|NCT04922216|580910514|FG026|Overall Study|Lost to Follow-up|0|||
160868817|NCT04922216|580910515|FG027|Overall Study|Lost to Follow-up|0|||
160868818|NCT04922216|580910516|FG028|Overall Study|Lost to Follow-up|1|||
160868819|NCT04922216|580910517|FG029|Overall Study|Lost to Follow-up|0|||
160868820|NCT04922216|580910518|FG030|Overall Study|Lost to Follow-up|2|||
160868821|NCT04922216|580910519|FG031|Overall Study|Lost to Follow-up|1|||
160868822|NCT03278249|580910520|FG000|Overall Study|Withdrawal by Subject|2|||
160868823|NCT03278249|580910520|FG000|Overall Study|Lost to Follow-up|1|||
160868824|NCT03207763|580912031|FG000|Overall Study|Lost to Follow-up|1|||
160868825|NCT03207763|580912032|FG001|Overall Study|Lost to Follow-up|0|||
160868826|NCT02102204|580912033|FG000|Overall Study|Withdrawal by Subject|137|||
160868827|NCT02102204|580912033|FG000|Overall Study|Death|92|||
160868828|NCT02102204|580912033|FG000|Overall Study|Lost to Follow-up|65|||
160868829|NCT02102204|580912033|FG000|Overall Study|Sponsor Decision|5|||
160868830|NCT02102204|580912033|FG000|Overall Study|Ongoing|5|||
160868831|NCT02605122|580912034|FG000|Overall Study|Withdrawal by Subject|4|||
160868832|NCT02605122|580912035|FG001|Overall Study|Withdrawal by Subject|1|||
160868833|NCT02605122|580912034|FG000|Overall Study|Lost to Follow-up|1|||
160868834|NCT02605122|580912035|FG001|Overall Study|Lost to Follow-up|1|||
160868835|NCT00990704|580912036|FG000|Overall Study|Adverse Event|1|||
160868836|NCT00990704|580912037|FG001|Overall Study|Adverse Event|1|||
160868837|NCT00990704|580912036|FG000|Overall Study|Physician Decision|0|||
160868838|NCT00990704|580912037|FG001|Overall Study|Physician Decision|1|||
160868839|NCT00807001|580912039|FG000|Overall Study|Non-compliance|0|||
160868840|NCT00807001|580912040|FG001|Overall Study|Non-compliance|1|||
160868841|NCT00807001|580912041|FG002|Overall Study|Non-compliance|0|||
160868842|NCT00807001|580912042|FG003|Overall Study|Non-compliance|0|||
160868843|NCT00807001|580912043|FG004|Overall Study|Non-compliance|0|||
160868844|NCT01399372|580912045|FG000|Overall Study|Protocol Violation|3|||
160868845|NCT01399372|580912046|FG001|Overall Study|Protocol Violation|1|||
160868846|NCT03773796|580912047|FG000|Overall Study|Adverse Event|1|||
160868847|NCT03773796|580912047|FG000|Overall Study|Withdrawal by Subject|1|||
160868848|NCT03773796|580912047|FG000|Overall Study|Lack of Efficacy|1|||
160868849|NCT03805659|580912049|FG000|Overall Study|Withdrawal by Subject|0|||
160868850|NCT03805659|580912050|FG001|Overall Study|Withdrawal by Subject|1|||
160868851|NCT01027273|580912052|FG000|Overall Study|Lost to Follow-up|57|||
160868852|NCT01027273|580912053|FG001|Overall Study|Lost to Follow-up|31|||
160868853|NCT01027273|580912052|FG000|Overall Study|Death|2|||
160868854|NCT01027273|580912053|FG001|Overall Study|Death|2|||
160868855|NCT00499616|580912056|FG000|Overall Study|Death|1|||
160868856|NCT00499616|580912057|FG001|Overall Study|Death|5|||
160868857|NCT00499616|580912058|FG002|Overall Study|Death|3|||
160868858|NCT00499616|580912059|FG003|Overall Study|Death|1|||
160868859|NCT00499616|580912056|FG000|Overall Study|Lack of Efficacy|5|||
160868860|NCT00499616|580912057|FG001|Overall Study|Lack of Efficacy|0|||
160868861|NCT00499616|580912058|FG002|Overall Study|Lack of Efficacy|19|||
160868862|NCT00499616|580912059|FG003|Overall Study|Lack of Efficacy|0|||
160868863|NCT00499616|580912056|FG000|Overall Study|Lost to Follow-up|0|||
160868864|NCT00499616|580912057|FG001|Overall Study|Lost to Follow-up|0|||
160868865|NCT00499616|580912058|FG002|Overall Study|Lost to Follow-up|1|||
160868866|NCT00499616|580912059|FG003|Overall Study|Lost to Follow-up|0|||
160868867|NCT00499616|580912056|FG000|Overall Study|Physician Decision|6|||
160868868|NCT00499616|580912057|FG001|Overall Study|Physician Decision|16|||
160868869|NCT00499616|580912058|FG002|Overall Study|Physician Decision|9|||
160868870|NCT00499616|580912059|FG003|Overall Study|Physician Decision|0|||
160868871|NCT00499616|580912056|FG000|Overall Study|Withdrawal by Subject|1|||
160868872|NCT00499616|580912057|FG001|Overall Study|Withdrawal by Subject|0|||
160868873|NCT00499616|580912058|FG002|Overall Study|Withdrawal by Subject|1|||
160868874|NCT00499616|580912059|FG003|Overall Study|Withdrawal by Subject|0|||
160868875|NCT00499616|580912056|FG000|Overall Study|Ineligible|1|||
160868876|NCT00499616|580912057|FG001|Overall Study|Ineligible|2|||
160868877|NCT00499616|580912058|FG002|Overall Study|Ineligible|0|||
160868878|NCT00499616|580912059|FG003|Overall Study|Ineligible|15|||
160868879|NCT00499616|580912056|FG000|Overall Study|Not evaluable|0|||
160868880|NCT00499616|580912057|FG001|Overall Study|Not evaluable|0|||
160868881|NCT00499616|580912058|FG002|Overall Study|Not evaluable|0|||
160868882|NCT00499616|580912059|FG003|Overall Study|Not evaluable|41|||
160868883|NCT00499616|580912056|FG000|Overall Study|Patient/Parent Refusal|1|||
160527302|NCT04484259|579660950|FG004|Randomized Treatment|Withdrawal by Subject|0|||
160868884|NCT00499616|580912057|FG001|Overall Study|Patient/Parent Refusal|5|||
160868885|NCT00499616|580912058|FG002|Overall Study|Patient/Parent Refusal|3|||
160527303|NCT04498832|579660951|FG000|Overall Study|Adverse Event|1|||
160868886|NCT00499616|580912059|FG003|Overall Study|Patient/Parent Refusal|0|||
160868887|NCT02636595|580912060|FG000|Overall Study|Lost to Follow-up|1|||
160868888|NCT02636595|580912060|FG000|Overall Study|Other|1|||
160868889|NCT02223858|580912061|FG000|Overall Study|Death|1|||
160868890|NCT02223858|580912062|FG001|Overall Study|Death|1|||
160868891|NCT02223858|580912061|FG000|Overall Study|Lost to Follow-up|6|||
160868892|NCT02223858|580912062|FG001|Overall Study|Lost to Follow-up|11|||
160868893|NCT02223858|580912061|FG000|Overall Study|Withdrawal by Subject|8|||
160868894|NCT02223858|580912062|FG001|Overall Study|Withdrawal by Subject|5|||
160868895|NCT02223858|580912061|FG000|Overall Study|Refused|9|||
160868896|NCT02223858|580912062|FG001|Overall Study|Refused|9|||
160868897|NCT00241839|580912064|FG000|Overall Study|Withdrawal by Subject|18|||
160868898|NCT00241839|580912065|FG001|Overall Study|Withdrawal by Subject|17|||
160868899|NCT00241839|580912064|FG000|Overall Study|Adverse Event|1|||
160868900|NCT00241839|580912065|FG001|Overall Study|Adverse Event|1|||
160868901|NCT00831181|580912068|FG000|Overall Study|Adverse Event|12|||
160868902|NCT04313244|580912069|FG000|Overall Study|Withdrawal of Consent|3|||
160868903|NCT04313244|580912070|FG001|Overall Study|Withdrawal of Consent|3|||
160868904|NCT04313244|580912069|FG000|Overall Study|Met Exclusion Criteria|1|||
160868905|NCT04313244|580912070|FG001|Overall Study|Met Exclusion Criteria|0|||
160868906|NCT04313244|580912069|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
160868907|NCT04313244|580912070|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
160868908|NCT02976038|580912071|FG000|Overall Study|Physician Decision|22|||
160868909|NCT02976038|580912071|FG000|Overall Study|Withdrawal by Subject|3|||
160868910|NCT02976038|580912071|FG000|Overall Study|Lost to Follow-up|2|||
160868911|NCT02976038|580912071|FG000|Overall Study|Adverse Event|1|||
160868912|NCT05021978|580912074|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
160868913|NCT05021978|580912075|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
160868914|NCT05021978|580912076|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
160868915|NCT05021978|580912077|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
160868916|NCT05021978|580912074|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
160868917|NCT05021978|580912075|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
160868918|NCT05021978|580912076|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
160868919|NCT05021978|580912077|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
160868920|NCT00196313|580912078|FG000|Overall Study|Protocol Violation|2|||
160868921|NCT00196313|580912079|FG001|Overall Study|Protocol Violation|3|||
160868922|NCT00196313|580912078|FG000|Overall Study|Withdrawal by Subject|3|||
160868923|NCT00196313|580912079|FG001|Overall Study|Withdrawal by Subject|1|||
160868924|NCT00196313|580912078|FG000|Overall Study|Adverse Event|3|||
160868925|NCT00196313|580912079|FG001|Overall Study|Adverse Event|1|||
160868926|NCT00196313|580912078|FG000|Overall Study|Subject Pregnant|1|||
160868927|NCT00196313|580912079|FG001|Overall Study|Subject Pregnant|1|||
160868928|NCT00196313|580912078|FG000|Overall Study|Lost to Follow-up|2|||
160868929|NCT00196313|580912079|FG001|Overall Study|Lost to Follow-up|2|||
160868930|NCT00043979|580912080|FG000|Period 1|recipient with progressive disease|7|||
160868931|NCT00043979|580912081|FG001|Period 1|recipient with progressive disease|4|||
160868932|NCT00043979|580912082|FG002|Period 1|recipient with progressive disease|3|||
160868933|NCT03096288|580912084|FG000|Overall Study|Withdrawal by Subject|0|||
160868934|NCT03096288|580912085|FG001|Overall Study|Withdrawal by Subject|1|||
160868935|NCT03096288|580912086|FG002|Overall Study|Withdrawal by Subject|0|||
160868936|NCT03096288|580912087|FG003|Overall Study|Withdrawal by Subject|1|||
160868937|NCT04639258|580912088|FG000|Overall Study|Screen failure|5|||
160868938|NCT04639258|580912088|FG000|Overall Study|Physician Decision|2|||
160868939|NCT04639258|580912088|FG000|Overall Study|Early study termination|3|||
160868940|NCT04639258|580912088|FG000|Overall Study|Withdrawal by Subject|1|||
160868941|NCT00414596|580912089|FG000|Overall Study|Protocol Violation|2|||
160868942|NCT01635153|580912092|FG000|Overall Study|Lost to Follow-up|40|||
160868943|NCT01635153|580912093|FG001|Overall Study|Lost to Follow-up|43|||
160868944|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Adverse Event|9|||
160868945|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Adverse Event|3|||
160868946|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Death|7|||
160868947|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Death|7|||
160764645|NCT01462942|580528659|FG000|Overall Study|Lost to Follow-up|0|||
160764646|NCT01462942|580528660|FG001|Overall Study|Lost to Follow-up|1|||
160764647|NCT01462942|580528661|FG002|Overall Study|Lost to Follow-up|1|||
160764648|NCT01462942|580528662|FG003|Overall Study|Lost to Follow-up|1|||
160764649|NCT01462942|580528663|FG004|Overall Study|Lost to Follow-up|1|||
160764650|NCT01462942|580528659|FG000|Overall Study|Protocol Violation|4|||
160764651|NCT01462942|580528660|FG001|Overall Study|Protocol Violation|6|||
160764652|NCT01462942|580528661|FG002|Overall Study|Protocol Violation|9|||
160764653|NCT01462942|580528662|FG003|Overall Study|Protocol Violation|9|||
160764654|NCT01462942|580528663|FG004|Overall Study|Protocol Violation|6|||
160868948|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
160764655|NCT02737722|580528666|FG000|Overall Study|Physician Decision|0|||
160764656|NCT02737722|580528667|FG001|Overall Study|Physician Decision|0|||
160868949|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
160868950|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Physician Decision|1|||
160868951|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Physician Decision|0|||
160868952|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
160868953|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
160868954|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
160868955|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
160764657|NCT02737722|580528668|FG002|Overall Study|Physician Decision|1|||
160764658|NCT02737722|580528669|FG003|Overall Study|Physician Decision|0|||
160917922|NCT02673489|581094149|FG001|Treatment Period|Participant was incarcerated|1|||
160868956|NCT02558296|580912094|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
160527304|NCT04498832|579660952|FG001|Overall Study|Adverse Event|3|||
160527305|NCT04498832|579660951|FG000|Overall Study|Withdrawal by Subject|0|||
160527306|NCT04498832|579660952|FG001|Overall Study|Withdrawal by Subject|1|||
160527307|NCT01313650|579660954|FG000|Overall Study|Adverse Event|9|||
160868957|NCT02558296|580912095|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
160868958|NCT02558296|580912094|FG000|Completed the Study|Adverse Event|14|||
160868959|NCT02558296|580912095|FG001|Completed the Study|Adverse Event|5|||
160868960|NCT02558296|580912094|FG000|Completed the Study|Death|39|||
160868961|NCT02558296|580912095|FG001|Completed the Study|Death|25|||
160868962|NCT02558296|580912094|FG000|Completed the Study|Lost to Follow-up|31|||
160868963|NCT02558296|580912095|FG001|Completed the Study|Lost to Follow-up|23|||
160868964|NCT02558296|580912094|FG000|Completed the Study|Physician Decision|6|||
160868965|NCT02558296|580912095|FG001|Completed the Study|Physician Decision|0|||
160868966|NCT02558296|580912094|FG000|Completed the Study|Protocol Violation|2|||
160868967|NCT02558296|580912095|FG001|Completed the Study|Protocol Violation|1|||
160868968|NCT02558296|580912094|FG000|Completed the Study|Withdrawal by Subject|53|||
160868969|NCT02558296|580912095|FG001|Completed the Study|Withdrawal by Subject|31|||
160868970|NCT02558296|580912094|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
160868971|NCT02558296|580912095|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
160868972|NCT02919995|580912098|FG000|Overall Study|Adverse Event|0|||
160868973|NCT02919995|580912099|FG001|Overall Study|Adverse Event|0|||
160868974|NCT02919995|580912100|FG002|Overall Study|Adverse Event|0|||
160868975|NCT02919995|580912101|FG003|Overall Study|Adverse Event|0|||
160868976|NCT02919995|580912102|FG004|Overall Study|Adverse Event|0|||
160868977|NCT02919995|580912103|FG005|Overall Study|Adverse Event|1|||
160868978|NCT01263197|580912115|FG000|First Intervention (Period 1)|Adverse Event|0|||
160868979|NCT01263197|580912116|FG001|First Intervention (Period 1)|Adverse Event|0|||
160868980|NCT01263197|580912117|FG002|First Intervention (Period 1)|Adverse Event|0|||
160868981|NCT01263197|580912118|FG003|First Intervention (Period 1)|Adverse Event|0|||
160868982|NCT01263197|580912119|FG004|First Intervention (Period 1)|Adverse Event|0|||
160868983|NCT01263197|580912120|FG005|First Intervention (Period 1)|Adverse Event|1|||
160868984|NCT01263197|580912115|FG000|Washout Period 1|Protocol Violation|0|||
160868985|NCT01263197|580912116|FG001|Washout Period 1|Protocol Violation|0|||
160868986|NCT01263197|580912117|FG002|Washout Period 1|Protocol Violation|0|||
160527308|NCT01313650|579660955|FG001|Overall Study|Adverse Event|34|||
160527309|NCT01313650|579660956|FG002|Overall Study|Adverse Event|24|||
160527310|NCT01313650|579660957|FG003|Overall Study|Adverse Event|23|||
160868987|NCT01263197|580912118|FG003|Washout Period 1|Protocol Violation|0|||
160868988|NCT01263197|580912119|FG004|Washout Period 1|Protocol Violation|1|||
160868989|NCT01263197|580912120|FG005|Washout Period 1|Protocol Violation|0|||
160868990|NCT01263197|580912115|FG000|Washout Period 2|Physician Decision|0|||
160868991|NCT01263197|580912116|FG001|Washout Period 2|Physician Decision|0|||
160868992|NCT01263197|580912117|FG002|Washout Period 2|Physician Decision|0|||
160868993|NCT01263197|580912118|FG003|Washout Period 2|Physician Decision|0|||
160868994|NCT01263197|580912119|FG004|Washout Period 2|Physician Decision|0|||
160868995|NCT01263197|580912120|FG005|Washout Period 2|Physician Decision|1|||
160868996|NCT01263197|580912115|FG000|Washout Period 2|Protocol Violation|0|||
160527311|NCT01313650|579660954|FG000|Overall Study|Lack of Efficacy|37|||
160527312|NCT01313650|579660955|FG001|Overall Study|Lack of Efficacy|20|||
160527313|NCT01313650|579660956|FG002|Overall Study|Lack of Efficacy|32|||
160527314|NCT01313650|579660957|FG003|Overall Study|Lack of Efficacy|20|||
160527315|NCT01313650|579660954|FG000|Overall Study|Lost to Follow-up|1|||
160527316|NCT01313650|579660955|FG001|Overall Study|Lost to Follow-up|0|||
160527317|NCT01313650|579660956|FG002|Overall Study|Lost to Follow-up|3|||
160527318|NCT01313650|579660957|FG003|Overall Study|Lost to Follow-up|2|||
160527319|NCT01313650|579660954|FG000|Overall Study|Withdrawal by Subject|16|||
160527320|NCT01313650|579660955|FG001|Overall Study|Withdrawal by Subject|20|||
160527321|NCT01313650|579660956|FG002|Overall Study|Withdrawal by Subject|15|||
160527322|NCT01313650|579660957|FG003|Overall Study|Withdrawal by Subject|15|||
160527323|NCT01313650|579660954|FG000|Overall Study|Protocol Violation|4|||
160527324|NCT01313650|579660955|FG001|Overall Study|Protocol Violation|7|||
160527325|NCT01313650|579660956|FG002|Overall Study|Protocol Violation|5|||
160527326|NCT01313650|579660957|FG003|Overall Study|Protocol Violation|6|||
160527327|NCT01313650|579660954|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
160527328|NCT01313650|579660955|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
160527329|NCT01313650|579660956|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
160527330|NCT01313650|579660957|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
160527331|NCT04029480|579660958|FG000|Overall Study|Physician Decision|0|||
160527332|NCT04029480|579660959|FG001|Overall Study|Physician Decision|0|||
160527333|NCT04029480|579660960|FG002|Overall Study|Physician Decision|2|||
160527334|NCT04029480|579660961|FG003|Overall Study|Physician Decision|1|||
160868997|NCT01263197|580912116|FG001|Washout Period 2|Protocol Violation|0|||
160868998|NCT01263197|580912117|FG002|Washout Period 2|Protocol Violation|0|||
160527335|NCT04029480|579660958|FG000|Overall Study|Withdrawal by Subject|2|||
160527336|NCT04029480|579660959|FG001|Overall Study|Withdrawal by Subject|0|||
160527337|NCT04029480|579660960|FG002|Overall Study|Withdrawal by Subject|1|||
160527338|NCT04029480|579660961|FG003|Overall Study|Withdrawal by Subject|1|||
160868999|NCT01263197|580912118|FG003|Washout Period 2|Protocol Violation|1|||
160869000|NCT01263197|580912119|FG004|Washout Period 2|Protocol Violation|0|||
160869001|NCT01263197|580912120|FG005|Washout Period 2|Protocol Violation|0|||
160869002|NCT01263197|580912115|FG000|Third Intervention (Period 3)|Adverse Event|0|||
160869003|NCT01263197|580912116|FG001|Third Intervention (Period 3)|Adverse Event|1|||
160869004|NCT01263197|580912117|FG002|Third Intervention (Period 3)|Adverse Event|0|||
160869005|NCT01263197|580912118|FG003|Third Intervention (Period 3)|Adverse Event|0|||
160869006|NCT01263197|580912119|FG004|Third Intervention (Period 3)|Adverse Event|0|||
160869007|NCT01263197|580912120|FG005|Third Intervention (Period 3)|Adverse Event|0|||
160869008|NCT02577718|580912121|FG000|Overall Study|Death|6|||
160869009|NCT02577718|580912121|FG000|Overall Study|Withdrawal by Subject|2|||
160869010|NCT00594815|580912123|FG000|Overall Study|Never Treated|3|||
160869011|NCT00594815|580912123|FG000|Overall Study|Withdrawal by Subject|2|||
160869012|NCT00594815|580912123|FG000|Overall Study|Toxicity|4|||
160869013|NCT01932437|580912125|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
160869014|NCT01932437|580912126|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
160869015|NCT01932437|580912127|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
160869016|NCT01932437|580912128|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
160869017|NCT01932437|580912129|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
160869018|NCT01932437|580912130|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
160869019|NCT04269889|580912131|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
160869020|NCT00949702|580912136|FG000|Overall Study|Death|40|||
160869021|NCT00949702|580912136|FG000|Overall Study|Disease progression|7|||
160869022|NCT00949702|580912136|FG000|Overall Study|Withdrawal of consent|1|||
160869023|NCT01654302|580912137|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
160869024|NCT01654302|580912138|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
160869025|NCT01286480|580912139|FG000|Overall Study|Withdrawal by Subject|5|||
160869026|NCT01286480|580912140|FG001|Overall Study|Withdrawal by Subject|3|||
160869027|NCT01918306|580912141|FG000|Overall Study|progresive disease|4|||
160869028|NCT01918306|580912142|FG001|Overall Study|progresive disease|0|||
160869029|NCT01918306|580912143|FG002|Overall Study|progresive disease|1|||
160869030|NCT01918306|580912144|FG003|Overall Study|progresive disease|1|||
160869031|NCT01918306|580912141|FG000|Overall Study|Withdrawal by Subject|0|||
160869032|NCT01918306|580912142|FG001|Overall Study|Withdrawal by Subject|0|||
160869033|NCT01918306|580912143|FG002|Overall Study|Withdrawal by Subject|0|||
160869034|NCT01918306|580912144|FG003|Overall Study|Withdrawal by Subject|2|||
160869035|NCT01918306|580912141|FG000|Overall Study|neutropenia|1|||
160869036|NCT01918306|580912142|FG001|Overall Study|neutropenia|0|||
160869037|NCT01918306|580912143|FG002|Overall Study|neutropenia|0|||
160869038|NCT01918306|580912144|FG003|Overall Study|neutropenia|0|||
160869039|NCT01918306|580912141|FG000|Overall Study|Lack of Efficacy|1|||
160869040|NCT01918306|580912142|FG001|Overall Study|Lack of Efficacy|0|||
160869041|NCT01918306|580912143|FG002|Overall Study|Lack of Efficacy|0|||
160527339|NCT01839487|579660962|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
160527340|NCT01839487|579660963|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
160527341|NCT01839487|579660964|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
160869042|NCT01918306|580912144|FG003|Overall Study|Lack of Efficacy|0|||
160869043|NCT01918306|580912141|FG000|Overall Study|progress disease, crossover|0|||
160869044|NCT01918306|580912142|FG001|Overall Study|progress disease, crossover|0|||
160636424|NCT01682512|580051544|FG002|Overall Study|Withdrawal by Subject|3|||
160636425|NCT01682512|580051542|FG000|Overall Study|Physician Decision|0|||
160764659|NCT01026493|580528670|FG000|Overall Study|Protocol Violation|0|||
160764660|NCT01026493|580528671|FG001|Overall Study|Protocol Violation|1|||
160764661|NCT01026493|580528672|FG002|Overall Study|Protocol Violation|0|||
160764662|NCT01026493|580528673|FG003|Overall Study|Protocol Violation|0|||
160764663|NCT01026493|580528674|FG004|Overall Study|Protocol Violation|2|||
160764664|NCT01026493|580528675|FG005|Overall Study|Protocol Violation|3|||
160764665|NCT01026493|580528676|FG006|Overall Study|Protocol Violation|4|||
160764666|NCT01026493|580528677|FG007|Overall Study|Protocol Violation|1|||
160764667|NCT02662569|580528678|FG000|Overall Study|Withdrawal by Subject|6|||
160764668|NCT02662569|580528679|FG001|Overall Study|Withdrawal by Subject|1|||
160764669|NCT02662569|580528680|FG002|Overall Study|Withdrawal by Subject|6|||
160764670|NCT02662569|580528681|FG003|Overall Study|Withdrawal by Subject|4|||
160764671|NCT02662569|580528678|FG000|Overall Study|Lost to Follow-up|1|||
160764672|NCT02662569|580528679|FG001|Overall Study|Lost to Follow-up|0|||
160764673|NCT02662569|580528680|FG002|Overall Study|Lost to Follow-up|0|||
160764674|NCT02662569|580528681|FG003|Overall Study|Lost to Follow-up|0|||
160764675|NCT03154086|580528682|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764676|NCT03154086|580528683|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764677|NCT03154086|580528684|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764678|NCT03154086|580528685|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
160764679|NCT03154086|580528686|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764680|NCT03154086|580528687|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764681|NCT03154086|580528688|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764682|NCT03154086|580528689|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764683|NCT03154086|580528690|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764684|NCT03154086|580528691|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764685|NCT03154086|580528692|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764686|NCT03154086|580528693|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764687|NCT03154086|580528694|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764688|NCT03154086|580528695|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764689|NCT03154086|580528696|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
160764690|NCT03154086|580528682|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764691|NCT03154086|580528683|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
160764692|NCT03154086|580528684|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764693|NCT03154086|580528685|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764694|NCT03154086|580528686|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764695|NCT03154086|580528687|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764696|NCT03154086|580528688|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764697|NCT03154086|580528689|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764698|NCT03154086|580528690|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764699|NCT03154086|580528691|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764700|NCT03154086|580528692|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764701|NCT03154086|580528693|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764702|NCT03154086|580528694|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764703|NCT03154086|580528695|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764704|NCT03154086|580528696|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
160764705|NCT03154086|580528682|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764706|NCT03154086|580528683|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764707|NCT03154086|580528684|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
160764708|NCT03154086|580528685|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764709|NCT03154086|580528686|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764710|NCT03154086|580528687|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764711|NCT03154086|580528688|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764712|NCT03154086|580528689|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764713|NCT03154086|580528690|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764714|NCT03154086|580528691|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764715|NCT03154086|580528692|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764716|NCT03154086|580528693|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764717|NCT03154086|580528694|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764718|NCT03154086|580528695|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764719|NCT03154086|580528696|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
160764720|NCT03154086|580528682|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
160764721|NCT03154086|580528683|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764722|NCT03154086|580528684|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764723|NCT03154086|580528685|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764724|NCT03154086|580528686|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160869045|NCT01918306|580912143|FG002|Overall Study|progress disease, crossover|1|||
160869046|NCT01918306|580912144|FG003|Overall Study|progress disease, crossover|0|||
160869047|NCT02908672|580912149|FG000|Run-in Period|Death|12|||
160869048|NCT02908672|580912150|FG001|Run-in Period|Death|10|||
160869049|NCT02908672|580912151|FG002|Run-in Period|Death|0|||
160869050|NCT02908672|580912152|FG003|Run-in Period|Death|0|||
160869051|NCT02908672|580912149|FG000|Run-in Period|Lost to Follow-up|1|||
160869052|NCT02908672|580912150|FG001|Run-in Period|Lost to Follow-up|1|||
160869053|NCT02908672|580912151|FG002|Run-in Period|Lost to Follow-up|0|||
160869054|NCT02908672|580912152|FG003|Run-in Period|Lost to Follow-up|0|||
160869055|NCT02908672|580912149|FG000|Run-in Period|Reason Not Specified|2|||
160869056|NCT02908672|580912150|FG001|Run-in Period|Reason Not Specified|0|||
160869057|NCT02908672|580912151|FG002|Run-in Period|Reason Not Specified|0|||
160869058|NCT02908672|580912152|FG003|Run-in Period|Reason Not Specified|0|||
160869059|NCT02908672|580912149|FG000|Run-in Period|Protocol Violation|1|||
160869060|NCT02908672|580912150|FG001|Run-in Period|Protocol Violation|1|||
160869061|NCT02908672|580912151|FG002|Run-in Period|Protocol Violation|0|||
160869062|NCT02908672|580912152|FG003|Run-in Period|Protocol Violation|0|||
160869063|NCT02908672|580912149|FG000|Run-in Period|Study Ended by Sponsor|5|||
160869064|NCT02908672|580912150|FG001|Run-in Period|Study Ended by Sponsor|1|||
160869065|NCT02908672|580912151|FG002|Run-in Period|Study Ended by Sponsor|0|||
160869066|NCT02908672|580912152|FG003|Run-in Period|Study Ended by Sponsor|0|||
160869067|NCT02908672|580912149|FG000|Run-in Period|Withdrawal by Subject|3|||
160869068|NCT02908672|580912150|FG001|Run-in Period|Withdrawal by Subject|9|||
160869069|NCT02908672|580912151|FG002|Run-in Period|Withdrawal by Subject|0|||
160869070|NCT02908672|580912152|FG003|Run-in Period|Withdrawal by Subject|0|||
160869071|NCT02908672|580912149|FG000|Triple Combination Period|Death|0|||
160869072|NCT02908672|580912150|FG001|Triple Combination Period|Death|0|||
160869073|NCT02908672|580912151|FG002|Triple Combination Period|Death|150|||
160869074|NCT02908672|580912152|FG003|Triple Combination Period|Death|127|||
160869075|NCT02908672|580912149|FG000|Triple Combination Period|Lost to Follow-up|0|||
160869076|NCT02908672|580912150|FG001|Triple Combination Period|Lost to Follow-up|0|||
160869077|NCT02908672|580912151|FG002|Triple Combination Period|Lost to Follow-up|6|||
160869078|NCT02908672|580912152|FG003|Triple Combination Period|Lost to Follow-up|8|||
160869079|NCT02908672|580912149|FG000|Triple Combination Period|Reason Not Specified|0|||
160869080|NCT02908672|580912150|FG001|Triple Combination Period|Reason Not Specified|0|||
160869081|NCT02908672|580912151|FG002|Triple Combination Period|Reason Not Specified|0|||
160869082|NCT02908672|580912152|FG003|Triple Combination Period|Reason Not Specified|1|||
160869083|NCT02908672|580912149|FG000|Triple Combination Period|Physician Decision|0|||
160869084|NCT02908672|580912150|FG001|Triple Combination Period|Physician Decision|0|||
160869085|NCT02908672|580912151|FG002|Triple Combination Period|Physician Decision|1|||
160869086|NCT02908672|580912152|FG003|Triple Combination Period|Physician Decision|1|||
160869087|NCT02908672|580912149|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
160869088|NCT02908672|580912150|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
160869089|NCT02908672|580912151|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
160869090|NCT02908672|580912152|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
160869091|NCT02908672|580912149|FG000|Triple Combination Period|Withdrawal by Subject|0|||
160869092|NCT02908672|580912150|FG001|Triple Combination Period|Withdrawal by Subject|0|||
160869093|NCT02908672|580912151|FG002|Triple Combination Period|Withdrawal by Subject|13|||
160869094|NCT02908672|580912152|FG003|Triple Combination Period|Withdrawal by Subject|16|||
160869095|NCT01185080|580912156|FG000|Overall Study|Adverse Event|1|||
160869096|NCT01185080|580912157|FG001|Overall Study|Adverse Event|1|||
160869097|NCT01185080|580912158|FG002|Overall Study|Adverse Event|0|||
160869098|NCT01185080|580912156|FG000|Overall Study|Personal reasons|0|||
160869099|NCT01185080|580912157|FG001|Overall Study|Personal reasons|0|||
160869100|NCT01185080|580912158|FG002|Overall Study|Personal reasons|1|||
160869101|NCT02876601|580912159|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
160869102|NCT02876601|580912160|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
160869103|NCT02876601|580912161|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
160869104|NCT02876601|580912162|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
160869105|NCT06083506|580912164|FG000|Overall Study|Physician Decision|2|||
160869106|NCT06083506|580912164|FG000|Overall Study|Lack of Efficacy|1|||
160869107|NCT02864394|580912166|FG000|Overall Study|Death|184|||
160869108|NCT02864394|580912167|FG001|Overall Study|Death|189|||
160869109|NCT02864394|580912166|FG000|Overall Study|Lost to Follow-up|0|||
160869110|NCT02864394|580912167|FG001|Overall Study|Lost to Follow-up|2|||
160869111|NCT02864394|580912166|FG000|Overall Study|Sponsor Decision|26|||
160869112|NCT02864394|580912167|FG001|Overall Study|Sponsor Decision|11|||
160869113|NCT02864394|580912166|FG000|Overall Study|Withdrawal by Subject|3|||
160869114|NCT02864394|580912167|FG001|Overall Study|Withdrawal by Subject|10|||
160869115|NCT00905164|580912168|FG000|Period 1|Protocol Violation|0|||
160869116|NCT00905164|580912169|FG001|Period 1|Protocol Violation|1|||
160869117|NCT01442103|580913629|FG000|Overall Study|Lost to Follow-up|2|||
160869118|NCT03751657|580913631|FG000|Overall Study|Physician Decision|0|||
160869119|NCT03751657|580913632|FG001|Overall Study|Physician Decision|1|||
160869120|NCT03751657|580913631|FG000|Overall Study|Withdrawal by Subject|1|||
160869121|NCT03751657|580913632|FG001|Overall Study|Withdrawal by Subject|1|||
160869122|NCT03751657|580913631|FG000|Overall Study|Lost to Follow-up|2|||
160869123|NCT03751657|580913632|FG001|Overall Study|Lost to Follow-up|1|||
160869124|NCT03894813|580913639|FG000|Overall Study|Adverse Event|1|||
160869125|NCT03894813|580913640|FG001|Overall Study|Adverse Event|1|||
160869126|NCT03894813|580913639|FG000|Overall Study|Lack of Efficacy|3|||
160869127|NCT03894813|580913640|FG001|Overall Study|Lack of Efficacy|3|||
160869128|NCT03894813|580913639|FG000|Overall Study|Lost to Follow-up|1|||
160869129|NCT03894813|580913640|FG001|Overall Study|Lost to Follow-up|0|||
160869130|NCT03894813|580913639|FG000|Overall Study|Pregnancy|2|||
160869131|NCT03894813|580913640|FG001|Overall Study|Pregnancy|1|||
160869132|NCT03894813|580913639|FG000|Overall Study|Protocol Violation|3|||
160869133|NCT03894813|580913640|FG001|Overall Study|Protocol Violation|7|||
160869134|NCT03894813|580913639|FG000|Overall Study|Withdrawal by Subject|1|||
160869135|NCT03894813|580913640|FG001|Overall Study|Withdrawal by Subject|3|||
160869136|NCT03894813|580913639|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
160869137|NCT03894813|580913640|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
160869138|NCT02269267|580913642|FG000|Overall Study|Death|5|||
160869139|NCT02604160|580913643|FG000|Overall Study|Protocol Violation|0|||
160869140|NCT02604160|580913644|FG001|Overall Study|Protocol Violation|1|||
160869141|NCT02604160|580913643|FG000|Overall Study|Physician Decision|0|||
160869142|NCT02604160|580913644|FG001|Overall Study|Physician Decision|1|||
160869143|NCT01069900|580913647|FG000|Overall Study|Technical problems|0|||
160869144|NCT01069900|580913648|FG001|Overall Study|Technical problems|1|||
160869145|NCT01069900|580913647|FG000|Overall Study|Lost to Follow-up|7|||
160869146|NCT01069900|580913648|FG001|Overall Study|Lost to Follow-up|1|||
160869147|NCT01069900|580913647|FG000|Overall Study|Withdrawal by Subject|6|||
160869148|NCT01069900|580913648|FG001|Overall Study|Withdrawal by Subject|1|||
160869149|NCT01069900|580913647|FG000|Overall Study|Protocol Violation|4|||
160869150|NCT01069900|580913648|FG001|Overall Study|Protocol Violation|1|||
160869151|NCT01069900|580913647|FG000|Overall Study|Insufficient Therapeutic effect|1|||
160869152|NCT01069900|580913648|FG001|Overall Study|Insufficient Therapeutic effect|0|||
160869153|NCT00145158|580913649|FG000|Overall Study|premature withdrawal|2|||
160869154|NCT00145158|580913650|FG001|Overall Study|premature withdrawal|3|||
160869155|NCT02741518|580913651|FG000|Overall Study|Withdrawal by Subject|1|||
160869156|NCT02741518|580913652|FG001|Overall Study|Withdrawal by Subject|1|||
160869157|NCT00476008|580913655|FG000|Overall Study|Adverse Event|4|||
160869158|NCT00476008|580913656|FG001|Overall Study|Adverse Event|4|||
160869159|NCT00476008|580913655|FG000|Overall Study|Placebo concerns|2|||
160869160|NCT00476008|580913656|FG001|Overall Study|Placebo concerns|2|||
160869161|NCT00476008|580913655|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
160869162|NCT00476008|580913656|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
160869163|NCT00476008|580913655|FG000|Overall Study|Withdrawal by Subject|0|||
160869164|NCT00476008|580913656|FG001|Overall Study|Withdrawal by Subject|1|||
160869165|NCT00476008|580913655|FG000|Overall Study|Death|1|||
160869166|NCT00476008|580913656|FG001|Overall Study|Death|0|||
160869167|NCT01788358|580913657|FG000|Overall Study|Other|11|||
160869168|NCT01788358|580913657|FG000|Overall Study|Logistical difficulties|1|||
160869169|NCT01788358|580913657|FG000|Overall Study|Lost to Follow-up|5|||
160869170|NCT01788358|580913657|FG000|Overall Study|Protocol Violation|3|||
160869171|NCT01788358|580913657|FG000|Overall Study|Withdrawal by Subject|26|||
160869172|NCT01788358|580913657|FG000|Overall Study|Lack of Efficacy|1|||
160869173|NCT01788358|580913657|FG000|Overall Study|Adverse Event|51|||
160869174|NCT01168219|580913658|FG000|Overall Study|off study before starting treatment|2|||
160869175|NCT01168219|580913658|FG000|Overall Study|withdrew before transplant|1|||
160869176|NCT01168219|580913658|FG000|Overall Study|ineligible due to CML|2|||
160869177|NCT01227018|580913659|FG000|Overall Study|Disease progression|9|||
160869178|NCT01227018|580913659|FG000|Overall Study|Toxicity|2|||
160869179|NCT01227018|580913659|FG000|Overall Study|Withdrew after beginning treatment|4|||
160869180|NCT02948634|580913667|FG000|Overall Study|Lack of efficacy and study suspended|10|||
160869181|NCT02948634|580913668|FG001|Overall Study|Lack of efficacy and study suspended|2|||
160869182|NCT00753649|580913673|FG000|Overall Study|Migrated/moved from study area|1|||
160869183|NCT00753649|580913674|FG001|Overall Study|Migrated/moved from study area|0|||
160869184|NCT00753649|580913673|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
160869185|NCT00753649|580913674|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
160869186|NCT00753649|580913673|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
160869187|NCT00753649|580913674|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
160869188|NCT00753649|580913673|FG000|Overall Study|Protocol Violation|2|||
160869189|NCT00753649|580913674|FG001|Overall Study|Protocol Violation|0|||
160869190|NCT01039519|580913680|FG000|Treatment|Progressive disease|20|||
160869191|NCT01039519|580913680|FG000|Treatment|Treatment failure|2|||
160869192|NCT01039519|580913680|FG000|Treatment|Adverse Event|3|||
160869193|NCT01039519|580913680|FG000|Treatment|Physician Decision|2|||
160869194|NCT01039519|580913680|FG000|Survival Follow-up|Death|23|||
160869195|NCT01039519|580913680|FG000|Survival Follow-up|Sponsor decision|4|||
160869196|NCT01255436|580913683|FG000|Overall Study|Lost to Follow-up|178|||
160527342|NCT01839487|579660965|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
160527343|NCT01839487|579660966|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
160527344|NCT01839487|579660967|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
160527345|NCT01839487|579660962|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
160527346|NCT01839487|579660963|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
160527347|NCT01839487|579660964|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
160527348|NCT01839487|579660965|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
160527349|NCT01839487|579660966|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
160764725|NCT03154086|580528687|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764726|NCT03154086|580528688|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764727|NCT03154086|580528689|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764728|NCT03154086|580528690|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764729|NCT03154086|580528691|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764730|NCT03154086|580528692|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764731|NCT03154086|580528693|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764732|NCT03154086|580528694|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764733|NCT03154086|580528695|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764734|NCT03154086|580528696|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
160764735|NCT03154086|580528682|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764736|NCT03154086|580528683|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764737|NCT03154086|580528684|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764738|NCT03154086|580528685|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764739|NCT03154086|580528686|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764740|NCT03154086|580528687|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764741|NCT03154086|580528688|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764742|NCT03154086|580528689|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764743|NCT03154086|580528690|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
160764744|NCT03154086|580528691|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764745|NCT03154086|580528692|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764746|NCT03154086|580528693|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764747|NCT03154086|580528694|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764748|NCT03154086|580528695|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764749|NCT03154086|580528696|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
160764750|NCT03154086|580528682|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764751|NCT03154086|580528683|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764752|NCT03154086|580528684|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764753|NCT03154086|580528685|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764754|NCT03154086|580528686|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764755|NCT03154086|580528687|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764756|NCT03154086|580528688|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764757|NCT03154086|580528689|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
160764758|NCT03154086|580528690|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764759|NCT03154086|580528691|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764760|NCT03154086|580528692|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764761|NCT03154086|580528693|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764762|NCT03154086|580528694|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764763|NCT03154086|580528695|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764764|NCT03154086|580528696|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
160764765|NCT03154086|580528682|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
160764766|NCT03154086|580528683|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
160764767|NCT03154086|580528684|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
160764768|NCT03154086|580528685|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
160764769|NCT03154086|580528686|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
160764770|NCT03154086|580528687|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
160764771|NCT03154086|580528688|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
160764772|NCT03154086|580528689|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
160764773|NCT03154086|580528690|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
160764774|NCT03154086|580528691|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
160764775|NCT03154086|580528692|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
160764776|NCT03154086|580528693|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
160764777|NCT03154086|580528694|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
160527350|NCT01839487|579660967|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
160764778|NCT03154086|580528695|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
160764779|NCT03154086|580528696|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
160764780|NCT01603277|580528699|FG000|Overall Study|Adverse Event|1|||
160764781|NCT01603277|580528700|FG001|Overall Study|Adverse Event|2|||
160764782|NCT01603277|580528699|FG000|Overall Study|Physician Decision|0|||
160527351|NCT01839487|579660962|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
160527352|NCT01839487|579660963|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
160527353|NCT01839487|579660964|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
160527354|NCT01839487|579660965|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
160527355|NCT01839487|579660966|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
160527356|NCT01839487|579660967|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
160527357|NCT01839487|579660962|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
160527358|NCT01839487|579660963|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
160527359|NCT01839487|579660964|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
160527360|NCT01839487|579660965|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
160527361|NCT01839487|579660966|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
160527362|NCT01839487|579660967|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
160527363|NCT01839487|579660962|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
160527364|NCT01839487|579660963|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
160527365|NCT01839487|579660964|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
160527366|NCT01839487|579660965|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
160527367|NCT01839487|579660966|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
160527368|NCT01839487|579660967|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
160527369|NCT01839487|579660962|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
160527370|NCT01839487|579660963|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
160527371|NCT01839487|579660964|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
160527372|NCT01839487|579660965|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
160527373|NCT01839487|579660966|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
160527374|NCT01839487|579660967|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
160527375|NCT01839487|579660962|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
160527376|NCT01839487|579660963|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
160527377|NCT01839487|579660964|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
160527378|NCT01839487|579660965|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
160527379|NCT01839487|579660966|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
160527380|NCT01839487|579660967|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
160527381|NCT01839487|579660962|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
160527382|NCT01839487|579660963|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
160527383|NCT01839487|579660964|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
160527384|NCT01839487|579660965|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
160527385|NCT01839487|579660966|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
160527386|NCT01839487|579660967|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
160527387|NCT01839487|579660962|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
160527388|NCT01839487|579660963|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
160527389|NCT01839487|579660964|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
160527390|NCT01839487|579660965|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
160527391|NCT01839487|579660966|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
160527392|NCT01839487|579660967|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
160527393|NCT00447382|579660973|FG000|Overall Study|Adverse Event|1|||
160527394|NCT00447382|579660974|FG001|Overall Study|Adverse Event|1|||
160764783|NCT01603277|580528700|FG001|Overall Study|Physician Decision|1|||
160764784|NCT01603277|580528699|FG000|Overall Study|Protocol Violation|6|||
160764785|NCT01603277|580528700|FG001|Overall Study|Protocol Violation|10|||
160527395|NCT00447382|579660973|FG000|Overall Study|Lack of Efficacy|1|||
160527396|NCT00447382|579660974|FG001|Overall Study|Lack of Efficacy|0|||
160527397|NCT00447382|579660973|FG000|Overall Study|Protocol Violation|2|||
160527398|NCT00447382|579660974|FG001|Overall Study|Protocol Violation|0|||
160527399|NCT00447382|579660973|FG000|Overall Study|Unclassified|2|||
160527400|NCT00447382|579660974|FG001|Overall Study|Unclassified|5|||
160527401|NCT02408861|579660975|FG000|Overall Study|Death|0|||
160527402|NCT02408861|579660976|FG001|Overall Study|Death|3|||
160527403|NCT02408861|579660977|FG002|Overall Study|Death|1|||
160527404|NCT02408861|579660978|FG003|Overall Study|Death|2|||
160527405|NCT02408861|579660979|FG004|Overall Study|Death|4|||
160527406|NCT02408861|579660980|FG005|Overall Study|Death|1|||
160527407|NCT02408861|579660981|FG006|Overall Study|Death|0|||
160527408|NCT02408861|579660975|FG000|Overall Study|Lost to Follow-up|0|||
160527409|NCT02408861|579660976|FG001|Overall Study|Lost to Follow-up|0|||
160527410|NCT02408861|579660977|FG002|Overall Study|Lost to Follow-up|1|||
160527411|NCT02408861|579660978|FG003|Overall Study|Lost to Follow-up|1|||
160527412|NCT02408861|579660979|FG004|Overall Study|Lost to Follow-up|4|||
160527413|NCT02408861|579660980|FG005|Overall Study|Lost to Follow-up|2|||
160527414|NCT02408861|579660981|FG006|Overall Study|Lost to Follow-up|1|||
160527415|NCT02408861|579660975|FG000|Overall Study|Disease Progression|0|||
160527416|NCT02408861|579660976|FG001|Overall Study|Disease Progression|0|||
160527417|NCT02408861|579660977|FG002|Overall Study|Disease Progression|1|||
160527418|NCT02408861|579660978|FG003|Overall Study|Disease Progression|0|||
160527419|NCT02408861|579660979|FG004|Overall Study|Disease Progression|3|||
160527420|NCT02408861|579660980|FG005|Overall Study|Disease Progression|1|||
160527421|NCT02408861|579660981|FG006|Overall Study|Disease Progression|1|||
160527422|NCT02408861|579660975|FG000|Overall Study|Adverse Event|1|||
160527423|NCT02408861|579660976|FG001|Overall Study|Adverse Event|0|||
160527424|NCT02408861|579660977|FG002|Overall Study|Adverse Event|1|||
160527425|NCT02408861|579660978|FG003|Overall Study|Adverse Event|0|||
160527426|NCT02408861|579660979|FG004|Overall Study|Adverse Event|2|||
160527427|NCT02408861|579660980|FG005|Overall Study|Adverse Event|0|||
160527428|NCT02408861|579660981|FG006|Overall Study|Adverse Event|0|||
160527429|NCT02408861|579660975|FG000|Overall Study|Physician Decision|1|||
160527430|NCT02408861|579660976|FG001|Overall Study|Physician Decision|1|||
160527431|NCT02408861|579660977|FG002|Overall Study|Physician Decision|1|||
160527432|NCT02408861|579660978|FG003|Overall Study|Physician Decision|0|||
160527433|NCT02408861|579660979|FG004|Overall Study|Physician Decision|0|||
160527434|NCT02408861|579660980|FG005|Overall Study|Physician Decision|1|||
160527435|NCT02408861|579660981|FG006|Overall Study|Physician Decision|0|||
160527436|NCT02408861|579660975|FG000|Overall Study|Protocol Violation|1|||
160527437|NCT02408861|579660976|FG001|Overall Study|Protocol Violation|0|||
160527438|NCT02408861|579660977|FG002|Overall Study|Protocol Violation|0|||
160527439|NCT02408861|579660978|FG003|Overall Study|Protocol Violation|0|||
160527440|NCT02408861|579660979|FG004|Overall Study|Protocol Violation|0|||
160527441|NCT02408861|579660980|FG005|Overall Study|Protocol Violation|0|||
160527442|NCT02408861|579660981|FG006|Overall Study|Protocol Violation|0|||
160527443|NCT02408861|579660975|FG000|Overall Study|Withdrawal by Subject|0|||
160527444|NCT02408861|579660976|FG001|Overall Study|Withdrawal by Subject|0|||
160527445|NCT02408861|579660977|FG002|Overall Study|Withdrawal by Subject|0|||
160527446|NCT02408861|579660978|FG003|Overall Study|Withdrawal by Subject|0|||
160527447|NCT02408861|579660979|FG004|Overall Study|Withdrawal by Subject|1|||
160527448|NCT02408861|579660980|FG005|Overall Study|Withdrawal by Subject|1|||
160527449|NCT02408861|579660981|FG006|Overall Study|Withdrawal by Subject|0|||
160527450|NCT02408861|579660975|FG000|Overall Study|Other Treatment|0|||
160527451|NCT02408861|579660976|FG001|Overall Study|Other Treatment|0|||
160527452|NCT02408861|579660977|FG002|Overall Study|Other Treatment|0|||
160527453|NCT02408861|579660978|FG003|Overall Study|Other Treatment|0|||
160527454|NCT02408861|579660979|FG004|Overall Study|Other Treatment|0|||
160527455|NCT02408861|579660980|FG005|Overall Study|Other Treatment|1|||
160527456|NCT02408861|579660981|FG006|Overall Study|Other Treatment|1|||
160527457|NCT04890054|579662694|FG000|Overall Study|Lost to Follow-up|202|||
160527458|NCT04890054|579662695|FG001|Overall Study|Lost to Follow-up|219|||
160527459|NCT05586269|579662696|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
160527460|NCT05586269|579662697|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
160527461|NCT05586269|579662698|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
160527462|NCT05586269|579662699|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
160527463|NCT05586269|579662696|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
160527464|NCT05586269|579662697|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
160527465|NCT05586269|579662698|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
160527466|NCT05586269|579662699|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
160869197|NCT01255436|580913684|FG001|Overall Study|Lost to Follow-up|191|||
160527467|NCT04752475|579662700|FG000|Overall Study|Withdrawal by Subject|1|||
160527468|NCT04752475|579662701|FG001|Overall Study|Withdrawal by Subject|1|||
160527469|NCT03335163|579662702|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
160527470|NCT03335163|579662702|FG000|Overall Study|Withdrawal by Subject|18|||
160527471|NCT01448213|579662708|FG000|Overall Study|Lost to Follow-up|12|||
160527472|NCT01448213|579662709|FG001|Overall Study|Lost to Follow-up|10|||
160527473|NCT01448213|579662708|FG000|Overall Study|Adverse Event|4|||
160527474|NCT01448213|579662709|FG001|Overall Study|Adverse Event|10|||
160527475|NCT01448213|579662708|FG000|Overall Study|Protocol Violation|1|||
160527476|NCT01448213|579662709|FG001|Overall Study|Protocol Violation|2|||
160527477|NCT00929656|579662710|FG000|Overall Study|Lost to Follow-up|0|||
160527478|NCT00929656|579662711|FG001|Overall Study|Lost to Follow-up|1|||
160527479|NCT04606771|579662715|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
160527480|NCT04606771|579662716|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
160527481|NCT04606771|579662715|FG000|Overall Study|Death|5|||
160527482|NCT04606771|579662716|FG001|Overall Study|Death|6|||
160527483|NCT04606771|579662715|FG000|Overall Study|Wrong randomisation|0|||
160527484|NCT04606771|579662716|FG001|Overall Study|Wrong randomisation|1|||
160527485|NCT01008696|579662718|FG000|Overall Study|Participant's evasion of hospital visit|5|||
160527486|NCT01008696|579662719|FG001|Overall Study|Participant's evasion of hospital visit|4|||
160527487|NCT01008696|579662718|FG000|Overall Study|Withdrawal by Subject|2|||
160527488|NCT01008696|579662719|FG001|Overall Study|Withdrawal by Subject|4|||
160527489|NCT01008696|579662718|FG000|Overall Study|Physician Decision|5|||
160527490|NCT01008696|579662719|FG001|Overall Study|Physician Decision|1|||
160527491|NCT01008696|579662718|FG000|Overall Study|Adverse Event|1|||
160527492|NCT01008696|579662719|FG001|Overall Study|Adverse Event|0|||
160527493|NCT01008696|579662718|FG000|Overall Study|Participants' non-cooperation|2|||
160527494|NCT01008696|579662719|FG001|Overall Study|Participants' non-cooperation|3|||
160527495|NCT01008696|579662718|FG000|Overall Study|Other|2|||
160527496|NCT01008696|579662719|FG001|Overall Study|Other|3|||
160527497|NCT01008696|579662718|FG000|Overall Study|Other|0|||
160527498|NCT01008696|579662719|FG001|Overall Study|Other|2|||
160527499|NCT04464265|579662722|FG000|Overall Study|Physician Decision|2|||
160527500|NCT00634010|579662725|FG000|Overall Study|Adverse Event|2|||
160527501|NCT00634010|579662726|FG001|Overall Study|Adverse Event|5|||
160527502|NCT00634010|579662725|FG000|Overall Study|Withdrawal by Subject|5|||
160527503|NCT00634010|579662726|FG001|Overall Study|Withdrawal by Subject|6|||
160527504|NCT00634010|579662725|FG000|Overall Study|Physician Decision|1|||
160527505|NCT00634010|579662726|FG001|Overall Study|Physician Decision|1|||
160527506|NCT00634010|579662725|FG000|Overall Study|Disease Progression|1|||
160527507|NCT00634010|579662726|FG001|Overall Study|Disease Progression|1|||
160527508|NCT00634010|579662725|FG000|Overall Study|Non-Compliant|1|||
160527509|NCT00634010|579662726|FG001|Overall Study|Non-Compliant|1|||
160527510|NCT01026142|579662727|FG000|Overall Study|Death|136|||
160527511|NCT01026142|579662728|FG001|Overall Study|Death|134|||
160527512|NCT01026142|579662727|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
160527513|NCT01026142|579662728|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
160527514|NCT00890929|579662729|FG000|Overall Study|Death before treatment|2|||
160527515|NCT00890929|579662729|FG000|Overall Study|Withdrawal by Subject|3|||
160527516|NCT00890929|579662729|FG000|Overall Study|Physician Decision|1|||
160527517|NCT00882310|579662730|FG000|Overall Study|Screen Failure|10|||
160527518|NCT00882310|579662730|FG000|Overall Study|Never received treatment|1|||
160527519|NCT00882310|579662730|FG000|Overall Study|Death|6|||
160527520|NCT00882310|579662730|FG000|Overall Study|Progression of disease|4|||
160527521|NCT00882310|579662730|FG000|Overall Study|Adverse Event|1|||
160527522|NCT03684642|579662735|FG000|Overall Study|Adverse Event|6|||
160527523|NCT03684642|579662736|FG001|Overall Study|Adverse Event|15|||
160527524|NCT03684642|579662737|FG002|Overall Study|Adverse Event|11|||
160527525|NCT03684642|579662735|FG000|Overall Study|Withdrawal by Subject|35|||
160527526|NCT03684642|579662736|FG001|Overall Study|Withdrawal by Subject|53|||
160527527|NCT03684642|579662737|FG002|Overall Study|Withdrawal by Subject|23|||
160527528|NCT03684642|579662735|FG000|Overall Study|Lack of Efficacy|0|||
160764786|NCT01603277|580528699|FG000|Overall Study|Withdrawal by Subject|5|||
160527529|NCT03684642|579662736|FG001|Overall Study|Lack of Efficacy|0|||
160527530|NCT03684642|579662737|FG002|Overall Study|Lack of Efficacy|1|||
160527531|NCT03684642|579662735|FG000|Overall Study|Poor compliance to protocol|0|||
160527532|NCT03684642|579662736|FG001|Overall Study|Poor compliance to protocol|4|||
160527533|NCT03684642|579662737|FG002|Overall Study|Poor compliance to protocol|1|||
160527534|NCT03684642|579662735|FG000|Overall Study|Other than specified|62|||
160527535|NCT03684642|579662736|FG001|Overall Study|Other than specified|60|||
160527536|NCT03684642|579662737|FG002|Overall Study|Other than specified|67|||
160527537|NCT03684642|579662735|FG000|Overall Study|Randomized and not treated|0|||
160527538|NCT03684642|579662736|FG001|Overall Study|Randomized and not treated|0|||
160764787|NCT01603277|580528700|FG001|Overall Study|Withdrawal by Subject|4|||
160764788|NCT01603277|580528699|FG000|Overall Study|Non-Compliance|2|||
160527539|NCT03684642|579662737|FG002|Overall Study|Randomized and not treated|1|||
160527540|NCT03684642|579662735|FG000|Overall Study|Missing completion status but alive at last contact|0|||
160527541|NCT03684642|579662736|FG001|Overall Study|Missing completion status but alive at last contact|1|||
160527542|NCT03684642|579662737|FG002|Overall Study|Missing completion status but alive at last contact|2|||
160527543|NCT01843218|579662740|FG000|Overall Study|Withdrawal by Subject|5|||
160527544|NCT01431534|579662741|FG000|Treatment Phase|Adverse Event|0|||
160764789|NCT01603277|580528700|FG001|Overall Study|Non-Compliance|1|||
160527545|NCT01431534|579662742|FG001|Treatment Phase|Adverse Event|0|||
160527546|NCT01431534|579662743|FG002|Treatment Phase|Adverse Event|1|||
160527547|NCT01431534|579662741|FG000|Treatment Phase|Progressive Disease|4|||
160527548|NCT01431534|579662742|FG001|Treatment Phase|Progressive Disease|3|||
160527549|NCT01431534|579662743|FG002|Treatment Phase|Progressive Disease|10|||
160527550|NCT02742766|579662745|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527551|NCT02742766|579662746|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527552|NCT02742766|579662747|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527553|NCT02742766|579662748|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527554|NCT02742766|579662749|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527555|NCT02742766|579662750|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527556|NCT02742766|579662751|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527557|NCT02742766|579662752|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527558|NCT02742766|579662753|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527559|NCT02742766|579662754|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527560|NCT02742766|579662755|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527561|NCT02742766|579662756|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527562|NCT02742766|579662757|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527563|NCT02742766|579662758|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
160527564|NCT02742766|579662759|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527565|NCT02742766|579662760|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527566|NCT02742766|579662761|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527567|NCT02742766|579662762|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527568|NCT02742766|579662763|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
160527569|NCT02742766|579662745|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527570|NCT02742766|579662746|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527571|NCT02742766|579662747|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527572|NCT02742766|579662748|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527573|NCT02742766|579662749|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527574|NCT02742766|579662750|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527575|NCT02742766|579662751|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527576|NCT02742766|579662752|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527577|NCT02742766|579662753|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527578|NCT02742766|579662754|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527579|NCT02742766|579662755|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527580|NCT02742766|579662756|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527581|NCT02742766|579662757|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
160527582|NCT02742766|579662758|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
160527583|NCT02742766|579662759|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527584|NCT02742766|579662760|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
160527585|NCT02742766|579662761|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527586|NCT02742766|579662762|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527587|NCT02742766|579662763|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
160527588|NCT01395316|579662765|FG000|Overall Study|Lost to Follow-up|2|||
160527589|NCT01395316|579662765|FG000|Overall Study|poor MRI quality|1|||
160527590|NCT03359590|579662766|FG000|First Intervention|Withdrawal by Subject|1|||
160527591|NCT03359590|579662767|FG001|First Intervention|Withdrawal by Subject|1|||
160527592|NCT03359590|579662766|FG000|First Intervention|Protocol Violation|0|||
160527593|NCT03359590|579662767|FG001|First Intervention|Protocol Violation|1|||
160527594|NCT02540538|579662768|FG000|Overall Study|Pregnancy|0|||
160527595|NCT02540538|579662769|FG001|Overall Study|Pregnancy|1|||
160527596|NCT02540538|579662770|FG002|Overall Study|Pregnancy|0|||
160527597|NCT02846532|579662771|FG000|Overall Study|Lost to Follow-up|0|||
160527598|NCT02846532|579662772|FG001|Overall Study|Lost to Follow-up|1|||
160527599|NCT02846532|579662773|FG002|Overall Study|Lost to Follow-up|1|||
160527600|NCT02846532|579662771|FG000|Overall Study|Withdrawal by Subject|1|||
160527601|NCT02846532|579662772|FG001|Overall Study|Withdrawal by Subject|2|||
160527602|NCT02846532|579662773|FG002|Overall Study|Withdrawal by Subject|0|||
160527603|NCT04908189|579662775|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
160527604|NCT04908189|579662776|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
160527605|NCT04908189|579662777|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
160527606|NCT04908189|579662775|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
160869198|NCT01255436|580913683|FG000|Overall Study|Death, stroke, or MI|4|||
160527607|NCT04908189|579662776|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
160527608|NCT04908189|579662777|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
160527609|NCT04908189|579662775|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
160527610|NCT04908189|579662776|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
160527611|NCT04908189|579662777|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
160527612|NCT04908189|579662775|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
160527613|NCT04908189|579662776|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
160527614|NCT04908189|579662777|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
160527615|NCT04908189|579662775|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
160527616|NCT04908189|579662776|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
160527617|NCT04908189|579662777|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
160527618|NCT04908189|579662775|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
160527619|NCT04908189|579662776|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
160527620|NCT04908189|579662777|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
160527621|NCT04908189|579662775|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
160527622|NCT04908189|579662776|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
160527623|NCT04908189|579662777|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
160527624|NCT04908189|579662775|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
160527625|NCT04908189|579662776|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
160527626|NCT04908189|579662777|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
160527627|NCT04908189|579662775|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
160527628|NCT04908189|579662776|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
160527629|NCT04908189|579662777|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
160527630|NCT04908189|579662775|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
160527631|NCT04908189|579662776|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
160527632|NCT04908189|579662777|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
160527633|NCT04908189|579662775|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
160527634|NCT04908189|579662776|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
160527635|NCT04908189|579662777|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
160527636|NCT04908189|579662775|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
160527637|NCT04908189|579662776|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
160527638|NCT04908189|579662777|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
160527639|NCT04598477|579662778|FG000|Overall Study|Adverse Event|2|||
160527640|NCT04598477|579662779|FG001|Overall Study|Adverse Event|0|||
160527641|NCT04598477|579662778|FG000|Overall Study|Death|0|||
160527642|NCT04598477|579662779|FG001|Overall Study|Death|1|||
160527643|NCT04598477|579662778|FG000|Overall Study|Lost to Follow-up|1|||
160527644|NCT04598477|579662779|FG001|Overall Study|Lost to Follow-up|0|||
160527645|NCT04598477|579662778|FG000|Overall Study|Physician Decision|7|||
160527646|NCT04598477|579662779|FG001|Overall Study|Physician Decision|2|||
160527647|NCT04598477|579662778|FG000|Overall Study|Pregnancy|0|||
160527648|NCT04598477|579662779|FG001|Overall Study|Pregnancy|1|||
160527649|NCT04598477|579662778|FG000|Overall Study|Requires Prohibited Medication|0|||
160527650|NCT04598477|579662779|FG001|Overall Study|Requires Prohibited Medication|1|||
160527651|NCT04598477|579662778|FG000|Overall Study|Study Terminated by Sponsor|18|||
160527652|NCT04598477|579662779|FG001|Overall Study|Study Terminated by Sponsor|12|||
160527653|NCT04598477|579662778|FG000|Overall Study|Withdrawal by Subject|16|||
160527654|NCT04598477|579662779|FG001|Overall Study|Withdrawal by Subject|12|||
160527655|NCT04598477|579662778|FG000|Overall Study|Other|15|||
160527656|NCT04598477|579662779|FG001|Overall Study|Other|8|||
160527657|NCT05579990|579662787|FG000|Overall Study|Lost to Follow-up|3|||
160527658|NCT00607022|579662788|FG000|Overall Study|Withdrawal by Subject|1|||
160527659|NCT00607022|579662789|FG001|Overall Study|Withdrawal by Subject|0|||
160527660|NCT00607022|579662790|FG002|Overall Study|Withdrawal by Subject|0|||
160527661|NCT04786119|579662791|FG000|Overall Study|Withdrawal by Subject|4|||
160527662|NCT04786119|579662792|FG001|Overall Study|Withdrawal by Subject|5|||
160527663|NCT04786119|579662791|FG000|Overall Study|Lost to Follow-up|5|||
160527664|NCT04786119|579662792|FG001|Overall Study|Lost to Follow-up|5|||
160527665|NCT04786119|579662791|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
160527666|NCT04786119|579662792|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
160527667|NCT02593786|579662797|FG000|Overall Study|Disease progression|12|||
160527668|NCT02593786|579662798|FG001|Overall Study|Disease progression|16|||
160527669|NCT02593786|579662799|FG002|Overall Study|Disease progression|10|||
160527670|NCT02593786|579662800|FG003|Overall Study|Disease progression|7|||
160527671|NCT02593786|579662797|FG000|Overall Study|Study drug toxicity|1|||
160527672|NCT02593786|579662798|FG001|Overall Study|Study drug toxicity|0|||
160527673|NCT02593786|579662799|FG002|Overall Study|Study drug toxicity|0|||
160527674|NCT02593786|579662800|FG003|Overall Study|Study drug toxicity|0|||
160527675|NCT02593786|579662797|FG000|Overall Study|Adverse event unrelated to study drug|1|||
160527676|NCT02593786|579662798|FG001|Overall Study|Adverse event unrelated to study drug|1|||
160527677|NCT02593786|579662799|FG002|Overall Study|Adverse event unrelated to study drug|1|||
160527678|NCT02593786|579662800|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160527679|NCT02593786|579662797|FG000|Overall Study|Participant request to discontinue study therapy|0|||
160527680|NCT02593786|579662798|FG001|Overall Study|Participant request to discontinue study therapy|2|||
160636426|NCT01682512|580051543|FG001|Overall Study|Physician Decision|2|||
160869199|NCT01255436|580913684|FG001|Overall Study|Death, stroke, or MI|3|||
160527681|NCT02593786|579662799|FG002|Overall Study|Participant request to discontinue study therapy|0|||
160527682|NCT02593786|579662800|FG003|Overall Study|Participant request to discontinue study therapy|0|||
160527683|NCT02593786|579662797|FG000|Overall Study|Other reasons|1|||
160869200|NCT04816669|580913685|FG000|Part 1|Adverse Event|1|||
160869201|NCT04816669|580913686|FG001|Part 1|Adverse Event|1|||
160869202|NCT04816669|580913687|FG002|Part 1|Adverse Event|0|||
160869203|NCT04816669|580913688|FG003|Part 1|Adverse Event|0|||
160869204|NCT04816669|580913685|FG000|Part 1|Lost to Follow-up|2|||
160869205|NCT04816669|580913686|FG001|Part 1|Lost to Follow-up|2|||
160869206|NCT04816669|580913687|FG002|Part 1|Lost to Follow-up|0|||
160527684|NCT02593786|579662798|FG001|Overall Study|Other reasons|1|||
160527685|NCT02593786|579662799|FG002|Overall Study|Other reasons|0|||
160527686|NCT02593786|579662800|FG003|Overall Study|Other reasons|5|||
160527687|NCT01130051|579662801|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
160527688|NCT01130051|579662802|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
160527689|NCT01130051|579662801|FG000|Washout Period of 14 Days|Protocol Violation|1|||
160527690|NCT01130051|579662802|FG001|Washout Period of 14 Days|Protocol Violation|1|||
160527691|NCT00835120|579662806|FG000|Overall Study|Lack of Efficacy|1|||
160527692|NCT00835120|579662806|FG000|Overall Study|Lost to Follow-up|3|||
160527693|NCT00835120|579662806|FG000|Overall Study|Adverse Event|2|||
160527694|NCT00835120|579662806|FG000|Overall Study|Withdrawal by Subject|2|||
160527695|NCT01658826|579662807|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
160869207|NCT04816669|580913688|FG003|Part 1|Lost to Follow-up|0|||
160869208|NCT04816669|580913685|FG000|Part 1|Protocol Violation|0|||
160869209|NCT04816669|580913686|FG001|Part 1|Protocol Violation|1|||
160869210|NCT04816669|580913687|FG002|Part 1|Protocol Violation|0|||
160869211|NCT04816669|580913688|FG003|Part 1|Protocol Violation|0|||
160869212|NCT04816669|580913685|FG000|Part 1|Withdrawal by Subject|1|||
160869213|NCT04816669|580913686|FG001|Part 1|Withdrawal by Subject|2|||
160869214|NCT04816669|580913687|FG002|Part 1|Withdrawal by Subject|0|||
160869215|NCT04816669|580913688|FG003|Part 1|Withdrawal by Subject|0|||
160869216|NCT04816669|580913685|FG000|Part 2|Other|0|||
160869217|NCT04816669|580913686|FG001|Part 2|Other|0|||
160869218|NCT04816669|580913687|FG002|Part 2|Other|1|||
160869219|NCT04816669|580913688|FG003|Part 2|Other|0|||
160869220|NCT04816669|580913685|FG000|Part 2|Withdrawal by Subject|0|||
160869221|NCT04816669|580913686|FG001|Part 2|Withdrawal by Subject|0|||
160869222|NCT04816669|580913687|FG002|Part 2|Withdrawal by Subject|0|||
160764790|NCT01701245|580528706|FG000|Overall Study|Protocol Violation|1|||
160764791|NCT01701245|580528707|FG001|Overall Study|Protocol Violation|3|||
160869223|NCT04816669|580913688|FG003|Part 2|Withdrawal by Subject|1|||
160869224|NCT04816669|580913685|FG000|Part 2|Lost to Follow-up|0|||
160869225|NCT04816669|580913686|FG001|Part 2|Lost to Follow-up|0|||
160869226|NCT04816669|580913687|FG002|Part 2|Lost to Follow-up|1|||
160869227|NCT04816669|580913688|FG003|Part 2|Lost to Follow-up|0|||
160869228|NCT01229267|580913689|FG000|Overall Study|Adverse Event|4|||
160869229|NCT01229267|580913690|FG001|Overall Study|Adverse Event|6|||
160869230|NCT01229267|580913691|FG002|Overall Study|Adverse Event|3|||
160869231|NCT01229267|580913692|FG003|Overall Study|Adverse Event|2|||
160869232|NCT01229267|580913693|FG004|Overall Study|Adverse Event|10|||
160869233|NCT01229267|580913689|FG000|Overall Study|Death|40|||
160869234|NCT01229267|580913690|FG001|Overall Study|Death|37|||
160869235|NCT01229267|580913691|FG002|Overall Study|Death|35|||
160869236|NCT01229267|580913692|FG003|Overall Study|Death|13|||
160869237|NCT01229267|580913693|FG004|Overall Study|Death|103|||
160869238|NCT01229267|580913689|FG000|Overall Study|Withdrawal by Subject|23|||
160869239|NCT01229267|580913690|FG001|Overall Study|Withdrawal by Subject|22|||
160869240|NCT01229267|580913691|FG002|Overall Study|Withdrawal by Subject|32|||
160869241|NCT01229267|580913692|FG003|Overall Study|Withdrawal by Subject|14|||
160869242|NCT01229267|580913693|FG004|Overall Study|Withdrawal by Subject|59|||
160527696|NCT01658826|579662808|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
160527697|NCT01658826|579662807|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
160527698|NCT01658826|579662808|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
160527699|NCT01658826|579662807|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
160527700|NCT01658826|579662808|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
160527701|NCT01658826|579662807|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
160527702|NCT01658826|579662808|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
160527703|NCT01658826|579662807|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
160527704|NCT01658826|579662808|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
160527705|NCT01658826|579662807|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
160527706|NCT01658826|579662808|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
160527707|NCT01658826|579662807|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
160527708|NCT01658826|579662808|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
160527709|NCT01658826|579662807|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
160527710|NCT01658826|579662808|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
160527711|NCT01658826|579662807|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
160527712|NCT01658826|579662808|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
160527713|NCT01019980|579662810|FG000|Overall Study|Drug not available.|2|||
160527714|NCT01019980|579662811|FG001|Overall Study|Drug not available.|0|||
160527715|NCT03610165|579662812|FG000|Overall Study|Device didn't work|0|||
160527716|NCT03610165|579662813|FG001|Overall Study|Device didn't work|1|||
160527717|NCT02038920|579662826|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
160527718|NCT02038920|579662827|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
160527719|NCT02038920|579662828|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
160527720|NCT02038920|579662829|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
160527721|NCT02038920|579662830|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
160527722|NCT02038920|579662831|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
160527723|NCT02038920|579662826|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
160527724|NCT02038920|579662827|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
160527725|NCT02038920|579662828|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
160527726|NCT02038920|579662829|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
160527727|NCT02038920|579662830|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
160527728|NCT02038920|579662831|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
160527729|NCT02038920|579662826|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
160527730|NCT02038920|579662827|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
160527731|NCT02038920|579662828|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
160527732|NCT02038920|579662829|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
160527733|NCT02038920|579662830|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
160527734|NCT02038920|579662831|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
160527735|NCT02038920|579662826|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
160527736|NCT02038920|579662827|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
160527737|NCT02038920|579662828|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
160527738|NCT02038920|579662829|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
160527739|NCT02038920|579662830|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
160527740|NCT02038920|579662831|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
160527741|NCT02038920|579662826|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
160527742|NCT02038920|579662827|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
160527743|NCT02038920|579662828|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
160527744|NCT02038920|579662829|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
160527745|NCT02038920|579662830|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
160527746|NCT02038920|579662831|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
160527747|NCT02038920|579662826|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
160527748|NCT02038920|579662827|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
160527749|NCT02038920|579662828|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
160527750|NCT02038920|579662829|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
160527751|NCT02038920|579662830|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
160527752|NCT02038920|579662831|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
160527753|NCT02038920|579662826|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
160527754|NCT02038920|579662827|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
160527755|NCT02038920|579662828|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
160636427|NCT01682512|580051544|FG002|Overall Study|Physician Decision|0|||
160636428|NCT01682512|580051542|FG000|Overall Study|Study terminated by sponsor|46|||
160636429|NCT01682512|580051543|FG001|Overall Study|Study terminated by sponsor|43|||
160527756|NCT02038920|579662829|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
160527757|NCT02038920|579662830|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
160527758|NCT02038920|579662831|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
160527759|NCT02038920|579662826|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
160527760|NCT02038920|579662827|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
160527761|NCT02038920|579662828|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
160527762|NCT02038920|579662829|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
160527763|NCT02038920|579662830|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
160527764|NCT02038920|579662831|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
160527765|NCT02038920|579662826|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
160527766|NCT02038920|579662827|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
160527767|NCT02038920|579662828|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
160527768|NCT02038920|579662829|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
160527769|NCT02038920|579662830|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
160527770|NCT02038920|579662831|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
160527771|NCT02038920|579662826|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
160527772|NCT02038920|579662827|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
160527773|NCT02038920|579662828|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
160527774|NCT02038920|579662829|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
160527775|NCT02038920|579662830|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
160527776|NCT02038920|579662831|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
160527777|NCT02038920|579662826|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
160527778|NCT02038920|579662827|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
160527779|NCT02038920|579662828|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
160527780|NCT02038920|579662829|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
160527781|NCT02038920|579662830|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
160527782|NCT02038920|579662831|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
160527783|NCT02038920|579662826|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
160527784|NCT02038920|579662827|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
160527785|NCT02038920|579662828|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
160527786|NCT02038920|579662829|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
160869243|NCT01229267|580913689|FG000|Overall Study|Protocol Violation|0|||
160869244|NCT01229267|580913690|FG001|Overall Study|Protocol Violation|1|||
160764792|NCT01701245|580528706|FG000|Overall Study|Did not complete the open label period|11|||
160764793|NCT01701245|580528707|FG001|Overall Study|Did not complete the open label period|12|||
160764794|NCT01604785|580528710|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
160764795|NCT01604785|580528711|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
160764796|NCT01118052|580528714|FG000|Overall Study|Never treated|2|||
160764797|NCT00843492|580528715|FG000|Overall Study|Adverse Event|0|||
160764798|NCT00843492|580528716|FG001|Overall Study|Adverse Event|3|||
160764799|NCT00843492|580528715|FG000|Overall Study|Lost to Follow-up|4|||
160764800|NCT00843492|580528716|FG001|Overall Study|Lost to Follow-up|4|||
160764801|NCT00843492|580528715|FG000|Overall Study|Withdrawal by Subject|0|||
160764802|NCT00843492|580528716|FG001|Overall Study|Withdrawal by Subject|4|||
160764803|NCT00843492|580528715|FG000|Overall Study|Immobilization Stopped|1|||
160764804|NCT00843492|580528716|FG001|Overall Study|Immobilization Stopped|0|||
160764805|NCT00843492|580528715|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
160764806|NCT00843492|580528716|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
160764807|NCT00843492|580528715|FG000|Overall Study|Orthopedic Surgery|0|||
160764808|NCT00843492|580528716|FG001|Overall Study|Orthopedic Surgery|2|||
160764809|NCT00843492|580528715|FG000|Overall Study|Visit Not Performed|1|||
160764810|NCT00843492|580528716|FG001|Overall Study|Visit Not Performed|0|||
160764811|NCT00843492|580528715|FG000|Overall Study|Deep-vein Thrombosis|1|||
160764812|NCT00843492|580528716|FG001|Overall Study|Deep-vein Thrombosis|0|||
160764813|NCT01677741|580528717|FG000|Overall Study|Death|0|||
160764814|NCT01677741|580528718|FG001|Overall Study|Death|0|||
160764815|NCT01677741|580528719|FG002|Overall Study|Death|0|||
160764816|NCT01677741|580528720|FG003|Overall Study|Death|1|||
160869245|NCT01229267|580913691|FG002|Overall Study|Protocol Violation|0|||
160869246|NCT01229267|580913692|FG003|Overall Study|Protocol Violation|0|||
160869247|NCT01229267|580913693|FG004|Overall Study|Protocol Violation|0|||
160869248|NCT01229267|580913689|FG000|Overall Study|Progressive disease|0|||
160869249|NCT01229267|580913690|FG001|Overall Study|Progressive disease|0|||
160869250|NCT01229267|580913691|FG002|Overall Study|Progressive disease|0|||
160869251|NCT01229267|580913692|FG003|Overall Study|Progressive disease|0|||
160869252|NCT01229267|580913693|FG004|Overall Study|Progressive disease|1|||
160869253|NCT01229267|580913689|FG000|Overall Study|Physician Decision|8|||
160869254|NCT01229267|580913690|FG001|Overall Study|Physician Decision|11|||
160869255|NCT01229267|580913691|FG002|Overall Study|Physician Decision|8|||
160869256|NCT01229267|580913692|FG003|Overall Study|Physician Decision|3|||
160869257|NCT01229267|580913693|FG004|Overall Study|Physician Decision|25|||
160869258|NCT01229267|580913689|FG000|Overall Study|Lost to Follow-up|6|||
160869259|NCT01229267|580913690|FG001|Overall Study|Lost to Follow-up|5|||
160869260|NCT01229267|580913691|FG002|Overall Study|Lost to Follow-up|8|||
160869261|NCT01229267|580913692|FG003|Overall Study|Lost to Follow-up|3|||
160869262|NCT01229267|580913693|FG004|Overall Study|Lost to Follow-up|22|||
160869263|NCT00808080|580913697|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
160869264|NCT01837823|580913700|FG000|Overall Study|Lost to Follow-up|6|||
160869265|NCT03052400|580913701|FG000|Overall Study|Lost to Follow-up|1|||
160869266|NCT03052400|580913702|FG001|Overall Study|Lost to Follow-up|0|||
160869267|NCT03052400|580913701|FG000|Overall Study|Withdrawal by Subject|0|||
160869268|NCT03052400|580913702|FG001|Overall Study|Withdrawal by Subject|1|||
160869269|NCT00867815|580913703|FG000|Overall Study|Lost to Follow-up|1|||
160869270|NCT00001213|580913704|FG000|Overall Study|Death|18|||
160869271|NCT00859456|580913705|FG000|Overall Study|Adverse Event|3|||
160869272|NCT00859456|580913705|FG000|Overall Study|Progressive disease|2|||
160869273|NCT00859456|580913705|FG000|Overall Study|Non-compliance|3|||
160869274|NCT05782179|580913709|FG000|Overall Study|Adverse Event|0|||
160869275|NCT05782179|580913710|FG001|Overall Study|Adverse Event|0|||
160869276|NCT05782179|580913711|FG002|Overall Study|Adverse Event|2|||
160869277|NCT05782179|580913712|FG003|Overall Study|Adverse Event|0|||
160869278|NCT05782179|580913713|FG004|Overall Study|Adverse Event|0|||
160869279|NCT05782179|580913714|FG005|Overall Study|Adverse Event|0|||
160869280|NCT06170242|580913715|FG000|Overall Study|Lost to Follow-up|0|||
160869281|NCT06170242|580913716|FG001|Overall Study|Lost to Follow-up|0|||
160869282|NCT06170242|580913717|FG002|Overall Study|Lost to Follow-up|1|||
160869283|NCT06170242|580913718|FG003|Overall Study|Lost to Follow-up|1|||
160869284|NCT00927953|580913719|FG000|Overall Study|Death|2|||
160869285|NCT00927953|580913720|FG001|Overall Study|Death|1|||
160869286|NCT01491607|580913721|FG000|Overall Study|Lost to Follow-up|7|||
160869287|NCT01491607|580913721|FG000|Overall Study|Withdrawal by Subject|3|||
160869288|NCT02194985|580913724|FG000|Overall Study|Adverse Event|1|||
160869289|NCT02194985|580913724|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
160869290|NCT02194985|580913724|FG000|Overall Study|Physician Decision|4|||
160869291|NCT02194985|580913724|FG000|Overall Study|Lost to Follow-up|1|||
160869292|NCT02194985|580913724|FG000|Overall Study|Withdrawal by Subject|2|||
160869293|NCT01733680|580913727|FG000|Overall Study|Withdrawal by Subject|0|||
160869294|NCT01733680|580913728|FG001|Overall Study|Withdrawal by Subject|1|||
160869295|NCT02839200|580913731|FG000|Overall Study|Withdrawal by Subject|2|||
160869296|NCT02839200|580913732|FG001|Overall Study|Withdrawal by Subject|0|||
160869297|NCT02839200|580913733|FG002|Overall Study|Withdrawal by Subject|1|||
160869298|NCT02839200|580913734|FG003|Overall Study|Withdrawal by Subject|0|||
160869299|NCT02839200|580913735|FG004|Overall Study|Withdrawal by Subject|0|||
160869300|NCT02839200|580913736|FG005|Overall Study|Withdrawal by Subject|1|||
160869301|NCT02839200|580913731|FG000|Overall Study|Lost to Follow-up|2|||
160869302|NCT02839200|580913732|FG001|Overall Study|Lost to Follow-up|0|||
160869303|NCT02839200|580913733|FG002|Overall Study|Lost to Follow-up|0|||
160869304|NCT02839200|580913734|FG003|Overall Study|Lost to Follow-up|0|||
160869305|NCT02839200|580913735|FG004|Overall Study|Lost to Follow-up|1|||
160869306|NCT02839200|580913736|FG005|Overall Study|Lost to Follow-up|0|||
160869307|NCT02839200|580913731|FG000|Overall Study|Adverse Event|0|||
160869308|NCT02839200|580913732|FG001|Overall Study|Adverse Event|0|||
160869309|NCT02839200|580913733|FG002|Overall Study|Adverse Event|0|||
160869310|NCT02839200|580913734|FG003|Overall Study|Adverse Event|0|||
160869311|NCT02839200|580913735|FG004|Overall Study|Adverse Event|1|||
160869312|NCT02839200|580913736|FG005|Overall Study|Adverse Event|0|||
160869313|NCT02839200|580913731|FG000|Overall Study|Randomized in error|0|||
160869314|NCT02839200|580913732|FG001|Overall Study|Randomized in error|1|||
160869315|NCT02839200|580913733|FG002|Overall Study|Randomized in error|0|||
160869316|NCT02839200|580913734|FG003|Overall Study|Randomized in error|0|||
160869317|NCT02839200|580913735|FG004|Overall Study|Randomized in error|0|||
160869318|NCT02839200|580913736|FG005|Overall Study|Randomized in error|0|||
160527787|NCT02038920|579662830|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
160527788|NCT02038920|579662831|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
160527789|NCT02383589|579662832|FG000|Treatment Period|Adverse Event|1|||
160527790|NCT02383589|579662833|FG001|Treatment Period|Adverse Event|3|||
160527791|NCT02383589|579662832|FG000|Treatment Period|Lost to Follow-up|0|||
160527792|NCT02383589|579662833|FG001|Treatment Period|Lost to Follow-up|1|||
160527793|NCT02383589|579662832|FG000|Treatment Period|Withdrawal by Subject|0|||
160527794|NCT02383589|579662833|FG001|Treatment Period|Withdrawal by Subject|5|||
160527795|NCT02383589|579662832|FG000|Treatment Period|Non-compliance with study drug|0|||
160527796|NCT02383589|579662833|FG001|Treatment Period|Non-compliance with study drug|1|||
160527797|NCT02383589|579662832|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
160527798|NCT02383589|579662833|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
160527799|NCT02383589|579662832|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
160527800|NCT02383589|579662833|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
160527801|NCT02383589|579662832|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
160527802|NCT02383589|579662833|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
160527803|NCT00866697|579662834|FG000|Overall Study|Study closed/terminated|156|||
160527804|NCT00866697|579662835|FG001|Overall Study|Study closed/terminated|138|||
160527805|NCT00866697|579662834|FG000|Overall Study|Lost to Follow-up|22|||
160527806|NCT00866697|579662835|FG001|Overall Study|Lost to Follow-up|28|||
160636430|NCT01682512|580051544|FG002|Overall Study|Study terminated by sponsor|0|||
160636431|NCT01682512|580051542|FG000|Overall Study|Lost to Follow-up|3|||
160527807|NCT00866697|579662834|FG000|Overall Study|Physician Decision|3|||
160869319|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
160869320|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
160764817|NCT01677741|580528721|FG004|Overall Study|Death|0|||
160764818|NCT01677741|580528722|FG005|Overall Study|Death|1|||
160764819|NCT01677741|580528723|FG006|Overall Study|Death|0|||
160764820|NCT01677741|580528724|FG007|Overall Study|Death|0|||
160764821|NCT01677741|580528717|FG000|Overall Study|Withdrawal by Subject|2|||
160764822|NCT01677741|580528718|FG001|Overall Study|Withdrawal by Subject|7|||
160764823|NCT01677741|580528719|FG002|Overall Study|Withdrawal by Subject|5|||
160764824|NCT01677741|580528720|FG003|Overall Study|Withdrawal by Subject|4|||
160764825|NCT01677741|580528721|FG004|Overall Study|Withdrawal by Subject|11|||
160764826|NCT01677741|580528722|FG005|Overall Study|Withdrawal by Subject|20|||
160764827|NCT01677741|580528723|FG006|Overall Study|Withdrawal by Subject|4|||
160764828|NCT01677741|580528724|FG007|Overall Study|Withdrawal by Subject|2|||
160764829|NCT01677741|580528717|FG000|Overall Study|Enrolled in a rollover study|0|||
160764830|NCT01677741|580528718|FG001|Overall Study|Enrolled in a rollover study|3|||
160869321|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
160764831|NCT01677741|580528719|FG002|Overall Study|Enrolled in a rollover study|2|||
160869322|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
160869323|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
160869324|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
160869325|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
160869326|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
160869327|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
160869328|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
160869329|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
160869330|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
160869331|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
160869332|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
160869333|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
160869334|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
160869335|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
160869336|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
160869337|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
160869338|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
160869339|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
160869340|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
160869341|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
160869342|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
160527808|NCT00866697|579662835|FG001|Overall Study|Physician Decision|5|||
160527809|NCT00866697|579662834|FG000|Overall Study|Withdrawal by Subject|33|||
160527810|NCT00866697|579662835|FG001|Overall Study|Withdrawal by Subject|57|||
160527811|NCT02906787|579662838|FG000|Overall Study|Withdrawal by Subject|12|||
160527812|NCT02906787|579662839|FG001|Overall Study|Withdrawal by Subject|10|||
160527813|NCT02906787|579662838|FG000|Overall Study|Missed|24|||
160527814|NCT02906787|579662839|FG001|Overall Study|Missed|22|||
160527815|NCT03901053|579662844|FG000|Overall Study|Lost to Follow-up|6|||
160527816|NCT03901053|579662845|FG001|Overall Study|Lost to Follow-up|2|||
160527817|NCT03901053|579662844|FG000|Overall Study|Withdrawal by Subject|4|||
160527818|NCT03901053|579662845|FG001|Overall Study|Withdrawal by Subject|3|||
160527819|NCT03901053|579662844|FG000|Overall Study|Unsatisfactory Device|1|||
160527820|NCT03901053|579662845|FG001|Overall Study|Unsatisfactory Device|2|||
160527821|NCT03901053|579662844|FG000|Overall Study|No longer meets study criteria|1|||
160527822|NCT03901053|579662845|FG001|Overall Study|No longer meets study criteria|3|||
160527823|NCT03901053|579662844|FG000|Overall Study|Subject's Medical Status|0|||
160527824|NCT03901053|579662845|FG001|Overall Study|Subject's Medical Status|1|||
160527825|NCT03901053|579662844|FG000|Overall Study|Screening Failure|1|||
160527826|NCT03901053|579662845|FG001|Overall Study|Screening Failure|0|||
160527827|NCT04313153|579664812|FG000|Overall Study|Adverse Event (includes Death)|14|||
160527828|NCT04313153|579664813|FG001|Overall Study|Adverse Event (includes Death)|19|||
160527829|NCT04313153|579664814|FG002|Overall Study|Adverse Event (includes Death)|10|||
160527830|NCT04313153|579664812|FG000|Overall Study|Physician Decision|4|||
160527831|NCT04313153|579664813|FG001|Overall Study|Physician Decision|2|||
160527832|NCT04313153|579664814|FG002|Overall Study|Physician Decision|1|||
160527833|NCT04313153|579664812|FG000|Overall Study|Withdrawal by Subject|7|||
160527834|NCT04313153|579664813|FG001|Overall Study|Withdrawal by Subject|6|||
160527835|NCT04313153|579664814|FG002|Overall Study|Withdrawal by Subject|2|||
160527836|NCT04313153|579664812|FG000|Overall Study|Lack of Efficacy|3|||
160527837|NCT04313153|579664813|FG001|Overall Study|Lack of Efficacy|3|||
160527838|NCT04313153|579664814|FG002|Overall Study|Lack of Efficacy|0|||
160527839|NCT04313153|579664812|FG000|Overall Study|Lost to Follow-up|1|||
160527840|NCT04313153|579664813|FG001|Overall Study|Lost to Follow-up|0|||
160527841|NCT04313153|579664814|FG002|Overall Study|Lost to Follow-up|2|||
160527842|NCT04313153|579664812|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
160527843|NCT04313153|579664813|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
160527844|NCT04313153|579664814|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
160527845|NCT04313153|579664812|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
160527846|NCT04313153|579664813|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
160527847|NCT04313153|579664814|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
160527848|NCT04313153|579664812|FG000|Overall Study|Change in Dialysis Modality|0|||
160527849|NCT04313153|579664813|FG001|Overall Study|Change in Dialysis Modality|1|||
160527850|NCT04313153|579664814|FG002|Overall Study|Change in Dialysis Modality|2|||
160527851|NCT04313153|579664812|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
160527852|NCT04313153|579664813|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
160527853|NCT04313153|579664814|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
160527854|NCT04313153|579664812|FG000|Overall Study|Other|5|||
160527855|NCT04313153|579664813|FG001|Overall Study|Other|3|||
160527856|NCT04313153|579664814|FG002|Overall Study|Other|2|||
160527857|NCT01310803|579664820|FG000|Overall Study|Subject terminated by Sponsor|1|||
160527858|NCT01310803|579664821|FG001|Overall Study|Subject terminated by Sponsor|0|||
160527859|NCT02113579|579664824|FG000|Overall Study|Adverse Event|1|||
160527860|NCT02113579|579664825|FG001|Overall Study|Adverse Event|0|||
160636432|NCT01682512|580051543|FG001|Overall Study|Lost to Follow-up|0|||
160636433|NCT01682512|580051544|FG002|Overall Study|Lost to Follow-up|2|||
160636434|NCT01682512|580051542|FG000|Overall Study|Protocol Violation|2|||
160636435|NCT01682512|580051543|FG001|Overall Study|Protocol Violation|3|||
160636436|NCT01682512|580051544|FG002|Overall Study|Protocol Violation|2|||
160636437|NCT01682512|580051542|FG000|Overall Study|Primary lack of efficacy|10|||
160636438|NCT01682512|580051543|FG001|Overall Study|Primary lack of efficacy|7|||
160636439|NCT01682512|580051544|FG002|Overall Study|Primary lack of efficacy|7|||
160636440|NCT01682512|580051542|FG000|Overall Study|Secondary lack of efficacy|1|||
160636441|NCT01682512|580051543|FG001|Overall Study|Secondary lack of efficacy|1|||
160636442|NCT01682512|580051544|FG002|Overall Study|Secondary lack of efficacy|0|||
160527861|NCT02113579|579664824|FG000|Overall Study|Withdrawal by Subject|3|||
160527862|NCT02113579|579664825|FG001|Overall Study|Withdrawal by Subject|2|||
160527863|NCT02113579|579664824|FG000|Overall Study|Lost to Follow-up|6|||
160527864|NCT02113579|579664825|FG001|Overall Study|Lost to Follow-up|2|||
160527865|NCT03047551|579664826|FG000|Overall Study|Did not receive TAS|1|||
160527866|NCT03047551|579664827|FG001|Overall Study|Did not receive TAS|0|||
160527867|NCT03047551|579664826|FG000|Overall Study|Physician Decision|1|||
160527868|NCT03047551|579664827|FG001|Overall Study|Physician Decision|0|||
160527869|NCT03047551|579664826|FG000|Overall Study|Withdrawal by Subject|0|||
160636443|NCT01682512|580051542|FG000|Overall Study|Other than stated above|2|||
160764832|NCT01677741|580528720|FG003|Overall Study|Enrolled in a rollover study|1|||
160764833|NCT01677741|580528721|FG004|Overall Study|Enrolled in a rollover study|6|||
160764834|NCT01677741|580528722|FG005|Overall Study|Enrolled in a rollover study|6|||
160764835|NCT01677741|580528723|FG006|Overall Study|Enrolled in a rollover study|7|||
160764836|NCT01677741|580528724|FG007|Overall Study|Enrolled in a rollover study|0|||
160764837|NCT01677741|580528717|FG000|Overall Study|Progressive disease|1|||
160764838|NCT01677741|580528718|FG001|Overall Study|Progressive disease|0|||
160764839|NCT01677741|580528719|FG002|Overall Study|Progressive disease|1|||
160764840|NCT01677741|580528720|FG003|Overall Study|Progressive disease|0|||
160764841|NCT01677741|580528721|FG004|Overall Study|Progressive disease|0|||
160764842|NCT01677741|580528722|FG005|Overall Study|Progressive disease|1|||
160764843|NCT01677741|580528723|FG006|Overall Study|Progressive disease|0|||
160764844|NCT01677741|580528724|FG007|Overall Study|Progressive disease|0|||
160764845|NCT01441973|580528725|FG000|Overall Study|Disease progression|8|||
160764846|NCT01441973|580528726|FG001|Overall Study|Disease progression|6|||
160764847|NCT01441973|580528725|FG000|Overall Study|Adverse event unrelated to study drug|3|||
160764848|NCT01441973|580528726|FG001|Overall Study|Adverse event unrelated to study drug|2|||
160764849|NCT01441973|580528725|FG000|Overall Study|Participant request to discontinue|1|||
160764850|NCT01441973|580528726|FG001|Overall Study|Participant request to discontinue|1|||
160764851|NCT01441973|580528725|FG000|Overall Study|Poor compliance/noncompliance|0|||
160764852|NCT01441973|580528726|FG001|Overall Study|Poor compliance/noncompliance|1|||
160764853|NCT01441973|580528725|FG000|Overall Study|Administrative reason by sponsor|3|||
160764854|NCT01441973|580528726|FG001|Overall Study|Administrative reason by sponsor|5|||
160764855|NCT01441973|580528725|FG000|Overall Study|Participant withdrew consent|0|||
160764856|NCT01441973|580528726|FG001|Overall Study|Participant withdrew consent|1|||
160764857|NCT01898078|580530278|FG000|Overall Study|Progressive Disease|1|||
160764858|NCT01898078|580530279|FG001|Overall Study|Progressive Disease|5|||
160764859|NCT01898078|580530278|FG000|Overall Study|Adverse Event|2|||
160764860|NCT01898078|580530279|FG001|Overall Study|Adverse Event|1|||
160764861|NCT01898078|580530278|FG000|Overall Study|Withdrawal by Subject|1|||
160764862|NCT01898078|580530279|FG001|Overall Study|Withdrawal by Subject|1|||
160764863|NCT01898078|580530278|FG000|Overall Study|Symptomatic Deterioration|2|||
160764864|NCT01898078|580530279|FG001|Overall Study|Symptomatic Deterioration|0|||
160764865|NCT01898078|580530278|FG000|Overall Study|Reason not Specified|0|||
160764866|NCT01898078|580530279|FG001|Overall Study|Reason not Specified|1|||
160764867|NCT00408499|580530287|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
160764868|NCT00408499|580530288|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
160764869|NCT00408499|580530289|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
160764870|NCT00408499|580530290|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
160764871|NCT00408499|580530291|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
160764872|NCT00408499|580530287|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
160764873|NCT00408499|580530288|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
160764874|NCT00408499|580530289|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
160764875|NCT00408499|580530290|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
160764876|NCT00408499|580530291|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
160764877|NCT00408499|580530287|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
160764878|NCT00408499|580530288|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
160764879|NCT00408499|580530289|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
160764880|NCT00408499|580530290|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
160764881|NCT00408499|580530291|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
160764882|NCT00408499|580530287|FG000|Phase II- MTD Expansion|Adverse Event|0|||
160764883|NCT00408499|580530288|FG001|Phase II- MTD Expansion|Adverse Event|0|||
160764884|NCT00408499|580530289|FG002|Phase II- MTD Expansion|Adverse Event|0|||
160764885|NCT00408499|580530290|FG003|Phase II- MTD Expansion|Adverse Event|0|||
160764886|NCT00408499|580530291|FG004|Phase II- MTD Expansion|Adverse Event|9|||
160764887|NCT00408499|580530287|FG000|Phase II- MTD Expansion|Death|0|||
160764888|NCT00408499|580530288|FG001|Phase II- MTD Expansion|Death|0|||
160764889|NCT00408499|580530289|FG002|Phase II- MTD Expansion|Death|0|||
160764890|NCT00408499|580530290|FG003|Phase II- MTD Expansion|Death|0|||
160764891|NCT00408499|580530291|FG004|Phase II- MTD Expansion|Death|2|||
160764892|NCT00408499|580530287|FG000|Phase II- MTD Expansion|Physician Decision|0|||
160764893|NCT00408499|580530288|FG001|Phase II- MTD Expansion|Physician Decision|0|||
160764894|NCT00408499|580530289|FG002|Phase II- MTD Expansion|Physician Decision|0|||
160764895|NCT00408499|580530290|FG003|Phase II- MTD Expansion|Physician Decision|0|||
160764896|NCT00408499|580530291|FG004|Phase II- MTD Expansion|Physician Decision|1|||
160764897|NCT00408499|580530287|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
160764898|NCT00408499|580530288|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
160764899|NCT00408499|580530289|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
160764900|NCT00408499|580530290|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
160764901|NCT00408499|580530291|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
160764902|NCT00408499|580530287|FG000|Phase II- MTD Expansion|treatment delay|0|||
160764903|NCT00408499|580530288|FG001|Phase II- MTD Expansion|treatment delay|0|||
160764904|NCT00408499|580530289|FG002|Phase II- MTD Expansion|treatment delay|0|||
160764905|NCT00408499|580530290|FG003|Phase II- MTD Expansion|treatment delay|0|||
160764906|NCT00408499|580530291|FG004|Phase II- MTD Expansion|treatment delay|3|||
160764907|NCT00266708|580530298|FG000|Overall Study|No renal function|1|||
160764908|NCT00266708|580530299|FG001|Overall Study|No renal function|1|||
160764909|NCT00266708|580530298|FG000|Overall Study|Refused biopsy|3|||
160764910|NCT00266708|580530299|FG001|Overall Study|Refused biopsy|6|||
160764911|NCT00266708|580530298|FG000|Overall Study|Asthma|0|||
160764912|NCT00266708|580530299|FG001|Overall Study|Asthma|2|||
160764913|NCT02791269|580530300|FG000|Overall Study|Lost to Follow-up|0|||
160764914|NCT02791269|580530301|FG001|Overall Study|Lost to Follow-up|1|||
160764915|NCT02683109|580530302|FG000|Overall Study|Adverse Event|1|||
160764916|NCT02683109|580530303|FG001|Overall Study|Adverse Event|0|||
160764917|NCT00368251|580530304|FG000|Overall Study|SAE, non-fatal|1|||
160764918|NCT00368251|580530305|FG001|Overall Study|SAE, non-fatal|0|||
160764919|NCT00368251|580530306|FG002|Overall Study|SAE, non-fatal|0|||
160764920|NCT00368251|580530304|FG000|Overall Study|AE, non-serious non-fatal|0|||
160764921|NCT00368251|580530305|FG001|Overall Study|AE, non-serious non-fatal|0|||
160764922|NCT00368251|580530306|FG002|Overall Study|AE, non-serious non-fatal|1|||
160764923|NCT03617588|580530314|FG000|Overall Study|Withdrawal by Subject|1|||
160764924|NCT03617588|580530315|FG001|Overall Study|Withdrawal by Subject|0|||
160764925|NCT00900562|580530320|FG000|Overall Study|Progressive disease|9|||
160764926|NCT00900562|580530321|FG001|Overall Study|Progressive disease|5|||
160764927|NCT00900562|580530320|FG000|Overall Study|Toxicity|1|||
160764928|NCT00900562|580530321|FG001|Overall Study|Toxicity|0|||
160764929|NCT00900562|580530320|FG000|Overall Study|Death|1|||
160527870|NCT03047551|579664827|FG001|Overall Study|Withdrawal by Subject|1|||
160527871|NCT03047551|579664826|FG000|Overall Study|Probe malfunction|0|||
160527872|NCT03047551|579664827|FG001|Overall Study|Probe malfunction|1|||
160527873|NCT03047551|579664826|FG000|Overall Study|Ineligible|0|||
160527874|NCT03047551|579664827|FG001|Overall Study|Ineligible|1|||
160527875|NCT00726622|579664828|FG000|Overall Study|Withdrawal by Subject|16|||
160527876|NCT00726622|579664829|FG001|Overall Study|Withdrawal by Subject|2|||
160527877|NCT00726622|579664828|FG000|Overall Study|Physician Decision|0|||
160527878|NCT00726622|579664829|FG001|Overall Study|Physician Decision|1|||
160527879|NCT00726622|579664828|FG000|Overall Study|Metastasis|2|||
160527880|NCT00726622|579664829|FG001|Overall Study|Metastasis|0|||
160527881|NCT02462928|579664831|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
160527882|NCT02462928|579664832|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
160527883|NCT02462928|579664833|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
160869343|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
160869344|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
160527884|NCT02462928|579664831|FG000|Overall Study|Adverse Event|47|||
160527885|NCT02462928|579664832|FG001|Overall Study|Adverse Event|51|||
160527886|NCT02462928|579664833|FG002|Overall Study|Adverse Event|25|||
160527887|NCT02462928|579664831|FG000|Overall Study|Lack of Efficacy|3|||
160527888|NCT02462928|579664832|FG001|Overall Study|Lack of Efficacy|8|||
160527889|NCT02462928|579664833|FG002|Overall Study|Lack of Efficacy|3|||
160527890|NCT02462928|579664831|FG000|Overall Study|Lost to Follow-up|4|||
160527891|NCT02462928|579664832|FG001|Overall Study|Lost to Follow-up|4|||
160527892|NCT02462928|579664833|FG002|Overall Study|Lost to Follow-up|1|||
160527893|NCT02462928|579664831|FG000|Overall Study|Withdrawal by Patient|31|||
160527894|NCT02462928|579664832|FG001|Overall Study|Withdrawal by Patient|21|||
160527895|NCT02462928|579664833|FG002|Overall Study|Withdrawal by Patient|21|||
160527896|NCT02462928|579664831|FG000|Overall Study|Protocol Violation|0|||
160527897|NCT02462928|579664832|FG001|Overall Study|Protocol Violation|1|||
160527898|NCT02462928|579664833|FG002|Overall Study|Protocol Violation|0|||
160527899|NCT02462928|579664831|FG000|Overall Study|Reason not Specified|4|||
160527900|NCT02462928|579664832|FG001|Overall Study|Reason not Specified|6|||
160527901|NCT02462928|579664833|FG002|Overall Study|Reason not Specified|5|||
160764930|NCT00900562|580530321|FG001|Overall Study|Death|1|||
160764931|NCT00900562|580530320|FG000|Overall Study|Withdrawal by Subject|0|||
160764932|NCT00900562|580530321|FG001|Overall Study|Withdrawal by Subject|1|||
160764933|NCT00900562|580530320|FG000|Overall Study|Unrelated adverse event|1|||
160764934|NCT00900562|580530321|FG001|Overall Study|Unrelated adverse event|0|||
160764935|NCT03098979|580530322|FG000|Overall Study|Adverse Event|1|||
160764936|NCT03098979|580530323|FG001|Overall Study|Adverse Event|0|||
160764937|NCT03098979|580530324|FG002|Overall Study|Adverse Event|1|||
160764938|NCT03098979|580530325|FG003|Overall Study|Adverse Event|4|||
160764939|NCT03098979|580530326|FG004|Overall Study|Adverse Event|6|||
160764940|NCT03098979|580530327|FG005|Overall Study|Adverse Event|1|||
160764941|NCT03098979|580530322|FG000|Overall Study|Withdrawal by Subject|2|||
160764942|NCT03098979|580530323|FG001|Overall Study|Withdrawal by Subject|1|||
160764943|NCT03098979|580530324|FG002|Overall Study|Withdrawal by Subject|1|||
160764944|NCT03098979|580530325|FG003|Overall Study|Withdrawal by Subject|1|||
160764945|NCT03098979|580530326|FG004|Overall Study|Withdrawal by Subject|2|||
160764946|NCT03098979|580530327|FG005|Overall Study|Withdrawal by Subject|1|||
160764947|NCT03098979|580530322|FG000|Overall Study|Death|1|||
160764948|NCT03098979|580530323|FG001|Overall Study|Death|0|||
160764949|NCT03098979|580530324|FG002|Overall Study|Death|2|||
160764950|NCT03098979|580530325|FG003|Overall Study|Death|0|||
160764951|NCT03098979|580530326|FG004|Overall Study|Death|1|||
160764952|NCT03098979|580530327|FG005|Overall Study|Death|0|||
160764953|NCT03098979|580530322|FG000|Overall Study|Physician Decision|2|||
160764954|NCT03098979|580530323|FG001|Overall Study|Physician Decision|1|||
160869345|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
160869346|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
160527902|NCT00395863|579664834|FG000|Overall Study|Patients did not complete both exams|2|||
160527903|NCT00395863|579664835|FG001|Overall Study|Patients did not complete both exams|3|||
160527904|NCT01940354|579664839|FG000|Overall Study|Withdrawal by Subject|4|||
160527905|NCT01940354|579664840|FG001|Overall Study|Withdrawal by Subject|2|||
160527906|NCT02020863|579664841|FG000|Overall Study|Discovery of Metastatic disease|4|||
160527907|NCT02020863|579664841|FG000|Overall Study|Team chose not to place an a line|1|||
160527908|NCT03873493|579664842|FG000|Overall Study|Withdrawal by Subject|1|||
160527909|NCT03873493|579664842|FG000|Overall Study|Death|9|||
160527910|NCT03873493|579664842|FG000|Overall Study|Lost to Follow-up|1|||
160527911|NCT03873493|579664842|FG000|Overall Study|Study Terminated by Sponsor|1|||
160527912|NCT03873493|579664842|FG000|Overall Study|Other|2|||
160764955|NCT03098979|580530324|FG002|Overall Study|Physician Decision|0|||
160764956|NCT03098979|580530325|FG003|Overall Study|Physician Decision|0|||
160764957|NCT03098979|580530326|FG004|Overall Study|Physician Decision|0|||
160764958|NCT03098979|580530327|FG005|Overall Study|Physician Decision|0|||
160764959|NCT03098979|580530322|FG000|Overall Study|Non-compliance|0|||
160764960|NCT03098979|580530323|FG001|Overall Study|Non-compliance|0|||
160527913|NCT00909792|579664846|FG000|Period 1|Did not meet inclusion criteria|0|||
160764961|NCT03098979|580530324|FG002|Overall Study|Non-compliance|0|||
160764962|NCT03098979|580530325|FG003|Overall Study|Non-compliance|0|||
160764963|NCT03098979|580530326|FG004|Overall Study|Non-compliance|0|||
160764964|NCT03098979|580530327|FG005|Overall Study|Non-compliance|1|||
160764965|NCT03098979|580530322|FG000|Overall Study|Protocol Violation|0|||
160764966|NCT03098979|580530323|FG001|Overall Study|Protocol Violation|0|||
160527914|NCT00909792|579664847|FG001|Period 1|Did not meet inclusion criteria|1|||
160527915|NCT00909792|579664846|FG000|Period 2|Biomicroscopy|1|||
160527916|NCT00909792|579664847|FG001|Period 2|Biomicroscopy|0|||
160527917|NCT00909792|579664846|FG000|Period 2|Lost to Follow-up|0|||
160527918|NCT00909792|579664847|FG001|Period 2|Lost to Follow-up|1|||
160527919|NCT03503513|579664852|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
160527920|NCT03503513|579664852|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
160527921|NCT03503513|579664852|FG000|Overall Study|Physician Decision|3|||
160527922|NCT03503513|579664852|FG000|Overall Study|Withdrawal by Subject|2|||
160527923|NCT03503513|579664852|FG000|Overall Study|Lost to Follow-up|1|||
160527924|NCT01170039|579664853|FG000|Overall Study|Withdrawal by Subject|5|||
160527925|NCT01170039|579664854|FG001|Overall Study|Withdrawal by Subject|3|||
160527926|NCT01170039|579664853|FG000|Overall Study|Lack of funding, drug not available|3|||
160527927|NCT01170039|579664854|FG001|Overall Study|Lack of funding, drug not available|3|||
160527928|NCT01524133|579664855|FG000|Treatment Phase|Withdrawal by Subject|13|||
160527929|NCT01524133|579664856|FG001|Treatment Phase|Withdrawal by Subject|28|||
160527930|NCT01524133|579664857|FG002|Treatment Phase|Withdrawal by Subject|31|||
160869347|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
160869348|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
160869349|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
160869350|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
160869351|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
160869352|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
160869353|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
160869354|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
160869355|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
160869356|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
160869357|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
160869358|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Not treated|0|||
160869359|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Not treated|0|||
160869360|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Not treated|1|||
160869361|NCT03614156|580913740|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
160869362|NCT03614156|580913741|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
160869363|NCT03614156|580913742|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
160869364|NCT03614156|580913743|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
160869365|NCT03614156|580913740|FG000|Open-Label Treatment Period|Adverse Event|7|||
160869366|NCT03614156|580913741|FG001|Open-Label Treatment Period|Adverse Event|0|||
160869367|NCT03614156|580913742|FG002|Open-Label Treatment Period|Adverse Event|0|||
160869368|NCT03614156|580913743|FG003|Open-Label Treatment Period|Adverse Event|0|||
160869369|NCT03614156|580913740|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
160869370|NCT03614156|580913741|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
160527931|NCT01524133|579664855|FG000|Treatment Phase|Physician Decision|6|||
160527932|NCT01524133|579664856|FG001|Treatment Phase|Physician Decision|3|||
160527933|NCT01524133|579664857|FG002|Treatment Phase|Physician Decision|3|||
160527934|NCT01524133|579664855|FG000|Treatment Phase|Lost to Follow-up|0|||
160764967|NCT03098979|580530324|FG002|Overall Study|Protocol Violation|0|||
160764968|NCT03098979|580530325|FG003|Overall Study|Protocol Violation|0|||
160764969|NCT03098979|580530326|FG004|Overall Study|Protocol Violation|0|||
160764970|NCT03098979|580530327|FG005|Overall Study|Protocol Violation|1|||
160764971|NCT03451071|580530333|FG000|First Vaccine|Withdrawal by Subject|1|||
160764972|NCT03451071|580530333|FG000|Second Vaccine|Lost to Follow-up|19|||
160764973|NCT03451071|580530333|FG000|Third Vaccine|Lost to Follow-up|22|||
160764974|NCT03451071|580530333|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
160764975|NCT00929669|580530338|FG000|Overall Study|elevated glucose levels|1|||
160764976|NCT03555149|580530343|FG000|Overall Study|Death|18|||
160764977|NCT03555149|580530344|FG001|Overall Study|Death|15|||
160764978|NCT03555149|580530345|FG002|Overall Study|Death|15|||
160764979|NCT03555149|580530346|FG003|Overall Study|Death|4|||
160764980|NCT03555149|580530347|FG004|Overall Study|Death|4|||
160764981|NCT03555149|580530348|FG005|Overall Study|Death|11|||
160764982|NCT03555149|580530349|FG006|Overall Study|Death|12|||
160764983|NCT03555149|580530350|FG007|Overall Study|Death|1|||
160764984|NCT03555149|580530343|FG000|Overall Study|Lost to Follow-up|1|||
160764985|NCT03555149|580530344|FG001|Overall Study|Lost to Follow-up|0|||
160764986|NCT03555149|580530345|FG002|Overall Study|Lost to Follow-up|0|||
160869371|NCT03614156|580913742|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
160527935|NCT01524133|579664856|FG001|Treatment Phase|Lost to Follow-up|1|||
160527936|NCT01524133|579664857|FG002|Treatment Phase|Lost to Follow-up|2|||
160527937|NCT01524133|579664855|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
160764987|NCT03555149|580530346|FG003|Overall Study|Lost to Follow-up|0|||
160764988|NCT03555149|580530347|FG004|Overall Study|Lost to Follow-up|0|||
160764989|NCT03555149|580530348|FG005|Overall Study|Lost to Follow-up|1|||
160764990|NCT03555149|580530349|FG006|Overall Study|Lost to Follow-up|0|||
160764991|NCT03555149|580530350|FG007|Overall Study|Lost to Follow-up|0|||
160527938|NCT01524133|579664856|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
160527939|NCT01524133|579664857|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
160527940|NCT01524133|579664855|FG000|Overall Study 52 Weeks|Physician Decision|1|||
160527941|NCT01524133|579664856|FG001|Overall Study 52 Weeks|Physician Decision|0|||
160527942|NCT01524133|579664857|FG002|Overall Study 52 Weeks|Physician Decision|2|||
160527943|NCT01524133|579664855|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
160527944|NCT01524133|579664856|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
160527945|NCT01524133|579664857|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
160527946|NCT02366728|579664858|FG000|Overall Study|Death|0|||
160527947|NCT02366728|579664859|FG001|Overall Study|Death|0|||
160527948|NCT02366728|579664860|FG002|Overall Study|Death|1|||
160527949|NCT02366728|579664858|FG000|Overall Study|Adverse Event|1|||
160527950|NCT02366728|579664859|FG001|Overall Study|Adverse Event|0|||
160527951|NCT02366728|579664860|FG002|Overall Study|Adverse Event|0|||
160527952|NCT02366728|579664858|FG000|Overall Study|Screen Failure|2|||
160527953|NCT02366728|579664859|FG001|Overall Study|Screen Failure|1|||
160527954|NCT02366728|579664860|FG002|Overall Study|Screen Failure|0|||
160527955|NCT02366728|579664858|FG000|Overall Study|Only yielded 2 vaccines|1|||
160527956|NCT02366728|579664859|FG001|Overall Study|Only yielded 2 vaccines|0|||
160527957|NCT02366728|579664860|FG002|Overall Study|Only yielded 2 vaccines|0|||
160527958|NCT00059839|579664862|FG000|Overall Study|Death|1|||
160527959|NCT00059839|579664863|FG001|Overall Study|Death|1|||
160527960|NCT00059839|579664862|FG000|Overall Study|Lack of Efficacy|6|||
160527961|NCT00059839|579664863|FG001|Overall Study|Lack of Efficacy|5|||
160527962|NCT00059839|579664862|FG000|Overall Study|Lost to Follow-up|2|||
160527963|NCT00059839|579664863|FG001|Overall Study|Lost to Follow-up|0|||
160527964|NCT00059839|579664862|FG000|Overall Study|Physician Decision|1|||
160527965|NCT00059839|579664863|FG001|Overall Study|Physician Decision|2|||
160527966|NCT00059839|579664862|FG000|Overall Study|Withdrawal by Subject|1|||
160527967|NCT00059839|579664863|FG001|Overall Study|Withdrawal by Subject|6|||
160527968|NCT00059839|579664862|FG000|Overall Study|Ineligible|1|||
160527969|NCT00059839|579664863|FG001|Overall Study|Ineligible|3|||
160527970|NCT00733304|579664864|FG000|Overall Study|Adverse Event|3|||
160527971|NCT00733304|579664865|FG001|Overall Study|Adverse Event|0|||
160527972|NCT00733304|579664866|FG002|Overall Study|Adverse Event|0|||
160527973|NCT00733304|579664864|FG000|Overall Study|Lack of Efficacy|0|||
160527974|NCT00733304|579664865|FG001|Overall Study|Lack of Efficacy|0|||
160527975|NCT00733304|579664866|FG002|Overall Study|Lack of Efficacy|2|||
160527976|NCT00733304|579664864|FG000|Overall Study|Lost to Follow-up|0|||
160527977|NCT00733304|579664865|FG001|Overall Study|Lost to Follow-up|1|||
160527978|NCT00733304|579664866|FG002|Overall Study|Lost to Follow-up|0|||
160527979|NCT00733304|579664864|FG000|Overall Study|Physician Decision|3|||
160527980|NCT00733304|579664865|FG001|Overall Study|Physician Decision|1|||
160527981|NCT00733304|579664866|FG002|Overall Study|Physician Decision|3|||
160527982|NCT00733304|579664864|FG000|Overall Study|Withdrawal by Subject|1|||
160527983|NCT00733304|579664865|FG001|Overall Study|Withdrawal by Subject|1|||
160527984|NCT00733304|579664866|FG002|Overall Study|Withdrawal by Subject|0|||
160527985|NCT01330914|579664867|FG000|Overall Study|Withdrawal by Subject|4|||
160527986|NCT01330914|579664867|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
160527987|NCT05352048|579664872|FG000|Overall Study|Lost to Follow-up|1|||
160527988|NCT05352048|579664872|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
160527989|NCT00528567|579664873|FG000|Overall Study|Death|4|||
160527990|NCT00528567|579664874|FG001|Overall Study|Death|5|||
160527991|NCT00528567|579664873|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
160527992|NCT00528567|579664874|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
160527993|NCT00528567|579664873|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
160527994|NCT00528567|579664874|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
160527995|NCT00528567|579664873|FG000|Overall Study|Violation Criteria at Entry|3|||
160764992|NCT03555149|580530343|FG000|Overall Study|Physician Decision|1|||
160764993|NCT03555149|580530344|FG001|Overall Study|Physician Decision|0|||
160764994|NCT03555149|580530345|FG002|Overall Study|Physician Decision|0|||
160764995|NCT03555149|580530346|FG003|Overall Study|Physician Decision|0|||
160527996|NCT00528567|579664874|FG001|Overall Study|Violation Criteria at Entry|17|||
160527997|NCT00528567|579664873|FG000|Overall Study|Withdrew Consent|59|||
160527998|NCT00528567|579664874|FG001|Overall Study|Withdrew Consent|55|||
160527999|NCT00528567|579664873|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
160528000|NCT00528567|579664874|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
160528001|NCT00528567|579664873|FG000|Overall Study|Failure to Return|1|||
160528002|NCT00528567|579664874|FG001|Overall Study|Failure to Return|4|||
160528003|NCT00528567|579664873|FG000|Overall Study|Other Protocol Violation|5|||
160528004|NCT00528567|579664874|FG001|Overall Study|Other Protocol Violation|21|||
160528005|NCT00528567|579664873|FG000|Overall Study|Administrative/Other|22|||
160528006|NCT00528567|579664874|FG001|Overall Study|Administrative/Other|75|||
160528007|NCT03085758|579664877|FG000|Overall Study|Death|26|||
160528008|NCT03085758|579664878|FG001|Overall Study|Death|24|||
160528009|NCT03085758|579664879|FG002|Overall Study|Death|53|||
160528010|NCT03085758|579664877|FG000|Overall Study|Lost to Follow-up|1|||
160528011|NCT03085758|579664878|FG001|Overall Study|Lost to Follow-up|1|||
160528012|NCT03085758|579664879|FG002|Overall Study|Lost to Follow-up|1|||
160528013|NCT03085758|579664877|FG000|Overall Study|Withdrawal by Subject|2|||
160528014|NCT03085758|579664878|FG001|Overall Study|Withdrawal by Subject|2|||
160528015|NCT03085758|579664879|FG002|Overall Study|Withdrawal by Subject|1|||
160528016|NCT03085758|579664877|FG000|Overall Study|Refusal to recall it up to day 90|0|||
160528017|NCT03085758|579664878|FG001|Overall Study|Refusal to recall it up to day 90|0|||
160528018|NCT03085758|579664879|FG002|Overall Study|Refusal to recall it up to day 90|1|||
160528019|NCT03085758|579664877|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
160528020|NCT03085758|579664878|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
160528021|NCT03085758|579664879|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
160528022|NCT01122576|579664880|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
160528023|NCT01122576|579664881|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
160528024|NCT01122576|579664882|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
160528025|NCT01122576|579664880|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
160528026|NCT01122576|579664881|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
160528027|NCT01122576|579664882|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
160528028|NCT01122576|579664880|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
160528029|NCT01122576|579664881|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
160528030|NCT01122576|579664882|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
160528031|NCT05696236|579664883|FG000|Overall Study|Lost to Follow-up|1|||
160528032|NCT05696236|579664884|FG001|Overall Study|Lost to Follow-up|0|||
160528033|NCT05696236|579664883|FG000|Overall Study|Later determined to not be eligible for participation|0|||
160636444|NCT01682512|580051543|FG001|Overall Study|Other than stated above|4|||
160764996|NCT03555149|580530347|FG004|Overall Study|Physician Decision|0|||
160764997|NCT03555149|580530348|FG005|Overall Study|Physician Decision|0|||
160764998|NCT03555149|580530349|FG006|Overall Study|Physician Decision|0|||
160764999|NCT03555149|580530350|FG007|Overall Study|Physician Decision|0|||
160765000|NCT03555149|580530343|FG000|Overall Study|Study Terminated By Sponsor|1|||
160765001|NCT03555149|580530344|FG001|Overall Study|Study Terminated By Sponsor|0|||
160765002|NCT03555149|580530345|FG002|Overall Study|Study Terminated By Sponsor|0|||
160765003|NCT03555149|580530346|FG003|Overall Study|Study Terminated By Sponsor|0|||
160765004|NCT03555149|580530347|FG004|Overall Study|Study Terminated By Sponsor|0|||
160765005|NCT03555149|580530348|FG005|Overall Study|Study Terminated By Sponsor|2|||
160765006|NCT03555149|580530349|FG006|Overall Study|Study Terminated By Sponsor|3|||
160765007|NCT03555149|580530350|FG007|Overall Study|Study Terminated By Sponsor|1|||
160765008|NCT03555149|580530343|FG000|Overall Study|Withdrawal by Subject|3|||
160765009|NCT03555149|580530344|FG001|Overall Study|Withdrawal by Subject|0|||
160765010|NCT03555149|580530345|FG002|Overall Study|Withdrawal by Subject|0|||
160765011|NCT03555149|580530346|FG003|Overall Study|Withdrawal by Subject|2|||
160765012|NCT03555149|580530347|FG004|Overall Study|Withdrawal by Subject|0|||
160765013|NCT03555149|580530348|FG005|Overall Study|Withdrawal by Subject|1|||
160765014|NCT03555149|580530349|FG006|Overall Study|Withdrawal by Subject|0|||
160765015|NCT03555149|580530350|FG007|Overall Study|Withdrawal by Subject|0|||
160765016|NCT01299584|580530374|FG000|Overall Study|Protocol Violation|9|||
160765017|NCT00572832|580530375|FG000|Overall Study|Lost to Follow-up|0|||
160528034|NCT05696236|579664884|FG001|Overall Study|Later determined to not be eligible for participation|1|||
160765018|NCT00572832|580530376|FG001|Overall Study|Lost to Follow-up|11|||
160765019|NCT00572832|580530375|FG000|Overall Study|Pregnancy|0|||
160765020|NCT00572832|580530376|FG001|Overall Study|Pregnancy|1|||
160765021|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
160765022|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
160917923|NCT02673489|581094148|FG000|Treatment Period|Adverse Event|0|||
160528035|NCT05696236|579664883|FG000|Overall Study|Withdrawal by Subject|2|||
160528036|NCT05696236|579664884|FG001|Overall Study|Withdrawal by Subject|2|||
160528037|NCT01829360|579664887|FG000|Overall Study|Protocol Violation|0|||
160528038|NCT01829360|579664888|FG001|Overall Study|Protocol Violation|0|||
160528039|NCT01829360|579664889|FG002|Overall Study|Protocol Violation|1|||
160528040|NCT01829360|579664890|FG003|Overall Study|Protocol Violation|0|||
160528041|NCT03974334|579664894|FG000|Overall Study|Lost to Follow-up|1|||
160528042|NCT00024167|579664895|FG000|Overall Study|Death|53|||
160528043|NCT00024167|579664896|FG001|Overall Study|Death|47|||
160528044|NCT01109173|579664897|FG000|Overall Study|Adverse Event|15|||
160528045|NCT01109173|579664898|FG001|Overall Study|Adverse Event|17|||
160528046|NCT01109173|579664899|FG002|Overall Study|Adverse Event|9|||
160528047|NCT01109173|579664900|FG003|Overall Study|Adverse Event|6|||
160528048|NCT01109173|579664897|FG000|Overall Study|Lost to Follow-up|0|||
160528049|NCT01109173|579664898|FG001|Overall Study|Lost to Follow-up|1|||
160528050|NCT01109173|579664899|FG002|Overall Study|Lost to Follow-up|0|||
160528051|NCT01109173|579664900|FG003|Overall Study|Lost to Follow-up|0|||
160528052|NCT01109173|579664897|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
160528053|NCT01109173|579664898|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
160528054|NCT01109173|579664899|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
160528055|NCT01109173|579664900|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
160528056|NCT01109173|579664897|FG000|Overall Study|Noncompliance|0|||
160528057|NCT01109173|579664898|FG001|Overall Study|Noncompliance|1|||
160528058|NCT01109173|579664899|FG002|Overall Study|Noncompliance|0|||
160528059|NCT01109173|579664900|FG003|Overall Study|Noncompliance|0|||
160528060|NCT01109173|579664897|FG000|Overall Study|Treatment Failure|25|||
160528061|NCT01109173|579664898|FG001|Overall Study|Treatment Failure|32|||
160528062|NCT01109173|579664899|FG002|Overall Study|Treatment Failure|69|||
160528063|NCT01109173|579664900|FG003|Overall Study|Treatment Failure|64|||
160528064|NCT01109173|579664897|FG000|Overall Study|Protocol Violation|4|||
160528065|NCT01109173|579664898|FG001|Overall Study|Protocol Violation|5|||
160528066|NCT01109173|579664899|FG002|Overall Study|Protocol Violation|1|||
160528067|NCT01109173|579664900|FG003|Overall Study|Protocol Violation|2|||
160528068|NCT01109173|579664897|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
160528069|NCT01109173|579664898|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
160528070|NCT01109173|579664899|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
160528071|NCT01109173|579664900|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
160528072|NCT01109173|579664897|FG000|Overall Study|Not Specifiied|5|||
160528073|NCT01109173|579664898|FG001|Overall Study|Not Specifiied|4|||
160528074|NCT01109173|579664899|FG002|Overall Study|Not Specifiied|9|||
160528075|NCT01109173|579664900|FG003|Overall Study|Not Specifiied|14|||
160528076|NCT01019317|579664901|FG000|Overall Study|Not Eligible|4|||
160528077|NCT02545322|579664902|FG000|Overall Study|Withdrawal by Subject|3|||
160528078|NCT00041067|579664903|FG000|Overall Study|Adverse Event|20|||
160528079|NCT00041067|579664903|FG000|Overall Study|Progression|19|||
160528080|NCT00041067|579664903|FG000|Overall Study|Patient refusal|12|||
160528081|NCT00041067|579664903|FG000|Overall Study|Other reasons|23|||
160528082|NCT00041067|579664903|FG000|Overall Study|Ineligible|2|||
160528083|NCT00778622|579664904|FG000|Overall Study|Adverse Event|5|||
160528084|NCT00778622|579664905|FG001|Overall Study|Adverse Event|4|||
160528085|NCT00778622|579664906|FG002|Overall Study|Adverse Event|7|||
160528086|NCT00778622|579664904|FG000|Overall Study|Withdrawal by Subject|4|||
160528087|NCT00778622|579664905|FG001|Overall Study|Withdrawal by Subject|5|||
160528088|NCT00778622|579664906|FG002|Overall Study|Withdrawal by Subject|5|||
160528089|NCT00778622|579664904|FG000|Overall Study|Lost to Follow-up|3|||
160528090|NCT00778622|579664905|FG001|Overall Study|Lost to Follow-up|3|||
160528091|NCT00778622|579664906|FG002|Overall Study|Lost to Follow-up|2|||
160528092|NCT00778622|579664904|FG000|Overall Study|Protocol Violation|0|||
160765023|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
160765024|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
160765025|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
160765026|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
160765027|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
160765028|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
160765029|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
160528093|NCT00778622|579664905|FG001|Overall Study|Protocol Violation|3|||
160528094|NCT00778622|579664906|FG002|Overall Study|Protocol Violation|0|||
160528095|NCT00778622|579664904|FG000|Overall Study|Lack of Efficacy|2|||
160528096|NCT00778622|579664905|FG001|Overall Study|Lack of Efficacy|0|||
160528097|NCT00778622|579664906|FG002|Overall Study|Lack of Efficacy|0|||
160528098|NCT00778622|579664904|FG000|Overall Study|immigration|1|||
160528099|NCT00778622|579664905|FG001|Overall Study|immigration|0|||
160917924|NCT02673489|581094149|FG001|Treatment Period|Adverse Event|1|||
160528100|NCT00778622|579664906|FG002|Overall Study|immigration|0|||
160528101|NCT00778622|579664904|FG000|Overall Study|Other|1|||
160528102|NCT00778622|579664905|FG001|Overall Study|Other|0|||
160528103|NCT00778622|579664906|FG002|Overall Study|Other|1|||
160528104|NCT01251120|579664909|FG000|Overall Study|Lack of Efficacy|0|||
160528105|NCT01251120|579664910|FG001|Overall Study|Lack of Efficacy|1|||
160528106|NCT01968070|579664911|FG000|Period 1|Withdrawal by Subject|0|||
160528107|NCT01968070|579664912|FG001|Period 1|Withdrawal by Subject|1|||
160528108|NCT01968070|579664913|FG002|Period 1|Withdrawal by Subject|0|||
160528109|NCT01968070|579664914|FG003|Period 1|Withdrawal by Subject|0|||
160528110|NCT01968070|579664915|FG004|Period 1|Withdrawal by Subject|0|||
160528111|NCT01968070|579664916|FG005|Period 1|Withdrawal by Subject|0|||
160528112|NCT01968070|579664917|FG006|Period 1|Withdrawal by Subject|1|||
160528113|NCT01968070|579664918|FG007|Period 1|Withdrawal by Subject|0|||
160528114|NCT01968070|579664919|FG008|Period 1|Withdrawal by Subject|0|||
160528115|NCT01968070|579664920|FG009|Period 1|Withdrawal by Subject|0|||
160528116|NCT01968070|579664921|FG010|Period 1|Withdrawal by Subject|0|||
160528117|NCT01968070|579664922|FG011|Period 1|Withdrawal by Subject|0|||
160528118|NCT01968070|579664923|FG012|Period 1|Withdrawal by Subject|0|||
160528119|NCT01968070|579664924|FG013|Period 1|Withdrawal by Subject|0|||
160528120|NCT01968070|579664925|FG014|Period 1|Withdrawal by Subject|0|||
160528121|NCT01968070|579664926|FG015|Period 1|Withdrawal by Subject|1|||
160528122|NCT01968070|579664927|FG016|Period 1|Withdrawal by Subject|0|||
160528123|NCT01968070|579664928|FG017|Period 1|Withdrawal by Subject|0|||
160528124|NCT01968070|579664911|FG000|Period 1|Protocol Violation|0|||
160528125|NCT01968070|579664912|FG001|Period 1|Protocol Violation|0|||
160528126|NCT01968070|579664913|FG002|Period 1|Protocol Violation|0|||
160528127|NCT01968070|579664914|FG003|Period 1|Protocol Violation|1|||
160528128|NCT01968070|579664915|FG004|Period 1|Protocol Violation|1|||
160528129|NCT01968070|579664916|FG005|Period 1|Protocol Violation|0|||
160528130|NCT01968070|579664917|FG006|Period 1|Protocol Violation|0|||
160528131|NCT01968070|579664918|FG007|Period 1|Protocol Violation|0|||
160528132|NCT01968070|579664919|FG008|Period 1|Protocol Violation|0|||
160528133|NCT01968070|579664920|FG009|Period 1|Protocol Violation|0|||
160528134|NCT01968070|579664921|FG010|Period 1|Protocol Violation|0|||
160528135|NCT01968070|579664922|FG011|Period 1|Protocol Violation|0|||
160528136|NCT01968070|579664923|FG012|Period 1|Protocol Violation|0|||
160528137|NCT01968070|579664924|FG013|Period 1|Protocol Violation|0|||
160528138|NCT01968070|579664925|FG014|Period 1|Protocol Violation|0|||
160528139|NCT01968070|579664926|FG015|Period 1|Protocol Violation|0|||
160528140|NCT01968070|579664927|FG016|Period 1|Protocol Violation|0|||
160528141|NCT01968070|579664928|FG017|Period 1|Protocol Violation|0|||
160528142|NCT01968070|579664911|FG000|Period 1|Lost to Follow-up|0|||
160528143|NCT01968070|579664912|FG001|Period 1|Lost to Follow-up|0|||
160528144|NCT01968070|579664913|FG002|Period 1|Lost to Follow-up|0|||
160528145|NCT01968070|579664914|FG003|Period 1|Lost to Follow-up|1|||
160528146|NCT01968070|579664915|FG004|Period 1|Lost to Follow-up|0|||
160528147|NCT01968070|579664916|FG005|Period 1|Lost to Follow-up|0|||
160528148|NCT01968070|579664917|FG006|Period 1|Lost to Follow-up|0|||
160528149|NCT01968070|579664918|FG007|Period 1|Lost to Follow-up|0|||
160528150|NCT01968070|579664919|FG008|Period 1|Lost to Follow-up|0|||
160528151|NCT01968070|579664920|FG009|Period 1|Lost to Follow-up|0|||
160528152|NCT01968070|579664921|FG010|Period 1|Lost to Follow-up|0|||
160528153|NCT01968070|579664922|FG011|Period 1|Lost to Follow-up|0|||
160528154|NCT01968070|579664923|FG012|Period 1|Lost to Follow-up|0|||
160528155|NCT01968070|579664924|FG013|Period 1|Lost to Follow-up|0|||
160528156|NCT01968070|579664925|FG014|Period 1|Lost to Follow-up|0|||
160528157|NCT01968070|579664926|FG015|Period 1|Lost to Follow-up|0|||
160528158|NCT01968070|579664927|FG016|Period 1|Lost to Follow-up|0|||
160528159|NCT01968070|579664928|FG017|Period 1|Lost to Follow-up|0|||
160528160|NCT01968070|579664911|FG000|Period 1|Adverse Event|0|||
160528161|NCT01968070|579664912|FG001|Period 1|Adverse Event|0|||
160528162|NCT01968070|579664913|FG002|Period 1|Adverse Event|0|||
160528163|NCT01968070|579664914|FG003|Period 1|Adverse Event|0|||
160528164|NCT01968070|579664915|FG004|Period 1|Adverse Event|0|||
160528165|NCT01968070|579664916|FG005|Period 1|Adverse Event|0|||
160528166|NCT01968070|579664917|FG006|Period 1|Adverse Event|1|||
160528167|NCT01968070|579664918|FG007|Period 1|Adverse Event|0|||
160765030|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
160765031|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
160765032|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
160528168|NCT01968070|579664919|FG008|Period 1|Adverse Event|0|||
160528169|NCT01968070|579664920|FG009|Period 1|Adverse Event|0|||
160528170|NCT01968070|579664921|FG010|Period 1|Adverse Event|0|||
160528171|NCT01968070|579664922|FG011|Period 1|Adverse Event|0|||
160528172|NCT01968070|579664923|FG012|Period 1|Adverse Event|0|||
160528173|NCT01968070|579664924|FG013|Period 1|Adverse Event|0|||
160528174|NCT01968070|579664925|FG014|Period 1|Adverse Event|0|||
160528175|NCT01968070|579664926|FG015|Period 1|Adverse Event|0|||
160528176|NCT01968070|579664927|FG016|Period 1|Adverse Event|0|||
160528177|NCT01968070|579664928|FG017|Period 1|Adverse Event|0|||
160528178|NCT01968070|579664911|FG000|Period 1|Physician Decision|0|||
160528179|NCT01968070|579664912|FG001|Period 1|Physician Decision|0|||
160528180|NCT01968070|579664913|FG002|Period 1|Physician Decision|0|||
160528181|NCT01968070|579664914|FG003|Period 1|Physician Decision|0|||
160528182|NCT01968070|579664915|FG004|Period 1|Physician Decision|0|||
160528183|NCT01968070|579664916|FG005|Period 1|Physician Decision|0|||
160528184|NCT01968070|579664917|FG006|Period 1|Physician Decision|0|||
160869372|NCT03614156|580913743|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
160869373|NCT03614156|580913740|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
160869374|NCT03614156|580913741|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
160869375|NCT03614156|580913742|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
160869376|NCT03614156|580913743|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
160869377|NCT03614156|580913740|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
160869378|NCT03614156|580913741|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
160869379|NCT03614156|580913742|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
160869380|NCT03614156|580913743|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
160528185|NCT01968070|579664918|FG007|Period 1|Physician Decision|0|||
160528186|NCT01968070|579664919|FG008|Period 1|Physician Decision|0|||
160528187|NCT01968070|579664920|FG009|Period 1|Physician Decision|0|||
160528188|NCT01968070|579664921|FG010|Period 1|Physician Decision|0|||
160528189|NCT01968070|579664922|FG011|Period 1|Physician Decision|1|||
160528190|NCT01968070|579664923|FG012|Period 1|Physician Decision|0|||
160528191|NCT01968070|579664924|FG013|Period 1|Physician Decision|0|||
160528192|NCT01968070|579664925|FG014|Period 1|Physician Decision|0|||
160528193|NCT01968070|579664926|FG015|Period 1|Physician Decision|0|||
160528194|NCT01968070|579664927|FG016|Period 1|Physician Decision|0|||
160528195|NCT01968070|579664928|FG017|Period 1|Physician Decision|0|||
160528196|NCT01968070|579664911|FG000|Period 2|Withdrawal by Subject|0|||
160528197|NCT01968070|579664912|FG001|Period 2|Withdrawal by Subject|0|||
160528198|NCT01968070|579664913|FG002|Period 2|Withdrawal by Subject|0|||
160869381|NCT03614156|580913740|FG000|Open-Label Treatment Period|Protocol Violation|2|||
160528199|NCT01968070|579664914|FG003|Period 2|Withdrawal by Subject|0|||
160528200|NCT01968070|579664915|FG004|Period 2|Withdrawal by Subject|1|||
160869382|NCT03614156|580913741|FG001|Open-Label Treatment Period|Protocol Violation|0|||
160528201|NCT01968070|579664916|FG005|Period 2|Withdrawal by Subject|0|||
160528202|NCT01968070|579664917|FG006|Period 2|Withdrawal by Subject|0|||
160528203|NCT01968070|579664918|FG007|Period 2|Withdrawal by Subject|0|||
160528204|NCT01968070|579664919|FG008|Period 2|Withdrawal by Subject|0|||
160528205|NCT01968070|579664920|FG009|Period 2|Withdrawal by Subject|0|||
160528206|NCT01968070|579664921|FG010|Period 2|Withdrawal by Subject|0|||
160528207|NCT01968070|579664922|FG011|Period 2|Withdrawal by Subject|0|||
160528208|NCT01968070|579664923|FG012|Period 2|Withdrawal by Subject|0|||
160528209|NCT01968070|579664924|FG013|Period 2|Withdrawal by Subject|0|||
160528210|NCT01968070|579664925|FG014|Period 2|Withdrawal by Subject|0|||
160528211|NCT01968070|579664926|FG015|Period 2|Withdrawal by Subject|0|||
160528212|NCT01968070|579664927|FG016|Period 2|Withdrawal by Subject|0|||
160528213|NCT01968070|579664928|FG017|Period 2|Withdrawal by Subject|0|||
160528214|NCT01822522|579664931|FG000|Overall Study|Adverse Event|1|||
160528215|NCT01822522|579664932|FG001|Overall Study|Adverse Event|1|||
160528216|NCT01822522|579664933|FG002|Overall Study|Adverse Event|1|||
160528217|NCT01822522|579664934|FG003|Overall Study|Adverse Event|0|||
160528218|NCT01822522|579664935|FG004|Overall Study|Adverse Event|0|||
160528219|NCT01822522|579664936|FG005|Overall Study|Adverse Event|1|||
160528220|NCT01822522|579664931|FG000|Overall Study|Death|3|||
160528221|NCT01822522|579664932|FG001|Overall Study|Death|0|||
160528222|NCT01822522|579664933|FG002|Overall Study|Death|2|||
160528223|NCT01822522|579664934|FG003|Overall Study|Death|0|||
160528224|NCT01822522|579664935|FG004|Overall Study|Death|0|||
160528225|NCT01822522|579664936|FG005|Overall Study|Death|0|||
160528226|NCT01822522|579664931|FG000|Overall Study|Lost to Follow-up|0|||
160528227|NCT01822522|579664932|FG001|Overall Study|Lost to Follow-up|0|||
160528228|NCT01822522|579664933|FG002|Overall Study|Lost to Follow-up|1|||
160528229|NCT01822522|579664934|FG003|Overall Study|Lost to Follow-up|1|||
160528230|NCT01822522|579664935|FG004|Overall Study|Lost to Follow-up|0|||
160528231|NCT01822522|579664936|FG005|Overall Study|Lost to Follow-up|1|||
160528232|NCT01822522|579664931|FG000|Overall Study|Withdrawal by Subject|0|||
160528233|NCT01822522|579664932|FG001|Overall Study|Withdrawal by Subject|0|||
160528234|NCT01822522|579664933|FG002|Overall Study|Withdrawal by Subject|0|||
160528235|NCT01822522|579664934|FG003|Overall Study|Withdrawal by Subject|1|||
160528236|NCT01822522|579664935|FG004|Overall Study|Withdrawal by Subject|0|||
160528237|NCT01822522|579664936|FG005|Overall Study|Withdrawal by Subject|0|||
160528238|NCT01822522|579664931|FG000|Overall Study|Lack of Efficacy|0|||
160528239|NCT01822522|579664932|FG001|Overall Study|Lack of Efficacy|0|||
160528240|NCT01822522|579664933|FG002|Overall Study|Lack of Efficacy|0|||
160528241|NCT01822522|579664934|FG003|Overall Study|Lack of Efficacy|0|||
160528242|NCT01822522|579664935|FG004|Overall Study|Lack of Efficacy|0|||
160528243|NCT01822522|579664936|FG005|Overall Study|Lack of Efficacy|2|||
160528244|NCT01807923|579664937|FG000|Overall Study|Adverse Event|2|||
160528245|NCT01807923|579664938|FG001|Overall Study|Adverse Event|1|||
160528246|NCT01807923|579664939|FG002|Overall Study|Adverse Event|2|||
160528247|NCT01807923|579664937|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
160528248|NCT01807923|579664938|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
160528249|NCT01807923|579664939|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
160528250|NCT01807923|579664937|FG000|Overall Study|Physician Decision|0|||
160528251|NCT01807923|579664938|FG001|Overall Study|Physician Decision|0|||
160528252|NCT01807923|579664939|FG002|Overall Study|Physician Decision|1|||
160528253|NCT01807923|579664937|FG000|Overall Study|Not Eligible (Genotype)|0|||
160528254|NCT01807923|579664938|FG001|Overall Study|Not Eligible (Genotype)|0|||
160528255|NCT01807923|579664939|FG002|Overall Study|Not Eligible (Genotype)|1|||
160528256|NCT01807923|579664937|FG000|Overall Study|Randomized But Not Treated|3|||
160528257|NCT01807923|579664938|FG001|Overall Study|Randomized But Not Treated|2|||
160528258|NCT01807923|579664939|FG002|Overall Study|Randomized But Not Treated|5|||
160528259|NCT00108069|579664940|FG000|Overall Study|Never rec'd study drug|0|||
160528260|NCT00108069|579664941|FG001|Overall Study|Never rec'd study drug|1|||
160765033|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
160765034|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
160765035|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
160765036|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
160765037|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
160528261|NCT00108069|579664940|FG000|Overall Study|Adverse Event|1|||
160528262|NCT00108069|579664941|FG001|Overall Study|Adverse Event|1|||
160528263|NCT00108069|579664940|FG000|Overall Study|Withdrawal by Subject|1|||
160528264|NCT00108069|579664941|FG001|Overall Study|Withdrawal by Subject|0|||
160528265|NCT00108069|579664940|FG000|Overall Study|Death|1|||
160528266|NCT00108069|579664941|FG001|Overall Study|Death|0|||
160528267|NCT00108069|579664940|FG000|Overall Study|Progessive disease|27|||
160528268|NCT00108069|579664941|FG001|Overall Study|Progessive disease|11|||
160765038|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
160528269|NCT01237340|579664947|FG000|Overall Study|Adverse Event|3|||
160528270|NCT01237340|579664947|FG000|Overall Study|Withdrawal by Subject|1|||
160528271|NCT01237340|579664947|FG000|Overall Study|Early termination of the trial|36|||
160528272|NCT03836807|579664948|FG000|Overall Study|Physician Decision|1|||
160528273|NCT03836807|579664949|FG001|Overall Study|Physician Decision|0|||
160528274|NCT00685685|579664950|FG000|Washout Period of 7 Days|Adverse Event|2|||
160528275|NCT00685685|579664951|FG001|Washout Period of 7 Days|Adverse Event|0|||
160528276|NCT00685685|579664950|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
160528277|NCT00685685|579664951|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
160528278|NCT04029116|579664952|FG000|Overall Study|Adverse Event|0|||
160528279|NCT04029116|579664953|FG001|Overall Study|Adverse Event|2|||
160528280|NCT04029116|579664952|FG000|Overall Study|Lost to Follow-up|3|||
160528281|NCT04029116|579664953|FG001|Overall Study|Lost to Follow-up|5|||
160528282|NCT04029116|579664952|FG000|Overall Study|Physician Decision|2|||
160528283|NCT04029116|579664953|FG001|Overall Study|Physician Decision|0|||
160528284|NCT04029116|579664952|FG000|Overall Study|Pregnancy|1|||
160528285|NCT04029116|579664953|FG001|Overall Study|Pregnancy|2|||
160528286|NCT04029116|579664952|FG000|Overall Study|Withdrawal by Subject|4|||
160528287|NCT04029116|579664953|FG001|Overall Study|Withdrawal by Subject|6|||
160528288|NCT04029116|579664952|FG000|Overall Study|Other|2|||
160528289|NCT04029116|579664953|FG001|Overall Study|Other|1|||
160528290|NCT02019420|579664956|FG000|Overall Study|Did not receive study drug|2|||
160528291|NCT02019420|579664957|FG001|Overall Study|Did not receive study drug|2|||
160528292|NCT02019420|579664956|FG000|Overall Study|Withdrawal by Subject|1|||
160528293|NCT02019420|579664957|FG001|Overall Study|Withdrawal by Subject|3|||
160528294|NCT02019420|579664956|FG000|Overall Study|At request of sponsor or investigator|0|||
160528295|NCT02019420|579664957|FG001|Overall Study|At request of sponsor or investigator|1|||
160528296|NCT02019420|579664956|FG000|Overall Study|Death|104|||
160528297|NCT02019420|579664957|FG001|Overall Study|Death|99|||
160528298|NCT02019420|579664956|FG000|Overall Study|Transferred to other care facility|1|||
160528299|NCT02019420|579664957|FG001|Overall Study|Transferred to other care facility|1|||
160528300|NCT02469896|579664958|FG000|Overall Study|Withdrawal by Subject|2|||
160528301|NCT02469896|579664959|FG001|Overall Study|Withdrawal by Subject|0|||
160528302|NCT02510560|579664960|FG000|Overall Study|Discontinued from Treatment|27|||
160528303|NCT02510560|579664961|FG001|Overall Study|Discontinued from Treatment|18|||
160528304|NCT02510560|579664962|FG002|Overall Study|Discontinued from Treatment|19|||
160528305|NCT02510560|579664960|FG000|Overall Study|Other|4|||
160528306|NCT02510560|579664961|FG001|Overall Study|Other|4|||
160528307|NCT02510560|579664962|FG002|Overall Study|Other|3|||
160528308|NCT02401412|579664963|FG000|Overall Study|Lost to Follow-up|1|||
160528309|NCT02401412|579664964|FG001|Overall Study|Lost to Follow-up|0|||
160528310|NCT02401412|579664963|FG000|Overall Study|Discontinued Intervention|15|||
160528311|NCT02401412|579664964|FG001|Overall Study|Discontinued Intervention|21|||
160528312|NCT02401412|579664963|FG000|Overall Study|Withdrawal by Subject|4|||
160528313|NCT02401412|579664964|FG001|Overall Study|Withdrawal by Subject|4|||
160528314|NCT02401412|579664963|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
160528315|NCT02401412|579664964|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
160528316|NCT02401412|579664963|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
160528317|NCT02401412|579664964|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
160528318|NCT02014740|579664971|FG000|Overall Study|Lost to Follow-up|4|||
160528319|NCT02014740|579664972|FG001|Overall Study|Lost to Follow-up|4|||
160528320|NCT02014740|579664971|FG000|Overall Study|Withdrawal by Subject|2|||
160528321|NCT02014740|579664972|FG001|Overall Study|Withdrawal by Subject|1|||
160528322|NCT03739437|579664975|FG000|Overall Study|Lost to Follow-up|2|||
160528323|NCT03739437|579664976|FG001|Overall Study|Lost to Follow-up|5|||
160528324|NCT01130974|579664977|FG000|Overall Study|Protocol Violation|10|||
160528325|NCT01130974|579664978|FG001|Overall Study|Protocol Violation|10|||
160528326|NCT01130974|579664977|FG000|Overall Study|Withdrawal by Subject|0|||
160528327|NCT01130974|579664978|FG001|Overall Study|Withdrawal by Subject|1|||
160528328|NCT01130974|579664977|FG000|Overall Study|Ineligibility criteria|5|||
160765039|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
160528329|NCT01130974|579664978|FG001|Overall Study|Ineligibility criteria|2|||
160528330|NCT05118204|579664983|FG000|Overall Study|Lost to Follow-up|3|||
160528331|NCT05118204|579664984|FG001|Overall Study|Lost to Follow-up|2|||
160528332|NCT05118204|579664983|FG000|Overall Study|Withdrawal by Subject|0|||
160528333|NCT05118204|579664984|FG001|Overall Study|Withdrawal by Subject|2|||
160528334|NCT05393037|579664986|FG000|Part A|Death|1|||
160528335|NCT05393037|579664987|FG001|Part A|Death|0|||
160528336|NCT05393037|579664986|FG000|Part A|Lost to Follow-up|1|||
160528337|NCT05393037|579664987|FG001|Part A|Lost to Follow-up|1|||
160528338|NCT05393037|579664986|FG000|Part A|Withdrawal by Subject|2|||
160528339|NCT05393037|579664987|FG001|Part A|Withdrawal by Subject|4|||
160528340|NCT05393037|579664986|FG000|Part B|Lost to Follow-up|1|||
160528341|NCT05393037|579664987|FG001|Part B|Lost to Follow-up|0|||
160528342|NCT04409353|579664988|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
160528343|NCT04409353|579664989|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
160528344|NCT04409353|579664990|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
160528345|NCT04409353|579664988|FG000|Overall Study|Lost to Follow-up|6|||
160528346|NCT04409353|579664989|FG001|Overall Study|Lost to Follow-up|8|||
160528347|NCT04409353|579664990|FG002|Overall Study|Lost to Follow-up|7|||
160528348|NCT04409353|579664988|FG000|Overall Study|Major surgery during participation window|4|||
160528349|NCT04409353|579664989|FG001|Overall Study|Major surgery during participation window|3|||
160528350|NCT04409353|579664990|FG002|Overall Study|Major surgery during participation window|3|||
160528351|NCT04409353|579664988|FG000|Overall Study|Life event occurred during participation window|3|||
160528352|NCT04409353|579664989|FG001|Overall Study|Life event occurred during participation window|2|||
160528353|NCT04409353|579664990|FG002|Overall Study|Life event occurred during participation window|4|||
160528354|NCT04409353|579664988|FG000|Overall Study|Lack of Efficacy|4|||
160528355|NCT04409353|579664989|FG001|Overall Study|Lack of Efficacy|1|||
160528356|NCT04409353|579664990|FG002|Overall Study|Lack of Efficacy|3|||
160528357|NCT04409353|579664988|FG000|Overall Study|Adverse Event|2|||
160528358|NCT04409353|579664989|FG001|Overall Study|Adverse Event|1|||
160528359|NCT04409353|579664990|FG002|Overall Study|Adverse Event|1|||
160528360|NCT04409353|579664988|FG000|Overall Study|Disease burden - unable to participate|0|||
160528361|NCT04409353|579664989|FG001|Overall Study|Disease burden - unable to participate|1|||
160528362|NCT04409353|579664990|FG002|Overall Study|Disease burden - unable to participate|1|||
160528363|NCT04409353|579664988|FG000|Overall Study|Intervention too complicated|1|||
160528364|NCT04409353|579664989|FG001|Overall Study|Intervention too complicated|0|||
160528365|NCT04409353|579664990|FG002|Overall Study|Intervention too complicated|1|||
160528366|NCT01012739|579664991|FG000|Treatment Period 1|Adverse Event|0|||
160528367|NCT01012739|579664992|FG001|Treatment Period 1|Adverse Event|0|||
160528368|NCT01012739|579664993|FG002|Treatment Period 1|Adverse Event|0|||
160528369|NCT01012739|579664994|FG003|Treatment Period 1|Adverse Event|1|||
160528370|NCT01012739|579664991|FG000|Treatment Period 2|Abnormal test procedure results|0|||
160528371|NCT01012739|579664992|FG001|Treatment Period 2|Abnormal test procedure results|0|||
160528372|NCT01012739|579664993|FG002|Treatment Period 2|Abnormal test procedure results|0|||
160528373|NCT01012739|579664994|FG003|Treatment Period 2|Abnormal test procedure results|1|||
160528374|NCT04540133|579664995|FG000|Overall Study|Lost to Follow-up|1|||
160528375|NCT04540133|579664996|FG001|Overall Study|Lost to Follow-up|0|||
160528376|NCT04014361|579664997|FG000|Period 2|Physician Decision|0|||
160528377|NCT04014361|579664998|FG001|Period 2|Physician Decision|0|||
160528378|NCT04014361|579664999|FG002|Period 2|Physician Decision|0|||
160528379|NCT04014361|579665000|FG003|Period 2|Physician Decision|1|||
160528380|NCT04014361|579665001|FG004|Period 2|Physician Decision|0|||
160528381|NCT04014361|579665002|FG005|Period 2|Physician Decision|0|||
160528382|NCT04014361|579665003|FG006|Period 2|Physician Decision|0|||
160528383|NCT04014361|579665004|FG007|Period 2|Physician Decision|0|||
160528384|NCT06308666|579665005|FG000|Overall Study|Withdrawal by Subject|1|||
160528385|NCT06308666|579665005|FG000|Overall Study|Protocol Violation|2|||
160528386|NCT04252287|579665007|FG000|Overall Study|Death|5|||
160528387|NCT04252287|579665008|FG001|Overall Study|Death|3|||
160528388|NCT04252287|579665007|FG000|Overall Study|Lost to Follow-up|4|||
160528389|NCT04252287|579665008|FG001|Overall Study|Lost to Follow-up|6|||
160528390|NCT04252287|579665007|FG000|Overall Study|Withdrawal by Subject|19|||
160528391|NCT04252287|579665008|FG001|Overall Study|Withdrawal by Subject|16|||
160528392|NCT04252287|579665007|FG000|Overall Study|Protocol Violation|3|||
160528393|NCT04252287|579665008|FG001|Overall Study|Protocol Violation|4|||
160528394|NCT04600336|579665011|FG000|Initial Treatment|Withdrawal by Subject|1|||
160528395|NCT04600336|579665012|FG001|Initial Treatment|Withdrawal by Subject|2|||
160528396|NCT04600336|579665013|FG002|Initial Treatment|Withdrawal by Subject|0|||
160528397|NCT04600336|579665014|FG003|Initial Treatment|Withdrawal by Subject|0|||
160528398|NCT04600336|579665011|FG000|Initial Treatment|Adverse Event|0|||
160528399|NCT04600336|579665012|FG001|Initial Treatment|Adverse Event|2|||
160528400|NCT04600336|579665013|FG002|Initial Treatment|Adverse Event|0|||
160528401|NCT04600336|579665014|FG003|Initial Treatment|Adverse Event|0|||
160528402|NCT04600336|579665011|FG000|Initial Treatment|Other complicating disease|0|||
160528403|NCT04600336|579665012|FG001|Initial Treatment|Other complicating disease|0|||
160528404|NCT04600336|579665013|FG002|Initial Treatment|Other complicating disease|1|||
160528405|NCT04600336|579665014|FG003|Initial Treatment|Other complicating disease|0|||
160765040|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
160765041|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
160528406|NCT04600336|579665011|FG000|Crossover Treatment|Withdrawal by Subject|0|||
160528407|NCT04600336|579665012|FG001|Crossover Treatment|Withdrawal by Subject|0|||
160528408|NCT04600336|579665013|FG002|Crossover Treatment|Withdrawal by Subject|2|||
160869383|NCT03614156|580913742|FG002|Open-Label Treatment Period|Protocol Violation|0|||
160528409|NCT04600336|579665014|FG003|Crossover Treatment|Withdrawal by Subject|1|||
160528410|NCT04600336|579665011|FG000|Crossover Treatment|Adverse Event|0|||
160528411|NCT04600336|579665012|FG001|Crossover Treatment|Adverse Event|0|||
160528412|NCT04600336|579665013|FG002|Crossover Treatment|Adverse Event|1|||
160528413|NCT04600336|579665014|FG003|Crossover Treatment|Adverse Event|1|||
160528414|NCT05028517|579665015|FG000|Overall Study|Lost to Follow-up|13|||
160528415|NCT05028517|579665016|FG001|Overall Study|Lost to Follow-up|20|||
160528416|NCT05028517|579665017|FG002|Overall Study|Lost to Follow-up|12|||
160528417|NCT05028517|579665015|FG000|Overall Study|Withdrawal by Subject|0|||
160528418|NCT05028517|579665016|FG001|Overall Study|Withdrawal by Subject|0|||
160528419|NCT05028517|579665017|FG002|Overall Study|Withdrawal by Subject|1|||
160528420|NCT02973425|579666325|FG000|Overall Study|Lost to Follow-up|49|||
160528421|NCT02973425|579666326|FG001|Overall Study|Lost to Follow-up|53|||
160528422|NCT01205438|579666327|FG000|Overall Study|Adverse Event|19|||
160528423|NCT01205438|579666328|FG001|Overall Study|Adverse Event|17|||
160528424|NCT01205438|579666329|FG002|Overall Study|Adverse Event|24|||
160528425|NCT01205438|579666327|FG000|Overall Study|Death|1|||
160528426|NCT01205438|579666328|FG001|Overall Study|Death|1|||
160528427|NCT01205438|579666329|FG002|Overall Study|Death|3|||
160528428|NCT01205438|579666327|FG000|Overall Study|Entry Criteria Not Met|16|||
160528429|NCT01205438|579666328|FG001|Overall Study|Entry Criteria Not Met|15|||
160528430|NCT01205438|579666329|FG002|Overall Study|Entry Criteria Not Met|13|||
160528431|NCT01205438|579666327|FG000|Overall Study|Lack of Efficacy|14|||
160528432|NCT01205438|579666328|FG001|Overall Study|Lack of Efficacy|11|||
160528433|NCT01205438|579666329|FG002|Overall Study|Lack of Efficacy|14|||
160528434|NCT01205438|579666327|FG000|Overall Study|Lost to Follow-up|6|||
160528435|NCT01205438|579666328|FG001|Overall Study|Lost to Follow-up|7|||
160528436|NCT01205438|579666329|FG002|Overall Study|Lost to Follow-up|8|||
160528437|NCT01205438|579666327|FG000|Overall Study|Withdrawal by Subject|19|||
160528438|NCT01205438|579666328|FG001|Overall Study|Withdrawal by Subject|25|||
160528439|NCT01205438|579666329|FG002|Overall Study|Withdrawal by Subject|19|||
160528440|NCT01205438|579666327|FG000|Overall Study|Physician Decision|0|||
160528441|NCT01205438|579666328|FG001|Overall Study|Physician Decision|3|||
160528442|NCT01205438|579666329|FG002|Overall Study|Physician Decision|2|||
160528443|NCT01205438|579666327|FG000|Overall Study|Protocol Violation|2|||
160528444|NCT01205438|579666328|FG001|Overall Study|Protocol Violation|7|||
160528445|NCT01205438|579666329|FG002|Overall Study|Protocol Violation|4|||
160528446|NCT01205438|579666327|FG000|Overall Study|Sponsor Decision|0|||
160528447|NCT01205438|579666328|FG001|Overall Study|Sponsor Decision|1|||
160528448|NCT01205438|579666329|FG002|Overall Study|Sponsor Decision|1|||
160528449|NCT03823404|579666330|FG000|Overall Study|Lost to Follow-up|1|||
160528450|NCT03823404|579666331|FG001|Overall Study|Lost to Follow-up|2|||
160528451|NCT03823404|579666332|FG002|Overall Study|Lost to Follow-up|3|||
160528452|NCT03823404|579666330|FG000|Overall Study|Protocol Violation|2|||
160528453|NCT03823404|579666331|FG001|Overall Study|Protocol Violation|0|||
160528454|NCT03823404|579666332|FG002|Overall Study|Protocol Violation|2|||
160528455|NCT03823404|579666330|FG000|Overall Study|Adverse Event|35|||
160528456|NCT03823404|579666331|FG001|Overall Study|Adverse Event|38|||
160528457|NCT03823404|579666332|FG002|Overall Study|Adverse Event|8|||
160528458|NCT03823404|579666330|FG000|Overall Study|Withdrawal by Subject|38|||
160528459|NCT03823404|579666331|FG001|Overall Study|Withdrawal by Subject|40|||
160528460|NCT03823404|579666332|FG002|Overall Study|Withdrawal by Subject|35|||
160528461|NCT03823404|579666330|FG000|Overall Study|Death|4|||
160528462|NCT03823404|579666331|FG001|Overall Study|Death|0|||
160528463|NCT03823404|579666332|FG002|Overall Study|Death|0|||
160528464|NCT03823404|579666330|FG000|Overall Study|Other: Various reasons provided|5|||
160528465|NCT03823404|579666331|FG001|Overall Study|Other: Various reasons provided|5|||
160528466|NCT03823404|579666332|FG002|Overall Study|Other: Various reasons provided|6|||
160528467|NCT03842163|579666334|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
160528468|NCT03842163|579666334|FG000|Overall Study|Scintigraphy was not performed|44|||
160528469|NCT03829241|579666338|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
160528470|NCT03829241|579666339|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
160528471|NCT03829241|579666338|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
160528472|NCT03829241|579666339|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
160528473|NCT03829241|579666338|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
160528474|NCT03829241|579666339|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
160528475|NCT03829241|579666338|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
160528476|NCT03829241|579666339|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
160528477|NCT03829241|579666338|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
160528478|NCT03829241|579666339|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
160528479|NCT03829241|579666338|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
160528480|NCT03829241|579666339|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
160528481|NCT03829241|579666338|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
160528482|NCT03829241|579666339|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
160528483|NCT03829241|579666338|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
160528484|NCT03829241|579666339|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
160528485|NCT03829241|579666338|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
160528486|NCT03829241|579666339|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
160528487|NCT03829241|579666338|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
160528488|NCT03829241|579666339|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
160528489|NCT03829241|579666338|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
160765042|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
160765043|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
160765044|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
160765045|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
160765046|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
160765047|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
160765048|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
160765049|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
160765050|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
160765051|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
160765052|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
160765053|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
160765054|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
160765055|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
160765056|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
160765057|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
160765058|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
160765059|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
160765060|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
160765061|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
160765062|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
160765063|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
160765064|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
160528490|NCT03829241|579666339|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
160528491|NCT03829241|579666338|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
160528492|NCT03829241|579666339|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
160528493|NCT03829241|579666338|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
160528494|NCT03829241|579666339|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
160528495|NCT03829241|579666338|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
160528496|NCT03829241|579666339|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
160528497|NCT00698451|579666340|FG000|Overall Study|Adverse Event|22|||
160528498|NCT00698451|579666340|FG000|Overall Study|Physician Decision|2|||
160528499|NCT00698451|579666340|FG000|Overall Study|Protocol Violation|6|||
160528500|NCT00698451|579666340|FG000|Overall Study|Withdrawal by Subject|6|||
160528501|NCT00698451|579666340|FG000|Overall Study|Disease progression|3|||
160528502|NCT02224599|579666344|FG000|Overall Study|Physician Decision|1|||
160528503|NCT02224599|579666344|FG000|Overall Study|Progression of Disease|1|||
160528504|NCT01187550|579666345|FG000|Overall Study|Protocol Violation|3|||
160528505|NCT01187550|579666346|FG001|Overall Study|Protocol Violation|1|||
160528506|NCT01187550|579666345|FG000|Overall Study|Other|3|||
160528507|NCT01187550|579666346|FG001|Overall Study|Other|0|||
160528508|NCT01187550|579666345|FG000|Overall Study|Randomized but not treated|8|||
160528509|NCT01187550|579666346|FG001|Overall Study|Randomized but not treated|0|||
160528510|NCT00129623|579666347|FG000|Overall Study|Adverse Event|3|||
160528511|NCT00129623|579666348|FG001|Overall Study|Adverse Event|7|||
160528512|NCT00129623|579666347|FG000|Overall Study|Refused Treatment|5|||
160528513|NCT00129623|579666348|FG001|Overall Study|Refused Treatment|3|||
160528514|NCT00129623|579666347|FG000|Overall Study|Failure to Return|1|||
160528515|NCT00129623|579666348|FG001|Overall Study|Failure to Return|1|||
160528516|NCT00129623|579666347|FG000|Overall Study|Relocated job out of state|1|||
160528517|NCT00129623|579666348|FG001|Overall Study|Relocated job out of state|0|||
160528518|NCT00129623|579666347|FG000|Overall Study|Uncertainty to return|0|||
160528519|NCT00129623|579666348|FG001|Overall Study|Uncertainty to return|1|||
160528520|NCT00596934|579666349|FG000|Overall Study|Protocol Violation|1|||
160528521|NCT00596934|579666349|FG000|Overall Study|Withdrawal by Subject|1|||
160528522|NCT02315898|579666352|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
160528523|NCT02315898|579666353|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
160528524|NCT02315898|579666354|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
160528525|NCT02315898|579666355|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
160528526|NCT02445755|579666356|FG000|Overall Study|Withdrawal by Subject|2|||
160528527|NCT02445755|579666356|FG000|Overall Study|Protocol Violation|6|||
160528528|NCT02445755|579666356|FG000|Overall Study|Screen Failure|5|||
160528529|NCT00056862|579666368|FG000|Overall Study|Protocol Violation|1|||
160528530|NCT00056862|579666369|FG001|Overall Study|Protocol Violation|0|||
160528531|NCT01132612|579666371|FG000|Overall Study|Death|0|||
160528532|NCT01132612|579666372|FG001|Overall Study|Death|0|||
160528533|NCT01132612|579666373|FG002|Overall Study|Death|1|||
160528534|NCT01132612|579666371|FG000|Overall Study|Protocol deviation|0|||
160528535|NCT01132612|579666372|FG001|Overall Study|Protocol deviation|0|||
160528536|NCT01132612|579666373|FG002|Overall Study|Protocol deviation|3|||
160528537|NCT01132612|579666371|FG000|Overall Study|Lost to Follow-up|2|||
160528538|NCT01132612|579666372|FG001|Overall Study|Lost to Follow-up|2|||
160528539|NCT01132612|579666373|FG002|Overall Study|Lost to Follow-up|7|||
160528540|NCT01132612|579666371|FG000|Overall Study|Adverse Event|5|||
160528541|NCT01132612|579666372|FG001|Overall Study|Adverse Event|2|||
160528542|NCT01132612|579666373|FG002|Overall Study|Adverse Event|15|||
160528543|NCT01132612|579666371|FG000|Overall Study|Withdrawal by Subject|5|||
160528544|NCT01132612|579666372|FG001|Overall Study|Withdrawal by Subject|8|||
160528545|NCT01132612|579666373|FG002|Overall Study|Withdrawal by Subject|19|||
160528546|NCT01132612|579666371|FG000|Overall Study|Administrative problems|5|||
160528547|NCT01132612|579666372|FG001|Overall Study|Administrative problems|1|||
160528548|NCT01132612|579666373|FG002|Overall Study|Administrative problems|52|||
160528549|NCT01132612|579666371|FG000|Overall Study|Lack of Efficacy|23|||
160528550|NCT01132612|579666372|FG001|Overall Study|Lack of Efficacy|22|||
160528551|NCT01132612|579666373|FG002|Overall Study|Lack of Efficacy|73|||
160528552|NCT02252536|579666377|FG000|Overall Study|Lost to Follow-up|5|||
160528553|NCT02252536|579666378|FG001|Overall Study|Lost to Follow-up|3|||
160528554|NCT01438151|579666380|FG000|Overall Study|study terminated|8|||
160528555|NCT01186796|579666389|FG000|Overall Study|Adverse Event|3|||
160528556|NCT01186796|579666390|FG001|Overall Study|Adverse Event|0|||
160528557|NCT01186796|579666389|FG000|Overall Study|Withdrawal by Subject|1|||
160528558|NCT01186796|579666390|FG001|Overall Study|Withdrawal by Subject|1|||
160528559|NCT01186796|579666389|FG000|Overall Study|Protocol Violation|0|||
160528560|NCT01186796|579666390|FG001|Overall Study|Protocol Violation|1|||
160869384|NCT03614156|580913743|FG003|Open-Label Treatment Period|Protocol Violation|0|||
160528561|NCT03838198|579666391|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
160528562|NCT03838198|579666392|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
160528563|NCT03838198|579666393|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
160528564|NCT03838198|579666394|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
160528565|NCT03838198|579666391|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
160528566|NCT03838198|579666392|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
160528567|NCT03838198|579666393|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
160528568|NCT03838198|579666394|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
160528569|NCT02378220|579666399|FG000|Overall Study|Death|6|||
160528570|NCT02378220|579666400|FG001|Overall Study|Death|1|||
160528571|NCT00578786|579666401|FG000|Overall Study|Adverse Event|27|||
160528572|NCT00578786|579666402|FG001|Overall Study|Adverse Event|37|||
160528573|NCT00578786|579666403|FG002|Overall Study|Adverse Event|17|||
160528574|NCT00578786|579666401|FG000|Overall Study|Lack of Efficacy|2|||
160528575|NCT00578786|579666402|FG001|Overall Study|Lack of Efficacy|5|||
160528576|NCT00578786|579666403|FG002|Overall Study|Lack of Efficacy|2|||
160528577|NCT00578786|579666401|FG000|Overall Study|Early Escape from Prior Study|2|||
160528578|NCT00578786|579666402|FG001|Overall Study|Early Escape from Prior Study|1|||
160528579|NCT00578786|579666403|FG002|Overall Study|Early Escape from Prior Study|2|||
160528580|NCT00578786|579666401|FG000|Overall Study|Withdrawal by Subject|7|||
160528581|NCT00578786|579666402|FG001|Overall Study|Withdrawal by Subject|8|||
160528582|NCT00578786|579666403|FG002|Overall Study|Withdrawal by Subject|5|||
160528583|NCT00578786|579666401|FG000|Overall Study|Protocol Violation|0|||
160528584|NCT00578786|579666402|FG001|Overall Study|Protocol Violation|3|||
160528585|NCT00578786|579666403|FG002|Overall Study|Protocol Violation|1|||
160528586|NCT00578786|579666401|FG000|Overall Study|Physician Decision|1|||
160528587|NCT00578786|579666402|FG001|Overall Study|Physician Decision|0|||
160528588|NCT00578786|579666403|FG002|Overall Study|Physician Decision|1|||
160528589|NCT00578786|579666401|FG000|Overall Study|Sponsor Decision|0|||
160528590|NCT00578786|579666402|FG001|Overall Study|Sponsor Decision|0|||
160528591|NCT00578786|579666403|FG002|Overall Study|Sponsor Decision|1|||
160528592|NCT00578786|579666401|FG000|Overall Study|Lost to Follow-up|0|||
160528593|NCT00578786|579666402|FG001|Overall Study|Lost to Follow-up|4|||
160528594|NCT00578786|579666403|FG002|Overall Study|Lost to Follow-up|0|||
160528595|NCT00578786|579666401|FG000|Overall Study|Pregnancy|0|||
160528596|NCT00578786|579666402|FG001|Overall Study|Pregnancy|1|||
160528597|NCT00578786|579666403|FG002|Overall Study|Pregnancy|0|||
160528598|NCT00578786|579666401|FG000|Overall Study|Not Otherwise Specified|0|||
160528599|NCT00578786|579666402|FG001|Overall Study|Not Otherwise Specified|4|||
160528600|NCT00578786|579666403|FG002|Overall Study|Not Otherwise Specified|1|||
160528601|NCT00578786|579666401|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
160528602|NCT00578786|579666402|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
160528603|NCT00578786|579666403|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
160528604|NCT00312221|579666404|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
160528605|NCT00312221|579666405|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
160528606|NCT00312221|579666406|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
160528607|NCT00312221|579666407|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
160528608|NCT00312221|579666404|FG000|Open-label Run-in Period|Adverse Event|74|||
160528609|NCT00312221|579666405|FG001|Open-label Run-in Period|Adverse Event|0|||
160528610|NCT00312221|579666406|FG002|Open-label Run-in Period|Adverse Event|0|||
160528611|NCT00312221|579666407|FG003|Open-label Run-in Period|Adverse Event|0|||
160528612|NCT00312221|579666404|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
160528613|NCT00312221|579666405|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
160528614|NCT00312221|579666406|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
160528615|NCT00312221|579666407|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
160528616|NCT00312221|579666404|FG000|Open-label Run-in Period|Administrative|42|||
160528617|NCT00312221|579666405|FG001|Open-label Run-in Period|Administrative|0|||
160528618|NCT00312221|579666406|FG002|Open-label Run-in Period|Administrative|0|||
160528619|NCT00312221|579666407|FG003|Open-label Run-in Period|Administrative|0|||
160528620|NCT00312221|579666404|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
160528621|NCT00312221|579666405|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
160528622|NCT00312221|579666406|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
160528623|NCT00312221|579666407|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
160528624|NCT00312221|579666404|FG000|Open-label Run-in Period|Did not qualify|5|||
160528625|NCT00312221|579666405|FG001|Open-label Run-in Period|Did not qualify|0|||
160528626|NCT00312221|579666406|FG002|Open-label Run-in Period|Did not qualify|0|||
160528627|NCT00312221|579666407|FG003|Open-label Run-in Period|Did not qualify|0|||
160528628|NCT00312221|579666404|FG000|Double-blind Phase|Withdrawal by Subject|0|||
160528629|NCT00312221|579666405|FG001|Double-blind Phase|Withdrawal by Subject|6|||
160528630|NCT00312221|579666406|FG002|Double-blind Phase|Withdrawal by Subject|8|||
160528631|NCT00312221|579666407|FG003|Double-blind Phase|Withdrawal by Subject|7|||
160528632|NCT00312221|579666404|FG000|Double-blind Phase|Adverse Event|0|||
160528633|NCT00312221|579666405|FG001|Double-blind Phase|Adverse Event|10|||
160528634|NCT00312221|579666406|FG002|Double-blind Phase|Adverse Event|19|||
160528635|NCT00312221|579666407|FG003|Double-blind Phase|Adverse Event|18|||
160528636|NCT00312221|579666404|FG000|Double-blind Phase|Lost to Follow-up|0|||
160528637|NCT00312221|579666405|FG001|Double-blind Phase|Lost to Follow-up|0|||
160528638|NCT00312221|579666406|FG002|Double-blind Phase|Lost to Follow-up|2|||
160528639|NCT00312221|579666407|FG003|Double-blind Phase|Lost to Follow-up|2|||
160528640|NCT00312221|579666404|FG000|Double-blind Phase|Administrative|0|||
160528641|NCT00312221|579666405|FG001|Double-blind Phase|Administrative|26|||
160528642|NCT00312221|579666406|FG002|Double-blind Phase|Administrative|37|||
160528643|NCT00312221|579666407|FG003|Double-blind Phase|Administrative|33|||
160528644|NCT00312221|579666404|FG000|Double-blind Phase|Lack of Efficacy|0|||
160528645|NCT00312221|579666405|FG001|Double-blind Phase|Lack of Efficacy|17|||
160528646|NCT00312221|579666406|FG002|Double-blind Phase|Lack of Efficacy|6|||
160528647|NCT00312221|579666407|FG003|Double-blind Phase|Lack of Efficacy|10|||
160528648|NCT02060721|579666408|FG000|Overall Study|Lost to Follow-up|1|||
160528649|NCT02060721|579666408|FG000|Overall Study|Physician Decision|2|||
160528650|NCT02060721|579666408|FG000|Overall Study|Death|14|||
160528651|NCT02060721|579666408|FG000|Overall Study|Withdrawal by Subject|2|||
160528652|NCT02060721|579666408|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
160528653|NCT05105789|579666409|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
160528654|NCT00728481|579666413|FG000|Overall Study|Withdrawal by Subject|0|||
160528655|NCT00728481|579666414|FG001|Overall Study|Withdrawal by Subject|1|||
160528656|NCT00728481|579666413|FG000|Overall Study|Adverse Event|0|||
160528657|NCT00728481|579666414|FG001|Overall Study|Adverse Event|1|||
160528658|NCT00728481|579666413|FG000|Overall Study|Study medication non-compliance|0|||
160528659|NCT00728481|579666414|FG001|Overall Study|Study medication non-compliance|2|||
160528660|NCT00728481|579666413|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
160528661|NCT00728481|579666414|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
160528662|NCT03690141|579666415|FG000|Overall Study|Adverse Event|5|||
160528663|NCT03690141|579666415|FG000|Overall Study|Withdrawal by Subject|3|||
160528664|NCT03690141|579666415|FG000|Overall Study|Physician Decision|4|||
160528665|NCT03690141|579666415|FG000|Overall Study|Disease progression|4|||
160528666|NCT04744285|579666416|FG000|Overall Study|Withdrawal by Subject|1|||
160528667|NCT04744285|579666417|FG001|Overall Study|Withdrawal by Subject|1|||
160528668|NCT04744285|579666418|FG002|Overall Study|Withdrawal by Subject|2|||
160528669|NCT04744285|579666419|FG003|Overall Study|Withdrawal by Subject|1|||
160528670|NCT01610687|579666424|FG000|Overall Study|Lack of Efficacy|26|||
160528671|NCT01610687|579666424|FG000|Overall Study|Adverse Event|18|||
160765065|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
160765066|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
160765067|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
160528672|NCT01610687|579666424|FG000|Overall Study|Moved out of area|6|||
160765068|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
160528673|NCT01610687|579666424|FG000|Overall Study|Withdrawal by Subject|7|||
160528674|NCT01610687|579666424|FG000|Overall Study|Lost to Follow-up|4|||
160528675|NCT01610687|579666424|FG000|Overall Study|Symptom control without study medication|2|||
160528676|NCT01610687|579666424|FG000|Overall Study|Unable to make journey|1|||
160528677|NCT01610687|579666424|FG000|Overall Study|Death|1|||
160528678|NCT01610687|579666424|FG000|Overall Study|Cannabis affecting job|1|||
160528679|NCT01610687|579666424|FG000|Overall Study|Felt more alter without study medication|1|||
160528680|NCT01272947|579666425|FG000|Overall Study|Abnormal Laboratory Value|2|||
160528681|NCT01272947|579666426|FG001|Overall Study|Abnormal Laboratory Value|2|||
160528682|NCT03675776|579666427|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
160528683|NCT03675776|579666428|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
160528684|NCT03675776|579666429|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
160528685|NCT03675776|579666427|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
160528686|NCT03675776|579666428|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
160528687|NCT03675776|579666429|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
160528688|NCT06132425|579666430|FG000|Overall Study|Withdrawal by Subject|3|||
160528689|NCT06132425|579666431|FG001|Overall Study|Withdrawal by Subject|0|||
160528690|NCT06132425|579666430|FG000|Overall Study|Did not follow study instructions|0|||
160528691|NCT06132425|579666431|FG001|Overall Study|Did not follow study instructions|2|||
160528692|NCT06132425|579666430|FG000|Overall Study|Lost to Follow-up|3|||
160528693|NCT06132425|579666431|FG001|Overall Study|Lost to Follow-up|5|||
160528694|NCT00671554|579666437|FG000|Overall Study|Disease progression|3|||
160528695|NCT00708175|579666445|FG000|Overall Study|Adverse Event|4|||
160528696|NCT00708175|579666446|FG001|Overall Study|Adverse Event|5|||
160528697|NCT00708175|579666445|FG000|Overall Study|Protocol Violation|2|||
160528698|NCT00708175|579666446|FG001|Overall Study|Protocol Violation|3|||
160528699|NCT00708175|579666445|FG000|Overall Study|Lost to Follow-up|5|||
160528700|NCT00708175|579666446|FG001|Overall Study|Lost to Follow-up|3|||
160869385|NCT03614156|580913740|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
160528701|NCT00708175|579666445|FG000|Overall Study|Withdrawal by Subject|5|||
160528702|NCT00708175|579666446|FG001|Overall Study|Withdrawal by Subject|7|||
160528703|NCT00708175|579666445|FG000|Overall Study|BMD loss >7%|2|||
160528704|NCT00708175|579666446|FG001|Overall Study|BMD loss >7%|3|||
160528705|NCT04435782|579666448|FG000|Overall Study|Study terminated by sponsor|4|||
160528706|NCT03672461|579666449|FG000|Overall Study|COVID Related|4|||
160528707|NCT03672461|579666450|FG001|Overall Study|COVID Related|2|||
160528708|NCT03672461|579666449|FG000|Overall Study|Adverse Event|2|||
160528709|NCT03672461|579666450|FG001|Overall Study|Adverse Event|0|||
160528710|NCT03672461|579666449|FG000|Overall Study|Serious Adverse Event|0|||
160528711|NCT03672461|579666450|FG001|Overall Study|Serious Adverse Event|1|||
160528712|NCT03672461|579666449|FG000|Overall Study|Too Busy|3|||
160528713|NCT03672461|579666450|FG001|Overall Study|Too Busy|1|||
160528714|NCT03672461|579666449|FG000|Overall Study|Lost to Follow-up|1|||
160528715|NCT03672461|579666450|FG001|Overall Study|Lost to Follow-up|2|||
160528716|NCT03672461|579666449|FG000|Overall Study|Family|2|||
160528717|NCT03672461|579666450|FG001|Overall Study|Family|2|||
160528718|NCT03672461|579666449|FG000|Overall Study|No remote technology access|0|||
160528719|NCT03672461|579666450|FG001|Overall Study|No remote technology access|1|||
160528720|NCT03672461|579666449|FG000|Overall Study|Withdrawal by Subject|1|||
160528721|NCT03672461|579666450|FG001|Overall Study|Withdrawal by Subject|0|||
160528722|NCT03672461|579666449|FG000|Overall Study|Cannot tolerate intervention|1|||
160528723|NCT03672461|579666450|FG001|Overall Study|Cannot tolerate intervention|0|||
160528724|NCT03672461|579666449|FG000|Overall Study|Incomplete outcome data|6|||
160528725|NCT03672461|579666450|FG001|Overall Study|Incomplete outcome data|1|||
160528726|NCT00977574|579666451|FG000|Overall Study|Never Treated|4|||
160528727|NCT00977574|579666452|FG001|Overall Study|Never Treated|2|||
160528728|NCT00977574|579666453|FG002|Overall Study|Never Treated|4|||
160528729|NCT04223791|579666454|FG000|Overall Study|Lost to Follow-up|0|||
160528730|NCT04223791|579666455|FG001|Overall Study|Lost to Follow-up|4|||
160528731|NCT04223791|579666454|FG000|Overall Study|Physician Decision|5|||
160528732|NCT04223791|579666455|FG001|Overall Study|Physician Decision|1|||
160765069|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
160765070|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
160765071|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
160765072|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
160765073|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
160765074|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
160765075|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
160765076|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
160528733|NCT04223791|579666454|FG000|Overall Study|Protocol Violation|1|||
160528734|NCT04223791|579666455|FG001|Overall Study|Protocol Violation|1|||
160528735|NCT04223791|579666454|FG000|Overall Study|Withdrawal by Subject|10|||
160528736|NCT04223791|579666455|FG001|Overall Study|Withdrawal by Subject|12|||
160528737|NCT04223791|579666454|FG000|Overall Study|Pregnancy|1|||
160528738|NCT04223791|579666455|FG001|Overall Study|Pregnancy|1|||
160528739|NCT04223791|579666454|FG000|Overall Study|Ongoing in Study|305|||
160528740|NCT04223791|579666455|FG001|Overall Study|Ongoing in Study|302|||
160528741|NCT04667247|579666456|FG000|Overall Study|Withdrawal by Subject|0|||
160528742|NCT04667247|579666457|FG001|Overall Study|Withdrawal by Subject|1|||
160528743|NCT00332839|579667997|FG000|Core (Months 0 - 12)|Administrative problems|1|||
160528744|NCT00332839|579667998|FG001|Core (Months 0 - 12)|Administrative problems|1|||
160528745|NCT00332839|579667997|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
160765077|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
160765078|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
160765079|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
160528746|NCT00332839|579667998|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
160528747|NCT00332839|579667997|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
160528748|NCT00332839|579667998|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
160528749|NCT00332839|579667997|FG000|Core (Months 0 - 12)|Adverse Event|5|||
160528750|NCT00332839|579667998|FG001|Core (Months 0 - 12)|Adverse Event|15|||
160528751|NCT00332839|579667997|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
160528752|NCT00332839|579667998|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
160528753|NCT00332839|579667997|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
160765080|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
160528754|NCT00332839|579667998|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
160528755|NCT00332839|579667997|FG000|Follow-up (Months 12 - 60)|Death|1|||
160528756|NCT00332839|579667998|FG001|Follow-up (Months 12 - 60)|Death|1|||
160528757|NCT00594516|579668002|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
160528758|NCT00594516|579668003|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
160528759|NCT00594516|579668004|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
160528760|NCT00594516|579668002|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
160636445|NCT01682512|580051544|FG002|Overall Study|Other than stated above|2|||
160528761|NCT00594516|579668003|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
160528762|NCT00594516|579668004|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
160528763|NCT00594516|579668002|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
160528764|NCT00594516|579668003|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
160528765|NCT00594516|579668004|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
160528766|NCT00594516|579668002|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
160528767|NCT00594516|579668003|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
160528768|NCT00594516|579668004|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
160528769|NCT00594516|579668002|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
160528770|NCT00594516|579668003|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
160528771|NCT00594516|579668004|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
160528772|NCT00594516|579668002|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
160528773|NCT00594516|579668003|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
160528774|NCT00594516|579668004|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
160528775|NCT00594516|579668002|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
160528776|NCT00594516|579668003|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
160528777|NCT00594516|579668004|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
160528778|NCT00594516|579668002|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
160528779|NCT00594516|579668003|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
160528780|NCT00594516|579668004|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
160528781|NCT00594516|579668002|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
160528782|NCT00594516|579668003|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
160528783|NCT00594516|579668004|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
160528784|NCT01493557|579668005|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
160528785|NCT01493557|579668006|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
160528786|NCT01493557|579668007|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
160528787|NCT01493557|579668005|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
160528788|NCT01493557|579668006|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
160528789|NCT01493557|579668007|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
160528790|NCT01493557|579668005|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
160528791|NCT01493557|579668006|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
160528792|NCT01493557|579668007|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
160528793|NCT01493557|579668005|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
160528794|NCT01493557|579668006|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
160528795|NCT01493557|579668007|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
160528796|NCT01493557|579668005|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
160528797|NCT01493557|579668006|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
160528798|NCT01493557|579668007|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
160528799|NCT01493557|579668005|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
160528800|NCT01493557|579668006|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
160528801|NCT01493557|579668007|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
160528802|NCT01493557|579668005|FG000|Not Randomized to Management Strategies|Early termination|0|||
160528803|NCT01493557|579668006|FG001|Not Randomized to Management Strategies|Early termination|0|||
160528804|NCT01493557|579668007|FG002|Not Randomized to Management Strategies|Early termination|34|||
160528805|NCT01493557|579668005|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
160528806|NCT01493557|579668006|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
160528807|NCT01493557|579668007|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
160765081|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
160765082|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
160765083|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
160765084|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
160765085|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
160765086|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
160765087|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
160765088|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
160765089|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
160765090|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
160765091|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
160765092|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
160765093|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
160765094|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
160765095|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
160765096|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
160765097|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
160528808|NCT01493557|579668005|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
160528809|NCT01493557|579668006|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
160528810|NCT01493557|579668007|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
160528811|NCT01493557|579668005|FG000|Randomized to Management Strategies|Other adverse event|8|||
160528812|NCT01493557|579668006|FG001|Randomized to Management Strategies|Other adverse event|5|||
160528813|NCT01493557|579668007|FG002|Randomized to Management Strategies|Other adverse event|0|||
160528814|NCT01493557|579668005|FG000|Randomized to Management Strategies|Protocol Violation|3|||
160528815|NCT01493557|579668006|FG001|Randomized to Management Strategies|Protocol Violation|0|||
160528816|NCT01493557|579668007|FG002|Randomized to Management Strategies|Protocol Violation|0|||
160528817|NCT01493557|579668005|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
160528818|NCT01493557|579668006|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
160528819|NCT01493557|579668007|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
160528820|NCT01493557|579668005|FG000|Randomized to Management Strategies|Other than stated above|1|||
160528821|NCT01493557|579668006|FG001|Randomized to Management Strategies|Other than stated above|3|||
160528822|NCT01493557|579668007|FG002|Randomized to Management Strategies|Other than stated above|0|||
160528823|NCT01493557|579668005|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
160528824|NCT01493557|579668006|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
160528825|NCT01493557|579668007|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
160528826|NCT01493557|579668005|FG000|Adding the Second Strategy|Other adverse event|1|||
160528827|NCT01493557|579668006|FG001|Adding the Second Strategy|Other adverse event|2|||
160528828|NCT01493557|579668007|FG002|Adding the Second Strategy|Other adverse event|0|||
160528829|NCT01493557|579668005|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
160528830|NCT01493557|579668006|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
160528831|NCT01493557|579668007|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
160528832|NCT01876251|579668010|FG000|Overall Study|Clinical progression|1|||
160528833|NCT01876251|579668011|FG001|Overall Study|Clinical progression|0|||
160528834|NCT01876251|579668012|FG002|Overall Study|Clinical progression|0|||
160528835|NCT01876251|579668010|FG000|Overall Study|Death|2|||
160528836|NCT01876251|579668011|FG001|Overall Study|Death|0|||
160528837|NCT01876251|579668012|FG002|Overall Study|Death|1|||
160528838|NCT01876251|579668010|FG000|Overall Study|Participant started new treatment|1|||
160528839|NCT01876251|579668011|FG001|Overall Study|Participant started new treatment|0|||
160528840|NCT01876251|579668012|FG002|Overall Study|Participant started new treatment|1|||
160528841|NCT01876251|579668010|FG000|Overall Study|Participant refused further follow-up|0|||
160528842|NCT01876251|579668011|FG001|Overall Study|Participant refused further follow-up|0|||
160528843|NCT01876251|579668012|FG002|Overall Study|Participant refused further follow-up|1|||
160528844|NCT01876251|579668010|FG000|Overall Study|Study terminated|1|||
160528845|NCT01876251|579668011|FG001|Overall Study|Study terminated|0|||
160528846|NCT01876251|579668012|FG002|Overall Study|Study terminated|0|||
160528847|NCT01876251|579668010|FG000|Overall Study|Objective progression or relapse|10|||
160528848|NCT01876251|579668011|FG001|Overall Study|Objective progression or relapse|3|||
160528849|NCT01876251|579668012|FG002|Overall Study|Objective progression or relapse|8|||
160528850|NCT01798992|579668023|FG000|Overall Study|Administrative withdrawal|0|||
160528851|NCT01798992|579668024|FG001|Overall Study|Administrative withdrawal|1|||
160528852|NCT01798992|579668025|FG002|Overall Study|Administrative withdrawal|0|||
160528853|NCT01798992|579668026|FG003|Overall Study|Administrative withdrawal|1|||
160528854|NCT01798992|579668023|FG000|Overall Study|Lost to Follow-up|0|||
160528855|NCT01798992|579668024|FG001|Overall Study|Lost to Follow-up|1|||
160528856|NCT01798992|579668025|FG002|Overall Study|Lost to Follow-up|1|||
160528857|NCT01798992|579668026|FG003|Overall Study|Lost to Follow-up|0|||
160528858|NCT01798992|579668023|FG000|Overall Study|Insufficient biopsy tissue|0|||
160528859|NCT01798992|579668024|FG001|Overall Study|Insufficient biopsy tissue|0|||
160528860|NCT01798992|579668025|FG002|Overall Study|Insufficient biopsy tissue|1|||
160528861|NCT01798992|579668026|FG003|Overall Study|Insufficient biopsy tissue|0|||
160528862|NCT02294682|579668027|FG000|Overall Study|Could not swallow pills|1|||
160528863|NCT02294682|579668028|FG001|Overall Study|Could not swallow pills|0|||
160528864|NCT01516970|579668029|FG000|Overall Study|Lost to Follow-up|7|||
160528865|NCT01516970|579668030|FG001|Overall Study|Lost to Follow-up|8|||
160528866|NCT01516970|579668029|FG000|Overall Study|Adverse Event|1|||
160528867|NCT01516970|579668030|FG001|Overall Study|Adverse Event|5|||
160528868|NCT01516970|579668029|FG000|Overall Study|Withdrawal by Subject|1|||
160528869|NCT01516970|579668030|FG001|Overall Study|Withdrawal by Subject|1|||
160528870|NCT01516970|579668029|FG000|Overall Study|Other|9|||
160528871|NCT01516970|579668030|FG001|Overall Study|Other|7|||
160528872|NCT00434421|579668031|FG000|Overall Study|Withdrawal by Subject|1|||
160528873|NCT00434421|579668031|FG000|Overall Study|Non-compliance with study treatment|1|||
160528874|NCT01087957|579668034|FG000|Overall Study|Death|2|||
160528875|NCT01087957|579668035|FG001|Overall Study|Death|2|||
160528876|NCT01087957|579668034|FG000|Overall Study|Lost to Follow-up|3|||
160528877|NCT01087957|579668035|FG001|Overall Study|Lost to Follow-up|4|||
160528878|NCT01087957|579668034|FG000|Overall Study|Protocol Violation|13|||
160528879|NCT01087957|579668035|FG001|Overall Study|Protocol Violation|25|||
160528880|NCT01087957|579668034|FG000|Overall Study|Withdrawal by Subject|18|||
160528881|NCT01087957|579668035|FG001|Overall Study|Withdrawal by Subject|15|||
160528882|NCT01087957|579668034|FG000|Overall Study|Physician Decision|5|||
160528883|NCT01087957|579668035|FG001|Overall Study|Physician Decision|9|||
160528884|NCT01296035|579668037|FG000|Overall Study|Withdrawal by Subject|1|||
160528885|NCT01674712|579668038|FG000|Overall Study|Adverse Event|5|||
160528886|NCT01674712|579668039|FG001|Overall Study|Adverse Event|6|||
160528887|NCT01674712|579668040|FG002|Overall Study|Adverse Event|3|||
160528888|NCT01674712|579668041|FG003|Overall Study|Adverse Event|4|||
160528889|NCT01674712|579668042|FG004|Overall Study|Adverse Event|6|||
160869386|NCT03614156|580913741|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
160869387|NCT03614156|580913742|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
160869388|NCT03614156|580913743|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
160869389|NCT03614156|580913740|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
160869390|NCT03614156|580913741|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
160869391|NCT03614156|580913742|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
160869392|NCT03614156|580913743|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
160869393|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
160869394|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
160869395|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
160869396|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
160869397|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
160528890|NCT01674712|579668038|FG000|Overall Study|Lost to Follow-up|1|||
160528891|NCT01674712|579668039|FG001|Overall Study|Lost to Follow-up|0|||
160528892|NCT01674712|579668040|FG002|Overall Study|Lost to Follow-up|0|||
160528893|NCT01674712|579668041|FG003|Overall Study|Lost to Follow-up|0|||
160528894|NCT01674712|579668042|FG004|Overall Study|Lost to Follow-up|0|||
160528895|NCT01674712|579668038|FG000|Overall Study|Protocol Violation|2|||
160869398|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
160869399|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
160869400|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
160528896|NCT01674712|579668039|FG001|Overall Study|Protocol Violation|0|||
160528897|NCT01674712|579668040|FG002|Overall Study|Protocol Violation|0|||
160869401|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160528898|NCT01674712|579668041|FG003|Overall Study|Protocol Violation|0|||
160636446|NCT03137082|580051545|FG000|Overall Study|Withdrawal by Subject|1|||
160528899|NCT01674712|579668042|FG004|Overall Study|Protocol Violation|0|||
160528900|NCT01674712|579668038|FG000|Overall Study|Withdrawal by Subject|2|||
160528901|NCT01674712|579668039|FG001|Overall Study|Withdrawal by Subject|2|||
160528902|NCT01674712|579668040|FG002|Overall Study|Withdrawal by Subject|5|||
160528903|NCT01674712|579668041|FG003|Overall Study|Withdrawal by Subject|4|||
160528904|NCT01674712|579668042|FG004|Overall Study|Withdrawal by Subject|3|||
160528905|NCT01674712|579668038|FG000|Overall Study|Administrative|0|||
160528906|NCT01674712|579668039|FG001|Overall Study|Administrative|1|||
160528907|NCT01674712|579668040|FG002|Overall Study|Administrative|0|||
160869402|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160528908|NCT01674712|579668041|FG003|Overall Study|Administrative|0|||
160528909|NCT01674712|579668042|FG004|Overall Study|Administrative|1|||
160528910|NCT01674712|579668038|FG000|Overall Study|Lack of Efficacy|0|||
160528911|NCT01674712|579668039|FG001|Overall Study|Lack of Efficacy|0|||
160528912|NCT01674712|579668040|FG002|Overall Study|Lack of Efficacy|1|||
160528913|NCT01674712|579668041|FG003|Overall Study|Lack of Efficacy|0|||
160528914|NCT01674712|579668042|FG004|Overall Study|Lack of Efficacy|1|||
160528915|NCT00006392|579668043|FG000|Overall Study|Ineligible|11|||
160528916|NCT00006392|579668044|FG001|Overall Study|Ineligible|3|||
160528917|NCT00006392|579668045|FG002|Overall Study|Ineligible|5|||
160528918|NCT00006392|579668046|FG003|Overall Study|Ineligible|5|||
160528919|NCT00006392|579668043|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
160528920|NCT00006392|579668044|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
160528921|NCT00006392|579668045|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
160528922|NCT00006392|579668046|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
160528923|NCT02459769|579668048|FG000|Overall Study|Withdrawal by Subject|7|||
160528924|NCT02459769|579668049|FG001|Overall Study|Withdrawal by Subject|4|||
160528925|NCT02459769|579668050|FG002|Overall Study|Withdrawal by Subject|8|||
160528926|NCT02459769|579668051|FG003|Overall Study|Withdrawal by Subject|5|||
160528927|NCT02459769|579668048|FG000|Overall Study|Lost to Follow-up|1|||
160528928|NCT02459769|579668049|FG001|Overall Study|Lost to Follow-up|0|||
160528929|NCT02459769|579668050|FG002|Overall Study|Lost to Follow-up|1|||
160528930|NCT02459769|579668051|FG003|Overall Study|Lost to Follow-up|0|||
160528931|NCT05372653|579668058|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
160528932|NCT05372653|579668059|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
160528933|NCT05372653|579668058|FG000|Overall Study|Adverse Event|0|||
160528934|NCT05372653|579668059|FG001|Overall Study|Adverse Event|1|||
160528935|NCT00117507|579668060|FG000|Overall Study|Adverse Event|4|||
160528936|NCT00117507|579668060|FG000|Overall Study|Abnormal laboratory values|3|||
160528937|NCT00117507|579668060|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160528938|NCT00117507|579668060|FG000|Overall Study|Patient withdrew consent|4|||
160528939|NCT00117507|579668060|FG000|Overall Study|Death|3|||
160528940|NCT00866723|579668061|FG000|Overall Study|Withdrawal by Subject|1|||
160528941|NCT00866723|579668061|FG000|Overall Study|Disease Progression|4|||
160528942|NCT03740997|579668064|FG000|Overall Study|Withdrawal by Subject|1|||
160528943|NCT03740997|579668065|FG001|Overall Study|Withdrawal by Subject|0|||
160528944|NCT03740997|579668064|FG000|Overall Study|Participant was unable to complete study procedures|1|||
160528945|NCT03740997|579668065|FG001|Overall Study|Participant was unable to complete study procedures|0|||
160528946|NCT05211739|579668066|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
160528947|NCT05211739|579668067|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
160528948|NCT05211739|579668066|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
160528949|NCT05211739|579668067|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
160869403|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
160869404|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
160869405|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
160869406|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
160869407|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
160869408|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
160869409|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
160869410|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
160869411|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
160869412|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
160869413|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
160528950|NCT05211739|579668066|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
160528951|NCT05211739|579668067|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
160528952|NCT05211739|579668066|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
160528953|NCT05211739|579668067|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
160528954|NCT04178967|579668068|FG000|Induction Period|Adverse Event|4|||
160528955|NCT04178967|579668069|FG001|Induction Period|Adverse Event|6|||
160528956|NCT04178967|579668070|FG002|Induction Period|Adverse Event|0|||
160528957|NCT04178967|579668071|FG003|Induction Period|Adverse Event|0|||
160528958|NCT04178967|579668072|FG004|Induction Period|Adverse Event|0|||
160869414|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
160528959|NCT04178967|579668073|FG005|Induction Period|Adverse Event|0|||
160528960|NCT04178967|579668074|FG006|Induction Period|Adverse Event|0|||
160528961|NCT04178967|579668075|FG007|Induction Period|Adverse Event|0|||
160528962|NCT04178967|579668076|FG008|Induction Period|Adverse Event|0|||
160528963|NCT04178967|579668077|FG009|Induction Period|Adverse Event|0|||
160528964|NCT04178967|579668078|FG010|Induction Period|Adverse Event|0|||
160528965|NCT04178967|579668068|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
160528966|NCT04178967|579668069|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
160528967|NCT04178967|579668070|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
160528968|NCT04178967|579668071|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
160528969|NCT04178967|579668072|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
160528970|NCT04178967|579668073|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
160528971|NCT04178967|579668074|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
160528972|NCT04178967|579668075|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
160528973|NCT04178967|579668076|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
160528974|NCT04178967|579668077|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
160528975|NCT04178967|579668078|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
160528976|NCT04178967|579668068|FG000|Induction Period|Lack of Efficacy|4|||
160528977|NCT04178967|579668069|FG001|Induction Period|Lack of Efficacy|1|||
160528978|NCT04178967|579668070|FG002|Induction Period|Lack of Efficacy|0|||
160528979|NCT04178967|579668071|FG003|Induction Period|Lack of Efficacy|0|||
160528980|NCT04178967|579668072|FG004|Induction Period|Lack of Efficacy|0|||
160528981|NCT04178967|579668073|FG005|Induction Period|Lack of Efficacy|0|||
160528982|NCT04178967|579668074|FG006|Induction Period|Lack of Efficacy|0|||
160528983|NCT04178967|579668075|FG007|Induction Period|Lack of Efficacy|0|||
160528984|NCT04178967|579668076|FG008|Induction Period|Lack of Efficacy|0|||
160528985|NCT04178967|579668077|FG009|Induction Period|Lack of Efficacy|0|||
160528986|NCT04178967|579668078|FG010|Induction Period|Lack of Efficacy|0|||
160528987|NCT04178967|579668068|FG000|Induction Period|Protocol Violation|0|||
160528988|NCT04178967|579668069|FG001|Induction Period|Protocol Violation|6|||
160528989|NCT04178967|579668070|FG002|Induction Period|Protocol Violation|0|||
160528990|NCT04178967|579668071|FG003|Induction Period|Protocol Violation|0|||
160528991|NCT04178967|579668072|FG004|Induction Period|Protocol Violation|0|||
160528992|NCT04178967|579668073|FG005|Induction Period|Protocol Violation|0|||
160528993|NCT04178967|579668074|FG006|Induction Period|Protocol Violation|0|||
160528994|NCT04178967|579668075|FG007|Induction Period|Protocol Violation|0|||
160528995|NCT04178967|579668076|FG008|Induction Period|Protocol Violation|0|||
160528996|NCT04178967|579668077|FG009|Induction Period|Protocol Violation|0|||
160528997|NCT04178967|579668078|FG010|Induction Period|Protocol Violation|0|||
160528998|NCT04178967|579668068|FG000|Induction Period|Withdrawal by Subject|6|||
160528999|NCT04178967|579668069|FG001|Induction Period|Withdrawal by Subject|4|||
160529000|NCT04178967|579668070|FG002|Induction Period|Withdrawal by Subject|0|||
160529001|NCT04178967|579668071|FG003|Induction Period|Withdrawal by Subject|0|||
160529002|NCT04178967|579668072|FG004|Induction Period|Withdrawal by Subject|0|||
160529003|NCT04178967|579668073|FG005|Induction Period|Withdrawal by Subject|0|||
160529004|NCT04178967|579668074|FG006|Induction Period|Withdrawal by Subject|0|||
160529005|NCT04178967|579668075|FG007|Induction Period|Withdrawal by Subject|0|||
160529006|NCT04178967|579668076|FG008|Induction Period|Withdrawal by Subject|0|||
160529007|NCT04178967|579668077|FG009|Induction Period|Withdrawal by Subject|0|||
160529008|NCT04178967|579668078|FG010|Induction Period|Withdrawal by Subject|0|||
160529009|NCT04178967|579668068|FG000|Induction Period|Lost to Follow-up|2|||
160529010|NCT04178967|579668069|FG001|Induction Period|Lost to Follow-up|0|||
160529011|NCT04178967|579668070|FG002|Induction Period|Lost to Follow-up|0|||
160529012|NCT04178967|579668071|FG003|Induction Period|Lost to Follow-up|0|||
160529013|NCT04178967|579668072|FG004|Induction Period|Lost to Follow-up|0|||
160529014|NCT04178967|579668073|FG005|Induction Period|Lost to Follow-up|0|||
160529015|NCT04178967|579668074|FG006|Induction Period|Lost to Follow-up|0|||
160529016|NCT04178967|579668075|FG007|Induction Period|Lost to Follow-up|0|||
160529017|NCT04178967|579668076|FG008|Induction Period|Lost to Follow-up|0|||
160529018|NCT04178967|579668077|FG009|Induction Period|Lost to Follow-up|0|||
160529019|NCT04178967|579668078|FG010|Induction Period|Lost to Follow-up|0|||
160529020|NCT04178967|579668068|FG000|Induction Period|Participant Missed Study Visits|0|||
160529021|NCT04178967|579668069|FG001|Induction Period|Participant Missed Study Visits|1|||
160529022|NCT04178967|579668070|FG002|Induction Period|Participant Missed Study Visits|0|||
160529023|NCT04178967|579668071|FG003|Induction Period|Participant Missed Study Visits|0|||
160529024|NCT04178967|579668072|FG004|Induction Period|Participant Missed Study Visits|0|||
160529025|NCT04178967|579668073|FG005|Induction Period|Participant Missed Study Visits|0|||
160529026|NCT04178967|579668074|FG006|Induction Period|Participant Missed Study Visits|0|||
160529027|NCT04178967|579668075|FG007|Induction Period|Participant Missed Study Visits|0|||
160529028|NCT04178967|579668076|FG008|Induction Period|Participant Missed Study Visits|0|||
160529029|NCT04178967|579668077|FG009|Induction Period|Participant Missed Study Visits|0|||
160529030|NCT04178967|579668078|FG010|Induction Period|Participant Missed Study Visits|0|||
160529031|NCT04178967|579668068|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
160529032|NCT04178967|579668069|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
160529033|NCT04178967|579668070|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
160529034|NCT04178967|579668071|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
160529035|NCT04178967|579668072|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
160529036|NCT04178967|579668073|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
160529037|NCT04178967|579668074|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
160529038|NCT04178967|579668075|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
160529039|NCT04178967|579668076|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
160529040|NCT04178967|579668077|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
160529041|NCT04178967|579668078|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
160529042|NCT04178967|579668068|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160529043|NCT04178967|579668069|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160529044|NCT04178967|579668070|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160529045|NCT04178967|579668071|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160529046|NCT04178967|579668072|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160529047|NCT04178967|579668073|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
160529048|NCT04178967|579668074|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160529049|NCT04178967|579668075|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160529050|NCT04178967|579668076|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160529051|NCT04178967|579668077|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160529052|NCT04178967|579668078|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160529053|NCT04178967|579668068|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160529054|NCT04178967|579668069|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160529055|NCT04178967|579668070|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160529056|NCT04178967|579668071|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
160529057|NCT04178967|579668072|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160529058|NCT04178967|579668073|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160529059|NCT04178967|579668074|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160529060|NCT04178967|579668075|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160529061|NCT04178967|579668076|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160529062|NCT04178967|579668077|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160529063|NCT04178967|579668078|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160529064|NCT04178967|579668068|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
160529065|NCT04178967|579668069|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
160529066|NCT04178967|579668070|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
160529067|NCT04178967|579668071|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
160529068|NCT04178967|579668072|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
160529069|NCT04178967|579668073|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
160529070|NCT04178967|579668074|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
160529071|NCT04178967|579668075|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
160529072|NCT04178967|579668076|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
160529073|NCT04178967|579668077|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
160529074|NCT04178967|579668078|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
160529075|NCT04178967|579668068|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160529076|NCT04178967|579668069|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160529077|NCT04178967|579668070|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160529078|NCT04178967|579668071|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160529079|NCT04178967|579668072|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
160529080|NCT04178967|579668073|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
160529081|NCT04178967|579668074|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160529082|NCT04178967|579668075|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
160529083|NCT04178967|579668076|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160529084|NCT04178967|579668077|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160529085|NCT04178967|579668078|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160529086|NCT04178967|579668068|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
160529087|NCT04178967|579668069|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
160529088|NCT04178967|579668070|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
160529089|NCT04178967|579668071|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
160529090|NCT04178967|579668072|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
160529091|NCT04178967|579668073|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
160529092|NCT04178967|579668074|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
160529093|NCT04178967|579668075|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
160529094|NCT04178967|579668076|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
160529095|NCT04178967|579668077|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
160529096|NCT04178967|579668078|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
160529097|NCT04178967|579668068|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160529098|NCT04178967|579668069|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160636447|NCT03137082|580051546|FG001|Overall Study|Withdrawal by Subject|1|||
160529099|NCT04178967|579668070|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160529100|NCT04178967|579668071|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
160529101|NCT04178967|579668072|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160529102|NCT04178967|579668073|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
160529103|NCT04178967|579668074|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
160529104|NCT04178967|579668075|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
160529105|NCT04178967|579668076|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160529106|NCT04178967|579668077|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160529107|NCT04178967|579668078|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160529108|NCT04178967|579668068|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
160529109|NCT04178967|579668069|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
160529110|NCT04178967|579668070|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
160529111|NCT04178967|579668071|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
160529112|NCT04178967|579668072|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
160529113|NCT04178967|579668073|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
160529114|NCT04178967|579668074|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
160529115|NCT04178967|579668075|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
160529116|NCT04178967|579668076|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
160529117|NCT04178967|579668077|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
160529118|NCT04178967|579668078|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
160529119|NCT04178967|579668068|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160529120|NCT04178967|579668069|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160529121|NCT04178967|579668070|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160529122|NCT04178967|579668071|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160529123|NCT04178967|579668072|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160529124|NCT04178967|579668073|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160529125|NCT04178967|579668074|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160529126|NCT04178967|579668075|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160529127|NCT04178967|579668076|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
160529128|NCT04178967|579668077|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
160529129|NCT04178967|579668078|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
160529130|NCT04178967|579668068|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160529131|NCT04178967|579668069|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160529132|NCT04178967|579668070|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160529133|NCT04178967|579668071|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160529134|NCT04178967|579668072|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160529135|NCT04178967|579668073|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160529136|NCT04178967|579668074|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160529137|NCT04178967|579668075|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160529138|NCT04178967|579668076|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160529139|NCT04178967|579668077|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
160529140|NCT04178967|579668078|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160529141|NCT04178967|579668068|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160529142|NCT04178967|579668069|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160529143|NCT04178967|579668070|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160529144|NCT04178967|579668071|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160529145|NCT04178967|579668072|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160529146|NCT04178967|579668073|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160529147|NCT04178967|579668074|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160529148|NCT04178967|579668075|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160529149|NCT04178967|579668076|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
160529150|NCT04178967|579668077|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
160529151|NCT04178967|579668078|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
160529152|NCT04178967|579668068|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
160529153|NCT04178967|579668069|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
160529154|NCT04178967|579668070|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
160765098|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
160765099|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
160765100|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
160765101|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
160765102|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
160765103|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
160765104|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
160765105|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
160869415|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
160869416|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
160765106|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
160765107|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
160765108|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
160765109|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
160529155|NCT04178967|579668071|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
160529156|NCT04178967|579668072|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
160529157|NCT04178967|579668073|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
160529158|NCT04178967|579668074|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
160529159|NCT04178967|579668075|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
160529160|NCT04178967|579668076|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
160529161|NCT04178967|579668077|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
160529162|NCT04178967|579668078|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
160529163|NCT04178967|579668068|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
160529164|NCT04178967|579668069|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
160529165|NCT04178967|579668070|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
160529166|NCT04178967|579668071|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
160529167|NCT04178967|579668072|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
160529168|NCT04178967|579668073|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
160529169|NCT04178967|579668074|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
160529170|NCT04178967|579668075|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
160529171|NCT04178967|579668076|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
160529172|NCT04178967|579668077|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
160529173|NCT04178967|579668078|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
160529174|NCT00628251|579668082|FG000|Randomised Part|Withdrawal by Subject|0|||
160529175|NCT00628251|579668083|FG001|Randomised Part|Withdrawal by Subject|0|||
160529176|NCT00628251|579668084|FG002|Randomised Part|Withdrawal by Subject|1|||
160529177|NCT00628251|579668082|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
160529178|NCT00628251|579668083|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
160529179|NCT00628251|579668084|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
160529180|NCT00628251|579668082|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
160529181|NCT00628251|579668083|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
160529182|NCT00628251|579668084|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
160529183|NCT00628251|579668082|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
160529184|NCT00628251|579668083|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
160529185|NCT00628251|579668084|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
160529186|NCT00628251|579668082|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
160529187|NCT00628251|579668083|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
160529188|NCT00628251|579668084|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
160529189|NCT00628251|579668082|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
160529190|NCT00628251|579668083|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
160529191|NCT00628251|579668084|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
160529192|NCT01505010|579668085|FG000|Overall Study|Protocol Violation|0|||
160529193|NCT01505010|579668086|FG001|Overall Study|Protocol Violation|1|||
160529194|NCT01505010|579668085|FG000|Overall Study|Lost to Follow-up|0|||
160529195|NCT01505010|579668086|FG001|Overall Study|Lost to Follow-up|1|||
160529196|NCT02558231|579668091|FG000|Overall Study|Death|4|||
160529197|NCT02558231|579668092|FG001|Overall Study|Death|12|||
160529198|NCT02558231|579668091|FG000|Overall Study|Lost to Follow-up|7|||
160529199|NCT02558231|579668092|FG001|Overall Study|Lost to Follow-up|4|||
160529200|NCT02558231|579668091|FG000|Overall Study|Withdrawal by Subject|7|||
160529201|NCT02558231|579668092|FG001|Overall Study|Withdrawal by Subject|4|||
160529202|NCT02558231|579668091|FG000|Overall Study|Physician Decision|7|||
160529203|NCT02558231|579668092|FG001|Overall Study|Physician Decision|5|||
160529204|NCT02558231|579668091|FG000|Overall Study|Sponsor Decision|0|||
160529205|NCT02558231|579668092|FG001|Overall Study|Sponsor Decision|1|||
160529206|NCT00995007|579668093|FG000|Overall Study|Withdrew consent|1|||
160529207|NCT00995007|579668094|FG001|Overall Study|Withdrew consent|0|||
160529208|NCT00995007|579668093|FG000|Overall Study|Refused further treatment|8|||
160529209|NCT00995007|579668094|FG001|Overall Study|Refused further treatment|2|||
160529210|NCT00995007|579668093|FG000|Overall Study|Toxicity|8|||
160529211|NCT00995007|579668094|FG001|Overall Study|Toxicity|0|||
160529212|NCT03933397|579668095|FG000|Overall Study|No emergency department visit|65|||
160529213|NCT03933397|579668096|FG001|Overall Study|No emergency department visit|71|||
160529214|NCT03933397|579668095|FG000|Overall Study|Missed emergency department visit|25|||
160529215|NCT03933397|579668096|FG001|Overall Study|Missed emergency department visit|30|||
160529216|NCT03933397|579668095|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
160529217|NCT03933397|579668096|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
160529218|NCT03933397|579668095|FG000|Overall Study|Withdrawal by Subject|1|||
160636448|NCT03137082|580051545|FG000|Overall Study|Lost to Follow-up|1|||
160529219|NCT03933397|579668096|FG001|Overall Study|Withdrawal by Subject|0|||
160529220|NCT03933397|579668095|FG000|Overall Study|Physician Decision|1|||
160529221|NCT03933397|579668096|FG001|Overall Study|Physician Decision|1|||
160529222|NCT03933397|579668095|FG000|Overall Study|missing pain score|1|||
160529223|NCT03933397|579668096|FG001|Overall Study|missing pain score|1|||
160529224|NCT03933397|579668095|FG000|Overall Study|Confirmed COVID-19|1|||
160529225|NCT03933397|579668096|FG001|Overall Study|Confirmed COVID-19|2|||
160529226|NCT02066051|579668098|FG000|Overall Study|Subject developed active GVHD|1|||
160529227|NCT01294150|579668099|FG000|Overall Study|Physician Decision|2|||
160869417|NCT03614156|580913740|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
160869418|NCT03614156|580913741|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
160869419|NCT03614156|580913742|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
160869420|NCT03614156|580913743|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
160869421|NCT03614156|580913740|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
160869422|NCT03614156|580913741|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
160869423|NCT03614156|580913742|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
160869424|NCT03614156|580913743|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
160869425|NCT03614156|580913740|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
160869426|NCT03614156|580913741|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
160869427|NCT03614156|580913742|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
160869428|NCT03614156|580913743|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
160869429|NCT03070964|580913745|FG000|Overall Study|Progressive disease|8|||
160869430|NCT03070964|580913745|FG000|Overall Study|Treatment-unrelated adverse event|2|||
160869431|NCT03070964|580913745|FG000|Overall Study|Never treated|1|||
160869432|NCT03070964|580913745|FG000|Overall Study|Physician Decision|1|||
160869433|NCT03070964|580913745|FG000|Overall Study|Withdrawal by Subject|1|||
160869434|NCT03070964|580913745|FG000|Overall Study|Adverse Event|1|||
160869435|NCT01094119|580913746|FG000|Overall Study|Lack of Efficacy|2|||
160869436|NCT01094119|580913747|FG001|Overall Study|Lack of Efficacy|4|||
160869437|NCT00834093|580913748|FG000|Overall Study|Progressive Disease|3|||
160869438|NCT00834093|580913748|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
160869439|NCT01587924|580913749|FG000|Overall Study|Adverse Event|0|||
160869440|NCT01587924|580913750|FG001|Overall Study|Adverse Event|2|||
160869441|NCT01587924|580913751|FG002|Overall Study|Adverse Event|0|||
160869442|NCT01587924|580913752|FG003|Overall Study|Adverse Event|0|||
160869443|NCT01587924|580913749|FG000|Overall Study|Protocol Violation|2|||
160869444|NCT01587924|580913750|FG001|Overall Study|Protocol Violation|1|||
160869445|NCT01587924|580913751|FG002|Overall Study|Protocol Violation|2|||
160869446|NCT01587924|580913752|FG003|Overall Study|Protocol Violation|1|||
160869447|NCT01587924|580913749|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
160869448|NCT01587924|580913750|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
160869449|NCT01587924|580913751|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
160869450|NCT01587924|580913752|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
160869451|NCT01587924|580913749|FG000|Overall Study|Withdrawal by Subject|0|||
160869452|NCT01587924|580913750|FG001|Overall Study|Withdrawal by Subject|1|||
160869453|NCT01587924|580913751|FG002|Overall Study|Withdrawal by Subject|1|||
160869454|NCT01587924|580913752|FG003|Overall Study|Withdrawal by Subject|0|||
160869455|NCT01578486|580913753|FG000|Overall Study|Physician Decision|3|||
160869456|NCT01578486|580913753|FG000|Overall Study|Withdrawal by Subject|2|||
160869457|NCT00357903|580913755|FG000|Overall Study|Adverse Event|87|||
160869458|NCT00357903|580913756|FG001|Overall Study|Adverse Event|4|||
160869459|NCT00357903|580913755|FG000|Overall Study|Death|33|||
160869460|NCT00357903|580913756|FG001|Overall Study|Death|0|||
160869461|NCT00357903|580913755|FG000|Overall Study|Lost to Follow-up|23|||
160869462|NCT00357903|580913756|FG001|Overall Study|Lost to Follow-up|4|||
160869463|NCT00357903|580913755|FG000|Overall Study|Physician Decision|39|||
160869464|NCT00357903|580913756|FG001|Overall Study|Physician Decision|5|||
160869465|NCT00357903|580913755|FG000|Overall Study|Withdrawal by Subject|57|||
160869466|NCT00357903|580913756|FG001|Overall Study|Withdrawal by Subject|7|||
160869467|NCT00357903|580913755|FG000|Overall Study|Completed month 12 only|0|||
160529228|NCT01294150|579668100|FG001|Overall Study|Physician Decision|2|||
160529229|NCT01093625|579668101|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
160529230|NCT01093625|579668102|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
160636449|NCT03137082|580051546|FG001|Overall Study|Lost to Follow-up|0|||
160636450|NCT00417027|580051547|FG000|Overall Study|Protocol Violation|0|||
160869468|NCT00357903|580913756|FG001|Overall Study|Completed month 12 only|1|||
160869469|NCT00357903|580913755|FG000|Overall Study|Protocol issues|14|||
160869470|NCT00357903|580913756|FG001|Overall Study|Protocol issues|3|||
160869471|NCT00357903|580913755|FG000|Overall Study|Response status|61|||
160869472|NCT00357903|580913756|FG001|Overall Study|Response status|9|||
160869473|NCT00357903|580913755|FG000|Overall Study|Other|49|||
160869474|NCT00357903|580913756|FG001|Overall Study|Other|10|||
160869475|NCT00606593|580913757|FG000|Overall Study|Adverse Event|0|||
160869476|NCT00606593|580913758|FG001|Overall Study|Adverse Event|0|||
160869477|NCT00606593|580913759|FG002|Overall Study|Adverse Event|0|||
160869478|NCT00606593|580913760|FG003|Overall Study|Adverse Event|1|||
160869479|NCT00606593|580913761|FG004|Overall Study|Adverse Event|1|||
160869480|NCT00606593|580913762|FG005|Overall Study|Adverse Event|0|||
160869481|NCT00606593|580913763|FG006|Overall Study|Adverse Event|1|||
160869482|NCT00606593|580913764|FG007|Overall Study|Adverse Event|2|||
160869483|NCT00606593|580913765|FG008|Overall Study|Adverse Event|1|||
160869484|NCT00606593|580913766|FG009|Overall Study|Adverse Event|0|||
160869485|NCT00606593|580913757|FG000|Overall Study|Withdrawal of consent|1|||
160869486|NCT00606593|580913758|FG001|Overall Study|Withdrawal of consent|0|||
160869487|NCT00606593|580913759|FG002|Overall Study|Withdrawal of consent|1|||
160869488|NCT00606593|580913760|FG003|Overall Study|Withdrawal of consent|0|||
160869489|NCT00606593|580913761|FG004|Overall Study|Withdrawal of consent|0|||
160869490|NCT00606593|580913762|FG005|Overall Study|Withdrawal of consent|0|||
160765110|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
160765111|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
160765112|NCT01791595|580530386|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
160765113|NCT01791595|580530387|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
160765114|NCT01791595|580530388|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
160765115|NCT01791595|580530389|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
160529231|NCT01093625|579668101|FG000|2-Week Visit|Withdrawal by Subject|1|||
160529232|NCT01093625|579668102|FG001|2-Week Visit|Withdrawal by Subject|0|||
160529233|NCT01093625|579668101|FG000|1-Month Visit|Lost to Follow-up|2|||
160529234|NCT01093625|579668102|FG001|1-Month Visit|Lost to Follow-up|0|||
160529235|NCT01093625|579668101|FG000|3-Month Visit|Lost to Follow-up|2|||
160529236|NCT01093625|579668102|FG001|3-Month Visit|Lost to Follow-up|0|||
160529237|NCT01093625|579668101|FG000|6-Month Visit|Withdrawal by Subject|6|||
160529238|NCT01093625|579668102|FG001|6-Month Visit|Withdrawal by Subject|7|||
160529239|NCT01093625|579668101|FG000|6-Month Visit|Lost to Follow-up|2|||
160529240|NCT01093625|579668102|FG001|6-Month Visit|Lost to Follow-up|2|||
160529241|NCT01093625|579668101|FG000|1-Year Visit|Lost to Follow-up|5|||
160529242|NCT01093625|579668102|FG001|1-Year Visit|Lost to Follow-up|3|||
160529243|NCT00698932|579668103|FG000|Overall Study|Adverse Event|0|||
160529244|NCT00698932|579668104|FG001|Overall Study|Adverse Event|2|||
160529245|NCT00698932|579668103|FG000|Overall Study|Incorrect enrollment|0|||
160529246|NCT00698932|579668104|FG001|Overall Study|Incorrect enrollment|2|||
160529247|NCT00698932|579668103|FG000|Overall Study|Study specific discontinuation criteria|3|||
160529248|NCT00698932|579668104|FG001|Overall Study|Study specific discontinuation criteria|4|||
160529249|NCT00698932|579668103|FG000|Overall Study|Withdrawal by Subject|11|||
160529250|NCT00698932|579668104|FG001|Overall Study|Withdrawal by Subject|23|||
160529251|NCT00698932|579668103|FG000|Overall Study|Lost to Follow-up|6|||
160529252|NCT00698932|579668104|FG001|Overall Study|Lost to Follow-up|1|||
160529253|NCT00698932|579668103|FG000|Overall Study|Severe non-compliance to protocol|1|||
160529254|NCT00698932|579668104|FG001|Overall Study|Severe non-compliance to protocol|2|||
160529255|NCT00698932|579668103|FG000|Overall Study|Safety reasons|0|||
160529256|NCT00698932|579668104|FG001|Overall Study|Safety reasons|2|||
160529257|NCT00698932|579668103|FG000|Overall Study|Death|1|||
160529258|NCT00698932|579668104|FG001|Overall Study|Death|0|||
160529259|NCT01245387|579668105|FG000|Overall Study|Lost to Follow-up|106|||
160529260|NCT01245387|579668105|FG000|Overall Study|Lack of Efficacy|195|||
160529261|NCT01245387|579668105|FG000|Overall Study|Adverse Event|9|||
160529262|NCT01245387|579668105|FG000|Overall Study|Death|3|||
160529263|NCT01245387|579668105|FG000|Overall Study|Other|131|||
160529264|NCT01245387|579668105|FG000|Overall Study|Missing discontinuation status|369|||
160529265|NCT00601705|579668106|FG000|Overall Study|Withdrawal by Subject|1|||
160529266|NCT04513665|579668107|FG000|Overall Study|Adverse Event|2|||
160529267|NCT04513665|579668108|FG001|Overall Study|Adverse Event|0|||
160529268|NCT04513665|579668107|FG000|Overall Study|Lack of Efficacy|14|||
160529269|NCT04513665|579668108|FG001|Overall Study|Lack of Efficacy|0|||
160529270|NCT02608879|579668112|FG000|Overall Study|Lost to Follow-up|1|||
160529271|NCT02608879|579668113|FG001|Overall Study|Lost to Follow-up|0|||
160529272|NCT02608879|579668114|FG002|Overall Study|Lost to Follow-up|0|||
160529273|NCT02608879|579668112|FG000|Overall Study|Did not meet continuation criteria|0|||
160529274|NCT02608879|579668113|FG001|Overall Study|Did not meet continuation criteria|0|||
160529275|NCT02608879|579668114|FG002|Overall Study|Did not meet continuation criteria|3|||
160529276|NCT04246801|579668115|FG000|Overall Study|Adverse Event|1|||
160529277|NCT04246801|579668116|FG001|Overall Study|Adverse Event|1|||
160529278|NCT04246801|579668115|FG000|Overall Study|Protocol Violation|1|||
160529279|NCT04246801|579668116|FG001|Overall Study|Protocol Violation|1|||
160529280|NCT04246801|579668115|FG000|Overall Study|Lack of Efficacy|0|||
160529281|NCT04246801|579668116|FG001|Overall Study|Lack of Efficacy|2|||
160529282|NCT04246801|579668115|FG000|Overall Study|Lost to Follow-up|1|||
160529283|NCT04246801|579668116|FG001|Overall Study|Lost to Follow-up|1|||
160529284|NCT04246801|579668115|FG000|Overall Study|Withdrawal by Subject|2|||
160529285|NCT04246801|579668116|FG001|Overall Study|Withdrawal by Subject|1|||
160529286|NCT01621542|579668120|FG000|Overall Study|Adverse Event|0|||
160529287|NCT01621542|579668121|FG001|Overall Study|Adverse Event|0|||
160529288|NCT01621542|579668122|FG002|Overall Study|Adverse Event|1|||
160529289|NCT01621542|579668123|FG003|Overall Study|Adverse Event|3|||
160529290|NCT01621542|579668124|FG004|Overall Study|Adverse Event|0|||
160529291|NCT01621542|579668125|FG005|Overall Study|Adverse Event|0|||
160529292|NCT01621542|579668120|FG000|Overall Study|Death|0|||
160529293|NCT01621542|579668121|FG001|Overall Study|Death|1|||
160529294|NCT01621542|579668122|FG002|Overall Study|Death|0|||
160529295|NCT01621542|579668123|FG003|Overall Study|Death|0|||
160529296|NCT01621542|579668124|FG004|Overall Study|Death|0|||
160529297|NCT01621542|579668125|FG005|Overall Study|Death|0|||
160529298|NCT01621542|579668120|FG000|Overall Study|Physician Decision|1|||
160869491|NCT00606593|580913763|FG006|Overall Study|Withdrawal of consent|0|||
160869492|NCT00606593|580913764|FG007|Overall Study|Withdrawal of consent|0|||
160529299|NCT01621542|579668121|FG001|Overall Study|Physician Decision|0|||
160529300|NCT01621542|579668122|FG002|Overall Study|Physician Decision|1|||
160529301|NCT01621542|579668123|FG003|Overall Study|Physician Decision|13|||
160529302|NCT01621542|579668124|FG004|Overall Study|Physician Decision|3|||
160529303|NCT01621542|579668125|FG005|Overall Study|Physician Decision|1|||
160529304|NCT01621542|579668120|FG000|Overall Study|Withdrawal by Subject|2|||
160529305|NCT01621542|579668121|FG001|Overall Study|Withdrawal by Subject|0|||
160529306|NCT01621542|579668122|FG002|Overall Study|Withdrawal by Subject|1|||
160529307|NCT01621542|579668123|FG003|Overall Study|Withdrawal by Subject|3|||
160529308|NCT01621542|579668124|FG004|Overall Study|Withdrawal by Subject|3|||
160529309|NCT01621542|579668125|FG005|Overall Study|Withdrawal by Subject|3|||
160529310|NCT01621542|579668120|FG000|Overall Study|progression/treatment failure|2|||
160529311|NCT01621542|579668121|FG001|Overall Study|progression/treatment failure|4|||
160529312|NCT01621542|579668122|FG002|Overall Study|progression/treatment failure|3|||
160529313|NCT01621542|579668123|FG003|Overall Study|progression/treatment failure|7|||
160529314|NCT01621542|579668124|FG004|Overall Study|progression/treatment failure|3|||
160529315|NCT01621542|579668125|FG005|Overall Study|progression/treatment failure|5|||
160529316|NCT01621542|579668120|FG000|Overall Study|Protocol Violation|0|||
160529317|NCT01621542|579668121|FG001|Overall Study|Protocol Violation|0|||
160529318|NCT01621542|579668122|FG002|Overall Study|Protocol Violation|0|||
160529319|NCT01621542|579668123|FG003|Overall Study|Protocol Violation|1|||
160529320|NCT01621542|579668124|FG004|Overall Study|Protocol Violation|0|||
160529321|NCT01621542|579668125|FG005|Overall Study|Protocol Violation|0|||
160529322|NCT01621542|579668120|FG000|Overall Study|study stopped by sponsor|0|||
160529323|NCT01621542|579668121|FG001|Overall Study|study stopped by sponsor|0|||
160529324|NCT01621542|579668122|FG002|Overall Study|study stopped by sponsor|0|||
160529325|NCT01621542|579668123|FG003|Overall Study|study stopped by sponsor|1|||
160529326|NCT01621542|579668124|FG004|Overall Study|study stopped by sponsor|0|||
160529327|NCT01621542|579668125|FG005|Overall Study|study stopped by sponsor|0|||
160765116|NCT01791595|580530390|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
160765117|NCT01791595|580530391|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
160765118|NCT01791595|580530392|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
160765119|NCT01791595|580530386|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
160765120|NCT01791595|580530387|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
160765121|NCT01791595|580530388|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
160765122|NCT01791595|580530389|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
160765123|NCT01791595|580530390|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
160765124|NCT01791595|580530391|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
160765125|NCT01791595|580530392|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
160765126|NCT01791595|580530386|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
160765127|NCT01791595|580530387|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
160765128|NCT01791595|580530388|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
160765129|NCT01791595|580530389|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
160765130|NCT01791595|580530390|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
160765131|NCT01791595|580530391|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
160765132|NCT01791595|580530392|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
160765133|NCT01791595|580530386|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
160765134|NCT01791595|580530387|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
160765135|NCT01791595|580530388|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
160765136|NCT01791595|580530389|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
160765137|NCT01791595|580530390|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
160765138|NCT01791595|580530391|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
160765139|NCT01791595|580530392|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
160765140|NCT01791595|580530386|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
160765141|NCT01791595|580530387|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
160765142|NCT01791595|580530388|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
160765143|NCT01791595|580530389|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
160765144|NCT01791595|580530390|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
160765145|NCT01791595|580530391|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
160765146|NCT01791595|580530392|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
160765147|NCT01776554|580530393|FG000|Overall Study|Adverse Event|1|||
160765148|NCT01776554|580530394|FG001|Overall Study|Adverse Event|0|||
160765149|NCT01776554|580530393|FG000|Overall Study|Withdrawal by Subject|3|||
160765150|NCT01776554|580530394|FG001|Overall Study|Withdrawal by Subject|8|||
160765151|NCT01776554|580530393|FG000|Overall Study|Lost to Follow-up|6|||
160765152|NCT01776554|580530394|FG001|Overall Study|Lost to Follow-up|9|||
160765153|NCT01776554|580530393|FG000|Overall Study|Administrative Reason|2|||
160765154|NCT01776554|580530394|FG001|Overall Study|Administrative Reason|5|||
160765155|NCT01776554|580530393|FG000|Overall Study|Protocol Violation|1|||
160765156|NCT01776554|580530394|FG001|Overall Study|Protocol Violation|0|||
160765157|NCT01776554|580530393|FG000|Overall Study|Unclassified|4|||
160765158|NCT01776554|580530394|FG001|Overall Study|Unclassified|1|||
160765159|NCT01041859|580530395|FG000|Open-Label Titration|Adverse Event|69|||
160765160|NCT01041859|580530396|FG001|Open-Label Titration|Adverse Event|0|||
160765161|NCT01041859|580530397|FG002|Open-Label Titration|Adverse Event|0|||
160529328|NCT01368042|579668126|FG000|Overall Study|Death|14|||
160529329|NCT01368042|579668126|FG000|Overall Study|Protocol Violation|11|||
160529330|NCT01368042|579668126|FG000|Overall Study|Lost to Follow-up|4|||
160765162|NCT01041859|580530395|FG000|Open-Label Titration|Lack of Efficacy|3|||
160765163|NCT01041859|580530396|FG001|Open-Label Titration|Lack of Efficacy|0|||
160765164|NCT01041859|580530397|FG002|Open-Label Titration|Lack of Efficacy|0|||
160765165|NCT01041859|580530395|FG000|Open-Label Titration|Lost to Follow-up|1|||
160765166|NCT01041859|580530396|FG001|Open-Label Titration|Lost to Follow-up|0|||
160765167|NCT01041859|580530397|FG002|Open-Label Titration|Lost to Follow-up|0|||
160765168|NCT01041859|580530395|FG000|Open-Label Titration|Physician Decision|1|||
160765169|NCT01041859|580530396|FG001|Open-Label Titration|Physician Decision|0|||
160765170|NCT01041859|580530397|FG002|Open-Label Titration|Physician Decision|0|||
160765171|NCT01041859|580530395|FG000|Open-Label Titration|Protocol Violation|1|||
160765172|NCT01041859|580530396|FG001|Open-Label Titration|Protocol Violation|0|||
160765173|NCT01041859|580530397|FG002|Open-Label Titration|Protocol Violation|0|||
160765174|NCT01041859|580530395|FG000|Open-Label Titration|Other|7|||
160765175|NCT01041859|580530396|FG001|Open-Label Titration|Other|0|||
160765176|NCT01041859|580530397|FG002|Open-Label Titration|Other|0|||
160765177|NCT01041859|580530395|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
160765178|NCT01041859|580530396|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
160765179|NCT01041859|580530397|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
160765180|NCT01041859|580530395|FG000|Open-Label Titration|Withdrawal by Subject|11|||
160765181|NCT01041859|580530396|FG001|Open-Label Titration|Withdrawal by Subject|0|||
160765182|NCT01041859|580530397|FG002|Open-Label Titration|Withdrawal by Subject|0|||
160765183|NCT01041859|580530395|FG000|Double-Blind Maintenance|Adverse Event|0|||
160765184|NCT01041859|580530396|FG001|Double-Blind Maintenance|Adverse Event|23|||
160765185|NCT01041859|580530397|FG002|Double-Blind Maintenance|Adverse Event|13|||
160765186|NCT01041859|580530395|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
160529331|NCT01368042|579668126|FG000|Overall Study|Transplanted|1|||
160529332|NCT02632721|579668128|FG000|Overall Study|Adverse Event|0|||
160529333|NCT02632721|579668129|FG001|Overall Study|Adverse Event|0|||
160529334|NCT02632721|579668130|FG002|Overall Study|Adverse Event|2|||
160529335|NCT02632721|579668131|FG003|Overall Study|Adverse Event|5|||
160529336|NCT02632721|579668132|FG004|Overall Study|Adverse Event|3|||
160529337|NCT02632721|579668128|FG000|Overall Study|Dose limiting toxicity|0|||
160529338|NCT02632721|579668129|FG001|Overall Study|Dose limiting toxicity|0|||
160529339|NCT02632721|579668130|FG002|Overall Study|Dose limiting toxicity|0|||
160529340|NCT02632721|579668131|FG003|Overall Study|Dose limiting toxicity|1|||
160529341|NCT02632721|579668132|FG004|Overall Study|Dose limiting toxicity|0|||
160529342|NCT02632721|579668128|FG000|Overall Study|Progressive disease|3|||
160529343|NCT02632721|579668129|FG001|Overall Study|Progressive disease|0|||
160529344|NCT02632721|579668130|FG002|Overall Study|Progressive disease|4|||
160529345|NCT02632721|579668131|FG003|Overall Study|Progressive disease|6|||
160529346|NCT02632721|579668132|FG004|Overall Study|Progressive disease|5|||
160529347|NCT02632721|579668128|FG000|Overall Study|Refused to continue taking trial medication|0|||
160529348|NCT02632721|579668129|FG001|Overall Study|Refused to continue taking trial medication|1|||
160529349|NCT02632721|579668130|FG002|Overall Study|Refused to continue taking trial medication|1|||
160529350|NCT02632721|579668131|FG003|Overall Study|Refused to continue taking trial medication|1|||
160529351|NCT02632721|579668132|FG004|Overall Study|Refused to continue taking trial medication|2|||
160529352|NCT02632721|579668128|FG000|Overall Study|Inadequate clinical condition|0|||
160529353|NCT02632721|579668129|FG001|Overall Study|Inadequate clinical condition|0|||
160529354|NCT02632721|579668130|FG002|Overall Study|Inadequate clinical condition|0|||
160529355|NCT02632721|579668131|FG003|Overall Study|Inadequate clinical condition|0|||
160529356|NCT02632721|579668132|FG004|Overall Study|Inadequate clinical condition|1|||
160529357|NCT02632721|579668128|FG000|Overall Study|No meet eligibility|0|||
160529358|NCT02632721|579668129|FG001|Overall Study|No meet eligibility|0|||
160529359|NCT02632721|579668130|FG002|Overall Study|No meet eligibility|0|||
160529360|NCT02632721|579668131|FG003|Overall Study|No meet eligibility|0|||
160529361|NCT02632721|579668132|FG004|Overall Study|No meet eligibility|1|||
160529362|NCT02632721|579668128|FG000|Overall Study|Allergic reaction|0|||
160529363|NCT02632721|579668129|FG001|Overall Study|Allergic reaction|0|||
160529364|NCT02632721|579668130|FG002|Overall Study|Allergic reaction|0|||
160529365|NCT02632721|579668131|FG003|Overall Study|Allergic reaction|1|||
160529366|NCT02632721|579668132|FG004|Overall Study|Allergic reaction|0|||
160529367|NCT02632721|579668128|FG000|Overall Study|Receiving Decitabine locally|0|||
160529368|NCT02632721|579668129|FG001|Overall Study|Receiving Decitabine locally|0|||
160529369|NCT02632721|579668130|FG002|Overall Study|Receiving Decitabine locally|1|||
160529370|NCT02632721|579668131|FG003|Overall Study|Receiving Decitabine locally|0|||
160529371|NCT02632721|579668132|FG004|Overall Study|Receiving Decitabine locally|0|||
160529372|NCT02632721|579668128|FG000|Overall Study|No benefit from study treatment|1|||
160529373|NCT02632721|579668129|FG001|Overall Study|No benefit from study treatment|1|||
160529374|NCT02632721|579668130|FG002|Overall Study|No benefit from study treatment|0|||
160529375|NCT02632721|579668131|FG003|Overall Study|No benefit from study treatment|0|||
160529376|NCT02632721|579668132|FG004|Overall Study|No benefit from study treatment|1|||
160529377|NCT02632721|579668128|FG000|Overall Study|Patient wish for other treatment|0|||
160529378|NCT02632721|579668129|FG001|Overall Study|Patient wish for other treatment|1|||
160529379|NCT02632721|579668130|FG002|Overall Study|Patient wish for other treatment|0|||
160529380|NCT02632721|579668131|FG003|Overall Study|Patient wish for other treatment|0|||
160529381|NCT02632721|579668132|FG004|Overall Study|Patient wish for other treatment|0|||
160529382|NCT02632721|579668128|FG000|Overall Study|Relapsed Pneumonia|0|||
160529383|NCT02632721|579668129|FG001|Overall Study|Relapsed Pneumonia|0|||
160529384|NCT02632721|579668130|FG002|Overall Study|Relapsed Pneumonia|0|||
160529385|NCT02632721|579668131|FG003|Overall Study|Relapsed Pneumonia|0|||
160529386|NCT02632721|579668132|FG004|Overall Study|Relapsed Pneumonia|1|||
160529387|NCT02632721|579668128|FG000|Overall Study|Therapy refractory AML|0|||
160529388|NCT02632721|579668129|FG001|Overall Study|Therapy refractory AML|0|||
160529389|NCT02632721|579668130|FG002|Overall Study|Therapy refractory AML|0|||
160529390|NCT02632721|579668131|FG003|Overall Study|Therapy refractory AML|0|||
160529391|NCT02632721|579668132|FG004|Overall Study|Therapy refractory AML|1|||
160529392|NCT02632721|579668128|FG000|Overall Study|Increase of white blood cell count|0|||
160529393|NCT02632721|579668129|FG001|Overall Study|Increase of white blood cell count|0|||
160529394|NCT02632721|579668130|FG002|Overall Study|Increase of white blood cell count|0|||
160529395|NCT02632721|579668131|FG003|Overall Study|Increase of white blood cell count|0|||
160529396|NCT02632721|579668132|FG004|Overall Study|Increase of white blood cell count|1|||
160529397|NCT02632721|579668128|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
160529398|NCT02632721|579668129|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
160529399|NCT02632721|579668130|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
160529400|NCT02632721|579668131|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
160529401|NCT02632721|579668132|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
160529402|NCT02966223|579668136|FG000|Overall Study|Physician Decision|3|||
160529403|NCT02966223|579668136|FG000|Overall Study|Withdrawal by Subject|11|||
160765187|NCT01041859|580530396|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
160765188|NCT01041859|580530397|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
160765189|NCT01041859|580530395|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
160765190|NCT01041859|580530396|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
160765191|NCT01041859|580530397|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
160765192|NCT01041859|580530395|FG000|Double-Blind Maintenance|Physician Decision|0|||
160765193|NCT01041859|580530396|FG001|Double-Blind Maintenance|Physician Decision|2|||
160765194|NCT01041859|580530397|FG002|Double-Blind Maintenance|Physician Decision|1|||
160765195|NCT01041859|580530395|FG000|Double-Blind Maintenance|Protocol Violation|0|||
160529404|NCT02966223|579668136|FG000|Overall Study|Lost to Follow-up|1|||
160529405|NCT04275297|579668140|FG000|Overall Study|Lost to Follow-up|1|||
160869493|NCT00606593|580913765|FG008|Overall Study|Withdrawal of consent|0|||
160869494|NCT00606593|580913766|FG009|Overall Study|Withdrawal of consent|0|||
160869495|NCT00606593|580913757|FG000|Overall Study|Administrative/Other|0|||
160869496|NCT00606593|580913758|FG001|Overall Study|Administrative/Other|0|||
160869497|NCT00606593|580913759|FG002|Overall Study|Administrative/Other|1|||
160869498|NCT00606593|580913760|FG003|Overall Study|Administrative/Other|0|||
160869499|NCT00606593|580913761|FG004|Overall Study|Administrative/Other|0|||
160529406|NCT04275297|579668141|FG001|Overall Study|Lost to Follow-up|1|||
160529407|NCT01093326|579668142|FG000|Overall Study|Death|0|||
160529408|NCT01093326|579668143|FG001|Overall Study|Death|1|||
160529409|NCT01093326|579668144|FG002|Overall Study|Death|0|||
160869500|NCT00606593|580913762|FG005|Overall Study|Administrative/Other|0|||
160869501|NCT00606593|580913763|FG006|Overall Study|Administrative/Other|0|||
160869502|NCT00606593|580913764|FG007|Overall Study|Administrative/Other|0|||
160869503|NCT00606593|580913765|FG008|Overall Study|Administrative/Other|0|||
160869504|NCT00606593|580913766|FG009|Overall Study|Administrative/Other|0|||
160869505|NCT03181529|580913767|FG000|Overall Study|Withdrawal by Subject|1|||
160869506|NCT03181529|580913768|FG001|Overall Study|Withdrawal by Subject|1|||
160869507|NCT03181529|580913767|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
160869508|NCT03181529|580913768|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
160869509|NCT00607373|580913771|FG000|Treatment Period|Adverse Event|0|||
160869510|NCT00607373|580913772|FG001|Treatment Period|Adverse Event|4|||
160869511|NCT00607373|580913771|FG000|Treatment Period|Physician Decision|0|||
160869512|NCT00607373|580913772|FG001|Treatment Period|Physician Decision|1|||
160869513|NCT00607373|580913771|FG000|Treatment Period|Withdrawal by Subject|0|||
160981503|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
160529410|NCT01093326|579668142|FG000|Overall Study|Lack of Efficacy|7|||
160765196|NCT01041859|580530396|FG001|Double-Blind Maintenance|Protocol Violation|1|||
160529411|NCT01093326|579668143|FG001|Overall Study|Lack of Efficacy|6|||
160529412|NCT01093326|579668144|FG002|Overall Study|Lack of Efficacy|3|||
160529413|NCT01093326|579668142|FG000|Overall Study|Lost to Follow-up|2|||
160529414|NCT01093326|579668143|FG001|Overall Study|Lost to Follow-up|5|||
160529415|NCT01093326|579668144|FG002|Overall Study|Lost to Follow-up|4|||
160529416|NCT01093326|579668142|FG000|Overall Study|Physician Decision|3|||
160529417|NCT01093326|579668143|FG001|Overall Study|Physician Decision|1|||
160529418|NCT01093326|579668144|FG002|Overall Study|Physician Decision|3|||
160529419|NCT01093326|579668142|FG000|Overall Study|Withdrawal by Subject|30|||
160529420|NCT01093326|579668143|FG001|Overall Study|Withdrawal by Subject|27|||
160529421|NCT01093326|579668144|FG002|Overall Study|Withdrawal by Subject|26|||
160529422|NCT01093326|579668142|FG000|Overall Study|Adverse Event|2|||
160529423|NCT01093326|579668143|FG001|Overall Study|Adverse Event|1|||
160529424|NCT01093326|579668144|FG002|Overall Study|Adverse Event|4|||
160529425|NCT01093326|579668142|FG000|Overall Study|Other|0|||
160529426|NCT01093326|579668143|FG001|Overall Study|Other|0|||
160529427|NCT01093326|579668144|FG002|Overall Study|Other|1|||
160529428|NCT04225806|579668145|FG000|Overall Study|Trial termination|15|||
160529429|NCT05460273|579668148|FG000|Overall Study|Death|43|||
160765197|NCT01041859|580530397|FG002|Double-Blind Maintenance|Protocol Violation|3|||
160765198|NCT01041859|580530395|FG000|Double-Blind Maintenance|Other|0|||
160765199|NCT01041859|580530396|FG001|Double-Blind Maintenance|Other|6|||
160765200|NCT01041859|580530397|FG002|Double-Blind Maintenance|Other|2|||
160765201|NCT01041859|580530395|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
160765202|NCT01041859|580530396|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
160765203|NCT01041859|580530397|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
160765204|NCT01041859|580530395|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
160765205|NCT01041859|580530396|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
160765206|NCT01041859|580530397|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
160765207|NCT02027025|580530398|FG000|Overall Study|Adverse Event|0|||
160765208|NCT02027025|580530399|FG001|Overall Study|Adverse Event|1|||
160765209|NCT02027025|580530400|FG002|Overall Study|Adverse Event|1|||
160765210|NCT02027025|580530398|FG000|Overall Study|Protocol Violation|1|||
160765211|NCT02027025|580530399|FG001|Overall Study|Protocol Violation|0|||
160765212|NCT02027025|580530400|FG002|Overall Study|Protocol Violation|0|||
160765213|NCT02027025|580530398|FG000|Overall Study|Lost to Follow-up|0|||
160765214|NCT02027025|580530399|FG001|Overall Study|Lost to Follow-up|2|||
160765215|NCT02027025|580530400|FG002|Overall Study|Lost to Follow-up|0|||
160765216|NCT02027025|580530398|FG000|Overall Study|Withdrawal by Subject|0|||
160765217|NCT02027025|580530399|FG001|Overall Study|Withdrawal by Subject|1|||
160765218|NCT02027025|580530400|FG002|Overall Study|Withdrawal by Subject|0|||
160765219|NCT02027025|580530398|FG000|Overall Study|Sponsor's decision|0|||
160765220|NCT02027025|580530399|FG001|Overall Study|Sponsor's decision|1|||
160765221|NCT02027025|580530400|FG002|Overall Study|Sponsor's decision|0|||
160765222|NCT04798027|580530401|FG000|Overall Study|Protocol Violation|0|||
160765223|NCT04798027|580530402|FG001|Overall Study|Protocol Violation|0|||
160765224|NCT04798027|580530403|FG002|Overall Study|Protocol Violation|0|||
160765225|NCT04798027|580530404|FG003|Overall Study|Protocol Violation|0|||
160765226|NCT04798027|580530405|FG004|Overall Study|Protocol Violation|1|||
160765227|NCT04798027|580530406|FG005|Overall Study|Protocol Violation|0|||
160765228|NCT04798027|580530407|FG006|Overall Study|Protocol Violation|0|||
160765229|NCT04798027|580530408|FG007|Overall Study|Protocol Violation|1|||
160765230|NCT04798027|580530409|FG008|Overall Study|Protocol Violation|0|||
160765231|NCT04798027|580530401|FG000|Overall Study|Withdrawal by Subject|1|||
160765232|NCT04798027|580530402|FG001|Overall Study|Withdrawal by Subject|0|||
160765233|NCT04798027|580530403|FG002|Overall Study|Withdrawal by Subject|1|||
160765234|NCT04798027|580530404|FG003|Overall Study|Withdrawal by Subject|1|||
160765235|NCT04798027|580530405|FG004|Overall Study|Withdrawal by Subject|1|||
160765236|NCT04798027|580530406|FG005|Overall Study|Withdrawal by Subject|1|||
160765237|NCT04798027|580530407|FG006|Overall Study|Withdrawal by Subject|3|||
160765238|NCT04798027|580530408|FG007|Overall Study|Withdrawal by Subject|2|||
160765239|NCT04798027|580530409|FG008|Overall Study|Withdrawal by Subject|2|||
160765240|NCT04798027|580530401|FG000|Overall Study|Lost to Follow-up|1|||
160981504|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
160529430|NCT05460273|579668149|FG001|Overall Study|Death|9|||
160765241|NCT04798027|580530402|FG001|Overall Study|Lost to Follow-up|3|||
160529431|NCT05460273|579668148|FG000|Overall Study|Lost to Follow-up|7|||
160869514|NCT00607373|580913772|FG001|Treatment Period|Withdrawal by Subject|1|||
160529432|NCT05460273|579668149|FG001|Overall Study|Lost to Follow-up|0|||
160529433|NCT05460273|579668148|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
160529434|NCT05460273|579668149|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
160529435|NCT04124614|579668150|FG000|Placebo Run-in Period|Not Randomized|34|||
160529436|NCT04124614|579668151|FG001|Placebo Run-in Period|Not Randomized|0|||
160529437|NCT04124614|579668152|FG002|Placebo Run-in Period|Not Randomized|0|||
160529438|NCT04124614|579668150|FG000|Double Blind Treatment Period|Adverse Event|0|||
160529439|NCT04124614|579668151|FG001|Double Blind Treatment Period|Adverse Event|7|||
160529440|NCT04124614|579668152|FG002|Double Blind Treatment Period|Adverse Event|22|||
160529441|NCT04124614|579668150|FG000|Double Blind Treatment Period|Death|0|||
160529442|NCT04124614|579668151|FG001|Double Blind Treatment Period|Death|0|||
160529443|NCT04124614|579668152|FG002|Double Blind Treatment Period|Death|1|||
160529444|NCT04124614|579668150|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
160529445|NCT04124614|579668151|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
160529446|NCT04124614|579668152|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
160529447|NCT04124614|579668150|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
160529448|NCT04124614|579668151|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
160529449|NCT04124614|579668152|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
160529450|NCT04124614|579668150|FG000|Double Blind Treatment Period|Physician Decision|0|||
160529451|NCT04124614|579668151|FG001|Double Blind Treatment Period|Physician Decision|0|||
160529452|NCT04124614|579668152|FG002|Double Blind Treatment Period|Physician Decision|3|||
160529453|NCT04124614|579668150|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
160529454|NCT04124614|579668151|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
160529455|NCT04124614|579668152|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
160529456|NCT04124614|579668150|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
160529457|NCT04124614|579668151|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
160529458|NCT04124614|579668152|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
160529459|NCT04124614|579668150|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
160529460|NCT04124614|579668151|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
160529461|NCT04124614|579668152|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
160529462|NCT02012296|579669933|FG000|Overall Study|Lack of Efficacy|0|||
160529463|NCT02012296|579669934|FG001|Overall Study|Lack of Efficacy|0|||
160529464|NCT02012296|579669935|FG002|Overall Study|Lack of Efficacy|15|||
160529465|NCT02012296|579669933|FG000|Overall Study|Adverse Event|0|||
160529466|NCT02012296|579669934|FG001|Overall Study|Adverse Event|0|||
160529467|NCT02012296|579669935|FG002|Overall Study|Adverse Event|2|||
160529468|NCT02012296|579669933|FG000|Overall Study|Early study closure|0|||
160529469|NCT02012296|579669934|FG001|Overall Study|Early study closure|0|||
160529470|NCT02012296|579669935|FG002|Overall Study|Early study closure|5|||
160529471|NCT02012296|579669933|FG000|Overall Study|Protocol Violation|0|||
160529472|NCT02012296|579669934|FG001|Overall Study|Protocol Violation|1|||
160529473|NCT02012296|579669935|FG002|Overall Study|Protocol Violation|0|||
160529474|NCT03876171|579669936|FG000|Overall Study|Withdrawal by Subject|3|||
160529475|NCT03876171|579669937|FG001|Overall Study|Withdrawal by Subject|3|||
160529476|NCT03876171|579669936|FG000|Overall Study|Re-arrest|0|||
160529477|NCT03876171|579669937|FG001|Overall Study|Re-arrest|4|||
160529478|NCT00727649|579669938|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
160529479|NCT00727649|579669939|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
160529480|NCT00727649|579669938|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
160529481|NCT00727649|579669939|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
160529482|NCT00727649|579669938|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
160529483|NCT00727649|579669939|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
160529484|NCT00727649|579669938|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
160529485|NCT00727649|579669939|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
160529486|NCT00727649|579669938|FG000|Second Intervention (4-weeks)|Death|1|||
160529487|NCT00727649|579669939|FG001|Second Intervention (4-weeks)|Death|0|||
160529488|NCT00727649|579669938|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
160529489|NCT00727649|579669939|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
160529490|NCT00727649|579669938|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
160529491|NCT00727649|579669939|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
160529492|NCT03627767|579669941|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
160529493|NCT03627767|579669942|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
160529494|NCT03627767|579669943|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
160529495|NCT03627767|579669944|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
160529496|NCT03627767|579669945|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
160529497|NCT03627767|579669941|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
160529498|NCT03627767|579669942|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
160529499|NCT03627767|579669943|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
160529500|NCT03627767|579669944|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
160529501|NCT03627767|579669945|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
160529502|NCT03627767|579669941|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
160529503|NCT03627767|579669942|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
160529504|NCT03627767|579669943|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
160529505|NCT03627767|579669944|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
160869515|NCT00607373|580913771|FG000|Follow-up Period|Other|0|||
160869516|NCT00607373|580913772|FG001|Follow-up Period|Other|1|||
160529506|NCT03627767|579669945|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
160529507|NCT03627767|579669941|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
160529508|NCT03627767|579669942|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
160529509|NCT03627767|579669943|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
160529510|NCT03627767|579669944|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
160529511|NCT03627767|579669945|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
160529512|NCT03627767|579669941|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
160529513|NCT03627767|579669942|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
160529514|NCT03627767|579669943|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
160529515|NCT03627767|579669944|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
160529516|NCT03627767|579669945|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
160529517|NCT03627767|579669941|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
160529518|NCT03627767|579669942|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
160529519|NCT03627767|579669943|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
160529520|NCT03627767|579669944|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
160529521|NCT03627767|579669945|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
160529522|NCT03627767|579669941|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
160529523|NCT03627767|579669942|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
160529524|NCT03627767|579669943|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
160529525|NCT03627767|579669944|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
160529526|NCT03627767|579669945|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
160529527|NCT03627767|579669941|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
160529528|NCT03627767|579669942|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
160529529|NCT03627767|579669943|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
160529530|NCT03627767|579669944|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
160529531|NCT03627767|579669945|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
160529532|NCT03627767|579669941|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
160529533|NCT03627767|579669942|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
160529534|NCT03627767|579669943|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
160869517|NCT00607373|580913771|FG000|Follow-up Period|Protocol Violation|0|||
160869518|NCT00607373|580913772|FG001|Follow-up Period|Protocol Violation|1|||
160869519|NCT00607373|580913771|FG000|Follow-up Period|Withdrawal by Subject|1|||
160869520|NCT00607373|580913772|FG001|Follow-up Period|Withdrawal by Subject|3|||
160869521|NCT04949490|580913773|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
160869522|NCT04949490|580913774|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
160869523|NCT04949490|580913775|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
160869524|NCT04949490|580913776|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
160869525|NCT04949490|580913777|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
160869526|NCT04949490|580913778|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
160869527|NCT04949490|580913773|FG000|Group A and Group B|Withdrawal by Subject|0|||
160869528|NCT04949490|580913774|FG001|Group A and Group B|Withdrawal by Subject|0|||
160869529|NCT04949490|580913775|FG002|Group A and Group B|Withdrawal by Subject|1|||
160869530|NCT04949490|580913776|FG003|Group A and Group B|Withdrawal by Subject|0|||
160869531|NCT04949490|580913777|FG004|Group A and Group B|Withdrawal by Subject|0|||
160869532|NCT04949490|580913778|FG005|Group A and Group B|Withdrawal by Subject|0|||
160869533|NCT04949490|580913773|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
160869534|NCT04949490|580913774|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
160765242|NCT04798027|580530403|FG002|Overall Study|Lost to Follow-up|0|||
160765243|NCT04798027|580530404|FG003|Overall Study|Lost to Follow-up|0|||
160765244|NCT04798027|580530405|FG004|Overall Study|Lost to Follow-up|0|||
160765245|NCT04798027|580530406|FG005|Overall Study|Lost to Follow-up|1|||
160765246|NCT04798027|580530407|FG006|Overall Study|Lost to Follow-up|0|||
160765247|NCT04798027|580530408|FG007|Overall Study|Lost to Follow-up|0|||
160765248|NCT04798027|580530409|FG008|Overall Study|Lost to Follow-up|1|||
160765249|NCT04798027|580530401|FG000|Overall Study|Withdrawal by Sponsor|8|||
160765250|NCT04798027|580530402|FG001|Overall Study|Withdrawal by Sponsor|22|||
160765251|NCT04798027|580530403|FG002|Overall Study|Withdrawal by Sponsor|9|||
160765252|NCT04798027|580530404|FG003|Overall Study|Withdrawal by Sponsor|26|||
160765253|NCT04798027|580530405|FG004|Overall Study|Withdrawal by Sponsor|24|||
160765254|NCT04798027|580530406|FG005|Overall Study|Withdrawal by Sponsor|11|||
160765255|NCT04798027|580530407|FG006|Overall Study|Withdrawal by Sponsor|25|||
160765256|NCT04798027|580530408|FG007|Overall Study|Withdrawal by Sponsor|26|||
160765257|NCT04798027|580530409|FG008|Overall Study|Withdrawal by Sponsor|11|||
160765258|NCT00828711|580530412|FG000|Overall Study|Lost to Follow-up|1|||
160765259|NCT00828711|580530413|FG001|Overall Study|Lost to Follow-up|0|||
160765260|NCT00828711|580530414|FG002|Overall Study|Lost to Follow-up|0|||
160765261|NCT01618968|580530415|FG000|Overall Study|Adverse Event|1|||
160765262|NCT01618968|580530416|FG001|Overall Study|Adverse Event|0|||
160765263|NCT01618968|580530417|FG002|Overall Study|Adverse Event|0|||
160765264|NCT01618968|580530418|FG003|Overall Study|Adverse Event|0|||
160765265|NCT01618968|580530415|FG000|Overall Study|Death|0|||
160765266|NCT01618968|580530416|FG001|Overall Study|Death|0|||
160765267|NCT01618968|580530417|FG002|Overall Study|Death|0|||
160765268|NCT01618968|580530418|FG003|Overall Study|Death|1|||
160765269|NCT03087058|580530422|FG000|Overall Study|Withdrawal by Subject|2|||
160765270|NCT03087058|580530423|FG001|Overall Study|Withdrawal by Subject|0|||
160765271|NCT03087058|580530424|FG002|Overall Study|Withdrawal by Subject|0|||
160765272|NCT05158140|580530425|FG000|Overall Study|Death|0|||
160765273|NCT05158140|580530426|FG001|Overall Study|Death|0|||
160765274|NCT05158140|580530427|FG002|Overall Study|Death|0|||
160765275|NCT05158140|580530428|FG003|Overall Study|Death|1|||
160765276|NCT05158140|580530425|FG000|Overall Study|Lost to Follow-up|3|||
160765277|NCT05158140|580530426|FG001|Overall Study|Lost to Follow-up|6|||
160765278|NCT05158140|580530427|FG002|Overall Study|Lost to Follow-up|4|||
160765279|NCT05158140|580530428|FG003|Overall Study|Lost to Follow-up|3|||
160765280|NCT05158140|580530425|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160765281|NCT05158140|580530426|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160765282|NCT05158140|580530427|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
160765283|NCT05158140|580530428|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160765284|NCT05158140|580530425|FG000|Overall Study|Withdrawal by Subject|3|||
160765285|NCT05158140|580530426|FG001|Overall Study|Withdrawal by Subject|7|||
160765286|NCT05158140|580530427|FG002|Overall Study|Withdrawal by Subject|3|||
160765287|NCT05158140|580530428|FG003|Overall Study|Withdrawal by Subject|7|||
160765288|NCT00617279|580530429|FG000|Overall Study|Study terminated by Sponsor|10|||
160765289|NCT00617279|580530430|FG001|Overall Study|Study terminated by Sponsor|15|||
160765290|NCT00617279|580530429|FG000|Overall Study|Graft abandonment|2|||
160765291|NCT00617279|580530430|FG001|Overall Study|Graft abandonment|0|||
160765292|NCT00617279|580530429|FG000|Overall Study|Lost to Follow-up|1|||
160765293|NCT00617279|580530430|FG001|Overall Study|Lost to Follow-up|0|||
160765294|NCT00617279|580530429|FG000|Overall Study|Death|1|||
160765295|NCT00617279|580530430|FG001|Overall Study|Death|2|||
160765296|NCT04158219|580530432|FG000|Overall Study|Lost to Follow-up|1|||
160529535|NCT03627767|579669944|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
160529536|NCT03627767|579669945|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
160529537|NCT03627767|579669941|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
160529538|NCT03627767|579669942|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
160529539|NCT03627767|579669943|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
160529540|NCT03627767|579669944|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
160529541|NCT03627767|579669945|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
160529542|NCT03627767|579669941|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
160529543|NCT03627767|579669942|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
160529544|NCT03627767|579669943|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
160529545|NCT03627767|579669944|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
160529546|NCT03627767|579669945|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
160529547|NCT03627767|579669941|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
160529548|NCT03627767|579669942|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
160529549|NCT03627767|579669943|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
160529550|NCT03627767|579669944|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
160529551|NCT03627767|579669945|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
160529552|NCT03627767|579669941|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
160529553|NCT03627767|579669942|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
160529554|NCT03627767|579669943|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
160529555|NCT03627767|579669944|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
160529556|NCT03627767|579669945|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
160529557|NCT03627767|579669941|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
160529558|NCT03627767|579669942|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
160529559|NCT03627767|579669943|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
160529560|NCT03627767|579669944|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
160529561|NCT03627767|579669945|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
160529562|NCT03627767|579669941|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
160529563|NCT03627767|579669942|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
160529564|NCT03627767|579669943|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
160529565|NCT03627767|579669944|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
160529566|NCT03627767|579669945|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
160529567|NCT03627767|579669941|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
160529568|NCT03627767|579669942|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
160529569|NCT03627767|579669943|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
160529570|NCT03627767|579669944|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
160529571|NCT03627767|579669945|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
160529572|NCT03627767|579669941|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
160529573|NCT03627767|579669942|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
160529574|NCT03627767|579669943|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
160529575|NCT03627767|579669944|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
160529576|NCT03627767|579669945|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
160529577|NCT03627767|579669941|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
160529578|NCT03627767|579669942|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
160529579|NCT03627767|579669943|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
160529580|NCT03627767|579669944|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
160529581|NCT03627767|579669945|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
160529582|NCT03627767|579669941|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
160529583|NCT03627767|579669942|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
160529584|NCT03627767|579669943|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
160529585|NCT03627767|579669944|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
160529586|NCT03627767|579669945|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
160529587|NCT03627767|579669941|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
160529588|NCT03627767|579669942|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
160529589|NCT03627767|579669943|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
160529590|NCT03627767|579669944|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
160529591|NCT03627767|579669945|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
160765297|NCT01814007|580530434|FG000|Overall Study|Withdrawal by Subject|1|||
160765298|NCT01324947|580530435|FG000|Overall Study|Adverse Event|7|||
160765299|NCT01324947|580530435|FG000|Overall Study|Death|10|||
160765300|NCT01324947|580530435|FG000|Overall Study|Other|3|||
160765301|NCT01324947|580530435|FG000|Overall Study|Progressive Disease|50|||
160765302|NCT01324947|580530435|FG000|Overall Study|Withdrawal by Subject|3|||
160765303|NCT01324947|580530435|FG000|Overall Study|1 discontinued before starting drug|1|||
160765304|NCT01274351|580530436|FG000|Overall Study|Lost to Follow-up|1|||
160765305|NCT01274351|580530436|FG000|Overall Study|patient not compliant with the protocol|1|||
160869535|NCT04949490|580913775|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
160869536|NCT04949490|580913776|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
160869537|NCT04949490|580913777|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
160869538|NCT04949490|580913778|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
160869539|NCT04949490|580913773|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
160869540|NCT04949490|580913774|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
160869541|NCT04949490|580913775|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
160869542|NCT04949490|580913776|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
160869543|NCT04949490|580913777|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
160869544|NCT04949490|580913778|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
160869545|NCT05232682|580913779|FG000|Overall Study|Lost to Follow-up|2|||
160869546|NCT04730804|580913780|FG000|Overall Study|Physician Decision|0|||
160869547|NCT04730804|580913781|FG001|Overall Study|Physician Decision|0|||
160869548|NCT04730804|580913782|FG002|Overall Study|Physician Decision|0|||
160869549|NCT04730804|580913783|FG003|Overall Study|Physician Decision|0|||
160869550|NCT04730804|580913784|FG004|Overall Study|Physician Decision|0|||
160869551|NCT04730804|580913785|FG005|Overall Study|Physician Decision|1|||
160869552|NCT04730804|580913780|FG000|Overall Study|Withdrawal by Subject|0|||
160529592|NCT00283049|579669946|FG000|Overall Study|Adverse Event|6|||
160529593|NCT00283049|579669947|FG001|Overall Study|Adverse Event|1|||
160529594|NCT00283049|579669948|FG002|Overall Study|Adverse Event|4|||
160529595|NCT00283049|579669946|FG000|Overall Study|Protocol Violation|3|||
160529596|NCT00283049|579669947|FG001|Overall Study|Protocol Violation|0|||
160529597|NCT00283049|579669948|FG002|Overall Study|Protocol Violation|3|||
160529598|NCT00283049|579669946|FG000|Overall Study|Death|1|||
160529599|NCT00283049|579669947|FG001|Overall Study|Death|1|||
160529600|NCT00283049|579669948|FG002|Overall Study|Death|1|||
160529601|NCT00283049|579669946|FG000|Overall Study|Lack of Efficacy|0|||
160529602|NCT00283049|579669947|FG001|Overall Study|Lack of Efficacy|1|||
160529603|NCT00283049|579669948|FG002|Overall Study|Lack of Efficacy|1|||
160529604|NCT00283049|579669946|FG000|Overall Study|Lost to Follow-up|4|||
160529605|NCT00283049|579669947|FG001|Overall Study|Lost to Follow-up|2|||
160529606|NCT00283049|579669948|FG002|Overall Study|Lost to Follow-up|5|||
160529607|NCT00283049|579669946|FG000|Overall Study|Withdrawal by Subject|26|||
160529608|NCT00283049|579669947|FG001|Overall Study|Withdrawal by Subject|24|||
160529609|NCT00283049|579669948|FG002|Overall Study|Withdrawal by Subject|19|||
160529610|NCT00283049|579669946|FG000|Overall Study|Discontinuation of Study|18|||
160529611|NCT00283049|579669947|FG001|Overall Study|Discontinuation of Study|16|||
160529612|NCT00283049|579669948|FG002|Overall Study|Discontinuation of Study|20|||
160529613|NCT00283049|579669946|FG000|Overall Study|No longer requires study treatment|0|||
160529614|NCT00283049|579669947|FG001|Overall Study|No longer requires study treatment|0|||
160529615|NCT00283049|579669948|FG002|Overall Study|No longer requires study treatment|1|||
160529616|NCT02953639|579669949|FG000|Overall Study|Adverse Event|2|||
160529617|NCT02953639|579669950|FG001|Overall Study|Adverse Event|0|||
160529618|NCT02953639|579669951|FG002|Overall Study|Adverse Event|1|||
160529619|NCT02953639|579669949|FG000|Overall Study|Lost to Follow-up|8|||
160529620|NCT02953639|579669950|FG001|Overall Study|Lost to Follow-up|4|||
160529621|NCT02953639|579669951|FG002|Overall Study|Lost to Follow-up|3|||
160529622|NCT02953639|579669949|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160529623|NCT02953639|579669950|FG001|Overall Study|Non-Compliance With Study Drug|2|||
160529624|NCT02953639|579669951|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160529625|NCT02953639|579669949|FG000|Overall Study|Multiple Reasons|1|||
160529626|NCT02953639|579669950|FG001|Overall Study|Multiple Reasons|0|||
160529627|NCT02953639|579669951|FG002|Overall Study|Multiple Reasons|1|||
160529628|NCT02953639|579669949|FG000|Overall Study|Physician Decision|1|||
160529629|NCT02953639|579669950|FG001|Overall Study|Physician Decision|0|||
160529630|NCT02953639|579669951|FG002|Overall Study|Physician Decision|0|||
160529631|NCT02953639|579669949|FG000|Overall Study|Withdrawal by Subject|7|||
160765306|NCT01274351|580530436|FG000|Overall Study|Pregnancy|1|||
160765307|NCT01274351|580530436|FG000|Overall Study|Death|2|||
160765308|NCT01274351|580530436|FG000|Overall Study|Withdrawal by Subject|3|||
160765309|NCT01274351|580530436|FG000|Overall Study|Adverse Event|8|||
160765310|NCT01274351|580530436|FG000|Overall Study|progression of disease|3|||
160765311|NCT01274351|580530436|FG000|Overall Study|hospitalization|1|||
160765312|NCT01296412|580530439|FG000|Overall Study|Adverse Event|8|||
160765313|NCT01296412|580530440|FG001|Overall Study|Adverse Event|29|||
160765314|NCT01296412|580530439|FG000|Overall Study|Lack of Efficacy|1|||
160765315|NCT01296412|580530440|FG001|Overall Study|Lack of Efficacy|0|||
160765316|NCT01296412|580530439|FG000|Overall Study|Lost to Follow-up|10|||
160765317|NCT01296412|580530440|FG001|Overall Study|Lost to Follow-up|7|||
160765318|NCT01296412|580530439|FG000|Overall Study|Non-compliance with study drug|1|||
160765319|NCT01296412|580530440|FG001|Overall Study|Non-compliance with study drug|2|||
160765320|NCT01296412|580530439|FG000|Overall Study|Other reason not specified|20|||
160765321|NCT01296412|580530440|FG001|Overall Study|Other reason not specified|15|||
160765322|NCT01296412|580530439|FG000|Overall Study|Physician Decision|1|||
160765323|NCT01296412|580530440|FG001|Overall Study|Physician Decision|3|||
160765324|NCT01296412|580530439|FG000|Overall Study|Pregnancy|0|||
160765325|NCT01296412|580530440|FG001|Overall Study|Pregnancy|1|||
160765326|NCT01296412|580530439|FG000|Overall Study|Withdrawal by Subject|10|||
160765327|NCT01296412|580530440|FG001|Overall Study|Withdrawal by Subject|13|||
160765328|NCT02160626|580530441|FG000|Overall Study|Adverse Event|1|||
160765329|NCT02160626|580530442|FG001|Overall Study|Adverse Event|0|||
160765330|NCT02160626|580530443|FG002|Overall Study|Adverse Event|0|||
160765331|NCT02160626|580530441|FG000|Overall Study|Schedule not conducive to study visits|0|||
160765332|NCT02160626|580530442|FG001|Overall Study|Schedule not conducive to study visits|0|||
160765333|NCT02160626|580530443|FG002|Overall Study|Schedule not conducive to study visits|1|||
160765334|NCT02160626|580530441|FG000|Overall Study|Withdrawal by Subject|0|||
160765335|NCT02160626|580530442|FG001|Overall Study|Withdrawal by Subject|1|||
160765336|NCT02160626|580530443|FG002|Overall Study|Withdrawal by Subject|0|||
160765337|NCT00959751|580532742|FG000|Overall Study|Lost to Follow-up|2|||
160529632|NCT02953639|579669950|FG001|Overall Study|Withdrawal by Subject|8|||
160765338|NCT00959751|580532743|FG001|Overall Study|Lost to Follow-up|3|||
160765339|NCT00959751|580532742|FG000|Overall Study|Consent Withdrawn|0|||
160765340|NCT00959751|580532743|FG001|Overall Study|Consent Withdrawn|1|||
160765341|NCT00959751|580532742|FG000|Overall Study|Non-compliance to Study Procedures|0|||
160529633|NCT02953639|579669951|FG002|Overall Study|Withdrawal by Subject|10|||
160529634|NCT02953639|579669949|FG000|Overall Study|Completed or Discontinued information is missing|1|||
160529635|NCT02953639|579669950|FG001|Overall Study|Completed or Discontinued information is missing|0|||
160529636|NCT02953639|579669951|FG002|Overall Study|Completed or Discontinued information is missing|0|||
160529637|NCT01667081|579669952|FG000|Overall Study|Death|43|||
160529638|NCT01667081|579669953|FG001|Overall Study|Death|3|||
160529639|NCT01667081|579669952|FG000|Overall Study|Lost to Follow-up|99|||
160529640|NCT01667081|579669953|FG001|Overall Study|Lost to Follow-up|48|||
160529641|NCT01667081|579669952|FG000|Overall Study|Physician Decision|16|||
160529642|NCT01667081|579669953|FG001|Overall Study|Physician Decision|2|||
160529643|NCT01667081|579669952|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
160529644|NCT01667081|579669953|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
160529645|NCT01667081|579669952|FG000|Overall Study|Withdrawal by Subject|90|||
160529646|NCT01667081|579669953|FG001|Overall Study|Withdrawal by Subject|35|||
160529647|NCT03034460|579669954|FG000|Overall Study|Adverse Event|0|||
160529648|NCT03034460|579669955|FG001|Overall Study|Adverse Event|1|||
160529649|NCT03034460|579669954|FG000|Overall Study|Withdrawal by Subject|2|||
160529650|NCT03034460|579669955|FG001|Overall Study|Withdrawal by Subject|2|||
160529651|NCT03034460|579669954|FG000|Overall Study|Personal Reasons|1|||
160529652|NCT03034460|579669955|FG001|Overall Study|Personal Reasons|0|||
160529653|NCT00295633|579669958|FG000|Overall Study|Lack of Efficacy|19|||
160529654|NCT00295633|579669959|FG001|Overall Study|Lack of Efficacy|7|||
160529655|NCT00295633|579669960|FG002|Overall Study|Lack of Efficacy|16|||
160529656|NCT00295633|579669958|FG000|Overall Study|Withdrawal of consent by subject|16|||
160529657|NCT00295633|579669959|FG001|Overall Study|Withdrawal of consent by subject|16|||
160529658|NCT00295633|579669960|FG002|Overall Study|Withdrawal of consent by subject|26|||
160529659|NCT00295633|579669958|FG000|Overall Study|Adverse Event|9|||
160529660|NCT00295633|579669959|FG001|Overall Study|Adverse Event|17|||
160529661|NCT00295633|579669960|FG002|Overall Study|Adverse Event|9|||
160529662|NCT00295633|579669958|FG000|Overall Study|Lost to Follow-up|6|||
160529663|NCT00295633|579669959|FG001|Overall Study|Lost to Follow-up|11|||
160529664|NCT00295633|579669960|FG002|Overall Study|Lost to Follow-up|7|||
160529665|NCT00295633|579669958|FG000|Overall Study|Physician Decision|9|||
160529666|NCT00295633|579669959|FG001|Overall Study|Physician Decision|10|||
160529667|NCT00295633|579669960|FG002|Overall Study|Physician Decision|8|||
160529668|NCT00295633|579669958|FG000|Overall Study|Poor/Noncompliance|2|||
160529669|NCT00295633|579669959|FG001|Overall Study|Poor/Noncompliance|2|||
160529670|NCT00295633|579669960|FG002|Overall Study|Poor/Noncompliance|6|||
160529671|NCT00295633|579669958|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
160529672|NCT00295633|579669959|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
160529673|NCT00295633|579669960|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
160529674|NCT00295633|579669958|FG000|Overall Study|Death|1|||
160529675|NCT00295633|579669959|FG001|Overall Study|Death|1|||
160529676|NCT00295633|579669960|FG002|Overall Study|Death|0|||
160529677|NCT00295633|579669958|FG000|Overall Study|Administrative reason by sponsor|0|||
160529678|NCT00295633|579669959|FG001|Overall Study|Administrative reason by sponsor|0|||
160765342|NCT00959751|580532743|FG001|Overall Study|Non-compliance to Study Procedures|1|||
160765343|NCT00959751|580532742|FG000|Overall Study|No migraine headache without aura|7|||
160765344|NCT00959751|580532743|FG001|Overall Study|No migraine headache without aura|7|||
160765345|NCT03737994|580532744|FG000|Overall Study|Withdrawal by Subject|0|||
160765346|NCT03737994|580532745|FG001|Overall Study|Withdrawal by Subject|0|||
160765347|NCT03737994|580532746|FG002|Overall Study|Withdrawal by Subject|0|||
160765348|NCT03737994|580532747|FG003|Overall Study|Withdrawal by Subject|0|||
160765349|NCT03737994|580532748|FG004|Overall Study|Withdrawal by Subject|0|||
160765350|NCT03737994|580532749|FG005|Overall Study|Withdrawal by Subject|0|||
160765351|NCT03737994|580532750|FG006|Overall Study|Withdrawal by Subject|1|||
160765352|NCT03861039|580532753|FG000|Overall Study|Adverse Event|2|||
160765353|NCT03861039|580532754|FG001|Overall Study|Adverse Event|5|||
160765354|NCT03861039|580532755|FG002|Overall Study|Adverse Event|11|||
160765355|NCT03861039|580532753|FG000|Overall Study|Withdrawal by Subject|1|||
160765356|NCT03861039|580532754|FG001|Overall Study|Withdrawal by Subject|3|||
160765357|NCT03861039|580532755|FG002|Overall Study|Withdrawal by Subject|4|||
160765358|NCT01113749|580532756|FG000|Overall Study|Lost to Follow-up|1|||
160765359|NCT01113749|580532757|FG001|Overall Study|Lost to Follow-up|2|||
160529679|NCT00295633|579669960|FG002|Overall Study|Administrative reason by sponsor|1|||
160529680|NCT01069120|579669963|FG000|Overall Study|Study prematurely terminated|27|||
160529681|NCT00763971|579669964|FG000|Overall Study|Adverse Event|5|||
160529682|NCT00763971|579669965|FG001|Overall Study|Adverse Event|2|||
160765360|NCT03427892|580532758|FG000|Overall Study|Lost to Follow-up|2|||
160765361|NCT03255187|580532759|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
160529683|NCT00763971|579669966|FG002|Overall Study|Adverse Event|4|||
160529684|NCT00763971|579669964|FG000|Overall Study|Protocol Violation|3|||
160529685|NCT00763971|579669965|FG001|Overall Study|Protocol Violation|3|||
160529686|NCT00763971|579669966|FG002|Overall Study|Protocol Violation|2|||
160529687|NCT00763971|579669964|FG000|Overall Study|Withdrawal by Subject|4|||
160636451|NCT00417027|580051548|FG001|Overall Study|Protocol Violation|5|||
160529688|NCT00763971|579669965|FG001|Overall Study|Withdrawal by Subject|5|||
160529689|NCT00763971|579669966|FG002|Overall Study|Withdrawal by Subject|5|||
160529690|NCT00763971|579669964|FG000|Overall Study|Lost to Follow-up|0|||
160529691|NCT00763971|579669965|FG001|Overall Study|Lost to Follow-up|1|||
160529692|NCT00763971|579669966|FG002|Overall Study|Lost to Follow-up|0|||
160529693|NCT00763971|579669964|FG000|Overall Study|Lack of Efficacy|11|||
160529694|NCT00763971|579669965|FG001|Overall Study|Lack of Efficacy|22|||
160529695|NCT00763971|579669966|FG002|Overall Study|Lack of Efficacy|54|||
160529696|NCT00763971|579669964|FG000|Overall Study|Unable to swallow capsule|2|||
160529697|NCT00763971|579669965|FG001|Overall Study|Unable to swallow capsule|1|||
160529698|NCT00763971|579669966|FG002|Overall Study|Unable to swallow capsule|1|||
160529699|NCT00763971|579669964|FG000|Overall Study|Personal reason|3|||
160529700|NCT00763971|579669965|FG001|Overall Study|Personal reason|0|||
160529701|NCT00763971|579669966|FG002|Overall Study|Personal reason|0|||
160529702|NCT00763971|579669964|FG000|Overall Study|Exclusion criteria met|1|||
160529703|NCT00763971|579669965|FG001|Overall Study|Exclusion criteria met|0|||
160529704|NCT00763971|579669966|FG002|Overall Study|Exclusion criteria met|0|||
160529705|NCT00763971|579669964|FG000|Overall Study|Sponsor decision|1|||
160529706|NCT00763971|579669965|FG001|Overall Study|Sponsor decision|0|||
160529707|NCT00763971|579669966|FG002|Overall Study|Sponsor decision|0|||
160529708|NCT00763971|579669964|FG000|Overall Study|Due to holiday season|2|||
160529709|NCT00763971|579669965|FG001|Overall Study|Due to holiday season|0|||
160529710|NCT00763971|579669966|FG002|Overall Study|Due to holiday season|1|||
160529711|NCT00763971|579669964|FG000|Overall Study|Randomization error|0|||
160529712|NCT00763971|579669965|FG001|Overall Study|Randomization error|0|||
160529713|NCT00763971|579669966|FG002|Overall Study|Randomization error|1|||
160529714|NCT00763971|579669964|FG000|Overall Study|Medical monitor decision|0|||
160529715|NCT00763971|579669965|FG001|Overall Study|Medical monitor decision|0|||
160529716|NCT00763971|579669966|FG002|Overall Study|Medical monitor decision|1|||
160529717|NCT00763971|579669964|FG000|Overall Study|Moved to another country|0|||
160529718|NCT00763971|579669965|FG001|Overall Study|Moved to another country|1|||
160529719|NCT00763971|579669966|FG002|Overall Study|Moved to another country|0|||
160529720|NCT00763971|579669964|FG000|Overall Study|Subject wanted dose reduction|0|||
160529721|NCT00763971|579669965|FG001|Overall Study|Subject wanted dose reduction|1|||
160529722|NCT00763971|579669966|FG002|Overall Study|Subject wanted dose reduction|0|||
160529723|NCT00763971|579669964|FG000|Overall Study|Lack of availability|0|||
160529724|NCT00763971|579669965|FG001|Overall Study|Lack of availability|1|||
160529725|NCT00763971|579669966|FG002|Overall Study|Lack of availability|0|||
160529726|NCT00763971|579669964|FG000|Overall Study|Performed final visit on phone|0|||
160529727|NCT00763971|579669965|FG001|Overall Study|Performed final visit on phone|1|||
160765362|NCT03255187|580532760|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
160765363|NCT03255187|580532759|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
160765364|NCT03255187|580532760|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
160765365|NCT02934178|580532761|FG000|Received Vaccination 2|Death|0|||
160765366|NCT02934178|580532762|FG001|Received Vaccination 2|Death|1|||
160765367|NCT02934178|580532761|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
160765368|NCT02934178|580532762|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
160765369|NCT00720278|580532766|FG000|Overall Study|Adverse Event|5|||
160765370|NCT00720278|580532767|FG001|Overall Study|Adverse Event|3|||
160765371|NCT00720278|580532768|FG002|Overall Study|Adverse Event|4|||
160765372|NCT00720278|580532766|FG000|Overall Study|Withdrawal by Subject|0|||
160765373|NCT00720278|580532767|FG001|Overall Study|Withdrawal by Subject|1|||
160765374|NCT00720278|580532768|FG002|Overall Study|Withdrawal by Subject|0|||
160765375|NCT00720278|580532766|FG000|Overall Study|Lost to Follow-up|0|||
160765376|NCT00720278|580532767|FG001|Overall Study|Lost to Follow-up|0|||
160765377|NCT00720278|580532768|FG002|Overall Study|Lost to Follow-up|1|||
160765378|NCT00720278|580532766|FG000|Overall Study|Non-compliance|1|||
160765379|NCT00720278|580532767|FG001|Overall Study|Non-compliance|0|||
160765380|NCT00720278|580532768|FG002|Overall Study|Non-compliance|0|||
160765381|NCT00720278|580532766|FG000|Overall Study|eligibility criteria violation|1|||
160765382|NCT00720278|580532767|FG001|Overall Study|eligibility criteria violation|0|||
160765383|NCT00720278|580532768|FG002|Overall Study|eligibility criteria violation|1|||
160765384|NCT01075048|580532770|FG000|Overall Study|Death|4|||
160981505|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
160529728|NCT00763971|579669966|FG002|Overall Study|Performed final visit on phone|0|||
160529729|NCT00763971|579669964|FG000|Overall Study|Participation in 489-326 required|1|||
160529730|NCT00763971|579669965|FG001|Overall Study|Participation in 489-326 required|0|||
160529731|NCT00763971|579669966|FG002|Overall Study|Participation in 489-326 required|0|||
160529732|NCT01641237|579669971|FG000|Period II|Withdrawal by Subject|1|||
160529733|NCT01641237|579669972|FG001|Period II|Withdrawal by Subject|0|||
160765385|NCT01075048|580532771|FG001|Overall Study|Death|17|||
160765386|NCT01075048|580532772|FG002|Overall Study|Death|12|||
160529734|NCT01641237|579669973|FG002|Period II|Withdrawal by Subject|0|||
160529735|NCT01641237|579669974|FG003|Period II|Withdrawal by Subject|0|||
160529736|NCT01641237|579669971|FG000|Period III|Lost to Follow-up|1|||
160529737|NCT01641237|579669972|FG001|Period III|Lost to Follow-up|0|||
160765387|NCT01075048|580532770|FG000|Overall Study|Start of other or new therapy|4|||
160765388|NCT01075048|580532771|FG001|Overall Study|Start of other or new therapy|36|||
160765389|NCT01075048|580532772|FG002|Overall Study|Start of other or new therapy|46|||
160765390|NCT01075048|580532770|FG000|Overall Study|Withdrawal by Subject|1|||
160765391|NCT01075048|580532771|FG001|Overall Study|Withdrawal by Subject|6|||
160765392|NCT01075048|580532772|FG002|Overall Study|Withdrawal by Subject|3|||
160765393|NCT01075048|580532770|FG000|Overall Study|Lost to Follow-up|0|||
160765394|NCT01075048|580532771|FG001|Overall Study|Lost to Follow-up|1|||
160765395|NCT01075048|580532772|FG002|Overall Study|Lost to Follow-up|1|||
160765396|NCT03944616|580532773|FG000|Overall Study|Lost to Follow-up|0|||
160765397|NCT03944616|580532774|FG001|Overall Study|Lost to Follow-up|2|||
160765398|NCT00997334|580532778|FG000|Overall Study|still on therapy|12|||
160765399|NCT00997334|580532778|FG000|Overall Study|Adverse Event|3|||
160765400|NCT00997334|580532778|FG000|Overall Study|Patient non-compliance|1|||
160765401|NCT00997334|580532778|FG000|Overall Study|Withdrawal by Subject|3|||
160765402|NCT00997334|580532778|FG000|Overall Study|Death|2|||
160765403|NCT00997334|580532778|FG000|Overall Study|Urgent Palliative Care|2|||
160529738|NCT01641237|579669973|FG002|Period III|Lost to Follow-up|0|||
160529739|NCT01641237|579669974|FG003|Period III|Lost to Follow-up|0|||
160529740|NCT00884325|579669975|FG000|Overall Study|Lost to Follow-up|1|||
160529741|NCT00884325|579669976|FG001|Overall Study|Lost to Follow-up|2|||
160529742|NCT00884325|579669975|FG000|Overall Study|Lack of Efficacy|0|||
160529743|NCT00884325|579669976|FG001|Overall Study|Lack of Efficacy|1|||
160529744|NCT00884325|579669975|FG000|Overall Study|Withdrawal by Subject|1|||
160529745|NCT00884325|579669976|FG001|Overall Study|Withdrawal by Subject|1|||
160529746|NCT00884325|579669975|FG000|Overall Study|Not provided|1|||
160529747|NCT00884325|579669976|FG001|Overall Study|Not provided|0|||
160529748|NCT01301456|579669977|FG000|Stage 1|Withdrawal by Subject|0|||
160529749|NCT01301456|579669978|FG001|Stage 1|Withdrawal by Subject|0|||
160529750|NCT01301456|579669979|FG002|Stage 1|Withdrawal by Subject|1|||
160529751|NCT01301456|579669980|FG003|Stage 1|Withdrawal by Subject|0|||
160529752|NCT01301456|579669981|FG004|Stage 1|Withdrawal by Subject|1|||
160529753|NCT01301456|579669982|FG005|Stage 1|Withdrawal by Subject|0|||
160529754|NCT01301456|579669983|FG006|Stage 1|Withdrawal by Subject|0|||
160529755|NCT01301456|579669984|FG007|Stage 1|Withdrawal by Subject|0|||
160529756|NCT01301456|579669985|FG008|Stage 1|Withdrawal by Subject|0|||
160529757|NCT01301456|579669986|FG009|Stage 1|Withdrawal by Subject|0|||
160529758|NCT01301456|579669987|FG010|Stage 1|Withdrawal by Subject|0|||
160529759|NCT01301456|579669988|FG011|Stage 1|Withdrawal by Subject|0|||
160529760|NCT01301456|579669977|FG000|Stage 1|Randomized but not treated|0|||
160529761|NCT01301456|579669978|FG001|Stage 1|Randomized but not treated|0|||
160529762|NCT01301456|579669979|FG002|Stage 1|Randomized but not treated|0|||
160529763|NCT01301456|579669980|FG003|Stage 1|Randomized but not treated|0|||
160529764|NCT01301456|579669981|FG004|Stage 1|Randomized but not treated|0|||
160529765|NCT01301456|579669982|FG005|Stage 1|Randomized but not treated|0|||
160529766|NCT01301456|579669983|FG006|Stage 1|Randomized but not treated|1|||
160529767|NCT01301456|579669984|FG007|Stage 1|Randomized but not treated|0|||
160529768|NCT01301456|579669985|FG008|Stage 1|Randomized but not treated|0|||
160529769|NCT01301456|579669986|FG009|Stage 1|Randomized but not treated|0|||
160529770|NCT01301456|579669987|FG010|Stage 1|Randomized but not treated|0|||
160529771|NCT01301456|579669988|FG011|Stage 1|Randomized but not treated|0|||
160529772|NCT01301456|579669977|FG000|Stage 2|Adverse Event|0|||
160529773|NCT01301456|579669978|FG001|Stage 2|Adverse Event|0|||
160529774|NCT01301456|579669979|FG002|Stage 2|Adverse Event|0|||
160529775|NCT01301456|579669980|FG003|Stage 2|Adverse Event|0|||
160529776|NCT01301456|579669981|FG004|Stage 2|Adverse Event|0|||
160529777|NCT01301456|579669982|FG005|Stage 2|Adverse Event|0|||
160529778|NCT01301456|579669983|FG006|Stage 2|Adverse Event|0|||
160529779|NCT01301456|579669984|FG007|Stage 2|Adverse Event|0|||
160529780|NCT01301456|579669985|FG008|Stage 2|Adverse Event|0|||
160529781|NCT01301456|579669986|FG009|Stage 2|Adverse Event|0|||
160529782|NCT01301456|579669987|FG010|Stage 2|Adverse Event|1|||
160529783|NCT01301456|579669988|FG011|Stage 2|Adverse Event|0|||
160529784|NCT01446016|579669989|FG000|Overall Study|Lost to Follow-up|3|||
160529785|NCT01446016|579669989|FG000|Overall Study|Withdrawal by Subject|1|||
160529786|NCT01446016|579669989|FG000|Overall Study|Toxicity|3|||
160529787|NCT00404066|579669996|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
160529788|NCT00404066|579669996|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
160529789|NCT01399190|579669999|FG000|Overall Study|Not Eligible for Final Analysis|5|||
160529790|NCT01399190|579669999|FG000|Overall Study|Adverse Event|8|||
160529791|NCT01399190|579669999|FG000|Overall Study|Participant's Request|5|||
160529792|NCT01399190|579669999|FG000|Overall Study|Physician Decision|2|||
160529793|NCT03239483|579670000|FG000|Overall Study|Lost to Follow-up|1|||
160529794|NCT03239483|579670001|FG001|Overall Study|Lost to Follow-up|0|||
160529795|NCT03239483|579670000|FG000|Overall Study|Withdrawal by Subject|1|||
160529796|NCT03239483|579670001|FG001|Overall Study|Withdrawal by Subject|0|||
160529797|NCT03678103|579670002|FG000|Overall Study|Withdrawn prior to completion|4|||
160529798|NCT00381563|579670005|FG000|Overall Study|Withdrawal by Subject|5|||
160529799|NCT00381563|579670006|FG001|Overall Study|Withdrawal by Subject|5|||
160529800|NCT00381563|579670005|FG000|Overall Study|Lost to Follow-up|2|||
160529801|NCT00381563|579670006|FG001|Overall Study|Lost to Follow-up|0|||
160529802|NCT00381563|579670005|FG000|Overall Study|Protocol Violation|0|||
160529803|NCT00381563|579670006|FG001|Overall Study|Protocol Violation|1|||
160529804|NCT01003990|579670007|FG000|Overall Study|Adverse Event|8|||
160529805|NCT01003990|579670008|FG001|Overall Study|Adverse Event|5|||
160529806|NCT01003990|579670009|FG002|Overall Study|Adverse Event|11|||
160529807|NCT01003990|579670007|FG000|Overall Study|Death|0|||
160529808|NCT01003990|579670008|FG001|Overall Study|Death|8|||
160529809|NCT01003990|579670009|FG002|Overall Study|Death|1|||
160529810|NCT01003990|579670007|FG000|Overall Study|Lack of Efficacy|10|||
160529811|NCT01003990|579670008|FG001|Overall Study|Lack of Efficacy|2|||
160529812|NCT01003990|579670009|FG002|Overall Study|Lack of Efficacy|3|||
160529813|NCT01003990|579670007|FG000|Overall Study|Lost to Follow-up|30|||
160529814|NCT01003990|579670008|FG001|Overall Study|Lost to Follow-up|12|||
160529815|NCT01003990|579670009|FG002|Overall Study|Lost to Follow-up|7|||
160529816|NCT01003990|579670007|FG000|Overall Study|Reasons Not Identified|14|||
160529817|NCT01003990|579670008|FG001|Overall Study|Reasons Not Identified|13|||
160529818|NCT01003990|579670009|FG002|Overall Study|Reasons Not Identified|8|||
160529819|NCT01003990|579670007|FG000|Overall Study|Poor/Non-compliance|4|||
160529820|NCT01003990|579670008|FG001|Overall Study|Poor/Non-compliance|3|||
160529821|NCT01003990|579670009|FG002|Overall Study|Poor/Non-compliance|2|||
160529822|NCT01003990|579670007|FG000|Overall Study|Pregnancy|10|||
160529823|NCT01003990|579670008|FG001|Overall Study|Pregnancy|2|||
160529824|NCT01003990|579670009|FG002|Overall Study|Pregnancy|4|||
160529825|NCT01003990|579670007|FG000|Overall Study|No Longer Met Study Criteria|4|||
160529826|NCT01003990|579670008|FG001|Overall Study|No Longer Met Study Criteria|1|||
160529827|NCT01003990|579670009|FG002|Overall Study|No Longer Met Study Criteria|0|||
160529828|NCT01003990|579670007|FG000|Overall Study|Subject Withdrew Consent|12|||
160529829|NCT01003990|579670008|FG001|Overall Study|Subject Withdrew Consent|5|||
160529830|NCT01003990|579670009|FG002|Overall Study|Subject Withdrew Consent|7|||
160529831|NCT01271803|579670010|FG000|Overall Study|Progressive disease|0|||
160529832|NCT01271803|579670011|FG001|Overall Study|Progressive disease|0|||
160529833|NCT01271803|579670012|FG002|Overall Study|Progressive disease|2|||
160529834|NCT01271803|579670010|FG000|Overall Study|Death|53|||
160529835|NCT01271803|579670011|FG001|Overall Study|Death|34|||
160529836|NCT01271803|579670012|FG002|Overall Study|Death|0|||
160529837|NCT01271803|579670010|FG000|Overall Study|Withdrawal by Subject|1|||
160529838|NCT01271803|579670011|FG001|Overall Study|Withdrawal by Subject|5|||
160529839|NCT01271803|579670012|FG002|Overall Study|Withdrawal by Subject|0|||
160529840|NCT01271803|579670010|FG000|Overall Study|Lost to Follow-up|1|||
160529841|NCT01271803|579670011|FG001|Overall Study|Lost to Follow-up|0|||
160529842|NCT01271803|579670012|FG002|Overall Study|Lost to Follow-up|0|||
160529843|NCT01975428|579670013|FG000|Overall Study|Lost to Follow-up|17|||
160529844|NCT01975428|579670014|FG001|Overall Study|Lost to Follow-up|4|||
160529845|NCT01975428|579670013|FG000|Overall Study|Withdrawal by Subject|3|||
160529846|NCT01975428|579670014|FG001|Overall Study|Withdrawal by Subject|10|||
160529847|NCT02187809|579670015|FG000|Overall Study|The study was terminated|3|||
160529848|NCT02663271|579670018|FG000|Overall Study|Withdrawal by Subject|5|||
160529849|NCT02663271|579670018|FG000|Overall Study|Lack of Efficacy|1|||
160529850|NCT01572675|579670019|FG000|Overall Study|End of prescribed treatment|140|||
160529851|NCT01572675|579670020|FG001|Overall Study|End of prescribed treatment|118|||
160529852|NCT01572675|579670019|FG000|Overall Study|Recovery|16|||
160529853|NCT01572675|579670020|FG001|Overall Study|Recovery|23|||
160529854|NCT01572675|579670019|FG000|Overall Study|Lack of Efficacy|31|||
160529855|NCT01572675|579670020|FG001|Overall Study|Lack of Efficacy|31|||
160529856|NCT01572675|579670019|FG000|Overall Study|Intolerance|6|||
160529857|NCT01572675|579670020|FG001|Overall Study|Intolerance|5|||
160529858|NCT01572675|579670019|FG000|Overall Study|Improved symptoms|8|||
160529859|NCT01572675|579670020|FG001|Overall Study|Improved symptoms|2|||
160529860|NCT01572675|579670019|FG000|Overall Study|Surgical intervention|3|||
160529861|NCT01572675|579670020|FG001|Overall Study|Surgical intervention|6|||
160529862|NCT01572675|579670019|FG000|Overall Study|Withdrawal by Subject|5|||
160529863|NCT01572675|579670020|FG001|Overall Study|Withdrawal by Subject|1|||
160529864|NCT01572675|579670019|FG000|Overall Study|Physician Decision|2|||
160529865|NCT01572675|579670020|FG001|Overall Study|Physician Decision|2|||
160529866|NCT01572675|579670019|FG000|Overall Study|Death unrelated to coxibs|1|||
160529867|NCT01572675|579670020|FG001|Overall Study|Death unrelated to coxibs|1|||
160529868|NCT01572675|579670019|FG000|Overall Study|Other disease detected|1|||
160529869|NCT01572675|579670020|FG001|Overall Study|Other disease detected|1|||
160529870|NCT01572675|579670019|FG000|Overall Study|Unknown reason|1|||
160529871|NCT01572675|579670020|FG001|Overall Study|Unknown reason|1|||
160529872|NCT01572675|579670019|FG000|Overall Study|Rheumatologist new evaluation|0|||
160529873|NCT01572675|579670020|FG001|Overall Study|Rheumatologist new evaluation|1|||
160529874|NCT01572675|579670019|FG000|Overall Study|Missing data|1|||
160529875|NCT01572675|579670020|FG001|Overall Study|Missing data|4|||
160529876|NCT01572675|579670019|FG000|Overall Study|Lost to Follow-up|22|||
160529877|NCT01572675|579670020|FG001|Overall Study|Lost to Follow-up|27|||
160529878|NCT03346057|579670022|FG000|Overall Study|Death|1|||
160765404|NCT00997334|580532778|FG000|Overall Study|No lesion amenable|1|||
160765405|NCT00997334|580532778|FG000|Overall Study|Ineligible|1|||
160765406|NCT01586195|580532780|FG000|Overall Study|Death|11|||
160529879|NCT03346057|579670023|FG001|Overall Study|Death|2|||
160529880|NCT03346057|579670024|FG002|Overall Study|Death|0|||
160529881|NCT03346057|579670025|FG003|Overall Study|Death|0|||
160529882|NCT03346057|579670022|FG000|Overall Study|Lost to Follow-up|0|||
160529883|NCT03346057|579670023|FG001|Overall Study|Lost to Follow-up|2|||
160529884|NCT03346057|579670024|FG002|Overall Study|Lost to Follow-up|1|||
160529885|NCT03346057|579670025|FG003|Overall Study|Lost to Follow-up|0|||
160529886|NCT03346057|579670022|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
160529887|NCT03346057|579670023|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
160529888|NCT03346057|579670024|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
160529889|NCT03346057|579670025|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
160765407|NCT01586195|580532780|FG000|Overall Study|Withdrawal of Consent|5|||
160529890|NCT03346057|579670022|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
160529891|NCT03346057|579670023|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
160529892|NCT03346057|579670024|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
160869553|NCT04730804|580913781|FG001|Overall Study|Withdrawal by Subject|0|||
160869554|NCT04730804|580913782|FG002|Overall Study|Withdrawal by Subject|0|||
160869555|NCT04730804|580913783|FG003|Overall Study|Withdrawal by Subject|0|||
160869556|NCT04730804|580913784|FG004|Overall Study|Withdrawal by Subject|1|||
160869557|NCT04730804|580913785|FG005|Overall Study|Withdrawal by Subject|2|||
160869558|NCT02656693|580915573|FG000|Overall Study|Pregnancy|1|||
160869559|NCT02656693|580915574|FG001|Overall Study|Pregnancy|1|||
160869560|NCT02656693|580915575|FG002|Overall Study|Pregnancy|1|||
160869561|NCT02656693|580915573|FG000|Overall Study|Bariatric surgery|0|||
160869562|NCT02656693|580915574|FG001|Overall Study|Bariatric surgery|1|||
160869563|NCT02656693|580915575|FG002|Overall Study|Bariatric surgery|2|||
160869564|NCT02565784|580915576|FG000|First Treatment|Adverse Event|1|||
160869565|NCT02565784|580915576|FG000|First Treatment|Withdrawal by Subject|1|||
160869566|NCT02565784|580915576|FG000|Second Treatment|Withdrawal by Subject|2|||
160869567|NCT01596062|580915577|FG000|Overall Study|Adverse Event|1|||
160869568|NCT01596062|580915578|FG001|Overall Study|Adverse Event|0|||
160869569|NCT01596062|580915579|FG002|Overall Study|Adverse Event|2|||
160869570|NCT01596062|580915577|FG000|Overall Study|Lack of Efficacy|0|||
160869571|NCT01596062|580915578|FG001|Overall Study|Lack of Efficacy|0|||
160869572|NCT01596062|580915579|FG002|Overall Study|Lack of Efficacy|1|||
160869573|NCT03180840|580915580|FG000|Overall Study|Withdrawal by Subject|1|||
160869574|NCT02863419|580915587|FG000|Overall Study|Lost to Follow-up|0|||
160869575|NCT02863419|580915588|FG001|Overall Study|Lost to Follow-up|1|||
160869576|NCT02863419|580915589|FG002|Overall Study|Lost to Follow-up|4|||
160869577|NCT02863419|580915587|FG000|Overall Study|Withdrawal by Subject|5|||
160869578|NCT02863419|580915588|FG001|Overall Study|Withdrawal by Subject|5|||
160869579|NCT02863419|580915589|FG002|Overall Study|Withdrawal by Subject|3|||
160869580|NCT02863419|580915587|FG000|Overall Study|Died|3|||
160869581|NCT02863419|580915588|FG001|Overall Study|Died|4|||
160869582|NCT02863419|580915589|FG002|Overall Study|Died|1|||
160869583|NCT00297258|580915592|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
160869584|NCT00297258|580915592|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
160869585|NCT00297258|580915592|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
160869586|NCT00297258|580915592|FG000|Overall Study|Intercurrent Illness|3|||
160869587|NCT00297258|580915592|FG000|Overall Study|Intercurrent Death|2|||
160869588|NCT00297258|580915592|FG000|Overall Study|Deteriorization of General Condition|1|||
160869589|NCT00297258|580915592|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
160869590|NCT00297258|580915592|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
160869591|NCT00297258|580915592|FG000|Overall Study|Switch to Commercial Treatment|1|||
160869592|NCT00297258|580915592|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
160869593|NCT02454517|580915593|FG000|Overall Study|Withdrawal by Subject|3|||
160869594|NCT02454517|580915594|FG001|Overall Study|Withdrawal by Subject|0|||
160869595|NCT02454517|580915593|FG000|Overall Study|Lost to Follow-up|4|||
160869596|NCT02454517|580915594|FG001|Overall Study|Lost to Follow-up|7|||
160869597|NCT02454517|580915593|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
160529893|NCT03346057|579670025|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
160529894|NCT03346057|579670022|FG000|Overall Study|Physician Decision|3|||
160529895|NCT03346057|579670023|FG001|Overall Study|Physician Decision|2|||
160529896|NCT03346057|579670024|FG002|Overall Study|Physician Decision|0|||
160529897|NCT03346057|579670025|FG003|Overall Study|Physician Decision|2|||
160529898|NCT03346057|579670022|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
160529899|NCT03346057|579670023|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
160529900|NCT03346057|579670024|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
160529901|NCT03346057|579670025|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
160529902|NCT03346057|579670022|FG000|Overall Study|Withdrawal by Subject|1|||
160529903|NCT03346057|579670023|FG001|Overall Study|Withdrawal by Subject|0|||
160529904|NCT03346057|579670024|FG002|Overall Study|Withdrawal by Subject|0|||
160529905|NCT03346057|579670025|FG003|Overall Study|Withdrawal by Subject|0|||
160529906|NCT01351623|579670026|FG000|Overall Study|Protocol Violation|2|||
160529907|NCT01351623|579670026|FG000|Overall Study|Adverse Event|4|||
160529908|NCT01351623|579670026|FG000|Overall Study|Withdrawal by Subject|1|||
160529909|NCT01351623|579670026|FG000|Overall Study|Death|2|||
160529910|NCT04399122|579670029|FG000|Overall Study|Lost to Follow-up|2|||
160529911|NCT04399122|579670030|FG001|Overall Study|Lost to Follow-up|0|||
160529912|NCT04399122|579670029|FG000|Overall Study|Withdrawal by Subject|1|||
160529913|NCT04399122|579670030|FG001|Overall Study|Withdrawal by Subject|0|||
160529914|NCT02322229|579670031|FG000|Overall Study|Physician Decision|2|||
160529915|NCT00705432|579670032|FG000|Treatment Period|Adverse Event|45|||
160529916|NCT00705432|579670033|FG001|Treatment Period|Adverse Event|37|||
160529917|NCT00705432|579670034|FG002|Treatment Period|Adverse Event|51|||
160529918|NCT00705432|579670035|FG003|Treatment Period|Adverse Event|12|||
160529919|NCT00705432|579670036|FG004|Treatment Period|Adverse Event|8|||
160529920|NCT00705432|579670037|FG005|Treatment Period|Adverse Event|9|||
160529921|NCT00705432|579670032|FG000|Treatment Period|Treatment failure|92|||
160529922|NCT00705432|579670033|FG001|Treatment Period|Treatment failure|42|||
160529923|NCT00705432|579670034|FG002|Treatment Period|Treatment failure|33|||
160529924|NCT00705432|579670035|FG003|Treatment Period|Treatment failure|25|||
160529925|NCT00705432|579670036|FG004|Treatment Period|Treatment failure|13|||
160529926|NCT00705432|579670037|FG005|Treatment Period|Treatment failure|14|||
160529927|NCT00705432|579670032|FG000|Treatment Period|Non medical reason|26|||
160529928|NCT00705432|579670033|FG001|Treatment Period|Non medical reason|32|||
160529929|NCT00705432|579670034|FG002|Treatment Period|Non medical reason|37|||
160529930|NCT00705432|579670035|FG003|Treatment Period|Non medical reason|4|||
160529931|NCT00705432|579670036|FG004|Treatment Period|Non medical reason|7|||
160529932|NCT00705432|579670037|FG005|Treatment Period|Non medical reason|7|||
160529933|NCT00705432|579670032|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
160529934|NCT00705432|579670033|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
160529935|NCT00705432|579670034|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
160529936|NCT00705432|579670035|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
160529937|NCT00705432|579670036|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
160529938|NCT00705432|579670037|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
160529939|NCT00705432|579670032|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
160529940|NCT00705432|579670033|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
160529941|NCT00705432|579670034|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
160529942|NCT00705432|579670035|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
160529943|NCT00705432|579670036|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
160529944|NCT00705432|579670037|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
160529945|NCT00521053|579670038|FG000|Observation Phase|Disease Progression|55|||
160529946|NCT00521053|579670038|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
160529947|NCT00521053|579670038|FG000|Observation Phase|Death|2|||
160529948|NCT00521053|579670038|FG000|Observation Phase|Adverse Event|1|||
160529949|NCT00521053|579670038|FG000|Observation Phase|Other non-study melanoma treatment|1|||
160529950|NCT00521053|579670038|FG000|Observation Phase|Physician Decision|1|||
160529951|NCT01667107|579670039|FG000|Overall Study|Adverse Event|4|||
160529952|NCT01667107|579670040|FG001|Overall Study|Adverse Event|3|||
160529953|NCT01667107|579670039|FG000|Overall Study|Tolerability issues|0|||
160529954|NCT01667107|579670040|FG001|Overall Study|Tolerability issues|2|||
160765408|NCT01586195|580532780|FG000|Overall Study|Started new anti-melanoma therapy|1|||
160765409|NCT01586195|580532780|FG000|Overall Study|Reason not specified|9|||
160765410|NCT01287936|580532781|FG000|Overall Study|Lost to Follow-up|0|||
160529955|NCT01667107|579670039|FG000|Overall Study|Protocol Violation|0|||
160529956|NCT01667107|579670040|FG001|Overall Study|Protocol Violation|1|||
160529957|NCT01667107|579670039|FG000|Overall Study|Lack of Efficacy|0|||
160529958|NCT01667107|579670040|FG001|Overall Study|Lack of Efficacy|1|||
160529959|NCT01557348|579670041|FG000|Overall Study|Adverse Event|6|||
160529960|NCT01557348|579670042|FG001|Overall Study|Adverse Event|16|||
160529961|NCT01557348|579670041|FG000|Overall Study|Infusion reaction event|5|||
160529962|NCT01557348|579670042|FG001|Overall Study|Infusion reaction event|5|||
160529963|NCT01557348|579670041|FG000|Overall Study|Death|7|||
160529964|NCT01557348|579670042|FG001|Overall Study|Death|4|||
160529965|NCT01557348|579670041|FG000|Overall Study|Insufficient Therapeutic Response|13|||
160869598|NCT02454517|580915594|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
160869599|NCT00473382|580915595|FG000|Core Study|Adverse Event|3|||
160869600|NCT00473382|580915596|FG001|Core Study|Adverse Event|1|||
160869601|NCT00473382|580915597|FG002|Core Study|Adverse Event|1|||
160869602|NCT00473382|580915595|FG000|Core Study|Death|3|||
160869603|NCT00473382|580915596|FG001|Core Study|Death|5|||
160869604|NCT00473382|580915597|FG002|Core Study|Death|10|||
160869605|NCT00473382|580915595|FG000|Core Study|Lost to Follow-up|3|||
160869606|NCT00473382|580915596|FG001|Core Study|Lost to Follow-up|3|||
160869607|NCT00473382|580915597|FG002|Core Study|Lost to Follow-up|3|||
160869608|NCT00473382|580915595|FG000|Core Study|Physician Decision|1|||
160869609|NCT00473382|580915596|FG001|Core Study|Physician Decision|2|||
160869610|NCT00473382|580915597|FG002|Core Study|Physician Decision|2|||
160869611|NCT00473382|580915595|FG000|Core Study|Subject non-compliance|5|||
160869612|NCT00473382|580915596|FG001|Core Study|Subject non-compliance|2|||
160869613|NCT00473382|580915597|FG002|Core Study|Subject non-compliance|1|||
160869614|NCT00473382|580915595|FG000|Core Study|Subject needed other treatment|1|||
160869615|NCT00473382|580915596|FG001|Core Study|Subject needed other treatment|3|||
160869616|NCT00473382|580915597|FG002|Core Study|Subject needed other treatment|2|||
160869617|NCT00473382|580915595|FG000|Core Study|Subject's decision|12|||
160869618|NCT00473382|580915596|FG001|Core Study|Subject's decision|11|||
160869619|NCT00473382|580915597|FG002|Core Study|Subject's decision|10|||
160869620|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
160869621|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
160869622|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
160869623|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Death|1|||
160869624|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Death|3|||
160869625|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Death|3|||
160869626|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
160869627|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
160869628|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
160869629|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
160869630|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
160529966|NCT01557348|579670042|FG001|Overall Study|Insufficient Therapeutic Response|28|||
160869631|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
160869632|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
160869633|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
160869634|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
160869635|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
160869636|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
160869637|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
160869638|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
160869639|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
160869640|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
160869641|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Death|1|||
160869642|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Death|7|||
160869643|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Death|4|||
160869644|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
160869645|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
160869646|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
160869647|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
160869648|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
160869649|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
160869650|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
160869651|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
160869652|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
160869653|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
160869654|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
160869655|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
160869656|NCT02999672|580915598|FG000|Overall Study|Death|0|||
160869657|NCT02999672|580915599|FG001|Overall Study|Death|1|||
160869658|NCT02999672|580915598|FG000|Overall Study|Study Terminated by Sponsor|0|||
160869659|NCT02999672|580915599|FG001|Overall Study|Study Terminated by Sponsor|1|||
160869660|NCT02999672|580915598|FG000|Overall Study|Progressive Disease|9|||
160869661|NCT02999672|580915599|FG001|Overall Study|Progressive Disease|5|||
160869662|NCT02999672|580915598|FG000|Overall Study|Adverse Event|4|||
160869663|NCT02999672|580915599|FG001|Overall Study|Adverse Event|0|||
160869664|NCT03565497|580915600|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
160869665|NCT03565497|580915601|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
160869666|NCT03565497|580915602|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
160869667|NCT03565497|580915600|FG000|Overall Study|Lost to Follow-up|1|||
160869668|NCT03565497|580915601|FG001|Overall Study|Lost to Follow-up|1|||
160869669|NCT03565497|580915602|FG002|Overall Study|Lost to Follow-up|2|||
160869670|NCT03565497|580915600|FG000|Overall Study|Withdrawal by Subject|1|||
160869671|NCT03565497|580915601|FG001|Overall Study|Withdrawal by Subject|1|||
160869672|NCT03565497|580915602|FG002|Overall Study|Withdrawal by Subject|1|||
160869673|NCT01470326|580915603|FG000|Overall Study|Protocol Violation|32|||
160869674|NCT01470326|580915603|FG000|Overall Study|No Drug Administration Information|2|||
160869675|NCT01470326|580915603|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
160869676|NCT01166282|580915604|FG000|Open-label Period|Adverse Event|0|||
160869677|NCT01166282|580915605|FG001|Open-label Period|Adverse Event|0|||
160869678|NCT01166282|580915606|FG002|Open-label Period|Adverse Event|6|||
160869679|NCT01166282|580915604|FG000|Open-label Period|Withdrawal by Subject|0|||
160869680|NCT01166282|580915605|FG001|Open-label Period|Withdrawal by Subject|0|||
160869681|NCT01166282|580915606|FG002|Open-label Period|Withdrawal by Subject|4|||
160869682|NCT01166282|580915604|FG000|Open-label Period|Lack of Efficacy|0|||
160869683|NCT01166282|580915605|FG001|Open-label Period|Lack of Efficacy|0|||
160869684|NCT01166282|580915606|FG002|Open-label Period|Lack of Efficacy|2|||
160869685|NCT01166282|580915604|FG000|Open-label Period|Remission|0|||
160869686|NCT01166282|580915605|FG001|Open-label Period|Remission|0|||
160869687|NCT01166282|580915606|FG002|Open-label Period|Remission|4|||
160869688|NCT01166282|580915604|FG000|Open-label Period|Irregular Compliance|0|||
160869689|NCT01166282|580915605|FG001|Open-label Period|Irregular Compliance|0|||
160869690|NCT01166282|580915606|FG002|Open-label Period|Irregular Compliance|1|||
160869691|NCT02561832|580915607|FG000|Overall Study|Withdrawal by Subject|1|||
160869692|NCT02561832|580915608|FG001|Overall Study|Withdrawal by Subject|1|||
160869693|NCT02561832|580915607|FG000|Overall Study|Adverse Event|3|||
160869694|NCT02561832|580915608|FG001|Overall Study|Adverse Event|0|||
160869695|NCT02561832|580915607|FG000|Overall Study|Disease progression|3|||
160869696|NCT02561832|580915608|FG001|Overall Study|Disease progression|3|||
160869697|NCT02892448|580915615|FG000|Overall Study|Screening failure|2|||
160869698|NCT02892448|580915616|FG001|Overall Study|Screening failure|2|||
160869699|NCT02892448|580915617|FG002|Overall Study|Screening failure|1|||
160869700|NCT02023697|580915619|FG000|Treatment Period|Radiological progression|13|||
160869701|NCT02023697|580915620|FG001|Treatment Period|Radiological progression|17|||
160869702|NCT02023697|580915621|FG002|Treatment Period|Radiological progression|26|||
160869703|NCT02023697|580915619|FG000|Treatment Period|Never Treated|5|||
160529967|NCT01557348|579670041|FG000|Overall Study|Withdrawal by Subject|5|||
160529968|NCT01557348|579670042|FG001|Overall Study|Withdrawal by Subject|4|||
160529969|NCT01557348|579670041|FG000|Overall Study|Lost to Follow-up|26|||
160529970|NCT01557348|579670042|FG001|Overall Study|Lost to Follow-up|22|||
160529971|NCT01557348|579670041|FG000|Overall Study|Administrative|18|||
160529972|NCT01557348|579670042|FG001|Overall Study|Administrative|11|||
160529973|NCT03427125|579670043|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
160529974|NCT03427125|579670044|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
160529975|NCT03427125|579670045|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
160529976|NCT05390580|579670048|FG000|Overall Study|Physician Decision|3|||
160529977|NCT05390580|579670049|FG001|Overall Study|Physician Decision|2|||
160529978|NCT04448756|579670050|FG000|Overall Study|Adverse Event|0|||
160529979|NCT04448756|579670051|FG001|Overall Study|Adverse Event|1|||
160529980|NCT04448756|579670052|FG002|Overall Study|Adverse Event|0|||
160529981|NCT04448756|579670050|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
160529982|NCT04448756|579670051|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
160529983|NCT04448756|579670052|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
160529984|NCT04448756|579670050|FG000|Overall Study|Withdrawal by Subject|0|||
160529985|NCT04448756|579670051|FG001|Overall Study|Withdrawal by Subject|3|||
160529986|NCT04448756|579670052|FG002|Overall Study|Withdrawal by Subject|1|||
160529987|NCT04448756|579670050|FG000|Overall Study|Death|2|||
160529988|NCT04448756|579670051|FG001|Overall Study|Death|1|||
160529989|NCT04448756|579670052|FG002|Overall Study|Death|0|||
160529990|NCT02733185|579670053|FG000|Overall Study|Withdrawal by Subject|12|||
160529991|NCT02733185|579670054|FG001|Overall Study|Withdrawal by Subject|10|||
160529992|NCT02733185|579670055|FG002|Overall Study|Withdrawal by Subject|17|||
160529993|NCT02733185|579670056|FG003|Overall Study|Withdrawal by Subject|21|||
160529994|NCT02733185|579670053|FG000|Overall Study|Death|46|||
160529995|NCT02733185|579670054|FG001|Overall Study|Death|34|||
160529996|NCT02733185|579670055|FG002|Overall Study|Death|35|||
160869704|NCT02023697|580915620|FG001|Treatment Period|Never Treated|6|||
160869705|NCT02023697|580915621|FG002|Treatment Period|Never Treated|10|||
160869706|NCT02023697|580915619|FG000|Treatment Period|Adverse Event|13|||
160869707|NCT02023697|580915620|FG001|Treatment Period|Adverse Event|25|||
160869708|NCT02023697|580915621|FG002|Treatment Period|Adverse Event|23|||
160869709|NCT02023697|580915619|FG000|Treatment Period|Logistical difficulties|1|||
160869710|NCT02023697|580915620|FG001|Treatment Period|Logistical difficulties|1|||
160869711|NCT02023697|580915621|FG002|Treatment Period|Logistical difficulties|1|||
160869712|NCT02023697|580915619|FG000|Treatment Period|Clinical progression|10|||
160869713|NCT02023697|580915620|FG001|Treatment Period|Clinical progression|8|||
160869714|NCT02023697|580915621|FG002|Treatment Period|Clinical progression|28|||
160869715|NCT02023697|580915619|FG000|Treatment Period|Withdrawal by Subject|4|||
160869716|NCT02023697|580915620|FG001|Treatment Period|Withdrawal by Subject|5|||
160869717|NCT02023697|580915621|FG002|Treatment Period|Withdrawal by Subject|13|||
160869718|NCT02023697|580915619|FG000|Treatment Period|Safety outcome reached|0|||
160869719|NCT02023697|580915620|FG001|Treatment Period|Safety outcome reached|1|||
160869720|NCT02023697|580915621|FG002|Treatment Period|Safety outcome reached|0|||
160869721|NCT02023697|580915619|FG000|Treatment Period|Physician Decision|0|||
160869722|NCT02023697|580915620|FG001|Treatment Period|Physician Decision|0|||
160869723|NCT02023697|580915621|FG002|Treatment Period|Physician Decision|1|||
160869724|NCT02023697|580915619|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
160869725|NCT02023697|580915620|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
160869726|NCT02023697|580915621|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
160869727|NCT02023697|580915619|FG000|Active Follow-up Period|Lost to Follow-up|1|||
160869728|NCT02023697|580915620|FG001|Active Follow-up Period|Lost to Follow-up|1|||
160869729|NCT02023697|580915621|FG002|Active Follow-up Period|Lost to Follow-up|1|||
160869730|NCT02023697|580915619|FG000|Active Follow-up Period|Deterioration of general condition|1|||
160869731|NCT02023697|580915620|FG001|Active Follow-up Period|Deterioration of general condition|1|||
160869732|NCT02023697|580915621|FG002|Active Follow-up Period|Deterioration of general condition|1|||
160869733|NCT02023697|580915619|FG000|Active Follow-up Period|Other unspecified|2|||
160869734|NCT02023697|580915620|FG001|Active Follow-up Period|Other unspecified|0|||
160869735|NCT02023697|580915621|FG002|Active Follow-up Period|Other unspecified|1|||
160869736|NCT02023697|580915619|FG000|Active Follow-up Period|Clinical progression|0|||
160869737|NCT02023697|580915620|FG001|Active Follow-up Period|Clinical progression|2|||
160869738|NCT02023697|580915621|FG002|Active Follow-up Period|Clinical progression|1|||
160869739|NCT02023697|580915619|FG000|Active Follow-up Period|Radiological progression|0|||
160529997|NCT02733185|579670056|FG003|Overall Study|Death|43|||
160529998|NCT02733185|579670053|FG000|Overall Study|Lost to Follow-up|17|||
160529999|NCT02733185|579670054|FG001|Overall Study|Lost to Follow-up|18|||
160530000|NCT02733185|579670055|FG002|Overall Study|Lost to Follow-up|16|||
160530001|NCT02733185|579670056|FG003|Overall Study|Lost to Follow-up|11|||
160530002|NCT02499770|579670059|FG000|Overall Study|Death|17|||
160530003|NCT02499770|579670060|FG001|Overall Study|Death|56|||
160530004|NCT02499770|579670059|FG000|Overall Study|Study completion|1|||
160869740|NCT02023697|580915620|FG001|Active Follow-up Period|Radiological progression|0|||
160530005|NCT02499770|579670060|FG001|Overall Study|Study completion|10|||
160530006|NCT02499770|579670059|FG000|Overall Study|Withdrawal by Subject|0|||
160530007|NCT02499770|579670060|FG001|Overall Study|Withdrawal by Subject|7|||
160530008|NCT02499770|579670059|FG000|Overall Study|Lost to Follow-up|0|||
160530009|NCT02499770|579670060|FG001|Overall Study|Lost to Follow-up|2|||
160530010|NCT02499770|579670059|FG000|Overall Study|Subject declined further treatment|1|||
160530011|NCT02499770|579670060|FG001|Overall Study|Subject declined further treatment|0|||
160530012|NCT02499770|579670059|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
160530013|NCT02499770|579670060|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
160530014|NCT02499770|579670059|FG000|Overall Study|Randomized but not enrolled|0|||
160530015|NCT02499770|579670060|FG001|Overall Study|Randomized but not enrolled|1|||
160530016|NCT02129205|579670063|FG000|Overall Study|Withdrawal by Subject|0|||
160530017|NCT02129205|579670064|FG001|Overall Study|Withdrawal by Subject|0|||
160530018|NCT02129205|579670065|FG002|Overall Study|Withdrawal by Subject|0|||
160530019|NCT02129205|579670066|FG003|Overall Study|Withdrawal by Subject|0|||
160530020|NCT02129205|579670067|FG004|Overall Study|Withdrawal by Subject|1|||
160530021|NCT02129205|579670068|FG005|Overall Study|Withdrawal by Subject|1|||
160530022|NCT02129205|579670069|FG006|Overall Study|Withdrawal by Subject|1|||
160530023|NCT02129205|579670070|FG007|Overall Study|Withdrawal by Subject|0|||
160530024|NCT02129205|579670071|FG008|Overall Study|Withdrawal by Subject|1|||
160530025|NCT02129205|579670072|FG009|Overall Study|Withdrawal by Subject|0|||
160530026|NCT02129205|579670063|FG000|Overall Study|Other|1|||
160530027|NCT02129205|579670064|FG001|Overall Study|Other|0|||
160530028|NCT02129205|579670065|FG002|Overall Study|Other|0|||
160530029|NCT02129205|579670066|FG003|Overall Study|Other|0|||
160530030|NCT02129205|579670067|FG004|Overall Study|Other|2|||
160530031|NCT02129205|579670068|FG005|Overall Study|Other|3|||
160530032|NCT02129205|579670069|FG006|Overall Study|Other|3|||
160530033|NCT02129205|579670070|FG007|Overall Study|Other|2|||
160530034|NCT02129205|579670071|FG008|Overall Study|Other|1|||
160530035|NCT02129205|579670072|FG009|Overall Study|Other|0|||
160530036|NCT04376060|579670073|FG000|Overall Study|Physician Decision|1|||
160530037|NCT01791803|579670076|FG000|Overall Study|Withdrawal by Subject|0|||
160530038|NCT01791803|579670077|FG001|Overall Study|Withdrawal by Subject|0|||
160530039|NCT01791803|579670078|FG002|Overall Study|Withdrawal by Subject|0|||
160530040|NCT01791803|579670079|FG003|Overall Study|Withdrawal by Subject|2|||
160530041|NCT01791803|579670076|FG000|Overall Study|Physician Decision|0|||
160530042|NCT01791803|579670077|FG001|Overall Study|Physician Decision|2|||
160765411|NCT01287936|580532782|FG001|Overall Study|Lost to Follow-up|1|||
160765412|NCT01287936|580532783|FG002|Overall Study|Lost to Follow-up|1|||
160765413|NCT01855958|580532784|FG000|Overall Study|Withdrawal by Subject|1|||
160765414|NCT01855958|580532785|FG001|Overall Study|Withdrawal by Subject|0|||
160765415|NCT00296244|580532786|FG000|Overall Study|Underwent retransplant|0|||
160765416|NCT00296244|580532787|FG001|Overall Study|Underwent retransplant|1|||
160765417|NCT00703534|580532788|FG000|Overall Study|Adverse Event|14|||
160765418|NCT00703534|580532789|FG001|Overall Study|Adverse Event|3|||
160765419|NCT00703534|580532788|FG000|Overall Study|Withdrawal by Subject|8|||
160765420|NCT00703534|580532789|FG001|Overall Study|Withdrawal by Subject|7|||
160765421|NCT00703534|580532788|FG000|Overall Study|Incorrect Enrollment|6|||
160765422|NCT00703534|580532789|FG001|Overall Study|Incorrect Enrollment|6|||
160765423|NCT00703534|580532788|FG000|Overall Study|Lost to Follow-up|1|||
160765424|NCT00703534|580532789|FG001|Overall Study|Lost to Follow-up|4|||
160765425|NCT00703534|580532788|FG000|Overall Study|Severe Non Compliance|1|||
160765426|NCT00703534|580532789|FG001|Overall Study|Severe Non Compliance|5|||
160765427|NCT00427934|580532790|FG000|Overall Study|Adverse Event|1|||
160765428|NCT00427934|580532791|FG001|Overall Study|Adverse Event|0|||
160765429|NCT00427934|580532792|FG002|Overall Study|Adverse Event|5|||
160765430|NCT00427934|580532793|FG003|Overall Study|Adverse Event|4|||
160765431|NCT00427934|580532790|FG000|Overall Study|Lack of Efficacy|0|||
160765432|NCT00427934|580532791|FG001|Overall Study|Lack of Efficacy|0|||
160765433|NCT00427934|580532792|FG002|Overall Study|Lack of Efficacy|5|||
160765434|NCT00427934|580532793|FG003|Overall Study|Lack of Efficacy|2|||
160765435|NCT00427934|580532790|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
160765436|NCT00427934|580532791|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
160765437|NCT00427934|580532792|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
160765438|NCT00427934|580532793|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
160765439|NCT00427934|580532790|FG000|Overall Study|Other|0|||
160765440|NCT00427934|580532791|FG001|Overall Study|Other|0|||
160765441|NCT00427934|580532792|FG002|Overall Study|Other|11|||
160765442|NCT00427934|580532793|FG003|Overall Study|Other|5|||
160765443|NCT00427934|580532790|FG000|Overall Study|Withdrawal by Subject|0|||
160765444|NCT00427934|580532791|FG001|Overall Study|Withdrawal by Subject|0|||
160765445|NCT00427934|580532792|FG002|Overall Study|Withdrawal by Subject|1|||
160765446|NCT00427934|580532793|FG003|Overall Study|Withdrawal by Subject|3|||
160765447|NCT01373164|580532794|FG000|Overall Study|Lost to Follow-up|0|||
160765448|NCT01373164|580532795|FG001|Overall Study|Lost to Follow-up|0|||
160765449|NCT01373164|580532796|FG002|Overall Study|Lost to Follow-up|1|||
160765450|NCT01373164|580532797|FG003|Overall Study|Lost to Follow-up|2|||
160765451|NCT01373164|580532798|FG004|Overall Study|Lost to Follow-up|0|||
160765452|NCT01373164|580532794|FG000|Overall Study|Withdrawal by Subject|0|||
160765453|NCT01373164|580532795|FG001|Overall Study|Withdrawal by Subject|1|||
160765454|NCT01373164|580532796|FG002|Overall Study|Withdrawal by Subject|0|||
160765455|NCT01373164|580532797|FG003|Overall Study|Withdrawal by Subject|10|||
160765456|NCT01373164|580532798|FG004|Overall Study|Withdrawal by Subject|2|||
160869741|NCT02023697|580915621|FG002|Active Follow-up Period|Radiological progression|1|||
160869742|NCT02023697|580915619|FG000|Active Follow-up Period|Death|83|||
160869743|NCT02023697|580915620|FG001|Active Follow-up Period|Death|82|||
160869744|NCT02023697|580915621|FG002|Active Follow-up Period|Death|87|||
160869745|NCT02023697|580915619|FG000|Long-term Follow-up Period|Death|9|||
160869746|NCT02023697|580915620|FG001|Long-term Follow-up Period|Death|6|||
160869747|NCT02023697|580915621|FG002|Long-term Follow-up Period|Death|4|||
160869748|NCT02023697|580915619|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
160869749|NCT02023697|580915620|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
160869750|NCT02023697|580915621|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
160869751|NCT02023697|580915619|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
160869752|NCT02023697|580915620|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
160869753|NCT02023697|580915621|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
160869754|NCT02023697|580915619|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
160869755|NCT02023697|580915620|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
160869756|NCT02023697|580915621|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
160869757|NCT02023697|580915619|FG000|Long-term Follow-up Period|Technical problems|0|||
160530043|NCT01791803|579670078|FG002|Overall Study|Physician Decision|0|||
160530044|NCT01791803|579670079|FG003|Overall Study|Physician Decision|1|||
160530045|NCT01791803|579670076|FG000|Overall Study|Death|0|||
160530046|NCT01791803|579670077|FG001|Overall Study|Death|0|||
160530047|NCT01791803|579670078|FG002|Overall Study|Death|2|||
160530048|NCT01791803|579670079|FG003|Overall Study|Death|2|||
160530049|NCT04572854|579670080|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
160530050|NCT04572854|579670081|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
160530051|NCT04572854|579670082|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
160530052|NCT04572854|579670083|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
160530053|NCT04572854|579670080|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
160530054|NCT04572854|579670081|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
160530055|NCT04572854|579670082|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
160530056|NCT04572854|579670083|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
160530057|NCT00972777|579670086|FG000|Overall Study|Adverse Event|3|||
160530058|NCT00972777|579670087|FG001|Overall Study|Adverse Event|2|||
160530059|NCT00972777|579670086|FG000|Overall Study|Lost to Follow-up|0|||
160530060|NCT00972777|579670087|FG001|Overall Study|Lost to Follow-up|4|||
160530061|NCT00972777|579670086|FG000|Overall Study|Withdrawal by Subject|4|||
160530062|NCT00972777|579670087|FG001|Overall Study|Withdrawal by Subject|5|||
160530063|NCT00972777|579670086|FG000|Overall Study|Physician Decision|4|||
160530064|NCT00972777|579670087|FG001|Overall Study|Physician Decision|0|||
160530065|NCT00972777|579670086|FG000|Overall Study|Protocol Violation|0|||
160530066|NCT00972777|579670087|FG001|Overall Study|Protocol Violation|2|||
160530067|NCT00972777|579670086|FG000|Overall Study|Screening Failure|2|||
160530068|NCT00972777|579670087|FG001|Overall Study|Screening Failure|1|||
160530069|NCT00972777|579670086|FG000|Overall Study|Missed visit|1|||
160530070|NCT00972777|579670087|FG001|Overall Study|Missed visit|0|||
160530071|NCT07052682|579670090|FG000|Overall Study|Withdrawal by Subject|4|||
160530072|NCT05749952|579670091|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
160530073|NCT02060383|579671610|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
160530074|NCT02060383|579671611|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
160530075|NCT02060383|579671612|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
160765457|NCT00761319|580532799|FG000|Overall Study|Protocol Violation|21|||
160765458|NCT00761319|580532800|FG001|Overall Study|Protocol Violation|14|||
160765459|NCT00761319|580532799|FG000|Overall Study|Adverse Event|11|||
160765460|NCT00761319|580532800|FG001|Overall Study|Adverse Event|7|||
160765461|NCT00761319|580532799|FG000|Overall Study|Withdrawal by Subject|8|||
160765462|NCT00761319|580532800|FG001|Overall Study|Withdrawal by Subject|7|||
160765463|NCT00761319|580532799|FG000|Overall Study|Noncompliance|4|||
160765464|NCT00761319|580532800|FG001|Overall Study|Noncompliance|3|||
160765465|NCT00761319|580532799|FG000|Overall Study|Lost to Follow-up|1|||
160765466|NCT00761319|580532800|FG001|Overall Study|Lost to Follow-up|1|||
160765467|NCT00761319|580532799|FG000|Overall Study|Nonspecified|2|||
160765468|NCT00761319|580532800|FG001|Overall Study|Nonspecified|2|||
160765469|NCT00761319|580532799|FG000|Overall Study|Missing|1|||
160765470|NCT00761319|580532800|FG001|Overall Study|Missing|0|||
160765471|NCT01125930|580532805|FG000|Overall Study|Adverse Event|0|||
160765472|NCT01125930|580532806|FG001|Overall Study|Adverse Event|1|||
160765473|NCT01125930|580532805|FG000|Overall Study|Withdrawal by Subject|1|||
160765474|NCT01125930|580532806|FG001|Overall Study|Withdrawal by Subject|6|||
160765475|NCT01125930|580532805|FG000|Overall Study|Protocol Violation|0|||
160765476|NCT01125930|580532806|FG001|Overall Study|Protocol Violation|1|||
160765477|NCT01125930|580532805|FG000|Overall Study|Lost to Follow-up|0|||
160765478|NCT01125930|580532806|FG001|Overall Study|Lost to Follow-up|2|||
160765479|NCT01715831|580532811|FG000|Overall Study|Adverse Event|1|||
160765480|NCT03261401|580532812|FG000|Overall Study|Withdrawal by Subject|0|||
160765481|NCT03261401|580532813|FG001|Overall Study|Withdrawal by Subject|0|||
160765482|NCT03261401|580532814|FG002|Overall Study|Withdrawal by Subject|0|||
160765483|NCT03261401|580532815|FG003|Overall Study|Withdrawal by Subject|0|||
160765484|NCT03261401|580532816|FG004|Overall Study|Withdrawal by Subject|0|||
160765485|NCT03261401|580532817|FG005|Overall Study|Withdrawal by Subject|1|||
160765486|NCT03261401|580532818|FG006|Overall Study|Withdrawal by Subject|0|||
160765487|NCT03261401|580532819|FG007|Overall Study|Withdrawal by Subject|0|||
160765488|NCT03261401|580532820|FG008|Overall Study|Withdrawal by Subject|0|||
160765489|NCT03261401|580532821|FG009|Overall Study|Withdrawal by Subject|0|||
160765490|NCT03261401|580532822|FG010|Overall Study|Withdrawal by Subject|0|||
160765491|NCT03261401|580532823|FG011|Overall Study|Withdrawal by Subject|0|||
160530076|NCT02060383|579671613|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
160530077|NCT02060383|579671614|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
160530078|NCT02060383|579671610|FG000|Core Phase|Adverse Event|2|||
160530079|NCT02060383|579671611|FG001|Core Phase|Adverse Event|0|||
160530080|NCT02060383|579671612|FG002|Core Phase|Adverse Event|0|||
160530081|NCT02060383|579671613|FG003|Core Phase|Adverse Event|2|||
160765492|NCT03261401|580532824|FG012|Overall Study|Withdrawal by Subject|0|||
160765493|NCT03261401|580532812|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
160765494|NCT03261401|580532813|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
160765495|NCT03261401|580532814|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
160869758|NCT02023697|580915620|FG001|Long-term Follow-up Period|Technical problems|0|||
160869759|NCT02023697|580915621|FG002|Long-term Follow-up Period|Technical problems|1|||
160869760|NCT02023697|580915619|FG000|Long-term Follow-up Period|Other unspecified|6|||
160869761|NCT02023697|580915620|FG001|Long-term Follow-up Period|Other unspecified|3|||
160869762|NCT02023697|580915621|FG002|Long-term Follow-up Period|Other unspecified|5|||
160869763|NCT00541385|580915622|FG000|Overall Study|Adverse Event|6|||
160869764|NCT00541385|580915623|FG001|Overall Study|Adverse Event|3|||
160869765|NCT00541385|580915622|FG000|Overall Study|Withdrawal by Subject|2|||
160869766|NCT00541385|580915623|FG001|Overall Study|Withdrawal by Subject|2|||
160869767|NCT00541385|580915622|FG000|Overall Study|Lost to Follow-up|6|||
160869768|NCT00541385|580915623|FG001|Overall Study|Lost to Follow-up|1|||
160869769|NCT00541385|580915622|FG000|Overall Study|Parasite reappearance/malaria|67|||
160869770|NCT00541385|580915623|FG001|Overall Study|Parasite reappearance/malaria|32|||
160869771|NCT01469377|580915624|FG000|Overall Study|Protocol Deviation|7|||
160869772|NCT01469377|580915625|FG001|Overall Study|Protocol Deviation|10|||
160869773|NCT01469377|580915626|FG002|Overall Study|Protocol Deviation|10|||
160869774|NCT01469377|580915624|FG000|Overall Study|Lost to Follow-up|3|||
160869775|NCT01469377|580915625|FG001|Overall Study|Lost to Follow-up|2|||
160869776|NCT01469377|580915626|FG002|Overall Study|Lost to Follow-up|5|||
160869777|NCT01469377|580915624|FG000|Overall Study|Withdrawal of Consent|12|||
160869778|NCT01469377|580915625|FG001|Overall Study|Withdrawal of Consent|14|||
160869779|NCT01469377|580915626|FG002|Overall Study|Withdrawal of Consent|15|||
160869780|NCT01469377|580915624|FG000|Overall Study|Adverse Event|8|||
160869781|NCT01469377|580915625|FG001|Overall Study|Adverse Event|18|||
160869782|NCT01469377|580915626|FG002|Overall Study|Adverse Event|36|||
160869783|NCT01469377|580915624|FG000|Overall Study|Insufficient Therapeutic Response|3|||
160869784|NCT01469377|580915625|FG001|Overall Study|Insufficient Therapeutic Response|4|||
160869785|NCT01469377|580915626|FG002|Overall Study|Insufficient Therapeutic Response|0|||
160869786|NCT01469377|580915624|FG000|Overall Study|Other Miscellaneous Reasons|2|||
160869787|NCT01469377|580915625|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160869788|NCT01469377|580915626|FG002|Overall Study|Other Miscellaneous Reasons|0|||
160869789|NCT03857867|580915627|FG000|Overall Study|Physician Decision|1|||
160869790|NCT00885534|580915628|FG000|Overall Study|Patient deemed ineligible|1|||
160869791|NCT02453711|580915629|FG000|Overall Study|Withdrawal by Subject|5|||
160869792|NCT02453711|580915630|FG001|Overall Study|Withdrawal by Subject|4|||
160869793|NCT02453711|580915631|FG002|Overall Study|Withdrawal by Subject|6|||
160869794|NCT02453711|580915632|FG003|Overall Study|Withdrawal by Subject|4|||
160869795|NCT02453711|580915633|FG004|Overall Study|Withdrawal by Subject|1|||
160869796|NCT02453711|580915634|FG005|Overall Study|Withdrawal by Subject|1|||
160869797|NCT02453711|580915635|FG006|Overall Study|Withdrawal by Subject|0|||
160869798|NCT02453711|580915636|FG007|Overall Study|Withdrawal by Subject|1|||
160869799|NCT02453711|580915637|FG008|Overall Study|Withdrawal by Subject|7|||
160869800|NCT02453711|580915629|FG000|Overall Study|Lost to Follow-up|5|||
160869801|NCT02453711|580915630|FG001|Overall Study|Lost to Follow-up|3|||
160869802|NCT02453711|580915631|FG002|Overall Study|Lost to Follow-up|2|||
160869803|NCT02453711|580915632|FG003|Overall Study|Lost to Follow-up|3|||
160869804|NCT02453711|580915633|FG004|Overall Study|Lost to Follow-up|1|||
160869805|NCT02453711|580915634|FG005|Overall Study|Lost to Follow-up|5|||
160869806|NCT02453711|580915635|FG006|Overall Study|Lost to Follow-up|2|||
160869807|NCT02453711|580915636|FG007|Overall Study|Lost to Follow-up|6|||
160869808|NCT02453711|580915637|FG008|Overall Study|Lost to Follow-up|6|||
160869809|NCT02453711|580915629|FG000|Overall Study|Death|0|||
160869810|NCT02453711|580915630|FG001|Overall Study|Death|0|||
160869811|NCT02453711|580915631|FG002|Overall Study|Death|0|||
160869812|NCT02453711|580915632|FG003|Overall Study|Death|0|||
160869813|NCT02453711|580915633|FG004|Overall Study|Death|0|||
160869814|NCT02453711|580915634|FG005|Overall Study|Death|0|||
160869815|NCT02453711|580915635|FG006|Overall Study|Death|1|||
160869816|NCT02453711|580915636|FG007|Overall Study|Death|0|||
160869817|NCT02453711|580915637|FG008|Overall Study|Death|0|||
160869818|NCT02453711|580915629|FG000|Overall Study|Unclassified|1|||
160869819|NCT02453711|580915630|FG001|Overall Study|Unclassified|0|||
160869820|NCT02453711|580915631|FG002|Overall Study|Unclassified|1|||
160869821|NCT02453711|580915632|FG003|Overall Study|Unclassified|0|||
160869822|NCT02453711|580915633|FG004|Overall Study|Unclassified|0|||
160869823|NCT02453711|580915634|FG005|Overall Study|Unclassified|0|||
160869824|NCT02453711|580915635|FG006|Overall Study|Unclassified|0|||
160869825|NCT02453711|580915636|FG007|Overall Study|Unclassified|0|||
160869826|NCT02453711|580915637|FG008|Overall Study|Unclassified|0|||
160869827|NCT00314795|580915642|FG000|Overall Study|Adverse Event|8|||
160869828|NCT00314795|580915642|FG000|Overall Study|Death|4|||
160869829|NCT00314795|580915642|FG000|Overall Study|Reason not Specified|3|||
160869830|NCT00314795|580915642|FG000|Overall Study|Renal Transplant|3|||
160869831|NCT00314795|580915642|FG000|Overall Study|Participants Withdrew Consent|2|||
160869832|NCT02170077|580915647|FG000|Overall Study|Withdrawal by Subject|3|||
160869833|NCT02170077|580915648|FG001|Overall Study|Withdrawal by Subject|4|||
160869834|NCT02170077|580915649|FG002|Overall Study|Withdrawal by Subject|2|||
160869835|NCT02170077|580915647|FG000|Overall Study|Adverse Event|4|||
160869836|NCT02170077|580915648|FG001|Overall Study|Adverse Event|4|||
160869837|NCT02170077|580915649|FG002|Overall Study|Adverse Event|4|||
160869838|NCT02170077|580915647|FG000|Overall Study|Lost to Follow-up|0|||
160869839|NCT02170077|580915648|FG001|Overall Study|Lost to Follow-up|1|||
160869840|NCT02170077|580915649|FG002|Overall Study|Lost to Follow-up|0|||
160869841|NCT02170077|580915647|FG000|Overall Study|Exclusion criteria|2|||
160869842|NCT02170077|580915648|FG001|Overall Study|Exclusion criteria|2|||
160869843|NCT02170077|580915649|FG002|Overall Study|Exclusion criteria|5|||
160869844|NCT02170077|580915647|FG000|Overall Study|Exacerbation of seizures|0|||
160869845|NCT02170077|580915648|FG001|Overall Study|Exacerbation of seizures|2|||
160869846|NCT02170077|580915649|FG002|Overall Study|Exacerbation of seizures|1|||
160869847|NCT01780974|580915654|FG000|Overall Study|Death|1|||
160869848|NCT01780974|580915655|FG001|Overall Study|Death|0|||
160869849|NCT01780974|580915654|FG000|Overall Study|Adverse Event|1|||
160869850|NCT01780974|580915655|FG001|Overall Study|Adverse Event|3|||
160869851|NCT02447003|580915663|FG000|Overall Study|Other|0|||
160869852|NCT02447003|580915664|FG001|Overall Study|Other|4|||
160869853|NCT02447003|580915663|FG000|Overall Study|Site discontinued|0|||
160869854|NCT02447003|580915664|FG001|Overall Study|Site discontinued|2|||
160869855|NCT02447003|580915663|FG000|Overall Study|Physician Decision|0|||
160869856|NCT02447003|580915664|FG001|Overall Study|Physician Decision|1|||
160869857|NCT02447003|580915663|FG000|Overall Study|Withdrawal by Subject|4|||
160869858|NCT02447003|580915664|FG001|Overall Study|Withdrawal by Subject|3|||
160869859|NCT02447003|580915663|FG000|Overall Study|Sponsor Decision|6|||
160869860|NCT02447003|580915664|FG001|Overall Study|Sponsor Decision|11|||
160869861|NCT02447003|580915663|FG000|Overall Study|Progressive Disease|1|||
160530082|NCT02060383|579671614|FG004|Core Phase|Adverse Event|6|||
160869862|NCT02447003|580915664|FG001|Overall Study|Progressive Disease|0|||
160869863|NCT02447003|580915663|FG000|Overall Study|Lost to Follow-up|5|||
160869864|NCT02447003|580915664|FG001|Overall Study|Lost to Follow-up|0|||
160530083|NCT02060383|579671610|FG000|Core Phase|Administrative problems|0|||
160869865|NCT02447003|580915663|FG000|Overall Study|Death|154|||
160869866|NCT02447003|580915664|FG001|Overall Study|Death|63|||
160869867|NCT00750438|580915665|FG000|Overall Study|Protocol Violation|4|||
160869868|NCT00750438|580915666|FG001|Overall Study|Protocol Violation|1|||
160869869|NCT00750438|580915665|FG000|Overall Study|Physician Decision|2|||
160869870|NCT00750438|580915666|FG001|Overall Study|Physician Decision|2|||
160869871|NCT00750438|580915665|FG000|Overall Study|Withdrawal by Subject|1|||
160869872|NCT00750438|580915666|FG001|Overall Study|Withdrawal by Subject|1|||
160530084|NCT02060383|579671611|FG001|Core Phase|Administrative problems|1|||
160530085|NCT02060383|579671612|FG002|Core Phase|Administrative problems|0|||
160530086|NCT02060383|579671613|FG003|Core Phase|Administrative problems|0|||
160530087|NCT02060383|579671614|FG004|Core Phase|Administrative problems|0|||
160530088|NCT02060383|579671610|FG000|Core Phase|Protocol Violation|0|||
160530089|NCT02060383|579671611|FG001|Core Phase|Protocol Violation|0|||
160530090|NCT02060383|579671612|FG002|Core Phase|Protocol Violation|0|||
160530091|NCT02060383|579671613|FG003|Core Phase|Protocol Violation|1|||
160530092|NCT02060383|579671614|FG004|Core Phase|Protocol Violation|0|||
160530093|NCT02060383|579671610|FG000|Core Phase|Withdrawal by Subject|0|||
160530094|NCT02060383|579671611|FG001|Core Phase|Withdrawal by Subject|0|||
160530095|NCT02060383|579671612|FG002|Core Phase|Withdrawal by Subject|0|||
160530096|NCT02060383|579671613|FG003|Core Phase|Withdrawal by Subject|4|||
160530097|NCT02060383|579671614|FG004|Core Phase|Withdrawal by Subject|2|||
160530098|NCT02060383|579671610|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
160530099|NCT02060383|579671611|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
160530100|NCT02060383|579671612|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
160530101|NCT02060383|579671613|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
160530102|NCT02060383|579671614|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
160530103|NCT02060383|579671610|FG000|Extension Phase|Adverse Event|1|||
160530104|NCT02060383|579671611|FG001|Extension Phase|Adverse Event|1|||
160530105|NCT02060383|579671612|FG002|Extension Phase|Adverse Event|2|||
160530106|NCT02060383|579671613|FG003|Extension Phase|Adverse Event|0|||
160530107|NCT02060383|579671614|FG004|Extension Phase|Adverse Event|1|||
160530108|NCT02060383|579671610|FG000|Extension Phase|Withdrawal by Subject|0|||
160530109|NCT02060383|579671611|FG001|Extension Phase|Withdrawal by Subject|1|||
160530110|NCT02060383|579671612|FG002|Extension Phase|Withdrawal by Subject|0|||
160530111|NCT02060383|579671613|FG003|Extension Phase|Withdrawal by Subject|0|||
160869873|NCT03848728|580915667|FG000|Overall Study|Death|16|||
160869874|NCT03848728|580915668|FG001|Overall Study|Death|13|||
160869875|NCT03848728|580915667|FG000|Overall Study|Outmigrated to non-study community|98|||
160869876|NCT03848728|580915668|FG001|Overall Study|Outmigrated to non-study community|106|||
160530112|NCT02060383|579671614|FG004|Extension Phase|Withdrawal by Subject|2|||
160530113|NCT02060383|579671610|FG000|Extension Phase|Administrative problems|1|||
160530114|NCT02060383|579671611|FG001|Extension Phase|Administrative problems|0|||
160530115|NCT02060383|579671612|FG002|Extension Phase|Administrative problems|0|||
160530116|NCT02060383|579671613|FG003|Extension Phase|Administrative problems|0|||
160869877|NCT03848728|580915667|FG000|Overall Study|Transfered to non-study clinic|32|||
160869878|NCT03848728|580915668|FG001|Overall Study|Transfered to non-study clinic|48|||
160765496|NCT03261401|580532815|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
160765497|NCT03261401|580532816|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
160765498|NCT03261401|580532817|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
160765499|NCT03261401|580532818|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
160765500|NCT03261401|580532819|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
160765501|NCT03261401|580532820|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
160765502|NCT03261401|580532821|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
160765503|NCT03261401|580532822|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
160765504|NCT03261401|580532823|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
160765505|NCT03261401|580532824|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
160765506|NCT01516216|580532825|FG000|Overall Study|Adverse Event|2|||
160765507|NCT01516216|580532826|FG001|Overall Study|Adverse Event|4|||
160765508|NCT01516216|580532825|FG000|Overall Study|Disease Progression|38|||
160765509|NCT01516216|580532826|FG001|Overall Study|Disease Progression|34|||
160765510|NCT01516216|580532825|FG000|Overall Study|Withdrawal by Subject|9|||
160869879|NCT03848728|580915667|FG000|Overall Study|Withdrawal by Subject|1|||
160530117|NCT02060383|579671614|FG004|Extension Phase|Administrative problems|0|||
160530118|NCT02060383|579671610|FG000|Extension Phase|Death|0|||
160530119|NCT02060383|579671611|FG001|Extension Phase|Death|0|||
160530120|NCT02060383|579671612|FG002|Extension Phase|Death|1|||
160530121|NCT02060383|579671613|FG003|Extension Phase|Death|0|||
160530122|NCT02060383|579671614|FG004|Extension Phase|Death|1|||
160530123|NCT02060383|579671610|FG000|Extension Phase|Protocol Violation|0|||
160530124|NCT02060383|579671611|FG001|Extension Phase|Protocol Violation|0|||
160530125|NCT02060383|579671612|FG002|Extension Phase|Protocol Violation|0|||
160530126|NCT02060383|579671613|FG003|Extension Phase|Protocol Violation|0|||
160530127|NCT02060383|579671614|FG004|Extension Phase|Protocol Violation|1|||
160530128|NCT05162027|579671615|FG000|Overall Study|Adverse Event|1|||
160530129|NCT05162027|579671616|FG001|Overall Study|Adverse Event|0|||
160530130|NCT00525044|579671617|FG000|Overall Study|Lost to Follow-up|0|||
160530131|NCT00525044|579671618|FG001|Overall Study|Lost to Follow-up|1|||
160530132|NCT02460497|579671619|FG000|Overall Study|Participant Requested Withdrawal|4|||
160530133|NCT02460497|579671619|FG000|Overall Study|Non-Compliance|1|||
160530134|NCT02460497|579671619|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
160530135|NCT02460497|579671619|FG000|Overall Study|Lost to Follow-up|2|||
160530136|NCT02460497|579671619|FG000|Overall Study|Investigator Decision|1|||
160530137|NCT00908583|579671620|FG000|Phase 1|Withdrawal by Subject|1|||
160530138|NCT00908583|579671620|FG000|Phase 1|Adverse Event|4|||
160530139|NCT00908583|579671620|FG000|Phase 2|Physician Decision|1|||
160530140|NCT00908583|579671620|FG000|Phase 2|Adverse Event|1|||
160530141|NCT00908583|579671620|FG000|Phase 3|Adverse Event|2|||
160530142|NCT00908583|579671620|FG000|Phase 4|Adverse Event|1|||
160530143|NCT00908583|579671620|FG000|Phase 4|Physician Decision|1|||
160530144|NCT00908583|579671620|FG000|Phase 5|Adverse Event|3|||
160530145|NCT00993954|579671621|FG000|Overall Study|Protocol Violation|21|||
160530146|NCT00993954|579671622|FG001|Overall Study|Protocol Violation|2|||
160530147|NCT01830855|579671626|FG000|Overall Study|Other|7|||
160530148|NCT01830855|579671627|FG001|Overall Study|Other|1|||
160530149|NCT01830855|579671628|FG002|Overall Study|Other|4|||
160530150|NCT01830855|579671629|FG003|Overall Study|Other|4|||
160530151|NCT01830855|579671626|FG000|Overall Study|Medication error without associated AE|1|||
160530152|NCT01830855|579671627|FG001|Overall Study|Medication error without associated AE|0|||
160530153|NCT01830855|579671628|FG002|Overall Study|Medication error without associated AE|0|||
160530154|NCT01830855|579671629|FG003|Overall Study|Medication error without associated AE|1|||
160530155|NCT01830855|579671626|FG000|Overall Study|Pregnancy|3|||
160530156|NCT01830855|579671627|FG001|Overall Study|Pregnancy|1|||
160530157|NCT01830855|579671628|FG002|Overall Study|Pregnancy|2|||
160530158|NCT01830855|579671629|FG003|Overall Study|Pregnancy|1|||
160530159|NCT01830855|579671626|FG000|Overall Study|No longer meets eligibility criteria|11|||
160530160|NCT01830855|579671627|FG001|Overall Study|No longer meets eligibility criteria|2|||
160530161|NCT01830855|579671628|FG002|Overall Study|No longer meets eligibility criteria|3|||
160530162|NCT01830855|579671629|FG003|Overall Study|No longer meets eligibility criteria|5|||
160530163|NCT01830855|579671626|FG000|Overall Study|Adverse Event|11|||
160530164|NCT01830855|579671627|FG001|Overall Study|Adverse Event|5|||
160530165|NCT01830855|579671628|FG002|Overall Study|Adverse Event|6|||
160530166|NCT01830855|579671629|FG003|Overall Study|Adverse Event|3|||
160530167|NCT01830855|579671626|FG000|Overall Study|Protocol deviation|10|||
160530168|NCT01830855|579671627|FG001|Overall Study|Protocol deviation|5|||
160530169|NCT01830855|579671628|FG002|Overall Study|Protocol deviation|6|||
160530170|NCT01830855|579671629|FG003|Overall Study|Protocol deviation|6|||
160530171|NCT01830855|579671626|FG000|Overall Study|Withdrawal by Subject|33|||
160530172|NCT01830855|579671627|FG001|Overall Study|Withdrawal by Subject|14|||
160530173|NCT01830855|579671628|FG002|Overall Study|Withdrawal by Subject|10|||
160530174|NCT01830855|579671629|FG003|Overall Study|Withdrawal by Subject|12|||
160530175|NCT01830855|579671626|FG000|Overall Study|No longer willing to participate|32|||
160530176|NCT01830855|579671627|FG001|Overall Study|No longer willing to participate|13|||
160530177|NCT01830855|579671628|FG002|Overall Study|No longer willing to participate|12|||
160530178|NCT01830855|579671629|FG003|Overall Study|No longer willing to participate|17|||
160530179|NCT01830855|579671626|FG000|Overall Study|Lost to Follow-up|47|||
160530180|NCT01830855|579671627|FG001|Overall Study|Lost to Follow-up|20|||
160530181|NCT01830855|579671628|FG002|Overall Study|Lost to Follow-up|23|||
160530182|NCT01830855|579671629|FG003|Overall Study|Lost to Follow-up|33|||
160530183|NCT01950247|579671630|FG000|Overall Study|Withdrawal by Subject|28|||
160765511|NCT01516216|580532826|FG001|Overall Study|Withdrawal by Subject|11|||
160765512|NCT01516216|580532825|FG000|Overall Study|Potentially Curative Resection|6|||
160765513|NCT01516216|580532826|FG001|Overall Study|Potentially Curative Resection|12|||
160765514|NCT01516216|580532825|FG000|Overall Study|Nonadherence|2|||
160765515|NCT01516216|580532826|FG001|Overall Study|Nonadherence|3|||
160765516|NCT01516216|580532825|FG000|Overall Study|Physician Decision|6|||
160765517|NCT01516216|580532826|FG001|Overall Study|Physician Decision|3|||
160530184|NCT01950247|579671631|FG001|Overall Study|Withdrawal by Subject|13|||
160530185|NCT01950247|579671630|FG000|Overall Study|Lost to Follow-up|18|||
160530186|NCT01950247|579671631|FG001|Overall Study|Lost to Follow-up|16|||
160530187|NCT01950247|579671630|FG000|Overall Study|Physician Decision|3|||
160869880|NCT03848728|580915668|FG001|Overall Study|Withdrawal by Subject|0|||
160869881|NCT00536744|580915671|FG000|Overall Study|Adverse Event|13|||
160869882|NCT00536744|580915672|FG001|Overall Study|Adverse Event|10|||
160869883|NCT00536744|580915671|FG000|Overall Study|Death|2|||
160869884|NCT00536744|580915672|FG001|Overall Study|Death|1|||
160869885|NCT00536744|580915671|FG000|Overall Study|Physician Decision|3|||
160869886|NCT00536744|580915672|FG001|Overall Study|Physician Decision|1|||
160636452|NCT00417027|580051549|FG002|Overall Study|Protocol Violation|5|||
160869887|NCT00536744|580915671|FG000|Overall Study|Lost to Follow-up|3|||
160869888|NCT00536744|580915672|FG001|Overall Study|Lost to Follow-up|5|||
160530188|NCT01950247|579671631|FG001|Overall Study|Physician Decision|4|||
160530189|NCT01950247|579671630|FG000|Overall Study|Adverse Event|3|||
160530190|NCT01950247|579671631|FG001|Overall Study|Adverse Event|2|||
160530191|NCT01950247|579671630|FG000|Overall Study|Death|1|||
160530192|NCT01950247|579671631|FG001|Overall Study|Death|1|||
160530193|NCT01950247|579671630|FG000|Overall Study|Not Defined|4|||
160530194|NCT01950247|579671631|FG001|Overall Study|Not Defined|10|||
160530195|NCT02713542|579671632|FG000|Overall Study|Use of prohibited medication|14|||
160530196|NCT02713542|579671633|FG001|Overall Study|Use of prohibited medication|5|||
160530197|NCT02713542|579671632|FG000|Overall Study|Withdrawal by Subject|4|||
160530198|NCT02713542|579671633|FG001|Overall Study|Withdrawal by Subject|1|||
160530199|NCT03631667|579671634|FG000|Overall Study|Withdrawal by Subject|3|||
160530200|NCT01949155|579671646|FG000|Overall Study|Lost to Follow-up|1|||
160530201|NCT01949155|579671647|FG001|Overall Study|Lost to Follow-up|0|||
160530202|NCT01949155|579671646|FG000|Overall Study|Protocol Violation|1|||
160530203|NCT01949155|579671647|FG001|Overall Study|Protocol Violation|0|||
160530204|NCT05395104|579671648|FG000|Overall Study|Met Liver Stopping Criteria|1|||
160530205|NCT05395104|579671648|FG000|Overall Study|Withdrawal by Subject|1|||
160530206|NCT02448225|579671649|FG000|Overall Study|Withdrawal by Subject|1|||
160530207|NCT02448225|579671649|FG000|Overall Study|Did not get FSPG scan|18|||
160530208|NCT02448225|579671649|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
160530209|NCT01287364|579671654|FG000|Overall Study|Adverse Event|0|||
160530210|NCT01287364|579671655|FG001|Overall Study|Adverse Event|3|||
160530211|NCT01287364|579671654|FG000|Overall Study|Protocol Violation|5|||
160530212|NCT01287364|579671655|FG001|Overall Study|Protocol Violation|5|||
160530213|NCT01287364|579671654|FG000|Overall Study|Other Reason|4|||
160530214|NCT01287364|579671655|FG001|Overall Study|Other Reason|2|||
160530215|NCT04422990|579671657|FG000|Overall Study|Withdrawal by Subject|0|||
160530216|NCT04422990|579671658|FG001|Overall Study|Withdrawal by Subject|1|||
160530217|NCT04422990|579671657|FG000|Overall Study|Travel|3|||
160530218|NCT04422990|579671658|FG001|Overall Study|Travel|0|||
160530219|NCT00770770|579671667|FG000|Overall Study|Lost to Follow-up|1|||
160530220|NCT00770770|579671668|FG001|Overall Study|Lost to Follow-up|0|||
160530221|NCT00770770|579671667|FG000|Overall Study|Withdrawal by Subject|1|||
160530222|NCT00770770|579671668|FG001|Overall Study|Withdrawal by Subject|0|||
160530223|NCT00770770|579671667|FG000|Overall Study|Death|0|||
160530224|NCT00770770|579671668|FG001|Overall Study|Death|1|||
160530225|NCT00770770|579671667|FG000|Overall Study|Study Terminated|8|||
160530226|NCT00770770|579671668|FG001|Overall Study|Study Terminated|0|||
160530227|NCT02486653|579671669|FG000|Overall Study|Withdrawal by Subject|1|||
160530228|NCT02486653|579671670|FG001|Overall Study|Withdrawal by Subject|3|||
160530229|NCT02486653|579671669|FG000|Overall Study|Protocol Violation|1|||
160530230|NCT02486653|579671670|FG001|Overall Study|Protocol Violation|0|||
160530231|NCT02486653|579671669|FG000|Overall Study|surgery cancelled|4|||
160530232|NCT02486653|579671670|FG001|Overall Study|surgery cancelled|1|||
160530233|NCT00800436|579671671|FG000|Overall Study|Withdrawal by Subject|0|||
160530234|NCT00800436|579671672|FG001|Overall Study|Withdrawal by Subject|0|||
160530235|NCT00800436|579671673|FG002|Overall Study|Withdrawal by Subject|1|||
160530236|NCT00800436|579671674|FG003|Overall Study|Withdrawal by Subject|1|||
160530237|NCT00800436|579671675|FG004|Overall Study|Withdrawal by Subject|0|||
160530238|NCT00800436|579671676|FG005|Overall Study|Withdrawal by Subject|0|||
160530239|NCT00800436|579671677|FG006|Overall Study|Withdrawal by Subject|0|||
160530240|NCT00711529|579671678|FG000|Overall Study|Protocol Violation|2|||
160530241|NCT00711529|579671679|FG001|Overall Study|Protocol Violation|0|||
160530242|NCT00711529|579671678|FG000|Overall Study|Withdrawal by Subject|2|||
160530243|NCT00711529|579671679|FG001|Overall Study|Withdrawal by Subject|6|||
160530244|NCT01230554|579671683|FG000|Overall Study|Lost to Follow-up|2|||
160530245|NCT01230554|579671683|FG000|Overall Study|Inability to maintain visit schedule|1|||
160530246|NCT01006265|579671684|FG000|Overall Study|Lost to Follow-up|1|||
160530247|NCT01006265|579671685|FG001|Overall Study|Lost to Follow-up|0|||
160530248|NCT01006265|579671686|FG002|Overall Study|Lost to Follow-up|1|||
160530249|NCT01006265|579671687|FG003|Overall Study|Lost to Follow-up|0|||
160530250|NCT01006265|579671684|FG000|Overall Study|Withdrawal by Subject|4|||
160530251|NCT01006265|579671685|FG001|Overall Study|Withdrawal by Subject|7|||
160530252|NCT01006265|579671686|FG002|Overall Study|Withdrawal by Subject|5|||
160530253|NCT01006265|579671687|FG003|Overall Study|Withdrawal by Subject|5|||
160530254|NCT01006265|579671684|FG000|Overall Study|Administrative reason|1|||
160530255|NCT01006265|579671685|FG001|Overall Study|Administrative reason|2|||
160530256|NCT01006265|579671686|FG002|Overall Study|Administrative reason|3|||
160530257|NCT01006265|579671687|FG003|Overall Study|Administrative reason|0|||
160530258|NCT01177384|579671688|FG000|Overall Study|Adverse Event|6|||
160530259|NCT01177384|579671689|FG001|Overall Study|Adverse Event|4|||
160530260|NCT01177384|579671688|FG000|Overall Study|Lack of Efficacy|0|||
160530261|NCT01177384|579671689|FG001|Overall Study|Lack of Efficacy|1|||
160530262|NCT01177384|579671688|FG000|Overall Study|Lost to Follow-up|3|||
160530263|NCT01177384|579671689|FG001|Overall Study|Lost to Follow-up|4|||
160530264|NCT01177384|579671688|FG000|Overall Study|Physician Decision|0|||
160530265|NCT01177384|579671689|FG001|Overall Study|Physician Decision|3|||
160530266|NCT01177384|579671688|FG000|Overall Study|Protocol Violation|0|||
160869889|NCT00536744|580915671|FG000|Overall Study|Withdrawal by Subject|7|||
160869890|NCT00536744|580915672|FG001|Overall Study|Withdrawal by Subject|8|||
160869891|NCT00536744|580915671|FG000|Overall Study|PI tried alternative treatment|1|||
160869892|NCT00536744|580915672|FG001|Overall Study|PI tried alternative treatment|3|||
160530267|NCT01177384|579671689|FG001|Overall Study|Protocol Violation|2|||
160530268|NCT01177384|579671688|FG000|Overall Study|Withdrawal by Subject|5|||
160530269|NCT01177384|579671689|FG001|Overall Study|Withdrawal by Subject|12|||
160530270|NCT01849497|579671690|FG000|Overall Study|Withdrawal by Subject|1|||
160530271|NCT01849497|579671691|FG001|Overall Study|Withdrawal by Subject|2|||
160530272|NCT01849497|579671690|FG000|Overall Study|Sponsor Decision|0|||
160530273|NCT01849497|579671691|FG001|Overall Study|Sponsor Decision|1|||
160530274|NCT01849497|579671690|FG000|Overall Study|Lost to Follow-up|0|||
160530275|NCT01849497|579671691|FG001|Overall Study|Lost to Follow-up|1|||
160530276|NCT02146599|579671692|FG000|Overall Study|Failed to meet inclusion criteria|5|||
160530277|NCT02101021|579671693|FG000|Overall Study|Death|4|||
160530278|NCT02101021|579671694|FG001|Overall Study|Death|3|||
160530279|NCT02101021|579671695|FG002|Overall Study|Death|6|||
160530280|NCT02101021|579671696|FG003|Overall Study|Death|0|||
160530281|NCT02101021|579671697|FG004|Overall Study|Death|3|||
160530282|NCT02101021|579671693|FG000|Overall Study|Withdrew Consent from study|1|||
160530283|NCT02101021|579671694|FG001|Overall Study|Withdrew Consent from study|1|||
160530284|NCT02101021|579671695|FG002|Overall Study|Withdrew Consent from study|0|||
160530285|NCT02101021|579671696|FG003|Overall Study|Withdrew Consent from study|2|||
160530286|NCT02101021|579671697|FG004|Overall Study|Withdrew Consent from study|0|||
160530287|NCT02101021|579671693|FG000|Overall Study|Lost to Follow-up|1|||
160530288|NCT02101021|579671694|FG001|Overall Study|Lost to Follow-up|0|||
160530289|NCT02101021|579671695|FG002|Overall Study|Lost to Follow-up|0|||
160530290|NCT02101021|579671696|FG003|Overall Study|Lost to Follow-up|0|||
160530291|NCT02101021|579671697|FG004|Overall Study|Lost to Follow-up|0|||
160530292|NCT02101021|579671693|FG000|Overall Study|Study Terminated by Sponsor|1|||
160530293|NCT02101021|579671694|FG001|Overall Study|Study Terminated by Sponsor|0|||
160530294|NCT02101021|579671695|FG002|Overall Study|Study Terminated by Sponsor|1|||
160530295|NCT02101021|579671696|FG003|Overall Study|Study Terminated by Sponsor|1|||
160530296|NCT02101021|579671697|FG004|Overall Study|Study Terminated by Sponsor|1|||
160530297|NCT00544648|579671700|FG000|Overall Study|Withdrawal by Subject|1|||
160530298|NCT00544648|579671701|FG001|Overall Study|Withdrawal by Subject|0|||
160530299|NCT00544648|579671700|FG000|Overall Study|Adverse Event|1|||
160530300|NCT00544648|579671701|FG001|Overall Study|Adverse Event|1|||
160530301|NCT00544648|579671700|FG000|Overall Study|progression of disease|1|||
160530302|NCT00544648|579671701|FG001|Overall Study|progression of disease|0|||
160530303|NCT00999713|579671702|FG000|Overall Study|Physician Decision|2|||
160530304|NCT00999713|579671703|FG001|Overall Study|Physician Decision|0|||
160530305|NCT02921269|579671706|FG000|Overall Study|Did not complete DLT period|1|||
160530306|NCT01326728|579671707|FG000|Overall Study|Death|13|||
160530307|NCT01326728|579671708|FG001|Overall Study|Death|0|||
160530308|NCT01326728|579671707|FG000|Overall Study|Early closure of study|34|||
160530309|NCT01326728|579671708|FG001|Overall Study|Early closure of study|9|||
160530310|NCT01184053|579671709|FG000|Overall Study|progression while on treatment|3|||
160530311|NCT02536755|579671713|FG000|Overall Study|Adverse Event|4|||
160530312|NCT02301936|579671714|FG000|Overall Study|Lost to Follow-up|1|||
160530313|NCT02301936|579671715|FG001|Overall Study|Lost to Follow-up|0|||
160530314|NCT03065023|579671719|FG000|Overall Study|Progressive Disease|0|||
160530315|NCT03065023|579671720|FG001|Overall Study|Progressive Disease|1|||
160530316|NCT03065023|579671721|FG002|Overall Study|Progressive Disease|0|||
160530317|NCT03065023|579671722|FG003|Overall Study|Progressive Disease|0|||
160530318|NCT03065023|579671723|FG004|Overall Study|Progressive Disease|0|||
160530319|NCT03065023|579671719|FG000|Overall Study|Death|2|||
160530320|NCT03065023|579671720|FG001|Overall Study|Death|0|||
160530321|NCT03065023|579671721|FG002|Overall Study|Death|1|||
160869893|NCT00787644|580915673|FG000|Overall Study|Lost to Follow-up|1|||
160530322|NCT03065023|579671722|FG003|Overall Study|Death|1|||
160869894|NCT00787644|580915674|FG001|Overall Study|Lost to Follow-up|1|||
160530323|NCT03065023|579671723|FG004|Overall Study|Death|0|||
160869895|NCT00787644|580915673|FG000|Overall Study|Withdrawal by Subject|1|||
160869896|NCT00787644|580915674|FG001|Overall Study|Withdrawal by Subject|1|||
160869897|NCT01642589|580915678|FG000|Overall Study|Withdrawal by Subject|1|||
160869898|NCT01642589|580915679|FG001|Overall Study|Withdrawal by Subject|1|||
160869899|NCT01108185|580915680|FG000|Overall Study|Non-compliance|15|||
160869900|NCT01108185|580915680|FG000|Overall Study|Lost to Follow-up|12|||
160869901|NCT02581410|580915685|FG000|Vaccination Phase|Adverse Event|2|||
160530324|NCT03065023|579671719|FG000|Overall Study|Lost to Follow-up|0|||
160530325|NCT03065023|579671720|FG001|Overall Study|Lost to Follow-up|1|||
160530326|NCT03065023|579671721|FG002|Overall Study|Lost to Follow-up|0|||
160530327|NCT03065023|579671722|FG003|Overall Study|Lost to Follow-up|0|||
160530328|NCT03065023|579671723|FG004|Overall Study|Lost to Follow-up|0|||
160530329|NCT03065023|579671719|FG000|Overall Study|Participant Decision|0|||
160530330|NCT03065023|579671720|FG001|Overall Study|Participant Decision|0|||
160530331|NCT03065023|579671721|FG002|Overall Study|Participant Decision|0|||
160530332|NCT03065023|579671722|FG003|Overall Study|Participant Decision|1|||
160530333|NCT03065023|579671723|FG004|Overall Study|Participant Decision|0|||
160530334|NCT03065023|579671719|FG000|Overall Study|Withdrawal by Subject|0|||
160530335|NCT03065023|579671720|FG001|Overall Study|Withdrawal by Subject|0|||
160530336|NCT03065023|579671721|FG002|Overall Study|Withdrawal by Subject|0|||
160530337|NCT03065023|579671722|FG003|Overall Study|Withdrawal by Subject|1|||
160530338|NCT03065023|579671723|FG004|Overall Study|Withdrawal by Subject|0|||
160530339|NCT01102803|579671724|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
160530340|NCT01102803|579671725|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
160530341|NCT01102803|579671724|FG000|Post to Follow-Up|Lost to Follow-up|1|||
160530342|NCT01102803|579671725|FG001|Post to Follow-Up|Lost to Follow-up|3|||
160530343|NCT02281357|579671726|FG000|Overall Study|Adverse Event|2|||
160530344|NCT02281357|579671727|FG001|Overall Study|Adverse Event|1|||
160530345|NCT02281357|579671726|FG000|Overall Study|Lost to Follow-up|1|||
160530346|NCT02281357|579671727|FG001|Overall Study|Lost to Follow-up|0|||
160530347|NCT02281357|579671726|FG000|Overall Study|Withdrawal by Subject|4|||
160530348|NCT02281357|579671727|FG001|Overall Study|Withdrawal by Subject|3|||
160530349|NCT01162239|579671728|FG000|Treatment Phase|Withdrawal by Subject|1|||
160530350|NCT01162239|579671729|FG001|Treatment Phase|Withdrawal by Subject|3|||
160530351|NCT01162239|579671730|FG002|Treatment Phase|Withdrawal by Subject|2|||
160530352|NCT01162239|579671731|FG003|Treatment Phase|Withdrawal by Subject|3|||
160530353|NCT01162239|579671728|FG000|Treatment Phase|Death|0|||
160530354|NCT01162239|579671729|FG001|Treatment Phase|Death|0|||
160530355|NCT01162239|579671730|FG002|Treatment Phase|Death|0|||
160530356|NCT01162239|579671731|FG003|Treatment Phase|Death|1|||
160530357|NCT01162239|579671728|FG000|Treatment Phase|Lost to Follow-up|5|||
160530358|NCT01162239|579671729|FG001|Treatment Phase|Lost to Follow-up|4|||
160530359|NCT01162239|579671730|FG002|Treatment Phase|Lost to Follow-up|2|||
160530360|NCT01162239|579671731|FG003|Treatment Phase|Lost to Follow-up|1|||
160530361|NCT01162239|579671728|FG000|Extended Follow-up|Lost to Follow-up|8|||
160530362|NCT01162239|579671729|FG001|Extended Follow-up|Lost to Follow-up|13|||
160530363|NCT01162239|579671730|FG002|Extended Follow-up|Lost to Follow-up|8|||
160530364|NCT01162239|579671731|FG003|Extended Follow-up|Lost to Follow-up|6|||
160530365|NCT05975840|579671732|FG000|Overall Study|Other|1|||
160530366|NCT05975840|579671733|FG001|Overall Study|Other|0|||
160530367|NCT05975840|579671734|FG002|Overall Study|Other|0|||
160530368|NCT05975840|579671735|FG003|Overall Study|Other|0|||
160530369|NCT05975840|579671736|FG004|Overall Study|Other|1|||
160530370|NCT05975840|579671737|FG005|Overall Study|Other|0|||
160530371|NCT05975840|579671738|FG006|Overall Study|Other|0|||
160530372|NCT05975840|579671739|FG007|Overall Study|Other|0|||
160530373|NCT05975840|579671732|FG000|Overall Study|Lost to Follow-up|3|||
160530374|NCT05975840|579671733|FG001|Overall Study|Lost to Follow-up|6|||
160530375|NCT05975840|579671734|FG002|Overall Study|Lost to Follow-up|3|||
160530376|NCT05975840|579671735|FG003|Overall Study|Lost to Follow-up|1|||
160530377|NCT05975840|579671736|FG004|Overall Study|Lost to Follow-up|4|||
160530378|NCT05975840|579671737|FG005|Overall Study|Lost to Follow-up|1|||
160530379|NCT05975840|579671738|FG006|Overall Study|Lost to Follow-up|2|||
160530380|NCT05975840|579671739|FG007|Overall Study|Lost to Follow-up|4|||
160530381|NCT05975840|579671732|FG000|Overall Study|Migrated/moved from the study area|1|||
160530382|NCT05975840|579671733|FG001|Overall Study|Migrated/moved from the study area|0|||
160530383|NCT05975840|579671734|FG002|Overall Study|Migrated/moved from the study area|0|||
160530384|NCT05975840|579671735|FG003|Overall Study|Migrated/moved from the study area|0|||
160530385|NCT05975840|579671736|FG004|Overall Study|Migrated/moved from the study area|0|||
160530386|NCT05975840|579671737|FG005|Overall Study|Migrated/moved from the study area|0|||
160530387|NCT05975840|579671738|FG006|Overall Study|Migrated/moved from the study area|0|||
160530388|NCT05975840|579671739|FG007|Overall Study|Migrated/moved from the study area|0|||
160530389|NCT05975840|579671732|FG000|Overall Study|Withdrawal by Subject|0|||
160530390|NCT05975840|579671733|FG001|Overall Study|Withdrawal by Subject|5|||
160530391|NCT05975840|579671734|FG002|Overall Study|Withdrawal by Subject|2|||
160530392|NCT05975840|579671735|FG003|Overall Study|Withdrawal by Subject|2|||
160530393|NCT05975840|579671736|FG004|Overall Study|Withdrawal by Subject|0|||
160530394|NCT05975840|579671737|FG005|Overall Study|Withdrawal by Subject|2|||
160530395|NCT05975840|579671738|FG006|Overall Study|Withdrawal by Subject|2|||
160530396|NCT05975840|579671739|FG007|Overall Study|Withdrawal by Subject|1|||
160530397|NCT05975840|579671732|FG000|Overall Study|Protocol Violation|0|||
160530398|NCT05975840|579671733|FG001|Overall Study|Protocol Violation|1|||
160530399|NCT05975840|579671734|FG002|Overall Study|Protocol Violation|0|||
160530400|NCT05975840|579671735|FG003|Overall Study|Protocol Violation|0|||
160530401|NCT05975840|579671736|FG004|Overall Study|Protocol Violation|0|||
160530402|NCT05975840|579671737|FG005|Overall Study|Protocol Violation|0|||
160530403|NCT05975840|579671738|FG006|Overall Study|Protocol Violation|0|||
160530404|NCT05975840|579671739|FG007|Overall Study|Protocol Violation|0|||
160530405|NCT05975840|579671732|FG000|Overall Study|Adverse Event|0|||
160530406|NCT05975840|579671733|FG001|Overall Study|Adverse Event|0|||
160530407|NCT05975840|579671734|FG002|Overall Study|Adverse Event|0|||
160530408|NCT05975840|579671735|FG003|Overall Study|Adverse Event|1|||
160530409|NCT05975840|579671736|FG004|Overall Study|Adverse Event|0|||
160530410|NCT05975840|579671737|FG005|Overall Study|Adverse Event|0|||
160869902|NCT02581410|580915686|FG001|Vaccination Phase|Adverse Event|1|||
160869903|NCT02581410|580915685|FG000|Vaccination Phase|Withdrawal by Subject|0|||
160530411|NCT05975840|579671738|FG006|Overall Study|Adverse Event|0|||
160530412|NCT05975840|579671739|FG007|Overall Study|Adverse Event|0|||
160530413|NCT05975840|579671732|FG000|Overall Study|Death|0|||
160530414|NCT05975840|579671733|FG001|Overall Study|Death|1|||
160530415|NCT05975840|579671734|FG002|Overall Study|Death|0|||
160530416|NCT05975840|579671735|FG003|Overall Study|Death|0|||
160530417|NCT05975840|579671736|FG004|Overall Study|Death|0|||
160530418|NCT05975840|579671737|FG005|Overall Study|Death|0|||
160530419|NCT05975840|579671738|FG006|Overall Study|Death|0|||
160530420|NCT05975840|579671739|FG007|Overall Study|Death|1|||
160530421|NCT02877927|579671743|FG000|Overall Study|Adverse Event|1|||
160530422|NCT02877927|579671744|FG001|Overall Study|Adverse Event|0|||
160530423|NCT02877927|579671743|FG000|Overall Study|Lost to Follow-up|37|||
160530424|NCT02877927|579671744|FG001|Overall Study|Lost to Follow-up|38|||
160530425|NCT02877927|579671743|FG000|Overall Study|Withdrawal by Subject|11|||
160530426|NCT02877927|579671744|FG001|Overall Study|Withdrawal by Subject|12|||
160530427|NCT02877927|579671743|FG000|Overall Study|Physician Decision|0|||
160530428|NCT02877927|579671744|FG001|Overall Study|Physician Decision|1|||
160530429|NCT02877927|579671743|FG000|Overall Study|Missed EOT/PTE Visit|5|||
160530430|NCT02877927|579671744|FG001|Overall Study|Missed EOT/PTE Visit|6|||
160530431|NCT00601250|579671745|FG000|Overall Study|Adverse Event|3|||
160530432|NCT00601250|579671746|FG001|Overall Study|Adverse Event|9|||
160530433|NCT00601250|579671745|FG000|Overall Study|Protocol Violation|3|||
160530434|NCT00601250|579671746|FG001|Overall Study|Protocol Violation|2|||
160530435|NCT00601250|579671745|FG000|Overall Study|Lost to Follow-up|2|||
160530436|NCT00601250|579671746|FG001|Overall Study|Lost to Follow-up|6|||
160530437|NCT00601250|579671745|FG000|Overall Study|Withdrawal by Subject|4|||
160530438|NCT00601250|579671746|FG001|Overall Study|Withdrawal by Subject|13|||
160530439|NCT00601250|579671745|FG000|Overall Study|Other incl. lack of efficacy|2|||
160530440|NCT00601250|579671746|FG001|Overall Study|Other incl. lack of efficacy|9|||
160530441|NCT06950879|579671749|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
160530442|NCT02246582|579673456|FG000|Overall Study|Withdrawal by Subject|3|||
160530443|NCT02246582|579673457|FG001|Overall Study|Withdrawal by Subject|4|||
160530444|NCT03441334|579673459|FG000|Overall Study|Withdrawal by Subject|1|||
160530445|NCT03441334|579673460|FG001|Overall Study|Withdrawal by Subject|0|||
160530446|NCT00088907|579673461|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
160530447|NCT00088907|579673462|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
160530448|NCT00088907|579673461|FG000|Randomized Study (Step 1)|Adverse Event|14|||
160530449|NCT00088907|579673462|FG001|Randomized Study (Step 1)|Adverse Event|19|||
160530450|NCT00088907|579673461|FG000|Randomized Study (Step 1)|Death|11|||
160530451|NCT00088907|579673462|FG001|Randomized Study (Step 1)|Death|12|||
160530452|NCT00088907|579673461|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
160530453|NCT00088907|579673462|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
160530454|NCT00088907|579673461|FG000|Randomized Study (Step 1)|complicating disease|3|||
160530455|NCT00088907|579673462|FG001|Randomized Study (Step 1)|complicating disease|1|||
160530456|NCT00088907|579673461|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
160530457|NCT00088907|579673462|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
160530458|NCT00088907|579673461|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
160530459|NCT00088907|579673462|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
160530460|NCT00088907|579673461|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
160530461|NCT00088907|579673462|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
160530462|NCT00088907|579673461|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
160530463|NCT00088907|579673462|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
160530464|NCT00088907|579673461|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
160530465|NCT00088907|579673462|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
160530466|NCT00088907|579673461|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
160530467|NCT00088907|579673462|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
160530468|NCT03426787|579673469|FG000|Overall Study|Withdrawal by Subject|6|||
160530469|NCT03426787|579673469|FG000|Overall Study|Lost to Follow-up|7|||
160530470|NCT03426787|579673469|FG000|Overall Study|Unrelated to intervention death|1|||
160530471|NCT00257166|579673475|FG000|Overall Study|Adverse Event|18|||
160530472|NCT00257166|579673476|FG001|Overall Study|Adverse Event|13|||
160530473|NCT00257166|579673475|FG000|Overall Study|Laboratory abnormality|1|||
160530474|NCT00257166|579673476|FG001|Overall Study|Laboratory abnormality|0|||
160530475|NCT00257166|579673475|FG000|Overall Study|Lost to Follow-up|8|||
160530476|NCT00257166|579673476|FG001|Overall Study|Lost to Follow-up|1|||
160530477|NCT00257166|579673475|FG000|Overall Study|Withdrawal by Subject|9|||
160530478|NCT00257166|579673476|FG001|Overall Study|Withdrawal by Subject|2|||
160530479|NCT00257166|579673475|FG000|Overall Study|Other|16|||
160530480|NCT00257166|579673476|FG001|Overall Study|Other|21|||
160530481|NCT00257166|579673475|FG000|Overall Study|Randomized, but not treated|1|||
160530482|NCT00257166|579673476|FG001|Overall Study|Randomized, but not treated|0|||
160636453|NCT04285983|580051550|FG000|Overall Study|Protocol Violation|6|||
160530483|NCT02592551|579673477|FG000|Overall Study|Not evaluable|1|||
160530484|NCT02592551|579673478|FG001|Overall Study|Not evaluable|3|||
160530485|NCT02592551|579673479|FG002|Overall Study|Not evaluable|0|||
160530486|NCT00761306|579673480|FG000|Overall Study|Adverse Event|5|||
160530487|NCT00761306|579673480|FG000|Overall Study|Lack of Efficacy|4|||
160530488|NCT00761306|579673480|FG000|Overall Study|Protocol Violation|2|||
160869904|NCT02581410|580915686|FG001|Vaccination Phase|Withdrawal by Subject|1|||
160869905|NCT02581410|580915685|FG000|Vaccination Phase|Migrated/moved from study area|0|||
160869906|NCT02581410|580915686|FG001|Vaccination Phase|Migrated/moved from study area|1|||
160869907|NCT02581410|580915685|FG000|End of Study Phase|Adverse Event|4|||
160869908|NCT02581410|580915686|FG001|End of Study Phase|Adverse Event|3|||
160869909|NCT02581410|580915685|FG000|End of Study Phase|Withdrawal by Subject|1|||
160869910|NCT02581410|580915686|FG001|End of Study Phase|Withdrawal by Subject|2|||
160869911|NCT02581410|580915685|FG000|End of Study Phase|Migrated/moved from study area|0|||
160869912|NCT02581410|580915686|FG001|End of Study Phase|Migrated/moved from study area|3|||
160869913|NCT02581410|580915685|FG000|End of Study Phase|Lost to Follow-up|0|||
160869914|NCT02581410|580915686|FG001|End of Study Phase|Lost to Follow-up|2|||
160869915|NCT02581410|580915685|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
160869916|NCT02581410|580915686|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
160869917|NCT00670748|580915688|FG000|Overall Study|Death during treatment|1|||
160869918|NCT00670748|580915689|FG001|Overall Study|Death during treatment|1|||
160869919|NCT00670748|580915690|FG002|Overall Study|Death during treatment|1|||
160869920|NCT00670748|580915691|FG003|Overall Study|Death during treatment|0|||
160869921|NCT00670748|580915688|FG000|Overall Study|Not off study|2|||
160869922|NCT00670748|580915689|FG001|Overall Study|Not off study|1|||
160869923|NCT00670748|580915690|FG002|Overall Study|Not off study|1|||
160869924|NCT00670748|580915691|FG003|Overall Study|Not off study|1|||
160869925|NCT00759941|580915692|FG000|Overall Study|Use of medication|1|||
160869926|NCT00759941|580915693|FG001|Overall Study|Use of medication|0|||
160869927|NCT00759941|580915692|FG000|Overall Study|Adverse Event|1|||
160869928|NCT00759941|580915693|FG001|Overall Study|Adverse Event|0|||
160869929|NCT00759941|580915692|FG000|Overall Study|Exited in error by site|1|||
160869930|NCT00759941|580915693|FG001|Overall Study|Exited in error by site|1|||
160869931|NCT02736578|580915694|FG000|Overall Study|Adverse Event|1|||
160869932|NCT02736578|580915695|FG001|Overall Study|Adverse Event|0|||
160869933|NCT00354432|580915696|FG000|Overall Study|Adverse Event|3|||
160869934|NCT00354432|580915697|FG001|Overall Study|Adverse Event|1|||
160869935|NCT00354432|580915698|FG002|Overall Study|Adverse Event|5|||
160869936|NCT00354432|580915699|FG003|Overall Study|Adverse Event|5|||
160869937|NCT00354432|580915696|FG000|Overall Study|Off/Toxicity|3|||
160530489|NCT00761306|579673480|FG000|Overall Study|Withdrawal of Consent|3|||
160530490|NCT00761306|579673480|FG000|Overall Study|Lost to Follow-up|1|||
160530491|NCT00761306|579673480|FG000|Overall Study|Administrative or Other Reasons|5|||
160530492|NCT02553265|579673482|FG000|Enrollment|Death|0|||
160530493|NCT02553265|579673483|FG001|Enrollment|Death|0|||
160530494|NCT02553265|579673484|FG002|Enrollment|Death|1|||
160530495|NCT02553265|579673482|FG000|First Intervention (28 Days)|Adverse Event|1|||
160530496|NCT02553265|579673483|FG001|First Intervention (28 Days)|Adverse Event|0|||
160530497|NCT02553265|579673484|FG002|First Intervention (28 Days)|Adverse Event|0|||
160530498|NCT02553265|579673482|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
160530499|NCT02553265|579673483|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
160530500|NCT02553265|579673484|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
160530501|NCT02553265|579673482|FG000|Second Intervention (28 Days)|Adverse Event|1|||
160530502|NCT02553265|579673483|FG001|Second Intervention (28 Days)|Adverse Event|0|||
160530503|NCT02553265|579673484|FG002|Second Intervention (28 Days)|Adverse Event|0|||
160530504|NCT02553265|579673482|FG000|Third Intervention (28 Days)|Adverse Event|1|||
160530505|NCT02553265|579673483|FG001|Third Intervention (28 Days)|Adverse Event|0|||
160530506|NCT02553265|579673484|FG002|Third Intervention (28 Days)|Adverse Event|0|||
160530507|NCT02553265|579673482|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
160530508|NCT02553265|579673483|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
160530509|NCT02553265|579673484|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
160530510|NCT00860951|579673491|FG000|Overall Study|Withdrawal by Subject|2|||
160530511|NCT00860951|579673491|FG000|Overall Study|Lost to Follow-up|5|||
160530512|NCT02982239|579673492|FG000|Overall Study|Lost to Follow-up|3|||
160530513|NCT02982239|579673493|FG001|Overall Study|Lost to Follow-up|2|||
160530514|NCT01650285|579673497|FG000|Overall Study|Adverse Event|1|||
160530515|NCT00659529|579673498|FG000|Overall Study|Withdrawal by Subject|4|||
160530516|NCT00659529|579673498|FG000|Overall Study|Protocol Violation|3|||
160530517|NCT00659529|579673498|FG000|Overall Study|Screen failure|9|||
160530518|NCT00907257|579673501|FG000|Overall Study|Adverse Event|0|||
160530519|NCT00907257|579673502|FG001|Overall Study|Adverse Event|4|||
160530520|NCT00907257|579673501|FG000|Overall Study|Protocol Violation|1|||
160530521|NCT00907257|579673502|FG001|Overall Study|Protocol Violation|2|||
160869938|NCT00354432|580915697|FG001|Overall Study|Off/Toxicity|7|||
160869939|NCT00354432|580915698|FG002|Overall Study|Off/Toxicity|5|||
160869940|NCT00354432|580915699|FG003|Overall Study|Off/Toxicity|5|||
160869941|NCT03863080|580915700|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
160869942|NCT03863080|580915701|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
160530522|NCT00907257|579673501|FG000|Overall Study|Lost to Follow-up|3|||
160530523|NCT00907257|579673502|FG001|Overall Study|Lost to Follow-up|3|||
160530524|NCT00907257|579673501|FG000|Overall Study|Withdrawal by Subject|1|||
160765518|NCT01516216|580532825|FG000|Overall Study|Prolonged Treatment Delay|5|||
160765519|NCT01516216|580532826|FG001|Overall Study|Prolonged Treatment Delay|1|||
160765520|NCT01516216|580532825|FG000|Overall Study|Intercurrent Illness|1|||
160765521|NCT01516216|580532826|FG001|Overall Study|Intercurrent Illness|0|||
160765522|NCT01516216|580532825|FG000|Overall Study|Death|1|||
160765523|NCT01516216|580532826|FG001|Overall Study|Death|1|||
160765524|NCT01715298|580532827|FG000|Overall Study|Lost to Follow-up|0|||
160765525|NCT01715298|580532828|FG001|Overall Study|Lost to Follow-up|2|||
160765526|NCT01715298|580532827|FG000|Overall Study|Patient/guardian decision|7|||
160765527|NCT01715298|580532828|FG001|Overall Study|Patient/guardian decision|9|||
160765528|NCT02419807|580532829|FG000|Overall Study|Withdrawal by Subject|4|||
160765529|NCT02419807|580532829|FG000|Overall Study|Physician Decision|1|||
160765530|NCT02419807|580532829|FG000|Overall Study|Protocol Violation|5|||
160765531|NCT01499511|580532832|FG000|Overall Study|Death|1|||
160765532|NCT01499511|580532833|FG001|Overall Study|Death|0|||
160765533|NCT01006629|580532834|FG000|Overall Study|Adverse Event|1|||
160765534|NCT01006629|580532834|FG000|Overall Study|Parent refused to continue participation|1|||
160765535|NCT01006629|580532834|FG000|Overall Study|Parent unable to perform site visit|4|||
160765536|NCT01065818|580532837|FG000|Overall Study|Withdrawal by Subject|1|||
160765537|NCT01065818|580532837|FG000|Overall Study|Not a candidate for surgery|1|||
160765538|NCT04459338|580532840|FG000|Overall Study|Loss of IV during study|1|||
160765539|NCT04459338|580532841|FG001|Overall Study|Loss of IV during study|0|||
160765540|NCT03157089|580532842|FG000|Overall Study|Treated only with pembrolizumab|1|||
160765541|NCT03157089|580532843|FG001|Overall Study|Treated only with pembrolizumab|0|||
160765542|NCT03157089|580532842|FG000|Overall Study|Adverse Event|5|||
160765543|NCT03157089|580532843|FG001|Overall Study|Adverse Event|4|||
160765544|NCT03157089|580532842|FG000|Overall Study|Progressive disease|6|||
160765545|NCT03157089|580532843|FG001|Overall Study|Progressive disease|8|||
160765546|NCT00958074|580532844|FG000|Overall Study|Withdrawal by Subject|0|||
160765547|NCT00958074|580532845|FG001|Overall Study|Withdrawal by Subject|1|||
160765548|NCT00784875|580532846|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
160765549|NCT00784875|580532847|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
160765550|NCT00784875|580532848|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
160765551|NCT00784875|580532849|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
160765552|NCT00784875|580532846|FG000|Period A - Baseline|Adverse Event|0|||
160869943|NCT03863080|580915702|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
160869944|NCT03863080|580915703|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
160765553|NCT00784875|580532847|FG001|Period A - Baseline|Adverse Event|0|||
160765554|NCT00784875|580532848|FG002|Period A - Baseline|Adverse Event|0|||
160765555|NCT00784875|580532849|FG003|Period A - Baseline|Adverse Event|8|||
160765556|NCT00784875|580532846|FG000|Period A - Baseline|Protocol Violation|0|||
160765557|NCT00784875|580532847|FG001|Period A - Baseline|Protocol Violation|0|||
160765558|NCT00784875|580532848|FG002|Period A - Baseline|Protocol Violation|0|||
160765559|NCT00784875|580532849|FG003|Period A - Baseline|Protocol Violation|25|||
160530525|NCT00907257|579673502|FG001|Overall Study|Withdrawal by Subject|2|||
160530526|NCT00907257|579673501|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
160530527|NCT00907257|579673502|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
160530528|NCT00907257|579673501|FG000|Overall Study|Moved|1|||
160530529|NCT00907257|579673502|FG001|Overall Study|Moved|0|||
160530530|NCT00907257|579673501|FG000|Overall Study|Personal Reasons|6|||
160530531|NCT00907257|579673502|FG001|Overall Study|Personal Reasons|1|||
160530532|NCT04163900|579673503|FG000|Overall Study|Radiological disease progression|112|||
160530533|NCT04163900|579673504|FG001|Overall Study|Radiological disease progression|127|||
160530534|NCT04163900|579673503|FG000|Overall Study|Study closure|98|||
160530535|NCT04163900|579673504|FG001|Overall Study|Study closure|133|||
160530536|NCT04163900|579673503|FG000|Overall Study|Adverse Event|78|||
160530537|NCT04163900|579673504|FG001|Overall Study|Adverse Event|32|||
160530538|NCT04163900|579673503|FG000|Overall Study|Withdrawal by Subject|37|||
160530539|NCT04163900|579673504|FG001|Overall Study|Withdrawal by Subject|34|||
160530540|NCT04163900|579673503|FG000|Overall Study|Death|29|||
160530541|NCT04163900|579673504|FG001|Overall Study|Death|16|||
160530542|NCT04163900|579673503|FG000|Overall Study|Physician Decision|17|||
160530543|NCT04163900|579673504|FG001|Overall Study|Physician Decision|25|||
160530544|NCT04163900|579673503|FG000|Overall Study|Clinical disease progression|14|||
160530545|NCT04163900|579673504|FG001|Overall Study|Clinical disease progression|13|||
160530546|NCT04163900|579673503|FG000|Overall Study|Protocol Violation|3|||
160530547|NCT04163900|579673504|FG001|Overall Study|Protocol Violation|4|||
160530548|NCT04163900|579673503|FG000|Overall Study|Lost to Follow-up|0|||
160530549|NCT04163900|579673504|FG001|Overall Study|Lost to Follow-up|1|||
160530550|NCT01873417|579673505|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
160530551|NCT01873417|579673505|FG000|Overall Study|Adverse Event|24|||
160530552|NCT01873417|579673505|FG000|Overall Study|Lost to Follow-up|2|||
160530553|NCT01873417|579673505|FG000|Overall Study|Withdrawal by Subject|2|||
160530554|NCT01873417|579673505|FG000|Overall Study|Physician Decision|3|||
160530555|NCT00785044|579673506|FG000|Overall Study|Dosed at non-participating sites|152|||
160530556|NCT00785044|579673506|FG000|Overall Study|Death|77|||
160530557|NCT00785044|579673506|FG000|Overall Study|Lost to Follow-up|266|||
160530558|NCT00785044|579673506|FG000|Overall Study|Withdrawal by Subject|1|||
160530559|NCT01628107|579673507|FG000|Overall Study|Withdrawal by Subject|17|||
160530560|NCT01628107|579673507|FG000|Overall Study|Lost to Follow-up|4|||
160530561|NCT01628107|579673507|FG000|Overall Study|Adverse Event|33|||
160530562|NCT01628107|579673507|FG000|Overall Study|Physician Decision|2|||
160530563|NCT01628107|579673507|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
160530564|NCT01628107|579673507|FG000|Overall Study|Non-compliant with Study Procedures|10|||
160530565|NCT01628107|579673507|FG000|Overall Study|Not Treated|8|||
160530566|NCT01628107|579673507|FG000|Overall Study|Sponsor Decision|11|||
160530567|NCT01628107|579673507|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
160530568|NCT01628107|579673507|FG000|Overall Study|Relocated|8|||
160530569|NCT01628107|579673507|FG000|Overall Study|Kidney Transplant|9|||
160530570|NCT01628107|579673507|FG000|Overall Study|Use of Standard of Care|9|||
160530571|NCT01086410|579673508|FG000|Overall Study|Adverse Event|1|||
160530572|NCT01086410|579673509|FG001|Overall Study|Adverse Event|0|||
160530573|NCT01086410|579673510|FG002|Overall Study|Adverse Event|0|||
160530574|NCT01086410|579673511|FG003|Overall Study|Adverse Event|2|||
160530575|NCT01086410|579673508|FG000|Overall Study|Lack of Efficacy|1|||
160530576|NCT01086410|579673509|FG001|Overall Study|Lack of Efficacy|1|||
160530577|NCT01086410|579673510|FG002|Overall Study|Lack of Efficacy|0|||
160530578|NCT01086410|579673511|FG003|Overall Study|Lack of Efficacy|0|||
160530579|NCT01086410|579673508|FG000|Overall Study|Protocol Violation|1|||
160530580|NCT01086410|579673509|FG001|Overall Study|Protocol Violation|1|||
160530581|NCT01086410|579673510|FG002|Overall Study|Protocol Violation|0|||
160530582|NCT01086410|579673511|FG003|Overall Study|Protocol Violation|0|||
160530583|NCT01086410|579673508|FG000|Overall Study|Lost to Follow-up|0|||
160530584|NCT01086410|579673509|FG001|Overall Study|Lost to Follow-up|0|||
160530585|NCT01086410|579673510|FG002|Overall Study|Lost to Follow-up|1|||
160530586|NCT01086410|579673511|FG003|Overall Study|Lost to Follow-up|0|||
160530587|NCT02023242|579673513|FG000|Overall Study|Lost to Follow-up|3|||
160530588|NCT02023242|579673514|FG001|Overall Study|Lost to Follow-up|1|||
160530589|NCT02023242|579673513|FG000|Overall Study|Death|0|||
160530590|NCT02023242|579673514|FG001|Overall Study|Death|1|||
160530591|NCT01809132|579673518|FG000|Overall Study|Withdrawal by Subject|0|||
160530592|NCT01809132|579673519|FG001|Overall Study|Withdrawal by Subject|0|||
160530593|NCT01809132|579673520|FG002|Overall Study|Withdrawal by Subject|1|||
160530594|NCT04854434|579673521|FG000|Overall Study|Death|1|||
160530595|NCT04854434|579673522|FG001|Overall Study|Death|3|||
160530596|NCT04854434|579673523|FG002|Overall Study|Death|4|||
160530597|NCT04854434|579673521|FG000|Overall Study|Study Terminated by Sponsor|2|||
160530598|NCT04854434|579673522|FG001|Overall Study|Study Terminated by Sponsor|0|||
160530599|NCT04854434|579673523|FG002|Overall Study|Study Terminated by Sponsor|0|||
160530600|NCT04854434|579673521|FG000|Overall Study|Other|1|||
160530601|NCT04854434|579673522|FG001|Overall Study|Other|1|||
160530602|NCT04854434|579673523|FG002|Overall Study|Other|0|||
160530603|NCT03349775|579673524|FG000|Overall Study|Side Effects|1|||
160530604|NCT03349775|579673525|FG001|Overall Study|Side Effects|2|||
160530605|NCT03349775|579673524|FG000|Overall Study|Withdrawal by Subject|1|||
160530606|NCT03349775|579673525|FG001|Overall Study|Withdrawal by Subject|1|||
160530607|NCT03349775|579673524|FG000|Overall Study|No primary outcome measurements|0|||
160530608|NCT03349775|579673525|FG001|Overall Study|No primary outcome measurements|1|||
160530609|NCT03383289|579673535|FG000|Overall Study|Death|83|||
160530610|NCT03383289|579673536|FG001|Overall Study|Death|78|||
160530611|NCT03383289|579673535|FG000|Overall Study|discharge from facility|84|||
160530612|NCT03383289|579673536|FG001|Overall Study|discharge from facility|84|||
160530613|NCT03383289|579673535|FG000|Overall Study|Withdrawal by Subject|4|||
160530614|NCT03383289|579673536|FG001|Overall Study|Withdrawal by Subject|1|||
160530615|NCT00832117|579673537|FG000|Overall Study|Death|1|||
160530616|NCT00832117|579673537|FG000|Overall Study|Disease Progression|11|||
160530617|NCT04439071|579673538|FG000|Overall Study|Lost to Follow-up|0|||
160530618|NCT04439071|579673539|FG001|Overall Study|Lost to Follow-up|3|||
160530619|NCT04439071|579673538|FG000|Overall Study|Withdrawal by Subject|3|||
160530620|NCT04439071|579673539|FG001|Overall Study|Withdrawal by Subject|8|||
160530621|NCT04439071|579673538|FG000|Overall Study|Death|6|||
160530622|NCT04439071|579673539|FG001|Overall Study|Death|4|||
160530623|NCT04439071|579673538|FG000|Overall Study|Other than specified|3|||
160530624|NCT04439071|579673539|FG001|Overall Study|Other than specified|3|||
160530625|NCT04439071|579673538|FG000|Overall Study|Randomized but not treated|2|||
160530626|NCT04439071|579673539|FG001|Overall Study|Randomized but not treated|0|||
160530627|NCT00892177|579673540|FG000|Phase II|Ineligible|0|||
160530628|NCT00892177|579673541|FG001|Phase II|Ineligible|0|||
160530629|NCT00892177|579673542|FG002|Phase II|Ineligible|0|||
160530630|NCT00892177|579673543|FG003|Phase II|Ineligible|0|||
160530631|NCT00892177|579673544|FG004|Phase II|Ineligible|1|||
160530632|NCT00892177|579673545|FG005|Phase II|Ineligible|1|||
160530633|NCT00892177|579673540|FG000|Phase II|Withdrawal by Subject|0|||
160530634|NCT00892177|579673541|FG001|Phase II|Withdrawal by Subject|0|||
160530635|NCT00892177|579673542|FG002|Phase II|Withdrawal by Subject|0|||
160530636|NCT00892177|579673543|FG003|Phase II|Withdrawal by Subject|0|||
160869945|NCT03863080|580915700|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
160869946|NCT03863080|580915701|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
160869947|NCT03863080|580915702|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
160869948|NCT03863080|580915703|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
160869949|NCT03863080|580915700|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
160869950|NCT03863080|580915701|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
160869951|NCT03863080|580915702|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
160869952|NCT03863080|580915703|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
160869953|NCT00802945|580915706|FG000|Overall Study|Death|27|||
160869954|NCT00802945|580915707|FG001|Overall Study|Death|23|||
160869955|NCT00802945|580915706|FG000|Overall Study|Terminated by sponsor|8|||
160869956|NCT00802945|580915707|FG001|Overall Study|Terminated by sponsor|12|||
160869957|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
160869958|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
160869959|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
160869960|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
160869961|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
160869962|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
160869963|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
160869964|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
160869965|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
160869966|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
160869967|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
160869968|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
160869969|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
160869970|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
160869971|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
160530637|NCT00892177|579673544|FG004|Phase II|Withdrawal by Subject|4|||
160530638|NCT00892177|579673545|FG005|Phase II|Withdrawal by Subject|1|||
160530639|NCT03583450|579673546|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
160869972|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
160869973|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
160869974|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
160530640|NCT03583450|579673547|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
160530641|NCT05097716|579673552|FG000|Period 1|Adverse Event|1|||
160869975|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
160530642|NCT05097716|579673552|FG000|Period 1|Close contact with highly-transmissible infection|1|||
160530643|NCT00791258|579673553|FG000|Overall Study|Adverse Event|87|||
160530644|NCT00791258|579673553|FG000|Overall Study|Lost to Follow-up|18|||
160765560|NCT00784875|580532846|FG000|Period A - Baseline|Withdrawal by Subject|0|||
160765561|NCT00784875|580532847|FG001|Period A - Baseline|Withdrawal by Subject|0|||
160765562|NCT00784875|580532848|FG002|Period A - Baseline|Withdrawal by Subject|0|||
160765563|NCT00784875|580532849|FG003|Period A - Baseline|Withdrawal by Subject|27|||
160765564|NCT00784875|580532846|FG000|Period A - Baseline|Physician Decision|0|||
160765565|NCT00784875|580532847|FG001|Period A - Baseline|Physician Decision|0|||
160765566|NCT00784875|580532848|FG002|Period A - Baseline|Physician Decision|0|||
160765567|NCT00784875|580532849|FG003|Period A - Baseline|Physician Decision|2|||
160765568|NCT00784875|580532846|FG000|Period A - Baseline|Sponsor Decision|0|||
160765569|NCT00784875|580532847|FG001|Period A - Baseline|Sponsor Decision|0|||
160765570|NCT00784875|580532848|FG002|Period A - Baseline|Sponsor Decision|0|||
160765571|NCT00784875|580532849|FG003|Period A - Baseline|Sponsor Decision|113|||
160765572|NCT00784875|580532846|FG000|Period A - Baseline|Lost to Follow-up|0|||
160981506|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
160869976|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
160869977|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
160869978|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
160869979|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
160869980|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
160869981|NCT05307692|580915708|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
160869982|NCT05307692|580915709|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
160869983|NCT05307692|580915710|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
160869984|NCT05307692|580915711|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
160869985|NCT05307692|580915708|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
160869986|NCT05307692|580915709|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
160869987|NCT05307692|580915710|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
160869988|NCT05307692|580915711|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
160869989|NCT04500158|580915712|FG000|Overall Study|Physician Decision|17|||
160869990|NCT04500158|580915713|FG001|Overall Study|Physician Decision|11|||
160869991|NCT03493464|580915716|FG000|Overall Study|Surgery not performed|1|||
160869992|NCT01077050|580917282|FG000|Overall Study|Subjects signed ICF could not be located|1|||
160869993|NCT01077050|580917282|FG000|Overall Study|Screen failure|8|||
160869994|NCT03126344|580917296|FG000|Overall Study|Lost to Follow-up|0|||
160869995|NCT03126344|580917297|FG001|Overall Study|Lost to Follow-up|0|||
160869996|NCT03126344|580917298|FG002|Overall Study|Lost to Follow-up|5|||
160869997|NCT01715857|580917299|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
160869998|NCT02563067|580917300|FG000|Overall Study|Subject/guardian decision|14|||
160869999|NCT02563067|580917301|FG001|Overall Study|Subject/guardian decision|20|||
160870000|NCT02563067|580917302|FG002|Overall Study|Subject/guardian decision|16|||
160870001|NCT02563067|580917300|FG000|Overall Study|Physician Decision|0|||
160870002|NCT02563067|580917301|FG001|Overall Study|Physician Decision|1|||
160870003|NCT02563067|580917302|FG002|Overall Study|Physician Decision|3|||
160870004|NCT02563067|580917300|FG000|Overall Study|Lost to Follow-up|1|||
160870005|NCT02563067|580917301|FG001|Overall Study|Lost to Follow-up|2|||
160870006|NCT02563067|580917302|FG002|Overall Study|Lost to Follow-up|0|||
160870007|NCT02563067|580917300|FG000|Overall Study|Technical problems|0|||
160870008|NCT02563067|580917301|FG001|Overall Study|Technical problems|1|||
160870009|NCT02563067|580917302|FG002|Overall Study|Technical problems|0|||
160870010|NCT02563067|580917300|FG000|Overall Study|Lack of Efficacy|1|||
160870011|NCT02563067|580917301|FG001|Overall Study|Lack of Efficacy|0|||
160870012|NCT02563067|580917302|FG002|Overall Study|Lack of Efficacy|0|||
160870013|NCT02563067|580917300|FG000|Overall Study|Death|0|||
160870014|NCT02563067|580917301|FG001|Overall Study|Death|1|||
160530645|NCT00791258|579673553|FG000|Overall Study|Protocol Violation|109|||
160530646|NCT00791258|579673553|FG000|Overall Study|Withdrawal by Subject|40|||
160530647|NCT00791258|579673553|FG000|Overall Study|Did not take medication for >3 days|1|||
160530648|NCT00791258|579673553|FG000|Overall Study|subject left area|2|||
160530649|NCT00791258|579673553|FG000|Overall Study|non-compliance|3|||
160530650|NCT00791258|579673553|FG000|Overall Study|Subject incarcerated|1|||
160530651|NCT00791258|579673553|FG000|Overall Study|Subject required restricted medication|1|||
160530652|NCT00791258|579673553|FG000|Overall Study|Lack of Efficacy|1|||
160530653|NCT00436618|579673554|FG000|Overall Study|Withdrawal by Subject|5|||
160530654|NCT00436618|579673555|FG001|Overall Study|Withdrawal by Subject|8|||
160530655|NCT00436618|579673556|FG002|Overall Study|Withdrawal by Subject|11|||
160530656|NCT00436618|579673554|FG000|Overall Study|Adverse Event|8|||
160530657|NCT00436618|579673555|FG001|Overall Study|Adverse Event|8|||
160530658|NCT00436618|579673556|FG002|Overall Study|Adverse Event|9|||
160530659|NCT00436618|579673554|FG000|Overall Study|Alternate Treatment|3|||
160530660|NCT00436618|579673555|FG001|Overall Study|Alternate Treatment|4|||
160530661|NCT00436618|579673556|FG002|Overall Study|Alternate Treatment|12|||
160530662|NCT00436618|579673554|FG000|Overall Study|Other Medical Problems|3|||
160530663|NCT00436618|579673555|FG001|Overall Study|Other Medical Problems|1|||
160530664|NCT00436618|579673556|FG002|Overall Study|Other Medical Problems|7|||
160530665|NCT00436618|579673554|FG000|Overall Study|Death|4|||
160530666|NCT00436618|579673555|FG001|Overall Study|Death|2|||
160530667|NCT00436618|579673556|FG002|Overall Study|Death|3|||
160530668|NCT00436618|579673554|FG000|Overall Study|New Primary or Other Reasons|6|||
160530669|NCT00436618|579673555|FG001|Overall Study|New Primary or Other Reasons|2|||
160530670|NCT00436618|579673556|FG002|Overall Study|New Primary or Other Reasons|12|||
160530671|NCT00436618|579673554|FG000|Overall Study|Still on treatment|1|||
160530672|NCT00436618|579673555|FG001|Overall Study|Still on treatment|2|||
160530673|NCT00436618|579673556|FG002|Overall Study|Still on treatment|7|||
160530674|NCT00698204|579673557|FG000|Overall Study|Withdrawal by Subject|1|||
160530675|NCT00698204|579673558|FG001|Overall Study|Withdrawal by Subject|0|||
160530676|NCT00058552|579673559|FG000|Overall Study|Died prior to receiving treatment|4|||
160530677|NCT00058552|579673560|FG001|Overall Study|Died prior to receiving treatment|2|||
160530678|NCT00058552|579673559|FG000|Overall Study|Disease progression|52|||
160530679|NCT00058552|579673560|FG001|Overall Study|Disease progression|44|||
160530680|NCT00058552|579673559|FG000|Overall Study|Adverse Event|4|||
160530681|NCT00058552|579673560|FG001|Overall Study|Adverse Event|2|||
160530682|NCT00058552|579673559|FG000|Overall Study|Withdrawal by Subject|3|||
160530683|NCT00058552|579673560|FG001|Overall Study|Withdrawal by Subject|5|||
160530684|NCT00058552|579673559|FG000|Overall Study|Physician Decision|2|||
160530685|NCT00058552|579673560|FG001|Overall Study|Physician Decision|5|||
160530686|NCT00058552|579673559|FG000|Overall Study|Clinical disease progression|0|||
160530687|NCT00058552|579673560|FG001|Overall Study|Clinical disease progression|4|||
160530688|NCT02066311|579673561|FG000|Overall Study|Adverse Event|4|||
160530689|NCT02066311|579673561|FG000|Overall Study|Withdrawal by Subject|1|||
160530690|NCT01372150|579673564|FG000|Overall Study|Lack of Efficacy|3|||
160530691|NCT01372150|579673565|FG001|Overall Study|Lack of Efficacy|0|||
160530692|NCT01372150|579673566|FG002|Overall Study|Lack of Efficacy|1|||
160530693|NCT01372150|579673564|FG000|Overall Study|Lost to Follow-up|4|||
160530694|NCT01372150|579673565|FG001|Overall Study|Lost to Follow-up|5|||
160530695|NCT01372150|579673566|FG002|Overall Study|Lost to Follow-up|6|||
160530696|NCT01372150|579673564|FG000|Overall Study|Protocol Violation|1|||
160530697|NCT01372150|579673565|FG001|Overall Study|Protocol Violation|0|||
160530698|NCT01372150|579673566|FG002|Overall Study|Protocol Violation|3|||
160530699|NCT01372150|579673564|FG000|Overall Study|Withdrawal by Subject|2|||
160530700|NCT01372150|579673565|FG001|Overall Study|Withdrawal by Subject|7|||
160530701|NCT01372150|579673566|FG002|Overall Study|Withdrawal by Subject|2|||
160530702|NCT01372150|579673564|FG000|Overall Study|Other|1|||
160530703|NCT01372150|579673565|FG001|Overall Study|Other|0|||
160530704|NCT01372150|579673566|FG002|Overall Study|Other|2|||
160530705|NCT01372150|579673564|FG000|Overall Study|Adverse Event|2|||
160530706|NCT01372150|579673565|FG001|Overall Study|Adverse Event|1|||
160530707|NCT01372150|579673566|FG002|Overall Study|Adverse Event|2|||
160530708|NCT01372150|579673564|FG000|Overall Study|Randomized but not treated|0|||
160530709|NCT01372150|579673565|FG001|Overall Study|Randomized but not treated|1|||
160530710|NCT01372150|579673566|FG002|Overall Study|Randomized but not treated|0|||
160530711|NCT02316340|579673567|FG000|First Progression|Clinical progression|2|||
160530712|NCT02316340|579673568|FG001|First Progression|Clinical progression|1|||
160530713|NCT02316340|579673567|FG000|First Progression|Withdrawal by Subject|1|||
160530714|NCT02316340|579673568|FG001|First Progression|Withdrawal by Subject|0|||
160530715|NCT01835015|579673569|FG000|Overall Study|Adverse Event|0|||
160530716|NCT01835015|579673570|FG001|Overall Study|Adverse Event|0|||
160530717|NCT01835015|579673571|FG002|Overall Study|Adverse Event|1|||
160530718|NCT01835015|579673572|FG003|Overall Study|Adverse Event|0|||
160530719|NCT01835015|579673573|FG004|Overall Study|Adverse Event|0|||
160530720|NCT00975715|579673577|FG000|Titration Period|Adverse Event|6|||
160530721|NCT00975715|579673578|FG001|Titration Period|Adverse Event|0|||
160530722|NCT00975715|579673577|FG000|Titration Period|Protocol Violation|1|||
160530723|NCT00975715|579673578|FG001|Titration Period|Protocol Violation|0|||
160530724|NCT00975715|579673577|FG000|Maintenance Period|Adverse Event|2|||
160530725|NCT00975715|579673578|FG001|Maintenance Period|Adverse Event|1|||
160530726|NCT01241552|579673582|FG000|Overall Study|Lack of Efficacy|1|||
160530727|NCT01241552|579673583|FG001|Overall Study|Lack of Efficacy|0|||
160530728|NCT01241552|579673584|FG002|Overall Study|Lack of Efficacy|0|||
160530729|NCT01241552|579673585|FG003|Overall Study|Lack of Efficacy|0|||
160530730|NCT01241552|579673582|FG000|Overall Study|Death|26|||
160530731|NCT01241552|579673583|FG001|Overall Study|Death|30|||
160530732|NCT01241552|579673584|FG002|Overall Study|Death|20|||
160530733|NCT01241552|579673585|FG003|Overall Study|Death|25|||
160530734|NCT01241552|579673582|FG000|Overall Study|Adverse Event|1|||
160530735|NCT01241552|579673583|FG001|Overall Study|Adverse Event|1|||
160530736|NCT01241552|579673584|FG002|Overall Study|Adverse Event|0|||
160530737|NCT01241552|579673585|FG003|Overall Study|Adverse Event|0|||
160530738|NCT01241552|579673582|FG000|Overall Study|Technical Problems|2|||
160530739|NCT01241552|579673583|FG001|Overall Study|Technical Problems|0|||
160530740|NCT01241552|579673584|FG002|Overall Study|Technical Problems|2|||
160530741|NCT01241552|579673585|FG003|Overall Study|Technical Problems|2|||
160530742|NCT01241552|579673582|FG000|Overall Study|Progressive Disease|0|||
160530743|NCT01241552|579673583|FG001|Overall Study|Progressive Disease|0|||
160530744|NCT01241552|579673584|FG002|Overall Study|Progressive Disease|1|||
160530745|NCT01241552|579673585|FG003|Overall Study|Progressive Disease|2|||
160530746|NCT01241552|579673582|FG000|Overall Study|Protocol Violation|0|||
160530747|NCT01241552|579673583|FG001|Overall Study|Protocol Violation|2|||
160530748|NCT01241552|579673584|FG002|Overall Study|Protocol Violation|6|||
160530749|NCT01241552|579673585|FG003|Overall Study|Protocol Violation|1|||
160530750|NCT01241552|579673582|FG000|Overall Study|Withdrawal by Subject|7|||
160530751|NCT01241552|579673583|FG001|Overall Study|Withdrawal by Subject|15|||
160530752|NCT01241552|579673584|FG002|Overall Study|Withdrawal by Subject|14|||
160530753|NCT01241552|579673585|FG003|Overall Study|Withdrawal by Subject|15|||
160530754|NCT01241552|579673582|FG000|Overall Study|Physician Decision|2|||
160530755|NCT01241552|579673583|FG001|Overall Study|Physician Decision|4|||
160530756|NCT01241552|579673584|FG002|Overall Study|Physician Decision|2|||
160530757|NCT01241552|579673585|FG003|Overall Study|Physician Decision|3|||
160530758|NCT01241552|579673582|FG000|Overall Study|Lost to Follow-up|2|||
160530759|NCT01241552|579673583|FG001|Overall Study|Lost to Follow-up|11|||
160530760|NCT01241552|579673584|FG002|Overall Study|Lost to Follow-up|15|||
160530761|NCT01241552|579673585|FG003|Overall Study|Lost to Follow-up|16|||
160530762|NCT04004429|579673586|FG000|Overall Study|Protocol Violation|1|||
160530763|NCT04004429|579673587|FG001|Overall Study|Protocol Violation|0|||
160530764|NCT04004429|579673588|FG002|Overall Study|Protocol Violation|0|||
160530765|NCT04004429|579673586|FG000|Overall Study|Physician Decision|0|||
160765573|NCT00784875|580532847|FG001|Period A - Baseline|Lost to Follow-up|0|||
160765574|NCT00784875|580532848|FG002|Period A - Baseline|Lost to Follow-up|0|||
160765575|NCT00784875|580532849|FG003|Period A - Baseline|Lost to Follow-up|2|||
160765576|NCT00784875|580532846|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
160765577|NCT00784875|580532847|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
160765578|NCT00784875|580532848|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
160765579|NCT00784875|580532849|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
160765580|NCT00784875|580532846|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
160765581|NCT00784875|580532847|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
160765582|NCT00784875|580532848|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
160765583|NCT00784875|580532849|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
160765584|NCT00784875|580532846|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
160765585|NCT00784875|580532847|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
160765586|NCT00784875|580532848|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
160765587|NCT00784875|580532849|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
160765588|NCT00784875|580532846|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
160765589|NCT00784875|580532847|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
160765590|NCT00784875|580532848|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
160765591|NCT00784875|580532849|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
160765592|NCT00784875|580532846|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
160765593|NCT00784875|580532847|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
160530766|NCT04004429|579673587|FG001|Overall Study|Physician Decision|1|||
160530767|NCT04004429|579673588|FG002|Overall Study|Physician Decision|1|||
160530768|NCT04004429|579673586|FG000|Overall Study|Withdrawal by Subject|1|||
160530769|NCT04004429|579673587|FG001|Overall Study|Withdrawal by Subject|1|||
160530770|NCT04004429|579673588|FG002|Overall Study|Withdrawal by Subject|1|||
160530771|NCT00718549|579673589|FG000|Induction Phase|Disease Progression|1|||
160530772|NCT00718549|579673590|FG001|Induction Phase|Disease Progression|0|||
160530773|NCT00718549|579673591|FG002|Induction Phase|Disease Progression|0|||
160530774|NCT00718549|579673589|FG000|Induction Phase|Eligibility Criteria Violation|2|||
160765594|NCT00784875|580532848|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
160530775|NCT00718549|579673590|FG001|Induction Phase|Eligibility Criteria Violation|0|||
160530776|NCT00718549|579673591|FG002|Induction Phase|Eligibility Criteria Violation|0|||
160870015|NCT02563067|580917302|FG002|Overall Study|Death|1|||
160870016|NCT02563067|580917300|FG000|Overall Study|Adverse Event|2|||
160870017|NCT02563067|580917301|FG001|Overall Study|Adverse Event|1|||
160870018|NCT02563067|580917302|FG002|Overall Study|Adverse Event|0|||
160870019|NCT02563067|580917300|FG000|Overall Study|Death post Treatment/safety period|1|||
160870020|NCT02563067|580917301|FG001|Overall Study|Death post Treatment/safety period|0|||
160870021|NCT02563067|580917302|FG002|Overall Study|Death post Treatment/safety period|0|||
160870022|NCT03544333|580917303|FG000|Overall Study|Withdrawal by Subject|1|||
160530777|NCT00718549|579673589|FG000|Induction Phase|Early Termination - No Additional Info|59|||
160530778|NCT00718549|579673590|FG001|Induction Phase|Early Termination - No Additional Info|0|||
160530779|NCT00718549|579673591|FG002|Induction Phase|Early Termination - No Additional Info|0|||
160530780|NCT00718549|579673589|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
160530781|NCT00718549|579673590|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
160530782|NCT00718549|579673591|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
160530783|NCT00718549|579673589|FG000|Maintenance/ Observation Phase|Death|0|||
160530784|NCT00718549|579673590|FG001|Maintenance/ Observation Phase|Death|1|||
160530785|NCT00718549|579673591|FG002|Maintenance/ Observation Phase|Death|2|||
160530786|NCT00718549|579673589|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
160530787|NCT00718549|579673590|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
160530788|NCT00718549|579673591|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
160530789|NCT00718549|579673589|FG000|Maintenance/ Observation Phase|Progression|0|||
160530790|NCT00718549|579673590|FG001|Maintenance/ Observation Phase|Progression|5|||
160530791|NCT00718549|579673591|FG002|Maintenance/ Observation Phase|Progression|14|||
160530792|NCT00718549|579673589|FG000|Maintenance/ Observation Phase|Relapse|0|||
160530793|NCT00718549|579673590|FG001|Maintenance/ Observation Phase|Relapse|3|||
160530794|NCT00718549|579673591|FG002|Maintenance/ Observation Phase|Relapse|2|||
160530795|NCT02606461|579673592|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
160530796|NCT02606461|579673593|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
160530797|NCT02606461|579673594|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
160530798|NCT02606461|579673595|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
160530799|NCT02606461|579673596|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
160530800|NCT02606461|579673597|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
160530801|NCT00239226|579673598|FG000|Overall Study|permAF during stabilization period|0|||
160530802|NCT00239226|579673599|FG001|Overall Study|permAF during stabilization period|0|||
160530803|NCT00239226|579673600|FG002|Overall Study|permAF during stabilization period|0|||
160530804|NCT00239226|579673601|FG003|Overall Study|permAF during stabilization period|3|||
160530805|NCT00239226|579673598|FG000|Overall Study|Lost to Follow-up|1|||
160530806|NCT00239226|579673599|FG001|Overall Study|Lost to Follow-up|0|||
160530807|NCT00239226|579673600|FG002|Overall Study|Lost to Follow-up|1|||
160530808|NCT00239226|579673601|FG003|Overall Study|Lost to Follow-up|0|||
160530809|NCT01303965|579673603|FG000|Overall Study|Adverse Event|1|||
160530810|NCT01303965|579673604|FG001|Overall Study|Adverse Event|1|||
160530811|NCT01303965|579673603|FG000|Overall Study|Death|0|||
160530812|NCT01303965|579673604|FG001|Overall Study|Death|3|||
160530813|NCT01303965|579673603|FG000|Overall Study|Withdrawal by Subject|1|||
160530814|NCT01303965|579673604|FG001|Overall Study|Withdrawal by Subject|0|||
160530815|NCT01303965|579673603|FG000|Overall Study|Disease Progression|1|||
160530816|NCT01303965|579673604|FG001|Overall Study|Disease Progression|6|||
160530817|NCT00851682|579673607|FG000|Overall Study|screen failure|5|||
160530818|NCT00851682|579673608|FG001|Overall Study|screen failure|0|||
160530819|NCT01829425|579673609|FG000|Overall Study|Withdrawal by Subject|4|||
160530820|NCT01829425|579673610|FG001|Overall Study|Withdrawal by Subject|3|||
160530821|NCT01829425|579673609|FG000|Overall Study|Lost to Follow-up|2|||
160870023|NCT03544333|580917304|FG001|Overall Study|Withdrawal by Subject|0|||
160870024|NCT00475306|580917309|FG000|Overall Study|Protocol Violation|1|||
160870025|NCT00475306|580917310|FG001|Overall Study|Protocol Violation|1|||
160870026|NCT00475306|580917311|FG002|Overall Study|Protocol Violation|0|||
160870027|NCT00475306|580917312|FG003|Overall Study|Protocol Violation|1|||
160870028|NCT02405442|580917314|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
160870029|NCT02405442|580917315|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
160870030|NCT02405442|580917316|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
160870031|NCT02405442|580917317|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
160870032|NCT02405442|580917314|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
160870033|NCT02405442|580917315|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
160870034|NCT02405442|580917316|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
160870035|NCT02405442|580917317|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
160870036|NCT02405442|580917314|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
160870037|NCT02405442|580917315|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
160870038|NCT02405442|580917316|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
160870039|NCT02405442|580917317|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
160870040|NCT02405442|580917314|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
160870041|NCT02405442|580917315|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
160870042|NCT02405442|580917316|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
160870043|NCT02405442|580917317|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
160870044|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
160870045|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
160530822|NCT01829425|579673610|FG001|Overall Study|Lost to Follow-up|1|||
160530823|NCT03681951|579673611|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
160530824|NCT03681951|579673612|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
160530825|NCT03681951|579673613|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
160870046|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
160870047|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
160870048|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
160870049|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
160870050|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
160530826|NCT03681951|579673614|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
160530827|NCT03681951|579673615|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
160530828|NCT03681951|579673616|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
160530829|NCT03681951|579673617|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
160530830|NCT03681951|579673618|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
160530831|NCT03681951|579673611|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
160530832|NCT03681951|579673612|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
160530833|NCT03681951|579673613|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
160530834|NCT03681951|579673614|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
160530835|NCT03681951|579673615|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
160530836|NCT03681951|579673616|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
160530837|NCT03681951|579673617|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
160530838|NCT03681951|579673618|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
160530839|NCT03681951|579673611|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
160530840|NCT03681951|579673612|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
160530841|NCT03681951|579673613|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
160530842|NCT03681951|579673614|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
160530843|NCT03681951|579673615|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
160530844|NCT03681951|579673616|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
160530845|NCT03681951|579673617|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
160530846|NCT03681951|579673618|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
160530847|NCT00232141|579673619|FG000|Overall Study|Adverse Event|9|||
160530848|NCT00232141|579673620|FG001|Overall Study|Adverse Event|4|||
160530849|NCT00232141|579673619|FG000|Overall Study|Lack of Efficacy|0|||
160530850|NCT00232141|579673620|FG001|Overall Study|Lack of Efficacy|3|||
160530851|NCT00232141|579673619|FG000|Overall Study|Lost to Follow-up|9|||
160530852|NCT00232141|579673620|FG001|Overall Study|Lost to Follow-up|6|||
160530853|NCT00232141|579673619|FG000|Overall Study|Other|8|||
160530854|NCT00232141|579673620|FG001|Overall Study|Other|10|||
160530855|NCT00232141|579673619|FG000|Overall Study|Withdrawal by Subject|5|||
160530856|NCT00232141|579673620|FG001|Overall Study|Withdrawal by Subject|3|||
160530857|NCT01810016|579673621|FG000|Overall Study|Progressive disease|1|||
160530858|NCT01810016|579673622|FG001|Overall Study|Progressive disease|1|||
160530859|NCT01810016|579673623|FG002|Overall Study|Progressive disease|0|||
160530860|NCT01810016|579673621|FG000|Overall Study|Death|0|||
160530861|NCT01810016|579673622|FG001|Overall Study|Death|0|||
160530862|NCT01810016|579673623|FG002|Overall Study|Death|1|||
160530863|NCT02229539|579674952|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
160530864|NCT02229539|579674953|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
160530865|NCT02229539|579674954|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
160530866|NCT02229539|579674952|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
160530867|NCT02229539|579674953|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
160530868|NCT02229539|579674954|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
160530869|NCT02229539|579674952|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
160530870|NCT02229539|579674953|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
160530871|NCT02229539|579674954|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
160530872|NCT02229539|579674952|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
160530873|NCT02229539|579674953|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
160530874|NCT02229539|579674954|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
160530875|NCT02229539|579674952|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
160530876|NCT02229539|579674953|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
160530877|NCT02229539|579674954|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
160530878|NCT02229539|579674952|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
160530879|NCT02229539|579674953|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
160530880|NCT02229539|579674954|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
160530881|NCT00682448|579674955|FG000|Overall Study|Adverse Event|1|||
160530882|NCT00682448|579674956|FG001|Overall Study|Adverse Event|2|||
160530883|NCT00682448|579674955|FG000|Overall Study|Lack of Efficacy|1|||
160530884|NCT00682448|579674956|FG001|Overall Study|Lack of Efficacy|0|||
160530885|NCT00682448|579674955|FG000|Overall Study|Lost to Follow-up|1|||
160530886|NCT00682448|579674956|FG001|Overall Study|Lost to Follow-up|3|||
160530887|NCT00682448|579674955|FG000|Overall Study|Pregnancy|0|||
160530888|NCT00682448|579674956|FG001|Overall Study|Pregnancy|1|||
160530889|NCT00682448|579674955|FG000|Overall Study|Withdrawal by Subject|2|||
160530890|NCT00682448|579674956|FG001|Overall Study|Withdrawal by Subject|0|||
160765595|NCT00784875|580532849|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
160870051|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
160870052|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
160870053|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
160870054|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
160870055|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
160870056|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
160870057|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
160530891|NCT04050670|579674959|FG000|Period 3|Physician Decision|0|||
160530892|NCT04050670|579674960|FG001|Period 3|Physician Decision|1|||
160530893|NCT04050670|579674961|FG002|Period 3|Physician Decision|0|||
160530894|NCT00268437|579674962|FG000|Overall Study|Ineligible|1|||
160530895|NCT01022996|579674966|FG000|Overall Study|Adverse Event|14|||
160530896|NCT01022996|579674966|FG000|Overall Study|Withdrawal by Subject|3|||
160530897|NCT01022996|579674966|FG000|Overall Study|Lost to Follow-up|1|||
160530898|NCT01022996|579674966|FG000|Overall Study|Administrative problems|6|||
160530899|NCT01022996|579674966|FG000|Overall Study|Disease Progression|32|||
160530900|NCT01022996|579674966|FG000|Overall Study|Protocol Violation|1|||
160530901|NCT02767323|579674967|FG000|Overall Study|Withdrawal by Subject|17|||
160530902|NCT02767323|579674968|FG001|Overall Study|Withdrawal by Subject|5|||
160530903|NCT02767323|579674969|FG002|Overall Study|Withdrawal by Subject|13|||
160530904|NCT02767323|579674970|FG003|Overall Study|Withdrawal by Subject|0|||
160530905|NCT02767323|579674967|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
160530906|NCT02767323|579674968|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
160870058|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
160870059|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
160870060|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
160870061|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
160870062|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
160870063|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
160870064|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
160870065|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
160870066|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
160870067|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
160870068|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
160870069|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
160870070|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
160870071|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
160870072|NCT02405442|580917314|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
160870073|NCT02405442|580917315|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
160870074|NCT02405442|580917316|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
160870075|NCT02405442|580917317|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
160870076|NCT02405442|580917314|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
160870077|NCT02405442|580917315|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
160870078|NCT02405442|580917316|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
160870079|NCT02405442|580917317|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
160870080|NCT02405442|580917314|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
160530907|NCT02767323|579674969|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
160870081|NCT02405442|580917315|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
160870082|NCT02405442|580917316|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
160870083|NCT02405442|580917317|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
160870084|NCT03830892|580917321|FG000|Overall Study|Physician Decision|2|||
160870085|NCT03830892|580917322|FG001|Overall Study|Physician Decision|3|||
160870086|NCT03830892|580917321|FG000|Overall Study|Study terminated due to COVID|4|||
160870087|NCT03830892|580917322|FG001|Overall Study|Study terminated due to COVID|0|||
160870088|NCT03830892|580917321|FG000|Overall Study|Protocol Violation|0|||
160870089|NCT03830892|580917322|FG001|Overall Study|Protocol Violation|1|||
160870090|NCT03830892|580917321|FG000|Overall Study|Withdrawal by Subject|0|||
160870091|NCT03830892|580917322|FG001|Overall Study|Withdrawal by Subject|2|||
160870092|NCT01499277|580917323|FG000|Overall Study|Adverse Event|3|||
160870093|NCT01499277|580917324|FG001|Overall Study|Adverse Event|6|||
160870094|NCT01499277|580917323|FG000|Overall Study|Death|3|||
160870095|NCT01499277|580917324|FG001|Overall Study|Death|2|||
160870096|NCT01499277|580917323|FG000|Overall Study|Lost to Follow-up|15|||
160870097|NCT01499277|580917324|FG001|Overall Study|Lost to Follow-up|8|||
160870098|NCT01499277|580917323|FG000|Overall Study|Protocol Violation|2|||
160870099|NCT01499277|580917324|FG001|Overall Study|Protocol Violation|3|||
160870100|NCT01499277|580917323|FG000|Overall Study|Withdrawal by Subject|16|||
160870101|NCT01499277|580917324|FG001|Overall Study|Withdrawal by Subject|6|||
160870102|NCT01499277|580917323|FG000|Overall Study|Lack of therapeutic response and other|8|||
160870103|NCT01499277|580917324|FG001|Overall Study|Lack of therapeutic response and other|7|||
160870104|NCT00975689|580917325|FG000|Overall Study|Adverse Event|0|||
160870105|NCT00975689|580917326|FG001|Overall Study|Adverse Event|3|||
160870106|NCT00975689|580917325|FG000|Overall Study|Withdrawal by Subject|1|||
160870107|NCT00975689|580917326|FG001|Overall Study|Withdrawal by Subject|0|||
160870108|NCT00975689|580917325|FG000|Overall Study|Physician Decision|1|||
160870109|NCT00975689|580917326|FG001|Overall Study|Physician Decision|0|||
160870110|NCT00372593|580917329|FG000|Overall Study|Adverse Event|43|||
160870111|NCT00372593|580917330|FG001|Overall Study|Adverse Event|45|||
160870112|NCT00372593|580917331|FG002|Overall Study|Adverse Event|0|||
160870113|NCT00372593|580917329|FG000|Overall Study|Death|16|||
160870114|NCT00372593|580917330|FG001|Overall Study|Death|20|||
160870115|NCT00372593|580917331|FG002|Overall Study|Death|1|||
160870116|NCT00372593|580917329|FG000|Overall Study|Lack of Efficacy|82|||
160870117|NCT00372593|580917330|FG001|Overall Study|Lack of Efficacy|71|||
160870118|NCT00372593|580917331|FG002|Overall Study|Lack of Efficacy|2|||
160870119|NCT00372593|580917329|FG000|Overall Study|Lost to Follow-up|1|||
160870120|NCT00372593|580917330|FG001|Overall Study|Lost to Follow-up|0|||
160530908|NCT02767323|579674970|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
160870121|NCT00372593|580917331|FG002|Overall Study|Lost to Follow-up|0|||
160870122|NCT00372593|580917329|FG000|Overall Study|Physician Decision|42|||
160870123|NCT00372593|580917330|FG001|Overall Study|Physician Decision|41|||
160870124|NCT00372593|580917331|FG002|Overall Study|Physician Decision|0|||
160870125|NCT00372593|580917329|FG000|Overall Study|Ineligible|20|||
160870126|NCT00372593|580917330|FG001|Overall Study|Ineligible|21|||
160870127|NCT00372593|580917331|FG002|Overall Study|Ineligible|1|||
160870128|NCT02974543|580917332|FG000|Overall Study|Withdrawal by Subject|1|||
160870129|NCT02974543|580917333|FG001|Overall Study|Withdrawal by Subject|0|||
160870130|NCT03534180|580917334|FG000|Overall Study|Withdrawal by Subject|1|||
160870131|NCT00220636|580917335|FG000|Overall Study|Withdrawal by Subject|4|||
160870132|NCT00330967|580917336|FG000|Overall Study|Withdrawal by Subject|0|||
160870133|NCT00330967|580917337|FG001|Overall Study|Withdrawal by Subject|5|||
160870134|NCT00330967|580917336|FG000|Overall Study|Physician Decision|0|||
160765596|NCT00784875|580532846|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
160765597|NCT00784875|580532847|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
160765598|NCT00784875|580532848|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
160765599|NCT00784875|580532849|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
160765600|NCT00784875|580532846|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
160765601|NCT00784875|580532847|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
160765602|NCT00784875|580532848|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
160765603|NCT00784875|580532849|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
160765604|NCT00784875|580532846|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
160765605|NCT00784875|580532847|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
160765606|NCT00784875|580532848|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
160765607|NCT00784875|580532849|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
160765608|NCT00784875|580532846|FG000|Period C|Adverse Event|1|||
160765609|NCT00784875|580532847|FG001|Period C|Adverse Event|0|||
160765610|NCT00784875|580532848|FG002|Period C|Adverse Event|4|||
160765611|NCT00784875|580532849|FG003|Period C|Adverse Event|2|||
160765612|NCT00784875|580532846|FG000|Period C|Protocol Violation|0|||
160530909|NCT00930722|579674971|FG000|Overall Study|Lost to Follow-up|16|||
160530910|NCT00930722|579674971|FG000|Overall Study|No longer willing to participate|9|||
160530911|NCT00930722|579674971|FG000|Overall Study|Study terminated by sponsor|2|||
160530912|NCT02230254|579674972|FG000|Overall Study|Lost to Follow-up|3|||
160530913|NCT03523728|579674973|FG000|Stage 1 (24 Months)|Adverse Event|2|||
160530914|NCT03523728|579674974|FG001|Stage 1 (24 Months)|Adverse Event|2|||
160530915|NCT03523728|579674975|FG002|Stage 1 (24 Months)|Adverse Event|4|||
160530916|NCT03523728|579674976|FG003|Stage 1 (24 Months)|Adverse Event|0|||
160530917|NCT03523728|579674977|FG004|Stage 1 (24 Months)|Adverse Event|0|||
160530918|NCT03523728|579674973|FG000|Stage 1 (24 Months)|Progressive disease|0|||
160530919|NCT03523728|579674974|FG001|Stage 1 (24 Months)|Progressive disease|0|||
160530920|NCT03523728|579674975|FG002|Stage 1 (24 Months)|Progressive disease|1|||
160530921|NCT03523728|579674976|FG003|Stage 1 (24 Months)|Progressive disease|0|||
160530922|NCT03523728|579674977|FG004|Stage 1 (24 Months)|Progressive disease|0|||
160530923|NCT03523728|579674973|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
160530924|NCT03523728|579674974|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
160530925|NCT03523728|579674975|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
160530926|NCT03523728|579674976|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
160530927|NCT03523728|579674977|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
160530928|NCT03523728|579674973|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
160530929|NCT03523728|579674974|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
160530930|NCT03523728|579674975|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
160530931|NCT03523728|579674976|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
160530932|NCT03523728|579674977|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
160530933|NCT03523728|579674973|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
160530934|NCT03523728|579674974|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
160530935|NCT03523728|579674975|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
160530936|NCT03523728|579674976|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
160530937|NCT03523728|579674977|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
160530938|NCT03523728|579674973|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
160530939|NCT03523728|579674974|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
160530940|NCT03523728|579674975|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
160530941|NCT03523728|579674976|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
160530942|NCT03523728|579674977|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
160530943|NCT03523728|579674973|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
160530944|NCT03523728|579674974|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
160530945|NCT03523728|579674975|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
160530946|NCT03523728|579674976|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
160530947|NCT03523728|579674977|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
160530948|NCT03523728|579674973|FG000|Stage 2 (24 Months)|Adverse Event|0|||
160530949|NCT03523728|579674974|FG001|Stage 2 (24 Months)|Adverse Event|0|||
160530950|NCT03523728|579674975|FG002|Stage 2 (24 Months)|Adverse Event|0|||
160530951|NCT03523728|579674976|FG003|Stage 2 (24 Months)|Adverse Event|1|||
160530952|NCT03523728|579674977|FG004|Stage 2 (24 Months)|Adverse Event|2|||
160530953|NCT03523728|579674973|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
160530954|NCT03523728|579674974|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
160530955|NCT03523728|579674975|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
160530956|NCT03523728|579674976|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
160530957|NCT03523728|579674977|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
160530958|NCT03523728|579674973|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
160530959|NCT03523728|579674974|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
160530960|NCT03523728|579674975|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
160530961|NCT03523728|579674976|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
160530962|NCT03523728|579674977|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
160530963|NCT03523728|579674973|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
160530964|NCT03523728|579674974|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
160530965|NCT03523728|579674975|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
160530966|NCT03523728|579674976|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
160530967|NCT03523728|579674977|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
160530968|NCT03523728|579674973|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
160530969|NCT03523728|579674974|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
160530970|NCT03523728|579674975|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
160870135|NCT00330967|580917337|FG001|Overall Study|Physician Decision|9|||
160870136|NCT01237899|580917338|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
160870137|NCT01237899|580917339|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
160870138|NCT01237899|580917340|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
160530971|NCT03523728|579674976|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
160530972|NCT03523728|579674977|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
160870139|NCT01237899|580917341|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
160530973|NCT00621751|579674978|FG000|Overall Study|Adverse Event|0|||
160530974|NCT00621751|579674979|FG001|Overall Study|Adverse Event|1|||
160530975|NCT00710879|579674982|FG000|Overall Study|Lost to Follow-up|2|||
160530976|NCT00710879|579674983|FG001|Overall Study|Lost to Follow-up|1|||
160530977|NCT00710879|579674982|FG000|Overall Study|Protocol Violation|0|||
160870140|NCT01237899|580917342|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
160530978|NCT00710879|579674983|FG001|Overall Study|Protocol Violation|3|||
160530979|NCT01274715|579674984|FG000|Overall Study|Lost to Follow-up|1|||
160530980|NCT01274715|579674984|FG000|Overall Study|After consent, met exclusion criteria.|1|||
160530981|NCT01274715|579674984|FG000|Overall Study|After consent, met exclusion criteria.|1|||
160765613|NCT00784875|580532847|FG001|Period C|Protocol Violation|0|||
160765614|NCT00784875|580532848|FG002|Period C|Protocol Violation|1|||
160765615|NCT00784875|580532849|FG003|Period C|Protocol Violation|2|||
160530982|NCT01274715|579674984|FG000|Overall Study|After consent, met exclusion criteria.|1|||
160870141|NCT01237899|580917343|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
160870142|NCT01237899|580917344|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
160870143|NCT01237899|580917345|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
160870144|NCT01237899|580917346|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
160870145|NCT01237899|580917347|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
160870146|NCT01237899|580917348|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
160870147|NCT00790088|580917349|FG000|Overall Study|Protocol Violation|11|||
160870148|NCT00790088|580917349|FG000|Overall Study|Withdrawal by Subject|17|||
160870149|NCT00790088|580917349|FG000|Overall Study|Lost to Follow-up|7|||
160870150|NCT00790088|580917349|FG000|Overall Study|Physician Decision|4|||
160870151|NCT00337675|580917350|FG000|Overall Study|Adverse Event|10|||
160870152|NCT00337675|580917351|FG001|Overall Study|Adverse Event|9|||
160870153|NCT00337675|580917352|FG002|Overall Study|Adverse Event|19|||
160870154|NCT00337675|580917350|FG000|Overall Study|Lack of Efficacy|10|||
160870155|NCT00337675|580917351|FG001|Overall Study|Lack of Efficacy|7|||
160870156|NCT00337675|580917352|FG002|Overall Study|Lack of Efficacy|9|||
160870157|NCT00337675|580917350|FG000|Overall Study|Lost to Follow-up|22|||
160870158|NCT00337675|580917351|FG001|Overall Study|Lost to Follow-up|19|||
160870159|NCT00337675|580917352|FG002|Overall Study|Lost to Follow-up|17|||
160870160|NCT00337675|580917350|FG000|Overall Study|Physician Decision|9|||
160870161|NCT00337675|580917351|FG001|Overall Study|Physician Decision|17|||
160870162|NCT00337675|580917352|FG002|Overall Study|Physician Decision|14|||
160870163|NCT00337675|580917350|FG000|Overall Study|Protocol Violation|21|||
160870164|NCT00337675|580917351|FG001|Overall Study|Protocol Violation|24|||
160870165|NCT00337675|580917352|FG002|Overall Study|Protocol Violation|19|||
160870166|NCT00337675|580917350|FG000|Overall Study|Withdrawal by Subject|25|||
160870167|NCT00337675|580917351|FG001|Overall Study|Withdrawal by Subject|25|||
160870168|NCT00337675|580917352|FG002|Overall Study|Withdrawal by Subject|19|||
160765616|NCT00784875|580532846|FG000|Period C|Lack of Efficacy|0|||
160765617|NCT00784875|580532847|FG001|Period C|Lack of Efficacy|0|||
160530983|NCT04479436|579674985|FG000|Overall Study|Progressive disease|26|||
160530984|NCT04479436|579674986|FG001|Overall Study|Progressive disease|1|||
160530985|NCT04479436|579674985|FG000|Overall Study|Adverse Event|6|||
160530986|NCT04479436|579674986|FG001|Overall Study|Adverse Event|0|||
160530987|NCT04479436|579674985|FG000|Overall Study|Withdrawal by Subject|5|||
160530988|NCT04479436|579674986|FG001|Overall Study|Withdrawal by Subject|0|||
160530989|NCT04479436|579674985|FG000|Overall Study|Clinical progression|1|||
160530990|NCT04479436|579674986|FG001|Overall Study|Clinical progression|0|||
160530991|NCT04479436|579674985|FG000|Overall Study|Physician Decision|1|||
160530992|NCT04479436|579674986|FG001|Overall Study|Physician Decision|0|||
160530993|NCT01186939|579674991|FG000|Overall Study|Death|7|||
160530994|NCT01186939|579674991|FG000|Overall Study|Withdrawal by Subject|2|||
160530995|NCT01186939|579674991|FG000|Overall Study|No longer receiving clinical benefit|17|||
160530996|NCT01186939|579674991|FG000|Overall Study|Program closed|5|||
160530997|NCT01186939|579674991|FG000|Overall Study|Sponsor decision|4|||
160530998|NCT01186939|579674991|FG000|Overall Study|Started additional treatment|1|||
160530999|NCT01186939|579674991|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
160531000|NCT01186939|579674991|FG000|Overall Study|Myocardial infarction|1|||
160531001|NCT01186939|579674991|FG000|Overall Study|Bone marrow transplant|1|||
160531002|NCT01186939|579674991|FG000|Overall Study|Transformation to AML|1|||
160531003|NCT03945591|579674992|FG000|Overall Study|Participant not transplanted|1|||
160531004|NCT03945591|579674992|FG000|Overall Study|Change in treatment plan|3|||
160531005|NCT03945591|579674992|FG000|Overall Study|Adverse Event|1|||
160531006|NCT00314249|579674995|FG000|Overall Study|Adverse Event|73|||
160531007|NCT00314249|579674996|FG001|Overall Study|Adverse Event|94|||
160531008|NCT00314249|579674995|FG000|Overall Study|Lack of Efficacy|33|||
160531009|NCT00314249|579674996|FG001|Overall Study|Lack of Efficacy|24|||
160531010|NCT00314249|579674995|FG000|Overall Study|Withdrawal by Subject|21|||
160531011|NCT00314249|579674996|FG001|Overall Study|Withdrawal by Subject|28|||
160531012|NCT00314249|579674995|FG000|Overall Study|Lost to Follow-up|15|||
160531013|NCT00314249|579674996|FG001|Overall Study|Lost to Follow-up|9|||
160531014|NCT00314249|579674995|FG000|Overall Study|Physician Decision|1|||
160531015|NCT00314249|579674996|FG001|Overall Study|Physician Decision|1|||
160531016|NCT00314249|579674995|FG000|Overall Study|Withdrawn for other reasons|4|||
160531017|NCT00314249|579674996|FG001|Overall Study|Withdrawn for other reasons|1|||
160531018|NCT00314249|579674995|FG000|Overall Study|Non-Compliant|5|||
160531019|NCT00314249|579674996|FG001|Overall Study|Non-Compliant|6|||
160531020|NCT03781323|579674997|FG000|Overall Study|Withdrawal by Subject|1|||
160531021|NCT04060563|579675000|FG000|Overall Study|Lost to Follow-up|1|||
160531022|NCT04060563|579675001|FG001|Overall Study|Lost to Follow-up|1|||
160531023|NCT04060563|579675000|FG000|Overall Study|Physician Decision|0|||
160531024|NCT04060563|579675001|FG001|Overall Study|Physician Decision|1|||
160531025|NCT01379573|579675006|FG000|Overall Study|Lost to Follow-up|1|||
160531026|NCT01379573|579675006|FG000|Overall Study|Screen Failure|10|||
160531027|NCT01020448|579675020|FG000|Pre-assignment|Adverse Event|6|||
160531028|NCT01020448|579675020|FG000|Pre-assignment|Withdrawal by Subject|5|||
160531029|NCT01020448|579675020|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
160531030|NCT01020448|579675020|FG000|Treatment|Adverse Event|11|||
160531031|NCT01020448|579675020|FG000|Treatment|Consent Withdrawn|3|||
160531032|NCT01020448|579675020|FG000|Treatment|Disease Progression|2|||
160531033|NCT01020448|579675020|FG000|Treatment|Lack of Efficacy|8|||
160531034|NCT01020448|579675020|FG000|Treatment|Lost to Follow-up|2|||
160531035|NCT02871778|579675021|FG000|Part A: Treatment Period 1|Adverse Event|1|||
160531036|NCT02871778|579675022|FG001|Part A: Treatment Period 1|Adverse Event|1|||
160531037|NCT02871778|579675023|FG002|Part A: Treatment Period 1|Adverse Event|1|||
160531038|NCT02871778|579675024|FG003|Part A: Treatment Period 1|Adverse Event|0|||
160531039|NCT02871778|579675025|FG004|Part A: Treatment Period 1|Adverse Event|0|||
160531040|NCT02871778|579675026|FG005|Part A: Treatment Period 1|Adverse Event|0|||
160531041|NCT02871778|579675027|FG006|Part A: Treatment Period 1|Adverse Event|0|||
160531042|NCT02871778|579675028|FG007|Part A: Treatment Period 1|Adverse Event|0|||
160531043|NCT02871778|579675021|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
160531044|NCT02871778|579675022|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
160531045|NCT02871778|579675023|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
160531046|NCT02871778|579675024|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
160531047|NCT02871778|579675025|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
160531048|NCT02871778|579675026|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
160531049|NCT02871778|579675027|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
160531050|NCT02871778|579675028|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
160531051|NCT02871778|579675021|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
160531052|NCT02871778|579675022|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
160531053|NCT02871778|579675023|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
160531054|NCT02871778|579675024|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
160531055|NCT02871778|579675025|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
160531056|NCT02871778|579675026|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
160531057|NCT02871778|579675027|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
160870169|NCT00337675|580917350|FG000|Overall Study|Progressive Disease|0|||
160870170|NCT00337675|580917351|FG001|Overall Study|Progressive Disease|2|||
160870171|NCT00337675|580917352|FG002|Overall Study|Progressive Disease|0|||
160870172|NCT00337675|580917350|FG000|Overall Study|Trial Terminated|0|||
160870173|NCT00337675|580917351|FG001|Overall Study|Trial Terminated|0|||
160870174|NCT00337675|580917352|FG002|Overall Study|Trial Terminated|2|||
160870175|NCT02015637|580917356|FG000|Overall Study|Lost to Follow-up|3|||
160870176|NCT02015637|580917357|FG001|Overall Study|Lost to Follow-up|5|||
160870177|NCT02015637|580917356|FG000|Overall Study|Adverse Event|3|||
160870178|NCT02015637|580917357|FG001|Overall Study|Adverse Event|0|||
160870179|NCT02015637|580917356|FG000|Overall Study|Did not take study drug|2|||
160870180|NCT02015637|580917357|FG001|Overall Study|Did not take study drug|0|||
160870181|NCT03682770|580917370|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870182|NCT03682770|580917371|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
160870183|NCT03682770|580917372|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870184|NCT03682770|580917373|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870185|NCT03682770|580917374|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870186|NCT03682770|580917375|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870187|NCT03682770|580917376|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870188|NCT03682770|580917370|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
160870189|NCT03682770|580917371|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
160870190|NCT03682770|580917372|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
160870191|NCT03682770|580917373|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
160870192|NCT03682770|580917374|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
160870193|NCT03682770|580917375|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
160531058|NCT02871778|579675028|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
160531059|NCT02871778|579675021|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
160531060|NCT02871778|579675022|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
160765618|NCT00784875|580532848|FG002|Period C|Lack of Efficacy|1|||
160765619|NCT00784875|580532849|FG003|Period C|Lack of Efficacy|0|||
160765620|NCT00784875|580532846|FG000|Period C|Withdrawal by Subject|1|||
160765621|NCT00784875|580532847|FG001|Period C|Withdrawal by Subject|1|||
160765622|NCT00784875|580532848|FG002|Period C|Withdrawal by Subject|2|||
160765623|NCT00784875|580532849|FG003|Period C|Withdrawal by Subject|0|||
160765624|NCT00784875|580532846|FG000|Period C|Physician Decision|0|||
160765625|NCT00784875|580532847|FG001|Period C|Physician Decision|0|||
160765626|NCT00784875|580532848|FG002|Period C|Physician Decision|1|||
160765627|NCT00784875|580532849|FG003|Period C|Physician Decision|1|||
160765628|NCT00784875|580532846|FG000|Period C|Sponsor Decision|5|||
160765629|NCT00784875|580532847|FG001|Period C|Sponsor Decision|5|||
160765630|NCT00784875|580532848|FG002|Period C|Sponsor Decision|4|||
160765631|NCT00784875|580532849|FG003|Period C|Sponsor Decision|2|||
160765632|NCT00784875|580532846|FG000|Period D|Adverse Event|0|||
160765633|NCT00784875|580532847|FG001|Period D|Adverse Event|2|||
160765634|NCT00784875|580532848|FG002|Period D|Adverse Event|2|||
160765635|NCT00784875|580532849|FG003|Period D|Adverse Event|0|||
160765636|NCT00784875|580532846|FG000|Period D|Protocol Violation|1|||
160765637|NCT00784875|580532847|FG001|Period D|Protocol Violation|0|||
160870194|NCT03682770|580917376|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
160531061|NCT02871778|579675023|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
160765638|NCT00784875|580532848|FG002|Period D|Protocol Violation|0|||
160765639|NCT00784875|580532849|FG003|Period D|Protocol Violation|0|||
160765640|NCT00784875|580532846|FG000|Period D|Withdrawal by Subject|2|||
160765641|NCT00784875|580532847|FG001|Period D|Withdrawal by Subject|0|||
160870195|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
160765642|NCT00784875|580532848|FG002|Period D|Withdrawal by Subject|2|||
160765643|NCT00784875|580532849|FG003|Period D|Withdrawal by Subject|0|||
160765644|NCT00784875|580532846|FG000|Period D|Physician Decision|0|||
160765645|NCT00784875|580532847|FG001|Period D|Physician Decision|1|||
160765646|NCT00784875|580532848|FG002|Period D|Physician Decision|0|||
160765647|NCT00784875|580532849|FG003|Period D|Physician Decision|0|||
160765648|NCT00784875|580532846|FG000|Period D|Sponsor Decision|1|||
160765649|NCT00784875|580532847|FG001|Period D|Sponsor Decision|1|||
160765650|NCT00784875|580532848|FG002|Period D|Sponsor Decision|1|||
160765651|NCT00784875|580532849|FG003|Period D|Sponsor Decision|0|||
160765652|NCT00784875|580532846|FG000|Period D|Lost to Follow-up|1|||
160765653|NCT00784875|580532847|FG001|Period D|Lost to Follow-up|0|||
160765654|NCT00784875|580532848|FG002|Period D|Lost to Follow-up|1|||
160765655|NCT00784875|580532849|FG003|Period D|Lost to Follow-up|1|||
160765656|NCT00853385|580532850|FG000|Overall Study|Death|0|||
160765657|NCT00853385|580532851|FG001|Overall Study|Death|0|||
160765658|NCT00853385|580532852|FG002|Overall Study|Death|0|||
160765659|NCT00853385|580532853|FG003|Overall Study|Death|0|||
160765660|NCT00853385|580532854|FG004|Overall Study|Death|1|||
160765661|NCT00853385|580532850|FG000|Overall Study|Adverse Event|24|||
160765662|NCT00853385|580532851|FG001|Overall Study|Adverse Event|24|||
160765663|NCT00853385|580532852|FG002|Overall Study|Adverse Event|2|||
160765664|NCT00853385|580532853|FG003|Overall Study|Adverse Event|5|||
160765665|NCT00853385|580532854|FG004|Overall Study|Adverse Event|22|||
160765666|NCT00853385|580532850|FG000|Overall Study|Lack of Efficacy|6|||
160765667|NCT00853385|580532851|FG001|Overall Study|Lack of Efficacy|7|||
160765668|NCT00853385|580532852|FG002|Overall Study|Lack of Efficacy|3|||
160870196|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
160765669|NCT00853385|580532853|FG003|Overall Study|Lack of Efficacy|3|||
160765670|NCT00853385|580532854|FG004|Overall Study|Lack of Efficacy|6|||
160765671|NCT00853385|580532850|FG000|Overall Study|Lost to Follow-up|2|||
160765672|NCT00853385|580532851|FG001|Overall Study|Lost to Follow-up|1|||
160765673|NCT00853385|580532852|FG002|Overall Study|Lost to Follow-up|0|||
160765674|NCT00853385|580532853|FG003|Overall Study|Lost to Follow-up|0|||
160765675|NCT00853385|580532854|FG004|Overall Study|Lost to Follow-up|0|||
160765676|NCT00853385|580532850|FG000|Overall Study|Withdrawal by Subject|4|||
160765677|NCT00853385|580532851|FG001|Overall Study|Withdrawal by Subject|2|||
160765678|NCT00853385|580532852|FG002|Overall Study|Withdrawal by Subject|0|||
160765679|NCT00853385|580532853|FG003|Overall Study|Withdrawal by Subject|1|||
160765680|NCT00853385|580532854|FG004|Overall Study|Withdrawal by Subject|1|||
160870197|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
160870198|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
160870199|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
160870200|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
160870201|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
160870202|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
160870203|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
160870204|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
160870205|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
160870206|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
160870207|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
160765681|NCT00853385|580532850|FG000|Overall Study|Other|18|||
160531062|NCT02871778|579675024|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
160765682|NCT00853385|580532851|FG001|Overall Study|Other|9|||
160765683|NCT00853385|580532852|FG002|Overall Study|Other|4|||
160765684|NCT00853385|580532853|FG003|Overall Study|Other|4|||
160765685|NCT00853385|580532854|FG004|Overall Study|Other|12|||
160765686|NCT00941928|580532859|FG000|Overall Study|Withdrawal by Subject|1|||
160765687|NCT00941928|580532859|FG000|Overall Study|Disease Progression|1|||
160765688|NCT02300610|580532860|FG000|Overall Study|Withdrawal by Subject|1|||
160765689|NCT02300610|580532861|FG001|Overall Study|Withdrawal by Subject|0|||
160765690|NCT02300610|580532862|FG002|Overall Study|Withdrawal by Subject|1|||
160765691|NCT00095979|580532863|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
160765692|NCT01829347|580532864|FG000|VTI-210|Death|5|||
160765693|NCT01829347|580532865|FG001|VTI-210|Death|3|||
160765694|NCT01829347|580532864|FG000|VTI-210|Withdrawal by Subject|1|||
160765695|NCT01829347|580532865|FG001|VTI-210|Withdrawal by Subject|0|||
160765696|NCT01829347|580532864|FG000|VTI-210E|Death|2|||
160765697|NCT01829347|580532865|FG001|VTI-210E|Death|1|||
160765698|NCT01829347|580532864|FG000|VTI-210E|Study terminated prematurely|1|||
160765699|NCT01829347|580532865|FG001|VTI-210E|Study terminated prematurely|5|||
160765700|NCT02051296|580532869|FG000|Overall Study|Lost to Follow-up|1|||
160765701|NCT02051296|580532870|FG001|Overall Study|Lost to Follow-up|2|||
160765702|NCT02051296|580532869|FG000|Overall Study|withdraw prior to treatment|7|||
160765703|NCT02051296|580532870|FG001|Overall Study|withdraw prior to treatment|7|||
160765704|NCT02515227|580532871|FG000|Overall Study|Adverse Event|0|||
160765705|NCT02515227|580532872|FG001|Overall Study|Adverse Event|2|||
160765706|NCT02515227|580532871|FG000|Overall Study|Progressive disease|2|||
160765707|NCT02515227|580532872|FG001|Overall Study|Progressive disease|9|||
160765708|NCT00250588|580532879|FG000|Overall Study|Withdrawal by Subject|3|||
160765709|NCT00250588|580532880|FG001|Overall Study|Withdrawal by Subject|6|||
160765710|NCT00250588|580532881|FG002|Overall Study|Withdrawal by Subject|0|||
160765711|NCT00250588|580532879|FG000|Overall Study|Lost to Follow-up|6|||
160765712|NCT00250588|580532880|FG001|Overall Study|Lost to Follow-up|13|||
160765713|NCT00250588|580532881|FG002|Overall Study|Lost to Follow-up|13|||
160765714|NCT00706797|580532884|FG000|Overall Study|Lack of Efficacy|3|||
160765715|NCT00706797|580532885|FG001|Overall Study|Lack of Efficacy|0|||
160765716|NCT00706797|580532884|FG000|Overall Study|Adverse Event|0|||
160765717|NCT00706797|580532885|FG001|Overall Study|Adverse Event|3|||
160765718|NCT00706797|580532884|FG000|Overall Study|Withdrawal by Subject|8|||
160765719|NCT00706797|580532885|FG001|Overall Study|Withdrawal by Subject|1|||
160765720|NCT00706797|580532884|FG000|Overall Study|Death|1|||
160765721|NCT00706797|580532885|FG001|Overall Study|Death|0|||
160765722|NCT00706797|580532884|FG000|Overall Study|Discontinuation of study by sponsor|52|||
160765723|NCT00706797|580532885|FG001|Overall Study|Discontinuation of study by sponsor|63|||
160765724|NCT00706797|580532884|FG000|Overall Study|Protocol Violation|3|||
160765725|NCT00706797|580532885|FG001|Overall Study|Protocol Violation|2|||
160765726|NCT00706797|580532884|FG000|Overall Study|Lost to Follow-up|1|||
160765727|NCT00706797|580532885|FG001|Overall Study|Lost to Follow-up|2|||
160765728|NCT00706797|580532884|FG000|Overall Study|Other|1|||
160765729|NCT00706797|580532885|FG001|Overall Study|Other|0|||
160531063|NCT02871778|579675025|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
160531064|NCT02871778|579675026|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
160531065|NCT02871778|579675027|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
160531066|NCT02871778|579675028|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
160531067|NCT02871778|579675021|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
160531068|NCT02871778|579675022|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
160531069|NCT02871778|579675023|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
160531070|NCT02871778|579675024|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
160531071|NCT02871778|579675025|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
160531072|NCT02871778|579675026|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
160531073|NCT02871778|579675027|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
160531074|NCT02871778|579675028|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
160531075|NCT02871778|579675021|FG000|Part A: Treatment Period 2|Adverse Event|2|||
160531076|NCT02871778|579675022|FG001|Part A: Treatment Period 2|Adverse Event|2|||
160531077|NCT02871778|579675023|FG002|Part A: Treatment Period 2|Adverse Event|0|||
160531078|NCT02871778|579675024|FG003|Part A: Treatment Period 2|Adverse Event|0|||
160531079|NCT02871778|579675025|FG004|Part A: Treatment Period 2|Adverse Event|0|||
160531080|NCT02871778|579675026|FG005|Part A: Treatment Period 2|Adverse Event|0|||
160531081|NCT02871778|579675027|FG006|Part A: Treatment Period 2|Adverse Event|0|||
160531082|NCT02871778|579675028|FG007|Part A: Treatment Period 2|Adverse Event|0|||
160531083|NCT02871778|579675021|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
160531084|NCT02871778|579675022|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
160531085|NCT02871778|579675023|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
160531086|NCT02871778|579675024|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
160531087|NCT02871778|579675025|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
160531088|NCT02871778|579675026|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
160531089|NCT02871778|579675027|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
160531090|NCT02871778|579675028|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
160531091|NCT02871778|579675021|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
160531092|NCT02871778|579675022|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
160531093|NCT02871778|579675023|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
160531094|NCT02871778|579675024|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
160531095|NCT02871778|579675025|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
160531096|NCT02871778|579675026|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
160531097|NCT02871778|579675027|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
160531098|NCT02871778|579675028|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
160531099|NCT02871778|579675021|FG000|Part B: Treatment Period 3|Adverse Event|0|||
160531100|NCT02871778|579675022|FG001|Part B: Treatment Period 3|Adverse Event|0|||
160531101|NCT02871778|579675023|FG002|Part B: Treatment Period 3|Adverse Event|0|||
160531102|NCT02871778|579675024|FG003|Part B: Treatment Period 3|Adverse Event|0|||
160531103|NCT02871778|579675025|FG004|Part B: Treatment Period 3|Adverse Event|1|||
160531104|NCT02871778|579675026|FG005|Part B: Treatment Period 3|Adverse Event|1|||
160531105|NCT02871778|579675027|FG006|Part B: Treatment Period 3|Adverse Event|1|||
160531106|NCT02871778|579675028|FG007|Part B: Treatment Period 3|Adverse Event|0|||
160531107|NCT02653300|579675029|FG000|Overall Study|Withdrawal by Subject|2|||
160531108|NCT01390272|579675040|FG000|Overall Study|Death|3|||
160531109|NCT01390272|579675041|FG001|Overall Study|Death|2|||
160531110|NCT01390272|579675040|FG000|Overall Study|Withdrawal by Subject|9|||
160531111|NCT01390272|579675041|FG001|Overall Study|Withdrawal by Subject|5|||
160531112|NCT01390272|579675040|FG000|Overall Study|Patient moved, no longer eligible|5|||
160531113|NCT01390272|579675041|FG001|Overall Study|Patient moved, no longer eligible|8|||
160531114|NCT00590044|579675042|FG000|Overall Study|Withdrawal by Subject|2|||
160531115|NCT00590044|579675043|FG001|Overall Study|Withdrawal by Subject|2|||
160531116|NCT00590044|579675042|FG000|Overall Study|wrong insulin arm assigned|1|||
160531117|NCT00590044|579675043|FG001|Overall Study|wrong insulin arm assigned|0|||
160531118|NCT00590044|579675042|FG000|Overall Study|Protocol Violation|1|||
160531119|NCT00590044|579675043|FG001|Overall Study|Protocol Violation|0|||
160531120|NCT01514136|579675044|FG000|Test Period 1; Test A|Protocol Violation|1|||
160531121|NCT01514136|579675045|FG001|Test Period 1; Test A|Protocol Violation|0|||
160531122|NCT01514136|579675046|FG002|Test Period 1; Test A|Protocol Violation|0|||
160531123|NCT01514136|579675047|FG003|Test Period 1; Test A|Protocol Violation|0|||
160531124|NCT01514136|579675048|FG004|Test Period 1; Test A|Protocol Violation|0|||
160531125|NCT01514136|579675049|FG005|Test Period 1; Test A|Protocol Violation|0|||
160531126|NCT01514136|579675050|FG006|Test Period 1; Test A|Protocol Violation|0|||
160765730|NCT03502798|580532886|FG000|Overall Study|equipment failure|0|||
160765731|NCT03502798|580532887|FG001|Overall Study|equipment failure|7|||
160765732|NCT01027845|580532889|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
160765733|NCT01027845|580532890|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
160765734|NCT01027845|580532891|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
160765735|NCT01027845|580532892|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
160531127|NCT01514136|579675051|FG007|Test Period 1; Test A|Protocol Violation|0|||
160531128|NCT01514136|579675044|FG000|Test Period 1; Test A|Break from study holiday|2|||
160870208|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
160870209|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
160870210|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
160870211|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
160870212|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
160870213|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
160870214|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
160870215|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
160870216|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870217|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870218|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
160870219|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870220|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870221|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870222|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870223|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870224|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870225|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
160870226|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870227|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870228|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870229|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870230|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870231|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870232|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870233|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
160870234|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870235|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870236|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870237|NCT03682770|580917370|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
160870238|NCT03682770|580917371|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
160870239|NCT03682770|580917372|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
160870240|NCT03682770|580917373|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
160870241|NCT03682770|580917374|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
160870242|NCT03682770|580917375|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
160870243|NCT03682770|580917376|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
160870244|NCT03682770|580917370|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870245|NCT03682770|580917371|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870246|NCT03682770|580917372|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870247|NCT03682770|580917373|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870248|NCT03682770|580917374|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
160870249|NCT03682770|580917375|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870250|NCT03682770|580917376|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870251|NCT03682770|580917370|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870252|NCT03682770|580917371|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870253|NCT03682770|580917372|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870254|NCT03682770|580917373|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870255|NCT03682770|580917374|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870256|NCT03682770|580917375|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
160870257|NCT03682770|580917376|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870258|NCT03682770|580917370|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
160870259|NCT03682770|580917371|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
160870260|NCT03682770|580917372|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
160531129|NCT01514136|579675045|FG001|Test Period 1; Test A|Break from study holiday|0|||
160531130|NCT01514136|579675046|FG002|Test Period 1; Test A|Break from study holiday|0|||
160531131|NCT01514136|579675047|FG003|Test Period 1; Test A|Break from study holiday|0|||
160531132|NCT01514136|579675048|FG004|Test Period 1; Test A|Break from study holiday|0|||
160531133|NCT01514136|579675049|FG005|Test Period 1; Test A|Break from study holiday|0|||
160531134|NCT01514136|579675050|FG006|Test Period 1; Test A|Break from study holiday|0|||
160531135|NCT01514136|579675051|FG007|Test Period 1; Test A|Break from study holiday|0|||
160531136|NCT01514136|579675044|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
160531137|NCT01514136|579675045|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
160531138|NCT01514136|579675046|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
160531139|NCT01514136|579675047|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
160870261|NCT03682770|580917373|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
160870262|NCT03682770|580917374|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
160870263|NCT03682770|580917375|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
160531140|NCT01514136|579675048|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
160531141|NCT01514136|579675049|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
160531142|NCT01514136|579675050|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
160531143|NCT01514136|579675051|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
160531144|NCT01514136|579675044|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
160531145|NCT01514136|579675045|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
160531146|NCT01514136|579675046|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
160531147|NCT01514136|579675047|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
160531148|NCT01514136|579675048|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
160531149|NCT01514136|579675049|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
160531150|NCT01514136|579675050|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
160531151|NCT01514136|579675051|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
160531152|NCT01514136|579675044|FG000|Test Period 2; Test A*|Adverse Event|0|||
160531153|NCT01514136|579675045|FG001|Test Period 2; Test A*|Adverse Event|0|||
160870264|NCT03682770|580917376|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
160870265|NCT02362282|580917377|FG000|Overall Study|Withdrawal by Subject|1|||
160870266|NCT02362282|580917378|FG001|Overall Study|Withdrawal by Subject|0|||
160870267|NCT02004093|580917379|FG000|Overall Study|Death|2|||
160870268|NCT02004093|580917380|FG001|Overall Study|Death|1|||
160870269|NCT02004093|580917379|FG000|Overall Study|Lack of Efficacy|66|||
160870270|NCT02004093|580917380|FG001|Overall Study|Lack of Efficacy|62|||
160870271|NCT02004093|580917379|FG000|Overall Study|Protocol Violation|0|||
160870272|NCT02004093|580917380|FG001|Overall Study|Protocol Violation|1|||
160870273|NCT02004093|580917379|FG000|Overall Study|Lost to Follow-up|0|||
160870274|NCT02004093|580917380|FG001|Overall Study|Lost to Follow-up|1|||
160870275|NCT02004093|580917379|FG000|Overall Study|Withdrawal by Subject|3|||
160870276|NCT02004093|580917380|FG001|Overall Study|Withdrawal by Subject|7|||
160870277|NCT02004093|580917379|FG000|Overall Study|Other|3|||
160870278|NCT02004093|580917380|FG001|Overall Study|Other|1|||
160870279|NCT04085289|580917381|FG000|Overall Study|Withdrawal by Subject|0|||
160870280|NCT04085289|580917382|FG001|Overall Study|Withdrawal by Subject|0|||
160870281|NCT04085289|580917383|FG002|Overall Study|Withdrawal by Subject|1|||
160870282|NCT01317277|580917386|FG000|Overall Study|Lost to Follow-up|3|||
160870283|NCT01317277|580917387|FG001|Overall Study|Lost to Follow-up|1|||
160870284|NCT01317277|580917386|FG000|Overall Study|Lost MEMS|1|||
160870285|NCT01317277|580917387|FG001|Overall Study|Lost MEMS|1|||
160870286|NCT01317277|580917386|FG000|Overall Study|Unable to comply with intervention|1|||
160870287|NCT01317277|580917387|FG001|Overall Study|Unable to comply with intervention|0|||
160870288|NCT01317277|580917386|FG000|Overall Study|Withdrawal by Subject|1|||
160870289|NCT01317277|580917387|FG001|Overall Study|Withdrawal by Subject|0|||
160870290|NCT01317277|580917386|FG000|Overall Study|Adverse Event|1|||
160870291|NCT01317277|580917387|FG001|Overall Study|Adverse Event|0|||
160870292|NCT00774566|580917388|FG000|Overall Study|Protocol Violation|18|||
160870293|NCT00774566|580917389|FG001|Overall Study|Protocol Violation|15|||
160870294|NCT04896073|580917394|FG000|Overall Study|Screen failure|0|||
160870295|NCT04896073|580917395|FG001|Overall Study|Screen failure|2|||
160870296|NCT04896073|580917394|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
160870297|NCT04896073|580917395|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
160870298|NCT01262989|580917396|FG000|Period 1|Lost to Follow-up|1|||
160870299|NCT01262989|580917397|FG001|Period 1|Lost to Follow-up|1|||
160870300|NCT01262989|580917396|FG000|Period 1|Intercurrent disease|0|||
160870301|NCT01262989|580917397|FG001|Period 1|Intercurrent disease|1|||
160870302|NCT01262989|580917396|FG000|Period 1|Positive answer for exclusion criteria|0|||
160870303|NCT01262989|580917397|FG001|Period 1|Positive answer for exclusion criteria|1|||
160870304|NCT01262989|580917396|FG000|Period 2|Intercurrent disease|0|||
160531154|NCT01514136|579675046|FG002|Test Period 2; Test A*|Adverse Event|0|||
160531155|NCT01514136|579675047|FG003|Test Period 2; Test A*|Adverse Event|0|||
160531156|NCT01514136|579675048|FG004|Test Period 2; Test A*|Adverse Event|1|||
160531157|NCT01514136|579675049|FG005|Test Period 2; Test A*|Adverse Event|0|||
160870305|NCT01262989|580917397|FG001|Period 2|Intercurrent disease|1|||
160870306|NCT03599089|580917398|FG000|Overall Study|Lost to Follow-up|1|||
160870307|NCT03599089|580917399|FG001|Overall Study|Lost to Follow-up|0|||
160870308|NCT03599089|580917400|FG002|Overall Study|Lost to Follow-up|0|||
160870309|NCT03599089|580917401|FG003|Overall Study|Lost to Follow-up|0|||
160870310|NCT03599089|580917398|FG000|Overall Study|Withdrawal by Subject|2|||
160870311|NCT03599089|580917399|FG001|Overall Study|Withdrawal by Subject|1|||
160870312|NCT03599089|580917400|FG002|Overall Study|Withdrawal by Subject|0|||
160870313|NCT03599089|580917401|FG003|Overall Study|Withdrawal by Subject|0|||
160870314|NCT03599089|580917398|FG000|Overall Study|Lack of Efficacy|0|||
160870315|NCT03599089|580917399|FG001|Overall Study|Lack of Efficacy|0|||
160870316|NCT03599089|580917400|FG002|Overall Study|Lack of Efficacy|1|||
160870317|NCT03599089|580917401|FG003|Overall Study|Lack of Efficacy|2|||
160870318|NCT03214666|580917402|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
160870319|NCT03214666|580917403|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
160870320|NCT03214666|580917404|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
160870321|NCT03214666|580917405|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
160870322|NCT03214666|580917406|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
160870323|NCT03214666|580917407|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
160870324|NCT03048578|580917408|FG000|Overall Study|Withdrawal by Subject|5|||
160870325|NCT03048578|580917409|FG001|Overall Study|Withdrawal by Subject|6|||
160870326|NCT03048578|580917408|FG000|Overall Study|Lost to Follow-up|22|||
160870327|NCT03048578|580917409|FG001|Overall Study|Lost to Follow-up|10|||
160870328|NCT03048578|580917408|FG000|Overall Study|Adverse Event|1|||
160870329|NCT03048578|580917409|FG001|Overall Study|Adverse Event|2|||
160870330|NCT03048578|580917408|FG000|Overall Study|Terminated|3|||
160870331|NCT03048578|580917409|FG001|Overall Study|Terminated|2|||
160870332|NCT00459186|580917415|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
160870333|NCT00459186|580917415|FG000|PET Imaging and Assessment|Adverse Event|3|||
160870334|NCT02500797|580917416|FG000|Overall Study|Cancel (rapid disease progression)|0|||
160870335|NCT02500797|580917417|FG001|Overall Study|Cancel (rapid disease progression)|0|||
160870336|NCT02500797|580917418|FG002|Overall Study|Cancel (rapid disease progression)|0|||
160870337|NCT02500797|580917419|FG003|Overall Study|Cancel (rapid disease progression)|0|||
160870338|NCT02500797|580917420|FG004|Overall Study|Cancel (rapid disease progression)|1|||
160870339|NCT02500797|580917421|FG005|Overall Study|Cancel (rapid disease progression)|1|||
160870340|NCT02500797|580917422|FG006|Overall Study|Cancel (rapid disease progression)|0|||
160870341|NCT02500797|580917423|FG007|Overall Study|Cancel (rapid disease progression)|0|||
160870342|NCT02500797|580917416|FG000|Overall Study|Withdrawal by Subject|1|||
160870343|NCT02500797|580917417|FG001|Overall Study|Withdrawal by Subject|0|||
160870344|NCT02500797|580917418|FG002|Overall Study|Withdrawal by Subject|0|||
160870345|NCT02500797|580917419|FG003|Overall Study|Withdrawal by Subject|0|||
160870346|NCT02500797|580917420|FG004|Overall Study|Withdrawal by Subject|0|||
160870347|NCT02500797|580917421|FG005|Overall Study|Withdrawal by Subject|0|||
160870348|NCT02500797|580917422|FG006|Overall Study|Withdrawal by Subject|0|||
160870349|NCT02500797|580917423|FG007|Overall Study|Withdrawal by Subject|0|||
160870350|NCT00357006|580917430|FG000|Overall Study|Lost to Follow-up|1|||
160870351|NCT00357006|580917431|FG001|Overall Study|Lost to Follow-up|2|||
160870352|NCT00357006|580917432|FG002|Overall Study|Lost to Follow-up|1|||
160870353|NCT00357006|580917430|FG000|Overall Study|Withdrawal by Subject|1|||
160870354|NCT00357006|580917431|FG001|Overall Study|Withdrawal by Subject|3|||
160870355|NCT00357006|580917432|FG002|Overall Study|Withdrawal by Subject|2|||
160870356|NCT03710161|580917433|FG000|Overall Study|Study halted due to COVID pandemic|3|||
160870357|NCT03710161|580917434|FG001|Overall Study|Study halted due to COVID pandemic|2|||
160870358|NCT02637037|580917437|FG000|Overall Study|Positive drug screen at admission|1|||
160870359|NCT02637037|580917438|FG001|Overall Study|Positive drug screen at admission|0|||
160870360|NCT02637037|580917437|FG000|Overall Study|Withdrawal by Subject|2|||
160870361|NCT02637037|580917438|FG001|Overall Study|Withdrawal by Subject|1|||
160870362|NCT02637037|580917437|FG000|Overall Study|Adverse Event|1|||
160870363|NCT02637037|580917438|FG001|Overall Study|Adverse Event|0|||
160531158|NCT01514136|579675050|FG006|Test Period 2; Test A*|Adverse Event|0|||
160531159|NCT01514136|579675051|FG007|Test Period 2; Test A*|Adverse Event|0|||
160531160|NCT01514136|579675044|FG000|Test Period 2; Test A*|Holiday|0|||
160531161|NCT01514136|579675045|FG001|Test Period 2; Test A*|Holiday|0|||
160531162|NCT01514136|579675046|FG002|Test Period 2; Test A*|Holiday|0|||
160531163|NCT01514136|579675047|FG003|Test Period 2; Test A*|Holiday|0|||
160531164|NCT01514136|579675048|FG004|Test Period 2; Test A*|Holiday|1|||
160531165|NCT01514136|579675049|FG005|Test Period 2; Test A*|Holiday|0|||
160531166|NCT01514136|579675050|FG006|Test Period 2; Test A*|Holiday|0|||
160870364|NCT00074490|580917446|FG000|Overall Study|Progressive malignancy|0|||
160870365|NCT00074490|580917447|FG001|Overall Study|Progressive malignancy|7|||
160870366|NCT00074490|580917448|FG002|Overall Study|Progressive malignancy|0|||
160870367|NCT00074490|580917449|FG003|Overall Study|Progressive malignancy|0|||
160870368|NCT00074490|580917450|FG004|Overall Study|Progressive malignancy|3|||
160870369|NCT00074490|580917451|FG005|Overall Study|Progressive malignancy|0|||
160870370|NCT04139798|580917454|FG000|Overall Study|Withdrawal by Subject|6|||
160870371|NCT04139798|580917455|FG001|Overall Study|Withdrawal by Subject|5|||
160531167|NCT01514136|579675051|FG007|Test Period 2; Test A*|Holiday|0|||
160531168|NCT01514136|579675044|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
160531169|NCT01514136|579675045|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
160531170|NCT01514136|579675046|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
160531171|NCT01514136|579675047|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
160531172|NCT01514136|579675048|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
160531173|NCT01514136|579675049|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
160531174|NCT01514136|579675050|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
160531175|NCT01514136|579675051|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
160531176|NCT01514136|579675044|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
160531177|NCT01514136|579675045|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
160531178|NCT01514136|579675046|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
160531179|NCT01514136|579675047|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
160531180|NCT01514136|579675048|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
160531181|NCT01514136|579675049|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
160531182|NCT01514136|579675050|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
160531183|NCT01514136|579675051|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
160531184|NCT01514136|579675044|FG000|Test Period 2; Test C*|holiday|0|||
160531185|NCT01514136|579675045|FG001|Test Period 2; Test C*|holiday|0|||
160531186|NCT01514136|579675046|FG002|Test Period 2; Test C*|holiday|0|||
160531187|NCT01514136|579675047|FG003|Test Period 2; Test C*|holiday|0|||
160531188|NCT01514136|579675048|FG004|Test Period 2; Test C*|holiday|0|||
160531189|NCT01514136|579675049|FG005|Test Period 2; Test C*|holiday|0|||
160531190|NCT01514136|579675050|FG006|Test Period 2; Test C*|holiday|1|||
160531191|NCT01514136|579675051|FG007|Test Period 2; Test C*|holiday|0|||
160531192|NCT01514136|579675044|FG000|Test Period 2; Test C*|Protocol Violation|0|||
160531193|NCT01514136|579675045|FG001|Test Period 2; Test C*|Protocol Violation|0|||
160531194|NCT01514136|579675046|FG002|Test Period 2; Test C*|Protocol Violation|0|||
160531195|NCT01514136|579675047|FG003|Test Period 2; Test C*|Protocol Violation|0|||
160531196|NCT01514136|579675048|FG004|Test Period 2; Test C*|Protocol Violation|0|||
160531197|NCT01514136|579675049|FG005|Test Period 2; Test C*|Protocol Violation|0|||
160531198|NCT01514136|579675050|FG006|Test Period 2; Test C*|Protocol Violation|1|||
160531199|NCT01514136|579675051|FG007|Test Period 2; Test C*|Protocol Violation|0|||
160531200|NCT02729740|579675056|FG000|Overall Study|Early Termination|130|||
160531201|NCT02729740|579675056|FG000|Overall Study|Other|1|||
160531202|NCT00888381|579675057|FG000|Overall Study|Lost to Follow-up|0|||
160531203|NCT00888381|579675058|FG001|Overall Study|Lost to Follow-up|1|||
160531204|NCT00307333|579675059|FG000|Overall Study|Lost to Follow-up|11|||
160531205|NCT00307333|579675060|FG001|Overall Study|Lost to Follow-up|3|||
160531206|NCT00757003|579675064|FG000|Overall Study|Death|33|||
160531207|NCT00757003|579675064|FG000|Overall Study|Lost to Follow-up|9|||
160531208|NCT00757003|579675064|FG000|Overall Study|Withdrawal by Subject|4|||
160531209|NCT00757003|579675064|FG000|Overall Study|Surgically explanted|2|||
160531210|NCT00757003|579675064|FG000|Overall Study|Not implanted|1|||
160531211|NCT03044249|579675067|FG000|Overall Study|Adverse Event|4|||
160531212|NCT03044249|579675068|FG001|Overall Study|Adverse Event|9|||
160531213|NCT03044249|579675067|FG000|Overall Study|Lost to Follow-up|1|||
160531214|NCT03044249|579675068|FG001|Overall Study|Lost to Follow-up|0|||
160531215|NCT03044249|579675067|FG000|Overall Study|Non-compliance with Study Drug|1|||
160531216|NCT03044249|579675068|FG001|Overall Study|Non-compliance with Study Drug|0|||
160531217|NCT03044249|579675067|FG000|Overall Study|Study Terminated by Sponsor|2|||
160531218|NCT03044249|579675068|FG001|Overall Study|Study Terminated by Sponsor|0|||
160531219|NCT03044249|579675067|FG000|Overall Study|Withdrawal by Subject|2|||
160531220|NCT03044249|579675068|FG001|Overall Study|Withdrawal by Subject|5|||
160531221|NCT00955279|579675069|FG000|Overall Study|Other|0|||
160531222|NCT00955279|579675070|FG001|Overall Study|Other|0|||
160531223|NCT00955279|579675071|FG002|Overall Study|Other|3|||
160531224|NCT00955279|579675069|FG000|Overall Study|Death|1|||
160531225|NCT00955279|579675070|FG001|Overall Study|Death|1|||
160531226|NCT00955279|579675071|FG002|Overall Study|Death|1|||
160531227|NCT00955279|579675069|FG000|Overall Study|Lost to Follow-up|0|||
160531228|NCT00955279|579675070|FG001|Overall Study|Lost to Follow-up|3|||
160531229|NCT00955279|579675071|FG002|Overall Study|Lost to Follow-up|1|||
160531230|NCT00955279|579675069|FG000|Overall Study|Withdrawal by Subject|2|||
160531231|NCT00955279|579675070|FG001|Overall Study|Withdrawal by Subject|0|||
160531232|NCT00955279|579675071|FG002|Overall Study|Withdrawal by Subject|3|||
160531233|NCT00387764|579675082|FG000|Overall Study|Adverse Event|12|||
160531234|NCT00387764|579675082|FG000|Overall Study|Withdrawal by Subject|8|||
160531235|NCT00387764|579675082|FG000|Overall Study|Sponsor Terminated Study|1|||
160531236|NCT00387764|579675082|FG000|Overall Study|Physician Decision|1|||
160531237|NCT00387764|579675082|FG000|Overall Study|Other|2|||
160765736|NCT01027845|580532889|FG000|Primary Vaccination Phase|Adverse Event|1|||
160531238|NCT00387764|579675082|FG000|Overall Study|Death|7|||
160531239|NCT03785678|579675083|FG000|Overall Study|Death|44|||
160765737|NCT01027845|580532890|FG001|Primary Vaccination Phase|Adverse Event|0|||
160531240|NCT03785678|579675084|FG001|Overall Study|Death|42|||
160531241|NCT03785678|579675083|FG000|Overall Study|Lost to Follow-up|4|||
160531242|NCT03785678|579675084|FG001|Overall Study|Lost to Follow-up|2|||
160531243|NCT03785678|579675083|FG000|Overall Study|Physician Decision|0|||
160765738|NCT01027845|580532891|FG002|Primary Vaccination Phase|Adverse Event|0|||
160870372|NCT04139798|580917454|FG000|Overall Study|Lost to Follow-up|2|||
160870373|NCT04139798|580917455|FG001|Overall Study|Lost to Follow-up|5|||
160870374|NCT04139798|580917454|FG000|Overall Study|Discontinued|4|||
160870375|NCT04139798|580917455|FG001|Overall Study|Discontinued|2|||
160531244|NCT03785678|579675084|FG001|Overall Study|Physician Decision|2|||
160531245|NCT03785678|579675083|FG000|Overall Study|Withdrawal by Subject|5|||
160531246|NCT03785678|579675084|FG001|Overall Study|Withdrawal by Subject|3|||
160531247|NCT01159912|579675085|FG000|Overall Study|Adverse Event|2|||
160531248|NCT01159912|579675086|FG001|Overall Study|Adverse Event|2|||
160531249|NCT01159912|579675087|FG002|Overall Study|Adverse Event|3|||
160531250|NCT01159912|579675085|FG000|Overall Study|Lack of Efficacy|23|||
160531251|NCT01159912|579675086|FG001|Overall Study|Lack of Efficacy|15|||
160531252|NCT01159912|579675087|FG002|Overall Study|Lack of Efficacy|14|||
160531253|NCT01159912|579675085|FG000|Overall Study|Protocol Violation|1|||
160531254|NCT01159912|579675086|FG001|Overall Study|Protocol Violation|2|||
160531255|NCT01159912|579675087|FG002|Overall Study|Protocol Violation|3|||
160531256|NCT01159912|579675085|FG000|Overall Study|Lost to Follow-up|4|||
160531257|NCT01159912|579675086|FG001|Overall Study|Lost to Follow-up|0|||
160531258|NCT01159912|579675087|FG002|Overall Study|Lost to Follow-up|0|||
160531259|NCT01159912|579675085|FG000|Overall Study|Physician Decision|0|||
160531260|NCT01159912|579675086|FG001|Overall Study|Physician Decision|0|||
160531261|NCT01159912|579675087|FG002|Overall Study|Physician Decision|3|||
160531262|NCT01159912|579675085|FG000|Overall Study|Withdrawal by Subject|10|||
160531263|NCT01159912|579675086|FG001|Overall Study|Withdrawal by Subject|3|||
160531264|NCT01159912|579675087|FG002|Overall Study|Withdrawal by Subject|3|||
160531265|NCT01174238|579675091|FG000|Overall Study|Lost to Follow-up|2|||
160531266|NCT00375219|579675095|FG000|Overall Study|Failure to achieve a response|16|||
160531267|NCT00375219|579675096|FG001|Overall Study|Failure to achieve a response|2|||
160531268|NCT00375219|579675097|FG002|Overall Study|Failure to achieve a response|0|||
160531269|NCT00375219|579675095|FG000|Overall Study|Adverse Event|8|||
160531270|NCT00375219|579675096|FG001|Overall Study|Adverse Event|2|||
160531271|NCT00375219|579675097|FG002|Overall Study|Adverse Event|1|||
160531272|NCT00375219|579675095|FG000|Overall Study|Protocol Violation|1|||
160531273|NCT00375219|579675096|FG001|Overall Study|Protocol Violation|0|||
160531274|NCT00375219|579675097|FG002|Overall Study|Protocol Violation|1|||
160531275|NCT00375219|579675095|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
160531276|NCT00375219|579675096|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
160531277|NCT00375219|579675097|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
160531278|NCT00375219|579675095|FG000|Overall Study|Lost to Follow-up|1|||
160531279|NCT00375219|579675096|FG001|Overall Study|Lost to Follow-up|1|||
160531280|NCT00375219|579675097|FG002|Overall Study|Lost to Follow-up|0|||
160531281|NCT00375219|579675095|FG000|Overall Study|Disease progression|18|||
160531282|NCT00375219|579675096|FG001|Overall Study|Disease progression|9|||
160531283|NCT00375219|579675097|FG002|Overall Study|Disease progression|12|||
160531284|NCT00375219|579675095|FG000|Overall Study|Death|4|||
160531285|NCT00375219|579675096|FG001|Overall Study|Death|3|||
160531286|NCT00375219|579675097|FG002|Overall Study|Death|7|||
160531287|NCT00375219|579675095|FG000|Overall Study|Hematologic resistance|1|||
160531288|NCT00375219|579675096|FG001|Overall Study|Hematologic resistance|0|||
160531289|NCT00375219|579675097|FG002|Overall Study|Hematologic resistance|0|||
160531290|NCT00375219|579675095|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
160531291|NCT00375219|579675096|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
160531292|NCT00375219|579675097|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
160531293|NCT00375219|579675095|FG000|Overall Study|Allograft|2|||
160531294|NCT00375219|579675096|FG001|Overall Study|Allograft|0|||
160531295|NCT00375219|579675097|FG002|Overall Study|Allograft|0|||
160531296|NCT00375219|579675095|FG000|Overall Study|Cord blood transplantation|1|||
160531297|NCT00375219|579675096|FG001|Overall Study|Cord blood transplantation|0|||
160531298|NCT00375219|579675097|FG002|Overall Study|Cord blood transplantation|0|||
160870376|NCT04139798|580917454|FG000|Overall Study|Adverse Event|1|||
160531299|NCT00375219|579675095|FG000|Overall Study|Withdrawal by Subject|1|||
160531300|NCT00375219|579675096|FG001|Overall Study|Withdrawal by Subject|0|||
160531301|NCT00375219|579675097|FG002|Overall Study|Withdrawal by Subject|0|||
160531302|NCT02684279|579675100|FG000|Overall Study|Adverse Event|87|||
160531303|NCT02684279|579675100|FG000|Overall Study|Lack of Efficacy|4|||
160531304|NCT02684279|579675100|FG000|Overall Study|Lost to Follow-up|61|||
160531305|NCT02684279|579675100|FG000|Overall Study|Protocol Violation|6|||
160531306|NCT02684279|579675100|FG000|Overall Study|Pregnancy|8|||
160531307|NCT02684279|579675100|FG000|Overall Study|Withdrawal by Subject|92|||
160531308|NCT02684279|579675100|FG000|Overall Study|non-compliance with study drug|9|||
160531309|NCT02684279|579675100|FG000|Overall Study|non compliance with study visits|2|||
160531310|NCT02684279|579675100|FG000|Overall Study|subject to have surgery|1|||
160531311|NCT02684279|579675100|FG000|Overall Study|family emergency|1|||
160531312|NCT02684279|579675100|FG000|Overall Study|Site closures|7|||
160870377|NCT04139798|580917455|FG001|Overall Study|Adverse Event|3|||
160870378|NCT04139798|580917454|FG000|Overall Study|Protocol Violation|1|||
160531313|NCT02684279|579675100|FG000|Overall Study|Physician Decision|1|||
160531314|NCT00228566|579675101|FG000|Overall Study|Adverse Event|31|||
160531315|NCT00228566|579675101|FG000|Overall Study|Lack of Efficacy|14|||
160531316|NCT00228566|579675101|FG000|Overall Study|Lost to Follow-up|16|||
160531317|NCT00228566|579675101|FG000|Overall Study|Physician Decision|5|||
160531318|NCT00228566|579675101|FG000|Overall Study|Withdrawal by Subject|4|||
160531319|NCT00228566|579675101|FG000|Overall Study|Miscellaneous|1|||
160531320|NCT04263896|579675102|FG000|Overall Study|Withdrawal by Subject|2|||
160531321|NCT04263896|579675103|FG001|Overall Study|Withdrawal by Subject|4|||
160531322|NCT04263896|579675102|FG000|Overall Study|converted to open procedure|0|||
160531323|NCT04263896|579675103|FG001|Overall Study|converted to open procedure|1|||
160531324|NCT04263896|579675102|FG000|Overall Study|Lost to Follow-up|9|||
160531325|NCT04263896|579675103|FG001|Overall Study|Lost to Follow-up|11|||
160531326|NCT04263896|579675102|FG000|Overall Study|surveys lost in mail|5|||
160531327|NCT04263896|579675103|FG001|Overall Study|surveys lost in mail|3|||
160531328|NCT04263896|579675102|FG000|Overall Study|excluded from analysis|1|||
160531329|NCT04263896|579675103|FG001|Overall Study|excluded from analysis|0|||
160531330|NCT02142738|579676304|FG000|Overall Study|Adverse Event|13|||
160531331|NCT02142738|579676305|FG001|Overall Study|Adverse Event|9|||
160531332|NCT02142738|579676304|FG000|Overall Study|Death|92|||
160531333|NCT02142738|579676305|FG001|Overall Study|Death|112|||
160531334|NCT02142738|579676304|FG000|Overall Study|Lost to Follow-up|0|||
160531335|NCT02142738|579676305|FG001|Overall Study|Lost to Follow-up|3|||
160531336|NCT02142738|579676304|FG000|Overall Study|Withdrawal by Subject|6|||
160531337|NCT02142738|579676305|FG001|Overall Study|Withdrawal by Subject|7|||
160531338|NCT02142738|579676304|FG000|Overall Study|Follow up ended by sponsor|43|||
160531339|NCT02142738|579676305|FG001|Overall Study|Follow up ended by sponsor|20|||
160531340|NCT00880555|579676307|FG000|Overall Study|Physician Decision|0|||
160531341|NCT00880555|579676308|FG001|Overall Study|Physician Decision|8|||
160531342|NCT00880555|579676309|FG002|Overall Study|Physician Decision|0|||
160531343|NCT00880555|579676310|FG003|Overall Study|Physician Decision|2|||
160531344|NCT00880555|579676311|FG004|Overall Study|Physician Decision|1|||
160531345|NCT00880555|579676312|FG005|Overall Study|Physician Decision|0|||
160531346|NCT00880555|579676307|FG000|Overall Study|Withdrawal by Subject|1|||
160531347|NCT00880555|579676308|FG001|Overall Study|Withdrawal by Subject|1|||
160531348|NCT00880555|579676309|FG002|Overall Study|Withdrawal by Subject|0|||
160531349|NCT00880555|579676310|FG003|Overall Study|Withdrawal by Subject|0|||
160531350|NCT00880555|579676311|FG004|Overall Study|Withdrawal by Subject|0|||
160531351|NCT00880555|579676312|FG005|Overall Study|Withdrawal by Subject|0|||
160531352|NCT00880555|579676307|FG000|Overall Study|Lack of resources (hired rater)|9|||
160531353|NCT00880555|579676308|FG001|Overall Study|Lack of resources (hired rater)|7|||
160531354|NCT00880555|579676309|FG002|Overall Study|Lack of resources (hired rater)|5|||
160531355|NCT00880555|579676310|FG003|Overall Study|Lack of resources (hired rater)|0|||
160531356|NCT00880555|579676311|FG004|Overall Study|Lack of resources (hired rater)|0|||
160531357|NCT00880555|579676312|FG005|Overall Study|Lack of resources (hired rater)|0|||
160531358|NCT00880555|579676307|FG000|Overall Study|Death|0|||
160531359|NCT00880555|579676308|FG001|Overall Study|Death|0|||
160531360|NCT00880555|579676309|FG002|Overall Study|Death|0|||
160531361|NCT00880555|579676310|FG003|Overall Study|Death|0|||
160531362|NCT00880555|579676311|FG004|Overall Study|Death|0|||
160531363|NCT00880555|579676312|FG005|Overall Study|Death|1|||
160531364|NCT00880555|579676307|FG000|Overall Study|Lost to Follow-up|0|||
160531365|NCT00880555|579676308|FG001|Overall Study|Lost to Follow-up|1|||
160531366|NCT00880555|579676309|FG002|Overall Study|Lost to Follow-up|0|||
160531367|NCT00880555|579676310|FG003|Overall Study|Lost to Follow-up|0|||
160531368|NCT00880555|579676311|FG004|Overall Study|Lost to Follow-up|0|||
160531369|NCT00880555|579676312|FG005|Overall Study|Lost to Follow-up|0|||
160531370|NCT04196803|579676313|FG000|Overall Study|Withdrawal by Subject|1|||
160531371|NCT04196803|579676314|FG001|Overall Study|Withdrawal by Subject|3|||
160531372|NCT04196803|579676313|FG000|Overall Study|Adverse Event|4|||
160531373|NCT04196803|579676314|FG001|Overall Study|Adverse Event|2|||
160870379|NCT04139798|580917455|FG001|Overall Study|Protocol Violation|0|||
160870380|NCT01526733|580917456|FG000|Phase 1|Protocol Violation|1|||
160870381|NCT01526733|580917457|FG001|Phase 1|Protocol Violation|0|||
160870382|NCT01526733|580917456|FG000|Phase 1|Withdrawal by Subject|1|||
160870383|NCT01526733|580917457|FG001|Phase 1|Withdrawal by Subject|1|||
160531374|NCT04196803|579676313|FG000|Overall Study|Lost to Follow-up|0|||
160531375|NCT04196803|579676314|FG001|Overall Study|Lost to Follow-up|1|||
160531376|NCT01168973|579676315|FG000|Overall Study|Progressive Disease|341|||
160531377|NCT01168973|579676316|FG001|Overall Study|Progressive Disease|429|||
160531378|NCT01168973|579676315|FG000|Overall Study|Adverse Event|94|||
160531379|NCT01168973|579676316|FG001|Overall Study|Adverse Event|55|||
160531380|NCT01168973|579676315|FG000|Overall Study|Withdrawal by Subject|90|||
160531381|NCT01168973|579676316|FG001|Overall Study|Withdrawal by Subject|53|||
160531382|NCT01168973|579676315|FG000|Overall Study|Death|42|||
160870384|NCT02506244|580917458|FG000|Overall Study|Did not undergo active monitoring|458|||
160531383|NCT01168973|579676316|FG001|Overall Study|Death|45|||
160531384|NCT01168973|579676315|FG000|Overall Study|Physician Decision|37|||
160531385|NCT01168973|579676316|FG001|Overall Study|Physician Decision|19|||
160531386|NCT01168973|579676315|FG000|Overall Study|Sponsor Decision|2|||
160531387|NCT01168973|579676316|FG001|Overall Study|Sponsor Decision|1|||
160870385|NCT02506244|580917459|FG001|Overall Study|Did not undergo active monitoring|459|||
160870386|NCT02506244|580917460|FG002|Overall Study|Did not undergo active monitoring|0|||
160870387|NCT05615922|580917465|FG000|Overall Study|Lost to Follow-up|1|||
160870388|NCT04774094|580917471|FG000|Overall Study|Other|2|||
160870389|NCT04774094|580917471|FG000|Overall Study|Withdrawal by Subject|9|||
160870390|NCT04774094|580917471|FG000|Overall Study|Lost to Follow-up|7|||
160870391|NCT04774094|580917471|FG000|Overall Study|Lack of Efficacy|5|||
160870392|NCT04774094|580917471|FG000|Overall Study|Death|17|||
160870393|NCT04774094|580917471|FG000|Overall Study|Adverse Event|4|||
160870394|NCT02374450|580917472|FG000|Overall Study|Protocol Violation|0|||
160870395|NCT02374450|580917473|FG001|Overall Study|Protocol Violation|1|||
160870396|NCT02374450|580917474|FG002|Overall Study|Protocol Violation|0|||
160870397|NCT02374450|580917472|FG000|Overall Study|Withdrawal by Subject|91|||
160870398|NCT02374450|580917473|FG001|Overall Study|Withdrawal by Subject|110|||
160870399|NCT02374450|580917474|FG002|Overall Study|Withdrawal by Subject|4|||
160870400|NCT02374450|580917472|FG000|Overall Study|Lost to Follow-up|168|||
160870401|NCT02374450|580917473|FG001|Overall Study|Lost to Follow-up|194|||
160870402|NCT02374450|580917474|FG002|Overall Study|Lost to Follow-up|138|||
160870403|NCT02374450|580917472|FG000|Overall Study|Death|173|||
160870404|NCT02374450|580917473|FG001|Overall Study|Death|185|||
160870405|NCT02374450|580917474|FG002|Overall Study|Death|81|||
160870406|NCT02374450|580917472|FG000|Overall Study|Migrated from the study area|538|||
160870407|NCT02374450|580917473|FG001|Overall Study|Migrated from the study area|648|||
160870408|NCT02374450|580917474|FG002|Overall Study|Migrated from the study area|181|||
160870409|NCT02374450|580917472|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
160870410|NCT02374450|580917473|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
160870411|NCT02374450|580917474|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
160870412|NCT02374450|580917472|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
160870413|NCT02374450|580917473|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
160870414|NCT02374450|580917474|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
160870415|NCT02374450|580917472|FG000|Overall Study|Other|0|||
160870416|NCT02374450|580917473|FG001|Overall Study|Other|21|||
160870417|NCT02374450|580917474|FG002|Overall Study|Other|79|||
160870418|NCT01006291|580918950|FG000|Overall Study|Adverse Event|2|||
160870419|NCT01006291|580918951|FG001|Overall Study|Adverse Event|1|||
160870420|NCT01006291|580918952|FG002|Overall Study|Adverse Event|2|||
160870421|NCT01006291|580918950|FG000|Overall Study|Lack of Efficacy|2|||
160870422|NCT01006291|580918951|FG001|Overall Study|Lack of Efficacy|2|||
160870423|NCT01006291|580918952|FG002|Overall Study|Lack of Efficacy|1|||
160870424|NCT01006291|580918950|FG000|Overall Study|Protocol Violation|3|||
160870425|NCT01006291|580918951|FG001|Overall Study|Protocol Violation|3|||
160870426|NCT01006291|580918952|FG002|Overall Study|Protocol Violation|3|||
160870427|NCT01006291|580918950|FG000|Overall Study|Withdrawal criteria|5|||
160870428|NCT01006291|580918951|FG001|Overall Study|Withdrawal criteria|4|||
160870429|NCT01006291|580918952|FG002|Overall Study|Withdrawal criteria|4|||
160870430|NCT01006291|580918950|FG000|Overall Study|Other|14|||
160531388|NCT01168973|579676315|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
160531389|NCT01168973|579676316|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
160531390|NCT00419120|579676320|FG000|Long Term Follow up Period|study ongoing|10|||
160531391|NCT00388505|579676321|FG000|Overall Study|Adverse Event or Death|43|||
160531392|NCT00388505|579676322|FG001|Overall Study|Adverse Event or Death|17|||
160531393|NCT00388505|579676321|FG000|Overall Study|Withdrawal by Subject|24|||
160531394|NCT00388505|579676322|FG001|Overall Study|Withdrawal by Subject|9|||
160531395|NCT00388505|579676321|FG000|Overall Study|Lost to Follow-up|5|||
160531396|NCT00388505|579676322|FG001|Overall Study|Lost to Follow-up|3|||
160531397|NCT00388505|579676321|FG000|Overall Study|Inappropriate Enrollment|0|||
160531398|NCT00388505|579676322|FG001|Overall Study|Inappropriate Enrollment|1|||
160531399|NCT00388505|579676321|FG000|Overall Study|Administrative Reason|1|||
160531400|NCT00388505|579676322|FG001|Overall Study|Administrative Reason|0|||
160531401|NCT00388505|579676321|FG000|Overall Study|Protocol Violation|6|||
160531402|NCT00388505|579676322|FG001|Overall Study|Protocol Violation|5|||
160531403|NCT00388505|579676321|FG000|Overall Study|Unable to classify|4|||
160870431|NCT01006291|580918951|FG001|Overall Study|Other|14|||
160870432|NCT01006291|580918952|FG002|Overall Study|Other|17|||
160531404|NCT00388505|579676322|FG001|Overall Study|Unable to classify|3|||
160870433|NCT00684060|580918953|FG000|Overall Study|Lost to Follow-up|1|||
160531405|NCT02667275|579676324|FG000|Overall Study|Protocol Violation|11|||
160531406|NCT02667275|579676325|FG001|Overall Study|Protocol Violation|7|||
160870434|NCT00684060|580918954|FG001|Overall Study|Lost to Follow-up|0|||
160870435|NCT00684060|580918953|FG000|Overall Study|New stenosis identified|1|||
160870436|NCT00684060|580918954|FG001|Overall Study|New stenosis identified|0|||
160531407|NCT02667275|579676324|FG000|Overall Study|Lost to Follow-up|0|||
160531408|NCT02667275|579676325|FG001|Overall Study|Lost to Follow-up|2|||
160531409|NCT02667275|579676324|FG000|Overall Study|Withdrawal by Subject|0|||
160531410|NCT02667275|579676325|FG001|Overall Study|Withdrawal by Subject|5|||
160870437|NCT00684060|580918953|FG000|Overall Study|Unable to collect MRI|1|||
160870438|NCT00684060|580918954|FG001|Overall Study|Unable to collect MRI|2|||
160870439|NCT00684060|580918953|FG000|Overall Study|Death|0|||
160870440|NCT00684060|580918954|FG001|Overall Study|Death|1|||
160870441|NCT00702715|580918959|FG000|Overall Study|Lost to Follow-up|1|||
160870442|NCT00702715|580918960|FG001|Overall Study|Lost to Follow-up|0|||
160870443|NCT01677377|580918961|FG000|Overall Study|Protocol Violation|1|||
160870444|NCT01677377|580918962|FG001|Overall Study|Protocol Violation|0|||
160870445|NCT01677377|580918963|FG002|Overall Study|Protocol Violation|0|||
160870446|NCT01677377|580918961|FG000|Overall Study|Lost to Follow-up|0|||
160870447|NCT01677377|580918962|FG001|Overall Study|Lost to Follow-up|1|||
160870448|NCT01677377|580918963|FG002|Overall Study|Lost to Follow-up|1|||
160870449|NCT01677377|580918961|FG000|Overall Study|Withdrawal by Subject|0|||
160870450|NCT01677377|580918962|FG001|Overall Study|Withdrawal by Subject|0|||
160870451|NCT01677377|580918963|FG002|Overall Study|Withdrawal by Subject|3|||
160870452|NCT01677377|580918961|FG000|Overall Study|Lack of Efficacy|0|||
160870453|NCT01677377|580918962|FG001|Overall Study|Lack of Efficacy|0|||
160870454|NCT01677377|580918963|FG002|Overall Study|Lack of Efficacy|1|||
160870455|NCT01677377|580918961|FG000|Overall Study|Pregnancy|0|||
160870456|NCT01677377|580918962|FG001|Overall Study|Pregnancy|0|||
160870457|NCT01677377|580918963|FG002|Overall Study|Pregnancy|1|||
160870458|NCT02260180|580918964|FG000|Overall Study|Adverse Event|2|||
160870459|NCT02260180|580918965|FG001|Overall Study|Adverse Event|0|||
160870460|NCT02260180|580918966|FG002|Overall Study|Adverse Event|1|||
160870461|NCT01193257|580918967|FG000|Overall Study|Death|202|||
160870462|NCT01193257|580918968|FG001|Overall Study|Death|391|||
160870463|NCT01193257|580918967|FG000|Overall Study|Study termination by sponsor|0|||
160870464|NCT01193257|580918968|FG001|Overall Study|Study termination by sponsor|3|||
160870465|NCT01193257|580918967|FG000|Overall Study|Withdrawal by Subject|26|||
160870466|NCT01193257|580918968|FG001|Overall Study|Withdrawal by Subject|86|||
160870467|NCT01193257|580918967|FG000|Overall Study|Lost to Follow-up|2|||
160870468|NCT01193257|580918968|FG001|Overall Study|Lost to Follow-up|3|||
160870469|NCT01193257|580918967|FG000|Overall Study|Unblinded due to futility|135|||
160870470|NCT01193257|580918968|FG001|Overall Study|Unblinded due to futility|251|||
160870471|NCT01330108|580918984|FG000|Overall Study|Withdrawal by Subject|4|||
160870472|NCT04849559|580918989|FG000|Overall Study|Withdrawal by Subject|2|||
160870473|NCT04849559|580918990|FG001|Overall Study|Withdrawal by Subject|1|||
160870474|NCT02910986|580918991|FG000|Overall Study|non-Latina|14|||
160870475|NCT02910986|580918992|FG001|Overall Study|non-Latina|13|||
160870476|NCT02910986|580918993|FG002|Overall Study|non-Latina|12|||
160531411|NCT02667275|579676324|FG000|Overall Study|Discontinued early without completing|0|||
160531412|NCT02667275|579676325|FG001|Overall Study|Discontinued early without completing|1|||
160531413|NCT01756040|579676326|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
160531414|NCT01756040|579676326|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
160870477|NCT02910986|580918991|FG000|Overall Study|Failure to return T! survey|72|||
160870478|NCT02910986|580918992|FG001|Overall Study|Failure to return T! survey|84|||
160870479|NCT02910986|580918993|FG002|Overall Study|Failure to return T! survey|72|||
160870480|NCT02910986|580918991|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
160870481|NCT02910986|580918992|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
160870482|NCT02910986|580918993|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
160870483|NCT02910986|580918991|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
160870484|NCT02910986|580918992|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
160870485|NCT02910986|580918993|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
160870486|NCT02304367|580918994|FG000|Overall Study|Lack of Response to Bruosumab|1|||
160870487|NCT02304367|580918994|FG000|Overall Study|Sponsor Decision|3|||
160870488|NCT02304367|580918994|FG000|Overall Study|Death|2|||
160870489|NCT02304367|580918994|FG000|Overall Study|Physician Decision|1|||
160870490|NCT02304367|580918994|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
160870491|NCT03527732|580918995|FG000|Overall Study|Lost to Follow-up|21|||
160870492|NCT03527732|580918996|FG001|Overall Study|Lost to Follow-up|23|||
160870493|NCT03527732|580918997|FG002|Overall Study|Lost to Follow-up|80|||
160870494|NCT03527732|580918998|FG003|Overall Study|Lost to Follow-up|62|||
160870495|NCT03527732|580918999|FG004|Overall Study|Lost to Follow-up|12|||
160870496|NCT03527732|580919000|FG005|Overall Study|Lost to Follow-up|20|||
160870497|NCT00470275|580919001|FG000|Overall Study|Death|1|||
160870498|NCT00470275|580919001|FG000|Overall Study|Lack of Efficacy|7|||
160870499|NCT00470275|580919001|FG000|Overall Study|Withdrawal by Subject|2|||
160870500|NCT02207088|580919002|FG000|Overall Study|Adverse Event|2|||
160870501|NCT03306173|580919004|FG000|Overall Study|Lost to Follow-up|16|||
160870502|NCT03306173|580919005|FG001|Overall Study|Lost to Follow-up|23|||
160531415|NCT01756040|579676326|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
160531416|NCT01179672|579676329|FG000|Overall Study|Adverse Event|17|||
160531417|NCT01179672|579676330|FG001|Overall Study|Adverse Event|8|||
160531418|NCT01179672|579676329|FG000|Overall Study|Withdrawal by Subject|10|||
160531419|NCT01179672|579676330|FG001|Overall Study|Withdrawal by Subject|12|||
160531420|NCT01179672|579676329|FG000|Overall Study|Entry Criteria Not Met|0|||
160531421|NCT01179672|579676330|FG001|Overall Study|Entry Criteria Not Met|2|||
160531422|NCT01179672|579676329|FG000|Overall Study|Lost to Follow-up|0|||
160531423|NCT01179672|579676330|FG001|Overall Study|Lost to Follow-up|1|||
160531424|NCT01179672|579676329|FG000|Overall Study|Protocol Violation|2|||
160531425|NCT01179672|579676330|FG001|Overall Study|Protocol Violation|2|||
160531426|NCT01179672|579676329|FG000|Overall Study|Physician Decision|1|||
160531427|NCT01179672|579676330|FG001|Overall Study|Physician Decision|1|||
160531428|NCT01994382|579676331|FG000|Overall Study|Informed consent withdrawn|0|||
160531429|NCT01994382|579676332|FG001|Overall Study|Informed consent withdrawn|0|||
160531430|NCT01994382|579676333|FG002|Overall Study|Informed consent withdrawn|0|||
160531431|NCT01994382|579676334|FG003|Overall Study|Informed consent withdrawn|0|||
160531432|NCT01994382|579676335|FG004|Overall Study|Informed consent withdrawn|0|||
160531433|NCT01994382|579676336|FG005|Overall Study|Informed consent withdrawn|0|||
160531434|NCT01994382|579676337|FG006|Overall Study|Informed consent withdrawn|1|||
160531435|NCT01994382|579676338|FG007|Overall Study|Informed consent withdrawn|0|||
160531436|NCT01994382|579676339|FG008|Overall Study|Informed consent withdrawn|0|||
160531437|NCT01994382|579676340|FG009|Overall Study|Informed consent withdrawn|0|||
160531438|NCT01994382|579676341|FG010|Overall Study|Informed consent withdrawn|0|||
160531439|NCT01994382|579676342|FG011|Overall Study|Informed consent withdrawn|0|||
160870503|NCT03306173|580919004|FG000|Overall Study|Withdrawal by Subject|4|||
160870504|NCT03306173|580919005|FG001|Overall Study|Withdrawal by Subject|3|||
160870505|NCT03306173|580919004|FG000|Overall Study|Discontinued|4|||
160870506|NCT03306173|580919005|FG001|Overall Study|Discontinued|4|||
160870507|NCT00573144|580919006|FG000|Overall Study|Withdrawal by Subject|2|||
160870508|NCT00573144|580919007|FG001|Overall Study|Withdrawal by Subject|3|||
160870509|NCT03339219|580919010|FG000|Overall Study|Death|12|||
160870510|NCT03339219|580919010|FG000|Overall Study|Site Terminated by Sponsor|22|||
160531440|NCT01994382|579676343|FG012|Overall Study|Informed consent withdrawn|0|||
160531441|NCT01994382|579676344|FG013|Overall Study|Informed consent withdrawn|0|||
160531442|NCT01994382|579676345|FG014|Overall Study|Informed consent withdrawn|0|||
160531443|NCT01994382|579676346|FG015|Overall Study|Informed consent withdrawn|0|||
160531444|NCT01994382|579676347|FG016|Overall Study|Informed consent withdrawn|0|||
160531445|NCT01994382|579676331|FG000|Overall Study|Progressive disease|3|||
160531446|NCT01994382|579676332|FG001|Overall Study|Progressive disease|4|||
160870511|NCT03339219|580919010|FG000|Overall Study|Withdrawal by Subject|1|||
160870512|NCT03155841|580919016|FG000|Overall Study|Protocol Violation|3|||
160870513|NCT03155841|580919017|FG001|Overall Study|Protocol Violation|4|||
160870514|NCT04308291|580919018|FG000|Run-In Phase|Withdrawal by Subject|4|||
160870515|NCT04308291|580919018|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
160531447|NCT01994382|579676333|FG002|Overall Study|Progressive disease|4|||
160531448|NCT01994382|579676334|FG003|Overall Study|Progressive disease|3|||
160531449|NCT01994382|579676335|FG004|Overall Study|Progressive disease|2|||
160531450|NCT01994382|579676336|FG005|Overall Study|Progressive disease|3|||
160531451|NCT01994382|579676337|FG006|Overall Study|Progressive disease|3|||
160531452|NCT01994382|579676338|FG007|Overall Study|Progressive disease|6|||
160531453|NCT01994382|579676339|FG008|Overall Study|Progressive disease|2|||
160531454|NCT01994382|579676340|FG009|Overall Study|Progressive disease|2|||
160531455|NCT01994382|579676341|FG010|Overall Study|Progressive disease|13|||
160531456|NCT01994382|579676342|FG011|Overall Study|Progressive disease|8|||
160531457|NCT01994382|579676343|FG012|Overall Study|Progressive disease|7|||
160870516|NCT04308291|580919018|FG000|Study Phase 6-M|Physician Decision|2|||
160870517|NCT04308291|580919018|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
160870518|NCT04308291|580919018|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
160870519|NCT04308291|580919018|FG000|Study Phase 12-M|Physician Decision|2|||
160870520|NCT04308291|580919018|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
160870521|NCT04411667|580919019|FG000|Overall Study|Physician Decision|1|||
160870522|NCT04411667|580919020|FG001|Overall Study|Physician Decision|0|||
160870523|NCT00714870|580919024|FG000|Overall Study|Lost to Follow-up|22|||
160870524|NCT00714870|580919025|FG001|Overall Study|Lost to Follow-up|5|||
160870525|NCT00714870|580919024|FG000|Overall Study|patient unable to come b/c back pain|1|||
160870526|NCT00714870|580919025|FG001|Overall Study|patient unable to come b/c back pain|0|||
160870527|NCT00714870|580919024|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
160870528|NCT00714870|580919025|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
160870529|NCT03399552|580919026|FG000|Overall Study|No evidence of disease|1|||
160870530|NCT03399552|580919026|FG000|Overall Study|Unevaluable|1|||
160870531|NCT02357368|580919027|FG000|Overall Study|Lost to Follow-up|0|||
160870532|NCT02357368|580919028|FG001|Overall Study|Lost to Follow-up|0|||
160870533|NCT02357368|580919029|FG002|Overall Study|Lost to Follow-up|0|||
160870534|NCT02357368|580919030|FG003|Overall Study|Lost to Follow-up|1|||
160531458|NCT01994382|579676344|FG013|Overall Study|Progressive disease|3|||
160531459|NCT01994382|579676345|FG014|Overall Study|Progressive disease|6|||
160531460|NCT01994382|579676346|FG015|Overall Study|Progressive disease|44|||
160531461|NCT01994382|579676347|FG016|Overall Study|Progressive disease|28|||
160531462|NCT01994382|579676331|FG000|Overall Study|Physician Decision|0|||
160531463|NCT01994382|579676332|FG001|Overall Study|Physician Decision|1|||
160531464|NCT01994382|579676333|FG002|Overall Study|Physician Decision|0|||
160531465|NCT01994382|579676334|FG003|Overall Study|Physician Decision|0|||
160531466|NCT01994382|579676335|FG004|Overall Study|Physician Decision|0|||
160531467|NCT01994382|579676336|FG005|Overall Study|Physician Decision|0|||
160531468|NCT01994382|579676337|FG006|Overall Study|Physician Decision|0|||
160531469|NCT01994382|579676338|FG007|Overall Study|Physician Decision|0|||
160531470|NCT01994382|579676339|FG008|Overall Study|Physician Decision|0|||
160531471|NCT01994382|579676340|FG009|Overall Study|Physician Decision|0|||
160531472|NCT01994382|579676341|FG010|Overall Study|Physician Decision|3|||
160531473|NCT01994382|579676342|FG011|Overall Study|Physician Decision|1|||
160531474|NCT01994382|579676343|FG012|Overall Study|Physician Decision|1|||
160531475|NCT01994382|579676344|FG013|Overall Study|Physician Decision|0|||
160531476|NCT01994382|579676345|FG014|Overall Study|Physician Decision|1|||
160531477|NCT01994382|579676346|FG015|Overall Study|Physician Decision|4|||
160531478|NCT01994382|579676347|FG016|Overall Study|Physician Decision|2|||
160531479|NCT01994382|579676331|FG000|Overall Study|Death|0|||
160531480|NCT01994382|579676332|FG001|Overall Study|Death|0|||
160531481|NCT01994382|579676333|FG002|Overall Study|Death|0|||
160531482|NCT01994382|579676334|FG003|Overall Study|Death|0|||
160531483|NCT01994382|579676335|FG004|Overall Study|Death|1|||
160531484|NCT01994382|579676336|FG005|Overall Study|Death|0|||
160531485|NCT01994382|579676337|FG006|Overall Study|Death|0|||
160531486|NCT01994382|579676338|FG007|Overall Study|Death|0|||
160870535|NCT02357368|580919027|FG000|Overall Study|Pregnancy|3|||
160870536|NCT02357368|580919028|FG001|Overall Study|Pregnancy|2|||
160870537|NCT02357368|580919029|FG002|Overall Study|Pregnancy|0|||
160870538|NCT02357368|580919030|FG003|Overall Study|Pregnancy|0|||
160870539|NCT02357368|580919027|FG000|Overall Study|Withdrawal by Subject|3|||
160870540|NCT02357368|580919028|FG001|Overall Study|Withdrawal by Subject|1|||
160531487|NCT01994382|579676339|FG008|Overall Study|Death|1|||
160531488|NCT01994382|579676340|FG009|Overall Study|Death|1|||
160531489|NCT01994382|579676341|FG010|Overall Study|Death|0|||
160531490|NCT01994382|579676342|FG011|Overall Study|Death|0|||
160531491|NCT01994382|579676343|FG012|Overall Study|Death|0|||
160531492|NCT01994382|579676344|FG013|Overall Study|Death|0|||
160531493|NCT01994382|579676345|FG014|Overall Study|Death|0|||
160531494|NCT01994382|579676346|FG015|Overall Study|Death|1|||
160870541|NCT02357368|580919029|FG002|Overall Study|Withdrawal by Subject|1|||
160870542|NCT02357368|580919030|FG003|Overall Study|Withdrawal by Subject|2|||
160531495|NCT01994382|579676347|FG016|Overall Study|Death|0|||
160531496|NCT01994382|579676331|FG000|Overall Study|Adverse Event|0|||
160531497|NCT01994382|579676332|FG001|Overall Study|Adverse Event|1|||
160531498|NCT01994382|579676333|FG002|Overall Study|Adverse Event|2|||
160531499|NCT01994382|579676334|FG003|Overall Study|Adverse Event|0|||
160870543|NCT01931566|580919031|FG000|Overall Study|Randomized But Not Treated|6|||
160870544|NCT01931566|580919032|FG001|Overall Study|Randomized But Not Treated|9|||
160870545|NCT01931566|580919033|FG002|Overall Study|Randomized But Not Treated|14|||
160870546|NCT01931566|580919031|FG000|Overall Study|Adverse Event|37|||
160870547|NCT01931566|580919032|FG001|Overall Study|Adverse Event|167|||
160870548|NCT01931566|580919033|FG002|Overall Study|Adverse Event|132|||
160531500|NCT01994382|579676335|FG004|Overall Study|Adverse Event|0|||
160531501|NCT01994382|579676336|FG005|Overall Study|Adverse Event|0|||
160870549|NCT01931566|580919031|FG000|Overall Study|Major Protocol Deviation|5|||
160870550|NCT01931566|580919032|FG001|Overall Study|Major Protocol Deviation|14|||
160870551|NCT01931566|580919033|FG002|Overall Study|Major Protocol Deviation|21|||
160870552|NCT01931566|580919031|FG000|Overall Study|Lost to Follow-up|3|||
160870553|NCT01931566|580919032|FG001|Overall Study|Lost to Follow-up|26|||
160531502|NCT01994382|579676337|FG006|Overall Study|Adverse Event|0|||
160531503|NCT01994382|579676338|FG007|Overall Study|Adverse Event|0|||
160531504|NCT01994382|579676339|FG008|Overall Study|Adverse Event|0|||
160531505|NCT01994382|579676340|FG009|Overall Study|Adverse Event|0|||
160531506|NCT01994382|579676341|FG010|Overall Study|Adverse Event|15|||
160531507|NCT01994382|579676342|FG011|Overall Study|Adverse Event|2|||
160531508|NCT01994382|579676343|FG012|Overall Study|Adverse Event|7|||
160531509|NCT01994382|579676344|FG013|Overall Study|Adverse Event|3|||
160531510|NCT01994382|579676345|FG014|Overall Study|Adverse Event|17|||
160531511|NCT01994382|579676346|FG015|Overall Study|Adverse Event|6|||
160531512|NCT01994382|579676347|FG016|Overall Study|Adverse Event|3|||
160531513|NCT01994382|579676331|FG000|Overall Study|Other than specified|0|||
160531514|NCT01994382|579676332|FG001|Overall Study|Other than specified|0|||
160531515|NCT01994382|579676333|FG002|Overall Study|Other than specified|0|||
160531516|NCT01994382|579676334|FG003|Overall Study|Other than specified|0|||
160531517|NCT01994382|579676335|FG004|Overall Study|Other than specified|0|||
160531518|NCT01994382|579676336|FG005|Overall Study|Other than specified|0|||
160531519|NCT01994382|579676337|FG006|Overall Study|Other than specified|0|||
160531520|NCT01994382|579676338|FG007|Overall Study|Other than specified|0|||
160531521|NCT01994382|579676339|FG008|Overall Study|Other than specified|0|||
160531522|NCT01994382|579676340|FG009|Overall Study|Other than specified|0|||
160531523|NCT01994382|579676341|FG010|Overall Study|Other than specified|2|||
160531524|NCT01994382|579676342|FG011|Overall Study|Other than specified|0|||
160531525|NCT01994382|579676343|FG012|Overall Study|Other than specified|2|||
160531526|NCT01994382|579676344|FG013|Overall Study|Other than specified|0|||
160531527|NCT01994382|579676345|FG014|Overall Study|Other than specified|0|||
160531528|NCT01994382|579676346|FG015|Overall Study|Other than specified|4|||
160531529|NCT01994382|579676347|FG016|Overall Study|Other than specified|4|||
160531530|NCT01994382|579676331|FG000|Overall Study|Withdrawal by Subject|0|||
160531531|NCT01994382|579676332|FG001|Overall Study|Withdrawal by Subject|0|||
160531532|NCT01994382|579676333|FG002|Overall Study|Withdrawal by Subject|0|||
160531533|NCT01994382|579676334|FG003|Overall Study|Withdrawal by Subject|0|||
160531534|NCT01994382|579676335|FG004|Overall Study|Withdrawal by Subject|0|||
160870554|NCT01931566|580919033|FG002|Overall Study|Lost to Follow-up|23|||
160870555|NCT01931566|580919031|FG000|Overall Study|Voluntary Withdrawal|78|||
160870556|NCT01931566|580919032|FG001|Overall Study|Voluntary Withdrawal|245|||
160870557|NCT01931566|580919033|FG002|Overall Study|Voluntary Withdrawal|225|||
160870558|NCT01931566|580919031|FG000|Overall Study|Study Termination|289|||
160870559|NCT01931566|580919032|FG001|Overall Study|Study Termination|968|||
160870560|NCT01931566|580919033|FG002|Overall Study|Study Termination|1037|||
160870561|NCT01931566|580919031|FG000|Overall Study|Reason Not Specified|11|||
160870562|NCT01931566|580919032|FG001|Overall Study|Reason Not Specified|47|||
160870563|NCT01931566|580919033|FG002|Overall Study|Reason Not Specified|53|||
160870564|NCT01931566|580919031|FG000|Overall Study|Missing|0|||
160870565|NCT01931566|580919032|FG001|Overall Study|Missing|0|||
160870566|NCT01931566|580919033|FG002|Overall Study|Missing|1|||
160870567|NCT01147874|580919038|FG000|Overall Study|Adverse Event|5|||
160870568|NCT01147874|580919038|FG000|Overall Study|Investigator's Request|1|||
160870569|NCT01147874|580919038|FG000|Overall Study|Lost to Follow-up|25|||
160531535|NCT01994382|579676336|FG005|Overall Study|Withdrawal by Subject|0|||
160531536|NCT01994382|579676337|FG006|Overall Study|Withdrawal by Subject|0|||
160531537|NCT01994382|579676338|FG007|Overall Study|Withdrawal by Subject|0|||
160531538|NCT01994382|579676339|FG008|Overall Study|Withdrawal by Subject|0|||
160531539|NCT01994382|579676340|FG009|Overall Study|Withdrawal by Subject|0|||
160531540|NCT01994382|579676341|FG010|Overall Study|Withdrawal by Subject|6|||
160531541|NCT01994382|579676342|FG011|Overall Study|Withdrawal by Subject|0|||
160531542|NCT01994382|579676343|FG012|Overall Study|Withdrawal by Subject|2|||
160531543|NCT01994382|579676344|FG013|Overall Study|Withdrawal by Subject|0|||
160531544|NCT01994382|579676345|FG014|Overall Study|Withdrawal by Subject|4|||
160531545|NCT01994382|579676346|FG015|Overall Study|Withdrawal by Subject|3|||
160531546|NCT01994382|579676347|FG016|Overall Study|Withdrawal by Subject|0|||
160870570|NCT01147874|580919038|FG000|Overall Study|Other|5|||
160870571|NCT01147874|580919038|FG000|Overall Study|Protocol Violation|5|||
160870572|NCT01147874|580919038|FG000|Overall Study|Sponsor's Decision|2|||
160531547|NCT01994382|579676331|FG000|Overall Study|Lost to Follow-up|0|||
160531548|NCT01994382|579676332|FG001|Overall Study|Lost to Follow-up|0|||
160531549|NCT01994382|579676333|FG002|Overall Study|Lost to Follow-up|0|||
160870573|NCT01147874|580919038|FG000|Overall Study|Withdrawal by Subject|24|||
160870574|NCT02991040|580919039|FG000|Overall Study|Withdrawal by Subject|2|||
160870575|NCT02991040|580919039|FG000|Overall Study|Lost to Follow-up|2|||
160870576|NCT04287517|580919040|FG000|Overall Study|Withdrawal by Subject|1|||
160870577|NCT04287517|580919041|FG001|Overall Study|Withdrawal by Subject|1|||
160870578|NCT01869764|580919048|FG000|Overall Study|Withdrawal by Subject|0|||
160870579|NCT01869764|580919049|FG001|Overall Study|Withdrawal by Subject|2|||
160870580|NCT02175030|580919050|FG000|Overall Study|Failed screen after consent|7|||
160870581|NCT02175030|580919051|FG001|Overall Study|Failed screen after consent|6|||
160870582|NCT02175030|580919050|FG000|Overall Study|Failed IUD Insertion|20|||
160870583|NCT02175030|580919051|FG001|Overall Study|Failed IUD Insertion|21|||
160870584|NCT02175030|580919050|FG000|Overall Study|Physician Decision|1|||
160870585|NCT02175030|580919051|FG001|Overall Study|Physician Decision|1|||
160870586|NCT02175030|580919050|FG000|Overall Study|Lost to Follow-up|6|||
160870587|NCT02175030|580919051|FG001|Overall Study|Lost to Follow-up|6|||
160870588|NCT02175030|580919050|FG000|Overall Study|Withdrawal by Subject|1|||
160531550|NCT01994382|579676334|FG003|Overall Study|Lost to Follow-up|0|||
160531551|NCT01994382|579676335|FG004|Overall Study|Lost to Follow-up|0|||
160531552|NCT01994382|579676336|FG005|Overall Study|Lost to Follow-up|0|||
160531553|NCT01994382|579676337|FG006|Overall Study|Lost to Follow-up|0|||
160531554|NCT01994382|579676338|FG007|Overall Study|Lost to Follow-up|0|||
160531555|NCT01994382|579676339|FG008|Overall Study|Lost to Follow-up|0|||
160531556|NCT01994382|579676340|FG009|Overall Study|Lost to Follow-up|0|||
160531557|NCT01994382|579676341|FG010|Overall Study|Lost to Follow-up|1|||
160531558|NCT01994382|579676342|FG011|Overall Study|Lost to Follow-up|0|||
160531559|NCT01994382|579676343|FG012|Overall Study|Lost to Follow-up|0|||
160531560|NCT01994382|579676344|FG013|Overall Study|Lost to Follow-up|0|||
160531561|NCT01994382|579676345|FG014|Overall Study|Lost to Follow-up|0|||
160531562|NCT01994382|579676346|FG015|Overall Study|Lost to Follow-up|0|||
160531563|NCT01994382|579676347|FG016|Overall Study|Lost to Follow-up|0|||
160531564|NCT01994382|579676331|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531565|NCT01994382|579676332|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531566|NCT01994382|579676333|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531567|NCT01994382|579676334|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531568|NCT01994382|579676335|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531569|NCT01994382|579676336|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531570|NCT01994382|579676337|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531571|NCT01994382|579676338|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531572|NCT01994382|579676339|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531573|NCT01994382|579676340|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531574|NCT01994382|579676341|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
160531575|NCT01994382|579676342|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531576|NCT01994382|579676343|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
160531577|NCT01994382|579676344|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531578|NCT01994382|579676345|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
160531579|NCT01994382|579676346|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
160531580|NCT01994382|579676347|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
160531581|NCT01994382|579676331|FG000|Overall Study|Protocol violation/noncompliance|0|||
160531582|NCT01994382|579676332|FG001|Overall Study|Protocol violation/noncompliance|0|||
160531583|NCT01994382|579676333|FG002|Overall Study|Protocol violation/noncompliance|0|||
160531584|NCT01994382|579676334|FG003|Overall Study|Protocol violation/noncompliance|0|||
160531585|NCT01994382|579676335|FG004|Overall Study|Protocol violation/noncompliance|0|||
160531586|NCT01994382|579676336|FG005|Overall Study|Protocol violation/noncompliance|0|||
160531587|NCT01994382|579676337|FG006|Overall Study|Protocol violation/noncompliance|0|||
160531588|NCT01994382|579676338|FG007|Overall Study|Protocol violation/noncompliance|0|||
160531589|NCT01994382|579676339|FG008|Overall Study|Protocol violation/noncompliance|0|||
160531590|NCT01994382|579676340|FG009|Overall Study|Protocol violation/noncompliance|0|||
160531591|NCT01994382|579676341|FG010|Overall Study|Protocol violation/noncompliance|0|||
160531592|NCT01994382|579676342|FG011|Overall Study|Protocol violation/noncompliance|1|||
160531593|NCT01994382|579676343|FG012|Overall Study|Protocol violation/noncompliance|0|||
160531594|NCT01994382|579676344|FG013|Overall Study|Protocol violation/noncompliance|0|||
160531595|NCT01994382|579676345|FG014|Overall Study|Protocol violation/noncompliance|0|||
160531596|NCT01994382|579676346|FG015|Overall Study|Protocol violation/noncompliance|0|||
160531597|NCT01994382|579676347|FG016|Overall Study|Protocol violation/noncompliance|2|||
160531598|NCT01994382|579676331|FG000|Overall Study|Rolled over to Phase 2a|0|||
160531599|NCT01994382|579676332|FG001|Overall Study|Rolled over to Phase 2a|0|||
160531600|NCT01994382|579676333|FG002|Overall Study|Rolled over to Phase 2a|1|||
160531601|NCT01994382|579676334|FG003|Overall Study|Rolled over to Phase 2a|0|||
160531602|NCT01994382|579676335|FG004|Overall Study|Rolled over to Phase 2a|0|||
160531603|NCT01994382|579676336|FG005|Overall Study|Rolled over to Phase 2a|0|||
160531604|NCT01994382|579676337|FG006|Overall Study|Rolled over to Phase 2a|0|||
160531605|NCT01994382|579676338|FG007|Overall Study|Rolled over to Phase 2a|0|||
160531606|NCT01994382|579676339|FG008|Overall Study|Rolled over to Phase 2a|0|||
160870589|NCT02175030|580919051|FG001|Overall Study|Withdrawal by Subject|4|||
160531607|NCT01994382|579676340|FG009|Overall Study|Rolled over to Phase 2a|2|||
160531608|NCT01994382|579676341|FG010|Overall Study|Rolled over to Phase 2a|0|||
160531609|NCT01994382|579676342|FG011|Overall Study|Rolled over to Phase 2a|0|||
160531610|NCT01994382|579676343|FG012|Overall Study|Rolled over to Phase 2a|0|||
160870590|NCT02533453|580919052|FG000|Overall Study|Adverse Event|6|||
160870591|NCT02533453|580919052|FG000|Overall Study|Protocol Violation|1|||
160870592|NCT02533453|580919052|FG000|Overall Study|Withdrawal by Subject|2|||
160870593|NCT01273519|580919057|FG000|Overall Study|Adverse Event|3|||
160870594|NCT01273519|580919058|FG001|Overall Study|Adverse Event|0|||
160870595|NCT01273519|580919059|FG002|Overall Study|Adverse Event|0|||
160870596|NCT01273519|580919057|FG000|Overall Study|Lost to Follow-up|2|||
160870597|NCT01273519|580919058|FG001|Overall Study|Lost to Follow-up|1|||
160870598|NCT01273519|580919059|FG002|Overall Study|Lost to Follow-up|3|||
160870599|NCT01273519|580919057|FG000|Overall Study|Lack of Efficacy|8|||
160870600|NCT01273519|580919058|FG001|Overall Study|Lack of Efficacy|3|||
160870601|NCT01273519|580919059|FG002|Overall Study|Lack of Efficacy|4|||
160870602|NCT01273519|580919057|FG000|Overall Study|Other|6|||
160870603|NCT01273519|580919058|FG001|Overall Study|Other|1|||
160870604|NCT01273519|580919059|FG002|Overall Study|Other|1|||
160870605|NCT03695367|580919060|FG000|Overall Study|Missed the Day 28 visit.|1|||
160870606|NCT03695367|580919061|FG001|Overall Study|Missed the Day 28 visit.|0|||
160870607|NCT03695367|580919060|FG000|Overall Study|Lost to Follow-up|0|||
160870608|NCT03695367|580919061|FG001|Overall Study|Lost to Follow-up|1|||
160870609|NCT03695367|580919060|FG000|Overall Study|Withdrawal by Subject|0|||
160870610|NCT03695367|580919061|FG001|Overall Study|Withdrawal by Subject|1|||
160870611|NCT03695367|580919060|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
160870612|NCT03695367|580919061|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
160870613|NCT00068419|580919064|FG000|Overall Study|Adverse Event|3|||
160870614|NCT00068419|580919064|FG000|Overall Study|Lack of Efficacy|24|||
160870615|NCT00068419|580919064|FG000|Overall Study|Lost to Follow-up|1|||
160870616|NCT00068419|580919064|FG000|Overall Study|Physician Decision|7|||
160870617|NCT00068419|580919064|FG000|Overall Study|Withdrawal by Subject|14|||
160870618|NCT00068419|580919064|FG000|Overall Study|Ineligible|11|||
160870619|NCT00396253|580919068|FG000|Overall Study|Protocol Violation|1|||
160870620|NCT00396253|580919068|FG000|Overall Study|Withdrawal by Subject|7|||
160870621|NCT00396253|580919068|FG000|Overall Study|Death|3|||
160870622|NCT00396253|580919068|FG000|Overall Study|Physician Decision|1|||
160870623|NCT00396253|580919068|FG000|Overall Study|Change in eligibility status|1|||
160870624|NCT00092443|580919069|FG000|Overall Study|Adverse Event|9|||
160870625|NCT00092443|580919070|FG001|Overall Study|Adverse Event|13|||
160870626|NCT00092443|580919069|FG000|Overall Study|Lost to Follow-up|7|||
160870627|NCT00092443|580919070|FG001|Overall Study|Lost to Follow-up|3|||
160870628|NCT00092443|580919069|FG000|Overall Study|Protocol Violation|11|||
160870629|NCT00092443|580919070|FG001|Overall Study|Protocol Violation|9|||
160870630|NCT00092443|580919069|FG000|Overall Study|Withdrawal by Subject|9|||
160870631|NCT00092443|580919070|FG001|Overall Study|Withdrawal by Subject|11|||
160870632|NCT00092443|580919069|FG000|Overall Study|Moved|5|||
160870633|NCT00092443|580919070|FG001|Overall Study|Moved|5|||
160870634|NCT00092443|580919069|FG000|Overall Study|Other|17|||
160870635|NCT00092443|580919070|FG001|Overall Study|Other|13|||
160870636|NCT04717336|580919071|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
160870637|NCT04717336|580919072|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
160870638|NCT04717336|580919071|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
160870639|NCT04717336|580919072|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
160870640|NCT02039843|580919073|FG000|Randomization and Observation Period|Adverse Event|2|||
160870641|NCT02039843|580919074|FG001|Randomization and Observation Period|Adverse Event|0|||
160870642|NCT02039843|580919073|FG000|Randomization and Observation Period|Death|1|||
160870643|NCT02039843|580919074|FG001|Randomization and Observation Period|Death|0|||
160870644|NCT02039843|580919073|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
160531611|NCT01994382|579676344|FG013|Overall Study|Rolled over to Phase 2a|0|||
160870645|NCT02039843|580919074|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
160531612|NCT01994382|579676345|FG014|Overall Study|Rolled over to Phase 2a|0|||
160531613|NCT01994382|579676346|FG015|Overall Study|Rolled over to Phase 2a|0|||
160531614|NCT01994382|579676347|FG016|Overall Study|Rolled over to Phase 2a|0|||
160531615|NCT04667377|579676348|FG000|Dose Escalation Period|Other not specified below|3|||
160531616|NCT04667377|579676349|FG001|Dose Escalation Period|Other not specified below|3|||
160531617|NCT04667377|579676350|FG002|Dose Escalation Period|Other not specified below|2|||
160531618|NCT04667377|579676351|FG003|Dose Escalation Period|Other not specified below|1|||
160531619|NCT04667377|579676352|FG004|Dose Escalation Period|Other not specified below|3|||
160531620|NCT04667377|579676348|FG000|Dose Escalation Period|Protocol Violation|2|||
160531621|NCT04667377|579676349|FG001|Dose Escalation Period|Protocol Violation|2|||
160531622|NCT04667377|579676350|FG002|Dose Escalation Period|Protocol Violation|0|||
160531623|NCT04667377|579676351|FG003|Dose Escalation Period|Protocol Violation|2|||
160531624|NCT04667377|579676352|FG004|Dose Escalation Period|Protocol Violation|1|||
160531625|NCT04667377|579676348|FG000|Dose Escalation Period|Burden of study procedures|2|||
160531626|NCT04667377|579676349|FG001|Dose Escalation Period|Burden of study procedures|1|||
160531627|NCT04667377|579676350|FG002|Dose Escalation Period|Burden of study procedures|1|||
160531628|NCT04667377|579676351|FG003|Dose Escalation Period|Burden of study procedures|1|||
160531629|NCT04667377|579676352|FG004|Dose Escalation Period|Burden of study procedures|5|||
160531630|NCT04667377|579676348|FG000|Dose Escalation Period|Change of residence|0|||
160531631|NCT04667377|579676349|FG001|Dose Escalation Period|Change of residence|0|||
160531632|NCT04667377|579676350|FG002|Dose Escalation Period|Change of residence|1|||
160531633|NCT04667377|579676351|FG003|Dose Escalation Period|Change of residence|0|||
160531634|NCT04667377|579676352|FG004|Dose Escalation Period|Change of residence|0|||
160531635|NCT04667377|579676348|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
160531636|NCT04667377|579676349|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
160531637|NCT04667377|579676350|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
160531638|NCT04667377|579676351|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
160531639|NCT04667377|579676352|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
160531640|NCT04667377|579676348|FG000|Dose Escalation Period|Adverse Event|9|||
160531641|NCT04667377|579676349|FG001|Dose Escalation Period|Adverse Event|10|||
160531642|NCT04667377|579676350|FG002|Dose Escalation Period|Adverse Event|12|||
160531643|NCT04667377|579676351|FG003|Dose Escalation Period|Adverse Event|17|||
160531644|NCT04667377|579676352|FG004|Dose Escalation Period|Adverse Event|3|||
160531645|NCT04667377|579676348|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
160531646|NCT04667377|579676349|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
160531647|NCT04667377|579676350|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
160531648|NCT04667377|579676351|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
160531649|NCT04667377|579676352|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
160531650|NCT04667377|579676348|FG000|Dose Escalation Period|Not treated|1|||
160531651|NCT04667377|579676349|FG001|Dose Escalation Period|Not treated|0|||
160531652|NCT04667377|579676350|FG002|Dose Escalation Period|Not treated|0|||
160531653|NCT04667377|579676351|FG003|Dose Escalation Period|Not treated|0|||
160531654|NCT04667377|579676352|FG004|Dose Escalation Period|Not treated|0|||
160531655|NCT04667377|579676348|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
160531656|NCT04667377|579676349|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
160531657|NCT04667377|579676350|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
160531658|NCT04667377|579676351|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
160531659|NCT04667377|579676352|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
160531660|NCT04667377|579676348|FG000|Dose Escalation Period|Lost to Follow-up|0|||
160531661|NCT04667377|579676349|FG001|Dose Escalation Period|Lost to Follow-up|1|||
160531662|NCT04667377|579676350|FG002|Dose Escalation Period|Lost to Follow-up|0|||
160531663|NCT04667377|579676351|FG003|Dose Escalation Period|Lost to Follow-up|0|||
160531664|NCT04667377|579676352|FG004|Dose Escalation Period|Lost to Follow-up|0|||
160531665|NCT04667377|579676348|FG000|Maintenance Period|Perceived lack of efficacy|0|||
160531666|NCT04667377|579676349|FG001|Maintenance Period|Perceived lack of efficacy|2|||
160531667|NCT04667377|579676350|FG002|Maintenance Period|Perceived lack of efficacy|1|||
160531668|NCT04667377|579676351|FG003|Maintenance Period|Perceived lack of efficacy|0|||
160531669|NCT04667377|579676352|FG004|Maintenance Period|Perceived lack of efficacy|1|||
160531670|NCT04667377|579676348|FG000|Maintenance Period|Adverse Event|2|||
160531671|NCT04667377|579676349|FG001|Maintenance Period|Adverse Event|8|||
160531672|NCT04667377|579676350|FG002|Maintenance Period|Adverse Event|5|||
160531673|NCT04667377|579676351|FG003|Maintenance Period|Adverse Event|4|||
160531674|NCT04667377|579676352|FG004|Maintenance Period|Adverse Event|1|||
160531675|NCT04667377|579676348|FG000|Maintenance Period|Adverse event: COVID infection|0|||
160531676|NCT04667377|579676349|FG001|Maintenance Period|Adverse event: COVID infection|1|||
160531677|NCT04667377|579676350|FG002|Maintenance Period|Adverse event: COVID infection|0|||
160531678|NCT04667377|579676351|FG003|Maintenance Period|Adverse event: COVID infection|0|||
160531679|NCT04667377|579676352|FG004|Maintenance Period|Adverse event: COVID infection|0|||
160531680|NCT04667377|579676348|FG000|Maintenance Period|COVID-related|0|||
160531681|NCT04667377|579676349|FG001|Maintenance Period|COVID-related|0|||
160531682|NCT04667377|579676350|FG002|Maintenance Period|COVID-related|1|||
160531683|NCT04667377|579676351|FG003|Maintenance Period|COVID-related|1|||
160531684|NCT04667377|579676352|FG004|Maintenance Period|COVID-related|0|||
160531685|NCT04667377|579676348|FG000|Maintenance Period|Protocol Violation|1|||
160870646|NCT02039843|580919073|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
160870647|NCT02039843|580919074|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
160870648|NCT02039843|580919073|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
160870649|NCT02039843|580919074|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
160870650|NCT02039843|580919073|FG000|Pairing With a Study Dog|Death|1|||
160870651|NCT02039843|580919074|FG001|Pairing With a Study Dog|Death|0|||
160870652|NCT02039843|580919073|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
160870653|NCT02039843|580919074|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
160870654|NCT02039843|580919073|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
160870655|NCT02039843|580919074|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
160870656|NCT02039843|580919073|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
160870657|NCT02039843|580919074|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
160870658|NCT01958164|580919077|FG000|Overall Study|Adverse Event|0|||
160870659|NCT01958164|580919078|FG001|Overall Study|Adverse Event|2|||
160870660|NCT01958164|580919077|FG000|Overall Study|Lost to Follow-up|2|||
160870661|NCT01958164|580919078|FG001|Overall Study|Lost to Follow-up|3|||
160870662|NCT00740857|580919079|FG000|Overall Study|Withdrawal by Subject|1|||
160870663|NCT00740857|580919080|FG001|Overall Study|Withdrawal by Subject|0|||
160870664|NCT00740857|580919081|FG002|Overall Study|Withdrawal by Subject|0|||
160870665|NCT02963506|580919082|FG000|Double-Blind Period|Adverse Event|0|||
160870666|NCT02963506|580919083|FG001|Double-Blind Period|Adverse Event|0|||
160870667|NCT02963506|580919084|FG002|Double-Blind Period|Adverse Event|1|||
160870668|NCT02963506|580919085|FG003|Double-Blind Period|Adverse Event|0|||
160870669|NCT02963506|580919086|FG004|Double-Blind Period|Adverse Event|0|||
160870670|NCT02963506|580919087|FG005|Double-Blind Period|Adverse Event|0|||
160870671|NCT02963506|580919088|FG006|Double-Blind Period|Adverse Event|0|||
160870672|NCT02963506|580919089|FG007|Double-Blind Period|Adverse Event|0|||
160870673|NCT02963506|580919090|FG008|Double-Blind Period|Adverse Event|0|||
160870674|NCT02963506|580919091|FG009|Double-Blind Period|Adverse Event|0|||
160870675|NCT02963506|580919092|FG010|Double-Blind Period|Adverse Event|0|||
160870676|NCT02963506|580919093|FG011|Double-Blind Period|Adverse Event|0|||
160870677|NCT02963506|580919094|FG012|Double-Blind Period|Adverse Event|0|||
160870678|NCT02963506|580919082|FG000|Double-Blind Period|Death|0|||
160870679|NCT02963506|580919083|FG001|Double-Blind Period|Death|0|||
160870680|NCT02963506|580919084|FG002|Double-Blind Period|Death|0|||
160870681|NCT02963506|580919085|FG003|Double-Blind Period|Death|1|||
160870682|NCT02963506|580919086|FG004|Double-Blind Period|Death|0|||
160870683|NCT02963506|580919087|FG005|Double-Blind Period|Death|0|||
160870684|NCT02963506|580919088|FG006|Double-Blind Period|Death|0|||
160870685|NCT02963506|580919089|FG007|Double-Blind Period|Death|0|||
160870686|NCT02963506|580919090|FG008|Double-Blind Period|Death|0|||
160870687|NCT02963506|580919091|FG009|Double-Blind Period|Death|0|||
160870688|NCT02963506|580919092|FG010|Double-Blind Period|Death|0|||
160870689|NCT02963506|580919093|FG011|Double-Blind Period|Death|0|||
160870690|NCT02963506|580919094|FG012|Double-Blind Period|Death|0|||
160870691|NCT02963506|580919082|FG000|Double-Blind Period|Lost to Follow-up|0|||
160870692|NCT02963506|580919083|FG001|Double-Blind Period|Lost to Follow-up|1|||
160870693|NCT02963506|580919084|FG002|Double-Blind Period|Lost to Follow-up|0|||
160870694|NCT02963506|580919085|FG003|Double-Blind Period|Lost to Follow-up|0|||
160870695|NCT02963506|580919086|FG004|Double-Blind Period|Lost to Follow-up|0|||
160870696|NCT02963506|580919087|FG005|Double-Blind Period|Lost to Follow-up|0|||
160870697|NCT02963506|580919088|FG006|Double-Blind Period|Lost to Follow-up|0|||
160870698|NCT02963506|580919089|FG007|Double-Blind Period|Lost to Follow-up|0|||
160870699|NCT02963506|580919090|FG008|Double-Blind Period|Lost to Follow-up|0|||
160870700|NCT02963506|580919091|FG009|Double-Blind Period|Lost to Follow-up|0|||
160870701|NCT02963506|580919092|FG010|Double-Blind Period|Lost to Follow-up|0|||
160870702|NCT02963506|580919093|FG011|Double-Blind Period|Lost to Follow-up|0|||
160870703|NCT02963506|580919094|FG012|Double-Blind Period|Lost to Follow-up|0|||
160870704|NCT02963506|580919082|FG000|Double-Blind Period|Withdrawal by Subject|0|||
160870705|NCT02963506|580919083|FG001|Double-Blind Period|Withdrawal by Subject|0|||
160870706|NCT02963506|580919084|FG002|Double-Blind Period|Withdrawal by Subject|1|||
160870707|NCT02963506|580919085|FG003|Double-Blind Period|Withdrawal by Subject|1|||
160870708|NCT02963506|580919086|FG004|Double-Blind Period|Withdrawal by Subject|0|||
160870709|NCT02963506|580919087|FG005|Double-Blind Period|Withdrawal by Subject|0|||
160870710|NCT02963506|580919088|FG006|Double-Blind Period|Withdrawal by Subject|0|||
160870711|NCT02963506|580919089|FG007|Double-Blind Period|Withdrawal by Subject|0|||
160870712|NCT02963506|580919090|FG008|Double-Blind Period|Withdrawal by Subject|0|||
160870713|NCT02963506|580919091|FG009|Double-Blind Period|Withdrawal by Subject|0|||
160870714|NCT02963506|580919092|FG010|Double-Blind Period|Withdrawal by Subject|0|||
160870715|NCT02963506|580919093|FG011|Double-Blind Period|Withdrawal by Subject|0|||
160870716|NCT02963506|580919094|FG012|Double-Blind Period|Withdrawal by Subject|0|||
160870717|NCT02963506|580919082|FG000|Double-Blind Period|No compliance|0|||
160870718|NCT02963506|580919083|FG001|Double-Blind Period|No compliance|1|||
160870719|NCT02963506|580919084|FG002|Double-Blind Period|No compliance|0|||
160870720|NCT02963506|580919085|FG003|Double-Blind Period|No compliance|0|||
160870721|NCT02963506|580919086|FG004|Double-Blind Period|No compliance|0|||
160870722|NCT02963506|580919087|FG005|Double-Blind Period|No compliance|0|||
160870723|NCT02963506|580919088|FG006|Double-Blind Period|No compliance|0|||
160870724|NCT02963506|580919089|FG007|Double-Blind Period|No compliance|0|||
160870725|NCT02963506|580919090|FG008|Double-Blind Period|No compliance|0|||
160870726|NCT02963506|580919091|FG009|Double-Blind Period|No compliance|0|||
160870727|NCT02963506|580919092|FG010|Double-Blind Period|No compliance|0|||
160870728|NCT02963506|580919093|FG011|Double-Blind Period|No compliance|0|||
160870729|NCT02963506|580919094|FG012|Double-Blind Period|No compliance|0|||
160870730|NCT02963506|580919082|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870731|NCT02963506|580919083|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
160870732|NCT02963506|580919084|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870733|NCT02963506|580919085|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870734|NCT02963506|580919086|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870735|NCT02963506|580919087|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870736|NCT02963506|580919088|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870737|NCT02963506|580919089|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870738|NCT02963506|580919090|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870739|NCT02963506|580919091|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870740|NCT02963506|580919092|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870741|NCT02963506|580919093|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870742|NCT02963506|580919094|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870743|NCT02963506|580919082|FG000|Dose-Blind Period|Adverse Event|0|||
160870744|NCT02963506|580919083|FG001|Dose-Blind Period|Adverse Event|0|||
160870745|NCT02963506|580919084|FG002|Dose-Blind Period|Adverse Event|0|||
160870746|NCT02963506|580919085|FG003|Dose-Blind Period|Adverse Event|0|||
160870747|NCT02963506|580919086|FG004|Dose-Blind Period|Adverse Event|0|||
160870748|NCT02963506|580919087|FG005|Dose-Blind Period|Adverse Event|1|||
160870749|NCT02963506|580919088|FG006|Dose-Blind Period|Adverse Event|3|||
160870750|NCT02963506|580919089|FG007|Dose-Blind Period|Adverse Event|2|||
160870751|NCT02963506|580919090|FG008|Dose-Blind Period|Adverse Event|2|||
160870752|NCT02963506|580919091|FG009|Dose-Blind Period|Adverse Event|2|||
160870753|NCT02963506|580919092|FG010|Dose-Blind Period|Adverse Event|1|||
160870754|NCT02963506|580919093|FG011|Dose-Blind Period|Adverse Event|1|||
160870755|NCT02963506|580919094|FG012|Dose-Blind Period|Adverse Event|6|||
160870756|NCT02963506|580919082|FG000|Dose-Blind Period|Lack of Efficacy|0|||
160870757|NCT02963506|580919083|FG001|Dose-Blind Period|Lack of Efficacy|0|||
160870758|NCT02963506|580919084|FG002|Dose-Blind Period|Lack of Efficacy|0|||
160870759|NCT02963506|580919085|FG003|Dose-Blind Period|Lack of Efficacy|0|||
160870760|NCT02963506|580919086|FG004|Dose-Blind Period|Lack of Efficacy|0|||
160870761|NCT02963506|580919087|FG005|Dose-Blind Period|Lack of Efficacy|0|||
160870762|NCT02963506|580919088|FG006|Dose-Blind Period|Lack of Efficacy|0|||
160870763|NCT02963506|580919089|FG007|Dose-Blind Period|Lack of Efficacy|1|||
160870764|NCT02963506|580919090|FG008|Dose-Blind Period|Lack of Efficacy|0|||
160870765|NCT02963506|580919091|FG009|Dose-Blind Period|Lack of Efficacy|1|||
160870766|NCT02963506|580919092|FG010|Dose-Blind Period|Lack of Efficacy|0|||
160870767|NCT02963506|580919093|FG011|Dose-Blind Period|Lack of Efficacy|0|||
160870768|NCT02963506|580919094|FG012|Dose-Blind Period|Lack of Efficacy|0|||
160870769|NCT02963506|580919082|FG000|Dose-Blind Period|Lost to Follow-up|0|||
160870770|NCT02963506|580919083|FG001|Dose-Blind Period|Lost to Follow-up|0|||
160870771|NCT02963506|580919084|FG002|Dose-Blind Period|Lost to Follow-up|0|||
160870772|NCT02963506|580919085|FG003|Dose-Blind Period|Lost to Follow-up|0|||
160870773|NCT02963506|580919086|FG004|Dose-Blind Period|Lost to Follow-up|0|||
160870774|NCT02963506|580919087|FG005|Dose-Blind Period|Lost to Follow-up|1|||
160870775|NCT02963506|580919088|FG006|Dose-Blind Period|Lost to Follow-up|0|||
160870776|NCT02963506|580919089|FG007|Dose-Blind Period|Lost to Follow-up|0|||
160870777|NCT02963506|580919090|FG008|Dose-Blind Period|Lost to Follow-up|1|||
160870778|NCT02963506|580919091|FG009|Dose-Blind Period|Lost to Follow-up|0|||
160870779|NCT02963506|580919092|FG010|Dose-Blind Period|Lost to Follow-up|0|||
160870780|NCT02963506|580919093|FG011|Dose-Blind Period|Lost to Follow-up|1|||
160870781|NCT02963506|580919094|FG012|Dose-Blind Period|Lost to Follow-up|0|||
160870782|NCT02963506|580919082|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
160870783|NCT02963506|580919083|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
160870784|NCT02963506|580919084|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
160870785|NCT02963506|580919085|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
160870786|NCT02963506|580919086|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
160870787|NCT02963506|580919087|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
160870788|NCT02963506|580919088|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
160870789|NCT02963506|580919089|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
160870790|NCT02963506|580919090|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
160870791|NCT02963506|580919091|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
160870792|NCT02963506|580919092|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
160870793|NCT02963506|580919093|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
160870794|NCT02963506|580919094|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
160870795|NCT02963506|580919082|FG000|Dose-Blind Period|Sponsor decision|0|||
160870796|NCT02963506|580919083|FG001|Dose-Blind Period|Sponsor decision|0|||
160870797|NCT02963506|580919084|FG002|Dose-Blind Period|Sponsor decision|0|||
160870798|NCT02963506|580919085|FG003|Dose-Blind Period|Sponsor decision|0|||
160870799|NCT02963506|580919086|FG004|Dose-Blind Period|Sponsor decision|0|||
160870800|NCT02963506|580919087|FG005|Dose-Blind Period|Sponsor decision|1|||
160870801|NCT02963506|580919088|FG006|Dose-Blind Period|Sponsor decision|0|||
160870802|NCT02963506|580919089|FG007|Dose-Blind Period|Sponsor decision|0|||
160870803|NCT02963506|580919090|FG008|Dose-Blind Period|Sponsor decision|0|||
160870804|NCT02963506|580919091|FG009|Dose-Blind Period|Sponsor decision|0|||
160870805|NCT02963506|580919092|FG010|Dose-Blind Period|Sponsor decision|0|||
160870806|NCT02963506|580919093|FG011|Dose-Blind Period|Sponsor decision|0|||
160870807|NCT02963506|580919094|FG012|Dose-Blind Period|Sponsor decision|0|||
160870808|NCT02963506|580919082|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870809|NCT02963506|580919083|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870810|NCT02963506|580919084|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870811|NCT02963506|580919085|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870812|NCT02963506|580919086|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870813|NCT02963506|580919087|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870814|NCT02963506|580919088|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870815|NCT02963506|580919089|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870816|NCT02963506|580919090|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870817|NCT02963506|580919091|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870818|NCT02963506|580919092|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870819|NCT02963506|580919093|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870820|NCT02963506|580919094|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
160870821|NCT01724346|580919095|FG000|Overall Study|Death|42|||
160870822|NCT01724346|580919096|FG001|Overall Study|Death|42|||
160870823|NCT01724346|580919095|FG000|Overall Study|Lost to Follow-up|5|||
160870824|NCT01724346|580919096|FG001|Overall Study|Lost to Follow-up|1|||
160870825|NCT01724346|580919095|FG000|Overall Study|Withdrawal by Subject|27|||
160870826|NCT01724346|580919096|FG001|Overall Study|Withdrawal by Subject|19|||
160870827|NCT01724346|580919095|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
160870828|NCT01724346|580919096|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
160870829|NCT00525161|580919099|FG000|Overall Study|Adverse Event|1|||
160870830|NCT01076361|580919100|FG000|Overall Study|22 leads were excluded from analysis|21|||
160870831|NCT00943072|580921111|FG000|Overall Study|Adverse Event|0|||
160870832|NCT00943072|580921112|FG001|Overall Study|Adverse Event|3|||
160870833|NCT00943072|580921111|FG000|Overall Study|Death|0|||
160870834|NCT00943072|580921112|FG001|Overall Study|Death|2|||
160870835|NCT00943072|580921111|FG000|Overall Study|Withdrawal by Subject|3|||
160870836|NCT00943072|580921112|FG001|Overall Study|Withdrawal by Subject|1|||
160870837|NCT00943072|580921111|FG000|Overall Study|Protocol Violation|0|||
160870838|NCT00943072|580921112|FG001|Overall Study|Protocol Violation|1|||
160870839|NCT00943072|580921111|FG000|Overall Study|Lost to Follow-up|1|||
160870840|NCT00943072|580921112|FG001|Overall Study|Lost to Follow-up|2|||
160870841|NCT00943072|580921111|FG000|Overall Study|Lack of Efficacy|0|||
160870842|NCT00943072|580921112|FG001|Overall Study|Lack of Efficacy|4|||
160870843|NCT00943072|580921111|FG000|Overall Study|Other|1|||
160870844|NCT00943072|580921112|FG001|Overall Study|Other|1|||
160870845|NCT00423917|580921113|FG000|Overall Study|Cancel|2|||
160870846|NCT00423917|580921113|FG000|Overall Study|Ineligible|1|||
160870847|NCT00555061|580921114|FG000|Overall Study|Adverse Event|3|||
160870848|NCT00555061|580921114|FG000|Overall Study|Protocol Violation|1|||
160870849|NCT00555061|580921114|FG000|Overall Study|Lost to Follow-up|2|||
160870850|NCT00555061|580921114|FG000|Overall Study|Withdrawal by Subject|2|||
160870851|NCT00555061|580921114|FG000|Overall Study|Participant enrolled, but never treated|1|||
160870852|NCT01175083|580921115|FG000|Primary Epoch|Withdrawal by Subject|0|||
160870853|NCT01175083|580921116|FG001|Primary Epoch|Withdrawal by Subject|0|||
160870854|NCT01175083|580921117|FG002|Primary Epoch|Withdrawal by Subject|0|||
160870855|NCT01175083|580921118|FG003|Primary Epoch|Withdrawal by Subject|0|||
160870856|NCT01175083|580921119|FG004|Primary Epoch|Withdrawal by Subject|0|||
160870857|NCT01175083|580921120|FG005|Primary Epoch|Withdrawal by Subject|2|||
160870858|NCT01175083|580921115|FG000|Primary Epoch|Lost to Follow-up|0|||
160870859|NCT01175083|580921116|FG001|Primary Epoch|Lost to Follow-up|0|||
160870860|NCT01175083|580921117|FG002|Primary Epoch|Lost to Follow-up|0|||
160870861|NCT01175083|580921118|FG003|Primary Epoch|Lost to Follow-up|0|||
160870862|NCT01175083|580921119|FG004|Primary Epoch|Lost to Follow-up|0|||
160870863|NCT01175083|580921120|FG005|Primary Epoch|Lost to Follow-up|1|||
160870864|NCT01175083|580921115|FG000|Booster Epoch|Death|0|||
160870865|NCT01175083|580921116|FG001|Booster Epoch|Death|0|||
160870866|NCT01175083|580921117|FG002|Booster Epoch|Death|1|||
160870867|NCT01175083|580921118|FG003|Booster Epoch|Death|0|||
160870868|NCT01175083|580921119|FG004|Booster Epoch|Death|0|||
160870869|NCT01175083|580921120|FG005|Booster Epoch|Death|0|||
160870870|NCT01175083|580921115|FG000|Booster Epoch|Withdrawal by Subject|0|||
160870871|NCT01175083|580921116|FG001|Booster Epoch|Withdrawal by Subject|0|||
160870872|NCT01175083|580921117|FG002|Booster Epoch|Withdrawal by Subject|0|||
160870873|NCT01175083|580921118|FG003|Booster Epoch|Withdrawal by Subject|1|||
160870874|NCT01175083|580921119|FG004|Booster Epoch|Withdrawal by Subject|0|||
160870875|NCT01175083|580921120|FG005|Booster Epoch|Withdrawal by Subject|0|||
160870876|NCT02881567|580921121|FG000|Overall Study|Adverse Event|1|||
160870877|NCT02881567|580921121|FG000|Overall Study|Lost to Follow-up|3|||
160870878|NCT02881567|580921121|FG000|Overall Study|Consent withdrawn|1|||
160870879|NCT02881567|580921121|FG000|Overall Study|Investigator decision|1|||
160870880|NCT02881567|580921121|FG000|Overall Study|Study terminated by sponsor|9|||
160870881|NCT02881567|580921121|FG000|Overall Study|Reason not Specified|3|||
160870882|NCT00373113|580921123|FG000|Overall Study|Death|1|||
160870883|NCT00373113|580921124|FG001|Overall Study|Death|7|||
160870884|NCT00373113|580921123|FG000|Overall Study|Adverse Event|38|||
160870885|NCT00373113|580921124|FG001|Overall Study|Adverse Event|24|||
160870886|NCT00373113|580921123|FG000|Overall Study|Study terminated by sponsor|9|||
160870887|NCT00373113|580921124|FG001|Overall Study|Study terminated by sponsor|1|||
160870888|NCT00373113|580921123|FG000|Overall Study|Global deterioration of health status|10|||
160870889|NCT00373113|580921124|FG001|Overall Study|Global deterioration of health status|7|||
160870890|NCT00373113|580921123|FG000|Overall Study|Lost to Follow-up|1|||
160870891|NCT00373113|580921124|FG001|Overall Study|Lost to Follow-up|3|||
160870892|NCT00373113|580921123|FG000|Overall Study|Objective progression or relapse|150|||
160870893|NCT00373113|580921124|FG001|Overall Study|Objective progression or relapse|169|||
160870894|NCT00373113|580921123|FG000|Overall Study|Other|14|||
160870895|NCT00373113|580921124|FG001|Overall Study|Other|17|||
160870896|NCT00373113|580921123|FG000|Overall Study|Protocol Violation|5|||
160870897|NCT00373113|580921124|FG001|Overall Study|Protocol Violation|1|||
160870898|NCT00373113|580921123|FG000|Overall Study|Withdrawal by Subject|10|||
160870899|NCT00373113|580921124|FG001|Overall Study|Withdrawal by Subject|15|||
160870900|NCT03275350|580921125|FG000|Overall Study|Lost to Follow-up|4|||
160870901|NCT03275350|580921126|FG001|Overall Study|Lost to Follow-up|6|||
160870902|NCT03275350|580921125|FG000|Overall Study|Death|2|||
160870903|NCT03275350|580921126|FG001|Overall Study|Death|1|||
160870904|NCT03275350|580921125|FG000|Overall Study|Physician Decision|1|||
160870905|NCT03275350|580921126|FG001|Overall Study|Physician Decision|0|||
160870906|NCT03275350|580921125|FG000|Overall Study|Incarcerated|1|||
160870907|NCT03275350|580921126|FG001|Overall Study|Incarcerated|1|||
160870908|NCT03656562|580921127|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
160870909|NCT03656562|580921128|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
160870910|NCT03656562|580921129|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
160870911|NCT03656562|580921130|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
160870912|NCT03656562|580921127|FG000|Overall Study|Physician Decision|1|||
160870913|NCT03656562|580921128|FG001|Overall Study|Physician Decision|2|||
160870914|NCT03656562|580921129|FG002|Overall Study|Physician Decision|0|||
160870915|NCT03656562|580921130|FG003|Overall Study|Physician Decision|0|||
160870916|NCT03656562|580921127|FG000|Overall Study|Subject Decision|3|||
160870917|NCT03656562|580921128|FG001|Overall Study|Subject Decision|5|||
160870918|NCT03656562|580921129|FG002|Overall Study|Subject Decision|0|||
160870919|NCT03656562|580921130|FG003|Overall Study|Subject Decision|2|||
160870920|NCT00905645|580921131|FG000|Overall Study|Death (not device related)|10|||
160870921|NCT00905645|580921132|FG001|Overall Study|Death (not device related)|4|||
160870922|NCT00905645|580921133|FG002|Overall Study|Death (not device related)|15|||
160870923|NCT00905645|580921134|FG003|Overall Study|Death (not device related)|8|||
160870924|NCT00905645|580921131|FG000|Overall Study|Explantation of study device(s)|78|||
160870925|NCT00905645|580921132|FG001|Overall Study|Explantation of study device(s)|47|||
160870926|NCT00905645|580921133|FG002|Overall Study|Explantation of study device(s)|28|||
160870927|NCT00905645|580921134|FG003|Overall Study|Explantation of study device(s)|21|||
160870928|NCT00905645|580921131|FG000|Overall Study|Subject Request|41|||
160870929|NCT00905645|580921132|FG001|Overall Study|Subject Request|17|||
160870930|NCT00905645|580921133|FG002|Overall Study|Subject Request|13|||
160870931|NCT00905645|580921134|FG003|Overall Study|Subject Request|11|||
160870932|NCT00905645|580921131|FG000|Overall Study|Lost to Follow-up|299|||
160870933|NCT00905645|580921132|FG001|Overall Study|Lost to Follow-up|103|||
160870934|NCT00905645|580921133|FG002|Overall Study|Lost to Follow-up|51|||
160870935|NCT00905645|580921134|FG003|Overall Study|Lost to Follow-up|12|||
160870936|NCT01386970|580921135|FG000|Overall Study|Withdrawal by Subject|0|||
160870937|NCT01386970|580921136|FG001|Overall Study|Withdrawal by Subject|1|||
160870938|NCT01386970|580921135|FG000|Overall Study|Adverse Event|4|||
160870939|NCT01386970|580921136|FG001|Overall Study|Adverse Event|1|||
160870940|NCT04269265|580921137|FG000|Overall Study|Physician Decision|1|||
160870941|NCT04269265|580921137|FG000|Overall Study|Withdrawal by Subject|1|||
160870942|NCT04269265|580921137|FG000|Overall Study|Overenrolled (sample size reached)|4|||
160870943|NCT04439136|580921138|FG000|Overall Study|Ineligible|1|||
160870944|NCT04439136|580921138|FG000|Overall Study|Never Started Treatment|2|||
160870945|NCT04439136|580921138|FG000|Overall Study|Adverse Event|4|||
160870946|NCT04439136|580921138|FG000|Overall Study|Death|3|||
160870947|NCT04439136|580921138|FG000|Overall Study|Disease Progression|27|||
160870948|NCT04439136|580921138|FG000|Overall Study|Alternative Therapy|1|||
160870949|NCT04439136|580921138|FG000|Overall Study|Increased Tumor Burden|1|||
160870950|NCT04439136|580921138|FG000|Overall Study|Symptomatic Detrioration|1|||
160870951|NCT04693234|580921139|FG000|Overall Study|Death|79|||
160870952|NCT04693234|580921140|FG001|Overall Study|Death|19|||
160870953|NCT04693234|580921139|FG000|Overall Study|Sponsor Ended Study|47|||
160870954|NCT04693234|580921140|FG001|Overall Study|Sponsor Ended Study|18|||
160870955|NCT04693234|580921139|FG000|Overall Study|Withdrawal by Subject|10|||
160870956|NCT04693234|580921140|FG001|Overall Study|Withdrawal by Subject|2|||
160870957|NCT04693234|580921139|FG000|Overall Study|Lost to Follow-up|2|||
160870958|NCT04693234|580921140|FG001|Overall Study|Lost to Follow-up|1|||
160870959|NCT02578706|580921143|FG000|Overall Study|Withdrawal by Subject|1|||
160870960|NCT02578706|580921144|FG001|Overall Study|Withdrawal by Subject|0|||
160870961|NCT02578706|580921145|FG002|Overall Study|Withdrawal by Subject|0|||
160870962|NCT02578706|580921143|FG000|Overall Study|Lost to Follow-up|0|||
160870963|NCT02578706|580921144|FG001|Overall Study|Lost to Follow-up|4|||
160870964|NCT02578706|580921145|FG002|Overall Study|Lost to Follow-up|0|||
160870965|NCT02578706|580921143|FG000|Overall Study|Physician Decision|0|||
160870966|NCT02578706|580921144|FG001|Overall Study|Physician Decision|1|||
160870967|NCT02578706|580921145|FG002|Overall Study|Physician Decision|0|||
160870968|NCT00578292|580921146|FG000|Overall Study|Death|1|||
160870969|NCT00578292|580921146|FG000|Overall Study|Graft failure|2|||
160870970|NCT03901469|580921147|FG000|Overall Study|Radiographic Progression|4|||
160870971|NCT03901469|580921148|FG001|Overall Study|Radiographic Progression|6|||
160870972|NCT03901469|580921149|FG002|Overall Study|Radiographic Progression|3|||
160870973|NCT03901469|580921150|FG003|Overall Study|Radiographic Progression|30|||
160870974|NCT03901469|580921151|FG004|Overall Study|Radiographic Progression|7|||
160870975|NCT03901469|580921152|FG005|Overall Study|Radiographic Progression|2|||
160870976|NCT03901469|580921153|FG006|Overall Study|Radiographic Progression|11|||
160870977|NCT03901469|580921147|FG000|Overall Study|Clinical Progression|0|||
160870978|NCT03901469|580921148|FG001|Overall Study|Clinical Progression|2|||
160870979|NCT03901469|580921149|FG002|Overall Study|Clinical Progression|0|||
160870980|NCT03901469|580921150|FG003|Overall Study|Clinical Progression|7|||
160870981|NCT03901469|580921151|FG004|Overall Study|Clinical Progression|6|||
160870982|NCT03901469|580921152|FG005|Overall Study|Clinical Progression|0|||
160870983|NCT03901469|580921153|FG006|Overall Study|Clinical Progression|2|||
160870984|NCT03901469|580921147|FG000|Overall Study|Adverse Event|1|||
160870985|NCT03901469|580921148|FG001|Overall Study|Adverse Event|0|||
160870986|NCT03901469|580921149|FG002|Overall Study|Adverse Event|0|||
160870987|NCT03901469|580921150|FG003|Overall Study|Adverse Event|0|||
160870988|NCT03901469|580921151|FG004|Overall Study|Adverse Event|0|||
160870989|NCT03901469|580921152|FG005|Overall Study|Adverse Event|0|||
160870990|NCT03901469|580921153|FG006|Overall Study|Adverse Event|9|||
160870991|NCT03901469|580921147|FG000|Overall Study|Physician Decision|0|||
160870992|NCT03901469|580921148|FG001|Overall Study|Physician Decision|0|||
160870993|NCT03901469|580921149|FG002|Overall Study|Physician Decision|0|||
160870994|NCT03901469|580921150|FG003|Overall Study|Physician Decision|1|||
160870995|NCT03901469|580921151|FG004|Overall Study|Physician Decision|0|||
160870996|NCT03901469|580921152|FG005|Overall Study|Physician Decision|0|||
160870997|NCT03901469|580921153|FG006|Overall Study|Physician Decision|0|||
160870998|NCT03901469|580921147|FG000|Overall Study|Withdrawal by Subject|0|||
160870999|NCT03901469|580921148|FG001|Overall Study|Withdrawal by Subject|0|||
160871000|NCT03901469|580921149|FG002|Overall Study|Withdrawal by Subject|0|||
160871001|NCT03901469|580921150|FG003|Overall Study|Withdrawal by Subject|0|||
160871002|NCT03901469|580921151|FG004|Overall Study|Withdrawal by Subject|2|||
160871003|NCT03901469|580921152|FG005|Overall Study|Withdrawal by Subject|0|||
160871004|NCT03901469|580921153|FG006|Overall Study|Withdrawal by Subject|8|||
160871005|NCT03901469|580921147|FG000|Overall Study|Death|0|||
160871006|NCT03901469|580921148|FG001|Overall Study|Death|0|||
160871007|NCT03901469|580921149|FG002|Overall Study|Death|0|||
160871008|NCT03901469|580921150|FG003|Overall Study|Death|3|||
160871009|NCT03901469|580921151|FG004|Overall Study|Death|5|||
160871010|NCT03901469|580921152|FG005|Overall Study|Death|0|||
160871011|NCT03901469|580921153|FG006|Overall Study|Death|1|||
160871012|NCT03901469|580921147|FG000|Overall Study|Termination of study by sponsor|0|||
160871013|NCT03901469|580921148|FG001|Overall Study|Termination of study by sponsor|0|||
160871014|NCT03901469|580921149|FG002|Overall Study|Termination of study by sponsor|0|||
160871015|NCT03901469|580921150|FG003|Overall Study|Termination of study by sponsor|0|||
160871016|NCT03901469|580921151|FG004|Overall Study|Termination of study by sponsor|1|||
160871017|NCT03901469|580921152|FG005|Overall Study|Termination of study by sponsor|1|||
160871018|NCT03901469|580921153|FG006|Overall Study|Termination of study by sponsor|0|||
160871019|NCT03901469|580921147|FG000|Overall Study|Not Reported|1|||
160871020|NCT03901469|580921148|FG001|Overall Study|Not Reported|0|||
160871021|NCT03901469|580921149|FG002|Overall Study|Not Reported|0|||
160871022|NCT03901469|580921150|FG003|Overall Study|Not Reported|1|||
160871023|NCT03901469|580921151|FG004|Overall Study|Not Reported|0|||
160871024|NCT03901469|580921152|FG005|Overall Study|Not Reported|0|||
160871025|NCT03901469|580921153|FG006|Overall Study|Not Reported|1|||
160871026|NCT01662102|580921159|FG000|Overall Study|Sponsor's decision|1|||
160871027|NCT01662102|580921160|FG001|Overall Study|Sponsor's decision|0|||
160871028|NCT02586207|580921161|FG000|Overall Study|Physician Decision|1|||
160871029|NCT02586207|580921161|FG000|Overall Study|Withdrawal by Subject|1|||
160871030|NCT00392769|580921163|FG000|Overall Study|Clinical Deterioration|9|||
160871031|NCT00392769|580921163|FG000|Overall Study|Adverse Event|1|||
160871032|NCT00439517|580921165|FG000|Overall Study|Subject on treatment|1|||
160871033|NCT00439517|580921166|FG001|Overall Study|Subject on treatment|0|||
160871034|NCT00439517|580921165|FG000|Overall Study|Subject in survival follow-up|1|||
160871035|NCT00439517|580921166|FG001|Overall Study|Subject in survival follow-up|0|||
160871036|NCT01077076|580921169|FG000|First Intervention|Withdrawal by Subject|1|||
160871037|NCT01077076|580921170|FG001|First Intervention|Withdrawal by Subject|0|||
160871038|NCT01077076|580921171|FG002|First Intervention|Withdrawal by Subject|0|||
160871039|NCT01077076|580921172|FG003|First Intervention|Withdrawal by Subject|0|||
160871040|NCT01077076|580921173|FG004|First Intervention|Withdrawal by Subject|0|||
160871041|NCT01077076|580921174|FG005|First Intervention|Withdrawal by Subject|0|||
160871042|NCT01077076|580921169|FG000|Third Intervention|Death in the participant's family|0|||
160871043|NCT01077076|580921170|FG001|Third Intervention|Death in the participant's family|0|||
160871044|NCT01077076|580921171|FG002|Third Intervention|Death in the participant's family|0|||
160871045|NCT01077076|580921172|FG003|Third Intervention|Death in the participant's family|0|||
160871046|NCT01077076|580921173|FG004|Third Intervention|Death in the participant's family|0|||
160871047|NCT01077076|580921174|FG005|Third Intervention|Death in the participant's family|1|||
160871048|NCT00060840|580921177|FG000|Overall Study|Change in surgical plan|2|||
160871049|NCT00060840|580921178|FG001|Overall Study|Change in surgical plan|6|||
160871050|NCT00060840|580921177|FG000|Overall Study|Death|0|||
160871051|NCT00060840|580921178|FG001|Overall Study|Death|1|||
160871052|NCT00060840|580921177|FG000|Overall Study|Withdrawal by Subject|0|||
160871053|NCT00060840|580921178|FG001|Overall Study|Withdrawal by Subject|1|||
160871054|NCT00060840|580921177|FG000|Overall Study|Subinvestigator unavailable|0|||
160871055|NCT00060840|580921178|FG001|Overall Study|Subinvestigator unavailable|1|||
160871056|NCT00060840|580921177|FG000|Overall Study|Physician Decision|1|||
160871057|NCT00060840|580921178|FG001|Overall Study|Physician Decision|0|||
160871058|NCT00060840|580921177|FG000|Overall Study|Other|1|||
160871059|NCT00060840|580921178|FG001|Overall Study|Other|0|||
160871060|NCT01388335|580921179|FG000|Period 1|Progressive Disease|1|||
160871061|NCT01388335|580921179|FG000|Period 2|Progressive Disease|2|||
160871062|NCT01388335|580921179|FG000|Period 2|Sponsor Decision|1|||
160871063|NCT01388335|580921179|FG000|Safety Extension|Progressive Disease|7|||
160871064|NCT01415882|580921180|FG000|Overall Study|Ineligible|1|||
160871065|NCT01415882|580921181|FG001|Overall Study|Ineligible|0|||
160871066|NCT01415882|580921182|FG002|Overall Study|Ineligible|0|||
160871067|NCT01415882|580921183|FG003|Overall Study|Ineligible|3|||
160871068|NCT01415882|580921184|FG004|Overall Study|Ineligible|0|||
160871069|NCT01415882|580921180|FG000|Overall Study|Withdrawal by Subject|0|||
160871070|NCT01415882|580921181|FG001|Overall Study|Withdrawal by Subject|1|||
160871071|NCT01415882|580921182|FG002|Overall Study|Withdrawal by Subject|0|||
160871072|NCT01415882|580921183|FG003|Overall Study|Withdrawal by Subject|1|||
160871073|NCT01415882|580921184|FG004|Overall Study|Withdrawal by Subject|0|||
160871074|NCT00976560|580921185|FG000|Overall Study|Adverse Event|5|||
160871075|NCT00976560|580921186|FG001|Overall Study|Adverse Event|5|||
160871076|NCT00976560|580921185|FG000|Overall Study|Lack of Efficacy|3|||
160871077|NCT00976560|580921186|FG001|Overall Study|Lack of Efficacy|5|||
160871078|NCT00976560|580921185|FG000|Overall Study|Protocol Violation|1|||
160871079|NCT00976560|580921186|FG001|Overall Study|Protocol Violation|0|||
160871080|NCT00976560|580921185|FG000|Overall Study|Lost to Follow-up|1|||
160871081|NCT00976560|580921186|FG001|Overall Study|Lost to Follow-up|0|||
160871082|NCT00976560|580921185|FG000|Overall Study|Physician Decision|2|||
160871083|NCT00976560|580921186|FG001|Overall Study|Physician Decision|0|||
160871084|NCT00976560|580921185|FG000|Overall Study|Withdrawal by Subject|2|||
160871085|NCT00976560|580921186|FG001|Overall Study|Withdrawal by Subject|3|||
160871086|NCT00125164|580921189|FG000|Overall Study|Adverse Event|0|||
160871087|NCT00125164|580921190|FG001|Overall Study|Adverse Event|0|||
160871088|NCT00125164|580921191|FG002|Overall Study|Adverse Event|2|||
160871089|NCT00125164|580921192|FG003|Overall Study|Adverse Event|4|||
160871090|NCT00125164|580921189|FG000|Overall Study|Lost to Follow-up|0|||
160871091|NCT00125164|580921190|FG001|Overall Study|Lost to Follow-up|0|||
160871092|NCT00125164|580921191|FG002|Overall Study|Lost to Follow-up|1|||
160871093|NCT00125164|580921192|FG003|Overall Study|Lost to Follow-up|1|||
160871094|NCT00125164|580921189|FG000|Overall Study|Withdrawal by Subject|2|||
160871095|NCT00125164|580921190|FG001|Overall Study|Withdrawal by Subject|0|||
160871096|NCT00125164|580921191|FG002|Overall Study|Withdrawal by Subject|1|||
160871097|NCT00125164|580921192|FG003|Overall Study|Withdrawal by Subject|1|||
160871098|NCT01339052|580921196|FG000|Overall Study|Disease progression|13|||
160871099|NCT01339052|580921197|FG001|Overall Study|Disease progression|46|||
160871100|NCT01339052|580921196|FG000|Overall Study|Adverse Event|1|||
160871101|NCT01339052|580921197|FG001|Overall Study|Adverse Event|1|||
160871102|NCT01339052|580921196|FG000|Overall Study|Withdrawal by Subject|0|||
160871103|NCT01339052|580921197|FG001|Overall Study|Withdrawal by Subject|3|||
160871104|NCT01339052|580921196|FG000|Overall Study|Physician Decision|1|||
160871105|NCT01339052|580921197|FG001|Overall Study|Physician Decision|0|||
160871106|NCT01301027|580921200|FG000|Overall Study|Physician Decision|2|||
160871107|NCT01301027|580921201|FG001|Overall Study|Physician Decision|0|||
160531686|NCT04667377|579676349|FG001|Maintenance Period|Protocol Violation|0|||
160531687|NCT04667377|579676350|FG002|Maintenance Period|Protocol Violation|0|||
160531688|NCT04667377|579676351|FG003|Maintenance Period|Protocol Violation|0|||
160871108|NCT01301027|580921200|FG000|Overall Study|Withdrawal by Subject|2|||
160531689|NCT04667377|579676352|FG004|Maintenance Period|Protocol Violation|1|||
160531690|NCT04667377|579676348|FG000|Maintenance Period|Burden of study procedures|1|||
160531691|NCT04667377|579676349|FG001|Maintenance Period|Burden of study procedures|2|||
160531692|NCT04667377|579676350|FG002|Maintenance Period|Burden of study procedures|0|||
160531693|NCT04667377|579676351|FG003|Maintenance Period|Burden of study procedures|1|||
160531694|NCT04667377|579676352|FG004|Maintenance Period|Burden of study procedures|0|||
160531695|NCT04667377|579676348|FG000|Maintenance Period|Change of residence|0|||
160531696|NCT04667377|579676349|FG001|Maintenance Period|Change of residence|1|||
160871109|NCT01301027|580921201|FG001|Overall Study|Withdrawal by Subject|3|||
160871110|NCT01301027|580921200|FG000|Overall Study|Adverse Event|0|||
160871111|NCT01301027|580921201|FG001|Overall Study|Adverse Event|2|||
160871112|NCT01301027|580921200|FG000|Overall Study|Fracture|1|||
160871113|NCT01301027|580921201|FG001|Overall Study|Fracture|3|||
160871114|NCT01301027|580921200|FG000|Overall Study|Transplant|0|||
160871115|NCT01301027|580921201|FG001|Overall Study|Transplant|2|||
160871116|NCT01301027|580921200|FG000|Overall Study|Volume Overload|3|||
160871117|NCT01301027|580921201|FG001|Overall Study|Volume Overload|0|||
160871118|NCT04939415|580921202|FG000|Overall Study|Withdrawal by Subject|1|||
160871119|NCT04939415|580921203|FG001|Overall Study|Withdrawal by Subject|3|||
160871120|NCT04939415|580921202|FG000|Overall Study|Lost to Follow-up|0|||
160871121|NCT04939415|580921203|FG001|Overall Study|Lost to Follow-up|2|||
160871122|NCT01354314|580921207|FG000|Overall Study|Lost to Follow-up|1|||
160871123|NCT01354314|580921208|FG001|Overall Study|Lost to Follow-up|0|||
160871124|NCT01354314|580921209|FG002|Overall Study|Lost to Follow-up|1|||
160871125|NCT01354314|580921210|FG003|Overall Study|Lost to Follow-up|1|||
160871126|NCT01354314|580921207|FG000|Overall Study|Withdrawal by Subject|0|||
160871127|NCT01354314|580921208|FG001|Overall Study|Withdrawal by Subject|0|||
160871128|NCT01354314|580921209|FG002|Overall Study|Withdrawal by Subject|1|||
160871129|NCT01354314|580921210|FG003|Overall Study|Withdrawal by Subject|0|||
160871130|NCT01354314|580921207|FG000|Overall Study|Adverse Event|0|||
160531697|NCT04667377|579676350|FG002|Maintenance Period|Change of residence|0|||
160871131|NCT01354314|580921208|FG001|Overall Study|Adverse Event|0|||
160871132|NCT01354314|580921209|FG002|Overall Study|Adverse Event|0|||
160871133|NCT01354314|580921210|FG003|Overall Study|Adverse Event|1|||
160871134|NCT01354314|580921207|FG000|Overall Study|Protocol Violation|1|||
160871135|NCT01354314|580921208|FG001|Overall Study|Protocol Violation|1|||
160531698|NCT04667377|579676351|FG003|Maintenance Period|Change of residence|0|||
160531699|NCT04667377|579676352|FG004|Maintenance Period|Change of residence|1|||
160531700|NCT04667377|579676348|FG000|Maintenance Period|Missing|1|||
160871136|NCT01354314|580921209|FG002|Overall Study|Protocol Violation|0|||
160871137|NCT01354314|580921210|FG003|Overall Study|Protocol Violation|0|||
160871138|NCT01354314|580921207|FG000|Overall Study|Less than 90% Adherence|4|||
160871139|NCT01354314|580921208|FG001|Overall Study|Less than 90% Adherence|2|||
160871140|NCT01354314|580921209|FG002|Overall Study|Less than 90% Adherence|6|||
160871141|NCT01354314|580921210|FG003|Overall Study|Less than 90% Adherence|4|||
160871142|NCT00478023|580921211|FG000|Overall Study|Adverse Event|11|||
160871143|NCT00478023|580921212|FG001|Overall Study|Adverse Event|7|||
160871144|NCT00478023|580921213|FG002|Overall Study|Adverse Event|8|||
160871145|NCT00478023|580921214|FG003|Overall Study|Adverse Event|14|||
160871146|NCT00478023|580921215|FG004|Overall Study|Adverse Event|6|||
160871147|NCT00478023|580921211|FG000|Overall Study|Death|1|||
160871148|NCT00478023|580921212|FG001|Overall Study|Death|0|||
160871149|NCT00478023|580921213|FG002|Overall Study|Death|0|||
160871150|NCT00478023|580921214|FG003|Overall Study|Death|0|||
160871151|NCT00478023|580921215|FG004|Overall Study|Death|0|||
160871152|NCT00478023|580921211|FG000|Overall Study|Lack of Efficacy|11|||
160871153|NCT00478023|580921212|FG001|Overall Study|Lack of Efficacy|10|||
160871154|NCT00478023|580921213|FG002|Overall Study|Lack of Efficacy|4|||
160871155|NCT00478023|580921214|FG003|Overall Study|Lack of Efficacy|5|||
160871156|NCT00478023|580921215|FG004|Overall Study|Lack of Efficacy|41|||
160871157|NCT00478023|580921211|FG000|Overall Study|Lost to Follow-up|3|||
160871158|NCT00478023|580921212|FG001|Overall Study|Lost to Follow-up|1|||
160871159|NCT00478023|580921213|FG002|Overall Study|Lost to Follow-up|1|||
160871160|NCT00478023|580921214|FG003|Overall Study|Lost to Follow-up|1|||
160871161|NCT00478023|580921215|FG004|Overall Study|Lost to Follow-up|0|||
160871162|NCT00478023|580921211|FG000|Overall Study|Withdrawal by Subject|2|||
160871163|NCT00478023|580921212|FG001|Overall Study|Withdrawal by Subject|3|||
160871164|NCT00478023|580921213|FG002|Overall Study|Withdrawal by Subject|2|||
160871165|NCT00478023|580921214|FG003|Overall Study|Withdrawal by Subject|4|||
160871166|NCT00478023|580921215|FG004|Overall Study|Withdrawal by Subject|5|||
160871167|NCT00478023|580921211|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
160871168|NCT00478023|580921212|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
160871169|NCT00478023|580921213|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
160871170|NCT00478023|580921214|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
160871171|NCT00478023|580921215|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
160871172|NCT00369265|580921217|FG000|Overall Study|Study terminated|4|||
160871173|NCT00369265|580921218|FG001|Overall Study|Study terminated|7|||
160871174|NCT03895840|580921219|FG000|Overall Study|Withdrawal by Subject|21|||
160871175|NCT00611026|580921222|FG000|Randomized to Double-blind Treatment|Not treated|2|||
160871176|NCT00611026|580921223|FG001|Randomized to Double-blind Treatment|Not treated|1|||
160871177|NCT00611026|580921224|FG002|Randomized to Double-blind Treatment|Not treated|3|||
160871178|NCT00611026|580921222|FG000|Double-blind Treatment Period|Death|1|||
160871179|NCT00611026|580921223|FG001|Double-blind Treatment Period|Death|0|||
160871180|NCT00611026|580921224|FG002|Double-blind Treatment Period|Death|0|||
160871181|NCT00611026|580921222|FG000|Double-blind Treatment Period|Adverse Event|9|||
160871182|NCT00611026|580921223|FG001|Double-blind Treatment Period|Adverse Event|28|||
160871183|NCT00611026|580921224|FG002|Double-blind Treatment Period|Adverse Event|46|||
160871184|NCT00611026|580921222|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
160871185|NCT00611026|580921223|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
160871186|NCT00611026|580921224|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
160871187|NCT00611026|580921222|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
160871188|NCT00611026|580921223|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
160871189|NCT00611026|580921224|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
160871190|NCT00611026|580921222|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
160871191|NCT00611026|580921223|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
160871192|NCT00611026|580921224|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
160871193|NCT00611026|580921222|FG000|Double-blind Treatment Period|Other|13|||
160871194|NCT00611026|580921223|FG001|Double-blind Treatment Period|Other|20|||
160871195|NCT00611026|580921224|FG002|Double-blind Treatment Period|Other|18|||
160871196|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
160531701|NCT04667377|579676349|FG001|Maintenance Period|Missing|0|||
160531702|NCT04667377|579676350|FG002|Maintenance Period|Missing|0|||
160531703|NCT04667377|579676351|FG003|Maintenance Period|Missing|0|||
160531704|NCT04667377|579676352|FG004|Maintenance Period|Missing|0|||
160531705|NCT04667377|579676348|FG000|Maintenance Period|Other than listed above|2|||
160531706|NCT04667377|579676349|FG001|Maintenance Period|Other than listed above|0|||
160531707|NCT04667377|579676350|FG002|Maintenance Period|Other than listed above|3|||
160531708|NCT04667377|579676351|FG003|Maintenance Period|Other than listed above|2|||
160531709|NCT04667377|579676352|FG004|Maintenance Period|Other than listed above|6|||
160531710|NCT04667377|579676348|FG000|Maintenance Period|Withdrawal by Subject|0|||
160531711|NCT04667377|579676349|FG001|Maintenance Period|Withdrawal by Subject|1|||
160531712|NCT04667377|579676350|FG002|Maintenance Period|Withdrawal by Subject|0|||
160531713|NCT04667377|579676351|FG003|Maintenance Period|Withdrawal by Subject|0|||
160871197|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
160871198|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
160871199|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
160871200|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871201|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871202|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871203|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
160871204|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
160871205|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871206|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
160871207|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871208|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871209|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871210|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
160871211|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
160871212|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
160871213|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
160871214|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871215|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871216|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871217|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
160871218|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
160871219|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
160871220|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
160871221|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
160871222|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
160871223|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
160871224|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
160871225|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
160871226|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
160871227|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
160871228|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
160871229|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
160871230|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
160871231|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
160871232|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871233|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871234|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871235|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871236|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871237|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871238|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
160871239|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871240|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
160871241|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
160531714|NCT04667377|579676352|FG004|Maintenance Period|Withdrawal by Subject|0|||
160531715|NCT04667377|579676348|FG000|Maintenance Period|Lost to Follow-up|1|||
160871242|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871243|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160981507|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
160531716|NCT04667377|579676349|FG001|Maintenance Period|Lost to Follow-up|0|||
160531717|NCT04667377|579676350|FG002|Maintenance Period|Lost to Follow-up|1|||
160871244|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871245|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
160871246|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
160871247|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
160871248|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871249|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871250|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871251|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
160871252|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
160871253|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
160871254|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
160871255|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871256|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871257|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871258|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
160871259|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
160871260|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871261|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871262|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871263|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
160871264|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
160871265|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
160871266|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
160871267|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
160871268|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
160871269|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
160871270|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
160871271|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
160871272|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
160871273|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
160871274|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
160871275|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
160871276|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
160871277|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
160871278|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
160871279|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
160871280|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871281|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871282|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871283|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871284|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871285|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
160871286|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871287|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
160871288|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
160871289|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
160871290|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871291|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871292|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
160871293|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871294|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
160531718|NCT04667377|579676351|FG003|Maintenance Period|Lost to Follow-up|0|||
160531719|NCT04667377|579676352|FG004|Maintenance Period|Lost to Follow-up|1|||
160531720|NCT00210184|579676353|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
160531721|NCT03861936|579676354|FG000|Overall Study|Withdrawal by Subject|4|||
160531722|NCT03861936|579676355|FG001|Overall Study|Withdrawal by Subject|1|||
160531723|NCT03861936|579676356|FG002|Overall Study|Withdrawal by Subject|3|||
160531724|NCT03861936|579676354|FG000|Overall Study|Lost to Follow-up|5|||
160531725|NCT03861936|579676355|FG001|Overall Study|Lost to Follow-up|3|||
160531726|NCT03861936|579676356|FG002|Overall Study|Lost to Follow-up|3|||
160531727|NCT03861936|579676354|FG000|Overall Study|Physician Decision|0|||
160871295|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
160871296|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
160871297|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
160871298|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
160871299|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
160871300|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
160871301|NCT00760617|580921232|FG000|Overall Study|Adverse Event|5|||
160871302|NCT00760617|580921233|FG001|Overall Study|Adverse Event|2|||
160871303|NCT00760617|580921234|FG002|Overall Study|Adverse Event|0|||
160871304|NCT00760617|580921232|FG000|Overall Study|Lost to Follow-up|0|||
160531728|NCT03861936|579676355|FG001|Overall Study|Physician Decision|1|||
160531729|NCT03861936|579676356|FG002|Overall Study|Physician Decision|0|||
160531730|NCT03861936|579676354|FG000|Overall Study|Protocol Deviation|0|||
160531731|NCT03861936|579676355|FG001|Overall Study|Protocol Deviation|0|||
160871305|NCT00760617|580921233|FG001|Overall Study|Lost to Follow-up|0|||
160871306|NCT00760617|580921234|FG002|Overall Study|Lost to Follow-up|5|||
160871307|NCT04625101|580921235|FG000|Overall Study|Withdrawal by Subject|0|||
160871308|NCT04625101|580921236|FG001|Overall Study|Withdrawal by Subject|1|||
160871309|NCT04625101|580921235|FG000|Overall Study|Protocol Deviation|1|||
160871310|NCT04625101|580921236|FG001|Overall Study|Protocol Deviation|0|||
160871311|NCT00467753|580921238|FG000|Overall Study|Lost to Follow-up|1|||
160871312|NCT00467753|580921239|FG001|Overall Study|Lost to Follow-up|2|||
160871313|NCT00467753|580921238|FG000|Overall Study|Adverse Event|2|||
160871314|NCT00467753|580921239|FG001|Overall Study|Adverse Event|0|||
160871315|NCT02817464|580921240|FG000|Overall Study|Lost to Follow-up|1|||
160871316|NCT02817464|580921241|FG001|Overall Study|Lost to Follow-up|0|||
160871317|NCT02817464|580921240|FG000|Overall Study|Discontinued early due to personal decision|1|||
160871318|NCT02817464|580921241|FG001|Overall Study|Discontinued early due to personal decision|1|||
160871319|NCT01026324|580921243|FG000|Follow up/Survival|Withdrawal by Subject|1|||
160871320|NCT01026324|580921244|FG001|Follow up/Survival|Withdrawal by Subject|0|||
160871321|NCT01026324|580921245|FG002|Follow up/Survival|Withdrawal by Subject|0|||
160871322|NCT01500720|580921252|FG000|Overall Study|Randomized But Not Treated|1|||
160871323|NCT01500720|580921253|FG001|Overall Study|Randomized But Not Treated|1|||
160871324|NCT01500720|580921252|FG000|Overall Study|Other|4|||
160871325|NCT01500720|580921253|FG001|Overall Study|Other|8|||
160871326|NCT02624986|580921255|FG000|Overall Study|Death|0|||
160871327|NCT02624986|580921256|FG001|Overall Study|Death|1|||
160871328|NCT02624986|580921257|FG002|Overall Study|Death|2|||
160871329|NCT02624986|580921258|FG003|Overall Study|Death|2|||
160871330|NCT02624986|580921259|FG004|Overall Study|Death|2|||
160871331|NCT02624986|580921260|FG005|Overall Study|Death|0|||
160871332|NCT02624986|580921261|FG006|Overall Study|Death|0|||
160871333|NCT02624986|580921262|FG007|Overall Study|Death|1|||
160871334|NCT02624986|580921255|FG000|Overall Study|Study Terminated by Sponsor|1|||
160871335|NCT02624986|580921256|FG001|Overall Study|Study Terminated by Sponsor|1|||
160871336|NCT02624986|580921257|FG002|Overall Study|Study Terminated by Sponsor|0|||
160871337|NCT02624986|580921258|FG003|Overall Study|Study Terminated by Sponsor|1|||
160871338|NCT02624986|580921259|FG004|Overall Study|Study Terminated by Sponsor|2|||
160871339|NCT02624986|580921260|FG005|Overall Study|Study Terminated by Sponsor|2|||
160871340|NCT02624986|580921261|FG006|Overall Study|Study Terminated by Sponsor|4|||
160871341|NCT02624986|580921262|FG007|Overall Study|Study Terminated by Sponsor|3|||
160871342|NCT02624986|580921255|FG000|Overall Study|Progressive Disease|0|||
160871343|NCT02624986|580921256|FG001|Overall Study|Progressive Disease|1|||
160871344|NCT02624986|580921257|FG002|Overall Study|Progressive Disease|0|||
160871345|NCT02624986|580921258|FG003|Overall Study|Progressive Disease|0|||
160871346|NCT02624986|580921259|FG004|Overall Study|Progressive Disease|0|||
160871347|NCT02624986|580921260|FG005|Overall Study|Progressive Disease|0|||
160871348|NCT02624986|580921261|FG006|Overall Study|Progressive Disease|0|||
160871349|NCT02624986|580921262|FG007|Overall Study|Progressive Disease|0|||
160871350|NCT02624986|580921255|FG000|Overall Study|Protocol Violation|1|||
160871351|NCT02624986|580921256|FG001|Overall Study|Protocol Violation|0|||
160871352|NCT02624986|580921257|FG002|Overall Study|Protocol Violation|0|||
160871353|NCT02624986|580921258|FG003|Overall Study|Protocol Violation|0|||
160871354|NCT02624986|580921259|FG004|Overall Study|Protocol Violation|0|||
160871355|NCT02624986|580921260|FG005|Overall Study|Protocol Violation|0|||
160871356|NCT02624986|580921261|FG006|Overall Study|Protocol Violation|0|||
160871357|NCT02624986|580921262|FG007|Overall Study|Protocol Violation|0|||
160871358|NCT02624986|580921255|FG000|Overall Study|Withdrawal by Subject|0|||
160871359|NCT02624986|580921256|FG001|Overall Study|Withdrawal by Subject|0|||
160871360|NCT02624986|580921257|FG002|Overall Study|Withdrawal by Subject|0|||
160871361|NCT02624986|580921258|FG003|Overall Study|Withdrawal by Subject|0|||
160871362|NCT02624986|580921259|FG004|Overall Study|Withdrawal by Subject|0|||
160871363|NCT02624986|580921260|FG005|Overall Study|Withdrawal by Subject|0|||
160871364|NCT02624986|580921261|FG006|Overall Study|Withdrawal by Subject|0|||
160871365|NCT02624986|580921262|FG007|Overall Study|Withdrawal by Subject|1|||
160871366|NCT03532451|580921263|FG000|Overall Study|Withdrawal by Subject|0|||
160531732|NCT03861936|579676356|FG002|Overall Study|Protocol Deviation|1|||
160871367|NCT03532451|580921264|FG001|Overall Study|Withdrawal by Subject|1|||
160871368|NCT03532451|580921263|FG000|Overall Study|Did not undergo surgery|1|||
160871369|NCT03532451|580921264|FG001|Overall Study|Did not undergo surgery|1|||
160871370|NCT01287741|580921272|FG000|Overall Study|Withdrawal by Subject|35|||
160871371|NCT01287741|580921273|FG001|Overall Study|Withdrawal by Subject|38|||
160871372|NCT01287741|580921272|FG000|Overall Study|Protocol Violation|2|||
160871373|NCT01287741|580921273|FG001|Overall Study|Protocol Violation|0|||
160871374|NCT01287741|580921272|FG000|Overall Study|Physician Decision|15|||
160871375|NCT01287741|580921273|FG001|Overall Study|Physician Decision|23|||
160871376|NCT01287741|580921272|FG000|Overall Study|Non-compliance|8|||
160871377|NCT01287741|580921273|FG001|Overall Study|Non-compliance|6|||
160871378|NCT01287741|580921272|FG000|Overall Study|Lost to Follow-up|10|||
160871379|NCT01287741|580921273|FG001|Overall Study|Lost to Follow-up|8|||
160871380|NCT01287741|580921272|FG000|Overall Study|Death|32|||
160871381|NCT01287741|580921273|FG001|Overall Study|Death|44|||
160871382|NCT01287741|580921272|FG000|Overall Study|Adverse Event|4|||
160871383|NCT01287741|580921273|FG001|Overall Study|Adverse Event|6|||
160871384|NCT01287741|580921272|FG000|Overall Study|Study terminated by Sponsor|307|||
160871385|NCT01287741|580921273|FG001|Overall Study|Study terminated by Sponsor|315|||
160871386|NCT01287741|580921272|FG000|Overall Study|Progressive disease|190|||
160871387|NCT01287741|580921273|FG001|Overall Study|Progressive disease|166|||
160871388|NCT01287741|580921272|FG000|Overall Study|Reason not specified|23|||
160871389|NCT01287741|580921273|FG001|Overall Study|Reason not specified|9|||
160871390|NCT02930018|580921274|FG000|Overall Study|Lost to Follow-up|1|||
160871391|NCT02930018|580921275|FG001|Overall Study|Lost to Follow-up|1|||
160871392|NCT02930018|580921274|FG000|Overall Study|Withdrawal by Subject|5|||
160871393|NCT02930018|580921275|FG001|Overall Study|Withdrawal by Subject|2|||
160871394|NCT02807402|580921276|FG000|Overall Study|Failure to Return|1|||
160871395|NCT02807402|580921276|FG000|Overall Study|Death|3|||
160871396|NCT02807402|580921276|FG000|Overall Study|Other|2|||
160871397|NCT01865552|580922748|FG000|Period 1|Adverse Event|1|||
160871398|NCT01865552|580922749|FG001|Period 1|Adverse Event|0|||
160871399|NCT01865552|580922750|FG002|Period 1|Adverse Event|0|||
160871400|NCT01865552|580922751|FG003|Period 1|Adverse Event|1|||
160871401|NCT01865552|580922752|FG004|Period 1|Adverse Event|1|||
160871402|NCT01865552|580922753|FG005|Period 1|Adverse Event|1|||
160871403|NCT01865552|580922748|FG000|Period 1|Pathological lab|0|||
160871404|NCT01865552|580922749|FG001|Period 1|Pathological lab|0|||
160871405|NCT01865552|580922750|FG002|Period 1|Pathological lab|0|||
160871406|NCT01865552|580922751|FG003|Period 1|Pathological lab|0|||
160871407|NCT01865552|580922752|FG004|Period 1|Pathological lab|1|||
160871408|NCT01865552|580922753|FG005|Period 1|Pathological lab|0|||
160871409|NCT01865552|580922748|FG000|Period 1|Other|0|||
160871410|NCT01865552|580922749|FG001|Period 1|Other|0|||
160871411|NCT01865552|580922750|FG002|Period 1|Other|0|||
160871412|NCT01865552|580922751|FG003|Period 1|Other|0|||
160871413|NCT01865552|580922752|FG004|Period 1|Other|1|||
160871414|NCT01865552|580922753|FG005|Period 1|Other|0|||
160871415|NCT03079102|580922756|FG000|Overall Study|Physician Decision|0|||
160871416|NCT03079102|580922757|FG001|Overall Study|Physician Decision|1|||
160871417|NCT02923921|580922758|FG000|Overall Study|Sponsor Decision|39|||
160871418|NCT02923921|580922759|FG001|Overall Study|Sponsor Decision|38|||
160765739|NCT01027845|580532892|FG003|Primary Vaccination Phase|Adverse Event|0|||
160765740|NCT01027845|580532889|FG000|Primary Vaccination Phase|Protocol Violation|1|||
160765741|NCT01027845|580532890|FG001|Primary Vaccination Phase|Protocol Violation|0|||
160765742|NCT01027845|580532891|FG002|Primary Vaccination Phase|Protocol Violation|0|||
160765743|NCT01027845|580532892|FG003|Primary Vaccination Phase|Protocol Violation|0|||
160765744|NCT01027845|580532889|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
160765745|NCT01027845|580532890|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
160765746|NCT01027845|580532891|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
160765747|NCT01027845|580532892|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
160765748|NCT01027845|580532889|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
160531733|NCT03861936|579676354|FG000|Overall Study|Reason not Specified|5|||
160531734|NCT03861936|579676355|FG001|Overall Study|Reason not Specified|5|||
160531735|NCT03861936|579676356|FG002|Overall Study|Reason not Specified|3|||
160531736|NCT00359021|579676357|FG000|Overall Study|Adverse Event|26|||
160531737|NCT00359021|579676358|FG001|Overall Study|Adverse Event|8|||
160531738|NCT00359021|579676357|FG000|Overall Study|Subject Non-Compliant|1|||
160531739|NCT00359021|579676358|FG001|Overall Study|Subject Non-Compliant|2|||
160531740|NCT00359021|579676357|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
160531741|NCT00359021|579676358|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
160531742|NCT00359021|579676357|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
160531743|NCT00359021|579676358|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
160531744|NCT00359021|579676357|FG000|Overall Study|Withdrawal by Subject|2|||
160765749|NCT01027845|580532890|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
160871419|NCT02923921|580922758|FG000|Overall Study|Lost to Follow-up|1|||
160531745|NCT00359021|579676358|FG001|Overall Study|Withdrawal by Subject|9|||
160531746|NCT00359021|579676357|FG000|Overall Study|Lost to Follow-up|1|||
160531747|NCT00359021|579676358|FG001|Overall Study|Lost to Follow-up|0|||
160531748|NCT00359021|579676357|FG000|Overall Study|Other|4|||
160531749|NCT00359021|579676358|FG001|Overall Study|Other|1|||
160531750|NCT00359021|579676357|FG000|Overall Study|Pregnancy|1|||
160531751|NCT00359021|579676358|FG001|Overall Study|Pregnancy|0|||
160531752|NCT05418673|579676359|FG000|Overall Study|Study Terminated by Sponsor|2|||
160531753|NCT05418673|579676360|FG001|Overall Study|Study Terminated by Sponsor|4|||
160871420|NCT02923921|580922759|FG001|Overall Study|Lost to Follow-up|0|||
160531754|NCT05418673|579676359|FG000|Overall Study|Lost to Follow-up|1|||
160871421|NCT02923921|580922758|FG000|Overall Study|Withdrawal by Subject|6|||
160871422|NCT02923921|580922759|FG001|Overall Study|Withdrawal by Subject|13|||
160871423|NCT02923921|580922758|FG000|Overall Study|Unknown, Not Collected|7|||
160871424|NCT02923921|580922759|FG001|Overall Study|Unknown, Not Collected|6|||
160871425|NCT03083873|580922760|FG000|Overall Study|Death|6|||
160871426|NCT03083873|580922761|FG001|Overall Study|Death|15|||
160871427|NCT03083873|580922762|FG002|Overall Study|Death|13|||
160871428|NCT03083873|580922763|FG003|Overall Study|Death|9|||
160871429|NCT03083873|580922764|FG004|Overall Study|Death|0|||
160765750|NCT01027845|580532891|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
160765751|NCT01027845|580532892|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
160765752|NCT01027845|580532889|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
160765753|NCT01027845|580532890|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
160765754|NCT01027845|580532891|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
160765755|NCT01027845|580532892|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
160765756|NCT01670292|580532893|FG000|Overall Study|Lost to Follow-up|14|||
160765757|NCT00087178|580532897|FG000|Overall Study|No follow up data|5|||
160765758|NCT00087178|580532898|FG001|Overall Study|No follow up data|15|||
160765759|NCT00087178|580532897|FG000|Overall Study|No clinical assessment|1|||
160765760|NCT00087178|580532898|FG001|Overall Study|No clinical assessment|2|||
160765761|NCT00087178|580532897|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
160765762|NCT00087178|580532898|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
160765763|NCT01692119|580532901|FG000|Overall Study|Protocol Violation|3|||
160765764|NCT01692119|580532902|FG001|Overall Study|Protocol Violation|1|||
160765765|NCT01692119|580532901|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
160765766|NCT01692119|580532902|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
160765767|NCT03895086|580532903|FG000|Overall Study|Early termination study|1|||
160765768|NCT03895086|580532904|FG001|Overall Study|Early termination study|0|||
160765769|NCT00846053|580532905|FG000|Overall Study|Physician Decision|3|||
160765770|NCT00846053|580532906|FG001|Overall Study|Physician Decision|0|||
160765771|NCT03883386|580532907|FG000|First Assignment|Lost to Follow-up|1|||
160765772|NCT03883386|580532908|FG001|First Assignment|Lost to Follow-up|0|||
160765773|NCT03883386|580532907|FG000|First Assignment|Withdrawal by Subject|1|||
160765774|NCT03883386|580532908|FG001|First Assignment|Withdrawal by Subject|1|||
160765775|NCT01326871|580532909|FG000|Overall Study|Major surgery|0|||
160765776|NCT01326871|580532910|FG001|Overall Study|Major surgery|1|||
160765777|NCT01326871|580532911|FG002|Overall Study|Major surgery|0|||
160765778|NCT01326871|580532909|FG000|Overall Study|SAE and death|0|||
160765779|NCT01326871|580532910|FG001|Overall Study|SAE and death|2|||
160765780|NCT01326871|580532911|FG002|Overall Study|SAE and death|0|||
160765781|NCT01326871|580532909|FG000|Overall Study|Physician decision and decreased performance status|0|||
160765782|NCT01326871|580532910|FG001|Overall Study|Physician decision and decreased performance status|1|||
160765783|NCT01326871|580532911|FG002|Overall Study|Physician decision and decreased performance status|0|||
160765784|NCT01326871|580532909|FG000|Overall Study|Disease progression|0|||
160765785|NCT01326871|580532910|FG001|Overall Study|Disease progression|11|||
160765786|NCT01326871|580532911|FG002|Overall Study|Disease progression|5|||
160765787|NCT01326871|580532909|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
160765788|NCT01326871|580532910|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
160765789|NCT01326871|580532911|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
160765790|NCT01326871|580532909|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
160765791|NCT01326871|580532910|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
160765792|NCT01326871|580532911|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
160765793|NCT01326871|580532909|FG000|Overall Study|Withdrawal by Subject|0|||
160765794|NCT01326871|580532910|FG001|Overall Study|Withdrawal by Subject|1|||
160765795|NCT01326871|580532911|FG002|Overall Study|Withdrawal by Subject|0|||
160765796|NCT01326871|580532909|FG000|Overall Study|DLT|0|||
160765797|NCT01326871|580532910|FG001|Overall Study|DLT|2|||
160871430|NCT03083873|580922760|FG000|Overall Study|Sponsor Terminated Study|0|||
160871431|NCT03083873|580922761|FG001|Overall Study|Sponsor Terminated Study|1|||
160871432|NCT03083873|580922762|FG002|Overall Study|Sponsor Terminated Study|2|||
160871433|NCT03083873|580922763|FG003|Overall Study|Sponsor Terminated Study|3|||
160871434|NCT03083873|580922764|FG004|Overall Study|Sponsor Terminated Study|0|||
160871435|NCT03083873|580922760|FG000|Overall Study|Lost to Follow-up|0|||
160871436|NCT03083873|580922761|FG001|Overall Study|Lost to Follow-up|1|||
160871437|NCT03083873|580922762|FG002|Overall Study|Lost to Follow-up|1|||
160871438|NCT03083873|580922763|FG003|Overall Study|Lost to Follow-up|0|||
160871439|NCT03083873|580922764|FG004|Overall Study|Lost to Follow-up|0|||
160871440|NCT03083873|580922760|FG000|Overall Study|Withdrawal by Subject|2|||
160871441|NCT03083873|580922761|FG001|Overall Study|Withdrawal by Subject|0|||
160871442|NCT03083873|580922762|FG002|Overall Study|Withdrawal by Subject|0|||
160871443|NCT03083873|580922763|FG003|Overall Study|Withdrawal by Subject|0|||
160871444|NCT03083873|580922764|FG004|Overall Study|Withdrawal by Subject|0|||
160871445|NCT03083873|580922760|FG000|Overall Study|Did Not Receive TIL|2|||
160871446|NCT03083873|580922761|FG001|Overall Study|Did Not Receive TIL|5|||
160871447|NCT03083873|580922762|FG002|Overall Study|Did Not Receive TIL|3|||
160871448|NCT03083873|580922763|FG003|Overall Study|Did Not Receive TIL|1|||
160871449|NCT03083873|580922764|FG004|Overall Study|Did Not Receive TIL|0|||
160871450|NCT00479687|580922765|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
160871451|NCT00479687|580922766|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
160871452|NCT00479687|580922767|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
160871453|NCT00479687|580922765|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
160871454|NCT00479687|580922766|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
160871455|NCT00479687|580922767|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
160981508|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
160531755|NCT05418673|579676360|FG001|Overall Study|Lost to Follow-up|0|||
160531756|NCT02665052|579676361|FG000|Overall Study|Lost to Follow-up|1|||
160531757|NCT02665052|579676362|FG001|Overall Study|Lost to Follow-up|0|||
160531758|NCT02665052|579676363|FG002|Overall Study|Lost to Follow-up|0|||
160531759|NCT02665052|579676364|FG003|Overall Study|Lost to Follow-up|0|||
160531760|NCT02665052|579676361|FG000|Overall Study|Withdrawal by Subject|1|||
160531761|NCT02665052|579676362|FG001|Overall Study|Withdrawal by Subject|1|||
160871456|NCT00479687|580922765|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
160871457|NCT00479687|580922766|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
160871458|NCT00479687|580922767|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
160871459|NCT00479687|580922765|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
160871460|NCT00479687|580922766|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
160871461|NCT00479687|580922767|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
160531762|NCT02665052|579676363|FG002|Overall Study|Withdrawal by Subject|0|||
160871462|NCT00479687|580922765|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
160871463|NCT00479687|580922766|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
160871464|NCT00479687|580922767|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
160871465|NCT00479687|580922765|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
160871466|NCT00479687|580922766|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
160871467|NCT00479687|580922767|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
160871468|NCT00479687|580922765|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
160871469|NCT00479687|580922766|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
160871470|NCT00479687|580922767|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
160871471|NCT00479687|580922765|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
160871472|NCT00479687|580922766|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
160871473|NCT00479687|580922767|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
160871474|NCT00479687|580922765|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
160871475|NCT00479687|580922766|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
160871476|NCT00479687|580922767|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
160871477|NCT00295880|580922768|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
160871478|NCT00295880|580922768|FG000|Overall Study|Unit randomization did not occur|1|||
160871479|NCT01474239|580922769|FG000|Overall Study|Disease Progression|37|||
160871480|NCT01474239|580922770|FG001|Overall Study|Disease Progression|25|||
160871481|NCT01474239|580922769|FG000|Overall Study|Adverse Event|12|||
160871482|NCT01474239|580922770|FG001|Overall Study|Adverse Event|3|||
160871483|NCT01474239|580922769|FG000|Overall Study|Withdrawal by Subject|1|||
160871484|NCT01474239|580922770|FG001|Overall Study|Withdrawal by Subject|2|||
160871485|NCT01474239|580922769|FG000|Overall Study|Death|1|||
160871486|NCT01474239|580922770|FG001|Overall Study|Death|1|||
160871487|NCT01474239|580922769|FG000|Overall Study|Clinical Disease Progression|7|||
160871488|NCT01474239|580922770|FG001|Overall Study|Clinical Disease Progression|1|||
160871489|NCT01474239|580922769|FG000|Overall Study|Withdrawal for Economic Reason|1|||
160871490|NCT01474239|580922770|FG001|Overall Study|Withdrawal for Economic Reason|0|||
160871491|NCT00854113|580922771|FG000|Overall Study|Adverse Event|0|||
160871492|NCT00854113|580922772|FG001|Overall Study|Adverse Event|0|||
160871493|NCT00854113|580922773|FG002|Overall Study|Adverse Event|0|||
160871494|NCT00854113|580922774|FG003|Overall Study|Adverse Event|0|||
160871495|NCT00854113|580922775|FG004|Overall Study|Adverse Event|0|||
160871496|NCT00854113|580922776|FG005|Overall Study|Adverse Event|0|||
160871497|NCT00854113|580922777|FG006|Overall Study|Adverse Event|0|||
160871498|NCT00854113|580922778|FG007|Overall Study|Adverse Event|2|||
160871499|NCT00854113|580922779|FG008|Overall Study|Adverse Event|0|||
160871500|NCT00854113|580922780|FG009|Overall Study|Adverse Event|0|||
160871501|NCT00854113|580922781|FG010|Overall Study|Adverse Event|0|||
160871502|NCT00854113|580922771|FG000|Overall Study|Withdrawal by Subject|0|||
160871503|NCT00854113|580922772|FG001|Overall Study|Withdrawal by Subject|0|||
160871504|NCT00854113|580922773|FG002|Overall Study|Withdrawal by Subject|0|||
160871505|NCT00854113|580922774|FG003|Overall Study|Withdrawal by Subject|0|||
160871506|NCT00854113|580922775|FG004|Overall Study|Withdrawal by Subject|0|||
160871507|NCT00854113|580922776|FG005|Overall Study|Withdrawal by Subject|0|||
160531763|NCT02665052|579676364|FG003|Overall Study|Withdrawal by Subject|5|||
160531764|NCT02665052|579676361|FG000|Overall Study|Adverse Event|1|||
160531765|NCT02665052|579676362|FG001|Overall Study|Adverse Event|1|||
160531766|NCT02665052|579676363|FG002|Overall Study|Adverse Event|0|||
160531767|NCT02665052|579676364|FG003|Overall Study|Adverse Event|0|||
160531768|NCT01986920|579676367|FG000|A- 101 25%|Withdrawal by Subject|1|||
160531769|NCT01986920|579676368|FG001|A- 101 25%|Withdrawal by Subject|0|||
160531770|NCT01986920|579676369|FG002|A- 101 25%|Withdrawal by Subject|0|||
160531771|NCT01986920|579676370|FG003|A- 101 25%|Withdrawal by Subject|0|||
160531772|NCT01986920|579676367|FG000|A-101 32.5%|Withdrawal by Subject|0|||
160531773|NCT01986920|579676368|FG001|A-101 32.5%|Withdrawal by Subject|1|||
160531774|NCT01986920|579676369|FG002|A-101 32.5%|Withdrawal by Subject|0|||
160871508|NCT00854113|580922777|FG006|Overall Study|Withdrawal by Subject|0|||
160871509|NCT00854113|580922778|FG007|Overall Study|Withdrawal by Subject|1|||
160531775|NCT01986920|579676370|FG003|A-101 32.5%|Withdrawal by Subject|0|||
160531776|NCT01986920|579676367|FG000|A-101 40%|Withdrawal by Subject|0|||
160531777|NCT01986920|579676368|FG001|A-101 40%|Withdrawal by Subject|0|||
160531778|NCT01986920|579676369|FG002|A-101 40%|Withdrawal by Subject|1|||
160531779|NCT01986920|579676370|FG003|A-101 40%|Withdrawal by Subject|0|||
160531780|NCT01986920|579676367|FG000|Placebo|Withdrawal by Subject|0|||
160871510|NCT00854113|580922779|FG008|Overall Study|Withdrawal by Subject|1|||
160871511|NCT00854113|580922780|FG009|Overall Study|Withdrawal by Subject|0|||
160871512|NCT00854113|580922781|FG010|Overall Study|Withdrawal by Subject|0|||
160871513|NCT00796419|580922783|FG000|Overall Study|Death|0|||
160871514|NCT00796419|580922784|FG001|Overall Study|Death|1|||
160871515|NCT00539864|580922787|FG000|Overall Study|Lost to Follow-up|0|||
160871516|NCT00539864|580922788|FG001|Overall Study|Lost to Follow-up|1|||
160871517|NCT00539864|580922787|FG000|Overall Study|Withdrawal by Subject|1|||
160765798|NCT01326871|580532911|FG002|Overall Study|DLT|0|||
160765799|NCT01326871|580532909|FG000|Overall Study|SAE, disease progression and subject decision|0|||
160765800|NCT01326871|580532910|FG001|Overall Study|SAE, disease progression and subject decision|1|||
160765801|NCT01326871|580532911|FG002|Overall Study|SAE, disease progression and subject decision|0|||
160765802|NCT01326871|580532909|FG000|Overall Study|Death|0|||
160765803|NCT01326871|580532910|FG001|Overall Study|Death|1|||
160765804|NCT01326871|580532911|FG002|Overall Study|Death|0|||
160765805|NCT01326871|580532909|FG000|Overall Study|Other|0|||
160765806|NCT01326871|580532910|FG001|Overall Study|Other|3|||
160765807|NCT01326871|580532911|FG002|Overall Study|Other|0|||
160765808|NCT01326871|580532909|FG000|Overall Study|SAE and disease progression|0|||
160765809|NCT01326871|580532910|FG001|Overall Study|SAE and disease progression|0|||
160765810|NCT01326871|580532911|FG002|Overall Study|SAE and disease progression|1|||
160765811|NCT01326871|580532909|FG000|Overall Study|SAE and physician decision|0|||
160765812|NCT01326871|580532910|FG001|Overall Study|SAE and physician decision|0|||
160765813|NCT01326871|580532911|FG002|Overall Study|SAE and physician decision|1|||
160765814|NCT01326871|580532909|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
160765815|NCT01326871|580532910|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
160765816|NCT01326871|580532911|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
160765817|NCT01326871|580532909|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
160765818|NCT01326871|580532910|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
160765819|NCT01326871|580532911|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
160765820|NCT01326871|580532909|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
160765821|NCT01326871|580532910|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
160765822|NCT01326871|580532911|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
160765823|NCT01326871|580532909|FG000|Overall Study|Physician Decision|0|||
160765824|NCT01326871|580532910|FG001|Overall Study|Physician Decision|0|||
160765825|NCT01326871|580532911|FG002|Overall Study|Physician Decision|1|||
160765826|NCT01326871|580532909|FG000|Overall Study|SAE|0|||
160765827|NCT01326871|580532910|FG001|Overall Study|SAE|0|||
160765828|NCT01326871|580532911|FG002|Overall Study|SAE|1|||
160765829|NCT01326871|580532909|FG000|Overall Study|Disease progression and death|0|||
160765830|NCT01326871|580532910|FG001|Overall Study|Disease progression and death|0|||
160765831|NCT01326871|580532911|FG002|Overall Study|Disease progression and death|1|||
160765832|NCT01326871|580532909|FG000|Overall Study|Subject decision|0|||
160765833|NCT01326871|580532910|FG001|Overall Study|Subject decision|0|||
160765834|NCT01326871|580532911|FG002|Overall Study|Subject decision|1|||
160765835|NCT01387269|580532912|FG000|Overall Study|Death|38|||
160765836|NCT01387269|580532913|FG001|Overall Study|Death|20|||
160765837|NCT01387269|580532912|FG000|Overall Study|Other|8|||
160765838|NCT01387269|580532913|FG001|Overall Study|Other|7|||
160765839|NCT01387269|580532912|FG000|Overall Study|Unrelated AE|12|||
160765840|NCT01387269|580532913|FG001|Overall Study|Unrelated AE|3|||
160765841|NCT01387269|580532912|FG000|Overall Study|Withdrawal by patient|32|||
160765842|NCT01387269|580532913|FG001|Overall Study|Withdrawal by patient|10|||
160765843|NCT01387269|580532912|FG000|Overall Study|Study drug-related AE|1|||
160765844|NCT01387269|580532913|FG001|Overall Study|Study drug-related AE|0|||
160765845|NCT01387269|580532912|FG000|Overall Study|Lost to Follow-up|1|||
160765846|NCT01387269|580532913|FG001|Overall Study|Lost to Follow-up|0|||
160765847|NCT01200329|580532914|FG000|Overall Study|Lack of financial coverage|2|||
160765848|NCT01200329|580532914|FG000|Overall Study|Progressive disease|1|||
160765849|NCT02230891|580532917|FG000|Baseline|Did not meet inclusion|0|||
160765850|NCT02230891|580532918|FG001|Baseline|Did not meet inclusion|1|||
160765851|NCT02230891|580532919|FG002|Baseline|Did not meet inclusion|1|||
160765852|NCT02230891|580532917|FG000|2 Week|Withdrawal by Subject|2|||
160765853|NCT02230891|580532918|FG001|2 Week|Withdrawal by Subject|2|||
160765854|NCT02230891|580532919|FG002|2 Week|Withdrawal by Subject|0|||
160765855|NCT02230891|580532917|FG000|2 Week|Consent withdrawn|1|||
160765856|NCT02230891|580532918|FG001|2 Week|Consent withdrawn|0|||
160765857|NCT02230891|580532919|FG002|2 Week|Consent withdrawn|0|||
160765858|NCT02230891|580532917|FG000|6 Month|Withdrawal by Subject|1|||
160765859|NCT02230891|580532918|FG001|6 Month|Withdrawal by Subject|1|||
160765860|NCT02230891|580532919|FG002|6 Month|Withdrawal by Subject|1|||
160765861|NCT02230891|580532917|FG000|6 Month|Physician Decision|0|||
160765862|NCT02230891|580532918|FG001|6 Month|Physician Decision|2|||
160765863|NCT02230891|580532919|FG002|6 Month|Physician Decision|0|||
160765864|NCT02230891|580532917|FG000|12 Month|Death|1|||
160531781|NCT01986920|579676368|FG001|Placebo|Withdrawal by Subject|0|||
160765865|NCT02230891|580532918|FG001|12 Month|Death|0|||
160765866|NCT02230891|580532919|FG002|12 Month|Death|0|||
160765867|NCT02230891|580532917|FG000|12 Month|Lost to Follow-up|0|||
160765868|NCT02230891|580532918|FG001|12 Month|Lost to Follow-up|1|||
160765869|NCT02230891|580532919|FG002|12 Month|Lost to Follow-up|0|||
160765870|NCT02230891|580532917|FG000|12 Month|Withdrawal by Subject|0|||
160765871|NCT02230891|580532918|FG001|12 Month|Withdrawal by Subject|2|||
160765872|NCT02230891|580532919|FG002|12 Month|Withdrawal by Subject|0|||
160871518|NCT00539864|580922788|FG001|Overall Study|Withdrawal by Subject|1|||
160871519|NCT01250145|580922789|FG000|Overall Study|Adverse Event|2|||
160871520|NCT01250145|580922790|FG001|Overall Study|Adverse Event|1|||
160871521|NCT01250145|580922789|FG000|Overall Study|Withdrawal by Subject|0|||
160871522|NCT01250145|580922790|FG001|Overall Study|Withdrawal by Subject|4|||
160871523|NCT02840799|580922793|FG000|Phase 1|Physician Decision|1|||
160871524|NCT02840799|580922794|FG001|Phase 1|Physician Decision|3|||
160871525|NCT02840799|580922793|FG000|Phase 1|Withdrawal by Subject|4|||
160871526|NCT02840799|580922794|FG001|Phase 1|Withdrawal by Subject|0|||
160871527|NCT02840799|580922793|FG000|Phase 2 (Crossover)|Adverse Event|0|||
160871528|NCT02840799|580922794|FG001|Phase 2 (Crossover)|Adverse Event|1|||
160871529|NCT02840799|580922793|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
160871530|NCT02840799|580922794|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
160871531|NCT03983317|580922795|FG000|Overall Study|Physician Decision|5|||
160871532|NCT02687191|580922800|FG000|Overall Study|Death|0|||
160871533|NCT02687191|580922801|FG001|Overall Study|Death|1|||
160871534|NCT02687191|580922802|FG002|Overall Study|Death|1|||
160871535|NCT02687191|580922803|FG003|Overall Study|Death|0|||
160871536|NCT02687191|580922804|FG004|Overall Study|Death|1|||
160871537|NCT02687191|580922805|FG005|Overall Study|Death|1|||
160871538|NCT02687191|580922800|FG000|Overall Study|Withdrawal by Subject|0|||
160871539|NCT02687191|580922801|FG001|Overall Study|Withdrawal by Subject|0|||
160871540|NCT02687191|580922802|FG002|Overall Study|Withdrawal by Subject|0|||
160871541|NCT02687191|580922803|FG003|Overall Study|Withdrawal by Subject|1|||
160871542|NCT02687191|580922804|FG004|Overall Study|Withdrawal by Subject|0|||
160871543|NCT02687191|580922805|FG005|Overall Study|Withdrawal by Subject|0|||
160871544|NCT01864603|580922808|FG000|Stage 2|DSMB design modification|86056|||
160871545|NCT01864603|580922809|FG001|Stage 2|DSMB design modification|92558|||
160871546|NCT04661579|580922812|FG000|Overall Study|Lost to Follow-up|19|||
160871547|NCT04661579|580922813|FG001|Overall Study|Lost to Follow-up|10|||
160871548|NCT04661579|580922814|FG002|Overall Study|Lost to Follow-up|2|||
160871549|NCT04661579|580922815|FG003|Overall Study|Lost to Follow-up|7|||
160871550|NCT04661579|580922816|FG004|Overall Study|Lost to Follow-up|11|||
160871551|NCT04661579|580922812|FG000|Overall Study|Physician Decision|2|||
160871552|NCT04661579|580922813|FG001|Overall Study|Physician Decision|0|||
160871553|NCT04661579|580922814|FG002|Overall Study|Physician Decision|0|||
160871554|NCT04661579|580922815|FG003|Overall Study|Physician Decision|1|||
160871555|NCT04661579|580922816|FG004|Overall Study|Physician Decision|0|||
160871556|NCT04661579|580922812|FG000|Overall Study|Withdrawal by Subject|1|||
160871557|NCT04661579|580922813|FG001|Overall Study|Withdrawal by Subject|4|||
160871558|NCT04661579|580922814|FG002|Overall Study|Withdrawal by Subject|0|||
160871559|NCT04661579|580922815|FG003|Overall Study|Withdrawal by Subject|2|||
160871560|NCT04661579|580922816|FG004|Overall Study|Withdrawal by Subject|0|||
160871561|NCT04661579|580922812|FG000|Overall Study|Death|1|||
160871562|NCT04661579|580922813|FG001|Overall Study|Death|0|||
160871563|NCT04661579|580922814|FG002|Overall Study|Death|0|||
160871564|NCT04661579|580922815|FG003|Overall Study|Death|0|||
160871565|NCT04661579|580922816|FG004|Overall Study|Death|0|||
160871566|NCT04661579|580922812|FG000|Overall Study|Other|1|||
160871567|NCT04661579|580922813|FG001|Overall Study|Other|2|||
160871568|NCT04661579|580922814|FG002|Overall Study|Other|1|||
160871569|NCT04661579|580922815|FG003|Overall Study|Other|1|||
160871570|NCT04661579|580922816|FG004|Overall Study|Other|1|||
160871571|NCT04661579|580922812|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
160871572|NCT04661579|580922813|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
160871573|NCT04661579|580922814|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
160871574|NCT04661579|580922815|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
160871575|NCT04661579|580922816|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
160871576|NCT04335136|580922817|FG000|Overall Study|Death|8|||
160871577|NCT04335136|580922818|FG001|Overall Study|Death|4|||
160871578|NCT04335136|580922817|FG000|Overall Study|Lost to Follow-up|2|||
160871579|NCT04335136|580922818|FG001|Overall Study|Lost to Follow-up|0|||
160871580|NCT04335136|580922817|FG000|Overall Study|Protocol Violation|1|||
160871581|NCT04335136|580922818|FG001|Overall Study|Protocol Violation|0|||
160871582|NCT04335136|580922817|FG000|Overall Study|Withdrawal by Subject|1|||
160871583|NCT04335136|580922818|FG001|Overall Study|Withdrawal by Subject|1|||
160871584|NCT04335136|580922817|FG000|Overall Study|Health-threatening condition|0|||
160871585|NCT04335136|580922818|FG001|Overall Study|Health-threatening condition|1|||
160871586|NCT04335136|580922817|FG000|Overall Study|Adverse Event|0|||
160871587|NCT04335136|580922818|FG001|Overall Study|Adverse Event|1|||
160871588|NCT04335136|580922817|FG000|Overall Study|Erroneously randomized|2|||
160871589|NCT04335136|580922818|FG001|Overall Study|Erroneously randomized|0|||
160871590|NCT01396447|580922819|FG000|Overall Study|Did Not Receive Treatment|3|||
160531782|NCT01986920|579676369|FG002|Placebo|Withdrawal by Subject|0|||
160531783|NCT01986920|579676370|FG003|Placebo|Withdrawal by Subject|1|||
160531784|NCT03023059|579676373|FG000|Overall Study|Withdrawal by Subject|5|||
160531785|NCT01338415|579676374|FG000|Core + Extension|Adverse Event|8|||
160531786|NCT01338415|579676375|FG001|Core + Extension|Adverse Event|6|||
160531787|NCT01338415|579676376|FG002|Core + Extension|Adverse Event|0|||
160531788|NCT01338415|579676374|FG000|Core + Extension|Withdrawal by Subject|1|||
160531789|NCT01338415|579676375|FG001|Core + Extension|Withdrawal by Subject|1|||
160531790|NCT01338415|579676376|FG002|Core + Extension|Withdrawal by Subject|0|||
160531791|NCT01338415|579676374|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
160531792|NCT01338415|579676375|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
160531793|NCT01338415|579676376|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
160531794|NCT01338415|579676374|FG000|Core + Extension|Other (administrative reason)|1|||
160531795|NCT01338415|579676375|FG001|Core + Extension|Other (administrative reason)|0|||
160531796|NCT01338415|579676376|FG002|Core + Extension|Other (administrative reason)|0|||
160531797|NCT01338415|579676374|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
160531798|NCT01338415|579676375|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
160531799|NCT01338415|579676376|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
160531800|NCT01338415|579676374|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
160531801|NCT01338415|579676375|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
160531802|NCT01338415|579676376|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
160531803|NCT01338415|579676374|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
160531804|NCT01338415|579676375|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
160531805|NCT01338415|579676376|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
160531806|NCT01338415|579676374|FG000|Exceptional Use Treatment Period|Death|0|||
160531807|NCT01338415|579676375|FG001|Exceptional Use Treatment Period|Death|0|||
160531808|NCT01338415|579676376|FG002|Exceptional Use Treatment Period|Death|1|||
160531809|NCT01118325|579676377|FG000|Overall Study|Adverse Event|1|||
160531810|NCT01118325|579676378|FG001|Overall Study|Adverse Event|0|||
160531811|NCT01118325|579676379|FG002|Overall Study|Adverse Event|1|||
160765873|NCT02230891|580532917|FG000|18 Month End of Study|Death|0|||
160765874|NCT02230891|580532918|FG001|18 Month End of Study|Death|0|||
160765875|NCT02230891|580532919|FG002|18 Month End of Study|Death|1|||
160765876|NCT02230891|580532917|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
160765877|NCT02230891|580532918|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
160765878|NCT02230891|580532919|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
160765879|NCT04194814|580532932|FG000|Overall Study|Physician Decision|3|||
160765880|NCT04194814|580532933|FG001|Overall Study|Physician Decision|0|||
160765881|NCT04194814|580532932|FG000|Overall Study|Withdrawal by Subject|0|||
160765882|NCT04194814|580532933|FG001|Overall Study|Withdrawal by Subject|2|||
160765883|NCT00577408|580534752|FG000|Overall Study|Stopped attending study visits|9|||
160765884|NCT00577408|580534753|FG001|Overall Study|Stopped attending study visits|11|||
160765885|NCT00577408|580534752|FG000|Overall Study|Continued opioid use|3|||
160765886|NCT00577408|580534753|FG001|Overall Study|Continued opioid use|2|||
160765887|NCT00577408|580534752|FG000|Overall Study|Non-compliance with study meds|0|||
160765888|NCT00577408|580534753|FG001|Overall Study|Non-compliance with study meds|3|||
160765889|NCT00577408|580534752|FG000|Overall Study|Refused Oral Naltrexone|0|||
160765890|NCT00577408|580534753|FG001|Overall Study|Refused Oral Naltrexone|1|||
160765891|NCT00577408|580534752|FG000|Overall Study|Moved out of state|0|||
160765892|NCT00577408|580534753|FG001|Overall Study|Moved out of state|1|||
160765893|NCT00577408|580534752|FG000|Overall Study|Scheduling Issues|0|||
160765894|NCT00577408|580534753|FG001|Overall Study|Scheduling Issues|3|||
160765895|NCT00577408|580534752|FG000|Overall Study|Death|0|||
160765896|NCT00577408|580534753|FG001|Overall Study|Death|1|||
160765897|NCT00577408|580534752|FG000|Overall Study|Psychiatric hospitalization|0|||
160765898|NCT00577408|580534753|FG001|Overall Study|Psychiatric hospitalization|1|||
160765899|NCT03435055|580534754|FG000|Screening|Physician Decision|2|||
160765900|NCT03435055|580534754|FG000|Received Intervention|Did not complete nitrous administration|3|||
160765901|NCT03817528|580534755|FG000|Overall Study|Withdrawal by Subject|1|||
160765902|NCT03817528|580534755|FG000|Overall Study|Adverse Event|2|||
160765903|NCT02732639|580534760|FG000|Overall Study|Lost to Follow-up|1|||
160765904|NCT01668797|580534761|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
160765905|NCT01668797|580534762|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
160765906|NCT01668797|580534763|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
160765907|NCT01668797|580534764|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
160765908|NCT01668797|580534761|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
160765909|NCT01668797|580534762|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
160765910|NCT01668797|580534763|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
160765911|NCT01668797|580534764|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
160765912|NCT01668797|580534761|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
160765913|NCT01668797|580534762|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
160871591|NCT01396447|580922820|FG001|Overall Study|Did Not Receive Treatment|2|||
160765914|NCT01668797|580534763|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
160765915|NCT01668797|580534764|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
160765916|NCT01668797|580534761|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
160765917|NCT01668797|580534762|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
160765918|NCT01668797|580534763|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
160765919|NCT01668797|580534764|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
160765920|NCT01668797|580534761|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
160765921|NCT01668797|580534762|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
160871592|NCT01396447|580922821|FG002|Overall Study|Did Not Receive Treatment|1|||
160871593|NCT01396447|580922822|FG003|Overall Study|Did Not Receive Treatment|0|||
160871594|NCT01396447|580922819|FG000|Overall Study|Adverse Event|15|||
160871595|NCT01396447|580922820|FG001|Overall Study|Adverse Event|12|||
160871596|NCT01396447|580922821|FG002|Overall Study|Adverse Event|12|||
160871597|NCT01396447|580922822|FG003|Overall Study|Adverse Event|17|||
160871598|NCT01396447|580922819|FG000|Overall Study|Insufficient Therapeutic Response|5|||
160871599|NCT01396447|580922820|FG001|Overall Study|Insufficient Therapeutic Response|5|||
160871600|NCT01396447|580922821|FG002|Overall Study|Insufficient Therapeutic Response|2|||
160871601|NCT01396447|580922822|FG003|Overall Study|Insufficient Therapeutic Response|4|||
160871602|NCT01396447|580922819|FG000|Overall Study|Protocol Violation|5|||
160871603|NCT01396447|580922820|FG001|Overall Study|Protocol Violation|2|||
160871604|NCT01396447|580922821|FG002|Overall Study|Protocol Violation|3|||
160871605|NCT01396447|580922822|FG003|Overall Study|Protocol Violation|7|||
160871606|NCT01396447|580922819|FG000|Overall Study|Withdrawal of Consent|11|||
160871607|NCT01396447|580922820|FG001|Overall Study|Withdrawal of Consent|9|||
160871608|NCT01396447|580922821|FG002|Overall Study|Withdrawal of Consent|4|||
160871609|NCT01396447|580922822|FG003|Overall Study|Withdrawal of Consent|15|||
160871610|NCT01396447|580922819|FG000|Overall Study|Lost to Follow-up|4|||
160871611|NCT01396447|580922820|FG001|Overall Study|Lost to Follow-up|8|||
160871612|NCT01396447|580922821|FG002|Overall Study|Lost to Follow-up|7|||
160871613|NCT01396447|580922822|FG003|Overall Study|Lost to Follow-up|9|||
160871614|NCT01396447|580922819|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160871615|NCT01396447|580922820|FG001|Overall Study|Other Miscellaneous Reasons|2|||
160871616|NCT01396447|580922821|FG002|Overall Study|Other Miscellaneous Reasons|1|||
160871617|NCT01396447|580922822|FG003|Overall Study|Other Miscellaneous Reasons|0|||
160871618|NCT01402102|580922823|FG000|Overall Study|Protocol Violation|1|||
160871619|NCT01402102|580922824|FG001|Overall Study|Protocol Violation|0|||
160871620|NCT01402102|580922823|FG000|Overall Study|Insufficiency of compliance|1|||
160871621|NCT01402102|580922824|FG001|Overall Study|Insufficiency of compliance|1|||
160871622|NCT01402102|580922823|FG000|Overall Study|Withdrawal by Subject|0|||
160871623|NCT01402102|580922824|FG001|Overall Study|Withdrawal by Subject|2|||
160871624|NCT04838626|580922825|FG000|Overall Study|Adverse Event|2|||
160871625|NCT04838626|580922825|FG000|Overall Study|Physician Decision|6|||
160871626|NCT04838626|580922825|FG000|Overall Study|Protocol Violation|3|||
160871627|NCT04838626|580922825|FG000|Overall Study|Withdrawal by Subject|9|||
160871628|NCT04838626|580922825|FG000|Overall Study|Technical Problems|2|||
160871629|NCT00670306|580922828|FG000|Overall Study|Adverse Event|8|||
160871630|NCT00670306|580922828|FG000|Overall Study|Lack of Efficacy|10|||
160871631|NCT00670306|580922828|FG000|Overall Study|Withdrawal by Subject|9|||
160871632|NCT00670306|580922828|FG000|Overall Study|Physician Decision|1|||
160871633|NCT00670306|580922828|FG000|Overall Study|Lost to Follow-up|8|||
160871634|NCT00670306|580922828|FG000|Overall Study|incl/excl criterias did not meet|19|||
160871635|NCT01192191|580922829|FG000|Overall Study|Adverse Event|7|||
160871636|NCT01192191|580922830|FG001|Overall Study|Adverse Event|12|||
160871637|NCT01192191|580922829|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
160871638|NCT01192191|580922830|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
160871639|NCT01192191|580922829|FG000|Overall Study|Lost to Follow-up|0|||
160871640|NCT01192191|580922830|FG001|Overall Study|Lost to Follow-up|1|||
160871641|NCT01192191|580922829|FG000|Overall Study|Withdrawal by Subject|1|||
160871642|NCT01192191|580922830|FG001|Overall Study|Withdrawal by Subject|6|||
160871643|NCT01047553|580922831|FG000|Overall Study|Adverse Event|10|||
160871644|NCT01047553|580922832|FG001|Overall Study|Adverse Event|5|||
160871645|NCT01047553|580922831|FG000|Overall Study|Withdrawal by Subject|4|||
160871646|NCT01047553|580922832|FG001|Overall Study|Withdrawal by Subject|2|||
160871647|NCT01047553|580922831|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
160871648|NCT01047553|580922832|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
160871649|NCT01047553|580922831|FG000|Overall Study|Lost to Follow-up|1|||
160871650|NCT01047553|580922832|FG001|Overall Study|Lost to Follow-up|0|||
160871651|NCT01047553|580922831|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
160871652|NCT01047553|580922832|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
160871653|NCT01047553|580922831|FG000|Overall Study|PI's decision|0|||
160871654|NCT01047553|580922832|FG001|Overall Study|PI's decision|1|||
160871655|NCT04292899|580922834|FG000|Overall Study|Death|21|||
160871656|NCT04292899|580922835|FG001|Overall Study|Death|28|||
160871657|NCT04292899|580922836|FG002|Overall Study|Death|188|||
160871658|NCT04292899|580922837|FG003|Overall Study|Death|371|||
160871659|NCT04292899|580922834|FG000|Overall Study|Lost to Follow-up|8|||
160871660|NCT04292899|580922835|FG001|Overall Study|Lost to Follow-up|4|||
160871661|NCT04292899|580922836|FG002|Overall Study|Lost to Follow-up|22|||
160871662|NCT04292899|580922837|FG003|Overall Study|Lost to Follow-up|235|||
160871663|NCT04292899|580922834|FG000|Overall Study|Withdrew consent|1|||
160871664|NCT04292899|580922835|FG001|Overall Study|Withdrew consent|0|||
160871665|NCT04292899|580922836|FG002|Overall Study|Withdrew consent|11|||
160765922|NCT01668797|580534763|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
160765923|NCT01668797|580534764|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
160765924|NCT01668797|580534761|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
160765925|NCT01668797|580534762|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
160765926|NCT01668797|580534763|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
160765927|NCT01668797|580534764|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
160765928|NCT01668797|580534761|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
160765929|NCT01668797|580534762|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
160765930|NCT01668797|580534763|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
160765931|NCT01668797|580534764|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
160765932|NCT01668797|580534761|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
160765933|NCT01668797|580534762|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
160765934|NCT01668797|580534763|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
160765935|NCT01668797|580534764|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
160765936|NCT01668797|580534761|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
160765937|NCT01668797|580534762|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
160765938|NCT01668797|580534763|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
160765939|NCT01668797|580534764|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
160765940|NCT01668797|580534761|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
160765941|NCT01668797|580534762|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
160765942|NCT01668797|580534763|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
160765943|NCT01668797|580534764|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
160765944|NCT01668797|580534761|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
160765945|NCT01668797|580534762|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
160765946|NCT01668797|580534763|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
160765947|NCT01668797|580534764|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
160765948|NCT01668797|580534761|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
160765949|NCT01668797|580534762|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
160765950|NCT01668797|580534763|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
160765951|NCT01668797|580534764|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
160765952|NCT01668797|580534761|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
160765953|NCT01668797|580534762|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
160765954|NCT01668797|580534763|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
160765955|NCT01668797|580534764|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
160765956|NCT01668797|580534761|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
160765957|NCT01668797|580534762|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
160765958|NCT01668797|580534763|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
160765959|NCT01668797|580534764|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
160765960|NCT01668797|580534761|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
160765961|NCT01668797|580534762|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
160765962|NCT01668797|580534763|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
160765963|NCT01668797|580534764|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
160871666|NCT04292899|580922837|FG003|Overall Study|Withdrew consent|32|||
160871667|NCT04292899|580922834|FG000|Overall Study|Adverse Event|2|||
160871668|NCT04292899|580922835|FG001|Overall Study|Adverse Event|1|||
160871669|NCT04292899|580922836|FG002|Overall Study|Adverse Event|2|||
160871670|NCT04292899|580922837|FG003|Overall Study|Adverse Event|2|||
160871671|NCT04292899|580922834|FG000|Overall Study|Investigator's Discretion|0|||
160871672|NCT04292899|580922835|FG001|Overall Study|Investigator's Discretion|0|||
160871673|NCT04292899|580922836|FG002|Overall Study|Investigator's Discretion|0|||
160871674|NCT04292899|580922837|FG003|Overall Study|Investigator's Discretion|3|||
160531812|NCT03334409|579676380|FG000|Overall Study|Did not meet inclusion criteria|1|||
160531813|NCT03334409|579676381|FG001|Overall Study|Did not meet inclusion criteria|0|||
160531814|NCT05215262|579676388|FG000|Overall Study|Lost to Follow-up|12|||
160531815|NCT05215262|579676389|FG001|Overall Study|Lost to Follow-up|0|||
160531816|NCT04880447|579676391|FG000|Overall Study|No vaccination information|1|||
160531817|NCT04880447|579676391|FG000|Overall Study|No adverse event information (missing information)|1|||
160531818|NCT04880447|579676391|FG000|Overall Study|Disease not covered in this study|35|||
160531819|NCT01353508|579676397|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
160531820|NCT01353508|579676398|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
160531821|NCT01353508|579676399|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
160531822|NCT01353508|579676400|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
160531823|NCT01353508|579676397|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
160531824|NCT01353508|579676398|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
160531825|NCT01353508|579676399|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
160531826|NCT01353508|579676400|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
160531827|NCT01576172|579676401|FG000|Overall Study|Ineligible|2|||
160531828|NCT01576172|579676402|FG001|Overall Study|Ineligible|1|||
160531829|NCT01576172|579676401|FG000|Overall Study|Withdrawal by Subject|2|||
160531830|NCT01576172|579676402|FG001|Overall Study|Withdrawal by Subject|0|||
160531831|NCT01576172|579676401|FG000|Overall Study|Insurance issue|1|||
160871675|NCT04292899|580922834|FG000|Overall Study|Non-compliance With Study Drug|0|||
160871676|NCT04292899|580922835|FG001|Overall Study|Non-compliance With Study Drug|0|||
160871677|NCT04292899|580922836|FG002|Overall Study|Non-compliance With Study Drug|0|||
160871678|NCT04292899|580922837|FG003|Overall Study|Non-compliance With Study Drug|1|||
160871679|NCT04292899|580922834|FG000|Overall Study|Protocol Violation|0|||
160871680|NCT04292899|580922835|FG001|Overall Study|Protocol Violation|0|||
160871681|NCT04292899|580922836|FG002|Overall Study|Protocol Violation|0|||
160871682|NCT04292899|580922837|FG003|Overall Study|Protocol Violation|1|||
160871683|NCT00948441|580922838|FG000|Overall Study|no longer meet inclusion criteria|1|||
160871684|NCT00948441|580922839|FG001|Overall Study|no longer meet inclusion criteria|4|||
160871685|NCT05340478|580922844|FG000|Overall Study|Scheduling Issues|10|||
160871686|NCT05340478|580922845|FG001|Overall Study|Scheduling Issues|4|||
160871687|NCT05340478|580922844|FG000|Overall Study|Neither member of dyad started treatment|2|||
160871688|NCT05340478|580922845|FG001|Overall Study|Neither member of dyad started treatment|2|||
160871689|NCT05340478|580922844|FG000|Overall Study|Withdrawn from study|2|||
160871690|NCT05340478|580922845|FG001|Overall Study|Withdrawn from study|2|||
160871691|NCT05340478|580922844|FG000|Overall Study|Lost to Follow-up|1|||
160871692|NCT05340478|580922845|FG001|Overall Study|Lost to Follow-up|4|||
160871693|NCT01032889|580922846|FG000|Overall Study|Adverse Event|2|||
160871694|NCT01032889|580922847|FG001|Overall Study|Adverse Event|2|||
160871695|NCT01032889|580922848|FG002|Overall Study|Adverse Event|0|||
160871696|NCT01032889|580922846|FG000|Overall Study|Withdrawal of Consent|1|||
160871697|NCT01032889|580922847|FG001|Overall Study|Withdrawal of Consent|2|||
160871698|NCT01032889|580922848|FG002|Overall Study|Withdrawal of Consent|1|||
160871699|NCT01032889|580922846|FG000|Overall Study|Patient Request|0|||
160871700|NCT01032889|580922847|FG001|Overall Study|Patient Request|1|||
160871701|NCT01032889|580922848|FG002|Overall Study|Patient Request|0|||
160871702|NCT01032889|580922846|FG000|Overall Study|Lost to Follow-up|1|||
160871703|NCT01032889|580922847|FG001|Overall Study|Lost to Follow-up|1|||
160871704|NCT01032889|580922848|FG002|Overall Study|Lost to Follow-up|0|||
160871705|NCT01032889|580922846|FG000|Overall Study|Lack of Submental Fat|2|||
160871706|NCT01032889|580922847|FG001|Overall Study|Lack of Submental Fat|8|||
160871707|NCT01032889|580922848|FG002|Overall Study|Lack of Submental Fat|1|||
160871708|NCT01032889|580922846|FG000|Overall Study|Miscellaneous Reasons|2|||
160871709|NCT01032889|580922847|FG001|Overall Study|Miscellaneous Reasons|1|||
160531832|NCT01576172|579676402|FG001|Overall Study|Insurance issue|0|||
160871710|NCT01032889|580922848|FG002|Overall Study|Miscellaneous Reasons|1|||
160871711|NCT02116205|580922849|FG000|Overall Study|Withdrawal by Subject|2|||
160871712|NCT02116205|580922850|FG001|Overall Study|Withdrawal by Subject|4|||
160871713|NCT02116205|580922851|FG002|Overall Study|Withdrawal by Subject|1|||
160531833|NCT02844920|579676409|FG000|Overall Study|Lost to Follow-up|2|||
160531834|NCT01910116|579676412|FG000|Overall Study|Adverse Event|0|||
160531835|NCT01910116|579676413|FG001|Overall Study|Adverse Event|3|||
160531836|NCT01910116|579676412|FG000|Overall Study|Lack of Efficacy|3|||
160871714|NCT02116205|580922852|FG003|Overall Study|Withdrawal by Subject|3|||
160871715|NCT02116205|580922849|FG000|Overall Study|Lost to Follow-up|0|||
160871716|NCT02116205|580922850|FG001|Overall Study|Lost to Follow-up|2|||
160871717|NCT02116205|580922851|FG002|Overall Study|Lost to Follow-up|1|||
160531837|NCT01910116|579676413|FG001|Overall Study|Lack of Efficacy|4|||
160765964|NCT01668797|580534761|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
160765965|NCT01668797|580534762|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
160765966|NCT01668797|580534763|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
160765967|NCT01668797|580534764|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
160765968|NCT01668797|580534761|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
160765969|NCT01668797|580534762|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
160765970|NCT01668797|580534763|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
160765971|NCT01668797|580534764|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
160765972|NCT01668797|580534761|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
160765973|NCT01668797|580534762|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
160765974|NCT01668797|580534763|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
160765975|NCT01668797|580534764|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
160765976|NCT01668797|580534761|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
160765977|NCT01668797|580534762|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
160765978|NCT01668797|580534763|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
160765979|NCT01668797|580534764|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
160765980|NCT01668797|580534761|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
160765981|NCT01668797|580534762|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
160765982|NCT01668797|580534763|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
160765983|NCT01668797|580534764|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
160765984|NCT01668797|580534761|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
160765985|NCT01668797|580534762|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
160765986|NCT01668797|580534763|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
160765987|NCT01668797|580534764|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
160765988|NCT01668797|580534761|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
160765989|NCT01668797|580534762|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
160765990|NCT01668797|580534763|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
160765991|NCT01668797|580534764|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
160765992|NCT01668797|580534761|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
160765993|NCT01668797|580534762|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
160765994|NCT01668797|580534763|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
160765995|NCT01668797|580534764|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
160765996|NCT01668797|580534761|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
160765997|NCT01668797|580534762|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
160765998|NCT01668797|580534763|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
160765999|NCT01668797|580534764|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
160766000|NCT01668797|580534761|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
160766001|NCT01668797|580534762|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
160766002|NCT01668797|580534763|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
160766003|NCT01668797|580534764|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
160766004|NCT00827567|580534765|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
160766005|NCT01259245|580534773|FG000|Overall Study|Withdrawal by Subject|27|||
160766006|NCT01259245|580534774|FG001|Overall Study|Withdrawal by Subject|24|||
160766007|NCT01259245|580534773|FG000|Overall Study|Death|1|||
160766008|NCT01259245|580534774|FG001|Overall Study|Death|2|||
160766009|NCT03937778|580534775|FG000|Overall Study|Withdrawal by Subject|1|||
160766010|NCT03937778|580534775|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
160766011|NCT01200355|580534777|FG000|Overall Study|Death|7|||
160766012|NCT01200355|580534778|FG001|Overall Study|Death|2|||
160766013|NCT00485303|580534779|FG000|Overall Study|Adverse Event|5|||
160766014|NCT00485303|580534779|FG000|Overall Study|Progressive Disease|44|||
160766015|NCT00485303|580534779|FG000|Overall Study|Other|3|||
160766016|NCT00485303|580534779|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
160766017|NCT00485303|580534779|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
160766018|NCT00296335|580534785|FG000|Overall Study|Recurrence|3|||
160766019|NCT00296335|580534786|FG001|Overall Study|Recurrence|51|||
160766020|NCT00296335|580534785|FG000|Overall Study|Adverse Event|17|||
160766021|NCT00296335|580534786|FG001|Overall Study|Adverse Event|27|||
160766022|NCT00296335|580534785|FG000|Overall Study|Lost to Follow-up|7|||
160871718|NCT02116205|580922852|FG003|Overall Study|Lost to Follow-up|2|||
160871719|NCT02116205|580922849|FG000|Overall Study|Physician Decision|0|||
160871720|NCT02116205|580922850|FG001|Overall Study|Physician Decision|1|||
160871721|NCT02116205|580922851|FG002|Overall Study|Physician Decision|1|||
160871722|NCT02116205|580922852|FG003|Overall Study|Physician Decision|1|||
160871723|NCT02116205|580922849|FG000|Overall Study|Exclusion criteria|0|||
160871724|NCT02116205|580922850|FG001|Overall Study|Exclusion criteria|0|||
160871725|NCT02116205|580922851|FG002|Overall Study|Exclusion criteria|1|||
160871726|NCT02116205|580922852|FG003|Overall Study|Exclusion criteria|0|||
160871727|NCT00630838|580922857|FG000|Overall Study|Death|0|||
160871728|NCT00630838|580922858|FG001|Overall Study|Death|1|||
160871729|NCT00630838|580922857|FG000|Overall Study|Lost to Follow-up|0|||
160871730|NCT00630838|580922858|FG001|Overall Study|Lost to Follow-up|1|||
160871731|NCT00928408|580922859|FG000|Overall Study|Other|2|||
160871732|NCT00928408|580922859|FG000|Overall Study|Withdrawal by Subject|4|||
160871733|NCT00928408|580922859|FG000|Overall Study|Death|5|||
160871734|NCT00928408|580922859|FG000|Overall Study|Lost to Follow-up|12|||
160871735|NCT00256997|580922864|FG000|Overall Study|Protocol Violation|1|||
160871736|NCT00256997|580922865|FG001|Overall Study|Protocol Violation|4|||
160871737|NCT00256997|580922864|FG000|Overall Study|Lack of Efficacy|1|||
160871738|NCT00256997|580922865|FG001|Overall Study|Lack of Efficacy|4|||
160871739|NCT00256997|580922864|FG000|Overall Study|Death|2|||
160871740|NCT00256997|580922865|FG001|Overall Study|Death|0|||
160871741|NCT00256997|580922864|FG000|Overall Study|Adverse Event|4|||
160871742|NCT00256997|580922865|FG001|Overall Study|Adverse Event|0|||
160871743|NCT00256997|580922864|FG000|Overall Study|Lost to Follow-up|3|||
160871744|NCT00256997|580922865|FG001|Overall Study|Lost to Follow-up|5|||
160871745|NCT00256997|580922864|FG000|Overall Study|Withdrawal by Subject|13|||
160871746|NCT00256997|580922865|FG001|Overall Study|Withdrawal by Subject|3|||
160871747|NCT00256997|580922864|FG000|Overall Study|Started but not treated|2|||
160871748|NCT00256997|580922865|FG001|Overall Study|Started but not treated|0|||
160871749|NCT00256997|580922864|FG000|Overall Study|Other|5|||
160871750|NCT00256997|580922865|FG001|Overall Study|Other|8|||
160871751|NCT00256997|580922864|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
160871752|NCT00256997|580922865|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
160871753|NCT00256997|580922864|FG000|Overall Study|Participant Non-compliant|3|||
160871754|NCT00256997|580922865|FG001|Overall Study|Participant Non-compliant|6|||
160871755|NCT00256997|580922864|FG000|Overall Study|Investigator Withdrew Participant|2|||
160871756|NCT00256997|580922865|FG001|Overall Study|Investigator Withdrew Participant|1|||
160871757|NCT04672655|580922868|FG000|Overall Study|Lost to Follow-up|12|||
160871758|NCT04672655|580922869|FG001|Overall Study|Lost to Follow-up|17|||
160871759|NCT04672655|580922868|FG000|Overall Study|Withdrawal by Subject|1|||
160871760|NCT04672655|580922869|FG001|Overall Study|Withdrawal by Subject|0|||
160871761|NCT04672655|580922868|FG000|Overall Study|Withdrawal by Study|1|||
160871762|NCT04672655|580922869|FG001|Overall Study|Withdrawal by Study|0|||
160871763|NCT01326104|580922870|FG000|Overall Study|progressed prior to vaccine|0|||
160871764|NCT01326104|580922871|FG001|Overall Study|progressed prior to vaccine|2|||
160871765|NCT01326104|580922870|FG000|Overall Study|unable to make vaccine|0|||
160871766|NCT01326104|580922871|FG001|Overall Study|unable to make vaccine|2|||
160871767|NCT03843541|580922872|FG000|Overall Study|Adverse Event|4|||
160871768|NCT03843541|580922873|FG001|Overall Study|Adverse Event|2|||
160871769|NCT03843541|580922874|FG002|Overall Study|Adverse Event|3|||
160871770|NCT03843541|580922872|FG000|Overall Study|Death|1|||
160871771|NCT03843541|580922873|FG001|Overall Study|Death|0|||
160871772|NCT03843541|580922874|FG002|Overall Study|Death|0|||
160871773|NCT03843541|580922872|FG000|Overall Study|Lack of adherence to study medication|0|||
160871774|NCT03843541|580922873|FG001|Overall Study|Lack of adherence to study medication|0|||
160871775|NCT03843541|580922874|FG002|Overall Study|Lack of adherence to study medication|1|||
160871776|NCT03843541|580922872|FG000|Overall Study|Physician Decision|1|||
160871777|NCT03843541|580922873|FG001|Overall Study|Physician Decision|2|||
160871778|NCT03843541|580922874|FG002|Overall Study|Physician Decision|2|||
160871779|NCT03843541|580922872|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
160871780|NCT03843541|580922873|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
160871781|NCT03843541|580922874|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
160871782|NCT03843541|580922872|FG000|Overall Study|Withdrawal by Subject|6|||
160871783|NCT03843541|580922873|FG001|Overall Study|Withdrawal by Subject|9|||
160871784|NCT03843541|580922874|FG002|Overall Study|Withdrawal by Subject|7|||
160871785|NCT03843541|580922872|FG000|Overall Study|Administration of rescue mucolytic|0|||
160871786|NCT03843541|580922873|FG001|Overall Study|Administration of rescue mucolytic|0|||
160871787|NCT03843541|580922874|FG002|Overall Study|Administration of rescue mucolytic|1|||
160871788|NCT03843541|580922872|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
160871789|NCT03843541|580922873|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
160871790|NCT03843541|580922874|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
160871791|NCT04163016|580922875|FG000|Enrollment|Adverse Event|1|||
160871792|NCT04163016|580922876|FG001|Enrollment|Adverse Event|0|||
160871793|NCT04163016|580922877|FG002|Enrollment|Adverse Event|0|||
160871794|NCT04163016|580922878|FG003|Enrollment|Adverse Event|0|||
160871795|NCT04163016|580922875|FG000|Treatment|Adverse Event|0|||
160871796|NCT04163016|580922876|FG001|Treatment|Adverse Event|1|||
160871797|NCT04163016|580922877|FG002|Treatment|Adverse Event|0|||
160871798|NCT04163016|580922878|FG003|Treatment|Adverse Event|0|||
160871799|NCT04163016|580922875|FG000|Treatment|Withdrawal by Subject|0|||
160871800|NCT04163016|580922876|FG001|Treatment|Withdrawal by Subject|2|||
160871801|NCT04163016|580922877|FG002|Treatment|Withdrawal by Subject|0|||
160871802|NCT04163016|580922878|FG003|Treatment|Withdrawal by Subject|0|||
160871803|NCT04163016|580922875|FG000|Treatment|Indeterminate TB-test|0|||
160871804|NCT04163016|580922876|FG001|Treatment|Indeterminate TB-test|0|||
160871805|NCT04163016|580922877|FG002|Treatment|Indeterminate TB-test|0|||
160871806|NCT04163016|580922878|FG003|Treatment|Indeterminate TB-test|1|||
160871807|NCT04163016|580922875|FG000|Treatment|Participant did not want to continue in study|0|||
160871808|NCT04163016|580922876|FG001|Treatment|Participant did not want to continue in study|0|||
160871809|NCT04163016|580922877|FG002|Treatment|Participant did not want to continue in study|0|||
160871810|NCT04163016|580922878|FG003|Treatment|Participant did not want to continue in study|1|||
160871811|NCT01104311|580922885|FG000|Overall Study|Withdrawal by Subject|6|||
160871812|NCT01104311|580922886|FG001|Overall Study|Withdrawal by Subject|6|||
160871813|NCT01104311|580922885|FG000|Overall Study|Protocol Violation|0|||
160871814|NCT01104311|580922886|FG001|Overall Study|Protocol Violation|1|||
160871815|NCT01104311|580922885|FG000|Overall Study|Physician Decision|2|||
160871816|NCT01104311|580922886|FG001|Overall Study|Physician Decision|2|||
160871817|NCT01104311|580922885|FG000|Overall Study|low compliance|1|||
160871818|NCT01104311|580922886|FG001|Overall Study|low compliance|1|||
160871819|NCT01104311|580922885|FG000|Overall Study|Adverse Event|1|||
160531838|NCT01910116|579676412|FG000|Overall Study|Lost to Follow-up|1|||
160531839|NCT01910116|579676413|FG001|Overall Study|Lost to Follow-up|0|||
160531840|NCT01910116|579676412|FG000|Overall Study|Protocol Violation|1|||
160531841|NCT01910116|579676413|FG001|Overall Study|Protocol Violation|2|||
160531842|NCT01910116|579676412|FG000|Overall Study|Withdrawal by Subject|8|||
160531843|NCT01910116|579676413|FG001|Overall Study|Withdrawal by Subject|3|||
160531844|NCT01910116|579676412|FG000|Overall Study|uncertain allocation|1|||
160531845|NCT01910116|579676413|FG001|Overall Study|uncertain allocation|3|||
160531846|NCT01910116|579676412|FG000|Overall Study|incomplete data|0|||
160531847|NCT01910116|579676413|FG001|Overall Study|incomplete data|1|||
160531848|NCT00736034|579676414|FG000|Overall Study|Adverse Event|2|||
160531849|NCT02289352|579676417|FG000|Overall Study|Withdrawal by Subject|1|||
160531850|NCT02289352|579676418|FG001|Overall Study|Withdrawal by Subject|1|||
160531851|NCT02289352|579676419|FG002|Overall Study|Withdrawal by Subject|0|||
160531852|NCT03606980|579676420|FG000|Overall Study|Lost to Follow-up|3|||
160531853|NCT03606980|579676421|FG001|Overall Study|Lost to Follow-up|2|||
160531854|NCT03606980|579676422|FG002|Overall Study|Lost to Follow-up|3|||
160531855|NCT03606980|579676420|FG000|Overall Study|Withdrawal by Subject|1|||
160531856|NCT03606980|579676421|FG001|Overall Study|Withdrawal by Subject|0|||
160531857|NCT03606980|579676422|FG002|Overall Study|Withdrawal by Subject|4|||
160531858|NCT00911625|579676427|FG000|Overall Study|Lost to Follow-up|7|||
160871820|NCT01104311|580922886|FG001|Overall Study|Adverse Event|2|||
160871821|NCT04434937|580922888|FG000|Overall Study|Death|4|||
160871822|NCT04434937|580922888|FG000|Overall Study|Withdrawal by Subject|1|||
160871823|NCT04434937|580922888|FG000|Overall Study|Transitioned to Rollover Study|19|||
160871824|NCT04434937|580922888|FG000|Overall Study|Progressive Disease|18|||
160871825|NCT04193189|580922893|FG000|Overall Study|Lost to Follow-up|9|||
160871826|NCT04193189|580922894|FG001|Overall Study|Lost to Follow-up|7|||
160871827|NCT04193189|580922895|FG002|Overall Study|Lost to Follow-up|9|||
160871828|NCT04193189|580922896|FG003|Overall Study|Lost to Follow-up|0|||
160871829|NCT04193189|580922893|FG000|Overall Study|Withdrawal by Subject|1|||
160871830|NCT04193189|580922894|FG001|Overall Study|Withdrawal by Subject|2|||
160871831|NCT04193189|580922895|FG002|Overall Study|Withdrawal by Subject|2|||
160871832|NCT04193189|580922896|FG003|Overall Study|Withdrawal by Subject|0|||
160871833|NCT04193189|580922893|FG000|Overall Study|Death|1|||
160871834|NCT04193189|580922894|FG001|Overall Study|Death|1|||
160871835|NCT04193189|580922895|FG002|Overall Study|Death|0|||
160871836|NCT04193189|580922896|FG003|Overall Study|Death|0|||
160871837|NCT04193189|580922893|FG000|Overall Study|Protocol Violation|0|||
160871838|NCT04193189|580922894|FG001|Overall Study|Protocol Violation|0|||
160871839|NCT04193189|580922895|FG002|Overall Study|Protocol Violation|0|||
160871840|NCT04193189|580922896|FG003|Overall Study|Protocol Violation|1|||
160871841|NCT01243242|580924461|FG000|Overall Study|Adverse Event|1|||
160871842|NCT01243242|580924462|FG001|Overall Study|Adverse Event|1|||
160871843|NCT01243242|580924461|FG000|Overall Study|Withdrawal by Subject|1|||
160871844|NCT01243242|580924462|FG001|Overall Study|Withdrawal by Subject|1|||
160871845|NCT01243242|580924461|FG000|Overall Study|Physician Decision|0|||
160871846|NCT01243242|580924462|FG001|Overall Study|Physician Decision|1|||
160871847|NCT01243242|580924461|FG000|Overall Study|sponsor decision|0|||
160871848|NCT01243242|580924462|FG001|Overall Study|sponsor decision|1|||
160871849|NCT01243242|580924461|FG000|Overall Study|non compliance|1|||
160871850|NCT01243242|580924462|FG001|Overall Study|non compliance|0|||
160871851|NCT01349049|580924468|FG000|Overall Study|Disease progression|3|||
160871852|NCT01349049|580924469|FG001|Overall Study|Disease progression|5|||
160871853|NCT01349049|580924470|FG002|Overall Study|Disease progression|3|||
160871854|NCT01349049|580924471|FG003|Overall Study|Disease progression|2|||
160871855|NCT01349049|580924472|FG004|Overall Study|Disease progression|2|||
160871856|NCT01349049|580924473|FG005|Overall Study|Disease progression|2|||
160871857|NCT01349049|580924474|FG006|Overall Study|Disease progression|3|||
160871858|NCT01349049|580924475|FG007|Overall Study|Disease progression|2|||
160871859|NCT01349049|580924476|FG008|Overall Study|Disease progression|33|||
160871860|NCT01349049|580924468|FG000|Overall Study|Adverse Event|0|||
160531859|NCT00911625|579676428|FG001|Overall Study|Lost to Follow-up|0|||
160531860|NCT04166383|579676429|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
160871861|NCT01349049|580924469|FG001|Overall Study|Adverse Event|1|||
160531861|NCT04166383|579676429|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
160531862|NCT04166383|579676429|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
160531863|NCT03044886|579676430|FG000|Overall Study|Lost to Follow-up|15|||
160871862|NCT01349049|580924470|FG002|Overall Study|Adverse Event|0|||
160871863|NCT01349049|580924471|FG003|Overall Study|Adverse Event|0|||
160871864|NCT01349049|580924472|FG004|Overall Study|Adverse Event|0|||
160871865|NCT01349049|580924473|FG005|Overall Study|Adverse Event|3|||
160871866|NCT01349049|580924474|FG006|Overall Study|Adverse Event|1|||
160531864|NCT03044886|579676431|FG001|Overall Study|Lost to Follow-up|10|||
160531865|NCT03044886|579676432|FG002|Overall Study|Lost to Follow-up|12|||
160871867|NCT01349049|580924475|FG007|Overall Study|Adverse Event|0|||
160871868|NCT01349049|580924476|FG008|Overall Study|Adverse Event|4|||
160871869|NCT01349049|580924468|FG000|Overall Study|Physician Decision|0|||
160871870|NCT01349049|580924469|FG001|Overall Study|Physician Decision|1|||
160871871|NCT01349049|580924470|FG002|Overall Study|Physician Decision|0|||
160766023|NCT00296335|580534786|FG001|Overall Study|Lost to Follow-up|33|||
160766024|NCT00296335|580534785|FG000|Overall Study|Physician Decision|3|||
160766025|NCT00296335|580534786|FG001|Overall Study|Physician Decision|11|||
160766026|NCT04656652|580534787|FG000|Overall Study|Lost to Follow-up|2|||
160766027|NCT04656652|580534788|FG001|Overall Study|Lost to Follow-up|2|||
160766028|NCT04656652|580534787|FG000|Overall Study|Death|213|||
160766029|NCT04656652|580534788|FG001|Overall Study|Death|212|||
160766030|NCT04656652|580534787|FG000|Overall Study|Other|1|||
160766031|NCT04656652|580534788|FG001|Overall Study|Other|0|||
160766032|NCT04656652|580534787|FG000|Overall Study|Withdrawal by Subject|15|||
160766033|NCT04656652|580534788|FG001|Overall Study|Withdrawal by Subject|29|||
160766034|NCT02722967|580534789|FG000|Overall Study|Adverse Event|1|||
160766035|NCT02722967|580534790|FG001|Overall Study|Adverse Event|0|||
160766036|NCT02722967|580534791|FG002|Overall Study|Adverse Event|0|||
160766037|NCT02722967|580534789|FG000|Overall Study|Lost to Follow-up|0|||
160766038|NCT02722967|580534790|FG001|Overall Study|Lost to Follow-up|1|||
160766039|NCT02722967|580534791|FG002|Overall Study|Lost to Follow-up|0|||
160766040|NCT02722967|580534789|FG000|Overall Study|Non-compliance with patch wearing|2|||
160766041|NCT02722967|580534790|FG001|Overall Study|Non-compliance with patch wearing|1|||
160766042|NCT02722967|580534791|FG002|Overall Study|Non-compliance with patch wearing|1|||
160766043|NCT02722967|580534789|FG000|Overall Study|Withdrawal by Subject|1|||
160766044|NCT02722967|580534790|FG001|Overall Study|Withdrawal by Subject|0|||
160871872|NCT01349049|580924471|FG003|Overall Study|Physician Decision|0|||
160871873|NCT01349049|580924472|FG004|Overall Study|Physician Decision|0|||
160871874|NCT01349049|580924473|FG005|Overall Study|Physician Decision|0|||
160871875|NCT01349049|580924474|FG006|Overall Study|Physician Decision|0|||
160871876|NCT01349049|580924475|FG007|Overall Study|Physician Decision|0|||
160871877|NCT01349049|580924476|FG008|Overall Study|Physician Decision|2|||
160871878|NCT01349049|580924468|FG000|Overall Study|Protocol Violation|0|||
160871879|NCT01349049|580924469|FG001|Overall Study|Protocol Violation|0|||
160871880|NCT01349049|580924470|FG002|Overall Study|Protocol Violation|0|||
160871881|NCT01349049|580924471|FG003|Overall Study|Protocol Violation|0|||
160871882|NCT01349049|580924472|FG004|Overall Study|Protocol Violation|0|||
160871883|NCT01349049|580924473|FG005|Overall Study|Protocol Violation|0|||
160871884|NCT01349049|580924474|FG006|Overall Study|Protocol Violation|0|||
160766045|NCT02722967|580534791|FG002|Overall Study|Withdrawal by Subject|1|||
160766046|NCT02722967|580534789|FG000|Overall Study|Physician Decision|1|||
160766047|NCT02722967|580534790|FG001|Overall Study|Physician Decision|0|||
160766048|NCT02722967|580534791|FG002|Overall Study|Physician Decision|0|||
160766049|NCT02722967|580534789|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
160766050|NCT02722967|580534790|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
160871885|NCT01349049|580924475|FG007|Overall Study|Protocol Violation|0|||
160871886|NCT01349049|580924476|FG008|Overall Study|Protocol Violation|1|||
160871887|NCT01349049|580924468|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
160871888|NCT01349049|580924469|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
160871889|NCT01349049|580924470|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
160871890|NCT01349049|580924471|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
160871891|NCT01349049|580924472|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
160871892|NCT01349049|580924473|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
160871893|NCT01349049|580924474|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
160871894|NCT01349049|580924475|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
160871895|NCT01349049|580924476|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
160871896|NCT01349049|580924468|FG000|Overall Study|Other|0|||
160871897|NCT01349049|580924469|FG001|Overall Study|Other|0|||
160871898|NCT01349049|580924470|FG002|Overall Study|Other|0|||
160871899|NCT01349049|580924471|FG003|Overall Study|Other|0|||
160871900|NCT01349049|580924472|FG004|Overall Study|Other|0|||
160871901|NCT01349049|580924473|FG005|Overall Study|Other|1|||
160871902|NCT01349049|580924474|FG006|Overall Study|Other|0|||
160871903|NCT01349049|580924475|FG007|Overall Study|Other|0|||
160871904|NCT01349049|580924476|FG008|Overall Study|Other|4|||
160871905|NCT01349049|580924468|FG000|Overall Study|Death|0|||
160871906|NCT01349049|580924469|FG001|Overall Study|Death|0|||
160871907|NCT01349049|580924470|FG002|Overall Study|Death|0|||
160871908|NCT01349049|580924471|FG003|Overall Study|Death|0|||
160871909|NCT01349049|580924472|FG004|Overall Study|Death|0|||
160871910|NCT01349049|580924473|FG005|Overall Study|Death|0|||
160871911|NCT01349049|580924474|FG006|Overall Study|Death|0|||
160871912|NCT01349049|580924475|FG007|Overall Study|Death|1|||
160871913|NCT01349049|580924476|FG008|Overall Study|Death|5|||
160871914|NCT01349049|580924468|FG000|Overall Study|Non-compliance|0|||
160871915|NCT01349049|580924469|FG001|Overall Study|Non-compliance|0|||
160871916|NCT01349049|580924470|FG002|Overall Study|Non-compliance|0|||
160871917|NCT01349049|580924471|FG003|Overall Study|Non-compliance|1|||
160871918|NCT01349049|580924472|FG004|Overall Study|Non-compliance|0|||
160871919|NCT01349049|580924473|FG005|Overall Study|Non-compliance|0|||
160871920|NCT01349049|580924474|FG006|Overall Study|Non-compliance|0|||
160871921|NCT01349049|580924475|FG007|Overall Study|Non-compliance|0|||
160871922|NCT01349049|580924476|FG008|Overall Study|Non-compliance|0|||
160871923|NCT01349049|580924468|FG000|Overall Study|Withdrawal by Subject|0|||
160871924|NCT01349049|580924469|FG001|Overall Study|Withdrawal by Subject|0|||
160871925|NCT01349049|580924470|FG002|Overall Study|Withdrawal by Subject|0|||
160871926|NCT01349049|580924471|FG003|Overall Study|Withdrawal by Subject|0|||
160871927|NCT01349049|580924472|FG004|Overall Study|Withdrawal by Subject|0|||
160871928|NCT01349049|580924473|FG005|Overall Study|Withdrawal by Subject|0|||
160871929|NCT01349049|580924474|FG006|Overall Study|Withdrawal by Subject|0|||
160871930|NCT01349049|580924475|FG007|Overall Study|Withdrawal by Subject|0|||
160871931|NCT01349049|580924476|FG008|Overall Study|Withdrawal by Subject|6|||
160871932|NCT00552188|580924480|FG000|Overall Study|Adverse Event|0|||
160871933|NCT00552188|580924481|FG001|Overall Study|Adverse Event|2|||
160871934|NCT00552188|580924480|FG000|Overall Study|Lost to Follow-up|2|||
160871935|NCT00552188|580924481|FG001|Overall Study|Lost to Follow-up|1|||
160871936|NCT00552188|580924480|FG000|Overall Study|Withdrawal of consent|0|||
160871937|NCT00552188|580924481|FG001|Overall Study|Withdrawal of consent|1|||
160871938|NCT00552188|580924480|FG000|Overall Study|Subject returned to home country|0|||
160871939|NCT00552188|580924481|FG001|Overall Study|Subject returned to home country|1|||
160871940|NCT01256294|580924482|FG000|Overall Study|Adverse Event|1|||
160871941|NCT01256294|580924483|FG001|Overall Study|Adverse Event|0|||
160871942|NCT01256294|580924482|FG000|Overall Study|Withdrawal by Subject|1|||
160871943|NCT01256294|580924483|FG001|Overall Study|Withdrawal by Subject|1|||
160871944|NCT01256294|580924482|FG000|Overall Study|Protocol deviation|2|||
160871945|NCT01256294|580924483|FG001|Overall Study|Protocol deviation|1|||
160871946|NCT04681352|580924484|FG000|Overall Study|Lost to Follow-up|2|||
160871947|NCT04681352|580924484|FG000|Overall Study|Withdrawal by Subject|22|||
160871948|NCT03887702|580924485|FG000|Overall Study|Study terminated|0|||
160871949|NCT03887702|580924486|FG001|Overall Study|Study terminated|0|||
160871950|NCT03887702|580924487|FG002|Overall Study|Study terminated|2|||
160871951|NCT03887702|580924488|FG003|Overall Study|Study terminated|2|||
160871952|NCT01643772|580924489|FG000|Overall Study|Protocol Violation|0|||
160871953|NCT01643772|580924490|FG001|Overall Study|Protocol Violation|0|||
160871954|NCT01643772|580924491|FG002|Overall Study|Protocol Violation|0|||
160871955|NCT01643772|580924492|FG003|Overall Study|Protocol Violation|1|||
160871956|NCT01643772|580924489|FG000|Overall Study|Adverse Event|0|||
160531866|NCT02374021|579676435|FG000|Overall Study|Adverse Event|1|||
160871957|NCT01643772|580924490|FG001|Overall Study|Adverse Event|0|||
160871958|NCT01643772|580924491|FG002|Overall Study|Adverse Event|0|||
160871959|NCT01643772|580924492|FG003|Overall Study|Adverse Event|1|||
160871960|NCT01675544|580924495|FG000|Overall Study|Withdrawal by Subject|2|||
160871961|NCT03860818|580924496|FG000|Overall Study|Death|144|||
160871962|NCT03860818|580924497|FG001|Overall Study|Death|195|||
160871963|NCT03860818|580924496|FG000|Overall Study|Graft Loss|32|||
160871964|NCT03860818|580924497|FG001|Overall Study|Graft Loss|45|||
160871965|NCT00792571|580924498|FG000|Overall Study|Death|1|||
160871966|NCT00792571|580924498|FG000|Overall Study|Adverse Event|4|||
160871967|NCT00792571|580924498|FG000|Overall Study|Withdrawal by Subject|1|||
160871968|NCT00792571|580924498|FG000|Overall Study|Other|4|||
160871969|NCT02600819|580924499|FG000|GEN Phase|Adverse Event|2|||
160871970|NCT02600819|580924500|FG001|GEN Phase|Adverse Event|0|||
160871971|NCT02600819|580924499|FG000|GEN Phase|Death|2|||
160871972|NCT02600819|580924500|FG001|GEN Phase|Death|0|||
160871973|NCT02600819|580924499|FG000|GEN Phase|Investigator's Discretion|4|||
160871974|NCT02600819|580924500|FG001|GEN Phase|Investigator's Discretion|0|||
160871975|NCT02600819|580924499|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
160871976|NCT02600819|580924500|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
160871977|NCT02600819|580924499|FG000|GEN Phase|Withdrew Consent|5|||
160871978|NCT02600819|580924500|FG001|GEN Phase|Withdrew Consent|0|||
160871979|NCT02600819|580924499|FG000|GEN Phase|Lost to Follow-up|2|||
160871980|NCT02600819|580924500|FG001|GEN Phase|Lost to Follow-up|0|||
160871981|NCT00505778|580924501|FG000|Overall Study|Adverse Event|2|||
160871982|NCT00505778|580924502|FG001|Overall Study|Adverse Event|7|||
160871983|NCT00505778|580924501|FG000|Overall Study|Physician Decision|8|||
160871984|NCT00505778|580924502|FG001|Overall Study|Physician Decision|14|||
160871985|NCT00505778|580924501|FG000|Overall Study|Lost to Follow-up|17|||
160871986|NCT00505778|580924502|FG001|Overall Study|Lost to Follow-up|23|||
160871987|NCT00505778|580924501|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
160871988|NCT00505778|580924502|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
160871989|NCT00505778|580924501|FG000|Overall Study|Protocol Violation|7|||
160871990|NCT00505778|580924502|FG001|Overall Study|Protocol Violation|9|||
160871991|NCT00505778|580924501|FG000|Overall Study|Withdrawal by Subject|29|||
160871992|NCT00505778|580924502|FG001|Overall Study|Withdrawal by Subject|14|||
160871993|NCT00505778|580924501|FG000|Overall Study|Relapse|65|||
160871994|NCT00505778|580924502|FG001|Overall Study|Relapse|65|||
160871995|NCT00505778|580924501|FG000|Overall Study|Took No Study Drug|2|||
160871996|NCT00505778|580924502|FG001|Overall Study|Took No Study Drug|2|||
160871997|NCT01621802|580924504|FG000|Overall Study|Protocol Violation|0|||
160871998|NCT01621802|580924505|FG001|Overall Study|Protocol Violation|0|||
160871999|NCT01621802|580924506|FG002|Overall Study|Protocol Violation|0|||
160872000|NCT01621802|580924507|FG003|Overall Study|Protocol Violation|0|||
160872001|NCT01621802|580924508|FG004|Overall Study|Protocol Violation|0|||
160872002|NCT01621802|580924509|FG005|Overall Study|Protocol Violation|1|||
160872003|NCT01621802|580924504|FG000|Overall Study|Withdrawal by Subject|8|||
160872004|NCT01621802|580924505|FG001|Overall Study|Withdrawal by Subject|4|||
160872005|NCT01621802|580924506|FG002|Overall Study|Withdrawal by Subject|4|||
160872006|NCT01621802|580924507|FG003|Overall Study|Withdrawal by Subject|2|||
160872007|NCT01621802|580924508|FG004|Overall Study|Withdrawal by Subject|2|||
160872008|NCT01621802|580924509|FG005|Overall Study|Withdrawal by Subject|0|||
160872009|NCT01621802|580924504|FG000|Overall Study|Migrated/moved from study area|0|||
160872010|NCT01621802|580924505|FG001|Overall Study|Migrated/moved from study area|0|||
160872011|NCT01621802|580924506|FG002|Overall Study|Migrated/moved from study area|2|||
160872012|NCT01621802|580924507|FG003|Overall Study|Migrated/moved from study area|0|||
160872013|NCT01621802|580924508|FG004|Overall Study|Migrated/moved from study area|1|||
160872014|NCT01621802|580924509|FG005|Overall Study|Migrated/moved from study area|0|||
160872015|NCT01621802|580924504|FG000|Overall Study|Others|3|||
160872016|NCT01621802|580924505|FG001|Overall Study|Others|3|||
160872017|NCT01621802|580924506|FG002|Overall Study|Others|3|||
160872018|NCT01621802|580924507|FG003|Overall Study|Others|2|||
160872019|NCT01621802|580924508|FG004|Overall Study|Others|1|||
160872020|NCT01621802|580924509|FG005|Overall Study|Others|0|||
160872021|NCT01621802|580924504|FG000|Overall Study|Lost to Follow-up|36|||
160872022|NCT01621802|580924505|FG001|Overall Study|Lost to Follow-up|16|||
160872023|NCT01621802|580924506|FG002|Overall Study|Lost to Follow-up|24|||
160872024|NCT01621802|580924507|FG003|Overall Study|Lost to Follow-up|7|||
160872025|NCT01621802|580924508|FG004|Overall Study|Lost to Follow-up|31|||
160872026|NCT01621802|580924509|FG005|Overall Study|Lost to Follow-up|11|||
160872027|NCT03790696|580924510|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
160872028|NCT03790696|580924511|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
160872029|NCT01149148|580924512|FG000|Overall Study|Lost to Follow-up|1|||
160872030|NCT01149148|580924513|FG001|Overall Study|Lost to Follow-up|2|||
160872031|NCT01149148|580924512|FG000|Overall Study|Death|1|||
160872032|NCT01149148|580924513|FG001|Overall Study|Death|0|||
160531867|NCT02374021|579676436|FG001|Overall Study|Adverse Event|0|||
160872033|NCT03436082|580924514|FG000|Overall Study|Did not undergo procedure|1|||
160872034|NCT03436082|580924515|FG001|Overall Study|Did not undergo procedure|0|||
160872035|NCT04896086|580924516|FG000|Overall Study|Lost to Follow-up|0|||
160872036|NCT04896086|580924517|FG001|Overall Study|Lost to Follow-up|2|||
160872037|NCT04896086|580924518|FG002|Overall Study|Lost to Follow-up|1|||
160872038|NCT04896086|580924519|FG003|Overall Study|Lost to Follow-up|0|||
160872039|NCT04896086|580924520|FG004|Overall Study|Lost to Follow-up|0|||
160872040|NCT04896086|580924516|FG000|Overall Study|Physician Decision|0|||
160872041|NCT04896086|580924517|FG001|Overall Study|Physician Decision|1|||
160872042|NCT04896086|580924518|FG002|Overall Study|Physician Decision|0|||
160872043|NCT04896086|580924519|FG003|Overall Study|Physician Decision|0|||
160872044|NCT04896086|580924520|FG004|Overall Study|Physician Decision|0|||
160872045|NCT04896086|580924516|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
160872046|NCT04896086|580924517|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
160872047|NCT04896086|580924518|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
160872048|NCT04896086|580924519|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
160872049|NCT04896086|580924520|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
160872050|NCT04896086|580924516|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
160872051|NCT04896086|580924517|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
160872052|NCT04896086|580924518|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
160872053|NCT04896086|580924519|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
160872054|NCT04896086|580924520|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
160872055|NCT02249832|580924523|FG000|Overall Study|Withdrawal by Subject|3|||
160872056|NCT02249832|580924523|FG000|Overall Study|Lost to Follow-up|10|||
160872057|NCT04881942|580924530|FG000|Overall Study|Adverse Event|0|||
160872058|NCT04881942|580924531|FG001|Overall Study|Adverse Event|0|||
160872059|NCT04881942|580924532|FG002|Overall Study|Adverse Event|0|||
160872060|NCT04881942|580924533|FG003|Overall Study|Adverse Event|0|||
160872061|NCT04881942|580924534|FG004|Overall Study|Adverse Event|1|||
160872062|NCT04881942|580924530|FG000|Overall Study|Alternates|0|||
160872063|NCT04881942|580924531|FG001|Overall Study|Alternates|0|||
160872064|NCT04881942|580924532|FG002|Overall Study|Alternates|0|||
160872065|NCT04881942|580924533|FG003|Overall Study|Alternates|0|||
160872066|NCT04881942|580924534|FG004|Overall Study|Alternates|2|||
160872067|NCT02423902|580924535|FG000|Overall Study|Disease progression|1|||
160872068|NCT02423902|580924536|FG001|Overall Study|Disease progression|4|||
160872069|NCT02136069|580924537|FG000|Overall Study|UC flare-up|1|||
160872070|NCT02136069|580924538|FG001|Overall Study|UC flare-up|0|||
160872071|NCT02136069|580924537|FG000|Overall Study|Adverse Event|6|||
160872072|NCT02136069|580924538|FG001|Overall Study|Adverse Event|8|||
160872073|NCT02136069|580924537|FG000|Overall Study|Death|0|||
160872074|NCT02136069|580924538|FG001|Overall Study|Death|1|||
160872075|NCT02136069|580924537|FG000|Overall Study|Lack of Efficacy|10|||
160872076|NCT02136069|580924538|FG001|Overall Study|Lack of Efficacy|4|||
160872077|NCT02136069|580924537|FG000|Overall Study|Lost to Follow-up|1|||
160872078|NCT02136069|580924538|FG001|Overall Study|Lost to Follow-up|0|||
160872079|NCT02136069|580924537|FG000|Overall Study|Non-Compliance|1|||
160872080|NCT02136069|580924538|FG001|Overall Study|Non-Compliance|0|||
160872081|NCT02136069|580924537|FG000|Overall Study|Physician Decision|5|||
160872082|NCT02136069|580924538|FG001|Overall Study|Physician Decision|4|||
160872083|NCT02136069|580924537|FG000|Overall Study|Withdrawal by Subject|10|||
160872084|NCT02136069|580924538|FG001|Overall Study|Withdrawal by Subject|11|||
160872085|NCT02675634|580924539|FG000|Test Period 1|Adverse Event|0|||
160872086|NCT02675634|580924540|FG001|Test Period 1|Adverse Event|1|||
160872087|NCT02675634|580924541|FG002|Test Period 1|Adverse Event|0|||
160872088|NCT02675634|580924542|FG003|Test Period 1|Adverse Event|1|||
160872089|NCT02675634|580924543|FG004|Test Period 1|Adverse Event|0|||
160872090|NCT02675634|580924544|FG005|Test Period 1|Adverse Event|0|||
160872091|NCT02675634|580924539|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
160872092|NCT02675634|580924540|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
160872093|NCT02675634|580924541|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
160872094|NCT02675634|580924542|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
160872095|NCT02675634|580924543|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
160872096|NCT02675634|580924544|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
160872097|NCT02675634|580924539|FG000|Test Period 2|Lack of Efficacy|1|||
160872098|NCT02675634|580924540|FG001|Test Period 2|Lack of Efficacy|0|||
160872099|NCT02675634|580924541|FG002|Test Period 2|Lack of Efficacy|0|||
160636454|NCT03747939|580051551|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
160636455|NCT03747939|580051552|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
160872100|NCT02675634|580924542|FG003|Test Period 2|Lack of Efficacy|0|||
160872101|NCT02675634|580924543|FG004|Test Period 2|Lack of Efficacy|0|||
160872102|NCT02675634|580924544|FG005|Test Period 2|Lack of Efficacy|0|||
160872103|NCT02675634|580924539|FG000|Test Period 2|Adverse Event|0|||
160872104|NCT02675634|580924540|FG001|Test Period 2|Adverse Event|0|||
160872105|NCT02675634|580924541|FG002|Test Period 2|Adverse Event|0|||
160872106|NCT02675634|580924542|FG003|Test Period 2|Adverse Event|0|||
160872107|NCT02675634|580924543|FG004|Test Period 2|Adverse Event|0|||
160872108|NCT02675634|580924544|FG005|Test Period 2|Adverse Event|1|||
160531868|NCT02374021|579676435|FG000|Overall Study|Lost to Follow-up|3|||
160531869|NCT02374021|579676436|FG001|Overall Study|Lost to Follow-up|2|||
160531870|NCT02374021|579676435|FG000|Overall Study|Physician Decision|0|||
160531871|NCT02374021|579676436|FG001|Overall Study|Physician Decision|3|||
160531872|NCT02374021|579676435|FG000|Overall Study|Withdrawal by Subject|6|||
160531873|NCT02374021|579676436|FG001|Overall Study|Withdrawal by Subject|5|||
160531874|NCT02374021|579676435|FG000|Overall Study|Poor Adherence|0|||
160531875|NCT02374021|579676436|FG001|Overall Study|Poor Adherence|1|||
160531876|NCT02374021|579676435|FG000|Overall Study|Scan protocol not followed|0|||
160531877|NCT02374021|579676436|FG001|Overall Study|Scan protocol not followed|1|||
160531878|NCT02374021|579676435|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
160531879|NCT02374021|579676436|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
160531880|NCT00732251|579676437|FG000|Overall Study|Lost to Follow-up|3|||
160531881|NCT00732251|579676437|FG000|Overall Study|Withdrawal by Subject|3|||
160531882|NCT00732251|579676437|FG000|Overall Study|Early Term due to Site Closure|1|||
160531883|NCT01479829|579676438|FG000|Overall Study|Withdrawal by Subject|8|||
160531884|NCT01479829|579676439|FG001|Overall Study|Withdrawal by Subject|10|||
160531885|NCT01444456|579676444|FG000|Overall Study|Withdrawal by Subject|21|||
160531886|NCT01444456|579676444|FG000|Overall Study|Physician Decision|9|||
160531887|NCT01444456|579676444|FG000|Overall Study|Lost to Follow-up|37|||
160531888|NCT01444456|579676444|FG000|Overall Study|Death|73|||
160531889|NCT01444456|579676444|FG000|Overall Study|Ineligibility determined|23|||
160531890|NCT01444456|579676444|FG000|Overall Study|Other|18|||
160531891|NCT01444456|579676444|FG000|Overall Study|Not treated|104|||
160531892|NCT00467779|579678633|FG000|Stage 1|Adverse Event|1|||
160531893|NCT00467779|579678634|FG001|Stage 1|Adverse Event|0|||
160531894|NCT00467779|579678635|FG002|Stage 1|Adverse Event|0|||
160531895|NCT00467779|579678636|FG003|Stage 1|Adverse Event|0|||
160872109|NCT00811018|580924545|FG000|Overall Study|Additional Chronic Treatment|31|||
160872110|NCT00811018|580924545|FG000|Overall Study|Adverse Event|79|||
160872111|NCT00811018|580924545|FG000|Overall Study|Death|147|||
160872112|NCT00811018|580924545|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
160872113|NCT00811018|580924545|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
160872114|NCT00811018|580924545|FG000|Overall Study|Investigator Decision|57|||
160872115|NCT00811018|580924545|FG000|Overall Study|Lost to Follow-up|19|||
160872116|NCT00811018|580924545|FG000|Overall Study|Pregnancy|6|||
160872117|NCT00811018|580924545|FG000|Overall Study|Sponsor Decision|450|||
160872118|NCT00811018|580924545|FG000|Overall Study|Withdrawal by Subject|70|||
160872119|NCT00811018|580924545|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
160872120|NCT00811018|580924545|FG000|Overall Study|Other|26|||
160872121|NCT04154189|580924546|FG000|Overall Study|Withdrawal by Subject|4|||
160872122|NCT04154189|580924547|FG001|Overall Study|Withdrawal by Subject|6|||
160872123|NCT04154189|580924546|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
160872124|NCT04154189|580924547|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
160872125|NCT04154189|580924546|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
160872126|NCT04154189|580924547|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
160872127|NCT04154189|580924546|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
160531896|NCT00467779|579678637|FG004|Stage 1|Adverse Event|0|||
160531897|NCT00467779|579678638|FG005|Stage 1|Adverse Event|1|||
160531898|NCT00467779|579678639|FG006|Stage 1|Adverse Event|2|||
160531899|NCT00467779|579678640|FG007|Stage 1|Adverse Event|1|||
160872128|NCT04154189|580924547|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
160872129|NCT04154189|580924546|FG000|Overall Study|Death|25|||
160872130|NCT04154189|580924547|FG001|Overall Study|Death|25|||
160872131|NCT00845897|580924550|FG000|Overall Study|Lost to Follow-up|1|||
160872132|NCT00845897|580924551|FG001|Overall Study|Lost to Follow-up|1|||
160872133|NCT00845897|580924552|FG002|Overall Study|Lost to Follow-up|0|||
160872134|NCT00845897|580924550|FG000|Overall Study|Withdrawal by Subject|0|||
160872135|NCT00845897|580924551|FG001|Overall Study|Withdrawal by Subject|3|||
160872136|NCT00845897|580924552|FG002|Overall Study|Withdrawal by Subject|2|||
160531900|NCT00467779|579678641|FG008|Stage 1|Adverse Event|0|||
160531901|NCT00467779|579678642|FG009|Stage 1|Adverse Event|0|||
160531902|NCT00467779|579678643|FG010|Stage 1|Adverse Event|0|||
160531903|NCT00467779|579678644|FG011|Stage 1|Adverse Event|0|||
160872137|NCT00845897|580924550|FG000|Overall Study|Ulcer did not heal|1|||
160531904|NCT00467779|579678645|FG012|Stage 1|Adverse Event|0|||
160531905|NCT00467779|579678646|FG013|Stage 1|Adverse Event|0|||
160531906|NCT00467779|579678647|FG014|Stage 1|Adverse Event|0|||
160872138|NCT00845897|580924551|FG001|Overall Study|Ulcer did not heal|0|||
160872139|NCT00845897|580924552|FG002|Overall Study|Ulcer did not heal|1|||
160872140|NCT00845897|580924550|FG000|Overall Study|Too ill to participate|0|||
160872141|NCT00845897|580924551|FG001|Overall Study|Too ill to participate|1|||
160872142|NCT00845897|580924552|FG002|Overall Study|Too ill to participate|0|||
160872143|NCT02722499|580924554|FG000|Overall Study|Lost to Follow-up|2|||
160872144|NCT02722499|580924555|FG001|Overall Study|Lost to Follow-up|0|||
160872145|NCT02722499|580924556|FG002|Overall Study|Lost to Follow-up|1|||
160872146|NCT04999852|580924557|FG000|Overall Study|Withdrawal by Subject|11|||
160872147|NCT04999852|580924558|FG001|Overall Study|Withdrawal by Subject|1|||
160872148|NCT04999852|580924557|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
160872149|NCT04999852|580924558|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
160872150|NCT05626322|580924559|FG000|Overall Study|Death|2|||
160872151|NCT05626322|580924560|FG001|Overall Study|Death|0|||
160872152|NCT05626322|580924561|FG002|Overall Study|Death|0|||
160872153|NCT05626322|580924559|FG000|Overall Study|Physician Decision|1|||
160872154|NCT05626322|580924560|FG001|Overall Study|Physician Decision|0|||
160872155|NCT05626322|580924561|FG002|Overall Study|Physician Decision|0|||
160872156|NCT05626322|580924559|FG000|Overall Study|Progressive Disease|0|||
160872157|NCT05626322|580924560|FG001|Overall Study|Progressive Disease|1|||
160872158|NCT05626322|580924561|FG002|Overall Study|Progressive Disease|1|||
160872159|NCT05626322|580924559|FG000|Overall Study|Study terminated by sponsor|0|||
160872160|NCT05626322|580924560|FG001|Overall Study|Study terminated by sponsor|1|||
160872161|NCT05626322|580924561|FG002|Overall Study|Study terminated by sponsor|0|||
160872162|NCT04758637|580924564|FG000|Overall Study|Lost to Follow-up|0|||
160872163|NCT04758637|580924565|FG001|Overall Study|Lost to Follow-up|1|||
160872164|NCT04758637|580924566|FG002|Overall Study|Lost to Follow-up|0|||
160872165|NCT04758637|580924567|FG003|Overall Study|Lost to Follow-up|0|||
160872166|NCT03610269|580924568|FG000|Overall Study|Physician Decision|10|||
160872167|NCT03610269|580924568|FG000|Overall Study|Protocol Violation|1|||
160872168|NCT03610269|580924568|FG000|Overall Study|Unable to draw blood|1|||
160872169|NCT03610269|580924568|FG000|Overall Study|Screen fail|4|||
160872170|NCT00067002|580924569|FG000|Overall Study|Early Death|1|||
160766051|NCT02722967|580534791|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
160766052|NCT04142242|580534792|FG000|Stage I|Non-compliance with the protocol|1|||
160766053|NCT04142242|580534793|FG001|Stage I|Non-compliance with the protocol|0|||
160766054|NCT04142242|580534794|FG002|Stage I|Non-compliance with the protocol|0|||
160766055|NCT04142242|580534795|FG003|Stage I|Non-compliance with the protocol|0|||
160766056|NCT04142242|580534796|FG004|Stage I|Non-compliance with the protocol|0|||
160766057|NCT04142242|580534797|FG005|Stage I|Non-compliance with the protocol|1|||
160766058|NCT04142242|580534792|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
160766059|NCT04142242|580534793|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
160766060|NCT04142242|580534794|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
160766061|NCT04142242|580534795|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
160766062|NCT04142242|580534796|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
160766063|NCT04142242|580534797|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
160766064|NCT04142242|580534792|FG000|Stage II|Non-compliance with the protocol|0|||
160766065|NCT04142242|580534793|FG001|Stage II|Non-compliance with the protocol|0|||
160872171|NCT00067002|580924570|FG001|Overall Study|Early Death|2|||
160531907|NCT00467779|579678633|FG000|Stage 1|Disease Progression|2|||
160872172|NCT00067002|580924569|FG000|Overall Study|Delayed|1|||
160872173|NCT00067002|580924570|FG001|Overall Study|Delayed|1|||
160872174|NCT00067002|580924569|FG000|Overall Study|Graft Failure|5|||
160872175|NCT00067002|580924570|FG001|Overall Study|Graft Failure|6|||
160872176|NCT03350672|580924571|FG000|Overall Study|Withdrawal by Subject|7|||
160872177|NCT03350672|580924572|FG001|Overall Study|Withdrawal by Subject|0|||
160872178|NCT03350672|580924573|FG002|Overall Study|Withdrawal by Subject|0|||
160872179|NCT01599637|580924574|FG000|Overall Study|administrative problems|0|||
160872180|NCT01599637|580924575|FG001|Overall Study|administrative problems|2|||
160872181|NCT01599637|580924576|FG002|Overall Study|administrative problems|0|||
160872182|NCT01599637|580924574|FG000|Overall Study|Adverse Event|1|||
160872183|NCT01599637|580924575|FG001|Overall Study|Adverse Event|0|||
160872184|NCT01599637|580924576|FG002|Overall Study|Adverse Event|0|||
160872185|NCT04476797|580924579|FG000|Overall Study|Withdrawal by Subject|1|||
160872186|NCT04476797|580924580|FG001|Overall Study|Withdrawal by Subject|0|||
160872187|NCT04476797|580924581|FG002|Overall Study|Withdrawal by Subject|0|||
160872188|NCT04476797|580924579|FG000|Overall Study|Death|0|||
160872189|NCT04476797|580924580|FG001|Overall Study|Death|1|||
160872190|NCT04476797|580924581|FG002|Overall Study|Death|2|||
160872191|NCT04476797|580924579|FG000|Overall Study|Sponsor Terminated Study|0|||
160872192|NCT04476797|580924580|FG001|Overall Study|Sponsor Terminated Study|18|||
160872193|NCT04476797|580924581|FG002|Overall Study|Sponsor Terminated Study|17|||
160872194|NCT02395081|580924582|FG000|Overall Study|Withdrawal by Subject|1|||
160872195|NCT02395081|580924583|FG001|Overall Study|Withdrawal by Subject|1|||
160872196|NCT02395081|580924584|FG002|Overall Study|Withdrawal by Subject|0|||
160872197|NCT02395081|580924582|FG000|Overall Study|Moved where blood couldn't be collected|4|||
160872198|NCT02395081|580924583|FG001|Overall Study|Moved where blood couldn't be collected|1|||
160872199|NCT02395081|580924584|FG002|Overall Study|Moved where blood couldn't be collected|3|||
160872200|NCT02395081|580924582|FG000|Overall Study|Fetal Loss|2|||
160872201|NCT02395081|580924583|FG001|Overall Study|Fetal Loss|3|||
160872202|NCT02395081|580924584|FG002|Overall Study|Fetal Loss|1|||
160872203|NCT02721966|580924585|FG000|Overall Study|Protocol Violation|1|||
160872204|NCT02721966|580924586|FG001|Overall Study|Protocol Violation|0|||
160872205|NCT02721966|580924587|FG002|Overall Study|Protocol Violation|0|||
160872206|NCT02721966|580924588|FG003|Overall Study|Protocol Violation|0|||
160872207|NCT02721966|580924589|FG004|Overall Study|Protocol Violation|0|||
160872208|NCT02721966|580924585|FG000|Overall Study|Withdrawal by Subject|9|||
160872209|NCT02721966|580924586|FG001|Overall Study|Withdrawal by Subject|2|||
160872210|NCT02721966|580924587|FG002|Overall Study|Withdrawal by Subject|3|||
160872211|NCT02721966|580924588|FG003|Overall Study|Withdrawal by Subject|7|||
160872212|NCT02721966|580924589|FG004|Overall Study|Withdrawal by Subject|0|||
160872213|NCT02721966|580924585|FG000|Overall Study|Adverse Event|4|||
160872214|NCT02721966|580924586|FG001|Overall Study|Adverse Event|4|||
160872215|NCT02721966|580924587|FG002|Overall Study|Adverse Event|3|||
160872216|NCT02721966|580924588|FG003|Overall Study|Adverse Event|0|||
160872217|NCT02721966|580924589|FG004|Overall Study|Adverse Event|0|||
160872218|NCT02721966|580924585|FG000|Overall Study|Death|1|||
160872219|NCT02721966|580924586|FG001|Overall Study|Death|0|||
160872220|NCT02721966|580924587|FG002|Overall Study|Death|0|||
160872221|NCT02721966|580924588|FG003|Overall Study|Death|0|||
160872222|NCT02721966|580924589|FG004|Overall Study|Death|0|||
160872223|NCT02721966|580924585|FG000|Overall Study|Lack of Efficacy|7|||
160872224|NCT02721966|580924586|FG001|Overall Study|Lack of Efficacy|4|||
160872225|NCT02721966|580924587|FG002|Overall Study|Lack of Efficacy|0|||
160872226|NCT02721966|580924588|FG003|Overall Study|Lack of Efficacy|0|||
160872227|NCT02721966|580924589|FG004|Overall Study|Lack of Efficacy|0|||
160872228|NCT02721966|580924585|FG000|Overall Study|Lost to Follow-up|0|||
160872229|NCT02721966|580924586|FG001|Overall Study|Lost to Follow-up|0|||
160531908|NCT00467779|579678634|FG001|Stage 1|Disease Progression|2|||
160531909|NCT00467779|579678635|FG002|Stage 1|Disease Progression|2|||
160531910|NCT00467779|579678636|FG003|Stage 1|Disease Progression|3|||
160872230|NCT02721966|580924587|FG002|Overall Study|Lost to Follow-up|3|||
160872231|NCT02721966|580924588|FG003|Overall Study|Lost to Follow-up|0|||
160872232|NCT02721966|580924589|FG004|Overall Study|Lost to Follow-up|0|||
160872233|NCT02721966|580924585|FG000|Overall Study|Physician Decision|1|||
160872234|NCT02721966|580924586|FG001|Overall Study|Physician Decision|1|||
160872235|NCT02721966|580924587|FG002|Overall Study|Physician Decision|0|||
160872236|NCT02721966|580924588|FG003|Overall Study|Physician Decision|0|||
160872237|NCT02721966|580924589|FG004|Overall Study|Physician Decision|0|||
160872238|NCT02721966|580924585|FG000|Overall Study|Pregnancy|1|||
160531911|NCT00467779|579678637|FG004|Stage 1|Disease Progression|2|||
160872239|NCT02721966|580924586|FG001|Overall Study|Pregnancy|0|||
160872240|NCT02721966|580924587|FG002|Overall Study|Pregnancy|0|||
160872241|NCT02721966|580924588|FG003|Overall Study|Pregnancy|0|||
160872242|NCT02721966|580924589|FG004|Overall Study|Pregnancy|0|||
160872243|NCT02721966|580924585|FG000|Overall Study|Did not continue to period 2|5|||
160872244|NCT02721966|580924586|FG001|Overall Study|Did not continue to period 2|12|||
160531912|NCT00467779|579678638|FG005|Stage 1|Disease Progression|2|||
160872245|NCT02721966|580924587|FG002|Overall Study|Did not continue to period 2|0|||
160872246|NCT02721966|580924588|FG003|Overall Study|Did not continue to period 2|0|||
160872247|NCT02721966|580924589|FG004|Overall Study|Did not continue to period 2|5|||
160872248|NCT04200352|580924590|FG000|Overall Study|Death|1|||
160872249|NCT04200352|580924590|FG000|Overall Study|Adverse Event|6|||
160872250|NCT04200352|580924590|FG000|Overall Study|Withdrawal by parent/guardian|6|||
160872251|NCT04200352|580924590|FG000|Overall Study|Lack of Efficacy|1|||
160872252|NCT04200352|580924590|FG000|Overall Study|Other than specified|6|||
160872253|NCT02541604|580924591|FG000|Overall Study|Death|6|||
160872254|NCT02541604|580924592|FG001|Overall Study|Death|5|||
160872255|NCT02541604|580924593|FG002|Overall Study|Death|7|||
160872256|NCT02541604|580924594|FG003|Overall Study|Death|2|||
160872257|NCT02541604|580924595|FG004|Overall Study|Death|9|||
160872258|NCT02541604|580924596|FG005|Overall Study|Death|8|||
160872259|NCT02541604|580924597|FG006|Overall Study|Death|9|||
160872260|NCT02541604|580924598|FG007|Overall Study|Death|9|||
160872261|NCT02541604|580924599|FG008|Overall Study|Death|3|||
160872262|NCT02541604|580924600|FG009|Overall Study|Death|4|||
160872263|NCT02541604|580924601|FG010|Overall Study|Death|2|||
160872264|NCT02541604|580924602|FG011|Overall Study|Death|3|||
160872265|NCT02541604|580924591|FG000|Overall Study|Lost to Follow-up|2|||
160872266|NCT02541604|580924592|FG001|Overall Study|Lost to Follow-up|0|||
160872267|NCT02541604|580924593|FG002|Overall Study|Lost to Follow-up|1|||
160872268|NCT02541604|580924594|FG003|Overall Study|Lost to Follow-up|0|||
160872269|NCT02541604|580924595|FG004|Overall Study|Lost to Follow-up|0|||
160872270|NCT02541604|580924596|FG005|Overall Study|Lost to Follow-up|1|||
160872271|NCT02541604|580924597|FG006|Overall Study|Lost to Follow-up|1|||
160872272|NCT02541604|580924598|FG007|Overall Study|Lost to Follow-up|0|||
160872273|NCT02541604|580924599|FG008|Overall Study|Lost to Follow-up|0|||
160872274|NCT02541604|580924600|FG009|Overall Study|Lost to Follow-up|0|||
160872275|NCT02541604|580924601|FG010|Overall Study|Lost to Follow-up|0|||
160872276|NCT02541604|580924602|FG011|Overall Study|Lost to Follow-up|0|||
160872277|NCT02541604|580924591|FG000|Overall Study|Withdrawal by Subject|2|||
160872278|NCT02541604|580924592|FG001|Overall Study|Withdrawal by Subject|0|||
160872279|NCT02541604|580924593|FG002|Overall Study|Withdrawal by Subject|1|||
160872280|NCT02541604|580924594|FG003|Overall Study|Withdrawal by Subject|0|||
160872281|NCT02541604|580924595|FG004|Overall Study|Withdrawal by Subject|1|||
160872282|NCT02541604|580924596|FG005|Overall Study|Withdrawal by Subject|1|||
160872283|NCT02541604|580924597|FG006|Overall Study|Withdrawal by Subject|0|||
160872284|NCT02541604|580924598|FG007|Overall Study|Withdrawal by Subject|0|||
160872285|NCT02541604|580924599|FG008|Overall Study|Withdrawal by Subject|1|||
160872286|NCT02541604|580924600|FG009|Overall Study|Withdrawal by Subject|0|||
160872287|NCT02541604|580924601|FG010|Overall Study|Withdrawal by Subject|0|||
160872288|NCT02541604|580924602|FG011|Overall Study|Withdrawal by Subject|0|||
160872289|NCT02541604|580924591|FG000|Overall Study|Study Terminated by Sponsor|1|||
160872290|NCT02541604|580924592|FG001|Overall Study|Study Terminated by Sponsor|4|||
160872291|NCT02541604|580924593|FG002|Overall Study|Study Terminated by Sponsor|2|||
160872292|NCT02541604|580924594|FG003|Overall Study|Study Terminated by Sponsor|1|||
160872293|NCT02541604|580924595|FG004|Overall Study|Study Terminated by Sponsor|0|||
160872294|NCT02541604|580924596|FG005|Overall Study|Study Terminated by Sponsor|0|||
160872295|NCT02541604|580924597|FG006|Overall Study|Study Terminated by Sponsor|0|||
160872296|NCT02541604|580924598|FG007|Overall Study|Study Terminated by Sponsor|0|||
160872297|NCT02541604|580924599|FG008|Overall Study|Study Terminated by Sponsor|0|||
160872298|NCT02541604|580924600|FG009|Overall Study|Study Terminated by Sponsor|0|||
160872299|NCT02541604|580924601|FG010|Overall Study|Study Terminated by Sponsor|0|||
160872300|NCT02541604|580924602|FG011|Overall Study|Study Terminated by Sponsor|0|||
160872301|NCT02541604|580924591|FG000|Overall Study|Medical condition may jeopardize safety|0|||
160872302|NCT02541604|580924592|FG001|Overall Study|Medical condition may jeopardize safety|0|||
160872303|NCT02541604|580924593|FG002|Overall Study|Medical condition may jeopardize safety|0|||
160872304|NCT02541604|580924594|FG003|Overall Study|Medical condition may jeopardize safety|0|||
160872305|NCT02541604|580924595|FG004|Overall Study|Medical condition may jeopardize safety|0|||
160872306|NCT02541604|580924596|FG005|Overall Study|Medical condition may jeopardize safety|0|||
160872307|NCT02541604|580924597|FG006|Overall Study|Medical condition may jeopardize safety|0|||
160872308|NCT02541604|580924598|FG007|Overall Study|Medical condition may jeopardize safety|1|||
160872309|NCT02541604|580924599|FG008|Overall Study|Medical condition may jeopardize safety|0|||
160872310|NCT02541604|580924600|FG009|Overall Study|Medical condition may jeopardize safety|0|||
160872311|NCT02541604|580924601|FG010|Overall Study|Medical condition may jeopardize safety|0|||
160872312|NCT02541604|580924602|FG011|Overall Study|Medical condition may jeopardize safety|0|||
160872313|NCT00828204|580924603|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
160872314|NCT00828204|580924604|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
160872315|NCT00828204|580924603|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
160872316|NCT00828204|580924604|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
160872317|NCT00828204|580924603|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
160872318|NCT00828204|580924604|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
160872319|NCT00828204|580924603|FG000|Main Study: After Study Restart|Adverse Event|0|||
160872320|NCT00828204|580924604|FG001|Main Study: After Study Restart|Adverse Event|2|||
160872321|NCT00828204|580924603|FG000|Main Study: After Study Restart|Noncompliance|0|||
160872322|NCT00828204|580924604|FG001|Main Study: After Study Restart|Noncompliance|1|||
160872323|NCT00828204|580924603|FG000|Extension Study|Lost to Follow-up|0|||
160872324|NCT00828204|580924604|FG001|Extension Study|Lost to Follow-up|1|||
160872325|NCT00828204|580924603|FG000|Extension Study|Physician Decision|0|||
160872326|NCT00828204|580924604|FG001|Extension Study|Physician Decision|2|||
160872327|NCT00806819|580924605|FG000|Overall Study|progressive disease (modified RECIST )|217|||
160872328|NCT00806819|580924606|FG001|Overall Study|progressive disease (modified RECIST )|216|||
160872329|NCT00806819|580924605|FG000|Overall Study|Worsening or AE of underlying disease|18|||
160872330|NCT00806819|580924606|FG001|Overall Study|Worsening or AE of underlying disease|25|||
160872331|NCT00806819|580924605|FG000|Overall Study|Other AE|38|||
160872332|NCT00806819|580924606|FG001|Overall Study|Other AE|40|||
160872333|NCT00806819|580924605|FG000|Overall Study|Protocol Violation|9|||
160872334|NCT00806819|580924606|FG001|Overall Study|Protocol Violation|4|||
160872335|NCT00806819|580924605|FG000|Overall Study|Lost to Follow-up|1|||
160872336|NCT00806819|580924606|FG001|Overall Study|Lost to Follow-up|0|||
160872337|NCT00806819|580924605|FG000|Overall Study|Withdrawal by Subject|32|||
160872338|NCT00806819|580924606|FG001|Overall Study|Withdrawal by Subject|29|||
160872339|NCT00806819|580924605|FG000|Overall Study|Not treated|6|||
160872340|NCT00806819|580924606|FG001|Overall Study|Not treated|3|||
160872341|NCT00806819|580924605|FG000|Overall Study|Reasons other than stated above|25|||
160872342|NCT00806819|580924606|FG001|Overall Study|Reasons other than stated above|41|||
160872343|NCT02840461|580924609|FG000|Overall Study|Adverse Event|1|||
160872344|NCT02840461|580924610|FG001|Overall Study|Adverse Event|5|||
160872345|NCT02840461|580924611|FG002|Overall Study|Adverse Event|3|||
160872346|NCT02840461|580924609|FG000|Overall Study|Lost to Follow-up|10|||
160872347|NCT02840461|580924610|FG001|Overall Study|Lost to Follow-up|7|||
160872348|NCT02840461|580924611|FG002|Overall Study|Lost to Follow-up|6|||
160872349|NCT02840461|580924609|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
160872350|NCT02840461|580924610|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
160872351|NCT02840461|580924611|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
160872352|NCT02840461|580924609|FG000|Overall Study|Protocol Violation|2|||
160872353|NCT02840461|580924610|FG001|Overall Study|Protocol Violation|3|||
160872354|NCT02840461|580924611|FG002|Overall Study|Protocol Violation|1|||
160872355|NCT02840461|580924609|FG000|Overall Study|Withdrawal by Subject|10|||
160872356|NCT02840461|580924610|FG001|Overall Study|Withdrawal by Subject|6|||
160872357|NCT02840461|580924611|FG002|Overall Study|Withdrawal by Subject|2|||
160872358|NCT02840461|580924609|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
160872359|NCT02840461|580924610|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
160872360|NCT02840461|580924611|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
160872361|NCT01737502|580924612|FG000|Phase I|Disease progression|2|||
160872362|NCT01737502|580924613|FG001|Phase I|Disease progression|3|||
160872363|NCT01737502|580924612|FG000|Phase I|Complicating disease|1|||
160872364|NCT01737502|580924613|FG001|Phase I|Complicating disease|0|||
160872365|NCT01737502|580924612|FG000|Phase II|Adverse Event|0|||
160872366|NCT01737502|580924613|FG001|Phase II|Adverse Event|3|||
160872367|NCT01737502|580924612|FG000|Phase II|Disease progression|0|||
160872368|NCT01737502|580924613|FG001|Phase II|Disease progression|18|||
160872369|NCT01737502|580924612|FG000|Phase II|Death|0|||
160872370|NCT01737502|580924613|FG001|Phase II|Death|1|||
160872371|NCT01737502|580924612|FG000|Phase II|Transition to hospice care|0|||
160872372|NCT01737502|580924613|FG001|Phase II|Transition to hospice care|1|||
160872373|NCT04549545|580925603|FG000|Initial Period|Withdrawal by Subject|4|||
160872374|NCT04549545|580925604|FG001|Initial Period|Withdrawal by Subject|0|||
160872375|NCT04549545|580925603|FG000|Initial Period|Additional ENT Procedure|3|||
160872376|NCT04549545|580925604|FG001|Initial Period|Additional ENT Procedure|0|||
160872377|NCT04549545|580925603|FG000|Initial Period|Lost to Follow-up|3|||
160872378|NCT04549545|580925604|FG001|Initial Period|Lost to Follow-up|1|||
160872379|NCT04549545|580925603|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
160872380|NCT04549545|580925604|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
160872381|NCT04549545|580925603|FG000|Crossover Period|Additional ENT Procedure|0|||
160872382|NCT04549545|580925604|FG001|Crossover Period|Additional ENT Procedure|6|||
160872383|NCT04549545|580925603|FG000|Crossover Period|Lost to Follow-up|0|||
160872384|NCT04549545|580925604|FG001|Crossover Period|Lost to Follow-up|1|||
160872385|NCT04549545|580925603|FG000|Crossover Period|Withdrawal by Subject|0|||
160872386|NCT04549545|580925604|FG001|Crossover Period|Withdrawal by Subject|4|||
160872387|NCT00243269|580925608|FG000|Overall Study|Protocol Violation|2|||
160872388|NCT00243269|580925609|FG001|Overall Study|Protocol Violation|1|||
160872389|NCT00243269|580925610|FG002|Overall Study|Protocol Violation|0|||
160872390|NCT00243269|580925611|FG003|Overall Study|Protocol Violation|1|||
160872391|NCT00243269|580925608|FG000|Overall Study|Lost to Follow-up|1|||
160872392|NCT00243269|580925609|FG001|Overall Study|Lost to Follow-up|0|||
160872393|NCT00243269|580925610|FG002|Overall Study|Lost to Follow-up|1|||
160872394|NCT00243269|580925611|FG003|Overall Study|Lost to Follow-up|3|||
160872395|NCT00485134|580925617|FG000|Overall Study|Lost to Follow-up|1|||
160872396|NCT00485134|580925618|FG001|Overall Study|Lost to Follow-up|0|||
160872397|NCT00485134|580925619|FG002|Overall Study|Lost to Follow-up|0|||
160872398|NCT00485134|580925620|FG003|Overall Study|Lost to Follow-up|0|||
160872399|NCT00485134|580925621|FG004|Overall Study|Lost to Follow-up|0|||
160872400|NCT00485134|580925622|FG005|Overall Study|Lost to Follow-up|0|||
160872401|NCT00485134|580925623|FG006|Overall Study|Lost to Follow-up|0|||
160872402|NCT00485134|580925624|FG007|Overall Study|Lost to Follow-up|0|||
160872403|NCT00485134|580925617|FG000|Overall Study|Withdrawal by Subject|0|||
160872404|NCT00485134|580925618|FG001|Overall Study|Withdrawal by Subject|1|||
160872405|NCT00485134|580925619|FG002|Overall Study|Withdrawal by Subject|0|||
160872406|NCT00485134|580925620|FG003|Overall Study|Withdrawal by Subject|0|||
160872407|NCT00485134|580925621|FG004|Overall Study|Withdrawal by Subject|0|||
160872408|NCT00485134|580925622|FG005|Overall Study|Withdrawal by Subject|0|||
160872409|NCT00485134|580925623|FG006|Overall Study|Withdrawal by Subject|0|||
160872410|NCT00485134|580925624|FG007|Overall Study|Withdrawal by Subject|0|||
160872411|NCT00485134|580925617|FG000|Overall Study|Change in health status|0|||
160872412|NCT00485134|580925618|FG001|Overall Study|Change in health status|1|||
160872413|NCT00485134|580925619|FG002|Overall Study|Change in health status|2|||
160872414|NCT00485134|580925620|FG003|Overall Study|Change in health status|1|||
160531913|NCT00467779|579678639|FG006|Stage 1|Disease Progression|4|||
160531914|NCT00467779|579678640|FG007|Stage 1|Disease Progression|5|||
160531915|NCT00467779|579678641|FG008|Stage 1|Disease Progression|0|||
160531916|NCT00467779|579678642|FG009|Stage 1|Disease Progression|0|||
160531917|NCT00467779|579678643|FG010|Stage 1|Disease Progression|0|||
160531918|NCT00467779|579678644|FG011|Stage 1|Disease Progression|0|||
160531919|NCT00467779|579678645|FG012|Stage 1|Disease Progression|0|||
160531920|NCT00467779|579678646|FG013|Stage 1|Disease Progression|0|||
160531921|NCT00467779|579678647|FG014|Stage 1|Disease Progression|0|||
160531922|NCT00467779|579678633|FG000|Stage 1|Unspecified Reason|1|||
160531923|NCT00467779|579678634|FG001|Stage 1|Unspecified Reason|0|||
160531924|NCT00467779|579678635|FG002|Stage 1|Unspecified Reason|1|||
160531925|NCT00467779|579678636|FG003|Stage 1|Unspecified Reason|0|||
160531926|NCT00467779|579678637|FG004|Stage 1|Unspecified Reason|1|||
160531927|NCT00467779|579678638|FG005|Stage 1|Unspecified Reason|2|||
160531928|NCT00467779|579678639|FG006|Stage 1|Unspecified Reason|0|||
160531929|NCT00467779|579678640|FG007|Stage 1|Unspecified Reason|0|||
160531930|NCT00467779|579678641|FG008|Stage 1|Unspecified Reason|0|||
160531931|NCT00467779|579678642|FG009|Stage 1|Unspecified Reason|0|||
160531932|NCT00467779|579678643|FG010|Stage 1|Unspecified Reason|0|||
160531933|NCT00467779|579678644|FG011|Stage 1|Unspecified Reason|0|||
160531934|NCT00467779|579678645|FG012|Stage 1|Unspecified Reason|0|||
160531935|NCT00467779|579678646|FG013|Stage 1|Unspecified Reason|0|||
160531936|NCT00467779|579678647|FG014|Stage 1|Unspecified Reason|0|||
160531937|NCT00467779|579678633|FG000|Stage 1|Physician Decision|0|||
160531938|NCT00467779|579678634|FG001|Stage 1|Physician Decision|1|||
160531939|NCT00467779|579678635|FG002|Stage 1|Physician Decision|0|||
160531940|NCT00467779|579678636|FG003|Stage 1|Physician Decision|0|||
160531941|NCT00467779|579678637|FG004|Stage 1|Physician Decision|0|||
160531942|NCT00467779|579678638|FG005|Stage 1|Physician Decision|0|||
160531943|NCT00467779|579678639|FG006|Stage 1|Physician Decision|0|||
160531944|NCT00467779|579678640|FG007|Stage 1|Physician Decision|0|||
160531945|NCT00467779|579678641|FG008|Stage 1|Physician Decision|0|||
160531946|NCT00467779|579678642|FG009|Stage 1|Physician Decision|0|||
160531947|NCT00467779|579678643|FG010|Stage 1|Physician Decision|0|||
160531948|NCT00467779|579678644|FG011|Stage 1|Physician Decision|0|||
160872415|NCT00485134|580925621|FG004|Overall Study|Change in health status|0|||
160531949|NCT00467779|579678645|FG012|Stage 1|Physician Decision|0|||
160531950|NCT00467779|579678646|FG013|Stage 1|Physician Decision|0|||
160531951|NCT00467779|579678647|FG014|Stage 1|Physician Decision|0|||
160531952|NCT00467779|579678633|FG000|Stage 1|Withdrawal by Subject|0|||
160531953|NCT00467779|579678634|FG001|Stage 1|Withdrawal by Subject|0|||
160531954|NCT00467779|579678635|FG002|Stage 1|Withdrawal by Subject|0|||
160531955|NCT00467779|579678636|FG003|Stage 1|Withdrawal by Subject|0|||
160531956|NCT00467779|579678637|FG004|Stage 1|Withdrawal by Subject|0|||
160531957|NCT00467779|579678638|FG005|Stage 1|Withdrawal by Subject|0|||
160531958|NCT00467779|579678639|FG006|Stage 1|Withdrawal by Subject|1|||
160531959|NCT00467779|579678640|FG007|Stage 1|Withdrawal by Subject|1|||
160531960|NCT00467779|579678641|FG008|Stage 1|Withdrawal by Subject|0|||
160531961|NCT00467779|579678642|FG009|Stage 1|Withdrawal by Subject|0|||
160531962|NCT00467779|579678643|FG010|Stage 1|Withdrawal by Subject|0|||
160531963|NCT00467779|579678644|FG011|Stage 1|Withdrawal by Subject|0|||
160531964|NCT00467779|579678645|FG012|Stage 1|Withdrawal by Subject|0|||
160872416|NCT00485134|580925622|FG005|Overall Study|Change in health status|1|||
160872417|NCT00485134|580925623|FG006|Overall Study|Change in health status|0|||
160872418|NCT00485134|580925624|FG007|Overall Study|Change in health status|0|||
160872419|NCT00485134|580925617|FG000|Overall Study|Withdrew for adverse event|0|||
160531965|NCT00467779|579678646|FG013|Stage 1|Withdrawal by Subject|0|||
160531966|NCT00467779|579678647|FG014|Stage 1|Withdrawal by Subject|0|||
160531967|NCT00467779|579678633|FG000|Stage 1A|Adverse Event|0|||
160531968|NCT00467779|579678634|FG001|Stage 1A|Adverse Event|0|||
160531969|NCT00467779|579678635|FG002|Stage 1A|Adverse Event|0|||
160531970|NCT00467779|579678636|FG003|Stage 1A|Adverse Event|0|||
160531971|NCT00467779|579678637|FG004|Stage 1A|Adverse Event|0|||
160531972|NCT00467779|579678638|FG005|Stage 1A|Adverse Event|0|||
160531973|NCT00467779|579678639|FG006|Stage 1A|Adverse Event|0|||
160531974|NCT00467779|579678640|FG007|Stage 1A|Adverse Event|0|||
160531975|NCT00467779|579678641|FG008|Stage 1A|Adverse Event|0|||
160531976|NCT00467779|579678642|FG009|Stage 1A|Adverse Event|0|||
160531977|NCT00467779|579678643|FG010|Stage 1A|Adverse Event|0|||
160872420|NCT00485134|580925618|FG001|Overall Study|Withdrew for adverse event|0|||
160872421|NCT00485134|580925619|FG002|Overall Study|Withdrew for adverse event|1|||
160531978|NCT00467779|579678644|FG011|Stage 1A|Adverse Event|0|||
160531979|NCT00467779|579678645|FG012|Stage 1A|Adverse Event|1|||
160531980|NCT00467779|579678646|FG013|Stage 1A|Adverse Event|0|||
160531981|NCT00467779|579678647|FG014|Stage 1A|Adverse Event|0|||
160872422|NCT00485134|580925620|FG003|Overall Study|Withdrew for adverse event|0|||
160872423|NCT00485134|580925621|FG004|Overall Study|Withdrew for adverse event|0|||
160872424|NCT00485134|580925622|FG005|Overall Study|Withdrew for adverse event|0|||
160872425|NCT00485134|580925623|FG006|Overall Study|Withdrew for adverse event|0|||
160872426|NCT00485134|580925624|FG007|Overall Study|Withdrew for adverse event|0|||
160872427|NCT00485134|580925617|FG000|Overall Study|Positive drug test|0|||
160872428|NCT00485134|580925618|FG001|Overall Study|Positive drug test|0|||
160872429|NCT00485134|580925619|FG002|Overall Study|Positive drug test|0|||
160872430|NCT00485134|580925620|FG003|Overall Study|Positive drug test|0|||
160872431|NCT00485134|580925621|FG004|Overall Study|Positive drug test|2|||
160872432|NCT00485134|580925622|FG005|Overall Study|Positive drug test|1|||
160872433|NCT00485134|580925623|FG006|Overall Study|Positive drug test|0|||
160872434|NCT00485134|580925624|FG007|Overall Study|Positive drug test|0|||
160872435|NCT00485134|580925617|FG000|Overall Study|Non-compliance|0|||
160872436|NCT00485134|580925618|FG001|Overall Study|Non-compliance|0|||
160872437|NCT00485134|580925619|FG002|Overall Study|Non-compliance|0|||
160872438|NCT00485134|580925620|FG003|Overall Study|Non-compliance|0|||
160872439|NCT00485134|580925621|FG004|Overall Study|Non-compliance|1|||
160872440|NCT00485134|580925622|FG005|Overall Study|Non-compliance|2|||
160872441|NCT00485134|580925623|FG006|Overall Study|Non-compliance|2|||
160872442|NCT00485134|580925624|FG007|Overall Study|Non-compliance|0|||
160872443|NCT00485134|580925617|FG000|Overall Study|Unable to comply with study schedule|0|||
160872444|NCT00485134|580925618|FG001|Overall Study|Unable to comply with study schedule|0|||
160872445|NCT00485134|580925619|FG002|Overall Study|Unable to comply with study schedule|0|||
160872446|NCT00485134|580925620|FG003|Overall Study|Unable to comply with study schedule|0|||
160872447|NCT00485134|580925621|FG004|Overall Study|Unable to comply with study schedule|0|||
160872448|NCT00485134|580925622|FG005|Overall Study|Unable to comply with study schedule|0|||
160872449|NCT00485134|580925623|FG006|Overall Study|Unable to comply with study schedule|0|||
160872450|NCT00485134|580925624|FG007|Overall Study|Unable to comply with study schedule|1|||
160872451|NCT00485134|580925617|FG000|Overall Study|Pregnancy|0|||
160872452|NCT00485134|580925618|FG001|Overall Study|Pregnancy|0|||
160872453|NCT00485134|580925619|FG002|Overall Study|Pregnancy|0|||
160872454|NCT00485134|580925620|FG003|Overall Study|Pregnancy|0|||
160872455|NCT00485134|580925621|FG004|Overall Study|Pregnancy|0|||
160872456|NCT00485134|580925622|FG005|Overall Study|Pregnancy|0|||
160872457|NCT00485134|580925623|FG006|Overall Study|Pregnancy|1|||
160872458|NCT00485134|580925624|FG007|Overall Study|Pregnancy|0|||
160872459|NCT00970684|580925625|FG000|Overall Study|Lack of Efficacy|5|||
160872460|NCT00970684|580925625|FG000|Overall Study|Adverse Event|4|||
160872461|NCT00970684|580925625|FG000|Overall Study|Withdrawal by Subject|1|||
160872462|NCT00481091|580925626|FG000|Overall Study|Withdrawal by Subject|0|||
160872463|NCT00481091|580925627|FG001|Overall Study|Withdrawal by Subject|1|||
160872464|NCT00481091|580925628|FG002|Overall Study|Withdrawal by Subject|1|||
160872465|NCT00481091|580925629|FG003|Overall Study|Withdrawal by Subject|0|||
160872466|NCT00481091|580925630|FG004|Overall Study|Withdrawal by Subject|0|||
160872467|NCT00481091|580925631|FG005|Overall Study|Withdrawal by Subject|0|||
160872468|NCT00481091|580925632|FG006|Overall Study|Withdrawal by Subject|0|||
160872469|NCT00481091|580925633|FG007|Overall Study|Withdrawal by Subject|0|||
160872470|NCT00481091|580925634|FG008|Overall Study|Withdrawal by Subject|1|||
160872471|NCT00481091|580925635|FG009|Overall Study|Withdrawal by Subject|6|||
160872472|NCT00481091|580925626|FG000|Overall Study|Other, Not Specified|0|||
160872473|NCT00481091|580925627|FG001|Overall Study|Other, Not Specified|1|||
160531982|NCT00467779|579678633|FG000|Stage 1A|Death|0|||
160531983|NCT00467779|579678634|FG001|Stage 1A|Death|0|||
160531984|NCT00467779|579678635|FG002|Stage 1A|Death|0|||
160531985|NCT00467779|579678636|FG003|Stage 1A|Death|0|||
160872474|NCT00481091|580925628|FG002|Overall Study|Other, Not Specified|1|||
160872475|NCT00481091|580925629|FG003|Overall Study|Other, Not Specified|0|||
160872476|NCT00481091|580925630|FG004|Overall Study|Other, Not Specified|0|||
160872477|NCT00481091|580925631|FG005|Overall Study|Other, Not Specified|1|||
160872478|NCT00481091|580925632|FG006|Overall Study|Other, Not Specified|0|||
160872479|NCT00481091|580925633|FG007|Overall Study|Other, Not Specified|0|||
160872480|NCT00481091|580925634|FG008|Overall Study|Other, Not Specified|0|||
160872481|NCT00481091|580925635|FG009|Overall Study|Other, Not Specified|4|||
160531986|NCT00467779|579678637|FG004|Stage 1A|Death|0|||
160872482|NCT00481091|580925626|FG000|Overall Study|Adverse Event|1|||
160872483|NCT00481091|580925627|FG001|Overall Study|Adverse Event|2|||
160872484|NCT00481091|580925628|FG002|Overall Study|Adverse Event|0|||
160531987|NCT00467779|579678638|FG005|Stage 1A|Death|0|||
160872485|NCT00481091|580925629|FG003|Overall Study|Adverse Event|1|||
160872486|NCT00481091|580925630|FG004|Overall Study|Adverse Event|1|||
160872487|NCT00481091|580925631|FG005|Overall Study|Adverse Event|1|||
160872488|NCT00481091|580925632|FG006|Overall Study|Adverse Event|2|||
160872489|NCT00481091|580925633|FG007|Overall Study|Adverse Event|1|||
160872490|NCT00481091|580925634|FG008|Overall Study|Adverse Event|1|||
160872491|NCT00481091|580925635|FG009|Overall Study|Adverse Event|6|||
160872492|NCT00481091|580925626|FG000|Overall Study|Progressive disease clinical|0|||
160872493|NCT00481091|580925627|FG001|Overall Study|Progressive disease clinical|0|||
160872494|NCT00481091|580925628|FG002|Overall Study|Progressive disease clinical|0|||
160872495|NCT00481091|580925629|FG003|Overall Study|Progressive disease clinical|0|||
160872496|NCT00481091|580925630|FG004|Overall Study|Progressive disease clinical|0|||
160872497|NCT00481091|580925631|FG005|Overall Study|Progressive disease clinical|0|||
160872498|NCT00481091|580925632|FG006|Overall Study|Progressive disease clinical|0|||
160872499|NCT00481091|580925633|FG007|Overall Study|Progressive disease clinical|0|||
160872500|NCT00481091|580925634|FG008|Overall Study|Progressive disease clinical|1|||
160872501|NCT00481091|580925635|FG009|Overall Study|Progressive disease clinical|7|||
160872502|NCT00481091|580925626|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
160872503|NCT00481091|580925627|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
160872504|NCT00481091|580925628|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872505|NCT00481091|580925629|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872506|NCT00481091|580925630|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872507|NCT00481091|580925631|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
160872508|NCT00481091|580925632|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872509|NCT00481091|580925633|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872510|NCT00481091|580925634|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872511|NCT00481091|580925635|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872512|NCT00481091|580925626|FG000|Overall Study|Progressive disease other|1|||
160872513|NCT00481091|580925627|FG001|Overall Study|Progressive disease other|1|||
160872514|NCT00481091|580925628|FG002|Overall Study|Progressive disease other|0|||
160872515|NCT00481091|580925629|FG003|Overall Study|Progressive disease other|1|||
160872516|NCT00481091|580925630|FG004|Overall Study|Progressive disease other|1|||
160872517|NCT00481091|580925631|FG005|Overall Study|Progressive disease other|1|||
160872518|NCT00481091|580925632|FG006|Overall Study|Progressive disease other|0|||
160872519|NCT00481091|580925633|FG007|Overall Study|Progressive disease other|2|||
160872520|NCT00481091|580925634|FG008|Overall Study|Progressive disease other|0|||
160872521|NCT00481091|580925635|FG009|Overall Study|Progressive disease other|0|||
160872522|NCT00481091|580925626|FG000|Overall Study|No reason given|0|||
160872523|NCT00481091|580925627|FG001|Overall Study|No reason given|0|||
160872524|NCT00481091|580925628|FG002|Overall Study|No reason given|1|||
160872525|NCT00481091|580925629|FG003|Overall Study|No reason given|1|||
160872526|NCT00481091|580925630|FG004|Overall Study|No reason given|1|||
160872527|NCT00481091|580925631|FG005|Overall Study|No reason given|0|||
160872528|NCT00481091|580925632|FG006|Overall Study|No reason given|1|||
160872529|NCT00481091|580925633|FG007|Overall Study|No reason given|1|||
160872530|NCT00481091|580925634|FG008|Overall Study|No reason given|1|||
160872531|NCT00481091|580925635|FG009|Overall Study|No reason given|4|||
160872532|NCT04294680|580925636|FG000|Overall Study|Withdrawal by Subject|2|||
160872533|NCT04294680|580925637|FG001|Overall Study|Withdrawal by Subject|1|||
160872534|NCT04294680|580925636|FG000|Overall Study|Follow-up visits completed outside of window|1|||
160872535|NCT04294680|580925637|FG001|Overall Study|Follow-up visits completed outside of window|0|||
160872536|NCT02078960|580925640|FG000|Treatment Period|Other|0|||
160872537|NCT02078960|580925641|FG001|Treatment Period|Other|0|||
160872538|NCT02078960|580925642|FG002|Treatment Period|Other|1|||
160872539|NCT02078960|580925640|FG000|Treatment Period|Lack of Efficacy|0|||
160872540|NCT02078960|580925641|FG001|Treatment Period|Lack of Efficacy|1|||
160872541|NCT02078960|580925642|FG002|Treatment Period|Lack of Efficacy|0|||
160872542|NCT02078960|580925640|FG000|Treatment Period|Disease progression - accelerated phase|0|||
160872543|NCT02078960|580925641|FG001|Treatment Period|Disease progression - accelerated phase|1|||
160872544|NCT02078960|580925642|FG002|Treatment Period|Disease progression - accelerated phase|0|||
160872545|NCT02078960|580925640|FG000|Treatment Period|Disease progression - blast phase|1|||
160872546|NCT02078960|580925641|FG001|Treatment Period|Disease progression - blast phase|0|||
160872547|NCT02078960|580925642|FG002|Treatment Period|Disease progression - blast phase|0|||
160872548|NCT02078960|580925640|FG000|Treatment Period|Withdrawal by Subject|0|||
160531988|NCT00467779|579678639|FG006|Stage 1A|Death|0|||
160872549|NCT02078960|580925641|FG001|Treatment Period|Withdrawal by Subject|1|||
160872550|NCT02078960|580925642|FG002|Treatment Period|Withdrawal by Subject|1|||
160872551|NCT02078960|580925640|FG000|Treatment Period|Adverse Event|1|||
160872552|NCT02078960|580925641|FG001|Treatment Period|Adverse Event|0|||
160872553|NCT02078960|580925642|FG002|Treatment Period|Adverse Event|0|||
160872554|NCT02078960|580925640|FG000|Treatment Period|Death|0|||
160872555|NCT02078960|580925641|FG001|Treatment Period|Death|0|||
160872556|NCT02078960|580925642|FG002|Treatment Period|Death|1|||
160531989|NCT00467779|579678640|FG007|Stage 1A|Death|0|||
160531990|NCT00467779|579678641|FG008|Stage 1A|Death|0|||
160531991|NCT00467779|579678642|FG009|Stage 1A|Death|0|||
160531992|NCT00467779|579678643|FG010|Stage 1A|Death|0|||
160531993|NCT00467779|579678644|FG011|Stage 1A|Death|1|||
160872557|NCT02078960|580925640|FG000|Follow-up Period|Death|2|||
160872558|NCT02078960|580925641|FG001|Follow-up Period|Death|0|||
160872559|NCT02078960|580925642|FG002|Follow-up Period|Death|0|||
160872560|NCT02078960|580925640|FG000|Follow-up Period|Lost to Follow-up|0|||
160872561|NCT02078960|580925641|FG001|Follow-up Period|Lost to Follow-up|1|||
160872562|NCT02078960|580925642|FG002|Follow-up Period|Lost to Follow-up|0|||
160872563|NCT04605991|580925644|FG000|Overall Study|Adverse Event|5|||
160872564|NCT04605991|580925644|FG000|Overall Study|Lack of Efficacy|1|||
160872565|NCT04605991|580925644|FG000|Overall Study|Lost to Follow-up|8|||
160872566|NCT04605991|580925644|FG000|Overall Study|Physician Decision|4|||
160872567|NCT04605991|580925644|FG000|Overall Study|Withdrawal by Subject|14|||
160872568|NCT04605991|580925644|FG000|Overall Study|Non-compliance with study|1|||
160872569|NCT00859638|580925645|FG000|Overall Study|Lost to Follow-up|6|||
160872570|NCT00859638|580925646|FG001|Overall Study|Lost to Follow-up|1|||
160872571|NCT00859638|580925645|FG000|Overall Study|Withdrawal by Subject|3|||
160872572|NCT00859638|580925646|FG001|Overall Study|Withdrawal by Subject|2|||
160872573|NCT00859638|580925645|FG000|Overall Study|Ill health|1|||
160872574|NCT00859638|580925646|FG001|Overall Study|Ill health|1|||
160872575|NCT00771953|580925647|FG000|Overall Study|Adverse Event|5|||
160872576|NCT00771953|580925648|FG001|Overall Study|Adverse Event|3|||
160872577|NCT00771953|580925647|FG000|Overall Study|Death|2|||
160872578|NCT00771953|580925648|FG001|Overall Study|Death|2|||
160872579|NCT00771953|580925647|FG000|Overall Study|Progression before active Tx|1|||
160872580|NCT00771953|580925648|FG001|Overall Study|Progression before active Tx|2|||
160872581|NCT00771953|580925647|FG000|Overall Study|Sponsor decision|1|||
160872582|NCT00771953|580925648|FG001|Overall Study|Sponsor decision|0|||
160872583|NCT00771953|580925647|FG000|Overall Study|Other complicating disease|1|||
160872584|NCT00771953|580925648|FG001|Overall Study|Other complicating disease|0|||
160872585|NCT00771953|580925647|FG000|Overall Study|Withdrawal by Subject|0|||
160872586|NCT00771953|580925648|FG001|Overall Study|Withdrawal by Subject|3|||
160872587|NCT00947193|580925649|FG000|Overall Study|Lost to Follow-up|1|||
160872588|NCT00947193|580925650|FG001|Overall Study|Lost to Follow-up|0|||
160872589|NCT00947193|580925649|FG000|Overall Study|Withdrawal by Subject|1|||
160872590|NCT00947193|580925650|FG001|Overall Study|Withdrawal by Subject|0|||
160872591|NCT00947193|580925649|FG000|Overall Study|Factor VIII >1%|1|||
160872592|NCT00947193|580925650|FG001|Overall Study|Factor VIII >1%|0|||
160872593|NCT04364984|580925651|FG000|Overall Study|Death|2|||
160872594|NCT04364984|580925652|FG001|Overall Study|Death|2|||
160872595|NCT04364984|580925653|FG002|Overall Study|Death|0|||
160872596|NCT01349959|580925654|FG000|Overall Study|Adverse Event|7|||
160872597|NCT02722304|580925655|FG000|Overall Study|Study Terminated by Sponsor|1|||
160872598|NCT02722304|580925656|FG001|Overall Study|Study Terminated by Sponsor|0|||
160872599|NCT02722304|580925657|FG002|Overall Study|Study Terminated by Sponsor|2|||
160872600|NCT02722304|580925658|FG003|Overall Study|Study Terminated by Sponsor|1|||
160872601|NCT02722304|580925659|FG004|Overall Study|Study Terminated by Sponsor|1|||
160872602|NCT02722304|580925655|FG000|Overall Study|Other|0|||
160872603|NCT02722304|580925656|FG001|Overall Study|Other|0|||
160872604|NCT02722304|580925657|FG002|Overall Study|Other|0|||
160872605|NCT02722304|580925658|FG003|Overall Study|Other|1|||
160872606|NCT02722304|580925659|FG004|Overall Study|Other|1|||
160872607|NCT01727024|580925662|FG000|Period 1|Lost to Follow-up|1|||
160872608|NCT01727024|580925663|FG001|Period 1|Lost to Follow-up|1|||
160872609|NCT01727024|580925662|FG000|Period 1|Withdrawal by Subject|2|||
160872610|NCT01727024|580925663|FG001|Period 1|Withdrawal by Subject|3|||
160872611|NCT02920242|580925664|FG000|Overall Study|Withdrawal by Subject|1|||
160872612|NCT02920242|580925665|FG001|Overall Study|Withdrawal by Subject|0|||
160872613|NCT02920242|580925666|FG002|Overall Study|Withdrawal by Subject|1|||
160872614|NCT02920242|580925664|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
160872615|NCT02920242|580925665|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
160872616|NCT02920242|580925666|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
160872617|NCT04995419|580925672|FG000|Overall Study|Withdrawal by Subject|3|||
160872618|NCT04995419|580925672|FG000|Overall Study|Progressive Disease|19|||
160872619|NCT04995419|580925672|FG000|Overall Study|Adverse Event|2|||
160872620|NCT04995419|580925672|FG000|Overall Study|Ongoing|16|||
160872621|NCT02948088|580925673|FG000|Overall Study|Lost to Follow-up|8|||
160872622|NCT02948088|580925673|FG000|Overall Study|Death|1|||
160872623|NCT02948088|580925673|FG000|Overall Study|Withdrawal by Subject|4|||
160872624|NCT02948088|580925673|FG000|Overall Study|Other|2|||
160872625|NCT00634101|580925674|FG000|Overall Study|Study Terminated|3|||
160872626|NCT00634101|580925675|FG001|Overall Study|Study Terminated|3|||
160872627|NCT00634101|580925674|FG000|Overall Study|Lost to Follow-up|2|||
160872628|NCT00634101|580925675|FG001|Overall Study|Lost to Follow-up|0|||
160872629|NCT00139477|580925676|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
160872630|NCT00139477|580925677|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
160872631|NCT00139477|580925676|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
160872632|NCT00139477|580925677|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
160531994|NCT00467779|579678645|FG012|Stage 1A|Death|1|||
160531995|NCT00467779|579678646|FG013|Stage 1A|Death|0|||
160531996|NCT00467779|579678647|FG014|Stage 1A|Death|0|||
160531997|NCT00467779|579678633|FG000|Stage 1A|Disease Progression|0|||
160531998|NCT00467779|579678634|FG001|Stage 1A|Disease Progression|0|||
160531999|NCT00467779|579678635|FG002|Stage 1A|Disease Progression|0|||
160532000|NCT00467779|579678636|FG003|Stage 1A|Disease Progression|0|||
160532001|NCT00467779|579678637|FG004|Stage 1A|Disease Progression|0|||
160532002|NCT00467779|579678638|FG005|Stage 1A|Disease Progression|0|||
160532003|NCT00467779|579678639|FG006|Stage 1A|Disease Progression|0|||
160532004|NCT00467779|579678640|FG007|Stage 1A|Disease Progression|0|||
160532005|NCT00467779|579678641|FG008|Stage 1A|Disease Progression|0|||
160766066|NCT04142242|580534794|FG002|Stage II|Non-compliance with the protocol|0|||
160766067|NCT04142242|580534795|FG003|Stage II|Non-compliance with the protocol|2|||
160766068|NCT04142242|580534796|FG004|Stage II|Non-compliance with the protocol|0|||
160766069|NCT04142242|580534797|FG005|Stage II|Non-compliance with the protocol|0|||
160532006|NCT00467779|579678642|FG009|Stage 1A|Disease Progression|2|||
160766070|NCT04142242|580534792|FG000|Stage II|Lost to Follow-up|0|||
160532007|NCT00467779|579678643|FG010|Stage 1A|Disease Progression|2|||
160532008|NCT00467779|579678644|FG011|Stage 1A|Disease Progression|5|||
160532009|NCT00467779|579678645|FG012|Stage 1A|Disease Progression|2|||
160532010|NCT00467779|579678646|FG013|Stage 1A|Disease Progression|0|||
160532011|NCT00467779|579678647|FG014|Stage 1A|Disease Progression|0|||
160766071|NCT04142242|580534793|FG001|Stage II|Lost to Follow-up|0|||
160532012|NCT00467779|579678633|FG000|Stage 1A|Physician Decision|0|||
160532013|NCT00467779|579678634|FG001|Stage 1A|Physician Decision|0|||
160532014|NCT00467779|579678635|FG002|Stage 1A|Physician Decision|0|||
160532015|NCT00467779|579678636|FG003|Stage 1A|Physician Decision|0|||
160532016|NCT00467779|579678637|FG004|Stage 1A|Physician Decision|0|||
160532017|NCT00467779|579678638|FG005|Stage 1A|Physician Decision|0|||
160532018|NCT00467779|579678639|FG006|Stage 1A|Physician Decision|0|||
160532019|NCT00467779|579678640|FG007|Stage 1A|Physician Decision|0|||
160532020|NCT00467779|579678641|FG008|Stage 1A|Physician Decision|0|||
160532021|NCT00467779|579678642|FG009|Stage 1A|Physician Decision|1|||
160766072|NCT04142242|580534794|FG002|Stage II|Lost to Follow-up|1|||
160766073|NCT04142242|580534795|FG003|Stage II|Lost to Follow-up|2|||
160766074|NCT04142242|580534796|FG004|Stage II|Lost to Follow-up|0|||
160766075|NCT04142242|580534797|FG005|Stage II|Lost to Follow-up|0|||
160766076|NCT04142242|580534792|FG000|Stage II|Withdrawal by Subject|0|||
160766077|NCT04142242|580534793|FG001|Stage II|Withdrawal by Subject|0|||
160766078|NCT04142242|580534794|FG002|Stage II|Withdrawal by Subject|5|||
160766079|NCT04142242|580534795|FG003|Stage II|Withdrawal by Subject|9|||
160766080|NCT04142242|580534796|FG004|Stage II|Withdrawal by Subject|0|||
160766081|NCT04142242|580534797|FG005|Stage II|Withdrawal by Subject|0|||
160766082|NCT00062166|580534806|FG000|Overall Study|Withdrawal by Subject|6|||
160766083|NCT05063448|580534811|FG000|Overall Study|Withdrawal by Subject|1|||
160766084|NCT02475369|580534815|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
160766085|NCT02475369|580534816|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
160532022|NCT00467779|579678643|FG010|Stage 1A|Physician Decision|0|||
160532023|NCT00467779|579678644|FG011|Stage 1A|Physician Decision|0|||
160532024|NCT00467779|579678645|FG012|Stage 1A|Physician Decision|0|||
160532025|NCT00467779|579678646|FG013|Stage 1A|Physician Decision|0|||
160532026|NCT00467779|579678647|FG014|Stage 1A|Physician Decision|0|||
160532027|NCT00467779|579678633|FG000|Stage 1A|Withdrawal by Subject|0|||
160532028|NCT00467779|579678634|FG001|Stage 1A|Withdrawal by Subject|0|||
160532029|NCT00467779|579678635|FG002|Stage 1A|Withdrawal by Subject|0|||
160532030|NCT00467779|579678636|FG003|Stage 1A|Withdrawal by Subject|0|||
160532031|NCT00467779|579678637|FG004|Stage 1A|Withdrawal by Subject|0|||
160532032|NCT00467779|579678638|FG005|Stage 1A|Withdrawal by Subject|0|||
160532033|NCT00467779|579678639|FG006|Stage 1A|Withdrawal by Subject|0|||
160532034|NCT00467779|579678640|FG007|Stage 1A|Withdrawal by Subject|0|||
160532035|NCT00467779|579678641|FG008|Stage 1A|Withdrawal by Subject|0|||
160532036|NCT00467779|579678642|FG009|Stage 1A|Withdrawal by Subject|0|||
160532037|NCT00467779|579678643|FG010|Stage 1A|Withdrawal by Subject|1|||
160532038|NCT00467779|579678644|FG011|Stage 1A|Withdrawal by Subject|1|||
160532039|NCT00467779|579678645|FG012|Stage 1A|Withdrawal by Subject|1|||
160532040|NCT00467779|579678646|FG013|Stage 1A|Withdrawal by Subject|0|||
160532041|NCT00467779|579678647|FG014|Stage 1A|Withdrawal by Subject|0|||
160532042|NCT00467779|579678633|FG000|Stage 1A|Unspecified Reason|0|||
160532043|NCT00467779|579678634|FG001|Stage 1A|Unspecified Reason|0|||
160532044|NCT00467779|579678635|FG002|Stage 1A|Unspecified Reason|0|||
160532045|NCT00467779|579678636|FG003|Stage 1A|Unspecified Reason|0|||
160532046|NCT00467779|579678637|FG004|Stage 1A|Unspecified Reason|0|||
160766086|NCT03329885|580534822|FG000|Overall Study|Sponsor discontinued the study early|0|||
160766087|NCT03329885|580534823|FG001|Overall Study|Sponsor discontinued the study early|0|||
160766088|NCT03329885|580534824|FG002|Overall Study|Sponsor discontinued the study early|0|||
160766089|NCT03329885|580534825|FG003|Overall Study|Sponsor discontinued the study early|0|||
160766090|NCT03329885|580534826|FG004|Overall Study|Sponsor discontinued the study early|0|||
160532047|NCT00467779|579678638|FG005|Stage 1A|Unspecified Reason|0|||
160532048|NCT00467779|579678639|FG006|Stage 1A|Unspecified Reason|0|||
160532049|NCT00467779|579678640|FG007|Stage 1A|Unspecified Reason|0|||
160532050|NCT00467779|579678641|FG008|Stage 1A|Unspecified Reason|0|||
160532051|NCT00467779|579678642|FG009|Stage 1A|Unspecified Reason|0|||
160532052|NCT00467779|579678643|FG010|Stage 1A|Unspecified Reason|0|||
160532053|NCT00467779|579678644|FG011|Stage 1A|Unspecified Reason|1|||
160532054|NCT00467779|579678645|FG012|Stage 1A|Unspecified Reason|1|||
160532055|NCT00467779|579678646|FG013|Stage 1A|Unspecified Reason|0|||
160636456|NCT03747939|580051553|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
160872633|NCT00139477|580925676|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
160872634|NCT00139477|580925677|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
160872635|NCT00139477|580925676|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
160872636|NCT00139477|580925677|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
160872637|NCT00139477|580925676|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
160872638|NCT00139477|580925677|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
160981509|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160872639|NCT00139477|580925676|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
160872640|NCT00139477|580925677|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
160872641|NCT00139477|580925676|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
160872642|NCT00139477|580925677|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
160766091|NCT03329885|580534827|FG005|Overall Study|Sponsor discontinued the study early|0|||
160872643|NCT03776812|580925678|FG000|Overall Study|Death|53|||
160872644|NCT03776812|580925679|FG001|Overall Study|Death|49|||
160872645|NCT03776812|580925680|FG002|Overall Study|Death|56|||
160766092|NCT03329885|580534828|FG006|Overall Study|Sponsor discontinued the study early|1|||
160766093|NCT03329885|580534829|FG007|Overall Study|Sponsor discontinued the study early|1|||
160766094|NCT03329885|580534830|FG008|Overall Study|Sponsor discontinued the study early|0|||
160766095|NCT01991795|580534831|FG000|Overall Study|Lost to Follow-up|6|||
160766096|NCT01991795|580534832|FG001|Overall Study|Lost to Follow-up|4|||
160766097|NCT01991795|580534831|FG000|Overall Study|Withdrawal by Subject|117|||
160766098|NCT01991795|580534832|FG001|Overall Study|Withdrawal by Subject|94|||
160766099|NCT01991795|580534831|FG000|Overall Study|Site prematurely closed by sponsor|26|||
160766100|NCT01991795|580534832|FG001|Overall Study|Site prematurely closed by sponsor|25|||
160766101|NCT06494761|580534836|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
160766102|NCT06494761|580534836|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
160766103|NCT04865289|580534837|FG000|Overall Study|Death|34|||
160766104|NCT04865289|580534838|FG001|Overall Study|Death|25|||
160766105|NCT04865289|580534837|FG000|Overall Study|Physician Decision|27|||
160766106|NCT04865289|580534838|FG001|Overall Study|Physician Decision|27|||
160766107|NCT04865289|580534837|FG000|Overall Study|Sponsor Decision|11|||
160766108|NCT04865289|580534838|FG001|Overall Study|Sponsor Decision|1|||
160766109|NCT04865289|580534837|FG000|Overall Study|Withdrawal by Subject|2|||
160766110|NCT04865289|580534838|FG001|Overall Study|Withdrawal by Subject|3|||
160766111|NCT03104374|580534839|FG000|Period 1|Adverse Event|7|||
160766112|NCT03104374|580534840|FG001|Period 1|Adverse Event|7|||
160766113|NCT03104374|580534841|FG002|Period 1|Adverse Event|12|||
160766114|NCT03104374|580534842|FG003|Period 1|Adverse Event|14|||
160766115|NCT03104374|580534839|FG000|Period 1|Withdrawal by Subject|18|||
160766116|NCT03104374|580534840|FG001|Period 1|Withdrawal by Subject|9|||
160766117|NCT03104374|580534841|FG002|Period 1|Withdrawal by Subject|10|||
160766118|NCT03104374|580534842|FG003|Period 1|Withdrawal by Subject|17|||
160766119|NCT03104374|580534839|FG000|Period 1|Lost to Follow-up|4|||
160766120|NCT03104374|580534840|FG001|Period 1|Lost to Follow-up|4|||
160766121|NCT03104374|580534841|FG002|Period 1|Lost to Follow-up|6|||
160766122|NCT03104374|580534842|FG003|Period 1|Lost to Follow-up|8|||
160766123|NCT03104374|580534839|FG000|Period 1|Lack of Efficacy|6|||
160766124|NCT03104374|580534840|FG001|Period 1|Lack of Efficacy|7|||
160766125|NCT03104374|580534841|FG002|Period 1|Lack of Efficacy|12|||
160766126|NCT03104374|580534842|FG003|Period 1|Lack of Efficacy|6|||
160766127|NCT03104374|580534839|FG000|Period 1|Other|2|||
160766128|NCT03104374|580534840|FG001|Period 1|Other|2|||
160766129|NCT03104374|580534841|FG002|Period 1|Other|4|||
160766130|NCT03104374|580534842|FG003|Period 1|Other|7|||
160766131|NCT03104374|580534839|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
160766132|NCT03104374|580534840|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
160766133|NCT03104374|580534841|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
160766134|NCT03104374|580534842|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
160766135|NCT03104374|580534839|FG000|Period 2|Adverse Event|4|||
160766136|NCT03104374|580534840|FG001|Period 2|Adverse Event|7|||
160766137|NCT03104374|580534841|FG002|Period 2|Adverse Event|10|||
160766138|NCT03104374|580534842|FG003|Period 2|Adverse Event|10|||
160766139|NCT03104374|580534839|FG000|Period 2|Withdrawal by Subject|3|||
160766140|NCT03104374|580534840|FG001|Period 2|Withdrawal by Subject|7|||
160766141|NCT03104374|580534841|FG002|Period 2|Withdrawal by Subject|13|||
160766142|NCT03104374|580534842|FG003|Period 2|Withdrawal by Subject|16|||
160766143|NCT03104374|580534839|FG000|Period 2|Lost to Follow-up|2|||
160766144|NCT03104374|580534840|FG001|Period 2|Lost to Follow-up|2|||
160766145|NCT03104374|580534841|FG002|Period 2|Lost to Follow-up|3|||
160766146|NCT03104374|580534842|FG003|Period 2|Lost to Follow-up|5|||
160766147|NCT03104374|580534839|FG000|Period 2|Lack of Efficacy|2|||
160766148|NCT03104374|580534840|FG001|Period 2|Lack of Efficacy|4|||
160766149|NCT03104374|580534841|FG002|Period 2|Lack of Efficacy|7|||
160766150|NCT03104374|580534842|FG003|Period 2|Lack of Efficacy|4|||
160766151|NCT03104374|580534839|FG000|Period 2|COVID-19 Infection|0|||
160766152|NCT03104374|580534840|FG001|Period 2|COVID-19 Infection|0|||
160872646|NCT03776812|580925678|FG000|Overall Study|Withdrawal by Subject|1|||
160872647|NCT03776812|580925679|FG001|Overall Study|Withdrawal by Subject|7|||
160872648|NCT03776812|580925680|FG002|Overall Study|Withdrawal by Subject|2|||
160872649|NCT03776812|580925678|FG000|Overall Study|Lost to Follow-up|1|||
160872650|NCT03776812|580925679|FG001|Overall Study|Lost to Follow-up|1|||
160872651|NCT03776812|580925680|FG002|Overall Study|Lost to Follow-up|0|||
160872652|NCT03776812|580925678|FG000|Overall Study|Did not enter long-term follow-up|3|||
160872653|NCT03776812|580925679|FG001|Overall Study|Did not enter long-term follow-up|3|||
160872654|NCT03776812|580925680|FG002|Overall Study|Did not enter long-term follow-up|2|||
160872655|NCT02442804|580925684|FG000|Overall Study|Withdrawal by Subject|0|||
160872656|NCT02442804|580925685|FG001|Overall Study|Withdrawal by Subject|1|||
160872657|NCT02442804|580925684|FG000|Overall Study|Adverse Event|1|||
160872658|NCT02442804|580925685|FG001|Overall Study|Adverse Event|0|||
160872659|NCT02527421|580925689|FG000|Overall Study|Withdrawal by Subject|1|||
160872660|NCT02527421|580925690|FG001|Overall Study|Withdrawal by Subject|0|||
160872661|NCT00993148|580925691|FG000|Overall Study|Lost to Follow-up|2|||
160872662|NCT00993148|580925691|FG000|Overall Study|never initiated treatment|1|||
160872663|NCT00560352|580925708|FG000|Overall Study|Adverse event unrelated to study drug|2|||
160872664|NCT00560352|580925709|FG001|Overall Study|Adverse event unrelated to study drug|1|||
160872665|NCT00560352|580925710|FG002|Overall Study|Adverse event unrelated to study drug|1|||
160872666|NCT00560352|580925708|FG000|Overall Study|Study drug toxicity|3|||
160872667|NCT00560352|580925709|FG001|Overall Study|Study drug toxicity|0|||
160872668|NCT00560352|580925710|FG002|Overall Study|Study drug toxicity|1|||
160872669|NCT00560352|580925708|FG000|Overall Study|Disease progression|0|||
160872670|NCT00560352|580925709|FG001|Overall Study|Disease progression|1|||
160872671|NCT00560352|580925710|FG002|Overall Study|Disease progression|1|||
160872672|NCT00560352|580925708|FG000|Overall Study|Withdrawal by Subject|1|||
160872673|NCT00560352|580925709|FG001|Overall Study|Withdrawal by Subject|1|||
160872674|NCT00560352|580925710|FG002|Overall Study|Withdrawal by Subject|1|||
160872675|NCT00560352|580925708|FG000|Overall Study|Maximum clinical benefit|1|||
160872676|NCT00560352|580925709|FG001|Overall Study|Maximum clinical benefit|0|||
160532056|NCT00467779|579678647|FG014|Stage 1A|Unspecified Reason|0|||
160532057|NCT00467779|579678633|FG000|Stage 2|Adverse Event|0|||
160532058|NCT00467779|579678634|FG001|Stage 2|Adverse Event|0|||
160532059|NCT00467779|579678635|FG002|Stage 2|Adverse Event|0|||
160532060|NCT00467779|579678636|FG003|Stage 2|Adverse Event|0|||
160532061|NCT00467779|579678637|FG004|Stage 2|Adverse Event|0|||
160532062|NCT00467779|579678638|FG005|Stage 2|Adverse Event|0|||
160532063|NCT00467779|579678639|FG006|Stage 2|Adverse Event|0|||
160532064|NCT00467779|579678640|FG007|Stage 2|Adverse Event|0|||
160532065|NCT00467779|579678641|FG008|Stage 2|Adverse Event|1|||
160532066|NCT00467779|579678642|FG009|Stage 2|Adverse Event|0|||
160532067|NCT00467779|579678643|FG010|Stage 2|Adverse Event|0|||
160532068|NCT00467779|579678644|FG011|Stage 2|Adverse Event|0|||
160532069|NCT00467779|579678645|FG012|Stage 2|Adverse Event|0|||
160532070|NCT00467779|579678646|FG013|Stage 2|Adverse Event|0|||
160532071|NCT00467779|579678647|FG014|Stage 2|Adverse Event|0|||
160532072|NCT00467779|579678633|FG000|Stage 2|Death|0|||
160532073|NCT00467779|579678634|FG001|Stage 2|Death|0|||
160532074|NCT00467779|579678635|FG002|Stage 2|Death|0|||
160532075|NCT00467779|579678636|FG003|Stage 2|Death|0|||
160532076|NCT00467779|579678637|FG004|Stage 2|Death|0|||
160532077|NCT00467779|579678638|FG005|Stage 2|Death|0|||
160532078|NCT00467779|579678639|FG006|Stage 2|Death|0|||
160532079|NCT00467779|579678640|FG007|Stage 2|Death|0|||
160532080|NCT00467779|579678641|FG008|Stage 2|Death|1|||
160532081|NCT00467779|579678642|FG009|Stage 2|Death|0|||
160532082|NCT00467779|579678643|FG010|Stage 2|Death|0|||
160532083|NCT00467779|579678644|FG011|Stage 2|Death|0|||
160532084|NCT00467779|579678645|FG012|Stage 2|Death|0|||
160532085|NCT00467779|579678646|FG013|Stage 2|Death|0|||
160532086|NCT00467779|579678647|FG014|Stage 2|Death|0|||
160532087|NCT00467779|579678633|FG000|Stage 2|Disease Progression|0|||
160532088|NCT00467779|579678634|FG001|Stage 2|Disease Progression|0|||
160532089|NCT00467779|579678635|FG002|Stage 2|Disease Progression|0|||
160532090|NCT00467779|579678636|FG003|Stage 2|Disease Progression|0|||
160532091|NCT00467779|579678637|FG004|Stage 2|Disease Progression|0|||
160532092|NCT00467779|579678638|FG005|Stage 2|Disease Progression|0|||
160532093|NCT00467779|579678639|FG006|Stage 2|Disease Progression|0|||
160532094|NCT00467779|579678640|FG007|Stage 2|Disease Progression|0|||
160532095|NCT00467779|579678641|FG008|Stage 2|Disease Progression|16|||
160532096|NCT00467779|579678642|FG009|Stage 2|Disease Progression|0|||
160532097|NCT00467779|579678643|FG010|Stage 2|Disease Progression|0|||
160532098|NCT00467779|579678644|FG011|Stage 2|Disease Progression|0|||
160532099|NCT00467779|579678645|FG012|Stage 2|Disease Progression|0|||
160532100|NCT00467779|579678646|FG013|Stage 2|Disease Progression|0|||
160532101|NCT00467779|579678647|FG014|Stage 2|Disease Progression|0|||
160532102|NCT00467779|579678633|FG000|Stage 2|Unspecified Reason|0|||
160532103|NCT00467779|579678634|FG001|Stage 2|Unspecified Reason|0|||
160532104|NCT00467779|579678635|FG002|Stage 2|Unspecified Reason|0|||
160532105|NCT00467779|579678636|FG003|Stage 2|Unspecified Reason|0|||
160532106|NCT00467779|579678637|FG004|Stage 2|Unspecified Reason|0|||
160532107|NCT00467779|579678638|FG005|Stage 2|Unspecified Reason|0|||
160532108|NCT00467779|579678639|FG006|Stage 2|Unspecified Reason|0|||
160532109|NCT00467779|579678640|FG007|Stage 2|Unspecified Reason|0|||
160532110|NCT00467779|579678641|FG008|Stage 2|Unspecified Reason|3|||
160532111|NCT00467779|579678642|FG009|Stage 2|Unspecified Reason|0|||
160532112|NCT00467779|579678643|FG010|Stage 2|Unspecified Reason|0|||
160872677|NCT00560352|580925710|FG002|Overall Study|Maximum clinical benefit|0|||
160872678|NCT03892967|580925711|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
160872679|NCT03892967|580925712|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
160872680|NCT03892967|580925713|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
160532113|NCT00467779|579678644|FG011|Stage 2|Unspecified Reason|0|||
160532114|NCT00467779|579678645|FG012|Stage 2|Unspecified Reason|0|||
160532115|NCT00467779|579678646|FG013|Stage 2|Unspecified Reason|0|||
160532116|NCT00467779|579678647|FG014|Stage 2|Unspecified Reason|0|||
160532117|NCT00467779|579678633|FG000|Stage 2A|Adverse Event|0|||
160532118|NCT00467779|579678634|FG001|Stage 2A|Adverse Event|0|||
160532119|NCT00467779|579678635|FG002|Stage 2A|Adverse Event|0|||
160532120|NCT00467779|579678636|FG003|Stage 2A|Adverse Event|0|||
160532121|NCT00467779|579678637|FG004|Stage 2A|Adverse Event|0|||
160532122|NCT00467779|579678638|FG005|Stage 2A|Adverse Event|0|||
160532123|NCT00467779|579678639|FG006|Stage 2A|Adverse Event|0|||
160532124|NCT00467779|579678640|FG007|Stage 2A|Adverse Event|0|||
160532125|NCT00467779|579678641|FG008|Stage 2A|Adverse Event|0|||
160532126|NCT00467779|579678642|FG009|Stage 2A|Adverse Event|0|||
160532127|NCT00467779|579678643|FG010|Stage 2A|Adverse Event|0|||
160532128|NCT00467779|579678644|FG011|Stage 2A|Adverse Event|0|||
160532129|NCT00467779|579678645|FG012|Stage 2A|Adverse Event|0|||
160532130|NCT00467779|579678646|FG013|Stage 2A|Adverse Event|2|||
160532131|NCT00467779|579678647|FG014|Stage 2A|Adverse Event|0|||
160532132|NCT00467779|579678633|FG000|Stage 2A|Death|0|||
160532133|NCT00467779|579678634|FG001|Stage 2A|Death|0|||
160532134|NCT00467779|579678635|FG002|Stage 2A|Death|0|||
160872681|NCT03892967|580925714|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
160532135|NCT00467779|579678636|FG003|Stage 2A|Death|0|||
160872682|NCT03892967|580925715|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
160532136|NCT00467779|579678637|FG004|Stage 2A|Death|0|||
160532137|NCT00467779|579678638|FG005|Stage 2A|Death|0|||
160532138|NCT00467779|579678639|FG006|Stage 2A|Death|0|||
160532139|NCT00467779|579678640|FG007|Stage 2A|Death|0|||
160532140|NCT00467779|579678641|FG008|Stage 2A|Death|0|||
160872683|NCT03892967|580925711|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
160872684|NCT03892967|580925712|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
160872685|NCT03892967|580925713|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
160532141|NCT00467779|579678642|FG009|Stage 2A|Death|0|||
160532142|NCT00467779|579678643|FG010|Stage 2A|Death|0|||
160532143|NCT00467779|579678644|FG011|Stage 2A|Death|0|||
160532144|NCT00467779|579678645|FG012|Stage 2A|Death|0|||
160872686|NCT03892967|580925714|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
160872687|NCT03892967|580925715|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
160872688|NCT03892967|580925711|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
160872689|NCT03892967|580925712|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
160872690|NCT03892967|580925713|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
160872691|NCT03892967|580925714|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
160872692|NCT03892967|580925715|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
160872693|NCT03892967|580925711|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
160872694|NCT03892967|580925712|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
160872695|NCT03892967|580925713|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
160872696|NCT03892967|580925714|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
160872697|NCT03892967|580925715|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
160872698|NCT03892967|580925711|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
160872699|NCT03892967|580925712|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
160872700|NCT03892967|580925713|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
160872701|NCT03892967|580925714|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
160872702|NCT03892967|580925715|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
160872703|NCT03892967|580925711|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
160872704|NCT03892967|580925712|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
160872705|NCT03892967|580925713|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
160872706|NCT03892967|580925714|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
160872707|NCT03892967|580925715|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
160872708|NCT03568461|580925719|FG000|Overall Study|Death|7|||
160872709|NCT03568461|580925719|FG000|Overall Study|Physician Decision|5|||
160872710|NCT03568461|580925719|FG000|Overall Study|Subject decision|5|||
160872711|NCT03568461|580925719|FG000|Overall Study|Lost to Follow-up|1|||
160872712|NCT03387085|580925723|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
160872713|NCT01296672|580927805|FG000|Overall Study|Lost to Follow-up|73|||
160872714|NCT01296672|580927806|FG001|Overall Study|Lost to Follow-up|18|||
160872715|NCT01311024|580927810|FG000|Overall Study|Protocol Violation|35|||
160532145|NCT00467779|579678646|FG013|Stage 2A|Death|1|||
160532146|NCT00467779|579678647|FG014|Stage 2A|Death|0|||
160532147|NCT00467779|579678633|FG000|Stage 2A|Disease Progression|0|||
160532148|NCT00467779|579678634|FG001|Stage 2A|Disease Progression|0|||
160532149|NCT00467779|579678635|FG002|Stage 2A|Disease Progression|0|||
160532150|NCT00467779|579678636|FG003|Stage 2A|Disease Progression|0|||
160532151|NCT00467779|579678637|FG004|Stage 2A|Disease Progression|0|||
160532152|NCT00467779|579678638|FG005|Stage 2A|Disease Progression|0|||
160532153|NCT00467779|579678639|FG006|Stage 2A|Disease Progression|0|||
160532154|NCT00467779|579678640|FG007|Stage 2A|Disease Progression|0|||
160532155|NCT00467779|579678641|FG008|Stage 2A|Disease Progression|0|||
160532156|NCT00467779|579678642|FG009|Stage 2A|Disease Progression|0|||
160532157|NCT00467779|579678643|FG010|Stage 2A|Disease Progression|0|||
160872716|NCT01311024|580927811|FG001|Overall Study|Protocol Violation|22|||
160872717|NCT04643158|580927818|FG000|Overall Study|Study terminated by sponsor|0|||
160872718|NCT04643158|580927819|FG001|Overall Study|Study terminated by sponsor|0|||
160872719|NCT04643158|580927820|FG002|Overall Study|Study terminated by sponsor|1|||
160872720|NCT04643158|580927821|FG003|Overall Study|Study terminated by sponsor|0|||
160872721|NCT04643158|580927822|FG004|Overall Study|Study terminated by sponsor|0|||
160872722|NCT04643158|580927823|FG005|Overall Study|Study terminated by sponsor|1|||
160872723|NCT04643158|580927824|FG006|Overall Study|Study terminated by sponsor|0|||
160872724|NCT04643158|580927818|FG000|Overall Study|Global/country situation|0|||
160872725|NCT04643158|580927819|FG001|Overall Study|Global/country situation|0|||
160872726|NCT04643158|580927820|FG002|Overall Study|Global/country situation|1|||
160872727|NCT04643158|580927821|FG003|Overall Study|Global/country situation|0|||
160872728|NCT04643158|580927822|FG004|Overall Study|Global/country situation|0|||
160872729|NCT04643158|580927823|FG005|Overall Study|Global/country situation|0|||
160872730|NCT04643158|580927824|FG006|Overall Study|Global/country situation|0|||
160872731|NCT04643158|580927818|FG000|Overall Study|Withdrawal by Subject|0|||
160872732|NCT04643158|580927819|FG001|Overall Study|Withdrawal by Subject|0|||
160872733|NCT04643158|580927820|FG002|Overall Study|Withdrawal by Subject|0|||
160872734|NCT04643158|580927821|FG003|Overall Study|Withdrawal by Subject|0|||
160872735|NCT04643158|580927822|FG004|Overall Study|Withdrawal by Subject|0|||
160872736|NCT04643158|580927823|FG005|Overall Study|Withdrawal by Subject|1|||
160872737|NCT04643158|580927824|FG006|Overall Study|Withdrawal by Subject|0|||
160872738|NCT04329806|580927825|FG000|Overall Study|Physician Decision|3|||
160872739|NCT04329806|580927826|FG001|Overall Study|Physician Decision|4|||
160872740|NCT00622440|580927839|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
160872741|NCT00622440|580927840|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
160872742|NCT00622440|580927839|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
160872743|NCT00622440|580927840|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
160872744|NCT00622440|580927839|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
160872745|NCT00622440|580927840|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
160872746|NCT00622440|580927839|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
160872747|NCT00622440|580927840|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
160872748|NCT00856518|580927848|FG000|Overall Study|Lost to Follow-up|4|||
160872749|NCT00856518|580927849|FG001|Overall Study|Lost to Follow-up|2|||
160872750|NCT02867384|580927850|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
160872751|NCT02867384|580927851|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
160872752|NCT02867384|580927852|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
160872753|NCT02867384|580927850|FG000|Overall Study|Progression/ Relapse|15|||
160872754|NCT02867384|580927851|FG001|Overall Study|Progression/ Relapse|19|||
160872755|NCT02867384|580927852|FG002|Overall Study|Progression/ Relapse|0|||
160872756|NCT02867384|580927850|FG000|Overall Study|Adverse Event|13|||
160872757|NCT02867384|580927851|FG001|Overall Study|Adverse Event|1|||
160872758|NCT02867384|580927852|FG002|Overall Study|Adverse Event|0|||
160872759|NCT02867384|580927850|FG000|Overall Study|Withdrawal by Subject|6|||
160872760|NCT02867384|580927851|FG001|Overall Study|Withdrawal by Subject|5|||
160872761|NCT02867384|580927852|FG002|Overall Study|Withdrawal by Subject|0|||
160872762|NCT02867384|580927850|FG000|Overall Study|Physician Decision|1|||
160872763|NCT02867384|580927851|FG001|Overall Study|Physician Decision|2|||
160872764|NCT02867384|580927852|FG002|Overall Study|Physician Decision|0|||
160872765|NCT02867384|580927850|FG000|Overall Study|Patient compliance|1|||
160872766|NCT02867384|580927851|FG001|Overall Study|Patient compliance|0|||
160872767|NCT02867384|580927852|FG002|Overall Study|Patient compliance|0|||
160872768|NCT02867384|580927850|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
160872769|NCT02867384|580927851|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
160872770|NCT02867384|580927852|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
160872771|NCT02867384|580927850|FG000|Overall Study|Never start treatment|3|||
160872772|NCT02867384|580927851|FG001|Overall Study|Never start treatment|0|||
160872773|NCT02867384|580927852|FG002|Overall Study|Never start treatment|0|||
160872774|NCT01652534|580927853|FG000|Overall Study|Lack of Efficacy|1|||
160872775|NCT01652534|580927854|FG001|Overall Study|Lack of Efficacy|0|||
160872776|NCT01941186|580927855|FG000|Follow-up|Lost to Follow-up|1|||
160872777|NCT01941186|580927856|FG001|Follow-up|Lost to Follow-up|0|||
160872778|NCT02105961|580927857|FG000|Overall Study|Adverse Event|18|||
160872779|NCT02105961|580927858|FG001|Overall Study|Adverse Event|7|||
160872780|NCT02105961|580927859|FG002|Overall Study|Adverse Event|13|||
160872781|NCT02105961|580927857|FG000|Overall Study|Lack of Efficacy|3|||
160872782|NCT02105961|580927858|FG001|Overall Study|Lack of Efficacy|0|||
160872783|NCT02105961|580927859|FG002|Overall Study|Lack of Efficacy|3|||
160872784|NCT02105961|580927857|FG000|Overall Study|Lost to Follow-up|2|||
160872785|NCT02105961|580927858|FG001|Overall Study|Lost to Follow-up|0|||
160872786|NCT02105961|580927859|FG002|Overall Study|Lost to Follow-up|1|||
160766153|NCT03104374|580534841|FG002|Period 2|COVID-19 Infection|1|||
160766154|NCT03104374|580534842|FG003|Period 2|COVID-19 Infection|0|||
160766155|NCT03104374|580534839|FG000|Period 2|Other|3|||
160766156|NCT03104374|580534840|FG001|Period 2|Other|2|||
160766157|NCT03104374|580534841|FG002|Period 2|Other|2|||
160766158|NCT03104374|580534842|FG003|Period 2|Other|4|||
160766159|NCT03210714|580534843|FG000|Overall Study|Adverse Event|6|||
160766160|NCT03210714|580534843|FG000|Overall Study|Physician Decision|1|||
160766161|NCT03210714|580534843|FG000|Overall Study|Progressive disease|11|||
160766162|NCT03210714|580534843|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
160766163|NCT00803179|580534844|FG000|Overall Study|Lost to Follow-up|3|||
160766164|NCT04158648|580534845|FG000|Overall Study|Ongoing in the Study|69|||
160766165|NCT04158648|580534845|FG000|Overall Study|Withdrawal by Subject|4|||
160766166|NCT04609514|580534846|FG000|Overall Study|Lost to Follow-up|5|||
160766167|NCT04609514|580534847|FG001|Overall Study|Lost to Follow-up|4|||
160766168|NCT04609514|580534846|FG000|Overall Study|Withdrawal by PI|0|||
160766169|NCT04609514|580534847|FG001|Overall Study|Withdrawal by PI|2|||
160766170|NCT00885118|580534848|FG000|Overall Study|Adverse Event|1|||
160766171|NCT00885118|580534849|FG001|Overall Study|Adverse Event|0|||
160766172|NCT00885118|580534850|FG002|Overall Study|Adverse Event|0|||
160766173|NCT00885118|580534851|FG003|Overall Study|Adverse Event|0|||
160766174|NCT00885118|580534852|FG004|Overall Study|Adverse Event|0|||
160766175|NCT00885118|580534848|FG000|Overall Study|Withdrawal by Subject|0|||
160766176|NCT00885118|580534849|FG001|Overall Study|Withdrawal by Subject|0|||
160766177|NCT00885118|580534850|FG002|Overall Study|Withdrawal by Subject|0|||
160766178|NCT00885118|580534851|FG003|Overall Study|Withdrawal by Subject|0|||
160766179|NCT00885118|580534852|FG004|Overall Study|Withdrawal by Subject|1|||
160766180|NCT00885118|580534848|FG000|Overall Study|Other reason not defined above|0|||
160766181|NCT00885118|580534849|FG001|Overall Study|Other reason not defined above|0|||
160766182|NCT00885118|580534850|FG002|Overall Study|Other reason not defined above|1|||
160766183|NCT00885118|580534851|FG003|Overall Study|Other reason not defined above|0|||
160636457|NCT03747939|580051554|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
160766184|NCT00885118|580534852|FG004|Overall Study|Other reason not defined above|0|||
160766185|NCT00251758|580534861|FG000|Overall Study|Adverse Event|7|||
160872787|NCT02105961|580927857|FG000|Overall Study|Physician Decision|3|||
160872788|NCT02105961|580927858|FG001|Overall Study|Physician Decision|3|||
160872789|NCT02105961|580927859|FG002|Overall Study|Physician Decision|2|||
160872790|NCT02105961|580927857|FG000|Overall Study|Withdrawal by Subject|15|||
160872791|NCT02105961|580927858|FG001|Overall Study|Withdrawal by Subject|7|||
160872792|NCT02105961|580927859|FG002|Overall Study|Withdrawal by Subject|11|||
160872793|NCT00934362|580927863|FG000|Overall Study|Adverse Event|1|||
160872794|NCT00934362|580927864|FG001|Overall Study|Adverse Event|0|||
160872795|NCT01092117|580927867|FG000|Index Procedure to 1 Month|Death|1|||
160872796|NCT01092117|580927867|FG000|1 Month|Death|1|||
160872797|NCT01092117|580927867|FG000|1 Month|Withdrawal by Subject|1|||
160872798|NCT01092117|580927867|FG000|1 Month|Lost to Follow-up|1|||
160872799|NCT01092117|580927867|FG000|6 Months|Death|2|||
160872800|NCT01092117|580927867|FG000|6 Months|Withdrawal by Subject|3|||
160872801|NCT01092117|580927867|FG000|12 Month|Death|11|||
160872802|NCT01092117|580927867|FG000|12 Month|Withdrawal by Subject|2|||
160872803|NCT01092117|580927867|FG000|12 Month|Lost to Follow-up|1|||
160872804|NCT01092117|580927867|FG000|Year 2|Death|5|||
160872805|NCT01092117|580927867|FG000|Year 2|Withdrawal by Subject|4|||
160872806|NCT01092117|580927867|FG000|Year 2|Lost to Follow-up|1|||
160872807|NCT01092117|580927867|FG000|Year 3|Death|7|||
160872808|NCT01092117|580927867|FG000|Year 3|Withdrawal by Subject|9|||
160872809|NCT01092117|580927867|FG000|Year 3|Lost to Follow-up|3|||
160872810|NCT01092117|580927867|FG000|Year 4|Death|8|||
160872811|NCT01092117|580927867|FG000|Year 4|Withdrawal by Subject|4|||
160872812|NCT01092117|580927867|FG000|Year 4|Lost to Follow-up|4|||
160872813|NCT04380519|580927868|FG000|Overall Study|Withdrawal by Subject|4|||
160872814|NCT04380519|580927869|FG001|Overall Study|Withdrawal by Subject|0|||
160872815|NCT04380519|580927870|FG002|Overall Study|Withdrawal by Subject|1|||
160872816|NCT04380519|580927868|FG000|Overall Study|Death|14|||
160872817|NCT04380519|580927869|FG001|Overall Study|Death|9|||
160872818|NCT04380519|580927870|FG002|Overall Study|Death|6|||
160872819|NCT04380519|580927868|FG000|Overall Study|Adverse Event|0|||
160872820|NCT04380519|580927869|FG001|Overall Study|Adverse Event|1|||
160872821|NCT04380519|580927870|FG002|Overall Study|Adverse Event|0|||
160872822|NCT04380519|580927868|FG000|Overall Study|relatives' decision|0|||
160872823|NCT04380519|580927869|FG001|Overall Study|relatives' decision|1|||
160872824|NCT04380519|580927870|FG002|Overall Study|relatives' decision|0|||
160872825|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
160872826|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
160872827|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
160872828|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
160872829|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
160872830|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
160872831|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
160872832|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
160872833|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
160872834|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
160872835|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
160872836|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
160872837|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
160872838|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
160872839|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
160872840|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
160872841|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
160872842|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
160872843|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
160872844|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
160872845|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
160872846|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
160872847|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
160872848|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
160872849|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
160872850|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
160872851|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
160872852|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
160872853|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
160872854|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
160872855|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
160872856|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
160872857|NCT01623050|580927873|FG000|Overall Study|Lost to Follow-up|9|||
160872858|NCT00526071|580927876|FG000|Overall Study|Adverse Event|1|||
160872859|NCT00526071|580927876|FG000|Overall Study|Withdrawal by Subject|1|||
160872860|NCT00526071|580927876|FG000|Overall Study|Lack of Response to Study Drug|4|||
160872861|NCT01191762|580927877|FG000|Overall Study|Adverse Event|1|||
160872862|NCT01191762|580927878|FG001|Overall Study|Adverse Event|0|||
160872863|NCT03023813|580927881|FG000|Overall Study|Lost to Follow-up|1|||
160872864|NCT03023813|580927882|FG001|Overall Study|Lost to Follow-up|2|||
160872865|NCT03023813|580927883|FG002|Overall Study|Lost to Follow-up|0|||
160872866|NCT00393861|580927884|FG000|Overall Study|Adverse Event|2|||
160872867|NCT00393861|580927884|FG000|Overall Study|Disease Progression|24|||
160872868|NCT03710083|580927885|FG000|Overall Study|Withdrawal by Subject|2|||
160872869|NCT03710083|580927885|FG000|Overall Study|Unsuccessful Procedure|1|||
160872870|NCT05300763|580927886|FG000|Overall Study|Adverse Event|0|||
160872871|NCT05300763|580927887|FG001|Overall Study|Adverse Event|1|||
160872872|NCT05300763|580927886|FG000|Overall Study|Major Protocol Deviation|1|||
160872873|NCT05300763|580927887|FG001|Overall Study|Major Protocol Deviation|0|||
160872874|NCT05300763|580927886|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
160872875|NCT05300763|580927887|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
160872876|NCT01485172|580927888|FG000|Overall Study|Adverse Event|2|||
160872877|NCT01485172|580927889|FG001|Overall Study|Adverse Event|1|||
160872878|NCT01485172|580927890|FG002|Overall Study|Adverse Event|2|||
160872879|NCT01485172|580927891|FG003|Overall Study|Adverse Event|2|||
160872880|NCT01485172|580927892|FG004|Overall Study|Adverse Event|1|||
160872881|NCT01485172|580927893|FG005|Overall Study|Adverse Event|2|||
160872882|NCT01485172|580927888|FG000|Overall Study|Lack of Efficacy|2|||
160872883|NCT01485172|580927889|FG001|Overall Study|Lack of Efficacy|0|||
160872884|NCT01485172|580927890|FG002|Overall Study|Lack of Efficacy|0|||
160872885|NCT01485172|580927891|FG003|Overall Study|Lack of Efficacy|0|||
160872886|NCT01485172|580927892|FG004|Overall Study|Lack of Efficacy|0|||
160872887|NCT01485172|580927893|FG005|Overall Study|Lack of Efficacy|0|||
160872888|NCT01485172|580927888|FG000|Overall Study|Protocol Violation|0|||
160872889|NCT01485172|580927889|FG001|Overall Study|Protocol Violation|0|||
160872890|NCT01485172|580927890|FG002|Overall Study|Protocol Violation|4|||
160872891|NCT01485172|580927891|FG003|Overall Study|Protocol Violation|5|||
160872892|NCT01485172|580927892|FG004|Overall Study|Protocol Violation|1|||
160872893|NCT01485172|580927893|FG005|Overall Study|Protocol Violation|0|||
160872894|NCT01485172|580927888|FG000|Overall Study|Protocol defined stopping criteria|1|||
160872895|NCT01485172|580927889|FG001|Overall Study|Protocol defined stopping criteria|0|||
160872896|NCT01485172|580927890|FG002|Overall Study|Protocol defined stopping criteria|0|||
160872897|NCT01485172|580927891|FG003|Overall Study|Protocol defined stopping criteria|0|||
160872898|NCT01485172|580927892|FG004|Overall Study|Protocol defined stopping criteria|1|||
160872899|NCT01485172|580927893|FG005|Overall Study|Protocol defined stopping criteria|0|||
160872900|NCT01485172|580927888|FG000|Overall Study|Lost to Follow-up|0|||
160872901|NCT01485172|580927889|FG001|Overall Study|Lost to Follow-up|0|||
160872902|NCT01485172|580927890|FG002|Overall Study|Lost to Follow-up|1|||
160872903|NCT01485172|580927891|FG003|Overall Study|Lost to Follow-up|0|||
160872904|NCT01485172|580927892|FG004|Overall Study|Lost to Follow-up|0|||
160872905|NCT01485172|580927893|FG005|Overall Study|Lost to Follow-up|1|||
160872906|NCT01485172|580927888|FG000|Overall Study|Physician Decision|0|||
160872907|NCT01485172|580927889|FG001|Overall Study|Physician Decision|0|||
160872908|NCT01485172|580927890|FG002|Overall Study|Physician Decision|0|||
160872909|NCT01485172|580927891|FG003|Overall Study|Physician Decision|0|||
160872910|NCT01485172|580927892|FG004|Overall Study|Physician Decision|1|||
160872911|NCT01485172|580927893|FG005|Overall Study|Physician Decision|0|||
160872912|NCT01485172|580927888|FG000|Overall Study|Withdrawal by Subject|2|||
160766186|NCT00251758|580534862|FG001|Overall Study|Adverse Event|9|||
160766187|NCT00251758|580534863|FG002|Overall Study|Adverse Event|11|||
160766188|NCT00251758|580534861|FG000|Overall Study|Lost to Follow-up|4|||
160766189|NCT00251758|580534862|FG001|Overall Study|Lost to Follow-up|2|||
160766190|NCT00251758|580534863|FG002|Overall Study|Lost to Follow-up|5|||
160766191|NCT00251758|580534861|FG000|Overall Study|Withdrawal by Subject|13|||
160766192|NCT00251758|580534862|FG001|Overall Study|Withdrawal by Subject|7|||
160766193|NCT00251758|580534863|FG002|Overall Study|Withdrawal by Subject|3|||
160766194|NCT00251758|580534861|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
160766195|NCT00251758|580534862|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
160766196|NCT00251758|580534863|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
160766197|NCT00251758|580534861|FG000|Overall Study|Lack of Efficacy|3|||
160766198|NCT00251758|580534862|FG001|Overall Study|Lack of Efficacy|0|||
160766199|NCT00251758|580534863|FG002|Overall Study|Lack of Efficacy|0|||
160766200|NCT00251758|580534861|FG000|Overall Study|Noncompliant|0|||
160766201|NCT00251758|580534862|FG001|Overall Study|Noncompliant|2|||
160766202|NCT00251758|580534863|FG002|Overall Study|Noncompliant|2|||
160766203|NCT00251758|580534861|FG000|Overall Study|Pregnancy|0|||
160766204|NCT00251758|580534862|FG001|Overall Study|Pregnancy|1|||
160766205|NCT00251758|580534863|FG002|Overall Study|Pregnancy|0|||
160766206|NCT00251758|580534861|FG000|Overall Study|Per Subject Request|0|||
160766207|NCT00251758|580534862|FG001|Overall Study|Per Subject Request|0|||
160766208|NCT00251758|580534863|FG002|Overall Study|Per Subject Request|1|||
160766209|NCT00251758|580534861|FG000|Overall Study|Per Investigator Request|1|||
160766210|NCT00251758|580534862|FG001|Overall Study|Per Investigator Request|0|||
160766211|NCT00251758|580534863|FG002|Overall Study|Per Investigator Request|0|||
160766212|NCT03642990|580534867|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
160766213|NCT03642990|580534867|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
160766214|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
160766215|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
160766216|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
160766217|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
160766218|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
160766219|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
160766220|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
160766221|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
160766222|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
160766223|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
160766224|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
160766225|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
160766226|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
160766227|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
160766228|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
160766229|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
160766230|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
160766231|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
160766232|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
160766233|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
160766234|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
160766235|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
160766236|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
160766237|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
160766238|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
160766239|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
160766240|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
160766241|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
160766242|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
160766243|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
160766244|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
160766245|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
160766246|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
160532158|NCT00467779|579678644|FG011|Stage 2A|Disease Progression|0|||
160532159|NCT00467779|579678645|FG012|Stage 2A|Disease Progression|0|||
160532160|NCT00467779|579678646|FG013|Stage 2A|Disease Progression|10|||
160532161|NCT00467779|579678647|FG014|Stage 2A|Disease Progression|0|||
160532162|NCT00467779|579678633|FG000|Stage 2A|Unspecified Reason|0|||
160532163|NCT00467779|579678634|FG001|Stage 2A|Unspecified Reason|0|||
160532164|NCT00467779|579678635|FG002|Stage 2A|Unspecified Reason|0|||
160532165|NCT00467779|579678636|FG003|Stage 2A|Unspecified Reason|0|||
160872913|NCT01485172|580927889|FG001|Overall Study|Withdrawal by Subject|0|||
160872914|NCT01485172|580927890|FG002|Overall Study|Withdrawal by Subject|0|||
160872915|NCT01485172|580927891|FG003|Overall Study|Withdrawal by Subject|1|||
160872916|NCT01485172|580927892|FG004|Overall Study|Withdrawal by Subject|1|||
160872917|NCT01485172|580927893|FG005|Overall Study|Withdrawal by Subject|1|||
160872918|NCT01587014|580927894|FG000|Overall Study|Death|2|||
160872919|NCT01409811|580927895|FG000|Overall Study|Insurance denial|1|||
160872920|NCT00838513|580927896|FG000|Screening Period|Screen Failure|3|||
160872921|NCT00838513|580927896|FG000|Extension Treatment Period|Death|1|||
160872922|NCT00838513|580927896|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
160872923|NCT00975780|580927902|FG000|Follow Up|Death|88|||
160872924|NCT00975780|580927903|FG001|Follow Up|Death|122|||
160872925|NCT00975780|580927902|FG000|Follow Up|Facility Withdrawal|7|||
160872926|NCT00975780|580927903|FG001|Follow Up|Facility Withdrawal|23|||
160872927|NCT00975780|580927902|FG000|Follow Up|Discharged from Facility|7|||
160872928|NCT00975780|580927903|FG001|Follow Up|Discharged from Facility|12|||
160872929|NCT00441064|580927904|FG000|Overall Study|Adverse Event|1|||
160872930|NCT00441064|580927905|FG001|Overall Study|Adverse Event|0|||
160872931|NCT00441064|580927904|FG000|Overall Study|Abnormal laboratory values|0|||
160872932|NCT00441064|580927905|FG001|Overall Study|Abnormal laboratory values|2|||
160872933|NCT00441064|580927904|FG000|Overall Study|Abnormal test procedure results|0|||
160872934|NCT00441064|580927905|FG001|Overall Study|Abnormal test procedure results|1|||
160872935|NCT00441064|580927904|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160872936|NCT00441064|580927905|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160872937|NCT00441064|580927904|FG000|Overall Study|Protocol Deviation|3|||
160872938|NCT00441064|580927905|FG001|Overall Study|Protocol Deviation|2|||
160872939|NCT00441064|580927904|FG000|Overall Study|Patient withdrew consent|5|||
160872940|NCT00441064|580927905|FG001|Overall Study|Patient withdrew consent|2|||
160872941|NCT03051178|580927906|FG000|Overall Study|Withdrawal by Subject|5|||
160872942|NCT00953056|580927907|FG000|Overall Study|Withdrew Consent|0|||
160872943|NCT00953056|580927908|FG001|Overall Study|Withdrew Consent|0|||
160872944|NCT00953056|580927909|FG002|Overall Study|Withdrew Consent|0|||
160872945|NCT00953056|580927910|FG003|Overall Study|Withdrew Consent|0|||
160872946|NCT00953056|580927911|FG004|Overall Study|Withdrew Consent|2|||
160872947|NCT00953056|580927912|FG005|Overall Study|Withdrew Consent|3|||
160872948|NCT00953056|580927907|FG000|Overall Study|Serious Adverse Event|0|||
160872949|NCT00953056|580927908|FG001|Overall Study|Serious Adverse Event|0|||
160872950|NCT00953056|580927909|FG002|Overall Study|Serious Adverse Event|0|||
160872951|NCT00953056|580927910|FG003|Overall Study|Serious Adverse Event|0|||
160872952|NCT00953056|580927911|FG004|Overall Study|Serious Adverse Event|0|||
160872953|NCT00953056|580927912|FG005|Overall Study|Serious Adverse Event|1|||
160872954|NCT03962504|580927913|FG000|Overall Study|Other|11|||
160872955|NCT03962504|580927914|FG001|Overall Study|Other|32|||
160872956|NCT02813577|580927915|FG000|Overall Study|Study terminated|4|||
160872957|NCT01976741|580927916|FG000|Overall Study|Withdrawal by Subject|1|||
160872958|NCT01976741|580927917|FG001|Overall Study|Withdrawal by Subject|0|||
160872959|NCT01976741|580927918|FG002|Overall Study|Withdrawal by Subject|1|||
160872960|NCT01976741|580927919|FG003|Overall Study|Withdrawal by Subject|1|||
160872961|NCT01976741|580927920|FG004|Overall Study|Withdrawal by Subject|0|||
160872962|NCT01976741|580927921|FG005|Overall Study|Withdrawal by Subject|0|||
160872963|NCT01976741|580927922|FG006|Overall Study|Withdrawal by Subject|1|||
160872964|NCT01976741|580927923|FG007|Overall Study|Withdrawal by Subject|4|||
160872965|NCT01976741|580927924|FG008|Overall Study|Withdrawal by Subject|0|||
160872966|NCT01976741|580927925|FG009|Overall Study|Withdrawal by Subject|0|||
160872967|NCT01976741|580927916|FG000|Overall Study|Adverse Event|0|||
160872968|NCT01976741|580927917|FG001|Overall Study|Adverse Event|0|||
160532166|NCT00467779|579678637|FG004|Stage 2A|Unspecified Reason|0|||
160532167|NCT00467779|579678638|FG005|Stage 2A|Unspecified Reason|0|||
160532168|NCT00467779|579678639|FG006|Stage 2A|Unspecified Reason|0|||
160532169|NCT00467779|579678640|FG007|Stage 2A|Unspecified Reason|0|||
160532170|NCT00467779|579678641|FG008|Stage 2A|Unspecified Reason|0|||
160532171|NCT00467779|579678642|FG009|Stage 2A|Unspecified Reason|0|||
160872969|NCT01976741|580927918|FG002|Overall Study|Adverse Event|2|||
160872970|NCT01976741|580927919|FG003|Overall Study|Adverse Event|0|||
160872971|NCT01976741|580927920|FG004|Overall Study|Adverse Event|0|||
160872972|NCT01976741|580927921|FG005|Overall Study|Adverse Event|0|||
160872973|NCT01976741|580927922|FG006|Overall Study|Adverse Event|3|||
160872974|NCT01976741|580927923|FG007|Overall Study|Adverse Event|8|||
160872975|NCT01976741|580927924|FG008|Overall Study|Adverse Event|1|||
160872976|NCT01976741|580927925|FG009|Overall Study|Adverse Event|4|||
160532172|NCT00467779|579678643|FG010|Stage 2A|Unspecified Reason|0|||
160872977|NCT03566485|580927936|FG000|Overall Study|Disease progression|5|||
160872978|NCT03566485|580927937|FG001|Overall Study|Disease progression|4|||
160872979|NCT03566485|580927936|FG000|Overall Study|Clinical progression|0|||
160872980|NCT03566485|580927937|FG001|Overall Study|Clinical progression|1|||
160872981|NCT03566485|580927936|FG000|Overall Study|Toxicity|0|||
160872982|NCT03566485|580927937|FG001|Overall Study|Toxicity|2|||
160872983|NCT00048074|580927938|FG000|Overall Study|Adverse Event|46|||
160872984|NCT00048074|580927939|FG001|Overall Study|Adverse Event|41|||
160872985|NCT00048074|580927940|FG002|Overall Study|Adverse Event|53|||
160872986|NCT00048074|580927938|FG000|Overall Study|Death|3|||
160872987|NCT00048074|580927939|FG001|Overall Study|Death|3|||
160872988|NCT00048074|580927940|FG002|Overall Study|Death|2|||
160872989|NCT00048074|580927938|FG000|Overall Study|Lost to Follow-up|2|||
160872990|NCT00048074|580927939|FG001|Overall Study|Lost to Follow-up|6|||
160872991|NCT00048074|580927940|FG002|Overall Study|Lost to Follow-up|6|||
160872992|NCT00048074|580927938|FG000|Overall Study|Withdrawal by Subject|28|||
160872993|NCT00048074|580927939|FG001|Overall Study|Withdrawal by Subject|30|||
160872994|NCT00048074|580927940|FG002|Overall Study|Withdrawal by Subject|35|||
160872995|NCT00048074|580927938|FG000|Overall Study|Protocol Violation|1|||
160872996|NCT00048074|580927939|FG001|Overall Study|Protocol Violation|3|||
160872997|NCT00048074|580927940|FG002|Overall Study|Protocol Violation|0|||
160872998|NCT00048074|580927938|FG000|Overall Study|Study participation was terminated|0|||
160872999|NCT00048074|580927939|FG001|Overall Study|Study participation was terminated|1|||
160873000|NCT00048074|580927940|FG002|Overall Study|Study participation was terminated|0|||
160873001|NCT00048074|580927938|FG000|Overall Study|Husband ill|0|||
160873002|NCT00048074|580927939|FG001|Overall Study|Husband ill|1|||
160873003|NCT00048074|580927940|FG002|Overall Study|Husband ill|0|||
160873004|NCT00048074|580927938|FG000|Overall Study|Poor compliance|0|||
160873005|NCT00048074|580927939|FG001|Overall Study|Poor compliance|1|||
160873006|NCT00048074|580927940|FG002|Overall Study|Poor compliance|0|||
160873007|NCT00048074|580927938|FG000|Overall Study|Out of station|0|||
160873008|NCT00048074|580927939|FG001|Overall Study|Out of station|1|||
160873009|NCT00048074|580927940|FG002|Overall Study|Out of station|1|||
160873010|NCT00048074|580927938|FG000|Overall Study|Social reasons|1|||
160873011|NCT00048074|580927939|FG001|Overall Study|Social reasons|0|||
160873012|NCT00048074|580927940|FG002|Overall Study|Social reasons|0|||
160873013|NCT02873377|580927941|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
160873014|NCT02873377|580927942|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
160873015|NCT02873377|580927941|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
160873016|NCT02873377|580927942|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
160873017|NCT01583296|580927943|FG000|Overall Study|Withdrawal by Subject|11|||
160873018|NCT01583296|580927944|FG001|Overall Study|Withdrawal by Subject|10|||
160873019|NCT01063283|580927945|FG000|Cycle 1|Adverse Event|2|||
160873020|NCT01063283|580927946|FG001|Cycle 1|Adverse Event|0|||
160873021|NCT01063283|580927947|FG002|Cycle 1|Adverse Event|0|||
160873022|NCT01063283|580927945|FG000|Cycle 1|Technical failure in data collection|1|||
160873023|NCT01063283|580927946|FG001|Cycle 1|Technical failure in data collection|0|||
160873024|NCT01063283|580927947|FG002|Cycle 1|Technical failure in data collection|0|||
160873025|NCT02504216|580927950|FG000|Overall Study|Lost to Follow-up|3|||
160873026|NCT02504216|580927951|FG001|Overall Study|Lost to Follow-up|3|||
160873027|NCT02504216|580927950|FG000|Overall Study|Withdrawal by Subject|8|||
160873028|NCT02504216|580927951|FG001|Overall Study|Withdrawal by Subject|12|||
160873029|NCT00223080|580927952|FG000|Overall Study|Withdrawal by Subject|253|||
160873030|NCT00223080|580927953|FG001|Overall Study|Withdrawal by Subject|232|||
160873031|NCT00223080|580927952|FG000|Overall Study|Required contraindicated med|0|||
160873032|NCT00223080|580927953|FG001|Overall Study|Required contraindicated med|1|||
160873033|NCT00223080|580927952|FG000|Overall Study|Non-compliant|7|||
160873034|NCT00223080|580927953|FG001|Overall Study|Non-compliant|7|||
160873035|NCT00223080|580927952|FG000|Overall Study|Moved from study area|37|||
160873036|NCT00223080|580927953|FG001|Overall Study|Moved from study area|47|||
160873037|NCT00223080|580927952|FG000|Overall Study|Lost to Follow-up|259|||
160873038|NCT00223080|580927953|FG001|Overall Study|Lost to Follow-up|284|||
160873039|NCT00223080|580927952|FG000|Overall Study|Death|85|||
160873040|NCT00223080|580927953|FG001|Overall Study|Death|74|||
160873041|NCT00223080|580927952|FG000|Overall Study|Other|14|||
160873042|NCT00223080|580927953|FG001|Overall Study|Other|11|||
160873043|NCT00223080|580927952|FG000|Overall Study|Reason not provided|141|||
160873044|NCT00223080|580927953|FG001|Overall Study|Reason not provided|140|||
160873045|NCT00223080|580927952|FG000|Overall Study|Adverse Event|0|||
160873046|NCT00223080|580927953|FG001|Overall Study|Adverse Event|1|||
160873047|NCT02598583|580927954|FG000|Extension Period|Withdrawal by Subject|1|||
160873048|NCT02598583|580927955|FG001|Extension Period|Withdrawal by Subject|0|||
160873049|NCT03237286|580927956|FG000|Overall Study|Withdrawal by Subject|1|||
160873050|NCT03237286|580927957|FG001|Overall Study|Withdrawal by Subject|0|||
160873051|NCT03237286|580927958|FG002|Overall Study|Withdrawal by Subject|2|||
160873052|NCT03237286|580927956|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
160873053|NCT03237286|580927957|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
160873054|NCT03237286|580927958|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
160873055|NCT02792829|580927966|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873056|NCT02792829|580927967|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
160873057|NCT02792829|580927968|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873058|NCT02792829|580927969|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873059|NCT02792829|580927970|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873060|NCT02792829|580927971|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873061|NCT02792829|580927972|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873062|NCT02792829|580927973|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873063|NCT02792829|580927966|FG000|Treatment Period 2|Adverse Event|0|||
160873064|NCT02792829|580927967|FG001|Treatment Period 2|Adverse Event|0|||
160873065|NCT02792829|580927968|FG002|Treatment Period 2|Adverse Event|0|||
160873066|NCT02792829|580927969|FG003|Treatment Period 2|Adverse Event|0|||
160873067|NCT02792829|580927970|FG004|Treatment Period 2|Adverse Event|1|||
160873068|NCT02792829|580927971|FG005|Treatment Period 2|Adverse Event|0|||
160873069|NCT02792829|580927972|FG006|Treatment Period 2|Adverse Event|1|||
160873070|NCT02792829|580927973|FG007|Treatment Period 2|Adverse Event|1|||
160873071|NCT02792829|580927966|FG000|Treatment Period 2|Use of proscribed medications|0|||
160873072|NCT02792829|580927967|FG001|Treatment Period 2|Use of proscribed medications|0|||
160873073|NCT02792829|580927968|FG002|Treatment Period 2|Use of proscribed medications|0|||
160873074|NCT02792829|580927969|FG003|Treatment Period 2|Use of proscribed medications|0|||
160873075|NCT02792829|580927970|FG004|Treatment Period 2|Use of proscribed medications|0|||
160873076|NCT02792829|580927971|FG005|Treatment Period 2|Use of proscribed medications|0|||
160873077|NCT02792829|580927972|FG006|Treatment Period 2|Use of proscribed medications|0|||
160873078|NCT02792829|580927973|FG007|Treatment Period 2|Use of proscribed medications|1|||
160873079|NCT01262820|580927974|FG000|Overall Study|Adverse Event|5|||
160873080|NCT01262820|580927974|FG000|Overall Study|Lack of Efficacy|9|||
160873081|NCT01262820|580927974|FG000|Overall Study|Drug held for 21+ days|1|||
160873082|NCT00104520|580927975|FG000|Overall Study|Unrelated adverse event|34|||
160873083|NCT00104520|580927976|FG001|Overall Study|Unrelated adverse event|47|||
160873084|NCT00104520|580927975|FG000|Overall Study|Study drug intolerance|0|||
160873085|NCT00104520|580927976|FG001|Overall Study|Study drug intolerance|1|||
160873086|NCT00104520|580927975|FG000|Overall Study|Related adverse event|13|||
160873087|NCT00104520|580927976|FG001|Overall Study|Related adverse event|15|||
160873088|NCT00104520|580927975|FG000|Overall Study|Lost to Follow-up|1|||
160873089|NCT00104520|580927976|FG001|Overall Study|Lost to Follow-up|0|||
160873090|NCT00104520|580927975|FG000|Overall Study|Noncompliance|0|||
160873091|NCT00104520|580927976|FG001|Overall Study|Noncompliance|2|||
160873092|NCT00104520|580927975|FG000|Overall Study|Personal/administrative|1|||
160873093|NCT00104520|580927976|FG001|Overall Study|Personal/administrative|1|||
160873094|NCT00104520|580927975|FG000|Overall Study|Other|1|||
160873095|NCT00104520|580927976|FG001|Overall Study|Other|5|||
160873096|NCT00912197|580927983|FG000|Overall Study|Withdrawal by Subject|3|||
160873097|NCT00912197|580927984|FG001|Overall Study|Withdrawal by Subject|3|||
160873098|NCT03304249|580927987|FG000|Overall Study|Lost to Follow-up|8|||
160873099|NCT03304249|580927988|FG001|Overall Study|Lost to Follow-up|10|||
160873100|NCT03304249|580927987|FG000|Overall Study|Withdrawal by Subject|12|||
160873101|NCT03304249|580927988|FG001|Overall Study|Withdrawal by Subject|2|||
160873102|NCT03304249|580927987|FG000|Overall Study|Moved Out of District|4|||
160873103|NCT03304249|580927988|FG001|Overall Study|Moved Out of District|2|||
160873104|NCT05064358|580927992|FG000|Overall Study|Death|23|||
160873105|NCT05064358|580927993|FG001|Overall Study|Death|23|||
160873106|NCT05064358|580927994|FG002|Overall Study|Death|25|||
160873107|NCT05064358|580927995|FG003|Overall Study|Death|21|||
160873108|NCT05064358|580927996|FG004|Overall Study|Death|5|||
160873109|NCT05064358|580927992|FG000|Overall Study|Lost to Follow-up|1|||
160873110|NCT05064358|580927993|FG001|Overall Study|Lost to Follow-up|2|||
160873111|NCT05064358|580927994|FG002|Overall Study|Lost to Follow-up|0|||
160873112|NCT05064358|580927995|FG003|Overall Study|Lost to Follow-up|2|||
160873113|NCT05064358|580927996|FG004|Overall Study|Lost to Follow-up|0|||
160873114|NCT05064358|580927992|FG000|Overall Study|Physician Decision|1|||
160873115|NCT05064358|580927993|FG001|Overall Study|Physician Decision|1|||
160532173|NCT00467779|579678644|FG011|Stage 2A|Unspecified Reason|0|||
160873116|NCT05064358|580927994|FG002|Overall Study|Physician Decision|2|||
160873117|NCT05064358|580927995|FG003|Overall Study|Physician Decision|0|||
160873118|NCT05064358|580927996|FG004|Overall Study|Physician Decision|0|||
160873119|NCT05064358|580927992|FG000|Overall Study|Withdrawal by Subject|4|||
160873120|NCT05064358|580927993|FG001|Overall Study|Withdrawal by Subject|5|||
160873121|NCT05064358|580927994|FG002|Overall Study|Withdrawal by Subject|3|||
160873122|NCT05064358|580927995|FG003|Overall Study|Withdrawal by Subject|6|||
160873123|NCT05064358|580927996|FG004|Overall Study|Withdrawal by Subject|3|||
160873124|NCT05064358|580927992|FG000|Overall Study|Ongoing at the time of analysis|1|||
160873125|NCT05064358|580927993|FG001|Overall Study|Ongoing at the time of analysis|2|||
160873126|NCT05064358|580927994|FG002|Overall Study|Ongoing at the time of analysis|2|||
160873127|NCT05064358|580927995|FG003|Overall Study|Ongoing at the time of analysis|2|||
160873128|NCT05064358|580927996|FG004|Overall Study|Ongoing at the time of analysis|2|||
160873129|NCT04976192|580927998|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873130|NCT04976192|580927999|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
160873131|NCT04976192|580928000|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873132|NCT04976192|580928001|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873133|NCT04976192|580928002|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873134|NCT04976192|580928003|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873135|NCT04976192|580928004|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873136|NCT04976192|580928005|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873137|NCT04976192|580928006|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873138|NCT04976192|580928007|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873139|NCT04976192|580927998|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
160873140|NCT04976192|580927999|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
160873141|NCT04976192|580928000|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
160873142|NCT04976192|580928001|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
160873143|NCT04976192|580928002|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873144|NCT04976192|580928003|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873145|NCT04976192|580928004|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873146|NCT04976192|580928005|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873147|NCT04976192|580928006|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873148|NCT04976192|580928007|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873149|NCT04976192|580927998|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
160873150|NCT04976192|580927999|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873151|NCT04976192|580928000|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
160873152|NCT04976192|580928001|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873153|NCT04976192|580928002|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873154|NCT04976192|580928003|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873155|NCT04976192|580928004|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873156|NCT04976192|580928005|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873157|NCT04976192|580928006|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873158|NCT04976192|580928007|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873159|NCT04976192|580927998|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873160|NCT04976192|580927999|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873161|NCT04976192|580928000|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873162|NCT04976192|580928001|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873163|NCT04976192|580928002|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
160873164|NCT04976192|580928003|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
160873165|NCT04976192|580928004|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
160873166|NCT04976192|580928005|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
160873167|NCT04976192|580928006|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
160873168|NCT04976192|580928007|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
160873169|NCT04976192|580927998|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873170|NCT04976192|580927999|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873171|NCT04976192|580928000|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160766247|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
160766248|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
160766249|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
160766250|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
160766251|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
160766252|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
160766253|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
160766254|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
160873172|NCT04976192|580928001|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873173|NCT04976192|580928002|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
160873174|NCT04976192|580928003|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873175|NCT04976192|580928004|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873176|NCT04976192|580928005|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873177|NCT04976192|580928006|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873178|NCT04976192|580928007|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873179|NCT04976192|580927998|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873180|NCT04976192|580927999|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873181|NCT04976192|580928000|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873182|NCT04976192|580928001|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873183|NCT04976192|580928002|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873184|NCT04976192|580928003|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
160873185|NCT04976192|580928004|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873186|NCT04976192|580928005|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873187|NCT04976192|580928006|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873188|NCT04976192|580928007|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873189|NCT01395524|580929793|FG000|Overall Study|Non-compliance with study schedule|1|||
160873190|NCT01395524|580929794|FG001|Overall Study|Non-compliance with study schedule|0|||
160873191|NCT01395524|580929795|FG002|Overall Study|Non-compliance with study schedule|1|||
160873192|NCT01395524|580929793|FG000|Overall Study|Lost to Follow-up|3|||
160873193|NCT01395524|580929794|FG001|Overall Study|Lost to Follow-up|1|||
160873194|NCT01395524|580929795|FG002|Overall Study|Lost to Follow-up|1|||
160873195|NCT01395524|580929793|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
160873196|NCT01395524|580929794|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
160873197|NCT01395524|580929795|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
160873198|NCT01395524|580929793|FG000|Overall Study|Severe noncompliance with protocol|1|||
160873199|NCT01395524|580929794|FG001|Overall Study|Severe noncompliance with protocol|0|||
160873200|NCT01395524|580929795|FG002|Overall Study|Severe noncompliance with protocol|0|||
160873201|NCT01395524|580929793|FG000|Overall Study|Adverse Event|4|||
160873202|NCT01395524|580929794|FG001|Overall Study|Adverse Event|4|||
160873203|NCT01395524|580929795|FG002|Overall Study|Adverse Event|3|||
160873204|NCT01395524|580929793|FG000|Overall Study|Death|1|||
160873205|NCT01395524|580929794|FG001|Overall Study|Death|0|||
160873206|NCT01395524|580929795|FG002|Overall Study|Death|0|||
160873207|NCT01395524|580929793|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
160873208|NCT01395524|580929794|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
160873209|NCT01395524|580929795|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
160873210|NCT01395524|580929793|FG000|Overall Study|Withdrawal by Subject|4|||
160873211|NCT01395524|580929794|FG001|Overall Study|Withdrawal by Subject|8|||
160873212|NCT01395524|580929795|FG002|Overall Study|Withdrawal by Subject|8|||
160873213|NCT01395524|580929793|FG000|Overall Study|Did not receive treatment|1|||
160873214|NCT01395524|580929794|FG001|Overall Study|Did not receive treatment|1|||
160873215|NCT01395524|580929795|FG002|Overall Study|Did not receive treatment|3|||
160873216|NCT01395524|580929793|FG000|Overall Study|Subject had spinal surgery|0|||
160873217|NCT01395524|580929794|FG001|Overall Study|Subject had spinal surgery|0|||
160873218|NCT01395524|580929795|FG002|Overall Study|Subject had spinal surgery|1|||
160873219|NCT00122980|580929806|FG000|Overall Study|Death|0|||
160873220|NCT00122980|580929807|FG001|Overall Study|Death|1|||
160873221|NCT00122980|580929806|FG000|Overall Study|Physician Decision|2|||
160873222|NCT00122980|580929807|FG001|Overall Study|Physician Decision|0|||
160873223|NCT00122980|580929806|FG000|Overall Study|Protocol Violation|5|||
160873224|NCT00122980|580929807|FG001|Overall Study|Protocol Violation|1|||
160873225|NCT00122980|580929806|FG000|Overall Study|Withdrawal by Subject|2|||
160873226|NCT00122980|580929807|FG001|Overall Study|Withdrawal by Subject|3|||
160873227|NCT00122980|580929806|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
160873228|NCT00122980|580929807|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
160873229|NCT00122980|580929806|FG000|Overall Study|Study termination|27|||
160873230|NCT00122980|580929807|FG001|Overall Study|Study termination|35|||
160873231|NCT02175199|580929808|FG000|Overall Study|Withdrawal by Subject|1|||
160873232|NCT02175199|580929809|FG001|Overall Study|Withdrawal by Subject|5|||
160873233|NCT02175199|580929808|FG000|Overall Study|Randomized in Error|1|||
160873234|NCT02175199|580929809|FG001|Overall Study|Randomized in Error|0|||
160873235|NCT02175199|580929808|FG000|Overall Study|Sponsor Decision|1|||
160873236|NCT02175199|580929809|FG001|Overall Study|Sponsor Decision|0|||
160873237|NCT01124864|580929810|FG000|Overall Study|Follow up phase competed as per protocol|18|||
160873238|NCT01124864|580929811|FG001|Overall Study|Follow up phase competed as per protocol|22|||
160873239|NCT01124864|580929812|FG002|Overall Study|Follow up phase competed as per protocol|24|||
160532174|NCT00467779|579678645|FG012|Stage 2A|Unspecified Reason|0|||
160532175|NCT00467779|579678646|FG013|Stage 2A|Unspecified Reason|7|||
160873240|NCT01124864|580929813|FG003|Overall Study|Follow up phase competed as per protocol|18|||
160873241|NCT01124864|580929814|FG004|Overall Study|Follow up phase competed as per protocol|26|||
160873242|NCT01124864|580929815|FG005|Overall Study|Follow up phase competed as per protocol|2|||
160873243|NCT01124864|580929810|FG000|Overall Study|Death|6|||
160873244|NCT01124864|580929811|FG001|Overall Study|Death|9|||
160532176|NCT00467779|579678647|FG014|Stage 2A|Unspecified Reason|0|||
160532177|NCT00467779|579678633|FG000|Stage 2A|Withdrawal by Subject|0|||
160532178|NCT00467779|579678634|FG001|Stage 2A|Withdrawal by Subject|0|||
160532179|NCT00467779|579678635|FG002|Stage 2A|Withdrawal by Subject|0|||
160532180|NCT00467779|579678636|FG003|Stage 2A|Withdrawal by Subject|0|||
160532181|NCT00467779|579678637|FG004|Stage 2A|Withdrawal by Subject|0|||
160532182|NCT00467779|579678638|FG005|Stage 2A|Withdrawal by Subject|0|||
160532183|NCT00467779|579678639|FG006|Stage 2A|Withdrawal by Subject|0|||
160532184|NCT00467779|579678640|FG007|Stage 2A|Withdrawal by Subject|0|||
160532185|NCT00467779|579678641|FG008|Stage 2A|Withdrawal by Subject|0|||
160532186|NCT00467779|579678642|FG009|Stage 2A|Withdrawal by Subject|0|||
160532187|NCT00467779|579678643|FG010|Stage 2A|Withdrawal by Subject|0|||
160532188|NCT00467779|579678644|FG011|Stage 2A|Withdrawal by Subject|0|||
160532189|NCT00467779|579678645|FG012|Stage 2A|Withdrawal by Subject|0|||
160532190|NCT00467779|579678646|FG013|Stage 2A|Withdrawal by Subject|1|||
160532191|NCT00467779|579678647|FG014|Stage 2A|Withdrawal by Subject|0|||
160532192|NCT00467779|579678633|FG000|Stage 3|Adverse Event|0|||
160532193|NCT00467779|579678634|FG001|Stage 3|Adverse Event|0|||
160532194|NCT00467779|579678635|FG002|Stage 3|Adverse Event|0|||
160532195|NCT00467779|579678636|FG003|Stage 3|Adverse Event|0|||
160532196|NCT00467779|579678637|FG004|Stage 3|Adverse Event|0|||
160532197|NCT00467779|579678638|FG005|Stage 3|Adverse Event|0|||
160532198|NCT00467779|579678639|FG006|Stage 3|Adverse Event|0|||
160766255|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
160766256|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
160766257|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
160766258|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
160766259|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
160766260|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
160766261|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
160766262|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
160766263|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
160766264|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
160766265|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
160766266|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
160766267|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
160766268|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
160766269|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
160766270|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
160766271|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
160766272|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
160766273|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
160766274|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
160766275|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
160766276|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
160766277|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
160766278|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
160766279|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
160766280|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
160766281|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
160766282|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
160766283|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
160766284|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
160766285|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
160766286|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
160766287|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
160766288|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
160766289|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
160766290|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
160766291|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
160766292|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
160873245|NCT01124864|580929812|FG002|Overall Study|Death|6|||
160532199|NCT00467779|579678640|FG007|Stage 3|Adverse Event|0|||
160532200|NCT00467779|579678641|FG008|Stage 3|Adverse Event|0|||
160532201|NCT00467779|579678642|FG009|Stage 3|Adverse Event|0|||
160532202|NCT00467779|579678643|FG010|Stage 3|Adverse Event|0|||
160532203|NCT00467779|579678644|FG011|Stage 3|Adverse Event|0|||
160532204|NCT00467779|579678645|FG012|Stage 3|Adverse Event|0|||
160532205|NCT00467779|579678646|FG013|Stage 3|Adverse Event|0|||
160532206|NCT00467779|579678647|FG014|Stage 3|Adverse Event|2|||
160532207|NCT00467779|579678633|FG000|Stage 3|Death|0|||
160873246|NCT01124864|580929813|FG003|Overall Study|Death|2|||
160873247|NCT01124864|580929814|FG004|Overall Study|Death|1|||
160873248|NCT01124864|580929815|FG005|Overall Study|Death|0|||
160873249|NCT01124864|580929810|FG000|Overall Study|Withdrawal by Subject|2|||
160873250|NCT01124864|580929811|FG001|Overall Study|Withdrawal by Subject|3|||
160873251|NCT01124864|580929812|FG002|Overall Study|Withdrawal by Subject|4|||
160873252|NCT01124864|580929813|FG003|Overall Study|Withdrawal by Subject|0|||
160873253|NCT01124864|580929814|FG004|Overall Study|Withdrawal by Subject|2|||
160873254|NCT01124864|580929815|FG005|Overall Study|Withdrawal by Subject|1|||
160532208|NCT00467779|579678634|FG001|Stage 3|Death|0|||
160873255|NCT01124864|580929810|FG000|Overall Study|Lost to Follow-up|1|||
160873256|NCT01124864|580929811|FG001|Overall Study|Lost to Follow-up|1|||
160873257|NCT01124864|580929812|FG002|Overall Study|Lost to Follow-up|0|||
160532209|NCT00467779|579678635|FG002|Stage 3|Death|0|||
160873258|NCT01124864|580929813|FG003|Overall Study|Lost to Follow-up|1|||
160532210|NCT00467779|579678636|FG003|Stage 3|Death|0|||
160873259|NCT01124864|580929814|FG004|Overall Study|Lost to Follow-up|0|||
160873260|NCT01124864|580929815|FG005|Overall Study|Lost to Follow-up|0|||
160873261|NCT01124864|580929810|FG000|Overall Study|Protocol Violation|1|||
160873262|NCT01124864|580929811|FG001|Overall Study|Protocol Violation|0|||
160873263|NCT01124864|580929812|FG002|Overall Study|Protocol Violation|0|||
160873264|NCT01124864|580929813|FG003|Overall Study|Protocol Violation|0|||
160873265|NCT01124864|580929814|FG004|Overall Study|Protocol Violation|1|||
160873266|NCT01124864|580929815|FG005|Overall Study|Protocol Violation|0|||
160873267|NCT00798759|580929818|FG000|Overall Study|Adverse Event|3|||
160873268|NCT00798759|580929819|FG001|Overall Study|Adverse Event|3|||
160873269|NCT00798759|580929818|FG000|Overall Study|Lost to Follow-up|1|||
160873270|NCT00798759|580929819|FG001|Overall Study|Lost to Follow-up|1|||
160873271|NCT00798759|580929818|FG000|Overall Study|Protocol Violation|4|||
160873272|NCT00798759|580929819|FG001|Overall Study|Protocol Violation|8|||
160873273|NCT00798759|580929818|FG000|Overall Study|Other|0|||
160873274|NCT00798759|580929819|FG001|Overall Study|Other|1|||
160873275|NCT00724711|580929820|FG000|Overall Study|Adverse Event|7|||
160873276|NCT00724711|580929821|FG001|Overall Study|Adverse Event|3|||
160873277|NCT00724711|580929820|FG000|Overall Study|Pregnancy|0|||
160873278|NCT00724711|580929821|FG001|Overall Study|Pregnancy|1|||
160873279|NCT00724711|580929820|FG000|Overall Study|Lack of Efficacy|0|||
160873280|NCT00724711|580929821|FG001|Overall Study|Lack of Efficacy|1|||
160873281|NCT00724711|580929820|FG000|Overall Study|Physician Decision|0|||
160873282|NCT00724711|580929821|FG001|Overall Study|Physician Decision|3|||
160873283|NCT00724711|580929820|FG000|Overall Study|Withdrawal by Subject|5|||
160873284|NCT00724711|580929821|FG001|Overall Study|Withdrawal by Subject|4|||
160873285|NCT00724711|580929820|FG000|Overall Study|Lost to Follow-up|4|||
160873286|NCT00724711|580929821|FG001|Overall Study|Lost to Follow-up|5|||
160873287|NCT00724711|580929820|FG000|Overall Study|Protocol Violation|1|||
160873288|NCT00724711|580929821|FG001|Overall Study|Protocol Violation|0|||
160873289|NCT01368562|580929824|FG000|Overall Study|Adverse Event|1|||
160873290|NCT01368562|580929824|FG000|Overall Study|Disease progression|1|||
160873291|NCT01368562|580929824|FG000|Overall Study|Lost to Follow-up|1|||
160873292|NCT01368562|580929824|FG000|Overall Study|Death|6|||
160873293|NCT01368562|580929824|FG000|Overall Study|Unresponsive to treatment|5|||
160873294|NCT01368562|580929824|FG000|Overall Study|Other|3|||
160873295|NCT01368562|580929824|FG000|Overall Study|Other than specified|2|||
160873296|NCT02147561|580929825|FG000|Overall Study|Lost to Follow-up|3|||
160873297|NCT02147561|580929825|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
160873298|NCT02283762|580929828|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
160873299|NCT02283762|580929829|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
160873300|NCT02283762|580929828|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
160873301|NCT02283762|580929829|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
160873302|NCT02283762|580929828|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
160873303|NCT02283762|580929829|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
160873304|NCT02283762|580929828|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
160873305|NCT02283762|580929829|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
160873306|NCT02283762|580929828|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
160873307|NCT02283762|580929829|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
160873308|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
160532211|NCT00467779|579678637|FG004|Stage 3|Death|0|||
160873309|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
160873310|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
160873311|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
160873312|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
160873313|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
160873314|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
160873315|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
160873316|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
160873317|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
160873318|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
160873319|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
160873320|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
160873321|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
160873322|NCT00202878|580929833|FG000|Overall Study|Death|964|||
160873323|NCT00202878|580929834|FG001|Overall Study|Death|968|||
160873324|NCT00202878|580929833|FG000|Overall Study|Only Vital Status Known|357|||
160873325|NCT00202878|580929834|FG001|Overall Study|Only Vital Status Known|356|||
160873326|NCT00202878|580929833|FG000|Overall Study|Lost to Follow-up|44|||
160873327|NCT00202878|580929834|FG001|Overall Study|Lost to Follow-up|49|||
160873328|NCT00202878|580929833|FG000|Overall Study|Site Closure|39|||
160873329|NCT00202878|580929834|FG001|Overall Study|Site Closure|36|||
160873330|NCT00202878|580929833|FG000|Overall Study|Withdrawal by Subject|795|||
160873331|NCT00202878|580929834|FG001|Overall Study|Withdrawal by Subject|808|||
160873332|NCT02123472|580929835|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
160873333|NCT02123472|580929836|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
160873334|NCT00918736|580929837|FG000|Overall Study|Withdrawal by Subject|4|||
160873335|NCT00035932|580929841|FG000|Overall Study|Adverse Event|10|||
160873336|NCT00035932|580929842|FG001|Overall Study|Adverse Event|9|||
160873337|NCT00035932|580929843|FG002|Overall Study|Adverse Event|9|||
160873338|NCT00035932|580929841|FG000|Overall Study|Death|0|||
160873339|NCT00035932|580929842|FG001|Overall Study|Death|0|||
160873340|NCT00035932|580929843|FG002|Overall Study|Death|1|||
160873341|NCT00035932|580929841|FG000|Overall Study|Disease Progression / Relapse|1|||
160873342|NCT00035932|580929842|FG001|Overall Study|Disease Progression / Relapse|1|||
160873343|NCT00035932|580929843|FG002|Overall Study|Disease Progression / Relapse|0|||
160873344|NCT00035932|580929841|FG000|Overall Study|Lost to Follow-up|4|||
160873345|NCT00035932|580929842|FG001|Overall Study|Lost to Follow-up|4|||
160873346|NCT00035932|580929843|FG002|Overall Study|Lost to Follow-up|3|||
160873347|NCT00035932|580929841|FG000|Overall Study|Noncompliance|6|||
160873348|NCT00035932|580929842|FG001|Overall Study|Noncompliance|7|||
160873349|NCT00035932|580929843|FG002|Overall Study|Noncompliance|6|||
160873350|NCT00035932|580929841|FG000|Overall Study|Protocol Violation While on Study|0|||
160873351|NCT00035932|580929842|FG001|Overall Study|Protocol Violation While on Study|1|||
160873352|NCT00035932|580929843|FG002|Overall Study|Protocol Violation While on Study|2|||
160873353|NCT00035932|580929841|FG000|Overall Study|Withdrawal by Subject|1|||
160873354|NCT00035932|580929842|FG001|Overall Study|Withdrawal by Subject|5|||
160873355|NCT00035932|580929843|FG002|Overall Study|Withdrawal by Subject|0|||
160873356|NCT00035932|580929841|FG000|Overall Study|Study Termination by Sponsor|1|||
160873357|NCT00035932|580929842|FG001|Overall Study|Study Termination by Sponsor|0|||
160873358|NCT00035932|580929843|FG002|Overall Study|Study Termination by Sponsor|0|||
160873359|NCT00035932|580929841|FG000|Overall Study|Lack of Efficacy|33|||
160873360|NCT00035932|580929842|FG001|Overall Study|Lack of Efficacy|33|||
160873361|NCT00035932|580929843|FG002|Overall Study|Lack of Efficacy|28|||
160873362|NCT00889720|580929846|FG000|Overall Study|Withdrawal by Subject|4|||
160873363|NCT00889720|580929846|FG000|Overall Study|Other|4|||
160873364|NCT04080167|580929847|FG000|Overall Study|Lost to Follow-up-Patients|7|||
160873365|NCT04080167|580929848|FG001|Overall Study|Lost to Follow-up-Patients|14|||
160873366|NCT04080167|580929849|FG002|Overall Study|Lost to Follow-up-Patients|0|||
160873367|NCT04080167|580929847|FG000|Overall Study|Lost to Follow-up-Providers|2|||
160873368|NCT04080167|580929848|FG001|Overall Study|Lost to Follow-up-Providers|2|||
160873369|NCT04080167|580929849|FG002|Overall Study|Lost to Follow-up-Providers|0|||
160873370|NCT04080167|580929847|FG000|Overall Study|Withdrawal by Subject|1|||
160873371|NCT04080167|580929848|FG001|Overall Study|Withdrawal by Subject|2|||
160873372|NCT04080167|580929849|FG002|Overall Study|Withdrawal by Subject|0|||
160873373|NCT04080167|580929847|FG000|Overall Study|Withdrawal by Provider|0|||
160873374|NCT04080167|580929848|FG001|Overall Study|Withdrawal by Provider|0|||
160873375|NCT04080167|580929849|FG002|Overall Study|Withdrawal by Provider|4|||
160873376|NCT04080167|580929847|FG000|Overall Study|Death-Patient|2|||
160873377|NCT04080167|580929848|FG001|Overall Study|Death-Patient|1|||
160873378|NCT04080167|580929849|FG002|Overall Study|Death-Patient|0|||
160873379|NCT04080167|580929847|FG000|Overall Study|Hydroxyurea New Starts|0|||
160873380|NCT04080167|580929848|FG001|Overall Study|Hydroxyurea New Starts|0|||
160873381|NCT04080167|580929849|FG002|Overall Study|Hydroxyurea New Starts|1|||
160873382|NCT04080167|580929847|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
160873383|NCT04080167|580929848|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
160873384|NCT04080167|580929849|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
160873385|NCT02100696|580929850|FG000|Induction Phase|Adverse Event|0|||
160873386|NCT02100696|580929851|FG001|Induction Phase|Adverse Event|0|||
160873387|NCT02100696|580929852|FG002|Induction Phase|Adverse Event|1|||
160873388|NCT02100696|580929853|FG003|Induction Phase|Adverse Event|0|||
160873389|NCT02100696|580929854|FG004|Induction Phase|Adverse Event|0|||
160873390|NCT02100696|580929855|FG005|Induction Phase|Adverse Event|0|||
160532212|NCT00467779|579678638|FG005|Stage 3|Death|0|||
160532213|NCT00467779|579678639|FG006|Stage 3|Death|0|||
160532214|NCT00467779|579678640|FG007|Stage 3|Death|0|||
160532215|NCT00467779|579678641|FG008|Stage 3|Death|0|||
160532216|NCT00467779|579678642|FG009|Stage 3|Death|0|||
160532217|NCT00467779|579678643|FG010|Stage 3|Death|0|||
160532218|NCT00467779|579678644|FG011|Stage 3|Death|0|||
160532219|NCT00467779|579678645|FG012|Stage 3|Death|0|||
160532220|NCT00467779|579678646|FG013|Stage 3|Death|0|||
160532221|NCT00467779|579678647|FG014|Stage 3|Death|1|||
160532222|NCT00467779|579678633|FG000|Stage 3|Disease Progression|0|||
160532223|NCT00467779|579678634|FG001|Stage 3|Disease Progression|0|||
160532224|NCT00467779|579678635|FG002|Stage 3|Disease Progression|0|||
160532225|NCT00467779|579678636|FG003|Stage 3|Disease Progression|0|||
160532226|NCT00467779|579678637|FG004|Stage 3|Disease Progression|0|||
160532227|NCT00467779|579678638|FG005|Stage 3|Disease Progression|0|||
160532228|NCT00467779|579678639|FG006|Stage 3|Disease Progression|0|||
160532229|NCT00467779|579678640|FG007|Stage 3|Disease Progression|0|||
160532230|NCT00467779|579678641|FG008|Stage 3|Disease Progression|0|||
160532231|NCT00467779|579678642|FG009|Stage 3|Disease Progression|0|||
160873391|NCT02100696|580929850|FG000|Induction Phase|Lost to Follow-up|1|||
160873392|NCT02100696|580929851|FG001|Induction Phase|Lost to Follow-up|0|||
160873393|NCT02100696|580929852|FG002|Induction Phase|Lost to Follow-up|1|||
160873394|NCT02100696|580929853|FG003|Induction Phase|Lost to Follow-up|0|||
160873395|NCT02100696|580929854|FG004|Induction Phase|Lost to Follow-up|0|||
160873396|NCT02100696|580929855|FG005|Induction Phase|Lost to Follow-up|0|||
160873397|NCT02100696|580929850|FG000|Induction Phase|Protocol Violation|0|||
160873398|NCT02100696|580929851|FG001|Induction Phase|Protocol Violation|1|||
160873399|NCT02100696|580929852|FG002|Induction Phase|Protocol Violation|1|||
160873400|NCT02100696|580929853|FG003|Induction Phase|Protocol Violation|0|||
160873401|NCT02100696|580929854|FG004|Induction Phase|Protocol Violation|0|||
160873402|NCT02100696|580929855|FG005|Induction Phase|Protocol Violation|0|||
160873403|NCT02100696|580929850|FG000|Induction Phase|Withdrawal by Subject|8|||
160873404|NCT02100696|580929851|FG001|Induction Phase|Withdrawal by Subject|2|||
160873405|NCT02100696|580929852|FG002|Induction Phase|Withdrawal by Subject|13|||
160873406|NCT02100696|580929853|FG003|Induction Phase|Withdrawal by Subject|0|||
160873407|NCT02100696|580929854|FG004|Induction Phase|Withdrawal by Subject|0|||
160873408|NCT02100696|580929855|FG005|Induction Phase|Withdrawal by Subject|0|||
160532232|NCT00467779|579678643|FG010|Stage 3|Disease Progression|0|||
160532233|NCT00467779|579678644|FG011|Stage 3|Disease Progression|0|||
160532234|NCT00467779|579678645|FG012|Stage 3|Disease Progression|0|||
160532235|NCT00467779|579678646|FG013|Stage 3|Disease Progression|0|||
160532236|NCT00467779|579678647|FG014|Stage 3|Disease Progression|9|||
160532237|NCT00467779|579678633|FG000|Stage 3|Unspecified Reason|0|||
160532238|NCT00467779|579678634|FG001|Stage 3|Unspecified Reason|0|||
160532239|NCT00467779|579678635|FG002|Stage 3|Unspecified Reason|0|||
160532240|NCT00467779|579678636|FG003|Stage 3|Unspecified Reason|0|||
160532241|NCT00467779|579678637|FG004|Stage 3|Unspecified Reason|0|||
160873409|NCT02100696|580929850|FG000|Induction Phase|Physician Decision|1|||
160873410|NCT02100696|580929851|FG001|Induction Phase|Physician Decision|0|||
160873411|NCT02100696|580929852|FG002|Induction Phase|Physician Decision|2|||
160873412|NCT02100696|580929853|FG003|Induction Phase|Physician Decision|0|||
160873413|NCT02100696|580929854|FG004|Induction Phase|Physician Decision|0|||
160873414|NCT02100696|580929855|FG005|Induction Phase|Physician Decision|0|||
160873415|NCT02100696|580929850|FG000|Induction Phase|Multiple Reasons|5|||
160873416|NCT02100696|580929851|FG001|Induction Phase|Multiple Reasons|2|||
160873417|NCT02100696|580929852|FG002|Induction Phase|Multiple Reasons|8|||
160532242|NCT00467779|579678638|FG005|Stage 3|Unspecified Reason|0|||
160532243|NCT00467779|579678639|FG006|Stage 3|Unspecified Reason|0|||
160532244|NCT00467779|579678640|FG007|Stage 3|Unspecified Reason|0|||
160532245|NCT00467779|579678641|FG008|Stage 3|Unspecified Reason|0|||
160532246|NCT00467779|579678642|FG009|Stage 3|Unspecified Reason|0|||
160532247|NCT00467779|579678643|FG010|Stage 3|Unspecified Reason|0|||
160532248|NCT00467779|579678644|FG011|Stage 3|Unspecified Reason|0|||
160532249|NCT00467779|579678645|FG012|Stage 3|Unspecified Reason|0|||
160532250|NCT00467779|579678646|FG013|Stage 3|Unspecified Reason|0|||
160532251|NCT00467779|579678647|FG014|Stage 3|Unspecified Reason|5|||
160532252|NCT01509079|579678648|FG000|Overall Study|Lack of Efficacy|0|||
160532253|NCT01509079|579678649|FG001|Overall Study|Lack of Efficacy|2|||
160532254|NCT01509079|579678648|FG000|Overall Study|started an excluded medication|0|||
160532255|NCT01509079|579678649|FG001|Overall Study|started an excluded medication|1|||
160532256|NCT01195090|579678650|FG000|Overall Study|Adverse Event|1|||
160532257|NCT01195090|579678651|FG001|Overall Study|Adverse Event|2|||
160532258|NCT01195090|579678650|FG000|Overall Study|Lost to Follow-up|2|||
160873418|NCT02100696|580929853|FG003|Induction Phase|Multiple Reasons|0|||
160873419|NCT02100696|580929854|FG004|Induction Phase|Multiple Reasons|0|||
160873420|NCT02100696|580929855|FG005|Induction Phase|Multiple Reasons|0|||
160873421|NCT02100696|580929850|FG000|Maintenance Phase|Adverse Event|0|||
160873422|NCT02100696|580929851|FG001|Maintenance Phase|Adverse Event|0|||
160873423|NCT02100696|580929852|FG002|Maintenance Phase|Adverse Event|0|||
160873424|NCT02100696|580929853|FG003|Maintenance Phase|Adverse Event|0|||
160873425|NCT02100696|580929854|FG004|Maintenance Phase|Adverse Event|0|||
160873426|NCT02100696|580929855|FG005|Maintenance Phase|Adverse Event|2|||
160873427|NCT02100696|580929850|FG000|Maintenance Phase|Lost to Follow-up|0|||
160873428|NCT02100696|580929851|FG001|Maintenance Phase|Lost to Follow-up|0|||
160873429|NCT02100696|580929852|FG002|Maintenance Phase|Lost to Follow-up|0|||
160873430|NCT02100696|580929853|FG003|Maintenance Phase|Lost to Follow-up|0|||
160873431|NCT02100696|580929854|FG004|Maintenance Phase|Lost to Follow-up|1|||
160873432|NCT02100696|580929855|FG005|Maintenance Phase|Lost to Follow-up|0|||
160873433|NCT02100696|580929850|FG000|Maintenance Phase|Protocol Violation|0|||
160873434|NCT02100696|580929851|FG001|Maintenance Phase|Protocol Violation|0|||
160873435|NCT02100696|580929852|FG002|Maintenance Phase|Protocol Violation|0|||
160873436|NCT02100696|580929853|FG003|Maintenance Phase|Protocol Violation|0|||
160873437|NCT02100696|580929854|FG004|Maintenance Phase|Protocol Violation|1|||
160873438|NCT02100696|580929855|FG005|Maintenance Phase|Protocol Violation|0|||
160873439|NCT02100696|580929850|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160873440|NCT02100696|580929851|FG001|Maintenance Phase|Withdrawal by Subject|0|||
160873441|NCT02100696|580929852|FG002|Maintenance Phase|Withdrawal by Subject|0|||
160873442|NCT02100696|580929853|FG003|Maintenance Phase|Withdrawal by Subject|1|||
160873443|NCT02100696|580929854|FG004|Maintenance Phase|Withdrawal by Subject|4|||
160873444|NCT02100696|580929855|FG005|Maintenance Phase|Withdrawal by Subject|2|||
160873445|NCT02100696|580929850|FG000|Maintenance Phase|Physician Decision|0|||
160873446|NCT02100696|580929851|FG001|Maintenance Phase|Physician Decision|0|||
160873447|NCT02100696|580929852|FG002|Maintenance Phase|Physician Decision|0|||
160873448|NCT02100696|580929853|FG003|Maintenance Phase|Physician Decision|0|||
160873449|NCT02100696|580929854|FG004|Maintenance Phase|Physician Decision|1|||
160873450|NCT02100696|580929855|FG005|Maintenance Phase|Physician Decision|0|||
160873451|NCT02100696|580929850|FG000|Maintenance Phase|Multiple Reasons|0|||
160873452|NCT02100696|580929851|FG001|Maintenance Phase|Multiple Reasons|0|||
160873453|NCT02100696|580929852|FG002|Maintenance Phase|Multiple Reasons|0|||
160873454|NCT02100696|580929853|FG003|Maintenance Phase|Multiple Reasons|0|||
160873455|NCT02100696|580929854|FG004|Maintenance Phase|Multiple Reasons|2|||
160873456|NCT02100696|580929855|FG005|Maintenance Phase|Multiple Reasons|1|||
160873457|NCT03865381|580929859|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
160873458|NCT03865381|580929859|FG000|Overall Study|Withdrawal by Subject|2|||
160873459|NCT00452361|580929868|FG000|Overall Study|Adverse Event|8|||
160873460|NCT00452361|580929869|FG001|Overall Study|Adverse Event|0|||
160532259|NCT01195090|579678651|FG001|Overall Study|Lost to Follow-up|2|||
160532260|NCT01195090|579678650|FG000|Overall Study|Protocol Violation|3|||
160873461|NCT00452361|580929868|FG000|Overall Study|Withdrawal by Subject|0|||
160873462|NCT00452361|580929869|FG001|Overall Study|Withdrawal by Subject|1|||
160873463|NCT00452361|580929868|FG000|Overall Study|Premature termination|13|||
160873464|NCT00452361|580929869|FG001|Overall Study|Premature termination|9|||
160873465|NCT01010867|580929872|FG000|Overall Study|< 50% adherence to probiotic|1|||
160873466|NCT01668589|580929873|FG000|Overall Study|Lost to Follow-up|29|||
160532261|NCT01195090|579678651|FG001|Overall Study|Protocol Violation|4|||
160532262|NCT05111041|579678652|FG000|Overall Study|Lost to Follow-up|6|||
160873467|NCT01668589|580929874|FG001|Overall Study|Lost to Follow-up|37|||
160873468|NCT01668589|580929875|FG002|Overall Study|Lost to Follow-up|15|||
160532263|NCT05111041|579678653|FG001|Overall Study|Lost to Follow-up|7|||
160532264|NCT05111041|579678652|FG000|Overall Study|Withdrawal by Subject|1|||
160532265|NCT05111041|579678653|FG001|Overall Study|Withdrawal by Subject|0|||
160532266|NCT04912245|579678654|FG000|Overall Study|Withdrawal by Subject|21|||
160873469|NCT01668589|580929876|FG003|Overall Study|Lost to Follow-up|5|||
160873470|NCT01668589|580929873|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
160873471|NCT01668589|580929874|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
160873472|NCT01668589|580929875|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
160873473|NCT01668589|580929876|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
160873474|NCT01668589|580929873|FG000|Overall Study|Death|12|||
160873475|NCT01668589|580929874|FG001|Overall Study|Death|3|||
160873476|NCT01668589|580929875|FG002|Overall Study|Death|2|||
160873477|NCT01668589|580929876|FG003|Overall Study|Death|11|||
160873478|NCT01668589|580929873|FG000|Overall Study|Other|44|||
160873479|NCT01668589|580929874|FG001|Overall Study|Other|10|||
160873480|NCT01668589|580929875|FG002|Overall Study|Other|7|||
160873481|NCT01668589|580929876|FG003|Overall Study|Other|15|||
160873482|NCT02954172|580929877|FG000|Overall Study|Protocol Violation|3|||
160873483|NCT02954172|580929878|FG001|Overall Study|Protocol Violation|0|||
160873484|NCT02954172|580929877|FG000|Overall Study|allergic reaction|2|||
160873485|NCT02954172|580929878|FG001|Overall Study|allergic reaction|1|||
160873486|NCT02954172|580929877|FG000|Overall Study|non-measurable lesions at baseline|1|||
160873487|NCT02954172|580929878|FG001|Overall Study|non-measurable lesions at baseline|2|||
160873488|NCT00233064|580929879|FG000|Overall Study|Lost to Follow-up|7|||
160873489|NCT00233064|580929880|FG001|Overall Study|Lost to Follow-up|7|||
160873490|NCT00233064|580929879|FG000|Overall Study|Withdrawal by Subject|5|||
160873491|NCT00233064|580929880|FG001|Overall Study|Withdrawal by Subject|3|||
160873492|NCT00233064|580929879|FG000|Overall Study|Death|0|||
160873493|NCT00233064|580929880|FG001|Overall Study|Death|1|||
160873494|NCT00233064|580929879|FG000|Overall Study|Relocation|0|||
160873495|NCT00233064|580929880|FG001|Overall Study|Relocation|1|||
160873496|NCT00233064|580929879|FG000|Overall Study|Protocol Violation|1|||
160873497|NCT00233064|580929880|FG001|Overall Study|Protocol Violation|0|||
160873498|NCT00233064|580929879|FG000|Overall Study|Moved to Dom. Republic|1|||
160873499|NCT00233064|580929880|FG001|Overall Study|Moved to Dom. Republic|0|||
160873500|NCT02302339|580929881|FG000|Overall Study|Lost to Follow-up|1|||
160873501|NCT02302339|580929882|FG001|Overall Study|Lost to Follow-up|0|||
160873502|NCT02302339|580929883|FG002|Overall Study|Lost to Follow-up|0|||
160873503|NCT02302339|580929884|FG003|Overall Study|Lost to Follow-up|0|||
160873504|NCT02302339|580929881|FG000|Overall Study|Withdrawal by Subject|0|||
160873505|NCT02302339|580929882|FG001|Overall Study|Withdrawal by Subject|2|||
160873506|NCT02302339|580929883|FG002|Overall Study|Withdrawal by Subject|1|||
160873507|NCT02302339|580929884|FG003|Overall Study|Withdrawal by Subject|0|||
160873508|NCT02752165|580929888|FG000|Overall Study|Withdrawal by Subject|6|||
160873509|NCT02752165|580929889|FG001|Overall Study|Withdrawal by Subject|6|||
160873510|NCT02752165|580929888|FG000|Overall Study|Protocol Violation|6|||
160873511|NCT02752165|580929889|FG001|Overall Study|Protocol Violation|5|||
160873512|NCT02752165|580929888|FG000|Overall Study|Lost to Follow-up|33|||
160873513|NCT02752165|580929889|FG001|Overall Study|Lost to Follow-up|38|||
160873514|NCT01120964|580929890|FG000|Overall Study|Did not receive full treatment|1|||
160873515|NCT01120964|580929891|FG001|Overall Study|Did not receive full treatment|0|||
160873516|NCT01704599|580929895|FG000|Overall Study|Adverse Event|1|||
160873517|NCT04421027|580929898|FG000|Treatment Period|Adverse Event|5|||
160873518|NCT04421027|580929899|FG001|Treatment Period|Adverse Event|3|||
160873519|NCT04421027|580929900|FG002|Treatment Period|Adverse Event|0|||
160873520|NCT04421027|580929901|FG003|Treatment Period|Adverse Event|0|||
160873521|NCT04421027|580929898|FG000|Treatment Period|Death|98|||
160873522|NCT04421027|580929899|FG001|Treatment Period|Death|61|||
160873523|NCT04421027|580929900|FG002|Treatment Period|Death|0|||
160873524|NCT04421027|580929901|FG003|Treatment Period|Death|0|||
160873525|NCT04421027|580929898|FG000|Treatment Period|Lost to Follow-up|22|||
160873526|NCT04421027|580929899|FG001|Treatment Period|Lost to Follow-up|20|||
160873527|NCT04421027|580929900|FG002|Treatment Period|Lost to Follow-up|0|||
160873528|NCT04421027|580929901|FG003|Treatment Period|Lost to Follow-up|0|||
160873529|NCT04421027|580929898|FG000|Treatment Period|Other-Unknown|15|||
160873530|NCT04421027|580929899|FG001|Treatment Period|Other-Unknown|9|||
160873531|NCT04421027|580929900|FG002|Treatment Period|Other-Unknown|0|||
160873532|NCT04421027|580929901|FG003|Treatment Period|Other-Unknown|0|||
160873533|NCT04421027|580929898|FG000|Treatment Period|Physician Decision|1|||
160873534|NCT04421027|580929899|FG001|Treatment Period|Physician Decision|1|||
160873535|NCT04421027|580929900|FG002|Treatment Period|Physician Decision|0|||
160873536|NCT04421027|580929901|FG003|Treatment Period|Physician Decision|0|||
160873537|NCT04421027|580929898|FG000|Treatment Period|Withdrawal by Subject|7|||
160873538|NCT04421027|580929899|FG001|Treatment Period|Withdrawal by Subject|12|||
160873539|NCT04421027|580929900|FG002|Treatment Period|Withdrawal by Subject|0|||
160873540|NCT04421027|580929901|FG003|Treatment Period|Withdrawal by Subject|0|||
160873541|NCT04421027|580929898|FG000|Treatment Period|Randomized Not Dosed|9|||
160873542|NCT04421027|580929899|FG001|Treatment Period|Randomized Not Dosed|14|||
160873543|NCT04421027|580929900|FG002|Treatment Period|Randomized Not Dosed|0|||
160873544|NCT04421027|580929901|FG003|Treatment Period|Randomized Not Dosed|0|||
160873545|NCT04421027|580929898|FG000|Follow-Up Period|Adverse Event|0|||
160873546|NCT04421027|580929899|FG001|Follow-Up Period|Adverse Event|0|||
160873547|NCT04421027|580929900|FG002|Follow-Up Period|Adverse Event|0|||
160873548|NCT04421027|580929901|FG003|Follow-Up Period|Adverse Event|3|||
160873549|NCT04421027|580929898|FG000|Follow-Up Period|Death|0|||
160873550|NCT04421027|580929899|FG001|Follow-Up Period|Death|0|||
160873551|NCT04421027|580929900|FG002|Follow-Up Period|Death|16|||
160873552|NCT04421027|580929901|FG003|Follow-Up Period|Death|17|||
160873553|NCT04421027|580929898|FG000|Follow-Up Period|Lost to Follow-up|0|||
160873554|NCT04421027|580929899|FG001|Follow-Up Period|Lost to Follow-up|0|||
160873555|NCT04421027|580929900|FG002|Follow-Up Period|Lost to Follow-up|7|||
160873556|NCT04421027|580929901|FG003|Follow-Up Period|Lost to Follow-up|7|||
160873557|NCT04421027|580929898|FG000|Follow-Up Period|Protocol Deviation|0|||
160873558|NCT04421027|580929899|FG001|Follow-Up Period|Protocol Deviation|0|||
160873559|NCT04421027|580929900|FG002|Follow-Up Period|Protocol Deviation|1|||
160873560|NCT04421027|580929901|FG003|Follow-Up Period|Protocol Deviation|0|||
160873561|NCT04421027|580929898|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
160873562|NCT04421027|580929899|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
160873563|NCT04421027|580929900|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
160873564|NCT04421027|580929901|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
160873565|NCT04421027|580929898|FG000|Follow-Up Period|Left message, participant did not call back|0|||
160873566|NCT04421027|580929899|FG001|Follow-Up Period|Left message, participant did not call back|0|||
160873567|NCT04421027|580929900|FG002|Follow-Up Period|Left message, participant did not call back|0|||
160873568|NCT04421027|580929901|FG003|Follow-Up Period|Left message, participant did not call back|1|||
160873569|NCT04421027|580929898|FG000|Follow-Up Period|Participant died|0|||
160873570|NCT04421027|580929899|FG001|Follow-Up Period|Participant died|0|||
160873571|NCT04421027|580929900|FG002|Follow-Up Period|Participant died|0|||
160873572|NCT04421027|580929901|FG003|Follow-Up Period|Participant died|1|||
160873573|NCT04421027|580929898|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
160873574|NCT04421027|580929899|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
160873575|NCT04421027|580929900|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
160873576|NCT04421027|580929901|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
160873577|NCT00494676|580929902|FG000|Allocation|Withdrawal by Subject|2|||
160873578|NCT00494676|580929903|FG001|Allocation|Withdrawal by Subject|4|||
160873579|NCT00494676|580929902|FG000|First Intervention|Withdrawal by Subject|1|||
160873580|NCT00494676|580929903|FG001|First Intervention|Withdrawal by Subject|3|||
160873581|NCT00494676|580929902|FG000|Second Intervention|Withdrawal by Subject|1|||
160873582|NCT00494676|580929903|FG001|Second Intervention|Withdrawal by Subject|1|||
160873583|NCT04073225|580929904|FG000|Overall Study|Lost to Follow-up|4|||
160873584|NCT04073225|580929905|FG001|Overall Study|Lost to Follow-up|3|||
160873585|NCT04238819|580929913|FG000|Overall Study|Ongoing Treatment|0|||
160873586|NCT04238819|580929914|FG001|Overall Study|Ongoing Treatment|0|||
160873587|NCT04238819|580929915|FG002|Overall Study|Ongoing Treatment|0|||
160873588|NCT04238819|580929916|FG003|Overall Study|Ongoing Treatment|0|||
160873589|NCT04238819|580929917|FG004|Overall Study|Ongoing Treatment|1|||
160873590|NCT04238819|580929918|FG005|Overall Study|Ongoing Treatment|4|||
160873591|NCT04238819|580929919|FG006|Overall Study|Ongoing Treatment|0|||
160873592|NCT04238819|580929913|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
160873593|NCT04238819|580929914|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
160873594|NCT04238819|580929915|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
160873595|NCT04238819|580929916|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
160873596|NCT04238819|580929917|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
160873597|NCT04238819|580929918|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
160873598|NCT04238819|580929919|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
160873599|NCT02529553|580929923|FG000|Overall Study|Progressive Disease|1|||
160873600|NCT02529553|580929924|FG001|Overall Study|Progressive Disease|0|||
160873601|NCT02529553|580929925|FG002|Overall Study|Progressive Disease|1|||
160873602|NCT02529553|580929926|FG003|Overall Study|Progressive Disease|3|||
160873603|NCT02529553|580929927|FG004|Overall Study|Progressive Disease|2|||
160873604|NCT02529553|580929928|FG005|Overall Study|Progressive Disease|3|||
160873605|NCT02529553|580929929|FG006|Overall Study|Progressive Disease|3|||
160873606|NCT02529553|580929930|FG007|Overall Study|Progressive Disease|5|||
160873607|NCT02529553|580929931|FG008|Overall Study|Progressive Disease|3|||
160873608|NCT02529553|580929923|FG000|Overall Study|Physician Decision|0|||
160873609|NCT02529553|580929924|FG001|Overall Study|Physician Decision|1|||
160873610|NCT02529553|580929925|FG002|Overall Study|Physician Decision|0|||
160873611|NCT02529553|580929926|FG003|Overall Study|Physician Decision|0|||
160873612|NCT02529553|580929927|FG004|Overall Study|Physician Decision|1|||
160532267|NCT04912245|579678655|FG001|Overall Study|Withdrawal by Subject|4|||
160532268|NCT04912245|579678654|FG000|Overall Study|Lost to Follow-up|5|||
160532269|NCT04912245|579678655|FG001|Overall Study|Lost to Follow-up|11|||
160873613|NCT02529553|580929928|FG005|Overall Study|Physician Decision|0|||
160873614|NCT02529553|580929929|FG006|Overall Study|Physician Decision|0|||
160873615|NCT02529553|580929930|FG007|Overall Study|Physician Decision|0|||
160873616|NCT02529553|580929931|FG008|Overall Study|Physician Decision|0|||
160873617|NCT02529553|580929923|FG000|Overall Study|Withdrawal by Subject|0|||
160873618|NCT02529553|580929924|FG001|Overall Study|Withdrawal by Subject|0|||
160873619|NCT02529553|580929925|FG002|Overall Study|Withdrawal by Subject|0|||
160873620|NCT02529553|580929926|FG003|Overall Study|Withdrawal by Subject|0|||
160873621|NCT02529553|580929927|FG004|Overall Study|Withdrawal by Subject|0|||
160873622|NCT02529553|580929928|FG005|Overall Study|Withdrawal by Subject|1|||
160873623|NCT02529553|580929929|FG006|Overall Study|Withdrawal by Subject|0|||
160873624|NCT02529553|580929930|FG007|Overall Study|Withdrawal by Subject|1|||
160873625|NCT02529553|580929931|FG008|Overall Study|Withdrawal by Subject|0|||
160873626|NCT05767749|580929932|FG000|Overall Study|Withdrawal by Subject|0|||
160873627|NCT05767749|580929933|FG001|Overall Study|Withdrawal by Subject|0|||
160873628|NCT05767749|580929934|FG002|Overall Study|Withdrawal by Subject|2|||
160873629|NCT05767749|580929935|FG003|Overall Study|Withdrawal by Subject|2|||
160873630|NCT05767749|580929936|FG004|Overall Study|Withdrawal by Subject|2|||
160873631|NCT05767749|580929937|FG005|Overall Study|Withdrawal by Subject|2|||
160873632|NCT00114517|580929938|FG000|Overall Study|Adverse Event|6|||
160873633|NCT00114517|580929939|FG001|Overall Study|Adverse Event|1|||
160873634|NCT00114517|580929940|FG002|Overall Study|Adverse Event|6|||
160873635|NCT00114517|580929941|FG003|Overall Study|Adverse Event|3|||
160873636|NCT00114517|580929938|FG000|Overall Study|Lost to Follow-up|2|||
160873637|NCT00114517|580929939|FG001|Overall Study|Lost to Follow-up|2|||
160873638|NCT00114517|580929940|FG002|Overall Study|Lost to Follow-up|2|||
160873639|NCT00114517|580929941|FG003|Overall Study|Lost to Follow-up|1|||
160873640|NCT00114517|580929938|FG000|Overall Study|Too busy|3|||
160873641|NCT00114517|580929939|FG001|Overall Study|Too busy|1|||
160873642|NCT00114517|580929940|FG002|Overall Study|Too busy|1|||
160873643|NCT00114517|580929941|FG003|Overall Study|Too busy|2|||
160873644|NCT00114517|580929938|FG000|Overall Study|Moved from area|0|||
160873645|NCT00114517|580929939|FG001|Overall Study|Moved from area|3|||
160873646|NCT00114517|580929940|FG002|Overall Study|Moved from area|2|||
160873647|NCT00114517|580929941|FG003|Overall Study|Moved from area|1|||
160873648|NCT00114517|580929938|FG000|Overall Study|Did not want estradiol|1|||
160873649|NCT00114517|580929939|FG001|Overall Study|Did not want estradiol|1|||
160873650|NCT00114517|580929940|FG002|Overall Study|Did not want estradiol|0|||
160873651|NCT00114517|580929941|FG003|Overall Study|Did not want estradiol|0|||
160873652|NCT00114517|580929938|FG000|Overall Study|Armed-services duty|0|||
160873653|NCT00114517|580929939|FG001|Overall Study|Armed-services duty|1|||
160873654|NCT00114517|580929940|FG002|Overall Study|Armed-services duty|0|||
160873655|NCT00114517|580929941|FG003|Overall Study|Armed-services duty|1|||
160873656|NCT00114517|580929938|FG000|Overall Study|Competing family issue|0|||
160873657|NCT00114517|580929939|FG001|Overall Study|Competing family issue|1|||
160873658|NCT00114517|580929940|FG002|Overall Study|Competing family issue|0|||
160873659|NCT00114517|580929941|FG003|Overall Study|Competing family issue|1|||
160873660|NCT00114517|580929938|FG000|Overall Study|Physician Decision|0|||
160873661|NCT00114517|580929939|FG001|Overall Study|Physician Decision|1|||
160873662|NCT00114517|580929940|FG002|Overall Study|Physician Decision|0|||
160873663|NCT00114517|580929941|FG003|Overall Study|Physician Decision|0|||
160873664|NCT00114517|580929938|FG000|Overall Study|Lost interest|0|||
160873665|NCT00114517|580929939|FG001|Overall Study|Lost interest|0|||
160873666|NCT00114517|580929940|FG002|Overall Study|Lost interest|1|||
160873667|NCT00114517|580929941|FG003|Overall Study|Lost interest|0|||
160873668|NCT00114517|580929938|FG000|Overall Study|Weight increase|0|||
160873669|NCT00114517|580929939|FG001|Overall Study|Weight increase|0|||
160873670|NCT00114517|580929940|FG002|Overall Study|Weight increase|1|||
160873671|NCT00114517|580929941|FG003|Overall Study|Weight increase|0|||
160873672|NCT00114517|580929938|FG000|Overall Study|Concern about blood clots|0|||
160873673|NCT00114517|580929939|FG001|Overall Study|Concern about blood clots|0|||
160873674|NCT00114517|580929940|FG002|Overall Study|Concern about blood clots|1|||
160873675|NCT00114517|580929941|FG003|Overall Study|Concern about blood clots|0|||
160873676|NCT00114517|580929938|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
160873677|NCT00114517|580929939|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
160873678|NCT00114517|580929940|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
160873679|NCT00114517|580929941|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
160873680|NCT00924027|580929942|FG000|Overall Study|Lost to Further Follow-Up|4|||
160873681|NCT00924027|580929943|FG001|Overall Study|Lost to Further Follow-Up|0|||
160873682|NCT00924027|580929944|FG002|Overall Study|Lost to Further Follow-Up|0|||
160873683|NCT00924027|580929945|FG003|Overall Study|Lost to Further Follow-Up|0|||
160873684|NCT00924027|580929942|FG000|Overall Study|Physician Decision|1|||
160873685|NCT00924027|580929943|FG001|Overall Study|Physician Decision|0|||
160873686|NCT00924027|580929944|FG002|Overall Study|Physician Decision|0|||
160873687|NCT00924027|580929945|FG003|Overall Study|Physician Decision|1|||
160873688|NCT00924027|580929942|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
160873689|NCT00924027|580929943|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
160532270|NCT01205230|579678656|FG000|Overall Study|Adverse Event|4|||
160873690|NCT00924027|580929944|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
160873691|NCT00924027|580929945|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
160873692|NCT00924027|580929942|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
160873693|NCT00924027|580929943|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
160873694|NCT00924027|580929944|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
160873695|NCT00924027|580929945|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
160873696|NCT00924027|580929942|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
160873697|NCT00924027|580929943|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
160873698|NCT00924027|580929944|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
160873699|NCT00924027|580929945|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
160873700|NCT03387111|580931342|FG000|Overall Study|Progressive Disease|3|||
160873701|NCT03387111|580931342|FG000|Overall Study|Other|1|||
160873702|NCT00727441|580931344|FG000|Overall Study|Disease Progression|11|||
160873703|NCT00727441|580931345|FG001|Overall Study|Disease Progression|14|||
160873704|NCT00727441|580931346|FG002|Overall Study|Disease Progression|17|||
160873705|NCT00727441|580931344|FG000|Overall Study|Eligibility|7|||
160873706|NCT00727441|580931345|FG001|Overall Study|Eligibility|5|||
160873707|NCT00727441|580931346|FG002|Overall Study|Eligibility|7|||
160873708|NCT00727441|580931344|FG000|Overall Study|Death|0|||
160873709|NCT00727441|580931345|FG001|Overall Study|Death|1|||
160873710|NCT00727441|580931346|FG002|Overall Study|Death|1|||
160873711|NCT00727441|580931344|FG000|Overall Study|Physician Decision|0|||
160873712|NCT00727441|580931345|FG001|Overall Study|Physician Decision|1|||
160873713|NCT00727441|580931346|FG002|Overall Study|Physician Decision|0|||
160873714|NCT00727441|580931344|FG000|Overall Study|Withdrawal by Subject|0|||
160873715|NCT00727441|580931345|FG001|Overall Study|Withdrawal by Subject|1|||
160873716|NCT00727441|580931346|FG002|Overall Study|Withdrawal by Subject|0|||
160532271|NCT01205230|579678657|FG001|Overall Study|Adverse Event|0|||
160532272|NCT01205230|579678656|FG000|Overall Study|Physician Decision|1|||
160532273|NCT01205230|579678657|FG001|Overall Study|Physician Decision|0|||
160532274|NCT00041080|579678658|FG000|Overall Study|Adverse Event|21|||
160532275|NCT00041080|579678659|FG001|Overall Study|Adverse Event|1|||
160532276|NCT00041080|579678658|FG000|Overall Study|Withdrawal by Subject|6|||
160532277|NCT00041080|579678659|FG001|Overall Study|Withdrawal by Subject|6|||
160532278|NCT00041080|579678658|FG000|Overall Study|Concommitant Illness/Other|1|||
160532279|NCT00041080|579678659|FG001|Overall Study|Concommitant Illness/Other|2|||
160532280|NCT00041080|579678658|FG000|Overall Study|Did not start therapy|1|||
160532281|NCT00041080|579678659|FG001|Overall Study|Did not start therapy|1|||
160532282|NCT00041080|579678658|FG000|Overall Study|Ineligible|1|||
160532283|NCT00041080|579678659|FG001|Overall Study|Ineligible|0|||
160532284|NCT01011439|579678660|FG000|Overall Study|Death|37|||
160532285|NCT01011439|579678660|FG000|Overall Study|Lost to Follow-up|4|||
160532286|NCT01011439|579678660|FG000|Overall Study|Withdrawal by Subject|1|||
160532287|NCT01011439|579678660|FG000|Overall Study|Sponsor's decision|15|||
160532288|NCT02428855|579678661|FG000|Overall Study|Withdrawal by Subject|2|||
160532289|NCT03198520|579678666|FG000|Overall Study|Physician Decision|2|||
160532290|NCT03198520|579678666|FG000|Overall Study|Protocol Violation|2|||
160532291|NCT03198520|579678666|FG000|Overall Study|Withdrawal by Subject|1|||
160532292|NCT03198520|579678666|FG000|Overall Study|Study Ended|1|||
160532293|NCT01670539|579678667|FG000|Overall Study|Death|3|||
160532294|NCT01670539|579678668|FG001|Overall Study|Death|5|||
160873717|NCT01239992|580931347|FG000|Overall Study|Withdrawal by Subject|2|||
160873718|NCT00535288|580931348|FG000|Overall Study|Adverse Event|20|||
160873719|NCT00535288|580931349|FG001|Overall Study|Adverse Event|19|||
160873720|NCT00535288|580931350|FG002|Overall Study|Adverse Event|25|||
160873721|NCT00535288|580931351|FG003|Overall Study|Adverse Event|20|||
160873722|NCT00535288|580931352|FG004|Overall Study|Adverse Event|30|||
160873723|NCT00535288|580931348|FG000|Overall Study|Lost to Follow-up|0|||
160873724|NCT00535288|580931349|FG001|Overall Study|Lost to Follow-up|3|||
160873725|NCT00535288|580931350|FG002|Overall Study|Lost to Follow-up|0|||
160873726|NCT00535288|580931351|FG003|Overall Study|Lost to Follow-up|0|||
160873727|NCT00535288|580931352|FG004|Overall Study|Lost to Follow-up|0|||
160873728|NCT00535288|580931348|FG000|Overall Study|Lack of Efficacy|26|||
160873729|NCT00535288|580931349|FG001|Overall Study|Lack of Efficacy|3|||
160873730|NCT00535288|580931350|FG002|Overall Study|Lack of Efficacy|4|||
160873731|NCT00535288|580931351|FG003|Overall Study|Lack of Efficacy|4|||
160873732|NCT00535288|580931352|FG004|Overall Study|Lack of Efficacy|7|||
160873733|NCT00535288|580931348|FG000|Overall Study|Unwilling to cooperate|6|||
160873734|NCT00535288|580931349|FG001|Overall Study|Unwilling to cooperate|6|||
160532295|NCT01670539|579678667|FG000|Overall Study|Withdrawal by Subject|3|||
160532296|NCT01670539|579678668|FG001|Overall Study|Withdrawal by Subject|0|||
160532297|NCT04353596|579678669|FG000|Overall Study|Protocol Violation|4|||
160873735|NCT00535288|580931350|FG002|Overall Study|Unwilling to cooperate|3|||
160873736|NCT00535288|580931351|FG003|Overall Study|Unwilling to cooperate|3|||
160873737|NCT00535288|580931352|FG004|Overall Study|Unwilling to cooperate|4|||
160532298|NCT04353596|579678670|FG001|Overall Study|Protocol Violation|4|||
160532299|NCT04353596|579678669|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
160532300|NCT04353596|579678670|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
160873738|NCT00535288|580931348|FG000|Overall Study|Other|2|||
160873739|NCT00535288|580931349|FG001|Overall Study|Other|1|||
160873740|NCT00535288|580931350|FG002|Overall Study|Other|1|||
160873741|NCT00535288|580931351|FG003|Overall Study|Other|2|||
160873742|NCT00535288|580931352|FG004|Overall Study|Other|1|||
160873743|NCT02810444|580931353|FG000|Overall Study|Screen Failures|14|||
160873744|NCT02810444|580931353|FG000|Overall Study|Withdrawal by Subject|4|||
160873745|NCT02810444|580931353|FG000|Overall Study|Adverse Event|3|||
160873746|NCT00745849|580931354|FG000|First Intervention|Withdrawal by Subject|0|||
160873747|NCT00745849|580931355|FG001|First Intervention|Withdrawal by Subject|1|||
160873748|NCT00745849|580931354|FG000|First Intervention|Lost to Follow-up|1|||
160873749|NCT00745849|580931355|FG001|First Intervention|Lost to Follow-up|1|||
160873750|NCT00745849|580931354|FG000|Second Intervention|Lost to Follow-up|2|||
160873751|NCT00745849|580931355|FG001|Second Intervention|Lost to Follow-up|1|||
160873752|NCT01139008|580931356|FG000|Overall Study|Withdrawal by Subject|5|||
160873753|NCT01139008|580931356|FG000|Overall Study|Non-compliant, lost product|1|||
160873754|NCT02848729|580931359|FG000|Overall Study|Withdrawal by Subject|1|||
160873755|NCT02848729|580931360|FG001|Overall Study|Withdrawal by Subject|0|||
160873756|NCT02848729|580931359|FG000|Overall Study|Emesis|15|||
160873757|NCT02848729|580931360|FG001|Overall Study|Emesis|11|||
160873758|NCT03390101|580931361|FG000|Weeks 0-12|Withdrawal by Subject|0|||
160873759|NCT03390101|580931362|FG001|Weeks 0-12|Withdrawal by Subject|1|||
160873760|NCT03390101|580931363|FG002|Weeks 0-12|Withdrawal by Subject|1|||
160873761|NCT03390101|580931361|FG000|Weeks 0-12|Lost to Follow-up|0|||
160873762|NCT03390101|580931362|FG001|Weeks 0-12|Lost to Follow-up|1|||
160873763|NCT03390101|580931363|FG002|Weeks 0-12|Lost to Follow-up|0|||
160873764|NCT03390101|580931361|FG000|Weeks 12-54|Withdrawal by Subject|0|||
160873765|NCT03390101|580931362|FG001|Weeks 12-54|Withdrawal by Subject|3|||
160873766|NCT03390101|580931363|FG002|Weeks 12-54|Withdrawal by Subject|1|||
160873767|NCT03390101|580931361|FG000|Weeks 12-54|Pregnancy|1|||
160873768|NCT03390101|580931362|FG001|Weeks 12-54|Pregnancy|0|||
160873769|NCT03390101|580931363|FG002|Weeks 12-54|Pregnancy|0|||
160873770|NCT03390101|580931361|FG000|Weeks 12-54|Adverse Event|2|||
160873771|NCT03390101|580931362|FG001|Weeks 12-54|Adverse Event|1|||
160873772|NCT03390101|580931363|FG002|Weeks 12-54|Adverse Event|1|||
160873773|NCT04838977|580931364|FG000|Overall Study|Lost to Follow-up|2|||
160873774|NCT04838977|580931365|FG001|Overall Study|Lost to Follow-up|3|||
160873775|NCT04838977|580931364|FG000|Overall Study|Withdrawal by Subject|1|||
160873776|NCT04838977|580931365|FG001|Overall Study|Withdrawal by Subject|1|||
160873777|NCT05367492|580931366|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
160873778|NCT05367492|580931367|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
160873779|NCT05367492|580931368|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
160873780|NCT05367492|580931366|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
160873781|NCT05367492|580931367|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
160873782|NCT05367492|580931368|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
160873783|NCT05367492|580931366|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
160873784|NCT05367492|580931367|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
160873785|NCT05367492|580931368|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
160873786|NCT05367492|580931366|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
160873787|NCT05367492|580931367|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
160532301|NCT01236573|579678671|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
160873788|NCT05367492|580931368|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
160873789|NCT00950859|580931372|FG000|Overall Study|Adverse Event|3|||
160873790|NCT00950859|580931373|FG001|Overall Study|Adverse Event|3|||
160873791|NCT00950859|580931372|FG000|Overall Study|Insufficient Viral Load Response|12|||
160873792|NCT00950859|580931373|FG001|Overall Study|Insufficient Viral Load Response|3|||
160873793|NCT00950859|580931372|FG000|Overall Study|Protocol Violation|1|||
160873794|NCT00950859|580931373|FG001|Overall Study|Protocol Violation|1|||
160873795|NCT00950859|580931372|FG000|Overall Study|Lost to Follow-up|0|||
160873796|NCT00950859|580931373|FG001|Overall Study|Lost to Follow-up|3|||
160873797|NCT01463007|580931375|FG000|Overall Study|Physician Decision|1|||
160873798|NCT03583385|580931376|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160532302|NCT01236573|579678672|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
160766293|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
160766294|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
160766295|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
160766296|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
160766297|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
160766298|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
160766299|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
160766300|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
160766301|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
160766302|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
160766303|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
160766304|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
160766305|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
160766306|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
160766307|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
160766308|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
160766309|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
160766310|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
160766311|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
160766312|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
160766313|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
160766314|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
160766315|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
160766316|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
160766317|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
160766318|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
160766319|NCT02717195|580534868|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
160766320|NCT02717195|580534869|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
160766321|NCT02717195|580534870|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
160766322|NCT02717195|580534871|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
160766323|NCT02717195|580534872|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
160766324|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
160766325|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
160766326|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
160766327|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
160766328|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
160766329|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
160766330|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
160766331|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
160766332|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
160766333|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
160766334|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
160766335|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
160766336|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
160766337|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
160766338|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
160766339|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
160766340|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
160766341|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
160766342|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
160766343|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
160766344|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
160766345|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
160766346|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
160766347|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
160766348|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
160766349|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
160766350|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
160766351|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
160766352|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
160766353|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
160766354|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
160766355|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
160766356|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
160766357|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
160766358|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
160766359|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
160766360|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
160766361|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
160766362|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
160766363|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
160766364|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
160766365|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
160766366|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
160766367|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
160766368|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
160766369|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
160766370|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
160766371|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
160766372|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
160766373|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
160766374|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
160766375|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
160766376|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
160766377|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
160766378|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
160766379|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
160766380|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
160766381|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
160766382|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
160766383|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
160766384|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
160766385|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
160766386|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
160766387|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
160766388|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
160532303|NCT01236573|579678673|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
160873799|NCT03583385|580931377|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160873800|NCT03583385|580931376|FG000|Treatment Period 2|Adverse Event|1|||
160873801|NCT03583385|580931377|FG001|Treatment Period 2|Adverse Event|0|||
160873802|NCT00545272|580931381|FG000|Overall Study|Protocol deviation|0|||
160873803|NCT00545272|580931382|FG001|Overall Study|Protocol deviation|1|||
160873804|NCT00545272|580931383|FG002|Overall Study|Protocol deviation|0|||
160873805|NCT00545272|580931384|FG003|Overall Study|Protocol deviation|1|||
160873806|NCT00545272|580931385|FG004|Overall Study|Protocol deviation|0|||
160873807|NCT00545272|580931386|FG005|Overall Study|Protocol deviation|1|||
160873808|NCT00545272|580931381|FG000|Overall Study|Adverse Event|0|||
160873809|NCT00545272|580931382|FG001|Overall Study|Adverse Event|0|||
160873810|NCT00545272|580931383|FG002|Overall Study|Adverse Event|1|||
160873811|NCT00545272|580931384|FG003|Overall Study|Adverse Event|0|||
160873812|NCT00545272|580931385|FG004|Overall Study|Adverse Event|0|||
160873813|NCT00545272|580931386|FG005|Overall Study|Adverse Event|1|||
160873814|NCT00545272|580931381|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160873815|NCT00545272|580931382|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160873816|NCT00545272|580931383|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160873817|NCT00545272|580931384|FG003|Overall Study|Abnormal laboratory value(s)|0|||
160873818|NCT00545272|580931385|FG004|Overall Study|Abnormal laboratory value(s)|0|||
160873819|NCT00545272|580931386|FG005|Overall Study|Abnormal laboratory value(s)|1|||
160873820|NCT00545272|580931381|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160873821|NCT00545272|580931382|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160873822|NCT00545272|580931383|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160873823|NCT00545272|580931384|FG003|Overall Study|Abnormal test procedure result(s)|0|||
160873824|NCT00545272|580931385|FG004|Overall Study|Abnormal test procedure result(s)|1|||
160873825|NCT00545272|580931386|FG005|Overall Study|Abnormal test procedure result(s)|0|||
160873826|NCT00545272|580931381|FG000|Overall Study|Lost to Follow-up|0|||
160873827|NCT00545272|580931382|FG001|Overall Study|Lost to Follow-up|0|||
160873828|NCT00545272|580931383|FG002|Overall Study|Lost to Follow-up|0|||
160873829|NCT00545272|580931384|FG003|Overall Study|Lost to Follow-up|0|||
160873830|NCT00545272|580931385|FG004|Overall Study|Lost to Follow-up|1|||
160873831|NCT00545272|580931386|FG005|Overall Study|Lost to Follow-up|0|||
160873832|NCT02934503|580931387|FG000|Overall Study|progression of disease|3|||
160873833|NCT02934503|580931387|FG000|Overall Study|Withdrawal by Subject|1|||
160873834|NCT00724867|580931388|FG000|Overall Study|Adverse Event|25|||
160873835|NCT00724867|580931388|FG000|Overall Study|Lack of Efficacy|14|||
160873836|NCT00724867|580931388|FG000|Overall Study|Lost to Follow-up|12|||
160873837|NCT00724867|580931388|FG000|Overall Study|Non-compliance with study drug|6|||
160873838|NCT00724867|580931388|FG000|Overall Study|Physician Decision|17|||
160873839|NCT00724867|580931388|FG000|Overall Study|Protocol Violation|1|||
160873840|NCT00724867|580931388|FG000|Overall Study|Withdrawal by Subject|31|||
160873841|NCT00724867|580931388|FG000|Overall Study|Sponsor decision to end study|14|||
160873842|NCT00724867|580931388|FG000|Overall Study|Subject incarcerated|1|||
160532304|NCT01236573|579678674|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
160532305|NCT01236573|579678675|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
160532306|NCT01236573|579678676|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
160873843|NCT00724867|580931388|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
160873844|NCT00724867|580931388|FG000|Overall Study|Subject moved out of state|1|||
160873845|NCT00724867|580931388|FG000|Overall Study|Elected to exit due to site closure|2|||
160873846|NCT03539549|580931389|FG000|Overall Study|Adverse Event|12|||
160873847|NCT03539549|580931389|FG000|Overall Study|Lost to Follow-up|1|||
160873848|NCT03539549|580931389|FG000|Overall Study|Death|2|||
160873849|NCT03539549|580931389|FG000|Overall Study|Progressive Disease|1|||
160873850|NCT03539549|580931389|FG000|Overall Study|Reason not Specified|1|||
160873851|NCT00436345|580931390|FG000|Overall Study|ICU resident beyond follow-up period|3|||
160873852|NCT00436345|580931391|FG001|Overall Study|ICU resident beyond follow-up period|0|||
160873853|NCT04027608|580931392|FG000|Overall Study|Withdrawal by Subject|13|||
160873854|NCT04027608|580931393|FG001|Overall Study|Withdrawal by Subject|2|||
160873855|NCT04027608|580931392|FG000|Overall Study|Protocol Violation|2|||
160873856|NCT04027608|580931393|FG001|Overall Study|Protocol Violation|1|||
160873857|NCT04027608|580931392|FG000|Overall Study|Physician Decision|1|||
160873858|NCT04027608|580931393|FG001|Overall Study|Physician Decision|0|||
160873859|NCT04027608|580931392|FG000|Overall Study|Lost to Follow-up|20|||
160873860|NCT04027608|580931393|FG001|Overall Study|Lost to Follow-up|4|||
160873861|NCT04248491|580931394|FG000|Overall Study|Lost to Follow-up|1|||
160873862|NCT04248491|580931395|FG001|Overall Study|Lost to Follow-up|0|||
160873863|NCT01652469|580931401|FG000|Overall Study|Withdrawal by Subject|1|||
160873864|NCT01652469|580931402|FG001|Overall Study|Withdrawal by Subject|4|||
160873865|NCT01652469|580931401|FG000|Overall Study|Lost to Follow-up|0|||
160873866|NCT01652469|580931402|FG001|Overall Study|Lost to Follow-up|2|||
160873867|NCT01049009|580931403|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
160532307|NCT01236573|579678677|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
160873868|NCT01049009|580931404|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
160873869|NCT01049009|580931403|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160873870|NCT01049009|580931404|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160873871|NCT01049009|580931403|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
160873872|NCT01049009|580931404|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
160873873|NCT01049009|580931403|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
160873874|NCT01049009|580931404|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
160873875|NCT02644109|580931406|FG000|Overall Study|Adverse Event|0|||
160873876|NCT02644109|580931407|FG001|Overall Study|Adverse Event|4|||
160873877|NCT02474069|580931408|FG000|Selection Phase (SP)|Adverse Event|8|||
160873878|NCT02474069|580931409|FG001|Selection Phase (SP)|Adverse Event|0|||
160873879|NCT02474069|580931410|FG002|Selection Phase (SP)|Adverse Event|0|||
160873880|NCT02474069|580931408|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
160873881|NCT02474069|580931409|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
160873882|NCT02474069|580931410|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
160873883|NCT02474069|580931408|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
160873884|NCT02474069|580931409|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
160873885|NCT02474069|580931410|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
160873886|NCT02474069|580931408|FG000|Selection Phase (SP)|Physician Decision|1|||
160873887|NCT02474069|580931409|FG001|Selection Phase (SP)|Physician Decision|0|||
160873888|NCT02474069|580931410|FG002|Selection Phase (SP)|Physician Decision|0|||
160873889|NCT02474069|580931408|FG000|Selection Phase (SP)|Protocol Violation|1|||
160873890|NCT02474069|580931409|FG001|Selection Phase (SP)|Protocol Violation|0|||
160873891|NCT02474069|580931410|FG002|Selection Phase (SP)|Protocol Violation|0|||
160873892|NCT02474069|580931408|FG000|Selection Phase (SP)|No longer requires treatment|1|||
160873893|NCT02474069|580931409|FG001|Selection Phase (SP)|No longer requires treatment|0|||
160873894|NCT02474069|580931410|FG002|Selection Phase (SP)|No longer requires treatment|0|||
160873895|NCT02474069|580931408|FG000|Selection Phase (SP)|Technical Problem|1|||
160873896|NCT02474069|580931409|FG001|Selection Phase (SP)|Technical Problem|0|||
160873897|NCT02474069|580931410|FG002|Selection Phase (SP)|Technical Problem|0|||
160873898|NCT02474069|580931408|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
160873899|NCT02474069|580931409|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
160873900|NCT02474069|580931410|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
160873901|NCT02474069|580931408|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
160873902|NCT02474069|580931409|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
160873903|NCT02474069|580931410|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
160873904|NCT02474069|580931408|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
160873905|NCT02474069|580931409|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
160873906|NCT02474069|580931410|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
160873907|NCT02474069|580931408|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
160873908|NCT02474069|580931409|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
160532308|NCT01236573|579678678|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
160532309|NCT01236573|579678679|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
160532310|NCT01236573|579678680|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
160532311|NCT01236573|579678681|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
160532312|NCT01236573|579678671|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
160873909|NCT02474069|580931410|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
160873910|NCT02474069|580931408|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
160873911|NCT02474069|580931409|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
160873912|NCT02474069|580931410|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
160873913|NCT02474069|580931408|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
160873914|NCT02474069|580931409|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
160532313|NCT01236573|579678672|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
160873915|NCT02474069|580931410|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
160873916|NCT01474018|580931411|FG000|Overall Study|Lost to Follow-up|0|||
160873917|NCT01474018|580931412|FG001|Overall Study|Lost to Follow-up|1|||
160873918|NCT01474018|580931411|FG000|Overall Study|Withdrawal by Subject|0|||
160873919|NCT01474018|580931412|FG001|Overall Study|Withdrawal by Subject|2|||
160873920|NCT03801031|580931413|FG000|Overall Study|Lost to Follow-up|1|||
160873921|NCT03801031|580931414|FG001|Overall Study|Lost to Follow-up|0|||
160873922|NCT03801031|580931413|FG000|Overall Study|Unable to comply|1|||
160873923|NCT03801031|580931414|FG001|Overall Study|Unable to comply|0|||
160873924|NCT03801031|580931413|FG000|Overall Study|Withdrawal by Subject|0|||
160873925|NCT03801031|580931414|FG001|Overall Study|Withdrawal by Subject|1|||
160873926|NCT01942733|580931415|FG000|Overall Study|Lost to Follow-up|1|||
160873927|NCT01942733|580931415|FG000|Overall Study|Non-compliance with IMP|1|||
160873928|NCT01942733|580931415|FG000|Overall Study|Administrative|1|||
160873929|NCT00126490|580931416|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
160873930|NCT03462511|580931418|FG000|Overall Study|Withdrawal by Subject|2|||
160873931|NCT03462511|580931419|FG001|Overall Study|Withdrawal by Subject|3|||
160873932|NCT02925416|580931420|FG000|Overall Study|Adverse Event|2|||
160873933|NCT02925416|580931421|FG001|Overall Study|Adverse Event|0|||
160873934|NCT02625909|580931422|FG000|Overall Study|Death|2|||
160873935|NCT02625909|580931423|FG001|Overall Study|Death|0|||
160873936|NCT02625909|580931422|FG000|Overall Study|Lost to Follow-up|3|||
160873937|NCT02625909|580931423|FG001|Overall Study|Lost to Follow-up|5|||
160873938|NCT02625909|580931422|FG000|Overall Study|Lack of Efficacy|9|||
160873939|NCT02625909|580931423|FG001|Overall Study|Lack of Efficacy|2|||
160873940|NCT02625909|580931422|FG000|Overall Study|Reinfection|3|||
160873941|NCT02625909|580931423|FG001|Overall Study|Reinfection|2|||
160873942|NCT01598506|580931424|FG000|Overall Study|Withdrawal by Subject|2|||
160873943|NCT02067676|580931429|FG000|Overall Study|Withdrawal by Subject|1|||
160873944|NCT02067676|580931430|FG001|Overall Study|Withdrawal by Subject|0|||
160873945|NCT02067676|580931431|FG002|Overall Study|Withdrawal by Subject|0|||
160873946|NCT02067676|580931432|FG003|Overall Study|Withdrawal by Subject|0|||
160873947|NCT02067676|580931433|FG004|Overall Study|Withdrawal by Subject|0|||
160873948|NCT02067676|580931434|FG005|Overall Study|Withdrawal by Subject|0|||
160873949|NCT00476229|580931435|FG000|Overall Study|Progressive shortness of breath|1|||
160873950|NCT01387542|580931442|FG000|Overall Study|Adverse Event|3|||
160873951|NCT01387542|580931442|FG000|Overall Study|Withdrawal by Subject|1|||
160873952|NCT01387542|580931442|FG000|Overall Study|Changed diagnosis|1|||
160873953|NCT01387542|580931442|FG000|Overall Study|Insufficient response|1|||
160873954|NCT01387542|580931442|FG000|Overall Study|Non-compliant|1|||
160873955|NCT01387542|580931442|FG000|Overall Study|Lost to Follow-up|1|||
160873956|NCT01761240|580931445|FG000|Overall Study|Progressive disease:radiology assessment|3|||
160873957|NCT01761240|580931446|FG001|Overall Study|Progressive disease:radiology assessment|3|||
160873958|NCT01761240|580931447|FG002|Overall Study|Progressive disease:radiology assessment|0|||
160873959|NCT01761240|580931448|FG003|Overall Study|Progressive disease:radiology assessment|0|||
160873960|NCT01761240|580931449|FG004|Overall Study|Progressive disease:radiology assessment|0|||
160873961|NCT01761240|580931445|FG000|Overall Study|Progressive disease:clinical assessment|0|||
160873962|NCT01761240|580931446|FG001|Overall Study|Progressive disease:clinical assessment|0|||
160873963|NCT01761240|580931447|FG002|Overall Study|Progressive disease:clinical assessment|3|||
160873964|NCT01761240|580931448|FG003|Overall Study|Progressive disease:clinical assessment|1|||
160873965|NCT01761240|580931449|FG004|Overall Study|Progressive disease:clinical assessment|0|||
160873966|NCT01761240|580931445|FG000|Overall Study|Withdrawal by Subject|0|||
160873967|NCT01761240|580931446|FG001|Overall Study|Withdrawal by Subject|0|||
160873968|NCT01761240|580931447|FG002|Overall Study|Withdrawal by Subject|0|||
160873969|NCT01761240|580931448|FG003|Overall Study|Withdrawal by Subject|3|||
160873970|NCT01761240|580931449|FG004|Overall Study|Withdrawal by Subject|1|||
160873971|NCT01761240|580931445|FG000|Overall Study|Adverse Event|0|||
160873972|NCT01761240|580931446|FG001|Overall Study|Adverse Event|0|||
160873973|NCT01761240|580931447|FG002|Overall Study|Adverse Event|0|||
160766389|NCT02717195|580534868|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
160766390|NCT02717195|580534869|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
160766391|NCT02717195|580534870|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
160766392|NCT02717195|580534871|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
160766393|NCT02717195|580534872|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
160766418|NCT02078817|580534881|FG000|Overall Study|Withdrawal by Subject|1|||
160766419|NCT00769561|580534883|FG000|Overall Study|Withdrawal by Subject|2|||
160766420|NCT00769561|580534884|FG001|Overall Study|Withdrawal by Subject|2|||
160766421|NCT00769561|580534883|FG000|Overall Study|Lost to Follow-up|1|||
160766422|NCT00769561|580534884|FG001|Overall Study|Lost to Follow-up|3|||
160766423|NCT02370511|580534891|FG000|Overall Study|Death|10|||
160766424|NCT02370511|580534892|FG001|Overall Study|Death|7|||
160766425|NCT02370511|580534893|FG002|Overall Study|Death|1|||
160766426|NCT02370511|580534891|FG000|Overall Study|Withdrawal by Subject|2|||
160766427|NCT02370511|580534892|FG001|Overall Study|Withdrawal by Subject|0|||
160766428|NCT02370511|580534893|FG002|Overall Study|Withdrawal by Subject|0|||
160766429|NCT02370511|580534891|FG000|Overall Study|Lost to Follow-up|0|||
160766430|NCT02370511|580534892|FG001|Overall Study|Lost to Follow-up|4|||
160766431|NCT02370511|580534893|FG002|Overall Study|Lost to Follow-up|0|||
160766432|NCT01149655|580534894|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
160766433|NCT01149655|580534895|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
160766434|NCT01149655|580534896|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
160766435|NCT01149655|580534897|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
160766436|NCT01149655|580534894|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
160766437|NCT01149655|580534895|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
160766438|NCT01149655|580534896|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
160766439|NCT01149655|580534897|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
160766440|NCT01149655|580534894|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
160766441|NCT01149655|580534895|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
160766442|NCT01149655|580534896|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
160766443|NCT01149655|580534897|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
160766444|NCT01149655|580534894|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
160766445|NCT01149655|580534895|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
160766446|NCT01149655|580534896|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
160766447|NCT01149655|580534897|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
160766448|NCT01149655|580534894|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
160766449|NCT01149655|580534895|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
160766450|NCT01149655|580534896|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
160766451|NCT01149655|580534897|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
160766452|NCT01149655|580534894|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
160766453|NCT01149655|580534895|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
160766454|NCT01149655|580534896|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
160766455|NCT01149655|580534897|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
160766456|NCT01149655|580534894|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
160766457|NCT01149655|580534895|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
160766458|NCT01149655|580534896|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
160766459|NCT01149655|580534897|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
160532314|NCT01236573|579678673|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
160532315|NCT01236573|579678674|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
160532316|NCT01236573|579678675|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
160532317|NCT01236573|579678676|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
160532318|NCT01236573|579678677|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
160532319|NCT01236573|579678678|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
160532320|NCT01236573|579678679|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
160532321|NCT01236573|579678680|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
160532322|NCT01236573|579678681|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
160532323|NCT01236573|579678671|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
160532324|NCT01236573|579678672|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
160766460|NCT01149655|580534894|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
160766461|NCT01149655|580534895|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
160766462|NCT01149655|580534896|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
160766463|NCT01149655|580534897|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
160766464|NCT01149655|580534894|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
160766465|NCT01149655|580534895|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
160766466|NCT01149655|580534896|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
160766467|NCT01149655|580534897|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
160766468|NCT01149655|580534894|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
160766469|NCT01149655|580534895|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
160766470|NCT01149655|580534896|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
160766471|NCT01149655|580534897|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
160766472|NCT01149655|580534894|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
160766473|NCT01149655|580534895|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
160766474|NCT01149655|580534896|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
160766475|NCT01149655|580534897|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
160766476|NCT01149655|580534894|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
160766477|NCT01149655|580534895|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
160766478|NCT01149655|580534896|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
160766479|NCT01149655|580534897|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
160766480|NCT01149655|580534894|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
160766481|NCT01149655|580534895|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
160766482|NCT01149655|580534896|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
160766483|NCT01149655|580534897|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
160766484|NCT01149655|580534894|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
160766485|NCT01149655|580534895|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
160766486|NCT01149655|580534896|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
160766487|NCT01149655|580534897|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
160766488|NCT01149655|580534894|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
160766489|NCT01149655|580534895|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
160766490|NCT01149655|580534896|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
160766491|NCT01149655|580534897|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
160766492|NCT01149655|580534894|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
160766493|NCT01149655|580534895|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
160766494|NCT01149655|580534896|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
160766495|NCT01149655|580534897|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
160766496|NCT01265498|580534900|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
160766497|NCT01265498|580534901|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
160766498|NCT03092752|580534903|FG000|Overall Study|Aged <40 years|14209|||
160766499|NCT03092752|580534903|FG000|Overall Study|At least one claim with T2DM|61299|||
160766500|NCT03092752|580534903|FG000|Overall Study|Having no claim of study drugs|29282|||
160766501|NCT03092752|580534903|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
160766502|NCT03092752|580534903|FG000|Overall Study|<6 month history|245900|||
160766503|NCT00921024|580534906|FG000|Overall Study|Lost to Follow-up|2|||
160766504|NCT00921024|580534907|FG001|Overall Study|Lost to Follow-up|0|||
160766505|NCT00921024|580534906|FG000|Overall Study|Received concomittant therapy|2|||
160766506|NCT00921024|580534907|FG001|Overall Study|Received concomittant therapy|0|||
160766507|NCT00921024|580534906|FG000|Overall Study|Withdrawal by Subject|0|||
160766508|NCT00921024|580534907|FG001|Overall Study|Withdrawal by Subject|3|||
160766509|NCT02097823|580534908|FG000|Overall Study|Withdrawal by Subject|1|||
160766510|NCT02097823|580534909|FG001|Overall Study|Withdrawal by Subject|1|||
160766511|NCT01419535|580534910|FG000|Overall Study|could not maintain iv line|1|||
160766512|NCT01419535|580534911|FG001|Overall Study|could not maintain iv line|1|||
160766513|NCT01419535|580534910|FG000|Overall Study|Withdrawal by Subject|0|||
160766514|NCT01419535|580534911|FG001|Overall Study|Withdrawal by Subject|1|||
160766515|NCT04239924|580534916|FG000|Overall Study|Lost to Follow-up|2|||
160766516|NCT05399680|580536166|FG000|Overall Study|Lost to Follow-up|1|||
160766517|NCT05399680|580536167|FG001|Overall Study|Lost to Follow-up|0|||
160766518|NCT05399680|580536166|FG000|Overall Study|Death|0|||
160766519|NCT05399680|580536167|FG001|Overall Study|Death|1|||
160766520|NCT02659865|580536168|FG000|Period 1|Withdrawal by Subject|1|||
160766521|NCT02659865|580536169|FG001|Period 1|Withdrawal by Subject|0|||
160766522|NCT02659865|580536170|FG002|Period 1|Withdrawal by Subject|0|||
160766523|NCT02659865|580536171|FG003|Period 1|Withdrawal by Subject|0|||
160766524|NCT02659865|580536172|FG004|Period 1|Withdrawal by Subject|0|||
160766525|NCT02659865|580536168|FG000|Period 1|Adverse Event|0|||
160766526|NCT02659865|580536169|FG001|Period 1|Adverse Event|0|||
160766527|NCT02659865|580536170|FG002|Period 1|Adverse Event|0|||
160766528|NCT02659865|580536171|FG003|Period 1|Adverse Event|0|||
160766529|NCT02659865|580536172|FG004|Period 1|Adverse Event|1|||
160766530|NCT02325414|580536173|FG000|Overall Study|Withdrawal by Subject|3|||
160766531|NCT02325414|580536174|FG001|Overall Study|Withdrawal by Subject|1|||
160766532|NCT02325414|580536173|FG000|Overall Study|Lost to Follow-up|5|||
160766533|NCT02325414|580536174|FG001|Overall Study|Lost to Follow-up|5|||
160766534|NCT02775851|580536175|FG000|Overall Study|Adverse Event|1|||
160766535|NCT02775851|580536176|FG001|Overall Study|Adverse Event|10|||
160766536|NCT02775851|580536175|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
160766537|NCT02775851|580536176|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
160766538|NCT02775851|580536175|FG000|Overall Study|Progression/Relapse|0|||
160766539|NCT02775851|580536176|FG001|Overall Study|Progression/Relapse|4|||
160766540|NCT02775851|580536175|FG000|Overall Study|Other - Not Protocol Specified|0|||
160766541|NCT02775851|580536176|FG001|Overall Study|Other - Not Protocol Specified|7|||
160766542|NCT02775851|580536175|FG000|Overall Study|Withdrawal by Subject|1|||
160766543|NCT02775851|580536176|FG001|Overall Study|Withdrawal by Subject|0|||
160766544|NCT00998946|580536177|FG000|Overall Study|Lost to Follow-up|1|||
160766545|NCT00998946|580536177|FG000|Overall Study|Withdrawal by Subject|1|||
160766546|NCT00998946|580536177|FG000|Overall Study|Death|2|||
160766547|NCT00998946|580536177|FG000|Overall Study|Reason Unspecified|3|||
160766548|NCT00998946|580536177|FG000|Overall Study|Enrolled but not Dosed|2|||
160766549|NCT00915525|580536178|FG000|Overall Study|Protocol Violation|9|||
160766550|NCT00915525|580536179|FG001|Overall Study|Protocol Violation|4|||
160766551|NCT00915525|580536178|FG000|Overall Study|Withdrawal by Subject|59|||
160766552|NCT00915525|580536179|FG001|Overall Study|Withdrawal by Subject|21|||
160766553|NCT00915525|580536178|FG000|Overall Study|Lost to Follow-up|27|||
160766554|NCT00915525|580536179|FG001|Overall Study|Lost to Follow-up|16|||
160766555|NCT00915525|580536178|FG000|Overall Study|Pregnancy|2|||
160766556|NCT00915525|580536179|FG001|Overall Study|Pregnancy|0|||
160766557|NCT00915525|580536178|FG000|Overall Study|Lack of Efficacy|15|||
160766558|NCT00915525|580536179|FG001|Overall Study|Lack of Efficacy|32|||
160766559|NCT00915525|580536178|FG000|Overall Study|Adverse Event|29|||
160766560|NCT00915525|580536179|FG001|Overall Study|Adverse Event|13|||
160766561|NCT00915525|580536178|FG000|Overall Study|Missing|12|||
160766562|NCT00915525|580536179|FG001|Overall Study|Missing|1|||
160766563|NCT00915525|580536178|FG000|Overall Study|Other Reason|35|||
160766564|NCT00915525|580536179|FG001|Overall Study|Other Reason|12|||
160766565|NCT00915525|580536178|FG000|Overall Study|Site Closed|27|||
160766566|NCT00915525|580536179|FG001|Overall Study|Site Closed|9|||
160766567|NCT00915525|580536178|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
160766568|NCT00915525|580536179|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
160766569|NCT00915525|580536178|FG000|Overall Study|Study Burden|28|||
160766570|NCT00915525|580536179|FG001|Overall Study|Study Burden|12|||
160766571|NCT00915525|580536178|FG000|Overall Study|Non-Compliance|3|||
160766572|NCT00915525|580536179|FG001|Overall Study|Non-Compliance|1|||
160766573|NCT00915525|580536178|FG000|Overall Study|Patient Moved|15|||
160766574|NCT00915525|580536179|FG001|Overall Study|Patient Moved|9|||
160766575|NCT02765035|580536191|FG000|First Intervention (90 Days)|Adverse Event|1|||
160766576|NCT02765035|580536192|FG001|First Intervention (90 Days)|Adverse Event|1|||
160766577|NCT02765035|580536191|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
160766578|NCT02765035|580536192|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
160766579|NCT01281306|580536194|FG000|Overall Study|Lack of Efficacy|0|||
160766580|NCT01281306|580536195|FG001|Overall Study|Lack of Efficacy|1|||
160766581|NCT01281306|580536196|FG002|Overall Study|Lack of Efficacy|3|||
160873974|NCT01761240|580931448|FG003|Overall Study|Adverse Event|1|||
160766582|NCT01281306|580536197|FG003|Overall Study|Lack of Efficacy|0|||
160766583|NCT01281306|580536198|FG004|Overall Study|Lack of Efficacy|2|||
160873975|NCT01761240|580931449|FG004|Overall Study|Adverse Event|6|||
160766584|NCT01281306|580536199|FG005|Overall Study|Lack of Efficacy|0|||
160766585|NCT01281306|580536200|FG006|Overall Study|Lack of Efficacy|1|||
160766586|NCT01281306|580536194|FG000|Overall Study|Withdrawal by Subject|1|||
160766587|NCT01281306|580536195|FG001|Overall Study|Withdrawal by Subject|0|||
160766588|NCT01281306|580536196|FG002|Overall Study|Withdrawal by Subject|2|||
160766589|NCT01281306|580536197|FG003|Overall Study|Withdrawal by Subject|4|||
160766590|NCT01281306|580536198|FG004|Overall Study|Withdrawal by Subject|1|||
160766591|NCT01281306|580536199|FG005|Overall Study|Withdrawal by Subject|3|||
160766592|NCT01281306|580536200|FG006|Overall Study|Withdrawal by Subject|1|||
160766593|NCT01281306|580536194|FG000|Overall Study|Protocol deviation|0|||
160766594|NCT01281306|580536195|FG001|Overall Study|Protocol deviation|1|||
160532325|NCT01236573|579678673|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
160532326|NCT01236573|579678674|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
160532327|NCT01236573|579678675|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
160532328|NCT01236573|579678676|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
160532329|NCT01236573|579678677|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
160532330|NCT01236573|579678678|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
160532331|NCT01236573|579678679|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
160766595|NCT01281306|580536196|FG002|Overall Study|Protocol deviation|1|||
160766596|NCT01281306|580536197|FG003|Overall Study|Protocol deviation|1|||
160766597|NCT01281306|580536198|FG004|Overall Study|Protocol deviation|1|||
160766598|NCT01281306|580536199|FG005|Overall Study|Protocol deviation|0|||
160766599|NCT01281306|580536200|FG006|Overall Study|Protocol deviation|0|||
160766600|NCT01281306|580536194|FG000|Overall Study|Condition no longer requires study drug|1|||
160766601|NCT01281306|580536195|FG001|Overall Study|Condition no longer requires study drug|0|||
160766602|NCT01281306|580536196|FG002|Overall Study|Condition no longer requires study drug|0|||
160766603|NCT01281306|580536197|FG003|Overall Study|Condition no longer requires study drug|0|||
160766604|NCT01281306|580536198|FG004|Overall Study|Condition no longer requires study drug|0|||
160766605|NCT01281306|580536199|FG005|Overall Study|Condition no longer requires study drug|1|||
160766606|NCT01281306|580536200|FG006|Overall Study|Condition no longer requires study drug|1|||
160766607|NCT01281306|580536194|FG000|Overall Study|Lost to Follow-up|1|||
160766608|NCT01281306|580536195|FG001|Overall Study|Lost to Follow-up|0|||
160766609|NCT01281306|580536196|FG002|Overall Study|Lost to Follow-up|0|||
160766610|NCT01281306|580536197|FG003|Overall Study|Lost to Follow-up|2|||
160766611|NCT01281306|580536198|FG004|Overall Study|Lost to Follow-up|0|||
160766612|NCT01281306|580536199|FG005|Overall Study|Lost to Follow-up|0|||
160766613|NCT01281306|580536200|FG006|Overall Study|Lost to Follow-up|1|||
160766614|NCT01281306|580536194|FG000|Overall Study|Death|1|||
160766615|NCT01281306|580536195|FG001|Overall Study|Death|0|||
160766616|NCT01281306|580536196|FG002|Overall Study|Death|0|||
160766617|NCT01281306|580536197|FG003|Overall Study|Death|0|||
160766618|NCT01281306|580536198|FG004|Overall Study|Death|0|||
160766619|NCT01281306|580536199|FG005|Overall Study|Death|0|||
160766620|NCT01281306|580536200|FG006|Overall Study|Death|0|||
160766621|NCT01281306|580536194|FG000|Overall Study|Adverse Event|3|||
160766622|NCT01281306|580536195|FG001|Overall Study|Adverse Event|2|||
160766623|NCT01281306|580536196|FG002|Overall Study|Adverse Event|2|||
160766624|NCT01281306|580536197|FG003|Overall Study|Adverse Event|3|||
160766625|NCT01281306|580536198|FG004|Overall Study|Adverse Event|5|||
160766626|NCT01281306|580536199|FG005|Overall Study|Adverse Event|3|||
160766627|NCT01281306|580536200|FG006|Overall Study|Adverse Event|3|||
160766628|NCT01281306|580536194|FG000|Overall Study|Randomized in error|1|||
160766629|NCT01281306|580536195|FG001|Overall Study|Randomized in error|0|||
160766630|NCT01281306|580536196|FG002|Overall Study|Randomized in error|0|||
160766631|NCT01281306|580536197|FG003|Overall Study|Randomized in error|1|||
160766632|NCT01281306|580536198|FG004|Overall Study|Randomized in error|0|||
160766633|NCT01281306|580536199|FG005|Overall Study|Randomized in error|0|||
160766634|NCT01281306|580536200|FG006|Overall Study|Randomized in error|0|||
160766635|NCT00368550|580536201|FG000|Overall Study|Adverse Event|7|||
160766636|NCT00368550|580536202|FG001|Overall Study|Adverse Event|4|||
160766637|NCT00368550|580536201|FG000|Overall Study|Lack of Efficacy|4|||
160766638|NCT00368550|580536202|FG001|Overall Study|Lack of Efficacy|9|||
160766639|NCT00368550|580536201|FG000|Overall Study|Withdrawal by Subject|17|||
160766640|NCT00368550|580536202|FG001|Overall Study|Withdrawal by Subject|10|||
160766641|NCT01192815|580536203|FG000|Overall Study|Withdrawal by Subject|1|||
160766642|NCT01192815|580536203|FG000|Overall Study|Lack of Efficacy|1|||
160766643|NCT03451045|580536204|FG000|Overall Study|Lack of Efficacy|3|||
160766644|NCT03451045|580536205|FG001|Overall Study|Lack of Efficacy|2|||
160766645|NCT03451045|580536206|FG002|Overall Study|Lack of Efficacy|2|||
160766646|NCT03451045|580536204|FG000|Overall Study|Physician Decision|1|||
160766647|NCT03451045|580536205|FG001|Overall Study|Physician Decision|1|||
160766648|NCT03451045|580536206|FG002|Overall Study|Physician Decision|1|||
160766649|NCT03451045|580536204|FG000|Overall Study|Withdrawal by Subject|4|||
160766650|NCT03451045|580536205|FG001|Overall Study|Withdrawal by Subject|0|||
160873976|NCT01761240|580931445|FG000|Overall Study|Death|0|||
160873977|NCT01761240|580931446|FG001|Overall Study|Death|1|||
160873978|NCT01761240|580931447|FG002|Overall Study|Death|1|||
160873979|NCT01761240|580931448|FG003|Overall Study|Death|2|||
160873980|NCT01761240|580931449|FG004|Overall Study|Death|1|||
160873981|NCT01761240|580931445|FG000|Overall Study|Non-compliance|0|||
160873982|NCT01761240|580931446|FG001|Overall Study|Non-compliance|0|||
160873983|NCT01761240|580931447|FG002|Overall Study|Non-compliance|1|||
160873984|NCT01761240|580931448|FG003|Overall Study|Non-compliance|0|||
160873985|NCT01761240|580931449|FG004|Overall Study|Non-compliance|0|||
160873986|NCT05422638|580931450|FG000|Overall Study|Withdrawal by Subject|8|||
160873987|NCT05422638|580931451|FG001|Overall Study|Withdrawal by Subject|2|||
160873988|NCT01827956|580931452|FG000|Overall Study|Protocol Violation|3|||
160873989|NCT04393454|580931453|FG000|Overall Study|Death|1|||
160873990|NCT04393454|580931453|FG000|Overall Study|Lost to Follow-up|1|||
160873991|NCT02621151|580931454|FG000|Overall Study|Not eligible for trial|6|||
160873992|NCT04695977|580931459|FG000|Overall Study|Sponsor Decision|9|||
160873993|NCT04695977|580931460|FG001|Overall Study|Sponsor Decision|4|||
160873994|NCT04695977|580931459|FG000|Overall Study|Death|2|||
160873995|NCT04695977|580931460|FG001|Overall Study|Death|5|||
160873996|NCT04236141|580932640|FG000|Overall Study|Death|18|||
160873997|NCT04236141|580932641|FG001|Overall Study|Death|10|||
160873998|NCT04236141|580932640|FG000|Overall Study|Withdrawal by Participant|1|||
160873999|NCT04236141|580932641|FG001|Overall Study|Withdrawal by Participant|0|||
160532332|NCT01236573|579678680|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
160532333|NCT01236573|579678681|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
160874000|NCT04236141|580932640|FG000|Overall Study|Reason not Specified|1|||
160874001|NCT04236141|580932641|FG001|Overall Study|Reason not Specified|0|||
160874002|NCT04236141|580932640|FG000|Overall Study|Study terminated by Sponsor|8|||
160874003|NCT04236141|580932641|FG001|Overall Study|Study terminated by Sponsor|4|||
160874004|NCT00130247|580932642|FG000|Overall Study|Pregnancy|1|||
160874005|NCT00130247|580932643|FG001|Overall Study|Pregnancy|0|||
160874006|NCT00130247|580932642|FG000|Overall Study|Post-randomization exclusion|1|||
160874007|NCT00130247|580932643|FG001|Overall Study|Post-randomization exclusion|2|||
160874008|NCT00130247|580932642|FG000|Overall Study|Not compliant with DOT|0|||
160874009|NCT00130247|580932643|FG001|Overall Study|Not compliant with DOT|2|||
160874010|NCT01761162|580932648|FG000|Overall Study|Withdrawal by Subject|3|||
160874011|NCT02160899|580932653|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
160874012|NCT02160899|580932654|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
160874013|NCT02160899|580932655|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
160874014|NCT02160899|580932656|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
160874015|NCT02160899|580932657|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
160874016|NCT02160899|580932658|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
160874017|NCT04129151|580932659|FG000|Overall Study|Adverse Event|1|||
160874018|NCT04129151|580932659|FG000|Overall Study|Disease Progression|7|||
160874019|NCT04129151|580932659|FG000|Overall Study|Study closure|1|||
160874020|NCT04473235|580932660|FG000|Overall Study|Lost to Follow-up|6|||
160874021|NCT04473235|580932661|FG001|Overall Study|Lost to Follow-up|5|||
160874022|NCT04473235|580932660|FG000|Overall Study|Declined continuation|2|||
160874023|NCT04473235|580932661|FG001|Overall Study|Declined continuation|0|||
160874024|NCT04473235|580932660|FG000|Overall Study|Physician Decision|1|||
160874025|NCT04473235|580932661|FG001|Overall Study|Physician Decision|1|||
160874026|NCT04473235|580932660|FG000|Overall Study|Protocol Violation|10|||
160874027|NCT04473235|580932661|FG001|Overall Study|Protocol Violation|6|||
160874028|NCT01945710|580932664|FG000|Overall Study|Progressive Disease|5|||
160874029|NCT01945710|580932665|FG001|Overall Study|Progressive Disease|4|||
160874030|NCT01945710|580932666|FG002|Overall Study|Progressive Disease|3|||
160874031|NCT01945710|580932667|FG003|Overall Study|Progressive Disease|2|||
160874032|NCT01945710|580932668|FG004|Overall Study|Progressive Disease|7|||
160874033|NCT01945710|580932669|FG005|Overall Study|Progressive Disease|3|||
160874034|NCT01945710|580932670|FG006|Overall Study|Progressive Disease|19|||
160874035|NCT01945710|580932664|FG000|Overall Study|Adverse Event|0|||
160874036|NCT01945710|580932665|FG001|Overall Study|Adverse Event|1|||
160874037|NCT01945710|580932666|FG002|Overall Study|Adverse Event|0|||
160874038|NCT01945710|580932667|FG003|Overall Study|Adverse Event|0|||
160874039|NCT01945710|580932668|FG004|Overall Study|Adverse Event|0|||
160874040|NCT01945710|580932669|FG005|Overall Study|Adverse Event|0|||
160874041|NCT01945710|580932670|FG006|Overall Study|Adverse Event|0|||
160874042|NCT01945710|580932664|FG000|Overall Study|Other|2|||
160874043|NCT01945710|580932665|FG001|Overall Study|Other|0|||
160874044|NCT01945710|580932666|FG002|Overall Study|Other|3|||
160874045|NCT01945710|580932667|FG003|Overall Study|Other|1|||
160874046|NCT01945710|580932668|FG004|Overall Study|Other|1|||
160874047|NCT01945710|580932669|FG005|Overall Study|Other|0|||
160874048|NCT01945710|580932670|FG006|Overall Study|Other|4|||
160874049|NCT01945710|580932664|FG000|Overall Study|Withdrawal by Subject|0|||
160874050|NCT01945710|580932665|FG001|Overall Study|Withdrawal by Subject|1|||
160874051|NCT01945710|580932666|FG002|Overall Study|Withdrawal by Subject|1|||
160874052|NCT01945710|580932667|FG003|Overall Study|Withdrawal by Subject|0|||
160874053|NCT01945710|580932668|FG004|Overall Study|Withdrawal by Subject|1|||
160874054|NCT01945710|580932669|FG005|Overall Study|Withdrawal by Subject|0|||
160874055|NCT01945710|580932670|FG006|Overall Study|Withdrawal by Subject|0|||
160874056|NCT02730195|580932671|FG000|Overall Study|Withdrawal by Subject|1|||
160874057|NCT02785770|580932672|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
160874058|NCT02785770|580932673|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
160874059|NCT02785770|580932674|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
160874060|NCT02785770|580932675|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
160874061|NCT02785770|580932672|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
160874062|NCT02785770|580932673|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
160874063|NCT02785770|580932674|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
160874064|NCT02785770|580932675|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
160874065|NCT02785770|580932672|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
160874066|NCT02785770|580932673|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
160874067|NCT02785770|580932674|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
160874068|NCT02785770|580932675|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
160874069|NCT01088048|580932679|FG000|Overall Study|Adverse Event|7|||
160874070|NCT01088048|580932680|FG001|Overall Study|Adverse Event|9|||
160874071|NCT01088048|580932681|FG002|Overall Study|Adverse Event|7|||
160874072|NCT01088048|580932682|FG003|Overall Study|Adverse Event|5|||
160874073|NCT01088048|580932683|FG004|Overall Study|Adverse Event|6|||
160874074|NCT01088048|580932684|FG005|Overall Study|Adverse Event|3|||
160874075|NCT01088048|580932685|FG006|Overall Study|Adverse Event|3|||
160874076|NCT01088048|580932686|FG007|Overall Study|Adverse Event|0|||
160874077|NCT01088048|580932687|FG008|Overall Study|Adverse Event|2|||
160874078|NCT01088048|580932688|FG009|Overall Study|Adverse Event|2|||
160874079|NCT01088048|580932679|FG000|Overall Study|Withdrew Consent|1|||
160874080|NCT01088048|580932680|FG001|Overall Study|Withdrew Consent|1|||
160874081|NCT01088048|580932681|FG002|Overall Study|Withdrew Consent|1|||
160874082|NCT01088048|580932682|FG003|Overall Study|Withdrew Consent|1|||
160874083|NCT01088048|580932683|FG004|Overall Study|Withdrew Consent|2|||
160874084|NCT01088048|580932684|FG005|Overall Study|Withdrew Consent|1|||
160874085|NCT01088048|580932685|FG006|Overall Study|Withdrew Consent|0|||
160874086|NCT01088048|580932686|FG007|Overall Study|Withdrew Consent|2|||
160874087|NCT01088048|580932687|FG008|Overall Study|Withdrew Consent|2|||
160874088|NCT01088048|580932688|FG009|Overall Study|Withdrew Consent|1|||
160874089|NCT01088048|580932679|FG000|Overall Study|Concomitant Medication Prohibited|1|||
160874090|NCT01088048|580932680|FG001|Overall Study|Concomitant Medication Prohibited|0|||
160874091|NCT01088048|580932681|FG002|Overall Study|Concomitant Medication Prohibited|0|||
160874092|NCT01088048|580932682|FG003|Overall Study|Concomitant Medication Prohibited|0|||
160874093|NCT01088048|580932683|FG004|Overall Study|Concomitant Medication Prohibited|0|||
160874094|NCT01088048|580932684|FG005|Overall Study|Concomitant Medication Prohibited|0|||
160874095|NCT01088048|580932685|FG006|Overall Study|Concomitant Medication Prohibited|0|||
160874096|NCT01088048|580932686|FG007|Overall Study|Concomitant Medication Prohibited|0|||
160874097|NCT01088048|580932687|FG008|Overall Study|Concomitant Medication Prohibited|0|||
160874098|NCT01088048|580932688|FG009|Overall Study|Concomitant Medication Prohibited|0|||
160874099|NCT01088048|580932679|FG000|Overall Study|Investigator Request|2|||
160874100|NCT01088048|580932680|FG001|Overall Study|Investigator Request|2|||
160874101|NCT01088048|580932681|FG002|Overall Study|Investigator Request|0|||
160874102|NCT01088048|580932682|FG003|Overall Study|Investigator Request|0|||
160874103|NCT01088048|580932683|FG004|Overall Study|Investigator Request|3|||
160874104|NCT01088048|580932684|FG005|Overall Study|Investigator Request|1|||
160874105|NCT01088048|580932685|FG006|Overall Study|Investigator Request|1|||
160874106|NCT01088048|580932686|FG007|Overall Study|Investigator Request|0|||
160874107|NCT01088048|580932687|FG008|Overall Study|Investigator Request|0|||
160874108|NCT01088048|580932688|FG009|Overall Study|Investigator Request|0|||
160874109|NCT01088048|580932679|FG000|Overall Study|Patient Non-compliance|0|||
160874110|NCT01088048|580932680|FG001|Overall Study|Patient Non-compliance|1|||
160874111|NCT01088048|580932681|FG002|Overall Study|Patient Non-compliance|0|||
160874112|NCT01088048|580932682|FG003|Overall Study|Patient Non-compliance|0|||
160874113|NCT01088048|580932683|FG004|Overall Study|Patient Non-compliance|0|||
160874114|NCT01088048|580932684|FG005|Overall Study|Patient Non-compliance|0|||
160874115|NCT01088048|580932685|FG006|Overall Study|Patient Non-compliance|0|||
160874116|NCT01088048|580932686|FG007|Overall Study|Patient Non-compliance|0|||
160874117|NCT01088048|580932687|FG008|Overall Study|Patient Non-compliance|0|||
160874118|NCT01088048|580932688|FG009|Overall Study|Patient Non-compliance|0|||
160874119|NCT01088048|580932679|FG000|Overall Study|Disease Progression|7|||
160874120|NCT01088048|580932680|FG001|Overall Study|Disease Progression|4|||
160874121|NCT01088048|580932681|FG002|Overall Study|Disease Progression|3|||
160874122|NCT01088048|580932682|FG003|Overall Study|Disease Progression|5|||
160874123|NCT01088048|580932683|FG004|Overall Study|Disease Progression|3|||
160766651|NCT03451045|580536206|FG002|Overall Study|Withdrawal by Subject|5|||
160766652|NCT03451045|580536204|FG000|Overall Study|Pregnancy|0|||
160766653|NCT03451045|580536205|FG001|Overall Study|Pregnancy|0|||
160766654|NCT03451045|580536206|FG002|Overall Study|Pregnancy|2|||
160766655|NCT03451045|580536204|FG000|Overall Study|Adverse Event|7|||
160766656|NCT03451045|580536205|FG001|Overall Study|Adverse Event|1|||
160766657|NCT03451045|580536206|FG002|Overall Study|Adverse Event|3|||
160766658|NCT03451045|580536204|FG000|Overall Study|Non-compliance with study|2|||
160766659|NCT03451045|580536205|FG001|Overall Study|Non-compliance with study|0|||
160766660|NCT03451045|580536206|FG002|Overall Study|Non-compliance with study|1|||
160766661|NCT03451045|580536204|FG000|Overall Study|any other reason|10|||
160766662|NCT03451045|580536205|FG001|Overall Study|any other reason|2|||
160766663|NCT03451045|580536206|FG002|Overall Study|any other reason|13|||
160766664|NCT00863707|580536207|FG000|Overall Study|Randomized, but drug not received|4|||
160766665|NCT00863707|580536208|FG001|Overall Study|Randomized, but drug not received|3|||
160766666|NCT01142336|580536209|FG000|Overall Study|Adverse Event|1|||
160766667|NCT01142336|580536210|FG001|Overall Study|Adverse Event|1|||
160766668|NCT01142336|580536209|FG000|Overall Study|Lost to Follow-up|0|||
160766669|NCT01142336|580536210|FG001|Overall Study|Lost to Follow-up|1|||
160766670|NCT00830128|580536211|FG000|Overall Study|Adverse Event|5|||
160766671|NCT00830128|580536211|FG000|Overall Study|Lack of Efficacy|7|||
160766672|NCT00830128|580536211|FG000|Overall Study|Protocol Violation|1|||
160766673|NCT00830128|580536211|FG000|Overall Study|Withdrawal by Subject|2|||
160766674|NCT00830128|580536211|FG000|Overall Study|Family obligation|1|||
160766675|NCT00830128|580536211|FG000|Overall Study|Relocation|1|||
160766676|NCT00830128|580536211|FG000|Overall Study|Work obligation|1|||
160766677|NCT00830128|580536211|FG000|Overall Study|Operating a vehicle|1|||
160766678|NCT03040726|580536212|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
160766679|NCT03040726|580536213|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
160766680|NCT03040726|580536212|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
160766681|NCT03040726|580536213|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
160766682|NCT03040726|580536212|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
160766683|NCT03040726|580536213|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
160766684|NCT03040726|580536212|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
160766685|NCT03040726|580536213|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
160766686|NCT03040726|580536212|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
160766687|NCT03040726|580536213|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
160636458|NCT03747939|580051551|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
160636459|NCT03747939|580051552|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
160636460|NCT03747939|580051553|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
160636461|NCT03747939|580051554|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
160636462|NCT03747939|580051551|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
160636463|NCT03747939|580051552|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
160636464|NCT03747939|580051553|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
160636465|NCT03747939|580051554|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
160636466|NCT03747939|580051551|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
160636467|NCT03747939|580051552|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
160636468|NCT03747939|580051553|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
160636469|NCT03747939|580051554|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
160636470|NCT03747939|580051551|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
160636471|NCT03747939|580051552|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
160636472|NCT03747939|580051553|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
160636473|NCT03747939|580051554|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
160636474|NCT03747939|580051551|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
160636475|NCT03747939|580051552|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
160636476|NCT03747939|580051553|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
160636477|NCT03747939|580051554|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
160636478|NCT03747939|580051551|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
160636479|NCT03747939|580051552|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
160636480|NCT03747939|580051553|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
160636481|NCT03747939|580051554|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
160766688|NCT03025035|580536214|FG000|Overall Study|Death|2|||
160874124|NCT01088048|580932684|FG005|Overall Study|Disease Progression|3|||
160874125|NCT01088048|580932685|FG006|Overall Study|Disease Progression|2|||
160874126|NCT01088048|580932686|FG007|Overall Study|Disease Progression|1|||
160874127|NCT01088048|580932687|FG008|Overall Study|Disease Progression|0|||
160874128|NCT01088048|580932688|FG009|Overall Study|Disease Progression|0|||
160874129|NCT01088048|580932679|FG000|Overall Study|Death|1|||
160874130|NCT01088048|580932680|FG001|Overall Study|Death|5|||
160874131|NCT01088048|580932681|FG002|Overall Study|Death|3|||
160874132|NCT01088048|580932682|FG003|Overall Study|Death|3|||
160874133|NCT01088048|580932683|FG004|Overall Study|Death|1|||
160874134|NCT01088048|580932684|FG005|Overall Study|Death|3|||
160874135|NCT01088048|580932685|FG006|Overall Study|Death|0|||
160874136|NCT01088048|580932686|FG007|Overall Study|Death|0|||
160874137|NCT01088048|580932687|FG008|Overall Study|Death|3|||
160874138|NCT01088048|580932688|FG009|Overall Study|Death|1|||
160874139|NCT01088048|580932679|FG000|Overall Study|Other|3|||
160874140|NCT01088048|580932680|FG001|Overall Study|Other|5|||
160874141|NCT01088048|580932681|FG002|Overall Study|Other|0|||
160874142|NCT01088048|580932682|FG003|Overall Study|Other|0|||
160874143|NCT01088048|580932683|FG004|Overall Study|Other|2|||
160874144|NCT01088048|580932684|FG005|Overall Study|Other|0|||
160874145|NCT01088048|580932685|FG006|Overall Study|Other|0|||
160874146|NCT01088048|580932686|FG007|Overall Study|Other|2|||
160874147|NCT01088048|580932687|FG008|Overall Study|Other|0|||
160874148|NCT01088048|580932688|FG009|Overall Study|Other|0|||
160874149|NCT01343693|580932689|FG000|Overall Study|Lost to Follow-up|9|||
160874150|NCT00265148|580932690|FG000|Overall Study|Adverse Event|2|||
160874151|NCT00265148|580932691|FG001|Overall Study|Adverse Event|2|||
160874152|NCT00265148|580932690|FG000|Overall Study|Lack of Efficacy|0|||
160874153|NCT00265148|580932691|FG001|Overall Study|Lack of Efficacy|2|||
160874154|NCT00265148|580932690|FG000|Overall Study|Protocol Violation|3|||
160874155|NCT00265148|580932691|FG001|Overall Study|Protocol Violation|2|||
160874156|NCT00265148|580932690|FG000|Overall Study|Lost to Follow-up|0|||
160874157|NCT00265148|580932691|FG001|Overall Study|Lost to Follow-up|1|||
160874158|NCT00265148|580932690|FG000|Overall Study|Withdrawal by Subject|2|||
160874159|NCT00265148|580932691|FG001|Overall Study|Withdrawal by Subject|1|||
160874160|NCT00265148|580932690|FG000|Overall Study|Physician Decision|1|||
160874161|NCT00265148|580932691|FG001|Overall Study|Physician Decision|0|||
160874162|NCT00265148|580932690|FG000|Overall Study|Increasing frailty|0|||
160874163|NCT00265148|580932691|FG001|Overall Study|Increasing frailty|1|||
160874164|NCT00265148|580932690|FG000|Overall Study|Subject chose to change of the dose|1|||
160874165|NCT00265148|580932691|FG001|Overall Study|Subject chose to change of the dose|0|||
160874166|NCT03760731|580932697|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
160874167|NCT03760731|580932698|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
160874168|NCT03760731|580932697|FG000|Treatment|Attended less than 70% of sessions|10|||
160874169|NCT03760731|580932698|FG001|Treatment|Attended less than 70% of sessions|15|||
160874170|NCT01092546|580932699|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
160874171|NCT01970358|580932700|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
160874172|NCT01970358|580932700|FG000|Overall Study|Ineligible at time of second consent|4|||
160874173|NCT01667419|580932701|FG000|Overall Study|Reason Not Specified|1|||
160874174|NCT01667419|580932702|FG001|Overall Study|Reason Not Specified|0|||
160874175|NCT01667419|580932703|FG002|Overall Study|Reason Not Specified|0|||
160874176|NCT01667419|580932704|FG003|Overall Study|Reason Not Specified|0|||
160874177|NCT01667419|580932701|FG000|Overall Study|Withdrawal by Subject|16|||
160874178|NCT01667419|580932702|FG001|Overall Study|Withdrawal by Subject|8|||
160874179|NCT01667419|580932703|FG002|Overall Study|Withdrawal by Subject|9|||
160874180|NCT01667419|580932704|FG003|Overall Study|Withdrawal by Subject|8|||
160874181|NCT01667419|580932701|FG000|Overall Study|Non-compliance|0|||
160874182|NCT01667419|580932702|FG001|Overall Study|Non-compliance|0|||
160874183|NCT01667419|580932703|FG002|Overall Study|Non-compliance|0|||
160532334|NCT00823823|579678684|FG000|Overall Study|Lost to Follow-up|3|||
160874184|NCT01667419|580932704|FG003|Overall Study|Non-compliance|1|||
160532335|NCT00823823|579678685|FG001|Overall Study|Lost to Follow-up|1|||
160874185|NCT01667419|580932701|FG000|Overall Study|Protocol Violation|1|||
160532336|NCT00823823|579678684|FG000|Overall Study|Protocol Violation|5|||
160874186|NCT01667419|580932702|FG001|Overall Study|Protocol Violation|0|||
160874187|NCT01667419|580932703|FG002|Overall Study|Protocol Violation|0|||
160874188|NCT01667419|580932704|FG003|Overall Study|Protocol Violation|0|||
160874189|NCT01667419|580932701|FG000|Overall Study|Lost to Follow-up|7|||
160874190|NCT01667419|580932702|FG001|Overall Study|Lost to Follow-up|6|||
160874191|NCT01667419|580932703|FG002|Overall Study|Lost to Follow-up|2|||
160874192|NCT01667419|580932704|FG003|Overall Study|Lost to Follow-up|4|||
160766689|NCT03025035|580536214|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
160766690|NCT01218802|580536215|FG000|Overall Study|Lost to Follow-up|5|||
160766691|NCT01218802|580536216|FG001|Overall Study|Lost to Follow-up|6|||
160766692|NCT01218802|580536215|FG000|Overall Study|Withdrawal by Subject|3|||
160766693|NCT01218802|580536216|FG001|Overall Study|Withdrawal by Subject|10|||
160766694|NCT01218802|580536215|FG000|Overall Study|Adverse Event|0|||
160766695|NCT01218802|580536216|FG001|Overall Study|Adverse Event|2|||
160766696|NCT01218802|580536215|FG000|Overall Study|Incarcerated|2|||
160766697|NCT01218802|580536216|FG001|Overall Study|Incarcerated|0|||
160766698|NCT01123655|580536221|FG000|Overall Study|Medication for RA had to be changed|1|||
160766699|NCT01123655|580536222|FG001|Overall Study|Medication for RA had to be changed|0|||
160766700|NCT01123655|580536223|FG002|Overall Study|Medication for RA had to be changed|0|||
160766701|NCT01123655|580536221|FG000|Overall Study|new illness|0|||
160766702|NCT01123655|580536222|FG001|Overall Study|new illness|1|||
160766703|NCT01123655|580536223|FG002|Overall Study|new illness|0|||
160766704|NCT01123655|580536221|FG000|Overall Study|began prohibitive drug|0|||
160766705|NCT01123655|580536222|FG001|Overall Study|began prohibitive drug|0|||
160766706|NCT01123655|580536223|FG002|Overall Study|began prohibitive drug|1|||
160766707|NCT02121210|580536224|FG000|Overall Study|Adverse Event|5|||
160766708|NCT02121210|580536225|FG001|Overall Study|Adverse Event|7|||
160766709|NCT02121210|580536224|FG000|Overall Study|Lack of Efficacy|2|||
160766710|NCT02121210|580536225|FG001|Overall Study|Lack of Efficacy|0|||
160766711|NCT02121210|580536224|FG000|Overall Study|Other than specified above|0|||
160766712|NCT02121210|580536225|FG001|Overall Study|Other than specified above|2|||
160766713|NCT01981616|580536227|FG000|Overall Study|Adverse Event|0|||
160766714|NCT01981616|580536228|FG001|Overall Study|Adverse Event|1|||
160766715|NCT01981616|580536227|FG000|Overall Study|Protocol Violation|1|||
160766716|NCT01981616|580536228|FG001|Overall Study|Protocol Violation|0|||
160766717|NCT02404545|580536229|FG000|Overall Study|Sponsor Termination|6|||
160766718|NCT02404545|580536230|FG001|Overall Study|Sponsor Termination|6|||
160766719|NCT03641508|580536231|FG000|First Injection|Lost to Follow-up|2|||
160766720|NCT03641508|580536232|FG001|First Injection|Lost to Follow-up|0|||
160766721|NCT00094445|580536233|FG000|Overall Study|Withdrawal by Subject|3|||
160766722|NCT00094445|580536233|FG000|Overall Study|Lost to Follow-up|1|||
160766723|NCT00094445|580536233|FG000|Overall Study|Progressive Disease|2|||
160766724|NCT00855218|580536236|FG000|Overall Study|Adverse Event|43|||
160766725|NCT00855218|580536237|FG001|Overall Study|Adverse Event|27|||
160766726|NCT00855218|580536236|FG000|Overall Study|Withdrawal by Subject|10|||
160766727|NCT00855218|580536237|FG001|Overall Study|Withdrawal by Subject|6|||
160766728|NCT00855218|580536236|FG000|Overall Study|Physician Decision|18|||
160766729|NCT00855218|580536237|FG001|Overall Study|Physician Decision|11|||
160766730|NCT00855218|580536236|FG000|Overall Study|Lost to Follow-up|0|||
160766731|NCT00855218|580536237|FG001|Overall Study|Lost to Follow-up|1|||
160766732|NCT00855218|580536236|FG000|Overall Study|Protocol Violation|5|||
160766733|NCT00855218|580536237|FG001|Overall Study|Protocol Violation|9|||
160766734|NCT00855218|580536236|FG000|Overall Study|non-compliant with study drug|3|||
160766735|NCT00855218|580536237|FG001|Overall Study|non-compliant with study drug|1|||
160766736|NCT00855218|580536236|FG000|Overall Study|patient convenience|2|||
160766737|NCT00855218|580536237|FG001|Overall Study|patient convenience|0|||
160766738|NCT00855218|580536236|FG000|Overall Study|technical problems|2|||
160766739|NCT00855218|580536237|FG001|Overall Study|technical problems|1|||
160766740|NCT00855218|580536236|FG000|Overall Study|Still treated with study medication|0|||
160766741|NCT00855218|580536237|FG001|Overall Study|Still treated with study medication|1|||
160766742|NCT00855218|580536236|FG000|Overall Study|Untreatable disease progression|54|||
160766743|NCT00855218|580536237|FG001|Overall Study|Untreatable disease progression|67|||
160766744|NCT00855218|580536236|FG000|Overall Study|Second malignancy|0|||
160766745|NCT00855218|580536237|FG001|Overall Study|Second malignancy|1|||
160766746|NCT00855218|580536236|FG000|Overall Study|Progression measurement proven|7|||
160766747|NCT00855218|580536237|FG001|Overall Study|Progression measurement proven|15|||
160766748|NCT00855218|580536236|FG000|Overall Study|Clinical endpoint reached|10|||
160766749|NCT00855218|580536237|FG001|Overall Study|Clinical endpoint reached|13|||
160766750|NCT03824561|580536238|FG000|Overall Study|Protocol Violation|19|||
160766751|NCT01773928|580536239|FG000|Overall Study|Adverse Event|0|||
160766752|NCT01773928|580536240|FG001|Overall Study|Adverse Event|0|||
160766753|NCT01773928|580536241|FG002|Overall Study|Adverse Event|0|||
160766754|NCT01773928|580536242|FG003|Overall Study|Adverse Event|0|||
160766755|NCT01773928|580536243|FG004|Overall Study|Adverse Event|0|||
160766756|NCT01773928|580536244|FG005|Overall Study|Adverse Event|0|||
160766757|NCT01773928|580536245|FG006|Overall Study|Adverse Event|0|||
160766758|NCT01773928|580536246|FG007|Overall Study|Adverse Event|1|||
160766759|NCT01773928|580536247|FG008|Overall Study|Adverse Event|0|||
160766760|NCT01773928|580536239|FG000|Overall Study|Physician Decision|0|||
160766761|NCT01773928|580536240|FG001|Overall Study|Physician Decision|0|||
160766762|NCT01773928|580536241|FG002|Overall Study|Physician Decision|0|||
160766763|NCT01773928|580536242|FG003|Overall Study|Physician Decision|1|||
160766764|NCT01773928|580536243|FG004|Overall Study|Physician Decision|0|||
160766765|NCT01773928|580536244|FG005|Overall Study|Physician Decision|0|||
160766766|NCT01773928|580536245|FG006|Overall Study|Physician Decision|0|||
160766767|NCT01773928|580536246|FG007|Overall Study|Physician Decision|0|||
160766768|NCT01773928|580536247|FG008|Overall Study|Physician Decision|0|||
160766769|NCT01773928|580536239|FG000|Overall Study|Withdrawal by Subject|5|||
160766770|NCT01773928|580536240|FG001|Overall Study|Withdrawal by Subject|4|||
160766771|NCT01773928|580536241|FG002|Overall Study|Withdrawal by Subject|4|||
160766772|NCT01773928|580536242|FG003|Overall Study|Withdrawal by Subject|4|||
160766773|NCT01773928|580536243|FG004|Overall Study|Withdrawal by Subject|7|||
160766774|NCT01773928|580536244|FG005|Overall Study|Withdrawal by Subject|1|||
160766775|NCT01773928|580536245|FG006|Overall Study|Withdrawal by Subject|0|||
160766776|NCT01773928|580536246|FG007|Overall Study|Withdrawal by Subject|0|||
160766777|NCT01773928|580536247|FG008|Overall Study|Withdrawal by Subject|1|||
160766778|NCT01773928|580536239|FG000|Overall Study|Lost to Follow-up|0|||
160766779|NCT01773928|580536240|FG001|Overall Study|Lost to Follow-up|0|||
160766780|NCT01773928|580536241|FG002|Overall Study|Lost to Follow-up|0|||
160766781|NCT01773928|580536242|FG003|Overall Study|Lost to Follow-up|0|||
160766782|NCT01773928|580536243|FG004|Overall Study|Lost to Follow-up|0|||
160766783|NCT01773928|580536244|FG005|Overall Study|Lost to Follow-up|1|||
160766784|NCT01773928|580536245|FG006|Overall Study|Lost to Follow-up|0|||
160766785|NCT01773928|580536246|FG007|Overall Study|Lost to Follow-up|0|||
160766786|NCT01773928|580536247|FG008|Overall Study|Lost to Follow-up|0|||
160766787|NCT01773928|580536239|FG000|Overall Study|Subject misrepresented age|0|||
160766788|NCT01773928|580536240|FG001|Overall Study|Subject misrepresented age|1|||
160766789|NCT01773928|580536241|FG002|Overall Study|Subject misrepresented age|0|||
160766790|NCT01773928|580536242|FG003|Overall Study|Subject misrepresented age|0|||
160766791|NCT01773928|580536243|FG004|Overall Study|Subject misrepresented age|0|||
160766792|NCT01773928|580536244|FG005|Overall Study|Subject misrepresented age|0|||
160766793|NCT01773928|580536245|FG006|Overall Study|Subject misrepresented age|0|||
160766794|NCT01773928|580536246|FG007|Overall Study|Subject misrepresented age|0|||
160766795|NCT01773928|580536247|FG008|Overall Study|Subject misrepresented age|0|||
160766796|NCT01773928|580536239|FG000|Overall Study|Subject met exclusion criteria|0|||
160766797|NCT01773928|580536240|FG001|Overall Study|Subject met exclusion criteria|0|||
160766798|NCT01773928|580536241|FG002|Overall Study|Subject met exclusion criteria|0|||
160766799|NCT01773928|580536242|FG003|Overall Study|Subject met exclusion criteria|0|||
160766800|NCT01773928|580536243|FG004|Overall Study|Subject met exclusion criteria|0|||
160766801|NCT01773928|580536244|FG005|Overall Study|Subject met exclusion criteria|0|||
160766802|NCT01773928|580536245|FG006|Overall Study|Subject met exclusion criteria|0|||
160766803|NCT01773928|580536246|FG007|Overall Study|Subject met exclusion criteria|0|||
160766804|NCT01773928|580536247|FG008|Overall Study|Subject met exclusion criteria|1|||
160766805|NCT01773928|580536239|FG000|Overall Study|Randomized, had to leave, never returned|0|||
160766806|NCT01773928|580536240|FG001|Overall Study|Randomized, had to leave, never returned|0|||
160766807|NCT01773928|580536241|FG002|Overall Study|Randomized, had to leave, never returned|0|||
160766808|NCT01773928|580536242|FG003|Overall Study|Randomized, had to leave, never returned|1|||
160766809|NCT01773928|580536243|FG004|Overall Study|Randomized, had to leave, never returned|0|||
160766810|NCT01773928|580536244|FG005|Overall Study|Randomized, had to leave, never returned|0|||
160766811|NCT01773928|580536245|FG006|Overall Study|Randomized, had to leave, never returned|0|||
160766812|NCT01773928|580536246|FG007|Overall Study|Randomized, had to leave, never returned|0|||
160766813|NCT01773928|580536247|FG008|Overall Study|Randomized, had to leave, never returned|0|||
160766814|NCT01773928|580536239|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
160766815|NCT01773928|580536240|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
160766816|NCT01773928|580536241|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
160766817|NCT01773928|580536242|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
160766818|NCT01773928|580536243|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
160766819|NCT01773928|580536244|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
160766820|NCT01773928|580536245|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
160766821|NCT01773928|580536246|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
160766822|NCT01773928|580536247|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
160766823|NCT03882918|580536249|FG000|Overall Study|Study terminated by sponsor|98|||
160766824|NCT03882918|580536249|FG000|Overall Study|Protocol Violation|1|||
160766825|NCT03882918|580536249|FG000|Overall Study|Other|9|||
160766826|NCT03882918|580536249|FG000|Overall Study|Lack of Efficacy|14|||
160766827|NCT03882918|580536249|FG000|Overall Study|Adverse Event|13|||
160766828|NCT03882918|580536249|FG000|Overall Study|Withdrawal by Subject|5|||
160766829|NCT06996301|580536250|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
160766830|NCT06996301|580536251|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
160874193|NCT01667419|580932701|FG000|Overall Study|Death|18|||
160766831|NCT06996301|580536250|FG000|Overall Study|Patients with discordant diagnostic results|107|||
160766832|NCT06996301|580536251|FG001|Overall Study|Patients with discordant diagnostic results|90|||
160766833|NCT06996301|580536250|FG000|Overall Study|Lost to Follow-up|31|||
160766834|NCT06996301|580536251|FG001|Overall Study|Lost to Follow-up|56|||
160766835|NCT06996301|580536250|FG000|Overall Study|Withdrawal by Subject|12|||
160766836|NCT06996301|580536251|FG001|Overall Study|Withdrawal by Subject|7|||
160766837|NCT04030598|580536252|FG000|Overall Study|Voluntary Withdrawal|0|||
160766838|NCT04030598|580536253|FG001|Overall Study|Voluntary Withdrawal|1|||
160766839|NCT04030598|580536254|FG002|Overall Study|Voluntary Withdrawal|0|||
160766840|NCT05117060|580536257|FG000|Overall Study|Adverse Event|3|||
160766841|NCT05117060|580536258|FG001|Overall Study|Adverse Event|5|||
160766842|NCT05117060|580536259|FG002|Overall Study|Adverse Event|6|||
160766843|NCT05117060|580536260|FG003|Overall Study|Adverse Event|1|||
160766844|NCT05117060|580536257|FG000|Overall Study|Lost to Follow-up|0|||
160766845|NCT05117060|580536258|FG001|Overall Study|Lost to Follow-up|0|||
160766846|NCT05117060|580536259|FG002|Overall Study|Lost to Follow-up|0|||
160766847|NCT05117060|580536260|FG003|Overall Study|Lost to Follow-up|1|||
160766848|NCT05117060|580536257|FG000|Overall Study|Lack of Efficacy|4|||
160766849|NCT05117060|580536258|FG001|Overall Study|Lack of Efficacy|5|||
160766850|NCT05117060|580536259|FG002|Overall Study|Lack of Efficacy|2|||
160766851|NCT05117060|580536260|FG003|Overall Study|Lack of Efficacy|6|||
160766852|NCT05117060|580536257|FG000|Overall Study|Withdrawal by Subject|8|||
160766853|NCT05117060|580536258|FG001|Overall Study|Withdrawal by Subject|5|||
160766854|NCT05117060|580536259|FG002|Overall Study|Withdrawal by Subject|5|||
160766855|NCT05117060|580536260|FG003|Overall Study|Withdrawal by Subject|6|||
160766856|NCT05117060|580536257|FG000|Overall Study|Other|2|||
160766857|NCT05117060|580536258|FG001|Overall Study|Other|1|||
160766858|NCT05117060|580536259|FG002|Overall Study|Other|3|||
160766859|NCT05117060|580536260|FG003|Overall Study|Other|1|||
160766860|NCT03141359|580536261|FG000|Overall Study|Death|32|||
160766861|NCT03141359|580536261|FG000|Overall Study|Still On Study (in follow up)|29|||
160766862|NCT05079321|580536262|FG000|Overall Study|Withdrawal by Subject|2|||
160766863|NCT05079321|580536263|FG001|Overall Study|Withdrawal by Subject|2|||
160766864|NCT05079321|580536262|FG000|Overall Study|Lost to Follow-up|0|||
160766865|NCT05079321|580536263|FG001|Overall Study|Lost to Follow-up|1|||
160766866|NCT01081626|580536264|FG000|Overall Study|Dosing error|1|||
160766867|NCT01081626|580536265|FG001|Overall Study|Dosing error|1|||
160766868|NCT01081626|580536264|FG000|Overall Study|Missing Estradiol|25|||
160766869|NCT01081626|580536265|FG001|Overall Study|Missing Estradiol|28|||
160766870|NCT01081626|580536264|FG000|Overall Study|Low antral follicle count|1|||
160766871|NCT01081626|580536265|FG001|Overall Study|Low antral follicle count|0|||
160766872|NCT01081626|580536264|FG000|Overall Study|Overstimulation|0|||
160766873|NCT01081626|580536265|FG001|Overall Study|Overstimulation|1|||
160766874|NCT01081626|580536264|FG000|Overall Study|Lost to Follow-up|0|||
160766875|NCT01081626|580536265|FG001|Overall Study|Lost to Follow-up|1|||
160766876|NCT01081626|580536264|FG000|Overall Study|Other|33|||
160766877|NCT01081626|580536265|FG001|Overall Study|Other|30|||
160766878|NCT02003144|580536266|FG000|Open Label Maintenance Phase|Other than specified|2|||
160766879|NCT02003144|580536267|FG001|Open Label Maintenance Phase|Other than specified|4|||
160766880|NCT02003144|580536266|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
160766881|NCT02003144|580536267|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
160766882|NCT02003144|580536266|FG000|Open Label Maintenance Phase|Pregnancy|0|||
160766883|NCT02003144|580536267|FG001|Open Label Maintenance Phase|Pregnancy|2|||
160766884|NCT02003144|580536266|FG000|Open Label Maintenance Phase|Physician Decision|1|||
160766885|NCT02003144|580536267|FG001|Open Label Maintenance Phase|Physician Decision|1|||
160766886|NCT02003144|580536266|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
160766887|NCT02003144|580536267|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
160766888|NCT02003144|580536266|FG000|Open Label Maintenance Phase|Adverse Event|2|||
160766889|NCT02003144|580536267|FG001|Open Label Maintenance Phase|Adverse Event|1|||
160766890|NCT05965752|580536271|FG000|Overall Study|Adverse Event|0|||
160766891|NCT05965752|580536272|FG001|Overall Study|Adverse Event|1|||
160766892|NCT05965752|580536273|FG002|Overall Study|Adverse Event|0|||
160766893|NCT05965752|580536274|FG003|Overall Study|Adverse Event|1|||
160766894|NCT05965752|580536275|FG004|Overall Study|Adverse Event|3|||
160766895|NCT05965752|580536271|FG000|Overall Study|Lost to Follow-up|2|||
160766896|NCT05965752|580536272|FG001|Overall Study|Lost to Follow-up|0|||
160766897|NCT05965752|580536273|FG002|Overall Study|Lost to Follow-up|1|||
160766898|NCT05965752|580536274|FG003|Overall Study|Lost to Follow-up|1|||
160766899|NCT05965752|580536275|FG004|Overall Study|Lost to Follow-up|1|||
160766900|NCT05965752|580536271|FG000|Overall Study|Withdrawal by Subject|2|||
160766901|NCT05965752|580536272|FG001|Overall Study|Withdrawal by Subject|2|||
160766902|NCT05965752|580536273|FG002|Overall Study|Withdrawal by Subject|1|||
160766903|NCT05965752|580536274|FG003|Overall Study|Withdrawal by Subject|5|||
160766904|NCT05965752|580536275|FG004|Overall Study|Withdrawal by Subject|0|||
160766905|NCT05965752|580536271|FG000|Overall Study|Disease Relapse|1|||
160766906|NCT05965752|580536272|FG001|Overall Study|Disease Relapse|0|||
160766907|NCT05965752|580536273|FG002|Overall Study|Disease Relapse|1|||
160766908|NCT05965752|580536274|FG003|Overall Study|Disease Relapse|0|||
160874194|NCT01667419|580932702|FG001|Overall Study|Death|33|||
160874195|NCT01667419|580932703|FG002|Overall Study|Death|25|||
160874196|NCT01667419|580932704|FG003|Overall Study|Death|26|||
160874197|NCT03869216|580932706|FG000|Overall Study|prostate removed during the study|1|||
160874198|NCT03869216|580932707|FG001|Overall Study|prostate removed during the study|1|||
160874199|NCT03869216|580932706|FG000|Overall Study|Withdrawal by Subject|0|||
160874200|NCT03869216|580932707|FG001|Overall Study|Withdrawal by Subject|1|||
160874201|NCT03869216|580932706|FG000|Overall Study|Lost to Follow-up|3|||
160874202|NCT03869216|580932707|FG001|Overall Study|Lost to Follow-up|12|||
160874203|NCT03869216|580932706|FG000|Overall Study|Changed clinical site or moved out of city|5|||
160874204|NCT03869216|580932707|FG001|Overall Study|Changed clinical site or moved out of city|9|||
160874205|NCT03869216|580932706|FG000|Overall Study|No primary care appointment scheduled|10|||
160874206|NCT03869216|580932707|FG001|Overall Study|No primary care appointment scheduled|4|||
160874207|NCT03869216|580932706|FG000|Overall Study|Death|1|||
160874208|NCT03869216|580932707|FG001|Overall Study|Death|1|||
160874209|NCT03646123|580932708|FG000|Overall Study|Withdrawal by Subject|2|||
160874210|NCT03646123|580932709|FG001|Overall Study|Withdrawal by Subject|2|||
160874211|NCT03646123|580932710|FG002|Overall Study|Withdrawal by Subject|3|||
160874212|NCT03646123|580932708|FG000|Overall Study|Study termination by sponsor|0|||
160874213|NCT03646123|580932709|FG001|Overall Study|Study termination by sponsor|45|||
160874214|NCT03646123|580932710|FG002|Overall Study|Study termination by sponsor|139|||
160874215|NCT03646123|580932708|FG000|Overall Study|Lost to Follow-up|4|||
160874216|NCT03646123|580932709|FG001|Overall Study|Lost to Follow-up|10|||
160874217|NCT03646123|580932710|FG002|Overall Study|Lost to Follow-up|10|||
160874218|NCT03646123|580932708|FG000|Overall Study|Death|2|||
160874219|NCT03646123|580932709|FG001|Overall Study|Death|1|||
160874220|NCT03646123|580932710|FG002|Overall Study|Death|1|||
160874221|NCT03646123|580932708|FG000|Overall Study|Other|2|||
160874222|NCT03646123|580932709|FG001|Overall Study|Other|0|||
160874223|NCT03646123|580932710|FG002|Overall Study|Other|2|||
160874224|NCT01068600|580932711|FG000|Overall Study|Withdrawal by Subject|5|||
160874225|NCT01068600|580932712|FG001|Overall Study|Withdrawal by Subject|6|||
160874226|NCT01068600|580932711|FG000|Overall Study|Adverse Event|3|||
160874227|NCT01068600|580932712|FG001|Overall Study|Adverse Event|3|||
160874228|NCT01068600|580932711|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160874229|NCT01068600|580932712|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160874230|NCT01068600|580932711|FG000|Overall Study|Lost to Follow-up|1|||
160874231|NCT01068600|580932712|FG001|Overall Study|Lost to Follow-up|2|||
160874232|NCT01068600|580932711|FG000|Overall Study|Protocol deviation|1|||
160874233|NCT01068600|580932712|FG001|Overall Study|Protocol deviation|1|||
160532337|NCT00823823|579678685|FG001|Overall Study|Protocol Violation|5|||
160532338|NCT02234284|579678686|FG000|Overall Study|Death|4|||
160532339|NCT02234284|579678687|FG001|Overall Study|Death|2|||
160532340|NCT02234284|579678686|FG000|Overall Study|Withdrawal by Subject|1|||
160532341|NCT02234284|579678687|FG001|Overall Study|Withdrawal by Subject|0|||
160532342|NCT02234284|579678686|FG000|Overall Study|Lost to Follow-up|20|||
160532343|NCT02234284|579678687|FG001|Overall Study|Lost to Follow-up|7|||
160532344|NCT00536809|579678688|FG000|Phase II|Adverse Event|1|||
160532345|NCT00536809|579678688|FG000|Phase II|Referred for surgical resection|1|||
160532346|NCT00233363|579678691|FG000|Overall Study|Adverse Event|1|||
160532347|NCT00233363|579678692|FG001|Overall Study|Adverse Event|2|||
160532348|NCT00233363|579678691|FG000|Overall Study|Lack of Efficacy|0|||
160532349|NCT00233363|579678692|FG001|Overall Study|Lack of Efficacy|2|||
160532350|NCT00233363|579678691|FG000|Overall Study|Withdrawal by Subject|1|||
160532351|NCT00233363|579678692|FG001|Overall Study|Withdrawal by Subject|1|||
160532352|NCT00233363|579678691|FG000|Overall Study|Aggravation of complication|1|||
160532353|NCT00233363|579678692|FG001|Overall Study|Aggravation of complication|0|||
160532354|NCT01526551|579678696|FG000|Overall Study|Lack of returned parental consent form|424|||
160532355|NCT00874770|579678697|FG000|Overall Study|Lack of Efficacy|2|||
160532356|NCT00874770|579678698|FG001|Overall Study|Lack of Efficacy|0|||
160532357|NCT00874770|579678699|FG002|Overall Study|Lack of Efficacy|0|||
160532358|NCT00874770|579678700|FG003|Overall Study|Lack of Efficacy|2|||
160532359|NCT00874770|579678697|FG000|Overall Study|Adverse Event|1|||
160532360|NCT00874770|579678698|FG001|Overall Study|Adverse Event|1|||
160874234|NCT01068600|580932711|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160874235|NCT01068600|580932712|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
160874236|NCT01068600|580932711|FG000|Overall Study|Administrative problems|0|||
160874237|NCT01068600|580932712|FG001|Overall Study|Administrative problems|1|||
160532361|NCT00874770|579678699|FG002|Overall Study|Adverse Event|4|||
160532362|NCT00874770|579678700|FG003|Overall Study|Adverse Event|2|||
160532363|NCT00874770|579678697|FG000|Overall Study|Lost to Follow-up|1|||
160874238|NCT01519869|580932713|FG000|Overall Study|Lost to Follow-up|1|||
160874239|NCT04075734|580932714|FG000|Overall Study|Lost to Follow-up|1|||
160874240|NCT04075734|580932715|FG001|Overall Study|Lost to Follow-up|1|||
160532364|NCT00874770|579678698|FG001|Overall Study|Lost to Follow-up|0|||
160532365|NCT00874770|579678699|FG002|Overall Study|Lost to Follow-up|0|||
160874241|NCT04075734|580932716|FG002|Overall Study|Lost to Follow-up|0|||
160874242|NCT04075734|580932714|FG000|Overall Study|Withdrawal by Subject|3|||
160766909|NCT05965752|580536275|FG004|Overall Study|Disease Relapse|0|||
160766910|NCT05965752|580536271|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
160766911|NCT05965752|580536272|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
160766912|NCT05965752|580536273|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
160766913|NCT05965752|580536274|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
160766914|NCT05965752|580536275|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
160766915|NCT05965752|580536271|FG000|Overall Study|Unable to Return for Study Visits|0|||
160766916|NCT05965752|580536272|FG001|Overall Study|Unable to Return for Study Visits|1|||
160766917|NCT05965752|580536273|FG002|Overall Study|Unable to Return for Study Visits|0|||
160766918|NCT05965752|580536274|FG003|Overall Study|Unable to Return for Study Visits|3|||
160766919|NCT05965752|580536275|FG004|Overall Study|Unable to Return for Study Visits|1|||
160766920|NCT05965752|580536271|FG000|Overall Study|Early Termination|0|||
160766921|NCT05965752|580536272|FG001|Overall Study|Early Termination|0|||
160766922|NCT05965752|580536273|FG002|Overall Study|Early Termination|1|||
160766923|NCT05965752|580536274|FG003|Overall Study|Early Termination|0|||
160766924|NCT05965752|580536275|FG004|Overall Study|Early Termination|0|||
160766925|NCT05965752|580536271|FG000|Overall Study|Reported Unwanted Symptoms|0|||
160766926|NCT05965752|580536272|FG001|Overall Study|Reported Unwanted Symptoms|0|||
160766927|NCT05965752|580536273|FG002|Overall Study|Reported Unwanted Symptoms|0|||
160766928|NCT05965752|580536274|FG003|Overall Study|Reported Unwanted Symptoms|0|||
160766929|NCT05965752|580536275|FG004|Overall Study|Reported Unwanted Symptoms|1|||
160766930|NCT05965752|580536271|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
160766931|NCT05965752|580536272|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
160766932|NCT05965752|580536273|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
160766933|NCT05965752|580536274|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
160766934|NCT05965752|580536275|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
160766935|NCT02074514|580536277|FG000|Overall Study|Lack of Efficacy|3|||
160766936|NCT02074514|580536278|FG001|Overall Study|Lack of Efficacy|2|||
160766937|NCT02074514|580536277|FG000|Overall Study|Lost to Follow-up|0|||
160766938|NCT02074514|580536278|FG001|Overall Study|Lost to Follow-up|1|||
160766939|NCT02074514|580536277|FG000|Overall Study|Withdrew Consent|0|||
160766940|NCT02074514|580536278|FG001|Overall Study|Withdrew Consent|1|||
160766941|NCT00666237|580536281|FG000|Overall Study|Death|5|||
160766942|NCT00666237|580536282|FG001|Overall Study|Death|5|||
160766943|NCT00666237|580536281|FG000|Overall Study|Lost to Follow-up|29|||
160766944|NCT00666237|580536282|FG001|Overall Study|Lost to Follow-up|25|||
160766945|NCT02839707|580536284|FG000|Phase I|Not eligible for analysis|9|||
160766946|NCT02839707|580536285|FG001|Phase I|Not eligible for analysis|0|||
160766947|NCT02839707|580536286|FG002|Phase I|Not eligible for analysis|0|||
160766948|NCT02839707|580536284|FG000|Phase II|Not treated according to protocol|4|||
160766949|NCT02839707|580536285|FG001|Phase II|Not treated according to protocol|0|||
160766950|NCT02839707|580536286|FG002|Phase II|Not treated according to protocol|2|||
160766951|NCT02839707|580536284|FG000|Phase III|Not treated according to protocol|0|||
160766952|NCT02839707|580536285|FG001|Phase III|Not treated according to protocol|0|||
160766953|NCT02839707|580536286|FG002|Phase III|Not treated according to protocol|4|||
160766954|NCT03675308|580537657|FG000|Overall Study|Adverse Event|3|||
160766955|NCT03675308|580537658|FG001|Overall Study|Adverse Event|2|||
160766956|NCT03675308|580537657|FG000|Overall Study|Withdrawal by Subject|6|||
160766957|NCT03675308|580537658|FG001|Overall Study|Withdrawal by Subject|4|||
160766958|NCT03675308|580537657|FG000|Overall Study|Lost to Follow-up|3|||
160766959|NCT03675308|580537658|FG001|Overall Study|Lost to Follow-up|0|||
160766960|NCT03675308|580537657|FG000|Overall Study|Lack of Efficacy|1|||
160766961|NCT03675308|580537658|FG001|Overall Study|Lack of Efficacy|1|||
160766962|NCT03675308|580537657|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
160766963|NCT03675308|580537658|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
160766964|NCT03675308|580537657|FG000|Overall Study|Other|0|||
160766965|NCT03675308|580537658|FG001|Overall Study|Other|1|||
160766966|NCT05722522|580537659|FG000|Overall Study|Adverse Event|0|||
160766967|NCT05722522|580537660|FG001|Overall Study|Adverse Event|1|||
160766968|NCT06125964|580537663|FG000|Overall Study|Lost to Follow-up|0|||
160766969|NCT06125964|580537664|FG001|Overall Study|Lost to Follow-up|1|||
160766970|NCT06125964|580537665|FG002|Overall Study|Lost to Follow-up|0|||
160766971|NCT06125964|580537666|FG003|Overall Study|Lost to Follow-up|0|||
160766972|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
160766973|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
160766974|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
160766975|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|Death|1|||
160766976|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|Death|1|||
160766977|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|Death|0|||
160766978|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
160766979|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
160766980|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
160766981|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
160766982|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
160766983|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
160766984|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
160766985|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
160766986|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
160766987|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
160766988|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
160766989|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
160766990|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
160766991|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
160766992|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
160766993|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
160766994|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
160766995|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
160766996|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
160766997|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
160766998|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
160766999|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
160767000|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
160767001|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
160767002|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|Other|10|||
160767003|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|Other|4|||
160767004|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|Other|0|||
160767005|NCT04006457|580537667|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
160767006|NCT04006457|580537668|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
160767007|NCT04006457|580537669|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
160767008|NCT04006457|580537667|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
160767009|NCT04006457|580537668|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
160767010|NCT04006457|580537669|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
160767011|NCT04006457|580537667|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
160767012|NCT04006457|580537668|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
160767013|NCT04006457|580537669|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
160767014|NCT04006457|580537667|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
160767015|NCT04006457|580537668|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
160767016|NCT04006457|580537669|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
160767017|NCT04006457|580537667|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
160767018|NCT04006457|580537668|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
160767019|NCT04006457|580537669|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
160767020|NCT04006457|580537667|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
160767021|NCT04006457|580537668|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
160767022|NCT04006457|580537669|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
160767023|NCT04006457|580537667|FG000|Main Study: Treatment Period 2|Other|2|||
160767024|NCT04006457|580537668|FG001|Main Study: Treatment Period 2|Other|3|||
160767025|NCT04006457|580537669|FG002|Main Study: Treatment Period 2|Other|0|||
160767026|NCT04006457|580537667|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
160767027|NCT04006457|580537668|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
160767028|NCT04006457|580537669|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
160767029|NCT04006457|580537667|FG000|Main Study: Treatment Period 2|Ongoing|86|||
160767030|NCT04006457|580537668|FG001|Main Study: Treatment Period 2|Ongoing|96|||
160767031|NCT04006457|580537669|FG002|Main Study: Treatment Period 2|Ongoing|0|||
160767032|NCT04006457|580537667|FG000|Main Study Observation Period|Adverse Event|1|||
160767033|NCT04006457|580537668|FG001|Main Study Observation Period|Adverse Event|1|||
160767034|NCT04006457|580537669|FG002|Main Study Observation Period|Adverse Event|0|||
160767035|NCT04006457|580537667|FG000|Main Study Observation Period|Lost to Follow-up|0|||
160767036|NCT04006457|580537668|FG001|Main Study Observation Period|Lost to Follow-up|1|||
160767037|NCT04006457|580537669|FG002|Main Study Observation Period|Lost to Follow-up|0|||
160767038|NCT04006457|580537667|FG000|Main Study Observation Period|Pregnancy|1|||
160767039|NCT04006457|580537668|FG001|Main Study Observation Period|Pregnancy|0|||
160767040|NCT04006457|580537669|FG002|Main Study Observation Period|Pregnancy|0|||
160767041|NCT04006457|580537667|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
160767042|NCT04006457|580537668|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
160767043|NCT04006457|580537669|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
160767044|NCT04006457|580537667|FG000|Main Study Observation Period|Other|8|||
160767045|NCT04006457|580537668|FG001|Main Study Observation Period|Other|16|||
160767046|NCT04006457|580537669|FG002|Main Study Observation Period|Other|0|||
160767047|NCT04006457|580537667|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
160767048|NCT04006457|580537668|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
160767049|NCT04006457|580537669|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
160767050|NCT04006457|580537667|FG000|Main Study Observation Period|Ongoing|2|||
160767051|NCT04006457|580537668|FG001|Main Study Observation Period|Ongoing|1|||
160767052|NCT04006457|580537669|FG002|Main Study Observation Period|Ongoing|0|||
160767053|NCT04006457|580537667|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
160767054|NCT04006457|580537668|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
160767055|NCT04006457|580537669|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
160767056|NCT03370172|580537670|FG000|Overall Study|Withdrawal by Subject|0|||
160767057|NCT03370172|580537671|FG001|Overall Study|Withdrawal by Subject|1|||
160767058|NCT05918055|580537672|FG000|Phase I - Dose Level 1|Ineligible|0|||
160767059|NCT05918055|580537673|FG001|Phase I - Dose Level 1|Ineligible|0|||
160767060|NCT05918055|580537674|FG002|Phase I - Dose Level 1|Ineligible|1|||
160767061|NCT05918055|580537672|FG000|Phase I - Dose Level -1|Physician Decision|1|||
160767062|NCT05918055|580537673|FG001|Phase I - Dose Level -1|Physician Decision|0|||
160767063|NCT05918055|580537674|FG002|Phase I - Dose Level -1|Physician Decision|0|||
160767064|NCT02194465|580537675|FG000|Overall Study|Adverse Event|6|||
160767065|NCT02194465|580537676|FG001|Overall Study|Adverse Event|1|||
160767066|NCT02194465|580537677|FG002|Overall Study|Adverse Event|4|||
160767067|NCT02194465|580537678|FG003|Overall Study|Adverse Event|4|||
160767068|NCT02194465|580537679|FG004|Overall Study|Adverse Event|4|||
160767069|NCT02194465|580537680|FG005|Overall Study|Adverse Event|2|||
160767070|NCT02194465|580537681|FG006|Overall Study|Adverse Event|0|||
160767071|NCT02194465|580537675|FG000|Overall Study|Lost to Follow-up|0|||
160767072|NCT02194465|580537676|FG001|Overall Study|Lost to Follow-up|0|||
160767073|NCT02194465|580537677|FG002|Overall Study|Lost to Follow-up|0|||
160767074|NCT02194465|580537678|FG003|Overall Study|Lost to Follow-up|1|||
160767075|NCT02194465|580537679|FG004|Overall Study|Lost to Follow-up|0|||
160767076|NCT02194465|580537680|FG005|Overall Study|Lost to Follow-up|1|||
160767077|NCT02194465|580537681|FG006|Overall Study|Lost to Follow-up|0|||
160767078|NCT02194465|580537675|FG000|Overall Study|Physician Decision|1|||
160767079|NCT02194465|580537676|FG001|Overall Study|Physician Decision|0|||
160767080|NCT02194465|580537677|FG002|Overall Study|Physician Decision|0|||
160767081|NCT02194465|580537678|FG003|Overall Study|Physician Decision|0|||
160767082|NCT02194465|580537679|FG004|Overall Study|Physician Decision|0|||
160767083|NCT02194465|580537680|FG005|Overall Study|Physician Decision|0|||
160767084|NCT02194465|580537681|FG006|Overall Study|Physician Decision|0|||
160767085|NCT02194465|580537675|FG000|Overall Study|Protocol Violation|1|||
160767086|NCT02194465|580537676|FG001|Overall Study|Protocol Violation|1|||
160767087|NCT02194465|580537677|FG002|Overall Study|Protocol Violation|2|||
160767088|NCT02194465|580537678|FG003|Overall Study|Protocol Violation|1|||
160767089|NCT02194465|580537679|FG004|Overall Study|Protocol Violation|1|||
160767090|NCT02194465|580537680|FG005|Overall Study|Protocol Violation|0|||
160767091|NCT02194465|580537681|FG006|Overall Study|Protocol Violation|0|||
160767092|NCT02194465|580537675|FG000|Overall Study|Withdrawal by Subject|1|||
160767093|NCT02194465|580537676|FG001|Overall Study|Withdrawal by Subject|3|||
160767094|NCT02194465|580537677|FG002|Overall Study|Withdrawal by Subject|1|||
160767095|NCT02194465|580537678|FG003|Overall Study|Withdrawal by Subject|2|||
160767096|NCT02194465|580537679|FG004|Overall Study|Withdrawal by Subject|2|||
160767097|NCT02194465|580537680|FG005|Overall Study|Withdrawal by Subject|1|||
160767098|NCT02194465|580537681|FG006|Overall Study|Withdrawal by Subject|2|||
160767099|NCT02194465|580537675|FG000|Overall Study|Discontinued follow-up period|0|||
160767100|NCT02194465|580537676|FG001|Overall Study|Discontinued follow-up period|2|||
160767101|NCT02194465|580537677|FG002|Overall Study|Discontinued follow-up period|1|||
160767102|NCT02194465|580537678|FG003|Overall Study|Discontinued follow-up period|0|||
160767103|NCT02194465|580537679|FG004|Overall Study|Discontinued follow-up period|2|||
160767104|NCT02194465|580537680|FG005|Overall Study|Discontinued follow-up period|0|||
160767105|NCT02194465|580537681|FG006|Overall Study|Discontinued follow-up period|0|||
160767106|NCT00420745|580537682|FG000|Overall Study|Adverse Event|2|||
160767107|NCT00420745|580537683|FG001|Overall Study|Adverse Event|2|||
160767108|NCT00420745|580537682|FG000|Overall Study|Lost to Follow-up|10|||
160767109|NCT00420745|580537683|FG001|Overall Study|Lost to Follow-up|2|||
160767110|NCT00420745|580537682|FG000|Overall Study|Protocol Violation|1|||
160767111|NCT00420745|580537683|FG001|Overall Study|Protocol Violation|0|||
160767112|NCT00420745|580537682|FG000|Overall Study|Physician Decision|1|||
160767113|NCT00420745|580537683|FG001|Overall Study|Physician Decision|1|||
160767114|NCT00420745|580537682|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
160767115|NCT00420745|580537683|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
160767116|NCT00420745|580537682|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
160767117|NCT00420745|580537683|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
160767118|NCT02058095|580537685|FG000|Overall Study|Adverse Event|1|||
160767119|NCT02058095|580537686|FG001|Overall Study|Adverse Event|0|||
160767120|NCT00726453|580537687|FG000|Primary Enrollment Group|Death|18|||
160767121|NCT00726453|580537688|FG001|Primary Enrollment Group|Death|0|||
160767122|NCT00726453|580537687|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
160767123|NCT00726453|580537688|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
160767124|NCT00726453|580537687|FG000|38 mm Length Group|Death|0|||
160767125|NCT00726453|580537688|FG001|38 mm Length Group|Death|3|||
160874243|NCT04075734|580932715|FG001|Overall Study|Withdrawal by Subject|0|||
160874244|NCT04075734|580932716|FG002|Overall Study|Withdrawal by Subject|0|||
160874245|NCT02433080|580932718|FG000|Overall Study|Lost to Follow-up|1|||
160874246|NCT02433080|580932719|FG001|Overall Study|Lost to Follow-up|2|||
160874247|NCT02433080|580932718|FG000|Overall Study|Withdrawal by Subject|0|||
160874248|NCT02433080|580932719|FG001|Overall Study|Withdrawal by Subject|2|||
160874249|NCT02367833|580932721|FG000|Overall Study|Withdrawal by Subject|1|||
160874250|NCT02367833|580932722|FG001|Overall Study|Withdrawal by Subject|1|||
160874251|NCT02367833|580932723|FG002|Overall Study|Withdrawal by Subject|0|||
160874252|NCT02167139|580932724|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
160874253|NCT02167139|580932725|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
160874254|NCT02167139|580932726|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
160874255|NCT02167139|580932727|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
160874256|NCT02167139|580932724|FG000|Randomised, Double-blind|Adverse Event|2|||
160874257|NCT02167139|580932725|FG001|Randomised, Double-blind|Adverse Event|9|||
160874258|NCT02167139|580932726|FG002|Randomised, Double-blind|Adverse Event|0|||
160874259|NCT02167139|580932727|FG003|Randomised, Double-blind|Adverse Event|0|||
160874260|NCT02167139|580932724|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
160874261|NCT02167139|580932725|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
160874262|NCT02167139|580932726|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
160874263|NCT02167139|580932727|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
160874264|NCT02167139|580932724|FG000|Randomised, Double-blind|Other|3|||
160874265|NCT02167139|580932725|FG001|Randomised, Double-blind|Other|0|||
160874266|NCT02167139|580932726|FG002|Randomised, Double-blind|Other|0|||
160874267|NCT02167139|580932727|FG003|Randomised, Double-blind|Other|0|||
160874268|NCT02167139|580932724|FG000|Transition-extension|Adverse Event|2|||
160874269|NCT02167139|580932725|FG001|Transition-extension|Adverse Event|0|||
160874270|NCT02167139|580932726|FG002|Transition-extension|Adverse Event|2|||
160874271|NCT02167139|580932727|FG003|Transition-extension|Adverse Event|3|||
160874272|NCT02167139|580932724|FG000|Transition-extension|Withdrawal by Subject|2|||
160874273|NCT02167139|580932725|FG001|Transition-extension|Withdrawal by Subject|0|||
160874274|NCT02167139|580932726|FG002|Transition-extension|Withdrawal by Subject|4|||
160874275|NCT02167139|580932727|FG003|Transition-extension|Withdrawal by Subject|1|||
160874276|NCT02167139|580932724|FG000|Transition-extension|Lack of Efficacy|0|||
160874277|NCT02167139|580932725|FG001|Transition-extension|Lack of Efficacy|0|||
160874278|NCT02167139|580932726|FG002|Transition-extension|Lack of Efficacy|1|||
160874279|NCT02167139|580932727|FG003|Transition-extension|Lack of Efficacy|1|||
160874280|NCT02167139|580932724|FG000|Transition-extension|Other|1|||
160874281|NCT02167139|580932725|FG001|Transition-extension|Other|0|||
160767126|NCT01588509|580537692|FG000|Overall Study|Lost to Follow-up|1|||
160767127|NCT01588509|580537693|FG001|Overall Study|Lost to Follow-up|0|||
160767128|NCT01983930|580537694|FG000|Overall Study|Withdrawal by Subject|9|||
160767129|NCT01983930|580537695|FG001|Overall Study|Withdrawal by Subject|8|||
160767130|NCT01983930|580537694|FG000|Overall Study|Adverse Event|0|||
160767131|NCT01983930|580537695|FG001|Overall Study|Adverse Event|1|||
160767132|NCT01454284|580537696|FG000|Overall Study|Adverse Event|20|||
160767133|NCT01454284|580537697|FG001|Overall Study|Adverse Event|7|||
160767134|NCT01454284|580537696|FG000|Overall Study|Death|0|||
160767135|NCT01454284|580537697|FG001|Overall Study|Death|3|||
160767136|NCT01454284|580537696|FG000|Overall Study|Lost to Follow-up|13|||
160767137|NCT01454284|580537697|FG001|Overall Study|Lost to Follow-up|8|||
160767138|NCT01454284|580537696|FG000|Overall Study|Protocol Violation|9|||
160767139|NCT01454284|580537697|FG001|Overall Study|Protocol Violation|6|||
160767140|NCT01454284|580537696|FG000|Overall Study|Withdrawal by Subject|58|||
160532366|NCT00874770|579678700|FG003|Overall Study|Lost to Follow-up|1|||
160532367|NCT00874770|579678697|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
160532368|NCT00874770|579678698|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
160532369|NCT00874770|579678699|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
160532370|NCT00874770|579678700|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
160532371|NCT00873366|579678701|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
160532372|NCT00873366|579678701|FG000|Overall Study|Off tamoxifen due to side effects|2|||
160532373|NCT00873366|579678701|FG000|Overall Study|Refused to continue DM-BT testing|3|||
160532374|NCT02092350|579678702|FG000|Overall Study|Adverse Event|0|||
160532375|NCT02092350|579678703|FG001|Overall Study|Adverse Event|3|||
160532376|NCT02092350|579678702|FG000|Overall Study|Death|2|||
160532377|NCT02092350|579678703|FG001|Overall Study|Death|5|||
160532378|NCT02092350|579678702|FG000|Overall Study|Lost to Follow-up|3|||
160532379|NCT02092350|579678703|FG001|Overall Study|Lost to Follow-up|1|||
160532380|NCT02092350|579678702|FG000|Overall Study|Protocol Violation|1|||
160532381|NCT02092350|579678703|FG001|Overall Study|Protocol Violation|0|||
160532382|NCT02092350|579678702|FG000|Overall Study|Physician Decision|1|||
160532383|NCT02092350|579678703|FG001|Overall Study|Physician Decision|1|||
160532384|NCT02092350|579678702|FG000|Overall Study|Screen Failure|1|||
160532385|NCT02092350|579678703|FG001|Overall Study|Screen Failure|0|||
160532386|NCT02092350|579678702|FG000|Overall Study|Withdrawal by Subject|2|||
160532387|NCT02092350|579678703|FG001|Overall Study|Withdrawal by Subject|2|||
160532388|NCT00646906|579678705|FG000|Crossover Period 1|Withdrawal by Subject|1|||
160532389|NCT00646906|579678706|FG001|Crossover Period 1|Withdrawal by Subject|0|||
160532390|NCT00646906|579678707|FG002|Crossover Period 1|Withdrawal by Subject|0|||
160532391|NCT00646906|579678708|FG003|Crossover Period 1|Withdrawal by Subject|0|||
160532392|NCT00646906|579678709|FG004|Crossover Period 1|Withdrawal by Subject|0|||
160532393|NCT00646906|579678710|FG005|Crossover Period 1|Withdrawal by Subject|1|||
160532394|NCT00646906|579678711|FG006|Crossover Period 1|Withdrawal by Subject|0|||
160532395|NCT00646906|579678705|FG000|Crossover Period 2|Withdrawal by Subject|0|||
160532396|NCT00646906|579678706|FG001|Crossover Period 2|Withdrawal by Subject|1|||
160532397|NCT00646906|579678707|FG002|Crossover Period 2|Withdrawal by Subject|2|||
160532398|NCT00646906|579678708|FG003|Crossover Period 2|Withdrawal by Subject|1|||
160532399|NCT00646906|579678709|FG004|Crossover Period 2|Withdrawal by Subject|0|||
160532400|NCT00646906|579678710|FG005|Crossover Period 2|Withdrawal by Subject|0|||
160532401|NCT00646906|579678711|FG006|Crossover Period 2|Withdrawal by Subject|0|||
160532402|NCT00646906|579678705|FG000|Crossover Period 2|Physician Decision|0|||
160532403|NCT00646906|579678706|FG001|Crossover Period 2|Physician Decision|0|||
160532404|NCT00646906|579678707|FG002|Crossover Period 2|Physician Decision|0|||
160532405|NCT00646906|579678708|FG003|Crossover Period 2|Physician Decision|0|||
160532406|NCT00646906|579678709|FG004|Crossover Period 2|Physician Decision|0|||
160532407|NCT00646906|579678710|FG005|Crossover Period 2|Physician Decision|0|||
160532408|NCT00646906|579678711|FG006|Crossover Period 2|Physician Decision|1|||
160532409|NCT00962390|579678721|FG000|Overall Study|Adverse Event|0|||
160532410|NCT00962390|579678722|FG001|Overall Study|Adverse Event|0|||
160532411|NCT00962390|579678723|FG002|Overall Study|Adverse Event|3|||
160532412|NCT00962390|579678724|FG003|Overall Study|Adverse Event|1|||
160532413|NCT00962390|579678721|FG000|Overall Study|Lost to Follow-up|2|||
160532414|NCT00962390|579678722|FG001|Overall Study|Lost to Follow-up|2|||
160532415|NCT00962390|579678723|FG002|Overall Study|Lost to Follow-up|0|||
160532416|NCT00962390|579678724|FG003|Overall Study|Lost to Follow-up|0|||
160532417|NCT00962390|579678721|FG000|Overall Study|Protocol Violation|1|||
160532418|NCT00962390|579678722|FG001|Overall Study|Protocol Violation|0|||
160532419|NCT00962390|579678723|FG002|Overall Study|Protocol Violation|0|||
160532420|NCT00962390|579678724|FG003|Overall Study|Protocol Violation|0|||
160532421|NCT00962390|579678721|FG000|Overall Study|Withdrawal by Subject|1|||
160532422|NCT00962390|579678722|FG001|Overall Study|Withdrawal by Subject|1|||
160532423|NCT00962390|579678723|FG002|Overall Study|Withdrawal by Subject|1|||
160532424|NCT00962390|579678724|FG003|Overall Study|Withdrawal by Subject|0|||
160532425|NCT02613884|579678727|FG000|Overall Study|Death|1|||
160532426|NCT02613884|579678727|FG000|Overall Study|Lost to Follow-up|1|||
160532427|NCT00433914|579678728|FG000|Overall Study|Withdrawal by Subject|0|||
160532428|NCT00433914|579678729|FG001|Overall Study|Withdrawal by Subject|2|||
160532429|NCT00433914|579678728|FG000|Overall Study|Lost to Follow-up|0|||
160532430|NCT00433914|579678729|FG001|Overall Study|Lost to Follow-up|1|||
160532431|NCT04534491|579678730|FG000|Overall Study|Not completed end-of-study interview|24|||
160532432|NCT04534491|579678730|FG000|Overall Study|Non-users|70|||
160532433|NCT04534491|579678730|FG000|Overall Study|Non-verifiable users|58|||
160532434|NCT00766090|579678733|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532435|NCT00766090|579678734|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532436|NCT00766090|579678735|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532437|NCT00766090|579678736|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532438|NCT00766090|579678737|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532439|NCT00766090|579678738|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532440|NCT00766090|579678739|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532441|NCT00766090|579678740|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532442|NCT00766090|579678741|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
160532443|NCT00766090|579678742|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532444|NCT00766090|579678743|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532445|NCT00766090|579678744|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160532446|NCT00766090|579678733|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
160532447|NCT00766090|579678734|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532448|NCT00766090|579678735|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532449|NCT00766090|579678736|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532450|NCT00766090|579678737|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532451|NCT00766090|579678738|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532452|NCT00766090|579678739|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532453|NCT00766090|579678740|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532454|NCT00766090|579678741|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532455|NCT00766090|579678742|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532456|NCT00766090|579678743|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532457|NCT00766090|579678744|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
160532458|NCT00766090|579678733|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
160532459|NCT00766090|579678734|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160532460|NCT00766090|579678735|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160532461|NCT00766090|579678736|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
160532462|NCT00766090|579678737|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160532463|NCT00766090|579678738|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160532464|NCT00766090|579678739|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160532465|NCT00766090|579678740|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160532466|NCT00766090|579678741|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160532467|NCT00766090|579678742|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160532468|NCT00766090|579678743|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160532469|NCT00766090|579678744|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160532470|NCT00766090|579678733|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532471|NCT00766090|579678734|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532472|NCT00766090|579678735|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
160532473|NCT00766090|579678736|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532474|NCT00766090|579678737|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532475|NCT00766090|579678738|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532476|NCT00766090|579678739|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532477|NCT00766090|579678740|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532478|NCT00766090|579678741|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532479|NCT00766090|579678742|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532480|NCT00766090|579678743|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532481|NCT00766090|579678744|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
160532482|NCT00766090|579678733|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532483|NCT00766090|579678734|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532484|NCT00766090|579678735|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532485|NCT00766090|579678736|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532486|NCT00766090|579678737|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
160532487|NCT00766090|579678738|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532488|NCT00766090|579678739|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532489|NCT00766090|579678740|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532490|NCT00766090|579678741|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532491|NCT00766090|579678742|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532492|NCT00766090|579678743|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532493|NCT00766090|579678744|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160532494|NCT00766090|579678733|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532495|NCT00766090|579678734|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532496|NCT00766090|579678735|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
160532497|NCT00766090|579678736|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532498|NCT00766090|579678737|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532499|NCT00766090|579678738|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532500|NCT00766090|579678739|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532501|NCT00766090|579678740|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532502|NCT00766090|579678741|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532503|NCT00766090|579678742|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532504|NCT00766090|579678743|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532505|NCT00766090|579678744|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
160532506|NCT00766090|579678733|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
160532507|NCT00766090|579678734|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
160532508|NCT00766090|579678735|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
160532509|NCT00766090|579678736|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
160532510|NCT00766090|579678737|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
160532511|NCT00766090|579678738|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
160532512|NCT00766090|579678739|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
160532513|NCT00766090|579678740|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
160874282|NCT02167139|580932726|FG002|Transition-extension|Other|1|||
160874283|NCT02167139|580932727|FG003|Transition-extension|Other|0|||
160874284|NCT02167139|580932724|FG000|Transition-extension|Lost to Follow-up|1|||
160874285|NCT02167139|580932725|FG001|Transition-extension|Lost to Follow-up|0|||
160874286|NCT02167139|580932726|FG002|Transition-extension|Lost to Follow-up|0|||
160874287|NCT02167139|580932727|FG003|Transition-extension|Lost to Follow-up|0|||
160874288|NCT00996333|580932728|FG000|Overall Study|Screen failure|1|||
160874289|NCT00996333|580932728|FG000|Overall Study|Withdrawal by Subject|1|||
160874290|NCT00996333|580932728|FG000|Overall Study|Death|4|||
160874291|NCT00996333|580932728|FG000|Overall Study|Adverse Event|1|||
160874292|NCT00996333|580932728|FG000|Overall Study|Physician Decision|1|||
160874293|NCT00996333|580932728|FG000|Overall Study|Other|5|||
160874294|NCT01015638|580932729|FG000|Overall Study|Withdrawal by Subject|1|||
160874295|NCT01015638|580932730|FG001|Overall Study|Withdrawal by Subject|0|||
160874296|NCT02164461|580932731|FG000|Overall Study|Adverse Event|0|||
160874297|NCT02164461|580932732|FG001|Overall Study|Adverse Event|0|||
160874298|NCT02164461|580932733|FG002|Overall Study|Adverse Event|1|||
160874299|NCT02164461|580932731|FG000|Overall Study|Disease Progression|1|||
160874300|NCT02164461|580932732|FG001|Overall Study|Disease Progression|3|||
160874301|NCT02164461|580932733|FG002|Overall Study|Disease Progression|4|||
160874302|NCT02164461|580932731|FG000|Overall Study|Withdrawal by Subject|0|||
160874303|NCT02164461|580932732|FG001|Overall Study|Withdrawal by Subject|3|||
160874304|NCT02164461|580932733|FG002|Overall Study|Withdrawal by Subject|0|||
160874305|NCT00324961|580932737|FG000|Overall Study|Adverse Event|5|||
160874306|NCT00324961|580932737|FG000|Overall Study|Consent Withdrawn|11|||
160874307|NCT00324961|580932737|FG000|Overall Study|Lost to Follow-up|22|||
160874308|NCT00324961|580932737|FG000|Overall Study|Protocol Violation|3|||
160874309|NCT00324961|580932737|FG000|Overall Study|Other|2|||
160874310|NCT00344487|580932738|FG000|Overall Study|immunologic failure|1|||
160874311|NCT04927364|580932741|FG000|Overall Study|Withdrawal by Subject|3|||
160874312|NCT04927364|580932741|FG000|Overall Study|Unable to complete preassessment MRI|1|||
160874313|NCT05188053|580932745|FG000|Overall Study|Lost to Follow-up|23|||
160874314|NCT05188053|580932746|FG001|Overall Study|Lost to Follow-up|30|||
160874315|NCT05188053|580932745|FG000|Overall Study|Protocol Violation|16|||
160874316|NCT05188053|580932746|FG001|Overall Study|Protocol Violation|16|||
160874317|NCT05188053|580932745|FG000|Overall Study|Physician Decision|3|||
160874318|NCT05188053|580932746|FG001|Overall Study|Physician Decision|0|||
160874319|NCT05188053|580932745|FG000|Overall Study|Withdrawal by Subject|0|||
160874320|NCT05188053|580932746|FG001|Overall Study|Withdrawal by Subject|1|||
160874321|NCT04198714|580932750|FG000|Overall Study|Physician Decision|0|||
160874322|NCT04198714|580932751|FG001|Overall Study|Physician Decision|1|||
160874323|NCT02355184|580932755|FG000|Overall Study|Lost to Follow-up|2|||
160874324|NCT02355184|580932755|FG000|Overall Study|Study Terminated|10|||
160874325|NCT01657461|580934166|FG000|Overall Study|Death|9|||
160874326|NCT01657461|580934167|FG001|Overall Study|Death|12|||
160874327|NCT01657461|580934166|FG000|Overall Study|Lost to Follow-up|0|||
160874328|NCT01657461|580934167|FG001|Overall Study|Lost to Follow-up|3|||
160874329|NCT01657461|580934166|FG000|Overall Study|Physician Decision|0|||
160874330|NCT01657461|580934167|FG001|Overall Study|Physician Decision|2|||
160874331|NCT01657461|580934166|FG000|Overall Study|Withdrawal by Subject|1|||
160874332|NCT01657461|580934167|FG001|Overall Study|Withdrawal by Subject|3|||
160874333|NCT01868542|580934168|FG000|Overall Study|Protocol Violation|0|||
160874334|NCT01868542|580934169|FG001|Overall Study|Protocol Violation|1|||
160874335|NCT01868542|580934168|FG000|Overall Study|Unclassified|0|||
160874336|NCT01868542|580934169|FG001|Overall Study|Unclassified|1|||
160874337|NCT03844945|580934170|FG000|Overall Study|Adverse Event|1|||
160874338|NCT03844945|580934171|FG001|Overall Study|Adverse Event|1|||
160874339|NCT03844945|580934172|FG002|Overall Study|Adverse Event|4|||
160874340|NCT03844945|580934173|FG003|Overall Study|Adverse Event|0|||
160874341|NCT03844945|580934170|FG000|Overall Study|Withdrawal by Subject|0|||
160874342|NCT03844945|580934171|FG001|Overall Study|Withdrawal by Subject|0|||
160874343|NCT03844945|580934172|FG002|Overall Study|Withdrawal by Subject|1|||
160874344|NCT03844945|580934173|FG003|Overall Study|Withdrawal by Subject|0|||
160874345|NCT03844945|580934170|FG000|Overall Study|Lack of Efficacy|0|||
160874346|NCT03844945|580934171|FG001|Overall Study|Lack of Efficacy|0|||
160874347|NCT03844945|580934172|FG002|Overall Study|Lack of Efficacy|0|||
160874348|NCT03844945|580934173|FG003|Overall Study|Lack of Efficacy|1|||
160874349|NCT03254459|580934175|FG000|Overall Study|Adverse Event|7|||
160874350|NCT03254459|580934176|FG001|Overall Study|Adverse Event|20|||
160874351|NCT03254459|580934175|FG000|Overall Study|Withdrawal by Subject Consent|3|||
160874352|NCT03254459|580934176|FG001|Overall Study|Withdrawal by Subject Consent|1|||
160874353|NCT03254459|580934175|FG000|Overall Study|Lost to Follow-up|0|||
160874354|NCT03254459|580934176|FG001|Overall Study|Lost to Follow-up|1|||
160874355|NCT03254459|580934175|FG000|Overall Study|Miscellaneous|0|||
160874356|NCT03254459|580934176|FG001|Overall Study|Miscellaneous|1|||
160874357|NCT01754727|580934177|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
160874358|NCT01904773|580934180|FG000|Screen|Screen failure|3|||
160874359|NCT01904773|580934181|FG001|Screen|Screen failure|0|||
160874360|NCT01904773|580934182|FG002|Screen|Screen failure|0|||
160874361|NCT01904773|580934183|FG003|Screen|Screen failure|0|||
160874362|NCT01904773|580934184|FG004|Screen|Screen failure|0|||
160874363|NCT01904773|580934185|FG005|Screen|Screen failure|0|||
160874364|NCT01904773|580934186|FG006|Screen|Screen failure|0|||
160874365|NCT01904773|580934187|FG007|Screen|Screen failure|0|||
160874366|NCT01904773|580934188|FG008|Screen|Screen failure|0|||
160874367|NCT01904773|580934180|FG000|Screen|Withdrawal by Subject|1|||
160874368|NCT01904773|580934181|FG001|Screen|Withdrawal by Subject|0|||
160874369|NCT01904773|580934182|FG002|Screen|Withdrawal by Subject|0|||
160874370|NCT01904773|580934183|FG003|Screen|Withdrawal by Subject|0|||
160874371|NCT01904773|580934184|FG004|Screen|Withdrawal by Subject|0|||
160874372|NCT01904773|580934185|FG005|Screen|Withdrawal by Subject|0|||
160874373|NCT01904773|580934186|FG006|Screen|Withdrawal by Subject|0|||
160874374|NCT01904773|580934187|FG007|Screen|Withdrawal by Subject|0|||
160874375|NCT01904773|580934188|FG008|Screen|Withdrawal by Subject|0|||
160874376|NCT01904773|580934180|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
160874377|NCT01904773|580934181|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874378|NCT01904773|580934182|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874379|NCT01904773|580934183|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160532514|NCT00766090|579678741|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
160532515|NCT00766090|579678742|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
160532516|NCT00766090|579678743|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
160532517|NCT00766090|579678744|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
160532518|NCT00766090|579678733|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532519|NCT00766090|579678734|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532520|NCT00766090|579678735|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532521|NCT00766090|579678736|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532522|NCT00766090|579678737|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532523|NCT00766090|579678738|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
160532524|NCT00766090|579678739|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532525|NCT00766090|579678740|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532526|NCT00766090|579678741|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532527|NCT00766090|579678742|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532528|NCT00766090|579678743|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532529|NCT00766090|579678744|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
160532530|NCT00766090|579678733|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
160532531|NCT00766090|579678734|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
160532532|NCT00766090|579678735|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
160532533|NCT00766090|579678736|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
160532534|NCT00766090|579678737|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
160532535|NCT00766090|579678738|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
160532536|NCT00766090|579678739|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
160532537|NCT00766090|579678740|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
160532538|NCT00766090|579678741|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
160532539|NCT00766090|579678742|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
160532540|NCT00766090|579678743|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
160532541|NCT00766090|579678744|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
160532542|NCT00766090|579678733|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532543|NCT00766090|579678734|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532544|NCT00766090|579678735|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532545|NCT00766090|579678736|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532546|NCT00766090|579678737|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
160532547|NCT00766090|579678738|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532548|NCT00766090|579678739|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532549|NCT00766090|579678740|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532550|NCT00766090|579678741|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532551|NCT00766090|579678742|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532552|NCT00766090|579678743|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532553|NCT00766090|579678744|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
160532554|NCT03024970|579678747|FG000|First Intervention|Adverse Event|1|||
160532555|NCT03024970|579678748|FG001|First Intervention|Adverse Event|0|||
160532556|NCT03024970|579678747|FG000|Second Intervention|Lost to Follow-up|1|||
160532557|NCT03024970|579678748|FG001|Second Intervention|Lost to Follow-up|0|||
160532558|NCT00131469|579678750|FG000|Overall Study|Withdrawal by Subject|3|||
160532559|NCT00131469|579678751|FG001|Overall Study|Withdrawal by Subject|4|||
160532560|NCT00131469|579678750|FG000|Overall Study|Protocol Violation|3|||
160532561|NCT00131469|579678751|FG001|Overall Study|Protocol Violation|1|||
160532562|NCT00131469|579678750|FG000|Overall Study|Death|0|||
160532563|NCT00131469|579678751|FG001|Overall Study|Death|1|||
160532564|NCT00131469|579678750|FG000|Overall Study|Lost to Follow-up|0|||
160532565|NCT00131469|579678751|FG001|Overall Study|Lost to Follow-up|1|||
160532566|NCT00131469|579678750|FG000|Overall Study|scan not analyzable|3|||
160532567|NCT00131469|579678751|FG001|Overall Study|scan not analyzable|6|||
160532568|NCT00574288|579678752|FG000|Overall Study|Adverse Event|2|||
160532569|NCT00574288|579678753|FG001|Overall Study|Adverse Event|0|||
160532570|NCT00574288|579678754|FG002|Overall Study|Adverse Event|0|||
160532571|NCT00574288|579678755|FG003|Overall Study|Adverse Event|0|||
160532572|NCT00574288|579678756|FG004|Overall Study|Adverse Event|1|||
160532573|NCT00574288|579678757|FG005|Overall Study|Adverse Event|0|||
160532574|NCT00574288|579678758|FG006|Overall Study|Adverse Event|0|||
160532575|NCT00574288|579678752|FG000|Overall Study|Death|0|||
160532576|NCT00574288|579678753|FG001|Overall Study|Death|0|||
160532577|NCT00574288|579678754|FG002|Overall Study|Death|0|||
160532578|NCT00574288|579678755|FG003|Overall Study|Death|0|||
160532579|NCT00574288|579678756|FG004|Overall Study|Death|0|||
160532580|NCT00574288|579678757|FG005|Overall Study|Death|25|||
160532581|NCT00574288|579678758|FG006|Overall Study|Death|21|||
160532582|NCT00574288|579678752|FG000|Overall Study|Lost to Follow-up|0|||
160532583|NCT00574288|579678753|FG001|Overall Study|Lost to Follow-up|0|||
160532584|NCT00574288|579678754|FG002|Overall Study|Lost to Follow-up|0|||
160532585|NCT00574288|579678755|FG003|Overall Study|Lost to Follow-up|0|||
160532586|NCT00574288|579678756|FG004|Overall Study|Lost to Follow-up|0|||
160767141|NCT01454284|580537697|FG001|Overall Study|Withdrawal by Subject|36|||
160532587|NCT00574288|579678757|FG005|Overall Study|Lost to Follow-up|1|||
160874380|NCT01904773|580934184|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874381|NCT01904773|580934185|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874382|NCT01904773|580934186|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874383|NCT01904773|580934187|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874384|NCT01904773|580934188|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874385|NCT01904773|580934180|FG000|First Intervention|Adverse Event|0|||
160874386|NCT01904773|580934181|FG001|First Intervention|Adverse Event|0|||
160874387|NCT01904773|580934182|FG002|First Intervention|Adverse Event|0|||
160874388|NCT01904773|580934183|FG003|First Intervention|Adverse Event|0|||
160874389|NCT01904773|580934184|FG004|First Intervention|Adverse Event|0|||
160874390|NCT01904773|580934185|FG005|First Intervention|Adverse Event|0|||
160874391|NCT01904773|580934186|FG006|First Intervention|Adverse Event|1|||
160874392|NCT01904773|580934187|FG007|First Intervention|Adverse Event|0|||
160874393|NCT01904773|580934188|FG008|First Intervention|Adverse Event|0|||
160874394|NCT01904773|580934180|FG000|Placebo Washout First Intervention|Condition worsened|0|||
160874395|NCT01904773|580934181|FG001|Placebo Washout First Intervention|Condition worsened|1|||
160874396|NCT01904773|580934182|FG002|Placebo Washout First Intervention|Condition worsened|0|||
160874397|NCT01904773|580934183|FG003|Placebo Washout First Intervention|Condition worsened|0|||
160874398|NCT01904773|580934184|FG004|Placebo Washout First Intervention|Condition worsened|0|||
160874399|NCT01904773|580934185|FG005|Placebo Washout First Intervention|Condition worsened|0|||
160532588|NCT00574288|579678758|FG006|Overall Study|Lost to Follow-up|2|||
160532589|NCT00574288|579678752|FG000|Overall Study|Study Terminated By Sponsor|0|||
160532590|NCT00574288|579678753|FG001|Overall Study|Study Terminated By Sponsor|0|||
160532591|NCT00574288|579678754|FG002|Overall Study|Study Terminated By Sponsor|0|||
160532592|NCT00574288|579678755|FG003|Overall Study|Study Terminated By Sponsor|0|||
160532593|NCT00574288|579678756|FG004|Overall Study|Study Terminated By Sponsor|0|||
160532594|NCT00574288|579678757|FG005|Overall Study|Study Terminated By Sponsor|0|||
160532595|NCT00574288|579678758|FG006|Overall Study|Study Terminated By Sponsor|5|||
160874400|NCT01904773|580934186|FG006|Placebo Washout First Intervention|Condition worsened|0|||
160532596|NCT00574288|579678752|FG000|Overall Study|Progressive Disease|17|||
160532597|NCT00574288|579678753|FG001|Overall Study|Progressive Disease|2|||
160874401|NCT01904773|580934187|FG007|Placebo Washout First Intervention|Condition worsened|0|||
160874402|NCT01904773|580934188|FG008|Placebo Washout First Intervention|Condition worsened|0|||
160532598|NCT00574288|579678754|FG002|Overall Study|Progressive Disease|3|||
160532599|NCT00574288|579678755|FG003|Overall Study|Progressive Disease|2|||
160532600|NCT00574288|579678756|FG004|Overall Study|Progressive Disease|1|||
160532601|NCT00574288|579678757|FG005|Overall Study|Progressive Disease|0|||
160532602|NCT00574288|579678758|FG006|Overall Study|Progressive Disease|0|||
160532603|NCT00574288|579678752|FG000|Overall Study|Other|1|||
160532604|NCT00574288|579678753|FG001|Overall Study|Other|1|||
160532605|NCT00574288|579678754|FG002|Overall Study|Other|0|||
160532606|NCT00574288|579678755|FG003|Overall Study|Other|0|||
160532607|NCT00574288|579678756|FG004|Overall Study|Other|0|||
160532608|NCT00574288|579678757|FG005|Overall Study|Other|0|||
160532609|NCT00574288|579678758|FG006|Overall Study|Other|0|||
160532610|NCT01106027|579678759|FG000|Overall Study|Lost graft early, discontinued|1|||
160532611|NCT00369785|579678761|FG000|Overall Study|Physician Decision|3|||
160532612|NCT00369785|579678762|FG001|Overall Study|Physician Decision|2|||
160532613|NCT00369785|579678761|FG000|Overall Study|Death|1|||
160532614|NCT00369785|579678762|FG001|Overall Study|Death|2|||
160532615|NCT00369785|579678761|FG000|Overall Study|Withdrawal by Subject|7|||
160532616|NCT00369785|579678762|FG001|Overall Study|Withdrawal by Subject|6|||
160532617|NCT00369785|579678761|FG000|Overall Study|Toxicity|6|||
160532618|NCT00369785|579678762|FG001|Overall Study|Toxicity|4|||
160532619|NCT00369785|579678761|FG000|Overall Study|Never started|0|||
160532620|NCT00369785|579678762|FG001|Overall Study|Never started|2|||
160532621|NCT00369785|579678761|FG000|Overall Study|Progression|4|||
160532622|NCT00369785|579678762|FG001|Overall Study|Progression|4|||
160532623|NCT00369785|579678761|FG000|Overall Study|Multiple reasons|6|||
160532624|NCT00369785|579678762|FG001|Overall Study|Multiple reasons|5|||
160532625|NCT00800683|579678763|FG000|Overall Study|Adverse Event|11|||
160532626|NCT00800683|579678764|FG001|Overall Study|Adverse Event|8|||
160532627|NCT00800683|579678763|FG000|Overall Study|Lost to Follow-up|3|||
160532628|NCT00800683|579678764|FG001|Overall Study|Lost to Follow-up|1|||
160532629|NCT00800683|579678763|FG000|Overall Study|Withdrawal by Subject|1|||
160532630|NCT00800683|579678764|FG001|Overall Study|Withdrawal by Subject|7|||
160532631|NCT00800683|579678763|FG000|Overall Study|Lack of Efficacy|1|||
160532632|NCT00800683|579678764|FG001|Overall Study|Lack of Efficacy|1|||
160532633|NCT00800683|579678763|FG000|Overall Study|Other|1|||
160532634|NCT00800683|579678764|FG001|Overall Study|Other|2|||
160532635|NCT02247960|579678766|FG000|Patient Consent and Randomization|Physician Decision|2|||
160532636|NCT02247960|579678767|FG001|Patient Consent and Randomization|Physician Decision|2|||
160532637|NCT02247960|579678766|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
160532638|NCT02247960|579678767|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
160532639|NCT02247960|579678766|FG000|Catheter Removed|Lost to Follow-up|7|||
160532640|NCT02247960|579678767|FG001|Catheter Removed|Lost to Follow-up|10|||
160532641|NCT00356889|579678768|FG000|Overall Study|Protocol Violation|2|||
160532642|NCT00356889|579678768|FG000|Overall Study|Adverse Event|1|||
160532643|NCT02678416|579678769|FG000|Part 1|Withdrawal by Subject|1|||
160532644|NCT02678416|579678769|FG000|Part 2|Adverse Event|2|||
160532645|NCT02678416|579678769|FG000|Part 2|Withdrawal by Subject|1|||
160532646|NCT01848353|579678770|FG000|Phase 1|Withdrawal by Subject|3|||
160532647|NCT01848353|579678771|FG001|Phase 1|Withdrawal by Subject|1|||
160532648|NCT01848353|579678772|FG002|Phase 1|Withdrawal by Subject|0|||
160532649|NCT01848353|579678773|FG003|Phase 1|Withdrawal by Subject|0|||
160532650|NCT01848353|579678770|FG000|Phase 2|Withdrawal by Subject|3|||
160532651|NCT01848353|579678771|FG001|Phase 2|Withdrawal by Subject|2|||
160532652|NCT01848353|579678772|FG002|Phase 2|Withdrawal by Subject|0|||
160532653|NCT01848353|579678773|FG003|Phase 2|Withdrawal by Subject|0|||
160532654|NCT01848353|579678770|FG000|Phase 3|Withdrawal by Subject|1|||
160532655|NCT01848353|579678771|FG001|Phase 3|Withdrawal by Subject|1|||
160532656|NCT01848353|579678772|FG002|Phase 3|Withdrawal by Subject|0|||
160532657|NCT01848353|579678773|FG003|Phase 3|Withdrawal by Subject|0|||
160532658|NCT02361944|579678783|FG000|Overall Study|surgery cancellation|0|||
160532659|NCT02361944|579678784|FG001|Overall Study|surgery cancellation|1|||
160532660|NCT03123250|579678785|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
160532661|NCT00773136|579678812|FG000|Overall Study|Physician Decision|2|||
160532662|NCT02003014|579678822|FG000|Overall Study|Case report forms uncollected|9|||
160532663|NCT02003014|579678822|FG000|Overall Study|Treatment started after contract period|1|||
160532664|NCT02003014|579678822|FG000|Overall Study|Patient did not visit the study site|5|||
160532665|NCT02003014|579678822|FG000|Overall Study|Investigator's transfer|4|||
160532666|NCT03007979|579678825|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
160532667|NCT03734016|579678826|FG000|Overall Study|Sponsor Ended Study|225|||
160532668|NCT03734016|579678827|FG001|Overall Study|Sponsor Ended Study|200|||
160532669|NCT03734016|579678826|FG000|Overall Study|Death|69|||
160532670|NCT03734016|579678827|FG001|Overall Study|Death|83|||
160532671|NCT03734016|579678826|FG000|Overall Study|Withdrawal by Subject|21|||
160532672|NCT03734016|579678827|FG001|Overall Study|Withdrawal by Subject|27|||
160532673|NCT03734016|579678826|FG000|Overall Study|Physician Decision|1|||
160532674|NCT03734016|579678827|FG001|Overall Study|Physician Decision|12|||
160532675|NCT03734016|579678826|FG000|Overall Study|Lost to Follow-up|6|||
160532676|NCT03734016|579678827|FG001|Overall Study|Lost to Follow-up|2|||
160532677|NCT03734016|579678826|FG000|Overall Study|Miscellaneous|5|||
160532678|NCT03734016|579678827|FG001|Overall Study|Miscellaneous|1|||
160532679|NCT01298518|579678830|FG000|Overall Study|Withdrawal by Subject|0|||
160532680|NCT01298518|579678831|FG001|Overall Study|Withdrawal by Subject|0|||
160532681|NCT01298518|579678832|FG002|Overall Study|Withdrawal by Subject|1|||
160532682|NCT02273726|579678833|FG000|Overall Study|Death|70|||
160532683|NCT02273726|579678834|FG001|Overall Study|Death|62|||
160532684|NCT02273726|579678833|FG000|Overall Study|Withdrawal by Subject|41|||
160532685|NCT02273726|579678834|FG001|Overall Study|Withdrawal by Subject|29|||
160532686|NCT02273726|579678833|FG000|Overall Study|Kidney transplant|31|||
160532687|NCT02273726|579678834|FG001|Overall Study|Kidney transplant|39|||
160532688|NCT02273726|579678833|FG000|Overall Study|Physician Decision|30|||
160532689|NCT02273726|579678834|FG001|Overall Study|Physician Decision|15|||
160532690|NCT02273726|579678833|FG000|Overall Study|Adverse Event|27|||
160532691|NCT02273726|579678834|FG001|Overall Study|Adverse Event|9|||
160532692|NCT02273726|579678833|FG000|Overall Study|Lost to Follow-up|6|||
160532693|NCT02273726|579678834|FG001|Overall Study|Lost to Follow-up|3|||
160532694|NCT02273726|579678833|FG000|Overall Study|Lack of Efficacy|6|||
160532695|NCT02273726|579678834|FG001|Overall Study|Lack of Efficacy|1|||
160532696|NCT02273726|579678833|FG000|Overall Study|Protocol Violation|4|||
160532697|NCT02273726|579678834|FG001|Overall Study|Protocol Violation|0|||
160532698|NCT02273726|579678833|FG000|Overall Study|Other than specified|28|||
160532699|NCT02273726|579678834|FG001|Overall Study|Other than specified|30|||
160532700|NCT01979835|579678835|FG000|Primary Outcome SA Measurment|failed insertion|18|||
160532701|NCT01979835|579678835|FG000|Follow-up|Lost to Follow-up|32|||
160532702|NCT03713034|579680496|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
160767142|NCT01454284|580537696|FG000|Overall Study|Physician Decision|16|||
160532703|NCT03713034|579680497|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
160532704|NCT02615470|579680498|FG000|Overall Study|Lost to Follow-up|21|||
160532705|NCT02615470|579680499|FG001|Overall Study|Lost to Follow-up|32|||
160532706|NCT02982590|579680503|FG000|Overall Study|Lost to Follow-up|0|||
160767143|NCT01454284|580537697|FG001|Overall Study|Physician Decision|11|||
160767144|NCT01454284|580537696|FG000|Overall Study|Sponsor Decision|0|||
160767145|NCT01454284|580537697|FG001|Overall Study|Sponsor Decision|2|||
160767146|NCT02842866|580537700|FG000|Overall Study|Serious Adverse Event|0|||
160767147|NCT02842866|580537701|FG001|Overall Study|Serious Adverse Event|1|||
160767148|NCT02842866|580537700|FG000|Overall Study|Protocol Violation|4|||
160767149|NCT02842866|580537701|FG001|Overall Study|Protocol Violation|2|||
160767150|NCT02842866|580537700|FG000|Overall Study|Lost to Follow-up|2|||
160767151|NCT02842866|580537701|FG001|Overall Study|Lost to Follow-up|0|||
160767152|NCT02842866|580537700|FG000|Overall Study|Withdrawal by Subject|1|||
160767153|NCT02842866|580537701|FG001|Overall Study|Withdrawal by Subject|0|||
160767154|NCT01432327|580537702|FG000|Posttest 3 Months|depression|3|||
160767155|NCT01432327|580537703|FG001|Posttest 3 Months|depression|0|||
160767156|NCT01432327|580537704|FG002|Posttest 3 Months|depression|0|||
160767157|NCT01432327|580537705|FG003|Posttest 3 Months|depression|0|||
160767158|NCT01432327|580537702|FG000|Posttest 3 Months|Lost to Follow-up|1|||
160767159|NCT01432327|580537703|FG001|Posttest 3 Months|Lost to Follow-up|0|||
160767160|NCT01432327|580537704|FG002|Posttest 3 Months|Lost to Follow-up|2|||
160767161|NCT01432327|580537705|FG003|Posttest 3 Months|Lost to Follow-up|1|||
160767162|NCT01432327|580537702|FG000|Posttest 3 Months|Allergic reaction|0|||
160767163|NCT01432327|580537703|FG001|Posttest 3 Months|Allergic reaction|2|||
160767164|NCT01432327|580537704|FG002|Posttest 3 Months|Allergic reaction|0|||
160767165|NCT01432327|580537705|FG003|Posttest 3 Months|Allergic reaction|0|||
160532707|NCT02982590|579680504|FG001|Overall Study|Lost to Follow-up|1|||
160532708|NCT02982590|579680503|FG000|Overall Study|Death|4|||
160532709|NCT02982590|579680504|FG001|Overall Study|Death|0|||
160532710|NCT02807480|579680509|FG000|Overall Study|Withdrawal by Subject|14|||
160532711|NCT02807480|579680510|FG001|Overall Study|Withdrawal by Subject|10|||
160532712|NCT02163187|579680511|FG000|Overall Study|Device removed|1|||
160532713|NCT02163187|579680512|FG001|Overall Study|Device removed|0|||
160532714|NCT02163187|579680511|FG000|Overall Study|Progressive disease|1|||
160532715|NCT02163187|579680512|FG001|Overall Study|Progressive disease|0|||
160532716|NCT02369848|579680513|FG000|Overall Study|Death|1|||
160532717|NCT02369848|579680513|FG000|Overall Study|Withdrawal by Subject|2|||
160532718|NCT02369848|579680513|FG000|Overall Study|Lost to Follow-up|1|||
160532719|NCT03281668|579680516|FG000|Overall Study|Physician Decision|1|||
160532720|NCT03281668|579680516|FG000|Overall Study|scheduling conflict, family circumstance|2|||
160532721|NCT03281668|579680516|FG000|Overall Study|Withdrawal by Subject|4|||
160532722|NCT03281668|579680516|FG000|Overall Study|Lost to Follow-up|1|||
160532723|NCT01858532|579680519|FG000|Overall Study|Adverse Event|58|||
160532724|NCT01858532|579680520|FG001|Overall Study|Adverse Event|50|||
160532725|NCT01858532|579680521|FG002|Overall Study|Adverse Event|23|||
160532726|NCT01858532|579680522|FG003|Overall Study|Adverse Event|28|||
160532727|NCT01858532|579680519|FG000|Overall Study|Withdrew consent|71|||
160532728|NCT01858532|579680520|FG001|Overall Study|Withdrew consent|93|||
160532729|NCT01858532|579680521|FG002|Overall Study|Withdrew consent|46|||
160532730|NCT01858532|579680522|FG003|Overall Study|Withdrew consent|27|||
160532731|NCT01858532|579680519|FG000|Overall Study|Lost to Follow-up|17|||
160532732|NCT01858532|579680520|FG001|Overall Study|Lost to Follow-up|26|||
160532733|NCT01858532|579680521|FG002|Overall Study|Lost to Follow-up|11|||
160532734|NCT01858532|579680522|FG003|Overall Study|Lost to Follow-up|14|||
160532735|NCT01858532|579680519|FG000|Overall Study|Deterioration of medical status|3|||
160532736|NCT01858532|579680520|FG001|Overall Study|Deterioration of medical status|4|||
160532737|NCT01858532|579680521|FG002|Overall Study|Deterioration of medical status|3|||
160532738|NCT01858532|579680522|FG003|Overall Study|Deterioration of medical status|7|||
160532739|NCT01858532|579680519|FG000|Overall Study|Investigator request|3|||
160532740|NCT01858532|579680520|FG001|Overall Study|Investigator request|4|||
160532741|NCT01858532|579680521|FG002|Overall Study|Investigator request|2|||
160532742|NCT01858532|579680522|FG003|Overall Study|Investigator request|6|||
160532743|NCT01858532|579680519|FG000|Overall Study|Other, not specified|29|||
160532744|NCT01858532|579680520|FG001|Overall Study|Other, not specified|15|||
160532745|NCT01858532|579680521|FG002|Overall Study|Other, not specified|13|||
160532746|NCT01858532|579680522|FG003|Overall Study|Other, not specified|11|||
160532747|NCT02081534|579680528|FG000|Overall Study|Adverse Event|5|||
160532748|NCT02081534|579680529|FG001|Overall Study|Adverse Event|4|||
160532749|NCT02081534|579680530|FG002|Overall Study|Adverse Event|3|||
160532750|NCT02081534|579680531|FG003|Overall Study|Adverse Event|10|||
160532751|NCT02081534|579680532|FG004|Overall Study|Adverse Event|2|||
160532752|NCT02081534|579680533|FG005|Overall Study|Adverse Event|8|||
160532753|NCT02081534|579680534|FG006|Overall Study|Adverse Event|2|||
160532754|NCT02081534|579680528|FG000|Overall Study|Withdrawal by Subject|0|||
160532755|NCT02081534|579680529|FG001|Overall Study|Withdrawal by Subject|1|||
160532756|NCT02081534|579680530|FG002|Overall Study|Withdrawal by Subject|1|||
160532757|NCT02081534|579680531|FG003|Overall Study|Withdrawal by Subject|1|||
160532758|NCT02081534|579680532|FG004|Overall Study|Withdrawal by Subject|1|||
160532759|NCT02081534|579680533|FG005|Overall Study|Withdrawal by Subject|0|||
160532760|NCT02081534|579680534|FG006|Overall Study|Withdrawal by Subject|1|||
160532761|NCT02081534|579680528|FG000|Overall Study|Protocol Violation|0|||
160532762|NCT02081534|579680529|FG001|Overall Study|Protocol Violation|3|||
160532763|NCT02081534|579680530|FG002|Overall Study|Protocol Violation|0|||
160532764|NCT02081534|579680531|FG003|Overall Study|Protocol Violation|0|||
160532765|NCT02081534|579680532|FG004|Overall Study|Protocol Violation|0|||
160532766|NCT02081534|579680533|FG005|Overall Study|Protocol Violation|0|||
160532767|NCT02081534|579680534|FG006|Overall Study|Protocol Violation|1|||
160532768|NCT02081534|579680528|FG000|Overall Study|Lost to Follow-up|0|||
160532769|NCT02081534|579680529|FG001|Overall Study|Lost to Follow-up|0|||
160532770|NCT02081534|579680530|FG002|Overall Study|Lost to Follow-up|0|||
160532771|NCT02081534|579680531|FG003|Overall Study|Lost to Follow-up|2|||
160532772|NCT02081534|579680532|FG004|Overall Study|Lost to Follow-up|1|||
160532773|NCT02081534|579680533|FG005|Overall Study|Lost to Follow-up|1|||
160532774|NCT02081534|579680534|FG006|Overall Study|Lost to Follow-up|0|||
160532775|NCT01848288|579680539|FG000|Overall Study|Death|1|||
160532776|NCT01848288|579680539|FG000|Overall Study|Protocol Violation|1|||
160532777|NCT01848288|579680539|FG000|Overall Study|Withdrawal by Subject|1|||
160532778|NCT01007032|579680541|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
160532779|NCT01007032|579680542|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
160532780|NCT01007032|579680543|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
160532781|NCT01007032|579680544|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
160532782|NCT01007032|579680541|FG000|Overall Study|Withdrawal by Subject|0|||
160532783|NCT01007032|579680542|FG001|Overall Study|Withdrawal by Subject|0|||
160532784|NCT01007032|579680543|FG002|Overall Study|Withdrawal by Subject|0|||
160532785|NCT01007032|579680544|FG003|Overall Study|Withdrawal by Subject|1|||
160532786|NCT01841749|579680545|FG000|Overall Study|Protocol Violation|1|||
160532787|NCT02285920|579680546|FG000|Overall Study|Kidney transplantation|2|||
160532788|NCT02285920|579680547|FG001|Overall Study|Kidney transplantation|2|||
160532789|NCT02285920|579680548|FG002|Overall Study|Kidney transplantation|2|||
160532790|NCT02285920|579680549|FG003|Overall Study|Kidney transplantation|0|||
160532791|NCT02285920|579680546|FG000|Overall Study|Change to peritoneal dialysis|0|||
160532792|NCT02285920|579680547|FG001|Overall Study|Change to peritoneal dialysis|0|||
160532793|NCT02285920|579680548|FG002|Overall Study|Change to peritoneal dialysis|1|||
160532794|NCT02285920|579680549|FG003|Overall Study|Change to peritoneal dialysis|0|||
160532795|NCT02285920|579680546|FG000|Overall Study|Transfer to non-participating unit|0|||
160532796|NCT02285920|579680547|FG001|Overall Study|Transfer to non-participating unit|1|||
160532797|NCT02285920|579680548|FG002|Overall Study|Transfer to non-participating unit|0|||
160532798|NCT02285920|579680549|FG003|Overall Study|Transfer to non-participating unit|0|||
160532799|NCT02285920|579680546|FG000|Overall Study|Dialysis discontinuation|0|||
160532800|NCT02285920|579680547|FG001|Overall Study|Dialysis discontinuation|1|||
160532801|NCT02285920|579680548|FG002|Overall Study|Dialysis discontinuation|0|||
160532802|NCT02285920|579680549|FG003|Overall Study|Dialysis discontinuation|0|||
160532803|NCT02285920|579680546|FG000|Overall Study|Death|2|||
160532804|NCT02285920|579680547|FG001|Overall Study|Death|0|||
160532805|NCT02285920|579680548|FG002|Overall Study|Death|2|||
160532806|NCT02285920|579680549|FG003|Overall Study|Death|1|||
160532807|NCT00677820|579680550|FG000|Overall Study|Lost to Follow-up|1|||
160532808|NCT00677820|579680551|FG001|Overall Study|Lost to Follow-up|0|||
160532809|NCT01480284|579680561|FG000|Overall Study|Withdrawal by Subject|2|||
160532810|NCT01480284|579680562|FG001|Overall Study|Withdrawal by Subject|0|||
160532811|NCT01480284|579680561|FG000|Overall Study|Adverse Event|1|||
160532812|NCT01480284|579680562|FG001|Overall Study|Adverse Event|0|||
160532813|NCT01480284|579680561|FG000|Overall Study|Study closed/terminated|3|||
160532814|NCT01480284|579680562|FG001|Overall Study|Study closed/terminated|0|||
160532815|NCT01480284|579680561|FG000|Overall Study|Lost to Follow-up|1|||
160532816|NCT01480284|579680562|FG001|Overall Study|Lost to Follow-up|0|||
160532817|NCT01480284|579680561|FG000|Overall Study|Physician Decision|1|||
160532818|NCT01480284|579680562|FG001|Overall Study|Physician Decision|0|||
160532819|NCT00066742|579680563|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
160532820|NCT00066742|579680563|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
160532821|NCT00066742|579680563|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
160532822|NCT00066742|579680563|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
160532823|NCT00066742|579680563|FG000|Induction Chemoradiotherapy|Ineligible|3|||
160532824|NCT00066742|579680563|FG000|Consolidation Chemotherapy|not protocol specified|1|||
160532825|NCT00066742|579680563|FG000|Consolidation Chemotherapy|Ineligible|2|||
160532826|NCT02357134|579680564|FG000|Overall Study|Lost to Follow-up|1|||
160532827|NCT02357134|579680565|FG001|Overall Study|Lost to Follow-up|0|||
160532828|NCT02357134|579680566|FG002|Overall Study|Lost to Follow-up|0|||
160532829|NCT02357134|579680567|FG003|Overall Study|Lost to Follow-up|0|||
160532830|NCT02716675|579680568|FG000|Overall Study|Death|2|||
160532831|NCT02716675|579680569|FG001|Overall Study|Death|3|||
160532832|NCT02716675|579680570|FG002|Overall Study|Death|0|||
160532833|NCT02716675|579680568|FG000|Overall Study|Physician Decision|2|||
160532834|NCT02716675|579680569|FG001|Overall Study|Physician Decision|1|||
160532835|NCT02716675|579680570|FG002|Overall Study|Physician Decision|1|||
160532836|NCT02716675|579680568|FG000|Overall Study|Lost to Follow-up|100|||
160532837|NCT02716675|579680569|FG001|Overall Study|Lost to Follow-up|87|||
160532838|NCT02716675|579680570|FG002|Overall Study|Lost to Follow-up|99|||
160532839|NCT02716675|579680568|FG000|Overall Study|Withdrawal by Subject|22|||
160532840|NCT02716675|579680569|FG001|Overall Study|Withdrawal by Subject|25|||
160874403|NCT01904773|580934180|FG000|Fifth Intervention|Adverse Event|0|||
160874404|NCT01904773|580934181|FG001|Fifth Intervention|Adverse Event|0|||
160874405|NCT01904773|580934182|FG002|Fifth Intervention|Adverse Event|0|||
160874406|NCT01904773|580934183|FG003|Fifth Intervention|Adverse Event|0|||
160532841|NCT02716675|579680570|FG002|Overall Study|Withdrawal by Subject|20|||
160532842|NCT02716675|579680568|FG000|Overall Study|Protocol Violation|0|||
160532843|NCT02716675|579680569|FG001|Overall Study|Protocol Violation|3|||
160532844|NCT02716675|579680570|FG002|Overall Study|Protocol Violation|1|||
160532845|NCT02716675|579680568|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
160532846|NCT02716675|579680569|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
160532847|NCT02716675|579680570|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
160532848|NCT02716675|579680568|FG000|Overall Study|Other|38|||
160532849|NCT02716675|579680569|FG001|Overall Study|Other|47|||
160532850|NCT02716675|579680570|FG002|Overall Study|Other|48|||
160532851|NCT03374995|579680575|FG000|Overall Study|Withdrawal by Subject|0|||
160532852|NCT03374995|579680576|FG001|Overall Study|Withdrawal by Subject|1|||
160532853|NCT01383096|579680579|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
160532854|NCT01383096|579680580|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
160532855|NCT01383096|579680581|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
160532856|NCT01383096|579680579|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
160532857|NCT01383096|579680580|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
160532858|NCT01383096|579680581|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
160532859|NCT01383096|579680579|FG000|Third Intervention (8 Days)|Elevated AST|0|||
160532860|NCT01383096|579680580|FG001|Third Intervention (8 Days)|Elevated AST|1|||
160532861|NCT01383096|579680581|FG002|Third Intervention (8 Days)|Elevated AST|0|||
160532862|NCT01383096|579680579|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
160532863|NCT01383096|579680580|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
160532864|NCT01383096|579680581|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
160532865|NCT01383096|579680579|FG000|Third Intervention (8 Days)|Adverse Event|1|||
160532866|NCT01383096|579680580|FG001|Third Intervention (8 Days)|Adverse Event|0|||
160532867|NCT01383096|579680581|FG002|Third Intervention (8 Days)|Adverse Event|0|||
160532868|NCT01383096|579680579|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
160532869|NCT01383096|579680580|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
160532870|NCT01383096|579680581|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
160532871|NCT01383096|579680579|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
160532872|NCT01383096|579680580|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
160532873|NCT01383096|579680581|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
160532874|NCT01383096|579680579|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
160532875|NCT01383096|579680580|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
160532876|NCT01383096|579680581|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
160532877|NCT01383096|579680579|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
160532878|NCT01383096|579680580|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
160532879|NCT01383096|579680581|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
160532880|NCT01383096|579680579|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
160532881|NCT01383096|579680580|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
160532882|NCT01383096|579680581|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
160532883|NCT01383096|579680579|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
160532884|NCT01383096|579680580|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
160532885|NCT01383096|579680581|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
160532886|NCT01211535|579680582|FG000|Overall Study|Adverse Event|0|||
160532887|NCT01211535|579680583|FG001|Overall Study|Adverse Event|1|||
160532888|NCT03593850|579680589|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
160532889|NCT03593850|579680590|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
160532890|NCT00003895|579680591|FG000|Overall Study|Adverse Event|4|||
160532891|NCT00003895|579680592|FG001|Overall Study|Adverse Event|0|||
160532892|NCT00003895|579680591|FG000|Overall Study|Lack of Efficacy|1|||
160532893|NCT00003895|579680592|FG001|Overall Study|Lack of Efficacy|1|||
160532894|NCT00003895|579680591|FG000|Overall Study|Patient Vacation|2|||
160532895|NCT00003895|579680592|FG001|Overall Study|Patient Vacation|0|||
160532896|NCT00003895|579680591|FG000|Overall Study|Withdrawal by Subject|0|||
160532897|NCT00003895|579680592|FG001|Overall Study|Withdrawal by Subject|3|||
160532898|NCT01380730|579680593|FG000|Overall Study|Death|0|||
160532899|NCT01380730|579680594|FG001|Overall Study|Death|0|||
160532900|NCT01380730|579680595|FG002|Overall Study|Death|0|||
160532901|NCT01380730|579680596|FG003|Overall Study|Death|0|||
160532902|NCT01380730|579680597|FG004|Overall Study|Death|1|||
160532903|NCT01380730|579680598|FG005|Overall Study|Death|0|||
160532904|NCT01380730|579680599|FG006|Overall Study|Death|0|||
160532905|NCT01380730|579680600|FG007|Overall Study|Death|0|||
160532906|NCT02490475|579680601|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
160532907|NCT02490475|579680602|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
160532908|NCT02490475|579680603|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
160532909|NCT02490475|579680604|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
160532910|NCT02490475|579680601|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
160532911|NCT02490475|579680602|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
160532912|NCT02490475|579680603|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
160532913|NCT02490475|579680604|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
160532914|NCT02490475|579680601|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
160532915|NCT02490475|579680602|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
160532916|NCT02490475|579680603|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
160532917|NCT02490475|579680604|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
160532918|NCT02490475|579680601|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
160532919|NCT02490475|579680602|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
160532920|NCT02490475|579680603|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
160532921|NCT02490475|579680604|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
160532922|NCT02490475|579680601|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
160532923|NCT02490475|579680602|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
160532924|NCT02490475|579680603|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
160532925|NCT02490475|579680604|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
160532926|NCT02490475|579680601|FG000|Period 2: Extension Phase|Refused Treatment|0|||
160532927|NCT02490475|579680602|FG001|Period 2: Extension Phase|Refused Treatment|0|||
160532928|NCT02490475|579680603|FG002|Period 2: Extension Phase|Refused Treatment|0|||
160532929|NCT02490475|579680604|FG003|Period 2: Extension Phase|Refused Treatment|1|||
160532930|NCT02490475|579680601|FG000|Period 2: Extension Phase|Adverse Event|0|||
160532931|NCT02490475|579680602|FG001|Period 2: Extension Phase|Adverse Event|0|||
160532932|NCT02490475|579680603|FG002|Period 2: Extension Phase|Adverse Event|1|||
160532933|NCT02490475|579680604|FG003|Period 2: Extension Phase|Adverse Event|0|||
160532934|NCT00616434|579680606|FG000|Overall Study|Adverse Event|5|||
160532935|NCT00616434|579680607|FG001|Overall Study|Adverse Event|2|||
160532936|NCT00616434|579680606|FG000|Overall Study|Physician Decision|0|||
160532937|NCT00616434|579680607|FG001|Overall Study|Physician Decision|4|||
160532938|NCT00616434|579680606|FG000|Overall Study|Withdrawal by Subject|1|||
160532939|NCT00616434|579680607|FG001|Overall Study|Withdrawal by Subject|1|||
160532940|NCT00616434|579680606|FG000|Overall Study|Protocol deviation|0|||
160532941|NCT00616434|579680607|FG001|Overall Study|Protocol deviation|1|||
160532942|NCT01299376|579680624|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
160532943|NCT01299376|579680625|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
160532944|NCT01299376|579680624|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
160532945|NCT01299376|579680625|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
160532946|NCT01299376|579680624|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
160532947|NCT01299376|579680625|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
160532948|NCT01299376|579680624|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
160532949|NCT01299376|579680625|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
160532950|NCT01299376|579680624|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
160532951|NCT01299376|579680625|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
160532952|NCT01299376|579680624|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
160532953|NCT01299376|579680625|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
160532954|NCT01299376|579680624|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
160532955|NCT01299376|579680625|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
160532956|NCT01299376|579680624|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
160532957|NCT01299376|579680625|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
160532958|NCT01299376|579680624|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
160532959|NCT01299376|579680625|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
160532960|NCT01299376|579680624|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
160532961|NCT01299376|579680625|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
160532962|NCT01299376|579680624|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
160532963|NCT01299376|579680625|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
160532964|NCT02463071|579680628|FG000|Overall Study|Adverse Event|3|||
160532965|NCT02463071|579680629|FG001|Overall Study|Adverse Event|5|||
160532966|NCT02463071|579680630|FG002|Overall Study|Adverse Event|1|||
160532967|NCT02463071|579680628|FG000|Overall Study|Death|1|||
160532968|NCT02463071|579680629|FG001|Overall Study|Death|0|||
160532969|NCT02463071|579680630|FG002|Overall Study|Death|0|||
160532970|NCT02463071|579680628|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
160532971|NCT02463071|579680629|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160532972|NCT02463071|579680630|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
160532973|NCT02463071|579680628|FG000|Overall Study|Reason not specified|7|||
160532974|NCT02463071|579680629|FG001|Overall Study|Reason not specified|9|||
160532975|NCT02463071|579680630|FG002|Overall Study|Reason not specified|4|||
160532976|NCT02463071|579680628|FG000|Overall Study|Protocol Violation|0|||
160532977|NCT02463071|579680629|FG001|Overall Study|Protocol Violation|2|||
160532978|NCT02463071|579680630|FG002|Overall Study|Protocol Violation|0|||
160532979|NCT02463071|579680628|FG000|Overall Study|Lost to Follow-up|0|||
160532980|NCT02463071|579680629|FG001|Overall Study|Lost to Follow-up|0|||
160532981|NCT02463071|579680630|FG002|Overall Study|Lost to Follow-up|1|||
160532982|NCT00175877|579680646|FG000|Overall Study|Adverse Event|136|||
160532983|NCT00175877|579680646|FG000|Overall Study|Withdrawal by Subject|141|||
160532984|NCT00175877|579680646|FG000|Overall Study|Lost to Follow-up|9|||
160532985|NCT00175877|579680646|FG000|Overall Study|Lack of Efficacy|26|||
160532986|NCT00175877|579680646|FG000|Overall Study|Protocol Violation|15|||
160532987|NCT00175877|579680646|FG000|Overall Study|Other Reason|20|||
160532988|NCT00175877|579680646|FG000|Overall Study|AE & Other|1|||
160532989|NCT00175877|579680646|FG000|Overall Study|Withdrawal by subject & Other|1|||
160532990|NCT00805025|579680649|FG000|Overall Study|Screened but not enrolled/treated|42|||
160532991|NCT00805025|579680649|FG000|Overall Study|Adverse Event|4|||
160532992|NCT00805025|579680649|FG000|Overall Study|Withdrawal by Subject|2|||
160532993|NCT00805025|579680649|FG000|Overall Study|Physician Decision|1|||
160532994|NCT04029961|579680655|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
160532995|NCT04029961|579680656|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
160532996|NCT04029961|579680655|FG000|Overall Study|Change in Treatment Course|0|||
160532997|NCT04029961|579680656|FG001|Overall Study|Change in Treatment Course|1|||
160532998|NCT00688155|579680660|FG000|Overall Study|Withdrawal by Subject|2|||
160532999|NCT00688155|579680661|FG001|Overall Study|Withdrawal by Subject|2|||
160533000|NCT00688155|579680662|FG002|Overall Study|Withdrawal by Subject|1|||
160533001|NCT00688155|579680663|FG003|Overall Study|Withdrawal by Subject|1|||
160533002|NCT01624259|579680666|FG000|Overall Study|Adverse Event|18|||
160533003|NCT01624259|579680667|FG001|Overall Study|Adverse Event|18|||
160533004|NCT01624259|579680666|FG000|Overall Study|Protocol Violation|1|||
160533005|NCT01624259|579680667|FG001|Overall Study|Protocol Violation|2|||
160533006|NCT01624259|579680666|FG000|Overall Study|Withdrawal by Subject|5|||
160533007|NCT01624259|579680667|FG001|Overall Study|Withdrawal by Subject|7|||
160533008|NCT01624259|579680666|FG000|Overall Study|Physician Decision|1|||
160533009|NCT01624259|579680667|FG001|Overall Study|Physician Decision|1|||
160533010|NCT01624259|579680666|FG000|Overall Study|Lost to Follow-up|2|||
160533011|NCT01624259|579680667|FG001|Overall Study|Lost to Follow-up|3|||
160533012|NCT01624259|579680666|FG000|Overall Study|Abnormal laboratory measure|3|||
160533013|NCT01624259|579680667|FG001|Overall Study|Abnormal laboratory measure|0|||
160533014|NCT02737852|579682009|FG000|Overall Study|Withdrawal by Subject|2|||
160533015|NCT03688880|579682010|FG000|Overall Study|Withdrawal by Subject|0|||
160533016|NCT03688880|579682011|FG001|Overall Study|Withdrawal by Subject|2|||
160533017|NCT03688880|579682010|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
160533018|NCT03688880|579682011|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
160533019|NCT03688880|579682010|FG000|Overall Study|Lost to Follow-up|4|||
160533020|NCT03688880|579682011|FG001|Overall Study|Lost to Follow-up|7|||
160533021|NCT03688880|579682010|FG000|Overall Study|Adverse Event|0|||
160533022|NCT03688880|579682011|FG001|Overall Study|Adverse Event|2|||
160533023|NCT03688880|579682010|FG000|Overall Study|Device deficiencies|0|||
160533024|NCT03688880|579682011|FG001|Overall Study|Device deficiencies|2|||
160533025|NCT03688880|579682010|FG000|Overall Study|Other|10|||
160533026|NCT03688880|579682011|FG001|Overall Study|Other|16|||
160533027|NCT01704287|579682013|FG000|Initial Treatment Period|Death|139|||
160533028|NCT01704287|579682014|FG001|Initial Treatment Period|Death|129|||
160533029|NCT01704287|579682015|FG002|Initial Treatment Period|Death|71|||
160533030|NCT01704287|579682016|FG003|Initial Treatment Period|Death|0|||
160533031|NCT01704287|579682017|FG004|Initial Treatment Period|Death|0|||
160533032|NCT01704287|579682013|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
160533033|NCT01704287|579682014|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
160533034|NCT01704287|579682015|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
160533035|NCT01704287|579682016|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
160533036|NCT01704287|579682017|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
160533037|NCT01704287|579682013|FG000|Initial Treatment Period|Lost to Follow-up|5|||
160533038|NCT01704287|579682014|FG001|Initial Treatment Period|Lost to Follow-up|3|||
160533039|NCT01704287|579682015|FG002|Initial Treatment Period|Lost to Follow-up|0|||
160533040|NCT01704287|579682016|FG003|Initial Treatment Period|Lost to Follow-up|0|||
160533041|NCT01704287|579682017|FG004|Initial Treatment Period|Lost to Follow-up|0|||
160533042|NCT01704287|579682013|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
160533043|NCT01704287|579682014|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
160533044|NCT01704287|579682015|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
160533045|NCT01704287|579682016|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
160533046|NCT01704287|579682017|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
160533047|NCT01704287|579682013|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
160533048|NCT01704287|579682014|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
160533049|NCT01704287|579682015|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
160533050|NCT01704287|579682016|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
160533051|NCT01704287|579682017|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
160533052|NCT01704287|579682013|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
160533053|NCT01704287|579682014|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
160533054|NCT01704287|579682015|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
160533055|NCT01704287|579682016|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
160533056|NCT01704287|579682017|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
160533057|NCT01704287|579682013|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
160533058|NCT01704287|579682014|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
160533059|NCT01704287|579682015|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
160533060|NCT01704287|579682016|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
160533061|NCT01704287|579682017|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
160533062|NCT04042740|579682018|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
160533063|NCT04042740|579682018|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
160533064|NCT01717287|579682019|FG000|Overall Study|Lost to Follow-up|0|||
160533065|NCT01717287|579682020|FG001|Overall Study|Lost to Follow-up|2|||
160533066|NCT01717287|579682019|FG000|Overall Study|Protocol Violation|0|||
160533067|NCT01717287|579682020|FG001|Overall Study|Protocol Violation|1|||
160533068|NCT04024228|579682021|FG000|Overall Study|Adverse Event|1|||
160533069|NCT04024228|579682022|FG001|Overall Study|Adverse Event|0|||
160533070|NCT04024228|579682021|FG000|Overall Study|Protocol Deviation|0|||
160533071|NCT04024228|579682022|FG001|Overall Study|Protocol Deviation|2|||
160533072|NCT04024228|579682021|FG000|Overall Study|Withdrawal by Subject|3|||
160533073|NCT04024228|579682022|FG001|Overall Study|Withdrawal by Subject|4|||
160533074|NCT04490395|579682026|FG000|Overall Study|Lost to Follow-up|0|||
160533075|NCT04490395|579682027|FG001|Overall Study|Lost to Follow-up|1|||
160533076|NCT00938717|579682028|FG000|Overall Study|Adverse Event|10|||
160533077|NCT00938717|579682029|FG001|Overall Study|Adverse Event|41|||
160533078|NCT00938717|579682028|FG000|Overall Study|Protocol Violation|11|||
160533079|NCT00938717|579682029|FG001|Overall Study|Protocol Violation|8|||
160533080|NCT00938717|579682028|FG000|Overall Study|Withdrawal by Subject|26|||
160533081|NCT00938717|579682029|FG001|Overall Study|Withdrawal by Subject|24|||
160533082|NCT00938717|579682028|FG000|Overall Study|Lost to Follow-up|13|||
160533083|NCT00938717|579682029|FG001|Overall Study|Lost to Follow-up|18|||
160533084|NCT00938717|579682028|FG000|Overall Study|Lack of Efficacy|33|||
160533085|NCT00938717|579682029|FG001|Overall Study|Lack of Efficacy|15|||
160533086|NCT00938717|579682028|FG000|Overall Study|Other reason|5|||
160533087|NCT00938717|579682029|FG001|Overall Study|Other reason|2|||
160533088|NCT05092919|579682032|FG000|Overall Study|Lost to Follow-up|7|||
160533089|NCT05092919|579682032|FG000|Overall Study|Withdrawal by Subject|2|||
160533090|NCT01942148|579682036|FG000|Overall Study|Adverse Event|4|||
160533091|NCT01942148|579682036|FG000|Overall Study|Lack of Efficacy|2|||
160533092|NCT01942148|579682036|FG000|Overall Study|Physician Decision|11|||
160533093|NCT01942148|579682036|FG000|Overall Study|Protocol Violation|1|||
160533094|NCT01942148|579682036|FG000|Overall Study|Withdrawal by Subject|8|||
160533095|NCT01942148|579682036|FG000|Overall Study|Use of the prohibition medicine|1|||
160533096|NCT02248259|579682037|FG000|Treatment Period 1|Adverse Event|0|||
160533097|NCT02248259|579682038|FG001|Treatment Period 1|Adverse Event|0|||
160767166|NCT01432327|580537702|FG000|Posttest 6 Months|Lost to Follow-up|0|||
160767167|NCT01432327|580537703|FG001|Posttest 6 Months|Lost to Follow-up|0|||
160533098|NCT02248259|579682039|FG002|Treatment Period 1|Adverse Event|1|||
160767168|NCT01432327|580537704|FG002|Posttest 6 Months|Lost to Follow-up|3|||
160767169|NCT01432327|580537705|FG003|Posttest 6 Months|Lost to Follow-up|2|||
160767170|NCT01432327|580537702|FG000|Posttest 6 Months|Allergic reaction|0|||
160533099|NCT02248259|579682040|FG003|Treatment Period 1|Adverse Event|0|||
160533100|NCT00096785|579682041|FG000|Overall Study|Lost to Follow-up|1|||
160533101|NCT00096785|579682042|FG001|Overall Study|Lost to Follow-up|0|||
160533102|NCT00096785|579682041|FG000|Overall Study|Withdrawal by Subject|0|||
160533103|NCT00096785|579682042|FG001|Overall Study|Withdrawal by Subject|1|||
160533104|NCT00096785|579682041|FG000|Overall Study|Relocated|1|||
160533105|NCT00096785|579682042|FG001|Overall Study|Relocated|0|||
160533106|NCT01838616|579682043|FG000|Titration Period|Adverse Event|18|||
160533107|NCT01838616|579682044|FG001|Titration Period|Adverse Event|48|||
160767171|NCT01432327|580537703|FG001|Posttest 6 Months|Allergic reaction|0|||
160874407|NCT01904773|580934184|FG004|Fifth Intervention|Adverse Event|0|||
160874408|NCT01904773|580934185|FG005|Fifth Intervention|Adverse Event|0|||
160874409|NCT01904773|580934186|FG006|Fifth Intervention|Adverse Event|0|||
160874410|NCT01904773|580934187|FG007|Fifth Intervention|Adverse Event|1|||
160874411|NCT01904773|580934188|FG008|Fifth Intervention|Adverse Event|0|||
160874412|NCT01904773|580934180|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874413|NCT01904773|580934181|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
160874414|NCT01904773|580934182|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874415|NCT01904773|580934183|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874416|NCT01904773|580934184|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874417|NCT01904773|580934185|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874418|NCT01904773|580934186|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874419|NCT01904773|580934187|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874420|NCT01904773|580934188|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874421|NCT00220779|580934189|FG000|Overall Study|Adverse Event|1|||
160874422|NCT00220779|580934190|FG001|Overall Study|Adverse Event|0|||
160874423|NCT00220779|580934191|FG002|Overall Study|Adverse Event|0|||
160874424|NCT00220779|580934189|FG000|Overall Study|Withdrawal by Subject|1|||
160874425|NCT00220779|580934190|FG001|Overall Study|Withdrawal by Subject|4|||
160874426|NCT00220779|580934191|FG002|Overall Study|Withdrawal by Subject|1|||
160874427|NCT00220779|580934189|FG000|Overall Study|Non-compliance|1|||
160874428|NCT00220779|580934190|FG001|Overall Study|Non-compliance|0|||
160874429|NCT00220779|580934191|FG002|Overall Study|Non-compliance|0|||
160874430|NCT00220779|580934189|FG000|Overall Study|Too time consuming|1|||
160874431|NCT00220779|580934190|FG001|Overall Study|Too time consuming|0|||
160874432|NCT00220779|580934191|FG002|Overall Study|Too time consuming|0|||
160874433|NCT00220779|580934189|FG000|Overall Study|Pregnancy|0|||
160874434|NCT00220779|580934190|FG001|Overall Study|Pregnancy|0|||
160874435|NCT00220779|580934191|FG002|Overall Study|Pregnancy|2|||
160874436|NCT00220779|580934189|FG000|Overall Study|Lack of Efficacy|3|||
160874437|NCT00220779|580934190|FG001|Overall Study|Lack of Efficacy|0|||
160874438|NCT00220779|580934191|FG002|Overall Study|Lack of Efficacy|1|||
160874439|NCT04518995|580934192|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
160874440|NCT04518995|580934193|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
160874441|NCT04518995|580934194|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
160874442|NCT04518995|580934192|FG000|Overall Study|Lack of Efficacy|2|||
160874443|NCT04518995|580934193|FG001|Overall Study|Lack of Efficacy|1|||
160874444|NCT04518995|580934194|FG002|Overall Study|Lack of Efficacy|0|||
160874445|NCT04518995|580934192|FG000|Overall Study|Non-compliance With Study Drug|0|||
160874446|NCT04518995|580934193|FG001|Overall Study|Non-compliance With Study Drug|3|||
160874447|NCT04518995|580934194|FG002|Overall Study|Non-compliance With Study Drug|2|||
160874448|NCT04518995|580934192|FG000|Overall Study|Pregnancy|0|||
160874449|NCT04518995|580934193|FG001|Overall Study|Pregnancy|0|||
160874450|NCT04518995|580934194|FG002|Overall Study|Pregnancy|1|||
160874451|NCT04518995|580934192|FG000|Overall Study|Protocol Violation|2|||
160874452|NCT04518995|580934193|FG001|Overall Study|Protocol Violation|0|||
160874453|NCT04518995|580934194|FG002|Overall Study|Protocol Violation|1|||
160874454|NCT04518995|580934192|FG000|Overall Study|Reason not Specified|4|||
160874455|NCT04518995|580934193|FG001|Overall Study|Reason not Specified|11|||
160874456|NCT04518995|580934194|FG002|Overall Study|Reason not Specified|2|||
160874457|NCT04518995|580934192|FG000|Overall Study|Lost to Follow-up|1|||
160874458|NCT04518995|580934193|FG001|Overall Study|Lost to Follow-up|10|||
160874459|NCT04518995|580934194|FG002|Overall Study|Lost to Follow-up|6|||
160874460|NCT01511055|580934197|FG000|Overall Study|Withdrawal by Subject|6|||
160767172|NCT01432327|580537704|FG002|Posttest 6 Months|Allergic reaction|1|||
160767173|NCT01432327|580537705|FG003|Posttest 6 Months|Allergic reaction|0|||
160767174|NCT01432327|580537702|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
160767175|NCT01432327|580537703|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
160767176|NCT01432327|580537704|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
160767177|NCT01432327|580537705|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
160767178|NCT01432327|580537702|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
160767179|NCT01432327|580537703|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
160767180|NCT01432327|580537704|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
160767181|NCT01432327|580537705|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
160767182|NCT01432327|580537702|FG000|Posttest 1 Year|Lost to Follow-up|0|||
160767183|NCT01432327|580537703|FG001|Posttest 1 Year|Lost to Follow-up|0|||
160767184|NCT01432327|580537704|FG002|Posttest 1 Year|Lost to Follow-up|4|||
160767185|NCT01432327|580537705|FG003|Posttest 1 Year|Lost to Follow-up|2|||
160767186|NCT01432327|580537702|FG000|Posttest 1 Year|Allergic reaction|0|||
160767187|NCT01432327|580537703|FG001|Posttest 1 Year|Allergic reaction|0|||
160767188|NCT01432327|580537704|FG002|Posttest 1 Year|Allergic reaction|1|||
160767189|NCT01432327|580537705|FG003|Posttest 1 Year|Allergic reaction|1|||
160767190|NCT03248037|580537706|FG000|Overall Study|Withdrawal by Subject|6|||
160767191|NCT03248037|580537707|FG001|Overall Study|Withdrawal by Subject|9|||
160767192|NCT03248037|580537706|FG000|Overall Study|Adverse Event|15|||
160767193|NCT03248037|580537707|FG001|Overall Study|Adverse Event|0|||
160767194|NCT02897349|580537711|FG000|Overall Study|Lost to Follow-up|2|||
160767195|NCT02897349|580537712|FG001|Overall Study|Lost to Follow-up|2|||
160767196|NCT02897349|580537711|FG000|Overall Study|Adverse Event|3|||
160767197|NCT02897349|580537712|FG001|Overall Study|Adverse Event|3|||
160767198|NCT02897349|580537711|FG000|Overall Study|Other than listed above|0|||
160767199|NCT02897349|580537712|FG001|Overall Study|Other than listed above|1|||
160767200|NCT03055013|580537713|FG000|Overall Study|Adverse Event|78|||
160767201|NCT03055013|580537714|FG001|Overall Study|Adverse Event|0|||
160767202|NCT03055013|580537713|FG000|Overall Study|Death|6|||
160767203|NCT03055013|580537714|FG001|Overall Study|Death|0|||
160767204|NCT03055013|580537713|FG000|Overall Study|Disease relapse|33|||
160767205|NCT03055013|580537714|FG001|Overall Study|Disease relapse|0|||
160767206|NCT03055013|580537713|FG000|Overall Study|Withdrawal by Subject|28|||
160767207|NCT03055013|580537714|FG001|Overall Study|Withdrawal by Subject|0|||
160767208|NCT03055013|580537713|FG000|Overall Study|Other complicating disease|5|||
160767209|NCT03055013|580537714|FG001|Overall Study|Other complicating disease|0|||
160767210|NCT03055013|580537713|FG000|Overall Study|Physician Decision|1|||
160767211|NCT03055013|580537714|FG001|Overall Study|Physician Decision|0|||
160767212|NCT03055013|580537713|FG000|Overall Study|Benign mass/non-RCC|4|||
160767213|NCT03055013|580537714|FG001|Overall Study|Benign mass/non-RCC|0|||
160767214|NCT03055013|580537713|FG000|Overall Study|Enrolled in another trial|1|||
160767215|NCT03055013|580537714|FG001|Overall Study|Enrolled in another trial|0|||
160767216|NCT03055013|580537713|FG000|Overall Study|Non-protocol therapy|1|||
160874461|NCT04590248|580934198|FG000|Overall Study|Lost to Follow-up|1|||
160874462|NCT04590248|580934198|FG000|Overall Study|Withdrawal by Subject|16|||
160874463|NCT04590248|580934198|FG000|Overall Study|Other|2|||
160874464|NCT02052414|580934201|FG000|Overall Study|Adverse Event|12|||
160874465|NCT02052414|580934201|FG000|Overall Study|Lack of Efficacy|2|||
160767217|NCT03055013|580537714|FG001|Overall Study|Non-protocol therapy|0|||
160767218|NCT03055013|580537713|FG000|Overall Study|Incompliance|1|||
160767219|NCT03055013|580537714|FG001|Overall Study|Incompliance|0|||
160767220|NCT03055013|580537713|FG000|Overall Study|Insurance issues|1|||
160767221|NCT03055013|580537714|FG001|Overall Study|Insurance issues|0|||
160767222|NCT03055013|580537713|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
160767223|NCT03055013|580537714|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
160767224|NCT03055013|580537713|FG000|Overall Study|Did not receive nivolumab|10|||
160767225|NCT03055013|580537714|FG001|Overall Study|Did not receive nivolumab|0|||
160767226|NCT03055013|580537713|FG000|Overall Study|Did not receive surgery|0|||
160767227|NCT03055013|580537714|FG001|Overall Study|Did not receive surgery|28|||
160767228|NCT00671749|580537718|FG000|Overall Study|Adverse Event|2|||
160533108|NCT01838616|579682043|FG000|Titration Period|Lack of Efficacy|5|||
160533109|NCT01838616|579682044|FG001|Titration Period|Lack of Efficacy|12|||
160533110|NCT01838616|579682043|FG000|Titration Period|Withdrawal by Subject|5|||
160533111|NCT01838616|579682044|FG001|Titration Period|Withdrawal by Subject|5|||
160533112|NCT01838616|579682043|FG000|Titration Period|Technical problems|1|||
160533113|NCT01838616|579682044|FG001|Titration Period|Technical problems|0|||
160533114|NCT01838616|579682043|FG000|Titration Period|Other|1|||
160533115|NCT01838616|579682044|FG001|Titration Period|Other|0|||
160533116|NCT01838616|579682043|FG000|Titration Period|Protocol Violation|0|||
160533117|NCT01838616|579682044|FG001|Titration Period|Protocol Violation|1|||
160533118|NCT01838616|579682043|FG000|Continuation Period|Lack of Efficacy|3|||
160533119|NCT01838616|579682044|FG001|Continuation Period|Lack of Efficacy|5|||
160533120|NCT01838616|579682043|FG000|Continuation Period|Adverse Event|8|||
160533121|NCT01838616|579682044|FG001|Continuation Period|Adverse Event|4|||
160533122|NCT01838616|579682043|FG000|Continuation Period|Protocol Violation|2|||
160533123|NCT01838616|579682044|FG001|Continuation Period|Protocol Violation|0|||
160533124|NCT01838616|579682043|FG000|Continuation Period|Lost to Follow-up|1|||
160767229|NCT00671749|580537718|FG000|Overall Study|Withdrawal by Subject|4|||
160767230|NCT00671749|580537718|FG000|Overall Study|Protocol Violation|1|||
160767231|NCT00671749|580537718|FG000|Overall Study|Lost to Follow-up|1|||
160767232|NCT01401322|580537719|FG000|Overall Study|Withdrawal by Subject|1|||
160767233|NCT01401322|580537719|FG000|Overall Study|Physician Decision|1|||
160767234|NCT03466346|580537722|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
160767235|NCT03466346|580537723|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
160767236|NCT03466346|580537724|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
160767237|NCT03466346|580537725|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
160767238|NCT03466346|580537726|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
160767239|NCT03466346|580537722|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
160767240|NCT03466346|580537723|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
160767241|NCT03466346|580537724|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
160767242|NCT03466346|580537725|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
160767243|NCT03466346|580537726|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
160767244|NCT03466346|580537722|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
160767245|NCT03466346|580537723|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
160767246|NCT03466346|580537724|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
160767247|NCT03466346|580537725|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
160767248|NCT03466346|580537726|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
160767249|NCT03466346|580537722|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
160767250|NCT03466346|580537723|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
160767251|NCT03466346|580537724|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
160767252|NCT03466346|580537725|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
160767253|NCT03466346|580537726|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
160767254|NCT03466346|580537722|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
160767255|NCT03466346|580537723|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
160767256|NCT03466346|580537724|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
160767257|NCT03466346|580537725|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
160767258|NCT03466346|580537726|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
160767259|NCT03466346|580537722|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
160767260|NCT03466346|580537723|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
160767261|NCT03466346|580537724|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
160767262|NCT03466346|580537725|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
160767263|NCT03466346|580537726|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
160767264|NCT03466346|580537722|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
160767265|NCT03466346|580537723|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
160767266|NCT03466346|580537724|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
160767267|NCT03466346|580537725|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
160767268|NCT03466346|580537726|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
160767269|NCT02410629|580537728|FG000|Overall Study|Family cannot commit to the study|2|||
160767270|NCT02410629|580537729|FG001|Overall Study|Family cannot commit to the study|1|||
160767271|NCT02410629|580537728|FG000|Overall Study|Subject returned to work|1|||
160767272|NCT02410629|580537729|FG001|Overall Study|Subject returned to work|0|||
160874466|NCT02052414|580934201|FG000|Overall Study|Withdrawal by Subject|3|||
160874467|NCT00813943|580934207|FG000|Overall Study|Ongoing at cut-off date|5|||
160533125|NCT01838616|579682044|FG001|Continuation Period|Lost to Follow-up|0|||
160533126|NCT01838616|579682043|FG000|Continuation Period|Withdrawal by Subject|0|||
160533127|NCT01838616|579682044|FG001|Continuation Period|Withdrawal by Subject|4|||
160533128|NCT01838616|579682043|FG000|Continuation Period|Technical problems|0|||
160533129|NCT01838616|579682044|FG001|Continuation Period|Technical problems|1|||
160533130|NCT01838616|579682043|FG000|Pick-up Arm|Lack of Efficacy|4|||
160533131|NCT01838616|579682044|FG001|Pick-up Arm|Lack of Efficacy|0|||
160533132|NCT01838616|579682043|FG000|Pick-up Arm|Adverse Event|9|||
160533133|NCT01838616|579682044|FG001|Pick-up Arm|Adverse Event|0|||
160533134|NCT01838616|579682043|FG000|Pick-up Arm|Withdrawal by Subject|1|||
160533135|NCT01838616|579682044|FG001|Pick-up Arm|Withdrawal by Subject|0|||
160533136|NCT01838616|579682043|FG000|Pick-up Arm|Technical problems|1|||
160533137|NCT01838616|579682044|FG001|Pick-up Arm|Technical problems|0|||
160533138|NCT02573870|579682045|FG000|Overall Study|Adverse Event|0|||
160533139|NCT02573870|579682046|FG001|Overall Study|Adverse Event|2|||
160533140|NCT02573870|579682045|FG000|Overall Study|Lack of Efficacy|0|||
160533141|NCT02573870|579682046|FG001|Overall Study|Lack of Efficacy|1|||
160533142|NCT02573870|579682045|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
160533143|NCT02573870|579682046|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
160533144|NCT02573870|579682045|FG000|Overall Study|Lost to Follow-up|0|||
160533145|NCT02573870|579682046|FG001|Overall Study|Lost to Follow-up|1|||
160533146|NCT02573870|579682045|FG000|Overall Study|Other: Fail to Meet Visit|0|||
160533147|NCT02573870|579682046|FG001|Overall Study|Other: Fail to Meet Visit|2|||
160533148|NCT00257725|579682047|FG000|Overall Study|Adverse Event|3|||
160533149|NCT00514514|579682048|FG000|Pre-phase|Death|10|||
160533150|NCT00514514|579682049|FG001|Pre-phase|Death|0|||
160533151|NCT00514514|579682050|FG002|Pre-phase|Death|0|||
160533152|NCT00514514|579682048|FG000|Pre-phase|administrative problems|2|||
160533153|NCT00514514|579682049|FG001|Pre-phase|administrative problems|0|||
160533154|NCT00514514|579682050|FG002|Pre-phase|administrative problems|0|||
160533155|NCT00514514|579682048|FG000|Pre-phase|Protocol Violation|6|||
160533156|NCT00514514|579682049|FG001|Pre-phase|Protocol Violation|0|||
160533157|NCT00514514|579682050|FG002|Pre-phase|Protocol Violation|0|||
160533158|NCT00514514|579682048|FG000|Pre-phase|condition no longer requires study drug|7|||
160533159|NCT00514514|579682049|FG001|Pre-phase|condition no longer requires study drug|0|||
160533160|NCT00514514|579682050|FG002|Pre-phase|condition no longer requires study drug|0|||
160533161|NCT00514514|579682048|FG000|Pre-phase|abnormal test procedure results|15|||
160533162|NCT00514514|579682049|FG001|Pre-phase|abnormal test procedure results|0|||
160533163|NCT00514514|579682050|FG002|Pre-phase|abnormal test procedure results|0|||
160533164|NCT00514514|579682048|FG000|Pre-phase|Lost to Follow-up|2|||
160533165|NCT00514514|579682049|FG001|Pre-phase|Lost to Follow-up|0|||
160533166|NCT00514514|579682050|FG002|Pre-phase|Lost to Follow-up|0|||
160533167|NCT00514514|579682048|FG000|Pre-phase|abnormal lab values|23|||
160533168|NCT00514514|579682049|FG001|Pre-phase|abnormal lab values|0|||
160533169|NCT00514514|579682050|FG002|Pre-phase|abnormal lab values|0|||
160533170|NCT00514514|579682048|FG000|Pre-phase|Lack of Efficacy|35|||
160533171|NCT00514514|579682049|FG001|Pre-phase|Lack of Efficacy|0|||
160533172|NCT00514514|579682050|FG002|Pre-phase|Lack of Efficacy|0|||
160533173|NCT00514514|579682048|FG000|Pre-phase|Adverse Event|137|||
160533174|NCT00514514|579682049|FG001|Pre-phase|Adverse Event|0|||
160533175|NCT00514514|579682050|FG002|Pre-phase|Adverse Event|0|||
160533176|NCT00514514|579682048|FG000|Pre-phase|Withdrawal by Subject|66|||
160533177|NCT00514514|579682049|FG001|Pre-phase|Withdrawal by Subject|0|||
160533178|NCT00514514|579682050|FG002|Pre-phase|Withdrawal by Subject|0|||
160533179|NCT00514514|579682048|FG000|Randomized - 9 Month|Death|3|||
160533180|NCT00514514|579682049|FG001|Randomized - 9 Month|Death|2|||
160533181|NCT00514514|579682050|FG002|Randomized - 9 Month|Death|2|||
160533182|NCT00514514|579682048|FG000|Randomized - 9 Month|Administrative problems|1|||
160533183|NCT00514514|579682049|FG001|Randomized - 9 Month|Administrative problems|1|||
160533184|NCT00514514|579682050|FG002|Randomized - 9 Month|Administrative problems|2|||
160533185|NCT00514514|579682048|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
160533186|NCT00514514|579682049|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
160533187|NCT00514514|579682050|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
160533188|NCT00514514|579682048|FG000|Randomized - 9 Month|Protocol Violation|1|||
160533189|NCT00514514|579682049|FG001|Randomized - 9 Month|Protocol Violation|1|||
160533190|NCT00514514|579682050|FG002|Randomized - 9 Month|Protocol Violation|0|||
160533191|NCT00514514|579682048|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
160533192|NCT00514514|579682049|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
160533193|NCT00514514|579682050|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
160533194|NCT00514514|579682048|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
160533195|NCT00514514|579682049|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
160533196|NCT00514514|579682050|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
160533197|NCT00514514|579682048|FG000|Randomized - 9 Month|Adverse Event|25|||
160533198|NCT00514514|579682049|FG001|Randomized - 9 Month|Adverse Event|44|||
160533199|NCT00514514|579682050|FG002|Randomized - 9 Month|Adverse Event|27|||
160533200|NCT00514514|579682048|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
160533201|NCT00514514|579682049|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
160533202|NCT00514514|579682050|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
160533203|NCT00514514|579682048|FG000|Extension - 4 Years|Lost to Follow-up|12|||
160533204|NCT00514514|579682049|FG001|Extension - 4 Years|Lost to Follow-up|10|||
160533205|NCT00514514|579682050|FG002|Extension - 4 Years|Lost to Follow-up|9|||
160533206|NCT00514514|579682048|FG000|Extension - 4 Years|Administrative problems|3|||
160533207|NCT00514514|579682049|FG001|Extension - 4 Years|Administrative problems|1|||
160533208|NCT00514514|579682050|FG002|Extension - 4 Years|Administrative problems|1|||
160533209|NCT00514514|579682048|FG000|Extension - 4 Years|Death|8|||
160533210|NCT00514514|579682049|FG001|Extension - 4 Years|Death|3|||
160533211|NCT00514514|579682050|FG002|Extension - 4 Years|Death|6|||
160533212|NCT00514514|579682048|FG000|Extension - 4 Years|Adverse Event|9|||
160533213|NCT00514514|579682049|FG001|Extension - 4 Years|Adverse Event|6|||
160533214|NCT00514514|579682050|FG002|Extension - 4 Years|Adverse Event|3|||
160533215|NCT00762892|579682053|FG000|Overall Study|Lost to Follow-up|2|||
160533216|NCT00762892|579682054|FG001|Overall Study|Lost to Follow-up|5|||
160533217|NCT00762892|579682053|FG000|Overall Study|Withdrawal by Subject|0|||
160533218|NCT00762892|579682054|FG001|Overall Study|Withdrawal by Subject|1|||
160533219|NCT00762892|579682053|FG000|Overall Study|Death|1|||
160533220|NCT00762892|579682054|FG001|Overall Study|Death|0|||
160533221|NCT00762892|579682053|FG000|Overall Study|Pregnancy|1|||
160533222|NCT00762892|579682054|FG001|Overall Study|Pregnancy|0|||
160533223|NCT00762892|579682053|FG000|Overall Study|Incarceration|1|||
160533224|NCT00762892|579682054|FG001|Overall Study|Incarceration|0|||
160533225|NCT02234479|579682055|FG000|Overall Study|Withdrawal by Subject|1|||
160533226|NCT02234479|579682056|FG001|Overall Study|Withdrawal by Subject|3|||
160533227|NCT00290290|579682060|FG000|Overall Study|Death|3|||
160533228|NCT00290290|579682061|FG001|Overall Study|Death|4|||
160533229|NCT00290290|579682060|FG000|Overall Study|Withdrawal by Subject|2|||
160533230|NCT00290290|579682061|FG001|Overall Study|Withdrawal by Subject|2|||
160533231|NCT00290290|579682060|FG000|Overall Study|Underwent clean surgical procedure|13|||
160533232|NCT00290290|579682061|FG001|Overall Study|Underwent clean surgical procedure|12|||
160533233|NCT04784897|579682066|FG000|Overall Study|Death|4|||
160533234|NCT04784897|579682067|FG001|Overall Study|Death|2|||
160533235|NCT04784897|579682068|FG002|Overall Study|Death|1|||
160533236|NCT04784897|579682066|FG000|Overall Study|Withdrawal by Subject|0|||
160533237|NCT04784897|579682067|FG001|Overall Study|Withdrawal by Subject|0|||
160533238|NCT04784897|579682068|FG002|Overall Study|Withdrawal by Subject|1|||
160533239|NCT02319668|579682069|FG000|Overall Study|Other (Not specified)|0|||
160533240|NCT02319668|579682070|FG001|Overall Study|Other (Not specified)|2|||
160533241|NCT01161043|579682071|FG000|Overall Study|Withdrawal by Subject|3|||
160533242|NCT02164929|579682072|FG000|Overall Study|Converted to open procedure|1|||
160533243|NCT02164929|579682073|FG001|Overall Study|Converted to open procedure|0|||
160533244|NCT02164929|579682074|FG002|Overall Study|Converted to open procedure|0|||
160533245|NCT02164929|579682075|FG003|Overall Study|Converted to open procedure|2|||
160533246|NCT02164929|579682072|FG000|Overall Study|Failed regional block|0|||
160533247|NCT02164929|579682073|FG001|Overall Study|Failed regional block|0|||
160533248|NCT02164929|579682074|FG002|Overall Study|Failed regional block|1|||
160533249|NCT02164929|579682075|FG003|Overall Study|Failed regional block|0|||
160533250|NCT00365456|579682076|FG000|Trial Period I (12 Months)|Adverse Event|84|||
160533251|NCT00365456|579682077|FG001|Trial Period I (12 Months)|Adverse Event|0|||
160533252|NCT00365456|579682076|FG000|Trial Period I (12 Months)|Non-compliance|3|||
160533253|NCT00365456|579682077|FG001|Trial Period I (12 Months)|Non-compliance|0|||
160533254|NCT00365456|579682076|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
160533255|NCT00365456|579682077|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
160533256|NCT00365456|579682076|FG000|Trial Period I (12 Months)|Other|11|||
160533257|NCT00365456|579682077|FG001|Trial Period I (12 Months)|Other|0|||
160533258|NCT00365456|579682076|FG000|Trial Period II (12 Months)|Adverse Event|0|||
160533259|NCT00365456|579682077|FG001|Trial Period II (12 Months)|Adverse Event|6|||
160533260|NCT00365456|579682076|FG000|Trial Period II (12 Months)|Non-compliance|0|||
160533261|NCT00365456|579682077|FG001|Trial Period II (12 Months)|Non-compliance|2|||
160533262|NCT00365456|579682076|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
160533263|NCT00365456|579682077|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
160533264|NCT00365456|579682076|FG000|Trial Period II (12 Months)|Other|0|||
160533265|NCT00365456|579682077|FG001|Trial Period II (12 Months)|Other|1|||
160533266|NCT00365456|579682076|FG000|Trial Period III (12 Months)|Adverse Event|13|||
160533267|NCT00365456|579682077|FG001|Trial Period III (12 Months)|Adverse Event|3|||
160533268|NCT00365456|579682076|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
160533269|NCT00365456|579682077|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
160533270|NCT00365456|579682076|FG000|Trial Period III (12 Months)|Other|1|||
160533271|NCT00365456|579682077|FG001|Trial Period III (12 Months)|Other|1|||
160533272|NCT04754802|579682080|FG000|Overall Study|Lost to Follow-up|0|||
160533273|NCT04754802|579682081|FG001|Overall Study|Lost to Follow-up|2|||
160767273|NCT02410629|580537728|FG000|Overall Study|Subject moved back to home country|0|||
160533274|NCT04754802|579682080|FG000|Overall Study|Withdrawal by Subject|2|||
160533275|NCT04754802|579682081|FG001|Overall Study|Withdrawal by Subject|0|||
160533276|NCT00701090|579682082|FG000|Overall Study|Adverse Event|11|||
160533277|NCT00701090|579682083|FG001|Overall Study|Adverse Event|2|||
160533278|NCT00701090|579682082|FG000|Overall Study|Death|0|||
160533279|NCT00701090|579682083|FG001|Overall Study|Death|1|||
160533280|NCT00701090|579682082|FG000|Overall Study|Lack of Efficacy|5|||
160533281|NCT00701090|579682083|FG001|Overall Study|Lack of Efficacy|4|||
160533282|NCT00701090|579682082|FG000|Overall Study|Lost to Follow-up|9|||
160533283|NCT00701090|579682083|FG001|Overall Study|Lost to Follow-up|9|||
160533284|NCT00701090|579682082|FG000|Overall Study|Physician Decision|3|||
160533285|NCT00701090|579682083|FG001|Overall Study|Physician Decision|4|||
160533286|NCT00701090|579682082|FG000|Overall Study|Protocol Violation|2|||
160533287|NCT00701090|579682083|FG001|Overall Study|Protocol Violation|3|||
160533288|NCT00701090|579682082|FG000|Overall Study|Withdrawal by Subject|11|||
160533289|NCT00701090|579682083|FG001|Overall Study|Withdrawal by Subject|16|||
160533290|NCT00701090|579682082|FG000|Overall Study|Other|7|||
160533291|NCT00701090|579682083|FG001|Overall Study|Other|12|||
160533292|NCT02170779|579682084|FG000|Overall Study|Withdrawal by Subject|1|||
160533293|NCT02170779|579682085|FG001|Overall Study|Withdrawal by Subject|0|||
160533294|NCT02170779|579682084|FG000|Overall Study|Lost to Follow-up|0|||
160533295|NCT02170779|579682085|FG001|Overall Study|Lost to Follow-up|1|||
160533296|NCT00935272|579682088|FG000|Overall Study|Lost to Follow-up|10|||
160533297|NCT00935272|579682089|FG001|Overall Study|Lost to Follow-up|3|||
160533298|NCT00935272|579682088|FG000|Overall Study|Withdrawal by Subject|8|||
160533299|NCT00935272|579682089|FG001|Overall Study|Withdrawal by Subject|2|||
160533300|NCT00935272|579682088|FG000|Overall Study|Physician Decision|1|||
160533301|NCT00935272|579682089|FG001|Overall Study|Physician Decision|0|||
160533302|NCT00935272|579682088|FG000|Overall Study|Protocol Violation|0|||
160533303|NCT00935272|579682089|FG001|Overall Study|Protocol Violation|1|||
160533304|NCT04340557|579682093|FG000|Overall Study|Transferred to ICU and/or death|1|||
160533305|NCT04340557|579682094|FG001|Overall Study|Transferred to ICU and/or death|2|||
160533306|NCT00529451|579682095|FG000|Overall Study|Subject withdrew consent|16|||
160533307|NCT00529451|579682096|FG001|Overall Study|Subject withdrew consent|21|||
160533308|NCT00529451|579682097|FG002|Overall Study|Subject withdrew consent|13|||
160533309|NCT00529451|579682098|FG003|Overall Study|Subject withdrew consent|12|||
160533310|NCT00529451|579682095|FG000|Overall Study|Adverse Event|9|||
160533311|NCT00529451|579682096|FG001|Overall Study|Adverse Event|16|||
160533312|NCT00529451|579682097|FG002|Overall Study|Adverse Event|14|||
160533313|NCT00529451|579682098|FG003|Overall Study|Adverse Event|8|||
160533314|NCT00529451|579682095|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
160533315|NCT00529451|579682096|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
160533316|NCT00529451|579682097|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
160533317|NCT00529451|579682098|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
160533318|NCT00529451|579682095|FG000|Overall Study|Lost to Follow-up|4|||
160533319|NCT00529451|579682096|FG001|Overall Study|Lost to Follow-up|7|||
160533320|NCT00529451|579682097|FG002|Overall Study|Lost to Follow-up|4|||
160533321|NCT00529451|579682098|FG003|Overall Study|Lost to Follow-up|4|||
160533322|NCT00529451|579682095|FG000|Overall Study|Protocol deviation|1|||
160533323|NCT00529451|579682096|FG001|Overall Study|Protocol deviation|1|||
160533324|NCT00529451|579682097|FG002|Overall Study|Protocol deviation|4|||
160533325|NCT00529451|579682098|FG003|Overall Study|Protocol deviation|1|||
160533326|NCT00529451|579682095|FG000|Overall Study|Administrative problems|1|||
160533327|NCT00529451|579682096|FG001|Overall Study|Administrative problems|1|||
160533328|NCT00529451|579682097|FG002|Overall Study|Administrative problems|0|||
160533329|NCT00529451|579682098|FG003|Overall Study|Administrative problems|2|||
160533330|NCT03700320|579682099|FG000|Overall Study|Adverse Event|5|||
160533331|NCT03700320|579682100|FG001|Overall Study|Adverse Event|31|||
160533332|NCT03700320|579682099|FG000|Overall Study|Lack of Efficacy|2|||
160533333|NCT03700320|579682100|FG001|Overall Study|Lack of Efficacy|5|||
160533334|NCT03700320|579682099|FG000|Overall Study|Withdrawal by Subject|29|||
160533335|NCT03700320|579682100|FG001|Overall Study|Withdrawal by Subject|75|||
160533336|NCT03700320|579682099|FG000|Overall Study|Lost to Follow-up|16|||
160533337|NCT03700320|579682100|FG001|Overall Study|Lost to Follow-up|23|||
160533338|NCT03700320|579682099|FG000|Overall Study|Pregnancy|2|||
160533339|NCT03700320|579682100|FG001|Overall Study|Pregnancy|4|||
160533340|NCT03700320|579682099|FG000|Overall Study|Protocol Deviation|7|||
160533341|NCT03700320|579682100|FG001|Overall Study|Protocol Deviation|31|||
160533342|NCT03700320|579682099|FG000|Overall Study|Non-compliance with Study Drug|1|||
160533343|NCT03700320|579682100|FG001|Overall Study|Non-compliance with Study Drug|3|||
160533344|NCT03700320|579682099|FG000|Overall Study|Reason not Specified|0|||
160533345|NCT03700320|579682100|FG001|Overall Study|Reason not Specified|1|||
160533346|NCT04305275|579682101|FG000|Overall Study|Adverse Event|4|||
160533347|NCT04305275|579682102|FG001|Overall Study|Adverse Event|0|||
160533348|NCT04305275|579682101|FG000|Overall Study|Lost to Follow-up|1|||
160533349|NCT04305275|579682102|FG001|Overall Study|Lost to Follow-up|1|||
160533350|NCT04305275|579682101|FG000|Overall Study|Withdrawal by Participant|8|||
160533351|NCT04305275|579682102|FG001|Overall Study|Withdrawal by Participant|1|||
160533352|NCT03061175|579682103|FG000|Baseline|Participant was deemed ineligible|1|||
160533353|NCT03061175|579682104|FG001|Baseline|Participant was deemed ineligible|0|||
160533354|NCT03061175|579682103|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
160533355|NCT03061175|579682104|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
160533356|NCT03061175|579682103|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
160533357|NCT03061175|579682104|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
160533358|NCT03061175|579682103|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
160533359|NCT03061175|579682104|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
160533360|NCT00199836|579682107|FG000|Overall Study|Progressive Disease|5|||
160533361|NCT00199836|579682107|FG000|Overall Study|Death|1|||
160533362|NCT00760669|579682108|FG000|Overall Study|Not assessed for overall improvement|18|||
160533363|NCT00760669|579682108|FG000|Overall Study|Participants missing efficacy assessment|6|||
160533364|NCT00760669|579682108|FG000|Overall Study|Participants with overlapping cases|1|||
160533365|NCT00760669|579682108|FG000|Overall Study|Took drug before entering in contract|5|||
160533366|NCT02054325|579682117|FG000|Overall Study|Lost to Follow-up|8|||
160533367|NCT02054325|579682118|FG001|Overall Study|Lost to Follow-up|5|||
160533368|NCT02456662|579682119|FG000|Overall Study|Lost to Follow-up|2|||
160533369|NCT02456662|579682120|FG001|Overall Study|Lost to Follow-up|1|||
160533370|NCT00504153|579682125|FG000|Overall Study|Withdrawal by Subject|1|||
160533371|NCT00504153|579682125|FG000|Overall Study|Adverse Event|4|||
160533372|NCT00504153|579682125|FG000|Overall Study|Death|1|||
160533373|NCT00617604|579682126|FG000|Overall Study|Death|2|||
160533374|NCT00617604|579682127|FG001|Overall Study|Death|1|||
160533375|NCT00617604|579682126|FG000|Overall Study|Lost to Follow-up|1|||
160533376|NCT00617604|579682127|FG001|Overall Study|Lost to Follow-up|0|||
160533377|NCT00617604|579682126|FG000|Overall Study|Miscellaneous Reasons|8|||
160533378|NCT00617604|579682127|FG001|Overall Study|Miscellaneous Reasons|10|||
160533379|NCT00617604|579682126|FG000|Overall Study|Withdrawal by Subject|4|||
160533380|NCT00617604|579682127|FG001|Overall Study|Withdrawal by Subject|6|||
160533381|NCT00617604|579682126|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
160533382|NCT00617604|579682127|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
160533383|NCT02303704|579682128|FG000|Overall Study|Protocol Violation|5|||
160533384|NCT02303704|579682129|FG001|Overall Study|Protocol Violation|9|||
160533385|NCT01252810|579682130|FG000|Overall Study|Withdrawal by Subject|4|||
160533386|NCT01252810|579682131|FG001|Overall Study|Withdrawal by Subject|1|||
160533387|NCT01252810|579682130|FG000|Overall Study|Lost to Follow-up|0|||
160533388|NCT01252810|579682131|FG001|Overall Study|Lost to Follow-up|1|||
160533389|NCT01252810|579682130|FG000|Overall Study|Physician Decision|2|||
160533390|NCT01252810|579682131|FG001|Overall Study|Physician Decision|1|||
160533391|NCT01252810|579682130|FG000|Overall Study|Various reasons|8|||
160533392|NCT01252810|579682131|FG001|Overall Study|Various reasons|0|||
160533393|NCT02811549|579682132|FG000|Overall Study|Lost to Follow-up|1|||
160533394|NCT02811549|579682132|FG000|Overall Study|Withdrawal by Subject|3|||
160533395|NCT02811549|579682132|FG000|Overall Study|Subject screen failed|4|||
160533396|NCT02811549|579682132|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
160533397|NCT05293743|579682133|FG000|Overall Study|Withdrawal by Subject|1|||
160533398|NCT05293743|579682134|FG001|Overall Study|Withdrawal by Subject|0|||
160533399|NCT03318978|579682139|FG000|Overall Study|Withdrawal by Subject|1|||
160533400|NCT02844816|579682140|FG000|Overall Study|No protocol treatment received|5|||
160533401|NCT02844816|579682141|FG001|Overall Study|No protocol treatment received|1|||
160533402|NCT02844816|579682140|FG000|Overall Study|Ineligible|22|||
160533403|NCT02844816|579682141|FG001|Overall Study|Ineligible|15|||
160533404|NCT02844816|579682140|FG000|Overall Study|Participant refusal|5|||
160533405|NCT02844816|579682141|FG001|Overall Study|Participant refusal|5|||
160533406|NCT02844816|579682140|FG000|Overall Study|Adverse Event|5|||
160533407|NCT02844816|579682141|FG001|Overall Study|Adverse Event|4|||
160533408|NCT02844816|579682140|FG000|Overall Study|Death|0|||
160533409|NCT02844816|579682141|FG001|Overall Study|Death|1|||
160533410|NCT02844816|579682140|FG000|Overall Study|Disease progression/recurrence|50|||
160533411|NCT02844816|579682141|FG001|Overall Study|Disease progression/recurrence|24|||
160533412|NCT02844816|579682140|FG000|Overall Study|Physician Decision|1|||
160533413|NCT02844816|579682141|FG001|Overall Study|Physician Decision|1|||
160533414|NCT01200238|579682142|FG000|Overall Study|Adverse Event|2|||
160533415|NCT01200238|579682143|FG001|Overall Study|Adverse Event|1|||
160533416|NCT01200238|579682142|FG000|Overall Study|Progressive Disease|5|||
160533417|NCT01200238|579682143|FG001|Overall Study|Progressive Disease|8|||
160533418|NCT01200238|579682142|FG000|Overall Study|Withdrawal by Subject|0|||
160533419|NCT01200238|579682143|FG001|Overall Study|Withdrawal by Subject|1|||
160533420|NCT02717754|579682144|FG000|Overall Study|Incorrect Infusion Duration|0|||
160533421|NCT02717754|579682145|FG001|Overall Study|Incorrect Infusion Duration|0|||
160533422|NCT02717754|579682146|FG002|Overall Study|Incorrect Infusion Duration|0|||
160533423|NCT02717754|579682147|FG003|Overall Study|Incorrect Infusion Duration|10|||
160533424|NCT02717754|579682148|FG004|Overall Study|Incorrect Infusion Duration|20|||
160533425|NCT02717754|579682149|FG005|Overall Study|Incorrect Infusion Duration|20|||
160533426|NCT00482703|579682150|FG000|Overall Study|Poor compliance|1|||
160533427|NCT00482703|579682151|FG001|Overall Study|Poor compliance|0|||
160533428|NCT03697720|579683757|FG000|Overall Study|Lost to Follow-up|7|||
160533429|NCT02322125|579683762|FG000|Overall Study|Withdrawal by Subject|2|||
160533430|NCT00382720|579683763|FG000|Overall Study|Adverse Event|21|||
160533431|NCT00382720|579683764|FG001|Overall Study|Adverse Event|23|||
160533432|NCT00382720|579683765|FG002|Overall Study|Adverse Event|15|||
160533433|NCT00382720|579683763|FG000|Overall Study|Protocol Violation|2|||
160533434|NCT00382720|579683764|FG001|Overall Study|Protocol Violation|5|||
160533435|NCT00382720|579683765|FG002|Overall Study|Protocol Violation|1|||
160533436|NCT00382720|579683763|FG000|Overall Study|Death|0|||
160533437|NCT00382720|579683764|FG001|Overall Study|Death|1|||
160533438|NCT00382720|579683765|FG002|Overall Study|Death|2|||
160533439|NCT00382720|579683763|FG000|Overall Study|Progressive disease|37|||
160533440|NCT00382720|579683764|FG001|Overall Study|Progressive disease|28|||
160533441|NCT00382720|579683765|FG002|Overall Study|Progressive disease|38|||
160533442|NCT00382720|579683763|FG000|Overall Study|Withdrew consent|1|||
160533443|NCT00382720|579683764|FG001|Overall Study|Withdrew consent|1|||
160533444|NCT00382720|579683765|FG002|Overall Study|Withdrew consent|2|||
160533445|NCT00382720|579683763|FG000|Overall Study|Withdrawal by Subject|11|||
160533446|NCT00382720|579683764|FG001|Overall Study|Withdrawal by Subject|20|||
160533447|NCT00382720|579683765|FG002|Overall Study|Withdrawal by Subject|12|||
160767274|NCT02410629|580537729|FG001|Overall Study|Subject moved back to home country|1|||
160453946|NCT02505984|579393977|FG000|Overall Study|Noncompliance with study protocol|0|||
160453947|NCT02505984|579393978|FG001|Overall Study|Noncompliance with study protocol|1|||
160453948|NCT03691935|579393983|FG000|Overall Study|Physician Decision|2|||
160453949|NCT03691935|579393984|FG001|Overall Study|Physician Decision|1|||
160453950|NCT03691935|579393983|FG000|Overall Study|Adverse Event|3|||
160453951|NCT03691935|579393984|FG001|Overall Study|Adverse Event|0|||
160453952|NCT03511664|579393996|FG000|Overall Study|Death|457|||
160453953|NCT03511664|579393997|FG001|Overall Study|Death|201|||
160453954|NCT03511664|579393998|FG002|Overall Study|Death|21|||
160453955|NCT03511664|579393996|FG000|Overall Study|Withdrew consent|40|||
160533448|NCT00382720|579683763|FG000|Overall Study|Surgery|1|||
160533449|NCT00382720|579683764|FG001|Overall Study|Surgery|1|||
160533450|NCT00382720|579683765|FG002|Overall Study|Surgery|4|||
160533451|NCT00382720|579683763|FG000|Overall Study|Patient did not receive study medication|1|||
160533452|NCT00382720|579683764|FG001|Overall Study|Patient did not receive study medication|1|||
160533453|NCT00382720|579683765|FG002|Overall Study|Patient did not receive study medication|4|||
160533454|NCT00382720|579683763|FG000|Overall Study|Clinically progressive disease|0|||
160533455|NCT00382720|579683764|FG001|Overall Study|Clinically progressive disease|1|||
160533456|NCT00382720|579683765|FG002|Overall Study|Clinically progressive disease|0|||
160533457|NCT00382720|579683763|FG000|Overall Study|Good prognosis|0|||
160533458|NCT00382720|579683764|FG001|Overall Study|Good prognosis|1|||
160533459|NCT00382720|579683765|FG002|Overall Study|Good prognosis|0|||
160533460|NCT00382720|579683763|FG000|Overall Study|Investigator/Clinical decision|5|||
160533461|NCT00382720|579683764|FG001|Overall Study|Investigator/Clinical decision|6|||
160533462|NCT00382720|579683765|FG002|Overall Study|Investigator/Clinical decision|6|||
160533463|NCT00382720|579683763|FG000|Overall Study|Discontinued at end of study|0|||
160533464|NCT00382720|579683764|FG001|Overall Study|Discontinued at end of study|1|||
160533465|NCT00382720|579683765|FG002|Overall Study|Discontinued at end of study|2|||
160533466|NCT01183143|579683768|FG000|Overall Study|Protocol Violation|115|||
160533467|NCT01183143|579683768|FG000|Overall Study|Withdrawal by Subject|19|||
160533468|NCT01183143|579683768|FG000|Overall Study|Subject Questionnaires not returned|5|||
160533469|NCT01183143|579683768|FG000|Overall Study|Subjects enrolled, but not treated|11|||
160533470|NCT04096274|579683769|FG000|Phase I|Lost to Follow-up|5|||
160533471|NCT04096274|579683770|FG001|Phase I|Lost to Follow-up|5|||
160533472|NCT04096274|579683769|FG000|Phase II|Lost to Follow-up|11|||
160533473|NCT04096274|579683770|FG001|Phase II|Lost to Follow-up|11|||
160533474|NCT00404820|579683771|FG000|Overall Study|Adverse Event|4|||
160533475|NCT00404820|579683772|FG001|Overall Study|Adverse Event|16|||
160533476|NCT00404820|579683771|FG000|Overall Study|Withdrawal by Subject|5|||
160533477|NCT00404820|579683772|FG001|Overall Study|Withdrawal by Subject|3|||
160533478|NCT00404820|579683771|FG000|Overall Study|Lost to Follow-up|7|||
160533479|NCT00404820|579683772|FG001|Overall Study|Lost to Follow-up|3|||
160533480|NCT00404820|579683771|FG000|Overall Study|Administrative problems|2|||
160533481|NCT00404820|579683772|FG001|Overall Study|Administrative problems|0|||
160533482|NCT00404820|579683771|FG000|Overall Study|Death|1|||
160533483|NCT00404820|579683772|FG001|Overall Study|Death|0|||
160533484|NCT00404820|579683771|FG000|Overall Study|Other|0|||
160533485|NCT00404820|579683772|FG001|Overall Study|Other|2|||
160533486|NCT00709111|579683773|FG000|Overall Study|Withdrawal by Subject|1|||
160533487|NCT00709111|579683773|FG000|Overall Study|Unable to attend clinic visits|1|||
160533488|NCT01735279|579683776|FG000|Overall Study|Lost to Follow-up|11|||
160533489|NCT01735279|579683777|FG001|Overall Study|Lost to Follow-up|8|||
160533490|NCT00806195|579683778|FG000|Overall Study|Death|6|||
160533491|NCT00806195|579683779|FG001|Overall Study|Death|0|||
160533492|NCT00806195|579683780|FG002|Overall Study|Death|1|||
160533493|NCT00806195|579683781|FG003|Overall Study|Death|0|||
160533494|NCT00806195|579683778|FG000|Overall Study|Adverse Event|25|||
160533495|NCT00806195|579683779|FG001|Overall Study|Adverse Event|5|||
160533496|NCT00806195|579683780|FG002|Overall Study|Adverse Event|11|||
160533497|NCT00806195|579683781|FG003|Overall Study|Adverse Event|2|||
160533498|NCT00806195|579683778|FG000|Overall Study|Withdrawal by Subject|119|||
160533499|NCT00806195|579683779|FG001|Overall Study|Withdrawal by Subject|31|||
160533500|NCT00806195|579683780|FG002|Overall Study|Withdrawal by Subject|76|||
160533501|NCT00806195|579683781|FG003|Overall Study|Withdrawal by Subject|35|||
160533502|NCT00806195|579683778|FG000|Overall Study|Lost to Follow-up|217|||
160533503|NCT00806195|579683779|FG001|Overall Study|Lost to Follow-up|66|||
160533504|NCT00806195|579683780|FG002|Overall Study|Lost to Follow-up|90|||
160533505|NCT00806195|579683781|FG003|Overall Study|Lost to Follow-up|34|||
160533506|NCT00806195|579683778|FG000|Overall Study|Inappropriate Enrollment|0|||
160533507|NCT00806195|579683779|FG001|Overall Study|Inappropriate Enrollment|1|||
160533508|NCT00806195|579683780|FG002|Overall Study|Inappropriate Enrollment|0|||
160533509|NCT00806195|579683781|FG003|Overall Study|Inappropriate Enrollment|0|||
160533510|NCT00806195|579683778|FG000|Overall Study|Administrative Reason|113|||
160533511|NCT00806195|579683779|FG001|Overall Study|Administrative Reason|35|||
160533512|NCT00806195|579683780|FG002|Overall Study|Administrative Reason|66|||
160533513|NCT00806195|579683781|FG003|Overall Study|Administrative Reason|26|||
160533514|NCT00806195|579683778|FG000|Overall Study|Protocol Violation|34|||
160533515|NCT00806195|579683779|FG001|Overall Study|Protocol Violation|24|||
160874468|NCT00813943|580934208|FG001|Overall Study|Ongoing at cut-off date|5|||
160533516|NCT00806195|579683780|FG002|Overall Study|Protocol Violation|26|||
160533517|NCT00806195|579683781|FG003|Overall Study|Protocol Violation|9|||
160533518|NCT00914927|579683787|FG000|Overall Study|Adverse Event|0|||
160533519|NCT00914927|579683788|FG001|Overall Study|Adverse Event|0|||
160533520|NCT00914927|579683789|FG002|Overall Study|Adverse Event|0|||
160533521|NCT00914927|579683790|FG003|Overall Study|Adverse Event|0|||
160533522|NCT00914927|579683791|FG004|Overall Study|Adverse Event|1|||
160533523|NCT00914927|579683792|FG005|Overall Study|Adverse Event|0|||
160533524|NCT00914927|579683793|FG006|Overall Study|Adverse Event|0|||
160767275|NCT02410629|580537728|FG000|Overall Study|Subject underwent heart surgery|0|||
160767276|NCT02410629|580537729|FG001|Overall Study|Subject underwent heart surgery|1|||
160767277|NCT01206764|580537730|FG000|Overall Study|Adverse Event|20|||
160767278|NCT01206764|580537730|FG000|Overall Study|Abnormal laboratory value|2|||
160767279|NCT01206764|580537730|FG000|Overall Study|Abnormal test procedure result|1|||
160767280|NCT01206764|580537730|FG000|Overall Study|Patient withdrew consent|5|||
160533525|NCT00914927|579683787|FG000|Overall Study|Withdrawal by Subject|0|||
160533526|NCT00914927|579683788|FG001|Overall Study|Withdrawal by Subject|1|||
160533527|NCT00914927|579683789|FG002|Overall Study|Withdrawal by Subject|0|||
160533528|NCT00914927|579683790|FG003|Overall Study|Withdrawal by Subject|1|||
160533529|NCT00914927|579683791|FG004|Overall Study|Withdrawal by Subject|0|||
160533530|NCT00914927|579683792|FG005|Overall Study|Withdrawal by Subject|0|||
160533531|NCT00914927|579683793|FG006|Overall Study|Withdrawal by Subject|0|||
160533532|NCT00914927|579683787|FG000|Overall Study|Lost to Follow-up|0|||
160533533|NCT00914927|579683788|FG001|Overall Study|Lost to Follow-up|0|||
160533534|NCT00914927|579683789|FG002|Overall Study|Lost to Follow-up|0|||
160533535|NCT00914927|579683790|FG003|Overall Study|Lost to Follow-up|1|||
160533536|NCT00914927|579683791|FG004|Overall Study|Lost to Follow-up|0|||
160533537|NCT00914927|579683792|FG005|Overall Study|Lost to Follow-up|0|||
160533538|NCT00914927|579683793|FG006|Overall Study|Lost to Follow-up|0|||
160533539|NCT00914927|579683787|FG000|Overall Study|Administrative/Other|2|||
160533540|NCT00914927|579683788|FG001|Overall Study|Administrative/Other|1|||
160533541|NCT00914927|579683789|FG002|Overall Study|Administrative/Other|0|||
160533542|NCT00914927|579683790|FG003|Overall Study|Administrative/Other|0|||
160533543|NCT00914927|579683791|FG004|Overall Study|Administrative/Other|1|||
160533544|NCT00914927|579683792|FG005|Overall Study|Administrative/Other|0|||
160533545|NCT00914927|579683793|FG006|Overall Study|Administrative/Other|0|||
160533546|NCT01519934|579683794|FG000|Overall Study|Lost to Follow-up|3|||
160533547|NCT00922480|579683795|FG000|Main Study|Protocol Violation|3|||
160533548|NCT00922480|579683796|FG001|Main Study|Protocol Violation|6|||
160533549|NCT00922480|579683795|FG000|Main Study|Adverse Event|6|||
160533550|NCT00922480|579683796|FG001|Main Study|Adverse Event|7|||
160533551|NCT00922480|579683795|FG000|Main Study|Lack of Efficacy|3|||
160533552|NCT00922480|579683796|FG001|Main Study|Lack of Efficacy|0|||
160533553|NCT00922480|579683795|FG000|Main Study|Withdrawal by Subject|20|||
160533554|NCT00922480|579683796|FG001|Main Study|Withdrawal by Subject|15|||
160533555|NCT00922480|579683795|FG000|Main Study|Lost to Follow-up|5|||
160533556|NCT00922480|579683796|FG001|Main Study|Lost to Follow-up|0|||
160533557|NCT00922480|579683795|FG000|Main Study|Physician Decision|0|||
160533558|NCT00922480|579683796|FG001|Main Study|Physician Decision|1|||
160533559|NCT00922480|579683795|FG000|Extension Study|Protocol Violation|3|||
160533560|NCT00922480|579683796|FG001|Extension Study|Protocol Violation|0|||
160533561|NCT00922480|579683795|FG000|Extension Study|Adverse Event|1|||
160533562|NCT00922480|579683796|FG001|Extension Study|Adverse Event|1|||
160533563|NCT00922480|579683795|FG000|Extension Study|Withdrawal by Subject|1|||
160533564|NCT00922480|579683796|FG001|Extension Study|Withdrawal by Subject|1|||
160533565|NCT00922480|579683795|FG000|Extension Study|Others|0|||
160533566|NCT00922480|579683796|FG001|Extension Study|Others|1|||
160533567|NCT00326209|579683803|FG000|Overall Study|Adverse Event|28|||
160533568|NCT00326209|579683803|FG000|Overall Study|Withdrawal by Subject|22|||
160533569|NCT00326209|579683803|FG000|Overall Study|Lack of Efficacy|31|||
160533570|NCT00326209|579683803|FG000|Overall Study|Lost to Follow-up|18|||
160533571|NCT00326209|579683803|FG000|Overall Study|Participant non-compliant|6|||
160533572|NCT00326209|579683803|FG000|Overall Study|Sponsor closed study|173|||
160533573|NCT00326209|579683803|FG000|Overall Study|Prohibited medication use|1|||
160533574|NCT00326209|579683803|FG000|Overall Study|Violation of entry criteria|1|||
160533575|NCT00326209|579683803|FG000|Overall Study|Withdrawn in error|1|||
160533576|NCT00326209|579683803|FG000|Overall Study|Pregnancy|1|||
160533577|NCT01490814|579683805|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
160874469|NCT00813943|580934209|FG002|Overall Study|Ongoing at cut-off date|3|||
160533578|NCT01490814|579683806|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
160533579|NCT01490814|579683805|FG000|Overall Study|Physician Decision|1|||
160533580|NCT01490814|579683806|FG001|Overall Study|Physician Decision|0|||
160533581|NCT01490814|579683805|FG000|Overall Study|Withdrawal by Subject|0|||
160533582|NCT01490814|579683806|FG001|Overall Study|Withdrawal by Subject|5|||
160533583|NCT01537198|579683807|FG000|Overall Study|RSV infection|2|||
160533584|NCT01537198|579683807|FG000|Overall Study|Adverse Event|4|||
160533585|NCT01537198|579683807|FG000|Overall Study|No Further Visits to the Clinic|37|||
160533586|NCT01537198|579683807|FG000|Overall Study|Other|111|||
160533587|NCT00113074|579683815|FG000|Overall Study|Lost to Follow-up|10|||
160533588|NCT00113074|579683816|FG001|Overall Study|Lost to Follow-up|10|||
160533589|NCT00113074|579683817|FG002|Overall Study|Lost to Follow-up|14|||
160533590|NCT03680911|579683818|FG000|At Home Treatment|Study Termination|3|||
160533591|NCT03680911|579683819|FG001|At Home Treatment|Study Termination|0|||
160533592|NCT03680911|579683818|FG000|At Home Treatment|Lost to Follow-up|0|||
160533593|NCT03680911|579683819|FG001|At Home Treatment|Lost to Follow-up|1|||
160533594|NCT03680911|579683818|FG000|At Home Treatment|Withdrawal by Subject|0|||
160533595|NCT03680911|579683819|FG001|At Home Treatment|Withdrawal by Subject|2|||
160533596|NCT03680911|579683818|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
160533597|NCT03680911|579683819|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
160533598|NCT03962738|579683826|FG000|Overall Study|Protocol Deviation|3|||
160533599|NCT03962738|579683827|FG001|Overall Study|Protocol Deviation|0|||
160533600|NCT03962738|579683828|FG002|Overall Study|Protocol Deviation|1|||
160533601|NCT03962738|579683829|FG003|Overall Study|Protocol Deviation|1|||
160533602|NCT03962738|579683826|FG000|Overall Study|Withdrawal by Subject|4|||
160533603|NCT03962738|579683827|FG001|Overall Study|Withdrawal by Subject|0|||
160533604|NCT03962738|579683828|FG002|Overall Study|Withdrawal by Subject|0|||
160533605|NCT03962738|579683829|FG003|Overall Study|Withdrawal by Subject|0|||
160533606|NCT03962738|579683826|FG000|Overall Study|Lost to Follow-up|0|||
160533607|NCT03962738|579683827|FG001|Overall Study|Lost to Follow-up|0|||
160533608|NCT03962738|579683828|FG002|Overall Study|Lost to Follow-up|1|||
160533609|NCT03962738|579683829|FG003|Overall Study|Lost to Follow-up|0|||
160533610|NCT03492554|579683830|FG000|Overall Study|Protocol Violation|0|||
160533611|NCT03492554|579683831|FG001|Overall Study|Protocol Violation|14|||
160533612|NCT01221727|579683832|FG000|Overall Study|Physician Decision|2|||
160533613|NCT01221727|579683833|FG001|Overall Study|Physician Decision|0|||
160533614|NCT01221727|579683832|FG000|Overall Study|Withdrawal by Subject|1|||
160533615|NCT01221727|579683833|FG001|Overall Study|Withdrawal by Subject|1|||
160533616|NCT02566577|579683834|FG000|Overall Study|Withdrawal by Subject|1|||
160533617|NCT02566577|579683835|FG001|Overall Study|Withdrawal by Subject|1|||
160533618|NCT02566577|579683834|FG000|Overall Study|Equipment failure|1|||
160533619|NCT02566577|579683835|FG001|Overall Study|Equipment failure|1|||
160533620|NCT02566577|579683834|FG000|Overall Study|Physical limitation|1|||
160533621|NCT02566577|579683835|FG001|Overall Study|Physical limitation|0|||
160533622|NCT01289821|579683836|FG000|Treatment Period|Withdrawal by Subject|1|||
160533623|NCT01289821|579683836|FG000|Treatment Period|Physician Decision|3|||
160533624|NCT01289821|579683836|FG000|Treatment Period|Adverse Event|4|||
160533625|NCT01289821|579683836|FG000|Treatment Period|Radiological Progression|43|||
160533626|NCT01289821|579683836|FG000|Treatment Period|Clinical Progression|2|||
160533627|NCT01289821|579683836|FG000|Treatment Period|Therapeutic procedure required|1|||
160533628|NCT01289821|579683836|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
160533629|NCT01289821|579683836|FG000|Safety Follow-up Period|Protocol Violation|3|||
160533630|NCT01289821|579683836|FG000|Safety Follow-up Period|Unspecified reason|1|||
160533631|NCT01289821|579683836|FG000|Survival Follow-up Period|Protocol Violation|1|||
160533632|NCT01289821|579683836|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
160533633|NCT01289821|579683836|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
160533634|NCT01010633|579683837|FG000|Overall Study|Adverse Event|1|||
160533635|NCT01010633|579683838|FG001|Overall Study|Adverse Event|1|||
160533636|NCT01010633|579683837|FG000|Overall Study|Protocol Violation|1|||
160533637|NCT01010633|579683838|FG001|Overall Study|Protocol Violation|2|||
160533638|NCT01010633|579683837|FG000|Overall Study|Withdrawal by Subject|2|||
160533639|NCT01010633|579683838|FG001|Overall Study|Withdrawal by Subject|1|||
160533640|NCT01010633|579683837|FG000|Overall Study|Investigator decision|0|||
160533641|NCT01010633|579683838|FG001|Overall Study|Investigator decision|1|||
160533642|NCT02941926|579683839|FG000|Core Phase|Progressive disease|1109|||
160533643|NCT02941926|579683839|FG000|Core Phase|Adverse Event|504|||
160533644|NCT02941926|579683839|FG000|Core Phase|Subject/guardian decision|127|||
160533645|NCT02941926|579683839|FG000|Core Phase|Physician Decision|112|||
160533646|NCT02941926|579683839|FG000|Core Phase|Death|46|||
160533647|NCT02941926|579683839|FG000|Core Phase|Protocol deviation|34|||
160533648|NCT02941926|579683839|FG000|Core Phase|Lost to Follow-up|8|||
160533649|NCT02941926|579683839|FG000|Core Phase|Technical problems|5|||
160533650|NCT02941926|579683839|FG000|Extension Phase|Physician Decision|155|||
160533651|NCT02941926|579683839|FG000|Extension Phase|Progressive disease|115|||
160533652|NCT02941926|579683839|FG000|Extension Phase|Adverse Event|13|||
160533653|NCT02941926|579683839|FG000|Extension Phase|Subject/Guardian decision|12|||
160533654|NCT02941926|579683839|FG000|Extension Phase|Death|6|||
160533655|NCT00097773|579683840|FG000|Overall Study|Lost to Follow-up|2|||
160533656|NCT00097773|579683841|FG001|Overall Study|Lost to Follow-up|2|||
160767281|NCT01206764|580537730|FG000|Overall Study|Lost to Follow-up|6|||
160533657|NCT00097773|579683842|FG002|Overall Study|Lost to Follow-up|0|||
160533658|NCT00097773|579683843|FG003|Overall Study|Lost to Follow-up|1|||
160533659|NCT00097773|579683840|FG000|Overall Study|Physician Decision|2|||
160533660|NCT00097773|579683841|FG001|Overall Study|Physician Decision|2|||
160533661|NCT00097773|579683842|FG002|Overall Study|Physician Decision|3|||
160533662|NCT00097773|579683843|FG003|Overall Study|Physician Decision|1|||
160533663|NCT00097773|579683840|FG000|Overall Study|Withdrawal by Subject|3|||
160533664|NCT00097773|579683841|FG001|Overall Study|Withdrawal by Subject|3|||
160533665|NCT00097773|579683842|FG002|Overall Study|Withdrawal by Subject|3|||
160533666|NCT00097773|579683843|FG003|Overall Study|Withdrawal by Subject|1|||
160533667|NCT00097773|579683840|FG000|Overall Study|Adverse Event|0|||
160533668|NCT00097773|579683841|FG001|Overall Study|Adverse Event|1|||
160533669|NCT00097773|579683842|FG002|Overall Study|Adverse Event|0|||
160533670|NCT00097773|579683843|FG003|Overall Study|Adverse Event|0|||
160533671|NCT00097773|579683840|FG000|Overall Study|Other|1|||
160533672|NCT00097773|579683841|FG001|Overall Study|Other|0|||
160533673|NCT00097773|579683842|FG002|Overall Study|Other|2|||
160533674|NCT00097773|579683843|FG003|Overall Study|Other|0|||
160533675|NCT01009034|579683844|FG000|Overall Study|Lost to Follow-up|2|||
160533676|NCT01009034|579683844|FG000|Overall Study|Withdrawal by Subject|2|||
160533677|NCT05093322|579683845|FG000|Overall Study|Death|6|||
160533678|NCT05093322|579683846|FG001|Overall Study|Death|2|||
160533679|NCT05093322|579683845|FG000|Overall Study|Other|4|||
160533680|NCT05093322|579683846|FG001|Overall Study|Other|1|||
160533681|NCT00898443|579683847|FG000|Overall Study|Withdrawal by Subject|1|||
160533682|NCT00898443|579683848|FG001|Overall Study|Withdrawal by Subject|0|||
160533683|NCT00074581|579683850|FG000|Overall Study|Death|15|||
160533684|NCT00074581|579683851|FG001|Overall Study|Death|16|||
160533685|NCT00074581|579683850|FG000|Overall Study|Withdrawal by Subject|50|||
160533686|NCT00074581|579683851|FG001|Overall Study|Withdrawal by Subject|49|||
160533687|NCT00074581|579683850|FG000|Overall Study|Unable to adhere to visit schedule|13|||
160533688|NCT00074581|579683851|FG001|Overall Study|Unable to adhere to visit schedule|14|||
160533689|NCT00074581|579683850|FG000|Overall Study|Relocated|14|||
160533690|NCT00074581|579683851|FG001|Overall Study|Relocated|9|||
160533691|NCT00074581|579683850|FG000|Overall Study|Were withdrawn by investigator|5|||
160533692|NCT00074581|579683851|FG001|Overall Study|Were withdrawn by investigator|2|||
160533693|NCT00074581|579683850|FG000|Overall Study|Lost to Follow-up|16|||
160533694|NCT00074581|579683851|FG001|Overall Study|Lost to Follow-up|11|||
160533695|NCT00074581|579683850|FG000|Overall Study|Ended relationship w. index participant|117|||
160533696|NCT00074581|579683851|FG001|Overall Study|Ended relationship w. index participant|106|||
160533697|NCT00074581|579683850|FG000|Overall Study|Other|14|||
160533698|NCT00074581|579683851|FG001|Overall Study|Other|19|||
160533699|NCT01770912|579683852|FG000|Overall Study|Lost to Follow-up|2|||
160533700|NCT01770912|579683853|FG001|Overall Study|Lost to Follow-up|0|||
160533701|NCT03250832|579683854|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
160533702|NCT03250832|579683855|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
160533703|NCT03250832|579683856|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
160533704|NCT03250832|579683857|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
160533705|NCT03250832|579683858|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
160533706|NCT03250832|579683859|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
160533707|NCT03250832|579683860|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
160533708|NCT03250832|579683861|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
160533709|NCT03250832|579683862|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
160533710|NCT03250832|579683863|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
160533711|NCT03250832|579683864|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
160533712|NCT03250832|579683865|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
160533713|NCT03250832|579683854|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
160533714|NCT03250832|579683855|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
160533715|NCT03250832|579683856|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
160533716|NCT03250832|579683857|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
160533717|NCT03250832|579683858|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
160533718|NCT03250832|579683859|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
160533719|NCT03250832|579683860|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
160533720|NCT03250832|579683861|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
160533721|NCT03250832|579683862|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
160533722|NCT03250832|579683863|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
160533723|NCT03250832|579683864|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
160533724|NCT03250832|579683865|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
160533725|NCT03250832|579683854|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533726|NCT03250832|579683855|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533727|NCT03250832|579683856|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
160533728|NCT03250832|579683857|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533729|NCT03250832|579683858|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533730|NCT03250832|579683859|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533731|NCT03250832|579683860|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533732|NCT03250832|579683861|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533733|NCT03250832|579683862|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533734|NCT03250832|579683863|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533735|NCT03250832|579683864|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533736|NCT03250832|579683865|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
160533737|NCT03250832|579683854|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533738|NCT03250832|579683855|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533739|NCT03250832|579683856|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533740|NCT03250832|579683857|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533741|NCT03250832|579683858|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533742|NCT03250832|579683859|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533743|NCT03250832|579683860|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533744|NCT03250832|579683861|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
160533745|NCT03250832|579683862|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533746|NCT03250832|579683863|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533747|NCT03250832|579683864|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533748|NCT03250832|579683865|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
160533749|NCT03250832|579683854|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160767282|NCT01206764|580537730|FG000|Overall Study|Death|11|||
160767283|NCT01206764|580537730|FG000|Overall Study|New cancer therapy|2|||
160767284|NCT01206764|580537730|FG000|Overall Study|Disease progression|88|||
160767285|NCT01206764|580537730|FG000|Overall Study|Protocol deviation|3|||
160767286|NCT04494646|580537731|FG000|Overall Study|Adverse Event|0|||
160767287|NCT04494646|580537732|FG001|Overall Study|Adverse Event|1|||
160533750|NCT03250832|579683855|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160533751|NCT03250832|579683856|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160533752|NCT03250832|579683857|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160767288|NCT04494646|580537731|FG000|Overall Study|Withdrawal by Subject|0|||
160533753|NCT03250832|579683858|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160533754|NCT03250832|579683859|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160533755|NCT03250832|579683860|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160533756|NCT03250832|579683861|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
160533757|NCT03250832|579683862|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160533758|NCT03250832|579683863|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160533759|NCT03250832|579683864|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160533760|NCT03250832|579683865|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
160533761|NCT03250832|579683854|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533762|NCT03250832|579683855|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533763|NCT03250832|579683856|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533764|NCT03250832|579683857|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533765|NCT03250832|579683858|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533766|NCT03250832|579683859|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533767|NCT03250832|579683860|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533768|NCT03250832|579683861|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
160533769|NCT03250832|579683862|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533770|NCT03250832|579683863|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533771|NCT03250832|579683864|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533772|NCT03250832|579683865|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
160533773|NCT03250832|579683854|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533774|NCT03250832|579683855|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533775|NCT03250832|579683856|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533776|NCT03250832|579683857|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533777|NCT03250832|579683858|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533778|NCT03250832|579683859|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533779|NCT03250832|579683860|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533780|NCT03250832|579683861|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
160533781|NCT03250832|579683862|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533782|NCT03250832|579683863|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533783|NCT03250832|579683864|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533784|NCT03250832|579683865|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
160533785|NCT03250832|579683854|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533786|NCT03250832|579683855|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533787|NCT03250832|579683856|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533788|NCT03250832|579683857|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533789|NCT03250832|579683858|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533790|NCT03250832|579683859|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533791|NCT03250832|579683860|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533792|NCT03250832|579683861|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
160533793|NCT03250832|579683862|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533794|NCT03250832|579683863|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533795|NCT03250832|579683864|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533796|NCT03250832|579683865|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
160533797|NCT03250832|579683854|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
160533798|NCT03250832|579683855|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
160533799|NCT03250832|579683856|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
160533800|NCT03250832|579683857|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
160533801|NCT03250832|579683858|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
160533802|NCT03250832|579683859|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
160533803|NCT03250832|579683860|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
160533804|NCT03250832|579683861|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
160533805|NCT03250832|579683862|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
160767289|NCT04494646|580537732|FG001|Overall Study|Withdrawal by Subject|1|||
160767290|NCT05282823|580537733|FG000|Overall Study|Withdrawal by Subject|9|||
160533806|NCT03250832|579683863|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
160533807|NCT03250832|579683864|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
160533808|NCT03250832|579683865|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
160533809|NCT03250832|579683854|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
160767291|NCT05282823|580537733|FG000|Overall Study|Adverse Event|1|||
160767292|NCT05282823|580537733|FG000|Overall Study|did not meet protocol criteria|2|||
160767293|NCT05282823|580537733|FG000|Overall Study|Withdrawal by Subject|7|||
160767294|NCT03620162|580537734|FG000|Overall Study|Physician Decision|4|||
160767295|NCT03620162|580537735|FG001|Overall Study|Physician Decision|0|||
160767296|NCT03620162|580537736|FG002|Overall Study|Physician Decision|1|||
160767297|NCT03620162|580537737|FG003|Overall Study|Physician Decision|0|||
160874470|NCT00387790|580934216|FG000|Overall Study|Adverse Event|5|||
160874471|NCT00387790|580934216|FG000|Overall Study|Lack of Efficacy|2|||
160533810|NCT03250832|579683855|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
160533811|NCT03250832|579683856|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
160533812|NCT03250832|579683857|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
160533813|NCT03250832|579683858|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
160533814|NCT03250832|579683859|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
160533815|NCT03250832|579683860|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
160533816|NCT03250832|579683861|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
160533817|NCT03250832|579683862|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
160533818|NCT03250832|579683863|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
160533819|NCT03250832|579683864|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
160533820|NCT03250832|579683865|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
160533821|NCT03250832|579683854|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
160533822|NCT03250832|579683855|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
160533823|NCT03250832|579683856|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
160533824|NCT03250832|579683857|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
160533825|NCT03250832|579683858|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
160533826|NCT03250832|579683859|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
160533827|NCT03250832|579683860|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
160533828|NCT03250832|579683861|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
160533829|NCT03250832|579683862|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
160533830|NCT03250832|579683863|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
160533831|NCT03250832|579683864|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
160533832|NCT03250832|579683865|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
160533833|NCT03250832|579683854|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533834|NCT03250832|579683855|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533835|NCT03250832|579683856|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533836|NCT03250832|579683857|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533837|NCT03250832|579683858|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533838|NCT03250832|579683859|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533839|NCT03250832|579683860|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533840|NCT03250832|579683861|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533841|NCT03250832|579683862|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533842|NCT03250832|579683863|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533843|NCT03250832|579683864|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
160533844|NCT03250832|579683865|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
160533845|NCT01708291|579683866|FG000|Overall Study|fighting|2|||
160533846|NCT01708291|579683867|FG001|Overall Study|fighting|1|||
160533847|NCT04411628|579683869|FG000|Overall Study|Withdrawal by Subject|1|||
160533848|NCT04411628|579683870|FG001|Overall Study|Withdrawal by Subject|1|||
160533849|NCT04411628|579683871|FG002|Overall Study|Withdrawal by Subject|2|||
160533850|NCT04411628|579683872|FG003|Overall Study|Withdrawal by Subject|0|||
160533851|NCT04411628|579683869|FG000|Overall Study|Lost to Follow-up|0|||
160533852|NCT04411628|579683870|FG001|Overall Study|Lost to Follow-up|1|||
160533853|NCT04411628|579683871|FG002|Overall Study|Lost to Follow-up|0|||
160533854|NCT04411628|579683872|FG003|Overall Study|Lost to Follow-up|0|||
160533855|NCT01034540|579683873|FG000|Overall Study|Adverse Event|0|||
160533856|NCT01034540|579683874|FG001|Overall Study|Adverse Event|1|||
160533857|NCT00932425|579683877|FG000|Overall Study|Lost to Follow-up|0|||
160533858|NCT00932425|579683878|FG001|Overall Study|Lost to Follow-up|1|||
160533859|NCT00932425|579683877|FG000|Overall Study|Withdrawal by Subject|0|||
160533860|NCT00932425|579683878|FG001|Overall Study|Withdrawal by Subject|1|||
160533861|NCT01721876|579683879|FG000|Overall Study|Not treated|1|||
160533862|NCT01721876|579683880|FG001|Overall Study|Not treated|4|||
160533863|NCT01721876|579683879|FG000|Overall Study|Disease progression / relapse|123|||
160533864|NCT01721876|579683880|FG001|Overall Study|Disease progression / relapse|156|||
160533865|NCT01721876|579683879|FG000|Overall Study|Death|6|||
160533866|NCT01721876|579683880|FG001|Overall Study|Death|13|||
160533867|NCT01721876|579683879|FG000|Overall Study|Adverse Event|41|||
160533868|NCT01721876|579683880|FG001|Overall Study|Adverse Event|165|||
160533869|NCT01721876|579683879|FG000|Overall Study|Protocol Violation|2|||
160533870|NCT01721876|579683880|FG001|Overall Study|Protocol Violation|1|||
160533871|NCT01721876|579683879|FG000|Overall Study|Withdrawal by Subject|15|||
160533872|NCT01721876|579683880|FG001|Overall Study|Withdrawal by Subject|38|||
160533873|NCT01721876|579683879|FG000|Overall Study|Reason not listed|34|||
160533874|NCT01721876|579683880|FG001|Overall Study|Reason not listed|63|||
160533875|NCT01721876|579683879|FG000|Overall Study|Sponsor terminated trial|0|||
160533876|NCT01721876|579683880|FG001|Overall Study|Sponsor terminated trial|4|||
160533877|NCT03805750|579683881|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
160533878|NCT03805750|579683882|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
160533879|NCT00493220|579683883|FG000|Third Intervention|Withdrawal by Subject|1|||
160533880|NCT00493220|579683884|FG001|Third Intervention|Withdrawal by Subject|0|||
160533881|NCT00493220|579683885|FG002|Third Intervention|Withdrawal by Subject|0|||
160533882|NCT00493220|579683886|FG003|Third Intervention|Withdrawal by Subject|0|||
160533883|NCT00493220|579683887|FG004|Third Intervention|Withdrawal by Subject|0|||
160533884|NCT00493220|579683888|FG005|Third Intervention|Withdrawal by Subject|0|||
160533885|NCT00310804|579683889|FG000|Overall Study|Lost to Follow-up|2|||
160533886|NCT00310804|579683890|FG001|Overall Study|Lost to Follow-up|0|||
160533887|NCT00310804|579683889|FG000|Overall Study|Withdrawal by Subject|3|||
160533888|NCT00310804|579683890|FG001|Overall Study|Withdrawal by Subject|0|||
160533889|NCT00445224|579683891|FG000|Specific Exercises|Withdrawal by Subject|3|||
160533890|NCT00445224|579683892|FG001|Specific Exercises|Withdrawal by Subject|3|||
160533891|NCT00445224|579683891|FG000|Specific Exercises|Withdrawal by Subject|1|||
160533892|NCT00445224|579683892|FG001|Specific Exercises|Withdrawal by Subject|0|||
160533893|NCT03184077|579683895|FG000|Overall Study|Lost to Follow-up|21|||
160533894|NCT03184077|579683896|FG001|Overall Study|Lost to Follow-up|21|||
160533895|NCT01889238|579683897|FG000|Overall Study|Death|1|||
160533896|NCT01889238|579683897|FG000|Overall Study|Withdrawal by Subject|1|||
160533897|NCT01889238|579683897|FG000|Overall Study|Adverse Event|6|||
160533898|NCT01889238|579683897|FG000|Overall Study|Disease Progression|104|||
160533899|NCT01889238|579683897|FG000|Overall Study|Other|6|||
160533900|NCT04136184|579683898|FG000|Overall Study|Lost to Follow-up|0|||
160533901|NCT04136184|579683899|FG001|Overall Study|Lost to Follow-up|3|||
160533902|NCT04136184|579683898|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
160533903|NCT04136184|579683899|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
160533904|NCT00667823|579683904|FG000|Overall Study|Lost to Follow-up|5|||
160533905|NCT00667823|579683904|FG000|Overall Study|Adverse Event|7|||
160533906|NCT00667823|579683904|FG000|Overall Study|Death|182|||
160533907|NCT00667823|579683904|FG000|Overall Study|Withdrawal by Subject|12|||
160533908|NCT00667823|579683904|FG000|Overall Study|Other|8|||
160533909|NCT00667823|579683904|FG000|Overall Study|Missing (completion page missing)|2|||
160533910|NCT01428661|579683907|FG000|Double-Masked Phase|Protocol Violation|9|||
160533911|NCT01428661|579683908|FG001|Double-Masked Phase|Protocol Violation|4|||
160533912|NCT01428661|579683909|FG002|Double-Masked Phase|Protocol Violation|0|||
160533913|NCT01428661|579683907|FG000|Double-Masked Phase|Adverse Event|13|||
160533914|NCT01428661|579683908|FG001|Double-Masked Phase|Adverse Event|4|||
160533915|NCT01428661|579683909|FG002|Double-Masked Phase|Adverse Event|0|||
160533916|NCT01428661|579683907|FG000|Double-Masked Phase|Lost to Follow-up|14|||
160533917|NCT01428661|579683908|FG001|Double-Masked Phase|Lost to Follow-up|14|||
160533918|NCT01428661|579683909|FG002|Double-Masked Phase|Lost to Follow-up|0|||
160533919|NCT01428661|579683907|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
160533920|NCT01428661|579683908|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
160533921|NCT01428661|579683909|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
160533922|NCT01428661|579683907|FG000|Double-Masked Phase|Lack of Efficacy|2|||
160533923|NCT01428661|579683908|FG001|Double-Masked Phase|Lack of Efficacy|1|||
160533924|NCT01428661|579683909|FG002|Double-Masked Phase|Lack of Efficacy|0|||
160533925|NCT01428661|579683907|FG000|Double-Masked Phase|*Various|1|||
160533926|NCT01428661|579683908|FG001|Double-Masked Phase|*Various|6|||
160533927|NCT01428661|579683909|FG002|Double-Masked Phase|*Various|0|||
160533928|NCT01428661|579683907|FG000|Open Label Extension|Protocol Violation|0|||
160533929|NCT01428661|579683908|FG001|Open Label Extension|Protocol Violation|0|||
160533930|NCT01428661|579683909|FG002|Open Label Extension|Protocol Violation|9|||
160533931|NCT01428661|579683907|FG000|Open Label Extension|Adverse Event|0|||
160533932|NCT01428661|579683908|FG001|Open Label Extension|Adverse Event|0|||
160533933|NCT01428661|579683909|FG002|Open Label Extension|Adverse Event|15|||
160533934|NCT01428661|579683907|FG000|Open Label Extension|Lost to Follow-up|0|||
160533935|NCT01428661|579683908|FG001|Open Label Extension|Lost to Follow-up|0|||
160767298|NCT03620162|580537738|FG004|Overall Study|Physician Decision|2|||
160767299|NCT03620162|580537734|FG000|Overall Study|Lost to Follow-up|2|||
160767300|NCT03620162|580537735|FG001|Overall Study|Lost to Follow-up|6|||
160767301|NCT03620162|580537736|FG002|Overall Study|Lost to Follow-up|7|||
160767302|NCT03620162|580537737|FG003|Overall Study|Lost to Follow-up|3|||
160767303|NCT03620162|580537738|FG004|Overall Study|Lost to Follow-up|2|||
160767304|NCT03620162|580537734|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
160767305|NCT03620162|580537735|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
160767306|NCT03620162|580537736|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
160533936|NCT01428661|579683909|FG002|Open Label Extension|Lost to Follow-up|38|||
160533937|NCT01428661|579683907|FG000|Open Label Extension|Withdrawal by Subject|0|||
160533938|NCT01428661|579683908|FG001|Open Label Extension|Withdrawal by Subject|0|||
160533939|NCT01428661|579683909|FG002|Open Label Extension|Withdrawal by Subject|49|||
160533940|NCT01428661|579683907|FG000|Open Label Extension|Lack of Efficacy|0|||
160533941|NCT01428661|579683908|FG001|Open Label Extension|Lack of Efficacy|0|||
160533942|NCT01428661|579683909|FG002|Open Label Extension|Lack of Efficacy|24|||
160767307|NCT03620162|580537737|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
160533943|NCT01428661|579683907|FG000|Open Label Extension|**Various|0|||
160533944|NCT01428661|579683908|FG001|Open Label Extension|**Various|0|||
160767308|NCT03620162|580537738|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
160533945|NCT01428661|579683909|FG002|Open Label Extension|**Various|185|||
160533946|NCT03828292|579683910|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
160533947|NCT03828292|579683911|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
160533948|NCT03828292|579683912|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
160533949|NCT03828292|579683913|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
160533950|NCT03828292|579683914|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
160533951|NCT03828292|579683915|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
160533952|NCT03828292|579683910|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
160533953|NCT03828292|579683911|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
160533954|NCT03828292|579683912|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
160533955|NCT03828292|579683913|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
160533956|NCT03828292|579683914|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
160533957|NCT03828292|579683915|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
160533958|NCT03828292|579683910|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
160533959|NCT03828292|579683911|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
160533960|NCT03828292|579683912|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
160533961|NCT03828292|579683913|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
160533962|NCT03828292|579683914|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
160767309|NCT05569174|580537739|FG000|Overall Study|Adverse Event|0|||
160767310|NCT05569174|580537740|FG001|Overall Study|Adverse Event|1|||
160767311|NCT05569174|580537739|FG000|Overall Study|Lack of compliance|0|||
160767312|NCT05569174|580537740|FG001|Overall Study|Lack of compliance|1|||
160767313|NCT05569174|580537739|FG000|Overall Study|Withdrawal of consent|0|||
160767314|NCT05569174|580537740|FG001|Overall Study|Withdrawal of consent|1|||
160533963|NCT03828292|579683915|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
160533964|NCT03828292|579683910|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
160533965|NCT03828292|579683911|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
160533966|NCT03828292|579683912|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
160767315|NCT05569174|580537739|FG000|Overall Study|Participant wish|0|||
160767316|NCT05569174|580537740|FG001|Overall Study|Participant wish|1|||
160767317|NCT05569174|580537739|FG000|Overall Study|Lost to Follow-up|0|||
160767318|NCT05569174|580537740|FG001|Overall Study|Lost to Follow-up|1|||
160767319|NCT00112957|580537741|FG000|Overall Study|Progressive disease|18|||
160767320|NCT00112957|580537741|FG000|Overall Study|Physician Decision|1|||
160767321|NCT00961415|580537745|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
160533967|NCT03828292|579683913|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
160533968|NCT03828292|579683914|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
160533969|NCT03828292|579683915|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
160533970|NCT03828292|579683910|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
160533971|NCT03828292|579683911|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
160533972|NCT03828292|579683912|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
160533973|NCT03828292|579683913|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
160767322|NCT00961415|580537746|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
160767323|NCT00961415|580537747|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
160533974|NCT03828292|579683914|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
160533975|NCT03828292|579683915|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
160533976|NCT06156215|579683916|FG000|Overall Study|Withdrawal by Subject|2|||
160533977|NCT06156215|579683917|FG001|Overall Study|Withdrawal by Subject|4|||
160533978|NCT06156215|579683918|FG002|Overall Study|Withdrawal by Subject|4|||
160533979|NCT06156215|579683919|FG003|Overall Study|Withdrawal by Subject|0|||
160533980|NCT06156215|579683920|FG004|Overall Study|Withdrawal by Subject|2|||
160533981|NCT06156215|579683921|FG005|Overall Study|Withdrawal by Subject|2|||
160533982|NCT06156215|579683916|FG000|Overall Study|Left ED without completing study|9|||
160533983|NCT06156215|579683917|FG001|Overall Study|Left ED without completing study|3|||
160533984|NCT06156215|579683918|FG002|Overall Study|Left ED without completing study|9|||
160533985|NCT06156215|579683919|FG003|Overall Study|Left ED without completing study|0|||
160533986|NCT06156215|579683920|FG004|Overall Study|Left ED without completing study|8|||
160533987|NCT06156215|579683921|FG005|Overall Study|Left ED without completing study|16|||
160533988|NCT06156215|579683916|FG000|Overall Study|Physician Decision|1|||
160533989|NCT06156215|579683917|FG001|Overall Study|Physician Decision|0|||
160533990|NCT06156215|579683918|FG002|Overall Study|Physician Decision|0|||
160533991|NCT06156215|579683919|FG003|Overall Study|Physician Decision|0|||
160533992|NCT06156215|579683920|FG004|Overall Study|Physician Decision|0|||
160533993|NCT06156215|579683921|FG005|Overall Study|Physician Decision|0|||
160533994|NCT06156215|579683916|FG000|Overall Study|Became or found ineligible|2|||
160533995|NCT06156215|579683917|FG001|Overall Study|Became or found ineligible|0|||
160533996|NCT06156215|579683918|FG002|Overall Study|Became or found ineligible|2|||
160533997|NCT06156215|579683919|FG003|Overall Study|Became or found ineligible|0|||
160533998|NCT06156215|579683920|FG004|Overall Study|Became or found ineligible|1|||
160533999|NCT06156215|579683921|FG005|Overall Study|Became or found ineligible|2|||
160534000|NCT04376827|579683922|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
160534001|NCT04376827|579683923|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
160534002|NCT04376827|579683922|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
160534003|NCT04376827|579683923|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
160534004|NCT04376827|579683922|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
160534005|NCT04376827|579683923|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
160534006|NCT04376827|579683922|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
160534007|NCT04376827|579683923|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
160534008|NCT04376827|579683922|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
160534009|NCT04376827|579683923|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
160534010|NCT04360551|579685509|FG000|Overall Study|Withdrawal by Subject|1|||
160534011|NCT04360551|579685510|FG001|Overall Study|Withdrawal by Subject|0|||
160534012|NCT03496012|579685514|FG000|Overall Study|Withdrawal by Subject|2|||
160534013|NCT03496012|579685515|FG001|Overall Study|Withdrawal by Subject|0|||
160534014|NCT03496012|579685516|FG002|Overall Study|Withdrawal by Subject|2|||
160534015|NCT03496012|579685514|FG000|Overall Study|Adverse Event|0|||
160534016|NCT03496012|579685515|FG001|Overall Study|Adverse Event|0|||
160534017|NCT03496012|579685516|FG002|Overall Study|Adverse Event|1|||
160534018|NCT03496012|579685514|FG000|Overall Study|Reason Not Specified|2|||
160534019|NCT03496012|579685515|FG001|Overall Study|Reason Not Specified|0|||
160534020|NCT03496012|579685516|FG002|Overall Study|Reason Not Specified|1|||
160534021|NCT01524198|579685525|FG000|Overall Study|Protocol Violation|8|||
160534022|NCT01524198|579685526|FG001|Overall Study|Protocol Violation|6|||
160534023|NCT01524198|579685525|FG000|Overall Study|Withdrawal by Subject|15|||
160534024|NCT01524198|579685526|FG001|Overall Study|Withdrawal by Subject|10|||
160534025|NCT02232802|579685527|FG000|Period 1|Sponsor request|1|||
160534026|NCT02232802|579685528|FG001|Period 1|Sponsor request|0|||
160534027|NCT02232802|579685527|FG000|Period 1|Adverse Event|1|||
160534028|NCT02232802|579685528|FG001|Period 1|Adverse Event|1|||
160534029|NCT00885703|579685533|FG000|Overall Study|Death|9|||
160534030|NCT00885703|579685534|FG001|Overall Study|Death|7|||
160534031|NCT00885703|579685535|FG002|Overall Study|Death|8|||
160534032|NCT00885703|579685536|FG003|Overall Study|Death|7|||
160534033|NCT00885703|579685537|FG004|Overall Study|Death|7|||
160534034|NCT00885703|579685538|FG005|Overall Study|Death|8|||
160534035|NCT00885703|579685539|FG006|Overall Study|Death|4|||
160534036|NCT00885703|579685533|FG000|Overall Study|Lost to Follow-up|0|||
160534037|NCT00885703|579685534|FG001|Overall Study|Lost to Follow-up|0|||
160534038|NCT00885703|579685535|FG002|Overall Study|Lost to Follow-up|1|||
160534039|NCT00885703|579685536|FG003|Overall Study|Lost to Follow-up|0|||
160534040|NCT00885703|579685537|FG004|Overall Study|Lost to Follow-up|0|||
160534041|NCT00885703|579685538|FG005|Overall Study|Lost to Follow-up|1|||
160534042|NCT00885703|579685539|FG006|Overall Study|Lost to Follow-up|0|||
160534043|NCT00885703|579685533|FG000|Overall Study|Withdrawal by Subject|0|||
160534044|NCT00885703|579685534|FG001|Overall Study|Withdrawal by Subject|0|||
160534045|NCT00885703|579685535|FG002|Overall Study|Withdrawal by Subject|0|||
160534046|NCT00885703|579685536|FG003|Overall Study|Withdrawal by Subject|1|||
160534047|NCT00885703|579685537|FG004|Overall Study|Withdrawal by Subject|3|||
160534048|NCT00885703|579685538|FG005|Overall Study|Withdrawal by Subject|1|||
160534049|NCT00885703|579685539|FG006|Overall Study|Withdrawal by Subject|1|||
160534050|NCT00885703|579685533|FG000|Overall Study|Ineligible (no CM)|1|||
160534051|NCT00885703|579685534|FG001|Overall Study|Ineligible (no CM)|3|||
160534052|NCT00885703|579685535|FG002|Overall Study|Ineligible (no CM)|2|||
160534053|NCT00885703|579685536|FG003|Overall Study|Ineligible (no CM)|1|||
160534054|NCT00885703|579685537|FG004|Overall Study|Ineligible (no CM)|2|||
160534055|NCT00885703|579685538|FG005|Overall Study|Ineligible (no CM)|3|||
160534056|NCT00885703|579685539|FG006|Overall Study|Ineligible (no CM)|1|||
160534057|NCT01490450|579685542|FG000|Period 1|Lack of Efficacy|2|||
160534058|NCT01490450|579685543|FG001|Period 1|Lack of Efficacy|0|||
160534059|NCT01490450|579685544|FG002|Period 1|Lack of Efficacy|3|||
160534060|NCT01490450|579685545|FG003|Period 1|Lack of Efficacy|0|||
160534061|NCT01490450|579685542|FG000|Period 1|Adverse Event|0|||
160534062|NCT01490450|579685543|FG001|Period 1|Adverse Event|0|||
160534063|NCT01490450|579685544|FG002|Period 1|Adverse Event|0|||
160534064|NCT01490450|579685545|FG003|Period 1|Adverse Event|5|||
160534065|NCT01490450|579685542|FG000|Period 1|Request to discontinue treatment|1|||
160534066|NCT01490450|579685543|FG001|Period 1|Request to discontinue treatment|0|||
160534067|NCT01490450|579685544|FG002|Period 1|Request to discontinue treatment|0|||
160534068|NCT01490450|579685545|FG003|Period 1|Request to discontinue treatment|0|||
160534069|NCT01490450|579685542|FG000|Period 1|Withdrawal by Subject|0|||
160534070|NCT01490450|579685543|FG001|Period 1|Withdrawal by Subject|0|||
160534071|NCT01490450|579685544|FG002|Period 1|Withdrawal by Subject|0|||
160534072|NCT01490450|579685545|FG003|Period 1|Withdrawal by Subject|3|||
160534073|NCT01490450|579685542|FG000|Period 1|No longer met study criteria|0|||
160534074|NCT01490450|579685543|FG001|Period 1|No longer met study criteria|1|||
160534075|NCT01490450|579685544|FG002|Period 1|No longer met study criteria|1|||
160534076|NCT01490450|579685545|FG003|Period 1|No longer met study criteria|0|||
160534077|NCT01490450|579685542|FG000|Period 2|Lack of Efficacy|0|||
160534078|NCT01490450|579685543|FG001|Period 2|Lack of Efficacy|0|||
160534079|NCT01490450|579685544|FG002|Period 2|Lack of Efficacy|0|||
160534080|NCT01490450|579685545|FG003|Period 2|Lack of Efficacy|1|||
160534081|NCT01490450|579685542|FG000|Period 2|Adverse Event|1|||
160534082|NCT01490450|579685543|FG001|Period 2|Adverse Event|1|||
160534083|NCT01490450|579685544|FG002|Period 2|Adverse Event|0|||
160534084|NCT01490450|579685545|FG003|Period 2|Adverse Event|1|||
160534085|NCT01490450|579685542|FG000|Period 2|Withdrawal by Subject|1|||
160534086|NCT01490450|579685543|FG001|Period 2|Withdrawal by Subject|0|||
160534087|NCT01490450|579685544|FG002|Period 2|Withdrawal by Subject|0|||
160534088|NCT01490450|579685545|FG003|Period 2|Withdrawal by Subject|0|||
160534089|NCT01490450|579685542|FG000|Period 2|Lost to Follow-up|0|||
160534090|NCT01490450|579685543|FG001|Period 2|Lost to Follow-up|0|||
160534091|NCT01490450|579685544|FG002|Period 2|Lost to Follow-up|0|||
160534092|NCT01490450|579685545|FG003|Period 2|Lost to Follow-up|2|||
160534093|NCT01462435|579685546|FG000|Overall Study|Lack of Efficacy|1|||
160534094|NCT01462435|579685547|FG001|Overall Study|Lack of Efficacy|0|||
160534095|NCT01462435|579685548|FG002|Overall Study|Lack of Efficacy|0|||
160534096|NCT01462435|579685549|FG003|Overall Study|Lack of Efficacy|3|||
160534097|NCT01462435|579685546|FG000|Overall Study|Physician Decision|0|||
160534098|NCT01462435|579685547|FG001|Overall Study|Physician Decision|0|||
160534099|NCT01462435|579685548|FG002|Overall Study|Physician Decision|1|||
160534100|NCT01462435|579685549|FG003|Overall Study|Physician Decision|0|||
160534101|NCT01462435|579685546|FG000|Overall Study|Withdrawal by Subject|0|||
160534102|NCT01462435|579685547|FG001|Overall Study|Withdrawal by Subject|0|||
160534103|NCT01462435|579685548|FG002|Overall Study|Withdrawal by Subject|0|||
160534104|NCT01462435|579685549|FG003|Overall Study|Withdrawal by Subject|1|||
160534105|NCT01462435|579685546|FG000|Overall Study|Lost to Follow-up|0|||
160534106|NCT01462435|579685547|FG001|Overall Study|Lost to Follow-up|0|||
160534107|NCT01462435|579685548|FG002|Overall Study|Lost to Follow-up|0|||
160534108|NCT01462435|579685549|FG003|Overall Study|Lost to Follow-up|1|||
160534109|NCT01543152|579685552|FG000|Overall Study|Withdrawal by Subject|0|||
160534110|NCT01543152|579685553|FG001|Overall Study|Withdrawal by Subject|2|||
160534111|NCT01543152|579685554|FG002|Overall Study|Withdrawal by Subject|0|||
160534112|NCT01543152|579685555|FG003|Overall Study|Withdrawal by Subject|0|||
160534113|NCT01543152|579685556|FG004|Overall Study|Withdrawal by Subject|0|||
160534114|NCT02053168|579685559|FG000|Overall Study|Withdrawal by Subject|1|||
160534115|NCT02053168|579685559|FG000|Overall Study|Physician Decision|1|||
160534116|NCT02053168|579685559|FG000|Overall Study|Lost to Follow-up|1|||
160534117|NCT00636675|579685561|FG000|Overall Study|Lost to Follow-up|121|||
160534118|NCT00636675|579685562|FG001|Overall Study|Lost to Follow-up|31|||
160534119|NCT00636675|579685561|FG000|Overall Study|Withdrawal by Subject|19|||
160534120|NCT00636675|579685562|FG001|Overall Study|Withdrawal by Subject|10|||
160534121|NCT02687542|579685563|FG000|Overall Study|Medication error without associated AEs|0|||
160534122|NCT02687542|579685564|FG001|Overall Study|Medication error without associated AEs|0|||
160534123|NCT02687542|579685565|FG002|Overall Study|Medication error without associated AEs|0|||
160534124|NCT02687542|579685566|FG003|Overall Study|Medication error without associated AEs|0|||
160534125|NCT02687542|579685567|FG004|Overall Study|Medication error without associated AEs|1|||
160534126|NCT02687542|579685563|FG000|Overall Study|Lost to Follow-up|0|||
160534127|NCT02687542|579685564|FG001|Overall Study|Lost to Follow-up|0|||
160534128|NCT02687542|579685565|FG002|Overall Study|Lost to Follow-up|0|||
160534129|NCT02687542|579685566|FG003|Overall Study|Lost to Follow-up|0|||
160534130|NCT02687542|579685567|FG004|Overall Study|Lost to Follow-up|1|||
160534131|NCT02687542|579685563|FG000|Overall Study|Protocol Violation|0|||
160534132|NCT02687542|579685564|FG001|Overall Study|Protocol Violation|1|||
160534133|NCT02687542|579685565|FG002|Overall Study|Protocol Violation|0|||
160534134|NCT02687542|579685566|FG003|Overall Study|Protocol Violation|0|||
160534135|NCT02687542|579685567|FG004|Overall Study|Protocol Violation|0|||
160534136|NCT02687542|579685563|FG000|Overall Study|Other|5|||
160534137|NCT02687542|579685564|FG001|Overall Study|Other|9|||
160534138|NCT02687542|579685565|FG002|Overall Study|Other|10|||
160534139|NCT02687542|579685566|FG003|Overall Study|Other|6|||
160534140|NCT02687542|579685567|FG004|Overall Study|Other|5|||
160534141|NCT02687542|579685563|FG000|Overall Study|Adverse Event|3|||
160534142|NCT02687542|579685564|FG001|Overall Study|Adverse Event|1|||
160534143|NCT02687542|579685565|FG002|Overall Study|Adverse Event|3|||
160534144|NCT02687542|579685566|FG003|Overall Study|Adverse Event|2|||
160534145|NCT02687542|579685567|FG004|Overall Study|Adverse Event|9|||
160534146|NCT02687542|579685563|FG000|Overall Study|Withdrawal by Subject|0|||
160767324|NCT00961415|580537745|FG000|Induction Treatment Phase|Death|77|||
160534147|NCT02687542|579685564|FG001|Overall Study|Withdrawal by Subject|1|||
160534148|NCT02687542|579685565|FG002|Overall Study|Withdrawal by Subject|1|||
160534149|NCT02687542|579685566|FG003|Overall Study|Withdrawal by Subject|2|||
160534150|NCT02687542|579685567|FG004|Overall Study|Withdrawal by Subject|4|||
160534151|NCT00176605|579685568|FG000|Overall Study|Withdrawal by Subject|2|||
160767325|NCT00961415|580537746|FG001|Induction Treatment Phase|Death|0|||
160767326|NCT00961415|580537747|FG002|Induction Treatment Phase|Death|0|||
160767327|NCT00961415|580537745|FG000|Induction Treatment Phase|Protocol Violation|1|||
160767328|NCT00961415|580537746|FG001|Induction Treatment Phase|Protocol Violation|0|||
160767329|NCT00961415|580537747|FG002|Induction Treatment Phase|Protocol Violation|0|||
160767330|NCT00961415|580537745|FG000|Induction Treatment Phase|Physician Decision|2|||
160534152|NCT03785925|579685569|FG000|Overall Study|Withdrawal by Subject|15|||
160534153|NCT03785925|579685569|FG000|Overall Study|Lost to Follow-up|1|||
160534154|NCT01227187|579685570|FG000|Overall Study|Physician Decision|0|||
160534155|NCT01227187|579685571|FG001|Overall Study|Physician Decision|0|||
160534156|NCT01227187|579685572|FG002|Overall Study|Physician Decision|0|||
160534157|NCT01227187|579685573|FG003|Overall Study|Physician Decision|1|||
160534158|NCT00957528|579685577|FG000|Overall Study|Protocol Violation|0|||
160534159|NCT00957528|579685578|FG001|Overall Study|Protocol Violation|1|||
160534160|NCT00957528|579685579|FG002|Overall Study|Protocol Violation|0|||
160534161|NCT00957528|579685577|FG000|Overall Study|Withdrawal by Subject|0|||
160534162|NCT00957528|579685578|FG001|Overall Study|Withdrawal by Subject|0|||
160534163|NCT00957528|579685579|FG002|Overall Study|Withdrawal by Subject|1|||
160534164|NCT02318667|579685580|FG000|Overall Study|Adverse Event|1|||
160534165|NCT02318667|579685580|FG000|Overall Study|Lack of Efficacy|6|||
160534166|NCT02318667|579685580|FG000|Overall Study|Protocol Violation|2|||
160767331|NCT00961415|580537746|FG001|Induction Treatment Phase|Physician Decision|0|||
160534167|NCT01101438|579685582|FG000|Overall Study|Withdrawal by Subject|8|||
160534168|NCT01101438|579685583|FG001|Overall Study|Withdrawal by Subject|9|||
160534169|NCT02289742|579685592|FG000|First Wear Period|Adverse event prior to treatment|0|||
160534170|NCT02289742|579685593|FG001|First Wear Period|Adverse event prior to treatment|1|||
160534171|NCT02289742|579685594|FG002|First Wear Period|Adverse event prior to treatment|0|||
160534172|NCT02289742|579685595|FG003|First Wear Period|Adverse event prior to treatment|0|||
160534173|NCT02289742|579685592|FG000|First Wear Period|Adverse Event|0|||
160534174|NCT02289742|579685593|FG001|First Wear Period|Adverse Event|0|||
160534175|NCT02289742|579685594|FG002|First Wear Period|Adverse Event|1|||
160534176|NCT02289742|579685595|FG003|First Wear Period|Adverse Event|0|||
160534177|NCT02289742|579685592|FG000|First Wear Period|Other prior to treatment|0|||
160534178|NCT02289742|579685593|FG001|First Wear Period|Other prior to treatment|0|||
160534179|NCT02289742|579685594|FG002|First Wear Period|Other prior to treatment|0|||
160534180|NCT02289742|579685595|FG003|First Wear Period|Other prior to treatment|1|||
160534181|NCT02289742|579685592|FG000|Third Wear Period|Adverse Event|0|||
160534182|NCT02289742|579685593|FG001|Third Wear Period|Adverse Event|1|||
160534183|NCT02289742|579685594|FG002|Third Wear Period|Adverse Event|0|||
160534184|NCT02289742|579685595|FG003|Third Wear Period|Adverse Event|0|||
160534185|NCT02289742|579685592|FG000|Third Wear Period|Reason not given|0|||
160534186|NCT02289742|579685593|FG001|Third Wear Period|Reason not given|0|||
160534187|NCT02289742|579685594|FG002|Third Wear Period|Reason not given|0|||
160534188|NCT02289742|579685595|FG003|Third Wear Period|Reason not given|1|||
160534189|NCT02865018|579685596|FG000|Overall Study|Withdrawal by Subject|1|||
160534190|NCT00915772|579685599|FG000|Overall Study|Adverse Event|12|||
160534191|NCT00915772|579685600|FG001|Overall Study|Adverse Event|13|||
160534192|NCT00915772|579685601|FG002|Overall Study|Adverse Event|11|||
160534193|NCT00915772|579685599|FG000|Overall Study|Protocol Violation|4|||
160534194|NCT00915772|579685600|FG001|Overall Study|Protocol Violation|1|||
160534195|NCT00915772|579685601|FG002|Overall Study|Protocol Violation|2|||
160534196|NCT00915772|579685599|FG000|Overall Study|Lost to Follow-up|1|||
160534197|NCT00915772|579685600|FG001|Overall Study|Lost to Follow-up|2|||
160534198|NCT00915772|579685601|FG002|Overall Study|Lost to Follow-up|2|||
160534199|NCT00915772|579685599|FG000|Overall Study|Lack of Efficacy|9|||
160534200|NCT00915772|579685600|FG001|Overall Study|Lack of Efficacy|15|||
160534201|NCT00915772|579685601|FG002|Overall Study|Lack of Efficacy|3|||
160534202|NCT00915772|579685599|FG000|Overall Study|Refused to continue trial medication|6|||
160534203|NCT00915772|579685600|FG001|Overall Study|Refused to continue trial medication|8|||
160534204|NCT00915772|579685601|FG002|Overall Study|Refused to continue trial medication|4|||
160534205|NCT00915772|579685599|FG000|Overall Study|Any other reason|4|||
160534206|NCT00915772|579685600|FG001|Overall Study|Any other reason|7|||
160534207|NCT00915772|579685601|FG002|Overall Study|Any other reason|7|||
160534208|NCT00971178|579685606|FG000|Overall Study|Lost to Follow-up|2|||
160534209|NCT00971178|579685607|FG001|Overall Study|Lost to Follow-up|2|||
160534210|NCT00971178|579685608|FG002|Overall Study|Lost to Follow-up|2|||
160534211|NCT02138617|579685609|FG000|Overall Study|Death|1|||
160534212|NCT02138617|579685610|FG001|Overall Study|Death|2|||
160534213|NCT02138617|579685611|FG002|Overall Study|Death|2|||
160534214|NCT02138617|579685609|FG000|Overall Study|Adverse Event|8|||
160534215|NCT02138617|579685610|FG001|Overall Study|Adverse Event|5|||
160534216|NCT02138617|579685611|FG002|Overall Study|Adverse Event|2|||
160534217|NCT02138617|579685609|FG000|Overall Study|Disease Progression|20|||
160534218|NCT02138617|579685610|FG001|Overall Study|Disease Progression|13|||
160534219|NCT02138617|579685611|FG002|Overall Study|Disease Progression|4|||
160534220|NCT02138617|579685609|FG000|Overall Study|Withdrawal by Subject|7|||
160534221|NCT02138617|579685610|FG001|Overall Study|Withdrawal by Subject|10|||
160534222|NCT02138617|579685611|FG002|Overall Study|Withdrawal by Subject|2|||
160534223|NCT02138617|579685609|FG000|Overall Study|other complicating disease|0|||
160534224|NCT02138617|579685610|FG001|Overall Study|other complicating disease|2|||
160534225|NCT02138617|579685611|FG002|Overall Study|other complicating disease|0|||
160534226|NCT02138617|579685609|FG000|Overall Study|Protocol Violation|1|||
160534227|NCT02138617|579685610|FG001|Overall Study|Protocol Violation|0|||
160534228|NCT02138617|579685611|FG002|Overall Study|Protocol Violation|0|||
160534229|NCT02138617|579685609|FG000|Overall Study|Physician Decision|7|||
160534230|NCT02138617|579685610|FG001|Overall Study|Physician Decision|6|||
160534231|NCT02138617|579685611|FG002|Overall Study|Physician Decision|0|||
160534232|NCT02138617|579685609|FG000|Overall Study|financial reason|0|||
160534233|NCT02138617|579685610|FG001|Overall Study|financial reason|1|||
160534234|NCT02138617|579685611|FG002|Overall Study|financial reason|0|||
160534235|NCT02138617|579685609|FG000|Overall Study|other therapy|3|||
160534236|NCT02138617|579685610|FG001|Overall Study|other therapy|4|||
160534237|NCT02138617|579685611|FG002|Overall Study|other therapy|0|||
160534238|NCT01671111|579685612|FG000|Overall Study|Adverse Event|2|||
160534239|NCT01671111|579685612|FG000|Overall Study|Lack of Efficacy|1|||
160534240|NCT01671111|579685612|FG000|Overall Study|Withdrawal by Subject|2|||
160534241|NCT01671111|579685612|FG000|Overall Study|Physician Decision|1|||
160767332|NCT00961415|580537747|FG002|Induction Treatment Phase|Physician Decision|0|||
160534242|NCT01671111|579685612|FG000|Overall Study|Other|24|||
160534243|NCT01231659|579685616|FG000|Overall Study|Adverse Event|9|||
160534244|NCT01231659|579685616|FG000|Overall Study|Disease Progression|48|||
160534245|NCT01231659|579685616|FG000|Overall Study|Death|2|||
160534246|NCT01231659|579685616|FG000|Overall Study|Patient refused to complete study visit|1|||
160534247|NCT01231659|579685616|FG000|Overall Study|Other protocol defined criteria|12|||
160534248|NCT00496730|579685617|FG000|Overall Study|Lost to Follow-up|4|||
160534249|NCT00496730|579685618|FG001|Overall Study|Lost to Follow-up|3|||
160534250|NCT00496730|579685617|FG000|Overall Study|Withdrawal by Subject|2|||
160534251|NCT00496730|579685618|FG001|Overall Study|Withdrawal by Subject|2|||
160534252|NCT01075412|579685619|FG000|Overall Study|Withdrawal by Subject|0|||
160534253|NCT01075412|579685620|FG001|Overall Study|Withdrawal by Subject|1|||
160534254|NCT00509067|579685621|FG000|Overall Study|Lost to Follow-up|1|||
160534255|NCT00509067|579685622|FG001|Overall Study|Lost to Follow-up|1|||
160534256|NCT00509067|579685621|FG000|Overall Study|Adverse Event|3|||
160534257|NCT00509067|579685622|FG001|Overall Study|Adverse Event|1|||
160534258|NCT00509067|579685621|FG000|Overall Study|Protocol Violation|0|||
160534259|NCT00509067|579685622|FG001|Overall Study|Protocol Violation|3|||
160534260|NCT00702325|579685634|FG000|Overall Study|Adverse Event|1|||
160534261|NCT00702325|579685635|FG001|Overall Study|Adverse Event|0|||
160534262|NCT00702325|579685634|FG000|Overall Study|Withdrawal by Subject|7|||
160534263|NCT00702325|579685635|FG001|Overall Study|Withdrawal by Subject|7|||
160534264|NCT00702325|579685634|FG000|Overall Study|Lost to Follow-up|3|||
160534265|NCT00702325|579685635|FG001|Overall Study|Lost to Follow-up|4|||
160534266|NCT00702325|579685634|FG000|Overall Study|Incorrect enrollment|5|||
160534267|NCT00702325|579685635|FG001|Overall Study|Incorrect enrollment|7|||
160534268|NCT00702325|579685634|FG000|Overall Study|Developed study discontinuation criteria|18|||
160534269|NCT00702325|579685635|FG001|Overall Study|Developed study discontinuation criteria|28|||
160534270|NCT00702325|579685634|FG000|Overall Study|Severe noncompliance to protocol|3|||
160534271|NCT00702325|579685635|FG001|Overall Study|Severe noncompliance to protocol|3|||
160534272|NCT00702325|579685634|FG000|Overall Study|Termination due to lab results|1|||
160534273|NCT00702325|579685635|FG001|Overall Study|Termination due to lab results|0|||
160534274|NCT00702325|579685634|FG000|Overall Study|Didn't follow study medication dosage|0|||
160534275|NCT00702325|579685635|FG001|Overall Study|Didn't follow study medication dosage|2|||
160534276|NCT00702325|579685634|FG000|Overall Study|Withdrew consent|0|||
160534277|NCT00702325|579685635|FG001|Overall Study|Withdrew consent|1|||
160534278|NCT00702325|579685634|FG000|Overall Study|Incorrectly Discontinued|0|||
160534279|NCT00702325|579685635|FG001|Overall Study|Incorrectly Discontinued|1|||
160534280|NCT04556136|579685641|FG000|Overall Study|Lost to Follow-up|6|||
160534281|NCT04556136|579685642|FG001|Overall Study|Lost to Follow-up|6|||
160534282|NCT04556136|579685641|FG000|Overall Study|Physician Decision|2|||
160534283|NCT04556136|579685642|FG001|Overall Study|Physician Decision|1|||
160534284|NCT04556136|579685641|FG000|Overall Study|Withdrawal by Subject|2|||
160534285|NCT04556136|579685642|FG001|Overall Study|Withdrawal by Subject|1|||
160534286|NCT01478360|579685645|FG000|Overall Study|Lost to Follow-up|1|||
160534287|NCT01478360|579685646|FG001|Overall Study|Lost to Follow-up|0|||
160534288|NCT01478360|579685645|FG000|Overall Study|Adverse Event|0|||
160534289|NCT01478360|579685646|FG001|Overall Study|Adverse Event|1|||
160534290|NCT01478360|579685645|FG000|Overall Study|Administrative problems|1|||
160534291|NCT01478360|579685646|FG001|Overall Study|Administrative problems|2|||
160534292|NCT03716050|579685647|FG000|Overall Study|Lost to Follow-up|0|||
160534293|NCT03716050|579685648|FG001|Overall Study|Lost to Follow-up|0|||
160534294|NCT03716050|579685649|FG002|Overall Study|Lost to Follow-up|1|||
160534295|NCT03716050|579685650|FG003|Overall Study|Lost to Follow-up|0|||
160534296|NCT03716050|579685651|FG004|Overall Study|Lost to Follow-up|0|||
160534297|NCT03716050|579685652|FG005|Overall Study|Lost to Follow-up|0|||
160534298|NCT03716050|579685653|FG006|Overall Study|Lost to Follow-up|0|||
160534299|NCT03716050|579685654|FG007|Overall Study|Lost to Follow-up|0|||
160534300|NCT03716050|579685647|FG000|Overall Study|Physician Decision|0|||
160534301|NCT03716050|579685648|FG001|Overall Study|Physician Decision|0|||
160534302|NCT03716050|579685649|FG002|Overall Study|Physician Decision|0|||
160534303|NCT03716050|579685650|FG003|Overall Study|Physician Decision|1|||
160534304|NCT03716050|579685651|FG004|Overall Study|Physician Decision|0|||
160534305|NCT03716050|579685652|FG005|Overall Study|Physician Decision|0|||
160534306|NCT03716050|579685653|FG006|Overall Study|Physician Decision|0|||
160534307|NCT03716050|579685654|FG007|Overall Study|Physician Decision|0|||
160534308|NCT03716050|579685647|FG000|Overall Study|Protocol Violation|0|||
160534309|NCT03716050|579685648|FG001|Overall Study|Protocol Violation|0|||
160534310|NCT03716050|579685649|FG002|Overall Study|Protocol Violation|0|||
160534311|NCT03716050|579685650|FG003|Overall Study|Protocol Violation|1|||
160534312|NCT03716050|579685651|FG004|Overall Study|Protocol Violation|0|||
160534313|NCT03716050|579685652|FG005|Overall Study|Protocol Violation|0|||
160534314|NCT03716050|579685653|FG006|Overall Study|Protocol Violation|0|||
160534315|NCT03716050|579685654|FG007|Overall Study|Protocol Violation|2|||
160534316|NCT01494350|579685655|FG000|Overall Study|Worsening of lesion|1|||
160534317|NCT00474708|579685656|FG000|Overall Study|Lack of Efficacy|11|||
160534318|NCT00474708|579685657|FG001|Overall Study|Lack of Efficacy|5|||
160534319|NCT00474708|579685656|FG000|Overall Study|Suicide ideation/behavior|0|||
160534320|NCT00474708|579685657|FG001|Overall Study|Suicide ideation/behavior|1|||
160534321|NCT00474708|579685656|FG000|Overall Study|Withdrawal by Subject|7|||
160534322|NCT00474708|579685657|FG001|Overall Study|Withdrawal by Subject|0|||
160534323|NCT00474708|579685656|FG000|Overall Study|Lack of compliance|12|||
160534324|NCT00474708|579685657|FG001|Overall Study|Lack of compliance|4|||
160534325|NCT00474708|579685656|FG000|Overall Study|Lost to Follow-up|18|||
160534326|NCT00474708|579685657|FG001|Overall Study|Lost to Follow-up|9|||
160534327|NCT00474708|579685656|FG000|Overall Study|Physician Decision|9|||
160534328|NCT00474708|579685657|FG001|Overall Study|Physician Decision|6|||
160534329|NCT02243865|579685660|FG000|Overall Study|Protocol Violation|1|||
160874472|NCT00387790|580934216|FG000|Overall Study|Physician Decision|2|||
160874473|NCT00387790|580934216|FG000|Overall Study|Withdrawal by Subject|3|||
160534330|NCT02243865|579685661|FG001|Overall Study|Protocol Violation|3|||
160534331|NCT02243865|579685660|FG000|Overall Study|Lost to Follow-up|1|||
160534332|NCT02243865|579685661|FG001|Overall Study|Lost to Follow-up|1|||
160534333|NCT02243865|579685660|FG000|Overall Study|Withdrawal by Subject|1|||
160534334|NCT02243865|579685661|FG001|Overall Study|Withdrawal by Subject|0|||
160534335|NCT02243865|579685660|FG000|Overall Study|Adverse Event|1|||
160534336|NCT02243865|579685661|FG001|Overall Study|Adverse Event|1|||
160874474|NCT00387790|580934216|FG000|Overall Study|Ineligible for study|2|||
160874475|NCT03860259|580934223|FG000|Overall Study|Lost to Follow-up|5|||
160874476|NCT03860259|580934224|FG001|Overall Study|Lost to Follow-up|5|||
160874477|NCT03860259|580934223|FG000|Overall Study|Protocol Violation|1|||
160874478|NCT03860259|580934224|FG001|Overall Study|Protocol Violation|0|||
160874479|NCT02280408|580934225|FG000|Overall Study|Lost to Follow-up|0|||
160874480|NCT02280408|580934226|FG001|Overall Study|Lost to Follow-up|2|||
160874481|NCT02280408|580934227|FG002|Overall Study|Lost to Follow-up|0|||
160874482|NCT02280408|580934228|FG003|Overall Study|Lost to Follow-up|0|||
160874483|NCT00486291|580934234|FG000|Overall Study|Adverse Event|3|||
160534337|NCT00545402|579685664|FG000|Overall Study|Discontinuation of treatment|17|||
160534338|NCT00545402|579685665|FG001|Overall Study|Discontinuation of treatment|9|||
160534339|NCT00545402|579685664|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
160534340|NCT00545402|579685665|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
160534341|NCT00545402|579685664|FG000|Overall Study|Death|5|||
160534342|NCT00545402|579685665|FG001|Overall Study|Death|7|||
160534343|NCT00545402|579685664|FG000|Overall Study|Graft loss|2|||
160534344|NCT00545402|579685665|FG001|Overall Study|Graft loss|4|||
160534345|NCT00545402|579685664|FG000|Overall Study|Withdrawal by Subject|0|||
160534346|NCT00545402|579685665|FG001|Overall Study|Withdrawal by Subject|1|||
160534347|NCT00545402|579685664|FG000|Overall Study|Protocol Violation|1|||
160534348|NCT00545402|579685665|FG001|Overall Study|Protocol Violation|0|||
160534349|NCT00545402|579685664|FG000|Overall Study|Reason not specified|1|||
160534350|NCT00545402|579685665|FG001|Overall Study|Reason not specified|1|||
160534351|NCT00427349|579685666|FG000|Overall Study|Lack of Efficacy|23|||
160534352|NCT00427349|579685666|FG000|Overall Study|Adverse Event|14|||
160534353|NCT00427349|579685666|FG000|Overall Study|Death|1|||
160534354|NCT00427349|579685666|FG000|Overall Study|Withdrawal by Subject|3|||
160534355|NCT00427349|579685666|FG000|Overall Study|Alternative therapy|1|||
160534356|NCT00427349|579685666|FG000|Overall Study|Other|2|||
160534357|NCT00427349|579685666|FG000|Overall Study|Ineligible|1|||
160534358|NCT00427349|579685666|FG000|Overall Study|Never started therapy|1|||
160534359|NCT00916279|579685669|FG000|Overall Study|Death|2|||
160534360|NCT00916279|579685669|FG000|Overall Study|Lost to Follow-up|2|||
160534361|NCT02592018|579685674|FG000|Overall Study|Adverse Event|1|||
160534362|NCT02592018|579685674|FG000|Overall Study|Lost to Follow-up|1|||
160534363|NCT01566773|579687396|FG000|Overall Study|Protocol specified criteria|4|||
160534364|NCT01566773|579687396|FG000|Overall Study|Protocol Violation|4|||
160534365|NCT01566773|579687396|FG000|Overall Study|Withdrawal by Subject|9|||
160534366|NCT01566773|579687396|FG000|Overall Study|Administrative reason|1|||
160534367|NCT01566773|579687396|FG000|Overall Study|Adverse Event|10|||
160534368|NCT01566773|579687396|FG000|Overall Study|Physician Decision|2|||
160534369|NCT00833053|579687397|FG000|Overall Study|Adverse Event|4|||
160534370|NCT00833053|579687398|FG001|Overall Study|Adverse Event|0|||
160534371|NCT00833053|579687397|FG000|Overall Study|Treatment Failure|3|||
160534372|NCT00833053|579687398|FG001|Overall Study|Treatment Failure|1|||
160534373|NCT00833053|579687397|FG000|Overall Study|Withdrawal by Subject|0|||
160534374|NCT00833053|579687398|FG001|Overall Study|Withdrawal by Subject|1|||
160534375|NCT00833053|579687397|FG000|Overall Study|Protocol Violation|2|||
160534376|NCT00833053|579687398|FG001|Overall Study|Protocol Violation|1|||
160534377|NCT02187471|579687399|FG000|Overall Study|Protocol Violation|4|||
160534378|NCT02187471|579687400|FG001|Overall Study|Protocol Violation|5|||
160534379|NCT02187471|579687401|FG002|Overall Study|Protocol Violation|4|||
160534380|NCT02187471|579687402|FG003|Overall Study|Protocol Violation|4|||
160534381|NCT02187471|579687399|FG000|Overall Study|Missing|0|||
160534382|NCT02187471|579687400|FG001|Overall Study|Missing|0|||
160534383|NCT02187471|579687401|FG002|Overall Study|Missing|0|||
160534384|NCT02187471|579687402|FG003|Overall Study|Missing|1|||
160534385|NCT02187471|579687399|FG000|Overall Study|Lack of Efficacy|18|||
160534386|NCT02187471|579687400|FG001|Overall Study|Lack of Efficacy|9|||
160534387|NCT02187471|579687401|FG002|Overall Study|Lack of Efficacy|13|||
160534388|NCT02187471|579687402|FG003|Overall Study|Lack of Efficacy|11|||
160534389|NCT02187471|579687399|FG000|Overall Study|Adverse Event|24|||
160534390|NCT02187471|579687400|FG001|Overall Study|Adverse Event|34|||
160534391|NCT02187471|579687401|FG002|Overall Study|Adverse Event|44|||
160534392|NCT02187471|579687402|FG003|Overall Study|Adverse Event|36|||
160534393|NCT02187471|579687399|FG000|Overall Study|Withdrawal by Subject|23|||
160534394|NCT02187471|579687400|FG001|Overall Study|Withdrawal by Subject|29|||
160534395|NCT02187471|579687401|FG002|Overall Study|Withdrawal by Subject|22|||
160534396|NCT02187471|579687402|FG003|Overall Study|Withdrawal by Subject|24|||
160534397|NCT02187471|579687399|FG000|Overall Study|Other|7|||
160534398|NCT02187471|579687400|FG001|Overall Study|Other|5|||
160534399|NCT02187471|579687401|FG002|Overall Study|Other|3|||
160534400|NCT02187471|579687402|FG003|Overall Study|Other|4|||
160534401|NCT01365039|579687405|FG000|Overall Study|Study related symptoms and complaints|1|||
160534402|NCT01365039|579687406|FG001|Overall Study|Study related symptoms and complaints|0|||
160534403|NCT00549939|579687413|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
160534404|NCT00549939|579687414|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
160534405|NCT00549939|579687415|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
160534406|NCT00549939|579687413|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
160534407|NCT00549939|579687414|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
160534408|NCT00549939|579687415|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
160534409|NCT00549939|579687413|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
160534410|NCT00549939|579687414|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
160534411|NCT00549939|579687415|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
160534412|NCT00549939|579687413|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
160534413|NCT00549939|579687414|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
160534414|NCT00549939|579687415|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
160534415|NCT00549939|579687413|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
160534416|NCT00549939|579687414|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
160534417|NCT00549939|579687415|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
160534418|NCT00549939|579687413|FG000|40-week Open Label Treatment Period|Other|0|||
160534419|NCT00549939|579687414|FG001|40-week Open Label Treatment Period|Other|1|||
160534420|NCT00549939|579687415|FG002|40-week Open Label Treatment Period|Other|4|||
160534421|NCT03677596|579687416|FG000|Overall Study|Adverse Event|0|||
160534422|NCT03677596|579687417|FG001|Overall Study|Adverse Event|1|||
160534423|NCT03677596|579687416|FG000|Overall Study|Death|10|||
160534424|NCT03677596|579687417|FG001|Overall Study|Death|6|||
160534425|NCT03677596|579687416|FG000|Overall Study|Lost to Follow-up|0|||
160534426|NCT03677596|579687417|FG001|Overall Study|Lost to Follow-up|1|||
160534427|NCT03677596|579687416|FG000|Overall Study|Progressive Disease|8|||
160534428|NCT03677596|579687417|FG001|Overall Study|Progressive Disease|8|||
160534429|NCT03677596|579687416|FG000|Overall Study|Withdrawal by Subject|3|||
160534430|NCT03677596|579687417|FG001|Overall Study|Withdrawal by Subject|0|||
160534431|NCT03677596|579687416|FG000|Overall Study|Disease Relapse|2|||
160534432|NCT03677596|579687417|FG001|Overall Study|Disease Relapse|2|||
160534433|NCT03677596|579687416|FG000|Overall Study|Other|0|||
160534434|NCT03677596|579687417|FG001|Overall Study|Other|1|||
160534435|NCT00294060|579687418|FG000|Overall Study|Death|225|||
160534436|NCT00294060|579687418|FG000|Overall Study|Other|59|||
160534437|NCT00294060|579687418|FG000|Overall Study|Lost to Follow-up|55|||
160534438|NCT00294060|579687418|FG000|Overall Study|Withdrawal by Subject|11|||
160534439|NCT00294060|579687418|FG000|Overall Study|Physician Decision|797|||
160534440|NCT00294060|579687418|FG000|Overall Study|Medical condition|3|||
160534441|NCT00294060|579687418|FG000|Overall Study|Device explanted/not replaced|23|||
160534442|NCT00139776|579687419|FG000|Period I|Did not enter Period II|575|||
160534443|NCT00139776|579687420|FG001|Period I|Did not enter Period II|0|||
160534444|NCT00139776|579687421|FG002|Period I|Did not enter Period II|0|||
160534445|NCT00139776|579687422|FG003|Period I|Did not enter Period II|0|||
160534446|NCT00139776|579687419|FG000|Period II|Not Randomized into Period III|0|||
160534447|NCT00139776|579687420|FG001|Period II|Not Randomized into Period III|322|||
160534448|NCT00139776|579687421|FG002|Period II|Not Randomized into Period III|0|||
160534449|NCT00139776|579687422|FG003|Period II|Not Randomized into Period III|0|||
160534450|NCT00139776|579687419|FG000|Period III|Adverse Event|0|||
160767333|NCT00961415|580537745|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
160534451|NCT00139776|579687420|FG001|Period III|Adverse Event|0|||
160534452|NCT00139776|579687421|FG002|Period III|Adverse Event|22|||
160534453|NCT00139776|579687422|FG003|Period III|Adverse Event|23|||
160534454|NCT00139776|579687419|FG000|Period III|Other|0|||
160534455|NCT00139776|579687420|FG001|Period III|Other|0|||
160534456|NCT00139776|579687421|FG002|Period III|Other|23|||
160534457|NCT00139776|579687422|FG003|Period III|Other|34|||
160534458|NCT00139776|579687419|FG000|Period III|Lack of Efficacy|0|||
160534459|NCT00139776|579687420|FG001|Period III|Lack of Efficacy|0|||
160534460|NCT00139776|579687421|FG002|Period III|Lack of Efficacy|10|||
160534461|NCT00139776|579687422|FG003|Period III|Lack of Efficacy|24|||
160534462|NCT00139776|579687419|FG000|Period III|Lost to Follow-up|0|||
160534463|NCT00139776|579687420|FG001|Period III|Lost to Follow-up|0|||
160534464|NCT00139776|579687421|FG002|Period III|Lost to Follow-up|5|||
160534465|NCT00139776|579687422|FG003|Period III|Lost to Follow-up|4|||
160534466|NCT00139776|579687419|FG000|Period III|Withdrawal by Subject|0|||
160534467|NCT00139776|579687420|FG001|Period III|Withdrawal by Subject|0|||
160534468|NCT00139776|579687421|FG002|Period III|Withdrawal by Subject|16|||
160534469|NCT00139776|579687422|FG003|Period III|Withdrawal by Subject|21|||
160534470|NCT00187096|579687423|FG000|Overall Study|unacceptable toxicity|0|||
160534471|NCT00187096|579687424|FG001|Overall Study|unacceptable toxicity|0|||
160534472|NCT00187096|579687425|FG002|Overall Study|unacceptable toxicity|1|||
160534473|NCT02161575|579687438|FG000|Overall Study|Protocol Violation|8|||
160534474|NCT02161575|579687438|FG000|Overall Study|Lack of Efficacy|1|||
160534475|NCT02161575|579687438|FG000|Overall Study|Adverse Event|2|||
160534476|NCT00714285|579687439|FG000|Overall Study|Lost to Follow-up|0|||
160534477|NCT00714285|579687440|FG001|Overall Study|Lost to Follow-up|2|||
160534478|NCT00714285|579687441|FG002|Overall Study|Lost to Follow-up|0|||
160534479|NCT00714285|579687442|FG003|Overall Study|Lost to Follow-up|1|||
160767334|NCT00961415|580537746|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
160534480|NCT00714285|579687439|FG000|Overall Study|Migrated/moved from study area|0|||
160534481|NCT00714285|579687440|FG001|Overall Study|Migrated/moved from study area|1|||
160534482|NCT00714285|579687441|FG002|Overall Study|Migrated/moved from study area|0|||
160534483|NCT00714285|579687442|FG003|Overall Study|Migrated/moved from study area|0|||
160534484|NCT01970488|579687444|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
160534485|NCT01970488|579687445|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
160534486|NCT01970488|579687446|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
160874484|NCT00486291|580934235|FG001|Overall Study|Adverse Event|4|||
160534487|NCT01970488|579687447|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
160534488|NCT01970488|579687448|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
160534489|NCT01970488|579687444|FG000|Part 1: Through Week 16|Protocol Violation|1|||
160534490|NCT01970488|579687445|FG001|Part 1: Through Week 16|Protocol Violation|2|||
160534491|NCT01970488|579687446|FG002|Part 1: Through Week 16|Protocol Violation|0|||
160534492|NCT01970488|579687447|FG003|Part 1: Through Week 16|Protocol Violation|0|||
160534493|NCT01970488|579687448|FG004|Part 1: Through Week 16|Protocol Violation|0|||
160534494|NCT01970488|579687444|FG000|Part 1: Through Week 16|Adverse Event|6|||
160534495|NCT01970488|579687445|FG001|Part 1: Through Week 16|Adverse Event|5|||
160534496|NCT01970488|579687446|FG002|Part 1: Through Week 16|Adverse Event|0|||
160534497|NCT01970488|579687447|FG003|Part 1: Through Week 16|Adverse Event|0|||
160534498|NCT01970488|579687448|FG004|Part 1: Through Week 16|Adverse Event|0|||
160534499|NCT01970488|579687444|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
160534500|NCT01970488|579687445|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
160534501|NCT01970488|579687446|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
160534502|NCT01970488|579687447|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
160534503|NCT01970488|579687448|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
160534504|NCT01970488|579687444|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
160534505|NCT01970488|579687445|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
160534506|NCT01970488|579687446|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
160534507|NCT01970488|579687447|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
160534508|NCT01970488|579687448|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
160534509|NCT01970488|579687444|FG000|Part 2: Post Week 16|Physician Decision|0|||
160534510|NCT01970488|579687445|FG001|Part 2: Post Week 16|Physician Decision|0|||
160534511|NCT01970488|579687446|FG002|Part 2: Post Week 16|Physician Decision|0|||
160534512|NCT01970488|579687447|FG003|Part 2: Post Week 16|Physician Decision|0|||
160534513|NCT01970488|579687448|FG004|Part 2: Post Week 16|Physician Decision|1|||
160534514|NCT01970488|579687444|FG000|Part 2: Post Week 16|Non-compliance|0|||
160534515|NCT01970488|579687445|FG001|Part 2: Post Week 16|Non-compliance|0|||
160534516|NCT01970488|579687446|FG002|Part 2: Post Week 16|Non-compliance|1|||
160534517|NCT01970488|579687447|FG003|Part 2: Post Week 16|Non-compliance|0|||
160534518|NCT01970488|579687448|FG004|Part 2: Post Week 16|Non-compliance|0|||
160534519|NCT01970488|579687444|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
160534520|NCT01970488|579687445|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
160534521|NCT01970488|579687446|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
160534522|NCT01970488|579687447|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
160534523|NCT01970488|579687448|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
160534524|NCT01970488|579687444|FG000|Part 2: Post Week 16|Adverse Event|0|||
160534525|NCT01970488|579687445|FG001|Part 2: Post Week 16|Adverse Event|0|||
160534526|NCT01970488|579687446|FG002|Part 2: Post Week 16|Adverse Event|5|||
160534527|NCT01970488|579687447|FG003|Part 2: Post Week 16|Adverse Event|1|||
160534528|NCT01970488|579687448|FG004|Part 2: Post Week 16|Adverse Event|1|||
160534529|NCT01970488|579687444|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
160534530|NCT01970488|579687445|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
160534531|NCT01970488|579687446|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
160534532|NCT01970488|579687447|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
160534533|NCT01970488|579687448|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
160534534|NCT01970488|579687444|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
160534535|NCT01970488|579687445|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
160534536|NCT01970488|579687446|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
160534537|NCT01970488|579687447|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
160534538|NCT01970488|579687448|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
160534539|NCT01816061|579687449|FG000|Overall Study|Lost to Follow-up|13|||
160534540|NCT01816061|579687450|FG001|Overall Study|Lost to Follow-up|24|||
160534541|NCT05525689|579687452|FG000|Overall Study|Lost to Follow-up|1|||
160534542|NCT05525689|579687453|FG001|Overall Study|Lost to Follow-up|0|||
160534543|NCT01022502|579687458|FG000|Overall Study|Adverse Event|1|||
160534544|NCT01022502|579687458|FG000|Overall Study|employment related reasons|1|||
160534545|NCT01022502|579687458|FG000|Overall Study|Withdrawal by Subject|1|||
160534546|NCT00073528|579687468|FG000|Overall Study|Death|488|||
160534547|NCT00073528|579687469|FG001|Overall Study|Death|473|||
160534548|NCT00073528|579687468|FG000|Overall Study|Lost to Follow-up|52|||
160534549|NCT00073528|579687469|FG001|Overall Study|Lost to Follow-up|45|||
160534550|NCT00073528|579687468|FG000|Overall Study|Withdrawal by Subject|50|||
160534551|NCT00073528|579687469|FG001|Overall Study|Withdrawal by Subject|45|||
160534552|NCT00073528|579687468|FG000|Overall Study|Study terminated by Sponsor|10|||
160534553|NCT00073528|579687469|FG001|Overall Study|Study terminated by Sponsor|29|||
160534554|NCT00073528|579687468|FG000|Overall Study|Other|18|||
160534555|NCT00073528|579687469|FG001|Overall Study|Other|19|||
160534556|NCT00073528|579687468|FG000|Overall Study|Other|9|||
160534557|NCT00073528|579687469|FG001|Overall Study|Other|12|||
160534558|NCT00073528|579687468|FG000|Overall Study|Protocol Violation|3|||
160534559|NCT00073528|579687469|FG001|Overall Study|Protocol Violation|5|||
160534560|NCT03086057|579687470|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
160534561|NCT03086057|579687471|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
160534562|NCT03086057|579687472|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
160534563|NCT03086057|579687473|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
160534564|NCT03086057|579687470|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
160534565|NCT03086057|579687471|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
160534566|NCT03086057|579687472|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
160534567|NCT03086057|579687473|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
160534568|NCT03086057|579687470|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
160534569|NCT03086057|579687471|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
160534570|NCT03086057|579687472|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
160534571|NCT03086057|579687473|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
160534572|NCT03086057|579687470|FG000|Stage 1: PrEP Uptake|Death|1|||
160534573|NCT03086057|579687471|FG001|Stage 1: PrEP Uptake|Death|0|||
160534574|NCT03086057|579687472|FG002|Stage 1: PrEP Uptake|Death|0|||
160534575|NCT03086057|579687473|FG003|Stage 1: PrEP Uptake|Death|0|||
160534576|NCT03086057|579687470|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
160534577|NCT03086057|579687471|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
160534578|NCT03086057|579687472|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
160534579|NCT03086057|579687473|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
160534580|NCT03086057|579687470|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
160534581|NCT03086057|579687471|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
160534582|NCT03086057|579687472|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
160534583|NCT03086057|579687473|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
160534584|NCT03086057|579687470|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
160534585|NCT03086057|579687471|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
160534586|NCT03086057|579687472|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
160534587|NCT03086057|579687473|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
160534588|NCT03199040|579687478|FG000|Overall Study|Lack of Efficacy|2|||
160534589|NCT03199040|579687479|FG001|Overall Study|Lack of Efficacy|0|||
160534590|NCT03199040|579687478|FG000|Overall Study|Withdrawal by Subject|2|||
160534591|NCT03199040|579687479|FG001|Overall Study|Withdrawal by Subject|0|||
160534592|NCT03199040|579687478|FG000|Overall Study|Adverse Event|0|||
160534593|NCT03199040|579687479|FG001|Overall Study|Adverse Event|1|||
160534594|NCT03199040|579687478|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
160534595|NCT03199040|579687479|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
160534596|NCT01786603|579687480|FG000|Overall Study|Death|5|||
160534597|NCT01786603|579687481|FG001|Overall Study|Death|1|||
160534598|NCT01786603|579687480|FG000|Overall Study|Adverse Event|6|||
160534599|NCT01786603|579687481|FG001|Overall Study|Adverse Event|2|||
160534600|NCT01786603|579687480|FG000|Overall Study|Physician decision to withdraw|6|||
160534601|NCT01786603|579687481|FG001|Overall Study|Physician decision to withdraw|7|||
160534602|NCT01786603|579687480|FG000|Overall Study|Lost to Follow-up|1|||
160534603|NCT01786603|579687481|FG001|Overall Study|Lost to Follow-up|2|||
160534604|NCT01226459|579687482|FG000|Overall Study|Adverse Event|2|||
160534605|NCT01226459|579687483|FG001|Overall Study|Adverse Event|8|||
160534606|NCT01226459|579687482|FG000|Overall Study|Protocol Violation|4|||
160534607|NCT01226459|579687483|FG001|Overall Study|Protocol Violation|3|||
160534608|NCT01226459|579687482|FG000|Overall Study|Withdrawal by Subject|10|||
160534609|NCT01226459|579687483|FG001|Overall Study|Withdrawal by Subject|13|||
160534610|NCT01226459|579687482|FG000|Overall Study|Lost to Follow-up|4|||
160534611|NCT01226459|579687483|FG001|Overall Study|Lost to Follow-up|8|||
160534612|NCT01226459|579687482|FG000|Overall Study|Pregnancy|1|||
160534613|NCT01226459|579687483|FG001|Overall Study|Pregnancy|0|||
160534614|NCT01092143|579687491|FG000|Overall Study|Adverse Event|10|||
160534615|NCT01092143|579687492|FG001|Overall Study|Adverse Event|5|||
160534616|NCT01092143|579687493|FG002|Overall Study|Adverse Event|1|||
160534617|NCT01092143|579687494|FG003|Overall Study|Adverse Event|4|||
160534618|NCT01092143|579687495|FG004|Overall Study|Adverse Event|3|||
160534619|NCT01092143|579687491|FG000|Overall Study|Lost to Follow-up|1|||
160534620|NCT01092143|579687492|FG001|Overall Study|Lost to Follow-up|0|||
160534621|NCT01092143|579687493|FG002|Overall Study|Lost to Follow-up|1|||
160534622|NCT01092143|579687494|FG003|Overall Study|Lost to Follow-up|0|||
160534623|NCT01092143|579687495|FG004|Overall Study|Lost to Follow-up|0|||
160534624|NCT01092143|579687491|FG000|Overall Study|Consent withdrawn|2|||
160534625|NCT01092143|579687492|FG001|Overall Study|Consent withdrawn|1|||
160534626|NCT01092143|579687493|FG002|Overall Study|Consent withdrawn|0|||
160534627|NCT01092143|579687494|FG003|Overall Study|Consent withdrawn|1|||
160534628|NCT01092143|579687495|FG004|Overall Study|Consent withdrawn|3|||
160534629|NCT01092143|579687491|FG000|Overall Study|Not treated|0|||
160534630|NCT01092143|579687492|FG001|Overall Study|Not treated|0|||
160534631|NCT01092143|579687493|FG002|Overall Study|Not treated|1|||
160534632|NCT01092143|579687494|FG003|Overall Study|Not treated|0|||
160534633|NCT01092143|579687495|FG004|Overall Study|Not treated|0|||
160534634|NCT01092143|579687491|FG000|Overall Study|did not reversibility criteria|0|||
160534635|NCT01092143|579687492|FG001|Overall Study|did not reversibility criteria|0|||
160534636|NCT01092143|579687493|FG002|Overall Study|did not reversibility criteria|1|||
160534637|NCT01092143|579687494|FG003|Overall Study|did not reversibility criteria|0|||
160534638|NCT01092143|579687495|FG004|Overall Study|did not reversibility criteria|0|||
160534639|NCT01092143|579687491|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
160534640|NCT01092143|579687492|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
160874485|NCT00486291|580934234|FG000|Overall Study|Lost to Follow-up|3|||
160534641|NCT01092143|579687493|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
160534642|NCT01092143|579687494|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
160534643|NCT01092143|579687495|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
160534644|NCT01092143|579687491|FG000|Overall Study|Ineligible patient|1|||
160534645|NCT01092143|579687492|FG001|Overall Study|Ineligible patient|0|||
160534646|NCT01092143|579687493|FG002|Overall Study|Ineligible patient|0|||
160534647|NCT01092143|579687494|FG003|Overall Study|Ineligible patient|0|||
160534648|NCT01092143|579687495|FG004|Overall Study|Ineligible patient|0|||
160534649|NCT01092143|579687491|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
160534650|NCT01092143|579687492|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
160534651|NCT01092143|579687493|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
160534652|NCT01092143|579687494|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
160534653|NCT01092143|579687495|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
160534654|NCT01092143|579687491|FG000|Overall Study|Patient travel|0|||
160534655|NCT01092143|579687492|FG001|Overall Study|Patient travel|0|||
160534656|NCT01092143|579687493|FG002|Overall Study|Patient travel|0|||
160534657|NCT01092143|579687494|FG003|Overall Study|Patient travel|0|||
160534658|NCT01092143|579687495|FG004|Overall Study|Patient travel|1|||
160534659|NCT01092143|579687491|FG000|Overall Study|Non compliance with study medication|0|||
160534660|NCT01092143|579687492|FG001|Overall Study|Non compliance with study medication|0|||
160534661|NCT01092143|579687493|FG002|Overall Study|Non compliance with study medication|0|||
160534662|NCT01092143|579687494|FG003|Overall Study|Non compliance with study medication|0|||
160534663|NCT01092143|579687495|FG004|Overall Study|Non compliance with study medication|1|||
160534664|NCT01092143|579687491|FG000|Overall Study|Randomized by mistake|0|||
160534665|NCT01092143|579687492|FG001|Overall Study|Randomized by mistake|0|||
160534666|NCT01092143|579687493|FG002|Overall Study|Randomized by mistake|0|||
160534667|NCT01092143|579687494|FG003|Overall Study|Randomized by mistake|1|||
160534668|NCT01092143|579687495|FG004|Overall Study|Randomized by mistake|0|||
160534669|NCT01092143|579687491|FG000|Overall Study|Pregnancy|0|||
160534670|NCT01092143|579687492|FG001|Overall Study|Pregnancy|0|||
160534671|NCT01092143|579687493|FG002|Overall Study|Pregnancy|0|||
160534672|NCT01092143|579687494|FG003|Overall Study|Pregnancy|1|||
160534673|NCT01092143|579687495|FG004|Overall Study|Pregnancy|0|||
160534674|NCT03654976|579687499|FG000|Overall Study|Withdrawal by Subject|12|||
160534675|NCT03654976|579687500|FG001|Overall Study|Withdrawal by Subject|11|||
160534676|NCT03654976|579687499|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
160534677|NCT03654976|579687500|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
160534678|NCT03654976|579687499|FG000|Overall Study|Adverse Event|5|||
160534679|NCT03654976|579687500|FG001|Overall Study|Adverse Event|0|||
160534680|NCT03654976|579687499|FG000|Overall Study|Lost to Follow-up|2|||
160534681|NCT03654976|579687500|FG001|Overall Study|Lost to Follow-up|0|||
160534682|NCT03654976|579687499|FG000|Overall Study|Lack of Efficacy|0|||
160534683|NCT03654976|579687500|FG001|Overall Study|Lack of Efficacy|1|||
160534684|NCT00117598|579687501|FG000|Prior to Treatment Cross Over|Death|40|||
160534685|NCT00117598|579687502|FG001|Prior to Treatment Cross Over|Death|41|||
160534686|NCT00117598|579687503|FG002|Prior to Treatment Cross Over|Death|37|||
160534687|NCT00117598|579687504|FG003|Prior to Treatment Cross Over|Death|0|||
160534688|NCT00117598|579687505|FG004|Prior to Treatment Cross Over|Death|0|||
160534689|NCT00117598|579687501|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
160534690|NCT00117598|579687502|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
160534691|NCT00117598|579687503|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
160534692|NCT00117598|579687504|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
160534693|NCT00117598|579687505|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
160534694|NCT00117598|579687501|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
160534695|NCT00117598|579687502|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
160534696|NCT00117598|579687503|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
160453956|NCT03511664|579393997|FG001|Overall Study|Withdrew consent|63|||
160453957|NCT03511664|579393998|FG002|Overall Study|Withdrew consent|3|||
160453958|NCT03511664|579393996|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
160453959|NCT03511664|579393997|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
160453960|NCT03511664|579393998|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
160453961|NCT03511664|579393996|FG000|Overall Study|Lost to Follow-up|8|||
160453962|NCT03511664|579393997|FG001|Overall Study|Lost to Follow-up|5|||
160453963|NCT03511664|579393998|FG002|Overall Study|Lost to Follow-up|0|||
160453964|NCT03511664|579393996|FG000|Overall Study|Physician Decision|2|||
160453965|NCT03511664|579393997|FG001|Overall Study|Physician Decision|1|||
160453966|NCT03511664|579393998|FG002|Overall Study|Physician Decision|0|||
160453967|NCT03511664|579393996|FG000|Overall Study|Patient non-compliance|1|||
160453968|NCT03511664|579393997|FG001|Overall Study|Patient non-compliance|0|||
160453969|NCT03511664|579393998|FG002|Overall Study|Patient non-compliance|0|||
160453970|NCT01946789|579393999|FG000|Overall Study|Death|0|||
160453971|NCT01946789|579394000|FG001|Overall Study|Death|2|||
160453972|NCT01946789|579394001|FG002|Overall Study|Death|1|||
160453973|NCT01946789|579394002|FG003|Overall Study|Death|1|||
160453974|NCT01946789|579394003|FG004|Overall Study|Death|1|||
160534697|NCT00117598|579687504|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
160534698|NCT00117598|579687505|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
160534699|NCT00117598|579687501|FG000|Prior to Treatment Cross Over|Other|15|||
160534700|NCT00117598|579687502|FG001|Prior to Treatment Cross Over|Other|9|||
160534701|NCT00117598|579687503|FG002|Prior to Treatment Cross Over|Other|9|||
160534702|NCT00117598|579687504|FG003|Prior to Treatment Cross Over|Other|0|||
160534703|NCT00117598|579687505|FG004|Prior to Treatment Cross Over|Other|0|||
160534704|NCT00117598|579687501|FG000|After Treament Cross Over|Death|0|||
160534705|NCT00117598|579687502|FG001|After Treament Cross Over|Death|0|||
160534706|NCT00117598|579687503|FG002|After Treament Cross Over|Death|0|||
160534707|NCT00117598|579687504|FG003|After Treament Cross Over|Death|1|||
160534708|NCT00117598|579687505|FG004|After Treament Cross Over|Death|2|||
160534709|NCT00117598|579687501|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
160534710|NCT00117598|579687502|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
160534711|NCT00117598|579687503|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
160534712|NCT00117598|579687504|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
160534713|NCT00117598|579687505|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
160534714|NCT00117598|579687501|FG000|After Treament Cross Over|Other|0|||
160534715|NCT00117598|579687502|FG001|After Treament Cross Over|Other|0|||
160534716|NCT00117598|579687503|FG002|After Treament Cross Over|Other|0|||
160534717|NCT00117598|579687504|FG003|After Treament Cross Over|Other|1|||
160534718|NCT00117598|579687505|FG004|After Treament Cross Over|Other|2|||
160534719|NCT01235793|579687506|FG000|Overall Study|Death|6|||
160534720|NCT03098836|579687507|FG000|Overall Study|Adverse Event|1|||
160534721|NCT03098836|579687508|FG001|Overall Study|Adverse Event|3|||
160534722|NCT03098836|579687507|FG000|Overall Study|Lack of Efficacy|30|||
160534723|NCT03098836|579687508|FG001|Overall Study|Lack of Efficacy|15|||
160534724|NCT03098836|579687507|FG000|Overall Study|Physician Decision|2|||
160534725|NCT03098836|579687508|FG001|Overall Study|Physician Decision|1|||
160534726|NCT03098836|579687507|FG000|Overall Study|Withdrawal by Subject|3|||
160534727|NCT03098836|579687508|FG001|Overall Study|Withdrawal by Subject|2|||
160534728|NCT03986866|579687509|FG000|Overall Study|Withdrawal by Subject|0|||
160534729|NCT03986866|579687510|FG001|Overall Study|Withdrawal by Subject|3|||
160534730|NCT03986866|579687509|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
160534731|NCT03986866|579687510|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
160534732|NCT00545064|579687513|FG000|Overall Study|Lost to Follow-up|3|||
160534733|NCT00545064|579687513|FG000|Overall Study|Withdrawal by Subject|2|||
160534734|NCT00545064|579687513|FG000|Overall Study|did not complete course of treatment|1|||
160534735|NCT00545064|579687513|FG000|Overall Study|cancel all appointments, no rebooking|1|||
160534736|NCT00545064|579687513|FG000|Overall Study|inclement weather|1|||
160534737|NCT01660451|579687514|FG000|Overall Study|Protocol Violation|0|||
160534738|NCT01660451|579687515|FG001|Overall Study|Protocol Violation|1|||
160534739|NCT01660451|579687516|FG002|Overall Study|Protocol Violation|1|||
160534740|NCT01660451|579687514|FG000|Overall Study|AE not associated with clinical disease progression|13|||
160534741|NCT01660451|579687515|FG001|Overall Study|AE not associated with clinical disease progression|10|||
160534742|NCT01660451|579687516|FG002|Overall Study|AE not associated with clinical disease progression|40|||
160534743|NCT01660451|579687514|FG000|Overall Study|AE associated with clinical disease progression|1|||
160534744|NCT01660451|579687515|FG001|Overall Study|AE associated with clinical disease progression|3|||
160534745|NCT01660451|579687516|FG002|Overall Study|AE associated with clinical disease progression|11|||
160534746|NCT01660451|579687514|FG000|Overall Study|Sponsor Decision|0|||
160534747|NCT01660451|579687515|FG001|Overall Study|Sponsor Decision|0|||
160534748|NCT01660451|579687516|FG002|Overall Study|Sponsor Decision|1|||
160534749|NCT01660451|579687514|FG000|Overall Study|Protocol Deviation|0|||
160534750|NCT01660451|579687515|FG001|Overall Study|Protocol Deviation|0|||
160534751|NCT01660451|579687516|FG002|Overall Study|Protocol Deviation|1|||
160534752|NCT01660451|579687514|FG000|Overall Study|Physician Decision|1|||
160534753|NCT01660451|579687515|FG001|Overall Study|Physician Decision|2|||
160534754|NCT01660451|579687516|FG002|Overall Study|Physician Decision|5|||
160534755|NCT01660451|579687514|FG000|Overall Study|Withdrawal by Subject|1|||
160534756|NCT01660451|579687515|FG001|Overall Study|Withdrawal by Subject|1|||
160534757|NCT01660451|579687516|FG002|Overall Study|Withdrawal by Subject|20|||
160534758|NCT01660451|579687514|FG000|Overall Study|Trial closure.|0|||
160534759|NCT01660451|579687515|FG001|Overall Study|Trial closure.|0|||
160534760|NCT01660451|579687516|FG002|Overall Study|Trial closure.|1|||
160534761|NCT01660451|579687514|FG000|Overall Study|Switching to other therapy|0|||
160534762|NCT01660451|579687515|FG001|Overall Study|Switching to other therapy|1|||
160534763|NCT01660451|579687516|FG002|Overall Study|Switching to other therapy|1|||
160534764|NCT01660451|579687514|FG000|Overall Study|Progressive disease - clinical progression|4|||
160534765|NCT01660451|579687515|FG001|Overall Study|Progressive disease - clinical progression|10|||
160534766|NCT01660451|579687516|FG002|Overall Study|Progressive disease - clinical progression|9|||
160534767|NCT01660451|579687514|FG000|Overall Study|Progressive disease - radiological progression|12|||
160534768|NCT01660451|579687515|FG001|Overall Study|Progressive disease - radiological progression|23|||
160534769|NCT01660451|579687516|FG002|Overall Study|Progressive disease - radiological progression|50|||
160534770|NCT01660451|579687514|FG000|Overall Study|Death|1|||
160534771|NCT01660451|579687515|FG001|Overall Study|Death|0|||
160534772|NCT01660451|579687516|FG002|Overall Study|Death|1|||
160534773|NCT01660451|579687514|FG000|Overall Study|Other|0|||
160534774|NCT01660451|579687515|FG001|Overall Study|Other|0|||
160534775|NCT01660451|579687516|FG002|Overall Study|Other|1|||
160534776|NCT04688775|579687517|FG000|Placebo-controlled Period|Randomized, not treated|1|||
160534777|NCT04688775|579687518|FG001|Placebo-controlled Period|Randomized, not treated|1|||
160534778|NCT04688775|579687519|FG002|Placebo-controlled Period|Randomized, not treated|0|||
160534779|NCT04688775|579687520|FG003|Placebo-controlled Period|Randomized, not treated|0|||
160534780|NCT04688775|579687517|FG000|Placebo-controlled Period|Adverse Event|2|||
160534781|NCT04688775|579687518|FG001|Placebo-controlled Period|Adverse Event|0|||
160534782|NCT04688775|579687519|FG002|Placebo-controlled Period|Adverse Event|0|||
160534783|NCT04688775|579687520|FG003|Placebo-controlled Period|Adverse Event|0|||
160534784|NCT04688775|579687517|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
160534785|NCT04688775|579687518|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
160534786|NCT04688775|579687519|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
160534787|NCT04688775|579687520|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
160534788|NCT04688775|579687517|FG000|Placebo-controlled Period|Protocol Violation|0|||
160534789|NCT04688775|579687518|FG001|Placebo-controlled Period|Protocol Violation|1|||
160534790|NCT04688775|579687519|FG002|Placebo-controlled Period|Protocol Violation|0|||
160534791|NCT04688775|579687520|FG003|Placebo-controlled Period|Protocol Violation|0|||
160534792|NCT04688775|579687517|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
160534793|NCT04688775|579687518|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
160534794|NCT04688775|579687519|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
160534795|NCT04688775|579687520|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
160534796|NCT04688775|579687517|FG000|Placebo-controlled Period|Other reasons|0|||
160534797|NCT04688775|579687518|FG001|Placebo-controlled Period|Other reasons|1|||
160534798|NCT04688775|579687519|FG002|Placebo-controlled Period|Other reasons|0|||
160534799|NCT04688775|579687520|FG003|Placebo-controlled Period|Other reasons|0|||
160534800|NCT04688775|579687517|FG000|Delayed Start Period|Adverse Event|0|||
160534801|NCT04688775|579687518|FG001|Delayed Start Period|Adverse Event|0|||
160534802|NCT04688775|579687519|FG002|Delayed Start Period|Adverse Event|1|||
160534803|NCT04688775|579687520|FG003|Delayed Start Period|Adverse Event|0|||
160534804|NCT04688775|579687517|FG000|Delayed Start Period|Lack of Efficacy|0|||
160534805|NCT04688775|579687518|FG001|Delayed Start Period|Lack of Efficacy|0|||
160534806|NCT04688775|579687519|FG002|Delayed Start Period|Lack of Efficacy|0|||
160534807|NCT04688775|579687520|FG003|Delayed Start Period|Lack of Efficacy|3|||
160534808|NCT04688775|579687517|FG000|Delayed Start Period|Withdrawal by Subject|0|||
160534809|NCT04688775|579687518|FG001|Delayed Start Period|Withdrawal by Subject|0|||
160534810|NCT04688775|579687519|FG002|Delayed Start Period|Withdrawal by Subject|2|||
160534811|NCT04688775|579687520|FG003|Delayed Start Period|Withdrawal by Subject|4|||
160534812|NCT04688775|579687517|FG000|Delayed Start Period|Lost to Follow-up|0|||
160534813|NCT04688775|579687518|FG001|Delayed Start Period|Lost to Follow-up|0|||
160534814|NCT04688775|579687519|FG002|Delayed Start Period|Lost to Follow-up|2|||
160534815|NCT04688775|579687520|FG003|Delayed Start Period|Lost to Follow-up|1|||
160534816|NCT04688775|579687517|FG000|Delayed Start Period|other reasons|0|||
160534817|NCT04688775|579687518|FG001|Delayed Start Period|other reasons|0|||
160534818|NCT04688775|579687519|FG002|Delayed Start Period|other reasons|1|||
160534819|NCT04688775|579687520|FG003|Delayed Start Period|other reasons|0|||
160534820|NCT01536951|579687525|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
160534821|NCT01536951|579687526|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
160534822|NCT01536951|579687527|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
160534823|NCT01536951|579687528|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
160534824|NCT01536951|579687529|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
160534825|NCT01536951|579687530|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
160534826|NCT01536951|579687531|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
160534827|NCT01536951|579687532|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
160534828|NCT01536951|579687533|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
160534829|NCT01536951|579687525|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
160534830|NCT01536951|579687526|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
160534831|NCT01536951|579687527|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
160874486|NCT00486291|580934235|FG001|Overall Study|Lost to Follow-up|7|||
160534832|NCT01536951|579687528|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
160534833|NCT01536951|579687529|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
160534834|NCT01536951|579687530|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
160534835|NCT01536951|579687531|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
160534836|NCT01536951|579687532|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
160534837|NCT01536951|579687533|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
160534838|NCT01843972|579687536|FG000|Overall Study|Withdrawal by Subject|0|||
160534839|NCT01843972|579687537|FG001|Overall Study|Withdrawal by Subject|0|||
160767335|NCT00961415|580537747|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
160534840|NCT01843972|579687538|FG002|Overall Study|Withdrawal by Subject|0|||
160534841|NCT01843972|579687539|FG003|Overall Study|Withdrawal by Subject|0|||
160534842|NCT01843972|579687540|FG004|Overall Study|Withdrawal by Subject|1|||
160534843|NCT01843972|579687541|FG005|Overall Study|Withdrawal by Subject|0|||
160534844|NCT01843972|579687542|FG006|Overall Study|Withdrawal by Subject|0|||
160534845|NCT01843972|579687543|FG007|Overall Study|Withdrawal by Subject|0|||
160534846|NCT01843972|579687544|FG008|Overall Study|Withdrawal by Subject|0|||
160534847|NCT01843972|579687545|FG009|Overall Study|Withdrawal by Subject|0|||
160534848|NCT01817751|579687551|FG000|Overall Study|Physician Decision|1|||
160534849|NCT00382018|579687552|FG000|Overall Study|Progression|0|||
160534850|NCT00382018|579687553|FG001|Overall Study|Progression|136|||
160534851|NCT00382018|579687554|FG002|Overall Study|Progression|51|||
160534852|NCT00382018|579687555|FG003|Overall Study|Progression|43|||
160534853|NCT00382018|579687552|FG000|Overall Study|Death|0|||
160534854|NCT00382018|579687553|FG001|Overall Study|Death|9|||
160534855|NCT00382018|579687554|FG002|Overall Study|Death|7|||
160534856|NCT00382018|579687555|FG003|Overall Study|Death|11|||
160534857|NCT00382018|579687552|FG000|Overall Study|Withdrawal by Subject|0|||
160534858|NCT00382018|579687553|FG001|Overall Study|Withdrawal by Subject|4|||
160534859|NCT00382018|579687554|FG002|Overall Study|Withdrawal by Subject|3|||
160534860|NCT00382018|579687555|FG003|Overall Study|Withdrawal by Subject|4|||
160534861|NCT00382018|579687552|FG000|Overall Study|Other, not protocol specified|0|||
160453975|NCT01946789|579394004|FG005|Overall Study|Death|1|||
160453976|NCT01946789|579394005|FG006|Overall Study|Death|3|||
160453977|NCT01946789|579394006|FG007|Overall Study|Death|1|||
160453978|NCT01946789|579394007|FG008|Overall Study|Death|2|||
160453979|NCT01946789|579393999|FG000|Overall Study|Progressive Disease|0|||
160453980|NCT01946789|579394000|FG001|Overall Study|Progressive Disease|0|||
160453981|NCT01946789|579394001|FG002|Overall Study|Progressive Disease|1|||
160453982|NCT01946789|579394002|FG003|Overall Study|Progressive Disease|0|||
160453983|NCT01946789|579394003|FG004|Overall Study|Progressive Disease|0|||
160453984|NCT01946789|579394004|FG005|Overall Study|Progressive Disease|2|||
160453985|NCT01946789|579394005|FG006|Overall Study|Progressive Disease|0|||
160453986|NCT01946789|579394006|FG007|Overall Study|Progressive Disease|0|||
160453987|NCT01946789|579394007|FG008|Overall Study|Progressive Disease|0|||
160453988|NCT01946789|579393999|FG000|Overall Study|Withdrawal by Subject|0|||
160453989|NCT01946789|579394000|FG001|Overall Study|Withdrawal by Subject|0|||
160453990|NCT01946789|579394001|FG002|Overall Study|Withdrawal by Subject|0|||
160453991|NCT01946789|579394002|FG003|Overall Study|Withdrawal by Subject|2|||
160453992|NCT01946789|579394003|FG004|Overall Study|Withdrawal by Subject|1|||
160453993|NCT01946789|579394004|FG005|Overall Study|Withdrawal by Subject|0|||
160453994|NCT01946789|579394005|FG006|Overall Study|Withdrawal by Subject|1|||
160453995|NCT01946789|579394006|FG007|Overall Study|Withdrawal by Subject|0|||
160453996|NCT01946789|579394007|FG008|Overall Study|Withdrawal by Subject|0|||
160453997|NCT04362254|579394011|FG000|Overall Study|Adverse Event|1|||
160453998|NCT04362254|579394011|FG000|Overall Study|Protocol Violation|1|||
160453999|NCT04362254|579394011|FG000|Overall Study|Due to early termination of the trial|10|||
160454000|NCT04076618|579394012|FG000|Overall Study|Lost to Follow-up|2|||
160454001|NCT04076618|579394013|FG001|Overall Study|Lost to Follow-up|1|||
160454002|NCT04076618|579394014|FG002|Overall Study|Lost to Follow-up|3|||
160454003|NCT04076618|579394012|FG000|Overall Study|Withdrawal by Subject|3|||
160454004|NCT04076618|579394013|FG001|Overall Study|Withdrawal by Subject|1|||
160454005|NCT04076618|579394014|FG002|Overall Study|Withdrawal by Subject|2|||
160454006|NCT04076618|579394012|FG000|Overall Study|Relocated out of state|0|||
160454007|NCT04076618|579394013|FG001|Overall Study|Relocated out of state|2|||
160454008|NCT04076618|579394014|FG002|Overall Study|Relocated out of state|0|||
160454009|NCT04076618|579394012|FG000|Overall Study|COVID concerns|0|||
160454010|NCT04076618|579394013|FG001|Overall Study|COVID concerns|1|||
160454011|NCT04076618|579394014|FG002|Overall Study|COVID concerns|0|||
160454012|NCT04076618|579394012|FG000|Overall Study|Adverse Event|0|||
160454013|NCT04076618|579394013|FG001|Overall Study|Adverse Event|0|||
160454014|NCT04076618|579394014|FG002|Overall Study|Adverse Event|2|||
160454015|NCT00321048|579394015|FG000|Overall Study|Withdrawal by Subject|6|||
160454016|NCT00321048|579394016|FG001|Overall Study|Withdrawal by Subject|8|||
160454017|NCT06473662|579394017|FG000|Overall Study|Withdrawal by Subject|1|||
160454018|NCT06473662|579394018|FG001|Overall Study|Withdrawal by Subject|6|||
160454019|NCT06473662|579394019|FG002|Overall Study|Withdrawal by Subject|5|||
160454020|NCT06473662|579394017|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
160454021|NCT06473662|579394018|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
160454022|NCT06473662|579394019|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
160454023|NCT06473662|579394017|FG000|Overall Study|Starting HbA1c below 7%|0|||
160454024|NCT06473662|579394018|FG001|Overall Study|Starting HbA1c below 7%|1|||
160454025|NCT06473662|579394019|FG002|Overall Study|Starting HbA1c below 7%|1|||
160454026|NCT06473662|579394017|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
160454027|NCT06473662|579394018|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
160454028|NCT06473662|579394019|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
160534862|NCT00382018|579687553|FG001|Overall Study|Other, not protocol specified|16|||
160534863|NCT00382018|579687554|FG002|Overall Study|Other, not protocol specified|3|||
160534864|NCT00382018|579687555|FG003|Overall Study|Other, not protocol specified|1|||
160534865|NCT01984164|579687556|FG000|Overall Study|Withdrawal by Subject|4|||
160534866|NCT01984164|579687557|FG001|Overall Study|Withdrawal by Subject|3|||
160534867|NCT01984164|579687556|FG000|Overall Study|Adverse Event|5|||
160534868|NCT01984164|579687557|FG001|Overall Study|Adverse Event|19|||
160534869|NCT01984164|579687556|FG000|Overall Study|Lost to Follow-up|1|||
160534870|NCT01984164|579687557|FG001|Overall Study|Lost to Follow-up|3|||
160534871|NCT05082376|579687561|FG000|Overall Study|Lost to Follow-up|2|||
160534872|NCT00574145|579688874|FG000|Overall Study|Withdrawal by Subject|2|||
160534873|NCT00574145|579688875|FG001|Overall Study|Withdrawal by Subject|1|||
160534874|NCT03227471|579688876|FG000|Overall Study|Withdrawal by Subject|0|||
160534875|NCT03227471|579688877|FG001|Overall Study|Withdrawal by Subject|0|||
160534876|NCT03227471|579688878|FG002|Overall Study|Withdrawal by Subject|0|||
160534877|NCT03227471|579688879|FG003|Overall Study|Withdrawal by Subject|0|||
160534878|NCT03227471|579688880|FG004|Overall Study|Withdrawal by Subject|1|||
160534879|NCT03227471|579688881|FG005|Overall Study|Withdrawal by Subject|0|||
160534880|NCT03227471|579688882|FG006|Overall Study|Withdrawal by Subject|0|||
160534881|NCT03227471|579688883|FG007|Overall Study|Withdrawal by Subject|0|||
160534882|NCT03227471|579688884|FG008|Overall Study|Withdrawal by Subject|0|||
160534883|NCT03227471|579688885|FG009|Overall Study|Withdrawal by Subject|0|||
160534884|NCT03227471|579688886|FG010|Overall Study|Withdrawal by Subject|0|||
160534885|NCT03227471|579688887|FG011|Overall Study|Withdrawal by Subject|0|||
160534886|NCT03227471|579688888|FG012|Overall Study|Withdrawal by Subject|1|||
160534887|NCT03227471|579688889|FG013|Overall Study|Withdrawal by Subject|0|||
160534888|NCT03227471|579688890|FG014|Overall Study|Withdrawal by Subject|0|||
160534889|NCT03227471|579688876|FG000|Overall Study|Randomized, Never Dosed|0|||
160534890|NCT03227471|579688877|FG001|Overall Study|Randomized, Never Dosed|0|||
160534891|NCT03227471|579688878|FG002|Overall Study|Randomized, Never Dosed|0|||
160534892|NCT03227471|579688879|FG003|Overall Study|Randomized, Never Dosed|0|||
160534893|NCT03227471|579688880|FG004|Overall Study|Randomized, Never Dosed|0|||
160534894|NCT03227471|579688881|FG005|Overall Study|Randomized, Never Dosed|0|||
160534895|NCT03227471|579688882|FG006|Overall Study|Randomized, Never Dosed|0|||
160534896|NCT03227471|579688883|FG007|Overall Study|Randomized, Never Dosed|0|||
160534897|NCT03227471|579688884|FG008|Overall Study|Randomized, Never Dosed|0|||
160534898|NCT03227471|579688885|FG009|Overall Study|Randomized, Never Dosed|0|||
160534899|NCT03227471|579688886|FG010|Overall Study|Randomized, Never Dosed|0|||
160534900|NCT03227471|579688887|FG011|Overall Study|Randomized, Never Dosed|0|||
160534901|NCT03227471|579688888|FG012|Overall Study|Randomized, Never Dosed|0|||
160534902|NCT03227471|579688889|FG013|Overall Study|Randomized, Never Dosed|0|||
160534903|NCT03227471|579688890|FG014|Overall Study|Randomized, Never Dosed|1|||
160534904|NCT00736255|579688898|FG000|Overall Study|Adverse Event|1|||
160534905|NCT00736255|579688899|FG001|Overall Study|Adverse Event|0|||
160534906|NCT00736255|579688898|FG000|Overall Study|Physician Decision|1|||
160534907|NCT00736255|579688899|FG001|Overall Study|Physician Decision|0|||
160534908|NCT00736255|579688898|FG000|Overall Study|Non-compliance|1|||
160534909|NCT00736255|579688899|FG001|Overall Study|Non-compliance|1|||
160534910|NCT00346073|579688901|FG000|Overall Study|Serious Adverse Event|2|||
160534911|NCT00346073|579688902|FG001|Overall Study|Serious Adverse Event|0|||
160534912|NCT00346073|579688901|FG000|Overall Study|Lost to Follow-up|39|||
160534913|NCT00346073|579688902|FG001|Overall Study|Lost to Follow-up|24|||
160534914|NCT00980200|579688904|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
160534915|NCT00980200|579688905|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
160534916|NCT00980200|579688906|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
160534917|NCT00980200|579688907|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
160534918|NCT00980200|579688908|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
160534919|NCT00980200|579688904|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
160534920|NCT00980200|579688905|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
160534921|NCT00980200|579688906|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
160534922|NCT00980200|579688907|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
160534923|NCT00980200|579688908|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
160534924|NCT01617460|579688909|FG000|Overall Study|Adverse Event|10|||
160534925|NCT01617460|579688909|FG000|Overall Study|Physician Decision|16|||
160534926|NCT01617460|579688909|FG000|Overall Study|Protocol Violation|5|||
160534927|NCT01617460|579688909|FG000|Overall Study|Withdrawal by Subject|9|||
160534928|NCT00457015|579688911|FG000|Overall Study|Left study site against medical advice|0|||
160534929|NCT00457015|579688912|FG001|Overall Study|Left study site against medical advice|1|||
160534930|NCT03670953|579688913|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
160534931|NCT03670953|579688914|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
160534932|NCT03670953|579688915|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
160534933|NCT03670953|579688916|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
160534934|NCT03670953|579688913|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
160534935|NCT03670953|579688914|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
160534936|NCT03670953|579688915|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
160534937|NCT03670953|579688916|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
160534938|NCT03670953|579688913|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
160534939|NCT03670953|579688914|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
160534940|NCT03670953|579688915|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
160534941|NCT03670953|579688916|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
160534942|NCT03670953|579688913|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
160534943|NCT03670953|579688914|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
160534944|NCT03670953|579688915|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
160534945|NCT03670953|579688916|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
160534946|NCT03670953|579688913|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
160534947|NCT03670953|579688914|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
160534948|NCT03670953|579688915|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
160534949|NCT03670953|579688916|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
160534950|NCT03670953|579688913|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
160534951|NCT03670953|579688914|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
160534952|NCT03670953|579688915|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
160534953|NCT03670953|579688916|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
160534954|NCT03670953|579688913|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
160534955|NCT03670953|579688914|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
160534956|NCT03670953|579688915|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
160534957|NCT03670953|579688916|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
160534958|NCT03670953|579688913|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
160534959|NCT03670953|579688914|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
160534960|NCT03670953|579688915|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
160534961|NCT03670953|579688916|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
160534962|NCT03670953|579688913|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
160534963|NCT03670953|579688914|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
160534964|NCT03670953|579688915|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
160534965|NCT03670953|579688916|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
160534966|NCT03670953|579688913|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
160534967|NCT03670953|579688914|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
160534968|NCT03670953|579688915|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
160534969|NCT03670953|579688916|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
160534970|NCT03670953|579688913|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
160534971|NCT03670953|579688914|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
160534972|NCT03670953|579688915|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
160534973|NCT03670953|579688916|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
160534974|NCT03670953|579688913|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
160534975|NCT03670953|579688914|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
160534976|NCT03670953|579688915|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
160534977|NCT03670953|579688916|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
160534978|NCT03670953|579688913|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
160534979|NCT03670953|579688914|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
160534980|NCT03670953|579688915|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
160534981|NCT03670953|579688916|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
160534982|NCT03670953|579688913|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
160534983|NCT03670953|579688914|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
160534984|NCT03670953|579688915|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
160534985|NCT03670953|579688916|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
160534986|NCT03670953|579688913|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
160534987|NCT03670953|579688914|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
160534988|NCT03670953|579688915|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
160534989|NCT03670953|579688916|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
160534990|NCT03670953|579688913|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
160534991|NCT03670953|579688914|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
160534992|NCT03670953|579688915|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
160534993|NCT03670953|579688916|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
160534994|NCT03670953|579688913|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
160534995|NCT03670953|579688914|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
160534996|NCT03670953|579688915|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
160534997|NCT03670953|579688916|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
160534998|NCT03670953|579688913|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
160534999|NCT03670953|579688914|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
160636482|NCT03747939|580051551|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
160636483|NCT03747939|580051552|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
160535000|NCT03670953|579688915|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
160535001|NCT03670953|579688916|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
160535002|NCT00937937|579688917|FG000|Overall Study|Adverse Event|6|||
160535003|NCT00937937|579688917|FG000|Overall Study|Withdrawal by Subject|2|||
160535004|NCT00937937|579688917|FG000|Overall Study|Progression/relapse|61|||
160535005|NCT00937937|579688917|FG000|Overall Study|Death|1|||
160535006|NCT00937937|579688917|FG000|Overall Study|Other|2|||
160535007|NCT00362414|579688918|FG000|Overall Study|Death|2|||
160535008|NCT00362414|579688918|FG000|Overall Study|Adverse Event|1|||
160535009|NCT01785160|579688922|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
160535010|NCT01785160|579688922|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
160535011|NCT01033734|579688923|FG000|Overall Study|Withdrawal by Subject|1|||
160535012|NCT01360554|579688924|FG000|Overall Study|Death|359|||
160535013|NCT01360554|579688925|FG001|Overall Study|Death|371|||
160535014|NCT01360554|579688924|FG000|Overall Study|Lost to Follow-up|4|||
160535015|NCT01360554|579688925|FG001|Overall Study|Lost to Follow-up|4|||
160535016|NCT01360554|579688924|FG000|Overall Study|Withdrawal by Subject|23|||
160535017|NCT01360554|579688925|FG001|Overall Study|Withdrawal by Subject|24|||
160535018|NCT01360554|579688924|FG000|Overall Study|Study terminated by sponsor|49|||
160535019|NCT01360554|579688925|FG001|Overall Study|Study terminated by sponsor|37|||
160535020|NCT01360554|579688924|FG000|Overall Study|Other, not specified|1|||
160535021|NCT01360554|579688925|FG001|Overall Study|Other, not specified|0|||
160535022|NCT01360554|579688924|FG000|Overall Study|Randomized but not treated.|3|||
160535023|NCT01360554|579688925|FG001|Overall Study|Randomized but not treated.|3|||
160535024|NCT02577406|579688928|FG000|Randomized Period|Death|1|||
160535025|NCT02577406|579688929|FG001|Randomized Period|Death|0|||
160535026|NCT02577406|579688928|FG000|Randomized Period|Other reasons|0|||
160535027|NCT02577406|579688929|FG001|Randomized Period|Other reasons|20|||
160535028|NCT02577406|579688928|FG000|Treatment Period|Death|38|||
160535029|NCT02577406|579688929|FG001|Treatment Period|Death|23|||
160535030|NCT02577406|579688928|FG000|Treatment Period|Adverse Event|17|||
160535031|NCT02577406|579688929|FG001|Treatment Period|Adverse Event|12|||
160535032|NCT02577406|579688928|FG000|Treatment Period|Progressive Disease|53|||
160535033|NCT02577406|579688929|FG001|Treatment Period|Progressive Disease|37|||
160535034|NCT02577406|579688928|FG000|Treatment Period|Withdrawal by Subject|10|||
160535035|NCT02577406|579688929|FG001|Treatment Period|Withdrawal by Subject|24|||
160535036|NCT02577406|579688928|FG000|Treatment Period|Lost to Follow-up|0|||
160535037|NCT02577406|579688929|FG001|Treatment Period|Lost to Follow-up|1|||
160535038|NCT02577406|579688928|FG000|Treatment Period|Transition to commercially available treatment|1|||
160535039|NCT02577406|579688929|FG001|Treatment Period|Transition to commercially available treatment|1|||
160535040|NCT02577406|579688928|FG000|Treatment Period|Physician Decision|1|||
160535041|NCT02577406|579688929|FG001|Treatment Period|Physician Decision|0|||
160535042|NCT02577406|579688928|FG000|Treatment Period|Disease Relapse|28|||
160535043|NCT02577406|579688929|FG001|Treatment Period|Disease Relapse|1|||
160535044|NCT02577406|579688928|FG000|Treatment Period|Protocol Violation|0|||
160535045|NCT02577406|579688929|FG001|Treatment Period|Protocol Violation|1|||
160535046|NCT02577406|579688928|FG000|Treatment Period|Other Reasons|3|||
160535047|NCT02577406|579688929|FG001|Treatment Period|Other Reasons|39|||
160535048|NCT02577406|579688928|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
160535049|NCT02577406|579688929|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
160535050|NCT01961349|579688930|FG000|Overall Study|Withdrawal by Subject|1|||
160535051|NCT01961349|579688931|FG001|Overall Study|Withdrawal by Subject|4|||
160535052|NCT01961349|579688932|FG002|Overall Study|Withdrawal by Subject|0|||
160535053|NCT01961349|579688930|FG000|Overall Study|Adverse Event|0|||
160535054|NCT01961349|579688931|FG001|Overall Study|Adverse Event|0|||
160535055|NCT01961349|579688932|FG002|Overall Study|Adverse Event|1|||
160535056|NCT01961349|579688930|FG000|Overall Study|registration error, personal reason etc|2|||
160535057|NCT01961349|579688931|FG001|Overall Study|registration error, personal reason etc|2|||
160535058|NCT01961349|579688932|FG002|Overall Study|registration error, personal reason etc|1|||
160535059|NCT01854645|579688933|FG000|Overall Study|Protocol-Specified Criteria|13|||
160535060|NCT01854645|579688934|FG001|Overall Study|Protocol-Specified Criteria|10|||
160535061|NCT01854645|579688935|FG002|Overall Study|Protocol-Specified Criteria|8|||
160535062|NCT01854645|579688936|FG003|Overall Study|Protocol-Specified Criteria|5|||
160535063|NCT01854645|579688937|FG004|Overall Study|Protocol-Specified Criteria|7|||
160535064|NCT01854645|579688933|FG000|Overall Study|Administrative Reasons / Missing|0|||
160535065|NCT01854645|579688934|FG001|Overall Study|Administrative Reasons / Missing|0|||
160535066|NCT01854645|579688935|FG002|Overall Study|Administrative Reasons / Missing|0|||
160535067|NCT01854645|579688936|FG003|Overall Study|Administrative Reasons / Missing|1|||
160535068|NCT01854645|579688937|FG004|Overall Study|Administrative Reasons / Missing|1|||
160535069|NCT01854645|579688933|FG000|Overall Study|Protocol Violation|3|||
160535070|NCT01854645|579688934|FG001|Overall Study|Protocol Violation|0|||
160535071|NCT01854645|579688935|FG002|Overall Study|Protocol Violation|5|||
160535072|NCT01854645|579688936|FG003|Overall Study|Protocol Violation|4|||
160535073|NCT01854645|579688937|FG004|Overall Study|Protocol Violation|1|||
160535074|NCT01854645|579688933|FG000|Overall Study|Lost to Follow-up|10|||
160535075|NCT01854645|579688934|FG001|Overall Study|Lost to Follow-up|7|||
160535076|NCT01854645|579688935|FG002|Overall Study|Lost to Follow-up|8|||
160535077|NCT01854645|579688936|FG003|Overall Study|Lost to Follow-up|5|||
160535078|NCT01854645|579688937|FG004|Overall Study|Lost to Follow-up|0|||
160535079|NCT01854645|579688933|FG000|Overall Study|Physician Decision|1|||
160535080|NCT01854645|579688934|FG001|Overall Study|Physician Decision|5|||
160535081|NCT01854645|579688935|FG002|Overall Study|Physician Decision|3|||
160535082|NCT01854645|579688936|FG003|Overall Study|Physician Decision|3|||
160535083|NCT01854645|579688937|FG004|Overall Study|Physician Decision|7|||
160535084|NCT01854645|579688933|FG000|Overall Study|Withdrawal by Subject|31|||
160535085|NCT01854645|579688934|FG001|Overall Study|Withdrawal by Subject|41|||
160535086|NCT01854645|579688935|FG002|Overall Study|Withdrawal by Subject|30|||
160535087|NCT01854645|579688936|FG003|Overall Study|Withdrawal by Subject|21|||
160535088|NCT01854645|579688937|FG004|Overall Study|Withdrawal by Subject|24|||
160535089|NCT01854645|579688933|FG000|Overall Study|Lack of Efficacy|7|||
160535090|NCT01854645|579688934|FG001|Overall Study|Lack of Efficacy|12|||
160535091|NCT01854645|579688935|FG002|Overall Study|Lack of Efficacy|9|||
160535092|NCT01854645|579688936|FG003|Overall Study|Lack of Efficacy|3|||
160535093|NCT01854645|579688937|FG004|Overall Study|Lack of Efficacy|9|||
160535094|NCT01854645|579688933|FG000|Overall Study|Adverse Event|33|||
160535095|NCT01854645|579688934|FG001|Overall Study|Adverse Event|31|||
160535096|NCT01854645|579688935|FG002|Overall Study|Adverse Event|19|||
160535097|NCT01854645|579688936|FG003|Overall Study|Adverse Event|20|||
160535098|NCT01854645|579688937|FG004|Overall Study|Adverse Event|11|||
160535099|NCT00555477|579688938|FG000|Overall Study|Adverse Event|0|||
160535100|NCT00555477|579688939|FG001|Overall Study|Adverse Event|9|||
160535101|NCT00555477|579688938|FG000|Overall Study|Withdrawal by Subject|1|||
160535102|NCT00555477|579688939|FG001|Overall Study|Withdrawal by Subject|2|||
160535103|NCT00555477|579688938|FG000|Overall Study|Physician Decision|1|||
160535104|NCT00555477|579688939|FG001|Overall Study|Physician Decision|2|||
160535105|NCT04702737|579688940|FG000|Overall Study|Decision by Sponsor|1|||
160535106|NCT04702737|579688940|FG000|Overall Study|Withdrawal of Consent from Study|3|||
160535107|NCT04702737|579688940|FG000|Overall Study|Lost to Follow-up|1|||
160535108|NCT04702737|579688940|FG000|Overall Study|Death|35|||
160535109|NCT01977820|579688943|FG000|Overall Study|Sponsor terminated the study|1|||
160535110|NCT01977820|579688944|FG001|Overall Study|Sponsor terminated the study|1|||
160535111|NCT00698997|579688945|FG000|Overall Study|Lost to Follow-up|3|||
160535112|NCT00698997|579688946|FG001|Overall Study|Lost to Follow-up|0|||
160535113|NCT00698997|579688945|FG000|Overall Study|Withdrawal by Subject|7|||
160535114|NCT00698997|579688946|FG001|Overall Study|Withdrawal by Subject|27|||
160535115|NCT00475722|579688947|FG000|Overall Study|Withdrawal by Subject|12|||
160535116|NCT00475722|579688948|FG001|Overall Study|Withdrawal by Subject|12|||
160535117|NCT00475722|579688947|FG000|Overall Study|Protocol Violation|3|||
160535118|NCT00475722|579688948|FG001|Overall Study|Protocol Violation|0|||
160535119|NCT02568475|579688951|FG000|Overall Study|Lost to Follow-up|40|||
160535120|NCT02568475|579688952|FG001|Overall Study|Lost to Follow-up|39|||
160535121|NCT02568475|579688951|FG000|Overall Study|Withdrawal by Subject|2|||
160535122|NCT02568475|579688952|FG001|Overall Study|Withdrawal by Subject|0|||
160535123|NCT02568475|579688951|FG000|Overall Study|Discharged home|4|||
160535124|NCT02568475|579688952|FG001|Overall Study|Discharged home|4|||
160535125|NCT02568475|579688951|FG000|Overall Study|Short-term: Discharge location unknown|4|||
160535126|NCT02568475|579688952|FG001|Overall Study|Short-term: Discharge location unknown|0|||
160535127|NCT02568475|579688951|FG000|Overall Study|Transferred to another facility|1|||
160535128|NCT02568475|579688952|FG001|Overall Study|Transferred to another facility|0|||
160535129|NCT02625233|579688953|FG000|Overall Study|Adverse Event|2|||
160535130|NCT02625233|579688954|FG001|Overall Study|Adverse Event|0|||
160535131|NCT02064920|579688957|FG000|Overall Study|Adverse Event|0|||
160535132|NCT02064920|579688958|FG001|Overall Study|Adverse Event|4|||
160535133|NCT02064920|579688957|FG000|Overall Study|Physician Decision|0|||
160535134|NCT02064920|579688958|FG001|Overall Study|Physician Decision|1|||
160535135|NCT02064920|579688957|FG000|Overall Study|Technical Problems|0|||
160535136|NCT02064920|579688958|FG001|Overall Study|Technical Problems|1|||
160535137|NCT02064920|579688957|FG000|Overall Study|Withdrawal by Subject|1|||
160535138|NCT02064920|579688958|FG001|Overall Study|Withdrawal by Subject|3|||
160535139|NCT02109562|579688959|FG000|Overall Study|Insufficient clinical response|2|||
160535140|NCT02109562|579688960|FG001|Overall Study|Insufficient clinical response|0|||
160535141|NCT02109562|579688961|FG002|Overall Study|Insufficient clinical response|4|||
160535142|NCT02109562|579688959|FG000|Overall Study|Adverse Event|0|||
160535143|NCT02109562|579688960|FG001|Overall Study|Adverse Event|2|||
160535144|NCT02109562|579688961|FG002|Overall Study|Adverse Event|3|||
160535145|NCT02109562|579688959|FG000|Overall Study|Lost to Follow-up|1|||
160535146|NCT02109562|579688960|FG001|Overall Study|Lost to Follow-up|0|||
160535147|NCT02109562|579688961|FG002|Overall Study|Lost to Follow-up|1|||
160535148|NCT02109562|579688959|FG000|Overall Study|Protocol Violation|0|||
160535149|NCT02109562|579688960|FG001|Overall Study|Protocol Violation|3|||
160535150|NCT02109562|579688961|FG002|Overall Study|Protocol Violation|1|||
160767336|NCT00961415|580537745|FG000|Induction Treatment Phase|Other Reason|5|||
160535151|NCT02109562|579688959|FG000|Overall Study|Withdrawal by Subject|20|||
160535152|NCT02109562|579688960|FG001|Overall Study|Withdrawal by Subject|25|||
160535153|NCT02109562|579688961|FG002|Overall Study|Withdrawal by Subject|21|||
160535154|NCT02109562|579688959|FG000|Overall Study|Physician Decision|3|||
160535155|NCT02109562|579688960|FG001|Overall Study|Physician Decision|4|||
160874487|NCT00486291|580934234|FG000|Overall Study|protocol non-compliance|10|||
160874488|NCT00486291|580934235|FG001|Overall Study|protocol non-compliance|15|||
160874489|NCT00486291|580934234|FG000|Overall Study|requirement for restricted medication|0|||
160535156|NCT02109562|579688961|FG002|Overall Study|Physician Decision|5|||
160535157|NCT00290186|579688971|FG000|Overall Study|Adverse Event|1|||
160535158|NCT00290186|579688972|FG001|Overall Study|Adverse Event|1|||
160535159|NCT00290186|579688971|FG000|Overall Study|Lost to Follow-up|3|||
160535160|NCT00290186|579688972|FG001|Overall Study|Lost to Follow-up|2|||
160535161|NCT00290186|579688971|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
160535162|NCT00290186|579688972|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
160535163|NCT00290186|579688971|FG000|Overall Study|Withdrawal by Subject|0|||
160535164|NCT00290186|579688972|FG001|Overall Study|Withdrawal by Subject|1|||
160535165|NCT00262522|579688975|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
160535166|NCT00262522|579688976|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
160535167|NCT00262522|579688977|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
160535168|NCT00262522|579688978|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
160535169|NCT00262522|579688975|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
160535170|NCT00262522|579688976|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
160535171|NCT00262522|579688977|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
160535172|NCT00262522|579688978|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
160535173|NCT00262522|579688975|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
160535174|NCT00262522|579688976|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
160535175|NCT00262522|579688977|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
160535176|NCT00262522|579688978|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
160535177|NCT00262522|579688975|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
160535178|NCT00262522|579688976|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
160535179|NCT00262522|579688977|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
160535180|NCT00262522|579688978|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
160535181|NCT00262522|579688975|FG000|Study Start Through 8 Weeks|Death|1|||
160535182|NCT00262522|579688976|FG001|Study Start Through 8 Weeks|Death|0|||
160535183|NCT00262522|579688977|FG002|Study Start Through 8 Weeks|Death|0|||
160535184|NCT00262522|579688978|FG003|Study Start Through 8 Weeks|Death|0|||
160535185|NCT00262522|579688975|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
160535186|NCT00262522|579688976|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
160535187|NCT00262522|579688977|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
160535188|NCT00262522|579688978|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
160535189|NCT00262522|579688975|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
160535190|NCT00262522|579688976|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
160535191|NCT00262522|579688977|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
160535192|NCT00262522|579688978|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
160535193|NCT00262522|579688975|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
160535194|NCT00262522|579688976|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
160535195|NCT00262522|579688977|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
160535196|NCT00262522|579688978|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
160535197|NCT00262522|579688975|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
160535198|NCT00262522|579688976|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
160535199|NCT00262522|579688977|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
160535200|NCT00262522|579688978|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
160535201|NCT00262522|579688975|FG000|Study Start Through 48 Weeks|Death|2|||
160535202|NCT00262522|579688976|FG001|Study Start Through 48 Weeks|Death|0|||
160535203|NCT00262522|579688977|FG002|Study Start Through 48 Weeks|Death|1|||
160535204|NCT00262522|579688978|FG003|Study Start Through 48 Weeks|Death|0|||
160535205|NCT00262522|579688975|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
160535206|NCT00262522|579688976|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
160535207|NCT00262522|579688977|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
160535208|NCT00262522|579688978|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
160535209|NCT00262522|579688975|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
160535210|NCT00262522|579688976|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
160535211|NCT00262522|579688977|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
160535212|NCT00262522|579688978|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
160535213|NCT00262522|579688975|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
160535214|NCT00262522|579688976|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
160535215|NCT00262522|579688977|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
160535216|NCT00262522|579688978|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
160535217|NCT00262522|579688975|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
160535218|NCT00262522|579688976|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
160535219|NCT00262522|579688977|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
160535220|NCT00262522|579688978|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
160535221|NCT00262522|579688975|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
160535222|NCT00262522|579688976|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
160535223|NCT00262522|579688977|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
160535224|NCT00262522|579688978|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
160535225|NCT00262522|579688975|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
160535226|NCT00262522|579688976|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
160535227|NCT00262522|579688977|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
160535228|NCT00262522|579688978|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
160535229|NCT00262522|579688975|FG000|Study Start Through 96 Weeks|Death|2|||
160535230|NCT00262522|579688976|FG001|Study Start Through 96 Weeks|Death|0|||
160535231|NCT00262522|579688977|FG002|Study Start Through 96 Weeks|Death|2|||
160535232|NCT00262522|579688978|FG003|Study Start Through 96 Weeks|Death|0|||
160535233|NCT00262522|579688975|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
160535234|NCT00262522|579688976|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
160535235|NCT00262522|579688977|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
160535236|NCT00262522|579688978|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
160535237|NCT00262522|579688975|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
160535238|NCT00262522|579688976|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
160535239|NCT00262522|579688977|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
160535240|NCT00262522|579688978|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
160535241|NCT01449461|579688990|FG000|Overall Study|Adverse Event|0|||
160535242|NCT01449461|579688991|FG001|Overall Study|Adverse Event|3|||
160535243|NCT01449461|579688992|FG002|Overall Study|Adverse Event|2|||
160535244|NCT01449461|579688993|FG003|Overall Study|Adverse Event|3|||
160535245|NCT01449461|579688994|FG004|Overall Study|Adverse Event|4|||
160535246|NCT01449461|579688995|FG005|Overall Study|Adverse Event|4|||
160535247|NCT01449461|579688990|FG000|Overall Study|Death|0|||
160535248|NCT01449461|579688991|FG001|Overall Study|Death|2|||
160535249|NCT01449461|579688992|FG002|Overall Study|Death|0|||
160535250|NCT01449461|579688993|FG003|Overall Study|Death|0|||
160535251|NCT01449461|579688994|FG004|Overall Study|Death|7|||
160535252|NCT01449461|579688995|FG005|Overall Study|Death|1|||
160535253|NCT01449461|579688990|FG000|Overall Study|Physician Decision|0|||
160535254|NCT01449461|579688991|FG001|Overall Study|Physician Decision|1|||
160535255|NCT01449461|579688992|FG002|Overall Study|Physician Decision|0|||
160535256|NCT01449461|579688993|FG003|Overall Study|Physician Decision|4|||
160535257|NCT01449461|579688994|FG004|Overall Study|Physician Decision|1|||
160535258|NCT01449461|579688995|FG005|Overall Study|Physician Decision|0|||
160535259|NCT01449461|579688990|FG000|Overall Study|Documented Progressive Disease|4|||
160535260|NCT01449461|579688991|FG001|Overall Study|Documented Progressive Disease|7|||
160535261|NCT01449461|579688992|FG002|Overall Study|Documented Progressive Disease|14|||
160535262|NCT01449461|579688993|FG003|Overall Study|Documented Progressive Disease|15|||
160535263|NCT01449461|579688994|FG004|Overall Study|Documented Progressive Disease|24|||
160535264|NCT01449461|579688995|FG005|Overall Study|Documented Progressive Disease|5|||
160535265|NCT01449461|579688990|FG000|Overall Study|Clinical Progressive Disease|2|||
160535266|NCT01449461|579688991|FG001|Overall Study|Clinical Progressive Disease|2|||
160535267|NCT01449461|579688992|FG002|Overall Study|Clinical Progressive Disease|0|||
160535268|NCT01449461|579688993|FG003|Overall Study|Clinical Progressive Disease|3|||
160535269|NCT01449461|579688994|FG004|Overall Study|Clinical Progressive Disease|4|||
160535270|NCT01449461|579688995|FG005|Overall Study|Clinical Progressive Disease|2|||
160535271|NCT01449461|579688990|FG000|Overall Study|Protocol Violation|0|||
160535272|NCT01449461|579688991|FG001|Overall Study|Protocol Violation|0|||
160535273|NCT01449461|579688992|FG002|Overall Study|Protocol Violation|0|||
160535274|NCT01449461|579688993|FG003|Overall Study|Protocol Violation|1|||
160535275|NCT01449461|579688994|FG004|Overall Study|Protocol Violation|0|||
160535276|NCT01449461|579688995|FG005|Overall Study|Protocol Violation|0|||
160535277|NCT01449461|579688990|FG000|Overall Study|Site Terminated by Sponsor|0|||
160535278|NCT01449461|579688991|FG001|Overall Study|Site Terminated by Sponsor|1|||
160535279|NCT01449461|579688992|FG002|Overall Study|Site Terminated by Sponsor|2|||
160535280|NCT01449461|579688993|FG003|Overall Study|Site Terminated by Sponsor|3|||
160535281|NCT01449461|579688994|FG004|Overall Study|Site Terminated by Sponsor|4|||
160535282|NCT01449461|579688995|FG005|Overall Study|Site Terminated by Sponsor|1|||
160535283|NCT01449461|579688990|FG000|Overall Study|Withdrawal by Subject|0|||
160535284|NCT01449461|579688991|FG001|Overall Study|Withdrawal by Subject|1|||
160535285|NCT01449461|579688992|FG002|Overall Study|Withdrawal by Subject|0|||
160535286|NCT01449461|579688993|FG003|Overall Study|Withdrawal by Subject|0|||
160535287|NCT01449461|579688994|FG004|Overall Study|Withdrawal by Subject|2|||
160535288|NCT01449461|579688995|FG005|Overall Study|Withdrawal by Subject|1|||
160535289|NCT01449461|579688990|FG000|Overall Study|Reason not Specified|0|||
160535290|NCT01449461|579688991|FG001|Overall Study|Reason not Specified|1|||
160535291|NCT01449461|579688992|FG002|Overall Study|Reason not Specified|0|||
160535292|NCT01449461|579688993|FG003|Overall Study|Reason not Specified|3|||
160535293|NCT01449461|579688994|FG004|Overall Study|Reason not Specified|2|||
160535294|NCT01449461|579688995|FG005|Overall Study|Reason not Specified|1|||
160535295|NCT05314517|579688996|FG000|Double-blind Period|Adverse Event|4|||
160535296|NCT05314517|579688997|FG001|Double-blind Period|Adverse Event|0|||
160535297|NCT05314517|579688998|FG002|Double-blind Period|Adverse Event|0|||
160535298|NCT05314517|579688999|FG003|Double-blind Period|Adverse Event|0|||
160535299|NCT05314517|579688996|FG000|Double-blind Period|Noncompliance|0|||
160535300|NCT05314517|579688997|FG001|Double-blind Period|Noncompliance|1|||
160535301|NCT05314517|579688998|FG002|Double-blind Period|Noncompliance|0|||
160535302|NCT05314517|579688999|FG003|Double-blind Period|Noncompliance|0|||
160535303|NCT05314517|579688996|FG000|Double-blind Period|Randomized, not treated|1|||
160535304|NCT05314517|579688997|FG001|Double-blind Period|Randomized, not treated|0|||
160535305|NCT05314517|579688998|FG002|Double-blind Period|Randomized, not treated|0|||
160535306|NCT05314517|579688999|FG003|Double-blind Period|Randomized, not treated|0|||
160535307|NCT05314517|579688996|FG000|Open-label Extension|Adverse Event|0|||
160535308|NCT05314517|579688997|FG001|Open-label Extension|Adverse Event|0|||
160535309|NCT05314517|579688998|FG002|Open-label Extension|Adverse Event|1|||
160535310|NCT05314517|579688999|FG003|Open-label Extension|Adverse Event|2|||
160535311|NCT05314517|579688996|FG000|Open-label Extension|Investigator decision|0|||
160535312|NCT05314517|579688997|FG001|Open-label Extension|Investigator decision|0|||
160535313|NCT05314517|579688998|FG002|Open-label Extension|Investigator decision|1|||
160535314|NCT05314517|579688999|FG003|Open-label Extension|Investigator decision|0|||
160535315|NCT05314517|579688996|FG000|Open-label Extension|Lost to Follow-up|0|||
160535316|NCT05314517|579688997|FG001|Open-label Extension|Lost to Follow-up|0|||
160535317|NCT05314517|579688998|FG002|Open-label Extension|Lost to Follow-up|0|||
160535318|NCT05314517|579688999|FG003|Open-label Extension|Lost to Follow-up|1|||
160535319|NCT05314517|579688996|FG000|Open-label Extension|Withdrawal by Subject|0|||
160535320|NCT05314517|579688997|FG001|Open-label Extension|Withdrawal by Subject|0|||
160535321|NCT05314517|579688998|FG002|Open-label Extension|Withdrawal by Subject|1|||
160535322|NCT05314517|579688999|FG003|Open-label Extension|Withdrawal by Subject|2|||
160535323|NCT05314517|579688996|FG000|Open-label Extension|Use of prohibited medication|0|||
160535324|NCT05314517|579688997|FG001|Open-label Extension|Use of prohibited medication|0|||
160535325|NCT05314517|579688998|FG002|Open-label Extension|Use of prohibited medication|1|||
160535326|NCT05314517|579688999|FG003|Open-label Extension|Use of prohibited medication|0|||
160535327|NCT05314517|579688996|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
160535328|NCT05314517|579688997|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
160535329|NCT05314517|579688998|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
160535330|NCT05314517|579688999|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
160535331|NCT02710136|579689002|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
160535332|NCT02710136|579689003|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
160535333|NCT02269787|579689004|FG000|Overall Study|Lost to Follow-up|20|||
160535334|NCT02269787|579689005|FG001|Overall Study|Lost to Follow-up|6|||
160535335|NCT02269787|579689004|FG000|Overall Study|Death|2|||
160535336|NCT02269787|579689005|FG001|Overall Study|Death|3|||
160535337|NCT02269787|579689004|FG000|Overall Study|Incapacitated|0|||
160535338|NCT02269787|579689005|FG001|Overall Study|Incapacitated|1|||
160535339|NCT00798135|579689006|FG000|Overall Study|Disease progression, relapse|11|||
160535340|NCT00798135|579689006|FG000|Overall Study|Disease progression, refractory|1|||
160535341|NCT00798135|579689006|FG000|Overall Study|Physician Decision|1|||
160535342|NCT02228720|579689007|FG000|Open Label - Day 30|Lost to Follow-up|1|||
160535343|NCT01401842|579689010|FG000|Overall Study|Withdrawal by Subject|3|||
160535344|NCT01401842|579689011|FG001|Overall Study|Withdrawal by Subject|2|||
160535345|NCT01401842|579689010|FG000|Overall Study|academic reason|4|||
160535346|NCT01401842|579689011|FG001|Overall Study|academic reason|1|||
160535347|NCT01401842|579689010|FG000|Overall Study|changed companies|20|||
160535348|NCT01401842|579689011|FG001|Overall Study|changed companies|34|||
160535349|NCT01401842|579689010|FG000|Overall Study|discharged from US Army|3|||
160535350|NCT01401842|579689011|FG001|Overall Study|discharged from US Army|4|||
160535351|NCT01401842|579689010|FG000|Overall Study|invalid follow-up strength data|1|||
160535352|NCT01401842|579689011|FG001|Overall Study|invalid follow-up strength data|4|||
160535353|NCT01401842|579689010|FG000|Overall Study|on profile|9|||
160535354|NCT01401842|579689011|FG001|Overall Study|on profile|5|||
160535355|NCT01401842|579689010|FG000|Overall Study|other/unknown|28|||
160535356|NCT01401842|579689011|FG001|Overall Study|other/unknown|17|||
160535357|NCT03337542|579689012|FG000|Overall Study|Withdrew Consent|17|||
160535358|NCT03337542|579689012|FG000|Overall Study|Allergic Adverse Event|1|||
160535359|NCT03337542|579689012|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
160535360|NCT03337542|579689012|FG000|Overall Study|Lost to Follow-up|1|||
160535361|NCT03337542|579689012|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
160535362|NCT00282295|579689013|FG000|Overall Study|Adverse Event|0|||
160535363|NCT00282295|579689014|FG001|Overall Study|Adverse Event|1|||
160535364|NCT00282295|579689015|FG002|Overall Study|Adverse Event|0|||
160535365|NCT00282295|579689013|FG000|Overall Study|Serious Adverse Events|0|||
160535366|NCT00282295|579689014|FG001|Overall Study|Serious Adverse Events|0|||
160535367|NCT00282295|579689015|FG002|Overall Study|Serious Adverse Events|1|||
160535368|NCT00282295|579689013|FG000|Overall Study|Protocol Violation|0|||
160535369|NCT00282295|579689014|FG001|Overall Study|Protocol Violation|2|||
160535370|NCT00282295|579689015|FG002|Overall Study|Protocol Violation|1|||
160535371|NCT00282295|579689013|FG000|Overall Study|Withdrawal by Subject|2|||
160535372|NCT00282295|579689014|FG001|Overall Study|Withdrawal by Subject|6|||
160535373|NCT00282295|579689015|FG002|Overall Study|Withdrawal by Subject|4|||
160535374|NCT00282295|579689013|FG000|Overall Study|Lost to Follow-up|1|||
160535375|NCT00282295|579689014|FG001|Overall Study|Lost to Follow-up|7|||
160535376|NCT00282295|579689015|FG002|Overall Study|Lost to Follow-up|2|||
160535377|NCT00282295|579689013|FG000|Overall Study|Other|0|||
160535378|NCT00282295|579689014|FG001|Overall Study|Other|1|||
160535379|NCT00282295|579689015|FG002|Overall Study|Other|0|||
160535380|NCT03197493|579690230|FG000|Overall Study|Withdrawal by Subject|5|||
160535381|NCT00054704|579690231|FG000|Overall Study|Lack of Efficacy|2|||
160535382|NCT00054704|579690232|FG001|Overall Study|Lack of Efficacy|3|||
160535383|NCT00054704|579690231|FG000|Overall Study|Adverse Event|3|||
160535384|NCT00054704|579690232|FG001|Overall Study|Adverse Event|1|||
160535385|NCT00054704|579690231|FG000|Overall Study|Lost to Follow-up|0|||
160535386|NCT00054704|579690232|FG001|Overall Study|Lost to Follow-up|1|||
160535387|NCT01469182|579690235|FG000|Overall Study|Adverse Event|21|||
160535388|NCT01469182|579690236|FG001|Overall Study|Adverse Event|3|||
160535389|NCT01469182|579690235|FG000|Overall Study|Lost to Follow-up|3|||
160535390|NCT01469182|579690236|FG001|Overall Study|Lost to Follow-up|0|||
160535391|NCT01469182|579690235|FG000|Overall Study|Withdrawal by Subject|4|||
160535392|NCT01469182|579690236|FG001|Overall Study|Withdrawal by Subject|1|||
160535393|NCT01469182|579690235|FG000|Overall Study|Protocol Violation|4|||
160535394|NCT01469182|579690236|FG001|Overall Study|Protocol Violation|2|||
160535395|NCT01469182|579690235|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
160535396|NCT01469182|579690236|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
160535397|NCT02236520|579690237|FG000|Overall Study|Physician Decision|0|||
160535398|NCT02236520|579690238|FG001|Overall Study|Physician Decision|5|||
160535399|NCT02236520|579690239|FG002|Overall Study|Physician Decision|0|||
160535400|NCT02236520|579690240|FG003|Overall Study|Physician Decision|0|||
160535401|NCT02236520|579690237|FG000|Overall Study|Withdrawal by Subject|1|||
160535402|NCT02236520|579690238|FG001|Overall Study|Withdrawal by Subject|0|||
160535403|NCT02236520|579690239|FG002|Overall Study|Withdrawal by Subject|0|||
160535404|NCT02236520|579690240|FG003|Overall Study|Withdrawal by Subject|1|||
160535405|NCT02236520|579690237|FG000|Overall Study|Pregnancy|1|||
160535406|NCT02236520|579690238|FG001|Overall Study|Pregnancy|0|||
160535407|NCT02236520|579690239|FG002|Overall Study|Pregnancy|0|||
160535408|NCT02236520|579690240|FG003|Overall Study|Pregnancy|0|||
160535409|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
160535410|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
160535411|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
160535412|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
160535413|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
160535414|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
160535415|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
160535416|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
160535417|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
160535418|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
160535419|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
160535420|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
160535421|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
160535422|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
160535423|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
160535424|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
160874490|NCT00486291|580934235|FG001|Overall Study|requirement for restricted medication|3|||
160535425|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
160535426|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
160535427|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
160535428|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
160535429|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
160535430|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
160535431|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
160535432|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
160535433|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
160535434|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
160535435|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
160535436|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
160535437|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
160535438|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
160535439|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
160535440|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
160535441|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
160535442|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
160535443|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
160535444|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
160535445|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
160535446|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
160535447|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
160535448|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
160535449|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
160535450|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
160535451|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
160535452|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
160535453|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
160535454|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
160535455|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
160535456|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
160535457|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
160535458|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
160535459|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
160535460|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
160535461|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
160535462|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
160535463|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
160535464|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
160535465|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
160535466|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
160535467|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
160535468|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
160535469|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
160535470|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
160535471|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
160535472|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
160767337|NCT00961415|580537746|FG001|Induction Treatment Phase|Other Reason|0|||
160767338|NCT00961415|580537747|FG002|Induction Treatment Phase|Other Reason|0|||
160767339|NCT00961415|580537745|FG000|Maintenance Treatment Phase|Death|0|||
160767340|NCT00961415|580537746|FG001|Maintenance Treatment Phase|Death|42|||
160767341|NCT00961415|580537747|FG002|Maintenance Treatment Phase|Death|34|||
160767342|NCT00961415|580537745|FG000|Maintenance Treatment Phase|Investigators decision|0|||
160767343|NCT00961415|580537746|FG001|Maintenance Treatment Phase|Investigators decision|2|||
160767344|NCT00961415|580537747|FG002|Maintenance Treatment Phase|Investigators decision|0|||
160874491|NCT04413617|580934240|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
160874492|NCT04413617|580934241|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
160874493|NCT04413617|580934242|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
160874494|NCT04413617|580934243|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
160874495|NCT04413617|580934244|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
160874496|NCT04413617|580934240|FG000|Overall Study|Protocol Violation|0|||
160874497|NCT04413617|580934241|FG001|Overall Study|Protocol Violation|1|||
160874498|NCT04413617|580934242|FG002|Overall Study|Protocol Violation|0|||
160874499|NCT04413617|580934243|FG003|Overall Study|Protocol Violation|0|||
160874500|NCT04413617|580934244|FG004|Overall Study|Protocol Violation|1|||
160874501|NCT04413617|580934240|FG000|Overall Study|Lack of Efficacy|2|||
160874502|NCT04413617|580934241|FG001|Overall Study|Lack of Efficacy|0|||
160874503|NCT04413617|580934242|FG002|Overall Study|Lack of Efficacy|2|||
160874504|NCT04413617|580934243|FG003|Overall Study|Lack of Efficacy|1|||
160874505|NCT04413617|580934244|FG004|Overall Study|Lack of Efficacy|0|||
160874506|NCT04413617|580934240|FG000|Overall Study|Withdrawal by Subject|3|||
160874507|NCT04413617|580934241|FG001|Overall Study|Withdrawal by Subject|4|||
160874508|NCT04413617|580934242|FG002|Overall Study|Withdrawal by Subject|2|||
160874509|NCT04413617|580934243|FG003|Overall Study|Withdrawal by Subject|5|||
160874510|NCT04413617|580934244|FG004|Overall Study|Withdrawal by Subject|3|||
160535473|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
160535474|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
160535475|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
160535476|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
160535477|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
160535478|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
160535479|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
160535480|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
160535481|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
160535482|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
160535483|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
160535484|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
160535485|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
160535486|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
160535487|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
160535488|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
160535489|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
160535490|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
160535491|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
160535492|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
160535493|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
160535494|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
160535495|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
160535496|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
160535497|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
160535498|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
160535499|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
160535500|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
160535501|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
160535502|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
160535503|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
160535504|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
160535505|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
160535506|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
160535507|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
160535508|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
160535509|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
160535510|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
160535511|NCT00111800|579690243|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
160767345|NCT00961415|580537745|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160767346|NCT00961415|580537746|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
160767347|NCT00961415|580537747|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
160767348|NCT00961415|580537745|FG000|Maintenance Treatment Phase|Other reason|0|||
160767349|NCT00961415|580537746|FG001|Maintenance Treatment Phase|Other reason|1|||
160767350|NCT00961415|580537747|FG002|Maintenance Treatment Phase|Other reason|3|||
160767351|NCT02309359|580537748|FG000|Overall Study|Adverse Event|4|||
160767352|NCT02309359|580537749|FG001|Overall Study|Adverse Event|5|||
160767353|NCT02309359|580537750|FG002|Overall Study|Adverse Event|5|||
160767354|NCT02309359|580537751|FG003|Overall Study|Adverse Event|4|||
160767355|NCT02309359|580537752|FG004|Overall Study|Adverse Event|4|||
160767356|NCT02309359|580537748|FG000|Overall Study|Death|1|||
160767357|NCT02309359|580537749|FG001|Overall Study|Death|0|||
160767358|NCT02309359|580537750|FG002|Overall Study|Death|0|||
160767359|NCT02309359|580537751|FG003|Overall Study|Death|0|||
160767360|NCT02309359|580537752|FG004|Overall Study|Death|0|||
160767361|NCT02309359|580537748|FG000|Overall Study|Withdrawal by Subject|2|||
160767362|NCT02309359|580537749|FG001|Overall Study|Withdrawal by Subject|2|||
160767363|NCT02309359|580537750|FG002|Overall Study|Withdrawal by Subject|4|||
160767364|NCT02309359|580537751|FG003|Overall Study|Withdrawal by Subject|4|||
160767365|NCT02309359|580537752|FG004|Overall Study|Withdrawal by Subject|0|||
160767366|NCT02309359|580537748|FG000|Overall Study|Lack of Efficacy|3|||
160767367|NCT02309359|580537749|FG001|Overall Study|Lack of Efficacy|1|||
160767368|NCT02309359|580537750|FG002|Overall Study|Lack of Efficacy|0|||
160767369|NCT02309359|580537751|FG003|Overall Study|Lack of Efficacy|0|||
160767370|NCT02309359|580537752|FG004|Overall Study|Lack of Efficacy|3|||
160767371|NCT02309359|580537748|FG000|Overall Study|Lost to Follow-up|0|||
160767372|NCT02309359|580537749|FG001|Overall Study|Lost to Follow-up|0|||
160535512|NCT00111800|579690244|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
160535513|NCT00111800|579690245|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
160535514|NCT00111800|579690246|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
160535515|NCT00111800|579690247|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
160535516|NCT00111800|579690248|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
160535517|NCT00111800|579690243|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
160535518|NCT00111800|579690244|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
160535519|NCT00111800|579690245|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
160535520|NCT00111800|579690246|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
160535521|NCT00111800|579690247|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
160535522|NCT00111800|579690248|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
160535523|NCT00111800|579690243|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
160535524|NCT00111800|579690244|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
160535525|NCT00111800|579690245|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
160535526|NCT00111800|579690246|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
160535527|NCT00111800|579690247|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
160535528|NCT00111800|579690248|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
160535529|NCT00111800|579690243|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
160535530|NCT00111800|579690244|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
160535531|NCT00111800|579690245|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
160535532|NCT00111800|579690246|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
160535533|NCT00111800|579690247|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
160535534|NCT00111800|579690248|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
160535535|NCT00111800|579690243|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
160535536|NCT00111800|579690244|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
160535537|NCT00111800|579690245|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
160535538|NCT00111800|579690246|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
160535539|NCT00111800|579690247|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
160535540|NCT00111800|579690248|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
160535541|NCT00111800|579690243|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
160535542|NCT00111800|579690244|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
160535543|NCT00111800|579690245|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
160535544|NCT00111800|579690246|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
160535545|NCT00111800|579690247|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
160535546|NCT00111800|579690248|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
160535547|NCT00111800|579690243|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
160535548|NCT00111800|579690244|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
160535549|NCT00111800|579690245|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
160535550|NCT00111800|579690246|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
160535551|NCT00111800|579690247|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
160535552|NCT00111800|579690248|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
160535553|NCT00111800|579690243|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
160535554|NCT00111800|579690244|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
160535555|NCT00111800|579690245|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
160535556|NCT00111800|579690246|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
160535557|NCT00111800|579690247|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
160535558|NCT00111800|579690248|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
160535559|NCT00111800|579690243|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
160535560|NCT00111800|579690244|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
160535561|NCT00111800|579690245|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
160535562|NCT00111800|579690246|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
160535563|NCT00111800|579690247|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
160535564|NCT00111800|579690248|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
160535565|NCT00094770|579690249|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
160535566|NCT00094770|579690250|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
160535567|NCT00094770|579690249|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
160535568|NCT00094770|579690250|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
160535569|NCT00094770|579690249|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
160535570|NCT00094770|579690250|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
160535571|NCT00094770|579690249|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
160535572|NCT00094770|579690250|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
160767373|NCT02309359|580537750|FG002|Overall Study|Lost to Follow-up|0|||
160767374|NCT02309359|580537751|FG003|Overall Study|Lost to Follow-up|1|||
160535573|NCT00094770|579690249|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
160535574|NCT00094770|579690250|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
160535575|NCT00094770|579690249|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
160535576|NCT00094770|579690250|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
160535577|NCT00094770|579690249|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
160535578|NCT00094770|579690250|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
160535579|NCT00094770|579690249|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
160535580|NCT00094770|579690250|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
160535581|NCT00094770|579690249|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
160535582|NCT00094770|579690250|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
160535583|NCT00094770|579690249|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
160535584|NCT00094770|579690250|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
160535585|NCT00094770|579690249|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
160535586|NCT00094770|579690250|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
160535587|NCT00094770|579690249|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
160535588|NCT00094770|579690250|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
160535589|NCT00094770|579690249|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
160535590|NCT00094770|579690250|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
160535591|NCT00094770|579690249|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
160535592|NCT00094770|579690250|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
160535593|NCT00094770|579690249|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
160535594|NCT00094770|579690250|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
160535595|NCT00094770|579690249|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
160535596|NCT00094770|579690250|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
160535597|NCT00094770|579690249|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
160535598|NCT00094770|579690250|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
160535599|NCT00094770|579690249|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
160535600|NCT00094770|579690250|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
160535601|NCT01911442|579690251|FG000|Overall Study|Adverse Event|2|||
160535602|NCT01911442|579690252|FG001|Overall Study|Adverse Event|2|||
160535603|NCT01911442|579690253|FG002|Overall Study|Adverse Event|4|||
160535604|NCT01911442|579690251|FG000|Overall Study|Lack of Efficacy|1|||
160535605|NCT01911442|579690252|FG001|Overall Study|Lack of Efficacy|1|||
160535606|NCT01911442|579690253|FG002|Overall Study|Lack of Efficacy|1|||
160535607|NCT01911442|579690251|FG000|Overall Study|Lost to Follow-up|2|||
160535608|NCT01911442|579690252|FG001|Overall Study|Lost to Follow-up|0|||
160535609|NCT01911442|579690253|FG002|Overall Study|Lost to Follow-up|1|||
160535610|NCT01911442|579690251|FG000|Overall Study|Withdrawal by Subject|1|||
160535611|NCT01911442|579690252|FG001|Overall Study|Withdrawal by Subject|0|||
160535612|NCT01911442|579690253|FG002|Overall Study|Withdrawal by Subject|6|||
160535613|NCT01911442|579690251|FG000|Overall Study|Mother's Work Schedule|0|||
160535614|NCT01911442|579690252|FG001|Overall Study|Mother's Work Schedule|1|||
160535615|NCT01911442|579690253|FG002|Overall Study|Mother's Work Schedule|0|||
160535616|NCT02752035|579690257|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
160535617|NCT02752035|579690258|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
160535618|NCT02752035|579690259|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
160535619|NCT02752035|579690260|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
160535620|NCT02752035|579690257|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
160535621|NCT02752035|579690258|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
160535622|NCT02752035|579690259|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
160535623|NCT02752035|579690260|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
160535624|NCT02752035|579690257|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
160535625|NCT02752035|579690258|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
160535626|NCT02752035|579690259|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
160535627|NCT02752035|579690260|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
160535628|NCT02752035|579690257|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
160535629|NCT02752035|579690258|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
160535630|NCT02752035|579690259|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
160535631|NCT02752035|579690260|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
160535632|NCT02752035|579690257|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
160535633|NCT02752035|579690258|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
160535634|NCT02752035|579690259|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
160535635|NCT02752035|579690260|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
160535636|NCT02752035|579690257|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
160535637|NCT02752035|579690258|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
160535638|NCT02752035|579690259|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
160535639|NCT02752035|579690260|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
160535640|NCT02752035|579690257|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
160535641|NCT02752035|579690258|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
160535642|NCT02752035|579690259|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
160535643|NCT02752035|579690260|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
160535644|NCT02752035|579690257|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
160535645|NCT02752035|579690258|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
160535646|NCT02752035|579690259|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
160535647|NCT02752035|579690260|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
160535648|NCT02752035|579690257|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
160535649|NCT02752035|579690258|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
160535650|NCT02752035|579690259|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
160535651|NCT02752035|579690260|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
160535652|NCT02752035|579690257|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
160535653|NCT02752035|579690258|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
160535654|NCT02752035|579690259|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
160535655|NCT02752035|579690260|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
160535656|NCT02752035|579690257|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
160535657|NCT02752035|579690258|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
160535658|NCT02752035|579690259|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
160535659|NCT02752035|579690260|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
160535660|NCT02752035|579690257|FG000|Randomization: Approximately 3 Years|Death|0|||
160535661|NCT02752035|579690258|FG001|Randomization: Approximately 3 Years|Death|25|||
160535662|NCT02752035|579690259|FG002|Randomization: Approximately 3 Years|Death|13|||
160535663|NCT02752035|579690260|FG003|Randomization: Approximately 3 Years|Death|4|||
160535664|NCT02752035|579690257|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
160535665|NCT02752035|579690258|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
160535666|NCT02752035|579690259|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
160535667|NCT02752035|579690260|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
160535668|NCT02752035|579690257|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
160535669|NCT02752035|579690258|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
160535670|NCT02752035|579690259|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
160535671|NCT02752035|579690260|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
160535672|NCT02752035|579690257|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
160535673|NCT02752035|579690258|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
160535674|NCT02752035|579690259|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
160535675|NCT02752035|579690260|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
160535676|NCT02752035|579690257|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
160535677|NCT02752035|579690258|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
160535678|NCT02752035|579690259|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
160535679|NCT02752035|579690260|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
160535680|NCT02752035|579690257|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
160535681|NCT02752035|579690258|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
160535682|NCT02752035|579690259|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
160535683|NCT02752035|579690260|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
160535684|NCT03668600|579690263|FG000|Overall Study|Study Terminated by the Sponsor|157|||
160535685|NCT03668600|579690263|FG000|Overall Study|Protocol Violation|1|||
160535686|NCT03668600|579690263|FG000|Overall Study|Pregnancy|1|||
160535687|NCT03668600|579690263|FG000|Overall Study|Lost to Follow-up|7|||
160535688|NCT03668600|579690263|FG000|Overall Study|Withdrawal by Subject|56|||
160535689|NCT03668600|579690263|FG000|Overall Study|Lack of Efficacy|7|||
160535690|NCT03668600|579690263|FG000|Overall Study|Adverse Event|1|||
160535691|NCT00424749|579690265|FG000|Overall Study|Withdrawal by Subject|1|||
160535692|NCT01263483|579690266|FG000|Overall Study|Adverse Event|4|||
160535693|NCT01263483|579690267|FG001|Overall Study|Adverse Event|0|||
160535694|NCT01263483|579690268|FG002|Overall Study|Adverse Event|3|||
160535695|NCT01263483|579690266|FG000|Overall Study|Withdrawal by Subject|1|||
160535696|NCT01263483|579690267|FG001|Overall Study|Withdrawal by Subject|0|||
160535697|NCT01263483|579690268|FG002|Overall Study|Withdrawal by Subject|0|||
160535698|NCT01263483|579690266|FG000|Overall Study|Lack of Efficacy|2|||
160535699|NCT01263483|579690267|FG001|Overall Study|Lack of Efficacy|0|||
160535700|NCT01263483|579690268|FG002|Overall Study|Lack of Efficacy|0|||
160535701|NCT01263483|579690266|FG000|Overall Study|Protocol Violation|0|||
160535702|NCT01263483|579690267|FG001|Overall Study|Protocol Violation|1|||
160535703|NCT01263483|579690268|FG002|Overall Study|Protocol Violation|1|||
160535704|NCT01263483|579690266|FG000|Overall Study|Participant Unavailability|0|||
160535705|NCT01263483|579690267|FG001|Overall Study|Participant Unavailability|1|||
160535706|NCT01263483|579690268|FG002|Overall Study|Participant Unavailability|1|||
160535707|NCT01131676|579690273|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
160535708|NCT01131676|579690274|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
160535709|NCT01131676|579690275|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
160535710|NCT01131676|579690273|FG000|Discontinuation From Treatment|Not treated|4|||
160535711|NCT01131676|579690274|FG001|Discontinuation From Treatment|Not treated|2|||
160535712|NCT01131676|579690275|FG002|Discontinuation From Treatment|Not treated|2|||
160535713|NCT01131676|579690273|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
160535714|NCT01131676|579690274|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
160535715|NCT01131676|579690275|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
160535716|NCT01131676|579690273|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
160535717|NCT01131676|579690274|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
160535718|NCT01131676|579690275|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
160535719|NCT01131676|579690273|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
160535720|NCT01131676|579690274|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
160535721|NCT01131676|579690275|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
160535722|NCT01131676|579690273|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
160535723|NCT01131676|579690274|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
160535724|NCT01131676|579690275|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
160535725|NCT01131676|579690273|FG000|Discontinuation From Treatment|Other than those specified|162|||
160535726|NCT01131676|579690274|FG001|Discontinuation From Treatment|Other than those specified|142|||
160535727|NCT01131676|579690275|FG002|Discontinuation From Treatment|Other than those specified|125|||
160535728|NCT01131676|579690273|FG000|Discontinuation From Treatment|Adverse Event|303|||
160535729|NCT01131676|579690274|FG001|Discontinuation From Treatment|Adverse Event|267|||
160535730|NCT01131676|579690275|FG002|Discontinuation From Treatment|Adverse Event|273|||
160535731|NCT01131676|579690273|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
160535732|NCT01131676|579690274|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
160535733|NCT01131676|579690275|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
160535734|NCT01131676|579690273|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
160535735|NCT01131676|579690274|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
160535736|NCT01131676|579690275|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
160535737|NCT01131676|579690273|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
160535738|NCT01131676|579690274|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
160535739|NCT01131676|579690275|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
160535740|NCT01131676|579690273|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
160535741|NCT01131676|579690274|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
160535742|NCT01131676|579690275|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
160535743|NCT01131676|579690273|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
160535744|NCT01131676|579690274|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
160535745|NCT01131676|579690275|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
160535746|NCT01131676|579690273|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
160535747|NCT01131676|579690274|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
160535748|NCT01131676|579690275|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
160535749|NCT04109222|579690276|FG000|Overall Study|Adverse Event|1|||
160535750|NCT04109222|579690277|FG001|Overall Study|Adverse Event|0|||
160535751|NCT04109222|579690278|FG002|Overall Study|Adverse Event|0|||
160535752|NCT01111851|579690284|FG000|Overall Study|All planned PET scans were not obtained.|2|||
160535753|NCT01111851|579690285|FG001|Overall Study|All planned PET scans were not obtained.|0|||
160535754|NCT05500274|579690286|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
160535755|NCT05500274|579690287|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
160535756|NCT05500274|579690286|FG000|Overall Study|Lost to Follow-up|76|||
160535757|NCT05500274|579690287|FG001|Overall Study|Lost to Follow-up|51|||
160535758|NCT02343159|579690289|FG000|Overall Study|Early Study Termination|16|||
160535759|NCT02343159|579690290|FG001|Overall Study|Early Study Termination|19|||
160535760|NCT02343159|579690291|FG002|Overall Study|Early Study Termination|23|||
160535761|NCT02343159|579690289|FG000|Overall Study|Physician Decision|2|||
160535762|NCT02343159|579690290|FG001|Overall Study|Physician Decision|0|||
160535763|NCT02343159|579690291|FG002|Overall Study|Physician Decision|1|||
160535764|NCT02343159|579690289|FG000|Overall Study|Withdrawal by Subject|3|||
160535765|NCT02343159|579690290|FG001|Overall Study|Withdrawal by Subject|0|||
160535766|NCT02343159|579690291|FG002|Overall Study|Withdrawal by Subject|2|||
160535767|NCT02343159|579690289|FG000|Overall Study|Lost to Follow-up|0|||
160535768|NCT02343159|579690290|FG001|Overall Study|Lost to Follow-up|2|||
160535769|NCT02343159|579690291|FG002|Overall Study|Lost to Follow-up|2|||
160535770|NCT02343159|579690289|FG000|Overall Study|Adverse Event|4|||
160535771|NCT02343159|579690290|FG001|Overall Study|Adverse Event|4|||
160535772|NCT02343159|579690291|FG002|Overall Study|Adverse Event|2|||
160535773|NCT02343159|579690289|FG000|Overall Study|Sponsor Decision|0|||
160535774|NCT02343159|579690290|FG001|Overall Study|Sponsor Decision|1|||
160535775|NCT02343159|579690291|FG002|Overall Study|Sponsor Decision|0|||
160535776|NCT02343159|579690289|FG000|Overall Study|Enrollment Error|1|||
160535777|NCT02343159|579690290|FG001|Overall Study|Enrollment Error|0|||
160535778|NCT02343159|579690291|FG002|Overall Study|Enrollment Error|0|||
160535779|NCT02114268|579690294|FG000|Overall Study|Lost to Follow-up|4|||
160535780|NCT02114268|579690295|FG001|Overall Study|Lost to Follow-up|1|||
160535781|NCT02114268|579690296|FG002|Overall Study|Lost to Follow-up|1|||
160535782|NCT02114268|579690297|FG003|Overall Study|Lost to Follow-up|0|||
160535783|NCT02114268|579690298|FG004|Overall Study|Lost to Follow-up|0|||
160535784|NCT02114268|579690299|FG005|Overall Study|Lost to Follow-up|2|||
160535785|NCT02114268|579690294|FG000|Overall Study|Withdrawal by Subject|1|||
160535786|NCT02114268|579690295|FG001|Overall Study|Withdrawal by Subject|0|||
160535787|NCT02114268|579690296|FG002|Overall Study|Withdrawal by Subject|0|||
160535788|NCT02114268|579690297|FG003|Overall Study|Withdrawal by Subject|0|||
160535789|NCT02114268|579690298|FG004|Overall Study|Withdrawal by Subject|0|||
160535790|NCT02114268|579690299|FG005|Overall Study|Withdrawal by Subject|1|||
160535791|NCT02114268|579690294|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
160535792|NCT02114268|579690295|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
160535793|NCT02114268|579690296|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
160535794|NCT02114268|579690297|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
160535795|NCT02114268|579690298|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
160535796|NCT02114268|579690299|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
160535797|NCT02790138|579690300|FG000|Overall Study|Adverse Event|5|||
160535798|NCT02790138|579690301|FG001|Overall Study|Adverse Event|2|||
160535799|NCT02790138|579690300|FG000|Overall Study|Significant Protocol Deviation|0|||
160535800|NCT02790138|579690301|FG001|Overall Study|Significant Protocol Deviation|1|||
160535801|NCT02790138|579690300|FG000|Overall Study|Lost to Follow-up|1|||
160535802|NCT02790138|579690301|FG001|Overall Study|Lost to Follow-up|0|||
160535803|NCT02790138|579690300|FG000|Overall Study|Voluntary Withdrawal|8|||
160535804|NCT02790138|579690301|FG001|Overall Study|Voluntary Withdrawal|9|||
160535805|NCT02790138|579690300|FG000|Overall Study|Lack of Efficacy|6|||
160535806|NCT02790138|579690301|FG001|Overall Study|Lack of Efficacy|7|||
160535807|NCT02790138|579690300|FG000|Overall Study|Reason not Specified|1|||
160535808|NCT02790138|579690301|FG001|Overall Study|Reason not Specified|0|||
160535809|NCT04037748|579690302|FG000|Treatment Period 1|Withdrawal by Subject|3|||
160535810|NCT04037748|579690303|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160535811|NCT04037748|579690302|FG000|Treatment Period 1|Adverse Event|1|||
160535812|NCT04037748|579690303|FG001|Treatment Period 1|Adverse Event|1|||
160535813|NCT04037748|579690302|FG000|Treatment Period 1|Protocol Violation|4|||
160535814|NCT04037748|579690303|FG001|Treatment Period 1|Protocol Violation|5|||
160535815|NCT04037748|579690302|FG000|Treatment Period 2|Adverse Event|0|||
160535816|NCT04037748|579690303|FG001|Treatment Period 2|Adverse Event|1|||
160535817|NCT04037748|579690302|FG000|Treatment Period 2|Protocol Violation|2|||
160535818|NCT04037748|579690303|FG001|Treatment Period 2|Protocol Violation|0|||
160535819|NCT01506960|579690309|FG000|Overall Study|Did not meet angiographic criteria|47|||
160535820|NCT00397033|579690310|FG000|Overall Study|Adverse Event|7|||
160535821|NCT00397033|579690311|FG001|Overall Study|Adverse Event|10|||
160535822|NCT00397033|579690312|FG002|Overall Study|Adverse Event|4|||
160535823|NCT00397033|579690310|FG000|Overall Study|Lack of Efficacy|22|||
160535824|NCT00397033|579690311|FG001|Overall Study|Lack of Efficacy|12|||
160535825|NCT00397033|579690312|FG002|Overall Study|Lack of Efficacy|9|||
160535826|NCT00397033|579690310|FG000|Overall Study|Lost to Follow-up|3|||
160535827|NCT00397033|579690311|FG001|Overall Study|Lost to Follow-up|3|||
160535828|NCT00397033|579690312|FG002|Overall Study|Lost to Follow-up|3|||
160535829|NCT00397033|579690310|FG000|Overall Study|Withdrawal by Subject|12|||
160535830|NCT00397033|579690311|FG001|Overall Study|Withdrawal by Subject|7|||
160535831|NCT00397033|579690312|FG002|Overall Study|Withdrawal by Subject|5|||
160535832|NCT00397033|579690310|FG000|Overall Study|Other|0|||
160535833|NCT00397033|579690311|FG001|Overall Study|Other|5|||
160535834|NCT00397033|579690312|FG002|Overall Study|Other|2|||
160535835|NCT03519867|579690313|FG000|Overall Study|Adverse Event|1|||
160535836|NCT03519867|579690314|FG001|Overall Study|Adverse Event|1|||
160535837|NCT03519867|579690315|FG002|Overall Study|Adverse Event|0|||
160535838|NCT03519867|579690316|FG003|Overall Study|Adverse Event|0|||
160535839|NCT03519867|579690317|FG004|Overall Study|Adverse Event|0|||
160535840|NCT03519867|579690318|FG005|Overall Study|Adverse Event|0|||
160535841|NCT03519867|579690319|FG006|Overall Study|Adverse Event|0|||
160535842|NCT03519867|579690320|FG007|Overall Study|Adverse Event|0|||
160535843|NCT03519867|579690321|FG008|Overall Study|Adverse Event|0|||
160535844|NCT03519867|579690322|FG009|Overall Study|Adverse Event|0|||
160535845|NCT03519867|579690313|FG000|Overall Study|Protocol Violation|0|||
160535846|NCT03519867|579690314|FG001|Overall Study|Protocol Violation|0|||
160535847|NCT03519867|579690315|FG002|Overall Study|Protocol Violation|0|||
160535848|NCT03519867|579690316|FG003|Overall Study|Protocol Violation|0|||
160535849|NCT03519867|579690317|FG004|Overall Study|Protocol Violation|0|||
160535850|NCT03519867|579690318|FG005|Overall Study|Protocol Violation|1|||
160535851|NCT03519867|579690319|FG006|Overall Study|Protocol Violation|0|||
160535852|NCT03519867|579690320|FG007|Overall Study|Protocol Violation|0|||
160535853|NCT03519867|579690321|FG008|Overall Study|Protocol Violation|0|||
160535854|NCT03519867|579690322|FG009|Overall Study|Protocol Violation|0|||
160535855|NCT03519867|579690313|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
160535856|NCT03519867|579690314|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
160535857|NCT03519867|579690315|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
160535858|NCT03519867|579690316|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
160535859|NCT03519867|579690317|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
160535860|NCT03519867|579690318|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
160535861|NCT03519867|579690319|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
160535862|NCT03519867|579690320|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
160535863|NCT03519867|579690321|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
160535864|NCT03519867|579690322|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
160535865|NCT03519867|579690313|FG000|Overall Study|Admin. of other reversal agent|1|||
160535866|NCT03519867|579690314|FG001|Overall Study|Admin. of other reversal agent|1|||
160535867|NCT03519867|579690315|FG002|Overall Study|Admin. of other reversal agent|0|||
160535868|NCT03519867|579690316|FG003|Overall Study|Admin. of other reversal agent|0|||
160535869|NCT03519867|579690317|FG004|Overall Study|Admin. of other reversal agent|0|||
160535870|NCT03519867|579690318|FG005|Overall Study|Admin. of other reversal agent|1|||
160535871|NCT03519867|579690319|FG006|Overall Study|Admin. of other reversal agent|0|||
160535872|NCT03519867|579690320|FG007|Overall Study|Admin. of other reversal agent|0|||
160535873|NCT03519867|579690321|FG008|Overall Study|Admin. of other reversal agent|0|||
160535874|NCT03519867|579690322|FG009|Overall Study|Admin. of other reversal agent|0|||
160535875|NCT03519867|579690313|FG000|Overall Study|Reason not provided|1|||
160535876|NCT03519867|579690314|FG001|Overall Study|Reason not provided|1|||
160535877|NCT03519867|579690315|FG002|Overall Study|Reason not provided|1|||
160535878|NCT03519867|579690316|FG003|Overall Study|Reason not provided|1|||
160535879|NCT03519867|579690317|FG004|Overall Study|Reason not provided|0|||
160535880|NCT03519867|579690318|FG005|Overall Study|Reason not provided|1|||
160535881|NCT03519867|579690319|FG006|Overall Study|Reason not provided|0|||
160535882|NCT03519867|579690320|FG007|Overall Study|Reason not provided|1|||
160535883|NCT03519867|579690321|FG008|Overall Study|Reason not provided|1|||
160535884|NCT03519867|579690322|FG009|Overall Study|Reason not provided|0|||
160535885|NCT01846624|579690323|FG000|Overall Study|Died during induction, no midostaurin|1|||
160535886|NCT01202279|579690326|FG000|Overall Study|Adverse Event|8|||
160535887|NCT01202279|579690327|FG001|Overall Study|Adverse Event|6|||
160535888|NCT01202279|579690326|FG000|Overall Study|Withdrawal by Subject|13|||
160535889|NCT01202279|579690327|FG001|Overall Study|Withdrawal by Subject|10|||
160535890|NCT01202279|579690326|FG000|Overall Study|Physician Decision|0|||
160535891|NCT01202279|579690327|FG001|Overall Study|Physician Decision|1|||
160535892|NCT01202279|579690326|FG000|Overall Study|Lost to Follow-up|10|||
160535893|NCT01202279|579690327|FG001|Overall Study|Lost to Follow-up|7|||
160535894|NCT01202279|579690326|FG000|Overall Study|Protocol Violation|1|||
160535895|NCT01202279|579690327|FG001|Overall Study|Protocol Violation|1|||
160535896|NCT01202279|579690326|FG000|Overall Study|study compliance|5|||
160535897|NCT01202279|579690327|FG001|Overall Study|study compliance|2|||
160535898|NCT03574753|579690328|FG000|Overall Study|Adverse Event|3|||
160535899|NCT03574753|579690328|FG000|Overall Study|Progression/relapse|19|||
160535900|NCT03574753|579690328|FG000|Overall Study|Death|1|||
160535901|NCT03472924|579690329|FG000|Overall Study|Adverse Event|1|||
160535902|NCT03472924|579690330|FG001|Overall Study|Adverse Event|0|||
160535903|NCT02546765|579690332|FG000|Overall Study|Withdrawal by Subject|0|||
160535904|NCT02546765|579690333|FG001|Overall Study|Withdrawal by Subject|1|||
160535905|NCT02546765|579690334|FG002|Overall Study|Withdrawal by Subject|0|||
160535906|NCT02546765|579690335|FG003|Overall Study|Withdrawal by Subject|0|||
160535907|NCT04425720|579690338|FG000|Overall Study|Withdrawal by Subject|0|||
160535908|NCT04425720|579690339|FG001|Overall Study|Withdrawal by Subject|20|||
160535909|NCT00807742|579690340|FG000|Overall Study|Death|9|||
160535910|NCT00807742|579690341|FG001|Overall Study|Death|2|||
160535911|NCT00807742|579690340|FG000|Overall Study|Withdrawal by Subject|2|||
160535912|NCT00807742|579690341|FG001|Overall Study|Withdrawal by Subject|1|||
160535913|NCT00807742|579690340|FG000|Overall Study|Lost to Follow-up|35|||
160535914|NCT00807742|579690341|FG001|Overall Study|Lost to Follow-up|51|||
160535915|NCT04814823|579690343|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
160535916|NCT05318937|579690347|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160535917|NCT05318937|579690348|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160535918|NCT05318937|579690347|FG000|Overall Study|Lost to Follow-up|0|||
160535919|NCT05318937|579690348|FG001|Overall Study|Lost to Follow-up|1|||
160535920|NCT05318937|579690347|FG000|Overall Study|Withdrawal by Subject|0|||
160535921|NCT05318937|579690348|FG001|Overall Study|Withdrawal by Subject|2|||
160535922|NCT05318937|579690347|FG000|Overall Study|Protocol Violation|0|||
160535923|NCT05318937|579690348|FG001|Overall Study|Protocol Violation|1|||
160535924|NCT04722042|579690349|FG000|Overall Study|Withdrawal by Subject|2|||
160535925|NCT04722042|579690350|FG001|Overall Study|Withdrawal by Subject|1|||
160767375|NCT02309359|580537752|FG004|Overall Study|Lost to Follow-up|0|||
160535926|NCT04722042|579690351|FG002|Overall Study|Withdrawal by Subject|0|||
160535927|NCT01877915|579690352|FG000|Overall Study|Lost to Follow-up|10|||
160535928|NCT01877915|579690353|FG001|Overall Study|Lost to Follow-up|9|||
160535929|NCT01877915|579690352|FG000|Overall Study|Withdrawal by Subject|42|||
160535930|NCT01877915|579690353|FG001|Overall Study|Withdrawal by Subject|55|||
160535931|NCT01877915|579690352|FG000|Overall Study|Other|2|||
160535932|NCT01877915|579690353|FG001|Overall Study|Other|4|||
160535933|NCT01045798|579690358|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
160535934|NCT01045798|579690359|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
160535935|NCT01045798|579690358|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
160535936|NCT01045798|579690359|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
160535937|NCT01045798|579690358|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
160535938|NCT01045798|579690359|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
160535939|NCT01045798|579690358|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
160535940|NCT01045798|579690359|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
160535941|NCT00430482|579690365|FG000|Completed Treatment|Insufficient Treatment|7|||
160535942|NCT00430482|579690366|FG001|Completed Treatment|Insufficient Treatment|11|||
160535943|NCT04198623|579691776|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
160535944|NCT05050318|579691782|FG000|Overall Study|Protocol Deviation|1|||
160535945|NCT05050318|579691783|FG001|Overall Study|Protocol Deviation|0|||
160535946|NCT05050318|579691784|FG002|Overall Study|Protocol Deviation|0|||
160535947|NCT04259411|579691785|FG000|Overall Study|Death|1|||
160535948|NCT04259411|579691785|FG000|Overall Study|Missed visit|2|||
160535949|NCT04183790|579691791|FG000|Overall Study|Participants did not rollover to Part B|12|||
160874511|NCT04413617|580934240|FG000|Overall Study|Death|1|||
160874512|NCT04413617|580934241|FG001|Overall Study|Death|0|||
160874513|NCT04413617|580934242|FG002|Overall Study|Death|0|||
160535950|NCT04183790|579691792|FG001|Overall Study|Participants did not rollover to Part B|0|||
160535951|NCT04183790|579691791|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
160535952|NCT04183790|579691792|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
160535953|NCT04183790|579691791|FG000|Overall Study|Commercial drug is available for participant|6|||
160535954|NCT04183790|579691792|FG001|Overall Study|Commercial drug is available for participant|0|||
160535955|NCT04183790|579691791|FG000|Overall Study|Adverse Event|1|||
160535956|NCT04183790|579691792|FG001|Overall Study|Adverse Event|0|||
160535957|NCT04183790|579691791|FG000|Overall Study|Not enrolled in 107 study|0|||
160535958|NCT04183790|579691792|FG001|Overall Study|Not enrolled in 107 study|2|||
160535959|NCT01251653|579691793|FG000|Overall Study|Progressive Disease|1|||
160535960|NCT01251653|579691794|FG001|Overall Study|Progressive Disease|7|||
160535961|NCT01251653|579691795|FG002|Overall Study|Progressive Disease|16|||
160535962|NCT01251653|579691796|FG003|Overall Study|Progressive Disease|4|||
160535963|NCT01251653|579691797|FG004|Overall Study|Progressive Disease|0|||
160535964|NCT01251653|579691798|FG005|Overall Study|Progressive Disease|17|||
160535965|NCT01251653|579691799|FG006|Overall Study|Progressive Disease|14|||
160535966|NCT01251653|579691800|FG007|Overall Study|Progressive Disease|7|||
160535967|NCT01251653|579691801|FG008|Overall Study|Progressive Disease|5|||
160535968|NCT01251653|579691793|FG000|Overall Study|Dose-limiting toxicity|0|||
160535969|NCT01251653|579691794|FG001|Overall Study|Dose-limiting toxicity|1|||
160535970|NCT01251653|579691795|FG002|Overall Study|Dose-limiting toxicity|1|||
160535971|NCT01251653|579691796|FG003|Overall Study|Dose-limiting toxicity|1|||
160535972|NCT01251653|579691797|FG004|Overall Study|Dose-limiting toxicity|0|||
160535973|NCT01251653|579691798|FG005|Overall Study|Dose-limiting toxicity|0|||
160535974|NCT01251653|579691799|FG006|Overall Study|Dose-limiting toxicity|2|||
160535975|NCT01251653|579691800|FG007|Overall Study|Dose-limiting toxicity|0|||
160535976|NCT01251653|579691801|FG008|Overall Study|Dose-limiting toxicity|0|||
160535977|NCT01251653|579691793|FG000|Overall Study|Adverse Event|1|||
160535978|NCT01251653|579691794|FG001|Overall Study|Adverse Event|0|||
160535979|NCT01251653|579691795|FG002|Overall Study|Adverse Event|2|||
160535980|NCT01251653|579691796|FG003|Overall Study|Adverse Event|1|||
160535981|NCT01251653|579691797|FG004|Overall Study|Adverse Event|1|||
160535982|NCT01251653|579691798|FG005|Overall Study|Adverse Event|0|||
160535983|NCT01251653|579691799|FG006|Overall Study|Adverse Event|2|||
160535984|NCT01251653|579691800|FG007|Overall Study|Adverse Event|2|||
160535985|NCT01251653|579691801|FG008|Overall Study|Adverse Event|1|||
160535986|NCT01251653|579691793|FG000|Overall Study|Withdrawal by Subject|1|||
160535987|NCT01251653|579691794|FG001|Overall Study|Withdrawal by Subject|0|||
160535988|NCT01251653|579691795|FG002|Overall Study|Withdrawal by Subject|1|||
160535989|NCT01251653|579691796|FG003|Overall Study|Withdrawal by Subject|0|||
160535990|NCT01251653|579691797|FG004|Overall Study|Withdrawal by Subject|1|||
160535991|NCT01251653|579691798|FG005|Overall Study|Withdrawal by Subject|1|||
160535992|NCT01251653|579691799|FG006|Overall Study|Withdrawal by Subject|0|||
160535993|NCT01251653|579691800|FG007|Overall Study|Withdrawal by Subject|1|||
160535994|NCT01251653|579691801|FG008|Overall Study|Withdrawal by Subject|0|||
160535995|NCT01251653|579691793|FG000|Overall Study|Other reason not mentioned above|0|||
160535996|NCT01251653|579691794|FG001|Overall Study|Other reason not mentioned above|0|||
160535997|NCT01251653|579691795|FG002|Overall Study|Other reason not mentioned above|0|||
160535998|NCT01251653|579691796|FG003|Overall Study|Other reason not mentioned above|0|||
160535999|NCT01251653|579691797|FG004|Overall Study|Other reason not mentioned above|0|||
160874514|NCT04413617|580934243|FG003|Overall Study|Death|0|||
160874515|NCT04413617|580934244|FG004|Overall Study|Death|0|||
160874516|NCT04413617|580934240|FG000|Overall Study|Adverse Event|1|||
160536000|NCT01251653|579691798|FG005|Overall Study|Other reason not mentioned above|0|||
160536001|NCT01251653|579691799|FG006|Overall Study|Other reason not mentioned above|0|||
160536002|NCT01251653|579691800|FG007|Overall Study|Other reason not mentioned above|2|||
160536003|NCT01251653|579691801|FG008|Overall Study|Other reason not mentioned above|0|||
160536004|NCT00847145|579691802|FG000|Overall Study|AE or Death|0|||
160536005|NCT00847145|579691803|FG001|Overall Study|AE or Death|1|||
160536006|NCT00847145|579691804|FG002|Overall Study|AE or Death|1|||
160536007|NCT00847145|579691805|FG003|Overall Study|AE or Death|0|||
160536008|NCT00847145|579691806|FG004|Overall Study|AE or Death|0|||
160536009|NCT00847145|579691807|FG005|Overall Study|AE or Death|0|||
160536010|NCT00847145|579691808|FG006|Overall Study|AE or Death|0|||
160536011|NCT00847145|579691809|FG007|Overall Study|AE or Death|0|||
160536012|NCT00847145|579691802|FG000|Overall Study|Withdrawal by Subject|3|||
160536013|NCT00847145|579691803|FG001|Overall Study|Withdrawal by Subject|4|||
160536014|NCT00847145|579691804|FG002|Overall Study|Withdrawal by Subject|6|||
160536015|NCT00847145|579691805|FG003|Overall Study|Withdrawal by Subject|1|||
160536016|NCT00847145|579691806|FG004|Overall Study|Withdrawal by Subject|0|||
160536017|NCT00847145|579691807|FG005|Overall Study|Withdrawal by Subject|0|||
160536018|NCT00847145|579691808|FG006|Overall Study|Withdrawal by Subject|1|||
160536019|NCT00847145|579691809|FG007|Overall Study|Withdrawal by Subject|1|||
160536020|NCT00847145|579691802|FG000|Overall Study|Lost to Follow-up|3|||
160536021|NCT00847145|579691803|FG001|Overall Study|Lost to Follow-up|1|||
160536022|NCT00847145|579691804|FG002|Overall Study|Lost to Follow-up|1|||
160536023|NCT00847145|579691805|FG003|Overall Study|Lost to Follow-up|0|||
160536024|NCT00847145|579691806|FG004|Overall Study|Lost to Follow-up|4|||
160536025|NCT00847145|579691807|FG005|Overall Study|Lost to Follow-up|4|||
160536026|NCT00847145|579691808|FG006|Overall Study|Lost to Follow-up|8|||
160536027|NCT00847145|579691809|FG007|Overall Study|Lost to Follow-up|2|||
160536028|NCT00847145|579691802|FG000|Overall Study|Inappropriate enrollment|0|||
160536029|NCT00847145|579691803|FG001|Overall Study|Inappropriate enrollment|0|||
160536030|NCT00847145|579691804|FG002|Overall Study|Inappropriate enrollment|0|||
160536031|NCT00847145|579691805|FG003|Overall Study|Inappropriate enrollment|0|||
160536032|NCT00847145|579691806|FG004|Overall Study|Inappropriate enrollment|1|||
160536033|NCT00847145|579691807|FG005|Overall Study|Inappropriate enrollment|0|||
160536034|NCT00847145|579691808|FG006|Overall Study|Inappropriate enrollment|0|||
160536035|NCT00847145|579691809|FG007|Overall Study|Inappropriate enrollment|0|||
160536036|NCT00847145|579691802|FG000|Overall Study|Protocol Violation|0|||
160536037|NCT00847145|579691803|FG001|Overall Study|Protocol Violation|0|||
160536038|NCT00847145|579691804|FG002|Overall Study|Protocol Violation|3|||
160536039|NCT00847145|579691805|FG003|Overall Study|Protocol Violation|0|||
160536040|NCT00847145|579691806|FG004|Overall Study|Protocol Violation|1|||
160536041|NCT00847145|579691807|FG005|Overall Study|Protocol Violation|0|||
160536042|NCT00847145|579691808|FG006|Overall Study|Protocol Violation|0|||
160536043|NCT00847145|579691809|FG007|Overall Study|Protocol Violation|1|||
160536044|NCT02833974|579691810|FG000|Overall Study|Lost to Follow-up|1|||
160536045|NCT02833974|579691811|FG001|Overall Study|Lost to Follow-up|0|||
160536046|NCT02833974|579691810|FG000|Overall Study|Adverse Event|0|||
160536047|NCT02833974|579691811|FG001|Overall Study|Adverse Event|3|||
160536048|NCT04419610|579691812|FG000|Overall Study|Withdrawal by Subject|3|||
160536049|NCT04419610|579691813|FG001|Overall Study|Withdrawal by Subject|1|||
160536050|NCT04419610|579691812|FG000|Overall Study|Adverse Event|1|||
160536051|NCT04419610|579691813|FG001|Overall Study|Adverse Event|0|||
160536052|NCT04419610|579691812|FG000|Overall Study|discharged early|1|||
160536053|NCT04419610|579691813|FG001|Overall Study|discharged early|1|||
160536054|NCT01439282|579691814|FG000|Overall Study|Adverse Event|5|||
160536055|NCT01439282|579691815|FG001|Overall Study|Adverse Event|0|||
160536056|NCT01439282|579691814|FG000|Overall Study|Withdrawal by Subject|2|||
160536057|NCT01439282|579691815|FG001|Overall Study|Withdrawal by Subject|0|||
160536058|NCT01439282|579691814|FG000|Overall Study|Other|1|||
160536059|NCT01439282|579691815|FG001|Overall Study|Other|1|||
160767376|NCT02309359|580537748|FG000|Overall Study|Other|2|||
160767377|NCT02309359|580537749|FG001|Overall Study|Other|0|||
160767378|NCT02309359|580537750|FG002|Overall Study|Other|2|||
160767379|NCT02309359|580537751|FG003|Overall Study|Other|3|||
160767380|NCT02309359|580537752|FG004|Overall Study|Other|2|||
160767381|NCT06129149|580537755|FG000|Overall Study|Death|1|||
160767382|NCT02391337|580537756|FG000|6 Months Follow-up|Death|5|||
160767383|NCT02391337|580537757|FG001|6 Months Follow-up|Death|4|||
160767384|NCT02391337|580537756|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
160767385|NCT02391337|580537757|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
160767386|NCT02391337|580537756|FG000|12 Months Follow-up|Death|2|||
160767387|NCT02391337|580537757|FG001|12 Months Follow-up|Death|0|||
160536060|NCT04179734|579691819|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
160536061|NCT04179734|579691820|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
160536062|NCT04179734|579691819|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
160536063|NCT04179734|579691820|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
160536064|NCT02603120|579691821|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
160536065|NCT02603120|579691822|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
160536066|NCT02603120|579691821|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
160536067|NCT02603120|579691822|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
160536068|NCT02603120|579691821|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
160536069|NCT02603120|579691822|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
160536070|NCT02603120|579691821|FG000|Double-Blind Treatment Phase|Death|2|||
160536071|NCT02603120|579691822|FG001|Double-Blind Treatment Phase|Death|0|||
160536072|NCT02603120|579691821|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
160536073|NCT02603120|579691822|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
160536074|NCT02603120|579691821|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
160536075|NCT02603120|579691822|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
160536076|NCT02603120|579691821|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
160536077|NCT02603120|579691822|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
160536078|NCT02603120|579691821|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
160536079|NCT02603120|579691822|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
160536080|NCT02603120|579691821|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
160536081|NCT02603120|579691822|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
160536082|NCT02603120|579691821|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
160536083|NCT02603120|579691822|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
160536084|NCT02603120|579691821|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
160536085|NCT02603120|579691822|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
160536086|NCT02603120|579691821|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
160536087|NCT02603120|579691822|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
160536088|NCT02603120|579691821|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
160536089|NCT02603120|579691822|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
160536090|NCT02603120|579691821|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
160536091|NCT02603120|579691822|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
160536092|NCT00916357|579691824|FG000|Period 1|Withdrawal by Subject|1|||
160536093|NCT00916357|579691825|FG001|Period 1|Withdrawal by Subject|0|||
160536094|NCT00916357|579691826|FG002|Period 1|Withdrawal by Subject|0|||
160536095|NCT00916357|579691827|FG003|Period 1|Withdrawal by Subject|0|||
160536096|NCT00916357|579691828|FG004|Period 1|Withdrawal by Subject|0|||
160536097|NCT00916357|579691829|FG005|Period 1|Withdrawal by Subject|0|||
160536098|NCT00916357|579691824|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
160536099|NCT00916357|579691825|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
160536100|NCT00916357|579691826|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
160536101|NCT00916357|579691827|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
160536102|NCT00916357|579691828|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
160536103|NCT00916357|579691829|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
160536104|NCT03807349|579691832|FG000|Overall Study|Early Study Termination|9|||
160536105|NCT05807464|579691835|FG000|Overall Study|Adverse Event|1|||
160536106|NCT04451161|579691836|FG000|Overall Study|Lost to Follow-up|28|||
160536107|NCT04451161|579691837|FG001|Overall Study|Lost to Follow-up|37|||
160536108|NCT04451161|579691838|FG002|Overall Study|Lost to Follow-up|22|||
160536109|NCT04451161|579691839|FG003|Overall Study|Lost to Follow-up|13|||
160536110|NCT04451161|579691840|FG004|Overall Study|Lost to Follow-up|11|||
160536111|NCT04451161|579691841|FG005|Overall Study|Lost to Follow-up|14|||
160536112|NCT04451161|579691836|FG000|Overall Study|Withdrawal by Subject|3|||
160536113|NCT04451161|579691837|FG001|Overall Study|Withdrawal by Subject|0|||
160536114|NCT04451161|579691838|FG002|Overall Study|Withdrawal by Subject|0|||
160536115|NCT04451161|579691839|FG003|Overall Study|Withdrawal by Subject|0|||
160536116|NCT04451161|579691840|FG004|Overall Study|Withdrawal by Subject|2|||
160536117|NCT04451161|579691841|FG005|Overall Study|Withdrawal by Subject|4|||
160536118|NCT01555151|579691845|FG000|Overall Study|Withdrawal by Subject|6|||
160536119|NCT01555151|579691846|FG001|Overall Study|Withdrawal by Subject|2|||
160536120|NCT01555151|579691847|FG002|Overall Study|Withdrawal by Subject|0|||
160536121|NCT01555151|579691848|FG003|Overall Study|Withdrawal by Subject|2|||
160536122|NCT01555151|579691845|FG000|Overall Study|Administrative|3|||
160536123|NCT01555151|579691846|FG001|Overall Study|Administrative|1|||
160536124|NCT01555151|579691847|FG002|Overall Study|Administrative|2|||
160536125|NCT01555151|579691848|FG003|Overall Study|Administrative|0|||
160536126|NCT01555151|579691845|FG000|Overall Study|Protocol Violation|3|||
160536127|NCT01555151|579691846|FG001|Overall Study|Protocol Violation|3|||
160536128|NCT01555151|579691847|FG002|Overall Study|Protocol Violation|3|||
160536129|NCT01555151|579691848|FG003|Overall Study|Protocol Violation|5|||
160536130|NCT01555151|579691845|FG000|Overall Study|Adverse Event|1|||
160536131|NCT01555151|579691846|FG001|Overall Study|Adverse Event|2|||
160536132|NCT01555151|579691847|FG002|Overall Study|Adverse Event|1|||
160536133|NCT01555151|579691848|FG003|Overall Study|Adverse Event|2|||
160536134|NCT01555151|579691845|FG000|Overall Study|Lost to Follow-up|0|||
160536135|NCT01555151|579691846|FG001|Overall Study|Lost to Follow-up|0|||
160536136|NCT01555151|579691847|FG002|Overall Study|Lost to Follow-up|0|||
160536137|NCT01555151|579691848|FG003|Overall Study|Lost to Follow-up|1|||
160536138|NCT03596866|579691849|FG000|Overall Study|Site terminated by Sponsor|64|||
160536139|NCT03596866|579691850|FG001|Overall Study|Site terminated by Sponsor|65|||
160536140|NCT03596866|579691849|FG000|Overall Study|Death|37|||
160536141|NCT03596866|579691850|FG001|Overall Study|Death|24|||
160536142|NCT03596866|579691849|FG000|Overall Study|Withdrawal by Subject|4|||
160536143|NCT03596866|579691850|FG001|Overall Study|Withdrawal by Subject|6|||
160536144|NCT03596866|579691849|FG000|Overall Study|Missing|0|||
160536145|NCT03596866|579691850|FG001|Overall Study|Missing|6|||
160536146|NCT03596866|579691849|FG000|Overall Study|Lost to Follow-up|2|||
160536147|NCT03596866|579691850|FG001|Overall Study|Lost to Follow-up|3|||
160536148|NCT03596866|579691849|FG000|Overall Study|Protocol Violation|1|||
160536149|NCT03596866|579691850|FG001|Overall Study|Protocol Violation|0|||
160536150|NCT03596866|579691849|FG000|Overall Study|Reason Not Specified|14|||
160536151|NCT03596866|579691850|FG001|Overall Study|Reason Not Specified|13|||
160536152|NCT01431274|579691855|FG000|Overall Study|Adverse Event|51|||
160536153|NCT01431274|579691856|FG001|Overall Study|Adverse Event|37|||
160536154|NCT01431274|579691857|FG002|Overall Study|Adverse Event|43|||
160536155|NCT01431274|579691858|FG003|Overall Study|Adverse Event|30|||
160536156|NCT01431274|579691859|FG004|Overall Study|Adverse Event|37|||
160536157|NCT01431274|579691855|FG000|Overall Study|Consent withdrawn not due to AE|29|||
160536158|NCT01431274|579691856|FG001|Overall Study|Consent withdrawn not due to AE|20|||
160536159|NCT01431274|579691857|FG002|Overall Study|Consent withdrawn not due to AE|17|||
160536160|NCT01431274|579691858|FG003|Overall Study|Consent withdrawn not due to AE|20|||
160536161|NCT01431274|579691859|FG004|Overall Study|Consent withdrawn not due to AE|11|||
160536162|NCT01431274|579691855|FG000|Overall Study|Non compliant with protocol|5|||
160536163|NCT01431274|579691856|FG001|Overall Study|Non compliant with protocol|8|||
160536164|NCT01431274|579691857|FG002|Overall Study|Non compliant with protocol|4|||
160536165|NCT01431274|579691858|FG003|Overall Study|Non compliant with protocol|4|||
160874517|NCT04413617|580934241|FG001|Overall Study|Adverse Event|0|||
160874518|NCT04413617|580934242|FG002|Overall Study|Adverse Event|0|||
160874519|NCT04413617|580934243|FG003|Overall Study|Adverse Event|1|||
160536166|NCT01431274|579691859|FG004|Overall Study|Non compliant with protocol|4|||
160536167|NCT01431274|579691855|FG000|Overall Study|Lost to Follow-up|6|||
160536168|NCT01431274|579691856|FG001|Overall Study|Lost to Follow-up|7|||
160536169|NCT01431274|579691857|FG002|Overall Study|Lost to Follow-up|1|||
160536170|NCT01431274|579691858|FG003|Overall Study|Lost to Follow-up|4|||
160536171|NCT01431274|579691859|FG004|Overall Study|Lost to Follow-up|0|||
160536172|NCT01431274|579691855|FG000|Overall Study|Other reason not stated above|6|||
160536173|NCT01431274|579691856|FG001|Overall Study|Other reason not stated above|5|||
160536174|NCT01431274|579691857|FG002|Overall Study|Other reason not stated above|7|||
160536175|NCT01431274|579691858|FG003|Overall Study|Other reason not stated above|2|||
160536176|NCT01431274|579691859|FG004|Overall Study|Other reason not stated above|4|||
160536177|NCT01378858|579691863|FG000|Overall Study|Withdrawal by Subject|4|||
160536178|NCT01378858|579691864|FG001|Overall Study|Withdrawal by Subject|4|||
160536179|NCT01358760|579691865|FG000|Overall Study|Adverse Event|3|||
160536180|NCT01358760|579691866|FG001|Overall Study|Adverse Event|4|||
160536181|NCT01358760|579691867|FG002|Overall Study|Adverse Event|3|||
160536182|NCT01358760|579691865|FG000|Overall Study|Lost to Follow-up|1|||
160536183|NCT01358760|579691866|FG001|Overall Study|Lost to Follow-up|1|||
160536184|NCT01358760|579691867|FG002|Overall Study|Lost to Follow-up|3|||
160536185|NCT01358760|579691865|FG000|Overall Study|Withdrawal by Subject|5|||
160536186|NCT01358760|579691866|FG001|Overall Study|Withdrawal by Subject|3|||
160536187|NCT01358760|579691867|FG002|Overall Study|Withdrawal by Subject|2|||
160536188|NCT01358760|579691865|FG000|Overall Study|Physician Decision|1|||
160536189|NCT01358760|579691866|FG001|Overall Study|Physician Decision|0|||
160536190|NCT01358760|579691867|FG002|Overall Study|Physician Decision|1|||
160536191|NCT01358760|579691865|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
160536192|NCT01358760|579691866|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
160536193|NCT01358760|579691867|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
160536194|NCT04695392|579691868|FG000|Overall Study|Withdrawn by parent/guardian|0|||
160536195|NCT04695392|579691869|FG001|Overall Study|Withdrawn by parent/guardian|1|||
160536196|NCT04695392|579691868|FG000|Overall Study|Withdrawn by physician|0|||
160874520|NCT04413617|580934244|FG004|Overall Study|Adverse Event|1|||
160874521|NCT04413617|580934240|FG000|Overall Study|COVID-19|0|||
160874522|NCT04413617|580934241|FG001|Overall Study|COVID-19|1|||
160874523|NCT04413617|580934242|FG002|Overall Study|COVID-19|0|||
160874524|NCT04413617|580934243|FG003|Overall Study|COVID-19|0|||
160536197|NCT04695392|579691869|FG001|Overall Study|Withdrawn by physician|1|||
160536198|NCT00450723|579691870|FG000|Overall Study|Physician Decision|5|||
160536199|NCT01721057|579691873|FG000|Treatment Period|Withdrawal by Subject|11|||
160536200|NCT01721057|579691874|FG001|Treatment Period|Withdrawal by Subject|5|||
160536201|NCT01721057|579691875|FG002|Treatment Period|Withdrawal by Subject|8|||
160536202|NCT01721057|579691876|FG003|Treatment Period|Withdrawal by Subject|0|||
160536203|NCT01721057|579691877|FG004|Treatment Period|Withdrawal by Subject|0|||
160536204|NCT01721057|579691878|FG005|Treatment Period|Withdrawal by Subject|0|||
160536205|NCT01721057|579691879|FG006|Treatment Period|Withdrawal by Subject|0|||
160536206|NCT01721057|579691873|FG000|Treatment Period|Adverse Event|7|||
160536207|NCT01721057|579691874|FG001|Treatment Period|Adverse Event|10|||
160536208|NCT01721057|579691875|FG002|Treatment Period|Adverse Event|12|||
160536209|NCT01721057|579691876|FG003|Treatment Period|Adverse Event|0|||
160536210|NCT01721057|579691877|FG004|Treatment Period|Adverse Event|0|||
160874525|NCT04413617|580934244|FG004|Overall Study|COVID-19|0|||
160767388|NCT02391337|580537756|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
160767389|NCT02391337|580537757|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
160767390|NCT02391337|580537756|FG000|12 Months Follow-up|Lost to Follow-up|0|||
160767391|NCT02391337|580537757|FG001|12 Months Follow-up|Lost to Follow-up|2|||
160767392|NCT00471497|580537766|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
160767393|NCT00471497|580537767|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
160767394|NCT00471497|580537768|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
160767395|NCT00471497|580537766|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
160767396|NCT00471497|580537767|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
160536211|NCT01721057|579691878|FG005|Treatment Period|Adverse Event|0|||
160536212|NCT01721057|579691879|FG006|Treatment Period|Adverse Event|0|||
160536213|NCT01721057|579691873|FG000|Treatment Period|Lack of Efficacy|7|||
160536214|NCT01721057|579691874|FG001|Treatment Period|Lack of Efficacy|3|||
160536215|NCT01721057|579691875|FG002|Treatment Period|Lack of Efficacy|0|||
160536216|NCT01721057|579691876|FG003|Treatment Period|Lack of Efficacy|0|||
160874526|NCT00984620|580934245|FG000|Overall Study|Adverse Event|5|||
160536217|NCT01721057|579691877|FG004|Treatment Period|Lack of Efficacy|0|||
160536218|NCT01721057|579691878|FG005|Treatment Period|Lack of Efficacy|0|||
160536219|NCT01721057|579691879|FG006|Treatment Period|Lack of Efficacy|0|||
160536220|NCT01721057|579691873|FG000|Treatment Period|Lost to Follow-up|1|||
160536221|NCT01721057|579691874|FG001|Treatment Period|Lost to Follow-up|0|||
160536222|NCT01721057|579691875|FG002|Treatment Period|Lost to Follow-up|0|||
160536223|NCT01721057|579691876|FG003|Treatment Period|Lost to Follow-up|0|||
160536224|NCT01721057|579691877|FG004|Treatment Period|Lost to Follow-up|0|||
160536225|NCT01721057|579691878|FG005|Treatment Period|Lost to Follow-up|0|||
160536226|NCT01721057|579691879|FG006|Treatment Period|Lost to Follow-up|0|||
160536227|NCT01721057|579691873|FG000|Treatment Period|Physician Decision|0|||
160636484|NCT03747939|580051553|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
160636485|NCT03747939|580051554|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
160536228|NCT01721057|579691874|FG001|Treatment Period|Physician Decision|1|||
160536229|NCT01721057|579691875|FG002|Treatment Period|Physician Decision|3|||
160536230|NCT01721057|579691876|FG003|Treatment Period|Physician Decision|0|||
160536231|NCT01721057|579691877|FG004|Treatment Period|Physician Decision|0|||
160536232|NCT01721057|579691878|FG005|Treatment Period|Physician Decision|0|||
160536233|NCT01721057|579691879|FG006|Treatment Period|Physician Decision|0|||
160536234|NCT01721057|579691873|FG000|Treatment Period|Death|2|||
160536235|NCT01721057|579691874|FG001|Treatment Period|Death|0|||
160536236|NCT01721057|579691875|FG002|Treatment Period|Death|0|||
160536237|NCT01721057|579691876|FG003|Treatment Period|Death|0|||
160536238|NCT01721057|579691877|FG004|Treatment Period|Death|0|||
160536239|NCT01721057|579691878|FG005|Treatment Period|Death|0|||
160536240|NCT01721057|579691879|FG006|Treatment Period|Death|0|||
160536241|NCT01721057|579691873|FG000|Rescue Period|Adverse Event|0|||
160536242|NCT01721057|579691874|FG001|Rescue Period|Adverse Event|0|||
160536243|NCT01721057|579691875|FG002|Rescue Period|Adverse Event|0|||
160874527|NCT00984620|580934246|FG001|Overall Study|Adverse Event|5|||
160874528|NCT00984620|580934245|FG000|Overall Study|Lost to Follow-up|1|||
160874529|NCT00984620|580934246|FG001|Overall Study|Lost to Follow-up|1|||
160874530|NCT00984620|580934245|FG000|Overall Study|Withdrawal by Subject|0|||
160874531|NCT00984620|580934246|FG001|Overall Study|Withdrawal by Subject|2|||
160874532|NCT00984620|580934245|FG000|Overall Study|reason other than listed above|0|||
160874533|NCT00984620|580934246|FG001|Overall Study|reason other than listed above|4|||
160874534|NCT01703754|580934247|FG000|Overall Study|Clinically significant disease progression|2|||
160536244|NCT01721057|579691876|FG003|Rescue Period|Adverse Event|1|||
160536245|NCT01721057|579691877|FG004|Rescue Period|Adverse Event|0|||
160536246|NCT01721057|579691878|FG005|Rescue Period|Adverse Event|0|||
160536247|NCT01721057|579691879|FG006|Rescue Period|Adverse Event|0|||
160536248|NCT01721057|579691873|FG000|Rescue Period|Lack of Efficacy|0|||
160536249|NCT01721057|579691874|FG001|Rescue Period|Lack of Efficacy|0|||
160536250|NCT01721057|579691875|FG002|Rescue Period|Lack of Efficacy|0|||
160536251|NCT01721057|579691876|FG003|Rescue Period|Lack of Efficacy|2|||
160536252|NCT01721057|579691877|FG004|Rescue Period|Lack of Efficacy|0|||
160536253|NCT01721057|579691878|FG005|Rescue Period|Lack of Efficacy|0|||
160536254|NCT01721057|579691879|FG006|Rescue Period|Lack of Efficacy|0|||
160536255|NCT02047253|579691880|FG000|Overall Study|Lost to Follow-up|8|||
160536256|NCT01987960|579691882|FG000|Period 1|Adverse Event|24|||
160536257|NCT01987960|579691883|FG001|Period 1|Adverse Event|0|||
160536258|NCT01987960|579691884|FG002|Period 1|Adverse Event|0|||
160536259|NCT01987960|579691885|FG003|Period 1|Adverse Event|0|||
160536260|NCT01987960|579691882|FG000|Period 1|Lack of Efficacy|4|||
160536261|NCT01987960|579691883|FG001|Period 1|Lack of Efficacy|0|||
160536262|NCT01987960|579691884|FG002|Period 1|Lack of Efficacy|0|||
160536263|NCT01987960|579691885|FG003|Period 1|Lack of Efficacy|0|||
160536264|NCT01987960|579691882|FG000|Period 1|Non-compliance with IMP|6|||
160536265|NCT01987960|579691883|FG001|Period 1|Non-compliance with IMP|0|||
160536266|NCT01987960|579691884|FG002|Period 1|Non-compliance with IMP|0|||
160536267|NCT01987960|579691885|FG003|Period 1|Non-compliance with IMP|0|||
160536268|NCT01987960|579691882|FG000|Period 1|Protocol Violation|12|||
160536269|NCT01987960|579691883|FG001|Period 1|Protocol Violation|0|||
160536270|NCT01987960|579691884|FG002|Period 1|Protocol Violation|0|||
160536271|NCT01987960|579691885|FG003|Period 1|Protocol Violation|0|||
160536272|NCT01987960|579691882|FG000|Period 1|Withdrawal by Subject|21|||
160536273|NCT01987960|579691883|FG001|Period 1|Withdrawal by Subject|0|||
160536274|NCT01987960|579691884|FG002|Period 1|Withdrawal by Subject|0|||
160536275|NCT01987960|579691885|FG003|Period 1|Withdrawal by Subject|0|||
160536276|NCT01987960|579691882|FG000|Period 1|Lost to Follow-up|40|||
160536277|NCT01987960|579691883|FG001|Period 1|Lost to Follow-up|0|||
160536278|NCT01987960|579691884|FG002|Period 1|Lost to Follow-up|0|||
160536279|NCT01987960|579691885|FG003|Period 1|Lost to Follow-up|0|||
160536280|NCT01987960|579691882|FG000|Period 1|administrative or other reason|75|||
160536281|NCT01987960|579691883|FG001|Period 1|administrative or other reason|0|||
160536282|NCT01987960|579691884|FG002|Period 1|administrative or other reason|0|||
160536283|NCT01987960|579691885|FG003|Period 1|administrative or other reason|0|||
160536284|NCT01987960|579691882|FG000|Period 1|Withdrawal of consent before treatment|4|||
160536285|NCT01987960|579691883|FG001|Period 1|Withdrawal of consent before treatment|0|||
160536286|NCT01987960|579691884|FG002|Period 1|Withdrawal of consent before treatment|0|||
160536287|NCT01987960|579691885|FG003|Period 1|Withdrawal of consent before treatment|0|||
160536288|NCT01987960|579691882|FG000|Period 2|Adverse Event|0|||
160536289|NCT01987960|579691883|FG001|Period 2|Adverse Event|0|||
160536290|NCT01987960|579691884|FG002|Period 2|Adverse Event|1|||
160536291|NCT01987960|579691885|FG003|Period 2|Adverse Event|0|||
160536292|NCT01987960|579691882|FG000|Period 2|Withdrawal by Subject|0|||
160536293|NCT01987960|579691883|FG001|Period 2|Withdrawal by Subject|0|||
160536294|NCT01987960|579691884|FG002|Period 2|Withdrawal by Subject|1|||
160536295|NCT01987960|579691885|FG003|Period 2|Withdrawal by Subject|0|||
160536296|NCT01987960|579691882|FG000|Period 2|Administrative or other reason|0|||
160536297|NCT01987960|579691883|FG001|Period 2|Administrative or other reason|5|||
160536298|NCT01987960|579691884|FG002|Period 2|Administrative or other reason|7|||
160536299|NCT01987960|579691885|FG003|Period 2|Administrative or other reason|0|||
160536300|NCT01987960|579691882|FG000|Period 3|Adverse Event|0|||
160536301|NCT01987960|579691883|FG001|Period 3|Adverse Event|0|||
160536302|NCT01987960|579691884|FG002|Period 3|Adverse Event|0|||
160536303|NCT01987960|579691885|FG003|Period 3|Adverse Event|7|||
160536304|NCT01987960|579691882|FG000|Period 3|Non-compliance with IMP|0|||
160536305|NCT01987960|579691883|FG001|Period 3|Non-compliance with IMP|0|||
160536306|NCT01987960|579691884|FG002|Period 3|Non-compliance with IMP|0|||
160536307|NCT01987960|579691885|FG003|Period 3|Non-compliance with IMP|1|||
160874535|NCT01703754|580934248|FG001|Overall Study|Clinically significant disease progression|2|||
160874536|NCT01703754|580934249|FG002|Overall Study|Clinically significant disease progression|1|||
160874537|NCT01703754|580934247|FG000|Overall Study|Adverse Event|1|||
160874538|NCT01703754|580934248|FG001|Overall Study|Adverse Event|1|||
160874539|NCT01703754|580934249|FG002|Overall Study|Adverse Event|0|||
160874540|NCT01703754|580934247|FG000|Overall Study|Withdrawal by Subject|2|||
160874541|NCT01703754|580934248|FG001|Overall Study|Withdrawal by Subject|0|||
160536308|NCT01987960|579691882|FG000|Period 3|Protocol Violation|0|||
160536309|NCT01987960|579691883|FG001|Period 3|Protocol Violation|0|||
160874542|NCT01703754|580934249|FG002|Overall Study|Withdrawal by Subject|0|||
160536310|NCT01987960|579691884|FG002|Period 3|Protocol Violation|0|||
160536311|NCT01987960|579691885|FG003|Period 3|Protocol Violation|6|||
160536312|NCT01987960|579691882|FG000|Period 3|Withdrawal by Subject|0|||
160536313|NCT01987960|579691883|FG001|Period 3|Withdrawal by Subject|0|||
160536314|NCT01987960|579691884|FG002|Period 3|Withdrawal by Subject|0|||
160536315|NCT01987960|579691885|FG003|Period 3|Withdrawal by Subject|9|||
160536316|NCT01987960|579691882|FG000|Period 3|Lost to Follow-up|0|||
160536317|NCT01987960|579691883|FG001|Period 3|Lost to Follow-up|0|||
160536318|NCT01987960|579691884|FG002|Period 3|Lost to Follow-up|0|||
160536319|NCT01987960|579691885|FG003|Period 3|Lost to Follow-up|5|||
160536320|NCT01987960|579691882|FG000|Period 3|Administrative or other reason|0|||
160536321|NCT01987960|579691883|FG001|Period 3|Administrative or other reason|0|||
160536322|NCT01987960|579691884|FG002|Period 3|Administrative or other reason|0|||
160536323|NCT01987960|579691885|FG003|Period 3|Administrative or other reason|43|||
160536324|NCT01177683|579691887|FG000|Study Treatment|Disease Progressions during treatment|2|||
160536325|NCT01177683|579691888|FG001|Study Treatment|Disease Progressions during treatment|0|||
160536326|NCT01177683|579691889|FG002|Study Treatment|Disease Progressions during treatment|3|||
160536327|NCT01177683|579691887|FG000|Study Treatment|Adverse Event|0|||
160536328|NCT01177683|579691888|FG001|Study Treatment|Adverse Event|1|||
160536329|NCT01177683|579691889|FG002|Study Treatment|Adverse Event|12|||
160536330|NCT01177683|579691887|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
160536331|NCT01177683|579691888|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
160536332|NCT01177683|579691889|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
160536333|NCT01177683|579691887|FG000|Study Treatment|Alternative therapy|0|||
160536334|NCT01177683|579691888|FG001|Study Treatment|Alternative therapy|0|||
160536335|NCT01177683|579691889|FG002|Study Treatment|Alternative therapy|4|||
160536336|NCT01177683|579691887|FG000|Study Treatment|Physician Decision|1|||
160536337|NCT01177683|579691888|FG001|Study Treatment|Physician Decision|0|||
160536338|NCT01177683|579691889|FG002|Study Treatment|Physician Decision|1|||
160536339|NCT01177683|579691887|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
160536340|NCT01177683|579691888|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
160536341|NCT01177683|579691889|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
160536342|NCT01177683|579691887|FG000|Study Treatment|Symptomatic Deterioration|0|||
160536343|NCT01177683|579691888|FG001|Study Treatment|Symptomatic Deterioration|0|||
160536344|NCT01177683|579691889|FG002|Study Treatment|Symptomatic Deterioration|1|||
160536345|NCT01177683|579691887|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
160536346|NCT01177683|579691888|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
160536347|NCT01177683|579691889|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
160536348|NCT01177683|579691887|FG000|Follow up|Patient lost to follow up|0|||
160536349|NCT01177683|579691888|FG001|Follow up|Patient lost to follow up|0|||
160536350|NCT01177683|579691889|FG002|Follow up|Patient lost to follow up|2|||
160536351|NCT01177683|579691887|FG000|Follow up|Death|2|||
160536352|NCT01177683|579691888|FG001|Follow up|Death|1|||
160536353|NCT01177683|579691889|FG002|Follow up|Death|7|||
160536354|NCT01177683|579691887|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
160536355|NCT01177683|579691888|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
160536356|NCT01177683|579691889|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
160536357|NCT00789880|579691890|FG000|Overall Study|Adverse Event|0|||
160536358|NCT00789880|579691891|FG001|Overall Study|Adverse Event|0|||
160536359|NCT00789880|579691892|FG002|Overall Study|Adverse Event|0|||
160536360|NCT00789880|579691893|FG003|Overall Study|Adverse Event|0|||
160536361|NCT00789880|579691894|FG004|Overall Study|Adverse Event|1|||
160536362|NCT00789880|579691895|FG005|Overall Study|Adverse Event|0|||
160536363|NCT00789880|579691890|FG000|Overall Study|Protocol Violation|0|||
160536364|NCT00789880|579691891|FG001|Overall Study|Protocol Violation|1|||
160536365|NCT00789880|579691892|FG002|Overall Study|Protocol Violation|0|||
160536366|NCT00789880|579691893|FG003|Overall Study|Protocol Violation|1|||
160536367|NCT00789880|579691894|FG004|Overall Study|Protocol Violation|0|||
160536368|NCT00789880|579691895|FG005|Overall Study|Protocol Violation|0|||
160536369|NCT00789880|579691890|FG000|Overall Study|Withdrawal by Subject|1|||
160536370|NCT00789880|579691891|FG001|Overall Study|Withdrawal by Subject|0|||
160536371|NCT00789880|579691892|FG002|Overall Study|Withdrawal by Subject|0|||
160536372|NCT00789880|579691893|FG003|Overall Study|Withdrawal by Subject|0|||
160536373|NCT00789880|579691894|FG004|Overall Study|Withdrawal by Subject|2|||
160536374|NCT00789880|579691895|FG005|Overall Study|Withdrawal by Subject|0|||
160536375|NCT06347731|579691896|FG000|Overall Study|Death|1|||
160536376|NCT06347731|579691896|FG000|Overall Study|Protocol Violation|1|||
160536377|NCT06347731|579691896|FG000|Overall Study|Withdrawal by Subject|2|||
160536378|NCT00609986|579691900|FG000|Overall Study|Did not receive transplant or treatment|8|||
160536379|NCT00609986|579691901|FG001|Overall Study|Did not receive transplant or treatment|3|||
160536380|NCT03159091|579691902|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
160536381|NCT03159091|579691903|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
160536382|NCT03159091|579691902|FG000|Overall Study|Patient has taken no dose of study drug|0|||
160767397|NCT00471497|580537768|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
160536383|NCT03159091|579691903|FG001|Overall Study|Patient has taken no dose of study drug|1|||
160536384|NCT02044133|579691904|FG000|Overall Study|Lost to Follow-up|1|||
160536385|NCT02044133|579691905|FG001|Overall Study|Lost to Follow-up|1|||
160536386|NCT02044133|579691904|FG000|Overall Study|Death|1|||
160536387|NCT02044133|579691905|FG001|Overall Study|Death|0|||
160536388|NCT02044133|579691904|FG000|Overall Study|Release|3|||
160536389|NCT02044133|579691905|FG001|Overall Study|Release|4|||
160536390|NCT02044133|579691904|FG000|Overall Study|Transfer|1|||
160536391|NCT02044133|579691905|FG001|Overall Study|Transfer|0|||
160536392|NCT02044133|579691904|FG000|Overall Study|refusal of blood sampling|0|||
160536393|NCT02044133|579691905|FG001|Overall Study|refusal of blood sampling|1|||
160536394|NCT04085523|579691906|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
160536395|NCT04085523|579691907|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
160536396|NCT04085523|579691908|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
160536397|NCT04085523|579691909|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
160536398|NCT04085523|579691910|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
160536399|NCT04085523|579691911|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
160536400|NCT05678257|579691912|FG000|Overall Study|Withdrawal by Subject|2|||
160536401|NCT05678257|579691913|FG001|Overall Study|Withdrawal by Subject|0|||
160536402|NCT05678257|579691914|FG002|Overall Study|Withdrawal by Subject|5|||
160536403|NCT05678257|579691912|FG000|Overall Study|Physician Decision|1|||
160536404|NCT05678257|579691913|FG001|Overall Study|Physician Decision|0|||
160536405|NCT05678257|579691914|FG002|Overall Study|Physician Decision|1|||
160536406|NCT05678257|579691912|FG000|Overall Study|Adverse Event|1|||
160536407|NCT05678257|579691913|FG001|Overall Study|Adverse Event|3|||
160536408|NCT05678257|579691914|FG002|Overall Study|Adverse Event|1|||
160536409|NCT05678257|579691912|FG000|Overall Study|Progressive disease|11|||
160536410|NCT05678257|579691913|FG001|Overall Study|Progressive disease|18|||
160536411|NCT05678257|579691914|FG002|Overall Study|Progressive disease|7|||
160536412|NCT05678257|579691912|FG000|Overall Study|No longer clinically benefitting|2|||
160536413|NCT05678257|579691913|FG001|Overall Study|No longer clinically benefitting|1|||
160767398|NCT00471497|580537766|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
160767399|NCT00471497|580537767|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
160536414|NCT05678257|579691914|FG002|Overall Study|No longer clinically benefitting|0|||
160536415|NCT05678257|579691912|FG000|Overall Study|Sponsor decision|5|||
160536416|NCT05678257|579691913|FG001|Overall Study|Sponsor decision|9|||
160536417|NCT05678257|579691914|FG002|Overall Study|Sponsor decision|8|||
160536418|NCT05678257|579691912|FG000|Overall Study|Protocol Violation|0|||
160536419|NCT05678257|579691913|FG001|Overall Study|Protocol Violation|0|||
160536420|NCT05678257|579691914|FG002|Overall Study|Protocol Violation|1|||
160536421|NCT05678257|579691912|FG000|Overall Study|Patient non-compliance|0|||
160536422|NCT05678257|579691913|FG001|Overall Study|Patient non-compliance|0|||
160874543|NCT01561313|580934250|FG000|Overall Study|Withdrawal by Subject|1|||
160874544|NCT01561313|580934251|FG001|Overall Study|Withdrawal by Subject|0|||
160874545|NCT01561313|580934250|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
160874546|NCT01561313|580934251|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
160536423|NCT05678257|579691914|FG002|Overall Study|Patient non-compliance|3|||
160536424|NCT02046096|579691915|FG000|Overall Study|Death|28|||
160874547|NCT06173063|580934256|FG000|Overall Study|Withdrawal by Subject|2|||
160874548|NCT01925131|580935559|FG000|Overall Study|Death|0|||
160874549|NCT01925131|580935560|FG001|Overall Study|Death|0|||
160874550|NCT01925131|580935561|FG002|Overall Study|Death|1|||
160874551|NCT01925131|580935562|FG003|Overall Study|Death|0|||
160874552|NCT01925131|580935563|FG004|Overall Study|Death|0|||
160874553|NCT01925131|580935564|FG005|Overall Study|Death|0|||
160874554|NCT01925131|580935559|FG000|Overall Study|Progression/Relapse|1|||
160874555|NCT01925131|580935560|FG001|Overall Study|Progression/Relapse|1|||
160874556|NCT01925131|580935561|FG002|Overall Study|Progression/Relapse|4|||
160874557|NCT01925131|580935562|FG003|Overall Study|Progression/Relapse|0|||
160874558|NCT01925131|580935563|FG004|Overall Study|Progression/Relapse|0|||
160874559|NCT01925131|580935564|FG005|Overall Study|Progression/Relapse|1|||
160874560|NCT01925131|580935559|FG000|Overall Study|Patient Refusal|1|||
160874561|NCT01925131|580935560|FG001|Overall Study|Patient Refusal|0|||
160874562|NCT01925131|580935561|FG002|Overall Study|Patient Refusal|0|||
160874563|NCT01925131|580935562|FG003|Overall Study|Patient Refusal|0|||
160874564|NCT01925131|580935563|FG004|Overall Study|Patient Refusal|0|||
160536425|NCT02046096|579691916|FG001|Overall Study|Death|45|||
160536426|NCT02046096|579691915|FG000|Overall Study|Lost to Follow-up|9|||
160536427|NCT02046096|579691916|FG001|Overall Study|Lost to Follow-up|20|||
160536428|NCT02046096|579691915|FG000|Overall Study|Withdrawal by Subject|5|||
160536429|NCT02046096|579691916|FG001|Overall Study|Withdrawal by Subject|17|||
160536430|NCT02046096|579691915|FG000|Overall Study|Other endpoint|2|||
160536431|NCT02046096|579691916|FG001|Overall Study|Other endpoint|19|||
160536432|NCT03520959|579691917|FG000|Overall Study|Study terminated by Sponsor|0|||
160536433|NCT03520959|579691918|FG001|Overall Study|Study terminated by Sponsor|1|||
160536434|NCT00687440|579691920|FG000|Overall Study|Adverse Event|3|||
160536435|NCT00687440|579691920|FG000|Overall Study|Lost to Follow-up|3|||
160536436|NCT00687440|579691920|FG000|Overall Study|Lack of Efficacy|2|||
160536437|NCT00687440|579691920|FG000|Overall Study|Death|2|||
160536438|NCT00687440|579691920|FG000|Overall Study|Other|1|||
160536439|NCT00687440|579691920|FG000|Overall Study|Missing|1|||
160536440|NCT01538628|579691930|FG000|Overall Study|Withdrawal by Subject|1|||
160536441|NCT01538628|579691931|FG001|Overall Study|Withdrawal by Subject|1|||
160536442|NCT01538628|579691930|FG000|Overall Study|Lost to Follow-up|0|||
160536443|NCT01538628|579691931|FG001|Overall Study|Lost to Follow-up|1|||
160536444|NCT00583024|579691932|FG000|Overall Study|Lost to Follow-up|4|||
160536445|NCT00449670|579692990|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
160536446|NCT00449670|579692991|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
160536447|NCT00449670|579692990|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
160874565|NCT01925131|580935564|FG005|Overall Study|Patient Refusal|0|||
160874566|NCT01925131|580935559|FG000|Overall Study|Adverse Event|0|||
160874567|NCT01925131|580935560|FG001|Overall Study|Adverse Event|0|||
160874568|NCT01925131|580935561|FG002|Overall Study|Adverse Event|2|||
160874569|NCT01925131|580935562|FG003|Overall Study|Adverse Event|0|||
160874570|NCT01925131|580935563|FG004|Overall Study|Adverse Event|1|||
160874571|NCT01925131|580935564|FG005|Overall Study|Adverse Event|3|||
160874572|NCT01925131|580935559|FG000|Overall Study|Other - Not Protocol Specified|3|||
160536448|NCT00449670|579692991|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
160536449|NCT00449670|579692990|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
160536450|NCT00449670|579692991|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
160536451|NCT00449670|579692990|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
160536452|NCT00449670|579692991|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
160536453|NCT00449670|579692990|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
160536454|NCT00449670|579692991|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
160536455|NCT00449670|579692990|FG000|Booster Phase (Study no.109873)|Other|0|||
160536456|NCT00449670|579692991|FG001|Booster Phase (Study no.109873)|Other|2|||
160536457|NCT01502709|579692992|FG000|Overall Study|Lost to Follow-up|4|||
160874573|NCT01925131|580935560|FG001|Overall Study|Other - Not Protocol Specified|1|||
160874574|NCT01925131|580935561|FG002|Overall Study|Other - Not Protocol Specified|2|||
160874575|NCT01925131|580935562|FG003|Overall Study|Other - Not Protocol Specified|5|||
160874576|NCT01925131|580935563|FG004|Overall Study|Other - Not Protocol Specified|10|||
160874577|NCT01925131|580935564|FG005|Overall Study|Other - Not Protocol Specified|6|||
160874578|NCT05091567|580935565|FG000|Enrollment Phase|Death|37|||
160874579|NCT05091567|580935566|FG001|Enrollment Phase|Death|0|||
160536458|NCT01502709|579692993|FG001|Overall Study|Lost to Follow-up|0|||
160536459|NCT02966509|579692998|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
160536460|NCT02966509|579692999|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
160536461|NCT02966509|579692998|FG000|Baseline Satisfaction Survey|Death|0|||
160536462|NCT02966509|579692999|FG001|Baseline Satisfaction Survey|Death|1|||
160536463|NCT02966509|579692998|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
160536464|NCT02966509|579692999|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
160536465|NCT02966509|579692998|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
160536466|NCT02966509|579692999|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
160536467|NCT02966509|579692998|FG000|6 Month Satisfaction Decision Survey|Death|22|||
160536468|NCT02966509|579692999|FG001|6 Month Satisfaction Decision Survey|Death|25|||
160536469|NCT02966509|579692998|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
160536470|NCT02966509|579692999|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
160874580|NCT05091567|580935567|FG002|Enrollment Phase|Death|0|||
160874581|NCT05091567|580935565|FG000|Enrollment Phase|Adverse Event|21|||
160536471|NCT02966509|579692998|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
160536472|NCT02966509|579692999|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
160536473|NCT02966509|579692998|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
160536474|NCT02966509|579692999|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
160536475|NCT02966509|579692998|FG000|6 Month Satisfaction Survey|Death|36|||
160536476|NCT02966509|579692999|FG001|6 Month Satisfaction Survey|Death|33|||
160536477|NCT02966509|579692998|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
160536478|NCT02966509|579692999|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
160536479|NCT02966509|579692998|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
160874582|NCT05091567|580935566|FG001|Enrollment Phase|Adverse Event|0|||
160874583|NCT05091567|580935567|FG002|Enrollment Phase|Adverse Event|0|||
160536480|NCT02966509|579692999|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
160536481|NCT02966509|579692998|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
160536482|NCT02966509|579692999|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
160536483|NCT02966509|579692998|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
160536484|NCT02966509|579692999|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
160536485|NCT02966509|579692998|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
160536486|NCT02966509|579692999|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
160536487|NCT01321710|579693004|FG000|Overall Study|Lost to Follow-up|4|||
160536488|NCT01321710|579693005|FG001|Overall Study|Lost to Follow-up|5|||
160536489|NCT01321710|579693006|FG002|Overall Study|Lost to Follow-up|0|||
160536490|NCT01761292|579693007|FG000|Part 1|Adverse Event|1|||
160536491|NCT01761292|579693007|FG000|Part 1|not receiving treatment in Part 1|1|||
160536492|NCT01761292|579693007|FG000|Extension 1|Withdrawal by Subject|1|||
160536493|NCT03332498|579693008|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
160536494|NCT03332498|579693009|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
160536495|NCT03332498|579693010|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
160536496|NCT03577730|579693011|FG000|Overall Study|Physician Decision|3|||
160536497|NCT03577730|579693012|FG001|Overall Study|Physician Decision|1|||
160536498|NCT03577730|579693011|FG000|Overall Study|Did not receive allocated intervention|1|||
160536499|NCT03577730|579693012|FG001|Overall Study|Did not receive allocated intervention|0|||
160536500|NCT03810781|579693014|FG000|Overall Study|COVID shut down|2|||
160536501|NCT05611671|579693018|FG000|Overall Study|Adverse Event|1|||
160536502|NCT05611671|579693019|FG001|Overall Study|Adverse Event|1|||
160536503|NCT05611671|579693020|FG002|Overall Study|Adverse Event|0|||
160536504|NCT05611671|579693021|FG003|Overall Study|Adverse Event|1|||
160536505|NCT05611671|579693018|FG000|Overall Study|Lack of Efficacy|1|||
160536506|NCT05611671|579693019|FG001|Overall Study|Lack of Efficacy|0|||
160536507|NCT05611671|579693020|FG002|Overall Study|Lack of Efficacy|1|||
160536508|NCT05611671|579693021|FG003|Overall Study|Lack of Efficacy|2|||
160536509|NCT05611671|579693018|FG000|Overall Study|Lost to Follow-up|0|||
160536510|NCT05611671|579693019|FG001|Overall Study|Lost to Follow-up|0|||
160536511|NCT05611671|579693020|FG002|Overall Study|Lost to Follow-up|0|||
160536512|NCT05611671|579693021|FG003|Overall Study|Lost to Follow-up|1|||
160536513|NCT05611671|579693018|FG000|Overall Study|Protocol Violation|0|||
160536514|NCT05611671|579693019|FG001|Overall Study|Protocol Violation|1|||
160536515|NCT05611671|579693020|FG002|Overall Study|Protocol Violation|0|||
160536516|NCT05611671|579693021|FG003|Overall Study|Protocol Violation|0|||
160536517|NCT05611671|579693018|FG000|Overall Study|Withdrawal by Subject|2|||
160536518|NCT05611671|579693019|FG001|Overall Study|Withdrawal by Subject|1|||
160536519|NCT05611671|579693020|FG002|Overall Study|Withdrawal by Subject|2|||
160536520|NCT05611671|579693021|FG003|Overall Study|Withdrawal by Subject|1|||
160536521|NCT00253643|579693022|FG000|Overall Study|Withdrawal by Subject|0|||
160536522|NCT00253643|579693023|FG001|Overall Study|Withdrawal by Subject|0|||
160536523|NCT00253643|579693024|FG002|Overall Study|Withdrawal by Subject|1|||
160536524|NCT00253643|579693025|FG003|Overall Study|Withdrawal by Subject|1|||
160536525|NCT00253643|579693022|FG000|Overall Study|Non-Compliance|0|||
160536526|NCT00253643|579693023|FG001|Overall Study|Non-Compliance|0|||
160536527|NCT00253643|579693024|FG002|Overall Study|Non-Compliance|0|||
160536528|NCT00253643|579693025|FG003|Overall Study|Non-Compliance|2|||
160536529|NCT01368536|579693026|FG000|Overall Study|Adverse Event|5|||
160536530|NCT01368536|579693027|FG001|Overall Study|Adverse Event|6|||
160536531|NCT01368536|579693028|FG002|Overall Study|Adverse Event|8|||
160536532|NCT01368536|579693026|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160874584|NCT05091567|580935565|FG000|Enrollment Phase|Progressive Disease|10|||
160874585|NCT05091567|580935566|FG001|Enrollment Phase|Progressive Disease|0|||
160874586|NCT05091567|580935567|FG002|Enrollment Phase|Progressive Disease|0|||
160874587|NCT05091567|580935565|FG000|Enrollment Phase|Withdrawal by Subject|8|||
160536533|NCT01368536|579693027|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160536534|NCT01368536|579693028|FG002|Overall Study|Abnormal laboratory value(s)|2|||
160536535|NCT01368536|579693026|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160536536|NCT01368536|579693027|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160536537|NCT01368536|579693028|FG002|Overall Study|Abnormal test procedure result(s)|1|||
160536538|NCT01368536|579693026|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
160536539|NCT01368536|579693027|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160536540|NCT01368536|579693028|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
160536541|NCT01368536|579693026|FG000|Overall Study|No longer required study medication|0|||
160536542|NCT01368536|579693027|FG001|Overall Study|No longer required study medication|0|||
160536543|NCT01368536|579693028|FG002|Overall Study|No longer required study medication|1|||
160536544|NCT01368536|579693026|FG000|Overall Study|Withdrawal by Subject|2|||
160536545|NCT01368536|579693027|FG001|Overall Study|Withdrawal by Subject|5|||
160536546|NCT01368536|579693028|FG002|Overall Study|Withdrawal by Subject|4|||
160536547|NCT01368536|579693026|FG000|Overall Study|Lost to Follow-up|3|||
160536548|NCT01368536|579693027|FG001|Overall Study|Lost to Follow-up|3|||
160536549|NCT01368536|579693028|FG002|Overall Study|Lost to Follow-up|5|||
160536550|NCT01368536|579693026|FG000|Overall Study|Administrative problems|34|||
160536551|NCT01368536|579693027|FG001|Overall Study|Administrative problems|39|||
160536552|NCT01368536|579693028|FG002|Overall Study|Administrative problems|35|||
160536553|NCT01368536|579693026|FG000|Overall Study|Protocol deviation|0|||
160536554|NCT01368536|579693027|FG001|Overall Study|Protocol deviation|3|||
160536555|NCT01368536|579693028|FG002|Overall Study|Protocol deviation|1|||
160536556|NCT00383084|579693029|FG000|Overall Study|Withdrawal by Subject|12|||
160536557|NCT00383084|579693030|FG001|Overall Study|Withdrawal by Subject|10|||
160536558|NCT01486927|579693031|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
160536559|NCT01486927|579693031|FG000|Overall Study|Physician Decision|1|||
160536560|NCT01486927|579693031|FG000|Overall Study|50 Exposure days not reached|2|||
160874588|NCT05091567|580935566|FG001|Enrollment Phase|Withdrawal by Subject|0|||
160874589|NCT05091567|580935567|FG002|Enrollment Phase|Withdrawal by Subject|0|||
160874590|NCT05091567|580935565|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
160536561|NCT01486927|579693031|FG000|Overall Study|Withdrawal by Subject|8|||
160536562|NCT01486927|579693031|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
160536563|NCT02159729|579693032|FG000|Overall Study|Adverse Event|0|||
160536564|NCT02159729|579693033|FG001|Overall Study|Adverse Event|1|||
160536565|NCT02159729|579693032|FG000|Overall Study|Subject's Request|13|||
160536566|NCT02159729|579693033|FG001|Overall Study|Subject's Request|10|||
160536567|NCT02159729|579693032|FG000|Overall Study|Lost to Follow-up|24|||
160536568|NCT02159729|579693033|FG001|Overall Study|Lost to Follow-up|9|||
160536569|NCT02159729|579693032|FG000|Overall Study|Non compliance|2|||
160536570|NCT02159729|579693033|FG001|Overall Study|Non compliance|0|||
160536571|NCT02159729|579693032|FG000|Overall Study|Other Unspecified|3|||
160536572|NCT02159729|579693033|FG001|Overall Study|Other Unspecified|1|||
160536573|NCT00573430|579693034|FG000|Overall Study|Incorrect enrollment of randomization|0|||
160536574|NCT00573430|579693035|FG001|Overall Study|Incorrect enrollment of randomization|4|||
160536575|NCT00573430|579693036|FG002|Overall Study|Incorrect enrollment of randomization|3|||
160874591|NCT05091567|580935566|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
160536576|NCT00573430|579693034|FG000|Overall Study|Adverse Event|0|||
160536577|NCT00573430|579693035|FG001|Overall Study|Adverse Event|0|||
160536578|NCT00573430|579693036|FG002|Overall Study|Adverse Event|2|||
160536579|NCT00573430|579693034|FG000|Overall Study|Withdrawal by Subject|1|||
160536580|NCT00573430|579693035|FG001|Overall Study|Withdrawal by Subject|0|||
160536581|NCT00573430|579693036|FG002|Overall Study|Withdrawal by Subject|1|||
160536582|NCT00573430|579693034|FG000|Overall Study|Protocol Violation|0|||
160536583|NCT00573430|579693035|FG001|Overall Study|Protocol Violation|1|||
160536584|NCT00573430|579693036|FG002|Overall Study|Protocol Violation|1|||
160536585|NCT00573430|579693034|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160536586|NCT00573430|579693035|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160536587|NCT00573430|579693036|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
160536588|NCT05895552|579693037|FG000|Overall Study|Adverse Event|2|||
160536589|NCT05895552|579693038|FG001|Overall Study|Adverse Event|2|||
160536590|NCT05895552|579693039|FG002|Overall Study|Adverse Event|1|||
160536591|NCT05895552|579693037|FG000|Overall Study|Lost to Follow-up|0|||
160536592|NCT05895552|579693038|FG001|Overall Study|Lost to Follow-up|1|||
160536593|NCT05895552|579693039|FG002|Overall Study|Lost to Follow-up|0|||
160536594|NCT05895552|579693037|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160536595|NCT05895552|579693038|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160536596|NCT05895552|579693039|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160536597|NCT05895552|579693037|FG000|Overall Study|Protocol Deviation|0|||
160536598|NCT05895552|579693038|FG001|Overall Study|Protocol Deviation|0|||
160536599|NCT05895552|579693039|FG002|Overall Study|Protocol Deviation|2|||
160536600|NCT05895552|579693037|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
160536601|NCT05895552|579693038|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
160536602|NCT05895552|579693039|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
160536603|NCT05895552|579693037|FG000|Overall Study|Withdrawal by Subject|2|||
160536604|NCT05895552|579693038|FG001|Overall Study|Withdrawal by Subject|2|||
160536605|NCT05895552|579693039|FG002|Overall Study|Withdrawal by Subject|4|||
160536606|NCT03810911|579693040|FG000|Overall Study|Death|1|||
160536607|NCT03810911|579693041|FG001|Overall Study|Death|1|||
160536608|NCT03810911|579693040|FG000|Overall Study|Withdrawal by Subject|1|||
160536609|NCT03810911|579693041|FG001|Overall Study|Withdrawal by Subject|1|||
160536610|NCT00596947|579693042|FG000|Overall Study|study halted due to low enrollment|5|||
160536611|NCT00596947|579693043|FG001|Overall Study|study halted due to low enrollment|3|||
160536612|NCT00596947|579693042|FG000|Overall Study|Lost to Follow-up|1|||
160536613|NCT00596947|579693043|FG001|Overall Study|Lost to Follow-up|0|||
160536614|NCT00829179|579693044|FG000|Overall Study|Withdrawal by Subject|1|||
160536615|NCT03000179|579693045|FG000|Overall Study|Lost to Follow-up|2|||
160536616|NCT00003702|579693047|FG000|Overall Study|Ineligible cell types|2|||
160536617|NCT00003702|579693048|FG001|Overall Study|Ineligible cell types|2|||
160536618|NCT00003702|579693047|FG000|Overall Study|Did not meet criteria for persistence|8|||
160536619|NCT00003702|579693048|FG001|Overall Study|Did not meet criteria for persistence|5|||
160536620|NCT00003702|579693047|FG000|Overall Study|WHO score > 6|2|||
160536621|NCT00003702|579693048|FG001|Overall Study|WHO score > 6|1|||
160536622|NCT00003702|579693047|FG000|Overall Study|Inadequate documentation of disease|1|||
160536623|NCT00003702|579693048|FG001|Overall Study|Inadequate documentation of disease|3|||
160536624|NCT00827606|579693049|FG000|Overall Study|Protocol Violation|4|||
160536625|NCT00827606|579693050|FG001|Overall Study|Protocol Violation|3|||
160536626|NCT00827606|579693049|FG000|Overall Study|Lost to Follow-up|3|||
160536627|NCT00827606|579693050|FG001|Overall Study|Lost to Follow-up|1|||
160536628|NCT00827606|579693049|FG000|Overall Study|Withdrawal by Subject|7|||
160536629|NCT00827606|579693050|FG001|Overall Study|Withdrawal by Subject|6|||
160536630|NCT00827606|579693049|FG000|Overall Study|Pregnancy|0|||
160536631|NCT00827606|579693050|FG001|Overall Study|Pregnancy|1|||
160536632|NCT00827606|579693049|FG000|Overall Study|Other|5|||
160536633|NCT00827606|579693050|FG001|Overall Study|Other|13|||
160536634|NCT00827606|579693049|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
160536635|NCT00827606|579693050|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
160536636|NCT00827606|579693049|FG000|Overall Study|Adverse Event|4|||
160536637|NCT00827606|579693050|FG001|Overall Study|Adverse Event|2|||
160536638|NCT00243386|579693053|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
160536639|NCT00243386|579693054|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
160874592|NCT05091567|580935567|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
160874593|NCT05091567|580935565|FG000|Enrollment Phase|Physician Decision|3|||
160874594|NCT05091567|580935566|FG001|Enrollment Phase|Physician Decision|0|||
160536640|NCT00243386|579693055|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
160536641|NCT00243386|579693053|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
160536642|NCT00243386|579693054|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
160536643|NCT00243386|579693055|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
160536644|NCT00243386|579693053|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
160536645|NCT00243386|579693054|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
160536646|NCT00243386|579693055|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
160536647|NCT00243386|579693053|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
160536648|NCT00243386|579693054|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
160536649|NCT00243386|579693055|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
160536650|NCT00243386|579693053|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
160536651|NCT00243386|579693054|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
160536652|NCT00243386|579693055|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
160536653|NCT00243386|579693053|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
160536654|NCT00243386|579693054|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
160536655|NCT00243386|579693055|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
160536656|NCT00243386|579693053|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
160536657|NCT00243386|579693054|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
160536658|NCT00243386|579693055|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
160536659|NCT00243386|579693053|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
160536660|NCT00243386|579693054|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
160536661|NCT00243386|579693055|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
160536662|NCT04995055|579693056|FG000|Period 1|COVID-19 Related|1|||
160536663|NCT04995055|579693057|FG001|Period 1|COVID-19 Related|0|||
160536664|NCT04995055|579693056|FG000|Period 1|Withdrawal by Subject|0|||
160536665|NCT04995055|579693057|FG001|Period 1|Withdrawal by Subject|1|||
160536666|NCT04995055|579693056|FG000|Period 1|Subject discontinued due to timing|4|||
160536667|NCT04995055|579693057|FG001|Period 1|Subject discontinued due to timing|4|||
160536668|NCT04810689|579693058|FG000|Overall Study|Withdrawal by Subject|0|||
160536669|NCT04810689|579693059|FG001|Overall Study|Withdrawal by Subject|1|||
160536670|NCT04969276|579693060|FG000|Overall Study|Protocol Deviation|0|||
160536671|NCT04969276|579693061|FG001|Overall Study|Protocol Deviation|1|||
160536672|NCT04969276|579693062|FG002|Overall Study|Protocol Deviation|0|||
160536673|NCT04969276|579693060|FG000|Overall Study|Withdrawal by Subject|1|||
160536674|NCT04969276|579693061|FG001|Overall Study|Withdrawal by Subject|10|||
160536675|NCT04969276|579693062|FG002|Overall Study|Withdrawal by Subject|0|||
160536676|NCT04969276|579693060|FG000|Overall Study|Lost to Follow-up|0|||
160536677|NCT04969276|579693061|FG001|Overall Study|Lost to Follow-up|1|||
160536678|NCT04969276|579693062|FG002|Overall Study|Lost to Follow-up|0|||
160536679|NCT00943579|579693065|FG000|Overall Study|Adverse Event|4|||
160536680|NCT00943579|579693066|FG001|Overall Study|Adverse Event|3|||
160536681|NCT00943579|579693065|FG000|Overall Study|Lack of Efficacy|2|||
160536682|NCT00943579|579693066|FG001|Overall Study|Lack of Efficacy|2|||
160536683|NCT00418665|579693069|FG000|Treatment Period|Ineligibility determined|1|||
160536684|NCT00418665|579693070|FG001|Treatment Period|Ineligibility determined|1|||
160536685|NCT00418665|579693071|FG002|Treatment Period|Ineligibility determined|0|||
160536686|NCT00418665|579693069|FG000|Treatment Period|Adverse Event|2|||
160536687|NCT00418665|579693070|FG001|Treatment Period|Adverse Event|2|||
160536688|NCT00418665|579693071|FG002|Treatment Period|Adverse Event|0|||
160536689|NCT00418665|579693069|FG000|Treatment Period|Withdrawal by Subject|0|||
160536690|NCT00418665|579693070|FG001|Treatment Period|Withdrawal by Subject|3|||
160536691|NCT00418665|579693071|FG002|Treatment Period|Withdrawal by Subject|1|||
160536692|NCT00418665|579693069|FG000|Treatment Period|Requirement for alternative therapy|1|||
160536693|NCT00418665|579693070|FG001|Treatment Period|Requirement for alternative therapy|0|||
160536694|NCT00418665|579693071|FG002|Treatment Period|Requirement for alternative therapy|0|||
160536695|NCT00418665|579693069|FG000|Treatment Period|Physician Decision|1|||
160536696|NCT00418665|579693070|FG001|Treatment Period|Physician Decision|0|||
160536697|NCT00418665|579693071|FG002|Treatment Period|Physician Decision|3|||
160536698|NCT00418665|579693069|FG000|Treatment Extension|Adverse Event|1|||
160536699|NCT00418665|579693070|FG001|Treatment Extension|Adverse Event|0|||
160536700|NCT00418665|579693071|FG002|Treatment Extension|Adverse Event|0|||
160536701|NCT00418665|579693069|FG000|Treatment Extension|Withdrawal by Subject|1|||
160536702|NCT00418665|579693070|FG001|Treatment Extension|Withdrawal by Subject|0|||
160536703|NCT00418665|579693071|FG002|Treatment Extension|Withdrawal by Subject|0|||
160536704|NCT00418665|579693069|FG000|Treatment Extension|Requirement for alternative therapy|2|||
160536705|NCT00418665|579693070|FG001|Treatment Extension|Requirement for alternative therapy|2|||
160536706|NCT00418665|579693071|FG002|Treatment Extension|Requirement for alternative therapy|0|||
160536707|NCT00418665|579693069|FG000|Treatment Extension|Physician Decision|2|||
160536708|NCT00418665|579693070|FG001|Treatment Extension|Physician Decision|2|||
160536709|NCT00418665|579693071|FG002|Treatment Extension|Physician Decision|1|||
160536710|NCT00418665|579693069|FG000|Treatment Extension|Death|0|||
160536711|NCT00418665|579693070|FG001|Treatment Extension|Death|0|||
160536712|NCT00418665|579693071|FG002|Treatment Extension|Death|1|||
160536713|NCT00853749|579693072|FG000|Overall Study|Lost to Follow-up|0|||
160536714|NCT00853749|579693073|FG001|Overall Study|Lost to Follow-up|1|||
160536715|NCT01392677|579693076|FG000|Overall Study|Adverse Event|3|||
160536716|NCT01392677|579693077|FG001|Overall Study|Adverse Event|1|||
160536717|NCT01392677|579693076|FG000|Overall Study|Withdrawal by Subject|0|||
160536718|NCT01392677|579693077|FG001|Overall Study|Withdrawal by Subject|2|||
160536719|NCT01392677|579693076|FG000|Overall Study|Incorrect enrollment|2|||
160536720|NCT01392677|579693077|FG001|Overall Study|Incorrect enrollment|3|||
160536721|NCT01392677|579693076|FG000|Overall Study|Other reason|3|||
160536722|NCT01392677|579693077|FG001|Overall Study|Other reason|2|||
160536723|NCT01357577|579693080|FG000|Overall Study|Lost to Follow-up|20|||
160536724|NCT01357577|579693081|FG001|Overall Study|Lost to Follow-up|16|||
160536725|NCT01357577|579693080|FG000|Overall Study|Withdrawal by Subject|16|||
160536726|NCT01357577|579693081|FG001|Overall Study|Withdrawal by Subject|8|||
160536727|NCT01357577|579693080|FG000|Overall Study|look at data in database?|1|||
160536728|NCT01357577|579693081|FG001|Overall Study|look at data in database?|2|||
160536729|NCT05493280|579693082|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
160536730|NCT05493280|579693083|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
160536731|NCT00766038|579694150|FG000|Overall Study|Lost to Follow-up|15|||
160536732|NCT00766038|579694151|FG001|Overall Study|Lost to Follow-up|14|||
160536733|NCT00307151|579694152|FG000|Overall Study|Death|4|||
160536734|NCT00307151|579694153|FG001|Overall Study|Death|3|||
160536735|NCT00307151|579694154|FG002|Overall Study|Death|10|||
160536736|NCT00307151|579694155|FG003|Overall Study|Death|3|||
160536737|NCT00307151|579694152|FG000|Overall Study|Severe debilitation, unable to continue|1|||
160536738|NCT00307151|579694153|FG001|Overall Study|Severe debilitation, unable to continue|0|||
160536739|NCT00307151|579694154|FG002|Overall Study|Severe debilitation, unable to continue|0|||
160536740|NCT00307151|579694155|FG003|Overall Study|Severe debilitation, unable to continue|0|||
160536741|NCT00307151|579694152|FG000|Overall Study|Subject unable to get to clinic|1|||
160536742|NCT00307151|579694153|FG001|Overall Study|Subject unable to get to clinic|0|||
160536743|NCT00307151|579694154|FG002|Overall Study|Subject unable to get to clinic|6|||
160536744|NCT00307151|579694155|FG003|Overall Study|Subject unable to get to clinic|2|||
160536745|NCT00307151|579694152|FG000|Overall Study|Withdrew consent|0|||
160536746|NCT00307151|579694153|FG001|Overall Study|Withdrew consent|1|||
160536747|NCT00307151|579694154|FG002|Overall Study|Withdrew consent|1|||
160536748|NCT00307151|579694155|FG003|Overall Study|Withdrew consent|3|||
160536749|NCT00307151|579694152|FG000|Overall Study|Not willing to adhere to study reqs|2|||
160536750|NCT00307151|579694153|FG001|Overall Study|Not willing to adhere to study reqs|0|||
160536751|NCT00307151|579694154|FG002|Overall Study|Not willing to adhere to study reqs|2|||
160636486|NCT03747939|580051551|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
160636487|NCT03747939|580051552|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
160636488|NCT03747939|580051553|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
160636489|NCT03747939|580051554|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
160636490|NCT03747939|580051551|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
160636491|NCT03747939|580051552|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
160636492|NCT03747939|580051553|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
160636493|NCT03747939|580051554|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
160636494|NCT03747939|580051551|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
160636495|NCT03747939|580051552|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
160636496|NCT03747939|580051553|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
160636497|NCT03747939|580051554|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
160636498|NCT03747939|580051551|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
160636499|NCT03747939|580051552|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
160636500|NCT03747939|580051553|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
160636501|NCT03747939|580051554|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
160636502|NCT03747939|580051551|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
160636503|NCT03747939|580051552|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
160636504|NCT03747939|580051553|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
160636505|NCT03747939|580051554|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
160636506|NCT03747939|580051551|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
160636507|NCT03747939|580051552|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
160636508|NCT03747939|580051553|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
160636509|NCT03747939|580051554|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
160636510|NCT01447628|580051555|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
160636511|NCT01447628|580051556|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
160636512|NCT01447628|580051557|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
160636513|NCT01447628|580051558|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
160636514|NCT00902278|580051563|FG000|Overall Study|Physician Decision|1|||
160636515|NCT00902278|580051564|FG001|Overall Study|Physician Decision|0|||
160636516|NCT00902278|580051565|FG002|Overall Study|Physician Decision|2|||
160636517|NCT00902278|580051566|FG003|Overall Study|Physician Decision|0|||
160636518|NCT00902278|580051567|FG004|Overall Study|Physician Decision|1|||
160636519|NCT00902278|580051563|FG000|Overall Study|Lost to Follow-up|3|||
160636520|NCT00902278|580051564|FG001|Overall Study|Lost to Follow-up|2|||
160636521|NCT00902278|580051565|FG002|Overall Study|Lost to Follow-up|3|||
160636522|NCT00902278|580051566|FG003|Overall Study|Lost to Follow-up|0|||
160636523|NCT00902278|580051567|FG004|Overall Study|Lost to Follow-up|1|||
160636524|NCT01289990|580051568|FG000|Overall Study|Death|0|||
160636525|NCT01289990|580051569|FG001|Overall Study|Death|0|||
160636526|NCT01289990|580051570|FG002|Overall Study|Death|0|||
160636527|NCT01289990|580051571|FG003|Overall Study|Death|1|||
160536752|NCT00307151|579694155|FG003|Overall Study|Not willing to adhere to study reqs|2|||
160536753|NCT00307151|579694152|FG000|Overall Study|Clinic unable to contact subject|3|||
160636528|NCT01289990|580051572|FG004|Overall Study|Death|2|||
160636529|NCT01289990|580051573|FG005|Overall Study|Death|1|||
160636530|NCT01289990|580051574|FG006|Overall Study|Death|0|||
160536754|NCT00307151|579694153|FG001|Overall Study|Clinic unable to contact subject|3|||
160536755|NCT00307151|579694154|FG002|Overall Study|Clinic unable to contact subject|1|||
160536756|NCT00307151|579694155|FG003|Overall Study|Clinic unable to contact subject|1|||
160536757|NCT03703882|579694156|FG000|Overall Study|Adverse Event|1|||
160536758|NCT03703882|579694157|FG001|Overall Study|Adverse Event|0|||
160536759|NCT03703882|579694156|FG000|Overall Study|Lost to Follow-up|0|||
160536760|NCT03703882|579694157|FG001|Overall Study|Lost to Follow-up|2|||
160536761|NCT03703882|579694156|FG000|Overall Study|Non-compliance with study drug|0|||
160536762|NCT03703882|579694157|FG001|Overall Study|Non-compliance with study drug|1|||
160536763|NCT03703882|579694156|FG000|Overall Study|Physician Decision|0|||
160536764|NCT03703882|579694157|FG001|Overall Study|Physician Decision|1|||
160536765|NCT03703882|579694156|FG000|Overall Study|Progressive disease|1|||
160536766|NCT03703882|579694157|FG001|Overall Study|Progressive disease|0|||
160536767|NCT03703882|579694156|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160536768|NCT03703882|579694157|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160536769|NCT03703882|579694156|FG000|Overall Study|Starting another treatment|0|||
160536770|NCT03703882|579694157|FG001|Overall Study|Starting another treatment|1|||
160536771|NCT03703882|579694156|FG000|Overall Study|noncompliance with study procedures|0|||
160536772|NCT03703882|579694157|FG001|Overall Study|noncompliance with study procedures|1|||
160536773|NCT02982954|579694161|FG000|Overall Study|Death|55|||
160536774|NCT02982954|579694162|FG001|Overall Study|Death|29|||
160536775|NCT02982954|579694163|FG002|Overall Study|Death|15|||
160536776|NCT02982954|579694164|FG003|Overall Study|Death|20|||
160536777|NCT02982954|579694161|FG000|Overall Study|Lost to Follow-up|2|||
160536778|NCT02982954|579694162|FG001|Overall Study|Lost to Follow-up|1|||
160536779|NCT02982954|579694163|FG002|Overall Study|Lost to Follow-up|0|||
160536780|NCT02982954|579694164|FG003|Overall Study|Lost to Follow-up|0|||
160536781|NCT02982954|579694161|FG000|Overall Study|Participant withdrew consent|7|||
160536782|NCT02982954|579694162|FG001|Overall Study|Participant withdrew consent|5|||
160536783|NCT02982954|579694163|FG002|Overall Study|Participant withdrew consent|1|||
160536784|NCT02982954|579694164|FG003|Overall Study|Participant withdrew consent|1|||
160536785|NCT02982954|579694161|FG000|Overall Study|Other reasons|42|||
160536786|NCT02982954|579694162|FG001|Overall Study|Other reasons|17|||
160536787|NCT02982954|579694163|FG002|Overall Study|Other reasons|12|||
160536788|NCT02982954|579694164|FG003|Overall Study|Other reasons|3|||
160536789|NCT02982954|579694161|FG000|Overall Study|Premature site closure|0|||
160536790|NCT02982954|579694162|FG001|Overall Study|Premature site closure|0|||
160536791|NCT02982954|579694163|FG002|Overall Study|Premature site closure|0|||
160536792|NCT02982954|579694164|FG003|Overall Study|Premature site closure|1|||
160536793|NCT00516048|579694165|FG000|Overall Study|Death|0|||
160536794|NCT00516048|579694166|FG001|Overall Study|Death|0|||
160536795|NCT00516048|579694167|FG002|Overall Study|Death|1|||
160536796|NCT00516048|579694165|FG000|Overall Study|Subject Decision|0|||
160536797|NCT00516048|579694166|FG001|Overall Study|Subject Decision|2|||
160536798|NCT00516048|579694167|FG002|Overall Study|Subject Decision|0|||
160536799|NCT02263079|579694168|FG000|Overall Study|Physician Decision|1|||
160536800|NCT02263079|579694169|FG001|Overall Study|Physician Decision|0|||
160536801|NCT02263079|579694170|FG002|Overall Study|Physician Decision|0|||
160536802|NCT02263079|579694168|FG000|Overall Study|Withdrawal by Subject|2|||
160536803|NCT02263079|579694169|FG001|Overall Study|Withdrawal by Subject|8|||
160536804|NCT02263079|579694170|FG002|Overall Study|Withdrawal by Subject|0|||
160536805|NCT00402649|579694171|FG000|Overall Study|Lost to Follow-up|1|||
160536806|NCT00402649|579694171|FG000|Overall Study|Withdrawal by Subject|1|||
160536807|NCT00840086|579694173|FG000|Overall Study|Adverse Event|1|||
160536808|NCT00840086|579694173|FG000|Overall Study|Protocol Violation|2|||
160536809|NCT00840086|579694173|FG000|Overall Study|Lost to Follow-up|1|||
160536810|NCT03179891|579694177|FG000|First Intervention|Withdrawal by Subject|1|||
160536811|NCT03179891|579694178|FG001|First Intervention|Withdrawal by Subject|1|||
160536812|NCT03179891|579694177|FG000|First Intervention|Unspecified reason|1|||
160536813|NCT03179891|579694178|FG001|First Intervention|Unspecified reason|0|||
160536814|NCT03179891|579694177|FG000|First Intervention|Protocol Violation|0|||
160536815|NCT03179891|579694178|FG001|First Intervention|Protocol Violation|1|||
160536816|NCT02113436|579694185|FG000|Period 1: 8 Weeks|Adverse Event|1|||
160536817|NCT02113436|579694186|FG001|Period 1: 8 Weeks|Adverse Event|0|||
160536818|NCT02113436|579694187|FG002|Period 1: 8 Weeks|Adverse Event|0|||
160536819|NCT02113436|579694188|FG003|Period 1: 8 Weeks|Adverse Event|0|||
160536820|NCT02113436|579694185|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
160536821|NCT02113436|579694186|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
160536822|NCT02113436|579694187|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
160536823|NCT02113436|579694188|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
160536824|NCT02113436|579694185|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
160536825|NCT02113436|579694186|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
160536826|NCT02113436|579694187|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
160536827|NCT02113436|579694188|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
160536828|NCT02113436|579694185|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
160536829|NCT02113436|579694186|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
160536830|NCT02113436|579694187|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
160536831|NCT02113436|579694188|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
160536832|NCT02113436|579694185|FG000|Period 2: 16 Weeks|Adverse Event|0|||
160536833|NCT02113436|579694186|FG001|Period 2: 16 Weeks|Adverse Event|0|||
160536834|NCT02113436|579694187|FG002|Period 2: 16 Weeks|Adverse Event|4|||
160536835|NCT02113436|579694188|FG003|Period 2: 16 Weeks|Adverse Event|5|||
160536836|NCT02113436|579694185|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
160536837|NCT02113436|579694186|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
160536838|NCT02113436|579694187|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
160536839|NCT02113436|579694188|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
160536840|NCT02113436|579694185|FG000|Period 2: 16 Weeks|Physician Decision|0|||
160536841|NCT02113436|579694186|FG001|Period 2: 16 Weeks|Physician Decision|0|||
160536842|NCT02113436|579694187|FG002|Period 2: 16 Weeks|Physician Decision|2|||
160536843|NCT02113436|579694188|FG003|Period 2: 16 Weeks|Physician Decision|0|||
160536844|NCT02113436|579694185|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
160536845|NCT02113436|579694186|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
160536846|NCT02113436|579694187|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
160536847|NCT02113436|579694188|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
160536848|NCT02636582|579694189|FG000|Overall Study|Surgical Pathology|1|||
160536849|NCT02636582|579694190|FG001|Overall Study|Surgical Pathology|0|||
160536850|NCT04770532|579694191|FG000|Overall Study|Withdrawal by Subject|0|||
160536851|NCT04770532|579694192|FG001|Overall Study|Withdrawal by Subject|3|||
160536852|NCT04770532|579694191|FG000|Overall Study|Physician Decision|1|||
160536853|NCT04770532|579694192|FG001|Overall Study|Physician Decision|0|||
160536854|NCT04770532|579694191|FG000|Overall Study|Death|2|||
160536855|NCT04770532|579694192|FG001|Overall Study|Death|2|||
160536856|NCT00454857|579694196|FG000|Overall Study|Withdrawal by Subject|15|||
160536857|NCT00454857|579694196|FG000|Overall Study|Lost to Follow-up|16|||
160536858|NCT00454857|579694196|FG000|Overall Study|Noncompliance|6|||
160536859|NCT00454857|579694196|FG000|Overall Study|Death|5|||
160536860|NCT00454857|579694196|FG000|Overall Study|Other|11|||
160536861|NCT00454857|579694196|FG000|Overall Study|Reason unknown|1|||
160536862|NCT04707157|579694197|FG000|Overall Study|Adverse Event|12|||
160536863|NCT04707157|579694198|FG001|Overall Study|Adverse Event|3|||
160536864|NCT04707157|579694197|FG000|Overall Study|Lost to Follow-up|2|||
160536865|NCT04707157|579694198|FG001|Overall Study|Lost to Follow-up|0|||
160536866|NCT04707157|579694197|FG000|Overall Study|Sponsor's decision|1|||
160536867|NCT04707157|579694198|FG001|Overall Study|Sponsor's decision|0|||
160536868|NCT04707157|579694197|FG000|Overall Study|Physician Decision|8|||
160536869|NCT04707157|579694198|FG001|Overall Study|Physician Decision|5|||
160536870|NCT04707157|579694197|FG000|Overall Study|Protocol Deviation|1|||
160536871|NCT04707157|579694198|FG001|Overall Study|Protocol Deviation|0|||
160536872|NCT04707157|579694197|FG000|Overall Study|Withdrawal by Subject|1|||
160536873|NCT04707157|579694198|FG001|Overall Study|Withdrawal by Subject|1|||
160536874|NCT02969915|579694199|FG000|Overall Study|Death|104|||
160536875|NCT02969915|579694200|FG001|Overall Study|Death|125|||
160536876|NCT02969915|579694199|FG000|Overall Study|Lost to Follow-up|108|||
160536877|NCT02969915|579694200|FG001|Overall Study|Lost to Follow-up|112|||
160536878|NCT02969915|579694199|FG000|Overall Study|Censored due to COVID-19|481|||
160536879|NCT02969915|579694200|FG001|Overall Study|Censored due to COVID-19|471|||
160536880|NCT03625687|579694201|FG000|Overall Study|Death|1|||
160536881|NCT04206605|579694202|FG000|Overall Study|Adverse Event|0|||
160536882|NCT04206605|579694203|FG001|Overall Study|Adverse Event|1|||
160536883|NCT04206605|579694202|FG000|Overall Study|Withdrawal by Subject|1|||
160536884|NCT04206605|579694203|FG001|Overall Study|Withdrawal by Subject|0|||
160536885|NCT00843518|579694209|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
160536886|NCT00843518|579694210|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
160536887|NCT00843518|579694209|FG000|Period 2 (Double-blind Treatment)|Death|0|||
160536888|NCT00843518|579694210|FG001|Period 2 (Double-blind Treatment)|Death|1|||
160536889|NCT00843518|579694209|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
160536890|NCT00843518|579694210|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
160536891|NCT00843518|579694209|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
160536892|NCT00843518|579694210|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
160536893|NCT00843518|579694209|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
160536894|NCT00843518|579694210|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
160536895|NCT00843518|579694209|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
160536896|NCT00843518|579694210|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
160536897|NCT00843518|579694209|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
160536898|NCT00843518|579694210|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
160536899|NCT00589420|579694211|FG000|Overall Study|screen failure|1|||
160536900|NCT00841568|579694212|FG000|Overall Study|Adverse Event|1|||
160536901|NCT00841568|579694212|FG000|Overall Study|Death|1|||
160536902|NCT00841568|579694212|FG000|Overall Study|Withdrawal by Subject|2|||
160536903|NCT00841568|579694212|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
160536904|NCT00133991|579694213|FG000|Overall Study|Death|4|||
160536905|NCT03418129|579694219|FG000|Overall Study|Lost to Follow-up|11|||
160536906|NCT03418129|579694220|FG001|Overall Study|Lost to Follow-up|20|||
160536907|NCT03418129|579694221|FG002|Overall Study|Lost to Follow-up|15|||
160536908|NCT03418129|579694219|FG000|Overall Study|Withdrawal by Subject|3|||
160536909|NCT03418129|579694220|FG001|Overall Study|Withdrawal by Subject|6|||
160536910|NCT03418129|579694221|FG002|Overall Study|Withdrawal by Subject|4|||
160536911|NCT02664272|579694224|FG000|Overall Study|Fluoroscopic images not made available|2|||
160536912|NCT03073980|579694225|FG000|Overall Study|Lost to Follow-up|10|||
160536913|NCT03073980|579694226|FG001|Overall Study|Lost to Follow-up|2|||
160536914|NCT03073980|579694227|FG002|Overall Study|Lost to Follow-up|9|||
160536915|NCT03073980|579694225|FG000|Overall Study|No post-procedure data|0|||
160536916|NCT03073980|579694226|FG001|Overall Study|No post-procedure data|0|||
160536917|NCT03073980|579694227|FG002|Overall Study|No post-procedure data|2|||
160536918|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
160536919|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
160536920|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
160536921|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
160536922|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
160536923|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
160536924|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
160536925|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
160536926|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
160536927|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
160536928|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
160536929|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
160536930|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
160536931|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
160536932|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
160536933|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
160536934|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
160536935|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
160536936|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
160536937|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
160536938|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
160536939|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
160536940|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
160536941|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
160536942|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Death|2|||
160536943|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Death|1|||
160536944|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Death|0|||
160536945|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Death|0|||
160536946|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
160536947|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
160536948|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
160536949|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
160536950|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
160536951|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
160536952|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
160536953|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
160536954|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
160536955|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
160536956|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
160536957|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
160536958|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
160536959|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
160536960|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
160536961|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
160536962|NCT01940471|579694228|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
160536963|NCT01940471|579694229|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
160536964|NCT01940471|579694230|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
160536965|NCT01940471|579694231|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
160536966|NCT01940471|579694228|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
160536967|NCT01940471|579694229|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
160536968|NCT01940471|579694230|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
160536969|NCT01940471|579694231|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
160536970|NCT01940471|579694228|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
160536971|NCT01940471|579694229|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
160536972|NCT01940471|579694230|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
160536973|NCT01940471|579694231|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
160536974|NCT01940471|579694228|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
160536975|NCT01940471|579694229|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
160536976|NCT01940471|579694230|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
160536977|NCT01940471|579694231|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
160536978|NCT01940471|579694228|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
160536979|NCT01940471|579694229|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
160536980|NCT01940471|579694230|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
160874595|NCT05091567|580935567|FG002|Enrollment Phase|Physician Decision|0|||
160536981|NCT01940471|579694231|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
160536982|NCT01940471|579694228|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
160536983|NCT01940471|579694229|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
160536984|NCT01940471|579694230|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
160536985|NCT01940471|579694231|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
160536986|NCT01940471|579694228|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
160536987|NCT01940471|579694229|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
160536988|NCT01940471|579694230|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
160536989|NCT01940471|579694231|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
160536990|NCT01940471|579694228|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
160536991|NCT01940471|579694229|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
160536992|NCT01940471|579694230|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
160536993|NCT01940471|579694231|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
160536994|NCT01940471|579694228|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
160536995|NCT01940471|579694229|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
160536996|NCT01940471|579694230|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
160536997|NCT01940471|579694231|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
160536998|NCT01940471|579694228|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
160536999|NCT01940471|579694229|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
160537000|NCT01940471|579694230|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
160537001|NCT01940471|579694231|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
160537002|NCT01131520|579694235|FG000|Overall Study|Computer problem|1|||
160537003|NCT01131520|579694236|FG001|Overall Study|Computer problem|0|||
160537004|NCT01131520|579694235|FG000|Overall Study|Counselor not available|0|||
160537005|NCT01131520|579694236|FG001|Overall Study|Counselor not available|3|||
160537006|NCT01131520|579694235|FG000|Overall Study|Subject changed history after enrollment|0|||
160537007|NCT01131520|579694236|FG001|Overall Study|Subject changed history after enrollment|1|||
160537008|NCT03302975|579694240|FG000|Overall Study|Lost to Follow-up|4|||
160537009|NCT01436084|579694241|FG000|Overall Study|Disease Progression|2|||
160537010|NCT01436084|579694241|FG000|Overall Study|Withdrawal by Subject|1|||
160537011|NCT01436084|579694241|FG000|Overall Study|Early Closure of Study|1|||
160537012|NCT05998148|579694242|FG000|Allocation|Did not attend any appointments|1|||
160537013|NCT05998148|579694243|FG001|Allocation|Did not attend any appointments|4|||
160537014|NCT05998148|579694242|FG000|Follow-Up|Lost to Follow-up|1|||
160537015|NCT05998148|579694243|FG001|Follow-Up|Lost to Follow-up|2|||
160537016|NCT05998148|579694242|FG000|Follow-Up|Change in insurance|1|||
160537017|NCT05998148|579694243|FG001|Follow-Up|Change in insurance|1|||
160537018|NCT03834519|579694245|FG000|Overall Study|Lost to Follow-up|2|||
160537019|NCT03834519|579694246|FG001|Overall Study|Lost to Follow-up|1|||
160537020|NCT03834519|579694245|FG000|Overall Study|Withdrawal by Subject|5|||
160537021|NCT03834519|579694246|FG001|Overall Study|Withdrawal by Subject|8|||
160537022|NCT03834519|579694245|FG000|Overall Study|Death|368|||
160537023|NCT03834519|579694246|FG001|Overall Study|Death|174|||
160537024|NCT03834519|579694245|FG000|Overall Study|Physician Decision|5|||
160537025|NCT03834519|579694246|FG001|Overall Study|Physician Decision|1|||
160537026|NCT03834519|579694245|FG000|Overall Study|Sponsor decision|149|||
160537027|NCT03834519|579694246|FG001|Overall Study|Sponsor decision|80|||
160537028|NCT01129921|579694253|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
160537029|NCT01129921|579694254|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
160537030|NCT01129921|579694253|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
160537031|NCT01129921|579694254|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
160767400|NCT00471497|580537768|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
160767401|NCT00471497|580537766|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
160767402|NCT00471497|580537767|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
160767403|NCT00471497|580537768|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
160767404|NCT00471497|580537766|FG000|Core Treatment Phase|Lost to Follow-up|6|||
160767405|NCT00471497|580537767|FG001|Core Treatment Phase|Lost to Follow-up|6|||
160767406|NCT00471497|580537768|FG002|Core Treatment Phase|Lost to Follow-up|3|||
160767407|NCT00471497|580537766|FG000|Core Treatment Phase|Death|3|||
160767408|NCT00471497|580537767|FG001|Core Treatment Phase|Death|9|||
160767409|NCT00471497|580537768|FG002|Core Treatment Phase|Death|3|||
160767410|NCT00471497|580537766|FG000|Core Treatment Phase|Disease Progression|10|||
160767411|NCT00471497|580537767|FG001|Core Treatment Phase|Disease Progression|2|||
160537032|NCT01129921|579694253|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
160537033|NCT01129921|579694254|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
160537034|NCT01129921|579694253|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
160537035|NCT01129921|579694254|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
160537036|NCT01380379|579694255|FG000|Overall Study|Pregnancy|1|||
160537037|NCT05937165|579694258|FG000|Overall Study|Withdrawal by Subject|0|||
160537038|NCT05937165|579694259|FG001|Overall Study|Withdrawal by Subject|1|||
160537039|NCT06608368|579694260|FG000|Overall Study|Family Emergency|0|||
160537040|NCT06608368|579694261|FG001|Overall Study|Family Emergency|1|||
160537041|NCT06608368|579694262|FG002|Overall Study|Family Emergency|0|||
160537042|NCT06608368|579694260|FG000|Overall Study|Scheduling Issues|0|||
160537043|NCT06608368|579694261|FG001|Overall Study|Scheduling Issues|1|||
160537044|NCT06608368|579694262|FG002|Overall Study|Scheduling Issues|0|||
160537045|NCT03977974|579694263|FG000|Period 2|Adverse Event|0|||
160537046|NCT03977974|579694264|FG001|Period 2|Adverse Event|0|||
160537047|NCT03977974|579694265|FG002|Period 2|Adverse Event|0|||
160537048|NCT03977974|579694266|FG003|Period 2|Adverse Event|0|||
160537049|NCT03977974|579694267|FG004|Period 2|Adverse Event|1|||
160537050|NCT03977974|579694268|FG005|Period 2|Adverse Event|0|||
160537051|NCT03977974|579694269|FG006|Period 2|Adverse Event|0|||
160537052|NCT03977974|579694270|FG007|Period 2|Adverse Event|0|||
160537053|NCT03977974|579694271|FG008|Period 2|Adverse Event|0|||
160537054|NCT03977974|579694272|FG009|Period 2|Adverse Event|0|||
160537055|NCT03977974|579694273|FG010|Period 2|Adverse Event|0|||
160537056|NCT03977974|579694274|FG011|Period 2|Adverse Event|0|||
160537057|NCT03977974|579694275|FG012|Period 2|Adverse Event|0|||
160537058|NCT00075400|579695389|FG000|Overall Study|Ineligible: wrong primary|1|||
160537059|NCT00075400|579695389|FG000|Overall Study|Never treated|2|||
160537060|NCT00666458|579695396|FG000|Overall Study|Adverse Event|8|||
160537061|NCT00666458|579695397|FG001|Overall Study|Adverse Event|7|||
160537062|NCT00666458|579695396|FG000|Overall Study|Withdrawal by Subject|5|||
160537063|NCT00666458|579695397|FG001|Overall Study|Withdrawal by Subject|4|||
160537064|NCT00666458|579695396|FG000|Overall Study|Lost to Follow-up|0|||
160537065|NCT00666458|579695397|FG001|Overall Study|Lost to Follow-up|3|||
160537066|NCT00666458|579695396|FG000|Overall Study|Administrative reason by sponsor|1|||
160537067|NCT00666458|579695397|FG001|Overall Study|Administrative reason by sponsor|1|||
160537068|NCT00666458|579695396|FG000|Overall Study|Incorrect enrollment|7|||
160537069|NCT00666458|579695397|FG001|Overall Study|Incorrect enrollment|1|||
160537070|NCT00666458|579695396|FG000|Overall Study|Study specific discontinuation criteria|14|||
160537071|NCT00666458|579695397|FG001|Overall Study|Study specific discontinuation criteria|7|||
160537072|NCT00666458|579695396|FG000|Overall Study|Severe non-compliance to the protocol|1|||
160537073|NCT00666458|579695397|FG001|Overall Study|Severe non-compliance to the protocol|1|||
160537074|NCT00666458|579695396|FG000|Overall Study|Safety reasons|1|||
160537075|NCT00666458|579695397|FG001|Overall Study|Safety reasons|0|||
160537076|NCT00666458|579695396|FG000|Overall Study|Medical history of anemia|1|||
160537077|NCT00666458|579695397|FG001|Overall Study|Medical history of anemia|0|||
160537078|NCT02554019|579695398|FG000|Overall Study|Withdrawal by Subject|1|||
160537079|NCT02554019|579695399|FG001|Overall Study|Withdrawal by Subject|0|||
160537080|NCT02554019|579695400|FG002|Overall Study|Withdrawal by Subject|2|||
160537081|NCT02554019|579695398|FG000|Overall Study|Adverse Event|1|||
160537082|NCT02554019|579695399|FG001|Overall Study|Adverse Event|0|||
160537083|NCT02554019|579695400|FG002|Overall Study|Adverse Event|0|||
160537084|NCT02463409|579695401|FG000|Overall Study|Withdrawal by Subject|1|||
160537085|NCT02463409|579695401|FG000|Overall Study|Screen failure|1|||
160537086|NCT01444742|579695402|FG000|Overall Study|Death|1|||
160537087|NCT02830880|579695403|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
160537088|NCT02830880|579695403|FG000|Overall Study|Death|1|||
160537089|NCT02830880|579695403|FG000|Overall Study|Physician Decision|1|||
160537090|NCT02349048|579695408|FG000|Overall Study|Withdrawal by Subject|4|||
160537091|NCT02349048|579695409|FG001|Overall Study|Withdrawal by Subject|0|||
160636531|NCT01289990|580051575|FG007|Overall Study|Death|0|||
160636532|NCT01289990|580051576|FG008|Overall Study|Death|0|||
160767412|NCT00471497|580537768|FG002|Core Treatment Phase|Disease Progression|4|||
160767413|NCT00471497|580537766|FG000|Core Treatment Phase|Protocol Violation|6|||
160537092|NCT02349048|579695408|FG000|Overall Study|Lost to Follow-up|1|||
160537093|NCT02349048|579695409|FG001|Overall Study|Lost to Follow-up|0|||
160537094|NCT01648790|579695414|FG000|Treatment 3|Withdrawal by Subject|0|||
160537095|NCT01648790|579695415|FG001|Treatment 3|Withdrawal by Subject|0|||
160537096|NCT01648790|579695416|FG002|Treatment 3|Withdrawal by Subject|0|||
160537097|NCT01648790|579695417|FG003|Treatment 3|Withdrawal by Subject|1|||
160537098|NCT01648790|579695418|FG004|Treatment 3|Withdrawal by Subject|0|||
160537099|NCT01278745|579695424|FG000|Overall Study|Death|2|||
160537100|NCT01278745|579695425|FG001|Overall Study|Death|5|||
160537101|NCT01278745|579695426|FG002|Overall Study|Death|7|||
160537102|NCT01278745|579695427|FG003|Overall Study|Death|0|||
160537103|NCT01278745|579695424|FG000|Overall Study|Physician Decision|1|||
160537104|NCT01278745|579695425|FG001|Overall Study|Physician Decision|0|||
160537105|NCT01278745|579695426|FG002|Overall Study|Physician Decision|0|||
160636533|NCT01289990|580051577|FG009|Overall Study|Death|0|||
160874596|NCT05091567|580935565|FG000|Enrollment Phase|Protocol Violation|2|||
160874597|NCT05091567|580935566|FG001|Enrollment Phase|Protocol Violation|0|||
160874598|NCT05091567|580935567|FG002|Enrollment Phase|Protocol Violation|0|||
160874599|NCT05091567|580935565|FG000|Enrollment Phase|Reason not Specified|1|||
160874600|NCT05091567|580935566|FG001|Enrollment Phase|Reason not Specified|0|||
160874601|NCT05091567|580935567|FG002|Enrollment Phase|Reason not Specified|0|||
160874602|NCT05091567|580935565|FG000|Randomized Phase|Death|0|||
160874603|NCT05091567|580935566|FG001|Randomized Phase|Death|135|||
160874604|NCT05091567|580935567|FG002|Randomized Phase|Death|112|||
160874605|NCT05091567|580935565|FG000|Randomized Phase|Progressive Disease|0|||
160874606|NCT05091567|580935566|FG001|Randomized Phase|Progressive Disease|2|||
160874607|NCT05091567|580935567|FG002|Randomized Phase|Progressive Disease|0|||
160874608|NCT05091567|580935565|FG000|Randomized Phase|Withdrawal by Subject|0|||
160874609|NCT05091567|580935566|FG001|Randomized Phase|Withdrawal by Subject|1|||
160874610|NCT05091567|580935567|FG002|Randomized Phase|Withdrawal by Subject|3|||
160874611|NCT05091567|580935565|FG000|Randomized Phase|Lost to Follow-up|0|||
160874612|NCT05091567|580935566|FG001|Randomized Phase|Lost to Follow-up|1|||
160874613|NCT05091567|580935567|FG002|Randomized Phase|Lost to Follow-up|1|||
160874614|NCT05091567|580935565|FG000|Randomized Phase|Ongoing in Study|0|||
160874615|NCT05091567|580935566|FG001|Randomized Phase|Ongoing in Study|102|||
160874616|NCT05091567|580935567|FG002|Randomized Phase|Ongoing in Study|126|||
160874617|NCT01696929|580935568|FG000|Overall Study|Physician Decision|1|||
160874618|NCT01129583|580935569|FG000|Overall Study|Death|1|||
160874619|NCT01129583|580935570|FG001|Overall Study|Death|0|||
160874620|NCT01129583|580935569|FG000|Overall Study|Lost to Follow-up|1|||
160874621|NCT01129583|580935570|FG001|Overall Study|Lost to Follow-up|1|||
160874622|NCT01129583|580935569|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
160874623|NCT01129583|580935570|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
160874624|NCT02891070|580935576|FG000|Overall Study|Adverse Event|1|||
160874625|NCT02891070|580935577|FG001|Overall Study|Adverse Event|0|||
160874626|NCT02891070|580935576|FG000|Overall Study|Physician Decision|0|||
160874627|NCT02891070|580935577|FG001|Overall Study|Physician Decision|1|||
160874628|NCT02891070|580935576|FG000|Overall Study|Lost to Follow-up|4|||
160874629|NCT02891070|580935577|FG001|Overall Study|Lost to Follow-up|4|||
160874630|NCT02891070|580935576|FG000|Overall Study|Other|1|||
160874631|NCT02891070|580935577|FG001|Overall Study|Other|0|||
160874632|NCT02891070|580935576|FG000|Overall Study|Protocol Violation|0|||
160874633|NCT02891070|580935577|FG001|Overall Study|Protocol Violation|1|||
160874634|NCT02891070|580935576|FG000|Overall Study|Withdrawal by Subject|1|||
160874635|NCT02891070|580935577|FG001|Overall Study|Withdrawal by Subject|2|||
160874636|NCT02891070|580935576|FG000|Overall Study|Death|3|||
160874637|NCT02891070|580935577|FG001|Overall Study|Death|0|||
160874638|NCT02704143|580935578|FG000|Overall Study|disease progression|10|||
160874639|NCT01235598|580935581|FG000|Overall Study|Adverse Event|0|||
160874640|NCT01235598|580935582|FG001|Overall Study|Adverse Event|3|||
160874641|NCT01235598|580935581|FG000|Overall Study|Lack of Efficacy|0|||
160874642|NCT01235598|580935582|FG001|Overall Study|Lack of Efficacy|1|||
160874643|NCT01235598|580935581|FG000|Overall Study|Withdrawal by Subject|1|||
160874644|NCT01235598|580935582|FG001|Overall Study|Withdrawal by Subject|0|||
160874645|NCT02551991|580935583|FG000|Overall Study|Death|5|||
160874646|NCT02551991|580935584|FG001|Overall Study|Death|7|||
160874647|NCT02551991|580935585|FG002|Overall Study|Death|8|||
160874648|NCT02551991|580935586|FG003|Overall Study|Death|7|||
160874649|NCT02551991|580935587|FG004|Overall Study|Death|17|||
160874650|NCT02551991|580935583|FG000|Overall Study|Withdrawal by Subject|1|||
160874651|NCT02551991|580935584|FG001|Overall Study|Withdrawal by Subject|0|||
160874652|NCT02551991|580935585|FG002|Overall Study|Withdrawal by Subject|0|||
160874653|NCT02551991|580935586|FG003|Overall Study|Withdrawal by Subject|0|||
160874654|NCT02551991|580935587|FG004|Overall Study|Withdrawal by Subject|2|||
160874655|NCT02551991|580935583|FG000|Overall Study|Lost to Follow-up|0|||
160874656|NCT02551991|580935584|FG001|Overall Study|Lost to Follow-up|0|||
160874657|NCT02551991|580935585|FG002|Overall Study|Lost to Follow-up|1|||
160874658|NCT02551991|580935586|FG003|Overall Study|Lost to Follow-up|0|||
160874659|NCT02551991|580935587|FG004|Overall Study|Lost to Follow-up|0|||
160874660|NCT02551991|580935583|FG000|Overall Study|Sponsor Decision|1|||
160874661|NCT02551991|580935584|FG001|Overall Study|Sponsor Decision|0|||
160874662|NCT02551991|580935585|FG002|Overall Study|Sponsor Decision|1|||
160874663|NCT02551991|580935586|FG003|Overall Study|Sponsor Decision|0|||
160874664|NCT02551991|580935587|FG004|Overall Study|Sponsor Decision|5|||
160874665|NCT02551991|580935583|FG000|Overall Study|Other|0|||
160874666|NCT02551991|580935584|FG001|Overall Study|Other|0|||
160874667|NCT02551991|580935585|FG002|Overall Study|Other|0|||
160874668|NCT02551991|580935586|FG003|Overall Study|Other|0|||
160874669|NCT02551991|580935587|FG004|Overall Study|Other|1|||
160874670|NCT00395343|580935588|FG000|Overall Study|Adverse Event|13|||
160874671|NCT00395343|580935589|FG001|Overall Study|Adverse Event|5|||
160874672|NCT00395343|580935588|FG000|Overall Study|Lack of Efficacy|0|||
160874673|NCT00395343|580935589|FG001|Overall Study|Lack of Efficacy|1|||
160874674|NCT00395343|580935588|FG000|Overall Study|Lost to Follow-up|4|||
160874675|NCT00395343|580935589|FG001|Overall Study|Lost to Follow-up|4|||
160874676|NCT00395343|580935588|FG000|Overall Study|Physician Decision|2|||
160874677|NCT00395343|580935589|FG001|Overall Study|Physician Decision|4|||
160874678|NCT00395343|580935588|FG000|Overall Study|Protocol Violation|6|||
160874679|NCT00395343|580935589|FG001|Overall Study|Protocol Violation|8|||
160874680|NCT00395343|580935588|FG000|Overall Study|Withdrawal by Subject|11|||
160874681|NCT00395343|580935589|FG001|Overall Study|Withdrawal by Subject|12|||
160874682|NCT00395343|580935588|FG000|Overall Study|Other|5|||
160874683|NCT00395343|580935589|FG001|Overall Study|Other|2|||
160874684|NCT00942994|580935593|FG000|Overall Study|Adverse Event|7|||
160874685|NCT00942994|580935594|FG001|Overall Study|Adverse Event|4|||
160874686|NCT00942994|580935593|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160874687|NCT00942994|580935594|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160874688|NCT00942994|580935593|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160874689|NCT00942994|580935594|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160874690|NCT00942994|580935593|FG000|Overall Study|Patient withdrew consent|5|||
160874691|NCT00942994|580935594|FG001|Overall Study|Patient withdrew consent|8|||
160874692|NCT00942994|580935593|FG000|Overall Study|Lost to Follow-up|1|||
160537106|NCT01278745|579695427|FG003|Overall Study|Physician Decision|9|||
160537107|NCT01278745|579695424|FG000|Overall Study|Withdrawal by Subject|1|||
160537108|NCT01278745|579695425|FG001|Overall Study|Withdrawal by Subject|1|||
160537109|NCT01278745|579695426|FG002|Overall Study|Withdrawal by Subject|5|||
160537110|NCT01278745|579695427|FG003|Overall Study|Withdrawal by Subject|1|||
160537111|NCT01278745|579695424|FG000|Overall Study|Sponsor Decision|1|||
160537112|NCT01278745|579695425|FG001|Overall Study|Sponsor Decision|0|||
160537113|NCT01278745|579695426|FG002|Overall Study|Sponsor Decision|62|||
160537114|NCT01278745|579695427|FG003|Overall Study|Sponsor Decision|6|||
160537115|NCT01278745|579695424|FG000|Overall Study|Ineligible|0|||
160537116|NCT01278745|579695425|FG001|Overall Study|Ineligible|0|||
160537117|NCT01278745|579695426|FG002|Overall Study|Ineligible|42|||
160537118|NCT01278745|579695427|FG003|Overall Study|Ineligible|61|||
160537119|NCT01278745|579695424|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
160537120|NCT01278745|579695425|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
160537121|NCT01278745|579695426|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
160537122|NCT01278745|579695427|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
160537123|NCT01148537|579695428|FG000|Overall Study|Withdrawal by Subject|1|||
160537124|NCT01148537|579695429|FG001|Overall Study|Withdrawal by Subject|0|||
160537125|NCT01148537|579695430|FG002|Overall Study|Withdrawal by Subject|2|||
160537126|NCT01148537|579695428|FG000|Overall Study|Adverse Event|2|||
160537127|NCT01148537|579695429|FG001|Overall Study|Adverse Event|0|||
160537128|NCT01148537|579695430|FG002|Overall Study|Adverse Event|1|||
160537130|NCT05374525|579695433|FG000|Overall Study|Adverse Event|5|||
160537131|NCT05374525|579695434|FG001|Overall Study|Adverse Event|6|||
160537132|NCT05374525|579695433|FG000|Overall Study|Lost to Follow-up|3|||
160874693|NCT00942994|580935594|FG001|Overall Study|Lost to Follow-up|4|||
160537133|NCT05374525|579695434|FG001|Overall Study|Lost to Follow-up|3|||
160537134|NCT05374525|579695433|FG000|Overall Study|Physician Decision|2|||
160537135|NCT05374525|579695434|FG001|Overall Study|Physician Decision|2|||
160537136|NCT05374525|579695433|FG000|Overall Study|Withdrawal by Subject|26|||
160537137|NCT05374525|579695434|FG001|Overall Study|Withdrawal by Subject|8|||
160537138|NCT01349101|579695437|FG000|Overall Study|Disease Progression|1|||
160537139|NCT01349101|579695438|FG001|Overall Study|Disease Progression|1|||
160537140|NCT01349101|579695437|FG000|Overall Study|Death|3|||
160537141|NCT01349101|579695438|FG001|Overall Study|Death|8|||
160537142|NCT01843842|579695441|FG000|Overall Study|Do not meet inclusion criteria|1|||
160537143|NCT01843842|579695442|FG001|Overall Study|Do not meet inclusion criteria|1|||
160537144|NCT02953340|579695443|FG000|Overall Study|Death|0|||
160537145|NCT02953340|579695444|FG001|Overall Study|Death|1|||
160874694|NCT00942994|580935593|FG000|Overall Study|Protocol deviation|1|||
160874695|NCT00942994|580935594|FG001|Overall Study|Protocol deviation|2|||
160874696|NCT04491604|580935595|FG000|Overall Study|Withdrawal by Subject|3|||
160874697|NCT01874340|580935598|FG000|Overall Study|Study terminated by Sponsor|6|||
160874698|NCT01874340|580935599|FG001|Overall Study|Study terminated by Sponsor|8|||
160874699|NCT01874340|580935600|FG002|Overall Study|Study terminated by Sponsor|8|||
160874700|NCT01874340|580935601|FG003|Overall Study|Study terminated by Sponsor|4|||
160874701|NCT01874340|580935598|FG000|Overall Study|Withdrawal by Subject|0|||
160874702|NCT01874340|580935599|FG001|Overall Study|Withdrawal by Subject|0|||
160874703|NCT01874340|580935600|FG002|Overall Study|Withdrawal by Subject|0|||
160874704|NCT01874340|580935601|FG003|Overall Study|Withdrawal by Subject|1|||
160874705|NCT00689117|580935605|FG000|Overall Study|Adverse Event|6|||
160874706|NCT00689117|580935606|FG001|Overall Study|Adverse Event|0|||
160874707|NCT00689117|580935607|FG002|Overall Study|Adverse Event|5|||
160874708|NCT00689117|580935608|FG003|Overall Study|Adverse Event|0|||
160874709|NCT00689117|580935605|FG000|Overall Study|Lost to Follow-up|26|||
160874710|NCT00689117|580935606|FG001|Overall Study|Lost to Follow-up|19|||
160874711|NCT00689117|580935607|FG002|Overall Study|Lost to Follow-up|17|||
160874712|NCT00689117|580935608|FG003|Overall Study|Lost to Follow-up|11|||
160874713|NCT00689117|580935605|FG000|Overall Study|Lack of Efficacy|1|||
160874714|NCT00689117|580935606|FG001|Overall Study|Lack of Efficacy|2|||
160874715|NCT00689117|580935607|FG002|Overall Study|Lack of Efficacy|2|||
160874716|NCT00689117|580935608|FG003|Overall Study|Lack of Efficacy|2|||
160874717|NCT00689117|580935605|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
160874718|NCT00689117|580935606|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
160537146|NCT02953340|579695443|FG000|Overall Study|Investigator Decision|3|||
160537147|NCT02953340|579695444|FG001|Overall Study|Investigator Decision|3|||
160537148|NCT02953340|579695443|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
160537149|NCT02953340|579695444|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
160537150|NCT02953340|579695443|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
160537151|NCT02953340|579695444|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
160537152|NCT02953340|579695443|FG000|Overall Study|Withdrawal by Subject|9|||
160537153|NCT02953340|579695444|FG001|Overall Study|Withdrawal by Subject|9|||
160537154|NCT02953340|579695443|FG000|Overall Study|Sponsor decision|0|||
160537155|NCT02953340|579695444|FG001|Overall Study|Sponsor decision|2|||
160537156|NCT02953340|579695443|FG000|Overall Study|Lost to Follow-up|3|||
160537157|NCT02953340|579695444|FG001|Overall Study|Lost to Follow-up|2|||
160874719|NCT00689117|580935607|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
160874720|NCT00689117|580935608|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
160874721|NCT00689117|580935605|FG000|Overall Study|Withdrawal by Subject|19|||
160874722|NCT00689117|580935606|FG001|Overall Study|Withdrawal by Subject|18|||
160874723|NCT00689117|580935607|FG002|Overall Study|Withdrawal by Subject|26|||
160874724|NCT00689117|580935608|FG003|Overall Study|Withdrawal by Subject|13|||
160874725|NCT00689117|580935605|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
160874726|NCT00689117|580935606|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
160874727|NCT00689117|580935607|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
160874728|NCT00689117|580935608|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
160874729|NCT00689117|580935605|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
160874730|NCT00689117|580935606|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
160874731|NCT00689117|580935607|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160874732|NCT00689117|580935608|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160874733|NCT00689117|580935605|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
160874734|NCT00689117|580935606|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
160874735|NCT00689117|580935607|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
160874736|NCT00689117|580935608|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
160874737|NCT00689117|580935605|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
160874738|NCT00689117|580935606|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
160874739|NCT00689117|580935607|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
160874740|NCT00689117|580935608|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
160874741|NCT00689117|580935605|FG000|Overall Study|Use of Prohibitive Medication|2|||
160874742|NCT00689117|580935606|FG001|Overall Study|Use of Prohibitive Medication|1|||
160874743|NCT00689117|580935607|FG002|Overall Study|Use of Prohibitive Medication|3|||
160874744|NCT00689117|580935608|FG003|Overall Study|Use of Prohibitive Medication|0|||
160874745|NCT00689117|580935605|FG000|Overall Study|Pregnancy|0|||
160874746|NCT00689117|580935606|FG001|Overall Study|Pregnancy|2|||
160874747|NCT00689117|580935607|FG002|Overall Study|Pregnancy|0|||
160874748|NCT00689117|580935608|FG003|Overall Study|Pregnancy|2|||
160874749|NCT00689117|580935605|FG000|Overall Study|Incarceration|2|||
160874750|NCT00689117|580935606|FG001|Overall Study|Incarceration|0|||
160874751|NCT00689117|580935607|FG002|Overall Study|Incarceration|0|||
160874752|NCT00689117|580935608|FG003|Overall Study|Incarceration|0|||
160874753|NCT00689117|580935605|FG000|Overall Study|Fear of Birth Defects|0|||
160874754|NCT00689117|580935606|FG001|Overall Study|Fear of Birth Defects|0|||
160874755|NCT00689117|580935607|FG002|Overall Study|Fear of Birth Defects|1|||
160874756|NCT00689117|580935608|FG003|Overall Study|Fear of Birth Defects|0|||
160874757|NCT00689117|580935605|FG000|Overall Study|Transportation|1|||
160874758|NCT00689117|580935606|FG001|Overall Study|Transportation|0|||
160874759|NCT00689117|580935607|FG002|Overall Study|Transportation|0|||
160874760|NCT00689117|580935608|FG003|Overall Study|Transportation|0|||
160874761|NCT00689117|580935605|FG000|Overall Study|Patient Withdrew from Study|0|||
160874762|NCT00689117|580935606|FG001|Overall Study|Patient Withdrew from Study|0|||
160874763|NCT00689117|580935607|FG002|Overall Study|Patient Withdrew from Study|0|||
160874764|NCT00689117|580935608|FG003|Overall Study|Patient Withdrew from Study|1|||
160874765|NCT00689117|580935605|FG000|Overall Study|Personal Reason|0|||
160874766|NCT00689117|580935606|FG001|Overall Study|Personal Reason|1|||
160874767|NCT00689117|580935607|FG002|Overall Study|Personal Reason|0|||
160874768|NCT00689117|580935608|FG003|Overall Study|Personal Reason|0|||
160874769|NCT00689117|580935605|FG000|Overall Study|Dispensing Error|0|||
160874770|NCT00689117|580935606|FG001|Overall Study|Dispensing Error|1|||
160874771|NCT00689117|580935607|FG002|Overall Study|Dispensing Error|0|||
160874772|NCT00689117|580935608|FG003|Overall Study|Dispensing Error|0|||
160874773|NCT01536067|580935610|FG000|Overall Study|Disease Progression|1|||
160874774|NCT02597478|580935611|FG000|Overall Study|Withdrawal by Subject|2|||
160874775|NCT02597478|580935612|FG001|Overall Study|Withdrawal by Subject|0|||
160874776|NCT02597478|580935611|FG000|Overall Study|Change of opioid dose|1|||
160874777|NCT02597478|580935612|FG001|Overall Study|Change of opioid dose|0|||
160874778|NCT02597478|580935611|FG000|Overall Study|Insufficient exertional dyspnea|0|||
160874779|NCT02597478|580935612|FG001|Overall Study|Insufficient exertional dyspnea|1|||
160874780|NCT02386189|580935615|FG000|Overall Study|Lost to Follow-up|2|||
160874781|NCT02386189|580935616|FG001|Overall Study|Lost to Follow-up|3|||
160874782|NCT02386189|580935615|FG000|Overall Study|Withdrawal by Subject|1|||
160874783|NCT02386189|580935616|FG001|Overall Study|Withdrawal by Subject|0|||
160874784|NCT02386189|580935615|FG000|Overall Study|Death|1|||
160874785|NCT02386189|580935616|FG001|Overall Study|Death|0|||
160636534|NCT01289990|580051578|FG010|Overall Study|Death|0|||
160874786|NCT04657666|580935617|FG000|Period 1|Withdrawal of participant consent|2|||
160874787|NCT04657666|580935618|FG001|Period 1|Withdrawal of participant consent|1|||
160874788|NCT04657666|580935617|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
160874789|NCT04657666|580935618|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
160874790|NCT04657666|580935617|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
160874791|NCT04657666|580935618|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
160874792|NCT04657666|580935617|FG000|Period 2|Other|2|||
160874793|NCT04657666|580935618|FG001|Period 2|Other|0|||
160874794|NCT04657666|580935617|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
160874795|NCT04657666|580935618|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
160874796|NCT00606905|580935619|FG000|Overall Study|No Pregnancy|9|||
160874797|NCT00606905|580935620|FG001|Overall Study|No Pregnancy|6|||
160874798|NCT00606905|580935619|FG000|Overall Study|Non-Index Pregnancy|1|||
160874799|NCT00606905|580935620|FG001|Overall Study|Non-Index Pregnancy|4|||
160874800|NCT00606905|580935619|FG000|Overall Study|Withdrew|5|||
160874801|NCT00606905|580935620|FG001|Overall Study|Withdrew|5|||
160874802|NCT03120351|580935622|FG000|Overall Study|Physician Decision|1|||
160874803|NCT03120351|580935623|FG001|Overall Study|Physician Decision|1|||
160874804|NCT04931888|580935625|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
160874805|NCT04931888|580935626|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
160874806|NCT04931888|580935627|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
160874807|NCT04931888|580935628|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
160874808|NCT01022398|580935629|FG000|Overall Study|Study terminated|2|||
160874809|NCT01022398|580935630|FG001|Overall Study|Study terminated|2|||
160874810|NCT02969408|580935632|FG000|Overall Study|Adverse Event|2|||
160874811|NCT02969408|580935632|FG000|Overall Study|Withdrawal by Subject|8|||
160874812|NCT02969408|580935632|FG000|Overall Study|Lost to Follow-up|4|||
160874813|NCT02969408|580935632|FG000|Overall Study|Protocol Violation|1|||
160874814|NCT02969408|580935632|FG000|Overall Study|Other than specified|1|||
160874815|NCT04540198|580935633|FG000|Overall Study|Lost to Follow-up|25|||
160874816|NCT04540198|580935634|FG001|Overall Study|Lost to Follow-up|23|||
160874817|NCT04540198|580935633|FG000|Overall Study|Withdrawal by Subject|15|||
160874818|NCT04540198|580935634|FG001|Overall Study|Withdrawal by Subject|9|||
160874819|NCT04540198|580935633|FG000|Overall Study|Discontinued|1|||
160874820|NCT04540198|580935634|FG001|Overall Study|Discontinued|0|||
160874821|NCT02350478|580935635|FG000|Overall Study|Lost to Follow-up|5|||
160874822|NCT02350478|580935636|FG001|Overall Study|Lost to Follow-up|1|||
160874823|NCT02779556|580935637|FG000|Baseline|Partial baseline interview completed|1|||
160874824|NCT02779556|580935638|FG001|Baseline|Partial baseline interview completed|0|||
160874825|NCT02779556|580935637|FG000|3 Months|Lost to Follow-up|40|||
160874826|NCT02779556|580935638|FG001|3 Months|Lost to Follow-up|29|||
160874827|NCT02779556|580935637|FG000|3 Months|Missed 3 month clinic visit|27|||
160874828|NCT02779556|580935638|FG001|3 Months|Missed 3 month clinic visit|19|||
160874829|NCT02779556|580935637|FG000|6 Month|Lost to Follow-up|33|||
160874830|NCT02779556|580935638|FG001|6 Month|Lost to Follow-up|39|||
160874831|NCT02779556|580935637|FG000|6 Month HbA1c|No value collected during window|69|||
160874832|NCT02779556|580935638|FG001|6 Month HbA1c|No value collected during window|50|||
160874833|NCT02779556|580935637|FG000|12 Month HbA1c|No value collected during window|138|||
160874834|NCT02779556|580935638|FG001|12 Month HbA1c|No value collected during window|102|||
160874835|NCT03110770|580935639|FG000|Overall Study|Death|1|||
160874836|NCT03110770|580935640|FG001|Overall Study|Death|0|||
160874837|NCT03110770|580935641|FG002|Overall Study|Death|0|||
160874838|NCT03110770|580935642|FG003|Overall Study|Death|1|||
160874839|NCT03110770|580935643|FG004|Overall Study|Death|0|||
160874840|NCT03110770|580935639|FG000|Overall Study|Enrolled but did not receive product|0|||
160874841|NCT03110770|580935640|FG001|Overall Study|Enrolled but did not receive product|0|||
160874842|NCT03110770|580935641|FG002|Overall Study|Enrolled but did not receive product|0|||
160874843|NCT03110770|580935642|FG003|Overall Study|Enrolled but did not receive product|8|||
160874844|NCT03110770|580935643|FG004|Overall Study|Enrolled but did not receive product|7|||
160874845|NCT03110770|580935639|FG000|Overall Study|Lost to Follow-up|0|||
160874846|NCT03110770|580935640|FG001|Overall Study|Lost to Follow-up|0|||
160874847|NCT03110770|580935641|FG002|Overall Study|Lost to Follow-up|0|||
160874848|NCT03110770|580935642|FG003|Overall Study|Lost to Follow-up|53|||
160874849|NCT03110770|580935643|FG004|Overall Study|Lost to Follow-up|45|||
160874850|NCT03110770|580935639|FG000|Overall Study|Investigator Decision|0|||
160874851|NCT03110770|580935640|FG001|Overall Study|Investigator Decision|0|||
160874852|NCT03110770|580935641|FG002|Overall Study|Investigator Decision|0|||
160874853|NCT03110770|580935642|FG003|Overall Study|Investigator Decision|5|||
160874854|NCT03110770|580935643|FG004|Overall Study|Investigator Decision|3|||
160874855|NCT03110770|580935639|FG000|Overall Study|Withdrawal by Subject|0|||
160874856|NCT03110770|580935640|FG001|Overall Study|Withdrawal by Subject|0|||
160874857|NCT03110770|580935641|FG002|Overall Study|Withdrawal by Subject|0|||
160874858|NCT03110770|580935642|FG003|Overall Study|Withdrawal by Subject|24|||
160874859|NCT03110770|580935643|FG004|Overall Study|Withdrawal by Subject|24|||
160874860|NCT03110770|580935639|FG000|Overall Study|Moved from area|5|||
160874861|NCT03110770|580935640|FG001|Overall Study|Moved from area|0|||
160874862|NCT03110770|580935641|FG002|Overall Study|Moved from area|2|||
160874863|NCT03110770|580935642|FG003|Overall Study|Moved from area|42|||
160636535|NCT01289990|580051579|FG011|Overall Study|Death|1|||
160874864|NCT03110770|580935643|FG004|Overall Study|Moved from area|43|||
160874865|NCT03110770|580935639|FG000|Overall Study|Illness/Injury unrelated to product|0|||
160874866|NCT03110770|580935640|FG001|Overall Study|Illness/Injury unrelated to product|0|||
160874867|NCT03110770|580935641|FG002|Overall Study|Illness/Injury unrelated to product|0|||
160767414|NCT00471497|580537767|FG001|Core Treatment Phase|Protocol Violation|15|||
160767415|NCT00471497|580537768|FG002|Core Treatment Phase|Protocol Violation|11|||
160767416|NCT00471497|580537766|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
160767417|NCT00471497|580537767|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
160767418|NCT00471497|580537768|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
160767419|NCT00471497|580537766|FG000|Core Treatment Phase|Administrative problems|14|||
160767420|NCT00471497|580537767|FG001|Core Treatment Phase|Administrative problems|14|||
160767421|NCT00471497|580537768|FG002|Core Treatment Phase|Administrative problems|12|||
160767422|NCT00471497|580537766|FG000|Core Treatment Phase|Adverse Event|43|||
160767423|NCT00471497|580537767|FG001|Core Treatment Phase|Adverse Event|53|||
160767424|NCT00471497|580537768|FG002|Core Treatment Phase|Adverse Event|89|||
160767425|NCT00471497|580537766|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
160767426|NCT00471497|580537767|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
160767427|NCT00471497|580537768|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
160767428|NCT00471497|580537766|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
160767429|NCT00471497|580537767|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
160767430|NCT00471497|580537768|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
160767431|NCT00471497|580537766|FG000|Extension Phase|Adverse Event|9|||
160767432|NCT00471497|580537767|FG001|Extension Phase|Adverse Event|5|||
160767433|NCT00471497|580537768|FG002|Extension Phase|Adverse Event|1|||
160767434|NCT00471497|580537766|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
160767435|NCT00471497|580537767|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
160767436|NCT00471497|580537768|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
160767437|NCT00471497|580537766|FG000|Extension Phase|Withdrawal by Subject|3|||
160767438|NCT00471497|580537767|FG001|Extension Phase|Withdrawal by Subject|1|||
160767439|NCT00471497|580537768|FG002|Extension Phase|Withdrawal by Subject|0|||
160767440|NCT00471497|580537766|FG000|Extension Phase|Lost to Follow-up|2|||
160767441|NCT00471497|580537767|FG001|Extension Phase|Lost to Follow-up|0|||
160767442|NCT00471497|580537768|FG002|Extension Phase|Lost to Follow-up|0|||
160767443|NCT00471497|580537766|FG000|Extension Phase|Death|1|||
160767444|NCT00471497|580537767|FG001|Extension Phase|Death|0|||
160767445|NCT00471497|580537768|FG002|Extension Phase|Death|0|||
160767446|NCT00471497|580537766|FG000|Extension Phase|Disease progression|2|||
160767447|NCT00471497|580537767|FG001|Extension Phase|Disease progression|0|||
160767448|NCT00471497|580537768|FG002|Extension Phase|Disease progression|0|||
160767449|NCT00471497|580537766|FG000|Extension Phase|Protocol Violation|2|||
160767450|NCT00471497|580537767|FG001|Extension Phase|Protocol Violation|2|||
160767451|NCT00471497|580537768|FG002|Extension Phase|Protocol Violation|0|||
160767452|NCT04004000|580537769|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
160767453|NCT01232283|580537772|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
160767454|NCT01232283|580537773|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
160767455|NCT01232283|580537774|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
160767456|NCT01232283|580537775|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
160767457|NCT01232283|580537776|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
160767458|NCT01232283|580537777|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
160767459|NCT01232283|580537778|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
160767460|NCT01232283|580537779|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
160767461|NCT01232283|580537780|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
160767462|NCT01232283|580537781|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
160767463|NCT01232283|580537772|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
160767464|NCT01232283|580537773|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
160767465|NCT01232283|580537774|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160767466|NCT01232283|580537775|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160767467|NCT01232283|580537776|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160767468|NCT01232283|580537777|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160767469|NCT01232283|580537778|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160767470|NCT01232283|580537779|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160767471|NCT01232283|580537780|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160767472|NCT01232283|580537781|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
160767473|NCT01232283|580537772|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
160767474|NCT01232283|580537773|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
160767475|NCT01232283|580537774|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
160767476|NCT01232283|580537775|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
160767477|NCT01232283|580537776|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
160767478|NCT01232283|580537777|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
160767479|NCT01232283|580537778|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
160767480|NCT01232283|580537779|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
160537158|NCT02953340|579695443|FG000|Overall Study|Reason not specified|2|||
160537159|NCT02953340|579695444|FG001|Overall Study|Reason not specified|2|||
160537160|NCT01376778|579695445|FG000|Overall Study|Lost to Follow-up|3|||
160537161|NCT01376778|579695446|FG001|Overall Study|Lost to Follow-up|2|||
160537162|NCT00632099|579695447|FG000|Overall Study|Lost to Follow-up|3|||
160537163|NCT00632099|579695448|FG001|Overall Study|Lost to Follow-up|3|||
160537164|NCT00271596|579695451|FG000|Overall Study|Protocol Violation|1|||
160537165|NCT00271596|579695452|FG001|Overall Study|Protocol Violation|0|||
160537166|NCT00271596|579695451|FG000|Overall Study|Withdrawal by Subject|0|||
160537167|NCT00271596|579695452|FG001|Overall Study|Withdrawal by Subject|1|||
160537168|NCT04232553|579695453|FG000|Overall Study|Adverse Event|3|||
160537169|NCT04232553|579695454|FG001|Overall Study|Adverse Event|2|||
160537170|NCT04232553|579695455|FG002|Overall Study|Adverse Event|1|||
160537171|NCT04232553|579695456|FG003|Overall Study|Adverse Event|2|||
160537172|NCT04232553|579695457|FG004|Overall Study|Adverse Event|1|||
160537173|NCT04232553|579695458|FG005|Overall Study|Adverse Event|1|||
160537174|NCT04232553|579695459|FG006|Overall Study|Adverse Event|0|||
160537175|NCT04232553|579695460|FG007|Overall Study|Adverse Event|0|||
160537176|NCT04232553|579695461|FG008|Overall Study|Adverse Event|0|||
160537177|NCT04232553|579695453|FG000|Overall Study|Death|0|||
160537178|NCT04232553|579695454|FG001|Overall Study|Death|1|||
160537179|NCT04232553|579695455|FG002|Overall Study|Death|0|||
160537180|NCT04232553|579695456|FG003|Overall Study|Death|1|||
160537181|NCT04232553|579695457|FG004|Overall Study|Death|0|||
160537182|NCT04232553|579695458|FG005|Overall Study|Death|0|||
160537183|NCT04232553|579695459|FG006|Overall Study|Death|0|||
160537184|NCT04232553|579695460|FG007|Overall Study|Death|0|||
160537185|NCT04232553|579695461|FG008|Overall Study|Death|0|||
160537186|NCT04232553|579695453|FG000|Overall Study|Lack of Efficacy|0|||
160537187|NCT04232553|579695454|FG001|Overall Study|Lack of Efficacy|2|||
160537188|NCT04232553|579695455|FG002|Overall Study|Lack of Efficacy|0|||
160537189|NCT04232553|579695456|FG003|Overall Study|Lack of Efficacy|0|||
160537190|NCT04232553|579695457|FG004|Overall Study|Lack of Efficacy|0|||
160537191|NCT04232553|579695458|FG005|Overall Study|Lack of Efficacy|0|||
160537192|NCT04232553|579695459|FG006|Overall Study|Lack of Efficacy|0|||
160537193|NCT04232553|579695460|FG007|Overall Study|Lack of Efficacy|0|||
160537194|NCT04232553|579695461|FG008|Overall Study|Lack of Efficacy|1|||
160537195|NCT04232553|579695453|FG000|Overall Study|Lost to Follow-up|0|||
160537196|NCT04232553|579695454|FG001|Overall Study|Lost to Follow-up|1|||
160537197|NCT04232553|579695455|FG002|Overall Study|Lost to Follow-up|0|||
160537198|NCT04232553|579695456|FG003|Overall Study|Lost to Follow-up|0|||
160537199|NCT04232553|579695457|FG004|Overall Study|Lost to Follow-up|1|||
160537200|NCT04232553|579695458|FG005|Overall Study|Lost to Follow-up|0|||
160537201|NCT04232553|579695459|FG006|Overall Study|Lost to Follow-up|0|||
160537202|NCT04232553|579695460|FG007|Overall Study|Lost to Follow-up|0|||
160537203|NCT04232553|579695461|FG008|Overall Study|Lost to Follow-up|1|||
160537204|NCT04232553|579695453|FG000|Overall Study|Other - As reported by the investigator|0|||
160537205|NCT04232553|579695454|FG001|Overall Study|Other - As reported by the investigator|1|||
160537206|NCT04232553|579695455|FG002|Overall Study|Other - As reported by the investigator|0|||
160537207|NCT04232553|579695456|FG003|Overall Study|Other - As reported by the investigator|0|||
160537208|NCT04232553|579695457|FG004|Overall Study|Other - As reported by the investigator|0|||
160537209|NCT04232553|579695458|FG005|Overall Study|Other - As reported by the investigator|0|||
160537210|NCT04232553|579695459|FG006|Overall Study|Other - As reported by the investigator|0|||
160537211|NCT04232553|579695460|FG007|Overall Study|Other - As reported by the investigator|0|||
160537212|NCT04232553|579695461|FG008|Overall Study|Other - As reported by the investigator|0|||
160537213|NCT04232553|579695453|FG000|Overall Study|Physician Decision|1|||
160537214|NCT04232553|579695454|FG001|Overall Study|Physician Decision|1|||
160537215|NCT04232553|579695455|FG002|Overall Study|Physician Decision|0|||
160537216|NCT04232553|579695456|FG003|Overall Study|Physician Decision|0|||
160537217|NCT04232553|579695457|FG004|Overall Study|Physician Decision|1|||
160537218|NCT04232553|579695458|FG005|Overall Study|Physician Decision|0|||
160537219|NCT04232553|579695459|FG006|Overall Study|Physician Decision|0|||
160537220|NCT04232553|579695460|FG007|Overall Study|Physician Decision|0|||
160537221|NCT04232553|579695461|FG008|Overall Study|Physician Decision|0|||
160537222|NCT04232553|579695453|FG000|Overall Study|Pregnancy|1|||
160537223|NCT04232553|579695454|FG001|Overall Study|Pregnancy|0|||
160537224|NCT04232553|579695455|FG002|Overall Study|Pregnancy|0|||
160537225|NCT04232553|579695456|FG003|Overall Study|Pregnancy|0|||
160537226|NCT04232553|579695457|FG004|Overall Study|Pregnancy|0|||
160537227|NCT04232553|579695458|FG005|Overall Study|Pregnancy|0|||
160537228|NCT04232553|579695459|FG006|Overall Study|Pregnancy|0|||
160537229|NCT04232553|579695460|FG007|Overall Study|Pregnancy|0|||
160874868|NCT03110770|580935642|FG003|Overall Study|Illness/Injury unrelated to product|0|||
160874869|NCT03110770|580935643|FG004|Overall Study|Illness/Injury unrelated to product|1|||
160874870|NCT01086358|580935646|FG000|First Intervention|Lost to Follow-up|9|||
160874871|NCT01086358|580935647|FG001|First Intervention|Lost to Follow-up|4|||
160874872|NCT01086358|580935646|FG000|First Intervention|Withdrawal by Subject|0|||
160874873|NCT01086358|580935647|FG001|First Intervention|Withdrawal by Subject|1|||
160874874|NCT01086358|580935646|FG000|Second Intervention|Lost to Follow-up|4|||
160874875|NCT01086358|580935647|FG001|Second Intervention|Lost to Follow-up|4|||
160874876|NCT02888119|580935650|FG000|Overall Study|Lost to Follow-up|5|||
160874877|NCT02888119|580935651|FG001|Overall Study|Lost to Follow-up|4|||
160537230|NCT04232553|579695461|FG008|Overall Study|Pregnancy|0|||
160537231|NCT04232553|579695453|FG000|Overall Study|Withdrawal by Subject|7|||
160537232|NCT04232553|579695454|FG001|Overall Study|Withdrawal by Subject|5|||
160537233|NCT04232553|579695455|FG002|Overall Study|Withdrawal by Subject|0|||
160537234|NCT04232553|579695456|FG003|Overall Study|Withdrawal by Subject|0|||
160537235|NCT04232553|579695457|FG004|Overall Study|Withdrawal by Subject|2|||
160537236|NCT04232553|579695458|FG005|Overall Study|Withdrawal by Subject|2|||
160537237|NCT04232553|579695459|FG006|Overall Study|Withdrawal by Subject|0|||
160537238|NCT04232553|579695460|FG007|Overall Study|Withdrawal by Subject|2|||
160537239|NCT04232553|579695461|FG008|Overall Study|Withdrawal by Subject|0|||
160537240|NCT04066491|579695466|FG000|Overall Study|Randomized, not treated|0|||
160537241|NCT04066491|579695467|FG001|Overall Study|Randomized, not treated|0|||
160537242|NCT04066491|579695468|FG002|Overall Study|Randomized, not treated|2|||
160537243|NCT04506086|579695469|FG000|Overall Study|Withdrawal by Subject|2|||
160537244|NCT01293968|579695472|FG000|Overall Study|non-cooperation|3|||
160537245|NCT01293968|579695473|FG001|Overall Study|non-cooperation|3|||
160537246|NCT01484977|579695474|FG000|Overall Study|Adverse Event|8|||
160537247|NCT01484977|579695474|FG000|Overall Study|Lack of Efficacy|4|||
160537248|NCT01484977|579695474|FG000|Overall Study|Protocol Violation|6|||
160537249|NCT01484977|579695474|FG000|Overall Study|Lost to Follow-up|1|||
160537250|NCT01484977|579695474|FG000|Overall Study|Withdrawal by Subject|4|||
160537251|NCT01484977|579695474|FG000|Overall Study|Subject Protocol Non-compliant|1|||
160537252|NCT01484977|579695474|FG000|Overall Study|Moving Overseas|1|||
160537253|NCT01484977|579695474|FG000|Overall Study|Low White Blood Cell Count|1|||
160537254|NCT01484977|579695474|FG000|Overall Study|Lack of Compliance|1|||
160537255|NCT01133379|579695475|FG000|Overall Study|Withdrawal by Subject|0|||
160537256|NCT01133379|579695476|FG001|Overall Study|Withdrawal by Subject|1|||
160537257|NCT01133379|579695477|FG002|Overall Study|Withdrawal by Subject|1|||
160537258|NCT01133379|579695475|FG000|Overall Study|Lost to Follow-up|1|||
160537259|NCT01133379|579695476|FG001|Overall Study|Lost to Follow-up|1|||
160537260|NCT01133379|579695477|FG002|Overall Study|Lost to Follow-up|1|||
160537261|NCT03996876|579695480|FG000|Overall Study|Incomplete Data|2|||
160537262|NCT03996876|579695481|FG001|Overall Study|Incomplete Data|4|||
160537263|NCT00121108|579695482|FG000|Overall Study|Lost to Follow-up|10|||
160537264|NCT00121108|579695483|FG001|Overall Study|Lost to Follow-up|22|||
160537265|NCT00121108|579695482|FG000|Overall Study|Withdrawal by Subject|106|||
160537266|NCT00121108|579695483|FG001|Overall Study|Withdrawal by Subject|195|||
160537267|NCT00121108|579695482|FG000|Overall Study|Death|5|||
160537268|NCT00121108|579695483|FG001|Overall Study|Death|8|||
160537269|NCT03080883|579695489|FG000|Overall Study|Withdrawal by Subject|11|||
160537270|NCT03080883|579695490|FG001|Overall Study|Withdrawal by Subject|15|||
160537271|NCT03080883|579695489|FG000|Overall Study|Adverse Event|22|||
160537272|NCT03080883|579695490|FG001|Overall Study|Adverse Event|22|||
160537273|NCT03080883|579695489|FG000|Overall Study|Alternative Therapy|0|||
160874878|NCT02888119|580935652|FG002|Overall Study|Lost to Follow-up|0|||
160874879|NCT03330002|580935656|FG000|Overall Study|Lost to Follow-up|15|||
160874880|NCT03330002|580935656|FG000|Overall Study|Death|7|||
160537274|NCT03080883|579695490|FG001|Overall Study|Alternative Therapy|3|||
160537275|NCT03080883|579695489|FG000|Overall Study|Other Complicating Disease|9|||
160537276|NCT03080883|579695490|FG001|Overall Study|Other Complicating Disease|5|||
160537277|NCT03080883|579695489|FG000|Overall Study|Death|21|||
160874881|NCT00833417|580935657|FG000|Overall Study|Adverse Event|5|||
160874882|NCT00833417|580935658|FG001|Overall Study|Adverse Event|16|||
160537278|NCT03080883|579695490|FG001|Overall Study|Death|16|||
160874883|NCT00833417|580935657|FG000|Overall Study|Death|1|||
160874884|NCT00833417|580935658|FG001|Overall Study|Death|3|||
160537279|NCT03080883|579695489|FG000|Overall Study|Physician Decision|2|||
160537280|NCT03080883|579695490|FG001|Overall Study|Physician Decision|2|||
160537281|NCT03080883|579695489|FG000|Overall Study|Disease Progression|2|||
160537282|NCT03080883|579695490|FG001|Overall Study|Disease Progression|8|||
160537283|NCT03080883|579695489|FG000|Overall Study|Lost to Follow-up|1|||
160537284|NCT03080883|579695490|FG001|Overall Study|Lost to Follow-up|1|||
160537285|NCT00388973|579697046|FG000|Overall Study|Adverse Event|16|||
160537286|NCT00388973|579697047|FG001|Overall Study|Adverse Event|6|||
160537287|NCT00388973|579697046|FG000|Overall Study|Lack of Efficacy|1|||
160874885|NCT00833417|580935657|FG000|Overall Study|Lost to Follow-up|1|||
160874886|NCT00833417|580935658|FG001|Overall Study|Lost to Follow-up|2|||
160874887|NCT00833417|580935657|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
160874888|NCT00833417|580935658|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
160874889|NCT00833417|580935657|FG000|Overall Study|Patient Decision to Withdraw|4|||
160874890|NCT00833417|580935658|FG001|Overall Study|Patient Decision to Withdraw|23|||
160874891|NCT00833417|580935657|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
160874892|NCT00833417|580935658|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
160874893|NCT00833417|580935657|FG000|Overall Study|Disease Progression|18|||
160874894|NCT00833417|580935658|FG001|Overall Study|Disease Progression|17|||
160874895|NCT00833417|580935657|FG000|Overall Study|Reason Not Specified|0|||
160874896|NCT00833417|580935658|FG001|Overall Study|Reason Not Specified|1|||
160874897|NCT01625260|580935659|FG000|Overall Study|Adverse Event|3|||
160874898|NCT01625260|580935660|FG001|Overall Study|Adverse Event|0|||
160874899|NCT01625260|580935659|FG000|Overall Study|Study Terminated by Investigator|2|||
160636536|NCT01289990|580051580|FG012|Overall Study|Death|0|||
160636537|NCT01289990|580051568|FG000|Overall Study|Lost to Follow-up|3|||
160636538|NCT01289990|580051569|FG001|Overall Study|Lost to Follow-up|2|||
160636539|NCT01289990|580051570|FG002|Overall Study|Lost to Follow-up|5|||
160636540|NCT01289990|580051571|FG003|Overall Study|Lost to Follow-up|5|||
160636541|NCT01289990|580051572|FG004|Overall Study|Lost to Follow-up|3|||
160636542|NCT01289990|580051573|FG005|Overall Study|Lost to Follow-up|4|||
160636543|NCT01289990|580051574|FG006|Overall Study|Lost to Follow-up|2|||
160636544|NCT01289990|580051575|FG007|Overall Study|Lost to Follow-up|2|||
160636545|NCT01289990|580051576|FG008|Overall Study|Lost to Follow-up|1|||
160636546|NCT01289990|580051577|FG009|Overall Study|Lost to Follow-up|4|||
160636547|NCT01289990|580051578|FG010|Overall Study|Lost to Follow-up|2|||
160636548|NCT01289990|580051579|FG011|Overall Study|Lost to Follow-up|1|||
160636549|NCT01289990|580051580|FG012|Overall Study|Lost to Follow-up|2|||
160636550|NCT01289990|580051568|FG000|Overall Study|Withdrawal by Subject|15|||
160636551|NCT01289990|580051569|FG001|Overall Study|Withdrawal by Subject|14|||
160636552|NCT01289990|580051570|FG002|Overall Study|Withdrawal by Subject|12|||
160636553|NCT01289990|580051571|FG003|Overall Study|Withdrawal by Subject|13|||
160636554|NCT01289990|580051572|FG004|Overall Study|Withdrawal by Subject|8|||
160636555|NCT01289990|580051573|FG005|Overall Study|Withdrawal by Subject|7|||
160636556|NCT01289990|580051574|FG006|Overall Study|Withdrawal by Subject|13|||
160636557|NCT01289990|580051575|FG007|Overall Study|Withdrawal by Subject|9|||
160636558|NCT01289990|580051576|FG008|Overall Study|Withdrawal by Subject|12|||
160636559|NCT01289990|580051577|FG009|Overall Study|Withdrawal by Subject|13|||
160636560|NCT01289990|580051578|FG010|Overall Study|Withdrawal by Subject|11|||
160636561|NCT01289990|580051579|FG011|Overall Study|Withdrawal by Subject|13|||
160636562|NCT01289990|580051580|FG012|Overall Study|Withdrawal by Subject|16|||
160636563|NCT01289990|580051568|FG000|Overall Study|discontinued in preceding trial|18|||
160636564|NCT01289990|580051569|FG001|Overall Study|discontinued in preceding trial|20|||
160636565|NCT01289990|580051570|FG002|Overall Study|discontinued in preceding trial|41|||
160636566|NCT01289990|580051571|FG003|Overall Study|discontinued in preceding trial|17|||
160636567|NCT01289990|580051572|FG004|Overall Study|discontinued in preceding trial|11|||
160636568|NCT01289990|580051573|FG005|Overall Study|discontinued in preceding trial|12|||
160636569|NCT01289990|580051574|FG006|Overall Study|discontinued in preceding trial|18|||
160636570|NCT01289990|580051575|FG007|Overall Study|discontinued in preceding trial|8|||
160636571|NCT01289990|580051576|FG008|Overall Study|discontinued in preceding trial|17|||
160636572|NCT01289990|580051577|FG009|Overall Study|discontinued in preceding trial|21|||
160636573|NCT01289990|580051578|FG010|Overall Study|discontinued in preceding trial|17|||
160636574|NCT01289990|580051579|FG011|Overall Study|discontinued in preceding trial|17|||
160636575|NCT01289990|580051580|FG012|Overall Study|discontinued in preceding trial|24|||
160636576|NCT01289990|580051568|FG000|Overall Study|did not continue in extension|41|||
160636577|NCT01289990|580051569|FG001|Overall Study|did not continue in extension|45|||
160636578|NCT01289990|580051570|FG002|Overall Study|did not continue in extension|51|||
160636579|NCT01289990|580051571|FG003|Overall Study|did not continue in extension|51|||
160636580|NCT01289990|580051572|FG004|Overall Study|did not continue in extension|48|||
160636581|NCT01289990|580051573|FG005|Overall Study|did not continue in extension|50|||
160636582|NCT01289990|580051574|FG006|Overall Study|did not continue in extension|54|||
160636583|NCT01289990|580051575|FG007|Overall Study|did not continue in extension|36|||
160636584|NCT01289990|580051576|FG008|Overall Study|did not continue in extension|44|||
160636585|NCT01289990|580051577|FG009|Overall Study|did not continue in extension|48|||
160636586|NCT01289990|580051578|FG010|Overall Study|did not continue in extension|45|||
160636587|NCT01289990|580051579|FG011|Overall Study|did not continue in extension|34|||
160636588|NCT01289990|580051580|FG012|Overall Study|did not continue in extension|56|||
160636589|NCT01289990|580051568|FG000|Overall Study|Not treated|0|||
160636590|NCT01289990|580051569|FG001|Overall Study|Not treated|0|||
160636591|NCT01289990|580051570|FG002|Overall Study|Not treated|0|||
160636592|NCT01289990|580051571|FG003|Overall Study|Not treated|0|||
160636593|NCT01289990|580051572|FG004|Overall Study|Not treated|0|||
160636594|NCT01289990|580051573|FG005|Overall Study|Not treated|0|||
160636595|NCT01289990|580051574|FG006|Overall Study|Not treated|1|||
160636596|NCT01289990|580051575|FG007|Overall Study|Not treated|0|||
160636597|NCT01289990|580051576|FG008|Overall Study|Not treated|1|||
160636598|NCT01289990|580051577|FG009|Overall Study|Not treated|0|||
160636599|NCT01289990|580051578|FG010|Overall Study|Not treated|1|||
160636600|NCT01289990|580051579|FG011|Overall Study|Not treated|2|||
160636601|NCT01289990|580051580|FG012|Overall Study|Not treated|0|||
160636602|NCT05166512|580051581|FG000|Randomized|Lost to Follow-up|2|||
160636603|NCT05166512|580051582|FG001|Randomized|Lost to Follow-up|0|||
160537288|NCT00388973|579697047|FG001|Overall Study|Lack of Efficacy|12|||
160537289|NCT00388973|579697046|FG000|Overall Study|Protocol Violation|3|||
160537290|NCT00388973|579697047|FG001|Overall Study|Protocol Violation|0|||
160537291|NCT00388973|579697046|FG000|Overall Study|Withdrawal by Subject|14|||
160537292|NCT00388973|579697047|FG001|Overall Study|Withdrawal by Subject|17|||
160537293|NCT00388973|579697046|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
160537294|NCT00388973|579697047|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
160537295|NCT00388973|579697046|FG000|Overall Study|Did not complete 61 days of treatment|5|||
160537296|NCT00388973|579697047|FG001|Overall Study|Did not complete 61 days of treatment|4|||
160537297|NCT00388973|579697046|FG000|Overall Study|Left region|0|||
160537298|NCT00388973|579697047|FG001|Overall Study|Left region|1|||
160537299|NCT00388973|579697046|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
160537300|NCT00388973|579697047|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
160537301|NCT01652885|579697048|FG000|Overall Study|Adverse Event|1|||
160537302|NCT03723707|579697049|FG000|Overall Study|Death|32|||
160874900|NCT01625260|580935660|FG001|Overall Study|Study Terminated by Investigator|0|||
160874901|NCT01625260|580935659|FG000|Overall Study|Disease Progression|2|||
160874902|NCT01625260|580935660|FG001|Overall Study|Disease Progression|0|||
160874903|NCT01625260|580935659|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
160874904|NCT01625260|580935660|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
160874905|NCT05573386|580935661|FG000|Overall Study|Withdrawal by Subject|3|||
160874906|NCT05573386|580935662|FG001|Overall Study|Withdrawal by Subject|2|||
160874907|NCT01776307|580935668|FG000|Overall Study|Not dosed|0|||
160874908|NCT01776307|580935669|FG001|Overall Study|Not dosed|0|||
160874909|NCT01776307|580935670|FG002|Overall Study|Not dosed|1|||
160874910|NCT02745145|580935676|FG000|Overall Study|Adverse Event|1|||
160874911|NCT02745145|580935677|FG001|Overall Study|Adverse Event|0|||
160874912|NCT02745145|580935678|FG002|Overall Study|Adverse Event|0|||
160874913|NCT02745145|580935676|FG000|Overall Study|Death|0|||
160874914|NCT02745145|580935677|FG001|Overall Study|Death|1|||
160874915|NCT02745145|580935678|FG002|Overall Study|Death|0|||
160874916|NCT02745145|580935676|FG000|Overall Study|Progressive disease|0|||
160874917|NCT02745145|580935677|FG001|Overall Study|Progressive disease|0|||
160874918|NCT02745145|580935678|FG002|Overall Study|Progressive disease|1|||
160874919|NCT02745145|580935676|FG000|Overall Study|Withdrew consent|1|||
160874920|NCT02745145|580935677|FG001|Overall Study|Withdrew consent|1|||
160874921|NCT02745145|580935678|FG002|Overall Study|Withdrew consent|1|||
160874922|NCT02745145|580935676|FG000|Overall Study|Study Termination|8|||
160874923|NCT02745145|580935677|FG001|Overall Study|Study Termination|3|||
160874924|NCT02745145|580935678|FG002|Overall Study|Study Termination|7|||
160874925|NCT01297491|580935687|FG000|Overall Study|Adverse Event|11|||
160874926|NCT01297491|580935688|FG001|Overall Study|Adverse Event|6|||
160874927|NCT01297491|580935687|FG000|Overall Study|Physician Decision|3|||
160874928|NCT01297491|580935688|FG001|Overall Study|Physician Decision|2|||
160874929|NCT01297491|580935687|FG000|Overall Study|Progressive disease|11|||
160874930|NCT01297491|580935688|FG001|Overall Study|Progressive disease|20|||
160874931|NCT01297491|580935687|FG000|Overall Study|Patient/Guardian decision|3|||
160874932|NCT01297491|580935688|FG001|Overall Study|Patient/Guardian decision|4|||
160874933|NCT01297491|580935687|FG000|Overall Study|Death|2|||
160874934|NCT01297491|580935688|FG001|Overall Study|Death|1|||
160874935|NCT00775593|580935694|FG000|Overall Study|Unmet eligibility criteria|6|||
160874936|NCT00775593|580935694|FG000|Overall Study|Death|1|||
160874937|NCT03530124|580935699|FG000|Overall Study|Withdrawal by Subject|0|||
160874938|NCT03530124|580935700|FG001|Overall Study|Withdrawal by Subject|1|||
160874939|NCT03530124|580935699|FG000|Overall Study|Protocol Violation|1|||
160874940|NCT03530124|580935700|FG001|Overall Study|Protocol Violation|0|||
160874941|NCT03530124|580935699|FG000|Overall Study|Discharged prior to study completion|1|||
160874942|NCT03530124|580935700|FG001|Overall Study|Discharged prior to study completion|0|||
160874943|NCT02379637|580935701|FG000|Overall Study|Protocol Violation|0|||
160874944|NCT02379637|580935702|FG001|Overall Study|Protocol Violation|1|||
160537303|NCT03723707|579697050|FG001|Overall Study|Death|32|||
160537304|NCT03723707|579697049|FG000|Overall Study|Admitted to long term care|12|||
160537305|NCT03723707|579697050|FG001|Overall Study|Admitted to long term care|12|||
160537306|NCT03723707|579697049|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
160636604|NCT05166512|580051581|FG000|Randomized|Withdrawal by Subject|1|||
160874945|NCT02379637|580935701|FG000|Overall Study|Adverse Event|1|||
160874946|NCT02379637|580935702|FG001|Overall Study|Adverse Event|0|||
160874947|NCT02379637|580935701|FG000|Overall Study|Withdrawal by Subject|1|||
160874948|NCT02379637|580935702|FG001|Overall Study|Withdrawal by Subject|0|||
160874949|NCT02447302|580935703|FG000|Overall Study|Physician Decision|1|||
160874950|NCT02447302|580935704|FG001|Overall Study|Physician Decision|0|||
160874951|NCT02447302|580935705|FG002|Overall Study|Physician Decision|0|||
160874952|NCT02447302|580935703|FG000|Overall Study|Adverse Event|4|||
160874953|NCT02447302|580935704|FG001|Overall Study|Adverse Event|3|||
160874954|NCT02447302|580935705|FG002|Overall Study|Adverse Event|0|||
160874955|NCT02447302|580935703|FG000|Overall Study|Withdrawal by Subject|0|||
160874956|NCT02447302|580935704|FG001|Overall Study|Withdrawal by Subject|1|||
160874957|NCT02447302|580935705|FG002|Overall Study|Withdrawal by Subject|5|||
160874958|NCT02447302|580935703|FG000|Overall Study|Sponsor Decision|0|||
160874959|NCT02447302|580935704|FG001|Overall Study|Sponsor Decision|0|||
160874960|NCT02447302|580935705|FG002|Overall Study|Sponsor Decision|1|||
160874961|NCT01742286|580935715|FG000|Escalation Phase|Administrative problems|1|||
160874962|NCT01742286|580935716|FG001|Escalation Phase|Administrative problems|1|||
160874963|NCT01742286|580935717|FG002|Escalation Phase|Administrative problems|0|||
160874964|NCT01742286|580935718|FG003|Escalation Phase|Administrative problems|0|||
160874965|NCT01742286|580935719|FG004|Escalation Phase|Administrative problems|0|||
160874966|NCT01742286|580935720|FG005|Escalation Phase|Administrative problems|0|||
160874967|NCT01742286|580935721|FG006|Escalation Phase|Administrative problems|2|||
160874968|NCT01742286|580935715|FG000|Escalation Phase|Adverse Event|0|||
160874969|NCT01742286|580935716|FG001|Escalation Phase|Adverse Event|1|||
160874970|NCT01742286|580935717|FG002|Escalation Phase|Adverse Event|2|||
160874971|NCT01742286|580935718|FG003|Escalation Phase|Adverse Event|0|||
160874972|NCT01742286|580935719|FG004|Escalation Phase|Adverse Event|0|||
160874973|NCT01742286|580935720|FG005|Escalation Phase|Adverse Event|1|||
160874974|NCT01742286|580935721|FG006|Escalation Phase|Adverse Event|0|||
160537307|NCT03723707|579697050|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
160537308|NCT03723707|579697049|FG000|Overall Study|Lost to Follow-up|40|||
160537309|NCT03723707|579697050|FG001|Overall Study|Lost to Follow-up|22|||
160537310|NCT03723707|579697049|FG000|Overall Study|Discontinued after study closure|24|||
160537311|NCT03723707|579697050|FG001|Overall Study|Discontinued after study closure|12|||
160537312|NCT00075023|579697051|FG000|Pilot Study|Physician Decision|1|||
160537313|NCT00075023|579697052|FG001|Pilot Study|Physician Decision|2|||
160537314|NCT00075023|579697051|FG000|Pilot Study|Withdrawal by Subject|1|||
160537315|NCT00075023|579697052|FG001|Pilot Study|Withdrawal by Subject|0|||
160537316|NCT04342871|579697053|FG000|Overall Study|Death|4|||
160537317|NCT04342871|579697053|FG000|Overall Study|Clinical deterioration/illness progression|2|||
160537318|NCT04342871|579697053|FG000|Overall Study|Did not complete baseline assessments|5|||
160537319|NCT04342871|579697053|FG000|Overall Study|Lost to Follow-up|13|||
160537320|NCT01429584|579697055|FG000|Overall Study|Withdrawal by Subject|1|||
160537321|NCT01429584|579697056|FG001|Overall Study|Withdrawal by Subject|0|||
160537322|NCT01429584|579697055|FG000|Overall Study|Protocol Violation|0|||
160537323|NCT01429584|579697056|FG001|Overall Study|Protocol Violation|1|||
160537324|NCT00750698|579697060|FG000|Overall Study|Withdrawal by Subject|1|||
160874975|NCT01742286|580935715|FG000|Escalation Phase|Disease progression|3|||
160874976|NCT01742286|580935716|FG001|Escalation Phase|Disease progression|7|||
160874977|NCT01742286|580935717|FG002|Escalation Phase|Disease progression|4|||
160874978|NCT01742286|580935718|FG003|Escalation Phase|Disease progression|1|||
160874979|NCT01742286|580935719|FG004|Escalation Phase|Disease progression|4|||
160874980|NCT01742286|580935720|FG005|Escalation Phase|Disease progression|3|||
160874981|NCT01742286|580935721|FG006|Escalation Phase|Disease progression|2|||
160874982|NCT01742286|580935715|FG000|Escalation Phase|Death|0|||
160874983|NCT01742286|580935716|FG001|Escalation Phase|Death|0|||
160874984|NCT01742286|580935717|FG002|Escalation Phase|Death|0|||
160874985|NCT01742286|580935718|FG003|Escalation Phase|Death|0|||
160874986|NCT01742286|580935719|FG004|Escalation Phase|Death|0|||
160874987|NCT01742286|580935720|FG005|Escalation Phase|Death|1|||
160537325|NCT00750698|579697061|FG001|Overall Study|Withdrawal by Subject|0|||
160537326|NCT00750698|579697060|FG000|Overall Study|Progressive disease|5|||
160537327|NCT00750698|579697061|FG001|Overall Study|Progressive disease|2|||
160537328|NCT01999465|579697062|FG000|Overall Study|Lost to Follow-up|0|||
160537329|NCT01999465|579697063|FG001|Overall Study|Lost to Follow-up|2|||
160537330|NCT01999465|579697062|FG000|Overall Study|Protocol Violation|0|||
160874988|NCT01742286|580935721|FG006|Escalation Phase|Death|0|||
160874989|NCT01742286|580935715|FG000|Escalation Phase|Physician Decision|0|||
160874990|NCT01742286|580935716|FG001|Escalation Phase|Physician Decision|3|||
160874991|NCT01742286|580935717|FG002|Escalation Phase|Physician Decision|0|||
160874992|NCT01742286|580935718|FG003|Escalation Phase|Physician Decision|1|||
160537331|NCT01999465|579697063|FG001|Overall Study|Protocol Violation|1|||
160537332|NCT00390546|579697064|FG000|Overall Study|Renal impairment|1|||
160537333|NCT00390546|579697065|FG001|Overall Study|Renal impairment|0|||
160537334|NCT00390546|579697064|FG000|Overall Study|Physician Decision|5|||
160537335|NCT00390546|579697065|FG001|Overall Study|Physician Decision|5|||
160537336|NCT01308008|579697066|FG000|4 Weeks|Illness, disinterest, time|9|||
160537337|NCT01308008|579697067|FG001|4 Weeks|Illness, disinterest, time|2|||
160874993|NCT01742286|580935719|FG004|Escalation Phase|Physician Decision|0|||
160537338|NCT02347098|579697068|FG000|Overall Study|Death|1|||
160537339|NCT02347098|579697069|FG001|Overall Study|Death|0|||
160537340|NCT02347098|579697068|FG000|Overall Study|Withdrawal by Subject|1|||
160537341|NCT02347098|579697069|FG001|Overall Study|Withdrawal by Subject|0|||
160874994|NCT01742286|580935720|FG005|Escalation Phase|Physician Decision|0|||
160874995|NCT01742286|580935721|FG006|Escalation Phase|Physician Decision|2|||
160874996|NCT01742286|580935715|FG000|Escalation Phase|Subject/guardian decision|1|||
160874997|NCT01742286|580935716|FG001|Escalation Phase|Subject/guardian decision|0|||
160874998|NCT01742286|580935717|FG002|Escalation Phase|Subject/guardian decision|0|||
160874999|NCT01742286|580935718|FG003|Escalation Phase|Subject/guardian decision|0|||
160875000|NCT01742286|580935719|FG004|Escalation Phase|Subject/guardian decision|0|||
160537342|NCT02347098|579697068|FG000|Overall Study|Lost to Follow-up|2|||
160537343|NCT02347098|579697069|FG001|Overall Study|Lost to Follow-up|2|||
160875001|NCT01742286|580935720|FG005|Escalation Phase|Subject/guardian decision|0|||
160875002|NCT01742286|580935721|FG006|Escalation Phase|Subject/guardian decision|0|||
160875003|NCT01742286|580935715|FG000|Expansion Phase|Administrative problems|0|||
160875004|NCT01742286|580935716|FG001|Expansion Phase|Administrative problems|0|||
160875005|NCT01742286|580935717|FG002|Expansion Phase|Administrative problems|0|||
160875006|NCT01742286|580935718|FG003|Expansion Phase|Administrative problems|0|||
160875007|NCT01742286|580935719|FG004|Expansion Phase|Administrative problems|0|||
160875008|NCT01742286|580935720|FG005|Expansion Phase|Administrative problems|0|||
160875009|NCT01742286|580935721|FG006|Expansion Phase|Administrative problems|5|||
160875010|NCT01742286|580935715|FG000|Expansion Phase|Physician Decision|0|||
160875011|NCT01742286|580935716|FG001|Expansion Phase|Physician Decision|0|||
160875012|NCT01742286|580935717|FG002|Expansion Phase|Physician Decision|4|||
160875013|NCT01742286|580935718|FG003|Expansion Phase|Physician Decision|0|||
160875014|NCT01742286|580935719|FG004|Expansion Phase|Physician Decision|0|||
160875015|NCT01742286|580935720|FG005|Expansion Phase|Physician Decision|0|||
160875016|NCT01742286|580935721|FG006|Expansion Phase|Physician Decision|9|||
160875017|NCT01742286|580935715|FG000|Expansion Phase|Adverse Event|0|||
160875018|NCT01742286|580935716|FG001|Expansion Phase|Adverse Event|0|||
160875019|NCT01742286|580935717|FG002|Expansion Phase|Adverse Event|0|||
160875020|NCT01742286|580935718|FG003|Expansion Phase|Adverse Event|0|||
160875021|NCT01742286|580935719|FG004|Expansion Phase|Adverse Event|0|||
160875022|NCT01742286|580935720|FG005|Expansion Phase|Adverse Event|0|||
160875023|NCT01742286|580935721|FG006|Expansion Phase|Adverse Event|6|||
160875024|NCT01742286|580935715|FG000|Expansion Phase|Disease progression|0|||
160875025|NCT01742286|580935716|FG001|Expansion Phase|Disease progression|0|||
160875026|NCT01742286|580935717|FG002|Expansion Phase|Disease progression|3|||
160875027|NCT01742286|580935718|FG003|Expansion Phase|Disease progression|0|||
160875028|NCT01742286|580935719|FG004|Expansion Phase|Disease progression|0|||
160875029|NCT01742286|580935720|FG005|Expansion Phase|Disease progression|0|||
160875030|NCT01742286|580935721|FG006|Expansion Phase|Disease progression|15|||
160875031|NCT01742286|580935715|FG000|Expansion Phase|Withdrawal by Subject|0|||
160875032|NCT01742286|580935716|FG001|Expansion Phase|Withdrawal by Subject|0|||
160875033|NCT01742286|580935717|FG002|Expansion Phase|Withdrawal by Subject|0|||
160875034|NCT01742286|580935718|FG003|Expansion Phase|Withdrawal by Subject|0|||
160875035|NCT01742286|580935719|FG004|Expansion Phase|Withdrawal by Subject|0|||
160537344|NCT02347098|579697068|FG000|Overall Study|Refuse Follow-up Visit|1|||
160537345|NCT02347098|579697069|FG001|Overall Study|Refuse Follow-up Visit|5|||
160537346|NCT02347098|579697068|FG000|Overall Study|no visit due to illness|2|||
160537347|NCT02347098|579697069|FG001|Overall Study|no visit due to illness|1|||
160537348|NCT02187172|579697070|FG000|Overall Study|Lost to Follow-up|1|||
160537349|NCT02187172|579697071|FG001|Overall Study|Lost to Follow-up|2|||
160537350|NCT02187172|579697070|FG000|Overall Study|Lack of Efficacy|1|||
160537351|NCT02187172|579697071|FG001|Overall Study|Lack of Efficacy|2|||
160537352|NCT02187172|579697070|FG000|Overall Study|Adverse Event|0|||
160537353|NCT02187172|579697071|FG001|Overall Study|Adverse Event|1|||
160537354|NCT02187172|579697070|FG000|Overall Study|Physician Decision|1|||
160537355|NCT02187172|579697071|FG001|Overall Study|Physician Decision|1|||
160537356|NCT00880399|579697072|FG000|Overall Study|Adverse Event|4|||
160537357|NCT00880399|579697073|FG001|Overall Study|Adverse Event|6|||
160537358|NCT00880399|579697074|FG002|Overall Study|Adverse Event|5|||
160537359|NCT00880399|579697072|FG000|Overall Study|Lack of Efficacy|1|||
160537360|NCT00880399|579697073|FG001|Overall Study|Lack of Efficacy|4|||
160537361|NCT00880399|579697074|FG002|Overall Study|Lack of Efficacy|2|||
160537362|NCT00880399|579697072|FG000|Overall Study|Protocol Violation|4|||
160537363|NCT00880399|579697073|FG001|Overall Study|Protocol Violation|4|||
160537364|NCT00880399|579697074|FG002|Overall Study|Protocol Violation|6|||
160537365|NCT00880399|579697072|FG000|Overall Study|Study closed/terminated|3|||
160537366|NCT00880399|579697073|FG001|Overall Study|Study closed/terminated|7|||
160537367|NCT00880399|579697074|FG002|Overall Study|Study closed/terminated|4|||
160537368|NCT00880399|579697072|FG000|Overall Study|Lost to Follow-up|8|||
160537369|NCT00880399|579697073|FG001|Overall Study|Lost to Follow-up|5|||
160875036|NCT01742286|580935720|FG005|Expansion Phase|Withdrawal by Subject|0|||
160875037|NCT01742286|580935721|FG006|Expansion Phase|Withdrawal by Subject|1|||
160875038|NCT01233232|580935722|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
160875039|NCT01233232|580935723|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
160875040|NCT01233232|580935724|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
160875041|NCT01217307|580939029|FG000|Overall Study|Withdrawal by Subject|0|||
160875042|NCT01217307|580939030|FG001|Overall Study|Withdrawal by Subject|1|||
160875043|NCT00843284|580939033|FG000|Overall Study|Adverse Event|39|||
160875044|NCT00843284|580939033|FG000|Overall Study|Lack of Efficacy|5|||
160537370|NCT00880399|579697074|FG002|Overall Study|Lost to Follow-up|3|||
160537371|NCT00880399|579697072|FG000|Overall Study|Physician Decision|5|||
160537372|NCT00880399|579697073|FG001|Overall Study|Physician Decision|0|||
160537373|NCT00880399|579697074|FG002|Overall Study|Physician Decision|3|||
160537374|NCT00880399|579697072|FG000|Overall Study|Withdrawal by Subject|6|||
160875045|NCT00843284|580939033|FG000|Overall Study|Lost to Follow-up|11|||
160875046|NCT00843284|580939033|FG000|Overall Study|Other|10|||
160875047|NCT00843284|580939033|FG000|Overall Study|Withdrawal by Subject|4|||
160875048|NCT00843284|580939033|FG000|Overall Study|Death|3|||
160875049|NCT01794338|580939037|FG000|Overall Study|Death|2|||
160875050|NCT01794338|580939038|FG001|Overall Study|Death|0|||
160875051|NCT01794338|580939037|FG000|Overall Study|Lost to Follow-up|6|||
160875052|NCT01794338|580939038|FG001|Overall Study|Lost to Follow-up|9|||
160875053|NCT01282463|580939039|FG000|Overall Study|Lost to Follow-up|1|||
160875054|NCT01282463|580939040|FG001|Overall Study|Lost to Follow-up|0|||
160875055|NCT01282463|580939041|FG002|Overall Study|Lost to Follow-up|0|||
160875056|NCT01282463|580939039|FG000|Overall Study|Withdrawal by Subject|6|||
160875057|NCT01282463|580939040|FG001|Overall Study|Withdrawal by Subject|2|||
160875058|NCT01282463|580939041|FG002|Overall Study|Withdrawal by Subject|3|||
160875059|NCT01282463|580939039|FG000|Overall Study|"Never Treated Death"|0|||
160875060|NCT01282463|580939040|FG001|Overall Study|"Never Treated Death"|1|||
160875061|NCT01282463|580939041|FG002|Overall Study|"Never Treated Death"|0|||
160875062|NCT01282463|580939039|FG000|Overall Study|"Never Treated PD"|0|||
160875063|NCT01282463|580939040|FG001|Overall Study|"Never Treated PD"|1|||
160875064|NCT01282463|580939041|FG002|Overall Study|"Never Treated PD"|0|||
160875065|NCT01282463|580939039|FG000|Overall Study|Protocol Violation|0|||
160875066|NCT01282463|580939040|FG001|Overall Study|Protocol Violation|0|||
160875067|NCT01282463|580939041|FG002|Overall Study|Protocol Violation|1|||
160875068|NCT01282463|580939039|FG000|Overall Study|Physician Decision|1|||
160875069|NCT01282463|580939040|FG001|Overall Study|Physician Decision|0|||
160875070|NCT01282463|580939041|FG002|Overall Study|Physician Decision|0|||
160875071|NCT03320824|580939042|FG000|Overall Study|Withdrawal by Subject|8|||
160875072|NCT03320824|580939043|FG001|Overall Study|Withdrawal by Subject|1|||
160875073|NCT03320824|580939042|FG000|Overall Study|Lost to Follow-up|10|||
160875074|NCT03320824|580939043|FG001|Overall Study|Lost to Follow-up|1|||
160875075|NCT03320824|580939042|FG000|Overall Study|moved out of state|0|||
160875076|NCT03320824|580939043|FG001|Overall Study|moved out of state|1|||
160875077|NCT03320824|580939042|FG000|Overall Study|could not complete final visit|0|||
160537375|NCT00880399|579697073|FG001|Overall Study|Withdrawal by Subject|3|||
160537376|NCT00880399|579697074|FG002|Overall Study|Withdrawal by Subject|3|||
160875078|NCT03320824|580939043|FG001|Overall Study|could not complete final visit|1|||
160875079|NCT00955305|580939044|FG000|Overall Study|Disease progression|39|||
160875080|NCT00955305|580939045|FG001|Overall Study|Disease progression|41|||
160875081|NCT00955305|580939044|FG000|Overall Study|Adverse Event|22|||
160875082|NCT00955305|580939045|FG001|Overall Study|Adverse Event|22|||
160875083|NCT00955305|580939044|FG000|Overall Study|Death|2|||
160875084|NCT00955305|580939045|FG001|Overall Study|Death|1|||
160875085|NCT00955305|580939044|FG000|Overall Study|Withdrawal by Subject|5|||
160875086|NCT00955305|580939045|FG001|Overall Study|Withdrawal by Subject|4|||
160875087|NCT00955305|580939044|FG000|Overall Study|Alternative therapy|4|||
160875088|NCT00955305|580939045|FG001|Overall Study|Alternative therapy|0|||
160875089|NCT00955305|580939044|FG000|Overall Study|Other complicating disease|2|||
160875090|NCT00955305|580939045|FG001|Overall Study|Other complicating disease|4|||
160875091|NCT00955305|580939044|FG000|Overall Study|Physician Decision|1|||
160875092|NCT00955305|580939045|FG001|Overall Study|Physician Decision|0|||
160875093|NCT00955305|580939044|FG000|Overall Study|Continued presence of residual disease|0|||
160875094|NCT00955305|580939045|FG001|Overall Study|Continued presence of residual disease|1|||
160875095|NCT00955305|580939044|FG000|Overall Study|Functional decline|2|||
160875096|NCT00955305|580939045|FG001|Overall Study|Functional decline|0|||
160875097|NCT00955305|580939044|FG000|Overall Study|Maximum response achieved|0|||
160875098|NCT00955305|580939045|FG001|Overall Study|Maximum response achieved|1|||
160875099|NCT00955305|580939044|FG000|Overall Study|Lost to Follow-up|0|||
160875100|NCT00955305|580939045|FG001|Overall Study|Lost to Follow-up|1|||
160875101|NCT00955305|580939044|FG000|Overall Study|No off-treatment reason submitted|1|||
160875102|NCT00955305|580939045|FG001|Overall Study|No off-treatment reason submitted|0|||
160875103|NCT00955305|580939044|FG000|Overall Study|Never started protocol treatment|5|||
160875104|NCT00955305|580939045|FG001|Overall Study|Never started protocol treatment|5|||
160875105|NCT00955305|580939044|FG000|Overall Study|Ineligible|5|||
160875106|NCT00955305|580939045|FG001|Overall Study|Ineligible|7|||
160875107|NCT00109590|580939046|FG000|Overall Study|Lost to Follow-up|1|||
160875108|NCT00109590|580939047|FG001|Overall Study|Lost to Follow-up|0|||
160537377|NCT02181816|579697075|FG000|Overall Study|Case Report Forms Uncollected|38|||
160537378|NCT02181816|579697075|FG000|Overall Study|Protocol Deviation|21|||
160537379|NCT00909181|579697076|FG000|Overall Study|Lost to Follow-up|39|||
160767481|NCT01232283|580537780|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
160767482|NCT01232283|580537781|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
160767483|NCT01232283|580537772|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
160767484|NCT01232283|580537773|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
160767485|NCT01232283|580537774|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160767486|NCT01232283|580537775|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160767487|NCT01232283|580537776|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160767488|NCT01232283|580537777|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160875109|NCT00109590|580939048|FG002|Overall Study|Lost to Follow-up|1|||
160875110|NCT00109590|580939046|FG000|Overall Study|Never Started Treatment|1|||
160537380|NCT00909181|579697077|FG001|Overall Study|Lost to Follow-up|18|||
160537381|NCT00909181|579697078|FG002|Overall Study|Lost to Follow-up|33|||
160875111|NCT00109590|580939047|FG001|Overall Study|Never Started Treatment|2|||
160875112|NCT00109590|580939048|FG002|Overall Study|Never Started Treatment|3|||
160875113|NCT01221285|580939049|FG000|Overall Study|Withdrawal by Subject|1|||
160875114|NCT00588861|580939050|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
160875115|NCT00588861|580939051|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
160537382|NCT01040351|579697079|FG000|Overall Study|poor ovarian response|1|||
160767489|NCT01232283|580537778|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160767490|NCT01232283|580537779|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160767491|NCT01232283|580537780|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160767492|NCT01232283|580537781|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
160767493|NCT01232283|580537772|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
160767494|NCT01232283|580537773|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
160767495|NCT01232283|580537774|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
160767496|NCT01232283|580537775|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
160767497|NCT01232283|580537776|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
160537383|NCT01040351|579697080|FG001|Overall Study|poor ovarian response|2|||
160767498|NCT01232283|580537777|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
160767499|NCT01232283|580537778|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
160767500|NCT01232283|580537779|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
160767501|NCT01232283|580537780|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
160767502|NCT01232283|580537781|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
160767503|NCT01232283|580537772|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
160767504|NCT01232283|580537773|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
160767505|NCT01232283|580537774|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160767506|NCT01232283|580537775|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160767507|NCT01232283|580537776|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160767508|NCT01232283|580537777|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160767509|NCT01232283|580537778|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160767510|NCT01232283|580537779|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160767511|NCT01232283|580537780|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160767512|NCT01232283|580537781|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160767513|NCT01232283|580537772|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
160767514|NCT01232283|580537773|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
160767515|NCT01232283|580537774|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
160767516|NCT01232283|580537775|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
160767517|NCT01232283|580537776|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
160767518|NCT01232283|580537777|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
160767519|NCT01232283|580537778|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
160767520|NCT01232283|580537779|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
160767521|NCT01232283|580537780|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
160767522|NCT01232283|580537781|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
160767523|NCT01232283|580537772|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
160767524|NCT01232283|580537773|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
160767525|NCT01232283|580537774|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
160767526|NCT01232283|580537775|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
160767527|NCT01232283|580537776|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
160767528|NCT01232283|580537777|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
160767529|NCT01232283|580537778|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
160767530|NCT01232283|580537779|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
160767531|NCT01232283|580537780|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
160767532|NCT01232283|580537781|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
160767533|NCT01232283|580537772|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
160767534|NCT01232283|580537773|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
160767535|NCT01232283|580537774|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
160767536|NCT01232283|580537775|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
160767537|NCT01232283|580537776|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
160767538|NCT01232283|580537777|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
160767539|NCT01232283|580537778|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
160767540|NCT01232283|580537779|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
160767541|NCT01232283|580537780|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
160767542|NCT01232283|580537781|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
160767543|NCT01232283|580537772|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160767544|NCT01232283|580537773|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160767545|NCT01232283|580537774|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
160767546|NCT01232283|580537775|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160767547|NCT01232283|580537776|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160875116|NCT00588861|580939050|FG000|6 Months|Patients did not return for follow-up|98|||
160875117|NCT00588861|580939051|FG001|6 Months|Patients did not return for follow-up|73|||
160875118|NCT00588861|580939050|FG000|1 Year|Patients did not return for follow-up|89|||
160875119|NCT00588861|580939051|FG001|1 Year|Patients did not return for follow-up|82|||
160875120|NCT00588861|580939050|FG000|2 Years|Patients did not return for follow-up|92|||
160875121|NCT00588861|580939051|FG001|2 Years|Patients did not return for follow-up|87|||
160875122|NCT00588861|580939050|FG000|4 Years|Patients did not return for follow-up|91|||
160875123|NCT00588861|580939051|FG001|4 Years|Patients did not return for follow-up|103|||
160875124|NCT00588861|580939050|FG000|6 Years|Patients did not return for follow-up|104|||
160875125|NCT00588861|580939051|FG001|6 Years|Patients did not return for follow-up|109|||
160875126|NCT00588861|580939050|FG000|8 Years|Patients did not return for follow-up|105|||
160875127|NCT00588861|580939051|FG001|8 Years|Patients did not return for follow-up|114|||
160875128|NCT00588861|580939050|FG000|10 Years|Incomplete due to study termination|107|||
160537384|NCT01923285|579697090|FG000|Overall Study|Withdrawal by Subject|7|||
160537385|NCT01923285|579697091|FG001|Overall Study|Withdrawal by Subject|6|||
160537386|NCT03374189|579697093|FG000|Overall Study|Lost to Follow-up|1|||
160537387|NCT03374189|579697094|FG001|Overall Study|Lost to Follow-up|0|||
160537388|NCT01517893|579697095|FG000|Overall Study|Withdrawal by Subject|3|||
160537389|NCT01517893|579697096|FG001|Overall Study|Withdrawal by Subject|0|||
160537390|NCT03462576|579697097|FG000|Overall Study|Protocol Violation|5|||
160537391|NCT03462576|579697098|FG001|Overall Study|Protocol Violation|11|||
160537392|NCT03462576|579697099|FG002|Overall Study|Protocol Violation|7|||
160537393|NCT03462576|579697097|FG000|Overall Study|Device Malfunction|0|||
160537394|NCT03462576|579697098|FG001|Overall Study|Device Malfunction|0|||
160537395|NCT03462576|579697099|FG002|Overall Study|Device Malfunction|1|||
160537396|NCT02018822|579697100|FG000|Overall Study|filling replaced by crown|0|||
160537397|NCT02018822|579697101|FG001|Overall Study|filling replaced by crown|1|||
160537398|NCT02018822|579697102|FG002|Overall Study|filling replaced by crown|0|||
160537399|NCT02018822|579697100|FG000|Overall Study|Physician Decision|0|||
160537400|NCT02018822|579697101|FG001|Overall Study|Physician Decision|1|||
160537401|NCT02018822|579697102|FG002|Overall Study|Physician Decision|1|||
160537402|NCT02018822|579697100|FG000|Overall Study|Lost to Follow-up|6|||
160537403|NCT02018822|579697101|FG001|Overall Study|Lost to Follow-up|6|||
160537404|NCT02018822|579697102|FG002|Overall Study|Lost to Follow-up|5|||
160537405|NCT03201458|579697103|FG000|Overall Study|No longer eligible|2|||
160537406|NCT03201458|579697104|FG001|Overall Study|No longer eligible|5|||
160537407|NCT03201458|579697103|FG000|Overall Study|Health event before starting|1|||
160537408|NCT03201458|579697104|FG001|Overall Study|Health event before starting|0|||
160537409|NCT03201458|579697103|FG000|Overall Study|Physician Decision|1|||
160537410|NCT03201458|579697104|FG001|Overall Study|Physician Decision|0|||
160537411|NCT00715026|579697105|FG000|Overall Study|Withdrawal by Subject|5|||
160537412|NCT00715026|579697105|FG000|Overall Study|Lost to Follow-up|3|||
160537413|NCT00715026|579697105|FG000|Overall Study|Protocol Violation|1|||
160537414|NCT00715026|579697105|FG000|Overall Study|Surgery done on non-study consented hip|1|||
160537415|NCT00750737|579697113|FG000|Overall Study|Withdrawal by Subject|3|||
160537416|NCT00750737|579697114|FG001|Overall Study|Withdrawal by Subject|3|||
160537417|NCT00865904|579697123|FG000|Overall Study|Randomized but not Treated|2|||
160537418|NCT00865904|579697124|FG001|Overall Study|Randomized but not Treated|0|||
160537419|NCT00865904|579697125|FG002|Overall Study|Randomized but not Treated|0|||
160537420|NCT00865904|579697126|FG003|Overall Study|Randomized but not Treated|1|||
160537421|NCT00865904|579697127|FG004|Overall Study|Randomized but not Treated|1|||
160537422|NCT01543828|579697128|FG000|Treatment 2|Lost to Follow-up|1|||
160537423|NCT01543828|579697129|FG001|Treatment 2|Lost to Follow-up|0|||
160537424|NCT01069172|579697130|FG000|Overall Study|Withdrawal by Subject|1|||
160537425|NCT01069172|579697131|FG001|Overall Study|Withdrawal by Subject|0|||
160537426|NCT00711425|579697134|FG000|Overall Study|Protocol Violation|1|||
160537427|NCT00711425|579697134|FG000|Overall Study|Death|2|||
160537428|NCT00711425|579697134|FG000|Overall Study|Lost to Follow-up|1|||
160537429|NCT05879107|579697137|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
160875129|NCT00588861|580939051|FG001|10 Years|Incomplete due to study termination|114|||
160875130|NCT00490529|580939056|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
160875131|NCT00490529|580939056|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
160537430|NCT05879107|579697138|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
160537431|NCT05879107|579697137|FG000|Overall Study|Migrated / moved from the study area|1|||
160875132|NCT00490529|580939056|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
160875133|NCT00490529|580939056|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
160875134|NCT00490529|580939056|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
160875135|NCT00490529|580939056|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
160537432|NCT05879107|579697138|FG001|Overall Study|Migrated / moved from the study area|1|||
160537433|NCT05879107|579697137|FG000|Overall Study|Lost to Follow-up|8|||
160537434|NCT05879107|579697138|FG001|Overall Study|Lost to Follow-up|13|||
160537435|NCT05879107|579697137|FG000|Overall Study|Death|0|||
160537436|NCT05879107|579697138|FG001|Overall Study|Death|2|||
160537437|NCT05879107|579697137|FG000|Overall Study|Other|0|||
160537438|NCT05879107|579697138|FG001|Overall Study|Other|3|||
160537439|NCT03901079|579697139|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
160537440|NCT02184195|579697140|FG000|Overall Study|Patient decision|5|||
160537441|NCT02184195|579697141|FG001|Overall Study|Patient decision|2|||
160537442|NCT02184195|579697140|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160537443|NCT02184195|579697141|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160537444|NCT02184195|579697140|FG000|Overall Study|Death|67|||
160537445|NCT02184195|579697141|FG001|Overall Study|Death|44|||
160537446|NCT02184195|579697140|FG000|Overall Study|Lost to Follow-up|1|||
160537447|NCT02184195|579697141|FG001|Overall Study|Lost to Follow-up|5|||
160537448|NCT02184195|579697140|FG000|Overall Study|Other|0|||
160537449|NCT02184195|579697141|FG001|Overall Study|Other|3|||
160537450|NCT00916149|579697142|FG000|Overall Study|Lost to Follow-up|3|||
160537451|NCT00916149|579697143|FG001|Overall Study|Lost to Follow-up|2|||
160537452|NCT00916149|579697144|FG002|Overall Study|Lost to Follow-up|0|||
160537453|NCT00916149|579697142|FG000|Overall Study|Unable to place scalp EEG leads|1|||
160537454|NCT00916149|579697143|FG001|Overall Study|Unable to place scalp EEG leads|0|||
160537455|NCT00916149|579697144|FG002|Overall Study|Unable to place scalp EEG leads|0|||
160537456|NCT03002155|579697145|FG000|Overall Study|Lost to Follow-up|1|||
160537457|NCT03002155|579697146|FG001|Overall Study|Lost to Follow-up|2|||
160537458|NCT03002155|579697145|FG000|Overall Study|Withdrawal by Subject|1|||
160537459|NCT03002155|579697146|FG001|Overall Study|Withdrawal by Subject|0|||
160537460|NCT03002155|579697145|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
160537461|NCT03002155|579697146|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
160537462|NCT00545298|579697147|FG000|Overall Study|Issues with Standard of Care|2|||
160537463|NCT00545298|579697148|FG001|Overall Study|Issues with Standard of Care|0|||
160537464|NCT00545298|579697149|FG002|Overall Study|Issues with Standard of Care|1|||
160537465|NCT00978029|579697150|FG000|Overall Study|Adverse Event|1|||
160537466|NCT00978029|579697151|FG001|Overall Study|Adverse Event|2|||
160537467|NCT00978029|579697152|FG002|Overall Study|Adverse Event|5|||
160537468|NCT00978029|579697150|FG000|Overall Study|Withdrawal by Subject|0|||
160537469|NCT00978029|579697151|FG001|Overall Study|Withdrawal by Subject|0|||
160537470|NCT00978029|579697152|FG002|Overall Study|Withdrawal by Subject|1|||
160537471|NCT00978029|579697150|FG000|Overall Study|Protocol Violation|0|||
160875136|NCT02617485|580939069|FG000|Treatment and Observation Period|Adverse Event|9|||
160875137|NCT02617485|580939070|FG001|Treatment and Observation Period|Adverse Event|1|||
160875138|NCT02617485|580939069|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
160875139|NCT02617485|580939070|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
160875140|NCT02617485|580939069|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
160875141|NCT02617485|580939070|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
160875142|NCT02617485|580939069|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
160875143|NCT02617485|580939070|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
160875144|NCT02617485|580939069|FG000|Treatment and Observation Period|Physician Decision|0|||
160767548|NCT01232283|580537777|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160875145|NCT02617485|580939070|FG001|Treatment and Observation Period|Physician Decision|1|||
160875146|NCT02617485|580939069|FG000|Follow-up Period|Adverse Event|1|||
160875147|NCT02617485|580939070|FG001|Follow-up Period|Adverse Event|0|||
160875148|NCT02617485|580939069|FG000|Follow-up Period|Withdrawal by Subject|1|||
160875149|NCT02617485|580939070|FG001|Follow-up Period|Withdrawal by Subject|0|||
160875150|NCT02617485|580939069|FG000|Follow-up Period|Disease progression|2|||
160875151|NCT02617485|580939070|FG001|Follow-up Period|Disease progression|1|||
160875152|NCT02617485|580939069|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
160875153|NCT02617485|580939070|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
160875154|NCT02617485|580939069|FG000|Follow-up Period|Patient needed radiotherapy|9|||
160537472|NCT00978029|579697151|FG001|Overall Study|Protocol Violation|1|||
160537473|NCT00978029|579697152|FG002|Overall Study|Protocol Violation|0|||
160537474|NCT01820364|579697153|FG000|Part I: LGX818|Death|1|||
160537475|NCT01820364|579697154|FG001|Part I: LGX818|Death|0|||
160537476|NCT01820364|579697153|FG000|Part I: LGX818|Administrative Problems|3|||
160537477|NCT01820364|579697154|FG001|Part I: LGX818|Administrative Problems|0|||
160537478|NCT01820364|579697153|FG000|Part I: LGX818|Adverse Event|6|||
160537479|NCT01820364|579697154|FG001|Part I: LGX818|Adverse Event|0|||
160537480|NCT01820364|579697153|FG000|Part I: LGX818|Disease Progression|4|||
160537481|NCT01820364|579697154|FG001|Part I: LGX818|Disease Progression|0|||
160537482|NCT01820364|579697153|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
160537483|NCT01820364|579697154|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
160537484|NCT01087775|579697155|FG000|Overall Study|failed inclusion criteria|2|||
160537485|NCT00974675|579697158|FG000|Overall Study|Adverse Event|2|||
160537486|NCT00974675|579697159|FG001|Overall Study|Adverse Event|1|||
160537487|NCT00974675|579697160|FG002|Overall Study|Adverse Event|1|||
160537488|NCT00974675|579697161|FG003|Overall Study|Adverse Event|1|||
160537489|NCT00974675|579697158|FG000|Overall Study|Physician Decision|0|||
160767549|NCT01232283|580537778|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160767550|NCT01232283|580537779|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160767551|NCT01232283|580537780|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160767552|NCT01232283|580537781|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160767553|NCT01232283|580537772|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160767554|NCT01232283|580537773|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160767555|NCT01232283|580537774|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
160767556|NCT01232283|580537775|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
160767557|NCT01232283|580537776|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160767558|NCT01232283|580537777|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160767559|NCT01232283|580537778|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160767560|NCT01232283|580537779|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160767561|NCT01232283|580537780|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160767562|NCT01232283|580537781|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160767563|NCT01232283|580537772|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
160767564|NCT01232283|580537773|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
160767565|NCT01232283|580537774|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
160767566|NCT01232283|580537775|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
160767567|NCT01232283|580537776|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
160767568|NCT01232283|580537777|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
160767569|NCT01232283|580537778|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
160767570|NCT01232283|580537779|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
160767571|NCT01232283|580537780|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
160767572|NCT01232283|580537781|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
160767573|NCT01232283|580537772|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
160767574|NCT01232283|580537773|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
160767575|NCT01232283|580537774|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
160537490|NCT00974675|579697159|FG001|Overall Study|Physician Decision|0|||
160537491|NCT00974675|579697160|FG002|Overall Study|Physician Decision|1|||
160537492|NCT00974675|579697161|FG003|Overall Study|Physician Decision|0|||
160537493|NCT00974675|579697158|FG000|Overall Study|Participant on holiday; unable to attend|0|||
160537494|NCT00974675|579697159|FG001|Overall Study|Participant on holiday; unable to attend|0|||
160767576|NCT01232283|580537775|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
160537495|NCT00974675|579697160|FG002|Overall Study|Participant on holiday; unable to attend|0|||
160537496|NCT00974675|579697161|FG003|Overall Study|Participant on holiday; unable to attend|1|||
160537497|NCT04744207|579697163|FG000|Treatment|Withdrawal by Subject|2|||
160537498|NCT04744207|579697164|FG001|Treatment|Withdrawal by Subject|0|||
160537499|NCT04744207|579697163|FG000|Treatment|Adverse Event|1|||
160537500|NCT04744207|579697164|FG001|Treatment|Adverse Event|2|||
160537501|NCT02973087|579697173|FG000|Overall Study|Withdrawal by Subject|2|||
160537502|NCT02973087|579697174|FG001|Overall Study|Withdrawal by Subject|1|||
160537503|NCT02973087|579697173|FG000|Overall Study|Adverse Event|1|||
160537504|NCT02973087|579697174|FG001|Overall Study|Adverse Event|0|||
160537505|NCT02973087|579697173|FG000|Overall Study|other|1|||
160537506|NCT02973087|579697174|FG001|Overall Study|other|1|||
160537507|NCT03710486|579697175|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
160537508|NCT03710486|579697176|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
160537509|NCT03710486|579697175|FG000|Overall Study|Missing|0|||
160537510|NCT03710486|579697176|FG001|Overall Study|Missing|2|||
160537511|NCT01147744|579697181|FG000|Overall Study|Protocol Violation|1|||
160537512|NCT01147744|579697182|FG001|Overall Study|Protocol Violation|0|||
160537513|NCT01147744|579697183|FG002|Overall Study|Protocol Violation|1|||
160537514|NCT01147744|579697184|FG003|Overall Study|Protocol Violation|0|||
160537515|NCT01147744|579697185|FG004|Overall Study|Protocol Violation|1|||
160537516|NCT01147744|579697186|FG005|Overall Study|Protocol Violation|3|||
160537517|NCT01147744|579697187|FG006|Overall Study|Protocol Violation|1|||
160537518|NCT01147744|579697181|FG000|Overall Study|Physician Decision|0|||
160537519|NCT01147744|579697182|FG001|Overall Study|Physician Decision|1|||
160537520|NCT01147744|579697183|FG002|Overall Study|Physician Decision|1|||
160537521|NCT01147744|579697184|FG003|Overall Study|Physician Decision|0|||
160537522|NCT01147744|579697185|FG004|Overall Study|Physician Decision|0|||
160767577|NCT01232283|580537776|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
160767578|NCT01232283|580537777|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
160767579|NCT01232283|580537778|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
160767580|NCT01232283|580537779|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
160767581|NCT01232283|580537780|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
160767582|NCT01232283|580537781|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
160767583|NCT01232283|580537772|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
160767584|NCT01232283|580537773|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
160767585|NCT01232283|580537774|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
160767586|NCT01232283|580537775|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
160767587|NCT01232283|580537776|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
160767588|NCT01232283|580537777|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
160767589|NCT01232283|580537778|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
160767590|NCT01232283|580537779|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
160767591|NCT01232283|580537780|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
160767592|NCT01232283|580537781|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
160767593|NCT01232283|580537772|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
160767594|NCT01232283|580537773|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
160767595|NCT01232283|580537774|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
160767596|NCT01232283|580537775|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
160767597|NCT01232283|580537776|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
160767598|NCT01232283|580537777|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
160767599|NCT01232283|580537778|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
160767600|NCT01232283|580537779|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
160767601|NCT01232283|580537780|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
160767602|NCT01232283|580537781|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
160767603|NCT01232283|580537772|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
160767604|NCT01232283|580537773|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
160767605|NCT01232283|580537774|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
160767606|NCT01232283|580537775|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
160767607|NCT01232283|580537776|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
160767608|NCT01232283|580537777|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
160767609|NCT01232283|580537778|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
160767610|NCT01232283|580537779|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
160767611|NCT01232283|580537780|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
160537523|NCT01147744|579697186|FG005|Overall Study|Physician Decision|0|||
160636605|NCT05166512|580051582|FG001|Randomized|Withdrawal by Subject|0|||
160767612|NCT01232283|580537781|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
160767613|NCT01232283|580537772|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
160537524|NCT01147744|579697187|FG006|Overall Study|Physician Decision|1|||
160537525|NCT01147744|579697181|FG000|Overall Study|Lack of Efficacy|11|||
160537526|NCT01147744|579697182|FG001|Overall Study|Lack of Efficacy|11|||
160537527|NCT01147744|579697183|FG002|Overall Study|Lack of Efficacy|9|||
160875155|NCT02617485|580939070|FG001|Follow-up Period|Patient needed radiotherapy|5|||
160537528|NCT01147744|579697184|FG003|Overall Study|Lack of Efficacy|11|||
160537529|NCT01147744|579697185|FG004|Overall Study|Lack of Efficacy|13|||
160875156|NCT02617485|580939069|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
160537530|NCT01147744|579697186|FG005|Overall Study|Lack of Efficacy|8|||
160537531|NCT01147744|579697187|FG006|Overall Study|Lack of Efficacy|7|||
160537532|NCT01147744|579697181|FG000|Overall Study|Adverse Event|1|||
160537533|NCT01147744|579697182|FG001|Overall Study|Adverse Event|2|||
160537534|NCT01147744|579697183|FG002|Overall Study|Adverse Event|3|||
160537535|NCT01147744|579697184|FG003|Overall Study|Adverse Event|0|||
160537536|NCT01147744|579697185|FG004|Overall Study|Adverse Event|2|||
160537537|NCT01147744|579697186|FG005|Overall Study|Adverse Event|1|||
160537538|NCT01147744|579697187|FG006|Overall Study|Adverse Event|2|||
160537539|NCT01147744|579697181|FG000|Overall Study|Withdrawal by Subject|8|||
160537540|NCT01147744|579697182|FG001|Overall Study|Withdrawal by Subject|4|||
160537541|NCT01147744|579697183|FG002|Overall Study|Withdrawal by Subject|2|||
160537542|NCT01147744|579697184|FG003|Overall Study|Withdrawal by Subject|2|||
160537543|NCT01147744|579697185|FG004|Overall Study|Withdrawal by Subject|2|||
160537544|NCT01147744|579697186|FG005|Overall Study|Withdrawal by Subject|5|||
160537545|NCT01147744|579697187|FG006|Overall Study|Withdrawal by Subject|2|||
160537546|NCT01147744|579697181|FG000|Overall Study|Lost to Follow-up|0|||
160537547|NCT01147744|579697182|FG001|Overall Study|Lost to Follow-up|1|||
160537548|NCT01147744|579697183|FG002|Overall Study|Lost to Follow-up|0|||
160537549|NCT01147744|579697184|FG003|Overall Study|Lost to Follow-up|0|||
160537550|NCT01147744|579697185|FG004|Overall Study|Lost to Follow-up|0|||
160537551|NCT01147744|579697186|FG005|Overall Study|Lost to Follow-up|0|||
160537552|NCT01147744|579697187|FG006|Overall Study|Lost to Follow-up|0|||
160537553|NCT01147744|579697181|FG000|Overall Study|Sponsor decision to amend protocol|7|||
160537554|NCT01147744|579697182|FG001|Overall Study|Sponsor decision to amend protocol|4|||
160537555|NCT01147744|579697183|FG002|Overall Study|Sponsor decision to amend protocol|2|||
160537556|NCT01147744|579697184|FG003|Overall Study|Sponsor decision to amend protocol|5|||
160875157|NCT02617485|580939070|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
160875158|NCT00791076|580939071|FG000|Overall Study|Study was terminated,PI left institution|8|||
160875159|NCT00669409|580939072|FG000|Part 2|Withdrawal by Subject|0|||
160875160|NCT00669409|580939073|FG001|Part 2|Withdrawal by Subject|0|||
160875161|NCT00669409|580939074|FG002|Part 2|Withdrawal by Subject|0|||
160875162|NCT00669409|580939075|FG003|Part 2|Withdrawal by Subject|0|||
160875163|NCT00669409|580939076|FG004|Part 2|Withdrawal by Subject|0|||
160537557|NCT01147744|579697185|FG004|Overall Study|Sponsor decision to amend protocol|7|||
160537558|NCT01147744|579697186|FG005|Overall Study|Sponsor decision to amend protocol|2|||
160537559|NCT01147744|579697187|FG006|Overall Study|Sponsor decision to amend protocol|6|||
160537560|NCT01147744|579697181|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
160537561|NCT01147744|579697182|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
160537562|NCT01147744|579697183|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
160537563|NCT01147744|579697184|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
160537564|NCT01147744|579697185|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
160537565|NCT01147744|579697186|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
160537566|NCT01147744|579697187|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
160537567|NCT02090413|579697189|FG000|Overall Study|Adverse Event|11|||
160537568|NCT02090413|579697190|FG001|Overall Study|Adverse Event|15|||
160537569|NCT02090413|579697191|FG002|Overall Study|Adverse Event|20|||
160537570|NCT02090413|579697189|FG000|Overall Study|Flushing event|2|||
160537571|NCT02090413|579697190|FG001|Overall Study|Flushing event|0|||
160537572|NCT02090413|579697191|FG002|Overall Study|Flushing event|1|||
160537573|NCT02090413|579697189|FG000|Overall Study|Withdrawal by Subject|2|||
160537574|NCT02090413|579697190|FG001|Overall Study|Withdrawal by Subject|2|||
160537575|NCT02090413|579697191|FG002|Overall Study|Withdrawal by Subject|2|||
160537576|NCT02090413|579697189|FG000|Overall Study|Investigator Decision|1|||
160537577|NCT02090413|579697190|FG001|Overall Study|Investigator Decision|1|||
160537578|NCT02090413|579697191|FG002|Overall Study|Investigator Decision|0|||
160537579|NCT02090413|579697189|FG000|Overall Study|Other|2|||
160875164|NCT00669409|580939077|FG005|Part 2|Withdrawal by Subject|0|||
160875165|NCT00669409|580939078|FG006|Part 2|Withdrawal by Subject|0|||
160875166|NCT00669409|580939079|FG007|Part 2|Withdrawal by Subject|0|||
160537580|NCT02090413|579697190|FG001|Overall Study|Other|1|||
160537581|NCT02090413|579697191|FG002|Overall Study|Other|0|||
160636606|NCT05166512|580051581|FG000|Baseline Data Collection|Lost to Follow-up|0|||
160875167|NCT00669409|580939080|FG008|Part 2|Withdrawal by Subject|0|||
160537582|NCT02090413|579697189|FG000|Overall Study|Lost to Follow-up|1|||
160537583|NCT02090413|579697190|FG001|Overall Study|Lost to Follow-up|1|||
160537584|NCT02090413|579697191|FG002|Overall Study|Lost to Follow-up|0|||
160537585|NCT05248295|579697192|FG000|Overall Study|found ineligible|4|||
160537586|NCT05248295|579697193|FG001|Overall Study|found ineligible|1|||
160537587|NCT05248295|579697192|FG000|Overall Study|Withdrawal by Subject|0|||
160537588|NCT05248295|579697193|FG001|Overall Study|Withdrawal by Subject|1|||
160537589|NCT05248295|579697192|FG000|Overall Study|Data loss: audio recording error|1|||
160537590|NCT05248295|579697193|FG001|Overall Study|Data loss: audio recording error|1|||
160767614|NCT01232283|580537773|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
160537591|NCT04490018|579697194|FG000|Overall Study|Protocol Violation|0|||
160767615|NCT01232283|580537774|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
160767616|NCT01232283|580537775|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
160767617|NCT01232283|580537776|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
160767618|NCT01232283|580537777|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
160767619|NCT01232283|580537778|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
160767620|NCT01232283|580537779|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
160767621|NCT01232283|580537780|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
160767622|NCT01232283|580537781|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
160767623|NCT01232283|580537772|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
160767624|NCT01232283|580537773|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
160767625|NCT01232283|580537774|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
160767626|NCT01232283|580537775|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
160767627|NCT01232283|580537776|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
160767628|NCT01232283|580537777|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
160767629|NCT01232283|580537778|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
160767630|NCT01232283|580537779|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
160767631|NCT01232283|580537780|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
160767632|NCT01232283|580537781|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
160767633|NCT01232283|580537772|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
160875168|NCT00669409|580939081|FG009|Part 2|Withdrawal by Subject|1|||
160537592|NCT04490018|579697195|FG001|Overall Study|Protocol Violation|2|||
160537593|NCT04490018|579697196|FG002|Overall Study|Protocol Violation|1|||
160537594|NCT04490018|579697194|FG000|Overall Study|Lost to Follow-up|2|||
160537595|NCT04490018|579697195|FG001|Overall Study|Lost to Follow-up|2|||
160537596|NCT04490018|579697196|FG002|Overall Study|Lost to Follow-up|0|||
160875169|NCT00669409|580939082|FG010|Part 2|Withdrawal by Subject|0|||
160875170|NCT00095940|580939085|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
160875171|NCT00095940|580939086|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
160875172|NCT00095940|580939087|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
160875173|NCT00095940|580939088|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
160875174|NCT00095940|580939089|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
160875175|NCT00095940|580939090|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
160875176|NCT00095940|580939091|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
160875177|NCT00095940|580939092|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
160875178|NCT00095940|580939093|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
160875179|NCT00095940|580939085|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
160875180|NCT00095940|580939086|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
160875181|NCT00095940|580939087|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
160875182|NCT00095940|580939088|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
160875183|NCT00095940|580939089|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
160875184|NCT00095940|580939090|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
160875185|NCT00095940|580939091|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
160875186|NCT00095940|580939092|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
160875187|NCT00095940|580939093|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
160875188|NCT00095940|580939085|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875189|NCT00095940|580939086|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
160537597|NCT04490018|579697194|FG000|Overall Study|Withdrawal by Subject|2|||
160537598|NCT04490018|579697195|FG001|Overall Study|Withdrawal by Subject|1|||
160767634|NCT01232283|580537773|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
160767635|NCT01232283|580537774|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
160767636|NCT01232283|580537775|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
160767637|NCT01232283|580537776|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
160767638|NCT01232283|580537777|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
160767639|NCT01232283|580537778|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
160767640|NCT01232283|580537779|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
160767641|NCT01232283|580537780|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
160767642|NCT01232283|580537781|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
160767643|NCT01232283|580537772|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
160875190|NCT00095940|580939087|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875191|NCT00095940|580939088|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875192|NCT00095940|580939089|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875193|NCT00095940|580939090|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875194|NCT00095940|580939091|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875195|NCT00095940|580939092|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
160875196|NCT00095940|580939093|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875197|NCT01716052|580939094|FG000|Overall Study|Withdrawal of funding|1|||
160875198|NCT01716052|580939095|FG001|Overall Study|Withdrawal of funding|1|||
160875199|NCT02864862|580939101|FG000|Overall Study|Lost to Follow-up|1|||
160875200|NCT02864862|580939102|FG001|Overall Study|Lost to Follow-up|0|||
160875201|NCT02864862|580939103|FG002|Overall Study|Lost to Follow-up|1|||
160875202|NCT02864862|580939101|FG000|Overall Study|Protocol Violation|0|||
160875203|NCT02864862|580939102|FG001|Overall Study|Protocol Violation|0|||
160875204|NCT02864862|580939103|FG002|Overall Study|Protocol Violation|1|||
160875205|NCT01523275|580939107|FG000|Overall Study|Lost to Follow-up|1|||
160875206|NCT01523275|580939108|FG001|Overall Study|Lost to Follow-up|2|||
160875207|NCT01523275|580939107|FG000|Overall Study|Withdrawal by Subject|1|||
160875208|NCT01523275|580939108|FG001|Overall Study|Withdrawal by Subject|0|||
160875209|NCT03263702|580939109|FG000|Overall Study|Lost to Follow-up|2|||
160875210|NCT03263702|580939110|FG001|Overall Study|Lost to Follow-up|2|||
160875211|NCT03263702|580939109|FG000|Overall Study|Withdrawal by Subject|1|||
160875212|NCT03263702|580939110|FG001|Overall Study|Withdrawal by Subject|2|||
160875213|NCT03598114|580939111|FG000|Overall Study|Staff turnover/left the program|3|||
160875214|NCT03598114|580939112|FG001|Overall Study|Staff turnover/left the program|39|||
160875215|NCT02527200|580939113|FG000|Overall Study|Withdrawal by Subject|3|||
160875216|NCT02527200|580939114|FG001|Overall Study|Withdrawal by Subject|2|||
160875217|NCT02527200|580939115|FG002|Overall Study|Withdrawal by Subject|1|||
160875218|NCT02527200|580939116|FG003|Overall Study|Withdrawal by Subject|0|||
160875219|NCT02527200|580939113|FG000|Overall Study|Unclassified|0|||
160875220|NCT02527200|580939114|FG001|Overall Study|Unclassified|1|||
160875221|NCT02527200|580939115|FG002|Overall Study|Unclassified|0|||
160875222|NCT02527200|580939116|FG003|Overall Study|Unclassified|0|||
160875223|NCT02527200|580939113|FG000|Overall Study|Lost to Follow-up|0|||
160875224|NCT02527200|580939114|FG001|Overall Study|Lost to Follow-up|0|||
160875225|NCT02527200|580939115|FG002|Overall Study|Lost to Follow-up|1|||
160875226|NCT02527200|580939116|FG003|Overall Study|Lost to Follow-up|0|||
160875227|NCT00966875|580939117|FG000|Part A|Adverse Event|2|||
160875228|NCT00966875|580939118|FG001|Part A|Adverse Event|1|||
160875229|NCT00966875|580939119|FG002|Part A|Adverse Event|0|||
160875230|NCT00966875|580939120|FG003|Part A|Adverse Event|1|||
160875231|NCT00966875|580939121|FG004|Part A|Adverse Event|0|||
160875232|NCT00966875|580939122|FG005|Part A|Adverse Event|1|||
160875233|NCT00966875|580939123|FG006|Part A|Adverse Event|0|||
160537599|NCT04490018|579697196|FG002|Overall Study|Withdrawal by Subject|0|||
160767644|NCT01232283|580537773|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
160767645|NCT01232283|580537774|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
160767646|NCT01232283|580537775|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
160767647|NCT01232283|580537776|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
160767648|NCT01232283|580537777|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
160767649|NCT01232283|580537778|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
160767650|NCT01232283|580537779|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
160767651|NCT01232283|580537780|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
160767652|NCT01232283|580537781|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
160767653|NCT01232283|580537772|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
160767654|NCT01232283|580537773|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
160767655|NCT01232283|580537774|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
160767656|NCT01232283|580537775|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
160767657|NCT01232283|580537776|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
160767658|NCT01232283|580537777|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
160767659|NCT01232283|580537778|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
160767660|NCT01232283|580537779|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
160767661|NCT01232283|580537780|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
160767662|NCT01232283|580537781|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
160767663|NCT01232283|580537772|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
160767664|NCT01232283|580537773|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
160767665|NCT01232283|580537774|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
160767666|NCT01232283|580537775|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
160767667|NCT01232283|580537776|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
160875234|NCT00966875|580939124|FG007|Part A|Adverse Event|3|||
160875235|NCT00966875|580939125|FG008|Part A|Adverse Event|3|||
160875236|NCT00966875|580939117|FG000|Part A|Entry Criteria|0|||
160875237|NCT00966875|580939118|FG001|Part A|Entry Criteria|0|||
160875238|NCT00966875|580939119|FG002|Part A|Entry Criteria|0|||
160875239|NCT00966875|580939120|FG003|Part A|Entry Criteria|0|||
160537600|NCT04490018|579697194|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160537601|NCT04490018|579697195|FG001|Overall Study|Withdrawal by parent/guardian|3|||
160537602|NCT04490018|579697196|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160537603|NCT02321930|579697197|FG000|Overall Study|Lost to Follow-up|1|||
160537604|NCT04857996|579697198|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
160537605|NCT04857996|579697199|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
160537606|NCT04857996|579697198|FG000|Overall Study|Lost to Follow-up|1|||
160537607|NCT04857996|579697199|FG001|Overall Study|Lost to Follow-up|3|||
160537608|NCT04857996|579697198|FG000|Overall Study|Site Closure|1|||
160537609|NCT04857996|579697199|FG001|Overall Study|Site Closure|0|||
160537610|NCT04857996|579697198|FG000|Overall Study|Withdrawal by Subject|1|||
160537611|NCT04857996|579697199|FG001|Overall Study|Withdrawal by Subject|0|||
160537612|NCT02988661|579697200|FG000|Overall Study|Death|2|||
160537613|NCT02988661|579697201|FG001|Overall Study|Death|18|||
160537614|NCT02988661|579697200|FG000|Overall Study|Lost to Follow-up|0|||
160537615|NCT02988661|579697201|FG001|Overall Study|Lost to Follow-up|33|||
160537616|NCT02988661|579697200|FG000|Overall Study|Withdrawal by Subject|0|||
160537617|NCT02988661|579697201|FG001|Overall Study|Withdrawal by Subject|6|||
160537618|NCT02988661|579697200|FG000|Overall Study|Unable to complete the 18-month survey|1|||
160537619|NCT02988661|579697201|FG001|Overall Study|Unable to complete the 18-month survey|27|||
160537620|NCT02325219|579698886|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
160537621|NCT02325219|579698887|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
160537622|NCT02325219|579698888|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
160537623|NCT02325219|579698889|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
160537624|NCT02325219|579698890|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
160537625|NCT02325219|579698886|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
160537626|NCT02325219|579698887|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
160537627|NCT02325219|579698888|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
160537628|NCT02325219|579698889|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
160537629|NCT02325219|579698890|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
160537630|NCT02325219|579698886|FG000|Controlled Period (Week 0 - 16)|Other|0|||
160537631|NCT02325219|579698887|FG001|Controlled Period (Week 0 - 16)|Other|0|||
160537632|NCT02325219|579698888|FG002|Controlled Period (Week 0 - 16)|Other|1|||
160537633|NCT02325219|579698889|FG003|Controlled Period (Week 0 - 16)|Other|0|||
160537634|NCT02325219|579698890|FG004|Controlled Period (Week 0 - 16)|Other|0|||
160537635|NCT02325219|579698886|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
160537636|NCT02325219|579698887|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
160537637|NCT02325219|579698888|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
160537638|NCT02325219|579698889|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
160537639|NCT02325219|579698890|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
160537640|NCT02325219|579698886|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
160537641|NCT02325219|579698887|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
160537642|NCT02325219|579698888|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
160767668|NCT01232283|580537777|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
160767669|NCT01232283|580537778|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
160767670|NCT01232283|580537779|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
160767671|NCT01232283|580537780|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
160767672|NCT01232283|580537781|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
160767673|NCT01232283|580537772|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
160767674|NCT01232283|580537773|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
160767675|NCT01232283|580537774|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
160767676|NCT01232283|580537775|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
160767677|NCT01232283|580537776|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
160767678|NCT01232283|580537777|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
160767679|NCT01232283|580537778|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
160767680|NCT01232283|580537779|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
160767681|NCT01232283|580537780|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
160767682|NCT01232283|580537781|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
160767683|NCT01232283|580537772|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
160767684|NCT01232283|580537773|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
160767685|NCT01232283|580537774|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
160767686|NCT01232283|580537775|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
160767687|NCT01232283|580537776|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
160767688|NCT01232283|580537777|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
160537643|NCT02325219|579698889|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
160537644|NCT02325219|579698890|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
160537645|NCT02325219|579698886|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
160875240|NCT00966875|580939121|FG004|Part A|Entry Criteria|0|||
160875241|NCT00966875|580939122|FG005|Part A|Entry Criteria|2|||
160875242|NCT00966875|580939123|FG006|Part A|Entry Criteria|0|||
160875243|NCT00966875|580939124|FG007|Part A|Entry Criteria|0|||
160875244|NCT00966875|580939125|FG008|Part A|Entry Criteria|0|||
160875245|NCT00966875|580939117|FG000|Part A|Lack of Efficacy|0|||
160875246|NCT00966875|580939118|FG001|Part A|Lack of Efficacy|1|||
160875247|NCT00966875|580939119|FG002|Part A|Lack of Efficacy|0|||
160875248|NCT00966875|580939120|FG003|Part A|Lack of Efficacy|0|||
160875249|NCT00966875|580939121|FG004|Part A|Lack of Efficacy|0|||
160875250|NCT00966875|580939122|FG005|Part A|Lack of Efficacy|0|||
160875251|NCT00966875|580939123|FG006|Part A|Lack of Efficacy|4|||
160875252|NCT00966875|580939124|FG007|Part A|Lack of Efficacy|0|||
160875253|NCT00966875|580939125|FG008|Part A|Lack of Efficacy|0|||
160875254|NCT00966875|580939117|FG000|Part A|Lost to Follow-up|2|||
160875255|NCT00966875|580939118|FG001|Part A|Lost to Follow-up|0|||
160875256|NCT00966875|580939119|FG002|Part A|Lost to Follow-up|0|||
160875257|NCT00966875|580939120|FG003|Part A|Lost to Follow-up|0|||
160875258|NCT00966875|580939121|FG004|Part A|Lost to Follow-up|0|||
160875259|NCT00966875|580939122|FG005|Part A|Lost to Follow-up|1|||
160875260|NCT00966875|580939123|FG006|Part A|Lost to Follow-up|0|||
160875261|NCT00966875|580939124|FG007|Part A|Lost to Follow-up|0|||
160875262|NCT00966875|580939125|FG008|Part A|Lost to Follow-up|0|||
160875263|NCT00966875|580939117|FG000|Part A|Parent/Caregiver Decision|0|||
160875264|NCT00966875|580939118|FG001|Part A|Parent/Caregiver Decision|0|||
160875265|NCT00966875|580939119|FG002|Part A|Parent/Caregiver Decision|0|||
160875266|NCT00966875|580939120|FG003|Part A|Parent/Caregiver Decision|1|||
160875267|NCT00966875|580939121|FG004|Part A|Parent/Caregiver Decision|0|||
160875268|NCT00966875|580939122|FG005|Part A|Parent/Caregiver Decision|0|||
160875269|NCT00966875|580939123|FG006|Part A|Parent/Caregiver Decision|0|||
160875270|NCT00966875|580939124|FG007|Part A|Parent/Caregiver Decision|0|||
160875271|NCT00966875|580939125|FG008|Part A|Parent/Caregiver Decision|0|||
160875272|NCT00966875|580939117|FG000|Part A|Physician Decision|0|||
160875273|NCT00966875|580939118|FG001|Part A|Physician Decision|0|||
160875274|NCT00966875|580939119|FG002|Part A|Physician Decision|0|||
160875275|NCT00966875|580939120|FG003|Part A|Physician Decision|0|||
160875276|NCT00966875|580939121|FG004|Part A|Physician Decision|1|||
160875277|NCT00966875|580939122|FG005|Part A|Physician Decision|0|||
160875278|NCT00966875|580939123|FG006|Part A|Physician Decision|1|||
160875279|NCT00966875|580939124|FG007|Part A|Physician Decision|0|||
160875280|NCT00966875|580939125|FG008|Part A|Physician Decision|2|||
160875281|NCT00966875|580939117|FG000|Part A|Sponsor Decision|0|||
160875282|NCT00966875|580939118|FG001|Part A|Sponsor Decision|0|||
160875283|NCT00966875|580939119|FG002|Part A|Sponsor Decision|1|||
160875284|NCT00966875|580939120|FG003|Part A|Sponsor Decision|0|||
160875285|NCT00966875|580939121|FG004|Part A|Sponsor Decision|1|||
160875286|NCT00966875|580939122|FG005|Part A|Sponsor Decision|0|||
160875287|NCT00966875|580939123|FG006|Part A|Sponsor Decision|0|||
160875288|NCT00966875|580939124|FG007|Part A|Sponsor Decision|2|||
160875289|NCT00966875|580939125|FG008|Part A|Sponsor Decision|1|||
160875290|NCT00966875|580939117|FG000|Part A|Withdrawal by Subject|2|||
160875291|NCT00966875|580939118|FG001|Part A|Withdrawal by Subject|2|||
160875292|NCT00966875|580939119|FG002|Part A|Withdrawal by Subject|1|||
160875293|NCT00966875|580939120|FG003|Part A|Withdrawal by Subject|1|||
160875294|NCT00966875|580939121|FG004|Part A|Withdrawal by Subject|3|||
160875295|NCT00966875|580939122|FG005|Part A|Withdrawal by Subject|0|||
160875296|NCT00966875|580939123|FG006|Part A|Withdrawal by Subject|5|||
160875297|NCT00966875|580939124|FG007|Part A|Withdrawal by Subject|1|||
160875298|NCT00966875|580939125|FG008|Part A|Withdrawal by Subject|1|||
160875299|NCT00966875|580939117|FG000|Part A|Protocol Violation|0|||
160875300|NCT00966875|580939118|FG001|Part A|Protocol Violation|0|||
160875301|NCT00966875|580939119|FG002|Part A|Protocol Violation|0|||
160875302|NCT00966875|580939120|FG003|Part A|Protocol Violation|0|||
160875303|NCT00966875|580939121|FG004|Part A|Protocol Violation|0|||
160875304|NCT00966875|580939122|FG005|Part A|Protocol Violation|0|||
160875305|NCT00966875|580939123|FG006|Part A|Protocol Violation|2|||
160875306|NCT00966875|580939124|FG007|Part A|Protocol Violation|1|||
160875307|NCT00966875|580939125|FG008|Part A|Protocol Violation|1|||
160875308|NCT00966875|580939117|FG000|Part B|Adverse Event|0|||
160875309|NCT00966875|580939118|FG001|Part B|Adverse Event|1|||
160875310|NCT00966875|580939119|FG002|Part B|Adverse Event|1|||
160875311|NCT00966875|580939120|FG003|Part B|Adverse Event|0|||
160875312|NCT00966875|580939121|FG004|Part B|Adverse Event|1|||
160875313|NCT00966875|580939122|FG005|Part B|Adverse Event|0|||
160875314|NCT00966875|580939123|FG006|Part B|Adverse Event|5|||
160875315|NCT00966875|580939124|FG007|Part B|Adverse Event|2|||
160875316|NCT00966875|580939125|FG008|Part B|Adverse Event|2|||
160875317|NCT00966875|580939117|FG000|Part B|Death|0|||
160875318|NCT00966875|580939118|FG001|Part B|Death|0|||
160875319|NCT00966875|580939119|FG002|Part B|Death|1|||
160875320|NCT00966875|580939120|FG003|Part B|Death|0|||
160875321|NCT00966875|580939121|FG004|Part B|Death|0|||
160875322|NCT00966875|580939122|FG005|Part B|Death|0|||
160875323|NCT00966875|580939123|FG006|Part B|Death|0|||
160875324|NCT00966875|580939124|FG007|Part B|Death|1|||
160875325|NCT00966875|580939125|FG008|Part B|Death|0|||
160875326|NCT00966875|580939117|FG000|Part B|Lack of Efficacy|2|||
160875327|NCT00966875|580939118|FG001|Part B|Lack of Efficacy|1|||
160875328|NCT00966875|580939119|FG002|Part B|Lack of Efficacy|1|||
160875329|NCT00966875|580939120|FG003|Part B|Lack of Efficacy|1|||
160875330|NCT00966875|580939121|FG004|Part B|Lack of Efficacy|2|||
160875331|NCT00966875|580939122|FG005|Part B|Lack of Efficacy|3|||
160875332|NCT00966875|580939123|FG006|Part B|Lack of Efficacy|12|||
160875333|NCT00966875|580939124|FG007|Part B|Lack of Efficacy|9|||
160875334|NCT00966875|580939125|FG008|Part B|Lack of Efficacy|6|||
160875335|NCT00966875|580939117|FG000|Part B|Lost to Follow-up|0|||
160875336|NCT00966875|580939118|FG001|Part B|Lost to Follow-up|0|||
160875337|NCT00966875|580939119|FG002|Part B|Lost to Follow-up|0|||
160875338|NCT00966875|580939120|FG003|Part B|Lost to Follow-up|1|||
160875339|NCT00966875|580939121|FG004|Part B|Lost to Follow-up|0|||
160875340|NCT00966875|580939122|FG005|Part B|Lost to Follow-up|0|||
160875341|NCT00966875|580939123|FG006|Part B|Lost to Follow-up|0|||
160875342|NCT00966875|580939124|FG007|Part B|Lost to Follow-up|0|||
160875343|NCT00966875|580939125|FG008|Part B|Lost to Follow-up|1|||
160875344|NCT00966875|580939117|FG000|Part B|Physician Decision|0|||
160875345|NCT00966875|580939118|FG001|Part B|Physician Decision|0|||
160875346|NCT00966875|580939119|FG002|Part B|Physician Decision|1|||
160875347|NCT00966875|580939120|FG003|Part B|Physician Decision|0|||
160875348|NCT00966875|580939121|FG004|Part B|Physician Decision|2|||
160875349|NCT00966875|580939122|FG005|Part B|Physician Decision|1|||
160875350|NCT00966875|580939123|FG006|Part B|Physician Decision|0|||
160875351|NCT00966875|580939124|FG007|Part B|Physician Decision|0|||
160537646|NCT02325219|579698887|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
160767689|NCT01232283|580537778|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
160767690|NCT01232283|580537779|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
160767691|NCT01232283|580537780|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
160537647|NCT02325219|579698888|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
160767692|NCT01232283|580537781|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
160767693|NCT01232283|580537772|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
160767694|NCT01232283|580537773|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
160767695|NCT01232283|580537774|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
160767696|NCT01232283|580537775|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
160767697|NCT01232283|580537776|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
160767698|NCT01232283|580537777|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
160767699|NCT01232283|580537778|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
160767700|NCT01232283|580537779|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
160767701|NCT01232283|580537780|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
160767702|NCT01232283|580537781|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
160767703|NCT01232283|580537772|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
160767704|NCT01232283|580537773|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
160767705|NCT01232283|580537774|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
160767706|NCT01232283|580537775|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
160767707|NCT01232283|580537776|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
160767708|NCT01232283|580537777|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
160767709|NCT01232283|580537778|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
160875352|NCT00966875|580939125|FG008|Part B|Physician Decision|2|||
160875353|NCT00966875|580939117|FG000|Part B|Sponsor Decision|1|||
160537648|NCT02325219|579698889|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
160537649|NCT02325219|579698890|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
160537650|NCT04766021|579698891|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
160537651|NCT04766021|579698891|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
160537652|NCT02257372|579698892|FG000|Overall Study|Adverse Event|3|||
160537653|NCT02257372|579698893|FG001|Overall Study|Adverse Event|7|||
160537654|NCT02257372|579698892|FG000|Overall Study|Lack of Efficacy|2|||
160537655|NCT02257372|579698893|FG001|Overall Study|Lack of Efficacy|1|||
160537656|NCT02257372|579698892|FG000|Overall Study|Protocol Violation|1|||
160537657|NCT02257372|579698893|FG001|Overall Study|Protocol Violation|1|||
160537658|NCT02257372|579698892|FG000|Overall Study|Lost to Follow-up|0|||
160537659|NCT02257372|579698893|FG001|Overall Study|Lost to Follow-up|1|||
160537660|NCT02257372|579698892|FG000|Overall Study|Withdrew consent|1|||
160537661|NCT02257372|579698893|FG001|Overall Study|Withdrew consent|0|||
160537662|NCT02634151|579698894|FG000|Overall Study|Withdrawal by Subject|1|||
160537663|NCT02634151|579698895|FG001|Overall Study|Withdrawal by Subject|0|||
160537664|NCT02634151|579698894|FG000|Overall Study|Non-Compliance|0|||
160537665|NCT02634151|579698895|FG001|Overall Study|Non-Compliance|1|||
160537666|NCT02634151|579698894|FG000|Overall Study|Other|0|||
160537667|NCT02634151|579698895|FG001|Overall Study|Other|1|||
160537668|NCT00003535|579698897|FG000|Overall Study|Not evaluable|5|||
160537669|NCT03709654|579698902|FG000|Overall Study|Lost to Follow-up|1|||
160537670|NCT03709654|579698903|FG001|Overall Study|Lost to Follow-up|1|||
160537671|NCT03709654|579698902|FG000|Overall Study|Withdrawal by Subject|1|||
160537672|NCT03709654|579698903|FG001|Overall Study|Withdrawal by Subject|1|||
160537673|NCT03709654|579698902|FG000|Overall Study|Adverse Event|1|||
160537674|NCT03709654|579698903|FG001|Overall Study|Adverse Event|0|||
160537675|NCT00530894|579698909|FG000|Overall Study|Death|84|||
160537676|NCT00530894|579698910|FG001|Overall Study|Death|89|||
160537677|NCT00530894|579698911|FG002|Overall Study|Death|55|||
160537678|NCT00530894|579698912|FG003|Overall Study|Death|89|||
160537679|NCT00530894|579698909|FG000|Overall Study|Lost to Follow-up|1|||
160537680|NCT00530894|579698910|FG001|Overall Study|Lost to Follow-up|3|||
160537681|NCT00530894|579698911|FG002|Overall Study|Lost to Follow-up|0|||
160537682|NCT00530894|579698912|FG003|Overall Study|Lost to Follow-up|0|||
160537683|NCT00530894|579698909|FG000|Overall Study|Withdrawal by Subject|1|||
160537684|NCT00530894|579698910|FG001|Overall Study|Withdrawal by Subject|23|||
160537685|NCT00530894|579698911|FG002|Overall Study|Withdrawal by Subject|0|||
160537686|NCT00530894|579698912|FG003|Overall Study|Withdrawal by Subject|5|||
160537687|NCT00530894|579698909|FG000|Overall Study|Alive and censored prior to 1 year|2|||
160537688|NCT00530894|579698910|FG001|Overall Study|Alive and censored prior to 1 year|0|||
160537689|NCT00530894|579698911|FG002|Overall Study|Alive and censored prior to 1 year|0|||
160537690|NCT00530894|579698912|FG003|Overall Study|Alive and censored prior to 1 year|0|||
160537691|NCT01230242|579698913|FG000|Overall Study|Physician Decision|2|||
160537692|NCT01230242|579698913|FG000|Overall Study|Withdrawal by Subject|1|||
160537693|NCT02256540|579698914|FG000|Overall Study|Withdrawal by Subject|0|||
160537694|NCT02256540|579698915|FG001|Overall Study|Withdrawal by Subject|1|||
160537695|NCT02256540|579698916|FG002|Overall Study|Withdrawal by Subject|1|||
160875354|NCT00966875|580939118|FG001|Part B|Sponsor Decision|0|||
160875355|NCT00966875|580939119|FG002|Part B|Sponsor Decision|0|||
160875356|NCT00966875|580939120|FG003|Part B|Sponsor Decision|0|||
160875357|NCT00966875|580939121|FG004|Part B|Sponsor Decision|0|||
160875358|NCT00966875|580939122|FG005|Part B|Sponsor Decision|1|||
160875359|NCT00966875|580939123|FG006|Part B|Sponsor Decision|0|||
160875360|NCT00966875|580939124|FG007|Part B|Sponsor Decision|2|||
160875361|NCT00966875|580939125|FG008|Part B|Sponsor Decision|1|||
160875362|NCT00966875|580939117|FG000|Part B|Withdrawal by Subject|2|||
160875363|NCT00966875|580939118|FG001|Part B|Withdrawal by Subject|1|||
160875364|NCT00966875|580939119|FG002|Part B|Withdrawal by Subject|2|||
160767710|NCT01232283|580537779|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
160767711|NCT01232283|580537780|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
160767712|NCT01232283|580537781|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
160767713|NCT01232283|580537772|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
160767714|NCT01232283|580537773|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
160767715|NCT01232283|580537774|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
160767716|NCT01232283|580537775|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
160875365|NCT00966875|580939120|FG003|Part B|Withdrawal by Subject|1|||
160875366|NCT00966875|580939121|FG004|Part B|Withdrawal by Subject|2|||
160875367|NCT00966875|580939122|FG005|Part B|Withdrawal by Subject|1|||
160875368|NCT00966875|580939123|FG006|Part B|Withdrawal by Subject|4|||
160875369|NCT00966875|580939124|FG007|Part B|Withdrawal by Subject|5|||
160875370|NCT00966875|580939125|FG008|Part B|Withdrawal by Subject|5|||
160875371|NCT00966875|580939117|FG000|Part B|Entry Criteria|0|||
160875372|NCT00966875|580939118|FG001|Part B|Entry Criteria|0|||
160875373|NCT00966875|580939119|FG002|Part B|Entry Criteria|0|||
160875374|NCT00966875|580939120|FG003|Part B|Entry Criteria|0|||
160875375|NCT00966875|580939121|FG004|Part B|Entry Criteria|0|||
160875376|NCT00966875|580939122|FG005|Part B|Entry Criteria|0|||
160875377|NCT00966875|580939123|FG006|Part B|Entry Criteria|1|||
160875378|NCT00966875|580939124|FG007|Part B|Entry Criteria|0|||
160875379|NCT00966875|580939125|FG008|Part B|Entry Criteria|1|||
160875380|NCT00444678|580939126|FG000|Overall Study|Toxicity|11|||
160875381|NCT00444678|580939126|FG000|Overall Study|Disease Progression|12|||
160875382|NCT00444678|580939126|FG000|Overall Study|Death|3|||
160875383|NCT00444678|580939126|FG000|Overall Study|Physician Decision|3|||
160875384|NCT00444678|580939126|FG000|Overall Study|Withdrawal by Subject|2|||
160875385|NCT01305577|580939129|FG000|Overall Study|Adverse Event|2|||
160875386|NCT01305577|580939130|FG001|Overall Study|Adverse Event|2|||
160875387|NCT01305577|580939131|FG002|Overall Study|Adverse Event|1|||
160875388|NCT01305577|580939129|FG000|Overall Study|Withdrawal by Subject|7|||
160875389|NCT01305577|580939130|FG001|Overall Study|Withdrawal by Subject|5|||
160875390|NCT01305577|580939131|FG002|Overall Study|Withdrawal by Subject|6|||
160875391|NCT01305577|580939129|FG000|Overall Study|Lost to Follow-up|4|||
160875392|NCT01305577|580939130|FG001|Overall Study|Lost to Follow-up|3|||
160875393|NCT01305577|580939131|FG002|Overall Study|Lost to Follow-up|2|||
160875394|NCT01305577|580939129|FG000|Overall Study|Protocol Deviation|0|||
160875395|NCT01305577|580939130|FG001|Overall Study|Protocol Deviation|1|||
160875396|NCT01305577|580939131|FG002|Overall Study|Protocol Deviation|1|||
160875397|NCT00796978|580939132|FG000|Overall Study|Cardiac adverse event|5|||
160875398|NCT00796978|580939132|FG000|Overall Study|Adverse Event|4|||
160875399|NCT00796978|580939132|FG000|Overall Study|Withdrawal by Subject|3|||
160875400|NCT01256190|580939133|FG000|Overall Study|Lost to Follow-up|2|||
160875401|NCT01256190|580939134|FG001|Overall Study|Lost to Follow-up|0|||
160875402|NCT02834793|580939135|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
160875403|NCT02834793|580939136|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
160875404|NCT02834793|580939137|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
160875405|NCT02834793|580939138|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
160875406|NCT02834793|580939135|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
160875407|NCT02834793|580939136|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
160875408|NCT02834793|580939137|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
160875409|NCT02834793|580939138|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
160875410|NCT02834793|580939135|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
160875411|NCT02834793|580939136|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
160875412|NCT02834793|580939137|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
160875413|NCT02834793|580939138|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
160875414|NCT02834793|580939135|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
160875415|NCT02834793|580939136|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
160875416|NCT02834793|580939137|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
160875417|NCT02834793|580939138|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
160875418|NCT02834793|580939135|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
160875419|NCT02834793|580939136|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
160875420|NCT02834793|580939137|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
160875421|NCT02834793|580939138|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
160875422|NCT02834793|580939135|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
160875423|NCT02834793|580939136|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
160875424|NCT02834793|580939137|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
160875425|NCT02834793|580939138|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
160875426|NCT02834793|580939135|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
160875427|NCT02834793|580939136|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
160875428|NCT02834793|580939137|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
160875429|NCT02834793|580939138|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
160875430|NCT02834793|580939135|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
160875431|NCT02834793|580939136|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
160875432|NCT02834793|580939137|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
160875433|NCT02834793|580939138|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
160875434|NCT02834793|580939135|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
160875435|NCT02834793|580939136|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
160875436|NCT02834793|580939137|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
160875437|NCT02834793|580939138|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
160875438|NCT02834793|580939135|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
160875439|NCT02834793|580939136|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
160875440|NCT02834793|580939137|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
160875441|NCT02834793|580939138|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
160875442|NCT02834793|580939135|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
160875443|NCT02834793|580939136|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
160875444|NCT02834793|580939137|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
160875445|NCT02834793|580939138|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
160875446|NCT02834793|580939135|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
160875447|NCT02834793|580939136|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
160875448|NCT02834793|580939137|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
160875449|NCT02834793|580939138|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
160875450|NCT02834793|580939135|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
160875451|NCT02834793|580939136|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
160875452|NCT02834793|580939137|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
160875453|NCT02834793|580939138|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
160875454|NCT02834793|580939135|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
160875455|NCT02834793|580939136|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
160875456|NCT02834793|580939137|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
160875457|NCT02834793|580939138|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
160875458|NCT02834793|580939135|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
160875459|NCT02834793|580939136|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
160875460|NCT02834793|580939137|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
160875461|NCT02834793|580939138|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
160875462|NCT02364336|580939139|FG000|Overall Study|Adverse Event|0|||
160875463|NCT02364336|580939140|FG001|Overall Study|Adverse Event|1|||
160875464|NCT01731938|580939141|FG000|Preliminary Part I|Withdrawal by Subject|2|||
160875465|NCT01731938|580939142|FG001|Preliminary Part I|Withdrawal by Subject|2|||
160875466|NCT01731938|580939141|FG000|Preliminary Part I|Physician Decision|1|||
160875467|NCT01731938|580939142|FG001|Preliminary Part I|Physician Decision|0|||
160875468|NCT01731938|580939141|FG000|Preliminary Part I|Lost to Follow-up|0|||
160875469|NCT01731938|580939142|FG001|Preliminary Part I|Lost to Follow-up|3|||
160875470|NCT01731938|580939141|FG000|Preliminary Part I|Missed Week 6 visit|0|||
160875471|NCT01731938|580939142|FG001|Preliminary Part I|Missed Week 6 visit|3|||
160875472|NCT01731938|580939141|FG000|Primary Part II|Withdrawal by Subject|5|||
160875473|NCT01731938|580939142|FG001|Primary Part II|Withdrawal by Subject|4|||
160875474|NCT01731938|580939141|FG000|Primary Part II|Lost to Follow-up|4|||
160875475|NCT01731938|580939142|FG001|Primary Part II|Lost to Follow-up|5|||
160875476|NCT01731938|580939141|FG000|Primary Part II|Death|2|||
160875477|NCT01731938|580939142|FG001|Primary Part II|Death|1|||
160875478|NCT01731938|580939141|FG000|Primary Part II|Missed Week 6 visit|2|||
160875479|NCT01731938|580939142|FG001|Primary Part II|Missed Week 6 visit|3|||
160875480|NCT03319745|580939143|FG000|Overall Study|Death|1|||
160875481|NCT03319745|580939143|FG000|Overall Study|Toxicity Precluding Surgery|1|||
160875482|NCT01317550|580939144|FG000|Overall Study|Withdrawal by Subject|1|||
160875483|NCT01317550|580939145|FG001|Overall Study|Withdrawal by Subject|0|||
160875484|NCT01317550|580939146|FG002|Overall Study|Withdrawal by Subject|0|||
160875485|NCT01317550|580939147|FG003|Overall Study|Withdrawal by Subject|0|||
160875486|NCT01317550|580939144|FG000|Overall Study|Lack of compliance study med|1|||
160875487|NCT01317550|580939145|FG001|Overall Study|Lack of compliance study med|0|||
160875488|NCT01317550|580939146|FG002|Overall Study|Lack of compliance study med|0|||
160875489|NCT01317550|580939147|FG003|Overall Study|Lack of compliance study med|0|||
160875490|NCT00870103|580939148|FG000|Overall Study|Physician Decision|2|||
160875491|NCT00870103|580939148|FG000|Overall Study|Lost to Follow-up|2|||
160875492|NCT03179202|580939149|FG000|Overall Study|Screen Failure|67|||
160875493|NCT03179202|580939149|FG000|Overall Study|Subject Lost to Follow Up|12|||
160875494|NCT03179202|580939149|FG000|Overall Study|Withdrawal by Subject|7|||
160875495|NCT03179202|580939149|FG000|Overall Study|Adverse Event|3|||
160875496|NCT03179202|580939149|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
160875497|NCT03179202|580939149|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
160875498|NCT03255629|580939150|FG000|Overall Study|Adverse Event|1|||
160875499|NCT03255629|580939151|FG001|Overall Study|Adverse Event|0|||
160875500|NCT03255629|580939150|FG000|Overall Study|did not experience hypoglycemia|2|||
160875501|NCT03255629|580939151|FG001|Overall Study|did not experience hypoglycemia|1|||
160875502|NCT02082340|580939153|FG000|Overall Study|Lost to Follow-up|1|||
160875503|NCT02082340|580939154|FG001|Overall Study|Lost to Follow-up|1|||
160875504|NCT03899805|580939155|FG000|Overall Study|Physician Decision|3|||
160875505|NCT03899805|580939156|FG001|Overall Study|Physician Decision|0|||
160875506|NCT03899805|580939157|FG002|Overall Study|Physician Decision|2|||
160875507|NCT03899805|580939155|FG000|Overall Study|Withdrawal by Subject|1|||
160875508|NCT03899805|580939156|FG001|Overall Study|Withdrawal by Subject|0|||
160875509|NCT03899805|580939157|FG002|Overall Study|Withdrawal by Subject|2|||
160875510|NCT03899805|580939155|FG000|Overall Study|Progressive Disease|10|||
160875511|NCT03899805|580939156|FG001|Overall Study|Progressive Disease|18|||
160875512|NCT03899805|580939157|FG002|Overall Study|Progressive Disease|12|||
160875513|NCT03899805|580939155|FG000|Overall Study|Adverse Event|3|||
160875514|NCT03899805|580939156|FG001|Overall Study|Adverse Event|1|||
160875515|NCT03899805|580939157|FG002|Overall Study|Adverse Event|0|||
160875516|NCT03899805|580939155|FG000|Overall Study|Death|2|||
160875517|NCT03899805|580939156|FG001|Overall Study|Death|0|||
160875518|NCT03899805|580939157|FG002|Overall Study|Death|0|||
160875519|NCT03899805|580939155|FG000|Overall Study|Came off for surgery|0|||
160875520|NCT03899805|580939156|FG001|Overall Study|Came off for surgery|0|||
160875521|NCT03899805|580939157|FG002|Overall Study|Came off for surgery|1|||
160875522|NCT05246514|580939158|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
160875523|NCT05246514|580939158|FG000|Overall Study|Withdrawal by Subject|1|||
160875524|NCT05246514|580939158|FG000|Overall Study|Death|13|||
160875525|NCT04195893|580939159|FG000|Second Intervention|Withdrawal by Subject|1|||
160875526|NCT04195893|580939160|FG001|Second Intervention|Withdrawal by Subject|0|||
160875527|NCT01802073|580939161|FG000|Overall Study|Lost to Follow-up|0|||
160875528|NCT01802073|580939162|FG001|Overall Study|Lost to Follow-up|1|||
160875529|NCT01802073|580939161|FG000|Overall Study|Non-compliant|4|||
160875530|NCT01802073|580939162|FG001|Overall Study|Non-compliant|2|||
160875531|NCT01802073|580939161|FG000|Overall Study|Withdrawal by Subject|1|||
160875532|NCT01802073|580939162|FG001|Overall Study|Withdrawal by Subject|1|||
160875533|NCT01802073|580939161|FG000|Overall Study|Physician Decision|0|||
160875534|NCT01802073|580939162|FG001|Overall Study|Physician Decision|7|||
160875535|NCT01137604|580939163|FG000|Overall Study|Adverse Event|3|||
160875536|NCT01137604|580939164|FG001|Overall Study|Adverse Event|6|||
160875537|NCT01137604|580939165|FG002|Overall Study|Adverse Event|9|||
160875538|NCT01137604|580939166|FG003|Overall Study|Adverse Event|9|||
160875539|NCT01137604|580939163|FG000|Overall Study|Participant Choice|0|||
160875540|NCT01137604|580939164|FG001|Overall Study|Participant Choice|2|||
160875541|NCT01137604|580939165|FG002|Overall Study|Participant Choice|2|||
160875542|NCT01137604|580939166|FG003|Overall Study|Participant Choice|0|||
160875543|NCT01137604|580939163|FG000|Overall Study|Withdrawal of consent|0|||
160875544|NCT01137604|580939164|FG001|Overall Study|Withdrawal of consent|0|||
160875545|NCT01137604|580939165|FG002|Overall Study|Withdrawal of consent|0|||
160875546|NCT01137604|580939166|FG003|Overall Study|Withdrawal of consent|2|||
160875547|NCT01137604|580939163|FG000|Overall Study|Clinical progression/deterioration|1|||
160875548|NCT01137604|580939164|FG001|Overall Study|Clinical progression/deterioration|2|||
160875549|NCT01137604|580939165|FG002|Overall Study|Clinical progression/deterioration|2|||
160875550|NCT01137604|580939166|FG003|Overall Study|Clinical progression/deterioration|0|||
160875551|NCT01327482|580939167|FG000|Overall Study|Adverse Event|1|||
160875552|NCT00312195|580939168|FG000|Overall Study|Adverse Event|4|||
160875553|NCT00312195|580939169|FG001|Overall Study|Adverse Event|6|||
160875554|NCT00312195|580939168|FG000|Overall Study|Lost to Follow-up|1|||
160875555|NCT00312195|580939169|FG001|Overall Study|Lost to Follow-up|0|||
160875556|NCT00312195|580939168|FG000|Overall Study|Protocol Violation|1|||
160875557|NCT00312195|580939169|FG001|Overall Study|Protocol Violation|0|||
160875558|NCT01018810|580939170|FG000|Overall Study|Withdrawal by Subject|0|||
160875559|NCT01018810|580939171|FG001|Overall Study|Withdrawal by Subject|1|||
160875560|NCT01018810|580939172|FG002|Overall Study|Withdrawal by Subject|0|||
160875561|NCT01018810|580939173|FG003|Overall Study|Withdrawal by Subject|0|||
160875562|NCT01018810|580939174|FG004|Overall Study|Withdrawal by Subject|0|||
160875563|NCT01018810|580939170|FG000|Overall Study|Sponsor Decision|2|||
160875564|NCT01018810|580939171|FG001|Overall Study|Sponsor Decision|0|||
160875565|NCT01018810|580939172|FG002|Overall Study|Sponsor Decision|1|||
160875566|NCT01018810|580939173|FG003|Overall Study|Sponsor Decision|1|||
160875567|NCT01018810|580939174|FG004|Overall Study|Sponsor Decision|1|||
160875568|NCT04145219|580939175|FG000|Overall Study|Adverse Event|18|||
160875569|NCT04145219|580939176|FG001|Overall Study|Adverse Event|6|||
160875570|NCT04145219|580939175|FG000|Overall Study|Lost to Follow-up|2|||
160875571|NCT04145219|580939176|FG001|Overall Study|Lost to Follow-up|3|||
160875572|NCT04145219|580939175|FG000|Overall Study|Physician Decision|0|||
160875573|NCT04145219|580939176|FG001|Overall Study|Physician Decision|2|||
160875574|NCT04145219|580939175|FG000|Overall Study|Withdrawal by Subject|12|||
160875575|NCT04145219|580939176|FG001|Overall Study|Withdrawal by Subject|8|||
160875576|NCT04145219|580939175|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
160875577|NCT04145219|580939176|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
160875578|NCT01459497|580939182|FG000|Overall Study|Inability to meet trial constraints.|1|||
160875579|NCT01459497|580939183|FG001|Overall Study|Inability to meet trial constraints.|0|||
160875580|NCT01459497|580939182|FG000|Overall Study|Physician Decision|1|||
160875581|NCT01459497|580939183|FG001|Overall Study|Physician Decision|1|||
160875582|NCT01459497|580939182|FG000|Overall Study|Hospitalization.|0|||
160875583|NCT01459497|580939183|FG001|Overall Study|Hospitalization.|3|||
160875584|NCT01459497|580939182|FG000|Overall Study|Disease progression.|0|||
160875585|NCT01459497|580939183|FG001|Overall Study|Disease progression.|1|||
160875586|NCT00862082|580939184|FG000|Overall Study|Sponsor decision to terminate the study|5|||
160875587|NCT00862082|580939185|FG001|Overall Study|Sponsor decision to terminate the study|0|||
160875588|NCT00862082|580939184|FG000|Overall Study|Withdrawal by Subject|0|||
160875589|NCT00862082|580939185|FG001|Overall Study|Withdrawal by Subject|1|||
160875590|NCT00947882|580939186|FG000|Overall Study|Adverse Event|0|||
160875591|NCT00947882|580939187|FG001|Overall Study|Adverse Event|1|||
160875592|NCT00947882|580939188|FG002|Overall Study|Adverse Event|4|||
160875593|NCT00947882|580939189|FG003|Overall Study|Adverse Event|4|||
160875594|NCT00947882|580939186|FG000|Overall Study|Withdrawal by Subject|2|||
160875595|NCT00947882|580939187|FG001|Overall Study|Withdrawal by Subject|0|||
160875596|NCT00947882|580939188|FG002|Overall Study|Withdrawal by Subject|8|||
160875597|NCT00947882|580939189|FG003|Overall Study|Withdrawal by Subject|2|||
160875598|NCT00947882|580939186|FG000|Overall Study|Protocol Violation|0|||
160875599|NCT00947882|580939187|FG001|Overall Study|Protocol Violation|0|||
160875600|NCT00947882|580939188|FG002|Overall Study|Protocol Violation|1|||
160875601|NCT00947882|580939189|FG003|Overall Study|Protocol Violation|0|||
160875602|NCT00947882|580939186|FG000|Overall Study|Lost to Follow-up|0|||
160875603|NCT00947882|580939187|FG001|Overall Study|Lost to Follow-up|2|||
160875604|NCT00947882|580939188|FG002|Overall Study|Lost to Follow-up|1|||
160875605|NCT00947882|580939189|FG003|Overall Study|Lost to Follow-up|0|||
160875606|NCT00947882|580939186|FG000|Overall Study|Other/Unknown|10|||
160875607|NCT00947882|580939187|FG001|Overall Study|Other/Unknown|13|||
160875608|NCT00947882|580939188|FG002|Overall Study|Other/Unknown|3|||
160875609|NCT00947882|580939189|FG003|Overall Study|Other/Unknown|6|||
160875610|NCT00947882|580939186|FG000|Overall Study|Trial Terminated by Sponsor|62|||
160875611|NCT00947882|580939187|FG001|Overall Study|Trial Terminated by Sponsor|61|||
160875612|NCT00947882|580939188|FG002|Overall Study|Trial Terminated by Sponsor|62|||
160875613|NCT00947882|580939189|FG003|Overall Study|Trial Terminated by Sponsor|70|||
160875614|NCT02791763|580939192|FG000|Overall Study|Protocol Violation|0|||
160875615|NCT02791763|580939193|FG001|Overall Study|Protocol Violation|0|||
160875616|NCT02791763|580939194|FG002|Overall Study|Protocol Violation|1|||
160875617|NCT02791763|580939192|FG000|Overall Study|Withdrawal by Subject|5|||
160875618|NCT02791763|580939193|FG001|Overall Study|Withdrawal by Subject|1|||
160875619|NCT02791763|580939194|FG002|Overall Study|Withdrawal by Subject|0|||
160875620|NCT02791763|580939192|FG000|Overall Study|Physician Decision|0|||
160875621|NCT02791763|580939193|FG001|Overall Study|Physician Decision|1|||
160875622|NCT02791763|580939194|FG002|Overall Study|Physician Decision|0|||
160875623|NCT02791763|580939192|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
160875624|NCT02791763|580939193|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
160875625|NCT02791763|580939194|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
160875626|NCT02791763|580939192|FG000|Overall Study|Cancer event|1|||
160875627|NCT02791763|580939193|FG001|Overall Study|Cancer event|3|||
160875628|NCT02791763|580939194|FG002|Overall Study|Cancer event|0|||
160875629|NCT02791763|580939192|FG000|Overall Study|Participant had renal transplant|3|||
160875630|NCT02791763|580939193|FG001|Overall Study|Participant had renal transplant|0|||
160875631|NCT02791763|580939194|FG002|Overall Study|Participant had renal transplant|0|||
160875632|NCT02791763|580939192|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
160875633|NCT02791763|580939193|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
160875634|NCT02791763|580939194|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
160875635|NCT02791763|580939192|FG000|Overall Study|Adverse Event|12|||
160875636|NCT02791763|580939193|FG001|Overall Study|Adverse Event|13|||
160875637|NCT02791763|580939194|FG002|Overall Study|Adverse Event|7|||
160875638|NCT05334212|580939195|FG000|Overall Study|Study terminated prematurely|7|||
160767717|NCT01232283|580537776|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
160767718|NCT01232283|580537777|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
160767719|NCT01232283|580537778|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
160767720|NCT01232283|580537779|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
160767721|NCT01232283|580537780|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
160767722|NCT01232283|580537781|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
160767723|NCT01232283|580537772|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
160767724|NCT01232283|580537773|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
160767725|NCT01232283|580537774|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
160767726|NCT01232283|580537775|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
160767727|NCT01232283|580537776|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
160767728|NCT01232283|580537777|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
160767729|NCT01232283|580537778|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
160767730|NCT01232283|580537779|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
160767731|NCT01232283|580537780|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
160767732|NCT01232283|580537781|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
160767733|NCT03191552|580537787|FG000|Overall Study|Lost to Follow-up|1|||
160767734|NCT03191552|580537788|FG001|Overall Study|Lost to Follow-up|0|||
160767735|NCT03191552|580537789|FG002|Overall Study|Lost to Follow-up|0|||
160767736|NCT03191552|580537787|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
160767737|NCT03191552|580537788|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
160767738|NCT03191552|580537789|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
160767739|NCT01884597|580537790|FG000|Overall Study|Adverse Event|0|||
160767740|NCT01884597|580537791|FG001|Overall Study|Adverse Event|0|||
160767741|NCT01884597|580537792|FG002|Overall Study|Adverse Event|1|||
160767742|NCT01884597|580537790|FG000|Overall Study|Lack of Efficacy|1|||
160767743|NCT01884597|580537791|FG001|Overall Study|Lack of Efficacy|0|||
160767744|NCT01884597|580537792|FG002|Overall Study|Lack of Efficacy|0|||
160767745|NCT01884597|580537790|FG000|Overall Study|Death|0|||
160767746|NCT01884597|580537791|FG001|Overall Study|Death|1|||
160767747|NCT01884597|580537792|FG002|Overall Study|Death|0|||
160767748|NCT01721798|580538990|FG000|Overall Study|Death|0|||
160767749|NCT01721798|580538991|FG001|Overall Study|Death|0|||
160767750|NCT01721798|580538992|FG002|Overall Study|Death|1|||
160767751|NCT01721798|580538993|FG003|Overall Study|Death|1|||
160767752|NCT01721798|580538990|FG000|Overall Study|Lost to Follow-up|2|||
160767753|NCT01721798|580538991|FG001|Overall Study|Lost to Follow-up|2|||
160767754|NCT01721798|580538992|FG002|Overall Study|Lost to Follow-up|9|||
160767755|NCT01721798|580538993|FG003|Overall Study|Lost to Follow-up|9|||
160767756|NCT01721798|580538990|FG000|Overall Study|Pregnancy|0|||
160767757|NCT01721798|580538991|FG001|Overall Study|Pregnancy|0|||
160767758|NCT01721798|580538992|FG002|Overall Study|Pregnancy|1|||
160767759|NCT01721798|580538993|FG003|Overall Study|Pregnancy|1|||
160767760|NCT01721798|580538990|FG000|Overall Study|Withdrawal by Subject|1|||
160767761|NCT01721798|580538991|FG001|Overall Study|Withdrawal by Subject|0|||
160767762|NCT01721798|580538992|FG002|Overall Study|Withdrawal by Subject|2|||
160767763|NCT01721798|580538993|FG003|Overall Study|Withdrawal by Subject|1|||
160767764|NCT01721798|580538990|FG000|Overall Study|Not eligible for 24 month visit|1|||
160767765|NCT01721798|580538991|FG001|Overall Study|Not eligible for 24 month visit|0|||
160767766|NCT01721798|580538992|FG002|Overall Study|Not eligible for 24 month visit|8|||
160767767|NCT01721798|580538993|FG003|Overall Study|Not eligible for 24 month visit|7|||
160767768|NCT00961064|580538994|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
160767769|NCT00961064|580538994|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
160767770|NCT00961064|580538994|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
160767771|NCT00961064|580538994|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
160767772|NCT00961064|580538994|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
160767773|NCT00961064|580538994|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
160767774|NCT00961064|580538994|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
160767775|NCT00961064|580538994|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
160767776|NCT01408641|580538995|FG000|Overall Study|Physician Decision|1|||
160767777|NCT01408641|580538996|FG001|Overall Study|Physician Decision|0|||
160767778|NCT01316614|580538997|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
160767779|NCT01316614|580538997|FG000|Overall Study|Cytology slides not available for review|4|||
160767780|NCT01316614|580538997|FG000|Overall Study|Cystic lesion|5|||
160767781|NCT01316614|580538997|FG000|Overall Study|Inadequate number of passes|2|||
160767782|NCT01316614|580538997|FG000|Overall Study|Medically unstable|1|||
160767783|NCT00076570|580538998|FG000|Overall Study|Drug intolerance|8|||
160767784|NCT00076570|580538999|FG001|Overall Study|Drug intolerance|8|||
160767785|NCT03979313|580539000|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
160767786|NCT03979313|580539001|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
160767787|NCT03979313|580539000|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
160767788|NCT03979313|580539001|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
160767789|NCT03979313|580539000|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
160875639|NCT00910299|580939196|FG000|Overall Study|Withdrawal by Subject|16|||
160875640|NCT00910299|580939197|FG001|Overall Study|Withdrawal by Subject|13|||
160875641|NCT00910299|580939196|FG000|Overall Study|Sponsor Decision|58|||
160875642|NCT00910299|580939197|FG001|Overall Study|Sponsor Decision|60|||
160875643|NCT00910299|580939196|FG000|Overall Study|Didn't receive any study drug|2|||
160875644|NCT00910299|580939197|FG001|Overall Study|Didn't receive any study drug|1|||
160875645|NCT01456897|580939198|FG000|Overall Study|Adverse Event|19|||
160875646|NCT01456897|580939199|FG001|Overall Study|Adverse Event|22|||
160875647|NCT01456897|580939198|FG000|Overall Study|Protocol Violation|3|||
160875648|NCT01456897|580939199|FG001|Overall Study|Protocol Violation|4|||
160875649|NCT01456897|580939198|FG000|Overall Study|Physician Decision|5|||
160875650|NCT01456897|580939199|FG001|Overall Study|Physician Decision|3|||
160875651|NCT01456897|580939198|FG000|Overall Study|Withdrawal by Subject|44|||
160875652|NCT01456897|580939199|FG001|Overall Study|Withdrawal by Subject|17|||
160875653|NCT01456897|580939198|FG000|Overall Study|Lack of Efficacy|4|||
160875654|NCT01456897|580939199|FG001|Overall Study|Lack of Efficacy|11|||
160875655|NCT04535453|580939200|FG000|Overall Study|Death|0|||
160875656|NCT04535453|580939201|FG001|Overall Study|Death|1|||
160875657|NCT04535453|580939202|FG002|Overall Study|Death|0|||
160875658|NCT04535453|580939203|FG003|Overall Study|Death|0|||
160875659|NCT04535453|580939204|FG004|Overall Study|Death|0|||
160875660|NCT04535453|580939205|FG005|Overall Study|Death|0|||
160875661|NCT04535453|580939206|FG006|Overall Study|Death|0|||
160875662|NCT04535453|580939207|FG007|Overall Study|Death|0|||
160875663|NCT04535453|580939208|FG008|Overall Study|Death|0|||
160875664|NCT04535453|580939209|FG009|Overall Study|Death|0|||
160875665|NCT04535453|580939210|FG010|Overall Study|Death|0|||
160875666|NCT04535453|580939211|FG011|Overall Study|Death|0|||
160875667|NCT04535453|580939200|FG000|Overall Study|Lost to Follow-up|1|||
160875668|NCT04535453|580939201|FG001|Overall Study|Lost to Follow-up|1|||
160875669|NCT04535453|580939202|FG002|Overall Study|Lost to Follow-up|1|||
160875670|NCT04535453|580939203|FG003|Overall Study|Lost to Follow-up|0|||
160875671|NCT04535453|580939204|FG004|Overall Study|Lost to Follow-up|3|||
160875672|NCT04535453|580939205|FG005|Overall Study|Lost to Follow-up|1|||
160875673|NCT04535453|580939206|FG006|Overall Study|Lost to Follow-up|0|||
160875674|NCT04535453|580939207|FG007|Overall Study|Lost to Follow-up|0|||
160875675|NCT04535453|580939208|FG008|Overall Study|Lost to Follow-up|1|||
160875676|NCT04535453|580939209|FG009|Overall Study|Lost to Follow-up|1|||
160875677|NCT04535453|580939210|FG010|Overall Study|Lost to Follow-up|0|||
160875678|NCT04535453|580939211|FG011|Overall Study|Lost to Follow-up|0|||
160875679|NCT04535453|580939200|FG000|Overall Study|Physician Decision|0|||
160875680|NCT04535453|580939201|FG001|Overall Study|Physician Decision|0|||
160875681|NCT04535453|580939202|FG002|Overall Study|Physician Decision|0|||
160875682|NCT04535453|580939203|FG003|Overall Study|Physician Decision|1|||
160875683|NCT04535453|580939204|FG004|Overall Study|Physician Decision|0|||
160875684|NCT04535453|580939205|FG005|Overall Study|Physician Decision|0|||
160875685|NCT04535453|580939206|FG006|Overall Study|Physician Decision|0|||
160875686|NCT04535453|580939207|FG007|Overall Study|Physician Decision|0|||
160875687|NCT04535453|580939208|FG008|Overall Study|Physician Decision|0|||
160875688|NCT04535453|580939209|FG009|Overall Study|Physician Decision|0|||
160875689|NCT04535453|580939210|FG010|Overall Study|Physician Decision|0|||
160875690|NCT04535453|580939211|FG011|Overall Study|Physician Decision|0|||
160875691|NCT04535453|580939200|FG000|Overall Study|Withdrawal by Subject|3|||
160875692|NCT04535453|580939201|FG001|Overall Study|Withdrawal by Subject|6|||
160875693|NCT04535453|580939202|FG002|Overall Study|Withdrawal by Subject|3|||
160875694|NCT04535453|580939203|FG003|Overall Study|Withdrawal by Subject|3|||
160875695|NCT04535453|580939204|FG004|Overall Study|Withdrawal by Subject|2|||
160875696|NCT04535453|580939205|FG005|Overall Study|Withdrawal by Subject|1|||
160875697|NCT04535453|580939206|FG006|Overall Study|Withdrawal by Subject|1|||
160875698|NCT04535453|580939207|FG007|Overall Study|Withdrawal by Subject|1|||
160875699|NCT04535453|580939208|FG008|Overall Study|Withdrawal by Subject|1|||
160875700|NCT04535453|580939209|FG009|Overall Study|Withdrawal by Subject|1|||
160875701|NCT04535453|580939210|FG010|Overall Study|Withdrawal by Subject|0|||
160875702|NCT04535453|580939211|FG011|Overall Study|Withdrawal by Subject|1|||
160875703|NCT04535453|580939200|FG000|Overall Study|Other|0|||
160875704|NCT04535453|580939201|FG001|Overall Study|Other|0|||
160875705|NCT04535453|580939202|FG002|Overall Study|Other|1|||
160875706|NCT04535453|580939203|FG003|Overall Study|Other|0|||
160875707|NCT04535453|580939204|FG004|Overall Study|Other|1|||
160875708|NCT04535453|580939205|FG005|Overall Study|Other|0|||
160875709|NCT04535453|580939206|FG006|Overall Study|Other|1|||
160875710|NCT04535453|580939207|FG007|Overall Study|Other|1|||
160875711|NCT04535453|580939208|FG008|Overall Study|Other|1|||
160875712|NCT04535453|580939209|FG009|Overall Study|Other|0|||
160875713|NCT04535453|580939210|FG010|Overall Study|Other|0|||
160875714|NCT04535453|580939211|FG011|Overall Study|Other|0|||
160875715|NCT00916929|580939212|FG000|Overall Study|Lost to Follow-up|1|||
160875716|NCT00916929|580939213|FG001|Overall Study|Lost to Follow-up|3|||
160875717|NCT00916929|580939212|FG000|Overall Study|Death|5|||
160875718|NCT00916929|580939213|FG001|Overall Study|Death|10|||
160875719|NCT00916929|580939212|FG000|Overall Study|Withdrawal by Subject|1|||
160875720|NCT00916929|580939213|FG001|Overall Study|Withdrawal by Subject|5|||
160875721|NCT00916929|580939212|FG000|Overall Study|Left ventricular epicardial lead|1|||
160875722|NCT00916929|580939213|FG001|Overall Study|Left ventricular epicardial lead|2|||
160875723|NCT00916929|580939212|FG000|Overall Study|Transferred to hospice care|1|||
160875724|NCT00916929|580939213|FG001|Overall Study|Transferred to hospice care|1|||
160875725|NCT00916929|580939212|FG000|Overall Study|System explant|1|||
160875726|NCT00916929|580939213|FG001|Overall Study|System explant|0|||
160875727|NCT00916929|580939212|FG000|Overall Study|Moved to another state|0|||
160875728|NCT00916929|580939213|FG001|Overall Study|Moved to another state|1|||
160875729|NCT00916929|580939212|FG000|Overall Study|Device unable to process impedance data|0|||
160875730|NCT00916929|580939213|FG001|Overall Study|Device unable to process impedance data|7|||
160875731|NCT02929407|580939214|FG000|Overall Study|Adverse Event|1|||
160875732|NCT02878798|580939215|FG000|Overall Study|Withdrawal by Subject|5|||
160875733|NCT02878798|580939216|FG001|Overall Study|Withdrawal by Subject|4|||
160875734|NCT02878798|580939215|FG000|Overall Study|Lost to Follow-up|2|||
160875735|NCT02878798|580939216|FG001|Overall Study|Lost to Follow-up|2|||
160875736|NCT02878798|580939215|FG000|Overall Study|Protocol Violation|0|||
160875737|NCT02878798|580939216|FG001|Overall Study|Protocol Violation|1|||
160875738|NCT01309282|580939217|FG000|Overall Study|Lost to Follow-up|1|||
160875739|NCT01708902|580939221|FG000|Overall Study|Adverse Event|3|||
160875740|NCT01708902|580939222|FG001|Overall Study|Adverse Event|4|||
160875741|NCT01708902|580939223|FG002|Overall Study|Adverse Event|9|||
160875742|NCT01708902|580939224|FG003|Overall Study|Adverse Event|2|||
160875743|NCT01708902|580939225|FG004|Overall Study|Adverse Event|7|||
160875744|NCT01708902|580939226|FG005|Overall Study|Adverse Event|3|||
160875745|NCT01708902|580939227|FG006|Overall Study|Adverse Event|5|||
160875746|NCT01708902|580939221|FG000|Overall Study|Lack of Efficacy|3|||
160875747|NCT01708902|580939222|FG001|Overall Study|Lack of Efficacy|1|||
160875748|NCT01708902|580939223|FG002|Overall Study|Lack of Efficacy|0|||
160875749|NCT01708902|580939224|FG003|Overall Study|Lack of Efficacy|0|||
160875750|NCT01708902|580939225|FG004|Overall Study|Lack of Efficacy|0|||
160875751|NCT01708902|580939226|FG005|Overall Study|Lack of Efficacy|1|||
160875752|NCT01708902|580939227|FG006|Overall Study|Lack of Efficacy|0|||
160875753|NCT01708902|580939221|FG000|Overall Study|Non compliance with protocol|0|||
160875754|NCT01708902|580939222|FG001|Overall Study|Non compliance with protocol|2|||
160875755|NCT01708902|580939223|FG002|Overall Study|Non compliance with protocol|1|||
160875756|NCT01708902|580939224|FG003|Overall Study|Non compliance with protocol|3|||
160875757|NCT01708902|580939225|FG004|Overall Study|Non compliance with protocol|0|||
160875758|NCT01708902|580939226|FG005|Overall Study|Non compliance with protocol|0|||
160875759|NCT01708902|580939227|FG006|Overall Study|Non compliance with protocol|0|||
160875760|NCT01708902|580939221|FG000|Overall Study|Lost to Follow-up|2|||
160875761|NCT01708902|580939222|FG001|Overall Study|Lost to Follow-up|1|||
160875762|NCT01708902|580939223|FG002|Overall Study|Lost to Follow-up|2|||
160875763|NCT01708902|580939224|FG003|Overall Study|Lost to Follow-up|2|||
160875764|NCT01708902|580939225|FG004|Overall Study|Lost to Follow-up|0|||
160875765|NCT01708902|580939226|FG005|Overall Study|Lost to Follow-up|0|||
160537696|NCT02256540|579698914|FG000|Overall Study|Back pain preventing exercise|0|||
160537697|NCT02256540|579698915|FG001|Overall Study|Back pain preventing exercise|0|||
160537698|NCT02256540|579698916|FG002|Overall Study|Back pain preventing exercise|1|||
160537699|NCT02969187|579698921|FG000|Overall Study|Physician Decision|12|||
160537700|NCT02969187|579698922|FG001|Overall Study|Physician Decision|13|||
160537701|NCT03923426|579698923|FG000|Overall Study|Other|19|||
160537702|NCT03923426|579698923|FG000|Overall Study|Lost to Follow-up|16|||
160537703|NCT03923426|579698923|FG000|Overall Study|Death|107|||
160537704|NCT03923426|579698923|FG000|Overall Study|Incomplete response to question|13|||
160875766|NCT01708902|580939227|FG006|Overall Study|Lost to Follow-up|1|||
160875767|NCT01708902|580939221|FG000|Overall Study|Refused to continue trial medication|8|||
160875768|NCT01708902|580939222|FG001|Overall Study|Refused to continue trial medication|0|||
160875769|NCT01708902|580939223|FG002|Overall Study|Refused to continue trial medication|4|||
160875770|NCT01708902|580939224|FG003|Overall Study|Refused to continue trial medication|2|||
160875771|NCT01708902|580939225|FG004|Overall Study|Refused to continue trial medication|8|||
160875772|NCT01708902|580939226|FG005|Overall Study|Refused to continue trial medication|1|||
160875773|NCT01708902|580939227|FG006|Overall Study|Refused to continue trial medication|1|||
160875774|NCT01708902|580939221|FG000|Overall Study|Other Reason|1|||
160875775|NCT01708902|580939222|FG001|Overall Study|Other Reason|0|||
160875776|NCT01708902|580939223|FG002|Overall Study|Other Reason|1|||
160875777|NCT01708902|580939224|FG003|Overall Study|Other Reason|1|||
160875778|NCT01708902|580939225|FG004|Overall Study|Other Reason|1|||
160875779|NCT01708902|580939226|FG005|Overall Study|Other Reason|2|||
160875780|NCT01708902|580939227|FG006|Overall Study|Other Reason|0|||
160875781|NCT02445794|580939231|FG000|Overall Study|Adverse Event|0|||
160875782|NCT02445794|580939232|FG001|Overall Study|Adverse Event|0|||
160875783|NCT02445794|580939233|FG002|Overall Study|Adverse Event|2|||
160875784|NCT02445794|580939234|FG003|Overall Study|Adverse Event|0|||
160875785|NCT01388985|580939235|FG000|Overall Study|Death|0|||
160875786|NCT01388985|580939236|FG001|Overall Study|Death|1|||
160875787|NCT01388985|580939235|FG000|Overall Study|Lost to Follow-up|30|||
160875788|NCT01388985|580939236|FG001|Overall Study|Lost to Follow-up|30|||
160875789|NCT01388985|580939235|FG000|Overall Study|Withdrawal by Subject|13|||
160875790|NCT01388985|580939236|FG001|Overall Study|Withdrawal by Subject|4|||
160875791|NCT01388985|580939235|FG000|Overall Study|Subject unavailable|1|||
160875792|NCT01388985|580939236|FG001|Overall Study|Subject unavailable|1|||
160875793|NCT01388985|580939235|FG000|Overall Study|Other (no reason)|0|||
160875794|NCT01388985|580939236|FG001|Overall Study|Other (no reason)|1|||
160875795|NCT01388985|580939235|FG000|Overall Study|Error of nurse|5|||
160875796|NCT01388985|580939236|FG001|Overall Study|Error of nurse|1|||
160875797|NCT01057589|580939237|FG000|Overall Study|Disease Progression|35|||
160875798|NCT01057589|580939237|FG000|Overall Study|Adverse Event|10|||
160875799|NCT01057589|580939237|FG000|Overall Study|Physician Decision|8|||
160875800|NCT01057589|580939237|FG000|Overall Study|Withdrawal by Subject|3|||
160875801|NCT01057589|580939237|FG000|Overall Study|Sponsor Decision|1|||
160875802|NCT01057589|580939237|FG000|Overall Study|Death|8|||
160875803|NCT01057589|580939237|FG000|Overall Study|Lost to Follow-up|1|||
160875804|NCT01519167|580939240|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
160875805|NCT01519167|580939241|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
160875806|NCT01519167|580939240|FG000|Overall Study|Adverse Event|0|||
160875807|NCT01519167|580939241|FG001|Overall Study|Adverse Event|1|||
160875808|NCT01519167|580939240|FG000|Overall Study|Lack of Efficacy|0|||
160875809|NCT01519167|580939241|FG001|Overall Study|Lack of Efficacy|1|||
160875810|NCT01519167|580939240|FG000|Overall Study|Medical condition changes&deep sedation|0|||
160875811|NCT01519167|580939241|FG001|Overall Study|Medical condition changes&deep sedation|2|||
160875812|NCT01519167|580939240|FG000|Overall Study|Physician Decision|0|||
160875813|NCT01519167|580939241|FG001|Overall Study|Physician Decision|1|||
160875814|NCT01031836|580940537|FG000|Stage I|Adverse Event|1|||
160875815|NCT01031836|580940538|FG001|Stage I|Adverse Event|1|||
160875816|NCT01031836|580940539|FG002|Stage I|Adverse Event|0|||
160875817|NCT01031836|580940540|FG003|Stage I|Adverse Event|0|||
160875818|NCT01031836|580940541|FG004|Stage I|Adverse Event|0|||
160875819|NCT01031836|580940542|FG005|Stage I|Adverse Event|0|||
160875820|NCT01031836|580940537|FG000|Stage I|Other|0|||
160875821|NCT01031836|580940538|FG001|Stage I|Other|1|||
160537705|NCT00766532|579698924|FG000|Overall Study|Protocol Violation|2|||
160537706|NCT01438489|579698925|FG000|Overall Study|Lost to Follow-up|4|||
160537707|NCT01438489|579698926|FG001|Overall Study|Lost to Follow-up|2|||
160537708|NCT01438489|579698927|FG002|Overall Study|Lost to Follow-up|2|||
160537709|NCT01438489|579698925|FG000|Overall Study|Withdrawal by Subject|11|||
160636607|NCT05166512|580051582|FG001|Baseline Data Collection|Lost to Follow-up|3|||
160875822|NCT01031836|580940539|FG002|Stage I|Other|0|||
160875823|NCT01031836|580940540|FG003|Stage I|Other|0|||
160875824|NCT01031836|580940541|FG004|Stage I|Other|0|||
160875825|NCT01031836|580940542|FG005|Stage I|Other|1|||
160875826|NCT01031836|580940537|FG000|Stage II|Adverse Event|0|||
160875827|NCT01031836|580940538|FG001|Stage II|Adverse Event|0|||
160875828|NCT01031836|580940539|FG002|Stage II|Adverse Event|2|||
160875829|NCT01031836|580940540|FG003|Stage II|Adverse Event|2|||
160875830|NCT01031836|580940541|FG004|Stage II|Adverse Event|1|||
160875831|NCT01031836|580940542|FG005|Stage II|Adverse Event|1|||
160875832|NCT01031836|580940537|FG000|Stage II|Other|2|||
160875833|NCT01031836|580940538|FG001|Stage II|Other|0|||
160875834|NCT01031836|580940539|FG002|Stage II|Other|0|||
160875835|NCT01031836|580940540|FG003|Stage II|Other|1|||
160875836|NCT01031836|580940541|FG004|Stage II|Other|1|||
160875837|NCT01031836|580940542|FG005|Stage II|Other|0|||
160875838|NCT01888432|580940547|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
160875839|NCT01888432|580940548|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
160875840|NCT01888432|580940547|FG000|12-month Analysis (FAS)|Physician Decision|1|||
160875841|NCT01888432|580940548|FG001|12-month Analysis (FAS)|Physician Decision|1|||
160875842|NCT01888432|580940547|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
160875843|NCT01888432|580940548|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
160875844|NCT01888432|580940547|FG000|12-month Analysis (FAS)|Death|4|||
160875845|NCT01888432|580940548|FG001|12-month Analysis (FAS)|Death|3|||
160875846|NCT01888432|580940547|FG000|24-month Analysis (FAS)|Graft loss|0|||
160875847|NCT01888432|580940548|FG001|24-month Analysis (FAS)|Graft loss|1|||
160875848|NCT01888432|580940547|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
160875849|NCT01888432|580940548|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
160875850|NCT01888432|580940547|FG000|24-month Analysis (FAS)|Physician Decision|2|||
160875851|NCT01888432|580940548|FG001|24-month Analysis (FAS)|Physician Decision|4|||
160875852|NCT01888432|580940547|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
160875853|NCT01888432|580940548|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
160875854|NCT01888432|580940547|FG000|24-month Analysis (FAS)|Death|8|||
160875855|NCT01888432|580940548|FG001|24-month Analysis (FAS)|Death|4|||
160875856|NCT01888432|580940547|FG000|36-month Analysis (Extension)|Death|1|||
160875857|NCT01888432|580940548|FG001|36-month Analysis (Extension)|Death|0|||
160875858|NCT01754402|580940552|FG000|Overall Study|Death|0|||
160875859|NCT01754402|580940553|FG001|Overall Study|Death|0|||
160875860|NCT01754402|580940554|FG002|Overall Study|Death|1|||
160875861|NCT01754402|580940552|FG000|Overall Study|Adverse Event|2|||
160875862|NCT01754402|580940553|FG001|Overall Study|Adverse Event|2|||
160875863|NCT01754402|580940554|FG002|Overall Study|Adverse Event|1|||
160875864|NCT01754402|580940552|FG000|Overall Study|Withdrawal by Subject|0|||
160875865|NCT01754402|580940553|FG001|Overall Study|Withdrawal by Subject|0|||
160875866|NCT01754402|580940554|FG002|Overall Study|Withdrawal by Subject|1|||
160875867|NCT01754402|580940552|FG000|Overall Study|Lack of Efficacy|0|||
160875868|NCT01754402|580940553|FG001|Overall Study|Lack of Efficacy|0|||
160875869|NCT01754402|580940554|FG002|Overall Study|Lack of Efficacy|1|||
160875870|NCT02051933|580940555|FG000|Overall Study|Physician Decision|0|||
160875871|NCT02051933|580940556|FG001|Overall Study|Physician Decision|1|||
160875872|NCT01954927|580940557|FG000|Overall Study|Withdrawal by Subject|3|||
160875873|NCT01954927|580940558|FG001|Overall Study|Withdrawal by Subject|1|||
160875874|NCT02156271|580940559|FG000|Overall Study|Physician Decision|4|||
160875875|NCT02156271|580940560|FG001|Overall Study|Physician Decision|3|||
160875876|NCT02123251|580940561|FG000|Overall Study|Death|1|||
160875877|NCT02123251|580940562|FG001|Overall Study|Death|1|||
160875878|NCT02123251|580940561|FG000|Overall Study|Withdrawal by Subject|0|||
160875879|NCT02123251|580940562|FG001|Overall Study|Withdrawal by Subject|3|||
160875880|NCT02123251|580940561|FG000|Overall Study|Lost Medicaid eligibility|29|||
160875881|NCT02123251|580940562|FG001|Overall Study|Lost Medicaid eligibility|22|||
160875882|NCT02123251|580940561|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
160875883|NCT02123251|580940562|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
160875884|NCT00375609|580940569|FG000|Overall Study|Did not receive treatment|1|||
160875885|NCT00375609|580940570|FG001|Overall Study|Did not receive treatment|0|||
160875886|NCT00375609|580940571|FG002|Overall Study|Did not receive treatment|0|||
160875887|NCT00375609|580940569|FG000|Overall Study|Adverse Event|0|||
160875888|NCT00375609|580940570|FG001|Overall Study|Adverse Event|3|||
160875889|NCT00375609|580940571|FG002|Overall Study|Adverse Event|0|||
160875890|NCT00375609|580940569|FG000|Overall Study|Lost to Follow-up|1|||
160875891|NCT00375609|580940570|FG001|Overall Study|Lost to Follow-up|0|||
160875892|NCT00375609|580940571|FG002|Overall Study|Lost to Follow-up|0|||
160875893|NCT00375609|580940569|FG000|Overall Study|Physician Decision|0|||
160875894|NCT00375609|580940570|FG001|Overall Study|Physician Decision|0|||
160875895|NCT00375609|580940571|FG002|Overall Study|Physician Decision|1|||
160875896|NCT00375609|580940569|FG000|Overall Study|Withdrawal by Subject|1|||
160875897|NCT00375609|580940570|FG001|Overall Study|Withdrawal by Subject|4|||
160875898|NCT00375609|580940571|FG002|Overall Study|Withdrawal by Subject|0|||
160875899|NCT00375609|580940569|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
160875900|NCT00375609|580940570|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
160875901|NCT00375609|580940571|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
160875902|NCT02338882|580940572|FG000|Overall Study|Death|1|||
160875903|NCT02338882|580940573|FG001|Overall Study|Death|0|||
160875904|NCT02338882|580940572|FG000|Overall Study|Lost to Follow-up|6|||
160875905|NCT02338882|580940573|FG001|Overall Study|Lost to Follow-up|3|||
160875906|NCT02184455|580940576|FG000|Overall Study|Lost to Follow-up|1|||
160875907|NCT02248675|580940583|FG000|Overall Study|Lost to Follow-up|3|||
160875908|NCT02248675|580940584|FG001|Overall Study|Lost to Follow-up|1|||
160875909|NCT00617669|580940585|FG000|Overall Study|Withdrawal by Subject|71|||
160875910|NCT00617669|580940586|FG001|Overall Study|Withdrawal by Subject|77|||
160875911|NCT00617669|580940585|FG000|Overall Study|Lost to Follow-up|3|||
160875912|NCT00617669|580940586|FG001|Overall Study|Lost to Follow-up|2|||
160875913|NCT00617669|580940585|FG000|Overall Study|Adverse Event|87|||
160875914|NCT00617669|580940586|FG001|Overall Study|Adverse Event|76|||
160875915|NCT00617669|580940585|FG000|Overall Study|Protocol Violation|2|||
160875916|NCT00617669|580940586|FG001|Overall Study|Protocol Violation|3|||
160875917|NCT00617669|580940585|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
160875918|NCT00617669|580940586|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
160875919|NCT00617669|580940585|FG000|Overall Study|Patients randomized but not treated|2|||
160875920|NCT00617669|580940586|FG001|Overall Study|Patients randomized but not treated|3|||
160875921|NCT03745820|580940589|FG000|Overall Study|Adverse Event|0|||
160875922|NCT03745820|580940590|FG001|Overall Study|Adverse Event|3|||
160875923|NCT03745820|580940591|FG002|Overall Study|Adverse Event|2|||
160875924|NCT03745820|580940589|FG000|Overall Study|Non-Compliance with Study Drug|4|||
160875925|NCT03745820|580940590|FG001|Overall Study|Non-Compliance with Study Drug|3|||
160875926|NCT03745820|580940591|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160875927|NCT03745820|580940589|FG000|Overall Study|Withdrawal by Subject|4|||
160875928|NCT03745820|580940590|FG001|Overall Study|Withdrawal by Subject|4|||
160875929|NCT03745820|580940591|FG002|Overall Study|Withdrawal by Subject|4|||
160875930|NCT03745820|580940589|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
160875931|NCT03745820|580940590|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
160875932|NCT03745820|580940591|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
160875933|NCT03745820|580940589|FG000|Overall Study|Lost to Follow-up|2|||
160875934|NCT03745820|580940590|FG001|Overall Study|Lost to Follow-up|0|||
160875935|NCT03745820|580940591|FG002|Overall Study|Lost to Follow-up|3|||
160875936|NCT03745820|580940589|FG000|Overall Study|Reason not Specified|2|||
160875937|NCT03745820|580940590|FG001|Overall Study|Reason not Specified|4|||
160875938|NCT03745820|580940591|FG002|Overall Study|Reason not Specified|1|||
160875939|NCT04250077|580940600|FG000|Overall Study|Withdrawal by Subject|0|||
160875940|NCT04250077|580940601|FG001|Overall Study|Withdrawal by Subject|1|||
160875941|NCT04250077|580940602|FG002|Overall Study|Withdrawal by Subject|0|||
160875942|NCT04250077|580940600|FG000|Overall Study|Lost to Follow-up|2|||
160875943|NCT04250077|580940601|FG001|Overall Study|Lost to Follow-up|3|||
160875944|NCT04250077|580940602|FG002|Overall Study|Lost to Follow-up|0|||
160875945|NCT00926029|580940603|FG000|Overall Study|Lost to Follow-up|2|||
160875946|NCT00926029|580940604|FG001|Overall Study|Lost to Follow-up|1|||
160875947|NCT00926029|580940605|FG002|Overall Study|Lost to Follow-up|1|||
160875948|NCT03206788|580940606|FG000|Overall Study|Withdrawal by Subject|0|||
160875949|NCT03206788|580940607|FG001|Overall Study|Withdrawal by Subject|1|||
160875950|NCT03206788|580940606|FG000|Overall Study|Adverse Event|0|||
160875951|NCT03206788|580940607|FG001|Overall Study|Adverse Event|1|||
160875952|NCT03206788|580940606|FG000|Overall Study|Physician Decision|0|||
160875953|NCT03206788|580940607|FG001|Overall Study|Physician Decision|1|||
160875954|NCT02471612|580940608|FG000|Overall Study|Lost to Follow-up|2|||
160875955|NCT01598129|580940609|FG000|Overall Study|Disease progression|6|||
160875956|NCT01598129|580940609|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
160875957|NCT01598129|580940609|FG000|Overall Study|Withdrawal by Subject|1|||
160875958|NCT00591318|580940610|FG000|Overall Study|Lack of Efficacy|2|||
160537710|NCT01438489|579698926|FG001|Overall Study|Withdrawal by Subject|3|||
160537711|NCT01438489|579698927|FG002|Overall Study|Withdrawal by Subject|8|||
160537712|NCT01438489|579698925|FG000|Overall Study|Death|0|||
160875959|NCT00591318|580940611|FG001|Overall Study|Lack of Efficacy|0|||
160875960|NCT00591318|580940610|FG000|Overall Study|Adverse Event|2|||
160875961|NCT00591318|580940611|FG001|Overall Study|Adverse Event|0|||
160875962|NCT03615040|580940612|FG000|Overall Study|Withdrawal by Subject|2|||
160875963|NCT03615040|580940613|FG001|Overall Study|Withdrawal by Subject|1|||
160875964|NCT03615040|580940612|FG000|Overall Study|Physician Decision|2|||
160875965|NCT03615040|580940613|FG001|Overall Study|Physician Decision|2|||
160875966|NCT03615040|580940612|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
160537713|NCT01438489|579698926|FG001|Overall Study|Death|0|||
160875967|NCT03615040|580940613|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
160875968|NCT03615040|580940612|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
160875969|NCT03615040|580940613|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
160875970|NCT03615040|580940612|FG000|Overall Study|Death|0|||
160875971|NCT03615040|580940613|FG001|Overall Study|Death|2|||
160875972|NCT01024309|580940616|FG000|Overall Study|Physician Decision|4|||
160875973|NCT01024309|580940617|FG001|Overall Study|Physician Decision|0|||
160875974|NCT01024309|580940616|FG000|Overall Study|Withdrawal by Subject|4|||
160875975|NCT01024309|580940617|FG001|Overall Study|Withdrawal by Subject|4|||
160875976|NCT00567255|580940618|FG000|Overall Study|Adverse Event|241|||
160875977|NCT00567255|580940619|FG001|Overall Study|Adverse Event|68|||
160875978|NCT00567255|580940618|FG000|Overall Study|Lost to Follow-up|77|||
160875979|NCT00567255|580940619|FG001|Overall Study|Lost to Follow-up|48|||
160875980|NCT00567255|580940618|FG000|Overall Study|Withdrawal by Subject|75|||
160875981|NCT00567255|580940619|FG001|Overall Study|Withdrawal by Subject|56|||
160875982|NCT00567255|580940618|FG000|Overall Study|Lack of Efficacy|19|||
160875983|NCT00567255|580940619|FG001|Overall Study|Lack of Efficacy|33|||
160875984|NCT00567255|580940618|FG000|Overall Study|Protocol Violation|20|||
160875985|NCT00567255|580940619|FG001|Overall Study|Protocol Violation|8|||
160875986|NCT00567255|580940618|FG000|Overall Study|Pregnancy|6|||
160875987|NCT00567255|580940619|FG001|Overall Study|Pregnancy|0|||
160875988|NCT00567255|580940618|FG000|Overall Study|Drug noncompliance,moved,other|25|||
160875989|NCT00567255|580940619|FG001|Overall Study|Drug noncompliance,moved,other|15|||
160875990|NCT03672097|580940624|FG000|Period 1|Withdrawal by Subject|2|||
160875991|NCT03672097|580940624|FG000|Period 1|Adverse Event|1|||
160875992|NCT03672097|580940624|FG000|Period 1|Did not receive treatment|1|||
160875993|NCT03672097|580940624|FG000|Period 2|Withdrawal by Subject|3|||
160875994|NCT03672097|580940624|FG000|Period 2|Other|1|||
160875995|NCT02657408|580940625|FG000|Overall Study|Adverse Event|3|||
160875996|NCT02657408|580940626|FG001|Overall Study|Adverse Event|7|||
160875997|NCT01403948|580940627|FG000|Overall Study|Progressive disease|0|||
160875998|NCT01403948|580940628|FG001|Overall Study|Progressive disease|2|||
160875999|NCT01403948|580940629|FG002|Overall Study|Progressive disease|2|||
160876000|NCT01403948|580940630|FG003|Overall Study|Progressive disease|4|||
160876001|NCT01403948|580940631|FG004|Overall Study|Progressive disease|2|||
160876002|NCT01403948|580940632|FG005|Overall Study|Progressive disease|6|||
160876003|NCT01403948|580940633|FG006|Overall Study|Progressive disease|2|||
160876004|NCT01403948|580940634|FG007|Overall Study|Progressive disease|4|||
160876005|NCT01403948|580940635|FG008|Overall Study|Progressive disease|5|||
160876006|NCT01403948|580940636|FG009|Overall Study|Progressive disease|5|||
160876007|NCT01403948|580940627|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876008|NCT01403948|580940628|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876009|NCT01403948|580940629|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876010|NCT01403948|580940630|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876011|NCT01403948|580940631|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
160876012|NCT01403948|580940632|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876013|NCT01403948|580940633|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
160876014|NCT01403948|580940634|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876015|NCT01403948|580940635|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
160876016|NCT01403948|580940636|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876017|NCT01403948|580940627|FG000|Overall Study|Lost to Follow-up|0|||
160876018|NCT01403948|580940628|FG001|Overall Study|Lost to Follow-up|0|||
160876019|NCT01403948|580940629|FG002|Overall Study|Lost to Follow-up|0|||
160876020|NCT01403948|580940630|FG003|Overall Study|Lost to Follow-up|0|||
160876021|NCT01403948|580940631|FG004|Overall Study|Lost to Follow-up|0|||
160876022|NCT01403948|580940632|FG005|Overall Study|Lost to Follow-up|0|||
160876023|NCT01403948|580940633|FG006|Overall Study|Lost to Follow-up|0|||
160876024|NCT01403948|580940634|FG007|Overall Study|Lost to Follow-up|0|||
160876025|NCT01403948|580940635|FG008|Overall Study|Lost to Follow-up|0|||
160876026|NCT01403948|580940636|FG009|Overall Study|Lost to Follow-up|1|||
160876027|NCT01403948|580940627|FG000|Overall Study|Refused cont. medication|0|||
160876028|NCT01403948|580940628|FG001|Overall Study|Refused cont. medication|0|||
160876029|NCT01403948|580940629|FG002|Overall Study|Refused cont. medication|0|||
160876030|NCT01403948|580940630|FG003|Overall Study|Refused cont. medication|0|||
160876031|NCT01403948|580940631|FG004|Overall Study|Refused cont. medication|1|||
160876032|NCT01403948|580940632|FG005|Overall Study|Refused cont. medication|0|||
160876033|NCT01403948|580940633|FG006|Overall Study|Refused cont. medication|0|||
160876034|NCT01403948|580940634|FG007|Overall Study|Refused cont. medication|0|||
160876035|NCT01403948|580940635|FG008|Overall Study|Refused cont. medication|0|||
160876036|NCT01403948|580940636|FG009|Overall Study|Refused cont. medication|1|||
160876037|NCT01403948|580940627|FG000|Overall Study|other than above|1|||
160876038|NCT01403948|580940628|FG001|Overall Study|other than above|2|||
160876039|NCT01403948|580940629|FG002|Overall Study|other than above|1|||
160876040|NCT01403948|580940630|FG003|Overall Study|other than above|0|||
160876041|NCT01403948|580940631|FG004|Overall Study|other than above|1|||
160876042|NCT01403948|580940632|FG005|Overall Study|other than above|1|||
160876043|NCT01403948|580940633|FG006|Overall Study|other than above|2|||
160876044|NCT01403948|580940634|FG007|Overall Study|other than above|0|||
160876045|NCT01403948|580940635|FG008|Overall Study|other than above|0|||
160876046|NCT01403948|580940636|FG009|Overall Study|other than above|0|||
160876047|NCT01090323|580940637|FG000|Overall Study|Adverse Event|12|||
160876048|NCT01090323|580940638|FG001|Overall Study|Adverse Event|2|||
160876049|NCT01090323|580940637|FG000|Overall Study|Abnormal Lab Values|3|||
160876050|NCT01090323|580940638|FG001|Overall Study|Abnormal Lab Values|1|||
160876051|NCT01090323|580940637|FG000|Overall Study|Abnormal Test Procedure Results|2|||
160876052|NCT01090323|580940638|FG001|Overall Study|Abnormal Test Procedure Results|0|||
160876053|NCT01090323|580940637|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160876054|NCT01090323|580940638|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160876055|NCT01090323|580940637|FG000|Overall Study|Condition no longer requires drug|5|||
160876056|NCT01090323|580940638|FG001|Overall Study|Condition no longer requires drug|4|||
160876057|NCT01090323|580940637|FG000|Overall Study|Protocol Violation|2|||
160876058|NCT01090323|580940638|FG001|Overall Study|Protocol Violation|1|||
160876059|NCT01090323|580940637|FG000|Overall Study|Withdrew consent|33|||
160876060|NCT01090323|580940638|FG001|Overall Study|Withdrew consent|11|||
160876061|NCT01090323|580940637|FG000|Overall Study|Lost to Follow-up|11|||
160876062|NCT01090323|580940638|FG001|Overall Study|Lost to Follow-up|6|||
160876063|NCT01090323|580940637|FG000|Overall Study|Administrative problems|6|||
160876064|NCT01090323|580940638|FG001|Overall Study|Administrative problems|4|||
160876065|NCT01090323|580940637|FG000|Overall Study|Death|1|||
160876066|NCT01090323|580940638|FG001|Overall Study|Death|2|||
160876067|NCT01090323|580940637|FG000|Overall Study|Stopped end of core|7|||
160876068|NCT01090323|580940638|FG001|Overall Study|Stopped end of core|0|||
160876069|NCT01090323|580940637|FG000|Overall Study|Stopped end of extension 1#|3|||
160876070|NCT01090323|580940638|FG001|Overall Study|Stopped end of extension 1#|1|||
160876071|NCT05498701|580940639|FG000|Period 3|Adverse Event|1|||
160876072|NCT05498701|580940640|FG001|Period 3|Adverse Event|0|||
160876073|NCT02424578|580940641|FG000|Overall Study|Withdrawal by Subject|0|||
160876074|NCT02424578|580940642|FG001|Overall Study|Withdrawal by Subject|1|||
160876075|NCT05343624|580940643|FG000|Overall Study|Chart review not completed|1|||
160876076|NCT00711477|580940645|FG000|Overall Study|Adverse Event|3|||
160876077|NCT00711477|580940646|FG001|Overall Study|Adverse Event|1|||
160876078|NCT00711477|580940645|FG000|Overall Study|Lost to Follow-up|0|||
160876079|NCT00711477|580940646|FG001|Overall Study|Lost to Follow-up|1|||
160876080|NCT00711477|580940645|FG000|Overall Study|Noncompliance|0|||
160876081|NCT00711477|580940646|FG001|Overall Study|Noncompliance|1|||
160876082|NCT02695420|580940647|FG000|Overall Study|Death|0|||
160876083|NCT02695420|580940648|FG001|Overall Study|Death|1|||
160876084|NCT02695420|580940649|FG002|Overall Study|Death|0|||
160876085|NCT02695420|580940650|FG003|Overall Study|Death|0|||
160876086|NCT02087423|580940651|FG000|Overall Study|Withdrawal by Subject|20|||
160876087|NCT02087423|580940652|FG001|Overall Study|Withdrawal by Subject|20|||
160876088|NCT02087423|580940653|FG002|Overall Study|Withdrawal by Subject|3|||
160876089|NCT02087423|580940651|FG000|Overall Study|Death|68|||
160876090|NCT02087423|580940652|FG001|Overall Study|Death|207|||
160876091|NCT02087423|580940653|FG002|Overall Study|Death|40|||
160876092|NCT02087423|580940651|FG000|Overall Study|Lost to Follow-up|0|||
160876093|NCT02087423|580940652|FG001|Overall Study|Lost to Follow-up|2|||
160876094|NCT02087423|580940653|FG002|Overall Study|Lost to Follow-up|0|||
160876095|NCT02087423|580940651|FG000|Overall Study|Terminated from study at final DCO|23|||
160876096|NCT02087423|580940652|FG001|Overall Study|Terminated from study at final DCO|36|||
160876097|NCT02087423|580940653|FG002|Overall Study|Terminated from study at final DCO|25|||
160876098|NCT02762370|580940654|FG000|Overall Study|Protocol Violation|1|||
160876099|NCT02762370|580940655|FG001|Overall Study|Protocol Violation|0|||
160876100|NCT00530816|580940659|FG000|Overall Study|Progressive Disease|16|||
160876101|NCT00530816|580940660|FG001|Overall Study|Progressive Disease|24|||
160876102|NCT00530816|580940661|FG002|Overall Study|Progressive Disease|24|||
160876103|NCT00530816|580940659|FG000|Overall Study|Adverse Event|6|||
160876104|NCT00530816|580940660|FG001|Overall Study|Adverse Event|13|||
160876105|NCT00530816|580940661|FG002|Overall Study|Adverse Event|7|||
160876106|NCT00530816|580940659|FG000|Overall Study|Other|3|||
160876107|NCT00530816|580940660|FG001|Overall Study|Other|3|||
160876108|NCT00530816|580940661|FG002|Overall Study|Other|4|||
160876109|NCT00530816|580940659|FG000|Overall Study|Withdrawal by Subject|1|||
160876110|NCT00530816|580940660|FG001|Overall Study|Withdrawal by Subject|2|||
160876111|NCT00530816|580940661|FG002|Overall Study|Withdrawal by Subject|6|||
160876112|NCT01516034|580940662|FG000|Overall Study|Physician Decision|1|||
160876113|NCT01516034|580940662|FG000|Overall Study|Lack of Efficacy|7|||
160876114|NCT01033448|580940663|FG000|Overall Study|Withdrawal by Subject|4|||
160876115|NCT01033448|580940663|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
160876116|NCT01033448|580940663|FG000|Overall Study|Lost to Follow-up|3|||
160876117|NCT01033448|580940663|FG000|Overall Study|Withdrew due to other reasons|3|||
160876118|NCT01033448|580940663|FG000|Overall Study|Unknown disposition|1|||
160876119|NCT00870584|580940667|FG000|Overall Study|Adverse Event|3|||
160876120|NCT00870584|580940668|FG001|Overall Study|Adverse Event|3|||
160876121|NCT00870584|580940667|FG000|Overall Study|Withdrawal by Subject|6|||
160876122|NCT00870584|580940668|FG001|Overall Study|Withdrawal by Subject|7|||
160876123|NCT00870584|580940667|FG000|Overall Study|Lost to Follow-up|5|||
160876124|NCT00870584|580940668|FG001|Overall Study|Lost to Follow-up|1|||
160876125|NCT00870584|580940667|FG000|Overall Study|Protocol Deviation|2|||
160876126|NCT00870584|580940668|FG001|Overall Study|Protocol Deviation|2|||
160767790|NCT03979313|580539001|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
160767791|NCT03979313|580539000|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
160767792|NCT03979313|580539001|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
160767793|NCT03979313|580539000|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
160767794|NCT03979313|580539001|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
160767795|NCT03979313|580539000|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
160767796|NCT03979313|580539001|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
160767797|NCT03979313|580539000|FG000|All Subjects|Any Other Reason|16|||
160767798|NCT03979313|580539001|FG001|All Subjects|Any Other Reason|23|||
160767799|NCT03979313|580539000|FG000|All Subjects|Covid-19|1|||
160767800|NCT03979313|580539001|FG001|All Subjects|Covid-19|3|||
160767801|NCT03979313|580539000|FG000|All Subjects|Withdrawal by Subject|35|||
160767802|NCT03979313|580539001|FG001|All Subjects|Withdrawal by Subject|44|||
160767803|NCT03979313|580539000|FG000|All Subjects|Death|0|||
160767804|NCT03979313|580539001|FG001|All Subjects|Death|5|||
160767805|NCT03979313|580539000|FG000|All Subjects|Lost to Follow-up|28|||
160767806|NCT03979313|580539001|FG001|All Subjects|Lost to Follow-up|61|||
160767807|NCT00089648|580539002|FG000|Overall Study|Adverse Event|7|||
160767808|NCT00089648|580539002|FG000|Overall Study|Withdrawal by Subject|1|||
160767809|NCT00089648|580539002|FG000|Overall Study|Lack of Efficacy|33|||
160767810|NCT00423605|580539003|FG000|Overall Study|Adverse Event|129|||
160767811|NCT00423605|580539003|FG000|Overall Study|Withdrawal by Subject|36|||
160767812|NCT00423605|580539003|FG000|Overall Study|Lost to Follow-up|15|||
160767813|NCT00423605|580539003|FG000|Overall Study|Lack of Efficacy|38|||
160767814|NCT00423605|580539003|FG000|Overall Study|Sponsor Decision|3|||
160767815|NCT00423605|580539003|FG000|Overall Study|Physician Decision|8|||
160767816|NCT00423605|580539003|FG000|Overall Study|Protocol Violation|7|||
160767817|NCT00423605|580539003|FG000|Overall Study|Not one of the pre-specified options|5|||
160767818|NCT03183908|580539004|FG000|Overall Study|Missing Symptom Diary Data|0|||
160767819|NCT03183908|580539005|FG001|Overall Study|Missing Symptom Diary Data|2|||
160767820|NCT00393367|580539006|FG000|Overall Study|Protocol Violation|2|||
160767821|NCT00393367|580539007|FG001|Overall Study|Protocol Violation|5|||
160767822|NCT00393367|580539006|FG000|Overall Study|Withdrawal by Subject|0|||
160767823|NCT00393367|580539007|FG001|Overall Study|Withdrawal by Subject|2|||
160767824|NCT01712178|580539008|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
160767825|NCT01712178|580539009|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
160767826|NCT01712178|580539008|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
160767827|NCT01712178|580539009|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
160767828|NCT01712178|580539008|FG000|Overall Study|Lost to Follow-up|0|||
160767829|NCT01712178|580539009|FG001|Overall Study|Lost to Follow-up|1|||
160767830|NCT00856180|580539010|FG000|Overall Study|Adverse Event|4|||
160767831|NCT00856180|580539010|FG000|Overall Study|Progressive Disease|16|||
160767832|NCT05001620|580539013|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
160767833|NCT05001620|580539014|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
160767834|NCT00486044|580539018|FG000|Overall Study|Withdrawal by Subject|2|||
160767835|NCT00486044|580539019|FG001|Overall Study|Withdrawal by Subject|1|||
160767836|NCT00486044|580539018|FG000|Overall Study|Adverse Event|0|||
160767837|NCT00486044|580539019|FG001|Overall Study|Adverse Event|1|||
160767838|NCT00486044|580539018|FG000|Overall Study|Lost to Follow-up|0|||
160767839|NCT00486044|580539019|FG001|Overall Study|Lost to Follow-up|1|||
160767840|NCT02701634|580539020|FG000|Overall Study|Adverse Event|2|||
160767841|NCT02701634|580539021|FG001|Overall Study|Adverse Event|3|||
160767842|NCT02701634|580539020|FG000|Overall Study|Death|1|||
160767843|NCT02701634|580539021|FG001|Overall Study|Death|0|||
160767844|NCT02701634|580539020|FG000|Overall Study|Investigator's Discretion|7|||
160767845|NCT02701634|580539021|FG001|Overall Study|Investigator's Discretion|4|||
160767846|NCT02701634|580539020|FG000|Overall Study|Study terminated by Sponsor|15|||
160767847|NCT02701634|580539021|FG001|Overall Study|Study terminated by Sponsor|17|||
160767848|NCT02701634|580539020|FG000|Overall Study|Withdrew Consent|6|||
160767849|NCT02701634|580539021|FG001|Overall Study|Withdrew Consent|7|||
160767850|NCT02701634|580539020|FG000|Overall Study|Randomized but not treated|1|||
160767851|NCT02701634|580539021|FG001|Overall Study|Randomized but not treated|0|||
160767852|NCT00537277|580539022|FG000|Overall Study|Adverse Event|1|||
160767853|NCT00537277|580539022|FG000|Overall Study|Lack of Efficacy|2|||
160767854|NCT00537277|580539022|FG000|Overall Study|Lost to Follow-up|12|||
160767855|NCT00537277|580539022|FG000|Overall Study|Protocol Violation|11|||
160876127|NCT02560025|580940669|FG000|Overall Study|Ineligible after consent/ registration|3|||
160876128|NCT01497366|580940670|FG000|Overall Study|Virologic failure|2|||
160876129|NCT01497366|580940671|FG001|Overall Study|Virologic failure|50|||
160876130|NCT01497366|580940670|FG000|Overall Study|Lost to Follow-up|11|||
160876131|NCT01497366|580940671|FG001|Overall Study|Lost to Follow-up|10|||
160876132|NCT01497366|580940670|FG000|Overall Study|Withdrawal by Subject|6|||
160876133|NCT01497366|580940671|FG001|Overall Study|Withdrawal by Subject|6|||
160876134|NCT01497366|580940670|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
160876135|NCT01497366|580940671|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
160876136|NCT01497366|580940670|FG000|Overall Study|Other|5|||
160876137|NCT01497366|580940671|FG001|Overall Study|Other|0|||
160876138|NCT01497366|580940670|FG000|Overall Study|Death|1|||
160876139|NCT01497366|580940671|FG001|Overall Study|Death|1|||
160876140|NCT01497366|580940670|FG000|Overall Study|Randomized but not treated|7|||
160876141|NCT01497366|580940671|FG001|Overall Study|Randomized but not treated|21|||
160876142|NCT02745080|580940681|FG000|Overall Study|Adverse Event|13|||
160876143|NCT02745080|580940682|FG001|Overall Study|Adverse Event|21|||
160876144|NCT02745080|580940681|FG000|Overall Study|Lack of Efficacy|11|||
160876145|NCT02745080|580940682|FG001|Overall Study|Lack of Efficacy|23|||
160876146|NCT02745080|580940681|FG000|Overall Study|Lost to Follow-up|3|||
160876147|NCT02745080|580940682|FG001|Overall Study|Lost to Follow-up|3|||
160876148|NCT02745080|580940681|FG000|Overall Study|Physician Decision|3|||
160876149|NCT02745080|580940682|FG001|Overall Study|Physician Decision|0|||
160876150|NCT02745080|580940681|FG000|Overall Study|Protocol Violation|3|||
160876151|NCT02745080|580940682|FG001|Overall Study|Protocol Violation|1|||
160876152|NCT02745080|580940681|FG000|Overall Study|Withdrawal by Subject|22|||
160876153|NCT02745080|580940682|FG001|Overall Study|Withdrawal by Subject|41|||
160876154|NCT00472030|580940686|FG000|Overall Study|Physician Decision|1|||
160876155|NCT00472030|580940687|FG001|Overall Study|Physician Decision|0|||
160876156|NCT00829504|580940688|FG000|First Intervention|Adverse Event|1|||
160876157|NCT00829504|580940689|FG001|First Intervention|Adverse Event|0|||
160876158|NCT00829504|580940688|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
160876159|NCT00829504|580940689|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
160876160|NCT00829504|580940688|FG000|Second Intervention|Physician Decision|1|||
160876161|NCT00829504|580940689|FG001|Second Intervention|Physician Decision|0|||
160876162|NCT00647270|580942013|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
160876163|NCT00647270|580942014|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
160876164|NCT00647270|580942015|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
160876165|NCT00647270|580942013|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
160876166|NCT00647270|580942014|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
160876167|NCT00647270|580942015|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
160876168|NCT00647270|580942013|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
160876169|NCT00647270|580942014|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
160876170|NCT00647270|580942015|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
160876171|NCT00647270|580942013|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
160876172|NCT00647270|580942014|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
160876173|NCT00647270|580942015|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
160876174|NCT00647270|580942013|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
160876175|NCT00647270|580942014|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
160876176|NCT00647270|580942015|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
160876177|NCT00647270|580942013|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
160876178|NCT00647270|580942014|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
160876179|NCT00647270|580942015|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
160876180|NCT00647270|580942013|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
160876181|NCT00647270|580942014|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
160876182|NCT00647270|580942015|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
160876183|NCT01743001|580942016|FG000|Overall Study|Physician Decision|1|||
160876184|NCT01743001|580942017|FG001|Overall Study|Physician Decision|0|||
160876185|NCT01743001|580942016|FG000|Overall Study|Pregnancy|1|||
160876186|NCT01743001|580942017|FG001|Overall Study|Pregnancy|0|||
160876187|NCT01743001|580942016|FG000|Overall Study|Death|1|||
160876188|NCT01743001|580942017|FG001|Overall Study|Death|0|||
160876189|NCT01864005|580942018|FG000|Overall Study|Protocol Violation|0|||
160876190|NCT01864005|580942019|FG001|Overall Study|Protocol Violation|1|||
160876191|NCT01864005|580942018|FG000|Overall Study|Withdrawal by Subject|0|||
160876192|NCT01864005|580942019|FG001|Overall Study|Withdrawal by Subject|1|||
160876193|NCT01864005|580942018|FG000|Overall Study|Incorrect enrolment|1|||
160876194|NCT01864005|580942019|FG001|Overall Study|Incorrect enrolment|0|||
160876195|NCT01864005|580942018|FG000|Overall Study|Disease need|1|||
160767856|NCT00537277|580539022|FG000|Overall Study|Unclassified|4|||
160767857|NCT00537277|580539022|FG000|Overall Study|Inability to tolerate trial medication|4|||
160767858|NCT00537277|580539022|FG000|Overall Study|Non-compliance with trial procedures|15|||
160767859|NCT04649359|580539023|FG000|Overall Study|Withdrawal by Subject|7|||
160767860|NCT04649359|580539024|FG001|Overall Study|Withdrawal by Subject|7|||
160767861|NCT04649359|580539023|FG000|Overall Study|Death|41|||
160767862|NCT04649359|580539024|FG001|Overall Study|Death|26|||
160767863|NCT04649359|580539023|FG000|Overall Study|Ongoing in the study|75|||
160767864|NCT04649359|580539024|FG001|Overall Study|Ongoing in the study|31|||
160767865|NCT03307174|580539025|FG000|Overall Study|Unplanned ICU Administrion|5|||
160767866|NCT03307174|580539026|FG001|Overall Study|Unplanned ICU Administrion|3|||
160767867|NCT03307174|580539025|FG000|Overall Study|Aborted Surgery|1|||
160767868|NCT03307174|580539026|FG001|Overall Study|Aborted Surgery|2|||
160767869|NCT03307174|580539025|FG000|Overall Study|Hypotension|6|||
160767870|NCT03307174|580539026|FG001|Overall Study|Hypotension|0|||
160767871|NCT03307174|580539025|FG000|Overall Study|Nonfunctional epidural|1|||
160767872|NCT03307174|580539026|FG001|Overall Study|Nonfunctional epidural|1|||
160767873|NCT03307174|580539025|FG000|Overall Study|Planned epidural removal|1|||
160767874|NCT03307174|580539026|FG001|Overall Study|Planned epidural removal|0|||
160767875|NCT03307174|580539025|FG000|Overall Study|Intrathecal catheter placement|0|||
160767876|NCT03307174|580539026|FG001|Overall Study|Intrathecal catheter placement|1|||
160767877|NCT05911841|580539027|FG000|Induction Period|Study Terminated by Sponsor|2|||
160767878|NCT05911841|580539028|FG001|Induction Period|Study Terminated by Sponsor|0|||
160767879|NCT05911841|580539029|FG002|Induction Period|Study Terminated by Sponsor|14|||
160767880|NCT05911841|580539030|FG003|Induction Period|Study Terminated by Sponsor|6|||
160767881|NCT05911841|580539031|FG004|Induction Period|Study Terminated by Sponsor|0|||
160767882|NCT05911841|580539032|FG005|Induction Period|Study Terminated by Sponsor|0|||
160876196|NCT01864005|580942019|FG001|Overall Study|Disease need|1|||
160876197|NCT01864005|580942018|FG000|Overall Study|Need GP IIb/IIIa|1|||
160876198|NCT01864005|580942019|FG001|Overall Study|Need GP IIb/IIIa|3|||
160876199|NCT02184572|580942020|FG000|Overall Study|Lost to Follow-up|29|||
160876200|NCT02184572|580942021|FG001|Overall Study|Lost to Follow-up|21|||
160876201|NCT02184572|580942020|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
160876202|NCT02184572|580942021|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
160876203|NCT02184572|580942020|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
160876204|NCT02184572|580942021|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
160876205|NCT02184572|580942020|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
160876206|NCT02184572|580942021|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
160876207|NCT02184572|580942020|FG000|Overall Study|Traveling Outside The Country|1|||
160876208|NCT02184572|580942021|FG001|Overall Study|Traveling Outside The Country|0|||
160876209|NCT02184572|580942020|FG000|Overall Study|Withdrawal by Subject|14|||
160876210|NCT02184572|580942021|FG001|Overall Study|Withdrawal by Subject|9|||
160876211|NCT03679754|580942025|FG000|Overall Study|Investigator request|1|||
160876212|NCT00964171|580942026|FG000|Overall Study|Death|5|||
160876213|NCT00080899|580942027|FG000|Overall Study|Adverse Event|1|||
160876214|NCT02872935|580942028|FG000|Overall Study|Other|0|||
160876215|NCT02872935|580942029|FG001|Overall Study|Other|1|||
160876216|NCT03179319|580942030|FG000|Overall Study|Lost to Follow-up|6|||
160876217|NCT03179319|580942031|FG001|Overall Study|Lost to Follow-up|0|||
160876218|NCT01120717|580942032|FG000|Overall Study|Withdrawal by Subject|11|||
160876219|NCT01120717|580942033|FG001|Overall Study|Withdrawal by Subject|6|||
160876220|NCT01120717|580942032|FG000|Overall Study|Adverse Event|10|||
160876221|NCT01120717|580942033|FG001|Overall Study|Adverse Event|6|||
160876222|NCT01120717|580942032|FG000|Overall Study|Protocol Deviation|2|||
160876223|NCT01120717|580942033|FG001|Overall Study|Protocol Deviation|5|||
160876224|NCT01120717|580942032|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160876225|NCT01120717|580942033|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160876226|NCT01120717|580942032|FG000|Overall Study|Lost to Follow-up|2|||
160876227|NCT01120717|580942033|FG001|Overall Study|Lost to Follow-up|3|||
160876228|NCT01120717|580942032|FG000|Overall Study|Death|3|||
160876229|NCT01120717|580942033|FG001|Overall Study|Death|1|||
160876230|NCT01120717|580942032|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
160876231|NCT01120717|580942033|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
160876232|NCT02640508|580942038|FG000|Overall Study|Death|19|||
160876233|NCT02640508|580942038|FG000|Overall Study|Withdrawal by Subject|8|||
160767883|NCT05911841|580539033|FG006|Induction Period|Study Terminated by Sponsor|0|||
160767884|NCT05911841|580539034|FG007|Induction Period|Study Terminated by Sponsor|0|||
160767885|NCT05911841|580539035|FG008|Induction Period|Study Terminated by Sponsor|0|||
160767886|NCT05911841|580539036|FG009|Induction Period|Study Terminated by Sponsor|0|||
160767887|NCT05911841|580539027|FG000|Induction Period|Withdrawal by Subject|4|||
160767888|NCT05911841|580539028|FG001|Induction Period|Withdrawal by Subject|3|||
160767889|NCT05911841|580539029|FG002|Induction Period|Withdrawal by Subject|4|||
160767890|NCT05911841|580539030|FG003|Induction Period|Withdrawal by Subject|6|||
160767891|NCT05911841|580539031|FG004|Induction Period|Withdrawal by Subject|0|||
160767892|NCT05911841|580539032|FG005|Induction Period|Withdrawal by Subject|0|||
160767893|NCT05911841|580539033|FG006|Induction Period|Withdrawal by Subject|0|||
160767894|NCT05911841|580539034|FG007|Induction Period|Withdrawal by Subject|0|||
160767895|NCT05911841|580539035|FG008|Induction Period|Withdrawal by Subject|0|||
160767896|NCT05911841|580539036|FG009|Induction Period|Withdrawal by Subject|0|||
160767897|NCT05911841|580539027|FG000|Induction Period|Lack of Efficacy|3|||
160876234|NCT02640508|580942038|FG000|Overall Study|Physician Decision|1|||
160876235|NCT02640508|580942038|FG000|Overall Study|Lost to Follow-up|1|||
160876236|NCT00865280|580942039|FG000|Overall Study|Withdrawal by Subject|4|||
160876237|NCT00865280|580942040|FG001|Overall Study|Withdrawal by Subject|1|||
160876238|NCT00865280|580942039|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
160876239|NCT00865280|580942040|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
160876240|NCT00865280|580942039|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
160876241|NCT00865280|580942040|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
160876242|NCT00865280|580942039|FG000|Overall Study|Exclusion Condition|1|||
160876243|NCT00865280|580942040|FG001|Overall Study|Exclusion Condition|0|||
160767898|NCT05911841|580539028|FG001|Induction Period|Lack of Efficacy|0|||
160767899|NCT05911841|580539029|FG002|Induction Period|Lack of Efficacy|3|||
160767900|NCT05911841|580539030|FG003|Induction Period|Lack of Efficacy|3|||
160767901|NCT05911841|580539031|FG004|Induction Period|Lack of Efficacy|0|||
160767902|NCT05911841|580539032|FG005|Induction Period|Lack of Efficacy|0|||
160767903|NCT05911841|580539033|FG006|Induction Period|Lack of Efficacy|0|||
160767904|NCT05911841|580539034|FG007|Induction Period|Lack of Efficacy|0|||
160767905|NCT05911841|580539035|FG008|Induction Period|Lack of Efficacy|0|||
160767906|NCT05911841|580539036|FG009|Induction Period|Lack of Efficacy|0|||
160876244|NCT00865280|580942039|FG000|Overall Study|Adverse Event|0|||
160876245|NCT00865280|580942040|FG001|Overall Study|Adverse Event|1|||
160876246|NCT00329797|580942041|FG000|Overall Study|Protocol Violation|1|||
160876247|NCT00329797|580942042|FG001|Overall Study|Protocol Violation|0|||
160876248|NCT00329797|580942041|FG000|Overall Study|Withdrawal by Subject|6|||
160876249|NCT00329797|580942042|FG001|Overall Study|Withdrawal by Subject|6|||
160876250|NCT03091348|580942049|FG000|Overall Study|Lost to Follow-up|2|||
160876251|NCT03091348|580942050|FG001|Overall Study|Lost to Follow-up|1|||
160876252|NCT04534686|580942051|FG000|Baseline Measurement|Lost to Follow-up|4|||
160876253|NCT04534686|580942052|FG001|Baseline Measurement|Lost to Follow-up|6|||
160876254|NCT04534686|580942051|FG000|Baseline Measurement|Withdrawal by Subject|3|||
160876255|NCT04534686|580942052|FG001|Baseline Measurement|Withdrawal by Subject|1|||
160876256|NCT04534686|580942051|FG000|Intervention|Withdrawal by Subject|2|||
160876257|NCT04534686|580942052|FG001|Intervention|Withdrawal by Subject|2|||
160876258|NCT03179605|580942053|FG000|Overall Study|Withdrawal by Subject|1|||
160876259|NCT00635999|580942054|FG000|Overall Study|Withdrawal by Subject|4|||
160876260|NCT00635999|580942055|FG001|Overall Study|Withdrawal by Subject|2|||
160876261|NCT00635999|580942056|FG002|Overall Study|Withdrawal by Subject|1|||
160876262|NCT01396070|580942058|FG000|Overall Study|Withdrawal by Subject|2|||
160876263|NCT01396070|580942058|FG000|Overall Study|Death|2|||
160876264|NCT01396070|580942058|FG000|Overall Study|Adverse Event|8|||
160876265|NCT01396070|580942058|FG000|Overall Study|Physician Decision|3|||
160876266|NCT01396070|580942058|FG000|Overall Study|Lack of Efficacy|4|||
160876267|NCT02636361|580942059|FG000|Period 4|Physician Decision|0|||
160876268|NCT02636361|580942060|FG001|Period 4|Physician Decision|0|||
160876269|NCT02636361|580942061|FG002|Period 4|Physician Decision|0|||
160876270|NCT02636361|580942062|FG003|Period 4|Physician Decision|1|||
160876271|NCT02636361|580942063|FG004|Period 4|Physician Decision|0|||
160876272|NCT03037580|580942068|FG000|Overall Study|Withdrawal by Subject|3|||
160876273|NCT03037580|580942069|FG001|Overall Study|Withdrawal by Subject|0|||
160876274|NCT03037580|580942068|FG000|Overall Study|Adverse Event|1|||
160876275|NCT03037580|580942069|FG001|Overall Study|Adverse Event|0|||
160876276|NCT03037580|580942068|FG000|Overall Study|Study Terminated by Sponsor|12|||
160876277|NCT03037580|580942069|FG001|Overall Study|Study Terminated by Sponsor|15|||
160876278|NCT03037580|580942068|FG000|Overall Study|Death|0|||
160876279|NCT03037580|580942069|FG001|Overall Study|Death|1|||
160876280|NCT02036853|580942070|FG000|Overall Study|Adverse Event|0|||
160876281|NCT02036853|580942071|FG001|Overall Study|Adverse Event|2|||
160876282|NCT02036853|580942070|FG000|Overall Study|Lack of Efficacy|0|||
160876283|NCT02036853|580942071|FG001|Overall Study|Lack of Efficacy|2|||
160876284|NCT02036853|580942070|FG000|Overall Study|Physician Decision|0|||
160876285|NCT02036853|580942071|FG001|Overall Study|Physician Decision|1|||
160876286|NCT02036853|580942070|FG000|Overall Study|Withdrawal by Subject|0|||
160876287|NCT02036853|580942071|FG001|Overall Study|Withdrawal by Subject|1|||
160876288|NCT00228553|580942072|FG000|Overall Study|Adverse Event|112|||
160876289|NCT00228553|580942072|FG000|Overall Study|Lack of Efficacy|34|||
160876290|NCT00228553|580942072|FG000|Overall Study|Lost to Follow-up|67|||
160876291|NCT00228553|580942072|FG000|Overall Study|Physician Decision|48|||
160876292|NCT00228553|580942072|FG000|Overall Study|Protocol Violation|6|||
160876293|NCT00228553|580942072|FG000|Overall Study|Withdrawal by Subject|115|||
160876294|NCT00228553|580942072|FG000|Overall Study|Pregnancy|2|||
160876295|NCT00228553|580942072|FG000|Overall Study|Miscellaneous|46|||
160876296|NCT04530136|580942073|FG000|Overall Study|Lost to Follow-up|2|||
160876297|NCT04530136|580942074|FG001|Overall Study|Lost to Follow-up|3|||
160876298|NCT04530136|580942073|FG000|Overall Study|Withdrawal by Subject|1|||
160876299|NCT04530136|580942074|FG001|Overall Study|Withdrawal by Subject|0|||
160876300|NCT04530136|580942073|FG000|Overall Study|Death|0|||
160876301|NCT04530136|580942074|FG001|Overall Study|Death|1|||
160767907|NCT05911841|580539027|FG000|Induction Period|Adverse Event|3|||
160767908|NCT05911841|580539028|FG001|Induction Period|Adverse Event|1|||
160876302|NCT00499590|580942078|FG000|Overall Study|Study Terminated|112|||
160876303|NCT00499590|580942079|FG001|Overall Study|Study Terminated|112|||
160876304|NCT00499590|580942080|FG002|Overall Study|Study Terminated|112|||
160537714|NCT01438489|579698927|FG002|Overall Study|Death|1|||
160537715|NCT01438489|579698925|FG000|Overall Study|Sponsor decision|4|||
160537716|NCT01438489|579698926|FG001|Overall Study|Sponsor decision|1|||
160537717|NCT01438489|579698927|FG002|Overall Study|Sponsor decision|4|||
160537718|NCT01438489|579698925|FG000|Overall Study|Subject choice/Subject moved|2|||
160537719|NCT01438489|579698926|FG001|Overall Study|Subject choice/Subject moved|1|||
160767909|NCT05911841|580539029|FG002|Induction Period|Adverse Event|2|||
160767910|NCT05911841|580539030|FG003|Induction Period|Adverse Event|0|||
160767911|NCT05911841|580539031|FG004|Induction Period|Adverse Event|0|||
160767912|NCT05911841|580539032|FG005|Induction Period|Adverse Event|0|||
160767913|NCT05911841|580539033|FG006|Induction Period|Adverse Event|0|||
160767914|NCT05911841|580539034|FG007|Induction Period|Adverse Event|0|||
160767915|NCT05911841|580539035|FG008|Induction Period|Adverse Event|0|||
160767916|NCT05911841|580539036|FG009|Induction Period|Adverse Event|0|||
160767917|NCT05911841|580539027|FG000|Induction Period|Assigned Treatment by Mistake|0|||
160767918|NCT05911841|580539028|FG001|Induction Period|Assigned Treatment by Mistake|1|||
160767919|NCT05911841|580539029|FG002|Induction Period|Assigned Treatment by Mistake|0|||
160767920|NCT05911841|580539030|FG003|Induction Period|Assigned Treatment by Mistake|1|||
160767921|NCT05911841|580539031|FG004|Induction Period|Assigned Treatment by Mistake|0|||
160767922|NCT05911841|580539032|FG005|Induction Period|Assigned Treatment by Mistake|0|||
160767923|NCT05911841|580539033|FG006|Induction Period|Assigned Treatment by Mistake|0|||
160767924|NCT05911841|580539034|FG007|Induction Period|Assigned Treatment by Mistake|0|||
160767925|NCT05911841|580539035|FG008|Induction Period|Assigned Treatment by Mistake|0|||
160767926|NCT05911841|580539036|FG009|Induction Period|Assigned Treatment by Mistake|0|||
160767927|NCT05911841|580539027|FG000|Induction Period|Lost to Follow-up|0|||
160767928|NCT05911841|580539028|FG001|Induction Period|Lost to Follow-up|0|||
160876305|NCT00499590|580942078|FG000|Overall Study|Not treated|1|||
160876306|NCT00499590|580942079|FG001|Overall Study|Not treated|0|||
160876307|NCT00499590|580942080|FG002|Overall Study|Not treated|1|||
160876308|NCT02633020|580942084|FG000|Overall Study|Adverse Event|1|||
160876309|NCT02633020|580942085|FG001|Overall Study|Adverse Event|0|||
160876310|NCT00934440|580942086|FG000|Overall Study|Lost to Follow-up|1|||
160876311|NCT05661851|580942087|FG000|Overall Study|Protocol Violation|1|||
160876312|NCT05661851|580942088|FG001|Overall Study|Protocol Violation|1|||
160876313|NCT05661851|580942087|FG000|Overall Study|Covid-19 Related|3|||
160876314|NCT05661851|580942088|FG001|Overall Study|Covid-19 Related|4|||
160876315|NCT05661851|580942087|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
160876316|NCT05661851|580942088|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
160876317|NCT05661851|580942087|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
160876318|NCT05661851|580942088|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
160876319|NCT02152956|580942089|FG000|Overall Study|Adverse Event|0|||
160876320|NCT02152956|580942090|FG001|Overall Study|Adverse Event|0|||
160876321|NCT02152956|580942091|FG002|Overall Study|Adverse Event|0|||
160876322|NCT02152956|580942092|FG003|Overall Study|Adverse Event|0|||
160876323|NCT02152956|580942093|FG004|Overall Study|Adverse Event|0|||
160876324|NCT02152956|580942094|FG005|Overall Study|Adverse Event|0|||
160876325|NCT02152956|580942095|FG006|Overall Study|Adverse Event|0|||
160876326|NCT02152956|580942096|FG007|Overall Study|Adverse Event|0|||
160876327|NCT02152956|580942097|FG008|Overall Study|Adverse Event|0|||
160876328|NCT02152956|580942098|FG009|Overall Study|Adverse Event|0|||
160876329|NCT02152956|580942099|FG010|Overall Study|Adverse Event|0|||
160876330|NCT02152956|580942100|FG011|Overall Study|Adverse Event|4|||
160876331|NCT02152956|580942101|FG012|Overall Study|Adverse Event|0|||
160876332|NCT02152956|580942089|FG000|Overall Study|Death|0|||
160876333|NCT02152956|580942090|FG001|Overall Study|Death|3|||
160876334|NCT02152956|580942091|FG002|Overall Study|Death|3|||
160876335|NCT02152956|580942092|FG003|Overall Study|Death|4|||
160876336|NCT02152956|580942093|FG004|Overall Study|Death|1|||
160876337|NCT02152956|580942094|FG005|Overall Study|Death|2|||
160876338|NCT02152956|580942095|FG006|Overall Study|Death|6|||
160876339|NCT02152956|580942096|FG007|Overall Study|Death|6|||
160876340|NCT02152956|580942097|FG008|Overall Study|Death|4|||
160876341|NCT02152956|580942098|FG009|Overall Study|Death|5|||
160876342|NCT02152956|580942099|FG010|Overall Study|Death|3|||
160876343|NCT02152956|580942100|FG011|Overall Study|Death|143|||
160876344|NCT02152956|580942101|FG012|Overall Study|Death|12|||
160876345|NCT02152956|580942089|FG000|Overall Study|Lost to Follow-up|0|||
160876346|NCT02152956|580942090|FG001|Overall Study|Lost to Follow-up|1|||
160876347|NCT02152956|580942091|FG002|Overall Study|Lost to Follow-up|0|||
160876348|NCT02152956|580942092|FG003|Overall Study|Lost to Follow-up|0|||
160876349|NCT02152956|580942093|FG004|Overall Study|Lost to Follow-up|0|||
160876350|NCT02152956|580942094|FG005|Overall Study|Lost to Follow-up|0|||
160876351|NCT02152956|580942095|FG006|Overall Study|Lost to Follow-up|0|||
160876352|NCT02152956|580942096|FG007|Overall Study|Lost to Follow-up|0|||
160876353|NCT02152956|580942097|FG008|Overall Study|Lost to Follow-up|0|||
160876354|NCT02152956|580942098|FG009|Overall Study|Lost to Follow-up|0|||
160876355|NCT02152956|580942099|FG010|Overall Study|Lost to Follow-up|0|||
160876356|NCT02152956|580942100|FG011|Overall Study|Lost to Follow-up|3|||
160876357|NCT02152956|580942101|FG012|Overall Study|Lost to Follow-up|0|||
160876358|NCT02152956|580942089|FG000|Overall Study|Withdrawal by Subject|1|||
160876359|NCT02152956|580942090|FG001|Overall Study|Withdrawal by Subject|0|||
160876360|NCT02152956|580942091|FG002|Overall Study|Withdrawal by Subject|1|||
160876361|NCT02152956|580942092|FG003|Overall Study|Withdrawal by Subject|0|||
160876362|NCT02152956|580942093|FG004|Overall Study|Withdrawal by Subject|2|||
160876363|NCT02152956|580942094|FG005|Overall Study|Withdrawal by Subject|2|||
160876364|NCT02152956|580942095|FG006|Overall Study|Withdrawal by Subject|0|||
160876365|NCT02152956|580942096|FG007|Overall Study|Withdrawal by Subject|0|||
160876366|NCT02152956|580942097|FG008|Overall Study|Withdrawal by Subject|1|||
160876367|NCT02152956|580942098|FG009|Overall Study|Withdrawal by Subject|0|||
160876368|NCT02152956|580942099|FG010|Overall Study|Withdrawal by Subject|0|||
160876369|NCT02152956|580942100|FG011|Overall Study|Withdrawal by Subject|4|||
160876370|NCT02152956|580942101|FG012|Overall Study|Withdrawal by Subject|0|||
160876371|NCT02152956|580942089|FG000|Overall Study|Physician Decision|0|||
160876372|NCT02152956|580942090|FG001|Overall Study|Physician Decision|0|||
160876373|NCT02152956|580942091|FG002|Overall Study|Physician Decision|0|||
160876374|NCT02152956|580942092|FG003|Overall Study|Physician Decision|0|||
160876375|NCT02152956|580942093|FG004|Overall Study|Physician Decision|0|||
160876376|NCT02152956|580942094|FG005|Overall Study|Physician Decision|0|||
160876377|NCT02152956|580942095|FG006|Overall Study|Physician Decision|0|||
160876378|NCT02152956|580942096|FG007|Overall Study|Physician Decision|0|||
160876379|NCT02152956|580942097|FG008|Overall Study|Physician Decision|0|||
160876380|NCT02152956|580942098|FG009|Overall Study|Physician Decision|0|||
160876381|NCT02152956|580942099|FG010|Overall Study|Physician Decision|0|||
160876382|NCT02152956|580942100|FG011|Overall Study|Physician Decision|1|||
160876383|NCT02152956|580942101|FG012|Overall Study|Physician Decision|0|||
160876384|NCT02152956|580942089|FG000|Overall Study|Study terminated by sponsor|0|||
160876385|NCT02152956|580942090|FG001|Overall Study|Study terminated by sponsor|0|||
160876386|NCT02152956|580942091|FG002|Overall Study|Study terminated by sponsor|0|||
160876387|NCT02152956|580942092|FG003|Overall Study|Study terminated by sponsor|0|||
160876388|NCT02152956|580942093|FG004|Overall Study|Study terminated by sponsor|0|||
160876389|NCT02152956|580942094|FG005|Overall Study|Study terminated by sponsor|0|||
160876390|NCT02152956|580942095|FG006|Overall Study|Study terminated by sponsor|0|||
160876391|NCT02152956|580942096|FG007|Overall Study|Study terminated by sponsor|0|||
160876392|NCT02152956|580942097|FG008|Overall Study|Study terminated by sponsor|0|||
160876393|NCT02152956|580942098|FG009|Overall Study|Study terminated by sponsor|0|||
160876394|NCT02152956|580942099|FG010|Overall Study|Study terminated by sponsor|0|||
160876395|NCT02152956|580942100|FG011|Overall Study|Study terminated by sponsor|29|||
160876396|NCT02152956|580942101|FG012|Overall Study|Study terminated by sponsor|0|||
160876397|NCT02152956|580942089|FG000|Overall Study|progressive disease|0|||
160767929|NCT05911841|580539029|FG002|Induction Period|Lost to Follow-up|1|||
160767930|NCT05911841|580539030|FG003|Induction Period|Lost to Follow-up|1|||
160767931|NCT05911841|580539031|FG004|Induction Period|Lost to Follow-up|0|||
160767932|NCT05911841|580539032|FG005|Induction Period|Lost to Follow-up|0|||
160767933|NCT05911841|580539033|FG006|Induction Period|Lost to Follow-up|0|||
160767934|NCT05911841|580539034|FG007|Induction Period|Lost to Follow-up|0|||
160767935|NCT05911841|580539035|FG008|Induction Period|Lost to Follow-up|0|||
160767936|NCT05911841|580539036|FG009|Induction Period|Lost to Follow-up|0|||
160767937|NCT05911841|580539027|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
160767938|NCT05911841|580539028|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
160767939|NCT05911841|580539029|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
160767940|NCT05911841|580539030|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
160767941|NCT05911841|580539031|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
160767942|NCT05911841|580539032|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
160767943|NCT05911841|580539033|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
160767944|NCT05911841|580539034|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
160767945|NCT05911841|580539035|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
160767946|NCT05911841|580539036|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
160767947|NCT05911841|580539027|FG000|Maintenance Period|Lack of Efficacy|0|||
160767948|NCT05911841|580539028|FG001|Maintenance Period|Lack of Efficacy|0|||
160767949|NCT05911841|580539029|FG002|Maintenance Period|Lack of Efficacy|0|||
160767950|NCT05911841|580539030|FG003|Maintenance Period|Lack of Efficacy|0|||
160767951|NCT05911841|580539031|FG004|Maintenance Period|Lack of Efficacy|1|||
160767952|NCT05911841|580539032|FG005|Maintenance Period|Lack of Efficacy|0|||
160767953|NCT05911841|580539033|FG006|Maintenance Period|Lack of Efficacy|1|||
160767954|NCT05911841|580539034|FG007|Maintenance Period|Lack of Efficacy|0|||
160767955|NCT05911841|580539035|FG008|Maintenance Period|Lack of Efficacy|0|||
160767956|NCT05911841|580539036|FG009|Maintenance Period|Lack of Efficacy|0|||
160767957|NCT05911841|580539027|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
160767958|NCT05911841|580539028|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
160767959|NCT05911841|580539029|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
160767960|NCT05911841|580539030|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
160767961|NCT05911841|580539031|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
160767962|NCT05911841|580539032|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
160767963|NCT05911841|580539033|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
160767964|NCT05911841|580539034|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
160767965|NCT05911841|580539035|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
160767966|NCT05911841|580539036|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
160767967|NCT05911841|580539027|FG000|Maintenance Period|Withdrawal by Subject|0|||
160767968|NCT05911841|580539028|FG001|Maintenance Period|Withdrawal by Subject|0|||
160767969|NCT05911841|580539029|FG002|Maintenance Period|Withdrawal by Subject|0|||
160767970|NCT05911841|580539030|FG003|Maintenance Period|Withdrawal by Subject|0|||
160767971|NCT05911841|580539031|FG004|Maintenance Period|Withdrawal by Subject|0|||
160876398|NCT02152956|580942090|FG001|Overall Study|progressive disease|0|||
160767972|NCT05911841|580539032|FG005|Maintenance Period|Withdrawal by Subject|1|||
160767973|NCT05911841|580539033|FG006|Maintenance Period|Withdrawal by Subject|0|||
160767974|NCT05911841|580539034|FG007|Maintenance Period|Withdrawal by Subject|1|||
160767975|NCT05911841|580539035|FG008|Maintenance Period|Withdrawal by Subject|0|||
160767976|NCT05911841|580539036|FG009|Maintenance Period|Withdrawal by Subject|0|||
160767977|NCT05911841|580539027|FG000|Maintenance Period|Adverse Event|0|||
160767978|NCT05911841|580539028|FG001|Maintenance Period|Adverse Event|0|||
160876399|NCT02152956|580942091|FG002|Overall Study|progressive disease|0|||
160876400|NCT02152956|580942092|FG003|Overall Study|progressive disease|0|||
160876401|NCT02152956|580942093|FG004|Overall Study|progressive disease|0|||
160876402|NCT02152956|580942094|FG005|Overall Study|progressive disease|0|||
160767979|NCT05911841|580539029|FG002|Maintenance Period|Adverse Event|0|||
160767980|NCT05911841|580539030|FG003|Maintenance Period|Adverse Event|0|||
160767981|NCT05911841|580539031|FG004|Maintenance Period|Adverse Event|0|||
160767982|NCT05911841|580539032|FG005|Maintenance Period|Adverse Event|0|||
160767983|NCT05911841|580539033|FG006|Maintenance Period|Adverse Event|0|||
160767984|NCT05911841|580539034|FG007|Maintenance Period|Adverse Event|1|||
160767985|NCT05911841|580539035|FG008|Maintenance Period|Adverse Event|0|||
160767986|NCT05911841|580539036|FG009|Maintenance Period|Adverse Event|0|||
160767987|NCT05911841|580539027|FG000|Escape Period|Adverse Event|0|||
160767988|NCT05911841|580539028|FG001|Escape Period|Adverse Event|0|||
160767989|NCT05911841|580539029|FG002|Escape Period|Adverse Event|0|||
160767990|NCT05911841|580539030|FG003|Escape Period|Adverse Event|0|||
160767991|NCT05911841|580539031|FG004|Escape Period|Adverse Event|0|||
160767992|NCT05911841|580539032|FG005|Escape Period|Adverse Event|0|||
160767993|NCT05911841|580539033|FG006|Escape Period|Adverse Event|0|||
160767994|NCT05911841|580539034|FG007|Escape Period|Adverse Event|0|||
160767995|NCT05911841|580539035|FG008|Escape Period|Adverse Event|0|||
160767996|NCT05911841|580539036|FG009|Escape Period|Adverse Event|1|||
160767997|NCT05911841|580539027|FG000|Escape Period|Lack of Efficacy|0|||
160767998|NCT05911841|580539028|FG001|Escape Period|Lack of Efficacy|0|||
160767999|NCT05911841|580539029|FG002|Escape Period|Lack of Efficacy|0|||
160768000|NCT05911841|580539030|FG003|Escape Period|Lack of Efficacy|0|||
160768001|NCT05911841|580539031|FG004|Escape Period|Lack of Efficacy|0|||
160768002|NCT05911841|580539032|FG005|Escape Period|Lack of Efficacy|0|||
160768003|NCT05911841|580539033|FG006|Escape Period|Lack of Efficacy|0|||
160768004|NCT05911841|580539034|FG007|Escape Period|Lack of Efficacy|0|||
160768005|NCT05911841|580539035|FG008|Escape Period|Lack of Efficacy|0|||
160768006|NCT05911841|580539036|FG009|Escape Period|Lack of Efficacy|31|||
160768007|NCT05911841|580539027|FG000|Escape Period|Lost to Follow-up|0|||
160768008|NCT05911841|580539028|FG001|Escape Period|Lost to Follow-up|0|||
160768009|NCT05911841|580539029|FG002|Escape Period|Lost to Follow-up|0|||
160768010|NCT05911841|580539030|FG003|Escape Period|Lost to Follow-up|0|||
160768011|NCT05911841|580539031|FG004|Escape Period|Lost to Follow-up|0|||
160768012|NCT05911841|580539032|FG005|Escape Period|Lost to Follow-up|0|||
160768013|NCT05911841|580539033|FG006|Escape Period|Lost to Follow-up|0|||
160768014|NCT05911841|580539034|FG007|Escape Period|Lost to Follow-up|0|||
160768015|NCT05911841|580539035|FG008|Escape Period|Lost to Follow-up|0|||
160768016|NCT05911841|580539036|FG009|Escape Period|Lost to Follow-up|1|||
160768017|NCT05911841|580539027|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
160768018|NCT05911841|580539028|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
160768019|NCT05911841|580539029|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
160768020|NCT05911841|580539030|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
160768021|NCT05911841|580539031|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
160768022|NCT05911841|580539032|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
160768023|NCT05911841|580539033|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
160768024|NCT05911841|580539034|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
160768025|NCT05911841|580539035|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
160768026|NCT05911841|580539036|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
160768027|NCT05911841|580539027|FG000|Escape Period|Site Terminated by Sponsor|0|||
160768028|NCT05911841|580539028|FG001|Escape Period|Site Terminated by Sponsor|0|||
160768029|NCT05911841|580539029|FG002|Escape Period|Site Terminated by Sponsor|0|||
160768030|NCT05911841|580539030|FG003|Escape Period|Site Terminated by Sponsor|0|||
160768031|NCT05911841|580539031|FG004|Escape Period|Site Terminated by Sponsor|0|||
160768032|NCT05911841|580539032|FG005|Escape Period|Site Terminated by Sponsor|0|||
160768033|NCT05911841|580539033|FG006|Escape Period|Site Terminated by Sponsor|0|||
160768034|NCT05911841|580539034|FG007|Escape Period|Site Terminated by Sponsor|0|||
160768035|NCT05911841|580539035|FG008|Escape Period|Site Terminated by Sponsor|0|||
160768036|NCT05911841|580539036|FG009|Escape Period|Site Terminated by Sponsor|1|||
160768037|NCT05911841|580539027|FG000|Escape Period|Study Terminated by Sponsor|0|||
160768038|NCT05911841|580539028|FG001|Escape Period|Study Terminated by Sponsor|0|||
160768039|NCT05911841|580539029|FG002|Escape Period|Study Terminated by Sponsor|0|||
160768040|NCT05911841|580539030|FG003|Escape Period|Study Terminated by Sponsor|0|||
160768041|NCT05911841|580539031|FG004|Escape Period|Study Terminated by Sponsor|0|||
160768042|NCT05911841|580539032|FG005|Escape Period|Study Terminated by Sponsor|0|||
160768043|NCT05911841|580539033|FG006|Escape Period|Study Terminated by Sponsor|0|||
160768044|NCT05911841|580539034|FG007|Escape Period|Study Terminated by Sponsor|0|||
160768045|NCT05911841|580539035|FG008|Escape Period|Study Terminated by Sponsor|0|||
160768046|NCT05911841|580539036|FG009|Escape Period|Study Terminated by Sponsor|34|||
160768047|NCT05911841|580539027|FG000|Escape Period|Withdrawal by Subject|0|||
160768048|NCT05911841|580539028|FG001|Escape Period|Withdrawal by Subject|0|||
160768049|NCT05911841|580539029|FG002|Escape Period|Withdrawal by Subject|0|||
160768050|NCT05911841|580539030|FG003|Escape Period|Withdrawal by Subject|0|||
160768051|NCT05911841|580539031|FG004|Escape Period|Withdrawal by Subject|0|||
160768052|NCT05911841|580539032|FG005|Escape Period|Withdrawal by Subject|0|||
160876403|NCT02152956|580942095|FG006|Overall Study|progressive disease|0|||
160876404|NCT02152956|580942096|FG007|Overall Study|progressive disease|0|||
160876405|NCT02152956|580942097|FG008|Overall Study|progressive disease|1|||
160876406|NCT02152956|580942098|FG009|Overall Study|progressive disease|0|||
160876407|NCT02152956|580942099|FG010|Overall Study|progressive disease|0|||
160876408|NCT02152956|580942100|FG011|Overall Study|progressive disease|1|||
160876409|NCT02152956|580942101|FG012|Overall Study|progressive disease|0|||
160876410|NCT01014910|580942102|FG000|Overall Study|Withdrawal by Subject|0|||
160876411|NCT01014910|580942103|FG001|Overall Study|Withdrawal by Subject|2|||
160876412|NCT03753789|580942104|FG000|Overall Study|Withdrawal by Subject|2|||
160876413|NCT01136785|580942106|FG000|Overall Study|Protocol Violation|2|||
160876414|NCT01136785|580942107|FG001|Overall Study|Protocol Violation|1|||
160876415|NCT02873429|580942108|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
160876416|NCT02873429|580942109|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
160876417|NCT02873429|580942108|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
160876418|NCT02873429|580942109|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
160876419|NCT02873429|580942108|FG000|16 Weeks|Lost to Follow-up|3|||
160876420|NCT02873429|580942109|FG001|16 Weeks|Lost to Follow-up|0|||
160876421|NCT00612807|580942110|FG000|Overall Study|Withdrawal by Subject|2|||
160876422|NCT00612807|580942111|FG001|Overall Study|Withdrawal by Subject|0|||
160876423|NCT00744042|580942114|FG000|Overall Study|Withdrawal by Subject|1|||
160876424|NCT00853567|580942115|FG000|Overall Study|Study prematurely terminated|71|||
160876425|NCT02055118|580942119|FG000|Overall Study|Withdrawal by Subject|0|||
160876426|NCT02055118|580942120|FG001|Overall Study|Withdrawal by Subject|2|||
160876427|NCT02055118|580942121|FG002|Overall Study|Withdrawal by Subject|0|||
160876428|NCT02281383|580942123|FG000|Overall Study|Progressive Disease|1|||
160876429|NCT02281383|580942123|FG000|Overall Study|Withdrawal by Subject|6|||
160876430|NCT02281383|580942123|FG000|Overall Study|Protocol Violation|2|||
160876431|NCT02281383|580942123|FG000|Overall Study|Death|1|||
160876432|NCT02281383|580942123|FG000|Overall Study|Adverse Event|2|||
160876433|NCT00599339|580942126|FG000|Overall Study|Adverse Event|79|||
160876434|NCT00599339|580942126|FG000|Overall Study|Withdrawal by Subject|137|||
160876435|NCT00599339|580942126|FG000|Overall Study|Other Reason|179|||
160876436|NCT00599339|580942126|FG000|Overall Study|Lost to Follow-up|221|||
160876437|NCT00599339|580942126|FG000|Overall Study|No valid data consent|36|||
160876438|NCT00599339|580942126|FG000|Overall Study|Study Termination Status Unknown|12|||
160876439|NCT05564052|580942127|FG000|Overall Study|Withdrawal by Subject|0|||
160876440|NCT05564052|580942128|FG001|Overall Study|Withdrawal by Subject|0|||
160876441|NCT05564052|580942129|FG002|Overall Study|Withdrawal by Subject|0|||
160876442|NCT05564052|580942130|FG003|Overall Study|Withdrawal by Subject|1|||
160876443|NCT01821560|580942131|FG000|Overall Study|Lost to Follow-up|5|||
160876444|NCT01821560|580942132|FG001|Overall Study|Lost to Follow-up|5|||
160876445|NCT01821560|580942131|FG000|Overall Study|Withdrawal by Subject|1|||
160876446|NCT01821560|580942132|FG001|Overall Study|Withdrawal by Subject|1|||
160876447|NCT01821560|580942131|FG000|Overall Study|Protocol Violation|0|||
160876448|NCT01821560|580942132|FG001|Overall Study|Protocol Violation|1|||
160876449|NCT04189224|580942134|FG000|Period 2|Adverse Event|0|||
160537720|NCT01438489|579698927|FG002|Overall Study|Subject choice/Subject moved|1|||
160876450|NCT04189224|580942135|FG001|Period 2|Adverse Event|1|||
160876451|NCT03338959|580943545|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
160876452|NCT03338959|580943545|FG000|Overall Study|Physician Decision|1|||
160537721|NCT01438489|579698925|FG000|Overall Study|Investigator decision|0|||
160876453|NCT00409331|580943547|FG000|Overall Study|Physician Decision|1|||
160876454|NCT00281658|580943548|FG000|Randomized Phase|Adverse Event|0|||
160876455|NCT00281658|580943549|FG001|Randomized Phase|Adverse Event|2|||
160876456|NCT00281658|580943550|FG002|Randomized Phase|Adverse Event|0|||
160876457|NCT00281658|580943551|FG003|Randomized Phase|Adverse Event|0|||
160876458|NCT00281658|580943548|FG000|Randomized Phase|Lost to Follow-up|34|||
160876459|NCT00281658|580943549|FG001|Randomized Phase|Lost to Follow-up|27|||
160876460|NCT00281658|580943550|FG002|Randomized Phase|Lost to Follow-up|0|||
160768053|NCT05911841|580539033|FG006|Escape Period|Withdrawal by Subject|0|||
160768054|NCT05911841|580539034|FG007|Escape Period|Withdrawal by Subject|0|||
160768055|NCT05911841|580539035|FG008|Escape Period|Withdrawal by Subject|0|||
160768056|NCT05911841|580539036|FG009|Escape Period|Withdrawal by Subject|10|||
160768057|NCT05595369|580539037|FG000|Overall Study|Adverse Event|2|||
160768058|NCT05595369|580539038|FG001|Overall Study|Adverse Event|0|||
160768059|NCT05595369|580539039|FG002|Overall Study|Adverse Event|0|||
160768060|NCT05595369|580539037|FG000|Overall Study|Lost to Follow-up|11|||
160768061|NCT05595369|580539038|FG001|Overall Study|Lost to Follow-up|10|||
160768062|NCT05595369|580539039|FG002|Overall Study|Lost to Follow-up|10|||
160768063|NCT05595369|580539037|FG000|Overall Study|Physician Decision|1|||
160768064|NCT05595369|580539038|FG001|Overall Study|Physician Decision|0|||
160768065|NCT05595369|580539039|FG002|Overall Study|Physician Decision|0|||
160768066|NCT05595369|580539037|FG000|Overall Study|Withdrawal by Subject|5|||
160768067|NCT05595369|580539038|FG001|Overall Study|Withdrawal by Subject|7|||
160768068|NCT05595369|580539039|FG002|Overall Study|Withdrawal by Subject|6|||
160768069|NCT05595369|580539037|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
160768070|NCT05595369|580539038|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
160768071|NCT05595369|580539039|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
160768072|NCT05595369|580539037|FG000|Overall Study|Study Drug Non-compliance|0|||
160768073|NCT05595369|580539038|FG001|Overall Study|Study Drug Non-compliance|1|||
160768074|NCT05595369|580539039|FG002|Overall Study|Study Drug Non-compliance|0|||
160768075|NCT05595369|580539037|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
160768076|NCT05595369|580539038|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
160768077|NCT05595369|580539039|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
160768078|NCT01704261|580539046|FG000|Overall Study|Withdrawal by Subject|12|||
160768079|NCT01704261|580539047|FG001|Overall Study|Withdrawal by Subject|15|||
160768080|NCT01704261|580539046|FG000|Overall Study|Lost to Follow-up|1|||
160768081|NCT01704261|580539047|FG001|Overall Study|Lost to Follow-up|0|||
160768082|NCT00465517|580539051|FG000|Overall Study|Adverse Event|7|||
160768083|NCT00465517|580539052|FG001|Overall Study|Adverse Event|3|||
160768084|NCT00465517|580539051|FG000|Overall Study|Lost to Follow-up|1|||
160768085|NCT00465517|580539052|FG001|Overall Study|Lost to Follow-up|0|||
160768086|NCT00465517|580539051|FG000|Overall Study|Withdrawal by Subject|4|||
160768087|NCT00465517|580539052|FG001|Overall Study|Withdrawal by Subject|1|||
160768088|NCT03704064|580539053|FG000|Overall Study|Lost to Follow-up|8|||
160768089|NCT03704064|580539054|FG001|Overall Study|Lost to Follow-up|4|||
160768090|NCT03704064|580539053|FG000|Overall Study|Withdrawal by Subject|1|||
160768091|NCT03704064|580539054|FG001|Overall Study|Withdrawal by Subject|1|||
160768092|NCT03704064|580539053|FG000|Overall Study|No longer available for study visits|0|||
160768093|NCT03704064|580539054|FG001|Overall Study|No longer available for study visits|1|||
160768094|NCT03704064|580539053|FG000|Overall Study|Censoring event|1|||
160768095|NCT03704064|580539054|FG001|Overall Study|Censoring event|0|||
160768096|NCT01286129|580539055|FG000|Overall Study|Withdrawal by Subject|4|||
160768097|NCT01286129|580539056|FG001|Overall Study|Withdrawal by Subject|1|||
160768098|NCT01286129|580539055|FG000|Overall Study|Could not comply with study requirements|4|||
160768099|NCT01286129|580539056|FG001|Overall Study|Could not comply with study requirements|4|||
160768100|NCT00111761|580539068|FG000|Part 1|Physician Decision|0|||
160768101|NCT00111761|580539069|FG001|Part 1|Physician Decision|1|||
160768102|NCT00111761|580539068|FG000|Part 1|Death|0|||
160768103|NCT00111761|580539069|FG001|Part 1|Death|2|||
160768104|NCT00111761|580539068|FG000|Part 1|Other|0|||
160768105|NCT00111761|580539069|FG001|Part 1|Other|1|||
160768106|NCT00111761|580539068|FG000|Part 1|Withdrawal by Subject|0|||
160768107|NCT00111761|580539069|FG001|Part 1|Withdrawal by Subject|1|||
160768108|NCT00111761|580539068|FG000|Part 2|Adverse Event|1|||
160768109|NCT00111761|580539069|FG001|Part 2|Adverse Event|0|||
160768110|NCT00111761|580539068|FG000|Part 2|Physician Decision|1|||
160768111|NCT00111761|580539069|FG001|Part 2|Physician Decision|0|||
160768112|NCT00111761|580539068|FG000|Part 2|Death|1|||
160768113|NCT00111761|580539069|FG001|Part 2|Death|0|||
160768114|NCT00111761|580539068|FG000|Part 2|Disease progression|3|||
160768115|NCT00111761|580539069|FG001|Part 2|Disease progression|0|||
160768116|NCT00111761|580539068|FG000|Part 2|Protocol-specified criteria|1|||
160768117|NCT00111761|580539069|FG001|Part 2|Protocol-specified criteria|0|||
160768118|NCT00111761|580539068|FG000|Part 2|Other|1|||
160768119|NCT00111761|580539069|FG001|Part 2|Other|0|||
160768120|NCT00071981|580539072|FG000|Overall Study|Lack of Efficacy|37|||
160768121|NCT00071981|580539073|FG001|Overall Study|Lack of Efficacy|29|||
160768122|NCT00071981|580539074|FG002|Overall Study|Lack of Efficacy|30|||
160768123|NCT00071981|580539075|FG003|Overall Study|Lack of Efficacy|43|||
160768124|NCT00071981|580539072|FG000|Overall Study|Adverse Event|4|||
160768125|NCT00071981|580539073|FG001|Overall Study|Adverse Event|4|||
160768126|NCT00071981|580539074|FG002|Overall Study|Adverse Event|3|||
160768127|NCT00071981|580539075|FG003|Overall Study|Adverse Event|1|||
160768128|NCT00071981|580539072|FG000|Overall Study|Death|0|||
160768129|NCT00071981|580539073|FG001|Overall Study|Death|0|||
160768130|NCT00071981|580539074|FG002|Overall Study|Death|1|||
160768131|NCT00071981|580539075|FG003|Overall Study|Death|1|||
160768132|NCT00071981|580539072|FG000|Overall Study|Withdrawal by Subject|3|||
160876461|NCT00281658|580943551|FG003|Randomized Phase|Lost to Follow-up|0|||
160876462|NCT00281658|580943548|FG000|Randomized Phase|Withdrawal by Subject|8|||
160876463|NCT00281658|580943549|FG001|Randomized Phase|Withdrawal by Subject|7|||
160876464|NCT00281658|580943550|FG002|Randomized Phase|Withdrawal by Subject|0|||
160876465|NCT00281658|580943551|FG003|Randomized Phase|Withdrawal by Subject|0|||
160876466|NCT00281658|580943548|FG000|Randomized Phase|Study closed/terminated|1|||
160876467|NCT00281658|580943549|FG001|Randomized Phase|Study closed/terminated|1|||
160876468|NCT00281658|580943550|FG002|Randomized Phase|Study closed/terminated|0|||
160876469|NCT00281658|580943551|FG003|Randomized Phase|Study closed/terminated|0|||
160876470|NCT00281658|580943548|FG000|Randomized Phase|Disease progression|36|||
160876471|NCT00281658|580943549|FG001|Randomized Phase|Disease progression|27|||
160876472|NCT00281658|580943550|FG002|Randomized Phase|Disease progression|0|||
160876473|NCT00281658|580943551|FG003|Randomized Phase|Disease progression|0|||
160876474|NCT00281658|580943548|FG000|Randomized Phase|Physician Decision|1|||
160876475|NCT00281658|580943549|FG001|Randomized Phase|Physician Decision|1|||
160876476|NCT00281658|580943550|FG002|Randomized Phase|Physician Decision|0|||
160876477|NCT00281658|580943551|FG003|Randomized Phase|Physician Decision|0|||
160876478|NCT00281658|580943548|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
160876479|NCT00281658|580943549|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
160876480|NCT00281658|580943550|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
160876481|NCT00281658|580943551|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
160876482|NCT00281658|580943548|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
160876483|NCT00281658|580943549|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
160876484|NCT00281658|580943550|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
160876485|NCT00281658|580943551|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
160876486|NCT00281658|580943548|FG000|Randomized Phase|Treatment ongoing|1|||
160876487|NCT00281658|580943549|FG001|Randomized Phase|Treatment ongoing|0|||
160876488|NCT00281658|580943550|FG002|Randomized Phase|Treatment ongoing|0|||
160876489|NCT00281658|580943551|FG003|Randomized Phase|Treatment ongoing|0|||
160876490|NCT00281658|580943548|FG000|Open Label Phase|Adverse Event|0|||
160876491|NCT00281658|580943549|FG001|Open Label Phase|Adverse Event|0|||
160876492|NCT00281658|580943550|FG002|Open Label Phase|Adverse Event|1|||
160876493|NCT00281658|580943551|FG003|Open Label Phase|Adverse Event|0|||
160876494|NCT00281658|580943548|FG000|Open Label Phase|Lost to Follow-up|0|||
160876495|NCT00281658|580943549|FG001|Open Label Phase|Lost to Follow-up|0|||
160876496|NCT00281658|580943550|FG002|Open Label Phase|Lost to Follow-up|16|||
160876497|NCT00281658|580943551|FG003|Open Label Phase|Lost to Follow-up|2|||
160876498|NCT00281658|580943548|FG000|Open Label Phase|Withdrawal by Subject|0|||
160876499|NCT00281658|580943549|FG001|Open Label Phase|Withdrawal by Subject|0|||
160876500|NCT00281658|580943550|FG002|Open Label Phase|Withdrawal by Subject|3|||
160876501|NCT00281658|580943551|FG003|Open Label Phase|Withdrawal by Subject|2|||
160876502|NCT00281658|580943548|FG000|Open Label Phase|Disease progression|0|||
160876503|NCT00281658|580943549|FG001|Open Label Phase|Disease progression|0|||
160876504|NCT00281658|580943550|FG002|Open Label Phase|Disease progression|18|||
160876505|NCT00281658|580943551|FG003|Open Label Phase|Disease progression|0|||
160876506|NCT00281658|580943548|FG000|Open Label Phase|Physician Decision|0|||
160876507|NCT00281658|580943549|FG001|Open Label Phase|Physician Decision|0|||
160876508|NCT00281658|580943550|FG002|Open Label Phase|Physician Decision|1|||
160876509|NCT00281658|580943551|FG003|Open Label Phase|Physician Decision|0|||
160876510|NCT00281658|580943548|FG000|Open Label Phase|Relocation of patient|0|||
160876511|NCT00281658|580943549|FG001|Open Label Phase|Relocation of patient|0|||
160876512|NCT00281658|580943550|FG002|Open Label Phase|Relocation of patient|1|||
160876513|NCT00281658|580943551|FG003|Open Label Phase|Relocation of patient|0|||
160876514|NCT00281658|580943548|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
160876515|NCT00281658|580943549|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
160876516|NCT00281658|580943550|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
160876517|NCT00281658|580943551|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
160876518|NCT02151773|580943552|FG000|Overall Study|Protocol Deviation|64|||
160876519|NCT03680742|580943553|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
160876520|NCT02894502|580943556|FG000|Baseline|Withdrawal by Subject|24|||
160876521|NCT02894502|580943557|FG001|Baseline|Withdrawal by Subject|31|||
160876522|NCT02894502|580943558|FG002|Baseline|Withdrawal by Subject|36|||
160876523|NCT02894502|580943556|FG000|Baseline|Death|3|||
160876524|NCT02894502|580943557|FG001|Baseline|Death|1|||
160876525|NCT02894502|580943558|FG002|Baseline|Death|9|||
160876526|NCT02894502|580943556|FG000|First Follow up|Withdrawal by Subject|32|||
160876527|NCT02894502|580943557|FG001|First Follow up|Withdrawal by Subject|29|||
160876528|NCT02894502|580943558|FG002|First Follow up|Withdrawal by Subject|37|||
160876529|NCT02894502|580943556|FG000|First Follow up|Death|2|||
160876530|NCT02894502|580943557|FG001|First Follow up|Death|2|||
160876531|NCT02894502|580943558|FG002|First Follow up|Death|3|||
160876532|NCT02894502|580943556|FG000|Second Follow up|Withdrawal by Subject|13|||
160876533|NCT02894502|580943557|FG001|Second Follow up|Withdrawal by Subject|15|||
160876534|NCT02894502|580943558|FG002|Second Follow up|Withdrawal by Subject|13|||
160876535|NCT02894502|580943556|FG000|Second Follow up|Death|2|||
160876536|NCT02894502|580943557|FG001|Second Follow up|Death|3|||
160876537|NCT02894502|580943558|FG002|Second Follow up|Death|1|||
160876538|NCT02894502|580943556|FG000|Third Follow up|Withdrawal by Subject|5|||
160876539|NCT02894502|580943557|FG001|Third Follow up|Withdrawal by Subject|6|||
160876540|NCT02894502|580943558|FG002|Third Follow up|Withdrawal by Subject|3|||
160876541|NCT02894502|580943556|FG000|Third Follow up|Death|1|||
160876542|NCT02894502|580943557|FG001|Third Follow up|Death|1|||
160876543|NCT02894502|580943558|FG002|Third Follow up|Death|0|||
160876544|NCT01410357|580943559|FG000|Overall Study|Death|2|||
160876545|NCT01410357|580943560|FG001|Overall Study|Death|1|||
160876546|NCT01410357|580943559|FG000|Overall Study|Withdrawal by Subject|1|||
160876547|NCT01410357|580943560|FG001|Overall Study|Withdrawal by Subject|2|||
160876548|NCT01410357|580943559|FG000|Overall Study|Lost to Follow-up|23|||
160876549|NCT01410357|580943560|FG001|Overall Study|Lost to Follow-up|21|||
160876550|NCT01206322|580943562|FG000|Overall Study|Adverse Event|0|||
160876551|NCT01206322|580943563|FG001|Overall Study|Adverse Event|0|||
160876552|NCT01206322|580943564|FG002|Overall Study|Adverse Event|0|||
160876553|NCT01206322|580943565|FG003|Overall Study|Adverse Event|1|||
160876554|NCT01589653|580943571|FG000|Overall Study|Protocol Violation|3|||
160876555|NCT01589653|580943572|FG001|Overall Study|Protocol Violation|1|||
160876556|NCT01589653|580943571|FG000|Overall Study|Withdrawal criteria|4|||
160876557|NCT01589653|580943572|FG001|Overall Study|Withdrawal criteria|7|||
160876558|NCT01589653|580943571|FG000|Overall Study|Unclassified|0|||
160876559|NCT01589653|580943572|FG001|Overall Study|Unclassified|3|||
160876560|NCT03700684|580943573|FG000|Overall Study|COVID-19|0|||
160876561|NCT03700684|580943574|FG001|Overall Study|COVID-19|0|||
160876562|NCT03700684|580943575|FG002|Overall Study|COVID-19|2|||
160876563|NCT01120782|580943576|FG000|Overall Study|Test article shipping error|11|||
160876564|NCT04140227|580943577|FG000|Overall Study|Withdrawal by Subject|26|||
160876565|NCT04140227|580943577|FG000|Overall Study|Lost to Follow-up|8|||
160876566|NCT04140227|580943577|FG000|Overall Study|Adverse Event|8|||
160876567|NCT04140227|580943577|FG000|Overall Study|Death|1|||
160876568|NCT04140227|580943577|FG000|Overall Study|Other|3|||
160876569|NCT04140227|580943577|FG000|Overall Study|Protocol Violation|2|||
160876570|NCT00538785|580943578|FG000|Overall Study|Death|9|||
160876571|NCT00538785|580943579|FG001|Overall Study|Death|10|||
160876572|NCT00538785|580943578|FG000|Overall Study|Withdrawal of consent|9|||
160876573|NCT00538785|580943579|FG001|Overall Study|Withdrawal of consent|7|||
160876574|NCT00538785|580943578|FG000|Overall Study|Lost to Follow-up|1|||
160876575|NCT00538785|580943579|FG001|Overall Study|Lost to Follow-up|0|||
160876576|NCT01767142|580943581|FG000|Overall Study|Lost to Follow-up|3|||
160876577|NCT03317405|580943582|FG000|Overall Study|Withdrawal by Subject|1|||
160876578|NCT03317405|580943583|FG001|Overall Study|Withdrawal by Subject|0|||
160876579|NCT03317405|580943584|FG002|Overall Study|Withdrawal by Subject|0|||
160876580|NCT03317405|580943582|FG000|Overall Study|Physician Decision|0|||
160876581|NCT03317405|580943583|FG001|Overall Study|Physician Decision|0|||
160537722|NCT01438489|579698926|FG001|Overall Study|Investigator decision|1|||
160876582|NCT03317405|580943584|FG002|Overall Study|Physician Decision|1|||
160876583|NCT03317405|580943582|FG000|Overall Study|Surgery Rescheduled|0|||
160876584|NCT03317405|580943583|FG001|Overall Study|Surgery Rescheduled|1|||
160876585|NCT03317405|580943584|FG002|Overall Study|Surgery Rescheduled|0|||
160876586|NCT00635219|580943585|FG000|Overall Study|Adverse Event|12|||
160876587|NCT00635219|580943586|FG001|Overall Study|Adverse Event|10|||
160876588|NCT00635219|580943587|FG002|Overall Study|Adverse Event|18|||
160876589|NCT00635219|580943588|FG003|Overall Study|Adverse Event|15|||
160876590|NCT00635219|580943589|FG004|Overall Study|Adverse Event|19|||
160876591|NCT00635219|580943585|FG000|Overall Study|Lack of Efficacy|5|||
160876592|NCT00635219|580943586|FG001|Overall Study|Lack of Efficacy|6|||
160876593|NCT00635219|580943587|FG002|Overall Study|Lack of Efficacy|3|||
160876594|NCT00635219|580943588|FG003|Overall Study|Lack of Efficacy|4|||
160876595|NCT00635219|580943589|FG004|Overall Study|Lack of Efficacy|6|||
160876596|NCT00635219|580943585|FG000|Overall Study|Non-compliance With Study Product|0|||
160876597|NCT00635219|580943586|FG001|Overall Study|Non-compliance With Study Product|0|||
160537723|NCT01438489|579698927|FG002|Overall Study|Investigator decision|0|||
160537724|NCT01438489|579698925|FG000|Overall Study|AE/SAEs|2|||
160537725|NCT01438489|579698926|FG001|Overall Study|AE/SAEs|1|||
160768133|NCT00071981|580539073|FG001|Overall Study|Withdrawal by Subject|1|||
160768134|NCT00071981|580539074|FG002|Overall Study|Withdrawal by Subject|0|||
160768135|NCT00071981|580539075|FG003|Overall Study|Withdrawal by Subject|0|||
160768136|NCT00071981|580539072|FG000|Overall Study|No protocol therapy|2|||
160768137|NCT00071981|580539073|FG001|Overall Study|No protocol therapy|5|||
160768138|NCT00071981|580539074|FG002|Overall Study|No protocol therapy|1|||
160768139|NCT00071981|580539075|FG003|Overall Study|No protocol therapy|0|||
160768140|NCT00071981|580539072|FG000|Overall Study|others (not specified in the study)|0|||
160768141|NCT00071981|580539073|FG001|Overall Study|others (not specified in the study)|2|||
160768142|NCT00071981|580539074|FG002|Overall Study|others (not specified in the study)|2|||
160768143|NCT00071981|580539075|FG003|Overall Study|others (not specified in the study)|0|||
160768144|NCT04108468|580539077|FG000|Overall Study|Physician Decision|0|||
160768145|NCT04108468|580539078|FG001|Overall Study|Physician Decision|1|||
160768146|NCT04108468|580539077|FG000|Overall Study|Lost to Follow-up|0|||
160768147|NCT04108468|580539078|FG001|Overall Study|Lost to Follow-up|1|||
160768148|NCT04108468|580539077|FG000|Overall Study|Non-compliance|1|||
160768149|NCT04108468|580539078|FG001|Overall Study|Non-compliance|1|||
160768150|NCT04108468|580539077|FG000|Overall Study|Unable to attend final visit|2|||
160768151|NCT04108468|580539078|FG001|Overall Study|Unable to attend final visit|0|||
160768152|NCT04108468|580539077|FG000|Overall Study|Missed study medication|0|||
160768153|NCT04108468|580539078|FG001|Overall Study|Missed study medication|1|||
160768154|NCT04711005|580539081|FG000|Overall Study|Withdrawal by Subject|0|||
160768155|NCT04711005|580539082|FG001|Overall Study|Withdrawal by Subject|0|||
160768156|NCT04711005|580539083|FG002|Overall Study|Withdrawal by Subject|0|||
160768157|NCT04711005|580539084|FG003|Overall Study|Withdrawal by Subject|0|||
160768158|NCT04711005|580539085|FG004|Overall Study|Withdrawal by Subject|0|||
160768159|NCT04711005|580539086|FG005|Overall Study|Withdrawal by Subject|0|||
160768160|NCT04711005|580539087|FG006|Overall Study|Withdrawal by Subject|0|||
160768161|NCT04711005|580539088|FG007|Overall Study|Withdrawal by Subject|1|||
160768162|NCT04711005|580539089|FG008|Overall Study|Withdrawal by Subject|0|||
160768163|NCT04711005|580539090|FG009|Overall Study|Withdrawal by Subject|0|||
160768164|NCT04711005|580539081|FG000|Overall Study|Physician Decision|0|||
160768165|NCT04711005|580539082|FG001|Overall Study|Physician Decision|0|||
160768166|NCT04711005|580539083|FG002|Overall Study|Physician Decision|0|||
160768167|NCT04711005|580539084|FG003|Overall Study|Physician Decision|0|||
160768168|NCT04711005|580539085|FG004|Overall Study|Physician Decision|0|||
160768169|NCT04711005|580539086|FG005|Overall Study|Physician Decision|0|||
160768170|NCT04711005|580539087|FG006|Overall Study|Physician Decision|0|||
160768171|NCT04711005|580539088|FG007|Overall Study|Physician Decision|2|||
160768172|NCT04711005|580539089|FG008|Overall Study|Physician Decision|1|||
160768173|NCT04711005|580539090|FG009|Overall Study|Physician Decision|0|||
160768174|NCT01499810|580539094|FG000|Overall Study|Lost to Follow-up|10|||
160768175|NCT01499810|580539094|FG000|Overall Study|Protocol Violation|1|||
160768176|NCT01499810|580539094|FG000|Overall Study|Withdrawal by Subject|1|||
160768177|NCT02634710|580539095|FG000|Overall Study|Death|4|||
160768178|NCT04530630|580540639|FG000|Overall Study|Physician Decision|1|||
160768179|NCT03834961|580540642|FG000|Overall Study|Lack of Efficacy|1|||
160768180|NCT03834961|580540643|FG001|Overall Study|Lack of Efficacy|1|||
160768181|NCT03834961|580540644|FG002|Overall Study|Lack of Efficacy|0|||
160768182|NCT03834961|580540642|FG000|Overall Study|Physician Decision|0|||
160768183|NCT03834961|580540643|FG001|Overall Study|Physician Decision|1|||
160768184|NCT03834961|580540644|FG002|Overall Study|Physician Decision|0|||
160768185|NCT04736199|580540647|FG000|Overall Study|Adverse Event|28|||
160768186|NCT04736199|580540648|FG001|Overall Study|Adverse Event|22|||
160768187|NCT04736199|580540647|FG000|Overall Study|Death|9|||
160768188|NCT04736199|580540648|FG001|Overall Study|Death|3|||
160768189|NCT04736199|580540647|FG000|Overall Study|Lost to Follow-up|4|||
160768190|NCT04736199|580540648|FG001|Overall Study|Lost to Follow-up|1|||
160768191|NCT04736199|580540647|FG000|Overall Study|Physician Decision|5|||
160768192|NCT04736199|580540648|FG001|Overall Study|Physician Decision|9|||
160768193|NCT04736199|580540647|FG000|Overall Study|Withdrawal by Subject|21|||
160768194|NCT04736199|580540648|FG001|Overall Study|Withdrawal by Subject|9|||
160768195|NCT04736199|580540647|FG000|Overall Study|Progressive disease|120|||
160768196|NCT04736199|580540648|FG001|Overall Study|Progressive disease|101|||
160768197|NCT04736199|580540647|FG000|Overall Study|Subject decision|13|||
160768198|NCT04736199|580540648|FG001|Overall Study|Subject decision|13|||
160768199|NCT04736199|580540647|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
160768200|NCT04736199|580540648|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
160768201|NCT04736199|580540647|FG000|Overall Study|Additional primary malignancy|1|||
160768202|NCT04736199|580540648|FG001|Overall Study|Additional primary malignancy|0|||
160768203|NCT04736199|580540647|FG000|Overall Study|Non-compliance with study drug|0|||
160768204|NCT04736199|580540648|FG001|Overall Study|Non-compliance with study drug|1|||
160768205|NCT04736199|580540647|FG000|Overall Study|Other reason|0|||
160768206|NCT04736199|580540648|FG001|Overall Study|Other reason|1|||
160537726|NCT01438489|579698927|FG002|Overall Study|AE/SAEs|1|||
160537727|NCT01438489|579698925|FG000|Overall Study|Received prohibited medication|1|||
160537728|NCT01438489|579698926|FG001|Overall Study|Received prohibited medication|0|||
160537729|NCT01438489|579698927|FG002|Overall Study|Received prohibited medication|0|||
160537730|NCT01438489|579698925|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
160768207|NCT04736199|580540647|FG000|Overall Study|Ongoing with study drug|240|||
160768208|NCT04736199|580540648|FG001|Overall Study|Ongoing with study drug|63|||
160768209|NCT04736199|580540647|FG000|Overall Study|Study drug never administered|3|||
160768210|NCT04736199|580540648|FG001|Overall Study|Study drug never administered|0|||
160768211|NCT05507437|580540649|FG000|Overall Study|Withdrawal by Subject|1|||
160768212|NCT05507437|580540650|FG001|Overall Study|Withdrawal by Subject|1|||
160768213|NCT05507437|580540649|FG000|Overall Study|Death|3|||
160768214|NCT05507437|580540650|FG001|Overall Study|Death|0|||
160768215|NCT05172609|580540651|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
160768216|NCT05172609|580540652|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
160768217|NCT05172609|580540651|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
160768218|NCT05172609|580540652|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
160768219|NCT05172609|580540651|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
160768220|NCT05172609|580540652|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
160768221|NCT05610605|580540655|FG000|6-month Assessment|Death|1|||
160768222|NCT05610605|580540656|FG001|6-month Assessment|Death|1|||
160768223|NCT05610605|580540655|FG000|6-month Assessment|Lost to Follow-up|20|||
160768224|NCT05610605|580540656|FG001|6-month Assessment|Lost to Follow-up|0|||
160768225|NCT05610605|580540655|FG000|6-month Assessment|Institutionalized|1|||
160768226|NCT05610605|580540656|FG001|6-month Assessment|Institutionalized|2|||
160768227|NCT05610605|580540655|FG000|12-month Assessment|Death|2|||
160768228|NCT05610605|580540656|FG001|12-month Assessment|Death|1|||
160768229|NCT05610605|580540655|FG000|12-month Assessment|Lost to Follow-up|1|||
160768230|NCT05610605|580540656|FG001|12-month Assessment|Lost to Follow-up|4|||
160768231|NCT05610605|580540655|FG000|12-month Assessment|Institutionalized|2|||
160768232|NCT05610605|580540656|FG001|12-month Assessment|Institutionalized|1|||
160768233|NCT00753519|580540657|FG000|Overall Study|Withdrawal by Subject|0|||
160768234|NCT00753519|580540658|FG001|Overall Study|Withdrawal by Subject|2|||
160768235|NCT00042289|580540659|FG000|Overall Study|Lost to Follow-up|3|||
160768236|NCT00042289|580540660|FG001|Overall Study|Lost to Follow-up|0|||
160768237|NCT00042289|580540661|FG002|Overall Study|Lost to Follow-up|0|||
160768238|NCT00042289|580540662|FG003|Overall Study|Lost to Follow-up|1|||
160768239|NCT00042289|580540663|FG004|Overall Study|Lost to Follow-up|3|||
160768240|NCT00042289|580540664|FG005|Overall Study|Lost to Follow-up|3|||
160768241|NCT00042289|580540665|FG006|Overall Study|Lost to Follow-up|6|||
160768242|NCT00042289|580540666|FG007|Overall Study|Lost to Follow-up|1|||
160768243|NCT00042289|580540667|FG008|Overall Study|Lost to Follow-up|1|||
160768244|NCT00042289|580540668|FG009|Overall Study|Lost to Follow-up|0|||
160768245|NCT00042289|580540669|FG010|Overall Study|Lost to Follow-up|0|||
160768246|NCT00042289|580540670|FG011|Overall Study|Lost to Follow-up|0|||
160768247|NCT00042289|580540671|FG012|Overall Study|Lost to Follow-up|0|||
160768248|NCT00042289|580540672|FG013|Overall Study|Lost to Follow-up|0|||
160768249|NCT00042289|580540673|FG014|Overall Study|Lost to Follow-up|0|||
160768250|NCT00042289|580540674|FG015|Overall Study|Lost to Follow-up|1|||
160768251|NCT00042289|580540675|FG016|Overall Study|Lost to Follow-up|1|||
160768252|NCT00042289|580540676|FG017|Overall Study|Lost to Follow-up|0|||
160768253|NCT00042289|580540677|FG018|Overall Study|Lost to Follow-up|3|||
160768254|NCT00042289|580540678|FG019|Overall Study|Lost to Follow-up|2|||
160768255|NCT00042289|580540679|FG020|Overall Study|Lost to Follow-up|0|||
160768256|NCT00042289|580540680|FG021|Overall Study|Lost to Follow-up|0|||
160768257|NCT00042289|580540681|FG022|Overall Study|Lost to Follow-up|0|||
160768258|NCT00042289|580540682|FG023|Overall Study|Lost to Follow-up|0|||
160768259|NCT00042289|580540683|FG024|Overall Study|Lost to Follow-up|0|||
160768260|NCT00042289|580540684|FG025|Overall Study|Lost to Follow-up|0|||
160768261|NCT00042289|580540685|FG026|Overall Study|Lost to Follow-up|2|||
160768262|NCT00042289|580540686|FG027|Overall Study|Lost to Follow-up|2|||
160768263|NCT00042289|580540687|FG028|Overall Study|Lost to Follow-up|2|||
160768264|NCT00042289|580540688|FG029|Overall Study|Lost to Follow-up|0|||
160768265|NCT00042289|580540689|FG030|Overall Study|Lost to Follow-up|0|||
160768266|NCT00042289|580540690|FG031|Overall Study|Lost to Follow-up|2|||
160768267|NCT00042289|580540691|FG032|Overall Study|Lost to Follow-up|1|||
160768268|NCT00042289|580540692|FG033|Overall Study|Lost to Follow-up|1|||
160768269|NCT00042289|580540693|FG034|Overall Study|Lost to Follow-up|1|||
160768270|NCT00042289|580540694|FG035|Overall Study|Lost to Follow-up|2|||
160768271|NCT00042289|580540695|FG036|Overall Study|Lost to Follow-up|1|||
160768272|NCT00042289|580540696|FG037|Overall Study|Lost to Follow-up|1|||
160768273|NCT00042289|580540697|FG038|Overall Study|Lost to Follow-up|0|||
160768274|NCT00042289|580540698|FG039|Overall Study|Lost to Follow-up|5|||
160768275|NCT00042289|580540699|FG040|Overall Study|Lost to Follow-up|0|||
160768276|NCT00042289|580540700|FG041|Overall Study|Lost to Follow-up|2|||
160768277|NCT00042289|580540701|FG042|Overall Study|Lost to Follow-up|2|||
160768278|NCT00042289|580540702|FG043|Overall Study|Lost to Follow-up|0|||
160876598|NCT00635219|580943587|FG002|Overall Study|Non-compliance With Study Product|0|||
160876599|NCT00635219|580943588|FG003|Overall Study|Non-compliance With Study Product|2|||
160876600|NCT00635219|580943589|FG004|Overall Study|Non-compliance With Study Product|1|||
160876601|NCT00635219|580943585|FG000|Overall Study|Protocol Violation|0|||
160876602|NCT00635219|580943586|FG001|Overall Study|Protocol Violation|2|||
160876603|NCT00635219|580943587|FG002|Overall Study|Protocol Violation|3|||
160876604|NCT00635219|580943588|FG003|Overall Study|Protocol Violation|2|||
160876605|NCT00635219|580943589|FG004|Overall Study|Protocol Violation|4|||
160876606|NCT00635219|580943585|FG000|Overall Study|Withdrawal of Consent|8|||
160876607|NCT00635219|580943586|FG001|Overall Study|Withdrawal of Consent|6|||
160876608|NCT00635219|580943587|FG002|Overall Study|Withdrawal of Consent|8|||
160876609|NCT00635219|580943588|FG003|Overall Study|Withdrawal of Consent|11|||
160876610|NCT00635219|580943589|FG004|Overall Study|Withdrawal of Consent|8|||
160876611|NCT00635219|580943585|FG000|Overall Study|Lost to Follow-up|0|||
160876612|NCT00635219|580943586|FG001|Overall Study|Lost to Follow-up|0|||
160876613|NCT00635219|580943587|FG002|Overall Study|Lost to Follow-up|2|||
160876614|NCT00635219|580943588|FG003|Overall Study|Lost to Follow-up|0|||
160876615|NCT00635219|580943589|FG004|Overall Study|Lost to Follow-up|3|||
160876616|NCT00635219|580943585|FG000|Overall Study|Administrative or Other Reasons|0|||
160876617|NCT00635219|580943586|FG001|Overall Study|Administrative or Other Reasons|1|||
160876618|NCT00635219|580943587|FG002|Overall Study|Administrative or Other Reasons|1|||
160876619|NCT00635219|580943588|FG003|Overall Study|Administrative or Other Reasons|0|||
160876620|NCT00635219|580943589|FG004|Overall Study|Administrative or Other Reasons|1|||
160876621|NCT04093024|580943592|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
160876622|NCT04093024|580943593|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
160876623|NCT04093024|580943592|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
160876624|NCT04093024|580943593|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
160876625|NCT04093024|580943592|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
160876626|NCT04093024|580943593|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
160876627|NCT04093024|580943592|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
160876628|NCT04093024|580943593|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
160876629|NCT00435045|580943600|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
160876630|NCT00435045|580943601|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
160876631|NCT00435045|580943600|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
160876632|NCT00435045|580943601|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
160876633|NCT00435045|580943600|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
160876634|NCT00435045|580943601|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
160876635|NCT00435045|580943600|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
160876636|NCT00435045|580943601|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
160876637|NCT00435045|580943600|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
160876638|NCT00435045|580943601|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
160876639|NCT00435045|580943600|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
160876640|NCT00435045|580943601|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
160876641|NCT00435045|580943600|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
160876642|NCT00435045|580943601|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
160876643|NCT00435045|580943600|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
160876644|NCT00435045|580943601|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
160876645|NCT00435045|580943600|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
160876646|NCT00435045|580943601|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
160876647|NCT00435045|580943600|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
160876648|NCT00435045|580943601|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
160876649|NCT00435045|580943600|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
160876650|NCT00435045|580943601|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
160876651|NCT03052426|580943602|FG000|Overall Study|Withdrawal by Subject|0|||
160876652|NCT03052426|580943603|FG001|Overall Study|Withdrawal by Subject|1|||
160876653|NCT03052426|580943604|FG002|Overall Study|Withdrawal by Subject|0|||
160876654|NCT03052426|580943602|FG000|Overall Study|Lost to Follow-up|2|||
160876655|NCT03052426|580943603|FG001|Overall Study|Lost to Follow-up|0|||
160876656|NCT03052426|580943604|FG002|Overall Study|Lost to Follow-up|1|||
160876657|NCT01853839|580943611|FG000|Overall Study|Violated inclusion criteria|2|||
160876658|NCT01853839|580943611|FG000|Overall Study|Not meet ITT population definition|58|||
160876659|NCT01853839|580943611|FG000|Overall Study|End of treatment visit too early|33|||
160876660|NCT01853839|580943611|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
160876661|NCT01640314|580943612|FG000|Overall Study|Protocol Violation|0|||
160876662|NCT01640314|580943613|FG001|Overall Study|Protocol Violation|1|||
160876663|NCT01290796|580943614|FG000|Overall Study|Lost to Follow-up|21|||
160876664|NCT01290796|580943614|FG000|Overall Study|Withdrawal by Subject|4|||
160876665|NCT01290796|580943614|FG000|Overall Study|Physician Decision|2|||
160876666|NCT01290796|580943614|FG000|Overall Study|Secondary Surgical Intervention|2|||
160876667|NCT01290796|580943614|FG000|Overall Study|Withdrawal by Sponsor|1|||
160876668|NCT02709538|580943616|FG000|Overall Study|Adverse Event|13|||
160876669|NCT02709538|580943617|FG001|Overall Study|Adverse Event|2|||
160876670|NCT02709538|580943618|FG002|Overall Study|Adverse Event|3|||
160876671|NCT02709538|580943616|FG000|Overall Study|Lack of Efficacy|1|||
160876672|NCT02709538|580943617|FG001|Overall Study|Lack of Efficacy|0|||
160876673|NCT02709538|580943618|FG002|Overall Study|Lack of Efficacy|0|||
160876674|NCT02709538|580943616|FG000|Overall Study|Lost to Follow-up|24|||
160876675|NCT02709538|580943617|FG001|Overall Study|Lost to Follow-up|8|||
160876676|NCT02709538|580943618|FG002|Overall Study|Lost to Follow-up|4|||
160876677|NCT02709538|580943616|FG000|Overall Study|Physician Decision|1|||
160876678|NCT02709538|580943617|FG001|Overall Study|Physician Decision|0|||
160876679|NCT02709538|580943618|FG002|Overall Study|Physician Decision|0|||
160876680|NCT02709538|580943616|FG000|Overall Study|Withdrawal by Subject|40|||
160876681|NCT02709538|580943617|FG001|Overall Study|Withdrawal by Subject|7|||
160876682|NCT02709538|580943618|FG002|Overall Study|Withdrawal by Subject|4|||
160876683|NCT02709538|580943616|FG000|Overall Study|Non-compliance with study procedures|5|||
160876684|NCT02709538|580943617|FG001|Overall Study|Non-compliance with study procedures|0|||
160876685|NCT02709538|580943618|FG002|Overall Study|Non-compliance with study procedures|0|||
160876686|NCT02709538|580943616|FG000|Overall Study|Non-compliance with study drug|2|||
160876687|NCT02709538|580943617|FG001|Overall Study|Non-compliance with study drug|0|||
160876688|NCT02709538|580943618|FG002|Overall Study|Non-compliance with study drug|0|||
160876689|NCT02709538|580943616|FG000|Overall Study|Protocol deviation|10|||
160876690|NCT02709538|580943617|FG001|Overall Study|Protocol deviation|4|||
160876691|NCT02709538|580943618|FG002|Overall Study|Protocol deviation|4|||
160876692|NCT02709538|580943616|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
160876693|NCT02709538|580943617|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
160876694|NCT02709538|580943618|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
160876695|NCT02709538|580943616|FG000|Overall Study|Other|16|||
160876696|NCT02709538|580943617|FG001|Overall Study|Other|7|||
160876697|NCT02709538|580943618|FG002|Overall Study|Other|5|||
160876698|NCT00835211|580943620|FG000|First Intervention|Withdrawal by Subject|0|||
160876699|NCT00835211|580943621|FG001|First Intervention|Withdrawal by Subject|1|||
160876700|NCT00835211|580943620|FG000|Washout: 7 Days|Adverse Event|2|||
160876701|NCT00835211|580943621|FG001|Washout: 7 Days|Adverse Event|1|||
160876702|NCT00835211|580943620|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
160876703|NCT00835211|580943621|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
160876704|NCT02343549|580943622|FG000|Overall Study|Death|11|||
160876705|NCT02343549|580943622|FG000|Overall Study|Withdrawal by Subject|2|||
160876706|NCT03087617|580943623|FG000|Overall Study|Lost to Follow-up|32|||
160876707|NCT03087617|580943624|FG001|Overall Study|Lost to Follow-up|30|||
160876708|NCT03087617|580943625|FG002|Overall Study|Lost to Follow-up|30|||
160876709|NCT03087617|580943626|FG003|Overall Study|Lost to Follow-up|39|||
160876710|NCT02160041|580943628|FG000|Overall Study|Adverse Event|11|||
160876711|NCT02160041|580943628|FG000|Overall Study|Death|2|||
160876712|NCT02160041|580943628|FG000|Overall Study|disease progression|57|||
160876713|NCT02160041|580943628|FG000|Overall Study|Protocol Violation|1|||
160876714|NCT02160041|580943628|FG000|Overall Study|non-compliance with study|1|||
160876715|NCT02160041|580943628|FG000|Overall Study|Physician Decision|3|||
160876716|NCT02160041|580943628|FG000|Overall Study|Withdrawal by Subject|8|||
160876717|NCT02160041|580943628|FG000|Overall Study|study terminated by by sponsor|1|||
160876718|NCT04450381|580943629|FG000|Overall Study|Protocol Violation|4|||
160876719|NCT04450381|580943629|FG000|Overall Study|Wrong device setting|2|||
160876720|NCT00763698|580943635|FG000|Overall Study|Unsuccessful Implant|5|||
160876721|NCT00763698|580943635|FG000|Overall Study|Death|4|||
160876722|NCT00763698|580943635|FG000|Overall Study|Withdrawal by Subject|1|||
160876723|NCT00782834|580943644|FG000|Treatment Phase|fibrous tumor not GIST|1|||
160876724|NCT02252939|580943645|FG000|Overall Study|Lost to Follow-up|3|||
160876725|NCT04270370|580943646|FG000|Overall Study|Lost to Follow-up|1|||
160876726|NCT04270370|580943647|FG001|Overall Study|Lost to Follow-up|0|||
160876727|NCT04270370|580943648|FG002|Overall Study|Lost to Follow-up|0|||
160876728|NCT04270370|580943649|FG003|Overall Study|Lost to Follow-up|0|||
160876729|NCT04270370|580943650|FG004|Overall Study|Lost to Follow-up|0|||
160876730|NCT04270370|580943651|FG005|Overall Study|Lost to Follow-up|0|||
160876731|NCT04270370|580943652|FG006|Overall Study|Lost to Follow-up|0|||
160876732|NCT04270370|580943653|FG007|Overall Study|Lost to Follow-up|0|||
160876733|NCT04270370|580943654|FG008|Overall Study|Lost to Follow-up|1|||
160876734|NCT04270370|580943655|FG009|Overall Study|Lost to Follow-up|0|||
160876735|NCT04270370|580943656|FG010|Overall Study|Lost to Follow-up|0|||
160876736|NCT04270370|580943657|FG011|Overall Study|Lost to Follow-up|0|||
160876737|NCT01324141|580943658|FG000|Overall Study|Declined to participate before treatment started|1|||
160876738|NCT01324141|580943658|FG000|Overall Study|Disease progression on study|1|||
160876739|NCT02703337|580943659|FG000|Period One (Part A)|Withdrawal by Subject|0|||
160876740|NCT02703337|580943660|FG001|Period One (Part A)|Withdrawal by Subject|0|||
160876741|NCT02703337|580943661|FG002|Period One (Part A)|Withdrawal by Subject|0|||
160876742|NCT02703337|580943662|FG003|Period One (Part A)|Withdrawal by Subject|0|||
160876743|NCT02703337|580943663|FG004|Period One (Part A)|Withdrawal by Subject|1|||
160768279|NCT00042289|580540703|FG044|Overall Study|Lost to Follow-up|0|||
160768280|NCT00042289|580540704|FG045|Overall Study|Lost to Follow-up|1|||
160768281|NCT00042289|580540705|FG046|Overall Study|Lost to Follow-up|0|||
160768282|NCT00042289|580540659|FG000|Overall Study|Other reason|0|||
160768283|NCT00042289|580540660|FG001|Overall Study|Other reason|0|||
160768284|NCT00042289|580540661|FG002|Overall Study|Other reason|0|||
160768285|NCT00042289|580540662|FG003|Overall Study|Other reason|2|||
160768286|NCT00042289|580540663|FG004|Overall Study|Other reason|0|||
160768287|NCT00042289|580540664|FG005|Overall Study|Other reason|0|||
160768288|NCT00042289|580540665|FG006|Overall Study|Other reason|0|||
160768289|NCT00042289|580540666|FG007|Overall Study|Other reason|0|||
160768290|NCT00042289|580540667|FG008|Overall Study|Other reason|0|||
160768291|NCT00042289|580540668|FG009|Overall Study|Other reason|0|||
160768292|NCT00042289|580540669|FG010|Overall Study|Other reason|0|||
160768293|NCT00042289|580540670|FG011|Overall Study|Other reason|0|||
160768294|NCT00042289|580540671|FG012|Overall Study|Other reason|0|||
160768295|NCT00042289|580540672|FG013|Overall Study|Other reason|0|||
160768296|NCT00042289|580540673|FG014|Overall Study|Other reason|0|||
160768297|NCT00042289|580540674|FG015|Overall Study|Other reason|0|||
160768298|NCT00042289|580540675|FG016|Overall Study|Other reason|0|||
160768299|NCT00042289|580540676|FG017|Overall Study|Other reason|0|||
160768300|NCT00042289|580540677|FG018|Overall Study|Other reason|1|||
160768301|NCT00042289|580540678|FG019|Overall Study|Other reason|0|||
160768302|NCT00042289|580540679|FG020|Overall Study|Other reason|0|||
160768303|NCT00042289|580540680|FG021|Overall Study|Other reason|0|||
160768304|NCT00042289|580540681|FG022|Overall Study|Other reason|0|||
160768305|NCT00042289|580540682|FG023|Overall Study|Other reason|1|||
160768306|NCT00042289|580540683|FG024|Overall Study|Other reason|0|||
160768307|NCT00042289|580540684|FG025|Overall Study|Other reason|0|||
160768308|NCT00042289|580540685|FG026|Overall Study|Other reason|1|||
160768309|NCT00042289|580540686|FG027|Overall Study|Other reason|0|||
160768310|NCT00042289|580540687|FG028|Overall Study|Other reason|3|||
160768311|NCT00042289|580540688|FG029|Overall Study|Other reason|0|||
160768312|NCT00042289|580540689|FG030|Overall Study|Other reason|0|||
160768313|NCT00042289|580540690|FG031|Overall Study|Other reason|1|||
160768314|NCT00042289|580540691|FG032|Overall Study|Other reason|0|||
160768315|NCT00042289|580540692|FG033|Overall Study|Other reason|1|||
160768316|NCT00042289|580540693|FG034|Overall Study|Other reason|0|||
160768317|NCT00042289|580540694|FG035|Overall Study|Other reason|2|||
160768318|NCT00042289|580540695|FG036|Overall Study|Other reason|0|||
160768319|NCT00042289|580540696|FG037|Overall Study|Other reason|0|||
160768320|NCT00042289|580540697|FG038|Overall Study|Other reason|0|||
160768321|NCT00042289|580540698|FG039|Overall Study|Other reason|0|||
160768322|NCT00042289|580540699|FG040|Overall Study|Other reason|0|||
160768323|NCT00042289|580540700|FG041|Overall Study|Other reason|0|||
160768324|NCT00042289|580540701|FG042|Overall Study|Other reason|0|||
160768325|NCT00042289|580540702|FG043|Overall Study|Other reason|1|||
160768326|NCT00042289|580540703|FG044|Overall Study|Other reason|0|||
160768327|NCT00042289|580540704|FG045|Overall Study|Other reason|0|||
160768328|NCT00042289|580540705|FG046|Overall Study|Other reason|0|||
160768329|NCT00042289|580540659|FG000|Overall Study|Severe debilitation, unable to continue|0|||
160768330|NCT00042289|580540660|FG001|Overall Study|Severe debilitation, unable to continue|0|||
160768331|NCT00042289|580540661|FG002|Overall Study|Severe debilitation, unable to continue|0|||
160768332|NCT00042289|580540662|FG003|Overall Study|Severe debilitation, unable to continue|0|||
160768333|NCT00042289|580540663|FG004|Overall Study|Severe debilitation, unable to continue|0|||
160768334|NCT00042289|580540664|FG005|Overall Study|Severe debilitation, unable to continue|0|||
160768335|NCT00042289|580540665|FG006|Overall Study|Severe debilitation, unable to continue|0|||
160768336|NCT00042289|580540666|FG007|Overall Study|Severe debilitation, unable to continue|0|||
160768337|NCT00042289|580540667|FG008|Overall Study|Severe debilitation, unable to continue|0|||
160768338|NCT00042289|580540668|FG009|Overall Study|Severe debilitation, unable to continue|0|||
160768339|NCT00042289|580540669|FG010|Overall Study|Severe debilitation, unable to continue|0|||
160537731|NCT01438489|579698926|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
160537732|NCT01438489|579698927|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
160768340|NCT00042289|580540670|FG011|Overall Study|Severe debilitation, unable to continue|0|||
160768341|NCT00042289|580540671|FG012|Overall Study|Severe debilitation, unable to continue|0|||
160768342|NCT00042289|580540672|FG013|Overall Study|Severe debilitation, unable to continue|0|||
160768343|NCT00042289|580540673|FG014|Overall Study|Severe debilitation, unable to continue|0|||
160768344|NCT00042289|580540674|FG015|Overall Study|Severe debilitation, unable to continue|0|||
160768345|NCT00042289|580540675|FG016|Overall Study|Severe debilitation, unable to continue|0|||
160768346|NCT00042289|580540676|FG017|Overall Study|Severe debilitation, unable to continue|0|||
160768347|NCT00042289|580540677|FG018|Overall Study|Severe debilitation, unable to continue|0|||
160768348|NCT00042289|580540678|FG019|Overall Study|Severe debilitation, unable to continue|0|||
160768349|NCT00042289|580540679|FG020|Overall Study|Severe debilitation, unable to continue|0|||
160768350|NCT00042289|580540680|FG021|Overall Study|Severe debilitation, unable to continue|1|||
160768351|NCT00042289|580540681|FG022|Overall Study|Severe debilitation, unable to continue|0|||
160768352|NCT00042289|580540682|FG023|Overall Study|Severe debilitation, unable to continue|1|||
160768353|NCT00042289|580540683|FG024|Overall Study|Severe debilitation, unable to continue|0|||
160768354|NCT00042289|580540684|FG025|Overall Study|Severe debilitation, unable to continue|0|||
160768355|NCT00042289|580540685|FG026|Overall Study|Severe debilitation, unable to continue|0|||
160768356|NCT00042289|580540686|FG027|Overall Study|Severe debilitation, unable to continue|1|||
160768357|NCT00042289|580540687|FG028|Overall Study|Severe debilitation, unable to continue|0|||
160768358|NCT00042289|580540688|FG029|Overall Study|Severe debilitation, unable to continue|0|||
160768359|NCT00042289|580540689|FG030|Overall Study|Severe debilitation, unable to continue|0|||
160768360|NCT00042289|580540690|FG031|Overall Study|Severe debilitation, unable to continue|1|||
160768361|NCT00042289|580540691|FG032|Overall Study|Severe debilitation, unable to continue|1|||
160768362|NCT00042289|580540692|FG033|Overall Study|Severe debilitation, unable to continue|0|||
160768363|NCT00042289|580540693|FG034|Overall Study|Severe debilitation, unable to continue|0|||
160768364|NCT00042289|580540694|FG035|Overall Study|Severe debilitation, unable to continue|0|||
160768365|NCT00042289|580540695|FG036|Overall Study|Severe debilitation, unable to continue|0|||
160768366|NCT00042289|580540696|FG037|Overall Study|Severe debilitation, unable to continue|0|||
160768367|NCT00042289|580540697|FG038|Overall Study|Severe debilitation, unable to continue|0|||
160768368|NCT00042289|580540698|FG039|Overall Study|Severe debilitation, unable to continue|0|||
160768369|NCT00042289|580540699|FG040|Overall Study|Severe debilitation, unable to continue|0|||
160768370|NCT00042289|580540700|FG041|Overall Study|Severe debilitation, unable to continue|0|||
160768371|NCT00042289|580540701|FG042|Overall Study|Severe debilitation, unable to continue|0|||
160768372|NCT00042289|580540702|FG043|Overall Study|Severe debilitation, unable to continue|0|||
160768373|NCT00042289|580540703|FG044|Overall Study|Severe debilitation, unable to continue|0|||
160768374|NCT00042289|580540704|FG045|Overall Study|Severe debilitation, unable to continue|0|||
160768375|NCT00042289|580540705|FG046|Overall Study|Severe debilitation, unable to continue|0|||
160768376|NCT00042289|580540659|FG000|Overall Study|Site closed|0|||
160768377|NCT00042289|580540660|FG001|Overall Study|Site closed|0|||
160768378|NCT00042289|580540661|FG002|Overall Study|Site closed|0|||
160768379|NCT00042289|580540662|FG003|Overall Study|Site closed|0|||
160768380|NCT00042289|580540663|FG004|Overall Study|Site closed|0|||
160768381|NCT00042289|580540664|FG005|Overall Study|Site closed|0|||
160768382|NCT00042289|580540665|FG006|Overall Study|Site closed|0|||
160768383|NCT00042289|580540666|FG007|Overall Study|Site closed|0|||
160768384|NCT00042289|580540667|FG008|Overall Study|Site closed|0|||
160768385|NCT00042289|580540668|FG009|Overall Study|Site closed|0|||
160768386|NCT00042289|580540669|FG010|Overall Study|Site closed|0|||
160768387|NCT00042289|580540670|FG011|Overall Study|Site closed|0|||
160768388|NCT00042289|580540671|FG012|Overall Study|Site closed|0|||
160768389|NCT00042289|580540672|FG013|Overall Study|Site closed|0|||
160768390|NCT00042289|580540673|FG014|Overall Study|Site closed|0|||
160768391|NCT00042289|580540674|FG015|Overall Study|Site closed|0|||
160768392|NCT00042289|580540675|FG016|Overall Study|Site closed|0|||
160768393|NCT00042289|580540676|FG017|Overall Study|Site closed|0|||
160768394|NCT00042289|580540677|FG018|Overall Study|Site closed|0|||
160768395|NCT00042289|580540678|FG019|Overall Study|Site closed|0|||
160768396|NCT00042289|580540679|FG020|Overall Study|Site closed|0|||
160768397|NCT00042289|580540680|FG021|Overall Study|Site closed|0|||
160768398|NCT00042289|580540681|FG022|Overall Study|Site closed|0|||
160768399|NCT00042289|580540682|FG023|Overall Study|Site closed|0|||
160768400|NCT00042289|580540683|FG024|Overall Study|Site closed|0|||
160768401|NCT00042289|580540684|FG025|Overall Study|Site closed|0|||
160768402|NCT00042289|580540685|FG026|Overall Study|Site closed|0|||
160768403|NCT00042289|580540686|FG027|Overall Study|Site closed|0|||
160768404|NCT00042289|580540687|FG028|Overall Study|Site closed|0|||
160768405|NCT00042289|580540688|FG029|Overall Study|Site closed|0|||
160537733|NCT01438489|579698925|FG000|Overall Study|Inadequate venous access|0|||
160537734|NCT01438489|579698926|FG001|Overall Study|Inadequate venous access|2|||
160768406|NCT00042289|580540689|FG030|Overall Study|Site closed|0|||
160768407|NCT00042289|580540690|FG031|Overall Study|Site closed|3|||
160768408|NCT00042289|580540691|FG032|Overall Study|Site closed|0|||
160768409|NCT00042289|580540692|FG033|Overall Study|Site closed|0|||
160768410|NCT00042289|580540693|FG034|Overall Study|Site closed|0|||
160876744|NCT02703337|580943664|FG005|Period One (Part A)|Withdrawal by Subject|0|||
160876745|NCT02703337|580943665|FG006|Period One (Part A)|Withdrawal by Subject|0|||
160876746|NCT02703337|580943666|FG007|Period One (Part A)|Withdrawal by Subject|0|||
160876747|NCT01001325|580943676|FG000|Overall Study|Lost to Follow-up|16|||
160876748|NCT01001325|580943677|FG001|Overall Study|Lost to Follow-up|10|||
160876749|NCT01001325|580943676|FG000|Overall Study|Protocol Violation|2|||
160876750|NCT01001325|580943677|FG001|Overall Study|Protocol Violation|0|||
160876751|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
160876752|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
160876753|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
160876754|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
160876755|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
160876756|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
160876757|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
160876758|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
160876759|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
160876760|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
160876761|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
160876762|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
160876763|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
160876764|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
160876765|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
160876766|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
160876767|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
160876768|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
160876769|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
160876770|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
160876771|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
160876772|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
160876773|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
160876774|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
160876775|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
160876776|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
160876777|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
160876778|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
160876779|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
160876780|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
160876781|NCT01584440|580943680|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
160876782|NCT01584440|580943681|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
160876783|NCT01584440|580943682|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
160876784|NCT01584440|580943683|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
160876785|NCT01584440|580943684|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
160876786|NCT01584440|580943680|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
160876787|NCT01584440|580943681|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
160876788|NCT01584440|580943682|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
160876789|NCT01584440|580943683|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
160876790|NCT01584440|580943684|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
160876791|NCT01584440|580943680|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
160876792|NCT01584440|580943681|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
160876793|NCT01584440|580943682|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
160876794|NCT01584440|580943683|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
160876795|NCT01584440|580943684|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
160876796|NCT04237116|580943685|FG000|Overall Study|Adverse Event|0|||
160876797|NCT04237116|580943686|FG001|Overall Study|Adverse Event|1|||
160876798|NCT04237116|580943685|FG000|Overall Study|Study terminated by Sponsor|4|||
160876799|NCT04237116|580943686|FG001|Overall Study|Study terminated by Sponsor|1|||
160876800|NCT00899431|580943687|FG000|Overall Study|Physician Decision|1|||
160876801|NCT00899431|580943688|FG001|Overall Study|Physician Decision|0|||
160876802|NCT00899431|580943689|FG002|Overall Study|Physician Decision|0|||
160876803|NCT03212144|580943690|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
160876804|NCT03212144|580943691|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
160876805|NCT03212144|580943690|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
160876806|NCT03212144|580943691|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
160876807|NCT00661427|580943695|FG000|Overall Study|Adverse Event|5|||
160876808|NCT00661427|580943696|FG001|Overall Study|Adverse Event|5|||
160876809|NCT00661427|580943695|FG000|Overall Study|Patient not treated|0|||
160876810|NCT00661427|580943696|FG001|Overall Study|Patient not treated|2|||
160876811|NCT01338298|580943697|FG000|Overall Study|Withdrawal by Subject|1|||
160876812|NCT01338298|580943698|FG001|Overall Study|Withdrawal by Subject|1|||
160876813|NCT01338298|580943697|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
160876814|NCT01338298|580943698|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
160876815|NCT01338298|580943697|FG000|Overall Study|Administrative error|0|||
160876816|NCT01338298|580943698|FG001|Overall Study|Administrative error|1|||
160876817|NCT01338298|580943697|FG000|Overall Study|Positive symptom worsening|1|||
160768411|NCT00042289|580540694|FG035|Overall Study|Site closed|0|||
160768412|NCT00042289|580540695|FG036|Overall Study|Site closed|1|||
160768413|NCT00042289|580540696|FG037|Overall Study|Site closed|0|||
160768414|NCT00042289|580540697|FG038|Overall Study|Site closed|0|||
160768415|NCT00042289|580540698|FG039|Overall Study|Site closed|0|||
160768416|NCT00042289|580540699|FG040|Overall Study|Site closed|0|||
160768417|NCT00042289|580540700|FG041|Overall Study|Site closed|0|||
160768418|NCT00042289|580540701|FG042|Overall Study|Site closed|1|||
160768419|NCT00042289|580540702|FG043|Overall Study|Site closed|0|||
160768420|NCT00042289|580540703|FG044|Overall Study|Site closed|0|||
160768421|NCT00042289|580540704|FG045|Overall Study|Site closed|0|||
160768422|NCT00042289|580540705|FG046|Overall Study|Site closed|0|||
160768423|NCT00042289|580540659|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
160768424|NCT00042289|580540660|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
160768425|NCT00042289|580540661|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
160768426|NCT00042289|580540662|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
160768427|NCT00042289|580540663|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
160768428|NCT00042289|580540664|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
160768429|NCT00042289|580540665|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
160768430|NCT00042289|580540666|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
160768431|NCT00042289|580540667|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
160768432|NCT00042289|580540668|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
160768433|NCT00042289|580540669|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
160768434|NCT00042289|580540670|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
160768435|NCT00042289|580540671|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
160768436|NCT00042289|580540672|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
160768437|NCT00042289|580540673|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
160768438|NCT00042289|580540674|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
160768439|NCT00042289|580540675|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
160768440|NCT00042289|580540676|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
160768441|NCT00042289|580540677|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
160768442|NCT00042289|580540678|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
160768443|NCT00042289|580540679|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
160768444|NCT00042289|580540680|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
160768445|NCT00042289|580540681|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
160768446|NCT00042289|580540682|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
160768447|NCT00042289|580540683|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
160768448|NCT00042289|580540684|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
160768449|NCT00042289|580540685|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
160768450|NCT00042289|580540686|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
160768451|NCT00042289|580540687|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
160768452|NCT00042289|580540688|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
160768453|NCT00042289|580540689|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
160768454|NCT00042289|580540690|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
160768455|NCT00042289|580540691|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
160768456|NCT00042289|580540692|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
160768457|NCT00042289|580540693|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
160768458|NCT00042289|580540694|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
160768459|NCT00042289|580540695|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
160768460|NCT00042289|580540696|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
160768461|NCT00042289|580540697|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
160768462|NCT00042289|580540698|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
160768463|NCT00042289|580540699|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
160768464|NCT00042289|580540700|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
160768465|NCT00042289|580540701|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
160768466|NCT00042289|580540702|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
160768467|NCT00042289|580540703|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
160768468|NCT00042289|580540704|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
160768469|NCT00042289|580540705|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
160768470|NCT00042289|580540659|FG000|Overall Study|Protocol Violation|0|||
160768471|NCT00042289|580540660|FG001|Overall Study|Protocol Violation|0|||
160768472|NCT00042289|580540661|FG002|Overall Study|Protocol Violation|0|||
160768473|NCT00042289|580540662|FG003|Overall Study|Protocol Violation|0|||
160876818|NCT01338298|580943698|FG001|Overall Study|Positive symptom worsening|0|||
160876819|NCT01338298|580943697|FG000|Overall Study|Depressive symptoms and nausea|1|||
160876820|NCT01338298|580943698|FG001|Overall Study|Depressive symptoms and nausea|0|||
160876821|NCT01338298|580943697|FG000|Overall Study|Non-adherence|1|||
160876822|NCT01338298|580943698|FG001|Overall Study|Non-adherence|0|||
160876823|NCT02872285|580943699|FG000|Overall Study|Withdrawal by Subject|2|||
160876824|NCT02872285|580943700|FG001|Overall Study|Withdrawal by Subject|0|||
160876825|NCT02872285|580943699|FG000|Overall Study|Lost to Follow-up|2|||
160876826|NCT02872285|580943700|FG001|Overall Study|Lost to Follow-up|2|||
160876827|NCT02872285|580943699|FG000|Overall Study|Discontinued due to back surgery|1|||
160876828|NCT02872285|580943700|FG001|Overall Study|Discontinued due to back surgery|0|||
160876829|NCT00531427|580943701|FG000|Overall Study|Withdrawal by Subject|7|||
160876830|NCT00531427|580943702|FG001|Overall Study|Withdrawal by Subject|13|||
160876831|NCT00531427|580943701|FG000|Overall Study|Adverse Event|44|||
160876832|NCT00531427|580943702|FG001|Overall Study|Adverse Event|30|||
160876833|NCT00531427|580943701|FG000|Overall Study|Lost to Follow-up|4|||
160876834|NCT00531427|580943702|FG001|Overall Study|Lost to Follow-up|3|||
160876835|NCT00531427|580943701|FG000|Overall Study|Lack of Efficacy|14|||
160876836|NCT00531427|580943702|FG001|Overall Study|Lack of Efficacy|39|||
160876837|NCT00531427|580943701|FG000|Overall Study|Administrative|4|||
160876838|NCT00531427|580943702|FG001|Overall Study|Administrative|9|||
160876839|NCT05477108|580943703|FG000|Overall Study|Participants randomized, not treated|1|||
160876840|NCT05477108|580943704|FG001|Overall Study|Participants randomized, not treated|1|||
160876841|NCT05477108|580943705|FG002|Overall Study|Participants randomized, not treated|1|||
160876842|NCT05477108|580943703|FG000|Overall Study|Physician Decision|0|||
160876843|NCT05477108|580943704|FG001|Overall Study|Physician Decision|0|||
160876844|NCT05477108|580943705|FG002|Overall Study|Physician Decision|1|||
160876845|NCT05477108|580943703|FG000|Overall Study|withdrawn from study|0|||
160876846|NCT05477108|580943704|FG001|Overall Study|withdrawn from study|0|||
160876847|NCT05477108|580943705|FG002|Overall Study|withdrawn from study|1|||
160876848|NCT01253577|580943706|FG000|Overall Study|Lost to Follow-up|3|||
160876849|NCT05688670|580943707|FG000|Overall Study|Change in surgery plan|1|||
160876850|NCT05688670|580943708|FG001|Overall Study|Change in surgery plan|4|||
160876851|NCT05688670|580943707|FG000|Overall Study|Inability to extubate|1|||
160876852|NCT05688670|580943708|FG001|Overall Study|Inability to extubate|2|||
160876853|NCT05688670|580943707|FG000|Overall Study|Day of surgery cancellation|0|||
160876854|NCT05688670|580943708|FG001|Overall Study|Day of surgery cancellation|1|||
160876855|NCT05688670|580943707|FG000|Overall Study|Reintubated on PCICU arrival|0|||
160876856|NCT05688670|580943708|FG001|Overall Study|Reintubated on PCICU arrival|1|||
160876857|NCT00488683|580943709|FG000|Overall Study|Withdrawal by Subject|1|||
160876858|NCT00488683|580943710|FG001|Overall Study|Withdrawal by Subject|2|||
160876859|NCT00488683|580943711|FG002|Overall Study|Withdrawal by Subject|2|||
160876860|NCT00488683|580943709|FG000|Overall Study|Lost to Follow-up|5|||
160876861|NCT00488683|580943710|FG001|Overall Study|Lost to Follow-up|3|||
160876862|NCT00488683|580943711|FG002|Overall Study|Lost to Follow-up|0|||
160876863|NCT00488683|580943709|FG000|Overall Study|Protocol Violation|5|||
160876864|NCT00488683|580943710|FG001|Overall Study|Protocol Violation|1|||
160876865|NCT00488683|580943711|FG002|Overall Study|Protocol Violation|0|||
160876866|NCT00488683|580943709|FG000|Overall Study|Unable to Classify|1|||
160876867|NCT00488683|580943710|FG001|Overall Study|Unable to Classify|0|||
160876868|NCT00488683|580943711|FG002|Overall Study|Unable to Classify|0|||
160876869|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
160876870|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
160876871|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
160876872|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
160876873|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
160876874|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
160876875|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
160876876|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
160876877|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
160876878|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
160876879|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
160876880|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
160876881|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
160876882|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
160876883|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
160876884|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
160876885|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
160876886|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
160876887|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
160876888|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
160876889|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
160876890|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
160876891|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
160876892|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
160876893|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
160876894|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
160876895|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
160876896|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
160876897|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
160876898|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
160876899|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
160876900|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
160876901|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
160876902|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
160876903|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
160876904|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
160876905|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
160876906|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
160876907|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
160876908|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
160876909|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
160876910|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
160876911|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
160876912|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
160876913|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
160876914|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
160876915|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
160876916|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
160876917|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
160876918|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
160876919|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
160876920|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
160876921|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
160876922|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
160876923|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
160876924|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
160876925|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
160876926|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
160876927|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
160876928|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
160876929|NCT00336856|580945254|FG000|Overall Study|Withdrawal by Subject|3|||
160876930|NCT00336856|580945254|FG000|Overall Study|Found ineligible at time of analysis|1|||
160876931|NCT00843778|580945267|FG000|Overall Study|Adverse Event|15|||
160876932|NCT00843778|580945267|FG000|Overall Study|Lack of Efficacy|14|||
160876933|NCT00843778|580945267|FG000|Overall Study|Loss of efficacy|2|||
160876934|NCT00843778|580945267|FG000|Overall Study|Withdrawal by Subject|4|||
160876935|NCT00830869|580945270|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
160876936|NCT00830869|580945271|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
160876937|NCT00830869|580945272|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
160876938|NCT00830869|580945273|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
160876939|NCT00830869|580945274|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
160876940|NCT00830869|580945275|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
160876941|NCT00830869|580945276|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
160876942|NCT00830869|580945277|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
160876943|NCT00830869|580945278|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
160876944|NCT00830869|580945279|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
160876945|NCT00830869|580945280|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
160876946|NCT00830869|580945281|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
160876947|NCT00830869|580945270|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
160876948|NCT00830869|580945271|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
160876949|NCT00830869|580945272|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
160876950|NCT00830869|580945273|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
160876951|NCT00830869|580945274|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
160876952|NCT00830869|580945275|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
160876953|NCT00830869|580945276|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
160876954|NCT00830869|580945277|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
160876955|NCT00830869|580945278|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
160876956|NCT00830869|580945279|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
160876957|NCT00830869|580945280|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
160876958|NCT00830869|580945281|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
160876959|NCT00830869|580945270|FG000|Period 1: Part 1|Adverse Event|0|||
160876960|NCT00830869|580945271|FG001|Period 1: Part 1|Adverse Event|0|||
160876961|NCT00830869|580945272|FG002|Period 1: Part 1|Adverse Event|0|||
160876962|NCT00830869|580945273|FG003|Period 1: Part 1|Adverse Event|0|||
160876963|NCT00830869|580945274|FG004|Period 1: Part 1|Adverse Event|0|||
160876964|NCT00830869|580945275|FG005|Period 1: Part 1|Adverse Event|1|||
160876965|NCT00830869|580945276|FG006|Period 1: Part 1|Adverse Event|1|||
160876966|NCT00830869|580945277|FG007|Period 1: Part 1|Adverse Event|0|||
160876967|NCT00830869|580945278|FG008|Period 1: Part 1|Adverse Event|0|||
160876968|NCT00830869|580945279|FG009|Period 1: Part 1|Adverse Event|0|||
160876969|NCT00830869|580945280|FG010|Period 1: Part 1|Adverse Event|0|||
160876970|NCT00830869|580945281|FG011|Period 1: Part 1|Adverse Event|0|||
160876971|NCT00830869|580945270|FG000|Period 1: Part 1|Progressive disease|1|||
160876972|NCT00830869|580945271|FG001|Period 1: Part 1|Progressive disease|0|||
160876973|NCT00830869|580945272|FG002|Period 1: Part 1|Progressive disease|1|||
160876974|NCT00830869|580945273|FG003|Period 1: Part 1|Progressive disease|6|||
160876975|NCT00830869|580945274|FG004|Period 1: Part 1|Progressive disease|4|||
160876976|NCT00830869|580945275|FG005|Period 1: Part 1|Progressive disease|4|||
160876977|NCT00830869|580945276|FG006|Period 1: Part 1|Progressive disease|1|||
160876978|NCT00830869|580945277|FG007|Period 1: Part 1|Progressive disease|0|||
160876979|NCT00830869|580945278|FG008|Period 1: Part 1|Progressive disease|0|||
160876980|NCT00830869|580945279|FG009|Period 1: Part 1|Progressive disease|0|||
160876981|NCT00830869|580945280|FG010|Period 1: Part 1|Progressive disease|0|||
160876982|NCT00830869|580945281|FG011|Period 1: Part 1|Progressive disease|0|||
160876983|NCT00830869|580945270|FG000|Period 2: Part 2|Protocol Violation|0|||
160876984|NCT00830869|580945271|FG001|Period 2: Part 2|Protocol Violation|0|||
160876985|NCT00830869|580945272|FG002|Period 2: Part 2|Protocol Violation|0|||
160876986|NCT00830869|580945273|FG003|Period 2: Part 2|Protocol Violation|0|||
160876987|NCT00830869|580945274|FG004|Period 2: Part 2|Protocol Violation|0|||
160876988|NCT00830869|580945275|FG005|Period 2: Part 2|Protocol Violation|0|||
160876989|NCT00830869|580945276|FG006|Period 2: Part 2|Protocol Violation|0|||
160876990|NCT00830869|580945277|FG007|Period 2: Part 2|Protocol Violation|1|||
160876991|NCT00830869|580945278|FG008|Period 2: Part 2|Protocol Violation|0|||
160876992|NCT00830869|580945279|FG009|Period 2: Part 2|Protocol Violation|1|||
160876993|NCT00830869|580945280|FG010|Period 2: Part 2|Protocol Violation|0|||
160876994|NCT00830869|580945281|FG011|Period 2: Part 2|Protocol Violation|0|||
160876995|NCT00830869|580945270|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
160876996|NCT00830869|580945271|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
160876997|NCT00830869|580945272|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
160876998|NCT00830869|580945273|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
160876999|NCT00830869|580945274|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
160877000|NCT00830869|580945275|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
160877001|NCT00830869|580945276|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
160877002|NCT00830869|580945277|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
160877003|NCT00830869|580945278|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
160877004|NCT00830869|580945279|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
160877005|NCT00830869|580945280|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
160877006|NCT00830869|580945281|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
160877007|NCT00830869|580945270|FG000|Period 2: Part 2|Adverse Event|0|||
160877008|NCT00830869|580945271|FG001|Period 2: Part 2|Adverse Event|0|||
160877009|NCT00830869|580945272|FG002|Period 2: Part 2|Adverse Event|0|||
160877010|NCT00830869|580945273|FG003|Period 2: Part 2|Adverse Event|0|||
160877011|NCT00830869|580945274|FG004|Period 2: Part 2|Adverse Event|0|||
160877012|NCT00830869|580945275|FG005|Period 2: Part 2|Adverse Event|0|||
160877013|NCT00830869|580945276|FG006|Period 2: Part 2|Adverse Event|0|||
160877014|NCT00830869|580945277|FG007|Period 2: Part 2|Adverse Event|4|||
160877015|NCT00830869|580945278|FG008|Period 2: Part 2|Adverse Event|3|||
160877016|NCT00830869|580945279|FG009|Period 2: Part 2|Adverse Event|2|||
160877017|NCT00830869|580945280|FG010|Period 2: Part 2|Adverse Event|2|||
160877018|NCT00830869|580945281|FG011|Period 2: Part 2|Adverse Event|0|||
160877019|NCT00830869|580945270|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
160877020|NCT00830869|580945271|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
160877021|NCT00830869|580945272|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
160877022|NCT00830869|580945273|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
160877023|NCT00830869|580945274|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
160877024|NCT00830869|580945275|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
160877025|NCT00830869|580945276|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
160877026|NCT00830869|580945277|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
160877027|NCT00830869|580945278|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
160877028|NCT00830869|580945279|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
160877029|NCT00830869|580945280|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
160877030|NCT00830869|580945281|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
160877031|NCT00830869|580945270|FG000|Period 2: Part 2|Progressive disease|0|||
160877032|NCT00830869|580945271|FG001|Period 2: Part 2|Progressive disease|0|||
160877033|NCT00830869|580945272|FG002|Period 2: Part 2|Progressive disease|0|||
160877034|NCT00830869|580945273|FG003|Period 2: Part 2|Progressive disease|0|||
160877035|NCT00830869|580945274|FG004|Period 2: Part 2|Progressive disease|0|||
160877036|NCT00830869|580945275|FG005|Period 2: Part 2|Progressive disease|0|||
160877037|NCT00830869|580945276|FG006|Period 2: Part 2|Progressive disease|0|||
160877038|NCT00830869|580945277|FG007|Period 2: Part 2|Progressive disease|14|||
160877039|NCT00830869|580945278|FG008|Period 2: Part 2|Progressive disease|11|||
160877040|NCT00830869|580945279|FG009|Period 2: Part 2|Progressive disease|12|||
160877041|NCT00830869|580945280|FG010|Period 2: Part 2|Progressive disease|8|||
160877042|NCT00830869|580945281|FG011|Period 2: Part 2|Progressive disease|15|||
160877043|NCT00830869|580945270|FG000|Period 2: Part 2|Other|0|||
160877044|NCT00830869|580945271|FG001|Period 2: Part 2|Other|0|||
160877045|NCT00830869|580945272|FG002|Period 2: Part 2|Other|0|||
160877046|NCT00830869|580945273|FG003|Period 2: Part 2|Other|0|||
160877047|NCT00830869|580945274|FG004|Period 2: Part 2|Other|0|||
160877048|NCT00830869|580945275|FG005|Period 2: Part 2|Other|0|||
160877049|NCT00830869|580945276|FG006|Period 2: Part 2|Other|0|||
160877050|NCT00830869|580945277|FG007|Period 2: Part 2|Other|0|||
160877051|NCT00830869|580945278|FG008|Period 2: Part 2|Other|0|||
160877052|NCT00830869|580945279|FG009|Period 2: Part 2|Other|1|||
160877053|NCT00830869|580945280|FG010|Period 2: Part 2|Other|0|||
160877054|NCT00830869|580945281|FG011|Period 2: Part 2|Other|0|||
160877055|NCT00507728|580945282|FG000|Randomization to Month 3|Lost to Follow-up|15|||
160877056|NCT00507728|580945283|FG001|Randomization to Month 3|Lost to Follow-up|14|||
160877057|NCT00507728|580945284|FG002|Randomization to Month 3|Lost to Follow-up|20|||
160877058|NCT00507728|580945282|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
160877059|NCT00507728|580945283|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
160877060|NCT00507728|580945284|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
160877061|NCT00730028|580945286|FG000|Overall Study|Adverse Event|23|||
160877062|NCT00730028|580945287|FG001|Overall Study|Adverse Event|26|||
160877063|NCT00730028|580945288|FG002|Overall Study|Adverse Event|16|||
160877064|NCT00730028|580945289|FG003|Overall Study|Adverse Event|20|||
160877065|NCT00730028|580945290|FG004|Overall Study|Adverse Event|43|||
160877066|NCT00730028|580945286|FG000|Overall Study|Lost to Follow-up|13|||
160877067|NCT00730028|580945287|FG001|Overall Study|Lost to Follow-up|26|||
160877068|NCT00730028|580945288|FG002|Overall Study|Lost to Follow-up|22|||
160877069|NCT00730028|580945289|FG003|Overall Study|Lost to Follow-up|26|||
160877070|NCT00730028|580945290|FG004|Overall Study|Lost to Follow-up|25|||
160877071|NCT00730028|580945286|FG000|Overall Study|Protocol Violation|6|||
160877072|NCT00730028|580945287|FG001|Overall Study|Protocol Violation|1|||
160877073|NCT00730028|580945288|FG002|Overall Study|Protocol Violation|1|||
160877074|NCT00730028|580945289|FG003|Overall Study|Protocol Violation|2|||
160877075|NCT00730028|580945290|FG004|Overall Study|Protocol Violation|0|||
160877076|NCT00730028|580945286|FG000|Overall Study|Withdrawal by Subject|9|||
160877077|NCT00730028|580945287|FG001|Overall Study|Withdrawal by Subject|5|||
160877078|NCT00730028|580945288|FG002|Overall Study|Withdrawal by Subject|4|||
160877079|NCT00730028|580945289|FG003|Overall Study|Withdrawal by Subject|5|||
160877080|NCT00730028|580945290|FG004|Overall Study|Withdrawal by Subject|9|||
160877081|NCT00730028|580945286|FG000|Overall Study|Physician Decision|3|||
160877082|NCT00730028|580945287|FG001|Overall Study|Physician Decision|3|||
160877083|NCT00730028|580945288|FG002|Overall Study|Physician Decision|2|||
160877084|NCT00730028|580945289|FG003|Overall Study|Physician Decision|3|||
160877085|NCT00730028|580945290|FG004|Overall Study|Physician Decision|2|||
160877086|NCT00730028|580945286|FG000|Overall Study|Treatment Failure|5|||
160877087|NCT00730028|580945287|FG001|Overall Study|Treatment Failure|5|||
160877088|NCT00730028|580945288|FG002|Overall Study|Treatment Failure|0|||
160877089|NCT00730028|580945289|FG003|Overall Study|Treatment Failure|0|||
160877090|NCT00730028|580945290|FG004|Overall Study|Treatment Failure|1|||
160877091|NCT00730028|580945286|FG000|Overall Study|Randomization Error|1|||
160877092|NCT00730028|580945287|FG001|Overall Study|Randomization Error|0|||
160877093|NCT00730028|580945288|FG002|Overall Study|Randomization Error|0|||
160877094|NCT00730028|580945289|FG003|Overall Study|Randomization Error|0|||
160877095|NCT00730028|580945290|FG004|Overall Study|Randomization Error|2|||
160877096|NCT00615901|580945291|FG000|Overall Study|Withdrawal by Subject|2|||
160877097|NCT00615901|580945291|FG000|Overall Study|Adverse Event|7|||
160877098|NCT01250496|580945294|FG000|Overall Study|Study terminated|124|||
160877099|NCT01250496|580945295|FG001|Overall Study|Study terminated|124|||
160877100|NCT00003590|580945296|FG000|Overall Study|Ineligible Patient|1|||
160877101|NCT00003590|580945296|FG000|Overall Study|Adverse Event|7|||
160877102|NCT00003590|580945296|FG000|Overall Study|Withdrawal by Subject|1|||
160877103|NCT00003590|580945296|FG000|Overall Study|Lack of Efficacy|11|||
160877104|NCT00003590|580945296|FG000|Overall Study|Death|1|||
160877105|NCT00003590|580945296|FG000|Overall Study|Physician Decision|1|||
160877106|NCT01425463|580945302|FG000|Overall Study|Adverse Event|5|||
160877107|NCT01425463|580945303|FG001|Overall Study|Adverse Event|7|||
160877108|NCT01425463|580945302|FG000|Overall Study|Lack of Efficacy|1|||
160877109|NCT01425463|580945303|FG001|Overall Study|Lack of Efficacy|1|||
160877110|NCT01425463|580945302|FG000|Overall Study|Protocol Violation|2|||
160877111|NCT01425463|580945303|FG001|Overall Study|Protocol Violation|2|||
160877112|NCT01425463|580945302|FG000|Overall Study|Lost to Follow-up|5|||
160877113|NCT01425463|580945303|FG001|Overall Study|Lost to Follow-up|2|||
160877114|NCT01425463|580945302|FG000|Overall Study|Withdrawal by Subject|7|||
160877115|NCT01425463|580945303|FG001|Overall Study|Withdrawal by Subject|5|||
160877116|NCT01425463|580945302|FG000|Overall Study|Unknown Reason|4|||
160877117|NCT01425463|580945303|FG001|Overall Study|Unknown Reason|7|||
160877118|NCT01332799|580945306|FG000|Overall Study|Insufficient funding|10|||
160877119|NCT01332799|580945307|FG001|Overall Study|Insufficient funding|10|||
160877120|NCT03467152|580945308|FG000|Overall Study|Adverse Event|4|||
160877121|NCT03467152|580945309|FG001|Overall Study|Adverse Event|5|||
160877122|NCT03467152|580945310|FG002|Overall Study|Adverse Event|0|||
160877123|NCT03467152|580945308|FG000|Overall Study|Subject Choice|1|||
160877124|NCT03467152|580945309|FG001|Overall Study|Subject Choice|3|||
160877125|NCT03467152|580945310|FG002|Overall Study|Subject Choice|0|||
160877126|NCT03467152|580945308|FG000|Overall Study|Lost to Follow-up|1|||
160877127|NCT03467152|580945309|FG001|Overall Study|Lost to Follow-up|0|||
160877128|NCT03467152|580945310|FG002|Overall Study|Lost to Follow-up|0|||
160877129|NCT03467152|580945308|FG000|Overall Study|Withdrawal by Subject|4|||
160877130|NCT03467152|580945309|FG001|Overall Study|Withdrawal by Subject|2|||
160877131|NCT03467152|580945310|FG002|Overall Study|Withdrawal by Subject|0|||
160877132|NCT03467152|580945308|FG000|Overall Study|Others|3|||
160877133|NCT03467152|580945309|FG001|Overall Study|Others|0|||
160877134|NCT03467152|580945310|FG002|Overall Study|Others|0|||
160877135|NCT03467152|580945308|FG000|Overall Study|Not treated|3|||
160877136|NCT03467152|580945309|FG001|Overall Study|Not treated|1|||
160877137|NCT03467152|580945310|FG002|Overall Study|Not treated|6|||
160877138|NCT00945906|580945312|FG000|Overall Study|Withdrawal by Subject|1|||
160877139|NCT00945906|580945312|FG000|Overall Study|Did not want to return for last visit|2|||
160877140|NCT00945906|580945312|FG000|Overall Study|Unable to return for last visit|2|||
160877141|NCT00945906|580945312|FG000|Overall Study|Moved to another country|2|||
160877142|NCT01236547|580945313|FG000|Overall Study|Protocol Violation|0|||
160877143|NCT01236547|580945314|FG001|Overall Study|Protocol Violation|1|||
160877144|NCT01236547|580945315|FG002|Overall Study|Protocol Violation|1|||
160877145|NCT01236547|580945316|FG003|Overall Study|Protocol Violation|6|||
160877146|NCT01236547|580945317|FG004|Overall Study|Protocol Violation|12|||
160877147|NCT04022733|580945318|FG000|Overall Study|conversion to open surgery|3|||
160877148|NCT04022733|580945319|FG001|Overall Study|conversion to open surgery|2|||
160877149|NCT04022733|580945318|FG000|Overall Study|bradycardia|0|||
160877150|NCT04022733|580945319|FG001|Overall Study|bradycardia|1|||
160877151|NCT03083990|580945320|FG000|Overall Study|Adverse Event|1|||
160877152|NCT03083990|580945321|FG001|Overall Study|Adverse Event|0|||
160877153|NCT00006409|580945322|FG000|Baseline|Protocol Violation|48|||
160877154|NCT00006409|580945323|FG001|Baseline|Protocol Violation|70|||
160877155|NCT00006409|580945324|FG002|Baseline|Protocol Violation|0|||
160877156|NCT00006409|580945325|FG003|Baseline|Protocol Violation|0|||
160877157|NCT00006409|580945326|FG004|Baseline|Protocol Violation|0|||
160877158|NCT00006409|580945327|FG005|Baseline|Protocol Violation|0|||
160877159|NCT00006409|580945322|FG000|Post-2 Year Intervention|Protocol Violation|0|||
160877160|NCT00006409|580945323|FG001|Post-2 Year Intervention|Protocol Violation|0|||
160877161|NCT00006409|580945324|FG002|Post-2 Year Intervention|Protocol Violation|251|||
160877162|NCT00006409|580945325|FG003|Post-2 Year Intervention|Protocol Violation|168|||
160877163|NCT00006409|580945326|FG004|Post-2 Year Intervention|Protocol Violation|0|||
160877164|NCT00006409|580945327|FG005|Post-2 Year Intervention|Protocol Violation|0|||
160877165|NCT00006409|580945322|FG000|Post-3 Year Intervention|Protocol Violation|0|||
160877166|NCT00006409|580945323|FG001|Post-3 Year Intervention|Protocol Violation|0|||
160877167|NCT00006409|580945324|FG002|Post-3 Year Intervention|Protocol Violation|0|||
160877168|NCT00006409|580945325|FG003|Post-3 Year Intervention|Protocol Violation|0|||
160877169|NCT00006409|580945326|FG004|Post-3 Year Intervention|Protocol Violation|62|||
160877170|NCT00006409|580945327|FG005|Post-3 Year Intervention|Protocol Violation|62|||
160877171|NCT02059291|580945328|FG000|Epoch 2|Lack of Efficacy|0|||
160877172|NCT02059291|580945329|FG001|Epoch 2|Lack of Efficacy|0|||
160877173|NCT02059291|580945330|FG002|Epoch 2|Lack of Efficacy|0|||
160877174|NCT02059291|580945331|FG003|Epoch 2|Lack of Efficacy|1|||
160877175|NCT02059291|580945332|FG004|Epoch 2|Lack of Efficacy|0|||
160877176|NCT02059291|580945333|FG005|Epoch 2|Lack of Efficacy|1|||
160877177|NCT02059291|580945334|FG006|Epoch 2|Lack of Efficacy|0|||
160877178|NCT02059291|580945335|FG007|Epoch 2|Lack of Efficacy|0|||
160877179|NCT02059291|580945336|FG008|Epoch 2|Lack of Efficacy|0|||
160877180|NCT02059291|580945337|FG009|Epoch 2|Lack of Efficacy|0|||
160877181|NCT02059291|580945338|FG010|Epoch 2|Lack of Efficacy|0|||
160877182|NCT02059291|580945339|FG011|Epoch 2|Lack of Efficacy|0|||
160877183|NCT02059291|580945340|FG012|Epoch 2|Lack of Efficacy|0|||
160877184|NCT02059291|580945341|FG013|Epoch 2|Lack of Efficacy|0|||
160877185|NCT02059291|580945342|FG014|Epoch 2|Lack of Efficacy|0|||
160877186|NCT02059291|580945343|FG015|Epoch 2|Lack of Efficacy|0|||
160877187|NCT02059291|580945344|FG016|Epoch 2|Lack of Efficacy|0|||
160877188|NCT02059291|580945345|FG017|Epoch 2|Lack of Efficacy|0|||
160877189|NCT02059291|580945346|FG018|Epoch 2|Lack of Efficacy|0|||
160877190|NCT02059291|580945347|FG019|Epoch 2|Lack of Efficacy|0|||
160877191|NCT02059291|580945348|FG020|Epoch 2|Lack of Efficacy|0|||
160877192|NCT02059291|580945349|FG021|Epoch 2|Lack of Efficacy|0|||
160877193|NCT02059291|580945350|FG022|Epoch 2|Lack of Efficacy|0|||
160877194|NCT02059291|580945351|FG023|Epoch 2|Lack of Efficacy|0|||
160877195|NCT02059291|580945352|FG024|Epoch 2|Lack of Efficacy|0|||
160877196|NCT02059291|580945328|FG000|Epoch 2|Adverse Event|0|||
160877197|NCT02059291|580945329|FG001|Epoch 2|Adverse Event|0|||
160877198|NCT02059291|580945330|FG002|Epoch 2|Adverse Event|1|||
160877199|NCT02059291|580945331|FG003|Epoch 2|Adverse Event|1|||
160877200|NCT02059291|580945332|FG004|Epoch 2|Adverse Event|0|||
160877201|NCT02059291|580945333|FG005|Epoch 2|Adverse Event|0|||
160877202|NCT02059291|580945334|FG006|Epoch 2|Adverse Event|0|||
160877203|NCT02059291|580945335|FG007|Epoch 2|Adverse Event|1|||
160877204|NCT02059291|580945336|FG008|Epoch 2|Adverse Event|1|||
160877205|NCT02059291|580945337|FG009|Epoch 2|Adverse Event|0|||
160877206|NCT02059291|580945338|FG010|Epoch 2|Adverse Event|0|||
160877207|NCT02059291|580945339|FG011|Epoch 2|Adverse Event|0|||
160877208|NCT02059291|580945340|FG012|Epoch 2|Adverse Event|0|||
160877209|NCT02059291|580945341|FG013|Epoch 2|Adverse Event|0|||
160877210|NCT02059291|580945342|FG014|Epoch 2|Adverse Event|0|||
160877211|NCT02059291|580945343|FG015|Epoch 2|Adverse Event|0|||
160877212|NCT02059291|580945344|FG016|Epoch 2|Adverse Event|0|||
160877213|NCT02059291|580945345|FG017|Epoch 2|Adverse Event|0|||
160877214|NCT02059291|580945346|FG018|Epoch 2|Adverse Event|0|||
160877215|NCT02059291|580945347|FG019|Epoch 2|Adverse Event|0|||
160877216|NCT02059291|580945348|FG020|Epoch 2|Adverse Event|0|||
160877217|NCT02059291|580945349|FG021|Epoch 2|Adverse Event|0|||
160877218|NCT02059291|580945350|FG022|Epoch 2|Adverse Event|0|||
160877219|NCT02059291|580945351|FG023|Epoch 2|Adverse Event|0|||
160877220|NCT02059291|580945352|FG024|Epoch 2|Adverse Event|0|||
160877221|NCT02059291|580945328|FG000|Epoch 2|Withdrawal by Subject|0|||
160877222|NCT02059291|580945329|FG001|Epoch 2|Withdrawal by Subject|1|||
160877223|NCT02059291|580945330|FG002|Epoch 2|Withdrawal by Subject|0|||
160877224|NCT02059291|580945331|FG003|Epoch 2|Withdrawal by Subject|0|||
160877225|NCT02059291|580945332|FG004|Epoch 2|Withdrawal by Subject|0|||
160877226|NCT02059291|580945333|FG005|Epoch 2|Withdrawal by Subject|1|||
160877227|NCT02059291|580945334|FG006|Epoch 2|Withdrawal by Subject|0|||
160877228|NCT02059291|580945335|FG007|Epoch 2|Withdrawal by Subject|0|||
160877229|NCT02059291|580945336|FG008|Epoch 2|Withdrawal by Subject|1|||
160877230|NCT02059291|580945337|FG009|Epoch 2|Withdrawal by Subject|0|||
160877231|NCT02059291|580945338|FG010|Epoch 2|Withdrawal by Subject|0|||
160877232|NCT02059291|580945339|FG011|Epoch 2|Withdrawal by Subject|0|||
160877233|NCT02059291|580945340|FG012|Epoch 2|Withdrawal by Subject|0|||
160877234|NCT02059291|580945341|FG013|Epoch 2|Withdrawal by Subject|0|||
160877235|NCT02059291|580945342|FG014|Epoch 2|Withdrawal by Subject|0|||
160877236|NCT02059291|580945343|FG015|Epoch 2|Withdrawal by Subject|0|||
160877237|NCT02059291|580945344|FG016|Epoch 2|Withdrawal by Subject|0|||
160877238|NCT02059291|580945345|FG017|Epoch 2|Withdrawal by Subject|0|||
160877239|NCT02059291|580945346|FG018|Epoch 2|Withdrawal by Subject|0|||
160877240|NCT02059291|580945347|FG019|Epoch 2|Withdrawal by Subject|0|||
160877241|NCT02059291|580945348|FG020|Epoch 2|Withdrawal by Subject|0|||
160877242|NCT02059291|580945349|FG021|Epoch 2|Withdrawal by Subject|0|||
160877243|NCT02059291|580945350|FG022|Epoch 2|Withdrawal by Subject|0|||
160877244|NCT02059291|580945351|FG023|Epoch 2|Withdrawal by Subject|0|||
160877245|NCT02059291|580945352|FG024|Epoch 2|Withdrawal by Subject|0|||
160877246|NCT02059291|580945328|FG000|Epoch 3|Physician Decision|0|||
160877247|NCT02059291|580945329|FG001|Epoch 3|Physician Decision|0|||
160877248|NCT02059291|580945330|FG002|Epoch 3|Physician Decision|0|||
160877249|NCT02059291|580945331|FG003|Epoch 3|Physician Decision|0|||
160877250|NCT02059291|580945332|FG004|Epoch 3|Physician Decision|0|||
160877251|NCT02059291|580945333|FG005|Epoch 3|Physician Decision|0|||
160877252|NCT02059291|580945334|FG006|Epoch 3|Physician Decision|0|||
160877253|NCT02059291|580945335|FG007|Epoch 3|Physician Decision|0|||
160877254|NCT02059291|580945336|FG008|Epoch 3|Physician Decision|0|||
160877255|NCT02059291|580945337|FG009|Epoch 3|Physician Decision|0|||
160877256|NCT02059291|580945338|FG010|Epoch 3|Physician Decision|0|||
160877257|NCT02059291|580945339|FG011|Epoch 3|Physician Decision|0|||
160877258|NCT02059291|580945340|FG012|Epoch 3|Physician Decision|0|||
160877259|NCT02059291|580945341|FG013|Epoch 3|Physician Decision|1|||
160877260|NCT02059291|580945342|FG014|Epoch 3|Physician Decision|0|||
160877261|NCT02059291|580945343|FG015|Epoch 3|Physician Decision|1|||
160877262|NCT02059291|580945344|FG016|Epoch 3|Physician Decision|0|||
160537735|NCT01438489|579698927|FG002|Overall Study|Inadequate venous access|0|||
160537736|NCT01372384|579698929|FG000|Overall Study|Progression of disease|3|||
160537737|NCT02576444|579698933|FG000|Overall Study|Death|1|||
160877263|NCT02059291|580945345|FG017|Epoch 3|Physician Decision|0|||
160537738|NCT02576444|579698934|FG001|Overall Study|Death|1|||
160537739|NCT02576444|579698935|FG002|Overall Study|Death|0|||
160537740|NCT02576444|579698936|FG003|Overall Study|Death|0|||
160537741|NCT02576444|579698933|FG000|Overall Study|Withdrawal by Subject|0|||
160537742|NCT02576444|579698934|FG001|Overall Study|Withdrawal by Subject|0|||
160537743|NCT02576444|579698935|FG002|Overall Study|Withdrawal by Subject|2|||
160537744|NCT02576444|579698936|FG003|Overall Study|Withdrawal by Subject|0|||
160537745|NCT02576444|579698933|FG000|Overall Study|Adverse Event|0|||
160537746|NCT02576444|579698934|FG001|Overall Study|Adverse Event|0|||
160537747|NCT02576444|579698935|FG002|Overall Study|Adverse Event|1|||
160537748|NCT02576444|579698936|FG003|Overall Study|Adverse Event|0|||
160537749|NCT02576444|579698933|FG000|Overall Study|Physician Decision|0|||
160537750|NCT02576444|579698934|FG001|Overall Study|Physician Decision|0|||
160537751|NCT02576444|579698935|FG002|Overall Study|Physician Decision|1|||
160537752|NCT02576444|579698936|FG003|Overall Study|Physician Decision|0|||
160537753|NCT03370120|579698938|FG000|Overall Study|Adverse event, non-fatal|24|||
160877264|NCT02059291|580945346|FG018|Epoch 3|Physician Decision|0|||
160877265|NCT02059291|580945347|FG019|Epoch 3|Physician Decision|0|||
160877266|NCT02059291|580945348|FG020|Epoch 3|Physician Decision|0|||
160877267|NCT02059291|580945349|FG021|Epoch 3|Physician Decision|0|||
160877268|NCT02059291|580945350|FG022|Epoch 3|Physician Decision|0|||
160877269|NCT02059291|580945351|FG023|Epoch 3|Physician Decision|0|||
160877270|NCT02059291|580945352|FG024|Epoch 3|Physician Decision|0|||
160877271|NCT02059291|580945328|FG000|Epoch 3|Adverse Event|0|||
160877272|NCT02059291|580945329|FG001|Epoch 3|Adverse Event|0|||
160877273|NCT02059291|580945330|FG002|Epoch 3|Adverse Event|0|||
160877274|NCT02059291|580945331|FG003|Epoch 3|Adverse Event|0|||
160877275|NCT02059291|580945332|FG004|Epoch 3|Adverse Event|0|||
160877276|NCT02059291|580945333|FG005|Epoch 3|Adverse Event|0|||
160877277|NCT02059291|580945334|FG006|Epoch 3|Adverse Event|0|||
160877278|NCT02059291|580945335|FG007|Epoch 3|Adverse Event|0|||
160877279|NCT02059291|580945336|FG008|Epoch 3|Adverse Event|0|||
160877280|NCT02059291|580945337|FG009|Epoch 3|Adverse Event|0|||
160877281|NCT02059291|580945338|FG010|Epoch 3|Adverse Event|0|||
160877282|NCT02059291|580945339|FG011|Epoch 3|Adverse Event|0|||
160877283|NCT02059291|580945340|FG012|Epoch 3|Adverse Event|0|||
160877284|NCT02059291|580945341|FG013|Epoch 3|Adverse Event|0|||
160877285|NCT02059291|580945342|FG014|Epoch 3|Adverse Event|0|||
160877286|NCT02059291|580945343|FG015|Epoch 3|Adverse Event|1|||
160877287|NCT02059291|580945344|FG016|Epoch 3|Adverse Event|0|||
160877288|NCT02059291|580945345|FG017|Epoch 3|Adverse Event|0|||
160877289|NCT02059291|580945346|FG018|Epoch 3|Adverse Event|0|||
160877290|NCT02059291|580945347|FG019|Epoch 3|Adverse Event|0|||
160877291|NCT02059291|580945348|FG020|Epoch 3|Adverse Event|0|||
160877292|NCT02059291|580945349|FG021|Epoch 3|Adverse Event|0|||
160877293|NCT02059291|580945350|FG022|Epoch 3|Adverse Event|0|||
160537754|NCT03370120|579698938|FG000|Overall Study|Withdrawal by Subject|6|||
160537755|NCT03370120|579698938|FG000|Overall Study|Lost to Follow-up|1|||
160537756|NCT03370120|579698938|FG000|Overall Study|Lack of Efficacy|37|||
160537757|NCT03370120|579698938|FG000|Overall Study|Per sponsor's instructions|1|||
160537758|NCT03370120|579698938|FG000|Overall Study|Study was terminated by parent company UCB|2|||
160537759|NCT03370120|579698938|FG000|Overall Study|The study was ended by the promoter|3|||
160537760|NCT03370120|579698938|FG000|Overall Study|Discontinuation of drug development|3|||
160537761|NCT03370120|579698938|FG000|Overall Study|End of project|2|||
160537762|NCT03370120|579698938|FG000|Overall Study|Premature study closure|2|||
160537763|NCT03370120|579698938|FG000|Overall Study|Premature program termination|1|||
160537764|NCT03370120|579698938|FG000|Overall Study|Premature study termination|7|||
160877294|NCT02059291|580945351|FG023|Epoch 3|Adverse Event|0|||
160877295|NCT02059291|580945352|FG024|Epoch 3|Adverse Event|0|||
160877296|NCT02059291|580945328|FG000|Epoch 3|Lack of Efficacy|0|||
160537765|NCT03370120|579698938|FG000|Overall Study|Trial terminated by sponsor|2|||
160877297|NCT02059291|580945329|FG001|Epoch 3|Lack of Efficacy|0|||
160877298|NCT02059291|580945330|FG002|Epoch 3|Lack of Efficacy|0|||
160877299|NCT02059291|580945331|FG003|Epoch 3|Lack of Efficacy|0|||
160877300|NCT02059291|580945332|FG004|Epoch 3|Lack of Efficacy|0|||
160877301|NCT02059291|580945333|FG005|Epoch 3|Lack of Efficacy|0|||
160877302|NCT02059291|580945334|FG006|Epoch 3|Lack of Efficacy|0|||
160537766|NCT03370120|579698938|FG000|Overall Study|Trial discontinued by sponsor|2|||
160537767|NCT03370120|579698938|FG000|Overall Study|Study ended|15|||
160537768|NCT03370120|579698938|FG000|Overall Study|Clinical trial has been cancelled|1|||
160877303|NCT02059291|580945335|FG007|Epoch 3|Lack of Efficacy|0|||
160877304|NCT02059291|580945336|FG008|Epoch 3|Lack of Efficacy|0|||
160877305|NCT02059291|580945337|FG009|Epoch 3|Lack of Efficacy|0|||
160877306|NCT02059291|580945338|FG010|Epoch 3|Lack of Efficacy|0|||
160537769|NCT03370120|579698938|FG000|Overall Study|End of study per sponsor decision|2|||
160877307|NCT02059291|580945339|FG011|Epoch 3|Lack of Efficacy|0|||
160877308|NCT02059291|580945340|FG012|Epoch 3|Lack of Efficacy|0|||
160877309|NCT02059291|580945341|FG013|Epoch 3|Lack of Efficacy|0|||
160877310|NCT02059291|580945342|FG014|Epoch 3|Lack of Efficacy|0|||
160537770|NCT03370120|579698938|FG000|Overall Study|Promoter's decision|2|||
160537771|NCT03370120|579698938|FG000|Overall Study|The trial has been suspended|3|||
160537772|NCT03370120|579698938|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
160537773|NCT03370120|579698938|FG000|Overall Study|Early termination by order of sponsor|2|||
160537774|NCT03370120|579698938|FG000|Overall Study|Discontinuation of the study|5|||
160537775|NCT03370120|579698938|FG000|Overall Study|End of clinical trial discontinuation|1|||
160537776|NCT03370120|579698938|FG000|Overall Study|Because the clinical trial ended halfway|4|||
160537777|NCT03370120|579698938|FG000|Overall Study|Development discontinued|5|||
160537778|NCT03370120|579698938|FG000|Overall Study|Padsenovil program closed|3|||
160537779|NCT03370120|579698938|FG000|Overall Study|End of project|2|||
160537780|NCT03370120|579698938|FG000|Overall Study|Termination of project|1|||
160537781|NCT03370120|579698938|FG000|Overall Study|The study was interrupted by sponsor|4|||
160537782|NCT03370120|579698938|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
160537783|NCT03370120|579698938|FG000|Overall Study|End of sponsor decision|1|||
160537784|NCT03370120|579698938|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
160537785|NCT03370120|579698938|FG000|Overall Study|Early termination of studies|5|||
160537786|NCT03370120|579698938|FG000|Overall Study|This study is ended early|1|||
160537787|NCT03370120|579698938|FG000|Overall Study|End of padsevonil program|2|||
160537788|NCT03370120|579698938|FG000|Overall Study|Decision of sponsor|6|||
160537789|NCT03370120|579698938|FG000|Overall Study|Asked by the sponsor|3|||
160537790|NCT03370120|579698938|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
160537791|NCT03370120|579698938|FG000|Overall Study|PI decision poor compliance from participant|1|||
160537792|NCT03370120|579698938|FG000|Overall Study|Promoter ended the study|3|||
160537793|NCT03370120|579698938|FG000|Overall Study|Premature study close by sponsor's decision|4|||
160537794|NCT03370120|579698938|FG000|Overall Study|Study terminated by sponsor|33|||
160537795|NCT03370120|579698938|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
160537796|NCT03370120|579698938|FG000|Overall Study|Sponsor decision to terminate study|63|||
160537797|NCT03370120|579698938|FG000|Overall Study|Program closure|3|||
160537798|NCT03370120|579698938|FG000|Overall Study|Study ended prematurely|1|||
160537799|NCT03370120|579698938|FG000|Overall Study|Study stopped by sponsor|2|||
160537800|NCT03370120|579698938|FG000|Overall Study|Program termination|55|||
160537801|NCT03370120|579698938|FG000|Overall Study|Sponsor decision|62|||
160537802|NCT03370120|579698938|FG000|Overall Study|Sponsor study closure|10|||
160537803|NCT00928889|579698940|FG000|Overall Study|Lost to Follow-up|3|||
160537804|NCT00928889|579698941|FG001|Overall Study|Lost to Follow-up|1|||
160537805|NCT00928889|579698940|FG000|Overall Study|Protocol Violation|0|||
160537806|NCT00928889|579698941|FG001|Overall Study|Protocol Violation|1|||
160537807|NCT00928889|579698940|FG000|Overall Study|Adverse Event|1|||
160537808|NCT00928889|579698941|FG001|Overall Study|Adverse Event|0|||
160537809|NCT00928889|579698940|FG000|Overall Study|Other|1|||
160537810|NCT00928889|579698941|FG001|Overall Study|Other|0|||
160537811|NCT04416555|579698943|FG000|Overall Study|Withdrawal by Subject|0|||
160537812|NCT04416555|579698944|FG001|Overall Study|Withdrawal by Subject|3|||
160537813|NCT00530270|579698945|FG000|Overall Study|Protocol Violation|1|||
160537814|NCT00530270|579698946|FG001|Overall Study|Protocol Violation|0|||
160537815|NCT02375724|579698955|FG000|Overall Study|Lack of Efficacy|1|||
160537816|NCT02375724|579698956|FG001|Overall Study|Lack of Efficacy|1|||
160537817|NCT02375724|579698955|FG000|Overall Study|Withdrawal by Subject|1|||
160537818|NCT02375724|579698956|FG001|Overall Study|Withdrawal by Subject|1|||
160537819|NCT02375724|579698955|FG000|Overall Study|Lost to Follow-up|1|||
160537820|NCT02375724|579698956|FG001|Overall Study|Lost to Follow-up|0|||
160537821|NCT02375724|579698955|FG000|Overall Study|Protocol Violation|1|||
160537822|NCT02375724|579698956|FG001|Overall Study|Protocol Violation|0|||
160537823|NCT02375724|579698955|FG000|Overall Study|Adverse Event|2|||
160537824|NCT02375724|579698956|FG001|Overall Study|Adverse Event|4|||
160537825|NCT04712110|579698957|FG000|Overall Study|Lost to Follow-up|0|||
160537826|NCT04712110|579698958|FG001|Overall Study|Lost to Follow-up|1|||
160537827|NCT04712110|579698957|FG000|Overall Study|Withdrawal by Subject|0|||
160537828|NCT04712110|579698958|FG001|Overall Study|Withdrawal by Subject|4|||
160768474|NCT00042289|580540663|FG004|Overall Study|Protocol Violation|0|||
160537829|NCT04712110|579698957|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
160537830|NCT04712110|579698958|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
160537831|NCT01356407|579698959|FG000|Overall Study|Lost to Follow-up|2|||
160537832|NCT01356407|579698960|FG001|Overall Study|Lost to Follow-up|0|||
160537833|NCT01356407|579698959|FG000|Overall Study|Patient Withdrew Consent|2|||
160537834|NCT01356407|579698960|FG001|Overall Study|Patient Withdrew Consent|1|||
160537835|NCT01356407|579698959|FG000|Overall Study|Could not afford IMP administration|0|||
160537836|NCT01356407|579698960|FG001|Overall Study|Could not afford IMP administration|1|||
160537837|NCT01356407|579698959|FG000|Overall Study|Not complete Endoscopy|2|||
160537838|NCT01356407|579698960|FG001|Overall Study|Not complete Endoscopy|2|||
160537839|NCT01197521|579698963|FG000|Overall Study|Not reported|24|||
160537840|NCT01197521|579698964|FG001|Overall Study|Not reported|25|||
160768475|NCT00042289|580540664|FG005|Overall Study|Protocol Violation|1|||
160768476|NCT00042289|580540665|FG006|Overall Study|Protocol Violation|0|||
160768477|NCT00042289|580540666|FG007|Overall Study|Protocol Violation|1|||
160768478|NCT00042289|580540667|FG008|Overall Study|Protocol Violation|0|||
160768479|NCT00042289|580540668|FG009|Overall Study|Protocol Violation|0|||
160768480|NCT00042289|580540669|FG010|Overall Study|Protocol Violation|0|||
160768481|NCT00042289|580540670|FG011|Overall Study|Protocol Violation|0|||
160768482|NCT00042289|580540671|FG012|Overall Study|Protocol Violation|0|||
160768483|NCT00042289|580540672|FG013|Overall Study|Protocol Violation|0|||
160768484|NCT00042289|580540673|FG014|Overall Study|Protocol Violation|0|||
160768485|NCT00042289|580540674|FG015|Overall Study|Protocol Violation|0|||
160768486|NCT00042289|580540675|FG016|Overall Study|Protocol Violation|0|||
160768487|NCT00042289|580540676|FG017|Overall Study|Protocol Violation|0|||
160768488|NCT00042289|580540677|FG018|Overall Study|Protocol Violation|0|||
160768489|NCT00042289|580540678|FG019|Overall Study|Protocol Violation|0|||
160768490|NCT00042289|580540679|FG020|Overall Study|Protocol Violation|0|||
160768491|NCT00042289|580540680|FG021|Overall Study|Protocol Violation|0|||
160768492|NCT00042289|580540681|FG022|Overall Study|Protocol Violation|0|||
160768493|NCT00042289|580540682|FG023|Overall Study|Protocol Violation|1|||
160768494|NCT00042289|580540683|FG024|Overall Study|Protocol Violation|1|||
160768495|NCT00042289|580540684|FG025|Overall Study|Protocol Violation|0|||
160768496|NCT00042289|580540685|FG026|Overall Study|Protocol Violation|2|||
160768497|NCT00042289|580540686|FG027|Overall Study|Protocol Violation|0|||
160768498|NCT00042289|580540687|FG028|Overall Study|Protocol Violation|0|||
160768499|NCT00042289|580540688|FG029|Overall Study|Protocol Violation|0|||
160768500|NCT00042289|580540689|FG030|Overall Study|Protocol Violation|1|||
160768501|NCT00042289|580540690|FG031|Overall Study|Protocol Violation|0|||
160768502|NCT00042289|580540691|FG032|Overall Study|Protocol Violation|0|||
160768503|NCT00042289|580540692|FG033|Overall Study|Protocol Violation|0|||
160768504|NCT00042289|580540693|FG034|Overall Study|Protocol Violation|0|||
160768505|NCT00042289|580540694|FG035|Overall Study|Protocol Violation|0|||
160768506|NCT00042289|580540695|FG036|Overall Study|Protocol Violation|0|||
160768507|NCT00042289|580540696|FG037|Overall Study|Protocol Violation|0|||
160768508|NCT00042289|580540697|FG038|Overall Study|Protocol Violation|0|||
160768509|NCT00042289|580540698|FG039|Overall Study|Protocol Violation|0|||
160768510|NCT00042289|580540699|FG040|Overall Study|Protocol Violation|0|||
160768511|NCT00042289|580540700|FG041|Overall Study|Protocol Violation|1|||
160768512|NCT00042289|580540701|FG042|Overall Study|Protocol Violation|1|||
160768513|NCT00042289|580540702|FG043|Overall Study|Protocol Violation|1|||
160768514|NCT00042289|580540703|FG044|Overall Study|Protocol Violation|0|||
160768515|NCT00042289|580540704|FG045|Overall Study|Protocol Violation|0|||
160768516|NCT00042289|580540705|FG046|Overall Study|Protocol Violation|0|||
160768517|NCT00042289|580540659|FG000|Overall Study|Withdrawal by Subject|4|||
160768518|NCT00042289|580540660|FG001|Overall Study|Withdrawal by Subject|1|||
160768519|NCT00042289|580540661|FG002|Overall Study|Withdrawal by Subject|0|||
160768520|NCT00042289|580540662|FG003|Overall Study|Withdrawal by Subject|2|||
160768521|NCT00042289|580540663|FG004|Overall Study|Withdrawal by Subject|0|||
160768522|NCT00042289|580540664|FG005|Overall Study|Withdrawal by Subject|2|||
160768523|NCT00042289|580540665|FG006|Overall Study|Withdrawal by Subject|0|||
160768524|NCT00042289|580540666|FG007|Overall Study|Withdrawal by Subject|0|||
160768525|NCT00042289|580540667|FG008|Overall Study|Withdrawal by Subject|0|||
160768526|NCT00042289|580540668|FG009|Overall Study|Withdrawal by Subject|1|||
160768527|NCT00042289|580540669|FG010|Overall Study|Withdrawal by Subject|0|||
160768528|NCT00042289|580540670|FG011|Overall Study|Withdrawal by Subject|0|||
160768529|NCT00042289|580540671|FG012|Overall Study|Withdrawal by Subject|2|||
160768530|NCT00042289|580540672|FG013|Overall Study|Withdrawal by Subject|0|||
160768531|NCT00042289|580540673|FG014|Overall Study|Withdrawal by Subject|0|||
160768532|NCT00042289|580540674|FG015|Overall Study|Withdrawal by Subject|0|||
160768533|NCT00042289|580540675|FG016|Overall Study|Withdrawal by Subject|0|||
160768534|NCT00042289|580540676|FG017|Overall Study|Withdrawal by Subject|0|||
160768535|NCT00042289|580540677|FG018|Overall Study|Withdrawal by Subject|0|||
160537841|NCT01197521|579698965|FG002|Overall Study|Not reported|21|||
160537842|NCT01197521|579698963|FG000|Overall Study|Enrolment in long term extension|42|||
160537843|NCT01197521|579698964|FG001|Overall Study|Enrolment in long term extension|36|||
160768536|NCT00042289|580540678|FG019|Overall Study|Withdrawal by Subject|0|||
160768537|NCT00042289|580540679|FG020|Overall Study|Withdrawal by Subject|0|||
160877311|NCT02059291|580945343|FG015|Epoch 3|Lack of Efficacy|3|||
160877312|NCT02059291|580945344|FG016|Epoch 3|Lack of Efficacy|0|||
160877313|NCT02059291|580945345|FG017|Epoch 3|Lack of Efficacy|0|||
160877314|NCT02059291|580945346|FG018|Epoch 3|Lack of Efficacy|0|||
160877315|NCT02059291|580945347|FG019|Epoch 3|Lack of Efficacy|0|||
160877316|NCT02059291|580945348|FG020|Epoch 3|Lack of Efficacy|0|||
160877317|NCT02059291|580945349|FG021|Epoch 3|Lack of Efficacy|0|||
160877318|NCT02059291|580945350|FG022|Epoch 3|Lack of Efficacy|0|||
160877319|NCT02059291|580945351|FG023|Epoch 3|Lack of Efficacy|0|||
160877320|NCT02059291|580945352|FG024|Epoch 3|Lack of Efficacy|0|||
160877321|NCT02059291|580945328|FG000|Epoch 3|Withdrawal by Subject|0|||
160877322|NCT02059291|580945329|FG001|Epoch 3|Withdrawal by Subject|0|||
160877323|NCT02059291|580945330|FG002|Epoch 3|Withdrawal by Subject|0|||
160877324|NCT02059291|580945331|FG003|Epoch 3|Withdrawal by Subject|0|||
160877325|NCT02059291|580945332|FG004|Epoch 3|Withdrawal by Subject|0|||
160877326|NCT02059291|580945333|FG005|Epoch 3|Withdrawal by Subject|0|||
160877327|NCT02059291|580945334|FG006|Epoch 3|Withdrawal by Subject|0|||
160877328|NCT02059291|580945335|FG007|Epoch 3|Withdrawal by Subject|0|||
160877329|NCT02059291|580945336|FG008|Epoch 3|Withdrawal by Subject|0|||
160877330|NCT02059291|580945337|FG009|Epoch 3|Withdrawal by Subject|0|||
160877331|NCT02059291|580945338|FG010|Epoch 3|Withdrawal by Subject|0|||
160877332|NCT02059291|580945339|FG011|Epoch 3|Withdrawal by Subject|0|||
160877333|NCT02059291|580945340|FG012|Epoch 3|Withdrawal by Subject|0|||
160877334|NCT02059291|580945341|FG013|Epoch 3|Withdrawal by Subject|0|||
160877335|NCT02059291|580945342|FG014|Epoch 3|Withdrawal by Subject|0|||
160877336|NCT02059291|580945343|FG015|Epoch 3|Withdrawal by Subject|1|||
160877337|NCT02059291|580945344|FG016|Epoch 3|Withdrawal by Subject|0|||
160877338|NCT02059291|580945345|FG017|Epoch 3|Withdrawal by Subject|0|||
160877339|NCT02059291|580945346|FG018|Epoch 3|Withdrawal by Subject|0|||
160877340|NCT02059291|580945347|FG019|Epoch 3|Withdrawal by Subject|0|||
160877341|NCT02059291|580945348|FG020|Epoch 3|Withdrawal by Subject|0|||
160877342|NCT02059291|580945349|FG021|Epoch 3|Withdrawal by Subject|0|||
160877343|NCT02059291|580945350|FG022|Epoch 3|Withdrawal by Subject|0|||
160877344|NCT02059291|580945351|FG023|Epoch 3|Withdrawal by Subject|0|||
160877345|NCT02059291|580945352|FG024|Epoch 3|Withdrawal by Subject|0|||
160877346|NCT02059291|580945328|FG000|Epoch 4|Adverse Event|0|||
160877347|NCT02059291|580945329|FG001|Epoch 4|Adverse Event|0|||
160877348|NCT02059291|580945330|FG002|Epoch 4|Adverse Event|0|||
160877349|NCT02059291|580945331|FG003|Epoch 4|Adverse Event|0|||
160877350|NCT02059291|580945332|FG004|Epoch 4|Adverse Event|0|||
160877351|NCT02059291|580945333|FG005|Epoch 4|Adverse Event|0|||
160877352|NCT02059291|580945334|FG006|Epoch 4|Adverse Event|0|||
160877353|NCT02059291|580945335|FG007|Epoch 4|Adverse Event|0|||
160877354|NCT02059291|580945336|FG008|Epoch 4|Adverse Event|0|||
160877355|NCT02059291|580945337|FG009|Epoch 4|Adverse Event|0|||
160877356|NCT02059291|580945338|FG010|Epoch 4|Adverse Event|0|||
160877357|NCT02059291|580945339|FG011|Epoch 4|Adverse Event|0|||
160877358|NCT02059291|580945340|FG012|Epoch 4|Adverse Event|0|||
160877359|NCT02059291|580945341|FG013|Epoch 4|Adverse Event|0|||
160877360|NCT02059291|580945342|FG014|Epoch 4|Adverse Event|0|||
160877361|NCT02059291|580945343|FG015|Epoch 4|Adverse Event|0|||
160877362|NCT02059291|580945344|FG016|Epoch 4|Adverse Event|1|||
160877363|NCT02059291|580945345|FG017|Epoch 4|Adverse Event|0|||
160877364|NCT02059291|580945346|FG018|Epoch 4|Adverse Event|0|||
160877365|NCT02059291|580945347|FG019|Epoch 4|Adverse Event|0|||
160877366|NCT02059291|580945348|FG020|Epoch 4|Adverse Event|0|||
160877367|NCT02059291|580945349|FG021|Epoch 4|Adverse Event|0|||
160877368|NCT02059291|580945350|FG022|Epoch 4|Adverse Event|1|||
160877369|NCT02059291|580945351|FG023|Epoch 4|Adverse Event|0|||
160877370|NCT02059291|580945352|FG024|Epoch 4|Adverse Event|0|||
160877371|NCT02059291|580945328|FG000|Epoch 4|Pregnancy|0|||
160877372|NCT02059291|580945329|FG001|Epoch 4|Pregnancy|0|||
160877373|NCT02059291|580945330|FG002|Epoch 4|Pregnancy|0|||
160877374|NCT02059291|580945331|FG003|Epoch 4|Pregnancy|0|||
160877375|NCT02059291|580945332|FG004|Epoch 4|Pregnancy|0|||
160877376|NCT02059291|580945333|FG005|Epoch 4|Pregnancy|0|||
160877377|NCT02059291|580945334|FG006|Epoch 4|Pregnancy|0|||
160877378|NCT02059291|580945335|FG007|Epoch 4|Pregnancy|0|||
160877379|NCT02059291|580945336|FG008|Epoch 4|Pregnancy|0|||
160877380|NCT02059291|580945337|FG009|Epoch 4|Pregnancy|0|||
160877381|NCT02059291|580945338|FG010|Epoch 4|Pregnancy|0|||
160877382|NCT02059291|580945339|FG011|Epoch 4|Pregnancy|0|||
160877383|NCT02059291|580945340|FG012|Epoch 4|Pregnancy|0|||
160877384|NCT02059291|580945341|FG013|Epoch 4|Pregnancy|0|||
160877385|NCT02059291|580945342|FG014|Epoch 4|Pregnancy|0|||
160877386|NCT02059291|580945343|FG015|Epoch 4|Pregnancy|0|||
160877387|NCT02059291|580945344|FG016|Epoch 4|Pregnancy|1|||
160877388|NCT02059291|580945345|FG017|Epoch 4|Pregnancy|0|||
160877389|NCT02059291|580945346|FG018|Epoch 4|Pregnancy|0|||
160877390|NCT02059291|580945347|FG019|Epoch 4|Pregnancy|0|||
160877391|NCT02059291|580945348|FG020|Epoch 4|Pregnancy|0|||
160877392|NCT02059291|580945349|FG021|Epoch 4|Pregnancy|0|||
160877393|NCT02059291|580945350|FG022|Epoch 4|Pregnancy|0|||
160877394|NCT02059291|580945351|FG023|Epoch 4|Pregnancy|0|||
160877395|NCT02059291|580945352|FG024|Epoch 4|Pregnancy|0|||
160877396|NCT02059291|580945328|FG000|Epoch 4|Withdrawal by Subject|0|||
160877397|NCT02059291|580945329|FG001|Epoch 4|Withdrawal by Subject|0|||
160877398|NCT02059291|580945330|FG002|Epoch 4|Withdrawal by Subject|0|||
160877399|NCT02059291|580945331|FG003|Epoch 4|Withdrawal by Subject|0|||
160877400|NCT02059291|580945332|FG004|Epoch 4|Withdrawal by Subject|0|||
160877401|NCT02059291|580945333|FG005|Epoch 4|Withdrawal by Subject|0|||
160877402|NCT02059291|580945334|FG006|Epoch 4|Withdrawal by Subject|0|||
160877403|NCT02059291|580945335|FG007|Epoch 4|Withdrawal by Subject|0|||
160877404|NCT02059291|580945336|FG008|Epoch 4|Withdrawal by Subject|0|||
160877405|NCT02059291|580945337|FG009|Epoch 4|Withdrawal by Subject|0|||
160877406|NCT02059291|580945338|FG010|Epoch 4|Withdrawal by Subject|0|||
160877407|NCT02059291|580945339|FG011|Epoch 4|Withdrawal by Subject|0|||
160877408|NCT02059291|580945340|FG012|Epoch 4|Withdrawal by Subject|0|||
160877409|NCT02059291|580945341|FG013|Epoch 4|Withdrawal by Subject|0|||
160877410|NCT02059291|580945342|FG014|Epoch 4|Withdrawal by Subject|0|||
160877411|NCT02059291|580945343|FG015|Epoch 4|Withdrawal by Subject|0|||
160877412|NCT02059291|580945344|FG016|Epoch 4|Withdrawal by Subject|0|||
160877413|NCT02059291|580945345|FG017|Epoch 4|Withdrawal by Subject|0|||
160877414|NCT02059291|580945346|FG018|Epoch 4|Withdrawal by Subject|0|||
160877415|NCT02059291|580945347|FG019|Epoch 4|Withdrawal by Subject|0|||
160877416|NCT02059291|580945348|FG020|Epoch 4|Withdrawal by Subject|1|||
160877417|NCT02059291|580945349|FG021|Epoch 4|Withdrawal by Subject|0|||
160877418|NCT02059291|580945350|FG022|Epoch 4|Withdrawal by Subject|0|||
160877419|NCT02059291|580945351|FG023|Epoch 4|Withdrawal by Subject|0|||
160877420|NCT02059291|580945352|FG024|Epoch 4|Withdrawal by Subject|0|||
160877421|NCT02059291|580945328|FG000|Epoch 4|Lack of Efficacy|0|||
160877422|NCT02059291|580945329|FG001|Epoch 4|Lack of Efficacy|0|||
160877423|NCT02059291|580945330|FG002|Epoch 4|Lack of Efficacy|0|||
160877424|NCT02059291|580945331|FG003|Epoch 4|Lack of Efficacy|0|||
160877425|NCT02059291|580945332|FG004|Epoch 4|Lack of Efficacy|0|||
160877426|NCT02059291|580945333|FG005|Epoch 4|Lack of Efficacy|0|||
160877427|NCT02059291|580945334|FG006|Epoch 4|Lack of Efficacy|0|||
160877428|NCT02059291|580945335|FG007|Epoch 4|Lack of Efficacy|0|||
160877429|NCT02059291|580945336|FG008|Epoch 4|Lack of Efficacy|0|||
160877430|NCT02059291|580945337|FG009|Epoch 4|Lack of Efficacy|0|||
160877431|NCT02059291|580945338|FG010|Epoch 4|Lack of Efficacy|0|||
160877432|NCT02059291|580945339|FG011|Epoch 4|Lack of Efficacy|0|||
160877433|NCT02059291|580945340|FG012|Epoch 4|Lack of Efficacy|0|||
160877434|NCT02059291|580945341|FG013|Epoch 4|Lack of Efficacy|0|||
160877435|NCT02059291|580945342|FG014|Epoch 4|Lack of Efficacy|0|||
160877436|NCT02059291|580945343|FG015|Epoch 4|Lack of Efficacy|0|||
160877437|NCT02059291|580945344|FG016|Epoch 4|Lack of Efficacy|0|||
160877438|NCT02059291|580945345|FG017|Epoch 4|Lack of Efficacy|0|||
160877439|NCT02059291|580945346|FG018|Epoch 4|Lack of Efficacy|0|||
160877440|NCT02059291|580945347|FG019|Epoch 4|Lack of Efficacy|0|||
160877441|NCT02059291|580945348|FG020|Epoch 4|Lack of Efficacy|0|||
160877442|NCT02059291|580945349|FG021|Epoch 4|Lack of Efficacy|0|||
160877443|NCT02059291|580945350|FG022|Epoch 4|Lack of Efficacy|0|||
160877444|NCT02059291|580945351|FG023|Epoch 4|Lack of Efficacy|1|||
160877445|NCT02059291|580945352|FG024|Epoch 4|Lack of Efficacy|0|||
160877446|NCT01276054|580945357|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
160877447|NCT01276054|580945358|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
160877448|NCT00787267|580945359|FG000|Overall Study|Screen failure/Ineligible|10|||
160877449|NCT00787267|580945359|FG000|Overall Study|No Reason Provided|1|||
160877450|NCT00787267|580945359|FG000|Overall Study|Withdrawal by Subject|1|||
160877451|NCT04343235|580945360|FG000|Overall Study|Lost to Follow-up|3|||
160877452|NCT04343235|580945361|FG001|Overall Study|Lost to Follow-up|2|||
160877453|NCT01763996|580945362|FG000|Treatment Period 2|Adverse Event|0|||
160877454|NCT01763996|580945363|FG001|Treatment Period 2|Adverse Event|1|||
160877455|NCT05405257|580945367|FG000|Overall Study|Withdrawal by Subject|1|||
160877456|NCT00776919|580945370|FG000|Overall Study|Withdrawal by Subject|16|||
160877457|NCT00776919|580945371|FG001|Overall Study|Withdrawal by Subject|14|||
160877458|NCT00776919|580945372|FG002|Overall Study|Withdrawal by Subject|15|||
160877459|NCT00776919|580945373|FG003|Overall Study|Withdrawal by Subject|26|||
160877460|NCT00776919|580945370|FG000|Overall Study|Lost to Follow-up|8|||
160877461|NCT00776919|580945371|FG001|Overall Study|Lost to Follow-up|12|||
160877462|NCT00776919|580945372|FG002|Overall Study|Lost to Follow-up|11|||
160877463|NCT00776919|580945373|FG003|Overall Study|Lost to Follow-up|8|||
160877464|NCT00776919|580945370|FG000|Overall Study|Adverse Event|1|||
160877465|NCT00776919|580945371|FG001|Overall Study|Adverse Event|0|||
160877466|NCT00776919|580945372|FG002|Overall Study|Adverse Event|2|||
160877467|NCT00776919|580945373|FG003|Overall Study|Adverse Event|2|||
160877468|NCT00776919|580945370|FG000|Overall Study|Protocol Violation|1|||
160877469|NCT00776919|580945371|FG001|Overall Study|Protocol Violation|2|||
160877470|NCT00776919|580945372|FG002|Overall Study|Protocol Violation|0|||
160877471|NCT00776919|580945373|FG003|Overall Study|Protocol Violation|1|||
160877472|NCT00776919|580945370|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
160877473|NCT00776919|580945371|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
160877474|NCT00776919|580945372|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
160877475|NCT00776919|580945373|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
160877476|NCT01788215|580945374|FG000|Overall Study|Withdrawal by Subject|0|||
160877477|NCT01788215|580945375|FG001|Overall Study|Withdrawal by Subject|1|||
160877478|NCT01788215|580945374|FG000|Overall Study|Lost to Follow-up|2|||
160877479|NCT01788215|580945375|FG001|Overall Study|Lost to Follow-up|0|||
160877480|NCT03116152|580945376|FG000|Overall Study|Disease Progression|49|||
160877481|NCT03116152|580945377|FG001|Overall Study|Disease Progression|47|||
160877482|NCT03116152|580945376|FG000|Overall Study|Death|5|||
160877483|NCT03116152|580945377|FG001|Overall Study|Death|2|||
160877484|NCT03116152|580945376|FG000|Overall Study|Adverse Event|21|||
160877485|NCT03116152|580945377|FG001|Overall Study|Adverse Event|7|||
160877486|NCT03116152|580945376|FG000|Overall Study|Protocol Violation|2|||
160877487|NCT03116152|580945377|FG001|Overall Study|Protocol Violation|2|||
160877488|NCT03116152|580945376|FG000|Overall Study|Withdrawal by Subject|0|||
160877489|NCT03116152|580945377|FG001|Overall Study|Withdrawal by Subject|1|||
160877490|NCT03116152|580945376|FG000|Overall Study|Physician Decision|3|||
160877491|NCT03116152|580945377|FG001|Overall Study|Physician Decision|2|||
160877492|NCT03116152|580945376|FG000|Overall Study|other|11|||
160877493|NCT03116152|580945377|FG001|Overall Study|other|34|||
160877494|NCT01396057|580945386|FG000|Overall Study|Adverse Event|2|||
160877495|NCT01396057|580945387|FG001|Overall Study|Adverse Event|6|||
160877496|NCT01396057|580945386|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160877497|NCT01396057|580945387|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
160877498|NCT01396057|580945386|FG000|Overall Study|Protocol deviation|4|||
160877499|NCT01396057|580945387|FG001|Overall Study|Protocol deviation|4|||
160877500|NCT01396057|580945386|FG000|Overall Study|Consent withdrawn|3|||
160877501|NCT01396057|580945387|FG001|Overall Study|Consent withdrawn|2|||
160877502|NCT01324401|580945390|FG000|Overall Study|Withdrawn before any treatment|0|||
160877503|NCT01324401|580945391|FG001|Overall Study|Withdrawn before any treatment|3|||
160877504|NCT01324401|580945390|FG000|Overall Study|Adverse Event|1|||
160877505|NCT01324401|580945391|FG001|Overall Study|Adverse Event|3|||
160877506|NCT00335764|580945392|FG000|Overall Study|wrong histology|1|||
160877507|NCT00335764|580945393|FG001|Overall Study|wrong histology|0|||
160877508|NCT00335764|580945394|FG002|Overall Study|wrong histology|0|||
160877509|NCT00335764|580945395|FG003|Overall Study|wrong histology|0|||
160877510|NCT00335764|580945396|FG004|Overall Study|wrong histology|1|||
160877511|NCT01578850|580945398|FG000|Period 1|Insufficient Clinical Response|1|||
160877512|NCT01578850|580945399|FG001|Period 1|Insufficient Clinical Response|0|||
160877513|NCT01578850|580945400|FG002|Period 1|Insufficient Clinical Response|0|||
160877514|NCT01578850|580945398|FG000|Period 1|Adverse Event|11|||
160877515|NCT01578850|580945399|FG001|Period 1|Adverse Event|0|||
160877516|NCT01578850|580945400|FG002|Period 1|Adverse Event|0|||
160877517|NCT01578850|580945398|FG000|Period 1|Death|1|||
160877518|NCT01578850|580945399|FG001|Period 1|Death|0|||
160877519|NCT01578850|580945400|FG002|Period 1|Death|0|||
160877520|NCT01578850|580945398|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
160877521|NCT01578850|580945399|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
160877522|NCT01578850|580945400|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
160877523|NCT01578850|580945398|FG000|Period 1|Withdrawal by Subject|9|||
160877524|NCT01578850|580945399|FG001|Period 1|Withdrawal by Subject|0|||
160877525|NCT01578850|580945400|FG002|Period 1|Withdrawal by Subject|0|||
160877526|NCT01578850|580945398|FG000|Period 1|Study Terminated by Sponsor|3|||
160877527|NCT01578850|580945399|FG001|Period 1|Study Terminated by Sponsor|0|||
160877528|NCT01578850|580945400|FG002|Period 1|Study Terminated by Sponsor|0|||
160877529|NCT01578850|580945398|FG000|Period 2|Insufficient Clinical Response|0|||
160877530|NCT01578850|580945399|FG001|Period 2|Insufficient Clinical Response|1|||
160877531|NCT01578850|580945400|FG002|Period 2|Insufficient Clinical Response|0|||
160877532|NCT01578850|580945398|FG000|Period 2|Adverse Event|0|||
160877533|NCT01578850|580945399|FG001|Period 2|Adverse Event|3|||
160877534|NCT01578850|580945400|FG002|Period 2|Adverse Event|6|||
160877535|NCT01578850|580945398|FG000|Period 2|Lost to Follow-up|0|||
160877536|NCT01578850|580945399|FG001|Period 2|Lost to Follow-up|1|||
160877537|NCT01578850|580945400|FG002|Period 2|Lost to Follow-up|2|||
160877538|NCT01578850|580945398|FG000|Period 2|Withdrawal by Subject|0|||
160877539|NCT01578850|580945399|FG001|Period 2|Withdrawal by Subject|2|||
160877540|NCT01578850|580945400|FG002|Period 2|Withdrawal by Subject|2|||
160877541|NCT01578850|580945398|FG000|Period 2|Study Terminated by Sponsor|0|||
160877542|NCT01578850|580945399|FG001|Period 2|Study Terminated by Sponsor|5|||
160877543|NCT01578850|580945400|FG002|Period 2|Study Terminated by Sponsor|4|||
160877544|NCT01578850|580945398|FG000|Period 2|Unspecified Reasons|0|||
160877545|NCT01578850|580945399|FG001|Period 2|Unspecified Reasons|1|||
160877546|NCT01578850|580945400|FG002|Period 2|Unspecified Reasons|0|||
160877547|NCT01215097|580945412|FG000|Overall Study|Adverse Event|1|||
160877548|NCT01215097|580945413|FG001|Overall Study|Adverse Event|3|||
160877549|NCT01215097|580945412|FG000|Overall Study|Protocol Violation|0|||
160877550|NCT01215097|580945413|FG001|Overall Study|Protocol Violation|2|||
160877551|NCT01215097|580945412|FG000|Overall Study|Lost to Follow-up|2|||
160636608|NCT05166512|580051581|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
160877552|NCT01215097|580945413|FG001|Overall Study|Lost to Follow-up|0|||
160877553|NCT01215097|580945412|FG000|Overall Study|Withdrawal by Subject|6|||
160877554|NCT01215097|580945413|FG001|Overall Study|Withdrawal by Subject|3|||
160877555|NCT01215097|580945412|FG000|Overall Study|Lack of Efficacy|0|||
160877556|NCT01215097|580945413|FG001|Overall Study|Lack of Efficacy|3|||
160877557|NCT01215097|580945412|FG000|Overall Study|patient's refusal to come|2|||
160877558|NCT01215097|580945413|FG001|Overall Study|patient's refusal to come|2|||
160877559|NCT01215097|580945412|FG000|Overall Study|patient's private reason|1|||
160877560|NCT01215097|580945413|FG001|Overall Study|patient's private reason|1|||
160877561|NCT02259088|580945414|FG000|Overall Study|Adverse Event|6|||
160877562|NCT02259088|580945415|FG001|Overall Study|Adverse Event|4|||
160877563|NCT02259088|580945414|FG000|Overall Study|Lost to Follow-up|2|||
160877564|NCT02259088|580945415|FG001|Overall Study|Lost to Follow-up|0|||
160877565|NCT02259088|580945414|FG000|Overall Study|Death|2|||
160877566|NCT02259088|580945415|FG001|Overall Study|Death|0|||
160877567|NCT02259088|580945414|FG000|Overall Study|Physician Decision|5|||
160877568|NCT02259088|580945415|FG001|Overall Study|Physician Decision|2|||
160877569|NCT02259088|580945414|FG000|Overall Study|Protocol deviation|5|||
160877570|NCT02259088|580945415|FG001|Overall Study|Protocol deviation|0|||
160877571|NCT02259088|580945414|FG000|Overall Study|Subject/guardian decision|8|||
160877572|NCT02259088|580945415|FG001|Overall Study|Subject/guardian decision|8|||
160877573|NCT01818752|580945417|FG000|Overall Study|Adverse Event|64|||
160537844|NCT01197521|579698965|FG002|Overall Study|Enrolment in long term extension|87|||
160537845|NCT01197521|579698963|FG000|Overall Study|Severe non-compliance to protocol|1|||
160537846|NCT01197521|579698964|FG001|Overall Study|Severe non-compliance to protocol|3|||
160537847|NCT01197521|579698965|FG002|Overall Study|Severe non-compliance to protocol|3|||
160537848|NCT01197521|579698963|FG000|Overall Study|Lack of therapeutic response|2|||
160537849|NCT01197521|579698964|FG001|Overall Study|Lack of therapeutic response|3|||
160537850|NCT01197521|579698965|FG002|Overall Study|Lack of therapeutic response|4|||
160537851|NCT01197521|579698963|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
160537852|NCT01197521|579698964|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
160537853|NCT01197521|579698965|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
160537854|NCT01197521|579698963|FG000|Overall Study|Lost to Follow-up|3|||
160537855|NCT01197521|579698964|FG001|Overall Study|Lost to Follow-up|2|||
160537856|NCT01197521|579698965|FG002|Overall Study|Lost to Follow-up|2|||
160537857|NCT01197521|579698963|FG000|Overall Study|Adverse Event|25|||
160537858|NCT01197521|579698964|FG001|Overall Study|Adverse Event|28|||
160537859|NCT01197521|579698965|FG002|Overall Study|Adverse Event|24|||
160537860|NCT01309659|579698966|FG000|Overall Study|Protocol Violation|0|||
160537861|NCT01309659|579698967|FG001|Overall Study|Protocol Violation|1|||
160537862|NCT02285777|579698968|FG000|Overall Study|Withdrawal by Subject|1|||
160537863|NCT02285777|579698969|FG001|Overall Study|Withdrawal by Subject|1|||
160537864|NCT02285777|579698968|FG000|Overall Study|Lost to Follow-up|4|||
160537865|NCT02285777|579698969|FG001|Overall Study|Lost to Follow-up|2|||
160537866|NCT00912028|579698970|FG000|Overall Study|Lost to Follow-up|2|||
160537867|NCT00912028|579698971|FG001|Overall Study|Lost to Follow-up|3|||
160537868|NCT00912028|579698972|FG002|Overall Study|Lost to Follow-up|0|||
160537869|NCT00912028|579698973|FG003|Overall Study|Lost to Follow-up|1|||
160537870|NCT00912028|579698974|FG004|Overall Study|Lost to Follow-up|3|||
160537871|NCT00912028|579698970|FG000|Overall Study|Withdrawal by Subject|3|||
160537872|NCT00912028|579698971|FG001|Overall Study|Withdrawal by Subject|0|||
160537873|NCT00912028|579698972|FG002|Overall Study|Withdrawal by Subject|0|||
160537874|NCT00912028|579698973|FG003|Overall Study|Withdrawal by Subject|0|||
160537875|NCT00912028|579698974|FG004|Overall Study|Withdrawal by Subject|0|||
160537876|NCT01793142|579698975|FG000|Overall Study|Randomized not treated|7|||
160537877|NCT02829138|579698976|FG000|Overall Study|Withdrawal by Subject|1|||
160537878|NCT02829138|579698977|FG001|Overall Study|Withdrawal by Subject|0|||
160537879|NCT01394627|579698978|FG000|First Intervention (1 Day)|poor intravenous access|0|||
160537880|NCT01394627|579698979|FG001|First Intervention (1 Day)|poor intravenous access|1|||
160537881|NCT01394627|579698978|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
160537882|NCT01394627|579698979|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
160537883|NCT00825162|579698982|FG000|Overall Study|Withdrawal by Subject|11|||
160537884|NCT00825162|579698983|FG001|Overall Study|Withdrawal by Subject|13|||
160537885|NCT00825162|579698984|FG002|Overall Study|Withdrawal by Subject|3|||
160537886|NCT00825162|579698982|FG000|Overall Study|Lost to Follow-up|9|||
160537887|NCT00825162|579698983|FG001|Overall Study|Lost to Follow-up|6|||
160537888|NCT00825162|579698984|FG002|Overall Study|Lost to Follow-up|3|||
160537889|NCT00825162|579698982|FG000|Overall Study|Physician Decision|2|||
160537890|NCT00825162|579698983|FG001|Overall Study|Physician Decision|0|||
160537891|NCT00825162|579698984|FG002|Overall Study|Physician Decision|0|||
160537892|NCT00825162|579698982|FG000|Overall Study|Move away from the study area|1|||
160537893|NCT00825162|579698983|FG001|Overall Study|Move away from the study area|0|||
160537894|NCT00825162|579698984|FG002|Overall Study|Move away from the study area|0|||
160537895|NCT00825162|579698982|FG000|Overall Study|Unable to attend the study visit|5|||
160537896|NCT00825162|579698983|FG001|Overall Study|Unable to attend the study visit|2|||
160537897|NCT00825162|579698984|FG002|Overall Study|Unable to attend the study visit|0|||
160537898|NCT00258674|579698992|FG000|Overall Study|Death|32|||
160877574|NCT01818752|580945418|FG001|Overall Study|Adverse Event|74|||
160537899|NCT00258674|579698993|FG001|Overall Study|Death|53|||
160537900|NCT00258674|579698994|FG002|Overall Study|Death|34|||
160537901|NCT01279850|579698995|FG000|Overall Study|Protocol Violation|50|||
160877575|NCT01818752|580945417|FG000|Overall Study|Death|14|||
160877576|NCT01818752|580945418|FG001|Overall Study|Death|18|||
160877577|NCT01818752|580945417|FG000|Overall Study|Non-compliance|16|||
160877578|NCT01818752|580945418|FG001|Overall Study|Non-compliance|20|||
160877579|NCT01818752|580945417|FG000|Overall Study|Withdrawal by Subject|15|||
160877580|NCT01818752|580945418|FG001|Overall Study|Withdrawal by Subject|14|||
160877581|NCT01818752|580945417|FG000|Overall Study|Physician Decision|9|||
160877582|NCT01818752|580945418|FG001|Overall Study|Physician Decision|8|||
160877583|NCT01818752|580945417|FG000|Overall Study|Disease Progression|54|||
160877584|NCT01818752|580945418|FG001|Overall Study|Disease Progression|48|||
160877585|NCT01818752|580945417|FG000|Overall Study|Other|7|||
160877586|NCT01818752|580945418|FG001|Overall Study|Other|8|||
160877587|NCT01818752|580945417|FG000|Overall Study|Continuing Treatment|1|||
160877588|NCT01818752|580945418|FG001|Overall Study|Continuing Treatment|4|||
160877589|NCT01818752|580945417|FG000|Overall Study|Randomized but not Dosed|7|||
160877590|NCT01818752|580945418|FG001|Overall Study|Randomized but not Dosed|4|||
160877591|NCT04629066|580945419|FG000|Overall Study|Lost to Follow-up|3|||
160877592|NCT04629066|580945420|FG001|Overall Study|Lost to Follow-up|2|||
160877593|NCT00282308|580945423|FG000|Treatment Period|Lost to Follow-up|1|||
160877594|NCT00282308|580945424|FG001|Treatment Period|Lost to Follow-up|0|||
160877595|NCT00282308|580945425|FG002|Treatment Period|Lost to Follow-up|0|||
160877596|NCT00282308|580945423|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
160877597|NCT00282308|580945424|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
160877598|NCT00282308|580945425|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
160877599|NCT00282308|580945423|FG000|Treatment Period|Adverse Event|0|||
160877600|NCT00282308|580945424|FG001|Treatment Period|Adverse Event|2|||
160877601|NCT00282308|580945425|FG002|Treatment Period|Adverse Event|0|||
160877602|NCT00282308|580945423|FG000|Treatment Period|Not Treated with Study Drug|1|||
160877603|NCT00282308|580945424|FG001|Treatment Period|Not Treated with Study Drug|0|||
160877604|NCT00282308|580945425|FG002|Treatment Period|Not Treated with Study Drug|0|||
160877605|NCT00282308|580945423|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
160877606|NCT00282308|580945424|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
160877607|NCT00282308|580945425|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
160877608|NCT00282308|580945423|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
160877609|NCT00282308|580945424|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
160877610|NCT00282308|580945425|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
160877611|NCT00282308|580945423|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
160877612|NCT00282308|580945424|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
160877613|NCT00282308|580945425|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
160877614|NCT00282308|580945423|FG000|Safety Follow-up Period|Adverse Event|0|||
160877615|NCT00282308|580945424|FG001|Safety Follow-up Period|Adverse Event|0|||
160877616|NCT00282308|580945425|FG002|Safety Follow-up Period|Adverse Event|1|||
160877617|NCT00282308|580945423|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
160877618|NCT00282308|580945424|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
160877619|NCT00282308|580945425|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
160877620|NCT00282308|580945423|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
160877621|NCT00282308|580945424|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
160877622|NCT00282308|580945425|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
160877623|NCT00282308|580945423|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
160877624|NCT00282308|580945424|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
160877625|NCT00282308|580945425|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
160877626|NCT02660983|580945426|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
160877627|NCT02660983|580945427|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
160877628|NCT02660983|580945426|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
160877629|NCT02660983|580945427|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
160877630|NCT02660983|580945426|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
160877631|NCT02660983|580945427|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
160877632|NCT02660983|580945426|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
160877633|NCT02660983|580945427|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
160877634|NCT02660983|580945426|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
160877635|NCT02660983|580945427|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
160877636|NCT02660983|580945426|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
160877637|NCT02660983|580945427|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
160877638|NCT02660983|580945426|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
160877639|NCT02660983|580945427|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
160877640|NCT00721968|580945430|FG000|Overall Study|Lost to Follow-up|2|||
160877641|NCT00721968|580945431|FG001|Overall Study|Lost to Follow-up|0|||
160877642|NCT03374202|580945432|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
160877643|NCT03374202|580945433|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
160877644|NCT03374202|580945434|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
160877645|NCT03374202|580945432|FG000|Five Year Long Term Follow Up|Death|0|||
160877646|NCT03374202|580945433|FG001|Five Year Long Term Follow Up|Death|1|||
160877647|NCT03374202|580945434|FG002|Five Year Long Term Follow Up|Death|0|||
160877648|NCT00361634|580947285|FG000|Overall Study|Lost to Follow-up|1|||
160877649|NCT00361634|580947285|FG000|Overall Study|Withdrawal by Subject|1|||
160877650|NCT05315908|580947286|FG000|Overall Study|Lost to Follow-up|4477|||
160877651|NCT05315908|580947287|FG001|Overall Study|Lost to Follow-up|4606|||
160877652|NCT00505076|580947296|FG000|Overall Study|Adverse Event|1|||
160877653|NCT00505076|580947297|FG001|Overall Study|Adverse Event|0|||
160877654|NCT00505076|580947298|FG002|Overall Study|Adverse Event|1|||
160877655|NCT00505076|580947296|FG000|Overall Study|Protocol Violation|2|||
160877656|NCT00505076|580947297|FG001|Overall Study|Protocol Violation|1|||
160877657|NCT00505076|580947298|FG002|Overall Study|Protocol Violation|2|||
160877658|NCT00505076|580947296|FG000|Overall Study|Withdrawal by Subject|0|||
160877659|NCT00505076|580947297|FG001|Overall Study|Withdrawal by Subject|1|||
160877660|NCT00505076|580947298|FG002|Overall Study|Withdrawal by Subject|2|||
160877661|NCT01541397|580947299|FG000|Overall Study|Study ended prior to data collection|4|||
160877662|NCT01541397|580947300|FG001|Overall Study|Study ended prior to data collection|2|||
160877663|NCT00233454|580947303|FG000|Overall Study|Death|6|||
160877664|NCT04224688|580947304|FG000|Overall Study|Withdrawal by Subject|1|||
160877665|NCT04224688|580947305|FG001|Overall Study|Withdrawal by Subject|3|||
160877666|NCT04224688|580947304|FG000|Overall Study|Lack of Efficacy|1|||
160877667|NCT04224688|580947305|FG001|Overall Study|Lack of Efficacy|1|||
160877668|NCT04224688|580947304|FG000|Overall Study|Adverse event, not fatal|0|||
160877669|NCT04224688|580947305|FG001|Overall Study|Adverse event, not fatal|2|||
160877670|NCT04224688|580947304|FG000|Overall Study|COVID-19|0|||
160877671|NCT04224688|580947305|FG001|Overall Study|COVID-19|1|||
160877672|NCT03595228|580947306|FG000|Overall Study|Death|2|||
160877673|NCT03595228|580947306|FG000|Overall Study|Lack of Efficacy|13|||
160877674|NCT03595228|580947306|FG000|Overall Study|Withdrawal by Subject|3|||
160877675|NCT03595228|580947306|FG000|Overall Study|Withdrawal by Sponsor|1|||
160877676|NCT01639729|580947307|FG000|Overall Study|Withdrawal by Subject|1|||
160877677|NCT01639729|580947308|FG001|Overall Study|Withdrawal by Subject|0|||
160877678|NCT01639729|580947309|FG002|Overall Study|Withdrawal by Subject|1|||
160877679|NCT01639729|580947310|FG003|Overall Study|Withdrawal by Subject|1|||
160877680|NCT01639729|580947311|FG004|Overall Study|Withdrawal by Subject|0|||
160877681|NCT01639729|580947312|FG005|Overall Study|Withdrawal by Subject|0|||
160877682|NCT03232333|580947313|FG000|Overall Study|Infection or Osteomyelitis|9|||
160877683|NCT03232333|580947313|FG000|Overall Study|Lost to Follow-up|4|||
160877684|NCT03232333|580947313|FG000|Overall Study|Withdrawal by Subject|2|||
160877685|NCT01155011|580947314|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
160877686|NCT01155011|580947315|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
160877687|NCT01155011|580947314|FG000|Baseline to 6 Months|investigator decision, moved|4|||
160877688|NCT01155011|580947315|FG001|Baseline to 6 Months|investigator decision, moved|5|||
160877689|NCT01155011|580947314|FG000|Baseline to 6 Months|Death|0|||
160877690|NCT01155011|580947315|FG001|Baseline to 6 Months|Death|1|||
160877691|NCT01155011|580947314|FG000|6 to 12 Months|Withdrawal by Subject|8|||
160877692|NCT01155011|580947315|FG001|6 to 12 Months|Withdrawal by Subject|5|||
160877693|NCT01155011|580947314|FG000|6 to 12 Months|Death|1|||
160877694|NCT01155011|580947315|FG001|6 to 12 Months|Death|5|||
160877695|NCT01087736|580947316|FG000|Overall Study|Lost to Follow-up|1|||
160877696|NCT01087736|580947317|FG001|Overall Study|Lost to Follow-up|0|||
160877697|NCT01087736|580947316|FG000|Overall Study|Death|0|||
160877698|NCT01087736|580947317|FG001|Overall Study|Death|1|||
160877699|NCT01087736|580947316|FG000|Overall Study|Withdrawal by Subject|0|||
160877700|NCT01087736|580947317|FG001|Overall Study|Withdrawal by Subject|1|||
160877701|NCT01253811|580947318|FG000|Overall Study|Withdrawal criteria|1|||
160877702|NCT00759564|580947319|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
160877703|NCT00759564|580947320|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
160877704|NCT00759564|580947321|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
160877705|NCT00759564|580947322|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
160877706|NCT00759564|580947323|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
160877707|NCT01565343|580947324|FG000|Overall Study|Administrative decision/technical issues|1|||
160877708|NCT01565343|580947325|FG001|Overall Study|Administrative decision/technical issues|0|||
160877709|NCT01565343|580947326|FG002|Overall Study|Administrative decision/technical issues|0|||
160877710|NCT01989208|580947329|FG000|200 mg (7 Days)|Protocol Violation|0|||
160877711|NCT01989208|580947330|FG001|200 mg (7 Days)|Protocol Violation|1|||
160877712|NCT04975438|580947331|FG000|Overall Study|Lost to Follow-up|1|||
160877713|NCT04975438|580947332|FG001|Overall Study|Lost to Follow-up|0|||
160877714|NCT04975438|580947333|FG002|Overall Study|Lost to Follow-up|1|||
160877715|NCT04975438|580947334|FG003|Overall Study|Lost to Follow-up|0|||
160877716|NCT04975438|580947331|FG000|Overall Study|Withdrawal by Subject|1|||
160877717|NCT04975438|580947332|FG001|Overall Study|Withdrawal by Subject|0|||
160877718|NCT04975438|580947333|FG002|Overall Study|Withdrawal by Subject|0|||
160877719|NCT04975438|580947334|FG003|Overall Study|Withdrawal by Subject|0|||
160877720|NCT04973436|580947335|FG000|Overall Study|Lost to Follow-up|3|||
160877721|NCT04973436|580947335|FG000|Overall Study|Withdrawal by Subject|1|||
160877722|NCT04973436|580947335|FG000|Overall Study|Death|2|||
160877723|NCT01798849|580947339|FG000|Overall Study|Physician Decision|0|||
160877724|NCT01798849|580947340|FG001|Overall Study|Physician Decision|0|||
160877725|NCT01798849|580947341|FG002|Overall Study|Physician Decision|1|||
160877726|NCT00743106|580947342|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
160877727|NCT00743106|580947343|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
160877728|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
160877729|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
160877730|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
160877731|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
160877732|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Death|3|||
160877733|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Death|0|||
160877734|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Death|0|||
160877735|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Death|0|||
160537902|NCT01279850|579698995|FG000|Overall Study|No Drug Administration Information|7|||
160537903|NCT01279850|579698995|FG000|Overall Study|No Visit After Treatment|34|||
160537904|NCT01342484|579699004|FG000|Overall Study|Other Reasons|1|||
160537905|NCT01342484|579699005|FG001|Overall Study|Other Reasons|0|||
160537906|NCT01342484|579699006|FG002|Overall Study|Other Reasons|0|||
160537907|NCT01342484|579699004|FG000|Overall Study|Protocol Violation|0|||
160537908|NCT01342484|579699005|FG001|Overall Study|Protocol Violation|0|||
160537909|NCT01342484|579699006|FG002|Overall Study|Protocol Violation|1|||
160537910|NCT01342484|579699004|FG000|Overall Study|Withdrawal by Subject|1|||
160537911|NCT01342484|579699005|FG001|Overall Study|Withdrawal by Subject|0|||
160537912|NCT01342484|579699006|FG002|Overall Study|Withdrawal by Subject|0|||
160537913|NCT00432042|579699007|FG000|Overall Study|Protocol Violation|2|||
160537914|NCT00432042|579699008|FG001|Overall Study|Protocol Violation|0|||
160537915|NCT00432042|579699009|FG002|Overall Study|Protocol Violation|0|||
160537916|NCT00432042|579699007|FG000|Overall Study|Withdrawal by Subject|0|||
160537917|NCT00432042|579699008|FG001|Overall Study|Withdrawal by Subject|0|||
160537918|NCT00432042|579699009|FG002|Overall Study|Withdrawal by Subject|2|||
160537919|NCT00432042|579699007|FG000|Overall Study|Lost to Follow-up|5|||
160537920|NCT00432042|579699008|FG001|Overall Study|Lost to Follow-up|1|||
160537921|NCT00432042|579699009|FG002|Overall Study|Lost to Follow-up|0|||
160537922|NCT01744665|579699011|FG000|Monitoring Phase|Adverse Event|4|||
160537923|NCT01744665|579699011|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
160537924|NCT01744665|579699011|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
160537925|NCT01744665|579699011|FG000|Monitoring Phase|Withdrawal by Subject|5|||
160537926|NCT01744665|579699011|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
160537927|NCT01744665|579699011|FG000|Consolidation Phase|Adverse Event|2|||
160537928|NCT01744665|579699011|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
160537929|NCT01744665|579699011|FG000|Consolidation Phase|Withdrawal by Subject|4|||
160537930|NCT01744665|579699011|FG000|Consolidation Phase|Administrative problems|9|||
160537931|NCT01744665|579699011|FG000|Re-initiation Phase|Administrative problems|10|||
160537932|NCT01744665|579699011|FG000|Re-initiation Phase|Adverse Event|1|||
160537933|NCT01744665|579699011|FG000|Re-initiation Phase|No longer required treatment|1|||
160537934|NCT01744665|579699011|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
160537935|NCT00492752|579699012|FG000|Double Blind Treatment|Death|13|||
160537936|NCT00492752|579699013|FG001|Double Blind Treatment|Death|0|||
160537937|NCT00492752|579699014|FG002|Double Blind Treatment|Death|2|||
160537938|NCT00492752|579699015|FG003|Double Blind Treatment|Death|0|||
160537939|NCT00492752|579699012|FG000|Double Blind Treatment|Adverse Event|1|||
160537940|NCT00492752|579699013|FG001|Double Blind Treatment|Adverse Event|0|||
160537941|NCT00492752|579699014|FG002|Double Blind Treatment|Adverse Event|0|||
160537942|NCT00492752|579699015|FG003|Double Blind Treatment|Adverse Event|0|||
160537943|NCT00492752|579699012|FG000|Double Blind Treatment|Protocol Violation|0|||
160537944|NCT00492752|579699013|FG001|Double Blind Treatment|Protocol Violation|0|||
160768538|NCT00042289|580540680|FG021|Overall Study|Withdrawal by Subject|1|||
160768539|NCT00042289|580540681|FG022|Overall Study|Withdrawal by Subject|1|||
160768540|NCT00042289|580540682|FG023|Overall Study|Withdrawal by Subject|1|||
160768541|NCT00042289|580540683|FG024|Overall Study|Withdrawal by Subject|0|||
160768542|NCT00042289|580540684|FG025|Overall Study|Withdrawal by Subject|0|||
160768543|NCT00042289|580540685|FG026|Overall Study|Withdrawal by Subject|1|||
160768544|NCT00042289|580540686|FG027|Overall Study|Withdrawal by Subject|0|||
160768545|NCT00042289|580540687|FG028|Overall Study|Withdrawal by Subject|2|||
160768546|NCT00042289|580540688|FG029|Overall Study|Withdrawal by Subject|0|||
160768547|NCT00042289|580540689|FG030|Overall Study|Withdrawal by Subject|0|||
160768548|NCT00042289|580540690|FG031|Overall Study|Withdrawal by Subject|1|||
160768549|NCT00042289|580540691|FG032|Overall Study|Withdrawal by Subject|2|||
160768550|NCT00042289|580540692|FG033|Overall Study|Withdrawal by Subject|1|||
160768551|NCT00042289|580540693|FG034|Overall Study|Withdrawal by Subject|0|||
160768552|NCT00042289|580540694|FG035|Overall Study|Withdrawal by Subject|0|||
160768553|NCT00042289|580540695|FG036|Overall Study|Withdrawal by Subject|0|||
160768554|NCT00042289|580540696|FG037|Overall Study|Withdrawal by Subject|1|||
160768555|NCT00042289|580540697|FG038|Overall Study|Withdrawal by Subject|0|||
160768556|NCT00042289|580540698|FG039|Overall Study|Withdrawal by Subject|0|||
160768557|NCT00042289|580540699|FG040|Overall Study|Withdrawal by Subject|0|||
160768558|NCT00042289|580540700|FG041|Overall Study|Withdrawal by Subject|0|||
160768559|NCT00042289|580540701|FG042|Overall Study|Withdrawal by Subject|1|||
160768560|NCT00042289|580540702|FG043|Overall Study|Withdrawal by Subject|0|||
160537945|NCT00492752|579699014|FG002|Double Blind Treatment|Protocol Violation|1|||
160537946|NCT00492752|579699015|FG003|Double Blind Treatment|Protocol Violation|0|||
160768561|NCT00042289|580540703|FG044|Overall Study|Withdrawal by Subject|0|||
160768562|NCT00042289|580540704|FG045|Overall Study|Withdrawal by Subject|0|||
160768563|NCT00042289|580540705|FG046|Overall Study|Withdrawal by Subject|0|||
160537947|NCT00492752|579699012|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
160537948|NCT00492752|579699013|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
160768564|NCT01171534|580540711|FG000|Overall Study|Lost to Follow-up|0|||
160768565|NCT01171534|580540712|FG001|Overall Study|Lost to Follow-up|2|||
160768566|NCT01171534|580540711|FG000|Overall Study|screen failure|0|||
160537949|NCT00492752|579699014|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
160537950|NCT00492752|579699015|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
160537951|NCT00492752|579699012|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
160537952|NCT00492752|579699013|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
160537953|NCT00492752|579699014|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
160537954|NCT00492752|579699015|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
160537955|NCT00492752|579699012|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
160537956|NCT00492752|579699013|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
160537957|NCT00492752|579699014|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
160537958|NCT00492752|579699015|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
160537959|NCT00492752|579699012|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
160537960|NCT00492752|579699013|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
160537961|NCT00492752|579699014|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
160537962|NCT00492752|579699015|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
160537963|NCT00492752|579699012|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
160537964|NCT00492752|579699013|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
160537965|NCT00492752|579699014|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
160537966|NCT00492752|579699015|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
160537967|NCT00492752|579699012|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
160877736|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
160877737|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
160877738|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
160877739|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
160877740|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
160877741|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
160877742|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
160877743|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
160877744|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
160877745|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
160877746|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
160877747|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
160877748|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
160877749|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
160877750|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
160877751|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
160877752|NCT00884741|580947355|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
160877753|NCT00884741|580947356|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
160877754|NCT00884741|580947357|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
160877755|NCT00884741|580947358|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
160877756|NCT00884741|580947355|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
160877757|NCT00884741|580947356|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
160877758|NCT00884741|580947357|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
160877759|NCT00884741|580947358|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
160877760|NCT00884741|580947355|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
160877761|NCT00884741|580947356|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
160877762|NCT00884741|580947357|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
160877763|NCT00884741|580947358|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
160537968|NCT00492752|579699013|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
160537969|NCT00492752|579699014|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
160537970|NCT00492752|579699015|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
160537971|NCT00492752|579699012|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
160537972|NCT00492752|579699013|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
160537973|NCT00492752|579699014|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
160537974|NCT00492752|579699015|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
160537975|NCT00492752|579699012|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
160537976|NCT00492752|579699013|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
160877764|NCT00884741|580947355|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
160537977|NCT00492752|579699014|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
160537978|NCT00492752|579699015|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
160537979|NCT03803059|579699016|FG000|Overall Study|Protocol Violation|2|||
160537980|NCT03803059|579699016|FG000|Overall Study|Lost to Follow-up|1|||
160537981|NCT05419128|579699020|FG000|Overall Study|Withdrawal by Subject|1|||
160537982|NCT05419128|579699021|FG001|Overall Study|Withdrawal by Subject|1|||
160537983|NCT05419128|579699022|FG002|Overall Study|Withdrawal by Subject|0|||
160537984|NCT05419128|579699023|FG003|Overall Study|Withdrawal by Subject|1|||
160537985|NCT05419128|579699024|FG004|Overall Study|Withdrawal by Subject|1|||
160537986|NCT05419128|579699025|FG005|Overall Study|Withdrawal by Subject|0|||
160537987|NCT05419128|579699020|FG000|Overall Study|Lost to Follow-up|0|||
160537988|NCT05419128|579699021|FG001|Overall Study|Lost to Follow-up|0|||
160537989|NCT05419128|579699022|FG002|Overall Study|Lost to Follow-up|1|||
160537990|NCT05419128|579699023|FG003|Overall Study|Lost to Follow-up|0|||
160537991|NCT05419128|579699024|FG004|Overall Study|Lost to Follow-up|0|||
160537992|NCT05419128|579699025|FG005|Overall Study|Lost to Follow-up|1|||
160537993|NCT02581202|579699030|FG000|Overall Study|Lack of Efficacy|2|||
160537994|NCT02581202|579699030|FG000|Overall Study|Withdrawal by Subject|4|||
160537995|NCT02581202|579699030|FG000|Overall Study|Lost to Follow-up|5|||
160537996|NCT02581202|579699030|FG000|Overall Study|Pregnancy|3|||
160537997|NCT04050982|579699031|FG000|Overall Study|Did not meet eligibility criteria|0|||
160537998|NCT04050982|579699032|FG001|Overall Study|Did not meet eligibility criteria|1|||
160537999|NCT04050982|579699033|FG002|Overall Study|Did not meet eligibility criteria|0|||
160538000|NCT04050982|579699031|FG000|Overall Study|Withdrawal by Subject|1|||
160538001|NCT04050982|579699032|FG001|Overall Study|Withdrawal by Subject|0|||
160538002|NCT04050982|579699033|FG002|Overall Study|Withdrawal by Subject|0|||
160538003|NCT04050982|579699031|FG000|Overall Study|Unable to enroll on platform|1|||
160538004|NCT04050982|579699032|FG001|Overall Study|Unable to enroll on platform|0|||
160538005|NCT04050982|579699033|FG002|Overall Study|Unable to enroll on platform|0|||
160538006|NCT00597753|579699034|FG000|Overall Study|Adverse Event|6|||
160538007|NCT00597753|579699035|FG001|Overall Study|Adverse Event|2|||
160538008|NCT00597753|579699034|FG000|Overall Study|Death|55|||
160538009|NCT00597753|579699035|FG001|Overall Study|Death|29|||
160538010|NCT00597753|579699034|FG000|Overall Study|Lack of Efficacy|2|||
160877765|NCT00884741|580947356|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
160877766|NCT00884741|580947357|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
160877767|NCT00884741|580947358|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
160877768|NCT00884741|580947355|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
160877769|NCT00884741|580947356|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
160877770|NCT00884741|580947357|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
160538011|NCT00597753|579699035|FG001|Overall Study|Lack of Efficacy|0|||
160538012|NCT00597753|579699034|FG000|Overall Study|Lost to Follow-up|10|||
160538013|NCT00597753|579699035|FG001|Overall Study|Lost to Follow-up|3|||
160538014|NCT00597753|579699034|FG000|Overall Study|Physician Decision|5|||
160538015|NCT00597753|579699035|FG001|Overall Study|Physician Decision|1|||
160877771|NCT00884741|580947358|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
160877772|NCT00884741|580947355|FG000|Randomization|Protocol Violation|0|||
160877773|NCT00884741|580947356|FG001|Randomization|Protocol Violation|0|||
160877774|NCT00884741|580947357|FG002|Randomization|Protocol Violation|8|||
160877775|NCT00884741|580947358|FG003|Randomization|Protocol Violation|8|||
160538016|NCT00597753|579699034|FG000|Overall Study|Pregnancy|1|||
160538017|NCT00597753|579699035|FG001|Overall Study|Pregnancy|0|||
160538018|NCT00597753|579699034|FG000|Overall Study|Withdrawal by Subject|35|||
160538019|NCT00597753|579699035|FG001|Overall Study|Withdrawal by Subject|12|||
160538020|NCT00597753|579699034|FG000|Overall Study|Discontinued Dialysis|0|||
160538021|NCT00597753|579699035|FG001|Overall Study|Discontinued Dialysis|1|||
160538022|NCT00597753|579699034|FG000|Overall Study|Never dosed|2|||
160538023|NCT00597753|579699035|FG001|Overall Study|Never dosed|0|||
160538024|NCT00597753|579699034|FG000|Overall Study|Noncompliance|2|||
160768567|NCT01171534|580540712|FG001|Overall Study|screen failure|1|||
160768568|NCT00548327|580540714|FG000|Overall Study|Adverse Event|0|||
160768569|NCT00548327|580540715|FG001|Overall Study|Adverse Event|1|||
160768570|NCT01673386|580540716|FG000|Overall Study|Study terminated by sponsor|16|||
160768571|NCT01673386|580540717|FG001|Overall Study|Study terminated by sponsor|22|||
160768572|NCT01673386|580540716|FG000|Overall Study|Adverse Event|5|||
160768573|NCT01673386|580540717|FG001|Overall Study|Adverse Event|2|||
160768574|NCT01673386|580540716|FG000|Overall Study|Progressive disease|4|||
160768575|NCT01673386|580540717|FG001|Overall Study|Progressive disease|1|||
160768576|NCT01673386|580540716|FG000|Overall Study|Withdrawal by Subject|0|||
160768577|NCT01673386|580540717|FG001|Overall Study|Withdrawal by Subject|2|||
160768578|NCT00274456|580540718|FG000|Overall Study|Still on treatment|2|||
160768579|NCT00274456|580540719|FG001|Overall Study|Still on treatment|3|||
160768580|NCT00274456|580540720|FG002|Overall Study|Still on treatment|5|||
160768581|NCT00274456|580540721|FG003|Overall Study|Still on treatment|1|||
160768582|NCT00274456|580540718|FG000|Overall Study|Unacceptable toxicity|10|||
160768583|NCT00274456|580540719|FG001|Overall Study|Unacceptable toxicity|5|||
160768584|NCT00274456|580540720|FG002|Overall Study|Unacceptable toxicity|12|||
160768585|NCT00274456|580540721|FG003|Overall Study|Unacceptable toxicity|16|||
160768586|NCT00274456|580540718|FG000|Overall Study|Adverse Event|0|||
160768587|NCT00274456|580540719|FG001|Overall Study|Adverse Event|1|||
160768588|NCT00274456|580540720|FG002|Overall Study|Adverse Event|2|||
160768589|NCT00274456|580540721|FG003|Overall Study|Adverse Event|2|||
160768590|NCT00274456|580540718|FG000|Overall Study|Physician Decision|7|||
160768591|NCT00274456|580540719|FG001|Overall Study|Physician Decision|5|||
160768592|NCT00274456|580540720|FG002|Overall Study|Physician Decision|6|||
160768593|NCT00274456|580540721|FG003|Overall Study|Physician Decision|13|||
160768594|NCT00274456|580540718|FG000|Overall Study|Lost to Follow-up|0|||
160768595|NCT00274456|580540719|FG001|Overall Study|Lost to Follow-up|0|||
160768596|NCT00274456|580540720|FG002|Overall Study|Lost to Follow-up|1|||
160768597|NCT00274456|580540721|FG003|Overall Study|Lost to Follow-up|0|||
160768598|NCT00274456|580540718|FG000|Overall Study|Withdrawal by Subject|18|||
160768599|NCT00274456|580540719|FG001|Overall Study|Withdrawal by Subject|13|||
160768600|NCT00274456|580540720|FG002|Overall Study|Withdrawal by Subject|9|||
160768601|NCT00274456|580540721|FG003|Overall Study|Withdrawal by Subject|13|||
160768602|NCT00109343|580540725|FG000|Overall Study|Adverse Event|1|||
160768603|NCT00109343|580540726|FG001|Overall Study|Adverse Event|0|||
160768604|NCT00109343|580540727|FG002|Overall Study|Adverse Event|2|||
160768605|NCT00109343|580540725|FG000|Overall Study|Lack of Efficacy|1|||
160768606|NCT00109343|580540726|FG001|Overall Study|Lack of Efficacy|0|||
160768607|NCT00109343|580540727|FG002|Overall Study|Lack of Efficacy|0|||
160768608|NCT00109343|580540725|FG000|Overall Study|Lost to Follow-up|35|||
160768609|NCT00109343|580540726|FG001|Overall Study|Lost to Follow-up|20|||
160768610|NCT00109343|580540727|FG002|Overall Study|Lost to Follow-up|14|||
160768611|NCT00109343|580540725|FG000|Overall Study|Protocol Violation|1|||
160768612|NCT00109343|580540726|FG001|Overall Study|Protocol Violation|2|||
160768613|NCT00109343|580540727|FG002|Overall Study|Protocol Violation|2|||
160768614|NCT00109343|580540725|FG000|Overall Study|Withdrawal by Subject|15|||
160768615|NCT00109343|580540726|FG001|Overall Study|Withdrawal by Subject|11|||
160768616|NCT00109343|580540727|FG002|Overall Study|Withdrawal by Subject|10|||
160768617|NCT00109343|580540725|FG000|Overall Study|Subject Moved|6|||
160768618|NCT00109343|580540726|FG001|Overall Study|Subject Moved|2|||
160768619|NCT00109343|580540727|FG002|Overall Study|Subject Moved|1|||
160768620|NCT00109343|580540725|FG000|Overall Study|Other|5|||
160768621|NCT00109343|580540726|FG001|Overall Study|Other|2|||
160768622|NCT00109343|580540727|FG002|Overall Study|Other|1|||
160768623|NCT04460885|580540729|FG000|Overall Study|Withdrawal by Subject|6|||
160768624|NCT04460885|580540730|FG001|Overall Study|Withdrawal by Subject|8|||
160768625|NCT04460885|580540729|FG000|Overall Study|Site closure|1|||
160768626|NCT04460885|580540730|FG001|Overall Study|Site closure|0|||
160768627|NCT04460885|580540729|FG000|Overall Study|Death|5|||
160768628|NCT04460885|580540730|FG001|Overall Study|Death|4|||
160768629|NCT04460885|580540729|FG000|Overall Study|Physician Decision|2|||
160768630|NCT04460885|580540730|FG001|Overall Study|Physician Decision|1|||
160768631|NCT04460885|580540729|FG000|Overall Study|Lost to Follow-up|4|||
160768632|NCT04460885|580540730|FG001|Overall Study|Lost to Follow-up|4|||
160768633|NCT02100631|580540734|FG000|Overall Study|Withdrawal by Subject|1|||
160768634|NCT02100631|580540735|FG001|Overall Study|Withdrawal by Subject|0|||
160768635|NCT02100631|580540736|FG002|Overall Study|Withdrawal by Subject|0|||
160538025|NCT00597753|579699035|FG001|Overall Study|Noncompliance|1|||
160538026|NCT00597753|579699034|FG000|Overall Study|Relocation|17|||
160877776|NCT04784442|580947359|FG000|Overall Study|Adverse Event|1|||
160877777|NCT04784442|580947360|FG001|Overall Study|Adverse Event|0|||
160877778|NCT04784442|580947361|FG002|Overall Study|Adverse Event|2|||
160877779|NCT04784442|580947362|FG003|Overall Study|Adverse Event|1|||
160877780|NCT04784442|580947359|FG000|Overall Study|Protocol Violation|1|||
160877781|NCT04784442|580947360|FG001|Overall Study|Protocol Violation|0|||
160877782|NCT04784442|580947361|FG002|Overall Study|Protocol Violation|0|||
160877783|NCT04784442|580947362|FG003|Overall Study|Protocol Violation|0|||
160877784|NCT04784442|580947359|FG000|Overall Study|Non-compliance with study drug|1|||
160877785|NCT04784442|580947360|FG001|Overall Study|Non-compliance with study drug|0|||
160877786|NCT04784442|580947361|FG002|Overall Study|Non-compliance with study drug|0|||
160877787|NCT04784442|580947362|FG003|Overall Study|Non-compliance with study drug|0|||
160877788|NCT03500224|580947363|FG000|Overall Study|Withdrawal by Subject|2|||
160877789|NCT02969655|580947364|FG000|Overall Study|Withdrawal by Subject|3|||
160877790|NCT02969655|580947365|FG001|Overall Study|Withdrawal by Subject|2|||
160877791|NCT02969655|580947364|FG000|Overall Study|Physician Decision|4|||
160877792|NCT02969655|580947365|FG001|Overall Study|Physician Decision|3|||
160877793|NCT02969655|580947364|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
160877794|NCT02969655|580947365|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
160877795|NCT02969655|580947364|FG000|Overall Study|Adverse Event|10|||
160877796|NCT02969655|580947365|FG001|Overall Study|Adverse Event|8|||
160877797|NCT00929643|580947366|FG000|Overall Study|Protocol Violation|2|||
160877798|NCT00145977|580947370|FG000|Overall Study|Lack of Efficacy|0|||
160877799|NCT00145977|580947371|FG001|Overall Study|Lack of Efficacy|4|||
160877800|NCT00145977|580947370|FG000|Overall Study|Lost to Follow-up|1|||
160877801|NCT00145977|580947371|FG001|Overall Study|Lost to Follow-up|0|||
160538027|NCT00597753|579699035|FG001|Overall Study|Relocation|6|||
160538028|NCT00597753|579699034|FG000|Overall Study|Renal transplant|10|||
160538029|NCT00597753|579699035|FG001|Overall Study|Renal transplant|3|||
160538030|NCT00597753|579699034|FG000|Overall Study|Site closed by sponsor|19|||
160538031|NCT00597753|579699035|FG001|Overall Study|Site closed by sponsor|7|||
160538032|NCT00597753|579699034|FG000|Overall Study|Site elected to close|2|||
160538033|NCT00597753|579699035|FG001|Overall Study|Site elected to close|4|||
160538034|NCT01417195|579700444|FG000|Overall Study|Stimulation failure|1|||
160538035|NCT01417195|579700445|FG001|Overall Study|Stimulation failure|0|||
160538036|NCT01417195|579700444|FG000|Overall Study|No embryos for transfer|0|||
160538037|NCT01417195|579700445|FG001|Overall Study|No embryos for transfer|1|||
160538038|NCT01417195|579700444|FG000|Overall Study|No transfer due to risk of OHSS|1|||
160538039|NCT01417195|579700445|FG001|Overall Study|No transfer due to risk of OHSS|0|||
160538040|NCT01417195|579700444|FG000|Overall Study|No transfer due to elevated progesterone|1|||
160538041|NCT01417195|579700445|FG001|Overall Study|No transfer due to elevated progesterone|0|||
160538042|NCT01849874|579700450|FG000|Overall Study|Death|89|||
160538043|NCT01849874|579700451|FG001|Overall Study|Death|42|||
160538044|NCT01849874|579700450|FG000|Overall Study|Withdrawal by Subject|17|||
160538045|NCT01849874|579700451|FG001|Overall Study|Withdrawal by Subject|16|||
160538046|NCT01849874|579700450|FG000|Overall Study|Lost to Follow-up|3|||
160538047|NCT01849874|579700451|FG001|Overall Study|Lost to Follow-up|2|||
160538048|NCT01849874|579700450|FG000|Overall Study|Study Termination By Sponsor|93|||
160538049|NCT01849874|579700451|FG001|Overall Study|Study Termination By Sponsor|48|||
160538050|NCT01849874|579700450|FG000|Overall Study|Completed as per protocol amendment 6|3|||
160538051|NCT01849874|579700451|FG001|Overall Study|Completed as per protocol amendment 6|0|||
160538052|NCT01849874|579700450|FG000|Overall Study|Physician Decision|7|||
160538053|NCT01849874|579700451|FG001|Overall Study|Physician Decision|1|||
160538054|NCT01849874|579700450|FG000|Overall Study|Other|16|||
160538055|NCT01849874|579700451|FG001|Overall Study|Other|4|||
160538056|NCT04640272|579700453|FG000|Overall Study|Subject moved out of area|1|||
160538057|NCT02535715|579700457|FG000|Overall Study|Withdrawal by Subject|0|||
160538058|NCT02535715|579700458|FG001|Overall Study|Withdrawal by Subject|0|||
160538059|NCT02535715|579700459|FG002|Overall Study|Withdrawal by Subject|1|||
160538060|NCT04353284|579700460|FG000|Overall Study|Adverse Event|1|||
160538061|NCT04353284|579700461|FG001|Overall Study|Adverse Event|1|||
160538062|NCT04353284|579700460|FG000|Overall Study|Lost to Follow-up|1|||
160538063|NCT04353284|579700461|FG001|Overall Study|Lost to Follow-up|0|||
160538064|NCT03719690|579700465|FG000|Overall Study|Withdrawal by Subject|5|||
160877802|NCT00145977|580947370|FG000|Overall Study|Withdrawal by Subject|1|||
160877803|NCT00145977|580947371|FG001|Overall Study|Withdrawal by Subject|0|||
160877804|NCT02717832|580947374|FG000|Overall Study|Inability to place IV|3|||
160877805|NCT01711216|580947375|FG000|Overall Study|Adverse Event|4|||
160877806|NCT01711216|580947375|FG000|Overall Study|Pregnancy|56|||
160877807|NCT01711216|580947375|FG000|Overall Study|Withdrawal by Subject|6|||
160877808|NCT01711216|580947375|FG000|Overall Study|Lost to Follow-up|46|||
160538065|NCT03719690|579700466|FG001|Overall Study|Withdrawal by Subject|10|||
160538066|NCT03719690|579700465|FG000|Overall Study|Death|40|||
160538067|NCT03719690|579700466|FG001|Overall Study|Death|149|||
160538068|NCT03719690|579700465|FG000|Overall Study|Miscellaneous|12|||
160538069|NCT03719690|579700466|FG001|Overall Study|Miscellaneous|56|||
160538070|NCT03719690|579700465|FG000|Overall Study|Lost to Follow-up|2|||
160877809|NCT01711216|580947375|FG000|Overall Study|variety of other minor reasons|83|||
160877810|NCT01711216|580947375|FG000|Overall Study|no reason specified|22|||
160877811|NCT03060551|580947376|FG000|Overall Study|Withdrawal by Subject|1|||
160877812|NCT03060551|580947376|FG000|Overall Study|Adverse Event|1|||
160877813|NCT03698591|580947379|FG000|Overall Study|Withdrawal by Subject|2|||
160877814|NCT03698591|580947380|FG001|Overall Study|Withdrawal by Subject|2|||
160877815|NCT03698591|580947379|FG000|Overall Study|Failed drug screen|1|||
160877816|NCT03698591|580947380|FG001|Overall Study|Failed drug screen|1|||
160538071|NCT03719690|579700466|FG001|Overall Study|Lost to Follow-up|18|||
160538072|NCT03719690|579700465|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
160538073|NCT03719690|579700466|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
160538074|NCT02700412|579700474|FG000|Overall Study|Adverse Event|6|||
160538075|NCT02700412|579700474|FG000|Overall Study|Death|1|||
160538076|NCT02700412|579700474|FG000|Overall Study|Lack of Efficacy|19|||
160538077|NCT02700412|579700474|FG000|Overall Study|Protocol Violation|5|||
160538078|NCT02700412|579700474|FG000|Overall Study|Withdrawal by Subject|2|||
160538079|NCT01074190|579700479|FG000|Overall Study|Emergency Cesarean Delivery|1|||
160538080|NCT01074190|579700480|FG001|Overall Study|Emergency Cesarean Delivery|2|||
160538081|NCT01074190|579700481|FG002|Overall Study|Emergency Cesarean Delivery|1|||
160538082|NCT01074190|579700479|FG000|Overall Study|Protocol Violation|2|||
160538083|NCT01074190|579700480|FG001|Overall Study|Protocol Violation|1|||
160538084|NCT01074190|579700481|FG002|Overall Study|Protocol Violation|0|||
160877817|NCT03698591|580947379|FG000|Overall Study|Failed health screen|0|||
160877818|NCT03698591|580947380|FG001|Overall Study|Failed health screen|1|||
160877819|NCT03698591|580947379|FG000|Overall Study|Ineligible for financial compensation|1|||
160877820|NCT03698591|580947380|FG001|Overall Study|Ineligible for financial compensation|0|||
160877821|NCT03698591|580947379|FG000|Overall Study|Equipment Error|1|||
160877822|NCT03698591|580947380|FG001|Overall Study|Equipment Error|0|||
160877823|NCT03698591|580947379|FG000|Overall Study|Could not establish TMS dosage|0|||
160877824|NCT03698591|580947380|FG001|Overall Study|Could not establish TMS dosage|1|||
160877825|NCT04303195|580947387|FG000|Overall Study|Adverse Event|1|||
160877826|NCT04303195|580947388|FG001|Overall Study|Adverse Event|3|||
160877827|NCT04303195|580947389|FG002|Overall Study|Adverse Event|7|||
160877828|NCT04303195|580947390|FG003|Overall Study|Adverse Event|0|||
160877829|NCT04303195|580947387|FG000|Overall Study|Lost to Follow-up|1|||
160877830|NCT04303195|580947388|FG001|Overall Study|Lost to Follow-up|0|||
160877831|NCT04303195|580947389|FG002|Overall Study|Lost to Follow-up|1|||
160877832|NCT04303195|580947390|FG003|Overall Study|Lost to Follow-up|4|||
160877833|NCT04303195|580947387|FG000|Overall Study|Withdrawal by Subject|3|||
160877834|NCT04303195|580947388|FG001|Overall Study|Withdrawal by Subject|1|||
160877835|NCT04303195|580947389|FG002|Overall Study|Withdrawal by Subject|1|||
160877836|NCT04303195|580947390|FG003|Overall Study|Withdrawal by Subject|1|||
160877837|NCT04303195|580947387|FG000|Overall Study|No study drug administered or protocol deviation|0|||
160877838|NCT04303195|580947388|FG001|Overall Study|No study drug administered or protocol deviation|2|||
160877839|NCT04303195|580947389|FG002|Overall Study|No study drug administered or protocol deviation|0|||
160877840|NCT04303195|580947390|FG003|Overall Study|No study drug administered or protocol deviation|2|||
160877841|NCT01064947|580947391|FG000|Overall Study|negative culture|41|||
160877842|NCT02970942|580947394|FG000|Overall Study|Death|0|||
160877843|NCT02970942|580947395|FG001|Overall Study|Death|1|||
160877844|NCT02970942|580947396|FG002|Overall Study|Death|0|||
160877845|NCT02970942|580947397|FG003|Overall Study|Death|0|||
160877846|NCT02970942|580947394|FG000|Overall Study|Lost to Follow-up|1|||
160877847|NCT02970942|580947395|FG001|Overall Study|Lost to Follow-up|0|||
160877848|NCT02970942|580947396|FG002|Overall Study|Lost to Follow-up|2|||
160877849|NCT02970942|580947397|FG003|Overall Study|Lost to Follow-up|1|||
160877850|NCT02970942|580947394|FG000|Overall Study|Withdrawal by Subject|3|||
160877851|NCT02970942|580947395|FG001|Overall Study|Withdrawal by Subject|5|||
160877852|NCT02970942|580947396|FG002|Overall Study|Withdrawal by Subject|3|||
160877853|NCT02970942|580947397|FG003|Overall Study|Withdrawal by Subject|2|||
160877854|NCT06457204|580947400|FG000|Washout|Adverse Event|0|||
160877855|NCT06457204|580947401|FG001|Washout|Adverse Event|2|||
160877856|NCT01457352|580947404|FG000|Period 1|Adverse Event|2|||
160877857|NCT01457352|580947405|FG001|Period 1|Adverse Event|0|||
160877858|NCT01457352|580947404|FG000|Period 1|Withdrawal by Subject|2|||
160877859|NCT01457352|580947405|FG001|Period 1|Withdrawal by Subject|0|||
160877860|NCT01457352|580947404|FG000|Period 1|Physician Decision|2|||
160877861|NCT01457352|580947405|FG001|Period 1|Physician Decision|0|||
160538085|NCT01074190|579700479|FG000|Overall Study|Delivered in under 90 minutes|0|||
160636609|NCT05166512|580051582|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
160877862|NCT01457352|580947404|FG000|Period 1|MS related disease progression|1|||
160877863|NCT01457352|580947405|FG001|Period 1|MS related disease progression|0|||
160877864|NCT01457352|580947404|FG000|Period 1|Withdrawn|1|||
160877865|NCT01457352|580947405|FG001|Period 1|Withdrawn|0|||
160877866|NCT01457352|580947404|FG000|Period 1|withdrew per sponsor|1|||
160877867|NCT01457352|580947405|FG001|Period 1|withdrew per sponsor|0|||
160538086|NCT01074190|579700480|FG001|Overall Study|Delivered in under 90 minutes|2|||
160538087|NCT01074190|579700481|FG002|Overall Study|Delivered in under 90 minutes|1|||
160538088|NCT01074190|579700479|FG000|Overall Study|Subject withdrew consent|1|||
160538089|NCT01074190|579700480|FG001|Overall Study|Subject withdrew consent|1|||
160538090|NCT01074190|579700481|FG002|Overall Study|Subject withdrew consent|1|||
160538091|NCT04607148|579700482|FG000|Overall Study|Withdrawal by Subject|0|||
160538092|NCT04607148|579700483|FG001|Overall Study|Withdrawal by Subject|4|||
160877868|NCT01457352|580947404|FG000|Period 1|Protocol Violation|4|||
160877869|NCT01457352|580947405|FG001|Period 1|Protocol Violation|0|||
160877870|NCT01457352|580947404|FG000|Period 1|Did not meet eligibility criteria|3|||
160877871|NCT01457352|580947405|FG001|Period 1|Did not meet eligibility criteria|0|||
160877872|NCT01457352|580947404|FG000|Period 2|Withdrawal by Subject|23|||
160877873|NCT01457352|580947405|FG001|Period 2|Withdrawal by Subject|0|||
160877874|NCT01457352|580947404|FG000|Period 2|Adverse Event|22|||
160877875|NCT01457352|580947405|FG001|Period 2|Adverse Event|0|||
160877876|NCT01457352|580947404|FG000|Period 2|no analysis|10|||
160877877|NCT01457352|580947405|FG001|Period 2|no analysis|0|||
160877878|NCT01457352|580947404|FG000|Period 2|Lack of Efficacy|8|||
160454029|NCT06473662|579394017|FG000|Overall Study|Did not take medication|2|||
160454030|NCT06473662|579394018|FG001|Overall Study|Did not take medication|3|||
160454031|NCT06473662|579394019|FG002|Overall Study|Did not take medication|2|||
160454032|NCT02038777|579394022|FG000|Overall Study|Death|0|||
160454033|NCT02038777|579394023|FG001|Overall Study|Death|2|||
160454034|NCT02038777|579394024|FG002|Overall Study|Death|0|||
160454035|NCT02038777|579394025|FG003|Overall Study|Death|1|||
160454036|NCT02038777|579394026|FG004|Overall Study|Death|2|||
160454037|NCT02038777|579394027|FG005|Overall Study|Death|4|||
160454038|NCT02038777|579394028|FG006|Overall Study|Death|0|||
160454039|NCT02038777|579394029|FG007|Overall Study|Death|11|||
160454040|NCT02038777|579394022|FG000|Overall Study|Lost to Follow-up|0|||
160454041|NCT02038777|579394023|FG001|Overall Study|Lost to Follow-up|0|||
160454042|NCT02038777|579394024|FG002|Overall Study|Lost to Follow-up|0|||
160454043|NCT02038777|579394025|FG003|Overall Study|Lost to Follow-up|1|||
160454044|NCT02038777|579394026|FG004|Overall Study|Lost to Follow-up|0|||
160454045|NCT02038777|579394027|FG005|Overall Study|Lost to Follow-up|0|||
160454046|NCT02038777|579394028|FG006|Overall Study|Lost to Follow-up|0|||
160454047|NCT02038777|579394029|FG007|Overall Study|Lost to Follow-up|0|||
160454048|NCT02038777|579394022|FG000|Overall Study|Other|0|||
160454049|NCT02038777|579394023|FG001|Overall Study|Other|1|||
160454050|NCT02038777|579394024|FG002|Overall Study|Other|0|||
160454051|NCT02038777|579394025|FG003|Overall Study|Other|2|||
160454052|NCT02038777|579394026|FG004|Overall Study|Other|1|||
160538093|NCT04607148|579700484|FG002|Overall Study|Withdrawal by Subject|2|||
160538094|NCT04607148|579700485|FG003|Overall Study|Withdrawal by Subject|8|||
160538095|NCT04607148|579700482|FG000|Overall Study|Study Terminated by Sponsor|14|||
160538096|NCT04607148|579700483|FG001|Overall Study|Study Terminated by Sponsor|59|||
160538097|NCT04607148|579700484|FG002|Overall Study|Study Terminated by Sponsor|9|||
160538098|NCT04607148|579700485|FG003|Overall Study|Study Terminated by Sponsor|39|||
160538099|NCT04607148|579700482|FG000|Overall Study|Sponsor Decision|0|||
160538100|NCT04607148|579700483|FG001|Overall Study|Sponsor Decision|0|||
160538101|NCT04607148|579700484|FG002|Overall Study|Sponsor Decision|1|||
160538102|NCT04607148|579700485|FG003|Overall Study|Sponsor Decision|0|||
160538103|NCT04607148|579700482|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160538104|NCT04607148|579700483|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160538105|NCT04607148|579700484|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160538106|NCT04607148|579700485|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160538107|NCT04607148|579700482|FG000|Overall Study|Lost to Follow-up|0|||
160538108|NCT04607148|579700483|FG001|Overall Study|Lost to Follow-up|2|||
160538109|NCT04607148|579700484|FG002|Overall Study|Lost to Follow-up|0|||
160538110|NCT04607148|579700485|FG003|Overall Study|Lost to Follow-up|0|||
160538111|NCT04607148|579700482|FG000|Overall Study|Death|0|||
160538112|NCT04607148|579700483|FG001|Overall Study|Death|3|||
160538113|NCT04607148|579700484|FG002|Overall Study|Death|0|||
160538114|NCT04607148|579700485|FG003|Overall Study|Death|1|||
160538115|NCT04607148|579700482|FG000|Overall Study|Adverse Event|0|||
160538116|NCT04607148|579700483|FG001|Overall Study|Adverse Event|1|||
160538117|NCT04607148|579700484|FG002|Overall Study|Adverse Event|0|||
160538118|NCT04607148|579700485|FG003|Overall Study|Adverse Event|0|||
160454053|NCT02038777|579394027|FG005|Overall Study|Other|0|||
160454054|NCT02038777|579394028|FG006|Overall Study|Other|0|||
160454055|NCT02038777|579394029|FG007|Overall Study|Other|0|||
160454056|NCT02038777|579394022|FG000|Overall Study|Randomized but not treated|0|||
160538119|NCT00804570|579700486|FG000|Overall Study|Adverse Event|14|||
160538120|NCT00804570|579700487|FG001|Overall Study|Adverse Event|7|||
160538121|NCT00804570|579700486|FG000|Overall Study|Lack of Efficacy|0|||
160877879|NCT01457352|580947405|FG001|Period 2|Lack of Efficacy|0|||
160877880|NCT01457352|580947404|FG000|Period 2|Protocol Violation|4|||
160877881|NCT01457352|580947405|FG001|Period 2|Protocol Violation|0|||
160877882|NCT01457352|580947404|FG000|Period 2|Sponsor's withdrawal|7|||
160877883|NCT01457352|580947405|FG001|Period 2|Sponsor's withdrawal|0|||
160877884|NCT01457352|580947404|FG000|Period 2|Lost to Follow-up|1|||
160877885|NCT01457352|580947405|FG001|Period 2|Lost to Follow-up|0|||
160877886|NCT01457352|580947404|FG000|Period 2|dose change|1|||
160877887|NCT01457352|580947405|FG001|Period 2|dose change|0|||
160877888|NCT01457352|580947404|FG000|Period 2|Physician Decision|1|||
160877889|NCT01457352|580947405|FG001|Period 2|Physician Decision|0|||
160877890|NCT01457352|580947404|FG000|Period 2|Did not meet eligibility criteria|3|||
160877891|NCT01457352|580947405|FG001|Period 2|Did not meet eligibility criteria|0|||
160877892|NCT01457352|580947404|FG000|Period 3|Adverse Event|1|||
160877893|NCT01457352|580947405|FG001|Period 3|Adverse Event|1|||
160877894|NCT01457352|580947404|FG000|Period 3|Withdrawal by Subject|0|||
160877895|NCT01457352|580947405|FG001|Period 3|Withdrawal by Subject|2|||
160877896|NCT01457352|580947404|FG000|Period 3|incorrect treatment|0|||
160877897|NCT01457352|580947405|FG001|Period 3|incorrect treatment|1|||
160877898|NCT01457352|580947404|FG000|Period 3|Sponsor's withdrawal|0|||
160877899|NCT01457352|580947405|FG001|Period 3|Sponsor's withdrawal|1|||
160877900|NCT01065454|580947406|FG000|Treatment|Adverse Event|7|||
160877901|NCT01065454|580947407|FG001|Treatment|Adverse Event|4|||
160877902|NCT01065454|580947408|FG002|Treatment|Adverse Event|3|||
160877903|NCT01065454|580947409|FG003|Treatment|Adverse Event|6|||
160877904|NCT01065454|580947406|FG000|Treatment|Death|1|||
160877905|NCT01065454|580947407|FG001|Treatment|Death|0|||
160877906|NCT01065454|580947408|FG002|Treatment|Death|0|||
160877907|NCT01065454|580947409|FG003|Treatment|Death|0|||
160877908|NCT01065454|580947406|FG000|Treatment|Non-compliance|1|||
160877909|NCT01065454|580947407|FG001|Treatment|Non-compliance|0|||
160877910|NCT01065454|580947408|FG002|Treatment|Non-compliance|0|||
160877911|NCT01065454|580947409|FG003|Treatment|Non-compliance|1|||
160877912|NCT01065454|580947406|FG000|Treatment|Protocol Decision|0|||
160877913|NCT01065454|580947407|FG001|Treatment|Protocol Decision|0|||
160877914|NCT01065454|580947408|FG002|Treatment|Protocol Decision|3|||
160877915|NCT01065454|580947409|FG003|Treatment|Protocol Decision|2|||
160877916|NCT01065454|580947406|FG000|Treatment|Protocol Violation|1|||
160877917|NCT01065454|580947407|FG001|Treatment|Protocol Violation|0|||
160877918|NCT01065454|580947408|FG002|Treatment|Protocol Violation|1|||
160877919|NCT01065454|580947409|FG003|Treatment|Protocol Violation|0|||
160877920|NCT01065454|580947406|FG000|Treatment|Withdrawal by Subject|3|||
160877921|NCT01065454|580947407|FG001|Treatment|Withdrawal by Subject|1|||
160877922|NCT01065454|580947408|FG002|Treatment|Withdrawal by Subject|2|||
160877923|NCT01065454|580947409|FG003|Treatment|Withdrawal by Subject|3|||
160877924|NCT01065454|580947406|FG000|Follow up|Adverse Event|1|||
160877925|NCT01065454|580947407|FG001|Follow up|Adverse Event|0|||
160877926|NCT01065454|580947408|FG002|Follow up|Adverse Event|0|||
160877927|NCT01065454|580947409|FG003|Follow up|Adverse Event|1|||
160877928|NCT01065454|580947406|FG000|Follow up|Death|0|||
160877929|NCT01065454|580947407|FG001|Follow up|Death|1|||
160877930|NCT01065454|580947408|FG002|Follow up|Death|1|||
160877931|NCT01065454|580947409|FG003|Follow up|Death|0|||
160877932|NCT01065454|580947406|FG000|Follow up|Lost to Follow-up|0|||
160877933|NCT01065454|580947407|FG001|Follow up|Lost to Follow-up|0|||
160877934|NCT01065454|580947408|FG002|Follow up|Lost to Follow-up|0|||
160877935|NCT01065454|580947409|FG003|Follow up|Lost to Follow-up|1|||
160877936|NCT01065454|580947406|FG000|Follow up|Progressive disease|0|||
160877937|NCT01065454|580947407|FG001|Follow up|Progressive disease|0|||
160877938|NCT01065454|580947408|FG002|Follow up|Progressive disease|0|||
160877939|NCT01065454|580947409|FG003|Follow up|Progressive disease|1|||
160877940|NCT01065454|580947406|FG000|Follow up|Withdrawal by Subject|1|||
160877941|NCT01065454|580947407|FG001|Follow up|Withdrawal by Subject|1|||
160877942|NCT01065454|580947408|FG002|Follow up|Withdrawal by Subject|1|||
160877943|NCT01065454|580947409|FG003|Follow up|Withdrawal by Subject|0|||
160877944|NCT01065454|580947406|FG000|Follow up|study ongoing|37|||
160877945|NCT01065454|580947407|FG001|Follow up|study ongoing|22|||
160877946|NCT01065454|580947408|FG002|Follow up|study ongoing|15|||
160877947|NCT01065454|580947409|FG003|Follow up|study ongoing|41|||
160877948|NCT04614324|580947410|FG000|Overall Study|Lost to Follow-up|3|||
160877949|NCT04614324|580947410|FG000|Overall Study|Physician Decision|1|||
160877950|NCT04614324|580947410|FG000|Overall Study|Withdrawal by Subject|2|||
160877951|NCT04614324|580947410|FG000|Overall Study|Remaining in Follow up|123|||
160877952|NCT03472547|580947411|FG000|Overall Study|Withdrawal by Subject|30|||
160877953|NCT05141448|580947412|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160877954|NCT05141448|580947413|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
160877955|NCT05141448|580947414|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160877956|NCT05141448|580947415|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160877957|NCT05141448|580947416|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160877958|NCT05141448|580947417|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160877959|NCT05141448|580947412|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160877960|NCT05141448|580947413|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160877961|NCT05141448|580947414|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160877962|NCT05141448|580947415|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160877963|NCT05141448|580947416|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
160877964|NCT05141448|580947417|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160877965|NCT05141448|580947412|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160877966|NCT05141448|580947413|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
160877967|NCT05141448|580947414|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160877968|NCT05141448|580947415|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160877969|NCT05141448|580947416|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160877970|NCT05141448|580947417|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160877971|NCT05141448|580947412|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160877972|NCT05141448|580947413|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160877973|NCT05141448|580947414|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160877974|NCT05141448|580947415|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160877975|NCT05141448|580947416|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160877976|NCT05141448|580947417|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
160877977|NCT05141448|580947412|FG000|Period 2|COVID-19 Related|0|||
160877978|NCT05141448|580947413|FG001|Period 2|COVID-19 Related|0|||
160877979|NCT05141448|580947414|FG002|Period 2|COVID-19 Related|0|||
160877980|NCT05141448|580947415|FG003|Period 2|COVID-19 Related|1|||
160877981|NCT05141448|580947416|FG004|Period 2|COVID-19 Related|0|||
160877982|NCT05141448|580947417|FG005|Period 2|COVID-19 Related|1|||
160877983|NCT05141448|580947412|FG000|3|Covid-19 related|2|||
160877984|NCT05141448|580947413|FG001|3|Covid-19 related|0|||
160877985|NCT05141448|580947414|FG002|3|Covid-19 related|0|||
160877986|NCT05141448|580947415|FG003|3|Covid-19 related|0|||
160877987|NCT05141448|580947416|FG004|3|Covid-19 related|0|||
160877988|NCT05141448|580947417|FG005|3|Covid-19 related|1|||
160877989|NCT05141448|580947412|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
160877990|NCT05141448|580947413|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
160877991|NCT05141448|580947414|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
160877992|NCT05141448|580947415|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
160877993|NCT05141448|580947416|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
160877994|NCT05141448|580947417|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
160877995|NCT01948193|580949732|FG000|Overall Study|Serious event|2|||
160877996|NCT01948193|580949732|FG000|Overall Study|Lost to Follow-up|7|||
160877997|NCT01325337|580949733|FG000|Overall Study|Adverse Event|0|||
160877998|NCT01325337|580949734|FG001|Overall Study|Adverse Event|2|||
160877999|NCT01325337|580949735|FG002|Overall Study|Adverse Event|2|||
160878000|NCT01325337|580949736|FG003|Overall Study|Adverse Event|1|||
160878001|NCT01325337|580949737|FG004|Overall Study|Adverse Event|2|||
160878002|NCT01325337|580949733|FG000|Overall Study|Lost to Follow-up|2|||
160878003|NCT01325337|580949734|FG001|Overall Study|Lost to Follow-up|2|||
160878004|NCT01325337|580949735|FG002|Overall Study|Lost to Follow-up|2|||
160878005|NCT01325337|580949736|FG003|Overall Study|Lost to Follow-up|1|||
160878006|NCT01325337|580949737|FG004|Overall Study|Lost to Follow-up|2|||
160878007|NCT01325337|580949733|FG000|Overall Study|Personal Reasons|2|||
160878008|NCT01325337|580949734|FG001|Overall Study|Personal Reasons|5|||
160878009|NCT01325337|580949735|FG002|Overall Study|Personal Reasons|4|||
160878010|NCT01325337|580949736|FG003|Overall Study|Personal Reasons|8|||
160878011|NCT01325337|580949737|FG004|Overall Study|Personal Reasons|3|||
160878012|NCT01325337|580949733|FG000|Overall Study|Withdrawal by Subject|1|||
160878013|NCT01325337|580949734|FG001|Overall Study|Withdrawal by Subject|0|||
160878014|NCT01325337|580949735|FG002|Overall Study|Withdrawal by Subject|1|||
160878015|NCT01325337|580949736|FG003|Overall Study|Withdrawal by Subject|0|||
160878016|NCT01325337|580949737|FG004|Overall Study|Withdrawal by Subject|1|||
160878017|NCT01604278|580949744|FG000|Overall Study|Lack of Efficacy|0|||
160878018|NCT01604278|580949745|FG001|Overall Study|Lack of Efficacy|1|||
160878019|NCT01604278|580949744|FG000|Overall Study|Lost to Follow-up|1|||
160878020|NCT01604278|580949745|FG001|Overall Study|Lost to Follow-up|0|||
160878021|NCT01604278|580949744|FG000|Overall Study|Administrative problems|2|||
160878022|NCT01604278|580949745|FG001|Overall Study|Administrative problems|1|||
160878023|NCT01604278|580949744|FG000|Overall Study|Withdrawal by Subject|3|||
160878024|NCT01604278|580949745|FG001|Overall Study|Withdrawal by Subject|3|||
160878025|NCT01604278|580949744|FG000|Overall Study|Adverse Event|3|||
160878026|NCT01604278|580949745|FG001|Overall Study|Adverse Event|5|||
160878027|NCT01604278|580949744|FG000|Overall Study|Protocol Deviation|5|||
160878028|NCT01604278|580949745|FG001|Overall Study|Protocol Deviation|3|||
160878029|NCT00668733|580949753|FG000|Overall Study|Lost to Follow-up|2|||
160878030|NCT00668733|580949754|FG001|Overall Study|Lost to Follow-up|3|||
160878031|NCT00668733|580949753|FG000|Overall Study|Withdrawal by Subject|0|||
160878032|NCT00668733|580949754|FG001|Overall Study|Withdrawal by Subject|4|||
160878033|NCT01122264|580949757|FG000|Overall Study|Adverse Event|6|||
160878034|NCT01122264|580949758|FG001|Overall Study|Adverse Event|5|||
160878035|NCT01122264|580949759|FG002|Overall Study|Adverse Event|7|||
160878036|NCT01122264|580949757|FG000|Overall Study|Death|1|||
160538122|NCT00804570|579700487|FG001|Overall Study|Lack of Efficacy|1|||
160878037|NCT01122264|580949758|FG001|Overall Study|Death|0|||
160878038|NCT01122264|580949759|FG002|Overall Study|Death|0|||
160878039|NCT01122264|580949757|FG000|Overall Study|Lost to Follow-up|5|||
160878040|NCT01122264|580949758|FG001|Overall Study|Lost to Follow-up|9|||
160878041|NCT01122264|580949759|FG002|Overall Study|Lost to Follow-up|13|||
160878042|NCT01122264|580949757|FG000|Overall Study|Entry Criteria Not Met|1|||
160878043|NCT01122264|580949758|FG001|Overall Study|Entry Criteria Not Met|0|||
160878044|NCT01122264|580949759|FG002|Overall Study|Entry Criteria Not Met|0|||
160878045|NCT01122264|580949757|FG000|Overall Study|Protocol Violation|7|||
160878046|NCT01122264|580949758|FG001|Overall Study|Protocol Violation|7|||
160878047|NCT01122264|580949759|FG002|Overall Study|Protocol Violation|9|||
160878048|NCT01122264|580949757|FG000|Overall Study|Withdrawal by Subject|6|||
160878049|NCT01122264|580949758|FG001|Overall Study|Withdrawal by Subject|6|||
160878050|NCT01122264|580949759|FG002|Overall Study|Withdrawal by Subject|16|||
160878051|NCT01122264|580949757|FG000|Overall Study|Physician Decision|3|||
160878052|NCT01122264|580949758|FG001|Overall Study|Physician Decision|1|||
160878053|NCT01122264|580949759|FG002|Overall Study|Physician Decision|1|||
160878054|NCT01122264|580949757|FG000|Overall Study|Lack of Efficacy|3|||
160878055|NCT01122264|580949758|FG001|Overall Study|Lack of Efficacy|1|||
160878056|NCT01122264|580949759|FG002|Overall Study|Lack of Efficacy|1|||
160878057|NCT00097981|580949768|FG000|Overall Study|Adverse Event|31|||
160878058|NCT00097981|580949769|FG001|Overall Study|Adverse Event|44|||
160878059|NCT00097981|580949768|FG000|Overall Study|Withdrawal by Subject|10|||
160878060|NCT00097981|580949769|FG001|Overall Study|Withdrawal by Subject|8|||
160878061|NCT00097981|580949768|FG000|Overall Study|Protocol Violation|1|||
160878062|NCT00097981|580949769|FG001|Overall Study|Protocol Violation|1|||
160878063|NCT00097981|580949768|FG000|Overall Study|Death|2|||
160878064|NCT00097981|580949769|FG001|Overall Study|Death|4|||
160878065|NCT00097981|580949768|FG000|Overall Study|Physician Decision|7|||
160878066|NCT00097981|580949769|FG001|Overall Study|Physician Decision|1|||
160878067|NCT00097981|580949768|FG000|Overall Study|Disease Progression|8|||
160878068|NCT00097981|580949769|FG001|Overall Study|Disease Progression|2|||
160878069|NCT00097981|580949768|FG000|Overall Study|Transplant planned|28|||
160878070|NCT00097981|580949769|FG001|Overall Study|Transplant planned|27|||
160878071|NCT00097981|580949768|FG000|Overall Study|Other|19|||
160878072|NCT00097981|580949769|FG001|Overall Study|Other|13|||
160878073|NCT01128621|580949782|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
160878074|NCT01128621|580949783|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
160878075|NCT04074161|580949784|FG000|Overall Study|Withdrawal by Subject|2|||
160878076|NCT04074161|580949785|FG001|Overall Study|Withdrawal by Subject|4|||
160878077|NCT04074161|580949786|FG002|Overall Study|Withdrawal by Subject|1|||
160878078|NCT04074161|580949784|FG000|Overall Study|Lost to Follow-up|4|||
160878079|NCT04074161|580949785|FG001|Overall Study|Lost to Follow-up|5|||
160878080|NCT04074161|580949786|FG002|Overall Study|Lost to Follow-up|3|||
160878081|NCT00796445|580949789|FG000|Overall Study|Protocol Violation|5|||
160878082|NCT00796445|580949790|FG001|Overall Study|Protocol Violation|3|||
160878083|NCT00796445|580949789|FG000|Overall Study|Adverse event, serious fatal|10|||
160878084|NCT00796445|580949790|FG001|Overall Study|Adverse event, serious fatal|5|||
160878085|NCT00796445|580949789|FG000|Overall Study|Adverse event, non-fatal|4|||
160878086|NCT00796445|580949790|FG001|Overall Study|Adverse event, non-fatal|0|||
160878087|NCT00796445|580949789|FG000|Overall Study|Disease progression/recurrence|537|||
160878088|NCT00796445|580949790|FG001|Overall Study|Disease progression/recurrence|268|||
160878089|NCT00796445|580949789|FG000|Overall Study|Other|10|||
160878090|NCT00796445|580949790|FG001|Overall Study|Other|7|||
160878091|NCT00796445|580949789|FG000|Overall Study|Withdrawal by Subject|18|||
160878092|NCT00796445|580949790|FG001|Overall Study|Withdrawal by Subject|9|||
160878093|NCT00796445|580949789|FG000|Overall Study|Invalid Informed Consent Form|1|||
160878094|NCT00796445|580949790|FG001|Overall Study|Invalid Informed Consent Form|0|||
160878095|NCT00388583|580949793|FG000|Overall Study|Protocol Violation|1|||
160878096|NCT00388583|580949794|FG001|Overall Study|Protocol Violation|0|||
160878097|NCT00388583|580949793|FG000|Overall Study|Withdrawal by Subject|3|||
160878098|NCT00388583|580949794|FG001|Overall Study|Withdrawal by Subject|3|||
160878099|NCT00388583|580949793|FG000|Overall Study|Serious Adverse Event|2|||
160878100|NCT00388583|580949794|FG001|Overall Study|Serious Adverse Event|0|||
160878101|NCT00388583|580949793|FG000|Overall Study|Did not receive vaccine|0|||
160878102|NCT00388583|580949794|FG001|Overall Study|Did not receive vaccine|1|||
160878103|NCT05194579|580949795|FG000|Overall Study|Lost to Follow-up|2|||
160878104|NCT05194579|580949796|FG001|Overall Study|Lost to Follow-up|3|||
160878105|NCT05194579|580949795|FG000|Overall Study|Withdrawal by Subject|3|||
160878106|NCT05194579|580949796|FG001|Overall Study|Withdrawal by Subject|4|||
160878107|NCT05194579|580949795|FG000|Overall Study|Refused further study procedures|0|||
160878108|NCT05194579|580949796|FG001|Overall Study|Refused further study procedures|1|||
160878109|NCT05194579|580949795|FG000|Overall Study|Protocol deviation|1|||
160878110|NCT05194579|580949796|FG001|Overall Study|Protocol deviation|0|||
160878111|NCT02500056|580949801|FG000|Overall Study|Lost to Follow-up|3|||
160878112|NCT02500056|580949802|FG001|Overall Study|Lost to Follow-up|7|||
160878113|NCT02500056|580949801|FG000|Overall Study|Recurrence|1|||
160878114|NCT02500056|580949802|FG001|Overall Study|Recurrence|0|||
160878115|NCT02500056|580949801|FG000|Overall Study|Death|3|||
160878116|NCT02500056|580949802|FG001|Overall Study|Death|1|||
160878117|NCT00638183|580949807|FG000|Overall Study|Adverse Event|23|||
160878118|NCT00638183|580949807|FG000|Overall Study|Lack of Efficacy|14|||
160878119|NCT00638183|580949807|FG000|Overall Study|Physician Decision|9|||
160878120|NCT00638183|580949807|FG000|Overall Study|Lost to Follow-up|46|||
160878121|NCT00638183|580949807|FG000|Overall Study|Other reason not defined above|27|||
160878122|NCT03180619|580949808|FG000|Overall Study|Withdrew Consent|5|||
160878123|NCT03180619|580949809|FG001|Overall Study|Withdrew Consent|0|||
160878124|NCT03180619|580949810|FG002|Overall Study|Withdrew Consent|2|||
160878125|NCT03180619|580949808|FG000|Overall Study|Death|2|||
160878126|NCT03180619|580949809|FG001|Overall Study|Death|1|||
160878127|NCT03180619|580949810|FG002|Overall Study|Death|2|||
160878128|NCT03180619|580949808|FG000|Overall Study|Adverse Event|2|||
160878129|NCT03180619|580949809|FG001|Overall Study|Adverse Event|0|||
160878130|NCT03180619|580949810|FG002|Overall Study|Adverse Event|1|||
160878131|NCT03180619|580949808|FG000|Overall Study|Investigator's discretion|2|||
160878132|NCT03180619|580949809|FG001|Overall Study|Investigator's discretion|0|||
160878133|NCT03180619|580949810|FG002|Overall Study|Investigator's discretion|1|||
160878134|NCT00275340|580949813|FG000|Overall Study|Lost to Follow-up|2|||
160878135|NCT00275340|580949814|FG001|Overall Study|Lost to Follow-up|4|||
160878136|NCT00862641|580949817|FG000|Overall Study|Randomized, but drug not received|1|||
160538123|NCT00804570|579700486|FG000|Overall Study|Lost to Follow-up|18|||
160538124|NCT00804570|579700487|FG001|Overall Study|Lost to Follow-up|21|||
160538125|NCT00804570|579700486|FG000|Overall Study|Entry criteria not met|5|||
160538126|NCT00804570|579700487|FG001|Overall Study|Entry criteria not met|5|||
160538127|NCT00804570|579700486|FG000|Overall Study|Protocol Violation|12|||
160538128|NCT00804570|579700487|FG001|Overall Study|Protocol Violation|16|||
160538129|NCT00804570|579700486|FG000|Overall Study|Physician Decision|1|||
160538130|NCT00804570|579700487|FG001|Overall Study|Physician Decision|2|||
160538131|NCT00804570|579700486|FG000|Overall Study|Sponsor decision|1|||
160538132|NCT00804570|579700487|FG001|Overall Study|Sponsor decision|4|||
160538133|NCT00804570|579700486|FG000|Overall Study|Withdrawal by Subject|21|||
160538134|NCT00804570|579700487|FG001|Overall Study|Withdrawal by Subject|38|||
160538135|NCT00290342|579700488|FG000|Overall Study|Other|0|||
160538136|NCT00290342|579700489|FG001|Overall Study|Other|1|||
160538137|NCT00290342|579700488|FG000|Overall Study|Withdrawal by Subject|6|||
160538138|NCT00290342|579700489|FG001|Overall Study|Withdrawal by Subject|4|||
160538139|NCT00290342|579700488|FG000|Overall Study|Lost to Follow-up|1|||
160538140|NCT00290342|579700489|FG001|Overall Study|Lost to Follow-up|0|||
160538141|NCT01056510|579700492|FG000|Overall Study|Dropout Before Start of Treatment|1|||
160538142|NCT01056510|579700493|FG001|Overall Study|Dropout Before Start of Treatment|1|||
160538143|NCT01056510|579700492|FG000|Overall Study|Withdrawal by Subject|4|||
160538144|NCT01056510|579700493|FG001|Overall Study|Withdrawal by Subject|2|||
160538145|NCT01056510|579700492|FG000|Overall Study|Death|29|||
160538146|NCT01056510|579700493|FG001|Overall Study|Death|34|||
160538147|NCT01056510|579700492|FG000|Overall Study|Noncompliance|1|||
160538148|NCT01056510|579700493|FG001|Overall Study|Noncompliance|3|||
160538149|NCT01056510|579700492|FG000|Overall Study|Physician Decision|4|||
160538150|NCT01056510|579700493|FG001|Overall Study|Physician Decision|5|||
160538151|NCT01056510|579700492|FG000|Overall Study|Lost to Follow-up|5|||
160538152|NCT01056510|579700493|FG001|Overall Study|Lost to Follow-up|6|||
160538153|NCT01056510|579700492|FG000|Overall Study|Other|10|||
160538154|NCT01056510|579700493|FG001|Overall Study|Other|12|||
160538155|NCT01056510|579700492|FG000|Overall Study|Missing|0|||
160538156|NCT01056510|579700493|FG001|Overall Study|Missing|1|||
160538157|NCT02285998|579700496|FG000|Overall Study|Adverse Event|9|||
160538158|NCT02285998|579700497|FG001|Overall Study|Adverse Event|8|||
160878137|NCT00862641|580949818|FG001|Overall Study|Randomized, but drug not received|4|||
160878138|NCT00862641|580949819|FG002|Overall Study|Randomized, but drug not received|1|||
160878139|NCT00862641|580949820|FG003|Overall Study|Randomized, but drug not received|4|||
160878140|NCT02365480|580949821|FG000|Overall Study|Withdrawal by Subject|2|||
160538159|NCT02285998|579700496|FG000|Overall Study|Physician Decision|1|||
160538160|NCT02285998|579700497|FG001|Overall Study|Physician Decision|2|||
160538161|NCT02285998|579700496|FG000|Overall Study|Lost to Follow-up|176|||
160538162|NCT02285998|579700497|FG001|Overall Study|Lost to Follow-up|172|||
160538163|NCT02285998|579700496|FG000|Overall Study|Withdrawal by Subject|53|||
160878141|NCT02365480|580949822|FG001|Overall Study|Withdrawal by Subject|0|||
160878142|NCT01419197|580949827|FG000|Overall Study|Death|247|||
160538164|NCT02285998|579700497|FG001|Overall Study|Withdrawal by Subject|61|||
160538165|NCT02285998|579700496|FG000|Overall Study|Other Reasons|7|||
160538166|NCT02285998|579700497|FG001|Overall Study|Other Reasons|10|||
160878143|NCT01419197|580949828|FG001|Overall Study|Death|122|||
160878144|NCT01419197|580949827|FG000|Overall Study|Physician Decision|4|||
160878145|NCT01419197|580949828|FG001|Overall Study|Physician Decision|4|||
160878146|NCT01419197|580949827|FG000|Overall Study|Non-compliance|3|||
160878147|NCT01419197|580949828|FG001|Overall Study|Non-compliance|1|||
160878148|NCT01419197|580949827|FG000|Overall Study|Withdrawal by Subject|33|||
160538167|NCT03451084|579700500|FG000|Overall Study|Withdrawal by Subject|2|||
160538168|NCT03451084|579700501|FG001|Overall Study|Withdrawal by Subject|1|||
160538169|NCT03451084|579700502|FG002|Overall Study|Withdrawal by Subject|2|||
160538170|NCT03451084|579700503|FG003|Overall Study|Withdrawal by Subject|1|||
160538171|NCT03451084|579700500|FG000|Overall Study|Disease recurrence|0|||
160538172|NCT03451084|579700501|FG001|Overall Study|Disease recurrence|2|||
160538173|NCT03451084|579700502|FG002|Overall Study|Disease recurrence|0|||
160538174|NCT03451084|579700503|FG003|Overall Study|Disease recurrence|0|||
160538175|NCT03451084|579700500|FG000|Overall Study|Lack of Efficacy|0|||
160538176|NCT03451084|579700501|FG001|Overall Study|Lack of Efficacy|3|||
160538177|NCT03451084|579700502|FG002|Overall Study|Lack of Efficacy|0|||
160538178|NCT03451084|579700503|FG003|Overall Study|Lack of Efficacy|1|||
160538179|NCT03451084|579700500|FG000|Overall Study|Death|1|||
160538180|NCT03451084|579700501|FG001|Overall Study|Death|0|||
160538181|NCT03451084|579700502|FG002|Overall Study|Death|2|||
160538182|NCT03451084|579700503|FG003|Overall Study|Death|0|||
160538183|NCT03451084|579700500|FG000|Overall Study|Physician Decision|0|||
160538184|NCT03451084|579700501|FG001|Overall Study|Physician Decision|0|||
160538185|NCT03451084|579700502|FG002|Overall Study|Physician Decision|2|||
160538186|NCT03451084|579700503|FG003|Overall Study|Physician Decision|2|||
160538187|NCT03451084|579700500|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
160538188|NCT03451084|579700501|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
160538189|NCT03451084|579700502|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
160538190|NCT03451084|579700503|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
160538191|NCT03029143|579700504|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
160538192|NCT03029143|579700505|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
160538193|NCT03029143|579700506|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
160538194|NCT03029143|579700504|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
160538195|NCT03029143|579700505|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
160878149|NCT01419197|580949828|FG001|Overall Study|Withdrawal by Subject|32|||
160878150|NCT01419197|580949827|FG000|Overall Study|Study Completed by Sponsor|103|||
160538196|NCT03029143|579700506|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
160538197|NCT03029143|579700504|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
160538198|NCT03029143|579700505|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
160538199|NCT03029143|579700506|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
160538200|NCT03029143|579700504|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
160538201|NCT03029143|579700505|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
160538202|NCT03029143|579700506|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
160538203|NCT03029143|579700504|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
160878151|NCT01419197|580949828|FG001|Overall Study|Study Completed by Sponsor|34|||
160878152|NCT01419197|580949827|FG000|Overall Study|Reason Not Specified|0|||
160878153|NCT01419197|580949828|FG001|Overall Study|Reason Not Specified|1|||
160878154|NCT01419197|580949827|FG000|Overall Study|Lost to Follow-up|14|||
160878155|NCT01419197|580949828|FG001|Overall Study|Lost to Follow-up|4|||
160878156|NCT01781299|580949829|FG000|Overall Study|Withdrawal by Subject|0|||
160878157|NCT01781299|580949830|FG001|Overall Study|Withdrawal by Subject|1|||
160878158|NCT00146848|580949834|FG000|Pre-randomization|Death|19|||
160878159|NCT00146848|580949835|FG001|Pre-randomization|Death|0|||
160878160|NCT00146848|580949836|FG002|Pre-randomization|Death|0|||
160878161|NCT00146848|580949834|FG000|Pre-randomization|Lost to Follow-up|70|||
160878162|NCT00146848|580949835|FG001|Pre-randomization|Lost to Follow-up|0|||
160878163|NCT00146848|580949836|FG002|Pre-randomization|Lost to Follow-up|0|||
160878164|NCT00146848|580949834|FG000|Pre-randomization|Physician Decision|8|||
160878165|NCT00146848|580949835|FG001|Pre-randomization|Physician Decision|0|||
160538204|NCT03029143|579700505|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
160538205|NCT03029143|579700506|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
160878166|NCT00146848|580949836|FG002|Pre-randomization|Physician Decision|0|||
160538206|NCT03029143|579700504|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
160538207|NCT03029143|579700505|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
160538208|NCT03029143|579700506|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
160878167|NCT00146848|580949834|FG000|Pre-randomization|Protocol Violation|172|||
160878168|NCT00146848|580949835|FG001|Pre-randomization|Protocol Violation|0|||
160878169|NCT00146848|580949836|FG002|Pre-randomization|Protocol Violation|0|||
160878170|NCT00146848|580949834|FG000|Pre-randomization|Withdrawal by Subject|40|||
160878171|NCT00146848|580949835|FG001|Pre-randomization|Withdrawal by Subject|0|||
160878172|NCT00146848|580949836|FG002|Pre-randomization|Withdrawal by Subject|0|||
160878173|NCT00146848|580949834|FG000|Post-randomization|Lost to Follow-up|12|||
160878174|NCT00146848|580949835|FG001|Post-randomization|Lost to Follow-up|15|||
160878175|NCT00146848|580949836|FG002|Post-randomization|Lost to Follow-up|12|||
160878176|NCT00146848|580949834|FG000|Post-randomization|Withdrawn|26|||
160878177|NCT00146848|580949835|FG001|Post-randomization|Withdrawn|32|||
160878178|NCT00146848|580949836|FG002|Post-randomization|Withdrawn|27|||
160878179|NCT02395172|580949837|FG000|Overall Study|Participants randomized but not treated|3|||
160878180|NCT02395172|580949838|FG001|Overall Study|Participants randomized but not treated|31|||
160878181|NCT02032238|580949839|FG000|Overall Study|Lost to Follow-up|2|||
160878182|NCT02032238|580949840|FG001|Overall Study|Lost to Follow-up|0|||
160878183|NCT00653939|580949841|FG000|Overall Study|Adverse Event|1|||
160878184|NCT00653939|580949842|FG001|Overall Study|Adverse Event|3|||
160878185|NCT00653939|580949841|FG000|Overall Study|Withdrawal by Subject|3|||
160878186|NCT00653939|580949842|FG001|Overall Study|Withdrawal by Subject|3|||
160878187|NCT00653939|580949841|FG000|Overall Study|Physician Decision|4|||
160878188|NCT00653939|580949842|FG001|Overall Study|Physician Decision|0|||
160878189|NCT00653939|580949841|FG000|Overall Study|Disease Progression|2|||
160878190|NCT00653939|580949842|FG001|Overall Study|Disease Progression|3|||
160878191|NCT00653939|580949841|FG000|Overall Study|Other|2|||
160878192|NCT00653939|580949842|FG001|Overall Study|Other|6|||
160878193|NCT00717236|580949843|FG000|Double-Blind Period|Adverse Event|33|||
160878194|NCT00717236|580949844|FG001|Double-Blind Period|Adverse Event|6|||
160878195|NCT00717236|580949843|FG000|Double-Blind Period|Lack of Efficacy|6|||
160878196|NCT00717236|580949844|FG001|Double-Blind Period|Lack of Efficacy|6|||
160878197|NCT00717236|580949843|FG000|Double-Blind Period|Lost to Follow-up|3|||
160878198|NCT00717236|580949844|FG001|Double-Blind Period|Lost to Follow-up|5|||
160878199|NCT00717236|580949843|FG000|Double-Blind Period|Withdrawal by Subject|10|||
160878200|NCT00717236|580949844|FG001|Double-Blind Period|Withdrawal by Subject|2|||
160878201|NCT00717236|580949843|FG000|Double-Blind Period|Loss of efficacy|3|||
160878202|NCT00717236|580949844|FG001|Double-Blind Period|Loss of efficacy|0|||
160768636|NCT02100631|580540734|FG000|Overall Study|Lost to Follow-up|3|||
160768637|NCT02100631|580540735|FG001|Overall Study|Lost to Follow-up|4|||
160768638|NCT02100631|580540736|FG002|Overall Study|Lost to Follow-up|0|||
160768639|NCT02100631|580540734|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
160538209|NCT03029143|579700504|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
160538210|NCT03029143|579700505|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
160538211|NCT03029143|579700506|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
160538212|NCT03029143|579700504|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160538213|NCT03029143|579700505|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
160538214|NCT03029143|579700506|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
160636610|NCT05166512|580051581|FG000|Baseline Data Collection|Protocol Violation|2|||
160768640|NCT02100631|580540735|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
160768641|NCT02100631|580540736|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
160768642|NCT00336544|580540737|FG000|Overall Study|Lack of Efficacy|8|||
160878203|NCT00717236|580949843|FG000|Double-Blind Period|Other: Death|1|||
160878204|NCT00717236|580949844|FG001|Double-Blind Period|Other: Death|0|||
160768643|NCT00336544|580540738|FG001|Overall Study|Lack of Efficacy|5|||
160768644|NCT00336544|580540737|FG000|Overall Study|Adverse Event|4|||
160768645|NCT00336544|580540738|FG001|Overall Study|Adverse Event|9|||
160768646|NCT00336544|580540737|FG000|Overall Study|Withdrawal by Subject|4|||
160768647|NCT00336544|580540738|FG001|Overall Study|Withdrawal by Subject|3|||
160768648|NCT00336544|580540737|FG000|Overall Study|Other|3|||
160768649|NCT00336544|580540738|FG001|Overall Study|Other|5|||
160768650|NCT00091819|580540741|FG000|Overall Study|Adverse Event|1|||
160768651|NCT00091819|580540742|FG001|Overall Study|Adverse Event|1|||
160768652|NCT00091819|580540741|FG000|Overall Study|Death|4|||
160768653|NCT00091819|580540742|FG001|Overall Study|Death|5|||
160768654|NCT00091819|580540741|FG000|Overall Study|Lost to Follow-up|26|||
160768655|NCT00091819|580540742|FG001|Overall Study|Lost to Follow-up|23|||
160878205|NCT00717236|580949843|FG000|Double-Blind Period|Other: Pregnancy|1|||
160878206|NCT00717236|580949844|FG001|Double-Blind Period|Other: Pregnancy|0|||
160878207|NCT00717236|580949843|FG000|Double-Blind Period|Other: Protocol Violation|2|||
160878208|NCT00717236|580949844|FG001|Double-Blind Period|Other: Protocol Violation|0|||
160768656|NCT00091819|580540741|FG000|Overall Study|Withdrawal by Subject|5|||
160768657|NCT00091819|580540742|FG001|Overall Study|Withdrawal by Subject|8|||
160878209|NCT00717236|580949843|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
160878210|NCT00717236|580949844|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
160878211|NCT00717236|580949843|FG000|Double-Blind Period|Other: Site withdrew|2|||
160878212|NCT00717236|580949844|FG001|Double-Blind Period|Other: Site withdrew|0|||
160878213|NCT00717236|580949843|FG000|Double-Blind Period|Other: Screening failure|1|||
160878214|NCT00717236|580949844|FG001|Double-Blind Period|Other: Screening failure|0|||
160878215|NCT00717236|580949843|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
160878216|NCT00717236|580949844|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
160636611|NCT05166512|580051582|FG001|Baseline Data Collection|Protocol Violation|0|||
160768658|NCT00091819|580540741|FG000|Overall Study|Protocol Violation|1|||
160768659|NCT00091819|580540742|FG001|Overall Study|Protocol Violation|2|||
160768660|NCT00091819|580540741|FG000|Overall Study|Other|2|||
160768661|NCT00091819|580540742|FG001|Overall Study|Other|3|||
160768662|NCT00091819|580540741|FG000|Overall Study|Never received study treatment|3|||
160768663|NCT00091819|580540742|FG001|Overall Study|Never received study treatment|4|||
160768664|NCT00819039|580540743|FG000|Overall Study|Physician Decision|1|||
160768665|NCT00819039|580540744|FG001|Overall Study|Physician Decision|0|||
160768666|NCT00819039|580540745|FG002|Overall Study|Physician Decision|1|||
160768667|NCT00819039|580540743|FG000|Overall Study|Protocol Violation|1|||
160768668|NCT00819039|580540744|FG001|Overall Study|Protocol Violation|0|||
160768669|NCT00819039|580540745|FG002|Overall Study|Protocol Violation|0|||
160768670|NCT04796415|580540746|FG000|Overall Study|not interested|12|||
160768671|NCT04796415|580540746|FG000|Overall Study|health issue|8|||
160768672|NCT04796415|580540746|FG000|Overall Study|Other|4|||
160768673|NCT04796415|580540746|FG000|Overall Study|discharged from home health service|3|||
160768674|NCT04796415|580540746|FG000|Overall Study|re-hospitalization|2|||
160768675|NCT04796415|580540746|FG000|Overall Study|moving to nursing home|1|||
160768676|NCT04796415|580540746|FG000|Overall Study|lost contact|1|||
160768677|NCT00997893|580540749|FG000|Overall Study|Adverse Event|1|||
160768678|NCT00997893|580540750|FG001|Overall Study|Adverse Event|0|||
160768679|NCT00997893|580540751|FG002|Overall Study|Adverse Event|0|||
160768680|NCT00997893|580540749|FG000|Overall Study|Unable to meet study timelines|1|||
160768681|NCT00997893|580540750|FG001|Overall Study|Unable to meet study timelines|0|||
160768682|NCT00997893|580540751|FG002|Overall Study|Unable to meet study timelines|0|||
160768683|NCT00997893|580540749|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
160768684|NCT00997893|580540750|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
160768685|NCT00997893|580540751|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
160768686|NCT04009837|580540754|FG000|Overall Study|Withdrawal by Subject|5|||
160768687|NCT04009837|580540755|FG001|Overall Study|Withdrawal by Subject|4|||
160768688|NCT04009837|580540754|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
160768689|NCT04009837|580540755|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
160768690|NCT05352815|580540757|FG000|Overall Study|Withdrawal by Subject|28|||
160768691|NCT05352815|580540758|FG001|Overall Study|Withdrawal by Subject|24|||
160768692|NCT05352815|580540757|FG000|Overall Study|Lost to Follow-up|4|||
160768693|NCT05352815|580540758|FG001|Overall Study|Lost to Follow-up|7|||
160768694|NCT05352815|580540757|FG000|Overall Study|Death|2|||
160768695|NCT05352815|580540758|FG001|Overall Study|Death|3|||
160768696|NCT05352815|580540757|FG000|Overall Study|Site closure|1|||
160768697|NCT05352815|580540758|FG001|Overall Study|Site closure|0|||
160768698|NCT00226655|580540759|FG000|Overall Study|Death|13|||
160768699|NCT00226655|580540759|FG000|Overall Study|Withdrawal by Subject|15|||
160768700|NCT00226655|580540759|FG000|Overall Study|Adverse Event|35|||
160768701|NCT00226655|580540759|FG000|Overall Study|Physician Decision|6|||
160768702|NCT00226655|580540759|FG000|Overall Study|Clinical deterioration|10|||
160768703|NCT05144945|580540760|FG000|Overall Study|Withdrawal by Subject|1|||
160768704|NCT05144945|580540761|FG001|Overall Study|Withdrawal by Subject|0|||
160768705|NCT02592824|580540765|FG000|Overall Study|Protocol Violation|5|||
160768706|NCT02592824|580540766|FG001|Overall Study|Protocol Violation|3|||
160768707|NCT02592824|580540765|FG000|Overall Study|Lost to Follow-up|2|||
160636612|NCT05166512|580051581|FG000|4 Month Data Collection|Lost to Follow-up|1|||
160636613|NCT05166512|580051582|FG001|4 Month Data Collection|Lost to Follow-up|0|||
160636614|NCT05166512|580051581|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
160636615|NCT05166512|580051582|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
160636616|NCT05166512|580051581|FG000|12 Month Data Collection|Lost to Follow-up|3|||
160636617|NCT05166512|580051582|FG001|12 Month Data Collection|Lost to Follow-up|1|||
160636618|NCT05166512|580051581|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
160636619|NCT05166512|580051582|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
160636620|NCT00420849|580051583|FG000|Overall Study|Lack of Efficacy|154|||
160636621|NCT00420849|580051583|FG000|Overall Study|Adverse Event|107|||
160636622|NCT00420849|580051583|FG000|Overall Study|Withdrawal by Subject|28|||
160636623|NCT00420849|580051583|FG000|Overall Study|Death|18|||
160636624|NCT00420849|580051583|FG000|Overall Study|Other|14|||
160636625|NCT00420849|580051583|FG000|Overall Study|Transplant|8|||
160636626|NCT00420849|580051583|FG000|Overall Study|Protocol Violation|1|||
160636627|NCT00420849|580051583|FG000|Overall Study|Lost to Follow-up|1|||
160636628|NCT01488071|580051584|FG000|Overall Study|Adverse Event|15|||
160768708|NCT02592824|580540766|FG001|Overall Study|Lost to Follow-up|1|||
160768709|NCT02855268|580540767|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
160768710|NCT02855268|580540768|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
160768711|NCT02855268|580540767|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
160768712|NCT02855268|580540768|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
160768713|NCT02855268|580540767|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
160768714|NCT02855268|580540768|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
160636629|NCT01488071|580051585|FG001|Overall Study|Adverse Event|23|||
160636630|NCT01488071|580051584|FG000|Overall Study|Lack of Efficacy|11|||
160878217|NCT00717236|580949843|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
160878218|NCT00717236|580949844|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
160878219|NCT00717236|580949843|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
160878220|NCT00717236|580949844|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
160878221|NCT00717236|580949843|FG000|Double-Blind Period|Other: History of cancer|1|||
160878222|NCT00717236|580949844|FG001|Double-Blind Period|Other: History of cancer|0|||
160878223|NCT00717236|580949843|FG000|Double-Blind Period|Other: Sponsor request|1|||
160878224|NCT00717236|580949844|FG001|Double-Blind Period|Other: Sponsor request|0|||
160878225|NCT00717236|580949843|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
160878226|NCT00717236|580949844|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
160878227|NCT00717236|580949843|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
160878228|NCT00717236|580949844|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
160878229|NCT00717236|580949843|FG000|Double-Blind Period|Other: Subject moved|1|||
160878230|NCT00717236|580949844|FG001|Double-Blind Period|Other: Subject moved|1|||
160878231|NCT00717236|580949843|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
160878232|NCT00717236|580949844|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
160878233|NCT00717236|580949843|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
160878234|NCT00717236|580949844|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
160878235|NCT00717236|580949843|FG000|Double-Blind Period|Other: Transportation problems|0|||
160878236|NCT00717236|580949844|FG001|Double-Blind Period|Other: Transportation problems|1|||
160878237|NCT00717236|580949843|FG000|Double-Blind Period|Other: Investigator Decision|0|||
160878238|NCT00717236|580949844|FG001|Double-Blind Period|Other: Investigator Decision|1|||
160878239|NCT00717236|580949843|FG000|Open-Label Period|Adverse Event|29|||
160878240|NCT00717236|580949844|FG001|Open-Label Period|Adverse Event|4|||
160878241|NCT00717236|580949843|FG000|Open-Label Period|Lack of Efficacy|30|||
160878242|NCT00717236|580949844|FG001|Open-Label Period|Lack of Efficacy|8|||
160878243|NCT00717236|580949843|FG000|Open-Label Period|Lost to Follow-up|28|||
160878244|NCT00717236|580949844|FG001|Open-Label Period|Lost to Follow-up|4|||
160878245|NCT00717236|580949843|FG000|Open-Label Period|Withdrawal by Subject|20|||
160878246|NCT00717236|580949844|FG001|Open-Label Period|Withdrawal by Subject|2|||
160878247|NCT00717236|580949843|FG000|Open-Label Period|Loss of Efficacy|6|||
160878248|NCT00717236|580949844|FG001|Open-Label Period|Loss of Efficacy|1|||
160878249|NCT00717236|580949843|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
160878250|NCT00717236|580949844|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
160878251|NCT00717236|580949843|FG000|Open-Label Period|Other: Lack of Compliance|1|||
160878252|NCT00717236|580949844|FG001|Open-Label Period|Other: Lack of Compliance|1|||
160878253|NCT00717236|580949843|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
160878254|NCT00717236|580949844|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
160878255|NCT00717236|580949843|FG000|Open-Label Period|Other: Moved|1|||
160878256|NCT00717236|580949844|FG001|Open-Label Period|Other: Moved|0|||
160878257|NCT00717236|580949843|FG000|Open-Label Period|Other: Investigator Decision|1|||
160878258|NCT00717236|580949844|FG001|Open-Label Period|Other: Investigator Decision|0|||
160878259|NCT00717236|580949843|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
160878260|NCT00717236|580949844|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
160878261|NCT00717236|580949843|FG000|Open-Label Period|Other: Sponsor Request|3|||
160878262|NCT00717236|580949844|FG001|Open-Label Period|Other: Sponsor Request|0|||
160878263|NCT00717236|580949843|FG000|Open-Label Period|Other: Cataract Surgery|1|||
160538215|NCT03029143|579700504|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
160538216|NCT03029143|579700505|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
160538217|NCT03029143|579700506|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
160538218|NCT03029143|579700504|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
160538219|NCT03029143|579700505|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
160538220|NCT03029143|579700506|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
160538221|NCT03029143|579700504|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
160538222|NCT03029143|579700505|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
160538223|NCT03029143|579700506|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
160538224|NCT02121262|579700509|FG000|Overall Study|Adverse Event|6|||
160538225|NCT02121262|579700510|FG001|Overall Study|Adverse Event|3|||
160538226|NCT02121262|579700509|FG000|Overall Study|Lack of Efficacy|3|||
160538227|NCT02121262|579700510|FG001|Overall Study|Lack of Efficacy|0|||
160538228|NCT02121262|579700509|FG000|Overall Study|Personal Reasons|19|||
160538229|NCT02121262|579700510|FG001|Overall Study|Personal Reasons|5|||
160538230|NCT02121262|579700509|FG000|Overall Study|Protocol Violation|1|||
160538231|NCT02121262|579700510|FG001|Overall Study|Protocol Violation|1|||
160538232|NCT02121262|579700509|FG000|Overall Study|Participant Dropped-out|0|||
160538233|NCT02121262|579700510|FG001|Overall Study|Participant Dropped-out|1|||
160538234|NCT02121262|579700509|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
160538235|NCT02121262|579700510|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
160538236|NCT02121262|579700509|FG000|Overall Study|Consent Withdrawn|1|||
160538237|NCT02121262|579700510|FG001|Overall Study|Consent Withdrawn|0|||
160538238|NCT02716987|579700511|FG000|Overall Study|Ligand synthesis failure|0|||
160538239|NCT02716987|579700512|FG001|Overall Study|Ligand synthesis failure|0|||
160538240|NCT02716987|579700513|FG002|Overall Study|Ligand synthesis failure|1|||
160538241|NCT02716987|579700514|FG003|Overall Study|Ligand synthesis failure|0|||
160878264|NCT00717236|580949844|FG001|Open-Label Period|Other: Cataract Surgery|0|||
160878265|NCT00717236|580949843|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
160878266|NCT00717236|580949844|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
160878267|NCT00717236|580949843|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
160878268|NCT00717236|580949844|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
160878269|NCT00717236|580949843|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
160538242|NCT02716987|579700515|FG004|Overall Study|Ligand synthesis failure|0|||
160538243|NCT02716987|579700516|FG005|Overall Study|Ligand synthesis failure|0|||
160538244|NCT02716987|579700511|FG000|Overall Study|Withdrawal by Subject|0|||
160538245|NCT02716987|579700512|FG001|Overall Study|Withdrawal by Subject|0|||
160538246|NCT02716987|579700513|FG002|Overall Study|Withdrawal by Subject|0|||
160538247|NCT02716987|579700514|FG003|Overall Study|Withdrawal by Subject|0|||
160538248|NCT02716987|579700515|FG004|Overall Study|Withdrawal by Subject|1|||
160538249|NCT02716987|579700516|FG005|Overall Study|Withdrawal by Subject|1|||
160538250|NCT01553188|579700517|FG000|Overall Study|Patient choice|1|||
160538251|NCT01553188|579700518|FG001|Overall Study|Patient choice|0|||
160538252|NCT01553188|579700519|FG002|Overall Study|Patient choice|0|||
160538253|NCT01553188|579700520|FG003|Overall Study|Patient choice|0|||
160538254|NCT01553188|579700517|FG000|Overall Study|Intercurrent illness and adverse event|0|||
160538255|NCT01553188|579700518|FG001|Overall Study|Intercurrent illness and adverse event|1|||
160538256|NCT01553188|579700519|FG002|Overall Study|Intercurrent illness and adverse event|2|||
160538257|NCT01553188|579700520|FG003|Overall Study|Intercurrent illness and adverse event|0|||
160538258|NCT01617070|579700522|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
160538259|NCT04544475|579700523|FG000|Overall Study|Withdrawal by Subject|1|||
160538260|NCT04544475|579700524|FG001|Overall Study|Withdrawal by Subject|3|||
160538261|NCT03223428|579700525|FG000|Overall Study|No longer taking Xermelo|27|||
160538262|NCT03223428|579700525|FG000|Overall Study|Declined Consent|1|||
160538263|NCT03223428|579700525|FG000|Overall Study|Non-responders|56|||
160538264|NCT03223428|579700525|FG000|Overall Study|Withdrawal by Subject|14|||
160538265|NCT02230384|579700527|FG000|Phase 1|Lost to Follow-up|1|||
160878270|NCT00717236|580949844|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
160538266|NCT02230384|579700528|FG001|Phase 1|Lost to Follow-up|0|||
160538267|NCT02230384|579700527|FG000|Phase 1|Physician Decision|0|||
160538268|NCT02230384|579700528|FG001|Phase 1|Physician Decision|1|||
160538269|NCT02230384|579700527|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
160538270|NCT02230384|579700528|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
160538271|NCT02230384|579700527|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
160538272|NCT02230384|579700528|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
160538273|NCT02230384|579700527|FG000|Phase 2 - Switch|Adverse Event|2|||
160538274|NCT02230384|579700528|FG001|Phase 2 - Switch|Adverse Event|0|||
160878271|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
160878272|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
160878273|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
160878274|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
160878275|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
160878276|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
160878277|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
160878278|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
160878279|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
160878280|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
160878281|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
160878282|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
160878283|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
160878284|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
160878285|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
160878286|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
160878287|NCT00612105|580949845|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
160878288|NCT00612105|580949846|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
160878289|NCT00612105|580949845|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
160878290|NCT00612105|580949846|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
160878291|NCT00612105|580949845|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
160878292|NCT00612105|580949846|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
160878293|NCT00612105|580949845|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
160878294|NCT00612105|580949846|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
160878295|NCT01105767|580949847|FG000|Overall Study|Lost to Follow-up|1160|||
160878296|NCT01105767|580949848|FG001|Overall Study|Lost to Follow-up|1614|||
160878297|NCT01105767|580949849|FG002|Overall Study|Lost to Follow-up|1184|||
160878298|NCT00475982|580949850|FG000|Overall Study|surgery rescheduled|7|||
160878299|NCT00475982|580949851|FG001|Overall Study|surgery rescheduled|3|||
160878300|NCT02410343|580949856|FG000|Core Period (24 Weeks)|Adverse Event|1|||
160878301|NCT02410343|580949857|FG001|Core Period (24 Weeks)|Adverse Event|0|||
160878302|NCT02410343|580949856|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
160878303|NCT02410343|580949857|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
160878304|NCT02410343|580949856|FG000|Extension Period (12 Months)|Adverse Event|1|||
160878305|NCT02410343|580949857|FG001|Extension Period (12 Months)|Adverse Event|0|||
160878306|NCT02410343|580949856|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
160878307|NCT02410343|580949857|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
160878308|NCT00029146|580949858|FG000|Overall Study|Lost to Follow-up|2|||
160878309|NCT00029146|580949859|FG001|Overall Study|Lost to Follow-up|1|||
160878310|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
160878311|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
160878312|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
160878313|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
160878314|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
160878315|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
160878316|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
160878317|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
160878318|NCT00946985|580949860|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
160878319|NCT00271505|580949861|FG000|Overall Study|Screen Failure|3|||
160878320|NCT00271505|580949861|FG000|Overall Study|Adverse Event|1|||
160878321|NCT00271505|580949861|FG000|Overall Study|Death|1|||
160878322|NCT04556383|580949862|FG000|PCP|Lack of Efficacy|28|||
160878323|NCT04556383|580949863|FG001|PCP|Lack of Efficacy|23|||
160538275|NCT00808236|579700529|FG000|Overall Study|Was not resuscitated|50|||
160878324|NCT04556383|580949864|FG002|PCP|Lack of Efficacy|23|||
160878325|NCT04556383|580949865|FG003|PCP|Lack of Efficacy|0|||
160878326|NCT04556383|580949862|FG000|PCP|Study terminated by sponsor|15|||
160878327|NCT04556383|580949863|FG001|PCP|Study terminated by sponsor|13|||
160878328|NCT04556383|580949864|FG002|PCP|Study terminated by sponsor|16|||
160878329|NCT04556383|580949865|FG003|PCP|Study terminated by sponsor|0|||
160878330|NCT04556383|580949862|FG000|PCP|Withdrawal by Subject|8|||
160538276|NCT00808236|579700530|FG001|Overall Study|Was not resuscitated|56|||
160878331|NCT04556383|580949863|FG001|PCP|Withdrawal by Subject|6|||
160878332|NCT04556383|580949864|FG002|PCP|Withdrawal by Subject|6|||
160878333|NCT04556383|580949865|FG003|PCP|Withdrawal by Subject|0|||
160878334|NCT04556383|580949862|FG000|PCP|Adverse Event|1|||
160878335|NCT04556383|580949863|FG001|PCP|Adverse Event|7|||
160878336|NCT04556383|580949864|FG002|PCP|Adverse Event|7|||
160878337|NCT04556383|580949865|FG003|PCP|Adverse Event|0|||
160878338|NCT04556383|580949862|FG000|PCP|Other, Not Specified|1|||
160878339|NCT04556383|580949863|FG001|PCP|Other, Not Specified|2|||
160878340|NCT04556383|580949864|FG002|PCP|Other, Not Specified|1|||
160878341|NCT04556383|580949865|FG003|PCP|Other, Not Specified|0|||
160878342|NCT04556383|580949862|FG000|PCP|Protocol Violation|1|||
160878343|NCT04556383|580949863|FG001|PCP|Protocol Violation|0|||
160878344|NCT04556383|580949864|FG002|PCP|Protocol Violation|1|||
160878345|NCT04556383|580949865|FG003|PCP|Protocol Violation|0|||
160878346|NCT04556383|580949862|FG000|PCP|Lost to Follow-up|1|||
160538277|NCT00808236|579700529|FG000|Overall Study|Pre-defined exclusion|13|||
160538278|NCT00808236|579700530|FG001|Overall Study|Pre-defined exclusion|3|||
160538279|NCT00808236|579700529|FG000|Overall Study|Lost to Follow-up|1|||
160538280|NCT00808236|579700530|FG001|Overall Study|Lost to Follow-up|1|||
160538281|NCT00808236|579700529|FG000|Overall Study|Physician Decision|0|||
160538282|NCT00808236|579700530|FG001|Overall Study|Physician Decision|1|||
160538283|NCT00808236|579700529|FG000|Overall Study|Death|18|||
160538284|NCT00808236|579700530|FG001|Overall Study|Death|30|||
160538285|NCT00961220|579700531|FG000|Overall Study|Adverse Event|3|||
160538286|NCT00961220|579700531|FG000|Overall Study|Lack of Efficacy|1|||
160538287|NCT00961220|579700531|FG000|Overall Study|No IV access for O6BG|1|||
160538288|NCT00961220|579700531|FG000|Overall Study|O6BG no longer supplied|1|||
160538289|NCT00961220|579700531|FG000|Overall Study|Complete Response prior to 12 courses|1|||
160538290|NCT05376215|579700532|FG000|Overall Study|Withdrawal by Subject|2|||
160538291|NCT05376215|579700533|FG001|Overall Study|Withdrawal by Subject|1|||
160538292|NCT05376215|579700532|FG000|Overall Study|Lost to Follow-up|0|||
160538293|NCT05376215|579700533|FG001|Overall Study|Lost to Follow-up|1|||
160538294|NCT01301950|579700534|FG000|Overall Study|Surgery was cancelled by patient|0|||
160538295|NCT01301950|579700535|FG001|Overall Study|Surgery was cancelled by patient|1|||
160538296|NCT00942175|579700536|FG000|Overall Study|Adverse Event|2|||
160538297|NCT00942175|579700537|FG001|Overall Study|Adverse Event|1|||
160538298|NCT00942175|579700538|FG002|Overall Study|Adverse Event|0|||
160538299|NCT00942175|579700539|FG003|Overall Study|Adverse Event|0|||
160538300|NCT00942175|579700536|FG000|Overall Study|Protocol Violation|0|||
160538301|NCT00942175|579700537|FG001|Overall Study|Protocol Violation|1|||
160538302|NCT00942175|579700538|FG002|Overall Study|Protocol Violation|2|||
160538303|NCT00942175|579700539|FG003|Overall Study|Protocol Violation|0|||
160538304|NCT00942175|579700536|FG000|Overall Study|Pregnancy|0|||
160538305|NCT00942175|579700537|FG001|Overall Study|Pregnancy|0|||
160538306|NCT00942175|579700538|FG002|Overall Study|Pregnancy|0|||
160538307|NCT00942175|579700539|FG003|Overall Study|Pregnancy|1|||
160538308|NCT00942175|579700536|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
160538309|NCT00942175|579700537|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
160538310|NCT00942175|579700538|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
160538311|NCT00942175|579700539|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
160538312|NCT00942175|579700536|FG000|Overall Study|Low Platelet Count|0|||
160538313|NCT00942175|579700537|FG001|Overall Study|Low Platelet Count|2|||
160538314|NCT00942175|579700538|FG002|Overall Study|Low Platelet Count|0|||
160538315|NCT00942175|579700539|FG003|Overall Study|Low Platelet Count|0|||
160538316|NCT01066585|579700540|FG000|Overall Study|Protocol Violation|1|||
160538317|NCT01066585|579700541|FG001|Overall Study|Protocol Violation|0|||
160538318|NCT01066585|579700540|FG000|Overall Study|Withdrawal by Subject|0|||
160538319|NCT01066585|579700541|FG001|Overall Study|Withdrawal by Subject|3|||
160538320|NCT04041284|579700543|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
160538321|NCT04041284|579700544|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
160538322|NCT04041284|579700543|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
160538323|NCT04041284|579700544|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
160538324|NCT04041284|579700543|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
160538325|NCT04041284|579700544|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
160538326|NCT04041284|579700543|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
160538327|NCT04041284|579700544|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
160538328|NCT04041284|579700543|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
160538329|NCT04041284|579700544|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
160538330|NCT04041284|579700543|FG000|DB Phase (12 Weeks)|Other than specified|1|||
160538331|NCT04041284|579700544|FG001|DB Phase (12 Weeks)|Other than specified|0|||
160538332|NCT04041284|579700543|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
160538333|NCT04041284|579700544|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
160538334|NCT04041284|579700543|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
160538335|NCT04041284|579700544|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
160538336|NCT04041284|579700543|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
160878347|NCT04556383|580949863|FG001|PCP|Lost to Follow-up|0|||
160878348|NCT04556383|580949864|FG002|PCP|Lost to Follow-up|0|||
160878349|NCT04556383|580949865|FG003|PCP|Lost to Follow-up|0|||
160878350|NCT04556383|580949862|FG000|PCP|Physician Decision|0|||
160538337|NCT04041284|579700544|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
160878351|NCT04556383|580949863|FG001|PCP|Physician Decision|1|||
160878352|NCT04556383|580949864|FG002|PCP|Physician Decision|0|||
160538338|NCT04041284|579700543|FG000|OL Phase (12 Weeks)|Other than specified|6|||
160538339|NCT04041284|579700544|FG001|OL Phase (12 Weeks)|Other than specified|2|||
160878353|NCT04556383|580949865|FG003|PCP|Physician Decision|0|||
160538340|NCT00886600|579700545|FG000|Double-blind Monotherapy|Adverse Event|1|||
160538341|NCT00886600|579700546|FG001|Double-blind Monotherapy|Adverse Event|1|||
160538342|NCT00886600|579700547|FG002|Double-blind Monotherapy|Adverse Event|1|||
160878354|NCT04556383|580949862|FG000|PCP|Site terminated by sponsor|0|||
160878355|NCT04556383|580949863|FG001|PCP|Site terminated by sponsor|1|||
160878356|NCT04556383|580949864|FG002|PCP|Site terminated by sponsor|0|||
160878357|NCT04556383|580949865|FG003|PCP|Site terminated by sponsor|0|||
160878358|NCT04556383|580949862|FG000|OLE|Study terminated by sponsor|0|||
160878359|NCT04556383|580949863|FG001|OLE|Study terminated by sponsor|0|||
160878360|NCT04556383|580949864|FG002|OLE|Study terminated by sponsor|0|||
160878361|NCT04556383|580949865|FG003|OLE|Study terminated by sponsor|68|||
160878362|NCT04556383|580949862|FG000|OLE|Withdrawal by Subject|0|||
160878363|NCT04556383|580949863|FG001|OLE|Withdrawal by Subject|0|||
160878364|NCT04556383|580949864|FG002|OLE|Withdrawal by Subject|0|||
160878365|NCT04556383|580949865|FG003|OLE|Withdrawal by Subject|10|||
160878366|NCT04556383|580949862|FG000|OLE|Lack of Efficacy|0|||
160878367|NCT04556383|580949863|FG001|OLE|Lack of Efficacy|0|||
160878368|NCT04556383|580949864|FG002|OLE|Lack of Efficacy|0|||
160878369|NCT04556383|580949865|FG003|OLE|Lack of Efficacy|7|||
160878370|NCT04556383|580949862|FG000|OLE|Adverse Event|0|||
160878371|NCT04556383|580949863|FG001|OLE|Adverse Event|0|||
160878372|NCT04556383|580949864|FG002|OLE|Adverse Event|0|||
160878373|NCT04556383|580949865|FG003|OLE|Adverse Event|2|||
160878374|NCT04556383|580949862|FG000|OLE|Other, Not Specified|0|||
160878375|NCT04556383|580949863|FG001|OLE|Other, Not Specified|0|||
160878376|NCT04556383|580949864|FG002|OLE|Other, Not Specified|0|||
160878377|NCT04556383|580949865|FG003|OLE|Other, Not Specified|2|||
160878378|NCT04556383|580949862|FG000|OLE|Death|0|||
160878379|NCT04556383|580949863|FG001|OLE|Death|0|||
160878380|NCT04556383|580949864|FG002|OLE|Death|0|||
160878381|NCT04556383|580949865|FG003|OLE|Death|1|||
160878382|NCT04556383|580949862|FG000|OLE|Lost to Follow-up|0|||
160878383|NCT04556383|580949863|FG001|OLE|Lost to Follow-up|0|||
160878384|NCT04556383|580949864|FG002|OLE|Lost to Follow-up|0|||
160878385|NCT04556383|580949865|FG003|OLE|Lost to Follow-up|1|||
160878386|NCT03704636|580949866|FG000|Overall Study|Inadequate Venous Flow|3|||
160878387|NCT02720042|580949867|FG000|Overall Study|Death|3|||
160878388|NCT02720042|580949867|FG000|Overall Study|Lost to Follow-up|4|||
160878389|NCT02720042|580949867|FG000|Overall Study|Withdrawal by Subject|1|||
160878390|NCT02720042|580949867|FG000|Overall Study|Physician Decision|3|||
160878391|NCT02720042|580949867|FG000|Overall Study|Phasix Mesh explanted|1|||
160878392|NCT02720042|580949867|FG000|Overall Study|unable due to non-study-related illness|3|||
160878393|NCT00539188|580949868|FG000|Overall Study|Withdrawal by Subject|1|||
160878394|NCT00539188|580949869|FG001|Overall Study|Withdrawal by Subject|0|||
160768715|NCT02855268|580540767|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
160768716|NCT02855268|580540768|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
160768717|NCT02855268|580540767|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
160768718|NCT02855268|580540768|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
160768719|NCT02855268|580540767|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
160768720|NCT02855268|580540768|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
160768721|NCT00726609|580540769|FG000|Overall Study|Adverse Event|10|||
160768722|NCT00726609|580540769|FG000|Overall Study|Withdrawal by Subject|2|||
160768723|NCT00726609|580540769|FG000|Overall Study|Lack of Efficacy|25|||
160768724|NCT00726609|580540769|FG000|Overall Study|Other|16|||
160768725|NCT00726609|580540769|FG000|Overall Study|Missing|42|||
160768726|NCT00726609|580540769|FG000|Overall Study|Other|3|||
160768727|NCT02029417|580540772|FG000|Overall Study|Death|1|||
160768728|NCT02029417|580540772|FG000|Overall Study|Adverse Event|1|||
160768729|NCT04458922|580540773|FG000|Overall Study|Withdrawal by Subject|1|||
160768730|NCT04458922|580540774|FG001|Overall Study|Withdrawal by Subject|0|||
160768731|NCT04458922|580540775|FG002|Overall Study|Withdrawal by Subject|2|||
160768732|NCT04458922|580540773|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
160768733|NCT04458922|580540774|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
160768734|NCT04458922|580540775|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
160768735|NCT04458922|580540773|FG000|Overall Study|Adverse Event|1|||
160768736|NCT04458922|580540774|FG001|Overall Study|Adverse Event|0|||
160768737|NCT04458922|580540775|FG002|Overall Study|Adverse Event|0|||
160768738|NCT04458922|580540773|FG000|Overall Study|Started new study|0|||
160768739|NCT04458922|580540774|FG001|Overall Study|Started new study|0|||
160878395|NCT00539188|580949868|FG000|Overall Study|Lost to Follow-up|2|||
160878396|NCT00539188|580949869|FG001|Overall Study|Lost to Follow-up|1|||
160878397|NCT00509145|580949870|FG000|Overall Study|Death|0|||
160878398|NCT00509145|580949871|FG001|Overall Study|Death|2|||
160538343|NCT00886600|579700548|FG003|Double-blind Monotherapy|Adverse Event|1|||
160538344|NCT00886600|579700545|FG000|Double-blind Monotherapy|Protocol Violation|0|||
160878399|NCT00509145|580949870|FG000|Overall Study|Adverse Event|42|||
160768740|NCT04458922|580540775|FG002|Overall Study|Started new study|1|||
160768741|NCT04458922|580540773|FG000|Overall Study|Progressive disease|6|||
160768742|NCT04458922|580540774|FG001|Overall Study|Progressive disease|8|||
160878400|NCT00509145|580949871|FG001|Overall Study|Adverse Event|28|||
160878401|NCT00509145|580949870|FG000|Overall Study|Withdrawal by Subject|32|||
160878402|NCT00509145|580949871|FG001|Overall Study|Withdrawal by Subject|38|||
160878403|NCT00509145|580949870|FG000|Overall Study|Physician Decision|11|||
160878404|NCT00509145|580949871|FG001|Overall Study|Physician Decision|14|||
160878405|NCT00509145|580949870|FG000|Overall Study|Protocol Violation|1|||
160878406|NCT00509145|580949871|FG001|Overall Study|Protocol Violation|6|||
160878407|NCT00509145|580949870|FG000|Overall Study|Pregnancy|3|||
160878408|NCT00509145|580949871|FG001|Overall Study|Pregnancy|8|||
160878409|NCT00509145|580949870|FG000|Overall Study|Lost to Follow-up|6|||
160878410|NCT00509145|580949871|FG001|Overall Study|Lost to Follow-up|5|||
160878411|NCT00509145|580949870|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
160878412|NCT00509145|580949871|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
160878413|NCT00509145|580949870|FG000|Overall Study|Other|6|||
160878414|NCT00509145|580949871|FG001|Overall Study|Other|6|||
160878415|NCT01994889|580949874|FG000|Overall Study|Adverse Event|5|||
160878416|NCT01994889|580949875|FG001|Overall Study|Adverse Event|12|||
160878417|NCT01994889|580949876|FG002|Overall Study|Adverse Event|11|||
160878418|NCT01994889|580949874|FG000|Overall Study|Cardiac Device Implantation|0|||
160878419|NCT01994889|580949875|FG001|Overall Study|Cardiac Device Implantation|2|||
160878420|NCT01994889|580949876|FG002|Overall Study|Cardiac Device Implantation|0|||
160878421|NCT01994889|580949874|FG000|Overall Study|Organ Transplantation|1|||
160538345|NCT00886600|579700546|FG001|Double-blind Monotherapy|Protocol Violation|0|||
160538346|NCT00886600|579700547|FG002|Double-blind Monotherapy|Protocol Violation|0|||
160538347|NCT00886600|579700548|FG003|Double-blind Monotherapy|Protocol Violation|1|||
160538348|NCT00886600|579700545|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
160538349|NCT00886600|579700546|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
160538350|NCT00886600|579700547|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
160538351|NCT00886600|579700548|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
160538352|NCT00886600|579700545|FG000|Combination Therapy Period|Adverse Event|0|||
160538353|NCT00886600|579700546|FG001|Combination Therapy Period|Adverse Event|0|||
160538354|NCT00886600|579700547|FG002|Combination Therapy Period|Adverse Event|1|||
160538355|NCT00886600|579700548|FG003|Combination Therapy Period|Adverse Event|0|||
160538356|NCT00886600|579700545|FG000|Combination Therapy Period|Protocol Violation|0|||
160538357|NCT00886600|579700546|FG001|Combination Therapy Period|Protocol Violation|0|||
160538358|NCT00886600|579700547|FG002|Combination Therapy Period|Protocol Violation|1|||
160538359|NCT00886600|579700548|FG003|Combination Therapy Period|Protocol Violation|0|||
160538360|NCT02016820|579700550|FG000|Overall Study|Lost to Follow-up|2|||
160538361|NCT02016820|579700551|FG001|Overall Study|Lost to Follow-up|4|||
160538362|NCT00884273|579700552|FG000|Overall Study|Adverse Event|0|||
160538363|NCT00884273|579700553|FG001|Overall Study|Adverse Event|2|||
160538364|NCT00884273|579700552|FG000|Overall Study|Protocol Violation|1|||
160538365|NCT00884273|579700553|FG001|Overall Study|Protocol Violation|3|||
160538366|NCT00884273|579700552|FG000|Overall Study|Practical reasons|1|||
160538367|NCT00884273|579700553|FG001|Overall Study|Practical reasons|0|||
160538368|NCT00578136|579700554|FG000|Overall Study|Not given intervention|1|||
160538369|NCT00578136|579700555|FG001|Overall Study|Not given intervention|1|||
160538370|NCT01840579|579700558|FG000|Overall Study|Status not recorded|0|||
160538371|NCT01840579|579700559|FG001|Overall Study|Status not recorded|0|||
160538372|NCT01840579|579700560|FG002|Overall Study|Status not recorded|2|||
160538373|NCT01840579|579700561|FG003|Overall Study|Status not recorded|3|||
160538374|NCT01840579|579700562|FG004|Overall Study|Status not recorded|4|||
160538375|NCT01840579|579700563|FG005|Overall Study|Status not recorded|3|||
160538376|NCT01840579|579700564|FG006|Overall Study|Status not recorded|0|||
160538377|NCT01840579|579700565|FG007|Overall Study|Status not recorded|3|||
160538378|NCT01840579|579700566|FG008|Overall Study|Status not recorded|3|||
160538379|NCT01840579|579700567|FG009|Overall Study|Status not recorded|3|||
160538380|NCT01840579|579700558|FG000|Overall Study|Progressive disease|3|||
160538381|NCT01840579|579700559|FG001|Overall Study|Progressive disease|5|||
160538382|NCT01840579|579700560|FG002|Overall Study|Progressive disease|0|||
160538383|NCT01840579|579700561|FG003|Overall Study|Progressive disease|0|||
160538384|NCT01840579|579700562|FG004|Overall Study|Progressive disease|0|||
160538385|NCT01840579|579700563|FG005|Overall Study|Progressive disease|0|||
160538386|NCT01840579|579700564|FG006|Overall Study|Progressive disease|0|||
160538387|NCT01840579|579700565|FG007|Overall Study|Progressive disease|0|||
160538388|NCT01840579|579700566|FG008|Overall Study|Progressive disease|0|||
160538389|NCT01840579|579700567|FG009|Overall Study|Progressive disease|0|||
160538390|NCT01840579|579700558|FG000|Overall Study|Ongoing in study|0|||
160538391|NCT01840579|579700559|FG001|Overall Study|Ongoing in study|1|||
160538392|NCT01840579|579700560|FG002|Overall Study|Ongoing in study|0|||
160538393|NCT01840579|579700561|FG003|Overall Study|Ongoing in study|0|||
160538394|NCT01840579|579700562|FG004|Overall Study|Ongoing in study|0|||
160538395|NCT01840579|579700563|FG005|Overall Study|Ongoing in study|0|||
160538396|NCT01840579|579700564|FG006|Overall Study|Ongoing in study|0|||
160538397|NCT01840579|579700565|FG007|Overall Study|Ongoing in study|0|||
160538398|NCT01840579|579700566|FG008|Overall Study|Ongoing in study|0|||
160538399|NCT01840579|579700567|FG009|Overall Study|Ongoing in study|0|||
160538400|NCT01840579|579700558|FG000|Overall Study|Death|0|||
160538401|NCT01840579|579700559|FG001|Overall Study|Death|0|||
160538402|NCT01840579|579700560|FG002|Overall Study|Death|0|||
160538403|NCT01840579|579700561|FG003|Overall Study|Death|0|||
160538404|NCT01840579|579700562|FG004|Overall Study|Death|0|||
160538405|NCT01840579|579700563|FG005|Overall Study|Death|1|||
160538406|NCT01840579|579700564|FG006|Overall Study|Death|0|||
160538407|NCT01840579|579700565|FG007|Overall Study|Death|0|||
160538408|NCT01840579|579700566|FG008|Overall Study|Death|0|||
160538409|NCT01840579|579700567|FG009|Overall Study|Death|0|||
160538410|NCT01840579|579700558|FG000|Overall Study|Adverse Event|0|||
160538411|NCT01840579|579700559|FG001|Overall Study|Adverse Event|1|||
160538412|NCT01840579|579700560|FG002|Overall Study|Adverse Event|0|||
160538413|NCT01840579|579700561|FG003|Overall Study|Adverse Event|0|||
160538414|NCT01840579|579700562|FG004|Overall Study|Adverse Event|0|||
160538415|NCT01840579|579700563|FG005|Overall Study|Adverse Event|0|||
160538416|NCT01840579|579700564|FG006|Overall Study|Adverse Event|0|||
160538417|NCT01840579|579700565|FG007|Overall Study|Adverse Event|0|||
160538418|NCT01840579|579700566|FG008|Overall Study|Adverse Event|0|||
160538419|NCT01840579|579700567|FG009|Overall Study|Adverse Event|0|||
160538420|NCT01840579|579700558|FG000|Overall Study|Follow-up ended by Sponsor|0|||
160538421|NCT01840579|579700559|FG001|Overall Study|Follow-up ended by Sponsor|0|||
160538422|NCT01840579|579700560|FG002|Overall Study|Follow-up ended by Sponsor|0|||
160538423|NCT01840579|579700561|FG003|Overall Study|Follow-up ended by Sponsor|0|||
160538424|NCT01840579|579700562|FG004|Overall Study|Follow-up ended by Sponsor|0|||
160538425|NCT01840579|579700563|FG005|Overall Study|Follow-up ended by Sponsor|0|||
160538426|NCT01840579|579700564|FG006|Overall Study|Follow-up ended by Sponsor|2|||
160538427|NCT01840579|579700565|FG007|Overall Study|Follow-up ended by Sponsor|0|||
160538428|NCT01840579|579700566|FG008|Overall Study|Follow-up ended by Sponsor|0|||
160538429|NCT01840579|579700567|FG009|Overall Study|Follow-up ended by Sponsor|0|||
160538430|NCT02437864|579700570|FG000|Overall Study|Protocol Violation|4|||
160538431|NCT02437864|579700571|FG001|Overall Study|Protocol Violation|0|||
160538432|NCT00645593|579700574|FG000|Overall Study|Later found to be ineligible|1|||
160538433|NCT00645593|579700575|FG001|Overall Study|Later found to be ineligible|0|||
160538434|NCT01585272|579700576|FG000|Overall Study|Adverse Event|22|||
160538435|NCT01585272|579700576|FG000|Overall Study|Protocol Violation|7|||
160538436|NCT01585272|579700576|FG000|Overall Study|Withdrawal by Subject|10|||
160538437|NCT04218201|579702220|FG000|Overall Study|Death|0|||
160538438|NCT04218201|579702221|FG001|Overall Study|Death|0|||
160538439|NCT04218201|579702222|FG002|Overall Study|Death|2|||
160538440|NCT04218201|579702223|FG003|Overall Study|Death|0|||
160538441|NCT04218201|579702220|FG000|Overall Study|Unable to contact participant|4|||
160538442|NCT04218201|579702221|FG001|Overall Study|Unable to contact participant|0|||
160538443|NCT04218201|579702222|FG002|Overall Study|Unable to contact participant|3|||
160538444|NCT04218201|579702223|FG003|Overall Study|Unable to contact participant|0|||
160538445|NCT04218201|579702220|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
160538446|NCT04218201|579702221|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
160538447|NCT04218201|579702222|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
160538448|NCT04218201|579702223|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
160538449|NCT04218201|579702220|FG000|Overall Study|Withdrawal by Subject|2|||
160538450|NCT04218201|579702221|FG001|Overall Study|Withdrawal by Subject|0|||
160538451|NCT04218201|579702222|FG002|Overall Study|Withdrawal by Subject|0|||
160538452|NCT04218201|579702223|FG003|Overall Study|Withdrawal by Subject|0|||
160538453|NCT04218201|579702220|FG000|Overall Study|PCP plans to leave practice|0|||
160538454|NCT04218201|579702221|FG001|Overall Study|PCP plans to leave practice|8|||
160538455|NCT04218201|579702222|FG002|Overall Study|PCP plans to leave practice|0|||
160538456|NCT04218201|579702223|FG003|Overall Study|PCP plans to leave practice|5|||
160538457|NCT04218201|579702220|FG000|Overall Study|Reduced panel|0|||
160538458|NCT04218201|579702221|FG001|Overall Study|Reduced panel|0|||
160538459|NCT04218201|579702222|FG002|Overall Study|Reduced panel|0|||
160538460|NCT04218201|579702223|FG003|Overall Study|Reduced panel|1|||
160538461|NCT04218201|579702220|FG000|Overall Study|No longer interested in participating|0|||
160538462|NCT04218201|579702221|FG001|Overall Study|No longer interested in participating|1|||
160538463|NCT04218201|579702222|FG002|Overall Study|No longer interested in participating|0|||
160538464|NCT04218201|579702223|FG003|Overall Study|No longer interested in participating|0|||
160538465|NCT04649255|579702224|FG000|Overall Study|Death|9|||
160538466|NCT04649255|579702224|FG000|Overall Study|Withdrawal by Subject|1|||
160538467|NCT02222207|579702225|FG000|Overall Study|Death|1|||
160538468|NCT02222207|579702225|FG000|Overall Study|Other reasons|2|||
160538469|NCT02222207|579702225|FG000|Overall Study|Adverse Event|1|||
160538470|NCT04682405|579702226|FG000|Overall Study|Adverse Event|0|||
160538471|NCT04682405|579702227|FG001|Overall Study|Adverse Event|1|||
160538472|NCT00747643|579702228|FG000|Overall Study|Withdrawal by Subject|36|||
160538473|NCT00747643|579702229|FG001|Overall Study|Withdrawal by Subject|27|||
160538474|NCT03557281|579702230|FG000|Overall Study|Investigator discretion|0|||
160538475|NCT03557281|579702231|FG001|Overall Study|Investigator discretion|0|||
160538476|NCT03557281|579702232|FG002|Overall Study|Investigator discretion|1|||
160538477|NCT03557281|579702233|FG003|Overall Study|Investigator discretion|0|||
160768743|NCT04458922|580540775|FG002|Overall Study|Progressive disease|2|||
160768744|NCT04458922|580540773|FG000|Overall Study|Death|1|||
160768745|NCT04458922|580540774|FG001|Overall Study|Death|0|||
160768746|NCT04458922|580540775|FG002|Overall Study|Death|2|||
160768747|NCT04458922|580540773|FG000|Overall Study|Participant started chemotherapy|0|||
160768748|NCT04458922|580540774|FG001|Overall Study|Participant started chemotherapy|1|||
160768749|NCT04458922|580540775|FG002|Overall Study|Participant started chemotherapy|0|||
160768750|NCT00465179|580540778|FG000|Overall Study|Adverse Event|4|||
160768751|NCT00465179|580540778|FG000|Overall Study|Withdrawal by Subject|2|||
160768752|NCT00465179|580540778|FG000|Overall Study|Progression of Disease|47|||
160768753|NCT00833755|580540781|FG000|Overall Study|Physician Decision|4|||
160768754|NCT00833755|580540782|FG001|Overall Study|Physician Decision|4|||
160878422|NCT01994889|580949875|FG001|Overall Study|Organ Transplantation|5|||
160878423|NCT01994889|580949876|FG002|Overall Study|Organ Transplantation|5|||
160878424|NCT01994889|580949874|FG000|Overall Study|No longer willing to participate|8|||
160878425|NCT01994889|580949875|FG001|Overall Study|No longer willing to participate|17|||
160878426|NCT01994889|580949876|FG002|Overall Study|No longer willing to participate|37|||
160878427|NCT01994889|580949874|FG000|Overall Study|Lost to Follow-up|0|||
160878428|NCT01994889|580949875|FG001|Overall Study|Lost to Follow-up|1|||
160878429|NCT01994889|580949876|FG002|Overall Study|Lost to Follow-up|0|||
160878430|NCT01994889|580949874|FG000|Overall Study|Protocol Violation|0|||
160878431|NCT01994889|580949875|FG001|Overall Study|Protocol Violation|1|||
160878432|NCT01994889|580949876|FG002|Overall Study|Protocol Violation|1|||
160878433|NCT01994889|580949874|FG000|Overall Study|Death|14|||
160878434|NCT01994889|580949875|FG001|Overall Study|Death|25|||
160878435|NCT01994889|580949876|FG002|Overall Study|Death|38|||
160878436|NCT00334113|580949881|FG000|Overall Study|Lost to Follow-up|2|||
160878437|NCT00334113|580949882|FG001|Overall Study|Lost to Follow-up|2|||
160878438|NCT00334113|580949881|FG000|Overall Study|Withdrawal by Subject|0|||
160878439|NCT00334113|580949882|FG001|Overall Study|Withdrawal by Subject|1|||
160878440|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
160878441|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
160878442|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
160878443|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
160878444|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Other|2|||
160878445|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
160878446|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
160878447|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
160878448|NCT02509026|580949887|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
160878449|NCT02509026|580949887|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
160878450|NCT02509026|580949887|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
160878451|NCT02509026|580949887|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
160878452|NCT02509026|580949887|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
160878453|NCT01165216|580949888|FG000|Overall Study|Adverse Event|6|||
160878454|NCT01165216|580949889|FG001|Overall Study|Adverse Event|3|||
160878455|NCT01165216|580949888|FG000|Overall Study|Withdrawal by Subject|1|||
160878456|NCT01165216|580949889|FG001|Overall Study|Withdrawal by Subject|1|||
160878457|NCT01165216|580949888|FG000|Overall Study|Disease progression|1|||
160878458|NCT01165216|580949889|FG001|Overall Study|Disease progression|3|||
160878459|NCT00243841|580949893|FG000|Overall Study|Physician Decision|0|||
160878460|NCT00243841|580949894|FG001|Overall Study|Physician Decision|0|||
160878461|NCT00243841|580949895|FG002|Overall Study|Physician Decision|1|||
160878462|NCT00243841|580949896|FG003|Overall Study|Physician Decision|0|||
160878463|NCT00243841|580949897|FG004|Overall Study|Physician Decision|0|||
160878464|NCT00243841|580949898|FG005|Overall Study|Physician Decision|2|||
160878465|NCT05601544|580949899|FG000|Phase 2 Period 1|Adverse Event|0|||
160878466|NCT05601544|580949900|FG001|Phase 2 Period 1|Adverse Event|1|||
160878467|NCT05601544|580949901|FG002|Phase 2 Period 1|Adverse Event|0|||
160878468|NCT05601544|580949902|FG003|Phase 2 Period 1|Adverse Event|0|||
160878469|NCT05601544|580949903|FG004|Phase 2 Period 1|Adverse Event|0|||
160878470|NCT05601544|580949904|FG005|Phase 2 Period 1|Adverse Event|0|||
160878471|NCT01601652|580949906|FG000|Overall Study|Death|1|||
160878472|NCT02537015|580949907|FG000|Overall Study|Adverse Event|3|||
160878473|NCT02537015|580949907|FG000|Overall Study|Withdrawal by Subject|2|||
160878474|NCT02537015|580949907|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160878475|NCT01808092|580949914|FG000|Overall Study|Death|39|||
160878476|NCT01808092|580949915|FG001|Overall Study|Death|29|||
160878477|NCT01808092|580949914|FG000|Overall Study|Lost to Follow-up|3|||
160878478|NCT01808092|580949915|FG001|Overall Study|Lost to Follow-up|7|||
160878479|NCT01808092|580949914|FG000|Overall Study|Withdrawal by Subject|9|||
160878480|NCT01808092|580949915|FG001|Overall Study|Withdrawal by Subject|4|||
160878481|NCT01808092|580949914|FG000|Overall Study|Other Eligibility criteria|3|||
160878482|NCT01808092|580949915|FG001|Overall Study|Other Eligibility criteria|5|||
160878483|NCT03865316|580952141|FG000|Overall Study|Procedure Cancelled|4|||
160878484|NCT03865316|580952141|FG000|Overall Study|Equipment failure|4|||
160878485|NCT01836276|580952145|FG000|Overall Study|Lost to Follow-up|28|||
160878486|NCT01836276|580952146|FG001|Overall Study|Lost to Follow-up|51|||
160878487|NCT02208063|580952153|FG000|Overall Study|Death|3|||
160878488|NCT02208063|580952154|FG001|Overall Study|Death|5|||
160878489|NCT02208063|580952153|FG000|Overall Study|Not Specified in report|3|||
160878490|NCT02208063|580952154|FG001|Overall Study|Not Specified in report|4|||
160878491|NCT02208063|580952153|FG000|Overall Study|Withdrawal by Subject|5|||
160878492|NCT02208063|580952154|FG001|Overall Study|Withdrawal by Subject|2|||
160878493|NCT02208063|580952153|FG000|Overall Study|Lost to Follow-up|1|||
160878494|NCT02208063|580952154|FG001|Overall Study|Lost to Follow-up|0|||
160878495|NCT00913458|580952155|FG000|Phase 1|Non-Responder|54|||
160878496|NCT00913458|580952156|FG001|Phase 1|Non-Responder|0|||
160878497|NCT00913458|580952157|FG002|Phase 1|Non-Responder|0|||
160878498|NCT00913458|580952158|FG003|Phase 1|Non-Responder|0|||
160878499|NCT00913458|580952159|FG004|Phase 1|Non-Responder|0|||
160538478|NCT03557281|579702234|FG004|Overall Study|Investigator discretion|0|||
160538479|NCT03557281|579702230|FG000|Overall Study|Withdrawal by Subject|0|||
160768755|NCT00833755|580540783|FG002|Overall Study|Physician Decision|2|||
160768756|NCT00833755|580540784|FG003|Overall Study|Physician Decision|6|||
160768757|NCT00833755|580540781|FG000|Overall Study|Subject had scheduling issues|0|||
160768758|NCT00833755|580540782|FG001|Overall Study|Subject had scheduling issues|1|||
160538480|NCT03557281|579702231|FG001|Overall Study|Withdrawal by Subject|1|||
160538481|NCT03557281|579702232|FG002|Overall Study|Withdrawal by Subject|1|||
160538482|NCT03557281|579702233|FG003|Overall Study|Withdrawal by Subject|1|||
160538483|NCT03557281|579702234|FG004|Overall Study|Withdrawal by Subject|2|||
160538484|NCT03557281|579702230|FG000|Overall Study|Randomized, but did not receive treatment|0|||
160538485|NCT03557281|579702231|FG001|Overall Study|Randomized, but did not receive treatment|0|||
160538486|NCT03557281|579702232|FG002|Overall Study|Randomized, but did not receive treatment|0|||
160538487|NCT03557281|579702233|FG003|Overall Study|Randomized, but did not receive treatment|0|||
160538488|NCT03557281|579702234|FG004|Overall Study|Randomized, but did not receive treatment|1|||
160538489|NCT01199042|579702235|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
160538490|NCT01199042|579702235|FG000|At Home (3 Months)|Lost to Follow-up|1|||
160538491|NCT03357731|579702240|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
160538492|NCT03357731|579702241|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
160538493|NCT03357731|579702242|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
160538494|NCT03357731|579702243|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
160538495|NCT03357731|579702244|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
160538496|NCT03357731|579702245|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
160538497|NCT03357731|579702240|FG000|Overall Study|Acute bradycardia and hypotension|0|||
160538498|NCT03357731|579702241|FG001|Overall Study|Acute bradycardia and hypotension|0|||
160538499|NCT03357731|579702242|FG002|Overall Study|Acute bradycardia and hypotension|0|||
160538500|NCT03357731|579702243|FG003|Overall Study|Acute bradycardia and hypotension|1|||
160538501|NCT03357731|579702244|FG004|Overall Study|Acute bradycardia and hypotension|0|||
160538502|NCT03357731|579702245|FG005|Overall Study|Acute bradycardia and hypotension|0|||
160538503|NCT03357731|579702240|FG000|Overall Study|Adverse Event|0|||
160538504|NCT03357731|579702241|FG001|Overall Study|Adverse Event|0|||
160538505|NCT03357731|579702242|FG002|Overall Study|Adverse Event|0|||
160538506|NCT03357731|579702243|FG003|Overall Study|Adverse Event|0|||
160538507|NCT03357731|579702244|FG004|Overall Study|Adverse Event|0|||
160538508|NCT03357731|579702245|FG005|Overall Study|Adverse Event|1|||
160538509|NCT03357731|579702240|FG000|Overall Study|Hypotension|0|||
160538510|NCT03357731|579702241|FG001|Overall Study|Hypotension|0|||
160538511|NCT03357731|579702242|FG002|Overall Study|Hypotension|1|||
160538512|NCT03357731|579702243|FG003|Overall Study|Hypotension|1|||
160538513|NCT03357731|579702244|FG004|Overall Study|Hypotension|0|||
160538514|NCT03357731|579702245|FG005|Overall Study|Hypotension|0|||
160538515|NCT03357731|579702240|FG000|Overall Study|Lost to Follow-up|0|||
160538516|NCT03357731|579702241|FG001|Overall Study|Lost to Follow-up|0|||
160538517|NCT03357731|579702242|FG002|Overall Study|Lost to Follow-up|0|||
160538518|NCT03357731|579702243|FG003|Overall Study|Lost to Follow-up|1|||
160768759|NCT00833755|580540783|FG002|Overall Study|Subject had scheduling issues|0|||
160768760|NCT00833755|580540784|FG003|Overall Study|Subject had scheduling issues|0|||
160768761|NCT06121609|580540785|FG000|Overall Study|Lack of Efficacy|0|||
160768762|NCT06121609|580540786|FG001|Overall Study|Lack of Efficacy|0|||
160768763|NCT06121609|580540787|FG002|Overall Study|Lack of Efficacy|45|||
160768764|NCT02867592|580540789|FG000|Overall Study|Adverse Event|3|||
160768765|NCT02867592|580540790|FG001|Overall Study|Adverse Event|0|||
160768766|NCT02867592|580540791|FG002|Overall Study|Adverse Event|2|||
160768767|NCT02867592|580540792|FG003|Overall Study|Adverse Event|1|||
160768768|NCT02867592|580540793|FG004|Overall Study|Adverse Event|1|||
160768769|NCT02867592|580540794|FG005|Overall Study|Adverse Event|5|||
160768770|NCT02867592|580540789|FG000|Overall Study|Death|0|||
160768771|NCT02867592|580540790|FG001|Overall Study|Death|0|||
160768772|NCT02867592|580540791|FG002|Overall Study|Death|0|||
160768773|NCT02867592|580540792|FG003|Overall Study|Death|1|||
160768774|NCT02867592|580540793|FG004|Overall Study|Death|0|||
160768775|NCT02867592|580540794|FG005|Overall Study|Death|1|||
160768776|NCT02867592|580540789|FG000|Overall Study|Lack of Efficacy|8|||
160768777|NCT02867592|580540790|FG001|Overall Study|Lack of Efficacy|10|||
160768778|NCT02867592|580540791|FG002|Overall Study|Lack of Efficacy|8|||
160768779|NCT02867592|580540792|FG003|Overall Study|Lack of Efficacy|8|||
160768780|NCT02867592|580540793|FG004|Overall Study|Lack of Efficacy|12|||
160768781|NCT02867592|580540794|FG005|Overall Study|Lack of Efficacy|17|||
160768782|NCT02867592|580540789|FG000|Overall Study|Physician Decision|1|||
160768783|NCT02867592|580540790|FG001|Overall Study|Physician Decision|2|||
160768784|NCT02867592|580540791|FG002|Overall Study|Physician Decision|2|||
160538519|NCT03357731|579702244|FG004|Overall Study|Lost to Follow-up|0|||
160538520|NCT03357731|579702245|FG005|Overall Study|Lost to Follow-up|0|||
160538521|NCT01773109|579702246|FG000|Overall Study|Symptomatic Progression|2|||
160538522|NCT01773109|579702246|FG000|Overall Study|Death|1|||
160538523|NCT01239342|579702247|FG000|Overall Study|Adverse Event|1|||
160538524|NCT01239342|579702248|FG001|Overall Study|Adverse Event|0|||
160878500|NCT00913458|580952160|FG005|Phase 1|Non-Responder|0|||
160878501|NCT00913458|580952161|FG006|Phase 1|Non-Responder|0|||
160878502|NCT00913458|580952155|FG000|Phase 1|Subject Request|17|||
160878503|NCT00913458|580952156|FG001|Phase 1|Subject Request|0|||
160878504|NCT00913458|580952157|FG002|Phase 1|Subject Request|0|||
160878505|NCT00913458|580952158|FG003|Phase 1|Subject Request|0|||
160878506|NCT00913458|580952159|FG004|Phase 1|Subject Request|0|||
160878507|NCT00913458|580952160|FG005|Phase 1|Subject Request|0|||
160878508|NCT00913458|580952161|FG006|Phase 1|Subject Request|0|||
160878509|NCT00913458|580952155|FG000|Phase 1|Adverse Event|20|||
160878510|NCT00913458|580952156|FG001|Phase 1|Adverse Event|0|||
160878511|NCT00913458|580952157|FG002|Phase 1|Adverse Event|0|||
160878512|NCT00913458|580952158|FG003|Phase 1|Adverse Event|0|||
160538525|NCT01239342|579702247|FG000|Overall Study|Withdrawal by Subject|1|||
160538526|NCT01239342|579702248|FG001|Overall Study|Withdrawal by Subject|5|||
160538527|NCT01239342|579702247|FG000|Overall Study|Reason Unknown|1|||
160538528|NCT01239342|579702248|FG001|Overall Study|Reason Unknown|1|||
160538529|NCT04036708|579702251|FG000|Overall Study|Lost to Follow-up|14|||
160538530|NCT04036708|579702252|FG001|Overall Study|Lost to Follow-up|4|||
160538531|NCT04036708|579702253|FG002|Overall Study|Lost to Follow-up|14|||
160538532|NCT04036708|579702254|FG003|Overall Study|Lost to Follow-up|4|||
160538533|NCT02918864|579702255|FG000|Overall Study|Withdrawal by Subject|1|||
160538534|NCT02918864|579702256|FG001|Overall Study|Withdrawal by Subject|1|||
160538535|NCT02918864|579702255|FG000|Overall Study|Lost to Follow-up|3|||
160538536|NCT02918864|579702256|FG001|Overall Study|Lost to Follow-up|2|||
160538537|NCT02104583|579702259|FG000|Overall Study|New ICD or CRT-D implanted|2|||
160538538|NCT02104583|579702260|FG001|Overall Study|New ICD or CRT-D implanted|0|||
160538539|NCT02104583|579702261|FG002|Overall Study|New ICD or CRT-D implanted|1|||
160538540|NCT02104583|579702262|FG003|Overall Study|New ICD or CRT-D implanted|0|||
160538541|NCT02104583|579702263|FG004|Overall Study|New ICD or CRT-D implanted|0|||
160538542|NCT02104583|579702259|FG000|Overall Study|Death|2|||
160538543|NCT02104583|579702260|FG001|Overall Study|Death|1|||
160538544|NCT02104583|579702261|FG002|Overall Study|Death|3|||
160538545|NCT02104583|579702262|FG003|Overall Study|Death|3|||
160538546|NCT02104583|579702263|FG004|Overall Study|Death|5|||
160538547|NCT02104583|579702259|FG000|Overall Study|Subject required cardiac ablation|6|||
160538548|NCT02104583|579702260|FG001|Overall Study|Subject required cardiac ablation|4|||
160538549|NCT02104583|579702261|FG002|Overall Study|Subject required cardiac ablation|4|||
160538550|NCT02104583|579702262|FG003|Overall Study|Subject required cardiac ablation|5|||
160538551|NCT02104583|579702263|FG004|Overall Study|Subject required cardiac ablation|4|||
160538552|NCT02104583|579702259|FG000|Overall Study|Subject required prohibited medication|0|||
160538553|NCT02104583|579702260|FG001|Overall Study|Subject required prohibited medication|1|||
160538554|NCT02104583|579702261|FG002|Overall Study|Subject required prohibited medication|1|||
160538555|NCT02104583|579702262|FG003|Overall Study|Subject required prohibited medication|0|||
160538556|NCT02104583|579702263|FG004|Overall Study|Subject required prohibited medication|1|||
160538557|NCT02104583|579702259|FG000|Overall Study|Withdrew Consent|3|||
160538558|NCT02104583|579702260|FG001|Overall Study|Withdrew Consent|2|||
160538559|NCT02104583|579702261|FG002|Overall Study|Withdrew Consent|0|||
160538560|NCT02104583|579702262|FG003|Overall Study|Withdrew Consent|2|||
160538561|NCT02104583|579702263|FG004|Overall Study|Withdrew Consent|1|||
160538562|NCT02104583|579702259|FG000|Overall Study|Investigator's Discretion|1|||
160538563|NCT02104583|579702260|FG001|Overall Study|Investigator's Discretion|0|||
160538564|NCT02104583|579702261|FG002|Overall Study|Investigator's Discretion|0|||
160538565|NCT02104583|579702262|FG003|Overall Study|Investigator's Discretion|0|||
160538566|NCT02104583|579702263|FG004|Overall Study|Investigator's Discretion|0|||
160538567|NCT02104583|579702259|FG000|Overall Study|Protocol Violation|0|||
160538568|NCT02104583|579702260|FG001|Overall Study|Protocol Violation|0|||
160538569|NCT02104583|579702261|FG002|Overall Study|Protocol Violation|1|||
160538570|NCT02104583|579702262|FG003|Overall Study|Protocol Violation|0|||
160538571|NCT02104583|579702263|FG004|Overall Study|Protocol Violation|0|||
160538572|NCT02104583|579702259|FG000|Overall Study|Adverse Event|3|||
160768785|NCT02867592|580540792|FG003|Overall Study|Physician Decision|0|||
160768786|NCT02867592|580540793|FG004|Overall Study|Physician Decision|5|||
160768787|NCT02867592|580540794|FG005|Overall Study|Physician Decision|1|||
160768788|NCT02867592|580540789|FG000|Overall Study|Protocol Violation|0|||
160768789|NCT02867592|580540790|FG001|Overall Study|Protocol Violation|0|||
160768790|NCT02867592|580540791|FG002|Overall Study|Protocol Violation|0|||
160768791|NCT02867592|580540792|FG003|Overall Study|Protocol Violation|0|||
160768792|NCT02867592|580540793|FG004|Overall Study|Protocol Violation|1|||
160768793|NCT02867592|580540794|FG005|Overall Study|Protocol Violation|1|||
160768794|NCT02867592|580540789|FG000|Overall Study|Withdrawal by Subject|0|||
160768795|NCT02867592|580540790|FG001|Overall Study|Withdrawal by Subject|1|||
160768796|NCT02867592|580540791|FG002|Overall Study|Withdrawal by Subject|0|||
160768797|NCT02867592|580540792|FG003|Overall Study|Withdrawal by Subject|1|||
160768798|NCT02867592|580540793|FG004|Overall Study|Withdrawal by Subject|3|||
160768799|NCT02867592|580540794|FG005|Overall Study|Withdrawal by Subject|3|||
160538573|NCT02104583|579702260|FG001|Overall Study|Adverse Event|3|||
160878513|NCT00913458|580952159|FG004|Phase 1|Adverse Event|0|||
160878514|NCT00913458|580952160|FG005|Phase 1|Adverse Event|0|||
160538574|NCT02104583|579702261|FG002|Overall Study|Adverse Event|6|||
160538575|NCT02104583|579702262|FG003|Overall Study|Adverse Event|6|||
160538576|NCT02104583|579702263|FG004|Overall Study|Adverse Event|1|||
160538577|NCT02104583|579702259|FG000|Overall Study|Lost to Follow-up|1|||
160538578|NCT02104583|579702260|FG001|Overall Study|Lost to Follow-up|0|||
160538579|NCT02104583|579702261|FG002|Overall Study|Lost to Follow-up|0|||
160538580|NCT02104583|579702262|FG003|Overall Study|Lost to Follow-up|0|||
160538581|NCT02104583|579702263|FG004|Overall Study|Lost to Follow-up|0|||
160538582|NCT02104583|579702259|FG000|Overall Study|Randomized but Never Treated|0|||
160538583|NCT02104583|579702260|FG001|Overall Study|Randomized but Never Treated|0|||
160538584|NCT02104583|579702261|FG002|Overall Study|Randomized but Never Treated|0|||
160538585|NCT02104583|579702262|FG003|Overall Study|Randomized but Never Treated|1|||
160538586|NCT02104583|579702263|FG004|Overall Study|Randomized but Never Treated|0|||
160538587|NCT00129766|579702264|FG000|Overall Study|Death|3|||
160538588|NCT00129766|579702265|FG001|Overall Study|Death|8|||
160538589|NCT00129766|579702264|FG000|Overall Study|Withdrawal of consent|31|||
160538590|NCT00129766|579702265|FG001|Overall Study|Withdrawal of consent|30|||
160538591|NCT00129766|579702264|FG000|Overall Study|Lost to Follow-up|26|||
160538592|NCT00129766|579702265|FG001|Overall Study|Lost to Follow-up|21|||
160538593|NCT01230307|579702267|FG000|Overall Study|LVAD Placement|0|||
160538594|NCT01230307|579702268|FG001|Overall Study|LVAD Placement|2|||
160538595|NCT04773106|579702269|FG000|Overall Study|Withdrawal by Subject|3|||
160538596|NCT04773106|579702269|FG000|Overall Study|Death|1|||
160768800|NCT02867592|580540789|FG000|Overall Study|Ineligible|1|||
160768801|NCT02867592|580540790|FG001|Overall Study|Ineligible|1|||
160768802|NCT02867592|580540791|FG002|Overall Study|Ineligible|0|||
160768803|NCT02867592|580540792|FG003|Overall Study|Ineligible|0|||
160768804|NCT02867592|580540793|FG004|Overall Study|Ineligible|2|||
160768805|NCT02867592|580540794|FG005|Overall Study|Ineligible|0|||
160768806|NCT02867592|580540789|FG000|Overall Study|No Treatment|1|||
160768807|NCT02867592|580540790|FG001|Overall Study|No Treatment|0|||
160768808|NCT02867592|580540791|FG002|Overall Study|No Treatment|0|||
160768809|NCT02867592|580540792|FG003|Overall Study|No Treatment|0|||
160768810|NCT02867592|580540793|FG004|Overall Study|No Treatment|0|||
160768811|NCT02867592|580540794|FG005|Overall Study|No Treatment|0|||
160768812|NCT02867592|580540789|FG000|Overall Study|Still on Therapy|0|||
160768813|NCT02867592|580540790|FG001|Overall Study|Still on Therapy|0|||
160768814|NCT02867592|580540791|FG002|Overall Study|Still on Therapy|0|||
160768815|NCT02867592|580540792|FG003|Overall Study|Still on Therapy|0|||
160768816|NCT02867592|580540793|FG004|Overall Study|Still on Therapy|1|||
160768817|NCT02867592|580540794|FG005|Overall Study|Still on Therapy|0|||
160768818|NCT02867592|580540789|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
160768819|NCT02867592|580540790|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
160768820|NCT02867592|580540791|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
160768821|NCT02867592|580540792|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
160768822|NCT02867592|580540793|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
160768823|NCT02867592|580540794|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
160768824|NCT02867592|580540789|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
160768825|NCT02867592|580540790|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
160768826|NCT02867592|580540791|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
160768827|NCT02867592|580540792|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
160768828|NCT02867592|580540793|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
160768829|NCT02867592|580540794|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
160768830|NCT00909870|580540795|FG000|Overall Study|Adverse Event|13|||
160768831|NCT00909870|580540796|FG001|Overall Study|Adverse Event|7|||
160768832|NCT00909870|580540795|FG000|Overall Study|Protocol Violation|1|||
160768833|NCT00909870|580540796|FG001|Overall Study|Protocol Violation|2|||
160768834|NCT00909870|580540795|FG000|Overall Study|Withdrawal by Subject|5|||
160768835|NCT00909870|580540796|FG001|Overall Study|Withdrawal by Subject|8|||
160768836|NCT00909870|580540795|FG000|Overall Study|Lost to Follow-up|3|||
160768837|NCT00909870|580540796|FG001|Overall Study|Lost to Follow-up|3|||
160768838|NCT00909870|580540795|FG000|Overall Study|Physician Decision|0|||
160768839|NCT00909870|580540796|FG001|Overall Study|Physician Decision|2|||
160768840|NCT00909870|580540795|FG000|Overall Study|Other|1|||
160768841|NCT00909870|580540796|FG001|Overall Study|Other|5|||
160768842|NCT00848497|580540797|FG000|Overall Study|Screen failure|2|||
160768843|NCT00848497|580540798|FG001|Overall Study|Screen failure|0|||
160768844|NCT00848497|580540797|FG000|Overall Study|Withdrawal by Subject|0|||
160768845|NCT00848497|580540798|FG001|Overall Study|Withdrawal by Subject|1|||
160768846|NCT01420536|580540809|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
160768847|NCT01420536|580540810|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
160768848|NCT00764790|580540811|FG000|Overall Study|Protocol Violation|0|||
160768849|NCT00764790|580540812|FG001|Overall Study|Protocol Violation|0|||
160878515|NCT00913458|580952161|FG006|Phase 1|Adverse Event|0|||
160878516|NCT00913458|580952155|FG000|Phase 1|Lost to Follow-up|2|||
160878517|NCT00913458|580952156|FG001|Phase 1|Lost to Follow-up|0|||
160878518|NCT00913458|580952157|FG002|Phase 1|Lost to Follow-up|0|||
160878519|NCT00913458|580952158|FG003|Phase 1|Lost to Follow-up|0|||
160878520|NCT00913458|580952159|FG004|Phase 1|Lost to Follow-up|0|||
160878521|NCT00913458|580952160|FG005|Phase 1|Lost to Follow-up|0|||
160878522|NCT00913458|580952161|FG006|Phase 1|Lost to Follow-up|0|||
160878523|NCT00913458|580952155|FG000|Phase 1|Protocol Violation|10|||
160878524|NCT00913458|580952156|FG001|Phase 1|Protocol Violation|0|||
160878525|NCT00913458|580952157|FG002|Phase 1|Protocol Violation|0|||
160878526|NCT00913458|580952158|FG003|Phase 1|Protocol Violation|0|||
160878527|NCT00913458|580952159|FG004|Phase 1|Protocol Violation|0|||
160878528|NCT00913458|580952160|FG005|Phase 1|Protocol Violation|0|||
160878529|NCT00913458|580952161|FG006|Phase 1|Protocol Violation|0|||
160878530|NCT00913458|580952155|FG000|Phase 1|Sponsor|2|||
160878531|NCT00913458|580952156|FG001|Phase 1|Sponsor|0|||
160878532|NCT00913458|580952157|FG002|Phase 1|Sponsor|0|||
160878533|NCT00913458|580952158|FG003|Phase 1|Sponsor|0|||
160878534|NCT00913458|580952159|FG004|Phase 1|Sponsor|0|||
160878535|NCT00913458|580952160|FG005|Phase 1|Sponsor|0|||
160878536|NCT00913458|580952161|FG006|Phase 1|Sponsor|0|||
160878537|NCT00913458|580952155|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
160878538|NCT00913458|580952156|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
160878539|NCT00913458|580952157|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
160878540|NCT00913458|580952158|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
160878541|NCT00913458|580952159|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
160878542|NCT00913458|580952160|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
160878543|NCT00913458|580952161|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
160878544|NCT00913458|580952155|FG000|Phase 2|Non-Responder|0|||
160878545|NCT00913458|580952156|FG001|Phase 2|Non-Responder|5|||
160878546|NCT00913458|580952157|FG002|Phase 2|Non-Responder|7|||
160878547|NCT00913458|580952158|FG003|Phase 2|Non-Responder|12|||
160878548|NCT00913458|580952159|FG004|Phase 2|Non-Responder|0|||
160878549|NCT00913458|580952160|FG005|Phase 2|Non-Responder|0|||
160878550|NCT00913458|580952161|FG006|Phase 2|Non-Responder|0|||
160878551|NCT00913458|580952155|FG000|Phase 2|Subject Request|0|||
160878552|NCT00913458|580952156|FG001|Phase 2|Subject Request|0|||
160878553|NCT00913458|580952157|FG002|Phase 2|Subject Request|1|||
160878554|NCT00913458|580952158|FG003|Phase 2|Subject Request|2|||
160878555|NCT00913458|580952159|FG004|Phase 2|Subject Request|0|||
160878556|NCT00913458|580952160|FG005|Phase 2|Subject Request|0|||
160878557|NCT00913458|580952161|FG006|Phase 2|Subject Request|0|||
160878558|NCT00913458|580952155|FG000|Phase 2|Adverse Event|0|||
160878559|NCT00913458|580952156|FG001|Phase 2|Adverse Event|3|||
160878560|NCT00913458|580952157|FG002|Phase 2|Adverse Event|0|||
160878561|NCT00913458|580952158|FG003|Phase 2|Adverse Event|1|||
160878562|NCT00913458|580952159|FG004|Phase 2|Adverse Event|0|||
160878563|NCT00913458|580952160|FG005|Phase 2|Adverse Event|0|||
160878564|NCT00913458|580952161|FG006|Phase 2|Adverse Event|0|||
160878565|NCT00913458|580952155|FG000|Phase 2|Lost to Follow-up|0|||
160878566|NCT00913458|580952156|FG001|Phase 2|Lost to Follow-up|0|||
160878567|NCT00913458|580952157|FG002|Phase 2|Lost to Follow-up|0|||
160878568|NCT00913458|580952158|FG003|Phase 2|Lost to Follow-up|1|||
160878569|NCT00913458|580952159|FG004|Phase 2|Lost to Follow-up|0|||
160878570|NCT00913458|580952160|FG005|Phase 2|Lost to Follow-up|0|||
160878571|NCT00913458|580952161|FG006|Phase 2|Lost to Follow-up|0|||
160878572|NCT00913458|580952155|FG000|Phase 2|Protocol Violation|0|||
160878573|NCT00913458|580952156|FG001|Phase 2|Protocol Violation|2|||
160878574|NCT00913458|580952157|FG002|Phase 2|Protocol Violation|0|||
160878575|NCT00913458|580952158|FG003|Phase 2|Protocol Violation|0|||
160878576|NCT00913458|580952159|FG004|Phase 2|Protocol Violation|0|||
160878577|NCT00913458|580952160|FG005|Phase 2|Protocol Violation|0|||
160878578|NCT00913458|580952161|FG006|Phase 2|Protocol Violation|0|||
160878579|NCT00913458|580952155|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
160878580|NCT00913458|580952156|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
160878581|NCT00913458|580952157|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
160878582|NCT00913458|580952158|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
160878583|NCT00913458|580952159|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
160878584|NCT00913458|580952160|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
160878585|NCT00913458|580952161|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
160878586|NCT00913458|580952155|FG000|Phase 3|Adverse Event|0|||
160878587|NCT00913458|580952156|FG001|Phase 3|Adverse Event|0|||
160878588|NCT00913458|580952157|FG002|Phase 3|Adverse Event|0|||
160878589|NCT00913458|580952158|FG003|Phase 3|Adverse Event|0|||
160878590|NCT00913458|580952159|FG004|Phase 3|Adverse Event|5|||
160878591|NCT00913458|580952160|FG005|Phase 3|Adverse Event|4|||
160878592|NCT00913458|580952161|FG006|Phase 3|Adverse Event|1|||
160878593|NCT00913458|580952155|FG000|Phase 3|Lost to Follow-up|0|||
160878594|NCT00913458|580952156|FG001|Phase 3|Lost to Follow-up|0|||
160878595|NCT00913458|580952157|FG002|Phase 3|Lost to Follow-up|0|||
160878596|NCT00913458|580952158|FG003|Phase 3|Lost to Follow-up|0|||
160878597|NCT00913458|580952159|FG004|Phase 3|Lost to Follow-up|2|||
160878598|NCT00913458|580952160|FG005|Phase 3|Lost to Follow-up|0|||
160878599|NCT00913458|580952161|FG006|Phase 3|Lost to Follow-up|0|||
160878600|NCT00913458|580952155|FG000|Phase 3|Non-Responder|0|||
160878601|NCT00913458|580952156|FG001|Phase 3|Non-Responder|0|||
160878602|NCT00913458|580952157|FG002|Phase 3|Non-Responder|0|||
160878603|NCT00913458|580952158|FG003|Phase 3|Non-Responder|0|||
160878604|NCT00913458|580952159|FG004|Phase 3|Non-Responder|0|||
160878605|NCT00913458|580952160|FG005|Phase 3|Non-Responder|1|||
160878606|NCT00913458|580952161|FG006|Phase 3|Non-Responder|3|||
160878607|NCT00913458|580952155|FG000|Phase 3|Withdrawal by Subject|0|||
160878608|NCT00913458|580952156|FG001|Phase 3|Withdrawal by Subject|0|||
160878609|NCT00913458|580952157|FG002|Phase 3|Withdrawal by Subject|0|||
160878610|NCT00913458|580952158|FG003|Phase 3|Withdrawal by Subject|0|||
160878611|NCT00913458|580952159|FG004|Phase 3|Withdrawal by Subject|1|||
160878612|NCT00913458|580952160|FG005|Phase 3|Withdrawal by Subject|2|||
160878613|NCT00913458|580952161|FG006|Phase 3|Withdrawal by Subject|0|||
160878614|NCT00913458|580952155|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
160878615|NCT00913458|580952156|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
160878616|NCT00913458|580952157|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
160878617|NCT00913458|580952158|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
160878618|NCT00913458|580952159|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
160878619|NCT00913458|580952160|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
160878620|NCT00913458|580952161|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
160878621|NCT02366091|580952162|FG000|Overall Study|Withdrawal by Subject|3|||
160878622|NCT02366091|580952163|FG001|Overall Study|Withdrawal by Subject|7|||
160878623|NCT02366091|580952164|FG002|Overall Study|Withdrawal by Subject|3|||
160878624|NCT02366091|580952165|FG003|Overall Study|Withdrawal by Subject|1|||
160878625|NCT02338232|580952166|FG000|Overall Study|Screen Failure|3|||
160878626|NCT02338232|580952166|FG000|Overall Study|Withdrawal by Subject|6|||
160878627|NCT02338232|580952166|FG000|Overall Study|Adverse Event|2|||
160878628|NCT03890666|580952167|FG000|Overall Study|Withdrawal by Subject|0|||
160878629|NCT03890666|580952168|FG001|Overall Study|Withdrawal by Subject|1|||
160878630|NCT03890666|580952167|FG000|Overall Study|Protocol deviation|1|||
160878631|NCT03890666|580952168|FG001|Overall Study|Protocol deviation|4|||
160878632|NCT03890666|580952167|FG000|Overall Study|Lost to Follow-up|2|||
160878633|NCT03890666|580952168|FG001|Overall Study|Lost to Follow-up|5|||
160878634|NCT03890666|580952167|FG000|Overall Study|Other than specified|1|||
160878635|NCT03890666|580952168|FG001|Overall Study|Other than specified|8|||
160878636|NCT01105065|580952169|FG000|Overall Study|Adverse Event|5|||
160878637|NCT01105065|580952169|FG000|Overall Study|Technical Problems|1|||
160878638|NCT02122783|580952173|FG000|Overall Study|Adverse Event|0|||
160878639|NCT02122783|580952174|FG001|Overall Study|Adverse Event|1|||
160878640|NCT00322621|580952175|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
160878641|NCT00322621|580952176|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
160878642|NCT00322621|580952177|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
160878643|NCT00322621|580952175|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
160878644|NCT00322621|580952176|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
160878645|NCT00322621|580952177|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
160878646|NCT00322621|580952175|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
160878647|NCT00322621|580952176|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
160878648|NCT00322621|580952177|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
160878649|NCT00322621|580952175|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
160878650|NCT00322621|580952176|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
160878651|NCT00322621|580952177|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
160878652|NCT00322621|580952175|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
160878653|NCT00322621|580952176|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
160878654|NCT00322621|580952177|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
160878655|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
160878656|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
160878657|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
160878658|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
160878659|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
160878660|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
160878661|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
160878662|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
160878663|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
160878664|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
160878665|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
160878666|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
160538597|NCT02819635|579702270|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
160538598|NCT02819635|579702271|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
160538599|NCT02819635|579702272|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
160768850|NCT00764790|580540813|FG002|Overall Study|Protocol Violation|1|||
160768851|NCT00764790|580540811|FG000|Overall Study|Withdrawal by Subject|10|||
160768852|NCT00764790|580540812|FG001|Overall Study|Withdrawal by Subject|12|||
160768853|NCT00764790|580540813|FG002|Overall Study|Withdrawal by Subject|6|||
160768854|NCT00764790|580540811|FG000|Overall Study|Lost to Follow-up|28|||
160768855|NCT00764790|580540812|FG001|Overall Study|Lost to Follow-up|29|||
160768856|NCT00764790|580540813|FG002|Overall Study|Lost to Follow-up|23|||
160768857|NCT04935879|580540814|FG000|Overall Study|Adverse Event|2|||
160768858|NCT04935879|580540815|FG001|Overall Study|Adverse Event|1|||
160768859|NCT04935879|580540814|FG000|Overall Study|Lost to Follow-up|1|||
160768860|NCT04935879|580540815|FG001|Overall Study|Lost to Follow-up|1|||
160768861|NCT04935879|580540814|FG000|Overall Study|Pregnancy|2|||
160768862|NCT04935879|580540815|FG001|Overall Study|Pregnancy|3|||
160768863|NCT04935879|580540814|FG000|Overall Study|Withdrawal by Subject|8|||
160768864|NCT04935879|580540815|FG001|Overall Study|Withdrawal by Subject|6|||
160768865|NCT04935879|580540814|FG000|Overall Study|Other|3|||
160768866|NCT04935879|580540815|FG001|Overall Study|Other|3|||
160768867|NCT03054428|580540816|FG000|Overall Study|Physician Decision|0|||
160768868|NCT03054428|580540817|FG001|Overall Study|Physician Decision|1|||
160768869|NCT03054428|580540818|FG002|Overall Study|Physician Decision|1|||
160768870|NCT03054428|580540816|FG000|Overall Study|Lack of Efficacy|3|||
160768871|NCT03054428|580540817|FG001|Overall Study|Lack of Efficacy|1|||
160768872|NCT03054428|580540818|FG002|Overall Study|Lack of Efficacy|0|||
160768873|NCT03054428|580540816|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
160768874|NCT03054428|580540817|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
160768875|NCT03054428|580540818|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
160768876|NCT03054428|580540816|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
160768877|NCT03054428|580540817|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
160768878|NCT03054428|580540818|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
160768879|NCT03054428|580540816|FG000|Overall Study|Transitioned to OLE study|76|||
160768880|NCT03054428|580540817|FG001|Overall Study|Transitioned to OLE study|76|||
160768881|NCT03054428|580540818|FG002|Overall Study|Transitioned to OLE study|73|||
160768882|NCT03054428|580540816|FG000|Overall Study|Withdrawal by Subject|3|||
160768883|NCT03054428|580540817|FG001|Overall Study|Withdrawal by Subject|2|||
160768884|NCT03054428|580540818|FG002|Overall Study|Withdrawal by Subject|3|||
160768885|NCT03054428|580540816|FG000|Overall Study|Lost to Follow-up|0|||
160768886|NCT03054428|580540817|FG001|Overall Study|Lost to Follow-up|0|||
160768887|NCT03054428|580540818|FG002|Overall Study|Lost to Follow-up|1|||
160768888|NCT01652690|580540819|FG000|Overall Study|Withdrawal by Subject|16|||
160768889|NCT01652690|580540820|FG001|Overall Study|Withdrawal by Subject|4|||
160768890|NCT01652690|580540819|FG000|Overall Study|Other|8|||
160768891|NCT01652690|580540820|FG001|Overall Study|Other|9|||
160768892|NCT01652690|580540819|FG000|Overall Study|Lost to Follow-up|6|||
160768893|NCT01652690|580540820|FG001|Overall Study|Lost to Follow-up|6|||
160768894|NCT01652690|580540819|FG000|Overall Study|Death|5|||
160768895|NCT01652690|580540820|FG001|Overall Study|Death|2|||
160768896|NCT03225287|580540823|FG000|Overall Study|Adverse Event|0|||
160768897|NCT03225287|580540824|FG001|Overall Study|Adverse Event|0|||
160768898|NCT03225287|580540825|FG002|Overall Study|Adverse Event|1|||
160768899|NCT03225287|580540823|FG000|Overall Study|Protocol non-compliance|0|||
160768900|NCT03225287|580540824|FG001|Overall Study|Protocol non-compliance|0|||
160768901|NCT03225287|580540825|FG002|Overall Study|Protocol non-compliance|1|||
160768902|NCT03225287|580540823|FG000|Overall Study|Subject withdraws consent|3|||
160768903|NCT03225287|580540824|FG001|Overall Study|Subject withdraws consent|0|||
160768904|NCT03225287|580540825|FG002|Overall Study|Subject withdraws consent|0|||
160768905|NCT03225287|580540823|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
160768906|NCT03225287|580540824|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
160768907|NCT03225287|580540825|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
160768908|NCT03225287|580540823|FG000|Overall Study|Trial drug not effective|0|||
160768909|NCT03225287|580540824|FG001|Overall Study|Trial drug not effective|1|||
160768910|NCT03225287|580540825|FG002|Overall Study|Trial drug not effective|0|||
160768911|NCT03225287|580540823|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
160768912|NCT03225287|580540824|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
160768913|NCT03225287|580540825|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
160768914|NCT03225287|580540823|FG000|Overall Study|Stem cell transplantation|0|||
160768915|NCT03225287|580540824|FG001|Overall Study|Stem cell transplantation|1|||
160768916|NCT03225287|580540825|FG002|Overall Study|Stem cell transplantation|0|||
160768917|NCT06070610|580540827|FG000|Washout period|Adverse Event|1|||
160768918|NCT06070610|580540827|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
160768919|NCT00834041|580540828|FG000|Overall Study|Withdrawal by Subject|1|||
160538600|NCT02819635|579702273|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
160768920|NCT00834041|580540829|FG001|Overall Study|Withdrawal by Subject|0|||
160768921|NCT00834041|580540828|FG000|Overall Study|Lost to Follow-up|0|||
160878667|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
160878668|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
160878669|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
160878670|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
160878671|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
160878672|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
160878673|NCT02238067|580952180|FG000|Overall Study|Not completed survey at Month 6|45|||
160878674|NCT02213133|580952184|FG000|Overall Study|Participant discontinued study therapy|2|||
160878675|NCT02213133|580952185|FG001|Overall Study|Participant discontinued study therapy|0|||
160878676|NCT02213133|580952186|FG002|Overall Study|Participant discontinued study therapy|0|||
160878677|NCT02213133|580952184|FG000|Overall Study|Participant withdrew informed consent|2|||
160878678|NCT02213133|580952185|FG001|Overall Study|Participant withdrew informed consent|1|||
160878679|NCT02213133|580952186|FG002|Overall Study|Participant withdrew informed consent|2|||
160878680|NCT02213133|580952184|FG000|Overall Study|Disease progression|11|||
160878681|NCT02213133|580952185|FG001|Overall Study|Disease progression|2|||
160878682|NCT02213133|580952186|FG002|Overall Study|Disease progression|0|||
160878683|NCT02213133|580952184|FG000|Overall Study|Adverse Event (AE)|1|||
160878684|NCT02213133|580952185|FG001|Overall Study|Adverse Event (AE)|0|||
160878685|NCT02213133|580952186|FG002|Overall Study|Adverse Event (AE)|0|||
160878686|NCT02213133|580952184|FG000|Overall Study|Death|16|||
160878687|NCT02213133|580952185|FG001|Overall Study|Death|2|||
160878688|NCT02213133|580952186|FG002|Overall Study|Death|1|||
160878689|NCT02213133|580952184|FG000|Overall Study|Other|5|||
160878690|NCT02213133|580952185|FG001|Overall Study|Other|0|||
160878691|NCT02213133|580952186|FG002|Overall Study|Other|0|||
160878692|NCT02350764|580952187|FG000|Overall Study|Adverse Event|4|||
160878693|NCT02350764|580952187|FG000|Overall Study|Death|3|||
160878694|NCT02350764|580952187|FG000|Overall Study|Physician Decision|2|||
160878695|NCT02350764|580952187|FG000|Overall Study|Withdrawal by Subject|2|||
160878696|NCT02743611|580952188|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
160878697|NCT02743611|580952189|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
160878698|NCT02743611|580952190|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
160878699|NCT02743611|580952191|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
160878700|NCT01433289|580952192|FG000|Overall Study|Pregnancy|0|||
160878701|NCT01433289|580952193|FG001|Overall Study|Pregnancy|1|||
160878702|NCT01433289|580952194|FG002|Overall Study|Pregnancy|0|||
160878703|NCT01433289|580952195|FG003|Overall Study|Pregnancy|0|||
160878704|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
160878705|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
160878706|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
160878707|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
160878708|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
160878709|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
160878710|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160878711|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
160538601|NCT02819635|579702274|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
160538602|NCT02819635|579702275|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
160538603|NCT02819635|579702276|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
160538604|NCT02819635|579702277|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
160538605|NCT02819635|579702278|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
160538606|NCT02819635|579702279|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
160538607|NCT02819635|579702280|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
160538608|NCT02819635|579702281|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
160538609|NCT02819635|579702270|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
160538610|NCT02819635|579702271|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
160538611|NCT02819635|579702272|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
160878712|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
160878713|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160878714|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160878715|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160878716|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
160878717|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
160878718|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
160538612|NCT02819635|579702273|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
160538613|NCT02819635|579702274|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
160538614|NCT02819635|579702275|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
160538615|NCT02819635|579702276|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
160538616|NCT02819635|579702277|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
160538617|NCT02819635|579702278|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
160636631|NCT01488071|580051585|FG001|Overall Study|Lack of Efficacy|17|||
160878719|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
160878720|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
160878721|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
160878722|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
160878723|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
160878724|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
160878725|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
160878726|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
160878727|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
160878728|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
160878729|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
160878730|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
160878731|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
160878732|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
160878733|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
160878734|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
160878735|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
160878736|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
160878737|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
160878738|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
160878739|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
160878740|NCT00600119|580952196|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
160878741|NCT00600119|580952197|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
160878742|NCT00600119|580952198|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160878743|NCT00600119|580952199|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
160878744|NCT00600119|580952200|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
160878745|NCT00600119|580952201|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
160878746|NCT00600119|580952196|FG000|Double-blind Treatment Period|Other|0|||
160878747|NCT00600119|580952197|FG001|Double-blind Treatment Period|Other|0|||
160878748|NCT00600119|580952198|FG002|Double-blind Treatment Period|Other|0|||
160878749|NCT00600119|580952199|FG003|Double-blind Treatment Period|Other|0|||
160878750|NCT00600119|580952200|FG004|Double-blind Treatment Period|Other|2|||
160878751|NCT00600119|580952201|FG005|Double-blind Treatment Period|Other|1|||
160878752|NCT00600119|580952196|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
160878753|NCT00600119|580952197|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
160878754|NCT00600119|580952198|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
160878755|NCT00600119|580952199|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
160878756|NCT00600119|580952200|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
160878757|NCT00600119|580952201|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
160878758|NCT00600119|580952196|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
160878759|NCT00600119|580952197|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
160878760|NCT00600119|580952198|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
160878761|NCT00600119|580952199|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
160878762|NCT00600119|580952200|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
160878763|NCT00600119|580952201|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
160878764|NCT00600119|580952196|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
160878765|NCT00600119|580952197|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
160878766|NCT00600119|580952198|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
160878767|NCT00600119|580952199|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
160878768|NCT00600119|580952200|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
160878769|NCT00600119|580952201|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
160878770|NCT00600119|580952196|FG000|Double-blind Treatment Period|Physician Decision|2|||
160878771|NCT00600119|580952197|FG001|Double-blind Treatment Period|Physician Decision|0|||
160878772|NCT00600119|580952198|FG002|Double-blind Treatment Period|Physician Decision|0|||
160878773|NCT00600119|580952199|FG003|Double-blind Treatment Period|Physician Decision|0|||
160878774|NCT00600119|580952200|FG004|Double-blind Treatment Period|Physician Decision|0|||
160878775|NCT00600119|580952201|FG005|Double-blind Treatment Period|Physician Decision|0|||
160878776|NCT00600119|580952196|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
160878777|NCT00600119|580952197|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
160878778|NCT00600119|580952198|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
160878779|NCT00600119|580952199|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
160878780|NCT00600119|580952200|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
160878781|NCT00600119|580952201|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
160878782|NCT00600119|580952196|FG000|Double-blind Treatment Period|Adverse Event|1|||
160878783|NCT00600119|580952197|FG001|Double-blind Treatment Period|Adverse Event|1|||
160878784|NCT00600119|580952198|FG002|Double-blind Treatment Period|Adverse Event|0|||
160878785|NCT00600119|580952199|FG003|Double-blind Treatment Period|Adverse Event|1|||
160878786|NCT00600119|580952200|FG004|Double-blind Treatment Period|Adverse Event|2|||
160878787|NCT00600119|580952201|FG005|Double-blind Treatment Period|Adverse Event|10|||
160878788|NCT00600119|580952196|FG000|Follow-up Period|Adverse Event|0|||
160878789|NCT00600119|580952197|FG001|Follow-up Period|Adverse Event|0|||
160878790|NCT00600119|580952198|FG002|Follow-up Period|Adverse Event|0|||
160878791|NCT00600119|580952199|FG003|Follow-up Period|Adverse Event|0|||
160878792|NCT00600119|580952200|FG004|Follow-up Period|Adverse Event|0|||
160878793|NCT00600119|580952201|FG005|Follow-up Period|Adverse Event|1|||
160878794|NCT00600119|580952196|FG000|Follow-up Period|Other|1|||
160878795|NCT00600119|580952197|FG001|Follow-up Period|Other|0|||
160878796|NCT00600119|580952198|FG002|Follow-up Period|Other|0|||
160878797|NCT00600119|580952199|FG003|Follow-up Period|Other|0|||
160878798|NCT00600119|580952200|FG004|Follow-up Period|Other|0|||
160878799|NCT00600119|580952201|FG005|Follow-up Period|Other|0|||
160878800|NCT00729469|580952202|FG000|Overall Study|Adverse Event|14|||
160878801|NCT00729469|580952203|FG001|Overall Study|Adverse Event|25|||
160878802|NCT00729469|580952202|FG000|Overall Study|Lost to Follow-up|9|||
160878803|NCT00729469|580952203|FG001|Overall Study|Lost to Follow-up|9|||
160878804|NCT00729469|580952202|FG000|Overall Study|Protocol Violation|2|||
160878805|NCT00729469|580952203|FG001|Overall Study|Protocol Violation|1|||
160878806|NCT00729469|580952202|FG000|Overall Study|Withdrawal by Subject|19|||
160878807|NCT00729469|580952203|FG001|Overall Study|Withdrawal by Subject|8|||
160878808|NCT00729469|580952202|FG000|Overall Study|Other-Not mentioned|9|||
160878809|NCT00729469|580952203|FG001|Overall Study|Other-Not mentioned|4|||
160878810|NCT00561977|580952204|FG000|Overall Study|Withdrawal by Subject|0|||
160878811|NCT00561977|580952205|FG001|Overall Study|Withdrawal by Subject|2|||
160878812|NCT00561977|580952206|FG002|Overall Study|Withdrawal by Subject|1|||
160878813|NCT00561977|580952204|FG000|Overall Study|Pregnancy|0|||
160878814|NCT00561977|580952205|FG001|Overall Study|Pregnancy|1|||
160878815|NCT00561977|580952206|FG002|Overall Study|Pregnancy|1|||
160878816|NCT00566696|580952207|FG000|Overall Study|Met Exclusion Criteria|2|||
160878817|NCT00566696|580952207|FG000|Overall Study|Muromonab not available|1|||
160878818|NCT00566696|580952207|FG000|Overall Study|Health Status Change|1|||
160878819|NCT00566696|580952207|FG000|Overall Study|Physician Decision|1|||
160878820|NCT00566696|580952207|FG000|Overall Study|Non-Patient Donors|37|||
160878821|NCT00706342|580952209|FG000|Overall Study|Adverse Event|3|||
160878822|NCT00706342|580952209|FG000|Overall Study|Not responding to treatment|2|||
160878823|NCT00706342|580952209|FG000|Overall Study|Withdrawn due to failure to respond|1|||
160878824|NCT00706342|580952209|FG000|Overall Study|Death|1|||
160878825|NCT00706342|580952209|FG000|Overall Study|Withdrew from the study on his own.|1|||
160878826|NCT00706342|580952209|FG000|Overall Study|Investigator discretion|2|||
160878827|NCT00706342|580952209|FG000|Overall Study|Non-responder Week 12|1|||
160878828|NCT00706342|580952209|FG000|Overall Study|Ongoing|6|||
160878829|NCT00706342|580952209|FG000|Overall Study|WIthdrawal of consent|1|||
160878830|NCT00119678|580952211|FG000|Double-blind Treatment Period|Death|1|||
160878831|NCT00119678|580952212|FG001|Double-blind Treatment Period|Death|0|||
160878832|NCT00119678|580952211|FG000|Double-blind Treatment Period|Adverse Event|7|||
160878833|NCT00119678|580952212|FG001|Double-blind Treatment Period|Adverse Event|1|||
160878834|NCT00119678|580952211|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
160878835|NCT00119678|580952212|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
160878836|NCT00119678|580952211|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
160878837|NCT00119678|580952212|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
160878838|NCT00119678|580952211|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
160878839|NCT00119678|580952212|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
160878840|NCT00119678|580952211|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
160878841|NCT00119678|580952212|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
160878842|NCT00119678|580952211|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
160878843|NCT00119678|580952212|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
160878844|NCT00119678|580952211|FG000|Double-blind Treatment Period|Pregnancy|0|||
160878845|NCT00119678|580952212|FG001|Double-blind Treatment Period|Pregnancy|2|||
160878846|NCT00119678|580952211|FG000|Double-blind Treatment Period|Not treated|1|||
160878847|NCT00119678|580952212|FG001|Double-blind Treatment Period|Not treated|2|||
160538618|NCT02819635|579702279|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
160538619|NCT02819635|579702280|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
160538620|NCT02819635|579702281|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
160538621|NCT02819635|579702270|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
160538622|NCT02819635|579702271|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
160538623|NCT02819635|579702272|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
160538624|NCT02819635|579702273|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
160538625|NCT02819635|579702274|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
160768922|NCT00834041|580540829|FG001|Overall Study|Lost to Follow-up|1|||
160538626|NCT02819635|579702275|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
160538627|NCT02819635|579702276|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
160538628|NCT02819635|579702277|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
160538629|NCT02819635|579702278|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
160538630|NCT02819635|579702279|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
160538631|NCT02819635|579702280|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
160538632|NCT02819635|579702281|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
160538633|NCT02819635|579702270|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160636632|NCT01488071|580051584|FG000|Overall Study|Non-compliance with study drug|2|||
160768923|NCT00788671|580542400|FG000|Overall Study|Death|2|||
160768924|NCT00788671|580542400|FG000|Overall Study|Unable to biopsy|1|||
160768925|NCT00788671|580542400|FG000|Overall Study|Withdrawal by Subject|4|||
160768926|NCT00788671|580542400|FG000|Overall Study|IUD expulsed|1|||
160768927|NCT00788671|580542400|FG000|Overall Study|Lost to follow up|2|||
160768928|NCT04780659|580542401|FG000|Overall Study|Adverse event, serious fatal|3|||
160768929|NCT04780659|580542402|FG001|Overall Study|Adverse event, serious fatal|0|||
160768930|NCT04780659|580542401|FG000|Overall Study|Withdrawal by Subject|3|||
160768931|NCT04780659|580542402|FG001|Overall Study|Withdrawal by Subject|0|||
160768932|NCT04780659|580542401|FG000|Overall Study|Physician Decision|1|||
160768933|NCT04780659|580542402|FG001|Overall Study|Physician Decision|0|||
160768934|NCT04780659|580542401|FG000|Overall Study|Died in original disease|2|||
160768935|NCT04780659|580542402|FG001|Overall Study|Died in original disease|0|||
160768936|NCT04780659|580542401|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
160768937|NCT04780659|580542402|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
160768938|NCT06583096|580542403|FG000|Overall Study|Lost to Follow-up|4|||
160768939|NCT06583096|580542404|FG001|Overall Study|Lost to Follow-up|10|||
160768940|NCT06583096|580542403|FG000|Overall Study|Withdrawal by Subject|0|||
160768941|NCT06583096|580542404|FG001|Overall Study|Withdrawal by Subject|2|||
160768942|NCT03729362|580542405|FG000|Overall Study|Withdrawal by Subject|2|||
160768943|NCT03729362|580542406|FG001|Overall Study|Withdrawal by Subject|0|||
160768944|NCT03729362|580542405|FG000|Overall Study|Physician Decision|1|||
160768945|NCT03729362|580542406|FG001|Overall Study|Physician Decision|0|||
160768946|NCT03729362|580542405|FG000|Overall Study|COVID-19 Pandemic|1|||
160768947|NCT03729362|580542406|FG001|Overall Study|COVID-19 Pandemic|0|||
160768948|NCT03729362|580542405|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
160768949|NCT03729362|580542406|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
160768950|NCT03729362|580542405|FG000|Overall Study|Adverse Event|0|||
160768951|NCT03729362|580542406|FG001|Overall Study|Adverse Event|1|||
160768952|NCT03729362|580542405|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
160768953|NCT03729362|580542406|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
160538634|NCT02819635|579702271|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160538635|NCT02819635|579702272|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160538636|NCT02819635|579702273|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160538637|NCT02819635|579702274|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160538638|NCT02819635|579702275|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160538639|NCT02819635|579702276|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
160538640|NCT02819635|579702277|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160538641|NCT02819635|579702278|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160538642|NCT02819635|579702279|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160538643|NCT02819635|579702280|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160538644|NCT02819635|579702281|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
160538645|NCT02819635|579702270|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
160538646|NCT02819635|579702271|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
160538647|NCT02819635|579702272|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
160538648|NCT02819635|579702273|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
160538649|NCT02819635|579702274|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
160538650|NCT02819635|579702275|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
160538651|NCT02819635|579702276|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
160538652|NCT02819635|579702277|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
160538653|NCT02819635|579702278|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
160636633|NCT01488071|580051585|FG001|Overall Study|Non-compliance with study drug|0|||
160878848|NCT00119678|580952211|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
160878849|NCT00119678|580952212|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
160878850|NCT00119678|580952211|FG000|Open-label Treatment Period|Death|1|||
160878851|NCT00119678|580952212|FG001|Open-label Treatment Period|Death|0|||
160878852|NCT00119678|580952211|FG000|Open-label Treatment Period|Adverse Event|3|||
160878853|NCT00119678|580952212|FG001|Open-label Treatment Period|Adverse Event|0|||
160878854|NCT00119678|580952211|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
160878855|NCT00119678|580952212|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
160878856|NCT00119678|580952211|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
160878857|NCT00119678|580952212|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
160878858|NCT00119678|580952211|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
160878859|NCT00119678|580952212|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
160878860|NCT00119678|580952211|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
160878861|NCT00119678|580952212|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
160878862|NCT00119678|580952211|FG000|Open-label Treatment Period|Pregnancy|1|||
160878863|NCT00119678|580952212|FG001|Open-label Treatment Period|Pregnancy|0|||
160878864|NCT00119678|580952211|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
160878865|NCT00119678|580952212|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
160878866|NCT01546623|580952215|FG000|Overall Study|Adverse Event|2|||
160878867|NCT01546623|580952216|FG001|Overall Study|Adverse Event|3|||
160878868|NCT01546623|580952215|FG000|Overall Study|Major Protocol Deviation|1|||
160878869|NCT01546623|580952216|FG001|Overall Study|Major Protocol Deviation|1|||
160878870|NCT01546623|580952215|FG000|Overall Study|High Prostate specific antigen|2|||
160878871|NCT01546623|580952216|FG001|Overall Study|High Prostate specific antigen|1|||
160878872|NCT01546623|580952215|FG000|Overall Study|Did Not Receive Study Drug|1|||
160878873|NCT01546623|580952216|FG001|Overall Study|Did Not Receive Study Drug|1|||
160878874|NCT03567343|580952217|FG000|Overall Study|Lost to Follow-up|2|||
160878875|NCT03567343|580952218|FG001|Overall Study|Lost to Follow-up|1|||
160878876|NCT03567343|580952217|FG000|Overall Study|No longer eligible|2|||
160878877|NCT03567343|580952218|FG001|Overall Study|No longer eligible|1|||
160878878|NCT03567343|580952217|FG000|Overall Study|Adverse Event|1|||
160878879|NCT03567343|580952218|FG001|Overall Study|Adverse Event|0|||
160878880|NCT03567343|580952217|FG000|Overall Study|Protocol Violation|1|||
160878881|NCT03567343|580952218|FG001|Overall Study|Protocol Violation|1|||
160878882|NCT01134705|580952219|FG000|Overall Study|Adverse Event|1|||
160878883|NCT01134705|580952220|FG001|Overall Study|Adverse Event|7|||
160878884|NCT01134705|580952219|FG000|Overall Study|Withdrawal by Subject|6|||
160878885|NCT01134705|580952220|FG001|Overall Study|Withdrawal by Subject|6|||
160878886|NCT01134705|580952219|FG000|Overall Study|Pregnancy|1|||
160878887|NCT01134705|580952220|FG001|Overall Study|Pregnancy|0|||
160878888|NCT01134705|580952219|FG000|Overall Study|Lost to Follow-up|5|||
160878889|NCT01134705|580952220|FG001|Overall Study|Lost to Follow-up|2|||
160878890|NCT01134705|580952219|FG000|Overall Study|Protocol Violation|1|||
160878891|NCT01134705|580952220|FG001|Overall Study|Protocol Violation|1|||
160878892|NCT01134705|580952219|FG000|Overall Study|Other|1|||
160878893|NCT01134705|580952220|FG001|Overall Study|Other|6|||
160878894|NCT00246740|580952221|FG000|Initial Enrollment|Death|1|||
160878895|NCT00246740|580952222|FG001|Initial Enrollment|Death|0|||
160878896|NCT00246740|580952221|FG000|Initial Enrollment|Additional surgery scheduled|0|||
160636634|NCT01488071|580051584|FG000|Overall Study|Protocol Violation|5|||
160636635|NCT01488071|580051585|FG001|Overall Study|Protocol Violation|7|||
160636636|NCT01488071|580051584|FG000|Overall Study|Withdrawal of Consent|14|||
160636637|NCT01488071|580051585|FG001|Overall Study|Withdrawal of Consent|12|||
160636638|NCT01488071|580051584|FG000|Overall Study|Lost to Follow-up|1|||
160636639|NCT01488071|580051585|FG001|Overall Study|Lost to Follow-up|0|||
160636640|NCT01488071|580051584|FG000|Overall Study|Administrative or Other Reason(s)|5|||
160636641|NCT01488071|580051585|FG001|Overall Study|Administrative or Other Reason(s)|4|||
160636642|NCT04449354|580051586|FG000|Overall Study|Withdrawal by Subject|1|||
160636643|NCT05789420|580051587|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
160636644|NCT05789420|580051587|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
160636645|NCT02278952|580051588|FG000|Overall Study|Insufficient Sample|6|||
160636646|NCT05473247|580051591|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
160768954|NCT03405870|580542407|FG000|Overall Study|Withdrawal|1|||
160768955|NCT03405870|580542408|FG001|Overall Study|Withdrawal|0|||
160768956|NCT03405870|580542409|FG002|Overall Study|Withdrawal|1|||
160768957|NCT03405870|580542410|FG003|Overall Study|Withdrawal|0|||
160768958|NCT03405870|580542411|FG004|Overall Study|Withdrawal|0|||
160768959|NCT03405870|580542412|FG005|Overall Study|Withdrawal|0|||
160768960|NCT03405870|580542413|FG006|Overall Study|Withdrawal|1|||
160768961|NCT03405870|580542414|FG007|Overall Study|Withdrawal|0|||
160768962|NCT00849056|580542415|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
160768963|NCT00849056|580542416|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
160768964|NCT00849056|580542415|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
160768965|NCT00849056|580542416|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
160768966|NCT00849056|580542415|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
160768967|NCT00849056|580542416|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
160768968|NCT00849056|580542415|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
160636647|NCT01311505|580051592|FG000|First Intervention Period|Protocol Violation|0|||
160636648|NCT01311505|580051593|FG001|First Intervention Period|Protocol Violation|1|||
160636649|NCT00828516|580051597|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
160636650|NCT00689273|580051598|FG000|Overall Study|Adverse Event|3|||
160636651|NCT00689273|580051599|FG001|Overall Study|Adverse Event|1|||
160636652|NCT00689273|580051598|FG000|Overall Study|Lack of Efficacy|3|||
160636653|NCT00689273|580051599|FG001|Overall Study|Lack of Efficacy|0|||
160636654|NCT00689273|580051598|FG000|Overall Study|Lost to Follow-up|0|||
160636655|NCT00689273|580051599|FG001|Overall Study|Lost to Follow-up|2|||
160636656|NCT00689273|580051598|FG000|Overall Study|Other|6|||
160636657|NCT00689273|580051599|FG001|Overall Study|Other|2|||
160636658|NCT00689273|580051598|FG000|Overall Study|Randomized but not Treated|1|||
160636659|NCT00689273|580051599|FG001|Overall Study|Randomized but not Treated|0|||
160636660|NCT03703297|580051604|FG000|Overall Study|Death|115|||
160636661|NCT03703297|580051605|FG001|Overall Study|Death|0|||
160636662|NCT03703297|580051606|FG002|Overall Study|Death|144|||
160636663|NCT03703297|580051604|FG000|Overall Study|Withdrawal by Subject|9|||
160636664|NCT03703297|580051605|FG001|Overall Study|Withdrawal by Subject|0|||
160636665|NCT03703297|580051606|FG002|Overall Study|Withdrawal by Subject|11|||
160636666|NCT03703297|580051604|FG000|Overall Study|Ongoing at the time of DCO|140|||
160636667|NCT03703297|580051605|FG001|Overall Study|Ongoing at the time of DCO|200|||
160636668|NCT03703297|580051606|FG002|Overall Study|Ongoing at the time of DCO|111|||
160636669|NCT01467570|580053547|FG000|Overall Study|Lost to Follow-up|8|||
160636670|NCT01467570|580053548|FG001|Overall Study|Lost to Follow-up|9|||
160636671|NCT02766088|580053561|FG000|Overall Study|Sponsor study termination|498|||
160636672|NCT02766088|580053561|FG000|Overall Study|Migrated/moved from the study area|1|||
160636673|NCT02766088|580053561|FG000|Overall Study|Lost to Follow-up|5|||
160636674|NCT02766088|580053561|FG000|Overall Study|Other|1|||
160636675|NCT02766088|580053561|FG000|Overall Study|Death|1|||
160636676|NCT01222715|580053562|FG000|Overall Study|Adverse Event|0|||
160636677|NCT01222715|580053563|FG001|Overall Study|Adverse Event|4|||
160636678|NCT01222715|580053562|FG000|Overall Study|Death|0|||
160636679|NCT01222715|580053563|FG001|Overall Study|Death|1|||
160636680|NCT01222715|580053562|FG000|Overall Study|Lack of Efficacy|22|||
160768969|NCT00849056|580542416|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
160768970|NCT00849056|580542415|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
160538654|NCT02819635|579702279|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
160538655|NCT02819635|579702280|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
160538656|NCT02819635|579702281|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
160538657|NCT02819635|579702270|FG000|Substudy 2, Part 2|Adverse Event|0|||
160878897|NCT00246740|580952222|FG001|Initial Enrollment|Additional surgery scheduled|2|||
160878898|NCT00246740|580952221|FG000|Initial Enrollment|Surgery schedule change|4|||
160878899|NCT00246740|580952222|FG001|Initial Enrollment|Surgery schedule change|4|||
160878900|NCT00246740|580952221|FG000|Initial Enrollment|Other|1|||
160878901|NCT00246740|580952222|FG001|Initial Enrollment|Other|2|||
160878902|NCT00101452|580952223|FG000|Overall Study|Adverse Event|2|||
160878903|NCT00101452|580952224|FG001|Overall Study|Adverse Event|0|||
160878904|NCT00101452|580952225|FG002|Overall Study|Adverse Event|1|||
160878905|NCT00101452|580952223|FG000|Overall Study|Lost to Follow-up|13|||
160878906|NCT00101452|580952224|FG001|Overall Study|Lost to Follow-up|8|||
160878907|NCT00101452|580952225|FG002|Overall Study|Lost to Follow-up|14|||
160878908|NCT00101452|580952223|FG000|Overall Study|Withdrawal by Subject|10|||
160878909|NCT00101452|580952224|FG001|Overall Study|Withdrawal by Subject|14|||
160878910|NCT00101452|580952225|FG002|Overall Study|Withdrawal by Subject|9|||
160538658|NCT02819635|579702271|FG001|Substudy 2, Part 2|Adverse Event|0|||
160878911|NCT00101452|580952223|FG000|Overall Study|Baseline Fail|2|||
160878912|NCT00101452|580952224|FG001|Overall Study|Baseline Fail|1|||
160878913|NCT00101452|580952225|FG002|Overall Study|Baseline Fail|2|||
160878914|NCT00101452|580952223|FG000|Overall Study|Physician Decision|0|||
160878915|NCT00101452|580952224|FG001|Overall Study|Physician Decision|3|||
160878916|NCT00101452|580952225|FG002|Overall Study|Physician Decision|2|||
160878917|NCT00101452|580952223|FG000|Overall Study|Protocol Violation|2|||
160878918|NCT00101452|580952224|FG001|Overall Study|Protocol Violation|1|||
160878919|NCT00101452|580952225|FG002|Overall Study|Protocol Violation|3|||
160878920|NCT00101452|580952223|FG000|Overall Study|Other|15|||
160878921|NCT00101452|580952224|FG001|Overall Study|Other|16|||
160878922|NCT00101452|580952225|FG002|Overall Study|Other|12|||
160878923|NCT01510769|580952226|FG000|Overall Study|Adverse Event|7|||
160878924|NCT01510769|580952227|FG001|Overall Study|Adverse Event|6|||
160878925|NCT01510769|580952228|FG002|Overall Study|Adverse Event|4|||
160878926|NCT01510769|580952226|FG000|Overall Study|Gout Flare|0|||
160878927|NCT01510769|580952227|FG001|Overall Study|Gout Flare|3|||
160878928|NCT01510769|580952228|FG002|Overall Study|Gout Flare|1|||
160878929|NCT01510769|580952226|FG000|Overall Study|Protocol Violation|11|||
160878930|NCT01510769|580952227|FG001|Overall Study|Protocol Violation|10|||
160878931|NCT01510769|580952228|FG002|Overall Study|Protocol Violation|9|||
160878932|NCT01510769|580952226|FG000|Overall Study|Lost to Follow-up|5|||
160878933|NCT01510769|580952227|FG001|Overall Study|Lost to Follow-up|1|||
160878934|NCT01510769|580952228|FG002|Overall Study|Lost to Follow-up|5|||
160878935|NCT01510769|580952226|FG000|Overall Study|Withdrawal by Subject|3|||
160878936|NCT01510769|580952227|FG001|Overall Study|Withdrawal by Subject|4|||
160878937|NCT01510769|580952228|FG002|Overall Study|Withdrawal by Subject|3|||
160878938|NCT01510769|580952226|FG000|Overall Study|Death|1|||
160878939|NCT01510769|580952227|FG001|Overall Study|Death|1|||
160878940|NCT01510769|580952228|FG002|Overall Study|Death|0|||
160878941|NCT02674204|580952229|FG000|Overall Study|Adverse Event|1|||
160878942|NCT02674204|580952230|FG001|Overall Study|Adverse Event|0|||
160878943|NCT02466659|580952233|FG000|Overall Study|Lost to Follow-up|5|||
160878944|NCT02466659|580952234|FG001|Overall Study|Lost to Follow-up|2|||
160878945|NCT01536392|580952235|FG000|Overall Study|Adverse Event|2|||
160878946|NCT01536392|580952236|FG001|Overall Study|Adverse Event|2|||
160878947|NCT01536392|580952235|FG000|Overall Study|Physician Decision|2|||
160878948|NCT01536392|580952236|FG001|Overall Study|Physician Decision|3|||
160878949|NCT01536392|580952235|FG000|Overall Study|Withdrawal by Subject|3|||
160878950|NCT01536392|580952236|FG001|Overall Study|Withdrawal by Subject|6|||
160878951|NCT01536392|580952235|FG000|Overall Study|Non Compliance|3|||
160878952|NCT01536392|580952236|FG001|Overall Study|Non Compliance|4|||
160878953|NCT01536392|580952235|FG000|Overall Study|Completed therapy early|3|||
160878954|NCT01536392|580952236|FG001|Overall Study|Completed therapy early|0|||
160538659|NCT02819635|579702272|FG002|Substudy 2, Part 2|Adverse Event|0|||
160538660|NCT02819635|579702273|FG003|Substudy 2, Part 2|Adverse Event|0|||
160878955|NCT02874144|580952237|FG000|Overall Study|Lost to Follow-up|3|||
160878956|NCT02874144|580952238|FG001|Overall Study|Lost to Follow-up|5|||
160878957|NCT00486811|580952240|FG000|Overall Study|Adverse Event|28|||
160878958|NCT00486811|580952241|FG001|Overall Study|Adverse Event|60|||
160878959|NCT00486811|580952242|FG002|Overall Study|Adverse Event|135|||
160878960|NCT00486811|580952240|FG000|Overall Study|Lack of Efficacy|34|||
160878961|NCT00486811|580952241|FG001|Overall Study|Lack of Efficacy|14|||
160878962|NCT00486811|580952242|FG002|Overall Study|Lack of Efficacy|7|||
160878963|NCT00486811|580952240|FG000|Overall Study|Lost to Follow-up|4|||
160878964|NCT00486811|580952241|FG001|Overall Study|Lost to Follow-up|6|||
160878965|NCT00486811|580952242|FG002|Overall Study|Lost to Follow-up|4|||
160878966|NCT00486811|580952240|FG000|Overall Study|Withdrawal by Subject|33|||
160878967|NCT00486811|580952241|FG001|Overall Study|Withdrawal by Subject|44|||
160878968|NCT00486811|580952242|FG002|Overall Study|Withdrawal by Subject|58|||
160878969|NCT00486811|580952240|FG000|Overall Study|Study drug non-compliant|5|||
160878970|NCT00486811|580952241|FG001|Overall Study|Study drug non-compliant|6|||
160878971|NCT00486811|580952242|FG002|Overall Study|Study drug non-compliant|3|||
160878972|NCT00486811|580952240|FG000|Overall Study|All other|18|||
160878973|NCT00486811|580952241|FG001|Overall Study|All other|11|||
160878974|NCT00486811|580952242|FG002|Overall Study|All other|7|||
160878975|NCT00852371|580952248|FG000|Overall Study|Lost to Follow-up|2|||
160878976|NCT00852371|580952249|FG001|Overall Study|Lost to Follow-up|3|||
160878977|NCT00852371|580952250|FG002|Overall Study|Lost to Follow-up|4|||
160878978|NCT00852371|580952251|FG003|Overall Study|Lost to Follow-up|2|||
160878979|NCT04525885|580952252|FG000|Overall Study|Screen Failure|1|||
160878980|NCT04525885|580952253|FG001|Overall Study|Screen Failure|0|||
160878981|NCT04525885|580952254|FG002|Overall Study|Screen Failure|0|||
160878982|NCT04525885|580952252|FG000|Overall Study|Withdrawal by Subject|14|||
160878983|NCT04525885|580952253|FG001|Overall Study|Withdrawal by Subject|6|||
160878984|NCT04525885|580952254|FG002|Overall Study|Withdrawal by Subject|20|||
160878985|NCT04525885|580952252|FG000|Overall Study|Physician Decision|1|||
160878986|NCT04525885|580952253|FG001|Overall Study|Physician Decision|0|||
160878987|NCT04525885|580952254|FG002|Overall Study|Physician Decision|1|||
160878988|NCT03158285|580952255|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
160878989|NCT03158285|580952256|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
160878990|NCT03158285|580952257|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
160878991|NCT03158285|580952255|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
160878992|NCT03158285|580952256|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
160878993|NCT03158285|580952257|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
160878994|NCT03158285|580952255|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
160878995|NCT03158285|580952256|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
160878996|NCT03158285|580952257|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
160878997|NCT03158285|580952255|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
160878998|NCT03158285|580952256|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
160538661|NCT02819635|579702274|FG004|Substudy 2, Part 2|Adverse Event|0|||
160538662|NCT02819635|579702275|FG005|Substudy 2, Part 2|Adverse Event|4|||
160768971|NCT00849056|580542416|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
160768972|NCT00849056|580542415|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
160768973|NCT00849056|580542416|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
160768974|NCT00849056|580542415|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
160768975|NCT00849056|580542416|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
160768976|NCT00849056|580542415|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
160768977|NCT00849056|580542416|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
160768978|NCT00849056|580542415|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
160768979|NCT00849056|580542416|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
160768980|NCT00849056|580542415|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
160768981|NCT00849056|580542416|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
160768982|NCT00849056|580542415|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
160768983|NCT00849056|580542416|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
160768984|NCT00849056|580542415|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
160768985|NCT00849056|580542416|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
160768986|NCT00849056|580542415|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
160768987|NCT00849056|580542416|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
160768988|NCT00849056|580542415|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
160768989|NCT00849056|580542416|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
160768990|NCT00849056|580542415|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
160768991|NCT00849056|580542416|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
160768992|NCT00849056|580542415|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
160768993|NCT00849056|580542416|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
160768994|NCT04588259|580542417|FG000|Run-in period|Run-in failure|0|||
160768995|NCT04588259|580542418|FG001|Run-in period|Run-in failure|23|||
160768996|NCT04588259|580542417|FG000|Run-in period|Withdrawn before randomisation|0|||
160768997|NCT04588259|580542418|FG001|Run-in period|Withdrawn before randomisation|8|||
160768998|NCT04588259|580542417|FG000|Treatment period|Withdrawal by Subject|6|||
160768999|NCT04588259|580542418|FG001|Treatment period|Withdrawal by Subject|6|||
160769000|NCT00715208|580542422|FG000|Overall Study|Withdrawal by Subject|1|||
160769001|NCT00715208|580542423|FG001|Overall Study|Withdrawal by Subject|1|||
160769002|NCT00715208|580542422|FG000|Overall Study|Adverse Event|0|||
160769003|NCT00715208|580542423|FG001|Overall Study|Adverse Event|6|||
160769004|NCT00715208|580542422|FG000|Overall Study|Lack of Efficacy|0|||
160769005|NCT00715208|580542423|FG001|Overall Study|Lack of Efficacy|2|||
160769006|NCT00576758|580542424|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
160878999|NCT03158285|580952257|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
160879000|NCT03158285|580952255|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
160879001|NCT03158285|580952256|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
160879002|NCT03158285|580952257|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
160538663|NCT02819635|579702276|FG006|Substudy 2, Part 2|Adverse Event|0|||
160538664|NCT02819635|579702277|FG007|Substudy 2, Part 2|Adverse Event|0|||
160538665|NCT02819635|579702278|FG008|Substudy 2, Part 2|Adverse Event|0|||
160538666|NCT02819635|579702279|FG009|Substudy 2, Part 2|Adverse Event|0|||
160538667|NCT02819635|579702280|FG010|Substudy 2, Part 2|Adverse Event|0|||
160538668|NCT02819635|579702281|FG011|Substudy 2, Part 2|Adverse Event|0|||
160538669|NCT02819635|579702270|FG000|Substudy 2, Part 2|Withdrew consent|0|||
160769007|NCT00576758|580542425|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
160769008|NCT00576758|580542424|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
160769009|NCT00576758|580542425|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
160769010|NCT00576758|580542424|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
160769011|NCT00576758|580542425|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
160769012|NCT00576758|580542424|FG000|Induction Treatment Period|Death|1|||
160769013|NCT00576758|580542425|FG001|Induction Treatment Period|Death|0|||
160769014|NCT00576758|580542424|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
160769015|NCT00576758|580542425|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
160769016|NCT00576758|580542424|FG000|Induction Treatment Period|Withdrew consent|1|||
160769017|NCT00576758|580542425|FG001|Induction Treatment Period|Withdrew consent|0|||
160769018|NCT00576758|580542424|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
160769019|NCT00576758|580542425|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
160769020|NCT00576758|580542424|FG000|Extension Treatment Period|Death|1|||
160769021|NCT00576758|580542425|FG001|Extension Treatment Period|Death|1|||
160769022|NCT00576758|580542424|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
160769023|NCT00576758|580542425|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
160769024|NCT00576758|580542424|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
160769025|NCT00576758|580542425|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
160769026|NCT00576758|580542424|FG000|Extension Treatment Period|Administrative/Other|3|||
160769027|NCT00576758|580542425|FG001|Extension Treatment Period|Administrative/Other|1|||
160769028|NCT00576758|580542424|FG000|Follow-up Period|Administrative/Other|6|||
160769029|NCT00576758|580542425|FG001|Follow-up Period|Administrative/Other|8|||
160769030|NCT00576758|580542424|FG000|Follow-up Period|Death|3|||
160769031|NCT00576758|580542425|FG001|Follow-up Period|Death|3|||
160769032|NCT00576758|580542424|FG000|Follow-up Period|Insufficient therapeutic response|16|||
160769033|NCT00576758|580542425|FG001|Follow-up Period|Insufficient therapeutic response|5|||
160769034|NCT00576758|580542424|FG000|Follow-up Period|Withdrew consent|2|||
160769035|NCT00576758|580542425|FG001|Follow-up Period|Withdrew consent|1|||
160769036|NCT03427411|580542426|FG000|Overall Study|Screen failure - platelets too low|0|||
160769037|NCT03427411|580542427|FG001|Overall Study|Screen failure - platelets too low|1|||
160769038|NCT00903968|580542428|FG000|Overall Study|Adverse Event|0|||
160769039|NCT00903968|580542429|FG001|Overall Study|Adverse Event|0|||
160769040|NCT00903968|580542430|FG002|Overall Study|Adverse Event|0|||
160769041|NCT00903968|580542431|FG003|Overall Study|Adverse Event|0|||
160769042|NCT00903968|580542432|FG004|Overall Study|Adverse Event|0|||
160769043|NCT00903968|580542433|FG005|Overall Study|Adverse Event|0|||
160769044|NCT00903968|580542434|FG006|Overall Study|Adverse Event|1|||
160769045|NCT00903968|580542435|FG007|Overall Study|Adverse Event|8|||
160769046|NCT00903968|580542428|FG000|Overall Study|DLT|0|||
160769047|NCT00903968|580542429|FG001|Overall Study|DLT|0|||
160769048|NCT00903968|580542430|FG002|Overall Study|DLT|0|||
160769049|NCT00903968|580542431|FG003|Overall Study|DLT|0|||
160769050|NCT00903968|580542432|FG004|Overall Study|DLT|0|||
160769051|NCT00903968|580542433|FG005|Overall Study|DLT|0|||
160769052|NCT00903968|580542434|FG006|Overall Study|DLT|2|||
160769053|NCT00903968|580542435|FG007|Overall Study|DLT|0|||
160769054|NCT00903968|580542428|FG000|Overall Study|Withdrawal by Subject|1|||
160769055|NCT00903968|580542429|FG001|Overall Study|Withdrawal by Subject|0|||
160769056|NCT00903968|580542430|FG002|Overall Study|Withdrawal by Subject|1|||
160769057|NCT00903968|580542431|FG003|Overall Study|Withdrawal by Subject|0|||
160769058|NCT00903968|580542432|FG004|Overall Study|Withdrawal by Subject|1|||
160769059|NCT00903968|580542433|FG005|Overall Study|Withdrawal by Subject|1|||
160769060|NCT00903968|580542434|FG006|Overall Study|Withdrawal by Subject|0|||
160769061|NCT00903968|580542435|FG007|Overall Study|Withdrawal by Subject|4|||
160769062|NCT00903968|580542428|FG000|Overall Study|Non-Compliance|0|||
160769063|NCT00903968|580542429|FG001|Overall Study|Non-Compliance|0|||
160769064|NCT00903968|580542430|FG002|Overall Study|Non-Compliance|0|||
160769065|NCT00903968|580542431|FG003|Overall Study|Non-Compliance|0|||
160769066|NCT00903968|580542432|FG004|Overall Study|Non-Compliance|0|||
160769067|NCT00903968|580542433|FG005|Overall Study|Non-Compliance|1|||
160769068|NCT00903968|580542434|FG006|Overall Study|Non-Compliance|0|||
160769069|NCT00903968|580542435|FG007|Overall Study|Non-Compliance|0|||
160769070|NCT00903968|580542428|FG000|Overall Study|Physician Decision|0|||
160769071|NCT00903968|580542429|FG001|Overall Study|Physician Decision|0|||
160769072|NCT00903968|580542430|FG002|Overall Study|Physician Decision|0|||
160769073|NCT00903968|580542431|FG003|Overall Study|Physician Decision|0|||
160769074|NCT00903968|580542432|FG004|Overall Study|Physician Decision|0|||
160769075|NCT00903968|580542433|FG005|Overall Study|Physician Decision|1|||
160769076|NCT00903968|580542434|FG006|Overall Study|Physician Decision|0|||
160769077|NCT00903968|580542435|FG007|Overall Study|Physician Decision|0|||
160769078|NCT00903968|580542428|FG000|Overall Study|Progressive Disease|2|||
160769079|NCT00903968|580542429|FG001|Overall Study|Progressive Disease|3|||
160769080|NCT00903968|580542430|FG002|Overall Study|Progressive Disease|2|||
160769081|NCT00903968|580542431|FG003|Overall Study|Progressive Disease|3|||
160769082|NCT00903968|580542432|FG004|Overall Study|Progressive Disease|3|||
160769083|NCT00903968|580542433|FG005|Overall Study|Progressive Disease|3|||
160769084|NCT00903968|580542434|FG006|Overall Study|Progressive Disease|0|||
160769085|NCT00903968|580542435|FG007|Overall Study|Progressive Disease|18|||
160769086|NCT00903968|580542428|FG000|Overall Study|Lack of Efficacy|0|||
160769087|NCT00903968|580542429|FG001|Overall Study|Lack of Efficacy|0|||
160769088|NCT00903968|580542430|FG002|Overall Study|Lack of Efficacy|0|||
160769089|NCT00903968|580542431|FG003|Overall Study|Lack of Efficacy|0|||
160769090|NCT00903968|580542432|FG004|Overall Study|Lack of Efficacy|0|||
160769091|NCT00903968|580542433|FG005|Overall Study|Lack of Efficacy|0|||
160769092|NCT00903968|580542434|FG006|Overall Study|Lack of Efficacy|0|||
160769093|NCT00903968|580542435|FG007|Overall Study|Lack of Efficacy|3|||
160769094|NCT01294046|580542436|FG000|Overall Study|Infection and surgical explant|1|||
160769095|NCT01294046|580542436|FG000|Overall Study|Eligibility criteria expanded|1|||
160769096|NCT01294046|580542436|FG000|Overall Study|Stimulation response inadqequate|1|||
160769097|NCT03738696|580542442|FG000|Overall Study|Withdrawal by Subject|0|||
160769098|NCT03738696|580542443|FG001|Overall Study|Withdrawal by Subject|1|||
160769099|NCT03738696|580542442|FG000|Overall Study|Lost to Follow-up|8|||
160769100|NCT03738696|580542443|FG001|Overall Study|Lost to Follow-up|14|||
160769101|NCT02690727|580542444|FG000|Overall Study|Adverse Event|2|||
160769102|NCT02690727|580542445|FG001|Overall Study|Adverse Event|2|||
160769103|NCT01027949|580542446|FG000|Overall Study|Death|174|||
160769104|NCT01027949|580542446|FG000|Overall Study|Progressive Disease|163|||
160769105|NCT01027949|580542446|FG000|Overall Study|Adverse Event|172|||
160769106|NCT01027949|580542446|FG000|Overall Study|Withdrawal by Subject|113|||
160769107|NCT01027949|580542446|FG000|Overall Study|Lost to Follow-up|17|||
160769108|NCT01027949|580542446|FG000|Overall Study|Protocol Violation|13|||
160769109|NCT01027949|580542446|FG000|Overall Study|PI Decision|8|||
160769110|NCT01027949|580542446|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
160769111|NCT01027949|580542446|FG000|Overall Study|Non-compliance with Study Procedures|7|||
160769112|NCT01027949|580542446|FG000|Overall Study|Lung Transplant|5|||
160879003|NCT03158285|580952255|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
160879004|NCT03158285|580952256|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
160538670|NCT02819635|579702271|FG001|Substudy 2, Part 2|Withdrew consent|0|||
160538671|NCT02819635|579702272|FG002|Substudy 2, Part 2|Withdrew consent|0|||
160769113|NCT01027949|580542446|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
160769114|NCT01027949|580542446|FG000|Overall Study|Use of Excluded Medication|2|||
160769115|NCT01027949|580542446|FG000|Overall Study|Patient Self-discontinuation|1|||
160769116|NCT01027949|580542446|FG000|Overall Study|Pregnancy|1|||
160769117|NCT01027949|580542446|FG000|Overall Study|Surgery|1|||
160769118|NCT00656617|580542447|FG000|Overall Study|Adverse Event|1|||
160769119|NCT00656617|580542447|FG000|Overall Study|Death|2|||
160769120|NCT00656617|580542447|FG000|Overall Study|Insurance Issues|2|||
160769121|NCT00656617|580542447|FG000|Overall Study|Move to different clinical trial|2|||
160769122|NCT02030600|580542450|FG000|Treatment Period 1|Adverse Event|5|||
160769123|NCT02030600|580542451|FG001|Treatment Period 1|Adverse Event|7|||
160769124|NCT02030600|580542450|FG000|Treatment Period 1|Lack of Efficacy|0|||
160769125|NCT02030600|580542451|FG001|Treatment Period 1|Lack of Efficacy|1|||
160769126|NCT02030600|580542450|FG000|Treatment Period 1|Lost to Follow-up|11|||
160538672|NCT02819635|579702273|FG003|Substudy 2, Part 2|Withdrew consent|0|||
160538673|NCT02819635|579702274|FG004|Substudy 2, Part 2|Withdrew consent|0|||
160538674|NCT02819635|579702275|FG005|Substudy 2, Part 2|Withdrew consent|3|||
160538675|NCT02819635|579702276|FG006|Substudy 2, Part 2|Withdrew consent|1|||
160538676|NCT02819635|579702277|FG007|Substudy 2, Part 2|Withdrew consent|0|||
160538677|NCT02819635|579702278|FG008|Substudy 2, Part 2|Withdrew consent|0|||
160538678|NCT02819635|579702279|FG009|Substudy 2, Part 2|Withdrew consent|0|||
160538679|NCT02819635|579702280|FG010|Substudy 2, Part 2|Withdrew consent|0|||
160538680|NCT02819635|579702281|FG011|Substudy 2, Part 2|Withdrew consent|0|||
160538681|NCT02819635|579702270|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
160538682|NCT02819635|579702271|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
160769127|NCT02030600|580542451|FG001|Treatment Period 1|Lost to Follow-up|3|||
160769128|NCT02030600|580542450|FG000|Treatment Period 1|Protocol Violation|22|||
160769129|NCT02030600|580542451|FG001|Treatment Period 1|Protocol Violation|17|||
160769130|NCT02030600|580542450|FG000|Treatment Period 1|Withdrawal by Subject|13|||
160769131|NCT02030600|580542451|FG001|Treatment Period 1|Withdrawal by Subject|17|||
160769132|NCT02030600|580542450|FG000|Treatment Period 1|Casebook Unsigned|1|||
160769133|NCT02030600|580542451|FG001|Treatment Period 1|Casebook Unsigned|0|||
160769134|NCT02030600|580542450|FG000|Treatment Period 1|Unclassified|1|||
160769135|NCT02030600|580542451|FG001|Treatment Period 1|Unclassified|0|||
160769136|NCT02030600|580542450|FG000|Treatment Period 2|Adverse Event|4|||
160769137|NCT02030600|580542451|FG001|Treatment Period 2|Adverse Event|4|||
160769138|NCT02030600|580542450|FG000|Treatment Period 2|Lack of Efficacy|2|||
160769139|NCT02030600|580542451|FG001|Treatment Period 2|Lack of Efficacy|1|||
160769140|NCT02030600|580542450|FG000|Treatment Period 2|Lost to Follow-up|4|||
160769141|NCT02030600|580542451|FG001|Treatment Period 2|Lost to Follow-up|2|||
160769142|NCT02030600|580542450|FG000|Treatment Period 2|Protocol Violation|1|||
160769143|NCT02030600|580542451|FG001|Treatment Period 2|Protocol Violation|2|||
160769144|NCT02030600|580542450|FG000|Treatment Period 2|Withdrawal by Subject|13|||
160769145|NCT02030600|580542451|FG001|Treatment Period 2|Withdrawal by Subject|9|||
160769146|NCT02030600|580542450|FG000|Treatment Period 2|Unclassified|1|||
160769147|NCT02030600|580542451|FG001|Treatment Period 2|Unclassified|0|||
160769148|NCT01513590|580542454|FG000|Overall Study|Adverse Event|2|||
160769149|NCT01513590|580542455|FG001|Overall Study|Adverse Event|3|||
160769150|NCT01513590|580542454|FG000|Overall Study|Withdrawal Criteria|3|||
160769151|NCT01513590|580542455|FG001|Overall Study|Withdrawal Criteria|0|||
160769152|NCT01513590|580542454|FG000|Overall Study|Unclassified|5|||
160769153|NCT01513590|580542455|FG001|Overall Study|Unclassified|10|||
160769154|NCT01240694|580542456|FG000|Overall Study|Adverse Event|9|||
160769155|NCT01240694|580542456|FG000|Overall Study|Lack of Efficacy|6|||
160769156|NCT01240694|580542456|FG000|Overall Study|Withdrawal by Subject|6|||
160769157|NCT01240694|580542456|FG000|Overall Study|Protocol Violation|2|||
160769158|NCT01240694|580542456|FG000|Overall Study|Lost to Follow-up|2|||
160769159|NCT01240694|580542456|FG000|Overall Study|Other than specified|3|||
160769160|NCT01240694|580542456|FG000|Overall Study|Withdrawn due to early study termination|107|||
160769161|NCT01056276|580542457|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
160769162|NCT01056276|580542458|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
160769163|NCT01056276|580542457|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
160769164|NCT01056276|580542458|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
160769165|NCT01056276|580542457|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
160769166|NCT01056276|580542458|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
160769167|NCT01056276|580542457|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
160769168|NCT01056276|580542458|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
160769169|NCT01056276|580542457|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
160769170|NCT01056276|580542458|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
160769171|NCT01056276|580542457|FG000|Treatment Period-Cycles 1-8|Death|3|||
160769172|NCT01056276|580542458|FG001|Treatment Period-Cycles 1-8|Death|1|||
160769173|NCT01056276|580542457|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
160769174|NCT01056276|580542458|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
160769175|NCT01056276|580542457|FG000|Maintenance Therapy|Toxicity|0|||
160769176|NCT01056276|580542458|FG001|Maintenance Therapy|Toxicity|2|||
160769177|NCT01056276|580542457|FG000|Maintenance Therapy|Progressive Disease|0|||
160769178|NCT01056276|580542458|FG001|Maintenance Therapy|Progressive Disease|9|||
160769179|NCT01056276|580542457|FG000|Maintenance Therapy|Physician Decision|0|||
160769180|NCT01056276|580542458|FG001|Maintenance Therapy|Physician Decision|1|||
160769181|NCT01056276|580542457|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
160769182|NCT01056276|580542458|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
160769183|NCT01056276|580542457|FG000|Maintenance Therapy|Intercurrent Illness|0|||
160769184|NCT01056276|580542458|FG001|Maintenance Therapy|Intercurrent Illness|1|||
160769185|NCT01056276|580542457|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
160769186|NCT01056276|580542458|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
160769187|NCT01881425|580542459|FG000|Overall Study|Death|5|||
160769188|NCT01881425|580542460|FG001|Overall Study|Death|1|||
160769189|NCT01881425|580542459|FG000|Overall Study|Withdrawal by Subject|8|||
160769190|NCT01881425|580542460|FG001|Overall Study|Withdrawal by Subject|3|||
160769191|NCT01881425|580542459|FG000|Overall Study|Physician Decision|2|||
160769192|NCT01881425|580542460|FG001|Overall Study|Physician Decision|1|||
160769193|NCT01881425|580542459|FG000|Overall Study|Adverse Event|3|||
160769194|NCT01881425|580542460|FG001|Overall Study|Adverse Event|0|||
160769195|NCT01881425|580542459|FG000|Overall Study|General Anesthesia panic attack|0|||
160769196|NCT01881425|580542460|FG001|Overall Study|General Anesthesia panic attack|1|||
160879005|NCT03158285|580952257|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
160879006|NCT03158285|580952255|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
160879007|NCT03158285|580952256|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
160879008|NCT03158285|580952257|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
160879009|NCT03158285|580952255|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
160879010|NCT03158285|580952256|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
160879011|NCT03158285|580952257|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
160879012|NCT03158285|580952255|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
160879013|NCT03158285|580952256|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
160879014|NCT03158285|580952257|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
160879015|NCT03158285|580952255|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
160879016|NCT03158285|580952256|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
160879017|NCT03158285|580952257|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
160879018|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
160879019|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
160879020|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
160879021|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
160879022|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
160879023|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
160879024|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
160879025|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
160879026|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
160879027|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
160538683|NCT02819635|579702272|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
160538684|NCT02819635|579702273|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
160769197|NCT01881425|580542459|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
160769198|NCT01881425|580542460|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
160769199|NCT01881425|580542459|FG000|Overall Study|Lost to Follow-up|7|||
160769200|NCT01881425|580542460|FG001|Overall Study|Lost to Follow-up|2|||
160769201|NCT04154956|580542461|FG000|Overall Study|Death|109|||
160769202|NCT04154956|580542462|FG001|Overall Study|Death|110|||
160769203|NCT04154956|580542461|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
160769204|NCT04154956|580542462|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
160769205|NCT04154956|580542461|FG000|Overall Study|Withdrawal by Subject|1|||
160769206|NCT04154956|580542462|FG001|Overall Study|Withdrawal by Subject|7|||
160769207|NCT04154956|580542461|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
160769208|NCT04154956|580542462|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
160769209|NCT04810962|580542463|FG000|Overall Study|Adverse Event|0|||
160769210|NCT04810962|580542464|FG001|Overall Study|Adverse Event|1|||
160769211|NCT04810962|580542463|FG000|Overall Study|Lost to Follow-up|2|||
160769212|NCT04810962|580542464|FG001|Overall Study|Lost to Follow-up|1|||
160769213|NCT04810962|580542463|FG000|Overall Study|Physician Decision|1|||
160769214|NCT04810962|580542464|FG001|Overall Study|Physician Decision|0|||
160769215|NCT04810962|580542463|FG000|Overall Study|Withdrawal by Subject|1|||
160769216|NCT04810962|580542464|FG001|Overall Study|Withdrawal by Subject|3|||
160769217|NCT04810962|580542463|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
160769218|NCT04810962|580542464|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
160769219|NCT01859741|580542465|FG000|Overall Study|Death|3|||
160769220|NCT01859741|580542466|FG001|Overall Study|Death|2|||
160769221|NCT01859741|580542467|FG002|Overall Study|Death|4|||
160769222|NCT01859741|580542468|FG003|Overall Study|Death|3|||
160769223|NCT01859741|580542469|FG004|Overall Study|Death|5|||
160769224|NCT01859741|580542470|FG005|Overall Study|Death|4|||
160769225|NCT01859741|580542471|FG006|Overall Study|Death|51|||
160769226|NCT01859741|580542472|FG007|Overall Study|Death|51|||
160769227|NCT01859741|580542465|FG000|Overall Study|Lost to Follow-up|0|||
160769228|NCT01859741|580542466|FG001|Overall Study|Lost to Follow-up|0|||
160769229|NCT01859741|580542467|FG002|Overall Study|Lost to Follow-up|0|||
160769230|NCT01859741|580542468|FG003|Overall Study|Lost to Follow-up|0|||
160769231|NCT01859741|580542469|FG004|Overall Study|Lost to Follow-up|0|||
160769232|NCT01859741|580542470|FG005|Overall Study|Lost to Follow-up|1|||
160769233|NCT01859741|580542471|FG006|Overall Study|Lost to Follow-up|0|||
160769234|NCT01859741|580542472|FG007|Overall Study|Lost to Follow-up|4|||
160769235|NCT01859741|580542465|FG000|Overall Study|Withdrawal by Subject|0|||
160769236|NCT01859741|580542466|FG001|Overall Study|Withdrawal by Subject|1|||
160769237|NCT01859741|580542467|FG002|Overall Study|Withdrawal by Subject|2|||
160879028|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
160879029|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
160879030|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Death|1|||
160879031|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Death|0|||
160879032|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Death|0|||
160879033|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Other|4|||
160879034|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Other|1|||
160879035|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Other|0|||
160879036|NCT02228980|580952258|FG000|Overall Study|Adverse Event|14|||
160879037|NCT02228980|580952259|FG001|Overall Study|Adverse Event|0|||
160879038|NCT02228980|580952260|FG002|Overall Study|Adverse Event|0|||
160879039|NCT02228980|580952261|FG003|Overall Study|Adverse Event|0|||
160879040|NCT02228980|580952258|FG000|Overall Study|Protocol Violation|7|||
160879041|NCT02228980|580952259|FG001|Overall Study|Protocol Violation|0|||
160879042|NCT02228980|580952260|FG002|Overall Study|Protocol Violation|0|||
160879043|NCT02228980|580952261|FG003|Overall Study|Protocol Violation|0|||
160879044|NCT02228980|580952258|FG000|Overall Study|Withdrawal by Subject|3|||
160879045|NCT02228980|580952259|FG001|Overall Study|Withdrawal by Subject|3|||
160879046|NCT02228980|580952260|FG002|Overall Study|Withdrawal by Subject|2|||
160879047|NCT02228980|580952261|FG003|Overall Study|Withdrawal by Subject|3|||
160879048|NCT01642615|580952262|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
160879049|NCT01642615|580952263|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
160879050|NCT01642615|580952264|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
160879051|NCT01642615|580952262|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
160879052|NCT01642615|580952263|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
160879053|NCT01642615|580952264|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
160879054|NCT01642615|580952262|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
160879055|NCT01642615|580952263|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
160879056|NCT01642615|580952264|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
160879057|NCT01642615|580952262|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
160879058|NCT01642615|580952263|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
160879059|NCT01642615|580952264|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
160879060|NCT01642615|580952262|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
160879061|NCT01642615|580952263|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
160879062|NCT01642615|580952264|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
160879063|NCT01642615|580952262|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
160879064|NCT01642615|580952263|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
160879065|NCT01642615|580952264|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
160879066|NCT01642615|580952262|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
160879067|NCT01642615|580952263|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
160879068|NCT01642615|580952264|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
160879069|NCT01642615|580952262|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
160879070|NCT01642615|580952263|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
160879071|NCT01642615|580952264|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
160879072|NCT01642615|580952262|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
160879073|NCT01642615|580952263|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
160879074|NCT01642615|580952264|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
160879075|NCT02744040|580952265|FG000|Overall Study|Withdrawal by Subject|3|||
160879076|NCT02744040|580952266|FG001|Overall Study|Withdrawal by Subject|2|||
160879077|NCT02744040|580952267|FG002|Overall Study|Withdrawal by Subject|2|||
160879078|NCT02744040|580952265|FG000|Overall Study|Physician Decision|0|||
160538685|NCT02819635|579702274|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
160538686|NCT02819635|579702275|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
160538687|NCT02819635|579702276|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
160636681|NCT01222715|580053563|FG001|Overall Study|Lack of Efficacy|14|||
160636682|NCT01222715|580053562|FG000|Overall Study|Physician Decision|12|||
160636683|NCT01222715|580053563|FG001|Overall Study|Physician Decision|2|||
160879079|NCT02744040|580952266|FG001|Overall Study|Physician Decision|8|||
160769238|NCT01859741|580542468|FG003|Overall Study|Withdrawal by Subject|0|||
160769239|NCT01859741|580542469|FG004|Overall Study|Withdrawal by Subject|0|||
160769240|NCT01859741|580542470|FG005|Overall Study|Withdrawal by Subject|1|||
160769241|NCT01859741|580542471|FG006|Overall Study|Withdrawal by Subject|1|||
160769242|NCT01859741|580542472|FG007|Overall Study|Withdrawal by Subject|1|||
160769243|NCT01859741|580542465|FG000|Overall Study|Study Terminated by Sponsor|0|||
160769244|NCT01859741|580542466|FG001|Overall Study|Study Terminated by Sponsor|0|||
160769245|NCT01859741|580542467|FG002|Overall Study|Study Terminated by Sponsor|0|||
160769246|NCT01859741|580542468|FG003|Overall Study|Study Terminated by Sponsor|0|||
160769247|NCT01859741|580542469|FG004|Overall Study|Study Terminated by Sponsor|1|||
160769248|NCT01859741|580542470|FG005|Overall Study|Study Terminated by Sponsor|0|||
160769249|NCT01859741|580542471|FG006|Overall Study|Study Terminated by Sponsor|16|||
160769250|NCT01859741|580542472|FG007|Overall Study|Study Terminated by Sponsor|14|||
160769251|NCT01859741|580542465|FG000|Overall Study|Other|0|||
160769252|NCT01859741|580542466|FG001|Overall Study|Other|0|||
160769253|NCT01859741|580542467|FG002|Overall Study|Other|0|||
160769254|NCT01859741|580542468|FG003|Overall Study|Other|0|||
160769255|NCT01859741|580542469|FG004|Overall Study|Other|0|||
160769256|NCT01859741|580542470|FG005|Overall Study|Other|0|||
160769257|NCT01859741|580542471|FG006|Overall Study|Other|2|||
160769258|NCT01859741|580542472|FG007|Overall Study|Other|0|||
160769259|NCT03185208|580542473|FG000|Overall Study|Did not start study medication|0|||
160769260|NCT03185208|580542474|FG001|Overall Study|Did not start study medication|3|||
160769261|NCT02606253|580542475|FG000|Overall Study|Adverse Event|2|||
160769262|NCT02606253|580542476|FG001|Overall Study|Adverse Event|0|||
160769263|NCT02606253|580542477|FG002|Overall Study|Adverse Event|0|||
160769264|NCT02606253|580542475|FG000|Overall Study|Protocol Violation|2|||
160769265|NCT02606253|580542476|FG001|Overall Study|Protocol Violation|1|||
160769266|NCT02606253|580542477|FG002|Overall Study|Protocol Violation|0|||
160769267|NCT02606253|580542475|FG000|Overall Study|Physician Decision|1|||
160769268|NCT02606253|580542476|FG001|Overall Study|Physician Decision|1|||
160769269|NCT02606253|580542477|FG002|Overall Study|Physician Decision|0|||
160769270|NCT03834350|580542478|FG000|Overall Study|Withdrawal by Subject|1|||
160769271|NCT00701363|580542483|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
160769272|NCT00701363|580542484|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
160769273|NCT00701363|580542485|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
160769274|NCT00701363|580542486|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
160769275|NCT00701363|580542483|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
160769276|NCT00701363|580542484|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
160769277|NCT00701363|580542485|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
160769278|NCT00701363|580542486|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
160769279|NCT00701363|580542483|FG000|Treatment Phase 1|Adverse Event|7|||
160769280|NCT00701363|580542484|FG001|Treatment Phase 1|Adverse Event|0|||
160769281|NCT00701363|580542485|FG002|Treatment Phase 1|Adverse Event|0|||
160769282|NCT00701363|580542486|FG003|Treatment Phase 1|Adverse Event|0|||
160769283|NCT00701363|580542483|FG000|Treatment Phase 1|Protocol Violation|1|||
160879080|NCT02744040|580952267|FG002|Overall Study|Physician Decision|13|||
160879081|NCT02744040|580952265|FG000|Overall Study|Lost to Follow-up|3|||
160879082|NCT02744040|580952266|FG001|Overall Study|Lost to Follow-up|1|||
160879083|NCT02744040|580952267|FG002|Overall Study|Lost to Follow-up|7|||
160879084|NCT00750152|580952268|FG000|Overall Study|Adverse Event|2|||
160879085|NCT00750152|580952269|FG001|Overall Study|Adverse Event|1|||
160879086|NCT00750152|580952268|FG000|Overall Study|Lost to Follow-up|8|||
160879087|NCT00750152|580952269|FG001|Overall Study|Lost to Follow-up|13|||
160879088|NCT00750152|580952268|FG000|Overall Study|Withdrawal by Subject|3|||
160769284|NCT00701363|580542484|FG001|Treatment Phase 1|Protocol Violation|0|||
160769285|NCT00701363|580542485|FG002|Treatment Phase 1|Protocol Violation|0|||
160769286|NCT00701363|580542486|FG003|Treatment Phase 1|Protocol Violation|0|||
160769287|NCT00701363|580542483|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
160769288|NCT00701363|580542484|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
160769289|NCT00701363|580542485|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
160769290|NCT00701363|580542486|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
160769291|NCT00701363|580542483|FG000|Treatment Phase 1|Lack of Efficacy|1|||
160769292|NCT00701363|580542484|FG001|Treatment Phase 1|Lack of Efficacy|0|||
160879089|NCT00750152|580952269|FG001|Overall Study|Withdrawal by Subject|3|||
160538688|NCT02819635|579702277|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
160538689|NCT02819635|579702278|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
160879090|NCT00750152|580952268|FG000|Overall Study|Physician Decision|1|||
160879091|NCT00750152|580952269|FG001|Overall Study|Physician Decision|1|||
160879092|NCT00750152|580952268|FG000|Overall Study|Non-compliance|0|||
160879093|NCT00750152|580952269|FG001|Overall Study|Non-compliance|1|||
160879094|NCT00750152|580952268|FG000|Overall Study|Termination by sponsor|1|||
160879095|NCT00750152|580952269|FG001|Overall Study|Termination by sponsor|0|||
160879096|NCT00750152|580952268|FG000|Overall Study|Other|7|||
160879097|NCT00750152|580952269|FG001|Overall Study|Other|8|||
160879098|NCT00402740|580952275|FG000|Overall Study|Withdrawal by Subject|18|||
160879099|NCT00402740|580952275|FG000|Overall Study|Death|50|||
160879100|NCT00402740|580952275|FG000|Overall Study|Lost to Follow-up|6|||
160879101|NCT00402740|580952275|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
160879102|NCT00402740|580952275|FG000|Overall Study|Subject disposition unknown.|1|||
160879103|NCT01214395|580952276|FG000|Overall Study|All patients had infection|5|||
160879104|NCT00715910|580952277|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
160879105|NCT00715910|580952278|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
160879106|NCT00715910|580952279|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
160879107|NCT00715910|580952280|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
160879108|NCT00715910|580952281|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
160879109|NCT00715910|580952282|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
160879110|NCT00715910|580952277|FG000|Booster and ESFU Phase|Other|0|||
160879111|NCT00715910|580952278|FG001|Booster and ESFU Phase|Other|0|||
160879112|NCT00715910|580952279|FG002|Booster and ESFU Phase|Other|0|||
160879113|NCT00715910|580952280|FG003|Booster and ESFU Phase|Other|5|||
160879114|NCT00715910|580952281|FG004|Booster and ESFU Phase|Other|1|||
160879115|NCT00715910|580952282|FG005|Booster and ESFU Phase|Other|0|||
160879116|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
160879117|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
160879118|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
160879119|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
160879120|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
160879121|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
160879122|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
160879123|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
160879124|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
160879125|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
160879126|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879127|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879128|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879129|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879130|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
160879131|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879132|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879133|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879134|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879135|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879136|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
160879137|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879138|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879139|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879140|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
160879141|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879142|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879143|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879144|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879145|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160538690|NCT02819635|579702279|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
160538691|NCT02819635|579702280|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
160538692|NCT02819635|579702281|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
160538693|NCT02819635|579702270|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160538694|NCT02819635|579702271|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160538695|NCT02819635|579702272|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160538696|NCT02819635|579702273|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160538697|NCT02819635|579702274|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160538698|NCT02819635|579702275|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160538699|NCT02819635|579702276|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
160538700|NCT02819635|579702277|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160879146|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879147|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879148|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
160879149|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879150|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
160879151|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879152|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879153|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879154|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879155|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879156|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879157|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879158|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879159|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879160|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
160879161|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879162|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879163|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879164|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879165|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879166|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
160879167|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879168|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879169|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879170|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
160879171|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879172|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879173|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879174|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879175|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879176|NCT01185353|580952286|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879177|NCT01185353|580952287|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879178|NCT01185353|580952288|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
160879179|NCT01185353|580952289|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879180|NCT01185353|580952290|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879181|NCT01185353|580952291|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
160879182|NCT01185353|580952292|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160769293|NCT00701363|580542485|FG002|Treatment Phase 1|Lack of Efficacy|0|||
160769294|NCT00701363|580542486|FG003|Treatment Phase 1|Lack of Efficacy|0|||
160769295|NCT00701363|580542483|FG000|Treatment Phase 2|Adverse Event|0|||
160879183|NCT01185353|580952293|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879184|NCT01185353|580952294|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879185|NCT01185353|580952295|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879186|NCT01185353|580952286|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879187|NCT01185353|580952287|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
160879188|NCT01185353|580952288|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879189|NCT01185353|580952289|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
160769296|NCT00701363|580542484|FG001|Treatment Phase 2|Adverse Event|0|||
160769297|NCT00701363|580542485|FG002|Treatment Phase 2|Adverse Event|1|||
160769298|NCT00701363|580542486|FG003|Treatment Phase 2|Adverse Event|0|||
160769299|NCT00701363|580542483|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
160769300|NCT00701363|580542484|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
160769301|NCT00701363|580542485|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
160769302|NCT00701363|580542486|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
160769303|NCT03426878|580542487|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
160769304|NCT03426878|580542487|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
160769305|NCT03426878|580542487|FG000|Overall Study|Declined to receive results|3|||
160769306|NCT03426878|580542487|FG000|Overall Study|Received negative results by mailed letter|65|||
160769307|NCT03426878|580542487|FG000|Overall Study|Lost to Follow-up|177|||
160769308|NCT00746551|580542494|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
160769309|NCT00746551|580542495|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
160769310|NCT00746551|580542494|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
160769311|NCT00746551|580542495|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
160769312|NCT00746551|580542494|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
160769313|NCT00746551|580542495|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
160769314|NCT00262925|580542498|FG000|Overall Study|Lack of Efficacy|3|||
160769315|NCT00262925|580542498|FG000|Overall Study|Adverse Event|4|||
160769316|NCT00262925|580542498|FG000|Overall Study|Death|2|||
160769317|NCT00262925|580542498|FG000|Overall Study|alternative therapy|1|||
160769318|NCT00262925|580542498|FG000|Overall Study|Other|1|||
160769319|NCT04682301|580542500|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
160769320|NCT04682301|580542500|FG000|Overall Study|Death|2|||
160769321|NCT00560404|580542501|FG000|Overall Study|Adverse Event|2|||
160769322|NCT00560404|580542502|FG001|Overall Study|Adverse Event|3|||
160769323|NCT00560404|580542501|FG000|Overall Study|Death|3|||
160769324|NCT00560404|580542502|FG001|Overall Study|Death|3|||
160769325|NCT00560404|580542501|FG000|Overall Study|Protocol Violation|12|||
160769326|NCT00560404|580542502|FG001|Overall Study|Protocol Violation|7|||
160769327|NCT00560404|580542501|FG000|Overall Study|Administrative Reasons|1|||
160769328|NCT00560404|580542502|FG001|Overall Study|Administrative Reasons|1|||
160769329|NCT00560404|580542501|FG000|Overall Study|Withdrew Consent|4|||
160769330|NCT00560404|580542502|FG001|Overall Study|Withdrew Consent|0|||
160769331|NCT00560404|580542501|FG000|Overall Study|Failure to return|1|||
160769332|NCT00560404|580542502|FG001|Overall Study|Failure to return|2|||
160769333|NCT00560404|580542501|FG000|Overall Study|Other withdrawal reason|13|||
160769334|NCT00560404|580542502|FG001|Overall Study|Other withdrawal reason|5|||
160769335|NCT02642042|580542509|FG000|Overall Study|Adverse Event|22|||
160769336|NCT02642042|580542509|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
160769337|NCT02642042|580542509|FG000|Overall Study|Progression/Relapse|28|||
160769338|NCT02642042|580542509|FG000|Overall Study|Death|1|||
160769339|NCT02642042|580542509|FG000|Overall Study|Not Protocol Specified|2|||
160769340|NCT03260023|580542510|FG000|Overall Study|Adverse Event|0|||
160769341|NCT03260023|580542511|FG001|Overall Study|Adverse Event|0|||
160769342|NCT03260023|580542512|FG002|Overall Study|Adverse Event|4|||
160538701|NCT02819635|579702278|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160879190|NCT01185353|580952290|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879191|NCT01185353|580952291|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879192|NCT01185353|580952292|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879193|NCT01185353|580952293|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879194|NCT01185353|580952294|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879195|NCT01185353|580952295|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879196|NCT01185353|580952286|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879197|NCT01185353|580952287|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879198|NCT01185353|580952288|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879199|NCT01185353|580952289|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
160879200|NCT01185353|580952290|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879201|NCT01185353|580952291|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879202|NCT01185353|580952292|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
160879203|NCT01185353|580952293|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879204|NCT01185353|580952294|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879205|NCT01185353|580952295|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879206|NCT01185353|580952286|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879207|NCT01185353|580952287|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879208|NCT01185353|580952288|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
160879209|NCT01185353|580952289|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
160879210|NCT01185353|580952290|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879211|NCT01185353|580952291|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
160879212|NCT01185353|580952292|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
160879213|NCT01185353|580952293|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879214|NCT01185353|580952294|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879215|NCT01185353|580952295|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879216|NCT01185353|580952286|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879217|NCT01185353|580952287|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879218|NCT01185353|580952288|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879219|NCT01185353|580952289|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879220|NCT01185353|580952290|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879221|NCT01185353|580952291|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879222|NCT01185353|580952292|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
160879223|NCT01185353|580952293|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879224|NCT01185353|580952294|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879225|NCT01185353|580952295|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879226|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879227|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879228|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879229|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879230|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160538702|NCT02819635|579702279|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160769343|NCT03260023|580542513|FG003|Overall Study|Adverse Event|4|||
160769344|NCT03260023|580542514|FG004|Overall Study|Adverse Event|4|||
160769345|NCT03260023|580542515|FG005|Overall Study|Adverse Event|1|||
160538703|NCT02819635|579702280|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160769346|NCT03260023|580542516|FG006|Overall Study|Adverse Event|2|||
160769347|NCT03260023|580542510|FG000|Overall Study|Clinical Progression|0|||
160769348|NCT03260023|580542511|FG001|Overall Study|Clinical Progression|1|||
160769349|NCT03260023|580542512|FG002|Overall Study|Clinical Progression|3|||
160769350|NCT03260023|580542513|FG003|Overall Study|Clinical Progression|1|||
160769351|NCT03260023|580542514|FG004|Overall Study|Clinical Progression|0|||
160769352|NCT03260023|580542515|FG005|Overall Study|Clinical Progression|0|||
160769353|NCT03260023|580542516|FG006|Overall Study|Clinical Progression|0|||
160769354|NCT03260023|580542510|FG000|Overall Study|Physician Decision|0|||
160769355|NCT03260023|580542511|FG001|Overall Study|Physician Decision|0|||
160769356|NCT03260023|580542512|FG002|Overall Study|Physician Decision|0|||
160769357|NCT03260023|580542513|FG003|Overall Study|Physician Decision|1|||
160769358|NCT03260023|580542514|FG004|Overall Study|Physician Decision|1|||
160769359|NCT03260023|580542515|FG005|Overall Study|Physician Decision|0|||
160769360|NCT03260023|580542516|FG006|Overall Study|Physician Decision|0|||
160769361|NCT03260023|580542510|FG000|Overall Study|Withdrawal by Subject|0|||
160769362|NCT03260023|580542511|FG001|Overall Study|Withdrawal by Subject|0|||
160769363|NCT03260023|580542512|FG002|Overall Study|Withdrawal by Subject|0|||
160769364|NCT03260023|580542513|FG003|Overall Study|Withdrawal by Subject|0|||
160769365|NCT03260023|580542514|FG004|Overall Study|Withdrawal by Subject|3|||
160769366|NCT03260023|580542515|FG005|Overall Study|Withdrawal by Subject|0|||
160769367|NCT03260023|580542516|FG006|Overall Study|Withdrawal by Subject|0|||
160769368|NCT03260023|580542510|FG000|Overall Study|Under trial intervention|0|||
160769369|NCT03260023|580542511|FG001|Overall Study|Under trial intervention|0|||
160769370|NCT03260023|580542512|FG002|Overall Study|Under trial intervention|2|||
160769371|NCT03260023|580542513|FG003|Overall Study|Under trial intervention|5|||
160769372|NCT03260023|580542514|FG004|Overall Study|Under trial intervention|3|||
160769373|NCT03260023|580542515|FG005|Overall Study|Under trial intervention|0|||
160769374|NCT03260023|580542516|FG006|Overall Study|Under trial intervention|0|||
160769375|NCT05035407|580542519|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
160769376|NCT05035407|580542520|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
160769377|NCT05035407|580542521|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
160769378|NCT05035407|580542522|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
160769379|NCT05035407|580542523|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
160769380|NCT05035407|580542524|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
160769381|NCT04220021|580542525|FG000|Overall Study|Withdrawal by Subject|11|||
160769382|NCT04220021|580542525|FG000|Overall Study|Physician Decision|2|||
160769383|NCT04220021|580542525|FG000|Overall Study|Non-study related illness|5|||
160769384|NCT04513366|580542526|FG000|Treatment Phase|Withdrawal by Subject|6|||
160769385|NCT04513366|580542527|FG001|Treatment Phase|Withdrawal by Subject|8|||
160769386|NCT04513366|580542528|FG002|Treatment Phase|Withdrawal by Subject|3|||
160769387|NCT04513366|580542526|FG000|Treatment Phase|Lost to Follow-up|1|||
160769388|NCT04513366|580542527|FG001|Treatment Phase|Lost to Follow-up|2|||
160769389|NCT04513366|580542528|FG002|Treatment Phase|Lost to Follow-up|5|||
160769390|NCT04513366|580542526|FG000|Treatment Phase|Other than Specified|1|||
160769391|NCT04513366|580542527|FG001|Treatment Phase|Other than Specified|0|||
160769392|NCT04513366|580542528|FG002|Treatment Phase|Other than Specified|2|||
160769393|NCT04513366|580542526|FG000|Treatment Phase|Physician Decision|2|||
160769394|NCT04513366|580542527|FG001|Treatment Phase|Physician Decision|0|||
160769395|NCT04513366|580542528|FG002|Treatment Phase|Physician Decision|0|||
160769396|NCT04513366|580542526|FG000|Treatment Phase|Adverse Event|0|||
160769397|NCT04513366|580542527|FG001|Treatment Phase|Adverse Event|1|||
160769398|NCT04513366|580542528|FG002|Treatment Phase|Adverse Event|1|||
160769399|NCT04513366|580542526|FG000|Extension Phase|Withdrawal by Subject|3|||
160769400|NCT04513366|580542527|FG001|Extension Phase|Withdrawal by Subject|1|||
160769401|NCT04513366|580542528|FG002|Extension Phase|Withdrawal by Subject|1|||
160769402|NCT04513366|580542526|FG000|Extension Phase|Other than Specified|4|||
160769403|NCT04513366|580542527|FG001|Extension Phase|Other than Specified|0|||
160769404|NCT04513366|580542528|FG002|Extension Phase|Other than Specified|1|||
160769405|NCT04513366|580542526|FG000|Extension Phase|Lost to Follow-up|1|||
160769406|NCT04513366|580542527|FG001|Extension Phase|Lost to Follow-up|1|||
160769407|NCT04513366|580542528|FG002|Extension Phase|Lost to Follow-up|1|||
160769408|NCT04513366|580542526|FG000|Extension Phase|Sponsor Decision|0|||
160769409|NCT04513366|580542527|FG001|Extension Phase|Sponsor Decision|1|||
160769410|NCT04513366|580542528|FG002|Extension Phase|Sponsor Decision|0|||
160769411|NCT04513366|580542526|FG000|Extension Phase|Death|0|||
160769412|NCT04513366|580542527|FG001|Extension Phase|Death|1|||
160769413|NCT04513366|580542528|FG002|Extension Phase|Death|0|||
160769414|NCT04513366|580542526|FG000|Extension Phase|Adverse Event|0|||
160769415|NCT04513366|580542527|FG001|Extension Phase|Adverse Event|0|||
160769416|NCT04513366|580542528|FG002|Extension Phase|Adverse Event|1|||
160769417|NCT02187783|580542529|FG000|Overall Study|Adverse Event|8|||
160769418|NCT02187783|580542529|FG000|Overall Study|Death|3|||
160769419|NCT02187783|580542529|FG000|Overall Study|Progressive disease|80|||
160769420|NCT02187783|580542529|FG000|Overall Study|Protocol Violation|3|||
160769421|NCT02187783|580542529|FG000|Overall Study|Physician Decision|2|||
160769422|NCT02187783|580542529|FG000|Overall Study|Withdrawal by Subject|9|||
160769423|NCT02187783|580542529|FG000|Overall Study|Study terminated by sponsor|1|||
160769424|NCT00171249|580542530|FG000|Overall Study|Withdrawal by Subject|2|||
160769425|NCT00171249|580542531|FG001|Overall Study|Withdrawal by Subject|0|||
160769426|NCT00171249|580542532|FG002|Overall Study|Withdrawal by Subject|0|||
160769427|NCT00171249|580542533|FG003|Overall Study|Withdrawal by Subject|6|||
160769428|NCT00171249|580542534|FG004|Overall Study|Withdrawal by Subject|0|||
160769429|NCT00171249|580542535|FG005|Overall Study|Withdrawal by Subject|0|||
160769430|NCT00171249|580542536|FG006|Overall Study|Withdrawal by Subject|0|||
160769431|NCT00171249|580542530|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
160769432|NCT00171249|580542531|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160769433|NCT00171249|580542532|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
160769434|NCT00171249|580542533|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
160769435|NCT00171249|580542534|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160769436|NCT00171249|580542535|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
160769437|NCT00171249|580542536|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
160769438|NCT00171249|580542530|FG000|Overall Study|Death|7|||
160769439|NCT00171249|580542531|FG001|Overall Study|Death|1|||
160769440|NCT00171249|580542532|FG002|Overall Study|Death|0|||
160769441|NCT00171249|580542533|FG003|Overall Study|Death|4|||
160769442|NCT00171249|580542534|FG004|Overall Study|Death|0|||
160769443|NCT00171249|580542535|FG005|Overall Study|Death|3|||
160769444|NCT00171249|580542536|FG006|Overall Study|Death|1|||
160769445|NCT00171249|580542530|FG000|Overall Study|Other|10|||
160769446|NCT00171249|580542531|FG001|Overall Study|Other|0|||
160769447|NCT00171249|580542532|FG002|Overall Study|Other|0|||
160769448|NCT00171249|580542533|FG003|Overall Study|Other|43|||
160769449|NCT00171249|580542534|FG004|Overall Study|Other|0|||
160769450|NCT00171249|580542535|FG005|Overall Study|Other|2|||
160769451|NCT00171249|580542536|FG006|Overall Study|Other|0|||
160879231|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879232|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879233|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
160879234|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
160879235|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
160879236|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879237|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879238|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879239|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879240|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879241|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879242|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879243|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
160879244|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
160879245|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
160879246|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879247|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879248|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879249|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879250|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879251|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879252|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879253|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
160879254|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
160879255|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
160879256|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879257|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879258|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879259|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879260|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879261|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879262|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879263|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879264|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
160879265|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879266|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Death|0|||
160879267|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Death|0|||
160879268|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Death|0|||
160879269|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Death|0|||
160879270|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Death|0|||
160879271|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Death|0|||
160879272|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Death|0|||
160769452|NCT00171249|580542530|FG000|Overall Study|No Longer Requires Study Drug|4|||
160769453|NCT00171249|580542531|FG001|Overall Study|No Longer Requires Study Drug|0|||
160769454|NCT00171249|580542532|FG002|Overall Study|No Longer Requires Study Drug|0|||
160769455|NCT00171249|580542533|FG003|Overall Study|No Longer Requires Study Drug|3|||
160769456|NCT00171249|580542534|FG004|Overall Study|No Longer Requires Study Drug|0|||
160879273|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Death|0|||
160879274|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Death|0|||
160879275|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Death|1|||
160879276|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879277|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879278|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879279|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879280|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879281|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879282|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879283|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879284|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879285|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
160879286|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879287|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879288|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879289|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879290|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879291|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879292|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879293|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879294|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879295|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
160879296|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879297|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879298|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879299|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879300|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879301|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879302|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879303|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879304|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
160879305|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879306|NCT01185353|580952286|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879307|NCT01185353|580952287|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879308|NCT01185353|580952288|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879309|NCT01185353|580952289|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879310|NCT01185353|580952290|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879311|NCT01185353|580952291|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879312|NCT01185353|580952292|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879313|NCT01185353|580952293|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
160879314|NCT01185353|580952294|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
160879315|NCT01185353|580952295|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879316|NCT01185353|580952286|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879317|NCT01185353|580952287|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879318|NCT01185353|580952288|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879319|NCT01185353|580952289|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879320|NCT01185353|580952290|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879321|NCT01185353|580952291|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879322|NCT01185353|580952292|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879323|NCT01185353|580952293|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
160879324|NCT01185353|580952294|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
160879325|NCT01185353|580952295|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
160879326|NCT01185353|580952286|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879327|NCT01185353|580952287|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879328|NCT01185353|580952288|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879329|NCT01185353|580952289|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879330|NCT01185353|580952290|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879331|NCT01185353|580952291|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879332|NCT01185353|580952292|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879333|NCT01185353|580952293|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
160879334|NCT01185353|580952294|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
160879335|NCT01185353|580952295|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879336|NCT02626624|580952307|FG000|Overall Study|Adverse Event|1|||
160879337|NCT02626624|580952307|FG000|Overall Study|Lost to Follow-up|3|||
160879338|NCT02626624|580952307|FG000|Overall Study|Protocol Violation|4|||
160879339|NCT02626624|580952307|FG000|Overall Study|Death|2|||
160879340|NCT01097005|580952308|FG000|Overall Study|Case Report Form not collected|18|||
160769457|NCT00171249|580542535|FG005|Overall Study|No Longer Requires Study Drug|5|||
160769458|NCT00171249|580542536|FG006|Overall Study|No Longer Requires Study Drug|0|||
160769459|NCT00171249|580542530|FG000|Overall Study|Administrative Problems|1|||
160769460|NCT00171249|580542531|FG001|Overall Study|Administrative Problems|0|||
160769461|NCT00171249|580542532|FG002|Overall Study|Administrative Problems|0|||
160769462|NCT00171249|580542533|FG003|Overall Study|Administrative Problems|2|||
160769463|NCT00171249|580542534|FG004|Overall Study|Administrative Problems|0|||
160769464|NCT00171249|580542535|FG005|Overall Study|Administrative Problems|0|||
160769465|NCT00171249|580542536|FG006|Overall Study|Administrative Problems|0|||
160769466|NCT00171249|580542530|FG000|Overall Study|Adverse Event|3|||
160769467|NCT00171249|580542531|FG001|Overall Study|Adverse Event|1|||
160769468|NCT00171249|580542532|FG002|Overall Study|Adverse Event|0|||
160769469|NCT00171249|580542533|FG003|Overall Study|Adverse Event|15|||
160769470|NCT00171249|580542534|FG004|Overall Study|Adverse Event|0|||
160769471|NCT00171249|580542535|FG005|Overall Study|Adverse Event|2|||
160769472|NCT00171249|580542536|FG006|Overall Study|Adverse Event|0|||
160769473|NCT00171249|580542530|FG000|Overall Study|Lost to Follow-up|5|||
160769474|NCT00171249|580542531|FG001|Overall Study|Lost to Follow-up|0|||
160769475|NCT00171249|580542532|FG002|Overall Study|Lost to Follow-up|0|||
160769476|NCT00171249|580542533|FG003|Overall Study|Lost to Follow-up|9|||
160769477|NCT00171249|580542534|FG004|Overall Study|Lost to Follow-up|0|||
160769478|NCT00171249|580542535|FG005|Overall Study|Lost to Follow-up|0|||
160879341|NCT01097005|580952308|FG000|Overall Study|Subjects cannot visit the hospital|1|||
160879342|NCT01097005|580952308|FG000|Overall Study|Poor medication compliance|1|||
160879343|NCT01097005|580952308|FG000|Overall Study|No examination data available|244|||
160879344|NCT01097005|580952308|FG000|Overall Study|Deviation from exclusion criteria|37|||
160769479|NCT00171249|580542536|FG006|Overall Study|Lost to Follow-up|0|||
160769480|NCT00392223|580542537|FG000|Overall Study|Adverse Event|5|||
160769481|NCT00392223|580542538|FG001|Overall Study|Adverse Event|4|||
160769482|NCT00392223|580542537|FG000|Overall Study|Lost to Follow-up|1|||
160769483|NCT00392223|580542538|FG001|Overall Study|Lost to Follow-up|4|||
160769484|NCT00392223|580542537|FG000|Overall Study|Protocol Violation|0|||
160769485|NCT00392223|580542538|FG001|Overall Study|Protocol Violation|3|||
160769486|NCT00392223|580542537|FG000|Overall Study|Withdrawal by Subject|3|||
160769487|NCT00392223|580542538|FG001|Overall Study|Withdrawal by Subject|2|||
160769488|NCT02908347|580542539|FG000|Overall Study|Adverse Event|0|||
160769489|NCT02908347|580542540|FG001|Overall Study|Adverse Event|1|||
160769490|NCT02908347|580542539|FG000|Overall Study|Lost to Follow-up|1|||
160769491|NCT02908347|580542540|FG001|Overall Study|Lost to Follow-up|0|||
160769492|NCT03344757|580542543|FG000|Overall Study|Withdrawal by Subject|18|||
160769493|NCT03344757|580542544|FG001|Overall Study|Withdrawal by Subject|16|||
160769494|NCT03344757|580542543|FG000|Overall Study|Lost to Follow-up|0|||
160769495|NCT03344757|580542544|FG001|Overall Study|Lost to Follow-up|2|||
160769496|NCT00269152|580542545|FG000|Overall Study|Adverse Event|9|||
160769497|NCT00269152|580542546|FG001|Overall Study|Adverse Event|3|||
160769498|NCT00269152|580542545|FG000|Overall Study|Withdrawal by Subject|7|||
160769499|NCT00269152|580542546|FG001|Overall Study|Withdrawal by Subject|3|||
160769500|NCT00269152|580542545|FG000|Overall Study|Physician Decision|2|||
160769501|NCT00269152|580542546|FG001|Overall Study|Physician Decision|3|||
160769502|NCT00269152|580542545|FG000|Overall Study|Protocol Violation|0|||
160769503|NCT00269152|580542546|FG001|Overall Study|Protocol Violation|1|||
160769504|NCT01316575|580542547|FG000|Overall Study|Withdrawal by Subject|2|||
160769505|NCT01316575|580542548|FG001|Overall Study|Withdrawal by Subject|0|||
160769506|NCT01316575|580542547|FG000|Overall Study|Required alternate treatment|0|||
160769507|NCT01316575|580542548|FG001|Overall Study|Required alternate treatment|1|||
160769508|NCT00402831|580542549|FG000|Overall Study|Lost to Follow-up|1|||
160769509|NCT00402831|580542550|FG001|Overall Study|Lost to Follow-up|2|||
160769510|NCT00402831|580542549|FG000|Overall Study|Non-compliance with protocol|0|||
160769511|NCT00402831|580542550|FG001|Overall Study|Non-compliance with protocol|1|||
160769512|NCT01832766|580542559|FG000|Washout|Lost to Follow-up|0|||
160769513|NCT01832766|580542560|FG001|Washout|Lost to Follow-up|1|||
160769514|NCT02814526|580542563|FG000|Overall Study|Adverse Event|4|||
160769515|NCT02814526|580542564|FG001|Overall Study|Adverse Event|3|||
160769516|NCT02814526|580542563|FG000|Overall Study|Death|1|||
160769517|NCT02814526|580542564|FG001|Overall Study|Death|1|||
160769518|NCT02814526|580542563|FG000|Overall Study|Lost to Follow-up|3|||
160769519|NCT02814526|580542564|FG001|Overall Study|Lost to Follow-up|4|||
160769520|NCT02814526|580542563|FG000|Overall Study|non site physician decision|1|||
160769521|NCT02814526|580542564|FG001|Overall Study|non site physician decision|0|||
160769522|NCT02814526|580542563|FG000|Overall Study|participant noncompliance|1|||
160769523|NCT02814526|580542564|FG001|Overall Study|participant noncompliance|1|||
160769524|NCT02814526|580542563|FG000|Overall Study|Withdrawal by Subject|20|||
160769525|NCT02814526|580542564|FG001|Overall Study|Withdrawal by Subject|14|||
160769526|NCT02814526|580542563|FG000|Overall Study|safety risk|2|||
160769527|NCT02814526|580542564|FG001|Overall Study|safety risk|1|||
160769528|NCT02814526|580542563|FG000|Overall Study|early termination-study terminated|1|||
160769529|NCT02814526|580542564|FG001|Overall Study|early termination-study terminated|2|||
160769530|NCT02814526|580542563|FG000|Overall Study|Other|0|||
160769531|NCT02814526|580542564|FG001|Overall Study|Other|4|||
160769532|NCT03533751|580542565|FG000|Overall Study|Withdrawal by Subject|12|||
160769533|NCT03533751|580542566|FG001|Overall Study|Withdrawal by Subject|6|||
160769534|NCT03533751|580542567|FG002|Overall Study|Withdrawal by Subject|11|||
160769535|NCT03533751|580542568|FG003|Overall Study|Withdrawal by Subject|9|||
160769536|NCT03533751|580542569|FG004|Overall Study|Withdrawal by Subject|10|||
160769537|NCT03533751|580542565|FG000|Overall Study|Adverse Event|4|||
160769538|NCT03533751|580542566|FG001|Overall Study|Adverse Event|7|||
160769539|NCT03533751|580542567|FG002|Overall Study|Adverse Event|2|||
160769540|NCT03533751|580542568|FG003|Overall Study|Adverse Event|4|||
160769541|NCT03533751|580542569|FG004|Overall Study|Adverse Event|5|||
160769542|NCT03533751|580542565|FG000|Overall Study|Physician Decision|0|||
160769543|NCT03533751|580542566|FG001|Overall Study|Physician Decision|2|||
160769544|NCT03533751|580542567|FG002|Overall Study|Physician Decision|1|||
160769545|NCT03533751|580542568|FG003|Overall Study|Physician Decision|2|||
160769546|NCT03533751|580542569|FG004|Overall Study|Physician Decision|1|||
160769547|NCT03533751|580542565|FG000|Overall Study|Sponsor Decision|0|||
160769548|NCT03533751|580542566|FG001|Overall Study|Sponsor Decision|0|||
160769549|NCT03533751|580542567|FG002|Overall Study|Sponsor Decision|1|||
160769550|NCT03533751|580542568|FG003|Overall Study|Sponsor Decision|1|||
160769551|NCT03533751|580542569|FG004|Overall Study|Sponsor Decision|0|||
160769552|NCT03533751|580542565|FG000|Overall Study|Lost to Follow-up|3|||
160769553|NCT03533751|580542566|FG001|Overall Study|Lost to Follow-up|7|||
160769554|NCT03533751|580542567|FG002|Overall Study|Lost to Follow-up|6|||
160769555|NCT03533751|580542568|FG003|Overall Study|Lost to Follow-up|4|||
160769556|NCT03533751|580542569|FG004|Overall Study|Lost to Follow-up|3|||
160769557|NCT03533751|580542565|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
160769558|NCT03533751|580542566|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
160769559|NCT03533751|580542567|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
160769560|NCT03533751|580542568|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
160769561|NCT03533751|580542569|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
160538704|NCT02819635|579702281|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
160538705|NCT02819635|579702270|FG000|Substudy 2, Part 2|Other, not specified|0|||
160538706|NCT02819635|579702271|FG001|Substudy 2, Part 2|Other, not specified|0|||
160538707|NCT02819635|579702272|FG002|Substudy 2, Part 2|Other, not specified|0|||
160538708|NCT02819635|579702273|FG003|Substudy 2, Part 2|Other, not specified|0|||
160538709|NCT02819635|579702274|FG004|Substudy 2, Part 2|Other, not specified|0|||
160769562|NCT03533751|580542565|FG000|Overall Study|Other|0|||
160769563|NCT03533751|580542566|FG001|Overall Study|Other|2|||
160769564|NCT03533751|580542567|FG002|Overall Study|Other|1|||
160769565|NCT03533751|580542568|FG003|Overall Study|Other|0|||
160769566|NCT03533751|580542569|FG004|Overall Study|Other|3|||
160769567|NCT01416571|580542570|FG000|Overall Study|Lost to Follow-up|2|||
160769568|NCT03608163|580542571|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
160769569|NCT03608163|580542572|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
160769570|NCT01288430|580544274|FG000|Part 1|Progressive disease|2|||
160769571|NCT01288430|580544275|FG001|Part 1|Progressive disease|1|||
160769572|NCT01288430|580544276|FG002|Part 1|Progressive disease|1|||
160769573|NCT01288430|580544277|FG003|Part 1|Progressive disease|6|||
160769574|NCT01288430|580544278|FG004|Part 1|Progressive disease|2|||
160769575|NCT01288430|580544279|FG005|Part 1|Progressive disease|4|||
160769576|NCT01288430|580544280|FG006|Part 1|Progressive disease|2|||
160769577|NCT01288430|580544281|FG007|Part 1|Progressive disease|0|||
160769578|NCT01288430|580544282|FG008|Part 1|Progressive disease|0|||
160769579|NCT01288430|580544283|FG009|Part 1|Progressive disease|0|||
160769580|NCT01288430|580544274|FG000|Part 1|Clinical disease progression|0|||
160769581|NCT01288430|580544275|FG001|Part 1|Clinical disease progression|0|||
160769582|NCT01288430|580544276|FG002|Part 1|Clinical disease progression|1|||
160769583|NCT01288430|580544277|FG003|Part 1|Clinical disease progression|0|||
160769584|NCT01288430|580544278|FG004|Part 1|Clinical disease progression|0|||
160769585|NCT01288430|580544279|FG005|Part 1|Clinical disease progression|2|||
160769586|NCT01288430|580544280|FG006|Part 1|Clinical disease progression|2|||
160769587|NCT01288430|580544281|FG007|Part 1|Clinical disease progression|0|||
160769588|NCT01288430|580544282|FG008|Part 1|Clinical disease progression|0|||
160769589|NCT01288430|580544283|FG009|Part 1|Clinical disease progression|0|||
160769590|NCT01288430|580544274|FG000|Part 1|Death due to disease progression|0|||
160769591|NCT01288430|580544275|FG001|Part 1|Death due to disease progression|0|||
160769592|NCT01288430|580544276|FG002|Part 1|Death due to disease progression|0|||
160769593|NCT01288430|580544277|FG003|Part 1|Death due to disease progression|0|||
160769594|NCT01288430|580544278|FG004|Part 1|Death due to disease progression|1|||
160769595|NCT01288430|580544279|FG005|Part 1|Death due to disease progression|0|||
160769596|NCT01288430|580544280|FG006|Part 1|Death due to disease progression|0|||
160769597|NCT01288430|580544281|FG007|Part 1|Death due to disease progression|0|||
160769598|NCT01288430|580544282|FG008|Part 1|Death due to disease progression|0|||
160769599|NCT01288430|580544283|FG009|Part 1|Death due to disease progression|0|||
160769600|NCT01288430|580544274|FG000|Part 1|Adverse Event|0|||
160769601|NCT01288430|580544275|FG001|Part 1|Adverse Event|0|||
160769602|NCT01288430|580544276|FG002|Part 1|Adverse Event|3|||
160769603|NCT01288430|580544277|FG003|Part 1|Adverse Event|1|||
160769604|NCT01288430|580544278|FG004|Part 1|Adverse Event|0|||
160769605|NCT01288430|580544279|FG005|Part 1|Adverse Event|0|||
160769606|NCT01288430|580544280|FG006|Part 1|Adverse Event|2|||
160769607|NCT01288430|580544281|FG007|Part 1|Adverse Event|0|||
160769608|NCT01288430|580544282|FG008|Part 1|Adverse Event|0|||
160769609|NCT01288430|580544283|FG009|Part 1|Adverse Event|0|||
160769610|NCT01288430|580544274|FG000|Part 1|Other|0|||
160769611|NCT01288430|580544275|FG001|Part 1|Other|2|||
160769612|NCT01288430|580544276|FG002|Part 1|Other|0|||
160769613|NCT01288430|580544277|FG003|Part 1|Other|0|||
160769614|NCT01288430|580544278|FG004|Part 1|Other|0|||
160769615|NCT01288430|580544279|FG005|Part 1|Other|0|||
160769616|NCT01288430|580544280|FG006|Part 1|Other|1|||
160769617|NCT01288430|580544281|FG007|Part 1|Other|0|||
160769618|NCT01288430|580544282|FG008|Part 1|Other|0|||
160769619|NCT01288430|580544283|FG009|Part 1|Other|0|||
160769620|NCT01288430|580544274|FG000|Part 2|Progressive disease|0|||
160769621|NCT01288430|580544275|FG001|Part 2|Progressive disease|0|||
160769622|NCT01288430|580544276|FG002|Part 2|Progressive disease|0|||
160769623|NCT01288430|580544277|FG003|Part 2|Progressive disease|0|||
160769624|NCT01288430|580544278|FG004|Part 2|Progressive disease|0|||
160769625|NCT01288430|580544279|FG005|Part 2|Progressive disease|0|||
160769626|NCT01288430|580544280|FG006|Part 2|Progressive disease|0|||
160769627|NCT01288430|580544281|FG007|Part 2|Progressive disease|8|||
160879345|NCT01097005|580952308|FG000|Overall Study|Adverse Event|14|||
160538710|NCT02819635|579702275|FG005|Substudy 2, Part 2|Other, not specified|4|||
160879346|NCT01097005|580952308|FG000|Overall Study|Discontinuance by complication|50|||
160879347|NCT03425253|580952312|FG000|Overall Study|Adverse Event|2|||
160879348|NCT03425253|580952312|FG000|Overall Study|Lost to Follow-up|3|||
160879349|NCT03425253|580952312|FG000|Overall Study|Withdrew Consent|6|||
160879350|NCT03425253|580952312|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
160879351|NCT04627285|580952317|FG000|Overall Study|Adverse Event|0|||
160879352|NCT04627285|580952318|FG001|Overall Study|Adverse Event|2|||
160879353|NCT04627285|580952317|FG000|Overall Study|Lost to Follow-up|1|||
160879354|NCT04627285|580952318|FG001|Overall Study|Lost to Follow-up|0|||
160879355|NCT04627285|580952317|FG000|Overall Study|Withdrawal by Subject|1|||
160879356|NCT04627285|580952318|FG001|Overall Study|Withdrawal by Subject|1|||
160879357|NCT04627285|580952317|FG000|Overall Study|Sponsor decision|5|||
160879358|NCT04627285|580952318|FG001|Overall Study|Sponsor decision|0|||
160879359|NCT04627285|580952317|FG000|Overall Study|Participant left country; aunt informed the site|0|||
160879360|NCT04627285|580952318|FG001|Overall Study|Participant left country; aunt informed the site|1|||
160879361|NCT03658876|580953865|FG000|Overall Study|Protocol Violation|3|||
160879362|NCT03658876|580953866|FG001|Overall Study|Protocol Violation|2|||
160769628|NCT01288430|580544282|FG008|Part 2|Progressive disease|7|||
160769629|NCT01288430|580544283|FG009|Part 2|Progressive disease|2|||
160769630|NCT01288430|580544274|FG000|Part 2|Clinical disease progression|0|||
160769631|NCT01288430|580544275|FG001|Part 2|Clinical disease progression|0|||
160769632|NCT01288430|580544276|FG002|Part 2|Clinical disease progression|0|||
160769633|NCT01288430|580544277|FG003|Part 2|Clinical disease progression|0|||
160769634|NCT01288430|580544278|FG004|Part 2|Clinical disease progression|0|||
160879363|NCT03658876|580953865|FG000|Overall Study|Withdrawal by Subject|2|||
160879364|NCT03658876|580953866|FG001|Overall Study|Withdrawal by Subject|0|||
160879365|NCT03658876|580953865|FG000|Overall Study|Death|0|||
160879366|NCT03658876|580953866|FG001|Overall Study|Death|1|||
160879367|NCT03658876|580953865|FG000|Overall Study|Intercurrent illness|6|||
160879368|NCT03658876|580953866|FG001|Overall Study|Intercurrent illness|4|||
160879369|NCT03658876|580953865|FG000|Overall Study|Transplantation/other operation|1|||
160879370|NCT03658876|580953866|FG001|Overall Study|Transplantation/other operation|5|||
160879371|NCT01330017|580953867|FG000|Overall Study|Adverse Event|0|||
160879372|NCT01330017|580953868|FG001|Overall Study|Adverse Event|1|||
160879373|NCT01330017|580953869|FG002|Overall Study|Adverse Event|1|||
160879374|NCT01330017|580953870|FG003|Overall Study|Adverse Event|4|||
160879375|NCT01330017|580953871|FG004|Overall Study|Adverse Event|0|||
160769635|NCT01288430|580544279|FG005|Part 2|Clinical disease progression|0|||
160769636|NCT01288430|580544280|FG006|Part 2|Clinical disease progression|0|||
160769637|NCT01288430|580544281|FG007|Part 2|Clinical disease progression|2|||
160769638|NCT01288430|580544282|FG008|Part 2|Clinical disease progression|0|||
160769639|NCT01288430|580544283|FG009|Part 2|Clinical disease progression|0|||
160769640|NCT01288430|580544274|FG000|Part 2|Withdrawal by Subject|0|||
160769641|NCT01288430|580544275|FG001|Part 2|Withdrawal by Subject|0|||
160769642|NCT01288430|580544276|FG002|Part 2|Withdrawal by Subject|0|||
160769643|NCT01288430|580544277|FG003|Part 2|Withdrawal by Subject|0|||
160769644|NCT01288430|580544278|FG004|Part 2|Withdrawal by Subject|0|||
160769645|NCT01288430|580544279|FG005|Part 2|Withdrawal by Subject|0|||
160769646|NCT01288430|580544280|FG006|Part 2|Withdrawal by Subject|0|||
160769647|NCT01288430|580544281|FG007|Part 2|Withdrawal by Subject|1|||
160769648|NCT01288430|580544282|FG008|Part 2|Withdrawal by Subject|4|||
160769649|NCT01288430|580544283|FG009|Part 2|Withdrawal by Subject|0|||
160769650|NCT01288430|580544274|FG000|Part 2|Adverse Event|0|||
160769651|NCT01288430|580544275|FG001|Part 2|Adverse Event|0|||
160769652|NCT01288430|580544276|FG002|Part 2|Adverse Event|0|||
160769653|NCT01288430|580544277|FG003|Part 2|Adverse Event|0|||
160769654|NCT01288430|580544278|FG004|Part 2|Adverse Event|0|||
160769655|NCT01288430|580544279|FG005|Part 2|Adverse Event|0|||
160879376|NCT01330017|580953867|FG000|Overall Study|Withdrawal by Subject|0|||
160879377|NCT01330017|580953868|FG001|Overall Study|Withdrawal by Subject|0|||
160769656|NCT01288430|580544280|FG006|Part 2|Adverse Event|0|||
160769657|NCT01288430|580544281|FG007|Part 2|Adverse Event|1|||
160769658|NCT01288430|580544282|FG008|Part 2|Adverse Event|1|||
160769659|NCT01288430|580544283|FG009|Part 2|Adverse Event|0|||
160769660|NCT01288430|580544274|FG000|Part 2|Other|0|||
160769661|NCT01288430|580544275|FG001|Part 2|Other|0|||
160769662|NCT01288430|580544276|FG002|Part 2|Other|0|||
160879378|NCT01330017|580953869|FG002|Overall Study|Withdrawal by Subject|1|||
160769663|NCT01288430|580544277|FG003|Part 2|Other|0|||
160769664|NCT01288430|580544278|FG004|Part 2|Other|0|||
160769665|NCT01288430|580544279|FG005|Part 2|Other|0|||
160769666|NCT01288430|580544280|FG006|Part 2|Other|0|||
160879379|NCT01330017|580953870|FG003|Overall Study|Withdrawal by Subject|0|||
160538711|NCT02819635|579702276|FG006|Substudy 2, Part 2|Other, not specified|8|||
160538712|NCT02819635|579702277|FG007|Substudy 2, Part 2|Other, not specified|0|||
160538713|NCT02819635|579702278|FG008|Substudy 2, Part 2|Other, not specified|0|||
160538714|NCT02819635|579702279|FG009|Substudy 2, Part 2|Other, not specified|0|||
160538715|NCT02819635|579702280|FG010|Substudy 2, Part 2|Other, not specified|0|||
160538716|NCT02819635|579702281|FG011|Substudy 2, Part 2|Other, not specified|0|||
160538717|NCT02819635|579702270|FG000|Substudy 3|Adverse Event|0|||
160538718|NCT02819635|579702271|FG001|Substudy 3|Adverse Event|0|||
160538719|NCT02819635|579702272|FG002|Substudy 3|Adverse Event|0|||
160538720|NCT02819635|579702273|FG003|Substudy 3|Adverse Event|0|||
160538721|NCT02819635|579702274|FG004|Substudy 3|Adverse Event|0|||
160538722|NCT02819635|579702275|FG005|Substudy 3|Adverse Event|0|||
160538723|NCT02819635|579702276|FG006|Substudy 3|Adverse Event|0|||
160538724|NCT02819635|579702277|FG007|Substudy 3|Adverse Event|0|||
160538725|NCT02819635|579702278|FG008|Substudy 3|Adverse Event|32|||
160538726|NCT02819635|579702279|FG009|Substudy 3|Adverse Event|3|||
160538727|NCT02819635|579702280|FG010|Substudy 3|Adverse Event|12|||
160769667|NCT01288430|580544281|FG007|Part 2|Other|0|||
160769668|NCT01288430|580544282|FG008|Part 2|Other|0|||
160769669|NCT01288430|580544283|FG009|Part 2|Other|1|||
160769670|NCT04770753|580544286|FG000|Overall Study|Randomized, never treated|1|||
160769671|NCT04770753|580544287|FG001|Overall Study|Randomized, never treated|1|||
160769672|NCT04770753|580544286|FG000|Overall Study|Withdrawal by Subject|3|||
160769673|NCT04770753|580544287|FG001|Overall Study|Withdrawal by Subject|1|||
160769674|NCT04770753|580544286|FG000|Overall Study|Adverse Event|2|||
160769675|NCT04770753|580544287|FG001|Overall Study|Adverse Event|0|||
160769676|NCT04770753|580544286|FG000|Overall Study|Pregnancy|1|||
160769677|NCT04770753|580544287|FG001|Overall Study|Pregnancy|0|||
160769678|NCT04770753|580544286|FG000|Overall Study|Other un-specified|1|||
160769679|NCT04770753|580544287|FG001|Overall Study|Other un-specified|0|||
160769680|NCT02807259|580544290|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
160769681|NCT02807259|580544291|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
160769682|NCT02807259|580544290|FG000|Midline (3 Months)|migration, refusal, not available|30|||
160769683|NCT02807259|580544291|FG001|Midline (3 Months)|migration, refusal, not available|34|||
160769684|NCT02807259|580544290|FG000|Endline (3 Months)|migration, refusal, not available|35|||
160769685|NCT02807259|580544291|FG001|Endline (3 Months)|migration, refusal, not available|87|||
160769686|NCT04476043|580544292|FG000|Overall Study|Withdrawal by Subject|1|||
160769687|NCT04476043|580544293|FG001|Overall Study|Withdrawal by Subject|3|||
160769688|NCT04476043|580544294|FG002|Overall Study|Withdrawal by Subject|4|||
160769689|NCT04476043|580544295|FG003|Overall Study|Withdrawal by Subject|1|||
160769690|NCT04476043|580544292|FG000|Overall Study|Lost to Follow-up|1|||
160769691|NCT04476043|580544293|FG001|Overall Study|Lost to Follow-up|1|||
160769692|NCT04476043|580544294|FG002|Overall Study|Lost to Follow-up|2|||
160769693|NCT04476043|580544295|FG003|Overall Study|Lost to Follow-up|1|||
160769694|NCT04476043|580544292|FG000|Overall Study|Adverse Event|2|||
160769695|NCT04476043|580544293|FG001|Overall Study|Adverse Event|0|||
160769696|NCT04476043|580544294|FG002|Overall Study|Adverse Event|1|||
160769697|NCT04476043|580544295|FG003|Overall Study|Adverse Event|0|||
160769698|NCT04476043|580544292|FG000|Overall Study|Protocol Violation|0|||
160769699|NCT04476043|580544293|FG001|Overall Study|Protocol Violation|1|||
160769700|NCT04476043|580544294|FG002|Overall Study|Protocol Violation|0|||
160769701|NCT04476043|580544295|FG003|Overall Study|Protocol Violation|0|||
160769702|NCT04757636|580544296|FG000|Overall Study|Adverse Event|25|||
160769703|NCT04757636|580544297|FG001|Overall Study|Adverse Event|8|||
160769704|NCT04757636|580544298|FG002|Overall Study|Adverse Event|11|||
160769705|NCT04757636|580544296|FG000|Overall Study|Death|9|||
160769706|NCT04757636|580544297|FG001|Overall Study|Death|12|||
160538728|NCT02819635|579702281|FG011|Substudy 3|Adverse Event|18|||
160769707|NCT04757636|580544298|FG002|Overall Study|Death|6|||
160769708|NCT04757636|580544296|FG000|Overall Study|Lack of Efficacy|2|||
160769709|NCT04757636|580544297|FG001|Overall Study|Lack of Efficacy|0|||
160769710|NCT04757636|580544298|FG002|Overall Study|Lack of Efficacy|0|||
160769711|NCT04757636|580544296|FG000|Overall Study|Lost to Follow-up|1|||
160769712|NCT04757636|580544297|FG001|Overall Study|Lost to Follow-up|6|||
160769713|NCT04757636|580544298|FG002|Overall Study|Lost to Follow-up|7|||
160769714|NCT04757636|580544296|FG000|Overall Study|Physician Decision|1|||
160769715|NCT04757636|580544297|FG001|Overall Study|Physician Decision|3|||
160769716|NCT04757636|580544298|FG002|Overall Study|Physician Decision|4|||
160769717|NCT04757636|580544296|FG000|Overall Study|Withdrawal by Subject|20|||
160769718|NCT04757636|580544297|FG001|Overall Study|Withdrawal by Subject|23|||
160769719|NCT04757636|580544298|FG002|Overall Study|Withdrawal by Subject|18|||
160769720|NCT04757636|580544296|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
160769721|NCT04757636|580544297|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
160769722|NCT04757636|580544298|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
160769723|NCT04757636|580544296|FG000|Overall Study|Study Terminated by Sponsor|103|||
160769724|NCT04757636|580544297|FG001|Overall Study|Study Terminated by Sponsor|104|||
160769725|NCT04757636|580544298|FG002|Overall Study|Study Terminated by Sponsor|114|||
160769726|NCT04757636|580544296|FG000|Overall Study|Sponsor Decision|0|||
160769727|NCT04757636|580544297|FG001|Overall Study|Sponsor Decision|0|||
160769728|NCT04757636|580544298|FG002|Overall Study|Sponsor Decision|1|||
160769729|NCT04757636|580544296|FG000|Overall Study|Randomized in Error|0|||
160769730|NCT04757636|580544297|FG001|Overall Study|Randomized in Error|0|||
160769731|NCT04757636|580544298|FG002|Overall Study|Randomized in Error|2|||
160769732|NCT01732692|580544302|FG000|Overall Study|Adverse Event|0|||
160769733|NCT01732692|580544303|FG001|Overall Study|Adverse Event|1|||
160769734|NCT01155323|580544310|FG000|First Intervention|exclusion criteria|1|||
160769735|NCT01155323|580544311|FG001|First Intervention|exclusion criteria|1|||
160769736|NCT01155323|580544310|FG000|Second Intervention|Lost to Follow-up|1|||
160769737|NCT01155323|580544311|FG001|Second Intervention|Lost to Follow-up|1|||
160769738|NCT01208051|580544312|FG000|Total Enrollment|Withdrawal by Subject|0|||
160879380|NCT01330017|580953871|FG004|Overall Study|Withdrawal by Subject|1|||
160879381|NCT01330017|580953867|FG000|Overall Study|Lost to Follow-up|0|||
160879382|NCT01330017|580953868|FG001|Overall Study|Lost to Follow-up|0|||
160879383|NCT01330017|580953869|FG002|Overall Study|Lost to Follow-up|1|||
160879384|NCT01330017|580953870|FG003|Overall Study|Lost to Follow-up|0|||
160879385|NCT01330017|580953871|FG004|Overall Study|Lost to Follow-up|0|||
160879386|NCT01330017|580953867|FG000|Overall Study|Protocol Violation|0|||
160879387|NCT01330017|580953868|FG001|Overall Study|Protocol Violation|0|||
160879388|NCT01330017|580953869|FG002|Overall Study|Protocol Violation|0|||
160879389|NCT01330017|580953870|FG003|Overall Study|Protocol Violation|1|||
160879390|NCT01330017|580953871|FG004|Overall Study|Protocol Violation|0|||
160879391|NCT01330017|580953867|FG000|Overall Study|Unknown Reason|5|||
160879392|NCT01330017|580953868|FG001|Overall Study|Unknown Reason|3|||
160879393|NCT01330017|580953869|FG002|Overall Study|Unknown Reason|5|||
160769739|NCT01208051|580544313|FG001|Total Enrollment|Withdrawal by Subject|1|||
160769740|NCT01208051|580544314|FG002|Total Enrollment|Withdrawal by Subject|0|||
160769741|NCT01208051|580544315|FG003|Total Enrollment|Withdrawal by Subject|0|||
160769742|NCT01208051|580544316|FG004|Total Enrollment|Withdrawal by Subject|2|||
160769743|NCT01208051|580544312|FG000|Total Enrollment|Brain metastases|0|||
160769744|NCT01208051|580544313|FG001|Total Enrollment|Brain metastases|0|||
160769745|NCT01208051|580544314|FG002|Total Enrollment|Brain metastases|1|||
160769746|NCT01208051|580544315|FG003|Total Enrollment|Brain metastases|0|||
160769747|NCT01208051|580544316|FG004|Total Enrollment|Brain metastases|0|||
160769748|NCT02349386|580544317|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
160769749|NCT02349386|580544318|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
160769750|NCT02349386|580544319|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
160769751|NCT02349386|580544320|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
160769752|NCT02349386|580544317|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
160769753|NCT02349386|580544318|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
160769754|NCT02349386|580544319|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
160769755|NCT02349386|580544320|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
160769756|NCT02349386|580544317|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
160769757|NCT02349386|580544318|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
160879394|NCT01330017|580953870|FG003|Overall Study|Unknown Reason|7|||
160879395|NCT01330017|580953871|FG004|Overall Study|Unknown Reason|2|||
160879396|NCT03137069|580953875|FG000|Overall Study|Withdrawal by Subject|1|||
160769758|NCT02349386|580544319|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
160769759|NCT02349386|580544320|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
160769760|NCT02349386|580544317|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
160769761|NCT02349386|580544318|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
160769762|NCT02349386|580544319|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
160769763|NCT02349386|580544320|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
160879397|NCT03137069|580953876|FG001|Overall Study|Withdrawal by Subject|2|||
160769764|NCT02349386|580544317|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
160879398|NCT03137069|580953877|FG002|Overall Study|Withdrawal by Subject|2|||
160879399|NCT03137069|580953878|FG003|Overall Study|Withdrawal by Subject|2|||
160879400|NCT03137069|580953879|FG004|Overall Study|Withdrawal by Subject|0|||
160879401|NCT03137069|580953880|FG005|Overall Study|Withdrawal by Subject|0|||
160879402|NCT03137069|580953875|FG000|Overall Study|Adverse Event|0|||
160879403|NCT03137069|580953876|FG001|Overall Study|Adverse Event|3|||
160879404|NCT03137069|580953877|FG002|Overall Study|Adverse Event|1|||
160538729|NCT02819635|579702270|FG000|Substudy 3|Withdrew consent|0|||
160538730|NCT02819635|579702271|FG001|Substudy 3|Withdrew consent|0|||
160538731|NCT02819635|579702272|FG002|Substudy 3|Withdrew consent|0|||
160879405|NCT03137069|580953878|FG003|Overall Study|Adverse Event|1|||
160538732|NCT02819635|579702273|FG003|Substudy 3|Withdrew consent|0|||
160538733|NCT02819635|579702274|FG004|Substudy 3|Withdrew consent|0|||
160538734|NCT02819635|579702275|FG005|Substudy 3|Withdrew consent|0|||
160538735|NCT02819635|579702276|FG006|Substudy 3|Withdrew consent|0|||
160538736|NCT02819635|579702277|FG007|Substudy 3|Withdrew consent|0|||
160538737|NCT02819635|579702278|FG008|Substudy 3|Withdrew consent|11|||
160879406|NCT03137069|580953879|FG004|Overall Study|Adverse Event|0|||
160879407|NCT03137069|580953880|FG005|Overall Study|Adverse Event|1|||
160879408|NCT03137069|580953875|FG000|Overall Study|Protocol Violation|0|||
160879409|NCT03137069|580953876|FG001|Overall Study|Protocol Violation|1|||
160879410|NCT03137069|580953877|FG002|Overall Study|Protocol Violation|0|||
160879411|NCT03137069|580953878|FG003|Overall Study|Protocol Violation|1|||
160538738|NCT02819635|579702279|FG009|Substudy 3|Withdrew consent|1|||
160538739|NCT02819635|579702280|FG010|Substudy 3|Withdrew consent|4|||
160538740|NCT02819635|579702281|FG011|Substudy 3|Withdrew consent|9|||
160538741|NCT02819635|579702270|FG000|Substudy 3|Lost to Follow-up|0|||
160879412|NCT03137069|580953879|FG004|Overall Study|Protocol Violation|1|||
160879413|NCT03137069|580953880|FG005|Overall Study|Protocol Violation|1|||
160538742|NCT02819635|579702271|FG001|Substudy 3|Lost to Follow-up|0|||
160538743|NCT02819635|579702272|FG002|Substudy 3|Lost to Follow-up|0|||
160538744|NCT02819635|579702273|FG003|Substudy 3|Lost to Follow-up|0|||
160879414|NCT03137069|580953875|FG000|Overall Study|Physician Decision|0|||
160879415|NCT03137069|580953876|FG001|Overall Study|Physician Decision|0|||
160879416|NCT03137069|580953877|FG002|Overall Study|Physician Decision|0|||
160879417|NCT03137069|580953878|FG003|Overall Study|Physician Decision|1|||
160879418|NCT03137069|580953879|FG004|Overall Study|Physician Decision|0|||
160879419|NCT03137069|580953880|FG005|Overall Study|Physician Decision|0|||
160879420|NCT03137069|580953875|FG000|Overall Study|Study Terminated by Sponsor|0|||
160879421|NCT03137069|580953876|FG001|Overall Study|Study Terminated by Sponsor|0|||
160879422|NCT03137069|580953877|FG002|Overall Study|Study Terminated by Sponsor|0|||
160879423|NCT03137069|580953878|FG003|Overall Study|Study Terminated by Sponsor|0|||
160879424|NCT03137069|580953879|FG004|Overall Study|Study Terminated by Sponsor|1|||
160879425|NCT03137069|580953880|FG005|Overall Study|Study Terminated by Sponsor|0|||
160879426|NCT03137069|580953875|FG000|Overall Study|Data Entry Error|0|||
160879427|NCT03137069|580953876|FG001|Overall Study|Data Entry Error|0|||
160879428|NCT03137069|580953877|FG002|Overall Study|Data Entry Error|0|||
160879429|NCT03137069|580953878|FG003|Overall Study|Data Entry Error|1|||
160879430|NCT03137069|580953879|FG004|Overall Study|Data Entry Error|0|||
160879431|NCT03137069|580953880|FG005|Overall Study|Data Entry Error|0|||
160879432|NCT02043899|580953882|FG000|Overall Study|Adverse Event|3|||
160879433|NCT02043899|580953882|FG000|Overall Study|Physician Decision|1|||
160879434|NCT02043899|580953882|FG000|Overall Study|Withdrawal by Subject|2|||
160879435|NCT02043899|580953882|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
160879436|NCT02043899|580953882|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
160879437|NCT02043899|580953882|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
160879438|NCT02043899|580953882|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
160879439|NCT02043899|580953882|FG000|Overall Study|Treatment delayed|1|||
160879440|NCT01771809|580953883|FG000|Overall Study|Adverse Event|4|||
160879441|NCT01771809|580953884|FG001|Overall Study|Adverse Event|12|||
160879442|NCT01771809|580953883|FG000|Overall Study|Protocol Violation|0|||
160879443|NCT01771809|580953884|FG001|Overall Study|Protocol Violation|1|||
160879444|NCT01771809|580953883|FG000|Overall Study|Withdrawal by Subject|34|||
160879445|NCT01771809|580953884|FG001|Overall Study|Withdrawal by Subject|42|||
160879446|NCT01771809|580953883|FG000|Overall Study|Lost to Follow-up|1|||
160879447|NCT01771809|580953884|FG001|Overall Study|Lost to Follow-up|3|||
160879448|NCT01771809|580953883|FG000|Overall Study|Other (Insufficient clinical response)|22|||
160879449|NCT01771809|580953884|FG001|Overall Study|Other (Insufficient clinical response)|20|||
160879450|NCT01771809|580953883|FG000|Overall Study|Death|1|||
160879451|NCT01771809|580953884|FG001|Overall Study|Death|0|||
160879452|NCT01771809|580953883|FG000|Overall Study|Other (other)|9|||
160879453|NCT01771809|580953884|FG001|Overall Study|Other (other)|5|||
160879454|NCT01106092|580953885|FG000|Overall Study|Withdrawal by Subject|0|||
160879455|NCT01106092|580953886|FG001|Overall Study|Withdrawal by Subject|0|||
160879456|NCT01106092|580953887|FG002|Overall Study|Withdrawal by Subject|0|||
160879457|NCT01106092|580953888|FG003|Overall Study|Withdrawal by Subject|1|||
160879458|NCT02434471|580953889|FG000|Overall Study|Physician Decision|9|||
160879459|NCT00369629|580953894|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
160879460|NCT00369629|580953895|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
160879461|NCT00369629|580953896|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
160879462|NCT00369629|580953897|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
160879463|NCT00369629|580953894|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
160879464|NCT00369629|580953895|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
160879465|NCT00369629|580953896|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
160879466|NCT00369629|580953897|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
160879467|NCT00369629|580953894|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
160879468|NCT00369629|580953895|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
160879469|NCT00369629|580953896|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
160879470|NCT00369629|580953897|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
160879471|NCT00369629|580953894|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
160879472|NCT00369629|580953895|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
160879473|NCT00369629|580953896|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
160879474|NCT00369629|580953897|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
160879475|NCT00369629|580953894|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
160879476|NCT00369629|580953895|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
160879477|NCT00369629|580953896|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
160879478|NCT00369629|580953897|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
160879479|NCT00369629|580953894|FG000|Completed 4 More Cycles|Progressive disease|2|||
160879480|NCT00369629|580953895|FG001|Completed 4 More Cycles|Progressive disease|1|||
160879481|NCT00369629|580953896|FG002|Completed 4 More Cycles|Progressive disease|2|||
160879482|NCT00369629|580953897|FG003|Completed 4 More Cycles|Progressive disease|0|||
160636684|NCT01222715|580053562|FG000|Overall Study|Refusal of further protocol therapy|0|||
160879483|NCT00369629|580953894|FG000|Follow up for 1 Year|Death|2|||
160879484|NCT00369629|580953895|FG001|Follow up for 1 Year|Death|1|||
160769765|NCT02349386|580544318|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
160769766|NCT02349386|580544319|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
160769767|NCT02349386|580544320|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
160769768|NCT02349386|580544317|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
160769769|NCT02349386|580544318|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
160769770|NCT02349386|580544319|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
160769771|NCT02349386|580544320|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
160769772|NCT00973973|580544321|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
160769773|NCT00973973|580544322|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
160769774|NCT00973973|580544321|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
160769775|NCT00973973|580544322|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
160769776|NCT00973973|580544321|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
160769777|NCT00973973|580544322|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
160769778|NCT00973973|580544321|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
160769779|NCT00973973|580544322|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
160769780|NCT00973973|580544321|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
160769781|NCT00973973|580544322|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
160879485|NCT00369629|580953896|FG002|Follow up for 1 Year|Death|1|||
160538745|NCT02819635|579702274|FG004|Substudy 3|Lost to Follow-up|0|||
160538746|NCT02819635|579702275|FG005|Substudy 3|Lost to Follow-up|0|||
160538747|NCT02819635|579702276|FG006|Substudy 3|Lost to Follow-up|0|||
160538748|NCT02819635|579702277|FG007|Substudy 3|Lost to Follow-up|0|||
160538749|NCT02819635|579702278|FG008|Substudy 3|Lost to Follow-up|1|||
160538750|NCT02819635|579702279|FG009|Substudy 3|Lost to Follow-up|0|||
160538751|NCT02819635|579702280|FG010|Substudy 3|Lost to Follow-up|1|||
160538752|NCT02819635|579702281|FG011|Substudy 3|Lost to Follow-up|1|||
160538753|NCT02819635|579702270|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
160538754|NCT02819635|579702271|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
160538755|NCT02819635|579702272|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
160538756|NCT02819635|579702273|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
160538757|NCT02819635|579702274|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
160538758|NCT02819635|579702275|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
160538759|NCT02819635|579702276|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
160879486|NCT00369629|580953897|FG003|Follow up for 1 Year|Death|0|||
160879487|NCT00369629|580953894|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
160879488|NCT00369629|580953895|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
160879489|NCT00369629|580953896|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
160879490|NCT00369629|580953897|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
160879491|NCT00369629|580953894|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
160879492|NCT00369629|580953895|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
160879493|NCT00369629|580953896|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
160879494|NCT00369629|580953897|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
160879495|NCT04839562|580953898|FG000|Overall Study|Withdrawal by Subject|0|||
160879496|NCT04839562|580953899|FG001|Overall Study|Withdrawal by Subject|1|||
160879497|NCT04839562|580953898|FG000|Overall Study|Physician Decision|0|||
160879498|NCT04839562|580953899|FG001|Overall Study|Physician Decision|1|||
160879499|NCT00877773|580953900|FG000|Overall Study|Disease Progression|44|||
160879500|NCT02907892|580953908|FG000|Overall Study|Lost to Follow-up|27|||
160879501|NCT02907892|580953909|FG001|Overall Study|Lost to Follow-up|40|||
160879502|NCT01974765|580953910|FG000|Overall Study|Withdrawal by Subject|1|||
160879503|NCT01974765|580953910|FG000|Overall Study|Death|1|||
160879504|NCT01974765|580953910|FG000|Overall Study|Adverse Event|2|||
160879505|NCT01347580|580953911|FG000|Overall Study|Withdrawal by Subject|13|||
160879506|NCT01347580|580953912|FG001|Overall Study|Withdrawal by Subject|23|||
160879507|NCT01347580|580953911|FG000|Overall Study|Death|30|||
160879508|NCT01347580|580953912|FG001|Overall Study|Death|19|||
160879509|NCT01347580|580953911|FG000|Overall Study|Protocol Violation|10|||
160538760|NCT02819635|579702277|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
160538761|NCT02819635|579702278|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
160769782|NCT00973973|580544321|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
160769783|NCT00973973|580544322|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
160769784|NCT00973973|580544321|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
160769785|NCT00973973|580544322|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
160769786|NCT00973973|580544321|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
160769787|NCT00973973|580544322|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
160769788|NCT00973973|580544321|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
160538762|NCT02819635|579702279|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
160769789|NCT00973973|580544322|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
160769790|NCT00973973|580544321|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
160769791|NCT00973973|580544322|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
160769792|NCT00973973|580544321|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
160769793|NCT00973973|580544322|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
160769794|NCT00973973|580544321|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
160769795|NCT00973973|580544322|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
160769796|NCT02471339|580544323|FG000|Overall Study|Did not provide follow-up data|2|||
160769797|NCT02471339|580544324|FG001|Overall Study|Did not provide follow-up data|0|||
160769798|NCT06057064|580544325|FG000|Overall Study|Death|2|||
160769799|NCT06057064|580544326|FG001|Overall Study|Death|0|||
160769800|NCT06057064|580544325|FG000|Overall Study|Physician Decision|1|||
160769801|NCT06057064|580544326|FG001|Overall Study|Physician Decision|0|||
160769802|NCT06057064|580544325|FG000|Overall Study|Withdrawal by Subject|1|||
160769803|NCT06057064|580544326|FG001|Overall Study|Withdrawal by Subject|1|||
160769804|NCT00851591|580544328|FG000|Overall Study|Withdrawal by Subject|2|||
160769805|NCT00851591|580544329|FG001|Overall Study|Withdrawal by Subject|0|||
160769806|NCT02736617|580544330|FG000|Treatment|Adverse Event|1|||
160769807|NCT02736617|580544330|FG000|Treatment|Lack of Efficacy|1|||
160769808|NCT02736617|580544330|FG000|Treatment|Withdrawal by Subject|1|||
160769809|NCT02736617|580544330|FG000|Maintenance|Lack of Efficacy|4|||
160769810|NCT02736617|580544330|FG000|Maintenance|Physician Decision|1|||
160769811|NCT00481676|580544333|FG000|Overall Study|Adverse Event|0|||
160769812|NCT00481676|580544334|FG001|Overall Study|Adverse Event|1|||
160769813|NCT00481676|580544333|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160769814|NCT00481676|580544334|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
160769815|NCT00481676|580544333|FG000|Overall Study|Administrative problem|1|||
160769816|NCT00481676|580544334|FG001|Overall Study|Administrative problem|0|||
160769817|NCT02911116|580544335|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160769818|NCT02911116|580544336|FG001|Overall Study|Insufficient Therapeutic Response|0|||
160769819|NCT02911116|580544335|FG000|Overall Study|Lost to Follow-up|0|||
160769820|NCT02911116|580544336|FG001|Overall Study|Lost to Follow-up|1|||
160769821|NCT02110693|580544337|FG000|Overall Study|Withdrawal by Subject|6|||
160769822|NCT02110693|580544338|FG001|Overall Study|Withdrawal by Subject|7|||
160769823|NCT02110693|580544337|FG000|Overall Study|skipped assessment|15|||
160769824|NCT02110693|580544338|FG001|Overall Study|skipped assessment|18|||
160769825|NCT02110693|580544337|FG000|Overall Study|technical difficulties|6|||
160769826|NCT02110693|580544338|FG001|Overall Study|technical difficulties|4|||
160769827|NCT02110693|580544337|FG000|Overall Study|Other|1|||
160769828|NCT02110693|580544338|FG001|Overall Study|Other|0|||
160769829|NCT00147238|580544343|FG000|Overall Study|Inevaluable|8|||
160769830|NCT04424901|580544344|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
160769831|NCT04424901|580544345|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
160769832|NCT01348269|580544346|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
160769833|NCT01348269|580544347|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
160769834|NCT01348269|580544346|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
160769835|NCT01348269|580544347|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
160769836|NCT01348269|580544346|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
160769837|NCT01348269|580544347|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
160769838|NCT00805532|580544348|FG000|Overall Study|invalid data|0|||
160769839|NCT00805532|580544349|FG001|Overall Study|invalid data|1|||
160769840|NCT02412657|580544350|FG000|Overall Study|Lost to Follow-up|1|||
160769841|NCT02412657|580544351|FG001|Overall Study|Lost to Follow-up|0|||
160769842|NCT02412657|580544352|FG002|Overall Study|Lost to Follow-up|0|||
160769843|NCT02412657|580544350|FG000|Overall Study|Protocol Violation|0|||
160769844|NCT02412657|580544351|FG001|Overall Study|Protocol Violation|2|||
160769845|NCT02412657|580544352|FG002|Overall Study|Protocol Violation|3|||
160769846|NCT00920816|580544356|FG000|Overall Study|Death|116|||
160769847|NCT00920816|580544357|FG001|Overall Study|Death|63|||
160769848|NCT00920816|580544358|FG002|Overall Study|Death|8|||
160769849|NCT00920816|580544359|FG003|Overall Study|Death|3|||
160769850|NCT00920816|580544356|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
160769851|NCT00920816|580544357|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
160769852|NCT00920816|580544358|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
160769853|NCT00920816|580544359|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
160769854|NCT00920816|580544356|FG000|Overall Study|Global deterioration of health status|2|||
160769855|NCT00920816|580544357|FG001|Overall Study|Global deterioration of health status|0|||
160769856|NCT00920816|580544358|FG002|Overall Study|Global deterioration of health status|0|||
160769857|NCT00920816|580544359|FG003|Overall Study|Global deterioration of health status|0|||
160769858|NCT00920816|580544356|FG000|Overall Study|Objective progression or relapse|6|||
160769859|NCT00920816|580544357|FG001|Overall Study|Objective progression or relapse|2|||
160769860|NCT00920816|580544358|FG002|Overall Study|Objective progression or relapse|0|||
160769861|NCT00920816|580544359|FG003|Overall Study|Objective progression or relapse|0|||
160769862|NCT00920816|580544356|FG000|Overall Study|Other|26|||
160769863|NCT00920816|580544357|FG001|Overall Study|Other|15|||
160769864|NCT00920816|580544358|FG002|Overall Study|Other|1|||
160769865|NCT00920816|580544359|FG003|Overall Study|Other|2|||
160769866|NCT00920816|580544356|FG000|Overall Study|Lost to Follow-up|11|||
160769867|NCT00920816|580544357|FG001|Overall Study|Lost to Follow-up|2|||
160769868|NCT00920816|580544358|FG002|Overall Study|Lost to Follow-up|0|||
160769869|NCT00920816|580544359|FG003|Overall Study|Lost to Follow-up|0|||
160769870|NCT00920816|580544356|FG000|Overall Study|Adverse Event|1|||
160769871|NCT00920816|580544357|FG001|Overall Study|Adverse Event|1|||
160769872|NCT00920816|580544358|FG002|Overall Study|Adverse Event|1|||
160769873|NCT00920816|580544359|FG003|Overall Study|Adverse Event|0|||
160769874|NCT00920816|580544356|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
160769875|NCT00920816|580544357|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
160769876|NCT00920816|580544358|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
160769877|NCT00920816|580544359|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
160769878|NCT00920816|580544356|FG000|Overall Study|Randomized but not treated|3|||
160769879|NCT00920816|580544357|FG001|Overall Study|Randomized but not treated|0|||
160769880|NCT00920816|580544358|FG002|Overall Study|Randomized but not treated|0|||
160769881|NCT00920816|580544359|FG003|Overall Study|Randomized but not treated|0|||
160769882|NCT02382939|580544362|FG000|Overall Study|Adverse Event|1|||
160769883|NCT02382939|580544363|FG001|Overall Study|Adverse Event|1|||
160769884|NCT02382939|580544362|FG000|Overall Study|Withdrawal by Subject|2|||
160769885|NCT02382939|580544363|FG001|Overall Study|Withdrawal by Subject|2|||
160769886|NCT00321763|580544364|FG000|Overall Study|Adverse Event|1|||
160769887|NCT00321763|580544365|FG001|Overall Study|Adverse Event|1|||
160769888|NCT00321763|580544366|FG002|Overall Study|Adverse Event|0|||
160769889|NCT00321763|580544367|FG003|Overall Study|Adverse Event|1|||
160769890|NCT00321763|580544364|FG000|Overall Study|Withdrawal by Subject|2|||
160769891|NCT00321763|580544365|FG001|Overall Study|Withdrawal by Subject|0|||
160769892|NCT00321763|580544366|FG002|Overall Study|Withdrawal by Subject|1|||
160769893|NCT00321763|580544367|FG003|Overall Study|Withdrawal by Subject|0|||
160769894|NCT00321763|580544364|FG000|Overall Study|Lost to Follow-up|3|||
160769895|NCT00321763|580544365|FG001|Overall Study|Lost to Follow-up|1|||
160769896|NCT00321763|580544366|FG002|Overall Study|Lost to Follow-up|5|||
160769897|NCT00321763|580544367|FG003|Overall Study|Lost to Follow-up|4|||
160769898|NCT04759131|580544371|FG000|Overall Study|Investigator's discretion|1|||
160769899|NCT04759131|580544372|FG001|Overall Study|Investigator's discretion|0|||
160769900|NCT04759131|580544371|FG000|Overall Study|Subject withdrawal|1|||
160769901|NCT04759131|580544372|FG001|Overall Study|Subject withdrawal|0|||
160769902|NCT00289276|580544374|FG000|Second Part of FAST Study (Expansion)|Death|0|||
160769903|NCT00289276|580544375|FG001|Second Part of FAST Study (Expansion)|Death|2|||
160769904|NCT00289276|580544374|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
160769905|NCT00289276|580544375|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
160769906|NCT00869960|580544376|FG000|Overall Study|Lost to Follow-up|2|||
160879510|NCT01347580|580953912|FG001|Overall Study|Protocol Violation|7|||
160769907|NCT05219162|580544379|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
160769908|NCT05219162|580544379|FG000|Overall Study|Withdrawal by Subject|23|||
160769909|NCT05516758|580544383|FG000|Overall Study|Adverse Event|5|||
160769910|NCT05516758|580544384|FG001|Overall Study|Adverse Event|1|||
160769911|NCT05516758|580544385|FG002|Overall Study|Adverse Event|3|||
160769912|NCT05516758|580544386|FG003|Overall Study|Adverse Event|0|||
160769913|NCT05516758|580544387|FG004|Overall Study|Adverse Event|1|||
160769914|NCT05516758|580544388|FG005|Overall Study|Adverse Event|3|||
160769915|NCT05516758|580544389|FG006|Overall Study|Adverse Event|5|||
160769916|NCT05516758|580544383|FG000|Overall Study|Assigned treatment by mistake|1|||
160769917|NCT05516758|580544384|FG001|Overall Study|Assigned treatment by mistake|0|||
160769918|NCT05516758|580544385|FG002|Overall Study|Assigned treatment by mistake|0|||
160769919|NCT05516758|580544386|FG003|Overall Study|Assigned treatment by mistake|0|||
160769920|NCT05516758|580544387|FG004|Overall Study|Assigned treatment by mistake|1|||
160769921|NCT05516758|580544388|FG005|Overall Study|Assigned treatment by mistake|0|||
160769922|NCT05516758|580544389|FG006|Overall Study|Assigned treatment by mistake|0|||
160769923|NCT05516758|580544383|FG000|Overall Study|Lack of Efficacy|6|||
160769924|NCT05516758|580544384|FG001|Overall Study|Lack of Efficacy|0|||
160769925|NCT05516758|580544385|FG002|Overall Study|Lack of Efficacy|2|||
160769926|NCT05516758|580544386|FG003|Overall Study|Lack of Efficacy|0|||
160769927|NCT05516758|580544387|FG004|Overall Study|Lack of Efficacy|3|||
160769928|NCT05516758|580544388|FG005|Overall Study|Lack of Efficacy|6|||
160769929|NCT05516758|580544389|FG006|Overall Study|Lack of Efficacy|3|||
160769930|NCT05516758|580544383|FG000|Overall Study|Lost to Follow-up|2|||
160769931|NCT05516758|580544384|FG001|Overall Study|Lost to Follow-up|0|||
160769932|NCT05516758|580544385|FG002|Overall Study|Lost to Follow-up|2|||
160769933|NCT05516758|580544386|FG003|Overall Study|Lost to Follow-up|0|||
160769934|NCT05516758|580544387|FG004|Overall Study|Lost to Follow-up|3|||
160769935|NCT05516758|580544388|FG005|Overall Study|Lost to Follow-up|2|||
160769936|NCT05516758|580544389|FG006|Overall Study|Lost to Follow-up|1|||
160769937|NCT05516758|580544383|FG000|Overall Study|Other- As reported by the site|2|||
160769938|NCT05516758|580544384|FG001|Overall Study|Other- As reported by the site|1|||
160769939|NCT05516758|580544385|FG002|Overall Study|Other- As reported by the site|8|||
160769940|NCT05516758|580544386|FG003|Overall Study|Other- As reported by the site|1|||
160769941|NCT05516758|580544387|FG004|Overall Study|Other- As reported by the site|2|||
160769942|NCT05516758|580544388|FG005|Overall Study|Other- As reported by the site|3|||
160769943|NCT05516758|580544389|FG006|Overall Study|Other- As reported by the site|8|||
160769944|NCT05516758|580544383|FG000|Overall Study|Physician Decision|1|||
160769945|NCT05516758|580544384|FG001|Overall Study|Physician Decision|0|||
160769946|NCT05516758|580544385|FG002|Overall Study|Physician Decision|7|||
160769947|NCT05516758|580544386|FG003|Overall Study|Physician Decision|0|||
160769948|NCT05516758|580544387|FG004|Overall Study|Physician Decision|1|||
160769949|NCT05516758|580544388|FG005|Overall Study|Physician Decision|1|||
160769950|NCT05516758|580544389|FG006|Overall Study|Physician Decision|2|||
160769951|NCT05516758|580544383|FG000|Overall Study|Protocol Deviation|1|||
160769952|NCT05516758|580544384|FG001|Overall Study|Protocol Deviation|0|||
160769953|NCT05516758|580544385|FG002|Overall Study|Protocol Deviation|0|||
160769954|NCT05516758|580544386|FG003|Overall Study|Protocol Deviation|0|||
160769955|NCT05516758|580544387|FG004|Overall Study|Protocol Deviation|0|||
160769956|NCT05516758|580544388|FG005|Overall Study|Protocol Deviation|1|||
160769957|NCT05516758|580544389|FG006|Overall Study|Protocol Deviation|5|||
160769958|NCT05516758|580544383|FG000|Overall Study|Withdrawal by Subject|11|||
160769959|NCT05516758|580544384|FG001|Overall Study|Withdrawal by Subject|1|||
160769960|NCT05516758|580544385|FG002|Overall Study|Withdrawal by Subject|15|||
160769961|NCT05516758|580544386|FG003|Overall Study|Withdrawal by Subject|2|||
160769962|NCT05516758|580544387|FG004|Overall Study|Withdrawal by Subject|7|||
160769963|NCT05516758|580544388|FG005|Overall Study|Withdrawal by Subject|7|||
160769964|NCT05516758|580544389|FG006|Overall Study|Withdrawal by Subject|6|||
160769965|NCT05516758|580544383|FG000|Overall Study|Death|1|||
160769966|NCT05516758|580544384|FG001|Overall Study|Death|0|||
160769967|NCT05516758|580544385|FG002|Overall Study|Death|0|||
160769968|NCT05516758|580544386|FG003|Overall Study|Death|0|||
160769969|NCT05516758|580544387|FG004|Overall Study|Death|0|||
160769970|NCT05516758|580544388|FG005|Overall Study|Death|0|||
160769971|NCT05516758|580544389|FG006|Overall Study|Death|0|||
160769972|NCT05516758|580544383|FG000|Overall Study|Non-compliance With Study Drug|0|||
160769973|NCT05516758|580544384|FG001|Overall Study|Non-compliance With Study Drug|0|||
160769974|NCT05516758|580544385|FG002|Overall Study|Non-compliance With Study Drug|1|||
160769975|NCT05516758|580544386|FG003|Overall Study|Non-compliance With Study Drug|0|||
160769976|NCT05516758|580544387|FG004|Overall Study|Non-compliance With Study Drug|0|||
160769977|NCT05516758|580544388|FG005|Overall Study|Non-compliance With Study Drug|0|||
160769978|NCT05516758|580544389|FG006|Overall Study|Non-compliance With Study Drug|0|||
160769979|NCT05516758|580544383|FG000|Overall Study|Site Terminated by Sponsor|2|||
160769980|NCT05516758|580544384|FG001|Overall Study|Site Terminated by Sponsor|0|||
160769981|NCT05516758|580544385|FG002|Overall Study|Site Terminated by Sponsor|0|||
160769982|NCT05516758|580544386|FG003|Overall Study|Site Terminated by Sponsor|0|||
160769983|NCT05516758|580544387|FG004|Overall Study|Site Terminated by Sponsor|0|||
160769984|NCT05516758|580544388|FG005|Overall Study|Site Terminated by Sponsor|0|||
160769985|NCT05516758|580544389|FG006|Overall Study|Site Terminated by Sponsor|0|||
160769986|NCT05516758|580544383|FG000|Overall Study|Study Terminated by Sponsor|4|||
160769987|NCT05516758|580544384|FG001|Overall Study|Study Terminated by Sponsor|0|||
160769988|NCT05516758|580544385|FG002|Overall Study|Study Terminated by Sponsor|3|||
160769989|NCT05516758|580544386|FG003|Overall Study|Study Terminated by Sponsor|0|||
160769990|NCT05516758|580544387|FG004|Overall Study|Study Terminated by Sponsor|2|||
160769991|NCT05516758|580544388|FG005|Overall Study|Study Terminated by Sponsor|3|||
160769992|NCT05516758|580544389|FG006|Overall Study|Study Terminated by Sponsor|0|||
160769993|NCT05516758|580544383|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
160769994|NCT05516758|580544384|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
160769995|NCT05516758|580544385|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
160769996|NCT05516758|580544386|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
160769997|NCT05516758|580544387|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
160769998|NCT05516758|580544388|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
160769999|NCT05516758|580544389|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
160770000|NCT05516758|580544383|FG000|Overall Study|Other|0|||
160770001|NCT05516758|580544384|FG001|Overall Study|Other|0|||
160770002|NCT05516758|580544385|FG002|Overall Study|Other|0|||
160770003|NCT05516758|580544386|FG003|Overall Study|Other|0|||
160770004|NCT05516758|580544387|FG004|Overall Study|Other|0|||
160770005|NCT05516758|580544388|FG005|Overall Study|Other|0|||
160770006|NCT05516758|580544389|FG006|Overall Study|Other|1|||
160770007|NCT02792504|580544390|FG000|Overall Study|Lost to Follow-up|24|||
160770008|NCT02792504|580544390|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
160770009|NCT01114724|580544391|FG000|Overall Study|Death|8|||
160770010|NCT01114724|580544391|FG000|Overall Study|Lost to Follow-up|1|||
160770011|NCT01114724|580544391|FG000|Overall Study|Withdrawal by Subject|1|||
160770012|NCT02485860|580544392|FG000|Overall Study|Lost to Follow-up|4|||
160770013|NCT02485860|580544393|FG001|Overall Study|Lost to Follow-up|1|||
160770014|NCT02485860|580544392|FG000|Overall Study|Physician Decision|1|||
160770015|NCT02485860|580544393|FG001|Overall Study|Physician Decision|2|||
160770016|NCT02485860|580544392|FG000|Overall Study|Health context (COVID-19)|1|||
160770017|NCT02485860|580544393|FG001|Overall Study|Health context (COVID-19)|0|||
160770018|NCT02273167|580544401|FG000|Overall Study|Adverse Event|1|||
160770019|NCT02273167|580544402|FG001|Overall Study|Adverse Event|0|||
160770020|NCT02273167|580544403|FG002|Overall Study|Adverse Event|0|||
160770021|NCT02273167|580544401|FG000|Overall Study|Protocol Violation|3|||
160770022|NCT02273167|580544402|FG001|Overall Study|Protocol Violation|1|||
160770023|NCT02273167|580544403|FG002|Overall Study|Protocol Violation|1|||
160770024|NCT02273167|580544401|FG000|Overall Study|Lost to Follow-up|0|||
160770025|NCT02273167|580544402|FG001|Overall Study|Lost to Follow-up|1|||
160770026|NCT02273167|580544403|FG002|Overall Study|Lost to Follow-up|1|||
160770027|NCT02273167|580544401|FG000|Overall Study|Withdrawal by Subject|10|||
160770028|NCT02273167|580544402|FG001|Overall Study|Withdrawal by Subject|12|||
160770029|NCT02273167|580544403|FG002|Overall Study|Withdrawal by Subject|11|||
160770030|NCT02273167|580544401|FG000|Overall Study|Various|10|||
160770031|NCT02273167|580544402|FG001|Overall Study|Various|9|||
160770032|NCT02273167|580544403|FG002|Overall Study|Various|8|||
160770033|NCT03082729|580544404|FG000|Overall Study|Lost to Follow-up|7|||
160770034|NCT03082729|580544404|FG000|Overall Study|Physician Decision|2|||
160770035|NCT03082729|580544404|FG000|Overall Study|Withdrawal by Subject|1|||
160770036|NCT03082729|580544404|FG000|Overall Study|Lack of Efficacy|9|||
160770037|NCT03082729|580544404|FG000|Overall Study|Adverse Event|4|||
160770038|NCT03082729|580544404|FG000|Overall Study|Protocol Violation|6|||
160770039|NCT03082729|580544404|FG000|Overall Study|Fear of study procedure|1|||
160770040|NCT03082729|580544404|FG000|Overall Study|Scheduling conflict|1|||
160770041|NCT03454555|580545896|FG000|Overall Study|Death|6|||
160770042|NCT03454555|580545897|FG001|Overall Study|Death|6|||
160770043|NCT03454555|580545896|FG000|Overall Study|Lost to Follow-up|31|||
160770044|NCT03454555|580545897|FG001|Overall Study|Lost to Follow-up|12|||
160770045|NCT03454555|580545896|FG000|Overall Study|Physician Decision|2|||
160770046|NCT03454555|580545897|FG001|Overall Study|Physician Decision|6|||
160879511|NCT01347580|580953911|FG000|Overall Study|Lost to Follow-up|3|||
160879512|NCT01347580|580953912|FG001|Overall Study|Lost to Follow-up|1|||
160879513|NCT01347580|580953911|FG000|Overall Study|Had other reason|9|||
160879514|NCT01347580|580953912|FG001|Overall Study|Had other reason|6|||
160879515|NCT01964755|580953915|FG000|Overall Study|Death|2|||
160879516|NCT02870933|580953916|FG000|Overall Study|Death|2|||
160879517|NCT02870933|580953917|FG001|Overall Study|Death|1|||
160879518|NCT02870933|580953916|FG000|Overall Study|Withdrawal by Subject|0|||
160879519|NCT02870933|580953917|FG001|Overall Study|Withdrawal by Subject|1|||
160879520|NCT02168387|580953918|FG000|Overall Study|Planned exubation|6|||
160879521|NCT02168387|580953919|FG001|Overall Study|Planned exubation|3|||
160879522|NCT02168387|580953918|FG000|Overall Study|Death|1|||
160879523|NCT02168387|580953919|FG001|Overall Study|Death|0|||
160879524|NCT01659554|580953920|FG000|Overall Study|Study Termination|4|||
160879525|NCT00412373|580953921|FG000|Overall Study|Adverse Event|8|||
160538763|NCT02819635|579702280|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
160538764|NCT02819635|579702281|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
160879526|NCT00412373|580953922|FG001|Overall Study|Adverse Event|13|||
160879527|NCT00412373|580953921|FG000|Overall Study|Lack of Efficacy|16|||
160879528|NCT00412373|580953922|FG001|Overall Study|Lack of Efficacy|22|||
160879529|NCT00412373|580953921|FG000|Overall Study|Lost to Follow-up|7|||
160879530|NCT00412373|580953922|FG001|Overall Study|Lost to Follow-up|13|||
160879531|NCT00412373|580953921|FG000|Overall Study|Withdrawal by Subject|8|||
160770047|NCT03454555|580545896|FG000|Overall Study|Withdrawal by Subject|34|||
160770048|NCT03454555|580545897|FG001|Overall Study|Withdrawal by Subject|5|||
160770049|NCT03454555|580545896|FG000|Overall Study|Ineligible|1|||
160770050|NCT03454555|580545897|FG001|Overall Study|Ineligible|5|||
160770051|NCT05493111|580545898|FG000|Overall Study|Adverse Event|3|||
160770052|NCT05493111|580545899|FG001|Overall Study|Adverse Event|4|||
160770053|NCT05493111|580545898|FG000|Overall Study|Withdrawal of Consent|19|||
160770054|NCT05493111|580545899|FG001|Overall Study|Withdrawal of Consent|10|||
160770055|NCT05493111|580545898|FG000|Overall Study|Non-compliance|1|||
160770056|NCT05493111|580545899|FG001|Overall Study|Non-compliance|1|||
160770057|NCT05493111|580545898|FG000|Overall Study|Lost to Follow-up|8|||
160770058|NCT05493111|580545899|FG001|Overall Study|Lost to Follow-up|1|||
160770059|NCT05493111|580545898|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
160879532|NCT00412373|580953922|FG001|Overall Study|Withdrawal by Subject|27|||
160879533|NCT00412373|580953921|FG000|Overall Study|Other|2|||
160879534|NCT00412373|580953922|FG001|Overall Study|Other|2|||
160879535|NCT00640224|580953923|FG000|Overall Study|Lost to Follow-up|5|||
160879536|NCT00640224|580953924|FG001|Overall Study|Lost to Follow-up|2|||
160879537|NCT00640224|580953925|FG002|Overall Study|Lost to Follow-up|0|||
160879538|NCT00640224|580953926|FG003|Overall Study|Lost to Follow-up|0|||
160879539|NCT00640224|580953923|FG000|Overall Study|Withdrawal by Subject|1|||
160879540|NCT00640224|580953924|FG001|Overall Study|Withdrawal by Subject|0|||
160879541|NCT00640224|580953925|FG002|Overall Study|Withdrawal by Subject|0|||
160879542|NCT00640224|580953926|FG003|Overall Study|Withdrawal by Subject|0|||
160879543|NCT00640224|580953923|FG000|Overall Study|Headaches|0|||
160879544|NCT00640224|580953924|FG001|Overall Study|Headaches|1|||
160879545|NCT00640224|580953925|FG002|Overall Study|Headaches|0|||
160879546|NCT00640224|580953926|FG003|Overall Study|Headaches|0|||
160879547|NCT00422513|580953927|FG000|Overall Study|Lack of Efficacy|4|||
160879548|NCT00422513|580953928|FG001|Overall Study|Lack of Efficacy|5|||
160879549|NCT00422513|580953927|FG000|Overall Study|Protocol Violation|23|||
160879550|NCT00422513|580953928|FG001|Overall Study|Protocol Violation|7|||
160879551|NCT00422513|580953927|FG000|Overall Study|Refused Treatment|4|||
160879552|NCT00422513|580953928|FG001|Overall Study|Refused Treatment|2|||
160879553|NCT00422513|580953927|FG000|Overall Study|Withdrawal by Subject|2|||
160770060|NCT05493111|580545899|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
160770061|NCT05493111|580545898|FG000|Overall Study|Withdrawal by Subject|1|||
160770062|NCT05493111|580545899|FG001|Overall Study|Withdrawal by Subject|1|||
160770068|NCT00375752|580545901|FG000|Overall Study|Lack of Efficacy|4|||
160770069|NCT00375752|580545902|FG001|Overall Study|Lack of Efficacy|4|||
160770070|NCT00375752|580545901|FG000|Overall Study|Adverse Event|1|||
160770071|NCT00375752|580545902|FG001|Overall Study|Adverse Event|6|||
160770072|NCT00375752|580545901|FG000|Overall Study|Withdrawal by Subject|6|||
160770073|NCT00375752|580545902|FG001|Overall Study|Withdrawal by Subject|1|||
160770074|NCT00375752|580545901|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
160770075|NCT00375752|580545902|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
160770076|NCT00375752|580545901|FG000|Overall Study|Protocol Violation|0|||
160770077|NCT00375752|580545902|FG001|Overall Study|Protocol Violation|2|||
160770078|NCT00375752|580545901|FG000|Overall Study|Administrative Problems|0|||
160770079|NCT00375752|580545902|FG001|Overall Study|Administrative Problems|1|||
160770080|NCT01140906|580545907|FG000|Overall Study|Adverse Event|7|||
160770081|NCT01140906|580545908|FG001|Overall Study|Adverse Event|10|||
160770082|NCT01140906|580545909|FG002|Overall Study|Adverse Event|17|||
160770083|NCT01140906|580545910|FG003|Overall Study|Adverse Event|7|||
160770084|NCT01140906|580545907|FG000|Overall Study|Lack of Efficacy|6|||
160770085|NCT01140906|580545908|FG001|Overall Study|Lack of Efficacy|8|||
160770086|NCT01140906|580545909|FG002|Overall Study|Lack of Efficacy|2|||
160879554|NCT00422513|580953928|FG001|Overall Study|Withdrawal by Subject|1|||
160770087|NCT01140906|580545910|FG003|Overall Study|Lack of Efficacy|1|||
160770088|NCT01140906|580545907|FG000|Overall Study|Non-compliance|0|||
160770089|NCT01140906|580545908|FG001|Overall Study|Non-compliance|1|||
160770090|NCT01140906|580545909|FG002|Overall Study|Non-compliance|0|||
160770091|NCT01140906|580545910|FG003|Overall Study|Non-compliance|1|||
160770092|NCT01140906|580545907|FG000|Overall Study|Protocol Violation|5|||
160879555|NCT00422513|580953927|FG000|Overall Study|early termination of the study|67|||
160879556|NCT00422513|580953928|FG001|Overall Study|early termination of the study|80|||
160770093|NCT01140906|580545908|FG001|Overall Study|Protocol Violation|3|||
160770094|NCT01140906|580545909|FG002|Overall Study|Protocol Violation|2|||
160770095|NCT01140906|580545910|FG003|Overall Study|Protocol Violation|1|||
160879557|NCT00422513|580953927|FG000|Overall Study|Adverse Event|4|||
160879558|NCT00422513|580953928|FG001|Overall Study|Adverse Event|4|||
160879559|NCT00422513|580953927|FG000|Overall Study|Death|3|||
160879560|NCT00422513|580953928|FG001|Overall Study|Death|7|||
160770096|NCT01140906|580545907|FG000|Overall Study|Withdrawal of consent|6|||
160879561|NCT03135119|580953929|FG000|Overall Study|Lost to Follow-up|2|||
160879562|NCT03135119|580953930|FG001|Overall Study|Lost to Follow-up|0|||
160879563|NCT03135119|580953929|FG000|Overall Study|Physician Decision|1|||
160879564|NCT03135119|580953930|FG001|Overall Study|Physician Decision|1|||
160879565|NCT03135119|580953929|FG000|Overall Study|COVID-19 Shutdown|2|||
160879566|NCT03135119|580953930|FG001|Overall Study|COVID-19 Shutdown|2|||
160879567|NCT01478048|580953931|FG000|Overall Study|Disease Progression|52|||
160879568|NCT01478048|580953932|FG001|Overall Study|Disease Progression|35|||
160879569|NCT01478048|580953931|FG000|Overall Study|study drug toxicity|11|||
160879570|NCT01478048|580953932|FG001|Overall Study|study drug toxicity|14|||
160879571|NCT01478048|580953931|FG000|Overall Study|Adverse Event|2|||
160879572|NCT01478048|580953932|FG001|Overall Study|Adverse Event|11|||
160879573|NCT01478048|580953931|FG000|Overall Study|subject request to discontinue treatment|3|||
160879574|NCT01478048|580953932|FG001|Overall Study|subject request to discontinue treatment|5|||
160879575|NCT01478048|580953931|FG000|Overall Study|Withdrawal by Subject|2|||
160879576|NCT01478048|580953932|FG001|Overall Study|Withdrawal by Subject|5|||
160879577|NCT01478048|580953931|FG000|Overall Study|non-specified|6|||
160879578|NCT01478048|580953932|FG001|Overall Study|non-specified|4|||
160879579|NCT01478048|580953931|FG000|Overall Study|poor/non-compliance|0|||
160879580|NCT01478048|580953932|FG001|Overall Study|poor/non-compliance|1|||
160879581|NCT01478048|580953931|FG000|Overall Study|no longer meets study criteria|1|||
160879582|NCT01478048|580953932|FG001|Overall Study|no longer meets study criteria|0|||
160879583|NCT01369329|580953934|FG000|Overall Study|Withdrawal by Subject|8|||
160879584|NCT01369329|580953935|FG001|Overall Study|Withdrawal by Subject|6|||
160879585|NCT01369329|580953936|FG002|Overall Study|Withdrawal by Subject|10|||
160879586|NCT01369329|580953934|FG000|Overall Study|Lost to Follow-up|2|||
160879587|NCT01369329|580953935|FG001|Overall Study|Lost to Follow-up|2|||
160879588|NCT01369329|580953936|FG002|Overall Study|Lost to Follow-up|2|||
160879589|NCT01369329|580953934|FG000|Overall Study|Other|2|||
160879590|NCT01369329|580953935|FG001|Overall Study|Other|3|||
160879591|NCT01369329|580953936|FG002|Overall Study|Other|2|||
160879592|NCT01252667|580953937|FG000|Overall Study|Transplant aborted post-conditioning|0|||
160879593|NCT01252667|580953938|FG001|Overall Study|Transplant aborted post-conditioning|0|||
160879594|NCT01252667|580953939|FG002|Overall Study|Transplant aborted post-conditioning|0|||
160879595|NCT01252667|580953940|FG003|Overall Study|Transplant aborted post-conditioning|0|||
160879596|NCT01252667|580953941|FG004|Overall Study|Transplant aborted post-conditioning|0|||
160879597|NCT01252667|580953942|FG005|Overall Study|Transplant aborted post-conditioning|1|||
160879598|NCT04644315|580953943|FG000|Overall Study|Subject withdrawal of consent|1|||
160879599|NCT03032380|580953944|FG000|Overall Study|Adverse Event|0|||
160879600|NCT03032380|580953945|FG001|Overall Study|Adverse Event|1|||
160879601|NCT03032380|580953944|FG000|Overall Study|Lack of Efficacy|1|||
160879602|NCT03032380|580953945|FG001|Overall Study|Lack of Efficacy|0|||
160879603|NCT03032380|580953944|FG000|Overall Study|Withdrawal by Subject|2|||
160879604|NCT03032380|580953945|FG001|Overall Study|Withdrawal by Subject|3|||
160879605|NCT03032380|580953944|FG000|Overall Study|Recovery|0|||
160879606|NCT03032380|580953945|FG001|Overall Study|Recovery|1|||
160879607|NCT03032380|580953944|FG000|Overall Study|Death|39|||
160879608|NCT03032380|580953945|FG001|Overall Study|Death|34|||
160879609|NCT03032380|580953944|FG000|Overall Study|Other - Miscellaneous|0|||
160879610|NCT03032380|580953945|FG001|Overall Study|Other - Miscellaneous|1|||
160879611|NCT02937584|580953946|FG000|Period 1|Adverse Event|1|||
160879612|NCT02937584|580953947|FG001|Period 1|Adverse Event|2|||
160879613|NCT02937584|580953946|FG000|Washout|Adverse Event|0|||
160879614|NCT02937584|580953947|FG001|Washout|Adverse Event|1|||
160879615|NCT01883453|580953948|FG000|Overall Study|No episode of common cold|25|||
160879616|NCT01883453|580953949|FG001|Overall Study|No episode of common cold|23|||
160879617|NCT02238080|580953950|FG000|Overall Study|Death|13|||
160879618|NCT02238080|580953950|FG000|Overall Study|Treatment interrupted|6|||
160879619|NCT02238080|580953950|FG000|Overall Study|Withdrawal by Subject|2|||
160879620|NCT02238080|580953950|FG000|Overall Study|Other|4|||
160879621|NCT00864916|580953951|FG000|Overall Study|Lost to Follow-up|4|||
160879622|NCT00864916|580953952|FG001|Overall Study|Lost to Follow-up|4|||
160879623|NCT00864916|580953951|FG000|Overall Study|Protocol Violation|1|||
160879624|NCT00864916|580953952|FG001|Overall Study|Protocol Violation|0|||
160879625|NCT00864916|580953951|FG000|Overall Study|Withdrawal by Subject|1|||
160879626|NCT00864916|580953952|FG001|Overall Study|Withdrawal by Subject|0|||
160879627|NCT01038869|580953954|FG000|Overall Study|Withdrawal by Subject|1|||
160879628|NCT01038869|580953954|FG000|Overall Study|Lost to Follow-up|6|||
160879629|NCT04136444|580953955|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
160879630|NCT04136444|580953956|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
160879631|NCT01950013|580953957|FG000|Overall Study|Withdrawal by Subject|0|||
160879632|NCT01950013|580953958|FG001|Overall Study|Withdrawal by Subject|2|||
160879633|NCT01950013|580953959|FG002|Overall Study|Withdrawal by Subject|0|||
160879634|NCT00783198|580953964|FG000|Overall Study|Adverse Event|15|||
160879635|NCT00783198|580953965|FG001|Overall Study|Adverse Event|19|||
160879636|NCT00783198|580953966|FG002|Overall Study|Adverse Event|3|||
160879637|NCT00783198|580953964|FG000|Overall Study|Lost to Follow-up|11|||
160879638|NCT00783198|580953965|FG001|Overall Study|Lost to Follow-up|1|||
160879639|NCT00783198|580953966|FG002|Overall Study|Lost to Follow-up|7|||
160879640|NCT00783198|580953964|FG000|Overall Study|Withdrawal by Subject|22|||
160879641|NCT00783198|580953965|FG001|Overall Study|Withdrawal by Subject|14|||
160879642|NCT00783198|580953966|FG002|Overall Study|Withdrawal by Subject|20|||
160879643|NCT00783198|580953964|FG000|Overall Study|Noncompliance with protocol|7|||
160879644|NCT00783198|580953965|FG001|Overall Study|Noncompliance with protocol|7|||
160879645|NCT00783198|580953966|FG002|Overall Study|Noncompliance with protocol|10|||
160879646|NCT00783198|580953964|FG000|Overall Study|Did not meet protocol eligibility|0|||
160879647|NCT00783198|580953965|FG001|Overall Study|Did not meet protocol eligibility|1|||
160879648|NCT00783198|580953966|FG002|Overall Study|Did not meet protocol eligibility|0|||
160879649|NCT00783198|580953964|FG000|Overall Study|Administrative|2|||
160879650|NCT00783198|580953965|FG001|Overall Study|Administrative|1|||
160879651|NCT00783198|580953966|FG002|Overall Study|Administrative|2|||
160538765|NCT02819635|579702270|FG000|Substudy 3|Other, not specified|0|||
160879652|NCT02756806|580953967|FG000|Overall Study|Study terminated early|5|||
160879653|NCT00978757|580953972|FG000|Overall Study|Physician Decision|1|||
160879654|NCT00978757|580953973|FG001|Overall Study|Physician Decision|3|||
160879655|NCT01028300|580953974|FG000|Overall Study|Study Terminated|4|||
160879656|NCT00946153|580953977|FG000|Phase 2|Adverse Event|0|||
160879657|NCT00946153|580953978|FG001|Phase 2|Adverse Event|0|||
160879658|NCT00946153|580953979|FG002|Phase 2|Adverse Event|0|||
160879659|NCT00946153|580953980|FG003|Phase 2|Adverse Event|0|||
160879660|NCT00946153|580953981|FG004|Phase 2|Adverse Event|6|||
160879661|NCT00946153|580953977|FG000|Phase 2|Need more reduction of dose|0|||
160879662|NCT00946153|580953978|FG001|Phase 2|Need more reduction of dose|0|||
160879663|NCT00946153|580953979|FG002|Phase 2|Need more reduction of dose|0|||
160879664|NCT00946153|580953980|FG003|Phase 2|Need more reduction of dose|0|||
160879665|NCT00946153|580953981|FG004|Phase 2|Need more reduction of dose|2|||
160879666|NCT00946153|580953977|FG000|Phase 2|Physician Decision|0|||
160879667|NCT00946153|580953978|FG001|Phase 2|Physician Decision|0|||
160879668|NCT00946153|580953979|FG002|Phase 2|Physician Decision|0|||
160879669|NCT00946153|580953980|FG003|Phase 2|Physician Decision|0|||
160879670|NCT00946153|580953981|FG004|Phase 2|Physician Decision|1|||
160879671|NCT00946153|580953977|FG000|Phase 2|14 days washout for recovery due to AE|0|||
160879672|NCT00946153|580953978|FG001|Phase 2|14 days washout for recovery due to AE|0|||
160879673|NCT00946153|580953979|FG002|Phase 2|14 days washout for recovery due to AE|0|||
160879674|NCT00946153|580953980|FG003|Phase 2|14 days washout for recovery due to AE|0|||
160879675|NCT00946153|580953981|FG004|Phase 2|14 days washout for recovery due to AE|4|||
160879676|NCT01030666|580953982|FG000|Overall Study|Lost to Follow-up|3|||
160879677|NCT01030666|580953983|FG001|Overall Study|Lost to Follow-up|2|||
160879678|NCT01144299|580953984|FG000|Overall Study|Lost to Follow-up|1|||
160879679|NCT01144299|580953985|FG001|Overall Study|Lost to Follow-up|0|||
160879680|NCT01144299|580953984|FG000|Overall Study|Withdrawal by Subject|1|||
160879681|NCT01144299|580953985|FG001|Overall Study|Withdrawal by Subject|0|||
160879682|NCT04002908|580953994|FG000|Overall Study|Death|41|||
160879683|NCT04002908|580953995|FG001|Overall Study|Death|0|||
160879684|NCT04002908|580953996|FG002|Overall Study|Death|0|||
160879685|NCT04002908|580953997|FG003|Overall Study|Death|0|||
160879686|NCT04002908|580953994|FG000|Overall Study|Withdrawal by Subject|112|||
160879687|NCT04002908|580953995|FG001|Overall Study|Withdrawal by Subject|0|||
160879688|NCT04002908|580953996|FG002|Overall Study|Withdrawal by Subject|0|||
160879689|NCT04002908|580953997|FG003|Overall Study|Withdrawal by Subject|0|||
160879690|NCT04002908|580953994|FG000|Overall Study|Lost to Follow-up|72|||
160879691|NCT04002908|580953995|FG001|Overall Study|Lost to Follow-up|0|||
160879692|NCT04002908|580953996|FG002|Overall Study|Lost to Follow-up|0|||
160879693|NCT04002908|580953997|FG003|Overall Study|Lost to Follow-up|0|||
160879694|NCT04002908|580953994|FG000|Overall Study|Infant died, so mother withdrawn|34|||
160879695|NCT04002908|580953995|FG001|Overall Study|Infant died, so mother withdrawn|0|||
160879696|NCT04002908|580953996|FG002|Overall Study|Infant died, so mother withdrawn|0|||
160879697|NCT04002908|580953997|FG003|Overall Study|Infant died, so mother withdrawn|0|||
160879698|NCT04359901|580954002|FG000|Overall Study|Withdrawal by Subject|0|||
160879699|NCT04359901|580954003|FG001|Overall Study|Withdrawal by Subject|1|||
160879700|NCT04359901|580954002|FG000|Overall Study|Death|6|||
160879701|NCT04359901|580954003|FG001|Overall Study|Death|2|||
160879702|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
160879703|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
160879704|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
160879705|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
160879706|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
160879707|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
160879708|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
160879709|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
160879710|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
160879711|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
160879712|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160538766|NCT02819635|579702271|FG001|Substudy 3|Other, not specified|0|||
160538767|NCT02819635|579702272|FG002|Substudy 3|Other, not specified|0|||
160879713|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
160879714|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160538768|NCT02819635|579702273|FG003|Substudy 3|Other, not specified|0|||
160538769|NCT02819635|579702274|FG004|Substudy 3|Other, not specified|0|||
160879715|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160879716|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160879717|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160879718|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160879719|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160879720|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
160879721|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
160879722|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
160879723|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
160770097|NCT01140906|580545908|FG001|Overall Study|Withdrawal of consent|6|||
160770098|NCT01140906|580545909|FG002|Overall Study|Withdrawal of consent|2|||
160770099|NCT01140906|580545910|FG003|Overall Study|Withdrawal of consent|2|||
160770100|NCT01140906|580545907|FG000|Overall Study|Lost to Follow-up|1|||
160770101|NCT01140906|580545908|FG001|Overall Study|Lost to Follow-up|1|||
160770102|NCT01140906|580545909|FG002|Overall Study|Lost to Follow-up|0|||
160770103|NCT01140906|580545910|FG003|Overall Study|Lost to Follow-up|2|||
160770104|NCT01140906|580545907|FG000|Overall Study|Administrative or other reason|0|||
160770105|NCT01140906|580545908|FG001|Overall Study|Administrative or other reason|5|||
160770106|NCT01140906|580545909|FG002|Overall Study|Administrative or other reason|3|||
160770107|NCT01140906|580545910|FG003|Overall Study|Administrative or other reason|2|||
160770108|NCT01649765|580545911|FG000|Overall Study|Adverse Event|5|||
160770109|NCT01649765|580545912|FG001|Overall Study|Adverse Event|3|||
160770110|NCT01649765|580545911|FG000|Overall Study|Lack of Efficacy|1|||
160770111|NCT01649765|580545912|FG001|Overall Study|Lack of Efficacy|1|||
160770112|NCT01649765|580545911|FG000|Overall Study|Physician Decision|0|||
160770113|NCT01649765|580545912|FG001|Overall Study|Physician Decision|3|||
160770114|NCT01649765|580545911|FG000|Overall Study|Protocol Violation|1|||
160770115|NCT01649765|580545912|FG001|Overall Study|Protocol Violation|0|||
160770116|NCT01649765|580545911|FG000|Overall Study|Withdrawal by Subject|2|||
160770117|NCT01649765|580545912|FG001|Overall Study|Withdrawal by Subject|1|||
160770118|NCT02469233|580545913|FG000|Overall Study|Death|1|||
160770119|NCT02469233|580545914|FG001|Overall Study|Death|1|||
160770120|NCT02469233|580545913|FG000|Overall Study|Lost to post or 6 month follow up|7|||
160770121|NCT02469233|580545914|FG001|Overall Study|Lost to post or 6 month follow up|2|||
160770122|NCT01648764|580545915|FG000|Overall Study|Progressive Disease|0|||
160770123|NCT01648764|580545916|FG001|Overall Study|Progressive Disease|1|||
160770124|NCT01648764|580545917|FG002|Overall Study|Progressive Disease|0|||
160770125|NCT01648764|580545918|FG003|Overall Study|Progressive Disease|0|||
160770126|NCT01648764|580545919|FG004|Overall Study|Progressive Disease|0|||
160770127|NCT01648764|580545920|FG005|Overall Study|Progressive Disease|1|||
160770128|NCT01648764|580545921|FG006|Overall Study|Progressive Disease|1|||
160770129|NCT01648764|580545922|FG007|Overall Study|Progressive Disease|0|||
160770130|NCT01648764|580545923|FG008|Overall Study|Progressive Disease|0|||
160770131|NCT01648764|580545924|FG009|Overall Study|Progressive Disease|2|||
160770132|NCT01648764|580545925|FG010|Overall Study|Progressive Disease|0|||
160770133|NCT01648764|580545926|FG011|Overall Study|Progressive Disease|1|||
160770134|NCT01648764|580545927|FG012|Overall Study|Progressive Disease|2|||
160879724|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
160879725|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
160879726|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
160879727|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
160879728|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
160879729|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|Other|0|||
160879730|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|Other|0|||
160879731|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|Other|1|||
160636685|NCT01222715|580053563|FG001|Overall Study|Refusal of further protocol therapy|4|||
160636686|NCT01222715|580053562|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
160636687|NCT01222715|580053563|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
160636688|NCT01222715|580053562|FG000|Overall Study|Ineligible|0|||
160636689|NCT01222715|580053563|FG001|Overall Study|Ineligible|1|||
160636690|NCT01222715|580053562|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
160636691|NCT01222715|580053563|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
160636692|NCT03836729|580053564|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
160636693|NCT00763269|580053568|FG000|Overall Study|Lost to Follow-up|12|||
160636694|NCT00763269|580053569|FG001|Overall Study|Lost to Follow-up|13|||
160636695|NCT01830920|580053577|FG000|Overall Study|Adverse Event|1|||
160636696|NCT01830920|580053578|FG001|Overall Study|Adverse Event|0|||
160636697|NCT01830920|580053579|FG002|Overall Study|Adverse Event|1|||
160636698|NCT01830920|580053580|FG003|Overall Study|Adverse Event|0|||
160770135|NCT01648764|580545928|FG013|Overall Study|Progressive Disease|1|||
160770136|NCT01648764|580545915|FG000|Overall Study|Adverse Event|0|||
160770137|NCT01648764|580545916|FG001|Overall Study|Adverse Event|0|||
160770138|NCT01648764|580545917|FG002|Overall Study|Adverse Event|0|||
160770139|NCT01648764|580545918|FG003|Overall Study|Adverse Event|0|||
160879732|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|Other|1|||
160879733|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|Other|0|||
160879734|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|Other|0|||
160879735|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|Other|0|||
160879736|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|Other|1|||
160879737|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|Other|0|||
160879738|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|Death|0|||
160879739|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|Death|0|||
160879740|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|Death|0|||
160879741|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|Death|0|||
160879742|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|Death|0|||
160879743|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|Death|1|||
160879744|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|Death|0|||
160879745|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|Death|0|||
160879746|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|Death|0|||
160879747|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879748|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879749|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879750|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879751|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879752|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
160879753|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
160879754|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879755|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879756|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
160879757|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879758|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879759|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879760|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879761|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879762|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879763|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879764|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879765|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879766|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879767|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879768|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879769|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879770|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879771|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879772|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879773|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
160879774|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879775|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160538770|NCT02819635|579702275|FG005|Substudy 3|Other, not specified|0|||
160879776|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879777|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879778|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879779|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879780|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879781|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879782|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
160879783|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
160538771|NCT02819635|579702276|FG006|Substudy 3|Other, not specified|0|||
160879784|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
160879785|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
160879786|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
160879787|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
160879788|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
160879789|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
160879790|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
160879791|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
160879792|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|Other|0|||
160879793|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|Other|0|||
160879794|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|Other|0|||
160879795|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|Other|0|||
160879796|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|Other|0|||
160879797|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|Other|0|||
160879798|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|Other|0|||
160879799|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|Other|0|||
160879800|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|Other|1|||
160879801|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|Death|0|||
160879802|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|Death|0|||
160879803|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|Death|0|||
160879804|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|Death|0|||
160879805|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|Death|0|||
160879806|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|Death|0|||
160879807|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|Death|0|||
160879808|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|Death|0|||
160879809|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|Death|2|||
160879810|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879811|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879812|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879813|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879814|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879815|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879816|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879817|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879818|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
160879819|NCT03255083|580954013|FG000|Overall Study|Clinical progression|1|||
160879820|NCT03255083|580954014|FG001|Overall Study|Clinical progression|0|||
160538772|NCT02819635|579702277|FG007|Substudy 3|Other, not specified|0|||
160879821|NCT03255083|580954015|FG002|Overall Study|Clinical progression|0|||
160879822|NCT03255083|580954016|FG003|Overall Study|Clinical progression|0|||
160879823|NCT03255083|580954013|FG000|Overall Study|Adverse Event|0|||
160879824|NCT03255083|580954014|FG001|Overall Study|Adverse Event|1|||
160879825|NCT03255083|580954015|FG002|Overall Study|Adverse Event|0|||
160879826|NCT03255083|580954016|FG003|Overall Study|Adverse Event|0|||
160879827|NCT03255083|580954013|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
160879828|NCT03255083|580954014|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
160879829|NCT03255083|580954015|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
160879830|NCT03255083|580954016|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
160879831|NCT03255083|580954013|FG000|Overall Study|Withdrawal by Subject|1|||
160879832|NCT03255083|580954014|FG001|Overall Study|Withdrawal by Subject|1|||
160879833|NCT03255083|580954015|FG002|Overall Study|Withdrawal by Subject|1|||
160879834|NCT03255083|580954016|FG003|Overall Study|Withdrawal by Subject|0|||
160879835|NCT00363545|580954017|FG000|Overall Study|Serious Adverse Event|0|||
160879836|NCT00363545|580954018|FG001|Overall Study|Serious Adverse Event|1|||
160879837|NCT00363545|580954017|FG000|Overall Study|Withdrawal by Subject|12|||
160879838|NCT00363545|580954018|FG001|Overall Study|Withdrawal by Subject|15|||
160879839|NCT00363545|580954017|FG000|Overall Study|Migrated/moved from study area|3|||
160879840|NCT00363545|580954018|FG001|Overall Study|Migrated/moved from study area|6|||
160879841|NCT00363545|580954017|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
160538773|NCT02819635|579702278|FG008|Substudy 3|Other, not specified|202|||
160879842|NCT00363545|580954018|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
160879843|NCT00363545|580954017|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
160879844|NCT00363545|580954018|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
160879845|NCT00363545|580954017|FG000|Overall Study|Others|1|||
160879846|NCT00363545|580954018|FG001|Overall Study|Others|0|||
160879847|NCT05009979|580954019|FG000|Overall Study|Withdrawal by Subject|1|||
160879848|NCT04174365|580954020|FG000|Overall Study|Lost to Follow-up|1|||
160879849|NCT04174365|580954021|FG001|Overall Study|Lost to Follow-up|2|||
160879850|NCT04174365|580954020|FG000|Overall Study|Adverse Event|2|||
160879851|NCT04174365|580954021|FG001|Overall Study|Adverse Event|1|||
160538774|NCT02819635|579702279|FG009|Substudy 3|Other, not specified|5|||
160538775|NCT02819635|579702280|FG010|Substudy 3|Other, not specified|89|||
160538776|NCT02819635|579702281|FG011|Substudy 3|Other, not specified|39|||
160879852|NCT04174365|580954020|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
160879853|NCT04174365|580954021|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
160879854|NCT04174365|580954020|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
160879855|NCT04174365|580954021|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
160879856|NCT04174365|580954020|FG000|Overall Study|Protocol Deviation|1|||
160879857|NCT04174365|580954021|FG001|Overall Study|Protocol Deviation|0|||
160879858|NCT04174365|580954020|FG000|Overall Study|Lack of Efficacy|0|||
160879859|NCT04174365|580954021|FG001|Overall Study|Lack of Efficacy|2|||
160879860|NCT04174365|580954020|FG000|Overall Study|Disease Relapse|1|||
160879861|NCT04174365|580954021|FG001|Overall Study|Disease Relapse|0|||
160879862|NCT04174365|580954020|FG000|Overall Study|Reason Not Specified|0|||
160879863|NCT04174365|580954021|FG001|Overall Study|Reason Not Specified|1|||
160879864|NCT02522624|580955238|FG000|Overall Study|Technical failure|1|||
160879865|NCT02522624|580955239|FG001|Overall Study|Technical failure|0|||
160879866|NCT00910624|580955241|FG000|Treatment Phase|Adverse Event|2|||
160879867|NCT00910624|580955242|FG001|Treatment Phase|Adverse Event|6|||
160879868|NCT00910624|580955243|FG002|Treatment Phase|Adverse Event|6|||
160879869|NCT00910624|580955244|FG003|Treatment Phase|Adverse Event|0|||
160879870|NCT00910624|580955241|FG000|Treatment Phase|Treatment Failure|23|||
160879871|NCT00910624|580955242|FG001|Treatment Phase|Treatment Failure|10|||
160879872|NCT00910624|580955243|FG002|Treatment Phase|Treatment Failure|0|||
160879873|NCT00910624|580955244|FG003|Treatment Phase|Treatment Failure|0|||
160879874|NCT00910624|580955241|FG000|Treatment Phase|Lost to Follow-up|0|||
160879875|NCT00910624|580955242|FG001|Treatment Phase|Lost to Follow-up|0|||
160879876|NCT00910624|580955243|FG002|Treatment Phase|Lost to Follow-up|1|||
160879877|NCT00910624|580955244|FG003|Treatment Phase|Lost to Follow-up|0|||
160879878|NCT00910624|580955241|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
160879879|NCT00910624|580955242|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
160879880|NCT00910624|580955243|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
160879881|NCT00910624|580955244|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
160879882|NCT00910624|580955241|FG000|Treatment Phase|Withdrawal by Subject|2|||
160879883|NCT00910624|580955242|FG001|Treatment Phase|Withdrawal by Subject|1|||
160879884|NCT00910624|580955243|FG002|Treatment Phase|Withdrawal by Subject|0|||
160879885|NCT00910624|580955244|FG003|Treatment Phase|Withdrawal by Subject|0|||
160879886|NCT00910624|580955241|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
160879887|NCT00910624|580955242|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
160879888|NCT00910624|580955243|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
160879889|NCT00910624|580955244|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
160879890|NCT00910624|580955241|FG000|Follow-Up Phase|Adverse Event|0|||
160879891|NCT00910624|580955242|FG001|Follow-Up Phase|Adverse Event|0|||
160879892|NCT00910624|580955243|FG002|Follow-Up Phase|Adverse Event|1|||
160879893|NCT00910624|580955244|FG003|Follow-Up Phase|Adverse Event|0|||
160879894|NCT00910624|580955241|FG000|Follow-Up Phase|Lost to Follow-up|3|||
160879895|NCT00910624|580955242|FG001|Follow-Up Phase|Lost to Follow-up|1|||
160879896|NCT00910624|580955243|FG002|Follow-Up Phase|Lost to Follow-up|2|||
160879897|NCT00910624|580955244|FG003|Follow-Up Phase|Lost to Follow-up|0|||
160879898|NCT00910624|580955241|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
160879899|NCT00910624|580955242|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
160879900|NCT00910624|580955243|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
160879901|NCT00910624|580955244|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
160879902|NCT00910624|580955241|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
160879903|NCT00910624|580955242|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
160879904|NCT00910624|580955243|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
160879905|NCT00910624|580955244|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
160879906|NCT00910624|580955241|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
160879907|NCT00910624|580955242|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
160879908|NCT00910624|580955243|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
160879909|NCT00910624|580955244|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
160879910|NCT00910624|580955241|FG000|Follow-Up Phase|Administrative|0|||
160879911|NCT00910624|580955242|FG001|Follow-Up Phase|Administrative|1|||
160879912|NCT00910624|580955243|FG002|Follow-Up Phase|Administrative|1|||
160879913|NCT00910624|580955244|FG003|Follow-Up Phase|Administrative|0|||
160879914|NCT00294762|580955245|FG000|Overall Study|Did not receive study treatment|3|||
160879915|NCT00294762|580955246|FG001|Overall Study|Did not receive study treatment|3|||
160879916|NCT01738646|580955247|FG000|Overall Study|Still Receiving Treatment|2|||
160879917|NCT00701662|580955249|FG000|Overall Study|Lack of Efficacy|1|||
160879918|NCT03642132|580955250|FG000|Chemotherapy Period|Adverse Event|1|||
160538777|NCT01349465|579702283|FG000|Overall Study|Adverse Event|1|||
160879919|NCT03642132|580955251|FG001|Chemotherapy Period|Adverse Event|1|||
160879920|NCT03642132|580955252|FG002|Chemotherapy Period|Adverse Event|0|||
160879921|NCT03642132|580955250|FG000|Chemotherapy Period|Physician's decision|4|||
160879922|NCT03642132|580955251|FG001|Chemotherapy Period|Physician's decision|1|||
160879923|NCT03642132|580955252|FG002|Chemotherapy Period|Physician's decision|0|||
160879924|NCT03642132|580955250|FG000|Chemotherapy Period|Progressive disease|0|||
160879925|NCT03642132|580955251|FG001|Chemotherapy Period|Progressive disease|0|||
160538778|NCT01349465|579702284|FG001|Overall Study|Adverse Event|0|||
160879926|NCT03642132|580955252|FG002|Chemotherapy Period|Progressive disease|1|||
160879927|NCT03642132|580955250|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
160879928|NCT03642132|580955251|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
160879929|NCT03642132|580955252|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
160879930|NCT03642132|580955250|FG000|Chemotherapy Period|Other|1|||
160879931|NCT03642132|580955251|FG001|Chemotherapy Period|Other|0|||
160879932|NCT03642132|580955252|FG002|Chemotherapy Period|Other|2|||
160879933|NCT03642132|580955250|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
160879934|NCT03642132|580955251|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
160879935|NCT03642132|580955252|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
160879936|NCT03642132|580955250|FG000|Maintenance Period|Adverse Event|1|||
160879937|NCT03642132|580955251|FG001|Maintenance Period|Adverse Event|2|||
160636699|NCT01830920|580053581|FG004|Overall Study|Adverse Event|0|||
160879938|NCT03642132|580955252|FG002|Maintenance Period|Adverse Event|0|||
160879939|NCT03642132|580955250|FG000|Maintenance Period|Non-compliance with study drug|0|||
160879940|NCT03642132|580955251|FG001|Maintenance Period|Non-compliance with study drug|0|||
160879941|NCT03642132|580955252|FG002|Maintenance Period|Non-compliance with study drug|1|||
160879942|NCT03642132|580955250|FG000|Maintenance Period|Physician's decision|2|||
160879943|NCT03642132|580955251|FG001|Maintenance Period|Physician's decision|2|||
160879944|NCT03642132|580955252|FG002|Maintenance Period|Physician's decision|2|||
160879945|NCT03642132|580955250|FG000|Maintenance Period|Progressive disease|9|||
160879946|NCT03642132|580955251|FG001|Maintenance Period|Progressive disease|3|||
160879947|NCT03642132|580955252|FG002|Maintenance Period|Progressive disease|6|||
160879948|NCT03642132|580955250|FG000|Maintenance Period|Other|0|||
160879949|NCT03642132|580955251|FG001|Maintenance Period|Other|0|||
160879950|NCT03642132|580955252|FG002|Maintenance Period|Other|3|||
160879951|NCT03642132|580955250|FG000|Maintenance Period|Withdrawal by Subject|1|||
160879952|NCT03642132|580955251|FG001|Maintenance Period|Withdrawal by Subject|1|||
160879953|NCT03642132|580955252|FG002|Maintenance Period|Withdrawal by Subject|2|||
160879954|NCT03642132|580955250|FG000|Follow-up Period|Other|0|||
160879955|NCT03642132|580955251|FG001|Follow-up Period|Other|0|||
160879956|NCT03642132|580955252|FG002|Follow-up Period|Other|1|||
160879957|NCT03642132|580955250|FG000|Follow-up Period|Withdrawal by Subject|1|||
160879958|NCT03642132|580955251|FG001|Follow-up Period|Withdrawal by Subject|2|||
160879959|NCT03642132|580955252|FG002|Follow-up Period|Withdrawal by Subject|0|||
160879960|NCT03642132|580955250|FG000|Follow-up Period|Study terminated by sponsor|1|||
160879961|NCT03642132|580955251|FG001|Follow-up Period|Study terminated by sponsor|0|||
160879962|NCT03642132|580955252|FG002|Follow-up Period|Study terminated by sponsor|1|||
160879963|NCT03642132|580955250|FG000|Follow-up Period|Lack of Efficacy|1|||
160879964|NCT03642132|580955251|FG001|Follow-up Period|Lack of Efficacy|0|||
160879965|NCT03642132|580955252|FG002|Follow-up Period|Lack of Efficacy|0|||
160879966|NCT03642132|580955250|FG000|Follow-up Period|Death|1|||
160879967|NCT03642132|580955251|FG001|Follow-up Period|Death|0|||
160879968|NCT03642132|580955252|FG002|Follow-up Period|Death|2|||
160879969|NCT03642132|580955250|FG000|Follow-up Period|Adverse Event|1|||
160879970|NCT03642132|580955251|FG001|Follow-up Period|Adverse Event|0|||
160879971|NCT03642132|580955252|FG002|Follow-up Period|Adverse Event|0|||
160879972|NCT04493892|580955258|FG000|Overall Study|Withdrawal by Subject|15|||
160879973|NCT02577887|580955261|FG000|Overall Study|Death|93|||
160879974|NCT02577887|580955261|FG000|Overall Study|Protocol Violation|125|||
160879975|NCT02577887|580955261|FG000|Overall Study|Withdrawal by Subject|80|||
160879976|NCT02267317|580955262|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
160879977|NCT02267317|580955263|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
160879978|NCT02267317|580955264|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
160879979|NCT02267317|580955265|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
160879980|NCT02267317|580955266|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
160879981|NCT02267317|580955267|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
160879982|NCT02267317|580955262|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
160879983|NCT02267317|580955263|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
160879984|NCT02267317|580955264|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
160879985|NCT02267317|580955265|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
160879986|NCT02267317|580955266|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
160879987|NCT02267317|580955267|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
160879988|NCT03595618|580955270|FG000|Overall Study|Adverse Event|16|||
160879989|NCT03595618|580955271|FG001|Overall Study|Adverse Event|17|||
160538779|NCT01349465|579702283|FG000|Overall Study|Death|3|||
160879990|NCT03595618|580955272|FG002|Overall Study|Adverse Event|20|||
160879991|NCT03595618|580955273|FG003|Overall Study|Adverse Event|8|||
160879992|NCT03595618|580955270|FG000|Overall Study|Withdrawal by Subject|12|||
160879993|NCT03595618|580955271|FG001|Overall Study|Withdrawal by Subject|14|||
160879994|NCT03595618|580955272|FG002|Overall Study|Withdrawal by Subject|14|||
160879995|NCT03595618|580955273|FG003|Overall Study|Withdrawal by Subject|10|||
160879996|NCT03595618|580955270|FG000|Overall Study|Lost to Follow-up|6|||
160879997|NCT03595618|580955271|FG001|Overall Study|Lost to Follow-up|4|||
160879998|NCT03595618|580955272|FG002|Overall Study|Lost to Follow-up|5|||
160879999|NCT03595618|580955273|FG003|Overall Study|Lost to Follow-up|6|||
160880000|NCT03595618|580955270|FG000|Overall Study|Protocol Violation|2|||
160538780|NCT01349465|579702284|FG001|Overall Study|Death|0|||
160880001|NCT03595618|580955271|FG001|Overall Study|Protocol Violation|0|||
160880002|NCT03595618|580955272|FG002|Overall Study|Protocol Violation|6|||
160880003|NCT03595618|580955273|FG003|Overall Study|Protocol Violation|2|||
160880004|NCT03595618|580955270|FG000|Overall Study|Physician Decision|0|||
160880005|NCT03595618|580955271|FG001|Overall Study|Physician Decision|0|||
160880006|NCT03595618|580955272|FG002|Overall Study|Physician Decision|1|||
160880007|NCT03595618|580955273|FG003|Overall Study|Physician Decision|2|||
160880008|NCT03595618|580955270|FG000|Overall Study|Miscellaneous|7|||
160880009|NCT03595618|580955271|FG001|Overall Study|Miscellaneous|5|||
160880010|NCT03595618|580955272|FG002|Overall Study|Miscellaneous|10|||
160880011|NCT03595618|580955273|FG003|Overall Study|Miscellaneous|6|||
160880012|NCT02279407|580955276|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
160880013|NCT02279407|580955277|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
160880014|NCT02279407|580955278|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
160880015|NCT02279407|580955279|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
160880016|NCT02279407|580955276|FG000|Overall Study|Withdrawal by Subject|1|||
160880017|NCT02279407|580955277|FG001|Overall Study|Withdrawal by Subject|0|||
160880018|NCT02279407|580955278|FG002|Overall Study|Withdrawal by Subject|1|||
160880019|NCT02279407|580955279|FG003|Overall Study|Withdrawal by Subject|1|||
160880020|NCT02279407|580955276|FG000|Overall Study|Adverse Event|1|||
160880021|NCT02279407|580955277|FG001|Overall Study|Adverse Event|1|||
160880022|NCT02279407|580955278|FG002|Overall Study|Adverse Event|2|||
160880023|NCT02279407|580955279|FG003|Overall Study|Adverse Event|0|||
160880024|NCT00422084|580955280|FG000|Overall Study|Adverse Event|21|||
160880025|NCT00422084|580955281|FG001|Overall Study|Adverse Event|7|||
160880026|NCT00422084|580955280|FG000|Overall Study|Withdrawal by Subject|12|||
160880027|NCT00422084|580955281|FG001|Overall Study|Withdrawal by Subject|9|||
160880028|NCT00422084|580955280|FG000|Overall Study|Lost to Follow-up|14|||
160880029|NCT00422084|580955281|FG001|Overall Study|Lost to Follow-up|9|||
160880030|NCT00422084|580955280|FG000|Overall Study|Protocol Violation|4|||
160880031|NCT00422084|580955281|FG001|Overall Study|Protocol Violation|1|||
160880032|NCT00422084|580955280|FG000|Overall Study|Lack of Efficacy|40|||
160880033|NCT00422084|580955281|FG001|Overall Study|Lack of Efficacy|42|||
160880034|NCT00422084|580955280|FG000|Overall Study|P. vivax infection|3|||
160880035|NCT00422084|580955281|FG001|Overall Study|P. vivax infection|6|||
160880036|NCT00422084|580955280|FG000|Overall Study|Cyesis|1|||
160880037|NCT00422084|580955281|FG001|Overall Study|Cyesis|0|||
160880038|NCT00422084|580955280|FG000|Overall Study|Withdrawn from study accidentally|1|||
160880039|NCT00422084|580955281|FG001|Overall Study|Withdrawn from study accidentally|0|||
160880040|NCT00422084|580955280|FG000|Overall Study|Non-compliance|1|||
160880041|NCT00422084|580955281|FG001|Overall Study|Non-compliance|0|||
160880042|NCT00422084|580955280|FG000|Overall Study|Re-location|0|||
160880043|NCT00422084|580955281|FG001|Overall Study|Re-location|1|||
160880044|NCT00422084|580955280|FG000|Overall Study|Not defined|1|||
160880045|NCT00422084|580955281|FG001|Overall Study|Not defined|1|||
160880046|NCT03774823|580955284|FG000|Overall Study|Withdrawal by Subject|1|||
160880047|NCT03774823|580955285|FG001|Overall Study|Withdrawal by Subject|1|||
160880048|NCT03996369|580955292|FG000|Overall Study|Protocol deviation|1|||
160880049|NCT03996369|580955293|FG001|Overall Study|Protocol deviation|1|||
160880050|NCT03996369|580955292|FG000|Overall Study|Physician Decision|4|||
160880051|NCT03996369|580955293|FG001|Overall Study|Physician Decision|2|||
160880052|NCT03996369|580955292|FG000|Overall Study|Participant decision|0|||
160880053|NCT03996369|580955293|FG001|Overall Study|Participant decision|1|||
160880054|NCT03996369|580955292|FG000|Overall Study|Lack of Efficacy|4|||
160880055|NCT03996369|580955293|FG001|Overall Study|Lack of Efficacy|0|||
160880056|NCT03996369|580955292|FG000|Overall Study|Adverse Event|9|||
160880057|NCT03996369|580955293|FG001|Overall Study|Adverse Event|0|||
160880058|NCT03996369|580955292|FG000|Overall Study|Withdrawal by Subject|6|||
160880059|NCT03996369|580955293|FG001|Overall Study|Withdrawal by Subject|8|||
160880060|NCT03996369|580955292|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
160880061|NCT03996369|580955293|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
160880062|NCT03996369|580955292|FG000|Overall Study|Lost to Follow-up|0|||
160880063|NCT03996369|580955293|FG001|Overall Study|Lost to Follow-up|1|||
160880064|NCT01579812|580955294|FG000|Overall Study|Ineligible after treatment start|40|||
160880065|NCT01579812|580955294|FG000|Overall Study|Patient choice|3|||
160880066|NCT01579812|580955294|FG000|Overall Study|Noncompliance|3|||
160880067|NCT01579812|580955294|FG000|Overall Study|Withdrawal by Subject|6|||
160880068|NCT00653432|580955295|FG000|Overall Study|Adverse Event|4|||
160880069|NCT00653432|580955296|FG001|Overall Study|Adverse Event|1|||
160880070|NCT00653432|580955295|FG000|Overall Study|Withdrawal by Subject|4|||
160880071|NCT00653432|580955296|FG001|Overall Study|Withdrawal by Subject|5|||
160880072|NCT00653432|580955295|FG000|Overall Study|Lost to Follow-up|7|||
160880073|NCT00653432|580955296|FG001|Overall Study|Lost to Follow-up|6|||
160880074|NCT00653432|580955295|FG000|Overall Study|Use/Need of Con Therapy|2|||
160880075|NCT00653432|580955296|FG001|Overall Study|Use/Need of Con Therapy|1|||
160880076|NCT00653432|580955295|FG000|Overall Study|Other - Reason Not Provided|5|||
160880077|NCT00653432|580955296|FG001|Overall Study|Other - Reason Not Provided|3|||
160880078|NCT01782469|580955297|FG000|Overall Study|Lost to Follow-up|1|||
160880079|NCT00357760|580955298|FG000|Overall Study|Disease progression|44|||
160880080|NCT00357760|580955299|FG001|Overall Study|Disease progression|17|||
160880081|NCT00357760|580955298|FG000|Overall Study|Adverse Event|10|||
160880082|NCT00357760|580955299|FG001|Overall Study|Adverse Event|7|||
160880083|NCT00357760|580955298|FG000|Overall Study|Death|0|||
160880084|NCT00357760|580955299|FG001|Overall Study|Death|3|||
160880085|NCT00357760|580955298|FG000|Overall Study|Alternative therapy|1|||
160880086|NCT00357760|580955299|FG001|Overall Study|Alternative therapy|0|||
160880087|NCT00357760|580955298|FG000|Overall Study|Withdrawal by Subject|0|||
160880088|NCT00357760|580955299|FG001|Overall Study|Withdrawal by Subject|2|||
160880089|NCT00357760|580955298|FG000|Overall Study|Never started treatment|2|||
160880090|NCT00357760|580955299|FG001|Overall Study|Never started treatment|1|||
160880091|NCT00357760|580955298|FG000|Overall Study|Ineligible|0|||
160880092|NCT00357760|580955299|FG001|Overall Study|Ineligible|2|||
160880093|NCT00357760|580955298|FG000|Overall Study|Physician Decision|2|||
160880094|NCT00357760|580955299|FG001|Overall Study|Physician Decision|1|||
160880095|NCT00357760|580955298|FG000|Overall Study|Protocol Violation|0|||
160880096|NCT00357760|580955299|FG001|Overall Study|Protocol Violation|1|||
160880097|NCT00357760|580955298|FG000|Overall Study|To receive hospice care|0|||
160880098|NCT00357760|580955299|FG001|Overall Study|To receive hospice care|1|||
160880099|NCT02353143|580955300|FG000|Overall Study|Withdrawal by Subject|1|||
160880100|NCT02353143|580955301|FG001|Overall Study|Withdrawal by Subject|0|||
160880101|NCT02353143|580955302|FG002|Overall Study|Withdrawal by Subject|0|||
160880102|NCT02353143|580955303|FG003|Overall Study|Withdrawal by Subject|0|||
160880103|NCT02353143|580955304|FG004|Overall Study|Withdrawal by Subject|1|||
160880104|NCT02353143|580955305|FG005|Overall Study|Withdrawal by Subject|0|||
160880105|NCT02353143|580955306|FG006|Overall Study|Withdrawal by Subject|0|||
160880106|NCT02353143|580955307|FG007|Overall Study|Withdrawal by Subject|1|||
160880107|NCT02353143|580955308|FG008|Overall Study|Withdrawal by Subject|1|||
160880108|NCT02353143|580955300|FG000|Overall Study|Lack of Efficacy|2|||
160880109|NCT02353143|580955301|FG001|Overall Study|Lack of Efficacy|1|||
160880110|NCT02353143|580955302|FG002|Overall Study|Lack of Efficacy|2|||
160880111|NCT02353143|580955303|FG003|Overall Study|Lack of Efficacy|4|||
160880112|NCT02353143|580955304|FG004|Overall Study|Lack of Efficacy|13|||
160880113|NCT02353143|580955305|FG005|Overall Study|Lack of Efficacy|2|||
160880114|NCT02353143|580955306|FG006|Overall Study|Lack of Efficacy|2|||
160880115|NCT02353143|580955307|FG007|Overall Study|Lack of Efficacy|2|||
160880116|NCT02353143|580955308|FG008|Overall Study|Lack of Efficacy|1|||
160880117|NCT02353143|580955300|FG000|Overall Study|reason not specified|1|||
160880118|NCT02353143|580955301|FG001|Overall Study|reason not specified|2|||
160880119|NCT02353143|580955302|FG002|Overall Study|reason not specified|0|||
160880120|NCT02353143|580955303|FG003|Overall Study|reason not specified|0|||
160880121|NCT02353143|580955304|FG004|Overall Study|reason not specified|6|||
160880122|NCT02353143|580955305|FG005|Overall Study|reason not specified|1|||
160880123|NCT02353143|580955306|FG006|Overall Study|reason not specified|0|||
160880124|NCT02353143|580955307|FG007|Overall Study|reason not specified|3|||
160880125|NCT02353143|580955308|FG008|Overall Study|reason not specified|1|||
160880126|NCT02353143|580955300|FG000|Overall Study|Physician Decision|0|||
160880127|NCT02353143|580955301|FG001|Overall Study|Physician Decision|4|||
160880128|NCT02353143|580955302|FG002|Overall Study|Physician Decision|2|||
160880129|NCT02353143|580955303|FG003|Overall Study|Physician Decision|3|||
160880130|NCT02353143|580955304|FG004|Overall Study|Physician Decision|4|||
160880131|NCT02353143|580955305|FG005|Overall Study|Physician Decision|0|||
160880132|NCT02353143|580955306|FG006|Overall Study|Physician Decision|1|||
160880133|NCT02353143|580955307|FG007|Overall Study|Physician Decision|2|||
160880134|NCT02353143|580955308|FG008|Overall Study|Physician Decision|0|||
160880135|NCT02353143|580955300|FG000|Overall Study|Adverse Event|0|||
160880136|NCT02353143|580955301|FG001|Overall Study|Adverse Event|0|||
160880137|NCT02353143|580955302|FG002|Overall Study|Adverse Event|1|||
160880138|NCT02353143|580955303|FG003|Overall Study|Adverse Event|0|||
160880139|NCT02353143|580955304|FG004|Overall Study|Adverse Event|1|||
160880140|NCT02353143|580955305|FG005|Overall Study|Adverse Event|1|||
160880141|NCT02353143|580955306|FG006|Overall Study|Adverse Event|0|||
160880142|NCT02353143|580955307|FG007|Overall Study|Adverse Event|0|||
160880143|NCT02353143|580955308|FG008|Overall Study|Adverse Event|0|||
160880144|NCT02353143|580955300|FG000|Overall Study|patient receiving other treatment for AML|0|||
160880145|NCT02353143|580955301|FG001|Overall Study|patient receiving other treatment for AML|0|||
160880146|NCT02353143|580955302|FG002|Overall Study|patient receiving other treatment for AML|1|||
160880147|NCT02353143|580955303|FG003|Overall Study|patient receiving other treatment for AML|0|||
160880148|NCT02353143|580955304|FG004|Overall Study|patient receiving other treatment for AML|0|||
160880149|NCT02353143|580955305|FG005|Overall Study|patient receiving other treatment for AML|0|||
160880150|NCT02353143|580955306|FG006|Overall Study|patient receiving other treatment for AML|0|||
160880151|NCT02353143|580955307|FG007|Overall Study|patient receiving other treatment for AML|0|||
160880152|NCT02353143|580955308|FG008|Overall Study|patient receiving other treatment for AML|0|||
160880153|NCT02353143|580955300|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
160880154|NCT02353143|580955301|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
160880155|NCT02353143|580955302|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
160880156|NCT02353143|580955303|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
160880157|NCT02353143|580955304|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
160880158|NCT02353143|580955305|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
160880159|NCT02353143|580955306|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
160880160|NCT02353143|580955307|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
160880161|NCT02353143|580955308|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
160880162|NCT04740905|580955309|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
160880163|NCT04740905|580955310|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
160880164|NCT04740905|580955309|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
160880165|NCT04740905|580955310|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
160880166|NCT04740905|580955309|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
160880167|NCT04740905|580955310|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
160880168|NCT04740905|580955309|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
160880169|NCT04740905|580955310|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
160880170|NCT04740905|580955309|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
160880171|NCT04740905|580955310|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
160880172|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
160880173|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
160880174|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
160880175|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
160880176|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
160880177|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
160880178|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
160880179|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
160880180|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
160880181|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
160880182|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
160880183|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
160880184|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
160880185|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
160880186|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
160880187|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
160880188|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
160880189|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
160880190|NCT01534182|580955314|FG000|Overall Study|Administrative problems|1|||
160880191|NCT01534182|580955315|FG001|Overall Study|Administrative problems|0|||
160880192|NCT01534182|580955314|FG000|Overall Study|Withdrawal by Subject|4|||
160880193|NCT01534182|580955315|FG001|Overall Study|Withdrawal by Subject|7|||
160880194|NCT01534182|580955314|FG000|Overall Study|Adverse Event|7|||
160880195|NCT01534182|580955315|FG001|Overall Study|Adverse Event|3|||
160880196|NCT03077087|580955316|FG000|Overall Study|Physician Decision|2|||
160880197|NCT01989468|580955317|FG000|Overall Study|Adverse Event|10|||
160880198|NCT01989468|580955318|FG001|Overall Study|Adverse Event|15|||
160880199|NCT01989468|580955319|FG002|Overall Study|Adverse Event|4|||
160880200|NCT01989468|580955320|FG003|Overall Study|Adverse Event|5|||
160880201|NCT01989468|580955321|FG004|Overall Study|Adverse Event|4|||
160880202|NCT01989468|580955317|FG000|Overall Study|Lack of Efficacy|11|||
160880203|NCT01989468|580955318|FG001|Overall Study|Lack of Efficacy|11|||
160880204|NCT01989468|580955319|FG002|Overall Study|Lack of Efficacy|7|||
160880205|NCT01989468|580955320|FG003|Overall Study|Lack of Efficacy|4|||
160880206|NCT01989468|580955321|FG004|Overall Study|Lack of Efficacy|2|||
160880207|NCT01989468|580955317|FG000|Overall Study|Lost to Follow-up|5|||
160880208|NCT01989468|580955318|FG001|Overall Study|Lost to Follow-up|2|||
160880209|NCT01989468|580955319|FG002|Overall Study|Lost to Follow-up|0|||
160880210|NCT01989468|580955320|FG003|Overall Study|Lost to Follow-up|1|||
160880211|NCT01989468|580955321|FG004|Overall Study|Lost to Follow-up|1|||
160880212|NCT01989468|580955317|FG000|Overall Study|Physician Decision|4|||
160880213|NCT01989468|580955318|FG001|Overall Study|Physician Decision|1|||
160880214|NCT01989468|580955319|FG002|Overall Study|Physician Decision|0|||
160880215|NCT01989468|580955320|FG003|Overall Study|Physician Decision|1|||
160880216|NCT01989468|580955321|FG004|Overall Study|Physician Decision|0|||
160880217|NCT01989468|580955317|FG000|Overall Study|Pregnancy|0|||
160880218|NCT01989468|580955318|FG001|Overall Study|Pregnancy|1|||
160880219|NCT01989468|580955319|FG002|Overall Study|Pregnancy|0|||
160880220|NCT01989468|580955320|FG003|Overall Study|Pregnancy|0|||
160880221|NCT01989468|580955321|FG004|Overall Study|Pregnancy|0|||
160880222|NCT01989468|580955317|FG000|Overall Study|Technical Problems|3|||
160880223|NCT01989468|580955318|FG001|Overall Study|Technical Problems|1|||
160880224|NCT01989468|580955319|FG002|Overall Study|Technical Problems|3|||
160880225|NCT01989468|580955320|FG003|Overall Study|Technical Problems|1|||
160880226|NCT01989468|580955321|FG004|Overall Study|Technical Problems|0|||
160880227|NCT01989468|580955317|FG000|Overall Study|Subject Guardian Decision|11|||
160880228|NCT01989468|580955318|FG001|Overall Study|Subject Guardian Decision|6|||
160880229|NCT01989468|580955319|FG002|Overall Study|Subject Guardian Decision|4|||
160880230|NCT01989468|580955320|FG003|Overall Study|Subject Guardian Decision|4|||
160880231|NCT01989468|580955321|FG004|Overall Study|Subject Guardian Decision|1|||
160880232|NCT01989468|580955317|FG000|Overall Study|Death|3|||
160880233|NCT01989468|580955318|FG001|Overall Study|Death|0|||
160880234|NCT01989468|580955319|FG002|Overall Study|Death|1|||
160538781|NCT01349465|579702283|FG000|Overall Study|Lost to Follow-up|10|||
160538782|NCT01349465|579702284|FG001|Overall Study|Lost to Follow-up|1|||
160538783|NCT01349465|579702283|FG000|Overall Study|Withdrawal by Subject|4|||
160538784|NCT01349465|579702284|FG001|Overall Study|Withdrawal by Subject|2|||
160538785|NCT01349465|579702283|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
160538786|NCT01349465|579702284|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
160538787|NCT04329702|579702287|FG000|Overall Study|illness|3|||
160538788|NCT04329702|579702288|FG001|Overall Study|illness|4|||
160880235|NCT01989468|580955320|FG003|Overall Study|Death|0|||
160880236|NCT01989468|580955321|FG004|Overall Study|Death|0|||
160880237|NCT01224782|580955324|FG000|Overall Study|Lost to Follow-up|177|||
160880238|NCT01224782|580955324|FG000|Overall Study|Withdrawal by Subject|16|||
160880239|NCT01224782|580955324|FG000|Overall Study|Death|14|||
160880240|NCT01224782|580955324|FG000|Overall Study|Improvement|13|||
160880241|NCT01224782|580955324|FG000|Overall Study|Adverse Event|12|||
160880242|NCT01224782|580955324|FG000|Overall Study|Adverse Reaction|11|||
160880243|NCT01224782|580955324|FG000|Overall Study|Noncompliance|10|||
160880244|NCT01224782|580955324|FG000|Overall Study|Other|4|||
160880245|NCT01224782|580955324|FG000|Overall Study|Start of Dialysis|3|||
160880246|NCT01224782|580955324|FG000|Overall Study|Change of Treatment|1|||
160880247|NCT01224782|580955324|FG000|Overall Study|Financial Reasons|1|||
160880248|NCT01224782|580955324|FG000|Overall Study|Deterioration|1|||
160880249|NCT01224782|580955324|FG000|Overall Study|Transplantation|1|||
160880250|NCT01960907|580955325|FG000|Overall Study|Death|4|||
160880251|NCT01960907|580955326|FG001|Overall Study|Death|3|||
160880252|NCT01960907|580955325|FG000|Overall Study|Withdrawal by Subject|32|||
160880253|NCT01960907|580955326|FG001|Overall Study|Withdrawal by Subject|42|||
160538789|NCT04329702|579702289|FG002|Overall Study|illness|0|||
160538790|NCT04329702|579702287|FG000|Overall Study|Lost to Follow-up|0|||
160538791|NCT04329702|579702288|FG001|Overall Study|Lost to Follow-up|0|||
160538792|NCT04329702|579702289|FG002|Overall Study|Lost to Follow-up|2|||
160538793|NCT04329702|579702287|FG000|Overall Study|Death|0|||
160538794|NCT04329702|579702288|FG001|Overall Study|Death|2|||
160538795|NCT04329702|579702289|FG002|Overall Study|Death|0|||
160538796|NCT01476475|579702290|FG000|Overall Study|Adverse Event|6|||
160538797|NCT01476475|579702291|FG001|Overall Study|Adverse Event|0|||
160538798|NCT01476475|579702290|FG000|Overall Study|Poor compliance to protocol|1|||
160880254|NCT00977080|580955329|FG000|Overall Study|Adverse Event|2|||
160880255|NCT00977080|580955330|FG001|Overall Study|Adverse Event|7|||
160880256|NCT00977080|580955331|FG002|Overall Study|Adverse Event|7|||
160880257|NCT00977080|580955332|FG003|Overall Study|Adverse Event|7|||
160880258|NCT00977080|580955329|FG000|Overall Study|Withdrawal by Subject|1|||
160880259|NCT00977080|580955330|FG001|Overall Study|Withdrawal by Subject|5|||
160880260|NCT00977080|580955331|FG002|Overall Study|Withdrawal by Subject|1|||
160880261|NCT00977080|580955332|FG003|Overall Study|Withdrawal by Subject|5|||
160538799|NCT01476475|579702291|FG001|Overall Study|Poor compliance to protocol|1|||
160538800|NCT01476475|579702290|FG000|Overall Study|Other reasons|4|||
160880262|NCT00977080|580955329|FG000|Overall Study|Protocol Violation|7|||
160880263|NCT00977080|580955330|FG001|Overall Study|Protocol Violation|3|||
160880264|NCT00977080|580955331|FG002|Overall Study|Protocol Violation|4|||
160880265|NCT00977080|580955332|FG003|Overall Study|Protocol Violation|3|||
160880266|NCT00977080|580955329|FG000|Overall Study|Noncompliance|0|||
160880267|NCT00977080|580955330|FG001|Overall Study|Noncompliance|2|||
160880268|NCT00977080|580955331|FG002|Overall Study|Noncompliance|1|||
160538801|NCT01476475|579702291|FG001|Overall Study|Other reasons|2|||
160538802|NCT00751400|579702295|FG000|Overall Study|Lost to Follow-up|10|||
160538803|NCT01918007|579702296|FG000|Overall Study|Baseline oximetry not acceptable|11|||
160538804|NCT01918007|579702297|FG001|Overall Study|Baseline oximetry not acceptable|7|||
160538805|NCT01918007|579702296|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
160538806|NCT01918007|579702297|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
160538807|NCT01918007|579702296|FG000|Overall Study|Lost to Follow-up|4|||
160538808|NCT01918007|579702297|FG001|Overall Study|Lost to Follow-up|7|||
160538809|NCT01471015|579702304|FG000|Overall Study|Death|0|||
160538810|NCT01471015|579702305|FG001|Overall Study|Death|1|||
160538811|NCT01471015|579702306|FG002|Overall Study|Death|1|||
160538812|NCT04206020|579702307|FG000|Overall Study|Adverse Event|1|||
160538813|NCT04206020|579702308|FG001|Overall Study|Adverse Event|4|||
160538814|NCT04206020|579702307|FG000|Overall Study|Protocol Violation|2|||
160538815|NCT04206020|579702308|FG001|Overall Study|Protocol Violation|0|||
160538816|NCT04206020|579702307|FG000|Overall Study|Withdrawal by Subject|2|||
160538817|NCT04206020|579702308|FG001|Overall Study|Withdrawal by Subject|0|||
160538818|NCT04206020|579702307|FG000|Overall Study|Lost to Follow-up|2|||
160538819|NCT04206020|579702308|FG001|Overall Study|Lost to Follow-up|0|||
160538820|NCT04206020|579702307|FG000|Overall Study|Pregnancy|0|||
160538821|NCT04206020|579702308|FG001|Overall Study|Pregnancy|1|||
160538822|NCT04206020|579702307|FG000|Overall Study|Unable to attend visits|1|||
160538823|NCT04206020|579702308|FG001|Overall Study|Unable to attend visits|2|||
160538824|NCT04962022|579702309|FG000|Period 1|Withdrawal by Subject|1|||
160538825|NCT04962022|579702310|FG001|Period 1|Withdrawal by Subject|0|||
160538826|NCT02055820|579702313|FG000|Phase I: Dose-Finding|Death|1|||
160538827|NCT02055820|579702314|FG001|Phase I: Dose-Finding|Death|0|||
160538828|NCT02055820|579702315|FG002|Phase I: Dose-Finding|Death|1|||
160538829|NCT02055820|579702316|FG003|Phase I: Dose-Finding|Death|2|||
160538830|NCT02055820|579702317|FG004|Phase I: Dose-Finding|Death|0|||
160538831|NCT02055820|579702318|FG005|Phase I: Dose-Finding|Death|1|||
160538832|NCT02055820|579702319|FG006|Phase I: Dose-Finding|Death|1|||
160538833|NCT02055820|579702320|FG007|Phase I: Dose-Finding|Death|0|||
160538834|NCT02055820|579702321|FG008|Phase I: Dose-Finding|Death|0|||
160538835|NCT02055820|579702322|FG009|Phase I: Dose-Finding|Death|0|||
160538836|NCT02055820|579702313|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
160538837|NCT02055820|579702314|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
160538838|NCT02055820|579702315|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
160538839|NCT02055820|579702316|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
160538840|NCT02055820|579702317|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
160538841|NCT02055820|579702318|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
160538842|NCT02055820|579702319|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
160538843|NCT02055820|579702320|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
160538844|NCT02055820|579702321|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
160538845|NCT02055820|579702322|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
160538846|NCT02055820|579702313|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
160538847|NCT02055820|579702314|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
160538848|NCT02055820|579702315|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
160538849|NCT02055820|579702316|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
160538850|NCT02055820|579702317|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
160538851|NCT02055820|579702318|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
160538852|NCT02055820|579702319|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
160538853|NCT02055820|579702320|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
160538854|NCT02055820|579702321|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
160538855|NCT02055820|579702322|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
160538856|NCT02055820|579702313|FG000|Phase II: Expansion|Death|0|||
160538857|NCT02055820|579702314|FG001|Phase II: Expansion|Death|0|||
160538858|NCT02055820|579702315|FG002|Phase II: Expansion|Death|0|||
160538859|NCT02055820|579702316|FG003|Phase II: Expansion|Death|0|||
160538860|NCT02055820|579702317|FG004|Phase II: Expansion|Death|33|||
160538861|NCT02055820|579702318|FG005|Phase II: Expansion|Death|0|||
160538862|NCT02055820|579702319|FG006|Phase II: Expansion|Death|0|||
160538863|NCT02055820|579702320|FG007|Phase II: Expansion|Death|0|||
160538864|NCT02055820|579702321|FG008|Phase II: Expansion|Death|0|||
160538865|NCT02055820|579702322|FG009|Phase II: Expansion|Death|0|||
160538866|NCT02055820|579702313|FG000|Phase II: Expansion|Lost to Follow-up|0|||
160538867|NCT02055820|579702314|FG001|Phase II: Expansion|Lost to Follow-up|0|||
160538868|NCT02055820|579702315|FG002|Phase II: Expansion|Lost to Follow-up|0|||
160538869|NCT02055820|579702316|FG003|Phase II: Expansion|Lost to Follow-up|0|||
160538870|NCT02055820|579702317|FG004|Phase II: Expansion|Lost to Follow-up|4|||
160538871|NCT02055820|579702318|FG005|Phase II: Expansion|Lost to Follow-up|0|||
160538872|NCT02055820|579702319|FG006|Phase II: Expansion|Lost to Follow-up|0|||
160538873|NCT02055820|579702320|FG007|Phase II: Expansion|Lost to Follow-up|0|||
160538874|NCT02055820|579702321|FG008|Phase II: Expansion|Lost to Follow-up|0|||
160538875|NCT02055820|579702322|FG009|Phase II: Expansion|Lost to Follow-up|0|||
160538876|NCT02055820|579702313|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
160538877|NCT02055820|579702314|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
160538878|NCT02055820|579702315|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
160880269|NCT00977080|580955332|FG003|Overall Study|Noncompliance|0|||
160880270|NCT00977080|580955329|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
160880271|NCT00977080|580955330|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
160880272|NCT00977080|580955331|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
160880273|NCT00977080|580955332|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
160880274|NCT00977080|580955329|FG000|Overall Study|Required kidney transplantation|1|||
160880275|NCT00977080|580955330|FG001|Overall Study|Required kidney transplantation|3|||
160880276|NCT00977080|580955331|FG002|Overall Study|Required kidney transplantation|3|||
160880277|NCT00977080|580955332|FG003|Overall Study|Required kidney transplantation|1|||
160880278|NCT00977080|580955329|FG000|Overall Study|Travel for family reasons|1|||
160880279|NCT00977080|580955330|FG001|Overall Study|Travel for family reasons|0|||
160880280|NCT00977080|580955331|FG002|Overall Study|Travel for family reasons|0|||
160880281|NCT00977080|580955332|FG003|Overall Study|Travel for family reasons|0|||
160880282|NCT01765218|580955335|FG000|Overall Study|Protocol Violation|1|||
160880283|NCT01765218|580955336|FG001|Overall Study|Protocol Violation|2|||
160880284|NCT00313781|580955337|FG000|Before Crossover|Death|22|||
160880285|NCT00313781|580955338|FG001|Before Crossover|Death|8|||
160880286|NCT00313781|580955339|FG002|Before Crossover|Death|0|||
160880287|NCT00313781|580955337|FG000|Before Crossover|Lost to Follow-up|0|||
160880288|NCT00313781|580955338|FG001|Before Crossover|Lost to Follow-up|3|||
160880289|NCT00313781|580955339|FG002|Before Crossover|Lost to Follow-up|0|||
160880290|NCT00313781|580955337|FG000|Before Crossover|Withdrawal by Subject|3|||
160880291|NCT00313781|580955338|FG001|Before Crossover|Withdrawal by Subject|1|||
160880292|NCT00313781|580955339|FG002|Before Crossover|Withdrawal by Subject|0|||
160880293|NCT00313781|580955337|FG000|Before Crossover|Other|45|||
160880294|NCT00313781|580955338|FG001|Before Crossover|Other|30|||
160880295|NCT00313781|580955339|FG002|Before Crossover|Other|0|||
160880296|NCT00313781|580955337|FG000|Before Crossover|Crossover|0|||
160880297|NCT00313781|580955338|FG001|Before Crossover|Crossover|37|||
160880298|NCT00313781|580955339|FG002|Before Crossover|Crossover|0|||
160880299|NCT00313781|580955337|FG000|Before Crossover|Randomized, not treated|5|||
160880300|NCT00313781|580955338|FG001|Before Crossover|Randomized, not treated|0|||
160880301|NCT00313781|580955339|FG002|Before Crossover|Randomized, not treated|0|||
160880302|NCT00313781|580955337|FG000|After Crossover|Death|0|||
160880303|NCT00313781|580955338|FG001|After Crossover|Death|0|||
160880304|NCT00313781|580955339|FG002|After Crossover|Death|6|||
160880305|NCT00313781|580955337|FG000|After Crossover|Withdrawal by Subject|0|||
160880306|NCT00313781|580955338|FG001|After Crossover|Withdrawal by Subject|0|||
160880307|NCT00313781|580955339|FG002|After Crossover|Withdrawal by Subject|3|||
160880308|NCT00313781|580955337|FG000|After Crossover|Other|0|||
160880309|NCT00313781|580955338|FG001|After Crossover|Other|0|||
160880310|NCT00313781|580955339|FG002|After Crossover|Other|18|||
160880311|NCT01590758|580955340|FG000|Overall Study|Withdrawal by Subject|0|||
160880312|NCT01590758|580955341|FG001|Overall Study|Withdrawal by Subject|3|||
160880313|NCT01590758|580955340|FG000|Overall Study|Physician Decision|1|||
160880314|NCT01590758|580955341|FG001|Overall Study|Physician Decision|2|||
160880315|NCT01590758|580955340|FG000|Overall Study|Lost to Follow-up|4|||
160880316|NCT01590758|580955341|FG001|Overall Study|Lost to Follow-up|2|||
160880317|NCT02929498|580955342|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
160880318|NCT02929498|580955343|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
160880319|NCT02929498|580955344|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
160880320|NCT02929498|580955342|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
160538879|NCT02055820|579702316|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
160538880|NCT02055820|579702317|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
160538881|NCT02055820|579702318|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
160880321|NCT02929498|580955343|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
160880322|NCT02929498|580955344|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
160880323|NCT01011309|580955349|FG000|Overall Study|Adverse Event|2|||
160880324|NCT01011309|580955350|FG001|Overall Study|Adverse Event|1|||
160880325|NCT01011309|580955351|FG002|Overall Study|Adverse Event|2|||
160880326|NCT01011309|580955349|FG000|Overall Study|Lack of Efficacy|0|||
160880327|NCT01011309|580955350|FG001|Overall Study|Lack of Efficacy|1|||
160880328|NCT01011309|580955351|FG002|Overall Study|Lack of Efficacy|0|||
160880329|NCT01011309|580955349|FG000|Overall Study|Protocol Violation|0|||
160880330|NCT01011309|580955350|FG001|Overall Study|Protocol Violation|1|||
160880331|NCT01011309|580955351|FG002|Overall Study|Protocol Violation|3|||
160880332|NCT00530504|580955354|FG000|Overall Study|Death|54|||
160538882|NCT02055820|579702319|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
160538883|NCT02055820|579702320|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
160538884|NCT02055820|579702321|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
160538885|NCT02055820|579702322|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
160538886|NCT00552175|579702323|FG000|Overall Study|Lack of Efficacy|2|||
160538887|NCT00552175|579702324|FG001|Overall Study|Lack of Efficacy|0|||
160538888|NCT00552175|579702325|FG002|Overall Study|Lack of Efficacy|1|||
160538889|NCT00552175|579702323|FG000|Overall Study|Adverse Event|9|||
160538890|NCT00552175|579702324|FG001|Overall Study|Adverse Event|9|||
160538891|NCT00552175|579702325|FG002|Overall Study|Adverse Event|10|||
160538892|NCT00552175|579702323|FG000|Overall Study|Withdrawal by Subject|2|||
160538893|NCT00552175|579702324|FG001|Overall Study|Withdrawal by Subject|2|||
160538894|NCT00552175|579702325|FG002|Overall Study|Withdrawal by Subject|1|||
160538895|NCT00552175|579702323|FG000|Overall Study|Lost to Follow-up|0|||
160538896|NCT00552175|579702324|FG001|Overall Study|Lost to Follow-up|0|||
160538897|NCT00552175|579702325|FG002|Overall Study|Lost to Follow-up|1|||
160538898|NCT00552175|579702323|FG000|Overall Study|Entry Criteria Not Met|1|||
160538899|NCT00552175|579702324|FG001|Overall Study|Entry Criteria Not Met|1|||
160538900|NCT00552175|579702325|FG002|Overall Study|Entry Criteria Not Met|0|||
160538901|NCT00552175|579702323|FG000|Overall Study|Reason Not Specified|3|||
160538902|NCT00552175|579702324|FG001|Overall Study|Reason Not Specified|1|||
160538903|NCT00552175|579702325|FG002|Overall Study|Reason Not Specified|1|||
160538904|NCT03962101|579702326|FG000|Overall Study|Adverse Event|1|||
160538905|NCT03962101|579702326|FG000|Overall Study|Physician Decision|2|||
160538906|NCT03962101|579702326|FG000|Overall Study|Not related to medical events|1|||
160538907|NCT03548935|579702327|FG000|Overall Study|Withdrawal by Subject|26|||
160538908|NCT03548935|579702328|FG001|Overall Study|Withdrawal by Subject|17|||
160538909|NCT03548935|579702327|FG000|Overall Study|Lost to Follow-up|39|||
160538910|NCT03548935|579702328|FG001|Overall Study|Lost to Follow-up|28|||
160538911|NCT03548935|579702327|FG000|Overall Study|Death|1|||
160538912|NCT03548935|579702328|FG001|Overall Study|Death|1|||
160538913|NCT02919436|579702331|FG000|Overall Study|Did not undergo surgery|16|||
160538914|NCT02919436|579702332|FG001|Overall Study|Did not undergo surgery|20|||
160538915|NCT02919436|579702331|FG000|Overall Study|Enrolled before trial registration|44|||
160538916|NCT02919436|579702332|FG001|Overall Study|Enrolled before trial registration|33|||
160538917|NCT05289570|579702334|FG000|Overall Study|Physician Decision|1|||
160538918|NCT00777101|579702339|FG000|Overall Study|Death|48|||
160880333|NCT00530504|580955354|FG000|Overall Study|Lost to Follow-up|26|||
160880334|NCT00530504|580955354|FG000|Overall Study|Withdrawal by Subject|39|||
160880335|NCT00530504|580955354|FG000|Overall Study|Exited study due to other reasons|33|||
160538919|NCT00777101|579702340|FG001|Overall Study|Death|43|||
160538920|NCT00777101|579702339|FG000|Overall Study|Withdrawal by Subject|11|||
160538921|NCT00777101|579702340|FG001|Overall Study|Withdrawal by Subject|6|||
160538922|NCT00777101|579702339|FG000|Overall Study|Lost to Follow-up|2|||
160538923|NCT00777101|579702340|FG001|Overall Study|Lost to Follow-up|1|||
160538924|NCT00777101|579702339|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
160538925|NCT00777101|579702340|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
160538926|NCT00777101|579702339|FG000|Overall Study|Failed to Return|0|||
160538927|NCT00777101|579702340|FG001|Overall Study|Failed to Return|1|||
160538928|NCT00282334|579702341|FG000|Overall Study|Withdrawal by Subject|8|||
160538929|NCT00282334|579702342|FG001|Overall Study|Withdrawal by Subject|5|||
160538930|NCT00964743|579702353|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
160538931|NCT03317795|579702354|FG000|Overall Study|IUD Expulsion|1|||
160538932|NCT03317795|579702355|FG001|Overall Study|IUD Expulsion|0|||
160538933|NCT03317795|579702354|FG000|Overall Study|Lost to Follow-up|1|||
160538934|NCT03317795|579702355|FG001|Overall Study|Lost to Follow-up|3|||
160538935|NCT03317795|579702354|FG000|Overall Study|Treatment change|0|||
160538936|NCT03317795|579702355|FG001|Overall Study|Treatment change|3|||
160538937|NCT03317795|579702354|FG000|Overall Study|Intolerance of medication|0|||
160538938|NCT03317795|579702355|FG001|Overall Study|Intolerance of medication|1|||
160538939|NCT00501007|579702356|FG000|Overall Study|Inclusion criteria not met.|29|||
160538940|NCT00501007|579702357|FG001|Overall Study|Inclusion criteria not met.|25|||
160538941|NCT03917823|579702358|FG000|Overall Study|Lost to Follow-up|1|||
160538942|NCT03917823|579702359|FG001|Overall Study|Lost to Follow-up|1|||
160880336|NCT00006289|580955355|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
160880337|NCT00006289|580955356|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
160538943|NCT03917823|579702358|FG000|Overall Study|Withdrawal by Subject|0|||
160538944|NCT03917823|579702359|FG001|Overall Study|Withdrawal by Subject|1|||
160538945|NCT02424253|579702362|FG000|Overall Study|Other, unspecified|1|||
160538946|NCT02424253|579702363|FG001|Overall Study|Other, unspecified|0|||
160538947|NCT02424253|579702362|FG000|Overall Study|Compliance problems|1|||
160538948|NCT02424253|579702363|FG001|Overall Study|Compliance problems|0|||
160538949|NCT02424253|579702362|FG000|Overall Study|Physician Decision|2|||
160538950|NCT02424253|579702363|FG001|Overall Study|Physician Decision|0|||
160538951|NCT02424253|579702362|FG000|Overall Study|Lack of Efficacy|0|||
160538952|NCT02424253|579702363|FG001|Overall Study|Lack of Efficacy|7|||
160538953|NCT02424253|579702362|FG000|Overall Study|Adverse Event|2|||
160880338|NCT00006289|580955355|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
160880339|NCT00006289|580955356|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
160880340|NCT00576420|580956946|FG000|Overall Study|Death|0|||
160880341|NCT00576420|580956947|FG001|Overall Study|Death|0|||
160880342|NCT00576420|580956948|FG002|Overall Study|Death|1|||
160880343|NCT02616146|580956949|FG000|Overall Study|Adverse Event|64|||
160880344|NCT02616146|580956950|FG001|Overall Study|Adverse Event|24|||
160880345|NCT02616146|580956949|FG000|Overall Study|Lost to Follow-up|23|||
160880346|NCT02616146|580956950|FG001|Overall Study|Lost to Follow-up|13|||
160880347|NCT02616146|580956949|FG000|Overall Study|Non-compliance with study protocol|2|||
160880348|NCT02616146|580956950|FG001|Overall Study|Non-compliance with study protocol|0|||
160880349|NCT02616146|580956949|FG000|Overall Study|Non-compliance with study drug|4|||
160880350|NCT02616146|580956950|FG001|Overall Study|Non-compliance with study drug|2|||
160880351|NCT02616146|580956949|FG000|Overall Study|Pregnancy|2|||
160880352|NCT02616146|580956950|FG001|Overall Study|Pregnancy|2|||
160880353|NCT02616146|580956949|FG000|Overall Study|Pregnancy wish|3|||
160880354|NCT02616146|580956950|FG001|Overall Study|Pregnancy wish|0|||
160880355|NCT02616146|580956949|FG000|Overall Study|Protocol Violation|6|||
160880356|NCT02616146|580956950|FG001|Overall Study|Protocol Violation|3|||
160880357|NCT02616146|580956949|FG000|Overall Study|Study terminated by sponsor|1372|||
160880358|NCT02616146|580956950|FG001|Overall Study|Study terminated by sponsor|432|||
160880359|NCT02616146|580956949|FG000|Overall Study|Participant moved|4|||
160880360|NCT02616146|580956950|FG001|Overall Study|Participant moved|3|||
160880361|NCT02616146|580956949|FG000|Overall Study|Withdrawal by Subject|30|||
160880362|NCT02616146|580956950|FG001|Overall Study|Withdrawal by Subject|24|||
160880363|NCT02616146|580956949|FG000|Overall Study|Physician Decision|2|||
160880364|NCT02616146|580956950|FG001|Overall Study|Physician Decision|1|||
160880365|NCT01221272|580956951|FG000|Period 1|Adverse Event|2|||
160538954|NCT02424253|579702363|FG001|Overall Study|Adverse Event|0|||
160880366|NCT01221272|580956952|FG001|Period 1|Adverse Event|0|||
160538955|NCT02424253|579702362|FG000|Overall Study|Consent withdrawn by subject|4|||
160880367|NCT01221272|580956951|FG000|Period 1|Consent Withdrawal|0|||
160880368|NCT01221272|580956952|FG001|Period 1|Consent Withdrawal|1|||
160880369|NCT01221272|580956951|FG000|Period 1|Significant Dosing Noncompliance|0|||
160880370|NCT01221272|580956952|FG001|Period 1|Significant Dosing Noncompliance|1|||
160880371|NCT01221272|580956951|FG000|Period 2|Adverse Event|0|||
160880372|NCT01221272|580956952|FG001|Period 2|Adverse Event|2|||
160880373|NCT01340872|580956953|FG000|Double-blind Phase|Adverse Event|6|||
160880374|NCT01340872|580956954|FG001|Double-blind Phase|Adverse Event|4|||
160880375|NCT01340872|580956955|FG002|Double-blind Phase|Adverse Event|0|||
160538956|NCT02424253|579702363|FG001|Overall Study|Consent withdrawn by subject|1|||
160538957|NCT02424253|579702362|FG000|Overall Study|Lost to Follow-up|1|||
160538958|NCT02424253|579702363|FG001|Overall Study|Lost to Follow-up|1|||
160538959|NCT00473343|579702364|FG000|Overall Study|Adverse Event|9|||
160538960|NCT00473343|579702364|FG000|Overall Study|Lost to Follow-up|8|||
160538961|NCT00473343|579702364|FG000|Overall Study|Treatment failure|27|||
160538962|NCT00473343|579702364|FG000|Overall Study|Withdrew consent|3|||
160538963|NCT00473343|579702364|FG000|Overall Study|Other un-specified reason|3|||
160538964|NCT02290873|579702365|FG000|Overall Study|Withdrawal by Subject|0|||
160538965|NCT02290873|579702366|FG001|Overall Study|Withdrawal by Subject|1|||
160538966|NCT02290873|579702367|FG002|Overall Study|Withdrawal by Subject|1|||
160538967|NCT02290873|579702365|FG000|Overall Study|Nellcor device error|1|||
160538968|NCT02290873|579702366|FG001|Overall Study|Nellcor device error|0|||
160538969|NCT02290873|579702367|FG002|Overall Study|Nellcor device error|0|||
160538970|NCT02290873|579702365|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
160538971|NCT02290873|579702366|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
160538972|NCT02290873|579702367|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
160538973|NCT02290873|579702365|FG000|Overall Study|Protocol Violation|0|||
160538974|NCT02290873|579702366|FG001|Overall Study|Protocol Violation|0|||
160538975|NCT02290873|579702367|FG002|Overall Study|Protocol Violation|1|||
160538976|NCT03715153|579702368|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
160538977|NCT03715153|579702369|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
160538978|NCT03715153|579702368|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
160538979|NCT03715153|579702369|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
160538980|NCT03715153|579702368|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
160538981|NCT03715153|579702369|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
160538982|NCT03715153|579702368|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
160538983|NCT03715153|579702369|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
160538984|NCT03715153|579702368|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
160538985|NCT03715153|579702369|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
160538986|NCT03715153|579702368|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
160538987|NCT03715153|579702369|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
160538988|NCT01519765|579702374|FG000|Overall Study|Adverse Event|0|||
160538989|NCT01519765|579702375|FG001|Overall Study|Adverse Event|1|||
160538990|NCT01519765|579702374|FG000|Overall Study|Lack of Efficacy|2|||
160538991|NCT01519765|579702375|FG001|Overall Study|Lack of Efficacy|0|||
160538992|NCT01519765|579702374|FG000|Overall Study|Protocol Violation|1|||
160538993|NCT01519765|579702375|FG001|Overall Study|Protocol Violation|0|||
160538994|NCT01519765|579702374|FG000|Overall Study|Withdrawal by Subject|0|||
160538995|NCT01519765|579702375|FG001|Overall Study|Withdrawal by Subject|1|||
160538996|NCT04126083|579702376|FG000|Overall Study|Withdrawal by Subject|1|||
160538997|NCT00609791|579704008|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
160538998|NCT02484911|579704011|FG000|Overall Study|Withdrawal by Subject|2|||
160538999|NCT02484911|579704012|FG001|Overall Study|Withdrawal by Subject|1|||
160539000|NCT02484911|579704011|FG000|Overall Study|Protocol Violation|2|||
160539001|NCT02484911|579704012|FG001|Overall Study|Protocol Violation|1|||
160539002|NCT04129528|579704016|FG000|Overall Study|Adverse Event|1|||
160539003|NCT04129528|579704017|FG001|Overall Study|Adverse Event|0|||
160539004|NCT04129528|579704016|FG000|Overall Study|Physician Decision|1|||
160539005|NCT04129528|579704017|FG001|Overall Study|Physician Decision|1|||
160539006|NCT04129528|579704016|FG000|Overall Study|Withdrawal by Subject|1|||
160539007|NCT04129528|579704017|FG001|Overall Study|Withdrawal by Subject|1|||
160539008|NCT00490568|579704023|FG000|Overall Study|Adverse Event|116|||
160539009|NCT00490568|579704023|FG000|Overall Study|Lost to Follow-up|13|||
160539010|NCT00490568|579704023|FG000|Overall Study|Protocol Violation|45|||
160539011|NCT00490568|579704023|FG000|Overall Study|Withdrawal by Subject|135|||
160880376|NCT01340872|580956956|FG003|Double-blind Phase|Adverse Event|0|||
160880377|NCT01340872|580956953|FG000|Double-blind Phase|Withdrawal by Subject|3|||
160880378|NCT01340872|580956954|FG001|Double-blind Phase|Withdrawal by Subject|5|||
160539012|NCT00490568|579704023|FG000|Overall Study|Still in the study at termination|974|||
160539013|NCT00490568|579704023|FG000|Overall Study|Other|1|||
160539014|NCT00490568|579704023|FG000|Overall Study|Exclusion criteria met|1|||
160539015|NCT00490568|579704023|FG000|Overall Study|Caregiver related|20|||
160539016|NCT00490568|579704023|FG000|Overall Study|Abnormal ECG|25|||
160539017|NCT00490568|579704023|FG000|Overall Study|Participant refused follow-up|9|||
160539018|NCT00490568|579704023|FG000|Overall Study|Legal representative withdrew consent|1|||
160539019|NCT00490568|579704023|FG000|Overall Study|Disease progression|4|||
160539020|NCT00490568|579704023|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
160539021|NCT00490568|579704023|FG000|Overall Study|Investigator decision|3|||
160539022|NCT00490568|579704023|FG000|Overall Study|Non-Compliance|7|||
160539023|NCT00490568|579704023|FG000|Overall Study|Efficacy related|3|||
160539024|NCT00490568|579704023|FG000|Overall Study|Participant died|1|||
160539025|NCT00490568|579704023|FG000|Overall Study|Participant withdrawal due to surgery|1|||
160539026|NCT03927105|579704026|FG000|Overall Study|Death|1|||
160880379|NCT01340872|580956955|FG002|Double-blind Phase|Withdrawal by Subject|0|||
160539027|NCT03927105|579704026|FG000|Overall Study|In observation for potential re-treatment|2|||
160770140|NCT01648764|580545919|FG004|Overall Study|Adverse Event|0|||
160770141|NCT01648764|580545920|FG005|Overall Study|Adverse Event|1|||
160770142|NCT01648764|580545921|FG006|Overall Study|Adverse Event|0|||
160770143|NCT01648764|580545922|FG007|Overall Study|Adverse Event|0|||
160770144|NCT01648764|580545923|FG008|Overall Study|Adverse Event|0|||
160770145|NCT01648764|580545924|FG009|Overall Study|Adverse Event|1|||
160770146|NCT01648764|580545925|FG010|Overall Study|Adverse Event|0|||
160770147|NCT01648764|580545926|FG011|Overall Study|Adverse Event|3|||
160770148|NCT01648764|580545927|FG012|Overall Study|Adverse Event|1|||
160770149|NCT01648764|580545928|FG013|Overall Study|Adverse Event|1|||
160770150|NCT01648764|580545915|FG000|Overall Study|Death|0|||
160770151|NCT01648764|580545916|FG001|Overall Study|Death|0|||
160770152|NCT01648764|580545917|FG002|Overall Study|Death|0|||
160770153|NCT01648764|580545918|FG003|Overall Study|Death|0|||
160770154|NCT01648764|580545919|FG004|Overall Study|Death|0|||
160770155|NCT01648764|580545920|FG005|Overall Study|Death|0|||
160770156|NCT01648764|580545921|FG006|Overall Study|Death|1|||
160770157|NCT01648764|580545922|FG007|Overall Study|Death|0|||
160770158|NCT01648764|580545923|FG008|Overall Study|Death|0|||
160770159|NCT01648764|580545924|FG009|Overall Study|Death|0|||
160770160|NCT01648764|580545925|FG010|Overall Study|Death|0|||
160770161|NCT01648764|580545926|FG011|Overall Study|Death|0|||
160770162|NCT01648764|580545927|FG012|Overall Study|Death|0|||
160770163|NCT01648764|580545928|FG013|Overall Study|Death|1|||
160770164|NCT01648764|580545915|FG000|Overall Study|Withdrawal by Subject|0|||
160770165|NCT01648764|580545916|FG001|Overall Study|Withdrawal by Subject|0|||
160770166|NCT01648764|580545917|FG002|Overall Study|Withdrawal by Subject|0|||
160770167|NCT01648764|580545918|FG003|Overall Study|Withdrawal by Subject|0|||
160770168|NCT01648764|580545919|FG004|Overall Study|Withdrawal by Subject|0|||
160770169|NCT01648764|580545920|FG005|Overall Study|Withdrawal by Subject|0|||
160770170|NCT01648764|580545921|FG006|Overall Study|Withdrawal by Subject|2|||
160770171|NCT01648764|580545922|FG007|Overall Study|Withdrawal by Subject|0|||
160770172|NCT01648764|580545923|FG008|Overall Study|Withdrawal by Subject|0|||
160770173|NCT01648764|580545924|FG009|Overall Study|Withdrawal by Subject|0|||
160770174|NCT01648764|580545925|FG010|Overall Study|Withdrawal by Subject|0|||
160770175|NCT01648764|580545926|FG011|Overall Study|Withdrawal by Subject|0|||
160770176|NCT01648764|580545927|FG012|Overall Study|Withdrawal by Subject|1|||
160770177|NCT01648764|580545928|FG013|Overall Study|Withdrawal by Subject|0|||
160770178|NCT01648764|580545915|FG000|Overall Study|Investigator Decision|0|||
160770179|NCT01648764|580545916|FG001|Overall Study|Investigator Decision|0|||
160770180|NCT01648764|580545917|FG002|Overall Study|Investigator Decision|0|||
160770181|NCT01648764|580545918|FG003|Overall Study|Investigator Decision|0|||
160770182|NCT01648764|580545919|FG004|Overall Study|Investigator Decision|0|||
160770183|NCT01648764|580545920|FG005|Overall Study|Investigator Decision|0|||
160770184|NCT01648764|580545921|FG006|Overall Study|Investigator Decision|1|||
160770185|NCT01648764|580545922|FG007|Overall Study|Investigator Decision|0|||
160770186|NCT01648764|580545923|FG008|Overall Study|Investigator Decision|0|||
160770187|NCT01648764|580545924|FG009|Overall Study|Investigator Decision|0|||
160770188|NCT01648764|580545925|FG010|Overall Study|Investigator Decision|0|||
160770189|NCT01648764|580545926|FG011|Overall Study|Investigator Decision|1|||
160770190|NCT01648764|580545927|FG012|Overall Study|Investigator Decision|0|||
160770191|NCT01648764|580545928|FG013|Overall Study|Investigator Decision|0|||
160770192|NCT04889040|580545929|FG000|Overall Study|Withdrawal by Subject|3|||
160770193|NCT04889040|580545930|FG001|Overall Study|Withdrawal by Subject|3|||
160770194|NCT04889040|580545929|FG000|Overall Study|Lost to Follow-up|0|||
160770195|NCT04889040|580545930|FG001|Overall Study|Lost to Follow-up|1|||
160770196|NCT04889040|580545929|FG000|Overall Study|Adverse Event|2|||
160770197|NCT04889040|580545930|FG001|Overall Study|Adverse Event|1|||
160770198|NCT03801252|580545933|FG000|Overall Study|Protocol Violation|1|||
160770199|NCT03801252|580545934|FG001|Overall Study|Protocol Violation|2|||
160770200|NCT00855582|580545940|FG000|Overall Study|Adverse Event|2|||
160770201|NCT00855582|580545941|FG001|Overall Study|Adverse Event|6|||
160770202|NCT00855582|580545942|FG002|Overall Study|Adverse Event|3|||
160770203|NCT00855582|580545940|FG000|Overall Study|Death|1|||
160770204|NCT00855582|580545941|FG001|Overall Study|Death|0|||
160770205|NCT00855582|580545942|FG002|Overall Study|Death|0|||
160770206|NCT00855582|580545940|FG000|Overall Study|Lack of Efficacy|1|||
160770207|NCT00855582|580545941|FG001|Overall Study|Lack of Efficacy|3|||
160770208|NCT00855582|580545942|FG002|Overall Study|Lack of Efficacy|8|||
160770209|NCT00855582|580545940|FG000|Overall Study|Lost to Follow-up|1|||
160770210|NCT00855582|580545941|FG001|Overall Study|Lost to Follow-up|3|||
160770211|NCT00855582|580545942|FG002|Overall Study|Lost to Follow-up|1|||
160770212|NCT00855582|580545940|FG000|Overall Study|Physician Decision|0|||
160539028|NCT03927105|579704026|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
160539029|NCT01351389|579704028|FG000|Overall Study|Withdrawal by Subject|7|||
160539030|NCT01351389|579704029|FG001|Overall Study|Withdrawal by Subject|0|||
160539031|NCT01351389|579704028|FG000|Overall Study|did not complete intervention|23|||
160539032|NCT01351389|579704029|FG001|Overall Study|did not complete intervention|15|||
160539033|NCT01902966|579704034|FG000|Overall Study|Death|1|||
160539034|NCT01902966|579704034|FG000|Overall Study|Physician Decision|1|||
160539035|NCT01902966|579704034|FG000|Overall Study|Withdrawal by Subject|1|||
160539036|NCT01549275|579704035|FG000|Overall Study|Lost to Follow-up|1|||
160539037|NCT01549275|579704036|FG001|Overall Study|Lost to Follow-up|0|||
160539038|NCT01081912|579704044|FG000|Conversion/Titration|Adverse Event|47|||
160539039|NCT01081912|579704045|FG001|Conversion/Titration|Adverse Event|0|||
160539040|NCT01081912|579704046|FG002|Conversion/Titration|Adverse Event|0|||
160539041|NCT01081912|579704044|FG000|Conversion/Titration|Lack of Efficacy|17|||
160539042|NCT01081912|579704045|FG001|Conversion/Titration|Lack of Efficacy|0|||
160539043|NCT01081912|579704046|FG002|Conversion/Titration|Lack of Efficacy|0|||
160539044|NCT01081912|579704044|FG000|Conversion/Titration|Lost to Follow-up|5|||
160539045|NCT01081912|579704045|FG001|Conversion/Titration|Lost to Follow-up|0|||
160539046|NCT01081912|579704046|FG002|Conversion/Titration|Lost to Follow-up|0|||
160539047|NCT01081912|579704044|FG000|Conversion/Titration|Physician Decision|2|||
160539048|NCT01081912|579704045|FG001|Conversion/Titration|Physician Decision|0|||
160539049|NCT01081912|579704046|FG002|Conversion/Titration|Physician Decision|0|||
160539050|NCT01081912|579704044|FG000|Conversion/Titration|Protocol Violation|67|||
160539051|NCT01081912|579704045|FG001|Conversion/Titration|Protocol Violation|0|||
160539052|NCT01081912|579704046|FG002|Conversion/Titration|Protocol Violation|0|||
160539053|NCT01081912|579704044|FG000|Conversion/Titration|Withdrawal by Subject|23|||
160539054|NCT01081912|579704045|FG001|Conversion/Titration|Withdrawal by Subject|0|||
160539055|NCT01081912|579704046|FG002|Conversion/Titration|Withdrawal by Subject|0|||
160539056|NCT01081912|579704044|FG000|Conversion/Titration|Non-Compliance|47|||
160539057|NCT01081912|579704045|FG001|Conversion/Titration|Non-Compliance|0|||
160539058|NCT01081912|579704046|FG002|Conversion/Titration|Non-Compliance|0|||
160539059|NCT01081912|579704044|FG000|Maintenance Treatment|Adverse Event|0|||
160539060|NCT01081912|579704045|FG001|Maintenance Treatment|Adverse Event|2|||
160539061|NCT01081912|579704046|FG002|Maintenance Treatment|Adverse Event|12|||
160880380|NCT01340872|580956956|FG003|Double-blind Phase|Withdrawal by Subject|0|||
160880381|NCT01340872|580956953|FG000|Double-blind Phase|Lost to Follow-up|0|||
160880382|NCT01340872|580956954|FG001|Double-blind Phase|Lost to Follow-up|1|||
160880383|NCT01340872|580956955|FG002|Double-blind Phase|Lost to Follow-up|0|||
160880384|NCT01340872|580956956|FG003|Double-blind Phase|Lost to Follow-up|0|||
160880385|NCT01340872|580956953|FG000|Double-blind Phase|Protocol Violation|0|||
160880386|NCT01340872|580956954|FG001|Double-blind Phase|Protocol Violation|1|||
160880387|NCT01340872|580956955|FG002|Double-blind Phase|Protocol Violation|0|||
160880388|NCT01340872|580956956|FG003|Double-blind Phase|Protocol Violation|0|||
160880389|NCT01340872|580956953|FG000|Open-label Phase|Physician Decision|0|||
160880390|NCT01340872|580956954|FG001|Open-label Phase|Physician Decision|0|||
160880391|NCT01340872|580956955|FG002|Open-label Phase|Physician Decision|2|||
160880392|NCT01340872|580956956|FG003|Open-label Phase|Physician Decision|1|||
160880393|NCT01340872|580956953|FG000|Open-label Phase|Pregnancy|0|||
160880394|NCT01340872|580956954|FG001|Open-label Phase|Pregnancy|0|||
160880395|NCT01340872|580956955|FG002|Open-label Phase|Pregnancy|1|||
160880396|NCT01340872|580956956|FG003|Open-label Phase|Pregnancy|0|||
160880397|NCT01340872|580956953|FG000|Open-label Phase|Adverse Event|0|||
160880398|NCT01340872|580956954|FG001|Open-label Phase|Adverse Event|0|||
160880399|NCT01340872|580956955|FG002|Open-label Phase|Adverse Event|8|||
160880400|NCT01340872|580956956|FG003|Open-label Phase|Adverse Event|4|||
160880401|NCT01340872|580956953|FG000|Open-label Phase|Withdrawal by Subject|0|||
160880402|NCT01340872|580956954|FG001|Open-label Phase|Withdrawal by Subject|0|||
160880403|NCT01340872|580956955|FG002|Open-label Phase|Withdrawal by Subject|1|||
160880404|NCT01340872|580956956|FG003|Open-label Phase|Withdrawal by Subject|6|||
160539062|NCT01081912|579704044|FG000|Maintenance Treatment|Lack of Efficacy|0|||
160539063|NCT01081912|579704045|FG001|Maintenance Treatment|Lack of Efficacy|14|||
160539064|NCT01081912|579704046|FG002|Maintenance Treatment|Lack of Efficacy|64|||
160539065|NCT01081912|579704044|FG000|Maintenance Treatment|Lost to Follow-up|0|||
160880405|NCT01340872|580956953|FG000|Open-label Phase|Worsening of IBD|0|||
160880406|NCT01340872|580956954|FG001|Open-label Phase|Worsening of IBD|0|||
160880407|NCT01340872|580956955|FG002|Open-label Phase|Worsening of IBD|1|||
160539066|NCT01081912|579704045|FG001|Maintenance Treatment|Lost to Follow-up|1|||
160539067|NCT01081912|579704046|FG002|Maintenance Treatment|Lost to Follow-up|0|||
160539068|NCT01081912|579704044|FG000|Maintenance Treatment|Physician Decision|0|||
160539069|NCT01081912|579704045|FG001|Maintenance Treatment|Physician Decision|0|||
160880408|NCT01340872|580956956|FG003|Open-label Phase|Worsening of IBD|0|||
160880409|NCT03039621|580956961|FG000|Overall Study|Violation of inclusion criteria|3|||
160880410|NCT03039621|580956962|FG001|Overall Study|Violation of inclusion criteria|2|||
160880411|NCT03039621|580956961|FG000|Overall Study|Non-compliance with protocol requirement|4|||
160880412|NCT03039621|580956962|FG001|Overall Study|Non-compliance with protocol requirement|5|||
160539070|NCT01081912|579704046|FG002|Maintenance Treatment|Physician Decision|1|||
160539071|NCT01081912|579704044|FG000|Maintenance Treatment|Protocol Violation|0|||
160539072|NCT01081912|579704045|FG001|Maintenance Treatment|Protocol Violation|1|||
160539073|NCT01081912|579704046|FG002|Maintenance Treatment|Protocol Violation|2|||
160539074|NCT01081912|579704044|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
160539075|NCT01081912|579704045|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
160539076|NCT01081912|579704046|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
160539077|NCT01081912|579704044|FG000|Maintenance Treatment|Non-Compliance|0|||
160539078|NCT01081912|579704045|FG001|Maintenance Treatment|Non-Compliance|4|||
160539079|NCT01081912|579704046|FG002|Maintenance Treatment|Non-Compliance|7|||
160539080|NCT01081912|579704044|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
160539081|NCT01081912|579704045|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
160539082|NCT01081912|579704046|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
160539083|NCT01140451|579704048|FG000|Overall Study|Withdrawal by Subject|26|||
160539084|NCT01140451|579704049|FG001|Overall Study|Withdrawal by Subject|33|||
160539085|NCT01140451|579704048|FG000|Overall Study|Adverse Event|2|||
160539086|NCT01140451|579704049|FG001|Overall Study|Adverse Event|6|||
160880413|NCT03039621|580956961|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
160880414|NCT03039621|580956962|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
160880415|NCT03039621|580956961|FG000|Overall Study|Violation of non-inclusion criteria|1|||
160880416|NCT03039621|580956962|FG001|Overall Study|Violation of non-inclusion criteria|2|||
160880417|NCT03254108|580956963|FG000|Overall Study|Adverse Event|0|||
160880418|NCT03254108|580956964|FG001|Overall Study|Adverse Event|2|||
160880419|NCT03254108|580956965|FG002|Overall Study|Adverse Event|0|||
160880420|NCT03254108|580956966|FG003|Overall Study|Adverse Event|1|||
160880421|NCT03254108|580956967|FG004|Overall Study|Adverse Event|1|||
160880422|NCT03254108|580956963|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
160880423|NCT03254108|580956964|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
160880424|NCT03254108|580956965|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
160880425|NCT03254108|580956966|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
160539087|NCT01140451|579704048|FG000|Overall Study|Physician Decision|5|||
160539088|NCT01140451|579704049|FG001|Overall Study|Physician Decision|3|||
160539089|NCT01140451|579704048|FG000|Overall Study|Lost to Follow-up|2|||
160539090|NCT01140451|579704049|FG001|Overall Study|Lost to Follow-up|0|||
160539091|NCT01140451|579704048|FG000|Overall Study|Participants Planning Pregnancy|3|||
160539092|NCT01140451|579704049|FG001|Overall Study|Participants Planning Pregnancy|0|||
160539093|NCT00441974|579704053|FG000|Overall Study|Adverse Event|6|||
160539094|NCT00441974|579704053|FG000|Overall Study|Consent Withdrawn|35|||
160539095|NCT00441974|579704053|FG000|Overall Study|Lost to Follow-up|80|||
160539096|NCT00441974|579704053|FG000|Overall Study|Protocol Violation|7|||
160539097|NCT01146873|579704061|FG000|Overall Study|Transfer out|0|||
160539098|NCT01146873|579704062|FG001|Overall Study|Transfer out|6|||
160539099|NCT03200366|579704065|FG000|Patient Navigation Intervention Given|Death|0|||
160539100|NCT03200366|579704066|FG001|Patient Navigation Intervention Given|Death|2|||
160539101|NCT03200366|579704067|FG002|Patient Navigation Intervention Given|Death|0|||
160539102|NCT03200366|579704065|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
160539103|NCT03200366|579704066|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
160539104|NCT03200366|579704067|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
160539105|NCT03200366|579704065|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
160539106|NCT03200366|579704066|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
160539107|NCT03200366|579704067|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
160539108|NCT03200366|579704065|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
160539109|NCT03200366|579704066|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
160539110|NCT03200366|579704067|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
160539111|NCT03200366|579704065|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
160539112|NCT03200366|579704066|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
160539113|NCT03200366|579704067|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
160539114|NCT03200366|579704065|FG000|6 Month Post-Baseline Interview|Death|1|||
160539115|NCT03200366|579704066|FG001|6 Month Post-Baseline Interview|Death|1|||
160539116|NCT03200366|579704067|FG002|6 Month Post-Baseline Interview|Death|1|||
160539117|NCT03200366|579704065|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
160539118|NCT03200366|579704066|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
160539119|NCT03200366|579704067|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
160880426|NCT03254108|580956967|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
160880427|NCT00362180|580956968|FG000|Treated Period|Withdrawal by Subject|1|||
160880428|NCT00362180|580956969|FG001|Treated Period|Withdrawal by Subject|0|||
160880429|NCT00362180|580956970|FG002|Treated Period|Withdrawal by Subject|0|||
160880430|NCT00362180|580956971|FG003|Treated Period|Withdrawal by Subject|0|||
160880431|NCT00362180|580956972|FG004|Treated Period|Withdrawal by Subject|0|||
160880432|NCT00362180|580956973|FG005|Treated Period|Withdrawal by Subject|0|||
160880433|NCT00362180|580956974|FG006|Treated Period|Withdrawal by Subject|0|||
160880434|NCT00362180|580956975|FG007|Treated Period|Withdrawal by Subject|0|||
160880435|NCT00362180|580956976|FG008|Treated Period|Withdrawal by Subject|0|||
160880436|NCT00362180|580956968|FG000|Treated Period|Adverse Event|0|||
160880437|NCT00362180|580956969|FG001|Treated Period|Adverse Event|0|||
160880438|NCT00362180|580956970|FG002|Treated Period|Adverse Event|0|||
160880439|NCT00362180|580956971|FG003|Treated Period|Adverse Event|0|||
160880440|NCT00362180|580956972|FG004|Treated Period|Adverse Event|0|||
160880441|NCT00362180|580956973|FG005|Treated Period|Adverse Event|1|||
160880442|NCT00362180|580956974|FG006|Treated Period|Adverse Event|0|||
160880443|NCT00362180|580956975|FG007|Treated Period|Adverse Event|1|||
160880444|NCT00362180|580956976|FG008|Treated Period|Adverse Event|0|||
160880445|NCT02600871|580956979|FG000|Overall Study|Lost to Follow-up|13|||
160880446|NCT02600871|580956980|FG001|Overall Study|Lost to Follow-up|10|||
160880447|NCT01246466|580956984|FG000|Overall Study|Death|1|||
160880448|NCT01246466|580956984|FG000|Overall Study|Withdrawal by Subject|1|||
160880449|NCT01142089|580956985|FG000|Overall Study|Physician Decision|1|||
160880450|NCT01142089|580956986|FG001|Overall Study|Physician Decision|0|||
160880451|NCT01142089|580956985|FG000|Overall Study|Withdrawal by Subject|1|||
160880452|NCT01142089|580956986|FG001|Overall Study|Withdrawal by Subject|2|||
160880453|NCT01142089|580956985|FG000|Overall Study|Use of prohibited medications|0|||
160880454|NCT01142089|580956986|FG001|Overall Study|Use of prohibited medications|1|||
160880455|NCT01142089|580956985|FG000|Overall Study|Noncompliance with study procedures|2|||
160880456|NCT01142089|580956986|FG001|Overall Study|Noncompliance with study procedures|1|||
160880457|NCT01142089|580956985|FG000|Overall Study|Patient required rescue medication|8|||
160880458|NCT01142089|580956986|FG001|Overall Study|Patient required rescue medication|17|||
160880459|NCT00348933|580956989|FG000|Overall Study|Withdrawal by Subject|10|||
160880460|NCT00348933|580956989|FG000|Overall Study|Lost to Follow-up|6|||
160880461|NCT00348933|580956989|FG000|Overall Study|Protocol Violation|2|||
160880462|NCT00348933|580956989|FG000|Overall Study|Adverse Event|7|||
160880463|NCT01489111|580956990|FG000|Overall Study|Withdrawal criterion|1|||
160880464|NCT00003472|580956995|FG000|Overall Study|Not evaluable|3|||
160880465|NCT00874939|580956996|FG000|Overall Study|Study terminated|4|||
160880466|NCT01350544|580956997|FG000|Overall Study|Administrative Withdrawal|0|||
160880467|NCT01350544|580956998|FG001|Overall Study|Administrative Withdrawal|1|||
160880468|NCT01350544|580956997|FG000|Overall Study|Death|1|||
160880469|NCT01350544|580956998|FG001|Overall Study|Death|2|||
160880470|NCT01350544|580956997|FG000|Overall Study|Moved out of LA County|2|||
160880471|NCT01350544|580956998|FG001|Overall Study|Moved out of LA County|2|||
160880472|NCT01350544|580956997|FG000|Overall Study|Medical Issues|1|||
160880473|NCT01350544|580956998|FG001|Overall Study|Medical Issues|1|||
160880474|NCT01350544|580956997|FG000|Overall Study|Withdrawal by Subject|0|||
160880475|NCT01350544|580956998|FG001|Overall Study|Withdrawal by Subject|1|||
160880476|NCT01350544|580956997|FG000|Overall Study|Incarceration|1|||
160880477|NCT01350544|580956998|FG001|Overall Study|Incarceration|0|||
160880478|NCT01350544|580956997|FG000|Overall Study|Lost to Follow-up|18|||
160880479|NCT01350544|580956998|FG001|Overall Study|Lost to Follow-up|15|||
160880480|NCT01444092|580956999|FG000|Overall Study|Adverse Event|8|||
160880481|NCT01444092|580956999|FG000|Overall Study|Protocol Violation|1|||
160880482|NCT01444092|580956999|FG000|Overall Study|Withdrawal by Subject|1|||
160880483|NCT01444092|580956999|FG000|Overall Study|Other Eligibility criteria|7|||
160880484|NCT00603590|580957000|FG000|Overall Study|Did not attend study clinic|39|||
160880485|NCT00603590|580957001|FG001|Overall Study|Did not attend study clinic|30|||
160880486|NCT00603590|580957000|FG000|Overall Study|Refused blood test|5|||
160880487|NCT00603590|580957001|FG001|Overall Study|Refused blood test|1|||
160880488|NCT00603590|580957000|FG000|Overall Study|Patient discontinued study drug|22|||
160880489|NCT00603590|580957001|FG001|Overall Study|Patient discontinued study drug|15|||
160880490|NCT00603590|580957000|FG000|Overall Study|Adverse Event|2|||
160880491|NCT00603590|580957001|FG001|Overall Study|Adverse Event|0|||
160880492|NCT00603590|580957000|FG000|Overall Study|Lost to Follow-up|8|||
160880493|NCT00603590|580957001|FG001|Overall Study|Lost to Follow-up|4|||
160880494|NCT00603590|580957000|FG000|Overall Study|Cardiovascular event|0|||
160880495|NCT00603590|580957001|FG001|Overall Study|Cardiovascular event|1|||
160880496|NCT03005873|580957005|FG000|Overall Study|Prohibited medication use post radnomization|1|||
160880497|NCT03005873|580957006|FG001|Overall Study|Prohibited medication use post radnomization|1|||
160880498|NCT03005873|580957007|FG002|Overall Study|Prohibited medication use post radnomization|1|||
160880499|NCT03005873|580957005|FG000|Overall Study|Withdrew consent|0|||
160880500|NCT03005873|580957006|FG001|Overall Study|Withdrew consent|1|||
160880501|NCT03005873|580957007|FG002|Overall Study|Withdrew consent|2|||
160880502|NCT03005873|580957005|FG000|Overall Study|Lost to Follow-up|0|||
160880503|NCT03005873|580957006|FG001|Overall Study|Lost to Follow-up|1|||
160880504|NCT03005873|580957007|FG002|Overall Study|Lost to Follow-up|0|||
160880505|NCT03005873|580957005|FG000|Overall Study|Ineligible post randomization|0|||
160880506|NCT03005873|580957006|FG001|Overall Study|Ineligible post randomization|0|||
160880507|NCT03005873|580957007|FG002|Overall Study|Ineligible post randomization|1|||
160880508|NCT04585009|580957008|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
160880509|NCT04585009|580957009|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880510|NCT04585009|580957010|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880511|NCT04585009|580957011|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880512|NCT04585009|580957012|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880513|NCT04585009|580957013|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880514|NCT04585009|580957014|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880515|NCT04585009|580957015|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880516|NCT04585009|580957016|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880517|NCT04585009|580957017|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880518|NCT04585009|580957018|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880519|NCT04585009|580957019|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880520|NCT04585009|580957008|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
160880521|NCT04585009|580957009|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880522|NCT04585009|580957010|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880523|NCT04585009|580957011|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880524|NCT04585009|580957012|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880525|NCT04585009|580957013|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880526|NCT04585009|580957014|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880527|NCT04585009|580957015|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880528|NCT04585009|580957016|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880529|NCT04585009|580957017|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880530|NCT04585009|580957018|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880531|NCT04585009|580957019|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880532|NCT04585009|580957008|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880533|NCT04585009|580957009|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880534|NCT04585009|580957010|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880535|NCT04585009|580957011|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880536|NCT04585009|580957012|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880537|NCT04585009|580957013|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880538|NCT04585009|580957014|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880539|NCT04585009|580957015|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
160880540|NCT04585009|580957016|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880541|NCT04585009|580957017|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880542|NCT04585009|580957018|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880543|NCT04585009|580957019|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880544|NCT04585009|580957008|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880545|NCT04585009|580957009|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880546|NCT04585009|580957010|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880547|NCT04585009|580957011|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880548|NCT04585009|580957012|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
160880549|NCT04585009|580957013|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880550|NCT04585009|580957014|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880551|NCT04585009|580957015|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880552|NCT04585009|580957016|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880553|NCT04585009|580957017|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880554|NCT04585009|580957018|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880555|NCT04585009|580957019|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880556|NCT04585009|580957008|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880557|NCT04585009|580957009|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880558|NCT04585009|580957010|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880559|NCT04585009|580957011|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880560|NCT04585009|580957012|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880561|NCT04585009|580957013|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880562|NCT04585009|580957014|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880563|NCT04585009|580957015|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880564|NCT04585009|580957016|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880565|NCT04585009|580957017|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
160880566|NCT04585009|580957018|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880567|NCT04585009|580957019|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880568|NCT04585009|580957008|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880569|NCT04585009|580957009|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880570|NCT04585009|580957010|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880571|NCT04585009|580957011|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880572|NCT04585009|580957012|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880573|NCT04585009|580957013|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880574|NCT04585009|580957014|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880575|NCT04585009|580957015|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880576|NCT04585009|580957016|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880577|NCT04585009|580957017|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880578|NCT04585009|580957018|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880579|NCT04585009|580957019|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
160880580|NCT03699475|580957020|FG000|Overall Study|Death|1|||
160880581|NCT04618770|580957032|FG000|Overall Study|Censored from Analysis|12|||
160880582|NCT04618770|580957032|FG000|Overall Study|Early Termination|25|||
160880583|NCT05338671|580957033|FG000|Overall Study|Lost to Follow-up|2|||
160880584|NCT05338671|580957034|FG001|Overall Study|Lost to Follow-up|2|||
160880585|NCT05338671|580957033|FG000|Overall Study|Root canal completed in a single visit|1|||
160880586|NCT05338671|580957034|FG001|Overall Study|Root canal completed in a single visit|0|||
160880587|NCT03859973|580957037|FG000|Overall Study|Other reason than listed|3|||
160880588|NCT03859973|580957038|FG001|Overall Study|Other reason than listed|2|||
160880589|NCT03859973|580957037|FG000|Overall Study|COVID-19 related, not due to AE|3|||
160880590|NCT03859973|580957038|FG001|Overall Study|COVID-19 related, not due to AE|4|||
160880591|NCT03859973|580957037|FG000|Overall Study|Withdrawal by Subject|8|||
160880592|NCT03859973|580957038|FG001|Overall Study|Withdrawal by Subject|9|||
160880593|NCT03859973|580957037|FG000|Overall Study|Lost to Follow-up|2|||
160880594|NCT03859973|580957038|FG001|Overall Study|Lost to Follow-up|3|||
160880595|NCT03859973|580957037|FG000|Overall Study|Protocol Violation|1|||
160880596|NCT03859973|580957038|FG001|Overall Study|Protocol Violation|3|||
160880597|NCT03859973|580957037|FG000|Overall Study|Adverse Event|3|||
160880598|NCT03859973|580957038|FG001|Overall Study|Adverse Event|5|||
160880599|NCT02855541|580957039|FG000|Overall Study|Change in health status|2|||
160880600|NCT02855541|580957039|FG000|Overall Study|Withdrawal by Subject|2|||
160880601|NCT03085914|580957040|FG000|Overall Study|Death|6|||
160880602|NCT03085914|580957041|FG001|Overall Study|Death|6|||
160880603|NCT03085914|580957042|FG002|Overall Study|Death|4|||
160880604|NCT03085914|580957043|FG003|Overall Study|Death|1|||
160880605|NCT03085914|580957044|FG004|Overall Study|Death|5|||
160880606|NCT03085914|580957045|FG005|Overall Study|Death|2|||
160880607|NCT03085914|580957046|FG006|Overall Study|Death|2|||
160880608|NCT03085914|580957040|FG000|Overall Study|Withdrawal by Subject|1|||
160880609|NCT03085914|580957041|FG001|Overall Study|Withdrawal by Subject|1|||
160880610|NCT03085914|580957042|FG002|Overall Study|Withdrawal by Subject|2|||
160880611|NCT03085914|580957043|FG003|Overall Study|Withdrawal by Subject|2|||
160880612|NCT03085914|580957044|FG004|Overall Study|Withdrawal by Subject|2|||
160880613|NCT03085914|580957045|FG005|Overall Study|Withdrawal by Subject|0|||
160880614|NCT03085914|580957046|FG006|Overall Study|Withdrawal by Subject|1|||
160880615|NCT03085914|580957040|FG000|Overall Study|Lost to Follow-up|0|||
160880616|NCT03085914|580957041|FG001|Overall Study|Lost to Follow-up|0|||
160880617|NCT03085914|580957042|FG002|Overall Study|Lost to Follow-up|1|||
160880618|NCT03085914|580957043|FG003|Overall Study|Lost to Follow-up|0|||
160880619|NCT03085914|580957044|FG004|Overall Study|Lost to Follow-up|0|||
160880620|NCT03085914|580957045|FG005|Overall Study|Lost to Follow-up|1|||
160880621|NCT03085914|580957046|FG006|Overall Study|Lost to Follow-up|1|||
160880622|NCT03085914|580957040|FG000|Overall Study|Reason was not specified,|2|||
160880623|NCT03085914|580957041|FG001|Overall Study|Reason was not specified,|2|||
160880624|NCT03085914|580957042|FG002|Overall Study|Reason was not specified,|2|||
160880625|NCT03085914|580957043|FG003|Overall Study|Reason was not specified,|3|||
160880626|NCT03085914|580957044|FG004|Overall Study|Reason was not specified,|3|||
160880627|NCT03085914|580957045|FG005|Overall Study|Reason was not specified,|3|||
160880628|NCT03085914|580957046|FG006|Overall Study|Reason was not specified,|6|||
160880629|NCT03085914|580957040|FG000|Overall Study|Progressive Disease|0|||
160880630|NCT03085914|580957041|FG001|Overall Study|Progressive Disease|0|||
160880631|NCT03085914|580957042|FG002|Overall Study|Progressive Disease|2|||
160880632|NCT03085914|580957043|FG003|Overall Study|Progressive Disease|2|||
160880633|NCT03085914|580957044|FG004|Overall Study|Progressive Disease|1|||
160880634|NCT03085914|580957045|FG005|Overall Study|Progressive Disease|1|||
160880635|NCT03085914|580957046|FG006|Overall Study|Progressive Disease|1|||
160880636|NCT03085914|580957040|FG000|Overall Study|Study Terminated by the Sponsor|0|||
160880637|NCT03085914|580957041|FG001|Overall Study|Study Terminated by the Sponsor|0|||
160880638|NCT03085914|580957042|FG002|Overall Study|Study Terminated by the Sponsor|0|||
160539120|NCT03200366|579704065|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
160880639|NCT03085914|580957043|FG003|Overall Study|Study Terminated by the Sponsor|1|||
160880640|NCT03085914|580957044|FG004|Overall Study|Study Terminated by the Sponsor|2|||
160880641|NCT03085914|580957045|FG005|Overall Study|Study Terminated by the Sponsor|1|||
160539121|NCT03200366|579704066|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
160539122|NCT03200366|579704067|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
160880642|NCT03085914|580957046|FG006|Overall Study|Study Terminated by the Sponsor|0|||
160880643|NCT03874429|580957048|FG000|Overall Study|Adverse Event|2|||
160880644|NCT03874429|580957049|FG001|Overall Study|Adverse Event|2|||
160880645|NCT03874429|580957048|FG000|Overall Study|Lack of Efficacy|0|||
160880646|NCT03874429|580957049|FG001|Overall Study|Lack of Efficacy|1|||
160880647|NCT03874429|580957048|FG000|Overall Study|Covid-19 pandemic|4|||
160880648|NCT03874429|580957049|FG001|Overall Study|Covid-19 pandemic|2|||
160880649|NCT01561898|580957052|FG000|Overall Study|Withdrawal by Subject|0|||
160880650|NCT01561898|580957053|FG001|Overall Study|Withdrawal by Subject|8|||
160880651|NCT01561898|580957054|FG002|Overall Study|Withdrawal by Subject|12|||
160880652|NCT01561898|580957055|FG003|Overall Study|Withdrawal by Subject|5|||
160880653|NCT01561898|580957052|FG000|Overall Study|Lack of Efficacy|0|||
160880654|NCT01561898|580957053|FG001|Overall Study|Lack of Efficacy|8|||
160880655|NCT01561898|580957054|FG002|Overall Study|Lack of Efficacy|10|||
160880656|NCT01561898|580957055|FG003|Overall Study|Lack of Efficacy|5|||
160880657|NCT01561898|580957052|FG000|Overall Study|Worsening of complications|0|||
160880658|NCT01561898|580957053|FG001|Overall Study|Worsening of complications|1|||
160880659|NCT01561898|580957054|FG002|Overall Study|Worsening of complications|0|||
160880660|NCT01561898|580957055|FG003|Overall Study|Worsening of complications|0|||
160880661|NCT01561898|580957052|FG000|Overall Study|Lost to Follow-up|0|||
160880662|NCT01561898|580957053|FG001|Overall Study|Lost to Follow-up|0|||
160880663|NCT01561898|580957054|FG002|Overall Study|Lost to Follow-up|1|||
160880664|NCT01561898|580957055|FG003|Overall Study|Lost to Follow-up|0|||
160880665|NCT01561898|580957052|FG000|Overall Study|Adverse Event|1|||
160880666|NCT01561898|580957053|FG001|Overall Study|Adverse Event|19|||
160880667|NCT01561898|580957054|FG002|Overall Study|Adverse Event|14|||
160880668|NCT01561898|580957055|FG003|Overall Study|Adverse Event|9|||
160880669|NCT01561898|580957052|FG000|Overall Study|Physician Decision|1|||
160880670|NCT01561898|580957053|FG001|Overall Study|Physician Decision|5|||
160880671|NCT01561898|580957054|FG002|Overall Study|Physician Decision|7|||
160880672|NCT01561898|580957055|FG003|Overall Study|Physician Decision|1|||
160880673|NCT00331552|580957056|FG000|Period 3: Phase II|Neurological Symptoms|1|||
160880674|NCT00331552|580957057|FG001|Period 3: Phase II|Neurological Symptoms|0|||
160880675|NCT00331552|580957056|FG000|Period 3: Phase II|Severe Nausea|1|||
160880676|NCT00331552|580957057|FG001|Period 3: Phase II|Severe Nausea|0|||
160880677|NCT01445548|580957058|FG000|Overall Study|Adverse Event|1|||
160880678|NCT03560518|580957059|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
160880679|NCT03560518|580957060|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
160880680|NCT03560518|580957061|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
160880681|NCT03560518|580957059|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
160880682|NCT03560518|580957060|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
160880683|NCT03560518|580957061|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
160880684|NCT03560518|580957059|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160880685|NCT03560518|580957060|FG001|Double Blind Treatment Period|Protocol Violation|2|||
160880686|NCT03560518|580957061|FG002|Double Blind Treatment Period|Protocol Violation|0|||
160880687|NCT03560518|580957059|FG000|Double Blind Treatment Period|Pregnancy|0|||
160880688|NCT03560518|580957060|FG001|Double Blind Treatment Period|Pregnancy|2|||
160880689|NCT03560518|580957061|FG002|Double Blind Treatment Period|Pregnancy|0|||
160880690|NCT03560518|580957059|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
160880691|NCT03560518|580957060|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
160880692|NCT03560518|580957061|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
160880693|NCT03560518|580957059|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
160880694|NCT03560518|580957060|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
160880695|NCT03560518|580957061|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
160880696|NCT03560518|580957059|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
160880697|NCT03560518|580957060|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
160880698|NCT03560518|580957061|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
160880699|NCT03560518|580957059|FG000|Double Blind Treatment Period|Adverse Event|0|||
160880700|NCT03560518|580957060|FG001|Double Blind Treatment Period|Adverse Event|3|||
160880701|NCT03560518|580957061|FG002|Double Blind Treatment Period|Adverse Event|1|||
160880702|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
160880703|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Adverse Event|9|||
160880704|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Death|4|||
160880705|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
160880706|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
160880707|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
160880708|NCT00159822|580957062|FG000|Post-treatment Follow-up Period|Death|1|||
160880709|NCT00159822|580957062|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
160880710|NCT00159822|580957062|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
160880711|NCT01215916|580957064|FG000|Overall Study|Progressive Disease|0|||
160880712|NCT01215916|580957065|FG001|Overall Study|Progressive Disease|2|||
160880713|NCT01215916|580957066|FG002|Overall Study|Progressive Disease|1|||
160880714|NCT01215916|580957067|FG003|Overall Study|Progressive Disease|2|||
160880715|NCT01215916|580957068|FG004|Overall Study|Progressive Disease|5|||
160880716|NCT01215916|580957069|FG005|Overall Study|Progressive Disease|4|||
160880717|NCT01215916|580957070|FG006|Overall Study|Progressive Disease|5|||
160880718|NCT01215916|580957071|FG007|Overall Study|Progressive Disease|3|||
160880719|NCT01215916|580957072|FG008|Overall Study|Progressive Disease|1|||
160880720|NCT01215916|580957064|FG000|Overall Study|Adverse Event|1|||
160539123|NCT03200366|579704065|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
160539124|NCT03200366|579704066|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
160539125|NCT03200366|579704067|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
160539126|NCT03200366|579704065|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
160539127|NCT03200366|579704066|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
160539128|NCT03200366|579704067|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
160539129|NCT03200366|579704065|FG000|9 Month Post-Baseline Interview|Death|1|||
160539130|NCT03200366|579704066|FG001|9 Month Post-Baseline Interview|Death|1|||
160539131|NCT03200366|579704067|FG002|9 Month Post-Baseline Interview|Death|1|||
160539132|NCT03200366|579704065|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
160539133|NCT03200366|579704066|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
160539134|NCT03200366|579704067|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
160539135|NCT03200366|579704065|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
160539136|NCT03200366|579704066|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
160539137|NCT03200366|579704067|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
160539138|NCT03200366|579704065|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
160539139|NCT03200366|579704066|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
160539140|NCT03200366|579704067|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
160539141|NCT00405067|579704068|FG000|Overall Study|Adverse Event|4|||
160539142|NCT00405067|579704069|FG001|Overall Study|Adverse Event|9|||
160539143|NCT00405067|579704070|FG002|Overall Study|Adverse Event|4|||
160539144|NCT00405067|579704068|FG000|Overall Study|Lost to Follow-up|0|||
160539145|NCT00405067|579704069|FG001|Overall Study|Lost to Follow-up|0|||
160539146|NCT00405067|579704070|FG002|Overall Study|Lost to Follow-up|1|||
160539147|NCT00631020|579704071|FG000|Overall Study|Lost to Follow-up|7|||
160539148|NCT00631020|579704071|FG000|Overall Study|Incarcerated|1|||
160539149|NCT01399788|579704078|FG000|First Intervention Period|Adverse Event|1|||
160539150|NCT01399788|579704079|FG001|First Intervention Period|Adverse Event|0|||
160539151|NCT00845728|579704080|FG000|Overall Study|Abnormal laboratory value (s)|2|||
160539152|NCT00845728|579704081|FG001|Overall Study|Abnormal laboratory value (s)|2|||
160539153|NCT00845728|579704080|FG000|Overall Study|Patient's inability to use the device|4|||
160539154|NCT00845728|579704081|FG001|Overall Study|Patient's inability to use the device|6|||
160539155|NCT00845728|579704080|FG000|Overall Study|Abnormal test procedure result (s)|7|||
160539156|NCT00845728|579704081|FG001|Overall Study|Abnormal test procedure result (s)|2|||
160539157|NCT00845728|579704080|FG000|Overall Study|Lost to Follow-up|22|||
160539158|NCT00845728|579704081|FG001|Overall Study|Lost to Follow-up|13|||
160539159|NCT00845728|579704080|FG000|Overall Study|Death|24|||
160539160|NCT00845728|579704081|FG001|Overall Study|Death|26|||
160539161|NCT00845728|579704080|FG000|Overall Study|Administrative Problems|34|||
160539162|NCT00845728|579704081|FG001|Overall Study|Administrative Problems|26|||
160539163|NCT00845728|579704080|FG000|Overall Study|Protocol Violation|36|||
160539164|NCT00845728|579704081|FG001|Overall Study|Protocol Violation|24|||
160539165|NCT00845728|579704080|FG000|Overall Study|Lack of Efficacy|51|||
160539166|NCT00845728|579704081|FG001|Overall Study|Lack of Efficacy|39|||
160539167|NCT00845728|579704080|FG000|Overall Study|Adverse Event|101|||
160539168|NCT00845728|579704081|FG001|Overall Study|Adverse Event|96|||
160539169|NCT00845728|579704080|FG000|Overall Study|Withdrawal by Subject|105|||
160539170|NCT00845728|579704081|FG001|Overall Study|Withdrawal by Subject|108|||
160539171|NCT01389752|579704082|FG000|Study Period 1|Sponsor decision|0|||
160539172|NCT01389752|579704083|FG001|Study Period 1|Sponsor decision|2|||
160539173|NCT01389752|579704082|FG000|Study Period 2|Sponsor decision|1|||
160539174|NCT01389752|579704083|FG001|Study Period 2|Sponsor decision|0|||
160539175|NCT03259074|579704084|FG000|Overall Study|Adverse Event|9|||
160539176|NCT03259074|579704085|FG001|Overall Study|Adverse Event|12|||
160539177|NCT03259074|579704086|FG002|Overall Study|Adverse Event|8|||
160539178|NCT03259074|579704084|FG000|Overall Study|Death|1|||
160539179|NCT03259074|579704085|FG001|Overall Study|Death|1|||
160539180|NCT03259074|579704086|FG002|Overall Study|Death|3|||
160539181|NCT03259074|579704084|FG000|Overall Study|Lost to Follow-up|2|||
160539182|NCT03259074|579704085|FG001|Overall Study|Lost to Follow-up|4|||
160539183|NCT03259074|579704086|FG002|Overall Study|Lost to Follow-up|3|||
160539184|NCT03259074|579704084|FG000|Overall Study|New Therapy For Study Indication|1|||
160539185|NCT03259074|579704085|FG001|Overall Study|New Therapy For Study Indication|2|||
160539186|NCT03259074|579704086|FG002|Overall Study|New Therapy For Study Indication|2|||
160539187|NCT03259074|579704084|FG000|Overall Study|Physician Decision|4|||
160539188|NCT03259074|579704085|FG001|Overall Study|Physician Decision|12|||
160539189|NCT03259074|579704086|FG002|Overall Study|Physician Decision|10|||
160539190|NCT03259074|579704084|FG000|Overall Study|Pregnancy|1|||
160539191|NCT03259074|579704085|FG001|Overall Study|Pregnancy|1|||
160880721|NCT01215916|580957065|FG001|Overall Study|Adverse Event|1|||
160880722|NCT01215916|580957066|FG002|Overall Study|Adverse Event|0|||
160880723|NCT01215916|580957067|FG003|Overall Study|Adverse Event|1|||
160539192|NCT03259074|579704086|FG002|Overall Study|Pregnancy|0|||
160539193|NCT03259074|579704084|FG000|Overall Study|Progressive Disease|1|||
160539194|NCT03259074|579704085|FG001|Overall Study|Progressive Disease|0|||
160880724|NCT01215916|580957068|FG004|Overall Study|Adverse Event|0|||
160880725|NCT01215916|580957069|FG005|Overall Study|Adverse Event|0|||
160880726|NCT01215916|580957070|FG006|Overall Study|Adverse Event|3|||
160880727|NCT01215916|580957071|FG007|Overall Study|Adverse Event|0|||
160880728|NCT01215916|580957072|FG008|Overall Study|Adverse Event|0|||
160880729|NCT01215916|580957064|FG000|Overall Study|Withdrawal by Subject|0|||
160880730|NCT01215916|580957065|FG001|Overall Study|Withdrawal by Subject|1|||
160880731|NCT01215916|580957066|FG002|Overall Study|Withdrawal by Subject|1|||
160880732|NCT01215916|580957067|FG003|Overall Study|Withdrawal by Subject|2|||
160880733|NCT01215916|580957068|FG004|Overall Study|Withdrawal by Subject|0|||
160880734|NCT01215916|580957069|FG005|Overall Study|Withdrawal by Subject|0|||
160880735|NCT01215916|580957070|FG006|Overall Study|Withdrawal by Subject|1|||
160880736|NCT01215916|580957071|FG007|Overall Study|Withdrawal by Subject|0|||
160880737|NCT01215916|580957072|FG008|Overall Study|Withdrawal by Subject|0|||
160880738|NCT01215916|580957064|FG000|Overall Study|Death|0|||
160880739|NCT01215916|580957065|FG001|Overall Study|Death|1|||
160880740|NCT01215916|580957066|FG002|Overall Study|Death|0|||
160880741|NCT01215916|580957067|FG003|Overall Study|Death|0|||
160880742|NCT01215916|580957068|FG004|Overall Study|Death|1|||
160880743|NCT01215916|580957069|FG005|Overall Study|Death|0|||
160880744|NCT01215916|580957070|FG006|Overall Study|Death|0|||
160880745|NCT01215916|580957071|FG007|Overall Study|Death|0|||
160880746|NCT01215916|580957072|FG008|Overall Study|Death|1|||
160880747|NCT01215916|580957064|FG000|Overall Study|Physician Decision|0|||
160880748|NCT01215916|580957065|FG001|Overall Study|Physician Decision|0|||
160880749|NCT01215916|580957066|FG002|Overall Study|Physician Decision|1|||
160880750|NCT01215916|580957067|FG003|Overall Study|Physician Decision|1|||
160880751|NCT01215916|580957068|FG004|Overall Study|Physician Decision|0|||
160880752|NCT01215916|580957069|FG005|Overall Study|Physician Decision|0|||
160880753|NCT01215916|580957070|FG006|Overall Study|Physician Decision|0|||
160880754|NCT01215916|580957071|FG007|Overall Study|Physician Decision|0|||
160880755|NCT01215916|580957072|FG008|Overall Study|Physician Decision|0|||
160880756|NCT01185301|580957073|FG000|Overall Study|Adverse Event|3|||
160880757|NCT01185301|580957074|FG001|Overall Study|Adverse Event|0|||
160880758|NCT01185301|580957075|FG002|Overall Study|Adverse Event|2|||
160880759|NCT01185301|580957076|FG003|Overall Study|Adverse Event|3|||
160880760|NCT01185301|580957073|FG000|Overall Study|Withdrawal by Subject|7|||
160880761|NCT01185301|580957074|FG001|Overall Study|Withdrawal by Subject|5|||
160880762|NCT01185301|580957075|FG002|Overall Study|Withdrawal by Subject|2|||
160880763|NCT01185301|580957076|FG003|Overall Study|Withdrawal by Subject|3|||
160880764|NCT01185301|580957073|FG000|Overall Study|Lost to Follow-up|2|||
160880765|NCT01185301|580957074|FG001|Overall Study|Lost to Follow-up|0|||
160880766|NCT01185301|580957075|FG002|Overall Study|Lost to Follow-up|0|||
160880767|NCT01185301|580957076|FG003|Overall Study|Lost to Follow-up|1|||
160880768|NCT01185301|580957073|FG000|Overall Study|Other Reason|3|||
160880769|NCT01185301|580957074|FG001|Overall Study|Other Reason|2|||
160880770|NCT01185301|580957075|FG002|Overall Study|Other Reason|2|||
160539195|NCT03259074|579704086|FG002|Overall Study|Progressive Disease|0|||
160539196|NCT03259074|579704084|FG000|Overall Study|Protocol Deviation|1|||
160539197|NCT03259074|579704085|FG001|Overall Study|Protocol Deviation|1|||
160539198|NCT03259074|579704086|FG002|Overall Study|Protocol Deviation|3|||
160539199|NCT03259074|579704084|FG000|Overall Study|Subject/Guardian Decision|13|||
160539200|NCT03259074|579704085|FG001|Overall Study|Subject/Guardian Decision|16|||
160539201|NCT03259074|579704086|FG002|Overall Study|Subject/Guardian Decision|14|||
160880771|NCT01185301|580957076|FG003|Overall Study|Other Reason|2|||
160539202|NCT01576549|579704097|FG000|Overall Study|Sponsor Decision|2|||
160880772|NCT02683746|580957077|FG000|Overall Study|Adverse Event|3|||
160880773|NCT02683746|580957078|FG001|Overall Study|Adverse Event|2|||
160880774|NCT02683746|580957077|FG000|Overall Study|Lost to Follow-up|5|||
160539203|NCT00053417|579704098|FG000|Overall Study|Adverse Event|1|||
160880775|NCT02683746|580957078|FG001|Overall Study|Lost to Follow-up|6|||
160880776|NCT02683746|580957077|FG000|Overall Study|Withdrawal by Subject|6|||
160539204|NCT00053417|579704099|FG001|Overall Study|Adverse Event|0|||
160539205|NCT00053417|579704100|FG002|Overall Study|Adverse Event|1|||
160539206|NCT00053417|579704101|FG003|Overall Study|Adverse Event|5|||
160539207|NCT00053417|579704098|FG000|Overall Study|Non-Compliance|0|||
160539208|NCT00053417|579704099|FG001|Overall Study|Non-Compliance|0|||
160880777|NCT02683746|580957078|FG001|Overall Study|Withdrawal by Subject|5|||
160880778|NCT02683746|580957077|FG000|Overall Study|Physician Decision|2|||
160880779|NCT02683746|580957078|FG001|Overall Study|Physician Decision|1|||
160880780|NCT03726996|580957082|FG000|Overall Study|Parent's decision|2|||
160880781|NCT03726996|580957082|FG000|Overall Study|Study early termination|2|||
160880782|NCT03531632|580957087|FG000|Overall Study|Adverse Event|0|||
160880783|NCT03531632|580957088|FG001|Overall Study|Adverse Event|0|||
160880784|NCT03531632|580957089|FG002|Overall Study|Adverse Event|1|||
160880785|NCT03531632|580957087|FG000|Overall Study|Death|4|||
160880786|NCT03531632|580957088|FG001|Overall Study|Death|0|||
160539209|NCT00053417|579704100|FG002|Overall Study|Non-Compliance|0|||
160539210|NCT00053417|579704101|FG003|Overall Study|Non-Compliance|1|||
160539211|NCT00053417|579704098|FG000|Overall Study|Withdrawal by Subject|0|||
160539212|NCT00053417|579704099|FG001|Overall Study|Withdrawal by Subject|1|||
160539213|NCT00053417|579704100|FG002|Overall Study|Withdrawal by Subject|0|||
160539214|NCT00053417|579704101|FG003|Overall Study|Withdrawal by Subject|0|||
160539215|NCT00053417|579704098|FG000|Overall Study|Lost to Follow-up|1|||
160539216|NCT00053417|579704099|FG001|Overall Study|Lost to Follow-up|1|||
160539217|NCT00053417|579704100|FG002|Overall Study|Lost to Follow-up|0|||
160539218|NCT00053417|579704101|FG003|Overall Study|Lost to Follow-up|0|||
160539219|NCT04081363|579704102|FG000|Overall Study|Withdrawal by Subject|1|||
160539220|NCT04081363|579704103|FG001|Overall Study|Withdrawal by Subject|0|||
160539221|NCT02409290|579704104|FG000|Overall Study|Protocol Violation|3|||
160539222|NCT02409290|579704105|FG001|Overall Study|Protocol Violation|6|||
160539223|NCT02409290|579704106|FG002|Overall Study|Protocol Violation|9|||
160539224|NCT02409290|579704107|FG003|Overall Study|Protocol Violation|4|||
160539225|NCT02409290|579704104|FG000|Overall Study|No positive culture/no baseline sample|3|||
160539226|NCT02409290|579704105|FG001|Overall Study|No positive culture/no baseline sample|9|||
160539227|NCT02409290|579704106|FG002|Overall Study|No positive culture/no baseline sample|6|||
160539228|NCT02409290|579704107|FG003|Overall Study|No positive culture/no baseline sample|5|||
160539229|NCT02409290|579704104|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
160539230|NCT02409290|579704105|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
160539231|NCT02409290|579704106|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
160539232|NCT02409290|579704107|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
160539233|NCT04251910|579704113|FG000|Overall Study|Covid 19 lockdown|0|||
160539234|NCT04251910|579704114|FG001|Overall Study|Covid 19 lockdown|5|||
160539235|NCT04251910|579704115|FG002|Overall Study|Covid 19 lockdown|0|||
160539236|NCT04251910|579704116|FG003|Overall Study|Covid 19 lockdown|4|||
160539237|NCT04251910|579704117|FG004|Overall Study|Covid 19 lockdown|0|||
160539238|NCT04251910|579704118|FG005|Overall Study|Covid 19 lockdown|0|||
160539239|NCT04251910|579704113|FG000|Overall Study|Assisted living facility was closed|0|||
160539240|NCT04251910|579704114|FG001|Overall Study|Assisted living facility was closed|0|||
160539241|NCT04251910|579704115|FG002|Overall Study|Assisted living facility was closed|0|||
160539242|NCT04251910|579704116|FG003|Overall Study|Assisted living facility was closed|0|||
160539243|NCT04251910|579704117|FG004|Overall Study|Assisted living facility was closed|1|||
160539244|NCT04251910|579704118|FG005|Overall Study|Assisted living facility was closed|0|||
160539245|NCT02830776|579704124|FG000|Overall Study|Lost to Follow-up|1|||
160539246|NCT01549002|579704127|FG000|Overall Study|Excessive pain|0|||
160539247|NCT01549002|579704128|FG001|Overall Study|Excessive pain|2|||
160539248|NCT01549002|579704127|FG000|Overall Study|Moderate sedation required|0|||
160539249|NCT01549002|579704128|FG001|Overall Study|Moderate sedation required|2|||
160539250|NCT00135668|579704129|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
160539251|NCT00135668|579704130|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
160539252|NCT00135668|579704131|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
160539253|NCT00135668|579704132|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
160539254|NCT00932360|579704133|FG000|Washout (One Week)|Withdrawal by Subject|0|||
160539255|NCT00932360|579704134|FG001|Washout (One Week)|Withdrawal by Subject|0|||
160539256|NCT00932360|579704135|FG002|Washout (One Week)|Withdrawal by Subject|0|||
160539257|NCT00932360|579704136|FG003|Washout (One Week)|Withdrawal by Subject|0|||
160539258|NCT00932360|579704137|FG004|Washout (One Week)|Withdrawal by Subject|2|||
160539259|NCT00932360|579704138|FG005|Washout (One Week)|Withdrawal by Subject|0|||
160770213|NCT00855582|580545941|FG001|Overall Study|Physician Decision|0|||
160770214|NCT00855582|580545942|FG002|Overall Study|Physician Decision|1|||
160770215|NCT00855582|580545940|FG000|Overall Study|Protocol Violation|6|||
160770216|NCT00855582|580545941|FG001|Overall Study|Protocol Violation|2|||
160770217|NCT00855582|580545942|FG002|Overall Study|Protocol Violation|6|||
160539260|NCT01892163|579704141|FG000|Overall Study|Death|1|||
160539261|NCT01892163|579704142|FG001|Overall Study|Death|1|||
160539262|NCT01892163|579704141|FG000|Overall Study|Lost to Follow-up|1|||
160539263|NCT01892163|579704142|FG001|Overall Study|Lost to Follow-up|0|||
160539264|NCT04143009|579704143|FG000|Pilot Trial|Lost to Follow-up|0|||
160539265|NCT04143009|579704144|FG001|Pilot Trial|Lost to Follow-up|1|||
160539266|NCT04143009|579704145|FG002|Pilot Trial|Lost to Follow-up|1|||
160539267|NCT02577146|579704150|FG000|Overall Study|Lost to Follow-up|8|||
160770218|NCT00855582|580545940|FG000|Overall Study|Entry Criteria Not Met|8|||
160770219|NCT00855582|580545941|FG001|Overall Study|Entry Criteria Not Met|6|||
160770220|NCT00855582|580545942|FG002|Overall Study|Entry Criteria Not Met|3|||
160770221|NCT00855582|580545940|FG000|Overall Study|Withdrawal by Subject|7|||
160770222|NCT00855582|580545941|FG001|Overall Study|Withdrawal by Subject|4|||
160770223|NCT00855582|580545942|FG002|Overall Study|Withdrawal by Subject|8|||
160770224|NCT02832037|580545943|FG000|Overall Study|Administrative reasons|0|||
160770225|NCT02832037|580545944|FG001|Overall Study|Administrative reasons|0|||
160770226|NCT02832037|580545945|FG002|Overall Study|Administrative reasons|1|||
160770227|NCT02832037|580545946|FG003|Overall Study|Administrative reasons|0|||
160539268|NCT02577146|579704150|FG000|Overall Study|Physician Decision|3|||
160539269|NCT02577146|579704150|FG000|Overall Study|Screen Failure|17|||
160539270|NCT00781911|579704151|FG000|Overall Study|Adverse Event|4|||
160539271|NCT00781911|579704152|FG001|Overall Study|Adverse Event|4|||
160539272|NCT00781911|579704151|FG000|Overall Study|Withdrawal by Subject|1|||
160539273|NCT00781911|579704152|FG001|Overall Study|Withdrawal by Subject|2|||
160539274|NCT00781911|579704151|FG000|Overall Study|Physician Decision|0|||
160539275|NCT00781911|579704152|FG001|Overall Study|Physician Decision|2|||
160539276|NCT00781911|579704151|FG000|Overall Study|Sponsor Decision|1|||
160539277|NCT00781911|579704152|FG001|Overall Study|Sponsor Decision|0|||
160539278|NCT01357655|579704153|FG000|Overall Study|Administrative Reason by Sponsor|45|||
160539279|NCT01357655|579704154|FG001|Overall Study|Administrative Reason by Sponsor|0|||
160539280|NCT01357655|579704153|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
160539281|NCT01357655|579704154|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160539282|NCT01357655|579704153|FG000|Overall Study|Disease Progression|1|||
160539283|NCT01357655|579704154|FG001|Overall Study|Disease Progression|0|||
160539284|NCT01357655|579704153|FG000|Overall Study|Lost to Follow-up|2|||
160539285|NCT01357655|579704154|FG001|Overall Study|Lost to Follow-up|0|||
160539286|NCT01357655|579704153|FG000|Overall Study|Maximum Clinical Benefit|2|||
160539287|NCT01357655|579704154|FG001|Overall Study|Maximum Clinical Benefit|0|||
160539288|NCT01357655|579704153|FG000|Overall Study|Reason Unspecified|1|||
160539289|NCT01357655|579704154|FG001|Overall Study|Reason Unspecified|0|||
160539290|NCT01357655|579704153|FG000|Overall Study|Study Drug Toxicity|11|||
160539291|NCT01357655|579704154|FG001|Overall Study|Study Drug Toxicity|0|||
160539292|NCT01357655|579704153|FG000|Overall Study|Subject Withdrew Consent|1|||
160539293|NCT01357655|579704154|FG001|Overall Study|Subject Withdrew Consent|0|||
160539294|NCT00361270|579704158|FG000|Overall Study|Death|0|||
160539295|NCT00361270|579704159|FG001|Overall Study|Death|0|||
160539296|NCT00361270|579704160|FG002|Overall Study|Death|0|||
160539297|NCT00361270|579704161|FG003|Overall Study|Death|2|||
160539298|NCT00361270|579704158|FG000|Overall Study|Lost to Follow-up|4|||
160539299|NCT00361270|579704159|FG001|Overall Study|Lost to Follow-up|1|||
160539300|NCT00361270|579704160|FG002|Overall Study|Lost to Follow-up|0|||
160539301|NCT00361270|579704161|FG003|Overall Study|Lost to Follow-up|0|||
160539302|NCT00361270|579704158|FG000|Overall Study|Physician Decision|0|||
160539303|NCT00361270|579704159|FG001|Overall Study|Physician Decision|0|||
160539304|NCT00361270|579704160|FG002|Overall Study|Physician Decision|1|||
160539305|NCT00361270|579704161|FG003|Overall Study|Physician Decision|0|||
160539306|NCT00361270|579704158|FG000|Overall Study|Protocol Violation|9|||
160539307|NCT00361270|579704159|FG001|Overall Study|Protocol Violation|4|||
160539308|NCT00361270|579704160|FG002|Overall Study|Protocol Violation|5|||
160539309|NCT00361270|579704161|FG003|Overall Study|Protocol Violation|4|||
160539310|NCT00361270|579704158|FG000|Overall Study|Withdrawal by Subject|6|||
160539311|NCT00361270|579704159|FG001|Overall Study|Withdrawal by Subject|6|||
160539312|NCT00361270|579704160|FG002|Overall Study|Withdrawal by Subject|3|||
160539313|NCT00361270|579704161|FG003|Overall Study|Withdrawal by Subject|7|||
160539314|NCT00361270|579704158|FG000|Overall Study|Afraid of Hypnosis|1|||
160539315|NCT00361270|579704159|FG001|Overall Study|Afraid of Hypnosis|2|||
160539316|NCT00361270|579704160|FG002|Overall Study|Afraid of Hypnosis|0|||
160539317|NCT00361270|579704161|FG003|Overall Study|Afraid of Hypnosis|0|||
160539318|NCT00361270|579704158|FG000|Overall Study|Problems with Transportation|4|||
160539319|NCT00361270|579704159|FG001|Overall Study|Problems with Transportation|0|||
160539320|NCT00361270|579704160|FG002|Overall Study|Problems with Transportation|0|||
160539321|NCT00361270|579704161|FG003|Overall Study|Problems with Transportation|0|||
160539322|NCT00361270|579704158|FG000|Overall Study|Adverse Event|0|||
160539323|NCT00361270|579704159|FG001|Overall Study|Adverse Event|1|||
160539324|NCT00361270|579704160|FG002|Overall Study|Adverse Event|1|||
160539325|NCT00361270|579704161|FG003|Overall Study|Adverse Event|0|||
160539326|NCT04013529|579704164|FG000|Overall Study|Withdrawal by Subject|1|||
160539327|NCT04013529|579704165|FG001|Overall Study|Withdrawal by Subject|1|||
160539328|NCT03116698|579704166|FG000|Overall Study|Adverse Event|1|||
160539329|NCT03116698|579704167|FG001|Overall Study|Adverse Event|1|||
160539330|NCT03116698|579704168|FG002|Overall Study|Adverse Event|1|||
160539331|NCT03116698|579704169|FG003|Overall Study|Adverse Event|0|||
160539332|NCT03116698|579704166|FG000|Overall Study|Withdrawal by Subject|1|||
160539333|NCT03116698|579704167|FG001|Overall Study|Withdrawal by Subject|4|||
160539334|NCT03116698|579704168|FG002|Overall Study|Withdrawal by Subject|5|||
160539335|NCT03116698|579704169|FG003|Overall Study|Withdrawal by Subject|2|||
160539336|NCT03116698|579704166|FG000|Overall Study|Lost to Follow-up|2|||
160539337|NCT03116698|579704167|FG001|Overall Study|Lost to Follow-up|0|||
160539338|NCT03116698|579704168|FG002|Overall Study|Lost to Follow-up|0|||
160539339|NCT03116698|579704169|FG003|Overall Study|Lost to Follow-up|0|||
160539340|NCT03116698|579704166|FG000|Overall Study|Physician Decision|1|||
160539341|NCT03116698|579704167|FG001|Overall Study|Physician Decision|1|||
160770228|NCT02832037|580545947|FG004|Overall Study|Administrative reasons|0|||
160770229|NCT02832037|580545943|FG000|Overall Study|Protocol Violation|3|||
160539342|NCT03116698|579704168|FG002|Overall Study|Physician Decision|0|||
160539343|NCT03116698|579704169|FG003|Overall Study|Physician Decision|0|||
160539344|NCT03116698|579704166|FG000|Overall Study|Protocol Violation|1|||
160770230|NCT02832037|580545944|FG001|Overall Study|Protocol Violation|0|||
160770231|NCT02832037|580545945|FG002|Overall Study|Protocol Violation|4|||
160770232|NCT02832037|580545946|FG003|Overall Study|Protocol Violation|1|||
160770233|NCT02832037|580545947|FG004|Overall Study|Protocol Violation|2|||
160770234|NCT02832037|580545943|FG000|Overall Study|Lost to Follow-up|2|||
160770235|NCT02832037|580545944|FG001|Overall Study|Lost to Follow-up|0|||
160770236|NCT02832037|580545945|FG002|Overall Study|Lost to Follow-up|3|||
160770237|NCT02832037|580545946|FG003|Overall Study|Lost to Follow-up|0|||
160770238|NCT02832037|580545947|FG004|Overall Study|Lost to Follow-up|5|||
160770239|NCT02832037|580545943|FG000|Overall Study|Withdrawal by Subject|9|||
160770240|NCT02832037|580545944|FG001|Overall Study|Withdrawal by Subject|8|||
160770241|NCT02832037|580545945|FG002|Overall Study|Withdrawal by Subject|0|||
160770242|NCT02832037|580545946|FG003|Overall Study|Withdrawal by Subject|4|||
160770243|NCT02832037|580545947|FG004|Overall Study|Withdrawal by Subject|8|||
160770244|NCT02832037|580545943|FG000|Overall Study|Adverse Event|5|||
160770245|NCT02832037|580545944|FG001|Overall Study|Adverse Event|4|||
160770246|NCT02832037|580545945|FG002|Overall Study|Adverse Event|0|||
160770247|NCT02832037|580545946|FG003|Overall Study|Adverse Event|2|||
160770248|NCT02832037|580545947|FG004|Overall Study|Adverse Event|4|||
160770249|NCT02378181|580545954|FG000|Overall Study|Lost to Follow-up|2|||
160770250|NCT02378181|580545955|FG001|Overall Study|Lost to Follow-up|5|||
160770251|NCT02378181|580545954|FG000|Overall Study|Withdrawal by Subject|1|||
160770252|NCT02378181|580545955|FG001|Overall Study|Withdrawal by Subject|1|||
160770253|NCT02378181|580545954|FG000|Overall Study|Incarcerated|0|||
160770254|NCT02378181|580545955|FG001|Overall Study|Incarcerated|1|||
160770255|NCT01180777|580545956|FG000|Overall Study|Protocol Violation|6|||
160770256|NCT01180777|580545956|FG000|Overall Study|Poor lens fit|4|||
160770257|NCT01180777|580545956|FG000|Overall Study|Lost to Follow-up|1|||
160770258|NCT01180777|580545956|FG000|Overall Study|Adverse Event|1|||
160770259|NCT02765165|580545957|FG000|Treatment Period|Progressive disease|3|||
160770260|NCT02765165|580545958|FG001|Treatment Period|Progressive disease|2|||
160770261|NCT02765165|580545959|FG002|Treatment Period|Progressive disease|3|||
160770262|NCT02765165|580545960|FG003|Treatment Period|Progressive disease|3|||
160770263|NCT02765165|580545961|FG004|Treatment Period|Progressive disease|4|||
160770264|NCT02765165|580545962|FG005|Treatment Period|Progressive disease|2|||
160770265|NCT02765165|580545963|FG006|Treatment Period|Progressive disease|2|||
160770266|NCT02765165|580545957|FG000|Treatment Period|Physician Decision|0|||
160770267|NCT02765165|580545958|FG001|Treatment Period|Physician Decision|1|||
160770268|NCT02765165|580545959|FG002|Treatment Period|Physician Decision|0|||
160770269|NCT02765165|580545960|FG003|Treatment Period|Physician Decision|0|||
160770270|NCT02765165|580545961|FG004|Treatment Period|Physician Decision|0|||
160770271|NCT02765165|580545962|FG005|Treatment Period|Physician Decision|0|||
160770272|NCT02765165|580545963|FG006|Treatment Period|Physician Decision|0|||
160770273|NCT02765165|580545957|FG000|Treatment Period|Adverse Event|0|||
160770274|NCT02765165|580545958|FG001|Treatment Period|Adverse Event|1|||
160770275|NCT02765165|580545959|FG002|Treatment Period|Adverse Event|0|||
160770276|NCT02765165|580545960|FG003|Treatment Period|Adverse Event|0|||
160770277|NCT02765165|580545961|FG004|Treatment Period|Adverse Event|0|||
160770278|NCT02765165|580545962|FG005|Treatment Period|Adverse Event|0|||
160770279|NCT02765165|580545963|FG006|Treatment Period|Adverse Event|0|||
160880787|NCT03531632|580957089|FG002|Overall Study|Death|14|||
160770280|NCT02765165|580545957|FG000|Treatment Period|Withdrawal by Subject|0|||
160770281|NCT02765165|580545958|FG001|Treatment Period|Withdrawal by Subject|0|||
160770282|NCT02765165|580545959|FG002|Treatment Period|Withdrawal by Subject|0|||
160539345|NCT03116698|579704167|FG001|Overall Study|Protocol Violation|0|||
160539346|NCT03116698|579704168|FG002|Overall Study|Protocol Violation|0|||
160770283|NCT02765165|580545960|FG003|Treatment Period|Withdrawal by Subject|0|||
160539347|NCT03116698|579704169|FG003|Overall Study|Protocol Violation|0|||
160770284|NCT02765165|580545961|FG004|Treatment Period|Withdrawal by Subject|2|||
160770285|NCT02765165|580545962|FG005|Treatment Period|Withdrawal by Subject|0|||
160770286|NCT02765165|580545963|FG006|Treatment Period|Withdrawal by Subject|0|||
160770287|NCT02765165|580545957|FG000|Treatment Period|Study terminated|0|||
160770288|NCT02765165|580545958|FG001|Treatment Period|Study terminated|0|||
160770289|NCT02765165|580545959|FG002|Treatment Period|Study terminated|0|||
160770290|NCT02765165|580545960|FG003|Treatment Period|Study terminated|0|||
160770291|NCT02765165|580545961|FG004|Treatment Period|Study terminated|0|||
160770292|NCT02765165|580545962|FG005|Treatment Period|Study terminated|1|||
160770293|NCT02765165|580545963|FG006|Treatment Period|Study terminated|2|||
160770294|NCT02765165|580545957|FG000|Post-treatment Follow-up|Death|1|||
160770295|NCT02765165|580545958|FG001|Post-treatment Follow-up|Death|2|||
160770296|NCT02765165|580545959|FG002|Post-treatment Follow-up|Death|1|||
160770297|NCT02765165|580545960|FG003|Post-treatment Follow-up|Death|1|||
160770298|NCT02765165|580545961|FG004|Post-treatment Follow-up|Death|1|||
160770299|NCT02765165|580545962|FG005|Post-treatment Follow-up|Death|1|||
160770300|NCT02765165|580545963|FG006|Post-treatment Follow-up|Death|0|||
160770301|NCT02765165|580545957|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
160770302|NCT02765165|580545958|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
160770303|NCT02765165|580545959|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
160770304|NCT02765165|580545960|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
160770305|NCT02765165|580545961|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
160770306|NCT02765165|580545962|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
160770307|NCT02765165|580545963|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
160770308|NCT02765165|580545957|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
160770309|NCT02765165|580545958|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
160770310|NCT02765165|580545959|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
160770311|NCT02765165|580545960|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
160770312|NCT02765165|580545961|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
160770313|NCT02765165|580545962|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
160770314|NCT02765165|580545963|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
160770315|NCT02765165|580545957|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
160770316|NCT02765165|580545958|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
160770317|NCT02765165|580545959|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
160770318|NCT02765165|580545960|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
160770319|NCT02765165|580545961|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
160770320|NCT02765165|580545962|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
160770321|NCT02765165|580545963|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
160770322|NCT02765165|580545957|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
160770323|NCT02765165|580545958|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
160770324|NCT02765165|580545959|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
160770325|NCT02765165|580545960|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
160770326|NCT02765165|580545961|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
160770327|NCT02765165|580545962|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
160770328|NCT02765165|580545963|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
160770329|NCT02765165|580545957|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
160770330|NCT02765165|580545958|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
160770331|NCT02765165|580545959|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
160770332|NCT02765165|580545960|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
160770333|NCT02765165|580545961|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
160770334|NCT02765165|580545962|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
160770335|NCT02765165|580545963|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
160770336|NCT00142415|580545966|FG000|Overall Study|Physician Decision|0|||
160770337|NCT00142415|580545967|FG001|Overall Study|Physician Decision|0|||
160770338|NCT00142415|580545968|FG002|Overall Study|Physician Decision|0|||
160770339|NCT00142415|580545969|FG003|Overall Study|Physician Decision|0|||
160770340|NCT00142415|580545970|FG004|Overall Study|Physician Decision|1|||
160770341|NCT00142415|580545971|FG005|Overall Study|Physician Decision|2|||
160770342|NCT01189266|580545974|FG000|Overall Study|Adverse Event|1|||
160770343|NCT01189266|580545975|FG001|Overall Study|Adverse Event|0|||
160770344|NCT01189266|580545976|FG002|Overall Study|Adverse Event|5|||
160770345|NCT01189266|580545974|FG000|Overall Study|Death|0|||
160770346|NCT01189266|580545975|FG001|Overall Study|Death|0|||
160770347|NCT01189266|580545976|FG002|Overall Study|Death|5|||
160770348|NCT01189266|580545974|FG000|Overall Study|Lack of Efficacy|4|||
160770349|NCT01189266|580545975|FG001|Overall Study|Lack of Efficacy|5|||
160770350|NCT01189266|580545976|FG002|Overall Study|Lack of Efficacy|44|||
160770351|NCT01189266|580545974|FG000|Overall Study|Physician Decision|0|||
160770352|NCT01189266|580545975|FG001|Overall Study|Physician Decision|0|||
160880788|NCT03531632|580957087|FG000|Overall Study|Study Terminated|1|||
160880789|NCT03531632|580957088|FG001|Overall Study|Study Terminated|3|||
160880790|NCT03531632|580957089|FG002|Overall Study|Study Terminated|11|||
160880791|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
160880792|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
160880793|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Adverse Event|7|||
160880794|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Adverse Event|6|||
160880795|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
160880796|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
160880797|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Physician Decision|4|||
160880798|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Physician Decision|4|||
160880799|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
160880800|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
160880801|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
160880802|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
160880803|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
160880804|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
160880805|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Non-compliance|1|||
160880806|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Non-compliance|0|||
160880807|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
160880808|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
160880809|NCT00470834|580957090|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
160880810|NCT00470834|580957091|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
160880811|NCT00470834|580957090|FG000|Extension Period (24 Months)|Adverse Event|3|||
160880812|NCT00470834|580957091|FG001|Extension Period (24 Months)|Adverse Event|4|||
160880813|NCT00470834|580957090|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
160880814|NCT00470834|580957091|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
160880815|NCT00470834|580957090|FG000|Extension Period (24 Months)|Physician Decision|4|||
160880816|NCT00470834|580957091|FG001|Extension Period (24 Months)|Physician Decision|3|||
160880817|NCT00470834|580957090|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
160880818|NCT00470834|580957091|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
160880819|NCT00470834|580957090|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
160880820|NCT00470834|580957091|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
160880821|NCT00470834|580957090|FG000|Extension Period (24 Months)|Non-compliance|0|||
160880822|NCT00470834|580957091|FG001|Extension Period (24 Months)|Non-compliance|1|||
160880823|NCT00470834|580957090|FG000|Extension Period (24 Months)|Disease Progression|0|||
160880824|NCT00470834|580957091|FG001|Extension Period (24 Months)|Disease Progression|1|||
160880825|NCT00065429|580957092|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880826|NCT00065429|580957093|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880827|NCT00065429|580957094|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880828|NCT00065429|580957095|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880829|NCT00065429|580957096|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880830|NCT00065429|580957097|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
160880831|NCT00065429|580957098|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880832|NCT00065429|580957092|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880833|NCT00065429|580957093|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880834|NCT00065429|580957094|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
160880835|NCT00065429|580957095|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880836|NCT00065429|580957096|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880837|NCT00065429|580957097|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880838|NCT00065429|580957098|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880839|NCT00065429|580957092|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
160880840|NCT00065429|580957093|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880841|NCT00065429|580957094|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880842|NCT00065429|580957095|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880843|NCT00065429|580957096|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880844|NCT00065429|580957097|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880845|NCT00065429|580957098|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880846|NCT00065429|580957092|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
160880847|NCT00065429|580957093|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
160880848|NCT00065429|580957094|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
160880849|NCT00065429|580957095|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
160880850|NCT00065429|580957096|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
160880851|NCT00065429|580957097|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
160539348|NCT03116698|579704166|FG000|Overall Study|Death|0|||
160880852|NCT00065429|580957098|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
160880853|NCT00065429|580957092|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
160880854|NCT00065429|580957093|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
160539349|NCT03116698|579704167|FG001|Overall Study|Death|0|||
160880855|NCT00065429|580957094|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
160880856|NCT00065429|580957095|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
160880857|NCT00065429|580957096|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
160880858|NCT00065429|580957097|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
160880859|NCT00065429|580957098|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
160880860|NCT00065429|580957092|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880861|NCT00065429|580957093|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880862|NCT00065429|580957094|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880863|NCT00065429|580957095|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880864|NCT00065429|580957096|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
160880865|NCT00065429|580957097|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880866|NCT00065429|580957098|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880867|NCT00065429|580957092|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880868|NCT00065429|580957093|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880869|NCT00065429|580957094|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880870|NCT00065429|580957095|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880871|NCT00065429|580957096|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
160880872|NCT00065429|580957097|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880873|NCT00065429|580957098|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880874|NCT01616693|580957100|FG000|Evaluated for Safety|Physician Decision|1|||
160880875|NCT01616693|580957101|FG001|Evaluated for Safety|Physician Decision|0|||
160880876|NCT01616693|580957102|FG002|Evaluated for Safety|Physician Decision|1|||
160880877|NCT01616693|580957103|FG003|Evaluated for Safety|Physician Decision|0|||
160880878|NCT01616693|580957100|FG000|Received Both Vaccines|Adverse Event|2|||
160880879|NCT01616693|580957101|FG001|Received Both Vaccines|Adverse Event|0|||
160880880|NCT01616693|580957102|FG002|Received Both Vaccines|Adverse Event|0|||
160880881|NCT01616693|580957103|FG003|Received Both Vaccines|Adverse Event|0|||
160880882|NCT01616693|580957100|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
160880883|NCT01616693|580957101|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
160880884|NCT01616693|580957102|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
160880885|NCT01616693|580957103|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
160880886|NCT01616693|580957100|FG000|Received Both Vaccines|Lost to Follow-up|4|||
160880887|NCT01616693|580957101|FG001|Received Both Vaccines|Lost to Follow-up|3|||
160880888|NCT01616693|580957102|FG002|Received Both Vaccines|Lost to Follow-up|4|||
160880889|NCT01616693|580957103|FG003|Received Both Vaccines|Lost to Follow-up|4|||
160880890|NCT01616693|580957100|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
160880891|NCT01616693|580957101|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
160880892|NCT01616693|580957102|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
160880893|NCT01616693|580957103|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
160880894|NCT00441116|580957107|FG000|Overall Study|Adverse Event|1|||
160880895|NCT00441116|580957108|FG001|Overall Study|Adverse Event|1|||
160880896|NCT00441116|580957107|FG000|Overall Study|Withdrawal by Subject|1|||
160880897|NCT00441116|580957108|FG001|Overall Study|Withdrawal by Subject|0|||
160880898|NCT00441116|580957107|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
160880899|NCT00441116|580957108|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
160880900|NCT02925338|580957109|FG000|Overall Study|Death|0|||
160880901|NCT02925338|580957110|FG001|Overall Study|Death|2|||
160880902|NCT02925338|580957111|FG002|Overall Study|Death|1|||
160880903|NCT02925338|580957112|FG003|Overall Study|Death|0|||
160880904|NCT02925338|580957113|FG004|Overall Study|Death|0|||
160880905|NCT02925338|580957109|FG000|Overall Study|Lost to Follow-up|30|||
160880906|NCT02925338|580957110|FG001|Overall Study|Lost to Follow-up|10|||
160880907|NCT02925338|580957111|FG002|Overall Study|Lost to Follow-up|1|||
160880908|NCT02925338|580957112|FG003|Overall Study|Lost to Follow-up|16|||
160880909|NCT02925338|580957113|FG004|Overall Study|Lost to Follow-up|3|||
160880910|NCT02925338|580957109|FG000|Overall Study|Withdrawal by Subject|3|||
160880911|NCT02925338|580957110|FG001|Overall Study|Withdrawal by Subject|0|||
160880912|NCT02925338|580957111|FG002|Overall Study|Withdrawal by Subject|3|||
160880913|NCT02925338|580957112|FG003|Overall Study|Withdrawal by Subject|2|||
160880914|NCT02925338|580957113|FG004|Overall Study|Withdrawal by Subject|2|||
160880915|NCT02925338|580957109|FG000|Overall Study|Missing|38|||
160880916|NCT02925338|580957110|FG001|Overall Study|Missing|27|||
160539350|NCT03116698|579704168|FG002|Overall Study|Death|2|||
160880917|NCT02925338|580957111|FG002|Overall Study|Missing|0|||
160880918|NCT02925338|580957112|FG003|Overall Study|Missing|3|||
160880919|NCT02925338|580957113|FG004|Overall Study|Missing|2|||
160880920|NCT02925338|580957109|FG000|Overall Study|Participant's Decision|11|||
160880921|NCT02925338|580957110|FG001|Overall Study|Participant's Decision|7|||
160880922|NCT02925338|580957111|FG002|Overall Study|Participant's Decision|3|||
160880923|NCT02925338|580957112|FG003|Overall Study|Participant's Decision|8|||
160880924|NCT02925338|580957113|FG004|Overall Study|Participant's Decision|1|||
160880925|NCT02925338|580957109|FG000|Overall Study|Treatment Discontinuation|144|||
160880926|NCT02925338|580957110|FG001|Overall Study|Treatment Discontinuation|65|||
160880927|NCT02925338|580957111|FG002|Overall Study|Treatment Discontinuation|56|||
160880928|NCT02925338|580957112|FG003|Overall Study|Treatment Discontinuation|131|||
160880929|NCT02925338|580957113|FG004|Overall Study|Treatment Discontinuation|22|||
160880930|NCT00636363|580957116|FG000|Overall Study|Conjunctivitis|0|||
160880931|NCT00636363|580957117|FG001|Overall Study|Conjunctivitis|0|||
160880932|NCT00636363|580957118|FG002|Overall Study|Conjunctivitis|1|||
160880933|NCT00636363|580957116|FG000|Overall Study|Adverse Event|0|||
160880934|NCT00636363|580957117|FG001|Overall Study|Adverse Event|0|||
160880935|NCT00636363|580957118|FG002|Overall Study|Adverse Event|1|||
160880936|NCT00636363|580957116|FG000|Overall Study|Positive slit lamp finding|0|||
160880937|NCT00636363|580957117|FG001|Overall Study|Positive slit lamp finding|2|||
160880938|NCT00636363|580957118|FG002|Overall Study|Positive slit lamp finding|1|||
160880939|NCT00636363|580957116|FG000|Overall Study|Study related symptoms/complaints|8|||
160880940|NCT00636363|580957117|FG001|Overall Study|Study related symptoms/complaints|7|||
160880941|NCT00636363|580957118|FG002|Overall Study|Study related symptoms/complaints|4|||
160880942|NCT00636363|580957116|FG000|Overall Study|Met ineligibility criteria|0|||
160880943|NCT00636363|580957117|FG001|Overall Study|Met ineligibility criteria|0|||
160880944|NCT00636363|580957118|FG002|Overall Study|Met ineligibility criteria|3|||
160880945|NCT00636363|580957116|FG000|Overall Study|Missed > 1 visit|0|||
160880946|NCT00636363|580957117|FG001|Overall Study|Missed > 1 visit|1|||
160880947|NCT00636363|580957118|FG002|Overall Study|Missed > 1 visit|3|||
160880948|NCT00636363|580957116|FG000|Overall Study|Lack of motivation|1|||
160880949|NCT00636363|580957117|FG001|Overall Study|Lack of motivation|0|||
160880950|NCT00636363|580957118|FG002|Overall Study|Lack of motivation|1|||
160880951|NCT00636363|580957116|FG000|Overall Study|Protocol Violation|0|||
160880952|NCT00636363|580957117|FG001|Overall Study|Protocol Violation|3|||
160880953|NCT00636363|580957118|FG002|Overall Study|Protocol Violation|0|||
160880954|NCT00636363|580957116|FG000|Overall Study|Lost to Follow-up|3|||
160880955|NCT00636363|580957117|FG001|Overall Study|Lost to Follow-up|4|||
160880956|NCT00636363|580957118|FG002|Overall Study|Lost to Follow-up|2|||
160880957|NCT00636363|580957116|FG000|Overall Study|Withdrawal by Subject|1|||
160880958|NCT00636363|580957117|FG001|Overall Study|Withdrawal by Subject|3|||
160880959|NCT00636363|580957118|FG002|Overall Study|Withdrawal by Subject|2|||
160880960|NCT03148691|580957121|FG000|Overall Study|Protocol Violation|1|||
160880961|NCT03148691|580957122|FG001|Overall Study|Protocol Violation|2|||
160880962|NCT03148691|580957123|FG002|Overall Study|Protocol Violation|7|||
160880963|NCT03148691|580957121|FG000|Overall Study|Lost to Follow-up|0|||
160880964|NCT03148691|580957122|FG001|Overall Study|Lost to Follow-up|0|||
160880965|NCT03148691|580957123|FG002|Overall Study|Lost to Follow-up|1|||
160880966|NCT03148691|580957121|FG000|Overall Study|Other|1|||
160880967|NCT03148691|580957122|FG001|Overall Study|Other|0|||
160880968|NCT03148691|580957123|FG002|Overall Study|Other|0|||
160880969|NCT03148691|580957121|FG000|Overall Study|Withdrawal by Subject|1|||
160880970|NCT03148691|580957122|FG001|Overall Study|Withdrawal by Subject|0|||
160880971|NCT03148691|580957123|FG002|Overall Study|Withdrawal by Subject|0|||
160880972|NCT00096356|580957124|FG000|Overall Study|Adverse Event|11|||
160880973|NCT00096356|580957125|FG001|Overall Study|Adverse Event|9|||
160880974|NCT00096356|580957124|FG000|Overall Study|Physician Decision|5|||
160880975|NCT00096356|580957125|FG001|Overall Study|Physician Decision|3|||
160880976|NCT00096356|580957124|FG000|Overall Study|Withdrawal by Subject|17|||
160880977|NCT00096356|580957125|FG001|Overall Study|Withdrawal by Subject|23|||
160880978|NCT00096356|580957124|FG000|Overall Study|Lack of Efficacy|1|||
160880979|NCT00096356|580957125|FG001|Overall Study|Lack of Efficacy|0|||
160880980|NCT00096356|580957124|FG000|Overall Study|multiple reasons|10|||
160880981|NCT00096356|580957125|FG001|Overall Study|multiple reasons|18|||
160539351|NCT03116698|579704169|FG003|Overall Study|Death|0|||
160539352|NCT02258451|579704170|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
160539353|NCT02258451|579704171|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
160539354|NCT02258451|579704170|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
160880982|NCT01008423|580957126|FG000|Overall Study|Adverse Event|13|||
160880983|NCT01008423|580957127|FG001|Overall Study|Adverse Event|6|||
160880984|NCT01008423|580957126|FG000|Overall Study|Withdrawal by Subject|4|||
160880985|NCT01008423|580957127|FG001|Overall Study|Withdrawal by Subject|7|||
160880986|NCT01008423|580957126|FG000|Overall Study|Lost to Follow-up|0|||
160880987|NCT01008423|580957127|FG001|Overall Study|Lost to Follow-up|2|||
160880988|NCT01008423|580957126|FG000|Overall Study|Low Cortisol|0|||
160880989|NCT01008423|580957127|FG001|Overall Study|Low Cortisol|1|||
160880990|NCT01008423|580957126|FG000|Overall Study|Lack of Efficacy|0|||
160880991|NCT01008423|580957127|FG001|Overall Study|Lack of Efficacy|5|||
160880992|NCT01008423|580957126|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
160880993|NCT01008423|580957127|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
160880994|NCT01008423|580957126|FG000|Overall Study|Personal Conflict|1|||
160880995|NCT01008423|580957127|FG001|Overall Study|Personal Conflict|0|||
160880996|NCT01008423|580957126|FG000|Overall Study|Other|0|||
160880997|NCT01008423|580957127|FG001|Overall Study|Other|1|||
160880998|NCT04391049|580958091|FG000|Overall Study|Protocol Violation|1|||
160880999|NCT01242813|580958092|FG000|Overall Study|Lost to Follow-up|2|||
160881000|NCT00958438|580958094|FG000|Overall Study|Protocol Violation|3|||
160881001|NCT00958438|580958095|FG001|Overall Study|Protocol Violation|2|||
160881002|NCT00958438|580958096|FG002|Overall Study|Protocol Violation|2|||
160881003|NCT00958438|580958094|FG000|Overall Study|Withdrawal by Subject|4|||
160881004|NCT00958438|580958095|FG001|Overall Study|Withdrawal by Subject|2|||
160881005|NCT00958438|580958096|FG002|Overall Study|Withdrawal by Subject|1|||
160881006|NCT00958438|580958094|FG000|Overall Study|Adverse Event|0|||
160881007|NCT00958438|580958095|FG001|Overall Study|Adverse Event|3|||
160881008|NCT00958438|580958096|FG002|Overall Study|Adverse Event|0|||
160881009|NCT00958438|580958094|FG000|Overall Study|Physician Decision|1|||
160881010|NCT00958438|580958095|FG001|Overall Study|Physician Decision|0|||
160881011|NCT00958438|580958096|FG002|Overall Study|Physician Decision|1|||
160881012|NCT00958438|580958094|FG000|Overall Study|Other than specified above|2|||
160881013|NCT00958438|580958095|FG001|Overall Study|Other than specified above|3|||
160881014|NCT00958438|580958096|FG002|Overall Study|Other than specified above|2|||
160881015|NCT02788279|580958097|FG000|Overall Study|Death|62|||
160881016|NCT02788279|580958098|FG001|Overall Study|Death|136|||
160881017|NCT02788279|580958099|FG002|Overall Study|Death|72|||
160881018|NCT02788279|580958097|FG000|Overall Study|Withdrawal by Subject|10|||
160881019|NCT02788279|580958098|FG001|Overall Study|Withdrawal by Subject|15|||
160881020|NCT02788279|580958099|FG002|Overall Study|Withdrawal by Subject|5|||
160881021|NCT02788279|580958097|FG000|Overall Study|Lost to Follow-up|0|||
160881022|NCT02788279|580958098|FG001|Overall Study|Lost to Follow-up|3|||
160881023|NCT02788279|580958099|FG002|Overall Study|Lost to Follow-up|2|||
160881024|NCT02788279|580958097|FG000|Overall Study|Sponsor decision|18|||
160881025|NCT02788279|580958098|FG001|Overall Study|Sponsor decision|29|||
160881026|NCT02788279|580958099|FG002|Overall Study|Sponsor decision|11|||
160881027|NCT00329849|580958101|FG000|Overall Study|Withdrawal by Subject|6|||
160881028|NCT00329849|580958102|FG001|Overall Study|Withdrawal by Subject|4|||
160881029|NCT01133990|580958107|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
160881030|NCT01133990|580958108|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160881031|NCT01133990|580958109|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160881032|NCT01133990|580958110|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160881033|NCT01133990|580958111|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160881034|NCT01133990|580958112|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160770353|NCT01189266|580545976|FG002|Overall Study|Physician Decision|1|||
160770354|NCT01189266|580545974|FG000|Overall Study|Protocol Violation|0|||
160770355|NCT01189266|580545975|FG001|Overall Study|Protocol Violation|1|||
160770356|NCT01189266|580545976|FG002|Overall Study|Protocol Violation|1|||
160770357|NCT01189266|580545974|FG000|Overall Study|Withdrawal by Subject|0|||
160770358|NCT01189266|580545975|FG001|Overall Study|Withdrawal by Subject|0|||
160770359|NCT01189266|580545976|FG002|Overall Study|Withdrawal by Subject|1|||
160770360|NCT01189266|580545974|FG000|Overall Study|Patient refuses further therapy|1|||
160770361|NCT01189266|580545975|FG001|Overall Study|Patient refuses further therapy|0|||
160770362|NCT01189266|580545976|FG002|Overall Study|Patient refuses further therapy|7|||
160770363|NCT01189266|580545974|FG000|Overall Study|No treatment|0|||
160770364|NCT01189266|580545975|FG001|Overall Study|No treatment|0|||
160770365|NCT01189266|580545976|FG002|Overall Study|No treatment|1|||
160770366|NCT03530696|580545977|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
160770367|NCT03530696|580545978|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
160770368|NCT01129128|580545979|FG000|Overall Study|Lost to Follow-up|2|||
160770369|NCT01129128|580545980|FG001|Overall Study|Lost to Follow-up|2|||
160770370|NCT01129128|580545981|FG002|Overall Study|Lost to Follow-up|1|||
160770371|NCT01129128|580545979|FG000|Overall Study|Protocol Violation|0|||
160770372|NCT01129128|580545980|FG001|Overall Study|Protocol Violation|1|||
160770373|NCT01129128|580545981|FG002|Overall Study|Protocol Violation|0|||
160770374|NCT01129128|580545979|FG000|Overall Study|Withdrawal by Subject|0|||
160770375|NCT01129128|580545980|FG001|Overall Study|Withdrawal by Subject|1|||
160770376|NCT01129128|580545981|FG002|Overall Study|Withdrawal by Subject|3|||
160770377|NCT01129128|580545979|FG000|Overall Study|Physician Decision|1|||
160770378|NCT01129128|580545980|FG001|Overall Study|Physician Decision|0|||
160770379|NCT01129128|580545981|FG002|Overall Study|Physician Decision|0|||
160770380|NCT01311661|580545984|FG000|Overall Study|Adverse Event|2|||
160881035|NCT01133990|580958107|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
160881036|NCT01133990|580958108|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
160881037|NCT01133990|580958109|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
160881038|NCT01133990|580958110|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
160881039|NCT01133990|580958111|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
160881040|NCT01133990|580958112|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
160881041|NCT01133990|580958107|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
160881042|NCT01133990|580958108|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160881043|NCT01133990|580958109|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160881044|NCT01133990|580958110|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160881045|NCT01133990|580958111|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160881046|NCT01133990|580958112|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160881047|NCT01133990|580958107|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
160881048|NCT01133990|580958108|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
160881049|NCT01133990|580958109|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
160881050|NCT01133990|580958110|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
160881051|NCT01133990|580958111|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
160881052|NCT01133990|580958112|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
160881053|NCT05277337|580958113|FG000|Overall Study|Lost to Follow-up|2|||
160881054|NCT05277337|580958114|FG001|Overall Study|Lost to Follow-up|0|||
160881055|NCT05277337|580958113|FG000|Overall Study|Withdrawal by Subject|1|||
160881056|NCT05277337|580958114|FG001|Overall Study|Withdrawal by Subject|0|||
160881057|NCT04987944|580958119|FG000|Overall Study|Adverse Event|0|||
160881058|NCT04987944|580958120|FG001|Overall Study|Adverse Event|1|||
160881059|NCT04987944|580958119|FG000|Overall Study|Withdrawal by Subject|0|||
160881060|NCT04987944|580958120|FG001|Overall Study|Withdrawal by Subject|1|||
160881061|NCT02946931|580958130|FG000|Overall Study|Did not require collection of CRFs|588|||
160881062|NCT02946931|580958130|FG000|Overall Study|Other than listed|37|||
160881063|NCT02946931|580958130|FG000|Overall Study|Discharge from hospital|118|||
160881064|NCT02946931|580958130|FG000|Overall Study|Adverse Event|81|||
160881065|NCT02946931|580958130|FG000|Overall Study|CRFs not valid|1|||
160881066|NCT02946931|580958130|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
160881067|NCT00869778|580958131|FG000|Overall Study|Adverse Event|2|||
160881068|NCT00869778|580958132|FG001|Overall Study|Adverse Event|0|||
160881069|NCT00869778|580958133|FG002|Overall Study|Adverse Event|0|||
160881070|NCT00869778|580958131|FG000|Overall Study|Withdrawal by Subject|3|||
160881071|NCT00869778|580958132|FG001|Overall Study|Withdrawal by Subject|4|||
160881072|NCT00869778|580958133|FG002|Overall Study|Withdrawal by Subject|5|||
160881073|NCT00869778|580958131|FG000|Overall Study|Pregnancy|1|||
160881074|NCT00869778|580958132|FG001|Overall Study|Pregnancy|0|||
160881075|NCT00869778|580958133|FG002|Overall Study|Pregnancy|0|||
160881076|NCT00869778|580958131|FG000|Overall Study|Protocol Violation|5|||
160881077|NCT00869778|580958132|FG001|Overall Study|Protocol Violation|3|||
160881078|NCT00869778|580958133|FG002|Overall Study|Protocol Violation|5|||
160881079|NCT00869778|580958131|FG000|Overall Study|Unblinding|1|||
160881080|NCT00869778|580958132|FG001|Overall Study|Unblinding|0|||
160881081|NCT00869778|580958133|FG002|Overall Study|Unblinding|0|||
160881082|NCT03339297|580958134|FG000|Overall Study|Relapse of Hematologic Disease|1|||
160881083|NCT03339297|580958135|FG001|Overall Study|Relapse of Hematologic Disease|0|||
160881084|NCT03339297|580958134|FG000|Overall Study|Death|10|||
160881085|NCT03339297|580958135|FG001|Overall Study|Death|7|||
160881086|NCT03339297|580958134|FG000|Overall Study|Hepatic Candidosis|1|||
160881087|NCT03339297|580958135|FG001|Overall Study|Hepatic Candidosis|0|||
160454057|NCT02038777|579394023|FG001|Overall Study|Randomized but not treated|1|||
160881088|NCT03339297|580958134|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
160881089|NCT03339297|580958135|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
160881090|NCT03339297|580958134|FG000|Overall Study|Consent Withdrawn by Participant|3|||
160881091|NCT03339297|580958135|FG001|Overall Study|Consent Withdrawn by Participant|3|||
160881092|NCT03339297|580958134|FG000|Overall Study|Disease Relapse|2|||
160881093|NCT03339297|580958135|FG001|Overall Study|Disease Relapse|0|||
160881094|NCT03339297|580958134|FG000|Overall Study|Physician Decision|1|||
160881095|NCT03339297|580958135|FG001|Overall Study|Physician Decision|1|||
160539355|NCT02258451|579704171|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
160881096|NCT03339297|580958134|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
160881097|NCT03339297|580958135|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
160881098|NCT03339297|580958134|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
160881099|NCT03339297|580958135|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
160881100|NCT03339297|580958134|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
160881101|NCT03339297|580958135|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
160881102|NCT03339297|580958134|FG000|Overall Study|Adverse Event, Non-fatal|1|||
160539356|NCT02258451|579704170|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
160539357|NCT02258451|579704171|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
160539358|NCT02258451|579704170|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
160539359|NCT02258451|579704171|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
160881103|NCT03339297|580958135|FG001|Overall Study|Adverse Event, Non-fatal|0|||
160881104|NCT03339297|580958134|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
160881105|NCT03339297|580958135|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
160881106|NCT03339297|580958134|FG000|Overall Study|Patient Was Not Eligible|1|||
160881107|NCT03339297|580958135|FG001|Overall Study|Patient Was Not Eligible|0|||
160881108|NCT03051620|580958138|FG000|Overall Study|Lost to Follow-up|6|||
160881109|NCT03051620|580958138|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
160881110|NCT00393510|580958139|FG000|Overall Study|Physician Decision|3|||
160881111|NCT00393510|580958140|FG001|Overall Study|Physician Decision|9|||
160881112|NCT02412488|580958141|FG000|Overall Study|Lost to Follow-up|10|||
160881113|NCT02412488|580958141|FG000|Overall Study|Withdrawal by Subject|5|||
160881114|NCT02412488|580958141|FG000|Overall Study|Physician Decision|1|||
160881115|NCT02412488|580958141|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
160881116|NCT02412488|580958141|FG000|Overall Study|Reveal LINQ explant|1|||
160881117|NCT00674154|580958142|FG000|Overall Study|Withdrawal by Subject|3|||
160881118|NCT00674154|580958143|FG001|Overall Study|Withdrawal by Subject|1|||
160881119|NCT00674154|580958142|FG000|Overall Study|Did not want parathyroidectomy|0|||
160881120|NCT00674154|580958143|FG001|Overall Study|Did not want parathyroidectomy|2|||
160881121|NCT00816023|580958144|FG000|Overall Study|Lost to Follow-up|1|||
160881122|NCT00816023|580958145|FG001|Overall Study|Lost to Follow-up|1|||
160881123|NCT00816023|580958146|FG002|Overall Study|Lost to Follow-up|0|||
160881124|NCT00816023|580958147|FG003|Overall Study|Lost to Follow-up|0|||
160881125|NCT00816023|580958144|FG000|Overall Study|Withdrawal by Subject|1|||
160881126|NCT00816023|580958145|FG001|Overall Study|Withdrawal by Subject|0|||
160881127|NCT00816023|580958146|FG002|Overall Study|Withdrawal by Subject|0|||
160881128|NCT00816023|580958147|FG003|Overall Study|Withdrawal by Subject|0|||
160881129|NCT00816023|580958144|FG000|Overall Study|Physician Decision|0|||
160881130|NCT00816023|580958145|FG001|Overall Study|Physician Decision|0|||
160881131|NCT00816023|580958146|FG002|Overall Study|Physician Decision|1|||
160881132|NCT00816023|580958147|FG003|Overall Study|Physician Decision|0|||
160881133|NCT00816023|580958144|FG000|Overall Study|assessments complete prior to window|1|||
160881134|NCT00816023|580958145|FG001|Overall Study|assessments complete prior to window|1|||
160881135|NCT00816023|580958146|FG002|Overall Study|assessments complete prior to window|2|||
160881136|NCT00816023|580958147|FG003|Overall Study|assessments complete prior to window|1|||
160881137|NCT00816023|580958144|FG000|Overall Study|Randomized Not Treated|6|||
160881138|NCT00816023|580958145|FG001|Overall Study|Randomized Not Treated|4|||
160881139|NCT00816023|580958146|FG002|Overall Study|Randomized Not Treated|6|||
160881140|NCT00816023|580958147|FG003|Overall Study|Randomized Not Treated|11|||
160881141|NCT03554486|580958148|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
160881142|NCT03554486|580958149|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
160881143|NCT03554486|580958150|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
160881144|NCT03554486|580958148|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
160881145|NCT03554486|580958149|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
160881146|NCT03554486|580958150|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
160881147|NCT03554486|580958148|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
160881148|NCT03554486|580958149|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
160881149|NCT03554486|580958150|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
160881150|NCT03288142|580958151|FG000|Overall Study|Lost to Follow-up|22|||
160881151|NCT03288142|580958152|FG001|Overall Study|Lost to Follow-up|15|||
160881152|NCT02034409|580958153|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
160881153|NCT02034409|580958154|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
160881154|NCT02034409|580958153|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
160881155|NCT02034409|580958154|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
160881156|NCT02034409|580958153|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
160881157|NCT02034409|580958154|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
160881158|NCT02034409|580958153|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
160881159|NCT02034409|580958154|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
160881160|NCT02034409|580958153|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
160881161|NCT02034409|580958154|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
160881162|NCT02034409|580958153|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
160881163|NCT02034409|580958154|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
160881164|NCT02270944|580958158|FG000|Overall Study|Lost to Follow-up|9|||
160881165|NCT02270944|580958159|FG001|Overall Study|Lost to Follow-up|4|||
160881166|NCT02270944|580958158|FG000|Overall Study|Withdrawal by Subject|2|||
160881167|NCT02270944|580958159|FG001|Overall Study|Withdrawal by Subject|1|||
160881168|NCT02342418|580958160|FG000|Overall Study|Adverse Event|0|||
160881169|NCT02342418|580958161|FG001|Overall Study|Adverse Event|1|||
160881170|NCT01699867|580958162|FG000|Overall Study|Screening Failure|3|||
160881171|NCT04255394|580958163|FG000|Overall Study|Death|35|||
160881172|NCT04255394|580958164|FG001|Overall Study|Death|25|||
160881173|NCT04255394|580958163|FG000|Overall Study|Device removed|2|||
160881174|NCT04255394|580958164|FG001|Overall Study|Device removed|10|||
160881175|NCT04255394|580958163|FG000|Overall Study|Withdrawal by Subject|9|||
160881176|NCT04255394|580958164|FG001|Overall Study|Withdrawal by Subject|8|||
160881177|NCT04255394|580958163|FG000|Overall Study|Screen Failure/Not treated|12|||
160881178|NCT04255394|580958164|FG001|Overall Study|Screen Failure/Not treated|8|||
160539360|NCT02258451|579704170|FG000|Overall Study|Discontinuation all treatment due to death|4|||
160539361|NCT02258451|579704171|FG001|Overall Study|Discontinuation all treatment due to death|3|||
160539362|NCT02258451|579704170|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
160539363|NCT02258451|579704171|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
160881179|NCT04255394|580958163|FG000|Overall Study|Lost to Follow-up|123|||
160881180|NCT04255394|580958164|FG001|Overall Study|Lost to Follow-up|265|||
160881181|NCT04255394|580958163|FG000|Overall Study|Adverse Event|1|||
160881182|NCT04255394|580958164|FG001|Overall Study|Adverse Event|3|||
160881183|NCT01181986|580958169|FG000|Phase 1|Lost to Follow-up|0|||
160881184|NCT01181986|580958170|FG001|Phase 1|Lost to Follow-up|1|||
160881185|NCT01181986|580958171|FG002|Phase 1|Lost to Follow-up|1|||
160881186|NCT01181986|580958169|FG000|Phase 1|Adverse Event|0|||
160881187|NCT01181986|580958170|FG001|Phase 1|Adverse Event|0|||
160881188|NCT01181986|580958171|FG002|Phase 1|Adverse Event|1|||
160881189|NCT01181986|580958169|FG000|Phase 1|Protocol Violation|1|||
160881190|NCT01181986|580958170|FG001|Phase 1|Protocol Violation|0|||
160881191|NCT01181986|580958171|FG002|Phase 1|Protocol Violation|0|||
160881192|NCT01181986|580958169|FG000|Phase 2|Adverse Event|0|||
160881193|NCT01181986|580958170|FG001|Phase 2|Adverse Event|3|||
160881194|NCT01181986|580958171|FG002|Phase 2|Adverse Event|0|||
160881195|NCT01181986|580958169|FG000|Phase 2|Medical condition|0|||
160881196|NCT01181986|580958170|FG001|Phase 2|Medical condition|1|||
160881197|NCT01181986|580958171|FG002|Phase 2|Medical condition|0|||
160881198|NCT00831493|580958172|FG000|Overall Study|Intractable nausea and vomiting|1|||
160881199|NCT00835731|580958175|FG000|Overall Study|Withdrawal by Subject|1|||
160881200|NCT00835731|580958176|FG001|Overall Study|Withdrawal by Subject|0|||
160881201|NCT00835731|580958175|FG000|Overall Study|Physician Decision|1|||
160881202|NCT00835731|580958176|FG001|Overall Study|Physician Decision|1|||
160881203|NCT00348881|580958177|FG000|Overall Study|Lost to Follow-up|12|||
160881204|NCT00348881|580958178|FG001|Overall Study|Lost to Follow-up|6|||
160881205|NCT00348881|580958177|FG000|Overall Study|Withdrawal by Subject|3|||
160881206|NCT00348881|580958178|FG001|Overall Study|Withdrawal by Subject|4|||
160881207|NCT00348881|580958177|FG000|Overall Study|Adverse Event|2|||
160881208|NCT00348881|580958178|FG001|Overall Study|Adverse Event|0|||
160881209|NCT00348881|580958177|FG000|Overall Study|Serious Adverse Event|0|||
160881210|NCT00348881|580958178|FG001|Overall Study|Serious Adverse Event|2|||
160881211|NCT05092360|580958186|FG000|Overall Study|Withdrawal by Subject|21|||
160881212|NCT05092360|580958187|FG001|Overall Study|Withdrawal by Subject|4|||
160881213|NCT05092360|580958188|FG002|Overall Study|Withdrawal by Subject|9|||
160881214|NCT05092360|580958189|FG003|Overall Study|Withdrawal by Subject|26|||
160881215|NCT05092360|580958186|FG000|Overall Study|Death|97|||
160881216|NCT05092360|580958187|FG001|Overall Study|Death|14|||
160881217|NCT05092360|580958188|FG002|Overall Study|Death|31|||
160881218|NCT05092360|580958189|FG003|Overall Study|Death|101|||
160881219|NCT05092360|580958186|FG000|Overall Study|Lost to Follow-up|1|||
160881220|NCT05092360|580958187|FG001|Overall Study|Lost to Follow-up|2|||
160881221|NCT05092360|580958188|FG002|Overall Study|Lost to Follow-up|2|||
160881222|NCT05092360|580958189|FG003|Overall Study|Lost to Follow-up|2|||
160881223|NCT05092360|580958186|FG000|Overall Study|Study terminated by sponsor|65|||
160881224|NCT05092360|580958187|FG001|Overall Study|Study terminated by sponsor|7|||
160539364|NCT02258451|579704170|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
160881225|NCT05092360|580958188|FG002|Overall Study|Study terminated by sponsor|13|||
160881226|NCT05092360|580958189|FG003|Overall Study|Study terminated by sponsor|61|||
160881227|NCT01675167|580958190|FG000|Open-label Titration Phase|Adverse Event|81|||
160881228|NCT01675167|580958191|FG001|Open-label Titration Phase|Adverse Event|0|||
160881229|NCT01675167|580958192|FG002|Open-label Titration Phase|Adverse Event|0|||
160881230|NCT01675167|580958190|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
160881231|NCT01675167|580958191|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
160881232|NCT01675167|580958192|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
160881233|NCT01675167|580958190|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
160881234|NCT01675167|580958191|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
160881235|NCT01675167|580958192|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
160881236|NCT01675167|580958190|FG000|Open-label Titration Phase|Protocol Violation|43|||
160881237|NCT01675167|580958191|FG001|Open-label Titration Phase|Protocol Violation|0|||
160881238|NCT01675167|580958192|FG002|Open-label Titration Phase|Protocol Violation|0|||
160881239|NCT01675167|580958190|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
160539365|NCT02258451|579704171|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
160539366|NCT02258451|579704170|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
160539367|NCT02258451|579704171|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
160539368|NCT02258451|579704170|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
160539369|NCT02258451|579704171|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
160539370|NCT02258451|579704170|FG000|Overall Study|Other reason|1|||
160539371|NCT02258451|579704171|FG001|Overall Study|Other reason|1|||
160539372|NCT02258451|579704170|FG000|Overall Study|Never treated|2|||
160539373|NCT02258451|579704171|FG001|Overall Study|Never treated|3|||
160539374|NCT00517751|579704174|FG000|Overall Study|Death|3|||
160539375|NCT00517751|579704174|FG000|Overall Study|Withdrawal by Subject|37|||
160539376|NCT00517751|579704174|FG000|Overall Study|Lost to Follow-up|4|||
160539377|NCT00517751|579704174|FG000|Overall Study|patient not over due|6|||
160539378|NCT00517751|579704174|FG000|Overall Study|Patient not due for visit|76|||
160539379|NCT00517751|579704174|FG000|Overall Study|Missing|3|||
160539380|NCT03021499|579704177|FG000|Overall Study|Adverse Event|1|||
160539381|NCT03021499|579704178|FG001|Overall Study|Adverse Event|0|||
160539382|NCT03021499|579704177|FG000|Overall Study|Death|1|||
160539383|NCT03021499|579704178|FG001|Overall Study|Death|5|||
160539384|NCT03021499|579704177|FG000|Overall Study|Lack of Efficacy|0|||
160539385|NCT03021499|579704178|FG001|Overall Study|Lack of Efficacy|1|||
160539386|NCT03021499|579704177|FG000|Overall Study|Lost to Follow-up|1|||
160539387|NCT03021499|579704178|FG001|Overall Study|Lost to Follow-up|3|||
160539388|NCT03021499|579704177|FG000|Overall Study|Physician Decision|2|||
160539389|NCT03021499|579704178|FG001|Overall Study|Physician Decision|3|||
160539390|NCT03021499|579704177|FG000|Overall Study|Pregnancy|1|||
160539391|NCT03021499|579704178|FG001|Overall Study|Pregnancy|0|||
160539392|NCT03021499|579704177|FG000|Overall Study|Withdrawal by Subject|7|||
160539393|NCT03021499|579704178|FG001|Overall Study|Withdrawal by Subject|14|||
160539394|NCT03021499|579704177|FG000|Overall Study|Prohibited medication required|1|||
160539395|NCT03021499|579704178|FG001|Overall Study|Prohibited medication required|0|||
160539396|NCT03021499|579704177|FG000|Overall Study|Protocol non-compliance|1|||
160539397|NCT03021499|579704178|FG001|Overall Study|Protocol non-compliance|1|||
160539398|NCT03021499|579704177|FG000|Overall Study|None of the above|0|||
160539399|NCT03021499|579704178|FG001|Overall Study|None of the above|4|||
160539400|NCT03021499|579704177|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
160881240|NCT01675167|580958191|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
160881241|NCT01675167|580958192|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
160881242|NCT01675167|580958190|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
160881243|NCT01675167|580958191|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
160881244|NCT01675167|580958192|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
160881245|NCT01675167|580958190|FG000|Open-label Titration Phase|Other|55|||
160881246|NCT01675167|580958191|FG001|Open-label Titration Phase|Other|0|||
160881247|NCT01675167|580958192|FG002|Open-label Titration Phase|Other|0|||
160881248|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
160881249|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
160881250|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
160881251|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160881252|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
160881253|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
160881254|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Adverse Event|0|||
160881255|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Adverse Event|5|||
160881256|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Adverse Event|13|||
160881257|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
160881258|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
160881259|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
160881260|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
160881261|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
160881262|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
160539401|NCT03021499|579704178|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
160539402|NCT00495820|579704179|FG000|Overall Study|Adverse Event|1|||
160539403|NCT00495820|579704180|FG001|Overall Study|Adverse Event|1|||
160539404|NCT00820950|579704181|FG000|Overall Study|Scheduling Conflict|0|||
160539405|NCT00820950|579704182|FG001|Overall Study|Scheduling Conflict|0|||
160539406|NCT00820950|579704183|FG002|Overall Study|Scheduling Conflict|0|||
160881263|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
160881264|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
160539407|NCT00820950|579704184|FG003|Overall Study|Scheduling Conflict|0|||
160539408|NCT00820950|579704185|FG004|Overall Study|Scheduling Conflict|0|||
160539409|NCT00820950|579704186|FG005|Overall Study|Scheduling Conflict|0|||
160539410|NCT00820950|579704187|FG006|Overall Study|Scheduling Conflict|1|||
160539411|NCT00820950|579704188|FG007|Overall Study|Scheduling Conflict|1|||
160881265|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
160770381|NCT01311661|580545984|FG000|Overall Study|Protocol Violation|3|||
160770382|NCT01311661|580545984|FG000|Overall Study|Withdrawal by Subject|2|||
160770383|NCT01900314|580545985|FG000|Overall Study|Lost to Follow-up|1|||
160770384|NCT01900314|580545986|FG001|Overall Study|Lost to Follow-up|0|||
160770385|NCT01900314|580545985|FG000|Overall Study|Protocol Violation|0|||
160770386|NCT01900314|580545986|FG001|Overall Study|Protocol Violation|1|||
160770387|NCT01900314|580545985|FG000|Overall Study|Withdrawal by Subject|3|||
160770388|NCT01900314|580545986|FG001|Overall Study|Withdrawal by Subject|3|||
160770389|NCT03197129|580545991|FG000|Overall Study|did not answer the VPT: shyness|4|||
160770390|NCT03197129|580545992|FG001|Overall Study|did not answer the VPT: shyness|5|||
160770391|NCT04848480|580545993|FG000|Main Phase (26 Weeks)|Death|1|||
160770392|NCT04848480|580545994|FG001|Main Phase (26 Weeks)|Death|0|||
160770393|NCT04848480|580545993|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
160770394|NCT04848480|580545994|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
160770395|NCT04848480|580545993|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
160770396|NCT04848480|580545994|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
160770397|NCT04848480|580545993|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
160770398|NCT04848480|580545994|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
160770399|NCT04848480|580545993|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
160770400|NCT04848480|580545994|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
160770401|NCT04848480|580545993|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
160770402|NCT04848480|580545994|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
160770403|NCT04428151|580545995|FG000|Overall Study|Death|100|||
160770404|NCT04428151|580545996|FG001|Overall Study|Death|86|||
160770405|NCT04428151|580545997|FG002|Overall Study|Death|57|||
160770406|NCT04428151|580545995|FG000|Overall Study|Lost to Follow-up|1|||
160770407|NCT04428151|580545996|FG001|Overall Study|Lost to Follow-up|1|||
160770408|NCT04428151|580545997|FG002|Overall Study|Lost to Follow-up|0|||
160770409|NCT04428151|580545995|FG000|Overall Study|Withdrawal by Subject|2|||
160770410|NCT04428151|580545996|FG001|Overall Study|Withdrawal by Subject|2|||
160770411|NCT04428151|580545997|FG002|Overall Study|Withdrawal by Subject|3|||
160770412|NCT04428151|580545995|FG000|Overall Study|Participant Ongoing in Study|41|||
160770413|NCT04428151|580545996|FG001|Overall Study|Participant Ongoing in Study|53|||
160770414|NCT04428151|580545997|FG002|Overall Study|Participant Ongoing in Study|28|||
160770415|NCT04585893|580545998|FG000|Overall Study|Death|1|||
160770416|NCT04585893|580545999|FG001|Overall Study|Death|0|||
160770417|NCT06178991|580546002|FG000|Overall Study|Withdrawal by Subject|2|||
160770418|NCT06178991|580546003|FG001|Overall Study|Withdrawal by Subject|6|||
160770419|NCT06178991|580546004|FG002|Overall Study|Withdrawal by Subject|44|||
160770420|NCT06178991|580546005|FG003|Overall Study|Withdrawal by Subject|23|||
160770421|NCT06178991|580546006|FG004|Overall Study|Withdrawal by Subject|7|||
160770422|NCT06178991|580546007|FG005|Overall Study|Withdrawal by Subject|7|||
160770423|NCT06178991|580546008|FG006|Overall Study|Withdrawal by Subject|7|||
160770424|NCT06178991|580546009|FG007|Overall Study|Withdrawal by Subject|5|||
160770425|NCT06178991|580546002|FG000|Overall Study|Lost to Follow-up|2|||
160770426|NCT06178991|580546003|FG001|Overall Study|Lost to Follow-up|4|||
160770427|NCT06178991|580546004|FG002|Overall Study|Lost to Follow-up|133|||
160770428|NCT06178991|580546005|FG003|Overall Study|Lost to Follow-up|65|||
160770429|NCT06178991|580546006|FG004|Overall Study|Lost to Follow-up|68|||
160770430|NCT06178991|580546007|FG005|Overall Study|Lost to Follow-up|57|||
160770431|NCT06178991|580546008|FG006|Overall Study|Lost to Follow-up|25|||
160770432|NCT06178991|580546009|FG007|Overall Study|Lost to Follow-up|18|||
160770433|NCT06178991|580546002|FG000|Overall Study|Death|1|||
160770434|NCT06178991|580546003|FG001|Overall Study|Death|0|||
160770435|NCT06178991|580546004|FG002|Overall Study|Death|2|||
160770436|NCT06178991|580546005|FG003|Overall Study|Death|1|||
160770437|NCT06178991|580546006|FG004|Overall Study|Death|1|||
160770438|NCT06178991|580546007|FG005|Overall Study|Death|0|||
160770439|NCT06178991|580546008|FG006|Overall Study|Death|1|||
160770440|NCT06178991|580546009|FG007|Overall Study|Death|1|||
160770441|NCT06178991|580546002|FG000|Overall Study|Randomized but not Vaccinated|4|||
160770442|NCT06178991|580546003|FG001|Overall Study|Randomized but not Vaccinated|1|||
160770443|NCT06178991|580546004|FG002|Overall Study|Randomized but not Vaccinated|15|||
160770444|NCT06178991|580546005|FG003|Overall Study|Randomized but not Vaccinated|9|||
160770445|NCT06178991|580546006|FG004|Overall Study|Randomized but not Vaccinated|8|||
160770446|NCT06178991|580546007|FG005|Overall Study|Randomized but not Vaccinated|4|||
160770447|NCT06178991|580546008|FG006|Overall Study|Randomized but not Vaccinated|2|||
160770448|NCT06178991|580546009|FG007|Overall Study|Randomized but not Vaccinated|2|||
160770449|NCT06178991|580546002|FG000|Overall Study|Other: Unspecified|0|||
160770450|NCT06178991|580546003|FG001|Overall Study|Other: Unspecified|1|||
160770451|NCT06178991|580546004|FG002|Overall Study|Other: Unspecified|7|||
160770452|NCT06178991|580546005|FG003|Overall Study|Other: Unspecified|6|||
160770453|NCT06178991|580546006|FG004|Overall Study|Other: Unspecified|1|||
160770454|NCT06178991|580546007|FG005|Overall Study|Other: Unspecified|1|||
160770455|NCT06178991|580546008|FG006|Overall Study|Other: Unspecified|1|||
160770456|NCT06178991|580546009|FG007|Overall Study|Other: Unspecified|0|||
160770457|NCT06178991|580546002|FG000|Overall Study|Physician Decision|0|||
160881266|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Other|0|||
160881267|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Other|7|||
160881268|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Other|5|||
160881269|NCT01525225|580958195|FG000|Enrollment|No longer met study criteria|1|||
160881270|NCT01525225|580958195|FG000|Enrollment|Other|1|||
160881271|NCT01379508|580958196|FG000|Treatment to Week 104|Adverse Event|2|||
160881272|NCT01379508|580958197|FG001|Treatment to Week 104|Adverse Event|0|||
160881273|NCT01379508|580958198|FG002|Treatment to Week 104|Adverse Event|5|||
160881274|NCT01379508|580958199|FG003|Treatment to Week 104|Adverse Event|0|||
160881275|NCT01379508|580958196|FG000|Treatment to Week 104|Abnormal lab value|1|||
160881276|NCT01379508|580958197|FG001|Treatment to Week 104|Abnormal lab value|0|||
160881277|NCT01379508|580958198|FG002|Treatment to Week 104|Abnormal lab value|0|||
160881278|NCT01379508|580958199|FG003|Treatment to Week 104|Abnormal lab value|0|||
160881279|NCT01379508|580958196|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
160881280|NCT01379508|580958197|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
160881281|NCT01379508|580958198|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
160881282|NCT01379508|580958199|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
160881283|NCT01379508|580958196|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
160881284|NCT01379508|580958197|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
160881285|NCT01379508|580958198|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
160881286|NCT01379508|580958199|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
160881287|NCT01379508|580958196|FG000|Treatment to Week 104|Lost to Follow-up|5|||
160881288|NCT01379508|580958197|FG001|Treatment to Week 104|Lost to Follow-up|0|||
160881289|NCT01379508|580958198|FG002|Treatment to Week 104|Lost to Follow-up|3|||
160881290|NCT01379508|580958199|FG003|Treatment to Week 104|Lost to Follow-up|0|||
160881291|NCT01379508|580958196|FG000|Treatment to Week 104|Administrative problems|3|||
160881292|NCT01379508|580958197|FG001|Treatment to Week 104|Administrative problems|1|||
160881293|NCT01379508|580958198|FG002|Treatment to Week 104|Administrative problems|0|||
160881294|NCT01379508|580958199|FG003|Treatment to Week 104|Administrative problems|0|||
160881295|NCT01379508|580958196|FG000|Treatment to Week 104|Protocol Violation|1|||
160881296|NCT01379508|580958197|FG001|Treatment to Week 104|Protocol Violation|1|||
160881297|NCT01379508|580958198|FG002|Treatment to Week 104|Protocol Violation|1|||
160881298|NCT01379508|580958199|FG003|Treatment to Week 104|Protocol Violation|0|||
160881299|NCT01379508|580958196|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
160881300|NCT01379508|580958197|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
160881301|NCT01379508|580958198|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
160881302|NCT01379508|580958199|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
160881303|NCT01379508|580958196|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
160881304|NCT01379508|580958197|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
160881305|NCT01379508|580958198|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
160881306|NCT01379508|580958199|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
160881307|NCT01379508|580958196|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
160881308|NCT01379508|580958197|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
160881309|NCT01379508|580958198|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
160881310|NCT01379508|580958199|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
160881311|NCT01379508|580958196|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
160881312|NCT01379508|580958197|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
160881313|NCT01379508|580958198|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
160881314|NCT01379508|580958199|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
160881315|NCT01182844|580958200|FG000|Overall Study|Withdrawal by Subject|0|||
160881316|NCT01182844|580958201|FG001|Overall Study|Withdrawal by Subject|2|||
160881317|NCT03952039|580958204|FG000|Overall Study|Adverse Event|22|||
160881318|NCT03952039|580958205|FG001|Overall Study|Adverse Event|8|||
160881319|NCT03952039|580958204|FG000|Overall Study|Withdrawal by Participant|17|||
160881320|NCT03952039|580958205|FG001|Overall Study|Withdrawal by Participant|12|||
160881321|NCT03952039|580958204|FG000|Overall Study|Death|13|||
160881322|NCT03952039|580958205|FG001|Overall Study|Death|6|||
160881323|NCT03952039|580958204|FG000|Overall Study|Lack of Efficacy|12|||
160881324|NCT03952039|580958205|FG001|Overall Study|Lack of Efficacy|2|||
160881325|NCT03952039|580958204|FG000|Overall Study|Physician Decision|9|||
160881326|NCT03952039|580958205|FG001|Overall Study|Physician Decision|3|||
160881327|NCT03952039|580958204|FG000|Overall Study|Progressive Disease|6|||
160881328|NCT03952039|580958205|FG001|Overall Study|Progressive Disease|4|||
160881329|NCT03952039|580958204|FG000|Overall Study|Other Reasons|12|||
160881330|NCT03952039|580958205|FG001|Overall Study|Other Reasons|4|||
160881331|NCT02055365|580960504|FG000|Overall Study|Prematurely Withdrawn|1|||
160881332|NCT03603509|580960508|FG000|Overall Study|Lost to Follow-up|3|||
160881333|NCT03603509|580960509|FG001|Overall Study|Lost to Follow-up|4|||
160881334|NCT02656680|580960512|FG000|Overall Study|Lost to Follow-up|0|||
160881335|NCT02656680|580960513|FG001|Overall Study|Lost to Follow-up|1|||
160881336|NCT02656680|580960514|FG002|Overall Study|Lost to Follow-up|7|||
160881337|NCT01258998|580960515|FG000|Overall Study|Ineligible|1|||
160881338|NCT01143389|580960516|FG000|Overall Study|Lost to Follow-up|26|||
160881339|NCT01143389|580960517|FG001|Overall Study|Lost to Follow-up|25|||
160770458|NCT06178991|580546003|FG001|Overall Study|Physician Decision|0|||
160770459|NCT06178991|580546004|FG002|Overall Study|Physician Decision|2|||
160770460|NCT06178991|580546005|FG003|Overall Study|Physician Decision|0|||
160770461|NCT06178991|580546006|FG004|Overall Study|Physician Decision|2|||
160770462|NCT06178991|580546007|FG005|Overall Study|Physician Decision|1|||
160770463|NCT06178991|580546008|FG006|Overall Study|Physician Decision|0|||
160770464|NCT06178991|580546009|FG007|Overall Study|Physician Decision|0|||
160770465|NCT06178991|580546002|FG000|Overall Study|Protocol Violation|0|||
160770466|NCT06178991|580546003|FG001|Overall Study|Protocol Violation|0|||
160770467|NCT06178991|580546004|FG002|Overall Study|Protocol Violation|1|||
160770468|NCT06178991|580546005|FG003|Overall Study|Protocol Violation|0|||
160770469|NCT06178991|580546006|FG004|Overall Study|Protocol Violation|0|||
160770470|NCT06178991|580546007|FG005|Overall Study|Protocol Violation|0|||
160770471|NCT06178991|580546008|FG006|Overall Study|Protocol Violation|0|||
160770472|NCT06178991|580546009|FG007|Overall Study|Protocol Violation|0|||
160770473|NCT01366092|580546013|FG000|Overall Study|Progressive cGVHD|2|||
160770474|NCT01366092|580546013|FG000|Overall Study|Physician Decision|1|||
160770475|NCT01366092|580546013|FG000|Overall Study|Withdrawal by Subject|1|||
160770476|NCT03353220|580546018|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
160770477|NCT03353220|580546019|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
160770478|NCT03586479|580546020|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
160770479|NCT03586479|580546021|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
160770480|NCT03586479|580546022|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
160770481|NCT03586479|580546020|FG000|Overall Study|Protocol Violation|2|||
160770482|NCT03586479|580546021|FG001|Overall Study|Protocol Violation|0|||
160770483|NCT03586479|580546022|FG002|Overall Study|Protocol Violation|0|||
160770484|NCT03586479|580546020|FG000|Overall Study|Lost to Follow-up|1|||
160770485|NCT03586479|580546021|FG001|Overall Study|Lost to Follow-up|1|||
160770486|NCT03586479|580546022|FG002|Overall Study|Lost to Follow-up|2|||
160770487|NCT03586479|580546020|FG000|Overall Study|Behavioral Issues|1|||
160770488|NCT03586479|580546021|FG001|Overall Study|Behavioral Issues|0|||
160770489|NCT03586479|580546022|FG002|Overall Study|Behavioral Issues|0|||
160770490|NCT00661388|580546024|FG000|Overall Study|Adverse Event|14|||
160770491|NCT00661388|580546024|FG000|Overall Study|Protocol Violation|7|||
160770492|NCT00661388|580546024|FG000|Overall Study|Renal transplantation|1|||
160770493|NCT00661388|580546024|FG000|Overall Study|Dialysis initiation|1|||
160770494|NCT00661388|580546024|FG000|Overall Study|Administrative reasons|1|||
160770495|NCT01963611|580547390|FG000|Overall Study|Adverse Event|1|||
160770496|NCT01963611|580547391|FG001|Overall Study|Adverse Event|1|||
160770497|NCT01963611|580547392|FG002|Overall Study|Adverse Event|3|||
160770498|NCT01963611|580547393|FG003|Overall Study|Adverse Event|4|||
160770499|NCT01963611|580547394|FG004|Overall Study|Adverse Event|3|||
160770500|NCT01963611|580547390|FG000|Overall Study|Protocol Violation|0|||
160770501|NCT01963611|580547391|FG001|Overall Study|Protocol Violation|0|||
160770502|NCT01963611|580547392|FG002|Overall Study|Protocol Violation|0|||
160770503|NCT01963611|580547393|FG003|Overall Study|Protocol Violation|1|||
160770504|NCT01963611|580547394|FG004|Overall Study|Protocol Violation|0|||
160770505|NCT01963611|580547390|FG000|Overall Study|Lack of Efficacy|0|||
160770506|NCT01963611|580547391|FG001|Overall Study|Lack of Efficacy|0|||
160770507|NCT01963611|580547392|FG002|Overall Study|Lack of Efficacy|0|||
160770508|NCT01963611|580547393|FG003|Overall Study|Lack of Efficacy|1|||
160770509|NCT01963611|580547394|FG004|Overall Study|Lack of Efficacy|0|||
160770510|NCT01963611|580547390|FG000|Overall Study|Withdrawal by Subject|3|||
160770511|NCT01963611|580547391|FG001|Overall Study|Withdrawal by Subject|2|||
160770512|NCT01963611|580547392|FG002|Overall Study|Withdrawal by Subject|1|||
160770513|NCT01963611|580547393|FG003|Overall Study|Withdrawal by Subject|1|||
160770514|NCT01963611|580547394|FG004|Overall Study|Withdrawal by Subject|3|||
160770515|NCT01963611|580547390|FG000|Overall Study|Other|47|||
160770516|NCT01963611|580547391|FG001|Overall Study|Other|46|||
160770517|NCT01963611|580547392|FG002|Overall Study|Other|48|||
160770518|NCT01963611|580547393|FG003|Overall Study|Other|45|||
160770519|NCT01963611|580547394|FG004|Overall Study|Other|45|||
160770520|NCT01126424|580547396|FG000|Overall Study|Adverse Event|0|||
160770521|NCT01126424|580547397|FG001|Overall Study|Adverse Event|0|||
160770522|NCT01126424|580547398|FG002|Overall Study|Adverse Event|0|||
160770523|NCT01126424|580547399|FG003|Overall Study|Adverse Event|0|||
160770524|NCT01126424|580547400|FG004|Overall Study|Adverse Event|1|||
160770525|NCT01126424|580547401|FG005|Overall Study|Adverse Event|0|||
160770526|NCT01126424|580547396|FG000|Overall Study|Withdrawal by Subject|0|||
160770527|NCT01126424|580547397|FG001|Overall Study|Withdrawal by Subject|0|||
160770528|NCT01126424|580547398|FG002|Overall Study|Withdrawal by Subject|1|||
160770529|NCT01126424|580547399|FG003|Overall Study|Withdrawal by Subject|3|||
160770530|NCT01126424|580547400|FG004|Overall Study|Withdrawal by Subject|1|||
160770531|NCT01126424|580547401|FG005|Overall Study|Withdrawal by Subject|0|||
160770532|NCT02127671|580547402|FG000|Overall Study|Death|2|||
160770533|NCT02127671|580547403|FG001|Overall Study|Death|2|||
160770534|NCT02127671|580547402|FG000|Overall Study|Lost to Follow-up|4|||
160770535|NCT02127671|580547403|FG001|Overall Study|Lost to Follow-up|2|||
160770536|NCT02127671|580547402|FG000|Overall Study|Physician Decision|1|||
160881340|NCT04966910|580960520|FG000|Baseline|Participant did not complete measure|0|||
160881341|NCT04966910|580960521|FG001|Baseline|Participant did not complete measure|0|||
160881342|NCT04966910|580960522|FG002|Baseline|Participant did not complete measure|1|||
160881343|NCT04966910|580960523|FG003|Baseline|Participant did not complete measure|0|||
160881344|NCT04966910|580960520|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
160881345|NCT04966910|580960521|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
160881346|NCT04966910|580960522|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
160881347|NCT04966910|580960523|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
160881348|NCT04966910|580960520|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
160881349|NCT04966910|580960521|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
160881350|NCT04966910|580960522|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
160881351|NCT04966910|580960523|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
160881352|NCT04966910|580960520|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
160881353|NCT04966910|580960521|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
160881354|NCT04966910|580960522|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
160881355|NCT04966910|580960523|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
160881356|NCT00002931|580960524|FG000|Overall Study|rapidly progressing disease during|2|||
160881357|NCT04531462|580960533|FG000|Overall Study|Withdrawal by Subject|3|||
160881358|NCT04531462|580960534|FG001|Overall Study|Withdrawal by Subject|1|||
160881359|NCT04531462|580960533|FG000|Overall Study|Adverse Event|3|||
160881360|NCT04531462|580960534|FG001|Overall Study|Adverse Event|3|||
160881361|NCT00504582|580960535|FG000|Overall Study|Lost to Follow-up|1|||
160881362|NCT00504582|580960536|FG001|Overall Study|Lost to Follow-up|0|||
160881363|NCT00504582|580960537|FG002|Overall Study|Lost to Follow-up|0|||
160881364|NCT01264081|580960540|FG000|Participants Screened|Screening failures|30|||
160881365|NCT01264081|580960540|FG000|Started Treatment|Withdrawal by Subject|1|||
160770537|NCT02127671|580547403|FG001|Overall Study|Physician Decision|0|||
160770538|NCT02127671|580547402|FG000|Overall Study|incarceration|0|||
160770539|NCT02127671|580547403|FG001|Overall Study|incarceration|1|||
160770540|NCT02127671|580547402|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
160770541|NCT02127671|580547403|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
160770542|NCT02394275|580547404|FG000|Overall Study|Adverse Event|22|||
160770543|NCT02394275|580547404|FG000|Overall Study|Lost to Follow-up|7|||
160770544|NCT00782067|580547406|FG000|Overall Study|Adverse Event|35|||
160770545|NCT00782067|580547406|FG000|Overall Study|Subject withdrew consent|11|||
160770546|NCT00782067|580547406|FG000|Overall Study|Lost to Follow-up|2|||
160770547|NCT00782067|580547406|FG000|Overall Study|Administrative problems|14|||
160770548|NCT00782067|580547406|FG000|Overall Study|Death|9|||
160770549|NCT00782067|580547406|FG000|Overall Study|Disease progression|43|||
160770550|NCT00782067|580547406|FG000|Overall Study|Protocol deviation|2|||
160770551|NCT02471183|580547407|FG000|Main Treatment Period|Adverse Event|1|||
160770552|NCT02471183|580547407|FG000|Main Treatment Period|Withdrawal by Subject|1|||
160770553|NCT02471183|580547407|FG000|Extended Treatment Period|Lack of Efficacy|1|||
160770554|NCT02328105|580547409|FG000|Overall Study|Death|6|||
160770555|NCT02328105|580547409|FG000|Overall Study|Withdrawal by Subject|1|||
160770556|NCT02328105|580547409|FG000|Overall Study|Still On Study in Follow-Up|4|||
160770557|NCT00614393|580547410|FG000|Overall Study|Adverse Event|20|||
160770558|NCT00614393|580547411|FG001|Overall Study|Adverse Event|2|||
160770559|NCT00614393|580547412|FG002|Overall Study|Adverse Event|3|||
160770560|NCT00614393|580547413|FG003|Overall Study|Adverse Event|13|||
160770561|NCT00614393|580547414|FG004|Overall Study|Adverse Event|21|||
160770562|NCT00614393|580547410|FG000|Overall Study|Lost to Follow-up|0|||
160770563|NCT00614393|580547411|FG001|Overall Study|Lost to Follow-up|0|||
160770564|NCT00614393|580547412|FG002|Overall Study|Lost to Follow-up|0|||
160770565|NCT00614393|580547413|FG003|Overall Study|Lost to Follow-up|1|||
160770566|NCT00614393|580547414|FG004|Overall Study|Lost to Follow-up|2|||
160770567|NCT00614393|580547410|FG000|Overall Study|Physician Decision|17|||
160770568|NCT00614393|580547411|FG001|Overall Study|Physician Decision|0|||
160770569|NCT00614393|580547412|FG002|Overall Study|Physician Decision|1|||
160770570|NCT00614393|580547413|FG003|Overall Study|Physician Decision|8|||
160770571|NCT00614393|580547414|FG004|Overall Study|Physician Decision|9|||
160770572|NCT00614393|580547410|FG000|Overall Study|Progressive Disease|118|||
160770573|NCT00614393|580547411|FG001|Overall Study|Progressive Disease|5|||
160881366|NCT01264081|580960540|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
160770574|NCT00614393|580547412|FG002|Overall Study|Progressive Disease|5|||
160770575|NCT00614393|580547413|FG003|Overall Study|Progressive Disease|138|||
160770576|NCT00614393|580547414|FG004|Overall Study|Progressive Disease|130|||
160770577|NCT00614393|580547410|FG000|Overall Study|Protocol Violation|1|||
160770578|NCT00614393|580547411|FG001|Overall Study|Protocol Violation|0|||
160770579|NCT00614393|580547412|FG002|Overall Study|Protocol Violation|0|||
160770580|NCT00614393|580547413|FG003|Overall Study|Protocol Violation|0|||
160770581|NCT00614393|580547414|FG004|Overall Study|Protocol Violation|0|||
160770582|NCT00614393|580547410|FG000|Overall Study|Terminated by Sponsor|0|||
160770583|NCT00614393|580547411|FG001|Overall Study|Terminated by Sponsor|0|||
160881367|NCT02716896|580960541|FG000|Overall Study|Physician Decision|0|||
160881368|NCT02716896|580960542|FG001|Overall Study|Physician Decision|1|||
160881369|NCT01727700|580960543|FG000|Overall Study|Adverse Event|0|||
160881370|NCT01727700|580960544|FG001|Overall Study|Adverse Event|7|||
160881371|NCT01727700|580960545|FG002|Overall Study|Adverse Event|1|||
160881372|NCT01727700|580960543|FG000|Overall Study|Particpant withdrew consent|0|||
160881373|NCT01727700|580960544|FG001|Overall Study|Particpant withdrew consent|3|||
160881374|NCT01727700|580960545|FG002|Overall Study|Particpant withdrew consent|1|||
160881375|NCT01727700|580960543|FG000|Overall Study|Protocol Violation|2|||
160881376|NCT01727700|580960544|FG001|Overall Study|Protocol Violation|0|||
160881377|NCT01727700|580960545|FG002|Overall Study|Protocol Violation|0|||
160881378|NCT01757691|580960547|FG000|Overall Study|Administrative problems|2|||
160881379|NCT01757691|580960548|FG001|Overall Study|Administrative problems|0|||
160881380|NCT02054481|580960552|FG000|Overall Study|Adverse Event|1|||
160881381|NCT02054481|580960553|FG001|Overall Study|Adverse Event|1|||
160881382|NCT02054481|580960554|FG002|Overall Study|Adverse Event|0|||
160881383|NCT02054481|580960555|FG003|Overall Study|Adverse Event|1|||
160881384|NCT02054481|580960552|FG000|Overall Study|Lost to Follow-up|1|||
160881385|NCT02054481|580960553|FG001|Overall Study|Lost to Follow-up|0|||
160881386|NCT02054481|580960554|FG002|Overall Study|Lost to Follow-up|0|||
160881387|NCT02054481|580960555|FG003|Overall Study|Lost to Follow-up|0|||
160881388|NCT02054481|580960552|FG000|Overall Study|Other reason|2|||
160881389|NCT02054481|580960553|FG001|Overall Study|Other reason|1|||
160881390|NCT02054481|580960554|FG002|Overall Study|Other reason|2|||
160881391|NCT02054481|580960555|FG003|Overall Study|Other reason|0|||
160881392|NCT01012219|580960557|FG000|Period 1|Withdrawal by Subject|1|||
160881393|NCT01012219|580960557|FG000|Period 2|Withdrawal by Subject|1|||
160881394|NCT01909791|580960558|FG000|Overall Study|Death|9|||
160881395|NCT01909791|580960559|FG001|Overall Study|Death|8|||
160881396|NCT01909791|580960560|FG002|Overall Study|Death|4|||
160881397|NCT01909791|580960558|FG000|Overall Study|Withdrawal by Subject|5|||
160881398|NCT01909791|580960559|FG001|Overall Study|Withdrawal by Subject|9|||
160881399|NCT01909791|580960560|FG002|Overall Study|Withdrawal by Subject|13|||
160881400|NCT01909791|580960558|FG000|Overall Study|Lost to Follow-up|5|||
160881401|NCT01909791|580960559|FG001|Overall Study|Lost to Follow-up|11|||
160881402|NCT01909791|580960560|FG002|Overall Study|Lost to Follow-up|10|||
160881403|NCT01909791|580960558|FG000|Overall Study|Missed Visit|2|||
160881404|NCT01909791|580960559|FG001|Overall Study|Missed Visit|0|||
160881405|NCT01909791|580960560|FG002|Overall Study|Missed Visit|1|||
160881406|NCT01328366|580960563|FG000|Overall Study|Death|1|||
160881407|NCT01328366|580960563|FG000|Overall Study|Withdrawal by Subject|2|||
160881408|NCT01328366|580960563|FG000|Overall Study|Lost to Follow-up|7|||
160881409|NCT01713933|580960564|FG000|Overall Study|Lost to Follow-up|2|||
160881410|NCT01713933|580960564|FG000|Overall Study|Withdrawal by Subject|3|||
160881411|NCT01713933|580960564|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
160881412|NCT00528970|580960565|FG000|Overall Study|Adverse Event|6|||
160881413|NCT00528970|580960566|FG001|Overall Study|Adverse Event|8|||
160881414|NCT00528970|580960567|FG002|Overall Study|Adverse Event|5|||
160881415|NCT00528970|580960565|FG000|Overall Study|Lost to Follow-up|0|||
160881416|NCT00528970|580960566|FG001|Overall Study|Lost to Follow-up|0|||
160881417|NCT00528970|580960567|FG002|Overall Study|Lost to Follow-up|1|||
160881418|NCT00528970|580960565|FG000|Overall Study|Other than specified|2|||
160881419|NCT00528970|580960566|FG001|Overall Study|Other than specified|3|||
160881420|NCT00528970|580960567|FG002|Overall Study|Other than specified|3|||
160881421|NCT00528970|580960565|FG000|Overall Study|Protocol Violation|2|||
160881422|NCT00528970|580960566|FG001|Overall Study|Protocol Violation|1|||
160881423|NCT00528970|580960567|FG002|Overall Study|Protocol Violation|4|||
160881424|NCT00528970|580960565|FG000|Overall Study|Lack of Efficacy|0|||
160881425|NCT00528970|580960566|FG001|Overall Study|Lack of Efficacy|0|||
160881426|NCT00528970|580960567|FG002|Overall Study|Lack of Efficacy|1|||
160881427|NCT00528970|580960565|FG000|Overall Study|Withdrawal by Subject|4|||
160881428|NCT00528970|580960566|FG001|Overall Study|Withdrawal by Subject|3|||
160881429|NCT00528970|580960567|FG002|Overall Study|Withdrawal by Subject|5|||
160881430|NCT00528970|580960565|FG000|Overall Study|Randomized but not treated|0|||
160881431|NCT00528970|580960566|FG001|Overall Study|Randomized but not treated|0|||
160881432|NCT00528970|580960567|FG002|Overall Study|Randomized but not treated|1|||
160881433|NCT02882152|580960568|FG000|Overall Study|Lost to Follow-up|1|||
160881434|NCT02882152|580960569|FG001|Overall Study|Lost to Follow-up|0|||
160881435|NCT01009840|580960570|FG000|Overall Study|Lost to Follow-up|1|||
160881436|NCT01009840|580960570|FG000|Overall Study|Adverse Event|4|||
160881437|NCT01009840|580960570|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
160881438|NCT01009840|580960570|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
160881439|NCT01009840|580960570|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
160881440|NCT01104376|580960573|FG000|Overall Study|Withdrawal by Subject|15|||
160881441|NCT01104376|580960573|FG000|Overall Study|Consented but excluded after labs|13|||
160881442|NCT00797966|580960576|FG000|Phase A|Lost to Follow-up|0|||
160881443|NCT00797966|580960577|FG001|Phase A|Lost to Follow-up|0|||
160881444|NCT00797966|580960578|FG002|Phase A|Lost to Follow-up|0|||
160881445|NCT00797966|580960579|FG003|Phase A|Lost to Follow-up|0|||
160881446|NCT00797966|580960580|FG004|Phase A|Lost to Follow-up|33|||
160881447|NCT00797966|580960581|FG005|Phase A|Lost to Follow-up|0|||
160881448|NCT00797966|580960576|FG000|Phase A|Adverse Event|0|||
160881449|NCT00797966|580960577|FG001|Phase A|Adverse Event|0|||
160881450|NCT00797966|580960578|FG002|Phase A|Adverse Event|0|||
160881451|NCT00797966|580960579|FG003|Phase A|Adverse Event|0|||
160881452|NCT00797966|580960580|FG004|Phase A|Adverse Event|46|||
160881453|NCT00797966|580960581|FG005|Phase A|Adverse Event|0|||
160881454|NCT00797966|580960576|FG000|Phase A|Met withdrawal criteria|0|||
160881455|NCT00797966|580960577|FG001|Phase A|Met withdrawal criteria|0|||
160881456|NCT00797966|580960578|FG002|Phase A|Met withdrawal criteria|0|||
160881457|NCT00797966|580960579|FG003|Phase A|Met withdrawal criteria|0|||
160881458|NCT00797966|580960580|FG004|Phase A|Met withdrawal criteria|4|||
160881459|NCT00797966|580960581|FG005|Phase A|Met withdrawal criteria|0|||
160881460|NCT00797966|580960576|FG000|Phase A|Physician Decision|0|||
160881461|NCT00797966|580960577|FG001|Phase A|Physician Decision|0|||
160881462|NCT00797966|580960578|FG002|Phase A|Physician Decision|0|||
160881463|NCT00797966|580960579|FG003|Phase A|Physician Decision|0|||
160881464|NCT00797966|580960580|FG004|Phase A|Physician Decision|13|||
160881465|NCT00797966|580960581|FG005|Phase A|Physician Decision|0|||
160881466|NCT00797966|580960576|FG000|Phase A|Withdrawal by Subject|0|||
160881467|NCT00797966|580960577|FG001|Phase A|Withdrawal by Subject|0|||
160881468|NCT00797966|580960578|FG002|Phase A|Withdrawal by Subject|0|||
160881469|NCT00797966|580960579|FG003|Phase A|Withdrawal by Subject|0|||
160881470|NCT00797966|580960580|FG004|Phase A|Withdrawal by Subject|33|||
160881471|NCT00797966|580960581|FG005|Phase A|Withdrawal by Subject|0|||
160881472|NCT00797966|580960576|FG000|Phase A|Protocol deviation|0|||
160881473|NCT00797966|580960577|FG001|Phase A|Protocol deviation|0|||
160881474|NCT00797966|580960578|FG002|Phase A|Protocol deviation|0|||
160881475|NCT00797966|580960579|FG003|Phase A|Protocol deviation|0|||
160881476|NCT00797966|580960580|FG004|Phase A|Protocol deviation|56|||
160881477|NCT00797966|580960581|FG005|Phase A|Protocol deviation|0|||
160881478|NCT00797966|580960576|FG000|Phase B|Lost to Follow-up|0|||
160881479|NCT00797966|580960577|FG001|Phase B|Lost to Follow-up|1|||
160881480|NCT00797966|580960578|FG002|Phase B|Lost to Follow-up|3|||
160881481|NCT00797966|580960579|FG003|Phase B|Lost to Follow-up|0|||
160881482|NCT00797966|580960580|FG004|Phase B|Lost to Follow-up|0|||
160881483|NCT00797966|580960581|FG005|Phase B|Lost to Follow-up|0|||
160881484|NCT00797966|580960576|FG000|Phase B|Adverse Event|2|||
160881485|NCT00797966|580960577|FG001|Phase B|Adverse Event|1|||
160881486|NCT00797966|580960578|FG002|Phase B|Adverse Event|3|||
160881487|NCT00797966|580960579|FG003|Phase B|Adverse Event|1|||
160881488|NCT00797966|580960580|FG004|Phase B|Adverse Event|0|||
160881489|NCT00797966|580960581|FG005|Phase B|Adverse Event|0|||
160881490|NCT00797966|580960576|FG000|Phase B|Met Withdrawal Criteria|3|||
160881491|NCT00797966|580960577|FG001|Phase B|Met Withdrawal Criteria|3|||
160881492|NCT00797966|580960578|FG002|Phase B|Met Withdrawal Criteria|6|||
160881493|NCT00797966|580960579|FG003|Phase B|Met Withdrawal Criteria|1|||
160881494|NCT00797966|580960580|FG004|Phase B|Met Withdrawal Criteria|0|||
160881495|NCT00797966|580960581|FG005|Phase B|Met Withdrawal Criteria|0|||
160881496|NCT00797966|580960576|FG000|Phase B|Physician Decision|1|||
160881497|NCT00797966|580960577|FG001|Phase B|Physician Decision|0|||
160881498|NCT00797966|580960578|FG002|Phase B|Physician Decision|3|||
160881499|NCT00797966|580960579|FG003|Phase B|Physician Decision|1|||
160881500|NCT00797966|580960580|FG004|Phase B|Physician Decision|0|||
160881501|NCT00797966|580960581|FG005|Phase B|Physician Decision|0|||
160881502|NCT00797966|580960576|FG000|Phase B|Withdrawal by Subject|1|||
160881503|NCT00797966|580960577|FG001|Phase B|Withdrawal by Subject|4|||
160881504|NCT00797966|580960578|FG002|Phase B|Withdrawal by Subject|3|||
160881505|NCT00797966|580960579|FG003|Phase B|Withdrawal by Subject|3|||
160881506|NCT00797966|580960580|FG004|Phase B|Withdrawal by Subject|0|||
160881507|NCT00797966|580960581|FG005|Phase B|Withdrawal by Subject|0|||
160881508|NCT00797966|580960576|FG000|Phase B|Protocol Deviation|4|||
160881509|NCT00797966|580960577|FG001|Phase B|Protocol Deviation|8|||
160881510|NCT00797966|580960578|FG002|Phase B|Protocol Deviation|2|||
160881511|NCT00797966|580960579|FG003|Phase B|Protocol Deviation|6|||
160881512|NCT00797966|580960580|FG004|Phase B|Protocol Deviation|0|||
160881513|NCT00797966|580960581|FG005|Phase B|Protocol Deviation|0|||
160881514|NCT00797966|580960576|FG000|Phase B|Lack of Efficacy|0|||
160881515|NCT00797966|580960577|FG001|Phase B|Lack of Efficacy|1|||
160881516|NCT00797966|580960578|FG002|Phase B|Lack of Efficacy|1|||
160881517|NCT00797966|580960579|FG003|Phase B|Lack of Efficacy|4|||
160881518|NCT00797966|580960580|FG004|Phase B|Lack of Efficacy|0|||
160881519|NCT00797966|580960581|FG005|Phase B|Lack of Efficacy|0|||
160881520|NCT00797966|580960576|FG000|Phase A+|Lost to Follow-up|0|||
160881521|NCT00797966|580960577|FG001|Phase A+|Lost to Follow-up|0|||
160881522|NCT00797966|580960578|FG002|Phase A+|Lost to Follow-up|0|||
160881523|NCT00797966|580960579|FG003|Phase A+|Lost to Follow-up|0|||
160881524|NCT00797966|580960580|FG004|Phase A+|Lost to Follow-up|0|||
160881525|NCT00797966|580960581|FG005|Phase A+|Lost to Follow-up|9|||
160881526|NCT00797966|580960576|FG000|Phase A+|Met withdrawal criteria|0|||
160881527|NCT00797966|580960577|FG001|Phase A+|Met withdrawal criteria|0|||
160881528|NCT00797966|580960578|FG002|Phase A+|Met withdrawal criteria|0|||
160881529|NCT00797966|580960579|FG003|Phase A+|Met withdrawal criteria|0|||
160881530|NCT00797966|580960580|FG004|Phase A+|Met withdrawal criteria|0|||
160881531|NCT00797966|580960581|FG005|Phase A+|Met withdrawal criteria|5|||
160881532|NCT00797966|580960576|FG000|Phase A+|Withdrawal by Subject|0|||
160881533|NCT00797966|580960577|FG001|Phase A+|Withdrawal by Subject|0|||
160881534|NCT00797966|580960578|FG002|Phase A+|Withdrawal by Subject|0|||
160881535|NCT00797966|580960579|FG003|Phase A+|Withdrawal by Subject|0|||
160881536|NCT00797966|580960580|FG004|Phase A+|Withdrawal by Subject|0|||
160881537|NCT00797966|580960581|FG005|Phase A+|Withdrawal by Subject|6|||
160881538|NCT00797966|580960576|FG000|Phase A+|Adverse Event|0|||
160881539|NCT00797966|580960577|FG001|Phase A+|Adverse Event|0|||
160881540|NCT00797966|580960578|FG002|Phase A+|Adverse Event|0|||
160881541|NCT00797966|580960579|FG003|Phase A+|Adverse Event|0|||
160881542|NCT00797966|580960580|FG004|Phase A+|Adverse Event|0|||
160881543|NCT00797966|580960581|FG005|Phase A+|Adverse Event|4|||
160636700|NCT01830920|580053577|FG000|Overall Study|Withdrawal by Subject|2|||
160636701|NCT01830920|580053578|FG001|Overall Study|Withdrawal by Subject|2|||
160636702|NCT01830920|580053579|FG002|Overall Study|Withdrawal by Subject|1|||
160636703|NCT01830920|580053580|FG003|Overall Study|Withdrawal by Subject|7|||
160636704|NCT01830920|580053581|FG004|Overall Study|Withdrawal by Subject|1|||
160636705|NCT01830920|580053577|FG000|Overall Study|Death|3|||
160636706|NCT01830920|580053578|FG001|Overall Study|Death|3|||
160636707|NCT01830920|580053579|FG002|Overall Study|Death|5|||
160636708|NCT01830920|580053580|FG003|Overall Study|Death|4|||
160636709|NCT01830920|580053581|FG004|Overall Study|Death|4|||
160636710|NCT01830920|580053577|FG000|Overall Study|Other|15|||
160636711|NCT01830920|580053578|FG001|Overall Study|Other|1|||
160636712|NCT01830920|580053579|FG002|Overall Study|Other|1|||
160636713|NCT01830920|580053580|FG003|Overall Study|Other|5|||
160636714|NCT01830920|580053581|FG004|Overall Study|Other|3|||
160636715|NCT02216214|580053582|FG000|Overall Study|Randomized Never Received Study Drug|1|||
160636716|NCT02216214|580053583|FG001|Overall Study|Randomized Never Received Study Drug|0|||
160636717|NCT02216214|580053582|FG000|Overall Study|Adverse Event|10|||
160636718|NCT02216214|580053583|FG001|Overall Study|Adverse Event|8|||
160636719|NCT02216214|580053582|FG000|Overall Study|Lack of Efficacy|2|||
160636720|NCT02216214|580053583|FG001|Overall Study|Lack of Efficacy|2|||
160636721|NCT02216214|580053582|FG000|Overall Study|Lost to Follow-up|3|||
160636722|NCT02216214|580053583|FG001|Overall Study|Lost to Follow-up|2|||
160636723|NCT02216214|580053582|FG000|Overall Study|Protocol Violation|4|||
160636724|NCT02216214|580053583|FG001|Overall Study|Protocol Violation|2|||
160636725|NCT02216214|580053582|FG000|Overall Study|Withdrawal by Subject|22|||
160636726|NCT02216214|580053583|FG001|Overall Study|Withdrawal by Subject|20|||
160636727|NCT02216214|580053582|FG000|Overall Study|Study Terminated By Sponsor|0|||
160636728|NCT02216214|580053583|FG001|Overall Study|Study Terminated By Sponsor|1|||
160636729|NCT02216214|580053582|FG000|Overall Study|Miscellaneous|1|||
160636730|NCT02216214|580053583|FG001|Overall Study|Miscellaneous|1|||
160636731|NCT05354206|580053584|FG000|Overall Study|Withdrawal by Subject|1|||
160636732|NCT05354206|580053585|FG001|Overall Study|Withdrawal by Subject|0|||
160636733|NCT04936334|580053586|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
160636734|NCT00713830|580053587|FG000|Overall Study|Adverse Event|23|||
160636735|NCT00713830|580053588|FG001|Overall Study|Adverse Event|71|||
160636736|NCT00713830|580053587|FG000|Overall Study|Lack of Efficacy|24|||
160636737|NCT00713830|580053588|FG001|Overall Study|Lack of Efficacy|16|||
160636738|NCT00713830|580053587|FG000|Overall Study|Lost to Follow-up|2|||
160636739|NCT00713830|580053588|FG001|Overall Study|Lost to Follow-up|9|||
160636740|NCT00713830|580053587|FG000|Overall Study|Withdrawal by Subject|13|||
160636741|NCT00713830|580053588|FG001|Overall Study|Withdrawal by Subject|23|||
160636742|NCT00713830|580053587|FG000|Overall Study|Poor Compliance to Protocol|7|||
160636743|NCT00713830|580053588|FG001|Overall Study|Poor Compliance to Protocol|14|||
160636744|NCT00713830|580053587|FG000|Overall Study|Familial and Personal Reasons|9|||
160636745|NCT00713830|580053588|FG001|Overall Study|Familial and Personal Reasons|34|||
160636746|NCT00713830|580053587|FG000|Overall Study|Sponsor Decision|4|||
160636747|NCT00713830|580053588|FG001|Overall Study|Sponsor Decision|10|||
160636748|NCT02787785|580053591|FG000|Overall Study|Death|3|||
160636749|NCT02787785|580053592|FG001|Overall Study|Death|4|||
160636750|NCT02787785|580053591|FG000|Overall Study|Lost to Follow-up|1|||
160636751|NCT02787785|580053592|FG001|Overall Study|Lost to Follow-up|1|||
160636752|NCT02787785|580053591|FG000|Overall Study|Withdrawal by Subject|0|||
160636753|NCT02787785|580053592|FG001|Overall Study|Withdrawal by Subject|5|||
160636754|NCT01440595|580053603|FG000|Overall Study|Lost to Follow-up|0|||
160636755|NCT01440595|580053604|FG001|Overall Study|Lost to Follow-up|1|||
160881544|NCT00797966|580960576|FG000|Phase A+|Protocol deviation|0|||
160881545|NCT00797966|580960577|FG001|Phase A+|Protocol deviation|0|||
160881546|NCT00797966|580960578|FG002|Phase A+|Protocol deviation|0|||
160881547|NCT00797966|580960579|FG003|Phase A+|Protocol deviation|0|||
160770584|NCT00614393|580547412|FG002|Overall Study|Terminated by Sponsor|0|||
160770585|NCT00614393|580547413|FG003|Overall Study|Terminated by Sponsor|0|||
160770586|NCT00614393|580547414|FG004|Overall Study|Terminated by Sponsor|1|||
160770587|NCT00614393|580547410|FG000|Overall Study|Withdrawal by Subject|20|||
160770588|NCT00614393|580547411|FG001|Overall Study|Withdrawal by Subject|1|||
160770589|NCT00614393|580547412|FG002|Overall Study|Withdrawal by Subject|1|||
160770590|NCT00614393|580547413|FG003|Overall Study|Withdrawal by Subject|16|||
160770591|NCT00614393|580547414|FG004|Overall Study|Withdrawal by Subject|13|||
160770592|NCT00614393|580547410|FG000|Overall Study|Other|4|||
160770593|NCT00614393|580547411|FG001|Overall Study|Other|0|||
160770594|NCT00614393|580547412|FG002|Overall Study|Other|0|||
160770595|NCT00614393|580547413|FG003|Overall Study|Other|4|||
160770596|NCT00614393|580547414|FG004|Overall Study|Other|2|||
160770597|NCT00614393|580547410|FG000|Overall Study|Not Treated|0|||
160770598|NCT00614393|580547411|FG001|Overall Study|Not Treated|0|||
160770599|NCT00614393|580547412|FG002|Overall Study|Not Treated|0|||
160770600|NCT00614393|580547413|FG003|Overall Study|Not Treated|0|||
160770601|NCT00614393|580547414|FG004|Overall Study|Not Treated|2|||
160770602|NCT03286504|580547421|FG000|Overall Study|Lost to Follow-up|19|||
160770603|NCT03286504|580547422|FG001|Overall Study|Lost to Follow-up|16|||
160770604|NCT00141921|580547425|FG000|Overall Study|Remain on Study|28|||
160770605|NCT00141921|580547425|FG000|Overall Study|Withdrawal by Subject|42|||
160770606|NCT00141921|580547425|FG000|Overall Study|Lost to Follow-up|19|||
160770607|NCT00141921|580547425|FG000|Overall Study|Noncompliance|17|||
160770608|NCT00141921|580547425|FG000|Overall Study|Disease Progression|7|||
160770609|NCT00141921|580547425|FG000|Overall Study|Protocol Deviation|7|||
160770610|NCT00141921|580547425|FG000|Overall Study|Adverse Event|5|||
160770611|NCT00141921|580547425|FG000|Overall Study|Administrative Decision|2|||
160770612|NCT00141921|580547425|FG000|Overall Study|Pregnancy|4|||
160770613|NCT00141921|580547425|FG000|Overall Study|Ineligibility Determined|2|||
160770614|NCT00141921|580547425|FG000|Overall Study|Other|8|||
160770615|NCT03320369|580547426|FG000|Overall Study|Adverse Event|1|||
160770616|NCT03320369|580547426|FG000|Overall Study|Withdrawal by Subject|2|||
160770617|NCT03813654|580547427|FG000|Overall Study|Protocol Violation|0|||
160770618|NCT03813654|580547428|FG001|Overall Study|Protocol Violation|1|||
160770619|NCT03813654|580547429|FG002|Overall Study|Protocol Violation|2|||
160770620|NCT03813654|580547427|FG000|Overall Study|Withdrawal by Subject|1|||
160770621|NCT03813654|580547428|FG001|Overall Study|Withdrawal by Subject|0|||
160770622|NCT03813654|580547429|FG002|Overall Study|Withdrawal by Subject|0|||
160770623|NCT04727749|580547450|FG000|Overall Study|Lost to Follow-up|10|||
160770624|NCT04727749|580547451|FG001|Overall Study|Lost to Follow-up|3|||
160770625|NCT00297167|580547453|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
160770626|NCT00297167|580547454|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
160770627|NCT00297167|580547455|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
160770628|NCT00297167|580547453|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
160770629|NCT00297167|580547454|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
160770630|NCT00297167|580547455|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
160770631|NCT04167462|580547456|FG000|Overall Study|Other reasons|3|||
160770632|NCT04167462|580547457|FG001|Overall Study|Other reasons|2|||
160770633|NCT04167462|580547456|FG000|Overall Study|Withdrawal by Subject|6|||
160770634|NCT04167462|580547457|FG001|Overall Study|Withdrawal by Subject|7|||
160770635|NCT04167462|580547456|FG000|Overall Study|Adverse Event|4|||
160770636|NCT04167462|580547457|FG001|Overall Study|Adverse Event|0|||
160770637|NCT04167462|580547456|FG000|Overall Study|Pregnancy|1|||
160770638|NCT04167462|580547457|FG001|Overall Study|Pregnancy|0|||
160770639|NCT04167462|580547456|FG000|Overall Study|Lack of Efficacy|0|||
160770640|NCT04167462|580547457|FG001|Overall Study|Lack of Efficacy|1|||
160770641|NCT02320396|580547458|FG000|Overall Study|Adverse Event|2|||
160770642|NCT02320396|580547459|FG001|Overall Study|Adverse Event|2|||
160770643|NCT02320396|580547458|FG000|Overall Study|Pregnancy|0|||
160770644|NCT02320396|580547459|FG001|Overall Study|Pregnancy|1|||
160770645|NCT02320396|580547458|FG000|Overall Study|Protocol Violation|0|||
160770646|NCT02320396|580547459|FG001|Overall Study|Protocol Violation|1|||
160770647|NCT02320396|580547458|FG000|Overall Study|Withdrawal by Subject|2|||
160770648|NCT02320396|580547459|FG001|Overall Study|Withdrawal by Subject|0|||
160770649|NCT00410163|580547460|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
160770650|NCT00410163|580547461|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
160770651|NCT00410163|580547460|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
160770652|NCT00410163|580547461|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
160770653|NCT00410163|580547460|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
160770654|NCT00410163|580547461|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
160770655|NCT00410163|580547460|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
160770656|NCT00410163|580547461|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
160770657|NCT00410163|580547460|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
160770658|NCT00410163|580547461|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
160770659|NCT00410163|580547460|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
160881548|NCT00797966|580960580|FG004|Phase A+|Protocol deviation|0|||
160881549|NCT00797966|580960581|FG005|Phase A+|Protocol deviation|4|||
160881550|NCT01002820|580960585|FG000|Overall Study|Adverse Event|1|||
160881551|NCT01002820|580960585|FG000|Overall Study|Withdrawal by Subject|2|||
160881552|NCT01002820|580960585|FG000|Overall Study|Lack of Efficacy|1|||
160881553|NCT01673347|580960586|FG000|Overall Study|failure of allograft|7|||
160881554|NCT01430754|580960590|FG000|Run-In Phase|Circadian Period Ineligible|24|||
160881555|NCT01430754|580960591|FG001|Run-In Phase|Circadian Period Ineligible|0|||
160881556|NCT01430754|580960590|FG000|Run-In Phase|Protocol Violation|6|||
160881557|NCT01430754|580960591|FG001|Run-In Phase|Protocol Violation|0|||
160881558|NCT01430754|580960590|FG000|Run-In Phase|Adverse Event|2|||
160881559|NCT01430754|580960591|FG001|Run-In Phase|Adverse Event|0|||
160881560|NCT01430754|580960590|FG000|Run-In Phase|Other|2|||
160881561|NCT01430754|580960591|FG001|Run-In Phase|Other|0|||
160881562|NCT01430754|580960590|FG000|Run-In Phase|Withdrawal by Subject|2|||
160881563|NCT01430754|580960591|FG001|Run-In Phase|Withdrawal by Subject|0|||
160881564|NCT01430754|580960590|FG000|Run-In Phase|Lost to Follow-up|1|||
160881565|NCT01430754|580960591|FG001|Run-In Phase|Lost to Follow-up|0|||
160881566|NCT00895011|580960592|FG000|Overall Study|Withdrawal by Subject|14|||
160881567|NCT00895011|580960593|FG001|Overall Study|Withdrawal by Subject|7|||
160881568|NCT00895011|580960594|FG002|Overall Study|Withdrawal by Subject|2|||
160881569|NCT00895011|580960592|FG000|Overall Study|Lost to Follow-up|5|||
160881570|NCT00895011|580960593|FG001|Overall Study|Lost to Follow-up|4|||
160881571|NCT00895011|580960594|FG002|Overall Study|Lost to Follow-up|1|||
160881572|NCT00895011|580960592|FG000|Overall Study|Protocol Violation|3|||
160881573|NCT00895011|580960593|FG001|Overall Study|Protocol Violation|1|||
160881574|NCT00895011|580960594|FG002|Overall Study|Protocol Violation|3|||
160881575|NCT00895011|580960592|FG000|Overall Study|Adverse Event|1|||
160881576|NCT00895011|580960593|FG001|Overall Study|Adverse Event|2|||
160881577|NCT00895011|580960594|FG002|Overall Study|Adverse Event|2|||
160881578|NCT00895011|580960592|FG000|Overall Study|schedule conflict|1|||
160881579|NCT00895011|580960593|FG001|Overall Study|schedule conflict|0|||
160881580|NCT00895011|580960594|FG002|Overall Study|schedule conflict|0|||
160881581|NCT02661178|580960601|FG000|Part 1|Protocol Violation|1|||
160881582|NCT02661178|580960602|FG001|Part 1|Protocol Violation|0|||
160881583|NCT02661178|580960603|FG002|Part 1|Protocol Violation|0|||
160881584|NCT02661178|580960604|FG003|Part 1|Protocol Violation|0|||
160881585|NCT02661178|580960605|FG004|Part 1|Protocol Violation|0|||
160881586|NCT02661178|580960606|FG005|Part 1|Protocol Violation|0|||
160881587|NCT02661178|580960607|FG006|Part 1|Protocol Violation|0|||
160881588|NCT02661178|580960608|FG007|Part 1|Protocol Violation|0|||
160881589|NCT02661178|580960609|FG008|Part 1|Protocol Violation|0|||
160881590|NCT02661178|580960610|FG009|Part 1|Protocol Violation|0|||
160881591|NCT02661178|580960611|FG010|Part 1|Protocol Violation|0|||
160881592|NCT02661178|580960612|FG011|Part 1|Protocol Violation|0|||
160881593|NCT02661178|580960613|FG012|Part 1|Protocol Violation|0|||
160881594|NCT02661178|580960614|FG013|Part 1|Protocol Violation|0|||
160881595|NCT02661178|580960615|FG014|Part 1|Protocol Violation|0|||
160881596|NCT02278471|580960616|FG000|Overall Study|Lost to Follow-up|6|||
160881597|NCT02278471|580960617|FG001|Overall Study|Lost to Follow-up|15|||
160881598|NCT02278471|580960616|FG000|Overall Study|Death|2|||
160881599|NCT02278471|580960617|FG001|Overall Study|Death|2|||
160881600|NCT02278471|580960616|FG000|Overall Study|Withdrawal by Subject|0|||
160881601|NCT02278471|580960617|FG001|Overall Study|Withdrawal by Subject|3|||
160881602|NCT00275821|580960618|FG000|Overall Study|Adverse Event|4|||
160881603|NCT00275821|580960619|FG001|Overall Study|Adverse Event|12|||
160881604|NCT00275821|580960620|FG002|Overall Study|Adverse Event|5|||
160881605|NCT00275821|580960618|FG000|Overall Study|Administrative problems|3|||
160881606|NCT00275821|580960619|FG001|Overall Study|Administrative problems|4|||
160881607|NCT00275821|580960620|FG002|Overall Study|Administrative problems|4|||
160881608|NCT00275821|580960618|FG000|Overall Study|Withdrawal by Subject|0|||
160881609|NCT00275821|580960619|FG001|Overall Study|Withdrawal by Subject|2|||
160881610|NCT00275821|580960620|FG002|Overall Study|Withdrawal by Subject|1|||
160881611|NCT00275821|580960618|FG000|Overall Study|Lost to Follow-up|0|||
160881612|NCT00275821|580960619|FG001|Overall Study|Lost to Follow-up|1|||
160881613|NCT00275821|580960620|FG002|Overall Study|Lost to Follow-up|1|||
160881614|NCT00275821|580960618|FG000|Overall Study|Death|0|||
160881615|NCT00275821|580960619|FG001|Overall Study|Death|2|||
160881616|NCT00275821|580960620|FG002|Overall Study|Death|1|||
160881617|NCT00275821|580960618|FG000|Overall Study|Lack of Efficacy|2|||
160881618|NCT00275821|580960619|FG001|Overall Study|Lack of Efficacy|1|||
160881619|NCT00275821|580960620|FG002|Overall Study|Lack of Efficacy|0|||
160881620|NCT00275821|580960618|FG000|Overall Study|Protocol Violation|5|||
160881621|NCT00275821|580960619|FG001|Overall Study|Protocol Violation|1|||
160881622|NCT00275821|580960620|FG002|Overall Study|Protocol Violation|0|||
160881623|NCT00409175|580960621|FG000|Overall Study|Adverse Event|4|||
160881624|NCT00409175|580960622|FG001|Overall Study|Adverse Event|3|||
160881625|NCT00409175|580960621|FG000|Overall Study|Withdrawal by Subject|1|||
160881626|NCT00409175|580960622|FG001|Overall Study|Withdrawal by Subject|2|||
160881627|NCT00409175|580960621|FG000|Overall Study|Negative genotype|0|||
160881628|NCT00409175|580960622|FG001|Overall Study|Negative genotype|1|||
160881629|NCT00409175|580960621|FG000|Overall Study|Liver transplantation|13|||
160881630|NCT00409175|580960622|FG001|Overall Study|Liver transplantation|13|||
160881631|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
160881632|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
160881633|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
160881634|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
160881635|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
160881636|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
160881637|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
160881638|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
160881639|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
160881640|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
160881641|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
160881642|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
160881643|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
160881644|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
160881645|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
160881646|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
160881647|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
160881648|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
160881649|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
160881650|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
160881651|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
160881652|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
160881653|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
160881654|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
160881655|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
160881656|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160881657|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160881658|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160881659|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160881660|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160881661|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160881662|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
160881663|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
160881664|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
160881665|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
160881666|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160881667|NCT01328444|580960625|FG000|Washout Period (14 Days)|Adverse Event|1|||
160881668|NCT01328444|580960626|FG001|Washout Period (14 Days)|Adverse Event|1|||
160881669|NCT01328444|580960627|FG002|Washout Period (14 Days)|Adverse Event|0|||
160881670|NCT01328444|580960628|FG003|Washout Period (14 Days)|Adverse Event|1|||
160881671|NCT01328444|580960629|FG004|Washout Period (14 Days)|Adverse Event|1|||
160881672|NCT01328444|580960630|FG005|Washout Period (14 Days)|Adverse Event|2|||
160881673|NCT01328444|580960625|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
160881674|NCT01328444|580960626|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
160881675|NCT01328444|580960627|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
160881676|NCT01328444|580960628|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
160881677|NCT01328444|580960629|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
160881678|NCT01328444|580960630|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
160881679|NCT01328444|580960625|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
160881680|NCT01328444|580960626|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
160881681|NCT01328444|580960627|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
160881682|NCT01328444|580960628|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
160881683|NCT01328444|580960629|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
160881684|NCT01328444|580960630|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
160881685|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
160881686|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
160881687|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160881688|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160881689|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160881690|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
160881691|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
160881692|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
160881693|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
160881694|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
160881695|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
160881696|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
160881697|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
160636756|NCT01440595|580053605|FG002|Overall Study|Lost to Follow-up|0|||
160636757|NCT01440595|580053603|FG000|Overall Study|Study terminated by sponsor.|1|||
160636758|NCT01440595|580053604|FG001|Overall Study|Study terminated by sponsor.|2|||
160636759|NCT01440595|580053605|FG002|Overall Study|Study terminated by sponsor.|1|||
160636760|NCT01347879|580053606|FG000|Overall Study|Adverse Event|0|||
160636761|NCT01347879|580053607|FG001|Overall Study|Adverse Event|12|||
160636762|NCT01347879|580053606|FG000|Overall Study|Lost to Follow-up|2|||
160636763|NCT01347879|580053607|FG001|Overall Study|Lost to Follow-up|0|||
160636764|NCT01347879|580053606|FG000|Overall Study|Withdrawal by Subject|3|||
160636765|NCT01347879|580053607|FG001|Overall Study|Withdrawal by Subject|2|||
160636766|NCT01347879|580053606|FG000|Overall Study|Other|2|||
160636767|NCT01347879|580053607|FG001|Overall Study|Other|3|||
160636768|NCT01850108|580053608|FG000|Overall Study|Lost to Follow-up|4|||
160636769|NCT01850108|580053608|FG000|Overall Study|Not eligible|1|||
160636770|NCT01850108|580053608|FG000|Overall Study|Failed engraftment|2|||
160636771|NCT01850108|580053608|FG000|Overall Study|Physician Decision|1|||
160636772|NCT03273712|580053617|FG000|Overall Study|Death|5|||
160636773|NCT03273712|580053617|FG000|Overall Study|Adverse Event|1|||
160636774|NCT03273712|580053617|FG000|Overall Study|Disease Progression|1|||
160636775|NCT03496207|580053618|FG000|Base Study|Adverse Event|0|||
160636776|NCT03496207|580053619|FG001|Base Study|Adverse Event|0|||
160636777|NCT03496207|580053620|FG002|Base Study|Adverse Event|1|||
160636778|NCT03496207|580053621|FG003|Base Study|Adverse Event|1|||
160770660|NCT00410163|580547461|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
160770661|NCT00410163|580547460|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
160770662|NCT00410163|580547461|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
160770663|NCT00410163|580547460|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
160770664|NCT00410163|580547461|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
160770665|NCT00410163|580547460|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
160770666|NCT00410163|580547461|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
160770667|NCT00410163|580547460|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
160770668|NCT00410163|580547461|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
160770669|NCT00410163|580547460|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
160770670|NCT00410163|580547461|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
160770671|NCT00410163|580547460|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
160770672|NCT00410163|580547461|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
160770673|NCT00410163|580547460|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
160770674|NCT00410163|580547461|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
160770675|NCT00410163|580547460|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
160770676|NCT00410163|580547461|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
160770677|NCT01572792|580547464|FG000|Lead-in Study|Lost to Follow-up|5|||
160770678|NCT01572792|580547465|FG001|Lead-in Study|Lost to Follow-up|9|||
160770679|NCT01572792|580547466|FG002|Lead-in Study|Lost to Follow-up|4|||
160770680|NCT01572792|580547467|FG003|Lead-in Study|Lost to Follow-up|2|||
160770681|NCT01572792|580547468|FG004|Lead-in Study|Lost to Follow-up|4|||
160770682|NCT01572792|580547464|FG000|Lead-in Study|Withdrawal by Subject|22|||
160770683|NCT01572792|580547465|FG001|Lead-in Study|Withdrawal by Subject|11|||
160770684|NCT01572792|580547466|FG002|Lead-in Study|Withdrawal by Subject|12|||
160770685|NCT01572792|580547467|FG003|Lead-in Study|Withdrawal by Subject|24|||
160770686|NCT01572792|580547468|FG004|Lead-in Study|Withdrawal by Subject|11|||
160770687|NCT01572792|580547464|FG000|Lead-in Study|Protocol Violation|19|||
160770688|NCT01572792|580547465|FG001|Lead-in Study|Protocol Violation|10|||
160770689|NCT01572792|580547466|FG002|Lead-in Study|Protocol Violation|12|||
160770690|NCT01572792|580547467|FG003|Lead-in Study|Protocol Violation|13|||
160770691|NCT01572792|580547468|FG004|Lead-in Study|Protocol Violation|21|||
160770692|NCT01572792|580547464|FG000|Lead-in Study|Lack of Efficacy|20|||
160770693|NCT01572792|580547465|FG001|Lead-in Study|Lack of Efficacy|5|||
160770694|NCT01572792|580547466|FG002|Lead-in Study|Lack of Efficacy|4|||
160770695|NCT01572792|580547467|FG003|Lead-in Study|Lack of Efficacy|8|||
160770696|NCT01572792|580547468|FG004|Lead-in Study|Lack of Efficacy|10|||
160770697|NCT01572792|580547464|FG000|Lead-in Study|Adverse Event|21|||
160770698|NCT01572792|580547465|FG001|Lead-in Study|Adverse Event|21|||
160770699|NCT01572792|580547466|FG002|Lead-in Study|Adverse Event|22|||
160770700|NCT01572792|580547467|FG003|Lead-in Study|Adverse Event|16|||
160770701|NCT01572792|580547468|FG004|Lead-in Study|Adverse Event|14|||
160770702|NCT01572792|580547464|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
160770703|NCT01572792|580547465|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
160770704|NCT01572792|580547466|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
160770705|NCT01572792|580547467|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
160770706|NCT01572792|580547468|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
160770707|NCT01572792|580547464|FG000|Extension Study|Lost to Follow-up|6|||
160636779|NCT03496207|580053622|FG004|Base Study|Adverse Event|4|||
160636780|NCT03496207|580053618|FG000|Base Study|Death|0|||
160636781|NCT03496207|580053619|FG001|Base Study|Death|0|||
160881698|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
160881699|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
160881700|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
160881701|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
160881702|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
160881703|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
160881704|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
160881705|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
160881706|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
160881707|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
160881708|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
160881709|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
160881710|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
160881711|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
160881712|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
160881713|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
160881714|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
160881715|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160881716|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160881717|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160881718|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160881719|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160881720|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160881721|NCT03241368|580960635|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
160881722|NCT03241368|580960635|FG000|Overall Study|Lost to Follow-up|1|||
160881723|NCT03241368|580960635|FG000|Overall Study|Physician Decision|6|||
160881724|NCT03241368|580960635|FG000|Overall Study|Withdrawal by Subject|6|||
160881725|NCT03241368|580960635|FG000|Overall Study|Protocol Violation|1|||
160881726|NCT03316911|580960636|FG000|Overall Study|Lost to Follow-up|33|||
160881727|NCT03316911|580960637|FG001|Overall Study|Lost to Follow-up|29|||
160881728|NCT01119937|580960638|FG000|Overall Study|Adverse Event|11|||
160881729|NCT01119937|580960639|FG001|Overall Study|Adverse Event|5|||
160881730|NCT01119937|580960638|FG000|Overall Study|Protocol deviation|3|||
160881731|NCT01119937|580960639|FG001|Overall Study|Protocol deviation|1|||
160881732|NCT01119937|580960638|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
160881733|NCT01119937|580960639|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160881734|NCT01119937|580960638|FG000|Overall Study|Withdrawal by Subject|2|||
160881735|NCT01119937|580960639|FG001|Overall Study|Withdrawal by Subject|1|||
160881736|NCT01270802|580960640|FG000|Overall Study|Withdrawal by Subject|1|||
160881737|NCT01270802|580960641|FG001|Overall Study|Withdrawal by Subject|0|||
160881738|NCT01270802|580960640|FG000|Overall Study|Adverse Event|1|||
160881739|NCT01270802|580960641|FG001|Overall Study|Adverse Event|0|||
160881740|NCT01270802|580960640|FG000|Overall Study|Lost to Follow-up|0|||
160881741|NCT01270802|580960641|FG001|Overall Study|Lost to Follow-up|1|||
160539412|NCT00820950|579704189|FG008|Overall Study|Scheduling Conflict|0|||
160881742|NCT01566214|580960642|FG000|Overall Study|Lost to Follow-up|3|||
160881743|NCT01566214|580960643|FG001|Overall Study|Lost to Follow-up|0|||
160881744|NCT04620798|580960646|FG000|Overall Study|Lost to Follow-up|126|||
160881745|NCT04620798|580960647|FG001|Overall Study|Lost to Follow-up|138|||
160881746|NCT03222492|580960653|FG000|Overall Study|Withdrawal by Subject|0|||
160881747|NCT03222492|580960654|FG001|Overall Study|Withdrawal by Subject|0|||
160881748|NCT03222492|580960655|FG002|Overall Study|Withdrawal by Subject|1|||
160881749|NCT03222492|580960656|FG003|Overall Study|Withdrawal by Subject|0|||
160881750|NCT03222492|580960653|FG000|Overall Study|COVID-19 related|0|||
160881751|NCT03222492|580960654|FG001|Overall Study|COVID-19 related|0|||
160881752|NCT03222492|580960655|FG002|Overall Study|COVID-19 related|1|||
160881753|NCT03222492|580960656|FG003|Overall Study|COVID-19 related|0|||
160881754|NCT01375075|580960663|FG000|Overall Study|Adverse Event|0|||
160881755|NCT01375075|580960664|FG001|Overall Study|Adverse Event|0|||
160881756|NCT01375075|580960665|FG002|Overall Study|Adverse Event|3|||
160539413|NCT00820950|579704190|FG009|Overall Study|Scheduling Conflict|0|||
160539414|NCT00820950|579704181|FG000|Overall Study|Protocol Violation|1|||
160539415|NCT00820950|579704182|FG001|Overall Study|Protocol Violation|1|||
160539416|NCT00820950|579704183|FG002|Overall Study|Protocol Violation|0|||
160539417|NCT00820950|579704184|FG003|Overall Study|Protocol Violation|0|||
160539418|NCT00820950|579704185|FG004|Overall Study|Protocol Violation|0|||
160881757|NCT01375075|580960666|FG003|Overall Study|Adverse Event|1|||
160881758|NCT01375075|580960667|FG004|Overall Study|Adverse Event|0|||
160881759|NCT01375075|580960668|FG005|Overall Study|Adverse Event|1|||
160881760|NCT01375075|580960663|FG000|Overall Study|Entry Criterion Not Met|1|||
160881761|NCT01375075|580960664|FG001|Overall Study|Entry Criterion Not Met|0|||
160881762|NCT01375075|580960665|FG002|Overall Study|Entry Criterion Not Met|0|||
160881763|NCT01375075|580960666|FG003|Overall Study|Entry Criterion Not Met|0|||
160881764|NCT01375075|580960667|FG004|Overall Study|Entry Criterion Not Met|0|||
160881765|NCT01375075|580960668|FG005|Overall Study|Entry Criterion Not Met|1|||
160881766|NCT01375075|580960663|FG000|Overall Study|Withdrawal by Subject|0|||
160881767|NCT01375075|580960664|FG001|Overall Study|Withdrawal by Subject|1|||
160881768|NCT01375075|580960665|FG002|Overall Study|Withdrawal by Subject|0|||
160881769|NCT01375075|580960666|FG003|Overall Study|Withdrawal by Subject|0|||
160881770|NCT01375075|580960667|FG004|Overall Study|Withdrawal by Subject|0|||
160770708|NCT01572792|580547465|FG001|Extension Study|Lost to Follow-up|2|||
160770709|NCT01572792|580547466|FG002|Extension Study|Lost to Follow-up|0|||
160770710|NCT01572792|580547467|FG003|Extension Study|Lost to Follow-up|3|||
160770711|NCT01572792|580547468|FG004|Extension Study|Lost to Follow-up|3|||
160770712|NCT01572792|580547464|FG000|Extension Study|Withdrawal by Subject|7|||
160881771|NCT01375075|580960668|FG005|Overall Study|Withdrawal by Subject|1|||
160881772|NCT00384111|580960669|FG000|Overall Study|Disease Progression|3|||
160881773|NCT00384111|580960669|FG000|Overall Study|Adverse Event|1|||
160881774|NCT00384111|580960669|FG000|Overall Study|Investigator Decision|3|||
160881775|NCT00384111|580960669|FG000|Overall Study|Study Terminated by the Sponsor|19|||
160881776|NCT00821509|580960670|FG000|Overall Study|Withdrawal by Subject|12|||
160881777|NCT00821509|580960671|FG001|Overall Study|Withdrawal by Subject|11|||
160881778|NCT00821509|580960672|FG002|Overall Study|Withdrawal by Subject|34|||
160881779|NCT01551420|580960673|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
160881780|NCT01551420|580960674|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
160881781|NCT01551420|580960673|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
160881782|NCT01551420|580960674|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
160881783|NCT01551420|580960673|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
160881784|NCT01551420|580960674|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
160881785|NCT01551420|580960673|FG000|Screened for Part B Eligibility|Declined participation|8|||
160881786|NCT01551420|580960674|FG001|Screened for Part B Eligibility|Declined participation|1|||
160881787|NCT01551420|580960673|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
160881788|NCT01551420|580960674|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
160881789|NCT01551420|580960673|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
160881790|NCT01551420|580960674|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
160881791|NCT01551420|580960673|FG000|Home Use (Part B)|Withdrawal by staff|0|||
160881792|NCT01551420|580960674|FG001|Home Use (Part B)|Withdrawal by staff|1|||
160881793|NCT03612856|580960675|FG000|Pre-dose Period|Physician Decision|0|||
160881794|NCT03612856|580960676|FG001|Pre-dose Period|Physician Decision|1|||
160881795|NCT03612856|580960677|FG002|Pre-dose Period|Physician Decision|1|||
160881796|NCT03612856|580960675|FG000|Pre-dose Period|Withdrawal by Subject|0|||
160881797|NCT03612856|580960676|FG001|Pre-dose Period|Withdrawal by Subject|1|||
160770713|NCT01572792|580547465|FG001|Extension Study|Withdrawal by Subject|6|||
160770714|NCT01572792|580547466|FG002|Extension Study|Withdrawal by Subject|11|||
160770715|NCT01572792|580547467|FG003|Extension Study|Withdrawal by Subject|8|||
160770716|NCT01572792|580547468|FG004|Extension Study|Withdrawal by Subject|14|||
160770717|NCT01572792|580547464|FG000|Extension Study|Protocol Violation|0|||
160770718|NCT01572792|580547465|FG001|Extension Study|Protocol Violation|4|||
160770719|NCT01572792|580547466|FG002|Extension Study|Protocol Violation|3|||
160770720|NCT01572792|580547467|FG003|Extension Study|Protocol Violation|4|||
160770721|NCT01572792|580547468|FG004|Extension Study|Protocol Violation|3|||
160770722|NCT01572792|580547464|FG000|Extension Study|Lack of Efficacy|2|||
160770723|NCT01572792|580547465|FG001|Extension Study|Lack of Efficacy|3|||
160770724|NCT01572792|580547466|FG002|Extension Study|Lack of Efficacy|3|||
160770725|NCT01572792|580547467|FG003|Extension Study|Lack of Efficacy|2|||
160770726|NCT01572792|580547468|FG004|Extension Study|Lack of Efficacy|2|||
160770727|NCT01572792|580547464|FG000|Extension Study|Adverse Event|7|||
160770728|NCT01572792|580547465|FG001|Extension Study|Adverse Event|6|||
160770729|NCT01572792|580547466|FG002|Extension Study|Adverse Event|5|||
160881798|NCT03612856|580960677|FG002|Pre-dose Period|Withdrawal by Subject|0|||
160539419|NCT00820950|579704186|FG005|Overall Study|Protocol Violation|0|||
160539420|NCT00820950|579704187|FG006|Overall Study|Protocol Violation|0|||
160539421|NCT00820950|579704188|FG007|Overall Study|Protocol Violation|0|||
160539422|NCT00820950|579704189|FG008|Overall Study|Protocol Violation|0|||
160539423|NCT00820950|579704190|FG009|Overall Study|Protocol Violation|0|||
160539424|NCT00122681|579705767|FG000|Overall Study|Adverse Event|20|||
160539425|NCT00122681|579705768|FG001|Overall Study|Adverse Event|16|||
160539426|NCT00122681|579705767|FG000|Overall Study|Lost to Follow-up|1080|||
160539427|NCT00122681|579705768|FG001|Overall Study|Lost to Follow-up|1097|||
160539428|NCT00122681|579705767|FG000|Overall Study|Protocol Violation|7|||
160539429|NCT00122681|579705768|FG001|Overall Study|Protocol Violation|10|||
160539430|NCT00122681|579705767|FG000|Overall Study|Withdrawal by Subject|257|||
160539431|NCT00122681|579705768|FG001|Overall Study|Withdrawal by Subject|251|||
160539432|NCT00122681|579705767|FG000|Overall Study|Personal reasons|150|||
160539433|NCT00122681|579705768|FG001|Overall Study|Personal reasons|147|||
160539434|NCT02037295|579705769|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
160539435|NCT02037295|579705770|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
160539436|NCT02037295|579705771|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
160539437|NCT02037295|579705772|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
160539438|NCT02770547|579705775|FG000|Overall Study|Patient non-compliant|1|||
160539439|NCT02770547|579705776|FG001|Overall Study|Patient non-compliant|0|||
160539440|NCT02770547|579705775|FG000|Overall Study|Adverse Event|0|||
160539441|NCT02770547|579705776|FG001|Overall Study|Adverse Event|1|||
160539442|NCT01324232|579705777|FG000|Overall Study|Protocol Violation|0|||
160539443|NCT01324232|579705778|FG001|Overall Study|Protocol Violation|0|||
160539444|NCT01324232|579705779|FG002|Overall Study|Protocol Violation|0|||
160539445|NCT01324232|579705780|FG003|Overall Study|Protocol Violation|2|||
160539446|NCT01324232|579705777|FG000|Overall Study|Missing|0|||
160539447|NCT01324232|579705778|FG001|Overall Study|Missing|0|||
160539448|NCT01324232|579705779|FG002|Overall Study|Missing|1|||
160539449|NCT01324232|579705780|FG003|Overall Study|Missing|0|||
160539450|NCT01324232|579705777|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
160539451|NCT01324232|579705778|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
160539452|NCT01324232|579705779|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
160539453|NCT01324232|579705780|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
160539454|NCT01324232|579705777|FG000|Overall Study|Lack of Efficacy|2|||
160539455|NCT01324232|579705778|FG001|Overall Study|Lack of Efficacy|1|||
160539456|NCT01324232|579705779|FG002|Overall Study|Lack of Efficacy|2|||
160539457|NCT01324232|579705780|FG003|Overall Study|Lack of Efficacy|2|||
160539458|NCT01324232|579705777|FG000|Overall Study|Participant Refused Medication|0|||
160539459|NCT01324232|579705778|FG001|Overall Study|Participant Refused Medication|1|||
160539460|NCT01324232|579705779|FG002|Overall Study|Participant Refused Medication|0|||
160539461|NCT01324232|579705780|FG003|Overall Study|Participant Refused Medication|0|||
160539462|NCT01324232|579705777|FG000|Overall Study|Intercurrent illness|0|||
160539463|NCT01324232|579705778|FG001|Overall Study|Intercurrent illness|0|||
160539464|NCT01324232|579705779|FG002|Overall Study|Intercurrent illness|0|||
160539465|NCT01324232|579705780|FG003|Overall Study|Intercurrent illness|1|||
160539466|NCT01324232|579705777|FG000|Overall Study|Adverse Event|2|||
160539467|NCT01324232|579705778|FG001|Overall Study|Adverse Event|5|||
160539468|NCT01324232|579705779|FG002|Overall Study|Adverse Event|6|||
160539469|NCT01324232|579705780|FG003|Overall Study|Adverse Event|6|||
160539470|NCT01324232|579705777|FG000|Overall Study|Withdrawal by Subject|0|||
160539471|NCT01324232|579705778|FG001|Overall Study|Withdrawal by Subject|3|||
160539472|NCT01324232|579705779|FG002|Overall Study|Withdrawal by Subject|4|||
160539473|NCT01324232|579705780|FG003|Overall Study|Withdrawal by Subject|0|||
160539474|NCT01324232|579705777|FG000|Overall Study|Lost to Follow-up|1|||
160539475|NCT01324232|579705778|FG001|Overall Study|Lost to Follow-up|0|||
160539476|NCT01324232|579705779|FG002|Overall Study|Lost to Follow-up|0|||
160539477|NCT01324232|579705780|FG003|Overall Study|Lost to Follow-up|0|||
160539478|NCT00661531|579705781|FG000|Overall Study|Withdrawal by Subject|3|||
160539479|NCT03134599|579705783|FG000|Week 1|Lost to Follow-up|0|||
160539480|NCT03134599|579705784|FG001|Week 1|Lost to Follow-up|0|||
160539481|NCT03134599|579705785|FG002|Week 1|Lost to Follow-up|0|||
160539482|NCT03134599|579705786|FG003|Week 1|Lost to Follow-up|0|||
160539483|NCT03134599|579705787|FG004|Week 1|Lost to Follow-up|1|||
160539484|NCT03134599|579705788|FG005|Week 1|Lost to Follow-up|0|||
160539485|NCT03134599|579705783|FG000|Week 2|Lost to Follow-up|1|||
160539486|NCT03134599|579705784|FG001|Week 2|Lost to Follow-up|0|||
160539487|NCT03134599|579705785|FG002|Week 2|Lost to Follow-up|0|||
160539488|NCT03134599|579705786|FG003|Week 2|Lost to Follow-up|1|||
160539489|NCT03134599|579705787|FG004|Week 2|Lost to Follow-up|1|||
160539490|NCT03134599|579705788|FG005|Week 2|Lost to Follow-up|0|||
160539491|NCT03134599|579705783|FG000|Week 3|Lost to Follow-up|0|||
160539492|NCT03134599|579705784|FG001|Week 3|Lost to Follow-up|0|||
160539493|NCT03134599|579705785|FG002|Week 3|Lost to Follow-up|0|||
160539494|NCT03134599|579705786|FG003|Week 3|Lost to Follow-up|1|||
160539495|NCT03134599|579705787|FG004|Week 3|Lost to Follow-up|0|||
160539496|NCT03134599|579705788|FG005|Week 3|Lost to Follow-up|1|||
160539497|NCT00393887|579705789|FG000|Overall Study|Physician Decision|5|||
160539498|NCT00393887|579705790|FG001|Overall Study|Physician Decision|0|||
160539499|NCT00393887|579705789|FG000|Overall Study|Lost to Follow-up|11|||
160539500|NCT00393887|579705790|FG001|Overall Study|Lost to Follow-up|9|||
160539501|NCT01265615|579705791|FG000|Overall Study|Protocol Violation|2|||
160539502|NCT01265615|579705792|FG001|Overall Study|Protocol Violation|2|||
160539503|NCT01265615|579705793|FG002|Overall Study|Protocol Violation|4|||
160539504|NCT01265615|579705794|FG003|Overall Study|Protocol Violation|3|||
160539505|NCT01732796|579705795|FG000|Overall Study|Adverse Event|16|||
160539506|NCT01732796|579705796|FG001|Overall Study|Adverse Event|16|||
160539507|NCT01732796|579705797|FG002|Overall Study|Adverse Event|4|||
160539508|NCT01732796|579705795|FG000|Overall Study|Lack of Efficacy|21|||
160539509|NCT01732796|579705796|FG001|Overall Study|Lack of Efficacy|18|||
160539510|NCT01732796|579705797|FG002|Overall Study|Lack of Efficacy|5|||
160539511|NCT01732796|579705795|FG000|Overall Study|Lost to Follow-up|2|||
160539512|NCT01732796|579705796|FG001|Overall Study|Lost to Follow-up|0|||
160539513|NCT01732796|579705797|FG002|Overall Study|Lost to Follow-up|0|||
160539514|NCT01732796|579705795|FG000|Overall Study|Withdrawal by Subject|6|||
160539515|NCT01732796|579705796|FG001|Overall Study|Withdrawal by Subject|8|||
160539516|NCT01732796|579705797|FG002|Overall Study|Withdrawal by Subject|2|||
160539517|NCT01732796|579705795|FG000|Overall Study|Other reason not defined above|1|||
160539518|NCT01732796|579705796|FG001|Overall Study|Other reason not defined above|0|||
160539519|NCT01732796|579705797|FG002|Overall Study|Other reason not defined above|2|||
160539520|NCT00876187|579705799|FG000|Overall Study|Adverse Event|14|||
160539521|NCT00876187|579705800|FG001|Overall Study|Adverse Event|12|||
160539522|NCT00876187|579705801|FG002|Overall Study|Adverse Event|19|||
160539523|NCT00876187|579705802|FG003|Overall Study|Adverse Event|29|||
160539524|NCT00876187|579705803|FG004|Overall Study|Adverse Event|10|||
160539525|NCT00876187|579705799|FG000|Overall Study|Lack of Efficacy|59|||
160539526|NCT00876187|579705800|FG001|Overall Study|Lack of Efficacy|34|||
160539527|NCT00876187|579705801|FG002|Overall Study|Lack of Efficacy|45|||
160539528|NCT00876187|579705802|FG003|Overall Study|Lack of Efficacy|34|||
160539529|NCT00876187|579705803|FG004|Overall Study|Lack of Efficacy|59|||
160539530|NCT00876187|579705799|FG000|Overall Study|Lost to Follow-up|9|||
160539531|NCT00876187|579705800|FG001|Overall Study|Lost to Follow-up|10|||
160539532|NCT00876187|579705801|FG002|Overall Study|Lost to Follow-up|8|||
160539533|NCT00876187|579705802|FG003|Overall Study|Lost to Follow-up|8|||
160539534|NCT00876187|579705803|FG004|Overall Study|Lost to Follow-up|11|||
160539535|NCT00876187|579705799|FG000|Overall Study|Protocol Violation|6|||
160539536|NCT00876187|579705800|FG001|Overall Study|Protocol Violation|7|||
160539537|NCT00876187|579705801|FG002|Overall Study|Protocol Violation|7|||
160539538|NCT00876187|579705802|FG003|Overall Study|Protocol Violation|6|||
160539539|NCT00876187|579705803|FG004|Overall Study|Protocol Violation|3|||
160539540|NCT00876187|579705799|FG000|Overall Study|Withdrawal by Subject|16|||
160539541|NCT00876187|579705800|FG001|Overall Study|Withdrawal by Subject|26|||
160539542|NCT00876187|579705801|FG002|Overall Study|Withdrawal by Subject|32|||
160539543|NCT00876187|579705802|FG003|Overall Study|Withdrawal by Subject|38|||
160539544|NCT00876187|579705803|FG004|Overall Study|Withdrawal by Subject|37|||
160539545|NCT00876187|579705799|FG000|Overall Study|Entered extension study|101|||
160539546|NCT00876187|579705800|FG001|Overall Study|Entered extension study|120|||
160539547|NCT00876187|579705801|FG002|Overall Study|Entered extension study|156|||
160539548|NCT00876187|579705802|FG003|Overall Study|Entered extension study|151|||
160539549|NCT00876187|579705803|FG004|Overall Study|Entered extension study|144|||
160539550|NCT00876187|579705799|FG000|Overall Study|Randomized but not treated|3|||
160539551|NCT00876187|579705800|FG001|Overall Study|Randomized but not treated|1|||
160539552|NCT00876187|579705801|FG002|Overall Study|Randomized but not treated|3|||
160539553|NCT00876187|579705802|FG003|Overall Study|Randomized but not treated|2|||
160539554|NCT00876187|579705803|FG004|Overall Study|Randomized but not treated|3|||
160539555|NCT00876187|579705799|FG000|Overall Study|Other|2|||
160539556|NCT00876187|579705800|FG001|Overall Study|Other|5|||
160539557|NCT00876187|579705801|FG002|Overall Study|Other|9|||
160539558|NCT00876187|579705802|FG003|Overall Study|Other|7|||
160539559|NCT00876187|579705803|FG004|Overall Study|Other|4|||
160539560|NCT00838331|579705804|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
160539561|NCT01379274|579705805|FG000|Overall Study|funding withdrawn|1|||
160539562|NCT03287219|579705809|FG000|Overall Study|Protocol Violation|0|||
160539563|NCT03287219|579705810|FG001|Overall Study|Protocol Violation|2|||
160539564|NCT00957008|579705811|FG000|Overall Study|Withdrawal by Subject|13|||
160539565|NCT00957008|579705812|FG001|Overall Study|Withdrawal by Subject|10|||
160539566|NCT00957008|579705813|FG002|Overall Study|Withdrawal by Subject|12|||
160539567|NCT00957008|579705814|FG003|Overall Study|Withdrawal by Subject|16|||
160539568|NCT00957008|579705811|FG000|Overall Study|Lost to Follow-up|3|||
160539569|NCT00957008|579705812|FG001|Overall Study|Lost to Follow-up|1|||
160539570|NCT00957008|579705813|FG002|Overall Study|Lost to Follow-up|3|||
160539571|NCT00957008|579705814|FG003|Overall Study|Lost to Follow-up|4|||
160539572|NCT00957008|579705811|FG000|Overall Study|Physician Decision|1|||
160539573|NCT00957008|579705812|FG001|Overall Study|Physician Decision|0|||
160539574|NCT00957008|579705813|FG002|Overall Study|Physician Decision|1|||
160539575|NCT00957008|579705814|FG003|Overall Study|Physician Decision|1|||
160539576|NCT00957008|579705811|FG000|Overall Study|Relocated; Family conflict|4|||
160539577|NCT00957008|579705812|FG001|Overall Study|Relocated; Family conflict|1|||
160539578|NCT00957008|579705813|FG002|Overall Study|Relocated; Family conflict|1|||
160539579|NCT00957008|579705814|FG003|Overall Study|Relocated; Family conflict|3|||
160539580|NCT02614859|579705821|FG000|Overall Study|Physician Decision|0|||
160539581|NCT02614859|579705822|FG001|Overall Study|Physician Decision|1|||
160539582|NCT03571646|579705825|FG000|Overall Study|Adverse Event|1|||
160539583|NCT03571646|579705826|FG001|Overall Study|Adverse Event|0|||
160539584|NCT03571646|579705825|FG000|Overall Study|Withdrawal by Subject|1|||
160539585|NCT03571646|579705826|FG001|Overall Study|Withdrawal by Subject|1|||
160539586|NCT03972969|579705827|FG000|3-month Follow-up|Death|1|||
160539587|NCT03972969|579705828|FG001|3-month Follow-up|Death|1|||
160539588|NCT03972969|579705829|FG002|3-month Follow-up|Death|0|||
160539589|NCT03972969|579705827|FG000|6-month Follow-up|Death|1|||
160539590|NCT03972969|579705828|FG001|6-month Follow-up|Death|1|||
160539591|NCT03972969|579705829|FG002|6-month Follow-up|Death|1|||
160539592|NCT03972969|579705827|FG000|6-month Follow-up|Lost to Follow-up|2|||
160539593|NCT03972969|579705828|FG001|6-month Follow-up|Lost to Follow-up|2|||
160539594|NCT03972969|579705829|FG002|6-month Follow-up|Lost to Follow-up|2|||
160539595|NCT04677959|579705830|FG000|Overall Study|Adverse Event|1|||
160539596|NCT04677959|579705831|FG001|Overall Study|Adverse Event|9|||
160539597|NCT04677959|579705830|FG000|Overall Study|Withdrawal by Subject|2|||
160539598|NCT04677959|579705831|FG001|Overall Study|Withdrawal by Subject|15|||
160539599|NCT04677959|579705830|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160539600|NCT04677959|579705831|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160539601|NCT04677959|579705830|FG000|Overall Study|Non-compliance with study drug|0|||
160539602|NCT04677959|579705831|FG001|Overall Study|Non-compliance with study drug|2|||
160539603|NCT04677959|579705830|FG000|Overall Study|Protocol deviation|0|||
160539604|NCT04677959|579705831|FG001|Overall Study|Protocol deviation|11|||
160539605|NCT04677959|579705830|FG000|Overall Study|Lost to Follow-up|9|||
160539606|NCT04677959|579705831|FG001|Overall Study|Lost to Follow-up|13|||
160539607|NCT04677959|579705830|FG000|Overall Study|Other than specified|0|||
160539608|NCT04677959|579705831|FG001|Overall Study|Other than specified|8|||
160539609|NCT00732303|579705832|FG000|Overall Study|Study Terminated|2|||
160539610|NCT00283595|579705833|FG000|Overall Study|Withdrawal by Subject|1|||
160539611|NCT00283595|579705834|FG001|Overall Study|Withdrawal by Subject|2|||
160539612|NCT04718974|579705838|FG000|Overall Study|Death|0|||
160539613|NCT04718974|579705839|FG001|Overall Study|Death|2|||
160539614|NCT04718974|579705838|FG000|Overall Study|Lost to Follow-up|10|||
160539615|NCT04718974|579705839|FG001|Overall Study|Lost to Follow-up|20|||
160539616|NCT04718974|579705838|FG000|Overall Study|Transferred out|2|||
160539617|NCT04718974|579705839|FG001|Overall Study|Transferred out|4|||
160539618|NCT00705783|579705840|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
160539619|NCT00705783|579705841|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
160539620|NCT00705783|579705842|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
160539621|NCT00705783|579705840|FG000|Conversion Phase|Lost to Follow-up|13|||
160539622|NCT00705783|579705841|FG001|Conversion Phase|Lost to Follow-up|0|||
160539623|NCT00705783|579705842|FG002|Conversion Phase|Lost to Follow-up|0|||
160539624|NCT00705783|579705840|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
160539625|NCT00705783|579705841|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
160539626|NCT00705783|579705842|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
160539627|NCT00705783|579705840|FG000|Conversion Phase|Withdrawn by Investigator|4|||
160539628|NCT00705783|579705841|FG001|Conversion Phase|Withdrawn by Investigator|0|||
160539629|NCT00705783|579705842|FG002|Conversion Phase|Withdrawn by Investigator|0|||
160539630|NCT00705783|579705840|FG000|Conversion Phase|Withdrew Consent|24|||
160539631|NCT00705783|579705841|FG001|Conversion Phase|Withdrew Consent|0|||
160539632|NCT00705783|579705842|FG002|Conversion Phase|Withdrew Consent|0|||
160539633|NCT00705783|579705840|FG000|Conversion Phase|Protocol Deviation|2|||
160539634|NCT00705783|579705841|FG001|Conversion Phase|Protocol Deviation|0|||
160539635|NCT00705783|579705842|FG002|Conversion Phase|Protocol Deviation|0|||
160539636|NCT00705783|579705840|FG000|Conversion Phase|Adverse Event|11|||
160539637|NCT00705783|579705841|FG001|Conversion Phase|Adverse Event|0|||
160539638|NCT00705783|579705842|FG002|Conversion Phase|Adverse Event|0|||
160539639|NCT00705783|579705840|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
160539640|NCT00705783|579705841|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
160636782|NCT03496207|580053620|FG002|Base Study|Death|0|||
160539641|NCT00705783|579705842|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
160539642|NCT00705783|579705840|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
160539643|NCT00705783|579705841|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
160539644|NCT00705783|579705842|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
160539645|NCT00705783|579705840|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
160539646|NCT00705783|579705841|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
160539647|NCT00705783|579705842|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
160539648|NCT00705783|579705840|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
160539649|NCT00705783|579705841|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
160539650|NCT00705783|579705842|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
160539651|NCT00705783|579705840|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
160539652|NCT00705783|579705841|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
160539653|NCT00705783|579705842|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
160539654|NCT00705783|579705840|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
160539655|NCT00705783|579705841|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
160539656|NCT00705783|579705842|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
160539657|NCT00705783|579705840|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
160539658|NCT00705783|579705841|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
160539659|NCT00705783|579705842|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
160539660|NCT00705783|579705840|FG000|Oral Stabilization Phase|Adverse Event|14|||
160539661|NCT00705783|579705841|FG001|Oral Stabilization Phase|Adverse Event|0|||
160539662|NCT00705783|579705842|FG002|Oral Stabilization Phase|Adverse Event|0|||
160539663|NCT00705783|579705840|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
160539664|NCT00705783|579705841|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
160539665|NCT00705783|579705842|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
160539666|NCT00705783|579705840|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
160881799|NCT01576159|580960678|FG000|Overall Study|Withdrawal by Subject|0|||
160881800|NCT01576159|580960679|FG001|Overall Study|Withdrawal by Subject|1|||
160881801|NCT01576159|580960680|FG002|Overall Study|Withdrawal by Subject|0|||
160539667|NCT00705783|579705841|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
160539668|NCT00705783|579705842|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
160539669|NCT00705783|579705840|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
160539670|NCT00705783|579705841|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
160539671|NCT00705783|579705842|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
160539672|NCT00705783|579705840|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
160539673|NCT00705783|579705841|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
160539674|NCT00705783|579705842|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
160539675|NCT00705783|579705840|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
160539676|NCT00705783|579705841|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
160539677|NCT00705783|579705842|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
160539678|NCT00705783|579705840|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
160539679|NCT00705783|579705841|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
160539680|NCT00705783|579705842|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
160539681|NCT00705783|579705840|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
160539682|NCT00705783|579705841|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
160539683|NCT00705783|579705842|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
160539684|NCT00705783|579705840|FG000|Depot Stabilization Phase|Adverse Event|17|||
160539685|NCT00705783|579705841|FG001|Depot Stabilization Phase|Adverse Event|0|||
160539686|NCT00705783|579705842|FG002|Depot Stabilization Phase|Adverse Event|0|||
160539687|NCT00705783|579705840|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
160539688|NCT00705783|579705841|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
160539689|NCT00705783|579705842|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
160539690|NCT00705783|579705840|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
160539691|NCT00705783|579705841|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
160539692|NCT00705783|579705842|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
160539693|NCT00705783|579705840|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
160539694|NCT00705783|579705841|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
160539695|NCT00705783|579705842|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
160539696|NCT00705783|579705840|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
160539697|NCT00705783|579705841|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
160539698|NCT00705783|579705842|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
160539699|NCT00705783|579705840|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
160539700|NCT00705783|579705841|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
160881802|NCT01576159|580960681|FG003|Overall Study|Withdrawal by Subject|0|||
160881803|NCT01576159|580960678|FG000|Overall Study|Physician Decision|0|||
160881804|NCT01576159|580960679|FG001|Overall Study|Physician Decision|0|||
160539701|NCT00705783|579705842|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
160881805|NCT01576159|580960680|FG002|Overall Study|Physician Decision|1|||
160881806|NCT01576159|580960681|FG003|Overall Study|Physician Decision|0|||
160539702|NCT00705783|579705840|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
160539703|NCT00705783|579705841|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
160539704|NCT00705783|579705842|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
160539705|NCT00705783|579705840|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
160539706|NCT00705783|579705841|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
160539707|NCT00705783|579705842|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
160539708|NCT00705783|579705840|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
160539709|NCT00705783|579705841|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
160539710|NCT00705783|579705842|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
160539711|NCT00705783|579705840|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
160539712|NCT00705783|579705841|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
160539713|NCT00705783|579705842|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
160539714|NCT00705783|579705840|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
160539715|NCT00705783|579705841|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
160539716|NCT00705783|579705842|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
160539717|NCT00705783|579705840|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
160539718|NCT00705783|579705841|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
160539719|NCT00705783|579705842|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
160539720|NCT02182687|579705843|FG000|Overall Study|Withdrawal by Subject|4|||
160539721|NCT02182687|579705844|FG001|Overall Study|Withdrawal by Subject|0|||
160539722|NCT02182687|579705843|FG000|Overall Study|Adverse Event|1|||
160539723|NCT02182687|579705844|FG001|Overall Study|Adverse Event|0|||
160539724|NCT02182687|579705843|FG000|Overall Study|Lost to Follow-up|0|||
160539725|NCT02182687|579705844|FG001|Overall Study|Lost to Follow-up|1|||
160539726|NCT01765920|579705854|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
160539727|NCT01765920|579705855|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
160539728|NCT01765920|579705854|FG000|Overall Study|Patient code disclosure|0|||
160539729|NCT01765920|579705855|FG001|Overall Study|Patient code disclosure|1|||
160539730|NCT02025907|579705856|FG000|Overall Study|Lack of Efficacy|1|||
160539731|NCT02025907|579705857|FG001|Overall Study|Lack of Efficacy|0|||
160539732|NCT02025907|579705856|FG000|Overall Study|Withdrawal by Subject|15|||
160539733|NCT02025907|579705857|FG001|Overall Study|Withdrawal by Subject|8|||
160539734|NCT02025907|579705856|FG000|Overall Study|Protocol Violation|2|||
160539735|NCT02025907|579705857|FG001|Overall Study|Protocol Violation|0|||
160539736|NCT02025907|579705856|FG000|Overall Study|Physician Decision|2|||
160539737|NCT02025907|579705857|FG001|Overall Study|Physician Decision|0|||
160539738|NCT02025907|579705856|FG000|Overall Study|Lost to Follow-up|2|||
160539739|NCT02025907|579705857|FG001|Overall Study|Lost to Follow-up|2|||
160539740|NCT02025907|579705856|FG000|Overall Study|Adverse Event|3|||
160539741|NCT02025907|579705857|FG001|Overall Study|Adverse Event|1|||
160539742|NCT02025907|579705856|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
160539743|NCT02025907|579705857|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
160539744|NCT02411539|579705861|FG000|Overall Study|Lost to Follow-up|2|||
160539745|NCT02411539|579705862|FG001|Overall Study|Lost to Follow-up|0|||
160539746|NCT02411539|579705861|FG000|Overall Study|Confounding medical condition|0|||
160539747|NCT02411539|579705862|FG001|Overall Study|Confounding medical condition|1|||
160539748|NCT01265797|579705865|FG000|Run-in Month|Withdrawal by Subject|0|||
160539749|NCT01265797|579705866|FG001|Run-in Month|Withdrawal by Subject|4|||
160539750|NCT01265797|579705865|FG000|Run-in Month|1st seizure during run-in month|0|||
160539751|NCT01265797|579705866|FG001|Run-in Month|1st seizure during run-in month|1|||
160539752|NCT01265797|579705865|FG000|Blinded Month|Lack of Efficacy|5|||
160539753|NCT01265797|579705866|FG001|Blinded Month|Lack of Efficacy|0|||
160539754|NCT01265797|579705865|FG000|Blinded Month|Lost to Follow-up|1|||
160539755|NCT01265797|579705866|FG001|Blinded Month|Lost to Follow-up|0|||
160539756|NCT01265797|579705865|FG000|Blinded Month|Protocol Violation|2|||
160539757|NCT01265797|579705866|FG001|Blinded Month|Protocol Violation|1|||
160539758|NCT01265797|579705865|FG000|Blinded Month|Adverse Event|2|||
160539759|NCT01265797|579705866|FG001|Blinded Month|Adverse Event|0|||
160539760|NCT01265797|579705865|FG000|Blinded Month|Diary data incomplete|0|||
160539761|NCT01265797|579705866|FG001|Blinded Month|Diary data incomplete|1|||
160539762|NCT01265797|579705865|FG000|Open Label Month|Lost to Follow-up|0|||
160539763|NCT01265797|579705866|FG001|Open Label Month|Lost to Follow-up|1|||
160539764|NCT01422915|579705867|FG000|Overall Study|Adverse Event|1|||
160539765|NCT00939783|579705868|FG000|Overall Study|Death|6|||
160539766|NCT00939783|579705868|FG000|Overall Study|Adverse Event|39|||
160539767|NCT00939783|579705868|FG000|Overall Study|Study Terminated by Sponsor|498|||
160539768|NCT00939783|579705868|FG000|Overall Study|Withdrawal by Subject|78|||
160539769|NCT00939783|579705868|FG000|Overall Study|Other|16|||
160539770|NCT00939783|579705868|FG000|Overall Study|Lost to Follow-up|8|||
160539771|NCT00939783|579705868|FG000|Overall Study|Protocol Violation|3|||
160539772|NCT00939783|579705868|FG000|Overall Study|Enrolled but not treated|1|||
160539773|NCT03631732|579705879|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
160539774|NCT03631732|579705880|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
160539775|NCT03631732|579705879|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
160539776|NCT03631732|579705880|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
160539777|NCT03631732|579705879|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
160539778|NCT03631732|579705880|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
160539779|NCT03631732|579705879|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
160539780|NCT03631732|579705880|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
160539781|NCT03631732|579705879|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
160539782|NCT03631732|579705880|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
160539783|NCT03631732|579705879|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
160539784|NCT03631732|579705880|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
160539785|NCT03631732|579705879|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
160539786|NCT03631732|579705880|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
160539787|NCT03631732|579705879|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
160539788|NCT03631732|579705880|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
160539789|NCT03631732|579705879|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
160539790|NCT03631732|579705880|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
160539791|NCT03631732|579705879|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
160539792|NCT03631732|579705880|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
160539793|NCT01439204|579705881|FG000|Overall Study|Withdrawal by Subject|0|||
160539794|NCT01439204|579705882|FG001|Overall Study|Withdrawal by Subject|1|||
160539795|NCT01439204|579705881|FG000|Overall Study|Lost to Follow-up|0|||
160539796|NCT01439204|579705882|FG001|Overall Study|Lost to Follow-up|2|||
160539797|NCT01439204|579705881|FG000|Overall Study|No longer meets study criteria|1|||
160539798|NCT01439204|579705882|FG001|Overall Study|No longer meets study criteria|0|||
160539799|NCT01439204|579705881|FG000|Overall Study|poor/non-compliance|3|||
160539800|NCT01439204|579705882|FG001|Overall Study|poor/non-compliance|0|||
160539801|NCT01251367|579705883|FG000|Overall Study|Protocol Violation|1|||
160539802|NCT01251367|579705883|FG000|Overall Study|Lack of Efficacy|2|||
160539803|NCT01251367|579705883|FG000|Overall Study|Adverse Event|19|||
160539804|NCT01251367|579705883|FG000|Overall Study|Withdrawal by Subject|36|||
160539805|NCT01251367|579705883|FG000|Overall Study|Lost to Follow-up|5|||
160539806|NCT01251367|579705883|FG000|Overall Study|Subject Required Alternative Treatment|7|||
160539807|NCT01251367|579705883|FG000|Overall Study|No Study Drug Available|1|||
160539808|NCT01251367|579705883|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
160539809|NCT01251367|579705883|FG000|Overall Study|End of Study Visit Performed in Error|1|||
160539810|NCT02255409|579705884|FG000|Overall Study|Administrative Reason|3|||
160539811|NCT02255409|579705885|FG001|Overall Study|Administrative Reason|7|||
160539812|NCT02255409|579705884|FG000|Overall Study|Withdrawal by Subject|1|||
160539813|NCT02255409|579705885|FG001|Overall Study|Withdrawal by Subject|5|||
160539814|NCT02255409|579705884|FG000|Overall Study|Lost to Follow-up|10|||
160539815|NCT02255409|579705885|FG001|Overall Study|Lost to Follow-up|19|||
160539816|NCT02370615|579705889|FG000|Overall Study|Adverse Event|1|||
160539817|NCT02370615|579705890|FG001|Overall Study|Adverse Event|0|||
160539818|NCT00455013|579705891|FG000|Short Term Period|Adverse Event|2|||
160539819|NCT00455013|579705892|FG001|Short Term Period|Adverse Event|5|||
160539820|NCT00455013|579705893|FG002|Short Term Period|Adverse Event|0|||
160539821|NCT00455013|579705891|FG000|Short Term Period|Withdrawal by Subject|0|||
160539822|NCT00455013|579705892|FG001|Short Term Period|Withdrawal by Subject|0|||
160539823|NCT00455013|579705893|FG002|Short Term Period|Withdrawal by Subject|1|||
160539824|NCT00455013|579705891|FG000|Short Term Period|Lack of Efficacy|4|||
160539825|NCT00455013|579705892|FG001|Short Term Period|Lack of Efficacy|0|||
160539826|NCT00455013|579705893|FG002|Short Term Period|Lack of Efficacy|0|||
160539827|NCT00455013|579705891|FG000|Short Term Period|Other|0|||
160539828|NCT00455013|579705892|FG001|Short Term Period|Other|0|||
160539829|NCT00455013|579705893|FG002|Short Term Period|Other|1|||
160539830|NCT00455013|579705891|FG000|Long Term Extension (LTE)|Adverse Event|0|||
160539831|NCT00455013|579705892|FG001|Long Term Extension (LTE)|Adverse Event|1|||
160539832|NCT00455013|579705893|FG002|Long Term Extension (LTE)|Adverse Event|1|||
160539833|NCT00455013|579705891|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
160539834|NCT00455013|579705892|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
160539835|NCT00455013|579705893|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
160539836|NCT00455013|579705891|FG000|Long Term Extension (LTE)|Death|1|||
160539837|NCT00455013|579705892|FG001|Long Term Extension (LTE)|Death|1|||
160539838|NCT00455013|579705893|FG002|Long Term Extension (LTE)|Death|0|||
160539839|NCT00455013|579705891|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
160539840|NCT00455013|579705892|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
160539841|NCT00455013|579705893|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
160539842|NCT00455013|579705891|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
160539843|NCT00455013|579705892|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
160539844|NCT00455013|579705893|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
160881807|NCT01576159|580960678|FG000|Overall Study|Lost to Follow-up|0|||
160539845|NCT00455013|579705891|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
160539846|NCT00455013|579705892|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
160881808|NCT01576159|580960679|FG001|Overall Study|Lost to Follow-up|0|||
160539847|NCT00455013|579705893|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
160539848|NCT00455013|579705891|FG000|Long Term Extension (LTE)|non-specified|0|||
160539849|NCT00455013|579705892|FG001|Long Term Extension (LTE)|non-specified|0|||
160539850|NCT00455013|579705893|FG002|Long Term Extension (LTE)|non-specified|1|||
160539851|NCT00078325|579705894|FG000|Overall Study|Adverse Event|15|||
160539852|NCT00078325|579705895|FG001|Overall Study|Adverse Event|10|||
160539853|NCT00078325|579705896|FG002|Overall Study|Adverse Event|5|||
160539854|NCT00078325|579705894|FG000|Overall Study|Protocol Violation|2|||
160539855|NCT00078325|579705895|FG001|Overall Study|Protocol Violation|2|||
160539856|NCT00078325|579705896|FG002|Overall Study|Protocol Violation|0|||
160539857|NCT00078325|579705894|FG000|Overall Study|Withdrawal by Subject|1|||
160539858|NCT00078325|579705895|FG001|Overall Study|Withdrawal by Subject|5|||
160539859|NCT00078325|579705896|FG002|Overall Study|Withdrawal by Subject|3|||
160539860|NCT00078325|579705894|FG000|Overall Study|Lost to Follow-up|0|||
160539861|NCT00078325|579705895|FG001|Overall Study|Lost to Follow-up|1|||
160539862|NCT00078325|579705896|FG002|Overall Study|Lost to Follow-up|1|||
160539863|NCT00078325|579705894|FG000|Overall Study|Physician Decision|2|||
160539864|NCT00078325|579705895|FG001|Overall Study|Physician Decision|0|||
160539865|NCT00078325|579705896|FG002|Overall Study|Physician Decision|1|||
160539866|NCT00078325|579705894|FG000|Overall Study|Miscellaneous|1|||
160539867|NCT00078325|579705895|FG001|Overall Study|Miscellaneous|1|||
160539868|NCT00078325|579705896|FG002|Overall Study|Miscellaneous|1|||
160539869|NCT05003622|579705898|FG000|Overall Study|Progressive disease|2|||
160539870|NCT05003622|579705898|FG000|Overall Study|Withdrawal by Subject|1|||
160539871|NCT01624662|579705900|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
160539872|NCT01624662|579705901|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
160539873|NCT01624662|579705902|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
160539874|NCT01624662|579705903|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
160539875|NCT01624662|579705900|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
160539876|NCT01624662|579705901|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
160539877|NCT01624662|579705902|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
160539878|NCT01624662|579705903|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
160539879|NCT01624662|579705900|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
160539880|NCT01624662|579705901|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
160539881|NCT01624662|579705902|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
160539882|NCT01624662|579705903|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
160539883|NCT01624662|579705900|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
160539884|NCT01624662|579705901|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
160539885|NCT01624662|579705902|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
160539886|NCT01624662|579705903|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
160539887|NCT01624662|579705900|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
160539888|NCT01624662|579705901|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
160539889|NCT01624662|579705902|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
160539890|NCT01624662|579705903|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
160539891|NCT01624662|579705900|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
160539892|NCT01624662|579705901|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
160539893|NCT01624662|579705902|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
160539894|NCT01624662|579705903|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
160539895|NCT01624662|579705900|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
160539896|NCT01624662|579705901|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
160539897|NCT01624662|579705902|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
160539898|NCT01624662|579705903|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
160539899|NCT01423851|579705907|FG000|Whole Study|Disease progression|2|||
160539900|NCT01423851|579705908|FG001|Whole Study|Disease progression|1|||
160539901|NCT01423851|579705909|FG002|Whole Study|Disease progression|1|||
160539902|NCT01423851|579705910|FG003|Whole Study|Disease progression|4|||
160539903|NCT01423851|579705911|FG004|Whole Study|Disease progression|1|||
160539904|NCT01423851|579705912|FG005|Whole Study|Disease progression|3|||
160539905|NCT01423851|579705913|FG006|Whole Study|Disease progression|1|||
160539906|NCT01423851|579705914|FG007|Whole Study|Disease progression|4|||
160539907|NCT01423851|579705915|FG008|Whole Study|Disease progression|0|||
160539908|NCT01423851|579705916|FG009|Whole Study|Disease progression|2|||
160539909|NCT01423851|579705917|FG010|Whole Study|Disease progression|10|||
160539910|NCT01423851|579705907|FG000|Whole Study|Physician Decision|0|||
160539911|NCT01423851|579705908|FG001|Whole Study|Physician Decision|1|||
160539912|NCT01423851|579705909|FG002|Whole Study|Physician Decision|2|||
160539913|NCT01423851|579705910|FG003|Whole Study|Physician Decision|0|||
160539914|NCT01423851|579705911|FG004|Whole Study|Physician Decision|2|||
160539915|NCT01423851|579705912|FG005|Whole Study|Physician Decision|0|||
160539916|NCT01423851|579705913|FG006|Whole Study|Physician Decision|2|||
160539917|NCT01423851|579705914|FG007|Whole Study|Physician Decision|1|||
160539918|NCT01423851|579705915|FG008|Whole Study|Physician Decision|3|||
160539919|NCT01423851|579705916|FG009|Whole Study|Physician Decision|4|||
160770730|NCT01572792|580547467|FG003|Extension Study|Adverse Event|6|||
160770731|NCT01572792|580547468|FG004|Extension Study|Adverse Event|4|||
160770732|NCT01572792|580547464|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
160770733|NCT01572792|580547465|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
160770734|NCT01572792|580547466|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
160770735|NCT01572792|580547467|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
160770736|NCT01572792|580547468|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
160770737|NCT03692949|580547474|FG000|Overall Study|Lost to Follow-up|0|||
160770738|NCT03692949|580547475|FG001|Overall Study|Lost to Follow-up|0|||
160770739|NCT03692949|580547476|FG002|Overall Study|Lost to Follow-up|0|||
160770740|NCT03692949|580547477|FG003|Overall Study|Lost to Follow-up|0|||
160770741|NCT03692949|580547478|FG004|Overall Study|Lost to Follow-up|0|||
160770742|NCT03692949|580547479|FG005|Overall Study|Lost to Follow-up|0|||
160770743|NCT03692949|580547480|FG006|Overall Study|Lost to Follow-up|0|||
160770744|NCT03692949|580547481|FG007|Overall Study|Lost to Follow-up|1|||
160770745|NCT02783690|580547485|FG000|Overall Study|Withdrawal by Subject|3|||
160770746|NCT02783690|580547486|FG001|Overall Study|Withdrawal by Subject|3|||
160770747|NCT00671788|580547487|FG000|Overall Study|Adverse Event|8|||
160770748|NCT00671788|580547487|FG000|Overall Study|Refused further treatment|3|||
160770749|NCT00671788|580547487|FG000|Overall Study|Ineligible|1|||
160539920|NCT01423851|579705917|FG010|Whole Study|Physician Decision|12|||
160539921|NCT01423851|579705907|FG000|Whole Study|Withdrawal by Subject|1|||
160539922|NCT01423851|579705908|FG001|Whole Study|Withdrawal by Subject|1|||
160539923|NCT01423851|579705909|FG002|Whole Study|Withdrawal by Subject|0|||
160539924|NCT01423851|579705910|FG003|Whole Study|Withdrawal by Subject|0|||
160539925|NCT01423851|579705911|FG004|Whole Study|Withdrawal by Subject|0|||
160539926|NCT01423851|579705912|FG005|Whole Study|Withdrawal by Subject|0|||
160539927|NCT01423851|579705913|FG006|Whole Study|Withdrawal by Subject|0|||
160539928|NCT01423851|579705914|FG007|Whole Study|Withdrawal by Subject|0|||
160539929|NCT01423851|579705915|FG008|Whole Study|Withdrawal by Subject|2|||
160539930|NCT01423851|579705916|FG009|Whole Study|Withdrawal by Subject|0|||
160539931|NCT01423851|579705917|FG010|Whole Study|Withdrawal by Subject|4|||
160539932|NCT01423851|579705907|FG000|Whole Study|Adverse Event|0|||
160539933|NCT01423851|579705908|FG001|Whole Study|Adverse Event|0|||
160539934|NCT01423851|579705909|FG002|Whole Study|Adverse Event|0|||
160539935|NCT01423851|579705910|FG003|Whole Study|Adverse Event|2|||
160539936|NCT01423851|579705911|FG004|Whole Study|Adverse Event|0|||
160539937|NCT01423851|579705912|FG005|Whole Study|Adverse Event|0|||
160539938|NCT01423851|579705913|FG006|Whole Study|Adverse Event|0|||
160539939|NCT01423851|579705914|FG007|Whole Study|Adverse Event|3|||
160539940|NCT01423851|579705915|FG008|Whole Study|Adverse Event|3|||
160539941|NCT01423851|579705916|FG009|Whole Study|Adverse Event|2|||
160539942|NCT01423851|579705917|FG010|Whole Study|Adverse Event|3|||
160539943|NCT05885737|579705921|FG000|DB Period|Adverse Event|4|||
160539944|NCT05885737|579705922|FG001|DB Period|Adverse Event|4|||
160539945|NCT05885737|579705921|FG000|DB Period|Lost to Follow-up|0|||
160539946|NCT05885737|579705922|FG001|DB Period|Lost to Follow-up|1|||
160539947|NCT05885737|579705921|FG000|DB Period|Physician Decision|2|||
160539948|NCT05885737|579705922|FG001|DB Period|Physician Decision|0|||
160539949|NCT05885737|579705921|FG000|DB Period|Withdrawal by Subject|12|||
160539950|NCT05885737|579705922|FG001|DB Period|Withdrawal by Subject|6|||
160539951|NCT05885737|579705921|FG000|DB Period|Other: Unspecified|2|||
160539952|NCT05885737|579705922|FG001|DB Period|Other: Unspecified|2|||
160539953|NCT05885737|579705921|FG000|OLE Period|Adverse Event|3|||
160539954|NCT05885737|579705922|FG001|OLE Period|Adverse Event|2|||
160539955|NCT05885737|579705921|FG000|OLE Period|Physician Decision|1|||
160539956|NCT05885737|579705922|FG001|OLE Period|Physician Decision|0|||
160539957|NCT05885737|579705921|FG000|OLE Period|Withdrawal by Subject|5|||
160539958|NCT05885737|579705922|FG001|OLE Period|Withdrawal by Subject|5|||
160539959|NCT05885737|579705921|FG000|OLE Period|Other: Unspecified|2|||
160770750|NCT00671788|580547487|FG000|Overall Study|MD Decision|1|||
160770751|NCT00671788|580547487|FG000|Overall Study|Other|1|||
160539960|NCT05885737|579705922|FG001|OLE Period|Other: Unspecified|1|||
160539961|NCT00789529|579707463|FG000|Overall Study|Withdrawal by Subject|0|||
160539962|NCT00789529|579707464|FG001|Overall Study|Withdrawal by Subject|1|||
160539963|NCT00789529|579707463|FG000|Overall Study|Other Reason|1|||
160539964|NCT00789529|579707464|FG001|Overall Study|Other Reason|0|||
160539965|NCT01870401|579707465|FG000|Overall Study|Death|48|||
160539966|NCT01870401|579707466|FG001|Overall Study|Death|24|||
160539967|NCT01870401|579707465|FG000|Overall Study|Withdrawal by Subject|39|||
160539968|NCT01870401|579707466|FG001|Overall Study|Withdrawal by Subject|26|||
160539969|NCT01870401|579707465|FG000|Overall Study|Lost to Follow-up|19|||
160539970|NCT01870401|579707466|FG001|Overall Study|Lost to Follow-up|14|||
160539971|NCT01870401|579707465|FG000|Overall Study|Other|9|||
160539972|NCT01870401|579707466|FG001|Overall Study|Other|7|||
160539973|NCT01870401|579707465|FG000|Overall Study|On-going in the Study|35|||
160539974|NCT01870401|579707466|FG001|Overall Study|On-going in the Study|25|||
160539975|NCT01135498|579707467|FG000|Overall Study|Adverse Event|20|||
160539976|NCT01135498|579707467|FG000|Overall Study|Progressive disease|38|||
160770752|NCT04739800|580547488|FG000|Overall Study|Adverse Event|2|||
160770753|NCT04739800|580547489|FG001|Overall Study|Adverse Event|1|||
160539977|NCT01135498|579707467|FG000|Overall Study|Investigator judgement|25|||
160539978|NCT01135498|579707467|FG000|Overall Study|Withdrawal by Subject|4|||
160539979|NCT01135498|579707467|FG000|Overall Study|Death|1|||
160539980|NCT01135498|579707467|FG000|Overall Study|Ongoing at time of analysis|2|||
160539981|NCT01192022|579707468|FG000|Overall Study|Withdrawal of Consent|3|||
160539982|NCT01192022|579707469|FG001|Overall Study|Withdrawal of Consent|1|||
160539983|NCT01192022|579707470|FG002|Overall Study|Withdrawal of Consent|0|||
160539984|NCT01192022|579707471|FG003|Overall Study|Withdrawal of Consent|0|||
160539985|NCT01192022|579707472|FG004|Overall Study|Withdrawal of Consent|0|||
160539986|NCT01192022|579707468|FG000|Overall Study|Lost to Follow-up|4|||
160539987|NCT01192022|579707469|FG001|Overall Study|Lost to Follow-up|2|||
160539988|NCT01192022|579707470|FG002|Overall Study|Lost to Follow-up|1|||
160539989|NCT01192022|579707471|FG003|Overall Study|Lost to Follow-up|1|||
160539990|NCT01192022|579707472|FG004|Overall Study|Lost to Follow-up|0|||
160539991|NCT01192022|579707468|FG000|Overall Study|Adverse Event|1|||
160539992|NCT01192022|579707469|FG001|Overall Study|Adverse Event|0|||
160539993|NCT01192022|579707470|FG002|Overall Study|Adverse Event|0|||
160539994|NCT01192022|579707471|FG003|Overall Study|Adverse Event|0|||
160539995|NCT01192022|579707472|FG004|Overall Study|Adverse Event|0|||
160539996|NCT01192022|579707468|FG000|Overall Study|Fatal Adverse Event|4|||
160539997|NCT01192022|579707469|FG001|Overall Study|Fatal Adverse Event|6|||
160539998|NCT01192022|579707470|FG002|Overall Study|Fatal Adverse Event|0|||
160539999|NCT01192022|579707471|FG003|Overall Study|Fatal Adverse Event|0|||
160540000|NCT01192022|579707472|FG004|Overall Study|Fatal Adverse Event|1|||
160540001|NCT01192022|579707468|FG000|Overall Study|Physician withdrew-patient hardship|1|||
160540002|NCT01192022|579707469|FG001|Overall Study|Physician withdrew-patient hardship|0|||
160540003|NCT01192022|579707470|FG002|Overall Study|Physician withdrew-patient hardship|0|||
160540004|NCT01192022|579707471|FG003|Overall Study|Physician withdrew-patient hardship|0|||
160540005|NCT01192022|579707472|FG004|Overall Study|Physician withdrew-patient hardship|0|||
160540006|NCT01192022|579707468|FG000|Overall Study|Patient too sick from chemotherapy|0|||
160540007|NCT01192022|579707469|FG001|Overall Study|Patient too sick from chemotherapy|1|||
160540008|NCT01192022|579707470|FG002|Overall Study|Patient too sick from chemotherapy|0|||
160540009|NCT01192022|579707471|FG003|Overall Study|Patient too sick from chemotherapy|0|||
160540010|NCT01192022|579707472|FG004|Overall Study|Patient too sick from chemotherapy|0|||
160540011|NCT01192022|579707468|FG000|Overall Study|Patient needed surgery|0|||
160540012|NCT01192022|579707469|FG001|Overall Study|Patient needed surgery|1|||
160540013|NCT01192022|579707470|FG002|Overall Study|Patient needed surgery|0|||
160540014|NCT01192022|579707471|FG003|Overall Study|Patient needed surgery|0|||
160540015|NCT01192022|579707472|FG004|Overall Study|Patient needed surgery|0|||
160540016|NCT01192022|579707468|FG000|Overall Study|Parents did not allow all follow up|0|||
160540017|NCT01192022|579707469|FG001|Overall Study|Parents did not allow all follow up|0|||
160540018|NCT01192022|579707470|FG002|Overall Study|Parents did not allow all follow up|0|||
160540019|NCT01192022|579707471|FG003|Overall Study|Parents did not allow all follow up|1|||
160540020|NCT01192022|579707472|FG004|Overall Study|Parents did not allow all follow up|0|||
160540021|NCT04839978|579707473|FG000|Overall Study|Lost to Follow-up|135|||
160540022|NCT04839978|579707474|FG001|Overall Study|Lost to Follow-up|147|||
160540023|NCT03551509|579707475|FG000|Overall Study|Lost to Follow-up|0|||
160540024|NCT03551509|579707476|FG001|Overall Study|Lost to Follow-up|1|||
160540025|NCT03551509|579707477|FG002|Overall Study|Lost to Follow-up|0|||
160540026|NCT03776175|579707478|FG000|Treatment Period (42 Days)|Adverse Event|0|||
160540027|NCT03776175|579707479|FG001|Treatment Period (42 Days)|Adverse Event|1|||
160540028|NCT03776175|579707480|FG002|Treatment Period (42 Days)|Adverse Event|1|||
160540029|NCT03776175|579707481|FG003|Treatment Period (42 Days)|Adverse Event|0|||
160540030|NCT03776175|579707478|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
160540031|NCT03776175|579707479|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
160540032|NCT03776175|579707480|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
160540033|NCT03776175|579707481|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
160540034|NCT03776175|579707478|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
160540035|NCT03776175|579707479|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
160540036|NCT03776175|579707480|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
160540037|NCT03776175|579707481|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
160636783|NCT03496207|580053621|FG003|Base Study|Death|0|||
160636784|NCT03496207|580053622|FG004|Base Study|Death|1|||
160636785|NCT03496207|580053618|FG000|Base Study|Withdrawal by Subject|0|||
160636786|NCT03496207|580053619|FG001|Base Study|Withdrawal by Subject|0|||
160636787|NCT03496207|580053620|FG002|Base Study|Withdrawal by Subject|1|||
160881809|NCT01576159|580960680|FG002|Overall Study|Lost to Follow-up|0|||
160881810|NCT01576159|580960681|FG003|Overall Study|Lost to Follow-up|1|||
160540038|NCT03776175|579707478|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
160540039|NCT03776175|579707479|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
160540040|NCT03776175|579707480|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
160540041|NCT03776175|579707481|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
160540042|NCT03776175|579707478|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
160636788|NCT03496207|580053621|FG003|Base Study|Withdrawal by Subject|0|||
160636789|NCT03496207|580053622|FG004|Base Study|Withdrawal by Subject|1|||
160540043|NCT03776175|579707479|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
160540044|NCT03776175|579707480|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
160540045|NCT03776175|579707481|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
160540046|NCT03776175|579707478|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
160540047|NCT03776175|579707479|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
160540048|NCT03776175|579707480|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
160540049|NCT03776175|579707481|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
160540050|NCT00783094|579707485|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
160540051|NCT00783094|579707486|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
160540052|NCT00783094|579707487|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
160540053|NCT00783094|579707485|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
160540054|NCT00783094|579707486|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
160540055|NCT00783094|579707487|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
160540056|NCT00783094|579707485|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
160540057|NCT00783094|579707486|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
160540058|NCT00783094|579707487|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
160540059|NCT00783094|579707485|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
160540060|NCT00783094|579707486|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
160540061|NCT00783094|579707487|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
160540062|NCT00783094|579707485|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
160540063|NCT00783094|579707486|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
160540064|NCT00783094|579707487|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
160540065|NCT00783094|579707485|FG000|Open-Label Extension Period|Adverse Event|12|||
160540066|NCT00783094|579707486|FG001|Open-Label Extension Period|Adverse Event|7|||
160540067|NCT00783094|579707487|FG002|Open-Label Extension Period|Adverse Event|16|||
160540068|NCT00783094|579707485|FG000|Open-Label Extension Period|Death|0|||
160540069|NCT00783094|579707486|FG001|Open-Label Extension Period|Death|0|||
160540070|NCT00783094|579707487|FG002|Open-Label Extension Period|Death|1|||
160540071|NCT00783094|579707485|FG000|Open-Label Extension Period|Protocol Violation|4|||
160540072|NCT00783094|579707486|FG001|Open-Label Extension Period|Protocol Violation|5|||
160540073|NCT00783094|579707487|FG002|Open-Label Extension Period|Protocol Violation|7|||
160540074|NCT00783094|579707485|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
160540075|NCT00783094|579707486|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
160540076|NCT00783094|579707487|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
160540077|NCT00783094|579707485|FG000|Open-Label Extension Period|Physician Decision|4|||
160540078|NCT00783094|579707486|FG001|Open-Label Extension Period|Physician Decision|2|||
160540079|NCT00783094|579707487|FG002|Open-Label Extension Period|Physician Decision|3|||
160540080|NCT00783094|579707485|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
160540081|NCT00783094|579707486|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
160540082|NCT00783094|579707487|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
160540083|NCT02513329|579707488|FG000|Overall Study|Lost to Follow-up|5|||
160540084|NCT02513329|579707489|FG001|Overall Study|Lost to Follow-up|2|||
160540085|NCT05440539|579707490|FG000|Overall Study|Lost to Follow-up|4|||
160540086|NCT05440539|579707491|FG001|Overall Study|Lost to Follow-up|4|||
160540087|NCT05440539|579707490|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
160540088|NCT05440539|579707491|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
160540089|NCT03808077|579707492|FG000|Overall Study|Physician Decision|2|||
160540090|NCT03808077|579707493|FG001|Overall Study|Physician Decision|3|||
160540091|NCT03808077|579707492|FG000|Overall Study|Withdrawal by Subject|1|||
160540092|NCT03808077|579707493|FG001|Overall Study|Withdrawal by Subject|0|||
160540093|NCT03808077|579707492|FG000|Overall Study|Equipment Issues|2|||
160540094|NCT03808077|579707493|FG001|Overall Study|Equipment Issues|1|||
160540095|NCT02004262|579707496|FG000|Overall Study|Death|67|||
160540096|NCT02004262|579707497|FG001|Overall Study|Death|64|||
160540097|NCT02004262|579707498|FG002|Overall Study|Death|66|||
160540098|NCT02004262|579707499|FG003|Overall Study|Death|28|||
160540099|NCT02004262|579707500|FG004|Overall Study|Death|29|||
160540100|NCT02004262|579707501|FG005|Overall Study|Death|22|||
160540101|NCT02004262|579707496|FG000|Overall Study|Withdrawal by Subject|1|||
160540102|NCT02004262|579707497|FG001|Overall Study|Withdrawal by Subject|0|||
160540103|NCT02004262|579707498|FG002|Overall Study|Withdrawal by Subject|4|||
160540104|NCT02004262|579707499|FG003|Overall Study|Withdrawal by Subject|0|||
160540105|NCT02004262|579707500|FG004|Overall Study|Withdrawal by Subject|1|||
160540106|NCT02004262|579707501|FG005|Overall Study|Withdrawal by Subject|3|||
160540107|NCT02004262|579707496|FG000|Overall Study|Lost to Follow-up|1|||
160540108|NCT02004262|579707497|FG001|Overall Study|Lost to Follow-up|1|||
160540109|NCT02004262|579707498|FG002|Overall Study|Lost to Follow-up|0|||
160540110|NCT02004262|579707499|FG003|Overall Study|Lost to Follow-up|0|||
160540111|NCT02004262|579707500|FG004|Overall Study|Lost to Follow-up|0|||
160540112|NCT02004262|579707501|FG005|Overall Study|Lost to Follow-up|0|||
160540113|NCT02004262|579707496|FG000|Overall Study|Study Terminated by Sponsor|4|||
160540114|NCT02004262|579707497|FG001|Overall Study|Study Terminated by Sponsor|3|||
160540115|NCT02004262|579707498|FG002|Overall Study|Study Terminated by Sponsor|2|||
160636790|NCT03496207|580053618|FG000|Extension Period|Adverse Event|0|||
160636791|NCT03496207|580053619|FG001|Extension Period|Adverse Event|0|||
160636792|NCT03496207|580053620|FG002|Extension Period|Adverse Event|0|||
160636793|NCT03496207|580053621|FG003|Extension Period|Adverse Event|1|||
160636794|NCT03496207|580053622|FG004|Extension Period|Adverse Event|1|||
160636795|NCT03496207|580053618|FG000|Extension Period|Death|1|||
160636796|NCT03496207|580053619|FG001|Extension Period|Death|0|||
160636797|NCT03496207|580053620|FG002|Extension Period|Death|0|||
160636798|NCT03496207|580053621|FG003|Extension Period|Death|1|||
160636799|NCT03496207|580053622|FG004|Extension Period|Death|2|||
160636800|NCT03496207|580053618|FG000|Extension Period|Withdrawal by Subject|1|||
160636801|NCT03496207|580053619|FG001|Extension Period|Withdrawal by Subject|0|||
160636802|NCT03496207|580053620|FG002|Extension Period|Withdrawal by Subject|0|||
160636803|NCT03496207|580053621|FG003|Extension Period|Withdrawal by Subject|1|||
160636804|NCT03496207|580053622|FG004|Extension Period|Withdrawal by Subject|1|||
160636805|NCT03496207|580053618|FG000|Extension Period|Elevated hemoglobin levels|0|||
160636806|NCT03496207|580053619|FG001|Extension Period|Elevated hemoglobin levels|0|||
160636807|NCT03496207|580053620|FG002|Extension Period|Elevated hemoglobin levels|0|||
160636808|NCT03496207|580053621|FG003|Extension Period|Elevated hemoglobin levels|0|||
160636809|NCT03496207|580053622|FG004|Extension Period|Elevated hemoglobin levels|1|||
160636810|NCT01542736|580053623|FG000|Overall Study|Death|1|||
160636811|NCT03674827|580053624|FG000|Treatment Phase|Adverse Event|0|||
160636812|NCT03674827|580053625|FG001|Treatment Phase|Adverse Event|0|||
160636813|NCT03674827|580053626|FG002|Treatment Phase|Adverse Event|0|||
160636814|NCT03674827|580053627|FG003|Treatment Phase|Adverse Event|0|||
160636815|NCT03674827|580053628|FG004|Treatment Phase|Adverse Event|0|||
160636816|NCT03674827|580053629|FG005|Treatment Phase|Adverse Event|2|||
160636817|NCT03674827|580053624|FG000|Treatment Phase|Death|2|||
160636818|NCT03674827|580053625|FG001|Treatment Phase|Death|0|||
160636819|NCT03674827|580053626|FG002|Treatment Phase|Death|0|||
160636820|NCT03674827|580053627|FG003|Treatment Phase|Death|0|||
160636821|NCT03674827|580053628|FG004|Treatment Phase|Death|1|||
160636822|NCT03674827|580053629|FG005|Treatment Phase|Death|0|||
160636823|NCT03674827|580053624|FG000|Treatment Phase|Progressive Disease|0|||
160540116|NCT02004262|579707499|FG003|Overall Study|Study Terminated by Sponsor|1|||
160540117|NCT02004262|579707500|FG004|Overall Study|Study Terminated by Sponsor|1|||
160540118|NCT02004262|579707501|FG005|Overall Study|Study Terminated by Sponsor|5|||
160540119|NCT03703102|579707502|FG000|Overall Study|Adverse Event|4|||
160540120|NCT03703102|579707503|FG001|Overall Study|Adverse Event|3|||
160540121|NCT03703102|579707504|FG002|Overall Study|Adverse Event|7|||
160540122|NCT03703102|579707505|FG003|Overall Study|Adverse Event|3|||
160540123|NCT03703102|579707506|FG004|Overall Study|Adverse Event|13|||
160540124|NCT03703102|579707502|FG000|Overall Study|Lack of Efficacy|4|||
160540125|NCT03703102|579707503|FG001|Overall Study|Lack of Efficacy|0|||
160540126|NCT03703102|579707504|FG002|Overall Study|Lack of Efficacy|1|||
160540127|NCT03703102|579707505|FG003|Overall Study|Lack of Efficacy|4|||
160540128|NCT03703102|579707506|FG004|Overall Study|Lack of Efficacy|1|||
160540129|NCT03703102|579707502|FG000|Overall Study|Lost to Follow-up|0|||
160540130|NCT03703102|579707503|FG001|Overall Study|Lost to Follow-up|0|||
160540131|NCT03703102|579707504|FG002|Overall Study|Lost to Follow-up|1|||
160540132|NCT03703102|579707505|FG003|Overall Study|Lost to Follow-up|2|||
160540133|NCT03703102|579707506|FG004|Overall Study|Lost to Follow-up|2|||
160540134|NCT03703102|579707502|FG000|Overall Study|Physician Decision|2|||
160540135|NCT03703102|579707503|FG001|Overall Study|Physician Decision|2|||
160540136|NCT03703102|579707504|FG002|Overall Study|Physician Decision|2|||
160540137|NCT03703102|579707505|FG003|Overall Study|Physician Decision|2|||
160540138|NCT03703102|579707506|FG004|Overall Study|Physician Decision|4|||
160540139|NCT03703102|579707502|FG000|Overall Study|Withdrawal by Subject|7|||
160540140|NCT03703102|579707503|FG001|Overall Study|Withdrawal by Subject|5|||
160540141|NCT03703102|579707504|FG002|Overall Study|Withdrawal by Subject|5|||
160540142|NCT03703102|579707505|FG003|Overall Study|Withdrawal by Subject|5|||
160540143|NCT03703102|579707506|FG004|Overall Study|Withdrawal by Subject|9|||
160540144|NCT03703102|579707502|FG000|Overall Study|Ineligibility|0|||
160636824|NCT03674827|580053625|FG001|Treatment Phase|Progressive Disease|4|||
160636825|NCT03674827|580053626|FG002|Treatment Phase|Progressive Disease|3|||
160770754|NCT04739800|580547490|FG002|Overall Study|Adverse Event|4|||
160770755|NCT04739800|580547491|FG003|Overall Study|Adverse Event|5|||
160770756|NCT04739800|580547488|FG000|Overall Study|Never Treated|2|||
160770757|NCT04739800|580547489|FG001|Overall Study|Never Treated|0|||
160770758|NCT04739800|580547490|FG002|Overall Study|Never Treated|1|||
160770759|NCT04739800|580547491|FG003|Overall Study|Never Treated|1|||
160770760|NCT04739800|580547488|FG000|Overall Study|On Treatment|5|||
160770761|NCT04739800|580547489|FG001|Overall Study|On Treatment|9|||
160770762|NCT04739800|580547490|FG002|Overall Study|On Treatment|9|||
160770763|NCT04739800|580547491|FG003|Overall Study|On Treatment|9|||
160770764|NCT04739800|580547488|FG000|Overall Study|Symptomatic Deterioration|1|||
160770765|NCT04739800|580547489|FG001|Overall Study|Symptomatic Deterioration|1|||
160770766|NCT04739800|580547490|FG002|Overall Study|Symptomatic Deterioration|3|||
160770767|NCT04739800|580547491|FG003|Overall Study|Symptomatic Deterioration|0|||
160770768|NCT04739800|580547488|FG000|Overall Study|Withdrawal by Subject|1|||
160770769|NCT04739800|580547489|FG001|Overall Study|Withdrawal by Subject|2|||
160770770|NCT04739800|580547490|FG002|Overall Study|Withdrawal by Subject|1|||
160770771|NCT04739800|580547491|FG003|Overall Study|Withdrawal by Subject|3|||
160770772|NCT04739800|580547488|FG000|Overall Study|Other Reason|1|||
160770773|NCT04739800|580547489|FG001|Overall Study|Other Reason|3|||
160770774|NCT04739800|580547490|FG002|Overall Study|Other Reason|5|||
160770775|NCT04739800|580547491|FG003|Overall Study|Other Reason|4|||
160770776|NCT03415178|580547493|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
160770777|NCT03415178|580547494|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
160770778|NCT03415178|580547493|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
160770779|NCT03415178|580547494|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
160770780|NCT04880850|580547495|FG000|Overall Study|Death|2|||
160770781|NCT04880850|580547496|FG001|Overall Study|Death|1|||
160770782|NCT04880850|580547495|FG000|Overall Study|Lost to Follow-up|3|||
160770783|NCT04880850|580547496|FG001|Overall Study|Lost to Follow-up|6|||
160770784|NCT04880850|580547495|FG000|Overall Study|Physician Decision|2|||
160770785|NCT04880850|580547496|FG001|Overall Study|Physician Decision|1|||
160770786|NCT04880850|580547495|FG000|Overall Study|Withdrawal by Subject|9|||
160770787|NCT04880850|580547496|FG001|Overall Study|Withdrawal by Subject|10|||
160770788|NCT03907488|580547497|FG000|Overall Study|Adverse Event|20|||
160770789|NCT03907488|580547498|FG001|Overall Study|Adverse Event|20|||
160770790|NCT03907488|580547497|FG000|Overall Study|Withdrawal by Subject|9|||
160770791|NCT03907488|580547498|FG001|Overall Study|Withdrawal by Subject|13|||
160770792|NCT03907488|580547497|FG000|Overall Study|Lack of Efficacy|0|||
160770793|NCT03907488|580547498|FG001|Overall Study|Lack of Efficacy|9|||
160770794|NCT03907488|580547497|FG000|Overall Study|Death|3|||
160770795|NCT03907488|580547498|FG001|Overall Study|Death|8|||
160770796|NCT03907488|580547497|FG000|Overall Study|not protocol specified|5|||
160770797|NCT03907488|580547498|FG001|Overall Study|not protocol specified|8|||
160770798|NCT03907488|580547497|FG000|Overall Study|Ineligible|9|||
160540145|NCT03703102|579707503|FG001|Overall Study|Ineligibility|0|||
160540146|NCT03703102|579707504|FG002|Overall Study|Ineligibility|1|||
160540147|NCT03703102|579707505|FG003|Overall Study|Ineligibility|0|||
160540148|NCT03703102|579707506|FG004|Overall Study|Ineligibility|0|||
160540149|NCT03703102|579707502|FG000|Overall Study|Protocol Deviation|4|||
160540150|NCT03703102|579707503|FG001|Overall Study|Protocol Deviation|4|||
160540151|NCT03703102|579707504|FG002|Overall Study|Protocol Deviation|3|||
160540152|NCT03703102|579707505|FG003|Overall Study|Protocol Deviation|0|||
160540153|NCT03703102|579707506|FG004|Overall Study|Protocol Deviation|0|||
160540154|NCT03703102|579707502|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160540155|NCT03703102|579707503|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160540156|NCT03703102|579707504|FG002|Overall Study|Non-Compliance with Study Drug|2|||
160540157|NCT03703102|579707505|FG003|Overall Study|Non-Compliance with Study Drug|1|||
160540158|NCT03703102|579707506|FG004|Overall Study|Non-Compliance with Study Drug|4|||
160540159|NCT02311153|579707507|FG000|Overall Study|Lost to Follow-up|5|||
160540160|NCT02311153|579707508|FG001|Overall Study|Lost to Follow-up|7|||
160540161|NCT01967628|579707509|FG000|Overall Study|Withdrawal by Subject|2|||
160540162|NCT01967628|579707510|FG001|Overall Study|Withdrawal by Subject|0|||
160540163|NCT01967628|579707509|FG000|Overall Study|Unable to complete bronchoscopy|4|||
160540164|NCT01967628|579707510|FG001|Overall Study|Unable to complete bronchoscopy|6|||
160540165|NCT01967628|579707509|FG000|Overall Study|Lost to Follow-up|1|||
160540166|NCT01967628|579707510|FG001|Overall Study|Lost to Follow-up|0|||
160540167|NCT01967628|579707509|FG000|Overall Study|Low protein concentration in sample|20|||
160540168|NCT01967628|579707510|FG001|Overall Study|Low protein concentration in sample|25|||
160540169|NCT00930761|579707515|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
160540170|NCT00930761|579707516|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
160540171|NCT00930761|579707515|FG000|Overall Study|less than 3 music therapy sessions|0|||
160770799|NCT03907488|580547498|FG001|Overall Study|Ineligible|15|||
160540172|NCT00930761|579707516|FG001|Overall Study|less than 3 music therapy sessions|3|||
160540173|NCT03699007|579707518|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
160770800|NCT01093846|580547500|FG000|Overall Study|Adverse Event|0|||
160770801|NCT01093846|580547501|FG001|Overall Study|Adverse Event|0|||
160881811|NCT01576159|580960678|FG000|Overall Study|Protocol Violation|1|||
160881812|NCT01576159|580960679|FG001|Overall Study|Protocol Violation|0|||
160881813|NCT01576159|580960680|FG002|Overall Study|Protocol Violation|0|||
160881814|NCT01576159|580960681|FG003|Overall Study|Protocol Violation|0|||
160881815|NCT04463069|580960682|FG000|Overall Study|Withdrawal by Subject|2|||
160881816|NCT04463069|580960683|FG001|Overall Study|Withdrawal by Subject|10|||
160881817|NCT04463069|580960682|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
160881818|NCT04463069|580960683|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
160881819|NCT00311584|580960685|FG000|Overall Study|Death|1|||
160881820|NCT00311584|580960686|FG001|Overall Study|Death|0|||
160881821|NCT00311584|580960685|FG000|Overall Study|Lack of Efficacy|12|||
160881822|NCT00311584|580960686|FG001|Overall Study|Lack of Efficacy|15|||
160881823|NCT00311584|580960685|FG000|Overall Study|Physician Decision|4|||
160881824|NCT00311584|580960686|FG001|Overall Study|Physician Decision|5|||
160881825|NCT00311584|580960685|FG000|Overall Study|Withdrawal by Subject|1|||
160881826|NCT00311584|580960686|FG001|Overall Study|Withdrawal by Subject|1|||
160881827|NCT00311584|580960685|FG000|Overall Study|ineligible|2|||
160881828|NCT00311584|580960686|FG001|Overall Study|ineligible|2|||
160881829|NCT03073733|580960693|FG000|Overall Study|Lost to Follow-up|1|||
160881830|NCT03073733|580960694|FG001|Overall Study|Lost to Follow-up|0|||
160881831|NCT03073733|580960695|FG002|Overall Study|Lost to Follow-up|0|||
160881832|NCT03073733|580960693|FG000|Overall Study|Physician Decision|0|||
160881833|NCT03073733|580960694|FG001|Overall Study|Physician Decision|1|||
160881834|NCT03073733|580960695|FG002|Overall Study|Physician Decision|0|||
160881835|NCT03073733|580960693|FG000|Overall Study|Withdrawal by Subject|0|||
160881836|NCT03073733|580960694|FG001|Overall Study|Withdrawal by Subject|0|||
160881837|NCT03073733|580960695|FG002|Overall Study|Withdrawal by Subject|1|||
160881838|NCT01454778|580960696|FG000|Overall Study|Lost to Follow-up|2|||
160881839|NCT01454778|580960696|FG000|Overall Study|Death|1|||
160881840|NCT01227629|580960698|FG000|Overall Study|Adverse Event|2|||
160881841|NCT01227629|580960699|FG001|Overall Study|Adverse Event|2|||
160881842|NCT01227629|580960700|FG002|Overall Study|Adverse Event|1|||
160540174|NCT03699007|579707519|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
160540175|NCT03699007|579707518|FG000|6-month Follow Up|Lost to Follow-up|2|||
160881843|NCT01227629|580960701|FG003|Overall Study|Adverse Event|6|||
160881844|NCT01227629|580960702|FG004|Overall Study|Adverse Event|1|||
160636826|NCT03674827|580053627|FG003|Treatment Phase|Progressive Disease|4|||
160636827|NCT03674827|580053628|FG004|Treatment Phase|Progressive Disease|4|||
160636828|NCT03674827|580053629|FG005|Treatment Phase|Progressive Disease|9|||
160636829|NCT03674827|580053624|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
160770802|NCT01093846|580547502|FG002|Overall Study|Adverse Event|1|||
160770803|NCT01093846|580547500|FG000|Overall Study|Lack of Efficacy|0|||
160770804|NCT01093846|580547501|FG001|Overall Study|Lack of Efficacy|0|||
160770805|NCT01093846|580547502|FG002|Overall Study|Lack of Efficacy|4|||
160770806|NCT01093846|580547500|FG000|Overall Study|Condition no longer required study drug|1|||
160770807|NCT01093846|580547501|FG001|Overall Study|Condition no longer required study drug|1|||
160770808|NCT01093846|580547502|FG002|Overall Study|Condition no longer required study drug|1|||
160770809|NCT01093846|580547500|FG000|Overall Study|Administrative Problems|18|||
160770810|NCT01093846|580547501|FG001|Overall Study|Administrative Problems|17|||
160770811|NCT01093846|580547502|FG002|Overall Study|Administrative Problems|15|||
160770812|NCT02781324|580547503|FG000|Overall Study|Withdrawal by Subject|1|||
160770813|NCT02781324|580547504|FG001|Overall Study|Withdrawal by Subject|0|||
160770814|NCT02781324|580547503|FG000|Overall Study|Physician Decision|1|||
160770815|NCT02781324|580547504|FG001|Overall Study|Physician Decision|2|||
160770816|NCT03074500|580547505|FG000|Overall Study|Lost to Follow-up|1|||
160770817|NCT03074500|580547506|FG001|Overall Study|Lost to Follow-up|0|||
160770818|NCT03074500|580547507|FG002|Overall Study|Lost to Follow-up|0|||
160770819|NCT03074500|580547505|FG000|Overall Study|Lack of Efficacy|0|||
160770820|NCT03074500|580547506|FG001|Overall Study|Lack of Efficacy|1|||
160770821|NCT03074500|580547507|FG002|Overall Study|Lack of Efficacy|0|||
160770822|NCT03074500|580547505|FG000|Overall Study|Adverse Event|0|||
160770823|NCT03074500|580547506|FG001|Overall Study|Adverse Event|0|||
160770824|NCT03074500|580547507|FG002|Overall Study|Adverse Event|1|||
160770825|NCT03321721|580547508|FG000|Overall Study|Lost to Follow-up|4|||
160770826|NCT03321721|580547509|FG001|Overall Study|Lost to Follow-up|8|||
160770827|NCT03321721|580547510|FG002|Overall Study|Lost to Follow-up|11|||
160770828|NCT03836053|580548780|FG000|Overall Study|Protocol-specified criteria|0|||
160770829|NCT03836053|580548781|FG001|Overall Study|Protocol-specified criteria|2|||
160770830|NCT03836053|580548782|FG002|Overall Study|Protocol-specified criteria|1|||
160770831|NCT03836053|580548780|FG000|Overall Study|Death|1|||
160770832|NCT03836053|580548781|FG001|Overall Study|Death|6|||
160770833|NCT03836053|580548782|FG002|Overall Study|Death|4|||
160770834|NCT03836053|580548780|FG000|Overall Study|Withdrawal of consent from study|0|||
160770835|NCT03836053|580548781|FG001|Overall Study|Withdrawal of consent from study|0|||
160770836|NCT03836053|580548782|FG002|Overall Study|Withdrawal of consent from study|1|||
160770837|NCT03836053|580548780|FG000|Overall Study|Decision by sponsor|0|||
160770838|NCT03836053|580548781|FG001|Overall Study|Decision by sponsor|2|||
160770839|NCT03836053|580548782|FG002|Overall Study|Decision by sponsor|4|||
160770840|NCT03846479|580548783|FG000|Overall Study|Death|8|||
160770841|NCT03846479|580548783|FG000|Overall Study|Lost to Follow-up|1|||
160770842|NCT02332707|580548784|FG000|Overall Study|Adverse Event|0|||
160770843|NCT02332707|580548785|FG001|Overall Study|Adverse Event|0|||
160770844|NCT02332707|580548786|FG002|Overall Study|Adverse Event|0|||
160770845|NCT02332707|580548787|FG003|Overall Study|Adverse Event|0|||
160770846|NCT02332707|580548788|FG004|Overall Study|Adverse Event|0|||
160770847|NCT02332707|580548789|FG005|Overall Study|Adverse Event|0|||
160770848|NCT02332707|580548790|FG006|Overall Study|Adverse Event|0|||
160770849|NCT02332707|580548791|FG007|Overall Study|Adverse Event|0|||
160770850|NCT02332707|580548792|FG008|Overall Study|Adverse Event|0|||
160770851|NCT02332707|580548793|FG009|Overall Study|Adverse Event|0|||
160770852|NCT02332707|580548794|FG010|Overall Study|Adverse Event|0|||
160770853|NCT02332707|580548795|FG011|Overall Study|Adverse Event|0|||
160770854|NCT02332707|580548796|FG012|Overall Study|Adverse Event|1|||
160770855|NCT02332707|580548797|FG013|Overall Study|Adverse Event|0|||
160770856|NCT02332707|580548798|FG014|Overall Study|Adverse Event|0|||
160770857|NCT02332707|580548799|FG015|Overall Study|Adverse Event|0|||
160770858|NCT02332707|580548800|FG016|Overall Study|Adverse Event|0|||
160770859|NCT02332707|580548801|FG017|Overall Study|Adverse Event|0|||
160770860|NCT02332707|580548784|FG000|Overall Study|Lost to Follow-up|0|||
160770861|NCT02332707|580548785|FG001|Overall Study|Lost to Follow-up|0|||
160770862|NCT02332707|580548786|FG002|Overall Study|Lost to Follow-up|0|||
160770863|NCT02332707|580548787|FG003|Overall Study|Lost to Follow-up|0|||
160770864|NCT02332707|580548788|FG004|Overall Study|Lost to Follow-up|0|||
160770865|NCT02332707|580548789|FG005|Overall Study|Lost to Follow-up|1|||
160770866|NCT02332707|580548790|FG006|Overall Study|Lost to Follow-up|0|||
160770867|NCT02332707|580548791|FG007|Overall Study|Lost to Follow-up|0|||
160770868|NCT02332707|580548792|FG008|Overall Study|Lost to Follow-up|0|||
160770869|NCT02332707|580548793|FG009|Overall Study|Lost to Follow-up|0|||
160881845|NCT01227629|580960703|FG005|Overall Study|Adverse Event|1|||
160770870|NCT02332707|580548794|FG010|Overall Study|Lost to Follow-up|2|||
160770871|NCT02332707|580548795|FG011|Overall Study|Lost to Follow-up|0|||
160770872|NCT02332707|580548796|FG012|Overall Study|Lost to Follow-up|3|||
160881846|NCT01227629|580960704|FG006|Overall Study|Adverse Event|6|||
160881847|NCT01227629|580960705|FG007|Overall Study|Adverse Event|6|||
160881848|NCT01227629|580960706|FG008|Overall Study|Adverse Event|4|||
160881849|NCT01227629|580960707|FG009|Overall Study|Adverse Event|0|||
160881850|NCT01227629|580960698|FG000|Overall Study|Protocol Violation|0|||
160881851|NCT01227629|580960699|FG001|Overall Study|Protocol Violation|0|||
160881852|NCT01227629|580960700|FG002|Overall Study|Protocol Violation|0|||
160881853|NCT01227629|580960701|FG003|Overall Study|Protocol Violation|1|||
160881854|NCT01227629|580960702|FG004|Overall Study|Protocol Violation|0|||
160881855|NCT01227629|580960703|FG005|Overall Study|Protocol Violation|0|||
160881856|NCT01227629|580960704|FG006|Overall Study|Protocol Violation|0|||
160881857|NCT01227629|580960705|FG007|Overall Study|Protocol Violation|0|||
160881858|NCT01227629|580960706|FG008|Overall Study|Protocol Violation|0|||
160881859|NCT01227629|580960707|FG009|Overall Study|Protocol Violation|0|||
160881860|NCT01227629|580960698|FG000|Overall Study|Lost to Follow-up|0|||
160881861|NCT01227629|580960699|FG001|Overall Study|Lost to Follow-up|0|||
160881862|NCT01227629|580960700|FG002|Overall Study|Lost to Follow-up|0|||
160881863|NCT01227629|580960701|FG003|Overall Study|Lost to Follow-up|0|||
160881864|NCT01227629|580960702|FG004|Overall Study|Lost to Follow-up|1|||
160881865|NCT01227629|580960703|FG005|Overall Study|Lost to Follow-up|0|||
160881866|NCT01227629|580960704|FG006|Overall Study|Lost to Follow-up|0|||
160881867|NCT01227629|580960705|FG007|Overall Study|Lost to Follow-up|0|||
160881868|NCT01227629|580960706|FG008|Overall Study|Lost to Follow-up|0|||
160881869|NCT01227629|580960707|FG009|Overall Study|Lost to Follow-up|0|||
160881870|NCT01227629|580960698|FG000|Overall Study|Withdrawal by Subject|0|||
160881871|NCT01227629|580960699|FG001|Overall Study|Withdrawal by Subject|0|||
160881872|NCT01227629|580960700|FG002|Overall Study|Withdrawal by Subject|0|||
160881873|NCT01227629|580960701|FG003|Overall Study|Withdrawal by Subject|0|||
160881874|NCT01227629|580960702|FG004|Overall Study|Withdrawal by Subject|0|||
160881875|NCT01227629|580960703|FG005|Overall Study|Withdrawal by Subject|0|||
160881876|NCT01227629|580960704|FG006|Overall Study|Withdrawal by Subject|2|||
160881877|NCT01227629|580960705|FG007|Overall Study|Withdrawal by Subject|0|||
160881878|NCT01227629|580960706|FG008|Overall Study|Withdrawal by Subject|0|||
160881879|NCT01227629|580960707|FG009|Overall Study|Withdrawal by Subject|1|||
160881880|NCT01227629|580960698|FG000|Overall Study|Other|0|||
160881881|NCT01227629|580960699|FG001|Overall Study|Other|0|||
160881882|NCT01227629|580960700|FG002|Overall Study|Other|0|||
160881883|NCT01227629|580960701|FG003|Overall Study|Other|1|||
160881884|NCT01227629|580960702|FG004|Overall Study|Other|0|||
160881885|NCT01227629|580960703|FG005|Overall Study|Other|0|||
160881886|NCT01227629|580960704|FG006|Overall Study|Other|0|||
160881887|NCT01227629|580960705|FG007|Overall Study|Other|0|||
160881888|NCT01227629|580960706|FG008|Overall Study|Other|2|||
160881889|NCT01227629|580960707|FG009|Overall Study|Other|1|||
160881890|NCT00129311|580960708|FG000|Overall Study|Withdrawal by Subject|12|||
160881891|NCT00129311|580960709|FG001|Overall Study|Withdrawal by Subject|19|||
160881892|NCT02446171|580962878|FG000|Overall Study|Withdrawal by Subject|0|||
160881893|NCT02446171|580962879|FG001|Overall Study|Withdrawal by Subject|0|||
160881894|NCT02446171|580962880|FG002|Overall Study|Withdrawal by Subject|2|||
160881895|NCT02446171|580962881|FG003|Overall Study|Withdrawal by Subject|0|||
160881896|NCT02320903|580962884|FG000|Overall Study|Withdrawal by Subject|0|||
160881897|NCT02320903|580962885|FG001|Overall Study|Withdrawal by Subject|9|||
160881898|NCT02320903|580962886|FG002|Overall Study|Withdrawal by Subject|9|||
160881899|NCT02320903|580962884|FG000|Overall Study|Exited therapy; no longer eligible|8|||
160881900|NCT02320903|580962885|FG001|Overall Study|Exited therapy; no longer eligible|2|||
160881901|NCT02320903|580962886|FG002|Overall Study|Exited therapy; no longer eligible|2|||
160881902|NCT02320903|580962884|FG000|Overall Study|Lost to Follow-up|0|||
160881903|NCT02320903|580962885|FG001|Overall Study|Lost to Follow-up|5|||
160881904|NCT02320903|580962886|FG002|Overall Study|Lost to Follow-up|5|||
160881905|NCT00773383|580962887|FG000|Overall Study|Adverse Event|4|||
160881906|NCT00773383|580962887|FG000|Overall Study|Death|1|||
160881907|NCT00773383|580962887|FG000|Overall Study|Progression of Disease|23|||
160881908|NCT00773383|580962887|FG000|Overall Study|Other|2|||
160881909|NCT00773383|580962887|FG000|Overall Study|No study dose received|1|||
160881910|NCT03811093|580962905|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
160881911|NCT03811093|580962906|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
160881912|NCT03811093|580962905|FG000|Overall Study|Unable to measure body fat percentage|2|||
160881913|NCT03811093|580962906|FG001|Overall Study|Unable to measure body fat percentage|0|||
160881914|NCT00464490|580962908|FG000|Overall Study|Physician Decision|11|||
160881915|NCT00464490|580962909|FG001|Overall Study|Physician Decision|11|||
160881916|NCT03188042|580962912|FG000|Overall Study|Withdrawal by Subject|1|||
160881917|NCT03188042|580962913|FG001|Overall Study|Withdrawal by Subject|1|||
160881918|NCT00039871|580962921|FG000|Overall Study|Adverse Event|165|||
160881919|NCT00039871|580962921|FG000|Overall Study|Lost to Follow-up|18|||
160881920|NCT00039871|580962921|FG000|Overall Study|Protocol Violation|24|||
160881921|NCT00039871|580962921|FG000|Overall Study|Withdrawal by Subject|97|||
160881922|NCT00039871|580962921|FG000|Overall Study|Did not meet eligibility criteria|11|||
160881923|NCT00039871|580962921|FG000|Overall Study|Administrative|1|||
160881924|NCT00039871|580962921|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
160881925|NCT00039871|580962921|FG000|Overall Study|Never entered follow-up|7|||
160881926|NCT02446743|580962922|FG000|Overall Study|Withdrawal by Subject|1|||
160881927|NCT02446743|580962923|FG001|Overall Study|Withdrawal by Subject|1|||
160881928|NCT02446743|580962922|FG000|Overall Study|Lost to Follow-up|1|||
160881929|NCT02446743|580962923|FG001|Overall Study|Lost to Follow-up|0|||
160636830|NCT03674827|580053625|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
160636831|NCT03674827|580053626|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
160881930|NCT02446743|580962922|FG000|Overall Study|Adverse Event|1|||
160881931|NCT02446743|580962923|FG001|Overall Study|Adverse Event|1|||
160881932|NCT02446743|580962922|FG000|Overall Study|Other|2|||
160881933|NCT02446743|580962923|FG001|Overall Study|Other|3|||
160881934|NCT02478398|580962924|FG000|Overall Study|Adverse Event|20|||
160881935|NCT02478398|580962925|FG001|Overall Study|Adverse Event|5|||
160881936|NCT02478398|580962924|FG000|Overall Study|Lost to Follow-up|5|||
160881937|NCT02478398|580962925|FG001|Overall Study|Lost to Follow-up|4|||
160881938|NCT02478398|580962924|FG000|Overall Study|Non-Compliance With Study Drug|5|||
160881939|NCT02478398|580962925|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160881940|NCT02478398|580962924|FG000|Overall Study|Protocol Violation|3|||
160881941|NCT02478398|580962925|FG001|Overall Study|Protocol Violation|1|||
160881942|NCT02478398|580962924|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
160881943|NCT02478398|580962925|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
160881944|NCT02478398|580962924|FG000|Overall Study|Withdrawal By Participant|10|||
160881945|NCT02478398|580962925|FG001|Overall Study|Withdrawal By Participant|4|||
160881946|NCT01475071|580962929|FG000|Overall Study|Physician Decision|1|||
160881947|NCT01475071|580962929|FG000|Overall Study|Withdrawal by Subject|6|||
160881948|NCT01475071|580962929|FG000|Overall Study|Lost to Follow-up|1|||
160881949|NCT01205581|580962933|FG000|Overall Study|Withdrawal by Subject|1|||
160881950|NCT01205581|580962934|FG001|Overall Study|Withdrawal by Subject|0|||
160881951|NCT01205581|580962935|FG002|Overall Study|Withdrawal by Subject|0|||
160881952|NCT01205581|580962936|FG003|Overall Study|Withdrawal by Subject|0|||
160881953|NCT01205581|580962937|FG004|Overall Study|Withdrawal by Subject|0|||
160881954|NCT01205581|580962938|FG005|Overall Study|Withdrawal by Subject|0|||
160881955|NCT00770146|580962950|FG000|Treatment Period|Withdrawal by Subject|6|||
160881956|NCT00770146|580962951|FG001|Treatment Period|Withdrawal by Subject|13|||
160881957|NCT00770146|580962950|FG000|Treatment Period|Adverse Event|2|||
160881958|NCT00770146|580962951|FG001|Treatment Period|Adverse Event|26|||
160881959|NCT00770146|580962950|FG000|Treatment Period|Other|1|||
160881960|NCT00770146|580962951|FG001|Treatment Period|Other|5|||
160881961|NCT00770146|580962950|FG000|Treatment Period|Protocol non-compliance|0|||
160770873|NCT02332707|580548797|FG013|Overall Study|Lost to Follow-up|0|||
160881962|NCT00770146|580962951|FG001|Treatment Period|Protocol non-compliance|1|||
160881963|NCT00770146|580962950|FG000|Follow-up Period|Withdrawal by Subject|7|||
160770874|NCT02332707|580548798|FG014|Overall Study|Lost to Follow-up|0|||
160770875|NCT02332707|580548799|FG015|Overall Study|Lost to Follow-up|0|||
160770876|NCT02332707|580548800|FG016|Overall Study|Lost to Follow-up|0|||
160770877|NCT02332707|580548801|FG017|Overall Study|Lost to Follow-up|0|||
160770878|NCT02332707|580548784|FG000|Overall Study|Physician Decision|0|||
160770879|NCT02332707|580548785|FG001|Overall Study|Physician Decision|0|||
160770880|NCT02332707|580548786|FG002|Overall Study|Physician Decision|0|||
160770881|NCT02332707|580548787|FG003|Overall Study|Physician Decision|1|||
160770882|NCT02332707|580548788|FG004|Overall Study|Physician Decision|0|||
160770883|NCT02332707|580548789|FG005|Overall Study|Physician Decision|0|||
160770884|NCT02332707|580548790|FG006|Overall Study|Physician Decision|0|||
160770885|NCT02332707|580548791|FG007|Overall Study|Physician Decision|0|||
160770886|NCT02332707|580548792|FG008|Overall Study|Physician Decision|0|||
160770887|NCT02332707|580548793|FG009|Overall Study|Physician Decision|0|||
160770888|NCT02332707|580548794|FG010|Overall Study|Physician Decision|0|||
160770889|NCT02332707|580548795|FG011|Overall Study|Physician Decision|0|||
160770890|NCT02332707|580548796|FG012|Overall Study|Physician Decision|1|||
160770891|NCT02332707|580548797|FG013|Overall Study|Physician Decision|0|||
160770892|NCT02332707|580548798|FG014|Overall Study|Physician Decision|0|||
160770893|NCT02332707|580548799|FG015|Overall Study|Physician Decision|0|||
160636832|NCT03674827|580053627|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
160636833|NCT03674827|580053628|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
160770894|NCT02332707|580548800|FG016|Overall Study|Physician Decision|0|||
160770895|NCT02332707|580548801|FG017|Overall Study|Physician Decision|0|||
160881964|NCT00770146|580962951|FG001|Follow-up Period|Withdrawal by Subject|13|||
160881965|NCT00770146|580962950|FG000|Follow-up Period|Adverse Event|0|||
160881966|NCT00770146|580962951|FG001|Follow-up Period|Adverse Event|2|||
160881967|NCT00770146|580962950|FG000|Follow-up Period|Other|4|||
160770896|NCT02332707|580548784|FG000|Overall Study|Withdrawal by Subject|0|||
160770897|NCT02332707|580548785|FG001|Overall Study|Withdrawal by Subject|0|||
160770898|NCT02332707|580548786|FG002|Overall Study|Withdrawal by Subject|1|||
160770899|NCT02332707|580548787|FG003|Overall Study|Withdrawal by Subject|0|||
160881968|NCT00770146|580962951|FG001|Follow-up Period|Other|5|||
160881969|NCT01525901|580962953|FG000|Period 2: 12 Weeks|Adverse Event|0|||
160770900|NCT02332707|580548788|FG004|Overall Study|Withdrawal by Subject|0|||
160636834|NCT03674827|580053629|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
160636835|NCT03674827|580053624|FG000|Treatment Phase|Withdrawal by Subject|0|||
160636836|NCT03674827|580053625|FG001|Treatment Phase|Withdrawal by Subject|0|||
160881970|NCT01525901|580962954|FG001|Period 2: 12 Weeks|Adverse Event|1|||
160881971|NCT01525901|580962955|FG002|Period 2: 12 Weeks|Adverse Event|0|||
160881972|NCT01525901|580962956|FG003|Period 2: 12 Weeks|Adverse Event|0|||
160881973|NCT04449029|580962958|FG000|Overall Study|Adverse Event|0|||
160881974|NCT04449029|580962959|FG001|Overall Study|Adverse Event|1|||
160881975|NCT04449029|580962960|FG002|Overall Study|Adverse Event|1|||
160881976|NCT04449029|580962961|FG003|Overall Study|Adverse Event|0|||
160881977|NCT04449029|580962962|FG004|Overall Study|Adverse Event|1|||
160881978|NCT04449029|580962963|FG005|Overall Study|Adverse Event|0|||
160881979|NCT04449029|580962964|FG006|Overall Study|Adverse Event|1|||
160881980|NCT04449029|580962965|FG007|Overall Study|Adverse Event|0|||
160881981|NCT04449029|580962958|FG000|Overall Study|Lost to Follow-up|0|||
160881982|NCT04449029|580962959|FG001|Overall Study|Lost to Follow-up|1|||
160881983|NCT04449029|580962960|FG002|Overall Study|Lost to Follow-up|0|||
160881984|NCT04449029|580962961|FG003|Overall Study|Lost to Follow-up|0|||
160881985|NCT04449029|580962962|FG004|Overall Study|Lost to Follow-up|0|||
160881986|NCT04449029|580962963|FG005|Overall Study|Lost to Follow-up|0|||
160881987|NCT04449029|580962964|FG006|Overall Study|Lost to Follow-up|0|||
160881988|NCT04449029|580962965|FG007|Overall Study|Lost to Follow-up|0|||
160636837|NCT03674827|580053626|FG002|Treatment Phase|Withdrawal by Subject|0|||
160636838|NCT03674827|580053627|FG003|Treatment Phase|Withdrawal by Subject|0|||
160636839|NCT03674827|580053628|FG004|Treatment Phase|Withdrawal by Subject|0|||
160636840|NCT03674827|580053629|FG005|Treatment Phase|Withdrawal by Subject|1|||
160636841|NCT03674827|580053624|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
160636842|NCT03674827|580053625|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
160636843|NCT03674827|580053626|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
160770901|NCT02332707|580548789|FG005|Overall Study|Withdrawal by Subject|0|||
160770902|NCT02332707|580548790|FG006|Overall Study|Withdrawal by Subject|0|||
160770903|NCT02332707|580548791|FG007|Overall Study|Withdrawal by Subject|0|||
160770904|NCT02332707|580548792|FG008|Overall Study|Withdrawal by Subject|0|||
160770905|NCT02332707|580548793|FG009|Overall Study|Withdrawal by Subject|3|||
160770906|NCT02332707|580548794|FG010|Overall Study|Withdrawal by Subject|0|||
160770907|NCT02332707|580548795|FG011|Overall Study|Withdrawal by Subject|0|||
160770908|NCT02332707|580548796|FG012|Overall Study|Withdrawal by Subject|0|||
160770909|NCT02332707|580548797|FG013|Overall Study|Withdrawal by Subject|0|||
160770910|NCT02332707|580548798|FG014|Overall Study|Withdrawal by Subject|0|||
160770911|NCT02332707|580548799|FG015|Overall Study|Withdrawal by Subject|0|||
160770912|NCT02332707|580548800|FG016|Overall Study|Withdrawal by Subject|0|||
160770913|NCT02332707|580548801|FG017|Overall Study|Withdrawal by Subject|0|||
160770914|NCT01473134|580548802|FG000|Overall Study|Lost to Follow-up|21|||
160770915|NCT01473134|580548803|FG001|Overall Study|Lost to Follow-up|13|||
160770916|NCT01473134|580548802|FG000|Overall Study|Protocol Violation|32|||
160770917|NCT01473134|580548803|FG001|Overall Study|Protocol Violation|19|||
160770918|NCT01473134|580548802|FG000|Overall Study|Withdrawal by Subject|1|||
160770919|NCT01473134|580548803|FG001|Overall Study|Withdrawal by Subject|2|||
160770920|NCT01473134|580548802|FG000|Overall Study|Death|0|||
160770921|NCT01473134|580548803|FG001|Overall Study|Death|1|||
160770922|NCT01473134|580548802|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
160770923|NCT01473134|580548803|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
160770924|NCT04761822|580548806|FG000|Overall Study|Adverse Event|3|||
160770925|NCT04761822|580548807|FG001|Overall Study|Adverse Event|1|||
160770926|NCT04761822|580548808|FG002|Overall Study|Adverse Event|1|||
160770927|NCT04761822|580548809|FG003|Overall Study|Adverse Event|3|||
160770928|NCT04761822|580548806|FG000|Overall Study|Lost to Follow-up|1|||
160770929|NCT04761822|580548807|FG001|Overall Study|Lost to Follow-up|0|||
160770930|NCT04761822|580548808|FG002|Overall Study|Lost to Follow-up|2|||
160770931|NCT04761822|580548809|FG003|Overall Study|Lost to Follow-up|3|||
160770932|NCT04761822|580548806|FG000|Overall Study|Physician Decision|0|||
160770933|NCT04761822|580548807|FG001|Overall Study|Physician Decision|1|||
160770934|NCT04761822|580548808|FG002|Overall Study|Physician Decision|0|||
160770935|NCT04761822|580548809|FG003|Overall Study|Physician Decision|0|||
160636844|NCT03674827|580053627|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
160636845|NCT03674827|580053628|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
160636846|NCT03674827|580053629|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
160770936|NCT04761822|580548806|FG000|Overall Study|Withdrawal by Subject|3|||
160881989|NCT04449029|580962958|FG000|Overall Study|Protocol Violation|0|||
160881990|NCT04449029|580962959|FG001|Overall Study|Protocol Violation|1|||
160881991|NCT04449029|580962960|FG002|Overall Study|Protocol Violation|0|||
160881992|NCT04449029|580962961|FG003|Overall Study|Protocol Violation|0|||
160636847|NCT03674827|580053624|FG000|Treatment Phase|Other|0|||
160636848|NCT03674827|580053625|FG001|Treatment Phase|Other|1|||
160636849|NCT03674827|580053626|FG002|Treatment Phase|Other|0|||
160636850|NCT03674827|580053627|FG003|Treatment Phase|Other|0|||
160636851|NCT03674827|580053628|FG004|Treatment Phase|Other|0|||
160636852|NCT03674827|580053629|FG005|Treatment Phase|Other|1|||
160636853|NCT03674827|580053624|FG000|Long-Term Follow-up Phase|Death|2|||
160636854|NCT03674827|580053625|FG001|Long-Term Follow-up Phase|Death|4|||
160636855|NCT03674827|580053626|FG002|Long-Term Follow-up Phase|Death|2|||
160636856|NCT03674827|580053627|FG003|Long-Term Follow-up Phase|Death|3|||
160636857|NCT03674827|580053628|FG004|Long-Term Follow-up Phase|Death|2|||
160636858|NCT03674827|580053629|FG005|Long-Term Follow-up Phase|Death|6|||
160636859|NCT03674827|580053624|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
160636860|NCT03674827|580053625|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
160636861|NCT03674827|580053626|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
160636862|NCT03674827|580053627|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
160636863|NCT03674827|580053628|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
160636864|NCT03674827|580053629|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
160636865|NCT03674827|580053624|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
160636866|NCT03674827|580053625|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
160881993|NCT04449029|580962962|FG004|Overall Study|Protocol Violation|0|||
160881994|NCT04449029|580962963|FG005|Overall Study|Protocol Violation|0|||
160881995|NCT04449029|580962964|FG006|Overall Study|Protocol Violation|0|||
160881996|NCT04449029|580962965|FG007|Overall Study|Protocol Violation|0|||
160881997|NCT04449029|580962958|FG000|Overall Study|Physician Decision|0|||
160881998|NCT04449029|580962959|FG001|Overall Study|Physician Decision|0|||
160881999|NCT04449029|580962960|FG002|Overall Study|Physician Decision|0|||
160882000|NCT04449029|580962961|FG003|Overall Study|Physician Decision|0|||
160882001|NCT04449029|580962962|FG004|Overall Study|Physician Decision|0|||
160882002|NCT04449029|580962963|FG005|Overall Study|Physician Decision|1|||
160882003|NCT04449029|580962964|FG006|Overall Study|Physician Decision|0|||
160882004|NCT04449029|580962965|FG007|Overall Study|Physician Decision|0|||
160882005|NCT04449029|580962958|FG000|Overall Study|Withdrawal by Subject|3|||
160882006|NCT04449029|580962959|FG001|Overall Study|Withdrawal by Subject|0|||
160882007|NCT04449029|580962960|FG002|Overall Study|Withdrawal by Subject|1|||
160882008|NCT04449029|580962961|FG003|Overall Study|Withdrawal by Subject|1|||
160882009|NCT04449029|580962962|FG004|Overall Study|Withdrawal by Subject|5|||
160882010|NCT04449029|580962963|FG005|Overall Study|Withdrawal by Subject|1|||
160882011|NCT04449029|580962964|FG006|Overall Study|Withdrawal by Subject|4|||
160882012|NCT04449029|580962965|FG007|Overall Study|Withdrawal by Subject|0|||
160882013|NCT02486627|580962968|FG000|Overall Study|Death|1|||
160882014|NCT02486627|580962969|FG001|Overall Study|Death|0|||
160882015|NCT02486627|580962968|FG000|Overall Study|Other Unspecified|0|||
160882016|NCT02486627|580962969|FG001|Overall Study|Other Unspecified|2|||
160882017|NCT02486627|580962968|FG000|Overall Study|Consent Withdrawn by Participant|4|||
160882018|NCT02486627|580962969|FG001|Overall Study|Consent Withdrawn by Participant|3|||
160882019|NCT02486627|580962968|FG000|Overall Study|Significant Participant Noncompliance|1|||
160882020|NCT02486627|580962969|FG001|Overall Study|Significant Participant Noncompliance|1|||
160882021|NCT02486627|580962968|FG000|Overall Study|Lost to Follow-up|1|||
160882022|NCT02486627|580962969|FG001|Overall Study|Lost to Follow-up|3|||
160882023|NCT02112045|580962973|FG000|Overall Study|Withdrawal by Subject|1|||
160882024|NCT02112045|580962974|FG001|Overall Study|Withdrawal by Subject|0|||
160882025|NCT00627445|580962975|FG000|Overall Study|Adverse Event|3|||
160882026|NCT00627445|580962976|FG001|Overall Study|Adverse Event|3|||
160882027|NCT00627445|580962975|FG000|Overall Study|Lack of Efficacy|0|||
160882028|NCT00627445|580962976|FG001|Overall Study|Lack of Efficacy|1|||
160882029|NCT00627445|580962975|FG000|Overall Study|Other|6|||
160882030|NCT00627445|580962976|FG001|Overall Study|Other|8|||
160882031|NCT01073462|580962977|FG000|Overall Study|Death|14|||
160882032|NCT01073462|580962977|FG000|Overall Study|Kidney transplant|10|||
160882033|NCT01073462|580962977|FG000|Overall Study|Low parathyroid hormone levels|8|||
160882034|NCT01073462|580962977|FG000|Overall Study|Serious adverse event|2|||
160636867|NCT03674827|580053626|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
160636868|NCT03674827|580053627|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
160636869|NCT03674827|580053628|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
160636870|NCT03674827|580053629|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
160636871|NCT00363129|580053634|FG000|Overall Study|Withdrawal by Subject|11|||
160882035|NCT01073462|580962977|FG000|Overall Study|Lost to Follow-up|7|||
160882036|NCT01238588|580962979|FG000|Overall Study|Withdrawal by Subject|1|||
160882037|NCT01238588|580962979|FG000|Overall Study|Physician Decision|2|||
160882038|NCT00247611|580962984|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
160882039|NCT00247611|580962985|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
160882040|NCT00247611|580962984|FG000|Baselined|Completed baseline only|9|||
160882041|NCT00247611|580962985|FG001|Baselined|Completed baseline only|8|||
160882042|NCT05395091|580962986|FG000|Baseline to Month 12|Adverse Event|7|||
160882043|NCT05395091|580962987|FG001|Baseline to Month 12|Adverse Event|2|||
160882044|NCT05395091|580962988|FG002|Baseline to Month 12|Adverse Event|0|||
160882045|NCT05395091|580962986|FG000|Baseline to Month 12|Death|3|||
160882046|NCT05395091|580962987|FG001|Baseline to Month 12|Death|1|||
160882047|NCT05395091|580962988|FG002|Baseline to Month 12|Death|0|||
160882048|NCT05395091|580962986|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
160882049|NCT05395091|580962987|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
160882050|NCT05395091|580962988|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
160882051|NCT05395091|580962986|FG000|Baseline to Month 12|Protocol Violation|2|||
160882052|NCT05395091|580962987|FG001|Baseline to Month 12|Protocol Violation|3|||
160882053|NCT05395091|580962988|FG002|Baseline to Month 12|Protocol Violation|0|||
160882054|NCT05395091|580962986|FG000|Baseline to Month 12|Physician Decision|1|||
160882055|NCT05395091|580962987|FG001|Baseline to Month 12|Physician Decision|0|||
160882056|NCT05395091|580962988|FG002|Baseline to Month 12|Physician Decision|0|||
160882057|NCT05395091|580962986|FG000|Month 12 to Month 18|Death|1|||
160882058|NCT05395091|580962987|FG001|Month 12 to Month 18|Death|0|||
160882059|NCT05395091|580962988|FG002|Month 12 to Month 18|Death|0|||
160882060|NCT05395091|580962986|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
160882061|NCT05395091|580962987|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
160882062|NCT05395091|580962988|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
160882063|NCT05395091|580962986|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
160882064|NCT05395091|580962987|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
160882065|NCT05395091|580962988|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
160882066|NCT05395091|580962986|FG000|Month 12 to Month 18|Other reasons|0|||
160882067|NCT05395091|580962987|FG001|Month 12 to Month 18|Other reasons|0|||
160882068|NCT05395091|580962988|FG002|Month 12 to Month 18|Other reasons|1|||
160882069|NCT01509053|580962990|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
160882070|NCT01509053|580962990|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
160882071|NCT01509053|580962990|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
160882072|NCT01509053|580962990|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
160882073|NCT01509053|580962990|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
160882074|NCT01509053|580962990|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
160882075|NCT01915303|580962996|FG000|Core Phase|Adverse Event|7|||
160882076|NCT01915303|580962996|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
160882077|NCT01915303|580962996|FG000|Core Phase|Death|2|||
160882078|NCT01915303|580962996|FG000|Core Phase|Protocol Violation|2|||
160882079|NCT01915303|580962996|FG000|Core Phase|Abnormal lab value|1|||
160882080|NCT01915303|580962996|FG000|Core Phase|Withdrawal by Subject|1|||
160882081|NCT01915303|580962996|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
160882082|NCT01915303|580962996|FG000|Extension Phase|Withdrawal by Subject|4|||
160882083|NCT01915303|580962996|FG000|Extension Phase|Adverse Event|3|||
160882084|NCT01915303|580962996|FG000|Extension Phase|Death|1|||
160882085|NCT01915303|580962996|FG000|Extension Phase|Protocol Violation|1|||
160882086|NCT02509117|580962998|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882087|NCT02509117|580962999|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
160882088|NCT02509117|580963000|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882089|NCT02509117|580963001|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882090|NCT02509117|580963002|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882091|NCT02509117|580963003|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882092|NCT02509117|580963004|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882093|NCT02509117|580963005|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882094|NCT02509117|580963006|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882095|NCT02509117|580963007|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882096|NCT02509117|580962998|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882097|NCT02509117|580962999|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882098|NCT02509117|580963000|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882099|NCT02509117|580963001|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882100|NCT02509117|580963002|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882101|NCT02509117|580963003|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882102|NCT02509117|580963004|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882103|NCT02509117|580963005|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882104|NCT02509117|580963006|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882105|NCT02509117|580963007|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
160882106|NCT02509117|580962998|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882107|NCT02509117|580962999|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882108|NCT02509117|580963000|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882109|NCT02509117|580963001|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882110|NCT02509117|580963002|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882111|NCT02509117|580963003|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882112|NCT02509117|580963004|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882113|NCT02509117|580963005|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882114|NCT02509117|580963006|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882115|NCT02509117|580963007|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
160882116|NCT00832624|580963008|FG000|Overall Study|Study Terminated|10|||
160882117|NCT00548184|580963011|FG000|Overall Study|Adverse Event|3|||
160882118|NCT00548184|580963011|FG000|Overall Study|took other drug|1|||
160882119|NCT00548184|580963011|FG000|Overall Study|Found Her2 negative|1|||
160882120|NCT00280748|580963018|FG000|Overall Study|Decline in performance|3|||
160882121|NCT00280748|580963018|FG000|Overall Study|Extra-cranial disease progression|1|||
160882122|NCT01433250|580963019|FG000|Overall Study|Protocol Violation|0|||
160882123|NCT01433250|580963020|FG001|Overall Study|Protocol Violation|1|||
160882124|NCT01433250|580963019|FG000|Overall Study|Withdrawal by Subject|3|||
160882125|NCT01433250|580963020|FG001|Overall Study|Withdrawal by Subject|2|||
160882126|NCT00796523|580963023|FG000|Overall Study|Lost to Follow-up|9|||
160882127|NCT00796523|580963024|FG001|Overall Study|Lost to Follow-up|7|||
160882128|NCT02431260|580963029|FG000|Overall Study|Subject Decision|0|||
160882129|NCT02431260|580963030|FG001|Overall Study|Subject Decision|1|||
160882130|NCT02431260|580963031|FG002|Overall Study|Subject Decision|1|||
160882131|NCT02431260|580963032|FG003|Overall Study|Subject Decision|0|||
160882132|NCT02431260|580963033|FG004|Overall Study|Subject Decision|0|||
160882133|NCT02431260|580963034|FG005|Overall Study|Subject Decision|0|||
160882134|NCT02431260|580963035|FG006|Overall Study|Subject Decision|0|||
160882135|NCT02431260|580963036|FG007|Overall Study|Subject Decision|0|||
160882136|NCT02431260|580963037|FG008|Overall Study|Subject Decision|1|||
160882137|NCT02431260|580963038|FG009|Overall Study|Subject Decision|1|||
160882138|NCT02431260|580963039|FG010|Overall Study|Subject Decision|0|||
160882139|NCT02431260|580963040|FG011|Overall Study|Subject Decision|1|||
160882140|NCT02431260|580963041|FG012|Overall Study|Subject Decision|0|||
160882141|NCT02431260|580963042|FG013|Overall Study|Subject Decision|0|||
160882142|NCT02431260|580963029|FG000|Overall Study|Death|4|||
160882143|NCT02431260|580963030|FG001|Overall Study|Death|4|||
160882144|NCT02431260|580963031|FG002|Overall Study|Death|3|||
160882145|NCT02431260|580963032|FG003|Overall Study|Death|4|||
160882146|NCT02431260|580963033|FG004|Overall Study|Death|2|||
160882147|NCT02431260|580963034|FG005|Overall Study|Death|2|||
160882148|NCT02431260|580963035|FG006|Overall Study|Death|3|||
160882149|NCT02431260|580963036|FG007|Overall Study|Death|1|||
160882150|NCT02431260|580963037|FG008|Overall Study|Death|6|||
160882151|NCT02431260|580963038|FG009|Overall Study|Death|6|||
160882152|NCT02431260|580963039|FG010|Overall Study|Death|3|||
160882153|NCT02431260|580963040|FG011|Overall Study|Death|2|||
160882154|NCT02431260|580963041|FG012|Overall Study|Death|5|||
160882155|NCT02431260|580963042|FG013|Overall Study|Death|1|||
160882156|NCT02431260|580963029|FG000|Overall Study|Lost to Follow-up|0|||
160882157|NCT02431260|580963030|FG001|Overall Study|Lost to Follow-up|0|||
160882158|NCT02431260|580963031|FG002|Overall Study|Lost to Follow-up|0|||
160882159|NCT02431260|580963032|FG003|Overall Study|Lost to Follow-up|0|||
160882160|NCT02431260|580963033|FG004|Overall Study|Lost to Follow-up|0|||
160882161|NCT02431260|580963034|FG005|Overall Study|Lost to Follow-up|1|||
160882162|NCT02431260|580963035|FG006|Overall Study|Lost to Follow-up|0|||
160882163|NCT02431260|580963036|FG007|Overall Study|Lost to Follow-up|0|||
160882164|NCT02431260|580963037|FG008|Overall Study|Lost to Follow-up|0|||
160882165|NCT02431260|580963038|FG009|Overall Study|Lost to Follow-up|0|||
160882166|NCT02431260|580963039|FG010|Overall Study|Lost to Follow-up|0|||
160882167|NCT02431260|580963040|FG011|Overall Study|Lost to Follow-up|0|||
160882168|NCT02431260|580963041|FG012|Overall Study|Lost to Follow-up|0|||
160882169|NCT02431260|580963042|FG013|Overall Study|Lost to Follow-up|0|||
160882170|NCT02431260|580963029|FG000|Overall Study|Study Terminated by the Sponsor|0|||
160882171|NCT02431260|580963030|FG001|Overall Study|Study Terminated by the Sponsor|0|||
160882172|NCT02431260|580963031|FG002|Overall Study|Study Terminated by the Sponsor|2|||
160882173|NCT02431260|580963032|FG003|Overall Study|Study Terminated by the Sponsor|1|||
160882174|NCT02431260|580963033|FG004|Overall Study|Study Terminated by the Sponsor|1|||
160882175|NCT02431260|580963034|FG005|Overall Study|Study Terminated by the Sponsor|0|||
160882176|NCT02431260|580963035|FG006|Overall Study|Study Terminated by the Sponsor|1|||
160882177|NCT02431260|580963036|FG007|Overall Study|Study Terminated by the Sponsor|2|||
160882178|NCT02431260|580963037|FG008|Overall Study|Study Terminated by the Sponsor|1|||
160882179|NCT02431260|580963038|FG009|Overall Study|Study Terminated by the Sponsor|1|||
160882180|NCT02431260|580963039|FG010|Overall Study|Study Terminated by the Sponsor|1|||
160882181|NCT02431260|580963040|FG011|Overall Study|Study Terminated by the Sponsor|0|||
160882182|NCT02431260|580963041|FG012|Overall Study|Study Terminated by the Sponsor|4|||
160882183|NCT02431260|580963042|FG013|Overall Study|Study Terminated by the Sponsor|0|||
160882184|NCT02431260|580963029|FG000|Overall Study|Physician Decision|0|||
160882185|NCT02431260|580963030|FG001|Overall Study|Physician Decision|0|||
160882186|NCT02431260|580963031|FG002|Overall Study|Physician Decision|0|||
160882187|NCT02431260|580963032|FG003|Overall Study|Physician Decision|0|||
160882188|NCT02431260|580963033|FG004|Overall Study|Physician Decision|0|||
160882189|NCT02431260|580963034|FG005|Overall Study|Physician Decision|1|||
160882190|NCT02431260|580963035|FG006|Overall Study|Physician Decision|0|||
160882191|NCT02431260|580963036|FG007|Overall Study|Physician Decision|0|||
160882192|NCT02431260|580963037|FG008|Overall Study|Physician Decision|0|||
160882193|NCT02431260|580963038|FG009|Overall Study|Physician Decision|0|||
160882194|NCT02431260|580963039|FG010|Overall Study|Physician Decision|0|||
160882195|NCT02431260|580963040|FG011|Overall Study|Physician Decision|0|||
160882196|NCT02431260|580963041|FG012|Overall Study|Physician Decision|0|||
160882197|NCT02431260|580963042|FG013|Overall Study|Physician Decision|0|||
160882198|NCT02431260|580963029|FG000|Overall Study|Other Unspecified|0|||
160882199|NCT02431260|580963030|FG001|Overall Study|Other Unspecified|0|||
160882200|NCT02431260|580963031|FG002|Overall Study|Other Unspecified|0|||
160882201|NCT02431260|580963032|FG003|Overall Study|Other Unspecified|0|||
160882202|NCT02431260|580963033|FG004|Overall Study|Other Unspecified|0|||
160882203|NCT02431260|580963034|FG005|Overall Study|Other Unspecified|0|||
160882204|NCT02431260|580963035|FG006|Overall Study|Other Unspecified|0|||
160882205|NCT02431260|580963036|FG007|Overall Study|Other Unspecified|0|||
160882206|NCT02431260|580963037|FG008|Overall Study|Other Unspecified|0|||
160882207|NCT02431260|580963038|FG009|Overall Study|Other Unspecified|0|||
160882208|NCT02431260|580963039|FG010|Overall Study|Other Unspecified|0|||
160882209|NCT02431260|580963040|FG011|Overall Study|Other Unspecified|1|||
160882210|NCT02431260|580963041|FG012|Overall Study|Other Unspecified|1|||
160882211|NCT02431260|580963042|FG013|Overall Study|Other Unspecified|0|||
160540176|NCT03699007|579707519|FG001|6-month Follow Up|Lost to Follow-up|3|||
160540177|NCT01970995|579707520|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
160882212|NCT00321646|580963043|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
160882213|NCT00321646|580963043|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
160882214|NCT00321646|580963043|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
160882215|NCT00336583|580964332|FG000|Overall Study|Lost to Follow-up|1|||
160882216|NCT00336583|580964332|FG000|Overall Study|Death|1|||
160882217|NCT02276027|580964335|FG000|Overall Study|Death|1|||
160882218|NCT02276027|580964336|FG001|Overall Study|Death|0|||
160882219|NCT02276027|580964337|FG002|Overall Study|Death|0|||
160882220|NCT02276027|580964338|FG003|Overall Study|Death|2|||
160882221|NCT02276027|580964335|FG000|Overall Study|Physician Decision|0|||
160882222|NCT02276027|580964336|FG001|Overall Study|Physician Decision|0|||
160882223|NCT02276027|580964337|FG002|Overall Study|Physician Decision|0|||
160882224|NCT02276027|580964338|FG003|Overall Study|Physician Decision|1|||
160882225|NCT02276027|580964335|FG000|Overall Study|Progressive disease|1|||
160882226|NCT02276027|580964336|FG001|Overall Study|Progressive disease|13|||
160882227|NCT02276027|580964337|FG002|Overall Study|Progressive disease|12|||
160882228|NCT02276027|580964338|FG003|Overall Study|Progressive disease|14|||
160882229|NCT02276027|580964335|FG000|Overall Study|Subject/guardian decision|0|||
160882230|NCT02276027|580964336|FG001|Overall Study|Subject/guardian decision|1|||
160882231|NCT02276027|580964337|FG002|Overall Study|Subject/guardian decision|0|||
160882232|NCT02276027|580964338|FG003|Overall Study|Subject/guardian decision|3|||
160882233|NCT02276027|580964335|FG000|Overall Study|Adverse Event|0|||
160882234|NCT02276027|580964336|FG001|Overall Study|Adverse Event|2|||
160882235|NCT02276027|580964337|FG002|Overall Study|Adverse Event|8|||
160882236|NCT02276027|580964338|FG003|Overall Study|Adverse Event|2|||
160882237|NCT03224598|580964339|FG000|Overall Study|Lost to Follow-up|0|||
160882238|NCT03224598|580964340|FG001|Overall Study|Lost to Follow-up|2|||
160882239|NCT03224598|580964341|FG002|Overall Study|Lost to Follow-up|0|||
160882240|NCT03224598|580964339|FG000|Overall Study|Other|0|||
160882241|NCT03224598|580964340|FG001|Overall Study|Other|1|||
160882242|NCT03224598|580964341|FG002|Overall Study|Other|0|||
160882243|NCT03328182|580964344|FG000|Overall Study|Withdrawal by Subject|1|||
160882244|NCT03328182|580964344|FG000|Overall Study|Protocol Violation|2|||
160882245|NCT03328182|580964344|FG000|Overall Study|No Product Evaluated|1|||
160882246|NCT00003830|580964345|FG000|Overall Study|No follow up data|3|||
160882247|NCT00003830|580964346|FG001|Overall Study|No follow up data|0|||
160882248|NCT00003830|580964345|FG000|Overall Study|Sentinel node positive patients|829|||
160882249|NCT00003830|580964346|FG001|Overall Study|Sentinel node positive patients|793|||
160882250|NCT01095094|580964347|FG000|Overall Study|Withdrawal by Subject|1|||
160882251|NCT01095094|580964347|FG000|Overall Study|Death|1|||
160882252|NCT01095094|580964347|FG000|Overall Study|Physician Decision|1|||
160882253|NCT05347147|580964348|FG000|Overall Study|Lost to Follow-up|0|||
160882254|NCT05347147|580964349|FG001|Overall Study|Lost to Follow-up|1|||
160882255|NCT05347147|580964348|FG000|Overall Study|Sponsor request|3|||
160882256|NCT05347147|580964349|FG001|Overall Study|Sponsor request|3|||
160882257|NCT05347147|580964348|FG000|Overall Study|Study termination|2|||
160882258|NCT05347147|580964349|FG001|Overall Study|Study termination|1|||
160882259|NCT00137839|580964351|FG000|Overall Study|Adverse Event|7|||
160882260|NCT00137839|580964351|FG000|Overall Study|Physician Decision|7|||
160882261|NCT00137839|580964351|FG000|Overall Study|Death|8|||
160882262|NCT00137839|580964351|FG000|Overall Study|Disease Progression|60|||
160882263|NCT00137839|580964351|FG000|Overall Study|Not Start Treatment|1|||
160882264|NCT00137839|580964351|FG000|Overall Study|Prolonged Treatment Delay|1|||
160882265|NCT01122394|580964352|FG000|Overall Study|Withdrawal by Subject|1|||
160882266|NCT01122394|580964353|FG001|Overall Study|Withdrawal by Subject|1|||
160882267|NCT01122394|580964352|FG000|Overall Study|Lost to Follow-up|2|||
160882268|NCT01122394|580964353|FG001|Overall Study|Lost to Follow-up|2|||
160882269|NCT01122394|580964352|FG000|Overall Study|Adverse Event|0|||
160882270|NCT01122394|580964353|FG001|Overall Study|Adverse Event|1|||
160882271|NCT03739242|580964354|FG000|Overall Study|Withdrawal by Subject|1|||
160882272|NCT03739242|580964355|FG001|Overall Study|Withdrawal by Subject|1|||
160882273|NCT03739242|580964354|FG000|Overall Study|Protocol Violation|0|||
160882274|NCT03739242|580964355|FG001|Overall Study|Protocol Violation|1|||
160882275|NCT03086967|580964356|FG000|Overall Study|Screen Failure|2|||
160882276|NCT03086967|580964357|FG001|Overall Study|Screen Failure|2|||
160882277|NCT03361176|580964358|FG000|Overall Study|Lost to Follow-up|1|||
160882278|NCT03361176|580964359|FG001|Overall Study|Lost to Follow-up|2|||
160882279|NCT03361176|580964358|FG000|Overall Study|Adverse Event|0|||
160882280|NCT03361176|580964359|FG001|Overall Study|Adverse Event|2|||
160882281|NCT03361176|580964358|FG000|Overall Study|Withdrawal by Subject|0|||
160882282|NCT03361176|580964359|FG001|Overall Study|Withdrawal by Subject|1|||
160882283|NCT02230527|580964363|FG000|Overall Study|Withdrawal by Subject|1|||
160882284|NCT02230527|580964364|FG001|Overall Study|Withdrawal by Subject|1|||
160882285|NCT02230527|580964363|FG000|Overall Study|Death|1|||
160882286|NCT02230527|580964364|FG001|Overall Study|Death|0|||
160882287|NCT02230527|580964363|FG000|Overall Study|Lost to Follow-up|2|||
160882288|NCT02230527|580964364|FG001|Overall Study|Lost to Follow-up|1|||
160882289|NCT02230527|580964363|FG000|Overall Study|Other|1|||
160882290|NCT02230527|580964364|FG001|Overall Study|Other|0|||
160882291|NCT01752036|580964365|FG000|Overall Study|Death|2|||
160882292|NCT01011478|580964366|FG000|Overall Study|No follow up data|12|||
160882293|NCT01011478|580964367|FG001|Overall Study|No follow up data|7|||
160882294|NCT01437995|580964371|FG000|Overall Study|Lost to Follow-up|11|||
160770937|NCT04761822|580548807|FG001|Overall Study|Withdrawal by Subject|8|||
160770938|NCT04761822|580548808|FG002|Overall Study|Withdrawal by Subject|1|||
160770939|NCT04761822|580548809|FG003|Overall Study|Withdrawal by Subject|11|||
160770940|NCT04761822|580548806|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
160770941|NCT04761822|580548807|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
160770942|NCT04761822|580548808|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
160770943|NCT04761822|580548809|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
160770944|NCT04761822|580548806|FG000|Overall Study|Participant requested unblinding|0|||
160770945|NCT04761822|580548807|FG001|Overall Study|Participant requested unblinding|0|||
160770946|NCT04761822|580548808|FG002|Overall Study|Participant requested unblinding|0|||
160770947|NCT04761822|580548809|FG003|Overall Study|Participant requested unblinding|1|||
160770948|NCT00362232|580548810|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
160770949|NCT00362232|580548811|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
160770950|NCT00362232|580548810|FG000|Treatment (12 +/- 2 Days)|Death|1|||
160770951|NCT00362232|580548811|FG001|Treatment (12 +/- 2 Days)|Death|3|||
160770952|NCT00362232|580548810|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
160770953|NCT00362232|580548811|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
160770954|NCT00362232|580548810|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
160770955|NCT00362232|580548811|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
160770956|NCT00362232|580548810|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
160770957|NCT00362232|580548811|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
160770958|NCT00362232|580548810|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
160770959|NCT00362232|580548811|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
160770960|NCT00362232|580548810|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
160770961|NCT00362232|580548811|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
160770962|NCT00362232|580548810|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
160770963|NCT00362232|580548811|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
160770964|NCT00362232|580548810|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
160770965|NCT00362232|580548811|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
160770966|NCT00362232|580548810|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
160770967|NCT00362232|580548811|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
160770968|NCT00362232|580548810|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
160770969|NCT00362232|580548811|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
160770970|NCT00362232|580548810|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
160770971|NCT00362232|580548811|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
160770972|NCT00362232|580548810|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
160770973|NCT00362232|580548811|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
160770974|NCT02233413|580548816|FG000|Overall Study|Lost to Follow-up|7|||
160770975|NCT02233413|580548817|FG001|Overall Study|Lost to Follow-up|9|||
160770976|NCT02233413|580548816|FG000|Overall Study|Withdrawal by Subject|4|||
160770977|NCT02233413|580548817|FG001|Overall Study|Withdrawal by Subject|5|||
160770978|NCT01799889|580548818|FG000|Overall Study|Adverse Event|4|||
160770979|NCT01799889|580548819|FG001|Overall Study|Adverse Event|4|||
160770980|NCT01799889|580548820|FG002|Overall Study|Adverse Event|5|||
160770981|NCT01799889|580548821|FG003|Overall Study|Adverse Event|1|||
160770982|NCT01799889|580548822|FG004|Overall Study|Adverse Event|11|||
160770983|NCT01799889|580548823|FG005|Overall Study|Adverse Event|1|||
160770984|NCT01799889|580548824|FG006|Overall Study|Adverse Event|5|||
160770985|NCT01799889|580548825|FG007|Overall Study|Adverse Event|2|||
160770986|NCT01799889|580548826|FG008|Overall Study|Adverse Event|3|||
160770987|NCT01799889|580548827|FG009|Overall Study|Adverse Event|1|||
160770988|NCT01799889|580548828|FG010|Overall Study|Adverse Event|1|||
160770989|NCT01799889|580548829|FG011|Overall Study|Adverse Event|0|||
160770990|NCT01799889|580548818|FG000|Overall Study|Death|1|||
160770991|NCT01799889|580548819|FG001|Overall Study|Death|0|||
160770992|NCT01799889|580548820|FG002|Overall Study|Death|5|||
160770993|NCT01799889|580548821|FG003|Overall Study|Death|3|||
160770994|NCT01799889|580548822|FG004|Overall Study|Death|1|||
160770995|NCT01799889|580548823|FG005|Overall Study|Death|0|||
160770996|NCT01799889|580548824|FG006|Overall Study|Death|0|||
160770997|NCT01799889|580548825|FG007|Overall Study|Death|0|||
160770998|NCT01799889|580548826|FG008|Overall Study|Death|1|||
160770999|NCT01799889|580548827|FG009|Overall Study|Death|0|||
160771000|NCT01799889|580548828|FG010|Overall Study|Death|1|||
160771001|NCT01799889|580548829|FG011|Overall Study|Death|0|||
160771002|NCT01799889|580548818|FG000|Overall Study|Lack of Efficacy|1|||
160771003|NCT01799889|580548819|FG001|Overall Study|Lack of Efficacy|1|||
160771004|NCT01799889|580548820|FG002|Overall Study|Lack of Efficacy|0|||
160771005|NCT01799889|580548821|FG003|Overall Study|Lack of Efficacy|1|||
160771006|NCT01799889|580548822|FG004|Overall Study|Lack of Efficacy|2|||
160771007|NCT01799889|580548823|FG005|Overall Study|Lack of Efficacy|2|||
160771008|NCT01799889|580548824|FG006|Overall Study|Lack of Efficacy|0|||
160771009|NCT01799889|580548825|FG007|Overall Study|Lack of Efficacy|0|||
160771010|NCT01799889|580548826|FG008|Overall Study|Lack of Efficacy|2|||
160771011|NCT01799889|580548827|FG009|Overall Study|Lack of Efficacy|0|||
160771012|NCT01799889|580548828|FG010|Overall Study|Lack of Efficacy|1|||
160771013|NCT01799889|580548829|FG011|Overall Study|Lack of Efficacy|0|||
160771014|NCT01799889|580548818|FG000|Overall Study|Lost to Follow-up|0|||
160636872|NCT00363129|580053635|FG001|Overall Study|Withdrawal by Subject|18|||
160636873|NCT00363129|580053634|FG000|Overall Study|Adverse Event|8|||
160636874|NCT00363129|580053635|FG001|Overall Study|Adverse Event|3|||
160636875|NCT00363129|580053634|FG000|Overall Study|Alternate Treatment|2|||
160636876|NCT00363129|580053635|FG001|Overall Study|Alternate Treatment|4|||
160771015|NCT01799889|580548819|FG001|Overall Study|Lost to Follow-up|1|||
160771016|NCT01799889|580548820|FG002|Overall Study|Lost to Follow-up|0|||
160771017|NCT01799889|580548821|FG003|Overall Study|Lost to Follow-up|0|||
160771018|NCT01799889|580548822|FG004|Overall Study|Lost to Follow-up|0|||
160771019|NCT01799889|580548823|FG005|Overall Study|Lost to Follow-up|0|||
160771020|NCT01799889|580548824|FG006|Overall Study|Lost to Follow-up|0|||
160771021|NCT01799889|580548825|FG007|Overall Study|Lost to Follow-up|0|||
160771022|NCT01799889|580548826|FG008|Overall Study|Lost to Follow-up|0|||
160771023|NCT01799889|580548827|FG009|Overall Study|Lost to Follow-up|0|||
160771024|NCT01799889|580548828|FG010|Overall Study|Lost to Follow-up|0|||
160771025|NCT01799889|580548829|FG011|Overall Study|Lost to Follow-up|0|||
160771026|NCT01799889|580548818|FG000|Overall Study|Physician Decision|3|||
160771027|NCT01799889|580548819|FG001|Overall Study|Physician Decision|2|||
160771028|NCT01799889|580548820|FG002|Overall Study|Physician Decision|4|||
160771029|NCT01799889|580548821|FG003|Overall Study|Physician Decision|4|||
160771030|NCT01799889|580548822|FG004|Overall Study|Physician Decision|5|||
160771031|NCT01799889|580548823|FG005|Overall Study|Physician Decision|5|||
160771032|NCT01799889|580548824|FG006|Overall Study|Physician Decision|5|||
160771033|NCT01799889|580548825|FG007|Overall Study|Physician Decision|2|||
160771034|NCT01799889|580548826|FG008|Overall Study|Physician Decision|6|||
160771035|NCT01799889|580548827|FG009|Overall Study|Physician Decision|0|||
160771036|NCT01799889|580548828|FG010|Overall Study|Physician Decision|0|||
160771037|NCT01799889|580548829|FG011|Overall Study|Physician Decision|1|||
160771038|NCT01799889|580548818|FG000|Overall Study|Progressive Disease|30|||
160771039|NCT01799889|580548819|FG001|Overall Study|Progressive Disease|26|||
160636877|NCT00363129|580053634|FG000|Overall Study|Other Medical Problems|2|||
160771040|NCT01799889|580548820|FG002|Overall Study|Progressive Disease|25|||
160771041|NCT01799889|580548821|FG003|Overall Study|Progressive Disease|30|||
160771042|NCT01799889|580548822|FG004|Overall Study|Progressive Disease|23|||
160771043|NCT01799889|580548823|FG005|Overall Study|Progressive Disease|9|||
160771044|NCT01799889|580548824|FG006|Overall Study|Progressive Disease|8|||
160771045|NCT01799889|580548825|FG007|Overall Study|Progressive Disease|13|||
160771046|NCT01799889|580548826|FG008|Overall Study|Progressive Disease|18|||
160771047|NCT01799889|580548827|FG009|Overall Study|Progressive Disease|5|||
160771048|NCT01799889|580548828|FG010|Overall Study|Progressive Disease|3|||
160771049|NCT01799889|580548829|FG011|Overall Study|Progressive Disease|1|||
160771050|NCT01799889|580548818|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
160771051|NCT01799889|580548819|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
160771052|NCT01799889|580548820|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
160771053|NCT01799889|580548821|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
160771054|NCT01799889|580548822|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
160771055|NCT01799889|580548823|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
160771056|NCT01799889|580548824|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
160771057|NCT01799889|580548825|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
160771058|NCT01799889|580548826|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
160771059|NCT01799889|580548827|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
160771060|NCT01799889|580548828|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
160771061|NCT01799889|580548829|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
160771062|NCT01799889|580548818|FG000|Overall Study|Study Terminated By Sponsor|1|||
160771063|NCT01799889|580548819|FG001|Overall Study|Study Terminated By Sponsor|0|||
160771064|NCT01799889|580548820|FG002|Overall Study|Study Terminated By Sponsor|0|||
160771065|NCT01799889|580548821|FG003|Overall Study|Study Terminated By Sponsor|0|||
160771066|NCT01799889|580548822|FG004|Overall Study|Study Terminated By Sponsor|2|||
160771067|NCT01799889|580548823|FG005|Overall Study|Study Terminated By Sponsor|1|||
160771068|NCT01799889|580548824|FG006|Overall Study|Study Terminated By Sponsor|0|||
160771069|NCT01799889|580548825|FG007|Overall Study|Study Terminated By Sponsor|2|||
160771070|NCT01799889|580548826|FG008|Overall Study|Study Terminated By Sponsor|1|||
160771071|NCT01799889|580548827|FG009|Overall Study|Study Terminated By Sponsor|1|||
160771072|NCT01799889|580548828|FG010|Overall Study|Study Terminated By Sponsor|0|||
160771073|NCT01799889|580548829|FG011|Overall Study|Study Terminated By Sponsor|0|||
160771074|NCT01799889|580548818|FG000|Overall Study|Withdrawal by Subject|1|||
160771075|NCT01799889|580548819|FG001|Overall Study|Withdrawal by Subject|6|||
160771076|NCT01799889|580548820|FG002|Overall Study|Withdrawal by Subject|4|||
160771077|NCT01799889|580548821|FG003|Overall Study|Withdrawal by Subject|0|||
160771078|NCT01799889|580548822|FG004|Overall Study|Withdrawal by Subject|5|||
160771079|NCT01799889|580548823|FG005|Overall Study|Withdrawal by Subject|1|||
160771080|NCT01799889|580548824|FG006|Overall Study|Withdrawal by Subject|3|||
160771081|NCT01799889|580548825|FG007|Overall Study|Withdrawal by Subject|1|||
160771082|NCT01799889|580548826|FG008|Overall Study|Withdrawal by Subject|2|||
160771083|NCT01799889|580548827|FG009|Overall Study|Withdrawal by Subject|1|||
160771084|NCT01799889|580548828|FG010|Overall Study|Withdrawal by Subject|1|||
160771085|NCT01799889|580548829|FG011|Overall Study|Withdrawal by Subject|1|||
160771086|NCT01799889|580548818|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160771087|NCT01799889|580548819|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160771088|NCT01799889|580548820|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160771089|NCT01799889|580548821|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160771090|NCT01799889|580548822|FG004|Overall Study|Non-Compliance With Study Drug|0|||
160771091|NCT01799889|580548823|FG005|Overall Study|Non-Compliance With Study Drug|1|||
160771092|NCT01799889|580548824|FG006|Overall Study|Non-Compliance With Study Drug|0|||
160771093|NCT01799889|580548825|FG007|Overall Study|Non-Compliance With Study Drug|0|||
160771094|NCT01799889|580548826|FG008|Overall Study|Non-Compliance With Study Drug|0|||
160771095|NCT01799889|580548827|FG009|Overall Study|Non-Compliance With Study Drug|0|||
160771096|NCT01799889|580548828|FG010|Overall Study|Non-Compliance With Study Drug|0|||
160771097|NCT01799889|580548829|FG011|Overall Study|Non-Compliance With Study Drug|0|||
160771098|NCT06217380|580548830|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
160771099|NCT06217380|580548830|FG000|Overall Study|Physician Decision|1|||
160771100|NCT06217380|580548830|FG000|Overall Study|Withdrawal by Subject|2|||
160771101|NCT06633965|580548831|FG000|Overall Study|Withdrawal by Subject|0|||
160771102|NCT06633965|580548832|FG001|Overall Study|Withdrawal by Subject|1|||
160771103|NCT00300053|580548838|FG000|Overall Study|Patient/Caregiver Preference|2|||
160771104|NCT00300053|580548839|FG001|Overall Study|Patient/Caregiver Preference|2|||
160771105|NCT00300053|580548840|FG002|Overall Study|Patient/Caregiver Preference|3|||
160771106|NCT00300053|580548838|FG000|Overall Study|Death|0|||
160771107|NCT00300053|580548839|FG001|Overall Study|Death|0|||
160771108|NCT00300053|580548840|FG002|Overall Study|Death|3|||
160771109|NCT00300053|580548838|FG000|Overall Study|Lost to Follow-up|0|||
160882295|NCT01437995|580964372|FG001|Overall Study|Lost to Follow-up|18|||
160882296|NCT01437995|580964373|FG002|Overall Study|Lost to Follow-up|20|||
160882297|NCT04456673|580964374|FG000|Overall Study|Adverse Event|7|||
160882298|NCT04456673|580964375|FG001|Overall Study|Adverse Event|14|||
160882299|NCT04456673|580964374|FG000|Overall Study|Poor compliance to protocol|1|||
160882300|NCT04456673|580964375|FG001|Overall Study|Poor compliance to protocol|0|||
160882301|NCT04456673|580964374|FG000|Overall Study|Withdrawal by Subject|31|||
160882302|NCT04456673|580964375|FG001|Overall Study|Withdrawal by Subject|23|||
160882303|NCT04456673|580964374|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
160882304|NCT04456673|580964375|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
160636878|NCT00363129|580053635|FG001|Overall Study|Other Medical Problems|4|||
160636879|NCT00363129|580053634|FG000|Overall Study|Death|0|||
160636880|NCT00363129|580053635|FG001|Overall Study|Death|1|||
160636881|NCT00363129|580053634|FG000|Overall Study|Other Reasons|6|||
160636882|NCT00363129|580053635|FG001|Overall Study|Other Reasons|3|||
160636883|NCT00659581|580053636|FG000|Overall Study|Adverse Event|1006|||
160636884|NCT00659581|580053636|FG000|Overall Study|Lack of Efficacy|1183|||
160636885|NCT00659581|580053636|FG000|Overall Study|Other|6393|||
160636886|NCT01892020|580053638|FG000|Period 1|Adverse Event|1|||
160636887|NCT01892020|580053639|FG001|Period 1|Adverse Event|1|||
160636888|NCT01892020|580053638|FG000|Period 1|Protocol Violation|2|||
160636889|NCT01892020|580053639|FG001|Period 1|Protocol Violation|4|||
160636890|NCT01892020|580053638|FG000|Period 1|Unclassified|0|||
160636891|NCT01892020|580053639|FG001|Period 1|Unclassified|1|||
160636892|NCT01892020|580053638|FG000|Period 2|Protocol Violation|1|||
160636893|NCT01892020|580053639|FG001|Period 2|Protocol Violation|0|||
160636894|NCT01831596|580053641|FG000|Overall Study|Other|8|||
160636895|NCT02508649|580053642|FG000|Overall Study|Withdrawal by Subject|4|||
160636896|NCT02508649|580053643|FG001|Overall Study|Withdrawal by Subject|6|||
160636897|NCT02508649|580053644|FG002|Overall Study|Withdrawal by Subject|5|||
160636898|NCT02508649|580053645|FG003|Overall Study|Withdrawal by Subject|6|||
160636899|NCT02508649|580053642|FG000|Overall Study|Investigator withdrew the subject|1|||
160636900|NCT02508649|580053643|FG001|Overall Study|Investigator withdrew the subject|2|||
160636901|NCT02508649|580053644|FG002|Overall Study|Investigator withdrew the subject|1|||
160636902|NCT02508649|580053645|FG003|Overall Study|Investigator withdrew the subject|0|||
160636903|NCT02508649|580053642|FG000|Overall Study|Post randomization screening failure|12|||
160636904|NCT02508649|580053643|FG001|Overall Study|Post randomization screening failure|4|||
160636905|NCT02508649|580053644|FG002|Overall Study|Post randomization screening failure|9|||
160636906|NCT02508649|580053645|FG003|Overall Study|Post randomization screening failure|3|||
160636907|NCT02508649|580053642|FG000|Overall Study|Lost to Follow-up|1|||
160636908|NCT02508649|580053643|FG001|Overall Study|Lost to Follow-up|1|||
160636909|NCT02508649|580053644|FG002|Overall Study|Lost to Follow-up|0|||
160636910|NCT02508649|580053645|FG003|Overall Study|Lost to Follow-up|1|||
160636911|NCT00446134|580053646|FG000|Overall Study|Adverse Event|7|||
160636912|NCT00446134|580053647|FG001|Overall Study|Adverse Event|17|||
160636913|NCT00446134|580053648|FG002|Overall Study|Adverse Event|13|||
160636914|NCT00446134|580053649|FG003|Overall Study|Adverse Event|18|||
160636915|NCT00446134|580053646|FG000|Overall Study|Lack of Efficacy|19|||
160882305|NCT02160002|580964376|FG000|Overall Study|Withdrawal by Subject|2|||
160882306|NCT02160002|580964377|FG001|Overall Study|Withdrawal by Subject|1|||
160882307|NCT04395001|580964379|FG000|Overall Study|Lost to Follow-up|8|||
160882308|NCT04395001|580964380|FG001|Overall Study|Lost to Follow-up|9|||
160882309|NCT04395001|580964381|FG002|Overall Study|Lost to Follow-up|5|||
160882310|NCT04395001|580964379|FG000|Overall Study|Withdrawal by Subject|3|||
160882311|NCT04395001|580964380|FG001|Overall Study|Withdrawal by Subject|1|||
160882312|NCT04395001|580964381|FG002|Overall Study|Withdrawal by Subject|3|||
160882313|NCT04395001|580964379|FG000|Overall Study|missed appointment|7|||
160882314|NCT04395001|580964380|FG001|Overall Study|missed appointment|4|||
160882315|NCT04395001|580964381|FG002|Overall Study|missed appointment|1|||
160882316|NCT04418661|580964382|FG000|Overall Study|Adverse Event|0|||
160882317|NCT04418661|580964383|FG001|Overall Study|Adverse Event|1|||
160882318|NCT04418661|580964384|FG002|Overall Study|Adverse Event|5|||
160882319|NCT04418661|580964385|FG003|Overall Study|Adverse Event|3|||
160882320|NCT04418661|580964386|FG004|Overall Study|Adverse Event|0|||
160882321|NCT04418661|580964387|FG005|Overall Study|Adverse Event|2|||
160882322|NCT04418661|580964382|FG000|Overall Study|Progressive disease|4|||
160882323|NCT04418661|580964383|FG001|Overall Study|Progressive disease|11|||
160882324|NCT04418661|580964384|FG002|Overall Study|Progressive disease|6|||
160882325|NCT04418661|580964385|FG003|Overall Study|Progressive disease|11|||
160882326|NCT04418661|580964386|FG004|Overall Study|Progressive disease|1|||
160882327|NCT04418661|580964387|FG005|Overall Study|Progressive disease|12|||
160882328|NCT04418661|580964382|FG000|Overall Study|Withdrawal by Subject|0|||
160882329|NCT04418661|580964383|FG001|Overall Study|Withdrawal by Subject|1|||
160882330|NCT04418661|580964384|FG002|Overall Study|Withdrawal by Subject|0|||
160636916|NCT00446134|580053647|FG001|Overall Study|Lack of Efficacy|19|||
160636917|NCT00446134|580053648|FG002|Overall Study|Lack of Efficacy|24|||
160882331|NCT04418661|580964385|FG003|Overall Study|Withdrawal by Subject|1|||
160882332|NCT04418661|580964386|FG004|Overall Study|Withdrawal by Subject|0|||
160636918|NCT00446134|580053649|FG003|Overall Study|Lack of Efficacy|19|||
160636919|NCT00446134|580053646|FG000|Overall Study|Protocol Violation|0|||
160636920|NCT00446134|580053647|FG001|Overall Study|Protocol Violation|2|||
160636921|NCT00446134|580053648|FG002|Overall Study|Protocol Violation|1|||
160636922|NCT00446134|580053649|FG003|Overall Study|Protocol Violation|0|||
160636923|NCT00446134|580053646|FG000|Overall Study|Lost to Follow-up|1|||
160636924|NCT00446134|580053647|FG001|Overall Study|Lost to Follow-up|3|||
160636925|NCT00446134|580053648|FG002|Overall Study|Lost to Follow-up|1|||
160636926|NCT00446134|580053649|FG003|Overall Study|Lost to Follow-up|1|||
160636927|NCT00446134|580053646|FG000|Overall Study|Withdrawal by Subject|3|||
160636928|NCT00446134|580053647|FG001|Overall Study|Withdrawal by Subject|3|||
160636929|NCT00446134|580053648|FG002|Overall Study|Withdrawal by Subject|1|||
160636930|NCT00446134|580053649|FG003|Overall Study|Withdrawal by Subject|3|||
160636931|NCT00446134|580053646|FG000|Overall Study|Physician Decision|0|||
160636932|NCT00446134|580053647|FG001|Overall Study|Physician Decision|0|||
160636933|NCT00446134|580053648|FG002|Overall Study|Physician Decision|0|||
160636934|NCT00446134|580053649|FG003|Overall Study|Physician Decision|2|||
160636935|NCT00446134|580053646|FG000|Overall Study|Adverse Event-Diarrhea|1|||
160636936|NCT00446134|580053647|FG001|Overall Study|Adverse Event-Diarrhea|1|||
160636937|NCT00446134|580053648|FG002|Overall Study|Adverse Event-Diarrhea|2|||
160636938|NCT00446134|580053649|FG003|Overall Study|Adverse Event-Diarrhea|0|||
160636939|NCT00446134|580053646|FG000|Overall Study|Reason Not Completed|3|||
160636940|NCT00446134|580053647|FG001|Overall Study|Reason Not Completed|0|||
160636941|NCT00446134|580053648|FG002|Overall Study|Reason Not Completed|1|||
160636942|NCT00446134|580053649|FG003|Overall Study|Reason Not Completed|2|||
160636943|NCT00567996|580053656|FG000|Overall Study|Adverse Event|18|||
160636944|NCT00567996|580053657|FG001|Overall Study|Adverse Event|16|||
160636945|NCT00567996|580053658|FG002|Overall Study|Adverse Event|13|||
160636946|NCT00567996|580053656|FG000|Overall Study|Protocol Deviation|9|||
160636947|NCT00567996|580053657|FG001|Overall Study|Protocol Deviation|11|||
160636948|NCT00567996|580053658|FG002|Overall Study|Protocol Deviation|13|||
160636949|NCT00567996|580053656|FG000|Overall Study|Withdrawal by Subject|8|||
160636950|NCT00567996|580053657|FG001|Overall Study|Withdrawal by Subject|12|||
160771110|NCT00300053|580548839|FG001|Overall Study|Lost to Follow-up|1|||
160771111|NCT00300053|580548840|FG002|Overall Study|Lost to Follow-up|0|||
160771112|NCT03095287|580548841|FG000|Overall Study|Treatment Failure|1|||
160771113|NCT03095287|580548841|FG000|Overall Study|Adverse Event|1|||
160771114|NCT01294514|580548844|FG000|Overall Study|Excluded due to Arrhythmia|1|||
160771115|NCT05350423|580548845|FG000|Overall Study|Lost to Follow-up|3|||
160771116|NCT05350423|580548846|FG001|Overall Study|Lost to Follow-up|3|||
160771117|NCT05350423|580548845|FG000|Overall Study|screen failure|5|||
160771118|NCT05350423|580548846|FG001|Overall Study|screen failure|6|||
160771119|NCT02097277|580548847|FG000|Overall Study|Subject no longer meets study criteria|0|||
160771120|NCT02097277|580548848|FG001|Overall Study|Subject no longer meets study criteria|1|||
160771121|NCT02097277|580548849|FG002|Overall Study|Subject no longer meets study criteria|0|||
160771122|NCT02097277|580548850|FG003|Overall Study|Subject no longer meets study criteria|1|||
160771123|NCT02097277|580548851|FG004|Overall Study|Subject no longer meets study criteria|0|||
160771124|NCT02097277|580548847|FG000|Overall Study|Subject request to discontinue treatment|0|||
160771125|NCT02097277|580548848|FG001|Overall Study|Subject request to discontinue treatment|0|||
160771126|NCT02097277|580548849|FG002|Overall Study|Subject request to discontinue treatment|0|||
160771127|NCT02097277|580548850|FG003|Overall Study|Subject request to discontinue treatment|0|||
160771128|NCT02097277|580548851|FG004|Overall Study|Subject request to discontinue treatment|1|||
160771129|NCT02097277|580548847|FG000|Overall Study|Lost to Follow-up|0|||
160771130|NCT02097277|580548848|FG001|Overall Study|Lost to Follow-up|1|||
160771131|NCT02097277|580548849|FG002|Overall Study|Lost to Follow-up|1|||
160771132|NCT02097277|580548850|FG003|Overall Study|Lost to Follow-up|0|||
160771133|NCT02097277|580548851|FG004|Overall Study|Lost to Follow-up|0|||
160771134|NCT02097277|580548847|FG000|Overall Study|Withdrawal by Subject|2|||
160771135|NCT02097277|580548848|FG001|Overall Study|Withdrawal by Subject|1|||
160771136|NCT02097277|580548849|FG002|Overall Study|Withdrawal by Subject|0|||
160771137|NCT02097277|580548850|FG003|Overall Study|Withdrawal by Subject|1|||
160771138|NCT02097277|580548851|FG004|Overall Study|Withdrawal by Subject|0|||
160771139|NCT02097277|580548847|FG000|Overall Study|Adverse Event|0|||
160771140|NCT02097277|580548848|FG001|Overall Study|Adverse Event|0|||
160771141|NCT02097277|580548849|FG002|Overall Study|Adverse Event|1|||
160771142|NCT02097277|580548850|FG003|Overall Study|Adverse Event|2|||
160771143|NCT02097277|580548851|FG004|Overall Study|Adverse Event|0|||
160771144|NCT00984867|580548855|FG000|Overall Study|Adverse Event|3|||
160771145|NCT00984867|580548856|FG001|Overall Study|Adverse Event|7|||
160771146|NCT00984867|580548855|FG000|Overall Study|Death|1|||
160771147|NCT00984867|580548856|FG001|Overall Study|Death|0|||
160771148|NCT00984867|580548855|FG000|Overall Study|Withdrawal by Subject|13|||
160771149|NCT00984867|580548856|FG001|Overall Study|Withdrawal by Subject|4|||
160771150|NCT00984867|580548855|FG000|Overall Study|Lost to Follow-up|3|||
160771151|NCT00984867|580548856|FG001|Overall Study|Lost to Follow-up|4|||
160771152|NCT00984867|580548855|FG000|Overall Study|Poor/non-compliance|0|||
160771153|NCT00984867|580548856|FG001|Overall Study|Poor/non-compliance|1|||
160771154|NCT00984867|580548855|FG000|Overall Study|Subject no longer meets study criteria|1|||
160771155|NCT00984867|580548856|FG001|Overall Study|Subject no longer meets study criteria|1|||
160771156|NCT00984867|580548855|FG000|Overall Study|site closing|1|||
160771157|NCT00984867|580548856|FG001|Overall Study|site closing|0|||
160771158|NCT00984867|580548855|FG000|Overall Study|lack of efficacy and subject compliance|1|||
160771159|NCT00984867|580548856|FG001|Overall Study|lack of efficacy and subject compliance|0|||
160771160|NCT00671060|580548857|FG000|Overall Study|Protocol Violation|1|||
160771161|NCT00671060|580548858|FG001|Overall Study|Protocol Violation|0|||
160771162|NCT00671060|580548857|FG000|Overall Study|Physician Decision|0|||
160771163|NCT00671060|580548858|FG001|Overall Study|Physician Decision|1|||
160771164|NCT00626639|580548866|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
160771165|NCT00626639|580548867|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
160771166|NCT01461551|580548868|FG000|Overall Study|Physician Decision|2|||
160882333|NCT04418661|580964387|FG005|Overall Study|Withdrawal by Subject|0|||
160882334|NCT04418661|580964382|FG000|Overall Study|Other|0|||
160882335|NCT04418661|580964383|FG001|Overall Study|Other|0|||
160882336|NCT04418661|580964384|FG002|Overall Study|Other|1|||
160882337|NCT04418661|580964385|FG003|Overall Study|Other|3|||
160882338|NCT04418661|580964386|FG004|Overall Study|Other|0|||
160882339|NCT04418661|580964387|FG005|Overall Study|Other|1|||
160882340|NCT03337490|580964388|FG000|Overall Study|Withdrawal by Subject|1|||
160882341|NCT03337490|580964389|FG001|Overall Study|Withdrawal by Subject|0|||
160882342|NCT03337490|580964390|FG002|Overall Study|Withdrawal by Subject|0|||
160882343|NCT03337490|580964388|FG000|Overall Study|Lack of Efficacy|10|||
160882344|NCT03337490|580964389|FG001|Overall Study|Lack of Efficacy|12|||
160882345|NCT03337490|580964390|FG002|Overall Study|Lack of Efficacy|35|||
160882346|NCT03337490|580964388|FG000|Overall Study|Physician Decision|0|||
160882347|NCT03337490|580964389|FG001|Overall Study|Physician Decision|1|||
160540178|NCT01970995|579707521|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
160540179|NCT01970995|579707522|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
160540180|NCT01970995|579707520|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
160540181|NCT01970995|579707521|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
160540182|NCT01970995|579707522|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
160540183|NCT01709435|579707523|FG000|Overall Study|Adverse Event|1|||
160540184|NCT01709435|579707524|FG001|Overall Study|Adverse Event|1|||
160540185|NCT01709435|579707525|FG002|Overall Study|Adverse Event|1|||
160540186|NCT01709435|579707526|FG003|Overall Study|Adverse Event|0|||
160540187|NCT01709435|579707527|FG004|Overall Study|Adverse Event|0|||
160540188|NCT01709435|579707528|FG005|Overall Study|Adverse Event|1|||
160540189|NCT01709435|579707523|FG000|Overall Study|Lack of Efficacy|5|||
160540190|NCT01709435|579707524|FG001|Overall Study|Lack of Efficacy|7|||
160540191|NCT01709435|579707525|FG002|Overall Study|Lack of Efficacy|2|||
160540192|NCT01709435|579707526|FG003|Overall Study|Lack of Efficacy|2|||
160540193|NCT01709435|579707527|FG004|Overall Study|Lack of Efficacy|6|||
160540194|NCT01709435|579707528|FG005|Overall Study|Lack of Efficacy|3|||
160540195|NCT01709435|579707523|FG000|Overall Study|Physician Decision|0|||
160540196|NCT01709435|579707524|FG001|Overall Study|Physician Decision|1|||
160540197|NCT01709435|579707525|FG002|Overall Study|Physician Decision|0|||
160540198|NCT01709435|579707526|FG003|Overall Study|Physician Decision|1|||
160540199|NCT01709435|579707527|FG004|Overall Study|Physician Decision|2|||
160540200|NCT01709435|579707528|FG005|Overall Study|Physician Decision|0|||
160540201|NCT01709435|579707523|FG000|Overall Study|Withdrawal by Subject|0|||
160540202|NCT01709435|579707524|FG001|Overall Study|Withdrawal by Subject|0|||
160540203|NCT01709435|579707525|FG002|Overall Study|Withdrawal by Subject|3|||
160540204|NCT01709435|579707526|FG003|Overall Study|Withdrawal by Subject|0|||
160540205|NCT01709435|579707527|FG004|Overall Study|Withdrawal by Subject|2|||
160540206|NCT01709435|579707528|FG005|Overall Study|Withdrawal by Subject|2|||
160540207|NCT01263639|579707529|FG000|Overall Study|Lost to Follow-up|66|||
160540208|NCT01263639|579707530|FG001|Overall Study|Lost to Follow-up|70|||
160540209|NCT01263639|579707529|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
160540210|NCT01263639|579707530|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
160540211|NCT01780662|579707531|FG000|Overall Study|Adverse Event|1|||
160540212|NCT01780662|579707532|FG001|Overall Study|Adverse Event|0|||
160540213|NCT01780662|579707533|FG002|Overall Study|Adverse Event|2|||
160540214|NCT01780662|579707531|FG000|Overall Study|Physician Decision|0|||
160540215|NCT01780662|579707532|FG001|Overall Study|Physician Decision|5|||
160540216|NCT01780662|579707533|FG002|Overall Study|Physician Decision|7|||
160540217|NCT01780662|579707531|FG000|Overall Study|Protocol Violation|0|||
160540218|NCT01780662|579707532|FG001|Overall Study|Protocol Violation|1|||
160540219|NCT01780662|579707533|FG002|Overall Study|Protocol Violation|0|||
160540220|NCT01780662|579707531|FG000|Overall Study|Ineligible|0|||
160540221|NCT01780662|579707532|FG001|Overall Study|Ineligible|0|||
160540222|NCT01780662|579707533|FG002|Overall Study|Ineligible|1|||
160540223|NCT03975920|579707535|FG000|Overall Study|Lost to Follow-up|1|||
160540224|NCT03975920|579707536|FG001|Overall Study|Lost to Follow-up|2|||
160540225|NCT03975920|579707535|FG000|Overall Study|Protocol Violation|1|||
160882348|NCT03337490|580964390|FG002|Overall Study|Physician Decision|0|||
160882349|NCT03337490|580964388|FG000|Overall Study|Lost to Follow-up|0|||
160882350|NCT03337490|580964389|FG001|Overall Study|Lost to Follow-up|1|||
160882351|NCT03337490|580964390|FG002|Overall Study|Lost to Follow-up|0|||
160882352|NCT01689532|580964391|FG000|Overall Study|Adverse Event|9|||
160882353|NCT01689532|580964392|FG001|Overall Study|Adverse Event|5|||
160882354|NCT01689532|580964391|FG000|Overall Study|Lack of Efficacy|2|||
160882355|NCT01689532|580964392|FG001|Overall Study|Lack of Efficacy|2|||
160882356|NCT01689532|580964391|FG000|Overall Study|Withdrawal by Subject|1|||
160882357|NCT01689532|580964392|FG001|Overall Study|Withdrawal by Subject|2|||
160882358|NCT01689532|580964391|FG000|Overall Study|Physician Decision|2|||
160882359|NCT01689532|580964392|FG001|Overall Study|Physician Decision|0|||
160882360|NCT01363349|580964393|FG000|Overall Study|Adverse Event|6|||
160882361|NCT01363349|580964394|FG001|Overall Study|Adverse Event|7|||
160882362|NCT01363349|580964393|FG000|Overall Study|Lack of Efficacy|3|||
160882363|NCT01363349|580964394|FG001|Overall Study|Lack of Efficacy|10|||
160882364|NCT01363349|580964393|FG000|Overall Study|Non compliance/Protocol deviations|2|||
160882365|NCT01363349|580964394|FG001|Overall Study|Non compliance/Protocol deviations|2|||
160882366|NCT01363349|580964393|FG000|Overall Study|Withdrawal by Subject|14|||
160882367|NCT01363349|580964394|FG001|Overall Study|Withdrawal by Subject|6|||
160882368|NCT01363349|580964393|FG000|Overall Study|Lost to Follow-up|5|||
160882369|NCT01363349|580964394|FG001|Overall Study|Lost to Follow-up|6|||
160882370|NCT01363349|580964393|FG000|Overall Study|Not reported|36|||
160882371|NCT01363349|580964394|FG001|Overall Study|Not reported|37|||
160882372|NCT01363349|580964393|FG000|Overall Study|missing|1|||
160882373|NCT01363349|580964394|FG001|Overall Study|missing|2|||
160882374|NCT00917644|580964396|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
160882375|NCT00917644|580964397|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
160882376|NCT00917644|580964396|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
160882377|NCT00917644|580964397|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
160882378|NCT00917644|580964396|FG000|Period 2: Second Intervention|family emergency|1|||
160882379|NCT00917644|580964397|FG001|Period 2: Second Intervention|family emergency|0|||
160882380|NCT02108262|580964407|FG000|Overall Study|Non-compliance|0|||
160636951|NCT00567996|580053658|FG002|Overall Study|Withdrawal by Subject|22|||
160636952|NCT00567996|580053656|FG000|Overall Study|Abnormal Lab value(s)|2|||
160636953|NCT00567996|580053657|FG001|Overall Study|Abnormal Lab value(s)|1|||
160636954|NCT00567996|580053658|FG002|Overall Study|Abnormal Lab value(s)|2|||
160636955|NCT00567996|580053656|FG000|Overall Study|Abnormal test procedure result(s)|2|||
160636956|NCT00567996|580053657|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160636957|NCT00567996|580053658|FG002|Overall Study|Abnormal test procedure result(s)|1|||
160636958|NCT00567996|580053656|FG000|Overall Study|Lost to Follow-up|2|||
160882381|NCT02108262|580964408|FG001|Overall Study|Non-compliance|2|||
160882382|NCT02108262|580964409|FG002|Overall Study|Non-compliance|1|||
160882383|NCT02108262|580964410|FG003|Overall Study|Non-compliance|1|||
160882384|NCT02108262|580964407|FG000|Overall Study|Randomized by error/screen failure|0|||
160882385|NCT02108262|580964408|FG001|Overall Study|Randomized by error/screen failure|0|||
160882386|NCT02108262|580964409|FG002|Overall Study|Randomized by error/screen failure|1|||
160882387|NCT02108262|580964410|FG003|Overall Study|Randomized by error/screen failure|0|||
160882388|NCT02108262|580964407|FG000|Overall Study|Distance to center|0|||
160636959|NCT00567996|580053657|FG001|Overall Study|Lost to Follow-up|5|||
160636960|NCT00567996|580053658|FG002|Overall Study|Lost to Follow-up|2|||
160636961|NCT00567996|580053656|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160636962|NCT00567996|580053657|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160636963|NCT00567996|580053658|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
160636964|NCT00567996|580053656|FG000|Overall Study|Administrative problems|1|||
160636965|NCT00567996|580053657|FG001|Overall Study|Administrative problems|1|||
160636966|NCT00567996|580053658|FG002|Overall Study|Administrative problems|0|||
160636967|NCT00567996|580053656|FG000|Overall Study|Death|1|||
160636968|NCT00567996|580053657|FG001|Overall Study|Death|0|||
160636969|NCT00567996|580053658|FG002|Overall Study|Death|2|||
160636970|NCT00567996|580053656|FG000|Overall Study|Patient's inability to use the device|0|||
160636971|NCT00567996|580053657|FG001|Overall Study|Patient's inability to use the device|1|||
160636972|NCT00567996|580053658|FG002|Overall Study|Patient's inability to use the device|0|||
160636973|NCT02149199|580053660|FG000|Overall Study|Study specific withdrawal criteria|4|||
160636974|NCT02149199|580053661|FG001|Overall Study|Study specific withdrawal criteria|21|||
160882389|NCT02108262|580964408|FG001|Overall Study|Distance to center|1|||
160882390|NCT02108262|580964409|FG002|Overall Study|Distance to center|1|||
160882391|NCT02108262|580964410|FG003|Overall Study|Distance to center|0|||
160882392|NCT02108262|580964407|FG000|Overall Study|Adverse Event|0|||
160882393|NCT02108262|580964408|FG001|Overall Study|Adverse Event|11|||
160882394|NCT02108262|580964409|FG002|Overall Study|Adverse Event|6|||
160882395|NCT02108262|580964410|FG003|Overall Study|Adverse Event|12|||
160882396|NCT02108262|580964407|FG000|Overall Study|Death|0|||
160636975|NCT02149199|580053662|FG002|Overall Study|Study specific withdrawal criteria|6|||
160636976|NCT02149199|580053660|FG000|Overall Study|Other|20|||
160882397|NCT02108262|580964408|FG001|Overall Study|Death|2|||
160882398|NCT02108262|580964409|FG002|Overall Study|Death|2|||
160882399|NCT02108262|580964410|FG003|Overall Study|Death|1|||
160540226|NCT03975920|579707536|FG001|Overall Study|Protocol Violation|1|||
160540227|NCT03975920|579707535|FG000|Overall Study|Did not complete survey|2|||
160540228|NCT03975920|579707536|FG001|Overall Study|Did not complete survey|1|||
160540229|NCT01081249|579707537|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
160540230|NCT01081249|579707538|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
160540231|NCT04839380|579707539|FG000|Overall Study|Withdrawal by Subject|2|||
160540232|NCT04839380|579707539|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
160540233|NCT03775421|579707542|FG000|Overall Study|Lost to Follow-up|2|||
160540234|NCT03775421|579707542|FG000|Overall Study|Withdrawal by Subject|10|||
160540235|NCT03775421|579707542|FG000|Overall Study|Physician Decision|3|||
160540236|NCT03775421|579707542|FG000|Overall Study|Death|1|||
160540237|NCT03775421|579707542|FG000|Overall Study|Study Terminated by Sponsor|94|||
160540238|NCT01378104|579707550|FG000|Overall Study|Adverse Event|8|||
160540239|NCT01378104|579707551|FG001|Overall Study|Adverse Event|8|||
160540240|NCT01378104|579707550|FG000|Overall Study|Lack of Efficacy|7|||
160540241|NCT01378104|579707551|FG001|Overall Study|Lack of Efficacy|5|||
160540242|NCT01378104|579707550|FG000|Overall Study|Withdrawal by Subject|12|||
160540243|NCT01378104|579707551|FG001|Overall Study|Withdrawal by Subject|13|||
160540244|NCT02287623|579707560|FG000|Overall Study|Protocol Violation|0|||
160540245|NCT02287623|579707561|FG001|Overall Study|Protocol Violation|1|||
160540246|NCT02700997|579707562|FG000|Overall Study|Did not undergo CT imaging|1|||
160540247|NCT02700997|579707562|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
160540248|NCT00205855|579707565|FG000|Overall Study|Only received temporary implants|16|||
160540249|NCT00205855|579707565|FG000|Overall Study|Withdrawal by Subject|5|||
160540250|NCT00506883|579707568|FG000|Overall Study|Lost to Follow-up|1|||
160540251|NCT00506883|579707569|FG001|Overall Study|Lost to Follow-up|1|||
160540252|NCT00506883|579707570|FG002|Overall Study|Lost to Follow-up|1|||
160540253|NCT00506883|579707568|FG000|Overall Study|Withdrawal by Subject|1|||
160540254|NCT00506883|579707569|FG001|Overall Study|Withdrawal by Subject|0|||
160540255|NCT00506883|579707570|FG002|Overall Study|Withdrawal by Subject|1|||
160540256|NCT00506883|579707568|FG000|Overall Study|Lack of Efficacy|0|||
160540257|NCT00506883|579707569|FG001|Overall Study|Lack of Efficacy|1|||
160540258|NCT00506883|579707570|FG002|Overall Study|Lack of Efficacy|1|||
160540259|NCT00506883|579707568|FG000|Overall Study|Other|5|||
160540260|NCT00506883|579707569|FG001|Overall Study|Other|1|||
160540261|NCT00506883|579707570|FG002|Overall Study|Other|1|||
160540262|NCT01445951|579707572|FG000|Overall Study|Adverse Event|16|||
160540263|NCT01445951|579707573|FG001|Overall Study|Adverse Event|9|||
160540264|NCT01445951|579707574|FG002|Overall Study|Adverse Event|0|||
160540265|NCT01445951|579707572|FG000|Overall Study|Protocol Violation|2|||
160540266|NCT01445951|579707573|FG001|Overall Study|Protocol Violation|2|||
160540267|NCT01445951|579707574|FG002|Overall Study|Protocol Violation|2|||
160540268|NCT01445951|579707572|FG000|Overall Study|Withdrawal by Subject|21|||
160540269|NCT01445951|579707573|FG001|Overall Study|Withdrawal by Subject|16|||
160540270|NCT01445951|579707574|FG002|Overall Study|Withdrawal by Subject|8|||
160540271|NCT01445951|579707572|FG000|Overall Study|Physician Decision|3|||
160540272|NCT01445951|579707573|FG001|Overall Study|Physician Decision|1|||
160540273|NCT01445951|579707574|FG002|Overall Study|Physician Decision|0|||
160540274|NCT01445951|579707572|FG000|Overall Study|Lost to Follow-up|1|||
160540275|NCT01445951|579707573|FG001|Overall Study|Lost to Follow-up|2|||
160540276|NCT01445951|579707574|FG002|Overall Study|Lost to Follow-up|4|||
160540277|NCT01445951|579707572|FG000|Overall Study|Pregnancy|0|||
160540278|NCT01445951|579707573|FG001|Overall Study|Pregnancy|1|||
160540279|NCT01445951|579707574|FG002|Overall Study|Pregnancy|4|||
160540280|NCT01445951|579707572|FG000|Overall Study|Death|0|||
160540281|NCT01445951|579707573|FG001|Overall Study|Death|0|||
160540282|NCT01445951|579707574|FG002|Overall Study|Death|1|||
160540283|NCT01445951|579707572|FG000|Overall Study|Non-compliance with study drug|1|||
160540284|NCT01445951|579707573|FG001|Overall Study|Non-compliance with study drug|2|||
160540285|NCT01445951|579707574|FG002|Overall Study|Non-compliance with study drug|0|||
160540286|NCT01445951|579707572|FG000|Overall Study|Non-compliance with protocol|0|||
160540287|NCT01445951|579707573|FG001|Overall Study|Non-compliance with protocol|1|||
160540288|NCT01445951|579707574|FG002|Overall Study|Non-compliance with protocol|0|||
160540289|NCT01445951|579707572|FG000|Overall Study|Sponsor decision - subject travel|0|||
160540290|NCT01445951|579707573|FG001|Overall Study|Sponsor decision - subject travel|1|||
160540291|NCT01445951|579707574|FG002|Overall Study|Sponsor decision - subject travel|0|||
160771167|NCT01461551|580548869|FG001|Overall Study|Physician Decision|1|||
160771168|NCT01461551|580548870|FG002|Overall Study|Physician Decision|2|||
160771169|NCT01155141|580548871|FG000|Overall Study|Withdrawal by Subject|1|||
160771170|NCT01155141|580548871|FG000|Overall Study|Screen Failure|1|||
160771171|NCT00303186|580548872|FG000|Overall Study|Other|52|||
160771172|NCT03473197|580548873|FG000|Overall Study|Adverse Event|4|||
160771173|NCT03473197|580548873|FG000|Overall Study|Lost to Follow-up|1|||
160771174|NCT03473197|580548873|FG000|Overall Study|Withdrawal by Subject|5|||
160771175|NCT02326883|580548874|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
160771176|NCT02326883|580548875|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
160882400|NCT02108262|580964407|FG000|Overall Study|Lost to Follow-up|0|||
160636977|NCT02149199|580053661|FG001|Overall Study|Other|25|||
160882401|NCT02108262|580964408|FG001|Overall Study|Lost to Follow-up|0|||
160882402|NCT02108262|580964409|FG002|Overall Study|Lost to Follow-up|1|||
160882403|NCT02108262|580964410|FG003|Overall Study|Lost to Follow-up|0|||
160882404|NCT02108262|580964407|FG000|Overall Study|Physician Decision|0|||
160882405|NCT02108262|580964408|FG001|Overall Study|Physician Decision|0|||
160882406|NCT02108262|580964409|FG002|Overall Study|Physician Decision|2|||
160882407|NCT02108262|580964410|FG003|Overall Study|Physician Decision|0|||
160882408|NCT02108262|580964407|FG000|Overall Study|Withdrawal by Subject|0|||
160882409|NCT02108262|580964408|FG001|Overall Study|Withdrawal by Subject|7|||
160882410|NCT02108262|580964409|FG002|Overall Study|Withdrawal by Subject|3|||
160882411|NCT02108262|580964410|FG003|Overall Study|Withdrawal by Subject|4|||
160882412|NCT02108262|580964407|FG000|Overall Study|Due to key hepatic values|0|||
160882413|NCT02108262|580964408|FG001|Overall Study|Due to key hepatic values|1|||
160882414|NCT02108262|580964409|FG002|Overall Study|Due to key hepatic values|0|||
160882415|NCT02108262|580964410|FG003|Overall Study|Due to key hepatic values|0|||
160882416|NCT02108262|580964407|FG000|Overall Study|Unable to contact patient|0|||
160882417|NCT02108262|580964408|FG001|Overall Study|Unable to contact patient|3|||
160882418|NCT02108262|580964409|FG002|Overall Study|Unable to contact patient|1|||
160882419|NCT02108262|580964410|FG003|Overall Study|Unable to contact patient|2|||
160882420|NCT02108262|580964407|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
160882421|NCT02108262|580964408|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
160882422|NCT02108262|580964409|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
160882423|NCT02108262|580964410|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
160882424|NCT02108262|580964407|FG000|Overall Study|Patient did not want another infusion|0|||
160882425|NCT02108262|580964408|FG001|Overall Study|Patient did not want another infusion|3|||
160882426|NCT02108262|580964409|FG002|Overall Study|Patient did not want another infusion|3|||
160882427|NCT02108262|580964410|FG003|Overall Study|Patient did not want another infusion|2|||
160882428|NCT02108262|580964407|FG000|Overall Study|Vacation|0|||
160882429|NCT02108262|580964408|FG001|Overall Study|Vacation|1|||
160882430|NCT02108262|580964409|FG002|Overall Study|Vacation|0|||
160882431|NCT02108262|580964410|FG003|Overall Study|Vacation|0|||
160882432|NCT02108262|580964407|FG000|Overall Study|Patient decision|0|||
160882433|NCT02108262|580964408|FG001|Overall Study|Patient decision|7|||
160882434|NCT02108262|580964409|FG002|Overall Study|Patient decision|9|||
160882435|NCT02108262|580964410|FG003|Overall Study|Patient decision|14|||
160882436|NCT02108262|580964407|FG000|Overall Study|Missed IV due to pharmacy error|0|||
160882437|NCT02108262|580964408|FG001|Overall Study|Missed IV due to pharmacy error|0|||
160882438|NCT02108262|580964409|FG002|Overall Study|Missed IV due to pharmacy error|1|||
160882439|NCT02108262|580964410|FG003|Overall Study|Missed IV due to pharmacy error|0|||
160882440|NCT02576145|580964418|FG000|Overall Study|Adverse Event|1|||
160882441|NCT02576145|580964419|FG001|Overall Study|Adverse Event|0|||
160882442|NCT02576145|580964418|FG000|Overall Study|Withdrawal by Subject|1|||
160882443|NCT02576145|580964419|FG001|Overall Study|Withdrawal by Subject|0|||
160882444|NCT02576145|580964418|FG000|Overall Study|Acute rejection|1|||
160882445|NCT02576145|580964419|FG001|Overall Study|Acute rejection|0|||
160882446|NCT02576145|580964418|FG000|Overall Study|Tetanus Titers Decreased|0|||
160882447|NCT02576145|580964419|FG001|Overall Study|Tetanus Titers Decreased|1|||
160882448|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
160882449|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
160882450|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
160882451|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
160882452|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
160882453|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
160882454|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
160882455|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
160882456|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
160882457|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
160882458|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
160882459|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
160882460|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
160882461|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
160882462|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
160882463|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
160882464|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
160882465|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
160882466|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
160882467|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
160882468|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
160882469|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
160882470|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
160882471|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
160882472|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
160882473|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
160882474|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
160882475|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
160882476|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
160882477|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
160882478|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
160636978|NCT02149199|580053662|FG002|Overall Study|Other|20|||
160636979|NCT02149199|580053660|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
160636980|NCT02149199|580053661|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
160636981|NCT02149199|580053662|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
160636982|NCT02149199|580053660|FG000|Overall Study|Withdrawal by Subject|75|||
160636983|NCT02149199|580053661|FG001|Overall Study|Withdrawal by Subject|93|||
160636984|NCT02149199|580053662|FG002|Overall Study|Withdrawal by Subject|77|||
160636985|NCT02149199|580053660|FG000|Overall Study|Protocol Violation|16|||
160636986|NCT02149199|580053661|FG001|Overall Study|Protocol Violation|13|||
160636987|NCT02149199|580053662|FG002|Overall Study|Protocol Violation|15|||
160636988|NCT02149199|580053660|FG000|Overall Study|Lost to Follow-up|3|||
160636989|NCT02149199|580053661|FG001|Overall Study|Lost to Follow-up|12|||
160636990|NCT02149199|580053662|FG002|Overall Study|Lost to Follow-up|11|||
160636991|NCT02149199|580053660|FG000|Overall Study|Death|0|||
160636992|NCT02149199|580053661|FG001|Overall Study|Death|0|||
160636993|NCT02149199|580053662|FG002|Overall Study|Death|1|||
160636994|NCT02149199|580053660|FG000|Overall Study|Adverse Event|6|||
160636995|NCT02149199|580053661|FG001|Overall Study|Adverse Event|15|||
160636996|NCT02149199|580053662|FG002|Overall Study|Adverse Event|9|||
160636997|NCT02956005|580053663|FG000|Overall Study|Not eligible|1|||
160636998|NCT02956005|580053663|FG000|Overall Study|Withdrawal by Subject|3|||
160636999|NCT02956005|580053663|FG000|Overall Study|Physician Decision|12|||
160882479|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
160882480|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
160882481|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
160882482|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
160882483|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
160882484|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
160882485|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
160882486|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
160882487|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
160882488|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
160882489|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
160882490|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
160882491|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
160882492|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
160882493|NCT00392379|580964425|FG000|Overall Study|Withdrawal by Subject|17|||
160882494|NCT00392379|580964426|FG001|Overall Study|Withdrawal by Subject|28|||
160882495|NCT00392379|580964425|FG000|Overall Study|Lost to Follow-up|4|||
160882496|NCT00392379|580964426|FG001|Overall Study|Lost to Follow-up|9|||
160882497|NCT00392379|580964425|FG000|Overall Study|Adverse Event|1|||
160882498|NCT00392379|580964426|FG001|Overall Study|Adverse Event|1|||
160882499|NCT01700387|580964432|FG000|Overall Study|Withdrawal by Subject|1|||
160882500|NCT01700387|580964433|FG001|Overall Study|Withdrawal by Subject|2|||
160882501|NCT01700387|580964432|FG000|Overall Study|Adverse Event|1|||
160882502|NCT01700387|580964433|FG001|Overall Study|Adverse Event|1|||
160882503|NCT01700387|580964432|FG000|Overall Study|Lost to Follow-up|2|||
160882504|NCT01700387|580964433|FG001|Overall Study|Lost to Follow-up|1|||
160882505|NCT02730793|580964436|FG000|Overall Study|Physician Decision|0|||
160882506|NCT02730793|580964437|FG001|Overall Study|Physician Decision|1|||
160882507|NCT02730793|580964436|FG000|Overall Study|Withdrawal by Subject|0|||
160882508|NCT02730793|580964437|FG001|Overall Study|Withdrawal by Subject|1|||
160882509|NCT02365233|580964438|FG000|Overall Study|IRB withheld the data|1|||
160882510|NCT02365233|580964439|FG001|Overall Study|IRB withheld the data|2|||
160882511|NCT02365233|580964440|FG002|Overall Study|IRB withheld the data|2|||
160882512|NCT00934843|580964441|FG000|Overall Study|Protocol Violation|0|||
160882513|NCT00934843|580964442|FG001|Overall Study|Protocol Violation|1|||
160882514|NCT00160667|580964443|FG000|Overall Study|Adverse Event|3|||
160882515|NCT00160667|580964444|FG001|Overall Study|Adverse Event|1|||
160882516|NCT00160667|580964445|FG002|Overall Study|Adverse Event|4|||
160882517|NCT00160667|580964443|FG000|Overall Study|Withdrawal by Subject|2|||
160882518|NCT00160667|580964444|FG001|Overall Study|Withdrawal by Subject|0|||
160882519|NCT00160667|580964445|FG002|Overall Study|Withdrawal by Subject|1|||
160882520|NCT00160667|580964443|FG000|Overall Study|Lack of Efficacy|0|||
160882521|NCT00160667|580964444|FG001|Overall Study|Lack of Efficacy|1|||
160882522|NCT00160667|580964445|FG002|Overall Study|Lack of Efficacy|0|||
160882523|NCT00160667|580964443|FG000|Overall Study|Protocol Violation|0|||
160882524|NCT00160667|580964444|FG001|Overall Study|Protocol Violation|1|||
160882525|NCT00160667|580964445|FG002|Overall Study|Protocol Violation|0|||
160882526|NCT00160667|580964443|FG000|Overall Study|Patient decision|0|||
160882527|NCT00160667|580964444|FG001|Overall Study|Patient decision|0|||
160882528|NCT00160667|580964445|FG002|Overall Study|Patient decision|1|||
160882529|NCT00995566|580964453|FG000|Overall Study|Adverse Event|2|||
160882530|NCT00995566|580964453|FG000|Overall Study|Early study termination|52|||
160882531|NCT01426789|580964454|FG000|Part 1|Protocol deviation|0|||
160882532|NCT01426789|580964455|FG001|Part 1|Protocol deviation|1|||
160882533|NCT01426789|580964456|FG002|Part 1|Protocol deviation|0|||
160882534|NCT01426789|580964457|FG003|Part 1|Protocol deviation|0|||
160882535|NCT01426789|580964458|FG004|Part 1|Protocol deviation|0|||
160882536|NCT01426789|580964459|FG005|Part 1|Protocol deviation|0|||
160882537|NCT01426789|580964454|FG000|Part 1|Lost to Follow-up|1|||
160882538|NCT01426789|580964455|FG001|Part 1|Lost to Follow-up|2|||
160882539|NCT01426789|580964456|FG002|Part 1|Lost to Follow-up|0|||
160882540|NCT01426789|580964457|FG003|Part 1|Lost to Follow-up|0|||
160882541|NCT01426789|580964458|FG004|Part 1|Lost to Follow-up|0|||
160882542|NCT01426789|580964459|FG005|Part 1|Lost to Follow-up|0|||
160882543|NCT01426789|580964454|FG000|Part 1|Lack of Efficacy|2|||
160882544|NCT01426789|580964455|FG001|Part 1|Lack of Efficacy|1|||
160882545|NCT01426789|580964456|FG002|Part 1|Lack of Efficacy|0|||
160882546|NCT01426789|580964457|FG003|Part 1|Lack of Efficacy|0|||
160882547|NCT01426789|580964458|FG004|Part 1|Lack of Efficacy|0|||
160882548|NCT01426789|580964459|FG005|Part 1|Lack of Efficacy|0|||
160882549|NCT01426789|580964454|FG000|Part 1|Adverse Event|3|||
160882550|NCT01426789|580964455|FG001|Part 1|Adverse Event|0|||
160882551|NCT01426789|580964456|FG002|Part 1|Adverse Event|0|||
160882552|NCT01426789|580964457|FG003|Part 1|Adverse Event|0|||
160882553|NCT01426789|580964458|FG004|Part 1|Adverse Event|0|||
160882554|NCT01426789|580964459|FG005|Part 1|Adverse Event|0|||
160882555|NCT01426789|580964454|FG000|Part 2|Protocol deviation|0|||
160882556|NCT01426789|580964455|FG001|Part 2|Protocol deviation|0|||
160882557|NCT01426789|580964456|FG002|Part 2|Protocol deviation|1|||
160882558|NCT01426789|580964457|FG003|Part 2|Protocol deviation|0|||
160882559|NCT01426789|580964458|FG004|Part 2|Protocol deviation|0|||
160882560|NCT01426789|580964459|FG005|Part 2|Protocol deviation|0|||
160882561|NCT01426789|580964454|FG000|Part 2|Death|0|||
160882562|NCT01426789|580964455|FG001|Part 2|Death|0|||
160882563|NCT01426789|580964456|FG002|Part 2|Death|1|||
160882564|NCT01426789|580964457|FG003|Part 2|Death|0|||
160882565|NCT01426789|580964458|FG004|Part 2|Death|1|||
160882566|NCT01426789|580964459|FG005|Part 2|Death|0|||
160882567|NCT01426789|580964454|FG000|Part 2|Administrative problems|0|||
160882568|NCT01426789|580964455|FG001|Part 2|Administrative problems|0|||
160882569|NCT01426789|580964456|FG002|Part 2|Administrative problems|2|||
160882570|NCT01426789|580964457|FG003|Part 2|Administrative problems|0|||
160882571|NCT01426789|580964458|FG004|Part 2|Administrative problems|1|||
160882572|NCT01426789|580964459|FG005|Part 2|Administrative problems|0|||
160882573|NCT01426789|580964454|FG000|Part 2|Lost to Follow-up|0|||
160882574|NCT01426789|580964455|FG001|Part 2|Lost to Follow-up|0|||
160882575|NCT01426789|580964456|FG002|Part 2|Lost to Follow-up|4|||
160882576|NCT01426789|580964457|FG003|Part 2|Lost to Follow-up|0|||
160882577|NCT01426789|580964458|FG004|Part 2|Lost to Follow-up|1|||
160882578|NCT01426789|580964459|FG005|Part 2|Lost to Follow-up|0|||
160882579|NCT01426789|580964454|FG000|Part 2|Withdrawal by Subject|0|||
160882580|NCT01426789|580964455|FG001|Part 2|Withdrawal by Subject|0|||
160882581|NCT01426789|580964456|FG002|Part 2|Withdrawal by Subject|0|||
160882582|NCT01426789|580964457|FG003|Part 2|Withdrawal by Subject|1|||
160882583|NCT01426789|580964458|FG004|Part 2|Withdrawal by Subject|2|||
160882584|NCT01426789|580964459|FG005|Part 2|Withdrawal by Subject|0|||
160882585|NCT01426789|580964454|FG000|Part 2|Lack of Efficacy|0|||
160637000|NCT03125629|580053664|FG000|Overall Study|Withdrawal by Subject|2|||
160882586|NCT01426789|580964455|FG001|Part 2|Lack of Efficacy|0|||
160882587|NCT01426789|580964456|FG002|Part 2|Lack of Efficacy|5|||
160882588|NCT01426789|580964457|FG003|Part 2|Lack of Efficacy|0|||
160882589|NCT01426789|580964458|FG004|Part 2|Lack of Efficacy|2|||
160882590|NCT01426789|580964459|FG005|Part 2|Lack of Efficacy|0|||
160882591|NCT01426789|580964454|FG000|Part 2|Adverse Event|0|||
160882592|NCT01426789|580964455|FG001|Part 2|Adverse Event|0|||
160882593|NCT01426789|580964456|FG002|Part 2|Adverse Event|2|||
160882594|NCT01426789|580964457|FG003|Part 2|Adverse Event|0|||
160882595|NCT01426789|580964458|FG004|Part 2|Adverse Event|1|||
160882596|NCT01426789|580964459|FG005|Part 2|Adverse Event|0|||
160882597|NCT00883688|580966471|FG000|Overall Study|Ineligible|2|||
160882598|NCT03860935|580966478|FG000|Overall Study|Withdrawal of Consent|15|||
160882599|NCT03860935|580966479|FG001|Overall Study|Withdrawal of Consent|6|||
160882600|NCT03860935|580966478|FG000|Overall Study|Death|75|||
160882601|NCT03860935|580966479|FG001|Overall Study|Death|51|||
160882602|NCT04461600|580966483|FG000|Overall Study|Death|6|||
160882603|NCT04461600|580966484|FG001|Overall Study|Death|5|||
160882604|NCT04461600|580966483|FG000|Overall Study|Withdrawal by Subject|0|||
160882605|NCT04461600|580966484|FG001|Overall Study|Withdrawal by Subject|1|||
160882606|NCT00704522|580966485|FG000|Overall Study|Lack of Efficacy|65|||
160882607|NCT00704522|580966486|FG001|Overall Study|Lack of Efficacy|17|||
160882608|NCT00704522|580966485|FG000|Overall Study|Failure to appear again at hospital|56|||
160882609|NCT00704522|580966486|FG001|Overall Study|Failure to appear again at hospital|10|||
160882610|NCT00704522|580966485|FG000|Overall Study|Withdrawal by Subject|17|||
160882611|NCT00704522|580966486|FG001|Overall Study|Withdrawal by Subject|8|||
160882612|NCT00704522|580966485|FG000|Overall Study|Adverse Event|9|||
160882613|NCT00704522|580966486|FG001|Overall Study|Adverse Event|1|||
160882614|NCT00704522|580966485|FG000|Overall Study|Undefined causes|9|||
160882615|NCT00704522|580966486|FG001|Overall Study|Undefined causes|7|||
160882616|NCT00704522|580966485|FG000|Overall Study|No information on therapy end|27|||
160882617|NCT00704522|580966486|FG001|Overall Study|No information on therapy end|2|||
160882618|NCT01958489|580966487|FG000|Period 2|Adverse Event|0|||
160882619|NCT01958489|580966488|FG001|Period 2|Adverse Event|1|||
160882620|NCT00992589|580966489|FG000|Open-Label Phase|Adverse Event|4|||
160882621|NCT00992589|580966490|FG001|Open-Label Phase|Adverse Event|0|||
160882622|NCT00992589|580966491|FG002|Open-Label Phase|Adverse Event|0|||
160882623|NCT00992589|580966492|FG003|Open-Label Phase|Adverse Event|0|||
160882624|NCT00992589|580966489|FG000|Open-Label Phase|Withdrawal by Subject|20|||
160882625|NCT00992589|580966490|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160882626|NCT00992589|580966491|FG002|Open-Label Phase|Withdrawal by Subject|0|||
160882627|NCT00992589|580966492|FG003|Open-Label Phase|Withdrawal by Subject|0|||
160882628|NCT00992589|580966489|FG000|Open-Label Phase|Lost to Follow-up|1|||
160882629|NCT00992589|580966490|FG001|Open-Label Phase|Lost to Follow-up|0|||
160882630|NCT00992589|580966491|FG002|Open-Label Phase|Lost to Follow-up|0|||
160882631|NCT00992589|580966492|FG003|Open-Label Phase|Lost to Follow-up|0|||
160882632|NCT00992589|580966489|FG000|Open-Label Phase|Protocol Violation|3|||
160882633|NCT00992589|580966490|FG001|Open-Label Phase|Protocol Violation|0|||
160882634|NCT00992589|580966491|FG002|Open-Label Phase|Protocol Violation|0|||
160882635|NCT00992589|580966492|FG003|Open-Label Phase|Protocol Violation|0|||
160882636|NCT00992589|580966489|FG000|Open-Label Phase|Physician Decision|4|||
160882637|NCT00992589|580966490|FG001|Open-Label Phase|Physician Decision|0|||
160882638|NCT00992589|580966491|FG002|Open-Label Phase|Physician Decision|0|||
160882639|NCT00992589|580966492|FG003|Open-Label Phase|Physician Decision|0|||
160882640|NCT00992589|580966489|FG000|Open-Label Phase|Other|45|||
160882641|NCT00992589|580966490|FG001|Open-Label Phase|Other|0|||
160882642|NCT00992589|580966491|FG002|Open-Label Phase|Other|0|||
160882643|NCT00992589|580966492|FG003|Open-Label Phase|Other|0|||
160882644|NCT00992589|580966489|FG000|Double-Blind Phase|Adverse Event|0|||
160882645|NCT00992589|580966490|FG001|Double-Blind Phase|Adverse Event|6|||
160882646|NCT00992589|580966491|FG002|Double-Blind Phase|Adverse Event|2|||
160882647|NCT00992589|580966492|FG003|Double-Blind Phase|Adverse Event|3|||
160882648|NCT00992589|580966489|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
160882649|NCT00992589|580966490|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
160882650|NCT00992589|580966491|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
160882651|NCT00992589|580966492|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
160882652|NCT00992589|580966489|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160882653|NCT00992589|580966490|FG001|Double-Blind Phase|Lost to Follow-up|0|||
160882654|NCT00992589|580966491|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160882655|NCT00992589|580966492|FG003|Double-Blind Phase|Lost to Follow-up|2|||
160882656|NCT00992589|580966489|FG000|Double-Blind Phase|Other|0|||
160882657|NCT00992589|580966490|FG001|Double-Blind Phase|Other|1|||
160882658|NCT00992589|580966491|FG002|Double-Blind Phase|Other|6|||
160882659|NCT00992589|580966492|FG003|Double-Blind Phase|Other|3|||
160882660|NCT00045942|580966493|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
160882661|NCT00045942|580966494|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882662|NCT00045942|580966495|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882663|NCT00045942|580966496|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882664|NCT00045942|580966497|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882665|NCT00045942|580966498|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882666|NCT00045942|580966499|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882667|NCT00045942|580966500|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882668|NCT00045942|580966501|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882669|NCT00045942|580966493|FG000|PKC412A2104 (Core)|Adverse Event|5|||
160882670|NCT00045942|580966494|FG001|PKC412A2104 (Core)|Adverse Event|0|||
160882671|NCT00045942|580966495|FG002|PKC412A2104 (Core)|Adverse Event|0|||
160882672|NCT00045942|580966496|FG003|PKC412A2104 (Core)|Adverse Event|0|||
160882673|NCT00045942|580966497|FG004|PKC412A2104 (Core)|Adverse Event|0|||
160882674|NCT00045942|580966498|FG005|PKC412A2104 (Core)|Adverse Event|0|||
160882675|NCT00045942|580966499|FG006|PKC412A2104 (Core)|Adverse Event|0|||
160882676|NCT00045942|580966500|FG007|PKC412A2104 (Core)|Adverse Event|0|||
160882677|NCT00045942|580966501|FG008|PKC412A2104 (Core)|Adverse Event|0|||
160882678|NCT00045942|580966493|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
160882679|NCT00045942|580966494|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882680|NCT00045942|580966495|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882681|NCT00045942|580966496|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882682|NCT00045942|580966497|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882683|NCT00045942|580966498|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882684|NCT00045942|580966499|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882685|NCT00045942|580966500|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882686|NCT00045942|580966501|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882687|NCT00045942|580966493|FG000|PKC412A2104 (Core)|Death|1|||
160882688|NCT00045942|580966494|FG001|PKC412A2104 (Core)|Death|0|||
160882689|NCT00045942|580966495|FG002|PKC412A2104 (Core)|Death|0|||
160882690|NCT00045942|580966496|FG003|PKC412A2104 (Core)|Death|0|||
160882691|NCT00045942|580966497|FG004|PKC412A2104 (Core)|Death|0|||
160882692|NCT00045942|580966498|FG005|PKC412A2104 (Core)|Death|0|||
160882693|NCT00045942|580966499|FG006|PKC412A2104 (Core)|Death|0|||
160882694|NCT00045942|580966500|FG007|PKC412A2104 (Core)|Death|0|||
160882695|NCT00045942|580966501|FG008|PKC412A2104 (Core)|Death|0|||
160882696|NCT00045942|580966493|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
160882697|NCT00045942|580966494|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
160882698|NCT00045942|580966495|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
160882699|NCT00045942|580966496|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
160882700|NCT00045942|580966497|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
160882701|NCT00045942|580966498|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
160882702|NCT00045942|580966499|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
160882703|NCT00045942|580966500|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
160882704|NCT00045942|580966501|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
160882705|NCT00045942|580966493|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
160882706|NCT00045942|580966494|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
160882707|NCT00045942|580966495|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
160882708|NCT00045942|580966496|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
160882709|NCT00045942|580966497|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
160882710|NCT00045942|580966498|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
160882711|NCT00045942|580966499|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
160882712|NCT00045942|580966500|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
160882713|NCT00045942|580966501|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
160882714|NCT00045942|580966493|FG000|PKC412A2104E1|Lack of Efficacy|0|||
160882715|NCT00045942|580966494|FG001|PKC412A2104E1|Lack of Efficacy|11|||
160882716|NCT00045942|580966495|FG002|PKC412A2104E1|Lack of Efficacy|11|||
160882717|NCT00045942|580966496|FG003|PKC412A2104E1|Lack of Efficacy|23|||
160882718|NCT00045942|580966497|FG004|PKC412A2104E1|Lack of Efficacy|17|||
160882719|NCT00045942|580966498|FG005|PKC412A2104E1|Lack of Efficacy|0|||
160882720|NCT00045942|580966499|FG006|PKC412A2104E1|Lack of Efficacy|0|||
160882721|NCT00045942|580966500|FG007|PKC412A2104E1|Lack of Efficacy|0|||
160882722|NCT00045942|580966501|FG008|PKC412A2104E1|Lack of Efficacy|0|||
160882723|NCT00045942|580966493|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
160882724|NCT00045942|580966494|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
160882725|NCT00045942|580966495|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
160882726|NCT00045942|580966496|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
160882727|NCT00045942|580966497|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
160882728|NCT00045942|580966498|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
160882729|NCT00045942|580966499|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
160882730|NCT00045942|580966500|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
160882731|NCT00045942|580966501|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
160882732|NCT00045942|580966493|FG000|PKC412A2104E1|Adverse Event|0|||
160882733|NCT00045942|580966494|FG001|PKC412A2104E1|Adverse Event|1|||
160882734|NCT00045942|580966495|FG002|PKC412A2104E1|Adverse Event|1|||
160882735|NCT00045942|580966496|FG003|PKC412A2104E1|Adverse Event|3|||
160882736|NCT00045942|580966497|FG004|PKC412A2104E1|Adverse Event|6|||
160882737|NCT00045942|580966498|FG005|PKC412A2104E1|Adverse Event|0|||
160882738|NCT00045942|580966499|FG006|PKC412A2104E1|Adverse Event|0|||
160882739|NCT00045942|580966500|FG007|PKC412A2104E1|Adverse Event|0|||
160882740|NCT00045942|580966501|FG008|PKC412A2104E1|Adverse Event|0|||
160882741|NCT00045942|580966493|FG000|PKC412A2104E1|Death|0|||
160882742|NCT00045942|580966494|FG001|PKC412A2104E1|Death|4|||
160882743|NCT00045942|580966495|FG002|PKC412A2104E1|Death|1|||
160882744|NCT00045942|580966496|FG003|PKC412A2104E1|Death|1|||
160882745|NCT00045942|580966497|FG004|PKC412A2104E1|Death|1|||
160882746|NCT00045942|580966498|FG005|PKC412A2104E1|Death|0|||
160882747|NCT00045942|580966499|FG006|PKC412A2104E1|Death|0|||
160882748|NCT00045942|580966500|FG007|PKC412A2104E1|Death|0|||
160882749|NCT00045942|580966501|FG008|PKC412A2104E1|Death|0|||
160882750|NCT00045942|580966493|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882751|NCT00045942|580966494|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882752|NCT00045942|580966495|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
160882753|NCT00045942|580966496|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
160882754|NCT00045942|580966497|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882755|NCT00045942|580966498|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882756|NCT00045942|580966499|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882757|NCT00045942|580966500|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882758|NCT00045942|580966501|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882759|NCT00045942|580966493|FG000|PKC412A2104E2|Lost to Follow-up|0|||
160882760|NCT00045942|580966494|FG001|PKC412A2104E2|Lost to Follow-up|0|||
160882761|NCT00045942|580966495|FG002|PKC412A2104E2|Lost to Follow-up|0|||
160882762|NCT00045942|580966496|FG003|PKC412A2104E2|Lost to Follow-up|0|||
160882763|NCT00045942|580966497|FG004|PKC412A2104E2|Lost to Follow-up|0|||
160882764|NCT00045942|580966498|FG005|PKC412A2104E2|Lost to Follow-up|0|||
160882765|NCT00045942|580966499|FG006|PKC412A2104E2|Lost to Follow-up|0|||
160882766|NCT00045942|580966500|FG007|PKC412A2104E2|Lost to Follow-up|3|||
160882767|NCT00045942|580966501|FG008|PKC412A2104E2|Lost to Follow-up|0|||
160882768|NCT00045942|580966493|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
160882769|NCT00045942|580966494|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
160882770|NCT00045942|580966495|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
160882771|NCT00045942|580966496|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
160882772|NCT00045942|580966497|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
160882773|NCT00045942|580966498|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
160882774|NCT00045942|580966499|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
160882775|NCT00045942|580966500|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
160882776|NCT00045942|580966501|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
160882777|NCT00045942|580966493|FG000|PKC412A2104E2|Lack of Efficacy|0|||
160882778|NCT00045942|580966494|FG001|PKC412A2104E2|Lack of Efficacy|0|||
160882779|NCT00045942|580966495|FG002|PKC412A2104E2|Lack of Efficacy|0|||
160882780|NCT00045942|580966496|FG003|PKC412A2104E2|Lack of Efficacy|0|||
160882781|NCT00045942|580966497|FG004|PKC412A2104E2|Lack of Efficacy|0|||
160882782|NCT00045942|580966498|FG005|PKC412A2104E2|Lack of Efficacy|3|||
160882783|NCT00045942|580966499|FG006|PKC412A2104E2|Lack of Efficacy|2|||
160882784|NCT00045942|580966500|FG007|PKC412A2104E2|Lack of Efficacy|2|||
160882785|NCT00045942|580966501|FG008|PKC412A2104E2|Lack of Efficacy|6|||
160882786|NCT00045942|580966493|FG000|PKC412A2104E2|Adverse Event|0|||
160882787|NCT00045942|580966494|FG001|PKC412A2104E2|Adverse Event|0|||
160882788|NCT00045942|580966495|FG002|PKC412A2104E2|Adverse Event|0|||
160882789|NCT00045942|580966496|FG003|PKC412A2104E2|Adverse Event|0|||
160882790|NCT00045942|580966497|FG004|PKC412A2104E2|Adverse Event|0|||
160882791|NCT00045942|580966498|FG005|PKC412A2104E2|Adverse Event|4|||
160882792|NCT00045942|580966499|FG006|PKC412A2104E2|Adverse Event|3|||
160882793|NCT00045942|580966500|FG007|PKC412A2104E2|Adverse Event|1|||
160882794|NCT00045942|580966501|FG008|PKC412A2104E2|Adverse Event|0|||
160882795|NCT00045942|580966493|FG000|PKC412A2104E2|Death|0|||
160882796|NCT00045942|580966494|FG001|PKC412A2104E2|Death|0|||
160882797|NCT00045942|580966495|FG002|PKC412A2104E2|Death|0|||
160882798|NCT00045942|580966496|FG003|PKC412A2104E2|Death|0|||
160882799|NCT00045942|580966497|FG004|PKC412A2104E2|Death|0|||
160882800|NCT00045942|580966498|FG005|PKC412A2104E2|Death|1|||
160882801|NCT00045942|580966499|FG006|PKC412A2104E2|Death|2|||
160882802|NCT00045942|580966500|FG007|PKC412A2104E2|Death|0|||
160882803|NCT00045942|580966501|FG008|PKC412A2104E2|Death|0|||
160882804|NCT05508074|580966502|FG000|Overall Study|Death|2|||
160882805|NCT05508074|580966503|FG001|Overall Study|Death|5|||
160882806|NCT05508074|580966502|FG000|Overall Study|Withdrawal by Subject|1|||
160882807|NCT05508074|580966503|FG001|Overall Study|Withdrawal by Subject|2|||
160882808|NCT05508074|580966502|FG000|Overall Study|Adverse Event|0|||
160882809|NCT05508074|580966503|FG001|Overall Study|Adverse Event|1|||
160882810|NCT05508074|580966502|FG000|Overall Study|Physician Decision|0|||
160882811|NCT05508074|580966503|FG001|Overall Study|Physician Decision|1|||
160882812|NCT05508074|580966502|FG000|Overall Study|wrongly randomized|0|||
160882813|NCT05508074|580966503|FG001|Overall Study|wrongly randomized|1|||
160882814|NCT05508074|580966502|FG000|Overall Study|non-compliance|0|||
160882815|NCT05508074|580966503|FG001|Overall Study|non-compliance|1|||
160882816|NCT01101308|580966504|FG000|Period 1|Adverse Event|2|||
160882817|NCT01101308|580966505|FG001|Period 1|Adverse Event|1|||
160882818|NCT01101308|580966504|FG000|Period 1|Positive for cotinine|1|||
160882819|NCT01101308|580966505|FG001|Period 1|Positive for cotinine|0|||
160882820|NCT00711516|580966506|FG000|Overall Study|Adverse Event|1|||
160882821|NCT00711516|580966507|FG001|Overall Study|Adverse Event|1|||
160637001|NCT03125629|580053664|FG000|Overall Study|Equipment malfunction|1|||
160882822|NCT00711516|580966506|FG000|Overall Study|Withdrawal by Subject|0|||
160882823|NCT00711516|580966507|FG001|Overall Study|Withdrawal by Subject|1|||
160882824|NCT00711516|580966506|FG000|Overall Study|Protocol Violation|0|||
160882825|NCT00711516|580966507|FG001|Overall Study|Protocol Violation|1|||
160882826|NCT04575597|580966508|FG000|Overall Study|Death|0|||
160882827|NCT04575597|580966509|FG001|Overall Study|Death|0|||
160882828|NCT04575597|580966510|FG002|Overall Study|Death|0|||
160882829|NCT04575597|580966511|FG003|Overall Study|Death|1|||
160882830|NCT04575597|580966512|FG004|Overall Study|Death|3|||
160882831|NCT04575597|580966513|FG005|Overall Study|Death|14|||
160882832|NCT04575597|580966508|FG000|Overall Study|Lost to Follow-up|2|||
160882833|NCT04575597|580966509|FG001|Overall Study|Lost to Follow-up|1|||
160882834|NCT04575597|580966510|FG002|Overall Study|Lost to Follow-up|1|||
160882835|NCT04575597|580966511|FG003|Overall Study|Lost to Follow-up|2|||
160882836|NCT04575597|580966512|FG004|Overall Study|Lost to Follow-up|10|||
160882837|NCT04575597|580966513|FG005|Overall Study|Lost to Follow-up|8|||
160882838|NCT04575597|580966508|FG000|Overall Study|Withdrawal by Subject|2|||
160882839|NCT04575597|580966509|FG001|Overall Study|Withdrawal by Subject|2|||
160882840|NCT04575597|580966510|FG002|Overall Study|Withdrawal by Subject|4|||
160882841|NCT04575597|580966511|FG003|Overall Study|Withdrawal by Subject|2|||
160882842|NCT04575597|580966512|FG004|Overall Study|Withdrawal by Subject|25|||
160882843|NCT04575597|580966513|FG005|Overall Study|Withdrawal by Subject|28|||
160882844|NCT04575597|580966508|FG000|Overall Study|Not Recorded|0|||
160882845|NCT04575597|580966509|FG001|Overall Study|Not Recorded|0|||
160882846|NCT04575597|580966510|FG002|Overall Study|Not Recorded|0|||
160882847|NCT04575597|580966511|FG003|Overall Study|Not Recorded|0|||
160882848|NCT04575597|580966512|FG004|Overall Study|Not Recorded|0|||
160882849|NCT04575597|580966513|FG005|Overall Study|Not Recorded|2|||
160882850|NCT04575597|580966508|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160882851|NCT04575597|580966509|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160882852|NCT04575597|580966510|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160882853|NCT04575597|580966511|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160882854|NCT04575597|580966512|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
160882855|NCT04575597|580966513|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
160882856|NCT02095132|580966515|FG000|Overall Study|Adverse Event|0|||
160882857|NCT02095132|580966516|FG001|Overall Study|Adverse Event|0|||
160882858|NCT02095132|580966517|FG002|Overall Study|Adverse Event|0|||
160882859|NCT02095132|580966518|FG003|Overall Study|Adverse Event|0|||
160882860|NCT02095132|580966519|FG004|Overall Study|Adverse Event|1|||
160882861|NCT02095132|580966520|FG005|Overall Study|Adverse Event|0|||
160882862|NCT02095132|580966521|FG006|Overall Study|Adverse Event|1|||
160882863|NCT02095132|580966522|FG007|Overall Study|Adverse Event|0|||
160882864|NCT02095132|580966523|FG008|Overall Study|Adverse Event|0|||
160882865|NCT02095132|580966515|FG000|Overall Study|Death|0|||
160882866|NCT02095132|580966516|FG001|Overall Study|Death|0|||
160882867|NCT02095132|580966517|FG002|Overall Study|Death|0|||
160882868|NCT02095132|580966518|FG003|Overall Study|Death|0|||
160882869|NCT02095132|580966519|FG004|Overall Study|Death|0|||
160882870|NCT02095132|580966520|FG005|Overall Study|Death|0|||
160882871|NCT02095132|580966521|FG006|Overall Study|Death|1|||
160882872|NCT02095132|580966522|FG007|Overall Study|Death|0|||
160882873|NCT02095132|580966523|FG008|Overall Study|Death|0|||
160882874|NCT02095132|580966515|FG000|Overall Study|Lack of Efficacy|3|||
160882875|NCT02095132|580966516|FG001|Overall Study|Lack of Efficacy|5|||
160882876|NCT02095132|580966517|FG002|Overall Study|Lack of Efficacy|2|||
160882877|NCT02095132|580966518|FG003|Overall Study|Lack of Efficacy|8|||
160882878|NCT02095132|580966519|FG004|Overall Study|Lack of Efficacy|3|||
160882879|NCT02095132|580966520|FG005|Overall Study|Lack of Efficacy|6|||
160882880|NCT02095132|580966521|FG006|Overall Study|Lack of Efficacy|10|||
160882881|NCT02095132|580966522|FG007|Overall Study|Lack of Efficacy|9|||
160882882|NCT02095132|580966523|FG008|Overall Study|Lack of Efficacy|8|||
160882883|NCT02095132|580966515|FG000|Overall Study|Physician Decision|1|||
160882884|NCT02095132|580966516|FG001|Overall Study|Physician Decision|0|||
160882885|NCT02095132|580966517|FG002|Overall Study|Physician Decision|0|||
160882886|NCT02095132|580966518|FG003|Overall Study|Physician Decision|0|||
160882887|NCT02095132|580966519|FG004|Overall Study|Physician Decision|0|||
160882888|NCT02095132|580966520|FG005|Overall Study|Physician Decision|0|||
160882889|NCT02095132|580966521|FG006|Overall Study|Physician Decision|1|||
160882890|NCT02095132|580966522|FG007|Overall Study|Physician Decision|0|||
160882891|NCT02095132|580966523|FG008|Overall Study|Physician Decision|2|||
160882892|NCT02095132|580966515|FG000|Overall Study|Withdrawal by Subject|0|||
160882893|NCT02095132|580966516|FG001|Overall Study|Withdrawal by Subject|0|||
160882894|NCT02095132|580966517|FG002|Overall Study|Withdrawal by Subject|2|||
160882895|NCT02095132|580966518|FG003|Overall Study|Withdrawal by Subject|2|||
160882896|NCT02095132|580966519|FG004|Overall Study|Withdrawal by Subject|3|||
160882897|NCT02095132|580966520|FG005|Overall Study|Withdrawal by Subject|0|||
160882898|NCT02095132|580966521|FG006|Overall Study|Withdrawal by Subject|5|||
160882899|NCT02095132|580966522|FG007|Overall Study|Withdrawal by Subject|0|||
160882900|NCT02095132|580966523|FG008|Overall Study|Withdrawal by Subject|0|||
160637002|NCT00743119|580053665|FG000|Overall Study|unreliable|3|||
160882901|NCT04905498|580966526|FG000|Overall Study|Lost to Follow-up|0|||
160882902|NCT04905498|580966527|FG001|Overall Study|Lost to Follow-up|2|||
160882903|NCT04905498|580966526|FG000|Overall Study|COVID lockdown|1|||
160882904|NCT04905498|580966527|FG001|Overall Study|COVID lockdown|0|||
160882905|NCT01029405|580966528|FG000|Overall Study|Withdrawal by Subject|0|||
160882906|NCT01029405|580966529|FG001|Overall Study|Withdrawal by Subject|1|||
160882907|NCT01029405|580966530|FG002|Overall Study|Withdrawal by Subject|2|||
160882908|NCT01029405|580966531|FG003|Overall Study|Withdrawal by Subject|0|||
160882909|NCT01029405|580966528|FG000|Overall Study|Protocol Violation|0|||
160882910|NCT01029405|580966529|FG001|Overall Study|Protocol Violation|0|||
160882911|NCT01029405|580966530|FG002|Overall Study|Protocol Violation|0|||
160882912|NCT01029405|580966531|FG003|Overall Study|Protocol Violation|1|||
160882913|NCT01029405|580966528|FG000|Overall Study|Adverse Event|0|||
160882914|NCT01029405|580966529|FG001|Overall Study|Adverse Event|0|||
160882915|NCT01029405|580966530|FG002|Overall Study|Adverse Event|1|||
160882916|NCT01029405|580966531|FG003|Overall Study|Adverse Event|1|||
160882917|NCT01029405|580966528|FG000|Overall Study|Lost to Follow-up|2|||
160882918|NCT01029405|580966529|FG001|Overall Study|Lost to Follow-up|1|||
160882919|NCT01029405|580966530|FG002|Overall Study|Lost to Follow-up|1|||
160882920|NCT01029405|580966531|FG003|Overall Study|Lost to Follow-up|2|||
160882921|NCT01029405|580966528|FG000|Overall Study|Other|0|||
160882922|NCT01029405|580966529|FG001|Overall Study|Other|1|||
160882923|NCT01029405|580966530|FG002|Overall Study|Other|0|||
160882924|NCT01029405|580966531|FG003|Overall Study|Other|1|||
160882925|NCT02692651|580966532|FG000|Study Treatment|Death|7|||
160882926|NCT02692651|580966533|FG001|Study Treatment|Death|3|||
160882927|NCT02692651|580966532|FG000|Study Treatment|comfort care|1|||
160882928|NCT02692651|580966533|FG001|Study Treatment|comfort care|1|||
160882929|NCT02692651|580966532|FG000|Study Treatment|Protocol violation per treating team preference|8|||
160882930|NCT02692651|580966533|FG001|Study Treatment|Protocol violation per treating team preference|6|||
160882931|NCT02692651|580966532|FG000|Post Study Treatment Follow-up|Death|4|||
160882932|NCT02692651|580966533|FG001|Post Study Treatment Follow-up|Death|4|||
160882933|NCT03490981|580966534|FG000|Overall Study|Lost to Follow-up|1|||
160882934|NCT03490981|580966535|FG001|Overall Study|Lost to Follow-up|2|||
160882935|NCT02480712|580966542|FG000|Overall Study|Enrolled but Never Treated|1|||
160882936|NCT02480712|580966542|FG000|Overall Study|Lost to Follow-up|5|||
160882937|NCT02480712|580966542|FG000|Overall Study|Withdrew Consent|3|||
160882938|NCT02480712|580966542|FG000|Overall Study|Death|1|||
160882939|NCT02480712|580966542|FG000|Overall Study|Lack of Efficacy|1|||
160882940|NCT01860846|580966543|FG000|Overall Study|Lost to Follow-up|33|||
160882941|NCT00466687|580966544|FG000|Overall Study|Adverse Event|1|||
160882942|NCT00466687|580966544|FG000|Overall Study|Other complicating illness|3|||
160882943|NCT00466687|580966544|FG000|Overall Study|Withdrawal by Subject|1|||
160882944|NCT00466687|580966544|FG000|Overall Study|Disease progression|29|||
160882945|NCT02586506|580966545|FG000|Overall Study|Protocol Violation|6|||
160882946|NCT02586506|580966545|FG000|Overall Study|Lost to Follow-up|1|||
160882947|NCT02586506|580966545|FG000|Overall Study|Other Reason|2|||
160882948|NCT05027971|580966555|FG000|Overall Study|Physician Decision|7|||
160882949|NCT05027971|580966556|FG001|Overall Study|Physician Decision|3|||
160882950|NCT05027971|580966555|FG000|Overall Study|Lost to Follow-up|1|||
160882951|NCT05027971|580966556|FG001|Overall Study|Lost to Follow-up|1|||
160882952|NCT05027971|580966555|FG000|Overall Study|Withdrawal by Subject|0|||
160882953|NCT05027971|580966556|FG001|Overall Study|Withdrawal by Subject|2|||
160882954|NCT05027971|580966555|FG000|Overall Study|Non-study fiber used.|0|||
160882955|NCT05027971|580966556|FG001|Overall Study|Non-study fiber used.|1|||
160882956|NCT05027971|580966555|FG000|Overall Study|Protocol Violation|0|||
160882957|NCT05027971|580966556|FG001|Overall Study|Protocol Violation|2|||
160882958|NCT02025556|580966557|FG000|Overall Study|Adverse Event|0|||
160882959|NCT02025556|580966558|FG001|Overall Study|Adverse Event|4|||
160882960|NCT02025556|580966559|FG002|Overall Study|Adverse Event|2|||
160882961|NCT02025556|580966557|FG000|Overall Study|Lack of Efficacy|2|||
160882962|NCT02025556|580966558|FG001|Overall Study|Lack of Efficacy|1|||
160882963|NCT02025556|580966559|FG002|Overall Study|Lack of Efficacy|0|||
160882964|NCT02025556|580966557|FG000|Overall Study|Protocol Violation|2|||
160882965|NCT02025556|580966558|FG001|Overall Study|Protocol Violation|1|||
160882966|NCT02025556|580966559|FG002|Overall Study|Protocol Violation|0|||
160882967|NCT02025556|580966557|FG000|Overall Study|Withdrawal by Subject|0|||
160882968|NCT02025556|580966558|FG001|Overall Study|Withdrawal by Subject|3|||
160882969|NCT02025556|580966559|FG002|Overall Study|Withdrawal by Subject|6|||
160882970|NCT02025556|580966557|FG000|Overall Study|Lost to Follow-up|2|||
160882971|NCT02025556|580966558|FG001|Overall Study|Lost to Follow-up|4|||
160882972|NCT02025556|580966559|FG002|Overall Study|Lost to Follow-up|0|||
160882973|NCT02025556|580966557|FG000|Overall Study|Reason not reported|0|||
160882974|NCT02025556|580966558|FG001|Overall Study|Reason not reported|0|||
160882975|NCT02025556|580966559|FG002|Overall Study|Reason not reported|1|||
160882976|NCT00796991|580966562|FG000|Overall Study|Adverse Event|0|||
160882977|NCT00796991|580966563|FG001|Overall Study|Adverse Event|0|||
160882978|NCT00796991|580966564|FG002|Overall Study|Adverse Event|1|||
160882979|NCT00796991|580966562|FG000|Overall Study|Death|2|||
160882980|NCT00796991|580966563|FG001|Overall Study|Death|0|||
160882981|NCT00796991|580966564|FG002|Overall Study|Death|0|||
160882982|NCT00796991|580966562|FG000|Overall Study|Disease Progression|10|||
160882983|NCT00796991|580966563|FG001|Overall Study|Disease Progression|9|||
160637003|NCT00743119|580053665|FG000|Overall Study|Withdrawal by Subject|1|||
160882984|NCT00796991|580966564|FG002|Overall Study|Disease Progression|7|||
160882985|NCT00796991|580966562|FG000|Overall Study|Study Drug Toxicity|3|||
160882986|NCT00796991|580966563|FG001|Overall Study|Study Drug Toxicity|3|||
160882987|NCT00796991|580966564|FG002|Overall Study|Study Drug Toxicity|5|||
160882988|NCT00796991|580966562|FG000|Overall Study|Withdrawal by Subject|0|||
160882989|NCT00796991|580966563|FG001|Overall Study|Withdrawal by Subject|0|||
160882990|NCT00796991|580966564|FG002|Overall Study|Withdrawal by Subject|1|||
160882991|NCT00171834|580966566|FG000|Overall Study|Adverse Event|2|||
160882992|NCT00171834|580966567|FG001|Overall Study|Adverse Event|1|||
160882993|NCT00171834|580966568|FG002|Overall Study|Adverse Event|3|||
160882994|NCT00171834|580966569|FG003|Overall Study|Adverse Event|2|||
160882995|NCT00171834|580966570|FG004|Overall Study|Adverse Event|2|||
160882996|NCT00171834|580966571|FG005|Overall Study|Adverse Event|15|||
160637004|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
160637005|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
160637006|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
160637007|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
160882997|NCT00171834|580966572|FG006|Overall Study|Adverse Event|1|||
160882998|NCT00171834|580966566|FG000|Overall Study|Withdrawal by Subject|0|||
160882999|NCT00171834|580966567|FG001|Overall Study|Withdrawal by Subject|2|||
160883000|NCT00171834|580966568|FG002|Overall Study|Withdrawal by Subject|0|||
160883001|NCT00171834|580966569|FG003|Overall Study|Withdrawal by Subject|1|||
160883002|NCT00171834|580966570|FG004|Overall Study|Withdrawal by Subject|1|||
160883003|NCT00171834|580966571|FG005|Overall Study|Withdrawal by Subject|1|||
160883004|NCT00171834|580966572|FG006|Overall Study|Withdrawal by Subject|0|||
160883005|NCT00171834|580966566|FG000|Overall Study|Death from study indication|0|||
160883006|NCT00171834|580966567|FG001|Overall Study|Death from study indication|1|||
160883007|NCT00171834|580966568|FG002|Overall Study|Death from study indication|0|||
160883008|NCT00171834|580966569|FG003|Overall Study|Death from study indication|0|||
160883009|NCT00171834|580966570|FG004|Overall Study|Death from study indication|1|||
160883010|NCT00171834|580966571|FG005|Overall Study|Death from study indication|0|||
160883011|NCT00171834|580966572|FG006|Overall Study|Death from study indication|0|||
160883012|NCT00171834|580966566|FG000|Overall Study|Disease Progression|4|||
160883013|NCT00171834|580966567|FG001|Overall Study|Disease Progression|8|||
160883014|NCT00171834|580966568|FG002|Overall Study|Disease Progression|8|||
160883015|NCT00171834|580966569|FG003|Overall Study|Disease Progression|9|||
160883016|NCT00171834|580966570|FG004|Overall Study|Disease Progression|2|||
160883017|NCT00171834|580966571|FG005|Overall Study|Disease Progression|18|||
160883018|NCT00171834|580966572|FG006|Overall Study|Disease Progression|3|||
160883019|NCT00171834|580966566|FG000|Overall Study|Treatment Duration Completed|0|||
160883020|NCT00171834|580966567|FG001|Overall Study|Treatment Duration Completed|0|||
160883021|NCT00171834|580966568|FG002|Overall Study|Treatment Duration Completed|1|||
160883022|NCT00171834|580966569|FG003|Overall Study|Treatment Duration Completed|0|||
160883023|NCT00171834|580966570|FG004|Overall Study|Treatment Duration Completed|2|||
160883024|NCT00171834|580966571|FG005|Overall Study|Treatment Duration Completed|1|||
160883025|NCT00171834|580966572|FG006|Overall Study|Treatment Duration Completed|0|||
160883026|NCT00834080|580966573|FG000|Overall Study|Adverse Event|7|||
160883027|NCT00834080|580966573|FG000|Overall Study|Lost to Follow-up|7|||
160883028|NCT00834080|580966573|FG000|Overall Study|Withdrawal by Subject|5|||
160883029|NCT00834080|580966573|FG000|Overall Study|Other - Pregnancy|1|||
160883030|NCT00834080|580966573|FG000|Overall Study|Other - False positive tests of the UDS|1|||
160883031|NCT00834080|580966573|FG000|Overall Study|Physician Decision|1|||
160883032|NCT00834080|580966573|FG000|Overall Study|Subject Relocated|1|||
160883033|NCT04345367|580966575|FG000|Overall Study|Other|3|||
160883034|NCT04345367|580966576|FG001|Overall Study|Other|4|||
160883035|NCT04345367|580966575|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
160883036|NCT04345367|580966576|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
160883037|NCT04345367|580966575|FG000|Overall Study|Withdrawal by Subject|11|||
160883038|NCT04345367|580966576|FG001|Overall Study|Withdrawal by Subject|11|||
160883039|NCT04345367|580966575|FG000|Overall Study|Protocol Violation|4|||
160883040|NCT04345367|580966576|FG001|Overall Study|Protocol Violation|3|||
160883041|NCT04345367|580966575|FG000|Overall Study|Lost to Follow-up|2|||
160883042|NCT04345367|580966576|FG001|Overall Study|Lost to Follow-up|4|||
160883043|NCT04345367|580966575|FG000|Overall Study|Lack of Efficacy|2|||
160883044|NCT04345367|580966576|FG001|Overall Study|Lack of Efficacy|0|||
160883045|NCT04345367|580966575|FG000|Overall Study|Death|2|||
160883046|NCT04345367|580966576|FG001|Overall Study|Death|0|||
160883047|NCT04345367|580966575|FG000|Overall Study|Adverse Event|10|||
160883048|NCT04345367|580966576|FG001|Overall Study|Adverse Event|9|||
160883049|NCT00439738|580966579|FG000|Overall Study|Withdrawal by Subject|16|||
160883050|NCT00439738|580966580|FG001|Overall Study|Withdrawal by Subject|13|||
160883051|NCT00439738|580966579|FG000|Overall Study|Adverse Event|6|||
160883052|NCT00439738|580966580|FG001|Overall Study|Adverse Event|4|||
160883053|NCT00439738|580966579|FG000|Overall Study|Lost to Follow-up|5|||
160883054|NCT00439738|580966580|FG001|Overall Study|Lost to Follow-up|6|||
160883055|NCT00439738|580966579|FG000|Overall Study|Protocol Violation|6|||
160883056|NCT00439738|580966580|FG001|Overall Study|Protocol Violation|3|||
160883057|NCT00439738|580966579|FG000|Overall Study|Lack of Efficacy|2|||
160883058|NCT00439738|580966580|FG001|Overall Study|Lack of Efficacy|2|||
160883059|NCT00439738|580966579|FG000|Overall Study|Abnormal Lab Values|1|||
160883060|NCT00439738|580966580|FG001|Overall Study|Abnormal Lab Values|0|||
160883061|NCT00781885|580966583|FG000|Overall Study|Physician Decision|1|||
160883062|NCT01755026|580966584|FG000|Overall Study|Adverse Event|1|||
160883063|NCT01755026|580966585|FG001|Overall Study|Adverse Event|0|||
160883064|NCT01755026|580966584|FG000|Overall Study|Withdrawal by Subject|1|||
160883065|NCT01755026|580966585|FG001|Overall Study|Withdrawal by Subject|1|||
160883066|NCT03836001|580966586|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
160883067|NCT03836001|580966587|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
160883068|NCT03836001|580966588|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
160883069|NCT03836001|580966586|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
160883070|NCT03836001|580966587|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
160883071|NCT03836001|580966588|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
160883072|NCT03836001|580966586|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
160883073|NCT03836001|580966587|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
160883074|NCT03836001|580966588|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
160883075|NCT03836001|580966586|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
160883076|NCT03836001|580966587|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
160883077|NCT03836001|580966588|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
160883078|NCT01284491|580966589|FG000|Overall Study|Study termination|13|||
160883079|NCT01978938|580966590|FG000|Overall Study|Lost to Follow-up|12|||
160883080|NCT01978938|580966591|FG001|Overall Study|Lost to Follow-up|6|||
160883081|NCT01978938|580966590|FG000|Overall Study|Withdrawal by Subject|8|||
160883082|NCT01978938|580966591|FG001|Overall Study|Withdrawal by Subject|4|||
160883083|NCT01978938|580966590|FG000|Overall Study|Adverse Event, non-fatal|2|||
160883084|NCT01978938|580966591|FG001|Overall Study|Adverse Event, non-fatal|1|||
160883085|NCT01978938|580966590|FG000|Overall Study|Participant noncompliance|1|||
160883086|NCT01978938|580966591|FG001|Overall Study|Participant noncompliance|1|||
160883087|NCT01978938|580966590|FG000|Overall Study|Did not meet inclusion criteria|0|||
160883088|NCT01978938|580966591|FG001|Overall Study|Did not meet inclusion criteria|1|||
160883089|NCT01978938|580966590|FG000|Overall Study|Previously scheduled procedure|0|||
160883090|NCT01978938|580966591|FG001|Overall Study|Previously scheduled procedure|1|||
160883091|NCT02694757|580966592|FG000|Overall Study|Lack of Efficacy|3|||
160883092|NCT02650921|580966593|FG000|Overall Study|Withdrawal by Subject|4|||
160883093|NCT02650921|580966593|FG000|Overall Study|Lost to Follow-up|2|||
160883094|NCT02650921|580966593|FG000|Overall Study|Adverse Event|1|||
160883095|NCT02650921|580966593|FG000|Overall Study|Due to Medical Condition|1|||
160883096|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
160883097|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
160883098|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
160883099|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
160883100|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
160637008|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
160637009|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
160883101|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
160883102|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
160883103|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
160883104|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
160883105|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
160883106|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
160883107|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
160883108|NCT01087788|580966594|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
160883109|NCT01087788|580966595|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
160883110|NCT01087788|580966596|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
160883111|NCT01087788|580966594|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
160883112|NCT01087788|580966595|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
160637010|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
160637011|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
160637012|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
160637013|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
160637014|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
160637015|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
160637016|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
160637017|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
160637018|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
160637019|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
160637020|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
160637021|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
160637022|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
160637023|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637024|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637025|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637026|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637027|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637028|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
160637029|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160883113|NCT01087788|580966596|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
160637030|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637031|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637032|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
160637033|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637034|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637035|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637036|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
160637037|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
160637038|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
160637039|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
160637040|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
160637041|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160637042|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
160637043|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637044|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637045|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637046|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637047|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
160637048|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637049|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637050|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637051|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637052|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637053|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637054|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637055|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637056|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
160637057|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637058|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637059|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
160637060|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
160637061|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637062|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637063|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637064|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637065|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637066|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637067|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637068|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637069|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637070|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637071|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
160637072|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637073|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637074|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
160637075|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637076|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637077|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
160637078|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
160637079|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160637080|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
160883114|NCT01087788|580966594|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
160883115|NCT01087788|580966595|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
160883116|NCT01087788|580966596|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
160883117|NCT01087788|580966594|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
160883118|NCT01087788|580966595|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
160883119|NCT01087788|580966596|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
160883120|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
160883121|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
160883122|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
160883123|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
160883124|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
160883125|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
160883126|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
160883127|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
160883128|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
160883129|NCT01087788|580966594|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
160883130|NCT01087788|580966595|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
160883131|NCT01087788|580966596|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
160883132|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
160883133|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
160883134|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
160883135|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
160883136|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
160883137|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
160883138|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
160883139|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
160883140|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
160883141|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
160883142|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
160883143|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
160883144|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
160883145|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
160883146|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
160883147|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
160883148|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
160883149|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
160883150|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
160883151|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
160883152|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
160883153|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|Patient moved|0|||
160883154|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|Patient moved|0|||
160883155|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|Patient moved|1|||
160883156|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
160883157|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
160883158|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
160883159|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
160883160|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
160883161|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
160883162|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
160883163|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
160883164|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
160883165|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
160883166|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
160540292|NCT01445951|579707572|FG000|Overall Study|Cough|0|||
160540293|NCT01445951|579707573|FG001|Overall Study|Cough|1|||
160771177|NCT02326883|580548876|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
160771178|NCT01385176|580548877|FG000|Randomization Phase|Death|1|||
160771179|NCT01385176|580548878|FG001|Randomization Phase|Death|2|||
160771180|NCT01385176|580548877|FG000|6-18 Month All VNS Active|Death|1|||
160771181|NCT01385176|580548878|FG001|6-18 Month All VNS Active|Death|2|||
160771182|NCT01385176|580548877|FG000|6-18 Month All VNS Active|Physician Decision|0|||
160771183|NCT01385176|580548878|FG001|6-18 Month All VNS Active|Physician Decision|1|||
160771184|NCT01385176|580548877|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
160771185|NCT01385176|580548878|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
160771186|NCT01385176|580548877|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
160771187|NCT01385176|580548878|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
160771188|NCT00284856|580548879|FG000|Overall Study|Adverse Event|3|||
160771189|NCT00284856|580548880|FG001|Overall Study|Adverse Event|3|||
160771190|NCT00284856|580548881|FG002|Overall Study|Adverse Event|3|||
160771191|NCT00284856|580548879|FG000|Overall Study|Lack of Efficacy|2|||
160771192|NCT00284856|580548880|FG001|Overall Study|Lack of Efficacy|1|||
160771193|NCT00284856|580548881|FG002|Overall Study|Lack of Efficacy|8|||
160771194|NCT00284856|580548879|FG000|Overall Study|Lost to Follow-up|25|||
160771195|NCT00284856|580548880|FG001|Overall Study|Lost to Follow-up|21|||
160771196|NCT00284856|580548881|FG002|Overall Study|Lost to Follow-up|22|||
160771197|NCT00284856|580548879|FG000|Overall Study|Protocol Violation|5|||
160771198|NCT00284856|580548880|FG001|Overall Study|Protocol Violation|4|||
160771199|NCT00284856|580548881|FG002|Overall Study|Protocol Violation|5|||
160771200|NCT00284856|580548879|FG000|Overall Study|Withdrawal by Subject|12|||
160771201|NCT00284856|580548880|FG001|Overall Study|Withdrawal by Subject|16|||
160771202|NCT00284856|580548881|FG002|Overall Study|Withdrawal by Subject|18|||
160771203|NCT00284856|580548879|FG000|Overall Study|Other|4|||
160771204|NCT00284856|580548880|FG001|Overall Study|Other|5|||
160771205|NCT00284856|580548881|FG002|Overall Study|Other|4|||
160771206|NCT01056536|580548882|FG000|Overall Study|Lost to Follow-up|202|||
160771207|NCT01056536|580548883|FG001|Overall Study|Lost to Follow-up|116|||
160771208|NCT01056536|580548884|FG002|Overall Study|Lost to Follow-up|248|||
160771209|NCT05853120|580548885|FG000|Overall Study|Lost to Follow-up|4|||
160771210|NCT05853120|580548886|FG001|Overall Study|Lost to Follow-up|4|||
160771211|NCT05853120|580548885|FG000|Overall Study|Physician Decision|3|||
160771212|NCT05853120|580548886|FG001|Overall Study|Physician Decision|0|||
160771213|NCT05853120|580548885|FG000|Overall Study|Withdrawal by Subject|5|||
160771214|NCT05853120|580548886|FG001|Overall Study|Withdrawal by Subject|2|||
160771215|NCT00790036|580548887|FG000|Overall Study|Abnormal lab values|3|||
160771216|NCT00790036|580548888|FG001|Overall Study|Abnormal lab values|2|||
160771217|NCT00790036|580548887|FG000|Overall Study|Administrative problems|5|||
160771218|NCT00790036|580548888|FG001|Overall Study|Administrative problems|9|||
160771219|NCT00790036|580548887|FG000|Overall Study|Adverse Event|113|||
160771220|NCT00790036|580548888|FG001|Overall Study|Adverse Event|44|||
160771221|NCT00790036|580548887|FG000|Overall Study|Death|1|||
160771222|NCT00790036|580548888|FG001|Overall Study|Death|0|||
160771223|NCT00790036|580548887|FG000|Overall Study|Disease progression|24|||
160771224|NCT00790036|580548888|FG001|Overall Study|Disease progression|48|||
160771225|NCT00790036|580548887|FG000|Overall Study|Lost to Follow-up|1|||
160771226|NCT00790036|580548888|FG001|Overall Study|Lost to Follow-up|2|||
160771227|NCT00790036|580548887|FG000|Overall Study|Protocol Violation|10|||
160771228|NCT00790036|580548888|FG001|Overall Study|Protocol Violation|2|||
160771229|NCT00790036|580548887|FG000|Overall Study|Withdrawal by Subject|18|||
160771230|NCT00790036|580548888|FG001|Overall Study|Withdrawal by Subject|7|||
160771231|NCT00790036|580548887|FG000|Overall Study|Subject/guardian decision|20|||
160771232|NCT00790036|580548888|FG001|Overall Study|Subject/guardian decision|7|||
160771233|NCT00879658|580548889|FG000|Overall Study|Abnormal laboratory value(s)|3|||
160771234|NCT00879658|580548890|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160771235|NCT00879658|580548891|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160771236|NCT00879658|580548892|FG003|Overall Study|Abnormal laboratory value(s)|1|||
160771237|NCT00879658|580548893|FG004|Overall Study|Abnormal laboratory value(s)|0|||
160771238|NCT00879658|580548894|FG005|Overall Study|Abnormal laboratory value(s)|0|||
160771239|NCT00879658|580548895|FG006|Overall Study|Abnormal laboratory value(s)|0|||
160771240|NCT00879658|580548889|FG000|Overall Study|Administrative problems|2|||
160771241|NCT00879658|580548890|FG001|Overall Study|Administrative problems|1|||
160771242|NCT00879658|580548891|FG002|Overall Study|Administrative problems|0|||
160771243|NCT00879658|580548892|FG003|Overall Study|Administrative problems|1|||
160771244|NCT00879658|580548893|FG004|Overall Study|Administrative problems|0|||
160771245|NCT00879658|580548894|FG005|Overall Study|Administrative problems|0|||
160771246|NCT00879658|580548895|FG006|Overall Study|Administrative problems|0|||
160771247|NCT00879658|580548889|FG000|Overall Study|Adverse Event|6|||
160771248|NCT00879658|580548890|FG001|Overall Study|Adverse Event|4|||
160771249|NCT00879658|580548891|FG002|Overall Study|Adverse Event|3|||
160771250|NCT00879658|580548892|FG003|Overall Study|Adverse Event|1|||
160771251|NCT00879658|580548893|FG004|Overall Study|Adverse Event|2|||
160771252|NCT00879658|580548894|FG005|Overall Study|Adverse Event|0|||
160883167|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
160883168|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
160883169|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
160883170|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
160883171|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
160883172|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
160883173|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
160883174|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
160883175|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
160883176|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
160883177|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
160883178|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
160883179|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
160883180|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
160883181|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
160883182|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
160883183|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
160883184|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
160883185|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
160883186|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
160883187|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
160883188|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
160883189|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
160883190|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
160883191|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
160883192|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
160883193|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
160883194|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
160883195|NCT00783302|580966597|FG000|Overall Study|Lost to Follow-up|17|||
160883196|NCT00783302|580966597|FG000|Overall Study|Technical Problems|11|||
160883197|NCT00783302|580966597|FG000|Overall Study|Protocol Violation|3|||
160883198|NCT00783302|580966597|FG000|Overall Study|Physician Decision|1|||
160883199|NCT00783302|580966597|FG000|Overall Study|Withdrawal by Subject|3|||
160883200|NCT01806662|580966598|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
160883201|NCT01806662|580966599|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
160883202|NCT01806662|580966598|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
160883203|NCT01806662|580966599|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
160883204|NCT01806662|580966598|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
160883205|NCT01806662|580966599|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
160883206|NCT01806662|580966598|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
160883207|NCT01806662|580966599|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
160883208|NCT00043550|580966600|FG000|Overall Study|Withdrawal by Subject|22|||
160883209|NCT00043550|580966601|FG001|Overall Study|Withdrawal by Subject|12|||
160883210|NCT00043550|580966602|FG002|Overall Study|Withdrawal by Subject|20|||
160883211|NCT01917656|580966603|FG000|Overall Study|Adverse Event|11|||
160883212|NCT01917656|580966604|FG001|Overall Study|Adverse Event|0|||
160883213|NCT01917656|580966603|FG000|Overall Study|Withdrawal criteria|8|||
160883214|NCT01917656|580966604|FG001|Overall Study|Withdrawal criteria|14|||
160883215|NCT01917656|580966603|FG000|Overall Study|Unclassified|0|||
160883216|NCT01917656|580966604|FG001|Overall Study|Unclassified|3|||
160883217|NCT01917656|580966603|FG000|Overall Study|Withdrawal by Subject|4|||
160883218|NCT01917656|580966604|FG001|Overall Study|Withdrawal by Subject|3|||
160883219|NCT01917656|580966603|FG000|Overall Study|Lost to Follow-up|3|||
160883220|NCT01917656|580966604|FG001|Overall Study|Lost to Follow-up|4|||
160883221|NCT02285062|580966605|FG000|Pre-Treatment Period|Protocol Violation|0|||
160883222|NCT02285062|580966606|FG001|Pre-Treatment Period|Protocol Violation|2|||
160883223|NCT02285062|580966605|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
160883224|NCT02285062|580966606|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
160883225|NCT02015221|580966607|FG000|Overall Study|Withdrawal by Subject|8|||
160883226|NCT02015221|580966608|FG001|Overall Study|Withdrawal by Subject|6|||
160883227|NCT02015221|580966607|FG000|Overall Study|Lost to Follow-up|1|||
160883228|NCT02015221|580966608|FG001|Overall Study|Lost to Follow-up|0|||
160883229|NCT01306929|580966609|FG000|Overall Study|Withdrawal by Subject|23|||
160883230|NCT01306929|580966609|FG000|Overall Study|Adverse Event|21|||
160883231|NCT01306929|580966609|FG000|Overall Study|Physician Decision|13|||
160883232|NCT01306929|580966609|FG000|Overall Study|Death|8|||
160883233|NCT01306929|580966609|FG000|Overall Study|Withdrawal by parent/guardian|5|||
160883234|NCT01306929|580966609|FG000|Overall Study|Protocol Violation|3|||
160883235|NCT01306929|580966609|FG000|Overall Study|Non-compliance with study drug|2|||
160883236|NCT01306929|580966609|FG000|Overall Study|Lost to Follow-up|2|||
160883237|NCT01306929|580966609|FG000|Overall Study|Various|17|||
160883238|NCT00483756|580966612|FG000|Overall Study|Death|2|||
160883239|NCT00483756|580966613|FG001|Overall Study|Death|0|||
160883240|NCT00483756|580966614|FG002|Overall Study|Death|1|||
160883241|NCT00483756|580966612|FG000|Overall Study|Adverse Event|19|||
160883242|NCT00483756|580966613|FG001|Overall Study|Adverse Event|38|||
160883243|NCT00483756|580966614|FG002|Overall Study|Adverse Event|40|||
160883244|NCT00483756|580966612|FG000|Overall Study|Lack of Efficacy|1|||
160883245|NCT00483756|580966613|FG001|Overall Study|Lack of Efficacy|0|||
160883246|NCT00483756|580966614|FG002|Overall Study|Lack of Efficacy|0|||
160883247|NCT00483756|580966612|FG000|Overall Study|Lost to Follow-up|3|||
160883248|NCT00483756|580966613|FG001|Overall Study|Lost to Follow-up|1|||
160883249|NCT00483756|580966614|FG002|Overall Study|Lost to Follow-up|0|||
160883250|NCT00483756|580966612|FG000|Overall Study|Withdrawal by Subject|5|||
160883251|NCT00483756|580966613|FG001|Overall Study|Withdrawal by Subject|3|||
160883252|NCT00483756|580966614|FG002|Overall Study|Withdrawal by Subject|4|||
160883253|NCT00483756|580966612|FG000|Overall Study|Other|2|||
160883254|NCT00483756|580966613|FG001|Overall Study|Other|4|||
160883255|NCT00483756|580966614|FG002|Overall Study|Other|3|||
160883256|NCT00483756|580966612|FG000|Overall Study|Randomized, Not Treated|1|||
160883257|NCT00483756|580966613|FG001|Overall Study|Randomized, Not Treated|4|||
160883258|NCT00483756|580966614|FG002|Overall Study|Randomized, Not Treated|4|||
160883259|NCT01829243|580966615|FG000|First Intervention|Screen Failure|4|||
160883260|NCT01829243|580966616|FG001|First Intervention|Screen Failure|2|||
160883261|NCT02282293|580966621|FG000|Overall Study|Lost to Follow-up|2|||
160883262|NCT02282293|580966622|FG001|Overall Study|Lost to Follow-up|2|||
160883263|NCT02282293|580966621|FG000|Overall Study|Unable to comply with study procedures|1|||
160883264|NCT02282293|580966622|FG001|Overall Study|Unable to comply with study procedures|0|||
160883265|NCT02282293|580966621|FG000|Overall Study|Moved out of study area|0|||
160883266|NCT02282293|580966622|FG001|Overall Study|Moved out of study area|1|||
160883267|NCT03011892|580966623|FG000|Double Blind (DB) Period|Adverse Event|0|||
160883268|NCT03011892|580966624|FG001|Double Blind (DB) Period|Adverse Event|1|||
160883269|NCT03011892|580966625|FG002|Double Blind (DB) Period|Adverse Event|1|||
160883270|NCT03011892|580966626|FG003|Double Blind (DB) Period|Adverse Event|0|||
160883271|NCT03011892|580966627|FG004|Double Blind (DB) Period|Adverse Event|0|||
160883272|NCT03011892|580966628|FG005|Double Blind (DB) Period|Adverse Event|0|||
160883273|NCT03011892|580966629|FG006|Double Blind (DB) Period|Adverse Event|0|||
160883274|NCT03011892|580966630|FG007|Double Blind (DB) Period|Adverse Event|0|||
160883275|NCT03011892|580966631|FG008|Double Blind (DB) Period|Adverse Event|0|||
160883276|NCT03011892|580966632|FG009|Double Blind (DB) Period|Adverse Event|0|||
160883277|NCT03011892|580966633|FG010|Double Blind (DB) Period|Adverse Event|0|||
160883278|NCT03011892|580966634|FG011|Double Blind (DB) Period|Adverse Event|0|||
160883279|NCT03011892|580966623|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
160883280|NCT03011892|580966624|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
160883281|NCT03011892|580966625|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
160883282|NCT03011892|580966626|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
160883283|NCT03011892|580966627|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
160883284|NCT03011892|580966628|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
160883285|NCT03011892|580966629|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
160883286|NCT03011892|580966630|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
160883287|NCT03011892|580966631|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
160883288|NCT03011892|580966632|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
160883289|NCT03011892|580966633|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
160883290|NCT03011892|580966634|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
160883291|NCT03011892|580966623|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
160883292|NCT03011892|580966624|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
160883293|NCT03011892|580966625|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
160883294|NCT03011892|580966626|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
160883295|NCT03011892|580966627|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
160883296|NCT03011892|580966628|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
160883297|NCT03011892|580966629|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
160883298|NCT03011892|580966630|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
160883299|NCT03011892|580966631|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
160883300|NCT03011892|580966632|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
160883301|NCT03011892|580966633|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
160883302|NCT03011892|580966634|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
160883303|NCT03011892|580966623|FG000|Double Blind (DB) Period|Other|1|||
160883304|NCT03011892|580966624|FG001|Double Blind (DB) Period|Other|1|||
160883305|NCT03011892|580966625|FG002|Double Blind (DB) Period|Other|1|||
160883306|NCT03011892|580966626|FG003|Double Blind (DB) Period|Other|0|||
160883307|NCT03011892|580966627|FG004|Double Blind (DB) Period|Other|1|||
160883308|NCT03011892|580966628|FG005|Double Blind (DB) Period|Other|0|||
160883309|NCT03011892|580966629|FG006|Double Blind (DB) Period|Other|0|||
160883310|NCT03011892|580966630|FG007|Double Blind (DB) Period|Other|0|||
160883311|NCT03011892|580966631|FG008|Double Blind (DB) Period|Other|0|||
160883312|NCT03011892|580966632|FG009|Double Blind (DB) Period|Other|0|||
160883313|NCT03011892|580966633|FG010|Double Blind (DB) Period|Other|0|||
160883314|NCT03011892|580966634|FG011|Double Blind (DB) Period|Other|0|||
160883315|NCT03011892|580966623|FG000|Double Blind (DB) Period|Physician Decision|1|||
160883316|NCT03011892|580966624|FG001|Double Blind (DB) Period|Physician Decision|0|||
160883317|NCT03011892|580966625|FG002|Double Blind (DB) Period|Physician Decision|1|||
160883318|NCT03011892|580966626|FG003|Double Blind (DB) Period|Physician Decision|0|||
160883319|NCT03011892|580966627|FG004|Double Blind (DB) Period|Physician Decision|0|||
160883320|NCT03011892|580966628|FG005|Double Blind (DB) Period|Physician Decision|0|||
160883321|NCT03011892|580966629|FG006|Double Blind (DB) Period|Physician Decision|0|||
160883322|NCT03011892|580966630|FG007|Double Blind (DB) Period|Physician Decision|0|||
160883323|NCT03011892|580966631|FG008|Double Blind (DB) Period|Physician Decision|0|||
160883324|NCT03011892|580966632|FG009|Double Blind (DB) Period|Physician Decision|0|||
160883325|NCT03011892|580966633|FG010|Double Blind (DB) Period|Physician Decision|0|||
160883326|NCT03011892|580966634|FG011|Double Blind (DB) Period|Physician Decision|0|||
160883327|NCT03011892|580966623|FG000|Double Blind (DB) Period|Pregnancy|0|||
160883328|NCT03011892|580966624|FG001|Double Blind (DB) Period|Pregnancy|0|||
160883329|NCT03011892|580966625|FG002|Double Blind (DB) Period|Pregnancy|0|||
160883330|NCT03011892|580966626|FG003|Double Blind (DB) Period|Pregnancy|0|||
160883331|NCT03011892|580966627|FG004|Double Blind (DB) Period|Pregnancy|1|||
160883332|NCT03011892|580966628|FG005|Double Blind (DB) Period|Pregnancy|0|||
160883333|NCT03011892|580966629|FG006|Double Blind (DB) Period|Pregnancy|0|||
160883334|NCT03011892|580966630|FG007|Double Blind (DB) Period|Pregnancy|0|||
160883335|NCT03011892|580966631|FG008|Double Blind (DB) Period|Pregnancy|0|||
160883336|NCT03011892|580966632|FG009|Double Blind (DB) Period|Pregnancy|0|||
160883337|NCT03011892|580966633|FG010|Double Blind (DB) Period|Pregnancy|0|||
160883338|NCT03011892|580966634|FG011|Double Blind (DB) Period|Pregnancy|0|||
160883339|NCT03011892|580966623|FG000|Double Blind (DB) Period|Protocol Violation|1|||
160883340|NCT03011892|580966624|FG001|Double Blind (DB) Period|Protocol Violation|0|||
160883341|NCT03011892|580966625|FG002|Double Blind (DB) Period|Protocol Violation|0|||
160883342|NCT03011892|580966626|FG003|Double Blind (DB) Period|Protocol Violation|0|||
160883343|NCT03011892|580966627|FG004|Double Blind (DB) Period|Protocol Violation|0|||
160883344|NCT03011892|580966628|FG005|Double Blind (DB) Period|Protocol Violation|0|||
160883345|NCT03011892|580966629|FG006|Double Blind (DB) Period|Protocol Violation|0|||
160883346|NCT03011892|580966630|FG007|Double Blind (DB) Period|Protocol Violation|0|||
160883347|NCT03011892|580966631|FG008|Double Blind (DB) Period|Protocol Violation|0|||
160883348|NCT03011892|580966632|FG009|Double Blind (DB) Period|Protocol Violation|0|||
160883349|NCT03011892|580966633|FG010|Double Blind (DB) Period|Protocol Violation|0|||
160883350|NCT03011892|580966634|FG011|Double Blind (DB) Period|Protocol Violation|0|||
160883351|NCT03011892|580966623|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
160883352|NCT03011892|580966624|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
160883353|NCT03011892|580966625|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
160883354|NCT03011892|580966626|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
160883355|NCT03011892|580966627|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
160883356|NCT03011892|580966628|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
160883357|NCT03011892|580966629|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883358|NCT03011892|580966630|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883359|NCT03011892|580966631|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883360|NCT03011892|580966632|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883361|NCT03011892|580966633|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883362|NCT03011892|580966634|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883363|NCT03011892|580966623|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
160883364|NCT03011892|580966624|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
160883365|NCT03011892|580966625|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
160883366|NCT03011892|580966626|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
160883367|NCT03011892|580966627|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
160883368|NCT03011892|580966628|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
160883369|NCT03011892|580966629|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
160883370|NCT03011892|580966630|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
160883371|NCT03011892|580966631|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
160883372|NCT03011892|580966632|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
160883373|NCT03011892|580966633|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
160883374|NCT03011892|580966634|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
160540294|NCT01445951|579707574|FG002|Overall Study|Cough|0|||
160883375|NCT03011892|580966623|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
160540295|NCT01473563|579707577|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
160540296|NCT03610724|579707578|FG000|Overall Study|Death|17|||
160540297|NCT03610724|579707578|FG000|Overall Study|Lost to Follow-up|1|||
160883376|NCT03011892|580966624|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
160883377|NCT03011892|580966625|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
160883378|NCT03011892|580966626|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
160883379|NCT03011892|580966627|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
160883380|NCT03011892|580966628|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
160883381|NCT03011892|580966629|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
160883382|NCT03011892|580966630|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
160883383|NCT03011892|580966631|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
160883384|NCT03011892|580966632|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
160883385|NCT03011892|580966633|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
160883386|NCT03011892|580966634|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
160883387|NCT03011892|580966623|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
160883388|NCT03011892|580966624|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
160883389|NCT03011892|580966625|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
160883390|NCT03011892|580966626|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
160883391|NCT03011892|580966627|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
160883392|NCT03011892|580966628|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
160883393|NCT03011892|580966629|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
160883394|NCT03011892|580966630|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
160883395|NCT03011892|580966631|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
160883396|NCT03011892|580966632|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
160883397|NCT03011892|580966633|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
160883398|NCT03011892|580966634|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
160883399|NCT03011892|580966623|FG000|Open Label (OL) Period|Reason not specified|0|||
160883400|NCT03011892|580966624|FG001|Open Label (OL) Period|Reason not specified|0|||
160883401|NCT03011892|580966625|FG002|Open Label (OL) Period|Reason not specified|0|||
160883402|NCT03011892|580966626|FG003|Open Label (OL) Period|Reason not specified|0|||
160883403|NCT03011892|580966627|FG004|Open Label (OL) Period|Reason not specified|0|||
160883404|NCT03011892|580966628|FG005|Open Label (OL) Period|Reason not specified|0|||
160883405|NCT03011892|580966629|FG006|Open Label (OL) Period|Reason not specified|0|||
160883406|NCT03011892|580966630|FG007|Open Label (OL) Period|Reason not specified|1|||
160883407|NCT03011892|580966631|FG008|Open Label (OL) Period|Reason not specified|0|||
160883408|NCT03011892|580966632|FG009|Open Label (OL) Period|Reason not specified|0|||
160883409|NCT03011892|580966633|FG010|Open Label (OL) Period|Reason not specified|0|||
160883410|NCT03011892|580966634|FG011|Open Label (OL) Period|Reason not specified|0|||
160883411|NCT00608569|580966635|FG000|Overall Study|Death|4|||
160883412|NCT00608569|580966636|FG001|Overall Study|Death|3|||
160883413|NCT00608569|580966635|FG000|Overall Study|Lost to Follow-up|4|||
160883414|NCT00608569|580966636|FG001|Overall Study|Lost to Follow-up|5|||
160883415|NCT00608569|580966635|FG000|Overall Study|Withdrawal by Subject|1|||
160883416|NCT00608569|580966636|FG001|Overall Study|Withdrawal by Subject|0|||
160883417|NCT00608569|580966635|FG000|Overall Study|Adverse Event|1|||
160883418|NCT00608569|580966636|FG001|Overall Study|Adverse Event|0|||
160883419|NCT00608569|580966635|FG000|Overall Study|Unable to adhere with study requirements|0|||
160883420|NCT00608569|580966636|FG001|Overall Study|Unable to adhere with study requirements|1|||
160883421|NCT02312687|580966651|FG000|Overall Study|Other, Not Specified|1|||
160883422|NCT00906971|580966652|FG000|Overall Study|Withdrawal by Subject|8|||
160883423|NCT00906971|580966653|FG001|Overall Study|Withdrawal by Subject|2|||
160883424|NCT00906971|580966652|FG000|Overall Study|Lost to Follow-up|0|||
160883425|NCT00906971|580966653|FG001|Overall Study|Lost to Follow-up|1|||
160883426|NCT00545129|580966656|FG000|Overall Study|Lack of Efficacy|2|||
160883427|NCT00545129|580966657|FG001|Overall Study|Lack of Efficacy|5|||
160883428|NCT00545129|580966656|FG000|Overall Study|Death|2|||
160883429|NCT00545129|580966657|FG001|Overall Study|Death|1|||
160883430|NCT00545129|580966656|FG000|Overall Study|Adverse Event|1|||
160883431|NCT00545129|580966657|FG001|Overall Study|Adverse Event|1|||
160883432|NCT00545129|580966656|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
160883433|NCT00545129|580966657|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
160883434|NCT00545129|580966656|FG000|Overall Study|Other|3|||
160883435|NCT00545129|580966657|FG001|Overall Study|Other|3|||
160883436|NCT03678870|580966658|FG000|Overall Study|prescribed non- protocol medications|10|||
160883437|NCT03678870|580966659|FG001|Overall Study|prescribed non- protocol medications|6|||
160883438|NCT03678870|580966658|FG000|Overall Study|Lost to Follow-up|3|||
160883439|NCT03678870|580966659|FG001|Overall Study|Lost to Follow-up|2|||
160883440|NCT03104816|580966661|FG000|Overall Study|Lack of Efficacy|0|||
160883441|NCT03104816|580966662|FG001|Overall Study|Lack of Efficacy|2|||
160883442|NCT03104816|580966663|FG002|Overall Study|Lack of Efficacy|0|||
160883443|NCT03104816|580966661|FG000|Overall Study|Protocol Violation|2|||
160883444|NCT03104816|580966662|FG001|Overall Study|Protocol Violation|0|||
160883445|NCT03104816|580966663|FG002|Overall Study|Protocol Violation|2|||
160883446|NCT01007253|580966668|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
160883447|NCT01007253|580966669|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
160883448|NCT01007253|580966670|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
160883449|NCT01007253|580966671|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
160883450|NCT04896229|580968416|FG000|Overall Study|Lost to Follow-up|113|||
160883451|NCT04896229|580968417|FG001|Overall Study|Lost to Follow-up|113|||
160883452|NCT00635024|580968418|FG000|Overall Study|Adverse Event|1|||
160883453|NCT02142387|580968419|FG000|Overall Study|<19 years old|49|||
160883454|NCT02142387|580968420|FG001|Overall Study|<19 years old|326|||
160883455|NCT02142387|580968419|FG000|Overall Study|non-cardiac etiology|504|||
160883456|NCT02142387|580968420|FG001|Overall Study|non-cardiac etiology|3431|||
160883457|NCT02142387|580968419|FG000|Overall Study|CPR not performed|74|||
160883458|NCT02142387|580968420|FG001|Overall Study|CPR not performed|473|||
160883459|NCT02142387|580968419|FG000|Overall Study|witnessed by paramedic|139|||
160883460|NCT02142387|580968420|FG001|Overall Study|witnessed by paramedic|917|||
160883461|NCT02142387|580968419|FG000|Overall Study|incomplete data|1|||
160883462|NCT02142387|580968420|FG001|Overall Study|incomplete data|9|||
160883463|NCT02142387|580968419|FG000|Overall Study|occurred not at home|298|||
160883464|NCT02142387|580968420|FG001|Overall Study|occurred not at home|2474|||
160883465|NCT02984943|580968421|FG000|Overall Study|Withdrawal by Subject|3|||
160883466|NCT02984943|580968421|FG000|Overall Study|Physician Decision|1|||
160883467|NCT02282345|580968424|FG000|Overall Study|Progression|0|||
160883468|NCT02282345|580968425|FG001|Overall Study|Progression|1|||
160883469|NCT02296138|580968426|FG000|Overall Study|Adverse Event|348|||
160883470|NCT02296138|580968427|FG001|Overall Study|Adverse Event|259|||
160883471|NCT02296138|580968426|FG000|Overall Study|Lack of Efficacy|59|||
160883472|NCT02296138|580968427|FG001|Overall Study|Lack of Efficacy|37|||
160883473|NCT02296138|580968426|FG000|Overall Study|Protocol Violation|35|||
160883474|NCT02296138|580968427|FG001|Overall Study|Protocol Violation|36|||
160883475|NCT02296138|580968426|FG000|Overall Study|Lost to Follow-up|9|||
160883476|NCT02296138|580968427|FG001|Overall Study|Lost to Follow-up|12|||
160883477|NCT02296138|580968426|FG000|Overall Study|Withdrawal by Subject|184|||
160883478|NCT02296138|580968427|FG001|Overall Study|Withdrawal by Subject|131|||
160883479|NCT02296138|580968426|FG000|Overall Study|Not Treated|1|||
160883480|NCT02296138|580968427|FG001|Overall Study|Not Treated|1|||
160883481|NCT02296138|580968426|FG000|Overall Study|Patients with data irregularities|10|||
160540298|NCT03610724|579707578|FG000|Overall Study|Physician Decision|1|||
160540299|NCT03610724|579707578|FG000|Overall Study|Died prior to infusion|1|||
160540300|NCT02739620|579707579|FG000|Overall Study|Lost to Follow-up|3|||
160540301|NCT02739620|579707580|FG001|Overall Study|Lost to Follow-up|1|||
160540302|NCT02739620|579707579|FG000|Overall Study|Adverse Event|0|||
160540303|NCT02739620|579707580|FG001|Overall Study|Adverse Event|1|||
160540304|NCT00786565|579707584|FG000|Enrollment Prior to Surgery|Site Closed|3|||
160540305|NCT00786565|579707584|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
160540306|NCT00786565|579707584|FG000|Post Surgery|Abnormal macular pucker|1|||
160540307|NCT00786565|579707584|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
160540308|NCT05513625|579707587|FG000|Overall Study|Withdrawal by Subject|1|||
160540309|NCT00754793|579707589|FG000|Overall Study|voluntary withdrawn from study|0|||
160540310|NCT00754793|579707590|FG001|Overall Study|voluntary withdrawn from study|1|||
160540311|NCT02943564|579707592|FG000|Overall Study|Miscellaneous Reasons|0|||
160540312|NCT02943564|579707593|FG001|Overall Study|Miscellaneous Reasons|0|||
160540313|NCT02943564|579707594|FG002|Overall Study|Miscellaneous Reasons|3|||
160540314|NCT02943564|579707592|FG000|Overall Study|Site terminated by sponsor|0|||
160540315|NCT02943564|579707593|FG001|Overall Study|Site terminated by sponsor|1|||
160540316|NCT02943564|579707594|FG002|Overall Study|Site terminated by sponsor|0|||
160540317|NCT02943564|579707592|FG000|Overall Study|Non-compliance with study drug|0|||
160637081|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
160883482|NCT02296138|580968427|FG001|Overall Study|Patients with data irregularities|11|||
160883483|NCT02296138|580968426|FG000|Overall Study|Other than specified|15|||
160883484|NCT02296138|580968427|FG001|Overall Study|Other than specified|13|||
160883485|NCT01895361|580968431|FG000|Overall Study|Adverse Event|1|||
160883486|NCT01895361|580968432|FG001|Overall Study|Adverse Event|1|||
160883487|NCT01895361|580968433|FG002|Overall Study|Adverse Event|3|||
160883488|NCT01895361|580968431|FG000|Overall Study|Death|2|||
160883489|NCT01895361|580968432|FG001|Overall Study|Death|1|||
160883490|NCT01895361|580968433|FG002|Overall Study|Death|2|||
160883491|NCT01895361|580968431|FG000|Overall Study|Lost to Follow-up|4|||
160883492|NCT01895361|580968432|FG001|Overall Study|Lost to Follow-up|4|||
160637082|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
160883493|NCT01895361|580968433|FG002|Overall Study|Lost to Follow-up|6|||
160883494|NCT01895361|580968431|FG000|Overall Study|Non-compliance with study|1|||
160883495|NCT01895361|580968432|FG001|Overall Study|Non-compliance with study|3|||
160883496|NCT01895361|580968433|FG002|Overall Study|Non-compliance with study|1|||
160883497|NCT01895361|580968431|FG000|Overall Study|Physician Decision|2|||
160883498|NCT01895361|580968432|FG001|Overall Study|Physician Decision|2|||
160883499|NCT01895361|580968433|FG002|Overall Study|Physician Decision|2|||
160883500|NCT01895361|580968431|FG000|Overall Study|Withdrawal by Subject|7|||
160883501|NCT01895361|580968432|FG001|Overall Study|Withdrawal by Subject|6|||
160540318|NCT02943564|579707593|FG001|Overall Study|Non-compliance with study drug|1|||
160540319|NCT02943564|579707594|FG002|Overall Study|Non-compliance with study drug|0|||
160540320|NCT02943564|579707592|FG000|Overall Study|Pregnancy|0|||
160883502|NCT01895361|580968433|FG002|Overall Study|Withdrawal by Subject|6|||
160883503|NCT01895361|580968431|FG000|Overall Study|Lack of Efficacy|0|||
160883504|NCT01895361|580968432|FG001|Overall Study|Lack of Efficacy|1|||
160883505|NCT01895361|580968433|FG002|Overall Study|Lack of Efficacy|0|||
160883506|NCT01895361|580968431|FG000|Overall Study|Reasons different from categories above|7|||
160883507|NCT01895361|580968432|FG001|Overall Study|Reasons different from categories above|3|||
160883508|NCT01895361|580968433|FG002|Overall Study|Reasons different from categories above|4|||
160883509|NCT02677324|580968434|FG000|Overall Study|Disease Progression|6|||
160883510|NCT02677324|580968434|FG000|Overall Study|Inability to Swallow pills|1|||
160883511|NCT02677324|580968434|FG000|Overall Study|Non-compliance|1|||
160883512|NCT02677324|580968434|FG000|Overall Study|Lack of Efficacy|1|||
160883513|NCT02677324|580968434|FG000|Overall Study|Medical insurance coverage|1|||
160883514|NCT02677324|580968434|FG000|Overall Study|Adverse Event|1|||
160883515|NCT02677324|580968434|FG000|Overall Study|IgM Myeloma diagnosis|1|||
160883516|NCT01268579|580968435|FG000|Overall Study|Adverse Event|1|||
160883517|NCT01268579|580968435|FG000|Overall Study|Withdrawal by Subject|2|||
160883518|NCT03312751|580968436|FG000|Overall Study|Death|7|||
160883519|NCT03312751|580968437|FG001|Overall Study|Death|9|||
160883520|NCT03312751|580968436|FG000|Overall Study|Study discontinuation due to other reason|0|||
160883521|NCT03312751|580968437|FG001|Overall Study|Study discontinuation due to other reason|1|||
160883522|NCT05463198|580968438|FG000|Overall Study|Withdrawal by Subject|19|||
160883523|NCT05463198|580968438|FG000|Overall Study|Procedure Notes Missing|18|||
160883524|NCT02239120|580968441|FG000|Overall Study|Death|56|||
160883525|NCT02239120|580968442|FG001|Overall Study|Death|58|||
160883526|NCT02239120|580968441|FG000|Overall Study|Lost to Follow-up|19|||
160883527|NCT02239120|580968442|FG001|Overall Study|Lost to Follow-up|14|||
160883528|NCT00046891|580968448|FG000|Overall Study|Cancels|5|||
160883529|NCT00046891|580968449|FG001|Overall Study|Cancels|9|||
160883530|NCT00046891|580968448|FG000|Overall Study|Ineligible|1|||
160883531|NCT00046891|580968449|FG001|Overall Study|Ineligible|1|||
160883532|NCT00046891|580968448|FG000|Overall Study|Withdrawal by Subject|18|||
160883533|NCT00046891|580968449|FG001|Overall Study|Withdrawal by Subject|15|||
160883534|NCT00046891|580968448|FG000|Overall Study|Adverse Event|5|||
160883535|NCT00046891|580968449|FG001|Overall Study|Adverse Event|5|||
160883536|NCT00420641|580968452|FG000|Overall Study|Adverse Event|3|||
160883537|NCT00420641|580968453|FG001|Overall Study|Adverse Event|25|||
160883538|NCT00420641|580968454|FG002|Overall Study|Adverse Event|10|||
160883539|NCT00420641|580968452|FG000|Overall Study|Lost to Follow-up|2|||
160883540|NCT00420641|580968453|FG001|Overall Study|Lost to Follow-up|4|||
160883541|NCT00420641|580968454|FG002|Overall Study|Lost to Follow-up|2|||
160883542|NCT00420641|580968452|FG000|Overall Study|Protocol Violation|8|||
160883543|NCT00420641|580968453|FG001|Overall Study|Protocol Violation|8|||
160883544|NCT00420641|580968454|FG002|Overall Study|Protocol Violation|7|||
160883545|NCT00420641|580968452|FG000|Overall Study|Withdrawal by Subject|15|||
160883546|NCT00420641|580968453|FG001|Overall Study|Withdrawal by Subject|21|||
160883547|NCT00420641|580968454|FG002|Overall Study|Withdrawal by Subject|14|||
160883548|NCT00420641|580968452|FG000|Overall Study|Lack of Efficacy|6|||
160883549|NCT00420641|580968453|FG001|Overall Study|Lack of Efficacy|5|||
160883550|NCT00420641|580968454|FG002|Overall Study|Lack of Efficacy|4|||
160883551|NCT00420641|580968452|FG000|Overall Study|Non-compliance|7|||
160883552|NCT00420641|580968453|FG001|Overall Study|Non-compliance|5|||
160883553|NCT00420641|580968454|FG002|Overall Study|Non-compliance|4|||
160883554|NCT00420641|580968452|FG000|Overall Study|Other|4|||
160883555|NCT00420641|580968453|FG001|Overall Study|Other|4|||
160883556|NCT00420641|580968454|FG002|Overall Study|Other|3|||
160883557|NCT02815280|580968466|FG000|Double-Blind Phase|Adverse Event|1|||
160883558|NCT02815280|580968467|FG001|Double-Blind Phase|Adverse Event|1|||
160883559|NCT02815280|580968466|FG000|Double-Blind Phase|Lost to Follow-up|10|||
160883560|NCT02815280|580968467|FG001|Double-Blind Phase|Lost to Follow-up|9|||
160883561|NCT02815280|580968466|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
160883562|NCT02815280|580968467|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
160883563|NCT02815280|580968466|FG000|Double-Blind Phase|Protocol Violation|2|||
160883564|NCT02815280|580968467|FG001|Double-Blind Phase|Protocol Violation|2|||
160771253|NCT00879658|580548895|FG006|Overall Study|Adverse Event|0|||
160771254|NCT00879658|580548889|FG000|Overall Study|Protocol Violation|1|||
160771255|NCT00879658|580548890|FG001|Overall Study|Protocol Violation|0|||
160771256|NCT00879658|580548891|FG002|Overall Study|Protocol Violation|0|||
160771257|NCT00879658|580548892|FG003|Overall Study|Protocol Violation|0|||
160771258|NCT00879658|580548893|FG004|Overall Study|Protocol Violation|0|||
160771259|NCT00879658|580548894|FG005|Overall Study|Protocol Violation|0|||
160771260|NCT00879658|580548895|FG006|Overall Study|Protocol Violation|0|||
160771261|NCT00879658|580548889|FG000|Overall Study|Withdrawal by Subject|3|||
160771262|NCT00879658|580548890|FG001|Overall Study|Withdrawal by Subject|0|||
160883565|NCT02815280|580968466|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
160883566|NCT02815280|580968467|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
160883567|NCT02815280|580968466|FG000|Open-Label Phase|Adverse Event|2|||
160883568|NCT02815280|580968467|FG001|Open-Label Phase|Adverse Event|3|||
160883569|NCT02815280|580968466|FG000|Open-Label Phase|Lost to Follow-up|18|||
160883570|NCT02815280|580968467|FG001|Open-Label Phase|Lost to Follow-up|9|||
160883571|NCT02815280|580968466|FG000|Open-Label Phase|Withdrawal by Subject|33|||
160883572|NCT02815280|580968467|FG001|Open-Label Phase|Withdrawal by Subject|18|||
160883573|NCT02815280|580968466|FG000|Open-Label Phase|Protocol Violation|3|||
160883574|NCT02815280|580968467|FG001|Open-Label Phase|Protocol Violation|0|||
160883575|NCT02815280|580968466|FG000|Open-Label Phase|Administrative|26|||
160883576|NCT02815280|580968467|FG001|Open-Label Phase|Administrative|12|||
160883577|NCT02815280|580968466|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
160883578|NCT02815280|580968467|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
160883579|NCT01944839|580968483|FG000|Overall Study|Physician Decision|2|||
160883580|NCT01944839|580968484|FG001|Overall Study|Physician Decision|2|||
160883581|NCT01944839|580968483|FG000|Overall Study|Protocol Violation|0|||
160883582|NCT01944839|580968484|FG001|Overall Study|Protocol Violation|1|||
160883583|NCT01944839|580968483|FG000|Overall Study|Adverse Event|10|||
160883584|NCT01944839|580968484|FG001|Overall Study|Adverse Event|5|||
160883585|NCT01944839|580968483|FG000|Overall Study|Withdrawal by Subject|9|||
160883586|NCT01944839|580968484|FG001|Overall Study|Withdrawal by Subject|17|||
160883587|NCT01944839|580968483|FG000|Overall Study|Lost to Follow-up|1|||
160883588|NCT01944839|580968484|FG001|Overall Study|Lost to Follow-up|0|||
160883589|NCT01944839|580968483|FG000|Overall Study|Subject non-compliance|0|||
160883590|NCT01944839|580968484|FG001|Overall Study|Subject non-compliance|3|||
160883591|NCT00609362|580968485|FG000|Overall Study|Withdrawal by Subject|2|||
160883592|NCT00609362|580968486|FG001|Overall Study|Withdrawal by Subject|1|||
160883593|NCT00609362|580968485|FG000|Overall Study|Adverse Event|1|||
160883594|NCT00609362|580968486|FG001|Overall Study|Adverse Event|0|||
160883595|NCT05093790|580968487|FG000|Overall Study|Failure to meet continuation criteria|0|||
160883596|NCT05093790|580968488|FG001|Overall Study|Failure to meet continuation criteria|0|||
160883597|NCT05093790|580968489|FG002|Overall Study|Failure to meet continuation criteria|1|||
160883598|NCT05093790|580968490|FG003|Overall Study|Failure to meet continuation criteria|0|||
160883599|NCT05093790|580968487|FG000|Overall Study|Adverse Event|1|||
160883600|NCT05093790|580968488|FG001|Overall Study|Adverse Event|0|||
160883601|NCT05093790|580968489|FG002|Overall Study|Adverse Event|0|||
160883602|NCT05093790|580968490|FG003|Overall Study|Adverse Event|0|||
160883603|NCT02582684|580968491|FG000|Overall Study|Unable to contact subject/parent|4|||
160883604|NCT02582684|580968491|FG000|Overall Study|Subject not able to get to clinic|10|||
160883605|NCT02582684|580968491|FG000|Overall Study|Subject withdrew consent|1|||
160883606|NCT02582684|580968491|FG000|Overall Study|Found to be ineligible after enrollment|2|||
160883607|NCT01587898|580968499|FG000|Overall Study|Adverse Event|1|||
160883608|NCT01587898|580968500|FG001|Overall Study|Adverse Event|1|||
160883609|NCT01587898|580968501|FG002|Overall Study|Adverse Event|0|||
160883610|NCT01587898|580968502|FG003|Overall Study|Adverse Event|0|||
160883611|NCT01587898|580968499|FG000|Overall Study|Protocol Violation|0|||
160883612|NCT01587898|580968500|FG001|Overall Study|Protocol Violation|2|||
160883613|NCT01587898|580968501|FG002|Overall Study|Protocol Violation|1|||
160883614|NCT01587898|580968502|FG003|Overall Study|Protocol Violation|1|||
160883615|NCT01587898|580968499|FG000|Overall Study|Lost to Follow-up|0|||
160883616|NCT01587898|580968500|FG001|Overall Study|Lost to Follow-up|0|||
160883617|NCT01587898|580968501|FG002|Overall Study|Lost to Follow-up|0|||
160883618|NCT01587898|580968502|FG003|Overall Study|Lost to Follow-up|1|||
160883619|NCT01587898|580968499|FG000|Overall Study|Withdrawal by Subject|2|||
160883620|NCT01587898|580968500|FG001|Overall Study|Withdrawal by Subject|1|||
160883621|NCT01587898|580968501|FG002|Overall Study|Withdrawal by Subject|0|||
160883622|NCT01587898|580968502|FG003|Overall Study|Withdrawal by Subject|0|||
160883623|NCT01587898|580968499|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
160883624|NCT01587898|580968500|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
160883625|NCT01587898|580968501|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
160883626|NCT01587898|580968502|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
160883627|NCT02720094|580968503|FG000|Overall Study|Ongoing|2210|||
160883628|NCT02720094|580968504|FG001|Overall Study|Ongoing|2203|||
160883629|NCT02720094|580968503|FG000|Overall Study|Scheduled exit visit/end of study|2|||
160883630|NCT02720094|580968504|FG001|Overall Study|Scheduled exit visit/end of study|1|||
160883631|NCT02720094|580968503|FG000|Overall Study|Death|4|||
160883632|NCT02720094|580968504|FG001|Overall Study|Death|7|||
160883633|NCT02720094|580968503|FG000|Overall Study|Withdrawal by Subject|55|||
160883634|NCT02720094|580968504|FG001|Overall Study|Withdrawal by Subject|56|||
160883635|NCT02720094|580968503|FG000|Overall Study|Lost to Follow-up|2|||
160883636|NCT02720094|580968504|FG001|Overall Study|Lost to Follow-up|7|||
160883637|NCT02720094|580968503|FG000|Overall Study|Physician Decision|1|||
160883638|NCT02720094|580968504|FG001|Overall Study|Physician Decision|3|||
160883639|NCT02720094|580968503|FG000|Overall Study|Inappropriate enrollment|1|||
160883640|NCT02720094|580968504|FG001|Overall Study|Inappropriate enrollment|3|||
160883641|NCT02720094|580968503|FG000|Overall Study|Relocation|1|||
160883642|NCT02720094|580968504|FG001|Overall Study|Relocation|1|||
160883643|NCT02437110|580968507|FG000|Screening|Lost to Follow-up|3|||
160883644|NCT02437110|580968507|FG000|Screening|Physician Decision|1|||
160883645|NCT02437110|580968507|FG000|ART|Adverse Event|3|||
160883646|NCT02437110|580968507|FG000|ART|Protocol Violation|3|||
160883647|NCT02437110|580968507|FG000|ART|Withdrawal by Subject|4|||
160883648|NCT02437110|580968507|FG000|ART|Lost to follow-up prior to start of intervention|1|||
160883649|NCT02437110|580968507|FG000|ART|Physician decision prior to start of intervention|2|||
160883650|NCT02437110|580968507|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
160883651|NCT02437110|580968507|FG000|Post-ART|Lost to Follow-up|3|||
160883652|NCT02437110|580968507|FG000|Post-ART|Protocol Violation|4|||
160883653|NCT02437110|580968507|FG000|Post-ART|Withdrawal by Subject|3|||
160883654|NCT03735238|580968508|FG000|Overall Study|Did not want to participate in research|3|||
160883655|NCT03735238|580968508|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
160883656|NCT01261780|580968509|FG000|Overall Study|Withdrawal by Subject|1|||
160883657|NCT01261780|580968510|FG001|Overall Study|Withdrawal by Subject|0|||
160883658|NCT01261780|580968509|FG000|Overall Study|Event not related to subject|1|||
160883659|NCT01261780|580968510|FG001|Overall Study|Event not related to subject|2|||
160883660|NCT01239732|580968511|FG000|Overall Study|Termination of study per protocol|667|||
160883661|NCT01239732|580968511|FG000|Overall Study|Death|226|||
160883662|NCT01239732|580968511|FG000|Overall Study|Withdrawal by Subject|87|||
160883663|NCT01239732|580968511|FG000|Overall Study|Adverse Event|6|||
160883664|NCT01239732|580968511|FG000|Overall Study|Protocol Violation|3|||
160883665|NCT01239732|580968511|FG000|Overall Study|Participant non compliance|5|||
160883666|NCT01239732|580968511|FG000|Overall Study|Study termination by sponsor|2|||
160883667|NCT01239732|580968511|FG000|Overall Study|Investigator's decision|4|||
160883668|NCT01239732|580968511|FG000|Overall Study|Treatment failure|2|||
160883669|NCT01239732|580968511|FG000|Overall Study|Other|19|||
160883670|NCT02395302|580968512|FG000|Overall Study|Screen Failure|3|||
160883671|NCT02395302|580968512|FG000|Overall Study|Run In Failure|7|||
160883672|NCT02395302|580968512|FG000|Overall Study|Withdrawal by Subject|2|||
160883673|NCT02395302|580968512|FG000|Overall Study|Physician Decision|2|||
160883674|NCT03041129|580968518|FG000|Overall Study|Withdrawal by Subject|2|||
160883675|NCT03041129|580968519|FG001|Overall Study|Withdrawal by Subject|0|||
160883676|NCT03041129|580968520|FG002|Overall Study|Withdrawal by Subject|0|||
160883677|NCT03041129|580968521|FG003|Overall Study|Withdrawal by Subject|0|||
160883678|NCT00436501|580968524|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
160883679|NCT00436501|580968525|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
160883680|NCT00436501|580968524|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
160883681|NCT00436501|580968525|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
160883682|NCT00169442|580968537|FG000|Overall Study|Withdrawal by Subject|0|||
160883683|NCT00169442|580968538|FG001|Overall Study|Withdrawal by Subject|0|||
160883684|NCT00169442|580968539|FG002|Overall Study|Withdrawal by Subject|1|||
160883685|NCT00169442|580968540|FG003|Overall Study|Withdrawal by Subject|0|||
160883686|NCT00169442|580968541|FG004|Overall Study|Withdrawal by Subject|0|||
160883687|NCT00169442|580968542|FG005|Overall Study|Withdrawal by Subject|0|||
160883688|NCT00169442|580968537|FG000|Overall Study|Migrated/moved from study area|0|||
160883689|NCT00169442|580968538|FG001|Overall Study|Migrated/moved from study area|0|||
160883690|NCT00169442|580968539|FG002|Overall Study|Migrated/moved from study area|0|||
160883691|NCT00169442|580968540|FG003|Overall Study|Migrated/moved from study area|0|||
160883692|NCT00169442|580968541|FG004|Overall Study|Migrated/moved from study area|0|||
160883693|NCT00169442|580968542|FG005|Overall Study|Migrated/moved from study area|2|||
160883694|NCT00169442|580968537|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160883695|NCT00169442|580968538|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160883696|NCT00169442|580968539|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160883697|NCT00169442|580968540|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160883698|NCT00169442|580968541|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
160883699|NCT00169442|580968542|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160883700|NCT00169442|580968537|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
160883701|NCT00169442|580968538|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
160883702|NCT00169442|580968539|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
160883703|NCT00169442|580968540|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
160883704|NCT00169442|580968541|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
160883705|NCT00169442|580968542|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
160883706|NCT01159431|580968543|FG000|Overall Study|Adverse Event|1|||
160883707|NCT01159431|580968544|FG001|Overall Study|Adverse Event|2|||
160883708|NCT01159431|580968543|FG000|Overall Study|non-compliance|1|||
160883709|NCT01159431|580968544|FG001|Overall Study|non-compliance|1|||
160883710|NCT01159431|580968543|FG000|Overall Study|Lack of Efficacy|0|||
160883711|NCT01159431|580968544|FG001|Overall Study|Lack of Efficacy|3|||
160883712|NCT03353740|580968547|FG000|Overall Study|Images for these participants not viable|52|||
160883713|NCT03976648|580968550|FG000|Overall Study|Adverse Event|0|||
160883714|NCT03976648|580968551|FG001|Overall Study|Adverse Event|2|||
160883715|NCT03976648|580968550|FG000|Overall Study|Study terminated by sponsor|21|||
160883716|NCT03976648|580968551|FG001|Overall Study|Study terminated by sponsor|8|||
160883717|NCT03645434|580968552|FG000|Period 1|Adverse Event|0|||
160883718|NCT03645434|580968553|FG001|Period 1|Adverse Event|0|||
160883719|NCT03645434|580968554|FG002|Period 1|Adverse Event|0|||
160883720|NCT03645434|580968555|FG003|Period 1|Adverse Event|1|||
160883721|NCT03645434|580968556|FG004|Period 1|Adverse Event|0|||
160883722|NCT03645434|580968557|FG005|Period 1|Adverse Event|0|||
160883723|NCT03645434|580968552|FG000|Period 1|COPD exacerbation|0|||
160883724|NCT03645434|580968553|FG001|Period 1|COPD exacerbation|0|||
160883725|NCT03645434|580968554|FG002|Period 1|COPD exacerbation|0|||
160883726|NCT03645434|580968555|FG003|Period 1|COPD exacerbation|0|||
160883727|NCT03645434|580968556|FG004|Period 1|COPD exacerbation|1|||
160883728|NCT03645434|580968557|FG005|Period 1|COPD exacerbation|0|||
160883729|NCT00881868|580968558|FG000|Overall Study|Adverse Event|0|||
160883730|NCT00881868|580968559|FG001|Overall Study|Adverse Event|1|||
160883731|NCT00881868|580968558|FG000|Overall Study|Lost to Follow-up|2|||
160883732|NCT00881868|580968559|FG001|Overall Study|Lost to Follow-up|1|||
160883733|NCT00881868|580968558|FG000|Overall Study|Physician Decision|4|||
160883734|NCT00881868|580968559|FG001|Overall Study|Physician Decision|0|||
160883735|NCT00881868|580968558|FG000|Overall Study|Protocol Violation|2|||
160883736|NCT00881868|580968559|FG001|Overall Study|Protocol Violation|0|||
160883737|NCT02880956|580968562|FG000|Overall Study|Adverse Event|3|||
160883738|NCT02880956|580968563|FG001|Overall Study|Adverse Event|6|||
160883739|NCT02880956|580968564|FG002|Overall Study|Adverse Event|5|||
160883740|NCT02880956|580968565|FG003|Overall Study|Adverse Event|4|||
160883741|NCT02880956|580968562|FG000|Overall Study|Withdrawal by Subject|9|||
160883742|NCT02880956|580968563|FG001|Overall Study|Withdrawal by Subject|4|||
160883743|NCT02880956|580968564|FG002|Overall Study|Withdrawal by Subject|6|||
160883744|NCT02880956|580968565|FG003|Overall Study|Withdrawal by Subject|11|||
160883745|NCT02880956|580968562|FG000|Overall Study|Lost to Follow-up|0|||
160883746|NCT02880956|580968563|FG001|Overall Study|Lost to Follow-up|1|||
160883747|NCT02880956|580968564|FG002|Overall Study|Lost to Follow-up|0|||
160883748|NCT02880956|580968565|FG003|Overall Study|Lost to Follow-up|0|||
160883749|NCT02880956|580968562|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
160883750|NCT02880956|580968563|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
160883751|NCT02880956|580968564|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
160883752|NCT02880956|580968565|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
160883753|NCT02880956|580968562|FG000|Overall Study|Other, Not Specified|4|||
160883754|NCT02880956|580968563|FG001|Overall Study|Other, Not Specified|2|||
160883755|NCT02880956|580968564|FG002|Overall Study|Other, Not Specified|0|||
160883756|NCT02880956|580968565|FG003|Overall Study|Other, Not Specified|3|||
160883757|NCT02081859|580968566|FG000|Overall Study|No fertilization|2|||
160883758|NCT02081859|580968567|FG001|Overall Study|No fertilization|2|||
160883759|NCT02081859|580968566|FG000|Overall Study|No sperm|1|||
160883760|NCT02081859|580968567|FG001|Overall Study|No sperm|0|||
160883761|NCT02081859|580968566|FG000|Overall Study|Unanticipated freeze all cycle|2|||
160883762|NCT02081859|580968567|FG001|Overall Study|Unanticipated freeze all cycle|6|||
160883763|NCT02081859|580968566|FG000|Overall Study|< 4 embryos|27|||
160883764|NCT02081859|580968567|FG001|Overall Study|< 4 embryos|23|||
160883765|NCT02081859|580968566|FG000|Overall Study|Other reasons|2|||
160883766|NCT02081859|580968567|FG001|Overall Study|Other reasons|0|||
160883767|NCT00282464|580970362|FG000|Overall Study|Adverse Event|26|||
160883768|NCT00282464|580970363|FG001|Overall Study|Adverse Event|20|||
160883769|NCT00282464|580970362|FG000|Overall Study|Lack of Efficacy|8|||
160883770|NCT00282464|580970363|FG001|Overall Study|Lack of Efficacy|8|||
160883771|NCT00282464|580970362|FG000|Overall Study|Lost to Follow-up|10|||
160883772|NCT00282464|580970363|FG001|Overall Study|Lost to Follow-up|10|||
160883773|NCT00282464|580970362|FG000|Overall Study|Withdrawal by Subject|24|||
160883774|NCT00282464|580970363|FG001|Overall Study|Withdrawal by Subject|10|||
160883775|NCT00282464|580970362|FG000|Overall Study|laboratory abnormality|1|||
160883776|NCT00282464|580970363|FG001|Overall Study|laboratory abnormality|2|||
160883777|NCT00282464|580970362|FG000|Overall Study|Protocol Violation|0|||
160883778|NCT00282464|580970363|FG001|Overall Study|Protocol Violation|7|||
160883779|NCT00282464|580970362|FG000|Overall Study|Patient moved|1|||
160883780|NCT00282464|580970363|FG001|Overall Study|Patient moved|0|||
160883781|NCT00282464|580970362|FG000|Overall Study|patient non-compliant|3|||
160883782|NCT00282464|580970363|FG001|Overall Study|patient non-compliant|0|||
160883783|NCT00282464|580970362|FG000|Overall Study|patient no show|0|||
160883784|NCT00282464|580970363|FG001|Overall Study|patient no show|1|||
160883785|NCT00282464|580970362|FG000|Overall Study|patient incarcerated|0|||
160883786|NCT00282464|580970363|FG001|Overall Study|patient incarcerated|1|||
160883787|NCT00282464|580970362|FG000|Overall Study|family crisis|0|||
160883788|NCT00282464|580970363|FG001|Overall Study|family crisis|1|||
160883789|NCT00282464|580970362|FG000|Overall Study|dispensed wrong kit|0|||
160883790|NCT00282464|580970363|FG001|Overall Study|dispensed wrong kit|1|||
160883791|NCT00282464|580970362|FG000|Overall Study|dropped due to missed visits|0|||
160883792|NCT00282464|580970363|FG001|Overall Study|dropped due to missed visits|1|||
160883793|NCT00475423|580970364|FG000|Overall Study|Protocol Violation|5|||
160883794|NCT00475423|580970364|FG000|Overall Study|Adverse Event|4|||
160883795|NCT00475423|580970364|FG000|Overall Study|Withdrawal by Subject|6|||
160883796|NCT00475423|580970364|FG000|Overall Study|Lack of Efficacy|8|||
160883797|NCT00475423|580970364|FG000|Overall Study|Death|1|||
160883798|NCT00475423|580970364|FG000|Overall Study|Reason not specified|1|||
160883799|NCT00475423|580970364|FG000|Overall Study|Lost to Follow-up|7|||
160883800|NCT01214174|580970365|FG000|Overall Study|Withdrawal by Subject|0|||
160883801|NCT01214174|580970366|FG001|Overall Study|Withdrawal by Subject|0|||
160883802|NCT01214174|580970367|FG002|Overall Study|Withdrawal by Subject|1|||
160883803|NCT00548405|580970368|FG000|Overall Study|Adverse Event|6|||
160883804|NCT00548405|580970369|FG001|Overall Study|Adverse Event|2|||
160883805|NCT00548405|580970370|FG002|Overall Study|Adverse Event|0|||
160883806|NCT00548405|580970368|FG000|Overall Study|Lack of Efficacy|6|||
160883807|NCT00548405|580970369|FG001|Overall Study|Lack of Efficacy|0|||
160883808|NCT00548405|580970370|FG002|Overall Study|Lack of Efficacy|0|||
160883809|NCT00548405|580970368|FG000|Overall Study|Physician Decision|3|||
160883810|NCT00548405|580970369|FG001|Overall Study|Physician Decision|4|||
160883811|NCT00548405|580970370|FG002|Overall Study|Physician Decision|1|||
160883812|NCT00548405|580970368|FG000|Overall Study|Pregnancy|1|||
160883813|NCT00548405|580970369|FG001|Overall Study|Pregnancy|0|||
160883814|NCT00548405|580970370|FG002|Overall Study|Pregnancy|0|||
160883815|NCT00548405|580970368|FG000|Overall Study|Protocol Violation|1|||
160883816|NCT00548405|580970369|FG001|Overall Study|Protocol Violation|0|||
160883817|NCT00548405|580970370|FG002|Overall Study|Protocol Violation|0|||
160883818|NCT00548405|580970368|FG000|Overall Study|Withdrawal by Subject|36|||
160883819|NCT00548405|580970369|FG001|Overall Study|Withdrawal by Subject|12|||
160883820|NCT00548405|580970370|FG002|Overall Study|Withdrawal by Subject|5|||
160883821|NCT00548405|580970368|FG000|Overall Study|Lost to Follow-up|1|||
160883822|NCT00548405|580970369|FG001|Overall Study|Lost to Follow-up|1|||
160883823|NCT00548405|580970370|FG002|Overall Study|Lost to Follow-up|2|||
160883824|NCT00548405|580970368|FG000|Overall Study|Death|0|||
160883825|NCT00548405|580970369|FG001|Overall Study|Death|1|||
160883826|NCT00548405|580970370|FG002|Overall Study|Death|1|||
160883827|NCT00548405|580970368|FG000|Overall Study|Sponsor decision|1|||
160883828|NCT00548405|580970369|FG001|Overall Study|Sponsor decision|0|||
160883829|NCT00548405|580970370|FG002|Overall Study|Sponsor decision|0|||
160883830|NCT00548405|580970368|FG000|Overall Study|Randomized but not treated|1|||
160883831|NCT00548405|580970369|FG001|Overall Study|Randomized but not treated|0|||
160883832|NCT00548405|580970370|FG002|Overall Study|Randomized but not treated|0|||
160883833|NCT01624870|580970371|FG000|Overall Study|Death|19|||
160883834|NCT01624870|580970371|FG000|Overall Study|Withdrawal by Subject|1|||
160883835|NCT01624870|580970371|FG000|Overall Study|CoreValve not implanted|6|||
160883836|NCT01624870|580970371|FG000|Overall Study|Lost to follow up|1|||
160883837|NCT01381562|580970374|FG000|Overall Study|Adverse Event|0|||
160883838|NCT01381562|580970375|FG001|Overall Study|Adverse Event|1|||
160883839|NCT01381562|580970376|FG002|Overall Study|Adverse Event|0|||
160883840|NCT02660138|580970378|FG000|Overall Study|Adverse Event|0|||
160883841|NCT02660138|580970379|FG001|Overall Study|Adverse Event|3|||
160883842|NCT02660138|580970380|FG002|Overall Study|Adverse Event|2|||
160883843|NCT02660138|580970378|FG000|Overall Study|Lack of Efficacy|1|||
160883844|NCT02660138|580970379|FG001|Overall Study|Lack of Efficacy|2|||
160883845|NCT02660138|580970380|FG002|Overall Study|Lack of Efficacy|1|||
160883846|NCT02660138|580970378|FG000|Overall Study|Withdrawal by Subject|7|||
160883847|NCT02660138|580970379|FG001|Overall Study|Withdrawal by Subject|6|||
160883848|NCT02660138|580970380|FG002|Overall Study|Withdrawal by Subject|6|||
160883849|NCT02660138|580970378|FG000|Overall Study|Lost to Follow-up|4|||
160883850|NCT02660138|580970379|FG001|Overall Study|Lost to Follow-up|4|||
160883851|NCT02660138|580970380|FG002|Overall Study|Lost to Follow-up|1|||
160883852|NCT02660138|580970378|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
160883853|NCT02660138|580970379|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
160883854|NCT02660138|580970380|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
160883855|NCT02660138|580970378|FG000|Overall Study|Other|1|||
160883856|NCT02660138|580970379|FG001|Overall Study|Other|1|||
160883857|NCT02660138|580970380|FG002|Overall Study|Other|0|||
160883858|NCT02660138|580970378|FG000|Overall Study|Not treated|0|||
160883859|NCT02660138|580970379|FG001|Overall Study|Not treated|1|||
160883860|NCT02660138|580970380|FG002|Overall Study|Not treated|0|||
160883861|NCT00308581|580970381|FG000|Induction Phase|Adverse Event|0|||
160883862|NCT00308581|580970382|FG001|Induction Phase|Adverse Event|0|||
160883863|NCT00308581|580970383|FG002|Induction Phase|Adverse Event|37|||
160883864|NCT00308581|580970381|FG000|Induction Phase|Lack of Efficacy|0|||
160883865|NCT00308581|580970382|FG001|Induction Phase|Lack of Efficacy|0|||
160883866|NCT00308581|580970383|FG002|Induction Phase|Lack of Efficacy|121|||
160883867|NCT00308581|580970381|FG000|Induction Phase|Withdrawal by Subject|0|||
160771263|NCT00879658|580548891|FG002|Overall Study|Withdrawal by Subject|2|||
160771264|NCT00879658|580548892|FG003|Overall Study|Withdrawal by Subject|0|||
160771265|NCT00879658|580548893|FG004|Overall Study|Withdrawal by Subject|0|||
160771266|NCT00879658|580548894|FG005|Overall Study|Withdrawal by Subject|1|||
160771267|NCT00879658|580548895|FG006|Overall Study|Withdrawal by Subject|0|||
160771268|NCT00879658|580548889|FG000|Overall Study|Lack of Efficacy|0|||
160771269|NCT00879658|580548890|FG001|Overall Study|Lack of Efficacy|0|||
160771270|NCT00879658|580548891|FG002|Overall Study|Lack of Efficacy|2|||
160771271|NCT00879658|580548892|FG003|Overall Study|Lack of Efficacy|0|||
160771272|NCT00879658|580548893|FG004|Overall Study|Lack of Efficacy|0|||
160771273|NCT00879658|580548894|FG005|Overall Study|Lack of Efficacy|0|||
160771274|NCT00879658|580548895|FG006|Overall Study|Lack of Efficacy|0|||
160771275|NCT00879658|580548889|FG000|Overall Study|misrandomized (never received study med)|0|||
160771276|NCT00879658|580548890|FG001|Overall Study|misrandomized (never received study med)|0|||
160771277|NCT00879658|580548891|FG002|Overall Study|misrandomized (never received study med)|0|||
160771278|NCT00879658|580548892|FG003|Overall Study|misrandomized (never received study med)|1|||
160771279|NCT00879658|580548893|FG004|Overall Study|misrandomized (never received study med)|0|||
160771280|NCT00879658|580548894|FG005|Overall Study|misrandomized (never received study med)|0|||
160771281|NCT00879658|580548895|FG006|Overall Study|misrandomized (never received study med)|0|||
160771282|NCT01035138|580548908|FG000|Overall Study|Adverse Event|4|||
160771283|NCT01035138|580548909|FG001|Overall Study|Adverse Event|0|||
160771284|NCT01035138|580548910|FG002|Overall Study|Adverse Event|2|||
160771285|NCT01035138|580548908|FG000|Overall Study|Caregiver Decision|2|||
160771286|NCT01035138|580548909|FG001|Overall Study|Caregiver Decision|0|||
160771287|NCT01035138|580548910|FG002|Overall Study|Caregiver Decision|1|||
160771288|NCT01035138|580548908|FG000|Overall Study|Withdrawal by Subject|1|||
160771289|NCT01035138|580548909|FG001|Overall Study|Withdrawal by Subject|0|||
160771290|NCT01035138|580548910|FG002|Overall Study|Withdrawal by Subject|0|||
160771291|NCT01035138|580548908|FG000|Overall Study|Physician Decision|0|||
160771292|NCT01035138|580548909|FG001|Overall Study|Physician Decision|0|||
160771293|NCT01035138|580548910|FG002|Overall Study|Physician Decision|1|||
160771294|NCT01035138|580548908|FG000|Overall Study|Sponsor Decision|66|||
160771295|NCT01035138|580548909|FG001|Overall Study|Sponsor Decision|60|||
160771296|NCT01035138|580548910|FG002|Overall Study|Sponsor Decision|42|||
160771297|NCT01035138|580548908|FG000|Overall Study|Lost to Follow-up|0|||
160771298|NCT01035138|580548909|FG001|Overall Study|Lost to Follow-up|0|||
160771299|NCT01035138|580548910|FG002|Overall Study|Lost to Follow-up|1|||
160771300|NCT03573297|580548916|FG000|Open Label Treatment Period|Adverse Event|67|||
160771301|NCT03573297|580548917|FG001|Open Label Treatment Period|Adverse Event|0|||
160771302|NCT03573297|580548918|FG002|Open Label Treatment Period|Adverse Event|0|||
160771303|NCT03573297|580548919|FG003|Open Label Treatment Period|Adverse Event|0|||
160771304|NCT03573297|580548916|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
160771305|NCT03573297|580548917|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
160771306|NCT03573297|580548918|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
160771307|NCT03573297|580548919|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
160771308|NCT03573297|580548916|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
160771309|NCT03573297|580548917|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
160771310|NCT03573297|580548918|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
160771311|NCT03573297|580548919|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
160771312|NCT03573297|580548916|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
160771313|NCT03573297|580548917|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
160771314|NCT03573297|580548918|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
160771315|NCT03573297|580548919|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
160771316|NCT03573297|580548916|FG000|Open Label Treatment Period|Pregnancy|1|||
160771317|NCT03573297|580548917|FG001|Open Label Treatment Period|Pregnancy|0|||
160771318|NCT03573297|580548918|FG002|Open Label Treatment Period|Pregnancy|0|||
160771319|NCT03573297|580548919|FG003|Open Label Treatment Period|Pregnancy|0|||
160771320|NCT03573297|580548916|FG000|Open Label Treatment Period|Protocol Violation|17|||
160771321|NCT03573297|580548917|FG001|Open Label Treatment Period|Protocol Violation|0|||
160771322|NCT03573297|580548918|FG002|Open Label Treatment Period|Protocol Violation|0|||
160771323|NCT03573297|580548919|FG003|Open Label Treatment Period|Protocol Violation|0|||
160771324|NCT03573297|580548916|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
160771325|NCT03573297|580548917|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
160771326|NCT03573297|580548918|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
160771327|NCT03573297|580548919|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
160771328|NCT03573297|580548916|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
160771329|NCT03573297|580548917|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
160771330|NCT03573297|580548918|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
160771331|NCT03573297|580548919|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
160771332|NCT03573297|580548916|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
160771333|NCT03573297|580548917|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
160883868|NCT00308581|580970382|FG001|Induction Phase|Withdrawal by Subject|0|||
160883869|NCT00308581|580970383|FG002|Induction Phase|Withdrawal by Subject|5|||
160883870|NCT00308581|580970381|FG000|Induction Phase|Unknown reason|0|||
160883871|NCT00308581|580970382|FG001|Induction Phase|Unknown reason|0|||
160883872|NCT00308581|580970383|FG002|Induction Phase|Unknown reason|3|||
160883873|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Adverse Event|10|||
160883874|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Adverse Event|17|||
160883875|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Adverse Event|0|||
160883876|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
160883877|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
160883878|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
160883879|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
160883880|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
160883881|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
160883882|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
160883883|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
160883884|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
160883885|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
160883886|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
160883887|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
160883888|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Unknown reason|3|||
160883889|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Unknown reason|0|||
160883890|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Unknown reason|0|||
160883891|NCT00899353|580970386|FG000|Overall Study|Adverse Event|2|||
160883892|NCT00899353|580970386|FG000|Overall Study|Lost to Follow-up|1|||
160883893|NCT00899353|580970386|FG000|Overall Study|Withdrawal by Subject|2|||
160883894|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
160883895|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
160883896|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
160883897|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
160883898|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
160883899|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
160883900|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
160883901|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
160883902|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
160883903|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
160883904|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
160883905|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
160883906|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
160883907|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
160883908|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
160883909|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
160883910|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
160883911|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
160883912|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
160883913|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
160883914|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
160883915|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
160883916|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
160883917|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
160883918|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
160883919|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
160883920|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
160883921|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
160883922|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
160883923|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
160883924|NCT00095147|580970392|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
160883925|NCT00095147|580970393|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
160883926|NCT00095147|580970394|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
160883927|NCT00095147|580970395|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
160883928|NCT00095147|580970396|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
160883929|NCT00095147|580970392|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
160883930|NCT00095147|580970393|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
160883931|NCT00095147|580970394|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
160883932|NCT00095147|580970395|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
160883933|NCT00095147|580970396|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
160883934|NCT00095147|580970392|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
160883935|NCT00095147|580970393|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
160540321|NCT02943564|579707593|FG001|Overall Study|Pregnancy|1|||
160883936|NCT00095147|580970394|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
160883937|NCT00095147|580970395|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
160883938|NCT00095147|580970396|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
160883939|NCT00095147|580970392|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
160883940|NCT00095147|580970393|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
160883941|NCT00095147|580970394|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
160883942|NCT00095147|580970395|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
160883943|NCT00095147|580970396|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
160883944|NCT00095147|580970392|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
160883945|NCT00095147|580970393|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
160883946|NCT00095147|580970394|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
160883947|NCT00095147|580970395|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
160883948|NCT00095147|580970396|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
160883949|NCT00095147|580970392|FG000|Long-term Extension Period|Death|0|||
160883950|NCT00095147|580970393|FG001|Long-term Extension Period|Death|0|||
160883951|NCT00095147|580970394|FG002|Long-term Extension Period|Death|0|||
160883952|NCT00095147|580970395|FG003|Long-term Extension Period|Death|0|||
160883953|NCT00095147|580970396|FG004|Long-term Extension Period|Death|3|||
160883954|NCT00095147|580970392|FG000|Long-term Extension Period|Adverse Event|0|||
160883955|NCT00095147|580970393|FG001|Long-term Extension Period|Adverse Event|0|||
160883956|NCT00095147|580970394|FG002|Long-term Extension Period|Adverse Event|0|||
160883957|NCT00095147|580970395|FG003|Long-term Extension Period|Adverse Event|0|||
160883958|NCT00095147|580970396|FG004|Long-term Extension Period|Adverse Event|11|||
160883959|NCT00095147|580970392|FG000|Long-term Extension Period|Lack of Efficacy|0|||
160883960|NCT00095147|580970393|FG001|Long-term Extension Period|Lack of Efficacy|0|||
160883961|NCT00095147|580970394|FG002|Long-term Extension Period|Lack of Efficacy|0|||
160883962|NCT00095147|580970395|FG003|Long-term Extension Period|Lack of Efficacy|0|||
160883963|NCT00095147|580970396|FG004|Long-term Extension Period|Lack of Efficacy|9|||
160883964|NCT00095147|580970392|FG000|Long-term Extension Period|Lost to Follow-up|0|||
160883965|NCT00095147|580970393|FG001|Long-term Extension Period|Lost to Follow-up|0|||
160883966|NCT00095147|580970394|FG002|Long-term Extension Period|Lost to Follow-up|0|||
160883967|NCT00095147|580970395|FG003|Long-term Extension Period|Lost to Follow-up|0|||
160883968|NCT00095147|580970396|FG004|Long-term Extension Period|Lost to Follow-up|6|||
160883969|NCT00095147|580970392|FG000|Long-term Extension Period|Withdrawal of consent|0|||
160883970|NCT00095147|580970393|FG001|Long-term Extension Period|Withdrawal of consent|0|||
160883971|NCT00095147|580970394|FG002|Long-term Extension Period|Withdrawal of consent|0|||
160883972|NCT00095147|580970395|FG003|Long-term Extension Period|Withdrawal of consent|0|||
160883973|NCT00095147|580970396|FG004|Long-term Extension Period|Withdrawal of consent|12|||
160883974|NCT00095147|580970392|FG000|Long-term Extension Period|Pregnancy|0|||
160883975|NCT00095147|580970393|FG001|Long-term Extension Period|Pregnancy|0|||
160883976|NCT00095147|580970394|FG002|Long-term Extension Period|Pregnancy|0|||
160883977|NCT00095147|580970395|FG003|Long-term Extension Period|Pregnancy|0|||
160883978|NCT00095147|580970396|FG004|Long-term Extension Period|Pregnancy|1|||
160883979|NCT00095147|580970392|FG000|Long-term Extension Period|No longer meets study criteria|0|||
160883980|NCT00095147|580970393|FG001|Long-term Extension Period|No longer meets study criteria|0|||
160883981|NCT00095147|580970394|FG002|Long-term Extension Period|No longer meets study criteria|0|||
160883982|NCT00095147|580970395|FG003|Long-term Extension Period|No longer meets study criteria|0|||
160883983|NCT00095147|580970396|FG004|Long-term Extension Period|No longer meets study criteria|1|||
160883984|NCT00095147|580970392|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
160883985|NCT00095147|580970393|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
160883986|NCT00095147|580970394|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
160883987|NCT00095147|580970395|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
160883988|NCT00095147|580970396|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
160883989|NCT00095147|580970392|FG000|Long-term Extension Period|Leaving country|0|||
160883990|NCT00095147|580970393|FG001|Long-term Extension Period|Leaving country|0|||
160883991|NCT00095147|580970394|FG002|Long-term Extension Period|Leaving country|0|||
160883992|NCT00095147|580970395|FG003|Long-term Extension Period|Leaving country|0|||
160883993|NCT00095147|580970396|FG004|Long-term Extension Period|Leaving country|1|||
160883994|NCT04604132|580970397|FG000|Overall Study|Adverse Event|2|||
160540322|NCT02943564|579707594|FG002|Overall Study|Pregnancy|1|||
160883995|NCT04604132|580970398|FG001|Overall Study|Adverse Event|0|||
160883996|NCT04604132|580970399|FG002|Overall Study|Adverse Event|0|||
160883997|NCT04604132|580970400|FG003|Overall Study|Adverse Event|1|||
160883998|NCT04604132|580970401|FG004|Overall Study|Adverse Event|2|||
160883999|NCT04604132|580970397|FG000|Overall Study|Study terminated by sponsor|0|||
160884000|NCT04604132|580970398|FG001|Overall Study|Study terminated by sponsor|0|||
160884001|NCT04604132|580970399|FG002|Overall Study|Study terminated by sponsor|0|||
160884002|NCT04604132|580970400|FG003|Overall Study|Study terminated by sponsor|0|||
160540323|NCT02943564|579707592|FG000|Overall Study|Protocol Violation|2|||
160540324|NCT02943564|579707593|FG001|Overall Study|Protocol Violation|2|||
160884003|NCT04604132|580970401|FG004|Overall Study|Study terminated by sponsor|1|||
160884004|NCT04604132|580970397|FG000|Overall Study|Progressive disease: Clinical progression|0|||
160884005|NCT04604132|580970398|FG001|Overall Study|Progressive disease: Clinical progression|0|||
160884006|NCT04604132|580970399|FG002|Overall Study|Progressive disease: Clinical progression|1|||
160884007|NCT04604132|580970400|FG003|Overall Study|Progressive disease: Clinical progression|0|||
160884008|NCT04604132|580970401|FG004|Overall Study|Progressive disease: Clinical progression|0|||
160884009|NCT04604132|580970397|FG000|Overall Study|Progressive disease: Radiological progression|8|||
160884010|NCT04604132|580970398|FG001|Overall Study|Progressive disease: Radiological progression|7|||
160884011|NCT04604132|580970399|FG002|Overall Study|Progressive disease: Radiological progression|10|||
160884012|NCT04604132|580970400|FG003|Overall Study|Progressive disease: Radiological progression|4|||
160884013|NCT04604132|580970401|FG004|Overall Study|Progressive disease: Radiological progression|3|||
160884014|NCT04604132|580970397|FG000|Overall Study|Death|3|||
160884015|NCT04604132|580970398|FG001|Overall Study|Death|1|||
160884016|NCT04604132|580970399|FG002|Overall Study|Death|2|||
160884017|NCT04604132|580970400|FG003|Overall Study|Death|1|||
160884018|NCT04604132|580970401|FG004|Overall Study|Death|0|||
160884019|NCT00952380|580970402|FG000|Overall Study|Other|0|||
160884020|NCT00952380|580970403|FG001|Overall Study|Other|0|||
160884021|NCT00952380|580970404|FG002|Overall Study|Other|0|||
160884022|NCT00952380|580970405|FG003|Overall Study|Other|0|||
160884023|NCT00952380|580970406|FG004|Overall Study|Other|1|||
160884024|NCT00952380|580970402|FG000|Overall Study|Withdrawal by Subject|0|||
160884025|NCT00952380|580970403|FG001|Overall Study|Withdrawal by Subject|0|||
160884026|NCT00952380|580970404|FG002|Overall Study|Withdrawal by Subject|1|||
160884027|NCT00952380|580970405|FG003|Overall Study|Withdrawal by Subject|0|||
160884028|NCT00952380|580970406|FG004|Overall Study|Withdrawal by Subject|2|||
160884029|NCT00952380|580970402|FG000|Overall Study|Adverse Event|0|||
160884030|NCT00952380|580970403|FG001|Overall Study|Adverse Event|1|||
160884031|NCT00952380|580970404|FG002|Overall Study|Adverse Event|0|||
160884032|NCT00952380|580970405|FG003|Overall Study|Adverse Event|0|||
160884033|NCT00952380|580970406|FG004|Overall Study|Adverse Event|3|||
160884034|NCT00952380|580970402|FG000|Overall Study|Physician Decision|0|||
160884035|NCT00952380|580970403|FG001|Overall Study|Physician Decision|0|||
160884036|NCT00952380|580970404|FG002|Overall Study|Physician Decision|1|||
160884037|NCT00952380|580970405|FG003|Overall Study|Physician Decision|2|||
160884038|NCT00952380|580970406|FG004|Overall Study|Physician Decision|0|||
160884039|NCT00952380|580970402|FG000|Overall Study|Non-compliant to protocol|0|||
160884040|NCT00952380|580970403|FG001|Overall Study|Non-compliant to protocol|0|||
160884041|NCT00952380|580970404|FG002|Overall Study|Non-compliant to protocol|0|||
160884042|NCT00952380|580970405|FG003|Overall Study|Non-compliant to protocol|1|||
160884043|NCT00952380|580970406|FG004|Overall Study|Non-compliant to protocol|0|||
160884044|NCT03400956|580970407|FG000|Treatment Period 1|Adverse Event|0|||
160884045|NCT03400956|580970408|FG001|Treatment Period 1|Adverse Event|1|||
160884046|NCT03400956|580970409|FG002|Treatment Period 1|Adverse Event|0|||
160884047|NCT03400956|580970407|FG000|Treatment Period 1|Lost to Follow-up|0|||
160884048|NCT03400956|580970408|FG001|Treatment Period 1|Lost to Follow-up|0|||
160884049|NCT03400956|580970409|FG002|Treatment Period 1|Lost to Follow-up|1|||
160884050|NCT03400956|580970407|FG000|Treatment Period 1|Protocol Violation|0|||
160884051|NCT03400956|580970408|FG001|Treatment Period 1|Protocol Violation|2|||
160884052|NCT03400956|580970409|FG002|Treatment Period 1|Protocol Violation|0|||
160884053|NCT03400956|580970407|FG000|Treatment Period 1|Study terminated by sponsor|3|||
160884054|NCT03400956|580970408|FG001|Treatment Period 1|Study terminated by sponsor|1|||
160884055|NCT03400956|580970409|FG002|Treatment Period 1|Study terminated by sponsor|1|||
160884056|NCT03400956|580970407|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160884057|NCT03400956|580970408|FG001|Treatment Period 1|Withdrawal by Subject|2|||
160884058|NCT03400956|580970409|FG002|Treatment Period 1|Withdrawal by Subject|4|||
160884059|NCT03400956|580970407|FG000|Treatment Period 1|Other|1|||
160884060|NCT03400956|580970408|FG001|Treatment Period 1|Other|2|||
160884061|NCT03400956|580970409|FG002|Treatment Period 1|Other|3|||
160884062|NCT03400956|580970407|FG000|Post-treatment Period 1|Adverse Event|0|||
160884063|NCT03400956|580970408|FG001|Post-treatment Period 1|Adverse Event|0|||
160884064|NCT03400956|580970409|FG002|Post-treatment Period 1|Adverse Event|1|||
160884065|NCT03400956|580970407|FG000|Post-treatment Period 1|Physician Decision|2|||
160884066|NCT03400956|580970408|FG001|Post-treatment Period 1|Physician Decision|3|||
160884067|NCT03400956|580970409|FG002|Post-treatment Period 1|Physician Decision|0|||
160884068|NCT03400956|580970407|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
160884069|NCT03400956|580970408|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
160884070|NCT03400956|580970409|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
160884071|NCT03400956|580970407|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
160884072|NCT03400956|580970408|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
160884073|NCT03400956|580970409|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
160884074|NCT03400956|580970407|FG000|Post-treatment Period 1|Other|4|||
160884075|NCT03400956|580970408|FG001|Post-treatment Period 1|Other|3|||
160884076|NCT03400956|580970409|FG002|Post-treatment Period 1|Other|4|||
160884077|NCT03400956|580970407|FG000|Treatment Period 2|Adverse Event|2|||
160884078|NCT03400956|580970408|FG001|Treatment Period 2|Adverse Event|1|||
160884079|NCT03400956|580970409|FG002|Treatment Period 2|Adverse Event|1|||
160884080|NCT03400956|580970407|FG000|Treatment Period 2|Lost to Follow-up|1|||
160884081|NCT03400956|580970408|FG001|Treatment Period 2|Lost to Follow-up|1|||
160884082|NCT03400956|580970409|FG002|Treatment Period 2|Lost to Follow-up|0|||
160884083|NCT03400956|580970407|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160884084|NCT03400956|580970408|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160884085|NCT03400956|580970409|FG002|Treatment Period 2|Withdrawal by Subject|3|||
160884086|NCT03400956|580970407|FG000|Treatment Period 2|Other|1|||
160884087|NCT03400956|580970408|FG001|Treatment Period 2|Other|1|||
160884088|NCT03400956|580970409|FG002|Treatment Period 2|Other|0|||
160884089|NCT03400956|580970407|FG000|Follow-up Period|Withdrawal by Subject|0|||
160884090|NCT03400956|580970408|FG001|Follow-up Period|Withdrawal by Subject|0|||
160884091|NCT03400956|580970409|FG002|Follow-up Period|Withdrawal by Subject|1|||
160884092|NCT03400956|580970407|FG000|Follow-up Period|Other|0|||
160884093|NCT03400956|580970408|FG001|Follow-up Period|Other|0|||
160884094|NCT03400956|580970409|FG002|Follow-up Period|Other|1|||
160884095|NCT02048241|580970411|FG000|Overall Study|Withdrawal by Subject|0|||
160884096|NCT02048241|580970412|FG001|Overall Study|Withdrawal by Subject|1|||
160884097|NCT00534313|580970413|FG000|Short-term Period|Adverse Event|1|||
160884098|NCT00534313|580970414|FG001|Short-term Period|Adverse Event|2|||
160884099|NCT00534313|580970415|FG002|Short-term Period|Adverse Event|1|||
160884100|NCT00534313|580970416|FG003|Short-term Period|Adverse Event|3|||
160884101|NCT00534313|580970413|FG000|Short-term Period|Lack of Efficacy|3|||
160884102|NCT00534313|580970414|FG001|Short-term Period|Lack of Efficacy|4|||
160884103|NCT00534313|580970415|FG002|Short-term Period|Lack of Efficacy|0|||
160884104|NCT00534313|580970416|FG003|Short-term Period|Lack of Efficacy|3|||
160884105|NCT00534313|580970413|FG000|Short-term Period|Participant not meeting study criteria|0|||
160884106|NCT00534313|580970414|FG001|Short-term Period|Participant not meeting study criteria|0|||
160884107|NCT00534313|580970415|FG002|Short-term Period|Participant not meeting study criteria|0|||
160884108|NCT00534313|580970416|FG003|Short-term Period|Participant not meeting study criteria|1|||
160884109|NCT00534313|580970413|FG000|Short-term Period|Participant withdrew consent|2|||
160884110|NCT00534313|580970414|FG001|Short-term Period|Participant withdrew consent|0|||
160884111|NCT00534313|580970415|FG002|Short-term Period|Participant withdrew consent|0|||
160884112|NCT00534313|580970416|FG003|Short-term Period|Participant withdrew consent|2|||
160884113|NCT00534313|580970413|FG000|Short-term Period|Pregnancy|0|||
160884114|NCT00534313|580970414|FG001|Short-term Period|Pregnancy|0|||
160884115|NCT00534313|580970415|FG002|Short-term Period|Pregnancy|1|||
160884116|NCT00534313|580970416|FG003|Short-term Period|Pregnancy|0|||
160884117|NCT00534313|580970413|FG000|Long-term Period|Adverse Event|2|||
160884118|NCT00534313|580970414|FG001|Long-term Period|Adverse Event|1|||
160884119|NCT00534313|580970415|FG002|Long-term Period|Adverse Event|0|||
160884120|NCT00534313|580970416|FG003|Long-term Period|Adverse Event|1|||
160884121|NCT00534313|580970413|FG000|Long-term Period|Lack of Efficacy|14|||
160884122|NCT00534313|580970414|FG001|Long-term Period|Lack of Efficacy|10|||
160884123|NCT00534313|580970415|FG002|Long-term Period|Lack of Efficacy|14|||
160884124|NCT00534313|580970416|FG003|Long-term Period|Lack of Efficacy|12|||
160884125|NCT00534313|580970413|FG000|Long-term Period|Lost to Follow-up|1|||
160884126|NCT00534313|580970414|FG001|Long-term Period|Lost to Follow-up|2|||
160884127|NCT00534313|580970415|FG002|Long-term Period|Lost to Follow-up|0|||
160884128|NCT00534313|580970416|FG003|Long-term Period|Lost to Follow-up|0|||
160884129|NCT00534313|580970413|FG000|Long-term Period|Withdrawal by Subject|2|||
160884130|NCT00534313|580970414|FG001|Long-term Period|Withdrawal by Subject|2|||
160884131|NCT00534313|580970415|FG002|Long-term Period|Withdrawal by Subject|0|||
160884132|NCT00534313|580970416|FG003|Long-term Period|Withdrawal by Subject|0|||
160884133|NCT00534313|580970413|FG000|Long-term Period|No longer meets study criteria|0|||
160884134|NCT00534313|580970414|FG001|Long-term Period|No longer meets study criteria|1|||
160884135|NCT00534313|580970415|FG002|Long-term Period|No longer meets study criteria|0|||
160884136|NCT00534313|580970416|FG003|Long-term Period|No longer meets study criteria|0|||
160884137|NCT00534313|580970413|FG000|Long-term Period|Poor compliance/noncompliance|0|||
160884138|NCT00534313|580970414|FG001|Long-term Period|Poor compliance/noncompliance|1|||
160884139|NCT00534313|580970415|FG002|Long-term Period|Poor compliance/noncompliance|1|||
160884140|NCT00534313|580970416|FG003|Long-term Period|Poor compliance/noncompliance|0|||
160884141|NCT00534313|580970413|FG000|Long-term Period|Administrative reason by sponsor|17|||
160884142|NCT00534313|580970414|FG001|Long-term Period|Administrative reason by sponsor|15|||
160884143|NCT00534313|580970415|FG002|Long-term Period|Administrative reason by sponsor|26|||
160884144|NCT00534313|580970416|FG003|Long-term Period|Administrative reason by sponsor|18|||
160884145|NCT00534313|580970413|FG000|Long-term Period|Other|1|||
160884146|NCT00534313|580970414|FG001|Long-term Period|Other|2|||
160884147|NCT00534313|580970415|FG002|Long-term Period|Other|2|||
160884148|NCT00534313|580970416|FG003|Long-term Period|Other|2|||
160884149|NCT00402233|580970417|FG000|Overall Study|Adverse Event|1|||
160884150|NCT00402233|580970418|FG001|Overall Study|Adverse Event|7|||
160884151|NCT00402233|580970419|FG002|Overall Study|Adverse Event|9|||
160771334|NCT03573297|580548918|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
160771335|NCT03573297|580548919|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
160771336|NCT03573297|580548916|FG000|Open Label Treatment Period|Other, Not Specified|7|||
160771337|NCT03573297|580548917|FG001|Open Label Treatment Period|Other, Not Specified|0|||
160771338|NCT03573297|580548918|FG002|Open Label Treatment Period|Other, Not Specified|0|||
160771339|NCT03573297|580548919|FG003|Open Label Treatment Period|Other, Not Specified|0|||
160771340|NCT03573297|580548916|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
160771341|NCT03573297|580548917|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
160771342|NCT03573297|580548918|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
160771343|NCT03573297|580548919|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
160771344|NCT03573297|580548916|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160771345|NCT03573297|580548917|FG001|Double-Blind Treatment Period|Adverse Event|1|||
160771346|NCT03573297|580548918|FG002|Double-Blind Treatment Period|Adverse Event|5|||
160771347|NCT03573297|580548919|FG003|Double-Blind Treatment Period|Adverse Event|1|||
160771348|NCT03573297|580548916|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
160771349|NCT03573297|580548917|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
160771350|NCT03573297|580548918|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
160771351|NCT03573297|580548919|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
160771352|NCT03573297|580548916|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160771353|NCT03573297|580548917|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
160771354|NCT03573297|580548918|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
160771355|NCT03573297|580548919|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
160771356|NCT03573297|580548916|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160771357|NCT03573297|580548917|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
160771358|NCT03573297|580548918|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
160771359|NCT03573297|580548919|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
160771360|NCT03573297|580548916|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
160771361|NCT03573297|580548917|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
160771362|NCT03573297|580548918|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
160771363|NCT03573297|580548919|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
160771364|NCT03573297|580548916|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
160771365|NCT03573297|580548917|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
160771366|NCT03573297|580548918|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
160771367|NCT03573297|580548919|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
160771368|NCT03573297|580548916|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
160771369|NCT03573297|580548917|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
160771370|NCT03573297|580548918|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
160771371|NCT03573297|580548919|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
160771372|NCT02696798|580548921|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
160771373|NCT02696798|580548922|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
160771374|NCT02696798|580548923|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
160771375|NCT02696798|580548921|FG000|Blinded Treatment Dosing Period|Death|0|||
160771376|NCT02696798|580548922|FG001|Blinded Treatment Dosing Period|Death|0|||
160771377|NCT02696798|580548923|FG002|Blinded Treatment Dosing Period|Death|1|||
160771378|NCT02696798|580548921|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
160771379|NCT02696798|580548922|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
160771380|NCT02696798|580548923|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
160771381|NCT02696798|580548921|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
160771382|NCT02696798|580548922|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
160771383|NCT02696798|580548923|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
160771384|NCT02696798|580548921|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
160771385|NCT02696798|580548922|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
160771386|NCT02696798|580548923|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
160771387|NCT02696798|580548921|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
160771388|NCT02696798|580548922|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
160771389|NCT02696798|580548923|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
160771390|NCT02696798|580548921|FG000|Extended Treatment Period|Adverse Event|1|||
160771391|NCT02696798|580548922|FG001|Extended Treatment Period|Adverse Event|4|||
160771392|NCT02696798|580548923|FG002|Extended Treatment Period|Adverse Event|5|||
160771393|NCT02696798|580548921|FG000|Extended Treatment Period|Lack of Efficacy|7|||
160771394|NCT02696798|580548922|FG001|Extended Treatment Period|Lack of Efficacy|2|||
160771395|NCT02696798|580548923|FG002|Extended Treatment Period|Lack of Efficacy|2|||
160771396|NCT02696798|580548921|FG000|Extended Treatment Period|Lost to Follow-up|1|||
160771397|NCT02696798|580548922|FG001|Extended Treatment Period|Lost to Follow-up|0|||
160771398|NCT02696798|580548923|FG002|Extended Treatment Period|Lost to Follow-up|0|||
160771399|NCT02696798|580548921|FG000|Extended Treatment Period|Physician Decision|0|||
160771400|NCT02696798|580548922|FG001|Extended Treatment Period|Physician Decision|1|||
160884152|NCT00402233|580970420|FG003|Overall Study|Adverse Event|9|||
160884153|NCT00402233|580970417|FG000|Overall Study|Protocol Violation|0|||
160884154|NCT00402233|580970418|FG001|Overall Study|Protocol Violation|1|||
160884155|NCT00402233|580970419|FG002|Overall Study|Protocol Violation|0|||
160884156|NCT00402233|580970420|FG003|Overall Study|Protocol Violation|0|||
160884157|NCT00402233|580970417|FG000|Overall Study|Withdrawal by Subject|2|||
160884158|NCT00402233|580970418|FG001|Overall Study|Withdrawal by Subject|1|||
160884159|NCT00402233|580970419|FG002|Overall Study|Withdrawal by Subject|2|||
160884160|NCT00402233|580970420|FG003|Overall Study|Withdrawal by Subject|2|||
160884161|NCT00402233|580970417|FG000|Overall Study|Worsening of disease under study|2|||
160884162|NCT00402233|580970418|FG001|Overall Study|Worsening of disease under study|0|||
160884163|NCT00402233|580970419|FG002|Overall Study|Worsening of disease under study|0|||
160884164|NCT00402233|580970420|FG003|Overall Study|Worsening of disease under study|0|||
160884165|NCT00402233|580970417|FG000|Overall Study|Worsening of other pre-existing disease|0|||
160884166|NCT00402233|580970418|FG001|Overall Study|Worsening of other pre-existing disease|1|||
160884167|NCT00402233|580970419|FG002|Overall Study|Worsening of other pre-existing disease|0|||
160884168|NCT00402233|580970420|FG003|Overall Study|Worsening of other pre-existing disease|0|||
160884169|NCT00927940|580970421|FG000|Overall Study|Death|1|||
160884170|NCT03007888|580970422|FG000|First Intervention (14 Days)|Adverse Event|1|||
160884171|NCT03007888|580970423|FG001|First Intervention (14 Days)|Adverse Event|0|||
160884172|NCT04658940|580970425|FG000|Overall Study|Withdrawal by Subject|1|||
160884173|NCT00827931|580970427|FG000|Overall Study|Death|3|||
160884174|NCT00827931|580970428|FG001|Overall Study|Death|5|||
160884175|NCT00827931|580970427|FG000|Overall Study|Adverse Event|1|||
160884176|NCT00827931|580970428|FG001|Overall Study|Adverse Event|0|||
160884177|NCT00827931|580970427|FG000|Overall Study|Lost to Follow-up|1|||
160884178|NCT00827931|580970428|FG001|Overall Study|Lost to Follow-up|0|||
160884179|NCT00827931|580970427|FG000|Overall Study|Withdrawal by Subject|0|||
160884180|NCT00827931|580970428|FG001|Overall Study|Withdrawal by Subject|1|||
160884181|NCT00827931|580970427|FG000|Overall Study|Other|1|||
160884182|NCT00827931|580970428|FG001|Overall Study|Other|0|||
160884183|NCT03579602|580970429|FG000|Overall Study|Subject unable to receive study drug|0|||
160884184|NCT03579602|580970430|FG001|Overall Study|Subject unable to receive study drug|2|||
160884185|NCT03579602|580970429|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
160884186|NCT03579602|580970430|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
160884187|NCT01870076|580970431|FG000|Overall Study|Withdrawal by Subject|1|||
160884188|NCT01870076|580970432|FG001|Overall Study|Withdrawal by Subject|0|||
160884189|NCT01870076|580970433|FG002|Overall Study|Withdrawal by Subject|1|||
160884190|NCT01870076|580970434|FG003|Overall Study|Withdrawal by Subject|0|||
160884191|NCT00492063|580970435|FG000|Overall Study|Death|0|||
160884192|NCT00492063|580970436|FG001|Overall Study|Death|0|||
160884193|NCT00492063|580970437|FG002|Overall Study|Death|1|||
160884194|NCT00492063|580970438|FG003|Overall Study|Death|2|||
160884195|NCT00492063|580970435|FG000|Overall Study|Withdrawal by Subject|4|||
160884196|NCT00492063|580970436|FG001|Overall Study|Withdrawal by Subject|3|||
160884197|NCT00492063|580970437|FG002|Overall Study|Withdrawal by Subject|5|||
160884198|NCT00492063|580970438|FG003|Overall Study|Withdrawal by Subject|4|||
160884199|NCT00492063|580970435|FG000|Overall Study|Lost to Follow-up|6|||
160884200|NCT00492063|580970436|FG001|Overall Study|Lost to Follow-up|11|||
160884201|NCT00492063|580970437|FG002|Overall Study|Lost to Follow-up|5|||
160884202|NCT00492063|580970438|FG003|Overall Study|Lost to Follow-up|3|||
160884203|NCT00492063|580970435|FG000|Overall Study|Protocol Violation|0|||
160884204|NCT00492063|580970436|FG001|Overall Study|Protocol Violation|0|||
160884205|NCT00492063|580970437|FG002|Overall Study|Protocol Violation|0|||
160884206|NCT00492063|580970438|FG003|Overall Study|Protocol Violation|1|||
160884207|NCT00495040|580970439|FG000|Overall Study|Withdrawal by Subject|3|||
160884208|NCT01894568|580970440|FG000|Overall Study|Adverse Event|2|||
160884209|NCT01894568|580970441|FG001|Overall Study|Adverse Event|3|||
160884210|NCT01894568|580970440|FG000|Overall Study|Protocol required discontinuation|2|||
160884211|NCT01894568|580970441|FG001|Overall Study|Protocol required discontinuation|1|||
160884212|NCT01894568|580970440|FG000|Overall Study|Withdrawal by Subject|5|||
160884213|NCT01894568|580970441|FG001|Overall Study|Withdrawal by Subject|5|||
160884214|NCT01894568|580970440|FG000|Overall Study|Physician Decision|1|||
160884215|NCT01894568|580970441|FG001|Overall Study|Physician Decision|0|||
160884216|NCT01894568|580970440|FG000|Overall Study|Lost to Follow-up|0|||
160884217|NCT01894568|580970441|FG001|Overall Study|Lost to Follow-up|1|||
160884218|NCT00807573|580970442|FG000|Overall Study|Withdrawal by Subject|1|||
160884219|NCT00807573|580970442|FG000|Overall Study|Adverse Event|1|||
160884220|NCT01514370|580970445|FG000|Overall Study|Protocol Violation|2|||
160884221|NCT01514370|580970446|FG001|Overall Study|Protocol Violation|3|||
160884222|NCT01514370|580970445|FG000|Overall Study|Lost to Follow-up|0|||
160884223|NCT01514370|580970446|FG001|Overall Study|Lost to Follow-up|2|||
160884224|NCT01514370|580970445|FG000|Overall Study|Withdrawal by Subject|2|||
160884225|NCT01514370|580970446|FG001|Overall Study|Withdrawal by Subject|1|||
160884226|NCT01514370|580970445|FG000|Overall Study|Adverse Event|1|||
160884227|NCT01514370|580970446|FG001|Overall Study|Adverse Event|3|||
160653382|NCT04634409|580110521|FG021|Overall Study|Other - As reported by Investigator|0|||
160884228|NCT01514370|580970445|FG000|Overall Study|Other|6|||
160884229|NCT01514370|580970446|FG001|Overall Study|Other|7|||
160884230|NCT01089361|580970447|FG000|Overall Study|Death|1|||
160884231|NCT01089361|580970448|FG001|Overall Study|Death|0|||
160884232|NCT04054947|580970449|FG000|Overall Study|Withdrawal by Subject|1|||
160884233|NCT04054947|580970450|FG001|Overall Study|Withdrawal by Subject|0|||
160884234|NCT04054947|580970449|FG000|Overall Study|Lost to Follow-up|2|||
160884235|NCT04054947|580970450|FG001|Overall Study|Lost to Follow-up|5|||
160884236|NCT01606878|580970453|FG000|Overall Study|Adverse Event|1|||
160884237|NCT01606878|580970454|FG001|Overall Study|Adverse Event|1|||
160884238|NCT01606878|580970455|FG002|Overall Study|Adverse Event|0|||
160884239|NCT01606878|580970456|FG003|Overall Study|Adverse Event|0|||
160884240|NCT01606878|580970457|FG004|Overall Study|Adverse Event|0|||
160884241|NCT01606878|580970458|FG005|Overall Study|Adverse Event|0|||
160884242|NCT01606878|580970459|FG006|Overall Study|Adverse Event|1|||
160884243|NCT01606878|580970460|FG007|Overall Study|Adverse Event|0|||
160884244|NCT01606878|580970461|FG008|Overall Study|Adverse Event|1|||
160884245|NCT01606878|580970462|FG009|Overall Study|Adverse Event|3|||
160884246|NCT01606878|580970463|FG010|Overall Study|Adverse Event|0|||
160884247|NCT01606878|580970453|FG000|Overall Study|Lack of Efficacy|1|||
160884248|NCT01606878|580970454|FG001|Overall Study|Lack of Efficacy|1|||
160884249|NCT01606878|580970455|FG002|Overall Study|Lack of Efficacy|1|||
160884250|NCT01606878|580970456|FG003|Overall Study|Lack of Efficacy|2|||
160884251|NCT01606878|580970457|FG004|Overall Study|Lack of Efficacy|1|||
160884252|NCT01606878|580970458|FG005|Overall Study|Lack of Efficacy|2|||
160884253|NCT01606878|580970459|FG006|Overall Study|Lack of Efficacy|1|||
160884254|NCT01606878|580970460|FG007|Overall Study|Lack of Efficacy|2|||
160884255|NCT01606878|580970461|FG008|Overall Study|Lack of Efficacy|2|||
160884256|NCT01606878|580970462|FG009|Overall Study|Lack of Efficacy|0|||
160884257|NCT01606878|580970463|FG010|Overall Study|Lack of Efficacy|1|||
160884258|NCT01606878|580970453|FG000|Overall Study|Physician Decision|1|||
160884259|NCT01606878|580970454|FG001|Overall Study|Physician Decision|0|||
160884260|NCT01606878|580970455|FG002|Overall Study|Physician Decision|2|||
160884261|NCT01606878|580970456|FG003|Overall Study|Physician Decision|1|||
160884262|NCT01606878|580970457|FG004|Overall Study|Physician Decision|1|||
160884263|NCT01606878|580970458|FG005|Overall Study|Physician Decision|1|||
160884264|NCT01606878|580970459|FG006|Overall Study|Physician Decision|2|||
160884265|NCT01606878|580970460|FG007|Overall Study|Physician Decision|0|||
160884266|NCT01606878|580970461|FG008|Overall Study|Physician Decision|1|||
160884267|NCT01606878|580970462|FG009|Overall Study|Physician Decision|0|||
160884268|NCT01606878|580970463|FG010|Overall Study|Physician Decision|0|||
160884269|NCT01606878|580970453|FG000|Overall Study|Withdrawal by Subject|3|||
160884270|NCT01606878|580970454|FG001|Overall Study|Withdrawal by Subject|2|||
160884271|NCT01606878|580970455|FG002|Overall Study|Withdrawal by Subject|2|||
160884272|NCT01606878|580970456|FG003|Overall Study|Withdrawal by Subject|0|||
160884273|NCT01606878|580970457|FG004|Overall Study|Withdrawal by Subject|1|||
160884274|NCT01606878|580970458|FG005|Overall Study|Withdrawal by Subject|1|||
160884275|NCT01606878|580970459|FG006|Overall Study|Withdrawal by Subject|2|||
160884276|NCT01606878|580970460|FG007|Overall Study|Withdrawal by Subject|1|||
160884277|NCT01606878|580970461|FG008|Overall Study|Withdrawal by Subject|2|||
160884278|NCT01606878|580970462|FG009|Overall Study|Withdrawal by Subject|0|||
160884279|NCT01606878|580970463|FG010|Overall Study|Withdrawal by Subject|2|||
160884280|NCT03720652|580970466|FG000|Overall Study|Withdrawal by Subject|2|||
160884281|NCT03720652|580970467|FG001|Overall Study|Withdrawal by Subject|7|||
160884282|NCT03720652|580970466|FG000|Overall Study|Lost to Follow-up|0|||
160884283|NCT03720652|580970467|FG001|Overall Study|Lost to Follow-up|4|||
160884284|NCT02232880|580970471|FG000|Overall Study|study stopped prior to randomization|1|||
160884285|NCT00604214|580970472|FG000|Baseline to Day 28|Death|223|||
160884286|NCT00604214|580970473|FG001|Baseline to Day 28|Death|202|||
160884287|NCT00604214|580970472|FG000|Baseline to Day 28|Lost to Follow-up|2|||
160884288|NCT00604214|580970473|FG001|Baseline to Day 28|Lost to Follow-up|4|||
160884289|NCT00604214|580970472|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
160884290|NCT00604214|580970473|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
160884291|NCT00604214|580970472|FG000|Day 29 to Day 90|Death|64|||
160884292|NCT00604214|580970473|FG001|Day 29 to Day 90|Death|67|||
160884293|NCT00604214|580970472|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
160884294|NCT00604214|580970473|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
160884295|NCT00604214|580970472|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
160884296|NCT00604214|580970473|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
160884297|NCT00604214|580970472|FG000|Day 91 to Day 180|Death|19|||
160884298|NCT00604214|580970473|FG001|Day 91 to Day 180|Death|23|||
160884299|NCT00604214|580970472|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
160884300|NCT00604214|580970473|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
160884301|NCT00604214|580970472|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
160884302|NCT00604214|580970473|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
160884303|NCT00534599|580970474|FG000|Overall Study|Adverse Event|25|||
160884304|NCT00534599|580970475|FG001|Overall Study|Adverse Event|4|||
160884305|NCT00534599|580970474|FG000|Overall Study|Incorrect enrollment|2|||
160884306|NCT00534599|580970475|FG001|Overall Study|Incorrect enrollment|1|||
160884307|NCT00534599|580970474|FG000|Overall Study|Mis-randomization|2|||
160884308|NCT00534599|580970475|FG001|Overall Study|Mis-randomization|2|||
160884309|NCT00534599|580970474|FG000|Overall Study|Developed study-specific d/c criteria|5|||
160884310|NCT00534599|580970475|FG001|Overall Study|Developed study-specific d/c criteria|0|||
160884311|NCT00534599|580970474|FG000|Overall Study|Lack of Efficacy|0|||
160884312|NCT00534599|580970475|FG001|Overall Study|Lack of Efficacy|1|||
160884313|NCT00534599|580970474|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
160884314|NCT00534599|580970475|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
160884315|NCT00534599|580970474|FG000|Overall Study|Protocol Violation|1|||
160884316|NCT00534599|580970475|FG001|Overall Study|Protocol Violation|3|||
160884317|NCT00534599|580970474|FG000|Overall Study|Lost to Follow-up|11|||
160884318|NCT00534599|580970475|FG001|Overall Study|Lost to Follow-up|14|||
160884319|NCT00534599|580970474|FG000|Overall Study|Withdrawal by Subject|4|||
160884320|NCT00534599|580970475|FG001|Overall Study|Withdrawal by Subject|6|||
160884321|NCT00534599|580970474|FG000|Overall Study|Other|7|||
160884322|NCT00534599|580970475|FG001|Overall Study|Other|0|||
160884323|NCT01155167|580970480|FG000|Overall Study|Insufficient ultrasound data|2|||
160884324|NCT01155167|580970481|FG001|Overall Study|Insufficient ultrasound data|0|||
160884325|NCT01155167|580970480|FG000|Overall Study|Access site changed to femoral artery|1|||
160884326|NCT01155167|580970481|FG001|Overall Study|Access site changed to femoral artery|0|||
160884327|NCT01981551|580970482|FG000|Overall Study|Refused further treatment|8|||
160884328|NCT01981551|580970482|FG000|Overall Study|Adverse Event|1|||
160884329|NCT00167778|580970483|FG000|Overall Study|Withdrawal by Subject|1|||
160884330|NCT02654717|580970484|FG000|Overall Study|Adverse Event|2|||
160884331|NCT02654717|580970485|FG001|Overall Study|Adverse Event|2|||
160884332|NCT02654717|580970484|FG000|Overall Study|Protocol Violation|1|||
160884333|NCT02654717|580970485|FG001|Overall Study|Protocol Violation|2|||
160884334|NCT02654717|580970484|FG000|Overall Study|Withdrawal by Subject|0|||
160884335|NCT02654717|580970485|FG001|Overall Study|Withdrawal by Subject|1|||
160884336|NCT02654717|580970484|FG000|Overall Study|Non-permitted medication|3|||
160884337|NCT02654717|580970485|FG001|Overall Study|Non-permitted medication|0|||
160884338|NCT01451437|580970486|FG000|Overall Study|Adverse Event|0|||
160884339|NCT01451437|580970487|FG001|Overall Study|Adverse Event|0|||
160884340|NCT01451437|580970488|FG002|Overall Study|Adverse Event|0|||
160884341|NCT01451437|580970489|FG003|Overall Study|Adverse Event|0|||
160884342|NCT01451437|580970490|FG004|Overall Study|Adverse Event|0|||
160884343|NCT01451437|580970491|FG005|Overall Study|Adverse Event|1|||
160884344|NCT01451437|580970492|FG006|Overall Study|Adverse Event|1|||
160884345|NCT01451437|580970493|FG007|Overall Study|Adverse Event|2|||
160884346|NCT01451437|580970494|FG008|Overall Study|Adverse Event|1|||
160884347|NCT01451437|580970486|FG000|Overall Study|Physician Decision|1|||
160884348|NCT01451437|580970487|FG001|Overall Study|Physician Decision|1|||
160884349|NCT01451437|580970488|FG002|Overall Study|Physician Decision|2|||
160884350|NCT01451437|580970489|FG003|Overall Study|Physician Decision|0|||
160884351|NCT01451437|580970490|FG004|Overall Study|Physician Decision|0|||
160884352|NCT01451437|580970491|FG005|Overall Study|Physician Decision|0|||
160884353|NCT01451437|580970492|FG006|Overall Study|Physician Decision|0|||
160884354|NCT01451437|580970493|FG007|Overall Study|Physician Decision|0|||
160884355|NCT01451437|580970494|FG008|Overall Study|Physician Decision|0|||
160884356|NCT01451437|580970486|FG000|Overall Study|Disease Progression|0|||
160884357|NCT01451437|580970487|FG001|Overall Study|Disease Progression|0|||
160884358|NCT01451437|580970488|FG002|Overall Study|Disease Progression|1|||
160884359|NCT01451437|580970489|FG003|Overall Study|Disease Progression|1|||
160884360|NCT01451437|580970490|FG004|Overall Study|Disease Progression|3|||
160884361|NCT01451437|580970491|FG005|Overall Study|Disease Progression|2|||
160884362|NCT01451437|580970492|FG006|Overall Study|Disease Progression|3|||
160884363|NCT01451437|580970493|FG007|Overall Study|Disease Progression|1|||
160884364|NCT01451437|580970494|FG008|Overall Study|Disease Progression|3|||
160884365|NCT01451437|580970486|FG000|Overall Study|Protocol Violation|0|||
160884366|NCT01451437|580970487|FG001|Overall Study|Protocol Violation|0|||
160884367|NCT01451437|580970488|FG002|Overall Study|Protocol Violation|0|||
160884368|NCT01451437|580970489|FG003|Overall Study|Protocol Violation|0|||
160884369|NCT01451437|580970490|FG004|Overall Study|Protocol Violation|0|||
160884370|NCT01451437|580970491|FG005|Overall Study|Protocol Violation|0|||
160884371|NCT01451437|580970492|FG006|Overall Study|Protocol Violation|1|||
160884372|NCT01451437|580970493|FG007|Overall Study|Protocol Violation|0|||
160884373|NCT01451437|580970494|FG008|Overall Study|Protocol Violation|0|||
160884374|NCT01451437|580970486|FG000|Overall Study|Withdrawal by Subject|0|||
160884375|NCT01451437|580970487|FG001|Overall Study|Withdrawal by Subject|0|||
160884376|NCT01451437|580970488|FG002|Overall Study|Withdrawal by Subject|0|||
160884377|NCT01451437|580970489|FG003|Overall Study|Withdrawal by Subject|0|||
160884378|NCT01451437|580970490|FG004|Overall Study|Withdrawal by Subject|1|||
160884379|NCT01451437|580970491|FG005|Overall Study|Withdrawal by Subject|0|||
160884380|NCT01451437|580970492|FG006|Overall Study|Withdrawal by Subject|1|||
160884381|NCT01451437|580970493|FG007|Overall Study|Withdrawal by Subject|0|||
160884382|NCT01451437|580970494|FG008|Overall Study|Withdrawal by Subject|0|||
160884383|NCT00853970|580970497|FG000|Overall Study|Withdrawal by Subject|2|||
160771401|NCT02696798|580548923|FG002|Extended Treatment Period|Physician Decision|0|||
160771402|NCT02696798|580548921|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
160771403|NCT02696798|580548922|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
160771404|NCT02696798|580548923|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
160771405|NCT02696798|580548921|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
160771406|NCT02696798|580548922|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
160771407|NCT02696798|580548923|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
160771408|NCT02696798|580548921|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
160771409|NCT02696798|580548922|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
160771410|NCT02696798|580548923|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
160771411|NCT02696798|580548921|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
160771412|NCT02696798|580548922|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
160771413|NCT02696798|580548923|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
160771414|NCT02696798|580548921|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
160771415|NCT02696798|580548922|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
160771416|NCT02696798|580548923|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
160771417|NCT02696798|580548921|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
160771418|NCT02696798|580548922|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
160771419|NCT02696798|580548923|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
160771420|NCT02696798|580548921|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
160771421|NCT02696798|580548922|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
160771422|NCT02696798|580548923|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
160771423|NCT05020015|580551284|FG000|Overall Study|Ongoing on study|1|||
160771424|NCT05020015|580551285|FG001|Overall Study|Ongoing on study|3|||
160771425|NCT05020015|580551286|FG002|Overall Study|Ongoing on study|4|||
160771426|NCT05020015|580551287|FG003|Overall Study|Ongoing on study|7|||
160771427|NCT05020015|580551284|FG000|Overall Study|Death|2|||
160771428|NCT05020015|580551285|FG001|Overall Study|Death|3|||
160771429|NCT05020015|580551286|FG002|Overall Study|Death|4|||
160771430|NCT05020015|580551287|FG003|Overall Study|Death|0|||
160771431|NCT05020015|580551284|FG000|Overall Study|Withdrawal by Subject|0|||
160771432|NCT05020015|580551285|FG001|Overall Study|Withdrawal by Subject|0|||
160771433|NCT05020015|580551286|FG002|Overall Study|Withdrawal by Subject|1|||
160771434|NCT05020015|580551287|FG003|Overall Study|Withdrawal by Subject|0|||
160771435|NCT05020015|580551284|FG000|Overall Study|Reason Not Specified|0|||
160771436|NCT05020015|580551285|FG001|Overall Study|Reason Not Specified|0|||
160771437|NCT05020015|580551286|FG002|Overall Study|Reason Not Specified|2|||
160771438|NCT05020015|580551287|FG003|Overall Study|Reason Not Specified|0|||
160771439|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
160771440|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
160771441|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
160771442|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
160771443|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
160771444|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
160771445|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
160771446|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
160771447|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
160771448|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
160771449|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
160771450|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
160771451|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
160771452|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
160771453|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
160771454|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
160771455|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
160771456|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
160771457|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
160771458|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
160771459|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
160771460|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
160771461|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
160771462|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
160771463|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
160771464|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
160771465|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
160771466|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
160861861|NCT02531802|580887857|FG012|Received Vaccination 2|Adverse Event|0|||
160884384|NCT00853970|580970498|FG001|Overall Study|Withdrawal by Subject|1|||
160884385|NCT00853970|580970497|FG000|Overall Study|Cancelled surgery|4|||
160884386|NCT00853970|580970498|FG001|Overall Study|Cancelled surgery|2|||
160884387|NCT00884377|580971778|FG000|Overall Study|Withdrawal by Subject|1|||
160884388|NCT00884377|580971779|FG001|Overall Study|Withdrawal by Subject|0|||
160884389|NCT00884377|580971778|FG000|Overall Study|Could not confirm diagnosis|1|||
160884390|NCT00884377|580971779|FG001|Overall Study|Could not confirm diagnosis|0|||
160884391|NCT00884377|580971778|FG000|Overall Study|Physician Decision|0|||
160884392|NCT00884377|580971779|FG001|Overall Study|Physician Decision|1|||
160884393|NCT00706849|580971782|FG000|Treatment Period|Adverse Event|0|||
160884394|NCT00706849|580971783|FG001|Treatment Period|Adverse Event|9|||
160884395|NCT00706849|580971782|FG000|Treatment Period|Other|0|||
160884396|NCT00706849|580971783|FG001|Treatment Period|Other|1|||
160884397|NCT00706849|580971782|FG000|Follow-up Period|Withdrawal by Subject|0|||
160884398|NCT00706849|580971783|FG001|Follow-up Period|Withdrawal by Subject|2|||
160884399|NCT00706849|580971782|FG000|Follow-up Period|Protocol non-compliance|0|||
160884400|NCT00706849|580971783|FG001|Follow-up Period|Protocol non-compliance|1|||
160884401|NCT01611454|580971785|FG000|Overall Study|Lack of Efficacy|18|||
160884402|NCT01611454|580971786|FG001|Overall Study|Lack of Efficacy|10|||
160884403|NCT01275339|580971789|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
160884404|NCT01275339|580971790|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
160884405|NCT01275339|580971791|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
160884406|NCT01275339|580971792|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
160884407|NCT01275339|580971789|FG000|Overall Study|Withdrawal by Subject|0|||
160884408|NCT01275339|580971790|FG001|Overall Study|Withdrawal by Subject|0|||
160884409|NCT01275339|580971791|FG002|Overall Study|Withdrawal by Subject|1|||
160884410|NCT01275339|580971792|FG003|Overall Study|Withdrawal by Subject|0|||
160884411|NCT03718299|580971793|FG000|Overall Study|Adverse Event|1|||
160884412|NCT03718299|580971793|FG000|Overall Study|Withdrawal by Subject|6|||
160884413|NCT03718299|580971793|FG000|Overall Study|Physician Decision|2|||
160884414|NCT03718299|580971793|FG000|Overall Study|Lost to Follow-up|1|||
160884415|NCT04389970|580971795|FG000|Overall Study|Lost to Follow-up|1|||
160884416|NCT03123185|580971796|FG000|Overall Study|Withdrawal by Subject|0|||
160884417|NCT03123185|580971797|FG001|Overall Study|Withdrawal by Subject|0|||
160884418|NCT03123185|580971798|FG002|Overall Study|Withdrawal by Subject|0|||
160884419|NCT03123185|580971799|FG003|Overall Study|Withdrawal by Subject|0|||
160884420|NCT03123185|580971800|FG004|Overall Study|Withdrawal by Subject|0|||
160884421|NCT03123185|580971801|FG005|Overall Study|Withdrawal by Subject|0|||
160884422|NCT03123185|580971802|FG006|Overall Study|Withdrawal by Subject|0|||
160884423|NCT03123185|580971803|FG007|Overall Study|Withdrawal by Subject|0|||
160884424|NCT03123185|580971804|FG008|Overall Study|Withdrawal by Subject|0|||
160884425|NCT03123185|580971805|FG009|Overall Study|Withdrawal by Subject|0|||
160884426|NCT03123185|580971806|FG010|Overall Study|Withdrawal by Subject|0|||
160884427|NCT03123185|580971807|FG011|Overall Study|Withdrawal by Subject|0|||
160884428|NCT03123185|580971808|FG012|Overall Study|Withdrawal by Subject|1|||
160884429|NCT03123185|580971809|FG013|Overall Study|Withdrawal by Subject|0|||
160884430|NCT00713310|580971814|FG000|Overall Study|Adverse Event|5|||
160884431|NCT00713310|580971815|FG001|Overall Study|Adverse Event|2|||
160884432|NCT00713310|580971814|FG000|Overall Study|Lack of Efficacy|0|||
160884433|NCT00713310|580971815|FG001|Overall Study|Lack of Efficacy|2|||
160884434|NCT00713310|580971814|FG000|Overall Study|Withdrawal by Subject|0|||
160884435|NCT00713310|580971815|FG001|Overall Study|Withdrawal by Subject|2|||
160884436|NCT00329901|580971816|FG000|Overall Study|Withdrawal by Subject|4|||
160884437|NCT00329901|580971817|FG001|Overall Study|Withdrawal by Subject|3|||
160884438|NCT00329901|580971818|FG002|Overall Study|Withdrawal by Subject|2|||
160884439|NCT00329901|580971816|FG000|Overall Study|Lost to Follow-up|2|||
160884440|NCT00329901|580971817|FG001|Overall Study|Lost to Follow-up|0|||
160884441|NCT00329901|580971818|FG002|Overall Study|Lost to Follow-up|1|||
160884442|NCT00329901|580971816|FG000|Overall Study|Protocol Violation|1|||
160884443|NCT00329901|580971817|FG001|Overall Study|Protocol Violation|0|||
160884444|NCT00329901|580971818|FG002|Overall Study|Protocol Violation|1|||
160884445|NCT00329901|580971816|FG000|Overall Study|Unable to classify|2|||
160884446|NCT00329901|580971817|FG001|Overall Study|Unable to classify|2|||
160884447|NCT00329901|580971818|FG002|Overall Study|Unable to classify|0|||
160884448|NCT05028361|580971819|FG000|Overall Study|Withdrawal by Subject|1|||
160884449|NCT05028361|580971820|FG001|Overall Study|Withdrawal by Subject|0|||
160884450|NCT01993836|580971821|FG000|Overall Study|Surgery Cancelled|3|||
160884451|NCT01993836|580971822|FG001|Overall Study|Surgery Cancelled|0|||
160884452|NCT01993836|580971823|FG002|Overall Study|Surgery Cancelled|0|||
160884453|NCT01993836|580971821|FG000|Overall Study|Physician Decision|2|||
160884454|NCT01993836|580971822|FG001|Overall Study|Physician Decision|1|||
160884455|NCT01993836|580971823|FG002|Overall Study|Physician Decision|0|||
160884456|NCT01993836|580971821|FG000|Overall Study|Death|0|||
160884457|NCT01993836|580971822|FG001|Overall Study|Death|2|||
160884458|NCT01993836|580971823|FG002|Overall Study|Death|0|||
160884459|NCT01993836|580971821|FG000|Overall Study|Withdrawal by Subject|12|||
160884460|NCT01993836|580971822|FG001|Overall Study|Withdrawal by Subject|10|||
160884461|NCT01993836|580971823|FG002|Overall Study|Withdrawal by Subject|5|||
160884462|NCT02195687|580971824|FG000|Overall Study|Personal Reasons|1|||
160884463|NCT02195687|580971825|FG001|Overall Study|Personal Reasons|1|||
160884464|NCT02195687|580971824|FG000|Overall Study|Lost to Follow-up|4|||
160884465|NCT02195687|580971825|FG001|Overall Study|Lost to Follow-up|1|||
160884466|NCT00779259|580971826|FG000|Quinine Alone|Adverse Event|2|||
160884467|NCT00686634|580971827|FG000|Overall Study|Protocol Violation|6|||
160884468|NCT04369924|580971831|FG000|Overall Study|Lost to Follow-up|302|||
160884469|NCT04369924|580971832|FG001|Overall Study|Lost to Follow-up|339|||
160884470|NCT01653132|580971835|FG000|First Intervention|Protocol Violation|1|||
160884471|NCT01653132|580971836|FG001|First Intervention|Protocol Violation|0|||
160884472|NCT03828370|580971837|FG000|3 Month Follow-up|Lost to Follow-up|4|||
160884473|NCT03828370|580971838|FG001|3 Month Follow-up|Lost to Follow-up|12|||
160884474|NCT03828370|580971837|FG000|9 Month Follow up|Lost to Follow-up|12|||
160884475|NCT03828370|580971838|FG001|9 Month Follow up|Lost to Follow-up|20|||
160884476|NCT01209832|580971842|FG000|Period 1|Sponsor Decision and was not dosed|1|||
160884477|NCT01209832|580971842|FG000|Period 2|Sponsor Decision|1|||
160884478|NCT00761150|580971843|FG000|Open-label Period|Adverse Event|36|||
160540325|NCT02943564|579707594|FG002|Overall Study|Protocol Violation|2|||
160884479|NCT00761150|580971844|FG001|Open-label Period|Adverse Event|0|||
160884480|NCT00761150|580971845|FG002|Open-label Period|Adverse Event|0|||
160884481|NCT00761150|580971843|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
160884482|NCT00761150|580971844|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
160884483|NCT00761150|580971845|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
160884484|NCT00761150|580971843|FG000|Open-label Period|Lost to Follow-up|7|||
160884485|NCT00761150|580971844|FG001|Open-label Period|Lost to Follow-up|0|||
160884486|NCT00761150|580971845|FG002|Open-label Period|Lost to Follow-up|0|||
160884487|NCT00761150|580971843|FG000|Open-label Period|Lack of Efficacy|4|||
160884488|NCT00761150|580971844|FG001|Open-label Period|Lack of Efficacy|0|||
160884489|NCT00761150|580971845|FG002|Open-label Period|Lack of Efficacy|0|||
160884490|NCT00761150|580971843|FG000|Open-label Period|Withdrawal by Subject|5|||
160884491|NCT00761150|580971844|FG001|Open-label Period|Withdrawal by Subject|0|||
160884492|NCT00761150|580971845|FG002|Open-label Period|Withdrawal by Subject|0|||
160884493|NCT00761150|580971843|FG000|Open-label Period|Noncompliance|2|||
160884494|NCT00761150|580971844|FG001|Open-label Period|Noncompliance|0|||
160884495|NCT00761150|580971845|FG002|Open-label Period|Noncompliance|0|||
160884496|NCT00761150|580971843|FG000|Open-label Period|Other|5|||
160884497|NCT00761150|580971844|FG001|Open-label Period|Other|0|||
160884498|NCT00761150|580971845|FG002|Open-label Period|Other|0|||
160884499|NCT00761150|580971843|FG000|Double-blind Period|Lack of Efficacy|0|||
160884500|NCT00761150|580971844|FG001|Double-blind Period|Lack of Efficacy|2|||
160884501|NCT00761150|580971845|FG002|Double-blind Period|Lack of Efficacy|19|||
160884502|NCT00761150|580971843|FG000|Double-blind Period|Adverse Event|0|||
160884503|NCT00761150|580971844|FG001|Double-blind Period|Adverse Event|3|||
160884504|NCT00761150|580971845|FG002|Double-blind Period|Adverse Event|3|||
160884505|NCT00761150|580971843|FG000|Double-blind Period|Withdrawal by Subject|0|||
160884506|NCT00761150|580971844|FG001|Double-blind Period|Withdrawal by Subject|3|||
160884507|NCT00761150|580971845|FG002|Double-blind Period|Withdrawal by Subject|2|||
160884508|NCT00761150|580971843|FG000|Double-blind Period|Lost to Follow-up|0|||
160884509|NCT00761150|580971844|FG001|Double-blind Period|Lost to Follow-up|2|||
160884510|NCT00761150|580971845|FG002|Double-blind Period|Lost to Follow-up|1|||
160884511|NCT00761150|580971843|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
160884512|NCT00761150|580971844|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
160884513|NCT00761150|580971845|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
160884514|NCT00761150|580971843|FG000|Double-blind Period|Noncompliance|0|||
160884515|NCT00761150|580971844|FG001|Double-blind Period|Noncompliance|1|||
160884516|NCT00761150|580971845|FG002|Double-blind Period|Noncompliance|0|||
160884517|NCT00761150|580971843|FG000|Double-blind Period|Other|0|||
160884518|NCT00761150|580971844|FG001|Double-blind Period|Other|3|||
160884519|NCT00761150|580971845|FG002|Double-blind Period|Other|3|||
160540326|NCT02943564|579707592|FG000|Overall Study|Lost to Follow-up|1|||
160540327|NCT02943564|579707593|FG001|Overall Study|Lost to Follow-up|0|||
160884520|NCT01925989|580971846|FG000|Period 1|Sponsor Decision|1|||
160884521|NCT01925989|580971847|FG001|Period 1|Sponsor Decision|1|||
160884522|NCT01925989|580971848|FG002|Period 1|Sponsor Decision|0|||
160884523|NCT01925989|580971846|FG000|Period 1|Withdrawal by Subject|0|||
160884524|NCT01925989|580971847|FG001|Period 1|Withdrawal by Subject|1|||
160884525|NCT01925989|580971848|FG002|Period 1|Withdrawal by Subject|0|||
160884526|NCT03901456|580971849|FG000|Overall Study|Withdrawal by Subject|0|||
160884527|NCT03901456|580971850|FG001|Overall Study|Withdrawal by Subject|0|||
160884528|NCT03901456|580971851|FG002|Overall Study|Withdrawal by Subject|1|||
160884529|NCT03901456|580971849|FG000|Overall Study|Lost to Follow-up|0|||
160884530|NCT03901456|580971850|FG001|Overall Study|Lost to Follow-up|1|||
160884531|NCT03901456|580971851|FG002|Overall Study|Lost to Follow-up|0|||
160884532|NCT05318183|580971853|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
160540328|NCT02943564|579707594|FG002|Overall Study|Lost to Follow-up|0|||
160540329|NCT02943564|579707592|FG000|Overall Study|Withdrawal by Subject|6|||
160540330|NCT02943564|579707593|FG001|Overall Study|Withdrawal by Subject|5|||
160884533|NCT05318183|580971854|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
160884534|NCT05318183|580971853|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
160884535|NCT05318183|580971854|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
160884536|NCT05318183|580971853|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
160884537|NCT05318183|580971854|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
160884538|NCT05318183|580971853|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
160884539|NCT05318183|580971854|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
160884540|NCT06400251|580971855|FG000|Overall Study|Never Start Protocol Therapy|1|||
160884541|NCT06400251|580971855|FG000|Overall Study|Ineligible|2|||
160884542|NCT06400251|580971855|FG000|Overall Study|Mutation Status Not Confirmed|3|||
160884543|NCT06400251|580971855|FG000|Overall Study|Disease Progression|25|||
160884544|NCT06400251|580971855|FG000|Overall Study|Adverse Event|1|||
160884545|NCT06400251|580971855|FG000|Overall Study|Complicating Disease|1|||
160884546|NCT06400251|580971855|FG000|Overall Study|Physician Decision|2|||
160884547|NCT04098224|580971856|FG000|Overall Study|Adverse Event|1|||
160884548|NCT04098224|580971857|FG001|Overall Study|Adverse Event|0|||
160884549|NCT04098224|580971856|FG000|Overall Study|Physician Decision|1|||
160884550|NCT04098224|580971857|FG001|Overall Study|Physician Decision|0|||
160884551|NCT04098224|580971856|FG000|Overall Study|Patient not required enteral feeding|1|||
160884552|NCT04098224|580971857|FG001|Overall Study|Patient not required enteral feeding|0|||
160884553|NCT04098224|580971856|FG000|Overall Study|Patient failure nasogastric tube|1|||
160884554|NCT04098224|580971857|FG001|Overall Study|Patient failure nasogastric tube|0|||
160884555|NCT04098224|580971856|FG000|Overall Study|Patient early extubation|1|||
160884556|NCT04098224|580971857|FG001|Overall Study|Patient early extubation|3|||
160884557|NCT02217527|580971858|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
160884558|NCT02217527|580971859|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
160884559|NCT02217527|580971858|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
160884560|NCT02217527|580971859|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
160884561|NCT01203852|580971863|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
160884562|NCT01203852|580971863|FG000|Washout 2 Weeks|Physician Decision|46|||
160884563|NCT01878149|580971866|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
160884564|NCT01878149|580971867|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
160884565|NCT04672252|580971868|FG000|Overall Study|Protocol Violation|1|||
160884566|NCT04672252|580971869|FG001|Overall Study|Protocol Violation|0|||
160884567|NCT06390839|580971871|FG000|Overall Study|Ineligible|2|||
160884568|NCT06390839|580971871|FG000|Overall Study|Never start protocol therapy|3|||
160884569|NCT06390839|580971871|FG000|Overall Study|Adverse Event|1|||
160884570|NCT06390839|580971871|FG000|Overall Study|Alternative therapy|2|||
160884571|NCT06390839|580971871|FG000|Overall Study|Death|3|||
160884572|NCT06390839|580971871|FG000|Overall Study|Disease progression|28|||
160884573|NCT06390839|580971871|FG000|Overall Study|Withdrawal by Subject|2|||
160884574|NCT06390839|580971871|FG000|Overall Study|Complicating disease|1|||
160884575|NCT06390839|580971871|FG000|Overall Study|Noncompliance|1|||
160884576|NCT01738477|580971872|FG000|Overall Study|Lost to Follow-up|1|||
160884577|NCT01738477|580971873|FG001|Overall Study|Lost to Follow-up|4|||
160884578|NCT00502203|580971874|FG000|Overall Study|Inevaluable|1|||
160884579|NCT01431638|580971877|FG000|Overall Study|Adverse Event|1|||
160884580|NCT01431638|580971878|FG001|Overall Study|Adverse Event|3|||
160884581|NCT01431638|580971879|FG002|Overall Study|Adverse Event|1|||
160884582|NCT01431638|580971877|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160884583|NCT01431638|580971878|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160884584|NCT01431638|580971879|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
160884585|NCT01431638|580971877|FG000|Overall Study|Participants condition no longer requires study drug|0|||
160884586|NCT01431638|580971878|FG001|Overall Study|Participants condition no longer requires study drug|1|||
160884587|NCT01431638|580971879|FG002|Overall Study|Participants condition no longer requires study drug|0|||
160884588|NCT01431638|580971877|FG000|Overall Study|Participant withdrew consent|14|||
160884589|NCT01431638|580971878|FG001|Overall Study|Participant withdrew consent|5|||
160884590|NCT01431638|580971879|FG002|Overall Study|Participant withdrew consent|8|||
160884591|NCT01431638|580971877|FG000|Overall Study|Lost to Follow-up|7|||
160884592|NCT01431638|580971878|FG001|Overall Study|Lost to Follow-up|9|||
160884593|NCT01431638|580971879|FG002|Overall Study|Lost to Follow-up|7|||
160884594|NCT01431638|580971877|FG000|Overall Study|Administrative problems|1|||
160884595|NCT01431638|580971878|FG001|Overall Study|Administrative problems|4|||
160884596|NCT01431638|580971879|FG002|Overall Study|Administrative problems|6|||
160884597|NCT01431638|580971877|FG000|Overall Study|Death|1|||
160884598|NCT01431638|580971878|FG001|Overall Study|Death|0|||
160884599|NCT01431638|580971879|FG002|Overall Study|Death|0|||
160884600|NCT01431638|580971877|FG000|Overall Study|Protocol deviation|1|||
160653383|NCT04634409|580110522|FG022|Overall Study|Other - As reported by Investigator|0|||
160884601|NCT01431638|580971878|FG001|Overall Study|Protocol deviation|1|||
160884602|NCT01431638|580971879|FG002|Overall Study|Protocol deviation|4|||
160884603|NCT01431638|580971877|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
160884604|NCT01431638|580971878|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
160884605|NCT01431638|580971879|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
160884606|NCT03709576|580971893|FG000|Overall Study|progression prior to enrollment|1|||
160884607|NCT00890045|580971901|FG000|Overall Study|Death|0|||
160884608|NCT00890045|580971902|FG001|Overall Study|Death|1|||
160884609|NCT00890045|580971901|FG000|Overall Study|Did not receive HeRO Graft|0|||
160884610|NCT00890045|580971902|FG001|Overall Study|Did not receive HeRO Graft|2|||
160884611|NCT00890045|580971901|FG000|Overall Study|Lost to Follow-up|5|||
160884612|NCT00890045|580971902|FG001|Overall Study|Lost to Follow-up|7|||
160884613|NCT00510653|580971903|FG000|Overall Study|Withdrawal by Subject|8|||
160884614|NCT00510653|580971903|FG000|Overall Study|Monetary|3|||
160884615|NCT00710762|580971906|FG000|Overall Study|Progressive disease|27|||
160884616|NCT00710762|580971907|FG001|Overall Study|Progressive disease|30|||
160884617|NCT00710762|580971906|FG000|Overall Study|Adverse Event other disease worsening|2|||
160884618|NCT00710762|580971907|FG001|Overall Study|Adverse Event other disease worsening|1|||
160884619|NCT00710762|580971906|FG000|Overall Study|Other Adverse Event|7|||
160884620|NCT00710762|580971907|FG001|Overall Study|Other Adverse Event|7|||
160884621|NCT00710762|580971906|FG000|Overall Study|Lost to Follow-up|1|||
160884622|NCT00710762|580971907|FG001|Overall Study|Lost to Follow-up|0|||
160884623|NCT00710762|580971906|FG000|Overall Study|Reason other than listed above|2|||
160884624|NCT00710762|580971907|FG001|Overall Study|Reason other than listed above|2|||
160884625|NCT01947855|580971908|FG000|Overall Study|Withdrawal by Subject|1|||
160884626|NCT01947855|580971909|FG001|Overall Study|Withdrawal by Subject|0|||
160884627|NCT01947855|580971910|FG002|Overall Study|Withdrawal by Subject|0|||
160884628|NCT00592774|580971914|FG000|Overall Study|Adverse Event|5|||
160884629|NCT00592774|580971915|FG001|Overall Study|Adverse Event|19|||
160884630|NCT00592774|580971916|FG002|Overall Study|Adverse Event|2|||
160884631|NCT00592774|580971917|FG003|Overall Study|Adverse Event|14|||
160884632|NCT00592774|580971918|FG004|Overall Study|Adverse Event|8|||
160884633|NCT00592774|580971914|FG000|Overall Study|Protocol Violation|0|||
160884634|NCT00592774|580971915|FG001|Overall Study|Protocol Violation|1|||
160884635|NCT00592774|580971916|FG002|Overall Study|Protocol Violation|0|||
160884636|NCT00592774|580971917|FG003|Overall Study|Protocol Violation|0|||
160884637|NCT00592774|580971918|FG004|Overall Study|Protocol Violation|1|||
160884638|NCT00592774|580971914|FG000|Overall Study|Withdrawal by Subject|3|||
160884639|NCT00592774|580971915|FG001|Overall Study|Withdrawal by Subject|7|||
160884640|NCT00592774|580971916|FG002|Overall Study|Withdrawal by Subject|0|||
160884641|NCT00592774|580971917|FG003|Overall Study|Withdrawal by Subject|0|||
160884642|NCT00592774|580971918|FG004|Overall Study|Withdrawal by Subject|0|||
160884643|NCT00592774|580971914|FG000|Overall Study|Lack of Efficacy|3|||
160884644|NCT00592774|580971915|FG001|Overall Study|Lack of Efficacy|3|||
160884645|NCT00592774|580971916|FG002|Overall Study|Lack of Efficacy|0|||
160884646|NCT00592774|580971917|FG003|Overall Study|Lack of Efficacy|0|||
160884647|NCT00592774|580971918|FG004|Overall Study|Lack of Efficacy|2|||
160884648|NCT00592774|580971914|FG000|Overall Study|Physician Decision|0|||
160884649|NCT00592774|580971915|FG001|Overall Study|Physician Decision|1|||
160884650|NCT00592774|580971916|FG002|Overall Study|Physician Decision|1|||
160884651|NCT00592774|580971917|FG003|Overall Study|Physician Decision|0|||
160884652|NCT00592774|580971918|FG004|Overall Study|Physician Decision|1|||
160884653|NCT00592774|580971914|FG000|Overall Study|Other|0|||
160884654|NCT00592774|580971915|FG001|Overall Study|Other|1|||
160884655|NCT00592774|580971916|FG002|Overall Study|Other|1|||
160884656|NCT00592774|580971917|FG003|Overall Study|Other|0|||
160884657|NCT00592774|580971918|FG004|Overall Study|Other|2|||
160884658|NCT01700439|580971919|FG000|Overall Study|Lost to Follow-up|47|||
160884659|NCT01700439|580971919|FG000|Overall Study|Withdrawal by Subject|183|||
160884660|NCT01700439|580971919|FG000|Overall Study|Death|186|||
160884661|NCT01892384|580971920|FG000|Overall Study|Withdrawal by Subject|1|||
160884662|NCT01892384|580971921|FG001|Overall Study|Withdrawal by Subject|1|||
160884663|NCT01892384|580971922|FG002|Overall Study|Withdrawal by Subject|0|||
160884664|NCT01892384|580971923|FG003|Overall Study|Withdrawal by Subject|0|||
160884665|NCT00621621|580971924|FG000|Overall Study|Subjects were exited at EP study|30|||
160884666|NCT00621621|580971925|FG001|Overall Study|Subjects were exited at EP study|0|||
160884667|NCT00053898|580971929|FG000|Overall Study|No follow-up data from any source|9|||
160884668|NCT00053898|580971930|FG001|Overall Study|No follow-up data from any source|12|||
160884669|NCT00053898|580971929|FG000|Overall Study|Follow-up from telephone contact only|5|||
160884670|NCT00053898|580971930|FG001|Overall Study|Follow-up from telephone contact only|1|||
160884671|NCT03985878|580971934|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
160884672|NCT03985878|580971934|FG000|Overall Study|Study Terminated by Sponsor|12|||
160884673|NCT03985878|580971934|FG000|Overall Study|Withdrawal by Subject|1|||
160884674|NCT02889562|580971935|FG000|Overall Study|Physician Decision|0|||
160884675|NCT02889562|580971936|FG001|Overall Study|Physician Decision|1|||
160884676|NCT02889562|580971935|FG000|Overall Study|Withdrawal by Subject|0|||
160884677|NCT02889562|580971936|FG001|Overall Study|Withdrawal by Subject|1|||
160884678|NCT00960570|580971942|FG000|21 Day Washout Period|Adverse Event|1|||
160884679|NCT00960570|580971942|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
160884680|NCT00960570|580971942|FG000|1 Day Period Between Dosing|Adverse Event|2|||
160884681|NCT00960570|580971942|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
160540331|NCT02943564|579707594|FG002|Overall Study|Withdrawal by Subject|2|||
160540332|NCT02943564|579707592|FG000|Overall Study|Adverse Event|1|||
160540333|NCT02943564|579707593|FG001|Overall Study|Adverse Event|2|||
160540334|NCT02943564|579707594|FG002|Overall Study|Adverse Event|1|||
160540335|NCT02943564|579707592|FG000|Overall Study|Lack of Efficacy|0|||
160540336|NCT02943564|579707593|FG001|Overall Study|Lack of Efficacy|1|||
160540337|NCT02943564|579707594|FG002|Overall Study|Lack of Efficacy|0|||
160540338|NCT02536313|579707595|FG000|Overall Study|Lack of Efficacy|0|||
160540339|NCT02536313|579707596|FG001|Overall Study|Lack of Efficacy|1|||
160540340|NCT00917150|579707597|FG000|Overall Study|Adverse Event|12|||
160540341|NCT00917150|579707598|FG001|Overall Study|Adverse Event|7|||
160540342|NCT00917150|579707599|FG002|Overall Study|Adverse Event|12|||
160540343|NCT00917150|579707600|FG003|Overall Study|Adverse Event|11|||
160540344|NCT00917150|579707597|FG000|Overall Study|Death|1|||
160540345|NCT00917150|579707598|FG001|Overall Study|Death|4|||
160540346|NCT00917150|579707599|FG002|Overall Study|Death|3|||
160540347|NCT00917150|579707600|FG003|Overall Study|Death|2|||
160540348|NCT00917150|579707597|FG000|Overall Study|Lost to Follow-up|1|||
160540349|NCT00917150|579707598|FG001|Overall Study|Lost to Follow-up|0|||
160540350|NCT00917150|579707599|FG002|Overall Study|Lost to Follow-up|4|||
160540351|NCT00917150|579707600|FG003|Overall Study|Lost to Follow-up|2|||
160540352|NCT00917150|579707597|FG000|Overall Study|Physician Decision|0|||
160540353|NCT00917150|579707598|FG001|Overall Study|Physician Decision|2|||
160540354|NCT00917150|579707599|FG002|Overall Study|Physician Decision|0|||
160540355|NCT00917150|579707600|FG003|Overall Study|Physician Decision|1|||
160540356|NCT00917150|579707597|FG000|Overall Study|Protocol Violation|5|||
160540357|NCT00917150|579707598|FG001|Overall Study|Protocol Violation|5|||
160540358|NCT00917150|579707599|FG002|Overall Study|Protocol Violation|3|||
160540359|NCT00917150|579707600|FG003|Overall Study|Protocol Violation|5|||
160540360|NCT00917150|579707597|FG000|Overall Study|Withdrawal by Subject|15|||
160540361|NCT00917150|579707598|FG001|Overall Study|Withdrawal by Subject|16|||
160540362|NCT00917150|579707599|FG002|Overall Study|Withdrawal by Subject|18|||
160540363|NCT00917150|579707600|FG003|Overall Study|Withdrawal by Subject|11|||
160540364|NCT00917150|579707597|FG000|Overall Study|Other than specified|3|||
160540365|NCT00917150|579707598|FG001|Overall Study|Other than specified|3|||
160540366|NCT00917150|579707599|FG002|Overall Study|Other than specified|2|||
160540367|NCT00917150|579707600|FG003|Overall Study|Other than specified|2|||
160540368|NCT03891264|579707602|FG000|Overall Study|Adverse Event|1|||
160540369|NCT03891264|579707602|FG000|Overall Study|Withdrawal by Subject|2|||
160540370|NCT03891264|579707602|FG000|Overall Study|Physician Decision|2|||
160540371|NCT01924182|579707603|FG000|Overall Study|Withdrawal by Subject|1|||
160540372|NCT01924182|579707604|FG001|Overall Study|Withdrawal by Subject|0|||
160540373|NCT00993265|579707605|FG000|Overall Study|Adverse Event|1|||
160540374|NCT00993265|579707606|FG001|Overall Study|Adverse Event|0|||
160540375|NCT00993265|579707605|FG000|Overall Study|Changed dose of concomitant drug|2|||
160540376|NCT00993265|579707606|FG001|Overall Study|Changed dose of concomitant drug|0|||
160884682|NCT04085367|580973043|FG000|Overall Study|Adverse Event|1|||
160884683|NCT04085367|580973044|FG001|Overall Study|Adverse Event|1|||
160884684|NCT04085367|580973043|FG000|Overall Study|Withdrawal by Subject|13|||
160540377|NCT00993265|579707605|FG000|Overall Study|Non-compliant with study medication|1|||
160540378|NCT00993265|579707606|FG001|Overall Study|Non-compliant with study medication|0|||
160540379|NCT00219284|579707607|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
160540380|NCT00219284|579707608|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
160540381|NCT00219284|579707607|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
160540382|NCT00219284|579707608|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
160540383|NCT00219284|579707607|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
160540384|NCT00219284|579707608|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
160540385|NCT00219284|579707607|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
160540386|NCT00219284|579707608|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
160540387|NCT00219284|579707607|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
160540388|NCT00219284|579707608|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
160540389|NCT00219284|579707607|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
160540390|NCT00219284|579707608|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
160884685|NCT04085367|580973044|FG001|Overall Study|Withdrawal by Subject|4|||
160884686|NCT04085367|580973043|FG000|Overall Study|Lost to Follow-up|3|||
160540391|NCT00219284|579707607|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
160540392|NCT00219284|579707608|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
160884687|NCT04085367|580973044|FG001|Overall Study|Lost to Follow-up|1|||
160884688|NCT04085367|580973043|FG000|Overall Study|Other unspecified|2|||
160884689|NCT04085367|580973044|FG001|Overall Study|Other unspecified|1|||
160540393|NCT00219284|579707607|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
160540394|NCT00219284|579707608|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
160540395|NCT00219284|579707607|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
160540396|NCT00219284|579707608|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
160540397|NCT01692275|579707609|FG000|Overall Study|Lost to Follow-up|57|||
160540398|NCT01692275|579707610|FG001|Overall Study|Lost to Follow-up|48|||
160540399|NCT01692275|579707609|FG000|Overall Study|Withdrawal by Subject|9|||
160540400|NCT01692275|579707610|FG001|Overall Study|Withdrawal by Subject|11|||
160540401|NCT05264740|579707617|FG000|Baseline|Withdrawal by Subject|0|||
160540402|NCT05264740|579707618|FG001|Baseline|Withdrawal by Subject|1|||
160540403|NCT05264740|579707617|FG000|Follow Up 1|Lost to Follow-up|1|||
160540404|NCT05264740|579707618|FG001|Follow Up 1|Lost to Follow-up|1|||
160540405|NCT05264740|579707617|FG000|Follow Up 1|Withdrawal by Subject|0|||
160540406|NCT05264740|579707618|FG001|Follow Up 1|Withdrawal by Subject|1|||
160540407|NCT05264740|579707617|FG000|Follow Up 2|Lost to Follow-up|1|||
160540408|NCT05264740|579707618|FG001|Follow Up 2|Lost to Follow-up|4|||
160884690|NCT04085367|580973043|FG000|Overall Study|Status Unknown|1|||
160884691|NCT04085367|580973044|FG001|Overall Study|Status Unknown|1|||
160540409|NCT05264740|579707617|FG000|Follow Up 3|Lost to Follow-up|7|||
160540410|NCT05264740|579707618|FG001|Follow Up 3|Lost to Follow-up|4|||
160540411|NCT02356562|579709285|FG000|Overall Study|Withdrawal by Subject|0|||
160540412|NCT02356562|579709286|FG001|Overall Study|Withdrawal by Subject|1|||
160540413|NCT02356562|579709285|FG000|Overall Study|Re-entered treatment in a previous study|1|||
160540414|NCT02356562|579709286|FG001|Overall Study|Re-entered treatment in a previous study|0|||
160540415|NCT02356562|579709285|FG000|Overall Study|site closure|1|||
160540416|NCT02356562|579709286|FG001|Overall Study|site closure|0|||
160540417|NCT00412750|579709287|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160540418|NCT00412750|579709288|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160540419|NCT00412750|579709289|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160540420|NCT00412750|579709287|FG000|Overall Study|Administrative problems|21|||
160540421|NCT00412750|579709288|FG001|Overall Study|Administrative problems|17|||
160540422|NCT00412750|579709289|FG002|Overall Study|Administrative problems|14|||
160540423|NCT00412750|579709287|FG000|Overall Study|Adverse Event|8|||
160540424|NCT00412750|579709288|FG001|Overall Study|Adverse Event|3|||
160884692|NCT00130442|580973048|FG000|Overall Study|Withdrawal by Subject|0|||
160884693|NCT00130442|580973049|FG001|Overall Study|Withdrawal by Subject|1|||
160884694|NCT00130442|580973048|FG000|Overall Study|did not meet criteria|1|||
160884695|NCT00130442|580973049|FG001|Overall Study|did not meet criteria|1|||
160884696|NCT00814333|580973050|FG000|Enrollment|Lost to Follow-up|1|||
160884697|NCT00814333|580973051|FG001|Enrollment|Lost to Follow-up|0|||
160884698|NCT01527357|580973052|FG000|Overall Study|Death|8|||
160884699|NCT01527357|580973053|FG001|Overall Study|Death|2|||
160884700|NCT01527357|580973052|FG000|Overall Study|Lost to Follow-up|6|||
160540425|NCT00412750|579709289|FG002|Overall Study|Adverse Event|3|||
160540426|NCT00412750|579709287|FG000|Overall Study|Lost to Follow-up|1|||
160540427|NCT00412750|579709288|FG001|Overall Study|Lost to Follow-up|0|||
160884701|NCT01527357|580973053|FG001|Overall Study|Lost to Follow-up|4|||
160884702|NCT01527357|580973052|FG000|Overall Study|Withdrew Consent|1|||
160884703|NCT01527357|580973053|FG001|Overall Study|Withdrew Consent|1|||
160884704|NCT01527357|580973052|FG000|Overall Study|Non-compliance|0|||
160884705|NCT01527357|580973053|FG001|Overall Study|Non-compliance|1|||
160884706|NCT01527357|580973052|FG000|Overall Study|No Day 29 Visit|0|||
160884707|NCT01527357|580973053|FG001|Overall Study|No Day 29 Visit|1|||
160653384|NCT04634409|580110523|FG023|Overall Study|Other - As reported by Investigator|0|||
160771467|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
160771468|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
160771469|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
160771470|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
160771471|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
160771472|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
160771473|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
160771474|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
160771475|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
160771476|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
160771477|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
160771478|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
160771479|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
160771480|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
160771481|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
160884708|NCT01527357|580973052|FG000|Overall Study|Did Not Receive Treatment|2|||
160884709|NCT01527357|580973053|FG001|Overall Study|Did Not Receive Treatment|0|||
160884710|NCT02233946|580973054|FG000|Baseline|Withdrawal by Subject|2|||
160884711|NCT02233946|580973055|FG001|Baseline|Withdrawal by Subject|0|||
160884712|NCT02233946|580973054|FG000|3-months Follow-up|Lost to Follow-up|53|||
160884713|NCT02233946|580973055|FG001|3-months Follow-up|Lost to Follow-up|29|||
160884714|NCT02233946|580973054|FG000|6-months Follow-up|Lost to Follow-up|21|||
160884715|NCT02233946|580973055|FG001|6-months Follow-up|Lost to Follow-up|2|||
160884716|NCT02233946|580973054|FG000|9-month Follow-up|Lost to Follow-up|20|||
160884717|NCT02233946|580973055|FG001|9-month Follow-up|Lost to Follow-up|11|||
160884718|NCT02233946|580973054|FG000|12-month Follow-up|Lost to Follow-up|28|||
160884719|NCT02233946|580973055|FG001|12-month Follow-up|Lost to Follow-up|11|||
160884720|NCT00910247|580973056|FG000|Overall Study|Adverse Event|15|||
160884721|NCT00910247|580973056|FG000|Overall Study|Death|2|||
160884722|NCT00910247|580973056|FG000|Overall Study|Lost to Follow-up|10|||
160884723|NCT00910247|580973056|FG000|Overall Study|Physician Decision|3|||
160884724|NCT00910247|580973056|FG000|Overall Study|Protocol Violation|10|||
160884725|NCT00910247|580973056|FG000|Overall Study|Withdrawal by Subject|25|||
160884726|NCT00910247|580973056|FG000|Overall Study|Not collected|4|||
160884727|NCT01879579|580973057|FG000|Overall Study|Phone incompatible with texting platform|3|||
160884728|NCT01879579|580973058|FG001|Overall Study|Phone incompatible with texting platform|0|||
160884729|NCT01879579|580973057|FG000|Overall Study|Did not enroll in texting platform|1|||
160884730|NCT01879579|580973058|FG001|Overall Study|Did not enroll in texting platform|0|||
160884731|NCT01879579|580973057|FG000|Overall Study|Did not initiate insulin treatment|1|||
160884732|NCT01879579|580973058|FG001|Overall Study|Did not initiate insulin treatment|0|||
160884733|NCT01879579|580973057|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
160884734|NCT01879579|580973058|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
160884735|NCT01879579|580973057|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
160884736|NCT01879579|580973058|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
160884737|NCT02927067|580973059|FG000|Overall Study|Withdrawn Consent|20|||
160884738|NCT02927067|580973060|FG001|Overall Study|Withdrawn Consent|12|||
160884739|NCT02927067|580973059|FG000|Overall Study|Death|18|||
160884740|NCT02927067|580973060|FG001|Overall Study|Death|31|||
160884741|NCT02927067|580973059|FG000|Overall Study|Adverse Event|13|||
160884742|NCT02927067|580973060|FG001|Overall Study|Adverse Event|10|||
160884743|NCT02927067|580973059|FG000|Overall Study|Noncompliance|5|||
160884744|NCT02927067|580973060|FG001|Overall Study|Noncompliance|2|||
160884745|NCT02927067|580973059|FG000|Overall Study|Reason not Specified|4|||
160884746|NCT02927067|580973060|FG001|Overall Study|Reason not Specified|6|||
160884747|NCT02292784|580973063|FG000|Overall Study|Lost to Follow-up|1|||
160884748|NCT02292784|580973064|FG001|Overall Study|Lost to Follow-up|17|||
160884749|NCT02292784|580973065|FG002|Overall Study|Lost to Follow-up|18|||
160884750|NCT02292784|580973063|FG000|Overall Study|Withdrawal by Subject|0|||
160884751|NCT02292784|580973064|FG001|Overall Study|Withdrawal by Subject|3|||
160884752|NCT02292784|580973065|FG002|Overall Study|Withdrawal by Subject|3|||
160884753|NCT02519855|580973066|FG000|Overall Study|Adverse Event|0|||
160884754|NCT02519855|580973067|FG001|Overall Study|Adverse Event|1|||
160884755|NCT02519855|580973066|FG000|Overall Study|Lost to Follow-up|3|||
160884756|NCT02519855|580973067|FG001|Overall Study|Lost to Follow-up|3|||
160884757|NCT02919969|580973068|FG000|Overall Study|Lack of Efficacy|22|||
160884758|NCT02919969|580973068|FG000|Overall Study|Death|4|||
160884759|NCT02919969|580973068|FG000|Overall Study|Physician Decision|3|||
160884760|NCT02919969|580973068|FG000|Overall Study|Withdrawal by Subject|2|||
160771482|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
160771483|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
160771484|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
160637083|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
160637084|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
160637085|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
160637086|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
160771485|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
160771486|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
160771487|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
160771488|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
160771489|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
160771490|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
160771491|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
160771492|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
160771493|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
160771494|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
160771495|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
160771496|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
160771497|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
160771498|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
160771499|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
160771500|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
160771501|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
160771502|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
160771503|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
160771504|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
160771505|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
160771506|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
160771507|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
160771508|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
160771509|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
160771510|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
160771511|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
160771512|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
160771513|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
160771514|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
160771515|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
160771516|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
160771517|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
160771518|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
160771519|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
160771520|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
160771521|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
160771522|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
160771523|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
160771524|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
160771525|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
160771526|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
160771527|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
160771528|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
160771529|NCT00090103|580551288|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
160771530|NCT00090103|580551289|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
160771531|NCT00090103|580551290|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
160771532|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
160771533|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
160771534|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
160771535|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
160771536|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
160771537|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
160771538|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
160637087|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
160884761|NCT03621475|580973069|FG000|Overall Study|No longer required restraints at initiation|0|||
160884762|NCT03621475|580973070|FG001|Overall Study|No longer required restraints at initiation|1|||
160884763|NCT01842633|580973071|FG000|Overall Study|Screen Failure|1|||
160884764|NCT01842633|580973072|FG001|Overall Study|Screen Failure|0|||
160884765|NCT01842633|580973073|FG002|Overall Study|Screen Failure|0|||
160884766|NCT01842633|580973071|FG000|Overall Study|Adverse Event|1|||
160884767|NCT01842633|580973072|FG001|Overall Study|Adverse Event|1|||
160884768|NCT01842633|580973073|FG002|Overall Study|Adverse Event|0|||
160884769|NCT01842633|580973071|FG000|Overall Study|Withdrawal by Subject|0|||
160884770|NCT01842633|580973072|FG001|Overall Study|Withdrawal by Subject|1|||
160884771|NCT01842633|580973073|FG002|Overall Study|Withdrawal by Subject|0|||
160884772|NCT01842633|580973071|FG000|Overall Study|Technical issues|1|||
160884773|NCT01842633|580973072|FG001|Overall Study|Technical issues|0|||
160540428|NCT00412750|579709289|FG002|Overall Study|Lost to Follow-up|1|||
160540429|NCT00412750|579709287|FG000|Overall Study|Withdrawal by Subject|0|||
160540430|NCT00412750|579709288|FG001|Overall Study|Withdrawal by Subject|1|||
160540431|NCT00412750|579709289|FG002|Overall Study|Withdrawal by Subject|2|||
160540432|NCT00412750|579709287|FG000|Overall Study|Lack of Efficacy|0|||
160540433|NCT00412750|579709288|FG001|Overall Study|Lack of Efficacy|0|||
160540434|NCT00412750|579709289|FG002|Overall Study|Lack of Efficacy|3|||
160540435|NCT00874120|579709296|FG000|First Intervention|Adverse Event|0|||
160540436|NCT00874120|579709297|FG001|First Intervention|Adverse Event|1|||
160540437|NCT00874120|579709296|FG000|First Intervention|Withdrawal by Subject|2|||
160540438|NCT00874120|579709297|FG001|First Intervention|Withdrawal by Subject|0|||
160540439|NCT00874120|579709296|FG000|First Intervention|Lost to Follow-up|0|||
160884774|NCT01842633|580973073|FG002|Overall Study|Technical issues|0|||
160884775|NCT02093351|580973077|FG000|Part A|Adverse Event|0|||
160884776|NCT02093351|580973078|FG001|Part A|Adverse Event|1|||
160884777|NCT02093351|580973079|FG002|Part A|Adverse Event|1|||
160884778|NCT02093351|580973080|FG003|Part A|Adverse Event|0|||
160884779|NCT02093351|580973077|FG000|Part A|Condition under investigation worsened|2|||
160884780|NCT02093351|580973078|FG001|Part A|Condition under investigation worsened|0|||
160884781|NCT02093351|580973079|FG002|Part A|Condition under investigation worsened|2|||
160884782|NCT02093351|580973080|FG003|Part A|Condition under investigation worsened|0|||
160884783|NCT02093351|580973077|FG000|Part A|Death|0|||
160884784|NCT02093351|580973078|FG001|Part A|Death|1|||
160884785|NCT02093351|580973079|FG002|Part A|Death|0|||
160884786|NCT02093351|580973080|FG003|Part A|Death|0|||
160884787|NCT02093351|580973077|FG000|Part B|Patient decision|0|||
160884788|NCT02093351|580973078|FG001|Part B|Patient decision|0|||
160884789|NCT02093351|580973079|FG002|Part B|Patient decision|0|||
160884790|NCT02093351|580973080|FG003|Part B|Patient decision|3|||
160884791|NCT02093351|580973077|FG000|Part B|Disease progression|0|||
160884792|NCT02093351|580973078|FG001|Part B|Disease progression|0|||
160884793|NCT02093351|580973079|FG002|Part B|Disease progression|0|||
160884794|NCT02093351|580973080|FG003|Part B|Disease progression|4|||
160884795|NCT02093351|580973077|FG000|Part B|Complete response|0|||
160884796|NCT02093351|580973078|FG001|Part B|Complete response|0|||
160884797|NCT02093351|580973079|FG002|Part B|Complete response|0|||
160884798|NCT02093351|580973080|FG003|Part B|Complete response|1|||
160884799|NCT02093351|580973077|FG000|Part B|Adverse event + disease progression|0|||
160884800|NCT02093351|580973078|FG001|Part B|Adverse event + disease progression|0|||
160884801|NCT02093351|580973079|FG002|Part B|Adverse event + disease progression|0|||
160884802|NCT02093351|580973080|FG003|Part B|Adverse event + disease progression|1|||
160884803|NCT02093351|580973077|FG000|Part B|Lack of therapeutic response|0|||
160884804|NCT02093351|580973078|FG001|Part B|Lack of therapeutic response|0|||
160884805|NCT02093351|580973079|FG002|Part B|Lack of therapeutic response|0|||
160884806|NCT02093351|580973080|FG003|Part B|Lack of therapeutic response|12|||
160884807|NCT02093351|580973077|FG000|Part B|Condition under investigation worsened|0|||
160884808|NCT02093351|580973078|FG001|Part B|Condition under investigation worsened|0|||
160884809|NCT02093351|580973079|FG002|Part B|Condition under investigation worsened|0|||
160884810|NCT02093351|580973080|FG003|Part B|Condition under investigation worsened|39|||
160884811|NCT02093351|580973077|FG000|Part B|Adverse Event|0|||
160884812|NCT02093351|580973078|FG001|Part B|Adverse Event|0|||
160884813|NCT02093351|580973079|FG002|Part B|Adverse Event|0|||
160884814|NCT02093351|580973080|FG003|Part B|Adverse Event|2|||
160884815|NCT02093351|580973077|FG000|Part B|Death|0|||
160884816|NCT02093351|580973078|FG001|Part B|Death|0|||
160884817|NCT02093351|580973079|FG002|Part B|Death|0|||
160884818|NCT02093351|580973080|FG003|Part B|Death|1|||
160884819|NCT03565367|580973081|FG000|Overall Study|No scan due to technical issues|4|||
160884820|NCT03565367|580973082|FG001|Overall Study|No scan due to technical issues|0|||
160884821|NCT01099709|580973085|FG000|Period 1|Withdrawal by Subject|0|||
160884822|NCT01099709|580973086|FG001|Period 1|Withdrawal by Subject|1|||
160884823|NCT01099709|580973085|FG000|Period 1|Positive cotinine test|0|||
160884824|NCT01099709|580973086|FG001|Period 1|Positive cotinine test|1|||
160884825|NCT01099709|580973085|FG000|Period 1|Adverse Event|1|||
160884826|NCT01099709|580973086|FG001|Period 1|Adverse Event|0|||
160884827|NCT00923364|580973088|FG000|Overall Study|Death|3|||
160884828|NCT00923364|580973089|FG001|Overall Study|Death|0|||
160884829|NCT00923364|580973088|FG000|Overall Study|Did not go to transplant|1|||
160771539|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
160771540|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
160771541|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
160771542|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
160771543|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
160771544|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
160771545|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
160771546|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
160771547|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
160771548|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
160771549|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
160771550|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
160771551|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
160771552|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
160771553|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
160771554|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
160771555|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
160771556|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
160771557|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
160771558|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
160771559|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
160771560|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
160771561|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
160771562|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
160771563|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
160771564|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
160771565|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
160771566|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
160771567|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
160771568|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
160771569|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
160771570|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
160771571|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
160771572|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
160771573|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
160771574|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
160771575|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
160771576|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
160771577|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
160771578|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
160771579|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
160771580|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Death|1|||
160771581|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Death|0|||
160884830|NCT00923364|580973089|FG001|Overall Study|Did not go to transplant|0|||
160884831|NCT00976508|580973091|FG000|Overall Study|Death|7|||
160540440|NCT00874120|579709297|FG001|First Intervention|Lost to Follow-up|1|||
160540441|NCT00874120|579709296|FG000|First Intervention|Protocol Violation|3|||
160540442|NCT00874120|579709297|FG001|First Intervention|Protocol Violation|0|||
160540443|NCT00874120|579709296|FG000|First Intervention|positive drug test|1|||
160540444|NCT00874120|579709297|FG001|First Intervention|positive drug test|0|||
160540445|NCT00874120|579709296|FG000|Second Intervention|Withdrawal by Subject|1|||
160540446|NCT00874120|579709297|FG001|Second Intervention|Withdrawal by Subject|0|||
160540447|NCT00874120|579709296|FG000|Second Intervention|Protocol Violation|1|||
160540448|NCT00874120|579709297|FG001|Second Intervention|Protocol Violation|0|||
160540449|NCT00105443|579709303|FG000|Double-Blind Treatment|Adverse Event|1|||
160540450|NCT00105443|579709304|FG001|Double-Blind Treatment|Adverse Event|0|||
160540451|NCT00105443|579709305|FG002|Double-Blind Treatment|Adverse Event|0|||
160540452|NCT00105443|579709306|FG003|Double-Blind Treatment|Adverse Event|0|||
160540453|NCT00105443|579709303|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
160540454|NCT00105443|579709304|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
160540455|NCT00105443|579709305|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
160540456|NCT00105443|579709306|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
160540457|NCT00105443|579709303|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
160540458|NCT00105443|579709304|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
160540459|NCT00105443|579709305|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
160540460|NCT00105443|579709306|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
160540461|NCT00105443|579709303|FG000|Double-Blind Treatment|Physician Decision|1|||
160884832|NCT00976508|580973092|FG001|Overall Study|Death|1|||
160771582|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Death|1|||
160771583|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
160771584|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
160771585|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
160771586|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
160771587|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
160771588|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
160771589|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
160771590|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
160771591|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
160771592|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
160771593|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
160771594|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
160771595|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
160771596|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
160771597|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
160771598|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
160771599|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
160771600|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
160771601|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
160771602|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
160771603|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
160771604|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Depression|0|||
160771605|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Depression|1|||
160771606|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Depression|0|||
160771607|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
160771608|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
160771609|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
160771610|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Jailed|0|||
160771611|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Jailed|1|||
160771612|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Jailed|0|||
160771613|NCT00090103|580551288|FG000|16-Week Safety Follow-up Period|Other|0|||
160771614|NCT00090103|580551289|FG001|16-Week Safety Follow-up Period|Other|1|||
160771615|NCT00090103|580551290|FG002|16-Week Safety Follow-up Period|Other|0|||
160771616|NCT00947544|580551295|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
160771617|NCT00947544|580551296|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
160771618|NCT02566005|580551298|FG000|Overall Study|vaginal bleeding|0|||
160540462|NCT00105443|579709304|FG001|Double-Blind Treatment|Physician Decision|0|||
160540463|NCT00105443|579709305|FG002|Double-Blind Treatment|Physician Decision|2|||
160540464|NCT00105443|579709306|FG003|Double-Blind Treatment|Physician Decision|0|||
160540465|NCT00105443|579709303|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
160540466|NCT00105443|579709304|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
160540467|NCT00105443|579709305|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
160540468|NCT00105443|579709306|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
160540469|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
160540470|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
160540471|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
160540472|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
160540473|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
160540474|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
160540475|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
160540476|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
160540477|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
160540478|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
160540479|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
160540480|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
160540481|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
160540482|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
160540483|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
160540484|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
160540485|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
160540486|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
160540487|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
160540488|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
160540489|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
160540490|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
160540491|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
160540492|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
160540493|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
160540494|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
160540495|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
160540496|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
160540497|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
160540498|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
160540499|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
160540500|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
160540501|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
160540502|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
160540503|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
160540504|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
160540505|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
160540506|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
160540507|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
160540508|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
160540509|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
160540510|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
160540511|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
160540512|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
160540513|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
160540514|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
160540515|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
160540516|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
160540517|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
160540518|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
160540519|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
160540520|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
160540521|NCT00105443|579709303|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
160771619|NCT02566005|580551299|FG001|Overall Study|vaginal bleeding|1|||
160771620|NCT02566005|580551298|FG000|Overall Study|received foley|8|||
160771621|NCT02566005|580551299|FG001|Overall Study|received foley|0|||
160771622|NCT02566005|580551298|FG000|Overall Study|did not receive foley|0|||
160771623|NCT02566005|580551299|FG001|Overall Study|did not receive foley|1|||
160771624|NCT02566005|580551298|FG000|Overall Study|labor after randomization|0|||
160540522|NCT00105443|579709304|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
160540523|NCT00105443|579709305|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
160540524|NCT00105443|579709306|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
160540525|NCT01157078|579709307|FG000|Overall Study|Withdrawal by Subject|12|||
160540526|NCT01157078|579709308|FG001|Overall Study|Withdrawal by Subject|14|||
160540527|NCT01157078|579709307|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
160540528|NCT01157078|579709308|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160771625|NCT02566005|580551299|FG001|Overall Study|labor after randomization|4|||
160771626|NCT02472405|580551300|FG000|Overall Study|Lost to Follow-up|9|||
160771627|NCT02472405|580551300|FG000|Overall Study|Adverse Event|1|||
160771628|NCT01431976|580551301|FG000|Overall Study|Adverse Event|6|||
160771629|NCT01431976|580551301|FG000|Overall Study|Lack of Efficacy|2|||
160771630|NCT01431976|580551301|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
160771631|NCT01431976|580551301|FG000|Overall Study|Physician Decision|1|||
160771632|NCT01431976|580551301|FG000|Overall Study|Withdrawal by Subject|1|||
160771633|NCT01134042|580551308|FG000|Overall Study|Adverse Event|3|||
160771634|NCT01134042|580551309|FG001|Overall Study|Adverse Event|7|||
160771635|NCT01134042|580551310|FG002|Overall Study|Adverse Event|2|||
160771636|NCT01134042|580551308|FG000|Overall Study|Lack of Efficacy|21|||
160771637|NCT01134042|580551309|FG001|Overall Study|Lack of Efficacy|6|||
160771638|NCT01134042|580551310|FG002|Overall Study|Lack of Efficacy|18|||
160771639|NCT01134042|580551308|FG000|Overall Study|Protocol Violation|5|||
160771640|NCT01134042|580551309|FG001|Overall Study|Protocol Violation|3|||
160771641|NCT01134042|580551310|FG002|Overall Study|Protocol Violation|5|||
160771642|NCT01134042|580551308|FG000|Overall Study|Lost to Follow-up|2|||
160771643|NCT01134042|580551309|FG001|Overall Study|Lost to Follow-up|0|||
160771644|NCT01134042|580551310|FG002|Overall Study|Lost to Follow-up|1|||
160771645|NCT01134042|580551308|FG000|Overall Study|Physician Decision|4|||
160771646|NCT01134042|580551309|FG001|Overall Study|Physician Decision|8|||
160771647|NCT01134042|580551310|FG002|Overall Study|Physician Decision|1|||
160771648|NCT01134042|580551308|FG000|Overall Study|Withdrawal by Subject|13|||
160771649|NCT01134042|580551309|FG001|Overall Study|Withdrawal by Subject|4|||
160771650|NCT01134042|580551310|FG002|Overall Study|Withdrawal by Subject|7|||
160771651|NCT03345004|580551311|FG000|Overall Study|Physician Decision|1|||
160771652|NCT03345004|580551312|FG001|Overall Study|Physician Decision|0|||
160771653|NCT03345004|580551311|FG000|Overall Study|Withdrawal by Subject|0|||
160771654|NCT03345004|580551312|FG001|Overall Study|Withdrawal by Subject|1|||
160771655|NCT01013753|580551315|FG000|Overall Study|Adverse Event|8|||
160771656|NCT01013753|580551315|FG000|Overall Study|Protocol Violation|3|||
160771657|NCT01013753|580551315|FG000|Overall Study|Lost to Follow-up|1|||
160771658|NCT01013753|580551315|FG000|Overall Study|Withdrawal by Subject|2|||
160771659|NCT01013753|580551315|FG000|Overall Study|Other|2|||
160771660|NCT01091259|580551320|FG000|Overall Study|Adverse Event|3|||
160771661|NCT01091259|580551320|FG000|Overall Study|Lack of Efficacy|2|||
160771662|NCT01541748|580551321|FG000|Overall Study|Lost to Follow-up|17|||
160771663|NCT01541748|580551321|FG000|Overall Study|Moved out of state|1|||
160771664|NCT01541748|580551321|FG000|Overall Study|Withdrawal by Subject|7|||
160771665|NCT01541748|580551321|FG000|Overall Study|Screen failure|5|||
160771666|NCT01541748|580551321|FG000|Overall Study|Did not receive study device|1|||
160771667|NCT00785629|580551324|FG000|Overall Study|Adverse Event|2|||
160771668|NCT00785629|580551325|FG001|Overall Study|Adverse Event|1|||
160771669|NCT00785629|580551326|FG002|Overall Study|Adverse Event|1|||
160771670|NCT00785629|580551327|FG003|Overall Study|Adverse Event|5|||
160771671|NCT00785629|580551324|FG000|Overall Study|Protocol Violation|1|||
160771672|NCT00785629|580551325|FG001|Overall Study|Protocol Violation|2|||
160771673|NCT00785629|580551326|FG002|Overall Study|Protocol Violation|4|||
160771674|NCT00785629|580551327|FG003|Overall Study|Protocol Violation|5|||
160771675|NCT00785629|580551324|FG000|Overall Study|administrative decision|5|||
160771676|NCT00785629|580551325|FG001|Overall Study|administrative decision|1|||
160771677|NCT00785629|580551326|FG002|Overall Study|administrative decision|3|||
160771678|NCT00785629|580551327|FG003|Overall Study|administrative decision|4|||
160771679|NCT00785629|580551324|FG000|Overall Study|Withdrawal by Subject|0|||
160771680|NCT00785629|580551325|FG001|Overall Study|Withdrawal by Subject|1|||
160771681|NCT00785629|580551326|FG002|Overall Study|Withdrawal by Subject|2|||
160771682|NCT00785629|580551327|FG003|Overall Study|Withdrawal by Subject|2|||
160771683|NCT02020941|580551328|FG000|Overall Study|Adverse Event|1|||
160771684|NCT02020941|580551328|FG000|Overall Study|Physician Decision|2|||
160771685|NCT02020941|580551328|FG000|Overall Study|Withdrawal by Subject|1|||
160771686|NCT02020941|580551328|FG000|Overall Study|Disease Progression|4|||
160771687|NCT02107898|580551331|FG000|Overall Study|Adverse Event|4|||
160771688|NCT02107898|580551332|FG001|Overall Study|Adverse Event|7|||
160771689|NCT02107898|580551331|FG000|Overall Study|Poor compliance to protocol|0|||
160771690|NCT02107898|580551332|FG001|Overall Study|Poor compliance to protocol|1|||
160771691|NCT02107898|580551331|FG000|Overall Study|Participant moved|0|||
160771692|NCT02107898|580551332|FG001|Overall Study|Participant moved|2|||
160771693|NCT02107898|580551331|FG000|Overall Study|Consent withdrawn by participant|2|||
160771694|NCT02107898|580551332|FG001|Overall Study|Consent withdrawn by participant|1|||
160884833|NCT00976508|580973091|FG000|Overall Study|Lost to Follow-up|1|||
160771695|NCT02107898|580551331|FG000|Overall Study|Randomized but not treated|0|||
160771696|NCT02107898|580551332|FG001|Overall Study|Randomized but not treated|1|||
160771697|NCT00634504|580551333|FG000|Overall Study|Protocol Violation|1|||
160771698|NCT00634504|580551334|FG001|Overall Study|Protocol Violation|0|||
160771699|NCT03329989|580551335|FG000|Overall Study|Withdrawal by Subject|9|||
160771700|NCT03329989|580551335|FG000|Overall Study|Lost to Follow-up|8|||
160771701|NCT03329989|580551335|FG000|Overall Study|Adverse Event|5|||
160771702|NCT03329989|580551335|FG000|Overall Study|Protocol Violation|1|||
160771703|NCT01283386|580551336|FG000|Overall Study|Death|2|||
160771704|NCT01283386|580551337|FG001|Overall Study|Death|0|||
160771705|NCT01283386|580551336|FG000|Overall Study|Withdrawal by Subject|2|||
160771706|NCT01283386|580551337|FG001|Overall Study|Withdrawal by Subject|1|||
160771707|NCT01283386|580551336|FG000|Overall Study|Relapse of underlying disease|1|||
160771708|NCT01283386|580551337|FG001|Overall Study|Relapse of underlying disease|3|||
160540529|NCT01157078|579709307|FG000|Overall Study|Adverse Event|6|||
160540530|NCT01157078|579709308|FG001|Overall Study|Adverse Event|6|||
160540531|NCT01157078|579709307|FG000|Overall Study|Severe non-compliance to protocol|2|||
160540532|NCT01157078|579709308|FG001|Overall Study|Severe non-compliance to protocol|4|||
160540533|NCT01157078|579709307|FG000|Overall Study|Condition under investigation worsened|0|||
160540534|NCT01157078|579709308|FG001|Overall Study|Condition under investigation worsened|1|||
160540535|NCT01157078|579709307|FG000|Overall Study|Lack of Efficacy|2|||
160540536|NCT01157078|579709308|FG001|Overall Study|Lack of Efficacy|0|||
160540537|NCT01157078|579709307|FG000|Overall Study|Study-specific withdrawal criteria|2|||
160540538|NCT01157078|579709308|FG001|Overall Study|Study-specific withdrawal criteria|2|||
160540539|NCT01157078|579709307|FG000|Overall Study|Lost to Follow-up|7|||
160540540|NCT01157078|579709308|FG001|Overall Study|Lost to Follow-up|5|||
160637088|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
160637089|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
160637090|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
160637091|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
160637092|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
160540541|NCT01157078|579709307|FG000|Overall Study|Other|2|||
160540542|NCT01157078|579709308|FG001|Overall Study|Other|4|||
160540543|NCT01623271|579709311|FG000|Overall Study|Withdrawal by Subject|2|||
160540544|NCT01611974|579709312|FG000|Overall Study|Death|10|||
160540545|NCT01611974|579709313|FG001|Overall Study|Death|12|||
160540546|NCT01611974|579709314|FG002|Overall Study|Death|10|||
160540547|NCT01611974|579709312|FG000|Overall Study|Lost to Follow-up|0|||
160540548|NCT01611974|579709313|FG001|Overall Study|Lost to Follow-up|1|||
160540549|NCT01611974|579709314|FG002|Overall Study|Lost to Follow-up|0|||
160540550|NCT01611974|579709312|FG000|Overall Study|Physician Decision|5|||
160540551|NCT01611974|579709313|FG001|Overall Study|Physician Decision|1|||
160540552|NCT01611974|579709314|FG002|Overall Study|Physician Decision|2|||
160540553|NCT01611974|579709312|FG000|Overall Study|Withdrawal by Subject|0|||
160540554|NCT01611974|579709313|FG001|Overall Study|Withdrawal by Subject|1|||
160540555|NCT01611974|579709314|FG002|Overall Study|Withdrawal by Subject|4|||
160540556|NCT00522431|579709315|FG000|Overall Study|Adverse Event|5|||
160540557|NCT00522431|579709315|FG000|Overall Study|Protocol Violation|2|||
160540558|NCT00522431|579709315|FG000|Overall Study|Withdrawal by Subject|2|||
160540559|NCT00522431|579709315|FG000|Overall Study|Subject non-compliance|1|||
160540560|NCT00522431|579709315|FG000|Overall Study|Other/unknown|1|||
160540561|NCT03246958|579709321|FG000|Overall Study|Withdrawal by Subject|0|||
160540562|NCT03246958|579709322|FG001|Overall Study|Withdrawal by Subject|1|||
160771709|NCT01283386|580551336|FG000|Overall Study|Progression of underlying disease|2|||
160540563|NCT03246958|579709323|FG002|Overall Study|Withdrawal by Subject|0|||
160540564|NCT03246958|579709324|FG003|Overall Study|Withdrawal by Subject|0|||
160540565|NCT03246958|579709325|FG004|Overall Study|Withdrawal by Subject|0|||
160540566|NCT03246958|579709326|FG005|Overall Study|Withdrawal by Subject|1|||
160540567|NCT03246958|579709327|FG006|Overall Study|Withdrawal by Subject|0|||
160540568|NCT03246958|579709321|FG000|Overall Study|Progression|13|||
160884834|NCT00976508|580973092|FG001|Overall Study|Lost to Follow-up|0|||
160884835|NCT00976508|580973091|FG000|Overall Study|Withdrawal by Subject|1|||
160454058|NCT02038777|579394024|FG002|Overall Study|Randomized but not treated|0|||
160653385|NCT04634409|580110524|FG024|Overall Study|Other - As reported by Investigator|0|||
160884836|NCT00976508|580973092|FG001|Overall Study|Withdrawal by Subject|0|||
160884837|NCT00976508|580973091|FG000|Overall Study|Disease Progression|4|||
160884838|NCT00976508|580973092|FG001|Overall Study|Disease Progression|4|||
160884839|NCT00976508|580973091|FG000|Overall Study|Subject Enrolled in Hospice|1|||
160884840|NCT00976508|580973092|FG001|Overall Study|Subject Enrolled in Hospice|0|||
160884841|NCT00976508|580973091|FG000|Overall Study|Terminated by the Sponsor|0|||
160884842|NCT00976508|580973092|FG001|Overall Study|Terminated by the Sponsor|1|||
160884843|NCT04352127|580973093|FG000|Overall Study|Unable to obtain readings|4|||
160884844|NCT04352127|580973094|FG001|Overall Study|Unable to obtain readings|1|||
160884845|NCT05954143|580973099|FG000|Overall Study|Progressive Disease|1|||
160884846|NCT05954143|580973100|FG001|Overall Study|Progressive Disease|0|||
160884847|NCT05954143|580973099|FG000|Overall Study|Physician Decision|1|||
160884848|NCT05954143|580973100|FG001|Overall Study|Physician Decision|0|||
160884849|NCT05954143|580973099|FG000|Overall Study|Study Terminated by Sponsor|2|||
160884850|NCT05954143|580973100|FG001|Overall Study|Study Terminated by Sponsor|4|||
160884851|NCT05954143|580973099|FG000|Overall Study|Death|1|||
160884852|NCT05954143|580973100|FG001|Overall Study|Death|0|||
160884853|NCT05954143|580973099|FG000|Overall Study|Withdrawal by Subject|0|||
160884854|NCT05954143|580973100|FG001|Overall Study|Withdrawal by Subject|1|||
160540569|NCT03246958|579709322|FG001|Overall Study|Progression|9|||
160540570|NCT03246958|579709323|FG002|Overall Study|Progression|3|||
160884855|NCT05954143|580973099|FG000|Overall Study|Other|1|||
160884856|NCT05954143|580973100|FG001|Overall Study|Other|0|||
160884857|NCT02496676|580973102|FG000|Phase 1 - Period 1|Adverse Event|0|||
160540571|NCT03246958|579709324|FG003|Overall Study|Progression|2|||
160884858|NCT02496676|580973103|FG001|Phase 1 - Period 1|Adverse Event|1|||
160771710|NCT01283386|580551337|FG001|Overall Study|Progression of underlying disease|7|||
160771711|NCT01283386|580551336|FG000|Overall Study|Reason not specified|1|||
160771712|NCT01283386|580551337|FG001|Overall Study|Reason not specified|0|||
160771713|NCT01283386|580551336|FG000|Overall Study|Protocol Violation|0|||
160771714|NCT01283386|580551337|FG001|Overall Study|Protocol Violation|1|||
160771715|NCT02469857|580551338|FG000|Overall Study|Death|24|||
160771716|NCT02469857|580551339|FG001|Overall Study|Death|29|||
160771717|NCT02469857|580551338|FG000|Overall Study|Discontinuation|1|||
160771718|NCT02469857|580551339|FG001|Overall Study|Discontinuation|3|||
160771719|NCT00937950|580551340|FG000|Overall Study|Withdrawal by Subject|23|||
160771720|NCT00937950|580551340|FG000|Overall Study|Migrated/moved from study area|27|||
160771721|NCT00937950|580551340|FG000|Overall Study|Lost to Follow-up|144|||
160771722|NCT00937950|580551340|FG000|Overall Study|Missing confirmed|4|||
160771723|NCT00937950|580551340|FG000|Overall Study|Other|18|||
160771724|NCT01137786|580551343|FG000|Overall Study|Lost to Follow-up|0|||
160771725|NCT01137786|580551344|FG001|Overall Study|Lost to Follow-up|2|||
160771726|NCT01137786|580551343|FG000|Overall Study|Withdrawal by Subject|1|||
160771727|NCT01137786|580551344|FG001|Overall Study|Withdrawal by Subject|1|||
160771728|NCT01531153|580551347|FG000|Overall Study|Withdrawal by Subject|10|||
160771729|NCT01531153|580551348|FG001|Overall Study|Withdrawal by Subject|9|||
160771730|NCT01531153|580551349|FG002|Overall Study|Withdrawal by Subject|15|||
160771731|NCT03483103|580551350|FG000|Pre-Treatment Phase|Other reasons|1|||
160771732|NCT03483103|580551350|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
160771733|NCT03483103|580551350|FG000|Pre-Treatment Phase|Disease-related complications|1|||
160771734|NCT03483103|580551350|FG000|Pre-Treatment Phase|Death|5|||
160771735|NCT03483103|580551350|FG000|Treatment Phase|Withdrawal by Subject|7|||
160771736|NCT03483103|580551350|FG000|Treatment Phase|Other reasons|1|||
160771737|NCT03483103|580551350|FG000|Treatment Phase|Death|23|||
160771738|NCT03483103|580551350|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
160771739|NCT03483103|580551350|FG000|Treatment Phase|Received nonconforming product|1|||
160771740|NCT06438601|580551351|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
160771741|NCT06438601|580551352|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
160771742|NCT06438601|580551351|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
160771743|NCT06438601|580551352|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
160771744|NCT01341470|580551353|FG000|Overall Study|Sponsor decision|0|||
160771745|NCT01341470|580551354|FG001|Overall Study|Sponsor decision|0|||
160771746|NCT01341470|580551355|FG002|Overall Study|Sponsor decision|1|||
160771747|NCT01341470|580551356|FG003|Overall Study|Sponsor decision|1|||
160771748|NCT01341470|580551357|FG004|Overall Study|Sponsor decision|0|||
160771749|NCT01341470|580551358|FG005|Overall Study|Sponsor decision|1|||
160771750|NCT05452239|580551359|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
160771751|NCT05452239|580551360|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
160771752|NCT05452239|580551359|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
160771753|NCT05452239|580551360|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
160771754|NCT05452239|580551359|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
160771755|NCT05452239|580551360|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
160771756|NCT05452239|580551359|FG000|Placebo-controlled Period|Randomized but not treated|2|||
160771757|NCT05452239|580551360|FG001|Placebo-controlled Period|Randomized but not treated|2|||
160771758|NCT05452239|580551359|FG000|Placebo-controlled Period|Other than specified|1|||
160771759|NCT05452239|580551360|FG001|Placebo-controlled Period|Other than specified|1|||
160771760|NCT05452239|580551359|FG000|Open-label Period|Withdrawal by Subject|2|||
160884859|NCT02496676|580973102|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
160884860|NCT02496676|580973103|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
160771761|NCT05452239|580551360|FG001|Open-label Period|Withdrawal by Subject|1|||
160771762|NCT05452239|580551359|FG000|Open-label Period|Lost to Follow-up|3|||
160771763|NCT05452239|580551360|FG001|Open-label Period|Lost to Follow-up|0|||
160771764|NCT05452239|580551359|FG000|Open-label Period|Other than specified|1|||
160771765|NCT05452239|580551360|FG001|Open-label Period|Other than specified|2|||
160771766|NCT03282097|580551361|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
160771767|NCT03282097|580551362|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
160771768|NCT03282097|580551361|FG000|Intervention Visit Complete|Patient Death|13|||
160771769|NCT03282097|580551362|FG001|Intervention Visit Complete|Patient Death|15|||
160771770|NCT03282097|580551361|FG000|Intervention Visit Complete|Caregiver Death|0|||
160771771|NCT03282097|580551362|FG001|Intervention Visit Complete|Caregiver Death|3|||
160771772|NCT03282097|580551361|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
160771773|NCT03282097|580551362|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
160771774|NCT03282097|580551361|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
160771775|NCT03282097|580551362|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
160771776|NCT03282097|580551361|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
160771777|NCT03282097|580551362|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
160771778|NCT03282097|580551361|FG000|Primary Outcome Data Collection Complete|Missing|2|||
160771779|NCT03282097|580551362|FG001|Primary Outcome Data Collection Complete|Missing|3|||
160771780|NCT03282097|580551361|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
160771781|NCT03282097|580551362|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
160771782|NCT03282097|580551361|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
160771783|NCT03282097|580551362|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
160771784|NCT03282097|580551361|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
160771785|NCT03282097|580551362|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
160771786|NCT03034967|580551366|FG000|Overall Study|Withdrawal by Subject|9|||
160771787|NCT03034967|580551367|FG001|Overall Study|Withdrawal by Subject|2|||
160771788|NCT03034967|580551368|FG002|Overall Study|Withdrawal by Subject|6|||
160771789|NCT03034967|580551369|FG003|Overall Study|Withdrawal by Subject|6|||
160771790|NCT03034967|580551370|FG004|Overall Study|Withdrawal by Subject|9|||
160771791|NCT03034967|580551371|FG005|Overall Study|Withdrawal by Subject|2|||
160771792|NCT03034967|580551366|FG000|Overall Study|Physician Decision|1|||
160771793|NCT03034967|580551367|FG001|Overall Study|Physician Decision|0|||
160771794|NCT03034967|580551368|FG002|Overall Study|Physician Decision|1|||
160771795|NCT03034967|580551369|FG003|Overall Study|Physician Decision|1|||
160771796|NCT03034967|580551370|FG004|Overall Study|Physician Decision|1|||
160771797|NCT03034967|580551371|FG005|Overall Study|Physician Decision|0|||
160771798|NCT03034967|580551366|FG000|Overall Study|Lost to Follow-up|0|||
160771799|NCT03034967|580551367|FG001|Overall Study|Lost to Follow-up|0|||
160771800|NCT03034967|580551368|FG002|Overall Study|Lost to Follow-up|0|||
160771801|NCT03034967|580551369|FG003|Overall Study|Lost to Follow-up|1|||
160771802|NCT03034967|580551370|FG004|Overall Study|Lost to Follow-up|0|||
160771803|NCT03034967|580551371|FG005|Overall Study|Lost to Follow-up|2|||
160771804|NCT03034967|580551366|FG000|Overall Study|Liver function test abnormality|0|||
160771805|NCT03034967|580551367|FG001|Overall Study|Liver function test abnormality|0|||
160771806|NCT03034967|580551368|FG002|Overall Study|Liver function test abnormality|1|||
160771807|NCT03034967|580551369|FG003|Overall Study|Liver function test abnormality|0|||
160771808|NCT03034967|580551370|FG004|Overall Study|Liver function test abnormality|0|||
160771809|NCT03034967|580551371|FG005|Overall Study|Liver function test abnormality|0|||
160771810|NCT03034967|580551366|FG000|Overall Study|Protocol Violation|1|||
160771811|NCT03034967|580551367|FG001|Overall Study|Protocol Violation|0|||
160771812|NCT03034967|580551368|FG002|Overall Study|Protocol Violation|0|||
160771813|NCT03034967|580551369|FG003|Overall Study|Protocol Violation|0|||
160771814|NCT03034967|580551370|FG004|Overall Study|Protocol Violation|0|||
160771815|NCT03034967|580551371|FG005|Overall Study|Protocol Violation|2|||
160771816|NCT03034967|580551366|FG000|Overall Study|Lack of Efficacy|0|||
160771817|NCT03034967|580551367|FG001|Overall Study|Lack of Efficacy|1|||
160771818|NCT03034967|580551368|FG002|Overall Study|Lack of Efficacy|2|||
160771819|NCT03034967|580551369|FG003|Overall Study|Lack of Efficacy|1|||
160771820|NCT03034967|580551370|FG004|Overall Study|Lack of Efficacy|1|||
160771821|NCT03034967|580551371|FG005|Overall Study|Lack of Efficacy|0|||
160771822|NCT03034967|580551366|FG000|Overall Study|Adverse Event, non-fatal|3|||
160771823|NCT03034967|580551367|FG001|Overall Study|Adverse Event, non-fatal|1|||
160771824|NCT03034967|580551368|FG002|Overall Study|Adverse Event, non-fatal|2|||
160771825|NCT03034967|580551369|FG003|Overall Study|Adverse Event, non-fatal|0|||
160771826|NCT03034967|580551370|FG004|Overall Study|Adverse Event, non-fatal|2|||
160771827|NCT03034967|580551371|FG005|Overall Study|Adverse Event, non-fatal|8|||
160771828|NCT03034967|580551366|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
160771829|NCT03034967|580551367|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
160771830|NCT03034967|580551368|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
160771831|NCT03034967|580551369|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
160771832|NCT03034967|580551370|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
160884861|NCT05442775|580973104|FG000|Overall Study|Trial terminated|61|||
160884862|NCT05442775|580973104|FG000|Overall Study|Lack of Efficacy|4|||
160884863|NCT05442775|580973104|FG000|Overall Study|Withdrawal by Subject|4|||
160884864|NCT05442775|580973104|FG000|Overall Study|Death|1|||
160884865|NCT05442775|580973104|FG000|Overall Study|Participant removed at Sponsor request|1|||
160884866|NCT03459690|580973106|FG000|Overall Study|Lost to Follow-up|0|||
160884867|NCT03459690|580973107|FG001|Overall Study|Lost to Follow-up|1|||
160884868|NCT03459690|580973106|FG000|Overall Study|Withdrawal by Subject|1|||
160884869|NCT03459690|580973107|FG001|Overall Study|Withdrawal by Subject|1|||
160884870|NCT02963831|580973109|FG000|Overall Study|Progressive Disease|3|||
160884871|NCT02963831|580973110|FG001|Overall Study|Progressive Disease|3|||
160884872|NCT02963831|580973111|FG002|Overall Study|Progressive Disease|16|||
160771833|NCT03034967|580551371|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
160771834|NCT03806296|580551372|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
160771835|NCT03806296|580551373|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
160884873|NCT02963831|580973112|FG003|Overall Study|Progressive Disease|27|||
160771836|NCT03806296|580551374|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
160771837|NCT03806296|580551372|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
160771838|NCT03806296|580551373|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
160771839|NCT03806296|580551374|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
160771840|NCT03806296|580551372|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
160771841|NCT03806296|580551373|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
160771842|NCT03806296|580551374|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
160771843|NCT01285518|580551381|FG000|Overall Study|Lost to Follow-up|0|||
160771844|NCT01285518|580551382|FG001|Overall Study|Lost to Follow-up|0|||
160771845|NCT01285518|580551383|FG002|Overall Study|Lost to Follow-up|0|||
160771846|NCT01285518|580551384|FG003|Overall Study|Lost to Follow-up|0|||
160771847|NCT01285518|580551385|FG004|Overall Study|Lost to Follow-up|0|||
160771848|NCT01285518|580551386|FG005|Overall Study|Lost to Follow-up|1|||
160771849|NCT01285518|580551387|FG006|Overall Study|Lost to Follow-up|0|||
160771850|NCT01285518|580551388|FG007|Overall Study|Lost to Follow-up|0|||
160771851|NCT00639509|580551391|FG000|Overall Study|Death|1|||
160771852|NCT02921256|580551392|FG000|Arm 1a v. Arm II|Adverse Event|6|||
160771853|NCT02921256|580551393|FG001|Arm 1a v. Arm II|Adverse Event|15|||
160771854|NCT02921256|580551394|FG002|Arm 1a v. Arm II|Adverse Event|0|||
160771855|NCT02921256|580551392|FG000|Arm 1a v. Arm II|Death|0|||
160771856|NCT02921256|580551393|FG001|Arm 1a v. Arm II|Death|2|||
160771857|NCT02921256|580551394|FG002|Arm 1a v. Arm II|Death|0|||
160771858|NCT02921256|580551392|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
160771859|NCT02921256|580551393|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
160771860|NCT02921256|580551394|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
160771861|NCT02921256|580551392|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
160771862|NCT02921256|580551393|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
160771863|NCT02921256|580551394|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
160771864|NCT02921256|580551392|FG000|Arm 1a v. Arm II|Physician Decision|1|||
160771865|NCT02921256|580551393|FG001|Arm 1a v. Arm II|Physician Decision|1|||
160771866|NCT02921256|580551394|FG002|Arm 1a v. Arm II|Physician Decision|0|||
160771867|NCT02921256|580551392|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
160771868|NCT02921256|580551393|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
160771869|NCT02921256|580551394|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
160771870|NCT02921256|580551392|FG000|Arm Ib v Arm III|Adverse Event|9|||
160771871|NCT02921256|580551393|FG001|Arm Ib v Arm III|Adverse Event|0|||
160771872|NCT02921256|580551394|FG002|Arm Ib v Arm III|Adverse Event|4|||
160771873|NCT02921256|580551392|FG000|Arm Ib v Arm III|Death|1|||
160771874|NCT02921256|580551393|FG001|Arm Ib v Arm III|Death|0|||
160771875|NCT02921256|580551394|FG002|Arm Ib v Arm III|Death|1|||
160771876|NCT02921256|580551392|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
160771877|NCT02921256|580551393|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
160771878|NCT02921256|580551394|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
160771879|NCT02921256|580551392|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
160771880|NCT02921256|580551393|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
160771881|NCT02921256|580551394|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
160771882|NCT02921256|580551392|FG000|Arm Ib v Arm III|Physician Decision|4|||
160771883|NCT02921256|580551393|FG001|Arm Ib v Arm III|Physician Decision|0|||
160771884|NCT02921256|580551394|FG002|Arm Ib v Arm III|Physician Decision|1|||
160771885|NCT02921256|580551392|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
160771886|NCT02921256|580551393|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
160771887|NCT02921256|580551394|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
160771888|NCT03507790|580551395|FG000|Overall Study|Adverse Event|0|||
160771889|NCT03507790|580551396|FG001|Overall Study|Adverse Event|11|||
160771890|NCT03507790|580551397|FG002|Overall Study|Adverse Event|3|||
160771891|NCT03507790|580551395|FG000|Overall Study|Withdrawal by Subject|2|||
160540572|NCT03246958|579709325|FG004|Overall Study|Progression|1|||
160540573|NCT03246958|579709326|FG005|Overall Study|Progression|2|||
160540574|NCT03246958|579709327|FG006|Overall Study|Progression|1|||
160540575|NCT03246958|579709321|FG000|Overall Study|Adverse Event|2|||
160540576|NCT03246958|579709322|FG001|Overall Study|Adverse Event|2|||
160540577|NCT03246958|579709323|FG002|Overall Study|Adverse Event|0|||
160540578|NCT03246958|579709324|FG003|Overall Study|Adverse Event|1|||
160540579|NCT03246958|579709325|FG004|Overall Study|Adverse Event|1|||
160540580|NCT03246958|579709326|FG005|Overall Study|Adverse Event|0|||
160540581|NCT03246958|579709327|FG006|Overall Study|Adverse Event|2|||
160540582|NCT03246958|579709321|FG000|Overall Study|Death|0|||
160540583|NCT03246958|579709322|FG001|Overall Study|Death|1|||
160771892|NCT03507790|580551396|FG001|Overall Study|Withdrawal by Subject|0|||
160771893|NCT03507790|580551397|FG002|Overall Study|Withdrawal by Subject|0|||
160771894|NCT03507790|580551395|FG000|Overall Study|Subject moved to another location|1|||
160771895|NCT03507790|580551396|FG001|Overall Study|Subject moved to another location|2|||
160771896|NCT03507790|580551397|FG002|Overall Study|Subject moved to another location|0|||
160771897|NCT03507790|580551395|FG000|Overall Study|Non-compliance with study drug|0|||
160771898|NCT03507790|580551396|FG001|Overall Study|Non-compliance with study drug|0|||
160771899|NCT03507790|580551397|FG002|Overall Study|Non-compliance with study drug|1|||
160540584|NCT03246958|579709323|FG002|Overall Study|Death|0|||
160771900|NCT03507790|580551395|FG000|Overall Study|COVID 19 Pandemic|0|||
160771901|NCT03507790|580551396|FG001|Overall Study|COVID 19 Pandemic|1|||
160771902|NCT03507790|580551397|FG002|Overall Study|COVID 19 Pandemic|0|||
160771903|NCT03507790|580551395|FG000|Overall Study|Lost to Follow-up|0|||
160771904|NCT03507790|580551396|FG001|Overall Study|Lost to Follow-up|1|||
160771905|NCT03507790|580551397|FG002|Overall Study|Lost to Follow-up|0|||
160771906|NCT03507790|580551395|FG000|Overall Study|Discontinuation of the trial at the site|1|||
160771907|NCT03507790|580551396|FG001|Overall Study|Discontinuation of the trial at the site|1|||
160771908|NCT03507790|580551397|FG002|Overall Study|Discontinuation of the trial at the site|0|||
160771909|NCT03507790|580551395|FG000|Overall Study|Randomized in error|0|||
160771910|NCT03507790|580551396|FG001|Overall Study|Randomized in error|0|||
160771911|NCT03507790|580551397|FG002|Overall Study|Randomized in error|1|||
160771912|NCT00157755|580551398|FG000|Overall Study|Death|2|||
160771913|NCT00157755|580551399|FG001|Overall Study|Death|3|||
160771914|NCT00157755|580551400|FG002|Overall Study|Death|3|||
160771915|NCT00157755|580551401|FG003|Overall Study|Death|2|||
160771916|NCT00157755|580551402|FG004|Overall Study|Death|0|||
160771917|NCT00157755|580551403|FG005|Overall Study|Death|0|||
160771918|NCT00157755|580551398|FG000|Overall Study|Lost to Follow-up|0|||
160771919|NCT00157755|580551399|FG001|Overall Study|Lost to Follow-up|0|||
160771920|NCT00157755|580551400|FG002|Overall Study|Lost to Follow-up|1|||
160771921|NCT00157755|580551401|FG003|Overall Study|Lost to Follow-up|0|||
160771922|NCT00157755|580551402|FG004|Overall Study|Lost to Follow-up|0|||
160771923|NCT00157755|580551403|FG005|Overall Study|Lost to Follow-up|0|||
160771924|NCT00157755|580551398|FG000|Overall Study|Withdrawal by Subject|0|||
160771925|NCT00157755|580551399|FG001|Overall Study|Withdrawal by Subject|0|||
160771926|NCT00157755|580551400|FG002|Overall Study|Withdrawal by Subject|1|||
160771927|NCT00157755|580551401|FG003|Overall Study|Withdrawal by Subject|1|||
160771928|NCT00157755|580551402|FG004|Overall Study|Withdrawal by Subject|1|||
160771929|NCT00157755|580551403|FG005|Overall Study|Withdrawal by Subject|2|||
160771930|NCT00157755|580551398|FG000|Overall Study|Explant due to infection|0|||
160771931|NCT00157755|580551399|FG001|Overall Study|Explant due to infection|0|||
160771932|NCT00157755|580551400|FG002|Overall Study|Explant due to infection|1|||
160771933|NCT00157755|580551401|FG003|Overall Study|Explant due to infection|0|||
160771934|NCT00157755|580551402|FG004|Overall Study|Explant due to infection|0|||
160771935|NCT00157755|580551403|FG005|Overall Study|Explant due to infection|0|||
160771936|NCT00157755|580551398|FG000|Overall Study|Medical reason|0|||
160771937|NCT00157755|580551399|FG001|Overall Study|Medical reason|0|||
160771938|NCT00157755|580551400|FG002|Overall Study|Medical reason|1|||
160771939|NCT00157755|580551401|FG003|Overall Study|Medical reason|1|||
160771940|NCT00157755|580551402|FG004|Overall Study|Medical reason|0|||
160771941|NCT00157755|580551403|FG005|Overall Study|Medical reason|0|||
160771942|NCT00157755|580551398|FG000|Overall Study|Study site closure|0|||
160771943|NCT00157755|580551399|FG001|Overall Study|Study site closure|1|||
160771944|NCT00157755|580551400|FG002|Overall Study|Study site closure|0|||
160771945|NCT00157755|580551401|FG003|Overall Study|Study site closure|0|||
160771946|NCT00157755|580551402|FG004|Overall Study|Study site closure|0|||
160771947|NCT00157755|580551403|FG005|Overall Study|Study site closure|0|||
160771948|NCT00157755|580551398|FG000|Overall Study|Subject non-compliance|0|||
160771949|NCT00157755|580551399|FG001|Overall Study|Subject non-compliance|0|||
160771950|NCT00157755|580551400|FG002|Overall Study|Subject non-compliance|0|||
160771951|NCT00157755|580551401|FG003|Overall Study|Subject non-compliance|0|||
160771952|NCT00157755|580551402|FG004|Overall Study|Subject non-compliance|0|||
160771953|NCT00157755|580551403|FG005|Overall Study|Subject non-compliance|1|||
160771954|NCT00157755|580551398|FG000|Overall Study|Study completion|0|||
160771955|NCT00157755|580551399|FG001|Overall Study|Study completion|0|||
160771956|NCT00157755|580551400|FG002|Overall Study|Study completion|0|||
160771957|NCT00157755|580551401|FG003|Overall Study|Study completion|0|||
160771958|NCT00157755|580551402|FG004|Overall Study|Study completion|1|||
160771959|NCT00157755|580551403|FG005|Overall Study|Study completion|2|||
160771960|NCT02421939|580551404|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
160771961|NCT02421939|580551405|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
160771962|NCT02421939|580551404|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
160771963|NCT02421939|580551405|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
160771964|NCT02421939|580551404|FG000|Randomization Period: Up to 3 Years|Death|38|||
160771965|NCT02421939|580551405|FG001|Randomization Period: Up to 3 Years|Death|10|||
160771966|NCT02421939|580551404|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
160771967|NCT02421939|580551405|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
160771968|NCT02421939|580551404|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
160771969|NCT02421939|580551405|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
160771970|NCT02421939|580551404|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
160771971|NCT02421939|580551405|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
160771972|NCT02421939|580551404|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
160771973|NCT02421939|580551405|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
160771974|NCT02421939|580551404|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
160771975|NCT02421939|580551405|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
160771976|NCT02421939|580551404|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
160771977|NCT02421939|580551405|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
160771978|NCT02421939|580551404|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
160771979|NCT02421939|580551405|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
160771980|NCT02421939|580551404|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
160771981|NCT02421939|580551405|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
160771982|NCT02421939|580551404|FG000|Long Term Follow up: up to 3 Years|Death|118|||
160771983|NCT02421939|580551405|FG001|Long Term Follow up: up to 3 Years|Death|65|||
160771984|NCT02421939|580551404|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
160771985|NCT02421939|580551405|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
160771986|NCT02966834|580551407|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
160771987|NCT02966834|580551408|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
160771988|NCT02966834|580551409|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
160771989|NCT02966834|580551410|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
160771990|NCT02966834|580551411|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
160771991|NCT02966834|580551412|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
160771992|NCT02966834|580551407|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
160771993|NCT02966834|580551408|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
160771994|NCT02966834|580551409|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
160771995|NCT02966834|580551410|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
160771996|NCT02966834|580551411|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
160771997|NCT02966834|580551412|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
160771998|NCT02966834|580551407|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
160771999|NCT02966834|580551408|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
160772000|NCT02966834|580551409|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
160772001|NCT02966834|580551410|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
160772002|NCT02966834|580551411|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
160772003|NCT02966834|580551412|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
160772004|NCT02966834|580551407|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
160772005|NCT02966834|580551408|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
160772006|NCT02966834|580551409|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
160772007|NCT02966834|580551410|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
160772008|NCT02966834|580551411|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
160772009|NCT02966834|580551412|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
160772010|NCT02966834|580551407|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160772011|NCT02966834|580551408|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160772012|NCT02966834|580551409|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160772013|NCT02966834|580551410|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
160772014|NCT02966834|580551411|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160772015|NCT02966834|580551412|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160772016|NCT02966834|580551407|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
160772017|NCT02966834|580551408|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
160772018|NCT02966834|580551409|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
160772019|NCT02966834|580551410|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
160772020|NCT02966834|580551411|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
160772021|NCT02966834|580551412|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
160772022|NCT00655889|580551422|FG000|Overall Study|Inadequate cell growth|1|||
160772023|NCT00655889|580551422|FG000|Overall Study|Protocol Violation|1|||
160772024|NCT01925417|580551423|FG000|Overall Study|Withdrawal by Subject|2|||
160772025|NCT01925417|580551423|FG000|Overall Study|Death|1|||
160772026|NCT04091451|580551425|FG000|Overall Study|Adverse Event|15|||
160540585|NCT03246958|579709324|FG003|Overall Study|Death|0|||
160540586|NCT03246958|579709325|FG004|Overall Study|Death|0|||
160637093|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
160637094|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
160637095|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
160637096|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
160637097|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
160637098|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
160637099|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
160637100|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
160637101|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
160637102|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
160637103|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
160637104|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
160637105|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
160637106|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
160637107|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
160637108|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
160637109|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
160637110|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
160637111|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
160637112|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
160637113|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
160637114|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
160637115|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
160637116|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
160637117|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
160637118|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637119|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637120|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637121|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637122|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
160637123|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637124|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637125|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637126|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637127|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
160637128|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637129|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637130|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637131|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637132|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637133|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637134|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637135|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637136|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
160637137|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
160637138|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
160637139|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
160637140|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
160637141|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
160637142|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
160637143|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
160637144|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
160637145|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
160637146|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
160637147|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
160637148|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
160637149|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
160637150|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
160637151|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
160637152|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
160637153|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
160637154|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
160637155|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
160772027|NCT04091451|580551426|FG001|Overall Study|Adverse Event|10|||
160772028|NCT04091451|580551425|FG000|Overall Study|Lost to Follow-up|8|||
160772029|NCT04091451|580551426|FG001|Overall Study|Lost to Follow-up|8|||
160772030|NCT04091451|580551425|FG000|Overall Study|Protocol Violation|5|||
160772031|NCT04091451|580551426|FG001|Overall Study|Protocol Violation|4|||
160772032|NCT04091451|580551425|FG000|Overall Study|Withdrawal by Subject|21|||
160772033|NCT04091451|580551426|FG001|Overall Study|Withdrawal by Subject|27|||
160772034|NCT04091451|580551425|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
160772035|NCT04091451|580551426|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
160772036|NCT04091451|580551425|FG000|Overall Study|Migrated/moved from the study area|3|||
160772037|NCT04091451|580551426|FG001|Overall Study|Migrated/moved from the study area|5|||
160772038|NCT04091451|580551425|FG000|Overall Study|Suspected HZ episode|1|||
160772039|NCT04091451|580551426|FG001|Overall Study|Suspected HZ episode|0|||
160772040|NCT00549055|580553094|FG000|Overall Study|Adverse Event|4|||
160772041|NCT00549055|580553094|FG000|Overall Study|Lack of Efficacy|18|||
160772042|NCT00549055|580553094|FG000|Overall Study|Stabilization|5|||
160772043|NCT00549055|580553094|FG000|Overall Study|Progression to fibrosis|2|||
160772044|NCT00549055|580553094|FG000|Overall Study|Decrease of size|1|||
160772045|NCT00549055|580553094|FG000|Overall Study|Active choroidal neovascula increased|1|||
160772046|NCT00549055|580553094|FG000|Overall Study|Vitreous hemorrhage|1|||
160772047|NCT00549055|580553094|FG000|Overall Study|Growth choroidal neovascularisation|1|||
160772048|NCT00549055|580553094|FG000|Overall Study|Choroidal neovascularization|1|||
160772049|NCT00549055|580553094|FG000|Overall Study|Very low visual acuity (VA)|1|||
160772050|NCT00770367|580553097|FG000|First Intervention|Withdrawal by Subject|0|||
160772051|NCT00770367|580553098|FG001|First Intervention|Withdrawal by Subject|2|||
160772052|NCT00770367|580553097|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
160772053|NCT00770367|580553098|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
160772054|NCT00770367|580553097|FG000|Second Intervention|Lost to Follow-up|2|||
160772055|NCT00770367|580553098|FG001|Second Intervention|Lost to Follow-up|0|||
160772056|NCT00435942|580553099|FG000|Overall Study|Death|17|||
160772057|NCT00435942|580553100|FG001|Overall Study|Death|10|||
160772058|NCT00435942|580553099|FG000|Overall Study|Withdrawal by Subject|2|||
160772059|NCT00435942|580553100|FG001|Overall Study|Withdrawal by Subject|0|||
160772060|NCT00435942|580553099|FG000|Overall Study|Lost to Follow-up|0|||
160772061|NCT00435942|580553100|FG001|Overall Study|Lost to Follow-up|16|||
160772062|NCT00435942|580553099|FG000|Overall Study|Conversion to Open Repair|1|||
160772063|NCT00435942|580553100|FG001|Overall Study|Conversion to Open Repair|0|||
160772064|NCT00435942|580553099|FG000|Overall Study|Technical Failure|3|||
160772065|NCT00435942|580553100|FG001|Overall Study|Technical Failure|0|||
160772066|NCT00435942|580553099|FG000|Overall Study|Other|0|||
160772067|NCT00435942|580553100|FG001|Overall Study|Other|1|||
160772068|NCT01898130|580553101|FG000|Treatment|Withdrawal by Subject|2|||
160772069|NCT01898130|580553101|FG000|Treatment|Progressive Disease|4|||
160772070|NCT01898130|580553101|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
160772071|NCT04115059|580553105|FG000|Overall Study|Withdrawal by Subject|1|||
160772072|NCT04115059|580553105|FG000|Overall Study|Lack of Efficacy|2|||
160772073|NCT04491994|580553106|FG000|Overall Study|Withdrawal by Subject|10|||
160772074|NCT04491994|580553107|FG001|Overall Study|Withdrawal by Subject|5|||
160772075|NCT04491994|580553106|FG000|Overall Study|developed fever > 3 days|4|||
160772076|NCT04491994|580553107|FG001|Overall Study|developed fever > 3 days|1|||
160772077|NCT04491994|580553106|FG000|Overall Study|Protocol Violation|11|||
160772078|NCT04491994|580553107|FG001|Overall Study|Protocol Violation|2|||
160772079|NCT04491994|580553106|FG000|Overall Study|Lost to Follow-up|4|||
160772080|NCT04491994|580553107|FG001|Overall Study|Lost to Follow-up|3|||
160772081|NCT03517137|580553115|FG000|Overall Study|Lack of Efficacy|1|||
160772082|NCT03517137|580553115|FG000|Overall Study|Adverse Event|2|||
160772083|NCT03517137|580553115|FG000|Overall Study|Withdrawal by Subject|2|||
160772084|NCT03517137|580553115|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
160772085|NCT03575364|580553116|FG000|Overall Study|Death|45|||
160772086|NCT03575364|580553116|FG000|Overall Study|Lost to Follow-up|114|||
160772087|NCT03575364|580553116|FG000|Overall Study|Withdrawal by Subject|21|||
160772088|NCT03575364|580553116|FG000|Overall Study|Physician Decision|11|||
160772089|NCT03575364|580553116|FG000|Overall Study|Subject Refused Follow-up|13|||
160772090|NCT03575364|580553116|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
160772091|NCT03575364|580553116|FG000|Overall Study|Patient moved out of the state|1|||
160637156|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637157|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637158|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637159|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637160|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637161|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637162|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637163|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637164|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637165|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637166|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
160637167|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637168|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637169|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637170|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637171|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637172|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637173|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637174|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160637175|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
160637176|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
160637177|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
160637178|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
160637179|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
160637180|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
160637181|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
160637182|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
160637183|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
160637184|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
160637185|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
160637186|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
160637187|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
160637188|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
160637189|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
160637190|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
160637191|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
160637192|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
160637193|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
160637194|NCT01915498|580053668|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
160637195|NCT01915498|580053669|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
160637196|NCT01915498|580053670|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
160637197|NCT01915498|580053671|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
160637198|NCT01915498|580053672|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
160637199|NCT01915498|580053673|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
160637200|NCT01915498|580053674|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
160637201|NCT01915498|580053675|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
160637202|NCT01915498|580053676|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
160637203|NCT01915498|580053677|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
160637204|NCT01915498|580053678|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
160637205|NCT01915498|580053679|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
160637206|NCT01915498|580053680|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
160637207|NCT01915498|580053681|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
160637208|NCT01915498|580053682|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
160637209|NCT01915498|580053683|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
160637210|NCT01915498|580053684|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
160637211|NCT01915498|580053685|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
160637212|NCT01915498|580053686|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
160637213|NCT01915498|580053668|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637214|NCT01915498|580053669|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637215|NCT01915498|580053670|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637216|NCT01915498|580053671|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637217|NCT01915498|580053672|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637218|NCT01915498|580053673|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637219|NCT01915498|580053674|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160772092|NCT03575364|580553116|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
160772093|NCT03575364|580553116|FG000|Overall Study|Patient is lost to follow up|1|||
160772094|NCT03575364|580553116|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
160772095|NCT02475213|580553117|FG000|Overall Study|Adverse Event|2|||
160772096|NCT02475213|580553118|FG001|Overall Study|Adverse Event|0|||
160772097|NCT02475213|580553119|FG002|Overall Study|Adverse Event|0|||
160772098|NCT02475213|580553120|FG003|Overall Study|Adverse Event|1|||
160772099|NCT02475213|580553121|FG004|Overall Study|Adverse Event|1|||
160772100|NCT02475213|580553122|FG005|Overall Study|Adverse Event|4|||
160772101|NCT02475213|580553123|FG006|Overall Study|Adverse Event|6|||
160772102|NCT02475213|580553124|FG007|Overall Study|Adverse Event|2|||
160772103|NCT02475213|580553117|FG000|Overall Study|Physician Decision|1|||
160772104|NCT02475213|580553118|FG001|Overall Study|Physician Decision|1|||
160772105|NCT02475213|580553119|FG002|Overall Study|Physician Decision|1|||
160772106|NCT02475213|580553120|FG003|Overall Study|Physician Decision|0|||
160772107|NCT02475213|580553121|FG004|Overall Study|Physician Decision|0|||
160772108|NCT02475213|580553122|FG005|Overall Study|Physician Decision|1|||
160772109|NCT02475213|580553123|FG006|Overall Study|Physician Decision|4|||
160772110|NCT02475213|580553124|FG007|Overall Study|Physician Decision|0|||
160772111|NCT02475213|580553117|FG000|Overall Study|Progressive Disease|3|||
160772112|NCT02475213|580553118|FG001|Overall Study|Progressive Disease|2|||
160772113|NCT02475213|580553119|FG002|Overall Study|Progressive Disease|2|||
160772114|NCT02475213|580553120|FG003|Overall Study|Progressive Disease|13|||
160772115|NCT02475213|580553121|FG004|Overall Study|Progressive Disease|15|||
160772116|NCT02475213|580553122|FG005|Overall Study|Progressive Disease|25|||
160772117|NCT02475213|580553123|FG006|Overall Study|Progressive Disease|30|||
160772118|NCT02475213|580553124|FG007|Overall Study|Progressive Disease|10|||
160772119|NCT02475213|580553117|FG000|Overall Study|Death|0|||
160772120|NCT02475213|580553118|FG001|Overall Study|Death|0|||
160772121|NCT02475213|580553119|FG002|Overall Study|Death|0|||
160772122|NCT02475213|580553120|FG003|Overall Study|Death|0|||
160772123|NCT02475213|580553121|FG004|Overall Study|Death|0|||
160772124|NCT02475213|580553122|FG005|Overall Study|Death|4|||
160772125|NCT02475213|580553123|FG006|Overall Study|Death|1|||
160772126|NCT02475213|580553124|FG007|Overall Study|Death|0|||
160772127|NCT02475213|580553117|FG000|Overall Study|Protocol Violation|0|||
160772128|NCT02475213|580553118|FG001|Overall Study|Protocol Violation|0|||
160772129|NCT02475213|580553119|FG002|Overall Study|Protocol Violation|0|||
160772130|NCT02475213|580553120|FG003|Overall Study|Protocol Violation|0|||
160772131|NCT02475213|580553121|FG004|Overall Study|Protocol Violation|1|||
160772132|NCT02475213|580553122|FG005|Overall Study|Protocol Violation|0|||
160772133|NCT02475213|580553123|FG006|Overall Study|Protocol Violation|0|||
160772134|NCT02475213|580553124|FG007|Overall Study|Protocol Violation|0|||
160772135|NCT02475213|580553117|FG000|Overall Study|Withdrawal by Subject|0|||
160772136|NCT02475213|580553118|FG001|Overall Study|Withdrawal by Subject|0|||
160772137|NCT02475213|580553119|FG002|Overall Study|Withdrawal by Subject|0|||
160772138|NCT02475213|580553120|FG003|Overall Study|Withdrawal by Subject|1|||
160772139|NCT02475213|580553121|FG004|Overall Study|Withdrawal by Subject|0|||
160772140|NCT02475213|580553122|FG005|Overall Study|Withdrawal by Subject|2|||
160772141|NCT02475213|580553123|FG006|Overall Study|Withdrawal by Subject|2|||
160772142|NCT02475213|580553124|FG007|Overall Study|Withdrawal by Subject|0|||
160772143|NCT02475213|580553117|FG000|Overall Study|Other|0|||
160772144|NCT02475213|580553118|FG001|Overall Study|Other|0|||
160772145|NCT02475213|580553119|FG002|Overall Study|Other|0|||
160772146|NCT02475213|580553120|FG003|Overall Study|Other|1|||
160540587|NCT03246958|579709326|FG005|Overall Study|Death|0|||
160540588|NCT03246958|579709327|FG006|Overall Study|Death|0|||
160540589|NCT03246958|579709321|FG000|Overall Study|Physician Decision|0|||
160540590|NCT03246958|579709322|FG001|Overall Study|Physician Decision|0|||
160772147|NCT02475213|580553121|FG004|Overall Study|Other|3|||
160772148|NCT02475213|580553122|FG005|Overall Study|Other|1|||
160772149|NCT02475213|580553123|FG006|Overall Study|Other|0|||
160772150|NCT02475213|580553124|FG007|Overall Study|Other|0|||
160772151|NCT01186770|580553125|FG000|Overall Study|Ineligibility|0|||
160772152|NCT01186770|580553126|FG001|Overall Study|Ineligibility|0|||
160772153|NCT01186770|580553127|FG002|Overall Study|Ineligibility|2|||
160772154|NCT01186770|580553128|FG003|Overall Study|Ineligibility|0|||
160772155|NCT01186770|580553125|FG000|Overall Study|Protocol Violation|7|||
160772156|NCT01186770|580553126|FG001|Overall Study|Protocol Violation|9|||
160540591|NCT03246958|579709323|FG002|Overall Study|Physician Decision|0|||
160772157|NCT01186770|580553127|FG002|Overall Study|Protocol Violation|12|||
160772158|NCT01186770|580553128|FG003|Overall Study|Protocol Violation|14|||
160772159|NCT01186770|580553125|FG000|Overall Study|Adverse Event|2|||
160540592|NCT03246958|579709324|FG003|Overall Study|Physician Decision|1|||
160772160|NCT01186770|580553126|FG001|Overall Study|Adverse Event|9|||
160772161|NCT01186770|580553127|FG002|Overall Study|Adverse Event|7|||
160772162|NCT01186770|580553128|FG003|Overall Study|Adverse Event|9|||
160772163|NCT01186770|580553125|FG000|Overall Study|Withdrawal by Subject|15|||
160772164|NCT01186770|580553126|FG001|Overall Study|Withdrawal by Subject|13|||
160772165|NCT01186770|580553127|FG002|Overall Study|Withdrawal by Subject|11|||
160772166|NCT01186770|580553128|FG003|Overall Study|Withdrawal by Subject|17|||
160772167|NCT01186770|580553125|FG000|Overall Study|Lost to Follow-up|10|||
160772168|NCT01186770|580553126|FG001|Overall Study|Lost to Follow-up|6|||
160772169|NCT01186770|580553127|FG002|Overall Study|Lost to Follow-up|14|||
160772170|NCT01186770|580553128|FG003|Overall Study|Lost to Follow-up|9|||
160772171|NCT01186770|580553125|FG000|Overall Study|Insufficient response to treatment|7|||
160772172|NCT01186770|580553126|FG001|Overall Study|Insufficient response to treatment|8|||
160772173|NCT01186770|580553127|FG002|Overall Study|Insufficient response to treatment|5|||
160772174|NCT01186770|580553128|FG003|Overall Study|Insufficient response to treatment|7|||
160772175|NCT01186770|580553125|FG000|Overall Study|Other than specified|0|||
160637220|NCT01915498|580053675|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637221|NCT01915498|580053676|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637222|NCT01915498|580053677|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637223|NCT01915498|580053678|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637224|NCT01915498|580053679|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637225|NCT01915498|580053680|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637226|NCT01915498|580053681|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637227|NCT01915498|580053682|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637228|NCT01915498|580053683|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637229|NCT01915498|580053684|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637230|NCT01915498|580053685|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160637231|NCT01915498|580053686|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
160637232|NCT01915498|580053668|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637233|NCT01915498|580053669|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637234|NCT01915498|580053670|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637235|NCT01915498|580053671|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637236|NCT01915498|580053672|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637237|NCT01915498|580053673|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637238|NCT01915498|580053674|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637239|NCT01915498|580053675|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637240|NCT01915498|580053676|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637241|NCT01915498|580053677|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637242|NCT01915498|580053678|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637243|NCT01915498|580053679|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637244|NCT01915498|580053680|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637245|NCT01915498|580053681|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637246|NCT01915498|580053682|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637247|NCT01915498|580053683|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637248|NCT01915498|580053684|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637249|NCT01915498|580053685|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
160637250|NCT01915498|580053686|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
160637251|NCT01915498|580053668|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637252|NCT01915498|580053669|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637253|NCT01915498|580053670|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637254|NCT01915498|580053671|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637255|NCT01915498|580053672|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637256|NCT01915498|580053673|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637257|NCT01915498|580053674|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637258|NCT01915498|580053675|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637259|NCT01915498|580053676|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637260|NCT01915498|580053677|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637261|NCT01915498|580053678|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160772176|NCT01186770|580553126|FG001|Overall Study|Other than specified|1|||
160772177|NCT01186770|580553127|FG002|Overall Study|Other than specified|1|||
160772178|NCT01186770|580553128|FG003|Overall Study|Other than specified|2|||
160884874|NCT02963831|580973109|FG000|Overall Study|Withdrawal by Subject|1|||
160637262|NCT01915498|580053679|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637263|NCT01915498|580053680|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637264|NCT01915498|580053681|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637265|NCT01915498|580053682|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637266|NCT01915498|580053683|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637267|NCT01915498|580053684|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160637268|NCT01915498|580053685|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160772179|NCT00505921|580553129|FG000|Overall Study|Ineligible|1|||
160884875|NCT02963831|580973110|FG001|Overall Study|Withdrawal by Subject|0|||
160884876|NCT02963831|580973111|FG002|Overall Study|Withdrawal by Subject|2|||
160884877|NCT02963831|580973112|FG003|Overall Study|Withdrawal by Subject|4|||
160884878|NCT02963831|580973109|FG000|Overall Study|Adverse Event|0|||
160884879|NCT02963831|580973110|FG001|Overall Study|Adverse Event|1|||
160884880|NCT02963831|580973111|FG002|Overall Study|Adverse Event|1|||
160884881|NCT02963831|580973112|FG003|Overall Study|Adverse Event|2|||
160884882|NCT02963831|580973109|FG000|Overall Study|Death|0|||
160884883|NCT02963831|580973110|FG001|Overall Study|Death|0|||
160884884|NCT02963831|580973111|FG002|Overall Study|Death|0|||
160884885|NCT02963831|580973112|FG003|Overall Study|Death|2|||
160884886|NCT01966432|580973113|FG000|Overall Study|Lost to Follow-up|3|||
160884887|NCT01966432|580973114|FG001|Overall Study|Lost to Follow-up|2|||
160884888|NCT01966432|580973115|FG002|Overall Study|Lost to Follow-up|5|||
160884889|NCT01966432|580973113|FG000|Overall Study|Withdrawal by Subject|1|||
160884890|NCT01966432|580973114|FG001|Overall Study|Withdrawal by Subject|3|||
160884891|NCT01966432|580973115|FG002|Overall Study|Withdrawal by Subject|0|||
160884892|NCT01966432|580973113|FG000|Overall Study|Subject Incarcerated|0|||
160884893|NCT01966432|580973114|FG001|Overall Study|Subject Incarcerated|0|||
160884894|NCT01966432|580973115|FG002|Overall Study|Subject Incarcerated|1|||
160884895|NCT01966432|580973113|FG000|Overall Study|SBIRT program ended|1|||
160884896|NCT01966432|580973114|FG001|Overall Study|SBIRT program ended|8|||
160884897|NCT01966432|580973115|FG002|Overall Study|SBIRT program ended|20|||
160884898|NCT02536404|580973120|FG000|Overall Study|Adverse Event|5|||
160884899|NCT02536404|580973121|FG001|Overall Study|Adverse Event|0|||
160884900|NCT02536404|580973120|FG000|Overall Study|Withdrawal by Subject|4|||
160884901|NCT02536404|580973121|FG001|Overall Study|Withdrawal by Subject|1|||
160884902|NCT02536404|580973120|FG000|Overall Study|Physician Decision|10|||
160884903|NCT02536404|580973121|FG001|Overall Study|Physician Decision|0|||
160884904|NCT02536404|580973120|FG000|Overall Study|Sponsor decision|1|||
160884905|NCT02536404|580973121|FG001|Overall Study|Sponsor decision|0|||
160884906|NCT02514473|580973122|FG000|Overall Study|Adverse Event|0|||
160884907|NCT02514473|580973123|FG001|Overall Study|Adverse Event|2|||
160884908|NCT02514473|580973122|FG000|Overall Study|Withdrawal by Subject|2|||
160884909|NCT02514473|580973123|FG001|Overall Study|Withdrawal by Subject|1|||
160884910|NCT02514473|580973122|FG000|Overall Study|Lost to Follow-up|0|||
160884911|NCT02514473|580973123|FG001|Overall Study|Lost to Follow-up|1|||
160884912|NCT02514473|580973122|FG000|Overall Study|Other|1|||
160884913|NCT02514473|580973123|FG001|Overall Study|Other|1|||
160884914|NCT04381988|580973124|FG000|Overall Study|The study was terminated|4|||
160884915|NCT04381988|580973125|FG001|Overall Study|The study was terminated|0|||
160884916|NCT02106923|580973126|FG000|Overall Study|Protocol Violation|0|||
160884917|NCT02106923|580973127|FG001|Overall Study|Protocol Violation|0|||
160884918|NCT02106923|580973128|FG002|Overall Study|Protocol Violation|0|||
160884919|NCT02106923|580973129|FG003|Overall Study|Protocol Violation|0|||
160884920|NCT02106923|580973130|FG004|Overall Study|Protocol Violation|0|||
160884921|NCT02106923|580973131|FG005|Overall Study|Protocol Violation|1|||
160884922|NCT03485495|580973132|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
160884923|NCT03485495|580973133|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
160884924|NCT03915860|580973134|FG000|Overall Study|Adverse Event|3|||
160884925|NCT03915860|580973134|FG000|Overall Study|Withdrawal by Subject|6|||
160884926|NCT03915860|580973134|FG000|Overall Study|Lost to Follow-up|2|||
160884927|NCT03915860|580973134|FG000|Overall Study|Other than specified|3|||
160884928|NCT01107379|580973138|FG000|Overall Study|Withdrawal by Subject|18|||
160884929|NCT01107379|580973138|FG000|Overall Study|Lost to Follow-up|3|||
160884930|NCT04559529|580973139|FG000|First Intervention (1 Day)|Adverse Event|0|||
160884931|NCT04559529|580973140|FG001|First Intervention (1 Day)|Adverse Event|0|||
160540593|NCT03246958|579709325|FG004|Overall Study|Physician Decision|0|||
160540594|NCT03246958|579709326|FG005|Overall Study|Physician Decision|0|||
160540595|NCT03246958|579709327|FG006|Overall Study|Physician Decision|0|||
160884932|NCT04559529|580973141|FG002|First Intervention (1 Day)|Adverse Event|0|||
160884933|NCT04559529|580973142|FG003|First Intervention (1 Day)|Adverse Event|1|||
160884934|NCT04559529|580973139|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
160884935|NCT04559529|580973140|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
160884936|NCT04559529|580973141|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
160884937|NCT04559529|580973142|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
160884938|NCT04559529|580973139|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
160884939|NCT04559529|580973140|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
160884940|NCT04559529|580973141|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
160884941|NCT04559529|580973142|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
160884942|NCT01009281|580973143|FG000|Overall Study|Administrative problems|7|||
160884943|NCT00924170|580973144|FG000|Overall Study|Refused further treatment|0|||
160884944|NCT00924170|580973145|FG001|Overall Study|Refused further treatment|1|||
160884945|NCT00924170|580973144|FG000|Overall Study|Physician Decision|0|||
160884946|NCT00924170|580973145|FG001|Overall Study|Physician Decision|1|||
160540596|NCT03246958|579709321|FG000|Overall Study|Never start treatment|1|||
160540597|NCT03246958|579709322|FG001|Overall Study|Never start treatment|0|||
160540598|NCT03246958|579709323|FG002|Overall Study|Never start treatment|0|||
160540599|NCT03246958|579709324|FG003|Overall Study|Never start treatment|0|||
160540600|NCT03246958|579709325|FG004|Overall Study|Never start treatment|0|||
160540601|NCT03246958|579709326|FG005|Overall Study|Never start treatment|0|||
160540602|NCT03246958|579709327|FG006|Overall Study|Never start treatment|0|||
160540603|NCT03246958|579709321|FG000|Overall Study|Over enrollment|0|||
160540604|NCT03246958|579709322|FG001|Overall Study|Over enrollment|2|||
160540605|NCT03246958|579709323|FG002|Overall Study|Over enrollment|0|||
160540606|NCT03246958|579709324|FG003|Overall Study|Over enrollment|0|||
160540607|NCT03246958|579709325|FG004|Overall Study|Over enrollment|0|||
160540608|NCT03246958|579709326|FG005|Overall Study|Over enrollment|0|||
160540609|NCT03246958|579709327|FG006|Overall Study|Over enrollment|0|||
160540610|NCT01650636|579709330|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
160540611|NCT01650636|579709331|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
160540612|NCT01650636|579709330|FG000|Washout up to 5 Months|Physician Decision|2|||
160540613|NCT01650636|579709331|FG001|Washout up to 5 Months|Physician Decision|2|||
160540614|NCT01650636|579709330|FG000|Washout up to 5 Months|Death|1|||
160540615|NCT01650636|579709331|FG001|Washout up to 5 Months|Death|0|||
160540616|NCT01650636|579709330|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
160540617|NCT01650636|579709331|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
160540618|NCT01650636|579709330|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
160540619|NCT01650636|579709331|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
160540620|NCT01650636|579709330|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
160540621|NCT01650636|579709331|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
160540622|NCT01560780|579709332|FG000|Overall Study|Death|2|||
160540623|NCT01560780|579709333|FG001|Overall Study|Death|1|||
160540624|NCT01560780|579709332|FG000|Overall Study|Patient Preference|11|||
160540625|NCT01560780|579709333|FG001|Overall Study|Patient Preference|11|||
160540626|NCT01118351|579709334|FG000|Overall Study|Adverse Event|3|||
160540627|NCT01118351|579709334|FG000|Overall Study|Withdrawal by Subject|1|||
160540628|NCT00811135|579709335|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
160540629|NCT00811135|579709335|FG000|Overall Study|Death|3|||
160540630|NCT00811135|579709335|FG000|Overall Study|Protocol Violation|2|||
160540631|NCT00811135|579709335|FG000|Overall Study|Violation of Selection Criteria|1|||
160540632|NCT00811135|579709335|FG000|Overall Study|Refused Treatment|1|||
160540633|NCT00811135|579709335|FG000|Overall Study|Withdrawal by Subject|3|||
160540634|NCT00811135|579709335|FG000|Overall Study|Administrative/Other Unspecified|11|||
160540635|NCT00811135|579709335|FG000|Overall Study|Ongoing|59|||
160540636|NCT02192827|579709337|FG000|Overall Study|Lost to Follow-up|25|||
160540637|NCT02192827|579709338|FG001|Overall Study|Lost to Follow-up|27|||
160540638|NCT02192827|579709337|FG000|Overall Study|Given additional steroids with admission|13|||
160540639|NCT02192827|579709338|FG001|Overall Study|Given additional steroids with admission|11|||
160540640|NCT01500278|579709340|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
160540641|NCT01500278|579709341|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
160540642|NCT01500278|579709340|FG000|Week 0 - Week 12|Protocol Violation|10|||
160540643|NCT01500278|579709341|FG001|Week 0 - Week 12|Protocol Violation|16|||
160772180|NCT00505921|580553129|FG000|Overall Study|Failed to Mobilize|8|||
160772181|NCT02567188|580553130|FG000|Overall Study|Death|10|||
160772182|NCT02567188|580553130|FG000|Overall Study|Terminated Mircera Treatment|9|||
160772183|NCT02567188|580553130|FG000|Overall Study|Lost to Follow-up|5|||
160772184|NCT02567188|580553130|FG000|Overall Study|Adverse Event|1|||
160772185|NCT02567188|580553130|FG000|Overall Study|Withdrawal by Subject|1|||
160772186|NCT02567188|580553130|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
160772187|NCT02567188|580553130|FG000|Overall Study|Moved and Changed Clinic|1|||
160772188|NCT02567188|580553130|FG000|Overall Study|Started Hemodialysis|2|||
160772189|NCT02567188|580553130|FG000|Overall Study|Protocol Violation|5|||
160772190|NCT02441283|580553131|FG000|Overall Study|Withdrew consent|15|||
160772191|NCT02441283|580553131|FG000|Overall Study|Lost to Follow-up|42|||
160772192|NCT02441283|580553131|FG000|Overall Study|Death|1|||
160772193|NCT02441283|580553131|FG000|Overall Study|Other, not specified|32|||
160772194|NCT01033136|580553132|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
160772195|NCT01033136|580553133|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
160772196|NCT00630292|580553134|FG000|Overall Study|Withdrawal by Subject|1|||
160772197|NCT05383209|580553135|FG000|Overall Study|Adverse Event: Non-ocular|0|||
160772198|NCT05383209|580553136|FG001|Overall Study|Adverse Event: Non-ocular|1|||
160772199|NCT05383209|580553137|FG002|Overall Study|Adverse Event: Non-ocular|0|||
160772200|NCT05383209|580553135|FG000|Overall Study|Lost to Follow-up|2|||
160772201|NCT05383209|580553136|FG001|Overall Study|Lost to Follow-up|1|||
160772202|NCT05383209|580553137|FG002|Overall Study|Lost to Follow-up|4|||
160772203|NCT05383209|580553135|FG000|Overall Study|Withdrawal by Subject|2|||
160772204|NCT05383209|580553136|FG001|Overall Study|Withdrawal by Subject|0|||
160772205|NCT05383209|580553137|FG002|Overall Study|Withdrawal by Subject|1|||
160772206|NCT05383209|580553135|FG000|Overall Study|Death|1|||
160772207|NCT05383209|580553136|FG001|Overall Study|Death|0|||
160772208|NCT05383209|580553137|FG002|Overall Study|Death|0|||
160772209|NCT05383209|580553135|FG000|Overall Study|Other|0|||
160772210|NCT05383209|580553136|FG001|Overall Study|Other|1|||
160772211|NCT05383209|580553137|FG002|Overall Study|Other|0|||
160772212|NCT00717886|580553139|FG000|Overall Study|Withdrawal by Subject|3|||
160772213|NCT00717886|580553139|FG000|Overall Study|Treatment Failure|1|||
160772214|NCT01553851|580553140|FG000|Overall Study|Adverse Event|2|||
160772215|NCT01553851|580553140|FG000|Overall Study|constipation|1|||
160884947|NCT00924170|580973144|FG000|Overall Study|Progressive disease|3|||
160772216|NCT02472353|580553143|FG000|Overall Study|Lost to Follow-up|1|||
160772217|NCT02472353|580553144|FG001|Overall Study|Lost to Follow-up|1|||
160772218|NCT02472353|580553143|FG000|Overall Study|Withdrawal by Subject|2|||
160772219|NCT02472353|580553144|FG001|Overall Study|Withdrawal by Subject|1|||
160772220|NCT02472353|580553143|FG000|Overall Study|Study Termination|1|||
160772221|NCT02472353|580553144|FG001|Overall Study|Study Termination|4|||
160772222|NCT02101294|580553145|FG000|Overall Study|Withdrawal by Subject|5|||
160772223|NCT02101294|580553145|FG000|Overall Study|Lost to Follow-up|6|||
160772224|NCT00797563|580553146|FG000|Overall Study|Adverse Event|1|||
160772225|NCT03416179|580553147|FG000|Overall Study|Death|90|||
160772226|NCT03416179|580553148|FG001|Overall Study|Death|87|||
160772227|NCT03416179|580553149|FG002|Overall Study|Death|117|||
160772228|NCT03416179|580553150|FG003|Overall Study|Death|113|||
160772229|NCT03416179|580553147|FG000|Overall Study|Withdrawal by Subject|15|||
160772230|NCT03416179|580553148|FG001|Overall Study|Withdrawal by Subject|20|||
160772231|NCT03416179|580553149|FG002|Overall Study|Withdrawal by Subject|6|||
160772232|NCT03416179|580553150|FG003|Overall Study|Withdrawal by Subject|9|||
160772233|NCT03416179|580553147|FG000|Overall Study|Lost to Follow-up|1|||
160772234|NCT03416179|580553148|FG001|Overall Study|Lost to Follow-up|1|||
160772235|NCT03416179|580553149|FG002|Overall Study|Lost to Follow-up|0|||
160772236|NCT03416179|580553150|FG003|Overall Study|Lost to Follow-up|3|||
160772237|NCT03416179|580553147|FG000|Overall Study|Study participation terminated by Sponsor|93|||
160772238|NCT03416179|580553148|FG001|Overall Study|Study participation terminated by Sponsor|91|||
160772239|NCT03416179|580553149|FG002|Overall Study|Study participation terminated by Sponsor|26|||
160772240|NCT03416179|580553150|FG003|Overall Study|Study participation terminated by Sponsor|31|||
160772241|NCT03416179|580553147|FG000|Overall Study|Other|2|||
160772242|NCT03416179|580553148|FG001|Overall Study|Other|3|||
160772243|NCT03416179|580553149|FG002|Overall Study|Other|1|||
160772244|NCT03416179|580553150|FG003|Overall Study|Other|0|||
160772245|NCT02313155|580553155|FG000|Overall Study|Lost to Follow-up|0|||
160772246|NCT02313155|580553156|FG001|Overall Study|Lost to Follow-up|1|||
160772247|NCT03822416|580553158|FG000|Overall Study|Lost to Follow-up|1|||
160772248|NCT03822416|580553159|FG001|Overall Study|Lost to Follow-up|0|||
160772249|NCT03822416|580553158|FG000|Overall Study|Withdrawal by Subject|0|||
160772250|NCT03822416|580553159|FG001|Overall Study|Withdrawal by Subject|1|||
160772251|NCT04666298|580553160|FG000|Overall Study|Subject decision|1|||
160772252|NCT04666298|580553161|FG001|Overall Study|Subject decision|0|||
160772253|NCT04666298|580553162|FG002|Overall Study|Subject decision|0|||
160772254|NCT04666298|580553163|FG003|Overall Study|Subject decision|2|||
160772255|NCT04666298|580553160|FG000|Overall Study|Death|1|||
160772256|NCT04666298|580553161|FG001|Overall Study|Death|0|||
160884948|NCT00924170|580973145|FG001|Overall Study|Progressive disease|6|||
160884949|NCT00924170|580973144|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
160884950|NCT00924170|580973145|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
160884951|NCT00924170|580973144|FG000|Overall Study|Death|1|||
160772257|NCT04666298|580553162|FG002|Overall Study|Death|0|||
160772258|NCT04666298|580553163|FG003|Overall Study|Death|0|||
160772259|NCT04666298|580553160|FG000|Overall Study|Lost to Follow-up|0|||
160772260|NCT04666298|580553161|FG001|Overall Study|Lost to Follow-up|0|||
160772261|NCT04666298|580553162|FG002|Overall Study|Lost to Follow-up|0|||
160772262|NCT04666298|580553163|FG003|Overall Study|Lost to Follow-up|1|||
160772263|NCT04666298|580553160|FG000|Overall Study|Physician Decision|0|||
160772264|NCT04666298|580553161|FG001|Overall Study|Physician Decision|0|||
160772265|NCT04666298|580553162|FG002|Overall Study|Physician Decision|0|||
160772266|NCT04666298|580553163|FG003|Overall Study|Physician Decision|1|||
160772267|NCT04666298|580553160|FG000|Overall Study|Protocol deviation|0|||
160772268|NCT04666298|580553161|FG001|Overall Study|Protocol deviation|0|||
160772269|NCT04666298|580553162|FG002|Overall Study|Protocol deviation|1|||
160772270|NCT04666298|580553163|FG003|Overall Study|Protocol deviation|0|||
160772271|NCT02178956|580553164|FG000|Overall Study|Lost to Follow-up|4|||
160772272|NCT02178956|580553165|FG001|Overall Study|Lost to Follow-up|4|||
160772273|NCT02178956|580553164|FG000|Overall Study|Sponsor terminated study|49|||
160772274|NCT02178956|580553165|FG001|Overall Study|Sponsor terminated study|58|||
160772275|NCT02178956|580553164|FG000|Overall Study|Withdrawal by Subject|15|||
160772276|NCT02178956|580553165|FG001|Overall Study|Withdrawal by Subject|11|||
160772277|NCT02178956|580553164|FG000|Overall Study|Various Reasons|3|||
160772278|NCT02178956|580553165|FG001|Overall Study|Various Reasons|5|||
160772279|NCT02709369|580553168|FG000|Overall Study|Lost to Follow-up|15|||
160772280|NCT02709369|580553168|FG000|Overall Study|Withdrawal by Subject|10|||
160772281|NCT02709369|580553168|FG000|Overall Study|Did not received intervention|2|||
160772282|NCT01104766|580553170|FG000|Overall Study|Did not meet inc/exc criteria|1|||
160772283|NCT01104766|580553171|FG001|Overall Study|Did not meet inc/exc criteria|0|||
160772284|NCT01104766|580553172|FG002|Overall Study|Did not meet inc/exc criteria|0|||
160772285|NCT01104766|580553173|FG003|Overall Study|Did not meet inc/exc criteria|0|||
160772286|NCT01104766|580553170|FG000|Overall Study|Adverse Event|17|||
160772287|NCT01104766|580553171|FG001|Overall Study|Adverse Event|15|||
160772288|NCT01104766|580553172|FG002|Overall Study|Adverse Event|20|||
160772289|NCT01104766|580553173|FG003|Overall Study|Adverse Event|14|||
160772290|NCT01104766|580553170|FG000|Overall Study|Lack of Efficacy|20|||
160772291|NCT01104766|580553171|FG001|Overall Study|Lack of Efficacy|15|||
160772292|NCT01104766|580553172|FG002|Overall Study|Lack of Efficacy|14|||
160772293|NCT01104766|580553173|FG003|Overall Study|Lack of Efficacy|8|||
160772294|NCT01104766|580553170|FG000|Overall Study|Protocol Violation|2|||
160772295|NCT01104766|580553171|FG001|Overall Study|Protocol Violation|0|||
160772296|NCT01104766|580553172|FG002|Overall Study|Protocol Violation|0|||
160772297|NCT01104766|580553173|FG003|Overall Study|Protocol Violation|0|||
160772298|NCT01104766|580553170|FG000|Overall Study|Withdrawal by Subject|17|||
160772299|NCT01104766|580553171|FG001|Overall Study|Withdrawal by Subject|19|||
160772300|NCT01104766|580553172|FG002|Overall Study|Withdrawal by Subject|25|||
160772301|NCT01104766|580553173|FG003|Overall Study|Withdrawal by Subject|15|||
160772302|NCT01104766|580553170|FG000|Overall Study|Lost to Follow-up|1|||
160772303|NCT01104766|580553171|FG001|Overall Study|Lost to Follow-up|2|||
160772304|NCT01104766|580553172|FG002|Overall Study|Lost to Follow-up|1|||
160772305|NCT01104766|580553173|FG003|Overall Study|Lost to Follow-up|1|||
160772306|NCT03965923|580553177|FG000|Overall Study|Withdrawal by Subject|1|||
160772307|NCT03965923|580553178|FG001|Overall Study|Withdrawal by Subject|2|||
160772308|NCT03965923|580553179|FG002|Overall Study|Withdrawal by Subject|3|||
160772309|NCT03965923|580553180|FG003|Overall Study|Withdrawal by Subject|1|||
160884952|NCT00924170|580973145|FG001|Overall Study|Death|0|||
160884953|NCT00899392|580973148|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
160884954|NCT00899392|580973149|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
160884955|NCT02486718|580973152|FG000|Enrollment Phase|Death|19|||
160884956|NCT02486718|580973153|FG001|Enrollment Phase|Death|0|||
160884957|NCT02486718|580973154|FG002|Enrollment Phase|Death|0|||
160884958|NCT02486718|580973152|FG000|Enrollment Phase|Symptomatic deterioration|1|||
160884959|NCT02486718|580973153|FG001|Enrollment Phase|Symptomatic deterioration|0|||
160884960|NCT02486718|580973154|FG002|Enrollment Phase|Symptomatic deterioration|0|||
160884961|NCT02486718|580973152|FG000|Enrollment Phase|Withdrawal by Subject|86|||
160884962|NCT02486718|580973153|FG001|Enrollment Phase|Withdrawal by Subject|0|||
160884963|NCT02486718|580973154|FG002|Enrollment Phase|Withdrawal by Subject|0|||
160884964|NCT02486718|580973152|FG000|Enrollment Phase|Protocol Violation|18|||
160884965|NCT02486718|580973153|FG001|Enrollment Phase|Protocol Violation|0|||
160884966|NCT02486718|580973154|FG002|Enrollment Phase|Protocol Violation|0|||
160884967|NCT02486718|580973152|FG000|Enrollment Phase|Physician Decision|18|||
160884968|NCT02486718|580973153|FG001|Enrollment Phase|Physician Decision|0|||
160884969|NCT02486718|580973154|FG002|Enrollment Phase|Physician Decision|0|||
160884970|NCT02486718|580973152|FG000|Enrollment Phase|Reason not provided|41|||
160884971|NCT02486718|580973153|FG001|Enrollment Phase|Reason not provided|0|||
160884972|NCT02486718|580973154|FG002|Enrollment Phase|Reason not provided|0|||
160884973|NCT02486718|580973152|FG000|Enrollment Phase|Disease relapse|54|||
160884974|NCT02486718|580973153|FG001|Enrollment Phase|Disease relapse|0|||
160884975|NCT02486718|580973154|FG002|Enrollment Phase|Disease relapse|0|||
160884976|NCT02486718|580973152|FG000|Enrollment Phase|Lost to Follow-up|4|||
160884977|NCT02486718|580973153|FG001|Enrollment Phase|Lost to Follow-up|0|||
160884978|NCT02486718|580973154|FG002|Enrollment Phase|Lost to Follow-up|0|||
160772310|NCT03965923|580553181|FG004|Overall Study|Withdrawal by Subject|2|||
160772311|NCT03965923|580553182|FG005|Overall Study|Withdrawal by Subject|0|||
160772312|NCT03965923|580553183|FG006|Overall Study|Withdrawal by Subject|4|||
160772313|NCT03965923|580553184|FG007|Overall Study|Withdrawal by Subject|3|||
160884979|NCT02486718|580973152|FG000|Enrollment Phase|Adverse Event|34|||
160884980|NCT02486718|580973153|FG001|Enrollment Phase|Adverse Event|0|||
160884981|NCT02486718|580973154|FG002|Enrollment Phase|Adverse Event|0|||
160884982|NCT02486718|580973152|FG000|Randomized Phase|Withdrawal by Subject|0|||
160884983|NCT02486718|580973153|FG001|Randomized Phase|Withdrawal by Subject|44|||
160884984|NCT02486718|580973154|FG002|Randomized Phase|Withdrawal by Subject|47|||
160884985|NCT02486718|580973152|FG000|Randomized Phase|Protocol Violation|0|||
160884986|NCT02486718|580973153|FG001|Randomized Phase|Protocol Violation|2|||
160884987|NCT02486718|580973154|FG002|Randomized Phase|Protocol Violation|0|||
160884988|NCT02486718|580973152|FG000|Randomized Phase|Physician Decision|0|||
160884989|NCT02486718|580973153|FG001|Randomized Phase|Physician Decision|0|||
160772314|NCT03965923|580553185|FG008|Overall Study|Withdrawal by Subject|4|||
160772315|NCT03965923|580553186|FG009|Overall Study|Withdrawal by Subject|0|||
160772316|NCT03965923|580553187|FG010|Overall Study|Withdrawal by Subject|2|||
160772317|NCT03965923|580553188|FG011|Overall Study|Withdrawal by Subject|0|||
160772318|NCT03965923|580553177|FG000|Overall Study|Lost to Follow-up|2|||
160772319|NCT03965923|580553178|FG001|Overall Study|Lost to Follow-up|1|||
160772320|NCT03965923|580553179|FG002|Overall Study|Lost to Follow-up|1|||
160772321|NCT03965923|580553180|FG003|Overall Study|Lost to Follow-up|0|||
160772322|NCT03965923|580553181|FG004|Overall Study|Lost to Follow-up|2|||
160772323|NCT03965923|580553182|FG005|Overall Study|Lost to Follow-up|1|||
160772324|NCT03965923|580553183|FG006|Overall Study|Lost to Follow-up|2|||
160772325|NCT03965923|580553184|FG007|Overall Study|Lost to Follow-up|1|||
160772326|NCT03965923|580553185|FG008|Overall Study|Lost to Follow-up|0|||
160772327|NCT03965923|580553186|FG009|Overall Study|Lost to Follow-up|2|||
160772328|NCT03965923|580553187|FG010|Overall Study|Lost to Follow-up|0|||
160772329|NCT03965923|580553188|FG011|Overall Study|Lost to Follow-up|0|||
160772330|NCT03965923|580553177|FG000|Overall Study|Death|0|||
160772331|NCT03965923|580553178|FG001|Overall Study|Death|0|||
160772332|NCT03965923|580553179|FG002|Overall Study|Death|0|||
160772333|NCT03965923|580553180|FG003|Overall Study|Death|0|||
160772334|NCT03965923|580553181|FG004|Overall Study|Death|0|||
160772335|NCT03965923|580553182|FG005|Overall Study|Death|0|||
160772336|NCT03965923|580553183|FG006|Overall Study|Death|0|||
160772337|NCT03965923|580553184|FG007|Overall Study|Death|1|||
160772338|NCT03965923|580553185|FG008|Overall Study|Death|4|||
160772339|NCT03965923|580553186|FG009|Overall Study|Death|0|||
160772340|NCT03965923|580553187|FG010|Overall Study|Death|4|||
160772341|NCT03965923|580553188|FG011|Overall Study|Death|0|||
160772342|NCT03965923|580553177|FG000|Overall Study|Other reason|0|||
160772343|NCT03965923|580553178|FG001|Overall Study|Other reason|0|||
160772344|NCT03965923|580553179|FG002|Overall Study|Other reason|0|||
160772345|NCT03965923|580553180|FG003|Overall Study|Other reason|1|||
160772346|NCT03965923|580553181|FG004|Overall Study|Other reason|0|||
160772347|NCT03965923|580553182|FG005|Overall Study|Other reason|0|||
160772348|NCT03965923|580553183|FG006|Overall Study|Other reason|0|||
160772349|NCT03965923|580553184|FG007|Overall Study|Other reason|0|||
160772350|NCT03965923|580553185|FG008|Overall Study|Other reason|0|||
160772351|NCT03965923|580553186|FG009|Overall Study|Other reason|0|||
160772352|NCT03965923|580553187|FG010|Overall Study|Other reason|2|||
160772353|NCT03965923|580553188|FG011|Overall Study|Other reason|0|||
160772354|NCT02755090|580553189|FG000|Overall Study|equipment malfunction|1|||
160772355|NCT02755090|580553190|FG001|Overall Study|equipment malfunction|0|||
160772356|NCT00207740|580553191|FG000|Overall Study|Adverse Event|4|||
160772357|NCT00207740|580553192|FG001|Overall Study|Adverse Event|14|||
160772358|NCT00207740|580553193|FG002|Overall Study|Adverse Event|14|||
160884990|NCT02486718|580973154|FG002|Randomized Phase|Physician Decision|3|||
160884991|NCT02486718|580973152|FG000|Randomized Phase|Lost to Follow-up|0|||
160884992|NCT02486718|580973153|FG001|Randomized Phase|Lost to Follow-up|5|||
160884993|NCT02486718|580973154|FG002|Randomized Phase|Lost to Follow-up|11|||
160884994|NCT02486718|580973152|FG000|Randomized Phase|Disease Relapse|0|||
160540644|NCT01500278|579709340|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
160772359|NCT00207740|580553194|FG003|Overall Study|Adverse Event|11|||
160772360|NCT00207740|580553191|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160772361|NCT00207740|580553192|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160772362|NCT00207740|580553193|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
160772363|NCT00207740|580553194|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
160772364|NCT00207740|580553191|FG000|Overall Study|Lost to Follow-up|0|||
160772365|NCT00207740|580553192|FG001|Overall Study|Lost to Follow-up|2|||
160772366|NCT00207740|580553193|FG002|Overall Study|Lost to Follow-up|1|||
160772367|NCT00207740|580553194|FG003|Overall Study|Lost to Follow-up|1|||
160772368|NCT00207740|580553191|FG000|Overall Study|Death|0|||
160772369|NCT00207740|580553192|FG001|Overall Study|Death|0|||
160772370|NCT00207740|580553193|FG002|Overall Study|Death|0|||
160772371|NCT00207740|580553194|FG003|Overall Study|Death|1|||
160772372|NCT00207740|580553191|FG000|Overall Study|Sponsor Directive|22|||
160772373|NCT00207740|580553192|FG001|Overall Study|Sponsor Directive|15|||
160772374|NCT00207740|580553193|FG002|Overall Study|Sponsor Directive|16|||
160772375|NCT00207740|580553194|FG003|Overall Study|Sponsor Directive|21|||
160772376|NCT00207740|580553191|FG000|Overall Study|Other|2|||
160772377|NCT00207740|580553192|FG001|Overall Study|Other|10|||
160772378|NCT00207740|580553193|FG002|Overall Study|Other|7|||
160772379|NCT00207740|580553194|FG003|Overall Study|Other|5|||
160772380|NCT02763566|580553200|FG000|Overall Study|Lost to Follow-up|1|||
160772381|NCT02763566|580553201|FG001|Overall Study|Lost to Follow-up|4|||
160772382|NCT02763566|580553202|FG002|Overall Study|Lost to Follow-up|0|||
160772383|NCT02763566|580553203|FG003|Overall Study|Lost to Follow-up|1|||
160772384|NCT02763566|580553200|FG000|Overall Study|On study treatment at study conclusion|114|||
160772385|NCT02763566|580553201|FG001|Overall Study|On study treatment at study conclusion|34|||
160772386|NCT02763566|580553202|FG002|Overall Study|On study treatment at study conclusion|54|||
160772387|NCT02763566|580553203|FG003|Overall Study|On study treatment at study conclusion|13|||
160772388|NCT02763566|580553200|FG000|Overall Study|Withdrawal by Subject|3|||
160772389|NCT02763566|580553201|FG001|Overall Study|Withdrawal by Subject|1|||
160772390|NCT02763566|580553202|FG002|Overall Study|Withdrawal by Subject|0|||
160772391|NCT02763566|580553203|FG003|Overall Study|Withdrawal by Subject|0|||
160772392|NCT04896385|580553204|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
160772393|NCT04896385|580553205|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
160772394|NCT04896385|580553206|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
160772395|NCT04896385|580553207|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
160772396|NCT04896385|580553204|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
160772397|NCT04896385|580553205|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
160772398|NCT04896385|580553206|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
160772399|NCT04896385|580553207|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
160772400|NCT04896385|580553204|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
160772401|NCT04896385|580553205|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
160772402|NCT04896385|580553206|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
160772403|NCT04896385|580553207|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
160772404|NCT04896385|580553204|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
160772405|NCT04896385|580553205|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
160772406|NCT04896385|580553206|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
160772407|NCT04896385|580553207|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
160772408|NCT04896385|580553204|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
160772409|NCT04896385|580553205|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
160772410|NCT04896385|580553206|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
160772411|NCT04896385|580553207|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
160772412|NCT04896385|580553204|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
160772413|NCT04896385|580553205|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
160772414|NCT04896385|580553206|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
160772415|NCT04896385|580553207|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
160772416|NCT05291689|580553210|FG000|Overall Study|Adverse Event|3|||
160772417|NCT05291689|580553210|FG000|Overall Study|Lack of Efficacy|10|||
160772418|NCT05291689|580553210|FG000|Overall Study|Withdrawal by Subject|4|||
160772419|NCT01931098|580553211|FG000|Overall Study|Withdrawal by Subject|0|||
160772420|NCT01931098|580553212|FG001|Overall Study|Withdrawal by Subject|1|||
160772421|NCT01931098|580553211|FG000|Overall Study|Enrolled in different protocol|0|||
160772422|NCT01931098|580553212|FG001|Overall Study|Enrolled in different protocol|1|||
160772423|NCT01931098|580553211|FG000|Overall Study|Unable to begin trmt:active infection|0|||
160772424|NCT01931098|580553212|FG001|Overall Study|Unable to begin trmt:active infection|1|||
160772425|NCT01931098|580553211|FG000|Overall Study|Refused further treatment|0|||
160772426|NCT01931098|580553212|FG001|Overall Study|Refused further treatment|1|||
160772427|NCT02612155|580553213|FG000|Overall Study|Death|1|||
160772428|NCT02612155|580553214|FG001|Overall Study|Death|1|||
160772429|NCT02612155|580553213|FG000|Overall Study|Lost to Follow-up|2|||
160772430|NCT02612155|580553214|FG001|Overall Study|Lost to Follow-up|2|||
160772431|NCT04235374|580553215|FG000|Overall Study|Death|91|||
160772432|NCT04235374|580553216|FG001|Overall Study|Death|91|||
160772433|NCT04235374|580553215|FG000|Overall Study|Refused|2|||
160772434|NCT04235374|580553216|FG001|Overall Study|Refused|2|||
160772435|NCT04235374|580553215|FG000|Overall Study|Unavailable|12|||
160772436|NCT04235374|580553216|FG001|Overall Study|Unavailable|3|||
160772437|NCT04235374|580553215|FG000|Overall Study|Withdrawal by Subject|0|||
160772438|NCT04235374|580553216|FG001|Overall Study|Withdrawal by Subject|1|||
160772439|NCT04235374|580553215|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
160884995|NCT02486718|580973153|FG001|Randomized Phase|Disease Relapse|1|||
160884996|NCT02486718|580973154|FG002|Randomized Phase|Disease Relapse|0|||
160772440|NCT04235374|580553216|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
160772441|NCT01551173|580553217|FG000|Overall Study|Withdrawal by Subject|11|||
160772442|NCT01551173|580553218|FG001|Overall Study|Withdrawal by Subject|16|||
160772443|NCT01551173|580553217|FG000|Overall Study|Adverse Event|7|||
160772444|NCT01551173|580553218|FG001|Overall Study|Adverse Event|6|||
160772445|NCT01551173|580553217|FG000|Overall Study|Lost to Follow-up|5|||
160772446|NCT01551173|580553218|FG001|Overall Study|Lost to Follow-up|7|||
160772447|NCT01551173|580553217|FG000|Overall Study|Other|5|||
160772448|NCT01551173|580553218|FG001|Overall Study|Other|3|||
160772449|NCT01394276|580553219|FG000|Overall Study|Related Adverse event (AEs)|15|||
160772450|NCT01394276|580553219|FG000|Overall Study|Not related AEs|9|||
160772451|NCT01394276|580553219|FG000|Overall Study|Remission of disease|2|||
160772452|NCT01394276|580553219|FG000|Overall Study|Insufficient therapeutic effect|17|||
160772453|NCT01394276|580553219|FG000|Overall Study|Insufficient compliance|9|||
160772454|NCT01394276|580553219|FG000|Overall Study|Lost to Follow-up|5|||
160772455|NCT01394276|580553219|FG000|Overall Study|Participant moved to another site|1|||
160772456|NCT01394276|580553219|FG000|Overall Study|Pregnancy|1|||
160772457|NCT01394276|580553219|FG000|Overall Study|unavailability of drug at the Hospital|2|||
160772458|NCT01394276|580553219|FG000|Overall Study|Symptoms of concurrent diseases|1|||
160772459|NCT04530344|580553220|FG000|Overall Study|Lost to Follow-up|3|||
160772460|NCT04530344|580553221|FG001|Overall Study|Lost to Follow-up|3|||
160772461|NCT04530344|580553222|FG002|Overall Study|Lost to Follow-up|3|||
160772462|NCT04530344|580553223|FG003|Overall Study|Lost to Follow-up|10|||
160772463|NCT04530344|580553220|FG000|Overall Study|Withdrawal by Subject|14|||
160772464|NCT04530344|580553221|FG001|Overall Study|Withdrawal by Subject|5|||
160772465|NCT04530344|580553222|FG002|Overall Study|Withdrawal by Subject|18|||
160772466|NCT04530344|580553223|FG003|Overall Study|Withdrawal by Subject|33|||
160772467|NCT04530344|580553220|FG000|Overall Study|Adverse Event|0|||
160637269|NCT01915498|580053686|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
160637270|NCT02524665|580053689|FG000|Overall Study|Lost to Follow-up|1|||
160637271|NCT00883129|580053690|FG000|Overall Study|Adverse Event|7|||
160637272|NCT00883129|580053691|FG001|Overall Study|Adverse Event|15|||
160637273|NCT00883129|580053690|FG000|Overall Study|Withdrawal by Subject|8|||
160637274|NCT00883129|580053691|FG001|Overall Study|Withdrawal by Subject|9|||
160637275|NCT00883129|580053690|FG000|Overall Study|Non-compliance|3|||
160637276|NCT00883129|580053691|FG001|Overall Study|Non-compliance|6|||
160637277|NCT00883129|580053690|FG000|Overall Study|Lost to Follow-up|1|||
160637278|NCT00883129|580053691|FG001|Overall Study|Lost to Follow-up|2|||
160637279|NCT00883129|580053690|FG000|Overall Study|Death|1|||
160637280|NCT00883129|580053691|FG001|Overall Study|Death|2|||
160637281|NCT00883129|580053690|FG000|Overall Study|Defined Treatment Failure|0|||
160637282|NCT00883129|580053691|FG001|Overall Study|Defined Treatment Failure|2|||
160637283|NCT01185639|580053693|FG000|Overall Study|Progressed and didn't receive therapy|2|||
160637284|NCT01966107|580053694|FG000|Overall Study|excluded from FAS|21|||
160637285|NCT01966107|580053695|FG001|Overall Study|excluded from FAS|20|||
160637286|NCT01966107|580053694|FG000|Overall Study|discontinued treatment|345|||
160637287|NCT01966107|580053695|FG001|Overall Study|discontinued treatment|372|||
160637288|NCT01966107|580053694|FG000|Overall Study|due to study closure|164|||
160637289|NCT01966107|580053695|FG001|Overall Study|due to study closure|186|||
160637290|NCT01966107|580053694|FG000|Overall Study|withdrew from the study|272|||
160637291|NCT01966107|580053695|FG001|Overall Study|withdrew from the study|303|||
160637292|NCT02200614|580053696|FG000|Double Blind Treatment|Adverse Event|86|||
160637293|NCT02200614|580053697|FG001|Double Blind Treatment|Adverse Event|48|||
160637294|NCT02200614|580053696|FG000|Double Blind Treatment|Confirmed metastasis|120|||
160637295|NCT02200614|580053697|FG001|Double Blind Treatment|Confirmed metastasis|140|||
160637296|NCT02200614|580053696|FG000|Double Blind Treatment|Judgment of the investigator|59|||
160772468|NCT04530344|580553221|FG001|Overall Study|Adverse Event|0|||
160772469|NCT04530344|580553222|FG002|Overall Study|Adverse Event|0|||
160772470|NCT04530344|580553223|FG003|Overall Study|Adverse Event|1|||
160884997|NCT02486718|580973152|FG000|Randomized Phase|Death|0|||
160637297|NCT02200614|580053697|FG001|Double Blind Treatment|Judgment of the investigator|99|||
160637298|NCT02200614|580053696|FG000|Double Blind Treatment|Metastasis by local reading|1|||
160637299|NCT02200614|580053697|FG001|Double Blind Treatment|Metastasis by local reading|3|||
160637300|NCT02200614|580053696|FG000|Double Blind Treatment|Other reason|6|||
160637301|NCT02200614|580053697|FG001|Double Blind Treatment|Other reason|2|||
160637302|NCT02200614|580053696|FG000|Double Blind Treatment|Personal reason|77|||
160637303|NCT02200614|580053697|FG001|Double Blind Treatment|Personal reason|85|||
160772471|NCT04530344|580553220|FG000|Overall Study|Lack of Efficacy|0|||
160772472|NCT04530344|580553221|FG001|Overall Study|Lack of Efficacy|0|||
160772473|NCT04530344|580553222|FG002|Overall Study|Lack of Efficacy|0|||
160772474|NCT04530344|580553223|FG003|Overall Study|Lack of Efficacy|1|||
160772475|NCT04530344|580553220|FG000|Overall Study|Physician Decision|0|||
160772476|NCT04530344|580553221|FG001|Overall Study|Physician Decision|0|||
160884998|NCT02486718|580973153|FG001|Randomized Phase|Death|154|||
160637304|NCT02200614|580053696|FG000|Double Blind Treatment|Protocol deviation|14|||
160637305|NCT02200614|580053697|FG001|Double Blind Treatment|Protocol deviation|7|||
160637306|NCT02200614|580053696|FG000|Double Blind Treatment|Not treated|1|||
160772477|NCT04530344|580553222|FG002|Overall Study|Physician Decision|1|||
160772478|NCT04530344|580553223|FG003|Overall Study|Physician Decision|1|||
160772479|NCT04530344|580553220|FG000|Overall Study|Pregnancy|0|||
160772480|NCT04530344|580553221|FG001|Overall Study|Pregnancy|0|||
160772481|NCT04530344|580553222|FG002|Overall Study|Pregnancy|2|||
160772482|NCT04530344|580553223|FG003|Overall Study|Pregnancy|1|||
160772483|NCT04530344|580553220|FG000|Overall Study|Protocol Violation|0|||
160772484|NCT04530344|580553221|FG001|Overall Study|Protocol Violation|0|||
160772485|NCT04530344|580553222|FG002|Overall Study|Protocol Violation|0|||
160772486|NCT04530344|580553223|FG003|Overall Study|Protocol Violation|1|||
160772487|NCT04530344|580553220|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
160772488|NCT04530344|580553221|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
160772489|NCT04530344|580553222|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
160772490|NCT04530344|580553223|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
160772491|NCT04530344|580553220|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
160772492|NCT04530344|580553221|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
160772493|NCT04530344|580553222|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
160772494|NCT04530344|580553223|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
160772495|NCT04530344|580553220|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
160772496|NCT04530344|580553221|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
160772497|NCT04530344|580553222|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
160772498|NCT04530344|580553223|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
160772499|NCT04530344|580553220|FG000|Overall Study|Personal Reasons|0|||
160772500|NCT04530344|580553221|FG001|Overall Study|Personal Reasons|0|||
160772501|NCT04530344|580553222|FG002|Overall Study|Personal Reasons|0|||
160772502|NCT04530344|580553223|FG003|Overall Study|Personal Reasons|1|||
160772503|NCT04530344|580553220|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
160772504|NCT04530344|580553221|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
160772505|NCT04530344|580553222|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
160772506|NCT04530344|580553223|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
160772507|NCT01402700|580553224|FG000|Overall Study|Death|3|||
160772508|NCT01402700|580553224|FG000|Overall Study|Withdrawal by Subject|3|||
160772509|NCT01402700|580553224|FG000|Overall Study|Missed Visit|1|||
160772510|NCT05352399|580553238|FG000|Overall Study|Discontinued intervention|6|||
160772511|NCT04058717|580553239|FG000|Randomization Period|Lost to Follow-up|2|||
160772512|NCT04058717|580553240|FG001|Randomization Period|Lost to Follow-up|3|||
160772513|NCT04058717|580553241|FG002|Randomization Period|Lost to Follow-up|4|||
160772514|NCT04058717|580553242|FG003|Randomization Period|Lost to Follow-up|4|||
160772515|NCT04058717|580553239|FG000|Randomization Period|Withdrawal by Subject|1|||
160772516|NCT04058717|580553240|FG001|Randomization Period|Withdrawal by Subject|3|||
160772517|NCT04058717|580553241|FG002|Randomization Period|Withdrawal by Subject|3|||
160772518|NCT04058717|580553242|FG003|Randomization Period|Withdrawal by Subject|3|||
160772519|NCT04058717|580553239|FG000|Randomization Period|PI decision|0|||
160772520|NCT04058717|580553240|FG001|Randomization Period|PI decision|1|||
160772521|NCT04058717|580553241|FG002|Randomization Period|PI decision|0|||
160772522|NCT04058717|580553242|FG003|Randomization Period|PI decision|0|||
160772523|NCT02164916|580553246|FG000|Overall Study|Adverse Event|3|||
160772524|NCT02164916|580553247|FG001|Overall Study|Adverse Event|8|||
160772525|NCT02164916|580553246|FG000|Overall Study|Death|1|||
160772526|NCT02164916|580553247|FG001|Overall Study|Death|1|||
160772527|NCT02164916|580553246|FG000|Overall Study|Refusal unrelated to adverse event|3|||
160772528|NCT02164916|580553247|FG001|Overall Study|Refusal unrelated to adverse event|7|||
160772529|NCT02164916|580553246|FG000|Overall Study|Progression|37|||
160772530|NCT02164916|580553247|FG001|Overall Study|Progression|26|||
160772531|NCT02164916|580553246|FG000|Overall Study|Not protocol specified|5|||
160772532|NCT02164916|580553247|FG001|Overall Study|Not protocol specified|1|||
160772533|NCT02164916|580553246|FG000|Overall Study|Reason under review|1|||
160772534|NCT02164916|580553247|FG001|Overall Study|Reason under review|6|||
160772535|NCT02164916|580553246|FG000|Overall Study|Not eligible|2|||
160772536|NCT02164916|580553247|FG001|Overall Study|Not eligible|5|||
160772537|NCT00596635|580553250|FG000|Overall Study|Lost to Follow-up|0|||
160637307|NCT02200614|580053697|FG001|Double Blind Treatment|Not treated|0|||
160637308|NCT02200614|580053696|FG000|Open Label|Adverse Event|41|||
160637309|NCT02200614|580053697|FG001|Open Label|Adverse Event|11|||
160637310|NCT02200614|580053696|FG000|Open Label|Confirmed metastasis|1|||
160637311|NCT02200614|580053697|FG001|Open Label|Confirmed metastasis|0|||
160637312|NCT02200614|580053696|FG000|Open Label|Judgment of the investigator|29|||
160637313|NCT02200614|580053697|FG001|Open Label|Judgment of the investigator|2|||
160637314|NCT02200614|580053696|FG000|Open Label|Metastasis by local reading|138|||
160637315|NCT02200614|580053697|FG001|Open Label|Metastasis by local reading|27|||
160637316|NCT02200614|580053696|FG000|Open Label|Other reason|22|||
160637317|NCT02200614|580053697|FG001|Open Label|Other reason|4|||
160637318|NCT02200614|580053696|FG000|Open Label|Personal reason|60|||
160637319|NCT02200614|580053697|FG001|Open Label|Personal reason|8|||
160637320|NCT02200614|580053696|FG000|Open Label|Protocol deviation|3|||
160637321|NCT02200614|580053697|FG001|Open Label|Protocol deviation|2|||
160637322|NCT02200614|580053696|FG000|Open Label|Missing|2|||
160637323|NCT02200614|580053697|FG001|Open Label|Missing|2|||
160637324|NCT02499406|580056046|FG000|Overall Study|missed 3 treatment sessions|4|||
160637325|NCT03591107|580056050|FG000|Overall Study|Same patient in both arms|1|||
160637326|NCT03591107|580056051|FG001|Overall Study|Same patient in both arms|1|||
160637327|NCT03591107|580056050|FG000|Overall Study|Sought care at other clinics|0|||
160637328|NCT03591107|580056051|FG001|Overall Study|Sought care at other clinics|2|||
160637329|NCT03591107|580056050|FG000|Overall Study|Discharged from clinic|0|||
160637330|NCT03591107|580056051|FG001|Overall Study|Discharged from clinic|1|||
160637331|NCT03591107|580056050|FG000|Overall Study|Withdrawal by Subject|0|||
160637332|NCT03591107|580056051|FG001|Overall Study|Withdrawal by Subject|1|||
160637333|NCT00350519|580056054|FG000|Overall Study|Death|0|||
160637334|NCT00350519|580056055|FG001|Overall Study|Death|1|||
160637335|NCT00350519|580056054|FG000|Overall Study|Physician Decision|0|||
160637336|NCT00350519|580056055|FG001|Overall Study|Physician Decision|1|||
160637337|NCT00350519|580056054|FG000|Overall Study|Protocol Violation|1|||
160637338|NCT00350519|580056055|FG001|Overall Study|Protocol Violation|2|||
160637339|NCT00350519|580056054|FG000|Overall Study|Withdrawal by Subject|3|||
160637340|NCT00350519|580056055|FG001|Overall Study|Withdrawal by Subject|2|||
160637341|NCT00736099|580056057|FG000|Overall Study|Adverse Event|61|||
160637342|NCT00736099|580056058|FG001|Overall Study|Adverse Event|18|||
160637343|NCT00736099|580056057|FG000|Overall Study|Protocol Violation|10|||
160637344|NCT00736099|580056058|FG001|Overall Study|Protocol Violation|4|||
160637345|NCT00736099|580056057|FG000|Overall Study|Lost to Follow-up|12|||
160637346|NCT00736099|580056058|FG001|Overall Study|Lost to Follow-up|5|||
160637347|NCT00736099|580056057|FG000|Overall Study|Withdrawal by Subject|42|||
160637348|NCT00736099|580056058|FG001|Overall Study|Withdrawal by Subject|13|||
160772538|NCT00596635|580553251|FG001|Overall Study|Lost to Follow-up|2|||
160772539|NCT00596635|580553252|FG002|Overall Study|Lost to Follow-up|0|||
160772540|NCT00596635|580553250|FG000|Overall Study|Treatment for symptomatic UTI|4|||
160637349|NCT00736099|580056057|FG000|Overall Study|Lack of Efficacy|15|||
160637350|NCT00736099|580056058|FG001|Overall Study|Lack of Efficacy|8|||
160637351|NCT00736099|580056057|FG000|Overall Study|Other reason|43|||
160772541|NCT00596635|580553251|FG001|Overall Study|Treatment for symptomatic UTI|6|||
160884999|NCT02486718|580973154|FG002|Randomized Phase|Death|155|||
160885000|NCT02486718|580973152|FG000|Randomized Phase|Ongoing|0|||
160885001|NCT02486718|580973153|FG001|Randomized Phase|Ongoing|301|||
160885002|NCT02486718|580973154|FG002|Randomized Phase|Ongoing|282|||
160885003|NCT02520089|580973155|FG000|Overall Study|Lost to Follow-up|3|||
160885004|NCT02520089|580973156|FG001|Overall Study|Lost to Follow-up|4|||
160885005|NCT01397825|580974867|FG000|Overall Study|Progressive Disease|10|||
160885006|NCT01397825|580974868|FG001|Overall Study|Progressive Disease|3|||
160772542|NCT00596635|580553252|FG002|Overall Study|Treatment for symptomatic UTI|3|||
160772543|NCT00596635|580553250|FG000|Overall Study|Hip fracture|2|||
160772544|NCT00596635|580553251|FG001|Overall Study|Hip fracture|3|||
160772545|NCT00596635|580553252|FG002|Overall Study|Hip fracture|3|||
160772546|NCT00596635|580553250|FG000|Overall Study|Could not provide urine specimen|1|||
160772547|NCT00596635|580553251|FG001|Overall Study|Could not provide urine specimen|2|||
160772548|NCT00596635|580553252|FG002|Overall Study|Could not provide urine specimen|2|||
160772549|NCT05032196|580553257|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
160772550|NCT05032196|580553258|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
160772551|NCT05032196|580553259|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
160772552|NCT05032196|580553260|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
160772553|NCT05032196|580553261|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
160772554|NCT05032196|580553262|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
160772555|NCT05032196|580553257|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
160772556|NCT05032196|580553258|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
160772557|NCT05032196|580553259|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
160772558|NCT05032196|580553260|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
160772559|NCT05032196|580553261|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
160772560|NCT05032196|580553262|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
160772561|NCT05032196|580553257|FG000|Period 2 (Multidose)|Physician Decision|0|||
160772562|NCT05032196|580553258|FG001|Period 2 (Multidose)|Physician Decision|0|||
160772563|NCT05032196|580553259|FG002|Period 2 (Multidose)|Physician Decision|0|||
160772564|NCT05032196|580553260|FG003|Period 2 (Multidose)|Physician Decision|0|||
160772565|NCT05032196|580553261|FG004|Period 2 (Multidose)|Physician Decision|1|||
160772566|NCT05032196|580553262|FG005|Period 2 (Multidose)|Physician Decision|0|||
160772567|NCT04809974|580554578|FG000|Lead-in Phase|Withdrawal by Subject|3|||
160772568|NCT04809974|580554579|FG001|Lead-in Phase|Withdrawal by Subject|0|||
160772569|NCT04809974|580554580|FG002|Lead-in Phase|Withdrawal by Subject|0|||
160772570|NCT04809974|580554578|FG000|Lead-in Phase|No longer eligible|11|||
160772571|NCT04809974|580554579|FG001|Lead-in Phase|No longer eligible|0|||
160772572|NCT04809974|580554580|FG002|Lead-in Phase|No longer eligible|0|||
160772573|NCT04809974|580554578|FG000|Randomized Phase|Lost to Follow-up|0|||
160772574|NCT04809974|580554579|FG001|Randomized Phase|Lost to Follow-up|1|||
160772575|NCT04809974|580554580|FG002|Randomized Phase|Lost to Follow-up|5|||
160772576|NCT04809974|580554578|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
160772577|NCT04809974|580554579|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
160772578|NCT04809974|580554580|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
160772579|NCT04809974|580554578|FG000|Randomized Phase|Adverse Event|0|||
160772580|NCT04809974|580554579|FG001|Randomized Phase|Adverse Event|1|||
160772581|NCT04809974|580554580|FG002|Randomized Phase|Adverse Event|4|||
160772582|NCT04809974|580554578|FG000|Randomized Phase|Withdrawal by Subject|0|||
160772583|NCT04809974|580554579|FG001|Randomized Phase|Withdrawal by Subject|0|||
160772584|NCT04809974|580554580|FG002|Randomized Phase|Withdrawal by Subject|5|||
160772585|NCT04338581|580554581|FG000|Overall Study|Lack of Efficacy|1|||
160772586|NCT04338581|580554582|FG001|Overall Study|Lack of Efficacy|0|||
160772587|NCT04338581|580554581|FG000|Overall Study|Withdrawal by Subject|4|||
160772588|NCT04338581|580554582|FG001|Overall Study|Withdrawal by Subject|4|||
160772589|NCT04338581|580554581|FG000|Overall Study|Prohibited Medication|1|||
160772590|NCT04338581|580554582|FG001|Overall Study|Prohibited Medication|0|||
160772591|NCT00770809|580554583|FG000|Overall Study|Adverse Event|9|||
160772592|NCT00770809|580554584|FG001|Overall Study|Adverse Event|1|||
160772593|NCT00770809|580554585|FG002|Overall Study|Adverse Event|12|||
160772594|NCT00770809|580554583|FG000|Overall Study|Death|1|||
160885007|NCT01397825|580974869|FG002|Overall Study|Progressive Disease|11|||
160885008|NCT01397825|580974870|FG003|Overall Study|Progressive Disease|1|||
160772595|NCT00770809|580554584|FG001|Overall Study|Death|0|||
160772596|NCT00770809|580554585|FG002|Overall Study|Death|0|||
160772597|NCT00770809|580554583|FG000|Overall Study|Withdrawal by Subject|3|||
160772598|NCT00770809|580554584|FG001|Overall Study|Withdrawal by Subject|3|||
160772599|NCT00770809|580554585|FG002|Overall Study|Withdrawal by Subject|7|||
160772600|NCT00770809|580554583|FG000|Overall Study|Progression|2|||
160772601|NCT00770809|580554584|FG001|Overall Study|Progression|2|||
160772602|NCT00770809|580554585|FG002|Overall Study|Progression|0|||
160772603|NCT00770809|580554583|FG000|Overall Study|Complicating illness|0|||
160772604|NCT00770809|580554584|FG001|Overall Study|Complicating illness|0|||
160772605|NCT00770809|580554585|FG002|Overall Study|Complicating illness|1|||
160772606|NCT00770809|580554583|FG000|Overall Study|Other Medical Reasons|2|||
160772607|NCT00770809|580554584|FG001|Overall Study|Other Medical Reasons|4|||
160772608|NCT00770809|580554585|FG002|Overall Study|Other Medical Reasons|3|||
160772609|NCT00764517|580554590|FG000|Overall Study|Adverse Event|9|||
160772610|NCT00764517|580554591|FG001|Overall Study|Adverse Event|3|||
160772611|NCT00764517|580554590|FG000|Overall Study|Death|3|||
160772612|NCT00764517|580554591|FG001|Overall Study|Death|11|||
160772613|NCT00764517|580554590|FG000|Overall Study|Physician Decision|3|||
160772614|NCT00764517|580554591|FG001|Overall Study|Physician Decision|0|||
160772615|NCT00460798|580554592|FG000|Overall Study|Death|59|||
160772616|NCT00460798|580554592|FG000|Overall Study|Adverse Event|27|||
160772617|NCT00460798|580554592|FG000|Overall Study|Lost to Follow-up|19|||
160772618|NCT00460798|580554592|FG000|Overall Study|Progressive Disease|99|||
160772619|NCT00460798|580554592|FG000|Overall Study|Other|27|||
160772620|NCT00460798|580554592|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
160772621|NCT00460798|580554592|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
160772622|NCT01369433|580554593|FG000|Overall Study|Adverse Event|31|||
160772623|NCT01369433|580554594|FG001|Overall Study|Adverse Event|1|||
160772624|NCT01369433|580554593|FG000|Overall Study|Required significant surgical procedure|1|||
160772625|NCT01369433|580554594|FG001|Overall Study|Required significant surgical procedure|0|||
160772626|NCT01369433|580554593|FG000|Overall Study|Non-compliance|1|||
160772627|NCT01369433|580554594|FG001|Overall Study|Non-compliance|0|||
160772628|NCT01369433|580554593|FG000|Overall Study|Withdrawal by Subject|5|||
160772629|NCT01369433|580554594|FG001|Overall Study|Withdrawal by Subject|2|||
160637352|NCT00736099|580056058|FG001|Overall Study|Other reason|10|||
160637353|NCT00948025|580056059|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
160637354|NCT00948025|580056060|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
160637355|NCT00948025|580056059|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
160637356|NCT00948025|580056060|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
160637357|NCT00948025|580056059|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
160637358|NCT00948025|580056060|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
160637359|NCT04006847|580056063|FG000|Overall Study|Product issue|1|||
160637360|NCT03555890|580056073|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160637361|NCT03555890|580056074|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160637362|NCT03555890|580056075|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160637363|NCT03555890|580056076|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
160637364|NCT03372369|580056077|FG000|Qualification Period|Withdrawal by Subject|16|||
160637365|NCT03372369|580056078|FG001|Qualification Period|Withdrawal by Subject|13|||
160637366|NCT03372369|580056077|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
160637367|NCT03372369|580056078|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
160637368|NCT03372369|580056077|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
160637369|NCT03372369|580056078|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
160637370|NCT02239601|580056079|FG000|Overall Study|Withdrawal by Subject|3|||
160637371|NCT02239601|580056080|FG001|Overall Study|Withdrawal by Subject|4|||
160637372|NCT02239601|580056079|FG000|Overall Study|Protocol Violation|4|||
160637373|NCT02239601|580056080|FG001|Overall Study|Protocol Violation|2|||
160637374|NCT01383954|580056081|FG000|Overall Study|Lack of Efficacy|2|||
160637375|NCT01383954|580056081|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
160637376|NCT01383954|580056081|FG000|Overall Study|Adverse Event|1|||
160637377|NCT01383954|580056081|FG000|Overall Study|Reason Not Specified|9|||
160637378|NCT01791127|580056082|FG000|Overall Study|Death|356|||
160637379|NCT01791127|580056082|FG000|Overall Study|Patient has withdrawn from study|293|||
160637380|NCT01791127|580056082|FG000|Overall Study|Lost to Follow-up|42|||
160637381|NCT01791127|580056082|FG000|Overall Study|All Siello leads are explanted|31|||
160637382|NCT01791127|580056082|FG000|Overall Study|Completion of 30 day safety registry|1|||
160637383|NCT01791127|580056082|FG000|Overall Study|Study terminated for EP Passion|749|||
160772630|NCT01369433|580554593|FG000|Overall Study|Study terminated by Sponsor|67|||
160772631|NCT01369433|580554594|FG001|Overall Study|Study terminated by Sponsor|0|||
160772632|NCT01369433|580554593|FG000|Overall Study|Lost to Follow-up|1|||
160772633|NCT01369433|580554594|FG001|Overall Study|Lost to Follow-up|0|||
160772634|NCT01369433|580554593|FG000|Overall Study|Death|5|||
160772635|NCT01369433|580554594|FG001|Overall Study|Death|0|||
160772636|NCT01369433|580554593|FG000|Overall Study|Investigator discretion|6|||
160637384|NCT00707174|580056083|FG000|Overall Study|Adverse Event|1|||
160637385|NCT00707174|580056084|FG001|Overall Study|Adverse Event|6|||
160772637|NCT01369433|580554594|FG001|Overall Study|Investigator discretion|1|||
160772638|NCT01369433|580554593|FG000|Overall Study|Progressive Disease|92|||
160772639|NCT01369433|580554594|FG001|Overall Study|Progressive Disease|12|||
160772640|NCT00688597|580554597|FG000|Overall Study|Adverse Event|2|||
160772641|NCT00688597|580554598|FG001|Overall Study|Adverse Event|0|||
160772642|NCT00688597|580554599|FG002|Overall Study|Adverse Event|0|||
160772643|NCT00688597|580554597|FG000|Overall Study|Physician Decision|1|||
160772644|NCT00688597|580554598|FG001|Overall Study|Physician Decision|0|||
160772645|NCT00688597|580554599|FG002|Overall Study|Physician Decision|0|||
160772646|NCT00933933|580554603|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
160772647|NCT00933933|580554604|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
160772648|NCT00933933|580554605|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
160772649|NCT00933933|580554603|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
160772650|NCT00933933|580554604|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
160772651|NCT00933933|580554605|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
160772652|NCT00844519|580554606|FG000|Overall Study|Withdrawal by Subject|1|||
160772653|NCT00844519|580554607|FG001|Overall Study|Withdrawal by Subject|1|||
160772654|NCT00844519|580554606|FG000|Overall Study|Adverse Event|1|||
160772655|NCT00844519|580554607|FG001|Overall Study|Adverse Event|0|||
160772656|NCT01303419|580554610|FG000|Overall Study|Discontinuation of study|60|||
160772657|NCT01303419|580554610|FG000|Overall Study|Did not complete both imaging methods|5|||
160772658|NCT01303419|580554610|FG000|Overall Study|Did not meet all I/E after screening|31|||
160772659|NCT01995201|580554611|FG000|From Baseline Until Week 24|Adverse Event|4|||
160772660|NCT01995201|580554612|FG001|From Baseline Until Week 24|Adverse Event|15|||
160772661|NCT01995201|580554613|FG002|From Baseline Until Week 24|Adverse Event|0|||
160772662|NCT01995201|580554614|FG003|From Baseline Until Week 24|Adverse Event|0|||
160772663|NCT01995201|580554615|FG004|From Baseline Until Week 24|Adverse Event|0|||
160772664|NCT01995201|580554616|FG005|From Baseline Until Week 24|Adverse Event|0|||
160772665|NCT01995201|580554617|FG006|From Baseline Until Week 24|Adverse Event|0|||
160772666|NCT01995201|580554611|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
160772667|NCT01995201|580554612|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
160772668|NCT01995201|580554613|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
160772669|NCT01995201|580554614|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
160772670|NCT01995201|580554615|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
160772671|NCT01995201|580554616|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
160772672|NCT01995201|580554617|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
160772673|NCT01995201|580554611|FG000|From Baseline Until Week 24|Death|0|||
160772674|NCT01995201|580554612|FG001|From Baseline Until Week 24|Death|1|||
160772675|NCT01995201|580554613|FG002|From Baseline Until Week 24|Death|0|||
160772676|NCT01995201|580554614|FG003|From Baseline Until Week 24|Death|0|||
160772677|NCT01995201|580554615|FG004|From Baseline Until Week 24|Death|0|||
160772678|NCT01995201|580554616|FG005|From Baseline Until Week 24|Death|0|||
160772679|NCT01995201|580554617|FG006|From Baseline Until Week 24|Death|0|||
160772680|NCT01995201|580554611|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
160772681|NCT01995201|580554612|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
160772682|NCT01995201|580554613|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
160772683|NCT01995201|580554614|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
160772684|NCT01995201|580554615|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
160637386|NCT00707174|580056083|FG000|Overall Study|Withdrawal by Subject|4|||
160637387|NCT00707174|580056084|FG001|Overall Study|Withdrawal by Subject|1|||
160637388|NCT00544557|580056085|FG000|Overall Study|Adverse Event|140|||
160637389|NCT00544557|580056085|FG000|Overall Study|Lack of Efficacy|196|||
160637390|NCT00544557|580056085|FG000|Overall Study|Other|98|||
160637391|NCT00467818|580056086|FG000|Overall Study|Adverse Event|1|||
160637392|NCT00467818|580056087|FG001|Overall Study|Adverse Event|0|||
160637393|NCT00467818|580056086|FG000|Overall Study|Lost to Follow-up|2|||
160637394|NCT00467818|580056087|FG001|Overall Study|Lost to Follow-up|2|||
160637395|NCT01017029|580056088|FG000|Overall Study|Lost to Follow-up|1|||
160637396|NCT01017029|580056089|FG001|Overall Study|Lost to Follow-up|0|||
160637397|NCT01017029|580056088|FG000|Overall Study|Administrative problem|0|||
160637398|NCT01017029|580056089|FG001|Overall Study|Administrative problem|1|||
160637399|NCT01017029|580056088|FG000|Overall Study|Death|3|||
160637400|NCT01017029|580056089|FG001|Overall Study|Death|1|||
160637401|NCT01313728|580056090|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
160637402|NCT00422058|580056092|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
160637403|NCT00422058|580056093|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
160637404|NCT00422058|580056094|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
160637405|NCT00422058|580056095|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
160637406|NCT00422058|580056096|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
160637407|NCT00422058|580056097|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
160637408|NCT00422058|580056092|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
160637409|NCT00422058|580056093|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
160637410|NCT00422058|580056094|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
160637411|NCT00422058|580056095|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
160637412|NCT00422058|580056096|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
160637413|NCT00422058|580056097|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
160637414|NCT00422058|580056092|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
160637415|NCT00422058|580056093|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
160637416|NCT00422058|580056094|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
160637417|NCT00422058|580056095|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
160637418|NCT00422058|580056096|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
160637419|NCT00422058|580056097|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
160637420|NCT00422058|580056092|FG000|Double-Blind, Week 0-20|Other|11|||
160637421|NCT00422058|580056093|FG001|Double-Blind, Week 0-20|Other|3|||
160637422|NCT00422058|580056094|FG002|Double-Blind, Week 0-20|Other|8|||
160637423|NCT00422058|580056095|FG003|Double-Blind, Week 0-20|Other|8|||
160637424|NCT00422058|580056096|FG004|Double-Blind, Week 0-20|Other|4|||
160637425|NCT00422058|580056097|FG005|Double-Blind, Week 0-20|Other|10|||
160637426|NCT00422058|580056092|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
160637427|NCT00422058|580056093|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
160637428|NCT00422058|580056094|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
160637429|NCT00422058|580056095|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
160637430|NCT00422058|580056096|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
160637431|NCT00422058|580056097|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
160637432|NCT00422058|580056092|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
160637433|NCT00422058|580056093|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
160637434|NCT00422058|580056094|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
160637435|NCT00422058|580056095|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
160637436|NCT00422058|580056096|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
160637437|NCT00422058|580056097|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
160637438|NCT00422058|580056092|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
160637439|NCT00422058|580056093|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
160637440|NCT00422058|580056094|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
160637441|NCT00422058|580056095|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
160637442|NCT00422058|580056096|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
160772685|NCT01995201|580554616|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
160772686|NCT01995201|580554617|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
160772687|NCT01995201|580554611|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
160772688|NCT01995201|580554612|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
160772689|NCT01995201|580554613|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
160772690|NCT01995201|580554614|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
160772691|NCT01995201|580554615|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
160772692|NCT01995201|580554616|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
160772693|NCT01995201|580554617|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
160772694|NCT01995201|580554611|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
160772695|NCT01995201|580554612|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
160637443|NCT00422058|580056097|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
160637444|NCT00422058|580056092|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
160637445|NCT00422058|580056093|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
160637446|NCT00422058|580056094|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
160772696|NCT01995201|580554613|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
160772697|NCT01995201|580554614|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
160772698|NCT01995201|580554615|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
160772699|NCT01995201|580554616|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
160772700|NCT01995201|580554617|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
160772701|NCT01995201|580554611|FG000|From Baseline Until Week 24|Physician Decision|0|||
160772702|NCT01995201|580554612|FG001|From Baseline Until Week 24|Physician Decision|2|||
160772703|NCT01995201|580554613|FG002|From Baseline Until Week 24|Physician Decision|0|||
160772704|NCT01995201|580554614|FG003|From Baseline Until Week 24|Physician Decision|0|||
160772705|NCT01995201|580554615|FG004|From Baseline Until Week 24|Physician Decision|0|||
160772706|NCT01995201|580554616|FG005|From Baseline Until Week 24|Physician Decision|0|||
160772707|NCT01995201|580554617|FG006|From Baseline Until Week 24|Physician Decision|0|||
160540645|NCT01500278|579709341|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
160540646|NCT01500278|579709340|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
160540647|NCT01500278|579709341|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
160540648|NCT01500278|579709340|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
160540649|NCT01500278|579709341|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
160540650|NCT01500278|579709340|FG000|Week 0 - Week 12|Patient decision|1|||
160540651|NCT01500278|579709341|FG001|Week 0 - Week 12|Patient decision|0|||
160540652|NCT01500278|579709340|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
160540653|NCT01500278|579709341|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
160540654|NCT01500278|579709340|FG000|Week 0 - Week 12|Investigator decision|1|||
160540655|NCT01500278|579709341|FG001|Week 0 - Week 12|Investigator decision|0|||
160540656|NCT01500278|579709340|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
160540657|NCT01500278|579709341|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
160540658|NCT01500278|579709340|FG000|Week 0 - Week 12|Sponsor decision|1|||
160540659|NCT01500278|579709341|FG001|Week 0 - Week 12|Sponsor decision|0|||
160540660|NCT01500278|579709340|FG000|Week 0 - Week 12|Personal reason|0|||
160540661|NCT01500278|579709341|FG001|Week 0 - Week 12|Personal reason|1|||
160540662|NCT01500278|579709340|FG000|Week 0 - Week 12|Other serious disease|0|||
160540663|NCT01500278|579709341|FG001|Week 0 - Week 12|Other serious disease|1|||
160540664|NCT01500278|579709340|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
160540665|NCT01500278|579709341|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
160540666|NCT01500278|579709340|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
160540667|NCT01500278|579709341|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
160540668|NCT01500278|579709340|FG000|Week 13 - Week 104|Protocol Violation|6|||
160540669|NCT01500278|579709341|FG001|Week 13 - Week 104|Protocol Violation|6|||
160540670|NCT01500278|579709340|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
160540671|NCT01500278|579709341|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
160540672|NCT01500278|579709340|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
160540673|NCT01500278|579709341|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
160540674|NCT01500278|579709340|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
160540675|NCT01500278|579709341|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
160540676|NCT01500278|579709340|FG000|Week 13 - Week 104|Non/bad compliance|7|||
160540677|NCT01500278|579709341|FG001|Week 13 - Week 104|Non/bad compliance|5|||
160540678|NCT01500278|579709340|FG000|Week 13 - Week 104|Recurrent infections|1|||
160540679|NCT01500278|579709341|FG001|Week 13 - Week 104|Recurrent infections|0|||
160540680|NCT01500278|579709340|FG000|Week 13 - Week 104|False positive test|1|||
160540681|NCT01500278|579709341|FG001|Week 13 - Week 104|False positive test|2|||
160540682|NCT01500278|579709340|FG000|Week 13 - Week 104|Sponsor request|4|||
160540683|NCT01500278|579709341|FG001|Week 13 - Week 104|Sponsor request|0|||
160540684|NCT01500278|579709340|FG000|Week 13 - Week 104|Withdrawn in error|1|||
160540685|NCT01500278|579709341|FG001|Week 13 - Week 104|Withdrawn in error|0|||
160540686|NCT01500278|579709340|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
160540687|NCT01500278|579709341|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
160772708|NCT01995201|580554611|FG000|From Baseline Until Week 24|Protocol Violation|0|||
160772709|NCT01995201|580554612|FG001|From Baseline Until Week 24|Protocol Violation|9|||
160885009|NCT01397825|580974871|FG004|Overall Study|Progressive Disease|0|||
160540688|NCT01500278|579709340|FG000|Week 13 - Week 104|Protocol deviation|1|||
160540689|NCT01500278|579709341|FG001|Week 13 - Week 104|Protocol deviation|0|||
160540690|NCT01500278|579709340|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
160540691|NCT01500278|579709341|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
160540692|NCT01500278|579709340|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
160540693|NCT01500278|579709341|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
160540694|NCT01500278|579709340|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
160540695|NCT01500278|579709341|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
160540696|NCT01500278|579709340|FG000|Week 13 - Week 104|Relocation|0|||
160540697|NCT01500278|579709341|FG001|Week 13 - Week 104|Relocation|1|||
160540698|NCT01500278|579709340|FG000|Week 13 - Week 104|Sponsor decision|0|||
160540699|NCT01500278|579709341|FG001|Week 13 - Week 104|Sponsor decision|2|||
160540700|NCT01500278|579709340|FG000|Week 13 - Week 104|Medical monitor decision|0|||
160540701|NCT01500278|579709341|FG001|Week 13 - Week 104|Medical monitor decision|2|||
160540702|NCT01500278|579709340|FG000|Week 13 - Week 104|Personal reason|0|||
160772710|NCT01995201|580554613|FG002|From Baseline Until Week 24|Protocol Violation|0|||
160772711|NCT01995201|580554614|FG003|From Baseline Until Week 24|Protocol Violation|0|||
160772712|NCT01995201|580554615|FG004|From Baseline Until Week 24|Protocol Violation|0|||
160772713|NCT01995201|580554616|FG005|From Baseline Until Week 24|Protocol Violation|0|||
160772714|NCT01995201|580554617|FG006|From Baseline Until Week 24|Protocol Violation|0|||
160772715|NCT01995201|580554611|FG000|From Week 24 Until Week 48|Adverse Event|0|||
160772716|NCT01995201|580554612|FG001|From Week 24 Until Week 48|Adverse Event|0|||
160772717|NCT01995201|580554613|FG002|From Week 24 Until Week 48|Adverse Event|2|||
160772718|NCT01995201|580554614|FG003|From Week 24 Until Week 48|Adverse Event|1|||
160772719|NCT01995201|580554615|FG004|From Week 24 Until Week 48|Adverse Event|1|||
160772720|NCT01995201|580554616|FG005|From Week 24 Until Week 48|Adverse Event|3|||
160772721|NCT01995201|580554617|FG006|From Week 24 Until Week 48|Adverse Event|1|||
160772722|NCT01995201|580554611|FG000|From Week 24 Until Week 48|Death|0|||
160772723|NCT01995201|580554612|FG001|From Week 24 Until Week 48|Death|0|||
160772724|NCT01995201|580554613|FG002|From Week 24 Until Week 48|Death|0|||
160772725|NCT01995201|580554614|FG003|From Week 24 Until Week 48|Death|0|||
160772726|NCT01995201|580554615|FG004|From Week 24 Until Week 48|Death|0|||
160772727|NCT01995201|580554616|FG005|From Week 24 Until Week 48|Death|2|||
160772728|NCT01995201|580554617|FG006|From Week 24 Until Week 48|Death|0|||
160772729|NCT01995201|580554611|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
160772730|NCT01995201|580554612|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
160772731|NCT01995201|580554613|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
160772732|NCT01995201|580554614|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
160772733|NCT01995201|580554615|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
160772734|NCT01995201|580554616|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
160772735|NCT01995201|580554617|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
160772736|NCT01995201|580554611|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
160772737|NCT01995201|580554612|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
160772738|NCT01995201|580554613|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
160772739|NCT01995201|580554614|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
160772740|NCT01995201|580554615|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
160772741|NCT01995201|580554616|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
160772742|NCT01995201|580554617|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
160772743|NCT01995201|580554611|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
160772744|NCT01995201|580554612|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
160772745|NCT01995201|580554613|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
160772746|NCT01995201|580554614|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
160772747|NCT01995201|580554615|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
160772748|NCT01995201|580554616|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
160772749|NCT01995201|580554617|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
160772750|NCT01995201|580554611|FG000|From Week 24 Until Week 48|Physician Decision|0|||
160772751|NCT01995201|580554612|FG001|From Week 24 Until Week 48|Physician Decision|0|||
160772752|NCT01995201|580554613|FG002|From Week 24 Until Week 48|Physician Decision|0|||
160772753|NCT01995201|580554614|FG003|From Week 24 Until Week 48|Physician Decision|0|||
160772754|NCT01995201|580554615|FG004|From Week 24 Until Week 48|Physician Decision|1|||
160772755|NCT01995201|580554616|FG005|From Week 24 Until Week 48|Physician Decision|0|||
160772756|NCT01995201|580554617|FG006|From Week 24 Until Week 48|Physician Decision|0|||
160772757|NCT01995201|580554611|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
160772758|NCT01995201|580554612|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
160772759|NCT01995201|580554613|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
160772760|NCT01995201|580554614|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
160772761|NCT01995201|580554615|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
160772762|NCT01995201|580554616|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
160772763|NCT01995201|580554617|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
160772764|NCT03329001|580554618|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
160772765|NCT03329001|580554619|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
160772766|NCT03329001|580554620|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
160772767|NCT03329001|580554621|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
160772768|NCT03329001|580554622|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
160637447|NCT00422058|580056095|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
160772769|NCT03329001|580554623|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
160772770|NCT03329001|580554624|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
160772771|NCT03329001|580554625|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
160772772|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
160772773|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
160772774|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
160772775|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
160772776|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
160772777|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
160772778|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
160772779|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
160772780|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
160772781|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
160772782|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
160772783|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
160772784|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
160772785|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
160772786|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
160772787|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
160772788|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
160637448|NCT00422058|580056096|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
160637449|NCT00422058|580056097|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
160637450|NCT00422058|580056092|FG000|Open-Label Extension, Week 20-104|Other|13|||
160637451|NCT00422058|580056093|FG001|Open-Label Extension, Week 20-104|Other|14|||
160637452|NCT00422058|580056094|FG002|Open-Label Extension, Week 20-104|Other|6|||
160637453|NCT00422058|580056095|FG003|Open-Label Extension, Week 20-104|Other|13|||
160637454|NCT00422058|580056096|FG004|Open-Label Extension, Week 20-104|Other|16|||
160637455|NCT00422058|580056097|FG005|Open-Label Extension, Week 20-104|Other|18|||
160637456|NCT04057118|580056098|FG000|Overall Study|Adverse Event|1|||
160637457|NCT04057118|580056099|FG001|Overall Study|Adverse Event|0|||
160637458|NCT04057118|580056100|FG002|Overall Study|Adverse Event|1|||
160637459|NCT04057118|580056101|FG003|Overall Study|Adverse Event|1|||
160637460|NCT04057118|580056098|FG000|Overall Study|Physician Decision|0|||
160637461|NCT04057118|580056099|FG001|Overall Study|Physician Decision|0|||
160637462|NCT04057118|580056100|FG002|Overall Study|Physician Decision|1|||
160637463|NCT04057118|580056101|FG003|Overall Study|Physician Decision|1|||
160637464|NCT04057118|580056098|FG000|Overall Study|Withdrawal by Subject|2|||
160637465|NCT04057118|580056099|FG001|Overall Study|Withdrawal by Subject|2|||
160637466|NCT04057118|580056100|FG002|Overall Study|Withdrawal by Subject|0|||
160637467|NCT04057118|580056101|FG003|Overall Study|Withdrawal by Subject|2|||
160637468|NCT04057118|580056098|FG000|Overall Study|Not Specific|0|||
160637469|NCT04057118|580056099|FG001|Overall Study|Not Specific|0|||
160637470|NCT04057118|580056100|FG002|Overall Study|Not Specific|1|||
160637471|NCT04057118|580056101|FG003|Overall Study|Not Specific|1|||
160637472|NCT04529096|580056103|FG000|Overall Study|Adverse Event|6|||
160637473|NCT04529096|580056104|FG001|Overall Study|Adverse Event|1|||
160637474|NCT04529096|580056103|FG000|Overall Study|Lack of Efficacy|1|||
160637475|NCT04529096|580056104|FG001|Overall Study|Lack of Efficacy|0|||
160637476|NCT04529096|580056103|FG000|Overall Study|Lost to Follow-up|1|||
160637477|NCT04529096|580056104|FG001|Overall Study|Lost to Follow-up|1|||
160637478|NCT04529096|580056103|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160637479|NCT04529096|580056104|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160637480|NCT04529096|580056103|FG000|Overall Study|Physician Decision|1|||
160637481|NCT04529096|580056104|FG001|Overall Study|Physician Decision|3|||
160637482|NCT04529096|580056103|FG000|Overall Study|Withdrawal by Subject|5|||
160637483|NCT04529096|580056104|FG001|Overall Study|Withdrawal by Subject|0|||
160637484|NCT04529499|580056105|FG000|Overall Study|Withdrawal by Subject|9|||
160637485|NCT04529499|580056106|FG001|Overall Study|Withdrawal by Subject|11|||
160637486|NCT04529499|580056105|FG000|Overall Study|Physician Decision|1|||
160772789|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
160772790|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
160772791|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
160772792|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
160772793|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
160772794|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
160772795|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
160637487|NCT04529499|580056106|FG001|Overall Study|Physician Decision|2|||
160637488|NCT04529499|580056105|FG000|Overall Study|Adverse Event|4|||
160637489|NCT04529499|580056106|FG001|Overall Study|Adverse Event|4|||
160637490|NCT04529499|580056105|FG000|Overall Study|Death|14|||
160637491|NCT04529499|580056106|FG001|Overall Study|Death|11|||
160637492|NCT04529499|580056105|FG000|Overall Study|Lost to Follow-up|1|||
160637493|NCT04529499|580056106|FG001|Overall Study|Lost to Follow-up|1|||
160637494|NCT04529499|580056105|FG000|Overall Study|Others|7|||
160885010|NCT01397825|580974867|FG000|Overall Study|Symptomatic Deterioration|2|||
160885011|NCT01397825|580974868|FG001|Overall Study|Symptomatic Deterioration|0|||
160772796|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
160885012|NCT01397825|580974869|FG002|Overall Study|Symptomatic Deterioration|4|||
160885013|NCT01397825|580974870|FG003|Overall Study|Symptomatic Deterioration|0|||
160885014|NCT01397825|580974871|FG004|Overall Study|Symptomatic Deterioration|0|||
160885015|NCT01397825|580974867|FG000|Overall Study|Adverse Event|0|||
160885016|NCT01397825|580974868|FG001|Overall Study|Adverse Event|1|||
160885017|NCT01397825|580974869|FG002|Overall Study|Adverse Event|5|||
160885018|NCT01397825|580974870|FG003|Overall Study|Adverse Event|1|||
160885019|NCT01397825|580974871|FG004|Overall Study|Adverse Event|0|||
160885020|NCT01397825|580974867|FG000|Overall Study|Withdrawal by Subject|1|||
160885021|NCT01397825|580974868|FG001|Overall Study|Withdrawal by Subject|0|||
160885022|NCT01397825|580974869|FG002|Overall Study|Withdrawal by Subject|5|||
160885023|NCT01397825|580974870|FG003|Overall Study|Withdrawal by Subject|1|||
160885024|NCT01397825|580974871|FG004|Overall Study|Withdrawal by Subject|0|||
160885025|NCT01931670|580974872|FG000|Treatment Period|Exclusionary Medication Received|1|||
160885026|NCT01931670|580974873|FG001|Treatment Period|Exclusionary Medication Received|1|||
160885027|NCT01931670|580974874|FG002|Treatment Period|Exclusionary Medication Received|1|||
160885028|NCT01931670|580974872|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
160885029|NCT01931670|580974873|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
160885030|NCT01931670|580974874|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
160885031|NCT01931670|580974872|FG000|Treatment Period|Subject Noncompliant|4|||
160885032|NCT01931670|580974873|FG001|Treatment Period|Subject Noncompliant|9|||
160885033|NCT01931670|580974874|FG002|Treatment Period|Subject Noncompliant|5|||
160885034|NCT01931670|580974872|FG000|Treatment Period|Adverse Event|19|||
160885035|NCT01931670|580974873|FG001|Treatment Period|Adverse Event|8|||
160885036|NCT01931670|580974874|FG002|Treatment Period|Adverse Event|21|||
160885037|NCT01931670|580974872|FG000|Treatment Period|Lack of Efficacy|11|||
160885038|NCT01931670|580974873|FG001|Treatment Period|Lack of Efficacy|2|||
160885039|NCT01931670|580974874|FG002|Treatment Period|Lack of Efficacy|2|||
160885040|NCT01931670|580974872|FG000|Treatment Period|Pregnancy|7|||
160885041|NCT01931670|580974873|FG001|Treatment Period|Pregnancy|2|||
160885042|NCT01931670|580974874|FG002|Treatment Period|Pregnancy|0|||
160885043|NCT01931670|580974872|FG000|Treatment Period|Other|8|||
160885044|NCT01931670|580974873|FG001|Treatment Period|Other|7|||
160885045|NCT01931670|580974874|FG002|Treatment Period|Other|2|||
160885046|NCT01931670|580974872|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
160885047|NCT01931670|580974873|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
160885048|NCT01931670|580974874|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
160885049|NCT01931670|580974872|FG000|Treatment Period|Lost to Follow-up|19|||
160885050|NCT01931670|580974873|FG001|Treatment Period|Lost to Follow-up|5|||
160885051|NCT01931670|580974874|FG002|Treatment Period|Lost to Follow-up|7|||
160885052|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
160885053|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
160885054|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
160885055|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
160885056|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
160772797|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
160772798|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
160772799|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
160772800|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
160885057|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
160885058|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
160540703|NCT01500278|579709341|FG001|Week 13 - Week 104|Personal reason|1|||
160885059|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
160885060|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
160885061|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
160885062|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
160885063|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
160772801|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
160772802|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
160772803|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
160772804|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
160772805|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
160772806|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
160772807|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
160772808|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
160772809|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
160772810|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
160772811|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
160772812|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
160772813|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
160772814|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
160772815|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
160772816|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
160772817|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
160772818|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
160772819|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
160772820|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
160772821|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
160772822|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
160772823|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
160772824|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
160772825|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
160772826|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
160772827|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
160772828|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
160540704|NCT01500278|579709340|FG000|Week 13 - Week 104|Not completed|0|||
160540705|NCT01500278|579709341|FG001|Week 13 - Week 104|Not completed|1|||
160772829|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
160772830|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
160772831|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
160772832|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
160772833|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
160772834|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
160772835|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
160772836|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
160772837|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
160772838|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
160772839|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
160772840|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
160772841|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
160772842|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
160772843|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
160772844|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
160772845|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
160772846|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
160772847|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
160772848|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
160885064|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
160540706|NCT01500278|579709340|FG000|Week 13 - Week 104|Death|2|||
160540707|NCT01500278|579709341|FG001|Week 13 - Week 104|Death|4|||
160540708|NCT01500278|579709340|FG000|Week 13 - Week 104|Adverse Event|54|||
160772849|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
160772850|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
160772851|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
160772852|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
160772853|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
160772854|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
160772855|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
160772856|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
160772857|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
160772858|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
160772859|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
160772860|NCT03329001|580554618|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
160772861|NCT03329001|580554619|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
160772862|NCT03329001|580554620|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
160772863|NCT03329001|580554621|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
160772864|NCT03329001|580554622|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
160772865|NCT03329001|580554623|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
160772866|NCT03329001|580554624|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
160772867|NCT03329001|580554625|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
160772868|NCT03329001|580554618|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
160772869|NCT03329001|580554619|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
160772870|NCT03329001|580554620|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
160772871|NCT03329001|580554621|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
160772872|NCT03329001|580554622|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
160772873|NCT03329001|580554623|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
160772874|NCT03329001|580554624|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
160772875|NCT03329001|580554625|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
160772876|NCT03329001|580554618|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
160772877|NCT03329001|580554619|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
160772878|NCT03329001|580554620|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
160772879|NCT03329001|580554621|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
160772880|NCT03329001|580554622|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
160772881|NCT03329001|580554623|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
160772882|NCT03329001|580554624|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
160772883|NCT03329001|580554625|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
160772884|NCT03329001|580554618|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
160772885|NCT03329001|580554619|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
160772886|NCT03329001|580554620|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
160772887|NCT03329001|580554621|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
160772888|NCT03329001|580554622|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
160772889|NCT03329001|580554623|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
160772890|NCT03329001|580554624|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
160772891|NCT03329001|580554625|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
160772892|NCT03329001|580554618|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
160772893|NCT03329001|580554619|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
160772894|NCT03329001|580554620|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
160772895|NCT03329001|580554621|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
160772896|NCT03329001|580554622|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
160772897|NCT03329001|580554623|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
160772898|NCT03329001|580554624|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
160772899|NCT03329001|580554625|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
160772900|NCT03329001|580554618|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
160772901|NCT03329001|580554619|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
160772902|NCT03329001|580554620|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
160772903|NCT03329001|580554621|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
160540709|NCT01500278|579709341|FG001|Week 13 - Week 104|Adverse Event|54|||
160885065|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
160885066|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
160885067|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
160540710|NCT00414453|579709342|FG000|Overall Study|Abnormal lab work|16|||
160540711|NCT00183274|579709343|FG000|Phase 1: Open-Label|Adverse Event|31|||
160885068|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
160540712|NCT00183274|579709344|FG001|Phase 1: Open-Label|Adverse Event|0|||
160540713|NCT00183274|579709345|FG002|Phase 1: Open-Label|Adverse Event|0|||
160540714|NCT00183274|579709346|FG003|Phase 1: Open-Label|Adverse Event|0|||
160540715|NCT00183274|579709347|FG004|Phase 1: Open-Label|Adverse Event|0|||
160540716|NCT00183274|579709348|FG005|Phase 1: Open-Label|Adverse Event|0|||
160540717|NCT00183274|579709343|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
160540718|NCT00183274|579709344|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
160540719|NCT00183274|579709345|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
160540720|NCT00183274|579709346|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
160540721|NCT00183274|579709347|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
160540722|NCT00183274|579709348|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
160540723|NCT00183274|579709343|FG000|Phase 1: Open-Label|Protocol Violation|11|||
160540724|NCT00183274|579709344|FG001|Phase 1: Open-Label|Protocol Violation|0|||
160540725|NCT00183274|579709345|FG002|Phase 1: Open-Label|Protocol Violation|0|||
160540726|NCT00183274|579709346|FG003|Phase 1: Open-Label|Protocol Violation|0|||
160540727|NCT00183274|579709347|FG004|Phase 1: Open-Label|Protocol Violation|0|||
160540728|NCT00183274|579709348|FG005|Phase 1: Open-Label|Protocol Violation|0|||
160540729|NCT00183274|579709343|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
160540730|NCT00183274|579709344|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
160540731|NCT00183274|579709345|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
160540732|NCT00183274|579709346|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
160540733|NCT00183274|579709347|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
160540734|NCT00183274|579709348|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
160540735|NCT00183274|579709343|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
160540736|NCT00183274|579709344|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
160540737|NCT00183274|579709345|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
160540738|NCT00183274|579709346|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
160540739|NCT00183274|579709347|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
160540740|NCT00183274|579709348|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
160540741|NCT00183274|579709343|FG000|Phase 1: Open-Label|Other|9|||
160540742|NCT00183274|579709344|FG001|Phase 1: Open-Label|Other|0|||
160540743|NCT00183274|579709345|FG002|Phase 1: Open-Label|Other|0|||
160540744|NCT00183274|579709346|FG003|Phase 1: Open-Label|Other|0|||
160540745|NCT00183274|579709347|FG004|Phase 1: Open-Label|Other|0|||
160540746|NCT00183274|579709348|FG005|Phase 1: Open-Label|Other|0|||
160540747|NCT00183274|579709343|FG000|Phase 2: Double-Blind|Relapsed|0|||
160540748|NCT00183274|579709344|FG001|Phase 2: Double-Blind|Relapsed|8|||
160540749|NCT00183274|579709345|FG002|Phase 2: Double-Blind|Relapsed|29|||
160540750|NCT00183274|579709346|FG003|Phase 2: Double-Blind|Relapsed|0|||
160540751|NCT00183274|579709347|FG004|Phase 2: Double-Blind|Relapsed|0|||
160540752|NCT00183274|579709348|FG005|Phase 2: Double-Blind|Relapsed|0|||
160540753|NCT00183274|579709343|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
160540754|NCT00183274|579709344|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
160540755|NCT00183274|579709345|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
160540756|NCT00183274|579709346|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
160540757|NCT00183274|579709347|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
160540758|NCT00183274|579709348|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
160540759|NCT00183274|579709343|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
160540760|NCT00183274|579709344|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
160540761|NCT00183274|579709345|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
160540762|NCT00183274|579709346|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
160540763|NCT00183274|579709347|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
160540764|NCT00183274|579709348|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
160540765|NCT00183274|579709343|FG000|Phase 3: Double-Blind|Relapsed|0|||
160540766|NCT00183274|579709344|FG001|Phase 3: Double-Blind|Relapsed|0|||
160540767|NCT00183274|579709345|FG002|Phase 3: Double-Blind|Relapsed|0|||
160540768|NCT00183274|579709346|FG003|Phase 3: Double-Blind|Relapsed|1|||
160540769|NCT00183274|579709347|FG004|Phase 3: Double-Blind|Relapsed|11|||
160540770|NCT00183274|579709348|FG005|Phase 3: Double-Blind|Relapsed|2|||
160540771|NCT03882970|579709353|FG000|Overall Study|Adverse Event|5|||
160772904|NCT03329001|580554622|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
160772905|NCT03329001|580554623|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
160772906|NCT03329001|580554624|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
160772907|NCT03329001|580554625|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
160772908|NCT03329001|580554618|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
160772909|NCT03329001|580554619|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
160772910|NCT03329001|580554620|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
160772911|NCT03329001|580554621|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
160772912|NCT03329001|580554622|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
160772913|NCT03329001|580554623|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
160772914|NCT03329001|580554624|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
160772915|NCT03329001|580554625|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
160772916|NCT03329001|580554618|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
160772917|NCT03329001|580554619|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
160772918|NCT03329001|580554620|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
160772919|NCT03329001|580554621|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
160772920|NCT03329001|580554622|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
160772921|NCT03329001|580554623|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
160772922|NCT03329001|580554624|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
160772923|NCT03329001|580554625|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
160772924|NCT03329001|580554618|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
160772925|NCT03329001|580554619|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
160772926|NCT03329001|580554620|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
160772927|NCT03329001|580554621|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
160772928|NCT03329001|580554622|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
160772929|NCT03329001|580554623|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
160772930|NCT03329001|580554624|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
160772931|NCT03329001|580554625|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
160772932|NCT03329001|580554618|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
160772933|NCT03329001|580554619|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
160772934|NCT03329001|580554620|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
160772935|NCT03329001|580554621|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
160772936|NCT03329001|580554622|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
160772937|NCT03329001|580554623|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
160772938|NCT03329001|580554624|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
160772939|NCT03329001|580554625|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
160772940|NCT03329001|580554618|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
160772941|NCT03329001|580554619|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
160772942|NCT03329001|580554620|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
160772943|NCT03329001|580554621|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
160772944|NCT03329001|580554622|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
160772945|NCT03329001|580554623|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
160772946|NCT03329001|580554624|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
160772947|NCT03329001|580554625|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
160772948|NCT03329001|580554618|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
160772949|NCT03329001|580554619|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
160772950|NCT03329001|580554620|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
160772951|NCT03329001|580554621|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
160772952|NCT03329001|580554622|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
160772953|NCT03329001|580554623|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
160772954|NCT03329001|580554624|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
160772955|NCT03329001|580554625|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
160772956|NCT03329001|580554618|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
160772957|NCT03329001|580554619|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
160772958|NCT03329001|580554620|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
160772959|NCT03329001|580554621|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
160772960|NCT03329001|580554622|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
160772961|NCT03329001|580554623|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
160772962|NCT03329001|580554624|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
160772963|NCT03329001|580554625|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
160540772|NCT03882970|579709354|FG001|Overall Study|Adverse Event|7|||
160885069|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
160885070|NCT03023046|580974880|FG000|Overall Study|Withdrawal by Subject|1|||
160540773|NCT03882970|579709355|FG002|Overall Study|Adverse Event|3|||
160540774|NCT03882970|579709356|FG003|Overall Study|Adverse Event|1|||
160540775|NCT03882970|579709353|FG000|Overall Study|Death|1|||
160540776|NCT03882970|579709354|FG001|Overall Study|Death|2|||
160540777|NCT03882970|579709355|FG002|Overall Study|Death|1|||
160540778|NCT03882970|579709356|FG003|Overall Study|Death|1|||
160540779|NCT03882970|579709353|FG000|Overall Study|Lost to Follow-up|8|||
160540780|NCT03882970|579709354|FG001|Overall Study|Lost to Follow-up|9|||
160540781|NCT03882970|579709355|FG002|Overall Study|Lost to Follow-up|5|||
160637495|NCT04529499|580056106|FG001|Overall Study|Others|11|||
160637496|NCT00683904|580056107|FG000|Dose Level 1|Disease progression|2|||
160637497|NCT00683904|580056108|FG001|Dose Level 1|Disease progression|0|||
160885071|NCT00640835|580974886|FG000|Overall Study|Adverse Event|5|||
160885072|NCT00640835|580974887|FG001|Overall Study|Adverse Event|3|||
160885073|NCT00640835|580974886|FG000|Overall Study|Withdrawal by Subject|12|||
160885074|NCT00640835|580974887|FG001|Overall Study|Withdrawal by Subject|14|||
160885075|NCT00640835|580974886|FG000|Overall Study|Physician Decision|10|||
160885076|NCT00640835|580974887|FG001|Overall Study|Physician Decision|14|||
160885077|NCT00640835|580974886|FG000|Overall Study|Sponsor's Decision|11|||
160885078|NCT00640835|580974887|FG001|Overall Study|Sponsor's Decision|7|||
160885079|NCT00640835|580974886|FG000|Overall Study|Protocol Violation|2|||
160885080|NCT00640835|580974887|FG001|Overall Study|Protocol Violation|2|||
160885081|NCT00640835|580974886|FG000|Overall Study|Lost to Follow-up|17|||
160885082|NCT00640835|580974887|FG001|Overall Study|Lost to Follow-up|13|||
160885083|NCT00640835|580974886|FG000|Overall Study|Other Reason|19|||
160885084|NCT00640835|580974887|FG001|Overall Study|Other Reason|4|||
160885085|NCT00470158|580974888|FG000|Overall Study|Death|0|||
160885086|NCT00470158|580974889|FG001|Overall Study|Death|0|||
160885087|NCT00470158|580974890|FG002|Overall Study|Death|0|||
160637498|NCT00683904|580056107|FG000|Dose Level 1|Adverse Event|1|||
160637499|NCT00683904|580056108|FG001|Dose Level 1|Adverse Event|0|||
160637500|NCT00683904|580056107|FG000|Dose Level 2|Adverse Event|0|||
160637501|NCT00683904|580056108|FG001|Dose Level 2|Adverse Event|2|||
160637502|NCT02702271|580056109|FG000|Overall Study|Death|36|||
160637503|NCT02702271|580056110|FG001|Overall Study|Death|7|||
160637504|NCT02702271|580056109|FG000|Overall Study|Lost to Follow-up|12|||
160637505|NCT02702271|580056110|FG001|Overall Study|Lost to Follow-up|0|||
160885088|NCT00470158|580974891|FG003|Overall Study|Death|0|||
160885089|NCT00470158|580974892|FG004|Overall Study|Death|2|||
160885090|NCT00470158|580974888|FG000|Overall Study|Lost to Follow-up|7|||
160885091|NCT00470158|580974889|FG001|Overall Study|Lost to Follow-up|8|||
160885092|NCT00470158|580974890|FG002|Overall Study|Lost to Follow-up|8|||
160885093|NCT00470158|580974891|FG003|Overall Study|Lost to Follow-up|5|||
160885094|NCT00470158|580974892|FG004|Overall Study|Lost to Follow-up|4|||
160885095|NCT00470158|580974888|FG000|Overall Study|Protocol Violation|1|||
160885096|NCT00470158|580974889|FG001|Overall Study|Protocol Violation|0|||
160885097|NCT00470158|580974890|FG002|Overall Study|Protocol Violation|0|||
160885098|NCT00470158|580974891|FG003|Overall Study|Protocol Violation|0|||
160885099|NCT00470158|580974892|FG004|Overall Study|Protocol Violation|0|||
160885100|NCT00880685|580974893|FG000|Memantine 10mg|Lost to Follow-up|2|||
160885101|NCT00880685|580974893|FG000|Memantine 20mg|Withdrawal by Subject|1|||
160885102|NCT04179890|580974894|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
160885103|NCT04179890|580974895|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
160885104|NCT04179890|580974894|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
160885105|NCT04179890|580974895|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
160885106|NCT04179890|580974894|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
160885107|NCT04179890|580974895|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
160885108|NCT04179890|580974894|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
160885109|NCT04179890|580974895|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
160885110|NCT04179890|580974894|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
160885111|NCT04179890|580974895|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
160885112|NCT04179890|580974894|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
160885113|NCT04179890|580974895|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
160637506|NCT02702271|580056109|FG000|Overall Study|Withdrawal by Subject|8|||
160637507|NCT02702271|580056110|FG001|Overall Study|Withdrawal by Subject|1|||
160637508|NCT02702271|580056109|FG000|Overall Study|Physician Decision|2|||
160917925|NCT02673489|581094148|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
160540782|NCT03882970|579709356|FG003|Overall Study|Lost to Follow-up|5|||
160540783|NCT03882970|579709353|FG000|Overall Study|Physician Decision|0|||
160637509|NCT02702271|580056110|FG001|Overall Study|Physician Decision|0|||
160637510|NCT02702271|580056109|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
160885114|NCT04179890|580974894|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
160885115|NCT04179890|580974895|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
160885116|NCT04179890|580974894|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
160885117|NCT04179890|580974895|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
160540784|NCT03882970|579709354|FG001|Overall Study|Physician Decision|2|||
160540785|NCT03882970|579709355|FG002|Overall Study|Physician Decision|2|||
160540786|NCT03882970|579709356|FG003|Overall Study|Physician Decision|2|||
160540787|NCT03882970|579709353|FG000|Overall Study|Protocol Violation|2|||
160540788|NCT03882970|579709354|FG001|Overall Study|Protocol Violation|0|||
160540789|NCT03882970|579709355|FG002|Overall Study|Protocol Violation|0|||
160540790|NCT03882970|579709356|FG003|Overall Study|Protocol Violation|0|||
160540791|NCT03882970|579709353|FG000|Overall Study|Withdrawal by Subject|8|||
160540792|NCT03882970|579709354|FG001|Overall Study|Withdrawal by Subject|17|||
160540793|NCT03882970|579709355|FG002|Overall Study|Withdrawal by Subject|7|||
160540794|NCT03882970|579709356|FG003|Overall Study|Withdrawal by Subject|22|||
160540795|NCT03882970|579709353|FG000|Overall Study|Personal Reason|2|||
160540796|NCT03882970|579709354|FG001|Overall Study|Personal Reason|3|||
160540797|NCT03882970|579709355|FG002|Overall Study|Personal Reason|1|||
160540798|NCT03882970|579709356|FG003|Overall Study|Personal Reason|3|||
160540799|NCT02863809|579709357|FG000|Overall Study|Adverse Event|8|||
160540800|NCT02863809|579709358|FG001|Overall Study|Adverse Event|8|||
160540801|NCT02863809|579709357|FG000|Overall Study|Withdrawal by Subject|0|||
160540802|NCT02863809|579709358|FG001|Overall Study|Withdrawal by Subject|1|||
160540803|NCT02863809|579709357|FG000|Overall Study|Lost to Follow-up|1|||
160540804|NCT02863809|579709358|FG001|Overall Study|Lost to Follow-up|1|||
160540805|NCT02863809|579709357|FG000|Overall Study|Death|1|||
160540806|NCT02863809|579709358|FG001|Overall Study|Death|0|||
160540807|NCT02980224|579709364|FG000|Overall Study|Adverse Event|4|||
160540808|NCT02980224|579709365|FG001|Overall Study|Adverse Event|1|||
160540809|NCT02980224|579709364|FG000|Overall Study|Withdrawal by Subject|0|||
160540810|NCT02980224|579709365|FG001|Overall Study|Withdrawal by Subject|2|||
160540811|NCT00606320|579709366|FG000|Overall Study|Adverse Event|3|||
160540812|NCT00606320|579709366|FG000|Overall Study|Lack of Efficacy|5|||
160540813|NCT00606320|579709366|FG000|Overall Study|Physician Decision|7|||
160540814|NCT00606320|579709366|FG000|Overall Study|Protocol Violation|8|||
160772964|NCT03329001|580554618|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
160772965|NCT03329001|580554619|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
160772966|NCT03329001|580554620|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
160772967|NCT03329001|580554621|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
160772968|NCT03329001|580554622|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
160772969|NCT03329001|580554623|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
160772970|NCT03329001|580554624|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
160772971|NCT03329001|580554625|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
160772972|NCT03329001|580554618|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
160772973|NCT03329001|580554619|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
160772974|NCT03329001|580554620|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
160772975|NCT03329001|580554621|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
160772976|NCT03329001|580554622|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
160772977|NCT03329001|580554623|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
160772978|NCT03329001|580554624|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
160772979|NCT03329001|580554625|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
160772980|NCT03329001|580554618|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
160772981|NCT03329001|580554619|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
160772982|NCT03329001|580554620|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
160772983|NCT03329001|580554621|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
160772984|NCT03329001|580554622|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
160772985|NCT03329001|580554623|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
160772986|NCT03329001|580554624|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
160772987|NCT03329001|580554625|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
160772988|NCT03329001|580554618|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
160772989|NCT03329001|580554619|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
160772990|NCT03329001|580554620|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
160772991|NCT03329001|580554621|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
160772992|NCT03329001|580554622|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
160772993|NCT03329001|580554623|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
160772994|NCT03329001|580554624|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
160772995|NCT03329001|580554625|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
160772996|NCT01138046|580554628|FG000|Overall Study|Withdrawal due to death|6|||
160772997|NCT04797169|580554630|FG000|Overall Study|Lost to Follow-up|84|||
160772998|NCT04797169|580554631|FG001|Overall Study|Lost to Follow-up|67|||
160772999|NCT04797169|580554630|FG000|Overall Study|Pregnancy|1|||
160773000|NCT04797169|580554631|FG001|Overall Study|Pregnancy|3|||
160773001|NCT04797169|580554630|FG000|Overall Study|Withdrawal by Subject|27|||
160773002|NCT04797169|580554631|FG001|Overall Study|Withdrawal by Subject|35|||
160773003|NCT03916926|580554632|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
160773004|NCT03916926|580554633|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
160773005|NCT03916926|580554632|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
160773006|NCT03916926|580554633|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
160773007|NCT03916926|580554632|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
160773008|NCT03916926|580554633|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
160773009|NCT03916926|580554632|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
160773010|NCT03916926|580554633|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
160773011|NCT05233761|580554645|FG000|Treatment Period A|Withdrawal by Subject|12|||
160773012|NCT05233761|580554646|FG001|Treatment Period A|Withdrawal by Subject|10|||
160773013|NCT05233761|580554645|FG000|Treatment Period A|Lost to Follow-up|6|||
160773014|NCT05233761|580554646|FG001|Treatment Period A|Lost to Follow-up|12|||
160773015|NCT05233761|580554645|FG000|Treatment Period A|Protocol Violation|8|||
160773016|NCT05233761|580554646|FG001|Treatment Period A|Protocol Violation|15|||
160773017|NCT01933594|580554647|FG000|Overall Study|Lost to Follow-up|1|||
160773018|NCT01933594|580554648|FG001|Overall Study|Lost to Follow-up|0|||
160773019|NCT01933594|580554649|FG002|Overall Study|Lost to Follow-up|0|||
160773020|NCT01933594|580554650|FG003|Overall Study|Lost to Follow-up|0|||
160773021|NCT01933594|580554651|FG004|Overall Study|Lost to Follow-up|1|||
160773022|NCT01933594|580554652|FG005|Overall Study|Lost to Follow-up|0|||
160773023|NCT01933594|580554647|FG000|Overall Study|Ineligible for subsequent study step|0|||
160773024|NCT01933594|580554648|FG001|Overall Study|Ineligible for subsequent study step|0|||
160773025|NCT01933594|580554649|FG002|Overall Study|Ineligible for subsequent study step|0|||
160773026|NCT01933594|580554650|FG003|Overall Study|Ineligible for subsequent study step|0|||
160773027|NCT01933594|580554651|FG004|Overall Study|Ineligible for subsequent study step|1|||
160773028|NCT01933594|580554652|FG005|Overall Study|Ineligible for subsequent study step|0|||
160773029|NCT01654276|580554654|FG000|Overall Study|Lack of Efficacy|1|||
160773030|NCT01654276|580554654|FG000|Overall Study|Lost to Follow-up|4|||
160773031|NCT01654276|580554654|FG000|Overall Study|Withdrawal by Subject|1|||
160773032|NCT02657551|580554655|FG000|Overall Study|Adverse Event|2|||
160773033|NCT02657551|580554655|FG000|Overall Study|Withdrawal by Subject|1|||
160773034|NCT02657551|580554655|FG000|Overall Study|Non-Compliance|1|||
160773035|NCT02657551|580554655|FG000|Overall Study|Progression / Relapse|4|||
160773036|NCT04478266|580554656|FG000|Overall Study|Adverse Event|20|||
160773037|NCT04478266|580554657|FG001|Overall Study|Adverse Event|21|||
160773038|NCT04478266|580554656|FG000|Overall Study|Progressive disease|146|||
160773039|NCT04478266|580554657|FG001|Overall Study|Progressive disease|168|||
160773040|NCT04478266|580554656|FG000|Overall Study|Poor compliance to protocol|1|||
160773041|NCT04478266|580554657|FG001|Overall Study|Poor compliance to protocol|0|||
160773042|NCT04478266|580554656|FG000|Overall Study|Withdrawal by Subject|19|||
160773043|NCT04478266|580554657|FG001|Overall Study|Withdrawal by Subject|16|||
160773044|NCT04478266|580554656|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
160773045|NCT04478266|580554657|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
160773046|NCT04478266|580554656|FG000|Overall Study|Study terminated by sponsor|33|||
160773047|NCT04478266|580554657|FG001|Overall Study|Study terminated by sponsor|35|||
160773048|NCT04478266|580554656|FG000|Overall Study|Other: unspecified|5|||
160773049|NCT04478266|580554657|FG001|Overall Study|Other: unspecified|7|||
160773050|NCT04478266|580554656|FG000|Overall Study|Randomized but not treated|1|||
160773051|NCT04478266|580554657|FG001|Overall Study|Randomized but not treated|1|||
160773052|NCT04770779|580554658|FG000|Overall Study|Randomized, never treated|0|||
160773053|NCT04770779|580554659|FG001|Overall Study|Randomized, never treated|1|||
160773054|NCT04770779|580554658|FG000|Overall Study|Adverse Event|9|||
160773055|NCT04770779|580554659|FG001|Overall Study|Adverse Event|1|||
160773056|NCT04770779|580554658|FG000|Overall Study|Withdrawal by Subject|7|||
160773057|NCT04770779|580554659|FG001|Overall Study|Withdrawal by Subject|1|||
160773058|NCT04770779|580554658|FG000|Overall Study|Pregnancy|0|||
160773059|NCT04770779|580554659|FG001|Overall Study|Pregnancy|1|||
160773060|NCT02799602|580554660|FG000|Overall Study|Protocol Violation|1|||
160773061|NCT02799602|580554661|FG001|Overall Study|Protocol Violation|0|||
160773062|NCT02799602|580554660|FG000|Overall Study|Physician Decision|5|||
160773063|NCT02799602|580554661|FG001|Overall Study|Physician Decision|6|||
160773064|NCT02799602|580554660|FG000|Overall Study|Lost to Follow-up|4|||
160773065|NCT02799602|580554661|FG001|Overall Study|Lost to Follow-up|2|||
160773066|NCT02799602|580554660|FG000|Overall Study|Additional primary malignancy|11|||
160773067|NCT02799602|580554661|FG001|Overall Study|Additional primary malignancy|6|||
160773068|NCT02799602|580554660|FG000|Overall Study|Non-compliance with study drug|14|||
160773069|NCT02799602|580554661|FG001|Overall Study|Non-compliance with study drug|12|||
160773070|NCT02799602|580554660|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
160773071|NCT02799602|580554661|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
160773072|NCT02799602|580554660|FG000|Overall Study|Withdrawal by Subject|26|||
160773073|NCT02799602|580554661|FG001|Overall Study|Withdrawal by Subject|40|||
160773074|NCT02799602|580554660|FG000|Overall Study|Progressive disease - clinical progression|131|||
160773075|NCT02799602|580554661|FG001|Overall Study|Progressive disease - clinical progression|276|||
160773076|NCT02799602|580554660|FG000|Overall Study|Progressive disease - radiological progression|90|||
160773077|NCT02799602|580554661|FG001|Overall Study|Progressive disease - radiological progression|133|||
160773078|NCT02799602|580554660|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
160773079|NCT02799602|580554661|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
160773080|NCT02799602|580554660|FG000|Overall Study|Death|9|||
160773081|NCT02799602|580554661|FG001|Overall Study|Death|5|||
160773082|NCT02799602|580554660|FG000|Overall Study|Other|287|||
160773083|NCT02799602|580554661|FG001|Overall Study|Other|118|||
160773084|NCT02799602|580554660|FG000|Overall Study|Study drug never administered|0|||
160773085|NCT02799602|580554661|FG001|Overall Study|Study drug never administered|3|||
160773086|NCT01192178|580554665|FG000|Overall Study|Withdrawal by Subject|6|||
160773087|NCT01192178|580554666|FG001|Overall Study|Withdrawal by Subject|10|||
160773088|NCT01192178|580554665|FG000|Overall Study|Protocol Violation|10|||
160773089|NCT01192178|580554666|FG001|Overall Study|Protocol Violation|3|||
160773090|NCT01192178|580554665|FG000|Overall Study|Physician Decision|2|||
160773091|NCT01192178|580554666|FG001|Overall Study|Physician Decision|4|||
160773092|NCT01192178|580554665|FG000|Overall Study|Lost to Follow-up|3|||
160773093|NCT01192178|580554666|FG001|Overall Study|Lost to Follow-up|3|||
160773094|NCT01192178|580554665|FG000|Overall Study|Adverse Event|2|||
160773095|NCT01192178|580554666|FG001|Overall Study|Adverse Event|1|||
160773096|NCT01192178|580554665|FG000|Overall Study|Lack of Efficacy|1|||
160773097|NCT01192178|580554666|FG001|Overall Study|Lack of Efficacy|2|||
160773098|NCT00296517|580554669|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
160773099|NCT00296517|580554670|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
160773100|NCT00296517|580554669|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
160773101|NCT00296517|580554670|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
160773102|NCT00296517|580554669|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
160773103|NCT00296517|580554670|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
160773104|NCT00296517|580554669|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
160773105|NCT00296517|580554670|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
160773106|NCT00296517|580554669|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
160773107|NCT00296517|580554670|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
160773108|NCT00296517|580554669|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
160773109|NCT00296517|580554670|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
160773110|NCT00296517|580554669|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
160773111|NCT00296517|580554670|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
160773112|NCT00296517|580554669|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
160773113|NCT00296517|580554670|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
160773114|NCT00296517|580554669|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
160773115|NCT00296517|580554670|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
160773116|NCT00964782|580554673|FG000|Overall Study|Lost to Follow-up|1|||
160773117|NCT00964782|580554674|FG001|Overall Study|Lost to Follow-up|0|||
160773118|NCT01143324|580554677|FG000|Overall Study|Lost to Follow-up|11|||
160773119|NCT01143324|580554677|FG000|Overall Study|Withdrawal by Subject|4|||
160773120|NCT01143324|580554677|FG000|Overall Study|Explant of the device|4|||
160773121|NCT01101178|580554681|FG000|Period 1|Withdrawal by Subject|1|||
160773122|NCT01101178|580554682|FG001|Period 1|Withdrawal by Subject|2|||
160773123|NCT01101178|580554681|FG000|Period 1|Positive drug screen|1|||
160773124|NCT01101178|580554682|FG001|Period 1|Positive drug screen|1|||
160773125|NCT01101178|580554681|FG000|Period 1|Adverse Event|2|||
160773126|NCT01101178|580554682|FG001|Period 1|Adverse Event|1|||
160773127|NCT01101178|580554681|FG000|Period 2|Withdrawal by Subject|0|||
160773128|NCT01101178|580554682|FG001|Period 2|Withdrawal by Subject|1|||
160773129|NCT01850641|580554683|FG000|Overall Study|Physician Decision|1|||
160773130|NCT01850641|580554683|FG000|Overall Study|Decrease in serum phosphorus|1|||
160773131|NCT01850641|580554683|FG000|Overall Study|Decrease in serum calcium|2|||
160773132|NCT01850641|580554683|FG000|Overall Study|Increase in serum ferritin|1|||
160773133|NCT00141817|580554684|FG000|Overall Study|Protocol Violation|0|||
160773134|NCT00141817|580554685|FG001|Overall Study|Protocol Violation|0|||
160773135|NCT00141817|580554686|FG002|Overall Study|Protocol Violation|1|||
160773136|NCT00141817|580554687|FG003|Overall Study|Protocol Violation|0|||
160773137|NCT00141817|580554684|FG000|Overall Study|Parent request|1|||
160773138|NCT00141817|580554685|FG001|Overall Study|Parent request|0|||
160773139|NCT00141817|580554686|FG002|Overall Study|Parent request|0|||
160773140|NCT00141817|580554687|FG003|Overall Study|Parent request|0|||
160773141|NCT00127803|580554688|FG000|Overall Study|Adverse Event|2|||
160773142|NCT00127803|580554689|FG001|Overall Study|Adverse Event|0|||
160773143|NCT00127803|580554690|FG002|Overall Study|Adverse Event|0|||
160773144|NCT00127803|580554691|FG003|Overall Study|Adverse Event|0|||
160773145|NCT00127803|580554688|FG000|Overall Study|Withdrawal by Subject|1|||
160773146|NCT00127803|580554689|FG001|Overall Study|Withdrawal by Subject|0|||
160773147|NCT00127803|580554690|FG002|Overall Study|Withdrawal by Subject|0|||
160773148|NCT00127803|580554691|FG003|Overall Study|Withdrawal by Subject|0|||
160885118|NCT04179890|580974894|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
160885119|NCT04179890|580974895|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
160885120|NCT01236118|580974897|FG000|Overall Study|Adverse Event|2|||
160773149|NCT00127803|580554688|FG000|Overall Study|Lost to Follow-up|0|||
160773150|NCT00127803|580554689|FG001|Overall Study|Lost to Follow-up|0|||
160773151|NCT00127803|580554690|FG002|Overall Study|Lost to Follow-up|0|||
160773152|NCT00127803|580554691|FG003|Overall Study|Lost to Follow-up|1|||
160773153|NCT00858988|580554694|FG000|Analysis|Lactulose unable to be detected in urine|2|||
160773154|NCT00858988|580554695|FG001|Analysis|Lactulose unable to be detected in urine|1|||
160773155|NCT00846365|580554698|FG000|Overall Study|Adverse Event|20|||
160773156|NCT00846365|580554699|FG001|Overall Study|Adverse Event|30|||
160773157|NCT00846365|580554700|FG002|Overall Study|Adverse Event|11|||
160773158|NCT00846365|580554698|FG000|Overall Study|Protocol Violation|5|||
160773159|NCT00846365|580554699|FG001|Overall Study|Protocol Violation|4|||
160773160|NCT00846365|580554700|FG002|Overall Study|Protocol Violation|0|||
160773161|NCT00846365|580554698|FG000|Overall Study|Lost to Follow-up|8|||
160773162|NCT00846365|580554699|FG001|Overall Study|Lost to Follow-up|2|||
160773163|NCT00846365|580554700|FG002|Overall Study|Lost to Follow-up|5|||
160885121|NCT01236118|580974898|FG001|Overall Study|Adverse Event|0|||
160773164|NCT00846365|580554698|FG000|Overall Study|Withdrawal by Subject|11|||
160773165|NCT00846365|580554699|FG001|Overall Study|Withdrawal by Subject|11|||
160773166|NCT00846365|580554700|FG002|Overall Study|Withdrawal by Subject|9|||
160773167|NCT00846365|580554698|FG000|Overall Study|Pregnancy|1|||
160773168|NCT00846365|580554699|FG001|Overall Study|Pregnancy|0|||
160773169|NCT00846365|580554700|FG002|Overall Study|Pregnancy|0|||
160773170|NCT00846365|580554698|FG000|Overall Study|Lack of Efficacy|1|||
160773171|NCT00846365|580554699|FG001|Overall Study|Lack of Efficacy|1|||
160773172|NCT00846365|580554700|FG002|Overall Study|Lack of Efficacy|2|||
160773173|NCT00846365|580554698|FG000|Overall Study|Other|9|||
160773174|NCT00846365|580554699|FG001|Overall Study|Other|1|||
160773175|NCT00846365|580554700|FG002|Overall Study|Other|6|||
160773176|NCT01277861|580554706|FG000|Overall Study|Physician Decision|2|||
160773177|NCT01277861|580554707|FG001|Overall Study|Physician Decision|2|||
160773178|NCT00857389|580554708|FG000|Overall Study|Did not proceed to transplant|2|||
160773179|NCT05260008|580554709|FG000|Overall Study|Physician Decision|0|||
160773180|NCT05260008|580554710|FG001|Overall Study|Physician Decision|1|||
160773181|NCT05260008|580554711|FG002|Overall Study|Physician Decision|0|||
160773182|NCT05260008|580554712|FG003|Overall Study|Physician Decision|0|||
160773183|NCT04584788|580554715|FG000|Overall Study|Physician Decision|8|||
160773184|NCT04584788|580554715|FG000|Overall Study|Withdrawal by Subject|1|||
160773185|NCT04584788|580554715|FG000|Overall Study|Adverse Event|3|||
160773186|NCT01136915|580555991|FG000|Overall Study|Lost to Follow-up|2|||
160773187|NCT01136915|580555992|FG001|Overall Study|Lost to Follow-up|0|||
160773188|NCT01136915|580555991|FG000|Overall Study|Exclusion criterion met|0|||
160773189|NCT01136915|580555992|FG001|Overall Study|Exclusion criterion met|1|||
160773190|NCT03188822|580555993|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
160773191|NCT03188822|580555993|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
160773192|NCT00924898|580556005|FG000|Overall Study|Withdrawal by Subject|2|||
160773193|NCT02278354|580556006|FG000|Overall Study|Lost to Follow-up|2|||
160773194|NCT02278354|580556007|FG001|Overall Study|Lost to Follow-up|2|||
160773195|NCT02278354|580556006|FG000|Overall Study|Withdrawal by Subject|0|||
160773196|NCT02278354|580556007|FG001|Overall Study|Withdrawal by Subject|1|||
160773197|NCT02278354|580556006|FG000|Overall Study|<10 professional fights|2|||
160773198|NCT02278354|580556007|FG001|Overall Study|<10 professional fights|0|||
160773199|NCT03126110|580556008|FG000|Phase 1|Death|2|||
160773200|NCT03126110|580556009|FG001|Phase 1|Death|2|||
160773201|NCT03126110|580556010|FG002|Phase 1|Death|4|||
160773202|NCT03126110|580556011|FG003|Phase 1|Death|3|||
160773203|NCT03126110|580556012|FG004|Phase 1|Death|4|||
160773204|NCT03126110|580556013|FG005|Phase 1|Death|4|||
160773205|NCT03126110|580556014|FG006|Phase 1|Death|3|||
160773206|NCT03126110|580556015|FG007|Phase 1|Death|4|||
160773207|NCT03126110|580556016|FG008|Phase 1|Death|5|||
160773208|NCT03126110|580556017|FG009|Phase 1|Death|2|||
160773209|NCT03126110|580556018|FG010|Phase 1|Death|6|||
160773210|NCT03126110|580556019|FG011|Phase 1|Death|0|||
160773211|NCT03126110|580556020|FG012|Phase 1|Death|0|||
160773212|NCT03126110|580556021|FG013|Phase 1|Death|0|||
160773213|NCT03126110|580556022|FG014|Phase 1|Death|0|||
160773214|NCT03126110|580556023|FG015|Phase 1|Death|0|||
160773215|NCT03126110|580556024|FG016|Phase 1|Death|0|||
160773216|NCT03126110|580556008|FG000|Phase 1|Lost to Follow-up|0|||
160885122|NCT01236118|580974899|FG002|Overall Study|Adverse Event|2|||
160637511|NCT02702271|580056110|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
160637512|NCT01494649|580056111|FG000|Overall Study|Lost to Follow-up|0|||
160637513|NCT01494649|580056112|FG001|Overall Study|Lost to Follow-up|1|||
160637514|NCT03091400|580056113|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
160637515|NCT03091400|580056114|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
160773217|NCT03126110|580556009|FG001|Phase 1|Lost to Follow-up|1|||
160773218|NCT03126110|580556010|FG002|Phase 1|Lost to Follow-up|0|||
160773219|NCT03126110|580556011|FG003|Phase 1|Lost to Follow-up|0|||
160773220|NCT03126110|580556012|FG004|Phase 1|Lost to Follow-up|0|||
160773221|NCT03126110|580556013|FG005|Phase 1|Lost to Follow-up|0|||
160773222|NCT03126110|580556014|FG006|Phase 1|Lost to Follow-up|0|||
160773223|NCT03126110|580556015|FG007|Phase 1|Lost to Follow-up|0|||
160773224|NCT03126110|580556016|FG008|Phase 1|Lost to Follow-up|1|||
160773225|NCT03126110|580556017|FG009|Phase 1|Lost to Follow-up|0|||
160773226|NCT03126110|580556018|FG010|Phase 1|Lost to Follow-up|0|||
160773227|NCT03126110|580556019|FG011|Phase 1|Lost to Follow-up|0|||
160885123|NCT01236118|580974897|FG000|Overall Study|Physician Decision|0|||
160885124|NCT01236118|580974898|FG001|Overall Study|Physician Decision|1|||
160885125|NCT01236118|580974899|FG002|Overall Study|Physician Decision|0|||
160773228|NCT03126110|580556020|FG012|Phase 1|Lost to Follow-up|0|||
160773229|NCT03126110|580556021|FG013|Phase 1|Lost to Follow-up|0|||
160773230|NCT03126110|580556022|FG014|Phase 1|Lost to Follow-up|0|||
160773231|NCT03126110|580556023|FG015|Phase 1|Lost to Follow-up|0|||
160773232|NCT03126110|580556024|FG016|Phase 1|Lost to Follow-up|0|||
160773233|NCT03126110|580556008|FG000|Phase 1|Withdrawal by Subject|1|||
160773234|NCT03126110|580556009|FG001|Phase 1|Withdrawal by Subject|0|||
160773235|NCT03126110|580556010|FG002|Phase 1|Withdrawal by Subject|0|||
160773236|NCT03126110|580556011|FG003|Phase 1|Withdrawal by Subject|1|||
160773237|NCT03126110|580556012|FG004|Phase 1|Withdrawal by Subject|1|||
160773238|NCT03126110|580556013|FG005|Phase 1|Withdrawal by Subject|0|||
160773239|NCT03126110|580556014|FG006|Phase 1|Withdrawal by Subject|0|||
160773240|NCT03126110|580556015|FG007|Phase 1|Withdrawal by Subject|0|||
160773241|NCT03126110|580556016|FG008|Phase 1|Withdrawal by Subject|2|||
160773242|NCT03126110|580556017|FG009|Phase 1|Withdrawal by Subject|1|||
160773243|NCT03126110|580556018|FG010|Phase 1|Withdrawal by Subject|0|||
160773244|NCT03126110|580556019|FG011|Phase 1|Withdrawal by Subject|0|||
160773245|NCT03126110|580556020|FG012|Phase 1|Withdrawal by Subject|0|||
160773246|NCT03126110|580556021|FG013|Phase 1|Withdrawal by Subject|0|||
160773247|NCT03126110|580556022|FG014|Phase 1|Withdrawal by Subject|0|||
160773248|NCT03126110|580556023|FG015|Phase 1|Withdrawal by Subject|0|||
160773249|NCT03126110|580556024|FG016|Phase 1|Withdrawal by Subject|0|||
160773250|NCT03126110|580556008|FG000|Phase 1|Safety follow-up no longer necessary|1|||
160773251|NCT03126110|580556009|FG001|Phase 1|Safety follow-up no longer necessary|0|||
160773252|NCT03126110|580556010|FG002|Phase 1|Safety follow-up no longer necessary|0|||
160773253|NCT03126110|580556011|FG003|Phase 1|Safety follow-up no longer necessary|0|||
160773254|NCT03126110|580556012|FG004|Phase 1|Safety follow-up no longer necessary|0|||
160773255|NCT03126110|580556013|FG005|Phase 1|Safety follow-up no longer necessary|0|||
160773256|NCT03126110|580556014|FG006|Phase 1|Safety follow-up no longer necessary|0|||
160773257|NCT03126110|580556015|FG007|Phase 1|Safety follow-up no longer necessary|0|||
160773258|NCT03126110|580556016|FG008|Phase 1|Safety follow-up no longer necessary|0|||
160773259|NCT03126110|580556017|FG009|Phase 1|Safety follow-up no longer necessary|0|||
160773260|NCT03126110|580556018|FG010|Phase 1|Safety follow-up no longer necessary|0|||
160773261|NCT03126110|580556019|FG011|Phase 1|Safety follow-up no longer necessary|0|||
160773262|NCT03126110|580556020|FG012|Phase 1|Safety follow-up no longer necessary|0|||
160773263|NCT03126110|580556021|FG013|Phase 1|Safety follow-up no longer necessary|0|||
160773264|NCT03126110|580556022|FG014|Phase 1|Safety follow-up no longer necessary|0|||
160773265|NCT03126110|580556023|FG015|Phase 1|Safety follow-up no longer necessary|0|||
160773266|NCT03126110|580556024|FG016|Phase 1|Safety follow-up no longer necessary|0|||
160773267|NCT03126110|580556008|FG000|Phase 1|Survival follow-up no longer necessary|0|||
160773268|NCT03126110|580556009|FG001|Phase 1|Survival follow-up no longer necessary|0|||
160773269|NCT03126110|580556010|FG002|Phase 1|Survival follow-up no longer necessary|1|||
160773270|NCT03126110|580556011|FG003|Phase 1|Survival follow-up no longer necessary|0|||
160773271|NCT03126110|580556012|FG004|Phase 1|Survival follow-up no longer necessary|0|||
160773272|NCT03126110|580556013|FG005|Phase 1|Survival follow-up no longer necessary|0|||
160773273|NCT03126110|580556014|FG006|Phase 1|Survival follow-up no longer necessary|0|||
160773274|NCT03126110|580556015|FG007|Phase 1|Survival follow-up no longer necessary|0|||
160773275|NCT03126110|580556016|FG008|Phase 1|Survival follow-up no longer necessary|0|||
160773276|NCT03126110|580556017|FG009|Phase 1|Survival follow-up no longer necessary|0|||
160773277|NCT03126110|580556018|FG010|Phase 1|Survival follow-up no longer necessary|0|||
160773278|NCT03126110|580556019|FG011|Phase 1|Survival follow-up no longer necessary|0|||
160773279|NCT03126110|580556020|FG012|Phase 1|Survival follow-up no longer necessary|0|||
160773280|NCT03126110|580556021|FG013|Phase 1|Survival follow-up no longer necessary|0|||
160773281|NCT03126110|580556022|FG014|Phase 1|Survival follow-up no longer necessary|0|||
160773282|NCT03126110|580556023|FG015|Phase 1|Survival follow-up no longer necessary|0|||
160885126|NCT01236118|580974897|FG000|Overall Study|Withdrawal by Subject|0|||
160885127|NCT01236118|580974898|FG001|Overall Study|Withdrawal by Subject|0|||
160885128|NCT01236118|580974899|FG002|Overall Study|Withdrawal by Subject|1|||
160885129|NCT04535167|580974900|FG000|Treatment|Adverse Event|0|||
160885130|NCT04535167|580974901|FG001|Treatment|Adverse Event|0|||
160885131|NCT04535167|580974902|FG002|Treatment|Adverse Event|0|||
160885132|NCT04535167|580974903|FG003|Treatment|Adverse Event|0|||
160885133|NCT04535167|580974904|FG004|Treatment|Adverse Event|0|||
160885134|NCT04535167|580974905|FG005|Treatment|Adverse Event|0|||
160885135|NCT04535167|580974906|FG006|Treatment|Adverse Event|1|||
160885136|NCT04535167|580974900|FG000|Follow-Up|Death|0|||
160885137|NCT04535167|580974901|FG001|Follow-Up|Death|0|||
160885138|NCT04535167|580974902|FG002|Follow-Up|Death|0|||
160637516|NCT03467971|580056115|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160637517|NCT03467971|580056116|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160773283|NCT03126110|580556024|FG016|Phase 1|Survival follow-up no longer necessary|0|||
160773284|NCT03126110|580556008|FG000|Phase 2|Study terminated by the sponsor|0|||
160773285|NCT03126110|580556009|FG001|Phase 2|Study terminated by the sponsor|0|||
160773286|NCT03126110|580556010|FG002|Phase 2|Study terminated by the sponsor|0|||
160773287|NCT03126110|580556011|FG003|Phase 2|Study terminated by the sponsor|0|||
160773288|NCT03126110|580556012|FG004|Phase 2|Study terminated by the sponsor|0|||
160773289|NCT03126110|580556013|FG005|Phase 2|Study terminated by the sponsor|0|||
160773290|NCT03126110|580556014|FG006|Phase 2|Study terminated by the sponsor|0|||
160773291|NCT03126110|580556015|FG007|Phase 2|Study terminated by the sponsor|0|||
160773292|NCT03126110|580556016|FG008|Phase 2|Study terminated by the sponsor|0|||
160773293|NCT03126110|580556017|FG009|Phase 2|Study terminated by the sponsor|0|||
160773294|NCT03126110|580556018|FG010|Phase 2|Study terminated by the sponsor|0|||
160885139|NCT04535167|580974903|FG003|Follow-Up|Death|0|||
160637518|NCT00975884|580056117|FG000|Overall Study|Adverse Event|1|||
160885140|NCT04535167|580974904|FG004|Follow-Up|Death|0|||
160885141|NCT04535167|580974905|FG005|Follow-Up|Death|0|||
160773295|NCT03126110|580556019|FG011|Phase 2|Study terminated by the sponsor|0|||
160773296|NCT03126110|580556020|FG012|Phase 2|Study terminated by the sponsor|0|||
160773297|NCT03126110|580556021|FG013|Phase 2|Study terminated by the sponsor|4|||
160773298|NCT03126110|580556022|FG014|Phase 2|Study terminated by the sponsor|0|||
160773299|NCT03126110|580556023|FG015|Phase 2|Study terminated by the sponsor|0|||
160773300|NCT03126110|580556024|FG016|Phase 2|Study terminated by the sponsor|0|||
160773301|NCT03126110|580556008|FG000|Phase 2|Withdrawal by Subject|0|||
160773302|NCT03126110|580556009|FG001|Phase 2|Withdrawal by Subject|0|||
160773303|NCT03126110|580556010|FG002|Phase 2|Withdrawal by Subject|0|||
160773304|NCT03126110|580556011|FG003|Phase 2|Withdrawal by Subject|0|||
160773305|NCT03126110|580556012|FG004|Phase 2|Withdrawal by Subject|0|||
160773306|NCT03126110|580556013|FG005|Phase 2|Withdrawal by Subject|0|||
160773307|NCT03126110|580556014|FG006|Phase 2|Withdrawal by Subject|0|||
160773308|NCT03126110|580556015|FG007|Phase 2|Withdrawal by Subject|0|||
160773309|NCT03126110|580556016|FG008|Phase 2|Withdrawal by Subject|0|||
160773310|NCT03126110|580556017|FG009|Phase 2|Withdrawal by Subject|0|||
160773311|NCT03126110|580556018|FG010|Phase 2|Withdrawal by Subject|0|||
160773312|NCT03126110|580556019|FG011|Phase 2|Withdrawal by Subject|1|||
160773313|NCT03126110|580556020|FG012|Phase 2|Withdrawal by Subject|3|||
160773314|NCT03126110|580556021|FG013|Phase 2|Withdrawal by Subject|3|||
160773315|NCT03126110|580556022|FG014|Phase 2|Withdrawal by Subject|2|||
160773316|NCT03126110|580556023|FG015|Phase 2|Withdrawal by Subject|1|||
160773317|NCT03126110|580556024|FG016|Phase 2|Withdrawal by Subject|0|||
160773318|NCT03126110|580556008|FG000|Phase 2|Lost to Follow-up|0|||
160773319|NCT03126110|580556009|FG001|Phase 2|Lost to Follow-up|0|||
160773320|NCT03126110|580556010|FG002|Phase 2|Lost to Follow-up|0|||
160773321|NCT03126110|580556011|FG003|Phase 2|Lost to Follow-up|0|||
160773322|NCT03126110|580556012|FG004|Phase 2|Lost to Follow-up|0|||
160773323|NCT03126110|580556013|FG005|Phase 2|Lost to Follow-up|0|||
160773324|NCT03126110|580556014|FG006|Phase 2|Lost to Follow-up|0|||
160773325|NCT03126110|580556015|FG007|Phase 2|Lost to Follow-up|0|||
160773326|NCT03126110|580556016|FG008|Phase 2|Lost to Follow-up|0|||
160773327|NCT03126110|580556017|FG009|Phase 2|Lost to Follow-up|0|||
160773328|NCT03126110|580556018|FG010|Phase 2|Lost to Follow-up|0|||
160773329|NCT03126110|580556019|FG011|Phase 2|Lost to Follow-up|1|||
160773330|NCT03126110|580556020|FG012|Phase 2|Lost to Follow-up|1|||
160773331|NCT03126110|580556021|FG013|Phase 2|Lost to Follow-up|1|||
160773332|NCT03126110|580556022|FG014|Phase 2|Lost to Follow-up|2|||
160773333|NCT03126110|580556023|FG015|Phase 2|Lost to Follow-up|0|||
160773334|NCT03126110|580556024|FG016|Phase 2|Lost to Follow-up|0|||
160773335|NCT03126110|580556008|FG000|Phase 2|Death|0|||
160773336|NCT03126110|580556009|FG001|Phase 2|Death|0|||
160773337|NCT03126110|580556010|FG002|Phase 2|Death|0|||
160773338|NCT03126110|580556011|FG003|Phase 2|Death|0|||
160773339|NCT03126110|580556012|FG004|Phase 2|Death|0|||
160773340|NCT03126110|580556013|FG005|Phase 2|Death|0|||
160773341|NCT03126110|580556014|FG006|Phase 2|Death|0|||
160773342|NCT03126110|580556015|FG007|Phase 2|Death|0|||
160773343|NCT03126110|580556016|FG008|Phase 2|Death|0|||
160773344|NCT03126110|580556017|FG009|Phase 2|Death|0|||
160773345|NCT03126110|580556018|FG010|Phase 2|Death|0|||
160773346|NCT03126110|580556019|FG011|Phase 2|Death|6|||
160773347|NCT03126110|580556020|FG012|Phase 2|Death|12|||
160773348|NCT03126110|580556021|FG013|Phase 2|Death|25|||
160773349|NCT03126110|580556022|FG014|Phase 2|Death|11|||
160773350|NCT03126110|580556023|FG015|Phase 2|Death|3|||
160885142|NCT04535167|580974906|FG006|Follow-Up|Death|1|||
160885143|NCT04535167|580974900|FG000|Follow-Up|Lost to Follow-up|0|||
160540815|NCT00606320|579709366|FG000|Overall Study|Withdrawal by Subject|10|||
160637519|NCT00975884|580056118|FG001|Overall Study|Adverse Event|0|||
160773351|NCT03126110|580556024|FG016|Phase 2|Death|2|||
160773352|NCT03126110|580556008|FG000|Phase 2|Progressive Disease|0|||
160773353|NCT03126110|580556009|FG001|Phase 2|Progressive Disease|0|||
160773354|NCT03126110|580556010|FG002|Phase 2|Progressive Disease|0|||
160773355|NCT03126110|580556011|FG003|Phase 2|Progressive Disease|0|||
160773356|NCT03126110|580556012|FG004|Phase 2|Progressive Disease|0|||
160773357|NCT03126110|580556013|FG005|Phase 2|Progressive Disease|0|||
160885144|NCT04535167|580974901|FG001|Follow-Up|Lost to Follow-up|0|||
160885145|NCT04535167|580974902|FG002|Follow-Up|Lost to Follow-up|0|||
160773358|NCT03126110|580556014|FG006|Phase 2|Progressive Disease|0|||
160773359|NCT03126110|580556015|FG007|Phase 2|Progressive Disease|0|||
160773360|NCT03126110|580556016|FG008|Phase 2|Progressive Disease|0|||
160773361|NCT03126110|580556017|FG009|Phase 2|Progressive Disease|0|||
160773362|NCT03126110|580556018|FG010|Phase 2|Progressive Disease|0|||
160773363|NCT03126110|580556019|FG011|Phase 2|Progressive Disease|0|||
160773364|NCT03126110|580556020|FG012|Phase 2|Progressive Disease|0|||
160885146|NCT04535167|580974903|FG003|Follow-Up|Lost to Follow-up|1|||
160773365|NCT03126110|580556021|FG013|Phase 2|Progressive Disease|1|||
160773366|NCT03126110|580556022|FG014|Phase 2|Progressive Disease|0|||
160773367|NCT03126110|580556023|FG015|Phase 2|Progressive Disease|0|||
160773368|NCT03126110|580556024|FG016|Phase 2|Progressive Disease|0|||
160773369|NCT03126110|580556008|FG000|Phase 2|Started new treatment|0|||
160773370|NCT03126110|580556009|FG001|Phase 2|Started new treatment|0|||
160773371|NCT03126110|580556010|FG002|Phase 2|Started new treatment|0|||
160885147|NCT04535167|580974904|FG004|Follow-Up|Lost to Follow-up|0|||
160773372|NCT03126110|580556011|FG003|Phase 2|Started new treatment|0|||
160773373|NCT03126110|580556012|FG004|Phase 2|Started new treatment|0|||
160773374|NCT03126110|580556013|FG005|Phase 2|Started new treatment|0|||
160773375|NCT03126110|580556014|FG006|Phase 2|Started new treatment|0|||
160773376|NCT03126110|580556015|FG007|Phase 2|Started new treatment|0|||
160773377|NCT03126110|580556016|FG008|Phase 2|Started new treatment|0|||
160773378|NCT03126110|580556017|FG009|Phase 2|Started new treatment|0|||
160773379|NCT03126110|580556018|FG010|Phase 2|Started new treatment|0|||
160773380|NCT03126110|580556019|FG011|Phase 2|Started new treatment|0|||
160773381|NCT03126110|580556020|FG012|Phase 2|Started new treatment|0|||
160773382|NCT03126110|580556021|FG013|Phase 2|Started new treatment|0|||
160773383|NCT03126110|580556022|FG014|Phase 2|Started new treatment|1|||
160773384|NCT03126110|580556023|FG015|Phase 2|Started new treatment|0|||
160773385|NCT03126110|580556024|FG016|Phase 2|Started new treatment|0|||
160773386|NCT00314145|580556025|FG000|Overall Study|Withdrawal by Subject|8|||
160773387|NCT00314145|580556026|FG001|Overall Study|Withdrawal by Subject|10|||
160773388|NCT00314145|580556025|FG000|Overall Study|Lost to Follow-up|5|||
160773389|NCT00314145|580556026|FG001|Overall Study|Lost to Follow-up|12|||
160773390|NCT00314145|580556025|FG000|Overall Study|Physician Decision|3|||
160773391|NCT00314145|580556026|FG001|Overall Study|Physician Decision|4|||
160773392|NCT00314145|580556025|FG000|Overall Study|Adverse Event|0|||
160773393|NCT00314145|580556026|FG001|Overall Study|Adverse Event|3|||
160773394|NCT00314145|580556025|FG000|Overall Study|Protocol Violation|3|||
160773395|NCT00314145|580556026|FG001|Overall Study|Protocol Violation|0|||
160773396|NCT00314145|580556025|FG000|Overall Study|Sponsor Decision|2|||
160773397|NCT00314145|580556026|FG001|Overall Study|Sponsor Decision|0|||
160773398|NCT00294658|580556027|FG000|Overall Study|Death|0|||
160773399|NCT00294658|580556028|FG001|Overall Study|Death|1|||
160773400|NCT00294658|580556027|FG000|Overall Study|Lost to Follow-up|4|||
160773401|NCT00294658|580556028|FG001|Overall Study|Lost to Follow-up|0|||
160773402|NCT00294658|580556027|FG000|Overall Study|Physician Decision|1|||
160773403|NCT00294658|580556028|FG001|Overall Study|Physician Decision|2|||
160773404|NCT00294658|580556027|FG000|Overall Study|Pregnancy|0|||
160773405|NCT00294658|580556028|FG001|Overall Study|Pregnancy|1|||
160773406|NCT00294658|580556027|FG000|Overall Study|Withdrawal by Subject|0|||
160885148|NCT04535167|580974905|FG005|Follow-Up|Lost to Follow-up|0|||
160885149|NCT04535167|580974906|FG006|Follow-Up|Lost to Follow-up|0|||
160885150|NCT00978432|580974907|FG000|Overall Study|Withdrawal by Subject|0|||
160885151|NCT00978432|580974908|FG001|Overall Study|Withdrawal by Subject|0|||
160885152|NCT00978432|580974909|FG002|Overall Study|Withdrawal by Subject|1|||
160885153|NCT00978432|580974907|FG000|Overall Study|Lack of Efficacy|1|||
160885154|NCT00978432|580974908|FG001|Overall Study|Lack of Efficacy|1|||
160885155|NCT00978432|580974909|FG002|Overall Study|Lack of Efficacy|3|||
160885156|NCT00978432|580974907|FG000|Overall Study|Adverse Event|2|||
160885157|NCT00978432|580974908|FG001|Overall Study|Adverse Event|0|||
160885158|NCT00978432|580974909|FG002|Overall Study|Adverse Event|1|||
160885159|NCT02579928|580974910|FG000|Overall Study|Withdrawal by Subject|1|||
160885160|NCT02579928|580974911|FG001|Overall Study|Withdrawal by Subject|0|||
160885161|NCT04300751|580974914|FG000|Overall Study|Withdrawal by Subject|1|||
160885162|NCT04656275|580974920|FG000|Overall Study|Study terminated by sponsor|2|||
160885163|NCT04656275|580974921|FG001|Overall Study|Study terminated by sponsor|4|||
160885164|NCT00924781|580974923|FG000|Overall Study|Study terminated by sponsor|12|||
160885165|NCT00924781|580974924|FG001|Overall Study|Study terminated by sponsor|10|||
160885166|NCT01155479|580974929|FG000|Part I|Adverse Event|13|||
160885167|NCT01155479|580974930|FG001|Part I|Adverse Event|8|||
160885168|NCT01155479|580974931|FG002|Part I|Adverse Event|18|||
160773407|NCT00294658|580556028|FG001|Overall Study|Withdrawal by Subject|4|||
160773408|NCT00294658|580556027|FG000|Overall Study|Found to have invasive thymoma|1|||
160773409|NCT00294658|580556028|FG001|Overall Study|Found to have invasive thymoma|0|||
160773410|NCT00294658|580556027|FG000|Overall Study|Patient and family were not satisfied|0|||
160773411|NCT00294658|580556028|FG001|Overall Study|Patient and family were not satisfied|1|||
160773412|NCT05049122|580556037|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
160773413|NCT05049122|580556037|FG000|Overall Study|Participant moved|1|||
160773414|NCT05049122|580556037|FG000|Overall Study|At the direction of the doctor|1|||
160885169|NCT01155479|580974932|FG003|Part I|Adverse Event|7|||
160885170|NCT01155479|580974933|FG004|Part I|Adverse Event|6|||
160885171|NCT01155479|580974929|FG000|Part I|Administrative|2|||
160885172|NCT01155479|580974930|FG001|Part I|Administrative|2|||
160773415|NCT03314935|580556038|FG000|Phase 1|Death|4|||
160773416|NCT03314935|580556039|FG001|Phase 1|Death|2|||
160885173|NCT01155479|580974931|FG002|Part I|Administrative|2|||
160885174|NCT01155479|580974932|FG003|Part I|Administrative|0|||
160773417|NCT03314935|580556040|FG002|Phase 1|Death|5|||
160773418|NCT03314935|580556041|FG003|Phase 1|Death|4|||
160773419|NCT03314935|580556042|FG004|Phase 1|Death|3|||
160773420|NCT03314935|580556043|FG005|Phase 1|Death|4|||
160773421|NCT03314935|580556044|FG006|Phase 1|Death|5|||
160773422|NCT03314935|580556045|FG007|Phase 1|Death|4|||
160773423|NCT03314935|580556046|FG008|Phase 1|Death|3|||
160773424|NCT03314935|580556047|FG009|Phase 1|Death|0|||
160773425|NCT03314935|580556048|FG010|Phase 1|Death|0|||
160773426|NCT03314935|580556049|FG011|Phase 1|Death|0|||
160773427|NCT03314935|580556050|FG012|Phase 1|Death|0|||
160773428|NCT03314935|580556051|FG013|Phase 1|Death|0|||
160773429|NCT03314935|580556052|FG014|Phase 1|Death|0|||
160773430|NCT03314935|580556038|FG000|Phase 1|Withdrawal by Subject|2|||
160773431|NCT03314935|580556039|FG001|Phase 1|Withdrawal by Subject|1|||
160773432|NCT03314935|580556040|FG002|Phase 1|Withdrawal by Subject|1|||
160773433|NCT03314935|580556041|FG003|Phase 1|Withdrawal by Subject|2|||
160773434|NCT03314935|580556042|FG004|Phase 1|Withdrawal by Subject|1|||
160773435|NCT03314935|580556043|FG005|Phase 1|Withdrawal by Subject|0|||
160773436|NCT03314935|580556044|FG006|Phase 1|Withdrawal by Subject|1|||
160773437|NCT03314935|580556045|FG007|Phase 1|Withdrawal by Subject|0|||
160773438|NCT03314935|580556046|FG008|Phase 1|Withdrawal by Subject|1|||
160773439|NCT03314935|580556047|FG009|Phase 1|Withdrawal by Subject|0|||
160773440|NCT03314935|580556048|FG010|Phase 1|Withdrawal by Subject|0|||
160773441|NCT03314935|580556049|FG011|Phase 1|Withdrawal by Subject|0|||
160773442|NCT03314935|580556050|FG012|Phase 1|Withdrawal by Subject|0|||
160773443|NCT03314935|580556051|FG013|Phase 1|Withdrawal by Subject|0|||
160773444|NCT03314935|580556052|FG014|Phase 1|Withdrawal by Subject|0|||
160773445|NCT03314935|580556038|FG000|Phase 1|Progressive Disease|2|||
160773446|NCT03314935|580556039|FG001|Phase 1|Progressive Disease|0|||
160773447|NCT03314935|580556040|FG002|Phase 1|Progressive Disease|0|||
160773448|NCT03314935|580556041|FG003|Phase 1|Progressive Disease|1|||
160773449|NCT03314935|580556042|FG004|Phase 1|Progressive Disease|0|||
160773450|NCT03314935|580556043|FG005|Phase 1|Progressive Disease|0|||
160773451|NCT03314935|580556044|FG006|Phase 1|Progressive Disease|0|||
160773452|NCT03314935|580556045|FG007|Phase 1|Progressive Disease|0|||
160773453|NCT03314935|580556046|FG008|Phase 1|Progressive Disease|0|||
160773454|NCT03314935|580556047|FG009|Phase 1|Progressive Disease|0|||
160773455|NCT03314935|580556048|FG010|Phase 1|Progressive Disease|0|||
160773456|NCT03314935|580556049|FG011|Phase 1|Progressive Disease|0|||
160773457|NCT03314935|580556050|FG012|Phase 1|Progressive Disease|0|||
160773458|NCT03314935|580556051|FG013|Phase 1|Progressive Disease|0|||
160773459|NCT03314935|580556052|FG014|Phase 1|Progressive Disease|0|||
160773460|NCT03314935|580556038|FG000|Phase 1|Study Terminated by Sponsor|0|||
160773461|NCT03314935|580556039|FG001|Phase 1|Study Terminated by Sponsor|1|||
160773462|NCT03314935|580556040|FG002|Phase 1|Study Terminated by Sponsor|0|||
160773463|NCT03314935|580556041|FG003|Phase 1|Study Terminated by Sponsor|0|||
160773464|NCT03314935|580556042|FG004|Phase 1|Study Terminated by Sponsor|0|||
160773465|NCT03314935|580556043|FG005|Phase 1|Study Terminated by Sponsor|0|||
160773466|NCT03314935|580556044|FG006|Phase 1|Study Terminated by Sponsor|0|||
160773467|NCT03314935|580556045|FG007|Phase 1|Study Terminated by Sponsor|0|||
160773468|NCT03314935|580556046|FG008|Phase 1|Study Terminated by Sponsor|1|||
160773469|NCT03314935|580556047|FG009|Phase 1|Study Terminated by Sponsor|0|||
160773470|NCT03314935|580556048|FG010|Phase 1|Study Terminated by Sponsor|0|||
160773471|NCT03314935|580556049|FG011|Phase 1|Study Terminated by Sponsor|0|||
160773472|NCT03314935|580556050|FG012|Phase 1|Study Terminated by Sponsor|0|||
160773473|NCT03314935|580556051|FG013|Phase 1|Study Terminated by Sponsor|0|||
160773474|NCT03314935|580556052|FG014|Phase 1|Study Terminated by Sponsor|0|||
160773475|NCT03314935|580556038|FG000|Phase 1|"Captured as Other in Database"|0|||
160773476|NCT03314935|580556039|FG001|Phase 1|"Captured as Other in Database"|2|||
160885175|NCT01155479|580974933|FG004|Part I|Administrative|0|||
160773477|NCT03314935|580556040|FG002|Phase 1|"Captured as Other in Database"|0|||
160637520|NCT00975884|580056117|FG000|Overall Study|Lost to Follow-up|5|||
160773478|NCT03314935|580556041|FG003|Phase 1|"Captured as Other in Database"|0|||
160773479|NCT03314935|580556042|FG004|Phase 1|"Captured as Other in Database"|0|||
160773480|NCT03314935|580556043|FG005|Phase 1|"Captured as Other in Database"|0|||
160773481|NCT03314935|580556044|FG006|Phase 1|"Captured as Other in Database"|1|||
160773482|NCT03314935|580556045|FG007|Phase 1|"Captured as Other in Database"|1|||
160773483|NCT03314935|580556046|FG008|Phase 1|"Captured as Other in Database"|1|||
160773484|NCT03314935|580556047|FG009|Phase 1|"Captured as Other in Database"|0|||
160773485|NCT03314935|580556048|FG010|Phase 1|"Captured as Other in Database"|0|||
160773486|NCT03314935|580556049|FG011|Phase 1|"Captured as Other in Database"|0|||
160773487|NCT03314935|580556050|FG012|Phase 1|"Captured as Other in Database"|0|||
160773488|NCT03314935|580556051|FG013|Phase 1|"Captured as Other in Database"|0|||
160773489|NCT03314935|580556052|FG014|Phase 1|"Captured as Other in Database"|0|||
160773490|NCT03314935|580556038|FG000|Phase 1|Lost to Follow-up|0|||
160773491|NCT03314935|580556039|FG001|Phase 1|Lost to Follow-up|0|||
160773492|NCT03314935|580556040|FG002|Phase 1|Lost to Follow-up|0|||
160773493|NCT03314935|580556041|FG003|Phase 1|Lost to Follow-up|0|||
160773494|NCT03314935|580556042|FG004|Phase 1|Lost to Follow-up|0|||
160773495|NCT03314935|580556043|FG005|Phase 1|Lost to Follow-up|0|||
160773496|NCT03314935|580556044|FG006|Phase 1|Lost to Follow-up|0|||
160773497|NCT03314935|580556045|FG007|Phase 1|Lost to Follow-up|0|||
160773498|NCT03314935|580556046|FG008|Phase 1|Lost to Follow-up|1|||
160773499|NCT03314935|580556047|FG009|Phase 1|Lost to Follow-up|0|||
160773500|NCT03314935|580556048|FG010|Phase 1|Lost to Follow-up|0|||
160773501|NCT03314935|580556049|FG011|Phase 1|Lost to Follow-up|0|||
160773502|NCT03314935|580556050|FG012|Phase 1|Lost to Follow-up|0|||
160773503|NCT03314935|580556051|FG013|Phase 1|Lost to Follow-up|0|||
160773504|NCT03314935|580556052|FG014|Phase 1|Lost to Follow-up|0|||
160773505|NCT03314935|580556038|FG000|Phase 2|Death|0|||
160773506|NCT03314935|580556039|FG001|Phase 2|Death|0|||
160773507|NCT03314935|580556040|FG002|Phase 2|Death|0|||
160773508|NCT03314935|580556041|FG003|Phase 2|Death|0|||
160773509|NCT03314935|580556042|FG004|Phase 2|Death|0|||
160885176|NCT01155479|580974929|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
160885177|NCT01155479|580974930|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
160885178|NCT01155479|580974931|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
160885179|NCT01155479|580974932|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
160885180|NCT01155479|580974933|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
160885181|NCT01155479|580974929|FG000|Part I|Withdrawal by Subject|11|||
160885182|NCT01155479|580974930|FG001|Part I|Withdrawal by Subject|13|||
160885183|NCT01155479|580974931|FG002|Part I|Withdrawal by Subject|8|||
160885184|NCT01155479|580974932|FG003|Part I|Withdrawal by Subject|8|||
160885185|NCT01155479|580974933|FG004|Part I|Withdrawal by Subject|9|||
160885186|NCT01155479|580974929|FG000|Part I|Lost to Follow-up|0|||
160885187|NCT01155479|580974930|FG001|Part I|Lost to Follow-up|0|||
160885188|NCT01155479|580974931|FG002|Part I|Lost to Follow-up|1|||
160885189|NCT01155479|580974932|FG003|Part I|Lost to Follow-up|1|||
160885190|NCT01155479|580974933|FG004|Part I|Lost to Follow-up|0|||
160885191|NCT01155479|580974929|FG000|Part I|Treatment Failure|3|||
160885192|NCT01155479|580974930|FG001|Part I|Treatment Failure|0|||
160885193|NCT01155479|580974931|FG002|Part I|Treatment Failure|3|||
160885194|NCT01155479|580974932|FG003|Part I|Treatment Failure|1|||
160885195|NCT01155479|580974933|FG004|Part I|Treatment Failure|2|||
160885196|NCT01155479|580974929|FG000|Part I|Did Not Receive Treatment|4|||
160885197|NCT01155479|580974930|FG001|Part I|Did Not Receive Treatment|2|||
160885198|NCT01155479|580974931|FG002|Part I|Did Not Receive Treatment|2|||
160885199|NCT01155479|580974932|FG003|Part I|Did Not Receive Treatment|6|||
160885200|NCT01155479|580974933|FG004|Part I|Did Not Receive Treatment|1|||
160885201|NCT01155479|580974929|FG000|Part I|Non-Compliance with Protocol|2|||
160885202|NCT01155479|580974930|FG001|Part I|Non-Compliance with Protocol|1|||
160885203|NCT01155479|580974931|FG002|Part I|Non-Compliance with Protocol|3|||
160885204|NCT01155479|580974932|FG003|Part I|Non-Compliance with Protocol|3|||
160885205|NCT01155479|580974933|FG004|Part I|Non-Compliance with Protocol|2|||
160885206|NCT01155479|580974929|FG000|Part II|Adverse Event|7|||
160885207|NCT01155479|580974930|FG001|Part II|Adverse Event|6|||
160885208|NCT01155479|580974931|FG002|Part II|Adverse Event|8|||
160885209|NCT01155479|580974932|FG003|Part II|Adverse Event|3|||
160885210|NCT01155479|580974933|FG004|Part II|Adverse Event|4|||
160773510|NCT03314935|580556043|FG005|Phase 2|Death|0|||
160773511|NCT03314935|580556044|FG006|Phase 2|Death|0|||
160885211|NCT01155479|580974929|FG000|Part II|Administrative|43|||
160885212|NCT01155479|580974930|FG001|Part II|Administrative|49|||
160885213|NCT01155479|580974931|FG002|Part II|Administrative|36|||
160885214|NCT01155479|580974932|FG003|Part II|Administrative|38|||
160885215|NCT01155479|580974933|FG004|Part II|Administrative|46|||
160773512|NCT03314935|580556045|FG007|Phase 2|Death|0|||
160773513|NCT03314935|580556046|FG008|Phase 2|Death|0|||
160773514|NCT03314935|580556047|FG009|Phase 2|Death|5|||
160773515|NCT03314935|580556048|FG010|Phase 2|Death|20|||
160885216|NCT01155479|580974929|FG000|Part II|Withdrawal by Subject|8|||
160885217|NCT01155479|580974930|FG001|Part II|Withdrawal by Subject|4|||
160885218|NCT01155479|580974931|FG002|Part II|Withdrawal by Subject|12|||
160885219|NCT01155479|580974932|FG003|Part II|Withdrawal by Subject|7|||
160885220|NCT01155479|580974933|FG004|Part II|Withdrawal by Subject|3|||
160885221|NCT01155479|580974929|FG000|Part II|Lost to Follow-up|1|||
160773516|NCT03314935|580556049|FG011|Phase 2|Death|6|||
160773517|NCT03314935|580556050|FG012|Phase 2|Death|7|||
160773518|NCT03314935|580556051|FG013|Phase 2|Death|6|||
160773519|NCT03314935|580556052|FG014|Phase 2|Death|17|||
160773520|NCT03314935|580556038|FG000|Phase 2|Withdrawal by Subject|0|||
160885222|NCT01155479|580974930|FG001|Part II|Lost to Follow-up|0|||
160885223|NCT01155479|580974931|FG002|Part II|Lost to Follow-up|0|||
160885224|NCT01155479|580974932|FG003|Part II|Lost to Follow-up|0|||
160885225|NCT01155479|580974933|FG004|Part II|Lost to Follow-up|1|||
160773521|NCT03314935|580556039|FG001|Phase 2|Withdrawal by Subject|0|||
160773522|NCT03314935|580556040|FG002|Phase 2|Withdrawal by Subject|0|||
160773523|NCT03314935|580556041|FG003|Phase 2|Withdrawal by Subject|0|||
160773524|NCT03314935|580556042|FG004|Phase 2|Withdrawal by Subject|0|||
160773525|NCT03314935|580556043|FG005|Phase 2|Withdrawal by Subject|0|||
160773526|NCT03314935|580556044|FG006|Phase 2|Withdrawal by Subject|0|||
160773527|NCT03314935|580556045|FG007|Phase 2|Withdrawal by Subject|0|||
160773528|NCT03314935|580556046|FG008|Phase 2|Withdrawal by Subject|0|||
160773529|NCT03314935|580556047|FG009|Phase 2|Withdrawal by Subject|1|||
160773530|NCT03314935|580556048|FG010|Phase 2|Withdrawal by Subject|4|||
160773531|NCT03314935|580556049|FG011|Phase 2|Withdrawal by Subject|0|||
160773532|NCT03314935|580556050|FG012|Phase 2|Withdrawal by Subject|1|||
160773533|NCT03314935|580556051|FG013|Phase 2|Withdrawal by Subject|0|||
160773534|NCT03314935|580556052|FG014|Phase 2|Withdrawal by Subject|1|||
160773535|NCT03314935|580556038|FG000|Phase 2|Progressive Disease|0|||
160773536|NCT03314935|580556039|FG001|Phase 2|Progressive Disease|0|||
160773537|NCT03314935|580556040|FG002|Phase 2|Progressive Disease|0|||
160773538|NCT03314935|580556041|FG003|Phase 2|Progressive Disease|0|||
160773539|NCT03314935|580556042|FG004|Phase 2|Progressive Disease|0|||
160773540|NCT03314935|580556043|FG005|Phase 2|Progressive Disease|0|||
160773541|NCT03314935|580556044|FG006|Phase 2|Progressive Disease|0|||
160773542|NCT03314935|580556045|FG007|Phase 2|Progressive Disease|0|||
160773543|NCT03314935|580556046|FG008|Phase 2|Progressive Disease|0|||
160773544|NCT03314935|580556047|FG009|Phase 2|Progressive Disease|1|||
160773545|NCT03314935|580556048|FG010|Phase 2|Progressive Disease|1|||
160773546|NCT03314935|580556049|FG011|Phase 2|Progressive Disease|1|||
160773547|NCT03314935|580556050|FG012|Phase 2|Progressive Disease|2|||
160773548|NCT03314935|580556051|FG013|Phase 2|Progressive Disease|0|||
160773549|NCT03314935|580556052|FG014|Phase 2|Progressive Disease|1|||
160773550|NCT03314935|580556038|FG000|Phase 2|Study Terminated by Sponsor|0|||
160773551|NCT03314935|580556039|FG001|Phase 2|Study Terminated by Sponsor|0|||
160773552|NCT03314935|580556040|FG002|Phase 2|Study Terminated by Sponsor|0|||
160773553|NCT03314935|580556041|FG003|Phase 2|Study Terminated by Sponsor|0|||
160773554|NCT03314935|580556042|FG004|Phase 2|Study Terminated by Sponsor|0|||
160773555|NCT03314935|580556043|FG005|Phase 2|Study Terminated by Sponsor|0|||
160773556|NCT03314935|580556044|FG006|Phase 2|Study Terminated by Sponsor|0|||
160773557|NCT03314935|580556045|FG007|Phase 2|Study Terminated by Sponsor|0|||
160773558|NCT03314935|580556046|FG008|Phase 2|Study Terminated by Sponsor|0|||
160773559|NCT03314935|580556047|FG009|Phase 2|Study Terminated by Sponsor|0|||
160773560|NCT03314935|580556048|FG010|Phase 2|Study Terminated by Sponsor|7|||
160773561|NCT03314935|580556049|FG011|Phase 2|Study Terminated by Sponsor|2|||
160885226|NCT01155479|580974929|FG000|Part II|Treatment Failure|0|||
160885227|NCT01155479|580974930|FG001|Part II|Treatment Failure|1|||
160885228|NCT01155479|580974931|FG002|Part II|Treatment Failure|2|||
160885229|NCT01155479|580974932|FG003|Part II|Treatment Failure|0|||
160885230|NCT01155479|580974933|FG004|Part II|Treatment Failure|1|||
160885231|NCT01155479|580974929|FG000|Part II|Non-Compliance with Protocol|0|||
160885232|NCT01155479|580974930|FG001|Part II|Non-Compliance with Protocol|1|||
160885233|NCT01155479|580974931|FG002|Part II|Non-Compliance with Protocol|0|||
160885234|NCT01155479|580974932|FG003|Part II|Non-Compliance with Protocol|2|||
160885235|NCT01155479|580974933|FG004|Part II|Non-Compliance with Protocol|0|||
160885236|NCT01857310|580974934|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
160885237|NCT01857310|580974935|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
160885238|NCT02360605|580974936|FG000|Overall Study|Withdrawal by Subject|4|||
160885239|NCT02360605|580974937|FG001|Overall Study|Withdrawal by Subject|9|||
160885240|NCT02360605|580974936|FG000|Overall Study|Lost to Follow-up|7|||
160885241|NCT02360605|580974937|FG001|Overall Study|Lost to Follow-up|8|||
160885242|NCT02360605|580974936|FG000|Overall Study|Death|0|||
160885243|NCT02360605|580974937|FG001|Overall Study|Death|1|||
160885244|NCT00290407|580974938|FG000|Overall Study|Physician Decision|2|||
160885245|NCT00868517|580974947|FG000|Overall Study|Withdrawal by Subject|3|||
160773562|NCT03314935|580556050|FG012|Phase 2|Study Terminated by Sponsor|1|||
160773563|NCT03314935|580556051|FG013|Phase 2|Study Terminated by Sponsor|4|||
160773564|NCT03314935|580556052|FG014|Phase 2|Study Terminated by Sponsor|4|||
160773565|NCT03314935|580556038|FG000|Phase 2|Lost to Follow-up|0|||
160885246|NCT00868517|580974948|FG001|Overall Study|Withdrawal by Subject|3|||
160885247|NCT00868517|580974949|FG002|Overall Study|Withdrawal by Subject|2|||
160885248|NCT00868517|580974947|FG000|Overall Study|Protocol Violation|1|||
160885249|NCT00868517|580974948|FG001|Overall Study|Protocol Violation|1|||
160885250|NCT00868517|580974949|FG002|Overall Study|Protocol Violation|0|||
160885251|NCT01721577|580974950|FG000|Overall Study|Lack of Efficacy|1|||
160885252|NCT01721577|580974951|FG001|Overall Study|Lack of Efficacy|0|||
160773566|NCT03314935|580556039|FG001|Phase 2|Lost to Follow-up|0|||
160885253|NCT01721577|580974950|FG000|Overall Study|Death|1|||
160885254|NCT01721577|580974951|FG001|Overall Study|Death|0|||
160773567|NCT03314935|580556040|FG002|Phase 2|Lost to Follow-up|0|||
160773568|NCT03314935|580556041|FG003|Phase 2|Lost to Follow-up|0|||
160773569|NCT03314935|580556042|FG004|Phase 2|Lost to Follow-up|0|||
160773570|NCT03314935|580556043|FG005|Phase 2|Lost to Follow-up|0|||
160773571|NCT03314935|580556044|FG006|Phase 2|Lost to Follow-up|0|||
160773572|NCT03314935|580556045|FG007|Phase 2|Lost to Follow-up|0|||
160773573|NCT03314935|580556046|FG008|Phase 2|Lost to Follow-up|0|||
160773574|NCT03314935|580556047|FG009|Phase 2|Lost to Follow-up|1|||
160773575|NCT03314935|580556048|FG010|Phase 2|Lost to Follow-up|0|||
160773576|NCT03314935|580556049|FG011|Phase 2|Lost to Follow-up|0|||
160773577|NCT03314935|580556050|FG012|Phase 2|Lost to Follow-up|0|||
160773578|NCT03314935|580556051|FG013|Phase 2|Lost to Follow-up|0|||
160773579|NCT03314935|580556052|FG014|Phase 2|Lost to Follow-up|1|||
160773580|NCT03314935|580556038|FG000|Phase 2|Physician Decision|0|||
160773581|NCT03314935|580556039|FG001|Phase 2|Physician Decision|0|||
160773582|NCT03314935|580556040|FG002|Phase 2|Physician Decision|0|||
160773583|NCT03314935|580556041|FG003|Phase 2|Physician Decision|0|||
160773584|NCT03314935|580556042|FG004|Phase 2|Physician Decision|0|||
160773585|NCT03314935|580556043|FG005|Phase 2|Physician Decision|0|||
160773586|NCT03314935|580556044|FG006|Phase 2|Physician Decision|0|||
160773587|NCT03314935|580556045|FG007|Phase 2|Physician Decision|0|||
160773588|NCT03314935|580556046|FG008|Phase 2|Physician Decision|0|||
160773589|NCT03314935|580556047|FG009|Phase 2|Physician Decision|0|||
160773590|NCT03314935|580556048|FG010|Phase 2|Physician Decision|1|||
160773591|NCT03314935|580556049|FG011|Phase 2|Physician Decision|0|||
160773592|NCT03314935|580556050|FG012|Phase 2|Physician Decision|0|||
160773593|NCT03314935|580556051|FG013|Phase 2|Physician Decision|0|||
160773594|NCT03314935|580556052|FG014|Phase 2|Physician Decision|0|||
160773595|NCT05845619|580556053|FG000|Overall Study|duplicate enrollment|2|||
160773596|NCT05845619|580556054|FG001|Overall Study|duplicate enrollment|2|||
160773597|NCT05845619|580556055|FG002|Overall Study|duplicate enrollment|1|||
160773598|NCT05252702|580556056|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
160773599|NCT05252702|580556056|FG000|Overall Study|Death|16|||
160773600|NCT05252702|580556056|FG000|Overall Study|System explant|5|||
160773601|NCT05252702|580556056|FG000|Overall Study|Lost to Follow-up|1|||
160773602|NCT05252702|580556056|FG000|Overall Study|Withdrawn by investigator|1|||
160773603|NCT05252702|580556056|FG000|Overall Study|Visit not due|306|||
160773604|NCT05252702|580556056|FG000|Overall Study|Visit within window but not completed|92|||
160773605|NCT05252702|580556056|FG000|Overall Study|Unsuccessful implant|1|||
160773606|NCT04153864|580556057|FG000|Overall Study|Withdrawal by Subject|21|||
160773607|NCT04153864|580556058|FG001|Overall Study|Withdrawal by Subject|7|||
160773608|NCT04153864|580556059|FG002|Overall Study|Withdrawal by Subject|23|||
160773609|NCT04153864|580556060|FG003|Overall Study|Withdrawal by Subject|2|||
160773610|NCT04153864|580556057|FG000|Overall Study|Lost to Follow-up|4|||
160773611|NCT04153864|580556058|FG001|Overall Study|Lost to Follow-up|0|||
160773612|NCT04153864|580556059|FG002|Overall Study|Lost to Follow-up|3|||
160773613|NCT04153864|580556060|FG003|Overall Study|Lost to Follow-up|0|||
160773614|NCT04153864|580556057|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
160773615|NCT04153864|580556058|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
160773616|NCT04153864|580556059|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
160773617|NCT04153864|580556060|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
160773618|NCT04717557|580556063|FG000|Overall Study|Withdrawal by Subject|2|||
160773619|NCT04717557|580556064|FG001|Overall Study|Withdrawal by Subject|0|||
160773620|NCT04717557|580556063|FG000|Overall Study|Death|1|||
160773621|NCT04717557|580556064|FG001|Overall Study|Death|0|||
160773622|NCT06354257|580556067|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160885255|NCT01721577|580974950|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
160885256|NCT01721577|580974951|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
160885257|NCT01721577|580974950|FG000|Overall Study|Adverse Event|0|||
160885258|NCT01721577|580974951|FG001|Overall Study|Adverse Event|2|||
160885259|NCT01055496|580974952|FG000|Overall Study|Withdrawal by Subject|2|||
160885260|NCT01055496|580974953|FG001|Overall Study|Withdrawal by Subject|4|||
160885261|NCT01055496|580974952|FG000|Overall Study|Death|13|||
160885262|NCT01055496|580974953|FG001|Overall Study|Death|23|||
160885263|NCT01055496|580974952|FG000|Overall Study|Lost to Follow-up|0|||
160885264|NCT01055496|580974953|FG001|Overall Study|Lost to Follow-up|2|||
160885265|NCT01055496|580974952|FG000|Overall Study|Other - Unspecified|0|||
160885266|NCT01055496|580974953|FG001|Overall Study|Other - Unspecified|1|||
160885267|NCT00584740|580974954|FG000|Overall Study|Adverse Event|1|||
160885268|NCT00584740|580974955|FG001|Overall Study|Adverse Event|1|||
160885269|NCT00584740|580974954|FG000|Overall Study|Lack of Efficacy|8|||
160885270|NCT00584740|580974955|FG001|Overall Study|Lack of Efficacy|2|||
160885271|NCT00584740|580974954|FG000|Overall Study|Withdrawal by Subject|3|||
160885272|NCT00584740|580974955|FG001|Overall Study|Withdrawal by Subject|2|||
160885273|NCT00584740|580974954|FG000|Overall Study|Lost to Follow-up|0|||
160885274|NCT00584740|580974955|FG001|Overall Study|Lost to Follow-up|1|||
160885275|NCT02158364|580974956|FG000|Overall Study|Case report forms uncollected|10|||
160885276|NCT02158364|580974956|FG000|Overall Study|Protocol Deviation|50|||
160885277|NCT00732940|580974960|FG000|Overall Study|Withdrawal by Subject|1|||
160885278|NCT00732940|580974961|FG001|Overall Study|Withdrawal by Subject|2|||
160885279|NCT00732940|580974960|FG000|Overall Study|Adverse Event|0|||
160885280|NCT00732940|580974961|FG001|Overall Study|Adverse Event|1|||
160885281|NCT00732940|580974960|FG000|Overall Study|Lost to Follow-up|1|||
160885282|NCT00732940|580974961|FG001|Overall Study|Lost to Follow-up|0|||
160885283|NCT01642732|580974962|FG000|Overall Study|Withdrawal by Subject|1|||
160885284|NCT01589770|580974967|FG000|Overall Study|EGFR <60ml/min|6|||
160885285|NCT01589770|580974968|FG001|Overall Study|EGFR <60ml/min|4|||
160885286|NCT01589770|580974967|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
160885287|NCT01589770|580974968|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
160885288|NCT01077375|580974972|FG000|Overall Study|Adverse Event|2|||
160885289|NCT01077375|580974973|FG001|Overall Study|Adverse Event|15|||
160885290|NCT01077375|580974972|FG000|Overall Study|Lack of Efficacy|6|||
160885291|NCT01077375|580974973|FG001|Overall Study|Lack of Efficacy|8|||
160885292|NCT01077375|580974972|FG000|Overall Study|Withdrawal by Subject|0|||
160885293|NCT01077375|580974973|FG001|Overall Study|Withdrawal by Subject|6|||
160885294|NCT01077375|580974972|FG000|Overall Study|Lost to Follow-up|2|||
160885295|NCT01077375|580974973|FG001|Overall Study|Lost to Follow-up|5|||
160885296|NCT01077375|580974972|FG000|Overall Study|Other Reason|0|||
160885297|NCT01077375|580974973|FG001|Overall Study|Other Reason|1|||
160885298|NCT03021564|580974977|FG000|Overall Study|Death|84|||
160885299|NCT03021564|580974978|FG001|Overall Study|Death|466|||
160885300|NCT03021564|580974977|FG000|Overall Study|Lost to Follow-up|0|||
160885301|NCT03021564|580974978|FG001|Overall Study|Lost to Follow-up|2|||
160885302|NCT00969280|580974979|FG000|Overall Study|Protocol Violation|2|||
160885303|NCT00969280|580974980|FG001|Overall Study|Protocol Violation|1|||
160885304|NCT00969280|580974979|FG000|Overall Study|Withdrawal by Subject|0|||
160885305|NCT00969280|580974980|FG001|Overall Study|Withdrawal by Subject|1|||
160885306|NCT00969280|580974979|FG000|Overall Study|infection of influenza A(H1N1)|0|||
160885307|NCT00969280|580974980|FG001|Overall Study|infection of influenza A(H1N1)|1|||
160885308|NCT00821327|580974981|FG000|Overall Study|Adverse Event|13|||
160885309|NCT00821327|580974981|FG000|Overall Study|Patient Request|1|||
160885310|NCT00821327|580974981|FG000|Overall Study|Investigator Request|2|||
160885311|NCT00821327|580974981|FG000|Overall Study|Sponsor Request|1|||
160885312|NCT00821327|580974981|FG000|Overall Study|Disease Progression|13|||
160540816|NCT00606320|579709366|FG000|Overall Study|Progression to depressive phase|4|||
160540817|NCT00879645|579709367|FG000|Overall Study|Adverse Event|1|||
160540818|NCT00879645|579709368|FG001|Overall Study|Adverse Event|0|||
160540819|NCT00879645|579709369|FG002|Overall Study|Adverse Event|0|||
160885313|NCT00821327|580974981|FG000|Overall Study|Other/Unknown|5|||
160885314|NCT00217464|580974982|FG000|Overall Study|Progression|15|||
160540820|NCT00879645|579709370|FG003|Overall Study|Adverse Event|0|||
160540821|NCT00749996|579709371|FG000|Overall Study|Lost to Follow-up|7|||
160540822|NCT00749996|579709372|FG001|Overall Study|Lost to Follow-up|4|||
160885315|NCT00217464|580974982|FG000|Overall Study|Other|2|||
160885316|NCT00459979|580974983|FG000|Overall Study|Withdrawal by Subject|1|||
160885317|NCT00459979|580974983|FG000|Overall Study|Protocol Violation|1|||
160885318|NCT00278915|580974984|FG000|Overall Study|Disease progression|1|||
160885319|NCT05214573|580974985|FG000|Overall Study|Physician Decision|5924|||
160885320|NCT05214573|580974986|FG001|Overall Study|Physician Decision|0|||
160885321|NCT00814801|580974987|FG000|Overall Study|Adverse Event|15|||
160885322|NCT00814801|580974988|FG001|Overall Study|Adverse Event|16|||
160885323|NCT00814801|580974989|FG002|Overall Study|Adverse Event|19|||
160885324|NCT00814801|580974987|FG000|Overall Study|Withdrawal by Subject|9|||
160885325|NCT00814801|580974988|FG001|Overall Study|Withdrawal by Subject|11|||
160885326|NCT00814801|580974989|FG002|Overall Study|Withdrawal by Subject|14|||
160885327|NCT00814801|580974987|FG000|Overall Study|Inappropriate as a subject|1|||
160885328|NCT00814801|580974988|FG001|Overall Study|Inappropriate as a subject|1|||
160885329|NCT00814801|580974989|FG002|Overall Study|Inappropriate as a subject|1|||
160885330|NCT00814801|580974987|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
160885331|NCT00814801|580974988|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
160885332|NCT00814801|580974989|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
160885333|NCT00814801|580974987|FG000|Overall Study|Missing or change of caregiver|6|||
160885334|NCT00814801|580974988|FG001|Overall Study|Missing or change of caregiver|2|||
160885335|NCT00814801|580974989|FG002|Overall Study|Missing or change of caregiver|4|||
160885336|NCT00814801|580974987|FG000|Overall Study|Non-compliance|0|||
160885337|NCT00814801|580974988|FG001|Overall Study|Non-compliance|1|||
160885338|NCT00814801|580974989|FG002|Overall Study|Non-compliance|1|||
160885339|NCT00814801|580974987|FG000|Overall Study|Other|2|||
160885340|NCT00814801|580974988|FG001|Overall Study|Other|6|||
160885341|NCT00814801|580974989|FG002|Overall Study|Other|4|||
160885342|NCT01037088|580974992|FG000|Overall Study|Withdrawal by Subject|3|||
160885343|NCT02216812|580974993|FG000|Overall Study|Lost to Follow-up|10|||
160885344|NCT02216812|580974994|FG001|Overall Study|Lost to Follow-up|5|||
160885345|NCT00527488|580974995|FG000|Overall Study|Withdrawn prior to dosing|0|||
160885346|NCT00527488|580974996|FG001|Overall Study|Withdrawn prior to dosing|1|||
160885347|NCT00527488|580974997|FG002|Overall Study|Withdrawn prior to dosing|1|||
160885348|NCT00527488|580974998|FG003|Overall Study|Withdrawn prior to dosing|0|||
160885349|NCT03036800|580974999|FG000|Overall Study|Protocol Violation|1|||
160885350|NCT03036800|580975000|FG001|Overall Study|Protocol Violation|0|||
160885351|NCT03036800|580974999|FG000|Overall Study|Non-compliance|1|||
160885352|NCT03036800|580975000|FG001|Overall Study|Non-compliance|0|||
160885353|NCT03036800|580974999|FG000|Overall Study|Lost to Follow-up|1|||
160885354|NCT03036800|580975000|FG001|Overall Study|Lost to Follow-up|0|||
160885355|NCT03036800|580974999|FG000|Overall Study|Death|1|||
160885356|NCT03036800|580975000|FG001|Overall Study|Death|0|||
160885357|NCT03036800|580974999|FG000|Overall Study|Tolerance|5|||
160885358|NCT03036800|580975000|FG001|Overall Study|Tolerance|0|||
160885359|NCT03036800|580974999|FG000|Overall Study|Unknown/no reason given|50|||
160885360|NCT03036800|580975000|FG001|Overall Study|Unknown/no reason given|39|||
160885361|NCT01986933|580975001|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
160885362|NCT01986933|580975002|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
160885363|NCT01986933|580975003|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
160885364|NCT01986933|580975004|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
160885365|NCT01986933|580975005|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
160885366|NCT01986933|580975001|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
160885367|NCT01986933|580975002|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
160885368|NCT01986933|580975003|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
160885369|NCT01986933|580975004|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
160885370|NCT01986933|580975005|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
160885371|NCT01986933|580975001|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
160885372|NCT01986933|580975002|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
160885373|NCT01986933|580975003|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
160885374|NCT01986933|580975004|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
160885375|NCT01986933|580975005|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
160885376|NCT01986933|580975001|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
160885377|NCT01986933|580975002|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
160885378|NCT01986933|580975003|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
160885379|NCT01986933|580975004|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
160885380|NCT01986933|580975005|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
160885381|NCT01986933|580975001|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
160885382|NCT01986933|580975002|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
160885383|NCT01986933|580975003|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
160885384|NCT01986933|580975004|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
160885385|NCT01986933|580975005|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
160885386|NCT01986933|580975001|FG000|Active-to-active (Part B)|Adverse Event|0|||
160885387|NCT01986933|580975002|FG001|Active-to-active (Part B)|Adverse Event|2|||
160885388|NCT01986933|580975003|FG002|Active-to-active (Part B)|Adverse Event|0|||
160885389|NCT01986933|580975004|FG003|Active-to-active (Part B)|Adverse Event|1|||
160885390|NCT01986933|580975005|FG004|Active-to-active (Part B)|Adverse Event|3|||
160885391|NCT01986933|580975001|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
160885392|NCT01986933|580975002|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
160885393|NCT01986933|580975003|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
160885394|NCT01986933|580975004|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
160885395|NCT01986933|580975005|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
160885396|NCT01986933|580975001|FG000|Active-to-active (Part B)|Pregnancy|0|||
160885397|NCT01986933|580975002|FG001|Active-to-active (Part B)|Pregnancy|0|||
160885398|NCT01986933|580975003|FG002|Active-to-active (Part B)|Pregnancy|0|||
160885399|NCT01986933|580975004|FG003|Active-to-active (Part B)|Pregnancy|0|||
160885400|NCT01986933|580975005|FG004|Active-to-active (Part B)|Pregnancy|1|||
160885401|NCT01986933|580975001|FG000|Active-to-active (Part B)|Physician Decision|0|||
160885402|NCT01986933|580975002|FG001|Active-to-active (Part B)|Physician Decision|0|||
160885403|NCT01986933|580975003|FG002|Active-to-active (Part B)|Physician Decision|1|||
160885404|NCT01986933|580975004|FG003|Active-to-active (Part B)|Physician Decision|1|||
160885405|NCT01986933|580975005|FG004|Active-to-active (Part B)|Physician Decision|0|||
160885406|NCT01986933|580975001|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
160885407|NCT01986933|580975002|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
160885408|NCT01986933|580975003|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
160885409|NCT01986933|580975004|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
160885410|NCT01986933|580975005|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
160885411|NCT01986933|580975001|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
160885412|NCT01986933|580975002|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
160885413|NCT01986933|580975003|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
160885414|NCT01986933|580975004|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
160885415|NCT01986933|580975005|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
160885416|NCT01986933|580975001|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
160885417|NCT01986933|580975002|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
160885418|NCT01986933|580975003|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
160885419|NCT01986933|580975004|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
160885420|NCT01986933|580975005|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
160885421|NCT01986933|580975001|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
160885422|NCT01986933|580975002|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
160885423|NCT01986933|580975003|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
160885424|NCT01986933|580975004|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
160885425|NCT01986933|580975005|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
160885426|NCT01986933|580975001|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
160885427|NCT01986933|580975002|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
160885428|NCT01986933|580975003|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
160885429|NCT01986933|580975004|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
160885430|NCT01986933|580975005|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
160885431|NCT01986933|580975001|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
160885432|NCT01986933|580975002|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
160885433|NCT01986933|580975003|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
160885434|NCT01986933|580975004|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
160885435|NCT01986933|580975005|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
160885436|NCT01986933|580975001|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
160885437|NCT01986933|580975002|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
160885438|NCT01986933|580975003|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
160885439|NCT01986933|580975004|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
160885440|NCT01986933|580975005|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
160885441|NCT01986933|580975001|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
160885442|NCT01986933|580975002|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
160885443|NCT01986933|580975003|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
160540823|NCT00749996|579709371|FG000|Overall Study|Withdrawal by Subject|5|||
160540824|NCT00749996|579709372|FG001|Overall Study|Withdrawal by Subject|4|||
160540825|NCT00749996|579709371|FG000|Overall Study|Protocol Violation|2|||
160540826|NCT00749996|579709372|FG001|Overall Study|Protocol Violation|3|||
160540827|NCT00749996|579709371|FG000|Overall Study|Physician Decision|2|||
160540828|NCT00749996|579709372|FG001|Overall Study|Physician Decision|0|||
160540829|NCT00749996|579709371|FG000|Overall Study|Pregnancy|0|||
160540830|NCT00749996|579709372|FG001|Overall Study|Pregnancy|2|||
160540831|NCT00749996|579709371|FG000|Overall Study|Adverse Event|1|||
160540832|NCT00749996|579709372|FG001|Overall Study|Adverse Event|0|||
160540833|NCT00749996|579709371|FG000|Overall Study|Death|1|||
160540834|NCT00749996|579709372|FG001|Overall Study|Death|0|||
160540835|NCT00996944|579709373|FG000|Double-blind Treatment Period|Adverse Event|2|||
160540836|NCT00996944|579709374|FG001|Double-blind Treatment Period|Adverse Event|1|||
160540837|NCT00996944|579709373|FG000|Double-blind Treatment Period|Protocol Violation|1|||
160540838|NCT00996944|579709374|FG001|Double-blind Treatment Period|Protocol Violation|0|||
160540839|NCT00996944|579709373|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
160540840|NCT00996944|579709374|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
160540841|NCT00996944|579709373|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
160540842|NCT00996944|579709374|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
160540843|NCT00996944|579709373|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
160540844|NCT00996944|579709374|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
160540845|NCT02250274|579709375|FG000|Overall Study|Insufficient blood draw amount|7|||
160540846|NCT02250274|579709376|FG001|Overall Study|Insufficient blood draw amount|6|||
160540847|NCT00583362|579709377|FG000|Overall Study|Adverse Event|44|||
160540848|NCT00583362|579709377|FG000|Overall Study|Lack of Efficacy|22|||
160637521|NCT00975884|580056118|FG001|Overall Study|Lost to Follow-up|3|||
160885444|NCT01986933|580975004|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
160885445|NCT01986933|580975005|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
160885446|NCT01077154|580975006|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
160885447|NCT01077154|580975007|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
160885448|NCT01077154|580975006|FG000|Overall Study|Withdrawal by Subject|369|||
160885449|NCT01077154|580975007|FG001|Overall Study|Withdrawal by Subject|385|||
160885450|NCT01077154|580975006|FG000|Overall Study|Death|215|||
160885451|NCT01077154|580975007|FG001|Overall Study|Death|214|||
160885452|NCT01077154|580975006|FG000|Overall Study|Lost to Follow-up|43|||
160885453|NCT01077154|580975007|FG001|Overall Study|Lost to Follow-up|35|||
160885454|NCT01077154|580975006|FG000|Overall Study|Noncompliance|22|||
160885455|NCT01077154|580975007|FG001|Overall Study|Noncompliance|20|||
160885456|NCT01077154|580975006|FG000|Overall Study|Disease Progression|18|||
160885457|NCT01077154|580975007|FG001|Overall Study|Disease Progression|20|||
160885458|NCT01077154|580975006|FG000|Overall Study|Ineligibility Determined|10|||
160885459|NCT01077154|580975007|FG001|Overall Study|Ineligibility Determined|14|||
160885460|NCT01077154|580975006|FG000|Overall Study|Other|14|||
160885461|NCT01077154|580975007|FG001|Overall Study|Other|11|||
160885462|NCT01077154|580975006|FG000|Overall Study|Adverse Event|9|||
160885463|NCT01077154|580975007|FG001|Overall Study|Adverse Event|9|||
160885464|NCT01077154|580975006|FG000|Overall Study|Administrative Decision|1|||
160885465|NCT01077154|580975007|FG001|Overall Study|Administrative Decision|6|||
160885466|NCT01077154|580975006|FG000|Overall Study|Protocol Deviation|1|||
160885467|NCT01077154|580975007|FG001|Overall Study|Protocol Deviation|0|||
160885468|NCT04030026|580975008|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
160885469|NCT04030026|580975009|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
160885470|NCT04030026|580975008|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
160885471|NCT04030026|580975009|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
160885472|NCT04030026|580975008|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
160885473|NCT04030026|580975009|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
160885474|NCT04030026|580975008|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
160885475|NCT04030026|580975009|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
160885476|NCT04030026|580975008|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
160885477|NCT04030026|580975009|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
160885478|NCT04030026|580975008|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
160885479|NCT04030026|580975009|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
160885480|NCT04030026|580975008|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
160885481|NCT04030026|580975009|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
160885482|NCT02545543|580975010|FG000|Overall Study|Lost to Follow-up|67|||
160885483|NCT02545543|580975011|FG001|Overall Study|Lost to Follow-up|25|||
160885484|NCT02545543|580975010|FG000|Overall Study|Physician Decision|3|||
160885485|NCT02545543|580975011|FG001|Overall Study|Physician Decision|0|||
160885486|NCT02545543|580975010|FG000|Overall Study|Withdrawal by Subject|9|||
160885487|NCT02545543|580975011|FG001|Overall Study|Withdrawal by Subject|8|||
160885488|NCT02545543|580975010|FG000|Overall Study|Noncomplaince|1|||
160885489|NCT02545543|580975011|FG001|Overall Study|Noncomplaince|0|||
160885490|NCT02545543|580975010|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
160885491|NCT02545543|580975011|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
160885492|NCT00811642|580975012|FG000|Overall Study|Adverse Event|3|||
160885493|NCT00811642|580975012|FG000|Overall Study|Protocol Violation|1|||
160885494|NCT00811642|580975012|FG000|Overall Study|Death|2|||
160885495|NCT00811642|580975012|FG000|Overall Study|Withdrawal by Subject|7|||
160885496|NCT00811642|580975012|FG000|Overall Study|Cumulative use of antifungal agent|2|||
160885497|NCT00622739|580976373|FG000|Overall Study|Physician Decision|1|||
160885498|NCT00622739|580976374|FG001|Overall Study|Physician Decision|0|||
160885499|NCT00622739|580976373|FG000|Overall Study|Adverse Event|1|||
160885500|NCT00622739|580976374|FG001|Overall Study|Adverse Event|2|||
160885501|NCT00622739|580976373|FG000|Overall Study|Lack of Efficacy|0|||
160885502|NCT00622739|580976374|FG001|Overall Study|Lack of Efficacy|2|||
160885503|NCT00622739|580976373|FG000|Overall Study|Withdrawal by Subject|0|||
160885504|NCT00622739|580976374|FG001|Overall Study|Withdrawal by Subject|1|||
160885505|NCT00622739|580976373|FG000|Overall Study|Lost to Follow-up|0|||
160885506|NCT00622739|580976374|FG001|Overall Study|Lost to Follow-up|1|||
160885507|NCT00134784|580976375|FG000|Overall Study|Withdrawal by Subject|2|||
160885508|NCT00134784|580976376|FG001|Overall Study|Withdrawal by Subject|2|||
160885509|NCT00134784|580976377|FG002|Overall Study|Withdrawal by Subject|2|||
160885510|NCT00134784|580976378|FG003|Overall Study|Withdrawal by Subject|1|||
160885511|NCT00625742|580976379|FG000|Overall Study|Disease Progression|2|||
160885512|NCT00625742|580976379|FG000|Overall Study|Withdrawal by Subject|1|||
160885513|NCT00625742|580976379|FG000|Overall Study|Adverse Event|4|||
160885514|NCT00625742|580976379|FG000|Overall Study|Lost to Follow-up|4|||
160885515|NCT00625742|580976379|FG000|Overall Study|Ineligible|1|||
160885516|NCT03384693|580976380|FG000|Overall Study|Adverse Event|3|||
160885517|NCT03387150|580976381|FG000|Overall Study|Withdrawal by Subject|3|||
160540849|NCT00583362|579709377|FG000|Overall Study|Lost to Follow-up|4|||
160885518|NCT03387150|580976382|FG001|Overall Study|Withdrawal by Subject|0|||
160885519|NCT03387150|580976383|FG002|Overall Study|Withdrawal by Subject|3|||
160885520|NCT03387150|580976384|FG003|Overall Study|Withdrawal by Subject|4|||
160885521|NCT03387150|580976385|FG004|Overall Study|Withdrawal by Subject|1|||
160885522|NCT03387150|580976386|FG005|Overall Study|Withdrawal by Subject|2|||
160885523|NCT03387150|580976387|FG006|Overall Study|Withdrawal by Subject|0|||
160885524|NCT03387150|580976381|FG000|Overall Study|Lost to Follow-up|3|||
160885525|NCT03387150|580976382|FG001|Overall Study|Lost to Follow-up|2|||
160885526|NCT03387150|580976383|FG002|Overall Study|Lost to Follow-up|2|||
160885527|NCT03387150|580976384|FG003|Overall Study|Lost to Follow-up|3|||
160885528|NCT03387150|580976385|FG004|Overall Study|Lost to Follow-up|3|||
160885529|NCT03387150|580976386|FG005|Overall Study|Lost to Follow-up|3|||
160637522|NCT00975884|580056117|FG000|Overall Study|Withdrawal by Subject|9|||
160637523|NCT00975884|580056118|FG001|Overall Study|Withdrawal by Subject|9|||
160637524|NCT00975884|580056117|FG000|Overall Study|Other|1|||
160637525|NCT00975884|580056118|FG001|Overall Study|Other|3|||
160637526|NCT03707522|580056119|FG000|Overall Study|Lost to Follow-up|24|||
160637527|NCT03707522|580056120|FG001|Overall Study|Lost to Follow-up|27|||
160637528|NCT03707522|580056121|FG002|Overall Study|Lost to Follow-up|41|||
160637529|NCT03707522|580056122|FG003|Overall Study|Lost to Follow-up|36|||
160637530|NCT00383019|580056123|FG000|Overall Study|Adverse Event|5|||
160637531|NCT00383019|580056124|FG001|Overall Study|Adverse Event|1|||
160637532|NCT00383019|580056123|FG000|Overall Study|Withdrawal by Subject|0|||
160637533|NCT00383019|580056124|FG001|Overall Study|Withdrawal by Subject|1|||
160637534|NCT01619085|580056128|FG000|Overall Study|Adverse Event|231|||
160637535|NCT01619085|580056128|FG000|Overall Study|Protocol Violation|4|||
160885530|NCT03387150|580976387|FG006|Overall Study|Lost to Follow-up|0|||
160885531|NCT03387150|580976381|FG000|Overall Study|Participant unable to adhere to visit|0|||
160885532|NCT03387150|580976382|FG001|Overall Study|Participant unable to adhere to visit|1|||
160885533|NCT03387150|580976383|FG002|Overall Study|Participant unable to adhere to visit|0|||
160885534|NCT03387150|580976384|FG003|Overall Study|Participant unable to adhere to visit|0|||
160885535|NCT03387150|580976385|FG004|Overall Study|Participant unable to adhere to visit|2|||
160885536|NCT03387150|580976386|FG005|Overall Study|Participant unable to adhere to visit|2|||
160885537|NCT03387150|580976387|FG006|Overall Study|Participant unable to adhere to visit|0|||
160885538|NCT04006119|580976388|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
160885539|NCT04006119|580976388|FG000|End of Treatment Veledimex|Adverse Event|2|||
160885540|NCT04006119|580976388|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
160885541|NCT04006119|580976388|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
160885542|NCT04006119|580976388|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
160637536|NCT01619085|580056128|FG000|Overall Study|Lost to Follow-up|3|||
160637537|NCT01619085|580056128|FG000|Overall Study|Withdrawal by Subject|45|||
160637538|NCT01619085|580056128|FG000|Overall Study|Other than specified|96|||
160637539|NCT01619085|580056128|FG000|Overall Study|Not treated|1|||
160637540|NCT01619085|580056128|FG000|Overall Study|Death|145|||
160637541|NCT01345058|580056129|FG000|Overall Study|Withdrawal by Subject|1|||
160637542|NCT01345058|580056130|FG001|Overall Study|Withdrawal by Subject|0|||
160637543|NCT01345058|580056129|FG000|Overall Study|Participant Reported Increase in Events|1|||
160637544|NCT01345058|580056130|FG001|Overall Study|Participant Reported Increase in Events|0|||
160637545|NCT01345058|580056129|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
160637546|NCT01345058|580056130|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
160637547|NCT01345058|580056129|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
160637548|NCT01345058|580056130|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
160637549|NCT01345058|580056129|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
160637550|NCT01345058|580056130|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
160885543|NCT04006119|580976388|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
160885544|NCT00920907|580976393|FG000|Induction Period|Adverse Event|0|||
160885545|NCT00920907|580976394|FG001|Induction Period|Adverse Event|2|||
160885546|NCT00920907|580976393|FG000|Induction Period|Death|1|||
160885547|NCT00920907|580976394|FG001|Induction Period|Death|1|||
160885548|NCT00920907|580976393|FG000|Induction Period|Disease Progression|12|||
160885549|NCT00920907|580976394|FG001|Induction Period|Disease Progression|11|||
160885550|NCT00920907|580976393|FG000|Induction Period|Study Drug Toxicity|8|||
160885551|NCT00920907|580976394|FG001|Induction Period|Study Drug Toxicity|6|||
160885552|NCT00920907|580976393|FG000|Induction Period|No longer meets study criteria|0|||
160885553|NCT00920907|580976394|FG001|Induction Period|No longer meets study criteria|1|||
160885554|NCT00920907|580976393|FG000|Induction Period|Withdrawal by Subject|1|||
160885555|NCT00920907|580976394|FG001|Induction Period|Withdrawal by Subject|1|||
160885556|NCT00920907|580976393|FG000|Maintenance Period|Disease Progression|3|||
160885557|NCT00920907|580976394|FG001|Maintenance Period|Disease Progression|7|||
160885558|NCT00920907|580976393|FG000|Maintenance Period|Administrative (study closure)|7|||
160637551|NCT00000135|580056131|FG000|Overall Study|Death|27|||
160637552|NCT00000135|580056132|FG001|Overall Study|Death|14|||
160637553|NCT02989610|580056135|FG000|Overall Study|Withdrawal by Subject|20|||
160637554|NCT02989610|580056135|FG000|Overall Study|Departure of PI from Site|8|||
160637555|NCT02989610|580056135|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
160637556|NCT02989610|580056135|FG000|Overall Study|Lost to Follow-up|3|||
160637557|NCT02989610|580056135|FG000|Overall Study|Death|3|||
160637558|NCT02989610|580056135|FG000|Overall Study|System Explant|3|||
160637559|NCT02989610|580056135|FG000|Overall Study|Subject Non-Compliance|2|||
160637560|NCT02989610|580056135|FG000|Overall Study|System Revision|2|||
160637561|NCT02989610|580056135|FG000|Overall Study|PI Left, Study Closing|1|||
160885559|NCT00920907|580976394|FG001|Maintenance Period|Administrative (study closure)|2|||
160885560|NCT00920907|580976393|FG000|Maintenance Period|Study Drug Toxicity|0|||
160885561|NCT00920907|580976394|FG001|Maintenance Period|Study Drug Toxicity|2|||
160885562|NCT00920907|580976393|FG000|Maintenance Period|Death|1|||
160637562|NCT02989610|580056135|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
160637563|NCT02989610|580056135|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
160637564|NCT02602080|580056141|FG000|Overall Study|Protocol Violation|6|||
160637565|NCT02602080|580056142|FG001|Overall Study|Protocol Violation|1|||
160637566|NCT02602080|580056143|FG002|Overall Study|Protocol Violation|3|||
160637567|NCT01066039|580056148|FG000|Overall Study|Adverse Event|6|||
160637568|NCT01066039|580056148|FG000|Overall Study|Withdrawal by Subject|17|||
160637569|NCT01066039|580056148|FG000|Overall Study|Protocol Violation|2|||
160637570|NCT01066039|580056148|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
160637571|NCT01066039|580056148|FG000|Overall Study|Investigator's Request|1|||
160637572|NCT01066039|580056148|FG000|Overall Study|Dropout due to Insulin Administration|1|||
160637573|NCT01066039|580056148|FG000|Overall Study|Additional Antihypertensive Required|4|||
160637574|NCT01066039|580056148|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
160637575|NCT01066039|580056148|FG000|Overall Study|Failure to Control Blood Pressure|1|||
160637576|NCT01066039|580056148|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
160637577|NCT02574260|580056149|FG000|Overall Study|Disease Progression|1|||
160885563|NCT00920907|580976394|FG001|Maintenance Period|Death|1|||
160885564|NCT00920907|580976393|FG000|Maintenance Period|Withdrawal by Subject|1|||
160885565|NCT00920907|580976394|FG001|Maintenance Period|Withdrawal by Subject|0|||
160885566|NCT00920907|580976393|FG000|Maintenance Period|Adverse Event|0|||
160885567|NCT00920907|580976394|FG001|Maintenance Period|Adverse Event|1|||
160885568|NCT02616601|580976395|FG000|Overall Study|Withdrawal by Subject|4|||
160885569|NCT02616601|580976396|FG001|Overall Study|Withdrawal by Subject|4|||
160885570|NCT02616601|580976397|FG002|Overall Study|Withdrawal by Subject|3|||
160885571|NCT02616601|580976395|FG000|Overall Study|Adverse Event|2|||
160885572|NCT02616601|580976396|FG001|Overall Study|Adverse Event|0|||
160885573|NCT02616601|580976397|FG002|Overall Study|Adverse Event|2|||
160885574|NCT02616601|580976395|FG000|Overall Study|Death|1|||
160885575|NCT02616601|580976396|FG001|Overall Study|Death|0|||
160885576|NCT02616601|580976397|FG002|Overall Study|Death|0|||
160885577|NCT02616601|580976395|FG000|Overall Study|Lost to Follow-up|1|||
160885578|NCT02616601|580976396|FG001|Overall Study|Lost to Follow-up|0|||
160885579|NCT02616601|580976397|FG002|Overall Study|Lost to Follow-up|1|||
160885580|NCT02616601|580976395|FG000|Overall Study|Non-Compliance with Test Article|1|||
160885581|NCT02616601|580976396|FG001|Overall Study|Non-Compliance with Test Article|0|||
160885582|NCT02616601|580976397|FG002|Overall Study|Non-Compliance with Test Article|1|||
160885583|NCT00371761|580976398|FG000|Overall Study|Adverse Event|1|||
160885584|NCT00371761|580976399|FG001|Overall Study|Adverse Event|1|||
160885585|NCT00371761|580976398|FG000|Overall Study|Withdrawal by Subject|1|||
160885586|NCT00371761|580976399|FG001|Overall Study|Withdrawal by Subject|3|||
160885587|NCT00371761|580976398|FG000|Overall Study|Investigator Judgment|2|||
160885588|NCT00371761|580976399|FG001|Overall Study|Investigator Judgment|3|||
160885589|NCT00371761|580976398|FG000|Overall Study|Study termination|4|||
160885590|NCT00371761|580976399|FG001|Overall Study|Study termination|3|||
160885591|NCT00718081|580976400|FG000|Overall Study|Adverse Event|0|||
160637578|NCT04508621|580056150|FG000|Overall Study|Adverse Event|39|||
160637579|NCT04508621|580056151|FG001|Overall Study|Adverse Event|16|||
160637580|NCT04508621|580056150|FG000|Overall Study|Lack of Efficacy|2|||
160637581|NCT04508621|580056151|FG001|Overall Study|Lack of Efficacy|8|||
160885592|NCT00718081|580976401|FG001|Overall Study|Adverse Event|1|||
160885593|NCT00718081|580976402|FG002|Overall Study|Adverse Event|0|||
160885594|NCT00718081|580976400|FG000|Overall Study|Lack of Efficacy|7|||
160885595|NCT00718081|580976401|FG001|Overall Study|Lack of Efficacy|3|||
160885596|NCT00718081|580976402|FG002|Overall Study|Lack of Efficacy|21|||
160885597|NCT00815516|580976403|FG000|Overall Study|Death|3|||
160885598|NCT00815516|580976404|FG001|Overall Study|Death|1|||
160885599|NCT00815516|580976403|FG000|Overall Study|Physician Decision|1|||
160885600|NCT00815516|580976404|FG001|Overall Study|Physician Decision|0|||
160885601|NCT01992159|580976411|FG000|Overall Study|Withdrawal by Subject|4|||
160637582|NCT04508621|580056150|FG000|Overall Study|Physician Decision|0|||
160637583|NCT04508621|580056151|FG001|Overall Study|Physician Decision|1|||
160637584|NCT04508621|580056150|FG000|Overall Study|Withdrawal by Subject|10|||
160637585|NCT04508621|580056151|FG001|Overall Study|Withdrawal by Subject|14|||
160637586|NCT04508621|580056150|FG000|Overall Study|Lost to Follow-up|12|||
160885602|NCT01992159|580976412|FG001|Overall Study|Withdrawal by Subject|7|||
160885603|NCT01992159|580976413|FG002|Overall Study|Withdrawal by Subject|0|||
160885604|NCT01992159|580976414|FG003|Overall Study|Withdrawal by Subject|3|||
160885605|NCT01992159|580976411|FG000|Overall Study|Adverse Event|0|||
160885606|NCT01992159|580976412|FG001|Overall Study|Adverse Event|1|||
160885607|NCT01992159|580976413|FG002|Overall Study|Adverse Event|0|||
160885608|NCT01992159|580976414|FG003|Overall Study|Adverse Event|1|||
160885609|NCT01992159|580976411|FG000|Overall Study|Death|0|||
160540850|NCT00583362|579709377|FG000|Overall Study|Non-compliance with study drug|28|||
160540851|NCT00583362|579709377|FG000|Overall Study|Pregnancy|7|||
160540852|NCT00583362|579709377|FG000|Overall Study|Miscommunication of visit window|5|||
160540853|NCT00583362|579709377|FG000|Overall Study|Current site closed|7|||
160540854|NCT00583362|579709377|FG000|Overall Study|Subject not dosed in LBSL99|1|||
160540855|NCT00583362|579709377|FG000|Overall Study|Subject moved out of the country/state|2|||
160540856|NCT00583362|579709377|FG000|Overall Study|Missed visits due to staff changes|1|||
160540857|NCT00583362|579709377|FG000|Overall Study|Misunderstanding of protocol|1|||
160540858|NCT00583362|579709377|FG000|Overall Study|Behavioral problems and non-compliance|1|||
160540859|NCT00583362|579709377|FG000|Overall Study|Sponsor request due to missed doses|1|||
160540860|NCT00583362|579709377|FG000|Overall Study|Physician Decision|19|||
160540861|NCT00583362|579709377|FG000|Overall Study|Protocol Violation|2|||
160540862|NCT00583362|579709377|FG000|Overall Study|Withdrawal by Subject|57|||
160540863|NCT03765138|579709380|FG000|Overall Study|Lost to Follow-up|1|||
160540864|NCT00640328|579709386|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
160540865|NCT00640328|579709387|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
160540866|NCT00640328|579709388|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
160540867|NCT00640328|579709389|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
160540868|NCT00640328|579709390|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
160540869|NCT00640328|579709391|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
160540870|NCT00640328|579709386|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
160540871|NCT00640328|579709387|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
160540872|NCT00640328|579709388|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
160540873|NCT00640328|579709389|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
160540874|NCT00640328|579709390|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
160540875|NCT00640328|579709391|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
160540876|NCT00640328|579709386|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
160540877|NCT00640328|579709387|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
160540878|NCT00640328|579709388|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
160540879|NCT00640328|579709389|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
160540880|NCT00640328|579709390|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
160540881|NCT00640328|579709391|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
160540882|NCT00640328|579709386|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
160540883|NCT00640328|579709387|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
160540884|NCT00640328|579709388|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
160540885|NCT00640328|579709389|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
160540886|NCT00640328|579709390|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
160540887|NCT00640328|579709391|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
160540888|NCT01714687|579709392|FG000|Overall Study|Withdrawal by Subject|1|||
160540889|NCT01714687|579709393|FG001|Overall Study|Withdrawal by Subject|0|||
160540890|NCT01714687|579709392|FG000|Overall Study|Lost to Follow-up|2|||
160540891|NCT01714687|579709393|FG001|Overall Study|Lost to Follow-up|4|||
160540892|NCT00788372|579709394|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
160540893|NCT00788372|579709394|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
160540894|NCT00788372|579709394|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
160540895|NCT00788372|579709394|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
160540896|NCT00788372|579709394|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
160540897|NCT00788372|579709394|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
160540898|NCT00788372|579709394|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
160540899|NCT03099187|579709403|FG000|Double-blind Treatment|Adverse Event|19|||
160540900|NCT03099187|579709404|FG001|Double-blind Treatment|Adverse Event|1|||
160540901|NCT03099187|579709405|FG002|Double-blind Treatment|Adverse Event|0|||
160540902|NCT03099187|579709406|FG003|Double-blind Treatment|Adverse Event|0|||
160540903|NCT03099187|579709403|FG000|Double-blind Treatment|Death|1|||
160540904|NCT03099187|579709404|FG001|Double-blind Treatment|Death|3|||
160540905|NCT03099187|579709405|FG002|Double-blind Treatment|Death|0|||
160540906|NCT03099187|579709406|FG003|Double-blind Treatment|Death|0|||
160540907|NCT03099187|579709403|FG000|Double-blind Treatment|Lack of Efficacy|1|||
160540908|NCT03099187|579709404|FG001|Double-blind Treatment|Lack of Efficacy|0|||
160540909|NCT03099187|579709405|FG002|Double-blind Treatment|Lack of Efficacy|0|||
160540910|NCT03099187|579709406|FG003|Double-blind Treatment|Lack of Efficacy|0|||
160540911|NCT03099187|579709403|FG000|Double-blind Treatment|Physician Decision|2|||
160540912|NCT03099187|579709404|FG001|Double-blind Treatment|Physician Decision|1|||
160540913|NCT03099187|579709405|FG002|Double-blind Treatment|Physician Decision|0|||
160540914|NCT03099187|579709406|FG003|Double-blind Treatment|Physician Decision|0|||
160540915|NCT03099187|579709403|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
160885610|NCT01992159|580976412|FG001|Overall Study|Death|0|||
160540916|NCT03099187|579709404|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
160540917|NCT03099187|579709405|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
160540918|NCT03099187|579709406|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
160540919|NCT03099187|579709403|FG000|Double-blind Treatment|Lung transplantation|0|||
160540920|NCT03099187|579709404|FG001|Double-blind Treatment|Lung transplantation|1|||
160540921|NCT03099187|579709405|FG002|Double-blind Treatment|Lung transplantation|0|||
160540922|NCT03099187|579709406|FG003|Double-blind Treatment|Lung transplantation|0|||
160540923|NCT03099187|579709403|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
160540924|NCT03099187|579709404|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
160540925|NCT03099187|579709405|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
160540926|NCT03099187|579709406|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
160540927|NCT03099187|579709403|FG000|Double-blind Treatment|Disease progression|0|||
160540928|NCT03099187|579709404|FG001|Double-blind Treatment|Disease progression|1|||
160540929|NCT03099187|579709405|FG002|Double-blind Treatment|Disease progression|0|||
160540930|NCT03099187|579709406|FG003|Double-blind Treatment|Disease progression|0|||
160540931|NCT03099187|579709403|FG000|Double-blind Treatment|Randomization error|0|||
160540932|NCT03099187|579709404|FG001|Double-blind Treatment|Randomization error|2|||
160540933|NCT03099187|579709405|FG002|Double-blind Treatment|Randomization error|0|||
160637587|NCT04508621|580056151|FG001|Overall Study|Lost to Follow-up|9|||
160637588|NCT04508621|580056150|FG000|Overall Study|COVID-19 related crisis|3|||
160637589|NCT04508621|580056151|FG001|Overall Study|COVID-19 related crisis|0|||
160637590|NCT04508621|580056150|FG000|Overall Study|Subject non-compliance|1|||
160637591|NCT04508621|580056151|FG001|Overall Study|Subject non-compliance|0|||
160637592|NCT00752895|580056152|FG000|Overall Study|Withdrawal by Subject|8|||
160637593|NCT00752895|580056153|FG001|Overall Study|Withdrawal by Subject|3|||
160637594|NCT03022799|580056154|FG000|Overall Study|Adverse Event|0|||
160637595|NCT03022799|580056155|FG001|Overall Study|Adverse Event|0|||
160637596|NCT03022799|580056156|FG002|Overall Study|Adverse Event|0|||
160637597|NCT03022799|580056157|FG003|Overall Study|Adverse Event|0|||
160637598|NCT03022799|580056158|FG004|Overall Study|Adverse Event|0|||
160637599|NCT03022799|580056159|FG005|Overall Study|Adverse Event|0|||
160637600|NCT03022799|580056160|FG006|Overall Study|Adverse Event|0|||
160637601|NCT03022799|580056161|FG007|Overall Study|Adverse Event|0|||
160637602|NCT03022799|580056162|FG008|Overall Study|Adverse Event|0|||
160637603|NCT03022799|580056163|FG009|Overall Study|Adverse Event|1|||
160637604|NCT03022799|580056164|FG010|Overall Study|Adverse Event|1|||
160637605|NCT03022799|580056165|FG011|Overall Study|Adverse Event|0|||
160637606|NCT03022799|580056166|FG012|Overall Study|Adverse Event|0|||
160637607|NCT04881448|580056169|FG000|Overall Study|Study cancelled by sponsor|220|||
160637608|NCT04881448|580056169|FG000|Overall Study|Withdrawal by Subject|2|||
160637609|NCT04881448|580056169|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
160637610|NCT03273257|580056171|FG000|Overall Study|Death|0|||
160637611|NCT03273257|580056172|FG001|Overall Study|Death|1|||
160637612|NCT03273257|580056171|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
160637613|NCT03273257|580056172|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
160637614|NCT03273257|580056171|FG000|Overall Study|Study terminated|3|||
160637615|NCT03273257|580056172|FG001|Overall Study|Study terminated|2|||
160637616|NCT01898884|580056173|FG000|Multiple Dose Period|Adverse Event|0|||
160637617|NCT01898884|580056174|FG001|Multiple Dose Period|Adverse Event|0|||
160637618|NCT01898884|580056175|FG002|Multiple Dose Period|Adverse Event|0|||
160637619|NCT01898884|580056176|FG003|Multiple Dose Period|Adverse Event|0|||
160637620|NCT01898884|580056177|FG004|Multiple Dose Period|Adverse Event|0|||
160637621|NCT01898884|580056178|FG005|Multiple Dose Period|Adverse Event|0|||
160637622|NCT01898884|580056179|FG006|Multiple Dose Period|Adverse Event|1|||
160637623|NCT01898884|580056180|FG007|Multiple Dose Period|Adverse Event|0|||
160637624|NCT01898884|580056181|FG008|Multiple Dose Period|Adverse Event|0|||
160637625|NCT01898884|580056173|FG000|Multiple Dose Period|Randomized Not Treated|0|||
160637626|NCT01898884|580056174|FG001|Multiple Dose Period|Randomized Not Treated|0|||
160637627|NCT01898884|580056175|FG002|Multiple Dose Period|Randomized Not Treated|0|||
160637628|NCT01898884|580056176|FG003|Multiple Dose Period|Randomized Not Treated|0|||
160637629|NCT01898884|580056177|FG004|Multiple Dose Period|Randomized Not Treated|0|||
160637630|NCT01898884|580056178|FG005|Multiple Dose Period|Randomized Not Treated|0|||
160637631|NCT01898884|580056179|FG006|Multiple Dose Period|Randomized Not Treated|0|||
160540934|NCT03099187|579709406|FG003|Double-blind Treatment|Randomization error|0|||
160637632|NCT01898884|580056180|FG007|Multiple Dose Period|Randomized Not Treated|0|||
160637633|NCT01898884|580056181|FG008|Multiple Dose Period|Randomized Not Treated|1|||
160637634|NCT00434148|580056182|FG000|Overall Study|Adverse Event|18|||
160637635|NCT00434148|580056183|FG001|Overall Study|Adverse Event|18|||
160637636|NCT00434148|580056182|FG000|Overall Study|Lack of Efficacy|25|||
160637637|NCT00434148|580056183|FG001|Overall Study|Lack of Efficacy|28|||
160637638|NCT00434148|580056182|FG000|Overall Study|Withdrawal by Subject|15|||
160540935|NCT03099187|579709403|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
160540936|NCT03099187|579709404|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
160885611|NCT01992159|580976413|FG002|Overall Study|Death|1|||
160885612|NCT01992159|580976414|FG003|Overall Study|Death|0|||
160885613|NCT01249118|580976415|FG000|First Washout Period|Physician Decision|0|||
160885614|NCT01249118|580976416|FG001|First Washout Period|Physician Decision|1|||
160885615|NCT01249118|580976417|FG002|First Washout Period|Physician Decision|0|||
160885616|NCT00997438|580976418|FG000|Overall Study|Blood draw difficulty|2|||
160885617|NCT00997438|580976419|FG001|Overall Study|Blood draw difficulty|0|||
160885618|NCT00997438|580976420|FG002|Overall Study|Blood draw difficulty|1|||
160885619|NCT00997438|580976418|FG000|Overall Study|Withdrawal by Subject|1|||
160885620|NCT00997438|580976419|FG001|Overall Study|Withdrawal by Subject|1|||
160885621|NCT00997438|580976420|FG002|Overall Study|Withdrawal by Subject|0|||
160885622|NCT00997438|580976418|FG000|Overall Study|Exclusion criteria at visit 1|2|||
160885623|NCT00997438|580976419|FG001|Overall Study|Exclusion criteria at visit 1|2|||
160885624|NCT00997438|580976420|FG002|Overall Study|Exclusion criteria at visit 1|3|||
160885625|NCT00095238|580976421|FG000|Overall Study|Lack of Efficacy|9|||
160885626|NCT00095238|580976422|FG001|Overall Study|Lack of Efficacy|9|||
160885627|NCT00095238|580976421|FG000|Overall Study|Adverse Event|331|||
160885628|NCT00095238|580976422|FG001|Overall Study|Adverse Event|287|||
160885629|NCT00095238|580976421|FG000|Overall Study|Subject Withdrew Consent|208|||
160885630|NCT00095238|580976422|FG001|Overall Study|Subject Withdrew Consent|223|||
160885631|NCT00095238|580976421|FG000|Overall Study|Death|154|||
160885632|NCT00095238|580976422|FG001|Overall Study|Death|170|||
160885633|NCT00095238|580976421|FG000|Overall Study|Lost to Follow-up|19|||
160885634|NCT00095238|580976422|FG001|Overall Study|Lost to Follow-up|24|||
160885635|NCT00095238|580976421|FG000|Overall Study|Noncompliance|44|||
160885636|NCT00095238|580976422|FG001|Overall Study|Noncompliance|45|||
160885637|NCT00095238|580976421|FG000|Overall Study|No longer met study criteria|4|||
160885638|NCT00095238|580976422|FG001|Overall Study|No longer met study criteria|5|||
160885639|NCT00095238|580976421|FG000|Overall Study|Study terminated by sponsor|0|||
160885640|NCT00095238|580976422|FG001|Overall Study|Study terminated by sponsor|1|||
160885641|NCT00095238|580976421|FG000|Overall Study|Missing|1|||
160885642|NCT00095238|580976422|FG001|Overall Study|Missing|0|||
160885643|NCT00095238|580976421|FG000|Overall Study|Other Reasons|87|||
160885644|NCT00095238|580976422|FG001|Overall Study|Other Reasons|88|||
160885645|NCT03754972|580976423|FG000|Overall Study|Protocol Violation|25|||
160885646|NCT02311582|580976424|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
160885647|NCT02311582|580976425|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
160885648|NCT02311582|580976426|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
160885649|NCT02311582|580976427|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
160885650|NCT02311582|580976428|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
160885651|NCT03404960|580976430|FG000|Overall Study|Adverse Event|0|||
160885652|NCT03404960|580976431|FG001|Overall Study|Adverse Event|2|||
160885653|NCT03404960|580976430|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
160885654|NCT03404960|580976431|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
160885655|NCT03404960|580976430|FG000|Overall Study|Bowel obstruction|0|||
160885656|NCT03404960|580976431|FG001|Overall Study|Bowel obstruction|1|||
160885657|NCT03404960|580976430|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
160885658|NCT03404960|580976431|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
160885659|NCT06460493|580976434|FG000|Overall Study|Withdrawal by Subject|2|||
160885660|NCT04972630|580976437|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
160885661|NCT04972630|580976438|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
160885662|NCT04972630|580976439|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
160885663|NCT00075270|580976444|FG000|Overall Study|Withdrawal by Subject|28|||
160885664|NCT00075270|580976445|FG001|Overall Study|Withdrawal by Subject|21|||
160885665|NCT00075270|580976444|FG000|Overall Study|Lost to Follow-up|25|||
160885666|NCT00075270|580976445|FG001|Overall Study|Lost to Follow-up|28|||
160885667|NCT00075270|580976444|FG000|Overall Study|Protocol Violation|0|||
160885668|NCT00075270|580976445|FG001|Overall Study|Protocol Violation|2|||
160885669|NCT00075270|580976444|FG000|Overall Study|Death|198|||
160885670|NCT00075270|580976445|FG001|Overall Study|Death|215|||
160885671|NCT00075270|580976444|FG000|Overall Study|Other/Unknown|9|||
160885672|NCT00075270|580976445|FG001|Overall Study|Other/Unknown|5|||
160885673|NCT00075270|580976444|FG000|Overall Study|Missing|26|||
160885674|NCT00075270|580976445|FG001|Overall Study|Missing|13|||
160885675|NCT00246571|580976446|FG000|Overall Study|Adverse Event|7|||
160885676|NCT00246571|580976447|FG001|Overall Study|Adverse Event|0|||
160885677|NCT00246571|580976446|FG000|Overall Study|Protocol Violation|0|||
160885678|NCT00246571|580976447|FG001|Overall Study|Protocol Violation|1|||
160885679|NCT00246571|580976446|FG000|Overall Study|Withdrawal by Subject|2|||
160885680|NCT00246571|580976447|FG001|Overall Study|Withdrawal by Subject|3|||
160885681|NCT00246571|580976446|FG000|Overall Study|Lack of Efficacy|84|||
160540937|NCT03099187|579709405|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
160540938|NCT03099187|579709406|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
160540939|NCT03099187|579709403|FG000|12-month Safety Follow-up|Adverse Event|0|||
160540940|NCT03099187|579709404|FG001|12-month Safety Follow-up|Adverse Event|0|||
160540941|NCT03099187|579709405|FG002|12-month Safety Follow-up|Adverse Event|5|||
160540942|NCT03099187|579709406|FG003|12-month Safety Follow-up|Adverse Event|12|||
160540943|NCT03099187|579709403|FG000|12-month Safety Follow-up|Death|0|||
160540944|NCT03099187|579709404|FG001|12-month Safety Follow-up|Death|0|||
160540945|NCT03099187|579709405|FG002|12-month Safety Follow-up|Death|7|||
160540946|NCT03099187|579709406|FG003|12-month Safety Follow-up|Death|9|||
160540947|NCT03099187|579709403|FG000|12-month Safety Follow-up|Lung transplantation|0|||
160540948|NCT03099187|579709404|FG001|12-month Safety Follow-up|Lung transplantation|0|||
160540949|NCT03099187|579709405|FG002|12-month Safety Follow-up|Lung transplantation|2|||
160540950|NCT03099187|579709406|FG003|12-month Safety Follow-up|Lung transplantation|1|||
160540951|NCT03099187|579709403|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
160540952|NCT03099187|579709404|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
160540953|NCT03099187|579709405|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
160540954|NCT03099187|579709406|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
160540955|NCT03099187|579709403|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
160540956|NCT03099187|579709404|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
160540957|NCT03099187|579709405|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
160540958|NCT03099187|579709406|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
160540959|NCT03099187|579709403|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
160540960|NCT03099187|579709404|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
160540961|NCT03099187|579709405|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
160540962|NCT03099187|579709406|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
160540963|NCT03099187|579709403|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
160540964|NCT03099187|579709404|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
160540965|NCT03099187|579709405|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
160540966|NCT03099187|579709406|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
160540967|NCT01210690|579709409|FG000|Overall Study|Adverse Event|7|||
160540968|NCT01210690|579709409|FG000|Overall Study|Lack of Efficacy|12|||
160540969|NCT01210690|579709409|FG000|Overall Study|Lost to Follow-up|3|||
160540970|NCT01210690|579709409|FG000|Overall Study|Disease Remission|1|||
160540971|NCT01210690|579709409|FG000|Overall Study|Withdrawal by Subject|1|||
160540972|NCT01210690|579709409|FG000|Overall Study|Patient refused to swallow|1|||
160540973|NCT01210690|579709409|FG000|Overall Study|Patient could not take glucose|1|||
160540974|NCT00470054|579709410|FG000|Overall Study|Ineligible|1|||
160540975|NCT01439555|579709411|FG000|Overall Study|Protocol Violation|1|||
160540976|NCT04869345|579709417|FG000|Overall Study|Lost to Follow-up|8|||
160540977|NCT04869345|579709418|FG001|Overall Study|Lost to Follow-up|3|||
160540978|NCT04194528|579709423|FG000|Overall Study|Adverse Event|1|||
160540979|NCT00528021|579709425|FG000|Overall Study|Lack of Efficacy|17|||
160540980|NCT00528021|579709426|FG001|Overall Study|Lack of Efficacy|13|||
160540981|NCT00528021|579709427|FG002|Overall Study|Lack of Efficacy|7|||
160540982|NCT00528021|579709428|FG003|Overall Study|Lack of Efficacy|9|||
160540983|NCT01246583|579709435|FG000|Overall Study|Lost to Follow-up|0|||
160540984|NCT01246583|579709436|FG001|Overall Study|Lost to Follow-up|0|||
160540985|NCT01246583|579709437|FG002|Overall Study|Lost to Follow-up|0|||
160540986|NCT01246583|579709438|FG003|Overall Study|Lost to Follow-up|1|||
160540987|NCT01246583|579709435|FG000|Overall Study|Protocol Violation|0|||
160540988|NCT01246583|579709436|FG001|Overall Study|Protocol Violation|0|||
160540989|NCT01246583|579709437|FG002|Overall Study|Protocol Violation|1|||
160540990|NCT01246583|579709438|FG003|Overall Study|Protocol Violation|0|||
160540991|NCT01246583|579709435|FG000|Overall Study|Withdrawal by Subject|1|||
160540992|NCT01246583|579709436|FG001|Overall Study|Withdrawal by Subject|0|||
160540993|NCT01246583|579709437|FG002|Overall Study|Withdrawal by Subject|0|||
160540994|NCT01246583|579709438|FG003|Overall Study|Withdrawal by Subject|0|||
160540995|NCT03077685|579709439|FG000|Overall Study|Lost to Follow-up|0|||
160540996|NCT03077685|579709440|FG001|Overall Study|Lost to Follow-up|0|||
160637639|NCT00434148|580056183|FG001|Overall Study|Withdrawal by Subject|15|||
160637640|NCT00434148|580056182|FG000|Overall Study|Protocol Violation|4|||
160637641|NCT00434148|580056183|FG001|Overall Study|Protocol Violation|0|||
160637642|NCT00434148|580056182|FG000|Overall Study|Administrative problems|6|||
160540997|NCT03077685|579709441|FG002|Overall Study|Lost to Follow-up|0|||
160540998|NCT03077685|579709442|FG003|Overall Study|Lost to Follow-up|0|||
160540999|NCT03077685|579709443|FG004|Overall Study|Lost to Follow-up|1|||
160541000|NCT03077685|579709439|FG000|Overall Study|Death|0|||
160541001|NCT03077685|579709440|FG001|Overall Study|Death|0|||
160541002|NCT03077685|579709441|FG002|Overall Study|Death|1|||
160541003|NCT03077685|579709442|FG003|Overall Study|Death|1|||
160541004|NCT03077685|579709443|FG004|Overall Study|Death|3|||
160541005|NCT03077685|579709439|FG000|Overall Study|Withdrawal by Subject|0|||
160541006|NCT03077685|579709440|FG001|Overall Study|Withdrawal by Subject|0|||
160541007|NCT03077685|579709441|FG002|Overall Study|Withdrawal by Subject|0|||
160541008|NCT03077685|579709442|FG003|Overall Study|Withdrawal by Subject|2|||
160541009|NCT03077685|579709443|FG004|Overall Study|Withdrawal by Subject|1|||
160541010|NCT03077685|579709439|FG000|Overall Study|Physician Decision|0|||
160541011|NCT03077685|579709440|FG001|Overall Study|Physician Decision|0|||
160541012|NCT03077685|579709441|FG002|Overall Study|Physician Decision|1|||
160541013|NCT03077685|579709442|FG003|Overall Study|Physician Decision|0|||
160541014|NCT03077685|579709443|FG004|Overall Study|Physician Decision|3|||
160541015|NCT03077685|579709439|FG000|Overall Study|Disease Progression|1|||
160541016|NCT03077685|579709440|FG001|Overall Study|Disease Progression|0|||
160541017|NCT03077685|579709441|FG002|Overall Study|Disease Progression|0|||
160541018|NCT03077685|579709442|FG003|Overall Study|Disease Progression|2|||
160541019|NCT03077685|579709443|FG004|Overall Study|Disease Progression|1|||
160541020|NCT03077685|579709439|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
160541021|NCT03077685|579709440|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
160541022|NCT03077685|579709441|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
160773623|NCT06354257|580556067|FG000|Treatment Period 2|Adverse Event|1|||
160773624|NCT02401230|580556068|FG000|Overall Study|Adverse Event|3|||
160773625|NCT02401230|580556069|FG001|Overall Study|Adverse Event|2|||
160773626|NCT02401230|580556070|FG002|Overall Study|Adverse Event|0|||
160773627|NCT02401230|580556068|FG000|Overall Study|Withdrawal by Subject|2|||
160773628|NCT02401230|580556069|FG001|Overall Study|Withdrawal by Subject|1|||
160773629|NCT02401230|580556070|FG002|Overall Study|Withdrawal by Subject|1|||
160773630|NCT02401230|580556068|FG000|Overall Study|Lost to Follow-up|1|||
160773631|NCT02401230|580556069|FG001|Overall Study|Lost to Follow-up|3|||
160773632|NCT02401230|580556070|FG002|Overall Study|Lost to Follow-up|3|||
160773633|NCT03980223|580556071|FG000|Overall Study|Lost to Follow-up|3|||
160773634|NCT03980223|580556072|FG001|Overall Study|Lost to Follow-up|7|||
160773635|NCT03980223|580556073|FG002|Overall Study|Lost to Follow-up|10|||
160773636|NCT03980223|580556074|FG003|Overall Study|Lost to Follow-up|8|||
160773637|NCT03980223|580556071|FG000|Overall Study|Withdrawal by Subject|0|||
160773638|NCT03980223|580556072|FG001|Overall Study|Withdrawal by Subject|0|||
160773639|NCT03980223|580556073|FG002|Overall Study|Withdrawal by Subject|1|||
160773640|NCT03980223|580556074|FG003|Overall Study|Withdrawal by Subject|2|||
160773641|NCT03980223|580556071|FG000|Overall Study|Physician Decision|0|||
160773642|NCT03980223|580556072|FG001|Overall Study|Physician Decision|0|||
160773643|NCT03980223|580556073|FG002|Overall Study|Physician Decision|1|||
160773644|NCT03980223|580556074|FG003|Overall Study|Physician Decision|0|||
160773645|NCT03980223|580556071|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
160773646|NCT03980223|580556072|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
160773647|NCT03980223|580556073|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
160773648|NCT03980223|580556074|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
160773649|NCT01349595|580556075|FG000|Overall Study|Lack of funding|2|||
160773650|NCT01349595|580556076|FG001|Overall Study|Lack of funding|2|||
160773651|NCT00720759|580556083|FG000|Overall Study|Lost to Follow-up|0|||
160773652|NCT00720759|580556084|FG001|Overall Study|Lost to Follow-up|1|||
160773653|NCT00720759|580556085|FG002|Overall Study|Lost to Follow-up|1|||
160773654|NCT00720759|580556086|FG003|Overall Study|Lost to Follow-up|0|||
160773655|NCT01047319|580556087|FG000|Overall Study|Teva requested participant withdrawal|3|||
160773656|NCT01047319|580556088|FG001|Overall Study|Teva requested participant withdrawal|0|||
160773657|NCT01047319|580556089|FG002|Overall Study|Teva requested participant withdrawal|1|||
160773658|NCT01047319|580556087|FG000|Overall Study|Protocol Violation|3|||
160773659|NCT01047319|580556088|FG001|Overall Study|Protocol Violation|2|||
160773660|NCT01047319|580556089|FG002|Overall Study|Protocol Violation|4|||
160773661|NCT01047319|580556087|FG000|Overall Study|Lack of Efficacy|4|||
160773662|NCT01047319|580556088|FG001|Overall Study|Lack of Efficacy|3|||
160773663|NCT01047319|580556089|FG002|Overall Study|Lack of Efficacy|3|||
160773664|NCT01047319|580556087|FG000|Overall Study|Death|5|||
160773665|NCT01047319|580556088|FG001|Overall Study|Death|1|||
160773666|NCT01047319|580556089|FG002|Overall Study|Death|5|||
160773667|NCT01047319|580556087|FG000|Overall Study|Pregnancy|13|||
160773668|NCT01047319|580556088|FG001|Overall Study|Pregnancy|8|||
160773669|NCT01047319|580556089|FG002|Overall Study|Pregnancy|8|||
160773670|NCT01047319|580556087|FG000|Overall Study|Physician Decision|12|||
160773671|NCT01047319|580556088|FG001|Overall Study|Physician Decision|9|||
160773672|NCT01047319|580556089|FG002|Overall Study|Physician Decision|10|||
160773673|NCT01047319|580556087|FG000|Overall Study|Lost to Follow-up|14|||
160773674|NCT01047319|580556088|FG001|Overall Study|Lost to Follow-up|10|||
160773675|NCT01047319|580556089|FG002|Overall Study|Lost to Follow-up|10|||
160773676|NCT01047319|580556087|FG000|Overall Study|Adverse Event|16|||
160773677|NCT01047319|580556088|FG001|Overall Study|Adverse Event|27|||
160773678|NCT01047319|580556089|FG002|Overall Study|Adverse Event|21|||
160773679|NCT01047319|580556087|FG000|Overall Study|Withdrawal by Subject|77|||
160773680|NCT01047319|580556088|FG001|Overall Study|Withdrawal by Subject|75|||
160773681|NCT01047319|580556089|FG002|Overall Study|Withdrawal by Subject|87|||
160773682|NCT01047319|580556087|FG000|Overall Study|Study terminated by Sponsor|198|||
160773683|NCT01047319|580556088|FG001|Overall Study|Study terminated by Sponsor|215|||
160885682|NCT00246571|580976447|FG001|Overall Study|Lack of Efficacy|21|||
160885683|NCT00246571|580976446|FG000|Overall Study|Death|17|||
160885684|NCT00246571|580976447|FG001|Overall Study|Death|3|||
160885685|NCT00246571|580976446|FG000|Overall Study|Sponsor|0|||
160885686|NCT00246571|580976447|FG001|Overall Study|Sponsor|1|||
160885687|NCT00246571|580976446|FG000|Overall Study|Did not meet entrance criteria|2|||
160885688|NCT00246571|580976447|FG001|Overall Study|Did not meet entrance criteria|1|||
160885689|NCT00246571|580976446|FG000|Overall Study|Laboratory abnormalities|1|||
160885690|NCT00246571|580976447|FG001|Overall Study|Laboratory abnormalities|0|||
160885691|NCT00246571|580976446|FG000|Overall Study|Crossover participants|0|||
160885692|NCT00246571|580976447|FG001|Overall Study|Crossover participants|74|||
160885693|NCT00775203|580976448|FG000|Overall Study|Adverse Event|25|||
160885694|NCT00775203|580976449|FG001|Overall Study|Adverse Event|6|||
160885695|NCT00775203|580976448|FG000|Overall Study|Lack of Efficacy|8|||
160885696|NCT00775203|580976449|FG001|Overall Study|Lack of Efficacy|9|||
160885697|NCT00775203|580976448|FG000|Overall Study|Withdrawal by Subject|11|||
160885698|NCT00775203|580976449|FG001|Overall Study|Withdrawal by Subject|9|||
160885699|NCT00775203|580976448|FG000|Overall Study|Lost to Follow-up|11|||
160885700|NCT00775203|580976449|FG001|Overall Study|Lost to Follow-up|15|||
160885701|NCT00775203|580976448|FG000|Overall Study|Administrative reason|2|||
160885702|NCT00775203|580976449|FG001|Overall Study|Administrative reason|0|||
160885703|NCT00775203|580976448|FG000|Overall Study|Noncompliance|4|||
160885704|NCT00775203|580976449|FG001|Overall Study|Noncompliance|2|||
160885705|NCT00775203|580976448|FG000|Overall Study|Protocol Violation|0|||
160885706|NCT00775203|580976449|FG001|Overall Study|Protocol Violation|1|||
160885707|NCT00775203|580976448|FG000|Overall Study|Entered other study|1|||
160885708|NCT00775203|580976449|FG001|Overall Study|Entered other study|0|||
160885709|NCT00775203|580976448|FG000|Overall Study|Physician Decision|0|||
160885710|NCT00775203|580976449|FG001|Overall Study|Physician Decision|1|||
160885711|NCT02987660|580976450|FG000|Overall Study|Study terminated by sponsor|10|||
160885712|NCT02987660|580976451|FG001|Overall Study|Study terminated by sponsor|10|||
160885713|NCT03422627|580976452|FG000|Overall Study|Protocol-specified Criteria|1|||
160885714|NCT03422627|580976453|FG001|Overall Study|Protocol-specified Criteria|1|||
160885715|NCT03422627|580976454|FG002|Overall Study|Protocol-specified Criteria|0|||
160885716|NCT03422627|580976455|FG003|Overall Study|Protocol-specified Criteria|0|||
160885717|NCT03422627|580976456|FG004|Overall Study|Protocol-specified Criteria|2|||
160885718|NCT03422627|580976452|FG000|Overall Study|Requirement for Alternative Therapy|1|||
160885719|NCT03422627|580976453|FG001|Overall Study|Requirement for Alternative Therapy|1|||
160885720|NCT03422627|580976454|FG002|Overall Study|Requirement for Alternative Therapy|2|||
160885721|NCT03422627|580976455|FG003|Overall Study|Requirement for Alternative Therapy|0|||
160885722|NCT03422627|580976456|FG004|Overall Study|Requirement for Alternative Therapy|0|||
160885723|NCT03422627|580976452|FG000|Overall Study|Disease Progression|1|||
160885724|NCT03422627|580976453|FG001|Overall Study|Disease Progression|0|||
160885725|NCT03422627|580976454|FG002|Overall Study|Disease Progression|1|||
160885726|NCT03422627|580976455|FG003|Overall Study|Disease Progression|2|||
160885727|NCT03422627|580976456|FG004|Overall Study|Disease Progression|0|||
160885728|NCT03422627|580976452|FG000|Overall Study|Adverse Event|2|||
160885729|NCT03422627|580976453|FG001|Overall Study|Adverse Event|1|||
160885730|NCT03422627|580976454|FG002|Overall Study|Adverse Event|0|||
160885731|NCT03422627|580976455|FG003|Overall Study|Adverse Event|0|||
160885732|NCT03422627|580976456|FG004|Overall Study|Adverse Event|2|||
160885733|NCT03422627|580976452|FG000|Overall Study|Ineligibility Determined|0|||
160885734|NCT03422627|580976453|FG001|Overall Study|Ineligibility Determined|1|||
160885735|NCT03422627|580976454|FG002|Overall Study|Ineligibility Determined|0|||
160885736|NCT03422627|580976455|FG003|Overall Study|Ineligibility Determined|0|||
160885737|NCT03422627|580976456|FG004|Overall Study|Ineligibility Determined|0|||
160885738|NCT03422627|580976452|FG000|Overall Study|Death|0|||
160885739|NCT03422627|580976453|FG001|Overall Study|Death|1|||
160885740|NCT03422627|580976454|FG002|Overall Study|Death|1|||
160885741|NCT03422627|580976455|FG003|Overall Study|Death|0|||
160885742|NCT03422627|580976456|FG004|Overall Study|Death|0|||
160885743|NCT03422627|580976452|FG000|Overall Study|Withdrawal by Subject|0|||
160885744|NCT03422627|580976453|FG001|Overall Study|Withdrawal by Subject|0|||
160885745|NCT03422627|580976454|FG002|Overall Study|Withdrawal by Subject|0|||
160885746|NCT03422627|580976455|FG003|Overall Study|Withdrawal by Subject|1|||
160885747|NCT03422627|580976456|FG004|Overall Study|Withdrawal by Subject|0|||
160885748|NCT05247398|580976457|FG000|Overall Study|Withdrawal by Subject|1|||
160885749|NCT04251156|580976458|FG000|Overall Study|Lost to Follow-up|1|||
160885750|NCT04251156|580976459|FG001|Overall Study|Lost to Follow-up|1|||
160885751|NCT04251156|580976458|FG000|Overall Study|Withdrawal by Subject|4|||
160885752|NCT04251156|580976459|FG001|Overall Study|Withdrawal by Subject|4|||
160885753|NCT05171816|580976460|FG000|Overall Study|Death|18|||
160637643|NCT00434148|580056183|FG001|Overall Study|Administrative problems|10|||
160637644|NCT00434148|580056182|FG000|Overall Study|Lost to Follow-up|0|||
160637645|NCT00434148|580056183|FG001|Overall Study|Lost to Follow-up|1|||
160637646|NCT00434148|580056182|FG000|Overall Study|Condition no longer requires study drug|1|||
160637647|NCT00434148|580056183|FG001|Overall Study|Condition no longer requires study drug|0|||
160637648|NCT00434148|580056182|FG000|Overall Study|Abnormal test procedure result|0|||
160637649|NCT00434148|580056183|FG001|Overall Study|Abnormal test procedure result|1|||
160637650|NCT00759759|580056184|FG000|Overall Study|didn't return for period 2|1|||
160637651|NCT00759759|580056185|FG001|Overall Study|didn't return for period 2|0|||
160637652|NCT00759759|580056184|FG000|Overall Study|Didn't receive drug in period 2|1|||
160637653|NCT00759759|580056185|FG001|Overall Study|Didn't receive drug in period 2|0|||
160637654|NCT00759759|580056184|FG000|Overall Study|Withdrawal by Subject|2|||
160637655|NCT00759759|580056185|FG001|Overall Study|Withdrawal by Subject|1|||
160637656|NCT01556165|580056189|FG000|Overall Study|Adverse Event|5|||
160637657|NCT01556165|580056190|FG001|Overall Study|Adverse Event|3|||
160637658|NCT01556165|580056189|FG000|Overall Study|Protocol Violation|0|||
160637659|NCT01556165|580056190|FG001|Overall Study|Protocol Violation|3|||
160637660|NCT01556165|580056189|FG000|Overall Study|Withdrawal of Consent|7|||
160637661|NCT01556165|580056190|FG001|Overall Study|Withdrawal of Consent|1|||
160637662|NCT02531698|580056193|FG000|Overall Study|Adverse Event|2|||
160637663|NCT02531698|580056194|FG001|Overall Study|Adverse Event|1|||
160637664|NCT02531698|580056193|FG000|Overall Study|Withdrawal by Subject|6|||
160637665|NCT02531698|580056194|FG001|Overall Study|Withdrawal by Subject|1|||
160637666|NCT02531698|580056193|FG000|Overall Study|Protocol Violation|2|||
160637667|NCT02531698|580056194|FG001|Overall Study|Protocol Violation|0|||
160637668|NCT02531698|580056193|FG000|Overall Study|Lost to Follow-up|1|||
160637669|NCT02531698|580056194|FG001|Overall Study|Lost to Follow-up|0|||
160637670|NCT01861717|580056195|FG000|Overall Study|Lost to Follow-up|1|||
160637671|NCT01861717|580056195|FG000|Overall Study|Withdrawal by Subject|1|||
160637672|NCT02395536|580056199|FG000|Overall Study|Lost to Follow-up|4|||
160637673|NCT02395536|580056200|FG001|Overall Study|Lost to Follow-up|4|||
160637674|NCT02395536|580056199|FG000|Overall Study|Death|2|||
160637675|NCT02395536|580056200|FG001|Overall Study|Death|0|||
160637676|NCT02395536|580056199|FG000|Overall Study|Physician Decision|4|||
160637677|NCT02395536|580056200|FG001|Overall Study|Physician Decision|6|||
160637678|NCT02395536|580056199|FG000|Overall Study|Withdrawal by Subject|9|||
160637679|NCT02395536|580056200|FG001|Overall Study|Withdrawal by Subject|17|||
160637680|NCT02395536|580056199|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
160637681|NCT02395536|580056200|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
160637682|NCT02395536|580056199|FG000|Overall Study|Insurance issue|0|||
160637683|NCT02395536|580056200|FG001|Overall Study|Insurance issue|1|||
160637684|NCT00701558|580056201|FG000|Overall Study|Death|7|||
160637685|NCT00701558|580056201|FG000|Overall Study|Lost to Follow-up|8|||
160637686|NCT01640964|580056204|FG000|Overall Study|Lost to Follow-up|0|||
160637687|NCT01640964|580056205|FG001|Overall Study|Lost to Follow-up|0|||
160637688|NCT01640964|580056206|FG002|Overall Study|Lost to Follow-up|1|||
160637689|NCT01640964|580056204|FG000|Overall Study|Protocol Deviation|1|||
160637690|NCT01640964|580056205|FG001|Overall Study|Protocol Deviation|1|||
160637691|NCT01640964|580056206|FG002|Overall Study|Protocol Deviation|2|||
160637692|NCT00833976|580057876|FG000|Overall Study|Withdrawal by Subject|5|||
160637693|NCT00833976|580057876|FG000|Overall Study|Lost to Follow-up|4|||
160637694|NCT00833976|580057876|FG000|Overall Study|Did not meet eligibility criteria|41|||
160637695|NCT00833976|580057876|FG000|Overall Study|Physician Decision|1|||
160637696|NCT02464059|580057877|FG000|Overall Study|Lost to Follow-up|6|||
160637697|NCT00304954|580057878|FG000|Overall Study|Withdrawal by Subject|0|||
160637698|NCT00304954|580057879|FG001|Overall Study|Withdrawal by Subject|0|||
160637699|NCT00304954|580057880|FG002|Overall Study|Withdrawal by Subject|1|||
160637700|NCT00304954|580057881|FG003|Overall Study|Withdrawal by Subject|0|||
160885754|NCT05171816|580976461|FG001|Overall Study|Death|16|||
160885755|NCT02937571|580976462|FG000|Overall Study|Adverse Event|0|||
160885756|NCT02937571|580976463|FG001|Overall Study|Adverse Event|0|||
160885757|NCT02937571|580976464|FG002|Overall Study|Adverse Event|4|||
160885758|NCT02937571|580976462|FG000|Overall Study|Withdrawal by Subject|0|||
160885759|NCT02937571|580976463|FG001|Overall Study|Withdrawal by Subject|0|||
160637701|NCT00304954|580057878|FG000|Overall Study|Adverse Event|1|||
160637702|NCT00304954|580057879|FG001|Overall Study|Adverse Event|0|||
160637703|NCT00304954|580057880|FG002|Overall Study|Adverse Event|0|||
160637704|NCT00304954|580057881|FG003|Overall Study|Adverse Event|0|||
160637705|NCT03101293|580057882|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
160637706|NCT03101293|580057883|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
160885760|NCT02937571|580976464|FG002|Overall Study|Withdrawal by Subject|3|||
160637707|NCT04023994|580057892|FG000|Overall Study|Lost to Follow-up|0|||
160637708|NCT04023994|580057893|FG001|Overall Study|Lost to Follow-up|1|||
160885761|NCT04214288|580976465|FG000|Overall Study|Ongoing in the study|41|||
160637709|NCT04023994|580057894|FG002|Overall Study|Lost to Follow-up|2|||
160637710|NCT04023994|580057895|FG003|Overall Study|Lost to Follow-up|0|||
160637711|NCT04023994|580057896|FG004|Overall Study|Lost to Follow-up|0|||
160541023|NCT03077685|579709442|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
160773684|NCT01047319|580556089|FG002|Overall Study|Study terminated by Sponsor|203|||
160541024|NCT03077685|579709443|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
160541025|NCT03077685|579709439|FG000|Overall Study|Subject entered hospice care|0|||
160541026|NCT03077685|579709440|FG001|Overall Study|Subject entered hospice care|0|||
160541027|NCT03077685|579709441|FG002|Overall Study|Subject entered hospice care|0|||
160541028|NCT03077685|579709442|FG003|Overall Study|Subject entered hospice care|0|||
160541029|NCT03077685|579709443|FG004|Overall Study|Subject entered hospice care|1|||
160541030|NCT02116777|579709444|FG000|Overall Study|Adverse Event|0|||
160541031|NCT02116777|579709445|FG001|Overall Study|Adverse Event|0|||
160541032|NCT02116777|579709446|FG002|Overall Study|Adverse Event|0|||
160541033|NCT02116777|579709447|FG003|Overall Study|Adverse Event|0|||
160541034|NCT02116777|579709448|FG004|Overall Study|Adverse Event|2|||
160541035|NCT02116777|579709449|FG005|Overall Study|Adverse Event|2|||
160541036|NCT02116777|579709450|FG006|Overall Study|Adverse Event|0|||
160541037|NCT02116777|579709444|FG000|Overall Study|Death|0|||
160541038|NCT02116777|579709445|FG001|Overall Study|Death|0|||
160541039|NCT02116777|579709446|FG002|Overall Study|Death|0|||
160541040|NCT02116777|579709447|FG003|Overall Study|Death|1|||
160541041|NCT02116777|579709448|FG004|Overall Study|Death|0|||
160773685|NCT02318940|580556090|FG000|Overall Study|lost the record|1|||
160773686|NCT02318940|580556091|FG001|Overall Study|lost the record|0|||
160773687|NCT05759338|580556098|FG000|Overall Study|Withdrawal by Subject|3|||
160773688|NCT04611126|580556099|FG000|Overall Study|TIL expansion unsuccessful|1|||
160773689|NCT04611126|580556100|FG001|Overall Study|TIL expansion unsuccessful|0|||
160773690|NCT01157845|580556101|FG000|Overall Study|Lost to Follow-up|5|||
160773691|NCT01157845|580556101|FG000|Overall Study|Withdrawal by Subject|12|||
160773692|NCT01157845|580556101|FG000|Overall Study|Physician Decision|3|||
160773693|NCT01157845|580556101|FG000|Overall Study|Protocol Violation|13|||
160773694|NCT01157845|580556101|FG000|Overall Study|Study was ended|1|||
160773695|NCT01157845|580556101|FG000|Overall Study|Device malfunction|1|||
160773696|NCT03311555|580556102|FG000|Overall Study|Adverse Event|1|||
160773697|NCT04284774|580556107|FG000|Overall Study|Progressive disease|5|||
160773698|NCT04817410|580557617|FG000|Overall Study|Withdrawal by Subject|5|||
160773699|NCT04817410|580557617|FG000|Overall Study|Physician Decision|3|||
160773700|NCT03595748|580557618|FG000|Overall Study|Death|11|||
160773701|NCT03595748|580557619|FG001|Overall Study|Death|12|||
160773702|NCT03595748|580557618|FG000|Overall Study|Withdrawal by Subject|28|||
160773703|NCT03595748|580557619|FG001|Overall Study|Withdrawal by Subject|29|||
160773704|NCT03595748|580557618|FG000|Overall Study|Protocol Violation|0|||
160773705|NCT03595748|580557619|FG001|Overall Study|Protocol Violation|1|||
160773706|NCT02328014|580557620|FG000|Overall Study|Adverse Event|1|||
160773707|NCT02328014|580557621|FG001|Overall Study|Adverse Event|0|||
160773708|NCT02328014|580557622|FG002|Overall Study|Adverse Event|0|||
160773709|NCT02328014|580557623|FG003|Overall Study|Adverse Event|1|||
160773710|NCT02328014|580557620|FG000|Overall Study|Death|0|||
160773711|NCT02328014|580557621|FG001|Overall Study|Death|0|||
160773712|NCT02328014|580557622|FG002|Overall Study|Death|0|||
160773713|NCT02328014|580557623|FG003|Overall Study|Death|4|||
160773714|NCT02328014|580557620|FG000|Overall Study|Physician Decision|0|||
160773715|NCT02328014|580557621|FG001|Overall Study|Physician Decision|0|||
160773716|NCT02328014|580557622|FG002|Overall Study|Physician Decision|0|||
160773717|NCT02328014|580557623|FG003|Overall Study|Physician Decision|1|||
160773718|NCT02328014|580557620|FG000|Overall Study|Disease Progression|1|||
160773719|NCT02328014|580557621|FG001|Overall Study|Disease Progression|0|||
160773720|NCT02328014|580557622|FG002|Overall Study|Disease Progression|1|||
160773721|NCT02328014|580557623|FG003|Overall Study|Disease Progression|3|||
160773722|NCT02328014|580557620|FG000|Overall Study|Study Terminated by Sponsor|4|||
160885762|NCT04214288|580976466|FG001|Overall Study|Ongoing in the study|51|||
160541042|NCT02116777|579709449|FG005|Overall Study|Death|0|||
160541043|NCT02116777|579709450|FG006|Overall Study|Death|0|||
160541044|NCT02116777|579709444|FG000|Overall Study|Lack of Efficacy|3|||
160541045|NCT02116777|579709445|FG001|Overall Study|Lack of Efficacy|3|||
160541046|NCT02116777|579709446|FG002|Overall Study|Lack of Efficacy|3|||
160541047|NCT02116777|579709447|FG003|Overall Study|Lack of Efficacy|8|||
160541048|NCT02116777|579709448|FG004|Overall Study|Lack of Efficacy|4|||
160541049|NCT02116777|579709449|FG005|Overall Study|Lack of Efficacy|1|||
160541050|NCT02116777|579709450|FG006|Overall Study|Lack of Efficacy|9|||
160541051|NCT02116777|579709444|FG000|Overall Study|Physician Decision|0|||
160541052|NCT02116777|579709445|FG001|Overall Study|Physician Decision|0|||
160773723|NCT02328014|580557621|FG001|Overall Study|Study Terminated by Sponsor|1|||
160773724|NCT02328014|580557622|FG002|Overall Study|Study Terminated by Sponsor|1|||
160773725|NCT02328014|580557623|FG003|Overall Study|Study Terminated by Sponsor|0|||
160773726|NCT02328014|580557620|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
160773727|NCT02328014|580557621|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
160773728|NCT02328014|580557622|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
160773729|NCT02328014|580557623|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
160773730|NCT02328014|580557620|FG000|Overall Study|Withdrawal by Subject|0|||
160773731|NCT02328014|580557621|FG001|Overall Study|Withdrawal by Subject|0|||
160773732|NCT02328014|580557622|FG002|Overall Study|Withdrawal by Subject|0|||
160773733|NCT02328014|580557623|FG003|Overall Study|Withdrawal by Subject|1|||
160773734|NCT05028569|580557640|FG000|Double-Blind Phase|Death|0|||
160773735|NCT05028569|580557641|FG001|Double-Blind Phase|Death|0|||
160773736|NCT05028569|580557642|FG002|Double-Blind Phase|Death|0|||
160773737|NCT05028569|580557643|FG003|Double-Blind Phase|Death|1|||
160773738|NCT05028569|580557644|FG004|Double-Blind Phase|Death|0|||
160773739|NCT05028569|580557645|FG005|Double-Blind Phase|Death|0|||
160773740|NCT05028569|580557646|FG006|Double-Blind Phase|Death|0|||
160773741|NCT05028569|580557640|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160773742|NCT05028569|580557641|FG001|Double-Blind Phase|Lost to Follow-up|6|||
160773743|NCT05028569|580557642|FG002|Double-Blind Phase|Lost to Follow-up|3|||
160773744|NCT05028569|580557643|FG003|Double-Blind Phase|Lost to Follow-up|9|||
160773745|NCT05028569|580557644|FG004|Double-Blind Phase|Lost to Follow-up|0|||
160773746|NCT05028569|580557645|FG005|Double-Blind Phase|Lost to Follow-up|0|||
160773747|NCT05028569|580557646|FG006|Double-Blind Phase|Lost to Follow-up|0|||
160773748|NCT05028569|580557640|FG000|Double-Blind Phase|Protocol Deviation|0|||
160773749|NCT05028569|580557641|FG001|Double-Blind Phase|Protocol Deviation|2|||
160773750|NCT05028569|580557642|FG002|Double-Blind Phase|Protocol Deviation|0|||
160773751|NCT05028569|580557643|FG003|Double-Blind Phase|Protocol Deviation|0|||
160773752|NCT05028569|580557644|FG004|Double-Blind Phase|Protocol Deviation|0|||
160773753|NCT05028569|580557645|FG005|Double-Blind Phase|Protocol Deviation|0|||
160773754|NCT05028569|580557646|FG006|Double-Blind Phase|Protocol Deviation|0|||
160773755|NCT05028569|580557640|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
160885763|NCT04214288|580976467|FG002|Overall Study|Ongoing in the study|12|||
160885764|NCT04214288|580976468|FG003|Overall Study|Ongoing in the study|39|||
160885765|NCT04214288|580976465|FG000|Overall Study|Adverse Event|1|||
160885766|NCT04214288|580976466|FG001|Overall Study|Adverse Event|0|||
160885767|NCT04214288|580976467|FG002|Overall Study|Adverse Event|0|||
160885768|NCT04214288|580976468|FG003|Overall Study|Adverse Event|0|||
160885769|NCT04214288|580976465|FG000|Overall Study|Death|22|||
160885770|NCT04214288|580976466|FG001|Overall Study|Death|13|||
160885771|NCT04214288|580976467|FG002|Overall Study|Death|7|||
160885772|NCT04214288|580976468|FG003|Overall Study|Death|19|||
160885773|NCT04214288|580976465|FG000|Overall Study|Lost to Follow-up|1|||
160885774|NCT04214288|580976466|FG001|Overall Study|Lost to Follow-up|2|||
160885775|NCT04214288|580976467|FG002|Overall Study|Lost to Follow-up|1|||
160885776|NCT04214288|580976468|FG003|Overall Study|Lost to Follow-up|0|||
160885777|NCT04214288|580976465|FG000|Overall Study|Other|1|||
160885778|NCT04214288|580976466|FG001|Overall Study|Other|2|||
160885779|NCT04214288|580976467|FG002|Overall Study|Other|0|||
160885780|NCT04214288|580976468|FG003|Overall Study|Other|6|||
160885781|NCT04214288|580976465|FG000|Overall Study|Protocol Violation|0|||
160885782|NCT04214288|580976466|FG001|Overall Study|Protocol Violation|1|||
160885783|NCT04214288|580976467|FG002|Overall Study|Protocol Violation|0|||
160885784|NCT04214288|580976468|FG003|Overall Study|Protocol Violation|0|||
160885785|NCT04214288|580976465|FG000|Overall Study|Withdrawal by Subject|8|||
160885786|NCT04214288|580976466|FG001|Overall Study|Withdrawal by Subject|4|||
160885787|NCT04214288|580976467|FG002|Overall Study|Withdrawal by Subject|0|||
160885788|NCT04214288|580976468|FG003|Overall Study|Withdrawal by Subject|9|||
160885789|NCT02455557|580976469|FG000|Overall Study|Withdrawal by Subject|2|||
160885790|NCT01129024|580976470|FG000|Overall Study|Physician Decision|5|||
160885791|NCT01129024|580976470|FG000|Overall Study|Study Terminated by Sponsor|8|||
160885792|NCT01129024|580976470|FG000|Overall Study|Withdrawal by Subject|2|||
160885793|NCT01129024|580976470|FG000|Overall Study|Lack of Efficacy|3|||
160885794|NCT01129024|580976470|FG000|Overall Study|Needed a Platelet Transfusion|1|||
160885795|NCT02207946|580976477|FG000|Overall Study|Lost to Follow-up|1|||
160885796|NCT02207946|580976478|FG001|Overall Study|Lost to Follow-up|0|||
160885797|NCT02207946|580976477|FG000|Overall Study|Adverse Event|0|||
160885798|NCT02207946|580976478|FG001|Overall Study|Adverse Event|1|||
160885799|NCT02829944|580976482|FG000|Overall Study|Physician Decision|0|||
160885800|NCT02829944|580976483|FG001|Overall Study|Physician Decision|1|||
160885801|NCT02829944|580976482|FG000|Overall Study|Screen Failure|2|||
160885802|NCT02829944|580976483|FG001|Overall Study|Screen Failure|2|||
160885803|NCT02829944|580976482|FG000|Overall Study|Inadequate Neuraxial Block|1|||
160885804|NCT02829944|580976483|FG001|Overall Study|Inadequate Neuraxial Block|1|||
160885805|NCT02829944|580976482|FG000|Overall Study|Withdrawal by Subject|2|||
160885806|NCT02829944|580976483|FG001|Overall Study|Withdrawal by Subject|1|||
160885807|NCT02829944|580976482|FG000|Overall Study|Catheter Displacement|1|||
160885808|NCT02829944|580976483|FG001|Overall Study|Catheter Displacement|0|||
160885809|NCT02829944|580976482|FG000|Overall Study|Catheter broke|0|||
160885810|NCT02829944|580976483|FG001|Overall Study|Catheter broke|1|||
160885811|NCT02829944|580976482|FG000|Overall Study|Staff unavailable|0|||
160885812|NCT02829944|580976483|FG001|Overall Study|Staff unavailable|1|||
160885813|NCT04675151|580976484|FG000|Overall Study|Protocol Violation|1|||
160541053|NCT02116777|579709446|FG002|Overall Study|Physician Decision|0|||
160541054|NCT02116777|579709447|FG003|Overall Study|Physician Decision|2|||
160541055|NCT02116777|579709448|FG004|Overall Study|Physician Decision|0|||
160541056|NCT02116777|579709449|FG005|Overall Study|Physician Decision|0|||
160541057|NCT02116777|579709450|FG006|Overall Study|Physician Decision|0|||
160541058|NCT02116777|579709444|FG000|Overall Study|Protocol Violation|0|||
160541059|NCT02116777|579709445|FG001|Overall Study|Protocol Violation|0|||
160541060|NCT02116777|579709446|FG002|Overall Study|Protocol Violation|0|||
160541061|NCT02116777|579709447|FG003|Overall Study|Protocol Violation|1|||
160541062|NCT02116777|579709448|FG004|Overall Study|Protocol Violation|0|||
160885814|NCT04675151|580976485|FG001|Overall Study|Protocol Violation|0|||
160885815|NCT04675151|580976486|FG002|Overall Study|Protocol Violation|0|||
160885816|NCT04675151|580976487|FG003|Overall Study|Protocol Violation|1|||
160885817|NCT01730937|580976488|FG000|Overall Study|Protocol Violation|5|||
160541063|NCT02116777|579709449|FG005|Overall Study|Protocol Violation|0|||
160885818|NCT01730937|580976489|FG001|Overall Study|Protocol Violation|11|||
160885819|NCT03947684|580976490|FG000|Overall Study|Lost to Follow-up|13|||
160637712|NCT04023994|580057897|FG005|Overall Study|Lost to Follow-up|0|||
160637713|NCT04023994|580057892|FG000|Overall Study|Withdrawal by Subject|0|||
160885820|NCT03947684|580976491|FG001|Overall Study|Lost to Follow-up|5|||
160885821|NCT03947684|580976492|FG002|Overall Study|Lost to Follow-up|1|||
160885822|NCT03947684|580976490|FG000|Overall Study|Withdrawal by Subject|11|||
160885823|NCT03947684|580976491|FG001|Overall Study|Withdrawal by Subject|4|||
160885824|NCT03947684|580976492|FG002|Overall Study|Withdrawal by Subject|0|||
160885825|NCT03947684|580976490|FG000|Overall Study|Physician Decision|1|||
160541064|NCT02116777|579709450|FG006|Overall Study|Protocol Violation|0|||
160541065|NCT02116777|579709444|FG000|Overall Study|Withdrawal by Subject|0|||
160885826|NCT03947684|580976491|FG001|Overall Study|Physician Decision|0|||
160885827|NCT03947684|580976492|FG002|Overall Study|Physician Decision|0|||
160885828|NCT03947684|580976490|FG000|Overall Study|Lack of adherence to study protocol|2|||
160885829|NCT03947684|580976491|FG001|Overall Study|Lack of adherence to study protocol|0|||
160885830|NCT03947684|580976492|FG002|Overall Study|Lack of adherence to study protocol|0|||
160773756|NCT05028569|580557641|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
160885831|NCT01395784|580976498|FG000|Overall Study|Lost to Follow-up|7|||
160885832|NCT01395784|580976498|FG000|Overall Study|Withdrawal by Subject|3|||
160885833|NCT01395784|580976498|FG000|Overall Study|Physician Decision|5|||
160885834|NCT05772702|580976499|FG000|Overall Study|Adverse Event|1|||
160885835|NCT04285580|580978189|FG000|Overall Study|Protocol Violation|0|||
160885836|NCT04285580|580978190|FG001|Overall Study|Protocol Violation|1|||
160885837|NCT00562627|580978191|FG000|Overall Study|Protocol Violation|1|||
160885838|NCT00562627|580978192|FG001|Overall Study|Protocol Violation|1|||
160885839|NCT00562627|580978193|FG002|Overall Study|Protocol Violation|1|||
160885840|NCT02316548|580978195|FG000|Overall Study|Protocol Violation|0|||
160885841|NCT02316548|580978196|FG001|Overall Study|Protocol Violation|1|||
160885842|NCT05313009|580978197|FG000|Overall Study|Death|1|||
160885843|NCT05313009|580978198|FG001|Overall Study|Death|0|||
160885844|NCT03269552|580978199|FG000|Overall Study|Adverse Event|2|||
160885845|NCT03468543|580978200|FG000|Overall Study|Protocol stopping rules met|3|||
160541066|NCT02116777|579709445|FG001|Overall Study|Withdrawal by Subject|0|||
160541067|NCT02116777|579709446|FG002|Overall Study|Withdrawal by Subject|0|||
160541068|NCT02116777|579709447|FG003|Overall Study|Withdrawal by Subject|1|||
160541069|NCT02116777|579709448|FG004|Overall Study|Withdrawal by Subject|0|||
160541070|NCT02116777|579709449|FG005|Overall Study|Withdrawal by Subject|0|||
160541071|NCT02116777|579709450|FG006|Overall Study|Withdrawal by Subject|0|||
160541072|NCT00102960|579709453|FG000|Overall Study|Death|23|||
160541073|NCT00102960|579709454|FG001|Overall Study|Death|11|||
160541074|NCT00102960|579709455|FG002|Overall Study|Death|11|||
160541075|NCT00102960|579709453|FG000|Overall Study|Lost to Follow-up|6|||
160541076|NCT00102960|579709454|FG001|Overall Study|Lost to Follow-up|12|||
160541077|NCT00102960|579709455|FG002|Overall Study|Lost to Follow-up|16|||
160541078|NCT00102960|579709453|FG000|Overall Study|Withdrawal by Subject|1|||
160541079|NCT00102960|579709454|FG001|Overall Study|Withdrawal by Subject|0|||
160541080|NCT00102960|579709455|FG002|Overall Study|Withdrawal by Subject|1|||
160541081|NCT01395394|579711159|FG000|Baseline Study Visit|Protocol Violation|1|||
160541082|NCT01395394|579711160|FG001|Baseline Study Visit|Protocol Violation|0|||
160541083|NCT01395394|579711161|FG002|Baseline Study Visit|Protocol Violation|0|||
160541084|NCT05121480|579711162|FG000|Overall Study|Lack of Efficacy|2|||
160541085|NCT05121480|579711163|FG001|Overall Study|Lack of Efficacy|2|||
160541086|NCT05121480|579711164|FG002|Overall Study|Lack of Efficacy|1|||
160541087|NCT05121480|579711165|FG003|Overall Study|Lack of Efficacy|4|||
160541088|NCT05121480|579711166|FG004|Overall Study|Lack of Efficacy|0|||
160541089|NCT05121480|579711167|FG005|Overall Study|Lack of Efficacy|1|||
160541090|NCT05121480|579711168|FG006|Overall Study|Lack of Efficacy|0|||
160541091|NCT05121480|579711169|FG007|Overall Study|Lack of Efficacy|2|||
160541092|NCT05121480|579711162|FG000|Overall Study|Treatment Failure|0|||
160541093|NCT05121480|579711163|FG001|Overall Study|Treatment Failure|2|||
160541094|NCT05121480|579711164|FG002|Overall Study|Treatment Failure|0|||
160541095|NCT05121480|579711165|FG003|Overall Study|Treatment Failure|1|||
160541096|NCT05121480|579711166|FG004|Overall Study|Treatment Failure|0|||
160541097|NCT05121480|579711167|FG005|Overall Study|Treatment Failure|0|||
160541098|NCT05121480|579711168|FG006|Overall Study|Treatment Failure|0|||
160541099|NCT05121480|579711169|FG007|Overall Study|Treatment Failure|0|||
160541100|NCT05121480|579711162|FG000|Overall Study|Adverse Event|0|||
160541101|NCT05121480|579711163|FG001|Overall Study|Adverse Event|1|||
160541102|NCT05121480|579711164|FG002|Overall Study|Adverse Event|0|||
160541103|NCT05121480|579711165|FG003|Overall Study|Adverse Event|5|||
160541104|NCT05121480|579711166|FG004|Overall Study|Adverse Event|3|||
160541105|NCT05121480|579711167|FG005|Overall Study|Adverse Event|2|||
160541106|NCT05121480|579711168|FG006|Overall Study|Adverse Event|0|||
160541107|NCT05121480|579711169|FG007|Overall Study|Adverse Event|4|||
160541108|NCT05121480|579711162|FG000|Overall Study|Withdrawal by Subject|4|||
160541109|NCT05121480|579711163|FG001|Overall Study|Withdrawal by Subject|9|||
160541110|NCT05121480|579711164|FG002|Overall Study|Withdrawal by Subject|1|||
160541111|NCT05121480|579711165|FG003|Overall Study|Withdrawal by Subject|8|||
160541112|NCT05121480|579711166|FG004|Overall Study|Withdrawal by Subject|0|||
160541113|NCT05121480|579711167|FG005|Overall Study|Withdrawal by Subject|9|||
160773757|NCT05028569|580557642|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
160773758|NCT05028569|580557643|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
160773759|NCT05028569|580557644|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
160773760|NCT05028569|580557645|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
160773761|NCT05028569|580557646|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
160773762|NCT05028569|580557640|FG000|Double-Blind Phase|Other, not specified|0|||
160773763|NCT05028569|580557641|FG001|Double-Blind Phase|Other, not specified|5|||
160541114|NCT05121480|579711168|FG006|Overall Study|Withdrawal by Subject|0|||
160541115|NCT05121480|579711169|FG007|Overall Study|Withdrawal by Subject|4|||
160541116|NCT05121480|579711162|FG000|Overall Study|Non-compliance with the protocol|0|||
160541117|NCT05121480|579711163|FG001|Overall Study|Non-compliance with the protocol|0|||
160637714|NCT04023994|580057893|FG001|Overall Study|Withdrawal by Subject|0|||
160637715|NCT04023994|580057894|FG002|Overall Study|Withdrawal by Subject|0|||
160637716|NCT04023994|580057895|FG003|Overall Study|Withdrawal by Subject|1|||
160637717|NCT04023994|580057896|FG004|Overall Study|Withdrawal by Subject|0|||
160637718|NCT04023994|580057897|FG005|Overall Study|Withdrawal by Subject|0|||
160637719|NCT02143947|580057899|FG000|Overall Study|Lost to Follow-up|4|||
160637720|NCT02143947|580057900|FG001|Overall Study|Lost to Follow-up|2|||
160637721|NCT00697112|580057905|FG000|Overall Study|Adverse Event|8|||
160637722|NCT00697112|580057905|FG000|Overall Study|Lost to Follow-up|1|||
160637723|NCT00697112|580057905|FG000|Overall Study|Did not meet inclusion criteria|1|||
160637724|NCT03402126|580057912|FG000|Overall Study|Lost to Follow-up|6|||
160637725|NCT03402126|580057912|FG000|Overall Study|Protocol Violation|10|||
160637726|NCT03402126|580057912|FG000|Overall Study|Sponsor request/Study termination|29|||
160637727|NCT03402126|580057912|FG000|Overall Study|Study product no longer in use|1|||
160637728|NCT03402126|580057912|FG000|Overall Study|Technical problems|1|||
160637729|NCT03402126|580057912|FG000|Overall Study|Withdrawal by Subject|6|||
160637730|NCT03402126|580057912|FG000|Overall Study|Physician Decision|2|||
160637731|NCT03402126|580057912|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
160637732|NCT03402126|580057912|FG000|Overall Study|Death|4|||
160637733|NCT00572156|580057913|FG000|Overall Study|Adverse Event|3|||
160637734|NCT00572156|580057914|FG001|Overall Study|Adverse Event|1|||
160637735|NCT00572156|580057915|FG002|Overall Study|Adverse Event|5|||
160637736|NCT00572156|580057916|FG003|Overall Study|Adverse Event|1|||
160637737|NCT00572156|580057913|FG000|Overall Study|Lost to Follow-up|1|||
160637738|NCT00572156|580057914|FG001|Overall Study|Lost to Follow-up|1|||
160637739|NCT00572156|580057915|FG002|Overall Study|Lost to Follow-up|1|||
160637740|NCT00572156|580057916|FG003|Overall Study|Lost to Follow-up|0|||
160637741|NCT00572156|580057913|FG000|Overall Study|Protocol Violation|1|||
160637742|NCT00572156|580057914|FG001|Overall Study|Protocol Violation|2|||
160637743|NCT00572156|580057915|FG002|Overall Study|Protocol Violation|0|||
160637744|NCT00572156|580057916|FG003|Overall Study|Protocol Violation|2|||
160637745|NCT00572156|580057913|FG000|Overall Study|Patient/Parent Decision|1|||
160637746|NCT00572156|580057914|FG001|Overall Study|Patient/Parent Decision|6|||
160637747|NCT00572156|580057915|FG002|Overall Study|Patient/Parent Decision|4|||
160637748|NCT00572156|580057916|FG003|Overall Study|Patient/Parent Decision|3|||
160637749|NCT00572156|580057913|FG000|Overall Study|Sponsor Decision|20|||
160637750|NCT00572156|580057914|FG001|Overall Study|Sponsor Decision|16|||
160637751|NCT00572156|580057915|FG002|Overall Study|Sponsor Decision|17|||
160637752|NCT00572156|580057916|FG003|Overall Study|Sponsor Decision|19|||
160637753|NCT02261974|580057917|FG000|Overall Study|Withdrawal by Subject|3|||
160637754|NCT02261974|580057918|FG001|Overall Study|Withdrawal by Subject|2|||
160637755|NCT02261974|580057917|FG000|Overall Study|Pregnancy|0|||
160637756|NCT02261974|580057918|FG001|Overall Study|Pregnancy|1|||
160637757|NCT02261974|580057917|FG000|Overall Study|Missed treatment cut-off date|6|||
160637758|NCT02261974|580057918|FG001|Overall Study|Missed treatment cut-off date|3|||
160637759|NCT02261974|580057917|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
160637760|NCT02261974|580057918|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
160637761|NCT02261974|580057917|FG000|Overall Study|Lost to Follow-up|2|||
160637762|NCT02261974|580057918|FG001|Overall Study|Lost to Follow-up|0|||
160637763|NCT02261974|580057917|FG000|Overall Study|Adverse Event|1|||
160637764|NCT02261974|580057918|FG001|Overall Study|Adverse Event|0|||
160637765|NCT02030834|580057919|FG000|Overall Study|Death|4|||
160637766|NCT02030834|580057920|FG001|Overall Study|Death|0|||
160637767|NCT02030834|580057921|FG002|Overall Study|Death|0|||
160637768|NCT02030834|580057919|FG000|Overall Study|Manufacturing failure|2|||
160637769|NCT02030834|580057920|FG001|Overall Study|Manufacturing failure|0|||
160637770|NCT02030834|580057921|FG002|Overall Study|Manufacturing failure|1|||
160637771|NCT02030834|580057919|FG000|Overall Study|Disease progression|2|||
160637772|NCT02030834|580057920|FG001|Overall Study|Disease progression|0|||
160637773|NCT02030834|580057921|FG002|Overall Study|Disease progression|2|||
160637774|NCT02030834|580057919|FG000|Overall Study|Lost to Follow-up|1|||
160637775|NCT02030834|580057920|FG001|Overall Study|Lost to Follow-up|0|||
160637776|NCT02030834|580057921|FG002|Overall Study|Lost to Follow-up|0|||
160637777|NCT02030834|580057919|FG000|Overall Study|Withdrawal by Subject|1|||
160637778|NCT02030834|580057920|FG001|Overall Study|Withdrawal by Subject|0|||
160637779|NCT02030834|580057921|FG002|Overall Study|Withdrawal by Subject|0|||
160637780|NCT02030834|580057919|FG000|Overall Study|Lack of funding|1|||
160637781|NCT02030834|580057920|FG001|Overall Study|Lack of funding|0|||
160637782|NCT02030834|580057921|FG002|Overall Study|Lack of funding|0|||
160637783|NCT03216954|580057924|FG000|Overall Study|Adverse Event|0|||
160637784|NCT03216954|580057925|FG001|Overall Study|Adverse Event|0|||
160637785|NCT03216954|580057926|FG002|Overall Study|Adverse Event|1|||
160637786|NCT03216954|580057927|FG003|Overall Study|Adverse Event|0|||
160637787|NCT03216954|580057928|FG004|Overall Study|Adverse Event|1|||
160637788|NCT03216954|580057924|FG000|Overall Study|Withdrawal by Subject|2|||
160637789|NCT03216954|580057925|FG001|Overall Study|Withdrawal by Subject|0|||
160637790|NCT03216954|580057926|FG002|Overall Study|Withdrawal by Subject|0|||
160885846|NCT03675321|580978202|FG000|Overall Study|Lack of Efficacy|2|||
160885847|NCT03675321|580978203|FG001|Overall Study|Lack of Efficacy|2|||
160885848|NCT03675321|580978202|FG000|Overall Study|Withdrawal by Subject|1|||
160885849|NCT03675321|580978203|FG001|Overall Study|Withdrawal by Subject|3|||
160885850|NCT00807027|580978204|FG000|Overall Study|Withdrawal by Subject|13|||
160885851|NCT00807027|580978205|FG001|Overall Study|Withdrawal by Subject|14|||
160885852|NCT00807027|580978204|FG000|Overall Study|Protocol Violation|1|||
160885853|NCT00807027|580978205|FG001|Overall Study|Protocol Violation|1|||
160885854|NCT00807027|580978204|FG000|Overall Study|Adverse Event|2|||
160773764|NCT05028569|580557642|FG002|Double-Blind Phase|Other, not specified|4|||
160773765|NCT05028569|580557643|FG003|Double-Blind Phase|Other, not specified|6|||
160773766|NCT05028569|580557644|FG004|Double-Blind Phase|Other, not specified|0|||
160773767|NCT05028569|580557645|FG005|Double-Blind Phase|Other, not specified|0|||
160773768|NCT05028569|580557646|FG006|Double-Blind Phase|Other, not specified|0|||
160773769|NCT05028569|580557640|FG000|Open-Label Phase|Death|0|||
160773770|NCT05028569|580557641|FG001|Open-Label Phase|Death|0|||
160773771|NCT05028569|580557642|FG002|Open-Label Phase|Death|0|||
160773772|NCT05028569|580557643|FG003|Open-Label Phase|Death|0|||
160773773|NCT05028569|580557644|FG004|Open-Label Phase|Death|0|||
160773774|NCT05028569|580557645|FG005|Open-Label Phase|Death|0|||
160773775|NCT05028569|580557646|FG006|Open-Label Phase|Death|1|||
160773776|NCT05028569|580557640|FG000|Open-Label Phase|Lost to Follow-up|0|||
160773777|NCT05028569|580557641|FG001|Open-Label Phase|Lost to Follow-up|0|||
160773778|NCT05028569|580557642|FG002|Open-Label Phase|Lost to Follow-up|0|||
160773779|NCT05028569|580557643|FG003|Open-Label Phase|Lost to Follow-up|0|||
160773780|NCT05028569|580557644|FG004|Open-Label Phase|Lost to Follow-up|5|||
160773781|NCT05028569|580557645|FG005|Open-Label Phase|Lost to Follow-up|5|||
160773782|NCT05028569|580557646|FG006|Open-Label Phase|Lost to Follow-up|4|||
160773783|NCT05028569|580557640|FG000|Open-Label Phase|Protocol Deviation|0|||
160773784|NCT05028569|580557641|FG001|Open-Label Phase|Protocol Deviation|0|||
160773785|NCT05028569|580557642|FG002|Open-Label Phase|Protocol Deviation|0|||
160773786|NCT05028569|580557643|FG003|Open-Label Phase|Protocol Deviation|0|||
160773787|NCT05028569|580557644|FG004|Open-Label Phase|Protocol Deviation|1|||
160773788|NCT05028569|580557645|FG005|Open-Label Phase|Protocol Deviation|0|||
160773789|NCT05028569|580557646|FG006|Open-Label Phase|Protocol Deviation|0|||
160773790|NCT05028569|580557640|FG000|Open-Label Phase|Pregnancy|0|||
160773791|NCT05028569|580557641|FG001|Open-Label Phase|Pregnancy|0|||
160773792|NCT05028569|580557642|FG002|Open-Label Phase|Pregnancy|0|||
160773793|NCT05028569|580557643|FG003|Open-Label Phase|Pregnancy|0|||
160885855|NCT00807027|580978205|FG001|Overall Study|Adverse Event|2|||
160885856|NCT02278341|580978206|FG000|Overall Study|Randomized but never received study drug|1|||
160885857|NCT02278341|580978207|FG001|Overall Study|Randomized but never received study drug|1|||
160885858|NCT02278341|580978206|FG000|Overall Study|Adverse Event|3|||
160885859|NCT02278341|580978207|FG001|Overall Study|Adverse Event|0|||
160885860|NCT02278341|580978206|FG000|Overall Study|Death|68|||
160885861|NCT02278341|580978207|FG001|Overall Study|Death|56|||
160885862|NCT02278341|580978206|FG000|Overall Study|Withdrawal by Subject|30|||
160885863|NCT02278341|580978207|FG001|Overall Study|Withdrawal by Subject|19|||
160885864|NCT02278341|580978206|FG000|Overall Study|Lost to Follow-up|0|||
160885865|NCT02278341|580978207|FG001|Overall Study|Lost to Follow-up|1|||
160885866|NCT02278341|580978206|FG000|Overall Study|Physician Decision|1|||
160885867|NCT02278341|580978207|FG001|Overall Study|Physician Decision|1|||
160885868|NCT02278341|580978206|FG000|Overall Study|Miscellaneous|15|||
160885869|NCT02278341|580978207|FG001|Overall Study|Miscellaneous|14|||
160885870|NCT04902326|580978210|FG000|Overall Study|Withdrawal by Subject|1|||
160885871|NCT04902326|580978211|FG001|Overall Study|Withdrawal by Subject|3|||
160885872|NCT04902326|580978212|FG002|Overall Study|Withdrawal by Subject|0|||
160885873|NCT04902326|580978213|FG003|Overall Study|Withdrawal by Subject|1|||
160885874|NCT04902326|580978210|FG000|Overall Study|Lost to Follow-up|14|||
160885875|NCT04902326|580978211|FG001|Overall Study|Lost to Follow-up|14|||
160885876|NCT04902326|580978212|FG002|Overall Study|Lost to Follow-up|14|||
160885877|NCT04902326|580978213|FG003|Overall Study|Lost to Follow-up|6|||
160885878|NCT00934648|580978216|FG000|Overall Study|Failure to return|8|||
160885879|NCT00934648|580978216|FG000|Overall Study|Withdrawal by Subject|1|||
160885880|NCT02361580|580978218|FG000|Overall Study|Lost to Follow-up|6|||
160885881|NCT02361580|580978219|FG001|Overall Study|Lost to Follow-up|3|||
160885882|NCT02047318|580978220|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
160885883|NCT02047318|580978220|FG000|Core Study Period|Adverse Event|1|||
160885884|NCT02047318|580978220|FG000|Core Study Period|Withdrawal by caregiver|3|||
160885885|NCT02047318|580978220|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
160885886|NCT01487577|580978221|FG000|Overall Study|Became ineligible after signing consent|1|||
160885887|NCT01479985|580978222|FG000|Overall Study|Tablet malfunction, no data saved|1|||
160885888|NCT01479985|580978223|FG001|Overall Study|Tablet malfunction, no data saved|1|||
160885889|NCT01479985|580978222|FG000|Overall Study|No decisional conflict scale responses|0|||
160885890|NCT01479985|580978223|FG001|Overall Study|No decisional conflict scale responses|2|||
160885891|NCT01479985|580978222|FG000|Overall Study|No post-visit survey|5|||
160885892|NCT01479985|580978223|FG001|Overall Study|No post-visit survey|3|||
160885893|NCT00708201|580978224|FG000|Overall Study|Adverse Event|4|||
160885894|NCT00708201|580978225|FG001|Overall Study|Adverse Event|4|||
160885895|NCT00708201|580978224|FG000|Overall Study|Withdrawal by Subject|1|||
160885896|NCT00708201|580978225|FG001|Overall Study|Withdrawal by Subject|1|||
160885897|NCT00708201|580978224|FG000|Overall Study|Lost to Follow-up|2|||
160885898|NCT00708201|580978225|FG001|Overall Study|Lost to Follow-up|0|||
160885899|NCT00708201|580978224|FG000|Overall Study|Protocol Violation|0|||
160885900|NCT00708201|580978225|FG001|Overall Study|Protocol Violation|1|||
160885901|NCT00761748|580978226|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
160885902|NCT00761748|580978227|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
160885903|NCT00761748|580978226|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
160885904|NCT00761748|580978227|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
160885905|NCT02554279|580978228|FG000|Overall Study|Adverse Event|2|||
160885906|NCT02554279|580978229|FG001|Overall Study|Adverse Event|5|||
160885907|NCT02554279|580978228|FG000|Overall Study|Lost to Follow-up|3|||
160885908|NCT02554279|580978229|FG001|Overall Study|Lost to Follow-up|2|||
160885909|NCT02554279|580978228|FG000|Overall Study|Withdrawal by Subject|6|||
160885910|NCT02554279|580978229|FG001|Overall Study|Withdrawal by Subject|4|||
160885911|NCT02554279|580978228|FG000|Overall Study|Protocol Violation|2|||
160885912|NCT02554279|580978229|FG001|Overall Study|Protocol Violation|1|||
160885913|NCT02554279|580978228|FG000|Overall Study|Other reason|19|||
160885914|NCT02554279|580978229|FG001|Overall Study|Other reason|6|||
160885915|NCT00812487|580978230|FG000|Overall Study|Lost to Follow-up|2|||
160885916|NCT00812487|580978231|FG001|Overall Study|Lost to Follow-up|0|||
160885917|NCT00812487|580978230|FG000|Overall Study|Withdrawal by Subject|3|||
160637791|NCT03216954|580057927|FG003|Overall Study|Withdrawal by Subject|0|||
160885918|NCT00812487|580978231|FG001|Overall Study|Withdrawal by Subject|2|||
160885919|NCT00812487|580978230|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
160885920|NCT00812487|580978231|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
160885921|NCT00812487|580978230|FG000|Overall Study|Protocol Violation|0|||
160885922|NCT00812487|580978231|FG001|Overall Study|Protocol Violation|1|||
160885923|NCT00998764|580978232|FG000|Overall Study|Lack of Efficacy|3|||
160885924|NCT00998764|580978233|FG001|Overall Study|Lack of Efficacy|6|||
160885925|NCT00998764|580978232|FG000|Overall Study|Adverse Event|17|||
160885926|NCT00998764|580978233|FG001|Overall Study|Adverse Event|12|||
160885927|NCT00998764|580978232|FG000|Overall Study|Withdrawal by Subject|19|||
160885928|NCT00998764|580978233|FG001|Overall Study|Withdrawal by Subject|25|||
160885929|NCT00998764|580978232|FG000|Overall Study|Physician Decision|3|||
160885930|NCT00998764|580978233|FG001|Overall Study|Physician Decision|3|||
160885931|NCT00998764|580978232|FG000|Overall Study|Death|3|||
160773794|NCT05028569|580557644|FG004|Open-Label Phase|Pregnancy|0|||
160773795|NCT05028569|580557645|FG005|Open-Label Phase|Pregnancy|1|||
160773796|NCT05028569|580557646|FG006|Open-Label Phase|Pregnancy|0|||
160773797|NCT05028569|580557640|FG000|Open-Label Phase|Withdrawal by Subject|0|||
160773798|NCT05028569|580557641|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160773799|NCT05028569|580557642|FG002|Open-Label Phase|Withdrawal by Subject|0|||
160773800|NCT05028569|580557643|FG003|Open-Label Phase|Withdrawal by Subject|0|||
160773801|NCT05028569|580557644|FG004|Open-Label Phase|Withdrawal by Subject|15|||
160773802|NCT05028569|580557645|FG005|Open-Label Phase|Withdrawal by Subject|8|||
160773803|NCT05028569|580557646|FG006|Open-Label Phase|Withdrawal by Subject|13|||
160773804|NCT05028569|580557640|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
160773805|NCT05028569|580557641|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
160773806|NCT05028569|580557642|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
160773807|NCT05028569|580557643|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
160773808|NCT05028569|580557644|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
160773809|NCT05028569|580557645|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
160773810|NCT05028569|580557646|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
160773811|NCT05028569|580557640|FG000|Open-Label Phase|Other, not specified|0|||
160773812|NCT05028569|580557641|FG001|Open-Label Phase|Other, not specified|0|||
160773813|NCT05028569|580557642|FG002|Open-Label Phase|Other, not specified|0|||
160773814|NCT05028569|580557643|FG003|Open-Label Phase|Other, not specified|0|||
160773815|NCT05028569|580557644|FG004|Open-Label Phase|Other, not specified|6|||
160773816|NCT05028569|580557645|FG005|Open-Label Phase|Other, not specified|5|||
160773817|NCT05028569|580557646|FG006|Open-Label Phase|Other, not specified|7|||
160773818|NCT05028569|580557640|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
160773819|NCT05028569|580557641|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
160773820|NCT05028569|580557642|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
160773821|NCT05028569|580557643|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
160773822|NCT05028569|580557644|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
160773823|NCT05028569|580557645|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
160773824|NCT05028569|580557646|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
160773825|NCT05028569|580557640|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
160773826|NCT05028569|580557641|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
160773827|NCT05028569|580557642|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
160773828|NCT05028569|580557643|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
160773829|NCT05028569|580557644|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
160773830|NCT05028569|580557645|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
160773831|NCT05028569|580557646|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
160773832|NCT04609553|580557647|FG000|Overall Study|Lost to Follow-up|27|||
160773833|NCT04609553|580557648|FG001|Overall Study|Lost to Follow-up|31|||
160773834|NCT04609553|580557649|FG002|Overall Study|Lost to Follow-up|24|||
160773835|NCT04609553|580557647|FG000|Overall Study|Discontinued|12|||
160773836|NCT04609553|580557648|FG001|Overall Study|Discontinued|10|||
160773837|NCT04609553|580557649|FG002|Overall Study|Discontinued|9|||
160773838|NCT01240746|580557650|FG000|Overall Study|Adverse Event|2|||
160773839|NCT01240746|580557651|FG001|Overall Study|Adverse Event|0|||
160773840|NCT01240746|580557652|FG002|Overall Study|Adverse Event|10|||
160773841|NCT01240746|580557650|FG000|Overall Study|Lost to Follow-up|23|||
160773842|NCT01240746|580557651|FG001|Overall Study|Lost to Follow-up|20|||
160773843|NCT01240746|580557652|FG002|Overall Study|Lost to Follow-up|102|||
160773844|NCT01240746|580557650|FG000|Overall Study|Protocol Violation|24|||
160773845|NCT01240746|580557651|FG001|Overall Study|Protocol Violation|15|||
160773846|NCT01240746|580557652|FG002|Overall Study|Protocol Violation|72|||
160773847|NCT01240746|580557650|FG000|Overall Study|Withdrawal by Subject|10|||
160773848|NCT01240746|580557651|FG001|Overall Study|Withdrawal by Subject|13|||
160773849|NCT01240746|580557652|FG002|Overall Study|Withdrawal by Subject|59|||
160773850|NCT01136954|580557653|FG000|Overall Study|Adverse Event|3|||
160773851|NCT01136954|580557654|FG001|Overall Study|Adverse Event|2|||
160773852|NCT01136954|580557653|FG000|Overall Study|Withdrawal by Subject|6|||
160885932|NCT00998764|580978233|FG001|Overall Study|Death|1|||
160885933|NCT00998764|580978232|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
160885934|NCT00998764|580978233|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
160885935|NCT00998764|580978232|FG000|Overall Study|Protocol Violation|0|||
160885936|NCT00998764|580978233|FG001|Overall Study|Protocol Violation|1|||
160541118|NCT05121480|579711164|FG002|Overall Study|Non-compliance with the protocol|0|||
160773853|NCT01136954|580557654|FG001|Overall Study|Withdrawal by Subject|2|||
160773854|NCT01136954|580557653|FG000|Overall Study|Lack of Efficacy|14|||
160773855|NCT01136954|580557654|FG001|Overall Study|Lack of Efficacy|13|||
160773856|NCT01136954|580557653|FG000|Overall Study|Physician Decision|0|||
160773857|NCT01136954|580557654|FG001|Overall Study|Physician Decision|1|||
160885937|NCT00998764|580978232|FG000|Overall Study|Failed to Return|1|||
160773858|NCT01136954|580557653|FG000|Overall Study|Other|1|||
160773859|NCT01136954|580557654|FG001|Overall Study|Other|3|||
160773860|NCT02362451|580557668|FG000|Overall Study|Withdrawal by Subject|0|||
160773861|NCT02362451|580557669|FG001|Overall Study|Withdrawal by Subject|1|||
160773862|NCT02362451|580557668|FG000|Overall Study|Lack of Efficacy|2|||
160773863|NCT02362451|580557669|FG001|Overall Study|Lack of Efficacy|0|||
160773864|NCT02362451|580557668|FG000|Overall Study|Progression|1|||
160773865|NCT02362451|580557669|FG001|Overall Study|Progression|0|||
160773866|NCT02362451|580557668|FG000|Overall Study|Participant chose other therapy.|1|||
160773867|NCT02362451|580557669|FG001|Overall Study|Participant chose other therapy.|0|||
160773868|NCT02239328|580557672|FG000|Overall Study|Benign disease noted at time of surgery|6|||
160773869|NCT02239328|580557672|FG000|Overall Study|Equipment or website malfunction|2|||
160773870|NCT03331562|580557674|FG000|Overall Study|Adverse Event|2|||
160773871|NCT03331562|580557675|FG001|Overall Study|Adverse Event|0|||
160773872|NCT03331562|580557674|FG000|Overall Study|Death|1|||
160773873|NCT03331562|580557675|FG001|Overall Study|Death|0|||
160773874|NCT03718000|580557683|FG000|Overall Study|Relocation|2|||
160773875|NCT03718000|580557684|FG001|Overall Study|Relocation|4|||
160773876|NCT03718000|580557683|FG000|Overall Study|Pregnancy|0|||
160773877|NCT03718000|580557684|FG001|Overall Study|Pregnancy|1|||
160773878|NCT00716417|580557685|FG000|Overall Study|Adverse Event|0|||
160773879|NCT00716417|580557686|FG001|Overall Study|Adverse Event|0|||
160773880|NCT00716417|580557687|FG002|Overall Study|Adverse Event|2|||
160773881|NCT00716417|580557688|FG003|Overall Study|Adverse Event|1|||
160773882|NCT00716417|580557689|FG004|Overall Study|Adverse Event|0|||
160773883|NCT00716417|580557690|FG005|Overall Study|Adverse Event|0|||
160773884|NCT00716417|580557691|FG006|Overall Study|Adverse Event|3|||
160773885|NCT00716417|580557692|FG007|Overall Study|Adverse Event|1|||
160773886|NCT00716417|580557693|FG008|Overall Study|Adverse Event|0|||
160773887|NCT00716417|580557694|FG009|Overall Study|Adverse Event|3|||
160773888|NCT00716417|580557685|FG000|Overall Study|Withdrawal by Subject|0|||
160773889|NCT00716417|580557686|FG001|Overall Study|Withdrawal by Subject|1|||
160773890|NCT00716417|580557687|FG002|Overall Study|Withdrawal by Subject|0|||
160773891|NCT00716417|580557688|FG003|Overall Study|Withdrawal by Subject|2|||
160773892|NCT00716417|580557689|FG004|Overall Study|Withdrawal by Subject|0|||
160773893|NCT00716417|580557690|FG005|Overall Study|Withdrawal by Subject|0|||
160773894|NCT00716417|580557691|FG006|Overall Study|Withdrawal by Subject|1|||
160773895|NCT00716417|580557692|FG007|Overall Study|Withdrawal by Subject|0|||
160773896|NCT00716417|580557693|FG008|Overall Study|Withdrawal by Subject|0|||
160773897|NCT00716417|580557694|FG009|Overall Study|Withdrawal by Subject|0|||
160773898|NCT00716417|580557685|FG000|Overall Study|Progressive disease|3|||
160773899|NCT00716417|580557686|FG001|Overall Study|Progressive disease|5|||
160773900|NCT00716417|580557687|FG002|Overall Study|Progressive disease|3|||
160773901|NCT00716417|580557688|FG003|Overall Study|Progressive disease|8|||
160773902|NCT00716417|580557689|FG004|Overall Study|Progressive disease|0|||
160773903|NCT00716417|580557690|FG005|Overall Study|Progressive disease|3|||
160773904|NCT00716417|580557691|FG006|Overall Study|Progressive disease|3|||
160773905|NCT00716417|580557692|FG007|Overall Study|Progressive disease|1|||
160773906|NCT00716417|580557693|FG008|Overall Study|Progressive disease|5|||
160773907|NCT00716417|580557694|FG009|Overall Study|Progressive disease|0|||
160773908|NCT00716417|580557685|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
160773909|NCT00716417|580557686|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
160773910|NCT00716417|580557687|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
160773911|NCT00716417|580557688|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
160773912|NCT00716417|580557689|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
160773913|NCT00716417|580557690|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
160773914|NCT00716417|580557691|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
160773915|NCT00716417|580557692|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
160773916|NCT00716417|580557693|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
160773917|NCT00716417|580557694|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
160773918|NCT00716417|580557685|FG000|Overall Study|On patient request due to toxicities|0|||
160773919|NCT00716417|580557686|FG001|Overall Study|On patient request due to toxicities|0|||
160773920|NCT00716417|580557687|FG002|Overall Study|On patient request due to toxicities|0|||
160773921|NCT00716417|580557688|FG003|Overall Study|On patient request due to toxicities|0|||
160885938|NCT00998764|580978233|FG001|Overall Study|Failed to Return|1|||
160885939|NCT00998764|580978232|FG000|Overall Study|Lost to Follow-up|1|||
160773922|NCT00716417|580557689|FG004|Overall Study|On patient request due to toxicities|0|||
160773923|NCT00716417|580557690|FG005|Overall Study|On patient request due to toxicities|0|||
160773924|NCT00716417|580557691|FG006|Overall Study|On patient request due to toxicities|0|||
160773925|NCT00716417|580557692|FG007|Overall Study|On patient request due to toxicities|1|||
160773926|NCT00716417|580557693|FG008|Overall Study|On patient request due to toxicities|0|||
160773927|NCT00716417|580557694|FG009|Overall Study|On patient request due to toxicities|0|||
160773928|NCT00689936|580557695|FG000|Active Treatment Phase|Adverse Event|68|||
160773929|NCT00689936|580557696|FG001|Active Treatment Phase|Adverse Event|71|||
160773930|NCT00689936|580557697|FG002|Active Treatment Phase|Adverse Event|76|||
160773931|NCT00689936|580557695|FG000|Active Treatment Phase|Disease Progression|273|||
160773932|NCT00689936|580557696|FG001|Active Treatment Phase|Disease Progression|362|||
160773933|NCT00689936|580557697|FG002|Active Treatment Phase|Disease Progression|339|||
160773934|NCT00689936|580557695|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
160773935|NCT00689936|580557696|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
160773936|NCT00689936|580557697|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
160773937|NCT00689936|580557695|FG000|Active Treatment Phase|Death|60|||
160773938|NCT00689936|580557696|FG001|Active Treatment Phase|Death|28|||
160773939|NCT00689936|580557697|FG002|Active Treatment Phase|Death|37|||
160773940|NCT00689936|580557695|FG000|Active Treatment Phase|Lost to Follow-up|0|||
160773941|NCT00689936|580557696|FG001|Active Treatment Phase|Lost to Follow-up|2|||
160773942|NCT00689936|580557697|FG002|Active Treatment Phase|Lost to Follow-up|2|||
160773943|NCT00689936|580557695|FG000|Active Treatment Phase|Protocol Violation|2|||
160773944|NCT00689936|580557696|FG001|Active Treatment Phase|Protocol Violation|2|||
160773945|NCT00689936|580557697|FG002|Active Treatment Phase|Protocol Violation|4|||
160773946|NCT00689936|580557695|FG000|Active Treatment Phase|Study Close Out|64|||
160773947|NCT00689936|580557696|FG001|Active Treatment Phase|Study Close Out|26|||
160773948|NCT00689936|580557697|FG002|Active Treatment Phase|Study Close Out|21|||
160773949|NCT00689936|580557695|FG000|Active Treatment Phase|Miscellaneous|52|||
160773950|NCT00689936|580557696|FG001|Active Treatment Phase|Miscellaneous|34|||
160773951|NCT00689936|580557697|FG002|Active Treatment Phase|Miscellaneous|47|||
160773952|NCT00689936|580557695|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
160773953|NCT00689936|580557696|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
160773954|NCT00689936|580557697|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
160773955|NCT03881371|580557698|FG000|Overall Study|Adverse Event|8|||
160773956|NCT03881371|580557699|FG001|Overall Study|Adverse Event|9|||
160773957|NCT03881371|580557698|FG000|Overall Study|Death|1|||
160885940|NCT00998764|580978233|FG001|Overall Study|Lost to Follow-up|1|||
160885941|NCT00998764|580978232|FG000|Overall Study|Loss of Caregiver|0|||
160885942|NCT00998764|580978233|FG001|Overall Study|Loss of Caregiver|3|||
160885943|NCT00998764|580978232|FG000|Overall Study|Other|4|||
160885944|NCT00998764|580978233|FG001|Overall Study|Other|4|||
160885945|NCT00998764|580978232|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
160885946|NCT00998764|580978233|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
160885947|NCT04761627|580978236|FG000|Run-in Period|Death|1|||
160885948|NCT04761627|580978237|FG001|Run-in Period|Death|0|||
160885949|NCT04761627|580978238|FG002|Run-in Period|Death|0|||
160885950|NCT04761627|580978236|FG000|Run-in Period|Required alternative therapy|2|||
160885951|NCT04761627|580978237|FG001|Run-in Period|Required alternative therapy|0|||
160885952|NCT04761627|580978238|FG002|Run-in Period|Required alternative therapy|0|||
160885953|NCT04761627|580978236|FG000|Run-in Period|Lost to Follow-up|2|||
160885954|NCT04761627|580978237|FG001|Run-in Period|Lost to Follow-up|0|||
160885955|NCT04761627|580978238|FG002|Run-in Period|Lost to Follow-up|0|||
160885956|NCT04761627|580978236|FG000|Run-in Period|Protocol Violation|3|||
160885957|NCT04761627|580978237|FG001|Run-in Period|Protocol Violation|0|||
160885958|NCT04761627|580978238|FG002|Run-in Period|Protocol Violation|0|||
160885959|NCT04761627|580978236|FG000|Run-in Period|Abnormal liver function|1|||
160885960|NCT04761627|580978237|FG001|Run-in Period|Abnormal liver function|0|||
160885961|NCT04761627|580978238|FG002|Run-in Period|Abnormal liver function|0|||
160885962|NCT04761627|580978236|FG000|Run-in Period|Adverse Event|6|||
160885963|NCT04761627|580978237|FG001|Run-in Period|Adverse Event|0|||
160885964|NCT04761627|580978238|FG002|Run-in Period|Adverse Event|0|||
160541119|NCT05121480|579711165|FG003|Overall Study|Non-compliance with the protocol|0|||
160541120|NCT05121480|579711166|FG004|Overall Study|Non-compliance with the protocol|1|||
160541121|NCT05121480|579711167|FG005|Overall Study|Non-compliance with the protocol|6|||
160773958|NCT03881371|580557699|FG001|Overall Study|Death|0|||
160773959|NCT03881371|580557698|FG000|Overall Study|Lost to Follow-up|1|||
160885965|NCT04761627|580978236|FG000|Run-in Period|Withdrawal by Subject|7|||
160773960|NCT03881371|580557699|FG001|Overall Study|Lost to Follow-up|0|||
160773961|NCT03881371|580557698|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160773962|NCT03881371|580557699|FG001|Overall Study|Non-Compliance with Study Drug|2|||
160885966|NCT04761627|580978237|FG001|Run-in Period|Withdrawal by Subject|0|||
160885967|NCT04761627|580978238|FG002|Run-in Period|Withdrawal by Subject|0|||
160885968|NCT04761627|580978236|FG000|Run-in Period|Did not meet PASI 50|15|||
160541122|NCT05121480|579711168|FG006|Overall Study|Non-compliance with the protocol|0|||
160541123|NCT05121480|579711169|FG007|Overall Study|Non-compliance with the protocol|1|||
160773963|NCT03881371|580557698|FG000|Overall Study|Physician Decision|3|||
160773964|NCT03881371|580557699|FG001|Overall Study|Physician Decision|3|||
160773965|NCT03881371|580557698|FG000|Overall Study|Withdrawal by Subject|2|||
160773966|NCT03881371|580557699|FG001|Overall Study|Withdrawal by Subject|10|||
160773967|NCT03881371|580557698|FG000|Overall Study|Discontinuation from Study|1|||
160885969|NCT04761627|580978237|FG001|Run-in Period|Did not meet PASI 50|0|||
160885970|NCT04761627|580978238|FG002|Run-in Period|Did not meet PASI 50|0|||
160885971|NCT04761627|580978236|FG000|Run-in Period|Study site closure|2|||
160885972|NCT04761627|580978237|FG001|Run-in Period|Study site closure|0|||
160885973|NCT04761627|580978238|FG002|Run-in Period|Study site closure|0|||
160885974|NCT04761627|580978236|FG000|Run-in Period|Pregnancy|2|||
160773968|NCT03881371|580557699|FG001|Overall Study|Discontinuation from Study|0|||
160773969|NCT00963235|580557702|FG000|Overall Study|Withdrawal by Subject|22|||
160773970|NCT00963235|580557702|FG000|Overall Study|Lost to Follow-up|14|||
160773971|NCT00963235|580557702|FG000|Overall Study|Failed to return|9|||
160773972|NCT00963235|580557702|FG000|Overall Study|Protocol Violation|7|||
160773973|NCT00963235|580557702|FG000|Overall Study|Adverse Event|5|||
160773974|NCT00963235|580557702|FG000|Overall Study|Physician Decision|2|||
160773975|NCT00963235|580557702|FG000|Overall Study|Other|1|||
160773976|NCT01756235|580557703|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
160773977|NCT05376358|580557704|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
160773978|NCT05376358|580557705|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
160773979|NCT05376358|580557704|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
160773980|NCT05376358|580557705|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
160773981|NCT05376358|580557704|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
160773982|NCT05376358|580557705|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
160773983|NCT05376358|580557704|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
160773984|NCT05376358|580557705|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
160773985|NCT05376358|580557704|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
160773986|NCT05376358|580557705|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
160773987|NCT05376358|580557704|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
160773988|NCT05376358|580557705|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
160773989|NCT06001866|580557712|FG000|Overall Study|Withdrawal by Subject|0|||
160773990|NCT06001866|580557713|FG001|Overall Study|Withdrawal by Subject|2|||
160773991|NCT06001866|580557712|FG000|Overall Study|Protocol Violation|0|||
160773992|NCT06001866|580557713|FG001|Overall Study|Protocol Violation|2|||
160773993|NCT04703192|580557714|FG000|Overall Study|Withdrawal by Subject|2|||
160773994|NCT04703192|580557715|FG001|Overall Study|Withdrawal by Subject|0|||
160773995|NCT04703192|580557714|FG000|Overall Study|Death|3|||
160773996|NCT04703192|580557715|FG001|Overall Study|Death|1|||
160773997|NCT04703192|580557714|FG000|Overall Study|Adverse Event|13|||
160773998|NCT04703192|580557715|FG001|Overall Study|Adverse Event|2|||
160773999|NCT04703192|580557714|FG000|Overall Study|Progressive or Relapsed Disease|46|||
160774000|NCT04703192|580557715|FG001|Overall Study|Progressive or Relapsed Disease|7|||
160774001|NCT04703192|580557714|FG000|Overall Study|Clinical Progression|19|||
160774002|NCT04703192|580557715|FG001|Overall Study|Clinical Progression|8|||
160774003|NCT04703192|580557714|FG000|Overall Study|Lost to Follow-up|1|||
160774004|NCT04703192|580557715|FG001|Overall Study|Lost to Follow-up|0|||
160774005|NCT04703192|580557714|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
160774006|NCT04703192|580557715|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
160774007|NCT04703192|580557714|FG000|Overall Study|Other|5|||
160774008|NCT04703192|580557715|FG001|Overall Study|Other|1|||
160774009|NCT04725188|580557718|FG000|Overall Study|Death|72|||
160774010|NCT04725188|580557719|FG001|Overall Study|Death|69|||
160774011|NCT04725188|580557720|FG002|Overall Study|Death|76|||
160774012|NCT04725188|580557718|FG000|Overall Study|Lost to Follow-up|1|||
160774013|NCT04725188|580557719|FG001|Overall Study|Lost to Follow-up|0|||
160774014|NCT04725188|580557720|FG002|Overall Study|Lost to Follow-up|1|||
160774015|NCT04725188|580557718|FG000|Overall Study|Withdrawal by Subject|2|||
160774016|NCT04725188|580557719|FG001|Overall Study|Withdrawal by Subject|2|||
160774017|NCT04725188|580557720|FG002|Overall Study|Withdrawal by Subject|1|||
160774018|NCT04725188|580557718|FG000|Overall Study|Sponsor Decision|12|||
160774019|NCT04725188|580557719|FG001|Overall Study|Sponsor Decision|12|||
160774020|NCT04725188|580557720|FG002|Overall Study|Sponsor Decision|7|||
160774021|NCT03839641|580557722|FG000|Overall Study|Withdrawal by Subject|1|||
160774022|NCT03839641|580557723|FG001|Overall Study|Withdrawal by Subject|1|||
160774023|NCT00390013|580557724|FG000|Phase 1|tired|0|||
160774024|NCT00390013|580557725|FG001|Phase 1|tired|0|||
160774025|NCT00390013|580557726|FG002|Phase 1|tired|0|||
160774026|NCT00390013|580557727|FG003|Phase 1|tired|1|||
160774027|NCT00390013|580557724|FG000|Phase 2 First Treatment|tired|1|||
160774028|NCT00390013|580557725|FG001|Phase 2 First Treatment|tired|0|||
160774029|NCT00390013|580557726|FG002|Phase 2 First Treatment|tired|0|||
160774030|NCT00390013|580557727|FG003|Phase 2 First Treatment|tired|0|||
160774031|NCT00390013|580557724|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
160774032|NCT00390013|580557725|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
160774033|NCT00390013|580557726|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
160774034|NCT00390013|580557727|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
160774035|NCT04537299|580557734|FG000|Overall Study|Withdrawal by Subject|2|||
160774036|NCT04537299|580557735|FG001|Overall Study|Withdrawal by Subject|0|||
160774037|NCT04537299|580557734|FG000|Overall Study|Protocol Violation|1|||
160774038|NCT04537299|580557735|FG001|Overall Study|Protocol Violation|1|||
160637792|NCT03216954|580057928|FG004|Overall Study|Withdrawal by Subject|0|||
160774039|NCT00876343|580557736|FG000|Overall Study|Adverse Event|7|||
160774040|NCT00876343|580557737|FG001|Overall Study|Adverse Event|8|||
160774041|NCT00876343|580557738|FG002|Overall Study|Adverse Event|2|||
160774042|NCT00876343|580557736|FG000|Overall Study|Withdrawal by Subject|4|||
160774043|NCT00876343|580557737|FG001|Overall Study|Withdrawal by Subject|4|||
160774044|NCT00876343|580557738|FG002|Overall Study|Withdrawal by Subject|3|||
160774045|NCT00876343|580557736|FG000|Overall Study|Lack of Efficacy|0|||
160774046|NCT00876343|580557737|FG001|Overall Study|Lack of Efficacy|0|||
160774047|NCT00876343|580557738|FG002|Overall Study|Lack of Efficacy|1|||
160774048|NCT00876343|580557736|FG000|Overall Study|Protocol Violation|4|||
160774049|NCT00876343|580557737|FG001|Overall Study|Protocol Violation|1|||
160774050|NCT00876343|580557738|FG002|Overall Study|Protocol Violation|1|||
160774051|NCT00876343|580557736|FG000|Overall Study|Physician Decision|0|||
160774052|NCT00876343|580557737|FG001|Overall Study|Physician Decision|1|||
160774053|NCT00876343|580557738|FG002|Overall Study|Physician Decision|1|||
160774054|NCT00876343|580557736|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
160774055|NCT00876343|580557737|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
160774056|NCT00876343|580557738|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
160774057|NCT00876343|580557736|FG000|Overall Study|Change of residence or other commitments|2|||
160774058|NCT00876343|580557737|FG001|Overall Study|Change of residence or other commitments|2|||
160774059|NCT00876343|580557738|FG002|Overall Study|Change of residence or other commitments|3|||
160774060|NCT01901562|580557746|FG000|Overall Study|Protocol Violation|5|||
160774061|NCT01901562|580557746|FG000|Overall Study|Excluded intraoperatively|4|||
160774062|NCT01925794|580557747|FG000|180 Days|Death|2|||
160774063|NCT01925794|580557747|FG000|180 Days|Withdrawal by Subject|2|||
160774064|NCT01925794|580557747|FG000|270 Days|Death|2|||
160774065|NCT01925794|580557747|FG000|270 Days|Protocol Violation|3|||
160774066|NCT00976027|580557748|FG000|Overall Study|Serious Adverse Event|36|||
160774067|NCT00976027|580557749|FG001|Overall Study|Serious Adverse Event|17|||
160774068|NCT00976027|580557748|FG000|Overall Study|Adverse Event|0|||
160774069|NCT00976027|580557749|FG001|Overall Study|Adverse Event|2|||
160774070|NCT00976027|580557748|FG000|Overall Study|Protocol Violation|60|||
160774071|NCT00976027|580557749|FG001|Overall Study|Protocol Violation|27|||
160774072|NCT00976027|580557748|FG000|Overall Study|Lost to Follow-up|208|||
160774073|NCT00976027|580557749|FG001|Overall Study|Lost to Follow-up|103|||
160774074|NCT00976027|580557748|FG000|Overall Study|Withdrawal by Subject|107|||
160774075|NCT00976027|580557749|FG001|Overall Study|Withdrawal by Subject|66|||
160774076|NCT01771107|580557752|FG000|Overall Study|Adverse Event|1|||
160774077|NCT01771107|580557753|FG001|Overall Study|Adverse Event|3|||
160774078|NCT01771107|580557752|FG000|Overall Study|Withdrawal by Subject|0|||
160774079|NCT01771107|580557753|FG001|Overall Study|Withdrawal by Subject|2|||
160774080|NCT01771107|580557752|FG000|Overall Study|Lost to Follow-up|0|||
160774081|NCT01771107|580557753|FG001|Overall Study|Lost to Follow-up|1|||
160774082|NCT01771107|580557752|FG000|Overall Study|participant moved|0|||
160774083|NCT01771107|580557753|FG001|Overall Study|participant moved|1|||
160774084|NCT01771107|580557752|FG000|Overall Study|Other|0|||
160774085|NCT01771107|580557753|FG001|Overall Study|Other|1|||
160774086|NCT03805841|580557754|FG000|Overall Study|Clinical Progression|2|||
160774087|NCT03805841|580557755|FG001|Overall Study|Clinical Progression|0|||
160774088|NCT03805841|580557756|FG002|Overall Study|Clinical Progression|0|||
160774089|NCT03805841|580557754|FG000|Overall Study|Death|0|||
160774090|NCT03805841|580557755|FG001|Overall Study|Death|3|||
160774091|NCT03805841|580557756|FG002|Overall Study|Death|1|||
160774092|NCT03805841|580557754|FG000|Overall Study|Lost to Follow-up|0|||
160774093|NCT03805841|580557755|FG001|Overall Study|Lost to Follow-up|0|||
160774094|NCT03805841|580557756|FG002|Overall Study|Lost to Follow-up|1|||
160774095|NCT03805841|580557754|FG000|Overall Study|Withdrawal by Subject|2|||
160774096|NCT03805841|580557755|FG001|Overall Study|Withdrawal by Subject|3|||
160774097|NCT03805841|580557756|FG002|Overall Study|Withdrawal by Subject|0|||
160774098|NCT03805841|580557754|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
160774099|NCT03805841|580557755|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
160774100|NCT03805841|580557756|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
160774101|NCT03621592|580557757|FG000|Overall Study|Lost to Follow-up|1|||
160774102|NCT03621592|580557758|FG001|Overall Study|Lost to Follow-up|0|||
160774103|NCT03621592|580557757|FG000|Overall Study|Lack of Improvement|1|||
160774104|NCT03621592|580557758|FG001|Overall Study|Lack of Improvement|0|||
160774105|NCT03621592|580557757|FG000|Overall Study|Preference to receive wound care closer to home|1|||
160774106|NCT03621592|580557758|FG001|Overall Study|Preference to receive wound care closer to home|0|||
160774107|NCT03621592|580557757|FG000|Overall Study|Lack of healing|0|||
160774108|NCT03621592|580557758|FG001|Overall Study|Lack of healing|2|||
160774109|NCT00831844|580557766|FG000|Overall Study|Adverse Event|2|||
160774110|NCT00831844|580557767|FG001|Overall Study|Adverse Event|0|||
160774111|NCT00831844|580557768|FG002|Overall Study|Adverse Event|0|||
160774112|NCT00831844|580557769|FG003|Overall Study|Adverse Event|0|||
160774113|NCT00831844|580557770|FG004|Overall Study|Adverse Event|1|||
160774114|NCT00831844|580557771|FG005|Overall Study|Adverse Event|1|||
160774115|NCT00831844|580557772|FG006|Overall Study|Adverse Event|2|||
160774116|NCT00831844|580557773|FG007|Overall Study|Adverse Event|0|||
160774117|NCT00831844|580557774|FG008|Overall Study|Adverse Event|0|||
160774118|NCT00831844|580557775|FG009|Overall Study|Adverse Event|0|||
160774119|NCT00831844|580557766|FG000|Overall Study|Death|0|||
160774120|NCT00831844|580557767|FG001|Overall Study|Death|0|||
160774121|NCT00831844|580557768|FG002|Overall Study|Death|0|||
160774122|NCT00831844|580557769|FG003|Overall Study|Death|1|||
160774123|NCT00831844|580557770|FG004|Overall Study|Death|0|||
160774124|NCT00831844|580557771|FG005|Overall Study|Death|0|||
160774125|NCT00831844|580557772|FG006|Overall Study|Death|0|||
160774126|NCT00831844|580557773|FG007|Overall Study|Death|0|||
160774127|NCT00831844|580557774|FG008|Overall Study|Death|0|||
160774128|NCT00831844|580557775|FG009|Overall Study|Death|0|||
160774129|NCT00831844|580557766|FG000|Overall Study|Lack of Efficacy|8|||
160774130|NCT00831844|580557767|FG001|Overall Study|Lack of Efficacy|10|||
160774131|NCT00831844|580557768|FG002|Overall Study|Lack of Efficacy|15|||
160774132|NCT00831844|580557769|FG003|Overall Study|Lack of Efficacy|8|||
160774133|NCT00831844|580557770|FG004|Overall Study|Lack of Efficacy|11|||
160774134|NCT00831844|580557771|FG005|Overall Study|Lack of Efficacy|17|||
160774135|NCT00831844|580557772|FG006|Overall Study|Lack of Efficacy|8|||
160774136|NCT00831844|580557773|FG007|Overall Study|Lack of Efficacy|9|||
160774137|NCT00831844|580557774|FG008|Overall Study|Lack of Efficacy|7|||
160774138|NCT00831844|580557775|FG009|Overall Study|Lack of Efficacy|0|||
160774139|NCT00831844|580557766|FG000|Overall Study|Physician Decision|0|||
160774140|NCT00831844|580557767|FG001|Overall Study|Physician Decision|1|||
160774141|NCT00831844|580557768|FG002|Overall Study|Physician Decision|3|||
160774142|NCT00831844|580557769|FG003|Overall Study|Physician Decision|1|||
160774143|NCT00831844|580557770|FG004|Overall Study|Physician Decision|1|||
160774144|NCT00831844|580557771|FG005|Overall Study|Physician Decision|1|||
160774145|NCT00831844|580557772|FG006|Overall Study|Physician Decision|0|||
160774146|NCT00831844|580557773|FG007|Overall Study|Physician Decision|0|||
160774147|NCT00831844|580557774|FG008|Overall Study|Physician Decision|1|||
160774148|NCT00831844|580557775|FG009|Overall Study|Physician Decision|0|||
160774149|NCT00831844|580557766|FG000|Overall Study|Withdrawal by Subject|0|||
160774150|NCT00831844|580557767|FG001|Overall Study|Withdrawal by Subject|0|||
160774151|NCT00831844|580557768|FG002|Overall Study|Withdrawal by Subject|1|||
160774152|NCT00831844|580557769|FG003|Overall Study|Withdrawal by Subject|0|||
160774153|NCT00831844|580557770|FG004|Overall Study|Withdrawal by Subject|0|||
160774154|NCT00831844|580557771|FG005|Overall Study|Withdrawal by Subject|0|||
160774155|NCT00831844|580557772|FG006|Overall Study|Withdrawal by Subject|0|||
160774156|NCT00831844|580557773|FG007|Overall Study|Withdrawal by Subject|1|||
160774157|NCT00831844|580557774|FG008|Overall Study|Withdrawal by Subject|1|||
160774158|NCT00831844|580557775|FG009|Overall Study|Withdrawal by Subject|0|||
160774159|NCT00831844|580557766|FG000|Overall Study|Ineligible|0|||
160774160|NCT00831844|580557767|FG001|Overall Study|Ineligible|1|||
160774161|NCT00831844|580557768|FG002|Overall Study|Ineligible|1|||
160774162|NCT00831844|580557769|FG003|Overall Study|Ineligible|0|||
160774163|NCT00831844|580557770|FG004|Overall Study|Ineligible|1|||
160774164|NCT00831844|580557771|FG005|Overall Study|Ineligible|0|||
160774165|NCT00831844|580557772|FG006|Overall Study|Ineligible|0|||
160774166|NCT00831844|580557773|FG007|Overall Study|Ineligible|0|||
160774167|NCT00831844|580557774|FG008|Overall Study|Ineligible|0|||
160774168|NCT00831844|580557775|FG009|Overall Study|Ineligible|0|||
160774169|NCT04133909|580557776|FG000|Overall Study|Death|11|||
160774170|NCT04133909|580557777|FG001|Overall Study|Death|11|||
160774171|NCT04133909|580557776|FG000|Overall Study|Adverse Event|4|||
160774172|NCT04133909|580557777|FG001|Overall Study|Adverse Event|5|||
160774173|NCT04133909|580557776|FG000|Overall Study|Lost to Follow-up|3|||
160774174|NCT04133909|580557777|FG001|Overall Study|Lost to Follow-up|5|||
160774175|NCT04133909|580557776|FG000|Overall Study|Physician Decision|4|||
160774176|NCT04133909|580557777|FG001|Overall Study|Physician Decision|7|||
160774177|NCT04133909|580557776|FG000|Overall Study|Withdrawal by Subject|40|||
160774178|NCT04133909|580557777|FG001|Overall Study|Withdrawal by Subject|35|||
160774179|NCT04133909|580557776|FG000|Overall Study|Lack of Efficacy|2|||
160774180|NCT04133909|580557777|FG001|Overall Study|Lack of Efficacy|7|||
160653386|NCT04634409|580110525|FG025|Overall Study|Other - As reported by Investigator|0|||
160774181|NCT04133909|580557776|FG000|Overall Study|Randomized in error|1|||
160774182|NCT04133909|580557777|FG001|Overall Study|Randomized in error|1|||
160774183|NCT02340949|580557778|FG000|Overall Study|Adverse Event|4|||
160774184|NCT02340949|580557779|FG001|Overall Study|Adverse Event|2|||
160774185|NCT02340949|580557778|FG000|Overall Study|Withdrawal by Subject|2|||
160774186|NCT02340949|580557779|FG001|Overall Study|Withdrawal by Subject|0|||
160774187|NCT02340949|580557778|FG000|Overall Study|Progression disease|6|||
160774188|NCT02340949|580557779|FG001|Overall Study|Progression disease|2|||
160774189|NCT02340949|580557778|FG000|Overall Study|Death|3|||
160774190|NCT02340949|580557779|FG001|Overall Study|Death|0|||
160774191|NCT02340949|580557778|FG000|Overall Study|Physician Decision|1|||
160774192|NCT02340949|580557779|FG001|Overall Study|Physician Decision|0|||
160774193|NCT02460289|580557783|FG000|Overall Study|Adverse Event|1|||
160774194|NCT02460289|580557783|FG000|Overall Study|Withdrawal by Subject|8|||
160774195|NCT02460289|580557783|FG000|Overall Study|Lost to Follow-up|1|||
160774196|NCT02916927|580557784|FG000|Overall Study|Discharged prior to study drug receipt|0|||
160774197|NCT02916927|580557785|FG001|Overall Study|Discharged prior to study drug receipt|2|||
160774198|NCT02916927|580557784|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
160774199|NCT02916927|580557785|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
160774200|NCT02916927|580557784|FG000|Overall Study|Withdrawal before first time point|1|||
160774201|NCT02916927|580557785|FG001|Overall Study|Withdrawal before first time point|0|||
160774202|NCT01020123|580557786|FG000|Main Period|Withdrawal by Subject|6|||
160774203|NCT01020123|580557787|FG001|Main Period|Withdrawal by Subject|5|||
160774204|NCT01020123|580557788|FG002|Main Period|Withdrawal by Subject|3|||
160774205|NCT01020123|580557789|FG003|Main Period|Withdrawal by Subject|1|||
160774206|NCT01020123|580557790|FG004|Main Period|Withdrawal by Subject|6|||
160774207|NCT01020123|580557791|FG005|Main Period|Withdrawal by Subject|3|||
160774208|NCT01020123|580557792|FG006|Main Period|Withdrawal by Subject|2|||
160774209|NCT01020123|580557786|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
160774210|NCT01020123|580557787|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
160774211|NCT01020123|580557788|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
160774212|NCT01020123|580557789|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
160774213|NCT01020123|580557790|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
160774214|NCT01020123|580557791|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
160774215|NCT01020123|580557792|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
160774216|NCT01020123|580557786|FG000|Main Period|Adverse Event|5|||
160774217|NCT01020123|580557787|FG001|Main Period|Adverse Event|2|||
160774218|NCT01020123|580557788|FG002|Main Period|Adverse Event|2|||
160774219|NCT01020123|580557789|FG003|Main Period|Adverse Event|1|||
160774220|NCT01020123|580557790|FG004|Main Period|Adverse Event|1|||
160774221|NCT01020123|580557791|FG005|Main Period|Adverse Event|2|||
160774222|NCT01020123|580557792|FG006|Main Period|Adverse Event|1|||
160774223|NCT01020123|580557786|FG000|Main Period|Protocol Violation|4|||
160774224|NCT01020123|580557787|FG001|Main Period|Protocol Violation|4|||
160774225|NCT01020123|580557788|FG002|Main Period|Protocol Violation|2|||
160774226|NCT01020123|580557789|FG003|Main Period|Protocol Violation|5|||
160774227|NCT01020123|580557790|FG004|Main Period|Protocol Violation|2|||
160774228|NCT01020123|580557791|FG005|Main Period|Protocol Violation|3|||
160774229|NCT01020123|580557792|FG006|Main Period|Protocol Violation|2|||
160774230|NCT01020123|580557786|FG000|Main Period|Lost to Follow-up|0|||
160774231|NCT01020123|580557787|FG001|Main Period|Lost to Follow-up|2|||
160774232|NCT01020123|580557788|FG002|Main Period|Lost to Follow-up|0|||
160774233|NCT01020123|580557789|FG003|Main Period|Lost to Follow-up|0|||
160774234|NCT01020123|580557790|FG004|Main Period|Lost to Follow-up|0|||
160774235|NCT01020123|580557791|FG005|Main Period|Lost to Follow-up|0|||
160774236|NCT01020123|580557792|FG006|Main Period|Lost to Follow-up|0|||
160774237|NCT01020123|580557786|FG000|Main Period|Unclasified|2|||
160774238|NCT01020123|580557787|FG001|Main Period|Unclasified|0|||
160774239|NCT01020123|580557788|FG002|Main Period|Unclasified|1|||
160774240|NCT01020123|580557789|FG003|Main Period|Unclasified|0|||
160774241|NCT01020123|580557790|FG004|Main Period|Unclasified|1|||
160774242|NCT01020123|580557791|FG005|Main Period|Unclasified|3|||
160774243|NCT01020123|580557792|FG006|Main Period|Unclasified|6|||
160774244|NCT01020123|580557786|FG000|Extention Period|Withdrawal by Subject|2|||
160774245|NCT01020123|580557787|FG001|Extention Period|Withdrawal by Subject|1|||
160774246|NCT01020123|580557788|FG002|Extention Period|Withdrawal by Subject|1|||
160774247|NCT01020123|580557789|FG003|Extention Period|Withdrawal by Subject|0|||
160774248|NCT01020123|580557790|FG004|Extention Period|Withdrawal by Subject|0|||
160774249|NCT01020123|580557791|FG005|Extention Period|Withdrawal by Subject|0|||
160774250|NCT01020123|580557792|FG006|Extention Period|Withdrawal by Subject|0|||
160774251|NCT01020123|580557786|FG000|Extention Period|Adverse Event|0|||
160774252|NCT01020123|580557787|FG001|Extention Period|Adverse Event|0|||
160774253|NCT01020123|580557788|FG002|Extention Period|Adverse Event|0|||
160774254|NCT01020123|580557789|FG003|Extention Period|Adverse Event|1|||
160774255|NCT01020123|580557790|FG004|Extention Period|Adverse Event|0|||
160774256|NCT01020123|580557791|FG005|Extention Period|Adverse Event|0|||
160774257|NCT01020123|580557792|FG006|Extention Period|Adverse Event|0|||
160774258|NCT01020123|580557786|FG000|Extention Period|Protocol Violation|1|||
160774259|NCT01020123|580557787|FG001|Extention Period|Protocol Violation|1|||
160774260|NCT01020123|580557788|FG002|Extention Period|Protocol Violation|1|||
160774261|NCT01020123|580557789|FG003|Extention Period|Protocol Violation|0|||
160774262|NCT01020123|580557790|FG004|Extention Period|Protocol Violation|0|||
160774263|NCT01020123|580557791|FG005|Extention Period|Protocol Violation|0|||
160774264|NCT01020123|580557792|FG006|Extention Period|Protocol Violation|1|||
160774265|NCT01020123|580557786|FG000|Extention Period|Lost to Follow-up|0|||
160774266|NCT01020123|580557787|FG001|Extention Period|Lost to Follow-up|0|||
160774267|NCT01020123|580557788|FG002|Extention Period|Lost to Follow-up|0|||
160774268|NCT01020123|580557789|FG003|Extention Period|Lost to Follow-up|0|||
160774269|NCT01020123|580557790|FG004|Extention Period|Lost to Follow-up|0|||
160774270|NCT01020123|580557791|FG005|Extention Period|Lost to Follow-up|2|||
160774271|NCT01020123|580557792|FG006|Extention Period|Lost to Follow-up|0|||
160774272|NCT03479905|580557793|FG000|Overall Study|Other airway method used|4|||
160774273|NCT03479905|580557794|FG001|Overall Study|Other airway method used|5|||
160774274|NCT03479905|580557795|FG002|Overall Study|Other airway method used|5|||
160774275|NCT01706328|580557796|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
160774276|NCT01706328|580557797|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160774277|NCT01706328|580557798|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160774278|NCT01706328|580557796|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
160774279|NCT01706328|580557797|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
160774280|NCT01706328|580557798|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
160774281|NCT01706328|580557796|FG000|2-week Run-in Period|Physician Decision|4|||
160774282|NCT01706328|580557797|FG001|2-week Run-in Period|Physician Decision|0|||
160774283|NCT01706328|580557798|FG002|2-week Run-in Period|Physician Decision|0|||
160774284|NCT01706328|580557796|FG000|2-week Run-in Period|Adverse Event|4|||
160774285|NCT01706328|580557797|FG001|2-week Run-in Period|Adverse Event|0|||
160774286|NCT01706328|580557798|FG002|2-week Run-in Period|Adverse Event|0|||
160774287|NCT01706328|580557796|FG000|2-week Run-in Period|Lost to Follow-up|2|||
160774288|NCT01706328|580557797|FG001|2-week Run-in Period|Lost to Follow-up|0|||
160774289|NCT01706328|580557798|FG002|2-week Run-in Period|Lost to Follow-up|0|||
160774290|NCT01706328|580557796|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
160774291|NCT01706328|580557797|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
160774292|NCT01706328|580557798|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
160774293|NCT01706328|580557796|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
160774294|NCT01706328|580557797|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
160774295|NCT01706328|580557798|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
160774296|NCT01706328|580557796|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
160774297|NCT01706328|580557797|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
160774298|NCT01706328|580557798|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
160774299|NCT01706328|580557796|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
160774300|NCT01706328|580557797|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
160774301|NCT01706328|580557798|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
160774302|NCT01706328|580557796|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
160774303|NCT01706328|580557797|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
160774304|NCT01706328|580557798|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
160774305|NCT01706328|580557796|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
160774306|NCT01706328|580557797|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
160774307|NCT01706328|580557798|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
160774308|NCT01706328|580557796|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160774309|NCT01706328|580557797|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
160774310|NCT01706328|580557798|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
160774311|NCT06481579|580557799|FG000|Overall Study|Death|1|||
160774312|NCT06481579|580557800|FG001|Overall Study|Death|0|||
160774313|NCT06481579|580557799|FG000|Overall Study|Withdrawal by Subject|3|||
160774314|NCT06481579|580557800|FG001|Overall Study|Withdrawal by Subject|0|||
160774315|NCT06481579|580557799|FG000|Overall Study|Other|1|||
160774316|NCT06481579|580557800|FG001|Overall Study|Other|1|||
160774317|NCT04225832|580559783|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
160774318|NCT04225832|580559784|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
160774319|NCT04225832|580559783|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
160774320|NCT04225832|580559784|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
160774321|NCT00311168|580559785|FG000|First Intervention|Withdrawal by Subject|2|||
160774322|NCT00311168|580559786|FG001|First Intervention|Withdrawal by Subject|2|||
160774323|NCT00311168|580559785|FG000|First Intervention|Lost to Follow-up|1|||
160774324|NCT00311168|580559786|FG001|First Intervention|Lost to Follow-up|1|||
160774325|NCT00311168|580559785|FG000|First Intervention|Protocol Violation|1|||
160774326|NCT00311168|580559786|FG001|First Intervention|Protocol Violation|1|||
160774327|NCT00311168|580559785|FG000|First Intervention|Adverse Event|1|||
160774328|NCT00311168|580559786|FG001|First Intervention|Adverse Event|0|||
160774329|NCT00311168|580559785|FG000|First Intervention|Other|2|||
160774330|NCT00311168|580559786|FG001|First Intervention|Other|2|||
160774331|NCT00311168|580559785|FG000|Second Intervention|Lost to Follow-up|9|||
160774332|NCT00311168|580559786|FG001|Second Intervention|Lost to Follow-up|2|||
160774333|NCT00311168|580559785|FG000|Second Intervention|Withdrawal by Subject|0|||
160774334|NCT00311168|580559786|FG001|Second Intervention|Withdrawal by Subject|1|||
160774335|NCT00311168|580559785|FG000|Second Intervention|Other|1|||
160774336|NCT00311168|580559786|FG001|Second Intervention|Other|1|||
160774337|NCT02452190|580559789|FG000|Overall Study|Withdrawal by Sponsor|1|||
160774338|NCT02452190|580559790|FG001|Overall Study|Withdrawal by Sponsor|3|||
160885975|NCT04761627|580978237|FG001|Run-in Period|Pregnancy|0|||
160774339|NCT02452190|580559789|FG000|Overall Study|Pregnancy|1|||
160885976|NCT04761627|580978238|FG002|Run-in Period|Pregnancy|0|||
160885977|NCT04761627|580978236|FG000|Post-randomization Period|Military service|0|||
160774340|NCT02452190|580559790|FG001|Overall Study|Pregnancy|0|||
160774341|NCT02452190|580559789|FG000|Overall Study|Investigator's Decision|2|||
160774342|NCT02452190|580559790|FG001|Overall Study|Investigator's Decision|0|||
160774343|NCT02452190|580559789|FG000|Overall Study|Lack of Efficacy|3|||
160774344|NCT02452190|580559790|FG001|Overall Study|Lack of Efficacy|1|||
160774345|NCT02452190|580559789|FG000|Overall Study|Lost to Follow-up|4|||
160774346|NCT02452190|580559790|FG001|Overall Study|Lost to Follow-up|3|||
160774347|NCT02452190|580559789|FG000|Overall Study|Adverse Event|2|||
160774348|NCT02452190|580559790|FG001|Overall Study|Adverse Event|5|||
160774349|NCT02452190|580559789|FG000|Overall Study|Withdrawal by Subject|20|||
160774350|NCT02452190|580559790|FG001|Overall Study|Withdrawal by Subject|11|||
160774351|NCT02452190|580559789|FG000|Overall Study|Noncompliance with study drug|1|||
160774352|NCT02452190|580559790|FG001|Overall Study|Noncompliance with study drug|0|||
160774353|NCT02452190|580559789|FG000|Overall Study|Participant traveled abroad|1|||
160774354|NCT02452190|580559790|FG001|Overall Study|Participant traveled abroad|0|||
160774355|NCT02452190|580559789|FG000|Overall Study|Death|0|||
160774356|NCT02452190|580559790|FG001|Overall Study|Death|1|||
160774357|NCT02327078|580559795|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
160774358|NCT02327078|580559796|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
160774359|NCT02327078|580559797|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
160774360|NCT02327078|580559798|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
160774361|NCT02327078|580559799|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
160774362|NCT02327078|580559800|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
160774363|NCT02327078|580559801|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
160774364|NCT02327078|580559802|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
160774365|NCT02327078|580559803|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
160774366|NCT02327078|580559795|FG000|Overall Study|Death|2|||
160774367|NCT02327078|580559796|FG001|Overall Study|Death|4|||
160774368|NCT02327078|580559797|FG002|Overall Study|Death|10|||
160774369|NCT02327078|580559798|FG003|Overall Study|Death|6|||
160774370|NCT02327078|580559799|FG004|Overall Study|Death|4|||
160774371|NCT02327078|580559800|FG005|Overall Study|Death|3|||
160774372|NCT02327078|580559801|FG006|Overall Study|Death|2|||
160774373|NCT02327078|580559802|FG007|Overall Study|Death|51|||
160774374|NCT02327078|580559803|FG008|Overall Study|Death|97|||
160774375|NCT02327078|580559795|FG000|Overall Study|Lost to Follow-up|0|||
160774376|NCT02327078|580559796|FG001|Overall Study|Lost to Follow-up|1|||
160774377|NCT02327078|580559797|FG002|Overall Study|Lost to Follow-up|1|||
160774378|NCT02327078|580559798|FG003|Overall Study|Lost to Follow-up|0|||
160774379|NCT02327078|580559799|FG004|Overall Study|Lost to Follow-up|0|||
160774380|NCT02327078|580559800|FG005|Overall Study|Lost to Follow-up|0|||
160774381|NCT02327078|580559801|FG006|Overall Study|Lost to Follow-up|0|||
160774382|NCT02327078|580559802|FG007|Overall Study|Lost to Follow-up|2|||
160774383|NCT02327078|580559803|FG008|Overall Study|Lost to Follow-up|5|||
160774384|NCT02327078|580559795|FG000|Overall Study|Site Terminated by Sponsor|1|||
160774385|NCT02327078|580559796|FG001|Overall Study|Site Terminated by Sponsor|0|||
160774386|NCT02327078|580559797|FG002|Overall Study|Site Terminated by Sponsor|1|||
160774387|NCT02327078|580559798|FG003|Overall Study|Site Terminated by Sponsor|4|||
160774388|NCT02327078|580559799|FG004|Overall Study|Site Terminated by Sponsor|0|||
160774389|NCT02327078|580559800|FG005|Overall Study|Site Terminated by Sponsor|0|||
160774390|NCT02327078|580559801|FG006|Overall Study|Site Terminated by Sponsor|0|||
160774391|NCT02327078|580559802|FG007|Overall Study|Site Terminated by Sponsor|11|||
160774392|NCT02327078|580559803|FG008|Overall Study|Site Terminated by Sponsor|25|||
160774393|NCT02327078|580559795|FG000|Overall Study|Physician Decision|0|||
160774394|NCT02327078|580559796|FG001|Overall Study|Physician Decision|0|||
160774395|NCT02327078|580559797|FG002|Overall Study|Physician Decision|0|||
160774396|NCT02327078|580559798|FG003|Overall Study|Physician Decision|1|||
160774397|NCT02327078|580559799|FG004|Overall Study|Physician Decision|0|||
160774398|NCT02327078|580559800|FG005|Overall Study|Physician Decision|0|||
160774399|NCT02327078|580559801|FG006|Overall Study|Physician Decision|0|||
160774400|NCT02327078|580559802|FG007|Overall Study|Physician Decision|0|||
160774401|NCT02327078|580559803|FG008|Overall Study|Physician Decision|1|||
160774402|NCT02327078|580559795|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
160774403|NCT02327078|580559796|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
160774404|NCT02327078|580559797|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
160774405|NCT02327078|580559798|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
160774406|NCT02327078|580559799|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
160774407|NCT02327078|580559800|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
160774408|NCT02327078|580559801|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
160774409|NCT02327078|580559802|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
160774410|NCT02327078|580559803|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
160774411|NCT02327078|580559795|FG000|Overall Study|Reason not Specified|0|||
160774412|NCT02327078|580559796|FG001|Overall Study|Reason not Specified|0|||
160774413|NCT02327078|580559797|FG002|Overall Study|Reason not Specified|0|||
160774414|NCT02327078|580559798|FG003|Overall Study|Reason not Specified|0|||
160774415|NCT02327078|580559799|FG004|Overall Study|Reason not Specified|0|||
160774416|NCT02327078|580559800|FG005|Overall Study|Reason not Specified|0|||
160774417|NCT02327078|580559801|FG006|Overall Study|Reason not Specified|0|||
160774418|NCT02327078|580559802|FG007|Overall Study|Reason not Specified|5|||
160774419|NCT02327078|580559803|FG008|Overall Study|Reason not Specified|12|||
160774420|NCT06001021|580559804|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
160774421|NCT06001021|580559805|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
160774422|NCT06001021|580559806|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
160774423|NCT06001021|580559807|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
160774424|NCT06001021|580559808|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
160774425|NCT06001021|580559809|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
160774426|NCT06001021|580559810|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
160774427|NCT06001021|580559804|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
160774428|NCT06001021|580559805|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
160774429|NCT06001021|580559806|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
160774430|NCT06001021|580559807|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
160774431|NCT06001021|580559808|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
160774432|NCT06001021|580559809|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
160774433|NCT06001021|580559810|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
160774434|NCT03112603|580559812|FG000|End of Randomization Period|Lost to Follow-up|3|||
160774435|NCT03112603|580559813|FG001|End of Randomization Period|Lost to Follow-up|0|||
160774436|NCT03112603|580559814|FG002|End of Randomization Period|Lost to Follow-up|0|||
160774437|NCT03112603|580559812|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
160774438|NCT03112603|580559813|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
160774439|NCT03112603|580559814|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
160774440|NCT03112603|580559812|FG000|End of Randomization Period|Physician Decision|43|||
160774441|NCT03112603|580559813|FG001|End of Randomization Period|Physician Decision|18|||
160774442|NCT03112603|580559814|FG002|End of Randomization Period|Physician Decision|0|||
160774443|NCT03112603|580559812|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
160774444|NCT03112603|580559813|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
160774445|NCT03112603|580559814|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
160774446|NCT03112603|580559812|FG000|End of Randomization Period|Death|10|||
160774447|NCT03112603|580559813|FG001|End of Randomization Period|Death|7|||
160774448|NCT03112603|580559814|FG002|End of Randomization Period|Death|0|||
160774449|NCT03112603|580559812|FG000|End of Randomization Period|Disease Relapse|12|||
160774450|NCT03112603|580559813|FG001|End of Randomization Period|Disease Relapse|7|||
160774451|NCT03112603|580559814|FG002|End of Randomization Period|Disease Relapse|0|||
160774452|NCT03112603|580559812|FG000|End of Randomization Period|Lack of Efficacy|25|||
160774453|NCT03112603|580559813|FG001|End of Randomization Period|Lack of Efficacy|77|||
160774454|NCT03112603|580559814|FG002|End of Randomization Period|Lack of Efficacy|0|||
160774455|NCT03112603|580559812|FG000|End of Randomization Period|Adverse Event|32|||
160774456|NCT03112603|580559813|FG001|End of Randomization Period|Adverse Event|12|||
160774457|NCT03112603|580559814|FG002|End of Randomization Period|Adverse Event|0|||
160774458|NCT03112603|580559812|FG000|End of Cross Over Period|Death|0|||
160774459|NCT03112603|580559813|FG001|End of Cross Over Period|Death|0|||
160774460|NCT03112603|580559814|FG002|End of Cross Over Period|Death|2|||
160774461|NCT03112603|580559812|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
160774462|NCT03112603|580559813|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
160774463|NCT03112603|580559814|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
160774464|NCT03112603|580559812|FG000|End of Cross Over Period|Physician Decision|0|||
160774465|NCT03112603|580559813|FG001|End of Cross Over Period|Physician Decision|0|||
160774466|NCT03112603|580559814|FG002|End of Cross Over Period|Physician Decision|29|||
160774467|NCT03112603|580559812|FG000|End of Cross Over Period|Lack of Efficacy|0|||
160774468|NCT03112603|580559813|FG001|End of Cross Over Period|Lack of Efficacy|0|||
160774469|NCT03112603|580559814|FG002|End of Cross Over Period|Lack of Efficacy|8|||
160774470|NCT03112603|580559812|FG000|End of Cross Over Period|Adverse Event|0|||
160774471|NCT03112603|580559813|FG001|End of Cross Over Period|Adverse Event|0|||
160774472|NCT03112603|580559814|FG002|End of Cross Over Period|Adverse Event|6|||
160774473|NCT03112603|580559812|FG000|End of Cross Over Period|Disease Relapse|0|||
160774474|NCT03112603|580559813|FG001|End of Cross Over Period|Disease Relapse|0|||
160774475|NCT03112603|580559814|FG002|End of Cross Over Period|Disease Relapse|2|||
160774476|NCT02802228|580559815|FG000|Overall Study|Withdrawal by Subject|2|||
160774477|NCT02802228|580559816|FG001|Overall Study|Withdrawal by Subject|0|||
160774478|NCT02802228|580559815|FG000|Overall Study|Lost to Follow-up|1|||
160885978|NCT04761627|580978237|FG001|Post-randomization Period|Military service|1|||
160541124|NCT05121480|579711162|FG000|Overall Study|Lost to Follow-up|0|||
160774479|NCT02802228|580559816|FG001|Overall Study|Lost to Follow-up|0|||
160774480|NCT02802228|580559815|FG000|Overall Study|Adverse Event|1|||
160774481|NCT02802228|580559816|FG001|Overall Study|Adverse Event|0|||
160774482|NCT02802228|580559815|FG000|Overall Study|Physician Decision|1|||
160774483|NCT02802228|580559816|FG001|Overall Study|Physician Decision|0|||
160774484|NCT00695019|580559819|FG000|Overall Study|Withdrawal by Subject|8|||
160774485|NCT00695019|580559820|FG001|Overall Study|Withdrawal by Subject|6|||
160774486|NCT00695019|580559821|FG002|Overall Study|Withdrawal by Subject|4|||
160774487|NCT00695019|580559819|FG000|Overall Study|Protocol Violation|1|||
160774488|NCT00695019|580559820|FG001|Overall Study|Protocol Violation|3|||
160774489|NCT00695019|580559821|FG002|Overall Study|Protocol Violation|1|||
160774490|NCT00695019|580559819|FG000|Overall Study|Lack of Efficacy|0|||
160774491|NCT00695019|580559820|FG001|Overall Study|Lack of Efficacy|0|||
160774492|NCT00695019|580559821|FG002|Overall Study|Lack of Efficacy|1|||
160774493|NCT00695019|580559819|FG000|Overall Study|Various|4|||
160774494|NCT00695019|580559820|FG001|Overall Study|Various|5|||
160774495|NCT00695019|580559821|FG002|Overall Study|Various|4|||
160774496|NCT01564407|580559830|FG000|Overall Study|Lost to Follow-up|0|||
160774497|NCT01564407|580559831|FG001|Overall Study|Lost to Follow-up|1|||
160774498|NCT01564407|580559832|FG002|Overall Study|Lost to Follow-up|0|||
160774499|NCT01564407|580559833|FG003|Overall Study|Lost to Follow-up|0|||
160774500|NCT01564407|580559834|FG004|Overall Study|Lost to Follow-up|0|||
160774501|NCT01564407|580559830|FG000|Overall Study|Withdrawal by Subject|0|||
160774502|NCT01564407|580559831|FG001|Overall Study|Withdrawal by Subject|1|||
160774503|NCT01564407|580559832|FG002|Overall Study|Withdrawal by Subject|0|||
160774504|NCT01564407|580559833|FG003|Overall Study|Withdrawal by Subject|0|||
160774505|NCT01564407|580559834|FG004|Overall Study|Withdrawal by Subject|0|||
160774506|NCT01564407|580559830|FG000|Overall Study|funding lost, study ended|0|||
160774507|NCT01564407|580559831|FG001|Overall Study|funding lost, study ended|0|||
160774508|NCT01564407|580559832|FG002|Overall Study|funding lost, study ended|0|||
160774509|NCT01564407|580559833|FG003|Overall Study|funding lost, study ended|1|||
160774510|NCT01564407|580559834|FG004|Overall Study|funding lost, study ended|0|||
160774511|NCT04435626|580559839|FG000|Overall Study|Lost to Follow-up|1|||
160774512|NCT04435626|580559840|FG001|Overall Study|Lost to Follow-up|5|||
160774513|NCT04435626|580559839|FG000|Overall Study|Withdrawal by Subject|6|||
160774514|NCT04435626|580559840|FG001|Overall Study|Withdrawal by Subject|7|||
160774515|NCT04435626|580559839|FG000|Overall Study|major GCP violations|8|||
160774516|NCT04435626|580559840|FG001|Overall Study|major GCP violations|7|||
160774517|NCT01160614|580559841|FG000|Overall Study|Withdrawal by Subject|0|||
160774518|NCT01160614|580559842|FG001|Overall Study|Withdrawal by Subject|2|||
160774519|NCT00984399|580559843|FG000|Overall Study|Adverse Event|0|||
160774520|NCT00984399|580559844|FG001|Overall Study|Adverse Event|1|||
160774521|NCT00984399|580559843|FG000|Overall Study|Physician Decision|1|||
160774522|NCT00984399|580559844|FG001|Overall Study|Physician Decision|0|||
160774523|NCT00984399|580559843|FG000|Overall Study|Withdrawal by Subject|1|||
160774524|NCT00984399|580559844|FG001|Overall Study|Withdrawal by Subject|1|||
160774525|NCT00984399|580559843|FG000|Overall Study|Protocol Violation|0|||
160774526|NCT00984399|580559844|FG001|Overall Study|Protocol Violation|1|||
160774527|NCT00984399|580559843|FG000|Overall Study|Pts did not start treatment|2|||
160774528|NCT00984399|580559844|FG001|Overall Study|Pts did not start treatment|2|||
160774529|NCT05248386|580559845|FG000|Overall Study|Technical problems|0|||
160774530|NCT05248386|580559846|FG001|Overall Study|Technical problems|1|||
160774531|NCT05248386|580559845|FG000|Overall Study|Withdrawal by Subject|15|||
160774532|NCT05248386|580559846|FG001|Overall Study|Withdrawal by Subject|10|||
160774533|NCT05248386|580559845|FG000|Overall Study|Physician Decision|0|||
160774534|NCT05248386|580559846|FG001|Overall Study|Physician Decision|1|||
160774535|NCT05248386|580559845|FG000|Overall Study|Adverse Event|2|||
160774536|NCT05248386|580559846|FG001|Overall Study|Adverse Event|4|||
160774537|NCT05248386|580559845|FG000|Overall Study|Other|1|||
160774538|NCT05248386|580559846|FG001|Overall Study|Other|0|||
160774539|NCT05248386|580559845|FG000|Overall Study|Lack of Efficacy|14|||
160774540|NCT05248386|580559846|FG001|Overall Study|Lack of Efficacy|12|||
160774541|NCT01723774|580559847|FG000|Neoadjuvant|Ki67 > 10%|4|||
160774542|NCT01723774|580559848|FG001|Neoadjuvant|Ki67 > 10%|0|||
160774543|NCT01723774|580559849|FG002|Neoadjuvant|Ki67 > 10%|10|||
160774544|NCT01723774|580559850|FG003|Neoadjuvant|Ki67 > 10%|0|||
160774545|NCT01723774|580559847|FG000|Neoadjuvant|Withdrawal by Subject|3|||
160774546|NCT01723774|580559848|FG001|Neoadjuvant|Withdrawal by Subject|1|||
160774547|NCT01723774|580559849|FG002|Neoadjuvant|Withdrawal by Subject|0|||
160774548|NCT01723774|580559850|FG003|Neoadjuvant|Withdrawal by Subject|0|||
160774549|NCT01723774|580559847|FG000|Neoadjuvant|Disease progression|0|||
160774550|NCT01723774|580559848|FG001|Neoadjuvant|Disease progression|1|||
160774551|NCT01723774|580559849|FG002|Neoadjuvant|Disease progression|1|||
160774552|NCT01723774|580559850|FG003|Neoadjuvant|Disease progression|0|||
160774553|NCT01723774|580559847|FG000|Neoadjuvant|Adverse Event|0|||
160774554|NCT01723774|580559848|FG001|Neoadjuvant|Adverse Event|1|||
160774555|NCT01723774|580559849|FG002|Neoadjuvant|Adverse Event|2|||
160774556|NCT01723774|580559850|FG003|Neoadjuvant|Adverse Event|0|||
160774557|NCT01723774|580559847|FG000|Neoadjuvant|High estradiol|0|||
160774558|NCT01723774|580559848|FG001|Neoadjuvant|High estradiol|1|||
160774559|NCT01723774|580559849|FG002|Neoadjuvant|High estradiol|0|||
160885979|NCT04761627|580978238|FG002|Post-randomization Period|Military service|0|||
160885980|NCT04761627|580978236|FG000|Post-randomization Period|Adverse Event|0|||
160885981|NCT04761627|580978237|FG001|Post-randomization Period|Adverse Event|4|||
160885982|NCT04761627|580978238|FG002|Post-randomization Period|Adverse Event|2|||
160885983|NCT04761627|580978236|FG000|Post-randomization Period|Lost to Follow-up|0|||
160885984|NCT04761627|580978237|FG001|Post-randomization Period|Lost to Follow-up|6|||
160885985|NCT04761627|580978238|FG002|Post-randomization Period|Lost to Follow-up|6|||
160885986|NCT04761627|580978236|FG000|Post-randomization Period|Withdrawal by Subject|0|||
160885987|NCT04761627|580978237|FG001|Post-randomization Period|Withdrawal by Subject|7|||
160885988|NCT04761627|580978238|FG002|Post-randomization Period|Withdrawal by Subject|6|||
160885989|NCT04761627|580978236|FG000|Post-randomization Period|Pregnancy|0|||
160885990|NCT04761627|580978237|FG001|Post-randomization Period|Pregnancy|0|||
160885991|NCT04761627|580978238|FG002|Post-randomization Period|Pregnancy|1|||
160885992|NCT04761627|580978236|FG000|Post-randomization Period|Study site closure|0|||
160885993|NCT04761627|580978237|FG001|Post-randomization Period|Study site closure|0|||
160885994|NCT04761627|580978238|FG002|Post-randomization Period|Study site closure|1|||
160885995|NCT04761627|580978236|FG000|Post-randomization Period|Family planning|0|||
160885996|NCT04761627|580978237|FG001|Post-randomization Period|Family planning|1|||
160885997|NCT04761627|580978238|FG002|Post-randomization Period|Family planning|0|||
160885998|NCT01634178|580978241|FG000|Treatment Period 1|Adverse Event|0|||
160885999|NCT01634178|580978242|FG001|Treatment Period 1|Adverse Event|1|||
160886000|NCT01634178|580978241|FG000|Treatment Period 2|Adverse Event|1|||
160886001|NCT01634178|580978242|FG001|Treatment Period 2|Adverse Event|0|||
160886002|NCT01933789|580978243|FG000|Overall Study|Death|0|||
160886003|NCT01933789|580978244|FG001|Overall Study|Death|0|||
160886004|NCT01933789|580978245|FG002|Overall Study|Death|0|||
160886005|NCT01933789|580978246|FG003|Overall Study|Death|0|||
160886006|NCT01933789|580978247|FG004|Overall Study|Death|21|||
160886007|NCT01933789|580978248|FG005|Overall Study|Death|32|||
160886008|NCT01933789|580978249|FG006|Overall Study|Death|0|||
160886009|NCT01933789|580978250|FG007|Overall Study|Death|0|||
160886010|NCT01933789|580978251|FG008|Overall Study|Death|0|||
160886011|NCT01933789|580978243|FG000|Overall Study|Lost to Follow-up|0|||
160886012|NCT01933789|580978244|FG001|Overall Study|Lost to Follow-up|0|||
160886013|NCT01933789|580978245|FG002|Overall Study|Lost to Follow-up|0|||
160886014|NCT01933789|580978246|FG003|Overall Study|Lost to Follow-up|1|||
160886015|NCT01933789|580978247|FG004|Overall Study|Lost to Follow-up|8|||
160886016|NCT01933789|580978248|FG005|Overall Study|Lost to Follow-up|9|||
160886017|NCT01933789|580978249|FG006|Overall Study|Lost to Follow-up|1|||
160886018|NCT01933789|580978250|FG007|Overall Study|Lost to Follow-up|4|||
160886019|NCT01933789|580978251|FG008|Overall Study|Lost to Follow-up|0|||
160886020|NCT01933789|580978243|FG000|Overall Study|Withdrawal by Subject|2|||
160886021|NCT01933789|580978244|FG001|Overall Study|Withdrawal by Subject|1|||
160886022|NCT01933789|580978245|FG002|Overall Study|Withdrawal by Subject|0|||
160886023|NCT01933789|580978246|FG003|Overall Study|Withdrawal by Subject|0|||
160886024|NCT01933789|580978247|FG004|Overall Study|Withdrawal by Subject|17|||
160886025|NCT01933789|580978248|FG005|Overall Study|Withdrawal by Subject|16|||
160886026|NCT01933789|580978249|FG006|Overall Study|Withdrawal by Subject|1|||
160886027|NCT01933789|580978250|FG007|Overall Study|Withdrawal by Subject|4|||
160886028|NCT01933789|580978251|FG008|Overall Study|Withdrawal by Subject|0|||
160886029|NCT01933789|580978243|FG000|Overall Study|Became Ineligible|4|||
160886030|NCT01933789|580978244|FG001|Overall Study|Became Ineligible|0|||
160886031|NCT01933789|580978245|FG002|Overall Study|Became Ineligible|0|||
160886032|NCT01933789|580978246|FG003|Overall Study|Became Ineligible|0|||
160886033|NCT01933789|580978247|FG004|Overall Study|Became Ineligible|13|||
160886034|NCT01933789|580978248|FG005|Overall Study|Became Ineligible|10|||
160886035|NCT01933789|580978249|FG006|Overall Study|Became Ineligible|13|||
160886036|NCT01933789|580978250|FG007|Overall Study|Became Ineligible|6|||
160886037|NCT01933789|580978251|FG008|Overall Study|Became Ineligible|0|||
160886038|NCT02915874|580978257|FG000|Overall Study|Lost to Follow-up|5|||
160886039|NCT02915874|580978258|FG001|Overall Study|Lost to Follow-up|4|||
160886040|NCT02915874|580978257|FG000|Overall Study|Withdrawal by Subject|1|||
160886041|NCT02915874|580978258|FG001|Overall Study|Withdrawal by Subject|1|||
160886042|NCT02915874|580978257|FG000|Overall Study|Started New Anxiety Medication|0|||
160886043|NCT02915874|580978258|FG001|Overall Study|Started New Anxiety Medication|1|||
160886044|NCT01903252|580978260|FG000|Double-Blind Induction|Adverse Event|20|||
160886045|NCT01903252|580978261|FG001|Double-Blind Induction|Adverse Event|18|||
160886046|NCT01903252|580978262|FG002|Double-Blind Induction|Adverse Event|0|||
160886047|NCT01903252|580978263|FG003|Double-Blind Induction|Adverse Event|0|||
160886048|NCT01903252|580978264|FG004|Double-Blind Induction|Adverse Event|0|||
160886049|NCT01903252|580978265|FG005|Double-Blind Induction|Adverse Event|0|||
160886050|NCT01903252|580978260|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
160886051|NCT01903252|580978261|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
160886052|NCT01903252|580978262|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
160886053|NCT01903252|580978263|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
160886054|NCT01903252|580978264|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
160886055|NCT01903252|580978265|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
160774560|NCT01723774|580559850|FG003|Neoadjuvant|High estradiol|0|||
160774561|NCT04967222|580559853|FG000|Randomized|Lost to Follow-up|0|||
160774562|NCT04967222|580559854|FG001|Randomized|Lost to Follow-up|1|||
160774563|NCT04967222|580559855|FG002|Randomized|Lost to Follow-up|1|||
160774564|NCT04967222|580559853|FG000|Randomized|Physician Decision|0|||
160774565|NCT04967222|580559854|FG001|Randomized|Physician Decision|0|||
160774566|NCT04967222|580559855|FG002|Randomized|Physician Decision|1|||
160774567|NCT04967222|580559853|FG000|Randomized|Withdrawal by Subject|0|||
160774568|NCT04967222|580559854|FG001|Randomized|Withdrawal by Subject|0|||
160774569|NCT04967222|580559855|FG002|Randomized|Withdrawal by Subject|2|||
160774570|NCT04967222|580559853|FG000|Randomized|abnormal finding in MRI|0|||
160774571|NCT04967222|580559854|FG001|Randomized|abnormal finding in MRI|2|||
160774572|NCT04967222|580559855|FG002|Randomized|abnormal finding in MRI|0|||
160774573|NCT03785366|580559863|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
160774574|NCT03785366|580559864|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
160774575|NCT03785366|580559863|FG000|Overall Study|Lost to Follow-up|1|||
160774576|NCT03785366|580559864|FG001|Overall Study|Lost to Follow-up|0|||
160774577|NCT03785366|580559863|FG000|Overall Study|Partial IUD Expulsion|0|||
160774578|NCT03785366|580559864|FG001|Overall Study|Partial IUD Expulsion|2|||
160774579|NCT03785366|580559863|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
160774580|NCT03785366|580559864|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
160774581|NCT05168800|580559865|FG000|Time 1 Survey|Did not start T1 survey|182|||
160774582|NCT05168800|580559866|FG001|Time 1 Survey|Did not start T1 survey|150|||
160774583|NCT05168800|580559867|FG002|Time 1 Survey|Did not start T1 survey|140|||
160774584|NCT05168800|580559865|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
160774585|NCT05168800|580559866|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
160774586|NCT05168800|580559867|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
160774587|NCT05168800|580559865|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
160774588|NCT05168800|580559866|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
160774589|NCT05168800|580559867|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
160774590|NCT05168800|580559865|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
160774591|NCT05168800|580559866|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
160774592|NCT05168800|580559867|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
160774593|NCT05168800|580559865|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
160774594|NCT05168800|580559866|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
160774595|NCT05168800|580559867|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
160774596|NCT05168800|580559865|FG000|Time 1 Survey|Withdrawal by Subject|6|||
160774597|NCT05168800|580559866|FG001|Time 1 Survey|Withdrawal by Subject|3|||
160774598|NCT05168800|580559867|FG002|Time 1 Survey|Withdrawal by Subject|2|||
160774599|NCT05168800|580559865|FG000|Time 2 Survey|Already excluded at Time 1|228|||
160774600|NCT05168800|580559866|FG001|Time 2 Survey|Already excluded at Time 1|202|||
160774601|NCT05168800|580559867|FG002|Time 2 Survey|Already excluded at Time 1|173|||
160774602|NCT05168800|580559865|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
160774603|NCT05168800|580559866|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
160774604|NCT05168800|580559867|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
160774605|NCT05168800|580559865|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
160774606|NCT05168800|580559866|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
160774607|NCT05168800|580559867|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
160774608|NCT05168800|580559865|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
160774609|NCT05168800|580559866|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
160774610|NCT05168800|580559867|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
160774611|NCT05168800|580559865|FG000|Time 2 Survey|Withdrawal by Subject|1|||
160774612|NCT05168800|580559866|FG001|Time 2 Survey|Withdrawal by Subject|0|||
160774613|NCT05168800|580559867|FG002|Time 2 Survey|Withdrawal by Subject|1|||
160774614|NCT05168800|580559865|FG000|Time 3 Survey|Already excluded at Time 1|228|||
160774615|NCT05168800|580559866|FG001|Time 3 Survey|Already excluded at Time 1|200|||
160774616|NCT05168800|580559867|FG002|Time 3 Survey|Already excluded at Time 1|173|||
160774617|NCT05168800|580559865|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
160774618|NCT05168800|580559866|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
160774619|NCT05168800|580559867|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
160774620|NCT05168800|580559865|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
160774621|NCT05168800|580559866|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
160774622|NCT05168800|580559867|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
160774623|NCT05168800|580559865|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
160774624|NCT05168800|580559866|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
160774625|NCT05168800|580559867|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
160886056|NCT01903252|580978260|FG000|Double-Blind Induction|Physician Decision|2|||
160886057|NCT01903252|580978261|FG001|Double-Blind Induction|Physician Decision|3|||
160886058|NCT01903252|580978262|FG002|Double-Blind Induction|Physician Decision|0|||
160774626|NCT04279522|580559868|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
160774627|NCT04279522|580559869|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
160886059|NCT01903252|580978263|FG003|Double-Blind Induction|Physician Decision|0|||
160774628|NCT04279522|580559868|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
160774629|NCT04279522|580559869|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
160774630|NCT04279522|580559868|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
160774631|NCT04279522|580559869|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
160774632|NCT04279522|580559868|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
160774633|NCT04279522|580559869|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
160774634|NCT04279522|580559868|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
160774635|NCT04279522|580559869|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
160774636|NCT04279522|580559868|FG000|Period 2: Open Label Phase|Physician Decision|0|||
160774637|NCT04279522|580559869|FG001|Period 2: Open Label Phase|Physician Decision|3|||
160774638|NCT04279522|580559868|FG000|Period 2: Open Label Phase|Adverse Event|0|||
160774639|NCT04279522|580559869|FG001|Period 2: Open Label Phase|Adverse Event|1|||
160774640|NCT04279522|580559868|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
160774641|NCT04279522|580559869|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
160774642|NCT02629159|580559870|FG000|Overall Study|Adverse Event|17|||
160774643|NCT02629159|580559871|FG001|Overall Study|Adverse Event|20|||
160774644|NCT02629159|580559872|FG002|Overall Study|Adverse Event|22|||
160774645|NCT02629159|580559870|FG000|Overall Study|Withdrawal by Subject|22|||
160774646|NCT02629159|580559871|FG001|Overall Study|Withdrawal by Subject|11|||
160774647|NCT02629159|580559872|FG002|Overall Study|Withdrawal by Subject|15|||
160774648|NCT02629159|580559870|FG000|Overall Study|Lost to Follow-up|7|||
160774649|NCT02629159|580559871|FG001|Overall Study|Lost to Follow-up|4|||
160774650|NCT02629159|580559872|FG002|Overall Study|Lost to Follow-up|5|||
160774651|NCT02629159|580559870|FG000|Overall Study|Lack of Efficacy|4|||
160774652|NCT02629159|580559871|FG001|Overall Study|Lack of Efficacy|0|||
160774653|NCT02629159|580559872|FG002|Overall Study|Lack of Efficacy|1|||
160774654|NCT02629159|580559870|FG000|Overall Study|Other|6|||
160774655|NCT02629159|580559871|FG001|Overall Study|Other|4|||
160774656|NCT02629159|580559872|FG002|Overall Study|Other|8|||
160774657|NCT02783274|580559881|FG000|Overall Study|Withdrawal by Subject|16|||
160774658|NCT02783274|580559881|FG000|Overall Study|Physician Decision|6|||
160774659|NCT02783274|580559881|FG000|Overall Study|Death|9|||
160774660|NCT02783274|580559881|FG000|Overall Study|Lost to Follow-up|22|||
160774661|NCT02783274|580559881|FG000|Overall Study|Other|22|||
160774662|NCT05722015|580559883|FG000|Overall Study|Death|57|||
160774663|NCT05722015|580559884|FG001|Overall Study|Death|37|||
160774664|NCT05722015|580559883|FG000|Overall Study|Lost to Follow-up|1|||
160774665|NCT05722015|580559884|FG001|Overall Study|Lost to Follow-up|0|||
160774666|NCT05722015|580559883|FG000|Overall Study|Withdrawal by Subject|5|||
160774667|NCT05722015|580559884|FG001|Overall Study|Withdrawal by Subject|1|||
160774668|NCT05722015|580559883|FG000|Overall Study|Participants Ongoing|188|||
160774669|NCT05722015|580559884|FG001|Overall Study|Participants Ongoing|88|||
160774670|NCT01802281|580559887|FG000|Overall Study|Death|1|||
160774671|NCT01802281|580559888|FG001|Overall Study|Death|2|||
160774672|NCT01802281|580559887|FG000|Overall Study|Withdrawal by Subject|2|||
160774673|NCT01802281|580559888|FG001|Overall Study|Withdrawal by Subject|1|||
160774674|NCT01802281|580559887|FG000|Overall Study|Ineligible|5|||
160774675|NCT01802281|580559888|FG001|Overall Study|Ineligible|3|||
160774676|NCT02685735|580559889|FG000|Overall Study|Surgery Cancelled|4|||
160774677|NCT02685735|580559890|FG001|Overall Study|Surgery Cancelled|9|||
160774678|NCT02685735|580559889|FG000|Overall Study|Adverse Event|10|||
160774679|NCT02685735|580559890|FG001|Overall Study|Adverse Event|3|||
160774680|NCT02685735|580559889|FG000|Overall Study|Preop testing found to be incomplete|2|||
160774681|NCT02685735|580559890|FG001|Overall Study|Preop testing found to be incomplete|2|||
160774682|NCT02685735|580559889|FG000|Overall Study|Withdrawal by Subject|1|||
160774683|NCT02685735|580559890|FG001|Overall Study|Withdrawal by Subject|2|||
160774684|NCT02685735|580559889|FG000|Overall Study|Death|1|||
160774685|NCT02685735|580559890|FG001|Overall Study|Death|0|||
160774686|NCT05020743|580559898|FG000|Overall Study|Enrollment in Interventional Study|2|||
160774687|NCT05020743|580559899|FG001|Overall Study|Enrollment in Interventional Study|9|||
160774688|NCT05020743|580559900|FG002|Overall Study|Enrollment in Interventional Study|0|||
160774689|NCT05020743|580559898|FG000|Overall Study|Withdrawal by Subject|0|||
160774690|NCT05020743|580559899|FG001|Overall Study|Withdrawal by Subject|3|||
160774691|NCT05020743|580559900|FG002|Overall Study|Withdrawal by Subject|1|||
160774692|NCT05020743|580559898|FG000|Overall Study|Lost to Follow-up|1|||
160774693|NCT05020743|580559899|FG001|Overall Study|Lost to Follow-up|0|||
160774694|NCT05020743|580559900|FG002|Overall Study|Lost to Follow-up|0|||
160774695|NCT05020743|580559898|FG000|Overall Study|Study Termination by Sponsor|10|||
160774696|NCT05020743|580559899|FG001|Overall Study|Study Termination by Sponsor|11|||
160774697|NCT05020743|580559900|FG002|Overall Study|Study Termination by Sponsor|10|||
160774698|NCT03488524|580559901|FG000|Overall Study|Withdrawal by Subject|51|||
160774699|NCT03488524|580559901|FG000|Overall Study|Death|19|||
160774700|NCT03488524|580559901|FG000|Overall Study|Study Sponsor|11|||
160774701|NCT03488524|580559901|FG000|Overall Study|Physician Decision|4|||
160774702|NCT03488524|580559901|FG000|Overall Study|Lost to Follow-up|3|||
160774703|NCT02003924|580559902|FG000|Double-blind Phase|Lost to Follow-up|2|||
160774704|NCT02003924|580559903|FG001|Double-blind Phase|Lost to Follow-up|1|||
160774705|NCT02003924|580559904|FG002|Double-blind Phase|Lost to Follow-up|0|||
160774706|NCT02003924|580559902|FG000|Double-blind Phase|Protocol Violation|1|||
160774707|NCT02003924|580559903|FG001|Double-blind Phase|Protocol Violation|2|||
160774708|NCT02003924|580559904|FG002|Double-blind Phase|Protocol Violation|0|||
160886060|NCT01903252|580978264|FG004|Double-Blind Induction|Physician Decision|0|||
160886061|NCT01903252|580978265|FG005|Double-Blind Induction|Physician Decision|0|||
160886062|NCT01903252|580978260|FG000|Double-Blind Induction|non-compliance,|7|||
160886063|NCT01903252|580978261|FG001|Double-Blind Induction|non-compliance,|7|||
160886064|NCT01903252|580978262|FG002|Double-Blind Induction|non-compliance,|0|||
160886065|NCT01903252|580978263|FG003|Double-Blind Induction|non-compliance,|0|||
160886066|NCT01903252|580978264|FG004|Double-Blind Induction|non-compliance,|0|||
160886067|NCT01903252|580978265|FG005|Double-Blind Induction|non-compliance,|0|||
160886068|NCT01903252|580978260|FG000|Extended Induction, Open-Label|Adverse Event|0|||
160886069|NCT01903252|580978261|FG001|Extended Induction, Open-Label|Adverse Event|0|||
160886070|NCT01903252|580978262|FG002|Extended Induction, Open-Label|Adverse Event|17|||
160886071|NCT01903252|580978263|FG003|Extended Induction, Open-Label|Adverse Event|0|||
160886072|NCT01903252|580978264|FG004|Extended Induction, Open-Label|Adverse Event|0|||
160886073|NCT01903252|580978265|FG005|Extended Induction, Open-Label|Adverse Event|0|||
160886074|NCT01903252|580978260|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
160886075|NCT01903252|580978261|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
160886076|NCT01903252|580978262|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
160886077|NCT01903252|580978263|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
160886078|NCT01903252|580978264|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
160886079|NCT01903252|580978265|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
160886080|NCT01903252|580978260|FG000|Extended Induction, Open-Label|Physician Decision|0|||
160886081|NCT01903252|580978261|FG001|Extended Induction, Open-Label|Physician Decision|0|||
160886082|NCT01903252|580978262|FG002|Extended Induction, Open-Label|Physician Decision|1|||
160886083|NCT01903252|580978263|FG003|Extended Induction, Open-Label|Physician Decision|0|||
160886084|NCT01903252|580978264|FG004|Extended Induction, Open-Label|Physician Decision|0|||
160886085|NCT01903252|580978265|FG005|Extended Induction, Open-Label|Physician Decision|0|||
160886086|NCT01903252|580978260|FG000|Maintenance, Open-Label|Adverse Event|0|||
160886087|NCT01903252|580978261|FG001|Maintenance, Open-Label|Adverse Event|0|||
160886088|NCT01903252|580978262|FG002|Maintenance, Open-Label|Adverse Event|0|||
160886089|NCT01903252|580978263|FG003|Maintenance, Open-Label|Adverse Event|3|||
160886090|NCT01903252|580978264|FG004|Maintenance, Open-Label|Adverse Event|9|||
160886091|NCT01903252|580978265|FG005|Maintenance, Open-Label|Adverse Event|14|||
160886092|NCT01903252|580978260|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
160886093|NCT01903252|580978261|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
160886094|NCT01903252|580978262|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
160886095|NCT01903252|580978263|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
160886096|NCT01903252|580978264|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
160886097|NCT01903252|580978265|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
160886098|NCT01903252|580978260|FG000|Maintenance, Open-Label|Other|0|||
160886099|NCT01903252|580978261|FG001|Maintenance, Open-Label|Other|0|||
160886100|NCT01903252|580978262|FG002|Maintenance, Open-Label|Other|0|||
160886101|NCT01903252|580978263|FG003|Maintenance, Open-Label|Other|2|||
160886102|NCT01903252|580978264|FG004|Maintenance, Open-Label|Other|6|||
160886103|NCT01903252|580978265|FG005|Maintenance, Open-Label|Other|2|||
160886104|NCT03562767|580978266|FG000|Overall Study|Physician Decision|2|||
160886105|NCT03562767|580978267|FG001|Overall Study|Physician Decision|0|||
160886106|NCT03562767|580978268|FG002|Overall Study|Physician Decision|0|||
160886107|NCT03562767|580978266|FG000|Overall Study|Logistic Reason|1|||
160886108|NCT03562767|580978267|FG001|Overall Study|Logistic Reason|3|||
160886109|NCT03562767|580978268|FG002|Overall Study|Logistic Reason|0|||
160886110|NCT02518464|580978271|FG000|Overall Study|Adverse Event|2|||
160886111|NCT01120067|580978272|FG000|Overall Study|Lost to Follow-up|3|||
160774709|NCT02003924|580559902|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
160886112|NCT01120067|580978273|FG001|Overall Study|Lost to Follow-up|1|||
160774710|NCT02003924|580559903|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
160774711|NCT02003924|580559904|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
160774712|NCT02003924|580559902|FG000|Double-blind Phase|Disease Progression|229|||
160886113|NCT01120067|580978272|FG000|Overall Study|fail to engage >3 sessions|2|||
160886114|NCT01120067|580978273|FG001|Overall Study|fail to engage >3 sessions|0|||
160886115|NCT03761797|580978274|FG000|Overall Study|Changing hospital|11|||
160886116|NCT03761797|580978274|FG000|Overall Study|Improvement/remission|6|||
160886117|NCT03761797|580978274|FG000|Overall Study|Withdrawal by Subject|19|||
160886118|NCT03761797|580978274|FG000|Overall Study|Lost to Follow-up|33|||
160886119|NCT03761797|580978274|FG000|Overall Study|Adverse Event|37|||
160886120|NCT03761797|580978274|FG000|Overall Study|Case report form (CRF) not collected|5|||
160774713|NCT02003924|580559903|FG001|Double-blind Phase|Disease Progression|247|||
160774714|NCT02003924|580559904|FG002|Double-blind Phase|Disease Progression|0|||
160774715|NCT02003924|580559902|FG000|Double-blind Phase|Adverse Event|120|||
160774716|NCT02003924|580559903|FG001|Double-blind Phase|Adverse Event|31|||
160774717|NCT02003924|580559904|FG002|Double-blind Phase|Adverse Event|0|||
160774718|NCT02003924|580559902|FG000|Double-blind Phase|Randomized But not Treated|3|||
160774719|NCT02003924|580559903|FG001|Double-blind Phase|Randomized But not Treated|3|||
160774720|NCT02003924|580559904|FG002|Double-blind Phase|Randomized But not Treated|0|||
160774721|NCT02003924|580559902|FG000|Double-blind Phase|Other|29|||
160774722|NCT02003924|580559903|FG001|Double-blind Phase|Other|50|||
160774723|NCT02003924|580559904|FG002|Double-blind Phase|Other|0|||
160774724|NCT02003924|580559902|FG000|Open-label Phase|Lost to Follow-up|0|||
160774725|NCT02003924|580559903|FG001|Open-label Phase|Lost to Follow-up|0|||
160774726|NCT02003924|580559904|FG002|Open-label Phase|Lost to Follow-up|1|||
160774727|NCT02003924|580559902|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
160774728|NCT02003924|580559903|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
160774729|NCT02003924|580559904|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
160774730|NCT02003924|580559902|FG000|Open-label Phase|Disease Progression|59|||
160774731|NCT02003924|580559903|FG001|Open-label Phase|Disease Progression|0|||
160774732|NCT02003924|580559904|FG002|Open-label Phase|Disease Progression|5|||
160774733|NCT02003924|580559902|FG000|Open-label Phase|Adverse Event|25|||
160774734|NCT02003924|580559903|FG001|Open-label Phase|Adverse Event|0|||
160774735|NCT02003924|580559904|FG002|Open-label Phase|Adverse Event|10|||
160774736|NCT02003924|580559902|FG000|Open-label Phase|Other|7|||
160774737|NCT02003924|580559903|FG001|Open-label Phase|Other|0|||
160774738|NCT02003924|580559904|FG002|Open-label Phase|Other|0|||
160774739|NCT02003924|580559902|FG000|Long-term Follow-up Phase|Death|288|||
160774740|NCT02003924|580559903|FG001|Long-term Follow-up Phase|Death|174|||
160774741|NCT02003924|580559904|FG002|Long-term Follow-up Phase|Death|4|||
160774742|NCT02003924|580559902|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
160774743|NCT02003924|580559903|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
160774744|NCT02003924|580559904|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
160774745|NCT02003924|580559902|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
160774746|NCT02003924|580559903|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
160774747|NCT02003924|580559904|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
160774748|NCT02003924|580559902|FG000|Long-term Follow-up Phase|Other|5|||
160774749|NCT02003924|580559903|FG001|Long-term Follow-up Phase|Other|2|||
160774750|NCT02003924|580559904|FG002|Long-term Follow-up Phase|Other|1|||
160774751|NCT00830765|580559905|FG000|Overall Study|Protocol Violation|3|||
160774752|NCT00830765|580559906|FG001|Overall Study|Protocol Violation|2|||
160774753|NCT00315445|580559907|FG000|Overall Study|Adverse Event|7|||
160774754|NCT00315445|580559908|FG001|Overall Study|Adverse Event|12|||
160774755|NCT00315445|580559909|FG002|Overall Study|Adverse Event|15|||
160774756|NCT00315445|580559907|FG000|Overall Study|Lack of Efficacy|16|||
160774757|NCT00315445|580559908|FG001|Overall Study|Lack of Efficacy|1|||
160774758|NCT00315445|580559909|FG002|Overall Study|Lack of Efficacy|7|||
160774759|NCT00315445|580559907|FG000|Overall Study|Lost to Follow-up|1|||
160774760|NCT00315445|580559908|FG001|Overall Study|Lost to Follow-up|0|||
160774761|NCT00315445|580559909|FG002|Overall Study|Lost to Follow-up|1|||
160774762|NCT00315445|580559907|FG000|Overall Study|Protocol Violation|2|||
160774763|NCT00315445|580559908|FG001|Overall Study|Protocol Violation|0|||
160774764|NCT00315445|580559909|FG002|Overall Study|Protocol Violation|1|||
160774765|NCT00315445|580559907|FG000|Overall Study|Other|1|||
160774766|NCT00315445|580559908|FG001|Overall Study|Other|3|||
160774767|NCT00315445|580559909|FG002|Overall Study|Other|0|||
160774768|NCT02390284|580559910|FG000|Overall Study|Physician Decision|0|||
160774769|NCT02390284|580559911|FG001|Overall Study|Physician Decision|0|||
160774770|NCT02390284|580559912|FG002|Overall Study|Physician Decision|9|||
160774771|NCT01299909|580559913|FG000|Overall Study|Lost to Follow-up|22|||
160774772|NCT01299909|580559914|FG001|Overall Study|Lost to Follow-up|18|||
160774773|NCT01299909|580559915|FG002|Overall Study|Lost to Follow-up|17|||
160774774|NCT01811238|580559916|FG000|Overall Study|Withdrawal by Subject|42|||
160774775|NCT01811238|580559916|FG000|Overall Study|Adverse Event|25|||
160774776|NCT01811238|580559916|FG000|Overall Study|Protocol Violation|4|||
160774777|NCT01811238|580559916|FG000|Overall Study|Lack of Efficacy|4|||
160774778|NCT01811238|580559916|FG000|Overall Study|subject refused study medication|6|||
160774779|NCT01977846|580559917|FG000|Total Study - Prospective|Death|0|||
160774780|NCT01977846|580559918|FG001|Total Study - Prospective|Death|1|||
160774781|NCT01977846|580559917|FG000|Total Study - Prospective|Lost to Follow-up|0|||
160774782|NCT01977846|580559918|FG001|Total Study - Prospective|Lost to Follow-up|8|||
160774783|NCT01977846|580559917|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
160774784|NCT01977846|580559918|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
160774785|NCT01977846|580559917|FG000|Total Study - Prospective|Not available at time of visit|0|||
160774786|NCT01977846|580559918|FG001|Total Study - Prospective|Not available at time of visit|5|||
160774787|NCT01977846|580559917|FG000|Total Study - Prospective|No show|0|||
160774788|NCT01977846|580559918|FG001|Total Study - Prospective|No show|1|||
160774789|NCT01977846|580559917|FG000|Total Study - Prospective|Protocol Violation|0|||
160886121|NCT03761797|580978274|FG000|Overall Study|No patient visit after entry|13|||
160886122|NCT03761797|580978274|FG000|Overall Study|Switch to other diabetes medication|10|||
160886123|NCT03761797|580978274|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
160886124|NCT03761797|580978274|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
160886125|NCT03761797|580978274|FG000|Overall Study|Insufficient effectives|2|||
160886126|NCT03761797|580978274|FG000|Overall Study|Excessive alcohol intake|1|||
160886127|NCT00266877|580978275|FG000|Overall Study|Death|1|||
160886128|NCT00266877|580978276|FG001|Overall Study|Death|1|||
160774790|NCT01977846|580559918|FG001|Total Study - Prospective|Protocol Violation|1|||
160774791|NCT01155570|580559919|FG000|Overall Study|Adverse Event|39|||
160774792|NCT01155570|580559919|FG000|Overall Study|Lack of Efficacy|46|||
160774793|NCT01155570|580559919|FG000|Overall Study|Participant's Economic Reasons|17|||
160774794|NCT01155570|580559919|FG000|Overall Study|No Hospital Visits|7|||
160774795|NCT01155570|580559919|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
160774796|NCT01155570|580559919|FG000|Overall Study|Adverse Event + Other Reasons|7|||
160774797|NCT01155570|580559919|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
160774798|NCT01155570|580559919|FG000|Overall Study|Other Reasons|23|||
160774799|NCT01922934|580559923|FG000|Eligible Patients|Death|0|||
160774800|NCT01922934|580559924|FG001|Eligible Patients|Death|7|||
160774801|NCT01922934|580559923|FG000|Eligible Patients|Physician Decision|17|||
160774802|NCT01922934|580559924|FG001|Eligible Patients|Physician Decision|0|||
160774803|NCT01922934|580559923|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
160774804|NCT01922934|580559924|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
160774805|NCT01922934|580559923|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
160774806|NCT01922934|580559924|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
160774807|NCT01922934|580559923|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
160774808|NCT01922934|580559924|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
160774809|NCT01922934|580559923|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
160774810|NCT01922934|580559924|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
160774811|NCT02774889|580559927|FG000|Overall Study|Lost to Follow-up|2|||
160774812|NCT02774889|580559928|FG001|Overall Study|Lost to Follow-up|1|||
160774813|NCT01069939|580559929|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
160774814|NCT01069939|580559930|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
160774815|NCT01069939|580559929|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
160774816|NCT01069939|580559930|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
160774817|NCT01069939|580559929|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
160774818|NCT01069939|580559930|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
160774819|NCT01069939|580559929|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
160774820|NCT01069939|580559930|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
160774821|NCT01069939|580559929|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
160774822|NCT01069939|580559930|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
160774823|NCT01069939|580559929|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
160774824|NCT01069939|580559930|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
160774825|NCT01069939|580559929|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
160774826|NCT01069939|580559930|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
160774827|NCT01069939|580559929|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
160774828|NCT01069939|580559930|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
160774829|NCT01069939|580559929|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
160774830|NCT01069939|580559930|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
160774831|NCT01069939|580559929|FG000|Randomised and Included in the Analyses|Removal|1|||
160774832|NCT01069939|580559930|FG001|Randomised and Included in the Analyses|Removal|0|||
160774833|NCT00724945|580559931|FG000|Period 1|non-compliance|1|||
160774834|NCT00724945|580559932|FG001|Period 1|non-compliance|0|||
160774835|NCT00724945|580559931|FG000|Period 1|Adverse Event|1|||
160774836|NCT00724945|580559932|FG001|Period 1|Adverse Event|1|||
160774837|NCT00724945|580559931|FG000|Period 1|Lost to Follow-up|1|||
160774838|NCT00724945|580559932|FG001|Period 1|Lost to Follow-up|0|||
160774839|NCT00724945|580559931|FG000|Period 2|lens comfort issue|3|||
160774840|NCT00724945|580559932|FG001|Period 2|lens comfort issue|0|||
160774841|NCT00724945|580559931|FG000|Period 2|lens physiology issue|1|||
160886129|NCT00266877|580978277|FG002|Overall Study|Death|1|||
160886130|NCT00266877|580978275|FG000|Overall Study|Adverse Event|6|||
160886131|NCT00266877|580978276|FG001|Overall Study|Adverse Event|4|||
160886132|NCT00266877|580978277|FG002|Overall Study|Adverse Event|1|||
160886133|NCT00266877|580978275|FG000|Overall Study|Physician Decision|2|||
160886134|NCT00266877|580978276|FG001|Overall Study|Physician Decision|1|||
160886135|NCT00266877|580978277|FG002|Overall Study|Physician Decision|1|||
160886136|NCT00266877|580978275|FG000|Overall Study|Withdrawal by Subject|3|||
160886137|NCT00266877|580978276|FG001|Overall Study|Withdrawal by Subject|1|||
160886138|NCT00266877|580978277|FG002|Overall Study|Withdrawal by Subject|1|||
160886139|NCT00266877|580978275|FG000|Overall Study|Disease Progression|72|||
160886140|NCT00266877|580978276|FG001|Overall Study|Disease Progression|37|||
160886141|NCT00266877|580978277|FG002|Overall Study|Disease Progression|23|||
160637793|NCT03216954|580057924|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
160637794|NCT03216954|580057925|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
160637795|NCT03216954|580057926|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
160637796|NCT03216954|580057927|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
160637797|NCT03216954|580057928|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
160637798|NCT04736576|580057931|FG000|Overall Study|Progressive disease|3|||
160637799|NCT04736576|580057932|FG001|Overall Study|Progressive disease|1|||
160637800|NCT04736576|580057931|FG000|Overall Study|Death|1|||
160637801|NCT04736576|580057932|FG001|Overall Study|Death|0|||
160637802|NCT00720304|580057933|FG000|Overall Study|Withdrawal by Subject|14|||
160637803|NCT00720304|580057934|FG001|Overall Study|Withdrawal by Subject|1|||
160637804|NCT00720304|580057933|FG000|Overall Study|Death|1|||
160637805|NCT00720304|580057934|FG001|Overall Study|Death|0|||
160637806|NCT00720304|580057933|FG000|Overall Study|Physician Decision|5|||
160637807|NCT00720304|580057934|FG001|Overall Study|Physician Decision|2|||
160637808|NCT00720304|580057933|FG000|Overall Study|Adverse Event|3|||
160637809|NCT00720304|580057934|FG001|Overall Study|Adverse Event|1|||
160886142|NCT00266877|580978275|FG000|Overall Study|Symptomatic Deterioration|6|||
160886143|NCT00266877|580978276|FG001|Overall Study|Symptomatic Deterioration|3|||
160886144|NCT00266877|580978277|FG002|Overall Study|Symptomatic Deterioration|1|||
160886145|NCT00266877|580978275|FG000|Overall Study|Hospitalization|1|||
160886146|NCT00266877|580978276|FG001|Overall Study|Hospitalization|0|||
160886147|NCT00266877|580978277|FG002|Overall Study|Hospitalization|0|||
160886148|NCT00266877|580978275|FG000|Overall Study|Concomitant Radiotherapy|0|||
160886149|NCT00266877|580978276|FG001|Overall Study|Concomitant Radiotherapy|1|||
160886150|NCT00266877|580978277|FG002|Overall Study|Concomitant Radiotherapy|0|||
160886151|NCT01924429|580978283|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
160886152|NCT01924429|580978284|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
160886153|NCT01150474|580978285|FG000|Overall Study|Withdrawal by Subject|5|||
160886154|NCT01150474|580978286|FG001|Overall Study|Withdrawal by Subject|2|||
160886155|NCT01150474|580978285|FG000|Overall Study|Cancer found|1|||
160886156|NCT01150474|580978286|FG001|Overall Study|Cancer found|0|||
160886157|NCT01150474|580978285|FG000|Overall Study|Multiple Studies|0|||
160886158|NCT01150474|580978286|FG001|Overall Study|Multiple Studies|1|||
160886159|NCT01150474|580978285|FG000|Overall Study|Rectotomy|1|||
160886160|NCT01150474|580978286|FG001|Overall Study|Rectotomy|0|||
160886161|NCT01150474|580978285|FG000|Overall Study|Drug did not arrive in time|1|||
160886162|NCT01150474|580978286|FG001|Overall Study|Drug did not arrive in time|0|||
160886163|NCT01150474|580978285|FG000|Overall Study|Drug not administered|1|||
160886164|NCT01150474|580978286|FG001|Overall Study|Drug not administered|0|||
160886165|NCT01150474|580978285|FG000|Overall Study|Surgery Changed|1|||
160886166|NCT01150474|580978286|FG001|Overall Study|Surgery Changed|0|||
160886167|NCT04231981|580978287|FG000|Overall Study|Adverse Event|1|||
160886168|NCT04231981|580978287|FG000|Overall Study|Death|16|||
160886169|NCT04231981|580978287|FG000|Overall Study|Lost to Follow-up|1|||
160886170|NCT02581943|580978288|FG000|Overall Study|Death|5|||
160886171|NCT02581943|580978289|FG001|Overall Study|Death|2|||
160886172|NCT02581943|580978288|FG000|Overall Study|Disease Progression|12|||
160886173|NCT02581943|580978289|FG001|Overall Study|Disease Progression|15|||
160886174|NCT02581943|580978288|FG000|Overall Study|Withdrawal by Subject|1|||
160886175|NCT02581943|580978289|FG001|Overall Study|Withdrawal by Subject|2|||
160886176|NCT01470989|580978290|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
160886177|NCT01470989|580978291|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
160886178|NCT01470989|580978290|FG000|Overall Study|Adverse Event|2|||
160886179|NCT01470989|580978291|FG001|Overall Study|Adverse Event|5|||
160886180|NCT01470989|580978290|FG000|Overall Study|Abnormal laboratory value|1|||
160637810|NCT00720304|580057933|FG000|Overall Study|Disease progression|6|||
160886181|NCT01470989|580978291|FG001|Overall Study|Abnormal laboratory value|1|||
160886182|NCT01470989|580978290|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160886183|NCT01470989|580978291|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
160886184|NCT01470989|580978290|FG000|Overall Study|Withdrawal by Subject|19|||
160886185|NCT01470989|580978291|FG001|Overall Study|Withdrawal by Subject|17|||
160886186|NCT01470989|580978290|FG000|Overall Study|Lost to Follow-up|18|||
160886187|NCT01470989|580978291|FG001|Overall Study|Lost to Follow-up|13|||
160774842|NCT00724945|580559932|FG001|Period 2|lens physiology issue|0|||
160774843|NCT05166876|580559933|FG000|Overall Study|Withdrawal by Subject|1|||
160774844|NCT05166876|580559934|FG001|Overall Study|Withdrawal by Subject|0|||
160774845|NCT05166876|580559935|FG002|Overall Study|Withdrawal by Subject|0|||
160774846|NCT00658528|580559936|FG000|Overall Study|Adverse Event|5|||
160774847|NCT00658528|580559937|FG001|Overall Study|Adverse Event|7|||
160774848|NCT00658528|580559936|FG000|Overall Study|Lost to Follow-up|14|||
160774849|NCT00658528|580559937|FG001|Overall Study|Lost to Follow-up|22|||
160774850|NCT00658528|580559936|FG000|Overall Study|Withdrawal by Subject|8|||
160774851|NCT00658528|580559937|FG001|Overall Study|Withdrawal by Subject|6|||
160774852|NCT00658528|580559936|FG000|Overall Study|Withdrawal of consent|5|||
160774853|NCT00658528|580559937|FG001|Overall Study|Withdrawal of consent|6|||
160774854|NCT00658528|580559936|FG000|Overall Study|Other|8|||
160774855|NCT00658528|580559937|FG001|Overall Study|Other|4|||
160774856|NCT01147458|580559944|FG000|First Intervention|Study terminated by sponsor|8|||
160774857|NCT01147458|580559945|FG001|First Intervention|Study terminated by sponsor|8|||
160774858|NCT01147458|580559946|FG002|First Intervention|Study terminated by sponsor|7|||
160774859|NCT01147458|580559947|FG003|First Intervention|Study terminated by sponsor|8|||
160774860|NCT01147458|580559944|FG000|First Intervention|Protocol Violation|2|||
160774861|NCT01147458|580559945|FG001|First Intervention|Protocol Violation|3|||
160774862|NCT01147458|580559946|FG002|First Intervention|Protocol Violation|2|||
160774863|NCT01147458|580559947|FG003|First Intervention|Protocol Violation|3|||
160774864|NCT01147458|580559944|FG000|First Intervention|Withdrawal by Subject|3|||
160774865|NCT01147458|580559945|FG001|First Intervention|Withdrawal by Subject|0|||
160774866|NCT01147458|580559946|FG002|First Intervention|Withdrawal by Subject|1|||
160774867|NCT01147458|580559947|FG003|First Intervention|Withdrawal by Subject|0|||
160774868|NCT01147458|580559944|FG000|First Intervention|Adverse Event|0|||
160774869|NCT01147458|580559945|FG001|First Intervention|Adverse Event|3|||
160774870|NCT01147458|580559946|FG002|First Intervention|Adverse Event|2|||
160774871|NCT01147458|580559947|FG003|First Intervention|Adverse Event|3|||
160774872|NCT01147458|580559944|FG000|First Intervention|Other|1|||
160774873|NCT01147458|580559945|FG001|First Intervention|Other|2|||
160774874|NCT01147458|580559946|FG002|First Intervention|Other|0|||
160774875|NCT01147458|580559947|FG003|First Intervention|Other|0|||
160774876|NCT01147458|580559944|FG000|Second Intervention|Study terminated by sponsor|7|||
160774877|NCT01147458|580559945|FG001|Second Intervention|Study terminated by sponsor|5|||
160774878|NCT01147458|580559946|FG002|Second Intervention|Study terminated by sponsor|5|||
160774879|NCT01147458|580559947|FG003|Second Intervention|Study terminated by sponsor|3|||
160774880|NCT01147458|580559944|FG000|Second Intervention|Protocol Violation|0|||
160774881|NCT01147458|580559945|FG001|Second Intervention|Protocol Violation|1|||
160774882|NCT01147458|580559946|FG002|Second Intervention|Protocol Violation|1|||
160774883|NCT01147458|580559947|FG003|Second Intervention|Protocol Violation|0|||
160774884|NCT01147458|580559944|FG000|Second Intervention|Withdrawal by Subject|0|||
160774885|NCT01147458|580559945|FG001|Second Intervention|Withdrawal by Subject|1|||
160774886|NCT01147458|580559946|FG002|Second Intervention|Withdrawal by Subject|0|||
160774887|NCT01147458|580559947|FG003|Second Intervention|Withdrawal by Subject|0|||
160774888|NCT01147458|580559944|FG000|Second Intervention|Adverse Event|2|||
160774889|NCT01147458|580559945|FG001|Second Intervention|Adverse Event|0|||
160774890|NCT01147458|580559946|FG002|Second Intervention|Adverse Event|1|||
160774891|NCT01147458|580559947|FG003|Second Intervention|Adverse Event|1|||
160774892|NCT01147458|580559944|FG000|Second Intervention|Other|0|||
160774893|NCT01147458|580559945|FG001|Second Intervention|Other|0|||
160774894|NCT01147458|580559946|FG002|Second Intervention|Other|1|||
160774895|NCT01147458|580559947|FG003|Second Intervention|Other|0|||
160774896|NCT02811159|580559959|FG000|Treatment Course 1|Lost to Follow-up|1|||
160774897|NCT04603066|580559960|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
160774898|NCT04603066|580559961|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
160637811|NCT00720304|580057934|FG001|Overall Study|Disease progression|1|||
160774899|NCT04409002|580559962|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
160774900|NCT04190225|580561688|FG000|Overall Study|Lost to Follow-up|2|||
160774901|NCT04190225|580561689|FG001|Overall Study|Lost to Follow-up|3|||
160774902|NCT04190225|580561688|FG000|Overall Study|Withdrawal by Subject|3|||
160774903|NCT04190225|580561689|FG001|Overall Study|Withdrawal by Subject|2|||
160774904|NCT04190225|580561688|FG000|Overall Study|Unrelated health condition|2|||
160774905|NCT04190225|580561689|FG001|Overall Study|Unrelated health condition|0|||
160774906|NCT01732783|580561690|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
160774907|NCT01732783|580561691|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
160774908|NCT01732783|580561692|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
160774909|NCT01732783|580561690|FG000|Overall Study|Death|13|||
160774910|NCT01732783|580561691|FG001|Overall Study|Death|4|||
160774911|NCT01732783|580561692|FG002|Overall Study|Death|1|||
160774912|NCT01732783|580561690|FG000|Overall Study|Lost to Follow-up|7|||
160774913|NCT01732783|580561691|FG001|Overall Study|Lost to Follow-up|1|||
160774914|NCT01732783|580561692|FG002|Overall Study|Lost to Follow-up|1|||
160774915|NCT01732783|580561690|FG000|Overall Study|Administrative Decision|8|||
160774916|NCT01732783|580561691|FG001|Overall Study|Administrative Decision|2|||
160774917|NCT01732783|580561692|FG002|Overall Study|Administrative Decision|1|||
160774918|NCT01732783|580561690|FG000|Overall Study|Withdrawal by Subject|1|||
160774919|NCT01732783|580561691|FG001|Overall Study|Withdrawal by Subject|0|||
160774920|NCT01732783|580561692|FG002|Overall Study|Withdrawal by Subject|0|||
160774921|NCT04429971|580561693|FG000|Overall Study|Lost to Follow-up|7|||
160774922|NCT04429971|580561694|FG001|Overall Study|Lost to Follow-up|8|||
160774923|NCT05522751|580561700|FG000|Overall Study|Adverse Event|1|||
160774924|NCT04044690|580561702|FG000|Period 1|Lack of Efficacy|1|||
160774925|NCT04044690|580561703|FG001|Period 1|Lack of Efficacy|1|||
160774926|NCT04044690|580561702|FG000|Period 1|Adverse Event|4|||
160774927|NCT04044690|580561703|FG001|Period 1|Adverse Event|2|||
160774928|NCT04044690|580561702|FG000|Period 1|Physician Decision|0|||
160774929|NCT04044690|580561703|FG001|Period 1|Physician Decision|1|||
160774930|NCT04044690|580561702|FG000|Period 1|Withdrawal by Subject|2|||
160637812|NCT04330482|580057937|FG000|Overall Study|Lost to Follow-up|2|||
160637813|NCT04330482|580057938|FG001|Overall Study|Lost to Follow-up|1|||
160637814|NCT04330482|580057937|FG000|Overall Study|Withdrawal by Subject|0|||
160637815|NCT04330482|580057938|FG001|Overall Study|Withdrawal by Subject|3|||
160637816|NCT05180630|580057939|FG000|First Intervention|Physician Decision|0|||
160637817|NCT05180630|580057940|FG001|First Intervention|Physician Decision|0|||
160637818|NCT05180630|580057941|FG002|First Intervention|Physician Decision|3|||
160637819|NCT04333199|580057944|FG000|Evaluated Patients|Lost to Follow-up|0|||
160637820|NCT04333199|580057945|FG001|Evaluated Patients|Lost to Follow-up|1|||
160637821|NCT04333199|580057946|FG002|Evaluated Patients|Lost to Follow-up|2|||
160637822|NCT00709735|580057948|FG000|Overall Study|Lost to Follow-up|1|||
160637823|NCT00709735|580057949|FG001|Overall Study|Lost to Follow-up|1|||
160637824|NCT00709735|580057948|FG000|Overall Study|Relapse into Opioid Abuse|0|||
160637825|NCT00709735|580057949|FG001|Overall Study|Relapse into Opioid Abuse|1|||
160637826|NCT00709735|580057948|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
160637827|NCT00709735|580057949|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
160637828|NCT01333475|580057950|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
160637829|NCT01333475|580057951|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
160637830|NCT01333475|580057950|FG000|Overall Study|Toxicity|1|||
160637831|NCT01333475|580057951|FG001|Overall Study|Toxicity|3|||
160637832|NCT04440007|580057952|FG000|Overall Study|Adverse Event|0|||
160637833|NCT04440007|580057953|FG001|Overall Study|Adverse Event|1|||
160637834|NCT04440007|580057952|FG000|Overall Study|Lost to Follow-up|1|||
160637835|NCT04440007|580057953|FG001|Overall Study|Lost to Follow-up|3|||
160637836|NCT04440007|580057952|FG000|Overall Study|Death|7|||
160637837|NCT04440007|580057953|FG001|Overall Study|Death|2|||
160637838|NCT04440007|580057952|FG000|Overall Study|Physician Decision|1|||
160637839|NCT04440007|580057953|FG001|Overall Study|Physician Decision|1|||
160637840|NCT04440007|580057952|FG000|Overall Study|Withdrawal by Subject|2|||
160637841|NCT04440007|580057953|FG001|Overall Study|Withdrawal by Subject|1|||
160637842|NCT04440007|580057952|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
160637843|NCT04440007|580057953|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
160637844|NCT04440007|580057952|FG000|Overall Study|Discontinued prior to dosing|0|||
160637845|NCT04440007|580057953|FG001|Overall Study|Discontinued prior to dosing|2|||
160637846|NCT01466673|580057954|FG000|Overall Study|Non-compliance with study treatment|2|||
160637847|NCT01466673|580057955|FG001|Overall Study|Non-compliance with study treatment|0|||
160637848|NCT01466673|580057954|FG000|Overall Study|Lost to Follow-up|3|||
160774931|NCT04044690|580561703|FG001|Period 1|Withdrawal by Subject|5|||
160774932|NCT04044690|580561702|FG000|Period 1|Protocol Deviation|2|||
160774933|NCT04044690|580561703|FG001|Period 1|Protocol Deviation|0|||
160774934|NCT04044690|580561702|FG000|Period 1|Site Terminated by Sponsor|0|||
160637849|NCT01466673|580057955|FG001|Overall Study|Lost to Follow-up|5|||
160637850|NCT01466673|580057954|FG000|Overall Study|Adverse Event|2|||
160637851|NCT01466673|580057955|FG001|Overall Study|Adverse Event|1|||
160637852|NCT02981602|580057956|FG000|Overall Study|Adverse Event|0|||
160637853|NCT02981602|580057957|FG001|Overall Study|Adverse Event|0|||
160637854|NCT02981602|580057958|FG002|Overall Study|Adverse Event|0|||
160637855|NCT02981602|580057959|FG003|Overall Study|Adverse Event|1|||
160637856|NCT02981602|580057960|FG004|Overall Study|Adverse Event|0|||
160774935|NCT04044690|580561703|FG001|Period 1|Site Terminated by Sponsor|1|||
160774936|NCT04044690|580561702|FG000|Period 1|Study Terminated by Sponsor|0|||
160774937|NCT04044690|580561703|FG001|Period 1|Study Terminated by Sponsor|1|||
160774938|NCT04044690|580561702|FG000|Period 1|Death|1|||
160774939|NCT04044690|580561703|FG001|Period 1|Death|1|||
160774940|NCT04044690|580561702|FG000|Period 1|Other: Unspecified|1|||
160886188|NCT01470989|580978290|FG000|Overall Study|Administrative problems|2|||
160886189|NCT01470989|580978291|FG001|Overall Study|Administrative problems|4|||
160886190|NCT01470989|580978290|FG000|Overall Study|Death|2|||
160886191|NCT01470989|580978291|FG001|Overall Study|Death|2|||
160886192|NCT01470989|580978290|FG000|Overall Study|Protocol deviation|1|||
160886193|NCT01470989|580978291|FG001|Overall Study|Protocol deviation|2|||
160886194|NCT01233687|580978292|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
160886195|NCT01233687|580978292|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
160886196|NCT01233687|580978292|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
160886197|NCT02197234|580978295|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
160886198|NCT02197234|580978295|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
160886199|NCT02197234|580978295|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
160886200|NCT02197234|580978295|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
160886201|NCT02197234|580978295|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
160886202|NCT02197234|580978295|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
160886203|NCT03783702|580978296|FG000|Overall Study|Lost to Follow-up|6|||
160886204|NCT03783702|580978297|FG001|Overall Study|Lost to Follow-up|8|||
160886205|NCT03783702|580978296|FG000|Overall Study|Protocol Violation|1|||
160886206|NCT03783702|580978297|FG001|Overall Study|Protocol Violation|3|||
160886207|NCT02119676|580978298|FG000|Overall Study|Adverse Event|9|||
160886208|NCT02119676|580978299|FG001|Overall Study|Adverse Event|17|||
160886209|NCT02119676|580978300|FG002|Overall Study|Adverse Event|10|||
160886210|NCT02119676|580978301|FG003|Overall Study|Adverse Event|10|||
160886211|NCT02119676|580978298|FG000|Overall Study|Disease progression|53|||
160886212|NCT02119676|580978299|FG001|Overall Study|Disease progression|55|||
160886213|NCT02119676|580978300|FG002|Overall Study|Disease progression|68|||
160886214|NCT02119676|580978301|FG003|Overall Study|Disease progression|73|||
160886215|NCT02119676|580978298|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
160774941|NCT04044690|580561703|FG001|Period 1|Other: Unspecified|0|||
160774942|NCT04044690|580561702|FG000|Period 2|Lack of Efficacy|0|||
160774943|NCT04044690|580561703|FG001|Period 2|Lack of Efficacy|1|||
160774944|NCT04044690|580561702|FG000|Period 2|Adverse Event|0|||
160774945|NCT04044690|580561703|FG001|Period 2|Adverse Event|1|||
160774946|NCT04044690|580561702|FG000|Period 2|Physician Decision|0|||
160774947|NCT04044690|580561703|FG001|Period 2|Physician Decision|2|||
160774948|NCT04044690|580561702|FG000|Period 2|Withdrawal by Subject|5|||
160774949|NCT04044690|580561703|FG001|Period 2|Withdrawal by Subject|5|||
160774950|NCT04044690|580561702|FG000|Period 2|Lost to Follow-up|0|||
160774951|NCT04044690|580561703|FG001|Period 2|Lost to Follow-up|1|||
160774952|NCT04044690|580561702|FG000|Period 2|Site Terminated by Sponsor|1|||
160774953|NCT04044690|580561703|FG001|Period 2|Site Terminated by Sponsor|3|||
160774954|NCT04044690|580561702|FG000|Period 2|Study Terminated by Sponsor|8|||
160774955|NCT04044690|580561703|FG001|Period 2|Study Terminated by Sponsor|3|||
160774956|NCT04044690|580561702|FG000|Period 2|Death|1|||
160774957|NCT04044690|580561703|FG001|Period 2|Death|0|||
160774958|NCT04044690|580561702|FG000|Period 2|Other: Unspecified|1|||
160774959|NCT04044690|580561703|FG001|Period 2|Other: Unspecified|1|||
160774960|NCT04044690|580561702|FG000|Period 3|Site Terminated by Sponsor|1|||
160774961|NCT04044690|580561703|FG001|Period 3|Site Terminated by Sponsor|2|||
160774962|NCT04044690|580561702|FG000|Period 3|Study Terminated by Sponsor|24|||
160774963|NCT04044690|580561703|FG001|Period 3|Study Terminated by Sponsor|18|||
160774964|NCT04044690|580561702|FG000|Period 3|Missing|0|||
160774965|NCT04044690|580561703|FG001|Period 3|Missing|2|||
160774966|NCT01582451|580561709|FG000|Overall Study|Adverse Event|1|||
160886216|NCT02119676|580978299|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
160886217|NCT02119676|580978300|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
160886218|NCT02119676|580978301|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
160886219|NCT02119676|580978298|FG000|Overall Study|Physician Decision|4|||
160637857|NCT00666718|580057961|FG000|Overall Study|Adverse Event|0|||
160637858|NCT00666718|580057962|FG001|Overall Study|Adverse Event|1|||
160774967|NCT01582451|580561710|FG001|Overall Study|Adverse Event|3|||
160774968|NCT01582451|580561709|FG000|Overall Study|Death|3|||
160774969|NCT01582451|580561710|FG001|Overall Study|Death|3|||
160774970|NCT01582451|580561709|FG000|Overall Study|Lost to Follow-up|0|||
160774971|NCT01582451|580561710|FG001|Overall Study|Lost to Follow-up|2|||
160886220|NCT02119676|580978299|FG001|Overall Study|Physician Decision|2|||
160774972|NCT01582451|580561709|FG000|Overall Study|Protocol Violation|11|||
160886221|NCT02119676|580978300|FG002|Overall Study|Physician Decision|3|||
160886222|NCT02119676|580978301|FG003|Overall Study|Physician Decision|2|||
160774973|NCT01582451|580561710|FG001|Overall Study|Protocol Violation|3|||
160774974|NCT01582451|580561709|FG000|Overall Study|Withdrawal by Subject|13|||
160774975|NCT01582451|580561710|FG001|Overall Study|Withdrawal by Subject|9|||
160774976|NCT01582451|580561709|FG000|Overall Study|Physician Decision|3|||
160774977|NCT01582451|580561710|FG001|Overall Study|Physician Decision|0|||
160886223|NCT02119676|580978298|FG000|Overall Study|Death|9|||
160886224|NCT02119676|580978299|FG001|Overall Study|Death|3|||
160886225|NCT02119676|580978300|FG002|Overall Study|Death|2|||
160886226|NCT02119676|580978301|FG003|Overall Study|Death|1|||
160886227|NCT02119676|580978298|FG000|Overall Study|Noncompliance|0|||
160886228|NCT02119676|580978299|FG001|Overall Study|Noncompliance|1|||
160886229|NCT02119676|580978300|FG002|Overall Study|Noncompliance|0|||
160886230|NCT02119676|580978301|FG003|Overall Study|Noncompliance|0|||
160886231|NCT02119676|580978298|FG000|Overall Study|Lost to Follow-up|0|||
160886232|NCT02119676|580978299|FG001|Overall Study|Lost to Follow-up|0|||
160886233|NCT02119676|580978300|FG002|Overall Study|Lost to Follow-up|1|||
160886234|NCT02119676|580978301|FG003|Overall Study|Lost to Follow-up|0|||
160886235|NCT02119676|580978298|FG000|Overall Study|Protocol deviation|0|||
160886236|NCT02119676|580978299|FG001|Overall Study|Protocol deviation|0|||
160886237|NCT02119676|580978300|FG002|Overall Study|Protocol deviation|1|||
160886238|NCT02119676|580978301|FG003|Overall Study|Protocol deviation|0|||
160886239|NCT02119676|580978298|FG000|Overall Study|Other, unspecified|2|||
160886240|NCT02119676|580978299|FG001|Overall Study|Other, unspecified|1|||
160637859|NCT00666718|580057961|FG000|Overall Study|Death|1|||
160637860|NCT00666718|580057962|FG001|Overall Study|Death|0|||
160637861|NCT00666718|580057961|FG000|Overall Study|Lost to Follow-up|1|||
160637862|NCT00666718|580057962|FG001|Overall Study|Lost to Follow-up|0|||
160637863|NCT00666718|580057961|FG000|Overall Study|Entry Criteria Not Met|2|||
160637864|NCT00666718|580057962|FG001|Overall Study|Entry Criteria Not Met|0|||
160637865|NCT00666718|580057961|FG000|Overall Study|Protocol Violation|1|||
160637866|NCT00666718|580057962|FG001|Overall Study|Protocol Violation|3|||
160637867|NCT00666718|580057961|FG000|Overall Study|Withdrawal by Subject|7|||
160637868|NCT00666718|580057962|FG001|Overall Study|Withdrawal by Subject|12|||
160637869|NCT00666718|580057961|FG000|Overall Study|Physician Decision|0|||
160637870|NCT00666718|580057962|FG001|Overall Study|Physician Decision|2|||
160637871|NCT00190684|580057969|FG000|Overall Study|Adverse Event|86|||
160637872|NCT00190684|580057969|FG000|Overall Study|Satisfactory response|80|||
160637873|NCT00190684|580057969|FG000|Overall Study|Lack of efficacy|204|||
160637874|NCT00190684|580057969|FG000|Overall Study|Lost to Follow-up|232|||
160637875|NCT00190684|580057969|FG000|Overall Study|Patient moved|60|||
160637876|NCT00190684|580057969|FG000|Overall Study|Patient Decision|432|||
160637877|NCT00190684|580057969|FG000|Overall Study|Clinical relapse|67|||
160637878|NCT00190684|580057969|FG000|Overall Study|Sponsor's decision|17|||
160637879|NCT00190684|580057969|FG000|Overall Study|Physician Decision|84|||
160637880|NCT00190684|580057969|FG000|Overall Study|Protocol Violation|123|||
160637881|NCT00190684|580057969|FG000|Overall Study|Study Period III Completed|103|||
160637882|NCT00190684|580057969|FG000|Overall Study|Study Period V Completed|1|||
160637883|NCT02567266|580057976|FG000|Overall Study|Withdrawal by Subject|10|||
160637884|NCT02567266|580057977|FG001|Overall Study|Withdrawal by Subject|7|||
160637885|NCT02567266|580057978|FG002|Overall Study|Withdrawal by Subject|6|||
160637886|NCT02567266|580057976|FG000|Overall Study|Lost to Follow-up|13|||
160637887|NCT02567266|580057977|FG001|Overall Study|Lost to Follow-up|8|||
160637888|NCT02567266|580057978|FG002|Overall Study|Lost to Follow-up|10|||
160637889|NCT02983227|580057979|FG000|Overall Study|Adverse Event|21|||
160637890|NCT02983227|580057980|FG001|Overall Study|Adverse Event|3|||
160637891|NCT02983227|580057979|FG000|Overall Study|Death|3|||
160637892|NCT02983227|580057980|FG001|Overall Study|Death|0|||
160637893|NCT02983227|580057979|FG000|Overall Study|Lack of Efficacy|8|||
160637894|NCT02983227|580057980|FG001|Overall Study|Lack of Efficacy|1|||
160637895|NCT02983227|580057979|FG000|Overall Study|Lost to Follow-up|3|||
160637896|NCT02983227|580057980|FG001|Overall Study|Lost to Follow-up|0|||
160637897|NCT02983227|580057979|FG000|Overall Study|Multiple Reasons|2|||
160637898|NCT02983227|580057980|FG001|Overall Study|Multiple Reasons|1|||
160637899|NCT02983227|580057979|FG000|Overall Study|Physician Decision|3|||
160637900|NCT02983227|580057980|FG001|Overall Study|Physician Decision|1|||
160637901|NCT02983227|580057979|FG000|Overall Study|Withdrawal by Subject|19|||
160637902|NCT02983227|580057980|FG001|Overall Study|Withdrawal by Subject|8|||
160637903|NCT02354976|580057981|FG000|Overall Study|Other - reason not specified|1|||
160637904|NCT02354976|580057982|FG001|Overall Study|Other - reason not specified|0|||
160637905|NCT02354976|580057983|FG002|Overall Study|Other - reason not specified|1|||
160637906|NCT02354976|580057981|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
160886241|NCT02119676|580978300|FG002|Overall Study|Other, unspecified|3|||
160886242|NCT02119676|580978301|FG003|Overall Study|Other, unspecified|4|||
160886243|NCT02119676|580978298|FG000|Overall Study|Did not receive study med|2|||
160886244|NCT02119676|580978299|FG001|Overall Study|Did not receive study med|2|||
160637907|NCT02354976|580057982|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
160637908|NCT02354976|580057983|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
160637909|NCT02354976|580057981|FG000|Overall Study|Adverse Event|1|||
160637910|NCT02354976|580057982|FG001|Overall Study|Adverse Event|0|||
160637911|NCT02354976|580057983|FG002|Overall Study|Adverse Event|2|||
160637912|NCT01155284|580057986|FG000|Overall Study|Withdrawal by Subject|4|||
160637913|NCT01155284|580057987|FG001|Overall Study|Withdrawal by Subject|3|||
160637914|NCT01155284|580057986|FG000|Overall Study|Lost to Follow-up|1|||
160637915|NCT01155284|580057987|FG001|Overall Study|Lost to Follow-up|2|||
160886245|NCT02119676|580978300|FG002|Overall Study|Did not receive study med|4|||
160774978|NCT01582451|580561709|FG000|Overall Study|Sponsor Decision|1|||
160774979|NCT01582451|580561710|FG001|Overall Study|Sponsor Decision|0|||
160774980|NCT00487188|580561713|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
160774981|NCT00487188|580561714|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
160774982|NCT00487188|580561715|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
160774983|NCT00487188|580561713|FG000|Induction Phase|Adverse Event|5|||
160774984|NCT00487188|580561714|FG001|Induction Phase|Adverse Event|0|||
160774985|NCT00487188|580561715|FG002|Induction Phase|Adverse Event|0|||
160774986|NCT00487188|580561713|FG000|Induction Phase|Lack of Efficacy|0|||
160774987|NCT00487188|580561714|FG001|Induction Phase|Lack of Efficacy|1|||
160774988|NCT00487188|580561715|FG002|Induction Phase|Lack of Efficacy|0|||
160774989|NCT00487188|580561713|FG000|Induction Phase|Protocol Violation|1|||
160774990|NCT00487188|580561714|FG001|Induction Phase|Protocol Violation|0|||
160774991|NCT00487188|580561715|FG002|Induction Phase|Protocol Violation|0|||
160774992|NCT00487188|580561713|FG000|Induction Phase|Refused Treatment|1|||
160774993|NCT00487188|580561714|FG001|Induction Phase|Refused Treatment|2|||
160774994|NCT00487188|580561715|FG002|Induction Phase|Refused Treatment|0|||
160774995|NCT00487188|580561713|FG000|Induction Phase|Lost to Follow-up|2|||
160774996|NCT00487188|580561714|FG001|Induction Phase|Lost to Follow-up|2|||
160774997|NCT00487188|580561715|FG002|Induction Phase|Lost to Follow-up|0|||
160774998|NCT00487188|580561713|FG000|Induction Phase|Administrative|0|||
160774999|NCT00487188|580561714|FG001|Induction Phase|Administrative|1|||
160775000|NCT00487188|580561715|FG002|Induction Phase|Administrative|0|||
160775001|NCT00487188|580561713|FG000|Maintenance Phase|Adverse Event|1|||
160775002|NCT00487188|580561714|FG001|Maintenance Phase|Adverse Event|0|||
160775003|NCT00487188|580561715|FG002|Maintenance Phase|Adverse Event|0|||
160775004|NCT00487188|580561713|FG000|Maintenance Phase|Death|1|||
160775005|NCT00487188|580561714|FG001|Maintenance Phase|Death|0|||
160775006|NCT00487188|580561715|FG002|Maintenance Phase|Death|0|||
160775007|NCT00487188|580561713|FG000|Maintenance Phase|Lost to Follow-up|1|||
160775008|NCT00487188|580561714|FG001|Maintenance Phase|Lost to Follow-up|0|||
160775009|NCT00487188|580561715|FG002|Maintenance Phase|Lost to Follow-up|0|||
160775010|NCT00487188|580561713|FG000|Maintenance Phase|Administrative|0|||
160775011|NCT00487188|580561714|FG001|Maintenance Phase|Administrative|0|||
160775012|NCT00487188|580561715|FG002|Maintenance Phase|Administrative|1|||
160775013|NCT01838876|580561716|FG000|Overall Study|Adverse Event|49|||
160775014|NCT01838876|580561716|FG000|Overall Study|Insufficient Therapeutic Response|10|||
160775015|NCT01838876|580561716|FG000|Overall Study|Protocol Violation|34|||
160775016|NCT01838876|580561716|FG000|Overall Study|Withdrawal of Consent|33|||
160775017|NCT01838876|580561716|FG000|Overall Study|Lost to Follow-up|21|||
160775018|NCT01838876|580561716|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
160775019|NCT01838876|580561716|FG000|Overall Study|Reason not Specified|7|||
160775020|NCT01838876|580561716|FG000|Overall Study|Did not meet eligibility criteria|78|||
160775021|NCT01682031|580561717|FG000|Overall Study|Withdrawal by Subject|0|||
160775022|NCT01682031|580561718|FG001|Overall Study|Withdrawal by Subject|1|||
160775023|NCT01682031|580561717|FG000|Overall Study|Adverse Event|0|||
160775024|NCT01682031|580561718|FG001|Overall Study|Adverse Event|2|||
160775025|NCT01682031|580561717|FG000|Overall Study|MRI results indicate increased nodul|0|||
160775026|NCT01682031|580561718|FG001|Overall Study|MRI results indicate increased nodul|1|||
160775027|NCT01682031|580561717|FG000|Overall Study|Patient could not swallow tablets|1|||
160775028|NCT01682031|580561718|FG001|Overall Study|Patient could not swallow tablets|0|||
160775029|NCT01682031|580561717|FG000|Overall Study|Patient stopped selenium on his own|0|||
160775030|NCT01682031|580561718|FG001|Overall Study|Patient stopped selenium on his own|1|||
160775031|NCT05472142|580561726|FG000|Total Participants|Lost to Follow-up|312|||
160775032|NCT05472142|580561727|FG001|Total Participants|Lost to Follow-up|0|||
160775033|NCT05472142|580561726|FG000|Clinic Patients|Lost to Follow-up|312|||
160775034|NCT05472142|580561727|FG001|Clinic Patients|Lost to Follow-up|0|||
160775035|NCT04092777|580561728|FG000|Overall Study|Lost to Follow-up|28|||
160775036|NCT04092777|580561729|FG001|Overall Study|Lost to Follow-up|46|||
160775037|NCT04092777|580561728|FG000|Overall Study|Withdrawal by Subject|8|||
160775038|NCT04092777|580561729|FG001|Overall Study|Withdrawal by Subject|5|||
160775039|NCT03330197|580561732|FG000|Overall Study|Adverse Event|0|||
160775040|NCT03330197|580561733|FG001|Overall Study|Adverse Event|1|||
160775041|NCT03330197|580561732|FG000|Overall Study|Withdrawal by Subject|0|||
160775042|NCT03330197|580561733|FG001|Overall Study|Withdrawal by Subject|1|||
160775043|NCT03765073|580561734|FG000|Stage 1|Lost to Follow-up|1|||
160775044|NCT03765073|580561735|FG001|Stage 1|Lost to Follow-up|0|||
160775045|NCT03765073|580561736|FG002|Stage 1|Lost to Follow-up|0|||
160775046|NCT03765073|580561737|FG003|Stage 1|Lost to Follow-up|0|||
160775047|NCT03765073|580561738|FG004|Stage 1|Lost to Follow-up|0|||
160775048|NCT03765073|580561739|FG005|Stage 1|Lost to Follow-up|0|||
160775049|NCT03765073|580561740|FG006|Stage 1|Lost to Follow-up|0|||
160775050|NCT03765073|580561741|FG007|Stage 1|Lost to Follow-up|0|||
160775051|NCT03765073|580561742|FG008|Stage 1|Lost to Follow-up|0|||
160775052|NCT03765073|580561743|FG009|Stage 1|Lost to Follow-up|0|||
160775053|NCT03765073|580561744|FG010|Stage 1|Lost to Follow-up|0|||
160775054|NCT03765073|580561745|FG011|Stage 1|Lost to Follow-up|0|||
160775055|NCT03765073|580561746|FG012|Stage 1|Lost to Follow-up|0|||
160775056|NCT03765073|580561747|FG013|Stage 1|Lost to Follow-up|0|||
160775057|NCT03765073|580561748|FG014|Stage 1|Lost to Follow-up|0|||
160775058|NCT03765073|580561749|FG015|Stage 1|Lost to Follow-up|0|||
160775059|NCT03765073|580561750|FG016|Stage 1|Lost to Follow-up|0|||
160775060|NCT03765073|580561751|FG017|Stage 1|Lost to Follow-up|0|||
160775061|NCT03765073|580561752|FG018|Stage 1|Lost to Follow-up|0|||
160775062|NCT03765073|580561753|FG019|Stage 1|Lost to Follow-up|0|||
160775063|NCT03765073|580561754|FG020|Stage 1|Lost to Follow-up|0|||
160775064|NCT03765073|580561734|FG000|Stage 1|Withdrawal by participant|0|||
160775065|NCT03765073|580561735|FG001|Stage 1|Withdrawal by participant|1|||
160775066|NCT03765073|580561736|FG002|Stage 1|Withdrawal by participant|0|||
160775067|NCT03765073|580561737|FG003|Stage 1|Withdrawal by participant|0|||
160775068|NCT03765073|580561738|FG004|Stage 1|Withdrawal by participant|0|||
160775069|NCT03765073|580561739|FG005|Stage 1|Withdrawal by participant|0|||
160775070|NCT03765073|580561740|FG006|Stage 1|Withdrawal by participant|0|||
160775071|NCT03765073|580561741|FG007|Stage 1|Withdrawal by participant|0|||
160775072|NCT03765073|580561742|FG008|Stage 1|Withdrawal by participant|0|||
160775073|NCT03765073|580561743|FG009|Stage 1|Withdrawal by participant|0|||
160775074|NCT03765073|580561744|FG010|Stage 1|Withdrawal by participant|0|||
160775075|NCT03765073|580561745|FG011|Stage 1|Withdrawal by participant|0|||
160775076|NCT03765073|580561746|FG012|Stage 1|Withdrawal by participant|0|||
160775077|NCT03765073|580561747|FG013|Stage 1|Withdrawal by participant|0|||
160775078|NCT03765073|580561748|FG014|Stage 1|Withdrawal by participant|0|||
160775079|NCT03765073|580561749|FG015|Stage 1|Withdrawal by participant|0|||
160775080|NCT03765073|580561750|FG016|Stage 1|Withdrawal by participant|0|||
160775081|NCT03765073|580561751|FG017|Stage 1|Withdrawal by participant|0|||
160775082|NCT03765073|580561752|FG018|Stage 1|Withdrawal by participant|0|||
160775083|NCT03765073|580561753|FG019|Stage 1|Withdrawal by participant|0|||
160775084|NCT03765073|580561754|FG020|Stage 1|Withdrawal by participant|0|||
160775085|NCT03765073|580561734|FG000|Stage 2|Death|0|||
160775086|NCT03765073|580561735|FG001|Stage 2|Death|0|||
160775087|NCT03765073|580561736|FG002|Stage 2|Death|0|||
160775088|NCT03765073|580561737|FG003|Stage 2|Death|0|||
160775089|NCT03765073|580561738|FG004|Stage 2|Death|0|||
160775090|NCT03765073|580561739|FG005|Stage 2|Death|0|||
160775091|NCT03765073|580561740|FG006|Stage 2|Death|0|||
160775092|NCT03765073|580561741|FG007|Stage 2|Death|0|||
160775093|NCT03765073|580561742|FG008|Stage 2|Death|0|||
160775094|NCT03765073|580561743|FG009|Stage 2|Death|1|||
160775095|NCT03765073|580561744|FG010|Stage 2|Death|0|||
160775096|NCT03765073|580561745|FG011|Stage 2|Death|1|||
160775097|NCT03765073|580561746|FG012|Stage 2|Death|0|||
160775098|NCT03765073|580561747|FG013|Stage 2|Death|0|||
160775099|NCT03765073|580561748|FG014|Stage 2|Death|0|||
160775100|NCT03765073|580561749|FG015|Stage 2|Death|0|||
160775101|NCT03765073|580561750|FG016|Stage 2|Death|2|||
160775102|NCT03765073|580561751|FG017|Stage 2|Death|0|||
160775103|NCT03765073|580561752|FG018|Stage 2|Death|0|||
160775104|NCT03765073|580561753|FG019|Stage 2|Death|0|||
160775105|NCT03765073|580561754|FG020|Stage 2|Death|0|||
160775106|NCT03765073|580561734|FG000|Stage 2|Lost to Follow-up|0|||
160775107|NCT03765073|580561735|FG001|Stage 2|Lost to Follow-up|0|||
160775108|NCT03765073|580561736|FG002|Stage 2|Lost to Follow-up|0|||
160775109|NCT03765073|580561737|FG003|Stage 2|Lost to Follow-up|5|||
160775110|NCT03765073|580561738|FG004|Stage 2|Lost to Follow-up|1|||
160775111|NCT03765073|580561739|FG005|Stage 2|Lost to Follow-up|0|||
160775112|NCT03765073|580561740|FG006|Stage 2|Lost to Follow-up|3|||
160775113|NCT03765073|580561741|FG007|Stage 2|Lost to Follow-up|3|||
160775114|NCT03765073|580561742|FG008|Stage 2|Lost to Follow-up|1|||
160775115|NCT03765073|580561743|FG009|Stage 2|Lost to Follow-up|6|||
160775116|NCT03765073|580561744|FG010|Stage 2|Lost to Follow-up|5|||
160775117|NCT03765073|580561745|FG011|Stage 2|Lost to Follow-up|1|||
160775118|NCT03765073|580561746|FG012|Stage 2|Lost to Follow-up|1|||
160775119|NCT03765073|580561747|FG013|Stage 2|Lost to Follow-up|3|||
160775120|NCT03765073|580561748|FG014|Stage 2|Lost to Follow-up|3|||
160775121|NCT03765073|580561749|FG015|Stage 2|Lost to Follow-up|1|||
160775122|NCT03765073|580561750|FG016|Stage 2|Lost to Follow-up|6|||
160775123|NCT03765073|580561751|FG017|Stage 2|Lost to Follow-up|0|||
160775124|NCT03765073|580561752|FG018|Stage 2|Lost to Follow-up|0|||
160775125|NCT03765073|580561753|FG019|Stage 2|Lost to Follow-up|0|||
160775126|NCT03765073|580561754|FG020|Stage 2|Lost to Follow-up|0|||
160775127|NCT03765073|580561734|FG000|Stage 2|Other|0|||
160775128|NCT03765073|580561735|FG001|Stage 2|Other|0|||
160775129|NCT03765073|580561736|FG002|Stage 2|Other|0|||
160775130|NCT03765073|580561737|FG003|Stage 2|Other|0|||
160775131|NCT03765073|580561738|FG004|Stage 2|Other|0|||
160775132|NCT03765073|580561739|FG005|Stage 2|Other|0|||
160775133|NCT03765073|580561740|FG006|Stage 2|Other|0|||
160775134|NCT03765073|580561741|FG007|Stage 2|Other|1|||
160775135|NCT03765073|580561742|FG008|Stage 2|Other|1|||
160775136|NCT03765073|580561743|FG009|Stage 2|Other|3|||
160775137|NCT03765073|580561744|FG010|Stage 2|Other|0|||
160775138|NCT03765073|580561745|FG011|Stage 2|Other|0|||
160775139|NCT03765073|580561746|FG012|Stage 2|Other|0|||
160775140|NCT03765073|580561747|FG013|Stage 2|Other|0|||
160886246|NCT02119676|580978301|FG003|Overall Study|Did not receive study med|5|||
160886247|NCT00219544|580978302|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
160886248|NCT00219544|580978303|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
160886249|NCT00219544|580978302|FG000|Single Blind Treatment Period|Adverse Event|9|||
160886250|NCT00219544|580978303|FG001|Single Blind Treatment Period|Adverse Event|0|||
160886251|NCT00219544|580978302|FG000|Single Blind Treatment Period|Protocol Violation|4|||
160886252|NCT00219544|580978303|FG001|Single Blind Treatment Period|Protocol Violation|0|||
160886253|NCT00219544|580978302|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
160886254|NCT00219544|580978303|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
160886255|NCT00219544|580978302|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
160886256|NCT00219544|580978303|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
160886257|NCT00219544|580978302|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
160886258|NCT00219544|580978303|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
160886259|NCT00989573|580978304|FG000|Overall Study|Adverse Event|8|||
160886260|NCT00989573|580978305|FG001|Overall Study|Adverse Event|12|||
160886261|NCT00989573|580978306|FG002|Overall Study|Adverse Event|4|||
160886262|NCT00989573|580978304|FG000|Overall Study|Physician Decision|0|||
160886263|NCT00989573|580978305|FG001|Overall Study|Physician Decision|2|||
160886264|NCT00989573|580978306|FG002|Overall Study|Physician Decision|0|||
160886265|NCT00989573|580978304|FG000|Overall Study|Protocol Violation|1|||
160886266|NCT00989573|580978305|FG001|Overall Study|Protocol Violation|1|||
160886267|NCT00989573|580978306|FG002|Overall Study|Protocol Violation|1|||
160886268|NCT00989573|580978304|FG000|Overall Study|Withdrawal by Subject|4|||
160886269|NCT00989573|580978305|FG001|Overall Study|Withdrawal by Subject|7|||
160886270|NCT00989573|580978306|FG002|Overall Study|Withdrawal by Subject|3|||
160886271|NCT01445886|580978308|FG000|Overall Study|Lost to Follow-up|2|||
160886272|NCT01445886|580978308|FG000|Overall Study|Protocol Violation|3|||
160886273|NCT03473548|580978309|FG000|Overall Study|Did not attempt HST testing|3|||
160886274|NCT03473548|580978310|FG001|Overall Study|Did not attempt HST testing|0|||
160886275|NCT05856760|580978321|FG000|Overall Study|Adverse Event|2|||
160886276|NCT05856760|580978321|FG000|Overall Study|Physician Decision|1|||
160886277|NCT05856760|580978321|FG000|Overall Study|Protocol Violation|1|||
160886278|NCT05856760|580978321|FG000|Overall Study|Withdrawal by Subject|3|||
160886279|NCT04035486|580978322|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
160886280|NCT04035486|580978323|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
160886281|NCT04035486|580978324|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
160886282|NCT04035486|580978325|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
160886283|NCT04035486|580978322|FG000|Overall Study|Death|6|||
160886284|NCT04035486|580978323|FG001|Overall Study|Death|3|||
160886285|NCT04035486|580978324|FG002|Overall Study|Death|70|||
160886286|NCT04035486|580978325|FG003|Overall Study|Death|77|||
160886287|NCT04035486|580978322|FG000|Overall Study|Screen Failure|0|||
160886288|NCT04035486|580978323|FG001|Overall Study|Screen Failure|0|||
160886289|NCT04035486|580978324|FG002|Overall Study|Screen Failure|1|||
160886290|NCT04035486|580978325|FG003|Overall Study|Screen Failure|1|||
160886291|NCT04035486|580978322|FG000|Overall Study|Withdrawal by Subject|1|||
160886292|NCT04035486|580978323|FG001|Overall Study|Withdrawal by Subject|1|||
160886293|NCT04035486|580978324|FG002|Overall Study|Withdrawal by Subject|11|||
160886294|NCT04035486|580978325|FG003|Overall Study|Withdrawal by Subject|9|||
160886295|NCT03875235|580978328|FG000|Overall Study|Ongoing study treatment|63|||
160886296|NCT03875235|580978329|FG001|Overall Study|Ongoing study treatment|20|||
160886297|NCT03875235|580978328|FG000|Overall Study|Off treatment|77|||
160886298|NCT03875235|580978329|FG001|Overall Study|Off treatment|91|||
160886299|NCT03875235|580978328|FG000|Overall Study|Withdrawal by Subject|3|||
160886300|NCT03875235|580978329|FG001|Overall Study|Withdrawal by Subject|10|||
160886301|NCT03875235|580978328|FG000|Overall Study|Death|198|||
160886302|NCT03875235|580978329|FG001|Overall Study|Death|223|||
160886303|NCT04268823|580978341|FG000|Overall Study|Adverse Event|1|||
160886304|NCT04268823|580978342|FG001|Overall Study|Adverse Event|0|||
160886305|NCT04268823|580978341|FG000|Overall Study|Participant Decision|1|||
160886306|NCT04268823|580978342|FG001|Overall Study|Participant Decision|0|||
160886307|NCT04078178|580979247|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
160886308|NCT04078178|580979248|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
160886309|NCT04078178|580979247|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
160886310|NCT04078178|580979248|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
160886311|NCT04078178|580979247|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
160886312|NCT04078178|580979248|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
160886313|NCT04078178|580979247|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
160886314|NCT04078178|580979248|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
160886315|NCT04078178|580979247|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
160886316|NCT04078178|580979248|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
160886317|NCT05710185|580979249|FG000|Overall Study|Adverse Event|1|||
160886318|NCT05710185|580979249|FG000|Overall Study|Lack of Efficacy|1|||
160886319|NCT02186301|580979254|FG000|Overall Study|Progressive Disease|7|||
160886320|NCT02186301|580979255|FG001|Overall Study|Progressive Disease|22|||
160775141|NCT03765073|580561748|FG014|Stage 2|Other|0|||
160775142|NCT03765073|580561749|FG015|Stage 2|Other|1|||
160775143|NCT03765073|580561750|FG016|Stage 2|Other|2|||
160775144|NCT03765073|580561751|FG017|Stage 2|Other|0|||
160775145|NCT03765073|580561752|FG018|Stage 2|Other|0|||
160775146|NCT03765073|580561753|FG019|Stage 2|Other|0|||
160775147|NCT03765073|580561754|FG020|Stage 2|Other|0|||
160775148|NCT03765073|580561734|FG000|Stage 2|Withdrawal by parent/guardian|0|||
160775149|NCT03765073|580561735|FG001|Stage 2|Withdrawal by parent/guardian|0|||
160775150|NCT03765073|580561736|FG002|Stage 2|Withdrawal by parent/guardian|0|||
160775151|NCT03765073|580561737|FG003|Stage 2|Withdrawal by parent/guardian|0|||
160775152|NCT03765073|580561738|FG004|Stage 2|Withdrawal by parent/guardian|0|||
160775153|NCT03765073|580561739|FG005|Stage 2|Withdrawal by parent/guardian|0|||
160775154|NCT03765073|580561740|FG006|Stage 2|Withdrawal by parent/guardian|0|||
160775155|NCT03765073|580561741|FG007|Stage 2|Withdrawal by parent/guardian|0|||
160775156|NCT03765073|580561742|FG008|Stage 2|Withdrawal by parent/guardian|0|||
160775157|NCT03765073|580561743|FG009|Stage 2|Withdrawal by parent/guardian|0|||
160775158|NCT03765073|580561744|FG010|Stage 2|Withdrawal by parent/guardian|3|||
160775159|NCT03765073|580561745|FG011|Stage 2|Withdrawal by parent/guardian|3|||
160775160|NCT03765073|580561746|FG012|Stage 2|Withdrawal by parent/guardian|3|||
160775161|NCT03765073|580561747|FG013|Stage 2|Withdrawal by parent/guardian|1|||
160775162|NCT03765073|580561748|FG014|Stage 2|Withdrawal by parent/guardian|1|||
160775163|NCT03765073|580561749|FG015|Stage 2|Withdrawal by parent/guardian|0|||
160775164|NCT03765073|580561750|FG016|Stage 2|Withdrawal by parent/guardian|3|||
160775165|NCT03765073|580561751|FG017|Stage 2|Withdrawal by parent/guardian|0|||
160775166|NCT03765073|580561752|FG018|Stage 2|Withdrawal by parent/guardian|0|||
160775167|NCT03765073|580561753|FG019|Stage 2|Withdrawal by parent/guardian|0|||
160775168|NCT03765073|580561754|FG020|Stage 2|Withdrawal by parent/guardian|0|||
160775169|NCT03765073|580561734|FG000|Stage 2|Withdrawal by Subject|0|||
160775170|NCT03765073|580561735|FG001|Stage 2|Withdrawal by Subject|0|||
160775171|NCT03765073|580561736|FG002|Stage 2|Withdrawal by Subject|0|||
160775172|NCT03765073|580561737|FG003|Stage 2|Withdrawal by Subject|3|||
160775173|NCT03765073|580561738|FG004|Stage 2|Withdrawal by Subject|3|||
160775174|NCT03765073|580561739|FG005|Stage 2|Withdrawal by Subject|3|||
160775175|NCT03765073|580561740|FG006|Stage 2|Withdrawal by Subject|0|||
160775176|NCT03765073|580561741|FG007|Stage 2|Withdrawal by Subject|1|||
160775177|NCT03765073|580561742|FG008|Stage 2|Withdrawal by Subject|0|||
160775178|NCT03765073|580561743|FG009|Stage 2|Withdrawal by Subject|5|||
160775179|NCT03765073|580561744|FG010|Stage 2|Withdrawal by Subject|0|||
160775180|NCT03765073|580561745|FG011|Stage 2|Withdrawal by Subject|0|||
160775181|NCT03765073|580561746|FG012|Stage 2|Withdrawal by Subject|0|||
160775182|NCT03765073|580561747|FG013|Stage 2|Withdrawal by Subject|0|||
160775183|NCT03765073|580561748|FG014|Stage 2|Withdrawal by Subject|0|||
160775184|NCT03765073|580561749|FG015|Stage 2|Withdrawal by Subject|0|||
160775185|NCT03765073|580561750|FG016|Stage 2|Withdrawal by Subject|0|||
160775186|NCT03765073|580561751|FG017|Stage 2|Withdrawal by Subject|0|||
160775187|NCT03765073|580561752|FG018|Stage 2|Withdrawal by Subject|0|||
160775188|NCT03765073|580561753|FG019|Stage 2|Withdrawal by Subject|0|||
160775189|NCT03765073|580561754|FG020|Stage 2|Withdrawal by Subject|0|||
160775190|NCT03765073|580561734|FG000|Stage 3|Adverse Event|0|||
160775191|NCT03765073|580561735|FG001|Stage 3|Adverse Event|0|||
160775192|NCT03765073|580561736|FG002|Stage 3|Adverse Event|0|||
160886321|NCT02186301|580979256|FG002|Overall Study|Progressive Disease|27|||
160775193|NCT03765073|580561737|FG003|Stage 3|Adverse Event|0|||
160775194|NCT03765073|580561738|FG004|Stage 3|Adverse Event|0|||
160886322|NCT02186301|580979254|FG000|Overall Study|Adverse Event|5|||
160637916|NCT01155284|580057986|FG000|Overall Study|Physician Decision|1|||
160637917|NCT01155284|580057987|FG001|Overall Study|Physician Decision|0|||
160637918|NCT01155284|580057986|FG000|Overall Study|Adverse Event|1|||
160637919|NCT01155284|580057987|FG001|Overall Study|Adverse Event|0|||
160637920|NCT01896700|580057988|FG000|Overall Study|Adverse Event|4|||
160637921|NCT01896700|580057989|FG001|Overall Study|Adverse Event|5|||
160637922|NCT01896700|580057988|FG000|Overall Study|Withdrawal by Subject|0|||
160637923|NCT01896700|580057989|FG001|Overall Study|Withdrawal by Subject|1|||
160637924|NCT00123487|580057990|FG000|Randomized|Death prior to starting treatment|0|||
160637925|NCT00123487|580057991|FG001|Randomized|Death prior to starting treatment|1|||
160637926|NCT00123487|580057990|FG000|Randomized|SAE prior to starting treatment|1|||
160637927|NCT00123487|580057991|FG001|Randomized|SAE prior to starting treatment|0|||
160637928|NCT00123487|580057990|FG000|Treated With Study Drug|Adverse Event|23|||
160637929|NCT00123487|580057991|FG001|Treated With Study Drug|Adverse Event|22|||
160637930|NCT00123487|580057990|FG000|Treated With Study Drug|Disease Progression|141|||
160775195|NCT03765073|580561739|FG005|Stage 3|Adverse Event|0|||
160775196|NCT03765073|580561740|FG006|Stage 3|Adverse Event|0|||
160775197|NCT03765073|580561741|FG007|Stage 3|Adverse Event|0|||
160775198|NCT03765073|580561742|FG008|Stage 3|Adverse Event|0|||
160775199|NCT03765073|580561743|FG009|Stage 3|Adverse Event|0|||
160775200|NCT03765073|580561744|FG010|Stage 3|Adverse Event|0|||
160775201|NCT03765073|580561745|FG011|Stage 3|Adverse Event|0|||
160775202|NCT03765073|580561746|FG012|Stage 3|Adverse Event|0|||
160775203|NCT03765073|580561747|FG013|Stage 3|Adverse Event|0|||
160775204|NCT03765073|580561748|FG014|Stage 3|Adverse Event|0|||
160775205|NCT03765073|580561749|FG015|Stage 3|Adverse Event|0|||
160775206|NCT03765073|580561750|FG016|Stage 3|Adverse Event|0|||
160775207|NCT03765073|580561751|FG017|Stage 3|Adverse Event|0|||
160775208|NCT03765073|580561752|FG018|Stage 3|Adverse Event|1|||
160775209|NCT03765073|580561753|FG019|Stage 3|Adverse Event|0|||
160775210|NCT03765073|580561754|FG020|Stage 3|Adverse Event|0|||
160775211|NCT03765073|580561734|FG000|Stage 3|Death|0|||
160775212|NCT03765073|580561735|FG001|Stage 3|Death|0|||
160775213|NCT03765073|580561736|FG002|Stage 3|Death|0|||
160775214|NCT03765073|580561737|FG003|Stage 3|Death|0|||
160775215|NCT03765073|580561738|FG004|Stage 3|Death|0|||
160775216|NCT03765073|580561739|FG005|Stage 3|Death|0|||
160775217|NCT03765073|580561740|FG006|Stage 3|Death|0|||
160775218|NCT03765073|580561741|FG007|Stage 3|Death|0|||
160775219|NCT03765073|580561742|FG008|Stage 3|Death|0|||
160775220|NCT03765073|580561743|FG009|Stage 3|Death|0|||
160775221|NCT03765073|580561744|FG010|Stage 3|Death|0|||
160775222|NCT03765073|580561745|FG011|Stage 3|Death|0|||
160775223|NCT03765073|580561746|FG012|Stage 3|Death|0|||
160775224|NCT03765073|580561747|FG013|Stage 3|Death|0|||
160775225|NCT03765073|580561748|FG014|Stage 3|Death|0|||
160775226|NCT03765073|580561749|FG015|Stage 3|Death|0|||
160775227|NCT03765073|580561750|FG016|Stage 3|Death|0|||
160775228|NCT03765073|580561751|FG017|Stage 3|Death|0|||
160775229|NCT03765073|580561752|FG018|Stage 3|Death|0|||
160775230|NCT03765073|580561753|FG019|Stage 3|Death|3|||
160775231|NCT03765073|580561754|FG020|Stage 3|Death|2|||
160775232|NCT03765073|580561734|FG000|Stage 3|Lost to Follow-up|0|||
160775233|NCT03765073|580561735|FG001|Stage 3|Lost to Follow-up|0|||
160775234|NCT03765073|580561736|FG002|Stage 3|Lost to Follow-up|0|||
160775235|NCT03765073|580561737|FG003|Stage 3|Lost to Follow-up|0|||
160775236|NCT03765073|580561738|FG004|Stage 3|Lost to Follow-up|0|||
160775237|NCT03765073|580561739|FG005|Stage 3|Lost to Follow-up|0|||
160775238|NCT03765073|580561740|FG006|Stage 3|Lost to Follow-up|0|||
160775239|NCT03765073|580561741|FG007|Stage 3|Lost to Follow-up|0|||
160775240|NCT03765073|580561742|FG008|Stage 3|Lost to Follow-up|0|||
160775241|NCT03765073|580561743|FG009|Stage 3|Lost to Follow-up|0|||
160775242|NCT03765073|580561744|FG010|Stage 3|Lost to Follow-up|0|||
160775243|NCT03765073|580561745|FG011|Stage 3|Lost to Follow-up|0|||
160775244|NCT03765073|580561746|FG012|Stage 3|Lost to Follow-up|0|||
160775245|NCT03765073|580561747|FG013|Stage 3|Lost to Follow-up|0|||
160775246|NCT03765073|580561748|FG014|Stage 3|Lost to Follow-up|0|||
160775247|NCT03765073|580561749|FG015|Stage 3|Lost to Follow-up|0|||
160775248|NCT03765073|580561750|FG016|Stage 3|Lost to Follow-up|0|||
160775249|NCT03765073|580561751|FG017|Stage 3|Lost to Follow-up|8|||
160775250|NCT03765073|580561752|FG018|Stage 3|Lost to Follow-up|5|||
160775251|NCT03765073|580561753|FG019|Stage 3|Lost to Follow-up|7|||
160775252|NCT03765073|580561754|FG020|Stage 3|Lost to Follow-up|4|||
160775253|NCT03765073|580561734|FG000|Stage 3|No longer meets eligibility criteria|0|||
160775254|NCT03765073|580561735|FG001|Stage 3|No longer meets eligibility criteria|0|||
160775255|NCT03765073|580561736|FG002|Stage 3|No longer meets eligibility criteria|0|||
160775256|NCT03765073|580561737|FG003|Stage 3|No longer meets eligibility criteria|0|||
160775257|NCT03765073|580561738|FG004|Stage 3|No longer meets eligibility criteria|0|||
160775258|NCT03765073|580561739|FG005|Stage 3|No longer meets eligibility criteria|0|||
160775259|NCT03765073|580561740|FG006|Stage 3|No longer meets eligibility criteria|0|||
160775260|NCT03765073|580561741|FG007|Stage 3|No longer meets eligibility criteria|0|||
160775261|NCT03765073|580561742|FG008|Stage 3|No longer meets eligibility criteria|0|||
160775262|NCT03765073|580561743|FG009|Stage 3|No longer meets eligibility criteria|0|||
160775263|NCT03765073|580561744|FG010|Stage 3|No longer meets eligibility criteria|0|||
160775264|NCT03765073|580561745|FG011|Stage 3|No longer meets eligibility criteria|0|||
160775265|NCT03765073|580561746|FG012|Stage 3|No longer meets eligibility criteria|0|||
160775266|NCT03765073|580561747|FG013|Stage 3|No longer meets eligibility criteria|0|||
160775267|NCT03765073|580561748|FG014|Stage 3|No longer meets eligibility criteria|0|||
160775268|NCT03765073|580561749|FG015|Stage 3|No longer meets eligibility criteria|0|||
160775269|NCT03765073|580561750|FG016|Stage 3|No longer meets eligibility criteria|0|||
160775270|NCT03765073|580561751|FG017|Stage 3|No longer meets eligibility criteria|0|||
160775271|NCT03765073|580561752|FG018|Stage 3|No longer meets eligibility criteria|1|||
160775272|NCT03765073|580561753|FG019|Stage 3|No longer meets eligibility criteria|0|||
160775273|NCT03765073|580561754|FG020|Stage 3|No longer meets eligibility criteria|1|||
160775274|NCT03765073|580561734|FG000|Stage 3|Other|0|||
160775275|NCT03765073|580561735|FG001|Stage 3|Other|0|||
160775276|NCT03765073|580561736|FG002|Stage 3|Other|0|||
160775277|NCT03765073|580561737|FG003|Stage 3|Other|0|||
160775278|NCT03765073|580561738|FG004|Stage 3|Other|0|||
160775279|NCT03765073|580561739|FG005|Stage 3|Other|0|||
160775280|NCT03765073|580561740|FG006|Stage 3|Other|0|||
160775281|NCT03765073|580561741|FG007|Stage 3|Other|0|||
160775282|NCT03765073|580561742|FG008|Stage 3|Other|0|||
160775283|NCT03765073|580561743|FG009|Stage 3|Other|0|||
160775284|NCT03765073|580561744|FG010|Stage 3|Other|0|||
160775285|NCT03765073|580561745|FG011|Stage 3|Other|0|||
160541125|NCT05121480|579711163|FG001|Overall Study|Lost to Follow-up|4|||
160541126|NCT05121480|579711164|FG002|Overall Study|Lost to Follow-up|1|||
160541127|NCT05121480|579711165|FG003|Overall Study|Lost to Follow-up|3|||
160541128|NCT05121480|579711166|FG004|Overall Study|Lost to Follow-up|1|||
160541129|NCT05121480|579711167|FG005|Overall Study|Lost to Follow-up|1|||
160541130|NCT05121480|579711168|FG006|Overall Study|Lost to Follow-up|1|||
160541131|NCT05121480|579711169|FG007|Overall Study|Lost to Follow-up|4|||
160541132|NCT05121480|579711162|FG000|Overall Study|Physician Decision|0|||
160541133|NCT05121480|579711163|FG001|Overall Study|Physician Decision|0|||
160541134|NCT05121480|579711164|FG002|Overall Study|Physician Decision|0|||
160541135|NCT05121480|579711165|FG003|Overall Study|Physician Decision|0|||
160541136|NCT05121480|579711166|FG004|Overall Study|Physician Decision|0|||
160541137|NCT05121480|579711167|FG005|Overall Study|Physician Decision|1|||
160541138|NCT05121480|579711168|FG006|Overall Study|Physician Decision|0|||
160541139|NCT05121480|579711169|FG007|Overall Study|Physician Decision|1|||
160541140|NCT05121480|579711162|FG000|Overall Study|Other Reason|0|||
160541141|NCT05121480|579711163|FG001|Overall Study|Other Reason|0|||
160541142|NCT05121480|579711164|FG002|Overall Study|Other Reason|0|||
160541143|NCT05121480|579711165|FG003|Overall Study|Other Reason|0|||
160541144|NCT05121480|579711166|FG004|Overall Study|Other Reason|0|||
160541145|NCT05121480|579711167|FG005|Overall Study|Other Reason|1|||
160541146|NCT05121480|579711168|FG006|Overall Study|Other Reason|1|||
160541147|NCT05121480|579711169|FG007|Overall Study|Other Reason|1|||
160541148|NCT02831673|579711170|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
160541149|NCT02831673|579711171|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
160541150|NCT02831673|579711172|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
160541151|NCT02831673|579711173|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
160541152|NCT02831673|579711174|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
160541153|NCT02831673|579711170|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
160541154|NCT02831673|579711171|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
160541155|NCT02831673|579711172|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
160541156|NCT02831673|579711173|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
160541157|NCT02831673|579711174|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
160541158|NCT02831673|579711170|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
160541159|NCT02831673|579711171|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
160541160|NCT02831673|579711172|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
160541161|NCT02831673|579711173|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
160541162|NCT02831673|579711174|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
160541163|NCT02831673|579711170|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
160541164|NCT02831673|579711171|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
160541165|NCT02831673|579711172|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
160541166|NCT02831673|579711173|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
160541167|NCT02831673|579711174|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
160541168|NCT02831673|579711170|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
160541169|NCT02831673|579711171|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
160541170|NCT02831673|579711172|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
160541171|NCT02831673|579711173|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
160541172|NCT02831673|579711174|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
160541173|NCT02831673|579711170|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
160541174|NCT02831673|579711171|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
160541175|NCT02831673|579711172|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
160541176|NCT02831673|579711173|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
160541177|NCT02831673|579711174|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
160541178|NCT02831673|579711170|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
160541179|NCT02831673|579711171|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
160541180|NCT02831673|579711172|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
160541181|NCT02831673|579711173|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
160541182|NCT02831673|579711174|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
160541183|NCT02831673|579711170|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
160541184|NCT02831673|579711171|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
160541185|NCT02831673|579711172|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
160541186|NCT02831673|579711173|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
160541187|NCT02831673|579711174|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
160541188|NCT02831673|579711170|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
160541189|NCT02831673|579711171|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
160541190|NCT02831673|579711172|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
160541191|NCT02831673|579711173|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
160541192|NCT02831673|579711174|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
160541193|NCT02831673|579711170|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160775286|NCT03765073|580561746|FG012|Stage 3|Other|0|||
160775287|NCT03765073|580561747|FG013|Stage 3|Other|0|||
160775288|NCT03765073|580561748|FG014|Stage 3|Other|0|||
160775289|NCT03765073|580561749|FG015|Stage 3|Other|0|||
160775290|NCT03765073|580561750|FG016|Stage 3|Other|0|||
160775291|NCT03765073|580561751|FG017|Stage 3|Other|1|||
160775292|NCT03765073|580561752|FG018|Stage 3|Other|2|||
160775293|NCT03765073|580561753|FG019|Stage 3|Other|2|||
160775294|NCT03765073|580561754|FG020|Stage 3|Other|2|||
160775295|NCT03765073|580561734|FG000|Stage 3|Withdrawal by parent/guardian|0|||
160775296|NCT03765073|580561735|FG001|Stage 3|Withdrawal by parent/guardian|0|||
160775297|NCT03765073|580561736|FG002|Stage 3|Withdrawal by parent/guardian|0|||
160775298|NCT03765073|580561737|FG003|Stage 3|Withdrawal by parent/guardian|0|||
160775299|NCT03765073|580561738|FG004|Stage 3|Withdrawal by parent/guardian|0|||
160775300|NCT03765073|580561739|FG005|Stage 3|Withdrawal by parent/guardian|0|||
160775301|NCT03765073|580561740|FG006|Stage 3|Withdrawal by parent/guardian|0|||
160775302|NCT03765073|580561741|FG007|Stage 3|Withdrawal by parent/guardian|0|||
160775303|NCT03765073|580561742|FG008|Stage 3|Withdrawal by parent/guardian|0|||
160775304|NCT03765073|580561743|FG009|Stage 3|Withdrawal by parent/guardian|0|||
160775305|NCT03765073|580561744|FG010|Stage 3|Withdrawal by parent/guardian|0|||
160775306|NCT03765073|580561745|FG011|Stage 3|Withdrawal by parent/guardian|0|||
160775307|NCT03765073|580561746|FG012|Stage 3|Withdrawal by parent/guardian|0|||
160775308|NCT03765073|580561747|FG013|Stage 3|Withdrawal by parent/guardian|0|||
160775309|NCT03765073|580561748|FG014|Stage 3|Withdrawal by parent/guardian|0|||
160775310|NCT03765073|580561749|FG015|Stage 3|Withdrawal by parent/guardian|0|||
160775311|NCT03765073|580561750|FG016|Stage 3|Withdrawal by parent/guardian|0|||
160775312|NCT03765073|580561751|FG017|Stage 3|Withdrawal by parent/guardian|0|||
160775313|NCT03765073|580561752|FG018|Stage 3|Withdrawal by parent/guardian|0|||
160775314|NCT03765073|580561753|FG019|Stage 3|Withdrawal by parent/guardian|6|||
160775315|NCT03765073|580561754|FG020|Stage 3|Withdrawal by parent/guardian|9|||
160775316|NCT03765073|580561734|FG000|Stage 3|Withdrawal by Subject|0|||
160775317|NCT03765073|580561735|FG001|Stage 3|Withdrawal by Subject|0|||
160775318|NCT03765073|580561736|FG002|Stage 3|Withdrawal by Subject|0|||
160775319|NCT03765073|580561737|FG003|Stage 3|Withdrawal by Subject|0|||
160775320|NCT03765073|580561738|FG004|Stage 3|Withdrawal by Subject|0|||
160775321|NCT03765073|580561739|FG005|Stage 3|Withdrawal by Subject|0|||
160775322|NCT03765073|580561740|FG006|Stage 3|Withdrawal by Subject|0|||
160775323|NCT03765073|580561741|FG007|Stage 3|Withdrawal by Subject|0|||
160775324|NCT03765073|580561742|FG008|Stage 3|Withdrawal by Subject|0|||
160775325|NCT03765073|580561743|FG009|Stage 3|Withdrawal by Subject|0|||
160775326|NCT03765073|580561744|FG010|Stage 3|Withdrawal by Subject|0|||
160775327|NCT03765073|580561745|FG011|Stage 3|Withdrawal by Subject|0|||
160775328|NCT03765073|580561746|FG012|Stage 3|Withdrawal by Subject|0|||
160775329|NCT03765073|580561747|FG013|Stage 3|Withdrawal by Subject|0|||
160775330|NCT03765073|580561748|FG014|Stage 3|Withdrawal by Subject|0|||
160775331|NCT03765073|580561749|FG015|Stage 3|Withdrawal by Subject|0|||
160775332|NCT03765073|580561750|FG016|Stage 3|Withdrawal by Subject|0|||
160775333|NCT03765073|580561751|FG017|Stage 3|Withdrawal by Subject|8|||
160775334|NCT03765073|580561752|FG018|Stage 3|Withdrawal by Subject|11|||
160775335|NCT03765073|580561753|FG019|Stage 3|Withdrawal by Subject|0|||
160775336|NCT03765073|580561754|FG020|Stage 3|Withdrawal by Subject|0|||
160775337|NCT00580840|580561758|FG000|Run-in|Adverse Event|17|||
160775338|NCT00580840|580561759|FG001|Run-in|Adverse Event|0|||
160775339|NCT00580840|580561760|FG002|Run-in|Adverse Event|0|||
160775340|NCT00580840|580561761|FG003|Run-in|Adverse Event|0|||
160886323|NCT02186301|580979255|FG001|Overall Study|Adverse Event|5|||
160886324|NCT02186301|580979256|FG002|Overall Study|Adverse Event|5|||
160886325|NCT02186301|580979254|FG000|Overall Study|Death|1|||
160886326|NCT02186301|580979255|FG001|Overall Study|Death|0|||
160886327|NCT02186301|580979256|FG002|Overall Study|Death|0|||
160886328|NCT02186301|580979254|FG000|Overall Study|Withdrawal by Subject|5|||
160775341|NCT00580840|580561758|FG000|Run-in|Lack of Efficacy|93|||
160775342|NCT00580840|580561759|FG001|Run-in|Lack of Efficacy|0|||
160775343|NCT00580840|580561760|FG002|Run-in|Lack of Efficacy|0|||
160775344|NCT00580840|580561761|FG003|Run-in|Lack of Efficacy|0|||
160775345|NCT00580840|580561758|FG000|Run-in|Loss of Efficacy|1|||
160886329|NCT02186301|580979255|FG001|Overall Study|Withdrawal by Subject|1|||
160886330|NCT02186301|580979256|FG002|Overall Study|Withdrawal by Subject|3|||
160775346|NCT00580840|580561759|FG001|Run-in|Loss of Efficacy|0|||
160775347|NCT00580840|580561760|FG002|Run-in|Loss of Efficacy|0|||
160775348|NCT00580840|580561761|FG003|Run-in|Loss of Efficacy|0|||
160775349|NCT00580840|580561758|FG000|Run-in|Lost to Follow-up|4|||
160775350|NCT00580840|580561759|FG001|Run-in|Lost to Follow-up|0|||
160775351|NCT00580840|580561760|FG002|Run-in|Lost to Follow-up|0|||
160775352|NCT00580840|580561761|FG003|Run-in|Lost to Follow-up|0|||
160775353|NCT00580840|580561758|FG000|Run-in|Withdrawal by Subject|5|||
160775354|NCT00580840|580561759|FG001|Run-in|Withdrawal by Subject|0|||
160775355|NCT00580840|580561760|FG002|Run-in|Withdrawal by Subject|0|||
160775356|NCT00580840|580561761|FG003|Run-in|Withdrawal by Subject|0|||
160775357|NCT00580840|580561758|FG000|Run-in|Other: Per Sponsor Request|2|||
160775358|NCT00580840|580561759|FG001|Run-in|Other: Per Sponsor Request|0|||
160775359|NCT00580840|580561760|FG002|Run-in|Other: Per Sponsor Request|0|||
160775360|NCT00580840|580561761|FG003|Run-in|Other: Per Sponsor Request|0|||
160886331|NCT02186301|580979254|FG000|Overall Study|Physician Decision|1|||
160886332|NCT02186301|580979255|FG001|Overall Study|Physician Decision|0|||
160886333|NCT02186301|580979256|FG002|Overall Study|Physician Decision|1|||
160886334|NCT02186301|580979254|FG000|Overall Study|Study Terminated by Sponsor|1|||
160886335|NCT02186301|580979255|FG001|Overall Study|Study Terminated by Sponsor|0|||
160886336|NCT02186301|580979256|FG002|Overall Study|Study Terminated by Sponsor|11|||
160886337|NCT02186301|580979254|FG000|Overall Study|Protocol Deviation|0|||
160886338|NCT02186301|580979255|FG001|Overall Study|Protocol Deviation|2|||
160886339|NCT02186301|580979256|FG002|Overall Study|Protocol Deviation|0|||
160886340|NCT02186301|580979254|FG000|Overall Study|Missing|0|||
160886341|NCT02186301|580979255|FG001|Overall Study|Missing|0|||
160886342|NCT02186301|580979256|FG002|Overall Study|Missing|2|||
160886343|NCT02186301|580979254|FG000|Overall Study|Other|0|||
160886344|NCT02186301|580979255|FG001|Overall Study|Other|0|||
160886345|NCT02186301|580979256|FG002|Overall Study|Other|1|||
160886346|NCT01343823|580979257|FG000|Overall Study|Study Terminated|1|||
160886347|NCT01343823|580979258|FG001|Overall Study|Study Terminated|0|||
160886348|NCT01343823|580979259|FG002|Overall Study|Study Terminated|0|||
160886349|NCT01343823|580979260|FG003|Overall Study|Study Terminated|1|||
160886350|NCT01343823|580979257|FG000|Overall Study|Withdrawal by Subject|1|||
160886351|NCT01343823|580979258|FG001|Overall Study|Withdrawal by Subject|0|||
160886352|NCT01343823|580979259|FG002|Overall Study|Withdrawal by Subject|0|||
160886353|NCT01343823|580979260|FG003|Overall Study|Withdrawal by Subject|0|||
160886354|NCT01117792|580979263|FG000|Overall Study|Death|1|||
160886355|NCT01117792|580979263|FG000|Overall Study|Adverse Event|3|||
160886356|NCT05867342|580979264|FG000|Overall Study|Investigator Decision|3|||
160886357|NCT05867342|580979265|FG001|Overall Study|Investigator Decision|3|||
160886358|NCT00723203|580979266|FG000|Overall Study|Withdrawal by Subject|3|||
160886359|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
160886360|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
160886361|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
160886362|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
160886363|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
160886364|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
160886365|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
160886366|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
160886367|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
160886368|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
160886369|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
160886370|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
160886371|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
160886372|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
160886373|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
160886374|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
160886375|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
160886376|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
160886377|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
160886378|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
160886379|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
160886380|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
160886381|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
160886382|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
160886383|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
160886384|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
160886385|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
160886386|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
160886387|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
160886388|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
160886389|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
160886390|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
160886391|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
160886392|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
160886393|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
160886394|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
160886395|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
160886396|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
160886397|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
160886398|NCT01903525|580979272|FG000|Overall Study|Lost to Follow-up|5|||
160886399|NCT01903525|580979273|FG001|Overall Study|Lost to Follow-up|9|||
160886400|NCT01903525|580979272|FG000|Overall Study|Adverse Event|0|||
160886401|NCT01903525|580979273|FG001|Overall Study|Adverse Event|1|||
160886402|NCT01673282|580979275|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
160886403|NCT01673282|580979276|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
160775361|NCT00580840|580561758|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
160775362|NCT00580840|580561759|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
160775363|NCT00580840|580561760|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
160775364|NCT00580840|580561761|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
160775365|NCT00580840|580561758|FG000|Run-in|Other: Exclusionary Lab Value|1|||
160775366|NCT00580840|580561759|FG001|Run-in|Other: Exclusionary Lab Value|0|||
160775367|NCT00580840|580561760|FG002|Run-in|Other: Exclusionary Lab Value|0|||
160775368|NCT00580840|580561761|FG003|Run-in|Other: Exclusionary Lab Value|0|||
160775369|NCT00580840|580561758|FG000|Double-Blind|Adverse Event|0|||
160775370|NCT00580840|580561759|FG001|Double-Blind|Adverse Event|3|||
160775371|NCT00580840|580561760|FG002|Double-Blind|Adverse Event|4|||
160775372|NCT00580840|580561761|FG003|Double-Blind|Adverse Event|1|||
160775373|NCT00580840|580561758|FG000|Double-Blind|Loss of Efficacy|0|||
160775374|NCT00580840|580561759|FG001|Double-Blind|Loss of Efficacy|1|||
160775375|NCT00580840|580561760|FG002|Double-Blind|Loss of Efficacy|2|||
160775376|NCT00580840|580561761|FG003|Double-Blind|Loss of Efficacy|10|||
160775377|NCT00580840|580561758|FG000|Double-Blind|Lost to Follow-up|0|||
160775378|NCT00580840|580561759|FG001|Double-Blind|Lost to Follow-up|1|||
160775379|NCT00580840|580561760|FG002|Double-Blind|Lost to Follow-up|0|||
160775380|NCT00580840|580561761|FG003|Double-Blind|Lost to Follow-up|2|||
160775381|NCT00580840|580561758|FG000|Double-Blind|Withdrawal by Subject|0|||
160775382|NCT00580840|580561759|FG001|Double-Blind|Withdrawal by Subject|1|||
160775383|NCT00580840|580561760|FG002|Double-Blind|Withdrawal by Subject|2|||
160775384|NCT00580840|580561761|FG003|Double-Blind|Withdrawal by Subject|2|||
160775385|NCT00580840|580561758|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
160775386|NCT00580840|580561759|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
160775387|NCT00580840|580561760|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
160775388|NCT00580840|580561761|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
160775389|NCT00580840|580561758|FG000|Double-Blind|Other: Forbidden Medication|0|||
160775390|NCT00580840|580561759|FG001|Double-Blind|Other: Forbidden Medication|0|||
160775391|NCT00580840|580561760|FG002|Double-Blind|Other: Forbidden Medication|1|||
160775392|NCT00580840|580561761|FG003|Double-Blind|Other: Forbidden Medication|0|||
160775393|NCT01910441|580561770|FG000|Overall Study|Sponsor decision|0|||
160775394|NCT01910441|580561771|FG001|Overall Study|Sponsor decision|2|||
160775395|NCT01910441|580561770|FG000|Overall Study|Lost to Follow-up|6|||
160775396|NCT01910441|580561771|FG001|Overall Study|Lost to Follow-up|5|||
160775397|NCT01910441|580561770|FG000|Overall Study|Withdrawal by Subject|0|||
160775398|NCT01910441|580561771|FG001|Overall Study|Withdrawal by Subject|1|||
160775399|NCT01910441|580561770|FG000|Overall Study|Non-compliance|0|||
160775400|NCT01910441|580561771|FG001|Overall Study|Non-compliance|1|||
160775401|NCT01910441|580561770|FG000|Overall Study|Adverse Event|1|||
160775402|NCT01910441|580561771|FG001|Overall Study|Adverse Event|0|||
160775403|NCT01910441|580561770|FG000|Overall Study|Physician Decision|0|||
160775404|NCT01910441|580561771|FG001|Overall Study|Physician Decision|1|||
160775405|NCT02964182|580561772|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
160775406|NCT02964182|580561773|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
160775407|NCT02964182|580561774|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
160775408|NCT02964182|580561775|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
160775409|NCT02964182|580561776|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
160775410|NCT02964182|580561777|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
160775411|NCT02964182|580561778|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
160775412|NCT02964182|580561779|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
160775413|NCT02964182|580561772|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
160775414|NCT02964182|580561773|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
160775415|NCT02964182|580561774|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
160775416|NCT02964182|580561775|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
160775417|NCT02964182|580561776|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
160775418|NCT02964182|580561777|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
160775419|NCT02964182|580561778|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
160775420|NCT02964182|580561779|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
160775421|NCT02964182|580561772|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
160775422|NCT02964182|580561773|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
160775423|NCT02964182|580561774|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
160775424|NCT02964182|580561775|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
160775425|NCT02964182|580561776|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
160775426|NCT02964182|580561777|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
160775427|NCT02964182|580561778|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
160775428|NCT02964182|580561779|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
160775429|NCT02964182|580561772|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
160886404|NCT01673282|580979275|FG000|Overall Study|Lack of Efficacy|9|||
160886405|NCT01673282|580979276|FG001|Overall Study|Lack of Efficacy|2|||
160886406|NCT01673282|580979275|FG000|Overall Study|Lost to Follow-up|11|||
160886407|NCT01673282|580979276|FG001|Overall Study|Lost to Follow-up|10|||
160886408|NCT01673282|580979275|FG000|Overall Study|Withdrawal by Subject|3|||
160886409|NCT01673282|580979276|FG001|Overall Study|Withdrawal by Subject|3|||
160886410|NCT01673282|580979275|FG000|Overall Study|Other|1|||
160886411|NCT01673282|580979276|FG001|Overall Study|Other|6|||
160886412|NCT04365257|580979277|FG000|Overall Study|Physician Decision|1|||
160886413|NCT04365257|580979278|FG001|Overall Study|Physician Decision|0|||
160886414|NCT04365257|580979277|FG000|Overall Study|Patient Noncompliance|1|||
160886415|NCT04365257|580979278|FG001|Overall Study|Patient Noncompliance|0|||
160886416|NCT04365257|580979277|FG000|Overall Study|Withdrawal by Subject|0|||
160886417|NCT04365257|580979278|FG001|Overall Study|Withdrawal by Subject|1|||
160886418|NCT02129777|580979283|FG000|Double-Blind Period|Adverse Event|0|||
160886419|NCT02129777|580979284|FG001|Double-Blind Period|Adverse Event|0|||
160886420|NCT02129777|580979285|FG002|Double-Blind Period|Adverse Event|0|||
160886421|NCT02129777|580979286|FG003|Double-Blind Period|Adverse Event|0|||
160886422|NCT02129777|580979287|FG004|Double-Blind Period|Adverse Event|1|||
160886423|NCT02129777|580979288|FG005|Double-Blind Period|Adverse Event|0|||
160886424|NCT02129777|580979289|FG006|Double-Blind Period|Adverse Event|0|||
160886425|NCT02129777|580979283|FG000|Double-Blind Period|Lost to Follow-up|1|||
160886426|NCT02129777|580979284|FG001|Double-Blind Period|Lost to Follow-up|1|||
160886427|NCT02129777|580979285|FG002|Double-Blind Period|Lost to Follow-up|1|||
160886428|NCT02129777|580979286|FG003|Double-Blind Period|Lost to Follow-up|2|||
160886429|NCT02129777|580979287|FG004|Double-Blind Period|Lost to Follow-up|0|||
160886430|NCT02129777|580979288|FG005|Double-Blind Period|Lost to Follow-up|0|||
160886431|NCT02129777|580979289|FG006|Double-Blind Period|Lost to Follow-up|0|||
160886432|NCT02129777|580979283|FG000|Double-Blind Period|Withdrawal by Subject|2|||
160886433|NCT02129777|580979284|FG001|Double-Blind Period|Withdrawal by Subject|4|||
160886434|NCT02129777|580979285|FG002|Double-Blind Period|Withdrawal by Subject|3|||
160886435|NCT02129777|580979286|FG003|Double-Blind Period|Withdrawal by Subject|2|||
160886436|NCT02129777|580979287|FG004|Double-Blind Period|Withdrawal by Subject|3|||
160886437|NCT02129777|580979288|FG005|Double-Blind Period|Withdrawal by Subject|0|||
160886438|NCT02129777|580979289|FG006|Double-Blind Period|Withdrawal by Subject|0|||
160886439|NCT02129777|580979283|FG000|Double-Blind Period|Pregnancy|0|||
160886440|NCT02129777|580979284|FG001|Double-Blind Period|Pregnancy|0|||
160886441|NCT02129777|580979285|FG002|Double-Blind Period|Pregnancy|0|||
160886442|NCT02129777|580979286|FG003|Double-Blind Period|Pregnancy|0|||
160886443|NCT02129777|580979287|FG004|Double-Blind Period|Pregnancy|1|||
160886444|NCT02129777|580979288|FG005|Double-Blind Period|Pregnancy|0|||
160886445|NCT02129777|580979289|FG006|Double-Blind Period|Pregnancy|0|||
160886446|NCT02129777|580979283|FG000|Double-Blind Period|Lack of Efficacy|3|||
160886447|NCT02129777|580979284|FG001|Double-Blind Period|Lack of Efficacy|1|||
160886448|NCT02129777|580979285|FG002|Double-Blind Period|Lack of Efficacy|0|||
160886449|NCT02129777|580979286|FG003|Double-Blind Period|Lack of Efficacy|3|||
160886450|NCT02129777|580979287|FG004|Double-Blind Period|Lack of Efficacy|2|||
160886451|NCT02129777|580979288|FG005|Double-Blind Period|Lack of Efficacy|0|||
160886452|NCT02129777|580979289|FG006|Double-Blind Period|Lack of Efficacy|0|||
160886453|NCT02129777|580979283|FG000|Double-Blind Period|Other|1|||
160886454|NCT02129777|580979284|FG001|Double-Blind Period|Other|2|||
160886455|NCT02129777|580979285|FG002|Double-Blind Period|Other|0|||
160886456|NCT02129777|580979286|FG003|Double-Blind Period|Other|0|||
160886457|NCT02129777|580979287|FG004|Double-Blind Period|Other|0|||
160886458|NCT02129777|580979288|FG005|Double-Blind Period|Other|0|||
160886459|NCT02129777|580979289|FG006|Double-Blind Period|Other|0|||
160886460|NCT02129777|580979283|FG000|Open-Label Period|Lack of Efficacy|0|||
160886461|NCT02129777|580979284|FG001|Open-Label Period|Lack of Efficacy|0|||
160886462|NCT02129777|580979285|FG002|Open-Label Period|Lack of Efficacy|0|||
160886463|NCT02129777|580979286|FG003|Open-Label Period|Lack of Efficacy|0|||
160886464|NCT02129777|580979287|FG004|Open-Label Period|Lack of Efficacy|0|||
160886465|NCT02129777|580979288|FG005|Open-Label Period|Lack of Efficacy|0|||
160775430|NCT02964182|580561773|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
160775431|NCT02964182|580561774|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
160775432|NCT02964182|580561775|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
160775433|NCT02964182|580561776|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
160775434|NCT02964182|580561777|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
160775435|NCT02964182|580561778|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
160775436|NCT02964182|580561779|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
160775437|NCT02964182|580561772|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
160775438|NCT02964182|580561773|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
160775439|NCT02964182|580561774|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
160775440|NCT02964182|580561775|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
160775441|NCT02964182|580561776|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
160775442|NCT02964182|580561777|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
160775443|NCT02964182|580561778|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
160775444|NCT02964182|580561779|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
160775445|NCT02964182|580561772|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
160775446|NCT02964182|580561773|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
160775447|NCT02964182|580561774|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
160775448|NCT02964182|580561775|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
160775449|NCT02964182|580561776|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
160775450|NCT02964182|580561777|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
160775451|NCT02964182|580561778|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
160775452|NCT02964182|580561779|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
160775453|NCT02964182|580561772|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
160775454|NCT02964182|580561773|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
160775455|NCT02964182|580561774|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
160775456|NCT02964182|580561775|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
160775457|NCT02964182|580561776|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
160775458|NCT02964182|580561777|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
160886466|NCT02129777|580979289|FG006|Open-Label Period|Lack of Efficacy|5|||
160886467|NCT02129777|580979283|FG000|Open-Label Period|Lost to Follow-up|0|||
160886468|NCT02129777|580979284|FG001|Open-Label Period|Lost to Follow-up|0|||
160886469|NCT02129777|580979285|FG002|Open-Label Period|Lost to Follow-up|0|||
160886470|NCT02129777|580979286|FG003|Open-Label Period|Lost to Follow-up|0|||
160886471|NCT02129777|580979287|FG004|Open-Label Period|Lost to Follow-up|0|||
160886472|NCT02129777|580979288|FG005|Open-Label Period|Lost to Follow-up|1|||
160886473|NCT02129777|580979289|FG006|Open-Label Period|Lost to Follow-up|1|||
160886474|NCT02129777|580979283|FG000|Open-Label Period|Withdrawal by Subject|0|||
160886475|NCT02129777|580979284|FG001|Open-Label Period|Withdrawal by Subject|0|||
160886476|NCT02129777|580979285|FG002|Open-Label Period|Withdrawal by Subject|0|||
160886477|NCT02129777|580979286|FG003|Open-Label Period|Withdrawal by Subject|0|||
160886478|NCT02129777|580979287|FG004|Open-Label Period|Withdrawal by Subject|0|||
160775459|NCT02964182|580561778|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
160775460|NCT02964182|580561779|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
160775461|NCT03636477|580561781|FG000|Overall Study|Adverse Event|0|||
160775462|NCT03636477|580561782|FG001|Overall Study|Adverse Event|0|||
160775463|NCT03636477|580561783|FG002|Overall Study|Adverse Event|1|||
160775464|NCT02382380|580561785|FG000|Overall Study|Withdrawal by Subject|2|||
160775465|NCT02382380|580561786|FG001|Overall Study|Withdrawal by Subject|2|||
160775466|NCT02382380|580561785|FG000|Overall Study|Lost to Follow-up|0|||
160775467|NCT02382380|580561786|FG001|Overall Study|Lost to Follow-up|1|||
160775468|NCT01295944|580561787|FG000|Overall Study|Switched to alternative treatment|1|||
160775469|NCT01295944|580561787|FG000|Overall Study|Ineligible|9|||
160775470|NCT01295944|580561787|FG000|Overall Study|Withdrawal by Subject|1|||
160775471|NCT01295944|580561787|FG000|Overall Study|Participant chose to be treated in Peru|1|||
160775472|NCT01295944|580561787|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
160775473|NCT01295944|580561787|FG000|Overall Study|Physician Decision|1|||
160775474|NCT01295944|580561787|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
160775475|NCT01295944|580561787|FG000|Overall Study|Disease progression|4|||
160775476|NCT01295944|580561787|FG000|Overall Study|Transferred care before starting new treatment|1|||
160886479|NCT02129777|580979288|FG005|Open-Label Period|Withdrawal by Subject|1|||
160775477|NCT04958707|580561788|FG000|Post Intervention|Withdrawal by Subject|1|||
160775478|NCT04958707|580561789|FG001|Post Intervention|Withdrawal by Subject|0|||
160775479|NCT04958707|580561790|FG002|Post Intervention|Withdrawal by Subject|0|||
160775480|NCT04958707|580561788|FG000|3 Months Follow- up|Lost to Follow-up|0|||
160775481|NCT04958707|580561789|FG001|3 Months Follow- up|Lost to Follow-up|3|||
160775482|NCT04958707|580561790|FG002|3 Months Follow- up|Lost to Follow-up|0|||
160775483|NCT04958707|580561788|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
160886480|NCT02129777|580979289|FG006|Open-Label Period|Withdrawal by Subject|3|||
160886481|NCT02129777|580979283|FG000|Open-Label Period|Study Termination|0|||
160886482|NCT02129777|580979284|FG001|Open-Label Period|Study Termination|0|||
160886483|NCT02129777|580979285|FG002|Open-Label Period|Study Termination|0|||
160886484|NCT02129777|580979286|FG003|Open-Label Period|Study Termination|0|||
160886485|NCT02129777|580979287|FG004|Open-Label Period|Study Termination|0|||
160541194|NCT02831673|579711171|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160541195|NCT02831673|579711172|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
160775484|NCT04958707|580561789|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
160775485|NCT04958707|580561790|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
160775486|NCT05523297|580561797|FG000|Overall Study|Death|7|||
160775487|NCT05523297|580561798|FG001|Overall Study|Death|8|||
160775488|NCT05523297|580561797|FG000|Overall Study|Lost to Follow-up|2|||
160775489|NCT05523297|580561798|FG001|Overall Study|Lost to Follow-up|1|||
160775490|NCT02246777|580561799|FG000|Overall Study|Adverse Event|2|||
160775491|NCT02246777|580561799|FG000|Overall Study|Change of residence|1|||
160541196|NCT02831673|579711173|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
160541197|NCT02831673|579711174|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160541198|NCT02831673|579711170|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
160541199|NCT02831673|579711171|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
160541200|NCT02831673|579711172|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
160775492|NCT00927472|580561800|FG000|Overall Study|Withdrawal by Subject|10|||
160775493|NCT00927472|580561801|FG001|Overall Study|Withdrawal by Subject|11|||
160775494|NCT00927472|580561800|FG000|Overall Study|Lost to Follow-up|1|||
160775495|NCT00927472|580561801|FG001|Overall Study|Lost to Follow-up|6|||
160775496|NCT00927472|580561800|FG000|Overall Study|Protocol Violation|0|||
160775497|NCT00927472|580561801|FG001|Overall Study|Protocol Violation|1|||
160775498|NCT00927472|580561800|FG000|Overall Study|Post treatment Assessment out of window|0|||
160775499|NCT00927472|580561801|FG001|Overall Study|Post treatment Assessment out of window|4|||
160775500|NCT00433537|580561802|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
160775501|NCT00433537|580561803|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
160775502|NCT00433537|580561804|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
160775503|NCT00433537|580561802|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
160775504|NCT00433537|580561803|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
160886486|NCT02129777|580979288|FG005|Open-Label Period|Study Termination|10|||
160886487|NCT02129777|580979289|FG006|Open-Label Period|Study Termination|39|||
160886488|NCT01609478|580979297|FG000|Overall Study|Adverse Event|3|||
160886489|NCT01609478|580979298|FG001|Overall Study|Adverse Event|1|||
160886490|NCT01609478|580979299|FG002|Overall Study|Adverse Event|5|||
160886491|NCT01609478|580979297|FG000|Overall Study|Protocol Deviation|0|||
160886492|NCT01609478|580979298|FG001|Overall Study|Protocol Deviation|1|||
160886493|NCT01609478|580979299|FG002|Overall Study|Protocol Deviation|1|||
160886494|NCT01609478|580979297|FG000|Overall Study|Non-Compliance with study treatment|1|||
160886495|NCT01609478|580979298|FG001|Overall Study|Non-Compliance with study treatment|0|||
160886496|NCT01609478|580979299|FG002|Overall Study|Non-Compliance with study treatment|0|||
160886497|NCT01609478|580979297|FG000|Overall Study|Physician Decision|1|||
160886498|NCT01609478|580979298|FG001|Overall Study|Physician Decision|0|||
160886499|NCT01609478|580979299|FG002|Overall Study|Physician Decision|1|||
160886500|NCT01609478|580979297|FG000|Overall Study|Withdrawal by Subject|2|||
160886501|NCT01609478|580979298|FG001|Overall Study|Withdrawal by Subject|0|||
160886502|NCT01609478|580979299|FG002|Overall Study|Withdrawal by Subject|2|||
160886503|NCT04973137|580979300|FG000|Double Blind Phase|Adverse Event|4|||
160886504|NCT04973137|580979301|FG001|Double Blind Phase|Adverse Event|0|||
160886505|NCT04973137|580979300|FG000|Double Blind Phase|Death|25|||
160886506|NCT04973137|580979301|FG001|Double Blind Phase|Death|15|||
160886507|NCT04973137|580979300|FG000|Double Blind Phase|Physician Decision|5|||
160886508|NCT04973137|580979301|FG001|Double Blind Phase|Physician Decision|1|||
160886509|NCT04973137|580979300|FG000|Double Blind Phase|Withdrawal by Subject|6|||
160886510|NCT04973137|580979301|FG001|Double Blind Phase|Withdrawal by Subject|1|||
160886511|NCT04973137|580979300|FG000|Double Blind Phase|Other|2|||
160886512|NCT04973137|580979301|FG001|Double Blind Phase|Other|2|||
160886513|NCT04973137|580979300|FG000|Open Label Extension Phase|Death|3|||
160886514|NCT04973137|580979301|FG001|Open Label Extension Phase|Death|0|||
160886515|NCT04973137|580979300|FG000|Open Label Extension Phase|Physician Decision|0|||
160886516|NCT04973137|580979301|FG001|Open Label Extension Phase|Physician Decision|1|||
160886517|NCT04973137|580979300|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
160775505|NCT00433537|580561804|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
160775506|NCT00433537|580561802|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
160775507|NCT00433537|580561803|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
160775508|NCT00433537|580561804|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
160775509|NCT00433537|580561802|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
160775510|NCT00433537|580561803|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
160886518|NCT04973137|580979301|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
160886519|NCT04973137|580979300|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
160886520|NCT04973137|580979301|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
160886521|NCT04973137|580979300|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
160886522|NCT04973137|580979301|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
160886523|NCT05040971|580979302|FG000|Overall Study|Withdrawal by Subject|0|||
160775511|NCT00433537|580561804|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
160886524|NCT05040971|580979303|FG001|Overall Study|Withdrawal by Subject|2|||
160886525|NCT05040971|580979302|FG000|Overall Study|Lost to Follow-up|8|||
160886526|NCT05040971|580979303|FG001|Overall Study|Lost to Follow-up|3|||
160886527|NCT05040971|580979302|FG000|Overall Study|Death|2|||
160886528|NCT05040971|580979303|FG001|Overall Study|Death|0|||
160886529|NCT04391569|580979306|FG000|Overall Study|Death|15|||
160886530|NCT04391569|580979307|FG001|Overall Study|Death|10|||
160886531|NCT04391569|580979306|FG000|Overall Study|Withdrawal by Subject|1|||
160886532|NCT04391569|580979307|FG001|Overall Study|Withdrawal by Subject|0|||
160886533|NCT04391569|580979306|FG000|Overall Study|Lost to Follow-up|3|||
160886534|NCT04391569|580979307|FG001|Overall Study|Lost to Follow-up|2|||
160886535|NCT04391569|580979306|FG000|Overall Study|Lack of Efficacy|0|||
160886536|NCT04391569|580979307|FG001|Overall Study|Lack of Efficacy|1|||
160886537|NCT04391569|580979306|FG000|Overall Study|Participant discharged to hospice facility|0|||
160886538|NCT04391569|580979307|FG001|Overall Study|Participant discharged to hospice facility|1|||
160886539|NCT04391569|580979306|FG000|Overall Study|Participant family decision|1|||
160886540|NCT04391569|580979307|FG001|Overall Study|Participant family decision|0|||
160886541|NCT04391569|580979306|FG000|Overall Study|Participant discharged prematurely|1|||
160775512|NCT00433537|580561802|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
160775513|NCT00433537|580561803|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
160775514|NCT00433537|580561804|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
160775515|NCT00433537|580561802|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
160775516|NCT00433537|580561803|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
160775517|NCT00433537|580561804|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
160775518|NCT00433537|580561802|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
160775519|NCT00433537|580561803|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
160775520|NCT00433537|580561804|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
160775521|NCT00433537|580561802|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
160775522|NCT00433537|580561803|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
160775523|NCT00433537|580561804|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
160775524|NCT00433537|580561802|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
160775525|NCT00433537|580561803|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
160775526|NCT00433537|580561804|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
160775527|NCT04635423|580561817|FG000|Overall Study|Ongoing|493|||
160775528|NCT04635423|580561818|FG001|Overall Study|Ongoing|501|||
160775529|NCT04635423|580561817|FG000|Overall Study|Withdrawal by Subject|36|||
160775530|NCT04635423|580561818|FG001|Overall Study|Withdrawal by Subject|29|||
160775531|NCT02555878|580561833|FG000|Overall Study|Lost to Follow-up|2|||
160775532|NCT02555878|580561834|FG001|Overall Study|Lost to Follow-up|3|||
160775533|NCT02555878|580561833|FG000|Overall Study|Withdrawal by Subject|48|||
160775534|NCT02555878|580561834|FG001|Overall Study|Withdrawal by Subject|48|||
160775535|NCT02555878|580561833|FG000|Overall Study|Adverse Event|12|||
160775536|NCT02555878|580561834|FG001|Overall Study|Adverse Event|8|||
160775537|NCT02555878|580561833|FG000|Overall Study|Death|74|||
160775538|NCT02555878|580561834|FG001|Overall Study|Death|59|||
160775539|NCT02555878|580561833|FG000|Overall Study|Protocol Violation|1|||
160775540|NCT02555878|580561834|FG001|Overall Study|Protocol Violation|2|||
160775541|NCT02555878|580561833|FG000|Overall Study|Physician Decision|12|||
160775542|NCT02555878|580561834|FG001|Overall Study|Physician Decision|13|||
160775543|NCT02555878|580561833|FG000|Overall Study|Other|17|||
160775544|NCT02555878|580561834|FG001|Overall Study|Other|17|||
160775545|NCT04835441|580561836|FG000|Overall Study|Physician Decision|4|||
160775546|NCT04835441|580561837|FG001|Overall Study|Physician Decision|4|||
160775547|NCT04835441|580561836|FG000|Overall Study|Other|1|||
160775548|NCT04835441|580561837|FG001|Overall Study|Other|1|||
160775549|NCT04835441|580561836|FG000|Overall Study|Lost to Follow-up|0|||
160775550|NCT04835441|580561837|FG001|Overall Study|Lost to Follow-up|1|||
160775551|NCT00143507|580563244|FG000|Overall Study|Death|572|||
160775552|NCT00143507|580563245|FG001|Overall Study|Death|547|||
160775553|NCT00143507|580563244|FG000|Overall Study|Withdrawal by Subject|114|||
160775554|NCT00143507|580563245|FG001|Overall Study|Withdrawal by Subject|102|||
160775555|NCT00143507|580563244|FG000|Overall Study|Lost to Follow-up|1|||
160775556|NCT00143507|580563245|FG001|Overall Study|Lost to Follow-up|0|||
160775557|NCT00143507|580563244|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
160775558|NCT00143507|580563245|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
160775559|NCT00177671|580563246|FG000|Overall Study|Withdrawal by Subject|5|||
160775560|NCT00177671|580563247|FG001|Overall Study|Withdrawal by Subject|6|||
160775561|NCT00177671|580563246|FG000|Overall Study|medical complications|2|||
160775562|NCT00177671|580563247|FG001|Overall Study|medical complications|0|||
160775563|NCT00177671|580563246|FG000|Overall Study|Adverse Event|6|||
160775564|NCT00177671|580563247|FG001|Overall Study|Adverse Event|0|||
160775565|NCT00177671|580563246|FG000|Overall Study|Physician Decision|12|||
160775566|NCT00177671|580563247|FG001|Overall Study|Physician Decision|8|||
160775567|NCT00690898|580563248|FG000|SCREENING|Screen failure|18|||
160775568|NCT00690898|580563248|FG000|TREATMENT|Adverse Event|3|||
160886542|NCT04391569|580979307|FG001|Overall Study|Participant discharged prematurely|0|||
160886543|NCT00938886|580979338|FG000|Overall Study|Death|0|||
160775569|NCT00690898|580563248|FG000|TREATMENT|Lack of Efficacy|18|||
160775570|NCT00690898|580563248|FG000|TREATMENT|Withdrawal by Subject|4|||
160775571|NCT00690898|580563248|FG000|TREATMENT|Other (not otherwise specified)|1|||
160775572|NCT01787838|580563253|FG000|Overall Study|refused|1413|||
160775573|NCT01991314|580563257|FG000|Overall Study|Adverse Event|5|||
160775574|NCT01991314|580563258|FG001|Overall Study|Adverse Event|1|||
160775575|NCT01991314|580563257|FG000|Overall Study|Lost to Follow-up|6|||
160775576|NCT01991314|580563258|FG001|Overall Study|Lost to Follow-up|10|||
160775577|NCT02782468|580563259|FG000|Overall Study|Progressive Disease|2|||
160775578|NCT02782468|580563260|FG001|Overall Study|Progressive Disease|5|||
160775579|NCT02782468|580563261|FG002|Overall Study|Progressive Disease|0|||
160775580|NCT02782468|580563262|FG003|Overall Study|Progressive Disease|4|||
160775581|NCT02782468|580563259|FG000|Overall Study|Adverse Event|0|||
160775582|NCT02782468|580563260|FG001|Overall Study|Adverse Event|2|||
160775583|NCT02782468|580563261|FG002|Overall Study|Adverse Event|2|||
160775584|NCT02782468|580563262|FG003|Overall Study|Adverse Event|3|||
160775585|NCT02782468|580563259|FG000|Overall Study|Other|0|||
160775586|NCT02782468|580563260|FG001|Overall Study|Other|0|||
160775587|NCT02782468|580563261|FG002|Overall Study|Other|1|||
160775588|NCT02782468|580563262|FG003|Overall Study|Other|1|||
160775589|NCT02782468|580563259|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
160775590|NCT02782468|580563260|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
160775591|NCT02782468|580563261|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
160775592|NCT02782468|580563262|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
160775593|NCT02782468|580563259|FG000|Overall Study|Symptomatic Deterioration|0|||
160775594|NCT02782468|580563260|FG001|Overall Study|Symptomatic Deterioration|0|||
160775595|NCT02782468|580563261|FG002|Overall Study|Symptomatic Deterioration|0|||
160775596|NCT02782468|580563262|FG003|Overall Study|Symptomatic Deterioration|1|||
160775597|NCT02782468|580563259|FG000|Overall Study|Withdrawal by Subject|1|||
160775598|NCT02782468|580563260|FG001|Overall Study|Withdrawal by Subject|0|||
160775599|NCT02782468|580563261|FG002|Overall Study|Withdrawal by Subject|0|||
160775600|NCT02782468|580563262|FG003|Overall Study|Withdrawal by Subject|0|||
160775601|NCT00356590|580563263|FG000|Overall Study|Adverse Event|54|||
160775602|NCT00356590|580563263|FG000|Overall Study|Death|10|||
160775603|NCT00356590|580563263|FG000|Overall Study|Lost to Follow-up|35|||
160775604|NCT00356590|580563263|FG000|Overall Study|Physician Decision|46|||
160775605|NCT00356590|580563263|FG000|Overall Study|Withdrawal by Subject|41|||
160775606|NCT00356590|580563263|FG000|Overall Study|Completed month 12 only|2|||
160775607|NCT00356590|580563263|FG000|Overall Study|Protocol issues|6|||
160775608|NCT00356590|580563263|FG000|Overall Study|Response status|28|||
160775609|NCT00356590|580563263|FG000|Overall Study|Other|52|||
160775610|NCT04919161|580563264|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
160775611|NCT04919161|580563265|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
160775612|NCT04919161|580563264|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
160775613|NCT04919161|580563265|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
160775614|NCT04919161|580563264|FG000|Overall Study|Acute ankle sprain after session 1|0|||
160775615|NCT04919161|580563265|FG001|Overall Study|Acute ankle sprain after session 1|1|||
160775616|NCT02175758|580563266|FG000|Treatment Phase|Lost to Follow-up|0|||
160775617|NCT02175758|580563267|FG001|Treatment Phase|Lost to Follow-up|1|||
160775618|NCT02175758|580563268|FG002|Treatment Phase|Lost to Follow-up|0|||
160775619|NCT02175758|580563269|FG003|Treatment Phase|Lost to Follow-up|0|||
160775620|NCT02175758|580563270|FG004|Treatment Phase|Lost to Follow-up|0|||
160775621|NCT02175758|580563271|FG005|Treatment Phase|Lost to Follow-up|0|||
160775622|NCT02175758|580563266|FG000|Treatment Phase|Adverse Event|0|||
160775623|NCT02175758|580563267|FG001|Treatment Phase|Adverse Event|0|||
160775624|NCT02175758|580563268|FG002|Treatment Phase|Adverse Event|0|||
160775625|NCT02175758|580563269|FG003|Treatment Phase|Adverse Event|0|||
160775626|NCT02175758|580563270|FG004|Treatment Phase|Adverse Event|1|||
160775627|NCT02175758|580563271|FG005|Treatment Phase|Adverse Event|0|||
160775628|NCT02489773|580563272|FG000|Overall Study|Lost to Follow-up|4|||
160775629|NCT02489773|580563273|FG001|Overall Study|Lost to Follow-up|1|||
160775630|NCT02489773|580563272|FG000|Overall Study|Physician Decision|1|||
160775631|NCT02489773|580563273|FG001|Overall Study|Physician Decision|0|||
160775632|NCT02489773|580563272|FG000|Overall Study|Withdrawal by Subject|1|||
160775633|NCT02489773|580563273|FG001|Overall Study|Withdrawal by Subject|0|||
160775634|NCT02489773|580563272|FG000|Overall Study|Leave the country or the state|1|||
160775635|NCT02489773|580563273|FG001|Overall Study|Leave the country or the state|1|||
160775636|NCT00712920|580563274|FG000|Overall Study|Adverse Event|3|||
160775637|NCT00712920|580563275|FG001|Overall Study|Adverse Event|4|||
160775638|NCT00712920|580563276|FG002|Overall Study|Adverse Event|7|||
160775639|NCT00712920|580563274|FG000|Overall Study|Withdrawal by Subject|4|||
160775640|NCT00712920|580563275|FG001|Overall Study|Withdrawal by Subject|2|||
160775641|NCT00712920|580563276|FG002|Overall Study|Withdrawal by Subject|1|||
160775642|NCT00712920|580563274|FG000|Overall Study|Lost to Follow-up|1|||
160775643|NCT00712920|580563275|FG001|Overall Study|Lost to Follow-up|4|||
160775644|NCT00712920|580563276|FG002|Overall Study|Lost to Follow-up|0|||
160886544|NCT00938886|580979339|FG001|Overall Study|Death|1|||
160886545|NCT00938886|580979338|FG000|Overall Study|Withdrawal by Subject|4|||
160886546|NCT00938886|580979339|FG001|Overall Study|Withdrawal by Subject|7|||
160886547|NCT00938886|580979338|FG000|Overall Study|Lost to Follow-up|3|||
160886548|NCT00938886|580979339|FG001|Overall Study|Lost to Follow-up|2|||
160886549|NCT03044574|580979340|FG000|Overall Study|Lost to Follow-up|37|||
160886550|NCT03044574|580979341|FG001|Overall Study|Lost to Follow-up|45|||
160886551|NCT00645788|580979342|FG000|Overall Study|Did not receive study drug|1|||
160886552|NCT00645788|580979343|FG001|Overall Study|Did not receive study drug|1|||
160886553|NCT00645788|580979344|FG002|Overall Study|Did not receive study drug|0|||
160886554|NCT00645788|580979345|FG003|Overall Study|Did not receive study drug|0|||
160886555|NCT00645788|580979342|FG000|Overall Study|Adverse Event|4|||
160886556|NCT00645788|580979343|FG001|Overall Study|Adverse Event|9|||
160886557|NCT00645788|580979344|FG002|Overall Study|Adverse Event|5|||
160886558|NCT00645788|580979345|FG003|Overall Study|Adverse Event|3|||
160886559|NCT00645788|580979342|FG000|Overall Study|Lost to Follow-up|1|||
160886560|NCT00645788|580979343|FG001|Overall Study|Lost to Follow-up|0|||
160886561|NCT00645788|580979344|FG002|Overall Study|Lost to Follow-up|0|||
160886562|NCT00645788|580979345|FG003|Overall Study|Lost to Follow-up|0|||
160886563|NCT00645788|580979342|FG000|Overall Study|Protocol Violation|1|||
160886564|NCT00645788|580979343|FG001|Overall Study|Protocol Violation|0|||
160886565|NCT00645788|580979344|FG002|Overall Study|Protocol Violation|2|||
160886566|NCT00645788|580979345|FG003|Overall Study|Protocol Violation|0|||
160886567|NCT00645788|580979342|FG000|Overall Study|Withdrawal by Subject|0|||
160886568|NCT00645788|580979343|FG001|Overall Study|Withdrawal by Subject|1|||
160886569|NCT00645788|580979344|FG002|Overall Study|Withdrawal by Subject|0|||
160886570|NCT00645788|580979345|FG003|Overall Study|Withdrawal by Subject|2|||
160886571|NCT00645788|580979342|FG000|Overall Study|Pulmonary exacerbation|13|||
160886572|NCT00645788|580979343|FG001|Overall Study|Pulmonary exacerbation|16|||
160886573|NCT00645788|580979344|FG002|Overall Study|Pulmonary exacerbation|11|||
160886574|NCT00645788|580979345|FG003|Overall Study|Pulmonary exacerbation|9|||
160886575|NCT03764033|580979348|FG000|Treatment Phase|Withdrawal by Subject|8|||
160886576|NCT03764033|580979349|FG001|Treatment Phase|Withdrawal by Subject|3|||
160886577|NCT03764033|580979348|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
160886578|NCT03764033|580979349|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
160886579|NCT03764033|580979348|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
160886580|NCT03764033|580979349|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
160886581|NCT01006603|580979350|FG000|Overall Study|Withdrawal by Subject|17|||
160886582|NCT01006603|580979351|FG001|Overall Study|Withdrawal by Subject|19|||
160886583|NCT01006603|580979350|FG000|Overall Study|Lost to Follow-up|0|||
160886584|NCT01006603|580979351|FG001|Overall Study|Lost to Follow-up|1|||
160886585|NCT01006603|580979350|FG000|Overall Study|Safety reason|1|||
160886586|NCT01006603|580979351|FG001|Overall Study|Safety reason|1|||
160886587|NCT01006603|580979350|FG000|Overall Study|Protocol Violation|1|||
160886588|NCT01006603|580979351|FG001|Overall Study|Protocol Violation|3|||
160886589|NCT01006603|580979350|FG000|Overall Study|Incorrect enrolment|0|||
160886590|NCT01006603|580979351|FG001|Overall Study|Incorrect enrolment|2|||
160886591|NCT01006603|580979350|FG000|Overall Study|Adverse Event|15|||
160886592|NCT01006603|580979351|FG001|Overall Study|Adverse Event|7|||
160886593|NCT01006603|580979350|FG000|Overall Study|Death|1|||
160886594|NCT01006603|580979351|FG001|Overall Study|Death|1|||
160886595|NCT01006603|580979350|FG000|Overall Study|Study specific discontinuation criteria|33|||
160886596|NCT01006603|580979351|FG001|Overall Study|Study specific discontinuation criteria|34|||
160886597|NCT01006603|580979350|FG000|Overall Study|Other|3|||
160886598|NCT01006603|580979351|FG001|Overall Study|Other|7|||
160886599|NCT01107418|580980536|FG000|Overall Study|Disease Progression|45|||
160886600|NCT01107418|580980536|FG000|Overall Study|Adverse Event|3|||
160886601|NCT01107418|580980536|FG000|Overall Study|Withdrawal by Subject|1|||
160886602|NCT01107418|580980536|FG000|Overall Study|Study Closing|1|||
160886603|NCT01107418|580980536|FG000|Overall Study|Started Other Therapy|1|||
160886604|NCT01107418|580980536|FG000|Overall Study|Entered Extension Study|1|||
160541201|NCT02831673|579711173|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
160886605|NCT03505671|580980537|FG000|Overall Study|Withdrawal by Subject|2|||
160886606|NCT03505671|580980538|FG001|Overall Study|Withdrawal by Subject|1|||
160886607|NCT03505671|580980537|FG000|Overall Study|Lost to Follow-up|1|||
160886608|NCT03505671|580980538|FG001|Overall Study|Lost to Follow-up|0|||
160886609|NCT02038829|580980539|FG000|Washout Period 1|Death|0|||
160886610|NCT02038829|580980540|FG001|Washout Period 1|Death|0|||
160886611|NCT02038829|580980541|FG002|Washout Period 1|Death|0|||
160886612|NCT02038829|580980542|FG003|Washout Period 1|Death|0|||
160886613|NCT02038829|580980543|FG004|Washout Period 1|Death|1|||
160886614|NCT02038829|580980544|FG005|Washout Period 1|Death|0|||
160886615|NCT02038829|580980545|FG006|Washout Period 1|Death|0|||
160886616|NCT02038829|580980546|FG007|Washout Period 1|Death|0|||
160886617|NCT02038829|580980547|FG008|Washout Period 1|Death|0|||
160886618|NCT02038829|580980548|FG009|Washout Period 1|Death|0|||
160886619|NCT02038829|580980549|FG010|Washout Period 1|Death|0|||
160886620|NCT02038829|580980550|FG011|Washout Period 1|Death|0|||
160886621|NCT02038829|580980539|FG000|Treatment Period 2|Adverse Event|0|||
160775645|NCT00712920|580563274|FG000|Overall Study|Lack of Efficacy|1|||
160775646|NCT00712920|580563275|FG001|Overall Study|Lack of Efficacy|0|||
160775647|NCT00712920|580563276|FG002|Overall Study|Lack of Efficacy|1|||
160775648|NCT00712920|580563274|FG000|Overall Study|Other|5|||
160775649|NCT00712920|580563275|FG001|Overall Study|Other|7|||
160775650|NCT00712920|580563276|FG002|Overall Study|Other|3|||
160775651|NCT00712920|580563274|FG000|Overall Study|Non-compliance|3|||
160775652|NCT00712920|580563275|FG001|Overall Study|Non-compliance|0|||
160775653|NCT00712920|580563276|FG002|Overall Study|Non-compliance|0|||
160775654|NCT02550795|580563284|FG000|Overall Study|Physician Decision|0|||
160775655|NCT02550795|580563285|FG001|Overall Study|Physician Decision|1|||
160775656|NCT02550795|580563286|FG002|Overall Study|Physician Decision|0|||
160775657|NCT02225587|580563287|FG000|Overall Study|Adverse Event|5|||
160775658|NCT02225587|580563288|FG001|Overall Study|Adverse Event|5|||
160775659|NCT02225587|580563287|FG000|Overall Study|Lost to Follow-up|5|||
160775660|NCT02225587|580563288|FG001|Overall Study|Lost to Follow-up|5|||
160775661|NCT02225587|580563287|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160775662|NCT02225587|580563288|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160775663|NCT02225587|580563287|FG000|Overall Study|Physician Decision|2|||
160775664|NCT02225587|580563288|FG001|Overall Study|Physician Decision|0|||
160775665|NCT02225587|580563287|FG000|Overall Study|Protocol Violation|1|||
160775666|NCT02225587|580563288|FG001|Overall Study|Protocol Violation|0|||
160775667|NCT02225587|580563287|FG000|Overall Study|Participant Moved|1|||
160775668|NCT02225587|580563288|FG001|Overall Study|Participant Moved|0|||
160775669|NCT02225587|580563287|FG000|Overall Study|Withdrawal by Subject|13|||
160775670|NCT02225587|580563288|FG001|Overall Study|Withdrawal by Subject|28|||
160775671|NCT03483584|580563291|FG000|Overall Study|Lost to Follow-up|40|||
160775672|NCT03483584|580563292|FG001|Overall Study|Lost to Follow-up|7|||
160775673|NCT03483584|580563291|FG000|Overall Study|Withdrawal by Subject|4|||
160775674|NCT03483584|580563292|FG001|Overall Study|Withdrawal by Subject|1|||
160775675|NCT02879695|580563293|FG000|Overall Study|Did not start study treatment|2|||
160775676|NCT02879695|580563294|FG001|Overall Study|Did not start study treatment|0|||
160775677|NCT02879695|580563295|FG002|Overall Study|Did not start study treatment|3|||
160775678|NCT02879695|580563296|FG003|Overall Study|Did not start study treatment|0|||
160775679|NCT04063163|580563297|FG000|Overall Study|Death|281|||
160775680|NCT04063163|580563298|FG001|Overall Study|Death|166|||
160775681|NCT04063163|580563297|FG000|Overall Study|Lost to Follow-up|12|||
160775682|NCT04063163|580563298|FG001|Overall Study|Lost to Follow-up|8|||
160775683|NCT04063163|580563297|FG000|Overall Study|Withdrawal by Subject|19|||
160775684|NCT04063163|580563298|FG001|Overall Study|Withdrawal by Subject|10|||
160775685|NCT02572167|580563301|FG000|Overall Study|Withdrawal by Subject|0|||
160775686|NCT02572167|580563302|FG001|Overall Study|Withdrawal by Subject|3|||
160775687|NCT02572167|580563303|FG002|Overall Study|Withdrawal by Subject|0|||
160775688|NCT02572167|580563301|FG000|Overall Study|Lost to Follow-up|2|||
160775689|NCT02572167|580563302|FG001|Overall Study|Lost to Follow-up|5|||
160775690|NCT02572167|580563303|FG002|Overall Study|Lost to Follow-up|3|||
160775691|NCT02572167|580563301|FG000|Overall Study|Death|0|||
160775692|NCT02572167|580563302|FG001|Overall Study|Death|8|||
160775693|NCT02572167|580563303|FG002|Overall Study|Death|3|||
160775694|NCT02572167|580563301|FG000|Overall Study|Did not meet inclusion criteria|0|||
160775695|NCT02572167|580563302|FG001|Overall Study|Did not meet inclusion criteria|0|||
160775696|NCT02572167|580563303|FG002|Overall Study|Did not meet inclusion criteria|1|||
160775697|NCT02572167|580563301|FG000|Overall Study|Study closure by Sponsor|4|||
160775698|NCT02572167|580563302|FG001|Overall Study|Study closure by Sponsor|40|||
160775699|NCT02572167|580563303|FG002|Overall Study|Study closure by Sponsor|24|||
160775700|NCT00005047|580563304|FG000|Overall Study|Withdrawal by Subject|12|||
160775701|NCT00005047|580563305|FG001|Overall Study|Withdrawal by Subject|0|||
160775702|NCT00005047|580563306|FG002|Overall Study|Withdrawal by Subject|0|||
160775703|NCT00005047|580563307|FG003|Overall Study|Withdrawal by Subject|0|||
160775704|NCT00005047|580563304|FG000|Overall Study|Adverse Event|5|||
160775705|NCT00005047|580563305|FG001|Overall Study|Adverse Event|0|||
160775706|NCT00005047|580563306|FG002|Overall Study|Adverse Event|0|||
160775707|NCT00005047|580563307|FG003|Overall Study|Adverse Event|0|||
160775708|NCT00005047|580563304|FG000|Overall Study|Lost to Follow-up|1|||
160775709|NCT00005047|580563305|FG001|Overall Study|Lost to Follow-up|0|||
160775710|NCT00005047|580563306|FG002|Overall Study|Lost to Follow-up|0|||
160775711|NCT00005047|580563307|FG003|Overall Study|Lost to Follow-up|0|||
160775712|NCT00005047|580563304|FG000|Overall Study|Lack of Efficacy|1|||
160775713|NCT00005047|580563305|FG001|Overall Study|Lack of Efficacy|0|||
160775714|NCT00005047|580563306|FG002|Overall Study|Lack of Efficacy|0|||
160541202|NCT02831673|579711174|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
160775715|NCT00005047|580563307|FG003|Overall Study|Lack of Efficacy|0|||
160775716|NCT03240874|580563308|FG000|Overall Study|Lost to Follow-up|0|||
160775717|NCT03240874|580563309|FG001|Overall Study|Lost to Follow-up|2|||
160541203|NCT02831673|579711170|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
160775718|NCT03240874|580563310|FG002|Overall Study|Lost to Follow-up|4|||
160775719|NCT03240874|580563311|FG003|Overall Study|Lost to Follow-up|1|||
160775720|NCT03036254|580563314|FG000|Overall Study|Adverse Event|6|||
160775721|NCT03036254|580563315|FG001|Overall Study|Adverse Event|4|||
160775722|NCT03036254|580563314|FG000|Overall Study|Death|3|||
160775723|NCT03036254|580563315|FG001|Overall Study|Death|1|||
160775724|NCT03036254|580563314|FG000|Overall Study|Lack of Efficacy|5|||
160775725|NCT03036254|580563315|FG001|Overall Study|Lack of Efficacy|1|||
160775726|NCT03036254|580563314|FG000|Overall Study|Withdrawal by Subject|3|||
160775727|NCT03036254|580563315|FG001|Overall Study|Withdrawal by Subject|5|||
160775728|NCT05567172|580563319|FG000|Overall Study|Death|3|||
160775729|NCT03168672|580563322|FG000|Overall Study|Withdrawal by Subject|13|||
160775730|NCT03168672|580563322|FG000|Overall Study|Death|3|||
160775731|NCT03168672|580563322|FG000|Overall Study|Investigator's Decision|137|||
160775732|NCT03168672|580563322|FG000|Overall Study|Adverse Event|1|||
160775733|NCT03168672|580563322|FG000|Overall Study|Other|2|||
160775734|NCT03168672|580563322|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
160775735|NCT05317546|580563323|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
160775736|NCT05317546|580563324|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
160775737|NCT05350202|580563325|FG000|Visit 1 - Baseline|Not-treated|18|||
160775738|NCT05350202|580563326|FG001|Visit 1 - Baseline|Not-treated|0|||
160775739|NCT05350202|580563325|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
160775740|NCT05350202|580563326|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
160775741|NCT05350202|580563325|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
160775742|NCT05350202|580563326|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
160775743|NCT05350202|580563325|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
160775744|NCT05350202|580563326|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
160775745|NCT05350202|580563325|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
160775746|NCT05350202|580563326|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
160775747|NCT05350202|580563325|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
160775748|NCT05350202|580563326|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
160775749|NCT05350202|580563325|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
160775750|NCT05350202|580563326|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
160775751|NCT04707469|580563327|FG000|Overall Study|Site closure|0|||
160775752|NCT04707469|580563328|FG001|Overall Study|Site closure|2|||
160775753|NCT04707469|580563329|FG002|Overall Study|Site closure|0|||
160775754|NCT04707469|580563327|FG000|Overall Study|Physician Decision|2|||
160775755|NCT04707469|580563328|FG001|Overall Study|Physician Decision|2|||
160775756|NCT04707469|580563329|FG002|Overall Study|Physician Decision|2|||
160775757|NCT04707469|580563327|FG000|Overall Study|Death|1|||
160775758|NCT04707469|580563328|FG001|Overall Study|Death|6|||
160775759|NCT04707469|580563329|FG002|Overall Study|Death|2|||
160775760|NCT04707469|580563327|FG000|Overall Study|Lost to Follow-up|9|||
160775761|NCT04707469|580563328|FG001|Overall Study|Lost to Follow-up|19|||
160775762|NCT04707469|580563329|FG002|Overall Study|Lost to Follow-up|14|||
160775763|NCT04707469|580563327|FG000|Overall Study|Withdrawal by Subject|17|||
160775764|NCT04707469|580563328|FG001|Overall Study|Withdrawal by Subject|16|||
160775765|NCT04707469|580563329|FG002|Overall Study|Withdrawal by Subject|12|||
160775766|NCT05556057|580563330|FG000|Overall Study|Lost to Follow-up|5|||
160775767|NCT05556057|580563331|FG001|Overall Study|Lost to Follow-up|4|||
160775768|NCT05556057|580563330|FG000|Overall Study|Withdrawal by Subject|0|||
160775769|NCT05556057|580563331|FG001|Overall Study|Withdrawal by Subject|2|||
160775770|NCT04364646|580563332|FG000|Overall Study|Lost to Follow-up|1|||
160775771|NCT04364646|580563333|FG001|Overall Study|Lost to Follow-up|0|||
160775772|NCT04364646|580563332|FG000|Overall Study|Withdrawal by Subject|7|||
160775773|NCT04364646|580563333|FG001|Overall Study|Withdrawal by Subject|14|||
160775774|NCT04364646|580563332|FG000|Overall Study|Protocol Violation|4|||
160775775|NCT04364646|580563333|FG001|Overall Study|Protocol Violation|5|||
160775776|NCT00765076|580563340|FG000|Overall Study|Adverse Event|1|||
160775777|NCT00765076|580563341|FG001|Overall Study|Adverse Event|0|||
160775778|NCT00765076|580563342|FG002|Overall Study|Adverse Event|0|||
160775779|NCT00765076|580563340|FG000|Overall Study|Withdrawal by Subject|0|||
160775780|NCT00765076|580563341|FG001|Overall Study|Withdrawal by Subject|0|||
160775781|NCT00765076|580563342|FG002|Overall Study|Withdrawal by Subject|1|||
160775782|NCT01164475|580563343|FG000|Overall Study|Lack of Efficacy|1|||
160775783|NCT01164475|580563344|FG001|Overall Study|Lack of Efficacy|0|||
160775784|NCT01164475|580563343|FG000|Overall Study|Other|0|||
160775785|NCT01164475|580563344|FG001|Overall Study|Other|1|||
160775786|NCT01164475|580563343|FG000|Overall Study|Progressive disease|0|||
160775787|NCT01164475|580563344|FG001|Overall Study|Progressive disease|1|||
160775788|NCT01164475|580563343|FG000|Overall Study|Protocol Violation|1|||
160775789|NCT01164475|580563344|FG001|Overall Study|Protocol Violation|0|||
160775790|NCT02335944|580563345|FG000|Treatment Phase|Progressive Disease|2|||
160775791|NCT02335944|580563346|FG001|Treatment Phase|Progressive Disease|5|||
160775792|NCT02335944|580563347|FG002|Treatment Phase|Progressive Disease|2|||
160775793|NCT02335944|580563348|FG003|Treatment Phase|Progressive Disease|11|||
160775794|NCT02335944|580563349|FG004|Treatment Phase|Progressive Disease|4|||
160775795|NCT02335944|580563350|FG005|Treatment Phase|Progressive Disease|25|||
160775796|NCT02335944|580563351|FG006|Treatment Phase|Progressive Disease|2|||
160775797|NCT02335944|580563352|FG007|Treatment Phase|Progressive Disease|30|||
160775798|NCT02335944|580563353|FG008|Treatment Phase|Progressive Disease|27|||
160775799|NCT02335944|580563354|FG009|Treatment Phase|Progressive Disease|0|||
160775800|NCT02335944|580563345|FG000|Treatment Phase|Adverse Event|2|||
160775801|NCT02335944|580563346|FG001|Treatment Phase|Adverse Event|0|||
160775802|NCT02335944|580563347|FG002|Treatment Phase|Adverse Event|0|||
160775803|NCT02335944|580563348|FG003|Treatment Phase|Adverse Event|2|||
160775804|NCT02335944|580563349|FG004|Treatment Phase|Adverse Event|1|||
160775805|NCT02335944|580563350|FG005|Treatment Phase|Adverse Event|15|||
160775806|NCT02335944|580563351|FG006|Treatment Phase|Adverse Event|0|||
160775807|NCT02335944|580563352|FG007|Treatment Phase|Adverse Event|5|||
160775808|NCT02335944|580563353|FG008|Treatment Phase|Adverse Event|7|||
160775809|NCT02335944|580563354|FG009|Treatment Phase|Adverse Event|0|||
160775810|NCT02335944|580563345|FG000|Treatment Phase|Physician Decision|0|||
160775811|NCT02335944|580563346|FG001|Treatment Phase|Physician Decision|0|||
160775812|NCT02335944|580563347|FG002|Treatment Phase|Physician Decision|0|||
160775813|NCT02335944|580563348|FG003|Treatment Phase|Physician Decision|1|||
160775814|NCT02335944|580563349|FG004|Treatment Phase|Physician Decision|0|||
160775815|NCT02335944|580563350|FG005|Treatment Phase|Physician Decision|6|||
160775816|NCT02335944|580563351|FG006|Treatment Phase|Physician Decision|1|||
160775817|NCT02335944|580563352|FG007|Treatment Phase|Physician Decision|2|||
160775818|NCT02335944|580563353|FG008|Treatment Phase|Physician Decision|1|||
160775819|NCT02335944|580563354|FG009|Treatment Phase|Physician Decision|0|||
160775820|NCT02335944|580563345|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
160775821|NCT02335944|580563346|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
160775822|NCT02335944|580563347|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
160775823|NCT02335944|580563348|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
160775824|NCT02335944|580563349|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
160775825|NCT02335944|580563350|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
160775826|NCT02335944|580563351|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
160775827|NCT02335944|580563352|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
160775828|NCT02335944|580563353|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
160775829|NCT02335944|580563354|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
160775830|NCT02335944|580563345|FG000|Treatment Phase|Subject/Guardian Decision|0|||
160775831|NCT02335944|580563346|FG001|Treatment Phase|Subject/Guardian Decision|0|||
160775832|NCT02335944|580563347|FG002|Treatment Phase|Subject/Guardian Decision|1|||
160775833|NCT02335944|580563348|FG003|Treatment Phase|Subject/Guardian Decision|0|||
160775834|NCT02335944|580563349|FG004|Treatment Phase|Subject/Guardian Decision|0|||
160775835|NCT02335944|580563350|FG005|Treatment Phase|Subject/Guardian Decision|1|||
160775836|NCT02335944|580563351|FG006|Treatment Phase|Subject/Guardian Decision|0|||
160775837|NCT02335944|580563352|FG007|Treatment Phase|Subject/Guardian Decision|4|||
160775838|NCT02335944|580563353|FG008|Treatment Phase|Subject/Guardian Decision|0|||
160775839|NCT02335944|580563354|FG009|Treatment Phase|Subject/Guardian Decision|0|||
160775840|NCT02335944|580563345|FG000|Post-treatment Follow-up|Progressive Disease|0|||
160775841|NCT02335944|580563346|FG001|Post-treatment Follow-up|Progressive Disease|0|||
160775842|NCT02335944|580563347|FG002|Post-treatment Follow-up|Progressive Disease|0|||
160775843|NCT02335944|580563348|FG003|Post-treatment Follow-up|Progressive Disease|1|||
160775844|NCT02335944|580563349|FG004|Post-treatment Follow-up|Progressive Disease|0|||
160775845|NCT02335944|580563350|FG005|Post-treatment Follow-up|Progressive Disease|9|||
160775846|NCT02335944|580563351|FG006|Post-treatment Follow-up|Progressive Disease|0|||
160775847|NCT02335944|580563352|FG007|Post-treatment Follow-up|Progressive Disease|2|||
160775848|NCT02335944|580563353|FG008|Post-treatment Follow-up|Progressive Disease|3|||
160775849|NCT02335944|580563354|FG009|Post-treatment Follow-up|Progressive Disease|0|||
160775850|NCT02335944|580563345|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
160775851|NCT02335944|580563346|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
160775852|NCT02335944|580563347|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
160775853|NCT02335944|580563348|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
160775854|NCT02335944|580563349|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
160541204|NCT02831673|579711171|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
160541205|NCT02831673|579711172|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
160541206|NCT02831673|579711173|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
160775855|NCT02335944|580563350|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
160775856|NCT02335944|580563351|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
160775857|NCT02335944|580563352|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
160775858|NCT02335944|580563353|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
160775859|NCT02335944|580563354|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
160775860|NCT02335944|580563345|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
160775861|NCT02335944|580563346|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
160775862|NCT02335944|580563347|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
160775863|NCT02335944|580563348|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
160775864|NCT02335944|580563349|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
160775865|NCT02335944|580563350|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
160775866|NCT02335944|580563351|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
160775867|NCT02335944|580563352|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
160775868|NCT02335944|580563353|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
160775869|NCT02335944|580563354|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
160775870|NCT02335944|580563345|FG000|Post-treatment Follow-up|Adverse Event|0|||
160775871|NCT02335944|580563346|FG001|Post-treatment Follow-up|Adverse Event|0|||
160775872|NCT02335944|580563347|FG002|Post-treatment Follow-up|Adverse Event|0|||
160775873|NCT02335944|580563348|FG003|Post-treatment Follow-up|Adverse Event|0|||
160775874|NCT02335944|580563349|FG004|Post-treatment Follow-up|Adverse Event|0|||
160775875|NCT02335944|580563350|FG005|Post-treatment Follow-up|Adverse Event|1|||
160775876|NCT02335944|580563351|FG006|Post-treatment Follow-up|Adverse Event|0|||
160775877|NCT02335944|580563352|FG007|Post-treatment Follow-up|Adverse Event|0|||
160775878|NCT02335944|580563353|FG008|Post-treatment Follow-up|Adverse Event|0|||
160775879|NCT02335944|580563354|FG009|Post-treatment Follow-up|Adverse Event|0|||
160775880|NCT02335944|580563345|FG000|Post-treatment Follow-up|Death|0|||
160775881|NCT02335944|580563346|FG001|Post-treatment Follow-up|Death|0|||
160775882|NCT02335944|580563347|FG002|Post-treatment Follow-up|Death|0|||
160775883|NCT02335944|580563348|FG003|Post-treatment Follow-up|Death|1|||
160775884|NCT02335944|580563349|FG004|Post-treatment Follow-up|Death|0|||
160775885|NCT02335944|580563350|FG005|Post-treatment Follow-up|Death|1|||
160775886|NCT02335944|580563351|FG006|Post-treatment Follow-up|Death|0|||
160775887|NCT02335944|580563352|FG007|Post-treatment Follow-up|Death|0|||
160775888|NCT02335944|580563353|FG008|Post-treatment Follow-up|Death|0|||
160775889|NCT02335944|580563354|FG009|Post-treatment Follow-up|Death|0|||
160775890|NCT02335944|580563345|FG000|Post-treatment Follow-up|Physician Decision|1|||
160775891|NCT02335944|580563346|FG001|Post-treatment Follow-up|Physician Decision|0|||
160775892|NCT02335944|580563347|FG002|Post-treatment Follow-up|Physician Decision|0|||
160775893|NCT02335944|580563348|FG003|Post-treatment Follow-up|Physician Decision|0|||
160775894|NCT02335944|580563349|FG004|Post-treatment Follow-up|Physician Decision|0|||
160775895|NCT02335944|580563350|FG005|Post-treatment Follow-up|Physician Decision|0|||
160775896|NCT02335944|580563351|FG006|Post-treatment Follow-up|Physician Decision|0|||
160775897|NCT02335944|580563352|FG007|Post-treatment Follow-up|Physician Decision|1|||
160775898|NCT02335944|580563353|FG008|Post-treatment Follow-up|Physician Decision|0|||
160775899|NCT02335944|580563354|FG009|Post-treatment Follow-up|Physician Decision|0|||
160775900|NCT00832975|580563355|FG000|Overall Study|Lost to Follow-up|7|||
160775901|NCT00832975|580563355|FG000|Overall Study|Protocol Violation|6|||
160775902|NCT00832975|580563355|FG000|Overall Study|Death|5|||
160775903|NCT00832975|580563355|FG000|Overall Study|Physician Decision|4|||
160775904|NCT00832975|580563355|FG000|Overall Study|Withdrawal by Subject|3|||
160775905|NCT00832975|580563355|FG000|Overall Study|Other reasons|14|||
160775906|NCT06081829|580563358|FG000|Overall Study|Participants still on-study|8|||
160775907|NCT06081829|580563358|FG000|Overall Study|Death|4|||
160775908|NCT01525589|580563359|FG000|Overall Study|Non-treatment-related AE|1|||
160775909|NCT01525589|580563360|FG001|Overall Study|Non-treatment-related AE|0|||
160775910|NCT01525589|580563361|FG002|Overall Study|Non-treatment-related AE|0|||
160775911|NCT01525589|580563359|FG000|Overall Study|Progressive disease|48|||
160775912|NCT01525589|580563360|FG001|Overall Study|Progressive disease|15|||
160775913|NCT01525589|580563361|FG002|Overall Study|Progressive disease|29|||
160775914|NCT01525589|580563359|FG000|Overall Study|Never treated|2|||
160775915|NCT01525589|580563360|FG001|Overall Study|Never treated|0|||
160775916|NCT01525589|580563361|FG002|Overall Study|Never treated|0|||
160775917|NCT01525589|580563359|FG000|Overall Study|Physician Decision|4|||
160775918|NCT01525589|580563360|FG001|Overall Study|Physician Decision|2|||
160775919|NCT01525589|580563361|FG002|Overall Study|Physician Decision|2|||
160775920|NCT01525589|580563359|FG000|Overall Study|Death|0|||
160775921|NCT01525589|580563360|FG001|Overall Study|Death|0|||
160775922|NCT01525589|580563361|FG002|Overall Study|Death|2|||
160541207|NCT02831673|579711174|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
160541208|NCT02831673|579711170|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
160775923|NCT01525589|580563359|FG000|Overall Study|Treatment-related AE|1|||
160775924|NCT01525589|580563360|FG001|Overall Study|Treatment-related AE|1|||
160775925|NCT01525589|580563361|FG002|Overall Study|Treatment-related AE|2|||
160775926|NCT01525589|580563359|FG000|Overall Study|Other reasons|0|||
160775927|NCT01525589|580563360|FG001|Overall Study|Other reasons|1|||
160775928|NCT01525589|580563361|FG002|Overall Study|Other reasons|0|||
160775929|NCT01525589|580563359|FG000|Overall Study|Withdrawal by Subject|0|||
160775930|NCT01525589|580563360|FG001|Overall Study|Withdrawal by Subject|1|||
160775931|NCT01525589|580563361|FG002|Overall Study|Withdrawal by Subject|0|||
160775932|NCT05253807|580563362|FG000|Overall Study|Death|1|||
160775933|NCT05253807|580563363|FG001|Overall Study|Death|4|||
160775934|NCT05253807|580563362|FG000|Overall Study|Withdrawal by Subject|1|||
160775935|NCT05253807|580563363|FG001|Overall Study|Withdrawal by Subject|0|||
160775936|NCT05253807|580563362|FG000|Overall Study|Study Terminated by Sponsor|1|||
160775937|NCT05253807|580563363|FG001|Overall Study|Study Terminated by Sponsor|1|||
160775938|NCT02145390|580563364|FG000|Overall Study|Withdrawal by Subject|1|||
160775939|NCT02293499|580564777|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
160775940|NCT02293499|580564778|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
160775941|NCT02293499|580564779|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
160775942|NCT02293499|580564777|FG000|Intervention - Camp|Withdrawal by Subject|3|||
160775943|NCT02293499|580564778|FG001|Intervention - Camp|Withdrawal by Subject|6|||
160775944|NCT02293499|580564779|FG002|Intervention - Camp|Withdrawal by Subject|2|||
160775945|NCT02293499|580564777|FG000|Intervention - Camp|these are those not showing up at camp|24|||
160775946|NCT02293499|580564778|FG001|Intervention - Camp|these are those not showing up at camp|28|||
160775947|NCT02293499|580564779|FG002|Intervention - Camp|these are those not showing up at camp|4|||
160775948|NCT02293499|580564777|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
160775949|NCT02293499|580564778|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
160775950|NCT02293499|580564779|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
160775951|NCT02293499|580564777|FG000|3 Month Follow Up|Lost to Follow-up|14|||
160775952|NCT02293499|580564778|FG001|3 Month Follow Up|Lost to Follow-up|15|||
160775953|NCT02293499|580564779|FG002|3 Month Follow Up|Lost to Follow-up|6|||
160775954|NCT02293499|580564777|FG000|6 Month Follow Up|Lost to Follow-up|17|||
160775955|NCT02293499|580564778|FG001|6 Month Follow Up|Lost to Follow-up|27|||
160775956|NCT02293499|580564779|FG002|6 Month Follow Up|Lost to Follow-up|6|||
160775957|NCT02293499|580564777|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
160775958|NCT02293499|580564778|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
160775959|NCT02293499|580564779|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
160775960|NCT02293499|580564777|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
160541209|NCT02831673|579711171|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
160541210|NCT02831673|579711172|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
160541211|NCT02831673|579711173|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
160541212|NCT02831673|579711174|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
160541213|NCT02831673|579711170|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
160541214|NCT02831673|579711171|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
160541215|NCT02831673|579711172|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
160541216|NCT02831673|579711173|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
160541217|NCT02831673|579711174|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
160541218|NCT02831673|579711170|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
160541219|NCT02831673|579711171|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
160775961|NCT02293499|580564778|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
160775962|NCT02293499|580564779|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
160775963|NCT02293499|580564777|FG000|9 Month Follow Up|Lost to Follow-up|24|||
160775964|NCT02293499|580564778|FG001|9 Month Follow Up|Lost to Follow-up|28|||
160775965|NCT02293499|580564779|FG002|9 Month Follow Up|Lost to Follow-up|4|||
160775966|NCT02293499|580564777|FG000|12 Month Follow Up|Lost to Follow-up|26|||
160886622|NCT02038829|580980540|FG001|Treatment Period 2|Adverse Event|0|||
160886623|NCT02038829|580980541|FG002|Treatment Period 2|Adverse Event|0|||
160886624|NCT02038829|580980542|FG003|Treatment Period 2|Adverse Event|0|||
160886625|NCT02038829|580980543|FG004|Treatment Period 2|Adverse Event|0|||
160541220|NCT02831673|579711172|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
160541221|NCT02831673|579711173|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
160541222|NCT02831673|579711174|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
160541223|NCT02831673|579711170|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
160541224|NCT02831673|579711171|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
160541225|NCT02831673|579711172|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
160541226|NCT02831673|579711173|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
160541227|NCT02831673|579711174|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
160541228|NCT02831673|579711170|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160541229|NCT02831673|579711171|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160541230|NCT02831673|579711172|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160541231|NCT02831673|579711173|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160541232|NCT02831673|579711174|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
160541233|NCT02831673|579711170|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160541234|NCT02831673|579711171|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160541235|NCT02831673|579711172|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160541236|NCT02831673|579711173|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160775967|NCT02293499|580564778|FG001|12 Month Follow Up|Lost to Follow-up|25|||
160775968|NCT02293499|580564779|FG002|12 Month Follow Up|Lost to Follow-up|6|||
160775969|NCT02293499|580564777|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
160775970|NCT02293499|580564778|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
160775971|NCT02293499|580564779|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
160775972|NCT02293499|580564777|FG000|15 Month Follow Up|Lost to Follow-up|22|||
160775973|NCT02293499|580564778|FG001|15 Month Follow Up|Lost to Follow-up|22|||
160775974|NCT02293499|580564779|FG002|15 Month Follow Up|Lost to Follow-up|7|||
160775975|NCT05977868|580564780|FG000|Overall Study|Withdrawal by Subject|1|||
160775976|NCT05977868|580564781|FG001|Overall Study|Withdrawal by Subject|2|||
160775977|NCT05977868|580564780|FG000|Overall Study|Transitioned to comfort care|1|||
160775978|NCT05977868|580564781|FG001|Overall Study|Transitioned to comfort care|0|||
160775979|NCT00876395|580564782|FG000|Overall Study|Untreated|8|||
160775980|NCT00876395|580564783|FG001|Overall Study|Untreated|1|||
160775981|NCT00876395|580564782|FG000|Overall Study|Adverse Event|63|||
160775982|NCT00876395|580564783|FG001|Overall Study|Adverse Event|11|||
160775983|NCT00876395|580564782|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160775984|NCT00876395|580564783|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160775985|NCT00876395|580564782|FG000|Overall Study|Disease progression|259|||
160775986|NCT00876395|580564783|FG001|Overall Study|Disease progression|162|||
160775987|NCT00876395|580564782|FG000|Overall Study|New cancer therapy|25|||
160775988|NCT00876395|580564783|FG001|Overall Study|New cancer therapy|7|||
160775989|NCT00876395|580564782|FG000|Overall Study|Protocol Violation|5|||
160775990|NCT00876395|580564783|FG001|Overall Study|Protocol Violation|2|||
160775991|NCT00876395|580564782|FG000|Overall Study|Withdrawal by Subject|66|||
160775992|NCT00876395|580564783|FG001|Overall Study|Withdrawal by Subject|33|||
160775993|NCT00876395|580564782|FG000|Overall Study|Lost to Follow-up|2|||
160775994|NCT00876395|580564783|FG001|Overall Study|Lost to Follow-up|0|||
160775995|NCT00876395|580564782|FG000|Overall Study|Administrative problems|39|||
160775996|NCT00876395|580564783|FG001|Overall Study|Administrative problems|23|||
160775997|NCT00876395|580564782|FG000|Overall Study|Death|12|||
160775998|NCT00876395|580564783|FG001|Overall Study|Death|0|||
160775999|NCT00970944|580564804|FG000|Overall Study|Death|1|||
160776000|NCT00970944|580564805|FG001|Overall Study|Death|0|||
160776001|NCT00970944|580564804|FG000|Overall Study|Physician Decision|0|||
160776002|NCT00970944|580564805|FG001|Overall Study|Physician Decision|2|||
160776003|NCT02008370|580564806|FG000|Overall Study|Lost to Follow-up|7|||
160776004|NCT00662259|580564807|FG000|Overall Study|Adverse Event|2|||
160776005|NCT00662259|580564808|FG001|Overall Study|Adverse Event|0|||
160776006|NCT00972738|580564809|FG000|Overall Study|Adverse Event|7|||
160776007|NCT00972738|580564810|FG001|Overall Study|Adverse Event|1|||
160776008|NCT00972738|580564811|FG002|Overall Study|Adverse Event|8|||
160776009|NCT00972738|580564809|FG000|Overall Study|Protocol Violation|2|||
160776010|NCT00972738|580564810|FG001|Overall Study|Protocol Violation|1|||
160776011|NCT00972738|580564811|FG002|Overall Study|Protocol Violation|3|||
160776012|NCT00972738|580564809|FG000|Overall Study|Lost to Follow-up|1|||
160776013|NCT00972738|580564810|FG001|Overall Study|Lost to Follow-up|0|||
160776014|NCT00972738|580564811|FG002|Overall Study|Lost to Follow-up|1|||
160776015|NCT00972738|580564809|FG000|Overall Study|Lack of Efficacy|5|||
160776016|NCT00972738|580564810|FG001|Overall Study|Lack of Efficacy|1|||
160776017|NCT00972738|580564811|FG002|Overall Study|Lack of Efficacy|11|||
160776018|NCT00972738|580564809|FG000|Overall Study|Withdrawal by Subject|5|||
160776019|NCT00972738|580564810|FG001|Overall Study|Withdrawal by Subject|1|||
160776020|NCT00972738|580564811|FG002|Overall Study|Withdrawal by Subject|4|||
160776021|NCT00972738|580564809|FG000|Overall Study|Moved|0|||
160776022|NCT00972738|580564810|FG001|Overall Study|Moved|0|||
160776023|NCT00972738|580564811|FG002|Overall Study|Moved|1|||
160776024|NCT00972738|580564809|FG000|Overall Study|Other|1|||
160776025|NCT00972738|580564810|FG001|Overall Study|Other|2|||
160776026|NCT00972738|580564811|FG002|Overall Study|Other|1|||
160776027|NCT03915067|580564813|FG000|Overall Study|Adverse Event|0|||
160776028|NCT03915067|580564814|FG001|Overall Study|Adverse Event|0|||
160776029|NCT03915067|580564815|FG002|Overall Study|Adverse Event|1|||
160776030|NCT03915067|580564813|FG000|Overall Study|Withdrawal by Subject|4|||
160776031|NCT03915067|580564814|FG001|Overall Study|Withdrawal by Subject|3|||
160776032|NCT03915067|580564815|FG002|Overall Study|Withdrawal by Subject|0|||
160776033|NCT03915067|580564813|FG000|Overall Study|Lost to Follow-up|3|||
160776034|NCT03915067|580564814|FG001|Overall Study|Lost to Follow-up|2|||
160776035|NCT03915067|580564815|FG002|Overall Study|Lost to Follow-up|0|||
160776036|NCT03915067|580564813|FG000|Overall Study|Protocol Deviation|0|||
160776037|NCT03915067|580564814|FG001|Overall Study|Protocol Deviation|0|||
160776038|NCT03915067|580564815|FG002|Overall Study|Protocol Deviation|1|||
160776039|NCT03915067|580564813|FG000|Overall Study|Covid-19 Related Issues|2|||
160776040|NCT03915067|580564814|FG001|Overall Study|Covid-19 Related Issues|4|||
160776041|NCT03915067|580564815|FG002|Overall Study|Covid-19 Related Issues|4|||
160776042|NCT03915067|580564813|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
160776043|NCT03915067|580564814|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
160776044|NCT03915067|580564815|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
160776045|NCT03317496|580564816|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
160776046|NCT03317496|580564817|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
160776047|NCT03317496|580564818|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
160776048|NCT03317496|580564819|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
160776049|NCT03317496|580564820|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
160776050|NCT03317496|580564816|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
160776051|NCT03317496|580564817|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
160776052|NCT03317496|580564818|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
160776053|NCT03317496|580564819|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
160776054|NCT03317496|580564820|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
160776055|NCT03317496|580564816|FG000|Phase 1b Lead-in: Treatment|Death|0|||
160776056|NCT03317496|580564817|FG001|Phase 1b Lead-in: Treatment|Death|0|||
160776057|NCT03317496|580564818|FG002|Phase 1b Lead-in: Treatment|Death|1|||
160776058|NCT03317496|580564819|FG003|Phase 1b Lead-in: Treatment|Death|0|||
160776059|NCT03317496|580564820|FG004|Phase 1b Lead-in: Treatment|Death|0|||
160776060|NCT03317496|580564816|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
160776061|NCT03317496|580564817|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
160776062|NCT03317496|580564818|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
160776063|NCT03317496|580564819|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
160776064|NCT03317496|580564820|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
160776065|NCT03317496|580564816|FG000|Phase 1b Lead-in: Treatment|Other|2|||
160776066|NCT03317496|580564817|FG001|Phase 1b Lead-in: Treatment|Other|1|||
160776067|NCT03317496|580564818|FG002|Phase 1b Lead-in: Treatment|Other|0|||
160776068|NCT03317496|580564819|FG003|Phase 1b Lead-in: Treatment|Other|0|||
160776069|NCT03317496|580564820|FG004|Phase 1b Lead-in: Treatment|Other|0|||
160776070|NCT03317496|580564816|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
160776071|NCT03317496|580564817|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
160776072|NCT03317496|580564818|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
160776073|NCT03317496|580564819|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
160776074|NCT03317496|580564820|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
160776075|NCT03317496|580564816|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
160776076|NCT03317496|580564817|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
160776077|NCT03317496|580564818|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
160776078|NCT03317496|580564819|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
160776079|NCT03317496|580564820|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
160776080|NCT03317496|580564816|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
160776081|NCT03317496|580564817|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
160776082|NCT03317496|580564818|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
160776083|NCT03317496|580564819|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
160776084|NCT03317496|580564820|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
160776085|NCT03317496|580564816|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
160776086|NCT03317496|580564817|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
160776087|NCT03317496|580564818|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
160776088|NCT03317496|580564819|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
160776089|NCT03317496|580564820|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
160776090|NCT03317496|580564816|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
160776091|NCT03317496|580564817|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
160776092|NCT03317496|580564818|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
160776093|NCT03317496|580564819|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
160776094|NCT03317496|580564820|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
160776095|NCT03317496|580564816|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
160776096|NCT03317496|580564817|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
160776097|NCT03317496|580564818|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
160776098|NCT03317496|580564819|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
160776099|NCT03317496|580564820|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
160776100|NCT03317496|580564816|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
160776101|NCT03317496|580564817|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
160776102|NCT03317496|580564818|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
160776103|NCT03317496|580564819|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
160776104|NCT03317496|580564820|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
160776105|NCT03317496|580564816|FG000|Phase 2: Treatment|Adverse Event|0|||
160776106|NCT03317496|580564817|FG001|Phase 2: Treatment|Adverse Event|0|||
160776107|NCT03317496|580564818|FG002|Phase 2: Treatment|Adverse Event|0|||
160776108|NCT03317496|580564819|FG003|Phase 2: Treatment|Adverse Event|0|||
160776109|NCT03317496|580564820|FG004|Phase 2: Treatment|Adverse Event|6|||
160776110|NCT03317496|580564816|FG000|Phase 2: Treatment|Progressive disease|0|||
160776111|NCT03317496|580564817|FG001|Phase 2: Treatment|Progressive disease|0|||
160776112|NCT03317496|580564818|FG002|Phase 2: Treatment|Progressive disease|0|||
160776113|NCT03317496|580564819|FG003|Phase 2: Treatment|Progressive disease|0|||
160776114|NCT03317496|580564820|FG004|Phase 2: Treatment|Progressive disease|22|||
160776115|NCT03317496|580564816|FG000|Phase 2: Treatment|Other|0|||
160776116|NCT03317496|580564817|FG001|Phase 2: Treatment|Other|0|||
160776117|NCT03317496|580564818|FG002|Phase 2: Treatment|Other|0|||
160776118|NCT03317496|580564819|FG003|Phase 2: Treatment|Other|0|||
160776119|NCT03317496|580564820|FG004|Phase 2: Treatment|Other|4|||
160776120|NCT03317496|580564816|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
160776121|NCT03317496|580564817|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
160776122|NCT03317496|580564818|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
160776123|NCT03317496|580564819|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
160776124|NCT03317496|580564820|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
160776125|NCT03317496|580564816|FG000|Phase 2: Treatment|Physician Decision|0|||
160776126|NCT03317496|580564817|FG001|Phase 2: Treatment|Physician Decision|0|||
160776127|NCT03317496|580564818|FG002|Phase 2: Treatment|Physician Decision|0|||
160776128|NCT03317496|580564819|FG003|Phase 2: Treatment|Physician Decision|0|||
160776129|NCT03317496|580564820|FG004|Phase 2: Treatment|Physician Decision|1|||
160776130|NCT03317496|580564816|FG000|Phase 2: Treatment|Death|0|||
160776131|NCT03317496|580564817|FG001|Phase 2: Treatment|Death|0|||
160776132|NCT03317496|580564818|FG002|Phase 2: Treatment|Death|0|||
160776133|NCT03317496|580564819|FG003|Phase 2: Treatment|Death|0|||
160776134|NCT03317496|580564820|FG004|Phase 2: Treatment|Death|1|||
160776135|NCT03317496|580564816|FG000|Phase 2: Follow-up|Death|0|||
160776136|NCT03317496|580564817|FG001|Phase 2: Follow-up|Death|0|||
160776137|NCT03317496|580564818|FG002|Phase 2: Follow-up|Death|0|||
160776138|NCT03317496|580564819|FG003|Phase 2: Follow-up|Death|0|||
160776139|NCT03317496|580564820|FG004|Phase 2: Follow-up|Death|24|||
160776140|NCT03317496|580564816|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
160776141|NCT03317496|580564817|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
160776142|NCT03317496|580564818|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
160776143|NCT03317496|580564819|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
160541237|NCT02831673|579711174|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
160541238|NCT02831673|579711170|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160541239|NCT02831673|579711171|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160541240|NCT02831673|579711172|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160541241|NCT02831673|579711173|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160541242|NCT02831673|579711174|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
160776144|NCT03317496|580564820|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
160776145|NCT03317496|580564816|FG000|Phase 2: Follow-up|Other|0|||
160776146|NCT03317496|580564817|FG001|Phase 2: Follow-up|Other|0|||
160776147|NCT03317496|580564818|FG002|Phase 2: Follow-up|Other|0|||
160776148|NCT03317496|580564819|FG003|Phase 2: Follow-up|Other|0|||
160776149|NCT03317496|580564820|FG004|Phase 2: Follow-up|Other|1|||
160776150|NCT03317496|580564816|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
160776151|NCT03317496|580564817|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
160776152|NCT03317496|580564818|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
160776153|NCT03317496|580564819|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
160776154|NCT03317496|580564820|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
160776155|NCT02693418|580564821|FG000|Overall Study|Lost to Follow-up|1|||
160776156|NCT02693418|580564822|FG001|Overall Study|Lost to Follow-up|2|||
160776157|NCT02693418|580564823|FG002|Overall Study|Lost to Follow-up|0|||
160776158|NCT02693418|580564824|FG003|Overall Study|Lost to Follow-up|0|||
160776159|NCT02693418|580564825|FG004|Overall Study|Lost to Follow-up|0|||
160776160|NCT02693418|580564821|FG000|Overall Study|Menses during study period|0|||
160776161|NCT02693418|580564822|FG001|Overall Study|Menses during study period|0|||
160776162|NCT02693418|580564823|FG002|Overall Study|Menses during study period|2|||
160776163|NCT02693418|580564824|FG003|Overall Study|Menses during study period|0|||
160776164|NCT02693418|580564825|FG004|Overall Study|Menses during study period|0|||
160776165|NCT01750346|580564828|FG000|Overall Study|Adverse Event|1|||
160776166|NCT01750346|580564829|FG001|Overall Study|Adverse Event|0|||
160776167|NCT01750346|580564830|FG002|Overall Study|Adverse Event|0|||
160776168|NCT01001104|580564833|FG000|Overall Study|Adverse Event|2|||
160776169|NCT01001104|580564834|FG001|Overall Study|Adverse Event|1|||
160776170|NCT01001104|580564835|FG002|Overall Study|Adverse Event|0|||
160776171|NCT01001104|580564836|FG003|Overall Study|Adverse Event|0|||
160776172|NCT01001104|580564833|FG000|Overall Study|Lost to Follow-up|0|||
160776173|NCT01001104|580564834|FG001|Overall Study|Lost to Follow-up|0|||
160776174|NCT01001104|580564835|FG002|Overall Study|Lost to Follow-up|1|||
160776175|NCT01001104|580564836|FG003|Overall Study|Lost to Follow-up|0|||
160776176|NCT01001104|580564833|FG000|Overall Study|Entry Criteria Not Met|0|||
160776177|NCT01001104|580564834|FG001|Overall Study|Entry Criteria Not Met|0|||
160776178|NCT01001104|580564835|FG002|Overall Study|Entry Criteria Not Met|0|||
160776179|NCT01001104|580564836|FG003|Overall Study|Entry Criteria Not Met|1|||
160776180|NCT01001104|580564833|FG000|Overall Study|Withdrawal by Subject|0|||
160776181|NCT01001104|580564834|FG001|Overall Study|Withdrawal by Subject|0|||
160776182|NCT01001104|580564835|FG002|Overall Study|Withdrawal by Subject|0|||
160776183|NCT01001104|580564836|FG003|Overall Study|Withdrawal by Subject|2|||
160776184|NCT02034591|580564837|FG000|Overall Study|Withdrawal by Subject|0|||
160776185|NCT02034591|580564838|FG001|Overall Study|Withdrawal by Subject|0|||
160776186|NCT02034591|580564839|FG002|Overall Study|Withdrawal by Subject|0|||
160776187|NCT02034591|580564840|FG003|Overall Study|Withdrawal by Subject|0|||
160776188|NCT02034591|580564841|FG004|Overall Study|Withdrawal by Subject|1|||
160776189|NCT02034591|580564842|FG005|Overall Study|Withdrawal by Subject|0|||
160776190|NCT00599313|580564845|FG000|Overall Study|Adverse Event|19|||
160776191|NCT00599313|580564845|FG000|Overall Study|Disease Progression|12|||
160776192|NCT00599313|580564845|FG000|Overall Study|Patient Request|4|||
160776193|NCT00599313|580564845|FG000|Overall Study|Ineligible|1|||
160776194|NCT01121926|580564846|FG000|First Intervention Period|Adverse Event|1|||
160776195|NCT01121926|580564847|FG001|First Intervention Period|Adverse Event|0|||
160776196|NCT01121926|580564846|FG000|Washout Period|Adverse Event|0|||
160776197|NCT01121926|580564847|FG001|Washout Period|Adverse Event|1|||
160776198|NCT01121926|580564846|FG000|Washout Period|Positive pregnancy test|0|||
160776199|NCT01121926|580564847|FG001|Washout Period|Positive pregnancy test|1|||
160776200|NCT01496456|580564849|FG000|Overall Study|Protocol Violation|1|||
160776201|NCT01496456|580564849|FG000|Overall Study|Lost to Follow-up|7|||
160776202|NCT00620542|580564852|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
160776203|NCT00620542|580564853|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
160776204|NCT00620542|580564854|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
160776205|NCT00620542|580564855|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
160776206|NCT00620542|580564852|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
160776207|NCT00620542|580564853|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
160776208|NCT00620542|580564854|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
160776209|NCT00620542|580564855|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
160776210|NCT00620542|580564852|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
160776211|NCT00620542|580564853|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
160776212|NCT00620542|580564854|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
160776213|NCT00620542|580564855|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
160541243|NCT02831673|579711170|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160541244|NCT02831673|579711171|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160541245|NCT02831673|579711172|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160541246|NCT02831673|579711173|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160541247|NCT02831673|579711174|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
160541248|NCT00150592|579711175|FG000|Overall Study|Adverse Event|4|||
160541249|NCT00150592|579711176|FG001|Overall Study|Adverse Event|1|||
160541250|NCT00150592|579711175|FG000|Overall Study|Protocol Violation|1|||
160541251|NCT00150592|579711176|FG001|Overall Study|Protocol Violation|0|||
160541252|NCT00150592|579711175|FG000|Overall Study|Withdrawal by Subject|1|||
160541253|NCT00150592|579711176|FG001|Overall Study|Withdrawal by Subject|2|||
160541254|NCT00150592|579711175|FG000|Overall Study|Non-compliance|1|||
160541255|NCT00150592|579711176|FG001|Overall Study|Non-compliance|0|||
160541256|NCT01823679|579711178|FG000|Overall Study|Death|1|||
160541257|NCT00477165|579711179|FG000|Overall Study|Adverse Event|7|||
160541258|NCT00477165|579711180|FG001|Overall Study|Adverse Event|2|||
160541259|NCT02135692|579711184|FG000|Overall Study|Adverse Event|3|||
160541260|NCT02135692|579711184|FG000|Overall Study|Lack of Efficacy|2|||
160541261|NCT02135692|579711184|FG000|Overall Study|Protocol Violation|2|||
160541262|NCT02135692|579711184|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
160541263|NCT02135692|579711184|FG000|Overall Study|Product commercially available|159|||
160541264|NCT02135692|579711184|FG000|Overall Study|Study closed/terminated|153|||
160541265|NCT02135692|579711184|FG000|Overall Study|Lost to Follow-up|4|||
160541266|NCT02135692|579711184|FG000|Overall Study|Withdrawal by Subject|15|||
160541267|NCT02495844|579711187|FG000|Overall Study|Lack of Efficacy|1|||
160541268|NCT02495844|579711188|FG001|Overall Study|Lack of Efficacy|2|||
160541269|NCT02495844|579711187|FG000|Overall Study|AE, non-fatal|0|||
160541270|NCT02495844|579711188|FG001|Overall Study|AE, non-fatal|1|||
160541271|NCT02495844|579711187|FG000|Overall Study|Hepatitis Positivity|0|||
160541272|NCT02495844|579711188|FG001|Overall Study|Hepatitis Positivity|1|||
160541273|NCT00132132|579711190|FG000|Overall Study|Lost to Follow-up|7|||
160541274|NCT00132132|579711191|FG001|Overall Study|Lost to Follow-up|2|||
160541275|NCT02145741|579711192|FG000|Overall Study|Progressive disease|3|||
160541276|NCT02145741|579711193|FG001|Overall Study|Progressive disease|6|||
160776214|NCT00620542|580564852|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
160776215|NCT00620542|580564853|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
160776216|NCT00620542|580564854|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
160776217|NCT00620542|580564855|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
160776218|NCT00620542|580564852|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
160776219|NCT00620542|580564853|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
160776220|NCT00620542|580564854|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
160776221|NCT00620542|580564855|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
160541277|NCT02145741|579711194|FG002|Overall Study|Progressive disease|6|||
160637931|NCT00123487|580057991|FG001|Treated With Study Drug|Disease Progression|122|||
160776222|NCT00620542|580564852|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
160776223|NCT00620542|580564853|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
160776224|NCT00620542|580564854|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
160776225|NCT00620542|580564855|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
160776226|NCT00620542|580564852|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
160776227|NCT00620542|580564853|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
160776228|NCT00620542|580564854|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
160776229|NCT00620542|580564855|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
160776230|NCT00620542|580564852|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
160776231|NCT00620542|580564853|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
160541278|NCT02145741|579711192|FG000|Overall Study|quality issue with the administered drug|3|||
160541279|NCT02145741|579711193|FG001|Overall Study|quality issue with the administered drug|0|||
160541280|NCT02145741|579711194|FG002|Overall Study|quality issue with the administered drug|0|||
160541281|NCT00623480|579711195|FG000|Overall Study|Lost to Follow-up|0|||
160541282|NCT00623480|579711196|FG001|Overall Study|Lost to Follow-up|1|||
160541283|NCT00623480|579711195|FG000|Overall Study|Withdrawal by Subject|2|||
160776232|NCT00620542|580564854|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
160776233|NCT00620542|580564855|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
160776234|NCT00620542|580564852|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
160776235|NCT00620542|580564853|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
160776236|NCT00620542|580564854|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
160776237|NCT00620542|580564855|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
160776238|NCT00620542|580564852|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
160776239|NCT00620542|580564853|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
160776240|NCT00620542|580564854|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
160776241|NCT00620542|580564855|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
160776242|NCT00620542|580564852|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
160776243|NCT00620542|580564853|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
160776244|NCT00620542|580564854|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
160776245|NCT00620542|580564855|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
160776246|NCT00620542|580564852|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
160776247|NCT00620542|580564853|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
160776248|NCT00620542|580564854|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
160776249|NCT00620542|580564855|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
160886626|NCT02038829|580980544|FG005|Treatment Period 2|Adverse Event|0|||
160886627|NCT02038829|580980545|FG006|Treatment Period 2|Adverse Event|0|||
160776250|NCT00620542|580564852|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
160776251|NCT00620542|580564853|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
160776252|NCT00620542|580564854|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
160776253|NCT00620542|580564855|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
160776254|NCT00620542|580564852|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
160776255|NCT00620542|580564853|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
160776256|NCT00620542|580564854|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
160776257|NCT00620542|580564855|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
160776258|NCT00620542|580564852|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
160776259|NCT00620542|580564853|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
160776260|NCT00620542|580564854|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
160776261|NCT00620542|580564855|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
160776262|NCT02696616|580564856|FG000|Overall Study|Adverse Event|0|||
160776263|NCT02696616|580564857|FG001|Overall Study|Adverse Event|1|||
160776264|NCT02696616|580564858|FG002|Overall Study|Adverse Event|0|||
160776265|NCT02696616|580564859|FG003|Overall Study|Adverse Event|0|||
160776266|NCT02696616|580564860|FG004|Overall Study|Adverse Event|0|||
160776267|NCT02696616|580564861|FG005|Overall Study|Adverse Event|0|||
160776268|NCT02696616|580564862|FG006|Overall Study|Adverse Event|0|||
160776269|NCT01500083|580564863|FG000|Overall Study|Adverse Event|4|||
160776270|NCT01500083|580564864|FG001|Overall Study|Adverse Event|17|||
160776271|NCT01500083|580564863|FG000|Overall Study|Death|0|||
160776272|NCT01500083|580564864|FG001|Overall Study|Death|2|||
160776273|NCT01500083|580564863|FG000|Overall Study|Lost to Follow-up|1|||
160776274|NCT01500083|580564864|FG001|Overall Study|Lost to Follow-up|0|||
160776275|NCT01500083|580564863|FG000|Overall Study|Withdrawal of Consent|0|||
160776276|NCT01500083|580564864|FG001|Overall Study|Withdrawal of Consent|1|||
160776277|NCT01500083|580564863|FG000|Overall Study|Disease Progression|2|||
160776278|NCT01500083|580564864|FG001|Overall Study|Disease Progression|10|||
160776279|NCT01500083|580564863|FG000|Overall Study|Investigator Discretion|3|||
160776280|NCT01500083|580564864|FG001|Overall Study|Investigator Discretion|8|||
160776281|NCT01500083|580564863|FG000|Overall Study|Other Reasons|2|||
160886628|NCT02038829|580980546|FG007|Treatment Period 2|Adverse Event|0|||
160886629|NCT02038829|580980547|FG008|Treatment Period 2|Adverse Event|0|||
160886630|NCT02038829|580980548|FG009|Treatment Period 2|Adverse Event|0|||
160886631|NCT02038829|580980549|FG010|Treatment Period 2|Adverse Event|1|||
160886632|NCT02038829|580980550|FG011|Treatment Period 2|Adverse Event|0|||
160776282|NCT01500083|580564864|FG001|Overall Study|Other Reasons|5|||
160776283|NCT01970371|580564865|FG000|Overall Study|Death|8|||
160776284|NCT01970371|580564866|FG001|Overall Study|Death|13|||
160776285|NCT01970371|580564867|FG002|Overall Study|Death|12|||
160776286|NCT01970371|580564865|FG000|Overall Study|Lost to Follow-up|0|||
160886633|NCT02038829|580980539|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160886634|NCT02038829|580980540|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160886635|NCT02038829|580980541|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160886636|NCT02038829|580980542|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160886637|NCT02038829|580980543|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160776287|NCT01970371|580564866|FG001|Overall Study|Lost to Follow-up|0|||
160776288|NCT01970371|580564867|FG002|Overall Study|Lost to Follow-up|1|||
160776289|NCT01481779|580564868|FG000|Overall Study|Adverse Event|23|||
160776290|NCT01481779|580564869|FG001|Overall Study|Adverse Event|5|||
160886638|NCT02038829|580980544|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160886639|NCT02038829|580980545|FG006|Treatment Period 2|Withdrawal by Subject|0|||
160541284|NCT00623480|579711196|FG001|Overall Study|Withdrawal by Subject|4|||
160776291|NCT01481779|580564868|FG000|Overall Study|Lost to Follow-up|3|||
160776292|NCT01481779|580564869|FG001|Overall Study|Lost to Follow-up|2|||
160776293|NCT01481779|580564868|FG000|Overall Study|Protocol Violation|2|||
160776294|NCT01481779|580564869|FG001|Overall Study|Protocol Violation|3|||
160776295|NCT01481779|580564868|FG000|Overall Study|Withdrawal by Subject|26|||
160776296|NCT01481779|580564869|FG001|Overall Study|Withdrawal by Subject|13|||
160776297|NCT01481779|580564868|FG000|Overall Study|Physician Decision|13|||
160776298|NCT01481779|580564869|FG001|Overall Study|Physician Decision|4|||
160776299|NCT01481779|580564868|FG000|Overall Study|Sponsor Decision|3|||
160776300|NCT01481779|580564869|FG001|Overall Study|Sponsor Decision|1|||
160776301|NCT01964404|580564872|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
160776302|NCT01964404|580564873|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
160776303|NCT01964404|580564874|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
160776304|NCT01964404|580564875|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
160776305|NCT01964404|580564876|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
160776306|NCT01964404|580564877|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
160776307|NCT01964404|580564878|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
160776308|NCT01964404|580564879|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
160776309|NCT01964404|580564880|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
160776310|NCT01964404|580564881|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
160776311|NCT01964404|580564872|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
160776312|NCT01964404|580564873|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
160776313|NCT01964404|580564874|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
160776314|NCT01964404|580564875|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
160776315|NCT01964404|580564876|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776316|NCT01964404|580564877|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776317|NCT01964404|580564878|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776318|NCT01964404|580564879|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776319|NCT01964404|580564880|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776320|NCT01964404|580564881|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776321|NCT01964404|580564872|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
160776322|NCT01964404|580564873|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
160776323|NCT01964404|580564874|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776324|NCT01964404|580564875|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
160776325|NCT01964404|580564876|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776326|NCT01964404|580564877|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776327|NCT01964404|580564878|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776328|NCT01964404|580564879|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776329|NCT01964404|580564880|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776330|NCT01964404|580564881|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
160776331|NCT04556097|580564882|FG000|Overall Study|Death|0|||
160776332|NCT04556097|580564883|FG001|Overall Study|Death|5|||
160776333|NCT04556097|580564884|FG002|Overall Study|Death|0|||
160886640|NCT02038829|580980546|FG007|Treatment Period 2|Withdrawal by Subject|0|||
160886641|NCT02038829|580980547|FG008|Treatment Period 2|Withdrawal by Subject|0|||
160886642|NCT02038829|580980548|FG009|Treatment Period 2|Withdrawal by Subject|0|||
160776334|NCT04556097|580564885|FG003|Overall Study|Death|0|||
160776335|NCT04556097|580564882|FG000|Overall Study|No caregiver|43|||
160776336|NCT04556097|580564883|FG001|Overall Study|No caregiver|53|||
160776337|NCT04556097|580564884|FG002|Overall Study|No caregiver|0|||
160776338|NCT04556097|580564885|FG003|Overall Study|No caregiver|0|||
160776339|NCT04556097|580564882|FG000|Overall Study|Ineligible, SNF|2|||
160776340|NCT04556097|580564883|FG001|Overall Study|Ineligible, SNF|2|||
160776341|NCT04556097|580564884|FG002|Overall Study|Ineligible, SNF|0|||
160776342|NCT04556097|580564885|FG003|Overall Study|Ineligible, SNF|0|||
160776343|NCT04556097|580564882|FG000|Overall Study|Ineligible, health|3|||
160776344|NCT04556097|580564883|FG001|Overall Study|Ineligible, health|4|||
160776345|NCT04556097|580564884|FG002|Overall Study|Ineligible, health|0|||
160776346|NCT04556097|580564885|FG003|Overall Study|Ineligible, health|0|||
160776347|NCT04556097|580564882|FG000|Overall Study|Ineligible, language|0|||
160776348|NCT04556097|580564883|FG001|Overall Study|Ineligible, language|1|||
160776349|NCT04556097|580564884|FG002|Overall Study|Ineligible, language|0|||
160776350|NCT04556097|580564885|FG003|Overall Study|Ineligible, language|0|||
160776351|NCT04556097|580564882|FG000|Overall Study|Ineligible, no longer in care management|0|||
160776352|NCT04556097|580564883|FG001|Overall Study|Ineligible, no longer in care management|2|||
160776353|NCT04556097|580564884|FG002|Overall Study|Ineligible, no longer in care management|1|||
160776354|NCT04556097|580564885|FG003|Overall Study|Ineligible, no longer in care management|0|||
160776355|NCT04556097|580564882|FG000|Overall Study|No dementia|13|||
160776356|NCT04556097|580564883|FG001|Overall Study|No dementia|3|||
160776357|NCT04556097|580564884|FG002|Overall Study|No dementia|0|||
160776358|NCT04556097|580564885|FG003|Overall Study|No dementia|0|||
160776359|NCT04556097|580564882|FG000|Overall Study|Missing identifier|2|||
160776360|NCT04556097|580564883|FG001|Overall Study|Missing identifier|4|||
160776361|NCT04556097|580564884|FG002|Overall Study|Missing identifier|0|||
160776362|NCT04556097|580564885|FG003|Overall Study|Missing identifier|0|||
160776363|NCT04556097|580564882|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
160776364|NCT04556097|580564883|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
160776365|NCT04556097|580564884|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
160776366|NCT04556097|580564885|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
160776367|NCT05436613|580564886|FG000|Overall Study|Lost to Follow-up|9|||
160776368|NCT05436613|580564886|FG000|Overall Study|Withdrawal by Subject|3|||
160776369|NCT02924376|580564893|FG000|Overall Study|Progressive Disease|4|||
160776370|NCT02924376|580564894|FG001|Overall Study|Progressive Disease|0|||
160776371|NCT02924376|580564895|FG002|Overall Study|Progressive Disease|1|||
160776372|NCT02924376|580564896|FG003|Overall Study|Progressive Disease|0|||
160776373|NCT02924376|580564893|FG000|Overall Study|Death|73|||
160776374|NCT02924376|580564894|FG001|Overall Study|Death|18|||
160776375|NCT02924376|580564895|FG002|Overall Study|Death|15|||
160776376|NCT02924376|580564896|FG003|Overall Study|Death|2|||
160776377|NCT02924376|580564893|FG000|Overall Study|Lost to Follow-up|3|||
160776378|NCT02924376|580564894|FG001|Overall Study|Lost to Follow-up|0|||
160776379|NCT02924376|580564895|FG002|Overall Study|Lost to Follow-up|0|||
160776380|NCT02924376|580564896|FG003|Overall Study|Lost to Follow-up|0|||
160776381|NCT02924376|580564893|FG000|Overall Study|Study Terminated by Sponsor|19|||
160886643|NCT02038829|580980549|FG010|Treatment Period 2|Withdrawal by Subject|0|||
160886644|NCT02038829|580980550|FG011|Treatment Period 2|Withdrawal by Subject|0|||
160886645|NCT02038829|580980539|FG000|Washout Period 2|Adverse Event|0|||
160886646|NCT02038829|580980540|FG001|Washout Period 2|Adverse Event|0|||
160886647|NCT02038829|580980541|FG002|Washout Period 2|Adverse Event|0|||
160886648|NCT02038829|580980542|FG003|Washout Period 2|Adverse Event|0|||
160886649|NCT02038829|580980543|FG004|Washout Period 2|Adverse Event|0|||
160886650|NCT02038829|580980544|FG005|Washout Period 2|Adverse Event|0|||
160886651|NCT02038829|580980545|FG006|Washout Period 2|Adverse Event|0|||
160886652|NCT02038829|580980546|FG007|Washout Period 2|Adverse Event|0|||
160886653|NCT02038829|580980547|FG008|Washout Period 2|Adverse Event|1|||
160886654|NCT02038829|580980548|FG009|Washout Period 2|Adverse Event|0|||
160886655|NCT02038829|580980549|FG010|Washout Period 2|Adverse Event|0|||
160886656|NCT02038829|580980550|FG011|Washout Period 2|Adverse Event|0|||
160886657|NCT02038829|580980539|FG000|Washout Period 2|Withdrawal by Subject|0|||
160886658|NCT02038829|580980540|FG001|Washout Period 2|Withdrawal by Subject|0|||
160886659|NCT02038829|580980541|FG002|Washout Period 2|Withdrawal by Subject|0|||
160886660|NCT02038829|580980542|FG003|Washout Period 2|Withdrawal by Subject|0|||
160886661|NCT02038829|580980543|FG004|Washout Period 2|Withdrawal by Subject|0|||
160886662|NCT02038829|580980544|FG005|Washout Period 2|Withdrawal by Subject|1|||
160886663|NCT02038829|580980545|FG006|Washout Period 2|Withdrawal by Subject|0|||
160886664|NCT02038829|580980546|FG007|Washout Period 2|Withdrawal by Subject|0|||
160886665|NCT02038829|580980547|FG008|Washout Period 2|Withdrawal by Subject|0|||
160886666|NCT02038829|580980548|FG009|Washout Period 2|Withdrawal by Subject|0|||
160886667|NCT02038829|580980549|FG010|Washout Period 2|Withdrawal by Subject|0|||
160886668|NCT02038829|580980550|FG011|Washout Period 2|Withdrawal by Subject|0|||
160886669|NCT02038829|580980539|FG000|Treatment Period 4|Adverse Event|0|||
160886670|NCT02038829|580980540|FG001|Treatment Period 4|Adverse Event|1|||
160886671|NCT02038829|580980541|FG002|Treatment Period 4|Adverse Event|0|||
160886672|NCT02038829|580980542|FG003|Treatment Period 4|Adverse Event|0|||
160886673|NCT02038829|580980543|FG004|Treatment Period 4|Adverse Event|0|||
160886674|NCT02038829|580980544|FG005|Treatment Period 4|Adverse Event|0|||
160886675|NCT02038829|580980545|FG006|Treatment Period 4|Adverse Event|0|||
160886676|NCT02038829|580980546|FG007|Treatment Period 4|Adverse Event|0|||
160886677|NCT02038829|580980547|FG008|Treatment Period 4|Adverse Event|0|||
160886678|NCT02038829|580980548|FG009|Treatment Period 4|Adverse Event|0|||
160886679|NCT02038829|580980549|FG010|Treatment Period 4|Adverse Event|0|||
160886680|NCT02038829|580980550|FG011|Treatment Period 4|Adverse Event|0|||
160776382|NCT02924376|580564894|FG001|Overall Study|Study Terminated by Sponsor|0|||
160776383|NCT02924376|580564895|FG002|Overall Study|Study Terminated by Sponsor|0|||
160776384|NCT02924376|580564896|FG003|Overall Study|Study Terminated by Sponsor|0|||
160776385|NCT02924376|580564893|FG000|Overall Study|Physician Decision|1|||
160776386|NCT02924376|580564894|FG001|Overall Study|Physician Decision|0|||
160776387|NCT02924376|580564895|FG002|Overall Study|Physician Decision|0|||
160776388|NCT02924376|580564896|FG003|Overall Study|Physician Decision|0|||
160886681|NCT02038829|580980539|FG000|Washout Period 4|Adverse Event|0|||
160886682|NCT02038829|580980540|FG001|Washout Period 4|Adverse Event|0|||
160886683|NCT02038829|580980541|FG002|Washout Period 4|Adverse Event|0|||
160776389|NCT02924376|580564893|FG000|Overall Study|Withdrawal by Subject|7|||
160776390|NCT02924376|580564894|FG001|Overall Study|Withdrawal by Subject|2|||
160776391|NCT02924376|580564895|FG002|Overall Study|Withdrawal by Subject|1|||
160776392|NCT02924376|580564896|FG003|Overall Study|Withdrawal by Subject|0|||
160776393|NCT02924376|580564893|FG000|Overall Study|Rolled Over to Another Study|1|||
160776394|NCT02924376|580564894|FG001|Overall Study|Rolled Over to Another Study|0|||
160776395|NCT02924376|580564895|FG002|Overall Study|Rolled Over to Another Study|0|||
160776396|NCT02924376|580564896|FG003|Overall Study|Rolled Over to Another Study|0|||
160776397|NCT03608033|580564897|FG000|Treatment Period|Death|0|||
160776398|NCT03608033|580564898|FG001|Treatment Period|Death|1|||
160776399|NCT03608033|580564897|FG000|Treatment Period|Adverse Event|1|||
160776400|NCT03608033|580564898|FG001|Treatment Period|Adverse Event|5|||
160776401|NCT03608033|580564897|FG000|Treatment Period|Lack of Efficacy|4|||
160776402|NCT03608033|580564898|FG001|Treatment Period|Lack of Efficacy|3|||
160776403|NCT03608033|580564897|FG000|Treatment Period|Lost to Follow-up|2|||
160776404|NCT03608033|580564898|FG001|Treatment Period|Lost to Follow-up|6|||
160776405|NCT03608033|580564897|FG000|Treatment Period|Physician Decision|6|||
160776406|NCT03608033|580564898|FG001|Treatment Period|Physician Decision|10|||
160776407|NCT03608033|580564897|FG000|Treatment Period|Pregnancy|1|||
160776408|NCT03608033|580564898|FG001|Treatment Period|Pregnancy|0|||
160776409|NCT03608033|580564897|FG000|Treatment Period|Protocol Violation|1|||
160776410|NCT03608033|580564898|FG001|Treatment Period|Protocol Violation|2|||
160776411|NCT03608033|580564897|FG000|Treatment Period|Withdrawal by Subject|46|||
160776412|NCT03608033|580564898|FG001|Treatment Period|Withdrawal by Subject|45|||
160776413|NCT03608033|580564897|FG000|Treatment Period|Study terminated by sponsor|82|||
160776414|NCT03608033|580564898|FG001|Treatment Period|Study terminated by sponsor|68|||
160776415|NCT03608033|580564897|FG000|Treatment Period|Site Terminated by Sponsor|1|||
160776416|NCT03608033|580564898|FG001|Treatment Period|Site Terminated by Sponsor|0|||
160776417|NCT03608033|580564897|FG000|Open-Label Period: OMS721|Adverse Event|1|||
160776418|NCT03608033|580564898|FG001|Open-Label Period: OMS721|Adverse Event|0|||
160776419|NCT03608033|580564897|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
160776420|NCT03608033|580564898|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
160776421|NCT03608033|580564897|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
160776422|NCT03608033|580564898|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
160776423|NCT03608033|580564897|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
160776424|NCT03608033|580564898|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
160776425|NCT03608033|580564897|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
160776426|NCT03608033|580564898|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
160776427|NCT02360579|580564900|FG000|Initial|Death|16|||
160776428|NCT02360579|580564901|FG001|Initial|Death|49|||
160776429|NCT02360579|580564902|FG002|Initial|Death|0|||
160776430|NCT02360579|580564903|FG003|Initial|Death|71|||
160776431|NCT02360579|580564900|FG000|Initial|Lost to Follow-up|0|||
160776432|NCT02360579|580564901|FG001|Initial|Lost to Follow-up|4|||
160776433|NCT02360579|580564902|FG002|Initial|Lost to Follow-up|0|||
160776434|NCT02360579|580564903|FG003|Initial|Lost to Follow-up|1|||
160776435|NCT02360579|580564900|FG000|Initial|Withdrawal by Subject|0|||
160776436|NCT02360579|580564901|FG001|Initial|Withdrawal by Subject|0|||
160776437|NCT02360579|580564902|FG002|Initial|Withdrawal by Subject|0|||
160776438|NCT02360579|580564903|FG003|Initial|Withdrawal by Subject|3|||
160776439|NCT02360579|580564900|FG000|Initial|Other|7|||
160776440|NCT02360579|580564901|FG001|Initial|Other|0|||
160776441|NCT02360579|580564902|FG002|Initial|Other|0|||
160776442|NCT02360579|580564903|FG003|Initial|Other|0|||
160776443|NCT02360579|580564900|FG000|Initial|Did not receive TIL|8|||
160776444|NCT02360579|580564901|FG001|Initial|Did not receive TIL|11|||
160776445|NCT02360579|580564902|FG002|Initial|Did not receive TIL|0|||
160776446|NCT02360579|580564903|FG003|Initial|Did not receive TIL|22|||
160776447|NCT02360579|580564900|FG000|Retreatment|Death|0|||
160776448|NCT02360579|580564901|FG001|Retreatment|Death|0|||
160776449|NCT02360579|580564902|FG002|Retreatment|Death|11|||
160776450|NCT02360579|580564903|FG003|Retreatment|Death|0|||
160776451|NCT03682848|580564906|FG000|Overall Study|Withdrawal by Subject|3|||
160776452|NCT03682848|580564906|FG000|Overall Study|Site closed|5|||
160776453|NCT03682848|580564906|FG000|Overall Study|Protocol Deviation|1|||
160776454|NCT03682848|580564906|FG000|Overall Study|Adverse Event|2|||
160776455|NCT03682848|580564906|FG000|Overall Study|Lack of Efficacy|1|||
160776456|NCT02337686|580564908|FG000|Overall Study|Adverse Event|1|||
160776457|NCT01793935|580565922|FG000|Overall Study|Pregnancy|1|||
160776458|NCT01793935|580565923|FG001|Overall Study|Pregnancy|0|||
160776459|NCT01793935|580565922|FG000|Overall Study|Protocol Violation|2|||
160776460|NCT01793935|580565923|FG001|Overall Study|Protocol Violation|1|||
160776461|NCT01793935|580565922|FG000|Overall Study|Adverse Event|2|||
160776462|NCT01793935|580565923|FG001|Overall Study|Adverse Event|0|||
160776463|NCT01793935|580565922|FG000|Overall Study|Patient did not take study medication|1|||
160886684|NCT02038829|580980542|FG003|Washout Period 4|Adverse Event|0|||
160886685|NCT02038829|580980543|FG004|Washout Period 4|Adverse Event|0|||
160776464|NCT01793935|580565923|FG001|Overall Study|Patient did not take study medication|1|||
160776465|NCT01793935|580565922|FG000|Overall Study|Lost to Follow-up|0|||
160776466|NCT01793935|580565923|FG001|Overall Study|Lost to Follow-up|1|||
160776467|NCT00817063|580565924|FG000|Overall Study|Adverse Event|32|||
160776468|NCT00817063|580565925|FG001|Overall Study|Adverse Event|13|||
160776469|NCT00817063|580565924|FG000|Overall Study|Death|1|||
160776470|NCT00817063|580565925|FG001|Overall Study|Death|1|||
160776471|NCT00817063|580565924|FG000|Overall Study|Lack of Efficacy|33|||
160776472|NCT00817063|580565925|FG001|Overall Study|Lack of Efficacy|86|||
160776473|NCT00817063|580565924|FG000|Overall Study|Failure to Return|13|||
160776474|NCT00817063|580565925|FG001|Overall Study|Failure to Return|12|||
160776475|NCT00817063|580565924|FG000|Overall Study|Violation of Selection at Entry|7|||
160776476|NCT00817063|580565925|FG001|Overall Study|Violation of Selection at Entry|4|||
160776477|NCT00817063|580565924|FG000|Overall Study|Protocol Violation|3|||
160776478|NCT00817063|580565925|FG001|Overall Study|Protocol Violation|8|||
160776479|NCT00817063|580565924|FG000|Overall Study|Withdrawal by Subject|17|||
160776480|NCT00817063|580565925|FG001|Overall Study|Withdrawal by Subject|37|||
160776481|NCT00817063|580565924|FG000|Overall Study|Early Improvement|19|||
160776482|NCT00817063|580565925|FG001|Overall Study|Early Improvement|4|||
160776483|NCT00817063|580565924|FG000|Overall Study|Administrative|10|||
160776484|NCT00817063|580565925|FG001|Overall Study|Administrative|4|||
160776485|NCT00817063|580565924|FG000|Overall Study|Abnormality of Laboratory Test|2|||
160776486|NCT00817063|580565925|FG001|Overall Study|Abnormality of Laboratory Test|1|||
160776487|NCT01555931|580565928|FG000|Overall Study|Lost to Follow-up|2|||
160776488|NCT01555931|580565929|FG001|Overall Study|Lost to Follow-up|5|||
160776489|NCT01510756|580565930|FG000|Overall Study|Death|1|||
160776490|NCT01510756|580565930|FG000|Overall Study|Lack of Efficacy|2|||
160776491|NCT01510756|580565930|FG000|Overall Study|Physician Decision|1|||
160776492|NCT01922011|580565931|FG000|Overall Study|Protocol Violation|0|||
160776493|NCT01922011|580565932|FG001|Overall Study|Protocol Violation|1|||
160776494|NCT01922011|580565931|FG000|Overall Study|Physician Decision|0|||
160886686|NCT02038829|580980544|FG005|Washout Period 4|Adverse Event|0|||
160886687|NCT02038829|580980545|FG006|Washout Period 4|Adverse Event|1|||
160886688|NCT02038829|580980546|FG007|Washout Period 4|Adverse Event|0|||
160886689|NCT02038829|580980547|FG008|Washout Period 4|Adverse Event|0|||
160776495|NCT01922011|580565932|FG001|Overall Study|Physician Decision|1|||
160886690|NCT02038829|580980548|FG009|Washout Period 4|Adverse Event|0|||
160886691|NCT02038829|580980549|FG010|Washout Period 4|Adverse Event|0|||
160886692|NCT02038829|580980550|FG011|Washout Period 4|Adverse Event|0|||
160886693|NCT02038829|580980539|FG000|Treatment Period 6|Adverse Event|0|||
160886694|NCT02038829|580980540|FG001|Treatment Period 6|Adverse Event|0|||
160886695|NCT02038829|580980541|FG002|Treatment Period 6|Adverse Event|1|||
160886696|NCT02038829|580980542|FG003|Treatment Period 6|Adverse Event|0|||
160886697|NCT02038829|580980543|FG004|Treatment Period 6|Adverse Event|0|||
160886698|NCT02038829|580980544|FG005|Treatment Period 6|Adverse Event|0|||
160886699|NCT02038829|580980545|FG006|Treatment Period 6|Adverse Event|0|||
160886700|NCT02038829|580980546|FG007|Treatment Period 6|Adverse Event|0|||
160886701|NCT02038829|580980547|FG008|Treatment Period 6|Adverse Event|0|||
160886702|NCT02038829|580980548|FG009|Treatment Period 6|Adverse Event|0|||
160886703|NCT02038829|580980549|FG010|Treatment Period 6|Adverse Event|0|||
160886704|NCT02038829|580980550|FG011|Treatment Period 6|Adverse Event|0|||
160886705|NCT00749580|580980551|FG000|Overall Study|Lost to Follow-up|4|||
160886706|NCT00749580|580980552|FG001|Overall Study|Lost to Follow-up|8|||
160886707|NCT00749580|580980551|FG000|Overall Study|Adverse Event|0|||
160886708|NCT00749580|580980552|FG001|Overall Study|Adverse Event|1|||
160886709|NCT05128929|580980554|FG000|Overall Study|Adverse Event|0|||
160886710|NCT05128929|580980555|FG001|Overall Study|Adverse Event|1|||
160886711|NCT03553836|580980558|FG000|Overall Study|Ongoing in Study|460|||
160886712|NCT03553836|580980559|FG001|Overall Study|Ongoing in Study|459|||
160886713|NCT03553836|580980558|FG000|Overall Study|Withdrawal by Subject|9|||
160886714|NCT03553836|580980559|FG001|Overall Study|Withdrawal by Subject|10|||
160886715|NCT03553836|580980558|FG000|Overall Study|Lost to Follow-up|1|||
160886716|NCT03553836|580980559|FG001|Overall Study|Lost to Follow-up|3|||
160886717|NCT03553836|580980558|FG000|Overall Study|Death|17|||
160886718|NCT03553836|580980559|FG001|Overall Study|Death|17|||
160776496|NCT01922011|580565931|FG000|Overall Study|Parent/Guardian Decision|3|||
160776497|NCT01922011|580565932|FG001|Overall Study|Parent/Guardian Decision|0|||
160776498|NCT01922011|580565931|FG000|Overall Study|Lost to Follow-up|0|||
160776499|NCT01922011|580565932|FG001|Overall Study|Lost to Follow-up|1|||
160776500|NCT01922011|580565931|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
160776501|NCT01922011|580565932|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
160776502|NCT01922011|580565931|FG000|Overall Study|Not Treated|1|||
160776503|NCT01922011|580565932|FG001|Overall Study|Not Treated|0|||
160776504|NCT01922011|580565931|FG000|Overall Study|Lack of willing home health agency|1|||
160886719|NCT05660850|580980560|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
160886720|NCT05660850|580980561|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
160886721|NCT05660850|580980562|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
160886722|NCT05660850|580980563|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
160886723|NCT02604017|580980564|FG000|Overall Study|Withdrew Consent|0|||
160886724|NCT02604017|580980565|FG001|Overall Study|Withdrew Consent|2|||
160886725|NCT02604017|580980564|FG000|Overall Study|Lost to Follow-up|5|||
160886726|NCT02604017|580980565|FG001|Overall Study|Lost to Follow-up|6|||
160886727|NCT02604017|580980564|FG000|Overall Study|Other|1|||
160886728|NCT02604017|580980565|FG001|Overall Study|Other|0|||
160886729|NCT01653782|580980571|FG000|Overall Study|Withdrawal by Subject|9|||
160886730|NCT01653782|580980572|FG001|Overall Study|Withdrawal by Subject|15|||
160886731|NCT01653782|580980573|FG002|Overall Study|Withdrawal by Subject|4|||
160886732|NCT01653782|580980571|FG000|Overall Study|Lost to Follow-up|7|||
160886733|NCT01653782|580980572|FG001|Overall Study|Lost to Follow-up|3|||
160886734|NCT01653782|580980573|FG002|Overall Study|Lost to Follow-up|2|||
160886735|NCT01315236|580980577|FG000|Double-blind Phase|Death|1|||
160886736|NCT01315236|580980578|FG001|Double-blind Phase|Death|0|||
160886737|NCT01315236|580980577|FG000|Double-blind Phase|Adverse Event|1|||
160886738|NCT01315236|580980578|FG001|Double-blind Phase|Adverse Event|0|||
160886739|NCT01315236|580980577|FG000|Double-blind Phase|Withdrawal of Consent|1|||
160886740|NCT01315236|580980578|FG001|Double-blind Phase|Withdrawal of Consent|0|||
160886741|NCT01315236|580980577|FG000|Double-blind Phase|Lost to Follow-up|1|||
160886742|NCT01315236|580980578|FG001|Double-blind Phase|Lost to Follow-up|0|||
160886743|NCT01315236|580980577|FG000|Open-label Phase|Death|1|||
160886744|NCT01315236|580980578|FG001|Open-label Phase|Death|0|||
160886745|NCT01315236|580980577|FG000|Open-label Phase|Adverse Event|0|||
160886746|NCT01315236|580980578|FG001|Open-label Phase|Adverse Event|1|||
160886747|NCT01315236|580980577|FG000|Open-label Phase|Other|0|||
160886748|NCT01315236|580980578|FG001|Open-label Phase|Other|1|||
160886749|NCT01315236|580980577|FG000|12-Month Follow-up Period|Death|0|||
160886750|NCT01315236|580980578|FG001|12-Month Follow-up Period|Death|1|||
160886751|NCT01315236|580980577|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
160886752|NCT01315236|580980578|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
160886753|NCT02497976|580980581|FG000|Overall Study|Withdrawal by Subject|2|||
160886754|NCT02497976|580980582|FG001|Overall Study|Withdrawal by Subject|0|||
160886755|NCT02497976|580980581|FG000|Overall Study|Moved out of area|0|||
160886756|NCT02497976|580980582|FG001|Overall Study|Moved out of area|1|||
160886757|NCT00058539|580980586|FG000|Overall Study|Disease progression|24|||
160886758|NCT00058539|580980586|FG000|Overall Study|Adverse Event|3|||
160886759|NCT00058539|580980586|FG000|Overall Study|Withdrawal by Subject|5|||
160886760|NCT00058539|580980586|FG000|Overall Study|Physician Decision|9|||
160886761|NCT00058539|580980586|FG000|Overall Study|Death|1|||
160886762|NCT02483533|580980587|FG000|Overall Study|Lack of Efficacy|50|||
160886763|NCT02483533|580980588|FG001|Overall Study|Lack of Efficacy|50|||
160886764|NCT01323920|580980589|FG000|Overall Study|Death|5|||
160886765|NCT01323920|580980589|FG000|Overall Study|Withdrawal by Subject|1|||
160886766|NCT02283177|580980592|FG000|Overall Study|Withdrawal by Subject|1|||
160886767|NCT02283177|580980593|FG001|Overall Study|Withdrawal by Subject|1|||
160886768|NCT00327470|580980601|FG000|Overall Study|Randomized, but not treated|0|||
160886769|NCT00327470|580980602|FG001|Overall Study|Randomized, but not treated|2|||
160886770|NCT00327470|580980601|FG000|Overall Study|Adverse Event|9|||
160886771|NCT00327470|580980602|FG001|Overall Study|Adverse Event|14|||
160886772|NCT00327470|580980601|FG000|Overall Study|Lack of Efficacy|7|||
160886773|NCT00327470|580980602|FG001|Overall Study|Lack of Efficacy|19|||
160886774|NCT00327470|580980601|FG000|Overall Study|Other|5|||
160886775|NCT00327470|580980602|FG001|Overall Study|Other|9|||
160886776|NCT00327470|580980601|FG000|Overall Study|Lost to Follow-up|1|||
160886777|NCT00327470|580980602|FG001|Overall Study|Lost to Follow-up|3|||
160886778|NCT00327470|580980601|FG000|Overall Study|Withdrawal by Subject|6|||
160886779|NCT00327470|580980602|FG001|Overall Study|Withdrawal by Subject|12|||
160886780|NCT00327470|580980601|FG000|Overall Study|Death|1|||
160886781|NCT00327470|580980602|FG001|Overall Study|Death|4|||
160886782|NCT00745615|580980609|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
160886783|NCT00745615|580980610|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
160886784|NCT00745615|580980611|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
160886785|NCT00745615|580980612|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
160886786|NCT00745615|580980613|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
160886787|NCT00745615|580980614|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
160886788|NCT00745615|580980609|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
160886789|NCT00745615|580980610|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
160886790|NCT00745615|580980611|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
160886791|NCT00745615|580980612|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
160886792|NCT00745615|580980613|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
160886793|NCT00745615|580980614|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
160886794|NCT00745615|580980609|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
160886795|NCT00745615|580980610|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
160886796|NCT00745615|580980611|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
160886797|NCT00745615|580980612|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
160886798|NCT00745615|580980613|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
160776505|NCT01922011|580565932|FG001|Overall Study|Lack of willing home health agency|0|||
160776506|NCT01922011|580565931|FG000|Overall Study|Randomized in error|1|||
160776507|NCT01922011|580565932|FG001|Overall Study|Randomized in error|0|||
160776508|NCT04398134|580565939|FG000|Overall Study|Adverse Event|0|||
160776509|NCT04398134|580565940|FG001|Overall Study|Adverse Event|0|||
160776510|NCT04398134|580565941|FG002|Overall Study|Adverse Event|1|||
160776511|NCT04398134|580565942|FG003|Overall Study|Adverse Event|0|||
160776512|NCT04398134|580565939|FG000|Overall Study|Withdrawal by Subject|2|||
160776513|NCT04398134|580565940|FG001|Overall Study|Withdrawal by Subject|0|||
160776514|NCT04398134|580565941|FG002|Overall Study|Withdrawal by Subject|0|||
160776515|NCT04398134|580565942|FG003|Overall Study|Withdrawal by Subject|1|||
160776516|NCT04398134|580565939|FG000|Overall Study|Study Terminated by Sponsor|30|||
160776517|NCT04398134|580565940|FG001|Overall Study|Study Terminated by Sponsor|11|||
160776518|NCT04398134|580565941|FG002|Overall Study|Study Terminated by Sponsor|32|||
160776519|NCT04398134|580565942|FG003|Overall Study|Study Terminated by Sponsor|11|||
160776520|NCT06420232|580565946|FG000|Overall Study|Withdrawal by Subject|3|||
160776521|NCT01697579|580565948|FG000|Base Study-Cycle 1|Adverse Event|1|||
160776522|NCT01697579|580565949|FG001|Base Study-Cycle 1|Adverse Event|0|||
160776523|NCT01697579|580565950|FG002|Base Study-Cycle 1|Adverse Event|0|||
160776524|NCT01697579|580565951|FG003|Base Study-Cycle 1|Adverse Event|0|||
160776525|NCT01697579|580565952|FG004|Base Study-Cycle 1|Adverse Event|0|||
160776526|NCT01697579|580565953|FG005|Base Study-Cycle 1|Adverse Event|0|||
160776527|NCT01697579|580565954|FG006|Base Study-Cycle 1|Adverse Event|0|||
160776528|NCT01697579|580565948|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
160776529|NCT01697579|580565949|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
160776530|NCT01697579|580565950|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
160776531|NCT01697579|580565951|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
160776532|NCT01697579|580565952|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
160776533|NCT01697579|580565953|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
160776534|NCT01697579|580565954|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
160886799|NCT00745615|580980614|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
160886800|NCT00745615|580980609|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
160886801|NCT00745615|580980610|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
160886802|NCT00745615|580980611|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
160886803|NCT00745615|580980612|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
160776535|NCT01697579|580565948|FG000|Base Study-Cycle 1|Protocol Violation|0|||
160776536|NCT01697579|580565949|FG001|Base Study-Cycle 1|Protocol Violation|0|||
160776537|NCT01697579|580565950|FG002|Base Study-Cycle 1|Protocol Violation|0|||
160776538|NCT01697579|580565951|FG003|Base Study-Cycle 1|Protocol Violation|0|||
160776539|NCT01697579|580565952|FG004|Base Study-Cycle 1|Protocol Violation|3|||
160776540|NCT01697579|580565953|FG005|Base Study-Cycle 1|Protocol Violation|0|||
160776541|NCT01697579|580565954|FG006|Base Study-Cycle 1|Protocol Violation|0|||
160776542|NCT01697579|580565948|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
160776543|NCT01697579|580565949|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
160776544|NCT01697579|580565950|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
160776545|NCT01697579|580565951|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
160776546|NCT01697579|580565952|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
160776547|NCT01697579|580565953|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
160776548|NCT01697579|580565954|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
160776549|NCT01697579|580565948|FG000|Base Study-Cycle 1|Technical Problems|0|||
160776550|NCT01697579|580565949|FG001|Base Study-Cycle 1|Technical Problems|0|||
160776551|NCT01697579|580565950|FG002|Base Study-Cycle 1|Technical Problems|1|||
160776552|NCT01697579|580565951|FG003|Base Study-Cycle 1|Technical Problems|1|||
160776553|NCT01697579|580565952|FG004|Base Study-Cycle 1|Technical Problems|0|||
160776554|NCT01697579|580565953|FG005|Base Study-Cycle 1|Technical Problems|0|||
160776555|NCT01697579|580565954|FG006|Base Study-Cycle 1|Technical Problems|0|||
160776556|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Death|0|||
160776557|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Death|0|||
160776558|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Death|0|||
160776559|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Death|0|||
160776560|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Death|0|||
160776561|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Death|0|||
160776562|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Death|2|||
160776563|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
160776564|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
160776565|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
160776566|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
160776567|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
160776568|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
160776569|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
160776570|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
160776571|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
160776572|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
160776573|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
160776574|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
160776575|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
160776576|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
160776577|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
160776578|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
160776579|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
160776580|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
160776581|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
160776582|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
160776583|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
160776584|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
160776585|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
160776586|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
160776587|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
160776588|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
160776589|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
160776590|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
160776591|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
160776592|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
160776593|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
160776594|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
160776595|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
160776596|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
160776597|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
160776598|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
160776599|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
160776600|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
160776601|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
160776602|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
160776603|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
160776604|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
160776605|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
160776606|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
160776607|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
160776608|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
160776609|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
160776610|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
160776611|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
160776612|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
160776613|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
160776614|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
160776615|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
160776616|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
160776617|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
160776618|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
160776619|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
160776620|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
160776621|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
160776622|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
160776623|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
160776624|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
160776625|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
160776626|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
160776627|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
160776628|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
160776629|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
160776630|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
160776631|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
160776632|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
160776633|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
160776634|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
160776635|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
160776636|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
160776637|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
160776638|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
160776639|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
160776640|NCT01697579|580565948|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
160776641|NCT01697579|580565949|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
160776642|NCT01697579|580565950|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
160776643|NCT01697579|580565951|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
160776644|NCT01697579|580565952|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
160776645|NCT01697579|580565953|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
160776646|NCT01697579|580565954|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
160776647|NCT01044498|580565955|FG000|Overall Study|Withdrew consent|1|||
160776648|NCT01044498|580565956|FG001|Overall Study|Withdrew consent|1|||
160776649|NCT01044498|580565955|FG000|Overall Study|Adverse Event|1|||
160776650|NCT01044498|580565956|FG001|Overall Study|Adverse Event|1|||
160776651|NCT01044498|580565955|FG000|Overall Study|Other|1|||
160776652|NCT01044498|580565956|FG001|Overall Study|Other|0|||
160776653|NCT02903914|580565959|FG000|Overall Study|Adverse Event|0|||
160776654|NCT02903914|580565960|FG001|Overall Study|Adverse Event|0|||
160776655|NCT02903914|580565961|FG002|Overall Study|Adverse Event|1|||
160776656|NCT02903914|580565962|FG003|Overall Study|Adverse Event|0|||
160776657|NCT02903914|580565963|FG004|Overall Study|Adverse Event|0|||
160776658|NCT02903914|580565964|FG005|Overall Study|Adverse Event|0|||
160776659|NCT02903914|580565965|FG006|Overall Study|Adverse Event|2|||
160776660|NCT02903914|580565966|FG007|Overall Study|Adverse Event|0|||
160776661|NCT02903914|580565959|FG000|Overall Study|Withdrawal by Subject|3|||
160776662|NCT02903914|580565960|FG001|Overall Study|Withdrawal by Subject|1|||
160776663|NCT02903914|580565961|FG002|Overall Study|Withdrawal by Subject|28|||
160776664|NCT02903914|580565962|FG003|Overall Study|Withdrawal by Subject|0|||
160776665|NCT02903914|580565963|FG004|Overall Study|Withdrawal by Subject|1|||
160776666|NCT02903914|580565964|FG005|Overall Study|Withdrawal by Subject|2|||
160886804|NCT00745615|580980613|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
160776667|NCT02903914|580565965|FG006|Overall Study|Withdrawal by Subject|12|||
160776668|NCT02903914|580565966|FG007|Overall Study|Withdrawal by Subject|0|||
160776669|NCT02903914|580565959|FG000|Overall Study|Progressive Disease|1|||
160776670|NCT02903914|580565960|FG001|Overall Study|Progressive Disease|0|||
160776671|NCT02903914|580565961|FG002|Overall Study|Progressive Disease|4|||
160776672|NCT02903914|580565962|FG003|Overall Study|Progressive Disease|0|||
160776673|NCT02903914|580565963|FG004|Overall Study|Progressive Disease|0|||
160776674|NCT02903914|580565964|FG005|Overall Study|Progressive Disease|0|||
160776675|NCT02903914|580565965|FG006|Overall Study|Progressive Disease|2|||
160776676|NCT02903914|580565966|FG007|Overall Study|Progressive Disease|0|||
160776677|NCT02903914|580565959|FG000|Overall Study|Death|0|||
160776678|NCT02903914|580565960|FG001|Overall Study|Death|0|||
160776679|NCT02903914|580565961|FG002|Overall Study|Death|9|||
160776680|NCT02903914|580565962|FG003|Overall Study|Death|0|||
160776681|NCT02903914|580565963|FG004|Overall Study|Death|1|||
160776682|NCT02903914|580565964|FG005|Overall Study|Death|3|||
160776683|NCT02903914|580565965|FG006|Overall Study|Death|24|||
160776684|NCT02903914|580565966|FG007|Overall Study|Death|2|||
160776685|NCT02903914|580565959|FG000|Overall Study|Lost to Follow-up|0|||
160776686|NCT02903914|580565960|FG001|Overall Study|Lost to Follow-up|1|||
160776687|NCT02903914|580565961|FG002|Overall Study|Lost to Follow-up|0|||
160776688|NCT02903914|580565962|FG003|Overall Study|Lost to Follow-up|0|||
160776689|NCT02903914|580565963|FG004|Overall Study|Lost to Follow-up|2|||
160776690|NCT02903914|580565964|FG005|Overall Study|Lost to Follow-up|0|||
160776691|NCT02903914|580565965|FG006|Overall Study|Lost to Follow-up|1|||
160776692|NCT02903914|580565966|FG007|Overall Study|Lost to Follow-up|0|||
160776693|NCT02903914|580565959|FG000|Overall Study|Physician Decision|0|||
160776694|NCT02903914|580565960|FG001|Overall Study|Physician Decision|0|||
160776695|NCT02903914|580565961|FG002|Overall Study|Physician Decision|1|||
160776696|NCT02903914|580565962|FG003|Overall Study|Physician Decision|0|||
160776697|NCT02903914|580565963|FG004|Overall Study|Physician Decision|0|||
160776698|NCT02903914|580565964|FG005|Overall Study|Physician Decision|0|||
160776699|NCT02903914|580565965|FG006|Overall Study|Physician Decision|1|||
160776700|NCT02903914|580565966|FG007|Overall Study|Physician Decision|0|||
160776701|NCT02903914|580565959|FG000|Overall Study|Symptomatic Deterioration|0|||
160776702|NCT02903914|580565960|FG001|Overall Study|Symptomatic Deterioration|0|||
160776703|NCT02903914|580565961|FG002|Overall Study|Symptomatic Deterioration|1|||
160776704|NCT02903914|580565962|FG003|Overall Study|Symptomatic Deterioration|0|||
160776705|NCT02903914|580565963|FG004|Overall Study|Symptomatic Deterioration|0|||
160776706|NCT02903914|580565964|FG005|Overall Study|Symptomatic Deterioration|0|||
160776707|NCT02903914|580565965|FG006|Overall Study|Symptomatic Deterioration|0|||
160776708|NCT02903914|580565966|FG007|Overall Study|Symptomatic Deterioration|0|||
160776709|NCT02903914|580565959|FG000|Overall Study|New Cancer Therapy|2|||
160776710|NCT02903914|580565960|FG001|Overall Study|New Cancer Therapy|2|||
160776711|NCT02903914|580565961|FG002|Overall Study|New Cancer Therapy|21|||
160776712|NCT02903914|580565962|FG003|Overall Study|New Cancer Therapy|4|||
160776713|NCT02903914|580565963|FG004|Overall Study|New Cancer Therapy|3|||
160776714|NCT02903914|580565964|FG005|Overall Study|New Cancer Therapy|6|||
160776715|NCT02903914|580565965|FG006|Overall Study|New Cancer Therapy|56|||
160776716|NCT02903914|580565966|FG007|Overall Study|New Cancer Therapy|3|||
160776717|NCT02903914|580565959|FG000|Overall Study|Didn't Return to Site|1|||
160776718|NCT02903914|580565960|FG001|Overall Study|Didn't Return to Site|0|||
160776719|NCT02903914|580565961|FG002|Overall Study|Didn't Return to Site|1|||
160776720|NCT02903914|580565962|FG003|Overall Study|Didn't Return to Site|1|||
160776721|NCT02903914|580565963|FG004|Overall Study|Didn't Return to Site|0|||
160776722|NCT02903914|580565964|FG005|Overall Study|Didn't Return to Site|0|||
160776723|NCT02903914|580565965|FG006|Overall Study|Didn't Return to Site|2|||
160776724|NCT02903914|580565966|FG007|Overall Study|Didn't Return to Site|0|||
160776725|NCT02903914|580565959|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
160776726|NCT02903914|580565960|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
160776727|NCT02903914|580565961|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
160776728|NCT02903914|580565962|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
160776729|NCT02903914|580565963|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
160776730|NCT02903914|580565964|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
160776731|NCT02903914|580565965|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
160776732|NCT02903914|580565966|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
160776733|NCT02903914|580565959|FG000|Overall Study|Follow-up Did Not Occur|0|||
160776734|NCT02903914|580565960|FG001|Overall Study|Follow-up Did Not Occur|1|||
160886805|NCT00745615|580980614|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
160886806|NCT00745615|580980609|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
160776735|NCT02903914|580565961|FG002|Overall Study|Follow-up Did Not Occur|1|||
160776736|NCT02903914|580565962|FG003|Overall Study|Follow-up Did Not Occur|0|||
160776737|NCT02903914|580565963|FG004|Overall Study|Follow-up Did Not Occur|2|||
160776738|NCT02903914|580565964|FG005|Overall Study|Follow-up Did Not Occur|0|||
160776739|NCT02903914|580565965|FG006|Overall Study|Follow-up Did Not Occur|8|||
160776740|NCT02903914|580565966|FG007|Overall Study|Follow-up Did Not Occur|0|||
160776741|NCT02903914|580565959|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
160776742|NCT02903914|580565960|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
160776743|NCT02903914|580565961|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
160776744|NCT02903914|580565962|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
160776745|NCT02903914|580565963|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
160776746|NCT02903914|580565964|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
160776747|NCT02903914|580565965|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
160776748|NCT02903914|580565966|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
160776749|NCT02903914|580565959|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
160776750|NCT02903914|580565960|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
160776751|NCT02903914|580565961|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
160776752|NCT02903914|580565962|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
160776753|NCT02903914|580565963|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
160776754|NCT02903914|580565964|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
160776755|NCT02903914|580565965|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
160776756|NCT02903914|580565966|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
160776757|NCT02903914|580565959|FG000|Overall Study|Clinical Disease Progression|0|||
160776758|NCT02903914|580565960|FG001|Overall Study|Clinical Disease Progression|0|||
160776759|NCT02903914|580565961|FG002|Overall Study|Clinical Disease Progression|2|||
160776760|NCT02903914|580565962|FG003|Overall Study|Clinical Disease Progression|0|||
160776761|NCT02903914|580565963|FG004|Overall Study|Clinical Disease Progression|0|||
160776762|NCT02903914|580565964|FG005|Overall Study|Clinical Disease Progression|0|||
160776763|NCT02903914|580565965|FG006|Overall Study|Clinical Disease Progression|0|||
160776764|NCT02903914|580565966|FG007|Overall Study|Clinical Disease Progression|0|||
160776765|NCT02903914|580565959|FG000|Overall Study|Completed Follow-up Period|0|||
160776766|NCT02903914|580565960|FG001|Overall Study|Completed Follow-up Period|0|||
160776767|NCT02903914|580565961|FG002|Overall Study|Completed Follow-up Period|6|||
160776768|NCT02903914|580565962|FG003|Overall Study|Completed Follow-up Period|2|||
160776769|NCT02903914|580565963|FG004|Overall Study|Completed Follow-up Period|1|||
160776770|NCT02903914|580565964|FG005|Overall Study|Completed Follow-up Period|0|||
160776771|NCT02903914|580565965|FG006|Overall Study|Completed Follow-up Period|9|||
160776772|NCT02903914|580565966|FG007|Overall Study|Completed Follow-up Period|1|||
160776773|NCT02903914|580565959|FG000|Overall Study|Taken off Treatment per Protocol|0|||
160776774|NCT02903914|580565960|FG001|Overall Study|Taken off Treatment per Protocol|0|||
160776775|NCT02903914|580565961|FG002|Overall Study|Taken off Treatment per Protocol|0|||
160776776|NCT02903914|580565962|FG003|Overall Study|Taken off Treatment per Protocol|0|||
160776777|NCT02903914|580565963|FG004|Overall Study|Taken off Treatment per Protocol|0|||
160776778|NCT02903914|580565964|FG005|Overall Study|Taken off Treatment per Protocol|1|||
160776779|NCT02903914|580565965|FG006|Overall Study|Taken off Treatment per Protocol|0|||
160776780|NCT02903914|580565966|FG007|Overall Study|Taken off Treatment per Protocol|0|||
160776781|NCT02903914|580565959|FG000|Overall Study|Refused Further Treatment/Contact|0|||
160776782|NCT02903914|580565960|FG001|Overall Study|Refused Further Treatment/Contact|0|||
160776783|NCT02903914|580565961|FG002|Overall Study|Refused Further Treatment/Contact|0|||
160776784|NCT02903914|580565962|FG003|Overall Study|Refused Further Treatment/Contact|0|||
160776785|NCT02903914|580565963|FG004|Overall Study|Refused Further Treatment/Contact|0|||
160776786|NCT02903914|580565964|FG005|Overall Study|Refused Further Treatment/Contact|0|||
160776787|NCT02903914|580565965|FG006|Overall Study|Refused Further Treatment/Contact|1|||
160776788|NCT02903914|580565966|FG007|Overall Study|Refused Further Treatment/Contact|0|||
160776789|NCT02903914|580565959|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
160776790|NCT02903914|580565960|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
160776791|NCT02903914|580565961|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
160776792|NCT02903914|580565962|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
160776793|NCT02903914|580565963|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
160776794|NCT02903914|580565964|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
160776795|NCT02903914|580565965|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
160776796|NCT02903914|580565966|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
160776797|NCT03487445|580565970|FG000|Randomization|Not treated for administrative reasons|1|||
160776798|NCT03487445|580565971|FG001|Randomization|Not treated for administrative reasons|0|||
160776799|NCT04225039|580565974|FG000|Overall Study|Withdrawal by Subject|1|||
160776800|NCT04225039|580565975|FG001|Overall Study|Withdrawal by Subject|0|||
160776801|NCT04225039|580565976|FG002|Overall Study|Withdrawal by Subject|0|||
160776802|NCT04225039|580565977|FG003|Overall Study|Withdrawal by Subject|1|||
160776803|NCT04225039|580565974|FG000|Overall Study|Currently active on study treatment|0|||
160776804|NCT04225039|580565975|FG001|Overall Study|Currently active on study treatment|1|||
160886807|NCT00745615|580980610|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
160886808|NCT00745615|580980611|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
160886809|NCT00745615|580980612|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
160776805|NCT04225039|580565976|FG002|Overall Study|Currently active on study treatment|0|||
160776806|NCT04225039|580565977|FG003|Overall Study|Currently active on study treatment|0|||
160776807|NCT04225039|580565974|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
160776808|NCT04225039|580565975|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
160776809|NCT04225039|580565976|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
160886810|NCT00745615|580980613|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
160776810|NCT04225039|580565977|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
160776811|NCT04225039|580565974|FG000|Overall Study|Ineligible for treatment|0|||
160776812|NCT04225039|580565975|FG001|Overall Study|Ineligible for treatment|0|||
160776813|NCT04225039|580565976|FG002|Overall Study|Ineligible for treatment|0|||
160776814|NCT04225039|580565977|FG003|Overall Study|Ineligible for treatment|4|||
160776815|NCT00975923|580565978|FG000|Overall Study|Withdrawal by Subject|0|||
160776816|NCT00975923|580565979|FG001|Overall Study|Withdrawal by Subject|1|||
160776817|NCT00325416|580565982|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
160776818|NCT00325416|580565983|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
160776819|NCT00325416|580565982|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
160776820|NCT00325416|580565983|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
160776821|NCT00325416|580565982|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
160776822|NCT00325416|580565983|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
160776823|NCT00325416|580565982|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
160776824|NCT00325416|580565983|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
160776825|NCT00325416|580565982|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
160776826|NCT00325416|580565983|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
160776827|NCT00325416|580565982|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
160776828|NCT00325416|580565983|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
160776829|NCT06239610|580565984|FG000|Overall Study|no usable migration data for minimum of one day|11|||
160776830|NCT02830087|580565987|FG000|Overall Study|No study staff to follow-up patients|4|||
160776831|NCT02830087|580565988|FG001|Overall Study|No study staff to follow-up patients|4|||
160776832|NCT02830087|580565989|FG002|Overall Study|No study staff to follow-up patients|4|||
160776833|NCT02830087|580565990|FG003|Overall Study|No study staff to follow-up patients|3|||
160776834|NCT02830087|580565991|FG004|Overall Study|No study staff to follow-up patients|3|||
160776835|NCT02830087|580565992|FG005|Overall Study|No study staff to follow-up patients|3|||
160776836|NCT02916771|580565993|FG000|Overall Study|Withdrawal by Subject|9|||
160776837|NCT02916771|580565993|FG000|Overall Study|Physician Decision|1|||
160776838|NCT02916771|580565993|FG000|Overall Study|Began treatment for another active malignancy|1|||
160776839|NCT06455111|580565996|FG000|Overall Study|Withdrawal by Subject|11|||
160776840|NCT06455111|580565997|FG001|Overall Study|Withdrawal by Subject|4|||
160776841|NCT03069989|580565999|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
160776842|NCT03069989|580566000|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
160776843|NCT00479232|580567143|FG000|Overall Study|Adverse Event|0|||
160776844|NCT00479232|580567144|FG001|Overall Study|Adverse Event|0|||
160776845|NCT00479232|580567145|FG002|Overall Study|Adverse Event|5|||
160776846|NCT00479232|580567146|FG003|Overall Study|Adverse Event|0|||
160776847|NCT00479232|580567147|FG004|Overall Study|Adverse Event|0|||
160776848|NCT00479232|580567148|FG005|Overall Study|Adverse Event|10|||
160776849|NCT00479232|580567143|FG000|Overall Study|Deviation from Protocol|0|||
160776850|NCT00479232|580567144|FG001|Overall Study|Deviation from Protocol|0|||
160776851|NCT00479232|580567145|FG002|Overall Study|Deviation from Protocol|1|||
160776852|NCT00479232|580567146|FG003|Overall Study|Deviation from Protocol|0|||
160776853|NCT00479232|580567147|FG004|Overall Study|Deviation from Protocol|0|||
160776854|NCT00479232|580567148|FG005|Overall Study|Deviation from Protocol|0|||
160776855|NCT00479232|580567143|FG000|Overall Study|Lack of Efficacy|0|||
160776856|NCT00479232|580567144|FG001|Overall Study|Lack of Efficacy|0|||
160776857|NCT00479232|580567145|FG002|Overall Study|Lack of Efficacy|2|||
160776858|NCT00479232|580567146|FG003|Overall Study|Lack of Efficacy|0|||
160776859|NCT00479232|580567147|FG004|Overall Study|Lack of Efficacy|0|||
160776860|NCT00479232|580567148|FG005|Overall Study|Lack of Efficacy|4|||
160776861|NCT00479232|580567143|FG000|Overall Study|Physician Decision|0|||
160776862|NCT00479232|580567144|FG001|Overall Study|Physician Decision|0|||
160776863|NCT00479232|580567145|FG002|Overall Study|Physician Decision|2|||
160776864|NCT00479232|580567146|FG003|Overall Study|Physician Decision|0|||
160776865|NCT00479232|580567147|FG004|Overall Study|Physician Decision|0|||
160776866|NCT00479232|580567148|FG005|Overall Study|Physician Decision|1|||
160776867|NCT00479232|580567143|FG000|Overall Study|Progressive Disease|3|||
160776868|NCT00479232|580567144|FG001|Overall Study|Progressive Disease|1|||
160776869|NCT00479232|580567145|FG002|Overall Study|Progressive Disease|12|||
160776870|NCT00479232|580567146|FG003|Overall Study|Progressive Disease|3|||
160776871|NCT00479232|580567147|FG004|Overall Study|Progressive Disease|3|||
160776872|NCT00479232|580567148|FG005|Overall Study|Progressive Disease|12|||
160776873|NCT00479232|580567143|FG000|Overall Study|Withdrew Consent|0|||
160776874|NCT00479232|580567144|FG001|Overall Study|Withdrew Consent|2|||
160776875|NCT00479232|580567145|FG002|Overall Study|Withdrew Consent|6|||
160776876|NCT00479232|580567146|FG003|Overall Study|Withdrew Consent|0|||
160776877|NCT00479232|580567147|FG004|Overall Study|Withdrew Consent|1|||
160776878|NCT00479232|580567148|FG005|Overall Study|Withdrew Consent|3|||
160776879|NCT02260986|580567151|FG000|Overall Study|Adverse Event|24|||
160776880|NCT02260986|580567152|FG001|Overall Study|Adverse Event|0|||
160776881|NCT02260986|580567153|FG002|Overall Study|Adverse Event|11|||
160776882|NCT02260986|580567151|FG000|Overall Study|Lack of Efficacy|27|||
160776883|NCT02260986|580567152|FG001|Overall Study|Lack of Efficacy|3|||
160776884|NCT02260986|580567153|FG002|Overall Study|Lack of Efficacy|0|||
160776885|NCT02260986|580567151|FG000|Overall Study|Protocol Violation|14|||
160776886|NCT02260986|580567152|FG001|Overall Study|Protocol Violation|5|||
160776887|NCT02260986|580567153|FG002|Overall Study|Protocol Violation|16|||
160776888|NCT02260986|580567151|FG000|Overall Study|Car accident|0|||
160776889|NCT02260986|580567152|FG001|Overall Study|Car accident|0|||
160776890|NCT02260986|580567153|FG002|Overall Study|Car accident|1|||
160776891|NCT02260986|580567151|FG000|Overall Study|Withdrawal by Subject|17|||
160776892|NCT02260986|580567152|FG001|Overall Study|Withdrawal by Subject|4|||
160776893|NCT02260986|580567153|FG002|Overall Study|Withdrawal by Subject|9|||
160776894|NCT02260986|580567151|FG000|Overall Study|Incorrect randomization|0|||
160776895|NCT02260986|580567152|FG001|Overall Study|Incorrect randomization|1|||
160776896|NCT02260986|580567153|FG002|Overall Study|Incorrect randomization|0|||
160776897|NCT02260986|580567151|FG000|Overall Study|Lack of investigation product supply|2|||
160776898|NCT02260986|580567152|FG001|Overall Study|Lack of investigation product supply|0|||
160776899|NCT02260986|580567153|FG002|Overall Study|Lack of investigation product supply|1|||
160776900|NCT02260986|580567151|FG000|Overall Study|Lost to Follow-up|4|||
160776901|NCT02260986|580567152|FG001|Overall Study|Lost to Follow-up|0|||
160776902|NCT02260986|580567153|FG002|Overall Study|Lost to Follow-up|3|||
160776903|NCT02260986|580567151|FG000|Overall Study|Pregnancy|2|||
160776904|NCT02260986|580567152|FG001|Overall Study|Pregnancy|0|||
160776905|NCT02260986|580567153|FG002|Overall Study|Pregnancy|0|||
160776906|NCT00313170|580567158|FG000|Overall Study|Death|2|||
160776907|NCT00313170|580567159|FG001|Overall Study|Death|4|||
160776908|NCT00313170|580567160|FG002|Overall Study|Death|2|||
160776909|NCT00313170|580567158|FG000|Overall Study|Adverse Event|1|||
160776910|NCT00313170|580567159|FG001|Overall Study|Adverse Event|2|||
160776911|NCT00313170|580567160|FG002|Overall Study|Adverse Event|0|||
160776912|NCT00313170|580567158|FG000|Overall Study|Disease progression|31|||
160776913|NCT00313170|580567159|FG001|Overall Study|Disease progression|26|||
160776914|NCT00313170|580567160|FG002|Overall Study|Disease progression|27|||
160776915|NCT00313170|580567158|FG000|Overall Study|Withdrawal by Subject|1|||
160776916|NCT00313170|580567159|FG001|Overall Study|Withdrawal by Subject|0|||
160776917|NCT00313170|580567160|FG002|Overall Study|Withdrawal by Subject|1|||
160776918|NCT00313170|580567158|FG000|Overall Study|Incorrect enrollment|0|||
160776919|NCT00313170|580567159|FG001|Overall Study|Incorrect enrollment|2|||
160776920|NCT00313170|580567160|FG002|Overall Study|Incorrect enrollment|1|||
160776921|NCT00313170|580567158|FG000|Overall Study|Lost to Follow-up|0|||
160776922|NCT00313170|580567159|FG001|Overall Study|Lost to Follow-up|0|||
160776923|NCT00313170|580567160|FG002|Overall Study|Lost to Follow-up|1|||
160776924|NCT00313170|580567158|FG000|Overall Study|Progression (investigators opinion)|1|||
160776925|NCT00313170|580567159|FG001|Overall Study|Progression (investigators opinion)|0|||
160886811|NCT00745615|580980614|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
160886812|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
160886813|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
160776926|NCT00313170|580567160|FG002|Overall Study|Progression (investigators opinion)|0|||
160776927|NCT00407511|580567166|FG000|Overall Study|Adverse Event|9|||
160776928|NCT00407511|580567166|FG000|Overall Study|Lost to Follow-up|4|||
160886814|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
160886815|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
160886816|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
160886817|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
160886818|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
160886819|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
160886820|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
160886821|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
160886822|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
160886823|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
160886824|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
160886825|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
160886826|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
160886827|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
160886828|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
160541285|NCT00623480|579711195|FG000|Overall Study|Lack of Efficacy|1|||
160776929|NCT00407511|580567166|FG000|Overall Study|Other|5|||
160776930|NCT00407511|580567166|FG000|Overall Study|Withdrawal by Subject|4|||
160541286|NCT00623480|579711196|FG001|Overall Study|Lack of Efficacy|0|||
160541287|NCT00623480|579711195|FG000|Overall Study|Non-compliant with study medication|4|||
160776931|NCT00529035|580567167|FG000|Overall Study|Withdrawal by Subject|1|||
160776932|NCT03439514|580567168|FG000|Double-Blind Treatment Period|Other|4|||
160776933|NCT03439514|580567169|FG001|Double-Blind Treatment Period|Other|1|||
160776934|NCT03439514|580567168|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
160776935|NCT03439514|580567169|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
160776936|NCT03439514|580567168|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
160776937|NCT03439514|580567169|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
160541288|NCT00623480|579711196|FG001|Overall Study|Non-compliant with study medication|0|||
160541289|NCT00623480|579711195|FG000|Overall Study|Protocol Violation|0|||
160541290|NCT00623480|579711196|FG001|Overall Study|Protocol Violation|1|||
160541291|NCT00623480|579711195|FG000|Overall Study|Site closed by sponsor|0|||
160541292|NCT00623480|579711196|FG001|Overall Study|Site closed by sponsor|1|||
160541293|NCT01594853|579711197|FG000|Overall Study|Withdrawal by Subject|1|||
160541294|NCT01594853|579711198|FG001|Overall Study|Withdrawal by Subject|1|||
160541295|NCT01594853|579711197|FG000|Overall Study|Lost to Follow-up|1|||
160541296|NCT01594853|579711198|FG001|Overall Study|Lost to Follow-up|1|||
160541297|NCT01594853|579711197|FG000|Overall Study|noncompliance with exercise|0|||
160541298|NCT01594853|579711198|FG001|Overall Study|noncompliance with exercise|1|||
160541299|NCT00769002|579711199|FG000|Overall Study|Study was not completed, no data|9|||
160541300|NCT00769002|579711200|FG001|Overall Study|Study was not completed, no data|9|||
160541301|NCT00960661|579711201|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
160541302|NCT00960661|579711202|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
160541303|NCT00960661|579711203|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
160541304|NCT00960661|579711201|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
160541305|NCT00960661|579711202|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
160541306|NCT00960661|579711203|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
160541307|NCT00960661|579711201|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
160541308|NCT00960661|579711202|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
160541309|NCT00960661|579711203|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
160541310|NCT00960661|579711201|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
160541311|NCT00960661|579711202|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
160541312|NCT00960661|579711203|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
160541313|NCT00960661|579711201|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
160541314|NCT00960661|579711202|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
160541315|NCT00960661|579711203|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
160541316|NCT00960661|579711201|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
160541317|NCT00960661|579711202|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
160541318|NCT00960661|579711203|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
160541319|NCT00960661|579711201|FG000|Interventional Phase|Adverse Event|0|||
160541320|NCT00960661|579711202|FG001|Interventional Phase|Adverse Event|17|||
160541321|NCT00960661|579711203|FG002|Interventional Phase|Adverse Event|8|||
160541322|NCT00960661|579711201|FG000|Interventional Phase|Death|0|||
160541323|NCT00960661|579711202|FG001|Interventional Phase|Death|1|||
160541324|NCT00960661|579711203|FG002|Interventional Phase|Death|0|||
160541325|NCT00960661|579711201|FG000|Interventional Phase|Lost to Follow-up|0|||
160541326|NCT00960661|579711202|FG001|Interventional Phase|Lost to Follow-up|0|||
160541327|NCT00960661|579711203|FG002|Interventional Phase|Lost to Follow-up|2|||
160541328|NCT00960661|579711201|FG000|Interventional Phase|entry criteria not met|0|||
160776938|NCT03439514|580567168|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
160776939|NCT03439514|580567169|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
160776940|NCT03439514|580567168|FG000|Double-Blind Treatment Period|Death|1|||
160776941|NCT03439514|580567169|FG001|Double-Blind Treatment Period|Death|2|||
160776942|NCT02636283|580567170|FG000|Overall Study|Adverse Event|2|||
160776943|NCT02636283|580567171|FG001|Overall Study|Adverse Event|0|||
160776944|NCT02636283|580567170|FG000|Overall Study|Trial Terminated Prematurely|0|||
160776945|NCT02636283|580567171|FG001|Overall Study|Trial Terminated Prematurely|3|||
160776946|NCT03418675|580567172|FG000|Overall Study|Lost to Follow-up|13|||
160776947|NCT03418675|580567173|FG001|Overall Study|Lost to Follow-up|10|||
160776948|NCT03418675|580567172|FG000|Overall Study|Adverse Event|2|||
160776949|NCT03418675|580567173|FG001|Overall Study|Adverse Event|0|||
160776950|NCT01879852|580567174|FG000|Overall Study|Withdrawal by Subject|2|||
160776951|NCT01879852|580567175|FG001|Overall Study|Withdrawal by Subject|0|||
160776952|NCT04900272|580567180|FG000|Overall Study|Lost to Follow-up|2|||
160776953|NCT04900272|580567180|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
160776954|NCT04900272|580567180|FG000|Overall Study|Withdrawal by Subject|1|||
160776955|NCT03086343|580567181|FG000|Period 1|Adverse Event|7|||
160776956|NCT03086343|580567182|FG001|Period 1|Adverse Event|7|||
160776957|NCT03086343|580567183|FG002|Period 1|Adverse Event|0|||
160541329|NCT00960661|579711202|FG001|Interventional Phase|entry criteria not met|3|||
160541330|NCT00960661|579711203|FG002|Interventional Phase|entry criteria not met|0|||
160541331|NCT00960661|579711201|FG000|Interventional Phase|Protocol Violation|0|||
160541332|NCT00960661|579711202|FG001|Interventional Phase|Protocol Violation|7|||
160541333|NCT00960661|579711203|FG002|Interventional Phase|Protocol Violation|2|||
160541334|NCT00960661|579711201|FG000|Interventional Phase|Withdrawal by Subject|0|||
160541335|NCT00960661|579711202|FG001|Interventional Phase|Withdrawal by Subject|18|||
160541336|NCT00960661|579711203|FG002|Interventional Phase|Withdrawal by Subject|29|||
160541337|NCT00960661|579711201|FG000|Interventional Phase|Physician Decision|0|||
160541338|NCT00960661|579711202|FG001|Interventional Phase|Physician Decision|3|||
160541339|NCT00960661|579711203|FG002|Interventional Phase|Physician Decision|5|||
160541340|NCT00960661|579711201|FG000|Interventional Phase|sponsor decision|0|||
160541341|NCT00960661|579711202|FG001|Interventional Phase|sponsor decision|1|||
160541342|NCT00960661|579711203|FG002|Interventional Phase|sponsor decision|0|||
160541343|NCT00960661|579711201|FG000|Interventional Phase|Lack of Efficacy|0|||
160541344|NCT00960661|579711202|FG001|Interventional Phase|Lack of Efficacy|2|||
160541345|NCT00960661|579711203|FG002|Interventional Phase|Lack of Efficacy|0|||
160541346|NCT02699892|579711204|FG000|Overall Study|Other|36|||
160541347|NCT00847912|579711205|FG000|Overall Study|Protocol Violation|6|||
160541348|NCT00847912|579711206|FG001|Overall Study|Protocol Violation|7|||
160541349|NCT00847912|579711205|FG000|Overall Study|Withdrawal by Subject|3|||
160541350|NCT00847912|579711206|FG001|Overall Study|Withdrawal by Subject|6|||
160541351|NCT02412787|579711207|FG000|Overall Study|Withdrawal by Subject|9|||
160541352|NCT02412787|579711207|FG000|Overall Study|Participation Terminated by Investigator|1|||
160541353|NCT02412787|579711207|FG000|Overall Study|Site Terminated by Sponsor|21|||
160541354|NCT02412787|579711207|FG000|Overall Study|Technical Problems|1|||
160541355|NCT02412787|579711207|FG000|Overall Study|Reason Not Specified|1|||
160541356|NCT02797808|579711208|FG000|Overall Study|Withdrawal by Subject|1|||
160541357|NCT02797808|579711209|FG001|Overall Study|Withdrawal by Subject|1|||
160541358|NCT02797808|579711208|FG000|Overall Study|Physician Decision|6|||
160541359|NCT02797808|579711209|FG001|Overall Study|Physician Decision|2|||
160541360|NCT00535132|579711212|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
160541361|NCT00535132|579711213|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
160541362|NCT00535132|579711212|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
160776958|NCT03086343|580567184|FG003|Period 1|Adverse Event|1|||
160776959|NCT03086343|580567181|FG000|Period 1|Withdrawal by Subject|6|||
160886829|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
160886830|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
160541363|NCT00535132|579711213|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
160541364|NCT00264875|579711214|FG000|Overall Study|Adverse Event|6|||
160541365|NCT00264875|579711214|FG000|Overall Study|Lost to Follow-up|6|||
160541366|NCT00264875|579711214|FG000|Overall Study|Protocol Violation|11|||
160541367|NCT00264875|579711214|FG000|Overall Study|Withdrawal by Subject|7|||
160541368|NCT01157364|579711217|FG000|Overall Study|Other Reasons|1|||
160541369|NCT01157364|579711218|FG001|Overall Study|Other Reasons|1|||
160541370|NCT01157364|579711219|FG002|Overall Study|Other Reasons|2|||
160541371|NCT01157364|579711220|FG003|Overall Study|Other Reasons|1|||
160541372|NCT01157364|579711221|FG004|Overall Study|Other Reasons|0|||
160541373|NCT01157364|579711222|FG005|Overall Study|Other Reasons|0|||
160541374|NCT01157364|579711217|FG000|Overall Study|Personal Reasons|0|||
160541375|NCT01157364|579711218|FG001|Overall Study|Personal Reasons|2|||
160541376|NCT01157364|579711219|FG002|Overall Study|Personal Reasons|0|||
160776960|NCT03086343|580567182|FG001|Period 1|Withdrawal by Subject|10|||
160776961|NCT03086343|580567183|FG002|Period 1|Withdrawal by Subject|0|||
160776962|NCT03086343|580567184|FG003|Period 1|Withdrawal by Subject|0|||
160776963|NCT03086343|580567181|FG000|Period 1|Lost to Follow-up|1|||
160776964|NCT03086343|580567182|FG001|Period 1|Lost to Follow-up|3|||
160776965|NCT03086343|580567183|FG002|Period 1|Lost to Follow-up|1|||
160776966|NCT03086343|580567184|FG003|Period 1|Lost to Follow-up|0|||
160776967|NCT03086343|580567181|FG000|Period 1|Other, Not Specified|10|||
160776968|NCT03086343|580567182|FG001|Period 1|Other, Not Specified|12|||
160776969|NCT03086343|580567183|FG002|Period 1|Other, Not Specified|2|||
160776970|NCT03086343|580567184|FG003|Period 1|Other, Not Specified|1|||
160776971|NCT03086343|580567181|FG000|Period 1|Missing|1|||
160776972|NCT03086343|580567182|FG001|Period 1|Missing|0|||
160776973|NCT03086343|580567183|FG002|Period 1|Missing|0|||
160776974|NCT03086343|580567184|FG003|Period 1|Missing|0|||
160776975|NCT03086343|580567181|FG000|Period 2|Adverse Event|20|||
160776976|NCT03086343|580567182|FG001|Period 2|Adverse Event|11|||
160776977|NCT03086343|580567183|FG002|Period 2|Adverse Event|1|||
160776978|NCT03086343|580567184|FG003|Period 2|Adverse Event|2|||
160776979|NCT03086343|580567181|FG000|Period 2|Withdrawal by Subject|15|||
160776980|NCT03086343|580567182|FG001|Period 2|Withdrawal by Subject|25|||
160776981|NCT03086343|580567183|FG002|Period 2|Withdrawal by Subject|2|||
160776982|NCT03086343|580567184|FG003|Period 2|Withdrawal by Subject|2|||
160776983|NCT03086343|580567181|FG000|Period 2|Lost to Follow-up|6|||
160776984|NCT03086343|580567182|FG001|Period 2|Lost to Follow-up|11|||
160776985|NCT03086343|580567183|FG002|Period 2|Lost to Follow-up|1|||
160776986|NCT03086343|580567184|FG003|Period 2|Lost to Follow-up|0|||
160776987|NCT03086343|580567181|FG000|Period 2|COVID-19 Infection|5|||
160776988|NCT03086343|580567182|FG001|Period 2|COVID-19 Infection|0|||
160776989|NCT03086343|580567183|FG002|Period 2|COVID-19 Infection|0|||
160776990|NCT03086343|580567184|FG003|Period 2|COVID-19 Infection|0|||
160776991|NCT03086343|580567181|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
160776992|NCT03086343|580567182|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
160776993|NCT03086343|580567183|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
160776994|NCT03086343|580567184|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
160776995|NCT03086343|580567181|FG000|Period 2|Other, Not Specified|23|||
160776996|NCT03086343|580567182|FG001|Period 2|Other, Not Specified|22|||
160776997|NCT03086343|580567183|FG002|Period 2|Other, Not Specified|2|||
160776998|NCT03086343|580567184|FG003|Period 2|Other, Not Specified|4|||
160776999|NCT01625182|580567186|FG000|Overall Study|Administrative problems|1|||
160777000|NCT01625182|580567187|FG001|Overall Study|Administrative problems|0|||
160777001|NCT01625182|580567186|FG000|Overall Study|Protocol deviation|0|||
160777002|NCT01625182|580567187|FG001|Overall Study|Protocol deviation|2|||
160777003|NCT01625182|580567186|FG000|Overall Study|Adverse Event|2|||
160777004|NCT01625182|580567187|FG001|Overall Study|Adverse Event|0|||
160777005|NCT01625182|580567186|FG000|Overall Study|Withdrawal by Subject|5|||
160777006|NCT01625182|580567187|FG001|Overall Study|Withdrawal by Subject|1|||
160777007|NCT01625182|580567186|FG000|Overall Study|Lack of Efficacy|12|||
160777008|NCT01625182|580567187|FG001|Overall Study|Lack of Efficacy|8|||
160886831|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
160777009|NCT00741611|580567188|FG000|Overall Study|Death|0|||
160777010|NCT00741611|580567189|FG001|Overall Study|Death|0|||
160777011|NCT00741611|580567190|FG002|Overall Study|Death|1|||
160777012|NCT00741611|580567188|FG000|Overall Study|Withdrawal by Subject|0|||
160777013|NCT00741611|580567189|FG001|Overall Study|Withdrawal by Subject|2|||
160777014|NCT00741611|580567190|FG002|Overall Study|Withdrawal by Subject|2|||
160777015|NCT05696847|580567192|FG000|Overall Study|Withdrawal by Subject|1|||
160777016|NCT05696847|580567193|FG001|Overall Study|Withdrawal by Subject|0|||
160777017|NCT05696847|580567194|FG002|Overall Study|Withdrawal by Subject|0|||
160777018|NCT05696847|580567195|FG003|Overall Study|Withdrawal by Subject|0|||
160777019|NCT05696847|580567196|FG004|Overall Study|Withdrawal by Subject|0|||
160777020|NCT05696847|580567197|FG005|Overall Study|Withdrawal by Subject|0|||
160777021|NCT05696847|580567192|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160777022|NCT05696847|580567193|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160777023|NCT05696847|580567194|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160777024|NCT05696847|580567195|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160777025|NCT05696847|580567196|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
160777026|NCT05696847|580567197|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
160777027|NCT05696847|580567192|FG000|Overall Study|Adverse Event|0|||
160777028|NCT05696847|580567193|FG001|Overall Study|Adverse Event|0|||
160777029|NCT05696847|580567194|FG002|Overall Study|Adverse Event|0|||
160777030|NCT05696847|580567195|FG003|Overall Study|Adverse Event|0|||
160541377|NCT01157364|579711220|FG003|Overall Study|Personal Reasons|0|||
160541378|NCT01157364|579711221|FG004|Overall Study|Personal Reasons|1|||
160541379|NCT01157364|579711222|FG005|Overall Study|Personal Reasons|1|||
160541380|NCT01157364|579711217|FG000|Overall Study|Lost to Follow-up|1|||
160541381|NCT01157364|579711218|FG001|Overall Study|Lost to Follow-up|0|||
160541382|NCT01157364|579711219|FG002|Overall Study|Lost to Follow-up|1|||
160541383|NCT01157364|579711220|FG003|Overall Study|Lost to Follow-up|0|||
160541384|NCT01157364|579711221|FG004|Overall Study|Lost to Follow-up|0|||
160541385|NCT01157364|579711222|FG005|Overall Study|Lost to Follow-up|0|||
160541386|NCT01157364|579711217|FG000|Overall Study|Lack of Efficacy|0|||
160541387|NCT01157364|579711218|FG001|Overall Study|Lack of Efficacy|0|||
160541388|NCT01157364|579711219|FG002|Overall Study|Lack of Efficacy|0|||
160541389|NCT01157364|579711220|FG003|Overall Study|Lack of Efficacy|1|||
160541390|NCT01157364|579711221|FG004|Overall Study|Lack of Efficacy|0|||
160541391|NCT01157364|579711222|FG005|Overall Study|Lack of Efficacy|0|||
160541392|NCT01157364|579711217|FG000|Overall Study|Adverse Event|0|||
160541393|NCT01157364|579711218|FG001|Overall Study|Adverse Event|1|||
160541394|NCT01157364|579711219|FG002|Overall Study|Adverse Event|1|||
160541395|NCT01157364|579711220|FG003|Overall Study|Adverse Event|0|||
160541396|NCT01157364|579711221|FG004|Overall Study|Adverse Event|1|||
160541397|NCT01157364|579711222|FG005|Overall Study|Adverse Event|0|||
160541398|NCT00586495|579711227|FG000|Treatment Period|Adverse Event|11|||
160541399|NCT00586495|579711227|FG000|Treatment Period|Death|1|||
160541400|NCT00586495|579711227|FG000|Treatment Period|Protocol Violation|1|||
160541401|NCT00586495|579711227|FG000|Treatment Period|Withdrawal by Subject|1|||
160541402|NCT00586495|579711227|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
160541403|NCT00586495|579711227|FG000|Treatment Period|Switch to commercial drug|10|||
160541404|NCT00586495|579711227|FG000|Follow-up|Death|40|||
160541405|NCT00586495|579711227|FG000|Follow-up|Lost to Follow-up|1|||
160541406|NCT00586495|579711227|FG000|Follow-up|Withdrawal by Subject|4|||
160541407|NCT00586495|579711227|FG000|Follow-up|Protocol driven decision point|37|||
160541408|NCT00586495|579711227|FG000|Follow-up|Switch to commercial drug|10|||
160541409|NCT02813694|579711230|FG000|Overall Study|Physician Decision|0|||
160541410|NCT02813694|579711231|FG001|Overall Study|Physician Decision|1|||
160541411|NCT02813694|579711230|FG000|Overall Study|Withdrawal by Subject|10|||
160541412|NCT02813694|579711231|FG001|Overall Study|Withdrawal by Subject|9|||
160541413|NCT02813694|579711230|FG000|Overall Study|Lost to Follow-up|1|||
160541414|NCT02813694|579711231|FG001|Overall Study|Lost to Follow-up|1|||
160541415|NCT02813694|579711230|FG000|Overall Study|Death|3|||
160541416|NCT02813694|579711231|FG001|Overall Study|Death|3|||
160777031|NCT05696847|580567196|FG004|Overall Study|Adverse Event|0|||
160541417|NCT02813694|579711230|FG000|Overall Study|Randomized- did not receive study drug|2|||
160541418|NCT02813694|579711231|FG001|Overall Study|Randomized- did not receive study drug|0|||
160541419|NCT02813694|579711230|FG000|Overall Study|Patient hospitalized|1|||
160541420|NCT02813694|579711231|FG001|Overall Study|Patient hospitalized|0|||
160541421|NCT01227044|579711232|FG000|Overall Study|Lost to Follow-up|5|||
160541422|NCT01227044|579711233|FG001|Overall Study|Lost to Follow-up|7|||
160541423|NCT01227044|579711232|FG000|Overall Study|Discontinued Intervention|1|||
160541424|NCT01227044|579711233|FG001|Overall Study|Discontinued Intervention|2|||
160541425|NCT04247061|579711234|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
160541426|NCT04247061|579711234|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
160541427|NCT04247061|579711234|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
160541428|NCT02039375|579711241|FG000|Overall Study|Lost to Follow-up|2|||
160777032|NCT05696847|580567197|FG005|Overall Study|Adverse Event|1|||
160637932|NCT00123487|580057990|FG000|Treated With Study Drug|Physician Decision|8|||
160777033|NCT05696847|580567192|FG000|Overall Study|Sponsor Decision|0|||
160541429|NCT04770389|579711242|FG000|Overall Study|Adverse Event|1|||
160541430|NCT04770389|579711243|FG001|Overall Study|Adverse Event|2|||
160777034|NCT05696847|580567193|FG001|Overall Study|Sponsor Decision|0|||
160777035|NCT05696847|580567194|FG002|Overall Study|Sponsor Decision|0|||
160777036|NCT05696847|580567195|FG003|Overall Study|Sponsor Decision|1|||
160777037|NCT05696847|580567196|FG004|Overall Study|Sponsor Decision|0|||
160777038|NCT05696847|580567197|FG005|Overall Study|Sponsor Decision|0|||
160777039|NCT04132050|580567206|FG000|Period I (Double-blind Period)|Adverse Event|3|||
160777040|NCT04132050|580567207|FG001|Period I (Double-blind Period)|Adverse Event|0|||
160777041|NCT04132050|580567206|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
160777042|NCT04132050|580567207|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
160777043|NCT04132050|580567206|FG000|R788 Treatment Period|Adverse Event|5|||
160777044|NCT04132050|580567207|FG001|R788 Treatment Period|Adverse Event|0|||
160777045|NCT04132050|580567206|FG000|R788 Treatment Period|Lack of Efficacy|5|||
160777046|NCT04132050|580567207|FG001|R788 Treatment Period|Lack of Efficacy|0|||
160777047|NCT04132050|580567206|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
160777048|NCT04132050|580567207|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
160777049|NCT02516241|580567213|FG000|Overall Study|Death|255|||
160777050|NCT02516241|580567214|FG001|Overall Study|Death|262|||
160777051|NCT02516241|580567215|FG002|Overall Study|Death|270|||
160777052|NCT02516241|580567213|FG000|Overall Study|Lost to Follow-up|1|||
160777053|NCT02516241|580567214|FG001|Overall Study|Lost to Follow-up|1|||
160777054|NCT02516241|580567215|FG002|Overall Study|Lost to Follow-up|3|||
160777055|NCT02516241|580567213|FG000|Overall Study|Withdrawal by Subject|2|||
160777056|NCT02516241|580567214|FG001|Overall Study|Withdrawal by Subject|7|||
160777057|NCT02516241|580567215|FG002|Overall Study|Withdrawal by Subject|12|||
160777058|NCT02516241|580567213|FG000|Overall Study|participants ongoing at data cut-off|84|||
160777059|NCT02516241|580567214|FG001|Overall Study|participants ongoing at data cut-off|76|||
160777060|NCT02516241|580567215|FG002|Overall Study|participants ongoing at data cut-off|59|||
160777061|NCT02875080|580567221|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
160777062|NCT02875080|580567222|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
160777063|NCT02875080|580567223|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
160777064|NCT03018938|580567224|FG000|Overall Study|Death|0|||
160777065|NCT03018938|580567225|FG001|Overall Study|Death|1|||
160777066|NCT03018938|580567224|FG000|Overall Study|Lost to Follow-up|21|||
160777067|NCT03018938|580567225|FG001|Overall Study|Lost to Follow-up|32|||
160777068|NCT03018938|580567224|FG000|Overall Study|Withdrawal by Subject|38|||
160777069|NCT03018938|580567225|FG001|Overall Study|Withdrawal by Subject|45|||
160777070|NCT03018938|580567224|FG000|Overall Study|Physician Decision|3|||
160777071|NCT03018938|580567225|FG001|Overall Study|Physician Decision|2|||
160777072|NCT03018938|580567224|FG000|Overall Study|Sponsor Decision|0|||
160777073|NCT03018938|580567225|FG001|Overall Study|Sponsor Decision|1|||
160777074|NCT03018938|580567224|FG000|Overall Study|Screen failure-After randomization|4|||
160886832|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
160886833|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
160886834|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
160886835|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
160777075|NCT03018938|580567225|FG001|Overall Study|Screen failure-After randomization|2|||
160777076|NCT03018938|580567224|FG000|Overall Study|Not recorded|0|||
160777077|NCT03018938|580567225|FG001|Overall Study|Not recorded|2|||
160777078|NCT00191100|580567226|FG000|Overall Study|Adverse Event|18|||
160777079|NCT00191100|580567227|FG001|Overall Study|Adverse Event|1|||
160777080|NCT00191100|580567226|FG000|Overall Study|Lost to Follow-up|2|||
160777081|NCT00191100|580567227|FG001|Overall Study|Lost to Follow-up|0|||
160777082|NCT00191100|580567226|FG000|Overall Study|Patient Moved|0|||
160777083|NCT00191100|580567227|FG001|Overall Study|Patient Moved|1|||
160777084|NCT00191100|580567226|FG000|Overall Study|Withdrawal by Subject|9|||
160777085|NCT00191100|580567227|FG001|Overall Study|Withdrawal by Subject|3|||
160777086|NCT00191100|580567226|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
160777087|NCT00191100|580567227|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
160777088|NCT00191100|580567226|FG000|Overall Study|Clinical Relapse|2|||
160777089|NCT00191100|580567227|FG001|Overall Study|Clinical Relapse|1|||
160777090|NCT00191100|580567226|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
160777091|NCT00191100|580567227|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
160777092|NCT00191100|580567226|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
160777093|NCT00191100|580567227|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
160777094|NCT00191100|580567226|FG000|Overall Study|Physician Decision|3|||
160777095|NCT00191100|580567227|FG001|Overall Study|Physician Decision|1|||
160777096|NCT00191100|580567226|FG000|Overall Study|Death from Study Drug Toxicity|2|||
160777097|NCT00191100|580567227|FG001|Overall Study|Death from Study Drug Toxicity|0|||
160777098|NCT00191100|580567226|FG000|Overall Study|Protocol Violation|1|||
160777099|NCT00191100|580567227|FG001|Overall Study|Protocol Violation|1|||
160777100|NCT00191100|580567226|FG000|Overall Study|Death from Other Cause|1|||
160777101|NCT00191100|580567227|FG001|Overall Study|Death from Other Cause|0|||
160777102|NCT00191100|580567226|FG000|Overall Study|Reason Not Specified|0|||
160777103|NCT00191100|580567227|FG001|Overall Study|Reason Not Specified|1|||
160777104|NCT02406612|580567230|FG000|Overall Study|Screening Failure|3|||
160777105|NCT02406612|580567231|FG001|Overall Study|Screening Failure|0|||
160777106|NCT02406612|580567230|FG000|Overall Study|Intra-procedural Exclusion|1|||
160777107|NCT02406612|580567231|FG001|Overall Study|Intra-procedural Exclusion|3|||
160777108|NCT02406612|580567230|FG000|Overall Study|Guidewire Failure|0|||
160777109|NCT02406612|580567231|FG001|Overall Study|Guidewire Failure|1|||
160777110|NCT03483012|580567235|FG000|Overall Study|Lack of Efficacy|6|||
160777111|NCT02900976|580567236|FG000|Overall Study|Adverse Event|0|||
160777112|NCT02900976|580567237|FG001|Overall Study|Adverse Event|1|||
160777113|NCT02900976|580567236|FG000|Overall Study|Physician Decision|0|||
160777114|NCT02900976|580567237|FG001|Overall Study|Physician Decision|2|||
160777115|NCT02900976|580567236|FG000|Overall Study|Progressive disease|0|||
160777116|NCT02900976|580567237|FG001|Overall Study|Progressive disease|6|||
160777117|NCT03611946|580567251|FG000|Overall Study|Withdrawal by Subject|0|||
160777118|NCT03611946|580567252|FG001|Overall Study|Withdrawal by Subject|0|||
160777119|NCT03611946|580567253|FG002|Overall Study|Withdrawal by Subject|1|||
160777120|NCT03611946|580567254|FG003|Overall Study|Withdrawal by Subject|0|||
160777121|NCT04766333|580568331|FG000|Overall Study|Lost to Follow-up|40|||
160777122|NCT04766333|580568332|FG001|Overall Study|Lost to Follow-up|826|||
160777123|NCT00639379|580568333|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
160777124|NCT00639379|580568334|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
160777125|NCT00639379|580568333|FG000|Period 1 - 2 Weeks|lens issue|3|||
160777126|NCT00639379|580568334|FG001|Period 1 - 2 Weeks|lens issue|0|||
160777127|NCT02536794|580568335|FG000|Reached 1st Response Assessment|Adverse Event|2|||
160777128|NCT02536794|580568335|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
160777129|NCT02536794|580568335|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
160777130|NCT02536794|580568335|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
160777131|NCT02536794|580568335|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
160777132|NCT02536794|580568335|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
160777133|NCT01521364|580568336|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
160777134|NCT01521364|580568336|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
160777135|NCT02447029|580568337|FG000|Overall Study|Withdrawal by Subject|3|||
160777136|NCT02447029|580568338|FG001|Overall Study|Withdrawal by Subject|2|||
160777137|NCT02299167|580568339|FG000|Overall Study|patients were excluded from the study|11|||
160777138|NCT03600428|580568340|FG000|Overall Study|Not eligible|0|||
160777139|NCT03600428|580568341|FG001|Overall Study|Not eligible|1|||
160777140|NCT03600428|580568340|FG000|Overall Study|Lost to Follow-up|5|||
160777141|NCT03600428|580568341|FG001|Overall Study|Lost to Follow-up|4|||
160777142|NCT00770484|580568342|FG000|Overall Study|Withdrawal by Subject|1|||
160777143|NCT00770484|580568343|FG001|Overall Study|Withdrawal by Subject|0|||
160777144|NCT01666652|580568351|FG000|Overall Study|Serious Adverse Event|0|||
160777145|NCT01666652|580568352|FG001|Overall Study|Serious Adverse Event|0|||
160777146|NCT01666652|580568353|FG002|Overall Study|Serious Adverse Event|0|||
160777147|NCT01666652|580568354|FG003|Overall Study|Serious Adverse Event|1|||
160777148|NCT01666652|580568355|FG004|Overall Study|Serious Adverse Event|0|||
160777149|NCT01666652|580568351|FG000|Overall Study|Withdrawal by Subject|0|||
160777150|NCT01666652|580568352|FG001|Overall Study|Withdrawal by Subject|0|||
160777151|NCT01666652|580568353|FG002|Overall Study|Withdrawal by Subject|0|||
160777152|NCT01666652|580568354|FG003|Overall Study|Withdrawal by Subject|0|||
160777153|NCT01666652|580568355|FG004|Overall Study|Withdrawal by Subject|1|||
160777154|NCT01666652|580568351|FG000|Overall Study|Moved from study area|1|||
160777155|NCT01666652|580568352|FG001|Overall Study|Moved from study area|0|||
160777156|NCT01666652|580568353|FG002|Overall Study|Moved from study area|0|||
160777157|NCT01666652|580568354|FG003|Overall Study|Moved from study area|2|||
160777158|NCT01666652|580568355|FG004|Overall Study|Moved from study area|0|||
160777159|NCT01666652|580568351|FG000|Overall Study|Lost to Follow-up|1|||
160777160|NCT01666652|580568352|FG001|Overall Study|Lost to Follow-up|1|||
160777161|NCT01666652|580568353|FG002|Overall Study|Lost to Follow-up|1|||
160777162|NCT01666652|580568354|FG003|Overall Study|Lost to Follow-up|1|||
160777163|NCT01666652|580568355|FG004|Overall Study|Lost to Follow-up|0|||
160777164|NCT00088153|580568356|FG000|Overall Study|Physician Decision|3|||
160777165|NCT00088153|580568357|FG001|Overall Study|Physician Decision|3|||
160777166|NCT00088153|580568356|FG000|Overall Study|Withdrawal by Subject|10|||
160777167|NCT00088153|580568357|FG001|Overall Study|Withdrawal by Subject|10|||
160777168|NCT00088153|580568356|FG000|Overall Study|Lost to Follow-up|11|||
160777169|NCT00088153|580568357|FG001|Overall Study|Lost to Follow-up|12|||
160777170|NCT01695746|580568358|FG000|Overall Study|Adverse Event|1|||
160777171|NCT01695746|580568358|FG000|Overall Study|Non-compliance by the participant|3|||
160777172|NCT01695746|580568358|FG000|Overall Study|Protocol Violation|5|||
160777173|NCT01695746|580568358|FG000|Overall Study|Participant not willing to participate|3|||
160777174|NCT03506477|580568361|FG000|Overall Study|Withdrawal by Subject|1|||
160777175|NCT03506477|580568362|FG001|Overall Study|Withdrawal by Subject|0|||
160777176|NCT03462680|580568363|FG000|Overall Study|Withdrawal by Subject|3|||
160777177|NCT03462680|580568364|FG001|Overall Study|Withdrawal by Subject|5|||
160777178|NCT01757847|580568365|FG000|Overall Study|Withdrawal by Subject|3|||
160777179|NCT01757847|580568366|FG001|Overall Study|Withdrawal by Subject|4|||
160777180|NCT01063114|580568367|FG000|Overall Study|Lost to Follow-up|1|||
160777181|NCT00462462|580568371|FG000|Overall Study|Physician Decision|0|||
160777182|NCT00462462|580568372|FG001|Overall Study|Physician Decision|1|||
160777183|NCT01163617|580568373|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
160777184|NCT01163617|580568374|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
160777185|NCT01163617|580568375|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
160777186|NCT01163617|580568376|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
160777187|NCT01163617|580568377|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
160777188|NCT01163617|580568378|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
160777189|NCT01163617|580568379|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
160777190|NCT01163617|580568380|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
160777191|NCT01163617|580568373|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
160777192|NCT01163617|580568374|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
160777193|NCT01163617|580568375|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
160777194|NCT01163617|580568376|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
160777195|NCT01163617|580568377|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
160777196|NCT01163617|580568378|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
160777197|NCT01163617|580568379|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
160777198|NCT01163617|580568380|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
160777199|NCT01163617|580568373|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
160777200|NCT01163617|580568374|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
160777201|NCT01163617|580568375|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
160777202|NCT01163617|580568376|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
160777203|NCT01163617|580568377|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
160777204|NCT01163617|580568378|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
160777205|NCT01163617|580568379|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
160777206|NCT01163617|580568380|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
160777207|NCT02394756|580568381|FG000|Period 1|Lens Discomfort|0|||
160777208|NCT02394756|580568382|FG001|Period 1|Lens Discomfort|0|||
160777209|NCT02394756|580568383|FG002|Period 1|Lens Discomfort|0|||
160777210|NCT02394756|580568384|FG003|Period 1|Lens Discomfort|0|||
160777211|NCT02394756|580568385|FG004|Period 1|Lens Discomfort|0|||
160777212|NCT02394756|580568386|FG005|Period 1|Lens Discomfort|1|||
160777213|NCT02394756|580568381|FG000|Period 1|Withdrawal by Subject|0|||
160777214|NCT02394756|580568382|FG001|Period 1|Withdrawal by Subject|1|||
160777215|NCT02394756|580568383|FG002|Period 1|Withdrawal by Subject|1|||
160886836|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
160886837|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
160777216|NCT02394756|580568384|FG003|Period 1|Withdrawal by Subject|1|||
160886838|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
160777217|NCT02394756|580568385|FG004|Period 1|Withdrawal by Subject|0|||
160777218|NCT02394756|580568386|FG005|Period 1|Withdrawal by Subject|0|||
160777219|NCT02394756|580568381|FG000|Period 2|Unsatisfactory Visual Response|0|||
160777220|NCT02394756|580568382|FG001|Period 2|Unsatisfactory Visual Response|0|||
160777221|NCT02394756|580568383|FG002|Period 2|Unsatisfactory Visual Response|0|||
160541431|NCT04770389|579711244|FG002|Overall Study|Adverse Event|0|||
160541432|NCT04770389|579711245|FG003|Overall Study|Adverse Event|1|||
160541433|NCT04770389|579711242|FG000|Overall Study|Withdrawal by Subject|0|||
160541434|NCT04770389|579711243|FG001|Overall Study|Withdrawal by Subject|2|||
160541435|NCT04770389|579711244|FG002|Overall Study|Withdrawal by Subject|1|||
160541436|NCT04770389|579711245|FG003|Overall Study|Withdrawal by Subject|0|||
160541437|NCT04770389|579711242|FG000|Overall Study|Failed attempt to draw blood|1|||
160541438|NCT04770389|579711243|FG001|Overall Study|Failed attempt to draw blood|0|||
160541439|NCT04770389|579711244|FG002|Overall Study|Failed attempt to draw blood|0|||
160541440|NCT04770389|579711245|FG003|Overall Study|Failed attempt to draw blood|0|||
160541441|NCT04770389|579711242|FG000|Overall Study|Left the country|0|||
160541442|NCT04770389|579711243|FG001|Overall Study|Left the country|0|||
160541443|NCT04770389|579711244|FG002|Overall Study|Left the country|1|||
160541444|NCT04770389|579711245|FG003|Overall Study|Left the country|2|||
160541445|NCT04770389|579711242|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
160541446|NCT04770389|579711243|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
160541447|NCT04770389|579711244|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
160541448|NCT04770389|579711245|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
160541449|NCT04770389|579711242|FG000|Overall Study|Lost to Follow-up|0|||
160541450|NCT04770389|579711243|FG001|Overall Study|Lost to Follow-up|0|||
160541451|NCT04770389|579711244|FG002|Overall Study|Lost to Follow-up|0|||
160541452|NCT04770389|579711245|FG003|Overall Study|Lost to Follow-up|1|||
160541453|NCT04770389|579711242|FG000|Overall Study|Moved away from study site|0|||
160541454|NCT04770389|579711243|FG001|Overall Study|Moved away from study site|1|||
160541455|NCT04770389|579711244|FG002|Overall Study|Moved away from study site|0|||
160541456|NCT04770389|579711245|FG003|Overall Study|Moved away from study site|0|||
160541457|NCT00794157|579711246|FG000|Overall Study|Adverse Event|4|||
160541458|NCT00794157|579711247|FG001|Overall Study|Adverse Event|1|||
160541459|NCT00794157|579711248|FG002|Overall Study|Adverse Event|8|||
160541460|NCT00794157|579711246|FG000|Overall Study|Subject withdrew consent|2|||
160541461|NCT00794157|579711247|FG001|Overall Study|Subject withdrew consent|0|||
160541462|NCT00794157|579711248|FG002|Overall Study|Subject withdrew consent|3|||
160541463|NCT00794157|579711246|FG000|Overall Study|Lost to Follow-up|2|||
160541464|NCT00794157|579711247|FG001|Overall Study|Lost to Follow-up|0|||
160541465|NCT00794157|579711248|FG002|Overall Study|Lost to Follow-up|1|||
160541466|NCT00794157|579711246|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160541467|NCT00794157|579711247|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160541468|NCT00794157|579711248|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
160541469|NCT00794157|579711246|FG000|Overall Study|Administrative problems|1|||
160541470|NCT00794157|579711247|FG001|Overall Study|Administrative problems|7|||
160541471|NCT00794157|579711248|FG002|Overall Study|Administrative problems|4|||
160541472|NCT00794157|579711246|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160541473|NCT00794157|579711247|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160541474|NCT00794157|579711248|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160541475|NCT00794157|579711246|FG000|Overall Study|Protocol deviation|0|||
160541476|NCT00794157|579711247|FG001|Overall Study|Protocol deviation|1|||
160541477|NCT00794157|579711248|FG002|Overall Study|Protocol deviation|1|||
160541478|NCT04486950|579711249|FG000|Overall Study|Lost to Follow-up|0|||
160541479|NCT04486950|579711250|FG001|Overall Study|Lost to Follow-up|0|||
160541480|NCT04486950|579711251|FG002|Overall Study|Lost to Follow-up|0|||
160541481|NCT04486950|579711252|FG003|Overall Study|Lost to Follow-up|0|||
160541482|NCT04486950|579711253|FG004|Overall Study|Lost to Follow-up|0|||
160541483|NCT04486950|579711254|FG005|Overall Study|Lost to Follow-up|1|||
160541484|NCT04486950|579711255|FG006|Overall Study|Lost to Follow-up|0|||
160541485|NCT02821715|579711256|FG000|Overall Study|Protocol Violation|1|||
160541486|NCT02821715|579711257|FG001|Overall Study|Protocol Violation|0|||
160541487|NCT02821715|579711258|FG002|Overall Study|Protocol Violation|0|||
160541488|NCT02821715|579711259|FG003|Overall Study|Protocol Violation|0|||
160637933|NCT00123487|580057991|FG001|Treated With Study Drug|Physician Decision|9|||
160886839|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
160541489|NCT02821715|579711260|FG004|Overall Study|Protocol Violation|0|||
160541490|NCT02821715|579711261|FG005|Overall Study|Protocol Violation|0|||
160541491|NCT02374099|579711262|FG000|Overall Study|Adverse Event|1|||
160541492|NCT02374099|579711263|FG001|Overall Study|Adverse Event|0|||
160541493|NCT02374099|579711262|FG000|Overall Study|Progressive Disease|35|||
160541494|NCT02374099|579711263|FG001|Overall Study|Progressive Disease|40|||
160637934|NCT00123487|580057990|FG000|Treated With Study Drug|Other|59|||
160541495|NCT02374099|579711262|FG000|Overall Study|Withdrawal by Subject|5|||
160541496|NCT02374099|579711263|FG001|Overall Study|Withdrawal by Subject|1|||
160541497|NCT02374099|579711262|FG000|Overall Study|Miscellaneous|2|||
160541498|NCT02374099|579711263|FG001|Overall Study|Miscellaneous|3|||
160541499|NCT02374099|579711262|FG000|Overall Study|Randomized, but not treated|2|||
160541500|NCT02374099|579711263|FG001|Overall Study|Randomized, but not treated|1|||
160541501|NCT02374099|579711262|FG000|Overall Study|Study Terminated by Sponsor|3|||
160541502|NCT02374099|579711263|FG001|Overall Study|Study Terminated by Sponsor|4|||
160541503|NCT01033825|579711264|FG000|Overall Study|Withdrawal by Subject|2|||
160541504|NCT01033825|579711265|FG001|Overall Study|Withdrawal by Subject|3|||
160541505|NCT01033825|579711266|FG002|Overall Study|Withdrawal by Subject|2|||
160541506|NCT01033825|579711267|FG003|Overall Study|Withdrawal by Subject|1|||
160777222|NCT02394756|580568384|FG003|Period 2|Unsatisfactory Visual Response|0|||
160777223|NCT02394756|580568385|FG004|Period 2|Unsatisfactory Visual Response|1|||
160777224|NCT02394756|580568386|FG005|Period 2|Unsatisfactory Visual Response|0|||
160777225|NCT02872714|580568391|FG000|Overall Study|Progressive Disease|1|||
160777226|NCT02872714|580568392|FG001|Overall Study|Progressive Disease|2|||
160777227|NCT02872714|580568393|FG002|Overall Study|Progressive Disease|0|||
160777228|NCT02872714|580568394|FG003|Overall Study|Progressive Disease|0|||
160777229|NCT02872714|580568395|FG004|Overall Study|Progressive Disease|0|||
160777230|NCT02872714|580568391|FG000|Overall Study|Death|87|||
160777231|NCT02872714|580568392|FG001|Overall Study|Death|36|||
160777232|NCT02872714|580568393|FG002|Overall Study|Death|8|||
160777233|NCT02872714|580568394|FG003|Overall Study|Death|81|||
160777234|NCT02872714|580568395|FG004|Overall Study|Death|2|||
160777235|NCT02872714|580568391|FG000|Overall Study|Lost to Follow-up|2|||
160777236|NCT02872714|580568392|FG001|Overall Study|Lost to Follow-up|1|||
160777237|NCT02872714|580568393|FG002|Overall Study|Lost to Follow-up|0|||
160777238|NCT02872714|580568394|FG003|Overall Study|Lost to Follow-up|3|||
160777239|NCT02872714|580568395|FG004|Overall Study|Lost to Follow-up|0|||
160777240|NCT02872714|580568391|FG000|Overall Study|Physician Decision|0|||
160777241|NCT02872714|580568392|FG001|Overall Study|Physician Decision|0|||
160777242|NCT02872714|580568393|FG002|Overall Study|Physician Decision|0|||
160777243|NCT02872714|580568394|FG003|Overall Study|Physician Decision|1|||
160777244|NCT02872714|580568395|FG004|Overall Study|Physician Decision|0|||
160777245|NCT02872714|580568391|FG000|Overall Study|Withdrawal by Subject|1|||
160777246|NCT02872714|580568392|FG001|Overall Study|Withdrawal by Subject|3|||
160777247|NCT02872714|580568393|FG002|Overall Study|Withdrawal by Subject|0|||
160777248|NCT02872714|580568394|FG003|Overall Study|Withdrawal by Subject|2|||
160777249|NCT02872714|580568395|FG004|Overall Study|Withdrawal by Subject|0|||
160777250|NCT02872714|580568391|FG000|Overall Study|Captured as Other|2|||
160777251|NCT02872714|580568392|FG001|Overall Study|Captured as Other|0|||
160777252|NCT02872714|580568393|FG002|Overall Study|Captured as Other|0|||
160777253|NCT02872714|580568394|FG003|Overall Study|Captured as Other|1|||
160777254|NCT02872714|580568395|FG004|Overall Study|Captured as Other|0|||
160777255|NCT06717399|580568396|FG000|Overall Study|Death|1|||
160777256|NCT03043573|580568399|FG000|Overall Study|Lost to Follow-up|3|||
160777257|NCT03043573|580568400|FG001|Overall Study|Lost to Follow-up|3|||
160777258|NCT03043573|580568399|FG000|Overall Study|Physician Decision|0|||
160777259|NCT03043573|580568400|FG001|Overall Study|Physician Decision|5|||
160777260|NCT03043573|580568399|FG000|Overall Study|Withdrawal by Subject|0|||
160777261|NCT03043573|580568400|FG001|Overall Study|Withdrawal by Subject|4|||
160777262|NCT03580928|580568405|FG000|Overall Study|Death|0|||
160777263|NCT03580928|580568406|FG001|Overall Study|Death|3|||
160777264|NCT03580928|580568405|FG000|Overall Study|Withdrawal by Subject|2|||
160777265|NCT03580928|580568406|FG001|Overall Study|Withdrawal by Subject|1|||
160541507|NCT01033825|579711268|FG004|Overall Study|Withdrawal by Subject|1|||
160541508|NCT01033825|579711269|FG005|Overall Study|Withdrawal by Subject|0|||
160541509|NCT01033825|579711270|FG006|Overall Study|Withdrawal by Subject|0|||
160541510|NCT01033825|579711264|FG000|Overall Study|Adverse Event|0|||
160541511|NCT01033825|579711265|FG001|Overall Study|Adverse Event|0|||
160541512|NCT01033825|579711266|FG002|Overall Study|Adverse Event|0|||
160541513|NCT01033825|579711267|FG003|Overall Study|Adverse Event|1|||
160541514|NCT01033825|579711268|FG004|Overall Study|Adverse Event|0|||
160541515|NCT01033825|579711269|FG005|Overall Study|Adverse Event|0|||
160777266|NCT03580928|580568405|FG000|Overall Study|Lost to Follow-up|2|||
160777267|NCT03580928|580568406|FG001|Overall Study|Lost to Follow-up|0|||
160777268|NCT03580928|580568405|FG000|Overall Study|Progressive Disease|0|||
160777269|NCT03580928|580568406|FG001|Overall Study|Progressive Disease|1|||
160777270|NCT04633447|580569859|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
160777271|NCT04633447|580569860|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
160777272|NCT04633447|580569859|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
160777273|NCT04633447|580569860|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
160777274|NCT04633447|580569859|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
160777275|NCT04633447|580569860|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
160777276|NCT04633447|580569859|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
160777277|NCT04633447|580569860|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
160777278|NCT04633447|580569859|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
160777279|NCT04633447|580569860|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
160777280|NCT04633447|580569859|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
160777281|NCT04633447|580569860|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
160777282|NCT04333498|580569861|FG000|Overall Study|Lost to Follow-up|1|||
160777283|NCT04333498|580569862|FG001|Overall Study|Lost to Follow-up|0|||
160777284|NCT04333498|580569861|FG000|Overall Study|Lost to Follow-up|0|||
160777285|NCT04333498|580569862|FG001|Overall Study|Lost to Follow-up|1|||
160777286|NCT01565694|580569863|FG000|Dose-Titration Period|Adverse Event|4|||
160777287|NCT01565694|580569863|FG000|Dose-Titration Period|Protocol Violation|10|||
160777288|NCT01565694|580569863|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
160777289|NCT05399771|580569864|FG000|Overall Study|Physician Decision|3|||
160886840|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
160886841|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
160886842|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
160886843|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
160886844|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
160886845|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
160886846|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
160886847|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
160886848|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
160886849|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
160886850|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
160886851|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
160886852|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
160886853|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
160886854|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
160886855|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
160886856|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
160886857|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
160886858|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
160886859|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
160886860|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
160777290|NCT05399771|580569864|FG000|Overall Study|Adverse Event|1|||
160777291|NCT00484159|580569871|FG000|Overall Study|Lost to Follow-up|1|||
160777292|NCT00484159|580569872|FG001|Overall Study|Lost to Follow-up|1|||
160777293|NCT00484159|580569873|FG002|Overall Study|Lost to Follow-up|0|||
160777294|NCT03234881|580569874|FG000|Overall Study|Lost to Follow-up|9|||
160777295|NCT03234881|580569875|FG001|Overall Study|Lost to Follow-up|3|||
160777296|NCT03807843|580569876|FG000|Overall Study|Lost to Follow-up|1|||
160777297|NCT03807843|580569877|FG001|Overall Study|Lost to Follow-up|0|||
160777298|NCT01312129|580569878|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
160777299|NCT01312129|580569879|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
160777300|NCT01239680|580569882|FG000|Overall Study|Withdrawal by Subject|2|||
160777301|NCT01239680|580569883|FG001|Overall Study|Withdrawal by Subject|0|||
160777302|NCT01797185|580569884|FG000|Overall Study|Adverse Event|5|||
160777303|NCT01797185|580569885|FG001|Overall Study|Adverse Event|15|||
160777304|NCT01797185|580569886|FG002|Overall Study|Adverse Event|6|||
160777305|NCT01797185|580569884|FG000|Overall Study|Withdrawal by Subject|6|||
160777306|NCT01797185|580569885|FG001|Overall Study|Withdrawal by Subject|9|||
160777307|NCT01797185|580569886|FG002|Overall Study|Withdrawal by Subject|5|||
160777308|NCT01797185|580569884|FG000|Overall Study|Site terminated|8|||
160777309|NCT01797185|580569885|FG001|Overall Study|Site terminated|4|||
160777310|NCT01797185|580569886|FG002|Overall Study|Site terminated|0|||
160777311|NCT01797185|580569884|FG000|Overall Study|Lost to Follow-up|2|||
160777312|NCT01797185|580569885|FG001|Overall Study|Lost to Follow-up|6|||
160777313|NCT01797185|580569886|FG002|Overall Study|Lost to Follow-up|1|||
160777314|NCT01797185|580569884|FG000|Overall Study|Withdrawn per sponsor|5|||
160777315|NCT01797185|580569885|FG001|Overall Study|Withdrawn per sponsor|0|||
160777316|NCT01797185|580569886|FG002|Overall Study|Withdrawn per sponsor|0|||
160777317|NCT01797185|580569884|FG000|Overall Study|Physician Decision|1|||
160777318|NCT01797185|580569885|FG001|Overall Study|Physician Decision|3|||
160777319|NCT01797185|580569886|FG002|Overall Study|Physician Decision|0|||
160777320|NCT01797185|580569884|FG000|Overall Study|Protocol Violation|1|||
160777321|NCT01797185|580569885|FG001|Overall Study|Protocol Violation|1|||
160777322|NCT01797185|580569886|FG002|Overall Study|Protocol Violation|0|||
160777323|NCT05177094|580569889|FG000|Overall Study|Adverse Event|5|||
160777324|NCT05177094|580569890|FG001|Overall Study|Adverse Event|5|||
160777325|NCT05177094|580569889|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
160777326|NCT05177094|580569890|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
160777327|NCT05177094|580569889|FG000|Overall Study|Protocol Deviation|3|||
160777328|NCT05177094|580569890|FG001|Overall Study|Protocol Deviation|0|||
160777329|NCT05177094|580569889|FG000|Overall Study|Withdrawal by Subject|6|||
160777330|NCT05177094|580569890|FG001|Overall Study|Withdrawal by Subject|3|||
160777331|NCT05177094|580569889|FG000|Overall Study|Participant could not tolerate long study visits|1|||
160777332|NCT05177094|580569890|FG001|Overall Study|Participant could not tolerate long study visits|0|||
160777333|NCT01033942|580569891|FG000|Overall Study|Withdrawal by Subject|1|||
160777334|NCT01033942|580569892|FG001|Overall Study|Withdrawal by Subject|1|||
160886861|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
160886862|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
160886863|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
160886864|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
160886865|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
160886866|NCT00570232|580980615|FG000|Overall Study|Adverse Event|10|||
160886867|NCT00570232|580980615|FG000|Overall Study|discontinued due to medical condition|3|||
160886868|NCT00570232|580980615|FG000|Overall Study|discontinued due to recurrence|8|||
160886869|NCT00570232|580980615|FG000|Overall Study|discontinued due to noncompliance|2|||
160886870|NCT01076075|580980616|FG000|Overall Study|Adverse Event|3|||
160886871|NCT01076075|580980617|FG001|Overall Study|Adverse Event|9|||
160886872|NCT01076075|580980616|FG000|Overall Study|Lack of Efficacy|5|||
160886873|NCT01076075|580980617|FG001|Overall Study|Lack of Efficacy|4|||
160886874|NCT01076075|580980616|FG000|Overall Study|Lost to Follow-up|6|||
160886875|NCT01076075|580980617|FG001|Overall Study|Lost to Follow-up|5|||
160886876|NCT01076075|580980616|FG000|Overall Study|other|19|||
160886877|NCT01076075|580980617|FG001|Overall Study|other|9|||
160886878|NCT01076075|580980616|FG000|Overall Study|Protocol Violation|0|||
160541516|NCT01033825|579711270|FG006|Overall Study|Adverse Event|0|||
160541517|NCT01033825|579711264|FG000|Overall Study|Protocol Violation|1|||
160777335|NCT01033942|580569893|FG002|Overall Study|Withdrawal by Subject|1|||
160777336|NCT01033942|580569891|FG000|Overall Study|Lost to Follow-up|1|||
160777337|NCT01033942|580569892|FG001|Overall Study|Lost to Follow-up|0|||
160777338|NCT01033942|580569893|FG002|Overall Study|Lost to Follow-up|0|||
160886879|NCT01076075|580980617|FG001|Overall Study|Protocol Violation|1|||
160777339|NCT01033942|580569891|FG000|Overall Study|Enrolled in Extension Study|0|||
160777340|NCT01033942|580569892|FG001|Overall Study|Enrolled in Extension Study|3|||
160777341|NCT01033942|580569893|FG002|Overall Study|Enrolled in Extension Study|0|||
160777342|NCT02737618|580569894|FG000|Overall Study|Withdrawal by Subject|9|||
160777343|NCT05276804|580569903|FG000|Overall Study|screen failure|23|||
160777344|NCT05276804|580569904|FG001|Overall Study|screen failure|0|||
160777345|NCT02827708|580569905|FG000|Overall Study|Lost to Follow-up|3|||
160777346|NCT02827708|580569906|FG001|Overall Study|Lost to Follow-up|1|||
160777347|NCT02827708|580569905|FG000|Overall Study|Withdrawal by Subject|1|||
160777348|NCT02827708|580569906|FG001|Overall Study|Withdrawal by Subject|2|||
160777349|NCT02827708|580569905|FG000|Overall Study|Death|1|||
160777350|NCT02827708|580569906|FG001|Overall Study|Death|2|||
160777351|NCT02115386|580569908|FG000|Overall Study|Protocol Violation|1|||
160777352|NCT02115386|580569908|FG000|Overall Study|Administrative - trial was terminated|6|||
160777353|NCT02493855|580569909|FG000|Overall Study|Non-compliance|1|||
160777354|NCT02493855|580569910|FG001|Overall Study|Non-compliance|0|||
160777355|NCT02493855|580569911|FG002|Overall Study|Non-compliance|0|||
160777356|NCT02493855|580569909|FG000|Overall Study|Adverse Event|0|||
160777357|NCT02493855|580569910|FG001|Overall Study|Adverse Event|1|||
160777358|NCT02493855|580569911|FG002|Overall Study|Adverse Event|0|||
160777359|NCT02493855|580569909|FG000|Overall Study|Withdrawal by Subject|1|||
160777360|NCT02493855|580569910|FG001|Overall Study|Withdrawal by Subject|0|||
160777361|NCT02493855|580569911|FG002|Overall Study|Withdrawal by Subject|0|||
160777362|NCT05059080|580569912|FG000|Overall Study|Withdrawal by Subject|3|||
160777363|NCT05059080|580569912|FG000|Overall Study|Study Terminated by Sponsor|64|||
160777364|NCT01047501|580569913|FG000|Overall Study|Adverse Event|7|||
160777365|NCT01047501|580569914|FG001|Overall Study|Adverse Event|8|||
160777366|NCT01047501|580569915|FG002|Overall Study|Adverse Event|5|||
160777367|NCT01047501|580569913|FG000|Overall Study|Withdrew Consent|6|||
160777368|NCT01047501|580569914|FG001|Overall Study|Withdrew Consent|2|||
160777369|NCT01047501|580569915|FG002|Overall Study|Withdrew Consent|4|||
160777370|NCT01047501|580569913|FG000|Overall Study|Lost to Follow-up|0|||
160777371|NCT01047501|580569914|FG001|Overall Study|Lost to Follow-up|1|||
160777372|NCT01047501|580569915|FG002|Overall Study|Lost to Follow-up|1|||
160777373|NCT01047501|580569913|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
160777374|NCT01047501|580569914|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
160777375|NCT01047501|580569915|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
160777376|NCT01047501|580569913|FG000|Overall Study|Death|1|||
160777377|NCT01047501|580569914|FG001|Overall Study|Death|0|||
160777378|NCT01047501|580569915|FG002|Overall Study|Death|0|||
160777379|NCT01047501|580569913|FG000|Overall Study|Other discontinuation|1|||
160777380|NCT01047501|580569914|FG001|Overall Study|Other discontinuation|0|||
160777381|NCT01047501|580569915|FG002|Overall Study|Other discontinuation|1|||
160777382|NCT01047501|580569913|FG000|Overall Study|Investigator judgement|0|||
160777383|NCT01047501|580569914|FG001|Overall Study|Investigator judgement|0|||
160777384|NCT01047501|580569915|FG002|Overall Study|Investigator judgement|1|||
160777385|NCT00549328|580569919|FG000|Overall Study|Adverse Event|2|||
160777386|NCT00549328|580569919|FG000|Overall Study|Disease Progression|10|||
160777387|NCT00549328|580569919|FG000|Overall Study|Death|1|||
160777388|NCT00549328|580569919|FG000|Overall Study|Use of Prohibited Medication|1|||
160777389|NCT04868682|580569920|FG000|Post-treatment|Lost to Follow-up|1|||
160777390|NCT04868682|580569921|FG001|Post-treatment|Lost to Follow-up|1|||
160777391|NCT04868682|580569920|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
160777392|NCT04868682|580569921|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
160777393|NCT04868682|580569920|FG000|Six-month Assessment|Lost to Follow-up|1|||
160777394|NCT04868682|580569921|FG001|Six-month Assessment|Lost to Follow-up|0|||
160777395|NCT04868682|580569920|FG000|Six-month Assessment|Death|1|||
160777396|NCT04868682|580569921|FG001|Six-month Assessment|Death|0|||
160777397|NCT04868682|580569920|FG000|Six-month Assessment|Refused|0|||
160777398|NCT04868682|580569921|FG001|Six-month Assessment|Refused|1|||
160777399|NCT04868682|580569920|FG000|12-month Assessment|Lost to Follow-up|2|||
160886880|NCT01076075|580980616|FG000|Overall Study|Withdrawal by Subject|8|||
160777400|NCT04868682|580569921|FG001|12-month Assessment|Lost to Follow-up|1|||
160777401|NCT04868682|580569920|FG000|12-month Assessment|Death|0|||
160777402|NCT04868682|580569921|FG001|12-month Assessment|Death|1|||
160777403|NCT03384966|580569925|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
160777404|NCT03384966|580569926|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
160777405|NCT03384966|580569927|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
160777406|NCT03384966|580569925|FG000|Follow-up Period|Adverse Event|1|||
160777407|NCT03384966|580569926|FG001|Follow-up Period|Adverse Event|0|||
160777408|NCT03384966|580569927|FG002|Follow-up Period|Adverse Event|0|||
160886881|NCT01076075|580980617|FG001|Overall Study|Withdrawal by Subject|19|||
160637935|NCT00123487|580057991|FG001|Treated With Study Drug|Other|58|||
160777409|NCT03880565|580569928|FG000|Overall Study|Withdrawal by Subject|1|||
160777410|NCT03880565|580569929|FG001|Overall Study|Withdrawal by Subject|0|||
160777411|NCT02202616|580569930|FG000|Overall Study|Screen failed|24|||
160777412|NCT02202616|580569930|FG000|Overall Study|Adverse Event|32|||
160777413|NCT02202616|580569930|FG000|Overall Study|Protocol deviation|18|||
160777414|NCT02202616|580569930|FG000|Overall Study|Patient withdrew consent|12|||
160777415|NCT02202616|580569930|FG000|Overall Study|Lost to Follow-up|6|||
160777416|NCT02202616|580569930|FG000|Overall Study|Administrative problems|6|||
160777417|NCT02202616|580569930|FG000|Overall Study|Abnormal test procedure result|1|||
160777418|NCT02202616|580569930|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160777419|NCT04327271|580569931|FG000|Overall Study|Death|1|||
160777420|NCT04327271|580569932|FG001|Overall Study|Death|0|||
160777421|NCT04327271|580569931|FG000|Overall Study|Withdrawal by Subject|1|||
160777422|NCT04327271|580569932|FG001|Overall Study|Withdrawal by Subject|0|||
160777423|NCT04327271|580569931|FG000|Overall Study|randomization error (data capture)|4|||
160777424|NCT04327271|580569932|FG001|Overall Study|randomization error (data capture)|3|||
160777425|NCT01716156|580569934|FG000|Overall Study|Protocol Violation|1|||
160777426|NCT01716156|580569935|FG001|Overall Study|Protocol Violation|0|||
160777427|NCT01716156|580569936|FG002|Overall Study|Protocol Violation|0|||
160777428|NCT01716156|580569934|FG000|Overall Study|Withdrawal by Subject|0|||
160777429|NCT01716156|580569935|FG001|Overall Study|Withdrawal by Subject|1|||
160777430|NCT01716156|580569936|FG002|Overall Study|Withdrawal by Subject|2|||
160777431|NCT01716156|580569934|FG000|Overall Study|Lost to Follow-up|1|||
160777432|NCT01716156|580569935|FG001|Overall Study|Lost to Follow-up|0|||
160777433|NCT01716156|580569936|FG002|Overall Study|Lost to Follow-up|0|||
160777434|NCT05513950|580569939|FG000|Overall Study|Not treated due to technical reasons|0|||
160777435|NCT05513950|580569940|FG001|Overall Study|Not treated due to technical reasons|0|||
160777436|NCT05513950|580569941|FG002|Overall Study|Not treated due to technical reasons|1|||
160777437|NCT05513950|580569942|FG003|Overall Study|Not treated due to technical reasons|0|||
160777438|NCT05221866|580569943|FG000|Overall Study|Withdrawal by Subject|5|||
160777439|NCT05221866|580569944|FG001|Overall Study|Withdrawal by Subject|7|||
160777440|NCT05221866|580569945|FG002|Overall Study|Withdrawal by Subject|6|||
160777441|NCT05221866|580569946|FG003|Overall Study|Withdrawal by Subject|4|||
160777442|NCT05221866|580569943|FG000|Overall Study|Physician Decision|3|||
160777443|NCT05221866|580569944|FG001|Overall Study|Physician Decision|2|||
160777444|NCT05221866|580569945|FG002|Overall Study|Physician Decision|1|||
160541518|NCT01033825|579711265|FG001|Overall Study|Protocol Violation|0|||
160541519|NCT01033825|579711266|FG002|Overall Study|Protocol Violation|0|||
160541520|NCT01033825|579711267|FG003|Overall Study|Protocol Violation|0|||
160541521|NCT01033825|579711268|FG004|Overall Study|Protocol Violation|0|||
160541522|NCT01033825|579711269|FG005|Overall Study|Protocol Violation|0|||
160541523|NCT01033825|579711270|FG006|Overall Study|Protocol Violation|0|||
160541524|NCT01033825|579711264|FG000|Overall Study|Other|0|||
160541525|NCT01033825|579711265|FG001|Overall Study|Other|0|||
160541526|NCT01033825|579711266|FG002|Overall Study|Other|0|||
160541527|NCT01033825|579711267|FG003|Overall Study|Other|0|||
160541528|NCT01033825|579711268|FG004|Overall Study|Other|1|||
160541529|NCT01033825|579711269|FG005|Overall Study|Other|0|||
160541530|NCT01033825|579711270|FG006|Overall Study|Other|0|||
160541531|NCT04294719|579711271|FG000|Overall Study|Withdrawal by Subject|1|||
160541532|NCT01464307|579711273|FG000|Main Period|Death|0|||
160541533|NCT01464307|579711274|FG001|Main Period|Death|1|||
160777445|NCT05221866|580569946|FG003|Overall Study|Physician Decision|4|||
160777446|NCT05221866|580569943|FG000|Overall Study|Lost to Follow-up|12|||
160777447|NCT05221866|580569944|FG001|Overall Study|Lost to Follow-up|17|||
160777448|NCT05221866|580569945|FG002|Overall Study|Lost to Follow-up|14|||
160777449|NCT05221866|580569946|FG003|Overall Study|Lost to Follow-up|14|||
160777450|NCT05221866|580569943|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
160777451|NCT05221866|580569944|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
160777452|NCT05221866|580569945|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
160777453|NCT05221866|580569946|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
160777454|NCT00221104|580569947|FG000|Overall Study|Adverse Event|1|||
160777455|NCT00221104|580569948|FG001|Overall Study|Adverse Event|0|||
160777456|NCT00221104|580569947|FG000|Overall Study|Physician Decision|1|||
160777457|NCT00221104|580569948|FG001|Overall Study|Physician Decision|0|||
160777458|NCT00221104|580569947|FG000|Overall Study|Protocol Violation|2|||
160886882|NCT01163032|580980622|FG000|Randomization Phase|Withdrawal by Subject|2|||
160541534|NCT01464307|579711273|FG000|Main Period|Adverse Event|6|||
160541535|NCT01464307|579711274|FG001|Main Period|Adverse Event|1|||
160541536|NCT01464307|579711273|FG000|Main Period|Lack of Efficacy|2|||
160777459|NCT00221104|580569948|FG001|Overall Study|Protocol Violation|0|||
160777460|NCT00221104|580569947|FG000|Overall Study|Withdrawal by Subject|42|||
160777461|NCT00221104|580569948|FG001|Overall Study|Withdrawal by Subject|29|||
160886883|NCT01163032|580980623|FG001|Randomization Phase|Withdrawal by Subject|3|||
160541537|NCT01464307|579711274|FG001|Main Period|Lack of Efficacy|0|||
160541538|NCT01464307|579711273|FG000|Main Period|Withdrawal by Subject|5|||
160541539|NCT01464307|579711274|FG001|Main Period|Withdrawal by Subject|2|||
160541540|NCT01464307|579711273|FG000|Main Period|Predefined discontinuation criteria|2|||
160541541|NCT01464307|579711274|FG001|Main Period|Predefined discontinuation criteria|1|||
160541542|NCT01464307|579711273|FG000|Open-Label Extension Period|Adverse Event|15|||
160541543|NCT01464307|579711274|FG001|Open-Label Extension Period|Adverse Event|0|||
160777462|NCT00221104|580569947|FG000|Overall Study|Others|37|||
160777463|NCT00221104|580569948|FG001|Overall Study|Others|47|||
160777464|NCT02989389|580569949|FG000|Period 1|Lost to Follow-up|0|||
160777465|NCT02989389|580569950|FG001|Period 1|Lost to Follow-up|1|||
160777466|NCT02989389|580569951|FG002|Period 1|Lost to Follow-up|0|||
160777467|NCT02989389|580569952|FG003|Period 1|Lost to Follow-up|0|||
160777468|NCT02989389|580569953|FG004|Period 1|Lost to Follow-up|0|||
160541544|NCT01464307|579711273|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
160541545|NCT01464307|579711274|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
160541546|NCT01464307|579711273|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
160777469|NCT02989389|580569954|FG005|Period 1|Lost to Follow-up|0|||
160777470|NCT02989389|580569955|FG006|Period 1|Lost to Follow-up|0|||
160777471|NCT02989389|580569956|FG007|Period 1|Lost to Follow-up|0|||
160777472|NCT02989389|580569957|FG008|Period 1|Lost to Follow-up|0|||
160777473|NCT02989389|580569958|FG009|Period 1|Lost to Follow-up|0|||
160777474|NCT02989389|580569949|FG000|Period 1|Physician Decision|0|||
160777475|NCT02989389|580569950|FG001|Period 1|Physician Decision|0|||
160777476|NCT02989389|580569951|FG002|Period 1|Physician Decision|0|||
160777477|NCT02989389|580569952|FG003|Period 1|Physician Decision|0|||
160777478|NCT02989389|580569953|FG004|Period 1|Physician Decision|0|||
160777479|NCT02989389|580569954|FG005|Period 1|Physician Decision|0|||
160777480|NCT02989389|580569955|FG006|Period 1|Physician Decision|0|||
160777481|NCT02989389|580569956|FG007|Period 1|Physician Decision|0|||
160777482|NCT02989389|580569957|FG008|Period 1|Physician Decision|1|||
160777483|NCT02989389|580569958|FG009|Period 1|Physician Decision|0|||
160777484|NCT01018979|580569959|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
160541547|NCT01464307|579711274|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
160541548|NCT01464307|579711273|FG000|Open-Label Extension Period|Death|1|||
160541549|NCT01464307|579711274|FG001|Open-Label Extension Period|Death|0|||
160541550|NCT01464307|579711273|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
160541551|NCT01464307|579711274|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
160541552|NCT01464307|579711273|FG000|Open-Label Extension Period|Non-compliance|9|||
160541553|NCT01464307|579711274|FG001|Open-Label Extension Period|Non-compliance|0|||
160541554|NCT01464307|579711273|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
160541555|NCT01464307|579711274|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
160541556|NCT03885089|579711277|FG000|Overall Study|No informed consent for publication of study results|2|||
160541557|NCT03349099|579711278|FG000|Overall Study|Physician Decision|3|||
160541558|NCT03349099|579711279|FG001|Overall Study|Physician Decision|4|||
160541559|NCT03349099|579711278|FG000|Overall Study|Stone migrated from the kidney|1|||
160541560|NCT03349099|579711279|FG001|Overall Study|Stone migrated from the kidney|0|||
160541561|NCT00278993|579711280|FG000|Overall Study|Adverse Event|24|||
160541562|NCT00278993|579711280|FG000|Overall Study|Withdrawal by Subject|5|||
160541563|NCT00278993|579711280|FG000|Overall Study|Progressive Disease|65|||
160541564|NCT00278993|579711280|FG000|Overall Study|Physician Decision|9|||
160541565|NCT00278993|579711280|FG000|Overall Study|Not Otherwise Specified|4|||
160541566|NCT00894556|579711282|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
160541567|NCT00894556|579711283|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
160541568|NCT00894556|579711284|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
160541569|NCT00894556|579711285|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
160541570|NCT00894556|579711282|FG000|Treatment Phase|Lost to Follow-up|2|||
160541571|NCT00894556|579711283|FG001|Treatment Phase|Lost to Follow-up|3|||
160541572|NCT00894556|579711284|FG002|Treatment Phase|Lost to Follow-up|1|||
160541573|NCT00894556|579711285|FG003|Treatment Phase|Lost to Follow-up|0|||
160541574|NCT00894556|579711282|FG000|Treatment Phase|Lack of Qualifying Event|2|||
160541575|NCT00894556|579711283|FG001|Treatment Phase|Lack of Qualifying Event|1|||
160541576|NCT00894556|579711284|FG002|Treatment Phase|Lack of Qualifying Event|0|||
160541577|NCT00894556|579711285|FG003|Treatment Phase|Lack of Qualifying Event|0|||
160541578|NCT01979536|579711289|FG000|Overall Study|Physician Decision|2|||
160541579|NCT01979536|579711290|FG001|Overall Study|Physician Decision|3|||
160541580|NCT01979536|579711289|FG000|Overall Study|Withdrawal by Subject|0|||
160541581|NCT01979536|579711290|FG001|Overall Study|Withdrawal by Subject|1|||
160541582|NCT01979536|579711289|FG000|Overall Study|Refusal|0|||
160541583|NCT01979536|579711290|FG001|Overall Study|Refusal|1|||
160541584|NCT01979536|579711289|FG000|Overall Study|Relapse|0|||
160541585|NCT01979536|579711290|FG001|Overall Study|Relapse|1|||
160541586|NCT01979536|579711289|FG000|Overall Study|Study terminated by Sponsor|0|||
160541587|NCT01979536|579711290|FG001|Overall Study|Study terminated by Sponsor|1|||
160777485|NCT01018979|580569960|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
160777486|NCT01018979|580569959|FG000|Overall Study|Not received at least one dose|0|||
160541588|NCT01979536|579711289|FG000|Overall Study|Did not start treatment|0|||
160541589|NCT01979536|579711290|FG001|Overall Study|Did not start treatment|1|||
160541590|NCT03921424|579711298|FG000|Overall Study|Lost to Follow-up|0|||
160541591|NCT03921424|579711299|FG001|Overall Study|Lost to Follow-up|1|||
160541592|NCT03921424|579711298|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
160541593|NCT03921424|579711299|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
160541594|NCT05054114|579711305|FG000|Overall Study|Protocol Violation|13|||
160541595|NCT05054114|579711306|FG001|Overall Study|Protocol Violation|1|||
160777487|NCT01018979|580569960|FG001|Overall Study|Not received at least one dose|1|||
160777488|NCT04057365|580569961|FG000|Overall Study|Withdrawal by Subject|2|||
160777489|NCT04057365|580569962|FG001|Overall Study|Withdrawal by Subject|0|||
160777490|NCT04598828|580569963|FG000|Overall Study|Physician Decision|1|||
160777491|NCT04598828|580569964|FG001|Overall Study|Physician Decision|0|||
160541596|NCT05054114|579711305|FG000|Overall Study|Pregnancy|0|||
160541597|NCT05054114|579711306|FG001|Overall Study|Pregnancy|1|||
160541598|NCT01806779|579711307|FG000|Overall Study|Physician Decision|2|||
160541599|NCT01806779|579711308|FG001|Overall Study|Physician Decision|0|||
160541600|NCT01806779|579711309|FG002|Overall Study|Physician Decision|1|||
160541601|NCT01806779|579711307|FG000|Overall Study|Lack of Efficacy|1|||
160886884|NCT01163032|580980624|FG002|Randomization Phase|Withdrawal by Subject|0|||
160886885|NCT01163032|580980622|FG000|Randomization Phase|Adverse Event|3|||
160541602|NCT01806779|579711308|FG001|Overall Study|Lack of Efficacy|1|||
160637936|NCT00123487|580057990|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
160637937|NCT00123487|580057991|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
160637938|NCT00123487|580057990|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
160637939|NCT00123487|580057991|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
160637940|NCT00123487|580057990|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
160637941|NCT00123487|580057991|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
160637942|NCT03118765|580057992|FG000|Overall Study|Withdrawal by Subject|0|||
160637943|NCT03118765|580057993|FG001|Overall Study|Withdrawal by Subject|0|||
160637944|NCT03118765|580057994|FG002|Overall Study|Withdrawal by Subject|1|||
160637945|NCT03118765|580057995|FG003|Overall Study|Withdrawal by Subject|0|||
160637946|NCT03118765|580057996|FG004|Overall Study|Withdrawal by Subject|0|||
160637947|NCT03118765|580057992|FG000|Overall Study|Adverse Event|1|||
160637948|NCT03118765|580057993|FG001|Overall Study|Adverse Event|1|||
160637949|NCT03118765|580057994|FG002|Overall Study|Adverse Event|1|||
160637950|NCT03118765|580057995|FG003|Overall Study|Adverse Event|1|||
160637951|NCT03118765|580057996|FG004|Overall Study|Adverse Event|1|||
160637952|NCT03118765|580057992|FG000|Overall Study|Non compliance with Study Procedures|0|||
160637953|NCT03118765|580057993|FG001|Overall Study|Non compliance with Study Procedures|0|||
160637954|NCT03118765|580057994|FG002|Overall Study|Non compliance with Study Procedures|0|||
160637955|NCT03118765|580057995|FG003|Overall Study|Non compliance with Study Procedures|1|||
160637956|NCT03118765|580057996|FG004|Overall Study|Non compliance with Study Procedures|0|||
160637957|NCT03118765|580057992|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
160637958|NCT03118765|580057993|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
160637959|NCT03118765|580057994|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
160637960|NCT03118765|580057995|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
160637961|NCT03118765|580057996|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
160637962|NCT03118765|580057992|FG000|Overall Study|COPD Exacerbation|1|||
160637963|NCT03118765|580057993|FG001|Overall Study|COPD Exacerbation|0|||
160637964|NCT03118765|580057994|FG002|Overall Study|COPD Exacerbation|0|||
160637965|NCT03118765|580057995|FG003|Overall Study|COPD Exacerbation|1|||
160637966|NCT03118765|580057996|FG004|Overall Study|COPD Exacerbation|0|||
160637967|NCT03118765|580057992|FG000|Overall Study|Lost to Follow-up|1|||
160637968|NCT03118765|580057993|FG001|Overall Study|Lost to Follow-up|0|||
160637969|NCT03118765|580057994|FG002|Overall Study|Lost to Follow-up|1|||
160637970|NCT03118765|580057995|FG003|Overall Study|Lost to Follow-up|0|||
160637971|NCT03118765|580057996|FG004|Overall Study|Lost to Follow-up|0|||
160637972|NCT03118765|580057992|FG000|Overall Study|Sponsor Decision|1|||
160637973|NCT03118765|580057993|FG001|Overall Study|Sponsor Decision|0|||
160637974|NCT03118765|580057994|FG002|Overall Study|Sponsor Decision|1|||
160637975|NCT03118765|580057995|FG003|Overall Study|Sponsor Decision|0|||
160637976|NCT03118765|580057996|FG004|Overall Study|Sponsor Decision|1|||
160637977|NCT01255722|580057997|FG000|Overall Study|Adverse Event|0|||
160637978|NCT01255722|580057998|FG001|Overall Study|Adverse Event|1|||
160637979|NCT01255722|580057999|FG002|Overall Study|Adverse Event|1|||
160637980|NCT01255722|580057997|FG000|Overall Study|asymptomatic patient|1|||
160637981|NCT01255722|580057998|FG001|Overall Study|asymptomatic patient|0|||
160637982|NCT01255722|580057999|FG002|Overall Study|asymptomatic patient|0|||
160637983|NCT01255722|580057997|FG000|Overall Study|beta-blocker contraindicated|2|||
160637984|NCT01255722|580057998|FG001|Overall Study|beta-blocker contraindicated|0|||
160637985|NCT01255722|580057999|FG002|Overall Study|beta-blocker contraindicated|0|||
160637986|NCT02164539|580058000|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
160637987|NCT02164539|580058001|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
160637988|NCT02164539|580058002|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
160637989|NCT02164539|580058003|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
160637990|NCT02164539|580058004|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
160637991|NCT02164539|580058005|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
160637992|NCT02164539|580058006|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
160637993|NCT02164539|580058000|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
160637994|NCT02164539|580058001|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
160886886|NCT01163032|580980623|FG001|Randomization Phase|Adverse Event|3|||
160541603|NCT01806779|579711309|FG002|Overall Study|Lack of Efficacy|0|||
160541604|NCT01806779|579711307|FG000|Overall Study|Lost to Follow-up|19|||
160637995|NCT02164539|580058002|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
160637996|NCT02164539|580058003|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
160637997|NCT02164539|580058004|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
160637998|NCT02164539|580058005|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
160777492|NCT04598828|580569963|FG000|Overall Study|Withdrawal by Subject|0|||
160777493|NCT04598828|580569964|FG001|Overall Study|Withdrawal by Subject|1|||
160777494|NCT04598828|580569963|FG000|Overall Study|Withdrawal by Subject|0|||
160777495|NCT04598828|580569964|FG001|Overall Study|Withdrawal by Subject|1|||
160777496|NCT02676973|580569965|FG000|Overall Study|Withdrawal by Subject|9|||
160777497|NCT02676973|580569966|FG001|Overall Study|Withdrawal by Subject|8|||
160777498|NCT02676973|580569967|FG002|Overall Study|Withdrawal by Subject|11|||
160777499|NCT02676973|580569965|FG000|Overall Study|Lost to Follow-up|8|||
160777500|NCT02676973|580569966|FG001|Overall Study|Lost to Follow-up|12|||
160777501|NCT02676973|580569967|FG002|Overall Study|Lost to Follow-up|8|||
160777502|NCT02676973|580569965|FG000|Overall Study|Death|2|||
160777503|NCT02676973|580569966|FG001|Overall Study|Death|1|||
160777504|NCT02676973|580569967|FG002|Overall Study|Death|5|||
160777505|NCT01078662|580569969|FG000|Overall Study|Death|41|||
160777506|NCT01078662|580569970|FG001|Overall Study|Death|103|||
160777507|NCT01078662|580569971|FG002|Overall Study|Death|18|||
160777508|NCT01078662|580569972|FG003|Overall Study|Death|5|||
160777509|NCT01078662|580569973|FG004|Overall Study|Death|8|||
160886887|NCT01163032|580980624|FG002|Randomization Phase|Adverse Event|0|||
160886888|NCT01163032|580980622|FG000|Randomization Phase|Protocol Violation|0|||
160886889|NCT01163032|580980623|FG001|Randomization Phase|Protocol Violation|1|||
160886890|NCT01163032|580980624|FG002|Randomization Phase|Protocol Violation|0|||
160886891|NCT01163032|580980622|FG000|Randomization Phase|Various*|5|||
160886892|NCT01163032|580980623|FG001|Randomization Phase|Various*|4|||
160886893|NCT01163032|580980624|FG002|Randomization Phase|Various*|0|||
160886894|NCT01163032|580980622|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
160886895|NCT01163032|580980623|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
160886896|NCT01163032|580980624|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
160886897|NCT01163032|580980622|FG000|Open Label Extension Phase|Adverse Event|0|||
160886898|NCT01163032|580980623|FG001|Open Label Extension Phase|Adverse Event|0|||
160886899|NCT01163032|580980624|FG002|Open Label Extension Phase|Adverse Event|3|||
160637999|NCT02164539|580058006|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
160638000|NCT02164539|580058000|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
160638001|NCT02164539|580058001|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
160638002|NCT02164539|580058002|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
160638003|NCT02164539|580058003|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
160638004|NCT02164539|580058004|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
160638005|NCT02164539|580058005|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
160638006|NCT02164539|580058006|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
160638007|NCT02164539|580058000|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
160638008|NCT02164539|580058001|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
160638009|NCT02164539|580058002|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
160638010|NCT02164539|580058003|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
160638011|NCT02164539|580058004|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
160638012|NCT02164539|580058005|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
160638013|NCT02164539|580058006|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
160638014|NCT02164539|580058000|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
160638015|NCT02164539|580058001|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
160638016|NCT02164539|580058002|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
160638017|NCT02164539|580058003|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
160638018|NCT02164539|580058004|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
160638019|NCT02164539|580058005|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
160638020|NCT02164539|580058006|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
160638021|NCT02164539|580058000|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
160638022|NCT02164539|580058001|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
160638023|NCT02164539|580058002|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
160638024|NCT02164539|580058003|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
160638025|NCT02164539|580058004|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
160638026|NCT02164539|580058005|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
160638027|NCT02164539|580058006|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
160638028|NCT00527397|580058009|FG000|Overall Study|Adverse Event|3|||
160638029|NCT00527397|580058009|FG000|Overall Study|Lack of Efficacy|1|||
160638030|NCT00527397|580058009|FG000|Overall Study|Protocol Violation|1|||
160638031|NCT00527397|580058009|FG000|Overall Study|Withdrawal by Subject|6|||
160638032|NCT00527397|580058009|FG000|Overall Study|Study terminated by sponsor|13|||
160638033|NCT00370396|580058013|FG000|Overall Study|Withdrawal by Subject|0|||
160638034|NCT00370396|580058014|FG001|Overall Study|Withdrawal by Subject|0|||
160638035|NCT00370396|580058015|FG002|Overall Study|Withdrawal by Subject|1|||
160638036|NCT00370396|580058013|FG000|Overall Study|Lost to Follow-up|11|||
160638037|NCT00370396|580058014|FG001|Overall Study|Lost to Follow-up|1|||
160777510|NCT01078662|580569969|FG000|Overall Study|Patients reached data cut-off|12|||
160777511|NCT01078662|580569970|FG001|Overall Study|Patients reached data cut-off|53|||
160777512|NCT01078662|580569971|FG002|Overall Study|Patients reached data cut-off|2|||
160777513|NCT01078662|580569972|FG003|Overall Study|Patients reached data cut-off|2|||
160777514|NCT01078662|580569973|FG004|Overall Study|Patients reached data cut-off|3|||
160777515|NCT01078662|580569969|FG000|Overall Study|Withdrawal by Subject|4|||
160777516|NCT01078662|580569970|FG001|Overall Study|Withdrawal by Subject|11|||
160777517|NCT01078662|580569971|FG002|Overall Study|Withdrawal by Subject|1|||
160777518|NCT01078662|580569972|FG003|Overall Study|Withdrawal by Subject|0|||
160777519|NCT01078662|580569973|FG004|Overall Study|Withdrawal by Subject|0|||
160777520|NCT01078662|580569969|FG000|Overall Study|Protocol Violation|0|||
160777521|NCT01078662|580569970|FG001|Overall Study|Protocol Violation|1|||
160777522|NCT01078662|580569971|FG002|Overall Study|Protocol Violation|0|||
160777523|NCT01078662|580569972|FG003|Overall Study|Protocol Violation|0|||
160777524|NCT01078662|580569973|FG004|Overall Study|Protocol Violation|0|||
160777525|NCT01078662|580569969|FG000|Overall Study|Lost to Follow-up|1|||
160777526|NCT01078662|580569970|FG001|Overall Study|Lost to Follow-up|0|||
160777527|NCT01078662|580569971|FG002|Overall Study|Lost to Follow-up|0|||
160777528|NCT01078662|580569972|FG003|Overall Study|Lost to Follow-up|0|||
160777529|NCT01078662|580569973|FG004|Overall Study|Lost to Follow-up|0|||
160777530|NCT01937299|580569977|FG000|Overall Study|Adverse Event|13|||
160777531|NCT01937299|580569978|FG001|Overall Study|Adverse Event|0|||
160777532|NCT01937299|580569977|FG000|Overall Study|Lack of Efficacy|0|||
160777533|NCT01937299|580569978|FG001|Overall Study|Lack of Efficacy|4|||
160777534|NCT01937299|580569977|FG000|Overall Study|Withdrawal by Subject|1|||
160777535|NCT01937299|580569978|FG001|Overall Study|Withdrawal by Subject|0|||
160777536|NCT01913353|580569979|FG000|Overall Study|Adverse Event|2|||
160777537|NCT01913353|580569980|FG001|Overall Study|Adverse Event|0|||
160777538|NCT01913353|580569979|FG000|Overall Study|Physician Decision|0|||
160777539|NCT01913353|580569980|FG001|Overall Study|Physician Decision|2|||
160777540|NCT01913353|580569979|FG000|Overall Study|Withdrawal by Subject|20|||
160777541|NCT01913353|580569980|FG001|Overall Study|Withdrawal by Subject|6|||
160777542|NCT01913353|580569979|FG000|Overall Study|multiple reasons|10|||
160777543|NCT01913353|580569980|FG001|Overall Study|multiple reasons|7|||
160777544|NCT00385840|580569981|FG000|Overall Study|Adverse Event|1|||
160777545|NCT00385840|580569982|FG001|Overall Study|Adverse Event|1|||
160777546|NCT00385840|580569981|FG000|Overall Study|Lost to Follow-up|3|||
160777547|NCT00385840|580569982|FG001|Overall Study|Lost to Follow-up|13|||
160777548|NCT01260948|580569983|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
160777549|NCT01260948|580569984|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
160777550|NCT01260948|580569983|FG000|Second Intervention|Emesis|0|||
160777551|NCT01260948|580569984|FG001|Second Intervention|Emesis|1|||
160777552|NCT01202591|580569985|FG000|Overall Study|Adverse Event|2|||
160777553|NCT01202591|580569986|FG001|Overall Study|Adverse Event|1|||
160777554|NCT01202591|580569987|FG002|Overall Study|Adverse Event|4|||
160777555|NCT01202591|580569988|FG003|Overall Study|Adverse Event|4|||
160777556|NCT01202591|580569989|FG004|Overall Study|Adverse Event|0|||
160777557|NCT01202591|580569990|FG005|Overall Study|Adverse Event|0|||
160777558|NCT01202591|580569985|FG000|Overall Study|Other reason as per investigator|3|||
160777559|NCT01202591|580569986|FG001|Overall Study|Other reason as per investigator|4|||
160777560|NCT01202591|580569987|FG002|Overall Study|Other reason as per investigator|7|||
160777561|NCT01202591|580569988|FG003|Overall Study|Other reason as per investigator|3|||
160777562|NCT01202591|580569989|FG004|Overall Study|Other reason as per investigator|1|||
160777563|NCT01202591|580569990|FG005|Overall Study|Other reason as per investigator|3|||
160777564|NCT01202591|580569985|FG000|Overall Study|Withdrawal by Subject|0|||
160777565|NCT01202591|580569986|FG001|Overall Study|Withdrawal by Subject|0|||
160777566|NCT01202591|580569987|FG002|Overall Study|Withdrawal by Subject|0|||
160777567|NCT01202591|580569988|FG003|Overall Study|Withdrawal by Subject|0|||
160777568|NCT01202591|580569989|FG004|Overall Study|Withdrawal by Subject|2|||
160777569|NCT01202591|580569990|FG005|Overall Study|Withdrawal by Subject|1|||
160777570|NCT01202591|580569985|FG000|Overall Study|Objective Disease Progression|0|||
160777571|NCT01202591|580569986|FG001|Overall Study|Objective Disease Progression|0|||
160777572|NCT01202591|580569987|FG002|Overall Study|Objective Disease Progression|0|||
160777573|NCT01202591|580569988|FG003|Overall Study|Objective Disease Progression|0|||
160777574|NCT01202591|580569989|FG004|Overall Study|Objective Disease Progression|2|||
160777575|NCT01202591|580569990|FG005|Overall Study|Objective Disease Progression|0|||
160777576|NCT00003456|580570969|FG000|Overall Study|Not evaluable|8|||
160886900|NCT01163032|580980622|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
160886901|NCT01163032|580980623|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
160777577|NCT00420407|580570971|FG000|Overall Study|Lost to Follow-up|0|||
160777578|NCT00420407|580570972|FG001|Overall Study|Lost to Follow-up|3|||
160777579|NCT00420407|580570971|FG000|Overall Study|Physician Decision|2|||
160886902|NCT01163032|580980624|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
160777580|NCT00420407|580570972|FG001|Overall Study|Physician Decision|1|||
160777581|NCT00420407|580570971|FG000|Overall Study|subject identified as detainee|1|||
160777582|NCT00420407|580570972|FG001|Overall Study|subject identified as detainee|0|||
160777583|NCT00420407|580570971|FG000|Overall Study|subject identified as Jehovah's witness|1|||
160777584|NCT00420407|580570972|FG001|Overall Study|subject identified as Jehovah's witness|0|||
160777585|NCT00420407|580570971|FG000|Overall Study|Withdrawal by Subject|0|||
160777586|NCT00420407|580570972|FG001|Overall Study|Withdrawal by Subject|2|||
160777587|NCT02397837|580570976|FG000|Overall Study|Withdrawal by Subject|6|||
160777588|NCT02397837|580570977|FG001|Overall Study|Withdrawal by Subject|5|||
160777589|NCT02397837|580570976|FG000|Overall Study|Physician Decision|1|||
160777590|NCT02397837|580570977|FG001|Overall Study|Physician Decision|1|||
160777591|NCT02506036|580570981|FG000|First Intervention (4-6 Weeks)|Death|1|||
160777592|NCT02506036|580570982|FG001|First Intervention (4-6 Weeks)|Death|0|||
160777593|NCT02506036|580570981|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
160777594|NCT02506036|580570982|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
160777595|NCT02506036|580570981|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
160777596|NCT02506036|580570982|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
160777597|NCT00898807|580570985|FG000|Overall Study|Withdrawal by Subject|5|||
160777598|NCT00898807|580570986|FG001|Overall Study|Withdrawal by Subject|3|||
160777599|NCT00898807|580570985|FG000|Overall Study|Family pressure to discontinue|2|||
160777600|NCT00898807|580570986|FG001|Overall Study|Family pressure to discontinue|2|||
160777601|NCT00898807|580570985|FG000|Overall Study|Lost to Follow-up|1|||
160777602|NCT00898807|580570986|FG001|Overall Study|Lost to Follow-up|3|||
160777603|NCT00898807|580570985|FG000|Overall Study|Death|0|||
160777604|NCT00898807|580570986|FG001|Overall Study|Death|1|||
160777605|NCT01482221|580570991|FG000|Overall Study|Lack of Efficacy|1|||
160777606|NCT01482221|580570992|FG001|Overall Study|Lack of Efficacy|0|||
160777607|NCT01482221|580570993|FG002|Overall Study|Lack of Efficacy|1|||
160777608|NCT01482221|580570991|FG000|Overall Study|Lost to Follow-up|3|||
160777609|NCT01482221|580570992|FG001|Overall Study|Lost to Follow-up|2|||
160777610|NCT01482221|580570993|FG002|Overall Study|Lost to Follow-up|1|||
160777611|NCT01482221|580570991|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
160777612|NCT01482221|580570992|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
160777613|NCT01482221|580570993|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
160777614|NCT01482221|580570991|FG000|Overall Study|Condition under Investigation Worsened|3|||
160777615|NCT01482221|580570992|FG001|Overall Study|Condition under Investigation Worsened|2|||
160777616|NCT01482221|580570993|FG002|Overall Study|Condition under Investigation Worsened|4|||
160777617|NCT01482221|580570991|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
160777618|NCT01482221|580570992|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
160777619|NCT01482221|580570993|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
160777620|NCT01482221|580570991|FG000|Overall Study|Adverse Event|1|||
160777621|NCT01482221|580570992|FG001|Overall Study|Adverse Event|7|||
160777622|NCT01482221|580570993|FG002|Overall Study|Adverse Event|3|||
160777623|NCT01482221|580570991|FG000|Overall Study|Withdrawal by Subject|10|||
160777624|NCT01482221|580570992|FG001|Overall Study|Withdrawal by Subject|7|||
160777625|NCT01482221|580570993|FG002|Overall Study|Withdrawal by Subject|12|||
160777626|NCT01482221|580570991|FG000|Overall Study|Incorrect randomization|0|||
160777627|NCT01482221|580570992|FG001|Overall Study|Incorrect randomization|1|||
160777628|NCT01482221|580570993|FG002|Overall Study|Incorrect randomization|0|||
160777629|NCT01482221|580570991|FG000|Overall Study|Physician Decision|0|||
160777630|NCT01482221|580570992|FG001|Overall Study|Physician Decision|1|||
160777631|NCT01482221|580570993|FG002|Overall Study|Physician Decision|0|||
160777632|NCT04602000|580570994|FG000|Overall Study|Withdrawal by Subject|3|||
160777633|NCT04602000|580570995|FG001|Overall Study|Withdrawal by Subject|6|||
160777634|NCT04602000|580570996|FG002|Overall Study|Withdrawal by Subject|3|||
160638038|NCT00370396|580058015|FG002|Overall Study|Lost to Follow-up|0|||
160638039|NCT02065791|580058016|FG000|Overall Study|Closed Site|1|||
160638040|NCT02065791|580058017|FG001|Overall Study|Closed Site|1|||
160638041|NCT02065791|580058016|FG000|Overall Study|Withdrawal by Subject|11|||
160638042|NCT02065791|580058017|FG001|Overall Study|Withdrawal by Subject|5|||
160638043|NCT02065791|580058016|FG000|Overall Study|Lost to Follow-up|13|||
160638044|NCT02065791|580058017|FG001|Overall Study|Lost to Follow-up|9|||
160638045|NCT01246973|580059172|FG000|Overall Study|Other|38|||
160638046|NCT01246973|580059173|FG001|Overall Study|Other|25|||
160638047|NCT01246973|580059172|FG000|Overall Study|Adverse Event|16|||
160638048|NCT01246973|580059173|FG001|Overall Study|Adverse Event|9|||
160638049|NCT01246973|580059172|FG000|Overall Study|Withdrawal by Subject|7|||
160777635|NCT04602000|580570997|FG003|Overall Study|Withdrawal by Subject|27|||
160777636|NCT04602000|580570998|FG004|Overall Study|Withdrawal by Subject|39|||
160777637|NCT04602000|580570994|FG000|Overall Study|Physician Decision|1|||
160777638|NCT04602000|580570995|FG001|Overall Study|Physician Decision|0|||
160777639|NCT04602000|580570996|FG002|Overall Study|Physician Decision|0|||
160777640|NCT04602000|580570997|FG003|Overall Study|Physician Decision|2|||
160777641|NCT04602000|580570998|FG004|Overall Study|Physician Decision|2|||
160777642|NCT04602000|580570994|FG000|Overall Study|Death|0|||
160777643|NCT04602000|580570995|FG001|Overall Study|Death|1|||
160777644|NCT04602000|580570996|FG002|Overall Study|Death|0|||
160777645|NCT04602000|580570997|FG003|Overall Study|Death|1|||
160886903|NCT01163032|580980622|FG000|Open Label Extension Phase|Protocol Violation|0|||
160886904|NCT01163032|580980623|FG001|Open Label Extension Phase|Protocol Violation|0|||
160777646|NCT04602000|580570998|FG004|Overall Study|Death|2|||
160777647|NCT04602000|580570994|FG000|Overall Study|Lost to Follow-up|0|||
160777648|NCT04602000|580570995|FG001|Overall Study|Lost to Follow-up|0|||
160638050|NCT01246973|580059173|FG001|Overall Study|Withdrawal by Subject|13|||
160638051|NCT02598622|580059175|FG000|Overall Study|Withdrawal by Subject|3|||
160777649|NCT04602000|580570996|FG002|Overall Study|Lost to Follow-up|0|||
160777650|NCT04602000|580570997|FG003|Overall Study|Lost to Follow-up|3|||
160777651|NCT04602000|580570998|FG004|Overall Study|Lost to Follow-up|4|||
160777652|NCT04602000|580570994|FG000|Overall Study|Other|4|||
160777653|NCT04602000|580570995|FG001|Overall Study|Other|1|||
160777654|NCT04602000|580570996|FG002|Overall Study|Other|2|||
160777655|NCT04602000|580570997|FG003|Overall Study|Other|5|||
160777656|NCT04602000|580570998|FG004|Overall Study|Other|4|||
160777657|NCT04602000|580570994|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
160777658|NCT04602000|580570995|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
160777659|NCT04602000|580570996|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
160777660|NCT04602000|580570997|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
160777661|NCT04602000|580570998|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
160777662|NCT05607043|580570999|FG000|Overall Study|Lost to Follow-up|2|||
160777663|NCT05427916|580571006|FG000|Overall Study|Adverse Event|3|||
160777664|NCT05427916|580571007|FG001|Overall Study|Adverse Event|0|||
160777665|NCT05427916|580571006|FG000|Overall Study|Lack of Efficacy|6|||
160777666|NCT05427916|580571007|FG001|Overall Study|Lack of Efficacy|0|||
160777667|NCT05427916|580571006|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
160777668|NCT05427916|580571007|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
160777669|NCT00429299|580571010|FG000|Overall Study|Disease Progression|1|||
160777670|NCT00429299|580571011|FG001|Overall Study|Disease Progression|1|||
160777671|NCT00429299|580571012|FG002|Overall Study|Disease Progression|0|||
160777672|NCT00429299|580571010|FG000|Overall Study|Adverse Event|2|||
160777673|NCT00429299|580571011|FG001|Overall Study|Adverse Event|5|||
160777674|NCT00429299|580571012|FG002|Overall Study|Adverse Event|1|||
160777675|NCT00429299|580571010|FG000|Overall Study|Protocol Violation|1|||
160777676|NCT00429299|580571011|FG001|Overall Study|Protocol Violation|0|||
160777677|NCT00429299|580571012|FG002|Overall Study|Protocol Violation|0|||
160777678|NCT00429299|580571010|FG000|Overall Study|Withdrawal by Subject|0|||
160777679|NCT00429299|580571011|FG001|Overall Study|Withdrawal by Subject|1|||
160777680|NCT00429299|580571012|FG002|Overall Study|Withdrawal by Subject|3|||
160777681|NCT01257542|580571013|FG000|Overall Study|Protocol Violation|3|||
160777682|NCT01257542|580571014|FG001|Overall Study|Protocol Violation|5|||
160777683|NCT01257542|580571013|FG000|Overall Study|Withdrawal by Subject|0|||
160777684|NCT01257542|580571014|FG001|Overall Study|Withdrawal by Subject|2|||
160777685|NCT00081458|580571016|FG000|Overall Study|Adverse Event|1|||
160777686|NCT00081458|580571017|FG001|Overall Study|Adverse Event|5|||
160777687|NCT00081458|580571018|FG002|Overall Study|Adverse Event|2|||
160777688|NCT00081458|580571016|FG000|Overall Study|Withdrawal by Subject|0|||
160777689|NCT00081458|580571017|FG001|Overall Study|Withdrawal by Subject|3|||
160777690|NCT00081458|580571018|FG002|Overall Study|Withdrawal by Subject|1|||
160777691|NCT00081458|580571016|FG000|Overall Study|Randomized but not dosed|0|||
160777692|NCT00081458|580571017|FG001|Overall Study|Randomized but not dosed|0|||
160777693|NCT00081458|580571018|FG002|Overall Study|Randomized but not dosed|1|||
160777694|NCT03097315|580571021|FG000|Overall Study|Withdrawal by Subject|1|||
160777695|NCT00195429|580571022|FG000|Overall Study|Adverse Event|2|||
160777696|NCT00195429|580571023|FG001|Overall Study|Adverse Event|4|||
160777697|NCT00195429|580571022|FG000|Overall Study|Lack of Efficacy|2|||
160777698|NCT00195429|580571023|FG001|Overall Study|Lack of Efficacy|1|||
160777699|NCT00195429|580571022|FG000|Overall Study|Lost to Follow-up|1|||
160777700|NCT00195429|580571023|FG001|Overall Study|Lost to Follow-up|0|||
160777701|NCT02948400|580571028|FG000|Overall Study|Withdrawal by Subject|17|||
160541605|NCT01806779|579711308|FG001|Overall Study|Lost to Follow-up|20|||
160541606|NCT01806779|579711309|FG002|Overall Study|Lost to Follow-up|0|||
160541607|NCT01806779|579711307|FG000|Overall Study|Withdrawal by Subject|20|||
160541608|NCT01806779|579711308|FG001|Overall Study|Withdrawal by Subject|23|||
160541609|NCT01806779|579711309|FG002|Overall Study|Withdrawal by Subject|22|||
160777702|NCT02948400|580571029|FG001|Overall Study|Withdrawal by Subject|10|||
160777703|NCT02948400|580571028|FG000|Overall Study|failed to attend appointments|47|||
160777704|NCT02948400|580571029|FG001|Overall Study|failed to attend appointments|34|||
160777705|NCT02948400|580571028|FG000|Overall Study|COVID-related closure|6|||
160777706|NCT02948400|580571029|FG001|Overall Study|COVID-related closure|2|||
160777707|NCT02948400|580571028|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
160777708|NCT02948400|580571029|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
160777709|NCT02948400|580571028|FG000|Overall Study|motion sickness in virtual reality|2|||
160777710|NCT02948400|580571029|FG001|Overall Study|motion sickness in virtual reality|0|||
160777711|NCT05561140|580571030|FG000|Randomized Treatment Period|Adverse Event|1|||
160777712|NCT05561140|580571031|FG001|Randomized Treatment Period|Adverse Event|0|||
160886905|NCT01163032|580980624|FG002|Open Label Extension Phase|Protocol Violation|1|||
160777713|NCT05561140|580571030|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
160777714|NCT05561140|580571031|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
160777715|NCT05561140|580571030|FG000|Open Label Treatment Period|Adverse Event|6|||
160777716|NCT05561140|580571031|FG001|Open Label Treatment Period|Adverse Event|4|||
160777717|NCT05561140|580571030|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
160886906|NCT01163032|580980622|FG000|Open Label Extension Phase|Study Termination|0|||
160886907|NCT01163032|580980623|FG001|Open Label Extension Phase|Study Termination|0|||
160886908|NCT01163032|580980624|FG002|Open Label Extension Phase|Study Termination|7|||
160886909|NCT01163032|580980622|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
160886910|NCT01163032|580980623|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
160886911|NCT01163032|580980624|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
160886912|NCT02751931|580980626|FG000|Overall Study|Adverse Event|3|||
160886913|NCT02751931|580980627|FG001|Overall Study|Adverse Event|0|||
160886914|NCT02751931|580980626|FG000|Overall Study|Other: Miscelleneous|10|||
160886915|NCT02751931|580980627|FG001|Overall Study|Other: Miscelleneous|8|||
160886916|NCT03326206|580980633|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
160886917|NCT03326206|580980634|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
160886918|NCT03326206|580980633|FG000|Overall Study - 24 months|Death|8|||
160886919|NCT03326206|580980634|FG001|Overall Study - 24 months|Death|92|||
160886920|NCT03326206|580980633|FG000|Overall Study - 24 months|Observational data not available|43|||
160886921|NCT03326206|580980634|FG001|Overall Study - 24 months|Observational data not available|2879|||
160886922|NCT03326206|580980633|FG000|12 months|Unable to match cases with controls|17|||
160886923|NCT03326206|580980634|FG001|12 months|Unable to match cases with controls|22721|||
160886924|NCT03326206|580980633|FG000|12 months|Death|2|||
160886925|NCT03326206|580980634|FG001|12 months|Death|50|||
160886926|NCT03326206|580980633|FG000|12 months|Observational data not available|49|||
160886927|NCT03326206|580980634|FG001|12 months|Observational data not available|2921|||
160886928|NCT04090411|580980635|FG000|Induction Period|Adverse Event|3|||
160886929|NCT04090411|580980636|FG001|Induction Period|Adverse Event|1|||
160886930|NCT04090411|580980637|FG002|Induction Period|Adverse Event|1|||
160886931|NCT04090411|580980638|FG003|Induction Period|Adverse Event|1|||
160886932|NCT04090411|580980639|FG004|Induction Period|Adverse Event|0|||
160886933|NCT04090411|580980640|FG005|Induction Period|Adverse Event|0|||
160886934|NCT04090411|580980641|FG006|Induction Period|Adverse Event|0|||
160886935|NCT04090411|580980642|FG007|Induction Period|Adverse Event|0|||
160886936|NCT04090411|580980643|FG008|Induction Period|Adverse Event|0|||
160886937|NCT04090411|580980644|FG009|Induction Period|Adverse Event|0|||
160886938|NCT04090411|580980645|FG010|Induction Period|Adverse Event|0|||
160886939|NCT04090411|580980646|FG011|Induction Period|Adverse Event|0|||
160886940|NCT04090411|580980647|FG012|Induction Period|Adverse Event|0|||
160886941|NCT04090411|580980635|FG000|Induction Period|Lack of Efficacy|0|||
160886942|NCT04090411|580980636|FG001|Induction Period|Lack of Efficacy|0|||
160886943|NCT04090411|580980637|FG002|Induction Period|Lack of Efficacy|1|||
160886944|NCT04090411|580980638|FG003|Induction Period|Lack of Efficacy|1|||
160886945|NCT04090411|580980639|FG004|Induction Period|Lack of Efficacy|0|||
160886946|NCT04090411|580980640|FG005|Induction Period|Lack of Efficacy|0|||
160886947|NCT04090411|580980641|FG006|Induction Period|Lack of Efficacy|0|||
160886948|NCT04090411|580980642|FG007|Induction Period|Lack of Efficacy|0|||
160886949|NCT04090411|580980643|FG008|Induction Period|Lack of Efficacy|0|||
160886950|NCT04090411|580980644|FG009|Induction Period|Lack of Efficacy|0|||
160886951|NCT04090411|580980645|FG010|Induction Period|Lack of Efficacy|0|||
160886952|NCT04090411|580980646|FG011|Induction Period|Lack of Efficacy|0|||
160886953|NCT04090411|580980647|FG012|Induction Period|Lack of Efficacy|0|||
160886954|NCT04090411|580980635|FG000|Induction Period|Physician Decision|0|||
160886955|NCT04090411|580980636|FG001|Induction Period|Physician Decision|0|||
160886956|NCT04090411|580980637|FG002|Induction Period|Physician Decision|1|||
160886957|NCT04090411|580980638|FG003|Induction Period|Physician Decision|0|||
160886958|NCT04090411|580980639|FG004|Induction Period|Physician Decision|0|||
160886959|NCT04090411|580980640|FG005|Induction Period|Physician Decision|0|||
160886960|NCT04090411|580980641|FG006|Induction Period|Physician Decision|0|||
160886961|NCT04090411|580980642|FG007|Induction Period|Physician Decision|0|||
160886962|NCT04090411|580980643|FG008|Induction Period|Physician Decision|0|||
160886963|NCT04090411|580980644|FG009|Induction Period|Physician Decision|0|||
160886964|NCT04090411|580980645|FG010|Induction Period|Physician Decision|0|||
160777718|NCT05561140|580571031|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
160777719|NCT05561140|580571030|FG000|Open Label Treatment Period|Physician Decision|0|||
160777720|NCT05561140|580571031|FG001|Open Label Treatment Period|Physician Decision|1|||
160777721|NCT05561140|580571030|FG000|Open Label Treatment Period|Pregnancy|1|||
160777722|NCT05561140|580571031|FG001|Open Label Treatment Period|Pregnancy|0|||
160777723|NCT05561140|580571030|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
160777724|NCT05561140|580571031|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
160777725|NCT05561140|580571030|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
160777726|NCT05561140|580571031|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
160777727|NCT05561140|580571030|FG000|Open Label Treatment Period|Other|1|||
160777728|NCT05561140|580571031|FG001|Open Label Treatment Period|Other|0|||
160777729|NCT05774977|580571034|FG000|Overall Study|Withdrawal by Subject|2|||
160777730|NCT01132755|580571036|FG000|Overall Study|Procedure not done due to medical reason|23|||
160777731|NCT01132755|580571036|FG000|Overall Study|Protocol Violation|15|||
160777732|NCT01132755|580571036|FG000|Overall Study|Withdrawal by Subject|4|||
160777733|NCT02324153|580571039|FG000|Overall Study|Withdrawal by Subject|4|||
160777734|NCT02324153|580571040|FG001|Overall Study|Withdrawal by Subject|1|||
160777735|NCT02324153|580571039|FG000|Overall Study|Surgery postponed after randomization|3|||
160777736|NCT02324153|580571040|FG001|Overall Study|Surgery postponed after randomization|0|||
160777737|NCT02324153|580571039|FG000|Overall Study|Developed delirium preoperatively|1|||
160777738|NCT02324153|580571040|FG001|Overall Study|Developed delirium preoperatively|0|||
160777739|NCT04017962|580571041|FG000|Overall Study|Death|2|||
160777740|NCT04017962|580571042|FG001|Overall Study|Death|0|||
160777741|NCT04017962|580571041|FG000|Overall Study|Lost to Follow-up|2|||
160777742|NCT04017962|580571042|FG001|Overall Study|Lost to Follow-up|0|||
160777743|NCT04017962|580571041|FG000|Overall Study|Physician Decision|1|||
160777744|NCT04017962|580571042|FG001|Overall Study|Physician Decision|0|||
160777745|NCT04017962|580571041|FG000|Overall Study|Discontinued LTV|5|||
160777746|NCT04017962|580571042|FG001|Overall Study|Discontinued LTV|0|||
160777747|NCT00700635|580571043|FG000|Overall Study|Adverse Event|1|||
160777748|NCT00700635|580571044|FG001|Overall Study|Adverse Event|0|||
160777749|NCT00700635|580571045|FG002|Overall Study|Adverse Event|0|||
160777750|NCT00700635|580571043|FG000|Overall Study|Lost to Follow-up|1|||
160777751|NCT00700635|580571044|FG001|Overall Study|Lost to Follow-up|3|||
160777752|NCT00700635|580571045|FG002|Overall Study|Lost to Follow-up|0|||
160777753|NCT00700635|580571043|FG000|Overall Study|Protocol Violation|2|||
160777754|NCT00700635|580571044|FG001|Overall Study|Protocol Violation|2|||
160777755|NCT00700635|580571045|FG002|Overall Study|Protocol Violation|0|||
160777756|NCT00700635|580571043|FG000|Overall Study|Withdrawal by Subject|7|||
160777757|NCT00700635|580571044|FG001|Overall Study|Withdrawal by Subject|3|||
160777758|NCT00700635|580571045|FG002|Overall Study|Withdrawal by Subject|1|||
160777759|NCT05172570|580571046|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
160777760|NCT05172570|580571047|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
160777761|NCT05172570|580571048|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
160777762|NCT05172570|580571046|FG000|Overall Study|PI Decision due to equipment shortages|0|||
160777763|NCT05172570|580571047|FG001|Overall Study|PI Decision due to equipment shortages|0|||
160777764|NCT05172570|580571048|FG002|Overall Study|PI Decision due to equipment shortages|1|||
160777765|NCT00768053|580571049|FG000|Overall Study|Adverse Event|10|||
160777766|NCT00768053|580571049|FG000|Overall Study|Lost to Follow-up|1|||
160777767|NCT00632359|580571056|FG000|Overall Study|Withdrawal by Subject|2|||
160777768|NCT01127061|580571996|FG000|Overall Study|Lost to Follow-up|7|||
160777769|NCT01127061|580571997|FG001|Overall Study|Lost to Follow-up|10|||
160777770|NCT01127061|580571996|FG000|Overall Study|Physician Decision|3|||
160777771|NCT01127061|580571997|FG001|Overall Study|Physician Decision|3|||
160777772|NCT03921541|580572000|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
160777773|NCT03921541|580572001|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
160777774|NCT00182637|580572002|FG000|Overall Study|Adverse Event|2|||
160777775|NCT00182637|580572002|FG000|Overall Study|Disease Progression|1|||
160777776|NCT04941898|580572003|FG000|Overall Study|Protocol Violation|1|||
160777777|NCT03641924|580572004|FG000|Overall Study|Withdrawal by Subject|26|||
160777778|NCT03641924|580572004|FG000|Overall Study|Lost to Follow-up|16|||
160777779|NCT03641924|580572004|FG000|Overall Study|Protocol Violation|10|||
160777780|NCT02068794|580572005|FG000|Overall Study|Withdrawal by Subject|0|||
160777781|NCT02068794|580572006|FG001|Overall Study|Withdrawal by Subject|1|||
160777782|NCT02068794|580572007|FG002|Overall Study|Withdrawal by Subject|2|||
160777783|NCT02068794|580572005|FG000|Overall Study|Early Progression|1|||
160638052|NCT02598622|580059176|FG001|Overall Study|Withdrawal by Subject|0|||
160777784|NCT02068794|580572006|FG001|Overall Study|Early Progression|0|||
160777785|NCT02068794|580572007|FG002|Overall Study|Early Progression|1|||
160777786|NCT02068794|580572005|FG000|Overall Study|Ineligible|0|||
160777787|NCT02068794|580572006|FG001|Overall Study|Ineligible|0|||
160777788|NCT02068794|580572007|FG002|Overall Study|Ineligible|1|||
160777789|NCT00541229|580572009|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
160777790|NCT00541229|580572010|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
160777791|NCT00541229|580572011|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
160777792|NCT00541229|580572012|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
160777793|NCT00541229|580572013|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
160777794|NCT00541229|580572014|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
160777795|NCT00541229|580572009|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
160777796|NCT00541229|580572010|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
160777797|NCT00541229|580572011|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
160777798|NCT00541229|580572012|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
160777799|NCT00541229|580572013|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
160777800|NCT00541229|580572014|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
160777801|NCT00541229|580572009|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
160777802|NCT00541229|580572010|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
160777803|NCT00541229|580572011|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
160777804|NCT00541229|580572012|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
160777805|NCT00541229|580572013|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
160777806|NCT00541229|580572014|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
160777807|NCT00541229|580572009|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
160777808|NCT00541229|580572010|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
160777809|NCT00541229|580572011|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
160777810|NCT00541229|580572012|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
160777811|NCT00541229|580572013|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
160777812|NCT00541229|580572014|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
160777813|NCT00541229|580572009|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
160777814|NCT00541229|580572010|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
160777815|NCT00541229|580572011|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
160777816|NCT00541229|580572012|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
160777817|NCT00541229|580572013|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
160777818|NCT00541229|580572014|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
160777819|NCT00541229|580572009|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
160777820|NCT00541229|580572010|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
160777821|NCT00541229|580572011|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
160777822|NCT00541229|580572012|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
160777823|NCT00541229|580572013|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
160777824|NCT00541229|580572014|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
160777825|NCT00541229|580572009|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
160777826|NCT00541229|580572010|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
160777827|NCT00541229|580572011|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
160777828|NCT00541229|580572012|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
160777829|NCT00541229|580572013|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
160777830|NCT00541229|580572014|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
160777831|NCT00541229|580572009|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
160777832|NCT00541229|580572010|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
160777833|NCT00541229|580572011|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
160777834|NCT00541229|580572012|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
160777835|NCT00541229|580572013|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
160777836|NCT00541229|580572014|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
160777837|NCT00541229|580572009|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
160777838|NCT00541229|580572010|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
160777839|NCT00541229|580572011|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
160777840|NCT00541229|580572012|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
160777841|NCT00541229|580572013|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
160777842|NCT00541229|580572014|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
160777843|NCT00541229|580572009|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
160777844|NCT00541229|580572010|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
160777845|NCT00541229|580572011|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
160777846|NCT00541229|580572012|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
160777847|NCT00541229|580572013|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
160777848|NCT00541229|580572014|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
160777849|NCT00541229|580572009|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
160777850|NCT00541229|580572010|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
160886965|NCT04090411|580980646|FG011|Induction Period|Physician Decision|0|||
160886966|NCT04090411|580980647|FG012|Induction Period|Physician Decision|0|||
160777851|NCT00541229|580572011|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
160777852|NCT00541229|580572012|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
160777853|NCT00541229|580572013|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
160777854|NCT00541229|580572014|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
160777855|NCT00541229|580572009|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
160886967|NCT04090411|580980635|FG000|Induction Period|Protocol Violation|0|||
160886968|NCT04090411|580980636|FG001|Induction Period|Protocol Violation|0|||
160886969|NCT04090411|580980637|FG002|Induction Period|Protocol Violation|0|||
160777856|NCT00541229|580572010|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
160777857|NCT00541229|580572011|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
160777858|NCT00541229|580572012|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
160777859|NCT00541229|580572013|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
160777860|NCT00541229|580572014|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
160777861|NCT00541229|580572009|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
160777862|NCT00541229|580572010|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
160777863|NCT00541229|580572011|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
160777864|NCT00541229|580572012|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
160777865|NCT00541229|580572013|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
160777866|NCT00541229|580572014|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
160777867|NCT00541229|580572009|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
160777868|NCT00541229|580572010|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
160777869|NCT00541229|580572011|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
160777870|NCT00541229|580572012|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
160777871|NCT00541229|580572013|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
160777872|NCT00541229|580572014|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
160777873|NCT00541229|580572009|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
160777874|NCT00541229|580572010|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
160777875|NCT00541229|580572011|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
160777876|NCT00541229|580572012|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
160777877|NCT00541229|580572013|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
160777878|NCT00541229|580572014|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
160777879|NCT00541229|580572009|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
160777880|NCT00541229|580572010|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
160777881|NCT00541229|580572011|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
160777882|NCT00541229|580572012|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
160777883|NCT00541229|580572013|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
160777884|NCT00541229|580572014|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
160777885|NCT01500096|580572017|FG000|Overall Study|Lost to Follow-up|1|||
160777886|NCT01500096|580572018|FG001|Overall Study|Lost to Follow-up|0|||
160777887|NCT01500096|580572019|FG002|Overall Study|Lost to Follow-up|0|||
160777888|NCT01500096|580572020|FG003|Overall Study|Lost to Follow-up|2|||
160777889|NCT00263562|580572021|FG000|Overall Study|Protocol Violation|3|||
160777890|NCT00263562|580572022|FG001|Overall Study|Protocol Violation|0|||
160777891|NCT02143778|580572023|FG000|Overall Study|Withdrawal by Subject|2|||
160777892|NCT02143778|580572023|FG000|Overall Study|Device malfunction|1|||
160777893|NCT05630755|580572024|FG000|Overall Study|Lost to Follow-up|7|||
160777894|NCT05630755|580572025|FG001|Overall Study|Lost to Follow-up|0|||
160777895|NCT05630755|580572024|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
160777896|NCT05630755|580572025|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
160777897|NCT05630755|580572024|FG000|Overall Study|Withdrawal by Subject|9|||
160777898|NCT05630755|580572025|FG001|Overall Study|Withdrawal by Subject|3|||
160777899|NCT05630755|580572024|FG000|Overall Study|Participant moved away from trial site|0|||
160777900|NCT05630755|580572025|FG001|Overall Study|Participant moved away from trial site|1|||
160777901|NCT05630755|580572024|FG000|Overall Study|Status not Recorded|316|||
160777902|NCT05630755|580572025|FG001|Overall Study|Status not Recorded|161|||
160777903|NCT00367458|580572026|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
160777904|NCT00367458|580572027|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
160777905|NCT04790201|580572032|FG000|Overall Study|Lost to Follow-up|0|||
160777906|NCT04790201|580572033|FG001|Overall Study|Lost to Follow-up|0|||
160777907|NCT04790201|580572034|FG002|Overall Study|Lost to Follow-up|2|||
160777908|NCT04790201|580572032|FG000|Overall Study|Death|0|||
160777909|NCT04790201|580572033|FG001|Overall Study|Death|1|||
160777910|NCT04790201|580572034|FG002|Overall Study|Death|0|||
160777911|NCT04790201|580572032|FG000|Overall Study|Protocol Violation|1|||
160777912|NCT04790201|580572033|FG001|Overall Study|Protocol Violation|0|||
160777913|NCT04790201|580572034|FG002|Overall Study|Protocol Violation|1|||
160777914|NCT01334515|580572035|FG000|Overall Study|Adverse Event|1|||
160777915|NCT01334515|580572036|FG001|Overall Study|Adverse Event|6|||
160777916|NCT01334515|580572035|FG000|Overall Study|Death|1|||
160777917|NCT01334515|580572036|FG001|Overall Study|Death|0|||
160886970|NCT04090411|580980638|FG003|Induction Period|Protocol Violation|1|||
160886971|NCT04090411|580980639|FG004|Induction Period|Protocol Violation|0|||
160886972|NCT04090411|580980640|FG005|Induction Period|Protocol Violation|0|||
160886973|NCT04090411|580980641|FG006|Induction Period|Protocol Violation|0|||
160638053|NCT02598622|580059175|FG000|Overall Study|Physician Decision|3|||
160638054|NCT02598622|580059176|FG001|Overall Study|Physician Decision|0|||
160638055|NCT00681824|580059180|FG000|Overall Study|withdrawn by investigator|0|||
160777918|NCT01334515|580572035|FG000|Overall Study|Lack of Efficacy|8|||
160777919|NCT01334515|580572036|FG001|Overall Study|Lack of Efficacy|21|||
160777920|NCT01334515|580572035|FG000|Overall Study|Physician Decision|1|||
160777921|NCT01334515|580572036|FG001|Overall Study|Physician Decision|1|||
160777922|NCT01334515|580572035|FG000|Overall Study|Withdrawal by Subject|1|||
160777923|NCT01334515|580572036|FG001|Overall Study|Withdrawal by Subject|1|||
160777924|NCT03637374|580572037|FG000|Overall Study|Death|2|||
160777925|NCT03637374|580572038|FG001|Overall Study|Death|0|||
160777926|NCT02836769|580572042|FG000|Overall Study|Lost to Follow-up|10|||
160777927|NCT02836769|580572042|FG000|Overall Study|Medical withdrawal|2|||
160777928|NCT02836769|580572042|FG000|Overall Study|Withdrawal by Subject|3|||
160777929|NCT04339972|580572043|FG000|Overall Study|Scheduling Issues|3|||
160777930|NCT04339972|580572044|FG001|Overall Study|Scheduling Issues|3|||
160777931|NCT04339972|580572043|FG000|Overall Study|dropout|1|||
160777932|NCT04339972|580572044|FG001|Overall Study|dropout|1|||
160777933|NCT04339972|580572043|FG000|Overall Study|Technical issues|1|||
160777934|NCT04339972|580572044|FG001|Overall Study|Technical issues|0|||
160777935|NCT04339972|580572043|FG000|Overall Study|Claustraphobia|0|||
160777936|NCT04339972|580572044|FG001|Overall Study|Claustraphobia|1|||
160777937|NCT00776997|580572045|FG000|Overall Study|Adverse Event|2|||
160777938|NCT02403271|580572046|FG000|Period 1|Other varied reasons|1|||
160777939|NCT02403271|580572047|FG001|Period 1|Other varied reasons|0|||
160777940|NCT02403271|580572046|FG000|Period 2|Withdrawal by Subject|0|||
160777941|NCT02403271|580572047|FG001|Period 2|Withdrawal by Subject|14|||
160777942|NCT02403271|580572046|FG000|Period 2|Death|0|||
160777943|NCT02403271|580572047|FG001|Period 2|Death|84|||
160777944|NCT02403271|580572046|FG000|Period 2|Lost to Follow-up|0|||
160777945|NCT02403271|580572047|FG001|Period 2|Lost to Follow-up|2|||
160777946|NCT02403271|580572046|FG000|Period 2|Study Terminated by Sponsor|0|||
160777947|NCT02403271|580572047|FG001|Period 2|Study Terminated by Sponsor|14|||
160777948|NCT02403271|580572046|FG000|Period 2|Other varied reasons|0|||
160777949|NCT02403271|580572047|FG001|Period 2|Other varied reasons|10|||
160777950|NCT03925220|580572048|FG000|Overall Study|Withdrawal by Subject|4|||
160777951|NCT03925220|580572049|FG001|Overall Study|Withdrawal by Subject|4|||
160777952|NCT03925220|580572050|FG002|Overall Study|Withdrawal by Subject|4|||
160777953|NCT03925220|580572051|FG003|Overall Study|Withdrawal by Subject|4|||
160777954|NCT03925220|580572048|FG000|Overall Study|Lost to Follow-up|40|||
160777955|NCT03925220|580572049|FG001|Overall Study|Lost to Follow-up|46|||
160777956|NCT03925220|580572050|FG002|Overall Study|Lost to Follow-up|37|||
160777957|NCT03925220|580572051|FG003|Overall Study|Lost to Follow-up|38|||
160777958|NCT00374868|580572052|FG000|Overall Study|Adverse Event|12|||
160777959|NCT00374868|580572052|FG000|Overall Study|Progressive Disease|7|||
160777960|NCT00374868|580572052|FG000|Overall Study|Physician Decision|13|||
160777961|NCT00374868|580572052|FG000|Overall Study|Lost to Follow-up|1|||
160777962|NCT00374868|580572052|FG000|Overall Study|Death|2|||
160777963|NCT00374868|580572052|FG000|Overall Study|Other - Not Specified|1|||
160777964|NCT04470427|580572053|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
160777965|NCT04470427|580572054|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
160777966|NCT04470427|580572055|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
160777967|NCT04470427|580572056|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
160777968|NCT04470427|580572057|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
160777969|NCT04470427|580572058|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
160777970|NCT04470427|580572053|FG000|Part B :Open-label|Other than specified|0|||
160777971|NCT04470427|580572054|FG001|Part B :Open-label|Other than specified|0|||
160777972|NCT04470427|580572055|FG002|Part B :Open-label|Other than specified|788|||
160777973|NCT04470427|580572056|FG003|Part B :Open-label|Other than specified|0|||
160777974|NCT04470427|580572057|FG004|Part B :Open-label|Other than specified|523|||
160777975|NCT04470427|580572058|FG005|Part B :Open-label|Other than specified|0|||
160777976|NCT04470427|580572053|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
160777977|NCT04470427|580572054|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
160777978|NCT04470427|580572055|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
160777979|NCT04470427|580572056|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
160777980|NCT04470427|580572057|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
160638056|NCT00681824|580059181|FG001|Overall Study|withdrawn by investigator|0|||
160777981|NCT04470427|580572058|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
160777982|NCT04470427|580572053|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
160777983|NCT04470427|580572054|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
160777984|NCT04470427|580572055|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
160777985|NCT04470427|580572056|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
160777986|NCT04470427|580572057|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
160777987|NCT04470427|580572058|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
160777988|NCT03301714|580572059|FG000|Overall Study|Lost to Follow-up|10|||
160777989|NCT03301714|580572060|FG001|Overall Study|Lost to Follow-up|4|||
160777990|NCT03301714|580572061|FG002|Overall Study|Lost to Follow-up|4|||
160777991|NCT03301714|580572059|FG000|Overall Study|Did not receive allocated intervention|0|||
160777992|NCT03301714|580572060|FG001|Overall Study|Did not receive allocated intervention|2|||
160777993|NCT03301714|580572061|FG002|Overall Study|Did not receive allocated intervention|3|||
160777994|NCT03188185|580572062|FG000|Stage 1|Adverse Event|4|||
160777995|NCT03188185|580572063|FG001|Stage 1|Adverse Event|12|||
160777996|NCT03188185|580572064|FG002|Stage 1|Adverse Event|0|||
160777997|NCT03188185|580572065|FG003|Stage 1|Adverse Event|0|||
160777998|NCT03188185|580572062|FG000|Stage 1|Lack of Efficacy|0|||
160777999|NCT03188185|580572063|FG001|Stage 1|Lack of Efficacy|2|||
160778000|NCT03188185|580572064|FG002|Stage 1|Lack of Efficacy|0|||
160778001|NCT03188185|580572065|FG003|Stage 1|Lack of Efficacy|0|||
160778002|NCT03188185|580572062|FG000|Stage 1|Lost to Follow-up|6|||
160778003|NCT03188185|580572063|FG001|Stage 1|Lost to Follow-up|1|||
160778004|NCT03188185|580572064|FG002|Stage 1|Lost to Follow-up|0|||
160778005|NCT03188185|580572065|FG003|Stage 1|Lost to Follow-up|0|||
160778006|NCT03188185|580572062|FG000|Stage 1|Withdrawal by Subject|9|||
160778007|NCT03188185|580572063|FG001|Stage 1|Withdrawal by Subject|0|||
160778008|NCT03188185|580572064|FG002|Stage 1|Withdrawal by Subject|0|||
160778009|NCT03188185|580572065|FG003|Stage 1|Withdrawal by Subject|0|||
160778010|NCT03188185|580572062|FG000|Stage 1|Identified as a professional patient|0|||
160778011|NCT03188185|580572063|FG001|Stage 1|Identified as a professional patient|1|||
160778012|NCT03188185|580572064|FG002|Stage 1|Identified as a professional patient|0|||
160778013|NCT03188185|580572065|FG003|Stage 1|Identified as a professional patient|0|||
160778014|NCT03188185|580572062|FG000|Stage 2|Adverse Event|0|||
160778015|NCT03188185|580572063|FG001|Stage 2|Adverse Event|0|||
160778016|NCT03188185|580572064|FG002|Stage 2|Adverse Event|2|||
160778017|NCT03188185|580572065|FG003|Stage 2|Adverse Event|4|||
160778018|NCT03188185|580572062|FG000|Stage 2|Lack of Efficacy|0|||
160778019|NCT03188185|580572063|FG001|Stage 2|Lack of Efficacy|0|||
160778020|NCT03188185|580572064|FG002|Stage 2|Lack of Efficacy|3|||
160778021|NCT03188185|580572065|FG003|Stage 2|Lack of Efficacy|0|||
160778022|NCT03188185|580572062|FG000|Stage 2|Lost to Follow-up|0|||
160778023|NCT03188185|580572063|FG001|Stage 2|Lost to Follow-up|0|||
160778024|NCT03188185|580572064|FG002|Stage 2|Lost to Follow-up|1|||
160778025|NCT03188185|580572065|FG003|Stage 2|Lost to Follow-up|0|||
160778026|NCT03188185|580572062|FG000|Stage 2|Physician Decision|0|||
160778027|NCT03188185|580572063|FG001|Stage 2|Physician Decision|0|||
160778028|NCT03188185|580572064|FG002|Stage 2|Physician Decision|0|||
160778029|NCT03188185|580572065|FG003|Stage 2|Physician Decision|1|||
160778030|NCT03188185|580572062|FG000|Stage 2|Withdrawal by Subject|0|||
160778031|NCT03188185|580572063|FG001|Stage 2|Withdrawal by Subject|0|||
160778032|NCT03188185|580572064|FG002|Stage 2|Withdrawal by Subject|3|||
160778033|NCT03188185|580572065|FG003|Stage 2|Withdrawal by Subject|1|||
160778034|NCT02112552|580572068|FG000|Overall Study|Withdrawal by Subject|1|||
160778035|NCT02112552|580572068|FG000|Overall Study|Adverse Event|1|||
160778036|NCT03349515|580572072|FG000|Overall Study|Lack of Efficacy|2|||
160778037|NCT03349515|580572073|FG001|Overall Study|Lack of Efficacy|0|||
160778038|NCT03349515|580572072|FG000|Overall Study|Physician Decision|3|||
160778039|NCT03349515|580572073|FG001|Overall Study|Physician Decision|1|||
160778040|NCT01529268|580572078|FG000|Overall Study|Lost to Follow-up|9|||
160778041|NCT01529268|580572079|FG001|Overall Study|Lost to Follow-up|3|||
160778042|NCT01529268|580572078|FG000|Overall Study|Moved|3|||
160778043|NCT01529268|580572079|FG001|Overall Study|Moved|0|||
160778044|NCT00303953|580572080|FG000|Overall Study|Ineligible|1|||
160541610|NCT00805480|579711310|FG000|Overall Study|Withdrawal by Subject|13|||
160778045|NCT00303953|580572080|FG000|Overall Study|Death|1|||
160778046|NCT00303953|580572080|FG000|Overall Study|Adverse Event|4|||
160778047|NCT00303953|580572080|FG000|Overall Study|Lack of Efficacy|12|||
160886974|NCT04090411|580980642|FG007|Induction Period|Protocol Violation|0|||
160778048|NCT00303953|580572080|FG000|Overall Study|Physician Decision|1|||
160778049|NCT02393755|580572081|FG000|Overall Study|Withdrawal by Subject|0|||
160541611|NCT00805480|579711311|FG001|Overall Study|Withdrawal by Subject|5|||
160778050|NCT02393755|580572082|FG001|Overall Study|Withdrawal by Subject|3|||
160778051|NCT02393755|580572081|FG000|Overall Study|Adverse Event|0|||
160778052|NCT02393755|580572082|FG001|Overall Study|Adverse Event|2|||
160541612|NCT00805480|579711312|FG002|Overall Study|Withdrawal by Subject|11|||
160778053|NCT02393755|580572081|FG000|Overall Study|Physician Decision|0|||
160778054|NCT02393755|580572082|FG001|Overall Study|Physician Decision|2|||
160778055|NCT01327703|580572083|FG000|Second Treatment Period|Adverse Event|1|||
160778056|NCT01327703|580572084|FG001|Second Treatment Period|Adverse Event|1|||
160778057|NCT01327703|580572083|FG000|Second Treatment Period|Protocol Violation|0|||
160778058|NCT01327703|580572084|FG001|Second Treatment Period|Protocol Violation|1|||
160778059|NCT05324371|580572085|FG000|Overall Study|Withdrawal by Subject|1|||
160778060|NCT05324371|580572085|FG000|Overall Study|Death|1|||
160778061|NCT00812097|580572086|FG000|Overall Study|Death|3|||
160778062|NCT00812097|580572087|FG001|Overall Study|Death|10|||
160778063|NCT00812097|580572088|FG002|Overall Study|Death|3|||
160638057|NCT00681824|580059182|FG002|Overall Study|withdrawn by investigator|1|||
160638058|NCT00681824|580059180|FG000|Overall Study|scheduling conflict|1|||
160638059|NCT00681824|580059181|FG001|Overall Study|scheduling conflict|0|||
160638060|NCT00681824|580059182|FG002|Overall Study|scheduling conflict|0|||
160638061|NCT00681824|580059180|FG000|Overall Study|Death|0|||
160638062|NCT00681824|580059181|FG001|Overall Study|Death|1|||
160638063|NCT00681824|580059182|FG002|Overall Study|Death|0|||
160638064|NCT04575038|580059183|FG000|Overall Study|Withdrawal by Subject|1|||
160638065|NCT04575038|580059184|FG001|Overall Study|Withdrawal by Subject|1|||
160638066|NCT01416142|580059189|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
160638067|NCT01416142|580059190|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
160638068|NCT01416142|580059191|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
160638069|NCT00678379|580059192|FG000|Overall Study|Injection performed after tonsillectomy|2|||
160638070|NCT00678379|580059193|FG001|Overall Study|Injection performed after tonsillectomy|0|||
160638071|NCT00678379|580059194|FG002|Overall Study|Injection performed after tonsillectomy|1|||
160638072|NCT00678379|580059192|FG000|Overall Study|Incomplete Data|4|||
160638073|NCT00678379|580059193|FG001|Overall Study|Incomplete Data|3|||
160638074|NCT00678379|580059194|FG002|Overall Study|Incomplete Data|3|||
160638075|NCT01835470|580059195|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
160638076|NCT01835470|580059195|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
160638077|NCT01011907|580059196|FG000|Overall Study|Withdrawal by Subject|13|||
160638078|NCT01011907|580059197|FG001|Overall Study|Withdrawal by Subject|11|||
160638079|NCT01011907|580059196|FG000|Overall Study|Adverse Event|1|||
160638080|NCT01011907|580059197|FG001|Overall Study|Adverse Event|4|||
160638081|NCT01637961|580059202|FG000|Overall Study|Ineligible: wrong primary|1|||
160638082|NCT01637961|580059202|FG000|Overall Study|Ineligible: inadequate pathology|1|||
160638083|NCT04682639|580059203|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
160638084|NCT04682639|580059204|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
160638085|NCT04682639|580059205|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
160638086|NCT04682639|580059206|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
160638087|NCT04682639|580059207|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
160638088|NCT04682639|580059203|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
160638089|NCT04682639|580059204|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
160638090|NCT04682639|580059205|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
160638091|NCT04682639|580059206|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160638092|NCT04682639|580059207|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160638093|NCT04682639|580059203|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
160638094|NCT04682639|580059204|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
160778064|NCT00812097|580572089|FG003|Overall Study|Death|3|||
160778065|NCT00812097|580572086|FG000|Overall Study|Withdrawal by Subject|14|||
160778066|NCT00812097|580572087|FG001|Overall Study|Withdrawal by Subject|12|||
160778067|NCT00812097|580572088|FG002|Overall Study|Withdrawal by Subject|8|||
160778068|NCT00812097|580572089|FG003|Overall Study|Withdrawal by Subject|2|||
160778069|NCT00812097|580572086|FG000|Overall Study|Lost to Follow-up|90|||
160778070|NCT00812097|580572087|FG001|Overall Study|Lost to Follow-up|14|||
160778071|NCT00812097|580572088|FG002|Overall Study|Lost to Follow-up|17|||
160778072|NCT00812097|580572089|FG003|Overall Study|Lost to Follow-up|5|||
160778073|NCT00812097|580572086|FG000|Overall Study|Explantation of study device(s)|27|||
160778074|NCT00812097|580572087|FG001|Overall Study|Explantation of study device(s)|29|||
160778075|NCT00812097|580572088|FG002|Overall Study|Explantation of study device(s)|14|||
160778076|NCT00812097|580572089|FG003|Overall Study|Explantation of study device(s)|20|||
160778077|NCT00812097|580572086|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
160778078|NCT00812097|580572087|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
160778079|NCT00812097|580572088|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
160778080|NCT00812097|580572089|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
160778081|NCT04822194|580572090|FG000|Overall Study|Withdrawal by Subject|5|||
160778082|NCT04822194|580572091|FG001|Overall Study|Withdrawal by Subject|4|||
160778083|NCT04822194|580572090|FG000|Overall Study|Technical issues with MR scanner|1|||
160778084|NCT04822194|580572091|FG001|Overall Study|Technical issues with MR scanner|0|||
160778085|NCT04822194|580572090|FG000|Overall Study|Lost to Follow-up|5|||
160778086|NCT04822194|580572091|FG001|Overall Study|Lost to Follow-up|7|||
160778087|NCT04738487|580572092|FG000|Overall Study|Participant Ongoing in Study|298|||
160778088|NCT04738487|580572093|FG001|Overall Study|Participant Ongoing in Study|297|||
160778089|NCT04738487|580572092|FG000|Overall Study|Withdrawal by Subject|7|||
160778090|NCT04738487|580572093|FG001|Overall Study|Withdrawal by Subject|9|||
160778091|NCT04738487|580572092|FG000|Overall Study|Lost to Follow-up|2|||
160778092|NCT04738487|580572093|FG001|Overall Study|Lost to Follow-up|0|||
160778093|NCT04738487|580572092|FG000|Overall Study|Death|287|||
160778094|NCT04738487|580572093|FG001|Overall Study|Death|306|||
160778095|NCT04818112|580572094|FG000|Overall Study|Withdrawal by Subject|54|||
160778096|NCT04818112|580572095|FG001|Overall Study|Withdrawal by Subject|12|||
160778097|NCT04818112|580572094|FG000|Overall Study|Lost to Follow-up|38|||
160541613|NCT00805480|579711313|FG003|Overall Study|Withdrawal by Subject|5|||
160541614|NCT00805480|579711310|FG000|Overall Study|Lost to Follow-up|1|||
160541615|NCT00805480|579711311|FG001|Overall Study|Lost to Follow-up|2|||
160638095|NCT04682639|580059205|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160638096|NCT04682639|580059206|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160638097|NCT04682639|580059207|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160638098|NCT04682639|580059203|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
160638099|NCT04682639|580059204|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
160638100|NCT04682639|580059205|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
160638101|NCT04682639|580059206|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
160638102|NCT04682639|580059207|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
160638103|NCT04682639|580059203|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
160638104|NCT04682639|580059204|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
160638105|NCT04682639|580059205|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
160638106|NCT04682639|580059206|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
160638107|NCT04682639|580059207|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
160638108|NCT04682639|580059203|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
160541616|NCT00805480|579711312|FG002|Overall Study|Lost to Follow-up|0|||
160541617|NCT00805480|579711313|FG003|Overall Study|Lost to Follow-up|0|||
160541618|NCT00805480|579711310|FG000|Overall Study|Adverse Event|0|||
160541619|NCT00805480|579711311|FG001|Overall Study|Adverse Event|0|||
160541620|NCT00805480|579711312|FG002|Overall Study|Adverse Event|1|||
160541621|NCT00805480|579711313|FG003|Overall Study|Adverse Event|0|||
160541622|NCT02595450|579711316|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
160541623|NCT02595450|579711316|FG000|Overall Study|Enrolled, but not treated|8|||
160541624|NCT00733954|579711321|FG000|Overall Study|Lost to Follow-up|5|||
160541625|NCT00733954|579711322|FG001|Overall Study|Lost to Follow-up|2|||
160541626|NCT00733954|579711321|FG000|Overall Study|Protocol Violation|1|||
160541627|NCT00733954|579711322|FG001|Overall Study|Protocol Violation|0|||
160541628|NCT00733954|579711321|FG000|Overall Study|Withdrawal by Subject|2|||
160541629|NCT00733954|579711322|FG001|Overall Study|Withdrawal by Subject|0|||
160541630|NCT02663453|579711323|FG000|Overall Study|Death|4|||
160541631|NCT02663453|579711324|FG001|Overall Study|Death|4|||
160778098|NCT04818112|580572095|FG001|Overall Study|Lost to Follow-up|10|||
160778099|NCT00640289|580572096|FG000|Overall Study|Death|3|||
160778100|NCT00640289|580572096|FG000|Overall Study|Withdrawal by Subject|1|||
160778101|NCT00640289|580572096|FG000|Overall Study|Lost to Follow-up|1|||
160778102|NCT00640289|580572096|FG000|Overall Study|Data collected under different amendment|2|||
160778103|NCT00640289|580572096|FG000|Overall Study|Transferred to another center|1|||
160778104|NCT00640289|580572096|FG000|Overall Study|Missing status|5|||
160778105|NCT03550209|580572097|FG000|Overall Study|Lost to Follow-up|1|||
160778106|NCT03550209|580572098|FG001|Overall Study|Lost to Follow-up|0|||
160778107|NCT03550209|580572099|FG002|Overall Study|Lost to Follow-up|1|||
160778108|NCT03550209|580572100|FG003|Overall Study|Lost to Follow-up|0|||
160778109|NCT03550209|580572097|FG000|Overall Study|Withdrawal by Subject|0|||
160778110|NCT03550209|580572098|FG001|Overall Study|Withdrawal by Subject|3|||
160778111|NCT03550209|580572099|FG002|Overall Study|Withdrawal by Subject|1|||
160778112|NCT03550209|580572100|FG003|Overall Study|Withdrawal by Subject|2|||
160778113|NCT03550209|580572097|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
160778114|NCT03550209|580572098|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
160778115|NCT03550209|580572099|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
160778116|NCT03550209|580572100|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
160778117|NCT06170827|580572103|FG000|Overall Study|Withdrawal by Subject|1|||
160778118|NCT06170827|580572104|FG001|Overall Study|Withdrawal by Subject|1|||
160778119|NCT03599713|580572109|FG000|Overall Study|Death|38|||
160778120|NCT03599713|580572110|FG001|Overall Study|Death|3|||
160778121|NCT03599713|580572109|FG000|Overall Study|Withdrawal by Subject|17|||
160778122|NCT03599713|580572110|FG001|Overall Study|Withdrawal by Subject|0|||
160778123|NCT03599713|580572109|FG000|Overall Study|Lost to Follow-up|4|||
160778124|NCT03599713|580572110|FG001|Overall Study|Lost to Follow-up|0|||
160778125|NCT03599713|580572109|FG000|Overall Study|Discontinued Due to End of Study|42|||
160778126|NCT03599713|580572110|FG001|Overall Study|Discontinued Due to End of Study|3|||
160778127|NCT05578872|580572113|FG000|Overall Study|Withdrawal by Subject|2|||
160778128|NCT05578872|580572114|FG001|Overall Study|Withdrawal by Subject|1|||
160778129|NCT05578872|580572113|FG000|Overall Study|Adverse Event|1|||
160778130|NCT05578872|580572114|FG001|Overall Study|Adverse Event|1|||
160778131|NCT05578872|580572113|FG000|Overall Study|Physician Decision|1|||
160778132|NCT05578872|580572114|FG001|Overall Study|Physician Decision|2|||
160778133|NCT05578872|580572113|FG000|Overall Study|Progressive disease|10|||
160778134|NCT05578872|580572114|FG001|Overall Study|Progressive disease|9|||
160778135|NCT05578872|580572113|FG000|Overall Study|Sponsor decision|0|||
160778136|NCT05578872|580572114|FG001|Overall Study|Sponsor decision|1|||
160778137|NCT05578872|580572113|FG000|Overall Study|Toxicity and Patient's decision|0|||
160778138|NCT05578872|580572114|FG001|Overall Study|Toxicity and Patient's decision|1|||
160778139|NCT05643794|580573399|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
160778140|NCT05643794|580573400|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
160778141|NCT05643794|580573401|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
160778142|NCT05643794|580573399|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160778143|NCT05643794|580573400|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160778144|NCT05643794|580573401|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160778145|NCT05643794|580573399|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
160778146|NCT05643794|580573400|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
160778147|NCT05643794|580573401|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
160778148|NCT05643794|580573399|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
160778149|NCT05643794|580573400|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
160778150|NCT05643794|580573401|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
160778151|NCT05643794|580573399|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
160778152|NCT05643794|580573400|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
160778153|NCT05643794|580573401|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
160778154|NCT05643794|580573399|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
160778155|NCT05643794|580573400|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
160778156|NCT05643794|580573401|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
160778157|NCT03439839|580573404|FG000|Overall Study|Death|3|||
160778158|NCT03439839|580573405|FG001|Overall Study|Death|0|||
160778159|NCT03720847|580573406|FG000|Washout|Physician Decision|1|||
160778160|NCT03720847|580573407|FG001|Washout|Physician Decision|2|||
160778161|NCT03033901|580573411|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
160778162|NCT03033901|580573411|FG000|Overall Study|Refused PSG|23|||
160778163|NCT03033901|580573411|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
160778164|NCT03033901|580573411|FG000|Overall Study|Missing Oximetry Data|3|||
160778165|NCT00924651|580573414|FG000|Overall Study|Chemo started too soon|2|||
160778166|NCT00924651|580573415|FG001|Overall Study|Chemo started too soon|3|||
160778167|NCT00924651|580573414|FG000|Overall Study|No Reason|3|||
160778168|NCT00924651|580573415|FG001|Overall Study|No Reason|7|||
160778169|NCT00924651|580573414|FG000|Overall Study|Overwhelmed|6|||
160778170|NCT00924651|580573415|FG001|Overall Study|Overwhelmed|6|||
160778171|NCT00924651|580573414|FG000|Overall Study|Noncompliant|1|||
160778172|NCT00924651|580573415|FG001|Overall Study|Noncompliant|4|||
160778173|NCT00924651|580573414|FG000|Overall Study|Medical|1|||
160778174|NCT00924651|580573415|FG001|Overall Study|Medical|3|||
160778175|NCT00924651|580573414|FG000|Overall Study|Changed Mind|10|||
160778176|NCT00924651|580573415|FG001|Overall Study|Changed Mind|1|||
160778177|NCT00924651|580573414|FG000|Overall Study|Incomplete Form|2|||
160778178|NCT00924651|580573415|FG001|Overall Study|Incomplete Form|1|||
160778179|NCT00723944|580573416|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
160778180|NCT00723944|580573417|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
160778181|NCT00723944|580573416|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
160778182|NCT00723944|580573417|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
160778183|NCT00723944|580573416|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
160778184|NCT00723944|580573417|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
160778185|NCT01847209|580573418|FG000|Overall Study|Withdrawal by Subject|1|||
160778186|NCT01847209|580573418|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
160778187|NCT00729586|580573419|FG000|Overall Study|Ineligible|0|||
160778188|NCT00729586|580573420|FG001|Overall Study|Ineligible|1|||
160778189|NCT00729586|580573419|FG000|Overall Study|never treated|1|||
160778190|NCT00729586|580573420|FG001|Overall Study|never treated|0|||
160541632|NCT02663453|579711323|FG000|Overall Study|Withdrawal by Subject|1|||
160541633|NCT02663453|579711324|FG001|Overall Study|Withdrawal by Subject|0|||
160778191|NCT02513199|580573423|FG000|Treatment|Death|1|||
160778192|NCT02513199|580573423|FG000|Treatment|Lost to Follow-up|1|||
160778193|NCT02513199|580573423|FG000|Follow-Up|Death|11|||
160778194|NCT00835978|580573424|FG000|Overall Study|Death|33|||
160778195|NCT00835978|580573425|FG001|Overall Study|Death|40|||
160778196|NCT00835978|580573426|FG002|Overall Study|Death|49|||
160778197|NCT00835978|580573427|FG003|Overall Study|Death|4|||
160778198|NCT00835978|580573424|FG000|Overall Study|Lost to Follow-up|3|||
160778199|NCT00835978|580573425|FG001|Overall Study|Lost to Follow-up|4|||
160778200|NCT00835978|580573426|FG002|Overall Study|Lost to Follow-up|2|||
160778201|NCT00835978|580573427|FG003|Overall Study|Lost to Follow-up|1|||
160778202|NCT00835978|580573424|FG000|Overall Study|Other|5|||
160778203|NCT00835978|580573425|FG001|Overall Study|Other|1|||
160778204|NCT00835978|580573426|FG002|Overall Study|Other|8|||
160778205|NCT00835978|580573427|FG003|Overall Study|Other|0|||
160778206|NCT00835978|580573424|FG000|Overall Study|Objective progression or relapse|2|||
160778207|NCT00835978|580573425|FG001|Overall Study|Objective progression or relapse|0|||
160778208|NCT00835978|580573426|FG002|Overall Study|Objective progression or relapse|1|||
160778209|NCT00835978|580573427|FG003|Overall Study|Objective progression or relapse|0|||
160778210|NCT00835978|580573424|FG000|Overall Study|Adverse Event|1|||
160778211|NCT00835978|580573425|FG001|Overall Study|Adverse Event|0|||
160778212|NCT00835978|580573426|FG002|Overall Study|Adverse Event|1|||
160778213|NCT00835978|580573427|FG003|Overall Study|Adverse Event|0|||
160778214|NCT00835978|580573424|FG000|Overall Study|Withdrawal by Subject|0|||
160778215|NCT00835978|580573425|FG001|Overall Study|Withdrawal by Subject|3|||
160778216|NCT00835978|580573426|FG002|Overall Study|Withdrawal by Subject|0|||
160778217|NCT00835978|580573427|FG003|Overall Study|Withdrawal by Subject|5|||
160778218|NCT00835978|580573424|FG000|Overall Study|Study terminated by sponsor|12|||
160778219|NCT00835978|580573425|FG001|Overall Study|Study terminated by sponsor|8|||
160778220|NCT00835978|580573426|FG002|Overall Study|Study terminated by sponsor|30|||
160778221|NCT00835978|580573427|FG003|Overall Study|Study terminated by sponsor|0|||
160778222|NCT03298061|580573431|FG000|Overall Study|Adverse Event|3|||
160778223|NCT03298061|580573431|FG000|Overall Study|Lack of Efficacy|6|||
160886975|NCT04090411|580980643|FG008|Induction Period|Protocol Violation|0|||
160541634|NCT03770260|579712783|FG000|Overall Study|Disease progression|0|||
160778224|NCT03298061|580573431|FG000|Overall Study|Protocol Violation|1|||
160778225|NCT03298061|580573431|FG000|Overall Study|Physician Decision|7|||
160778226|NCT03298061|580573431|FG000|Overall Study|Withdrawal by Subject|10|||
160541635|NCT03770260|579712784|FG001|Overall Study|Disease progression|1|||
160541636|NCT03770260|579712785|FG002|Overall Study|Disease progression|0|||
160541637|NCT03770260|579712786|FG003|Overall Study|Disease progression|0|||
160778227|NCT04307394|580573432|FG000|Overall Study|Lost to Follow-up|3|||
160778228|NCT04307394|580573432|FG000|Overall Study|Withdrawal by Subject|2|||
160778229|NCT01410604|580573433|FG000|Overall Study|Adverse Event|2|||
160778230|NCT01410604|580573434|FG001|Overall Study|Adverse Event|1|||
160778231|NCT01410604|580573433|FG000|Overall Study|Lost to Follow-up|1|||
160541638|NCT03040999|579712787|FG000|Overall Study|Lost to Follow-up|2|||
160778232|NCT01410604|580573434|FG001|Overall Study|Lost to Follow-up|0|||
160778233|NCT01410604|580573433|FG000|Overall Study|Physician Decision|0|||
160778234|NCT01410604|580573434|FG001|Overall Study|Physician Decision|1|||
160778235|NCT00800540|580573439|FG000|Period One: 6 Weeks|Noncompliance|1|||
160778236|NCT00800540|580573440|FG001|Period One: 6 Weeks|Noncompliance|0|||
160778237|NCT00800540|580573439|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
160778238|NCT00800540|580573440|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
160778239|NCT00800540|580573439|FG000|Period 2: 6 Weeks|Adverse Event|0|||
160778240|NCT00800540|580573440|FG001|Period 2: 6 Weeks|Adverse Event|1|||
160778241|NCT04871113|580573441|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778242|NCT04871113|580573442|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778243|NCT04871113|580573443|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778244|NCT04871113|580573444|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778245|NCT04871113|580573445|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778246|NCT04871113|580573446|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
160778247|NCT04871113|580573447|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778248|NCT04871113|580573448|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778249|NCT04871113|580573449|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778250|NCT04871113|580573450|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778251|NCT04871113|580573441|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778252|NCT04871113|580573442|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778253|NCT04871113|580573443|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778254|NCT04871113|580573444|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778255|NCT04871113|580573445|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778256|NCT04871113|580573446|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778257|NCT04871113|580573447|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
160778258|NCT04871113|580573448|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
160778259|NCT04871113|580573449|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778260|NCT04871113|580573450|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778261|NCT01946802|580573455|FG000|Overall Study|Death|1|||
160778262|NCT01946802|580573455|FG000|Overall Study|Withdrawal by Subject|2|||
160778263|NCT01946802|580573455|FG000|Overall Study|Combined septic shock|1|||
160778264|NCT01946802|580573455|FG000|Overall Study|Protocol Violation|1|||
160778265|NCT00153920|580573456|FG000|Overall Study|Adverse Event|9|||
160778266|NCT00153920|580573456|FG000|Overall Study|Progressive Disease|9|||
160778267|NCT00153920|580573456|FG000|Overall Study|Physician Decision|3|||
160778268|NCT00153920|580573456|FG000|Overall Study|Lack of Response|3|||
160778269|NCT00153920|580573456|FG000|Overall Study|Death|2|||
160778270|NCT00153920|580573456|FG000|Overall Study|Withdrawal by Subject|1|||
160778271|NCT00153920|580573456|FG000|Overall Study|Non-Protocol Therapy|1|||
160778272|NCT00153920|580573456|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
160778273|NCT00153920|580573456|FG000|Overall Study|Progressive Disease before Trt|1|||
160778274|NCT00827242|580573458|FG000|Overall Study|Withdrawal by Subject|2|||
160778275|NCT00827242|580573459|FG001|Overall Study|Withdrawal by Subject|4|||
160778276|NCT00827242|580573458|FG000|Overall Study|Protocol Violation|1|||
160778277|NCT00827242|580573459|FG001|Overall Study|Protocol Violation|3|||
160778278|NCT00827242|580573458|FG000|Overall Study|Lost to Follow-up|0|||
160778279|NCT00827242|580573459|FG001|Overall Study|Lost to Follow-up|3|||
160778280|NCT00827242|580573458|FG000|Overall Study|Adverse Event Excluding Death|2|||
160778281|NCT00827242|580573459|FG001|Overall Study|Adverse Event Excluding Death|1|||
160778282|NCT00827242|580573458|FG000|Overall Study|Entry Criteria Not Met|4|||
160778283|NCT00827242|580573459|FG001|Overall Study|Entry Criteria Not Met|1|||
160778284|NCT00827242|580573458|FG000|Overall Study|Physician Decision|2|||
160778285|NCT00827242|580573459|FG001|Overall Study|Physician Decision|0|||
160778286|NCT00827242|580573458|FG000|Overall Study|Death|1|||
160778287|NCT00827242|580573459|FG001|Overall Study|Death|0|||
160778288|NCT00827242|580573458|FG000|Overall Study|Lack of Efficacy|1|||
160778289|NCT00827242|580573459|FG001|Overall Study|Lack of Efficacy|0|||
160778290|NCT05762679|580573460|FG000|Overall Study|Withdrawal by Subject|1|||
160778291|NCT05762679|580573460|FG000|Overall Study|No analyzable imaging data|1|||
160778292|NCT01479530|580573465|FG000|Overall Study|Adverse Event|5|||
160778293|NCT01479530|580573466|FG001|Overall Study|Adverse Event|6|||
160778294|NCT01479530|580573465|FG000|Overall Study|Lack of Efficacy|0|||
160778295|NCT01479530|580573466|FG001|Overall Study|Lack of Efficacy|1|||
160778296|NCT01479530|580573465|FG000|Overall Study|Protocol Violation|2|||
160541639|NCT03040999|579712788|FG001|Overall Study|Lost to Follow-up|2|||
160541640|NCT03040999|579712787|FG000|Overall Study|Withdrawal by Subject|12|||
160541641|NCT03040999|579712788|FG001|Overall Study|Withdrawal by Subject|13|||
160541642|NCT03040999|579712787|FG000|Overall Study|Death|155|||
160541643|NCT03040999|579712788|FG001|Overall Study|Death|171|||
160541644|NCT03040999|579712787|FG000|Overall Study|Physician Decision|0|||
160541645|NCT03040999|579712788|FG001|Overall Study|Physician Decision|3|||
160541646|NCT01964352|579712795|FG000|Overall Study|Adverse Event|13|||
160541647|NCT01964352|579712796|FG001|Overall Study|Adverse Event|3|||
160541648|NCT01964352|579712797|FG002|Overall Study|Adverse Event|4|||
160541649|NCT01964352|579712798|FG003|Overall Study|Adverse Event|3|||
160541650|NCT01964352|579712795|FG000|Overall Study|Lack of Efficacy|6|||
160541651|NCT01964352|579712796|FG001|Overall Study|Lack of Efficacy|0|||
160541652|NCT01964352|579712797|FG002|Overall Study|Lack of Efficacy|0|||
160541653|NCT01964352|579712798|FG003|Overall Study|Lack of Efficacy|0|||
160541654|NCT01964352|579712795|FG000|Overall Study|Protocol Violation|2|||
160541655|NCT01964352|579712796|FG001|Overall Study|Protocol Violation|4|||
160541656|NCT01964352|579712797|FG002|Overall Study|Protocol Violation|0|||
160541657|NCT01964352|579712798|FG003|Overall Study|Protocol Violation|2|||
160541658|NCT01964352|579712795|FG000|Overall Study|Lost to Follow-up|1|||
160541659|NCT01964352|579712796|FG001|Overall Study|Lost to Follow-up|0|||
160541660|NCT01964352|579712797|FG002|Overall Study|Lost to Follow-up|0|||
160541661|NCT01964352|579712798|FG003|Overall Study|Lost to Follow-up|1|||
160541662|NCT01964352|579712795|FG000|Overall Study|Withdrawal by Subject|4|||
160541663|NCT01964352|579712796|FG001|Overall Study|Withdrawal by Subject|2|||
160541664|NCT01964352|579712797|FG002|Overall Study|Withdrawal by Subject|1|||
160541665|NCT01964352|579712798|FG003|Overall Study|Withdrawal by Subject|0|||
160541666|NCT01964352|579712795|FG000|Overall Study|Other than stated above|0|||
160541667|NCT01964352|579712796|FG001|Overall Study|Other than stated above|2|||
160541668|NCT01964352|579712797|FG002|Overall Study|Other than stated above|1|||
160541669|NCT01964352|579712798|FG003|Overall Study|Other than stated above|2|||
160541670|NCT01908101|579712799|FG000|Overall Study|Physician Decision|1|||
160541671|NCT01908101|579712799|FG000|Overall Study|Withdrawal by Subject|1|||
160541672|NCT01908101|579712799|FG000|Overall Study|Incorrect Diagnosis|2|||
160541673|NCT01908101|579712799|FG000|Overall Study|Incorrect Starting Dose|1|||
160778297|NCT01479530|580573466|FG001|Overall Study|Protocol Violation|3|||
160778298|NCT01479530|580573465|FG000|Overall Study|Withdrawal of Consent|3|||
160778299|NCT01479530|580573466|FG001|Overall Study|Withdrawal of Consent|2|||
160778300|NCT04795323|580573467|FG000|Overall Study|Did not interact with TARA|1|||
160778301|NCT04795323|580573468|FG001|Overall Study|Did not interact with TARA|0|||
160778302|NCT00933166|580573471|FG000|Overall Study|Lost to Follow-up|4|||
160778303|NCT00933166|580573471|FG000|Overall Study|Lack of Efficacy|9|||
160778304|NCT00933166|580573471|FG000|Overall Study|Unavailable|4|||
160778305|NCT00933166|580573471|FG000|Overall Study|Withdrawal by Subject|1|||
160778306|NCT01944774|580573472|FG000|Overall Study|Withdrawal by Subject|2|||
160778307|NCT01944774|580573473|FG001|Overall Study|Withdrawal by Subject|3|||
160778308|NCT01944774|580573474|FG002|Overall Study|Withdrawal by Subject|3|||
160541674|NCT01908101|579712799|FG000|Overall Study|Did not complete the first cycle|4|||
160541675|NCT01394939|579712800|FG000|Overall Study|Adverse Event|1|||
160541676|NCT01394939|579712801|FG001|Overall Study|Adverse Event|3|||
160541677|NCT01394939|579712802|FG002|Overall Study|Adverse Event|0|||
160541678|NCT01394939|579712803|FG003|Overall Study|Adverse Event|2|||
160778309|NCT01944774|580573472|FG000|Overall Study|Adverse Event|3|||
160778310|NCT01944774|580573473|FG001|Overall Study|Adverse Event|2|||
160778311|NCT01944774|580573474|FG002|Overall Study|Adverse Event|3|||
160778312|NCT01944774|580573472|FG000|Overall Study|Lack of Efficacy|1|||
160778313|NCT01944774|580573473|FG001|Overall Study|Lack of Efficacy|2|||
160778314|NCT01944774|580573474|FG002|Overall Study|Lack of Efficacy|2|||
160541679|NCT01394939|579712800|FG000|Overall Study|Death|0|||
160541680|NCT01394939|579712801|FG001|Overall Study|Death|2|||
160541681|NCT01394939|579712802|FG002|Overall Study|Death|0|||
160541682|NCT01394939|579712803|FG003|Overall Study|Death|0|||
160541683|NCT01394939|579712800|FG000|Overall Study|Physician Decision|0|||
160541684|NCT01394939|579712801|FG001|Overall Study|Physician Decision|1|||
160541685|NCT01394939|579712802|FG002|Overall Study|Physician Decision|0|||
160541686|NCT01394939|579712803|FG003|Overall Study|Physician Decision|0|||
160541687|NCT01394939|579712800|FG000|Overall Study|Withdrawal by Subject|0|||
160541688|NCT01394939|579712801|FG001|Overall Study|Withdrawal by Subject|2|||
160541689|NCT01394939|579712802|FG002|Overall Study|Withdrawal by Subject|0|||
160541690|NCT01394939|579712803|FG003|Overall Study|Withdrawal by Subject|2|||
160541691|NCT01394939|579712800|FG000|Overall Study|Others|0|||
160541692|NCT01394939|579712801|FG001|Overall Study|Others|2|||
160541693|NCT01394939|579712802|FG002|Overall Study|Others|0|||
160541694|NCT01394939|579712803|FG003|Overall Study|Others|3|||
160541695|NCT01097746|579712807|FG000|Overall Study|Adverse Event|4|||
160541696|NCT01097746|579712807|FG000|Overall Study|taken off study before any treatment given|1|||
160541697|NCT01659320|579712812|FG000|Overall Study|Withdrawal by Subject|2|||
160541698|NCT01659320|579712812|FG000|Overall Study|Physician Decision|1|||
160541699|NCT01514682|579712813|FG000|Overall Study|Withdrawal by Subject|2|||
160541700|NCT01514682|579712814|FG001|Overall Study|Withdrawal by Subject|3|||
160541701|NCT01514682|579712813|FG000|Overall Study|Physician Decision|4|||
160541702|NCT01514682|579712814|FG001|Overall Study|Physician Decision|3|||
160541703|NCT00590590|579712815|FG000|Overall Study|Lack of Efficacy|1|||
160541704|NCT00590590|579712816|FG001|Overall Study|Lack of Efficacy|2|||
160541705|NCT00590590|579712817|FG002|Overall Study|Lack of Efficacy|0|||
160541706|NCT00590590|579712815|FG000|Overall Study|Adverse Event|1|||
160541707|NCT00590590|579712816|FG001|Overall Study|Adverse Event|0|||
160541708|NCT00590590|579712817|FG002|Overall Study|Adverse Event|0|||
160541709|NCT00590590|579712815|FG000|Overall Study|Protocol Violation|0|||
160541710|NCT00590590|579712816|FG001|Overall Study|Protocol Violation|0|||
160541711|NCT00590590|579712817|FG002|Overall Study|Protocol Violation|2|||
160541712|NCT00590590|579712815|FG000|Overall Study|Lost to Follow-up|4|||
160541713|NCT00590590|579712816|FG001|Overall Study|Lost to Follow-up|1|||
160541714|NCT00590590|579712817|FG002|Overall Study|Lost to Follow-up|2|||
160541715|NCT00590590|579712815|FG000|Overall Study|Withdrawal by Subject|0|||
160541716|NCT00590590|579712816|FG001|Overall Study|Withdrawal by Subject|1|||
160541717|NCT00590590|579712817|FG002|Overall Study|Withdrawal by Subject|1|||
160541718|NCT00590590|579712815|FG000|Overall Study|Did not complete due to study closure|1|||
160541719|NCT00590590|579712816|FG001|Overall Study|Did not complete due to study closure|1|||
160541720|NCT00590590|579712817|FG002|Overall Study|Did not complete due to study closure|1|||
160541721|NCT00590590|579712815|FG000|Overall Study|Did not complete study|0|||
160541722|NCT00590590|579712816|FG001|Overall Study|Did not complete study|1|||
160541723|NCT00590590|579712817|FG002|Overall Study|Did not complete study|0|||
160541724|NCT03605680|579712819|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
160541725|NCT03605680|579712820|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
160541726|NCT03605680|579712821|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
160541727|NCT03605680|579712822|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
160541728|NCT03605680|579712819|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
160541729|NCT03605680|579712820|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
160541730|NCT03605680|579712821|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
160541731|NCT03605680|579712822|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
160541732|NCT03605680|579712819|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
160541733|NCT03605680|579712820|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
160541734|NCT03605680|579712821|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
160541735|NCT03605680|579712822|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
160541736|NCT03605680|579712819|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
160541737|NCT03605680|579712820|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
160541738|NCT03605680|579712821|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
160541739|NCT03605680|579712822|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
160541740|NCT03605680|579712819|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
160541741|NCT03605680|579712820|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
160541742|NCT03605680|579712821|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
160541743|NCT03605680|579712822|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
160541744|NCT03605680|579712819|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
160541745|NCT03605680|579712820|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
160541746|NCT03605680|579712821|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
160541747|NCT03605680|579712822|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
160541748|NCT03605680|579712819|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
160541749|NCT03605680|579712820|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
160541750|NCT03605680|579712821|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
160541751|NCT03605680|579712822|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
160541752|NCT03605680|579712819|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
160541753|NCT03605680|579712820|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
160541754|NCT03605680|579712821|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
160778315|NCT01944774|580573472|FG000|Overall Study|Lost to Follow-up|0|||
160778316|NCT01944774|580573473|FG001|Overall Study|Lost to Follow-up|1|||
160778317|NCT01944774|580573474|FG002|Overall Study|Lost to Follow-up|0|||
160778318|NCT00774748|580573475|FG000|Overall Study|Lost to Follow-up|3|||
160778319|NCT02965456|580573476|FG000|Overall Study|Lost to Follow-up|40|||
160778320|NCT02965456|580573477|FG001|Overall Study|Lost to Follow-up|18|||
160778321|NCT02965456|580573476|FG000|Overall Study|Subject Request|22|||
160778322|NCT02965456|580573477|FG001|Overall Study|Subject Request|13|||
160778323|NCT02965456|580573476|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
160778324|NCT02965456|580573477|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
160778325|NCT02965456|580573476|FG000|Overall Study|Adverse Event|3|||
160778326|NCT02965456|580573477|FG001|Overall Study|Adverse Event|0|||
160778327|NCT02965456|580573476|FG000|Overall Study|Noncompliance with Study Drug|1|||
160778328|NCT02965456|580573477|FG001|Overall Study|Noncompliance with Study Drug|1|||
160778329|NCT02965456|580573476|FG000|Overall Study|Worsening Condition|0|||
160778330|NCT02965456|580573477|FG001|Overall Study|Worsening Condition|2|||
160778331|NCT02965456|580573476|FG000|Overall Study|Lack of Efficacy|1|||
160778332|NCT02965456|580573477|FG001|Overall Study|Lack of Efficacy|0|||
160778333|NCT02965456|580573476|FG000|Overall Study|Physician Decision|0|||
160778334|NCT02965456|580573477|FG001|Overall Study|Physician Decision|1|||
160778335|NCT02965456|580573476|FG000|Overall Study|Pregnancy|1|||
160778336|NCT02965456|580573477|FG001|Overall Study|Pregnancy|0|||
160778337|NCT02965456|580573476|FG000|Overall Study|Protocol Violation|0|||
160778338|NCT02965456|580573477|FG001|Overall Study|Protocol Violation|1|||
160778339|NCT02965456|580573476|FG000|Overall Study|Participant ran out of study drug|0|||
160778340|NCT02965456|580573477|FG001|Overall Study|Participant ran out of study drug|1|||
160778341|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
160778342|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
160778343|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
160778344|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Death|1|||
160541755|NCT03605680|579712822|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
160778345|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Death|0|||
160778346|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Death|0|||
160778347|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
160886976|NCT04090411|580980644|FG009|Induction Period|Protocol Violation|0|||
160886977|NCT04090411|580980645|FG010|Induction Period|Protocol Violation|0|||
160886978|NCT04090411|580980646|FG011|Induction Period|Protocol Violation|0|||
160886979|NCT04090411|580980647|FG012|Induction Period|Protocol Violation|0|||
160886980|NCT04090411|580980635|FG000|Induction Period|Withdrawal by Subject|2|||
160886981|NCT04090411|580980636|FG001|Induction Period|Withdrawal by Subject|0|||
160886982|NCT04090411|580980637|FG002|Induction Period|Withdrawal by Subject|1|||
160886983|NCT04090411|580980638|FG003|Induction Period|Withdrawal by Subject|5|||
160886984|NCT04090411|580980639|FG004|Induction Period|Withdrawal by Subject|0|||
160886985|NCT04090411|580980640|FG005|Induction Period|Withdrawal by Subject|0|||
160886986|NCT04090411|580980641|FG006|Induction Period|Withdrawal by Subject|0|||
160886987|NCT04090411|580980642|FG007|Induction Period|Withdrawal by Subject|0|||
160886988|NCT04090411|580980643|FG008|Induction Period|Withdrawal by Subject|0|||
160886989|NCT04090411|580980644|FG009|Induction Period|Withdrawal by Subject|0|||
160886990|NCT04090411|580980645|FG010|Induction Period|Withdrawal by Subject|0|||
160886991|NCT04090411|580980646|FG011|Induction Period|Withdrawal by Subject|0|||
160886992|NCT04090411|580980647|FG012|Induction Period|Withdrawal by Subject|0|||
160886993|NCT04090411|580980635|FG000|Chronic Period|Adverse Event|0|||
160886994|NCT04090411|580980636|FG001|Chronic Period|Adverse Event|0|||
160886995|NCT04090411|580980637|FG002|Chronic Period|Adverse Event|0|||
160886996|NCT04090411|580980638|FG003|Chronic Period|Adverse Event|0|||
160886997|NCT04090411|580980639|FG004|Chronic Period|Adverse Event|0|||
160886998|NCT04090411|580980640|FG005|Chronic Period|Adverse Event|1|||
160886999|NCT04090411|580980641|FG006|Chronic Period|Adverse Event|0|||
160541756|NCT03605680|579712819|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
160541757|NCT03605680|579712820|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
160887000|NCT04090411|580980642|FG007|Chronic Period|Adverse Event|3|||
160887001|NCT04090411|580980643|FG008|Chronic Period|Adverse Event|0|||
160887002|NCT04090411|580980644|FG009|Chronic Period|Adverse Event|0|||
160541758|NCT03605680|579712821|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
160778348|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
160778349|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
160778350|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
160778351|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
160778352|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
160778353|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
160778354|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
160887003|NCT04090411|580980645|FG010|Chronic Period|Adverse Event|5|||
160887004|NCT04090411|580980646|FG011|Chronic Period|Adverse Event|1|||
160638109|NCT04682639|580059204|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
160638110|NCT04682639|580059205|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
160638111|NCT04682639|580059206|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
160638112|NCT04682639|580059207|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
160638113|NCT04682639|580059203|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
160638114|NCT04682639|580059204|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
160638115|NCT04682639|580059205|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
160638116|NCT04682639|580059206|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
160638117|NCT04682639|580059207|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
160638118|NCT04682639|580059203|FG000|OLE Period (28 Weeks)|Other|1|||
160638119|NCT04682639|580059204|FG001|OLE Period (28 Weeks)|Other|2|||
160638120|NCT04682639|580059205|FG002|OLE Period (28 Weeks)|Other|0|||
160638121|NCT04682639|580059206|FG003|OLE Period (28 Weeks)|Other|0|||
160638122|NCT04682639|580059207|FG004|OLE Period (28 Weeks)|Other|1|||
160638123|NCT04682639|580059203|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
160638124|NCT04682639|580059204|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
160638125|NCT04682639|580059205|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
160638126|NCT04682639|580059206|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
160638127|NCT04682639|580059207|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
160638128|NCT04682639|580059203|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
160638129|NCT04682639|580059204|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
160638130|NCT04682639|580059205|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
160638131|NCT04682639|580059206|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
160638132|NCT04682639|580059207|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
160638133|NCT04682639|580059203|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
160638134|NCT04682639|580059204|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
160638135|NCT04682639|580059205|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
160638136|NCT04682639|580059206|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
160638137|NCT04682639|580059207|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
160638138|NCT04682639|580059203|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
160638139|NCT04682639|580059204|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
160638140|NCT04682639|580059205|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
160638141|NCT04682639|580059206|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
160638142|NCT04682639|580059207|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
160638143|NCT02773446|580059208|FG000|First Admission|Withdrawal by Subject|0|||
160638144|NCT02773446|580059209|FG001|First Admission|Withdrawal by Subject|0|||
160638145|NCT02773446|580059210|FG002|First Admission|Withdrawal by Subject|0|||
160638146|NCT02773446|580059211|FG003|First Admission|Withdrawal by Subject|1|||
160638147|NCT02773446|580059212|FG004|First Admission|Withdrawal by Subject|0|||
160638148|NCT02773446|580059213|FG005|First Admission|Withdrawal by Subject|0|||
160638149|NCT02773446|580059208|FG000|First Admission|Lost to Follow-up|1|||
160638150|NCT02773446|580059209|FG001|First Admission|Lost to Follow-up|0|||
160638151|NCT02773446|580059210|FG002|First Admission|Lost to Follow-up|0|||
160638152|NCT02773446|580059211|FG003|First Admission|Lost to Follow-up|0|||
160638153|NCT02773446|580059212|FG004|First Admission|Lost to Follow-up|0|||
160638154|NCT02773446|580059213|FG005|First Admission|Lost to Follow-up|0|||
160638155|NCT01613131|580059214|FG000|Overall Study|Withdrawal by Subject|3|||
160638156|NCT01613131|580059215|FG001|Overall Study|Withdrawal by Subject|5|||
160638157|NCT02454972|580059216|FG000|Overall Study|Progressive disease|17|||
160638158|NCT02454972|580059217|FG001|Overall Study|Progressive disease|16|||
160638159|NCT02454972|580059218|FG002|Overall Study|Progressive disease|59|||
160638160|NCT02454972|580059219|FG003|Overall Study|Progressive disease|23|||
160638161|NCT02454972|580059220|FG004|Overall Study|Progressive disease|16|||
160638162|NCT02454972|580059221|FG005|Overall Study|Progressive disease|12|||
160638163|NCT02454972|580059222|FG006|Overall Study|Progressive disease|19|||
160638164|NCT02454972|580059223|FG007|Overall Study|Progressive disease|27|||
160638165|NCT02454972|580059224|FG008|Overall Study|Progressive disease|0|||
160638166|NCT02454972|580059216|FG000|Overall Study|Death|0|||
160638167|NCT02454972|580059217|FG001|Overall Study|Death|0|||
160638168|NCT02454972|580059218|FG002|Overall Study|Death|5|||
160638169|NCT02454972|580059219|FG003|Overall Study|Death|1|||
160638170|NCT02454972|580059220|FG004|Overall Study|Death|0|||
160638171|NCT02454972|580059221|FG005|Overall Study|Death|0|||
160638172|NCT02454972|580059222|FG006|Overall Study|Death|0|||
160638173|NCT02454972|580059223|FG007|Overall Study|Death|0|||
160638174|NCT02454972|580059224|FG008|Overall Study|Death|95|||
160638175|NCT02454972|580059216|FG000|Overall Study|Physician Decision|0|||
160638176|NCT02454972|580059217|FG001|Overall Study|Physician Decision|1|||
160887005|NCT04090411|580980647|FG012|Chronic Period|Adverse Event|1|||
160638177|NCT02454972|580059218|FG002|Overall Study|Physician Decision|2|||
160638178|NCT02454972|580059219|FG003|Overall Study|Physician Decision|1|||
160638179|NCT02454972|580059220|FG004|Overall Study|Physician Decision|2|||
160638180|NCT02454972|580059221|FG005|Overall Study|Physician Decision|0|||
160638181|NCT02454972|580059222|FG006|Overall Study|Physician Decision|0|||
160638182|NCT02454972|580059223|FG007|Overall Study|Physician Decision|1|||
160638183|NCT02454972|580059224|FG008|Overall Study|Physician Decision|0|||
160638184|NCT02454972|580059216|FG000|Overall Study|Non treatment-related adverse event|2|||
160638185|NCT02454972|580059217|FG001|Overall Study|Non treatment-related adverse event|0|||
160638186|NCT02454972|580059218|FG002|Overall Study|Non treatment-related adverse event|1|||
160638187|NCT02454972|580059219|FG003|Overall Study|Non treatment-related adverse event|0|||
160638188|NCT02454972|580059220|FG004|Overall Study|Non treatment-related adverse event|0|||
160638189|NCT02454972|580059221|FG005|Overall Study|Non treatment-related adverse event|1|||
160638190|NCT02454972|580059222|FG006|Overall Study|Non treatment-related adverse event|0|||
160638191|NCT02454972|580059223|FG007|Overall Study|Non treatment-related adverse event|1|||
160638192|NCT02454972|580059224|FG008|Overall Study|Non treatment-related adverse event|0|||
160638193|NCT02454972|580059216|FG000|Overall Study|Treatment-related adverse events|0|||
160638194|NCT02454972|580059217|FG001|Overall Study|Treatment-related adverse events|1|||
160638195|NCT02454972|580059218|FG002|Overall Study|Treatment-related adverse events|1|||
160638196|NCT02454972|580059219|FG003|Overall Study|Treatment-related adverse events|0|||
160638197|NCT02454972|580059220|FG004|Overall Study|Treatment-related adverse events|2|||
160638198|NCT02454972|580059221|FG005|Overall Study|Treatment-related adverse events|0|||
160638199|NCT02454972|580059222|FG006|Overall Study|Treatment-related adverse events|0|||
160638200|NCT02454972|580059223|FG007|Overall Study|Treatment-related adverse events|2|||
160638201|NCT02454972|580059224|FG008|Overall Study|Treatment-related adverse events|0|||
160638202|NCT02454972|580059216|FG000|Overall Study|Patient moves to compassionate use|0|||
160638203|NCT02454972|580059217|FG001|Overall Study|Patient moves to compassionate use|0|||
160638204|NCT02454972|580059218|FG002|Overall Study|Patient moves to compassionate use|0|||
160638205|NCT02454972|580059219|FG003|Overall Study|Patient moves to compassionate use|0|||
160638206|NCT02454972|580059220|FG004|Overall Study|Patient moves to compassionate use|0|||
160638207|NCT02454972|580059221|FG005|Overall Study|Patient moves to compassionate use|0|||
160638208|NCT02454972|580059222|FG006|Overall Study|Patient moves to compassionate use|2|||
160638209|NCT02454972|580059223|FG007|Overall Study|Patient moves to compassionate use|0|||
160638210|NCT02454972|580059224|FG008|Overall Study|Patient moves to compassionate use|0|||
160638211|NCT02454972|580059216|FG000|Overall Study|Withdrawal by Subject|0|||
160638212|NCT02454972|580059217|FG001|Overall Study|Withdrawal by Subject|1|||
160638213|NCT02454972|580059218|FG002|Overall Study|Withdrawal by Subject|5|||
160638214|NCT02454972|580059219|FG003|Overall Study|Withdrawal by Subject|2|||
160638215|NCT02454972|580059220|FG004|Overall Study|Withdrawal by Subject|3|||
160638216|NCT02454972|580059221|FG005|Overall Study|Withdrawal by Subject|2|||
160638217|NCT02454972|580059222|FG006|Overall Study|Withdrawal by Subject|0|||
160638218|NCT02454972|580059223|FG007|Overall Study|Withdrawal by Subject|1|||
160638219|NCT02454972|580059224|FG008|Overall Study|Withdrawal by Subject|2|||
160638220|NCT02454972|580059216|FG000|Overall Study|Multiple delay/holds on treatment|0|||
160638221|NCT02454972|580059217|FG001|Overall Study|Multiple delay/holds on treatment|0|||
160638222|NCT02454972|580059218|FG002|Overall Study|Multiple delay/holds on treatment|0|||
160638223|NCT02454972|580059219|FG003|Overall Study|Multiple delay/holds on treatment|1|||
160638224|NCT02454972|580059220|FG004|Overall Study|Multiple delay/holds on treatment|0|||
160638225|NCT02454972|580059221|FG005|Overall Study|Multiple delay/holds on treatment|0|||
160638226|NCT02454972|580059222|FG006|Overall Study|Multiple delay/holds on treatment|0|||
160638227|NCT02454972|580059223|FG007|Overall Study|Multiple delay/holds on treatment|0|||
160638228|NCT02454972|580059224|FG008|Overall Study|Multiple delay/holds on treatment|0|||
160638229|NCT02454972|580059216|FG000|Overall Study|Never treated|0|||
160638230|NCT02454972|580059217|FG001|Overall Study|Never treated|0|||
160638231|NCT02454972|580059218|FG002|Overall Study|Never treated|3|||
160638232|NCT02454972|580059219|FG003|Overall Study|Never treated|1|||
160638233|NCT02454972|580059220|FG004|Overall Study|Never treated|1|||
160638234|NCT02454972|580059221|FG005|Overall Study|Never treated|0|||
160638235|NCT02454972|580059222|FG006|Overall Study|Never treated|0|||
160638236|NCT02454972|580059223|FG007|Overall Study|Never treated|0|||
160638237|NCT02454972|580059224|FG008|Overall Study|Never treated|5|||
160638238|NCT02454972|580059216|FG000|Overall Study|Lost to Follow-up|0|||
160638239|NCT02454972|580059217|FG001|Overall Study|Lost to Follow-up|0|||
160638240|NCT02454972|580059218|FG002|Overall Study|Lost to Follow-up|0|||
160638241|NCT02454972|580059219|FG003|Overall Study|Lost to Follow-up|0|||
160638242|NCT02454972|580059220|FG004|Overall Study|Lost to Follow-up|0|||
160638243|NCT02454972|580059221|FG005|Overall Study|Lost to Follow-up|0|||
160638244|NCT02454972|580059222|FG006|Overall Study|Lost to Follow-up|0|||
160638245|NCT02454972|580059223|FG007|Overall Study|Lost to Follow-up|0|||
160638246|NCT02454972|580059224|FG008|Overall Study|Lost to Follow-up|2|||
160638247|NCT02454972|580059216|FG000|Overall Study|Study termination|0|||
160638248|NCT02454972|580059217|FG001|Overall Study|Study termination|0|||
160638249|NCT02454972|580059218|FG002|Overall Study|Study termination|0|||
160638250|NCT02454972|580059219|FG003|Overall Study|Study termination|0|||
160638251|NCT02454972|580059220|FG004|Overall Study|Study termination|0|||
160638252|NCT02454972|580059221|FG005|Overall Study|Study termination|0|||
160638253|NCT02454972|580059222|FG006|Overall Study|Study termination|0|||
160638254|NCT02454972|580059223|FG007|Overall Study|Study termination|0|||
160638255|NCT02454972|580059224|FG008|Overall Study|Study termination|6|||
160638256|NCT01020305|580059231|FG000|Overall Study|Adverse Event|2|||
160638257|NCT01070966|580059234|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
160638258|NCT01070966|580059234|FG000|Participants for Safety Evaluation|Off-label use|9|||
160638259|NCT01070966|580059234|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
160541759|NCT03605680|579712822|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
160541760|NCT03605680|579712819|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
160541761|NCT03605680|579712820|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
160778355|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
160778356|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
160778357|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
160778358|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
160778359|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
160778360|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
160778361|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
160778362|NCT05073315|580573478|FG000|Period 2|Adverse Event|0|||
160778363|NCT05073315|580573479|FG001|Period 2|Adverse Event|3|||
160778364|NCT05073315|580573480|FG002|Period 2|Adverse Event|6|||
160778365|NCT05073315|580573478|FG000|Period 2|Lost to Follow-up|0|||
160778366|NCT05073315|580573479|FG001|Period 2|Lost to Follow-up|5|||
160778367|NCT05073315|580573480|FG002|Period 2|Lost to Follow-up|5|||
160778368|NCT05073315|580573478|FG000|Period 2|Withdrawal by Subject|0|||
160778369|NCT05073315|580573479|FG001|Period 2|Withdrawal by Subject|4|||
160778370|NCT05073315|580573480|FG002|Period 2|Withdrawal by Subject|9|||
160778371|NCT05073315|580573478|FG000|Period 2|Protocol Violation|0|||
160778372|NCT05073315|580573479|FG001|Period 2|Protocol Violation|0|||
160778373|NCT05073315|580573480|FG002|Period 2|Protocol Violation|1|||
160778374|NCT04465955|580573481|FG000|Overall Study|Withdrew consent|6|||
160778375|NCT04465955|580573482|FG001|Overall Study|Withdrew consent|10|||
160778376|NCT04465955|580573483|FG002|Overall Study|Withdrew consent|7|||
160778377|NCT04465955|580573481|FG000|Overall Study|Adverse Event|6|||
160778378|NCT04465955|580573482|FG001|Overall Study|Adverse Event|5|||
160778379|NCT04465955|580573483|FG002|Overall Study|Adverse Event|1|||
160778380|NCT04465955|580573481|FG000|Overall Study|Lost to Follow-up|2|||
160778381|NCT04465955|580573482|FG001|Overall Study|Lost to Follow-up|0|||
160778382|NCT04465955|580573483|FG002|Overall Study|Lost to Follow-up|3|||
160778383|NCT04465955|580573481|FG000|Overall Study|Other|1|||
160778384|NCT04465955|580573482|FG001|Overall Study|Other|1|||
160778385|NCT04465955|580573483|FG002|Overall Study|Other|3|||
160778386|NCT00021255|580573484|FG000|Overall Study|Death|1|||
160778387|NCT00021255|580573485|FG001|Overall Study|Death|0|||
160778388|NCT00021255|580573486|FG002|Overall Study|Death|2|||
160778389|NCT00021255|580573484|FG000|Overall Study|Breast cancer relapse|5|||
160778390|NCT00021255|580573485|FG001|Overall Study|Breast cancer relapse|18|||
160778391|NCT00021255|580573486|FG002|Overall Study|Breast cancer relapse|11|||
160778392|NCT00021255|580573484|FG000|Overall Study|Second primary malignancy|0|||
160778393|NCT00021255|580573485|FG001|Overall Study|Second primary malignancy|4|||
160778394|NCT00021255|580573486|FG002|Overall Study|Second primary malignancy|1|||
160778395|NCT00021255|580573484|FG000|Overall Study|Withdrawal by Subject|41|||
160778396|NCT00021255|580573485|FG001|Overall Study|Withdrawal by Subject|64|||
160778397|NCT00021255|580573486|FG002|Overall Study|Withdrawal by Subject|26|||
160778398|NCT00021255|580573484|FG000|Overall Study|Lost to Follow-up|0|||
160778399|NCT00021255|580573485|FG001|Overall Study|Lost to Follow-up|2|||
160778400|NCT00021255|580573486|FG002|Overall Study|Lost to Follow-up|3|||
160778401|NCT00021255|580573484|FG000|Overall Study|Cardiac toxicity|0|||
160778402|NCT00021255|580573485|FG001|Overall Study|Cardiac toxicity|61|||
160778403|NCT00021255|580573486|FG002|Overall Study|Cardiac toxicity|32|||
160778404|NCT00021255|580573484|FG000|Overall Study|Herceptin toxicity|0|||
160778405|NCT00021255|580573485|FG001|Overall Study|Herceptin toxicity|22|||
160778406|NCT00021255|580573486|FG002|Overall Study|Herceptin toxicity|6|||
160778407|NCT00021255|580573484|FG000|Overall Study|Adverse Event|46|||
160778408|NCT00021255|580573485|FG001|Overall Study|Adverse Event|30|||
160778409|NCT00021255|580573486|FG002|Overall Study|Adverse Event|18|||
160778410|NCT00021255|580573484|FG000|Overall Study|Protocol Violation|0|||
160778411|NCT00021255|580573485|FG001|Overall Study|Protocol Violation|2|||
160778412|NCT00021255|580573486|FG002|Overall Study|Protocol Violation|0|||
160778413|NCT00021255|580573484|FG000|Overall Study|Other than specified above|0|||
160778414|NCT00021255|580573485|FG001|Overall Study|Other than specified above|38|||
160778415|NCT00021255|580573486|FG002|Overall Study|Other than specified above|19|||
160887006|NCT04090411|580980635|FG000|Chronic Period|Lack of Efficacy|0|||
160887007|NCT04090411|580980636|FG001|Chronic Period|Lack of Efficacy|0|||
160541762|NCT03605680|579712821|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
160778416|NCT00021255|580573484|FG000|Overall Study|Missing|0|||
160778417|NCT00021255|580573485|FG001|Overall Study|Missing|27|||
160778418|NCT00021255|580573486|FG002|Overall Study|Missing|13|||
160778419|NCT00021255|580573484|FG000|Overall Study|Randomized but not treated|28|||
160778420|NCT00021255|580573485|FG001|Overall Study|Randomized but not treated|2|||
160778421|NCT00021255|580573486|FG002|Overall Study|Randomized but not treated|18|||
160778422|NCT02232698|580573487|FG000|Overall Study|Pregnancy|1|||
160778423|NCT02232698|580573488|FG001|Overall Study|Pregnancy|1|||
160778424|NCT02232698|580573487|FG000|Overall Study|Met exclusion criteria|1|||
160778425|NCT02232698|580573488|FG001|Overall Study|Met exclusion criteria|1|||
160778426|NCT02232698|580573487|FG000|Overall Study|Had device-associated symptoms|7|||
160778427|NCT02232698|580573488|FG001|Overall Study|Had device-associated symptoms|0|||
160778428|NCT02232698|580573487|FG000|Overall Study|Non-compliance with study device|1|||
160778429|NCT02232698|580573488|FG001|Overall Study|Non-compliance with study device|4|||
160778430|NCT02232698|580573487|FG000|Overall Study|Allocated to control group|0|||
160778431|NCT02232698|580573488|FG001|Overall Study|Allocated to control group|3|||
160778432|NCT02232698|580573487|FG000|Overall Study|Withdrawal by Subject|0|||
160778433|NCT02232698|580573488|FG001|Overall Study|Withdrawal by Subject|11|||
160778434|NCT00927082|580573489|FG000|Overall Study|Lost to Follow-up|9|||
160778435|NCT00927082|580573490|FG001|Overall Study|Lost to Follow-up|8|||
160778436|NCT00927082|580573491|FG002|Overall Study|Lost to Follow-up|12|||
160778437|NCT00927082|580573492|FG003|Overall Study|Lost to Follow-up|16|||
160778438|NCT00927082|580573489|FG000|Overall Study|Withdrawal by Subject|3|||
160778439|NCT00927082|580573490|FG001|Overall Study|Withdrawal by Subject|2|||
160778440|NCT00927082|580573491|FG002|Overall Study|Withdrawal by Subject|7|||
160778441|NCT00927082|580573492|FG003|Overall Study|Withdrawal by Subject|2|||
160778442|NCT00927082|580573489|FG000|Overall Study|Death|0|||
160778443|NCT00927082|580573490|FG001|Overall Study|Death|0|||
160778444|NCT00927082|580573491|FG002|Overall Study|Death|1|||
160778445|NCT00927082|580573492|FG003|Overall Study|Death|0|||
160778446|NCT00927082|580573489|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
160778447|NCT00927082|580573490|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
160778448|NCT00927082|580573491|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
160778449|NCT00927082|580573492|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
160778450|NCT01786109|580573494|FG000|Overall Study|fail manometry barostat tube placement|1|||
160778451|NCT01786109|580573495|FG001|Overall Study|fail manometry barostat tube placement|0|||
160778452|NCT01786109|580573496|FG002|Overall Study|fail manometry barostat tube placement|0|||
160778453|NCT01786109|580573494|FG000|Overall Study|unrelated illness|0|||
160778454|NCT01786109|580573495|FG001|Overall Study|unrelated illness|0|||
160778455|NCT01786109|580573496|FG002|Overall Study|unrelated illness|1|||
160778456|NCT01786109|580573494|FG000|Overall Study|adverse effects colon preparation|0|||
160778457|NCT01786109|580573495|FG001|Overall Study|adverse effects colon preparation|0|||
160778458|NCT01786109|580573496|FG002|Overall Study|adverse effects colon preparation|1|||
160778459|NCT03369223|580573499|FG000|Overall Study|Lost to Follow-up|0|||
160778460|NCT03369223|580573500|FG001|Overall Study|Lost to Follow-up|0|||
160778461|NCT03369223|580573501|FG002|Overall Study|Lost to Follow-up|0|||
160778462|NCT03369223|580573502|FG003|Overall Study|Lost to Follow-up|0|||
160778463|NCT03369223|580573503|FG004|Overall Study|Lost to Follow-up|0|||
160778464|NCT03369223|580573504|FG005|Overall Study|Lost to Follow-up|0|||
160778465|NCT03369223|580573505|FG006|Overall Study|Lost to Follow-up|0|||
160778466|NCT03369223|580573506|FG007|Overall Study|Lost to Follow-up|0|||
160778467|NCT03369223|580573507|FG008|Overall Study|Lost to Follow-up|0|||
160778468|NCT03369223|580573508|FG009|Overall Study|Lost to Follow-up|0|||
160778469|NCT03369223|580573509|FG010|Overall Study|Lost to Follow-up|0|||
160778470|NCT03369223|580573510|FG011|Overall Study|Lost to Follow-up|0|||
160778471|NCT03369223|580573511|FG012|Overall Study|Lost to Follow-up|0|||
160778472|NCT03369223|580573512|FG013|Overall Study|Lost to Follow-up|0|||
160778473|NCT03369223|580573513|FG014|Overall Study|Lost to Follow-up|0|||
160887008|NCT04090411|580980637|FG002|Chronic Period|Lack of Efficacy|0|||
160887009|NCT04090411|580980638|FG003|Chronic Period|Lack of Efficacy|0|||
160887010|NCT04090411|580980639|FG004|Chronic Period|Lack of Efficacy|0|||
160887011|NCT04090411|580980640|FG005|Chronic Period|Lack of Efficacy|0|||
160778474|NCT03369223|580573514|FG015|Overall Study|Lost to Follow-up|0|||
160887012|NCT04090411|580980641|FG006|Chronic Period|Lack of Efficacy|1|||
160887013|NCT04090411|580980642|FG007|Chronic Period|Lack of Efficacy|4|||
160887014|NCT04090411|580980643|FG008|Chronic Period|Lack of Efficacy|2|||
160887015|NCT04090411|580980644|FG009|Chronic Period|Lack of Efficacy|2|||
160887016|NCT04090411|580980645|FG010|Chronic Period|Lack of Efficacy|2|||
160887017|NCT04090411|580980646|FG011|Chronic Period|Lack of Efficacy|1|||
160887018|NCT04090411|580980647|FG012|Chronic Period|Lack of Efficacy|2|||
160887019|NCT04090411|580980635|FG000|Chronic Period|Relocation|0|||
160778475|NCT03369223|580573515|FG016|Overall Study|Lost to Follow-up|0|||
160887020|NCT04090411|580980636|FG001|Chronic Period|Relocation|0|||
160778476|NCT03369223|580573516|FG017|Overall Study|Lost to Follow-up|0|||
160887021|NCT04090411|580980637|FG002|Chronic Period|Relocation|0|||
160887022|NCT04090411|580980638|FG003|Chronic Period|Relocation|0|||
160887023|NCT04090411|580980639|FG004|Chronic Period|Relocation|0|||
160887024|NCT04090411|580980640|FG005|Chronic Period|Relocation|0|||
160778477|NCT03369223|580573517|FG018|Overall Study|Lost to Follow-up|2|||
160778478|NCT03369223|580573518|FG019|Overall Study|Lost to Follow-up|1|||
160778479|NCT03369223|580573499|FG000|Overall Study|Participant no longer meets study criteria|0|||
160887025|NCT04090411|580980641|FG006|Chronic Period|Relocation|0|||
160887026|NCT04090411|580980642|FG007|Chronic Period|Relocation|1|||
160887027|NCT04090411|580980643|FG008|Chronic Period|Relocation|0|||
160887028|NCT04090411|580980644|FG009|Chronic Period|Relocation|0|||
160887029|NCT04090411|580980645|FG010|Chronic Period|Relocation|0|||
160887030|NCT04090411|580980646|FG011|Chronic Period|Relocation|0|||
160887031|NCT04090411|580980647|FG012|Chronic Period|Relocation|0|||
160887032|NCT04090411|580980635|FG000|Chronic Period|Physician Decision|0|||
160887033|NCT04090411|580980636|FG001|Chronic Period|Physician Decision|0|||
160887034|NCT04090411|580980637|FG002|Chronic Period|Physician Decision|0|||
160541763|NCT03605680|579712822|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
160541764|NCT03605680|579712819|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
160541765|NCT03605680|579712820|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
160541766|NCT03605680|579712821|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
160541767|NCT03605680|579712822|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
160541768|NCT03605680|579712819|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
160541769|NCT03605680|579712820|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
160541770|NCT03605680|579712821|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
160541771|NCT03605680|579712822|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
160541772|NCT03605680|579712819|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
160541773|NCT03605680|579712820|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
160541774|NCT03605680|579712821|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
160541775|NCT03605680|579712822|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
160541776|NCT03605680|579712819|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
160541777|NCT03605680|579712820|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
160541778|NCT03605680|579712821|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
160541779|NCT03605680|579712822|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
160541780|NCT03605680|579712819|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
160541781|NCT03605680|579712820|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
160541782|NCT03605680|579712821|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
160541783|NCT03605680|579712822|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
160638260|NCT01070966|580059234|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
160638261|NCT01070966|580059234|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
160638262|NCT01070966|580059234|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
160638263|NCT01070966|580059234|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
160638264|NCT01070966|580059234|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
160638265|NCT01725113|580059235|FG000|Overall Study|Kidney Transplant|1|||
160638266|NCT01725113|580059236|FG001|Overall Study|Kidney Transplant|1|||
160638267|NCT01725113|580059235|FG000|Overall Study|Withdrawal by Subject|0|||
160638268|NCT01725113|580059236|FG001|Overall Study|Withdrawal by Subject|1|||
160638269|NCT02753400|580059237|FG000|Overall Study|Adverse Event|3|||
160638270|NCT02753400|580059238|FG001|Overall Study|Adverse Event|0|||
160638271|NCT02753400|580059237|FG000|Overall Study|Withdrawal by Subject|2|||
160638272|NCT02753400|580059238|FG001|Overall Study|Withdrawal by Subject|1|||
160638273|NCT03989115|580059239|FG000|Overall Study|Withdrawal by Subject|2|||
160638274|NCT03989115|580059240|FG001|Overall Study|Withdrawal by Subject|1|||
160638275|NCT03989115|580059241|FG002|Overall Study|Withdrawal by Subject|3|||
160638276|NCT03989115|580059242|FG003|Overall Study|Withdrawal by Subject|0|||
160638277|NCT03989115|580059243|FG004|Overall Study|Withdrawal by Subject|17|||
160638278|NCT03989115|580059244|FG005|Overall Study|Withdrawal by Subject|1|||
160638279|NCT03989115|580059245|FG006|Overall Study|Withdrawal by Subject|0|||
160638280|NCT03989115|580059246|FG007|Overall Study|Withdrawal by Subject|0|||
160638281|NCT03989115|580059239|FG000|Overall Study|Sponsor decision to terminate the study|1|||
160638282|NCT03989115|580059240|FG001|Overall Study|Sponsor decision to terminate the study|1|||
160638283|NCT03989115|580059241|FG002|Overall Study|Sponsor decision to terminate the study|0|||
160638284|NCT03989115|580059242|FG003|Overall Study|Sponsor decision to terminate the study|1|||
160638285|NCT03989115|580059243|FG004|Overall Study|Sponsor decision to terminate the study|11|||
160638286|NCT03989115|580059244|FG005|Overall Study|Sponsor decision to terminate the study|0|||
160638287|NCT03989115|580059245|FG006|Overall Study|Sponsor decision to terminate the study|2|||
160638288|NCT03989115|580059246|FG007|Overall Study|Sponsor decision to terminate the study|1|||
160638289|NCT03989115|580059239|FG000|Overall Study|Lost to Follow-up|2|||
160638290|NCT03989115|580059240|FG001|Overall Study|Lost to Follow-up|0|||
160638291|NCT03989115|580059241|FG002|Overall Study|Lost to Follow-up|0|||
160638292|NCT03989115|580059242|FG003|Overall Study|Lost to Follow-up|0|||
160638293|NCT03989115|580059243|FG004|Overall Study|Lost to Follow-up|1|||
160638294|NCT03989115|580059244|FG005|Overall Study|Lost to Follow-up|0|||
160638295|NCT03989115|580059245|FG006|Overall Study|Lost to Follow-up|0|||
160638296|NCT03989115|580059246|FG007|Overall Study|Lost to Follow-up|0|||
160638297|NCT03989115|580059239|FG000|Overall Study|Death|2|||
160638298|NCT03989115|580059240|FG001|Overall Study|Death|2|||
160638299|NCT03989115|580059241|FG002|Overall Study|Death|9|||
160638300|NCT03989115|580059242|FG003|Overall Study|Death|6|||
160638301|NCT03989115|580059243|FG004|Overall Study|Death|31|||
160638302|NCT03989115|580059244|FG005|Overall Study|Death|6|||
160887035|NCT04090411|580980638|FG003|Chronic Period|Physician Decision|0|||
160778480|NCT03369223|580573500|FG001|Overall Study|Participant no longer meets study criteria|0|||
160778481|NCT03369223|580573501|FG002|Overall Study|Participant no longer meets study criteria|0|||
160778482|NCT03369223|580573502|FG003|Overall Study|Participant no longer meets study criteria|0|||
160778483|NCT03369223|580573503|FG004|Overall Study|Participant no longer meets study criteria|0|||
160778484|NCT03369223|580573504|FG005|Overall Study|Participant no longer meets study criteria|0|||
160778485|NCT03369223|580573505|FG006|Overall Study|Participant no longer meets study criteria|0|||
160778486|NCT03369223|580573506|FG007|Overall Study|Participant no longer meets study criteria|0|||
160778487|NCT03369223|580573507|FG008|Overall Study|Participant no longer meets study criteria|0|||
160778488|NCT03369223|580573508|FG009|Overall Study|Participant no longer meets study criteria|0|||
160778489|NCT03369223|580573509|FG010|Overall Study|Participant no longer meets study criteria|0|||
160778490|NCT03369223|580573510|FG011|Overall Study|Participant no longer meets study criteria|0|||
160778491|NCT03369223|580573511|FG012|Overall Study|Participant no longer meets study criteria|0|||
160778492|NCT03369223|580573512|FG013|Overall Study|Participant no longer meets study criteria|0|||
160778493|NCT03369223|580573513|FG014|Overall Study|Participant no longer meets study criteria|2|||
160778494|NCT03369223|580573514|FG015|Overall Study|Participant no longer meets study criteria|0|||
160778495|NCT03369223|580573515|FG016|Overall Study|Participant no longer meets study criteria|2|||
160778496|NCT03369223|580573516|FG017|Overall Study|Participant no longer meets study criteria|0|||
160778497|NCT03369223|580573517|FG018|Overall Study|Participant no longer meets study criteria|0|||
160778498|NCT03369223|580573518|FG019|Overall Study|Participant no longer meets study criteria|0|||
160778499|NCT03369223|580573499|FG000|Overall Study|Other reasons|0|||
160778500|NCT03369223|580573500|FG001|Overall Study|Other reasons|0|||
160778501|NCT03369223|580573501|FG002|Overall Study|Other reasons|0|||
160778502|NCT03369223|580573502|FG003|Overall Study|Other reasons|0|||
160778503|NCT03369223|580573503|FG004|Overall Study|Other reasons|0|||
160778504|NCT03369223|580573504|FG005|Overall Study|Other reasons|0|||
160778505|NCT03369223|580573505|FG006|Overall Study|Other reasons|0|||
160778506|NCT03369223|580573506|FG007|Overall Study|Other reasons|0|||
160778507|NCT03369223|580573507|FG008|Overall Study|Other reasons|0|||
160778508|NCT03369223|580573508|FG009|Overall Study|Other reasons|0|||
160778509|NCT03369223|580573509|FG010|Overall Study|Other reasons|0|||
160778510|NCT03369223|580573510|FG011|Overall Study|Other reasons|0|||
160778511|NCT03369223|580573511|FG012|Overall Study|Other reasons|0|||
160778512|NCT03369223|580573512|FG013|Overall Study|Other reasons|1|||
160778513|NCT03369223|580573513|FG014|Overall Study|Other reasons|2|||
160778514|NCT03369223|580573514|FG015|Overall Study|Other reasons|0|||
160778515|NCT03369223|580573515|FG016|Overall Study|Other reasons|1|||
160778516|NCT03369223|580573516|FG017|Overall Study|Other reasons|0|||
160778517|NCT03369223|580573517|FG018|Overall Study|Other reasons|0|||
160778518|NCT03369223|580573518|FG019|Overall Study|Other reasons|2|||
160778519|NCT03369223|580573499|FG000|Overall Study|Death|0|||
160778520|NCT03369223|580573500|FG001|Overall Study|Death|0|||
160778521|NCT03369223|580573501|FG002|Overall Study|Death|0|||
160778522|NCT03369223|580573502|FG003|Overall Study|Death|0|||
160778523|NCT03369223|580573503|FG004|Overall Study|Death|0|||
160778524|NCT03369223|580573504|FG005|Overall Study|Death|0|||
160778525|NCT03369223|580573505|FG006|Overall Study|Death|0|||
160778526|NCT03369223|580573506|FG007|Overall Study|Death|0|||
160778527|NCT03369223|580573507|FG008|Overall Study|Death|0|||
160778528|NCT03369223|580573508|FG009|Overall Study|Death|0|||
160778529|NCT03369223|580573509|FG010|Overall Study|Death|0|||
160778530|NCT03369223|580573510|FG011|Overall Study|Death|0|||
160778531|NCT03369223|580573511|FG012|Overall Study|Death|0|||
160778532|NCT03369223|580573512|FG013|Overall Study|Death|1|||
160778533|NCT03369223|580573513|FG014|Overall Study|Death|0|||
160887036|NCT04090411|580980639|FG004|Chronic Period|Physician Decision|1|||
160887037|NCT04090411|580980640|FG005|Chronic Period|Physician Decision|0|||
160887038|NCT04090411|580980641|FG006|Chronic Period|Physician Decision|0|||
160887039|NCT04090411|580980642|FG007|Chronic Period|Physician Decision|1|||
160887040|NCT04090411|580980643|FG008|Chronic Period|Physician Decision|0|||
160887041|NCT04090411|580980644|FG009|Chronic Period|Physician Decision|0|||
160887042|NCT04090411|580980645|FG010|Chronic Period|Physician Decision|0|||
160887043|NCT04090411|580980646|FG011|Chronic Period|Physician Decision|1|||
160887044|NCT04090411|580980647|FG012|Chronic Period|Physician Decision|1|||
160887045|NCT04090411|580980635|FG000|Chronic Period|Protocol Violation|0|||
160887046|NCT04090411|580980636|FG001|Chronic Period|Protocol Violation|0|||
160778534|NCT03369223|580573514|FG015|Overall Study|Death|0|||
160778535|NCT03369223|580573515|FG016|Overall Study|Death|0|||
160778536|NCT03369223|580573516|FG017|Overall Study|Death|0|||
160778537|NCT03369223|580573517|FG018|Overall Study|Death|1|||
160778538|NCT03369223|580573518|FG019|Overall Study|Death|0|||
160778539|NCT03369223|580573499|FG000|Overall Study|Adverse event unrelated to study drug|0|||
160778540|NCT03369223|580573500|FG001|Overall Study|Adverse event unrelated to study drug|0|||
160778541|NCT03369223|580573501|FG002|Overall Study|Adverse event unrelated to study drug|0|||
160887047|NCT04090411|580980637|FG002|Chronic Period|Protocol Violation|0|||
160887048|NCT04090411|580980638|FG003|Chronic Period|Protocol Violation|0|||
160638303|NCT03989115|580059245|FG006|Overall Study|Death|2|||
160638304|NCT03989115|580059246|FG007|Overall Study|Death|3|||
160638305|NCT03989115|580059239|FG000|Overall Study|Other|1|||
160638306|NCT03989115|580059240|FG001|Overall Study|Other|2|||
160638307|NCT03989115|580059241|FG002|Overall Study|Other|0|||
160638308|NCT03989115|580059242|FG003|Overall Study|Other|0|||
160638309|NCT03989115|580059243|FG004|Overall Study|Other|5|||
160638310|NCT03989115|580059244|FG005|Overall Study|Other|0|||
160638311|NCT03989115|580059245|FG006|Overall Study|Other|0|||
160638312|NCT03989115|580059246|FG007|Overall Study|Other|0|||
160638313|NCT01415921|580059247|FG000|Overall Study|Adverse Event|0|||
160638314|NCT01415921|580059248|FG001|Overall Study|Adverse Event|1|||
160638315|NCT01415921|580059247|FG000|Overall Study|Physician Decision|1|||
160638316|NCT01415921|580059248|FG001|Overall Study|Physician Decision|1|||
160638317|NCT01415921|580059247|FG000|Overall Study|Withdrawal by Subject|0|||
160638318|NCT01415921|580059248|FG001|Overall Study|Withdrawal by Subject|1|||
160638319|NCT01415921|580059247|FG000|Overall Study|Other|2|||
160638320|NCT01415921|580059248|FG001|Overall Study|Other|0|||
160638321|NCT02725671|580059250|FG000|Overall Study|Lost to Follow-up|1|||
160638322|NCT00963599|580059251|FG000|Overall Study|Adverse Event|2|||
160638323|NCT00963599|580059252|FG001|Overall Study|Adverse Event|0|||
160638324|NCT00963599|580059253|FG002|Overall Study|Adverse Event|1|||
160638325|NCT00963599|580059254|FG003|Overall Study|Adverse Event|2|||
160638326|NCT00963599|580059251|FG000|Overall Study|Lack of Efficacy|0|||
160638327|NCT00963599|580059252|FG001|Overall Study|Lack of Efficacy|2|||
160638328|NCT00963599|580059253|FG002|Overall Study|Lack of Efficacy|1|||
160638329|NCT00963599|580059254|FG003|Overall Study|Lack of Efficacy|4|||
160638330|NCT00963599|580059251|FG000|Overall Study|Lost to Follow-up|0|||
160638331|NCT00963599|580059252|FG001|Overall Study|Lost to Follow-up|1|||
160638332|NCT00963599|580059253|FG002|Overall Study|Lost to Follow-up|1|||
160638333|NCT00963599|580059254|FG003|Overall Study|Lost to Follow-up|1|||
160638334|NCT00963599|580059251|FG000|Overall Study|Protocol Violation|2|||
160638335|NCT00963599|580059252|FG001|Overall Study|Protocol Violation|2|||
160638336|NCT00963599|580059253|FG002|Overall Study|Protocol Violation|3|||
160638337|NCT00963599|580059254|FG003|Overall Study|Protocol Violation|4|||
160638338|NCT00963599|580059251|FG000|Overall Study|Withdrawal by Subject|2|||
160638339|NCT00963599|580059252|FG001|Overall Study|Withdrawal by Subject|1|||
160638340|NCT00963599|580059253|FG002|Overall Study|Withdrawal by Subject|3|||
160638341|NCT00963599|580059254|FG003|Overall Study|Withdrawal by Subject|3|||
160638342|NCT01706770|580059259|FG000|Overall Study|Lost to Follow-up|1|||
160638343|NCT01706770|580059260|FG001|Overall Study|Lost to Follow-up|0|||
160638344|NCT01706770|580059259|FG000|Overall Study|Physician Decision|1|||
160638345|NCT01706770|580059260|FG001|Overall Study|Physician Decision|0|||
160638346|NCT00068445|580059261|FG000|Randomization|Cancel|1|||
160638347|NCT00068445|580059262|FG001|Randomization|Cancel|3|||
160638348|NCT00068445|580059261|FG000|Randomization|Ineligible|1|||
160638349|NCT00068445|580059262|FG001|Randomization|Ineligible|1|||
160638350|NCT00068445|580059261|FG000|Treatment|Refused Further Treatment|13|||
160638351|NCT00068445|580059262|FG001|Treatment|Refused Further Treatment|10|||
160638352|NCT00068445|580059261|FG000|Treatment|Adverse Event|7|||
160638353|NCT00068445|580059262|FG001|Treatment|Adverse Event|1|||
160638354|NCT00068445|580059261|FG000|Treatment|Other (Specifics not available)|9|||
160638355|NCT00068445|580059262|FG001|Treatment|Other (Specifics not available)|5|||
160638356|NCT00423488|580059263|FG000|Overall Study|No evidence of study drug intake|2|||
160638357|NCT00423488|580059264|FG001|Overall Study|No evidence of study drug intake|1|||
160638358|NCT00423488|580059263|FG000|Overall Study|No post baseline data|3|||
160638359|NCT00423488|580059264|FG001|Overall Study|No post baseline data|0|||
160638360|NCT02643966|580059267|FG000|First Screening Round|ineligible|1|||
160638361|NCT02643966|580059267|FG000|First Screening Round|excluded from analysis|2|||
160638362|NCT02643966|580059267|FG000|First Screening Round|Lost to Follow-up|56|||
160638363|NCT02643966|580059267|FG000|First Screening Round|Withdrawal by Subject|28|||
160638364|NCT02643966|580059267|FG000|First Screening Round|Death|1|||
160638365|NCT02643966|580059267|FG000|Between First and Second Screening|Lost to Follow-up|65|||
160638366|NCT02643966|580059267|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
160638367|NCT02643966|580059267|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
160638368|NCT02643966|580059267|FG000|Second Screening Round|Withdrawal by Subject|20|||
160638369|NCT02643966|580059267|FG000|Second Screening Round|Lost to Follow-up|57|||
160778542|NCT03369223|580573502|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160778543|NCT03369223|580573503|FG004|Overall Study|Adverse event unrelated to study drug|0|||
160778544|NCT03369223|580573504|FG005|Overall Study|Adverse event unrelated to study drug|0|||
160778545|NCT03369223|580573505|FG006|Overall Study|Adverse event unrelated to study drug|1|||
160778546|NCT03369223|580573506|FG007|Overall Study|Adverse event unrelated to study drug|0|||
160778547|NCT03369223|580573507|FG008|Overall Study|Adverse event unrelated to study drug|0|||
160778548|NCT03369223|580573508|FG009|Overall Study|Adverse event unrelated to study drug|1|||
160778549|NCT03369223|580573509|FG010|Overall Study|Adverse event unrelated to study drug|0|||
160778550|NCT03369223|580573510|FG011|Overall Study|Adverse event unrelated to study drug|0|||
160778551|NCT03369223|580573511|FG012|Overall Study|Adverse event unrelated to study drug|0|||
160778552|NCT03369223|580573512|FG013|Overall Study|Adverse event unrelated to study drug|4|||
160778553|NCT03369223|580573513|FG014|Overall Study|Adverse event unrelated to study drug|2|||
160778554|NCT03369223|580573514|FG015|Overall Study|Adverse event unrelated to study drug|0|||
160887049|NCT04090411|580980639|FG004|Chronic Period|Protocol Violation|0|||
160887050|NCT04090411|580980640|FG005|Chronic Period|Protocol Violation|0|||
160887051|NCT04090411|580980641|FG006|Chronic Period|Protocol Violation|0|||
160778555|NCT03369223|580573515|FG016|Overall Study|Adverse event unrelated to study drug|2|||
160638370|NCT02643966|580059267|FG000|Second Screening Round|Physician Decision|2|||
160778556|NCT03369223|580573516|FG017|Overall Study|Adverse event unrelated to study drug|1|||
160778557|NCT03369223|580573517|FG018|Overall Study|Adverse event unrelated to study drug|3|||
160778558|NCT03369223|580573518|FG019|Overall Study|Adverse event unrelated to study drug|2|||
160778559|NCT03369223|580573499|FG000|Overall Study|Disease progression|6|||
160778560|NCT03369223|580573500|FG001|Overall Study|Disease progression|8|||
160778561|NCT03369223|580573501|FG002|Overall Study|Disease progression|5|||
160778562|NCT03369223|580573502|FG003|Overall Study|Disease progression|1|||
160778563|NCT03369223|580573503|FG004|Overall Study|Disease progression|9|||
160778564|NCT03369223|580573504|FG005|Overall Study|Disease progression|9|||
160778565|NCT03369223|580573505|FG006|Overall Study|Disease progression|4|||
160778566|NCT03369223|580573506|FG007|Overall Study|Disease progression|6|||
160778567|NCT03369223|580573507|FG008|Overall Study|Disease progression|10|||
160778568|NCT03369223|580573508|FG009|Overall Study|Disease progression|7|||
160778569|NCT03369223|580573509|FG010|Overall Study|Disease progression|4|||
160778570|NCT03369223|580573510|FG011|Overall Study|Disease progression|1|||
160778571|NCT03369223|580573511|FG012|Overall Study|Disease progression|1|||
160778572|NCT03369223|580573512|FG013|Overall Study|Disease progression|25|||
160778573|NCT03369223|580573513|FG014|Overall Study|Disease progression|22|||
160778574|NCT03369223|580573514|FG015|Overall Study|Disease progression|2|||
160778575|NCT03369223|580573515|FG016|Overall Study|Disease progression|10|||
160778576|NCT03369223|580573516|FG017|Overall Study|Disease progression|1|||
160778577|NCT03369223|580573517|FG018|Overall Study|Disease progression|18|||
160778578|NCT03369223|580573518|FG019|Overall Study|Disease progression|28|||
160778579|NCT03369223|580573499|FG000|Overall Study|Study drug toxicity|0|||
160778580|NCT03369223|580573500|FG001|Overall Study|Study drug toxicity|1|||
160778581|NCT03369223|580573501|FG002|Overall Study|Study drug toxicity|4|||
160778582|NCT03369223|580573502|FG003|Overall Study|Study drug toxicity|0|||
160778583|NCT03369223|580573503|FG004|Overall Study|Study drug toxicity|1|||
160778584|NCT03369223|580573504|FG005|Overall Study|Study drug toxicity|2|||
160778585|NCT03369223|580573505|FG006|Overall Study|Study drug toxicity|4|||
160778586|NCT03369223|580573506|FG007|Overall Study|Study drug toxicity|2|||
160778587|NCT03369223|580573507|FG008|Overall Study|Study drug toxicity|2|||
160778588|NCT03369223|580573508|FG009|Overall Study|Study drug toxicity|0|||
160778589|NCT03369223|580573509|FG010|Overall Study|Study drug toxicity|6|||
160778590|NCT03369223|580573510|FG011|Overall Study|Study drug toxicity|1|||
160778591|NCT03369223|580573511|FG012|Overall Study|Study drug toxicity|2|||
160778592|NCT03369223|580573512|FG013|Overall Study|Study drug toxicity|19|||
160778593|NCT03369223|580573513|FG014|Overall Study|Study drug toxicity|19|||
160778594|NCT03369223|580573514|FG015|Overall Study|Study drug toxicity|0|||
160778595|NCT03369223|580573515|FG016|Overall Study|Study drug toxicity|18|||
160778596|NCT03369223|580573516|FG017|Overall Study|Study drug toxicity|3|||
160778597|NCT03369223|580573517|FG018|Overall Study|Study drug toxicity|11|||
160778598|NCT03369223|580573518|FG019|Overall Study|Study drug toxicity|7|||
160778599|NCT03369223|580573499|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160778600|NCT03369223|580573500|FG001|Overall Study|Participant request to discontinue study treatment|1|||
160778601|NCT03369223|580573501|FG002|Overall Study|Participant request to discontinue study treatment|0|||
160887052|NCT04090411|580980642|FG007|Chronic Period|Protocol Violation|0|||
160887053|NCT04090411|580980643|FG008|Chronic Period|Protocol Violation|0|||
160887054|NCT04090411|580980644|FG009|Chronic Period|Protocol Violation|0|||
160887055|NCT04090411|580980645|FG010|Chronic Period|Protocol Violation|0|||
160887056|NCT04090411|580980646|FG011|Chronic Period|Protocol Violation|0|||
160887057|NCT04090411|580980647|FG012|Chronic Period|Protocol Violation|1|||
160887058|NCT04090411|580980635|FG000|Chronic Period|Withdrawal by Subject|0|||
160887059|NCT04090411|580980636|FG001|Chronic Period|Withdrawal by Subject|0|||
160887060|NCT04090411|580980637|FG002|Chronic Period|Withdrawal by Subject|0|||
160887061|NCT04090411|580980638|FG003|Chronic Period|Withdrawal by Subject|0|||
160887062|NCT04090411|580980639|FG004|Chronic Period|Withdrawal by Subject|0|||
160887063|NCT04090411|580980640|FG005|Chronic Period|Withdrawal by Subject|1|||
160887064|NCT04090411|580980641|FG006|Chronic Period|Withdrawal by Subject|1|||
160887065|NCT04090411|580980642|FG007|Chronic Period|Withdrawal by Subject|3|||
160887066|NCT04090411|580980643|FG008|Chronic Period|Withdrawal by Subject|3|||
160638371|NCT02643966|580059267|FG000|Second Screening Round|Death|4|||
160778602|NCT03369223|580573502|FG003|Overall Study|Participant request to discontinue study treatment|0|||
160778603|NCT03369223|580573503|FG004|Overall Study|Participant request to discontinue study treatment|1|||
160778604|NCT03369223|580573504|FG005|Overall Study|Participant request to discontinue study treatment|1|||
160778605|NCT03369223|580573505|FG006|Overall Study|Participant request to discontinue study treatment|1|||
160778606|NCT03369223|580573506|FG007|Overall Study|Participant request to discontinue study treatment|0|||
160778607|NCT03369223|580573507|FG008|Overall Study|Participant request to discontinue study treatment|0|||
160778608|NCT03369223|580573508|FG009|Overall Study|Participant request to discontinue study treatment|0|||
160778609|NCT03369223|580573509|FG010|Overall Study|Participant request to discontinue study treatment|0|||
160887067|NCT04090411|580980644|FG009|Chronic Period|Withdrawal by Subject|3|||
160887068|NCT04090411|580980645|FG010|Chronic Period|Withdrawal by Subject|1|||
160541784|NCT03605680|579712819|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
160541785|NCT03605680|579712820|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
160541786|NCT03605680|579712821|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
160541787|NCT03605680|579712822|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
160541788|NCT03605680|579712819|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
160541789|NCT03605680|579712820|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
160541790|NCT03605680|579712821|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
160541791|NCT03605680|579712822|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
160541792|NCT03605680|579712819|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
160541793|NCT03605680|579712820|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
160541794|NCT03605680|579712821|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
160541795|NCT03605680|579712822|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
160541796|NCT03605680|579712819|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
160541797|NCT03605680|579712820|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
160541798|NCT03605680|579712821|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
160541799|NCT03605680|579712822|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
160541800|NCT00647556|579712823|FG000|Overall Study|Adverse Event|0|||
160541801|NCT00647556|579712824|FG001|Overall Study|Adverse Event|1|||
160541802|NCT00647556|579712823|FG000|Overall Study|Lost to Follow-up|1|||
160541803|NCT00647556|579712824|FG001|Overall Study|Lost to Follow-up|0|||
160541804|NCT00647556|579712823|FG000|Overall Study|Protocol Violation|0|||
160541805|NCT00647556|579712824|FG001|Overall Study|Protocol Violation|1|||
160541806|NCT00647556|579712823|FG000|Overall Study|Withdrawal by Subject|1|||
160541807|NCT00647556|579712824|FG001|Overall Study|Withdrawal by Subject|0|||
160541808|NCT00647556|579712823|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
160541809|NCT00647556|579712824|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
160541810|NCT04677712|579712825|FG000|Overall Study|Lost to Follow-up|0|||
160887069|NCT04090411|580980646|FG011|Chronic Period|Withdrawal by Subject|3|||
160887070|NCT04090411|580980647|FG012|Chronic Period|Withdrawal by Subject|0|||
160541811|NCT04677712|579712826|FG001|Overall Study|Lost to Follow-up|1|||
160541812|NCT04677712|579712827|FG002|Overall Study|Lost to Follow-up|0|||
160541813|NCT04677712|579712828|FG003|Overall Study|Lost to Follow-up|0|||
160541814|NCT04677712|579712829|FG004|Overall Study|Lost to Follow-up|0|||
160541815|NCT04677712|579712830|FG005|Overall Study|Lost to Follow-up|0|||
160541816|NCT00711100|579712831|FG000|Overall Study|Lack of Efficacy|5|||
160541817|NCT00711100|579712831|FG000|Overall Study|Withdrawal by Subject|8|||
160541818|NCT01496885|579712832|FG000|Overall Study|Lost to Follow-up|13|||
160541819|NCT01496885|579712832|FG000|Overall Study|Withdrawal by Subject|7|||
160541820|NCT01496885|579712832|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
160541821|NCT01496885|579712832|FG000|Overall Study|Death|1|||
160541822|NCT03273166|579712833|FG000|Overall Study|Withdrawn prior to Completion|31|||
160541823|NCT01294670|579712834|FG000|Overall Study|Not treated|1|||
160541824|NCT01294670|579712835|FG001|Overall Study|Not treated|0|||
160541825|NCT01294670|579712836|FG002|Overall Study|Not treated|0|||
160541826|NCT01294670|579712837|FG003|Overall Study|Not treated|0|||
160541827|NCT01294670|579712838|FG004|Overall Study|Not treated|0|||
160541828|NCT02083380|579712839|FG000|Overall Study|Lack of Efficacy|68|||
160541829|NCT02083380|579712840|FG001|Overall Study|Lack of Efficacy|79|||
160541830|NCT02083380|579712841|FG002|Overall Study|Lack of Efficacy|64|||
160541831|NCT02083380|579712839|FG000|Overall Study|Withdrawal by Subject|9|||
160541832|NCT02083380|579712840|FG001|Overall Study|Withdrawal by Subject|3|||
160541833|NCT02083380|579712841|FG002|Overall Study|Withdrawal by Subject|7|||
160541834|NCT02083380|579712839|FG000|Overall Study|Physician Decision|1|||
160541835|NCT02083380|579712840|FG001|Overall Study|Physician Decision|6|||
160541836|NCT02083380|579712841|FG002|Overall Study|Physician Decision|3|||
160887071|NCT01958827|580980655|FG000|Overall Study|Adverse Event|3|||
160887072|NCT01958827|580980655|FG000|Overall Study|Lack of Efficacy|6|||
160887073|NCT01958827|580980655|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
160887074|NCT04594369|580980659|FG000|Overall Study|Adverse Event|10|||
160887075|NCT04594369|580980660|FG001|Overall Study|Adverse Event|10|||
160887076|NCT04594369|580980661|FG002|Overall Study|Adverse Event|9|||
160541837|NCT02083380|579712839|FG000|Overall Study|Adverse Event|0|||
160541838|NCT02083380|579712840|FG001|Overall Study|Adverse Event|0|||
160541839|NCT02083380|579712841|FG002|Overall Study|Adverse Event|1|||
160541840|NCT02083380|579712839|FG000|Overall Study|Lost to Follow-up|5|||
160541841|NCT02083380|579712840|FG001|Overall Study|Lost to Follow-up|3|||
160541842|NCT02083380|579712841|FG002|Overall Study|Lost to Follow-up|3|||
160541843|NCT02083380|579712839|FG000|Overall Study|Other|8|||
160541844|NCT02083380|579712840|FG001|Overall Study|Other|4|||
160541845|NCT02083380|579712841|FG002|Overall Study|Other|6|||
160887077|NCT04594369|580980659|FG000|Overall Study|Death|2|||
160887078|NCT04594369|580980660|FG001|Overall Study|Death|4|||
160887079|NCT04594369|580980661|FG002|Overall Study|Death|8|||
160887080|NCT04594369|580980659|FG000|Overall Study|Lost to Follow-up|10|||
160887081|NCT04594369|580980660|FG001|Overall Study|Lost to Follow-up|2|||
160778610|NCT03369223|580573510|FG011|Overall Study|Participant request to discontinue study treatment|0|||
160778611|NCT03369223|580573511|FG012|Overall Study|Participant request to discontinue study treatment|0|||
160778612|NCT03369223|580573512|FG013|Overall Study|Participant request to discontinue study treatment|1|||
160778613|NCT03369223|580573513|FG014|Overall Study|Participant request to discontinue study treatment|1|||
160778614|NCT03369223|580573514|FG015|Overall Study|Participant request to discontinue study treatment|0|||
160778615|NCT03369223|580573515|FG016|Overall Study|Participant request to discontinue study treatment|0|||
160778616|NCT03369223|580573516|FG017|Overall Study|Participant request to discontinue study treatment|0|||
160778617|NCT03369223|580573517|FG018|Overall Study|Participant request to discontinue study treatment|1|||
160778618|NCT03369223|580573518|FG019|Overall Study|Participant request to discontinue study treatment|0|||
160778619|NCT03369223|580573499|FG000|Overall Study|Participant withdrew consent|0|||
160778620|NCT03369223|580573500|FG001|Overall Study|Participant withdrew consent|1|||
160778621|NCT03369223|580573501|FG002|Overall Study|Participant withdrew consent|1|||
160778622|NCT03369223|580573502|FG003|Overall Study|Participant withdrew consent|0|||
160778623|NCT03369223|580573503|FG004|Overall Study|Participant withdrew consent|0|||
160778624|NCT03369223|580573504|FG005|Overall Study|Participant withdrew consent|0|||
160778625|NCT03369223|580573505|FG006|Overall Study|Participant withdrew consent|1|||
160778626|NCT03369223|580573506|FG007|Overall Study|Participant withdrew consent|1|||
160778627|NCT03369223|580573507|FG008|Overall Study|Participant withdrew consent|1|||
160778628|NCT03369223|580573508|FG009|Overall Study|Participant withdrew consent|0|||
160778629|NCT03369223|580573509|FG010|Overall Study|Participant withdrew consent|0|||
160778630|NCT03369223|580573510|FG011|Overall Study|Participant withdrew consent|1|||
160778631|NCT03369223|580573511|FG012|Overall Study|Participant withdrew consent|0|||
160778632|NCT03369223|580573512|FG013|Overall Study|Participant withdrew consent|0|||
160778633|NCT03369223|580573513|FG014|Overall Study|Participant withdrew consent|3|||
160778634|NCT03369223|580573514|FG015|Overall Study|Participant withdrew consent|0|||
160778635|NCT03369223|580573515|FG016|Overall Study|Participant withdrew consent|1|||
160778636|NCT03369223|580573516|FG017|Overall Study|Participant withdrew consent|0|||
160778637|NCT03369223|580573517|FG018|Overall Study|Participant withdrew consent|4|||
160778638|NCT03369223|580573518|FG019|Overall Study|Participant withdrew consent|2|||
160778639|NCT03369223|580573499|FG000|Overall Study|Randomized but not treated|0|||
160778640|NCT03369223|580573500|FG001|Overall Study|Randomized but not treated|0|||
160778641|NCT03369223|580573501|FG002|Overall Study|Randomized but not treated|0|||
160778642|NCT03369223|580573502|FG003|Overall Study|Randomized but not treated|0|||
160778643|NCT03369223|580573503|FG004|Overall Study|Randomized but not treated|0|||
160778644|NCT03369223|580573504|FG005|Overall Study|Randomized but not treated|0|||
160778645|NCT03369223|580573505|FG006|Overall Study|Randomized but not treated|0|||
160778646|NCT03369223|580573506|FG007|Overall Study|Randomized but not treated|0|||
160778647|NCT03369223|580573507|FG008|Overall Study|Randomized but not treated|0|||
160778648|NCT03369223|580573508|FG009|Overall Study|Randomized but not treated|0|||
160778649|NCT03369223|580573509|FG010|Overall Study|Randomized but not treated|0|||
160778650|NCT03369223|580573510|FG011|Overall Study|Randomized but not treated|0|||
160778651|NCT03369223|580573511|FG012|Overall Study|Randomized but not treated|0|||
160778652|NCT03369223|580573512|FG013|Overall Study|Randomized but not treated|1|||
160778653|NCT03369223|580573513|FG014|Overall Study|Randomized but not treated|1|||
160778654|NCT03369223|580573514|FG015|Overall Study|Randomized but not treated|0|||
160778655|NCT03369223|580573515|FG016|Overall Study|Randomized but not treated|0|||
160778656|NCT03369223|580573516|FG017|Overall Study|Randomized but not treated|0|||
160778657|NCT03369223|580573517|FG018|Overall Study|Randomized but not treated|0|||
160778658|NCT03369223|580573518|FG019|Overall Study|Randomized but not treated|0|||
160861862|NCT02531802|580887858|FG013|Received Vaccination 2|Adverse Event|0|||
160861863|NCT02531802|580887859|FG014|Received Vaccination 2|Adverse Event|0|||
160861864|NCT02531802|580887860|FG015|Received Vaccination 2|Adverse Event|0|||
160861865|NCT02531802|580887861|FG016|Received Vaccination 2|Adverse Event|0|||
160861866|NCT02531802|580887862|FG017|Received Vaccination 2|Adverse Event|2|||
160861867|NCT02531802|580887863|FG018|Received Vaccination 2|Adverse Event|1|||
160861868|NCT02531802|580887864|FG019|Received Vaccination 2|Adverse Event|0|||
160861869|NCT02531802|580887865|FG020|Received Vaccination 2|Adverse Event|1|||
160861870|NCT02531802|580887845|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
160861871|NCT02531802|580887846|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
160861872|NCT02531802|580887847|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
160861873|NCT02531802|580887848|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
160861874|NCT02531802|580887849|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
160861875|NCT02531802|580887850|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
160861876|NCT02531802|580887851|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
160861877|NCT02531802|580887852|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
160861878|NCT02531802|580887853|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
160861879|NCT02531802|580887854|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
160861880|NCT02531802|580887855|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
160861881|NCT02531802|580887856|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
160861882|NCT02531802|580887857|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
160861883|NCT02531802|580887858|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
160778659|NCT04706403|580574922|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
160778660|NCT04706403|580574923|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
160778661|NCT04706403|580574924|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
160778662|NCT04706403|580574925|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
160778663|NCT04706403|580574926|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
160778664|NCT01653262|580574927|FG000|Overall Study|Lack of Efficacy|1|||
160778665|NCT01653262|580574927|FG000|Overall Study|SAE, non-fatal|1|||
160778666|NCT01653262|580574927|FG000|Overall Study|AE, non-serious non-fatal|1|||
160778667|NCT01112267|580574928|FG000|Overall Study|Adverse Event|24|||
160778668|NCT01112267|580574929|FG001|Overall Study|Adverse Event|6|||
160778669|NCT01112267|580574928|FG000|Overall Study|Withdrawal by Subject|3|||
160778670|NCT01112267|580574929|FG001|Overall Study|Withdrawal by Subject|5|||
160778671|NCT01112267|580574928|FG000|Overall Study|Protocol Violation|5|||
160778672|NCT01112267|580574929|FG001|Overall Study|Protocol Violation|3|||
160778673|NCT01112267|580574928|FG000|Overall Study|Participants not compliant|1|||
160778674|NCT01112267|580574929|FG001|Overall Study|Participants not compliant|2|||
160778675|NCT01112267|580574928|FG000|Overall Study|Participants not receive any study drug|1|||
160778676|NCT01112267|580574929|FG001|Overall Study|Participants not receive any study drug|2|||
160778677|NCT01373229|580574930|FG000|Overall Study|Death|3|||
160778678|NCT01373229|580574930|FG000|Overall Study|Physician Decision|3|||
160778679|NCT00587457|580574931|FG000|Overall Study|Adverse Event|1|||
160778680|NCT00587457|580574932|FG001|Overall Study|Adverse Event|2|||
160778681|NCT00587457|580574933|FG002|Overall Study|Adverse Event|1|||
160778682|NCT00587457|580574931|FG000|Overall Study|Disease progression|2|||
160778683|NCT00587457|580574932|FG001|Overall Study|Disease progression|0|||
160778684|NCT00587457|580574933|FG002|Overall Study|Disease progression|2|||
160778685|NCT00587457|580574931|FG000|Overall Study|Initiation of alternative therapy|0|||
160778686|NCT00587457|580574932|FG001|Overall Study|Initiation of alternative therapy|1|||
160778687|NCT00587457|580574933|FG002|Overall Study|Initiation of alternative therapy|0|||
160778688|NCT00587457|580574931|FG000|Overall Study|Undefined|0|||
160778689|NCT00587457|580574932|FG001|Overall Study|Undefined|0|||
160778690|NCT00587457|580574933|FG002|Overall Study|Undefined|1|||
160778691|NCT00587457|580574931|FG000|Overall Study|Development of neutralizing Abs|0|||
160778692|NCT00587457|580574932|FG001|Overall Study|Development of neutralizing Abs|0|||
160778693|NCT00587457|580574933|FG002|Overall Study|Development of neutralizing Abs|1|||
160778694|NCT04439175|580574934|FG000|Overall Study|Never started treatment|4|||
160778695|NCT04439175|580574934|FG000|Overall Study|Ineligible|5|||
160778696|NCT04439175|580574934|FG000|Overall Study|Adverse Event|6|||
160778697|NCT04439175|580574934|FG000|Overall Study|Death|4|||
160778698|NCT04439175|580574934|FG000|Overall Study|Disease progression|44|||
160778699|NCT04439175|580574934|FG000|Overall Study|Withdrawal by Subject|4|||
160778700|NCT04439175|580574934|FG000|Overall Study|Alternative Therapy|1|||
160778701|NCT04439175|580574934|FG000|Overall Study|Other|2|||
160778702|NCT05417113|580574937|FG000|Overall Study|Lost to Follow-up|2|||
160778703|NCT05417113|580574938|FG001|Overall Study|Lost to Follow-up|2|||
160778704|NCT01022580|580574939|FG000|Overall Study|Death|18|||
160778705|NCT01022580|580574940|FG001|Overall Study|Death|22|||
160778706|NCT01166945|580574944|FG000|Randomized|diagnosed with Group A strep|4|||
160778707|NCT01166945|580574945|FG001|Randomized|diagnosed with Group A strep|4|||
160778708|NCT01166945|580574944|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
160778709|NCT01166945|580574945|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
160778710|NCT01166945|580574944|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
160778711|NCT01166945|580574945|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
160778712|NCT01166945|580574944|FG000|Day 30|Lost to Follow-up|4|||
160778713|NCT01166945|580574945|FG001|Day 30|Lost to Follow-up|3|||
160778714|NCT01178411|580574948|FG000|Overall Study|Adverse Event|5|||
160778715|NCT01178411|580574948|FG000|Overall Study|Withdrawal by Subject|4|||
160778716|NCT01178411|580574948|FG000|Overall Study|Protocol Violation|1|||
160778717|NCT01178411|580574948|FG000|Overall Study|Progressive disease per RECIST|32|||
160778718|NCT01178411|580574948|FG000|Overall Study|Progressive disease per clinician|9|||
160778719|NCT01178411|580574948|FG000|Overall Study|Physician Decision|6|||
160778720|NCT01178411|580574948|FG000|Overall Study|Death|1|||
160778721|NCT01178411|580574948|FG000|Overall Study|No reason provided|1|||
160778722|NCT01178411|580574948|FG000|Overall Study|Drug manufacturing ended|1|||
160778723|NCT02453048|580574951|FG000|Overall Study|Only part of initial 6 mo. study|0|||
160778724|NCT02453048|580574952|FG001|Overall Study|Only part of initial 6 mo. study|0|||
160778725|NCT02453048|580574953|FG002|Overall Study|Only part of initial 6 mo. study|0|||
160778726|NCT02453048|580574954|FG003|Overall Study|Only part of initial 6 mo. study|0|||
160778727|NCT02453048|580574955|FG004|Overall Study|Only part of initial 6 mo. study|6|||
160778728|NCT02453048|580574951|FG000|Overall Study|Lost to Follow-up|0|||
160778729|NCT02453048|580574952|FG001|Overall Study|Lost to Follow-up|1|||
160778730|NCT02453048|580574953|FG002|Overall Study|Lost to Follow-up|2|||
160778731|NCT02453048|580574954|FG003|Overall Study|Lost to Follow-up|0|||
160778732|NCT02453048|580574955|FG004|Overall Study|Lost to Follow-up|0|||
160778733|NCT02383173|580574957|FG000|Overall Study|Palliative Care Team withdrew|0|||
160778734|NCT02383173|580574958|FG001|Overall Study|Palliative Care Team withdrew|2|||
160778735|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
160778736|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
160778737|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
160778738|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
160778739|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
160778740|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
160778741|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
160778742|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
160778743|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
160778744|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
160778745|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
160778746|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
160778747|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
160778748|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
160778749|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
160778750|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
160778751|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
160778752|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
160778753|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
160778754|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
160778755|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
160778756|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
160778757|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
160778758|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
160778759|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
160778760|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
160778761|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
160778762|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
160778763|NCT03677401|580574961|FG000|Overall Study|Adverse Event|4|||
160778764|NCT03677401|580574962|FG001|Overall Study|Adverse Event|14|||
160778765|NCT03677401|580574961|FG000|Overall Study|Lack of Efficacy|3|||
160778766|NCT03677401|580574962|FG001|Overall Study|Lack of Efficacy|1|||
160778767|NCT03677401|580574961|FG000|Overall Study|Withdrawal by Subject|2|||
160887082|NCT04594369|580980661|FG002|Overall Study|Lost to Follow-up|4|||
160887083|NCT04594369|580980659|FG000|Overall Study|Physician Decision|2|||
160887084|NCT04594369|580980660|FG001|Overall Study|Physician Decision|2|||
160887085|NCT04594369|580980661|FG002|Overall Study|Physician Decision|3|||
160887086|NCT04594369|580980659|FG000|Overall Study|Protocol deviation|1|||
160887087|NCT04594369|580980660|FG001|Overall Study|Protocol deviation|3|||
160887088|NCT04594369|580980661|FG002|Overall Study|Protocol deviation|2|||
160887089|NCT04594369|580980659|FG000|Overall Study|Withdrawal by Subject|40|||
160887090|NCT04594369|580980660|FG001|Overall Study|Withdrawal by Subject|32|||
160887091|NCT04594369|580980661|FG002|Overall Study|Withdrawal by Subject|37|||
160887092|NCT04594369|580980659|FG000|Overall Study|Reason not specified|60|||
160887093|NCT04594369|580980660|FG001|Overall Study|Reason not specified|56|||
160887094|NCT04594369|580980661|FG002|Overall Study|Reason not specified|43|||
160887095|NCT02477696|580980662|FG000|Overall Study|Death|89|||
160887096|NCT02477696|580980663|FG001|Overall Study|Death|106|||
160887097|NCT02477696|580980662|FG000|Overall Study|Lost to Follow-up|7|||
160887098|NCT02477696|580980663|FG001|Overall Study|Lost to Follow-up|5|||
160887099|NCT02477696|580980662|FG000|Overall Study|Withdrawal by Subject|37|||
160887100|NCT02477696|580980663|FG001|Overall Study|Withdrawal by Subject|34|||
160887101|NCT02477696|580980662|FG000|Overall Study|Physician Decision|7|||
160541846|NCT00001379|579712842|FG000|Initial Treatment|Disease progression|21|||
160541847|NCT00001379|579712843|FG001|Initial Treatment|Disease progression|3|||
160887102|NCT02477696|580980663|FG001|Overall Study|Physician Decision|9|||
160541848|NCT00001379|579712844|FG002|Initial Treatment|Disease progression|0|||
160778768|NCT03677401|580574962|FG001|Overall Study|Withdrawal by Subject|2|||
160778769|NCT03677401|580574961|FG000|Overall Study|Sponsor decision|0|||
160778770|NCT03677401|580574962|FG001|Overall Study|Sponsor decision|1|||
160778771|NCT03677401|580574961|FG000|Overall Study|Reason Unspecified|1|||
160778772|NCT03677401|580574962|FG001|Overall Study|Reason Unspecified|0|||
160778773|NCT00726557|580574968|FG000|Overall Study|Screening failure|4|||
160778774|NCT00726557|580574968|FG000|Overall Study|No end of treatment documentation|37|||
160887103|NCT02477696|580980662|FG000|Overall Study|Study terminated by sponsor|103|||
160887104|NCT02477696|580980663|FG001|Overall Study|Study terminated by sponsor|99|||
160541849|NCT00001379|579712845|FG003|Initial Treatment|Disease progression|0|||
160778775|NCT00726557|580574968|FG000|Overall Study|No follow-up documentation available|55|||
160778776|NCT00726557|580574968|FG000|Overall Study|Treatment less than 3 months|17|||
160887105|NCT02477696|580980662|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
160887106|NCT02477696|580980663|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
160778777|NCT00726557|580574968|FG000|Overall Study|Inclusion criteria not met|15|||
160778778|NCT01239745|580574969|FG000|Overall Study|Study terminated by sponsor|45|||
160778779|NCT01239745|580574969|FG000|Overall Study|Adverse Event|1|||
160778780|NCT06262607|580574972|FG000|Overall Study|Physician Decision|0|||
160778781|NCT06262607|580574973|FG001|Overall Study|Physician Decision|1|||
160778782|NCT06262607|580574972|FG000|Overall Study|Withdrawal by Subject|2|||
160778783|NCT06262607|580574973|FG001|Overall Study|Withdrawal by Subject|0|||
160778784|NCT05161936|580574974|FG000|Overall Study|Study terminated by Sponsor|1|||
160778785|NCT05161936|580574975|FG001|Overall Study|Study terminated by Sponsor|0|||
160778786|NCT05161936|580574976|FG002|Overall Study|Study terminated by Sponsor|0|||
160778787|NCT05161936|580574974|FG000|Overall Study|Withdrawal by Subject|0|||
160778788|NCT05161936|580574975|FG001|Overall Study|Withdrawal by Subject|0|||
160778789|NCT05161936|580574976|FG002|Overall Study|Withdrawal by Subject|1|||
160778790|NCT02541903|580574977|FG000|Overall Study|Death|1|||
160778791|NCT02969018|580574982|FG000|Overall Study|Adverse Event|2|||
160778792|NCT02969018|580574983|FG001|Overall Study|Adverse Event|4|||
160778793|NCT02969018|580574984|FG002|Overall Study|Adverse Event|1|||
160778794|NCT02969018|580574985|FG003|Overall Study|Adverse Event|2|||
160778795|NCT02969018|580574986|FG004|Overall Study|Adverse Event|0|||
160778796|NCT02969018|580574987|FG005|Overall Study|Adverse Event|1|||
160778797|NCT02969018|580574988|FG006|Overall Study|Adverse Event|2|||
160778798|NCT02969018|580574989|FG007|Overall Study|Adverse Event|0|||
160778799|NCT02969018|580574982|FG000|Overall Study|Lack of Efficacy|0|||
160778800|NCT02969018|580574983|FG001|Overall Study|Lack of Efficacy|1|||
160778801|NCT02969018|580574984|FG002|Overall Study|Lack of Efficacy|0|||
160778802|NCT02969018|580574985|FG003|Overall Study|Lack of Efficacy|0|||
160778803|NCT02969018|580574986|FG004|Overall Study|Lack of Efficacy|1|||
160778804|NCT02969018|580574987|FG005|Overall Study|Lack of Efficacy|1|||
160778805|NCT02969018|580574988|FG006|Overall Study|Lack of Efficacy|1|||
160778806|NCT02969018|580574989|FG007|Overall Study|Lack of Efficacy|1|||
160778807|NCT02969018|580574982|FG000|Overall Study|Lost to Follow-up|1|||
160778808|NCT02969018|580574983|FG001|Overall Study|Lost to Follow-up|2|||
160778809|NCT02969018|580574984|FG002|Overall Study|Lost to Follow-up|2|||
160778810|NCT02969018|580574985|FG003|Overall Study|Lost to Follow-up|0|||
160778811|NCT02969018|580574986|FG004|Overall Study|Lost to Follow-up|1|||
160778812|NCT02969018|580574987|FG005|Overall Study|Lost to Follow-up|1|||
160887107|NCT02477696|580980662|FG000|Overall Study|Missing/Unknown|2|||
160887108|NCT02477696|580980663|FG001|Overall Study|Missing/Unknown|0|||
160887109|NCT02003365|580981746|FG000|Overall Study|Lost to Follow-up|0|||
160887110|NCT02003365|580981747|FG001|Overall Study|Lost to Follow-up|0|||
160887111|NCT02003365|580981748|FG002|Overall Study|Lost to Follow-up|1|||
160887112|NCT02582255|580981753|FG000|Overall Study|Protocol Violation|0|||
160887113|NCT02582255|580981754|FG001|Overall Study|Protocol Violation|3|||
160887114|NCT01709578|580981755|FG000|Overall Study|Rescued and entered in long term safety|63|||
160887115|NCT01709578|580981756|FG001|Overall Study|Rescued and entered in long term safety|25|||
160887116|NCT01709578|580981757|FG002|Overall Study|Rescued and entered in long term safety|26|||
160887117|NCT01709578|580981755|FG000|Overall Study|Adverse Event|9|||
160887118|NCT01709578|580981756|FG001|Overall Study|Adverse Event|18|||
160887119|NCT01709578|580981757|FG002|Overall Study|Adverse Event|17|||
160887120|NCT01709578|580981755|FG000|Overall Study|Lack of Efficacy|5|||
160887121|NCT01709578|580981756|FG001|Overall Study|Lack of Efficacy|4|||
160887122|NCT01709578|580981757|FG002|Overall Study|Lack of Efficacy|2|||
160887123|NCT01709578|580981755|FG000|Overall Study|Poor compliance to protocol|1|||
160887124|NCT01709578|580981756|FG001|Overall Study|Poor compliance to protocol|2|||
160887125|NCT01709578|580981757|FG002|Overall Study|Poor compliance to protocol|1|||
160887126|NCT01709578|580981755|FG000|Overall Study|Other, not related to safety or efficacy|2|||
160887127|NCT01709578|580981756|FG001|Overall Study|Other, not related to safety or efficacy|7|||
160887128|NCT01709578|580981757|FG002|Overall Study|Other, not related to safety or efficacy|5|||
160887129|NCT04050371|580981758|FG000|Overall Study|Withdrawal by Subject|1|||
160887130|NCT04050371|580981759|FG001|Overall Study|Withdrawal by Subject|0|||
160778813|NCT02969018|580574988|FG006|Overall Study|Lost to Follow-up|0|||
160887131|NCT00597701|580981760|FG000|Overall Study|Withdrawal by Subject|5|||
160778814|NCT02969018|580574989|FG007|Overall Study|Lost to Follow-up|1|||
160778815|NCT02969018|580574982|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778816|NCT02969018|580574983|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778817|NCT02969018|580574984|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778818|NCT02969018|580574985|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778819|NCT02969018|580574986|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778820|NCT02969018|580574987|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778821|NCT02969018|580574988|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
160778822|NCT02969018|580574989|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778823|NCT02969018|580574982|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160887132|NCT00597701|580981761|FG001|Overall Study|Withdrawal by Subject|5|||
160887133|NCT00597701|580981760|FG000|Overall Study|Death|0|||
160887134|NCT00597701|580981761|FG001|Overall Study|Death|1|||
160887135|NCT00597701|580981760|FG000|Overall Study|Physician Decision|2|||
160887136|NCT00597701|580981761|FG001|Overall Study|Physician Decision|0|||
160541850|NCT00001379|579712842|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
160541851|NCT00001379|579712843|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
160541852|NCT00001379|579712844|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
160541853|NCT00001379|579712845|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
160541854|NCT00001379|579712842|FG000|Initial Treatment|Received alternative treatment|2|||
160541855|NCT00001379|579712843|FG001|Initial Treatment|Received alternative treatment|1|||
160541856|NCT00001379|579712844|FG002|Initial Treatment|Received alternative treatment|0|||
160541857|NCT00001379|579712845|FG003|Initial Treatment|Received alternative treatment|0|||
160541858|NCT00001379|579712842|FG000|Initial Treatment|Refused further treatment|2|||
160541859|NCT00001379|579712843|FG001|Initial Treatment|Refused further treatment|0|||
160541860|NCT00001379|579712844|FG002|Initial Treatment|Refused further treatment|0|||
160541861|NCT00001379|579712845|FG003|Initial Treatment|Refused further treatment|0|||
160541862|NCT00001379|579712842|FG000|Initial Treatment|Did not receive protocol treatment|0|||
160541863|NCT00001379|579712843|FG001|Initial Treatment|Did not receive protocol treatment|0|||
160541864|NCT00001379|579712844|FG002|Initial Treatment|Did not receive protocol treatment|5|||
160541865|NCT00001379|579712845|FG003|Initial Treatment|Did not receive protocol treatment|0|||
160778824|NCT02969018|580574983|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160778825|NCT02969018|580574984|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160778826|NCT02969018|580574985|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160778827|NCT02969018|580574986|FG004|Overall Study|Non-Compliance With Study Drug|0|||
160778828|NCT02969018|580574987|FG005|Overall Study|Non-Compliance With Study Drug|0|||
160778829|NCT02969018|580574988|FG006|Overall Study|Non-Compliance With Study Drug|0|||
160887137|NCT00597701|580981760|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
160887138|NCT00597701|580981761|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
160887139|NCT04617795|580981766|FG000|Main Study|Lost to Follow-up|1|||
160887140|NCT04617795|580981767|FG001|Main Study|Lost to Follow-up|0|||
160778830|NCT02969018|580574989|FG007|Overall Study|Non-Compliance With Study Drug|0|||
160778831|NCT02969018|580574982|FG000|Overall Study|Other|0|||
160778832|NCT02969018|580574983|FG001|Overall Study|Other|0|||
160778833|NCT02969018|580574984|FG002|Overall Study|Other|0|||
160778834|NCT02969018|580574985|FG003|Overall Study|Other|1|||
160778835|NCT02969018|580574986|FG004|Overall Study|Other|0|||
160778836|NCT02969018|580574987|FG005|Overall Study|Other|0|||
160778837|NCT02969018|580574988|FG006|Overall Study|Other|0|||
160778838|NCT02969018|580574989|FG007|Overall Study|Other|2|||
160778839|NCT02969018|580574982|FG000|Overall Study|Pregnancy|0|||
160778840|NCT02969018|580574983|FG001|Overall Study|Pregnancy|0|||
160778841|NCT02969018|580574984|FG002|Overall Study|Pregnancy|0|||
160778842|NCT02969018|580574985|FG003|Overall Study|Pregnancy|0|||
160778843|NCT02969018|580574986|FG004|Overall Study|Pregnancy|0|||
160778844|NCT02969018|580574987|FG005|Overall Study|Pregnancy|1|||
160778845|NCT02969018|580574988|FG006|Overall Study|Pregnancy|0|||
160778846|NCT02969018|580574989|FG007|Overall Study|Pregnancy|0|||
160778847|NCT02969018|580574982|FG000|Overall Study|Protocol Violation|0|||
160778848|NCT02969018|580574983|FG001|Overall Study|Protocol Violation|0|||
160778849|NCT02969018|580574984|FG002|Overall Study|Protocol Violation|1|||
160778850|NCT02969018|580574985|FG003|Overall Study|Protocol Violation|1|||
160778851|NCT02969018|580574986|FG004|Overall Study|Protocol Violation|0|||
160778852|NCT02969018|580574987|FG005|Overall Study|Protocol Violation|0|||
160778853|NCT02969018|580574988|FG006|Overall Study|Protocol Violation|0|||
160778854|NCT02969018|580574989|FG007|Overall Study|Protocol Violation|0|||
160778855|NCT02969018|580574982|FG000|Overall Study|Withdrawal by Subject|0|||
160778856|NCT02969018|580574983|FG001|Overall Study|Withdrawal by Subject|1|||
160778857|NCT02969018|580574984|FG002|Overall Study|Withdrawal by Subject|2|||
160778858|NCT02969018|580574985|FG003|Overall Study|Withdrawal by Subject|1|||
160778859|NCT02969018|580574986|FG004|Overall Study|Withdrawal by Subject|0|||
160778860|NCT02969018|580574987|FG005|Overall Study|Withdrawal by Subject|4|||
160778861|NCT02969018|580574988|FG006|Overall Study|Withdrawal by Subject|4|||
160778862|NCT02969018|580574989|FG007|Overall Study|Withdrawal by Subject|3|||
160778863|NCT00376506|580574997|FG000|Overall Study|Death|0|||
160778864|NCT00376506|580574998|FG001|Overall Study|Death|2|||
160887141|NCT00472459|580981768|FG000|Overall Study|Adverse Event|13|||
160887142|NCT00472459|580981769|FG001|Overall Study|Adverse Event|13|||
160541866|NCT00001379|579712842|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
160778865|NCT02503865|580574999|FG000|Overall Study|Moved out of area|1|||
160541867|NCT00001379|579712843|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
160541868|NCT00001379|579712844|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
160778866|NCT02503865|580575000|FG001|Overall Study|Moved out of area|8|||
160778867|NCT02503865|580575001|FG002|Overall Study|Moved out of area|0|||
160778868|NCT02503865|580574999|FG000|Overall Study|Refused treatment|4|||
160778869|NCT02503865|580575000|FG001|Overall Study|Refused treatment|39|||
160778870|NCT02503865|580575001|FG002|Overall Study|Refused treatment|2|||
160778871|NCT02513563|580575006|FG000|Overall Study|Death|4|||
160778872|NCT02513563|580575006|FG000|Overall Study|Withdrawal by Subject|4|||
160887143|NCT00472459|580981768|FG000|Overall Study|Withdrawal by Subject|5|||
160778873|NCT02513563|580575006|FG000|Overall Study|Physician Decision|1|||
160778874|NCT00317369|580575007|FG000|Overall Study|Adverse Event|2|||
160778875|NCT00317369|580575008|FG001|Overall Study|Adverse Event|1|||
160778876|NCT00317369|580575009|FG002|Overall Study|Adverse Event|0|||
160778877|NCT00317369|580575007|FG000|Overall Study|Lack of Efficacy|0|||
160778878|NCT00317369|580575008|FG001|Overall Study|Lack of Efficacy|1|||
160778879|NCT00317369|580575009|FG002|Overall Study|Lack of Efficacy|1|||
160778880|NCT00317369|580575007|FG000|Overall Study|Withdrawal by Subject|0|||
160778881|NCT00317369|580575008|FG001|Overall Study|Withdrawal by Subject|0|||
160778882|NCT00317369|580575009|FG002|Overall Study|Withdrawal by Subject|1|||
160887144|NCT00472459|580981769|FG001|Overall Study|Withdrawal by Subject|5|||
160541869|NCT00001379|579712845|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
160541870|NCT00001379|579712842|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
160541871|NCT00001379|579712843|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
160541872|NCT00001379|579712844|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
160541873|NCT00001379|579712845|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
160541874|NCT00001379|579712842|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
160541875|NCT00001379|579712843|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
160541876|NCT00001379|579712844|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
160541877|NCT00001379|579712845|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
160887145|NCT00472459|580981768|FG000|Overall Study|Protocol Violation|3|||
160887146|NCT00472459|580981769|FG001|Overall Study|Protocol Violation|3|||
160887147|NCT00472459|580981768|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
160887148|NCT00472459|580981769|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
160887149|NCT00472459|580981768|FG000|Overall Study|Lost to Follow-up|1|||
160887150|NCT00472459|580981769|FG001|Overall Study|Lost to Follow-up|1|||
160887151|NCT04850313|580981770|FG000|Overall Study|Withdrawal by Subject|0|||
160887152|NCT04850313|580981771|FG001|Overall Study|Withdrawal by Subject|1|||
160887153|NCT04393298|580981778|FG000|Overall Study|Adverse Event|0|||
160887154|NCT04393298|580981779|FG001|Overall Study|Adverse Event|0|||
160887155|NCT04393298|580981780|FG002|Overall Study|Adverse Event|0|||
160887156|NCT04393298|580981781|FG003|Overall Study|Adverse Event|0|||
160887157|NCT04393298|580981782|FG004|Overall Study|Adverse Event|1|||
160887158|NCT04393298|580981783|FG005|Overall Study|Adverse Event|0|||
160887159|NCT04393298|580981784|FG006|Overall Study|Adverse Event|0|||
160887160|NCT04393298|580981785|FG007|Overall Study|Adverse Event|0|||
160887161|NCT04393298|580981786|FG008|Overall Study|Adverse Event|2|||
160887162|NCT04393298|580981787|FG009|Overall Study|Adverse Event|0|||
160887163|NCT04393298|580981788|FG010|Overall Study|Adverse Event|0|||
160887164|NCT04393298|580981789|FG011|Overall Study|Adverse Event|0|||
160887165|NCT04393298|580981790|FG012|Overall Study|Adverse Event|1|||
160887166|NCT04393298|580981791|FG013|Overall Study|Adverse Event|1|||
160887167|NCT04393298|580981792|FG014|Overall Study|Adverse Event|0|||
160887168|NCT04393298|580981778|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887169|NCT04393298|580981779|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887170|NCT04393298|580981780|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
160887171|NCT04393298|580981781|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887172|NCT04393298|580981782|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887173|NCT04393298|580981783|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887174|NCT04393298|580981784|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160541878|NCT00001379|579712842|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
160541879|NCT00001379|579712843|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
160541880|NCT00001379|579712844|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
160541881|NCT00001379|579712845|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
160541882|NCT00001379|579712842|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
160778883|NCT04069520|580575014|FG000|Overall Study|Lost to Follow-up|0|||
160778884|NCT04069520|580575015|FG001|Overall Study|Lost to Follow-up|2|||
160778885|NCT04069520|580575014|FG000|Overall Study|Withdrawal by Subject|0|||
160778886|NCT04069520|580575015|FG001|Overall Study|Withdrawal by Subject|1|||
160887175|NCT04393298|580981785|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887176|NCT04393298|580981786|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887177|NCT04393298|580981787|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887178|NCT04393298|580981788|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887179|NCT04393298|580981789|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887180|NCT04393298|580981790|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887181|NCT04393298|580981791|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887182|NCT04393298|580981792|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
160887183|NCT04393298|580981778|FG000|Overall Study|Lack of Efficacy|0|||
160887184|NCT04393298|580981779|FG001|Overall Study|Lack of Efficacy|0|||
160887185|NCT04393298|580981780|FG002|Overall Study|Lack of Efficacy|0|||
160778887|NCT04069520|580575014|FG000|Overall Study|Prior Injury|1|||
160778888|NCT04069520|580575015|FG001|Overall Study|Prior Injury|0|||
160778889|NCT04069520|580575014|FG000|Overall Study|Orthodontia|1|||
160778890|NCT04069520|580575015|FG001|Overall Study|Orthodontia|0|||
160778891|NCT04069520|580575014|FG000|Overall Study|Cut from team|0|||
160778892|NCT04069520|580575015|FG001|Overall Study|Cut from team|2|||
160778893|NCT01068912|580575016|FG000|Overall Study|Adverse Event|2|||
160778894|NCT01068912|580575017|FG001|Overall Study|Adverse Event|3|||
160778895|NCT01068912|580575018|FG002|Overall Study|Adverse Event|2|||
160778896|NCT01068912|580575016|FG000|Overall Study|Withdrawal by Subject|5|||
160778897|NCT01068912|580575017|FG001|Overall Study|Withdrawal by Subject|6|||
160778898|NCT01068912|580575018|FG002|Overall Study|Withdrawal by Subject|6|||
160778899|NCT01068912|580575016|FG000|Overall Study|Lost to Follow-up|3|||
160778900|NCT01068912|580575017|FG001|Overall Study|Lost to Follow-up|7|||
160778901|NCT01068912|580575018|FG002|Overall Study|Lost to Follow-up|3|||
160778902|NCT01068912|580575016|FG000|Overall Study|Protocol Violation|0|||
160778903|NCT01068912|580575017|FG001|Overall Study|Protocol Violation|2|||
160778904|NCT01068912|580575018|FG002|Overall Study|Protocol Violation|0|||
160778905|NCT01068912|580575016|FG000|Overall Study|aggravation influenza|1|||
160778906|NCT01068912|580575017|FG001|Overall Study|aggravation influenza|1|||
160778907|NCT01068912|580575018|FG002|Overall Study|aggravation influenza|1|||
160778908|NCT01068912|580575016|FG000|Overall Study|other underlying illness|0|||
160778909|NCT01068912|580575017|FG001|Overall Study|other underlying illness|3|||
160778910|NCT01068912|580575018|FG002|Overall Study|other underlying illness|3|||
160778911|NCT00849472|580575019|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
160778912|NCT00849472|580575019|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
160778913|NCT00849472|580575019|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
160778914|NCT00849472|580575019|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
160778915|NCT00849472|580575019|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
160778916|NCT00849472|580575019|FG000|Weekly Paclitaxel|Disease Progression|1|||
160778917|NCT00849472|580575019|FG000|Weekly Paclitaxel|Adverse Event|11|||
160778918|NCT00849472|580575019|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
160778919|NCT00849472|580575019|FG000|Weekly Paclitaxel|Physician Decision|3|||
160778920|NCT00849472|580575019|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
160778921|NCT00849472|580575019|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
160778922|NCT00849472|580575019|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
160778923|NCT00849472|580575019|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
160778924|NCT00849472|580575019|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
160778925|NCT00849472|580575019|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
160778926|NCT00849472|580575019|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
160778927|NCT00849472|580575019|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
160778928|NCT00825175|580575020|FG000|Overall Study|Withdrawal by Subject|0|||
160778929|NCT00825175|580575021|FG001|Overall Study|Withdrawal by Subject|5|||
160778930|NCT03998462|580575025|FG000|Overall Study|Withdrawal by Subject|10|||
160778931|NCT03998462|580575026|FG001|Overall Study|Withdrawal by Subject|4|||
160778932|NCT03998462|580575025|FG000|Overall Study|Lost to Follow-up|1|||
160778933|NCT03998462|580575026|FG001|Overall Study|Lost to Follow-up|0|||
160778934|NCT03998462|580575025|FG000|Overall Study|Technical Difficulties|1|||
160778935|NCT03998462|580575026|FG001|Overall Study|Technical Difficulties|2|||
160778936|NCT05710224|580575027|FG000|Overall Study|Death|1|||
160778937|NCT05710224|580575028|FG001|Overall Study|Death|0|||
160778938|NCT05710224|580575027|FG000|Overall Study|Lost to Follow-up|16|||
160778939|NCT05710224|580575028|FG001|Overall Study|Lost to Follow-up|7|||
160778940|NCT05710224|580575027|FG000|Overall Study|Withdrawal by Subject|4|||
160778941|NCT05710224|580575028|FG001|Overall Study|Withdrawal by Subject|6|||
160778942|NCT05710224|580575027|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160778943|NCT05710224|580575028|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
160778944|NCT05710224|580575027|FG000|Overall Study|Participants Left The City|0|||
160778945|NCT05710224|580575028|FG001|Overall Study|Participants Left The City|2|||
160778946|NCT05182125|580575029|FG000|Overall Study|Withdrawal by Subject|0|||
160778947|NCT05182125|580575030|FG001|Overall Study|Withdrawal by Subject|0|||
160778948|NCT05182125|580575031|FG002|Overall Study|Withdrawal by Subject|0|||
160778949|NCT05182125|580575032|FG003|Overall Study|Withdrawal by Subject|0|||
160778950|NCT05182125|580575033|FG004|Overall Study|Withdrawal by Subject|2|||
160887186|NCT04393298|580981781|FG003|Overall Study|Lack of Efficacy|0|||
160887187|NCT04393298|580981782|FG004|Overall Study|Lack of Efficacy|0|||
160778951|NCT05182125|580575034|FG005|Overall Study|Withdrawal by Subject|0|||
160778952|NCT05182125|580575029|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
160778953|NCT05182125|580575030|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
160778954|NCT05182125|580575031|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
160778955|NCT05182125|580575032|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
160778956|NCT05182125|580575033|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
160887188|NCT04393298|580981783|FG005|Overall Study|Lack of Efficacy|0|||
160887189|NCT04393298|580981784|FG006|Overall Study|Lack of Efficacy|0|||
160778957|NCT05182125|580575034|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
160778958|NCT05182125|580575029|FG000|Overall Study|Death|0|||
160778959|NCT05182125|580575030|FG001|Overall Study|Death|0|||
160778960|NCT05182125|580575031|FG002|Overall Study|Death|0|||
160778961|NCT05182125|580575032|FG003|Overall Study|Death|0|||
160778962|NCT05182125|580575033|FG004|Overall Study|Death|1|||
160778963|NCT05182125|580575034|FG005|Overall Study|Death|0|||
160778964|NCT04615507|580575035|FG000|Period 1|Covid-19 exposure|2|||
160778965|NCT04615507|580575036|FG001|Period 1|Covid-19 exposure|1|||
160778966|NCT04615507|580575035|FG000|Period 2|Covid-19 exposure|0|||
160778967|NCT04615507|580575036|FG001|Period 2|Covid-19 exposure|1|||
160778968|NCT04615507|580575035|FG000|Period 2|Protocol Violation|1|||
160778969|NCT04615507|580575036|FG001|Period 2|Protocol Violation|0|||
160778970|NCT04615507|580575035|FG000|Period 2|Withdrawal by Subject|1|||
160778971|NCT04615507|580575036|FG001|Period 2|Withdrawal by Subject|0|||
160778972|NCT04615507|580575035|FG000|Period 2|Adverse Event|0|||
160778973|NCT04615507|580575036|FG001|Period 2|Adverse Event|1|||
160778974|NCT04615507|580575035|FG000|Period 3|Covid-19 exposure|0|||
160778975|NCT04615507|580575036|FG001|Period 3|Covid-19 exposure|1|||
160778976|NCT02965833|580575037|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
160778977|NCT02965833|580575038|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
160778978|NCT02965833|580575037|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
160778979|NCT02965833|580575038|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
160778980|NCT02965833|580575037|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
160778981|NCT02965833|580575038|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
160778982|NCT02965833|580575037|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
160778983|NCT02965833|580575038|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
160778984|NCT02965833|580575037|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
160778985|NCT02965833|580575038|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
160778986|NCT03370302|580575040|FG000|Dose Escalation Phase|Other|0|||
160778987|NCT03370302|580575041|FG001|Dose Escalation Phase|Other|1|||
160778988|NCT03370302|580575042|FG002|Dose Escalation Phase|Other|1|||
160778989|NCT03370302|580575043|FG003|Dose Escalation Phase|Other|0|||
160778990|NCT03370302|580575044|FG004|Dose Escalation Phase|Other|0|||
160541883|NCT00001379|579712843|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
160778991|NCT03370302|580575045|FG005|Dose Escalation Phase|Other|0|||
160778992|NCT03370302|580575040|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
160778993|NCT03370302|580575041|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
160778994|NCT03370302|580575042|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
160778995|NCT03370302|580575043|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160778996|NCT03370302|580575044|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
160778997|NCT03370302|580575045|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
160778998|NCT03370302|580575040|FG000|Dose Escalation Phase|Adverse Event|1|||
160778999|NCT03370302|580575041|FG001|Dose Escalation Phase|Adverse Event|0|||
160779000|NCT03370302|580575042|FG002|Dose Escalation Phase|Adverse Event|2|||
160779001|NCT03370302|580575043|FG003|Dose Escalation Phase|Adverse Event|0|||
160779002|NCT03370302|580575044|FG004|Dose Escalation Phase|Adverse Event|0|||
160779003|NCT03370302|580575045|FG005|Dose Escalation Phase|Adverse Event|0|||
160779004|NCT03370302|580575040|FG000|Dose Escalation Phase|Progressive Disease|2|||
160779005|NCT03370302|580575041|FG001|Dose Escalation Phase|Progressive Disease|4|||
160779006|NCT03370302|580575042|FG002|Dose Escalation Phase|Progressive Disease|2|||
160779007|NCT03370302|580575043|FG003|Dose Escalation Phase|Progressive Disease|0|||
160779008|NCT03370302|580575044|FG004|Dose Escalation Phase|Progressive Disease|3|||
160779009|NCT03370302|580575045|FG005|Dose Escalation Phase|Progressive Disease|1|||
160779010|NCT03370302|580575040|FG000|Dose Expansion Phase|Progressive Disease|0|||
160779011|NCT03370302|580575041|FG001|Dose Expansion Phase|Progressive Disease|0|||
160779012|NCT03370302|580575042|FG002|Dose Expansion Phase|Progressive Disease|0|||
160779013|NCT03370302|580575043|FG003|Dose Expansion Phase|Progressive Disease|6|||
160779014|NCT03370302|580575044|FG004|Dose Expansion Phase|Progressive Disease|0|||
160779015|NCT03370302|580575045|FG005|Dose Expansion Phase|Progressive Disease|0|||
160779016|NCT00118287|580575046|FG000|Overall Study|Intracranial haemorrhage|1|||
160779017|NCT00118287|580575046|FG000|Overall Study|Muscle pain|1|||
160779018|NCT03976375|580575047|FG000|Overall Study|Death|158|||
160779019|NCT03976375|580575048|FG001|Overall Study|Death|160|||
160779020|NCT03976375|580575049|FG002|Overall Study|Death|42|||
160779021|NCT03976375|580575047|FG000|Overall Study|Lost to Follow-up|2|||
160779022|NCT03976375|580575048|FG001|Overall Study|Lost to Follow-up|1|||
160779023|NCT03976375|580575049|FG002|Overall Study|Lost to Follow-up|1|||
160779024|NCT03976375|580575047|FG000|Overall Study|Withdrawal by Subject|5|||
160779025|NCT03976375|580575048|FG001|Overall Study|Withdrawal by Subject|9|||
160779026|NCT03976375|580575049|FG002|Overall Study|Withdrawal by Subject|4|||
160779027|NCT03976375|580575047|FG000|Overall Study|Sponsor decision|20|||
160779028|NCT03976375|580575048|FG001|Overall Study|Sponsor decision|19|||
160779029|NCT03976375|580575049|FG002|Overall Study|Sponsor decision|1|||
160779030|NCT03091439|580575050|FG000|Overall Study|Study Terminated by the Sponsor|1|||
160779031|NCT03091439|580575051|FG001|Overall Study|Study Terminated by the Sponsor|0|||
160887190|NCT04393298|580981785|FG007|Overall Study|Lack of Efficacy|0|||
160887191|NCT04393298|580981786|FG008|Overall Study|Lack of Efficacy|0|||
160887192|NCT04393298|580981787|FG009|Overall Study|Lack of Efficacy|0|||
160887193|NCT04393298|580981788|FG010|Overall Study|Lack of Efficacy|0|||
160887194|NCT04393298|580981789|FG011|Overall Study|Lack of Efficacy|0|||
160887195|NCT04393298|580981790|FG012|Overall Study|Lack of Efficacy|0|||
160887196|NCT04393298|580981791|FG013|Overall Study|Lack of Efficacy|0|||
160887197|NCT04393298|580981792|FG014|Overall Study|Lack of Efficacy|1|||
160887198|NCT04393298|580981778|FG000|Overall Study|Progression|1|||
160887199|NCT04393298|580981779|FG001|Overall Study|Progression|0|||
160887200|NCT04393298|580981780|FG002|Overall Study|Progression|0|||
160887201|NCT04393298|580981781|FG003|Overall Study|Progression|0|||
160887202|NCT04393298|580981782|FG004|Overall Study|Progression|0|||
160887203|NCT04393298|580981783|FG005|Overall Study|Progression|0|||
160887204|NCT04393298|580981784|FG006|Overall Study|Progression|0|||
160887205|NCT04393298|580981785|FG007|Overall Study|Progression|0|||
160887206|NCT04393298|580981786|FG008|Overall Study|Progression|0|||
160887207|NCT04393298|580981787|FG009|Overall Study|Progression|0|||
160887208|NCT04393298|580981788|FG010|Overall Study|Progression|1|||
160887209|NCT04393298|580981789|FG011|Overall Study|Progression|1|||
160887210|NCT04393298|580981790|FG012|Overall Study|Progression|0|||
160887211|NCT04393298|580981791|FG013|Overall Study|Progression|0|||
160887212|NCT04393298|580981792|FG014|Overall Study|Progression|0|||
160887213|NCT04393298|580981778|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
160887214|NCT04393298|580981779|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887215|NCT04393298|580981780|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887216|NCT04393298|580981781|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887217|NCT04393298|580981782|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887218|NCT04393298|580981783|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887219|NCT04393298|580981784|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887220|NCT04393298|580981785|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887221|NCT04393298|580981786|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887222|NCT04393298|580981787|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887223|NCT04393298|580981788|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887224|NCT04393298|580981789|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887225|NCT04393298|580981790|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887226|NCT04393298|580981791|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887227|NCT04393298|580981792|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887228|NCT04393298|580981778|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887229|NCT04393298|580981779|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
160887230|NCT04393298|580981780|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887231|NCT04393298|580981781|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160779032|NCT03122106|580575052|FG000|Overall Study|Not enough tissue|1|||
160779033|NCT03122106|580575052|FG000|Overall Study|Disease progression during screening|2|||
160779034|NCT03122106|580575052|FG000|Overall Study|Poor RNA quality for vaccine|1|||
160779035|NCT02347787|580575053|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
160779036|NCT02347787|580575054|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
160779037|NCT02347787|580575053|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
160779038|NCT02347787|580575054|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
160779039|NCT02347787|580575053|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
160779040|NCT02347787|580575054|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
160779041|NCT02347787|580575053|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
160779042|NCT02347787|580575054|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
160779043|NCT00308685|580575056|FG000|Overall Study|Lost to Follow-up|1|||
160779044|NCT00308685|580575057|FG001|Overall Study|Lost to Follow-up|0|||
160779045|NCT00308685|580575056|FG000|Overall Study|Need to administer prohibited medication|1|||
160779046|NCT00308685|580575057|FG001|Overall Study|Need to administer prohibited medication|2|||
160779047|NCT00308685|580575056|FG000|Overall Study|Other than specified|1|||
160779048|NCT00308685|580575057|FG001|Overall Study|Other than specified|3|||
160887232|NCT04393298|580981782|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887233|NCT04393298|580981783|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887234|NCT04393298|580981784|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887235|NCT04393298|580981785|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887236|NCT04393298|580981786|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887237|NCT04393298|580981787|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887238|NCT04393298|580981788|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887239|NCT04393298|580981789|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887240|NCT04393298|580981790|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887241|NCT04393298|580981791|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887242|NCT04393298|580981792|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887243|NCT04393298|580981778|FG000|Overall Study|Clinical Progression|0|||
160887244|NCT04393298|580981779|FG001|Overall Study|Clinical Progression|2|||
160887245|NCT04393298|580981780|FG002|Overall Study|Clinical Progression|0|||
160779049|NCT02850406|580575061|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
160887246|NCT04393298|580981781|FG003|Overall Study|Clinical Progression|0|||
160887247|NCT04393298|580981782|FG004|Overall Study|Clinical Progression|0|||
160887248|NCT04393298|580981783|FG005|Overall Study|Clinical Progression|0|||
160887249|NCT04393298|580981784|FG006|Overall Study|Clinical Progression|0|||
160887250|NCT04393298|580981785|FG007|Overall Study|Clinical Progression|0|||
160887251|NCT04393298|580981786|FG008|Overall Study|Clinical Progression|0|||
160887252|NCT04393298|580981787|FG009|Overall Study|Clinical Progression|0|||
160887253|NCT04393298|580981788|FG010|Overall Study|Clinical Progression|0|||
160887254|NCT04393298|580981789|FG011|Overall Study|Clinical Progression|0|||
160887255|NCT04393298|580981790|FG012|Overall Study|Clinical Progression|0|||
160887256|NCT04393298|580981791|FG013|Overall Study|Clinical Progression|0|||
160887257|NCT04393298|580981792|FG014|Overall Study|Clinical Progression|0|||
160887258|NCT04393298|580981778|FG000|Overall Study|Disease Progression|0|||
160887259|NCT04393298|580981779|FG001|Overall Study|Disease Progression|1|||
160779050|NCT02850406|580575062|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779051|NCT02850406|580575063|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779052|NCT02850406|580575064|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
160779053|NCT02850406|580575065|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779054|NCT02850406|580575066|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779055|NCT02850406|580575067|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779056|NCT02850406|580575068|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779057|NCT02850406|580575061|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779058|NCT02850406|580575062|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779059|NCT02850406|580575063|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
160779060|NCT02850406|580575064|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
160779061|NCT02850406|580575065|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779062|NCT02850406|580575066|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779063|NCT02850406|580575067|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779064|NCT02850406|580575068|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779065|NCT02850406|580575061|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779066|NCT02850406|580575062|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779067|NCT02850406|580575063|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
160779068|NCT02850406|580575064|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779069|NCT02850406|580575065|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779070|NCT02850406|580575066|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779071|NCT02850406|580575067|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779072|NCT02850406|580575068|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779073|NCT02850406|580575061|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
160779074|NCT02850406|580575062|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
160779075|NCT02850406|580575063|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
160779076|NCT02850406|580575064|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
160779077|NCT02850406|580575065|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
160779078|NCT02850406|580575066|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
160779079|NCT02850406|580575067|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
160779080|NCT02850406|580575068|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
160779081|NCT02850406|580575061|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779082|NCT02850406|580575062|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779083|NCT02850406|580575063|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779084|NCT02850406|580575064|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779085|NCT02850406|580575065|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
160779086|NCT02850406|580575066|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
160779087|NCT02850406|580575067|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779088|NCT02850406|580575068|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779089|NCT02850406|580575061|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779090|NCT02850406|580575062|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779091|NCT02850406|580575063|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779092|NCT02850406|580575064|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779093|NCT02850406|580575065|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
160779094|NCT02850406|580575066|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
160779095|NCT02850406|580575067|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779096|NCT02850406|580575068|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779097|NCT02850406|580575061|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779098|NCT02850406|580575062|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779099|NCT02850406|580575063|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779100|NCT02850406|580575064|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779101|NCT02850406|580575065|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
160779102|NCT02850406|580575066|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779103|NCT02850406|580575067|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779104|NCT02850406|580575068|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779105|NCT02850406|580575061|FG000|Part C (Up to 52 Weeks)|Other|0|||
160779106|NCT02850406|580575062|FG001|Part C (Up to 52 Weeks)|Other|0|||
160779107|NCT02850406|580575063|FG002|Part C (Up to 52 Weeks)|Other|0|||
160887260|NCT04393298|580981780|FG002|Overall Study|Disease Progression|0|||
160779108|NCT02850406|580575064|FG003|Part C (Up to 52 Weeks)|Other|0|||
160779109|NCT02850406|580575065|FG004|Part C (Up to 52 Weeks)|Other|1|||
160779110|NCT02850406|580575066|FG005|Part C (Up to 52 Weeks)|Other|3|||
160779111|NCT02850406|580575067|FG006|Part C (Up to 52 Weeks)|Other|0|||
160779112|NCT02850406|580575068|FG007|Part C (Up to 52 Weeks)|Other|0|||
160779113|NCT02850406|580575061|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779114|NCT02850406|580575062|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779115|NCT02850406|580575063|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779116|NCT02850406|580575064|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779117|NCT02850406|580575065|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779118|NCT02850406|580575066|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779119|NCT02850406|580575067|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
160779120|NCT02850406|580575068|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779121|NCT02850406|580575061|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779122|NCT02850406|580575062|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779123|NCT02850406|580575063|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779124|NCT02850406|580575064|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779125|NCT02850406|580575065|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779126|NCT02850406|580575066|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779127|NCT02850406|580575067|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779128|NCT02850406|580575068|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
160779129|NCT02850406|580575061|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779130|NCT02850406|580575062|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779131|NCT02850406|580575063|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779132|NCT02850406|580575064|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779133|NCT02850406|580575065|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779134|NCT02850406|580575066|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779135|NCT02850406|580575067|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
160779136|NCT02850406|580575068|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
160779137|NCT02850406|580575061|FG000|Part D (Up to 52 Weeks)|Other|0|||
160779138|NCT02850406|580575062|FG001|Part D (Up to 52 Weeks)|Other|0|||
160779139|NCT02850406|580575063|FG002|Part D (Up to 52 Weeks)|Other|0|||
160779140|NCT02850406|580575064|FG003|Part D (Up to 52 Weeks)|Other|0|||
160779141|NCT02850406|580575065|FG004|Part D (Up to 52 Weeks)|Other|0|||
160779142|NCT02850406|580575066|FG005|Part D (Up to 52 Weeks)|Other|0|||
160779143|NCT02850406|580575067|FG006|Part D (Up to 52 Weeks)|Other|0|||
160779144|NCT02850406|580575068|FG007|Part D (Up to 52 Weeks)|Other|1|||
160779145|NCT04167670|580576589|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
160779146|NCT04167670|580576590|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
160779147|NCT04167670|580576591|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
160779148|NCT04167670|580576589|FG000|Overall Study|Significant protocol deviation|3|||
160779149|NCT04167670|580576590|FG001|Overall Study|Significant protocol deviation|1|||
160779150|NCT04167670|580576591|FG002|Overall Study|Significant protocol deviation|0|||
160779151|NCT04167670|580576589|FG000|Overall Study|Lost to Follow-up|0|||
160779152|NCT04167670|580576590|FG001|Overall Study|Lost to Follow-up|3|||
160779153|NCT04167670|580576591|FG002|Overall Study|Lost to Follow-up|3|||
160779154|NCT04167670|580576589|FG000|Overall Study|Voluntary Withdrawal|0|||
160779155|NCT04167670|580576590|FG001|Overall Study|Voluntary Withdrawal|1|||
160779156|NCT04167670|580576591|FG002|Overall Study|Voluntary Withdrawal|1|||
160779157|NCT04167670|580576589|FG000|Overall Study|Withdrawal of Consent|4|||
160779158|NCT04167670|580576590|FG001|Overall Study|Withdrawal of Consent|1|||
160779159|NCT04167670|580576591|FG002|Overall Study|Withdrawal of Consent|3|||
160779160|NCT04167670|580576589|FG000|Overall Study|Miscellaneous|7|||
160779161|NCT04167670|580576590|FG001|Overall Study|Miscellaneous|5|||
160779162|NCT04167670|580576591|FG002|Overall Study|Miscellaneous|3|||
160779163|NCT04827446|580576592|FG000|Overall Study|Lost to Follow-up|1|||
160779164|NCT04827446|580576593|FG001|Overall Study|Lost to Follow-up|1|||
160779165|NCT04827446|580576592|FG000|Overall Study|Death|2|||
160779166|NCT04827446|580576593|FG001|Overall Study|Death|0|||
160779167|NCT04827446|580576592|FG000|Overall Study|Withdrawal by Subject|2|||
160779168|NCT04827446|580576593|FG001|Overall Study|Withdrawal by Subject|2|||
160779169|NCT01363076|580576596|FG000|Overall Study|Withdrawal by Subject|0|||
160779170|NCT01363076|580576597|FG001|Overall Study|Withdrawal by Subject|1|||
160779171|NCT02642679|580576598|FG000|Overall Study|Withdrawal by Subject|1|||
160779172|NCT02642679|580576598|FG000|Overall Study|Physician Decision|1|||
160779173|NCT02642679|580576598|FG000|Overall Study|Physician Decision|1|||
160779174|NCT03735498|580576599|FG000|Overall Study|Withdrawal by Subject|3|||
160779175|NCT03735498|580576599|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
160779176|NCT02014103|580576601|FG000|Overall Study|Protocol Violation|7|||
160779177|NCT02014103|580576602|FG001|Overall Study|Protocol Violation|7|||
160779178|NCT02014103|580576601|FG000|Overall Study|Adverse Event|1|||
160779179|NCT02014103|580576602|FG001|Overall Study|Adverse Event|0|||
160779180|NCT02014103|580576601|FG000|Overall Study|Lost venous access|1|||
160779181|NCT02014103|580576602|FG001|Overall Study|Lost venous access|0|||
160541884|NCT00001379|579712844|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
160541885|NCT00001379|579712845|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
160541886|NCT01577186|579712851|FG000|Overall Study|Adverse Event|23|||
160541887|NCT01577186|579712851|FG000|Overall Study|Death|1|||
160541888|NCT01577186|579712851|FG000|Overall Study|Lost to Follow-up|28|||
160541889|NCT01577186|579712851|FG000|Overall Study|Withdrawal by Subject|35|||
160541890|NCT01577186|579712851|FG000|Overall Study|Insufficient Response|18|||
160541891|NCT01577186|579712851|FG000|Overall Study|Ineligible to Continue|15|||
160541892|NCT01577186|579712851|FG000|Overall Study|Non-Compliant|8|||
160541893|NCT01577186|579712851|FG000|Overall Study|Other|2|||
160541894|NCT01032915|579712852|FG000|Overall Study|Adverse Event|2|||
160541895|NCT01032915|579712853|FG001|Overall Study|Adverse Event|2|||
160541896|NCT01032915|579712854|FG002|Overall Study|Adverse Event|1|||
160541897|NCT01032915|579712855|FG003|Overall Study|Adverse Event|1|||
160541898|NCT01032915|579712852|FG000|Overall Study|Abnormal test procedure result|0|||
160541899|NCT01032915|579712853|FG001|Overall Study|Abnormal test procedure result|0|||
160541900|NCT01032915|579712854|FG002|Overall Study|Abnormal test procedure result|1|||
160541901|NCT01032915|579712855|FG003|Overall Study|Abnormal test procedure result|0|||
160541902|NCT01032915|579712852|FG000|Overall Study|Withdrawal by Subject|0|||
160541903|NCT01032915|579712853|FG001|Overall Study|Withdrawal by Subject|3|||
160541904|NCT01032915|579712854|FG002|Overall Study|Withdrawal by Subject|1|||
160541905|NCT01032915|579712855|FG003|Overall Study|Withdrawal by Subject|1|||
160541906|NCT01032915|579712852|FG000|Overall Study|Administrative reasons|5|||
160541907|NCT01032915|579712853|FG001|Overall Study|Administrative reasons|6|||
160541908|NCT01032915|579712854|FG002|Overall Study|Administrative reasons|4|||
160541909|NCT01032915|579712855|FG003|Overall Study|Administrative reasons|4|||
160541910|NCT01032915|579712852|FG000|Overall Study|Protocol Violation|1|||
160541911|NCT01032915|579712853|FG001|Overall Study|Protocol Violation|0|||
160541912|NCT01032915|579712854|FG002|Overall Study|Protocol Violation|0|||
160541913|NCT01032915|579712855|FG003|Overall Study|Protocol Violation|1|||
160541914|NCT02915523|579712857|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
160541915|NCT02915523|579712858|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
160541916|NCT02915523|579712859|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
160541917|NCT02915523|579712860|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
160541918|NCT02915523|579712857|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
160541919|NCT02915523|579712858|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
160541920|NCT02915523|579712859|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
160541921|NCT02915523|579712860|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
160541922|NCT02915523|579712857|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
160541923|NCT02915523|579712858|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
160541924|NCT02915523|579712859|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
160541925|NCT02915523|579712860|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
160541926|NCT02915523|579712857|FG000|Expansion Phase (Phase 2)|Death|0|||
160541927|NCT02915523|579712858|FG001|Expansion Phase (Phase 2)|Death|0|||
160541928|NCT02915523|579712859|FG002|Expansion Phase (Phase 2)|Death|26|||
160541929|NCT02915523|579712860|FG003|Expansion Phase (Phase 2)|Death|53|||
160541930|NCT02915523|579712857|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
160541931|NCT02915523|579712858|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
160541932|NCT02915523|579712859|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
160541933|NCT02915523|579712860|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
160541934|NCT02915523|579712857|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
160541935|NCT02915523|579712858|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
160541936|NCT02915523|579712859|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
160541937|NCT02915523|579712860|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
160541938|NCT02915523|579712857|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
160779182|NCT02014103|580576601|FG000|Overall Study|Withdrawal by Subject|0|||
160779183|NCT02014103|580576602|FG001|Overall Study|Withdrawal by Subject|2|||
160779184|NCT05638737|580576603|FG000|Overall Study|Withdrawal by Subject|4|||
160779185|NCT05638737|580576604|FG001|Overall Study|Withdrawal by Subject|7|||
160779186|NCT02927145|580576609|FG000|Initial Recruitment|Withdrawal by Subject|0|||
160779187|NCT02927145|580576610|FG001|Initial Recruitment|Withdrawal by Subject|1|||
160779188|NCT02927145|580576611|FG002|Initial Recruitment|Withdrawal by Subject|1|||
160779189|NCT02927145|580576612|FG003|Initial Recruitment|Withdrawal by Subject|4|||
160779190|NCT02927145|580576613|FG004|Initial Recruitment|Withdrawal by Subject|1|||
160779191|NCT02927145|580576614|FG005|Initial Recruitment|Withdrawal by Subject|1|||
160779192|NCT02927145|580576615|FG006|Initial Recruitment|Withdrawal by Subject|0|||
160779193|NCT02927145|580576616|FG007|Initial Recruitment|Withdrawal by Subject|0|||
160779194|NCT02927145|580576617|FG008|Initial Recruitment|Withdrawal by Subject|2|||
160779195|NCT02927145|580576609|FG000|Initial Recruitment|Adverse Event|0|||
160779196|NCT02927145|580576610|FG001|Initial Recruitment|Adverse Event|0|||
160779197|NCT02927145|580576611|FG002|Initial Recruitment|Adverse Event|0|||
160779198|NCT02927145|580576612|FG003|Initial Recruitment|Adverse Event|0|||
160779199|NCT02927145|580576613|FG004|Initial Recruitment|Adverse Event|2|||
160779200|NCT02927145|580576614|FG005|Initial Recruitment|Adverse Event|0|||
160779201|NCT02927145|580576615|FG006|Initial Recruitment|Adverse Event|0|||
160779202|NCT02927145|580576616|FG007|Initial Recruitment|Adverse Event|0|||
160779203|NCT02927145|580576617|FG008|Initial Recruitment|Adverse Event|0|||
160779204|NCT02927145|580576609|FG000|Invitation for Additional Challenge|Pregnancy|0|||
160779205|NCT02927145|580576610|FG001|Invitation for Additional Challenge|Pregnancy|0|||
160779206|NCT02927145|580576611|FG002|Invitation for Additional Challenge|Pregnancy|0|||
160779207|NCT02927145|580576612|FG003|Invitation for Additional Challenge|Pregnancy|0|||
160779208|NCT02927145|580576613|FG004|Invitation for Additional Challenge|Pregnancy|0|||
160779209|NCT02927145|580576614|FG005|Invitation for Additional Challenge|Pregnancy|0|||
160779210|NCT02927145|580576615|FG006|Invitation for Additional Challenge|Pregnancy|1|||
160779211|NCT02927145|580576616|FG007|Invitation for Additional Challenge|Pregnancy|0|||
160779212|NCT02927145|580576617|FG008|Invitation for Additional Challenge|Pregnancy|0|||
160779213|NCT01617967|580576621|FG000|Overall Study|Protocol Violation|0|||
160779214|NCT01617967|580576622|FG001|Overall Study|Protocol Violation|0|||
160779215|NCT01617967|580576623|FG002|Overall Study|Protocol Violation|0|||
160779216|NCT01617967|580576624|FG003|Overall Study|Protocol Violation|1|||
160779217|NCT01617967|580576625|FG004|Overall Study|Protocol Violation|0|||
160779218|NCT01617967|580576626|FG005|Overall Study|Protocol Violation|0|||
160779219|NCT01617967|580576621|FG000|Overall Study|Withdrawal by Subject|0|||
160779220|NCT01617967|580576622|FG001|Overall Study|Withdrawal by Subject|0|||
160779221|NCT01617967|580576623|FG002|Overall Study|Withdrawal by Subject|0|||
160779222|NCT01617967|580576624|FG003|Overall Study|Withdrawal by Subject|0|||
160779223|NCT01617967|580576625|FG004|Overall Study|Withdrawal by Subject|0|||
160779224|NCT01617967|580576626|FG005|Overall Study|Withdrawal by Subject|1|||
160779225|NCT01617967|580576621|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
160779226|NCT01617967|580576622|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
160779227|NCT01617967|580576623|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
160779228|NCT01617967|580576624|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
160779229|NCT01617967|580576625|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
160779230|NCT01617967|580576626|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
160779231|NCT00416949|580576627|FG000|Overall Study|Patients refused to participate|5|||
160779232|NCT01137812|580576630|FG000|Overall Study|Adverse Event|21|||
160779233|NCT01137812|580576631|FG001|Overall Study|Adverse Event|14|||
160779234|NCT01137812|580576630|FG000|Overall Study|Lost to Follow-up|6|||
160779235|NCT01137812|580576631|FG001|Overall Study|Lost to Follow-up|8|||
160779236|NCT01137812|580576630|FG000|Overall Study|Physician Decision|25|||
160779237|NCT01137812|580576631|FG001|Overall Study|Physician Decision|17|||
160779238|NCT01137812|580576630|FG000|Overall Study|Protocol Violation|5|||
160779239|NCT01137812|580576631|FG001|Overall Study|Protocol Violation|4|||
160779240|NCT01137812|580576630|FG000|Overall Study|Withdrawal by Subject|5|||
160779241|NCT01137812|580576631|FG001|Overall Study|Withdrawal by Subject|13|||
160779242|NCT01137812|580576630|FG000|Overall Study|Death|2|||
160779243|NCT01137812|580576631|FG001|Overall Study|Death|0|||
160779244|NCT01137812|580576630|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
160779245|NCT01137812|580576631|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
160779246|NCT01137812|580576630|FG000|Overall Study|Other|19|||
160779247|NCT01137812|580576631|FG001|Overall Study|Other|27|||
160779248|NCT00574951|580576634|FG000|Overall Study|Ineligible - improper prior treatment|1|||
160779249|NCT03142750|580576635|FG000|Overall Study|Lost to Follow-up|4|||
160779250|NCT03142750|580576636|FG001|Overall Study|Lost to Follow-up|1|||
160779251|NCT04925934|580576639|FG000|Overall Study|Adverse Event|1|||
160779252|NCT04925934|580576640|FG001|Overall Study|Adverse Event|0|||
160779253|NCT04925934|580576641|FG002|Overall Study|Adverse Event|0|||
160779254|NCT04925934|580576639|FG000|Overall Study|Lost to Follow-up|2|||
160779255|NCT04925934|580576640|FG001|Overall Study|Lost to Follow-up|0|||
160779256|NCT04925934|580576641|FG002|Overall Study|Lost to Follow-up|1|||
160779257|NCT04925934|580576639|FG000|Overall Study|Death|0|||
160779258|NCT04925934|580576640|FG001|Overall Study|Death|1|||
160779259|NCT04925934|580576641|FG002|Overall Study|Death|0|||
160779260|NCT04925934|580576639|FG000|Overall Study|Withdrawal by Subject|8|||
160779261|NCT04925934|580576640|FG001|Overall Study|Withdrawal by Subject|5|||
160779262|NCT04925934|580576641|FG002|Overall Study|Withdrawal by Subject|9|||
160779263|NCT04925934|580576639|FG000|Overall Study|Other|2|||
160779264|NCT04925934|580576640|FG001|Overall Study|Other|2|||
160779265|NCT04925934|580576641|FG002|Overall Study|Other|2|||
160779266|NCT04925934|580576639|FG000|Overall Study|Eastern European Conflict|7|||
160779267|NCT04925934|580576640|FG001|Overall Study|Eastern European Conflict|3|||
160887261|NCT04393298|580981781|FG003|Overall Study|Disease Progression|0|||
160887262|NCT04393298|580981782|FG004|Overall Study|Disease Progression|0|||
160887263|NCT04393298|580981783|FG005|Overall Study|Disease Progression|3|||
160887264|NCT04393298|580981784|FG006|Overall Study|Disease Progression|2|||
160887265|NCT04393298|580981785|FG007|Overall Study|Disease Progression|1|||
160887266|NCT04393298|580981786|FG008|Overall Study|Disease Progression|2|||
160887267|NCT04393298|580981787|FG009|Overall Study|Disease Progression|1|||
160887268|NCT04393298|580981788|FG010|Overall Study|Disease Progression|0|||
160887269|NCT04393298|580981789|FG011|Overall Study|Disease Progression|3|||
160887270|NCT04393298|580981790|FG012|Overall Study|Disease Progression|0|||
160887271|NCT04393298|580981791|FG013|Overall Study|Disease Progression|0|||
160887272|NCT04393298|580981792|FG014|Overall Study|Disease Progression|1|||
160887273|NCT04393298|580981778|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887274|NCT04393298|580981779|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887275|NCT04393298|580981780|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
160887276|NCT04393298|580981781|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887277|NCT04393298|580981782|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887278|NCT04393298|580981783|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887279|NCT04393298|580981784|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887280|NCT04393298|580981785|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887281|NCT04393298|580981786|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887282|NCT04393298|580981787|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887283|NCT04393298|580981788|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887284|NCT04393298|580981789|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887285|NCT04393298|580981790|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887286|NCT04393298|580981791|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887287|NCT04393298|580981792|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887288|NCT04393298|580981778|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887289|NCT04393298|580981779|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887290|NCT04393298|580981780|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
160887291|NCT04393298|580981781|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887292|NCT04393298|580981782|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887293|NCT04393298|580981783|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887294|NCT04393298|580981784|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887295|NCT04393298|580981785|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887296|NCT04393298|580981786|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887297|NCT04393298|580981787|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887298|NCT04393298|580981788|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887299|NCT04393298|580981789|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887300|NCT04393298|580981790|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887301|NCT04393298|580981791|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887302|NCT04393298|580981792|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887303|NCT04393298|580981778|FG000|Overall Study|Progressive Disease (PD)|0|||
160887304|NCT04393298|580981779|FG001|Overall Study|Progressive Disease (PD)|0|||
160887305|NCT04393298|580981780|FG002|Overall Study|Progressive Disease (PD)|0|||
160887306|NCT04393298|580981781|FG003|Overall Study|Progressive Disease (PD)|3|||
160779268|NCT04925934|580576641|FG002|Overall Study|Eastern European Conflict|2|||
160779269|NCT04425018|580576642|FG000|Overall Study|Withdrawal by Subject|1|||
160887307|NCT04393298|580981782|FG004|Overall Study|Progressive Disease (PD)|0|||
160887308|NCT04393298|580981783|FG005|Overall Study|Progressive Disease (PD)|0|||
160887309|NCT04393298|580981784|FG006|Overall Study|Progressive Disease (PD)|0|||
160887310|NCT04393298|580981785|FG007|Overall Study|Progressive Disease (PD)|0|||
160887311|NCT04393298|580981786|FG008|Overall Study|Progressive Disease (PD)|0|||
160887312|NCT04393298|580981787|FG009|Overall Study|Progressive Disease (PD)|0|||
160887313|NCT04393298|580981788|FG010|Overall Study|Progressive Disease (PD)|0|||
160887314|NCT04393298|580981789|FG011|Overall Study|Progressive Disease (PD)|0|||
160887315|NCT04393298|580981790|FG012|Overall Study|Progressive Disease (PD)|0|||
160887316|NCT04393298|580981791|FG013|Overall Study|Progressive Disease (PD)|0|||
160887317|NCT04393298|580981792|FG014|Overall Study|Progressive Disease (PD)|0|||
160887318|NCT04393298|580981778|FG000|Overall Study|Started a New Cancer Treatment|0|||
160887319|NCT04393298|580981779|FG001|Overall Study|Started a New Cancer Treatment|0|||
160887320|NCT04393298|580981780|FG002|Overall Study|Started a New Cancer Treatment|0|||
160887321|NCT04393298|580981781|FG003|Overall Study|Started a New Cancer Treatment|0|||
160887322|NCT04393298|580981782|FG004|Overall Study|Started a New Cancer Treatment|1|||
160887323|NCT04393298|580981783|FG005|Overall Study|Started a New Cancer Treatment|0|||
160887324|NCT04393298|580981784|FG006|Overall Study|Started a New Cancer Treatment|0|||
160887325|NCT04393298|580981785|FG007|Overall Study|Started a New Cancer Treatment|0|||
160887326|NCT04393298|580981786|FG008|Overall Study|Started a New Cancer Treatment|0|||
160887327|NCT04393298|580981787|FG009|Overall Study|Started a New Cancer Treatment|0|||
160887328|NCT04393298|580981788|FG010|Overall Study|Started a New Cancer Treatment|0|||
160887329|NCT04393298|580981789|FG011|Overall Study|Started a New Cancer Treatment|0|||
160887330|NCT04393298|580981790|FG012|Overall Study|Started a New Cancer Treatment|0|||
160887331|NCT04393298|580981791|FG013|Overall Study|Started a New Cancer Treatment|0|||
160887332|NCT04393298|580981792|FG014|Overall Study|Started a New Cancer Treatment|0|||
160887333|NCT04393298|580981778|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887334|NCT04393298|580981779|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887335|NCT04393298|580981780|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887336|NCT04393298|580981781|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887337|NCT04393298|580981782|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
160887338|NCT04393298|580981783|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887339|NCT04393298|580981784|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887340|NCT04393298|580981785|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887341|NCT04393298|580981786|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887342|NCT04393298|580981787|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887343|NCT04393298|580981788|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887344|NCT04393298|580981789|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887345|NCT04393298|580981790|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887346|NCT04393298|580981791|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887347|NCT04393298|580981792|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887348|NCT04393298|580981778|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887349|NCT04393298|580981779|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887350|NCT04393298|580981780|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887351|NCT04393298|580981781|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887352|NCT04393298|580981782|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887353|NCT04393298|580981783|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
160887354|NCT04393298|580981784|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887355|NCT04393298|580981785|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887356|NCT04393298|580981786|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887357|NCT04393298|580981787|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887358|NCT04393298|580981788|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887359|NCT04393298|580981789|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887360|NCT04393298|580981790|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887361|NCT04393298|580981791|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887362|NCT04393298|580981792|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887363|NCT04393298|580981778|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887364|NCT04393298|580981779|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887365|NCT04393298|580981780|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887366|NCT04393298|580981781|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887367|NCT04393298|580981782|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887368|NCT04393298|580981783|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
160887369|NCT04393298|580981784|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887370|NCT04393298|580981785|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887371|NCT04393298|580981786|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887372|NCT04393298|580981787|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887373|NCT04393298|580981788|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887374|NCT04393298|580981789|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887375|NCT04393298|580981790|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887376|NCT04393298|580981791|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887377|NCT04393298|580981792|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
160887378|NCT04393298|580981778|FG000|Overall Study|Death|0|||
160887379|NCT04393298|580981779|FG001|Overall Study|Death|0|||
160541939|NCT02915523|579712858|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
160887380|NCT04393298|580981780|FG002|Overall Study|Death|0|||
160887381|NCT04393298|580981781|FG003|Overall Study|Death|0|||
160887382|NCT04393298|580981782|FG004|Overall Study|Death|0|||
160541940|NCT02915523|579712859|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
160541941|NCT02915523|579712860|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
160541942|NCT00143312|579712872|FG000|Overall Study|Death|11|||
160541943|NCT00143312|579712872|FG000|Overall Study|Adverse Event|2|||
160541944|NCT00143312|579712872|FG000|Overall Study|Lost to Follow-up|1|||
160541945|NCT00143312|579712872|FG000|Overall Study|Other|1|||
160887383|NCT04393298|580981783|FG005|Overall Study|Death|1|||
160887384|NCT04393298|580981784|FG006|Overall Study|Death|1|||
160887385|NCT04393298|580981785|FG007|Overall Study|Death|0|||
160887386|NCT04393298|580981786|FG008|Overall Study|Death|1|||
160887387|NCT04393298|580981787|FG009|Overall Study|Death|1|||
160887388|NCT04393298|580981788|FG010|Overall Study|Death|0|||
160887389|NCT04393298|580981789|FG011|Overall Study|Death|1|||
160887390|NCT04393298|580981790|FG012|Overall Study|Death|1|||
160887391|NCT04393298|580981791|FG013|Overall Study|Death|0|||
160887392|NCT04393298|580981792|FG014|Overall Study|Death|1|||
160887393|NCT04393298|580981778|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887394|NCT04393298|580981779|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887395|NCT04393298|580981780|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887396|NCT04393298|580981781|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887397|NCT04393298|580981782|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887398|NCT04393298|580981783|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
160887399|NCT04393298|580981784|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887400|NCT04393298|580981785|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887401|NCT04393298|580981786|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887402|NCT04393298|580981787|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887403|NCT04393298|580981788|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887404|NCT04393298|580981789|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887405|NCT04393298|580981790|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887406|NCT04393298|580981791|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887407|NCT04393298|580981792|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887408|NCT04393298|580981778|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
160887409|NCT04393298|580981779|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
160887410|NCT04393298|580981780|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
160887411|NCT04393298|580981781|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
160887412|NCT04393298|580981782|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
160887413|NCT04393298|580981783|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
160887414|NCT04393298|580981784|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
160887415|NCT04393298|580981785|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
160887416|NCT04393298|580981786|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
160887417|NCT04393298|580981787|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
160887418|NCT04393298|580981788|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
160887419|NCT04393298|580981789|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
160887420|NCT04393298|580981790|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
160887421|NCT04393298|580981791|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
160887422|NCT04393298|580981792|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
160887423|NCT04393298|580981778|FG000|Overall Study|Patient Passed Away|0|||
160887424|NCT04393298|580981779|FG001|Overall Study|Patient Passed Away|0|||
160887425|NCT04393298|580981780|FG002|Overall Study|Patient Passed Away|0|||
160887426|NCT04393298|580981781|FG003|Overall Study|Patient Passed Away|0|||
160887427|NCT04393298|580981782|FG004|Overall Study|Patient Passed Away|0|||
160887428|NCT04393298|580981783|FG005|Overall Study|Patient Passed Away|0|||
160887429|NCT04393298|580981784|FG006|Overall Study|Patient Passed Away|0|||
160887430|NCT04393298|580981785|FG007|Overall Study|Patient Passed Away|1|||
160887431|NCT04393298|580981786|FG008|Overall Study|Patient Passed Away|0|||
160887432|NCT04393298|580981787|FG009|Overall Study|Patient Passed Away|0|||
160887433|NCT04393298|580981788|FG010|Overall Study|Patient Passed Away|0|||
160887434|NCT04393298|580981789|FG011|Overall Study|Patient Passed Away|0|||
160887435|NCT04393298|580981790|FG012|Overall Study|Patient Passed Away|0|||
160887436|NCT04393298|580981791|FG013|Overall Study|Patient Passed Away|0|||
160887437|NCT04393298|580981792|FG014|Overall Study|Patient Passed Away|0|||
160887438|NCT04393298|580981778|FG000|Overall Study|Patient Deceased|0|||
160887439|NCT04393298|580981779|FG001|Overall Study|Patient Deceased|0|||
160887440|NCT04393298|580981780|FG002|Overall Study|Patient Deceased|0|||
160887441|NCT04393298|580981781|FG003|Overall Study|Patient Deceased|0|||
160887442|NCT04393298|580981782|FG004|Overall Study|Patient Deceased|0|||
160887443|NCT04393298|580981783|FG005|Overall Study|Patient Deceased|0|||
160541946|NCT00143312|579712872|FG000|Overall Study|Withdrawal by Subject|1|||
160541947|NCT01029366|579712873|FG000|Overall Study|Withdrawal by Subject|1|||
160887444|NCT04393298|580981784|FG006|Overall Study|Patient Deceased|0|||
160887445|NCT04393298|580981785|FG007|Overall Study|Patient Deceased|1|||
160887446|NCT04393298|580981786|FG008|Overall Study|Patient Deceased|0|||
160887447|NCT04393298|580981787|FG009|Overall Study|Patient Deceased|0|||
160887448|NCT04393298|580981788|FG010|Overall Study|Patient Deceased|0|||
160887449|NCT04393298|580981789|FG011|Overall Study|Patient Deceased|0|||
160887450|NCT04393298|580981790|FG012|Overall Study|Patient Deceased|0|||
160887451|NCT04393298|580981791|FG013|Overall Study|Patient Deceased|0|||
160887452|NCT04393298|580981792|FG014|Overall Study|Patient Deceased|0|||
160887453|NCT04393298|580981778|FG000|Overall Study|Patient Discharged to Hospice|0|||
160887454|NCT04393298|580981779|FG001|Overall Study|Patient Discharged to Hospice|0|||
160887455|NCT04393298|580981780|FG002|Overall Study|Patient Discharged to Hospice|0|||
160887456|NCT04393298|580981781|FG003|Overall Study|Patient Discharged to Hospice|0|||
160887457|NCT04393298|580981782|FG004|Overall Study|Patient Discharged to Hospice|0|||
160887458|NCT04393298|580981783|FG005|Overall Study|Patient Discharged to Hospice|0|||
160887459|NCT04393298|580981784|FG006|Overall Study|Patient Discharged to Hospice|0|||
160887460|NCT04393298|580981785|FG007|Overall Study|Patient Discharged to Hospice|0|||
160887461|NCT04393298|580981786|FG008|Overall Study|Patient Discharged to Hospice|1|||
160887462|NCT04393298|580981787|FG009|Overall Study|Patient Discharged to Hospice|0|||
160887463|NCT04393298|580981788|FG010|Overall Study|Patient Discharged to Hospice|0|||
160887464|NCT04393298|580981789|FG011|Overall Study|Patient Discharged to Hospice|0|||
160887465|NCT04393298|580981790|FG012|Overall Study|Patient Discharged to Hospice|0|||
160887466|NCT04393298|580981791|FG013|Overall Study|Patient Discharged to Hospice|0|||
160887467|NCT04393298|580981792|FG014|Overall Study|Patient Discharged to Hospice|0|||
160887468|NCT04393298|580981778|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887469|NCT04393298|580981779|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887470|NCT04393298|580981780|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887471|NCT04393298|580981781|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887472|NCT04393298|580981782|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887473|NCT04393298|580981783|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887474|NCT04393298|580981784|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887475|NCT04393298|580981785|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887476|NCT04393298|580981786|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887477|NCT04393298|580981787|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
160887478|NCT04393298|580981788|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887479|NCT04393298|580981789|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887480|NCT04393298|580981790|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887481|NCT04393298|580981791|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887482|NCT04393298|580981792|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887483|NCT04393298|580981778|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
160887484|NCT04393298|580981779|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
160887485|NCT04393298|580981780|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
160887486|NCT04393298|580981781|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
160887487|NCT04393298|580981782|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
160887488|NCT04393298|580981783|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
160887489|NCT04393298|580981784|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
160887490|NCT04393298|580981785|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
160887491|NCT04393298|580981786|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
160887492|NCT04393298|580981787|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
160887493|NCT04393298|580981788|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
160887494|NCT04393298|580981789|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
160887495|NCT04393298|580981790|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
160887496|NCT04393298|580981791|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
160887497|NCT04393298|580981792|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
160887498|NCT04950608|580981800|FG000|Overall Study|Withdrawal by Subject|2|||
160887499|NCT04950608|580981800|FG000|Overall Study|Physician Decision|3|||
160887500|NCT01282203|580981804|FG000|Overall Study|Adverse Event|1|||
160887501|NCT03977454|580981805|FG000|Overall Study|immediate postoperative revision|2|||
160887502|NCT03977454|580981806|FG001|Overall Study|immediate postoperative revision|2|||
160887503|NCT00768469|580981809|FG000|Overall Study|Adverse Event|0|||
160887504|NCT00768469|580981810|FG001|Overall Study|Adverse Event|2|||
160887505|NCT00768469|580981809|FG000|Overall Study|Disease Progression|3|||
160887506|NCT00768469|580981810|FG001|Overall Study|Disease Progression|4|||
160887507|NCT00768469|580981809|FG000|Overall Study|Withdrawal by Subject|0|||
160887508|NCT00768469|580981810|FG001|Overall Study|Withdrawal by Subject|1|||
160887509|NCT04193410|580981811|FG000|Overall Study|Lost to Follow-up|7|||
160887510|NCT04193410|580981812|FG001|Overall Study|Lost to Follow-up|6|||
160887511|NCT01293799|580981816|FG000|Overall Study|Kidney transplantation|109|||
160887512|NCT01293799|580981817|FG001|Overall Study|Kidney transplantation|96|||
160779270|NCT04425018|580576643|FG001|Overall Study|Withdrawal by Subject|2|||
160779271|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
160779272|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
160779273|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
160779274|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
160779275|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
160779276|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
160779277|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
160779278|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
160779279|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
160779280|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
160779281|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
160779282|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
160779283|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
160779284|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
160779285|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
160779286|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
160779287|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
160779288|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
160779289|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
160779290|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
160779291|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
160779292|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
160779293|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
160779294|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
160779295|NCT02337946|580576644|FG000|In-between Period|Without Informed Consent|1|||
160779296|NCT02337946|580576645|FG001|In-between Period|Without Informed Consent|0|||
160779297|NCT02337946|580576646|FG002|In-between Period|Without Informed Consent|0|||
160779298|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
160779299|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
160779300|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
160779301|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
160779302|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
160779303|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
160779304|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
160779305|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
160779306|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
160779307|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
160779308|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
160779309|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
160779310|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
160779311|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
160779312|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
160779313|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
160779314|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
160779315|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
160779316|NCT01131585|580576648|FG000|Overall Study|Adverse Event|0|||
160779317|NCT01131585|580576649|FG001|Overall Study|Adverse Event|2|||
160779318|NCT01131585|580576648|FG000|Overall Study|Abnormal laboratory value|1|||
160779319|NCT01131585|580576649|FG001|Overall Study|Abnormal laboratory value|0|||
160779320|NCT01131585|580576648|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160779321|NCT01131585|580576649|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160779322|NCT01131585|580576648|FG000|Overall Study|Protocol Violation|2|||
160779323|NCT01131585|580576649|FG001|Overall Study|Protocol Violation|1|||
160779324|NCT01131585|580576648|FG000|Overall Study|Withdrawal by Subject|3|||
160779325|NCT01131585|580576649|FG001|Overall Study|Withdrawal by Subject|3|||
160779326|NCT01131585|580576648|FG000|Overall Study|Lost to Follow-up|0|||
160779327|NCT01131585|580576649|FG001|Overall Study|Lost to Follow-up|1|||
160779328|NCT01131585|580576648|FG000|Overall Study|Administrative problems|1|||
160779329|NCT01131585|580576649|FG001|Overall Study|Administrative problems|1|||
160779330|NCT01131585|580576648|FG000|Overall Study|Study termination|78|||
160779331|NCT01131585|580576649|FG001|Overall Study|Study termination|32|||
160779332|NCT02949934|580576652|FG000|Natural Drinking Period|Adverse Event|1|||
160779333|NCT02949934|580576653|FG001|Natural Drinking Period|Adverse Event|0|||
160779334|NCT02949934|580576654|FG002|Natural Drinking Period|Adverse Event|0|||
160779335|NCT02949934|580576655|FG003|Natural Drinking Period|Adverse Event|1|||
160779336|NCT02949934|580576656|FG004|Natural Drinking Period|Adverse Event|0|||
160779337|NCT02949934|580576657|FG005|Natural Drinking Period|Adverse Event|0|||
160779338|NCT02949934|580576652|FG000|Natural Drinking Period|Lost to Follow-up|0|||
160779339|NCT02949934|580576653|FG001|Natural Drinking Period|Lost to Follow-up|0|||
160887513|NCT01293799|580981816|FG000|Overall Study|Transfer to hemodialysis|70|||
160887514|NCT01293799|580981817|FG001|Overall Study|Transfer to hemodialysis|90|||
160887515|NCT01293799|580981816|FG000|Overall Study|Death|27|||
160887516|NCT01293799|580981817|FG001|Overall Study|Death|29|||
160887517|NCT01293799|580981816|FG000|Overall Study|Transfer to assisted PD|24|||
160887518|NCT01293799|580981817|FG001|Overall Study|Transfer to assisted PD|18|||
160887519|NCT01293799|580981816|FG000|Overall Study|Withdrawal by Subject|26|||
160887520|NCT01293799|580981817|FG001|Overall Study|Withdrawal by Subject|0|||
160887521|NCT01293799|580981816|FG000|Overall Study|Investigator decision|5|||
160887522|NCT01293799|580981817|FG001|Overall Study|Investigator decision|2|||
160887523|NCT01293799|580981816|FG000|Overall Study|Kidney function improved|6|||
160887524|NCT01293799|580981817|FG001|Overall Study|Kidney function improved|7|||
160887525|NCT01293799|580981816|FG000|Overall Study|Other causes|6|||
160887526|NCT01293799|580981817|FG001|Overall Study|Other causes|3|||
160887527|NCT04779216|580981820|FG000|Overall Study|Lost to Follow-up|1|||
160887528|NCT04779216|580981821|FG001|Overall Study|Lost to Follow-up|0|||
160887529|NCT04779216|580981820|FG000|Overall Study|Withdrawal by Subject|1|||
160887530|NCT04779216|580981821|FG001|Overall Study|Withdrawal by Subject|0|||
160887531|NCT02635646|580981822|FG000|Overall Study|Lost to Follow-up|24|||
160887532|NCT02635646|580981823|FG001|Overall Study|Lost to Follow-up|25|||
160887533|NCT02635646|580981822|FG000|Overall Study|Pregnancy|1|||
160887534|NCT02635646|580981823|FG001|Overall Study|Pregnancy|1|||
160887535|NCT00879879|580981824|FG000|Overall Study|Death|1|||
160887536|NCT00879879|580981824|FG000|Overall Study|Withdrawal by Subject|1|||
160887537|NCT00879879|580981824|FG000|Overall Study|Physician Decision|1|||
160887538|NCT00378079|580981828|FG000|Overall Study|Lost to Follow-up|6|||
160887539|NCT00378079|580981829|FG001|Overall Study|Lost to Follow-up|1|||
160887540|NCT00378079|580981830|FG002|Overall Study|Lost to Follow-up|0|||
160887541|NCT02274038|580981831|FG000|Overall Study|Death|1|||
160887542|NCT05458648|580981832|FG000|Overall Study|Physician Decision|1|||
160887543|NCT05458648|580981832|FG000|Overall Study|Patient presented in atrial flutter|1|||
160887544|NCT01163318|580981833|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
160887545|NCT01163318|580981833|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
160887546|NCT01163318|580981833|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
160887547|NCT01163318|580981833|FG000|Overall Study|Participants Without Case Report Form|7|||
160887548|NCT01163318|580981833|FG000|Overall Study|Multiple Reasons Per Participant|224|||
160887549|NCT03587727|580981837|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
160887550|NCT03587727|580981837|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
160887551|NCT05217927|580981838|FG000|DBT Phase|Adverse Event|7|||
160887552|NCT05217927|580981839|FG001|DBT Phase|Adverse Event|2|||
160887553|NCT05217927|580981840|FG002|DBT Phase|Adverse Event|5|||
160887554|NCT05217927|580981838|FG000|DBT Phase|Lack of Efficacy|1|||
160887555|NCT05217927|580981839|FG001|DBT Phase|Lack of Efficacy|0|||
160887556|NCT05217927|580981840|FG002|DBT Phase|Lack of Efficacy|0|||
160887557|NCT05217927|580981838|FG000|DBT Phase|Lost to Follow-up|0|||
160887558|NCT05217927|580981839|FG001|DBT Phase|Lost to Follow-up|2|||
160887559|NCT05217927|580981840|FG002|DBT Phase|Lost to Follow-up|0|||
160887560|NCT05217927|580981838|FG000|DBT Phase|Non-compliance|1|||
160887561|NCT05217927|580981839|FG001|DBT Phase|Non-compliance|0|||
160887562|NCT05217927|580981840|FG002|DBT Phase|Non-compliance|0|||
160887563|NCT05217927|580981838|FG000|DBT Phase|Pregnancy|0|||
160887564|NCT05217927|580981839|FG001|DBT Phase|Pregnancy|0|||
160887565|NCT05217927|580981840|FG002|DBT Phase|Pregnancy|1|||
160887566|NCT05217927|580981838|FG000|DBT Phase|Protocol Violation|0|||
160541948|NCT01029366|579712874|FG001|Overall Study|Withdrawal by Subject|0|||
160541949|NCT01029366|579712873|FG000|Overall Study|Death|1|||
160541950|NCT01029366|579712874|FG001|Overall Study|Death|1|||
160887567|NCT05217927|580981839|FG001|DBT Phase|Protocol Violation|2|||
160887568|NCT05217927|580981840|FG002|DBT Phase|Protocol Violation|1|||
160887569|NCT05217927|580981838|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
160887570|NCT05217927|580981839|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
160779340|NCT02949934|580576654|FG002|Natural Drinking Period|Lost to Follow-up|0|||
160779341|NCT02949934|580576655|FG003|Natural Drinking Period|Lost to Follow-up|0|||
160779342|NCT02949934|580576656|FG004|Natural Drinking Period|Lost to Follow-up|1|||
160779343|NCT02949934|580576657|FG005|Natural Drinking Period|Lost to Follow-up|0|||
160779344|NCT02949934|580576652|FG000|Neuroimaging|Protocol Violation|2|||
160779345|NCT02949934|580576653|FG001|Neuroimaging|Protocol Violation|0|||
160779346|NCT02949934|580576654|FG002|Neuroimaging|Protocol Violation|0|||
160779347|NCT02949934|580576655|FG003|Neuroimaging|Protocol Violation|0|||
160779348|NCT02949934|580576656|FG004|Neuroimaging|Protocol Violation|1|||
160779349|NCT02949934|580576657|FG005|Neuroimaging|Protocol Violation|0|||
160779350|NCT02949934|580576652|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
160779351|NCT02949934|580576653|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
160779352|NCT02949934|580576654|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
160779353|NCT02949934|580576655|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
160779354|NCT02949934|580576656|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
160779355|NCT02949934|580576657|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
160779356|NCT02949934|580576652|FG000|Neuroimaging|Not scanned|0|||
160779357|NCT02949934|580576653|FG001|Neuroimaging|Not scanned|0|||
160779358|NCT02949934|580576654|FG002|Neuroimaging|Not scanned|1|||
160779359|NCT02949934|580576655|FG003|Neuroimaging|Not scanned|0|||
160779360|NCT02949934|580576656|FG004|Neuroimaging|Not scanned|0|||
160779361|NCT02949934|580576657|FG005|Neuroimaging|Not scanned|2|||
160779362|NCT02949934|580576652|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
160779363|NCT02949934|580576653|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
160779364|NCT02949934|580576654|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
160779365|NCT02949934|580576655|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
160779366|NCT02949934|580576656|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
160779367|NCT02949934|580576657|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
160779368|NCT02949934|580576652|FG000|Bar Laboratory|Adverse Event|1|||
160779369|NCT02949934|580576653|FG001|Bar Laboratory|Adverse Event|0|||
160779370|NCT02949934|580576654|FG002|Bar Laboratory|Adverse Event|2|||
160779371|NCT02949934|580576655|FG003|Bar Laboratory|Adverse Event|0|||
160779372|NCT02949934|580576656|FG004|Bar Laboratory|Adverse Event|1|||
160779373|NCT02949934|580576657|FG005|Bar Laboratory|Adverse Event|0|||
160779374|NCT02949934|580576652|FG000|Bar Laboratory|Protocol Violation|0|||
160779375|NCT02949934|580576653|FG001|Bar Laboratory|Protocol Violation|0|||
160779376|NCT02949934|580576654|FG002|Bar Laboratory|Protocol Violation|0|||
160779377|NCT02949934|580576655|FG003|Bar Laboratory|Protocol Violation|1|||
160779378|NCT02949934|580576656|FG004|Bar Laboratory|Protocol Violation|0|||
160779379|NCT02949934|580576657|FG005|Bar Laboratory|Protocol Violation|0|||
160779380|NCT05128942|580576661|FG000|Overall Study|Withdrawal by Subject|1|||
160779381|NCT05128942|580576662|FG001|Overall Study|Withdrawal by Subject|0|||
160779382|NCT05128942|580576663|FG002|Overall Study|Withdrawal by Subject|1|||
160779383|NCT05128942|580576664|FG003|Overall Study|Withdrawal by Subject|0|||
160779384|NCT05128942|580576665|FG004|Overall Study|Withdrawal by Subject|0|||
160779385|NCT05128942|580576666|FG005|Overall Study|Withdrawal by Subject|0|||
160779386|NCT05128942|580576667|FG006|Overall Study|Withdrawal by Subject|0|||
160779387|NCT05128942|580576668|FG007|Overall Study|Withdrawal by Subject|0|||
160779388|NCT05128942|580576669|FG008|Overall Study|Withdrawal by Subject|0|||
160779389|NCT05128942|580576661|FG000|Overall Study|Other|2|||
160779390|NCT05128942|580576662|FG001|Overall Study|Other|0|||
160779391|NCT05128942|580576663|FG002|Overall Study|Other|2|||
160779392|NCT05128942|580576664|FG003|Overall Study|Other|0|||
160779393|NCT05128942|580576665|FG004|Overall Study|Other|0|||
160779394|NCT05128942|580576666|FG005|Overall Study|Other|0|||
160779395|NCT05128942|580576667|FG006|Overall Study|Other|0|||
160779396|NCT05128942|580576668|FG007|Overall Study|Other|0|||
160779397|NCT05128942|580576669|FG008|Overall Study|Other|0|||
160779398|NCT05128942|580576661|FG000|Overall Study|Termination by Sponsor|2|||
160779399|NCT05128942|580576662|FG001|Overall Study|Termination by Sponsor|6|||
160779400|NCT05128942|580576663|FG002|Overall Study|Termination by Sponsor|14|||
160779401|NCT05128942|580576664|FG003|Overall Study|Termination by Sponsor|2|||
160887571|NCT05217927|580981840|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
160887572|NCT05217927|580981838|FG000|DBT Phase|Withdrawal of consent|8|||
160887573|NCT05217927|580981839|FG001|DBT Phase|Withdrawal of consent|5|||
160887574|NCT05217927|580981840|FG002|DBT Phase|Withdrawal of consent|7|||
160887575|NCT05217927|580981838|FG000|DBT Phase|Other|7|||
160887576|NCT05217927|580981839|FG001|DBT Phase|Other|3|||
160779402|NCT05128942|580576665|FG004|Overall Study|Termination by Sponsor|4|||
160779403|NCT05128942|580576666|FG005|Overall Study|Termination by Sponsor|8|||
160779404|NCT05128942|580576667|FG006|Overall Study|Termination by Sponsor|11|||
160779405|NCT05128942|580576668|FG007|Overall Study|Termination by Sponsor|6|||
160779406|NCT05128942|580576669|FG008|Overall Study|Termination by Sponsor|0|||
160779407|NCT05128942|580576661|FG000|Overall Study|Adverse Event|0|||
160779408|NCT05128942|580576662|FG001|Overall Study|Adverse Event|0|||
160779409|NCT05128942|580576663|FG002|Overall Study|Adverse Event|0|||
160779410|NCT05128942|580576664|FG003|Overall Study|Adverse Event|0|||
160887577|NCT05217927|580981840|FG002|DBT Phase|Other|4|||
160887578|NCT05217927|580981838|FG000|DBT Phase|Randomized, not treated|2|||
160887579|NCT05217927|580981839|FG001|DBT Phase|Randomized, not treated|3|||
160887580|NCT05217927|580981840|FG002|DBT Phase|Randomized, not treated|2|||
160887581|NCT05217927|580981838|FG000|OLE Phase|Adverse Event|4|||
160887582|NCT05217927|580981839|FG001|OLE Phase|Adverse Event|1|||
160887583|NCT05217927|580981840|FG002|OLE Phase|Adverse Event|1|||
160887584|NCT05217927|580981838|FG000|OLE Phase|Extension phase eligibility failure|1|||
160887585|NCT05217927|580981839|FG001|OLE Phase|Extension phase eligibility failure|0|||
160887586|NCT05217927|580981840|FG002|OLE Phase|Extension phase eligibility failure|0|||
160887587|NCT05217927|580981838|FG000|OLE Phase|Lost to Follow-up|1|||
160887588|NCT05217927|580981839|FG001|OLE Phase|Lost to Follow-up|2|||
160887589|NCT05217927|580981840|FG002|OLE Phase|Lost to Follow-up|1|||
160887590|NCT05217927|580981838|FG000|OLE Phase|Non-compliance|0|||
160887591|NCT05217927|580981839|FG001|OLE Phase|Non-compliance|0|||
160887592|NCT05217927|580981840|FG002|OLE Phase|Non-compliance|1|||
160887593|NCT05217927|580981838|FG000|OLE Phase|Other|3|||
160887594|NCT05217927|580981839|FG001|OLE Phase|Other|5|||
160887595|NCT05217927|580981840|FG002|OLE Phase|Other|4|||
160887596|NCT05217927|580981838|FG000|OLE Phase|Withdrawal of consent|3|||
160887597|NCT05217927|580981839|FG001|OLE Phase|Withdrawal of consent|1|||
160887598|NCT05217927|580981840|FG002|OLE Phase|Withdrawal of consent|5|||
160887599|NCT00076024|580982548|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
160541951|NCT01029366|579712873|FG000|Overall Study|disease progression|2|||
160887600|NCT00076024|580982549|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
160887601|NCT00076024|580982550|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
160887602|NCT00076024|580982551|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
160887603|NCT00076024|580982548|FG000|Phase 1, Lead-in|Adverse Event|1|||
160779411|NCT05128942|580576665|FG004|Overall Study|Adverse Event|0|||
160779412|NCT05128942|580576666|FG005|Overall Study|Adverse Event|0|||
160779413|NCT05128942|580576667|FG006|Overall Study|Adverse Event|1|||
160779414|NCT05128942|580576668|FG007|Overall Study|Adverse Event|1|||
160779415|NCT05128942|580576669|FG008|Overall Study|Adverse Event|0|||
160779416|NCT05128942|580576661|FG000|Overall Study|Lost to Follow-up|0|||
160779417|NCT05128942|580576662|FG001|Overall Study|Lost to Follow-up|0|||
160779418|NCT05128942|580576663|FG002|Overall Study|Lost to Follow-up|0|||
160779419|NCT05128942|580576664|FG003|Overall Study|Lost to Follow-up|0|||
160779420|NCT05128942|580576665|FG004|Overall Study|Lost to Follow-up|1|||
160779421|NCT05128942|580576666|FG005|Overall Study|Lost to Follow-up|0|||
160779422|NCT05128942|580576667|FG006|Overall Study|Lost to Follow-up|0|||
160779423|NCT05128942|580576668|FG007|Overall Study|Lost to Follow-up|0|||
160779424|NCT05128942|580576669|FG008|Overall Study|Lost to Follow-up|0|||
160779425|NCT03407482|580576670|FG000|Overall Study|Adverse Event|12|||
160779426|NCT03407482|580576670|FG000|Overall Study|Disease Relapse|1|||
160779427|NCT03407482|580576670|FG000|Overall Study|Lost to Follow-up|1|||
160779428|NCT03407482|580576670|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160779429|NCT03407482|580576670|FG000|Overall Study|Pregnancy|2|||
160779430|NCT03407482|580576670|FG000|Overall Study|Protocol Violation|1|||
160779431|NCT03407482|580576670|FG000|Overall Study|Study Terminated By Sponsor|106|||
160779432|NCT03407482|580576670|FG000|Overall Study|Withdrawal by Subject|6|||
160779433|NCT03407482|580576670|FG000|Overall Study|Data Entry Error|1|||
160779434|NCT05887401|580576674|FG000|Overall Study|Withdrawal by Subject|0|||
160779435|NCT05887401|580576675|FG001|Overall Study|Withdrawal by Subject|0|||
160779436|NCT05887401|580576676|FG002|Overall Study|Withdrawal by Subject|0|||
160779437|NCT05887401|580576677|FG003|Overall Study|Withdrawal by Subject|0|||
160779438|NCT05887401|580576678|FG004|Overall Study|Withdrawal by Subject|0|||
160779439|NCT05887401|580576679|FG005|Overall Study|Withdrawal by Subject|0|||
160779440|NCT05887401|580576680|FG006|Overall Study|Withdrawal by Subject|0|||
160779441|NCT05887401|580576681|FG007|Overall Study|Withdrawal by Subject|0|||
160779442|NCT05887401|580576682|FG008|Overall Study|Withdrawal by Subject|0|||
160779443|NCT05887401|580576683|FG009|Overall Study|Withdrawal by Subject|1|||
160779444|NCT05887401|580576684|FG010|Overall Study|Withdrawal by Subject|0|||
160779445|NCT05887401|580576685|FG011|Overall Study|Withdrawal by Subject|0|||
160779446|NCT05887401|580576686|FG012|Overall Study|Withdrawal by Subject|0|||
160779447|NCT05887401|580576687|FG013|Overall Study|Withdrawal by Subject|0|||
160779448|NCT05887401|580576688|FG014|Overall Study|Withdrawal by Subject|0|||
160779449|NCT05887401|580576689|FG015|Overall Study|Withdrawal by Subject|1|||
160779450|NCT05887401|580576674|FG000|Overall Study|Lost to Follow-up|0|||
160779451|NCT05887401|580576675|FG001|Overall Study|Lost to Follow-up|1|||
160779452|NCT05887401|580576676|FG002|Overall Study|Lost to Follow-up|1|||
160779453|NCT05887401|580576677|FG003|Overall Study|Lost to Follow-up|2|||
160779454|NCT05887401|580576678|FG004|Overall Study|Lost to Follow-up|0|||
160779455|NCT05887401|580576679|FG005|Overall Study|Lost to Follow-up|0|||
160779456|NCT05887401|580576680|FG006|Overall Study|Lost to Follow-up|0|||
160779457|NCT05887401|580576681|FG007|Overall Study|Lost to Follow-up|0|||
160779458|NCT05887401|580576682|FG008|Overall Study|Lost to Follow-up|1|||
160779459|NCT05887401|580576683|FG009|Overall Study|Lost to Follow-up|1|||
160779460|NCT05887401|580576684|FG010|Overall Study|Lost to Follow-up|2|||
160887604|NCT00076024|580982549|FG001|Phase 1, Lead-in|Adverse Event|0|||
160779461|NCT05887401|580576685|FG011|Overall Study|Lost to Follow-up|1|||
160779462|NCT05887401|580576686|FG012|Overall Study|Lost to Follow-up|0|||
160779463|NCT05887401|580576687|FG013|Overall Study|Lost to Follow-up|0|||
160779464|NCT05887401|580576688|FG014|Overall Study|Lost to Follow-up|0|||
160779465|NCT05887401|580576689|FG015|Overall Study|Lost to Follow-up|0|||
160779466|NCT05942040|580576690|FG000|Overall Study|No longer employed at study site.|0|||
160779467|NCT05942040|580576691|FG001|Overall Study|No longer employed at study site.|0|||
160779468|NCT05942040|580576692|FG002|Overall Study|No longer employed at study site.|3|||
160779469|NCT03442569|580576693|FG000|Overall Study|Subject was ineligible after enrollment|1|||
160779470|NCT06461455|580576694|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
160779471|NCT06461455|580576695|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
160779472|NCT06461455|580576694|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
160779473|NCT06461455|580576695|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
160779474|NCT06461455|580576694|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
160779475|NCT06461455|580576695|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
160779476|NCT06142383|580576696|FG000|Overall Study|Mis-randomized|0|||
160779477|NCT06142383|580576697|FG001|Overall Study|Mis-randomized|0|||
160887605|NCT00076024|580982550|FG002|Phase 1, Lead-in|Adverse Event|0|||
160779478|NCT06142383|580576698|FG002|Overall Study|Mis-randomized|1|||
160779479|NCT06142383|580576699|FG003|Overall Study|Mis-randomized|0|||
160779480|NCT06142383|580576700|FG004|Overall Study|Mis-randomized|0|||
160779481|NCT06142383|580576696|FG000|Overall Study|Adverse Event|0|||
160779482|NCT06142383|580576697|FG001|Overall Study|Adverse Event|1|||
160779483|NCT06142383|580576698|FG002|Overall Study|Adverse Event|1|||
160887606|NCT00076024|580982551|FG003|Phase 1, Lead-in|Adverse Event|0|||
160779484|NCT06142383|580576699|FG003|Overall Study|Adverse Event|0|||
160779485|NCT06142383|580576700|FG004|Overall Study|Adverse Event|0|||
160779486|NCT06142383|580576696|FG000|Overall Study|Death|0|||
160779487|NCT06142383|580576697|FG001|Overall Study|Death|1|||
160779488|NCT06142383|580576698|FG002|Overall Study|Death|3|||
160779489|NCT06142383|580576699|FG003|Overall Study|Death|0|||
160779490|NCT06142383|580576700|FG004|Overall Study|Death|1|||
160779491|NCT06142383|580576696|FG000|Overall Study|Study Terminated by Sponsor|20|||
160779492|NCT06142383|580576697|FG001|Overall Study|Study Terminated by Sponsor|17|||
160779493|NCT06142383|580576698|FG002|Overall Study|Study Terminated by Sponsor|33|||
160779494|NCT06142383|580576699|FG003|Overall Study|Study Terminated by Sponsor|0|||
160779495|NCT06142383|580576700|FG004|Overall Study|Study Terminated by Sponsor|21|||
160779496|NCT06142383|580576696|FG000|Overall Study|Subject Decision|0|||
160779497|NCT06142383|580576697|FG001|Overall Study|Subject Decision|1|||
160779498|NCT06142383|580576698|FG002|Overall Study|Subject Decision|2|||
160779499|NCT06142383|580576699|FG003|Overall Study|Subject Decision|0|||
160779500|NCT06142383|580576700|FG004|Overall Study|Subject Decision|0|||
160779501|NCT03010501|580576704|FG000|Study Week 1|Withdrawal by Subject|2|||
160779502|NCT03010501|580576705|FG001|Study Week 1|Withdrawal by Subject|1|||
160779503|NCT03010501|580576706|FG002|Study Week 1|Withdrawal by Subject|0|||
160779504|NCT03010501|580576707|FG003|Study Week 1|Withdrawal by Subject|2|||
160779505|NCT03010501|580576708|FG004|Study Week 1|Withdrawal by Subject|0|||
160779506|NCT03010501|580576709|FG005|Study Week 1|Withdrawal by Subject|0|||
160779507|NCT03010501|580576704|FG000|Study Week 3|Withdrawal by Subject|0|||
160779508|NCT03010501|580576705|FG001|Study Week 3|Withdrawal by Subject|0|||
160779509|NCT03010501|580576706|FG002|Study Week 3|Withdrawal by Subject|0|||
160779510|NCT03010501|580576707|FG003|Study Week 3|Withdrawal by Subject|1|||
160779511|NCT03010501|580576708|FG004|Study Week 3|Withdrawal by Subject|0|||
160779512|NCT03010501|580576709|FG005|Study Week 3|Withdrawal by Subject|0|||
160779513|NCT00544882|580576715|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
160779514|NCT00544882|580576716|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
160779515|NCT00544882|580576717|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
160779516|NCT00544882|580576715|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
160779517|NCT00544882|580576716|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
160779518|NCT00544882|580576717|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
160779519|NCT00544882|580576715|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
160779520|NCT00544882|580576716|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
160779521|NCT00544882|580576717|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
160779522|NCT00544882|580576715|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
160779523|NCT00544882|580576716|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
160779524|NCT00544882|580576717|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
160779525|NCT00544882|580576715|FG000|Cycle 3: Follow-up|Noncompliance|0|||
160779526|NCT00544882|580576716|FG001|Cycle 3: Follow-up|Noncompliance|1|||
160779527|NCT00544882|580576717|FG002|Cycle 3: Follow-up|Noncompliance|0|||
160779528|NCT00544882|580576715|FG000|Cycle 3: Follow-up|Pregnancy|0|||
160779529|NCT00544882|580576716|FG001|Cycle 3: Follow-up|Pregnancy|1|||
160779530|NCT00544882|580576717|FG002|Cycle 3: Follow-up|Pregnancy|0|||
160779531|NCT03770455|580576718|FG000|Overall Study|Screen failures|3|||
160779532|NCT01121575|580576719|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
160779533|NCT01121575|580576720|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
160779534|NCT01121575|580576721|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
160779535|NCT01121575|580576722|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
160887607|NCT00076024|580982548|FG000|Phase 1, Lead-in|Clinical progression|1|||
160887608|NCT00076024|580982549|FG001|Phase 1, Lead-in|Clinical progression|0|||
160887609|NCT00076024|580982550|FG002|Phase 1, Lead-in|Clinical progression|0|||
160887610|NCT00076024|580982551|FG003|Phase 1, Lead-in|Clinical progression|0|||
160887611|NCT00076024|580982548|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
160887612|NCT00076024|580982549|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
160887613|NCT00076024|580982550|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
160887614|NCT00076024|580982551|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
160887615|NCT00076024|580982548|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
160887616|NCT00076024|580982549|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
160887617|NCT00076024|580982550|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
160887618|NCT00076024|580982551|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
160887619|NCT00076024|580982548|FG000|Phase 2, Double-blind|Adverse Event|0|||
160887620|NCT00076024|580982549|FG001|Phase 2, Double-blind|Adverse Event|25|||
160541952|NCT01029366|579712874|FG001|Overall Study|disease progression|0|||
160779536|NCT01121575|580576723|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
160887621|NCT00076024|580982550|FG002|Phase 2, Double-blind|Adverse Event|6|||
160779537|NCT01121575|580576724|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
160779538|NCT01121575|580576719|FG000|Overall Study|Unspecified Reasons|8|||
160887622|NCT00076024|580982551|FG003|Phase 2, Double-blind|Adverse Event|0|||
160887623|NCT00076024|580982548|FG000|Phase 2, Double-blind|Un-specified|0|||
160779539|NCT01121575|580576720|FG001|Overall Study|Unspecified Reasons|6|||
160779540|NCT01121575|580576721|FG002|Overall Study|Unspecified Reasons|7|||
160779541|NCT01121575|580576722|FG003|Overall Study|Unspecified Reasons|5|||
160887624|NCT00076024|580982549|FG001|Phase 2, Double-blind|Un-specified|14|||
160887625|NCT00076024|580982550|FG002|Phase 2, Double-blind|Un-specified|6|||
160887626|NCT00076024|580982551|FG003|Phase 2, Double-blind|Un-specified|0|||
160779542|NCT01121575|580576723|FG004|Overall Study|Unspecified Reasons|13|||
160779543|NCT01121575|580576724|FG005|Overall Study|Unspecified Reasons|10|||
160779544|NCT01121575|580576719|FG000|Overall Study|Death|6|||
160779545|NCT01121575|580576720|FG001|Overall Study|Death|0|||
160779546|NCT01121575|580576721|FG002|Overall Study|Death|0|||
160779547|NCT01121575|580576722|FG003|Overall Study|Death|1|||
160779548|NCT01121575|580576723|FG004|Overall Study|Death|7|||
160779549|NCT01121575|580576724|FG005|Overall Study|Death|1|||
160779550|NCT04937387|580576725|FG000|Overall Study|Adverse Event|1|||
160779551|NCT04937387|580576726|FG001|Overall Study|Adverse Event|0|||
160779552|NCT04937387|580576727|FG002|Overall Study|Adverse Event|2|||
160779553|NCT04937387|580576728|FG003|Overall Study|Adverse Event|0|||
160779554|NCT04937387|580576725|FG000|Overall Study|Lack of Efficacy|1|||
160779555|NCT04937387|580576726|FG001|Overall Study|Lack of Efficacy|0|||
160779556|NCT04937387|580576727|FG002|Overall Study|Lack of Efficacy|0|||
160779557|NCT04937387|580576728|FG003|Overall Study|Lack of Efficacy|1|||
160779558|NCT04937387|580576725|FG000|Overall Study|Withdrawal by Subject|1|||
160779559|NCT04937387|580576726|FG001|Overall Study|Withdrawal by Subject|0|||
160779560|NCT04937387|580576727|FG002|Overall Study|Withdrawal by Subject|1|||
160779561|NCT04937387|580576728|FG003|Overall Study|Withdrawal by Subject|1|||
160779562|NCT04937387|580576725|FG000|Overall Study|Randomized in error|0|||
160779563|NCT04937387|580576726|FG001|Overall Study|Randomized in error|0|||
160779564|NCT04937387|580576727|FG002|Overall Study|Randomized in error|0|||
160779565|NCT04937387|580576728|FG003|Overall Study|Randomized in error|1|||
160779566|NCT02583269|580576729|FG000|Overall Study|Patient hospitalized prior to start|1|||
160779567|NCT02583269|580576730|FG001|Overall Study|Patient hospitalized prior to start|0|||
160779568|NCT02583269|580576731|FG002|Overall Study|Patient hospitalized prior to start|0|||
160779569|NCT02583269|580576732|FG003|Overall Study|Patient hospitalized prior to start|0|||
160779570|NCT02583269|580576733|FG004|Overall Study|Patient hospitalized prior to start|0|||
160779571|NCT03244189|580576735|FG000|Overall Study|Death|0|||
160779572|NCT03244189|580576736|FG001|Overall Study|Death|2|||
160779573|NCT03244189|580576735|FG000|Overall Study|Lost to Follow-up|92|||
160779574|NCT03244189|580576736|FG001|Overall Study|Lost to Follow-up|107|||
160779575|NCT03244189|580576735|FG000|Overall Study|Physician Decision|4|||
160779576|NCT03244189|580576736|FG001|Overall Study|Physician Decision|2|||
160779577|NCT03244189|580576735|FG000|Overall Study|Pregnancy|7|||
160779578|NCT03244189|580576736|FG001|Overall Study|Pregnancy|5|||
160779579|NCT03244189|580576735|FG000|Overall Study|Protocol Violation|0|||
160779580|NCT03244189|580576736|FG001|Overall Study|Protocol Violation|2|||
160779581|NCT03244189|580576735|FG000|Overall Study|Withdrawal by Subject|45|||
160779582|NCT03244189|580576736|FG001|Overall Study|Withdrawal by Subject|23|||
160779583|NCT03244189|580576735|FG000|Overall Study|Technical Problems|2|||
160779584|NCT03244189|580576736|FG001|Overall Study|Technical Problems|0|||
160779585|NCT02369458|580576737|FG000|Overall Study|Determined to be not eligible|1|||
160887627|NCT00076024|580982548|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
160887628|NCT00076024|580982549|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
160887629|NCT00076024|580982550|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
160887630|NCT00076024|580982551|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
160779586|NCT02369458|580576738|FG001|Overall Study|Determined to be not eligible|0|||
160887631|NCT00076024|580982548|FG000|Phase 2, Open-label|Adverse Event|0|||
160887632|NCT00076024|580982549|FG001|Phase 2, Open-label|Adverse Event|0|||
160887633|NCT00076024|580982550|FG002|Phase 2, Open-label|Adverse Event|0|||
160887634|NCT00076024|580982551|FG003|Phase 2, Open-label|Adverse Event|2|||
160887635|NCT00076024|580982548|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
160887636|NCT00076024|580982549|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
160887637|NCT00076024|580982550|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
160887638|NCT00076024|580982551|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
160779587|NCT03853798|580576739|FG000|Overall Study|Death|0|||
160779588|NCT03853798|580576740|FG001|Overall Study|Death|0|||
160779589|NCT03853798|580576741|FG002|Overall Study|Death|0|||
160887639|NCT00076024|580982548|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
160887640|NCT00076024|580982549|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
160887641|NCT00076024|580982550|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
160887642|NCT00076024|580982551|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
160779590|NCT03853798|580576742|FG003|Overall Study|Death|0|||
160779591|NCT03853798|580576743|FG004|Overall Study|Death|0|||
160779592|NCT03853798|580576744|FG005|Overall Study|Death|1|||
160887643|NCT00076024|580982548|FG000|Phase 2, Open-label|Other|0|||
160887644|NCT00076024|580982549|FG001|Phase 2, Open-label|Other|0|||
160541953|NCT01029366|579712873|FG000|Overall Study|manufacturing failure|0|||
160779593|NCT03853798|580576745|FG006|Overall Study|Death|0|||
160779594|NCT03853798|580576746|FG007|Overall Study|Death|0|||
160779595|NCT03853798|580576747|FG008|Overall Study|Death|0|||
160779596|NCT03853798|580576739|FG000|Overall Study|Adverse Event|0|||
160779597|NCT03853798|580576740|FG001|Overall Study|Adverse Event|0|||
160779598|NCT03853798|580576741|FG002|Overall Study|Adverse Event|2|||
160779599|NCT03853798|580576742|FG003|Overall Study|Adverse Event|0|||
160779600|NCT03853798|580576743|FG004|Overall Study|Adverse Event|0|||
160779601|NCT03853798|580576744|FG005|Overall Study|Adverse Event|0|||
160779602|NCT03853798|580576745|FG006|Overall Study|Adverse Event|0|||
160779603|NCT03853798|580576746|FG007|Overall Study|Adverse Event|0|||
160779604|NCT03853798|580576747|FG008|Overall Study|Adverse Event|0|||
160779605|NCT03853798|580576739|FG000|Overall Study|Withdrawal by Subject|0|||
160779606|NCT03853798|580576740|FG001|Overall Study|Withdrawal by Subject|1|||
160779607|NCT03853798|580576741|FG002|Overall Study|Withdrawal by Subject|4|||
160779608|NCT03853798|580576742|FG003|Overall Study|Withdrawal by Subject|0|||
160779609|NCT03853798|580576743|FG004|Overall Study|Withdrawal by Subject|0|||
160779610|NCT03853798|580576744|FG005|Overall Study|Withdrawal by Subject|5|||
160779611|NCT03853798|580576745|FG006|Overall Study|Withdrawal by Subject|0|||
160779612|NCT03853798|580576746|FG007|Overall Study|Withdrawal by Subject|0|||
160779613|NCT03853798|580576747|FG008|Overall Study|Withdrawal by Subject|4|||
160779614|NCT03853798|580576739|FG000|Overall Study|Physician Decision|1|||
160779615|NCT03853798|580576740|FG001|Overall Study|Physician Decision|0|||
160779616|NCT03853798|580576741|FG002|Overall Study|Physician Decision|0|||
160779617|NCT03853798|580576742|FG003|Overall Study|Physician Decision|0|||
160779618|NCT03853798|580576743|FG004|Overall Study|Physician Decision|0|||
160779619|NCT03853798|580576744|FG005|Overall Study|Physician Decision|0|||
160779620|NCT03853798|580576745|FG006|Overall Study|Physician Decision|0|||
160779621|NCT03853798|580576746|FG007|Overall Study|Physician Decision|0|||
160779622|NCT03853798|580576747|FG008|Overall Study|Physician Decision|1|||
160779623|NCT03853798|580576739|FG000|Overall Study|Lack of Efficacy|0|||
160779624|NCT03853798|580576740|FG001|Overall Study|Lack of Efficacy|0|||
160779625|NCT03853798|580576741|FG002|Overall Study|Lack of Efficacy|2|||
160779626|NCT03853798|580576742|FG003|Overall Study|Lack of Efficacy|0|||
160779627|NCT03853798|580576743|FG004|Overall Study|Lack of Efficacy|0|||
160779628|NCT03853798|580576744|FG005|Overall Study|Lack of Efficacy|0|||
160779629|NCT03853798|580576745|FG006|Overall Study|Lack of Efficacy|0|||
160779630|NCT03853798|580576746|FG007|Overall Study|Lack of Efficacy|0|||
160779631|NCT03853798|580576747|FG008|Overall Study|Lack of Efficacy|1|||
160779632|NCT03853798|580576739|FG000|Overall Study|Approved Drug Available for Indication|0|||
160779633|NCT03853798|580576740|FG001|Overall Study|Approved Drug Available for Indication|0|||
160779634|NCT03853798|580576741|FG002|Overall Study|Approved Drug Available for Indication|1|||
160779635|NCT03853798|580576742|FG003|Overall Study|Approved Drug Available for Indication|0|||
160779636|NCT03853798|580576743|FG004|Overall Study|Approved Drug Available for Indication|0|||
160779637|NCT03853798|580576744|FG005|Overall Study|Approved Drug Available for Indication|1|||
160779638|NCT03853798|580576745|FG006|Overall Study|Approved Drug Available for Indication|0|||
160779639|NCT03853798|580576746|FG007|Overall Study|Approved Drug Available for Indication|0|||
160887645|NCT00076024|580982550|FG002|Phase 2, Open-label|Other|0|||
160887646|NCT00076024|580982551|FG003|Phase 2, Open-label|Other|2|||
160887647|NCT01362595|580982552|FG000|Overall Study|Screen failure|10|||
160887648|NCT01362595|580982552|FG000|Overall Study|Withdrawal by Subject|2|||
160887649|NCT00959374|580982553|FG000|Overall Study|Withdrawal by Subject|2|||
160887650|NCT00959374|580982553|FG000|Overall Study|Lost to Follow-up|14|||
160887651|NCT00959374|580982553|FG000|Overall Study|Death|1|||
160887652|NCT00959374|580982553|FG000|Overall Study|Protocol Violation|1|||
160887653|NCT00959374|580982553|FG000|Overall Study|Implant Removed/Not Replaced|4|||
160887654|NCT00959374|580982553|FG000|Overall Study|Physician Decision|1|||
160887655|NCT03350984|580982554|FG000|Overall Study|Death|1|||
160887656|NCT03350984|580982555|FG001|Overall Study|Death|0|||
160887657|NCT03350984|580982554|FG000|Overall Study|Lost to Follow-up|5|||
160887658|NCT03350984|580982555|FG001|Overall Study|Lost to Follow-up|6|||
160887659|NCT03350984|580982554|FG000|Overall Study|Protocol Violation|1|||
160887660|NCT03350984|580982555|FG001|Overall Study|Protocol Violation|2|||
160887661|NCT03350984|580982554|FG000|Overall Study|Physician Decision|1|||
160887662|NCT03350984|580982555|FG001|Overall Study|Physician Decision|0|||
160887663|NCT01741012|580982556|FG000|Overall Study|Lost to Follow-up|1|||
160887664|NCT01741012|580982556|FG000|Overall Study|Withdrawal by Subject|2|||
160887665|NCT00958789|580982557|FG000|Overall Study|Death|5|||
160887666|NCT00958789|580982557|FG000|Overall Study|Lost to Follow-up|14|||
160887667|NCT00958789|580982557|FG000|Overall Study|Withdrawal by Subject|17|||
160887668|NCT00958789|580982557|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
160887669|NCT00958789|580982557|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
160887670|NCT00958789|580982557|FG000|Overall Study|Subject terminated|2|||
160887671|NCT00958789|580982557|FG000|Overall Study|Revision|7|||
160887672|NCT04104438|580982560|FG000|Overall Study|Death|2|||
160779640|NCT03853798|580576747|FG008|Overall Study|Approved Drug Available for Indication|0|||
160779641|NCT03853798|580576739|FG000|Overall Study|Other un-specified|0|||
160779642|NCT03853798|580576740|FG001|Overall Study|Other un-specified|0|||
160887673|NCT04104438|580982561|FG001|Overall Study|Death|1|||
160887674|NCT04104438|580982562|FG002|Overall Study|Death|2|||
160779643|NCT03853798|580576741|FG002|Overall Study|Other un-specified|2|||
160779644|NCT03853798|580576742|FG003|Overall Study|Other un-specified|0|||
160779645|NCT03853798|580576743|FG004|Overall Study|Other un-specified|0|||
160779646|NCT03853798|580576744|FG005|Overall Study|Other un-specified|1|||
160887675|NCT04104438|580982560|FG000|Overall Study|Adverse Event|0|||
160887676|NCT04104438|580982561|FG001|Overall Study|Adverse Event|3|||
160887677|NCT04104438|580982562|FG002|Overall Study|Adverse Event|0|||
160887678|NCT04104438|580982560|FG000|Overall Study|Withdrawal by Subject|0|||
160779647|NCT03853798|580576745|FG006|Overall Study|Other un-specified|0|||
160779648|NCT03853798|580576746|FG007|Overall Study|Other un-specified|0|||
160779649|NCT03853798|580576747|FG008|Overall Study|Other un-specified|0|||
160779650|NCT02743494|580576748|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
160779651|NCT02743494|580576749|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
160779652|NCT02743494|580576748|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
160779653|NCT02743494|580576749|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
160779654|NCT02743494|580576748|FG000|Treatment Period|Disease recurrence|152|||
160779655|NCT02743494|580576749|FG001|Treatment Period|Disease recurrence|115|||
160779656|NCT02743494|580576748|FG000|Treatment Period|Study drug toxicity|56|||
160779657|NCT02743494|580576749|FG001|Treatment Period|Study drug toxicity|8|||
160779658|NCT02743494|580576748|FG000|Treatment Period|Death|1|||
160779659|NCT02743494|580576749|FG001|Treatment Period|Death|1|||
160779660|NCT02743494|580576748|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
160779661|NCT02743494|580576749|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
160779662|NCT02743494|580576748|FG000|Treatment Period|Participant request to discontinue treatment|31|||
160779663|NCT02743494|580576749|FG001|Treatment Period|Participant request to discontinue treatment|5|||
160779664|NCT02743494|580576748|FG000|Treatment Period|Participant withdrew consent|11|||
160779665|NCT02743494|580576749|FG001|Treatment Period|Participant withdrew consent|4|||
160779666|NCT02743494|580576748|FG000|Treatment Period|Lost to Follow-up|0|||
160779667|NCT02743494|580576749|FG001|Treatment Period|Lost to Follow-up|1|||
160779668|NCT02743494|580576748|FG000|Treatment Period|Poor/Non-compliance|2|||
160779669|NCT02743494|580576749|FG001|Treatment Period|Poor/Non-compliance|0|||
160779670|NCT02743494|580576748|FG000|Treatment Period|Other reasons|4|||
160779671|NCT02743494|580576749|FG001|Treatment Period|Other reasons|1|||
160779672|NCT02207608|580576750|FG000|Overall Study|Adverse Event|1|||
160779673|NCT02207608|580576751|FG001|Overall Study|Adverse Event|0|||
160779674|NCT05399485|580578536|FG000|DBT Phase|Other|6|||
160779675|NCT05399485|580578537|FG001|DBT Phase|Other|5|||
160779676|NCT05399485|580578536|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
160779677|NCT05399485|580578537|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
160779678|NCT05399485|580578536|FG000|DBT Phase|Withdrawal by Subject|3|||
160779679|NCT05399485|580578537|FG001|DBT Phase|Withdrawal by Subject|2|||
160779680|NCT05399485|580578536|FG000|DBT Phase|Protocol Violation|2|||
160779681|NCT05399485|580578537|FG001|DBT Phase|Protocol Violation|1|||
160779682|NCT05399485|580578536|FG000|DBT Phase|Physician Decision|0|||
160779683|NCT05399485|580578537|FG001|DBT Phase|Physician Decision|1|||
160779684|NCT05399485|580578536|FG000|DBT Phase|Adverse Event|2|||
160779685|NCT05399485|580578537|FG001|DBT Phase|Adverse Event|1|||
160779686|NCT05399485|580578536|FG000|OLE Phase|Protocol deviation|1|||
160779687|NCT05399485|580578537|FG001|OLE Phase|Protocol deviation|0|||
160779688|NCT05399485|580578536|FG000|OLE Phase|Other|5|||
160779689|NCT05399485|580578537|FG001|OLE Phase|Other|5|||
160779690|NCT05399485|580578536|FG000|OLE Phase|Withdrawal by Subject|12|||
160779691|NCT05399485|580578537|FG001|OLE Phase|Withdrawal by Subject|7|||
160779692|NCT05399485|580578536|FG000|OLE Phase|Pregnancy|0|||
160779693|NCT05399485|580578537|FG001|OLE Phase|Pregnancy|2|||
160887679|NCT04104438|580982561|FG001|Overall Study|Withdrawal by Subject|1|||
160887680|NCT04104438|580982562|FG002|Overall Study|Withdrawal by Subject|0|||
160887681|NCT04104438|580982560|FG000|Overall Study|Disenrolled due to noncompliance|0|||
160887682|NCT04104438|580982561|FG001|Overall Study|Disenrolled due to noncompliance|1|||
160887683|NCT04104438|580982562|FG002|Overall Study|Disenrolled due to noncompliance|0|||
160887684|NCT04104438|580982560|FG000|Overall Study|stopped due to possible operation|0|||
160779694|NCT05399485|580578536|FG000|OLE Phase|Physician Decision|3|||
160779695|NCT05399485|580578537|FG001|OLE Phase|Physician Decision|0|||
160779696|NCT05399485|580578536|FG000|OLE Phase|Adverse Event|2|||
160779697|NCT05399485|580578537|FG001|OLE Phase|Adverse Event|2|||
160779698|NCT03554473|580578538|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
160779699|NCT03554473|580578539|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
160887685|NCT04104438|580982561|FG001|Overall Study|stopped due to possible operation|1|||
160779700|NCT03554473|580578540|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
160779701|NCT03554473|580578538|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
160779702|NCT03554473|580578539|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
160779703|NCT03554473|580578540|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
160779704|NCT03554473|580578538|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
160779705|NCT03554473|580578539|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
160779706|NCT03554473|580578540|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
160779707|NCT05206604|580578541|FG000|Overall Study|Non-compliance with study drug|0|||
160779708|NCT05206604|580578542|FG001|Overall Study|Non-compliance with study drug|0|||
160779709|NCT05206604|580578543|FG002|Overall Study|Non-compliance with study drug|0|||
160779710|NCT05206604|580578544|FG003|Overall Study|Non-compliance with study drug|0|||
160779711|NCT05206604|580578545|FG004|Overall Study|Non-compliance with study drug|0|||
160779712|NCT05206604|580578546|FG005|Overall Study|Non-compliance with study drug|1|||
160779713|NCT05206604|580578547|FG006|Overall Study|Non-compliance with study drug|0|||
160779714|NCT05206604|580578548|FG007|Overall Study|Non-compliance with study drug|0|||
160779715|NCT00160615|580578549|FG000|Overall Study|Adverse Event|5|||
160779716|NCT00160615|580578550|FG001|Overall Study|Adverse Event|12|||
160779717|NCT00160615|580578549|FG000|Overall Study|Withdrawal by Subject|0|||
160779718|NCT00160615|580578550|FG001|Overall Study|Withdrawal by Subject|2|||
160779719|NCT00160615|580578549|FG000|Overall Study|Lack of Efficacy|11|||
160779720|NCT00160615|580578550|FG001|Overall Study|Lack of Efficacy|23|||
160779721|NCT00160615|580578549|FG000|Overall Study|Patient decision|1|||
160779722|NCT00160615|580578550|FG001|Overall Study|Patient decision|2|||
160779723|NCT00160615|580578549|FG000|Overall Study|Investigator decision|1|||
160779724|NCT00160615|580578550|FG001|Overall Study|Investigator decision|1|||
160779725|NCT00160615|580578549|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
160779726|NCT00160615|580578550|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
160779727|NCT00160615|580578549|FG000|Overall Study|Switch to surgical treatment|0|||
160779728|NCT00160615|580578550|FG001|Overall Study|Switch to surgical treatment|2|||
160779729|NCT00160615|580578549|FG000|Overall Study|Non-compliance was suspected|0|||
160779730|NCT00160615|580578550|FG001|Overall Study|Non-compliance was suspected|1|||
160779731|NCT00160615|580578549|FG000|Overall Study|Poor compliance|0|||
160779732|NCT00160615|580578550|FG001|Overall Study|Poor compliance|1|||
160779733|NCT03971422|580578554|FG000|Overall Study|Lost to Follow-up|0|||
160779734|NCT03971422|580578555|FG001|Overall Study|Lost to Follow-up|1|||
160779735|NCT03971422|580578556|FG002|Overall Study|Lost to Follow-up|0|||
160779736|NCT03971422|580578554|FG000|Overall Study|Lack of Efficacy|5|||
160779737|NCT03971422|580578555|FG001|Overall Study|Lack of Efficacy|1|||
160779738|NCT03971422|580578556|FG002|Overall Study|Lack of Efficacy|1|||
160779739|NCT03971422|580578554|FG000|Overall Study|Adverse event, not fatal|2|||
160779740|NCT03971422|580578555|FG001|Overall Study|Adverse event, not fatal|2|||
160779741|NCT03971422|580578556|FG002|Overall Study|Adverse event, not fatal|5|||
160779742|NCT03971422|580578554|FG000|Overall Study|Worsening of MG Symptoms|1|||
160779743|NCT03971422|580578555|FG001|Overall Study|Worsening of MG Symptoms|4|||
160887686|NCT04104438|580982562|FG002|Overall Study|stopped due to possible operation|0|||
160779744|NCT03971422|580578556|FG002|Overall Study|Worsening of MG Symptoms|2|||
160779745|NCT03971422|580578554|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
160779746|NCT03971422|580578555|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
160779747|NCT03971422|580578556|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
160887687|NCT04104438|580982560|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
160638372|NCT02643966|580059267|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
160638373|NCT02643966|580059267|FG000|Between Second and Third Screening|Death|1|||
160638374|NCT02643966|580059267|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
160779748|NCT03971422|580578554|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
160541954|NCT01029366|579712874|FG001|Overall Study|manufacturing failure|1|||
160541955|NCT01046877|579712875|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
160541956|NCT01046877|579712875|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
160541957|NCT01827670|579712876|FG000|Overall Study|Withdrawal of Consent|3|||
160541958|NCT01827670|579712877|FG001|Overall Study|Withdrawal of Consent|2|||
160541959|NCT01827670|579712876|FG000|Overall Study|Lost to Follow-up|0|||
160541960|NCT01827670|579712877|FG001|Overall Study|Lost to Follow-up|1|||
160541961|NCT00563186|579712885|FG000|Overall Study|LOS<48 hours|97|||
160541962|NCT00563186|579712886|FG001|Overall Study|LOS<48 hours|74|||
160541963|NCT00563186|579712885|FG000|Overall Study|Incomplete data|1|||
160541964|NCT00563186|579712886|FG001|Overall Study|Incomplete data|1|||
160541965|NCT00517829|579712889|FG000|Overall Study|Adverse Event|22|||
160541966|NCT00517829|579712890|FG001|Overall Study|Adverse Event|34|||
160541967|NCT00517829|579712889|FG000|Overall Study|Disease Progression|39|||
160541968|NCT00517829|579712890|FG001|Overall Study|Disease Progression|32|||
160541969|NCT00517829|579712889|FG000|Overall Study|Patient Request|6|||
160541970|NCT00517829|579712890|FG001|Overall Study|Patient Request|5|||
160541971|NCT00517829|579712889|FG000|Overall Study|Investigator Request|5|||
160541972|NCT00517829|579712890|FG001|Overall Study|Investigator Request|3|||
160541973|NCT00517829|579712889|FG000|Overall Study|Other|3|||
160541974|NCT00517829|579712890|FG001|Overall Study|Other|1|||
160541975|NCT00446511|579712892|FG000|Overall Study|Adverse Event|7|||
160541976|NCT00446511|579712893|FG001|Overall Study|Adverse Event|2|||
160541977|NCT00446511|579712894|FG002|Overall Study|Adverse Event|3|||
160541978|NCT00446511|579712895|FG003|Overall Study|Adverse Event|1|||
160541979|NCT00446511|579712892|FG000|Overall Study|Protocol Violation|0|||
160541980|NCT00446511|579712893|FG001|Overall Study|Protocol Violation|0|||
160541981|NCT00446511|579712894|FG002|Overall Study|Protocol Violation|0|||
160541982|NCT00446511|579712895|FG003|Overall Study|Protocol Violation|1|||
160541983|NCT00446511|579712892|FG000|Overall Study|Withdrawal by Subject|0|||
160541984|NCT00446511|579712893|FG001|Overall Study|Withdrawal by Subject|0|||
160541985|NCT00446511|579712894|FG002|Overall Study|Withdrawal by Subject|0|||
160541986|NCT00446511|579712895|FG003|Overall Study|Withdrawal by Subject|3|||
160541987|NCT00446511|579712892|FG000|Overall Study|Administrative Problems|3|||
160541988|NCT00446511|579712893|FG001|Overall Study|Administrative Problems|0|||
160541989|NCT00446511|579712894|FG002|Overall Study|Administrative Problems|4|||
160541990|NCT00446511|579712895|FG003|Overall Study|Administrative Problems|1|||
160541991|NCT01136655|579712896|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
160541992|NCT01136655|579712896|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
160541993|NCT01136655|579712896|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
160541994|NCT01136655|579712896|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
160541995|NCT01265550|579712897|FG000|Pre Randomization|Withdrawal by Subject|0|||
160541996|NCT01265550|579712898|FG001|Pre Randomization|Withdrawal by Subject|0|||
160541997|NCT01265550|579712899|FG002|Pre Randomization|Withdrawal by Subject|0|||
160638375|NCT02643966|580059267|FG000|Third Screening Round|PI excluded|2|||
160779749|NCT03971422|580578555|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
160779750|NCT03971422|580578556|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
160779751|NCT03971422|580578554|FG000|Overall Study|Due to COVID-19 pandemic|0|||
160779752|NCT03971422|580578555|FG001|Overall Study|Due to COVID-19 pandemic|1|||
160779753|NCT03971422|580578556|FG002|Overall Study|Due to COVID-19 pandemic|1|||
160779754|NCT01658878|580578557|FG000|Treatment Period|Disease Progression|1|||
160779755|NCT01658878|580578558|FG001|Treatment Period|Disease Progression|3|||
160779756|NCT01658878|580578559|FG002|Treatment Period|Disease Progression|2|||
160779757|NCT01658878|580578560|FG003|Treatment Period|Disease Progression|1|||
160779758|NCT01658878|580578561|FG004|Treatment Period|Disease Progression|13|||
160779759|NCT01658878|580578562|FG005|Treatment Period|Disease Progression|3|||
160779760|NCT01658878|580578563|FG006|Treatment Period|Disease Progression|4|||
160779761|NCT01658878|580578564|FG007|Treatment Period|Disease Progression|3|||
160779762|NCT01658878|580578565|FG008|Treatment Period|Disease Progression|5|||
160779763|NCT01658878|580578566|FG009|Treatment Period|Disease Progression|3|||
160779764|NCT01658878|580578567|FG010|Treatment Period|Disease Progression|3|||
160779765|NCT01658878|580578568|FG011|Treatment Period|Disease Progression|4|||
160779766|NCT01658878|580578569|FG012|Treatment Period|Disease Progression|43|||
160779767|NCT01658878|580578570|FG013|Treatment Period|Disease Progression|48|||
160779768|NCT01658878|580578571|FG014|Treatment Period|Disease Progression|33|||
160779769|NCT01658878|580578572|FG015|Treatment Period|Disease Progression|46|||
160779770|NCT01658878|580578573|FG016|Treatment Period|Disease Progression|41|||
160779771|NCT01658878|580578574|FG017|Treatment Period|Disease Progression|42|||
160779772|NCT01658878|580578575|FG018|Treatment Period|Disease Progression|28|||
160779773|NCT01658878|580578576|FG019|Treatment Period|Disease Progression|37|||
160779774|NCT01658878|580578577|FG020|Treatment Period|Disease Progression|37|||
160779775|NCT01658878|580578578|FG021|Treatment Period|Disease Progression|39|||
160779776|NCT01658878|580578579|FG022|Treatment Period|Disease Progression|27|||
160779777|NCT01658878|580578580|FG023|Treatment Period|Disease Progression|19|||
160779778|NCT01658878|580578557|FG000|Treatment Period|Study Drug Toxicity|0|||
160779779|NCT01658878|580578558|FG001|Treatment Period|Study Drug Toxicity|0|||
160779780|NCT01658878|580578559|FG002|Treatment Period|Study Drug Toxicity|0|||
160779781|NCT01658878|580578560|FG003|Treatment Period|Study Drug Toxicity|1|||
160779782|NCT01658878|580578561|FG004|Treatment Period|Study Drug Toxicity|0|||
160779783|NCT01658878|580578562|FG005|Treatment Period|Study Drug Toxicity|0|||
160779784|NCT01658878|580578563|FG006|Treatment Period|Study Drug Toxicity|0|||
160779785|NCT01658878|580578564|FG007|Treatment Period|Study Drug Toxicity|0|||
160779786|NCT01658878|580578565|FG008|Treatment Period|Study Drug Toxicity|0|||
160779787|NCT01658878|580578566|FG009|Treatment Period|Study Drug Toxicity|0|||
160779788|NCT01658878|580578567|FG010|Treatment Period|Study Drug Toxicity|0|||
160779789|NCT01658878|580578568|FG011|Treatment Period|Study Drug Toxicity|0|||
160779790|NCT01658878|580578569|FG012|Treatment Period|Study Drug Toxicity|7|||
160779791|NCT01658878|580578570|FG013|Treatment Period|Study Drug Toxicity|1|||
160779792|NCT01658878|580578571|FG014|Treatment Period|Study Drug Toxicity|5|||
160779793|NCT01658878|580578572|FG015|Treatment Period|Study Drug Toxicity|0|||
160779794|NCT01658878|580578573|FG016|Treatment Period|Study Drug Toxicity|5|||
160779795|NCT01658878|580578574|FG017|Treatment Period|Study Drug Toxicity|10|||
160779796|NCT01658878|580578575|FG018|Treatment Period|Study Drug Toxicity|12|||
160779797|NCT01658878|580578576|FG019|Treatment Period|Study Drug Toxicity|4|||
160779798|NCT01658878|580578577|FG020|Treatment Period|Study Drug Toxicity|2|||
160779799|NCT01658878|580578578|FG021|Treatment Period|Study Drug Toxicity|3|||
160779800|NCT01658878|580578579|FG022|Treatment Period|Study Drug Toxicity|2|||
160779801|NCT01658878|580578580|FG023|Treatment Period|Study Drug Toxicity|6|||
160779802|NCT01658878|580578557|FG000|Treatment Period|Maximum Clinical Benefit|0|||
160779803|NCT01658878|580578558|FG001|Treatment Period|Maximum Clinical Benefit|0|||
160779804|NCT01658878|580578559|FG002|Treatment Period|Maximum Clinical Benefit|1|||
160779805|NCT01658878|580578560|FG003|Treatment Period|Maximum Clinical Benefit|0|||
160779806|NCT01658878|580578561|FG004|Treatment Period|Maximum Clinical Benefit|0|||
160779807|NCT01658878|580578562|FG005|Treatment Period|Maximum Clinical Benefit|0|||
160779808|NCT01658878|580578563|FG006|Treatment Period|Maximum Clinical Benefit|0|||
160779809|NCT01658878|580578564|FG007|Treatment Period|Maximum Clinical Benefit|0|||
160779810|NCT01658878|580578565|FG008|Treatment Period|Maximum Clinical Benefit|0|||
160779811|NCT01658878|580578566|FG009|Treatment Period|Maximum Clinical Benefit|0|||
160779812|NCT01658878|580578567|FG010|Treatment Period|Maximum Clinical Benefit|0|||
160779813|NCT01658878|580578568|FG011|Treatment Period|Maximum Clinical Benefit|0|||
160779814|NCT01658878|580578569|FG012|Treatment Period|Maximum Clinical Benefit|0|||
160779815|NCT01658878|580578570|FG013|Treatment Period|Maximum Clinical Benefit|0|||
160779816|NCT01658878|580578571|FG014|Treatment Period|Maximum Clinical Benefit|0|||
160779817|NCT01658878|580578572|FG015|Treatment Period|Maximum Clinical Benefit|0|||
160779818|NCT01658878|580578573|FG016|Treatment Period|Maximum Clinical Benefit|0|||
160779819|NCT01658878|580578574|FG017|Treatment Period|Maximum Clinical Benefit|0|||
160779820|NCT01658878|580578575|FG018|Treatment Period|Maximum Clinical Benefit|1|||
160779821|NCT01658878|580578576|FG019|Treatment Period|Maximum Clinical Benefit|1|||
160779822|NCT01658878|580578577|FG020|Treatment Period|Maximum Clinical Benefit|0|||
160779823|NCT01658878|580578578|FG021|Treatment Period|Maximum Clinical Benefit|0|||
160779824|NCT01658878|580578579|FG022|Treatment Period|Maximum Clinical Benefit|0|||
160779825|NCT01658878|580578580|FG023|Treatment Period|Maximum Clinical Benefit|0|||
160779826|NCT01658878|580578557|FG000|Treatment Period|Other Reasons|0|||
160779827|NCT01658878|580578558|FG001|Treatment Period|Other Reasons|0|||
160779828|NCT01658878|580578559|FG002|Treatment Period|Other Reasons|0|||
160779829|NCT01658878|580578560|FG003|Treatment Period|Other Reasons|1|||
160779830|NCT01658878|580578561|FG004|Treatment Period|Other Reasons|0|||
160779831|NCT01658878|580578562|FG005|Treatment Period|Other Reasons|0|||
160779832|NCT01658878|580578563|FG006|Treatment Period|Other Reasons|0|||
160779833|NCT01658878|580578564|FG007|Treatment Period|Other Reasons|0|||
160779834|NCT01658878|580578565|FG008|Treatment Period|Other Reasons|0|||
160779835|NCT01658878|580578566|FG009|Treatment Period|Other Reasons|0|||
160779836|NCT01658878|580578567|FG010|Treatment Period|Other Reasons|0|||
160779837|NCT01658878|580578568|FG011|Treatment Period|Other Reasons|0|||
160779838|NCT01658878|580578569|FG012|Treatment Period|Other Reasons|2|||
160779839|NCT01658878|580578570|FG013|Treatment Period|Other Reasons|0|||
160779840|NCT01658878|580578571|FG014|Treatment Period|Other Reasons|0|||
160779841|NCT01658878|580578572|FG015|Treatment Period|Other Reasons|2|||
160779842|NCT01658878|580578573|FG016|Treatment Period|Other Reasons|1|||
160779843|NCT01658878|580578574|FG017|Treatment Period|Other Reasons|1|||
160779844|NCT01658878|580578575|FG018|Treatment Period|Other Reasons|3|||
160779845|NCT01658878|580578576|FG019|Treatment Period|Other Reasons|1|||
160779846|NCT01658878|580578577|FG020|Treatment Period|Other Reasons|4|||
160779847|NCT01658878|580578578|FG021|Treatment Period|Other Reasons|0|||
160779848|NCT01658878|580578579|FG022|Treatment Period|Other Reasons|0|||
160779849|NCT01658878|580578580|FG023|Treatment Period|Other Reasons|4|||
160779850|NCT01658878|580578557|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779851|NCT01658878|580578558|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779852|NCT01658878|580578559|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779853|NCT01658878|580578560|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779854|NCT01658878|580578561|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779855|NCT01658878|580578562|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779856|NCT01658878|580578563|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779857|NCT01658878|580578564|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779858|NCT01658878|580578565|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779859|NCT01658878|580578566|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779860|NCT01658878|580578567|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779861|NCT01658878|580578568|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779862|NCT01658878|580578569|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779863|NCT01658878|580578570|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779864|NCT01658878|580578571|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
160779865|NCT01658878|580578572|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779866|NCT01658878|580578573|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779867|NCT01658878|580578574|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
160779868|NCT01658878|580578575|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779869|NCT01658878|580578576|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779870|NCT01658878|580578577|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779871|NCT01658878|580578578|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779872|NCT01658878|580578579|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779873|NCT01658878|580578580|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779874|NCT01658878|580578557|FG000|Treatment Period|Poor/Non-compliance|0|||
160779875|NCT01658878|580578558|FG001|Treatment Period|Poor/Non-compliance|0|||
160779876|NCT01658878|580578559|FG002|Treatment Period|Poor/Non-compliance|0|||
160779877|NCT01658878|580578560|FG003|Treatment Period|Poor/Non-compliance|0|||
160779878|NCT01658878|580578561|FG004|Treatment Period|Poor/Non-compliance|0|||
160779879|NCT01658878|580578562|FG005|Treatment Period|Poor/Non-compliance|0|||
160779880|NCT01658878|580578563|FG006|Treatment Period|Poor/Non-compliance|0|||
160779881|NCT01658878|580578564|FG007|Treatment Period|Poor/Non-compliance|0|||
160779882|NCT01658878|580578565|FG008|Treatment Period|Poor/Non-compliance|0|||
160779883|NCT01658878|580578566|FG009|Treatment Period|Poor/Non-compliance|0|||
160779884|NCT01658878|580578567|FG010|Treatment Period|Poor/Non-compliance|0|||
160779885|NCT01658878|580578568|FG011|Treatment Period|Poor/Non-compliance|0|||
160779886|NCT01658878|580578569|FG012|Treatment Period|Poor/Non-compliance|0|||
160779887|NCT01658878|580578570|FG013|Treatment Period|Poor/Non-compliance|0|||
160779888|NCT01658878|580578571|FG014|Treatment Period|Poor/Non-compliance|0|||
160779889|NCT01658878|580578572|FG015|Treatment Period|Poor/Non-compliance|1|||
160779890|NCT01658878|580578573|FG016|Treatment Period|Poor/Non-compliance|0|||
160779891|NCT01658878|580578574|FG017|Treatment Period|Poor/Non-compliance|0|||
160779892|NCT01658878|580578575|FG018|Treatment Period|Poor/Non-compliance|0|||
160779893|NCT01658878|580578576|FG019|Treatment Period|Poor/Non-compliance|0|||
160779894|NCT01658878|580578577|FG020|Treatment Period|Poor/Non-compliance|0|||
160779895|NCT01658878|580578578|FG021|Treatment Period|Poor/Non-compliance|0|||
160779896|NCT01658878|580578579|FG022|Treatment Period|Poor/Non-compliance|0|||
160779897|NCT01658878|580578580|FG023|Treatment Period|Poor/Non-compliance|0|||
160779898|NCT01658878|580578557|FG000|Treatment Period|Participant Withdrew Consent|0|||
160779899|NCT01658878|580578558|FG001|Treatment Period|Participant Withdrew Consent|0|||
160779900|NCT01658878|580578559|FG002|Treatment Period|Participant Withdrew Consent|0|||
160779901|NCT01658878|580578560|FG003|Treatment Period|Participant Withdrew Consent|0|||
160779902|NCT01658878|580578561|FG004|Treatment Period|Participant Withdrew Consent|0|||
160779903|NCT01658878|580578562|FG005|Treatment Period|Participant Withdrew Consent|0|||
160779904|NCT01658878|580578563|FG006|Treatment Period|Participant Withdrew Consent|0|||
160779905|NCT01658878|580578564|FG007|Treatment Period|Participant Withdrew Consent|0|||
160779906|NCT01658878|580578565|FG008|Treatment Period|Participant Withdrew Consent|0|||
160779907|NCT01658878|580578566|FG009|Treatment Period|Participant Withdrew Consent|0|||
160779908|NCT01658878|580578567|FG010|Treatment Period|Participant Withdrew Consent|0|||
160779909|NCT01658878|580578568|FG011|Treatment Period|Participant Withdrew Consent|0|||
160779910|NCT01658878|580578569|FG012|Treatment Period|Participant Withdrew Consent|1|||
160779911|NCT01658878|580578570|FG013|Treatment Period|Participant Withdrew Consent|0|||
160779912|NCT01658878|580578571|FG014|Treatment Period|Participant Withdrew Consent|2|||
160779913|NCT01658878|580578572|FG015|Treatment Period|Participant Withdrew Consent|0|||
160779914|NCT01658878|580578573|FG016|Treatment Period|Participant Withdrew Consent|0|||
160779915|NCT01658878|580578574|FG017|Treatment Period|Participant Withdrew Consent|2|||
160779916|NCT01658878|580578575|FG018|Treatment Period|Participant Withdrew Consent|1|||
160779917|NCT01658878|580578576|FG019|Treatment Period|Participant Withdrew Consent|2|||
160779918|NCT01658878|580578577|FG020|Treatment Period|Participant Withdrew Consent|1|||
160779919|NCT01658878|580578578|FG021|Treatment Period|Participant Withdrew Consent|0|||
160779920|NCT01658878|580578579|FG022|Treatment Period|Participant Withdrew Consent|2|||
160779921|NCT01658878|580578580|FG023|Treatment Period|Participant Withdrew Consent|2|||
160779922|NCT01658878|580578557|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779923|NCT01658878|580578558|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779924|NCT01658878|580578559|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779925|NCT01658878|580578560|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779926|NCT01658878|580578561|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779927|NCT01658878|580578562|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779928|NCT01658878|580578563|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779929|NCT01658878|580578564|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779930|NCT01658878|580578565|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779931|NCT01658878|580578566|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779932|NCT01658878|580578567|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779933|NCT01658878|580578568|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779934|NCT01658878|580578569|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
160779935|NCT01658878|580578570|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
160779936|NCT01658878|580578571|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
160779937|NCT01658878|580578572|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
160779938|NCT01658878|580578573|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
160779939|NCT01658878|580578574|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
160779940|NCT01658878|580578575|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779941|NCT01658878|580578576|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
160779942|NCT01658878|580578577|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
160779943|NCT01658878|580578578|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
160779944|NCT01658878|580578579|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779945|NCT01658878|580578580|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
160779946|NCT01658878|580578557|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
160779947|NCT01658878|580578558|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
160779948|NCT01658878|580578559|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
160779949|NCT01658878|580578560|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
160779950|NCT01658878|580578561|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
160541998|NCT01265550|579712900|FG003|Pre Randomization|Withdrawal by Subject|70|||
160541999|NCT01265550|579712897|FG000|Pre Randomization|Technical Exclusions|0|||
160542000|NCT01265550|579712898|FG001|Pre Randomization|Technical Exclusions|0|||
160542001|NCT01265550|579712899|FG002|Pre Randomization|Technical Exclusions|0|||
160779951|NCT01658878|580578562|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
160779952|NCT01658878|580578563|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
160779953|NCT01658878|580578564|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
160779954|NCT01658878|580578565|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
160779955|NCT01658878|580578566|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
160779956|NCT01658878|580578567|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
160779957|NCT01658878|580578568|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
160779958|NCT01658878|580578569|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
160779959|NCT01658878|580578570|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
160779960|NCT01658878|580578571|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
160779961|NCT01658878|580578572|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
160779962|NCT01658878|580578573|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
160779963|NCT01658878|580578574|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
160779964|NCT01658878|580578575|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
160779965|NCT01658878|580578576|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
160779966|NCT01658878|580578577|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
160779967|NCT01658878|580578578|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
160779968|NCT01658878|580578579|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
160779969|NCT01658878|580578580|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
160779970|NCT01658878|580578557|FG000|Treatment Period|Death|0|||
160779971|NCT01658878|580578558|FG001|Treatment Period|Death|0|||
160779972|NCT01658878|580578559|FG002|Treatment Period|Death|0|||
160779973|NCT01658878|580578560|FG003|Treatment Period|Death|0|||
160779974|NCT01658878|580578561|FG004|Treatment Period|Death|0|||
160779975|NCT01658878|580578562|FG005|Treatment Period|Death|0|||
160779976|NCT01658878|580578563|FG006|Treatment Period|Death|0|||
160779977|NCT01658878|580578564|FG007|Treatment Period|Death|0|||
160779978|NCT01658878|580578565|FG008|Treatment Period|Death|0|||
160779979|NCT01658878|580578566|FG009|Treatment Period|Death|0|||
160779980|NCT01658878|580578567|FG010|Treatment Period|Death|0|||
160779981|NCT01658878|580578568|FG011|Treatment Period|Death|0|||
160779982|NCT01658878|580578569|FG012|Treatment Period|Death|1|||
160779983|NCT01658878|580578570|FG013|Treatment Period|Death|0|||
160779984|NCT01658878|580578571|FG014|Treatment Period|Death|0|||
160779985|NCT01658878|580578572|FG015|Treatment Period|Death|0|||
160779986|NCT01658878|580578573|FG016|Treatment Period|Death|1|||
160779987|NCT01658878|580578574|FG017|Treatment Period|Death|1|||
160779988|NCT01658878|580578575|FG018|Treatment Period|Death|0|||
160779989|NCT01658878|580578576|FG019|Treatment Period|Death|0|||
160779990|NCT01658878|580578577|FG020|Treatment Period|Death|0|||
160779991|NCT01658878|580578578|FG021|Treatment Period|Death|2|||
160779992|NCT01658878|580578579|FG022|Treatment Period|Death|0|||
160779993|NCT01658878|580578580|FG023|Treatment Period|Death|0|||
160779994|NCT01658878|580578557|FG000|Treatment Period|Adverse Event|0|||
160779995|NCT01658878|580578558|FG001|Treatment Period|Adverse Event|0|||
160779996|NCT01658878|580578559|FG002|Treatment Period|Adverse Event|0|||
160779997|NCT01658878|580578560|FG003|Treatment Period|Adverse Event|0|||
160779998|NCT01658878|580578561|FG004|Treatment Period|Adverse Event|0|||
160779999|NCT01658878|580578562|FG005|Treatment Period|Adverse Event|0|||
160780000|NCT01658878|580578563|FG006|Treatment Period|Adverse Event|0|||
160780001|NCT01658878|580578564|FG007|Treatment Period|Adverse Event|0|||
160780002|NCT01658878|580578565|FG008|Treatment Period|Adverse Event|0|||
160780003|NCT01658878|580578566|FG009|Treatment Period|Adverse Event|0|||
160780004|NCT01658878|580578567|FG010|Treatment Period|Adverse Event|0|||
160780005|NCT01658878|580578568|FG011|Treatment Period|Adverse Event|0|||
160780006|NCT01658878|580578569|FG012|Treatment Period|Adverse Event|0|||
160780007|NCT01658878|580578570|FG013|Treatment Period|Adverse Event|0|||
160780008|NCT01658878|580578571|FG014|Treatment Period|Adverse Event|0|||
160780009|NCT01658878|580578572|FG015|Treatment Period|Adverse Event|0|||
160780010|NCT01658878|580578573|FG016|Treatment Period|Adverse Event|10|||
160780011|NCT01658878|580578574|FG017|Treatment Period|Adverse Event|3|||
160780012|NCT01658878|580578575|FG018|Treatment Period|Adverse Event|3|||
160780013|NCT01658878|580578576|FG019|Treatment Period|Adverse Event|2|||
160780014|NCT01658878|580578577|FG020|Treatment Period|Adverse Event|3|||
160780015|NCT01658878|580578578|FG021|Treatment Period|Adverse Event|3|||
160780016|NCT01658878|580578579|FG022|Treatment Period|Adverse Event|4|||
160780017|NCT01658878|580578580|FG023|Treatment Period|Adverse Event|3|||
160780018|NCT01658878|580578557|FG000|Treatment Period|Lost to Follow-up|0|||
160780019|NCT01658878|580578558|FG001|Treatment Period|Lost to Follow-up|0|||
160780020|NCT01658878|580578559|FG002|Treatment Period|Lost to Follow-up|0|||
160780021|NCT01658878|580578560|FG003|Treatment Period|Lost to Follow-up|0|||
160780022|NCT01658878|580578561|FG004|Treatment Period|Lost to Follow-up|0|||
160780023|NCT01658878|580578562|FG005|Treatment Period|Lost to Follow-up|0|||
160780024|NCT01658878|580578563|FG006|Treatment Period|Lost to Follow-up|0|||
160780025|NCT01658878|580578564|FG007|Treatment Period|Lost to Follow-up|0|||
160780026|NCT01658878|580578565|FG008|Treatment Period|Lost to Follow-up|0|||
160780027|NCT01658878|580578566|FG009|Treatment Period|Lost to Follow-up|0|||
160780028|NCT01658878|580578567|FG010|Treatment Period|Lost to Follow-up|0|||
160780029|NCT01658878|580578568|FG011|Treatment Period|Lost to Follow-up|0|||
160780030|NCT01658878|580578569|FG012|Treatment Period|Lost to Follow-up|0|||
160780031|NCT01658878|580578570|FG013|Treatment Period|Lost to Follow-up|0|||
160780032|NCT01658878|580578571|FG014|Treatment Period|Lost to Follow-up|0|||
160780033|NCT01658878|580578572|FG015|Treatment Period|Lost to Follow-up|0|||
160780034|NCT01658878|580578573|FG016|Treatment Period|Lost to Follow-up|1|||
160780035|NCT01658878|580578574|FG017|Treatment Period|Lost to Follow-up|0|||
160780036|NCT01658878|580578575|FG018|Treatment Period|Lost to Follow-up|1|||
160780037|NCT01658878|580578576|FG019|Treatment Period|Lost to Follow-up|1|||
160780038|NCT01658878|580578577|FG020|Treatment Period|Lost to Follow-up|0|||
160780039|NCT01658878|580578578|FG021|Treatment Period|Lost to Follow-up|0|||
160780040|NCT01658878|580578579|FG022|Treatment Period|Lost to Follow-up|1|||
160780041|NCT01658878|580578580|FG023|Treatment Period|Lost to Follow-up|0|||
160780042|NCT03928704|580578583|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
160780043|NCT03928704|580578584|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
160780044|NCT03928704|580578585|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
160780045|NCT03928704|580578586|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
160780046|NCT03928704|580578587|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
160780047|NCT03928704|580578588|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
160780048|NCT03928704|580578583|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
160780049|NCT03928704|580578584|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
160780050|NCT03928704|580578585|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
160780051|NCT03928704|580578586|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
160780052|NCT03928704|580578587|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
160780053|NCT03928704|580578588|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
160780054|NCT03928704|580578583|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
160780055|NCT03928704|580578584|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
160780056|NCT03928704|580578585|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
160780057|NCT03928704|580578586|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
160780058|NCT03928704|580578587|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
160780059|NCT03928704|580578588|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
160780060|NCT03928704|580578583|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
160780061|NCT03928704|580578584|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
160780062|NCT03928704|580578585|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
160780063|NCT03928704|580578586|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
160780064|NCT03928704|580578587|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
160780065|NCT03928704|580578588|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
160780066|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
160780067|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
160780068|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
160780069|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
160780070|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
160780071|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
160780072|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
160780073|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
160780074|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
160780075|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
160780076|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
160780077|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
160780078|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
160780079|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
160780080|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
160780081|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
160780082|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
160780083|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
160780084|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
160780085|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
160780086|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
160780087|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
160780088|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
160780089|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
160887688|NCT04104438|580982561|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
160887689|NCT04104438|580982562|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
160780090|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
160780091|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
160780092|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
160780093|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
160780094|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
160780095|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
160780096|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
160780097|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
160780098|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
160780099|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
160780100|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
160780101|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
160780102|NCT01631188|580578589|FG000|Overall Study|Physician Decision|75|||
160780103|NCT04575324|580578593|FG000|Overall Study|Lost to Follow-up|29|||
160780104|NCT04575324|580578594|FG001|Overall Study|Lost to Follow-up|25|||
160780105|NCT04575324|580578593|FG000|Overall Study|Death|1|||
160780106|NCT04575324|580578594|FG001|Overall Study|Death|2|||
160780107|NCT04575324|580578593|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
160780108|NCT04575324|580578594|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
160780109|NCT01105130|580578595|FG000|Overall Study|Withdrawal by Subject|4|||
160780110|NCT01105130|580578596|FG001|Overall Study|Withdrawal by Subject|6|||
160780111|NCT01105130|580578597|FG002|Overall Study|Withdrawal by Subject|2|||
160780112|NCT01105130|580578595|FG000|Overall Study|Never Started|2|||
160780113|NCT01105130|580578596|FG001|Overall Study|Never Started|2|||
160780114|NCT01105130|580578597|FG002|Overall Study|Never Started|4|||
160780115|NCT01105130|580578595|FG000|Overall Study|Toxicity|1|||
160780116|NCT01105130|580578596|FG001|Overall Study|Toxicity|3|||
160780117|NCT01105130|580578597|FG002|Overall Study|Toxicity|2|||
160780118|NCT01105130|580578595|FG000|Overall Study|Multiple Reasons|3|||
160780119|NCT01105130|580578596|FG001|Overall Study|Multiple Reasons|0|||
160780120|NCT01105130|580578597|FG002|Overall Study|Multiple Reasons|2|||
160780121|NCT00530075|580578599|FG000|Overall Study|Adverse Event|1|||
160780122|NCT00530075|580578599|FG000|Overall Study|Death|1|||
160780123|NCT00530075|580578599|FG000|Overall Study|Lack of Efficacy|3|||
160780124|NCT00530075|580578599|FG000|Overall Study|Protocol Violation|1|||
160780125|NCT00530075|580578599|FG000|Overall Study|Withdrawal by Subject|1|||
160780126|NCT03520569|580578602|FG000|Overall Study|Withdrawal by Subject|1|||
160780127|NCT00784927|580578603|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
160780128|NCT00784927|580578603|FG000|Overall Study|Protocol Violation|1|||
160780129|NCT00784927|580578603|FG000|Overall Study|Ineligible|1|||
160780130|NCT01471574|580578604|FG000|Treatment Period|Lack of Efficacy|12|||
160780131|NCT01471574|580578605|FG001|Treatment Period|Lack of Efficacy|4|||
160780132|NCT01471574|580578606|FG002|Treatment Period|Lack of Efficacy|14|||
160780133|NCT01471574|580578607|FG003|Treatment Period|Lack of Efficacy|1|||
160780134|NCT01471574|580578604|FG000|Treatment Period|Adverse Event|7|||
160780135|NCT01471574|580578605|FG001|Treatment Period|Adverse Event|3|||
160780136|NCT01471574|580578606|FG002|Treatment Period|Adverse Event|6|||
160780137|NCT01471574|580578607|FG003|Treatment Period|Adverse Event|1|||
160780138|NCT01471574|580578604|FG000|Treatment Period|Withdrawal by Subject|5|||
160780139|NCT01471574|580578605|FG001|Treatment Period|Withdrawal by Subject|1|||
160780140|NCT01471574|580578606|FG002|Treatment Period|Withdrawal by Subject|1|||
160780141|NCT01471574|580578607|FG003|Treatment Period|Withdrawal by Subject|0|||
160780142|NCT01471574|580578604|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
160780143|NCT01471574|580578605|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
160780144|NCT01471574|580578606|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
160780145|NCT01471574|580578607|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
160780146|NCT01471574|580578604|FG000|Treatment Period|Lost to Follow-up|1|||
160780147|NCT01471574|580578605|FG001|Treatment Period|Lost to Follow-up|2|||
160780148|NCT01471574|580578606|FG002|Treatment Period|Lost to Follow-up|2|||
160780149|NCT01471574|580578607|FG003|Treatment Period|Lost to Follow-up|0|||
160780150|NCT01471574|580578604|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
160780151|NCT01471574|580578605|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
160780152|NCT01471574|580578606|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
160780153|NCT01471574|580578607|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
160780154|NCT01471574|580578604|FG000|Treatment Period|Other|1|||
160780155|NCT01471574|580578605|FG001|Treatment Period|Other|0|||
160780156|NCT01471574|580578606|FG002|Treatment Period|Other|0|||
160780157|NCT01471574|580578607|FG003|Treatment Period|Other|0|||
160780158|NCT01471574|580578604|FG000|Follow-up Period|Withdrawal by Subject|3|||
160780159|NCT01471574|580578605|FG001|Follow-up Period|Withdrawal by Subject|0|||
160780160|NCT01471574|580578606|FG002|Follow-up Period|Withdrawal by Subject|3|||
160780161|NCT01471574|580578607|FG003|Follow-up Period|Withdrawal by Subject|1|||
160780162|NCT01471574|580578604|FG000|Follow-up Period|Lost to Follow-up|4|||
160780163|NCT01471574|580578605|FG001|Follow-up Period|Lost to Follow-up|1|||
160780164|NCT01471574|580578606|FG002|Follow-up Period|Lost to Follow-up|3|||
160780165|NCT01471574|580578607|FG003|Follow-up Period|Lost to Follow-up|2|||
160780166|NCT01471574|580578604|FG000|Follow-up Period|Death|0|||
160780167|NCT01471574|580578605|FG001|Follow-up Period|Death|0|||
160780168|NCT01471574|580578606|FG002|Follow-up Period|Death|1|||
160780169|NCT01471574|580578607|FG003|Follow-up Period|Death|0|||
160780170|NCT01471574|580578604|FG000|Follow-up Period|Follow-up no longer required|0|||
160780171|NCT01471574|580578605|FG001|Follow-up Period|Follow-up no longer required|1|||
160780172|NCT01471574|580578606|FG002|Follow-up Period|Follow-up no longer required|0|||
160780173|NCT01471574|580578607|FG003|Follow-up Period|Follow-up no longer required|0|||
160780174|NCT01795937|580578608|FG000|Overall Study|Withdrawal by Subject|1|||
160780175|NCT01795937|580578609|FG001|Overall Study|Withdrawal by Subject|0|||
160780176|NCT01795937|580578610|FG002|Overall Study|Withdrawal by Subject|0|||
160780177|NCT01795937|580578608|FG000|Overall Study|Physician Decision|0|||
160780178|NCT01795937|580578609|FG001|Overall Study|Physician Decision|1|||
160780179|NCT01795937|580578610|FG002|Overall Study|Physician Decision|0|||
160780180|NCT03927157|580578611|FG000|Overall Study|Adverse Event|1|||
160780181|NCT03927157|580578612|FG001|Overall Study|Adverse Event|3|||
160780182|NCT03927157|580578611|FG000|Overall Study|Protocol Violation|1|||
160780183|NCT03927157|580578612|FG001|Overall Study|Protocol Violation|2|||
160780184|NCT03927157|580578611|FG000|Overall Study|Withdrawal by Subject|8|||
160780185|NCT03927157|580578612|FG001|Overall Study|Withdrawal by Subject|21|||
160780186|NCT03927157|580578611|FG000|Overall Study|Due to COVID-19 pandemic|5|||
160780187|NCT03927157|580578612|FG001|Overall Study|Due to COVID-19 pandemic|2|||
160780188|NCT03927157|580578611|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
160780189|NCT03927157|580578612|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
160780190|NCT03927157|580578611|FG000|Overall Study|Other than above|0|||
160780191|NCT03927157|580578612|FG001|Overall Study|Other than above|1|||
160780192|NCT02265744|580578615|FG000|Overall Study|Poor/Non-compliance|1|||
160780193|NCT02265744|580578616|FG001|Overall Study|Poor/Non-compliance|1|||
160780194|NCT02265744|580578617|FG002|Overall Study|Poor/Non-compliance|0|||
160780195|NCT02265744|580578618|FG003|Overall Study|Poor/Non-compliance|0|||
160780196|NCT02265744|580578619|FG004|Overall Study|Poor/Non-compliance|2|||
160780197|NCT02265744|580578615|FG000|Overall Study|Lost to Follow-up|0|||
160780198|NCT02265744|580578616|FG001|Overall Study|Lost to Follow-up|0|||
160780199|NCT02265744|580578617|FG002|Overall Study|Lost to Follow-up|0|||
160780200|NCT02265744|580578618|FG003|Overall Study|Lost to Follow-up|1|||
160780201|NCT02265744|580578619|FG004|Overall Study|Lost to Follow-up|0|||
160780202|NCT02265744|580578615|FG000|Overall Study|Death|0|||
160887690|NCT00930982|580982565|FG000|Overall Study|Adverse Event|19|||
160887691|NCT00930982|580982566|FG001|Overall Study|Adverse Event|23|||
160887692|NCT00930982|580982565|FG000|Overall Study|Protocol Violation|1|||
160887693|NCT00930982|580982566|FG001|Overall Study|Protocol Violation|5|||
160887694|NCT00930982|580982565|FG000|Overall Study|Withdrawal by Subject|1|||
160887695|NCT00930982|580982566|FG001|Overall Study|Withdrawal by Subject|1|||
160887696|NCT00518973|580982567|FG000|Overall Study|Withdrawal by Subject|3|||
160887697|NCT00518973|580982568|FG001|Overall Study|Withdrawal by Subject|2|||
160887698|NCT00582816|580982569|FG000|Overall Study|Engraftment Failure|3|||
160887699|NCT01923168|580982570|FG000|Overall Study|Protocol Violation|1|||
160887700|NCT01923168|580982571|FG001|Overall Study|Protocol Violation|1|||
160887701|NCT01923168|580982572|FG002|Overall Study|Protocol Violation|0|||
160887702|NCT01923168|580982570|FG000|Overall Study|Subject/guardian decision|14|||
160887703|NCT01923168|580982571|FG001|Overall Study|Subject/guardian decision|14|||
160887704|NCT01923168|580982572|FG002|Overall Study|Subject/guardian decision|4|||
160887705|NCT01923168|580982570|FG000|Overall Study|Adverse Event|12|||
160887706|NCT01923168|580982571|FG001|Overall Study|Adverse Event|12|||
160638376|NCT02643966|580059267|FG000|Third Screening Round|Lost to Follow-up|241|||
160638377|NCT01493531|580059268|FG000|Overall Study|Adverse Event|4|||
160780203|NCT02265744|580578616|FG001|Overall Study|Death|0|||
160780204|NCT02265744|580578617|FG002|Overall Study|Death|0|||
160780205|NCT02265744|580578618|FG003|Overall Study|Death|2|||
160780206|NCT02265744|580578619|FG004|Overall Study|Death|0|||
160780207|NCT02265744|580578615|FG000|Overall Study|Withdrawal by Subject|2|||
160780208|NCT02265744|580578616|FG001|Overall Study|Withdrawal by Subject|0|||
160780209|NCT02265744|580578617|FG002|Overall Study|Withdrawal by Subject|0|||
160780210|NCT02265744|580578618|FG003|Overall Study|Withdrawal by Subject|2|||
160780211|NCT02265744|580578619|FG004|Overall Study|Withdrawal by Subject|0|||
160887707|NCT01923168|580982572|FG002|Overall Study|Adverse Event|0|||
160780212|NCT02265744|580578615|FG000|Overall Study|Participant request to discontinue|2|||
160780213|NCT02265744|580578616|FG001|Overall Study|Participant request to discontinue|2|||
160887708|NCT01923168|580982570|FG000|Overall Study|Physician Decision|6|||
160887709|NCT01923168|580982571|FG001|Overall Study|Physician Decision|9|||
160887710|NCT01923168|580982572|FG002|Overall Study|Physician Decision|5|||
160887711|NCT01923168|580982570|FG000|Overall Study|Progressive disease|4|||
160887712|NCT01923168|580982571|FG001|Overall Study|Progressive disease|3|||
160887713|NCT01923168|580982572|FG002|Overall Study|Progressive disease|7|||
160887714|NCT01923168|580982570|FG000|Overall Study|Death|0|||
160887715|NCT01923168|580982571|FG001|Overall Study|Death|0|||
160887716|NCT01923168|580982572|FG002|Overall Study|Death|1|||
160887717|NCT00476047|580982573|FG000|Overall Study|Lost to Follow-up|1|||
160887718|NCT02241889|580982580|FG000|Overall Study|device issues|0|||
160887719|NCT02241889|580982581|FG001|Overall Study|device issues|0|||
160887720|NCT02241889|580982582|FG002|Overall Study|device issues|1|||
160887721|NCT02241889|580982583|FG003|Overall Study|device issues|0|||
160887722|NCT02241889|580982584|FG004|Overall Study|device issues|0|||
160887723|NCT02241889|580982585|FG005|Overall Study|device issues|0|||
160887724|NCT02241889|580982580|FG000|Overall Study|Withdrawal by Subject|0|||
160887725|NCT02241889|580982581|FG001|Overall Study|Withdrawal by Subject|0|||
160887726|NCT02241889|580982582|FG002|Overall Study|Withdrawal by Subject|0|||
160887727|NCT02241889|580982583|FG003|Overall Study|Withdrawal by Subject|0|||
160887728|NCT02241889|580982584|FG004|Overall Study|Withdrawal by Subject|0|||
160780214|NCT02265744|580578617|FG002|Overall Study|Participant request to discontinue|2|||
160780215|NCT02265744|580578618|FG003|Overall Study|Participant request to discontinue|0|||
160780216|NCT02265744|580578619|FG004|Overall Study|Participant request to discontinue|0|||
160780217|NCT02265744|580578615|FG000|Overall Study|Adverse Event|8|||
160780218|NCT02265744|580578616|FG001|Overall Study|Adverse Event|4|||
160780219|NCT02265744|580578617|FG002|Overall Study|Adverse Event|9|||
160780220|NCT02265744|580578618|FG003|Overall Study|Adverse Event|8|||
160780221|NCT02265744|580578619|FG004|Overall Study|Adverse Event|2|||
160780222|NCT02265744|580578615|FG000|Overall Study|Lack of Efficacy|2|||
160887729|NCT02241889|580982585|FG005|Overall Study|Withdrawal by Subject|1|||
160887730|NCT00773838|580982586|FG000|Overall Study|Adverse Event|29|||
160887731|NCT00773838|580982586|FG000|Overall Study|Lost to Follow-up|1|||
160887732|NCT00773838|580982586|FG000|Overall Study|Physician Decision|8|||
160887733|NCT00773838|580982586|FG000|Overall Study|Progressive Disease|82|||
160887734|NCT00773838|580982586|FG000|Overall Study|Protocol Violation|2|||
160887735|NCT00773838|580982586|FG000|Overall Study|Withdrawal by Subject|21|||
160887736|NCT00459056|580982590|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
160887737|NCT00459056|580982591|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
160887738|NCT02522871|580982592|FG000|Overall Study|Protocol Violation|1|||
160887739|NCT02522871|580982593|FG001|Overall Study|Protocol Violation|4|||
160887740|NCT02522871|580982592|FG000|Overall Study|Treated without randomization|1|||
160887741|NCT02522871|580982593|FG001|Overall Study|Treated without randomization|0|||
160887742|NCT02522871|580982592|FG000|Overall Study|Death|9|||
160887743|NCT02522871|580982593|FG001|Overall Study|Death|9|||
160887744|NCT02522871|580982592|FG000|Overall Study|Died in operating room prior to transplant|0|||
160887745|NCT02522871|580982593|FG001|Overall Study|Died in operating room prior to transplant|1|||
160887746|NCT01658813|580982594|FG000|Overall Study|Disease progression|3|||
160887747|NCT02398227|580982595|FG000|Overall Study|Lost to Follow-up|21|||
160887748|NCT02398227|580982596|FG001|Overall Study|Lost to Follow-up|12|||
160887749|NCT02398227|580982595|FG000|Overall Study|Withdrawal by Subject|5|||
160887750|NCT02398227|580982596|FG001|Overall Study|Withdrawal by Subject|6|||
160887751|NCT02398227|580982595|FG000|Overall Study|Removed from treatment and dropped out|1|||
160887752|NCT02398227|580982596|FG001|Overall Study|Removed from treatment and dropped out|0|||
160887753|NCT01715129|580982597|FG000|Overall Study|Adverse Event, fatal|1|||
160887754|NCT01715129|580982597|FG000|Overall Study|Lack of Efficacy|3|||
160887755|NCT01715129|580982597|FG000|Overall Study|Protocol Violation|1|||
160887756|NCT01715129|580982597|FG000|Overall Study|Consent Withdrawn|2|||
160887757|NCT01715129|580982597|FG000|Overall Study|Lost to Follow-up|1|||
160887758|NCT01715129|580982597|FG000|Overall Study|Other|1|||
160887759|NCT02793622|580982598|FG000|Overall Study|Lost to Follow-up|31|||
160887760|NCT02793622|580982599|FG001|Overall Study|Lost to Follow-up|19|||
160887761|NCT02793622|580982598|FG000|Overall Study|Withdrawal by Subject|21|||
160887762|NCT02793622|580982599|FG001|Overall Study|Withdrawal by Subject|17|||
160887763|NCT02793622|580982598|FG000|Overall Study|Adverse Event|0|||
160887764|NCT02793622|580982599|FG001|Overall Study|Adverse Event|1|||
160887765|NCT02793622|580982598|FG000|Overall Study|Protocol Violation|1|||
160887766|NCT02793622|580982599|FG001|Overall Study|Protocol Violation|5|||
160887767|NCT01101191|580982600|FG000|Period 1|Withdrawal by Subject|1|||
160887768|NCT01101191|580982601|FG001|Period 1|Withdrawal by Subject|0|||
160887769|NCT01101191|580982600|FG000|Period 1|Adverse Event|1|||
160780223|NCT02265744|580578616|FG001|Overall Study|Lack of Efficacy|4|||
160780224|NCT02265744|580578617|FG002|Overall Study|Lack of Efficacy|3|||
160780225|NCT02265744|580578618|FG003|Overall Study|Lack of Efficacy|4|||
160887770|NCT01101191|580982601|FG001|Period 1|Adverse Event|2|||
160887771|NCT01146860|580982602|FG000|Overall Study|Withdrawal by Subject|0|||
160887772|NCT01146860|580982603|FG001|Overall Study|Withdrawal by Subject|1|||
160887773|NCT02674854|580982608|FG000|Overall Study|Adverse Event|17|||
160887774|NCT02674854|580982609|FG001|Overall Study|Adverse Event|15|||
160780226|NCT02265744|580578619|FG004|Overall Study|Lack of Efficacy|5|||
160780227|NCT02265744|580578615|FG000|Overall Study|Reason not provided by Investigator|1|||
160780228|NCT02265744|580578616|FG001|Overall Study|Reason not provided by Investigator|0|||
160780229|NCT02265744|580578617|FG002|Overall Study|Reason not provided by Investigator|0|||
160780230|NCT02265744|580578618|FG003|Overall Study|Reason not provided by Investigator|2|||
160780231|NCT02265744|580578619|FG004|Overall Study|Reason not provided by Investigator|0|||
160780232|NCT02265744|580578615|FG000|Overall Study|Administrative reason by sponsor|3|||
160780233|NCT02265744|580578616|FG001|Overall Study|Administrative reason by sponsor|2|||
160780234|NCT02265744|580578617|FG002|Overall Study|Administrative reason by sponsor|2|||
160887775|NCT02674854|580982610|FG002|Overall Study|Adverse Event|5|||
160887776|NCT02674854|580982608|FG000|Overall Study|Withdrawal by Subject|1|||
160887777|NCT02674854|580982609|FG001|Overall Study|Withdrawal by Subject|5|||
160887778|NCT02674854|580982610|FG002|Overall Study|Withdrawal by Subject|4|||
160887779|NCT02674854|580982608|FG000|Overall Study|No-compliant subject|1|||
160887780|NCT02674854|580982609|FG001|Overall Study|No-compliant subject|0|||
160887781|NCT02674854|580982610|FG002|Overall Study|No-compliant subject|1|||
160887782|NCT02674854|580982608|FG000|Overall Study|Lost to Follow-up|1|||
160887783|NCT02674854|580982609|FG001|Overall Study|Lost to Follow-up|0|||
160887784|NCT02674854|580982610|FG002|Overall Study|Lost to Follow-up|2|||
160887785|NCT02674854|580982608|FG000|Overall Study|Lack of Efficacy|0|||
160887786|NCT02674854|580982609|FG001|Overall Study|Lack of Efficacy|3|||
160887787|NCT02674854|580982610|FG002|Overall Study|Lack of Efficacy|0|||
160887788|NCT02674854|580982608|FG000|Overall Study|Disallowed Concurrent Medication|2|||
160887789|NCT02674854|580982609|FG001|Overall Study|Disallowed Concurrent Medication|2|||
160887790|NCT02674854|580982610|FG002|Overall Study|Disallowed Concurrent Medication|0|||
160887791|NCT02674854|580982608|FG000|Overall Study|Protocol Violation|1|||
160887792|NCT02674854|580982609|FG001|Overall Study|Protocol Violation|1|||
160887793|NCT02674854|580982610|FG002|Overall Study|Protocol Violation|2|||
160887794|NCT02674854|580982608|FG000|Overall Study|Death|0|||
160887795|NCT02674854|580982609|FG001|Overall Study|Death|1|||
160887796|NCT02674854|580982610|FG002|Overall Study|Death|0|||
160887797|NCT02674854|580982608|FG000|Overall Study|Subject missed V6.2|1|||
160887798|NCT02674854|580982609|FG001|Overall Study|Subject missed V6.2|0|||
160887799|NCT02674854|580982610|FG002|Overall Study|Subject missed V6.2|0|||
160887800|NCT03149848|580982611|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
160887801|NCT03149848|580982611|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
160887802|NCT04738318|580982613|FG000|Overall Study|Protocol Violation|1|||
160887803|NCT04738318|580982614|FG001|Overall Study|Protocol Violation|0|||
160887804|NCT00586664|580982619|FG000|Overall Study|Withdrawal by Subject|3|||
160887805|NCT00586664|580982620|FG001|Overall Study|Withdrawal by Subject|7|||
160887806|NCT00586664|580982621|FG002|Overall Study|Withdrawal by Subject|1|||
160887807|NCT00586664|580982619|FG000|Overall Study|Exclusion criteria met|2|||
160887808|NCT00586664|580982620|FG001|Overall Study|Exclusion criteria met|0|||
160887809|NCT00586664|580982621|FG002|Overall Study|Exclusion criteria met|0|||
160887810|NCT01602666|580982625|FG000|Induction Chemotherapy|Death|2|||
160887811|NCT01602666|580982626|FG001|Induction Chemotherapy|Death|1|||
160887812|NCT01602666|580982625|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
160887813|NCT01602666|580982626|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
160887814|NCT01602666|580982625|FG000|Induction Chemotherapy|Physician Decision|12|||
160887815|NCT01602666|580982626|FG001|Induction Chemotherapy|Physician Decision|5|||
160887816|NCT01602666|580982625|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
160887817|NCT01602666|580982626|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
160887818|NCT01602666|580982625|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
160887819|NCT01602666|580982626|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
160887820|NCT01602666|580982625|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
160887821|NCT01602666|580982626|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
160887822|NCT01602666|580982625|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
160887823|NCT01602666|580982626|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
160887824|NCT01602666|580982625|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
160887825|NCT01602666|580982626|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
160887826|NCT01602666|580982625|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
160887827|NCT01602666|580982626|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
160887828|NCT01602666|580982625|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
160780235|NCT02265744|580578618|FG003|Overall Study|Administrative reason by sponsor|3|||
160887829|NCT01602666|580982626|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
160887830|NCT01602666|580982625|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
160887831|NCT01602666|580982626|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
160887832|NCT03610555|580982627|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
160887833|NCT03610555|580982628|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
160887834|NCT03610555|580982629|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
160780236|NCT02265744|580578619|FG004|Overall Study|Administrative reason by sponsor|3|||
160780237|NCT02265744|580578615|FG000|Overall Study|Subject no longer meets study criteria|0|||
160780238|NCT02265744|580578616|FG001|Overall Study|Subject no longer meets study criteria|0|||
160780239|NCT02265744|580578617|FG002|Overall Study|Subject no longer meets study criteria|0|||
160780240|NCT02265744|580578618|FG003|Overall Study|Subject no longer meets study criteria|0|||
160887835|NCT03610555|580982630|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
160887836|NCT01155219|580984016|FG000|Overall Study|Adverse Event|3|||
160887837|NCT01155219|580984017|FG001|Overall Study|Adverse Event|1|||
160887838|NCT01155219|580984016|FG000|Overall Study|non-medical reason|1|||
160887839|NCT01155219|580984017|FG001|Overall Study|non-medical reason|2|||
160887840|NCT03052764|580984018|FG000|Double-Blind Treatment Period|Adverse Event|2|||
160887841|NCT03052764|580984019|FG001|Double-Blind Treatment Period|Adverse Event|0|||
160887842|NCT03052764|580984018|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
160887843|NCT03052764|580984019|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
160887844|NCT03052764|580984018|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
160887845|NCT03052764|580984019|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
160780241|NCT02265744|580578619|FG004|Overall Study|Subject no longer meets study criteria|1|||
160780242|NCT02265744|580578615|FG000|Overall Study|Pregnancy|1|||
160780243|NCT02265744|580578616|FG001|Overall Study|Pregnancy|2|||
160780244|NCT02265744|580578617|FG002|Overall Study|Pregnancy|1|||
160780245|NCT02265744|580578618|FG003|Overall Study|Pregnancy|1|||
160780246|NCT02265744|580578619|FG004|Overall Study|Pregnancy|0|||
160780247|NCT00923702|580578620|FG000|Overall Study|Ongoing enrollment|0|||
160780248|NCT00923702|580578621|FG001|Overall Study|Ongoing enrollment|0|||
160780249|NCT00923702|580578622|FG002|Overall Study|Ongoing enrollment|0|||
160780250|NCT00923702|580578623|FG003|Overall Study|Ongoing enrollment|0|||
160780251|NCT00923702|580578624|FG004|Overall Study|Ongoing enrollment|354|||
160780252|NCT05950906|580578628|FG000|Overall Study|Adverse Event|0|||
160780253|NCT05950906|580578629|FG001|Overall Study|Adverse Event|0|||
160780254|NCT05950906|580578630|FG002|Overall Study|Adverse Event|0|||
160780255|NCT05950906|580578631|FG003|Overall Study|Adverse Event|0|||
160780256|NCT05950906|580578632|FG004|Overall Study|Adverse Event|0|||
160780257|NCT05950906|580578633|FG005|Overall Study|Adverse Event|0|||
160780258|NCT05950906|580578634|FG006|Overall Study|Adverse Event|0|||
160780259|NCT05950906|580578635|FG007|Overall Study|Adverse Event|0|||
160780260|NCT05950906|580578636|FG008|Overall Study|Adverse Event|0|||
160780261|NCT05950906|580578637|FG009|Overall Study|Adverse Event|0|||
160780262|NCT05950906|580578638|FG010|Overall Study|Adverse Event|0|||
160780263|NCT05950906|580578639|FG011|Overall Study|Adverse Event|0|||
160780264|NCT05950906|580578640|FG012|Overall Study|Adverse Event|1|||
160780265|NCT05950906|580578641|FG013|Overall Study|Adverse Event|0|||
160780266|NCT05950906|580578628|FG000|Overall Study|Physician Decision|0|||
160780267|NCT05950906|580578629|FG001|Overall Study|Physician Decision|0|||
160780268|NCT05950906|580578630|FG002|Overall Study|Physician Decision|0|||
160780269|NCT05950906|580578631|FG003|Overall Study|Physician Decision|0|||
160780270|NCT05950906|580578632|FG004|Overall Study|Physician Decision|0|||
160780271|NCT05950906|580578633|FG005|Overall Study|Physician Decision|0|||
160780272|NCT05950906|580578634|FG006|Overall Study|Physician Decision|0|||
160780273|NCT05950906|580578635|FG007|Overall Study|Physician Decision|0|||
160780274|NCT05950906|580578636|FG008|Overall Study|Physician Decision|0|||
160780275|NCT05950906|580578637|FG009|Overall Study|Physician Decision|0|||
160780276|NCT05950906|580578638|FG010|Overall Study|Physician Decision|0|||
160780277|NCT05950906|580578639|FG011|Overall Study|Physician Decision|0|||
160780278|NCT05950906|580578640|FG012|Overall Study|Physician Decision|1|||
160780279|NCT05950906|580578641|FG013|Overall Study|Physician Decision|0|||
160780280|NCT02448043|580578642|FG000|Overall Study|Withdrawal by Subject|2|||
160780281|NCT02448043|580578643|FG001|Overall Study|Withdrawal by Subject|2|||
160780282|NCT02448043|580578642|FG000|Overall Study|Protocol Violation|1|||
160780283|NCT02448043|580578643|FG001|Overall Study|Protocol Violation|2|||
160780284|NCT00303628|580578644|FG000|Overall Study|Disease progression|0|||
160780285|NCT00303628|580578645|FG001|Overall Study|Disease progression|1|||
160780286|NCT00303628|580578644|FG000|Overall Study|Adverse Event|26|||
160780287|NCT00303628|580578645|FG001|Overall Study|Adverse Event|36|||
160780288|NCT00303628|580578644|FG000|Overall Study|Death|0|||
160780289|NCT00303628|580578645|FG001|Overall Study|Death|1|||
160780290|NCT00303628|580578644|FG000|Overall Study|Withdrawal by Subject|11|||
160780291|NCT00303628|580578645|FG001|Overall Study|Withdrawal by Subject|20|||
160780292|NCT00303628|580578644|FG000|Overall Study|Alternative therapy|2|||
160780293|NCT00303628|580578645|FG001|Overall Study|Alternative therapy|0|||
160780294|NCT00303628|580578644|FG000|Overall Study|Other complicating disease|0|||
160780295|NCT00303628|580578645|FG001|Overall Study|Other complicating disease|1|||
160780296|NCT00303628|580578644|FG000|Overall Study|Not start protocol therapy|3|||
160780297|NCT00303628|580578645|FG001|Overall Study|Not start protocol therapy|5|||
160780298|NCT00303628|580578644|FG000|Overall Study|Other|8|||
160780299|NCT00303628|580578645|FG001|Overall Study|Other|9|||
160780300|NCT03158688|580578646|FG000|Overall Study|Withdrawal by Subject|14|||
160780301|NCT03158688|580578647|FG001|Overall Study|Withdrawal by Subject|28|||
160780302|NCT03158688|580578646|FG000|Overall Study|Decision by sponsor|13|||
160542002|NCT01265550|579712900|FG003|Pre Randomization|Technical Exclusions|54|||
160542003|NCT01265550|579712897|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
160542004|NCT01265550|579712898|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
160542005|NCT01265550|579712899|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
160542006|NCT01265550|579712900|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
160542007|NCT01265550|579712897|FG000|Pre Randomization|Non-GERD organic disorders|0|||
160542008|NCT01265550|579712898|FG001|Pre Randomization|Non-GERD organic disorders|0|||
160542009|NCT01265550|579712899|FG002|Pre Randomization|Non-GERD organic disorders|0|||
160542010|NCT01265550|579712900|FG003|Pre Randomization|Non-GERD organic disorders|23|||
160542011|NCT01265550|579712897|FG000|Pre Randomization|Functional heartburn|0|||
160542012|NCT01265550|579712898|FG001|Pre Randomization|Functional heartburn|0|||
160542013|NCT01265550|579712899|FG002|Pre Randomization|Functional heartburn|0|||
160542014|NCT01265550|579712900|FG003|Pre Randomization|Functional heartburn|99|||
160542015|NCT03873714|579712904|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
160542016|NCT01970501|579712905|FG000|Overall Study|Discontinuation of study by sponsor|16|||
160542017|NCT01970501|579712906|FG001|Overall Study|Discontinuation of study by sponsor|14|||
160542018|NCT01970501|579712905|FG000|Overall Study|Withdrawal by Subject|6|||
160542019|NCT01970501|579712906|FG001|Overall Study|Withdrawal by Subject|7|||
160542020|NCT01970501|579712905|FG000|Overall Study|Adverse Event|2|||
160542021|NCT01970501|579712906|FG001|Overall Study|Adverse Event|4|||
160542022|NCT01970501|579712905|FG000|Overall Study|Death|1|||
160542023|NCT01970501|579712906|FG001|Overall Study|Death|3|||
160542024|NCT01970501|579712905|FG000|Overall Study|Physician Decision|2|||
160542025|NCT01970501|579712906|FG001|Overall Study|Physician Decision|0|||
160542026|NCT00708123|579712907|FG000|Period 1|Protocol Violation|0|||
160542027|NCT00708123|579712908|FG001|Period 1|Protocol Violation|1|||
160542028|NCT00708123|579712909|FG002|Period 1|Protocol Violation|0|||
160542029|NCT00708123|579712910|FG003|Period 1|Protocol Violation|1|||
160542030|NCT00708123|579712911|FG004|Period 1|Protocol Violation|0|||
160542031|NCT00708123|579712907|FG000|Period 1|Adverse Event|0|||
160542032|NCT00708123|579712908|FG001|Period 1|Adverse Event|0|||
160542033|NCT00708123|579712909|FG002|Period 1|Adverse Event|1|||
160542034|NCT00708123|579712910|FG003|Period 1|Adverse Event|0|||
160887846|NCT03052764|580984018|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
160887847|NCT03052764|580984019|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160887848|NCT03052764|580984018|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
160887849|NCT03052764|580984019|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
160887850|NCT01314911|580984020|FG000|Overall Study|Lost to Follow-up|3|||
160887851|NCT01314911|580984021|FG001|Overall Study|Lost to Follow-up|2|||
160887852|NCT01314911|580984020|FG000|Overall Study|Withdrawal by Subject|1|||
160887853|NCT01314911|580984021|FG001|Overall Study|Withdrawal by Subject|3|||
160887854|NCT01314911|580984020|FG000|Overall Study|Received Non-randomized Study Drug|0|||
160887855|NCT01314911|580984021|FG001|Overall Study|Received Non-randomized Study Drug|1|||
160887856|NCT01314911|580984020|FG000|Overall Study|Never Started Treatment|1|||
160887857|NCT01314911|580984021|FG001|Overall Study|Never Started Treatment|0|||
160887858|NCT03150485|580984025|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
160887859|NCT03150485|580984026|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
160887860|NCT03150485|580984027|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
160887861|NCT03150485|580984028|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
160887862|NCT03150485|580984029|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
160887863|NCT03150485|580984030|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
160887864|NCT01394718|580984032|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
160887865|NCT01394718|580984033|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
160887866|NCT01695005|580984034|FG000|Overall Study|Lost to Follow-up|0|||
160887867|NCT01695005|580984035|FG001|Overall Study|Lost to Follow-up|1|||
160542035|NCT00708123|579712911|FG004|Period 1|Adverse Event|0|||
160542036|NCT00708123|579712907|FG000|Period 2|Protocol Violation|0|||
160542037|NCT00708123|579712908|FG001|Period 2|Protocol Violation|0|||
160638378|NCT01493531|580059269|FG001|Overall Study|Adverse Event|12|||
160887868|NCT01695005|580984036|FG002|Overall Study|Lost to Follow-up|1|||
160887869|NCT01695005|580984037|FG003|Overall Study|Lost to Follow-up|0|||
160887870|NCT01695005|580984038|FG004|Overall Study|Lost to Follow-up|0|||
160887871|NCT01695005|580984039|FG005|Overall Study|Lost to Follow-up|1|||
160887872|NCT01695005|580984040|FG006|Overall Study|Lost to Follow-up|1|||
160887873|NCT01695005|580984041|FG007|Overall Study|Lost to Follow-up|1|||
160887874|NCT01695005|580984042|FG008|Overall Study|Lost to Follow-up|3|||
160887875|NCT01695005|580984043|FG009|Overall Study|Lost to Follow-up|3|||
160638379|NCT01493531|580059270|FG002|Overall Study|Adverse Event|9|||
160887876|NCT01695005|580984044|FG010|Overall Study|Lost to Follow-up|8|||
160887877|NCT01695005|580984045|FG011|Overall Study|Lost to Follow-up|5|||
160542038|NCT00708123|579712909|FG002|Period 2|Protocol Violation|0|||
160542039|NCT00708123|579712910|FG003|Period 2|Protocol Violation|1|||
160542040|NCT00708123|579712911|FG004|Period 2|Protocol Violation|0|||
160542041|NCT00708123|579712907|FG000|Period 2|Other Reason|1|||
160542042|NCT00708123|579712908|FG001|Period 2|Other Reason|0|||
160542043|NCT00708123|579712909|FG002|Period 2|Other Reason|0|||
160887878|NCT01695005|580984046|FG012|Overall Study|Lost to Follow-up|2|||
160780303|NCT03158688|580578647|FG001|Overall Study|Decision by sponsor|37|||
160780304|NCT03158688|580578646|FG000|Overall Study|Lost to Follow-up|4|||
160780305|NCT03158688|580578647|FG001|Overall Study|Lost to Follow-up|3|||
160780306|NCT03158688|580578646|FG000|Overall Study|Death|74|||
160780307|NCT03158688|580578647|FG001|Overall Study|Death|142|||
160780308|NCT02942407|580578648|FG000|Overall Study|Lost to Follow-up|3|||
160780309|NCT02942407|580578649|FG001|Overall Study|Lost to Follow-up|2|||
160780310|NCT02942407|580578648|FG000|Overall Study|Withdrawal by Subject|7|||
160780311|NCT02942407|580578649|FG001|Overall Study|Withdrawal by Subject|9|||
160780312|NCT02942407|580578648|FG000|Overall Study|Death|16|||
160780313|NCT02942407|580578649|FG001|Overall Study|Death|13|||
160780314|NCT05937373|580578655|FG000|Overall Study|Out of Window|2|||
160780315|NCT05937373|580578656|FG001|Overall Study|Out of Window|0|||
160887879|NCT01695005|580984047|FG013|Overall Study|Lost to Follow-up|5|||
160887880|NCT01695005|580984048|FG014|Overall Study|Lost to Follow-up|0|||
160887881|NCT01695005|580984049|FG015|Overall Study|Lost to Follow-up|4|||
160887882|NCT01695005|580984050|FG016|Overall Study|Lost to Follow-up|0|||
160887883|NCT01695005|580984051|FG017|Overall Study|Lost to Follow-up|0|||
160887884|NCT01695005|580984052|FG018|Overall Study|Lost to Follow-up|0|||
160887885|NCT01695005|580984053|FG019|Overall Study|Lost to Follow-up|1|||
160887886|NCT01695005|580984054|FG020|Overall Study|Lost to Follow-up|1|||
160887887|NCT01695005|580984055|FG021|Overall Study|Lost to Follow-up|0|||
160887888|NCT01695005|580984056|FG022|Overall Study|Lost to Follow-up|2|||
160887889|NCT01695005|580984057|FG023|Overall Study|Lost to Follow-up|4|||
160887890|NCT01695005|580984058|FG024|Overall Study|Lost to Follow-up|2|||
160887891|NCT01695005|580984059|FG025|Overall Study|Lost to Follow-up|0|||
160887892|NCT01695005|580984060|FG026|Overall Study|Lost to Follow-up|0|||
160887893|NCT01695005|580984061|FG027|Overall Study|Lost to Follow-up|0|||
160887894|NCT01695005|580984062|FG028|Overall Study|Lost to Follow-up|1|||
160887895|NCT01695005|580984034|FG000|Overall Study|Withdrawal by Subject|0|||
160887896|NCT01695005|580984035|FG001|Overall Study|Withdrawal by Subject|0|||
160887897|NCT01695005|580984036|FG002|Overall Study|Withdrawal by Subject|0|||
160887898|NCT01695005|580984037|FG003|Overall Study|Withdrawal by Subject|2|||
160887899|NCT01695005|580984038|FG004|Overall Study|Withdrawal by Subject|0|||
160887900|NCT01695005|580984039|FG005|Overall Study|Withdrawal by Subject|1|||
160887901|NCT01695005|580984040|FG006|Overall Study|Withdrawal by Subject|0|||
160887902|NCT01695005|580984041|FG007|Overall Study|Withdrawal by Subject|1|||
160887903|NCT01695005|580984042|FG008|Overall Study|Withdrawal by Subject|0|||
160887904|NCT01695005|580984043|FG009|Overall Study|Withdrawal by Subject|1|||
160887905|NCT01695005|580984044|FG010|Overall Study|Withdrawal by Subject|2|||
160887906|NCT01695005|580984045|FG011|Overall Study|Withdrawal by Subject|1|||
160887907|NCT01695005|580984046|FG012|Overall Study|Withdrawal by Subject|1|||
160887908|NCT01695005|580984047|FG013|Overall Study|Withdrawal by Subject|0|||
160887909|NCT01695005|580984048|FG014|Overall Study|Withdrawal by Subject|0|||
160887910|NCT01695005|580984049|FG015|Overall Study|Withdrawal by Subject|0|||
160887911|NCT01695005|580984050|FG016|Overall Study|Withdrawal by Subject|0|||
160887912|NCT01695005|580984051|FG017|Overall Study|Withdrawal by Subject|0|||
160887913|NCT01695005|580984052|FG018|Overall Study|Withdrawal by Subject|2|||
160887914|NCT01695005|580984053|FG019|Overall Study|Withdrawal by Subject|0|||
160887915|NCT01695005|580984054|FG020|Overall Study|Withdrawal by Subject|1|||
160887916|NCT01695005|580984055|FG021|Overall Study|Withdrawal by Subject|0|||
160887917|NCT01695005|580984056|FG022|Overall Study|Withdrawal by Subject|0|||
160887918|NCT01695005|580984057|FG023|Overall Study|Withdrawal by Subject|0|||
160887919|NCT01695005|580984058|FG024|Overall Study|Withdrawal by Subject|1|||
160887920|NCT01695005|580984059|FG025|Overall Study|Withdrawal by Subject|0|||
160887921|NCT01695005|580984060|FG026|Overall Study|Withdrawal by Subject|0|||
160887922|NCT01695005|580984061|FG027|Overall Study|Withdrawal by Subject|1|||
160887923|NCT01695005|580984062|FG028|Overall Study|Withdrawal by Subject|0|||
160887924|NCT04478123|580984063|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
160780316|NCT05937373|580578655|FG000|Overall Study|Device fell off prior to date of surgery|0|||
160887925|NCT04478123|580984063|FG000|Overall Study|NE|1|||
160887926|NCT02395016|580984064|FG000|Overall Study|Adverse Event|4|||
160887927|NCT02395016|580984065|FG001|Overall Study|Adverse Event|3|||
160887928|NCT02395016|580984064|FG000|Overall Study|Withdrawal by Subject|9|||
160887929|NCT02395016|580984065|FG001|Overall Study|Withdrawal by Subject|6|||
160887930|NCT02395016|580984064|FG000|Overall Study|Protocol Violation|2|||
160887931|NCT02395016|580984065|FG001|Overall Study|Protocol Violation|3|||
160887932|NCT01547780|580984066|FG000|Baseline PET Scan|Physician Decision|1|||
160887933|NCT01547780|580984067|FG001|Baseline PET Scan|Physician Decision|0|||
160887934|NCT01547780|580984068|FG002|Baseline PET Scan|Physician Decision|1|||
160887935|NCT01547780|580984069|FG003|Baseline PET Scan|Physician Decision|0|||
160542044|NCT00708123|579712910|FG003|Period 2|Other Reason|0|||
160542045|NCT00708123|579712911|FG004|Period 2|Other Reason|0|||
160780317|NCT05937373|580578656|FG001|Overall Study|Device fell off prior to date of surgery|2|||
160542046|NCT00708123|579712907|FG000|Period 3|Lost to Follow-up|0|||
160542047|NCT00708123|579712908|FG001|Period 3|Lost to Follow-up|0|||
160542048|NCT00708123|579712909|FG002|Period 3|Lost to Follow-up|1|||
160542049|NCT00708123|579712910|FG003|Period 3|Lost to Follow-up|1|||
160542050|NCT00708123|579712911|FG004|Period 3|Lost to Follow-up|0|||
160542051|NCT00708123|579712907|FG000|Period 4|Protocol Violation|0|||
160542052|NCT00708123|579712908|FG001|Period 4|Protocol Violation|1|||
160542053|NCT00708123|579712909|FG002|Period 4|Protocol Violation|0|||
160542054|NCT00708123|579712910|FG003|Period 4|Protocol Violation|0|||
160542055|NCT00708123|579712911|FG004|Period 4|Protocol Violation|0|||
160542056|NCT02970292|579712912|FG000|Overall Study|Physician Decision|1|||
160542057|NCT02970292|579712913|FG001|Overall Study|Physician Decision|1|||
160542058|NCT02970292|579712912|FG000|Overall Study|Withdrawal by Subject|11|||
160542059|NCT02970292|579712913|FG001|Overall Study|Withdrawal by Subject|5|||
160542060|NCT02970292|579712912|FG000|Overall Study|Noncompliance with study drug|2|||
160542061|NCT02970292|579712913|FG001|Overall Study|Noncompliance with study drug|2|||
160542062|NCT02970292|579712912|FG000|Overall Study|Adverse Event|5|||
160780318|NCT03860584|580578664|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
160780319|NCT03860584|580578665|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
160780320|NCT03860584|580578664|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
160780321|NCT03860584|580578665|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
160780322|NCT03860584|580578664|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
160780323|NCT03860584|580578665|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
160780324|NCT03860584|580578664|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
160780325|NCT03860584|580578665|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
160780326|NCT05800145|580578666|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
160780327|NCT05800145|580578667|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160780328|NCT05800145|580578668|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160780329|NCT05800145|580578669|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
160780330|NCT05800145|580578670|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160780331|NCT05800145|580578671|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160780332|NCT05800145|580578666|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
160780333|NCT05800145|580578667|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
160780334|NCT05800145|580578668|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
160780335|NCT05800145|580578669|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
160780336|NCT05800145|580578670|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
160780337|NCT05800145|580578671|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
160780338|NCT05800145|580578666|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
160780339|NCT05800145|580578667|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
160780340|NCT05800145|580578668|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
160780341|NCT05800145|580578669|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
160780342|NCT05800145|580578670|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
160780343|NCT05800145|580578671|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
160780344|NCT02582632|580579744|FG000|Overall Study|Other|1|||
160780345|NCT00327171|580579745|FG000|Overall Study|Did not receive study medication|3|||
160780346|NCT00327171|580579746|FG001|Overall Study|Did not receive study medication|0|||
160780347|NCT00327171|580579745|FG000|Overall Study|Adverse Event|23|||
160780348|NCT00327171|580579746|FG001|Overall Study|Adverse Event|23|||
160780349|NCT00327171|580579745|FG000|Overall Study|Disease progression/lack of efficacy|68|||
160780350|NCT00327171|580579746|FG001|Overall Study|Disease progression/lack of efficacy|69|||
160780351|NCT00327171|580579745|FG000|Overall Study|Investigator/participant request|1|||
160780352|NCT00327171|580579746|FG001|Overall Study|Investigator/participant request|8|||
160780353|NCT00327171|580579745|FG000|Overall Study|Clinical progression|12|||
160780354|NCT00327171|580579746|FG001|Overall Study|Clinical progression|8|||
160780355|NCT00327171|580579745|FG000|Overall Study|Undisclosed history of ischemia|0|||
160780356|NCT00327171|580579746|FG001|Overall Study|Undisclosed history of ischemia|1|||
160780357|NCT00327171|580579745|FG000|Overall Study|Other|1|||
160780358|NCT00327171|580579746|FG001|Overall Study|Other|0|||
160780359|NCT01363440|580579747|FG000|Overall Study|Adverse Event|5|||
160780360|NCT01363440|580579748|FG001|Overall Study|Adverse Event|4|||
160780361|NCT01363440|580579749|FG002|Overall Study|Adverse Event|4|||
160780362|NCT01363440|580579747|FG000|Overall Study|Death|3|||
160780363|NCT01363440|580579748|FG001|Overall Study|Death|7|||
160780364|NCT01363440|580579749|FG002|Overall Study|Death|5|||
160780365|NCT01363440|580579747|FG000|Overall Study|Withdrawal by Subject|9|||
160780366|NCT01363440|580579748|FG001|Overall Study|Withdrawal by Subject|11|||
160780367|NCT01363440|580579749|FG002|Overall Study|Withdrawal by Subject|11|||
160780368|NCT01363440|580579747|FG000|Overall Study|Lost to Follow-up|2|||
160780369|NCT01363440|580579748|FG001|Overall Study|Lost to Follow-up|4|||
160780370|NCT01363440|580579749|FG002|Overall Study|Lost to Follow-up|5|||
160542063|NCT02970292|579712913|FG001|Overall Study|Adverse Event|0|||
160542064|NCT02970292|579712912|FG000|Overall Study|Lack of Efficacy|1|||
160542065|NCT02970292|579712913|FG001|Overall Study|Lack of Efficacy|0|||
160542066|NCT02970292|579712912|FG000|Overall Study|Lost to Follow-up|1|||
160780371|NCT01363440|580579747|FG000|Overall Study|Other|4|||
160780372|NCT01363440|580579748|FG001|Overall Study|Other|5|||
160887936|NCT01547780|580984066|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
160887937|NCT01547780|580984067|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
160887938|NCT01547780|580984068|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
160887939|NCT01547780|580984069|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
160887940|NCT00814879|580984071|FG000|By Week 24|Cancer Diagnosis|1|||
160887941|NCT00814879|580984072|FG001|By Week 24|Cancer Diagnosis|0|||
160887942|NCT00814879|580984071|FG000|By Week 24|Incarceration|0|||
160887943|NCT00814879|580984072|FG001|By Week 24|Incarceration|1|||
160887944|NCT00814879|580984071|FG000|By Week 48|Lost to Follow-up|2|||
160887945|NCT00814879|580984072|FG001|By Week 48|Lost to Follow-up|2|||
160887946|NCT00814879|580984071|FG000|By Week 48|Death|0|||
160887947|NCT00814879|580984072|FG001|By Week 48|Death|1|||
160887948|NCT00588952|580984073|FG000|Overall Study|Adverse Event|0|||
160887949|NCT00588952|580984074|FG001|Overall Study|Adverse Event|2|||
160887950|NCT00588952|580984073|FG000|Overall Study|Withdrawal by Subject|3|||
160887951|NCT00588952|580984074|FG001|Overall Study|Withdrawal by Subject|5|||
160887952|NCT01461057|580984075|FG000|Overall Study|Death|10|||
160887953|NCT01461057|580984076|FG001|Overall Study|Death|9|||
160887954|NCT01461057|580984075|FG000|Overall Study|Withdrawal by Subject|2|||
160887955|NCT01461057|580984076|FG001|Overall Study|Withdrawal by Subject|3|||
160887956|NCT01461057|580984075|FG000|Overall Study|Physician Decision|0|||
160887957|NCT01461057|580984076|FG001|Overall Study|Physician Decision|2|||
160887958|NCT01461057|580984075|FG000|Overall Study|Adverse Event|0|||
160887959|NCT01461057|580984076|FG001|Overall Study|Adverse Event|1|||
160887960|NCT01461057|580984075|FG000|Overall Study|Progression of Disease|1|||
160887961|NCT01461057|580984076|FG001|Overall Study|Progression of Disease|0|||
160780373|NCT01363440|580579749|FG002|Overall Study|Other|2|||
160780374|NCT01771913|580579750|FG000|Overall Study|Withdrawal by Subject|1|||
160780375|NCT01771913|580579751|FG001|Overall Study|Withdrawal by Subject|0|||
160780376|NCT00992836|580579752|FG000|Overall Study|Lost to Follow-up|1|||
160887962|NCT01461057|580984075|FG000|Overall Study|Study Terminated by Sponsor|2|||
160887963|NCT01461057|580984076|FG001|Overall Study|Study Terminated by Sponsor|0|||
160887964|NCT01288976|580984077|FG000|Overall Study|Withdrawal by Subject|58|||
160887965|NCT01288976|580984078|FG001|Overall Study|Withdrawal by Subject|12|||
160887966|NCT01288976|580984079|FG002|Overall Study|Withdrawal by Subject|9|||
160887967|NCT01288976|580984077|FG000|Overall Study|Death|98|||
160887968|NCT01288976|580984078|FG001|Overall Study|Death|6|||
160887969|NCT01288976|580984079|FG002|Overall Study|Death|4|||
160887970|NCT01288976|580984077|FG000|Overall Study|Data unavailable|22|||
160887971|NCT01288976|580984078|FG001|Overall Study|Data unavailable|9|||
160887972|NCT01288976|580984079|FG002|Overall Study|Data unavailable|7|||
160887973|NCT03560739|580984081|FG000|Overall Study|Adverse Event|0|||
160887974|NCT03560739|580984082|FG001|Overall Study|Adverse Event|1|||
160887975|NCT03560739|580984083|FG002|Overall Study|Adverse Event|0|||
160887976|NCT03560739|580984084|FG003|Overall Study|Adverse Event|0|||
160887977|NCT02448680|580984085|FG000|Overall Study|Physician Decision|1|||
160887978|NCT02448680|580984086|FG001|Overall Study|Physician Decision|1|||
160887979|NCT02448680|580984085|FG000|Overall Study|Withdrawal by Subject|0|||
160887980|NCT02448680|580984086|FG001|Overall Study|Withdrawal by Subject|2|||
160887981|NCT01739400|580984087|FG000|Overall Study|Physician Decision|3|||
160887982|NCT01739400|580984088|FG001|Overall Study|Physician Decision|0|||
160542067|NCT02970292|579712913|FG001|Overall Study|Lost to Follow-up|0|||
160542068|NCT02970292|579712912|FG000|Overall Study|Protocol Violation|2|||
160542069|NCT02970292|579712913|FG001|Overall Study|Protocol Violation|0|||
160780377|NCT00992836|580579752|FG000|Overall Study|Withdrawal by Subject|2|||
160780378|NCT00992836|580579752|FG000|Overall Study|Protocol Violation|2|||
160780379|NCT00266812|580579753|FG000|Overall Study|Disease Progression|9|||
160780380|NCT00266812|580579754|FG001|Overall Study|Disease Progression|3|||
160780381|NCT00266812|580579753|FG000|Overall Study|Death|5|||
160780382|NCT00266812|580579754|FG001|Overall Study|Death|4|||
160780383|NCT00266812|580579753|FG000|Overall Study|Adverse Event|3|||
160780384|NCT00266812|580579754|FG001|Overall Study|Adverse Event|1|||
160780385|NCT00266812|580579753|FG000|Overall Study|Protocol Violation|0|||
160780386|NCT00266812|580579754|FG001|Overall Study|Protocol Violation|1|||
160780387|NCT00266812|580579753|FG000|Overall Study|Withdrawal by Subject|0|||
160780388|NCT00266812|580579754|FG001|Overall Study|Withdrawal by Subject|2|||
160780389|NCT00266812|580579753|FG000|Overall Study|Discontinued before starting study drug|4|||
160780390|NCT00266812|580579754|FG001|Overall Study|Discontinued before starting study drug|0|||
160780391|NCT03695094|580579755|FG000|Overall Study|Adverse Event|1|||
160780392|NCT03695094|580579756|FG001|Overall Study|Adverse Event|1|||
160887983|NCT01739400|580984087|FG000|Overall Study|Lost to Follow-up|2|||
160887984|NCT01739400|580984088|FG001|Overall Study|Lost to Follow-up|0|||
160780393|NCT03695094|580579755|FG000|Overall Study|Withdrawal by Subject|1|||
160780394|NCT03695094|580579756|FG001|Overall Study|Withdrawal by Subject|0|||
160780395|NCT02323334|580579757|FG000|Period 3|Lost to Follow-up|0|||
160887985|NCT01739400|580984087|FG000|Overall Study|Death|5|||
160887986|NCT01739400|580984088|FG001|Overall Study|Death|2|||
160887987|NCT01739400|580984087|FG000|Overall Study|Withdrawal by Subject|7|||
160780396|NCT02323334|580579758|FG001|Period 3|Lost to Follow-up|0|||
160780397|NCT02323334|580579759|FG002|Period 3|Lost to Follow-up|1|||
160780398|NCT02323334|580579760|FG003|Period 3|Lost to Follow-up|0|||
160780399|NCT02323334|580579761|FG004|Period 3|Lost to Follow-up|0|||
160780400|NCT02323334|580579762|FG005|Period 3|Lost to Follow-up|0|||
160780401|NCT02323334|580579763|FG006|Period 3|Lost to Follow-up|0|||
160780402|NCT02323334|580579764|FG007|Period 3|Lost to Follow-up|0|||
160780403|NCT02323334|580579765|FG008|Period 3|Lost to Follow-up|0|||
160780404|NCT02323334|580579766|FG009|Period 3|Lost to Follow-up|0|||
160780405|NCT02323334|580579767|FG010|Period 3|Lost to Follow-up|0|||
160780406|NCT02323334|580579768|FG011|Period 3|Lost to Follow-up|0|||
160780407|NCT02323334|580579769|FG012|Period 3|Lost to Follow-up|0|||
160780408|NCT02323334|580579770|FG013|Period 3|Lost to Follow-up|0|||
160780409|NCT02323334|580579771|FG014|Period 3|Lost to Follow-up|0|||
160780410|NCT02323334|580579772|FG015|Period 3|Lost to Follow-up|0|||
160780411|NCT02323334|580579773|FG016|Period 3|Lost to Follow-up|0|||
160780412|NCT02323334|580579757|FG000|Period 3|Withdrawal by Subject|1|||
160780413|NCT02323334|580579758|FG001|Period 3|Withdrawal by Subject|0|||
160780414|NCT02323334|580579759|FG002|Period 3|Withdrawal by Subject|0|||
160780415|NCT02323334|580579760|FG003|Period 3|Withdrawal by Subject|0|||
160780416|NCT02323334|580579761|FG004|Period 3|Withdrawal by Subject|0|||
160780417|NCT02323334|580579762|FG005|Period 3|Withdrawal by Subject|0|||
160780418|NCT02323334|580579763|FG006|Period 3|Withdrawal by Subject|0|||
160780419|NCT02323334|580579764|FG007|Period 3|Withdrawal by Subject|0|||
160780420|NCT02323334|580579765|FG008|Period 3|Withdrawal by Subject|0|||
160780421|NCT02323334|580579766|FG009|Period 3|Withdrawal by Subject|0|||
160887988|NCT01739400|580984088|FG001|Overall Study|Withdrawal by Subject|7|||
160780422|NCT02323334|580579767|FG010|Period 3|Withdrawal by Subject|0|||
160887989|NCT01736657|580984089|FG000|Overall Study|insufficient vascular access|1|||
160887990|NCT00642473|580984098|FG000|Overall Study|Withdrawal by Subject|0|||
160887991|NCT00642473|580984099|FG001|Overall Study|Withdrawal by Subject|5|||
160887992|NCT00642473|580984098|FG000|Overall Study|Progression or death|2|||
160887993|NCT00642473|580984099|FG001|Overall Study|Progression or death|4|||
160887994|NCT00642473|580984098|FG000|Overall Study|Other|2|||
160887995|NCT00642473|580984099|FG001|Overall Study|Other|2|||
160887996|NCT04533880|580984100|FG000|Overall Study|Lost to Follow-up|0|||
160887997|NCT04533880|580984101|FG001|Overall Study|Lost to Follow-up|1|||
160887998|NCT04533880|580984102|FG002|Overall Study|Lost to Follow-up|1|||
160887999|NCT02284178|580984104|FG000|Overall Study|Met exclusion criteria|49|||
160888000|NCT02284178|580984105|FG001|Overall Study|Met exclusion criteria|54|||
160888001|NCT04123665|580984106|FG000|Overall Study|Withdrawal by Subject|7|||
160888002|NCT04123665|580984107|FG001|Overall Study|Withdrawal by Subject|0|||
160888003|NCT04123665|580984106|FG000|Overall Study|Lost to Follow-up|1|||
160888004|NCT04123665|580984107|FG001|Overall Study|Lost to Follow-up|0|||
160888005|NCT01711879|580984110|FG000|Overall Study|Death|1|||
160888006|NCT01711879|580984111|FG001|Overall Study|Death|0|||
160888007|NCT00478881|580984117|FG000|Overall Study|Adverse Event|31|||
160888008|NCT00478881|580984118|FG001|Overall Study|Adverse Event|12|||
160888009|NCT00478881|580984117|FG000|Overall Study|Lack of Efficacy|0|||
160888010|NCT00478881|580984118|FG001|Overall Study|Lack of Efficacy|3|||
160888011|NCT00478881|580984117|FG000|Overall Study|Lost to Follow-up|0|||
160888012|NCT00478881|580984118|FG001|Overall Study|Lost to Follow-up|1|||
160888013|NCT00478881|580984117|FG000|Overall Study|Protocol Violation|2|||
160888014|NCT00478881|580984118|FG001|Overall Study|Protocol Violation|2|||
160888015|NCT00478881|580984117|FG000|Overall Study|Withdrawal by Subject|6|||
160888016|NCT00478881|580984118|FG001|Overall Study|Withdrawal by Subject|2|||
160888017|NCT00478881|580984117|FG000|Overall Study|Non-Compliance with Study Medication|0|||
160888018|NCT00478881|580984118|FG001|Overall Study|Non-Compliance with Study Medication|2|||
160888019|NCT01466179|580984119|FG000|Overall Study|Ongoing in core study|2|||
160888020|NCT01466179|580984119|FG000|Overall Study|Physician Decision|46|||
160888021|NCT01466179|580984119|FG000|Overall Study|Progressive disease|43|||
160780423|NCT02323334|580579768|FG011|Period 3|Withdrawal by Subject|0|||
160888022|NCT01466179|580984119|FG000|Overall Study|Adverse Event|32|||
160888023|NCT01466179|580984119|FG000|Overall Study|Disease relapse|23|||
160888024|NCT01466179|580984119|FG000|Overall Study|Lack of Efficacy|14|||
160888025|NCT01466179|580984119|FG000|Overall Study|Death|7|||
160780424|NCT02323334|580579769|FG012|Period 3|Withdrawal by Subject|0|||
160780425|NCT02323334|580579770|FG013|Period 3|Withdrawal by Subject|0|||
160780426|NCT02323334|580579771|FG014|Period 3|Withdrawal by Subject|0|||
160780427|NCT02323334|580579772|FG015|Period 3|Withdrawal by Subject|0|||
160780428|NCT02323334|580579773|FG016|Period 3|Withdrawal by Subject|0|||
160888026|NCT01466179|580984119|FG000|Overall Study|Withdrawal by Subject|7|||
160888027|NCT01466179|580984119|FG000|Overall Study|Protocol Violation|2|||
160888028|NCT01466179|580984119|FG000|Overall Study|Other|3|||
160542070|NCT02970292|579712912|FG000|Overall Study|Other|1|||
160542071|NCT02970292|579712913|FG001|Overall Study|Other|0|||
160542072|NCT00845650|579712914|FG000|Overall Study|Withdrawal by Subject|0|||
160542073|NCT00845650|579712915|FG001|Overall Study|Withdrawal by Subject|0|||
160542074|NCT00845650|579712916|FG002|Overall Study|Withdrawal by Subject|0|||
160780429|NCT01177410|580579780|FG000|Overall Study|Adverse Event|0|||
160780430|NCT01177410|580579781|FG001|Overall Study|Adverse Event|2|||
160780431|NCT01177410|580579782|FG002|Overall Study|Adverse Event|2|||
160780432|NCT01177410|580579780|FG000|Overall Study|Withdrawal by Subject|1|||
160780433|NCT01177410|580579781|FG001|Overall Study|Withdrawal by Subject|4|||
160780434|NCT01177410|580579782|FG002|Overall Study|Withdrawal by Subject|3|||
160780435|NCT01177410|580579780|FG000|Overall Study|Lost to Follow-up|0|||
160780436|NCT01177410|580579781|FG001|Overall Study|Lost to Follow-up|1|||
160780437|NCT01177410|580579782|FG002|Overall Study|Lost to Follow-up|0|||
160780438|NCT00471354|580579783|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
160780439|NCT00471354|580579783|FG000|Overall Study|Adverse Event|13|||
160780440|NCT00471354|580579783|FG000|Overall Study|Protocol Violation|12|||
160780441|NCT00471354|580579783|FG000|Overall Study|Withdrawal by Subject|1|||
160780442|NCT00471354|580579783|FG000|Overall Study|Physician Decision|4|||
160780443|NCT00471354|580579783|FG000|Overall Study|Sponsor Decision|1|||
160780444|NCT00471354|580579783|FG000|Overall Study|Lost to Follow-up|3|||
160780445|NCT00471354|580579783|FG000|Overall Study|Lack of Efficacy|5|||
160780446|NCT00471354|580579783|FG000|Overall Study|Patient/Caregiver Decision|12|||
160780447|NCT05558410|580579785|FG000|Overall Study|Adverse Event|1|||
160780448|NCT05558410|580579786|FG001|Overall Study|Adverse Event|2|||
160780449|NCT05558410|580579787|FG002|Overall Study|Adverse Event|0|||
160780450|NCT05558410|580579785|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
160780451|NCT05558410|580579786|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
160780452|NCT05558410|580579787|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
160780453|NCT05558410|580579785|FG000|Overall Study|Lost to Follow-up|10|||
160780454|NCT05558410|580579786|FG001|Overall Study|Lost to Follow-up|17|||
160780455|NCT05558410|580579787|FG002|Overall Study|Lost to Follow-up|19|||
160780456|NCT05558410|580579785|FG000|Overall Study|Death|1|||
160780457|NCT05558410|580579786|FG001|Overall Study|Death|0|||
160780458|NCT05558410|580579787|FG002|Overall Study|Death|0|||
160780459|NCT05558410|580579785|FG000|Overall Study|Other non-compliance|0|||
160780460|NCT05558410|580579786|FG001|Overall Study|Other non-compliance|1|||
160780461|NCT05558410|580579787|FG002|Overall Study|Other non-compliance|2|||
160780462|NCT05558410|580579785|FG000|Overall Study|Sponsor Decision|1|||
160780463|NCT05558410|580579786|FG001|Overall Study|Sponsor Decision|0|||
160780464|NCT05558410|580579787|FG002|Overall Study|Sponsor Decision|0|||
160780465|NCT05558410|580579785|FG000|Overall Study|Other|1|||
160780466|NCT05558410|580579786|FG001|Overall Study|Other|0|||
160780467|NCT05558410|580579787|FG002|Overall Study|Other|1|||
160780468|NCT02691663|580579792|FG000|Overall Study|Screen failure after baseline|2|||
160780469|NCT02691663|580579793|FG001|Overall Study|Screen failure after baseline|2|||
160780470|NCT02691663|580579792|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
160780471|NCT02691663|580579793|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
160780472|NCT02691663|580579792|FG000|Overall Study|Withdrawn after Follow up 2|1|||
160780473|NCT02691663|580579793|FG001|Overall Study|Withdrawn after Follow up 2|1|||
160780474|NCT02691663|580579792|FG000|Overall Study|Lost to Follow-up|3|||
160780475|NCT02691663|580579793|FG001|Overall Study|Lost to Follow-up|2|||
160780476|NCT05887908|580579796|FG000|Overall Study|Adverse Event|6|||
160780477|NCT05887908|580579797|FG001|Overall Study|Adverse Event|1|||
160780478|NCT05887908|580579798|FG002|Overall Study|Adverse Event|1|||
160780479|NCT05887908|580579796|FG000|Overall Study|Physician Decision|4|||
160780480|NCT05887908|580579797|FG001|Overall Study|Physician Decision|1|||
160780481|NCT05887908|580579798|FG002|Overall Study|Physician Decision|0|||
160780482|NCT05887908|580579796|FG000|Overall Study|Withdrawal by Subject|3|||
160780483|NCT05887908|580579797|FG001|Overall Study|Withdrawal by Subject|2|||
160780484|NCT05887908|580579798|FG002|Overall Study|Withdrawal by Subject|3|||
160780485|NCT05887908|580579796|FG000|Overall Study|Ineligibility after the start of the study|4|||
160780486|NCT05887908|580579797|FG001|Overall Study|Ineligibility after the start of the study|1|||
160780487|NCT05887908|580579798|FG002|Overall Study|Ineligibility after the start of the study|0|||
160780488|NCT05887908|580579796|FG000|Overall Study|Subject non-compliance|4|||
160780489|NCT05887908|580579797|FG001|Overall Study|Subject non-compliance|0|||
160780490|NCT05887908|580579798|FG002|Overall Study|Subject non-compliance|4|||
160542075|NCT00845650|579712917|FG003|Overall Study|Withdrawal by Subject|0|||
160542076|NCT00845650|579712918|FG004|Overall Study|Withdrawal by Subject|2|||
160780491|NCT05887908|580579796|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
160780492|NCT05887908|580579797|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
160780493|NCT05887908|580579798|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
160780494|NCT05887908|580579796|FG000|Overall Study|Pregnancy|0|||
160780495|NCT05887908|580579797|FG001|Overall Study|Pregnancy|1|||
160780496|NCT05887908|580579798|FG002|Overall Study|Pregnancy|0|||
160542077|NCT00845650|579712919|FG005|Overall Study|Withdrawal by Subject|0|||
160888029|NCT03707184|580984120|FG000|Overall Study|Withdrawal by Subject|2|||
160888030|NCT04704154|580984121|FG000|Overall Study|Adverse Event|3|||
160888031|NCT04704154|580984122|FG001|Overall Study|Adverse Event|2|||
160888032|NCT04704154|580984123|FG002|Overall Study|Adverse Event|4|||
160888033|NCT04704154|580984124|FG003|Overall Study|Adverse Event|2|||
160888034|NCT04704154|580984125|FG004|Overall Study|Adverse Event|3|||
160888035|NCT04704154|580984126|FG005|Overall Study|Adverse Event|0|||
160888036|NCT04704154|580984121|FG000|Overall Study|Death|3|||
160888037|NCT04704154|580984122|FG001|Overall Study|Death|0|||
160888038|NCT04704154|580984123|FG002|Overall Study|Death|0|||
160888039|NCT04704154|580984124|FG003|Overall Study|Death|0|||
160888040|NCT04704154|580984125|FG004|Overall Study|Death|3|||
160888041|NCT04704154|580984126|FG005|Overall Study|Death|0|||
160888042|NCT04704154|580984121|FG000|Overall Study|Physician Decision|1|||
160888043|NCT04704154|580984122|FG001|Overall Study|Physician Decision|0|||
160888044|NCT04704154|580984123|FG002|Overall Study|Physician Decision|1|||
160888045|NCT04704154|580984124|FG003|Overall Study|Physician Decision|0|||
160888046|NCT04704154|580984125|FG004|Overall Study|Physician Decision|2|||
160888047|NCT04704154|580984126|FG005|Overall Study|Physician Decision|0|||
160888048|NCT04704154|580984121|FG000|Overall Study|Participant Decision|1|||
160888049|NCT04704154|580984122|FG001|Overall Study|Participant Decision|1|||
160888050|NCT04704154|580984123|FG002|Overall Study|Participant Decision|0|||
160888051|NCT04704154|580984124|FG003|Overall Study|Participant Decision|0|||
160888052|NCT04704154|580984125|FG004|Overall Study|Participant Decision|0|||
160888053|NCT04704154|580984126|FG005|Overall Study|Participant Decision|0|||
160888054|NCT04704154|580984121|FG000|Overall Study|Progressive Disease|19|||
160888055|NCT04704154|580984122|FG001|Overall Study|Progressive Disease|17|||
160888056|NCT04704154|580984123|FG002|Overall Study|Progressive Disease|20|||
160888057|NCT04704154|580984124|FG003|Overall Study|Progressive Disease|18|||
160888058|NCT04704154|580984125|FG004|Overall Study|Progressive Disease|36|||
160888059|NCT04704154|580984126|FG005|Overall Study|Progressive Disease|30|||
160888060|NCT04704154|580984121|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
160888061|NCT04704154|580984122|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
160888062|NCT04704154|580984123|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
160888063|NCT04704154|580984124|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
160888064|NCT04704154|580984125|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
160888065|NCT04704154|580984126|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
160888066|NCT04704154|580984121|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
160888067|NCT04704154|580984122|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
160888068|NCT04704154|580984123|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
160888069|NCT04704154|580984124|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
160888070|NCT04704154|580984125|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
160888071|NCT04704154|580984126|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
160888072|NCT03220438|580984127|FG000|Overall Study|Lost to Follow-up|0|||
160888073|NCT03220438|580984128|FG001|Overall Study|Lost to Follow-up|0|||
160780497|NCT05887908|580579796|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
160780498|NCT05887908|580579797|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
160780499|NCT05887908|580579798|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
160780500|NCT05887908|580579796|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
160780501|NCT05887908|580579797|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
160780502|NCT05887908|580579798|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
160780503|NCT05887908|580579796|FG000|Overall Study|Other Reason|3|||
160888074|NCT03220438|580984129|FG002|Overall Study|Lost to Follow-up|1|||
160888075|NCT03220438|580984130|FG003|Overall Study|Lost to Follow-up|0|||
160888076|NCT04062123|580984131|FG000|Overall Study|Withdrawal by Subject|0|||
160888077|NCT04062123|580984132|FG001|Overall Study|Withdrawal by Subject|1|||
160780504|NCT05887908|580579797|FG001|Overall Study|Other Reason|3|||
160780505|NCT05887908|580579798|FG002|Overall Study|Other Reason|3|||
160780506|NCT03928743|580579802|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
160780507|NCT03928743|580579803|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
160780508|NCT03928743|580579804|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
160888078|NCT04062123|580984133|FG002|Overall Study|Withdrawal by Subject|0|||
160888079|NCT04190680|580984134|FG000|Overall Study|Not meeting criteria for data analysis|1|||
160888080|NCT04190680|580984135|FG001|Overall Study|Not meeting criteria for data analysis|15|||
160888081|NCT04190680|580984134|FG000|Overall Study|Administrative error|0|||
160888082|NCT04190680|580984135|FG001|Overall Study|Administrative error|18|||
160888083|NCT01850602|580984136|FG000|Overall Study|Adverse Event|7|||
160888084|NCT01850602|580984137|FG001|Overall Study|Adverse Event|10|||
160888085|NCT01850602|580984136|FG000|Overall Study|Physician Decision|2|||
160888086|NCT01850602|580984137|FG001|Overall Study|Physician Decision|1|||
160780509|NCT03928743|580579802|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
160780510|NCT03928743|580579803|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
160780511|NCT03928743|580579804|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
160780512|NCT03928743|580579802|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
160780513|NCT03928743|580579803|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
160780514|NCT03928743|580579804|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
160780515|NCT03928743|580579802|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
160780516|NCT03928743|580579803|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
160780517|NCT03928743|580579804|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
160780518|NCT03928743|580579802|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
160780519|NCT03928743|580579803|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
160780520|NCT03928743|580579804|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
160780521|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
160780522|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
160780523|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
160780524|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
160888087|NCT01850602|580984136|FG000|Overall Study|Withdrawal by Subject|2|||
160888088|NCT01850602|580984137|FG001|Overall Study|Withdrawal by Subject|4|||
160888089|NCT01850602|580984136|FG000|Overall Study|Decrease in serum calcium|2|||
160888090|NCT01850602|580984137|FG001|Overall Study|Decrease in serum calcium|3|||
160780525|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
160780526|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
160888091|NCT01850602|580984136|FG000|Overall Study|Increase in serum ferritin|1|||
160888092|NCT01850602|580984137|FG001|Overall Study|Increase in serum ferritin|0|||
160888093|NCT01001299|580984140|FG000|Overall Study|Insufficient Therapeutic Response|20|||
160888094|NCT01001299|580984140|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
160888095|NCT01001299|580984140|FG000|Overall Study|Death|1|||
160888096|NCT01001299|580984140|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
160888097|NCT01001299|580984140|FG000|Overall Study|Withdrew Consent|1|||
160888098|NCT01565499|580984141|FG000|Overall Study|Physician Decision|1|||
160888099|NCT01565499|580984141|FG000|Overall Study|Adverse Event|5|||
160888100|NCT01565499|580984141|FG000|Overall Study|Withdrawal by Subject|2|||
160888101|NCT01892722|580984142|FG000|Overall Study|Protocol deviation|0|||
160888102|NCT01892722|580984143|FG001|Overall Study|Protocol deviation|1|||
160888103|NCT01892722|580984142|FG000|Overall Study|Administrative problems|0|||
160888104|NCT01892722|580984143|FG001|Overall Study|Administrative problems|1|||
160888105|NCT01892722|580984142|FG000|Overall Study|Patient/guardian decision|0|||
160888106|NCT01892722|580984143|FG001|Overall Study|Patient/guardian decision|2|||
160888107|NCT01892722|580984142|FG000|Overall Study|Physician Decision|1|||
160888108|NCT01892722|580984143|FG001|Overall Study|Physician Decision|2|||
160888109|NCT01892722|580984142|FG000|Overall Study|Adverse Event|3|||
160888110|NCT01892722|580984143|FG001|Overall Study|Adverse Event|2|||
160888111|NCT01892722|580984142|FG000|Overall Study|Lack of Efficacy|0|||
160888112|NCT01892722|580984143|FG001|Overall Study|Lack of Efficacy|7|||
160888113|NCT01892722|580984142|FG000|Overall Study|Withdrawal by Subject|3|||
160888114|NCT01892722|580984143|FG001|Overall Study|Withdrawal by Subject|5|||
160888115|NCT02275910|580984144|FG000|Overall Study|Subject Choice|0|||
160888116|NCT02275910|580984145|FG001|Overall Study|Subject Choice|0|||
160888117|NCT02275910|580984146|FG002|Overall Study|Subject Choice|0|||
160888118|NCT02275910|580984147|FG003|Overall Study|Subject Choice|0|||
160888119|NCT02275910|580984148|FG004|Overall Study|Subject Choice|0|||
160888120|NCT02275910|580984149|FG005|Overall Study|Subject Choice|0|||
160888121|NCT02275910|580984150|FG006|Overall Study|Subject Choice|0|||
160888122|NCT02275910|580984151|FG007|Overall Study|Subject Choice|0|||
160888123|NCT02275910|580984152|FG008|Overall Study|Subject Choice|1|||
160888124|NCT02275910|580984153|FG009|Overall Study|Subject Choice|0|||
160888125|NCT02275910|580984154|FG010|Overall Study|Subject Choice|0|||
160888126|NCT02275910|580984155|FG011|Overall Study|Subject Choice|0|||
160888127|NCT02275910|580984144|FG000|Overall Study|Radiological Disease Progression|0|||
160888128|NCT02275910|580984145|FG001|Overall Study|Radiological Disease Progression|0|||
160888129|NCT02275910|580984146|FG002|Overall Study|Radiological Disease Progression|0|||
160888130|NCT02275910|580984147|FG003|Overall Study|Radiological Disease Progression|0|||
160888131|NCT02275910|580984148|FG004|Overall Study|Radiological Disease Progression|0|||
160888132|NCT02275910|580984149|FG005|Overall Study|Radiological Disease Progression|0|||
160888133|NCT02275910|580984150|FG006|Overall Study|Radiological Disease Progression|1|||
160888134|NCT02275910|580984151|FG007|Overall Study|Radiological Disease Progression|1|||
160888135|NCT02275910|580984152|FG008|Overall Study|Radiological Disease Progression|0|||
160888136|NCT02275910|580984153|FG009|Overall Study|Radiological Disease Progression|1|||
160888137|NCT02275910|580984154|FG010|Overall Study|Radiological Disease Progression|0|||
160888138|NCT02275910|580984155|FG011|Overall Study|Radiological Disease Progression|0|||
160888139|NCT00096954|580985448|FG000|Overall Study|Adverse Event|3|||
160888140|NCT00096954|580985449|FG001|Overall Study|Adverse Event|1|||
160888141|NCT00096954|580985448|FG000|Overall Study|Withdrawal by Subject|9|||
160888142|NCT00096954|580985449|FG001|Overall Study|Withdrawal by Subject|8|||
160888143|NCT00096954|580985448|FG000|Overall Study|Physician Decision|1|||
160888144|NCT00096954|580985449|FG001|Overall Study|Physician Decision|1|||
160888145|NCT00096954|580985448|FG000|Overall Study|Sponsors Decision|1|||
160888146|NCT00096954|580985449|FG001|Overall Study|Sponsors Decision|1|||
160888147|NCT00096954|580985448|FG000|Overall Study|Pregnancy|1|||
160888148|NCT00096954|580985449|FG001|Overall Study|Pregnancy|1|||
160888149|NCT00096954|580985448|FG000|Overall Study|Initiation of immunotherapy|1|||
160888150|NCT00096954|580985449|FG001|Overall Study|Initiation of immunotherapy|0|||
160888151|NCT00096954|580985448|FG000|Overall Study|Non-compliance|0|||
160888152|NCT00096954|580985449|FG001|Overall Study|Non-compliance|3|||
160888153|NCT00096954|580985448|FG000|Overall Study|Lost to Follow-up|8|||
160888154|NCT00096954|580985449|FG001|Overall Study|Lost to Follow-up|5|||
160888155|NCT03410823|580985450|FG000|Overall Study|Death|1|||
160888156|NCT03410823|580985450|FG000|Overall Study|Withdrawal by Subject|2|||
160888157|NCT03410823|580985450|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
160888158|NCT04626310|580985452|FG000|Overall Study|4-miss from treatment|6|||
160888159|NCT04626310|580985453|FG001|Overall Study|4-miss from treatment|5|||
160888160|NCT04626310|580985454|FG002|Overall Study|4-miss from treatment|5|||
160888161|NCT04626310|580985452|FG000|Overall Study|Withdrawal by Subject|1|||
160888162|NCT04626310|580985453|FG001|Overall Study|Withdrawal by Subject|0|||
160888163|NCT04626310|580985454|FG002|Overall Study|Withdrawal by Subject|3|||
160888164|NCT03780400|580985455|FG000|Overall Study|Lost to Follow-up|5|||
160888165|NCT03780400|580985455|FG000|Overall Study|Withdrawal by Subject|2|||
160888166|NCT00740051|580985456|FG000|Overall Study|Lack of Efficacy|2|||
160888167|NCT00740051|580985457|FG001|Overall Study|Lack of Efficacy|5|||
160888168|NCT00740051|580985456|FG000|Overall Study|Adverse Event|1|||
160888169|NCT00740051|580985457|FG001|Overall Study|Adverse Event|4|||
160888170|NCT00740051|580985456|FG000|Overall Study|Protocol Violation|2|||
160888171|NCT00740051|580985457|FG001|Overall Study|Protocol Violation|6|||
160888172|NCT00740051|580985456|FG000|Overall Study|Lost to Follow-up|3|||
160888173|NCT00740051|580985457|FG001|Overall Study|Lost to Follow-up|8|||
160888174|NCT00740051|580985456|FG000|Overall Study|Withdrawal by Subject|6|||
160888175|NCT00740051|580985457|FG001|Overall Study|Withdrawal by Subject|8|||
160888176|NCT00740051|580985456|FG000|Overall Study|Other reason (not specified)|4|||
160888177|NCT00740051|580985457|FG001|Overall Study|Other reason (not specified)|1|||
160888178|NCT02011893|580985458|FG000|Enrollment to Randomization|Adverse Event|2|||
160888179|NCT02011893|580985459|FG001|Enrollment to Randomization|Adverse Event|0|||
160888180|NCT02011893|580985460|FG002|Enrollment to Randomization|Adverse Event|0|||
160888181|NCT02011893|580985458|FG000|Enrollment to Randomization|Physician Decision|10|||
160888182|NCT02011893|580985459|FG001|Enrollment to Randomization|Physician Decision|0|||
160888183|NCT02011893|580985460|FG002|Enrollment to Randomization|Physician Decision|0|||
160888184|NCT02011893|580985458|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
160888185|NCT02011893|580985459|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
160888186|NCT02011893|580985460|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
160888187|NCT02011893|580985458|FG000|Enrollment to Randomization|Screening Failure|29|||
160888188|NCT02011893|580985459|FG001|Enrollment to Randomization|Screening Failure|0|||
160888189|NCT02011893|580985460|FG002|Enrollment to Randomization|Screening Failure|0|||
160888190|NCT02011893|580985458|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
160888191|NCT02011893|580985459|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
160888192|NCT02011893|580985460|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
160888193|NCT02011893|580985458|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
160888194|NCT02011893|580985459|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
160888195|NCT02011893|580985460|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
160888196|NCT02011893|580985458|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
160888197|NCT02011893|580985459|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
160888198|NCT02011893|580985460|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
160888199|NCT02011893|580985458|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
160888200|NCT02011893|580985459|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
160888201|NCT02011893|580985460|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
160888202|NCT02011893|580985458|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
160888203|NCT02011893|580985459|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
160888204|NCT02011893|580985460|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
160888205|NCT00991952|580985461|FG000|Overall Study|Adverse Event|0|||
160888206|NCT00991952|580985462|FG001|Overall Study|Adverse Event|1|||
160638380|NCT01493531|580059268|FG000|Overall Study|Gout flare|3|||
160888207|NCT03452527|580985463|FG000|Overall Study|Withdrawal by Subject|1|||
160888208|NCT03452527|580985464|FG001|Overall Study|Withdrawal by Subject|1|||
160888209|NCT03452527|580985463|FG000|Overall Study|Study Terminated|2|||
160888210|NCT03452527|580985464|FG001|Overall Study|Study Terminated|3|||
160888211|NCT03116347|580985468|FG000|Overall Study|Withdrawal by Subject|1|||
160888212|NCT03116347|580985469|FG001|Overall Study|Withdrawal by Subject|2|||
160638381|NCT01493531|580059269|FG001|Overall Study|Gout flare|0|||
160780527|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
160780528|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
160780529|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
160780530|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
160780531|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
160780532|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
160780533|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
160780534|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
160780535|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
160888213|NCT01255787|580985470|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
160888214|NCT01255787|580985471|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
160888215|NCT01255787|580985472|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
160888216|NCT01255787|580985473|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
160888217|NCT01255787|580985470|FG000|Overall Study|Major Protocol Deviation|1|||
160888218|NCT01255787|580985471|FG001|Overall Study|Major Protocol Deviation|1|||
160888219|NCT01255787|580985472|FG002|Overall Study|Major Protocol Deviation|0|||
160888220|NCT01255787|580985473|FG003|Overall Study|Major Protocol Deviation|4|||
160888221|NCT01255787|580985470|FG000|Overall Study|Lost to Follow-up|1|||
160888222|NCT01255787|580985471|FG001|Overall Study|Lost to Follow-up|2|||
160888223|NCT01255787|580985472|FG002|Overall Study|Lost to Follow-up|4|||
160888224|NCT01255787|580985473|FG003|Overall Study|Lost to Follow-up|2|||
160888225|NCT01255787|580985470|FG000|Overall Study|Withdrawal of Consent|3|||
160888226|NCT01255787|580985471|FG001|Overall Study|Withdrawal of Consent|9|||
160888227|NCT01255787|580985472|FG002|Overall Study|Withdrawal of Consent|3|||
160888228|NCT01255787|580985473|FG003|Overall Study|Withdrawal of Consent|4|||
160888229|NCT01255787|580985470|FG000|Overall Study|Pregnancy|0|||
160888230|NCT01255787|580985471|FG001|Overall Study|Pregnancy|0|||
160888231|NCT01255787|580985472|FG002|Overall Study|Pregnancy|0|||
160888232|NCT01255787|580985473|FG003|Overall Study|Pregnancy|1|||
160888233|NCT01255787|580985470|FG000|Overall Study|Lack of Efficacy|2|||
160888234|NCT01255787|580985471|FG001|Overall Study|Lack of Efficacy|2|||
160888235|NCT01255787|580985472|FG002|Overall Study|Lack of Efficacy|2|||
160888236|NCT01255787|580985473|FG003|Overall Study|Lack of Efficacy|2|||
160888237|NCT01255787|580985470|FG000|Overall Study|Noncompliance with Study Drug|3|||
160888238|NCT01255787|580985471|FG001|Overall Study|Noncompliance with Study Drug|1|||
160888239|NCT01255787|580985472|FG002|Overall Study|Noncompliance with Study Drug|0|||
160888240|NCT01255787|580985473|FG003|Overall Study|Noncompliance with Study Drug|0|||
160888241|NCT04966741|580985474|FG000|Overall Study|Lost to Follow-up|1|||
160888242|NCT04966741|580985475|FG001|Overall Study|Lost to Follow-up|0|||
160888243|NCT05101317|580985478|FG000|Week1-13|Adverse Event|0|||
160888244|NCT05101317|580985479|FG001|Week1-13|Adverse Event|1|||
160888245|NCT05101317|580985480|FG002|Week1-13|Adverse Event|0|||
160888246|NCT05101317|580985481|FG003|Week1-13|Adverse Event|0|||
160888247|NCT05101317|580985478|FG000|Week1-13|Withdrawal by Subject|0|||
160888248|NCT05101317|580985479|FG001|Week1-13|Withdrawal by Subject|2|||
160888249|NCT05101317|580985480|FG002|Week1-13|Withdrawal by Subject|0|||
160888250|NCT05101317|580985481|FG003|Week1-13|Withdrawal by Subject|0|||
160888251|NCT05101317|580985478|FG000|Week1-13|Early Withdrawl|0|||
160888252|NCT05101317|580985479|FG001|Week1-13|Early Withdrawl|0|||
160888253|NCT05101317|580985480|FG002|Week1-13|Early Withdrawl|0|||
160888254|NCT05101317|580985481|FG003|Week1-13|Early Withdrawl|1|||
160888255|NCT05101317|580985478|FG000|Week 13-25|Lost to Follow-up|0|||
160888256|NCT05101317|580985479|FG001|Week 13-25|Lost to Follow-up|0|||
160888257|NCT05101317|580985480|FG002|Week 13-25|Lost to Follow-up|1|||
160780536|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
160888258|NCT05101317|580985481|FG003|Week 13-25|Lost to Follow-up|0|||
160888259|NCT05101317|580985478|FG000|Week 13-25|Withdrawal by Subject|1|||
160888260|NCT05101317|580985479|FG001|Week 13-25|Withdrawal by Subject|1|||
160888261|NCT05101317|580985480|FG002|Week 13-25|Withdrawal by Subject|0|||
160888262|NCT05101317|580985481|FG003|Week 13-25|Withdrawal by Subject|0|||
160888263|NCT05101317|580985478|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
160888264|NCT05101317|580985479|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
160888265|NCT05101317|580985480|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
160888266|NCT05101317|580985481|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
160888267|NCT05764265|580985482|FG000|Overall Study|Adverse Event|1|||
160888268|NCT05764265|580985483|FG001|Overall Study|Adverse Event|0|||
160888269|NCT05764265|580985482|FG000|Overall Study|Physician Decision|1|||
160888270|NCT05764265|580985483|FG001|Overall Study|Physician Decision|8|||
160888271|NCT05764265|580985482|FG000|Overall Study|Study Terminated By Sponsor|20|||
160888272|NCT05764265|580985483|FG001|Overall Study|Study Terminated By Sponsor|0|||
160888273|NCT05764265|580985482|FG000|Overall Study|Participant Decision|1|||
160888274|NCT05764265|580985483|FG001|Overall Study|Participant Decision|0|||
160888275|NCT00509262|580985484|FG000|Overall Study|Adverse Event|16|||
160888276|NCT00509262|580985485|FG001|Overall Study|Adverse Event|18|||
160888277|NCT00509262|580985484|FG000|Overall Study|Other|2|||
160888278|NCT00509262|580985485|FG001|Overall Study|Other|2|||
160888279|NCT00509262|580985484|FG000|Overall Study|Lack of Efficacy|1|||
160888280|NCT00509262|580985485|FG001|Overall Study|Lack of Efficacy|0|||
160888281|NCT00509262|580985484|FG000|Overall Study|Lost to Follow-up|1|||
160888282|NCT00509262|580985485|FG001|Overall Study|Lost to Follow-up|6|||
160888283|NCT00509262|580985484|FG000|Overall Study|Physician Decision|1|||
160888284|NCT00509262|580985485|FG001|Overall Study|Physician Decision|3|||
160888285|NCT00509262|580985484|FG000|Overall Study|Protocol Violation|2|||
160888286|NCT00509262|580985485|FG001|Overall Study|Protocol Violation|2|||
160888287|NCT00509262|580985484|FG000|Overall Study|Withdrawal by Subject|24|||
160888288|NCT00509262|580985485|FG001|Overall Study|Withdrawal by Subject|11|||
160888289|NCT00725842|580985486|FG000|Overall Study|Lost to Follow-up|19|||
160888290|NCT00725842|580985486|FG000|Overall Study|Death|1|||
160888291|NCT00725842|580985486|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
160888292|NCT00725842|580985486|FG000|Overall Study|Consent date prior to study start date|5|||
160888293|NCT00725842|580985486|FG000|Overall Study|Inclusion criterion not met|1|||
160888294|NCT00725842|580985486|FG000|Overall Study|No Visit 1 data|1|||
160888295|NCT01853618|580985487|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
160888296|NCT01853618|580985488|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
160888297|NCT01853618|580985489|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
160888298|NCT01853618|580985490|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
160888299|NCT01853618|580985491|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
160888300|NCT01853618|580985487|FG000|Overall Study|Progressive disease|1|||
160888301|NCT01853618|580985488|FG001|Overall Study|Progressive disease|1|||
160888302|NCT01853618|580985489|FG002|Overall Study|Progressive disease|1|||
160888303|NCT01853618|580985490|FG003|Overall Study|Progressive disease|1|||
160888304|NCT01853618|580985491|FG004|Overall Study|Progressive disease|2|||
160888305|NCT01853618|580985487|FG000|Overall Study|Physician Decision|0|||
160542078|NCT00845650|579712914|FG000|Overall Study|Lost to Follow-up|0|||
160542079|NCT00845650|579712915|FG001|Overall Study|Lost to Follow-up|0|||
160542080|NCT00845650|579712916|FG002|Overall Study|Lost to Follow-up|3|||
160542081|NCT00845650|579712917|FG003|Overall Study|Lost to Follow-up|1|||
160542082|NCT00845650|579712918|FG004|Overall Study|Lost to Follow-up|0|||
160888306|NCT01853618|580985488|FG001|Overall Study|Physician Decision|1|||
160888307|NCT01853618|580985489|FG002|Overall Study|Physician Decision|1|||
160888308|NCT01853618|580985490|FG003|Overall Study|Physician Decision|0|||
160888309|NCT01853618|580985491|FG004|Overall Study|Physician Decision|0|||
160888310|NCT01853618|580985487|FG000|Overall Study|Refused further treatment|0|||
160888311|NCT01853618|580985488|FG001|Overall Study|Refused further treatment|0|||
160888312|NCT01853618|580985489|FG002|Overall Study|Refused further treatment|0|||
160888313|NCT01853618|580985490|FG003|Overall Study|Refused further treatment|0|||
160888314|NCT01853618|580985491|FG004|Overall Study|Refused further treatment|1|||
160888315|NCT02009384|580985499|FG000|Overall Study|Death|2|||
160888316|NCT01092832|580985500|FG000|Overall Study|Other|1|||
160888317|NCT01092832|580985501|FG001|Overall Study|Other|0|||
160888318|NCT01075191|580985502|FG000|Overall Study|Death|1|||
160888319|NCT01075191|580985502|FG000|Overall Study|Intensification|3|||
160888320|NCT01075191|580985502|FG000|Overall Study|Co-morbidities|1|||
160888321|NCT01075191|580985502|FG000|Overall Study|Adverse Event|4|||
160888322|NCT01075191|580985502|FG000|Overall Study|Noncompliance|3|||
160888323|NCT01075191|580985502|FG000|Overall Study|Therapy Break|3|||
160888324|NCT01075191|580985502|FG000|Overall Study|Patient's Wish|2|||
160888325|NCT01075191|580985502|FG000|Overall Study|Unknown Reasons|1|||
160888326|NCT04777331|580985503|FG000|DBT Period|Death|2|||
160542083|NCT00845650|579712919|FG005|Overall Study|Lost to Follow-up|1|||
160542084|NCT00845650|579712914|FG000|Overall Study|Sponsor hold on dosing|0|||
160638382|NCT01493531|580059270|FG002|Overall Study|Gout flare|2|||
160888327|NCT04777331|580985504|FG001|DBT Period|Death|1|||
160888328|NCT04777331|580985505|FG002|DBT Period|Death|0|||
160542085|NCT00845650|579712915|FG001|Overall Study|Sponsor hold on dosing|0|||
160542086|NCT00845650|579712916|FG002|Overall Study|Sponsor hold on dosing|0|||
160542087|NCT00845650|579712917|FG003|Overall Study|Sponsor hold on dosing|0|||
160542088|NCT00845650|579712918|FG004|Overall Study|Sponsor hold on dosing|1|||
160542089|NCT00845650|579712919|FG005|Overall Study|Sponsor hold on dosing|1|||
160542090|NCT00845650|579712914|FG000|Overall Study|Unable to access IV line|1|||
160542091|NCT00845650|579712915|FG001|Overall Study|Unable to access IV line|0|||
160888329|NCT04777331|580985503|FG000|DBT Period|Reason not Specified|1|||
160888330|NCT04777331|580985504|FG001|DBT Period|Reason not Specified|1|||
160888331|NCT04777331|580985505|FG002|DBT Period|Reason not Specified|0|||
160888332|NCT04777331|580985503|FG000|DBT Period|Physician Decision|4|||
160888333|NCT04777331|580985504|FG001|DBT Period|Physician Decision|0|||
160888334|NCT04777331|580985505|FG002|DBT Period|Physician Decision|0|||
160888335|NCT04777331|580985503|FG000|DBT Period|Withdrawal by Subject|12|||
160888336|NCT04777331|580985504|FG001|DBT Period|Withdrawal by Subject|11|||
160888337|NCT04777331|580985505|FG002|DBT Period|Withdrawal by Subject|0|||
160888338|NCT04777331|580985503|FG000|DBT Period|Randomized but not Treated|1|||
160888339|NCT04777331|580985504|FG001|DBT Period|Randomized but not Treated|3|||
160888340|NCT04777331|580985505|FG002|DBT Period|Randomized but not Treated|0|||
160888341|NCT04777331|580985503|FG000|OLE Period|Ongoing in OLE|0|||
160888342|NCT04777331|580985504|FG001|OLE Period|Ongoing in OLE|0|||
160888343|NCT04777331|580985505|FG002|OLE Period|Ongoing in OLE|534|||
160888344|NCT01401959|580985506|FG000|Enrolled|Withdrawal by Subject|1|||
160888345|NCT01401959|580985507|FG001|Enrolled|Withdrawal by Subject|0|||
160888346|NCT01401959|580985508|FG002|Enrolled|Withdrawal by Subject|0|||
160888347|NCT01401959|580985506|FG000|Treated|Disease Progression|2|||
160888348|NCT01401959|580985507|FG001|Treated|Disease Progression|2|||
160888349|NCT01401959|580985508|FG002|Treated|Disease Progression|1|||
160888350|NCT01401959|580985506|FG000|Treated|Adverse Event|4|||
160888351|NCT01401959|580985507|FG001|Treated|Adverse Event|3|||
160888352|NCT01401959|580985508|FG002|Treated|Adverse Event|2|||
160888353|NCT01401959|580985506|FG000|Treated|Withdrawal by Subject|1|||
160888354|NCT01401959|580985507|FG001|Treated|Withdrawal by Subject|2|||
160888355|NCT01401959|580985508|FG002|Treated|Withdrawal by Subject|2|||
160888356|NCT01401959|580985506|FG000|Treated|Protocol Violation|0|||
160888357|NCT01401959|580985507|FG001|Treated|Protocol Violation|1|||
160888358|NCT01401959|580985508|FG002|Treated|Protocol Violation|0|||
160888359|NCT00400153|580985513|FG000|Overall Study|AE due to study disease worsening|14|||
160888360|NCT00400153|580985514|FG001|Overall Study|AE due to study disease worsening|19|||
160888361|NCT00400153|580985515|FG002|Overall Study|AE due to study disease worsening|20|||
160888362|NCT00400153|580985513|FG000|Overall Study|AE due to other disease worsening|2|||
160888363|NCT00400153|580985514|FG001|Overall Study|AE due to other disease worsening|1|||
160888364|NCT00400153|580985515|FG002|Overall Study|AE due to other disease worsening|0|||
160888365|NCT00400153|580985513|FG000|Overall Study|AE due to other condition|3|||
160888366|NCT00400153|580985514|FG001|Overall Study|AE due to other condition|14|||
160888367|NCT00400153|580985515|FG002|Overall Study|AE due to other condition|15|||
160888368|NCT00400153|580985513|FG000|Overall Study|Protocol Violation|7|||
160888369|NCT00400153|580985514|FG001|Overall Study|Protocol Violation|4|||
160888370|NCT00400153|580985515|FG002|Overall Study|Protocol Violation|9|||
160888371|NCT00400153|580985513|FG000|Overall Study|Lost to Follow-up|2|||
160888372|NCT00400153|580985514|FG001|Overall Study|Lost to Follow-up|1|||
160888373|NCT00400153|580985515|FG002|Overall Study|Lost to Follow-up|4|||
160888374|NCT00400153|580985513|FG000|Overall Study|Withdrawal by Subject|12|||
160888375|NCT00400153|580985514|FG001|Overall Study|Withdrawal by Subject|11|||
160888376|NCT00400153|580985515|FG002|Overall Study|Withdrawal by Subject|10|||
160888377|NCT00400153|580985513|FG000|Overall Study|Other reasons - not mentioned above|8|||
160888378|NCT00400153|580985514|FG001|Overall Study|Other reasons - not mentioned above|5|||
160888379|NCT00400153|580985515|FG002|Overall Study|Other reasons - not mentioned above|3|||
160888380|NCT01423604|580985517|FG000|Safety Run-In|Adverse Event|3|||
160888381|NCT01423604|580985518|FG001|Safety Run-In|Adverse Event|0|||
160888382|NCT01423604|580985517|FG000|Safety Run-In|Death|1|||
160888383|NCT01423604|580985518|FG001|Safety Run-In|Death|0|||
160888384|NCT01423604|580985517|FG000|Safety Run-In|Physician Decision|1|||
160888385|NCT01423604|580985518|FG001|Safety Run-In|Physician Decision|0|||
160888386|NCT01423604|580985517|FG000|Safety Run-In|Disease progression|3|||
160888387|NCT01423604|580985518|FG001|Safety Run-In|Disease progression|0|||
160888388|NCT01423604|580985517|FG000|Safety Run-In|Patient decision|1|||
160888389|NCT01423604|580985518|FG001|Safety Run-In|Patient decision|0|||
160888390|NCT01423604|580985517|FG000|Randomized|Adverse Event|4|||
160888391|NCT01423604|580985518|FG001|Randomized|Adverse Event|10|||
160638383|NCT01493531|580059268|FG000|Overall Study|Protocol Violation|8|||
160638384|NCT01493531|580059269|FG001|Overall Study|Protocol Violation|15|||
160542092|NCT00845650|579712916|FG002|Overall Study|Unable to access IV line|0|||
160542093|NCT00845650|579712917|FG003|Overall Study|Unable to access IV line|0|||
160888392|NCT01423604|580985517|FG000|Randomized|Death|1|||
160888393|NCT01423604|580985518|FG001|Randomized|Death|0|||
160888394|NCT01423604|580985517|FG000|Randomized|Physician Decision|16|||
160888395|NCT01423604|580985518|FG001|Randomized|Physician Decision|13|||
160888396|NCT01423604|580985517|FG000|Randomized|Other - unspecified|37|||
160780537|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
160780538|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
160780539|NCT06132386|580579814|FG000|Overall Study|ineligble laboratory|1|||
160780540|NCT06132386|580579815|FG001|Overall Study|ineligble laboratory|0|||
160780541|NCT06132386|580579816|FG002|Overall Study|ineligble laboratory|0|||
160780542|NCT06132386|580579817|FG003|Overall Study|ineligble laboratory|0|||
160780543|NCT06132386|580579818|FG004|Overall Study|ineligble laboratory|1|||
160780544|NCT06132386|580579819|FG005|Overall Study|ineligble laboratory|0|||
160780545|NCT06132386|580579814|FG000|Overall Study|ineligible vital signs|0|||
160780546|NCT06132386|580579815|FG001|Overall Study|ineligible vital signs|1|||
160780547|NCT06132386|580579816|FG002|Overall Study|ineligible vital signs|0|||
160780548|NCT06132386|580579817|FG003|Overall Study|ineligible vital signs|0|||
160780549|NCT06132386|580579818|FG004|Overall Study|ineligible vital signs|0|||
160780550|NCT06132386|580579819|FG005|Overall Study|ineligible vital signs|0|||
160780551|NCT02762604|580579820|FG000|Overall Study|Lost to Follow-up|2|||
160780552|NCT02762604|580579821|FG001|Overall Study|Lost to Follow-up|7|||
160780553|NCT02762604|580579820|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
160780554|NCT02762604|580579821|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
160780555|NCT04530526|580579824|FG000|Overall Study|Withdrawal by Subject|6|||
160780556|NCT05179603|580579825|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
160780557|NCT05179603|580579825|FG000|Overall Study|Withdrawal by Subject|1|||
160780558|NCT05179603|580579825|FG000|Overall Study|Progressive disease|4|||
160780559|NCT05179603|580579825|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
160888397|NCT01423604|580985518|FG001|Randomized|Other - unspecified|31|||
160888398|NCT01423604|580985517|FG000|Randomized|Patient decision|5|||
160888399|NCT01423604|580985518|FG001|Randomized|Patient decision|9|||
160888400|NCT02414139|580985521|FG000|Treatment Period|Adverse Event|11|||
160888401|NCT02414139|580985522|FG001|Treatment Period|Adverse Event|6|||
160888402|NCT02414139|580985523|FG002|Treatment Period|Adverse Event|8|||
160888403|NCT02414139|580985524|FG003|Treatment Period|Adverse Event|5|||
160888404|NCT02414139|580985525|FG004|Treatment Period|Adverse Event|14|||
160888405|NCT02414139|580985526|FG005|Treatment Period|Adverse Event|3|||
160888406|NCT02414139|580985527|FG006|Treatment Period|Adverse Event|6|||
160888407|NCT02414139|580985528|FG007|Treatment Period|Adverse Event|1|||
160888408|NCT02414139|580985529|FG008|Treatment Period|Adverse Event|6|||
160888409|NCT02414139|580985530|FG009|Treatment Period|Adverse Event|8|||
160888410|NCT02414139|580985521|FG000|Treatment Period|Death|0|||
160888411|NCT02414139|580985522|FG001|Treatment Period|Death|0|||
160888412|NCT02414139|580985523|FG002|Treatment Period|Death|1|||
160888413|NCT02414139|580985524|FG003|Treatment Period|Death|1|||
160888414|NCT02414139|580985525|FG004|Treatment Period|Death|0|||
160888415|NCT02414139|580985526|FG005|Treatment Period|Death|0|||
160888416|NCT02414139|580985527|FG006|Treatment Period|Death|0|||
160888417|NCT02414139|580985528|FG007|Treatment Period|Death|0|||
160888418|NCT02414139|580985529|FG008|Treatment Period|Death|0|||
160888419|NCT02414139|580985530|FG009|Treatment Period|Death|1|||
160888420|NCT02414139|580985521|FG000|Treatment Period|Physician Decision|5|||
160888421|NCT02414139|580985522|FG001|Treatment Period|Physician Decision|4|||
160638385|NCT01493531|580059270|FG002|Overall Study|Protocol Violation|12|||
160638386|NCT01493531|580059268|FG000|Overall Study|Sponsor terminated study|5|||
160638387|NCT01493531|580059269|FG001|Overall Study|Sponsor terminated study|2|||
160638388|NCT01493531|580059270|FG002|Overall Study|Sponsor terminated study|3|||
160638389|NCT01493531|580059268|FG000|Overall Study|Lost to Follow-up|5|||
160638390|NCT01493531|580059269|FG001|Overall Study|Lost to Follow-up|7|||
160638391|NCT01493531|580059270|FG002|Overall Study|Lost to Follow-up|11|||
160638392|NCT01493531|580059268|FG000|Overall Study|Withdrawal by Subject|16|||
160638393|NCT01493531|580059269|FG001|Overall Study|Withdrawal by Subject|13|||
160638394|NCT01493531|580059270|FG002|Overall Study|Withdrawal by Subject|11|||
160638395|NCT01493531|580059268|FG000|Overall Study|Death|0|||
160638396|NCT01493531|580059269|FG001|Overall Study|Death|1|||
160638397|NCT01493531|580059270|FG002|Overall Study|Death|0|||
160638398|NCT03835975|580059275|FG000|Overall Study|Lost to Follow-up|1|||
160638399|NCT03835975|580059276|FG001|Overall Study|Lost to Follow-up|1|||
160780560|NCT06061952|580579827|FG000|Overall Study|Withdrawal by Subject|1|||
160780561|NCT06061952|580579828|FG001|Overall Study|Withdrawal by Subject|2|||
160780562|NCT06061952|580579827|FG000|Overall Study|Lost to Follow-up|2|||
160780563|NCT06061952|580579828|FG001|Overall Study|Lost to Follow-up|2|||
160780564|NCT01405911|580579829|FG000|Overall Study|Pre-treatment lab AE|0|||
160888422|NCT02414139|580985523|FG002|Treatment Period|Physician Decision|6|||
160888423|NCT02414139|580985524|FG003|Treatment Period|Physician Decision|1|||
160888424|NCT02414139|580985525|FG004|Treatment Period|Physician Decision|4|||
160888425|NCT02414139|580985526|FG005|Treatment Period|Physician Decision|0|||
160888426|NCT02414139|580985527|FG006|Treatment Period|Physician Decision|2|||
160888427|NCT02414139|580985528|FG007|Treatment Period|Physician Decision|0|||
160888428|NCT02414139|580985529|FG008|Treatment Period|Physician Decision|1|||
160888429|NCT02414139|580985530|FG009|Treatment Period|Physician Decision|4|||
160888430|NCT02414139|580985521|FG000|Treatment Period|Progressive disease|48|||
160888431|NCT02414139|580985522|FG001|Treatment Period|Progressive disease|31|||
160780565|NCT01405911|580579830|FG001|Overall Study|Pre-treatment lab AE|1|||
160780566|NCT01405911|580579831|FG002|Overall Study|Pre-treatment lab AE|0|||
160780567|NCT01405911|580579829|FG000|Overall Study|Lost to Follow-up|0|||
160780568|NCT01405911|580579830|FG001|Overall Study|Lost to Follow-up|1|||
160780569|NCT01405911|580579831|FG002|Overall Study|Lost to Follow-up|0|||
160780570|NCT01405911|580579829|FG000|Overall Study|Protocol Violation|1|||
160780571|NCT01405911|580579830|FG001|Overall Study|Protocol Violation|0|||
160780572|NCT01405911|580579831|FG002|Overall Study|Protocol Violation|0|||
160780573|NCT01405911|580579829|FG000|Overall Study|Withdrawal by Subject|3|||
160780574|NCT01405911|580579830|FG001|Overall Study|Withdrawal by Subject|1|||
160780575|NCT01405911|580579831|FG002|Overall Study|Withdrawal by Subject|1|||
160780576|NCT06375655|580579832|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
160780577|NCT06375655|580579833|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
160780578|NCT01685437|580579836|FG000|Overall Study|Withdrawal by Subject|22|||
160780579|NCT01685437|580579836|FG000|Overall Study|Lost to Follow-up|3|||
160780580|NCT01685437|580579836|FG000|Overall Study|Adverse Event|1|||
160780581|NCT01685437|580579836|FG000|Overall Study|Protocol Violation|4|||
160780582|NCT01685437|580579836|FG000|Overall Study|Unable to make visits due to work|1|||
160780583|NCT00134719|580580653|FG000|Primary Vaccination Phase|Adverse Event|4|||
160888432|NCT02414139|580985523|FG002|Treatment Period|Progressive disease|37|||
160888433|NCT02414139|580985524|FG003|Treatment Period|Progressive disease|21|||
160888434|NCT02414139|580985525|FG004|Treatment Period|Progressive disease|43|||
160888435|NCT02414139|580985526|FG005|Treatment Period|Progressive disease|12|||
160888436|NCT02414139|580985527|FG006|Treatment Period|Progressive disease|16|||
160888437|NCT02414139|580985528|FG007|Treatment Period|Progressive disease|2|||
160888438|NCT02414139|580985529|FG008|Treatment Period|Progressive disease|20|||
160888439|NCT02414139|580985530|FG009|Treatment Period|Progressive disease|14|||
160888440|NCT02414139|580985521|FG000|Treatment Period|Protocol deviation|0|||
160888441|NCT02414139|580985522|FG001|Treatment Period|Protocol deviation|0|||
160888442|NCT02414139|580985523|FG002|Treatment Period|Protocol deviation|1|||
160888443|NCT02414139|580985524|FG003|Treatment Period|Protocol deviation|0|||
160780584|NCT00134719|580580654|FG001|Primary Vaccination Phase|Adverse Event|0|||
160780585|NCT00134719|580580655|FG002|Primary Vaccination Phase|Adverse Event|0|||
160780586|NCT00134719|580580653|FG000|Primary Vaccination Phase|Protocol Violation|1|||
160780587|NCT00134719|580580654|FG001|Primary Vaccination Phase|Protocol Violation|0|||
160780588|NCT00134719|580580655|FG002|Primary Vaccination Phase|Protocol Violation|0|||
160780589|NCT00134719|580580653|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
160780590|NCT00134719|580580654|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
160780591|NCT00134719|580580655|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
160780592|NCT00134719|580580653|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
160888444|NCT02414139|580985525|FG004|Treatment Period|Protocol deviation|0|||
160888445|NCT02414139|580985526|FG005|Treatment Period|Protocol deviation|0|||
160888446|NCT02414139|580985527|FG006|Treatment Period|Protocol deviation|0|||
160888447|NCT02414139|580985528|FG007|Treatment Period|Protocol deviation|0|||
160888448|NCT02414139|580985529|FG008|Treatment Period|Protocol deviation|0|||
160888449|NCT02414139|580985530|FG009|Treatment Period|Protocol deviation|0|||
160888450|NCT02414139|580985521|FG000|Treatment Period|Subject/Guardian decision|5|||
160888451|NCT02414139|580985522|FG001|Treatment Period|Subject/Guardian decision|1|||
160888452|NCT02414139|580985523|FG002|Treatment Period|Subject/Guardian decision|1|||
160888453|NCT02414139|580985524|FG003|Treatment Period|Subject/Guardian decision|2|||
160888454|NCT02414139|580985525|FG004|Treatment Period|Subject/Guardian decision|5|||
160888455|NCT02414139|580985526|FG005|Treatment Period|Subject/Guardian decision|0|||
160888456|NCT02414139|580985527|FG006|Treatment Period|Subject/Guardian decision|2|||
160888457|NCT02414139|580985528|FG007|Treatment Period|Subject/Guardian decision|0|||
160888458|NCT02414139|580985529|FG008|Treatment Period|Subject/Guardian decision|1|||
160888459|NCT02414139|580985530|FG009|Treatment Period|Subject/Guardian decision|1|||
160888460|NCT02414139|580985521|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160638400|NCT03835975|580059277|FG002|Overall Study|Lost to Follow-up|0|||
160638401|NCT03835975|580059278|FG003|Overall Study|Lost to Follow-up|0|||
160888461|NCT02414139|580985522|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160888462|NCT02414139|580985523|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160888463|NCT02414139|580985524|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160888464|NCT02414139|580985525|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
160638402|NCT03835975|580059279|FG004|Overall Study|Lost to Follow-up|0|||
160780593|NCT00134719|580580654|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
160780594|NCT00134719|580580655|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
160888465|NCT02414139|580985526|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160888466|NCT02414139|580985527|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
160780595|NCT00134719|580580653|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
160780596|NCT00134719|580580654|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
160780597|NCT00134719|580580655|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
160780598|NCT00134719|580580653|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
160888467|NCT02414139|580985528|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160888468|NCT02414139|580985529|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
160888469|NCT02414139|580985530|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
160888470|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
160888471|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888472|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888473|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888474|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
160888475|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888476|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888477|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888478|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888479|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888480|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Death|0|||
160888481|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Death|1|||
160888482|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Death|0|||
160888483|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Death|0|||
160638403|NCT03835975|580059275|FG000|Overall Study|No longer met eligibility criteria|0|||
160638404|NCT03835975|580059276|FG001|Overall Study|No longer met eligibility criteria|1|||
160638405|NCT03835975|580059277|FG002|Overall Study|No longer met eligibility criteria|0|||
160638406|NCT03835975|580059278|FG003|Overall Study|No longer met eligibility criteria|0|||
160638407|NCT03835975|580059279|FG004|Overall Study|No longer met eligibility criteria|0|||
160638408|NCT03835975|580059275|FG000|Overall Study|Protocol Violation|1|||
160638409|NCT03835975|580059276|FG001|Overall Study|Protocol Violation|1|||
160638410|NCT03835975|580059277|FG002|Overall Study|Protocol Violation|2|||
160638411|NCT03835975|580059278|FG003|Overall Study|Protocol Violation|0|||
160638412|NCT03835975|580059279|FG004|Overall Study|Protocol Violation|0|||
160638413|NCT03835975|580059275|FG000|Overall Study|Withdrawal by Subject|1|||
160638414|NCT03835975|580059276|FG001|Overall Study|Withdrawal by Subject|0|||
160638415|NCT03835975|580059277|FG002|Overall Study|Withdrawal by Subject|1|||
160638416|NCT03835975|580059278|FG003|Overall Study|Withdrawal by Subject|1|||
160638417|NCT03835975|580059279|FG004|Overall Study|Withdrawal by Subject|0|||
160638418|NCT03031431|580059280|FG000|Overall Study|Infant removed by maternal request|1|||
160638419|NCT01612702|580059281|FG000|Overall Study|Protocol Violation|11|||
160638420|NCT01612702|580059282|FG001|Overall Study|Protocol Violation|11|||
160638421|NCT03070431|580059283|FG000|Overall Study|Withdrawal by Subject|2|||
160638422|NCT03070431|580059283|FG000|Overall Study|Lost to Follow-up|2|||
160638423|NCT00995488|580059286|FG000|Overall Study|Withdrawal by Subject|1|||
160638424|NCT01656967|580059287|FG000|Overall Study|faulty monitor|1|||
160638425|NCT01656967|580059288|FG001|Overall Study|faulty monitor|0|||
160638426|NCT01656967|580059287|FG000|Overall Study|unsuccessful ETT insertion|3|||
160638427|NCT01656967|580059288|FG001|Overall Study|unsuccessful ETT insertion|2|||
160638428|NCT00051636|580059289|FG000|Period 1 - Core|Adverse Event|2|||
160638429|NCT00051636|580059290|FG001|Period 1 - Core|Adverse Event|2|||
160638430|NCT00051636|580059289|FG000|Period 1 - Core|Protocol Violation|1|||
160638431|NCT00051636|580059290|FG001|Period 1 - Core|Protocol Violation|0|||
160638432|NCT00051636|580059289|FG000|Period 1 - Core|Withdrawal by Subject|1|||
160638433|NCT00051636|580059290|FG001|Period 1 - Core|Withdrawal by Subject|2|||
160638434|NCT00051636|580059289|FG000|Period 1 - Core|Lost to Follow-up|0|||
160638435|NCT00051636|580059290|FG001|Period 1 - Core|Lost to Follow-up|2|||
160638436|NCT00051636|580059289|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
160638437|NCT00051636|580059290|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
160638438|NCT00051636|580059289|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
160638439|NCT00051636|580059290|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
160638440|NCT00051636|580059289|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
160638441|NCT00051636|580059290|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
160638442|NCT00051636|580059289|FG000|Period 2- Extended Observation Period|Death|4|||
160638443|NCT00051636|580059290|FG001|Period 2- Extended Observation Period|Death|5|||
160638444|NCT00051636|580059289|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
160638445|NCT00051636|580059290|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
160638446|NCT01174368|580059291|FG000|Overall Study|Withdrawal by Subject|1|||
160638447|NCT02340078|580059295|FG000|Overall Study|Protocol Violation|1|||
160888484|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Death|1|||
160888485|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Death|0|||
160888486|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Death|0|||
160888487|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Death|0|||
160888488|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Death|0|||
160638448|NCT03724916|580060640|FG000|Overall Study|Withdrawal by Subject|0|||
160638449|NCT03724916|580060641|FG001|Overall Study|Withdrawal by Subject|1|||
160638450|NCT03724916|580060642|FG002|Overall Study|Withdrawal by Subject|1|||
160638451|NCT03724916|580060643|FG003|Overall Study|Withdrawal by Subject|2|||
160638452|NCT03724916|580060640|FG000|Overall Study|Randomized but not Treated|1|||
160888489|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Death|1|||
160888490|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
160888491|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888492|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888493|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888494|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888495|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888496|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888497|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160780599|NCT00134719|580580654|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
160780600|NCT00134719|580580655|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
160780601|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
160780602|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
160780603|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
160780604|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
160780605|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
160780606|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
160780607|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
160780608|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
160780609|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
160780610|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
160780611|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
160780612|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
160780613|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
160780614|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
160780615|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780616|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780617|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
160780618|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780619|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780620|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780621|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780622|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
160780623|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780624|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780625|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780626|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780627|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780628|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780629|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780630|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780631|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
160780632|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780633|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780634|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780635|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780636|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
160780637|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780638|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780639|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780640|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780641|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780642|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780643|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
160780644|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
160638453|NCT03724916|580060641|FG001|Overall Study|Randomized but not Treated|0|||
160638454|NCT03724916|580060642|FG002|Overall Study|Randomized but not Treated|0|||
160638455|NCT03724916|580060643|FG003|Overall Study|Randomized but not Treated|0|||
160638456|NCT04335110|580060646|FG000|Overall Study|Withdrawal by Subject|1|||
160638457|NCT04335110|580060647|FG001|Overall Study|Withdrawal by Subject|1|||
160888498|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160780645|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
160780646|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
160780647|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
160780648|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
160638458|NCT04335110|580060646|FG000|Overall Study|Death|0|||
160638459|NCT04335110|580060647|FG001|Overall Study|Death|1|||
160638460|NCT04388527|580060650|FG000|Overall Study|Death|14|||
160780649|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
160780650|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780651|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780652|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780653|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
160780654|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780655|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780656|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780657|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
160780658|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780659|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780660|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780661|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780662|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780663|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780664|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780665|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
160780666|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780667|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780668|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780669|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780670|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780671|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
160780672|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
160780673|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
160780674|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
160780675|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
160780676|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
160780677|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
160780678|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
160780679|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
160780680|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
160780681|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
160780682|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
160780683|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
160780684|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
160780685|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
160780686|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
160780687|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
160780688|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
160780689|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
160780690|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
160780691|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
160780692|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
160780693|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
160780694|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
160780695|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
160780696|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
160780697|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
160780698|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
160780699|NCT01807520|580580656|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160780700|NCT01807520|580580657|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160780701|NCT01807520|580580658|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160780702|NCT01807520|580580659|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160780703|NCT01807520|580580660|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160780704|NCT01807520|580580661|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
160780705|NCT01807520|580580662|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160888499|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888500|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
160888501|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
160542094|NCT00845650|579712918|FG004|Overall Study|Unable to access IV line|0|||
160780706|NCT01807520|580580656|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160780707|NCT01807520|580580657|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160780708|NCT01807520|580580658|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160542095|NCT00845650|579712919|FG005|Overall Study|Unable to access IV line|0|||
160542096|NCT00814892|579712920|FG000|Overall Study|Disease Progression|1|||
160780709|NCT01807520|580580659|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160780710|NCT01807520|580580660|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160780711|NCT01807520|580580661|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
160780712|NCT01807520|580580662|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160780713|NCT01807520|580580656|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
160780714|NCT01807520|580580657|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
160780715|NCT01807520|580580658|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
160780716|NCT01807520|580580659|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
160780717|NCT01807520|580580660|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
160780718|NCT01807520|580580661|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
160780719|NCT01807520|580580662|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
160780720|NCT03600350|580580665|FG000|Overall Study|Death|1|||
160780721|NCT03600350|580580665|FG000|Overall Study|On Follow Up|18|||
160780722|NCT02400736|580580668|FG000|Overall Study|Lost to Follow-up|6|||
160780723|NCT02400736|580580669|FG001|Overall Study|Lost to Follow-up|6|||
160780724|NCT02400736|580580668|FG000|Overall Study|Withdrawal by Subject|2|||
160780725|NCT02400736|580580669|FG001|Overall Study|Withdrawal by Subject|1|||
160780726|NCT02400736|580580668|FG000|Overall Study|Moved from the area|3|||
160780727|NCT02400736|580580669|FG001|Overall Study|Moved from the area|1|||
160780728|NCT01002105|580580670|FG000|Overall Study|Lost to Follow-up|10|||
160780729|NCT01002105|580580671|FG001|Overall Study|Lost to Follow-up|16|||
160780730|NCT01002105|580580670|FG000|Overall Study|non compliance|5|||
160780731|NCT01002105|580580671|FG001|Overall Study|non compliance|3|||
160780732|NCT01002105|580580670|FG000|Overall Study|condition worsened|4|||
160780733|NCT01002105|580580671|FG001|Overall Study|condition worsened|2|||
160780734|NCT00552058|580580672|FG000|Overall Study|Adverse Event|8|||
160780735|NCT00552058|580580673|FG001|Overall Study|Adverse Event|7|||
160780736|NCT00552058|580580672|FG000|Overall Study|Lack of Efficacy|1|||
160780737|NCT00552058|580580673|FG001|Overall Study|Lack of Efficacy|5|||
160780738|NCT00552058|580580672|FG000|Overall Study|Lost to Follow-up|1|||
160780739|NCT00552058|580580673|FG001|Overall Study|Lost to Follow-up|0|||
160780740|NCT00552058|580580672|FG000|Overall Study|Withdrawal by Subject|4|||
160780741|NCT00552058|580580673|FG001|Overall Study|Withdrawal by Subject|4|||
160780742|NCT00552058|580580672|FG000|Overall Study|Other: Protocol Violation|0|||
160780743|NCT00552058|580580673|FG001|Overall Study|Other: Protocol Violation|1|||
160780744|NCT00552058|580580672|FG000|Overall Study|Other: Non Compliance|1|||
160780745|NCT00552058|580580673|FG001|Overall Study|Other: Non Compliance|2|||
160780746|NCT00552058|580580672|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
160780747|NCT00552058|580580673|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
160780748|NCT00552058|580580672|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
160780749|NCT00552058|580580673|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
160780750|NCT00552058|580580672|FG000|Overall Study|Other: Positive Stool Result|0|||
160780751|NCT00552058|580580673|FG001|Overall Study|Other: Positive Stool Result|1|||
160780752|NCT00552058|580580672|FG000|Overall Study|Other: Randomized in error|0|||
160780753|NCT00552058|580580673|FG001|Overall Study|Other: Randomized in error|1|||
160780754|NCT00552058|580580672|FG000|Overall Study|Other: Sponsors Decision|0|||
160780755|NCT00552058|580580673|FG001|Overall Study|Other: Sponsors Decision|1|||
160780756|NCT00552058|580580672|FG000|Overall Study|Other: Early Roll Over|1|||
160780757|NCT00552058|580580673|FG001|Overall Study|Other: Early Roll Over|0|||
160780758|NCT04621760|580580674|FG000|Overall Study|Lost to Follow-up|2|||
160780759|NCT04621760|580580675|FG001|Overall Study|Lost to Follow-up|4|||
160780760|NCT04621760|580580674|FG000|Overall Study|Withdrawal by Subject|1|||
160780761|NCT04621760|580580675|FG001|Overall Study|Withdrawal by Subject|0|||
160780762|NCT02965716|580580676|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
160780763|NCT02965716|580580677|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
160780764|NCT02965716|580580676|FG000|Overall Study|Progression/Relapse|8|||
160780765|NCT02965716|580580677|FG001|Overall Study|Progression/Relapse|16|||
160780766|NCT02965716|580580676|FG000|Overall Study|Death|1|||
160780767|NCT02965716|580580677|FG001|Overall Study|Death|0|||
160780768|NCT02965716|580580676|FG000|Overall Study|Not Protocol Specified|1|||
160780769|NCT02965716|580580677|FG001|Overall Study|Not Protocol Specified|3|||
160780770|NCT05141357|580580678|FG000|Overall Study|Adverse Event|3|||
160780771|NCT05141357|580580678|FG000|Overall Study|Lack of Efficacy|2|||
160780772|NCT01336972|580580679|FG000|Overall Study|Adverse Event|1|||
160780773|NCT01336972|580580680|FG001|Overall Study|Adverse Event|1|||
160780774|NCT01336972|580580681|FG002|Overall Study|Adverse Event|0|||
160542097|NCT00814892|579712920|FG000|Overall Study|Study Termination|1|||
160780775|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
160780776|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
160780777|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
160780778|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
160780779|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
160780780|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
160780781|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
160780782|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
160780783|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
160780784|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
160780785|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
160780786|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
160780787|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
160780788|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
160780789|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
160780790|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
160780791|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
160780792|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
160780793|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
160780794|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
160780795|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
160780796|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
160780797|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
160780798|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
160780799|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
160780800|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
160780801|NCT02639559|580580688|FG000|Overall Study|Mobilization failure|0|||
160780802|NCT02639559|580580689|FG001|Overall Study|Mobilization failure|3|||
160780803|NCT02639559|580580688|FG000|Overall Study|Issues with vascular acess|1|||
160780804|NCT02639559|580580689|FG001|Overall Study|Issues with vascular acess|0|||
160780805|NCT04740567|580580690|FG000|Overall Study|Death|31|||
160780806|NCT04740567|580580691|FG001|Overall Study|Death|43|||
160780807|NCT04740567|580580690|FG000|Overall Study|Lost to Follow-up|2|||
160780808|NCT04740567|580580691|FG001|Overall Study|Lost to Follow-up|11|||
160780809|NCT04740567|580580690|FG000|Overall Study|Patient declined to participate|13|||
160780810|NCT04740567|580580691|FG001|Overall Study|Patient declined to participate|26|||
160780811|NCT04740567|580580690|FG000|Overall Study|Patient was physically incapable|1|||
160780812|NCT04740567|580580691|FG001|Overall Study|Patient was physically incapable|3|||
160780813|NCT04740567|580580690|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
160780814|NCT04740567|580580691|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
160780815|NCT04828486|580580692|FG000|Overall Study|Adverse Event|2|||
160780816|NCT04828486|580580692|FG000|Overall Study|Death|1|||
160780817|NCT04828486|580580692|FG000|Overall Study|Disease Progression|8|||
160780818|NCT04828486|580580692|FG000|Overall Study|Other Complicating Disease|1|||
160780819|NCT04828486|580580692|FG000|Overall Study|Withdrawal by Subject|1|||
160780820|NCT03325439|580580693|FG000|Overall Study|Ineligibility|3|||
160780821|NCT06204887|580580694|FG000|Overall Study|Lost to Follow-up|3|||
160780822|NCT06204887|580580695|FG001|Overall Study|Lost to Follow-up|4|||
160780823|NCT06204887|580580696|FG002|Overall Study|Lost to Follow-up|1|||
160780824|NCT06204887|580580697|FG003|Overall Study|Lost to Follow-up|6|||
160780825|NCT02315625|580580698|FG000|First Intervention|Disease Progression|1|||
160780826|NCT02315625|580580699|FG001|First Intervention|Disease Progression|0|||
160780827|NCT02315625|580580698|FG000|Second Intervention|Physician Decision|2|||
160780828|NCT02315625|580580699|FG001|Second Intervention|Physician Decision|1|||
160780829|NCT02315625|580580698|FG000|Second Intervention|Study closure|1|||
160780830|NCT02315625|580580699|FG001|Second Intervention|Study closure|0|||
160780831|NCT02315625|580580698|FG000|Second Intervention|Disease Progression|1|||
160780832|NCT02315625|580580699|FG001|Second Intervention|Disease Progression|0|||
160780833|NCT03833167|580580700|FG000|Overall Study|Withdrawal by Subject|4|||
160780834|NCT03833167|580580701|FG001|Overall Study|Withdrawal by Subject|6|||
160780835|NCT03833167|580580700|FG000|Overall Study|Ongoing|186|||
160780836|NCT03833167|580580701|FG001|Overall Study|Ongoing|194|||
160780837|NCT03833167|580580700|FG000|Overall Study|Lost to Follow-up|1|||
160780838|NCT03833167|580580701|FG001|Overall Study|Lost to Follow-up|1|||
160780839|NCT03833167|580580700|FG000|Overall Study|Physician Decision|0|||
160780840|NCT03833167|580580701|FG001|Overall Study|Physician Decision|2|||
160780841|NCT03833167|580580700|FG000|Overall Study|Death|34|||
160780842|NCT03833167|580580701|FG001|Overall Study|Death|22|||
160780843|NCT01039675|580580703|FG000|Overall Study|Adverse Event|0|||
160780844|NCT01039675|580580704|FG001|Overall Study|Adverse Event|2|||
160780845|NCT01039675|580580703|FG000|Overall Study|Lack of Efficacy|0|||
160780846|NCT01039675|580580704|FG001|Overall Study|Lack of Efficacy|2|||
160780847|NCT01039675|580580703|FG000|Overall Study|Withdrawal by Subject|0|||
160780848|NCT01039675|580580704|FG001|Overall Study|Withdrawal by Subject|1|||
160780849|NCT01039675|580580703|FG000|Overall Study|Lost to Follow-up|0|||
160780850|NCT01039675|580580704|FG001|Overall Study|Lost to Follow-up|1|||
160780851|NCT01039675|580580703|FG000|Overall Study|Physician Decision|0|||
160780852|NCT01039675|580580704|FG001|Overall Study|Physician Decision|1|||
160780853|NCT06991803|580580707|FG000|Overall Study|Lost to Follow-up|0|||
160780854|NCT06991803|580580708|FG001|Overall Study|Lost to Follow-up|4|||
160780855|NCT06991803|580580709|FG002|Overall Study|Lost to Follow-up|0|||
160780856|NCT06991803|580580710|FG003|Overall Study|Lost to Follow-up|3|||
160780857|NCT06991803|580580711|FG004|Overall Study|Lost to Follow-up|2|||
160780858|NCT06991803|580580712|FG005|Overall Study|Lost to Follow-up|5|||
160780859|NCT03514017|580580715|FG000|Overall Study|Death|1|||
160780860|NCT03514017|580580715|FG000|Overall Study|Adverse Event|1|||
160780861|NCT06394323|580580716|FG000|Overall Study|Death|0|||
160780862|NCT06394323|580580717|FG001|Overall Study|Death|1|||
160780863|NCT06394323|580580718|FG002|Overall Study|Death|0|||
160780864|NCT06394323|580580719|FG003|Overall Study|Death|0|||
160780865|NCT06394323|580580716|FG000|Overall Study|Physician Decision|0|||
160780866|NCT06394323|580580717|FG001|Overall Study|Physician Decision|2|||
160780867|NCT06394323|580580718|FG002|Overall Study|Physician Decision|0|||
160780868|NCT06394323|580580719|FG003|Overall Study|Physician Decision|0|||
160780869|NCT06394323|580580716|FG000|Overall Study|Withdrawal by Subject|4|||
160780870|NCT06394323|580580717|FG001|Overall Study|Withdrawal by Subject|4|||
160780871|NCT06394323|580580718|FG002|Overall Study|Withdrawal by Subject|0|||
160780872|NCT06394323|580580719|FG003|Overall Study|Withdrawal by Subject|0|||
160780873|NCT00567580|580581530|FG000|Overall Study|Protocol Violation|28|||
160780874|NCT00567580|580581531|FG001|Overall Study|Protocol Violation|24|||
160780875|NCT00567580|580581532|FG002|Overall Study|Protocol Violation|24|||
160780876|NCT05788328|580581535|FG000|Treatment Period 4 (5 Days)|Other|1|||
160780877|NCT05788328|580581535|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
160780878|NCT00422461|580581536|FG000|Overall Study|Adverse Event|1|||
160780879|NCT00422461|580581537|FG001|Overall Study|Adverse Event|2|||
160780880|NCT00422461|580581538|FG002|Overall Study|Adverse Event|1|||
160780881|NCT00422461|580581539|FG003|Overall Study|Adverse Event|1|||
160780882|NCT00422461|580581536|FG000|Overall Study|Other|0|||
160780883|NCT00422461|580581537|FG001|Overall Study|Other|0|||
160780884|NCT00422461|580581538|FG002|Overall Study|Other|0|||
160780885|NCT00422461|580581539|FG003|Overall Study|Other|2|||
160780886|NCT00422461|580581536|FG000|Overall Study|Participants no longer willing to participate in study|1|||
160780887|NCT00422461|580581537|FG001|Overall Study|Participants no longer willing to participate in study|0|||
160780888|NCT00422461|580581538|FG002|Overall Study|Participants no longer willing to participate in study|0|||
160780889|NCT00422461|580581539|FG003|Overall Study|Participants no longer willing to participate in study|0|||
160780890|NCT00422461|580581536|FG000|Overall Study|Randomized but not treated|1|||
160780891|NCT00422461|580581537|FG001|Overall Study|Randomized but not treated|1|||
160780892|NCT00422461|580581538|FG002|Overall Study|Randomized but not treated|0|||
160780893|NCT00422461|580581539|FG003|Overall Study|Randomized but not treated|0|||
160780894|NCT02181621|580581541|FG000|Overall Study|Adverse Event|1|||
160780895|NCT02181621|580581542|FG001|Overall Study|Adverse Event|0|||
160780896|NCT02181621|580581541|FG000|Overall Study|Previously Enrolled|0|||
160780897|NCT02181621|580581542|FG001|Overall Study|Previously Enrolled|1|||
160780898|NCT02181621|580581541|FG000|Overall Study|Enrollment Hold|1|||
160780899|NCT02181621|580581542|FG001|Overall Study|Enrollment Hold|1|||
160780900|NCT00145327|580581543|FG000|Overall Study|Withdrawal by Subject|77|||
160638461|NCT04388527|580060650|FG000|Overall Study|Withdrawal by Subject|2|||
160638462|NCT04388527|580060650|FG000|Overall Study|Lost to Follow-up|1|||
160638463|NCT03333382|580060651|FG000|Overall Study|Lost to Follow-up|1|||
160638464|NCT03333382|580060652|FG001|Overall Study|Lost to Follow-up|0|||
160780901|NCT00145327|580581544|FG001|Overall Study|Withdrawal by Subject|72|||
160780902|NCT00145327|580581545|FG002|Overall Study|Withdrawal by Subject|164|||
160780903|NCT00145327|580581543|FG000|Overall Study|Death|26|||
160780904|NCT00145327|580581544|FG001|Overall Study|Death|18|||
160780905|NCT00145327|580581545|FG002|Overall Study|Death|30|||
160780906|NCT00145327|580581543|FG000|Overall Study|Adverse Event|14|||
160638465|NCT03471182|580060653|FG000|Overall Study|Withdrawal by Subject|1|||
160638466|NCT03471182|580060654|FG001|Overall Study|Withdrawal by Subject|1|||
160638467|NCT03471182|580060655|FG002|Overall Study|Withdrawal by Subject|0|||
160638468|NCT03471182|580060653|FG000|Overall Study|Technical failure|2|||
160638469|NCT03471182|580060654|FG001|Overall Study|Technical failure|0|||
160638470|NCT03471182|580060655|FG002|Overall Study|Technical failure|0|||
160638471|NCT00331773|580060659|FG000|Overall Study|Withdrawal by Subject|6|||
160780907|NCT00145327|580581544|FG001|Overall Study|Adverse Event|11|||
160780908|NCT00145327|580581545|FG002|Overall Study|Adverse Event|22|||
160780909|NCT00145327|580581543|FG000|Overall Study|Lost to Follow-up|9|||
160780910|NCT00145327|580581544|FG001|Overall Study|Lost to Follow-up|14|||
160780911|NCT00145327|580581545|FG002|Overall Study|Lost to Follow-up|14|||
160780912|NCT00145327|580581543|FG000|Overall Study|Administrative problems|12|||
160780913|NCT00145327|580581544|FG001|Overall Study|Administrative problems|9|||
160780914|NCT00145327|580581545|FG002|Overall Study|Administrative problems|13|||
160780915|NCT00145327|580581543|FG000|Overall Study|Protocol Violation|2|||
160638472|NCT00331773|580060660|FG001|Overall Study|Withdrawal by Subject|4|||
160638473|NCT00331773|580060659|FG000|Overall Study|Protocol Violation|10|||
160780916|NCT00145327|580581544|FG001|Overall Study|Protocol Violation|0|||
160780917|NCT00145327|580581545|FG002|Overall Study|Protocol Violation|2|||
160780918|NCT00145327|580581543|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160780919|NCT00145327|580581544|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160780920|NCT00145327|580581545|FG002|Overall Study|Abnormal laboratory value(s)|2|||
160780921|NCT00145327|580581543|FG000|Overall Study|Missing - not stated|1|||
160780922|NCT00145327|580581544|FG001|Overall Study|Missing - not stated|0|||
160542098|NCT00531752|579712924|FG000|First Double-blind Intervention Period|Adverse Event|2|||
160888502|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
160888503|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
160888504|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
160888505|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
160888506|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160888507|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
160888508|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
160888509|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160888510|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
160888511|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
160888512|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
160888513|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
160888514|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
160888515|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
160888516|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
160888517|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
160888518|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
160888519|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
160888520|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888521|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
160888522|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888523|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888524|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888525|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888526|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888527|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888528|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888529|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
160888530|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
160888531|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
160888532|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
160888533|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
160888534|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
160888535|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
160542099|NCT00531752|579712925|FG001|First Double-blind Intervention Period|Adverse Event|0|||
160542100|NCT00531752|579712926|FG002|First Double-blind Intervention Period|Adverse Event|1|||
160542101|NCT00531752|579712927|FG003|First Double-blind Intervention Period|Adverse Event|1|||
160542102|NCT00531752|579712924|FG000|First Double-blind Intervention Period|Other|1|||
160542103|NCT00531752|579712925|FG001|First Double-blind Intervention Period|Other|4|||
160542104|NCT00531752|579712926|FG002|First Double-blind Intervention Period|Other|4|||
160542105|NCT00531752|579712927|FG003|First Double-blind Intervention Period|Other|0|||
160542106|NCT00531752|579712924|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
160542107|NCT00531752|579712925|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
160780923|NCT00145327|580581545|FG002|Overall Study|Missing - not stated|1|||
160780924|NCT01028053|580581546|FG000|Overall Study|Screen Failure|113|||
160780925|NCT01028053|580581546|FG000|Overall Study|Patient Request|11|||
160780926|NCT01028053|580581546|FG000|Overall Study|Protocol Violation|1|||
160780927|NCT01028053|580581546|FG000|Overall Study|Physician Decision|2|||
160780928|NCT01028053|580581546|FG000|Overall Study|Technical Problem|1|||
160780929|NCT01028053|580581546|FG000|Overall Study|Terminated by Sponsor|1|||
160780930|NCT01028053|580581546|FG000|Overall Study|Various reasons|4|||
160780931|NCT00845182|580581547|FG000|Overall Study|Lost to Follow-up|3|||
160780932|NCT00845182|580581548|FG001|Overall Study|Lost to Follow-up|3|||
160780933|NCT00845182|580581549|FG002|Overall Study|Lost to Follow-up|4|||
160780934|NCT00845182|580581547|FG000|Overall Study|Adverse Event|0|||
160780935|NCT00845182|580581548|FG001|Overall Study|Adverse Event|1|||
160780936|NCT00845182|580581549|FG002|Overall Study|Adverse Event|1|||
160780937|NCT00845182|580581547|FG000|Overall Study|Physician Decision|0|||
160542108|NCT00531752|579712926|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
160542109|NCT00531752|579712927|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
160542110|NCT00531752|579712924|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
160542111|NCT00531752|579712925|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
160780938|NCT00845182|580581548|FG001|Overall Study|Physician Decision|0|||
160888536|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
160888537|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
160888538|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
160888539|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
160888540|NCT01226121|580985531|FG000|Overall Study|Lost to Follow-up|2|||
160888541|NCT01226121|580985532|FG001|Overall Study|Lost to Follow-up|0|||
160888542|NCT01226121|580985533|FG002|Overall Study|Lost to Follow-up|1|||
160888543|NCT04473482|580985534|FG000|Overall Study|Death|0|||
160888544|NCT04473482|580985535|FG001|Overall Study|Death|3|||
160888545|NCT04473482|580985534|FG000|Overall Study|Lost to Follow-up|9|||
160888546|NCT04473482|580985535|FG001|Overall Study|Lost to Follow-up|7|||
160888547|NCT04473482|580985534|FG000|Overall Study|Withdrawal by Subject|2|||
160888548|NCT04473482|580985535|FG001|Overall Study|Withdrawal by Subject|1|||
160888549|NCT01585584|580985536|FG000|Overall Study|Lack of Efficacy|1|||
160888550|NCT01585584|580985536|FG000|Overall Study|Withdrawal by Subject|1|||
160888551|NCT01585584|580985536|FG000|Overall Study|Physician Decision|2|||
160888552|NCT06785857|580985552|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
160888553|NCT06785857|580985553|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
160888554|NCT05952401|580985561|FG000|Overall Study|Lost to Follow-up|4|||
160888555|NCT05952401|580985562|FG001|Overall Study|Lost to Follow-up|1|||
160888556|NCT04369053|580986524|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
160888557|NCT04369053|580986524|FG000|Overall Study|Withdrawal by Subject|773|||
160888558|NCT04369053|580986524|FG000|Overall Study|Lost to Follow-up|182|||
160888559|NCT04369053|580986524|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
160888560|NCT01483690|580986525|FG000|Overall Study|Adverse Event|1|||
160888561|NCT01483690|580986526|FG001|Overall Study|Adverse Event|2|||
160888562|NCT01483690|580986525|FG000|Overall Study|clinical deterioration|1|||
160888563|NCT01483690|580986526|FG001|Overall Study|clinical deterioration|0|||
160888564|NCT01483690|580986525|FG000|Overall Study|Physician Decision|0|||
160888565|NCT01483690|580986526|FG001|Overall Study|Physician Decision|2|||
160888566|NCT01483690|580986525|FG000|Overall Study|exclusionary procedure|0|||
160888567|NCT01483690|580986526|FG001|Overall Study|exclusionary procedure|1|||
160888568|NCT02239224|580986527|FG000|Overall Study|Administrative|0|||
160888569|NCT02239224|580986528|FG001|Overall Study|Administrative|0|||
160888570|NCT02239224|580986529|FG002|Overall Study|Administrative|3|||
160888571|NCT02239224|580986530|FG003|Overall Study|Administrative|1|||
160888572|NCT03183778|580986532|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
160888573|NCT03228420|580986540|FG000|Overall Study|Lost to Follow-up|5|||
160888574|NCT03228420|580986541|FG001|Overall Study|Lost to Follow-up|3|||
160888575|NCT03228420|580986540|FG000|Overall Study|Withdrawal by Subject|10|||
160888576|NCT03228420|580986541|FG001|Overall Study|Withdrawal by Subject|0|||
160888577|NCT03228420|580986540|FG000|Overall Study|Adverse Event|5|||
160888578|NCT03228420|580986541|FG001|Overall Study|Adverse Event|2|||
160888579|NCT01083173|580986542|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
160888580|NCT01083173|580986543|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
160888581|NCT01083173|580986542|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
160888582|NCT01083173|580986543|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
160888583|NCT01083173|580986542|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
160888584|NCT01083173|580986543|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
160888585|NCT01083173|580986542|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
160888586|NCT01083173|580986543|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
160888587|NCT01083173|580986542|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
160888588|NCT01083173|580986543|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
160888589|NCT01083173|580986542|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
160888590|NCT01083173|580986543|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
160888591|NCT01083173|580986542|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
160888592|NCT01083173|580986543|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
160888593|NCT01083173|580986542|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
160888594|NCT01083173|580986543|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
160888595|NCT01083173|580986542|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
160888596|NCT01083173|580986543|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
160888597|NCT01083173|580986542|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
160888598|NCT01083173|580986543|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
160888599|NCT01083173|580986542|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
160888600|NCT01083173|580986543|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
160888601|NCT03954041|580986544|FG000|Overall Study|Lost to Follow-up|3|||
160888602|NCT03954041|580986545|FG001|Overall Study|Lost to Follow-up|3|||
160888603|NCT03954041|580986546|FG002|Overall Study|Lost to Follow-up|6|||
160888604|NCT03954041|580986544|FG000|Overall Study|Death|4|||
160780939|NCT00845182|580581549|FG002|Overall Study|Physician Decision|1|||
160780940|NCT02441114|580581550|FG000|Washout2|Withdrawal by Subject|4|||
160780941|NCT00471107|580581553|FG000|Overall Study|Technical problems/data loss|3|||
160780942|NCT00471107|580581554|FG001|Overall Study|Technical problems/data loss|1|||
160780943|NCT00471107|580581555|FG002|Overall Study|Technical problems/data loss|3|||
160780944|NCT02063724|580581557|FG000|Overall Study|Disease progression|1|||
160780945|NCT00896233|580581558|FG000|Overall Study|Claustrophobia during MRI|1|||
160780946|NCT02697422|580581559|FG000|Overall Study|Declined exit survey|9|||
160780947|NCT02697422|580581560|FG001|Overall Study|Declined exit survey|2|||
160780948|NCT02697422|580581559|FG000|Overall Study|Lost to Follow-up|13|||
160780949|NCT02697422|580581560|FG001|Overall Study|Lost to Follow-up|8|||
160780950|NCT02697422|580581559|FG000|Overall Study|Death|2|||
160780951|NCT02697422|580581560|FG001|Overall Study|Death|1|||
160780952|NCT02697422|580581559|FG000|Overall Study|Withdrawal by Subject|0|||
160780953|NCT02697422|580581560|FG001|Overall Study|Withdrawal by Subject|1|||
160780954|NCT02697422|580581559|FG000|Overall Study|Physician Decision|1|||
160780955|NCT02697422|580581560|FG001|Overall Study|Physician Decision|1|||
160780956|NCT02697422|580581559|FG000|Overall Study|Exit survey data lost|1|||
160780957|NCT02697422|580581560|FG001|Overall Study|Exit survey data lost|0|||
160780958|NCT02068599|580581563|FG000|Overall Study|Adverse Event|4|||
160780959|NCT02068599|580581564|FG001|Overall Study|Adverse Event|1|||
160780960|NCT02068599|580581565|FG002|Overall Study|Adverse Event|1|||
160780961|NCT02068599|580581563|FG000|Overall Study|Withdrawal by Subject|2|||
160780962|NCT02068599|580581564|FG001|Overall Study|Withdrawal by Subject|7|||
160780963|NCT02068599|580581565|FG002|Overall Study|Withdrawal by Subject|5|||
160780964|NCT02068599|580581563|FG000|Overall Study|Protocol Violation|4|||
160780965|NCT02068599|580581564|FG001|Overall Study|Protocol Violation|2|||
160780966|NCT02068599|580581565|FG002|Overall Study|Protocol Violation|3|||
160780967|NCT02068599|580581563|FG000|Overall Study|Lost to Follow-up|1|||
160780968|NCT02068599|580581564|FG001|Overall Study|Lost to Follow-up|0|||
160780969|NCT02068599|580581565|FG002|Overall Study|Lost to Follow-up|0|||
160780970|NCT02068599|580581563|FG000|Overall Study|Lack of Efficacy|0|||
160780971|NCT02068599|580581564|FG001|Overall Study|Lack of Efficacy|0|||
160780972|NCT02068599|580581565|FG002|Overall Study|Lack of Efficacy|3|||
160780973|NCT02068599|580581563|FG000|Overall Study|Noncompliance|0|||
160780974|NCT02068599|580581564|FG001|Overall Study|Noncompliance|0|||
160780975|NCT02068599|580581565|FG002|Overall Study|Noncompliance|1|||
160780976|NCT01263028|580581566|FG000|Overall Study|Withdrawal by Subject|1|||
160780977|NCT01263028|580581566|FG000|Overall Study|Adverse Event|1|||
160780978|NCT01263028|580581566|FG000|Overall Study|Study terminated due to low enrollment.|4|||
160780979|NCT03019588|580581567|FG000|Overall Study|Death|44|||
160780980|NCT03019588|580581568|FG001|Overall Study|Death|46|||
160780981|NCT03019588|580581567|FG000|Overall Study|Study terminated by Sponsor|3|||
160780982|NCT03019588|580581568|FG001|Overall Study|Study terminated by Sponsor|1|||
160780983|NCT02227199|580581569|FG000|Overall Study|Physician Decision|0|||
160780984|NCT02227199|580581570|FG001|Overall Study|Physician Decision|0|||
160780985|NCT02227199|580581571|FG002|Overall Study|Physician Decision|1|||
160780986|NCT02227199|580581569|FG000|Overall Study|Adverse Event|0|||
160780987|NCT02227199|580581570|FG001|Overall Study|Adverse Event|0|||
160780988|NCT02227199|580581571|FG002|Overall Study|Adverse Event|3|||
160780989|NCT01428128|580581572|FG000|Overall Study|Withdrawal by Subject|4|||
160638474|NCT00331773|580060660|FG001|Overall Study|Protocol Violation|3|||
160638475|NCT03451331|580060661|FG000|Overall Study|Withdrawal by Subject|1|||
160638476|NCT03451331|580060662|FG001|Overall Study|Withdrawal by Subject|0|||
160638477|NCT03451331|580060661|FG000|Overall Study|Unable to start treatment.|1|||
160638478|NCT03451331|580060662|FG001|Overall Study|Unable to start treatment.|1|||
160638479|NCT00289731|580060663|FG000|Overall Study|Adverse Event|1|||
160638480|NCT00289731|580060664|FG001|Overall Study|Adverse Event|2|||
160638481|NCT00289731|580060665|FG002|Overall Study|Adverse Event|2|||
160638482|NCT00289731|580060663|FG000|Overall Study|Other|1|||
160780990|NCT01428128|580581572|FG000|Overall Study|Screen failure by p53|10|||
160780991|NCT01428128|580581572|FG000|Overall Study|Received Neulasta in one cycle|2|||
160780992|NCT01428128|580581572|FG000|Overall Study|Adverse Event|1|||
160780993|NCT00250718|580581576|FG000|Overall Study|Death|1|||
160638483|NCT00289731|580060664|FG001|Overall Study|Other|0|||
160638484|NCT00289731|580060665|FG002|Overall Study|Other|0|||
160638485|NCT02513459|580060666|FG000|Overall Study|Adverse Event|7|||
160780994|NCT00250718|580581576|FG000|Overall Study|Adverse Event|1|||
160780995|NCT00250718|580581576|FG000|Overall Study|Withdrawal by Subject|1|||
160780996|NCT02939781|580581577|FG000|Overall Study|Protocol Violation|8|||
160780997|NCT02939781|580581577|FG000|Overall Study|Withdrawal by Subject|1|||
160780998|NCT03003962|580581580|FG000|Overall Study|Withdrawal by Subject|5|||
160780999|NCT03003962|580581581|FG001|Overall Study|Withdrawal by Subject|17|||
160781000|NCT03003962|580581580|FG000|Overall Study|Death|274|||
160781001|NCT03003962|580581581|FG001|Overall Study|Death|277|||
160781002|NCT03003962|580581580|FG000|Overall Study|Participants ongoing at DCO|55|||
160781003|NCT03003962|580581581|FG001|Overall Study|Participants ongoing at DCO|40|||
160781004|NCT06100250|580581582|FG000|Overall Study|Lost to Follow-up|5|||
160781005|NCT05259033|580581585|FG000|Overall Study|Withdrawal by Subject|10|||
160638486|NCT02513459|580060666|FG000|Overall Study|Withdrew consent|5|||
160638487|NCT02513459|580060666|FG000|Overall Study|Loss of efficacy|2|||
160638488|NCT02513459|580060666|FG000|Overall Study|Pregnancy|2|||
160638489|NCT02513459|580060666|FG000|Overall Study|Subject decision|2|||
160638490|NCT02513459|580060666|FG000|Overall Study|Lack of response|1|||
160638491|NCT02513459|580060666|FG000|Overall Study|Reproductive plans|1|||
160638492|NCT02513459|580060666|FG000|Overall Study|Surgery planned-- not done|1|||
160638493|NCT00923195|580060667|FG000|Overall Study|Death|0|||
160638494|NCT00923195|580060668|FG001|Overall Study|Death|1|||
160638495|NCT00525031|580060669|FG000|Overall Study|Disease Progression|1|||
160638496|NCT00525031|580060670|FG001|Overall Study|Disease Progression|1|||
160638497|NCT00787566|580060675|FG000|Overall Study|AE related to chemotherapy|0|||
160638498|NCT00787566|580060676|FG001|Overall Study|AE related to chemotherapy|1|||
160638499|NCT00787566|580060677|FG002|Overall Study|AE related to chemotherapy|0|||
160638500|NCT02140164|580060678|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
160638501|NCT01814761|580060679|FG000|Overall Study|Other Reasons|1|||
160638502|NCT01814761|580060680|FG001|Overall Study|Other Reasons|10|||
160638503|NCT01814761|580060679|FG000|Overall Study|Ocular Adverse Event|6|||
160638504|NCT01814761|580060680|FG001|Overall Study|Ocular Adverse Event|15|||
160638505|NCT01814761|580060679|FG000|Overall Study|Lost to Follow-up|1|||
160638506|NCT01814761|580060680|FG001|Overall Study|Lost to Follow-up|5|||
160638507|NCT00775983|580060681|FG000|Overall Study|Protocol Violation|1|||
160638508|NCT00775983|580060682|FG001|Overall Study|Protocol Violation|2|||
160638509|NCT00660790|580060691|FG000|Baseline to 3 Months|Death|1|||
160638510|NCT00660790|580060691|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
160638511|NCT00660790|580060691|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
160638512|NCT00686374|580060697|FG000|Overall Study|Lack of Efficacy|10|||
160638513|NCT00686374|580060697|FG000|Overall Study|Adverse Event|8|||
160638514|NCT00686374|580060697|FG000|Overall Study|Withdrew consent|5|||
160638515|NCT00686374|580060697|FG000|Overall Study|Lost to Follow-up|1|||
160638516|NCT00686374|580060697|FG000|Overall Study|Missing reason|33|||
160638517|NCT00686374|580060697|FG000|Overall Study|Other, not specified|4|||
160638518|NCT00618774|580060698|FG000|Overall Study|Adverse Event|5|||
160638519|NCT00618774|580060699|FG001|Overall Study|Adverse Event|3|||
160638520|NCT00618774|580060698|FG000|Overall Study|Withdrawal by Subject|1|||
160638521|NCT00618774|580060699|FG001|Overall Study|Withdrawal by Subject|0|||
160638522|NCT00996918|580060704|FG000|Overall Study|Lack of Efficacy|1|||
160638523|NCT00996918|580060705|FG001|Overall Study|Lack of Efficacy|1|||
160638524|NCT00996918|580060706|FG002|Overall Study|Lack of Efficacy|2|||
160638525|NCT00996918|580060707|FG003|Overall Study|Lack of Efficacy|2|||
160638526|NCT00996918|580060708|FG004|Overall Study|Lack of Efficacy|0|||
160638527|NCT00996918|580060704|FG000|Overall Study|Adverse Event|2|||
160638528|NCT00996918|580060705|FG001|Overall Study|Adverse Event|5|||
160638529|NCT00996918|580060706|FG002|Overall Study|Adverse Event|2|||
160638530|NCT00996918|580060707|FG003|Overall Study|Adverse Event|6|||
160638531|NCT00996918|580060708|FG004|Overall Study|Adverse Event|0|||
160638532|NCT00996918|580060704|FG000|Overall Study|Withdrawal by Subject|1|||
160638533|NCT00996918|580060705|FG001|Overall Study|Withdrawal by Subject|4|||
160638534|NCT00996918|580060706|FG002|Overall Study|Withdrawal by Subject|3|||
160638535|NCT00996918|580060707|FG003|Overall Study|Withdrawal by Subject|3|||
160638536|NCT00996918|580060708|FG004|Overall Study|Withdrawal by Subject|2|||
160638537|NCT00996918|580060704|FG000|Overall Study|Physician Decision|1|||
160638538|NCT00996918|580060705|FG001|Overall Study|Physician Decision|0|||
160638539|NCT00996918|580060706|FG002|Overall Study|Physician Decision|0|||
160638540|NCT00996918|580060707|FG003|Overall Study|Physician Decision|0|||
160638541|NCT00996918|580060708|FG004|Overall Study|Physician Decision|0|||
160638542|NCT00996918|580060704|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
160638543|NCT00996918|580060705|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
160638544|NCT00996918|580060706|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
160638545|NCT00996918|580060707|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
160638546|NCT00996918|580060708|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
160638547|NCT00996918|580060704|FG000|Overall Study|Loss of Caregiver|0|||
160638548|NCT00996918|580060705|FG001|Overall Study|Loss of Caregiver|1|||
160638549|NCT00996918|580060706|FG002|Overall Study|Loss of Caregiver|0|||
160638550|NCT00996918|580060707|FG003|Overall Study|Loss of Caregiver|0|||
160781006|NCT05259033|580581586|FG001|Overall Study|Withdrawal by Subject|5|||
160781007|NCT05259033|580581585|FG000|Overall Study|Lost to Follow-up|1|||
160781008|NCT05259033|580581586|FG001|Overall Study|Lost to Follow-up|0|||
160781009|NCT05259033|580581585|FG000|Overall Study|Death|2|||
160781010|NCT05259033|580581586|FG001|Overall Study|Death|0|||
160781011|NCT05537571|580581587|FG000|Overall Study|Withdrawal by Subject|1|||
160781012|NCT05537571|580581588|FG001|Overall Study|Withdrawal by Subject|1|||
160781013|NCT05537571|580581589|FG002|Overall Study|Withdrawal by Subject|0|||
160781014|NCT05537571|580581590|FG003|Overall Study|Withdrawal by Subject|0|||
160781015|NCT05537571|580581591|FG004|Overall Study|Withdrawal by Subject|0|||
160781016|NCT05537571|580581587|FG000|Overall Study|Adverse Event|2|||
160781017|NCT05537571|580581588|FG001|Overall Study|Adverse Event|0|||
160781018|NCT05537571|580581589|FG002|Overall Study|Adverse Event|0|||
160781019|NCT05537571|580581590|FG003|Overall Study|Adverse Event|0|||
160781020|NCT05537571|580581591|FG004|Overall Study|Adverse Event|0|||
160781021|NCT05537571|580581587|FG000|Overall Study|Hepatitis A screening result|2|||
160781022|NCT05537571|580581588|FG001|Overall Study|Hepatitis A screening result|0|||
160781023|NCT05537571|580581589|FG002|Overall Study|Hepatitis A screening result|0|||
160781024|NCT05537571|580581590|FG003|Overall Study|Hepatitis A screening result|0|||
160781025|NCT05537571|580581591|FG004|Overall Study|Hepatitis A screening result|0|||
160781026|NCT05537571|580581587|FG000|Overall Study|Lost to Follow-up|0|||
160781027|NCT05537571|580581588|FG001|Overall Study|Lost to Follow-up|0|||
160781028|NCT05537571|580581589|FG002|Overall Study|Lost to Follow-up|1|||
160781029|NCT05537571|580581590|FG003|Overall Study|Lost to Follow-up|0|||
160781030|NCT05537571|580581591|FG004|Overall Study|Lost to Follow-up|1|||
160781031|NCT04337021|580581592|FG000|Overall Study|Lost to Follow-up|54|||
160781032|NCT04337021|580581593|FG001|Overall Study|Lost to Follow-up|66|||
160781033|NCT00424008|580581594|FG000|Overall Study|Adverse Event|8|||
160781034|NCT00424008|580581595|FG001|Overall Study|Adverse Event|6|||
160781035|NCT00424008|580581594|FG000|Overall Study|Lack of Efficacy|40|||
160781036|NCT00424008|580581595|FG001|Overall Study|Lack of Efficacy|34|||
160781037|NCT00424008|580581594|FG000|Overall Study|Lost to Follow-up|1|||
160781038|NCT00424008|580581595|FG001|Overall Study|Lost to Follow-up|2|||
160781039|NCT00424008|580581594|FG000|Overall Study|Withdrawal by Subject|5|||
160781040|NCT00424008|580581595|FG001|Overall Study|Withdrawal by Subject|8|||
160781041|NCT00424008|580581594|FG000|Overall Study|Noncompliance with protocol|13|||
160781042|NCT00424008|580581595|FG001|Overall Study|Noncompliance with protocol|7|||
160781043|NCT00424008|580581594|FG000|Overall Study|Did not meet protocol eligibility|16|||
160781044|NCT00424008|580581595|FG001|Overall Study|Did not meet protocol eligibility|21|||
160781045|NCT00424008|580581594|FG000|Overall Study|Administrative|266|||
160781046|NCT00424008|580581595|FG001|Overall Study|Administrative|257|||
160781047|NCT02530242|580581599|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
160781048|NCT02530242|580581600|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
160781049|NCT00283959|580581601|FG000|Extension Period|Low Compliance|1|||
160781050|NCT02665455|580581604|FG000|Overall Study|Withdrawal by Subject|6|||
160781051|NCT02665455|580581604|FG000|Overall Study|Lost to Follow-up|1|||
160781052|NCT02665455|580581604|FG000|Overall Study|Adverse Event|1|||
160781053|NCT02665455|580581604|FG000|Overall Study|Protocol Violation|1|||
160781054|NCT05865886|580581605|FG000|Overall Study|Serious adverse event|0|||
160781055|NCT05865886|580581606|FG001|Overall Study|Serious adverse event|1|||
160781056|NCT01671059|580581607|FG000|Overall Study|Adverse Event|4|||
160781057|NCT01671059|580581607|FG000|Overall Study|Lack of Efficacy|1|||
160781058|NCT02564978|580581610|FG000|Overall Study|Adverse Event|8|||
160781059|NCT02564978|580581610|FG000|Overall Study|Death|1|||
160781060|NCT02564978|580581610|FG000|Overall Study|Lost to Follow-up|1|||
160781061|NCT02564978|580581610|FG000|Overall Study|Withdrawal by Subject|15|||
160638551|NCT00996918|580060708|FG004|Overall Study|Loss of Caregiver|0|||
160638552|NCT00996918|580060704|FG000|Overall Study|Other|3|||
160638553|NCT00996918|580060705|FG001|Overall Study|Other|1|||
160638554|NCT00996918|580060706|FG002|Overall Study|Other|0|||
160638555|NCT00996918|580060707|FG003|Overall Study|Other|0|||
160888605|NCT03954041|580986545|FG001|Overall Study|Death|0|||
160638556|NCT00996918|580060708|FG004|Overall Study|Other|0|||
160888606|NCT03954041|580986546|FG002|Overall Study|Death|1|||
160781062|NCT02564978|580581610|FG000|Overall Study|Early Study Closure|2|||
160781063|NCT02564978|580581610|FG000|Overall Study|Other Reason|5|||
160888607|NCT03954041|580986544|FG000|Overall Study|Death by neurologic criteria|0|||
160781064|NCT03787212|580583055|FG000|Period 1|Study Termination|2|||
160638557|NCT01965535|580060711|FG000|Overall Study|Lack of Efficacy|2|||
160638558|NCT01965535|580060712|FG001|Overall Study|Lack of Efficacy|1|||
160781065|NCT03787212|580583056|FG001|Period 1|Study Termination|2|||
160781066|NCT04289298|580583057|FG000|Overall Study|Lost to Follow-up|5|||
160781067|NCT04289298|580583058|FG001|Overall Study|Lost to Follow-up|0|||
160888608|NCT03954041|580986545|FG001|Overall Study|Death by neurologic criteria|0|||
160638559|NCT01169987|580060714|FG000|Overall Study|Withdrawal by Subject|3|||
160781068|NCT04289298|580583057|FG000|Overall Study|Withdrawal by Subject|2|||
160781069|NCT04289298|580583058|FG001|Overall Study|Withdrawal by Subject|0|||
160781070|NCT00620035|580583059|FG000|Overall Study|Adverse Event|106|||
160781071|NCT00620035|580583059|FG000|Overall Study|Withdrawal of Informed Consent|1|||
160888609|NCT03954041|580986546|FG002|Overall Study|Death by neurologic criteria|1|||
160888610|NCT03954041|580986544|FG000|Overall Study|Reason not specified|7|||
160888611|NCT03954041|580986545|FG001|Overall Study|Reason not specified|4|||
160888612|NCT03954041|580986546|FG002|Overall Study|Reason not specified|2|||
160888613|NCT03954041|580986544|FG000|Overall Study|Withdrew prior to dosing|4|||
160888614|NCT03954041|580986545|FG001|Overall Study|Withdrew prior to dosing|2|||
160888615|NCT03954041|580986546|FG002|Overall Study|Withdrew prior to dosing|0|||
160888616|NCT04565236|580986549|FG000|Overall Study|Patient/Guardian Decision|0|||
160888617|NCT04565236|580986550|FG001|Overall Study|Patient/Guardian Decision|0|||
160888618|NCT04565236|580986551|FG002|Overall Study|Patient/Guardian Decision|1|||
160888619|NCT04565236|580986552|FG003|Overall Study|Patient/Guardian Decision|0|||
160888620|NCT01041495|580986553|FG000|Overall Study|Withdrawal by Subject|2|||
160888621|NCT01041495|580986554|FG001|Overall Study|Withdrawal by Subject|5|||
160888622|NCT01041495|580986553|FG000|Overall Study|Adverse Event|2|||
160888623|NCT01041495|580986554|FG001|Overall Study|Adverse Event|1|||
160638560|NCT01169987|580060714|FG000|Overall Study|Lost to Follow-up|24|||
160638561|NCT01169987|580060714|FG000|Overall Study|Other|4|||
160638562|NCT00829439|580060716|FG000|Overall Study|Adverse Event|0|||
160888624|NCT01041495|580986553|FG000|Overall Study|Lost to Follow-up|0|||
160888625|NCT01041495|580986554|FG001|Overall Study|Lost to Follow-up|1|||
160888626|NCT00722371|580986555|FG000|Overall Study|Adverse Event|6|||
160888627|NCT00722371|580986556|FG001|Overall Study|Adverse Event|13|||
160888628|NCT00722371|580986557|FG002|Overall Study|Adverse Event|9|||
160888629|NCT00722371|580986558|FG003|Overall Study|Adverse Event|10|||
160888630|NCT00722371|580986559|FG004|Overall Study|Adverse Event|6|||
160888631|NCT00722371|580986560|FG005|Overall Study|Adverse Event|8|||
160888632|NCT00722371|580986561|FG006|Overall Study|Adverse Event|4|||
160888633|NCT00722371|580986555|FG000|Overall Study|Contraindication|0|||
160888634|NCT00722371|580986556|FG001|Overall Study|Contraindication|0|||
160888635|NCT00722371|580986557|FG002|Overall Study|Contraindication|1|||
160888636|NCT00722371|580986558|FG003|Overall Study|Contraindication|0|||
160888637|NCT00722371|580986559|FG004|Overall Study|Contraindication|0|||
160888638|NCT00722371|580986560|FG005|Overall Study|Contraindication|0|||
160888639|NCT00722371|580986561|FG006|Overall Study|Contraindication|0|||
160888640|NCT00722371|580986555|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
160888641|NCT00722371|580986556|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
160888642|NCT00722371|580986557|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
160888643|NCT00722371|580986558|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
160888644|NCT00722371|580986559|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
160888645|NCT00722371|580986560|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
160888646|NCT00722371|580986561|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
160888647|NCT00722371|580986555|FG000|Overall Study|Excluded medication|0|||
160888648|NCT00722371|580986556|FG001|Overall Study|Excluded medication|1|||
160888649|NCT00722371|580986557|FG002|Overall Study|Excluded medication|1|||
160888650|NCT00722371|580986558|FG003|Overall Study|Excluded medication|0|||
160888651|NCT00722371|580986559|FG004|Overall Study|Excluded medication|0|||
160888652|NCT00722371|580986560|FG005|Overall Study|Excluded medication|0|||
160888653|NCT00722371|580986561|FG006|Overall Study|Excluded medication|1|||
160888654|NCT00722371|580986555|FG000|Overall Study|Hyperglycemia|2|||
160638563|NCT00829439|580060717|FG001|Overall Study|Adverse Event|0|||
160638564|NCT00829439|580060718|FG002|Overall Study|Adverse Event|1|||
160638565|NCT00829439|580060719|FG003|Overall Study|Adverse Event|0|||
160638566|NCT00386100|580060720|FG000|Overall Study|Did not receive study medication|6|||
160638567|NCT00386100|580060721|FG001|Overall Study|Did not receive study medication|4|||
160638568|NCT00386100|580060720|FG000|Overall Study|Adverse Event|15|||
160638569|NCT00386100|580060721|FG001|Overall Study|Adverse Event|25|||
160638570|NCT00386100|580060720|FG000|Overall Study|Death|0|||
160638571|NCT00386100|580060721|FG001|Overall Study|Death|1|||
160638572|NCT00386100|580060720|FG000|Overall Study|Insufficient therapeutic effect|30|||
160638573|NCT00386100|580060721|FG001|Overall Study|Insufficient therapeutic effect|6|||
160888655|NCT00722371|580986556|FG001|Overall Study|Hyperglycemia|6|||
160888656|NCT00722371|580986557|FG002|Overall Study|Hyperglycemia|4|||
160888657|NCT00722371|580986558|FG003|Overall Study|Hyperglycemia|2|||
160888658|NCT00722371|580986559|FG004|Overall Study|Hyperglycemia|5|||
160888659|NCT00722371|580986560|FG005|Overall Study|Hyperglycemia|1|||
160888660|NCT00722371|580986561|FG006|Overall Study|Hyperglycemia|1|||
160888661|NCT00722371|580986555|FG000|Overall Study|Hypoglycemia|1|||
160888662|NCT00722371|580986556|FG001|Overall Study|Hypoglycemia|0|||
160888663|NCT00722371|580986557|FG002|Overall Study|Hypoglycemia|0|||
160888664|NCT00722371|580986558|FG003|Overall Study|Hypoglycemia|0|||
160888665|NCT00722371|580986559|FG004|Overall Study|Hypoglycemia|0|||
160638574|NCT00386100|580060720|FG000|Overall Study|Lost to Follow-up|29|||
160638575|NCT00386100|580060721|FG001|Overall Study|Lost to Follow-up|29|||
160638576|NCT00386100|580060720|FG000|Overall Study|Non-compliance|18|||
160888666|NCT00722371|580986560|FG005|Overall Study|Hypoglycemia|0|||
160888667|NCT00722371|580986561|FG006|Overall Study|Hypoglycemia|0|||
160888668|NCT00722371|580986555|FG000|Overall Study|Lack of Efficacy|4|||
160888669|NCT00722371|580986556|FG001|Overall Study|Lack of Efficacy|6|||
160888670|NCT00722371|580986557|FG002|Overall Study|Lack of Efficacy|6|||
160888671|NCT00722371|580986558|FG003|Overall Study|Lack of Efficacy|6|||
160888672|NCT00722371|580986559|FG004|Overall Study|Lack of Efficacy|2|||
160888673|NCT00722371|580986560|FG005|Overall Study|Lack of Efficacy|3|||
160888674|NCT00722371|580986561|FG006|Overall Study|Lack of Efficacy|0|||
160888675|NCT00722371|580986555|FG000|Overall Study|Lost to Follow-up|11|||
160888676|NCT00722371|580986556|FG001|Overall Study|Lost to Follow-up|14|||
160888677|NCT00722371|580986557|FG002|Overall Study|Lost to Follow-up|21|||
160888678|NCT00722371|580986558|FG003|Overall Study|Lost to Follow-up|13|||
160888679|NCT00722371|580986559|FG004|Overall Study|Lost to Follow-up|8|||
160888680|NCT00722371|580986560|FG005|Overall Study|Lost to Follow-up|16|||
160888681|NCT00722371|580986561|FG006|Overall Study|Lost to Follow-up|13|||
160888682|NCT00722371|580986555|FG000|Overall Study|Physician Decision|5|||
160888683|NCT00722371|580986556|FG001|Overall Study|Physician Decision|2|||
160888684|NCT00722371|580986557|FG002|Overall Study|Physician Decision|2|||
160888685|NCT00722371|580986558|FG003|Overall Study|Physician Decision|5|||
160888686|NCT00722371|580986559|FG004|Overall Study|Physician Decision|2|||
160888687|NCT00722371|580986560|FG005|Overall Study|Physician Decision|3|||
160888688|NCT00722371|580986561|FG006|Overall Study|Physician Decision|4|||
160888689|NCT00722371|580986555|FG000|Overall Study|Pregnancy|1|||
160888690|NCT00722371|580986556|FG001|Overall Study|Pregnancy|1|||
160888691|NCT00722371|580986557|FG002|Overall Study|Pregnancy|0|||
160888692|NCT00722371|580986558|FG003|Overall Study|Pregnancy|0|||
160888693|NCT00722371|580986559|FG004|Overall Study|Pregnancy|0|||
160888694|NCT00722371|580986560|FG005|Overall Study|Pregnancy|1|||
160888695|NCT00722371|580986561|FG006|Overall Study|Pregnancy|0|||
160888696|NCT00722371|580986555|FG000|Overall Study|Protocol Violation|6|||
160888697|NCT00722371|580986556|FG001|Overall Study|Protocol Violation|1|||
160542112|NCT00531752|579712926|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
160542113|NCT00531752|579712927|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
160542114|NCT00531752|579712924|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
160542115|NCT00531752|579712925|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
160542116|NCT00531752|579712926|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
160542117|NCT00531752|579712927|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
160542118|NCT00531752|579712924|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
160542119|NCT00531752|579712925|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
160542120|NCT00531752|579712926|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
160542121|NCT00531752|579712927|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
160542122|NCT00531752|579712924|FG000|Second Double-blind Intervention Period|Other|1|||
160542123|NCT00531752|579712925|FG001|Second Double-blind Intervention Period|Other|1|||
160542124|NCT00531752|579712926|FG002|Second Double-blind Intervention Period|Other|0|||
160542125|NCT00531752|579712927|FG003|Second Double-blind Intervention Period|Other|0|||
160542126|NCT00531752|579712924|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
160542127|NCT00531752|579712925|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
160542128|NCT00531752|579712926|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
160542129|NCT00531752|579712927|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
160542130|NCT00531752|579712924|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
160542131|NCT00531752|579712925|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
160542132|NCT00531752|579712926|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
160638577|NCT00386100|580060721|FG001|Overall Study|Non-compliance|19|||
160638578|NCT00386100|580060720|FG000|Overall Study|Protocol Violation|5|||
160888698|NCT00722371|580986557|FG002|Overall Study|Protocol Violation|0|||
160888699|NCT00722371|580986558|FG003|Overall Study|Protocol Violation|1|||
160888700|NCT00722371|580986559|FG004|Overall Study|Protocol Violation|4|||
160888701|NCT00722371|580986560|FG005|Overall Study|Protocol Violation|2|||
160888702|NCT00722371|580986561|FG006|Overall Study|Protocol Violation|1|||
160888703|NCT00722371|580986555|FG000|Overall Study|Withdrawal by Subject|18|||
160888704|NCT00722371|580986556|FG001|Overall Study|Withdrawal by Subject|27|||
160888705|NCT00722371|580986557|FG002|Overall Study|Withdrawal by Subject|19|||
160888706|NCT00722371|580986558|FG003|Overall Study|Withdrawal by Subject|23|||
160888707|NCT00722371|580986559|FG004|Overall Study|Withdrawal by Subject|19|||
160888708|NCT00722371|580986560|FG005|Overall Study|Withdrawal by Subject|18|||
160888709|NCT00722371|580986561|FG006|Overall Study|Withdrawal by Subject|26|||
160888710|NCT00718237|580986562|FG000|Overall Study|Adverse Event|1|||
160888711|NCT00718237|580986563|FG001|Overall Study|Adverse Event|3|||
160888712|NCT00718237|580986562|FG000|Overall Study|Lost to Follow-up|2|||
160888713|NCT00718237|580986563|FG001|Overall Study|Lost to Follow-up|2|||
160888714|NCT00718237|580986562|FG000|Overall Study|Physician Decision|1|||
160542133|NCT00531752|579712927|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
160542134|NCT03693625|579712932|FG000|Overall Study|Adverse Event|2|||
160542135|NCT03693625|579712933|FG001|Overall Study|Adverse Event|0|||
160888715|NCT00718237|580986563|FG001|Overall Study|Physician Decision|0|||
160888716|NCT00718237|580986562|FG000|Overall Study|Withdrawal by Subject|9|||
160888717|NCT00718237|580986563|FG001|Overall Study|Withdrawal by Subject|10|||
160888718|NCT01185834|580986564|FG000|Overall Study|Lost to Follow-up|2|||
160888719|NCT01185834|580986564|FG000|Overall Study|Discomfort|4|||
160888720|NCT01185834|580986564|FG000|Overall Study|Biomicroscopy|4|||
160638579|NCT00386100|580060721|FG001|Overall Study|Protocol Violation|3|||
160638580|NCT00386100|580060720|FG000|Overall Study|Withdrawal by Subject|32|||
160638581|NCT00386100|580060721|FG001|Overall Study|Withdrawal by Subject|31|||
160638582|NCT00386100|580060720|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
160638583|NCT00386100|580060721|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
160638584|NCT00386100|580060720|FG000|Overall Study|BMD <2.5|1|||
160638585|NCT00386100|580060721|FG001|Overall Study|BMD <2.5|0|||
160638586|NCT00386100|580060720|FG000|Overall Study|Consecutive elevated Hba1C|1|||
160638587|NCT00386100|580060721|FG001|Overall Study|Consecutive elevated Hba1C|0|||
160638588|NCT00386100|580060720|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
160638589|NCT00386100|580060721|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
160638590|NCT00386100|580060720|FG000|Overall Study|Laboratory findings|1|||
160638591|NCT00386100|580060721|FG001|Overall Study|Laboratory findings|0|||
160638592|NCT00386100|580060720|FG000|Overall Study|Participant's concern due to CPK levels|1|||
160781072|NCT00620035|580583059|FG000|Overall Study|Other Reason|38|||
160781073|NCT01778985|580583060|FG000|Overall Study|Lost to Follow-up|1|||
160781074|NCT01778985|580583061|FG001|Overall Study|Lost to Follow-up|0|||
160781075|NCT01778985|580583060|FG000|Overall Study|Physician Decision|2|||
160781076|NCT01778985|580583061|FG001|Overall Study|Physician Decision|2|||
160781077|NCT01778985|580583060|FG000|Overall Study|Protocol Violation|4|||
160781078|NCT01778985|580583061|FG001|Overall Study|Protocol Violation|1|||
160781079|NCT00504231|580583062|FG000|Overall Study|Discrepant chart documentation re route|0|||
160781080|NCT00504231|580583063|FG001|Overall Study|Discrepant chart documentation re route|0|||
160781081|NCT00504231|580583064|FG002|Overall Study|Discrepant chart documentation re route|1|||
160781082|NCT00504231|580583065|FG003|Overall Study|Discrepant chart documentation re route|0|||
160781083|NCT02316613|580583068|FG000|Overall Study|Death|63|||
160781084|NCT02316613|580583068|FG000|Overall Study|Lost to Follow-up|9|||
160781085|NCT02316613|580583068|FG000|Overall Study|Lymphoma transformation|2|||
160781086|NCT02316613|580583068|FG000|Overall Study|Participant moved/changed medical team|11|||
160781087|NCT02316613|580583068|FG000|Overall Study|No data and duplicate cases|5|||
160781088|NCT02316613|580583068|FG000|Overall Study|Did not met selection criteria|14|||
160781089|NCT02082483|580583073|FG000|Overall Study|Lost to Follow-up|1|||
160781090|NCT02082483|580583074|FG001|Overall Study|Lost to Follow-up|1|||
160781091|NCT02082483|580583073|FG000|Overall Study|Withdrawal by Subject|2|||
160781092|NCT02082483|580583074|FG001|Overall Study|Withdrawal by Subject|1|||
160781093|NCT02082483|580583073|FG000|Overall Study|Physician Decision|1|||
160781094|NCT02082483|580583074|FG001|Overall Study|Physician Decision|1|||
160781095|NCT02082483|580583073|FG000|Overall Study|Death|2|||
160781096|NCT02082483|580583074|FG001|Overall Study|Death|3|||
160781097|NCT01875237|580583078|FG000|Overall Study|GVDH before DLI|1|||
160781098|NCT01875237|580583079|FG001|Overall Study|GVDH before DLI|0|||
160781099|NCT01875237|580583078|FG000|Overall Study|DLI cells could not be produced|1|||
160781100|NCT01875237|580583079|FG001|Overall Study|DLI cells could not be produced|0|||
160781101|NCT01028560|580583081|FG000|Overall Study|Lack of Efficacy|3|||
160781102|NCT01028560|580583082|FG001|Overall Study|Lack of Efficacy|6|||
160781103|NCT01028560|580583081|FG000|Overall Study|Withdrawal by Subject|7|||
160781104|NCT01028560|580583082|FG001|Overall Study|Withdrawal by Subject|12|||
160781105|NCT01960842|580583085|FG000|Overall Study|Adverse Event|1|||
160781106|NCT01960842|580583085|FG000|Overall Study|Withdrawal by Subject|2|||
160781107|NCT05278065|580583090|FG000|Overall Study|Withdrawal by Subject|1|||
160781108|NCT05278065|580583091|FG001|Overall Study|Withdrawal by Subject|0|||
160781109|NCT02029443|580583092|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
160781110|NCT02029443|580583093|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
160781111|NCT02029443|580583094|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
160781112|NCT02029443|580583095|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
160781113|NCT02029443|580583096|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
160781114|NCT02029443|580583092|FG000|Overall Study|Death|13|||
160781115|NCT02029443|580583093|FG001|Overall Study|Death|2|||
160781116|NCT02029443|580583094|FG002|Overall Study|Death|2|||
160781117|NCT02029443|580583095|FG003|Overall Study|Death|11|||
160781118|NCT02029443|580583096|FG004|Overall Study|Death|2|||
160781119|NCT02029443|580583092|FG000|Overall Study|Lost to Follow-up|1|||
160781120|NCT02029443|580583093|FG001|Overall Study|Lost to Follow-up|0|||
160781121|NCT02029443|580583094|FG002|Overall Study|Lost to Follow-up|1|||
160781122|NCT02029443|580583095|FG003|Overall Study|Lost to Follow-up|1|||
160781123|NCT02029443|580583096|FG004|Overall Study|Lost to Follow-up|0|||
160781124|NCT02029443|580583092|FG000|Overall Study|Started other anti-cancer therapy|17|||
160781125|NCT02029443|580583093|FG001|Overall Study|Started other anti-cancer therapy|4|||
160781126|NCT02029443|580583094|FG002|Overall Study|Started other anti-cancer therapy|7|||
160781127|NCT02029443|580583095|FG003|Overall Study|Started other anti-cancer therapy|9|||
160781128|NCT02029443|580583096|FG004|Overall Study|Started other anti-cancer therapy|3|||
160781129|NCT02029443|580583092|FG000|Overall Study|Withdrawal by Subject|3|||
160781130|NCT02029443|580583093|FG001|Overall Study|Withdrawal by Subject|1|||
160781131|NCT02029443|580583094|FG002|Overall Study|Withdrawal by Subject|1|||
160781132|NCT02029443|580583095|FG003|Overall Study|Withdrawal by Subject|1|||
160781133|NCT02029443|580583096|FG004|Overall Study|Withdrawal by Subject|0|||
160781134|NCT02029443|580583092|FG000|Overall Study|Other|6|||
160781135|NCT02029443|580583093|FG001|Overall Study|Other|6|||
160781136|NCT02029443|580583094|FG002|Overall Study|Other|4|||
160781137|NCT02029443|580583095|FG003|Overall Study|Other|2|||
160781138|NCT02029443|580583096|FG004|Overall Study|Other|0|||
160781139|NCT02070991|580583102|FG000|Overall Study|Death|2|||
160781140|NCT02070991|580583103|FG001|Overall Study|Death|0|||
160781141|NCT02070991|580583102|FG000|Overall Study|Withdrawal by Subject|1|||
160638593|NCT00386100|580060721|FG001|Overall Study|Participant's concern due to CPK levels|0|||
160638594|NCT00386100|580060720|FG000|Overall Study|Participant moving out of state|2|||
160781142|NCT02070991|580583103|FG001|Overall Study|Withdrawal by Subject|0|||
160781143|NCT04999020|580583104|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
160781144|NCT04999020|580583105|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
160781145|NCT04999020|580583106|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
160781146|NCT04999020|580583107|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
160888721|NCT01185834|580986564|FG000|Overall Study|Time/Job Conflict|2|||
160888722|NCT01185834|580986564|FG000|Overall Study|Early exit - Site error|2|||
160888723|NCT01244490|580986565|FG000|Overall Study|Lack of Efficacy|14|||
160888724|NCT01244490|580986566|FG001|Overall Study|Lack of Efficacy|5|||
160888725|NCT01244490|580986567|FG002|Overall Study|Lack of Efficacy|5|||
160888726|NCT01244490|580986565|FG000|Overall Study|Withdrawal by Subject|4|||
160888727|NCT01244490|580986566|FG001|Overall Study|Withdrawal by Subject|4|||
160888728|NCT01244490|580986567|FG002|Overall Study|Withdrawal by Subject|9|||
160888729|NCT01244490|580986565|FG000|Overall Study|Adverse Event|1|||
160888730|NCT01244490|580986566|FG001|Overall Study|Adverse Event|9|||
160888731|NCT01244490|580986567|FG002|Overall Study|Adverse Event|5|||
160888732|NCT01244490|580986565|FG000|Overall Study|Lost to Follow-up|0|||
160888733|NCT01244490|580986566|FG001|Overall Study|Lost to Follow-up|6|||
160888734|NCT01244490|580986567|FG002|Overall Study|Lost to Follow-up|3|||
160888735|NCT01244490|580986565|FG000|Overall Study|Other|0|||
160888736|NCT01244490|580986566|FG001|Overall Study|Other|0|||
160888737|NCT01244490|580986567|FG002|Overall Study|Other|1|||
160888738|NCT02290431|580986570|FG000|Overall Study|Adverse Event|20|||
160888739|NCT02290431|580986570|FG000|Overall Study|Progressive disease|4|||
160888740|NCT02290431|580986570|FG000|Overall Study|Study terminated by Sponsor|1|||
160888741|NCT02290431|580986570|FG000|Overall Study|Physician Decision|2|||
160888742|NCT03324581|580986572|FG000|Overall Study|Adverse Event|18|||
160888743|NCT03324581|580986573|FG001|Overall Study|Adverse Event|11|||
160888744|NCT03324581|580986574|FG002|Overall Study|Adverse Event|7|||
160888745|NCT03324581|580986572|FG000|Overall Study|Lack of Efficacy|0|||
160888746|NCT03324581|580986573|FG001|Overall Study|Lack of Efficacy|1|||
160888747|NCT03324581|580986574|FG002|Overall Study|Lack of Efficacy|0|||
160888748|NCT03324581|580986572|FG000|Overall Study|Lost to Follow-up|5|||
160888749|NCT03324581|580986573|FG001|Overall Study|Lost to Follow-up|3|||
160888750|NCT03324581|580986574|FG002|Overall Study|Lost to Follow-up|6|||
160888751|NCT03324581|580986572|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
160888752|NCT03324581|580986573|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
160888753|NCT03324581|580986574|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
160888754|NCT03324581|580986572|FG000|Overall Study|Physician Decision|0|||
160888755|NCT03324581|580986573|FG001|Overall Study|Physician Decision|1|||
160888756|NCT03324581|580986574|FG002|Overall Study|Physician Decision|2|||
160888757|NCT03324581|580986572|FG000|Overall Study|Protocol Deviation|8|||
160888758|NCT03324581|580986573|FG001|Overall Study|Protocol Deviation|9|||
160888759|NCT03324581|580986574|FG002|Overall Study|Protocol Deviation|4|||
160888760|NCT03324581|580986572|FG000|Overall Study|Withdrawal by Subject|6|||
160888761|NCT03324581|580986573|FG001|Overall Study|Withdrawal by Subject|8|||
160888762|NCT03324581|580986574|FG002|Overall Study|Withdrawal by Subject|6|||
160888763|NCT03324581|580986572|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
160888764|NCT03324581|580986573|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
160888765|NCT03324581|580986574|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
160888766|NCT00321893|580986576|FG000|Overall Study|Non-Compliance/Refusal|16|||
160888767|NCT00321893|580986577|FG001|Overall Study|Non-Compliance/Refusal|10|||
160888768|NCT00321893|580986576|FG000|Overall Study|Lost to Follow-up|2|||
160888769|NCT00321893|580986577|FG001|Overall Study|Lost to Follow-up|1|||
160888770|NCT00321893|580986576|FG000|Overall Study|Adverse Event|6|||
160888771|NCT00321893|580986577|FG001|Overall Study|Adverse Event|3|||
160888772|NCT03523000|580986578|FG000|Overall Study|Withdrawal by Subject|3|||
160888773|NCT03523000|580986579|FG001|Overall Study|Withdrawal by Subject|0|||
160888774|NCT03523000|580986578|FG000|Overall Study|Unsuccessful trial|2|||
160888775|NCT03523000|580986579|FG001|Overall Study|Unsuccessful trial|0|||
160888776|NCT03993379|580986580|FG000|Overall Study|The study was terminated early due to business decision.|0|||
160888777|NCT03993379|580986581|FG001|Overall Study|The study was terminated early due to business decision.|2|||
160638595|NCT00386100|580060721|FG001|Overall Study|Participant moving out of state|0|||
160638596|NCT00386100|580060720|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
160638597|NCT00386100|580060721|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
160638598|NCT00386100|580060720|FG000|Overall Study|Didn't meet entry criteria|1|||
160638599|NCT00386100|580060721|FG001|Overall Study|Didn't meet entry criteria|1|||
160638600|NCT00386100|580060720|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
160638601|NCT00386100|580060721|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
160638602|NCT00386100|580060720|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
160638603|NCT00386100|580060721|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
160638604|NCT00386100|580060720|FG000|Overall Study|Bad metabolic control & patient security|1|||
160638605|NCT00386100|580060721|FG001|Overall Study|Bad metabolic control & patient security|0|||
160888778|NCT03993379|580986582|FG002|Overall Study|The study was terminated early due to business decision.|0|||
160888779|NCT03993379|580986583|FG003|Overall Study|The study was terminated early due to business decision.|0|||
160888780|NCT03993379|580986580|FG000|Overall Study|Withdrawal by Subject|0|||
160888781|NCT03993379|580986581|FG001|Overall Study|Withdrawal by Subject|1|||
160888782|NCT03993379|580986582|FG002|Overall Study|Withdrawal by Subject|0|||
160888783|NCT03993379|580986583|FG003|Overall Study|Withdrawal by Subject|0|||
160781147|NCT04999020|580583104|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
160781148|NCT04999020|580583105|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
160781149|NCT04999020|580583106|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
160781150|NCT04999020|580583107|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
160781151|NCT04999020|580583104|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
160781152|NCT04999020|580583105|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
160781153|NCT04999020|580583106|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
160781154|NCT04999020|580583107|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
160888784|NCT02380690|580986584|FG000|Overall Study|Lost to Follow-up|14|||
160888785|NCT02380690|580986585|FG001|Overall Study|Lost to Follow-up|4|||
160888786|NCT02380690|580986584|FG000|Overall Study|Withdrawal by Subject|20|||
160888787|NCT02380690|580986585|FG001|Overall Study|Withdrawal by Subject|8|||
160888788|NCT00266864|580986586|FG000|Overall Study|Lost to Follow-up|4|||
160888789|NCT00266864|580986587|FG001|Overall Study|Lost to Follow-up|1|||
160888790|NCT00266864|580986586|FG000|Overall Study|Withdrawal by Subject|1|||
160888791|NCT00266864|580986587|FG001|Overall Study|Withdrawal by Subject|1|||
160888792|NCT00727532|580986588|FG000|Overall Study|Adverse Event|1|||
160888793|NCT00727532|580986588|FG000|Overall Study|Withdrawal by Subject|1|||
160888794|NCT00829933|580986589|FG000|Overall Study|Adverse Event|2|||
160888795|NCT00829933|580986590|FG001|Overall Study|Adverse Event|3|||
160888796|NCT00829933|580986591|FG002|Overall Study|Adverse Event|2|||
160888797|NCT00829933|580986592|FG003|Overall Study|Adverse Event|1|||
160888798|NCT00829933|580986589|FG000|Overall Study|Death|0|||
160888799|NCT00829933|580986590|FG001|Overall Study|Death|0|||
160888800|NCT00829933|580986591|FG002|Overall Study|Death|1|||
160888801|NCT00829933|580986592|FG003|Overall Study|Death|1|||
160888802|NCT00829933|580986589|FG000|Overall Study|Lack of Efficacy|0|||
160888803|NCT00829933|580986590|FG001|Overall Study|Lack of Efficacy|1|||
160888804|NCT00829933|580986591|FG002|Overall Study|Lack of Efficacy|0|||
160888805|NCT00829933|580986592|FG003|Overall Study|Lack of Efficacy|0|||
160888806|NCT00829933|580986589|FG000|Overall Study|Physician Decision|5|||
160888807|NCT00829933|580986590|FG001|Overall Study|Physician Decision|7|||
160888808|NCT00829933|580986591|FG002|Overall Study|Physician Decision|8|||
160888809|NCT00829933|580986592|FG003|Overall Study|Physician Decision|1|||
160888810|NCT00829933|580986589|FG000|Overall Study|Pregnancy|0|||
160781155|NCT04999020|580583104|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160781156|NCT04999020|580583105|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160781157|NCT04999020|580583106|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
160781158|NCT04999020|580583107|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
160781159|NCT04999020|580583104|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
160781160|NCT04999020|580583105|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
160781161|NCT04999020|580583106|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
160781162|NCT04999020|580583107|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
160781163|NCT04999020|580583104|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
160781164|NCT04999020|580583105|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
160781165|NCT04999020|580583106|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
160781166|NCT04999020|580583107|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
160781167|NCT04999020|580583104|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160888811|NCT00829933|580986590|FG001|Overall Study|Pregnancy|0|||
160888812|NCT00829933|580986591|FG002|Overall Study|Pregnancy|0|||
160781168|NCT04999020|580583105|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160888813|NCT00829933|580986592|FG003|Overall Study|Pregnancy|2|||
160888814|NCT00829933|580986589|FG000|Overall Study|Protocol Violation|2|||
160888815|NCT00829933|580986590|FG001|Overall Study|Protocol Violation|1|||
160888816|NCT00829933|580986591|FG002|Overall Study|Protocol Violation|0|||
160542136|NCT03693625|579712932|FG000|Overall Study|Study Terminated By Sponsor|20|||
160781169|NCT04999020|580583106|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
160781170|NCT04999020|580583107|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160781171|NCT04999020|580583104|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
160781172|NCT04999020|580583105|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
160781173|NCT04999020|580583106|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
160781174|NCT04999020|580583107|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
160781175|NCT02609633|580583112|FG000|Overall Study|Consent Withdrawn|0|||
160781176|NCT02609633|580583113|FG001|Overall Study|Consent Withdrawn|1|||
160781177|NCT02609633|580583112|FG000|Overall Study|Protocol Deviation|1|||
160781178|NCT02609633|580583113|FG001|Overall Study|Protocol Deviation|0|||
160781179|NCT02609633|580583112|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
160781180|NCT02609633|580583113|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
160781181|NCT02609633|580583112|FG000|Overall Study|Reason not Specified|2|||
160781182|NCT02609633|580583113|FG001|Overall Study|Reason not Specified|1|||
160781183|NCT03123588|580583116|FG000|Overall Study|Study Terminated by Sponsor|2|||
160781184|NCT03123588|580583117|FG001|Overall Study|Study Terminated by Sponsor|5|||
160781185|NCT03123588|580583116|FG000|Overall Study|Withdrawal by Subject|1|||
160781186|NCT03123588|580583117|FG001|Overall Study|Withdrawal by Subject|0|||
160781187|NCT03123588|580583116|FG000|Overall Study|Adverse Event|1|||
160781188|NCT03123588|580583117|FG001|Overall Study|Adverse Event|0|||
160781189|NCT03123588|580583116|FG000|Overall Study|Physician Decision|2|||
160781190|NCT03123588|580583117|FG001|Overall Study|Physician Decision|1|||
160781191|NCT00866320|580583121|FG000|Overall Study|Withdrawal by Subject|4|||
160781192|NCT00866320|580583121|FG000|Overall Study|Death|2|||
160781193|NCT00366535|580583127|FG000|First Phase: 12 Weeks|Adverse Event|1|||
160781194|NCT00366535|580583128|FG001|First Phase: 12 Weeks|Adverse Event|3|||
160781195|NCT00366535|580583127|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
160781196|NCT00366535|580583128|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
160781197|NCT00366535|580583127|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
160781198|NCT00366535|580583128|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
160781199|NCT00366535|580583127|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
160781200|NCT00366535|580583128|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
160781201|NCT02958527|580583133|FG000|Overall Study|Not collected CRFs|12|||
160781202|NCT06042855|580583136|FG000|Overall Study|No Receipt of Study Drug|48|||
160781203|NCT06042855|580583137|FG001|Overall Study|No Receipt of Study Drug|57|||
160781204|NCT06042855|580583136|FG000|Overall Study|Administratively Withdrawn|59|||
160781205|NCT06042855|580583137|FG001|Overall Study|Administratively Withdrawn|59|||
160781206|NCT06038643|580583139|FG000|Overall Study|Withdrawal by Subject|9|||
160781207|NCT06038643|580583140|FG001|Overall Study|Withdrawal by Subject|4|||
160781208|NCT06038643|580583139|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
160781209|NCT06038643|580583140|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
160781210|NCT03573882|580583141|FG000|Overall Study|Study Terminated by Sponsor|22|||
160781211|NCT03573882|580583142|FG001|Overall Study|Study Terminated by Sponsor|17|||
160781212|NCT03573882|580583143|FG002|Overall Study|Study Terminated by Sponsor|18|||
160781213|NCT03573882|580583141|FG000|Overall Study|Withdrawal by Subject|6|||
160781214|NCT03573882|580583142|FG001|Overall Study|Withdrawal by Subject|11|||
160781215|NCT03573882|580583143|FG002|Overall Study|Withdrawal by Subject|7|||
160888817|NCT00829933|580986592|FG003|Overall Study|Protocol Violation|0|||
160542137|NCT03693625|579712933|FG001|Overall Study|Study Terminated By Sponsor|7|||
160781216|NCT03573882|580583141|FG000|Overall Study|Adverse Event|7|||
160781217|NCT03573882|580583142|FG001|Overall Study|Adverse Event|5|||
160781218|NCT03573882|580583143|FG002|Overall Study|Adverse Event|6|||
160781219|NCT03573882|580583141|FG000|Overall Study|Lost to Follow-up|2|||
160781220|NCT03573882|580583142|FG001|Overall Study|Lost to Follow-up|5|||
160781221|NCT03573882|580583143|FG002|Overall Study|Lost to Follow-up|3|||
160781222|NCT03573882|580583141|FG000|Overall Study|Physician Decision|4|||
160781223|NCT03573882|580583142|FG001|Overall Study|Physician Decision|3|||
160781224|NCT03573882|580583143|FG002|Overall Study|Physician Decision|2|||
160781225|NCT03573882|580583141|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
160781226|NCT03573882|580583142|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
160781227|NCT03573882|580583143|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
160781228|NCT03573882|580583141|FG000|Overall Study|Pregnancy|1|||
160781229|NCT03573882|580583142|FG001|Overall Study|Pregnancy|2|||
160781230|NCT03573882|580583143|FG002|Overall Study|Pregnancy|0|||
160781231|NCT03573882|580583141|FG000|Overall Study|Other|4|||
160781232|NCT03573882|580583142|FG001|Overall Study|Other|2|||
160781233|NCT03573882|580583143|FG002|Overall Study|Other|2|||
160781234|NCT02691572|580583144|FG000|Overall Study|Withdrawal by Subject|1|||
160638606|NCT00386100|580060720|FG000|Overall Study|Bone loss by DXA bone scan|1|||
160638607|NCT00386100|580060721|FG001|Overall Study|Bone loss by DXA bone scan|0|||
160638608|NCT00386100|580060720|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
160638609|NCT00386100|580060721|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
160638610|NCT00386100|580060720|FG000|Overall Study|7.6% bone loss|1|||
160638611|NCT00386100|580060721|FG001|Overall Study|7.6% bone loss|0|||
160638612|NCT00386100|580060720|FG000|Overall Study|Osteoporosis|0|||
160638613|NCT00386100|580060721|FG001|Overall Study|Osteoporosis|1|||
160638614|NCT00386100|580060720|FG000|Overall Study|Positive pregnancy test|1|||
160638615|NCT00386100|580060721|FG001|Overall Study|Positive pregnancy test|3|||
160638616|NCT00386100|580060720|FG000|Overall Study|Out of country for 5 months|1|||
160638617|NCT00386100|580060721|FG001|Overall Study|Out of country for 5 months|0|||
160638618|NCT00386100|580060720|FG000|Overall Study|Hb1Ac >8%|0|||
160638619|NCT00386100|580060721|FG001|Overall Study|Hb1Ac >8%|1|||
160638620|NCT00386100|580060720|FG000|Overall Study|Participant randomized in error|1|||
160638621|NCT00386100|580060721|FG001|Overall Study|Participant randomized in error|0|||
160638622|NCT02525562|580060722|FG000|Overall Study|Death|9|||
160638623|NCT02525562|580060723|FG001|Overall Study|Death|0|||
160638624|NCT02525562|580060724|FG002|Overall Study|Death|0|||
160638625|NCT02525562|580060722|FG000|Overall Study|Lost to Follow-up|19|||
160638626|NCT02525562|580060723|FG001|Overall Study|Lost to Follow-up|0|||
160638627|NCT02525562|580060724|FG002|Overall Study|Lost to Follow-up|0|||
160638628|NCT02525562|580060722|FG000|Overall Study|Withdrawal by Subject|37|||
160638629|NCT02525562|580060723|FG001|Overall Study|Withdrawal by Subject|0|||
160638630|NCT02525562|580060724|FG002|Overall Study|Withdrawal by Subject|0|||
160638631|NCT02525562|580060722|FG000|Overall Study|Revision/Removal of Study Device|4|||
160638632|NCT02525562|580060723|FG001|Overall Study|Revision/Removal of Study Device|0|||
160638633|NCT02525562|580060724|FG002|Overall Study|Revision/Removal of Study Device|0|||
160638634|NCT02525562|580060722|FG000|Overall Study|Study Closed by Sponsor|154|||
160638635|NCT02525562|580060723|FG001|Overall Study|Study Closed by Sponsor|0|||
160638636|NCT02525562|580060724|FG002|Overall Study|Study Closed by Sponsor|0|||
160638637|NCT01946282|580060728|FG000|Year 1|Did not return FIT kit|4186|||
160781235|NCT02691572|580583145|FG001|Overall Study|Withdrawal by Subject|0|||
160781236|NCT02691572|580583144|FG000|Overall Study|Protocol Violation|0|||
160638638|NCT01946282|580060729|FG001|Year 1|Did not return FIT kit|608|||
160638639|NCT01946282|580060730|FG002|Year 1|Did not return FIT kit|654|||
160638640|NCT01946282|580060728|FG000|Year 2|Did not return FIT kit|803|||
160638641|NCT01946282|580060729|FG001|Year 2|Did not return FIT kit|131|||
160638642|NCT01946282|580060730|FG002|Year 2|Did not return FIT kit|115|||
160638643|NCT01946282|580060728|FG000|Year 3|Did not return FIT kit|288|||
160638644|NCT01946282|580060729|FG001|Year 3|Did not return FIT kit|43|||
160638645|NCT01946282|580060730|FG002|Year 3|Did not return FIT kit|30|||
160781237|NCT02691572|580583145|FG001|Overall Study|Protocol Violation|1|||
160781238|NCT00699751|580583146|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
160781239|NCT00699751|580583147|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
160781240|NCT00699751|580583146|FG000|Period 1: Without/Before Drug Switch|Death|28|||
160781241|NCT00699751|580583147|FG001|Period 1: Without/Before Drug Switch|Death|29|||
160781242|NCT00699751|580583146|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
160781243|NCT00699751|580583147|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
160781244|NCT00699751|580583146|FG000|Period 1: Without/Before Drug Switch|Other|30|||
160781245|NCT00699751|580583147|FG001|Period 1: Without/Before Drug Switch|Other|20|||
160781246|NCT00699751|580583146|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
160638646|NCT00078819|580060731|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
160638647|NCT00078819|580060732|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
160638648|NCT00078819|580060733|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
160781247|NCT00699751|580583147|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
160781248|NCT00699751|580583146|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
160638649|NCT00078819|580060734|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
160638650|NCT00078819|580060731|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
160638651|NCT00078819|580060732|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
160638652|NCT00078819|580060733|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
160638653|NCT00078819|580060734|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
160638654|NCT00078819|580060731|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
160638655|NCT00078819|580060732|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
160638656|NCT00078819|580060733|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
160781249|NCT00699751|580583147|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
160781250|NCT00699751|580583146|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
160781251|NCT00699751|580583147|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
160781252|NCT00699751|580583146|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
160781253|NCT00699751|580583147|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
160781254|NCT01947933|580583148|FG000|Overall Study|Withdrawal by Subject|0|||
160781255|NCT01947933|580583149|FG001|Overall Study|Withdrawal by Subject|0|||
160781256|NCT01947933|580583150|FG002|Overall Study|Withdrawal by Subject|1|||
160781257|NCT01947933|580583151|FG003|Overall Study|Withdrawal by Subject|0|||
160781258|NCT01947933|580583152|FG004|Overall Study|Withdrawal by Subject|0|||
160781259|NCT01947933|580583153|FG005|Overall Study|Withdrawal by Subject|0|||
160781260|NCT01947933|580583154|FG006|Overall Study|Withdrawal by Subject|0|||
160781261|NCT01947933|580583155|FG007|Overall Study|Withdrawal by Subject|0|||
160781262|NCT01947933|580583156|FG008|Overall Study|Withdrawal by Subject|0|||
160781263|NCT01947933|580583148|FG000|Overall Study|Lost to Follow-up|0|||
160781264|NCT01947933|580583149|FG001|Overall Study|Lost to Follow-up|0|||
160781265|NCT01947933|580583150|FG002|Overall Study|Lost to Follow-up|0|||
160781266|NCT01947933|580583151|FG003|Overall Study|Lost to Follow-up|0|||
160781267|NCT01947933|580583152|FG004|Overall Study|Lost to Follow-up|0|||
160781268|NCT01947933|580583153|FG005|Overall Study|Lost to Follow-up|0|||
160781269|NCT01947933|580583154|FG006|Overall Study|Lost to Follow-up|0|||
160781270|NCT01947933|580583155|FG007|Overall Study|Lost to Follow-up|0|||
160781271|NCT01947933|580583156|FG008|Overall Study|Lost to Follow-up|1|||
160781272|NCT00294398|580583157|FG000|Overall Study|Lost to Follow-up|21|||
160781273|NCT00294398|580583158|FG001|Overall Study|Lost to Follow-up|26|||
160781274|NCT04439123|580583162|FG000|Overall Study|Adverse Event|11|||
160781275|NCT04439123|580583162|FG000|Overall Study|Death|1|||
160781276|NCT04439123|580583162|FG000|Overall Study|Disease progression|19|||
160781277|NCT04439123|580583162|FG000|Overall Study|Withdrawal by Subject|2|||
160781278|NCT04439123|580583162|FG000|Overall Study|Still on treatment|2|||
160781279|NCT02593864|580583164|FG000|Overall Study|Withdrawal by Subject|3|||
160781280|NCT02593864|580583164|FG000|Overall Study|Lost to Follow-up|3|||
160781281|NCT02114684|580583170|FG000|Overall Study|Death|6|||
160781282|NCT02114684|580583171|FG001|Overall Study|Death|4|||
160781283|NCT02114684|580583170|FG000|Overall Study|Lost to Follow-up|1|||
160781284|NCT02114684|580583171|FG001|Overall Study|Lost to Follow-up|2|||
160781285|NCT02114684|580583170|FG000|Overall Study|Withdrawal by Subject|1|||
160781286|NCT02114684|580583171|FG001|Overall Study|Withdrawal by Subject|2|||
160781287|NCT02114684|580583170|FG000|Overall Study|Relocation|3|||
160781288|NCT02114684|580583171|FG001|Overall Study|Relocation|1|||
160781289|NCT02114684|580583170|FG000|Overall Study|Rifampicin resistant on culture|0|||
160781290|NCT02114684|580583171|FG001|Overall Study|Rifampicin resistant on culture|1|||
160781291|NCT02114684|580583170|FG000|Overall Study|Patient Incarcerated|1|||
160781292|NCT02114684|580583171|FG001|Overall Study|Patient Incarcerated|0|||
160781293|NCT03345095|580583172|FG000|Overall Study|Lack of Efficacy|184|||
160781294|NCT03345095|580583173|FG001|Overall Study|Lack of Efficacy|156|||
160781295|NCT03345095|580583172|FG000|Overall Study|Adverse Event|36|||
160781296|NCT03345095|580583173|FG001|Overall Study|Adverse Event|118|||
160781297|NCT03345095|580583172|FG000|Overall Study|Withdrawal by Subject|22|||
160781298|NCT03345095|580583173|FG001|Overall Study|Withdrawal by Subject|59|||
160781299|NCT03345095|580583172|FG000|Overall Study|Physician Decision|3|||
160781300|NCT03345095|580583173|FG001|Overall Study|Physician Decision|18|||
160781301|NCT03345095|580583172|FG000|Overall Study|Death|2|||
160781302|NCT03345095|580583173|FG001|Overall Study|Death|4|||
160781303|NCT03345095|580583172|FG000|Overall Study|Other reasons|2|||
160638657|NCT00078819|580060734|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
160638658|NCT00078819|580060731|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
160638659|NCT00078819|580060732|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
160638660|NCT00078819|580060733|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
160638661|NCT00078819|580060734|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
160638662|NCT00078819|580060731|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
160638663|NCT00078819|580060732|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
160638664|NCT00078819|580060733|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
160638665|NCT00078819|580060734|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
160638666|NCT00078819|580060731|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
160638667|NCT00078819|580060732|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
160638668|NCT00078819|580060733|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
160638669|NCT00078819|580060734|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
160638670|NCT00078819|580060731|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
160638671|NCT00078819|580060732|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
160638672|NCT00078819|580060733|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
160781304|NCT03345095|580583173|FG001|Overall Study|Other reasons|11|||
160781305|NCT03345095|580583172|FG000|Overall Study|Protocol Violation|0|||
160781306|NCT03345095|580583173|FG001|Overall Study|Protocol Violation|1|||
160781307|NCT04971837|580584986|FG000|Overall Study|Long Term Illness|1|||
160781308|NCT04971837|580584986|FG000|Overall Study|BMI too low|9|||
160638673|NCT00078819|580060734|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
160638674|NCT00078819|580060731|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
160638675|NCT00078819|580060732|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
160638676|NCT00078819|580060733|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
160638677|NCT00078819|580060734|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
160638678|NCT04130919|580060735|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
160638679|NCT04130919|580060736|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
160638680|NCT04130919|580060737|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
160638681|NCT04130919|580060738|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
160638682|NCT04130919|580060739|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
160638683|NCT04130919|580060740|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
160781309|NCT04971837|580584986|FG000|Overall Study|geographic location|1|||
160781310|NCT04971837|580584986|FG000|Overall Study|Discontinued scheduling conflict|1|||
160781311|NCT03166631|580584987|FG000|Overall Study|Progressive disease|2|||
160781312|NCT03166631|580584988|FG001|Overall Study|Progressive disease|1|||
160781313|NCT03166631|580584989|FG002|Overall Study|Progressive disease|3|||
160781314|NCT03166631|580584990|FG003|Overall Study|Progressive disease|4|||
160781315|NCT03166631|580584991|FG004|Overall Study|Progressive disease|2|||
160781316|NCT03166631|580584992|FG005|Overall Study|Progressive disease|2|||
160781317|NCT03166631|580584993|FG006|Overall Study|Progressive disease|5|||
160888818|NCT00829933|580986589|FG000|Overall Study|withdrew before treatment started|5|||
160888819|NCT00829933|580986590|FG001|Overall Study|withdrew before treatment started|1|||
160888820|NCT00829933|580986591|FG002|Overall Study|withdrew before treatment started|2|||
160781318|NCT03166631|580584994|FG007|Overall Study|Progressive disease|6|||
160781319|NCT03166631|580584995|FG008|Overall Study|Progressive disease|11|||
160781320|NCT03166631|580584996|FG009|Overall Study|Progressive disease|5|||
160781321|NCT03166631|580584997|FG010|Overall Study|Progressive disease|7|||
160781322|NCT03166631|580584987|FG000|Overall Study|Physician Decision|0|||
160781323|NCT03166631|580584988|FG001|Overall Study|Physician Decision|0|||
160781324|NCT03166631|580584989|FG002|Overall Study|Physician Decision|0|||
160781325|NCT03166631|580584990|FG003|Overall Study|Physician Decision|0|||
160781326|NCT03166631|580584991|FG004|Overall Study|Physician Decision|0|||
160781327|NCT03166631|580584992|FG005|Overall Study|Physician Decision|0|||
160781328|NCT03166631|580584993|FG006|Overall Study|Physician Decision|1|||
160781329|NCT03166631|580584994|FG007|Overall Study|Physician Decision|0|||
160781330|NCT03166631|580584995|FG008|Overall Study|Physician Decision|1|||
160781331|NCT03166631|580584996|FG009|Overall Study|Physician Decision|0|||
160781332|NCT03166631|580584997|FG010|Overall Study|Physician Decision|1|||
160781333|NCT03166631|580584987|FG000|Overall Study|Death|0|||
160781334|NCT03166631|580584988|FG001|Overall Study|Death|0|||
160781335|NCT03166631|580584989|FG002|Overall Study|Death|0|||
160781336|NCT03166631|580584990|FG003|Overall Study|Death|0|||
160888821|NCT00829933|580986592|FG003|Overall Study|withdrew before treatment started|9|||
160888822|NCT03687970|580986596|FG000|Overall Study|visit scheduling conflicts|2|||
160888823|NCT03687970|580986597|FG001|Overall Study|visit scheduling conflicts|0|||
160888824|NCT00686998|580986598|FG000|Overall Study|Adverse Event|3|||
160888825|NCT00686998|580986599|FG001|Overall Study|Adverse Event|2|||
160888826|NCT00686998|580986600|FG002|Overall Study|Adverse Event|1|||
160888827|NCT00686998|580986598|FG000|Overall Study|Withdrawal by Subject|2|||
160888828|NCT00686998|580986599|FG001|Overall Study|Withdrawal by Subject|1|||
160888829|NCT00686998|580986600|FG002|Overall Study|Withdrawal by Subject|2|||
160888830|NCT00686998|580986598|FG000|Overall Study|Lack of Efficacy|7|||
160888831|NCT00686998|580986599|FG001|Overall Study|Lack of Efficacy|5|||
160888832|NCT00686998|580986600|FG002|Overall Study|Lack of Efficacy|0|||
160888833|NCT00686998|580986598|FG000|Overall Study|Other|0|||
160888834|NCT00686998|580986599|FG001|Overall Study|Other|0|||
160888835|NCT00686998|580986600|FG002|Overall Study|Other|1|||
160888836|NCT00686998|580986598|FG000|Overall Study|Safety Reasons|1|||
160888837|NCT00686998|580986599|FG001|Overall Study|Safety Reasons|0|||
160888838|NCT00686998|580986600|FG002|Overall Study|Safety Reasons|0|||
160888839|NCT06374394|580986604|FG000|Overall Study|Adverse Event|0|||
160888840|NCT06374394|580986605|FG001|Overall Study|Adverse Event|2|||
160888841|NCT06374394|580986604|FG000|Overall Study|Lost to Follow-up|6|||
160888842|NCT06374394|580986605|FG001|Overall Study|Lost to Follow-up|9|||
160888843|NCT06374394|580986604|FG000|Overall Study|Withdrawal by Subject|1|||
160888844|NCT06374394|580986605|FG001|Overall Study|Withdrawal by Subject|7|||
160888845|NCT06374394|580986604|FG000|Overall Study|Other|1|||
160888846|NCT06374394|580986605|FG001|Overall Study|Other|0|||
160888847|NCT00356122|580986606|FG000|TREATMENT|Lack of Efficacy|26|||
160888848|NCT00356122|580986606|FG000|TREATMENT|Adverse Event|10|||
160888849|NCT00356122|580986606|FG000|TREATMENT|Subject's request|4|||
160888850|NCT00356122|580986606|FG000|TREATMENT|Other|4|||
160888851|NCT00356122|580986606|FG000|TREATMENT|Did not receive study medication|1|||
160888852|NCT00356122|580986606|FG000|FOLLOW-UP|Death|37|||
160888853|NCT00356122|580986606|FG000|FOLLOW-UP|Lost to Follow-up|2|||
160888854|NCT00356122|580986606|FG000|FOLLOW-UP|Other|2|||
160888855|NCT02483429|580986612|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
160888856|NCT02483429|580986613|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
160888857|NCT03576274|580986614|FG000|Overall Study|Lost to Follow-up|3|||
160888858|NCT03576274|580986615|FG001|Overall Study|Lost to Follow-up|2|||
160888859|NCT03576274|580986616|FG002|Overall Study|Lost to Follow-up|3|||
160888860|NCT03576274|580986617|FG003|Overall Study|Lost to Follow-up|1|||
160888861|NCT03576274|580986618|FG004|Overall Study|Lost to Follow-up|3|||
160888862|NCT03576274|580986614|FG000|Overall Study|Withdrawal by Subject|5|||
160888863|NCT03576274|580986615|FG001|Overall Study|Withdrawal by Subject|3|||
160888864|NCT03576274|580986616|FG002|Overall Study|Withdrawal by Subject|2|||
160542138|NCT03693625|579712932|FG000|Overall Study|Withdrawal by Subject|1|||
160542139|NCT03693625|579712933|FG001|Overall Study|Withdrawal by Subject|1|||
160542140|NCT01883635|579712934|FG000|Overall Study|Withdrawal by Subject|4|||
160542141|NCT01883635|579712935|FG001|Overall Study|Withdrawal by Subject|0|||
160542142|NCT00761514|579712936|FG000|Overall Study|Adverse Event|1|||
160542143|NCT00761514|579712936|FG000|Overall Study|Withdrawal by Subject|2|||
160542144|NCT00761514|579712936|FG000|Overall Study|Lost to Follow-up|1|||
160542145|NCT00761514|579712936|FG000|Overall Study|Health insurance didn't cover study drug|1|||
160542146|NCT00761514|579712936|FG000|Overall Study|Problem complying with study visit|1|||
160542147|NCT00761514|579712936|FG000|Overall Study|Unable to pay for medications|1|||
160542148|NCT00159861|579712937|FG000|Core Study - 16 Weeks|Death|3|||
160542149|NCT00159861|579712938|FG001|Core Study - 16 Weeks|Death|0|||
160542150|NCT00159861|579712937|FG000|Core Study - 16 Weeks|Adverse Event|12|||
160542151|NCT00159861|579712938|FG001|Core Study - 16 Weeks|Adverse Event|6|||
160542152|NCT00159861|579712937|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
160542153|NCT00159861|579712938|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
160542154|NCT00159861|579712937|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
160542155|NCT00159861|579712938|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
160542156|NCT00159861|579712937|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
160888865|NCT03576274|580986617|FG003|Overall Study|Withdrawal by Subject|8|||
160888866|NCT03576274|580986618|FG004|Overall Study|Withdrawal by Subject|6|||
160888867|NCT00543855|580987772|FG000|Overall Study|Adverse Event|3|||
160888868|NCT00543855|580987773|FG001|Overall Study|Adverse Event|1|||
160888869|NCT00543855|580987774|FG002|Overall Study|Adverse Event|3|||
160888870|NCT00543855|580987775|FG003|Overall Study|Adverse Event|4|||
160888871|NCT00543855|580987772|FG000|Overall Study|Lost to Follow-up|0|||
160888872|NCT00543855|580987773|FG001|Overall Study|Lost to Follow-up|0|||
160888873|NCT00543855|580987774|FG002|Overall Study|Lost to Follow-up|1|||
160888874|NCT00543855|580987775|FG003|Overall Study|Lost to Follow-up|0|||
160888875|NCT00543855|580987772|FG000|Overall Study|Withdrawal by Subject|0|||
160888876|NCT00543855|580987773|FG001|Overall Study|Withdrawal by Subject|1|||
160542157|NCT00159861|579712938|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
160542158|NCT00159861|579712937|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
160542159|NCT00159861|579712938|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
160638684|NCT04130919|580060735|FG000|Blinded Treatment Phase|Adverse Event|0|||
160542160|NCT00159861|579712937|FG000|Extension Study - up to 3 Years|Death|24|||
160542161|NCT00159861|579712938|FG001|Extension Study - up to 3 Years|Death|28|||
160542162|NCT00159861|579712937|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
160542163|NCT00159861|579712938|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
160542164|NCT00159861|579712937|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
160542165|NCT00159861|579712938|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
160542166|NCT00159861|579712937|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
160542167|NCT00159861|579712938|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
160542168|NCT00159861|579712937|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
160542169|NCT00159861|579712938|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
160542170|NCT04294901|579712941|FG000|Overall Study|Death|86|||
160542171|NCT04294901|579712942|FG001|Overall Study|Death|110|||
160542172|NCT04294901|579712941|FG000|Overall Study|Provider did not have historical control patients|581|||
160638685|NCT04130919|580060736|FG001|Blinded Treatment Phase|Adverse Event|0|||
160888877|NCT00543855|580987774|FG002|Overall Study|Withdrawal by Subject|2|||
160888878|NCT00543855|580987775|FG003|Overall Study|Withdrawal by Subject|0|||
160888879|NCT00543855|580987772|FG000|Overall Study|Protocol Violation|1|||
160888880|NCT00543855|580987773|FG001|Overall Study|Protocol Violation|0|||
160888881|NCT00543855|580987774|FG002|Overall Study|Protocol Violation|0|||
160888882|NCT00543855|580987775|FG003|Overall Study|Protocol Violation|0|||
160888883|NCT04854642|580987776|FG000|Overall Study|Adverse Event|1|||
160888884|NCT04854642|580987777|FG001|Overall Study|Adverse Event|2|||
160888885|NCT04854642|580987776|FG000|Overall Study|Withdrawal by Subject|0|||
160888886|NCT04854642|580987777|FG001|Overall Study|Withdrawal by Subject|1|||
160888887|NCT00301821|580987782|FG000|Overall Study|Ineligible|25|||
160888888|NCT00301821|580987782|FG000|Overall Study|Cancel|1|||
160888889|NCT02294773|580987783|FG000|Overall Study|Withdrawal by Subject|0|||
160888890|NCT02294773|580987784|FG001|Overall Study|Withdrawal by Subject|2|||
160888891|NCT01865084|580987785|FG000|Double Blind Period (DB)|Adverse Event|2|||
160888892|NCT01865084|580987786|FG001|Double Blind Period (DB)|Adverse Event|2|||
160888893|NCT01865084|580987787|FG002|Double Blind Period (DB)|Adverse Event|1|||
160888894|NCT01865084|580987785|FG000|Double Blind Period (DB)|Protocol Violation|0|||
160888895|NCT01865084|580987786|FG001|Double Blind Period (DB)|Protocol Violation|0|||
160888896|NCT01865084|580987787|FG002|Double Blind Period (DB)|Protocol Violation|1|||
160638686|NCT04130919|580060737|FG002|Blinded Treatment Phase|Adverse Event|1|||
160638687|NCT04130919|580060738|FG003|Blinded Treatment Phase|Adverse Event|0|||
160638688|NCT04130919|580060739|FG004|Blinded Treatment Phase|Adverse Event|0|||
160638689|NCT04130919|580060740|FG005|Blinded Treatment Phase|Adverse Event|0|||
160638690|NCT04130919|580060735|FG000|Blinded Treatment Phase|Disease worsening|0|||
160638691|NCT04130919|580060736|FG001|Blinded Treatment Phase|Disease worsening|0|||
160638692|NCT04130919|580060737|FG002|Blinded Treatment Phase|Disease worsening|1|||
160638693|NCT04130919|580060738|FG003|Blinded Treatment Phase|Disease worsening|0|||
160638694|NCT04130919|580060739|FG004|Blinded Treatment Phase|Disease worsening|0|||
160638695|NCT04130919|580060740|FG005|Blinded Treatment Phase|Disease worsening|0|||
160638696|NCT04130919|580060735|FG000|Blinded Treatment Phase|Investigator's decision|0|||
160638697|NCT04130919|580060736|FG001|Blinded Treatment Phase|Investigator's decision|1|||
160638698|NCT04130919|580060737|FG002|Blinded Treatment Phase|Investigator's decision|0|||
160638699|NCT04130919|580060738|FG003|Blinded Treatment Phase|Investigator's decision|0|||
160638700|NCT04130919|580060739|FG004|Blinded Treatment Phase|Investigator's decision|0|||
160638701|NCT04130919|580060740|FG005|Blinded Treatment Phase|Investigator's decision|0|||
160638702|NCT04130919|580060735|FG000|Blinded Treatment Phase|Withdrew consent|1|||
160638703|NCT04130919|580060736|FG001|Blinded Treatment Phase|Withdrew consent|0|||
160638704|NCT04130919|580060737|FG002|Blinded Treatment Phase|Withdrew consent|0|||
160638705|NCT04130919|580060738|FG003|Blinded Treatment Phase|Withdrew consent|0|||
160638706|NCT04130919|580060739|FG004|Blinded Treatment Phase|Withdrew consent|0|||
160638707|NCT04130919|580060740|FG005|Blinded Treatment Phase|Withdrew consent|0|||
160638708|NCT04130919|580060735|FG000|Open-label Treatment Phase|Withdrew consent|0|||
160638709|NCT04130919|580060736|FG001|Open-label Treatment Phase|Withdrew consent|0|||
160638710|NCT04130919|580060737|FG002|Open-label Treatment Phase|Withdrew consent|0|||
160638711|NCT04130919|580060738|FG003|Open-label Treatment Phase|Withdrew consent|1|||
160638712|NCT04130919|580060739|FG004|Open-label Treatment Phase|Withdrew consent|1|||
160638713|NCT04130919|580060740|FG005|Open-label Treatment Phase|Withdrew consent|1|||
160638714|NCT04130919|580060735|FG000|Open-label Treatment Phase|Disease worsening|0|||
160638715|NCT04130919|580060736|FG001|Open-label Treatment Phase|Disease worsening|0|||
160638716|NCT04130919|580060737|FG002|Open-label Treatment Phase|Disease worsening|0|||
160638717|NCT04130919|580060738|FG003|Open-label Treatment Phase|Disease worsening|1|||
160638718|NCT04130919|580060739|FG004|Open-label Treatment Phase|Disease worsening|0|||
160638719|NCT04130919|580060740|FG005|Open-label Treatment Phase|Disease worsening|1|||
160638720|NCT04130919|580060735|FG000|Open-label Treatment Phase|Investigator's decision|0|||
160638721|NCT04130919|580060736|FG001|Open-label Treatment Phase|Investigator's decision|0|||
160638722|NCT04130919|580060737|FG002|Open-label Treatment Phase|Investigator's decision|0|||
160638723|NCT04130919|580060738|FG003|Open-label Treatment Phase|Investigator's decision|1|||
160638724|NCT04130919|580060739|FG004|Open-label Treatment Phase|Investigator's decision|0|||
160638725|NCT04130919|580060740|FG005|Open-label Treatment Phase|Investigator's decision|0|||
160638726|NCT04130919|580060735|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
160638727|NCT04130919|580060736|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
160638728|NCT04130919|580060737|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
160638729|NCT04130919|580060738|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
160638730|NCT04130919|580060739|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
160638731|NCT04130919|580060740|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
160638732|NCT04130919|580060735|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
160888897|NCT01865084|580987785|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
160888898|NCT01865084|580987786|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
160888899|NCT01865084|580987787|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
160888900|NCT01865084|580987785|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
160888901|NCT01865084|580987786|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
160888902|NCT01865084|580987787|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
160781337|NCT03166631|580584991|FG004|Overall Study|Death|1|||
160888903|NCT01865084|580987785|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
160888904|NCT01865084|580987786|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
160888905|NCT01865084|580987787|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
160888906|NCT01865084|580987785|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
160888907|NCT01865084|580987786|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
160888908|NCT01865084|580987787|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
160888909|NCT01865084|580987785|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
160888910|NCT01865084|580987786|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
160888911|NCT01865084|580987787|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
160888912|NCT01865084|580987785|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
160888913|NCT01865084|580987786|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
160888914|NCT01865084|580987787|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
160888915|NCT01865084|580987785|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
160888916|NCT01865084|580987786|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
160888917|NCT01865084|580987787|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
160888918|NCT01994590|580987790|FG000|Overall Study|Adverse Event|1|||
160888919|NCT01994590|580987790|FG000|Overall Study|Trial Terminated|1|||
160888920|NCT00719264|580987792|FG000|Overall Study|Adverse Event|41|||
160888921|NCT00719264|580987793|FG001|Overall Study|Adverse Event|49|||
160888922|NCT00719264|580987792|FG000|Overall Study|Death|13|||
160888923|NCT00719264|580987793|FG001|Overall Study|Death|10|||
160888924|NCT00719264|580987792|FG000|Overall Study|Administrative Problems|6|||
160888925|NCT00719264|580987793|FG001|Overall Study|Administrative Problems|4|||
160888926|NCT00719264|580987792|FG000|Overall Study|Lost to Follow-up|1|||
160888927|NCT00719264|580987793|FG001|Overall Study|Lost to Follow-up|1|||
160888928|NCT00719264|580987792|FG000|Overall Study|Withdrawal by Subject|12|||
160888929|NCT00719264|580987793|FG001|Overall Study|Withdrawal by Subject|7|||
160888930|NCT00719264|580987792|FG000|Overall Study|Protocol Deviation|1|||
160888931|NCT00719264|580987793|FG001|Overall Study|Protocol Deviation|3|||
160888932|NCT00719264|580987792|FG000|Overall Study|New Cancer Therapy|4|||
160888933|NCT00719264|580987793|FG001|Overall Study|New Cancer Therapy|2|||
160888934|NCT00719264|580987792|FG000|Overall Study|Disease Progression|104|||
160638733|NCT04130919|580060736|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
160638734|NCT04130919|580060737|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
160638735|NCT04130919|580060738|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
160638736|NCT04130919|580060739|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
160888935|NCT00719264|580987793|FG001|Overall Study|Disease Progression|107|||
160888936|NCT01277042|580987794|FG000|Overall Study|Adverse Event|4|||
160888937|NCT01277042|580987795|FG001|Overall Study|Adverse Event|3|||
160888938|NCT01277042|580987794|FG000|Overall Study|Lost to Follow-up|2|||
160888939|NCT01277042|580987795|FG001|Overall Study|Lost to Follow-up|2|||
160888940|NCT01277042|580987794|FG000|Overall Study|Withdrawal by Subject|2|||
160888941|NCT01277042|580987795|FG001|Overall Study|Withdrawal by Subject|0|||
160888942|NCT03581786|580987800|FG000|Overall Study|Death|67|||
160888943|NCT03581786|580987801|FG001|Overall Study|Death|47|||
160888944|NCT03581786|580987800|FG000|Overall Study|Withdrawal by Subject|2|||
160888945|NCT03581786|580987801|FG001|Overall Study|Withdrawal by Subject|5|||
160888946|NCT03581786|580987800|FG000|Overall Study|Lost to Follow-up|7|||
160888947|NCT03581786|580987801|FG001|Overall Study|Lost to Follow-up|4|||
160888948|NCT03581786|580987800|FG000|Overall Study|reason other than specified above|0|||
160888949|NCT03581786|580987801|FG001|Overall Study|reason other than specified above|1|||
160888950|NCT02469038|580987804|FG000|Overall Study|Physician Decision|4|||
160888951|NCT02469038|580987805|FG001|Overall Study|Physician Decision|5|||
160888952|NCT03435640|580987806|FG000|Overall Study|Withdrawal by Subject|0|||
160888953|NCT03435640|580987807|FG001|Overall Study|Withdrawal by Subject|1|||
160888954|NCT03435640|580987808|FG002|Overall Study|Withdrawal by Subject|0|||
160888955|NCT03435640|580987809|FG003|Overall Study|Withdrawal by Subject|2|||
160888956|NCT03435640|580987810|FG004|Overall Study|Withdrawal by Subject|0|||
160638737|NCT04130919|580060740|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
160638738|NCT01462695|580060741|FG000|Overall Study|Adverse Event|1|||
160638739|NCT01462695|580060742|FG001|Overall Study|Adverse Event|1|||
160638740|NCT01462695|580060741|FG000|Overall Study|Death|2|||
160638741|NCT01462695|580060742|FG001|Overall Study|Death|0|||
160638742|NCT01462695|580060741|FG000|Overall Study|Lack of Efficacy|6|||
160638743|NCT01462695|580060742|FG001|Overall Study|Lack of Efficacy|12|||
160638744|NCT01462695|580060741|FG000|Overall Study|Physician Decision|5|||
160638745|NCT01462695|580060742|FG001|Overall Study|Physician Decision|0|||
160638746|NCT01462695|580060741|FG000|Overall Study|Withdrawal by Subject|2|||
160638747|NCT01462695|580060742|FG001|Overall Study|Withdrawal by Subject|0|||
160638748|NCT01462695|580060741|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
160638749|NCT01462695|580060742|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
160638750|NCT02400905|580060743|FG000|Overall Study|Death|24|||
160638751|NCT02400905|580060743|FG000|Overall Study|Lost to Follow-up|18|||
160638752|NCT02400905|580060743|FG000|Overall Study|Withdrawal by Subject|16|||
160638753|NCT02400905|580060743|FG000|Overall Study|Physician Decision|4|||
160638754|NCT02400905|580060743|FG000|Overall Study|Other|1|||
160638755|NCT03196791|580060746|FG000|Overall Study|Protocol Violation|7|||
160638756|NCT03196791|580060747|FG001|Overall Study|Protocol Violation|3|||
160638757|NCT03196791|580060746|FG000|Overall Study|Withdrawal by Subject|3|||
160638758|NCT03196791|580060747|FG001|Overall Study|Withdrawal by Subject|2|||
160638759|NCT00479765|580060751|FG000|Overall Study|study terminated|4|||
160638760|NCT01021137|580060755|FG000|Overall Study|Lost to Follow-up|9|||
160638761|NCT01021137|580060756|FG001|Overall Study|Lost to Follow-up|4|||
160638762|NCT01021137|580060757|FG002|Overall Study|Lost to Follow-up|2|||
160638763|NCT01021137|580060758|FG003|Overall Study|Lost to Follow-up|6|||
160638764|NCT01021137|580060755|FG000|Overall Study|Withdrawal by Subject|1|||
160638765|NCT01021137|580060756|FG001|Overall Study|Withdrawal by Subject|0|||
160638766|NCT01021137|580060757|FG002|Overall Study|Withdrawal by Subject|0|||
160638767|NCT01021137|580060758|FG003|Overall Study|Withdrawal by Subject|3|||
160638768|NCT00725725|580060759|FG000|Overall Study|Adverse Event|1|||
160638769|NCT00725725|580060760|FG001|Overall Study|Adverse Event|3|||
160638770|NCT00725725|580060761|FG002|Overall Study|Adverse Event|2|||
160638771|NCT00725725|580060759|FG000|Overall Study|Lost to Follow-up|2|||
160638772|NCT00725725|580060760|FG001|Overall Study|Lost to Follow-up|0|||
160638773|NCT00725725|580060761|FG002|Overall Study|Lost to Follow-up|2|||
160638774|NCT00725725|580060759|FG000|Overall Study|Withdrawal by Subject|1|||
160638775|NCT00725725|580060760|FG001|Overall Study|Withdrawal by Subject|0|||
160638776|NCT00725725|580060761|FG002|Overall Study|Withdrawal by Subject|1|||
160638777|NCT00725725|580060759|FG000|Overall Study|Protocol Violation|0|||
160638778|NCT00725725|580060760|FG001|Overall Study|Protocol Violation|1|||
160638779|NCT00725725|580060761|FG002|Overall Study|Protocol Violation|0|||
160638780|NCT02392559|580060762|FG000|Overall Study|Withdrawal by Subject|0|||
160638781|NCT02392559|580060763|FG001|Overall Study|Withdrawal by Subject|1|||
160638782|NCT00944125|580060771|FG000|3 to 6 Months|Withdrawal by Subject|0|||
160638783|NCT00944125|580060772|FG001|3 to 6 Months|Withdrawal by Subject|2|||
160638784|NCT00944125|580060771|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
160638785|NCT00944125|580060772|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
160638786|NCT04816877|580060775|FG000|Overall Study|Withdrawal by Subject|1|||
160638787|NCT04816877|580060776|FG001|Overall Study|Withdrawal by Subject|0|||
160638788|NCT02176642|580060777|FG000|Overall Study|Withdrawal by Subject|0|||
160638789|NCT02176642|580060778|FG001|Overall Study|Withdrawal by Subject|1|||
160638790|NCT03338673|580060780|FG000|Overall Study|Lost to Follow-up|1|||
160638791|NCT03338673|580060781|FG001|Overall Study|Lost to Follow-up|1|||
160888957|NCT03435640|580987811|FG005|Overall Study|Withdrawal by Subject|0|||
160638792|NCT00995930|580060787|FG000|Overall Study|Protocol deviation|2|||
160638793|NCT00995930|580060788|FG001|Overall Study|Protocol deviation|5|||
160638794|NCT00995930|580060787|FG000|Overall Study|Death|0|||
160638795|NCT00995930|580060788|FG001|Overall Study|Death|1|||
160638796|NCT00995930|580060787|FG000|Overall Study|Administrative problems|4|||
160638797|NCT00995930|580060788|FG001|Overall Study|Administrative problems|2|||
160638798|NCT00995930|580060787|FG000|Overall Study|Lost to Follow-up|1|||
160638799|NCT00995930|580060788|FG001|Overall Study|Lost to Follow-up|2|||
160638800|NCT00995930|580060787|FG000|Overall Study|Withdrawal by Subject|3|||
160638801|NCT00995930|580060788|FG001|Overall Study|Withdrawal by Subject|4|||
160638802|NCT00995930|580060787|FG000|Overall Study|Adverse Event|11|||
160638803|NCT00995930|580060788|FG001|Overall Study|Adverse Event|14|||
160638804|NCT05788237|580060791|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
160638805|NCT05788237|580060792|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
160638806|NCT05788237|580060793|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
160638807|NCT05788237|580060794|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
160638808|NCT05788237|580060791|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
160638809|NCT05788237|580060792|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
160638810|NCT05788237|580060793|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
160638811|NCT05788237|580060794|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
160638812|NCT05788237|580060791|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
160638813|NCT05788237|580060792|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
160638814|NCT05788237|580060793|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
160638815|NCT05788237|580060794|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
160638816|NCT05788237|580060791|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
160638817|NCT05788237|580060792|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
160638818|NCT05788237|580060793|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
160638819|NCT05788237|580060794|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
160638820|NCT05788237|580060791|FG000|SSA (Approximately 2 Months)|Death|0|||
160638821|NCT05788237|580060792|FG001|SSA (Approximately 2 Months)|Death|1|||
160638822|NCT05788237|580060793|FG002|SSA (Approximately 2 Months)|Death|0|||
160638823|NCT05788237|580060794|FG003|SSA (Approximately 2 Months)|Death|0|||
160638824|NCT05788237|580060791|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
160638825|NCT05788237|580060792|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
160638826|NCT05788237|580060793|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
160638827|NCT05788237|580060794|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
160638828|NCT05788237|580060791|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
160638829|NCT05788237|580060792|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
160638830|NCT05788237|580060793|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
160638831|NCT05788237|580060794|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
160638832|NCT05788237|580060791|FG000|SSB (Approximately 1 Month)|Other|0|||
160638833|NCT05788237|580060792|FG001|SSB (Approximately 1 Month)|Other|0|||
160638834|NCT05788237|580060793|FG002|SSB (Approximately 1 Month)|Other|0|||
160638835|NCT05788237|580060794|FG003|SSB (Approximately 1 Month)|Other|1|||
160638836|NCT00686790|580062807|FG000|Overall Study|Adverse Event|2|||
160638837|NCT00686790|580062807|FG000|Overall Study|Withdrawal by Subject|1|||
160638838|NCT00686790|580062807|FG000|Overall Study|Death|1|||
160638839|NCT00686790|580062807|FG000|Overall Study|Lost to Follow-up|12|||
160638840|NCT00096382|580062808|FG000|Overall Study|Not treated|1|||
160638841|NCT00096382|580062809|FG001|Overall Study|Not treated|0|||
160638842|NCT00096382|580062808|FG000|Overall Study|Death during treatment|1|||
160638843|NCT00096382|580062809|FG001|Overall Study|Death during treatment|0|||
160638844|NCT03862625|580062813|FG000|Overall Study|Lost to Follow-up|0|||
160638845|NCT03862625|580062814|FG001|Overall Study|Lost to Follow-up|1|||
160638846|NCT01835132|580062815|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
160638847|NCT01681771|580062816|FG000|Overall Study|Lost to Follow-up|4|||
160638848|NCT01681771|580062817|FG001|Overall Study|Lost to Follow-up|2|||
160638849|NCT02770716|580062826|FG000|Overall Study|Death|101|||
160638850|NCT02770716|580062827|FG001|Overall Study|Death|45|||
160638851|NCT02770716|580062826|FG000|Overall Study|Withdrawal by Subject|4|||
160638852|NCT02770716|580062827|FG001|Overall Study|Withdrawal by Subject|2|||
160638853|NCT02770716|580062826|FG000|Overall Study|Lost to Follow-up|1|||
160638854|NCT02770716|580062827|FG001|Overall Study|Lost to Follow-up|0|||
160638855|NCT02770716|580062826|FG000|Overall Study|Various reasons|6|||
160638856|NCT02770716|580062827|FG001|Overall Study|Various reasons|2|||
160638857|NCT02424565|580062828|FG000|Period 1 (D0)|Protocol Violation|0|||
160638858|NCT02424565|580062829|FG001|Period 1 (D0)|Protocol Violation|1|||
160638859|NCT01677910|580062830|FG000|Double-Blind Treatment Period|Adverse Event|6|||
160638860|NCT01677910|580062831|FG001|Double-Blind Treatment Period|Adverse Event|2|||
160638861|NCT01677910|580062832|FG002|Double-Blind Treatment Period|Adverse Event|3|||
160638862|NCT01677910|580062833|FG003|Double-Blind Treatment Period|Adverse Event|0|||
160638863|NCT01677910|580062830|FG000|Double-Blind Treatment Period|Physician Decision|0|||
160638864|NCT01677910|580062831|FG001|Double-Blind Treatment Period|Physician Decision|0|||
160638865|NCT01677910|580062832|FG002|Double-Blind Treatment Period|Physician Decision|1|||
160542173|NCT04294901|579712942|FG001|Overall Study|Provider did not have historical control patients|0|||
160542174|NCT04294901|579712941|FG000|Overall Study|Provider did not have intervention patients|0|||
160542175|NCT04294901|579712942|FG001|Overall Study|Provider did not have intervention patients|98|||
160542176|NCT01934556|579712945|FG000|Overall Study|Withdrawal by Subject|0|||
160542177|NCT01934556|579712946|FG001|Overall Study|Withdrawal by Subject|1|||
160542178|NCT01934556|579712947|FG002|Overall Study|Withdrawal by Subject|1|||
160542179|NCT01934556|579712945|FG000|Overall Study|Lost to Follow-up|4|||
160542180|NCT01934556|579712946|FG001|Overall Study|Lost to Follow-up|10|||
160542181|NCT01934556|579712947|FG002|Overall Study|Lost to Follow-up|7|||
160542182|NCT01934556|579712945|FG000|Overall Study|Death|1|||
160542183|NCT01934556|579712946|FG001|Overall Study|Death|5|||
160542184|NCT01934556|579712947|FG002|Overall Study|Death|2|||
160542185|NCT05038020|579712949|FG000|Overall Study|Early Termination|3|||
160542186|NCT05038020|579712950|FG001|Overall Study|Early Termination|0|||
160542187|NCT03416153|579712951|FG000|Overall Study|Physician Decision|1|||
160542188|NCT03416153|579712952|FG001|Overall Study|Physician Decision|1|||
160542189|NCT03416153|579712951|FG000|Overall Study|Withdrawal by Subject|1|||
160542190|NCT03416153|579712952|FG001|Overall Study|Withdrawal by Subject|0|||
160542191|NCT03657043|579714166|FG000|Overall Study|Withdrawal by Subject|1|||
160542192|NCT03657043|579714167|FG001|Overall Study|Withdrawal by Subject|1|||
160542193|NCT03657043|579714168|FG002|Overall Study|Withdrawal by Subject|0|||
160542194|NCT03657043|579714169|FG003|Overall Study|Withdrawal by Subject|0|||
160542195|NCT03657043|579714170|FG004|Overall Study|Withdrawal by Subject|4|||
160542196|NCT03657043|579714166|FG000|Overall Study|Study closure by Sponsor|0|||
160542197|NCT03657043|579714167|FG001|Overall Study|Study closure by Sponsor|2|||
160542198|NCT03657043|579714168|FG002|Overall Study|Study closure by Sponsor|0|||
160542199|NCT03657043|579714169|FG003|Overall Study|Study closure by Sponsor|0|||
160888958|NCT03435640|580987812|FG006|Overall Study|Withdrawal by Subject|3|||
160888959|NCT03435640|580987813|FG007|Overall Study|Withdrawal by Subject|0|||
160888960|NCT03435640|580987814|FG008|Overall Study|Withdrawal by Subject|0|||
160888961|NCT03435640|580987815|FG009|Overall Study|Withdrawal by Subject|2|||
160888962|NCT03435640|580987816|FG010|Overall Study|Withdrawal by Subject|3|||
160888963|NCT03435640|580987806|FG000|Overall Study|Lost to Follow-up|0|||
160888964|NCT03435640|580987807|FG001|Overall Study|Lost to Follow-up|0|||
160888965|NCT03435640|580987808|FG002|Overall Study|Lost to Follow-up|1|||
160888966|NCT03435640|580987809|FG003|Overall Study|Lost to Follow-up|0|||
160888967|NCT03435640|580987810|FG004|Overall Study|Lost to Follow-up|0|||
160888968|NCT03435640|580987811|FG005|Overall Study|Lost to Follow-up|0|||
160888969|NCT03435640|580987812|FG006|Overall Study|Lost to Follow-up|0|||
160888970|NCT03435640|580987813|FG007|Overall Study|Lost to Follow-up|0|||
160888971|NCT03435640|580987814|FG008|Overall Study|Lost to Follow-up|0|||
160888972|NCT03435640|580987815|FG009|Overall Study|Lost to Follow-up|0|||
160888973|NCT03435640|580987816|FG010|Overall Study|Lost to Follow-up|0|||
160888974|NCT01347307|580987817|FG000|Overall Study|Death|0|||
160888975|NCT01347307|580987818|FG001|Overall Study|Death|4|||
160888976|NCT01347307|580987817|FG000|Overall Study|Physician Decision|0|||
160888977|NCT01347307|580987818|FG001|Overall Study|Physician Decision|1|||
160888978|NCT00740246|580987827|FG000|Overall Study|Received Blood Transfusion|0|||
160888979|NCT00740246|580987828|FG001|Overall Study|Received Blood Transfusion|1|||
160888980|NCT00740246|580987827|FG000|Overall Study|Adverse Event|1|||
160888981|NCT00740246|580987828|FG001|Overall Study|Adverse Event|2|||
160888982|NCT00740246|580987827|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
160888983|NCT00740246|580987828|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
160888984|NCT00740246|580987827|FG000|Overall Study|Lost to Follow-up|2|||
160888985|NCT00740246|580987828|FG001|Overall Study|Lost to Follow-up|2|||
160888986|NCT00740246|580987827|FG000|Overall Study|Withdrawal by Subject|4|||
160888987|NCT00740246|580987828|FG001|Overall Study|Withdrawal by Subject|3|||
160888988|NCT00740246|580987827|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
160888989|NCT00740246|580987828|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
160888990|NCT00740246|580987827|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
160888991|NCT00740246|580987828|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
160888992|NCT00740246|580987827|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
160888993|NCT00740246|580987828|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
160888994|NCT00740246|580987827|FG000|Overall Study|Unable To Comply With Study Visits|2|||
160888995|NCT00740246|580987828|FG001|Overall Study|Unable To Comply With Study Visits|0|||
160888996|NCT00740246|580987827|FG000|Overall Study|Unable to Access Vein|0|||
160888997|NCT00740246|580987828|FG001|Overall Study|Unable to Access Vein|2|||
160888998|NCT00740246|580987827|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
160888999|NCT00740246|580987828|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
160889000|NCT03584373|580987829|FG000|Overall Study|Lost to Follow-up|7|||
160889001|NCT03584373|580987830|FG001|Overall Study|Lost to Follow-up|8|||
160889002|NCT00662532|580987832|FG000|Overall Study|Adverse Event|0|||
160889003|NCT00662532|580987833|FG001|Overall Study|Adverse Event|1|||
160889004|NCT00662532|580987832|FG000|Overall Study|Lost to Follow-up|0|||
160889005|NCT00662532|580987833|FG001|Overall Study|Lost to Follow-up|1|||
160889006|NCT00366340|580987834|FG000|Infant Series|Protocol Violation|3|||
160889007|NCT00366340|580987835|FG001|Infant Series|Protocol Violation|4|||
160889008|NCT00366340|580987834|FG000|Infant Series|Withdrawal by Subject|3|||
160889009|NCT00366340|580987835|FG001|Infant Series|Withdrawal by Subject|3|||
160889010|NCT00366340|580987834|FG000|Infant Series|Adverse Event|0|||
160889011|NCT00366340|580987835|FG001|Infant Series|Adverse Event|2|||
160889012|NCT00366340|580987834|FG000|Infant Series|Lost to Follow-up|1|||
160889013|NCT00366340|580987835|FG001|Infant Series|Lost to Follow-up|1|||
160889014|NCT00366340|580987834|FG000|Infant Series|Failure to return|1|||
160889015|NCT00366340|580987835|FG001|Infant Series|Failure to return|0|||
160889016|NCT00366340|580987834|FG000|After the Infant Series|Parent/legal guardian request|1|||
160889017|NCT00366340|580987835|FG001|After the Infant Series|Parent/legal guardian request|1|||
160889018|NCT00366340|580987834|FG000|After the Infant Series|Failed to return|0|||
160889019|NCT00366340|580987835|FG001|After the Infant Series|Failed to return|1|||
160889020|NCT00366340|580987834|FG000|After the Infant Series|Protocol Violation|2|||
160889021|NCT00366340|580987835|FG001|After the Infant Series|Protocol Violation|2|||
160889022|NCT00366340|580987834|FG000|After the Infant Series|Adverse Event|0|||
160889023|NCT00366340|580987835|FG001|After the Infant Series|Adverse Event|1|||
160889024|NCT00366340|580987834|FG000|After the Infant Series|Lost to Follow-up|0|||
160889025|NCT00366340|580987835|FG001|After the Infant Series|Lost to Follow-up|1|||
160889026|NCT00366340|580987834|FG000|Toddler Dose|Failed to return|1|||
160889027|NCT00366340|580987835|FG001|Toddler Dose|Failed to return|0|||
160889028|NCT00366340|580987834|FG000|Toddler Dose|Parent/legal guardian request|0|||
160889029|NCT00366340|580987835|FG001|Toddler Dose|Parent/legal guardian request|1|||
160889030|NCT00367770|580987836|FG000|Overall Study|Adverse Event|1|||
160889031|NCT00367770|580987836|FG000|Overall Study|Withdrawal by Subject|1|||
160889032|NCT00442468|580987840|FG000|Overall Study|Adverse Event|4|||
160889033|NCT00442468|580987840|FG000|Overall Study|Withdrawal by Subject|91|||
160889034|NCT00442468|580987840|FG000|Overall Study|Did not complete all study procedures|88|||
160889035|NCT00589784|580987841|FG000|Overall Study|Withdrawal by Subject|0|||
160889036|NCT00589784|580987842|FG001|Overall Study|Withdrawal by Subject|6|||
160889037|NCT00589784|580987841|FG000|Overall Study|Patient inevaluable|1|||
160889038|NCT00589784|580987842|FG001|Overall Study|Patient inevaluable|0|||
160889039|NCT00589784|580987841|FG000|Overall Study|Adverse Event|0|||
160889040|NCT00589784|580987842|FG001|Overall Study|Adverse Event|4|||
160889041|NCT00287079|580987844|FG000|Overall Study|Qualifying relapse|12|||
160889042|NCT00287079|580987845|FG001|Overall Study|Qualifying relapse|1|||
160889043|NCT00287079|580987844|FG000|Overall Study|Non-qualifying relapse|1|||
160889044|NCT00287079|580987845|FG001|Overall Study|Non-qualifying relapse|0|||
160889045|NCT00287079|580987844|FG000|Overall Study|Adverse Event|5|||
160889046|NCT00287079|580987845|FG001|Overall Study|Adverse Event|0|||
160889047|NCT00287079|580987844|FG000|Overall Study|Protocol Violation|1|||
160889048|NCT00287079|580987845|FG001|Overall Study|Protocol Violation|0|||
160889049|NCT00287079|580987844|FG000|Overall Study|Other|3|||
160889050|NCT00287079|580987845|FG001|Overall Study|Other|0|||
160889051|NCT03282565|580987850|FG000|Overall Study|COVID-19 Research Shutdown|0|||
160889052|NCT03282565|580987851|FG001|Overall Study|COVID-19 Research Shutdown|2|||
160889053|NCT03282565|580987852|FG002|Overall Study|COVID-19 Research Shutdown|2|||
160889054|NCT00174291|580987858|FG000|Overall Study|Lost to Follow-up|1|||
160889055|NCT00174291|580987859|FG001|Overall Study|Lost to Follow-up|1|||
160889056|NCT00174291|580987858|FG000|Overall Study|Protocol Violation|0|||
160889057|NCT00174291|580987859|FG001|Overall Study|Protocol Violation|2|||
160889058|NCT00174291|580987858|FG000|Overall Study|Study terminated by sponsor|1|||
160889059|NCT00174291|580987859|FG001|Overall Study|Study terminated by sponsor|0|||
160889060|NCT00174291|580987858|FG000|Overall Study|Withdrawal by Subject|3|||
160889061|NCT00174291|580987859|FG001|Overall Study|Withdrawal by Subject|3|||
160889062|NCT03882008|580987860|FG000|Overall Study|Withdrawal by Subject|1|||
160889063|NCT03882008|580987860|FG000|Overall Study|Lost to Follow-up|1|||
160889064|NCT01582854|580987866|FG000|Overall Study|Death|8|||
160889065|NCT01582854|580987867|FG001|Overall Study|Death|5|||
160889066|NCT01582854|580987866|FG000|Overall Study|Adverse Event|2|||
160889067|NCT01582854|580987867|FG001|Overall Study|Adverse Event|3|||
160889068|NCT01582854|580987866|FG000|Overall Study|Withdrawal by Participant|8|||
160889069|NCT01582854|580987867|FG001|Overall Study|Withdrawal by Participant|11|||
160889070|NCT01582854|580987866|FG000|Overall Study|Lost to Follow-up|1|||
160889071|NCT01582854|580987867|FG001|Overall Study|Lost to Follow-up|2|||
160889072|NCT01582854|580987866|FG000|Overall Study|Physician Decision|0|||
160889073|NCT01582854|580987867|FG001|Overall Study|Physician Decision|1|||
160889074|NCT01582854|580987866|FG000|Overall Study|Recurrent Stroke|13|||
160889075|NCT01582854|580987867|FG001|Overall Study|Recurrent Stroke|8|||
160889076|NCT01582854|580987866|FG000|Overall Study|Disallowed Concomitant Medication|3|||
160889077|NCT01582854|580987867|FG001|Overall Study|Disallowed Concomitant Medication|2|||
160889078|NCT01582854|580987866|FG000|Overall Study|Carotid or Neurosurgery|0|||
160889079|NCT01582854|580987867|FG001|Overall Study|Carotid or Neurosurgery|1|||
160889080|NCT01582854|580987866|FG000|Overall Study|General Anaesthesia|0|||
160889081|NCT01582854|580987867|FG001|Overall Study|General Anaesthesia|1|||
160889082|NCT01582854|580987866|FG000|Overall Study|Other Miscellaneous Reason|1|||
160889083|NCT01582854|580987867|FG001|Overall Study|Other Miscellaneous Reason|0|||
160889084|NCT04068896|580987868|FG000|Overall Study|Adverse Event|2|||
160889085|NCT04068896|580987869|FG001|Overall Study|Adverse Event|0|||
160889086|NCT04068896|580987870|FG002|Overall Study|Adverse Event|1|||
160889087|NCT04068896|580987871|FG003|Overall Study|Adverse Event|0|||
160889088|NCT04068896|580987872|FG004|Overall Study|Adverse Event|0|||
160889089|NCT04068896|580987873|FG005|Overall Study|Adverse Event|0|||
160889090|NCT04068896|580987868|FG000|Overall Study|Death|3|||
160889091|NCT04068896|580987869|FG001|Overall Study|Death|1|||
160889092|NCT04068896|580987870|FG002|Overall Study|Death|3|||
160889093|NCT04068896|580987871|FG003|Overall Study|Death|19|||
160889094|NCT04068896|580987872|FG004|Overall Study|Death|17|||
160889095|NCT04068896|580987873|FG005|Overall Study|Death|0|||
160889096|NCT04068896|580987868|FG000|Overall Study|Physician Decision|0|||
160889097|NCT04068896|580987869|FG001|Overall Study|Physician Decision|0|||
160889098|NCT04068896|580987870|FG002|Overall Study|Physician Decision|0|||
160889099|NCT04068896|580987871|FG003|Overall Study|Physician Decision|1|||
160889100|NCT04068896|580987872|FG004|Overall Study|Physician Decision|0|||
160889101|NCT04068896|580987873|FG005|Overall Study|Physician Decision|0|||
160889102|NCT04068896|580987868|FG000|Overall Study|progressive disease|3|||
160889103|NCT04068896|580987869|FG001|Overall Study|progressive disease|5|||
160889104|NCT04068896|580987870|FG002|Overall Study|progressive disease|3|||
160889105|NCT04068896|580987871|FG003|Overall Study|progressive disease|2|||
160889106|NCT04068896|580987872|FG004|Overall Study|progressive disease|1|||
160889107|NCT04068896|580987873|FG005|Overall Study|progressive disease|2|||
160889108|NCT04068896|580987868|FG000|Overall Study|Study terminated by sponsor|0|||
160889109|NCT04068896|580987869|FG001|Overall Study|Study terminated by sponsor|0|||
160889110|NCT04068896|580987870|FG002|Overall Study|Study terminated by sponsor|1|||
160889111|NCT04068896|580987871|FG003|Overall Study|Study terminated by sponsor|2|||
160889112|NCT04068896|580987872|FG004|Overall Study|Study terminated by sponsor|1|||
160889113|NCT04068896|580987873|FG005|Overall Study|Study terminated by sponsor|4|||
160889114|NCT04068896|580987868|FG000|Overall Study|Protocol Violation|0|||
160889115|NCT04068896|580987869|FG001|Overall Study|Protocol Violation|0|||
160889116|NCT04068896|580987870|FG002|Overall Study|Protocol Violation|0|||
160889117|NCT04068896|580987871|FG003|Overall Study|Protocol Violation|1|||
160889118|NCT04068896|580987872|FG004|Overall Study|Protocol Violation|0|||
160889119|NCT04068896|580987873|FG005|Overall Study|Protocol Violation|0|||
160889120|NCT04068896|580987868|FG000|Overall Study|Withdrawal by Subject|0|||
160889121|NCT04068896|580987869|FG001|Overall Study|Withdrawal by Subject|3|||
160889122|NCT04068896|580987870|FG002|Overall Study|Withdrawal by Subject|0|||
160889123|NCT04068896|580987871|FG003|Overall Study|Withdrawal by Subject|2|||
160889124|NCT04068896|580987872|FG004|Overall Study|Withdrawal by Subject|1|||
160889125|NCT04068896|580987873|FG005|Overall Study|Withdrawal by Subject|0|||
160889126|NCT04068896|580987868|FG000|Overall Study|Symptomatic deterioration|2|||
160889127|NCT04068896|580987869|FG001|Overall Study|Symptomatic deterioration|0|||
160889128|NCT04068896|580987870|FG002|Overall Study|Symptomatic deterioration|0|||
160889129|NCT04068896|580987871|FG003|Overall Study|Symptomatic deterioration|0|||
160542200|NCT03657043|579714170|FG004|Overall Study|Study closure by Sponsor|17|||
160542201|NCT03657043|579714166|FG000|Overall Study|Lost to Follow-up|0|||
160542202|NCT03657043|579714167|FG001|Overall Study|Lost to Follow-up|0|||
160542203|NCT03657043|579714168|FG002|Overall Study|Lost to Follow-up|0|||
160542204|NCT03657043|579714169|FG003|Overall Study|Lost to Follow-up|0|||
160542205|NCT03657043|579714170|FG004|Overall Study|Lost to Follow-up|4|||
160889130|NCT04068896|580987872|FG004|Overall Study|Symptomatic deterioration|0|||
160889131|NCT04068896|580987873|FG005|Overall Study|Symptomatic deterioration|0|||
160889132|NCT02953509|580987874|FG000|Overall Study|Death|1|||
160889133|NCT02953509|580987875|FG001|Overall Study|Death|3|||
160889134|NCT02953509|580987876|FG002|Overall Study|Death|3|||
160889135|NCT02953509|580987877|FG003|Overall Study|Death|4|||
160889136|NCT02953509|580987878|FG004|Overall Study|Death|12|||
160889137|NCT02953509|580987879|FG005|Overall Study|Death|3|||
160889138|NCT02953509|580987880|FG006|Overall Study|Death|25|||
160889139|NCT02953509|580987881|FG007|Overall Study|Death|10|||
160889140|NCT02953509|580987882|FG008|Overall Study|Death|21|||
160889141|NCT02953509|580987883|FG009|Overall Study|Death|20|||
160889142|NCT02953509|580987874|FG000|Overall Study|Reason Not Specified|0|||
160889143|NCT02953509|580987875|FG001|Overall Study|Reason Not Specified|2|||
160889144|NCT02953509|580987876|FG002|Overall Study|Reason Not Specified|8|||
160889145|NCT02953509|580987877|FG003|Overall Study|Reason Not Specified|2|||
160889146|NCT02953509|580987878|FG004|Overall Study|Reason Not Specified|11|||
160889147|NCT02953509|580987879|FG005|Overall Study|Reason Not Specified|4|||
160889148|NCT02953509|580987880|FG006|Overall Study|Reason Not Specified|12|||
160889149|NCT02953509|580987881|FG007|Overall Study|Reason Not Specified|2|||
160889150|NCT02953509|580987882|FG008|Overall Study|Reason Not Specified|7|||
160889151|NCT02953509|580987883|FG009|Overall Study|Reason Not Specified|2|||
160542206|NCT03657043|579714166|FG000|Overall Study|Death|6|||
160542207|NCT03657043|579714167|FG001|Overall Study|Death|5|||
160542208|NCT03657043|579714168|FG002|Overall Study|Death|0|||
160542209|NCT03657043|579714169|FG003|Overall Study|Death|0|||
160542210|NCT03657043|579714170|FG004|Overall Study|Death|53|||
160781338|NCT03166631|580584992|FG005|Overall Study|Death|0|||
160781339|NCT03166631|580584993|FG006|Overall Study|Death|1|||
160781340|NCT03166631|580584994|FG007|Overall Study|Death|0|||
160781341|NCT03166631|580584995|FG008|Overall Study|Death|0|||
160781342|NCT03166631|580584996|FG009|Overall Study|Death|0|||
160781343|NCT03166631|580584997|FG010|Overall Study|Death|0|||
160781344|NCT03166631|580584987|FG000|Overall Study|Adverse Event|1|||
160781345|NCT03166631|580584988|FG001|Overall Study|Adverse Event|0|||
160781346|NCT03166631|580584989|FG002|Overall Study|Adverse Event|0|||
160781347|NCT03166631|580584990|FG003|Overall Study|Adverse Event|0|||
160781348|NCT03166631|580584991|FG004|Overall Study|Adverse Event|0|||
160781349|NCT03166631|580584992|FG005|Overall Study|Adverse Event|1|||
160781350|NCT03166631|580584993|FG006|Overall Study|Adverse Event|1|||
160781351|NCT03166631|580584994|FG007|Overall Study|Adverse Event|0|||
160781352|NCT03166631|580584995|FG008|Overall Study|Adverse Event|1|||
160889152|NCT02953509|580987874|FG000|Overall Study|Consent Withdrawn|1|||
160889153|NCT02953509|580987875|FG001|Overall Study|Consent Withdrawn|1|||
160889154|NCT02953509|580987876|FG002|Overall Study|Consent Withdrawn|2|||
160889155|NCT02953509|580987877|FG003|Overall Study|Consent Withdrawn|1|||
160889156|NCT02953509|580987878|FG004|Overall Study|Consent Withdrawn|3|||
160889157|NCT02953509|580987879|FG005|Overall Study|Consent Withdrawn|0|||
160542211|NCT03657043|579714166|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
160889158|NCT02953509|580987880|FG006|Overall Study|Consent Withdrawn|4|||
160889159|NCT02953509|580987881|FG007|Overall Study|Consent Withdrawn|1|||
160542212|NCT03657043|579714167|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
160542213|NCT03657043|579714168|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
160781353|NCT03166631|580584996|FG009|Overall Study|Adverse Event|2|||
160781354|NCT03166631|580584997|FG010|Overall Study|Adverse Event|1|||
160781355|NCT03166631|580584987|FG000|Overall Study|Withdrawal by Subject|0|||
160889160|NCT02953509|580987882|FG008|Overall Study|Consent Withdrawn|1|||
160889161|NCT02953509|580987883|FG009|Overall Study|Consent Withdrawn|4|||
160889162|NCT02953509|580987874|FG000|Overall Study|Lost to Follow-up|0|||
160889163|NCT02953509|580987875|FG001|Overall Study|Lost to Follow-up|0|||
160889164|NCT02953509|580987876|FG002|Overall Study|Lost to Follow-up|0|||
160889165|NCT02953509|580987877|FG003|Overall Study|Lost to Follow-up|0|||
160638866|NCT01677910|580062833|FG003|Double-Blind Treatment Period|Physician Decision|0|||
160638867|NCT01677910|580062830|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
160638868|NCT01677910|580062831|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
160638869|NCT01677910|580062832|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
160638870|NCT01677910|580062833|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
160638871|NCT01677910|580062830|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
160889166|NCT02953509|580987878|FG004|Overall Study|Lost to Follow-up|0|||
160889167|NCT02953509|580987879|FG005|Overall Study|Lost to Follow-up|0|||
160889168|NCT02953509|580987880|FG006|Overall Study|Lost to Follow-up|1|||
160889169|NCT02953509|580987881|FG007|Overall Study|Lost to Follow-up|1|||
160889170|NCT02953509|580987882|FG008|Overall Study|Lost to Follow-up|1|||
160889171|NCT02953509|580987883|FG009|Overall Study|Lost to Follow-up|1|||
160889172|NCT02953509|580987874|FG000|Overall Study|Study terminated by sponsor|1|||
160889173|NCT02953509|580987875|FG001|Overall Study|Study terminated by sponsor|0|||
160889174|NCT02953509|580987876|FG002|Overall Study|Study terminated by sponsor|0|||
160889175|NCT02953509|580987877|FG003|Overall Study|Study terminated by sponsor|0|||
160889176|NCT02953509|580987878|FG004|Overall Study|Study terminated by sponsor|0|||
160889177|NCT02953509|580987879|FG005|Overall Study|Study terminated by sponsor|0|||
160889178|NCT02953509|580987880|FG006|Overall Study|Study terminated by sponsor|1|||
160889179|NCT02953509|580987881|FG007|Overall Study|Study terminated by sponsor|0|||
160889180|NCT02953509|580987882|FG008|Overall Study|Study terminated by sponsor|1|||
160889181|NCT02953509|580987883|FG009|Overall Study|Study terminated by sponsor|1|||
160889182|NCT02325791|580987884|FG000|Overall Study|Adverse Event|0|||
160889183|NCT02325791|580987885|FG001|Overall Study|Adverse Event|1|||
160889184|NCT02325791|580987886|FG002|Overall Study|Adverse Event|1|||
160889185|NCT02325791|580987887|FG003|Overall Study|Adverse Event|0|||
160889186|NCT02325791|580987884|FG000|Overall Study|Death|0|||
160638872|NCT01677910|580062831|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
160638873|NCT01677910|580062832|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
160638874|NCT01677910|580062833|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
160638875|NCT01677910|580062830|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
160638876|NCT01677910|580062831|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
160638877|NCT01677910|580062832|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
160638878|NCT01677910|580062833|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
160638879|NCT01677910|580062830|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
160638880|NCT01677910|580062831|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
160638881|NCT01677910|580062832|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
160638882|NCT01677910|580062833|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
160638883|NCT01677910|580062830|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
160638884|NCT01677910|580062831|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
160638885|NCT01677910|580062832|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
160638886|NCT01677910|580062833|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
160638887|NCT01677910|580062830|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
160638888|NCT01677910|580062831|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
160638889|NCT01677910|580062832|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
160638890|NCT01677910|580062833|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
160638891|NCT01677910|580062830|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
160638892|NCT01677910|580062831|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
160889187|NCT02325791|580987885|FG001|Overall Study|Death|3|||
160889188|NCT02325791|580987886|FG002|Overall Study|Death|0|||
160638893|NCT01677910|580062832|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
160638894|NCT01677910|580062833|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
160638895|NCT01677910|580062830|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
160638896|NCT01677910|580062831|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
160638897|NCT01677910|580062832|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
160638898|NCT01677910|580062833|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
160889189|NCT02325791|580987887|FG003|Overall Study|Death|1|||
160889190|NCT02325791|580987884|FG000|Overall Study|Lost to Follow-up|0|||
160889191|NCT02325791|580987885|FG001|Overall Study|Lost to Follow-up|15|||
160889192|NCT02325791|580987886|FG002|Overall Study|Lost to Follow-up|14|||
160889193|NCT02325791|580987887|FG003|Overall Study|Lost to Follow-up|9|||
160638899|NCT01244815|580062836|FG000|Overall Study|Not Treated|0|||
160889194|NCT02325791|580987884|FG000|Overall Study|Physician Decision|0|||
160889195|NCT02325791|580987885|FG001|Overall Study|Physician Decision|1|||
160889196|NCT02325791|580987886|FG002|Overall Study|Physician Decision|1|||
160889197|NCT02325791|580987887|FG003|Overall Study|Physician Decision|0|||
160889198|NCT02325791|580987884|FG000|Overall Study|Protocol Violation|0|||
160781356|NCT03166631|580584988|FG001|Overall Study|Withdrawal by Subject|0|||
160781357|NCT03166631|580584989|FG002|Overall Study|Withdrawal by Subject|0|||
160781358|NCT03166631|580584990|FG003|Overall Study|Withdrawal by Subject|0|||
160781359|NCT03166631|580584991|FG004|Overall Study|Withdrawal by Subject|0|||
160781360|NCT03166631|580584992|FG005|Overall Study|Withdrawal by Subject|0|||
160781361|NCT03166631|580584993|FG006|Overall Study|Withdrawal by Subject|0|||
160781362|NCT03166631|580584994|FG007|Overall Study|Withdrawal by Subject|0|||
160781363|NCT03166631|580584995|FG008|Overall Study|Withdrawal by Subject|1|||
160781364|NCT03166631|580584996|FG009|Overall Study|Withdrawal by Subject|1|||
160781365|NCT03166631|580584997|FG010|Overall Study|Withdrawal by Subject|0|||
160781366|NCT00456612|580585006|FG000|Overall Study|Withdrawal by Subject|3|||
160781367|NCT01108796|580585007|FG000|Overall Study|Adverse Event|0|||
160781368|NCT01108796|580585008|FG001|Overall Study|Adverse Event|1|||
160542214|NCT03657043|579714169|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
160542215|NCT03657043|579714170|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
160542216|NCT03657043|579714166|FG000|Overall Study|Adverse Event|0|||
160542217|NCT03657043|579714167|FG001|Overall Study|Adverse Event|0|||
160542218|NCT03657043|579714168|FG002|Overall Study|Adverse Event|0|||
160542219|NCT03657043|579714169|FG003|Overall Study|Adverse Event|0|||
160542220|NCT03657043|579714170|FG004|Overall Study|Adverse Event|2|||
160542221|NCT03657043|579714166|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
160542222|NCT03657043|579714167|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
160542223|NCT03657043|579714168|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
160542224|NCT03657043|579714169|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
160542225|NCT03657043|579714170|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
160542226|NCT03657043|579714166|FG000|Overall Study|Withdrawal - declined follow-up|0|||
160542227|NCT03657043|579714167|FG001|Overall Study|Withdrawal - declined follow-up|0|||
160542228|NCT03657043|579714168|FG002|Overall Study|Withdrawal - declined follow-up|0|||
160542229|NCT03657043|579714169|FG003|Overall Study|Withdrawal - declined follow-up|0|||
160542230|NCT03657043|579714170|FG004|Overall Study|Withdrawal - declined follow-up|1|||
160542231|NCT01995071|579714171|FG000|Overall Study|Adverse Event|0|||
160542232|NCT01995071|579714172|FG001|Overall Study|Adverse Event|0|||
160542233|NCT01995071|579714173|FG002|Overall Study|Adverse Event|0|||
160542234|NCT01995071|579714174|FG003|Overall Study|Adverse Event|0|||
160542235|NCT01995071|579714175|FG004|Overall Study|Adverse Event|0|||
160542236|NCT01995071|579714176|FG005|Overall Study|Adverse Event|0|||
160542237|NCT01995071|579714177|FG006|Overall Study|Adverse Event|1|||
160542238|NCT01995071|579714178|FG007|Overall Study|Adverse Event|0|||
160542239|NCT01995071|579714179|FG008|Overall Study|Adverse Event|0|||
160542240|NCT01995071|579714180|FG009|Overall Study|Adverse Event|0|||
160542241|NCT01995071|579714181|FG010|Overall Study|Adverse Event|0|||
160542242|NCT01995071|579714182|FG011|Overall Study|Adverse Event|0|||
160542243|NCT01995071|579714171|FG000|Overall Study|Moved|0|||
160542244|NCT01995071|579714172|FG001|Overall Study|Moved|0|||
160542245|NCT01995071|579714173|FG002|Overall Study|Moved|1|||
160542246|NCT01995071|579714174|FG003|Overall Study|Moved|0|||
160542247|NCT01995071|579714175|FG004|Overall Study|Moved|1|||
160542248|NCT01995071|579714176|FG005|Overall Study|Moved|0|||
160542249|NCT01995071|579714177|FG006|Overall Study|Moved|0|||
160542250|NCT01995071|579714178|FG007|Overall Study|Moved|0|||
160542251|NCT01995071|579714179|FG008|Overall Study|Moved|0|||
160542252|NCT01995071|579714180|FG009|Overall Study|Moved|0|||
160542253|NCT01995071|579714181|FG010|Overall Study|Moved|1|||
160542254|NCT01995071|579714182|FG011|Overall Study|Moved|0|||
160542255|NCT01995071|579714171|FG000|Overall Study|Lost to Follow-up|1|||
160542256|NCT01995071|579714172|FG001|Overall Study|Lost to Follow-up|0|||
160542257|NCT01995071|579714173|FG002|Overall Study|Lost to Follow-up|0|||
160542258|NCT01995071|579714174|FG003|Overall Study|Lost to Follow-up|0|||
160542259|NCT01995071|579714175|FG004|Overall Study|Lost to Follow-up|0|||
160542260|NCT01995071|579714176|FG005|Overall Study|Lost to Follow-up|0|||
160542261|NCT01995071|579714177|FG006|Overall Study|Lost to Follow-up|0|||
160542262|NCT01995071|579714178|FG007|Overall Study|Lost to Follow-up|1|||
160542263|NCT01995071|579714179|FG008|Overall Study|Lost to Follow-up|1|||
160542264|NCT01995071|579714180|FG009|Overall Study|Lost to Follow-up|0|||
160542265|NCT01995071|579714181|FG010|Overall Study|Lost to Follow-up|0|||
160542266|NCT01995071|579714182|FG011|Overall Study|Lost to Follow-up|0|||
160542267|NCT01995071|579714171|FG000|Overall Study|Incarcerated|0|||
160542268|NCT01995071|579714172|FG001|Overall Study|Incarcerated|0|||
160542269|NCT01995071|579714173|FG002|Overall Study|Incarcerated|0|||
160542270|NCT01995071|579714174|FG003|Overall Study|Incarcerated|0|||
160542271|NCT01995071|579714175|FG004|Overall Study|Incarcerated|0|||
160542272|NCT01995071|579714176|FG005|Overall Study|Incarcerated|0|||
160542273|NCT01995071|579714177|FG006|Overall Study|Incarcerated|0|||
160542274|NCT01995071|579714178|FG007|Overall Study|Incarcerated|1|||
160542275|NCT01995071|579714179|FG008|Overall Study|Incarcerated|0|||
160542276|NCT01995071|579714180|FG009|Overall Study|Incarcerated|0|||
160542277|NCT01995071|579714181|FG010|Overall Study|Incarcerated|0|||
160542278|NCT01995071|579714182|FG011|Overall Study|Incarcerated|0|||
160781369|NCT01108796|580585007|FG000|Overall Study|Lost to Follow-up|7|||
160889199|NCT02325791|580987885|FG001|Overall Study|Protocol Violation|0|||
160889200|NCT02325791|580987886|FG002|Overall Study|Protocol Violation|1|||
160889201|NCT02325791|580987887|FG003|Overall Study|Protocol Violation|0|||
160889202|NCT02325791|580987884|FG000|Overall Study|Withdrawal by Subject|0|||
160889203|NCT02325791|580987885|FG001|Overall Study|Withdrawal by Subject|5|||
160889204|NCT02325791|580987886|FG002|Overall Study|Withdrawal by Subject|8|||
160889205|NCT02325791|580987887|FG003|Overall Study|Withdrawal by Subject|16|||
160889206|NCT02694718|580987889|FG000|Overall Study|Death|1|||
160889207|NCT02694718|580987889|FG000|Overall Study|Withdrawal by Subject|1|||
160889208|NCT00322153|580987891|FG000|Overall Study|Adverse Event|21|||
160889209|NCT00322153|580987892|FG001|Overall Study|Adverse Event|34|||
160889210|NCT00322153|580987891|FG000|Overall Study|Protocol Violation|6|||
160889211|NCT00322153|580987892|FG001|Overall Study|Protocol Violation|14|||
160889212|NCT00322153|580987891|FG000|Overall Study|Withdrawal by Subject|18|||
160889213|NCT00322153|580987892|FG001|Overall Study|Withdrawal by Subject|10|||
160889214|NCT00322153|580987891|FG000|Overall Study|Lack of Efficacy|8|||
160889215|NCT00322153|580987892|FG001|Overall Study|Lack of Efficacy|3|||
160889216|NCT00322153|580987891|FG000|Overall Study|Lost to Follow-up|5|||
160889217|NCT00322153|580987892|FG001|Overall Study|Lost to Follow-up|4|||
160889218|NCT00322153|580987891|FG000|Overall Study|Withdrawn for other reasons|5|||
160889219|NCT00322153|580987892|FG001|Overall Study|Withdrawn for other reasons|4|||
160889220|NCT03455764|580987894|FG000|Overall Study|Adverse Event|1|||
160889221|NCT03455764|580987895|FG001|Overall Study|Adverse Event|0|||
160889222|NCT03455764|580987896|FG002|Overall Study|Adverse Event|0|||
160889223|NCT03455764|580987897|FG003|Overall Study|Adverse Event|0|||
160889224|NCT03455764|580987898|FG004|Overall Study|Adverse Event|0|||
160889225|NCT03455764|580987894|FG000|Overall Study|Disease Progression|4|||
160889226|NCT03455764|580987895|FG001|Overall Study|Disease Progression|0|||
160889227|NCT03455764|580987896|FG002|Overall Study|Disease Progression|0|||
160889228|NCT03455764|580987897|FG003|Overall Study|Disease Progression|0|||
160889229|NCT03455764|580987898|FG004|Overall Study|Disease Progression|0|||
160889230|NCT03455764|580987894|FG000|Overall Study|On Treatment|1|||
160889231|NCT03455764|580987895|FG001|Overall Study|On Treatment|0|||
160889232|NCT03455764|580987896|FG002|Overall Study|On Treatment|0|||
160889233|NCT03455764|580987897|FG003|Overall Study|On Treatment|0|||
160889234|NCT03455764|580987898|FG004|Overall Study|On Treatment|0|||
160889235|NCT02361346|580987899|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889236|NCT02361346|580987900|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889237|NCT02361346|580987901|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889238|NCT02361346|580987902|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
160889239|NCT02361346|580987903|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889240|NCT02361346|580987904|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889241|NCT02361346|580987905|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889242|NCT02361346|580987906|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889243|NCT02361346|580987907|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889244|NCT02361346|580987899|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889245|NCT02361346|580987900|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889246|NCT02361346|580987901|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889247|NCT02361346|580987902|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889248|NCT02361346|580987903|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
160889249|NCT02361346|580987904|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889250|NCT02361346|580987905|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889251|NCT02361346|580987906|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889252|NCT02361346|580987907|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889253|NCT02361346|580987899|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
160889254|NCT02361346|580987900|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
160889255|NCT02361346|580987901|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
160889256|NCT02361346|580987902|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
160889257|NCT02361346|580987903|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
160638900|NCT01244815|580062837|FG001|Overall Study|Not Treated|1|||
160638901|NCT01244815|580062838|FG002|Overall Study|Not Treated|0|||
160638902|NCT01244815|580062839|FG003|Overall Study|Not Treated|0|||
160638903|NCT01244815|580062836|FG000|Overall Study|Adverse Event|4|||
160638904|NCT01244815|580062837|FG001|Overall Study|Adverse Event|7|||
160638905|NCT01244815|580062838|FG002|Overall Study|Adverse Event|5|||
160638906|NCT01244815|580062839|FG003|Overall Study|Adverse Event|5|||
160638907|NCT01244815|580062836|FG000|Overall Study|Treatment Failure|0|||
160638908|NCT01244815|580062837|FG001|Overall Study|Treatment Failure|0|||
160638909|NCT01244815|580062838|FG002|Overall Study|Treatment Failure|0|||
160638910|NCT01244815|580062839|FG003|Overall Study|Treatment Failure|1|||
160889258|NCT02361346|580987904|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
160889259|NCT02361346|580987905|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
160889260|NCT02361346|580987906|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
160889261|NCT02361346|580987907|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
160889262|NCT02361346|580987899|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889263|NCT02361346|580987900|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889264|NCT02361346|580987901|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889265|NCT02361346|580987902|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889266|NCT02361346|580987903|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889267|NCT02361346|580987904|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889268|NCT02361346|580987905|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889269|NCT02361346|580987906|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
160889270|NCT02361346|580987907|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889271|NCT02361346|580987899|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889272|NCT02361346|580987900|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889273|NCT02361346|580987901|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889274|NCT02361346|580987902|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889275|NCT02361346|580987903|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889276|NCT02361346|580987904|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889277|NCT02361346|580987905|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889278|NCT02361346|580987906|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
160889279|NCT02361346|580987907|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889280|NCT02361346|580987899|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889281|NCT02361346|580987900|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889282|NCT02361346|580987901|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889283|NCT02361346|580987902|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889284|NCT02361346|580987903|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889285|NCT02361346|580987904|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889286|NCT02361346|580987905|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889287|NCT02361346|580987906|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
160889288|NCT02361346|580987907|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889289|NCT01683019|580989484|FG000|Overall Study|Withdrawal by Subject|2|||
160889290|NCT01683019|580989485|FG001|Overall Study|Withdrawal by Subject|1|||
160889291|NCT01683019|580989486|FG002|Overall Study|Withdrawal by Subject|4|||
160889292|NCT03437512|580989487|FG000|Randomized|Withdrawal by Subject|0|||
160889293|NCT03437512|580989488|FG001|Randomized|Withdrawal by Subject|2|||
160889294|NCT03437512|580989487|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
160889295|NCT03437512|580989488|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
160889296|NCT03332771|580989489|FG000|Overall Study|Adverse Event|6|||
160889297|NCT03332771|580989490|FG001|Overall Study|Adverse Event|4|||
160889298|NCT03332771|580989491|FG002|Overall Study|Adverse Event|1|||
160889299|NCT03332771|580989492|FG003|Overall Study|Adverse Event|3|||
160889300|NCT03332771|580989489|FG000|Overall Study|Poor Compliance to Protocol|0|||
160889301|NCT03332771|580989490|FG001|Overall Study|Poor Compliance to Protocol|1|||
160889302|NCT03332771|580989491|FG002|Overall Study|Poor Compliance to Protocol|0|||
160889303|NCT03332771|580989492|FG003|Overall Study|Poor Compliance to Protocol|1|||
160889304|NCT03332771|580989489|FG000|Overall Study|Lost to Follow-up|2|||
160889305|NCT03332771|580989490|FG001|Overall Study|Lost to Follow-up|2|||
160889306|NCT03332771|580989491|FG002|Overall Study|Lost to Follow-up|1|||
160889307|NCT03332771|580989492|FG003|Overall Study|Lost to Follow-up|2|||
160889308|NCT03332771|580989489|FG000|Overall Study|At the Participant's own request|20|||
160889309|NCT03332771|580989490|FG001|Overall Study|At the Participant's own request|26|||
160889310|NCT03332771|580989491|FG002|Overall Study|At the Participant's own request|14|||
160889311|NCT03332771|580989492|FG003|Overall Study|At the Participant's own request|23|||
160889312|NCT03332771|580989489|FG000|Overall Study|Reason Not Specified|6|||
160889313|NCT03332771|580989490|FG001|Overall Study|Reason Not Specified|18|||
160889314|NCT03332771|580989491|FG002|Overall Study|Reason Not Specified|16|||
160889315|NCT03332771|580989492|FG003|Overall Study|Reason Not Specified|19|||
160889316|NCT03442764|580989493|FG000|Overall Study|Adverse Event|1|||
160889317|NCT03442764|580989494|FG001|Overall Study|Adverse Event|0|||
160889318|NCT03442764|580989495|FG002|Overall Study|Adverse Event|0|||
160889319|NCT01801072|580989496|FG000|Overall Study|Lost to Follow-up|17|||
160889320|NCT01801072|580989497|FG001|Overall Study|Lost to Follow-up|14|||
160889321|NCT01801072|580989496|FG000|Overall Study|Physician Decision|2|||
160889322|NCT01801072|580989497|FG001|Overall Study|Physician Decision|3|||
160889323|NCT01801072|580989496|FG000|Overall Study|Withdrawal by Subject|1|||
160638911|NCT01244815|580062836|FG000|Overall Study|Lost to Follow-up|3|||
160638912|NCT01244815|580062837|FG001|Overall Study|Lost to Follow-up|2|||
160889324|NCT01801072|580989497|FG001|Overall Study|Withdrawal by Subject|0|||
160889325|NCT01801072|580989496|FG000|Overall Study|Protocol Violation|2|||
160889326|NCT01801072|580989497|FG001|Overall Study|Protocol Violation|0|||
160889327|NCT01801072|580989496|FG000|Overall Study|Death|7|||
160889328|NCT01801072|580989497|FG001|Overall Study|Death|8|||
160889329|NCT03693170|580989498|FG000|Overall Study|Disease Progression|48|||
160889330|NCT03693170|580989498|FG000|Overall Study|Adverse Event|16|||
160889331|NCT03693170|580989498|FG000|Overall Study|Physician Decision|6|||
160889332|NCT03693170|580989498|FG000|Overall Study|Protocol Violation|2|||
160889333|NCT03693170|580989498|FG000|Overall Study|Death|1|||
160889334|NCT03693170|580989498|FG000|Overall Study|Non compliance with study drug|1|||
160542279|NCT00772954|579714187|FG000|Overall Study|Adverse Event|0|||
160542280|NCT00772954|579714188|FG001|Overall Study|Adverse Event|0|||
160542281|NCT00772954|579714189|FG002|Overall Study|Adverse Event|1|||
160542282|NCT01661140|579714190|FG000|Open-Label Period|Adverse Event|44|||
160542283|NCT01661140|579714191|FG001|Open-Label Period|Adverse Event|0|||
160542284|NCT01661140|579714192|FG002|Open-Label Period|Adverse Event|0|||
160542285|NCT01661140|579714190|FG000|Open-Label Period|Protocol Violation|3|||
160542286|NCT01661140|579714191|FG001|Open-Label Period|Protocol Violation|0|||
160542287|NCT01661140|579714192|FG002|Open-Label Period|Protocol Violation|0|||
160542288|NCT01661140|579714190|FG000|Open-Label Period|Withdrawal by Subject|5|||
160542289|NCT01661140|579714191|FG001|Open-Label Period|Withdrawal by Subject|0|||
160542290|NCT01661140|579714192|FG002|Open-Label Period|Withdrawal by Subject|0|||
160542291|NCT01661140|579714190|FG000|Open-Label Period|Investigator Decision|3|||
160542292|NCT01661140|579714191|FG001|Open-Label Period|Investigator Decision|0|||
160542293|NCT01661140|579714192|FG002|Open-Label Period|Investigator Decision|0|||
160542294|NCT01661140|579714190|FG000|Open-Label Period|Death|1|||
160542295|NCT01661140|579714191|FG001|Open-Label Period|Death|0|||
160542296|NCT01661140|579714192|FG002|Open-Label Period|Death|0|||
160542297|NCT01661140|579714190|FG000|Open-Label Period|Administrative/Other|1|||
160542298|NCT01661140|579714191|FG001|Open-Label Period|Administrative/Other|0|||
160542299|NCT01661140|579714192|FG002|Open-Label Period|Administrative/Other|0|||
160542300|NCT01661140|579714190|FG000|Open-Label Period|Sponsor termination|16|||
160542301|NCT01661140|579714191|FG001|Open-Label Period|Sponsor termination|0|||
160542302|NCT01661140|579714192|FG002|Open-Label Period|Sponsor termination|0|||
160542303|NCT01661140|579714190|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
160542304|NCT01661140|579714191|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
160542305|NCT01661140|579714192|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
160542306|NCT01661140|579714190|FG000|Open-Label Period|Lost to Follow-up|2|||
160542307|NCT01661140|579714191|FG001|Open-Label Period|Lost to Follow-up|0|||
160542308|NCT01661140|579714192|FG002|Open-Label Period|Lost to Follow-up|0|||
160542309|NCT01661140|579714190|FG000|Double-Blind Period|Refused Treatment|0|||
160542310|NCT01661140|579714191|FG001|Double-Blind Period|Refused Treatment|0|||
160781370|NCT01108796|580585008|FG001|Overall Study|Lost to Follow-up|6|||
160781371|NCT01562444|580585024|FG000|Overall Study|Did not meet entry criteria|2|||
160889335|NCT03693170|580989498|FG000|Overall Study|Withdrawal by Subject|1|||
160889336|NCT04444895|580989499|FG000|Overall Study|Adverse Event|2|||
160889337|NCT04444895|580989499|FG000|Overall Study|Lost to Follow-up|2|||
160889338|NCT04444895|580989499|FG000|Overall Study|Withdrawal by Subject|5|||
160889339|NCT03034200|580989500|FG000|Overall Study|Disease progression|8|||
160889340|NCT03034200|580989501|FG001|Overall Study|Disease progression|10|||
160889341|NCT03034200|580989502|FG002|Overall Study|Disease progression|4|||
160889342|NCT03034200|580989500|FG000|Overall Study|Physician Decision|2|||
160889343|NCT03034200|580989501|FG001|Overall Study|Physician Decision|0|||
160889344|NCT03034200|580989502|FG002|Overall Study|Physician Decision|3|||
160889345|NCT03034200|580989500|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
160889346|NCT03034200|580989501|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
160889347|NCT03034200|580989502|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
160638913|NCT01244815|580062838|FG002|Overall Study|Lost to Follow-up|3|||
160638914|NCT01244815|580062839|FG003|Overall Study|Lost to Follow-up|2|||
160638915|NCT01244815|580062836|FG000|Overall Study|Withdrawal by Subject|0|||
160638916|NCT01244815|580062837|FG001|Overall Study|Withdrawal by Subject|2|||
160638917|NCT01244815|580062838|FG002|Overall Study|Withdrawal by Subject|0|||
160638918|NCT01244815|580062839|FG003|Overall Study|Withdrawal by Subject|3|||
160638919|NCT01244815|580062836|FG000|Overall Study|Protocol Violation|7|||
160781372|NCT01562444|580585025|FG001|Overall Study|Did not meet entry criteria|0|||
160781373|NCT01562444|580585026|FG002|Overall Study|Did not meet entry criteria|3|||
160781374|NCT01562444|580585024|FG000|Overall Study|Did not comply with blood draw schedule|1|||
160781375|NCT01562444|580585025|FG001|Overall Study|Did not comply with blood draw schedule|0|||
160781376|NCT01562444|580585026|FG002|Overall Study|Did not comply with blood draw schedule|1|||
160781377|NCT01562444|580585024|FG000|Overall Study|Unavailable serological results|0|||
160781378|NCT01562444|580585025|FG001|Overall Study|Unavailable serological results|2|||
160781379|NCT01562444|580585026|FG002|Overall Study|Unavailable serological results|2|||
160781380|NCT01562444|580585024|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
160781381|NCT01562444|580585025|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
160781382|NCT01562444|580585026|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
160781383|NCT01562444|580585024|FG000|Overall Study|Protocol forbidden medication|1|||
160781384|NCT01562444|580585025|FG001|Overall Study|Protocol forbidden medication|0|||
160781385|NCT01562444|580585026|FG002|Overall Study|Protocol forbidden medication|0|||
160781386|NCT00720083|580585029|FG000|Overall Study|Ineligible|1|||
160781387|NCT00720083|580585030|FG001|Overall Study|Ineligible|2|||
160781388|NCT00894647|580585031|FG000|Overall Study|Adverse Event|5|||
160781389|NCT00894647|580585032|FG001|Overall Study|Adverse Event|4|||
160781390|NCT00894647|580585031|FG000|Overall Study|Withdrawal by Subject|4|||
160781391|NCT00894647|580585032|FG001|Overall Study|Withdrawal by Subject|4|||
160781392|NCT00894647|580585031|FG000|Overall Study|Lost to Follow-up|0|||
160781393|NCT00894647|580585032|FG001|Overall Study|Lost to Follow-up|2|||
160781394|NCT00894647|580585031|FG000|Overall Study|Non-compliance with study procedures|0|||
160781395|NCT00894647|580585032|FG001|Overall Study|Non-compliance with study procedures|2|||
160781396|NCT00894647|580585031|FG000|Overall Study|Other, not due to AE|1|||
160781397|NCT00894647|580585032|FG001|Overall Study|Other, not due to AE|2|||
160781398|NCT01913470|580585039|FG000|Overall Study|Lost to Follow-up|0|||
160781399|NCT01913470|580585040|FG001|Overall Study|Lost to Follow-up|1|||
160781400|NCT01913470|580585039|FG000|Overall Study|Physician Decision|0|||
160781401|NCT01913470|580585040|FG001|Overall Study|Physician Decision|1|||
160781402|NCT01913470|580585039|FG000|Overall Study|Withdrawal by Subject|0|||
160781403|NCT01913470|580585040|FG001|Overall Study|Withdrawal by Subject|1|||
160781404|NCT00245570|580585041|FG000|Washout Between Periods III and IV|Adverse Event|0|||
160781405|NCT00245570|580585042|FG001|Washout Between Periods III and IV|Adverse Event|1|||
160781406|NCT00245570|580585043|FG002|Washout Between Periods III and IV|Adverse Event|0|||
160781407|NCT00245570|580585044|FG003|Washout Between Periods III and IV|Adverse Event|0|||
160781408|NCT00245570|580585045|FG004|Washout Between Periods III and IV|Adverse Event|0|||
160781409|NCT00245570|580585046|FG005|Washout Between Periods III and IV|Adverse Event|0|||
160781410|NCT01524705|580585047|FG000|Overall Study|Adverse Event|2|||
160781411|NCT01524705|580585048|FG001|Overall Study|Adverse Event|0|||
160781412|NCT01524705|580585047|FG000|Overall Study|Death|1|||
160781413|NCT01524705|580585048|FG001|Overall Study|Death|0|||
160781414|NCT01524705|580585047|FG000|Overall Study|Lost to Follow-up|0|||
160781415|NCT01524705|580585048|FG001|Overall Study|Lost to Follow-up|1|||
160889348|NCT03034200|580989500|FG000|Overall Study|Adjuvant Therapy|0|||
160638920|NCT01244815|580062837|FG001|Overall Study|Protocol Violation|4|||
160638921|NCT01244815|580062838|FG002|Overall Study|Protocol Violation|3|||
160781416|NCT01524705|580585047|FG000|Overall Study|Withdrawal by Subject|0|||
160781417|NCT01524705|580585048|FG001|Overall Study|Withdrawal by Subject|1|||
160781418|NCT01524705|580585047|FG000|Overall Study|Pancreatic Cancer|0|||
160781419|NCT01524705|580585048|FG001|Overall Study|Pancreatic Cancer|1|||
160781420|NCT02573467|580585057|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
160781421|NCT02573467|580585058|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
160638922|NCT01244815|580062839|FG003|Overall Study|Protocol Violation|1|||
160638923|NCT01244815|580062836|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
160638924|NCT01244815|580062837|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
160638925|NCT01244815|580062838|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
160638926|NCT01244815|580062839|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
160638927|NCT01808209|580062841|FG000|Overall Study|Lost to Follow-up|0|||
160638928|NCT01808209|580062842|FG001|Overall Study|Lost to Follow-up|1|||
160638929|NCT01427920|580062849|FG000|Overall Study|Adverse Event|1|||
160638930|NCT01427920|580062850|FG001|Overall Study|Adverse Event|2|||
160638931|NCT01427920|580062849|FG000|Overall Study|Lack of Efficacy|1|||
160638932|NCT01427920|580062850|FG001|Overall Study|Lack of Efficacy|0|||
160638933|NCT01427920|580062849|FG000|Overall Study|Protocol Violation|1|||
160638934|NCT01427920|580062850|FG001|Overall Study|Protocol Violation|3|||
160638935|NCT01427920|580062849|FG000|Overall Study|Withdrawal Criteria|4|||
160638936|NCT01427920|580062850|FG001|Overall Study|Withdrawal Criteria|4|||
160638937|NCT01427920|580062849|FG000|Overall Study|Unclassified|2|||
160638938|NCT01427920|580062850|FG001|Overall Study|Unclassified|8|||
160638939|NCT00685919|580062851|FG000|Overall Study|Withdrawal by Subject|0|||
160638940|NCT00685919|580062852|FG001|Overall Study|Withdrawal by Subject|0|||
160638941|NCT00685919|580062853|FG002|Overall Study|Withdrawal by Subject|1|||
160638942|NCT00685919|580062854|FG003|Overall Study|Withdrawal by Subject|0|||
160638943|NCT00685919|580062851|FG000|Overall Study|Physician Decision|1|||
160638944|NCT00685919|580062852|FG001|Overall Study|Physician Decision|0|||
160638945|NCT00685919|580062853|FG002|Overall Study|Physician Decision|0|||
160638946|NCT00685919|580062854|FG003|Overall Study|Physician Decision|0|||
160638947|NCT04228302|580062855|FG000|Overall Study|Adverse Event|0|||
160638948|NCT04228302|580062856|FG001|Overall Study|Adverse Event|0|||
160638949|NCT04228302|580062857|FG002|Overall Study|Adverse Event|0|||
160638950|NCT04228302|580062858|FG003|Overall Study|Adverse Event|0|||
160638951|NCT04228302|580062859|FG004|Overall Study|Adverse Event|1|||
160638952|NCT04228302|580062860|FG005|Overall Study|Adverse Event|0|||
160638953|NCT02732561|580062862|FG000|Overall Study|Lost to Follow-up|1|||
160638954|NCT02732561|580062863|FG001|Overall Study|Lost to Follow-up|1|||
160638955|NCT02732561|580062862|FG000|Overall Study|Withdrawal by Subject|1|||
160638956|NCT02732561|580062863|FG001|Overall Study|Withdrawal by Subject|0|||
160638957|NCT03066440|580062864|FG000|Overall Study|Physician Decision|1|||
160638958|NCT03066440|580062865|FG001|Overall Study|Physician Decision|1|||
160638959|NCT03066440|580062864|FG000|Overall Study|Protocol Violation|0|||
160638960|NCT03066440|580062865|FG001|Overall Study|Protocol Violation|2|||
160638961|NCT00736333|580062866|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
160638962|NCT00736333|580062866|FG000|Overall Study|Data Missing|2|||
160638963|NCT00736333|580062866|FG000|Overall Study|Tumor Progression|75|||
160638964|NCT00736333|580062866|FG000|Overall Study|Toxicity|6|||
160638965|NCT00736333|580062866|FG000|Overall Study|Withdrawal by Subject|10|||
160638966|NCT00736333|580062866|FG000|Overall Study|Death|7|||
160638967|NCT00736333|580062866|FG000|Overall Study|Other|4|||
160638968|NCT04991311|580062868|FG000|Overall Study|Adverse Event|1|||
160638969|NCT00054275|580062870|FG000|Overall Study|Withdrawal by Subject|4|||
160781422|NCT02573467|580585059|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
160781423|NCT02573467|580585060|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
160781424|NCT02573467|580585057|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
160638970|NCT00054275|580062870|FG000|Overall Study|Adverse Event|5|||
160638971|NCT00054275|580062870|FG000|Overall Study|Progressive disease in cycle 1|1|||
160638972|NCT00054275|580062870|FG000|Overall Study|Physician Decision|1|||
160638973|NCT01106352|580062871|FG000|Overall Study|Subjects untreated|0|||
160638974|NCT01106352|580062872|FG001|Overall Study|Subjects untreated|0|||
160638975|NCT01106352|580062873|FG002|Overall Study|Subjects untreated|0|||
160889349|NCT03034200|580989501|FG001|Overall Study|Adjuvant Therapy|0|||
160889350|NCT03034200|580989502|FG002|Overall Study|Adjuvant Therapy|1|||
160889351|NCT00510874|580989503|FG000|Overall Study|Withdrawal by Subject|1|||
160889352|NCT00510874|580989504|FG001|Overall Study|Withdrawal by Subject|1|||
160889353|NCT00510874|580989505|FG002|Overall Study|Withdrawal by Subject|0|||
160889354|NCT00510874|580989506|FG003|Overall Study|Withdrawal by Subject|0|||
160889355|NCT00510874|580989507|FG004|Overall Study|Withdrawal by Subject|3|||
160889356|NCT00510874|580989508|FG005|Overall Study|Withdrawal by Subject|0|||
160889357|NCT00510874|580989509|FG006|Overall Study|Withdrawal by Subject|0|||
160781425|NCT02573467|580585058|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
160781426|NCT02573467|580585059|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
160781427|NCT02573467|580585060|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
160781428|NCT02573467|580585057|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
160781429|NCT02573467|580585058|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
160781430|NCT02573467|580585059|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
160781431|NCT02573467|580585060|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
160781432|NCT02573467|580585057|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
160889358|NCT00510874|580989503|FG000|Overall Study|Lost to Follow-up|2|||
160889359|NCT00510874|580989504|FG001|Overall Study|Lost to Follow-up|3|||
160889360|NCT00510874|580989505|FG002|Overall Study|Lost to Follow-up|1|||
160889361|NCT00510874|580989506|FG003|Overall Study|Lost to Follow-up|3|||
160889362|NCT00510874|580989507|FG004|Overall Study|Lost to Follow-up|4|||
160889363|NCT00510874|580989508|FG005|Overall Study|Lost to Follow-up|0|||
160889364|NCT00510874|580989509|FG006|Overall Study|Lost to Follow-up|1|||
160889365|NCT00636987|580989510|FG000|Overall Study|Death|44|||
160889366|NCT00636987|580989510|FG000|Overall Study|Explanted|13|||
160889367|NCT00636987|580989510|FG000|Overall Study|Lost to Follow-up|63|||
160889368|NCT00636987|580989510|FG000|Overall Study|5 year visit window not complete|69|||
160889369|NCT01251146|580989511|FG000|Overall Study|Lost to Follow-up|3|||
160889370|NCT01251146|580989512|FG001|Overall Study|Lost to Follow-up|10|||
160889371|NCT00053365|580989514|FG000|Overall Study|Incorrect cell type|1|||
160889372|NCT00053365|580989514|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
160889373|NCT00053365|580989514|FG000|Overall Study|Never treated|4|||
160889374|NCT00737464|580989523|FG000|Overall Study|Adverse Event|1|||
160889375|NCT00737464|580989523|FG000|Overall Study|Death|6|||
160889376|NCT00737464|580989523|FG000|Overall Study|Other - Failure to Return|1|||
160889377|NCT00737464|580989523|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
160889378|NCT00737464|580989523|FG000|Overall Study|Other reasons|4|||
160889379|NCT02423109|580989527|FG000|Lens 1|Adverse Event|1|||
160889380|NCT02423109|580989528|FG001|Lens 1|Adverse Event|0|||
160889381|NCT03347188|580989529|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
160889382|NCT03347188|580989530|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
160889383|NCT03347188|580989529|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
160889384|NCT03347188|580989530|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
160889385|NCT03347188|580989529|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
160889386|NCT03347188|580989530|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
160889387|NCT03347188|580989529|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
160889388|NCT03347188|580989530|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
160889389|NCT03347188|580989529|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
160889390|NCT03347188|580989530|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
160889391|NCT03347188|580989529|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
160889392|NCT03347188|580989530|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
160889393|NCT03347188|580989529|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
160889394|NCT03347188|580989530|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
160889395|NCT03347188|580989529|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
160889396|NCT03347188|580989530|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
160889397|NCT03868124|580989531|FG000|Overall Study|Withdrawal by Subject|4|||
160638976|NCT01106352|580062874|FG003|Overall Study|Subjects untreated|3|||
160638977|NCT01106352|580062875|FG004|Overall Study|Subjects untreated|4|||
160638978|NCT01106352|580062871|FG000|Overall Study|Sponsor Decision|1|||
160781433|NCT02573467|580585058|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
160781434|NCT02573467|580585059|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
160781435|NCT02573467|580585060|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
160889398|NCT03868124|580989532|FG001|Overall Study|Withdrawal by Subject|0|||
160889399|NCT03868124|580989533|FG002|Overall Study|Withdrawal by Subject|1|||
160889400|NCT03868124|580989531|FG000|Overall Study|Physician Decision|1|||
160638979|NCT01106352|580062872|FG001|Overall Study|Sponsor Decision|0|||
160889401|NCT03868124|580989532|FG001|Overall Study|Physician Decision|0|||
160889402|NCT03868124|580989533|FG002|Overall Study|Physician Decision|1|||
160889403|NCT03868124|580989531|FG000|Overall Study|Lost to Follow-up|1|||
160889404|NCT03868124|580989532|FG001|Overall Study|Lost to Follow-up|1|||
160889405|NCT03868124|580989533|FG002|Overall Study|Lost to Follow-up|2|||
160638980|NCT01106352|580062873|FG002|Overall Study|Sponsor Decision|0|||
160638981|NCT01106352|580062874|FG003|Overall Study|Sponsor Decision|0|||
160638982|NCT01106352|580062875|FG004|Overall Study|Sponsor Decision|0|||
160638983|NCT01106352|580062871|FG000|Overall Study|Too ill to come in for the visit|0|||
160638984|NCT01106352|580062872|FG001|Overall Study|Too ill to come in for the visit|0|||
160638985|NCT01106352|580062873|FG002|Overall Study|Too ill to come in for the visit|1|||
160638986|NCT01106352|580062874|FG003|Overall Study|Too ill to come in for the visit|0|||
160638987|NCT01106352|580062875|FG004|Overall Study|Too ill to come in for the visit|0|||
160638988|NCT01106352|580062871|FG000|Overall Study|Lost to Follow-up|0|||
160638989|NCT01106352|580062872|FG001|Overall Study|Lost to Follow-up|0|||
160638990|NCT01106352|580062873|FG002|Overall Study|Lost to Follow-up|0|||
160638991|NCT01106352|580062874|FG003|Overall Study|Lost to Follow-up|0|||
160638992|NCT01106352|580062875|FG004|Overall Study|Lost to Follow-up|1|||
160638993|NCT01106352|580062871|FG000|Overall Study|Death|0|||
160638994|NCT01106352|580062872|FG001|Overall Study|Death|0|||
160638995|NCT01106352|580062873|FG002|Overall Study|Death|1|||
160638996|NCT01106352|580062874|FG003|Overall Study|Death|3|||
160638997|NCT01106352|580062875|FG004|Overall Study|Death|1|||
160638998|NCT01106352|580062871|FG000|Overall Study|Disease progression|0|||
160638999|NCT01106352|580062872|FG001|Overall Study|Disease progression|0|||
160639000|NCT01106352|580062873|FG002|Overall Study|Disease progression|0|||
160639001|NCT01106352|580062874|FG003|Overall Study|Disease progression|1|||
160639002|NCT01106352|580062875|FG004|Overall Study|Disease progression|0|||
160639003|NCT01106352|580062871|FG000|Overall Study|Withdrawal by Subject|0|||
160639004|NCT01106352|580062872|FG001|Overall Study|Withdrawal by Subject|0|||
160639005|NCT01106352|580062873|FG002|Overall Study|Withdrawal by Subject|0|||
160639006|NCT01106352|580062874|FG003|Overall Study|Withdrawal by Subject|3|||
160639007|NCT01106352|580062875|FG004|Overall Study|Withdrawal by Subject|2|||
160639008|NCT01106352|580062871|FG000|Overall Study|Went on hospice|0|||
160639009|NCT01106352|580062872|FG001|Overall Study|Went on hospice|0|||
160639010|NCT01106352|580062873|FG002|Overall Study|Went on hospice|0|||
160639011|NCT01106352|580062874|FG003|Overall Study|Went on hospice|1|||
160639012|NCT01106352|580062875|FG004|Overall Study|Went on hospice|0|||
160639013|NCT01106352|580062871|FG000|Overall Study|Subject entered hospice|0|||
160639014|NCT01106352|580062872|FG001|Overall Study|Subject entered hospice|0|||
160639015|NCT01106352|580062873|FG002|Overall Study|Subject entered hospice|0|||
160639016|NCT01106352|580062874|FG003|Overall Study|Subject entered hospice|1|||
160639017|NCT01106352|580062875|FG004|Overall Study|Subject entered hospice|0|||
160639018|NCT01106352|580062871|FG000|Overall Study|Home hospice since July 2013|0|||
160639019|NCT01106352|580062872|FG001|Overall Study|Home hospice since July 2013|0|||
160639020|NCT01106352|580062873|FG002|Overall Study|Home hospice since July 2013|0|||
160639021|NCT01106352|580062874|FG003|Overall Study|Home hospice since July 2013|1|||
160639022|NCT01106352|580062875|FG004|Overall Study|Home hospice since July 2013|0|||
160639023|NCT03876873|580062876|FG000|Overall Study|Physician Decision|0|||
160639024|NCT03876873|580062877|FG001|Overall Study|Physician Decision|1|||
160639025|NCT03547531|580062878|FG000|Overall Study|not coming in data collection : sick|2|||
160639026|NCT03547531|580062879|FG001|Overall Study|not coming in data collection : sick|2|||
160639027|NCT03547531|580062878|FG000|Overall Study|having family occasion|0|||
160639028|NCT03547531|580062879|FG001|Overall Study|having family occasion|2|||
160639029|NCT03944707|580062880|FG000|Overall Study|Adverse Event|0|||
160639030|NCT03944707|580062881|FG001|Overall Study|Adverse Event|2|||
160639031|NCT03944707|580062880|FG000|Overall Study|Study terminated by sponsor|12|||
160639032|NCT03944707|580062881|FG001|Overall Study|Study terminated by sponsor|7|||
160639033|NCT03944707|580062880|FG000|Overall Study|Subject decision|0|||
160639034|NCT03944707|580062881|FG001|Overall Study|Subject decision|1|||
160639035|NCT02444182|580062890|FG000|Overall Study|non-compliance|2|||
160639036|NCT02444182|580062891|FG001|Overall Study|non-compliance|1|||
160639037|NCT02444182|580062890|FG000|Overall Study|Lost to Follow-up|0|||
160639038|NCT02444182|580062891|FG001|Overall Study|Lost to Follow-up|4|||
160639039|NCT01959230|580062892|FG000|Overall Study|Failure to follow study procedures|0|||
160639040|NCT01959230|580062893|FG001|Overall Study|Failure to follow study procedures|1|||
160639041|NCT01959230|580062892|FG000|Overall Study|Administrative reasons|2|||
160639042|NCT01959230|580062893|FG001|Overall Study|Administrative reasons|0|||
160639043|NCT01959230|580062892|FG000|Overall Study|Withdrawal by Subject|2|||
160639044|NCT01959230|580062893|FG001|Overall Study|Withdrawal by Subject|0|||
160639045|NCT01453374|580062894|FG000|Overall Study|Adverse Event|7|||
160639046|NCT01453374|580062894|FG000|Overall Study|Lack of Efficacy|1|||
160639047|NCT01453374|580062894|FG000|Overall Study|Lost to Follow-up|3|||
160639048|NCT01453374|580062894|FG000|Overall Study|Withdrawal by Subject|5|||
160639049|NCT01453374|580062894|FG000|Overall Study|Incarcerated|2|||
160639050|NCT00447694|580062897|FG000|Overall Study|Adverse Event|2|||
160639051|NCT00447694|580062897|FG000|Overall Study|Abnormal laboratory value|1|||
160639052|NCT00447694|580062897|FG000|Overall Study|Abnormal test procedure result|1|||
160639053|NCT00447694|580062897|FG000|Overall Study|Withdrawal by Subject|2|||
160639054|NCT00886782|580062898|FG000|Overall Study|Disease progression|3|||
160639055|NCT00886782|580062899|FG001|Overall Study|Disease progression|3|||
160639056|NCT00886782|580062900|FG002|Overall Study|Disease progression|3|||
160639057|NCT00886782|580062898|FG000|Overall Study|Study drug toxicity|0|||
160639058|NCT00886782|580062899|FG001|Overall Study|Study drug toxicity|0|||
160639059|NCT00886782|580062900|FG002|Overall Study|Study drug toxicity|1|||
160639060|NCT00886782|580062898|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
160639061|NCT00886782|580062899|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
160639062|NCT00886782|580062900|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
160639063|NCT03012815|580062901|FG000|Overall Study|Lost to Follow-up|1|||
160639064|NCT03012815|580062902|FG001|Overall Study|Lost to Follow-up|0|||
160639065|NCT03012815|580062901|FG000|Overall Study|Physician Decision|3|||
160639066|NCT03012815|580062902|FG001|Overall Study|Physician Decision|2|||
160639067|NCT03012815|580062901|FG000|Overall Study|Adverse Event|1|||
160639068|NCT03012815|580062902|FG001|Overall Study|Adverse Event|0|||
160639069|NCT00879970|580062904|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
160639070|NCT00879970|580062905|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
160781436|NCT02573467|580585057|FG000|Post-treatment Follow up Epoch|Death|1|||
160781437|NCT02573467|580585058|FG001|Post-treatment Follow up Epoch|Death|1|||
160781438|NCT02573467|580585059|FG002|Post-treatment Follow up Epoch|Death|0|||
160781439|NCT02573467|580585060|FG003|Post-treatment Follow up Epoch|Death|1|||
160781440|NCT02573467|580585057|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
160781441|NCT02573467|580585058|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
160781442|NCT02573467|580585059|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
160781443|NCT02573467|580585060|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
160781444|NCT02573467|580585057|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
160781445|NCT02573467|580585058|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
160781446|NCT02573467|580585059|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
160781447|NCT02573467|580585060|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
160781448|NCT01829165|580585061|FG000|Overall Study|Did not complete intervention|2|||
160781449|NCT01829165|580585062|FG001|Overall Study|Did not complete intervention|0|||
160781450|NCT00103506|580585064|FG000|Overall Study|Study closed by sponsor|34|||
160781451|NCT00103506|580585065|FG001|Overall Study|Study closed by sponsor|37|||
160781452|NCT00103506|580585064|FG000|Overall Study|Death|257|||
160781453|NCT00103506|580585065|FG001|Overall Study|Death|253|||
160781454|NCT00103506|580585064|FG000|Overall Study|Lost to Follow-up|13|||
160781455|NCT00103506|580585065|FG001|Overall Study|Lost to Follow-up|13|||
160781456|NCT00103506|580585064|FG000|Overall Study|Withdrawal by Subject|18|||
160781457|NCT00103506|580585065|FG001|Overall Study|Withdrawal by Subject|21|||
160781458|NCT00710970|580585068|FG000|Overall Study|Never took drug|3|||
160781459|NCT02153827|580585069|FG000|Overall Study|Lost to Follow-up|3|||
160781460|NCT02153827|580585070|FG001|Overall Study|Lost to Follow-up|9|||
160781461|NCT01060111|580585071|FG000|Overall Study|Adverse Event|9|||
160781462|NCT01060111|580585072|FG001|Overall Study|Adverse Event|5|||
160781463|NCT01060111|580585073|FG002|Overall Study|Adverse Event|18|||
160781464|NCT01060111|580585071|FG000|Overall Study|Lack of Efficacy|2|||
160781465|NCT01060111|580585072|FG001|Overall Study|Lack of Efficacy|1|||
160781466|NCT01060111|580585073|FG002|Overall Study|Lack of Efficacy|0|||
160781467|NCT01060111|580585071|FG000|Overall Study|Inappropriate participant|5|||
160781468|NCT01060111|580585072|FG001|Overall Study|Inappropriate participant|4|||
160781469|NCT01060111|580585073|FG002|Overall Study|Inappropriate participant|5|||
160781470|NCT01060111|580585071|FG000|Overall Study|Participants' evasion for hospital visit|0|||
160781471|NCT01060111|580585072|FG001|Overall Study|Participants' evasion for hospital visit|3|||
160781472|NCT01060111|580585073|FG002|Overall Study|Participants' evasion for hospital visit|2|||
160781473|NCT01060111|580585071|FG000|Overall Study|Participants' non-cooperation|8|||
160639071|NCT00879970|580062906|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
160639072|NCT00879970|580062907|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
160639073|NCT00879970|580062908|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
160639074|NCT00879970|580062904|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
160639075|NCT00879970|580062905|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
160781474|NCT01060111|580585072|FG001|Overall Study|Participants' non-cooperation|6|||
160781475|NCT01060111|580585073|FG002|Overall Study|Participants' non-cooperation|6|||
160781476|NCT01060111|580585071|FG000|Overall Study|Adverse event and insufficient effect|0|||
160781477|NCT01060111|580585072|FG001|Overall Study|Adverse event and insufficient effect|1|||
160781478|NCT01060111|580585073|FG002|Overall Study|Adverse event and insufficient effect|0|||
160639076|NCT00879970|580062906|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
160639077|NCT00879970|580062907|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
160639078|NCT00879970|580062908|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
160639079|NCT00879970|580062904|FG000|Period 1 TZD Randomization|Death|2|||
160639080|NCT00879970|580062905|FG001|Period 1 TZD Randomization|Death|1|||
160639081|NCT00879970|580062906|FG002|Period 1 TZD Randomization|Death|0|||
160639082|NCT00879970|580062907|FG003|Period 1 TZD Randomization|Death|0|||
160639083|NCT00879970|580062908|FG004|Period 1 TZD Randomization|Death|0|||
160639084|NCT00879970|580062904|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
160639085|NCT00879970|580062905|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
160639086|NCT00879970|580062906|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
160639087|NCT00879970|580062907|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
160639088|NCT00879970|580062908|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
160639089|NCT00879970|580062904|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
160639090|NCT00879970|580062905|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
160639091|NCT00879970|580062906|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
160639092|NCT00879970|580062907|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
160639093|NCT00879970|580062908|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
160639094|NCT00879970|580062904|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
160639095|NCT00879970|580062905|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
160639096|NCT00879970|580062906|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
160639097|NCT00879970|580062907|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
160639098|NCT00879970|580062908|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
160639099|NCT00879970|580062904|FG000|Period 2 Vitamin D Randomization|Death|0|||
160639100|NCT00879970|580062905|FG001|Period 2 Vitamin D Randomization|Death|0|||
160639101|NCT00879970|580062906|FG002|Period 2 Vitamin D Randomization|Death|0|||
160639102|NCT00879970|580062907|FG003|Period 2 Vitamin D Randomization|Death|2|||
160639103|NCT00879970|580062908|FG004|Period 2 Vitamin D Randomization|Death|0|||
160639104|NCT01749033|580062912|FG000|Overall Study|Did not receive allocated intervention|3|||
160639105|NCT01749033|580062913|FG001|Overall Study|Did not receive allocated intervention|3|||
160889406|NCT03868124|580989531|FG000|Overall Study|Death|1|||
160889407|NCT03868124|580989532|FG001|Overall Study|Death|1|||
160889408|NCT03868124|580989533|FG002|Overall Study|Death|2|||
160889409|NCT03868124|580989531|FG000|Overall Study|Adverse Event|0|||
160889410|NCT03868124|580989532|FG001|Overall Study|Adverse Event|0|||
160889411|NCT03868124|580989533|FG002|Overall Study|Adverse Event|3|||
160889412|NCT03868124|580989531|FG000|Overall Study|Explanted|2|||
160889413|NCT03868124|580989532|FG001|Overall Study|Explanted|1|||
160889414|NCT03868124|580989533|FG002|Overall Study|Explanted|0|||
160889415|NCT03868124|580989531|FG000|Overall Study|Ongoing in study|176|||
160889416|NCT03868124|580989532|FG001|Overall Study|Ongoing in study|180|||
160889417|NCT03868124|580989533|FG002|Overall Study|Ongoing in study|183|||
160889418|NCT04177355|580989534|FG000|Overall Study|Lost to Follow-up|0|||
160889419|NCT04177355|580989535|FG001|Overall Study|Lost to Follow-up|2|||
160889420|NCT04177355|580989536|FG002|Overall Study|Lost to Follow-up|0|||
160889421|NCT04177355|580989537|FG003|Overall Study|Lost to Follow-up|1|||
160889422|NCT04177355|580989538|FG004|Overall Study|Lost to Follow-up|2|||
160889423|NCT04177355|580989539|FG005|Overall Study|Lost to Follow-up|0|||
160889424|NCT04177355|580989540|FG006|Overall Study|Lost to Follow-up|1|||
160889425|NCT04177355|580989541|FG007|Overall Study|Lost to Follow-up|0|||
160889426|NCT04177355|580989542|FG008|Overall Study|Lost to Follow-up|0|||
160889427|NCT04177355|580989543|FG009|Overall Study|Lost to Follow-up|0|||
160889428|NCT04177355|580989544|FG010|Overall Study|Lost to Follow-up|0|||
160889429|NCT04177355|580989534|FG000|Overall Study|Withdrawal by Subject|0|||
160889430|NCT04177355|580989535|FG001|Overall Study|Withdrawal by Subject|0|||
160889431|NCT04177355|580989536|FG002|Overall Study|Withdrawal by Subject|0|||
160889432|NCT04177355|580989537|FG003|Overall Study|Withdrawal by Subject|1|||
160889433|NCT04177355|580989538|FG004|Overall Study|Withdrawal by Subject|1|||
160889434|NCT04177355|580989539|FG005|Overall Study|Withdrawal by Subject|0|||
160889435|NCT04177355|580989540|FG006|Overall Study|Withdrawal by Subject|0|||
160889436|NCT04177355|580989541|FG007|Overall Study|Withdrawal by Subject|0|||
160889437|NCT04177355|580989542|FG008|Overall Study|Withdrawal by Subject|1|||
160889438|NCT04177355|580989543|FG009|Overall Study|Withdrawal by Subject|0|||
160889439|NCT04177355|580989544|FG010|Overall Study|Withdrawal by Subject|0|||
160889440|NCT02742246|580989545|FG000|Overall Study|Never initiated treatment|5|||
160889441|NCT02742246|580989546|FG001|Overall Study|Never initiated treatment|3|||
160889442|NCT02742246|580989547|FG002|Overall Study|Never initiated treatment|1|||
160639106|NCT01749033|580062914|FG002|Overall Study|Did not receive allocated intervention|0|||
160889443|NCT02742246|580989545|FG000|Overall Study|dropped out during treatment|7|||
160889444|NCT02742246|580989546|FG001|Overall Study|dropped out during treatment|13|||
160889445|NCT02742246|580989547|FG002|Overall Study|dropped out during treatment|10|||
160889446|NCT02742246|580989545|FG000|Overall Study|Death|1|||
160889447|NCT02742246|580989546|FG001|Overall Study|Death|0|||
160889448|NCT02742246|580989547|FG002|Overall Study|Death|0|||
160781479|NCT01060111|580585071|FG000|Overall Study|Participants' non-cooperation|1|||
160781480|NCT01060111|580585072|FG001|Overall Study|Participants' non-cooperation|0|||
160781481|NCT01060111|580585073|FG002|Overall Study|Participants' non-cooperation|0|||
160781482|NCT01060111|580585071|FG000|Overall Study|Other|2|||
160781483|NCT01060111|580585072|FG001|Overall Study|Other|3|||
160781484|NCT01060111|580585073|FG002|Overall Study|Other|4|||
160781485|NCT03954938|580585074|FG000|Overall Study|Withdrawal by Subject|2|||
160781486|NCT03954938|580585074|FG000|Overall Study|Adverse Event|1|||
160781487|NCT00625378|580585075|FG000|Overall Study|Adverse Event|22|||
160781488|NCT00625378|580585076|FG001|Overall Study|Adverse Event|0|||
160781489|NCT00625378|580585075|FG000|Overall Study|Withdrawal by Subject|16|||
160781490|NCT00625378|580585076|FG001|Overall Study|Withdrawal by Subject|0|||
160781491|NCT00625378|580585075|FG000|Overall Study|Death|38|||
160781492|NCT00625378|580585076|FG001|Overall Study|Death|0|||
160781493|NCT00625378|580585075|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
160781494|NCT00625378|580585076|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
160781495|NCT00625378|580585075|FG000|Overall Study|Lost to Follow-up|17|||
160781496|NCT00625378|580585076|FG001|Overall Study|Lost to Follow-up|0|||
160781497|NCT00625378|580585075|FG000|Overall Study|Non-compliant with study medication|3|||
160781498|NCT00625378|580585076|FG001|Overall Study|Non-compliant with study medication|0|||
160781499|NCT00625378|580585075|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
160781500|NCT00625378|580585076|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
160781501|NCT00625378|580585075|FG000|Overall Study|Medical decision|1|||
160781502|NCT00625378|580585076|FG001|Overall Study|Medical decision|0|||
160781503|NCT00625378|580585075|FG000|Overall Study|Multiple toxicities|1|||
160781504|NCT00625378|580585076|FG001|Overall Study|Multiple toxicities|0|||
160781505|NCT00625378|580585075|FG000|Overall Study|New cancer|1|||
160781506|NCT00625378|580585076|FG001|Overall Study|New cancer|0|||
160781507|NCT00625378|580585075|FG000|Overall Study|PTA program|2|||
160781508|NCT00625378|580585076|FG001|Overall Study|PTA program|0|||
160781509|NCT00625378|580585075|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
160781510|NCT00625378|580585076|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
160781511|NCT00625378|580585075|FG000|Overall Study|Sponsor decision|1|||
160781512|NCT00625378|580585076|FG001|Overall Study|Sponsor decision|0|||
160781513|NCT00625378|580585075|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
160781514|NCT00625378|580585076|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
160781515|NCT00625378|580585075|FG000|Overall Study|Switch to commercial drug|6|||
160781516|NCT00625378|580585076|FG001|Overall Study|Switch to commercial drug|1|||
160781517|NCT00625378|580585075|FG000|Overall Study|Missing|2|||
160781518|NCT00625378|580585076|FG001|Overall Study|Missing|0|||
160781519|NCT00625378|580585075|FG000|Overall Study|End of treatment not available|2|||
160781520|NCT00625378|580585076|FG001|Overall Study|End of treatment not available|0|||
160781521|NCT00625378|580585075|FG000|Overall Study|Never treated|2|||
160781522|NCT00625378|580585076|FG001|Overall Study|Never treated|0|||
160781523|NCT01371565|580585077|FG000|Overall Study|Withdrawal by Subject|1|||
160781524|NCT01371565|580585077|FG000|Overall Study|Death|1|||
160781525|NCT01371565|580585077|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
160781526|NCT00617903|580585078|FG000|Overall Study|Withdrawal by Subject|2|||
160781527|NCT00617903|580585079|FG001|Overall Study|Withdrawal by Subject|3|||
160781528|NCT00617903|580585078|FG000|Overall Study|Lost to Follow-up|1|||
160781529|NCT00617903|580585079|FG001|Overall Study|Lost to Follow-up|1|||
160781530|NCT00617903|580585078|FG000|Overall Study|Lack of Efficacy|0|||
160781531|NCT00617903|580585079|FG001|Overall Study|Lack of Efficacy|1|||
160781532|NCT00617903|580585078|FG000|Overall Study|Adverse Event|0|||
160781533|NCT00617903|580585079|FG001|Overall Study|Adverse Event|1|||
160781534|NCT00617903|580585078|FG000|Overall Study|noncompliance|0|||
160781535|NCT00617903|580585079|FG001|Overall Study|noncompliance|1|||
160781536|NCT04676646|580585080|FG000|Open-label Run-in Phase|Adverse Event|3|||
160781537|NCT04676646|580585081|FG001|Open-label Run-in Phase|Adverse Event|0|||
160781538|NCT04676646|580585082|FG002|Open-label Run-in Phase|Adverse Event|0|||
160781539|NCT04676646|580585080|FG000|Open-label Run-in Phase|Death|3|||
160781540|NCT04676646|580585081|FG001|Open-label Run-in Phase|Death|0|||
160781541|NCT04676646|580585082|FG002|Open-label Run-in Phase|Death|0|||
160781542|NCT04676646|580585080|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
160542311|NCT01661140|579714192|FG002|Double-Blind Period|Refused Treatment|1|||
160542312|NCT01661140|579714190|FG000|Double-Blind Period|Adverse Event|0|||
160542313|NCT01661140|579714191|FG001|Double-Blind Period|Adverse Event|16|||
160542314|NCT01661140|579714192|FG002|Double-Blind Period|Adverse Event|18|||
160542315|NCT01661140|579714190|FG000|Double-Blind Period|Protocol Violation|0|||
160542316|NCT01661140|579714191|FG001|Double-Blind Period|Protocol Violation|2|||
160542317|NCT01661140|579714192|FG002|Double-Blind Period|Protocol Violation|3|||
160542318|NCT01661140|579714190|FG000|Double-Blind Period|Withdrawal by Subject|0|||
160542319|NCT01661140|579714191|FG001|Double-Blind Period|Withdrawal by Subject|1|||
160542320|NCT01661140|579714192|FG002|Double-Blind Period|Withdrawal by Subject|3|||
160542321|NCT01661140|579714190|FG000|Double-Blind Period|Investigator's Decision|0|||
160542322|NCT01661140|579714191|FG001|Double-Blind Period|Investigator's Decision|1|||
160542323|NCT01661140|579714192|FG002|Double-Blind Period|Investigator's Decision|2|||
160542324|NCT01661140|579714190|FG000|Double-Blind Period|Sponsor Termination|0|||
160542325|NCT01661140|579714191|FG001|Double-Blind Period|Sponsor Termination|14|||
160542326|NCT01661140|579714192|FG002|Double-Blind Period|Sponsor Termination|17|||
160542327|NCT01661140|579714190|FG000|Double-Blind Period|Administrative/Other|0|||
160542328|NCT01661140|579714191|FG001|Double-Blind Period|Administrative/Other|7|||
160542329|NCT01661140|579714192|FG002|Double-Blind Period|Administrative/Other|6|||
160639107|NCT01749033|580062912|FG000|Overall Study|Lost to Follow-up|0|||
160639108|NCT01749033|580062913|FG001|Overall Study|Lost to Follow-up|2|||
160639109|NCT01749033|580062914|FG002|Overall Study|Lost to Follow-up|1|||
160639110|NCT01256398|580062915|FG000|Overall Study|Withdrawal by Subject|1|||
160639111|NCT00061945|580062916|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
160639112|NCT00061945|580062917|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
160639113|NCT00061945|580062916|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
160639114|NCT00061945|580062917|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
160639115|NCT00061945|580062916|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
160639116|NCT00061945|580062917|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
160639117|NCT00061945|580062916|FG000|Course IV: Alemtuzumab|Early exits|6|||
160639118|NCT00061945|580062917|FG001|Course IV: Alemtuzumab|Early exits|15|||
160639119|NCT01039584|580062918|FG000|Overall Study|Withdrawal by Subject|4|||
160781543|NCT04676646|580585081|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
160781544|NCT04676646|580585082|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
160781545|NCT04676646|580585080|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
160781546|NCT04676646|580585081|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
160781547|NCT04676646|580585082|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
160781548|NCT04676646|580585080|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
160781549|NCT04676646|580585081|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
160781550|NCT04676646|580585082|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
160781551|NCT04676646|580585080|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
160781552|NCT04676646|580585081|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
160781553|NCT04676646|580585082|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
160781554|NCT04676646|580585080|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
160781555|NCT04676646|580585081|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
160781556|NCT04676646|580585082|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
160781557|NCT04676646|580585080|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
160781558|NCT04676646|580585081|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
160781559|NCT04676646|580585082|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
160781560|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
160781561|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
160781562|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
160781563|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Death|0|||
160781564|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Death|1|||
160781565|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Death|2|||
160781566|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
160781567|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
160781568|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
160781569|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
160781570|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
160781571|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
160781572|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
160781573|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
160781574|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
160781575|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
160542330|NCT02239939|579714193|FG000|Overall Study|Adverse Event|1|||
160639120|NCT01039584|580062919|FG001|Overall Study|Withdrawal by Subject|2|||
160542331|NCT02239939|579714194|FG001|Overall Study|Adverse Event|0|||
160542332|NCT02239939|579714193|FG000|Overall Study|Withdrawal by Subject|1|||
160542333|NCT02239939|579714194|FG001|Overall Study|Withdrawal by Subject|1|||
160542334|NCT02239939|579714193|FG000|Overall Study|Lost to Follow-up|0|||
160542335|NCT02239939|579714194|FG001|Overall Study|Lost to Follow-up|1|||
160542336|NCT03865706|579714200|FG000|Overall Study|Death|0|||
160542337|NCT03865706|579714201|FG001|Overall Study|Death|3|||
160542338|NCT03865706|579714202|FG002|Overall Study|Death|1|||
160542339|NCT02095535|579714203|FG000|Recruitment|Protocol Violation|2|||
160542340|NCT02646982|579714204|FG000|Overall Study|Adverse Event|1|||
160542341|NCT02646982|579714205|FG001|Overall Study|Adverse Event|1|||
160542342|NCT02646982|579714204|FG000|Overall Study|Withdrawal by Subject|2|||
160639121|NCT01039584|580062920|FG002|Overall Study|Withdrawal by Subject|1|||
160639122|NCT01039584|580062918|FG000|Overall Study|Protocol Violation|10|||
160639123|NCT01039584|580062919|FG001|Overall Study|Protocol Violation|4|||
160781576|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
160542343|NCT02646982|579714205|FG001|Overall Study|Withdrawal by Subject|1|||
160542344|NCT01877187|579714206|FG000|Overall Study|Death|2|||
160542345|NCT01877187|579714206|FG000|Overall Study|Withdrawal by Subject|4|||
160542346|NCT01877187|579714206|FG000|Overall Study|Lost to Follow-up|3|||
160542347|NCT01877187|579714206|FG000|Overall Study|Declining clinical status|11|||
160542348|NCT01877187|579714206|FG000|Overall Study|Liver transplant|2|||
160542349|NCT02590588|579714213|FG000|Overall Study|Adverse Event|1|||
160542350|NCT01780831|579714221|FG000|Overall Study|Withdrawal by Subject|0|||
160542351|NCT01780831|579714222|FG001|Overall Study|Withdrawal by Subject|0|||
160542352|NCT01780831|579714223|FG002|Overall Study|Withdrawal by Subject|4|||
160542353|NCT01780831|579714224|FG003|Overall Study|Withdrawal by Subject|0|||
160542354|NCT01780831|579714221|FG000|Overall Study|Lost to Follow-up|0|||
160542355|NCT01780831|579714222|FG001|Overall Study|Lost to Follow-up|0|||
160542356|NCT01780831|579714223|FG002|Overall Study|Lost to Follow-up|0|||
160542357|NCT01780831|579714224|FG003|Overall Study|Lost to Follow-up|1|||
160542358|NCT00708500|579714228|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
160542359|NCT00708500|579714229|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
160542360|NCT00708500|579714230|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
160542361|NCT00708500|579714228|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
160542362|NCT00708500|579714229|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
160542363|NCT00708500|579714230|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
160542364|NCT00708500|579714228|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
160542365|NCT00708500|579714229|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
160542366|NCT00708500|579714230|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
160542367|NCT00708500|579714228|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
160542368|NCT00708500|579714229|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
160542369|NCT00708500|579714230|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
160542370|NCT00708500|579714228|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
160542371|NCT00708500|579714229|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
160542372|NCT00708500|579714230|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
160542373|NCT00708500|579714228|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
160542374|NCT00708500|579714229|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
160542375|NCT00708500|579714230|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
160542376|NCT00708500|579714228|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
160542377|NCT00708500|579714229|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
160542378|NCT00708500|579714230|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
160542379|NCT00708500|579714228|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
160542380|NCT00708500|579714229|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
160542381|NCT00708500|579714230|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
160542382|NCT00708500|579714228|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
160542383|NCT00708500|579714229|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
160542384|NCT00708500|579714230|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
160542385|NCT00708500|579714228|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
160542386|NCT00708500|579714229|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
160542387|NCT00708500|579714230|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
160542388|NCT00708500|579714228|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
160542389|NCT00708500|579714229|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
160542390|NCT00708500|579714230|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
160542391|NCT00708500|579714228|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
160542392|NCT00708500|579714229|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
160542393|NCT00708500|579714230|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
160542394|NCT00708500|579714228|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
160542395|NCT00708500|579714229|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
160542396|NCT00708500|579714230|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
160542397|NCT00708500|579714228|FG000|FOLLOWUP|Adverse Event|0|||
160542398|NCT00708500|579714229|FG001|FOLLOWUP|Adverse Event|1|||
160542399|NCT00708500|579714230|FG002|FOLLOWUP|Adverse Event|0|||
160542400|NCT00708500|579714228|FG000|FOLLOWUP|Lost to Follow-up|1|||
160542401|NCT00708500|579714229|FG001|FOLLOWUP|Lost to Follow-up|6|||
160542402|NCT00708500|579714230|FG002|FOLLOWUP|Lost to Follow-up|4|||
160542403|NCT00708500|579714228|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
160542404|NCT00708500|579714229|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
160542405|NCT00708500|579714230|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
160542406|NCT00708500|579714228|FG000|FOLLOWUP|Subject withdrew consent|31|||
160542407|NCT00708500|579714229|FG001|FOLLOWUP|Subject withdrew consent|4|||
160542408|NCT00708500|579714230|FG002|FOLLOWUP|Subject withdrew consent|5|||
160542409|NCT00708500|579714228|FG000|FOLLOWUP|Non-compliance with protocol|5|||
160542410|NCT00708500|579714229|FG001|FOLLOWUP|Non-compliance with protocol|0|||
160542411|NCT00708500|579714230|FG002|FOLLOWUP|Non-compliance with protocol|1|||
160542412|NCT00382993|579714238|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
160542413|NCT00382993|579714239|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
160542414|NCT00382993|579714238|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
160542415|NCT00382993|579714239|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
160542416|NCT00382993|579714238|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
160542417|NCT00382993|579714239|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
160542418|NCT00382993|579714238|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
160542419|NCT00382993|579714239|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
160542420|NCT00382993|579714238|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
160542421|NCT00382993|579714239|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
160542422|NCT00382993|579714238|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
160542423|NCT00382993|579714239|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
160542424|NCT00382993|579714238|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
160542425|NCT00382993|579714239|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
160542426|NCT00382993|579714238|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
160542427|NCT00382993|579714239|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
160542428|NCT00382993|579714238|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
160542429|NCT00382993|579714239|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
160542430|NCT00382993|579714238|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
160542431|NCT00382993|579714239|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
160542432|NCT00794677|579714240|FG000|First Intervention|Withdrawal by Subject|2|||
160542433|NCT00794677|579714241|FG001|First Intervention|Withdrawal by Subject|0|||
160542434|NCT01965262|579714254|FG000|Second Intervention (7 Days)|Discontinued|0|||
160542435|NCT01965262|579714255|FG001|Second Intervention (7 Days)|Discontinued|1|||
160542436|NCT01965262|579714254|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
160542437|NCT01965262|579714255|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
160542438|NCT01965262|579714254|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
160542439|NCT01965262|579714255|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
160542440|NCT00607386|579714256|FG000|Overall Study|Physician Decision|1|||
160542441|NCT00440947|579714257|FG000|36-Week Induction Phase|Adverse Event|16|||
160542442|NCT00440947|579714258|FG001|36-Week Induction Phase|Adverse Event|0|||
160542443|NCT00440947|579714259|FG002|36-Week Induction Phase|Adverse Event|0|||
160542444|NCT00440947|579714260|FG003|36-Week Induction Phase|Adverse Event|0|||
160542445|NCT00440947|579714261|FG004|36-Week Induction Phase|Adverse Event|0|||
160542446|NCT00440947|579714257|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
160542447|NCT00440947|579714258|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
160542448|NCT00440947|579714259|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
160542449|NCT00440947|579714260|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
160542450|NCT00440947|579714261|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
160542451|NCT00440947|579714257|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
160542452|NCT00440947|579714258|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
160542453|NCT00440947|579714259|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
160542454|NCT00440947|579714260|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
160542455|NCT00440947|579714261|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
160542456|NCT00440947|579714257|FG000|36-Week Induction Phase|Non-compliance|10|||
160542457|NCT00440947|579714258|FG001|36-Week Induction Phase|Non-compliance|0|||
160542458|NCT00440947|579714259|FG002|36-Week Induction Phase|Non-compliance|0|||
160542459|NCT00440947|579714260|FG003|36-Week Induction Phase|Non-compliance|0|||
160542460|NCT00440947|579714261|FG004|36-Week Induction Phase|Non-compliance|0|||
160542461|NCT00440947|579714257|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
160542462|NCT00440947|579714258|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
160542463|NCT00440947|579714259|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
160542464|NCT00440947|579714260|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
160542465|NCT00440947|579714261|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
160542466|NCT00440947|579714257|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
160542467|NCT00440947|579714258|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
160542468|NCT00440947|579714259|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
160542469|NCT00440947|579714260|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
160542470|NCT00440947|579714261|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
160542471|NCT00440947|579714257|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
160542472|NCT00440947|579714258|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
160542473|NCT00440947|579714259|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
160639124|NCT01039584|580062920|FG002|Overall Study|Protocol Violation|6|||
160639125|NCT01039584|580062918|FG000|Overall Study|Lost to Follow-up|5|||
160542474|NCT00440947|579714260|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
160542475|NCT00440947|579714261|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
160639126|NCT01039584|580062919|FG001|Overall Study|Lost to Follow-up|3|||
160639127|NCT01039584|580062920|FG002|Overall Study|Lost to Follow-up|4|||
160639128|NCT01039584|580062918|FG000|Overall Study|Negative Baseline culture for Candida|59|||
160861884|NCT02531802|580887859|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
160542476|NCT00440947|579714257|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
160542477|NCT00440947|579714258|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
160542478|NCT00440947|579714259|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
160542479|NCT00440947|579714260|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
160542480|NCT00440947|579714261|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
160542481|NCT00440947|579714257|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
160542482|NCT00440947|579714258|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
160542483|NCT00440947|579714259|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
160542484|NCT00440947|579714260|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
160542485|NCT00440947|579714261|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
160542486|NCT00440947|579714257|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
160542487|NCT00440947|579714258|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
160542488|NCT00440947|579714259|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
160542489|NCT00440947|579714260|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
160542490|NCT00440947|579714261|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
160542491|NCT00440947|579714257|FG000|36-Week Induction Phase|Incarceration|3|||
160542492|NCT00440947|579714258|FG001|36-Week Induction Phase|Incarceration|0|||
160542493|NCT00440947|579714259|FG002|36-Week Induction Phase|Incarceration|0|||
160542494|NCT00440947|579714260|FG003|36-Week Induction Phase|Incarceration|0|||
160542495|NCT00440947|579714261|FG004|36-Week Induction Phase|Incarceration|0|||
160542496|NCT00440947|579714257|FG000|36-Week Induction Phase|Pregnancy|1|||
160542497|NCT00440947|579714258|FG001|36-Week Induction Phase|Pregnancy|0|||
160542498|NCT00440947|579714259|FG002|36-Week Induction Phase|Pregnancy|0|||
160542499|NCT00440947|579714260|FG003|36-Week Induction Phase|Pregnancy|0|||
160639129|NCT01039584|580062919|FG001|Overall Study|Negative Baseline culture for Candida|59|||
160639130|NCT01039584|580062920|FG002|Overall Study|Negative Baseline culture for Candida|24|||
160639131|NCT01039584|580062918|FG000|Overall Study|Lack of Efficacy|7|||
160639132|NCT01039584|580062919|FG001|Overall Study|Lack of Efficacy|6|||
160639133|NCT01039584|580062920|FG002|Overall Study|Lack of Efficacy|10|||
160542500|NCT00440947|579714261|FG004|36-Week Induction Phase|Pregnancy|0|||
160542501|NCT00440947|579714257|FG000|48-Week Randomization Phase|Adverse Event|0|||
160639134|NCT01039584|580062918|FG000|Overall Study|other|1|||
160542502|NCT00440947|579714258|FG001|48-Week Randomization Phase|Adverse Event|2|||
160542503|NCT00440947|579714259|FG002|48-Week Randomization Phase|Adverse Event|5|||
160542504|NCT00440947|579714260|FG003|48-Week Randomization Phase|Adverse Event|0|||
160542505|NCT00440947|579714261|FG004|48-Week Randomization Phase|Adverse Event|0|||
160542506|NCT00440947|579714257|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
160542507|NCT00440947|579714258|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
160542508|NCT00440947|579714259|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
160542509|NCT00440947|579714260|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
160542510|NCT00440947|579714261|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
160542511|NCT00440947|579714257|FG000|48-Week Randomization Phase|Non-compliance|0|||
160542512|NCT00440947|579714258|FG001|48-Week Randomization Phase|Non-compliance|3|||
160542513|NCT00440947|579714259|FG002|48-Week Randomization Phase|Non-compliance|4|||
160542514|NCT00440947|579714260|FG003|48-Week Randomization Phase|Non-compliance|0|||
160542515|NCT00440947|579714261|FG004|48-Week Randomization Phase|Non-compliance|0|||
160542516|NCT00440947|579714257|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
160542517|NCT00440947|579714258|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
160542518|NCT00440947|579714259|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
160542519|NCT00440947|579714260|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
160542520|NCT00440947|579714261|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
160542521|NCT00440947|579714257|FG000|48-Week Randomization Phase|Protocol Violation|0|||
160542522|NCT00440947|579714258|FG001|48-Week Randomization Phase|Protocol Violation|0|||
160542523|NCT00440947|579714259|FG002|48-Week Randomization Phase|Protocol Violation|1|||
160542524|NCT00440947|579714260|FG003|48-Week Randomization Phase|Protocol Violation|0|||
160542525|NCT00440947|579714261|FG004|48-Week Randomization Phase|Protocol Violation|0|||
160781577|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
160781578|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
160542526|NCT00440947|579714257|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
160542527|NCT00440947|579714258|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
160542528|NCT00440947|579714259|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
160542529|NCT00440947|579714260|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
160542530|NCT00440947|579714261|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
160542531|NCT00440947|579714257|FG000|48-Week Randomization Phase|Pregnancy|0|||
160542532|NCT00440947|579714258|FG001|48-Week Randomization Phase|Pregnancy|0|||
160542533|NCT00440947|579714259|FG002|48-Week Randomization Phase|Pregnancy|1|||
160542534|NCT00440947|579714260|FG003|48-Week Randomization Phase|Pregnancy|0|||
160542535|NCT00440947|579714261|FG004|48-Week Randomization Phase|Pregnancy|0|||
160542536|NCT00440947|579714257|FG000|48-Week Randomization Phase|Incarceration|0|||
160542537|NCT00440947|579714258|FG001|48-Week Randomization Phase|Incarceration|3|||
160542538|NCT00440947|579714259|FG002|48-Week Randomization Phase|Incarceration|0|||
160542539|NCT00440947|579714260|FG003|48-Week Randomization Phase|Incarceration|0|||
160542540|NCT00440947|579714261|FG004|48-Week Randomization Phase|Incarceration|0|||
160542541|NCT00440947|579714257|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
160542542|NCT00440947|579714258|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
160542543|NCT00440947|579714259|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
160542544|NCT00440947|579714260|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
160542545|NCT00440947|579714261|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
160542546|NCT00440947|579714257|FG000|48-Week Randomization Phase|Physician Decision|0|||
160542547|NCT00440947|579714258|FG001|48-Week Randomization Phase|Physician Decision|2|||
160542548|NCT00440947|579714259|FG002|48-Week Randomization Phase|Physician Decision|0|||
160542549|NCT00440947|579714260|FG003|48-Week Randomization Phase|Physician Decision|0|||
160542550|NCT00440947|579714261|FG004|48-Week Randomization Phase|Physician Decision|0|||
160542551|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
160542552|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
160542553|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
160542554|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
160542555|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
160542556|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
160542557|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
160542558|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
160542559|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
160542560|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
160542561|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
160542562|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
160542563|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
160542564|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
160542565|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
160542566|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
160542567|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
160542568|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
160542569|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
160542570|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
160542571|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
160542572|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
160542573|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
160542574|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
160542575|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
160542576|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
160542577|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
160542578|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
160542579|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
160542580|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
160542581|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
160542582|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
160542583|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
160639135|NCT01039584|580062919|FG001|Overall Study|other|3|||
160639136|NCT01039584|580062920|FG002|Overall Study|other|1|||
160542584|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
160542585|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
160542586|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
160542587|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
160542588|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
160542589|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
160542590|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
160542591|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
160542592|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
160542593|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
160639137|NCT01039584|580062918|FG000|Overall Study|Pap smear with significant pathology|10|||
160639138|NCT01039584|580062919|FG001|Overall Study|Pap smear with significant pathology|10|||
160781579|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
160781580|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
160639139|NCT01039584|580062920|FG002|Overall Study|Pap smear with significant pathology|3|||
160639140|NCT01039584|580062918|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
160639141|NCT01039584|580062919|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
160639142|NCT01039584|580062920|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
160639143|NCT03672396|580062923|FG000|Overall Study|Withdrawal by Subject|4|||
160639144|NCT03672396|580062923|FG000|Overall Study|Physician Decision|1|||
160639145|NCT03672396|580062923|FG000|Overall Study|Adverse Event|1|||
160639146|NCT04380701|580062926|FG000|Overall Study|Pregnancy|0|||
160639147|NCT04380701|580062927|FG001|Overall Study|Pregnancy|0|||
160639148|NCT04380701|580062928|FG002|Overall Study|Pregnancy|0|||
160639149|NCT04380701|580062929|FG003|Overall Study|Pregnancy|0|||
160639150|NCT04380701|580062930|FG004|Overall Study|Pregnancy|0|||
160639151|NCT04380701|580062931|FG005|Overall Study|Pregnancy|0|||
160639152|NCT04380701|580062932|FG006|Overall Study|Pregnancy|0|||
160639153|NCT04380701|580062933|FG007|Overall Study|Pregnancy|0|||
160639154|NCT04380701|580062934|FG008|Overall Study|Pregnancy|0|||
160639155|NCT04380701|580062935|FG009|Overall Study|Pregnancy|0|||
160639156|NCT04380701|580062936|FG010|Overall Study|Pregnancy|0|||
160639157|NCT04380701|580062937|FG011|Overall Study|Pregnancy|0|||
160639158|NCT04380701|580062938|FG012|Overall Study|Pregnancy|0|||
160639159|NCT04380701|580062939|FG013|Overall Study|Pregnancy|0|||
160639160|NCT04380701|580062940|FG014|Overall Study|Pregnancy|0|||
160639161|NCT04380701|580062941|FG015|Overall Study|Pregnancy|0|||
160639162|NCT04380701|580062942|FG016|Overall Study|Pregnancy|0|||
160639163|NCT04380701|580062943|FG017|Overall Study|Pregnancy|0|||
160639164|NCT04380701|580062944|FG018|Overall Study|Pregnancy|0|||
160639165|NCT04380701|580062945|FG019|Overall Study|Pregnancy|0|||
160639166|NCT04380701|580062946|FG020|Overall Study|Pregnancy|0|||
160639167|NCT04380701|580062947|FG021|Overall Study|Pregnancy|0|||
160639168|NCT04380701|580062948|FG022|Overall Study|Pregnancy|0|||
160639169|NCT04380701|580062949|FG023|Overall Study|Pregnancy|0|||
160639170|NCT04380701|580062950|FG024|Overall Study|Pregnancy|0|||
160639171|NCT04380701|580062951|FG025|Overall Study|Pregnancy|0|||
160639172|NCT04380701|580062952|FG026|Overall Study|Pregnancy|0|||
160639173|NCT04380701|580062953|FG027|Overall Study|Pregnancy|0|||
160639174|NCT04380701|580062954|FG028|Overall Study|Pregnancy|0|||
160639175|NCT04380701|580062955|FG029|Overall Study|Pregnancy|0|||
160639176|NCT04380701|580062956|FG030|Overall Study|Pregnancy|0|||
160639177|NCT04380701|580062957|FG031|Overall Study|Pregnancy|0|||
160639178|NCT04380701|580062958|FG032|Overall Study|Pregnancy|1|||
160639179|NCT04380701|580062959|FG033|Overall Study|Pregnancy|0|||
160639180|NCT04380701|580062926|FG000|Overall Study|Lost to Follow-up|0|||
160639181|NCT04380701|580062927|FG001|Overall Study|Lost to Follow-up|0|||
160639182|NCT04380701|580062928|FG002|Overall Study|Lost to Follow-up|0|||
160639183|NCT04380701|580062929|FG003|Overall Study|Lost to Follow-up|0|||
160639184|NCT04380701|580062930|FG004|Overall Study|Lost to Follow-up|0|||
160639185|NCT04380701|580062931|FG005|Overall Study|Lost to Follow-up|0|||
160639186|NCT04380701|580062932|FG006|Overall Study|Lost to Follow-up|0|||
160639187|NCT04380701|580062933|FG007|Overall Study|Lost to Follow-up|0|||
160639188|NCT04380701|580062934|FG008|Overall Study|Lost to Follow-up|0|||
160639189|NCT04380701|580062935|FG009|Overall Study|Lost to Follow-up|0|||
160639190|NCT04380701|580062936|FG010|Overall Study|Lost to Follow-up|0|||
160639191|NCT04380701|580062937|FG011|Overall Study|Lost to Follow-up|0|||
160639192|NCT04380701|580062938|FG012|Overall Study|Lost to Follow-up|0|||
160639193|NCT04380701|580062939|FG013|Overall Study|Lost to Follow-up|0|||
160639194|NCT04380701|580062940|FG014|Overall Study|Lost to Follow-up|0|||
160639195|NCT04380701|580062941|FG015|Overall Study|Lost to Follow-up|0|||
160861885|NCT02531802|580887860|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
160639196|NCT04380701|580062942|FG016|Overall Study|Lost to Follow-up|0|||
160639197|NCT04380701|580062943|FG017|Overall Study|Lost to Follow-up|0|||
160639198|NCT04380701|580062944|FG018|Overall Study|Lost to Follow-up|0|||
160639199|NCT04380701|580062945|FG019|Overall Study|Lost to Follow-up|0|||
160639200|NCT04380701|580062946|FG020|Overall Study|Lost to Follow-up|1|||
160639201|NCT04380701|580062947|FG021|Overall Study|Lost to Follow-up|0|||
160542594|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
160542595|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
160542596|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
160542597|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
160542598|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
160542599|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
160542600|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
160542601|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
160542602|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
160542603|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
160542604|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
160542605|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
160542606|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Other|0|||
160542607|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Other|0|||
160542608|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Other|0|||
160542609|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Other|1|||
160889449|NCT03489551|580989548|FG000|Overall Study|Withdrawal by Subject|2|||
160889450|NCT00054717|580989549|FG000|Overall Study|Randomized but not treated|2|||
160889451|NCT00054717|580989550|FG001|Overall Study|Randomized but not treated|8|||
160889452|NCT00054717|580989549|FG000|Overall Study|Adverse Event|70|||
160889453|NCT00054717|580989550|FG001|Overall Study|Adverse Event|22|||
160889454|NCT00054717|580989549|FG000|Overall Study|Protocol Violation|18|||
160889455|NCT00054717|580989550|FG001|Overall Study|Protocol Violation|19|||
160889456|NCT00054717|580989549|FG000|Overall Study|Lost to Follow-up|23|||
160889457|NCT00054717|580989550|FG001|Overall Study|Lost to Follow-up|13|||
160889458|NCT00054717|580989549|FG000|Overall Study|Withdrawal by Subject|32|||
160542610|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Other|0|||
160542611|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
160542612|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
160542613|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
160542614|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
160542615|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
160542616|NCT00440947|579714257|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
160542617|NCT00440947|579714258|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
160542618|NCT00440947|579714259|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
160542619|NCT00440947|579714260|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
160542620|NCT00440947|579714261|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
160542621|NCT01834274|579714267|FG000|Overall Study|Study Termination|41|||
160542622|NCT01834274|579714268|FG001|Overall Study|Study Termination|38|||
160542623|NCT01834274|579714267|FG000|Overall Study|Withdrawal by Subject|1|||
160542624|NCT01834274|579714268|FG001|Overall Study|Withdrawal by Subject|1|||
160542625|NCT01834274|579714267|FG000|Overall Study|Lost to Follow-up|3|||
160542626|NCT01834274|579714268|FG001|Overall Study|Lost to Follow-up|1|||
160542627|NCT01834274|579714267|FG000|Overall Study|Other|2|||
160542628|NCT01834274|579714268|FG001|Overall Study|Other|1|||
160542629|NCT02941627|579714274|FG000|Overall Study|Death|1|||
160542630|NCT02941627|579714274|FG000|Overall Study|Surgical failure|1|||
160542631|NCT02941627|579714274|FG000|Overall Study|cholesteatoma prevented implantation|1|||
160542632|NCT00513500|579714275|FG000|Overall Study|Lost to Follow-up|35|||
160542633|NCT00513500|579714276|FG001|Overall Study|Lost to Follow-up|39|||
160542634|NCT00513500|579714275|FG000|Overall Study|Death|2|||
160542635|NCT00513500|579714276|FG001|Overall Study|Death|1|||
160542636|NCT00513500|579714275|FG000|Overall Study|Hospitalized|4|||
160542637|NCT00513500|579714276|FG001|Overall Study|Hospitalized|14|||
160542638|NCT00769184|579714282|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
160542639|NCT00769184|579714283|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
160639202|NCT04380701|580062948|FG022|Overall Study|Lost to Follow-up|0|||
160542640|NCT00769184|579714282|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
160542641|NCT00769184|579714283|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
160542642|NCT00769184|579714282|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
160542643|NCT00769184|579714283|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
160542644|NCT01929408|579714288|FG000|Overall Study|received HCT as initial treatment|8|||
160542645|NCT01073267|579714289|FG000|Overall Study|Disease Progression|3|||
160542646|NCT00401375|579714292|FG000|Overall Study|Protocol Violation|2|||
160542647|NCT00401375|579714293|FG001|Overall Study|Protocol Violation|2|||
160542648|NCT00401375|579714294|FG002|Overall Study|Protocol Violation|1|||
160889459|NCT00054717|580989550|FG001|Overall Study|Withdrawal by Subject|20|||
160542649|NCT00401375|579714292|FG000|Overall Study|Adverse Event|6|||
160542650|NCT00401375|579714293|FG001|Overall Study|Adverse Event|11|||
160542651|NCT00401375|579714294|FG002|Overall Study|Adverse Event|10|||
160542652|NCT00401375|579714292|FG000|Overall Study|Withdrawal by Subject|9|||
160542653|NCT00401375|579714293|FG001|Overall Study|Withdrawal by Subject|7|||
160889460|NCT00054717|580989549|FG000|Overall Study|Other reason not defined above|117|||
160542654|NCT00401375|579714294|FG002|Overall Study|Withdrawal by Subject|7|||
160542655|NCT00401375|579714292|FG000|Overall Study|Lost to Follow-up|0|||
160542656|NCT00401375|579714293|FG001|Overall Study|Lost to Follow-up|1|||
160542657|NCT00401375|579714294|FG002|Overall Study|Lost to Follow-up|1|||
160542658|NCT00401375|579714292|FG000|Overall Study|Other than specified|2|||
160542659|NCT00401375|579714293|FG001|Overall Study|Other than specified|1|||
160542660|NCT00401375|579714294|FG002|Overall Study|Other than specified|3|||
160542661|NCT00401375|579714292|FG000|Overall Study|Randomized but not treated|3|||
160542662|NCT00401375|579714293|FG001|Overall Study|Randomized but not treated|3|||
160542663|NCT00401375|579714294|FG002|Overall Study|Randomized but not treated|3|||
160542664|NCT00677014|579714295|FG000|Overall Study|Lost to Follow-up|20|||
160542665|NCT00677014|579714296|FG001|Overall Study|Lost to Follow-up|12|||
160542666|NCT00677014|579714297|FG002|Overall Study|Lost to Follow-up|24|||
160542667|NCT00677014|579714295|FG000|Overall Study|Death|6|||
160542668|NCT00677014|579714296|FG001|Overall Study|Death|15|||
160542669|NCT00677014|579714297|FG002|Overall Study|Death|7|||
160542670|NCT00677014|579714295|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
160542671|NCT00677014|579714296|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
160542672|NCT00677014|579714297|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
160542673|NCT01326546|579714298|FG000|Overall Study|Lost to Follow-up|8|||
160542674|NCT01326546|579714299|FG001|Overall Study|Lost to Follow-up|7|||
160542675|NCT01326546|579714298|FG000|Overall Study|Protocol Violation|3|||
160542676|NCT01326546|579714299|FG001|Overall Study|Protocol Violation|4|||
160542677|NCT01326546|579714298|FG000|Overall Study|Pregnancy|0|||
160542678|NCT01326546|579714299|FG001|Overall Study|Pregnancy|1|||
160542679|NCT01326546|579714298|FG000|Overall Study|Adverse Event|1|||
160542680|NCT01326546|579714299|FG001|Overall Study|Adverse Event|0|||
160542681|NCT01326546|579714298|FG000|Overall Study|Withdrawal by Subject|5|||
160542682|NCT01326546|579714299|FG001|Overall Study|Withdrawal by Subject|1|||
160542683|NCT03152019|579714300|FG000|Overall Study|Adverse Event|0|||
160542684|NCT03152019|579714301|FG001|Overall Study|Adverse Event|1|||
160542685|NCT00923130|579714303|FG000|Overall Study|Stopped treatment due to progression|17|||
160542686|NCT00923130|579714303|FG000|Overall Study|Death|1|||
160542687|NCT00923130|579714303|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
160542688|NCT00923130|579714303|FG000|Overall Study|Switched to alternative treatment|2|||
160542689|NCT00923130|579714303|FG000|Overall Study|Refused further treatment|2|||
160542690|NCT01187953|579714304|FG000|Overall Study|Death|11|||
160542691|NCT01187953|579714305|FG001|Overall Study|Death|13|||
160542692|NCT01187953|579714304|FG000|Overall Study|Adverse Event|1|||
160542693|NCT01187953|579714305|FG001|Overall Study|Adverse Event|2|||
160542694|NCT01187953|579714304|FG000|Overall Study|Lost to Follow-up|0|||
160542695|NCT01187953|579714305|FG001|Overall Study|Lost to Follow-up|3|||
160542696|NCT01187953|579714304|FG000|Overall Study|Withdrawal by Subject|3|||
160542697|NCT01187953|579714305|FG001|Overall Study|Withdrawal by Subject|3|||
160542698|NCT01553136|579714307|FG000|Overall Study|Adverse Event|3|||
160542699|NCT01553136|579714308|FG001|Overall Study|Adverse Event|2|||
160542700|NCT01553136|579714307|FG000|Overall Study|Withdrawal by Subject|2|||
160542701|NCT01553136|579714308|FG001|Overall Study|Withdrawal by Subject|3|||
160542702|NCT01553136|579714307|FG000|Overall Study|Lost to Follow-up|4|||
160542703|NCT01553136|579714308|FG001|Overall Study|Lost to Follow-up|10|||
160542704|NCT01553136|579714307|FG000|Overall Study|Physician Decision|2|||
160542705|NCT01553136|579714308|FG001|Overall Study|Physician Decision|3|||
160542706|NCT01553136|579714307|FG000|Overall Study|Scheduling Difficulties|5|||
160542707|NCT01553136|579714308|FG001|Overall Study|Scheduling Difficulties|4|||
160542708|NCT03468855|579716286|FG000|Overall Study|Adverse Event|2|||
160542709|NCT03468855|579716286|FG000|Overall Study|Lost to Follow-up|5|||
160542710|NCT03468855|579716286|FG000|Overall Study|Withdrawal by Subject|3|||
160542711|NCT03468855|579716286|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
160542712|NCT02068547|579716287|FG000|Overall Study|Lost to Follow-up|3|||
160542713|NCT02068547|579716288|FG001|Overall Study|Lost to Follow-up|3|||
160542714|NCT02068547|579716287|FG000|Overall Study|Physician Decision|1|||
160542715|NCT02068547|579716288|FG001|Overall Study|Physician Decision|0|||
160542716|NCT00880893|579716289|FG000|Overall Study|Protocol Violation|13|||
160542717|NCT00880893|579716290|FG001|Overall Study|Protocol Violation|1|||
160542718|NCT00880893|579716289|FG000|Overall Study|Withdrawal by Subject|15|||
160542719|NCT00880893|579716290|FG001|Overall Study|Withdrawal by Subject|11|||
160542720|NCT00880893|579716289|FG000|Overall Study|Lost to Follow-up|76|||
160542721|NCT00880893|579716290|FG001|Overall Study|Lost to Follow-up|33|||
160542722|NCT00880893|579716289|FG000|Overall Study|Serious adverse event|3|||
160542723|NCT00880893|579716290|FG001|Overall Study|Serious adverse event|0|||
160542724|NCT01736579|579716294|FG000|Overall Study|Termination of Study by Sponsor|2|||
160542725|NCT01736579|579716295|FG001|Overall Study|Termination of Study by Sponsor|2|||
160542726|NCT01783678|579716302|FG000|Overall Study|Randomized but Not Treated|0|||
160542727|NCT01783678|579716303|FG001|Overall Study|Randomized but Not Treated|0|||
160542728|NCT01783678|579716304|FG002|Overall Study|Randomized but Not Treated|0|||
160542729|NCT01783678|579716305|FG003|Overall Study|Randomized but Not Treated|1|||
160542730|NCT01783678|579716306|FG004|Overall Study|Randomized but Not Treated|0|||
160542731|NCT01783678|579716307|FG005|Overall Study|Randomized but Not Treated|0|||
160542732|NCT01783678|579716302|FG000|Overall Study|Lack of Efficacy|1|||
160542733|NCT01783678|579716303|FG001|Overall Study|Lack of Efficacy|13|||
160542734|NCT01783678|579716304|FG002|Overall Study|Lack of Efficacy|1|||
160542735|NCT01783678|579716305|FG003|Overall Study|Lack of Efficacy|3|||
160542736|NCT01783678|579716306|FG004|Overall Study|Lack of Efficacy|6|||
160542737|NCT01783678|579716307|FG005|Overall Study|Lack of Efficacy|5|||
160542738|NCT01783678|579716302|FG000|Overall Study|Lost to Follow-up|0|||
160542739|NCT01783678|579716303|FG001|Overall Study|Lost to Follow-up|4|||
160542740|NCT01783678|579716304|FG002|Overall Study|Lost to Follow-up|0|||
160542741|NCT01783678|579716305|FG003|Overall Study|Lost to Follow-up|2|||
160542742|NCT01783678|579716306|FG004|Overall Study|Lost to Follow-up|1|||
160542743|NCT01783678|579716307|FG005|Overall Study|Lost to Follow-up|0|||
160542744|NCT01783678|579716302|FG000|Overall Study|Withdrew Consent|1|||
160542745|NCT01783678|579716303|FG001|Overall Study|Withdrew Consent|1|||
160889461|NCT00054717|580989550|FG001|Overall Study|Other reason not defined above|217|||
160889462|NCT03139604|580989555|FG000|Overall Study|Other|7|||
160889463|NCT03139604|580989556|FG001|Overall Study|Other|3|||
160889464|NCT03139604|580989555|FG000|Overall Study|Withdrawal by Subject|16|||
160889465|NCT03139604|580989556|FG001|Overall Study|Withdrawal by Subject|17|||
160889466|NCT03139604|580989555|FG000|Overall Study|Physician Decision|1|||
160889467|NCT03139604|580989556|FG001|Overall Study|Physician Decision|2|||
160889468|NCT03139604|580989555|FG000|Overall Study|Lost to Follow-up|3|||
160889469|NCT03139604|580989556|FG001|Overall Study|Lost to Follow-up|1|||
160889470|NCT03139604|580989555|FG000|Overall Study|Death|65|||
160889471|NCT03139604|580989556|FG001|Overall Study|Death|67|||
160889472|NCT03139604|580989555|FG000|Overall Study|Study Terminated by Sponsor|122|||
160889473|NCT03139604|580989556|FG001|Overall Study|Study Terminated by Sponsor|127|||
160889474|NCT03139604|580989555|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
160889475|NCT03139604|580989556|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
160889476|NCT04148911|580989557|FG000|Overall Study|Death|104|||
160889477|NCT04148911|580989557|FG000|Overall Study|Lost to Follow-up|5|||
160889478|NCT04148911|580989557|FG000|Overall Study|Withdrawal by Subject|17|||
160889479|NCT04148911|580989557|FG000|Overall Study|Study Ended by Sponsor|56|||
160889480|NCT00470184|580989560|FG000|Overall Study|Not Treated(became ineligible)|4|||
160542746|NCT01783678|579716304|FG002|Overall Study|Withdrew Consent|0|||
160542747|NCT01783678|579716305|FG003|Overall Study|Withdrew Consent|2|||
160542748|NCT01783678|579716306|FG004|Overall Study|Withdrew Consent|0|||
160542749|NCT01783678|579716307|FG005|Overall Study|Withdrew Consent|0|||
160542750|NCT02404103|579716308|FG000|Overall Study|Adverse Event|1|||
160542751|NCT02404103|579716309|FG001|Overall Study|Adverse Event|0|||
160542752|NCT02404103|579716308|FG000|Overall Study|Lost to Follow-up|3|||
160542753|NCT02404103|579716309|FG001|Overall Study|Lost to Follow-up|3|||
160542754|NCT01979523|579716313|FG000|Overall Study|Withdrawal by Subject|1|||
160542755|NCT01979523|579716314|FG001|Overall Study|Withdrawal by Subject|0|||
160542756|NCT00631371|579716322|FG000|Overall Study|Lost to Follow-up|24|||
160542757|NCT00631371|579716323|FG001|Overall Study|Lost to Follow-up|19|||
160542758|NCT00631371|579716322|FG000|Overall Study|Other reason|5|||
160542759|NCT00631371|579716323|FG001|Overall Study|Other reason|12|||
160542760|NCT00631371|579716322|FG000|Overall Study|subject request|38|||
160542761|NCT00631371|579716323|FG001|Overall Study|subject request|45|||
160542762|NCT00631371|579716322|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
160542763|NCT00631371|579716323|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
160542764|NCT00631371|579716322|FG000|Overall Study|Death|263|||
160542765|NCT00631371|579716323|FG001|Overall Study|Death|239|||
160639203|NCT04380701|580062949|FG023|Overall Study|Lost to Follow-up|1|||
160639204|NCT04380701|580062950|FG024|Overall Study|Lost to Follow-up|0|||
160639205|NCT04380701|580062951|FG025|Overall Study|Lost to Follow-up|0|||
160639206|NCT04380701|580062952|FG026|Overall Study|Lost to Follow-up|0|||
160889481|NCT00470184|580989560|FG000|Overall Study|Not treated (other)|1|||
160889482|NCT00470184|580989560|FG000|Overall Study|disease Progression|4|||
160889483|NCT00470184|580989560|FG000|Overall Study|Adverse Event|3|||
160889484|NCT00470184|580989560|FG000|Overall Study|Withdrawal by Subject|4|||
160889485|NCT00470184|580989560|FG000|Overall Study|other|5|||
160889486|NCT00470184|580989560|FG000|Overall Study|recurrence|1|||
160889487|NCT01606254|580989561|FG000|Overall Study|Withdrawal by Subject|1|||
160889488|NCT01606254|580989562|FG001|Overall Study|Withdrawal by Subject|3|||
160889489|NCT01606254|580989563|FG002|Overall Study|Withdrawal by Subject|0|||
160889490|NCT01606254|580989564|FG003|Overall Study|Withdrawal by Subject|2|||
160889491|NCT01606254|580989561|FG000|Overall Study|Adverse Event|1|||
160542766|NCT03354663|579716324|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
160542767|NCT03354663|579716324|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
160542768|NCT03354663|579716324|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
160542769|NCT03354663|579716324|FG000|Completed 30-day Visit|Missed Visit|1|||
160542770|NCT05594173|579716327|FG000|Overall Study|Adverse Event|1|||
160542771|NCT05594173|579716327|FG000|Overall Study|COVID-19 Pandemic|2|||
160542772|NCT00763139|579716328|FG000|Overall Study|Adverse Event|4|||
160542773|NCT00763139|579716329|FG001|Overall Study|Adverse Event|2|||
160889492|NCT01606254|580989562|FG001|Overall Study|Adverse Event|1|||
160889493|NCT01606254|580989563|FG002|Overall Study|Adverse Event|0|||
160889494|NCT01606254|580989564|FG003|Overall Study|Adverse Event|1|||
160889495|NCT04543409|580989565|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160889496|NCT04543409|580989566|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160889497|NCT04543409|580989565|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
160889498|NCT04543409|580989566|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
160889499|NCT04543409|580989565|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
160889500|NCT04543409|580989566|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
160889501|NCT04543409|580989565|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
160889502|NCT04543409|580989566|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
160889503|NCT04543409|580989565|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
160889504|NCT04543409|580989566|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
160889505|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
160889506|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
160889507|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
160889508|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
160889509|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
160889510|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
160889511|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
160889512|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
160889513|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
160889514|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
160889515|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
160889516|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
160889517|NCT02195011|580989569|FG000|Overall Study|Adverse Event|4|||
160889518|NCT02195011|580989570|FG001|Overall Study|Adverse Event|0|||
160889519|NCT02195011|580989569|FG000|Overall Study|Progressive Disease|18|||
160889520|NCT02195011|580989570|FG001|Overall Study|Progressive Disease|1|||
160889521|NCT02195011|580989569|FG000|Overall Study|Withdrawal by Subject|3|||
160889522|NCT02195011|580989570|FG001|Overall Study|Withdrawal by Subject|0|||
160889523|NCT00450112|580989571|FG000|Overall Study|Other Treatment Required|5|||
160889524|NCT00450112|580989572|FG001|Overall Study|Other Treatment Required|1|||
160889525|NCT00450112|580989571|FG000|Overall Study|Withdrawal by Subject|4|||
160889526|NCT00450112|580989572|FG001|Overall Study|Withdrawal by Subject|1|||
160889527|NCT00450112|580989571|FG000|Overall Study|Lost to Follow-up|2|||
160889528|NCT00450112|580989572|FG001|Overall Study|Lost to Follow-up|1|||
160889529|NCT00450112|580989571|FG000|Overall Study|Others|2|||
160889530|NCT00450112|580989572|FG001|Overall Study|Others|3|||
160889531|NCT03418571|580989573|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
160889532|NCT03418571|580989574|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
160889533|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
160889534|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
160889535|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
160889536|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
160889537|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
160889538|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
160889539|NCT00586326|580989575|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
160889540|NCT00586326|580989575|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
160889541|NCT00586326|580989575|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
160889542|NCT00586326|580989575|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
160889543|NCT00586326|580989575|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
160542774|NCT00763139|579716328|FG000|Overall Study|Withdrawal by Subject|0|||
160542775|NCT00763139|579716329|FG001|Overall Study|Withdrawal by Subject|1|||
160542776|NCT00763139|579716328|FG000|Overall Study|med change not allowed by protocol|1|||
160542777|NCT00763139|579716329|FG001|Overall Study|med change not allowed by protocol|0|||
160542778|NCT05634577|579716330|FG000|Overall Study|Lost to Follow-up|1|||
160542779|NCT05634577|579716330|FG000|Overall Study|Withdrawal by Subject|1|||
160542780|NCT03468309|579716331|FG000|Overall Study|Lost to Follow-up|4|||
160542781|NCT03468309|579716331|FG000|Overall Study|Withdrawal by Subject|2|||
160542782|NCT00713700|579716333|FG000|Overall Study|Lost to Follow-up|3|||
160542783|NCT00713700|579716333|FG000|Overall Study|Withdrawal by Subject|1|||
160542784|NCT00781456|579716334|FG000|Overall Study|Adverse Event|3|||
160542785|NCT00781456|579716335|FG001|Overall Study|Adverse Event|3|||
160542786|NCT00781456|579716334|FG000|Overall Study|Withdrawal by Subject|3|||
160542787|NCT00781456|579716335|FG001|Overall Study|Withdrawal by Subject|5|||
160542788|NCT00781456|579716334|FG000|Overall Study|Protocol Violation|4|||
160542789|NCT00781456|579716335|FG001|Overall Study|Protocol Violation|1|||
160542790|NCT00781456|579716334|FG000|Overall Study|Noncompliance With Protocol|1|||
160542791|NCT00781456|579716335|FG001|Overall Study|Noncompliance With Protocol|1|||
160542792|NCT00781456|579716334|FG000|Overall Study|Lost to Follow-up|10|||
160542793|NCT00781456|579716335|FG001|Overall Study|Lost to Follow-up|5|||
160542794|NCT00781456|579716334|FG000|Overall Study|Other Reason, Unknown|0|||
160542795|NCT00781456|579716335|FG001|Overall Study|Other Reason, Unknown|1|||
160542796|NCT02631200|579716338|FG000|First Period|Death|1|||
160542797|NCT02631200|579716339|FG001|First Period|Death|2|||
160542798|NCT02631200|579716338|FG000|First Period|Patient ill-health|2|||
160542799|NCT02631200|579716339|FG001|First Period|Patient ill-health|4|||
160542800|NCT02631200|579716338|FG000|First Period|Withdrawal by Subject|4|||
160542801|NCT02631200|579716339|FG001|First Period|Withdrawal by Subject|1|||
160542802|NCT02631200|579716338|FG000|Deferred Period|Death|0|||
160542803|NCT02631200|579716339|FG001|Deferred Period|Death|1|||
160542804|NCT02631200|579716338|FG000|Deferred Period|Received kidney transplant|0|||
160542805|NCT02631200|579716339|FG001|Deferred Period|Received kidney transplant|1|||
160542806|NCT02631200|579716338|FG000|Deferred Period|Withdrawal by Subject|0|||
160542807|NCT02631200|579716339|FG001|Deferred Period|Withdrawal by Subject|2|||
160639207|NCT04380701|580062953|FG027|Overall Study|Lost to Follow-up|0|||
160639208|NCT04380701|580062954|FG028|Overall Study|Lost to Follow-up|0|||
160639209|NCT04380701|580062955|FG029|Overall Study|Lost to Follow-up|1|||
160639210|NCT04380701|580062956|FG030|Overall Study|Lost to Follow-up|0|||
160639211|NCT04380701|580062957|FG031|Overall Study|Lost to Follow-up|0|||
160639212|NCT04380701|580062958|FG032|Overall Study|Lost to Follow-up|0|||
160639213|NCT04380701|580062959|FG033|Overall Study|Lost to Follow-up|1|||
160639214|NCT04380701|580062926|FG000|Overall Study|Private reason(s)|0|||
160639215|NCT04380701|580062927|FG001|Overall Study|Private reason(s)|0|||
160639216|NCT04380701|580062928|FG002|Overall Study|Private reason(s)|0|||
160639217|NCT04380701|580062929|FG003|Overall Study|Private reason(s)|0|||
160639218|NCT04380701|580062930|FG004|Overall Study|Private reason(s)|0|||
160639219|NCT04380701|580062931|FG005|Overall Study|Private reason(s)|0|||
160639220|NCT04380701|580062932|FG006|Overall Study|Private reason(s)|1|||
160639221|NCT04380701|580062933|FG007|Overall Study|Private reason(s)|0|||
160781581|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
160781582|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
160781583|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
160781584|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
160781585|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
160639222|NCT04380701|580062934|FG008|Overall Study|Private reason(s)|1|||
160639223|NCT04380701|580062935|FG009|Overall Study|Private reason(s)|1|||
160639224|NCT04380701|580062936|FG010|Overall Study|Private reason(s)|0|||
160639225|NCT04380701|580062937|FG011|Overall Study|Private reason(s)|0|||
160639226|NCT04380701|580062938|FG012|Overall Study|Private reason(s)|0|||
160639227|NCT04380701|580062939|FG013|Overall Study|Private reason(s)|0|||
160639228|NCT04380701|580062940|FG014|Overall Study|Private reason(s)|0|||
160639229|NCT04380701|580062941|FG015|Overall Study|Private reason(s)|0|||
160639230|NCT04380701|580062942|FG016|Overall Study|Private reason(s)|0|||
160639231|NCT04380701|580062943|FG017|Overall Study|Private reason(s)|0|||
160639232|NCT04380701|580062944|FG018|Overall Study|Private reason(s)|0|||
160639233|NCT04380701|580062945|FG019|Overall Study|Private reason(s)|0|||
160639234|NCT04380701|580062946|FG020|Overall Study|Private reason(s)|0|||
160542808|NCT02631200|579716338|FG000|Deferred Period|Lost to Follow-up|0|||
160542809|NCT02631200|579716339|FG001|Deferred Period|Lost to Follow-up|1|||
160542810|NCT04091087|579716344|FG000|Overall Study|Not treated|1|||
160542811|NCT04091087|579716345|FG001|Overall Study|Not treated|0|||
160542812|NCT04091087|579716344|FG000|Overall Study|Adverse Event|4|||
160542813|NCT04091087|579716345|FG001|Overall Study|Adverse Event|4|||
160639235|NCT04380701|580062947|FG021|Overall Study|Private reason(s)|0|||
160639236|NCT04380701|580062948|FG022|Overall Study|Private reason(s)|0|||
160639237|NCT04380701|580062949|FG023|Overall Study|Private reason(s)|1|||
160639238|NCT04380701|580062950|FG024|Overall Study|Private reason(s)|0|||
160542814|NCT04091087|579716344|FG000|Overall Study|Protocol Violation|0|||
160542815|NCT04091087|579716345|FG001|Overall Study|Protocol Violation|1|||
160542816|NCT04091087|579716344|FG000|Overall Study|Withdrawal by Subject|5|||
160542817|NCT04091087|579716345|FG001|Overall Study|Withdrawal by Subject|2|||
160542818|NCT04152161|579716346|FG000|Overall Study|Death|0|||
160542819|NCT04152161|579716347|FG001|Overall Study|Death|1|||
160542820|NCT04152161|579716346|FG000|Overall Study|Physician Decision|0|||
160542821|NCT04152161|579716347|FG001|Overall Study|Physician Decision|1|||
160542822|NCT04152161|579716346|FG000|Overall Study|Lost to Follow-up|9|||
160542823|NCT04152161|579716347|FG001|Overall Study|Lost to Follow-up|3|||
160542824|NCT04152161|579716346|FG000|Overall Study|Protocol Violation|1|||
160542825|NCT04152161|579716347|FG001|Overall Study|Protocol Violation|0|||
160542826|NCT04152161|579716346|FG000|Overall Study|Withdrawal by Subject|29|||
160542827|NCT04152161|579716347|FG001|Overall Study|Withdrawal by Subject|28|||
160542828|NCT04152161|579716346|FG000|Overall Study|Sponsor termination of study|750|||
160542829|NCT04152161|579716347|FG001|Overall Study|Sponsor termination of study|755|||
160542830|NCT04152161|579716346|FG000|Overall Study|Other|20|||
160542831|NCT04152161|579716347|FG001|Overall Study|Other|18|||
160542832|NCT03363321|579716349|FG000|Overall Study|Withdrawal by Subject|0|||
160542833|NCT03363321|579716350|FG001|Overall Study|Withdrawal by Subject|1|||
160542834|NCT03363321|579716351|FG002|Overall Study|Withdrawal by Subject|0|||
160542835|NCT03363321|579716352|FG003|Overall Study|Withdrawal by Subject|1|||
160542836|NCT03363321|579716353|FG004|Overall Study|Withdrawal by Subject|0|||
160542837|NCT00915681|579716354|FG000|Overall Study|Screening failures|46|||
160542838|NCT03221751|579716357|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
160889544|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
160889545|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
160889546|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
160889547|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
160889548|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
160889549|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
160889550|NCT01439347|580989576|FG000|Overall Study|Death|10|||
160889551|NCT01439347|580989577|FG001|Overall Study|Death|9|||
160889552|NCT01439347|580989576|FG000|Overall Study|Withdrawal by Subject|0|||
160889553|NCT01439347|580989577|FG001|Overall Study|Withdrawal by Subject|1|||
160889554|NCT01439347|580989576|FG000|Overall Study|Physician Decision|1|||
160889555|NCT01439347|580989577|FG001|Overall Study|Physician Decision|0|||
160889556|NCT01439347|580989576|FG000|Overall Study|Sponsor Terminated Study|2|||
160889557|NCT01439347|580989577|FG001|Overall Study|Sponsor Terminated Study|3|||
160889558|NCT03595774|580989578|FG000|Overall Study|Adverse Event|1|||
160889559|NCT03595774|580989579|FG001|Overall Study|Adverse Event|0|||
160889560|NCT03595774|580989580|FG002|Overall Study|Adverse Event|1|||
160889561|NCT03595774|580989581|FG003|Overall Study|Adverse Event|0|||
160889562|NCT03595774|580989578|FG000|Overall Study|screen failure|0|||
160889563|NCT03595774|580989579|FG001|Overall Study|screen failure|1|||
160889564|NCT03595774|580989580|FG002|Overall Study|screen failure|0|||
160889565|NCT03595774|580989581|FG003|Overall Study|screen failure|1|||
160889566|NCT03519386|580989586|FG000|Overall Study|Withdrawal by Subject|4|||
160889567|NCT03519386|580989587|FG001|Overall Study|Withdrawal by Subject|1|||
160889568|NCT03519386|580989588|FG002|Overall Study|Withdrawal by Subject|2|||
160889569|NCT03519386|580989586|FG000|Overall Study|Physician Decision|1|||
160889570|NCT03519386|580989587|FG001|Overall Study|Physician Decision|1|||
160889571|NCT03519386|580989588|FG002|Overall Study|Physician Decision|1|||
160889572|NCT03519386|580989586|FG000|Overall Study|Lost to Follow-up|0|||
160889573|NCT03519386|580989587|FG001|Overall Study|Lost to Follow-up|1|||
160889574|NCT03519386|580989588|FG002|Overall Study|Lost to Follow-up|1|||
160889575|NCT03519386|580989586|FG000|Overall Study|Death|1|||
160889576|NCT03519386|580989587|FG001|Overall Study|Death|0|||
160889577|NCT03519386|580989588|FG002|Overall Study|Death|4|||
160889578|NCT03519386|580989586|FG000|Overall Study|Adverse Event|2|||
160889579|NCT03519386|580989587|FG001|Overall Study|Adverse Event|1|||
160981510|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160542839|NCT03221751|579716358|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
160781586|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
160781587|NCT04270760|580585083|FG000|Overall Study|Withdrawal by Subject|0|||
160781588|NCT04270760|580585084|FG001|Overall Study|Withdrawal by Subject|1|||
160781589|NCT04270760|580585085|FG002|Overall Study|Withdrawal by Subject|3|||
160781590|NCT04270760|580585086|FG003|Overall Study|Withdrawal by Subject|0|||
160781591|NCT04270760|580585087|FG004|Overall Study|Withdrawal by Subject|0|||
160781592|NCT04270760|580585083|FG000|Overall Study|Lost to Follow-up|1|||
160781593|NCT04270760|580585084|FG001|Overall Study|Lost to Follow-up|2|||
160781594|NCT04270760|580585085|FG002|Overall Study|Lost to Follow-up|1|||
160781595|NCT04270760|580585086|FG003|Overall Study|Lost to Follow-up|0|||
160781596|NCT04270760|580585087|FG004|Overall Study|Lost to Follow-up|0|||
160781597|NCT04270760|580585083|FG000|Overall Study|Death|0|||
160781598|NCT04270760|580585084|FG001|Overall Study|Death|0|||
160781599|NCT04270760|580585085|FG002|Overall Study|Death|0|||
160781600|NCT04270760|580585086|FG003|Overall Study|Death|0|||
160781601|NCT04270760|580585087|FG004|Overall Study|Death|1|||
160781602|NCT03670628|580585088|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
160781603|NCT03670628|580585089|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
160781604|NCT03670628|580585088|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
160781605|NCT03670628|580585089|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
160781606|NCT00997126|580585091|FG000|Overall Study|Physician Decision|7|||
160781607|NCT00997126|580585092|FG001|Overall Study|Physician Decision|11|||
160781608|NCT01769443|580585093|FG000|Overall Study|Study closure|1|||
160781609|NCT01769443|580585094|FG001|Overall Study|Study closure|0|||
160781610|NCT00685698|580585095|FG000|Overall Study|Withdrawal by Subject|1|||
160781611|NCT00685698|580585095|FG000|Overall Study|Protocol Violation|6|||
160781612|NCT00685698|580585095|FG000|Overall Study|Adverse Event|3|||
160889580|NCT03519386|580989588|FG002|Overall Study|Adverse Event|2|||
160889581|NCT03519386|580989586|FG000|Overall Study|Explanted|2|||
160889582|NCT03519386|580989587|FG001|Overall Study|Explanted|1|||
160889583|NCT03519386|580989588|FG002|Overall Study|Explanted|0|||
160889584|NCT03519386|580989586|FG000|Overall Study|Ongoing in study|190|||
160889585|NCT03519386|580989587|FG001|Overall Study|Ongoing in study|192|||
160889586|NCT03519386|580989588|FG002|Overall Study|Ongoing in study|183|||
160889587|NCT03101267|580989589|FG000|Primary Study Period|Withdrawal by Subject|1|||
160781613|NCT00685698|580585095|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
160781614|NCT00685698|580585095|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
160639239|NCT04380701|580062951|FG025|Overall Study|Private reason(s)|0|||
160639240|NCT04380701|580062952|FG026|Overall Study|Private reason(s)|0|||
160639241|NCT04380701|580062953|FG027|Overall Study|Private reason(s)|0|||
160639242|NCT04380701|580062954|FG028|Overall Study|Private reason(s)|0|||
160639243|NCT04380701|580062955|FG029|Overall Study|Private reason(s)|1|||
160639244|NCT04380701|580062956|FG030|Overall Study|Private reason(s)|0|||
160639245|NCT04380701|580062957|FG031|Overall Study|Private reason(s)|0|||
160639246|NCT04380701|580062958|FG032|Overall Study|Private reason(s)|0|||
160639247|NCT04380701|580062959|FG033|Overall Study|Private reason(s)|0|||
160639248|NCT04380701|580062926|FG000|Overall Study|Withdrawal by Subject|0|||
160639249|NCT04380701|580062927|FG001|Overall Study|Withdrawal by Subject|0|||
160639250|NCT04380701|580062928|FG002|Overall Study|Withdrawal by Subject|0|||
160639251|NCT04380701|580062929|FG003|Overall Study|Withdrawal by Subject|0|||
160639252|NCT04380701|580062930|FG004|Overall Study|Withdrawal by Subject|0|||
160639253|NCT04380701|580062931|FG005|Overall Study|Withdrawal by Subject|0|||
160639254|NCT04380701|580062932|FG006|Overall Study|Withdrawal by Subject|1|||
160639255|NCT04380701|580062933|FG007|Overall Study|Withdrawal by Subject|1|||
160639256|NCT04380701|580062934|FG008|Overall Study|Withdrawal by Subject|0|||
160639257|NCT04380701|580062935|FG009|Overall Study|Withdrawal by Subject|0|||
160639258|NCT04380701|580062936|FG010|Overall Study|Withdrawal by Subject|0|||
160639259|NCT04380701|580062937|FG011|Overall Study|Withdrawal by Subject|1|||
160639260|NCT04380701|580062938|FG012|Overall Study|Withdrawal by Subject|0|||
160639261|NCT04380701|580062939|FG013|Overall Study|Withdrawal by Subject|1|||
160639262|NCT04380701|580062940|FG014|Overall Study|Withdrawal by Subject|0|||
160639263|NCT04380701|580062941|FG015|Overall Study|Withdrawal by Subject|0|||
160639264|NCT04380701|580062942|FG016|Overall Study|Withdrawal by Subject|1|||
160639265|NCT04380701|580062943|FG017|Overall Study|Withdrawal by Subject|0|||
160639266|NCT04380701|580062944|FG018|Overall Study|Withdrawal by Subject|0|||
160639267|NCT04380701|580062945|FG019|Overall Study|Withdrawal by Subject|0|||
160639268|NCT04380701|580062946|FG020|Overall Study|Withdrawal by Subject|0|||
160639269|NCT04380701|580062947|FG021|Overall Study|Withdrawal by Subject|0|||
160639270|NCT04380701|580062948|FG022|Overall Study|Withdrawal by Subject|2|||
160639271|NCT04380701|580062949|FG023|Overall Study|Withdrawal by Subject|2|||
160639272|NCT04380701|580062950|FG024|Overall Study|Withdrawal by Subject|1|||
160639273|NCT04380701|580062951|FG025|Overall Study|Withdrawal by Subject|1|||
160639274|NCT04380701|580062952|FG026|Overall Study|Withdrawal by Subject|0|||
160639275|NCT04380701|580062953|FG027|Overall Study|Withdrawal by Subject|0|||
160639276|NCT04380701|580062954|FG028|Overall Study|Withdrawal by Subject|0|||
160639277|NCT04380701|580062955|FG029|Overall Study|Withdrawal by Subject|0|||
160639278|NCT04380701|580062956|FG030|Overall Study|Withdrawal by Subject|0|||
160639279|NCT04380701|580062957|FG031|Overall Study|Withdrawal by Subject|0|||
160639280|NCT04380701|580062958|FG032|Overall Study|Withdrawal by Subject|0|||
160639281|NCT04380701|580062959|FG033|Overall Study|Withdrawal by Subject|0|||
160639282|NCT04380701|580062926|FG000|Overall Study|Adverse Event|0|||
160639283|NCT04380701|580062927|FG001|Overall Study|Adverse Event|0|||
160639284|NCT04380701|580062928|FG002|Overall Study|Adverse Event|0|||
160639285|NCT04380701|580062929|FG003|Overall Study|Adverse Event|0|||
160639286|NCT04380701|580062930|FG004|Overall Study|Adverse Event|0|||
160639287|NCT04380701|580062931|FG005|Overall Study|Adverse Event|1|||
160542840|NCT01784861|579716359|FG000|Overall Study|Adverse Event|0|||
160542841|NCT01784861|579716360|FG001|Overall Study|Adverse Event|0|||
160889588|NCT03101267|580989590|FG001|Primary Study Period|Withdrawal by Subject|2|||
160889589|NCT03101267|580989591|FG002|Primary Study Period|Withdrawal by Subject|3|||
160889590|NCT03101267|580989589|FG000|Primary Study Period|Miscellaneous|2|||
160889591|NCT03101267|580989590|FG001|Primary Study Period|Miscellaneous|0|||
160889592|NCT03101267|580989591|FG002|Primary Study Period|Miscellaneous|0|||
160542842|NCT01784861|579716361|FG002|Overall Study|Adverse Event|1|||
160542843|NCT01784861|579716362|FG003|Overall Study|Adverse Event|2|||
160542844|NCT01784861|579716363|FG004|Overall Study|Adverse Event|1|||
160542845|NCT01784861|579716364|FG005|Overall Study|Adverse Event|0|||
160542846|NCT01784861|579716359|FG000|Overall Study|Withdrawal by Subject|0|||
160542847|NCT01784861|579716360|FG001|Overall Study|Withdrawal by Subject|0|||
160542848|NCT01784861|579716361|FG002|Overall Study|Withdrawal by Subject|0|||
160889593|NCT00484185|580989594|FG000|Overall Study|Lost to Follow-up|44|||
160542849|NCT01784861|579716362|FG003|Overall Study|Withdrawal by Subject|1|||
160889594|NCT00484185|580989594|FG000|Overall Study|Other|20|||
160542850|NCT01784861|579716363|FG004|Overall Study|Withdrawal by Subject|0|||
160542851|NCT01784861|579716364|FG005|Overall Study|Withdrawal by Subject|0|||
160542852|NCT01784861|579716359|FG000|Overall Study|Physician Decision|0|||
160639288|NCT04380701|580062932|FG006|Overall Study|Adverse Event|0|||
160639289|NCT04380701|580062933|FG007|Overall Study|Adverse Event|0|||
160639290|NCT04380701|580062934|FG008|Overall Study|Adverse Event|0|||
160889595|NCT00484185|580989594|FG000|Overall Study|Randomized but not treated|5|||
160639291|NCT04380701|580062935|FG009|Overall Study|Adverse Event|0|||
160889596|NCT00484185|580989594|FG000|Overall Study|Death|2|||
160542853|NCT01784861|579716360|FG001|Overall Study|Physician Decision|0|||
160542854|NCT01784861|579716361|FG002|Overall Study|Physician Decision|0|||
160781615|NCT00685698|580585095|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
160781616|NCT03412890|580585096|FG000|Overall Study|Adverse Event|5|||
160781617|NCT03412890|580585097|FG001|Overall Study|Adverse Event|5|||
160781618|NCT03412890|580585098|FG002|Overall Study|Adverse Event|9|||
160781619|NCT03412890|580585096|FG000|Overall Study|Protocol deviation|2|||
160781620|NCT03412890|580585097|FG001|Overall Study|Protocol deviation|1|||
160781621|NCT03412890|580585098|FG002|Overall Study|Protocol deviation|2|||
160781622|NCT03412890|580585096|FG000|Overall Study|Lost to Follow-up|7|||
160781623|NCT03412890|580585097|FG001|Overall Study|Lost to Follow-up|10|||
160781624|NCT03412890|580585098|FG002|Overall Study|Lost to Follow-up|10|||
160781625|NCT03412890|580585096|FG000|Overall Study|Withdrawal by Subject|9|||
160781626|NCT03412890|580585097|FG001|Overall Study|Withdrawal by Subject|12|||
160781627|NCT03412890|580585098|FG002|Overall Study|Withdrawal by Subject|11|||
160781628|NCT03412890|580585096|FG000|Overall Study|Lack of Efficacy|2|||
160781629|NCT03412890|580585097|FG001|Overall Study|Lack of Efficacy|7|||
160781630|NCT03412890|580585098|FG002|Overall Study|Lack of Efficacy|5|||
160781631|NCT03412890|580585096|FG000|Overall Study|Other|5|||
160781632|NCT03412890|580585097|FG001|Overall Study|Other|6|||
160781633|NCT03412890|580585098|FG002|Overall Study|Other|5|||
160781634|NCT03412890|580585096|FG000|Overall Study|Participants who did not receive any study drug|0|||
160781635|NCT03412890|580585097|FG001|Overall Study|Participants who did not receive any study drug|1|||
160781636|NCT03412890|580585098|FG002|Overall Study|Participants who did not receive any study drug|0|||
160781637|NCT02583477|580585099|FG000|Overall Study|Adverse Event|0|||
160781638|NCT02583477|580585100|FG001|Overall Study|Adverse Event|2|||
160781639|NCT02583477|580585099|FG000|Overall Study|Death|1|||
160781640|NCT02583477|580585100|FG001|Overall Study|Death|16|||
160781641|NCT02583477|580585099|FG000|Overall Study|Study terminated|2|||
160781642|NCT02583477|580585100|FG001|Overall Study|Study terminated|2|||
160781643|NCT05507450|580585101|FG000|Overall Study|Death|0|||
160781644|NCT05507450|580585102|FG001|Overall Study|Death|0|||
160781645|NCT05507450|580585103|FG002|Overall Study|Death|1|||
160781646|NCT05507450|580585104|FG003|Overall Study|Death|0|||
160781647|NCT05507450|580585101|FG000|Overall Study|Lost to Follow-up|22|||
160781648|NCT05507450|580585102|FG001|Overall Study|Lost to Follow-up|20|||
160781649|NCT05507450|580585103|FG002|Overall Study|Lost to Follow-up|20|||
160781650|NCT05507450|580585104|FG003|Overall Study|Lost to Follow-up|7|||
160781651|NCT05507450|580585101|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160781652|NCT05507450|580585102|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
160781653|NCT05507450|580585103|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160781654|NCT05507450|580585104|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160781655|NCT05507450|580585101|FG000|Overall Study|Withdrawal by Subject|4|||
160781656|NCT05507450|580585102|FG001|Overall Study|Withdrawal by Subject|11|||
160781657|NCT05507450|580585103|FG002|Overall Study|Withdrawal by Subject|7|||
160781658|NCT05507450|580585104|FG003|Overall Study|Withdrawal by Subject|3|||
160781659|NCT05507450|580585101|FG000|Overall Study|Participant left the country|0|||
160781660|NCT05507450|580585102|FG001|Overall Study|Participant left the country|0|||
160781661|NCT05507450|580585103|FG002|Overall Study|Participant left the country|1|||
160781662|NCT05507450|580585104|FG003|Overall Study|Participant left the country|0|||
160781663|NCT05436288|580585105|FG000|Overall Study|Lost to Follow-up|1|||
160781664|NCT05436288|580585105|FG000|Overall Study|Adverse Event|1|||
160781665|NCT03767894|580585108|FG000|Overall Study|Withdrawal by Subject|1|||
160781666|NCT00387127|580585109|FG000|Overall Study|Lost to Follow-up|0|||
160781667|NCT00387127|580585110|FG001|Overall Study|Lost to Follow-up|4|||
160781668|NCT00387127|580585109|FG000|Overall Study|Death|16|||
160781669|NCT00387127|580585110|FG001|Overall Study|Death|16|||
160781670|NCT00387127|580585109|FG000|Overall Study|Physician Decision|0|||
160781671|NCT00387127|580585110|FG001|Overall Study|Physician Decision|1|||
160781672|NCT00387127|580585109|FG000|Overall Study|Withdrawal by Subject|3|||
160781673|NCT00387127|580585110|FG001|Overall Study|Withdrawal by Subject|2|||
160781674|NCT00387127|580585109|FG000|Overall Study|Required by Protocol Amendment #4|12|||
160781675|NCT00387127|580585110|FG001|Overall Study|Required by Protocol Amendment #4|10|||
160781676|NCT00387127|580585109|FG000|Overall Study|Serious Adverse Event|1|||
160781677|NCT00387127|580585110|FG001|Overall Study|Serious Adverse Event|1|||
160781678|NCT00387127|580585109|FG000|Overall Study|Sponsor Unblinded|1|||
160781679|NCT00387127|580585110|FG001|Overall Study|Sponsor Unblinded|0|||
160781680|NCT04149353|580585111|FG000|Overall Study|Study terminated|1|||
160781681|NCT01871727|580585112|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
160781682|NCT01871727|580585113|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
160781683|NCT01871727|580585114|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
160781684|NCT01871727|580585115|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
160781685|NCT01871727|580585116|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
160781686|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
160781687|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
160781688|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
160889597|NCT01222403|580989597|FG000|Overall Study|Inappropriate enrollment|0|||
160889598|NCT01222403|580989598|FG001|Overall Study|Inappropriate enrollment|2|||
160889599|NCT02068768|580989599|FG000|Overall Study|Lost to Follow-up|5|||
160889600|NCT02068768|580989599|FG000|Overall Study|Early Termination by Sponsor|2|||
160889601|NCT00555425|580989600|FG000|Overall Study|Missed Medication > 1 wk|34|||
160889602|NCT00555425|580989601|FG001|Overall Study|Missed Medication > 1 wk|15|||
160889603|NCT00555425|580989600|FG000|Overall Study|Missed 3 physician management visits|1|||
160889604|NCT00555425|580989601|FG001|Overall Study|Missed 3 physician management visits|0|||
160889605|NCT00555425|580989600|FG000|Overall Study|Met criteria for protective transfer|16|||
160889606|NCT00555425|580989601|FG001|Overall Study|Met criteria for protective transfer|3|||
160889607|NCT00555425|580989600|FG000|Overall Study|Became pregnant and transferred care|0|||
160889608|NCT00555425|580989601|FG001|Overall Study|Became pregnant and transferred care|1|||
160889609|NCT01262352|580989602|FG000|Period 1|Illness after randomization|1|||
160889610|NCT01262352|580989603|FG001|Period 1|Illness after randomization|0|||
160889611|NCT01262352|580989602|FG000|Washout|Adverse Event|1|||
160889612|NCT01262352|580989603|FG001|Washout|Adverse Event|1|||
160889613|NCT01262352|580989602|FG000|Washout|Extended Washout|0|||
160889614|NCT01262352|580989603|FG001|Washout|Extended Washout|1|||
160889615|NCT01298193|580989604|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
160889616|NCT01298193|580989604|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
160889617|NCT01298193|580989604|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
160889618|NCT01298193|580989604|FG000|Efficacy Phase (Second Cycle)|Death|1|||
160889619|NCT00913692|580989606|FG000|Screening (4 Months)|Physician Decision|3|||
160889620|NCT00913692|580989606|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
160889621|NCT00913692|580989606|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
160889622|NCT01975831|580989607|FG000|Overall Study|Adverse Event|1|||
160889623|NCT01975831|580989608|FG001|Overall Study|Adverse Event|2|||
160889624|NCT01975831|580989609|FG002|Overall Study|Adverse Event|2|||
160889625|NCT01975831|580989610|FG003|Overall Study|Adverse Event|0|||
160889626|NCT01975831|580989611|FG004|Overall Study|Adverse Event|1|||
160889627|NCT01975831|580989612|FG005|Overall Study|Adverse Event|1|||
160889628|NCT01975831|580989613|FG006|Overall Study|Adverse Event|3|||
160889629|NCT01975831|580989614|FG007|Overall Study|Adverse Event|4|||
160889630|NCT01975831|580989615|FG008|Overall Study|Adverse Event|1|||
160889631|NCT01975831|580989607|FG000|Overall Study|Death|1|||
160542855|NCT01784861|579716362|FG003|Overall Study|Physician Decision|2|||
160542856|NCT01784861|579716363|FG004|Overall Study|Physician Decision|0|||
160542857|NCT01784861|579716364|FG005|Overall Study|Physician Decision|1|||
160542858|NCT02599961|579716367|FG000|Overall Study|Withdrawal by Subject|1|||
160542859|NCT02599961|579716367|FG000|Overall Study|Subject Non-Compliance|2|||
160542860|NCT02599961|579716367|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
160542861|NCT02599961|579716367|FG000|Overall Study|Other, Not Specified|3|||
160542862|NCT00618410|579716368|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
160542863|NCT00618410|579716369|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
160542864|NCT00464334|579716370|FG000|Overall Study|Adverse Event|0|||
160542865|NCT00464334|579716371|FG001|Overall Study|Adverse Event|0|||
160542866|NCT00464334|579716372|FG002|Overall Study|Adverse Event|0|||
160542867|NCT00464334|579716373|FG003|Overall Study|Adverse Event|1|||
160542868|NCT00464334|579716374|FG004|Overall Study|Adverse Event|1|||
160542869|NCT00464334|579716375|FG005|Overall Study|Adverse Event|1|||
160542870|NCT00464334|579716376|FG006|Overall Study|Adverse Event|0|||
160542871|NCT00464334|579716377|FG007|Overall Study|Adverse Event|0|||
160542872|NCT00464334|579716378|FG008|Overall Study|Adverse Event|2|||
160542873|NCT00464334|579716379|FG009|Overall Study|Adverse Event|1|||
160542874|NCT00464334|579716380|FG010|Overall Study|Adverse Event|2|||
160639292|NCT04380701|580062936|FG010|Overall Study|Adverse Event|0|||
160542875|NCT00464334|579716370|FG000|Overall Study|Lack of Efficacy|0|||
160542876|NCT00464334|579716371|FG001|Overall Study|Lack of Efficacy|1|||
160542877|NCT00464334|579716372|FG002|Overall Study|Lack of Efficacy|0|||
160542878|NCT00464334|579716373|FG003|Overall Study|Lack of Efficacy|0|||
160542879|NCT00464334|579716374|FG004|Overall Study|Lack of Efficacy|0|||
160542880|NCT00464334|579716375|FG005|Overall Study|Lack of Efficacy|0|||
160542881|NCT00464334|579716376|FG006|Overall Study|Lack of Efficacy|0|||
160542882|NCT00464334|579716377|FG007|Overall Study|Lack of Efficacy|0|||
160542883|NCT00464334|579716378|FG008|Overall Study|Lack of Efficacy|0|||
160781689|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
160781690|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
160781691|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
160781692|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
160781693|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
160781694|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
160781695|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
160781696|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
160781697|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
160781698|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
160781699|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
160781700|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
160781701|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
160781702|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
160781703|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
160781704|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
160781705|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
160781706|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
160781707|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
160781708|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
160781709|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
160781710|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
160781711|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
160781712|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
160781713|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
160781714|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
160781715|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
160781716|NCT00002874|580585119|FG000|Overall Study|Withdrawal by Subject|1|||
160781717|NCT00002874|580585120|FG001|Overall Study|Withdrawal by Subject|1|||
160781718|NCT00002874|580585119|FG000|Overall Study|Protocol Violation|44|||
160781719|NCT00002874|580585120|FG001|Overall Study|Protocol Violation|34|||
160781720|NCT01397747|580585137|FG000|Overall Study|Multitarget DNA test excluded|689|||
160781721|NCT01397747|580585137|FG000|Overall Study|Colonoscopy excluded|304|||
160781722|NCT01397747|580585137|FG000|Overall Study|FIT excluded|34|||
160781723|NCT03828383|580585140|FG000|Overall Study|Lost to Follow-up|3|||
160781724|NCT03828383|580585141|FG001|Overall Study|Lost to Follow-up|2|||
160781725|NCT03828383|580585140|FG000|Overall Study|Withdrawal by Subject|4|||
160781726|NCT03828383|580585141|FG001|Overall Study|Withdrawal by Subject|5|||
160781727|NCT00504309|580585143|FG000|Overall Study|Death|0|||
160781728|NCT00504309|580585144|FG001|Overall Study|Death|0|||
160889632|NCT01975831|580989608|FG001|Overall Study|Death|1|||
160889633|NCT01975831|580989609|FG002|Overall Study|Death|0|||
160889634|NCT01975831|580989610|FG003|Overall Study|Death|0|||
160889635|NCT01975831|580989611|FG004|Overall Study|Death|1|||
160889636|NCT01975831|580989612|FG005|Overall Study|Death|0|||
160889637|NCT01975831|580989613|FG006|Overall Study|Death|1|||
160889638|NCT01975831|580989614|FG007|Overall Study|Death|0|||
160639293|NCT04380701|580062937|FG011|Overall Study|Adverse Event|0|||
160639294|NCT04380701|580062938|FG012|Overall Study|Adverse Event|0|||
160639295|NCT04380701|580062939|FG013|Overall Study|Adverse Event|0|||
160639296|NCT04380701|580062940|FG014|Overall Study|Adverse Event|0|||
160639297|NCT04380701|580062941|FG015|Overall Study|Adverse Event|1|||
160639298|NCT04380701|580062942|FG016|Overall Study|Adverse Event|0|||
160639299|NCT04380701|580062943|FG017|Overall Study|Adverse Event|0|||
160639300|NCT04380701|580062944|FG018|Overall Study|Adverse Event|0|||
160639301|NCT04380701|580062945|FG019|Overall Study|Adverse Event|1|||
160639302|NCT04380701|580062946|FG020|Overall Study|Adverse Event|0|||
160639303|NCT04380701|580062947|FG021|Overall Study|Adverse Event|0|||
160639304|NCT04380701|580062948|FG022|Overall Study|Adverse Event|0|||
160639305|NCT04380701|580062949|FG023|Overall Study|Adverse Event|0|||
160639306|NCT04380701|580062950|FG024|Overall Study|Adverse Event|0|||
160639307|NCT04380701|580062951|FG025|Overall Study|Adverse Event|0|||
160639308|NCT04380701|580062952|FG026|Overall Study|Adverse Event|0|||
160639309|NCT04380701|580062953|FG027|Overall Study|Adverse Event|0|||
160639310|NCT04380701|580062954|FG028|Overall Study|Adverse Event|0|||
160639311|NCT04380701|580062955|FG029|Overall Study|Adverse Event|0|||
160639312|NCT04380701|580062956|FG030|Overall Study|Adverse Event|0|||
160639313|NCT04380701|580062957|FG031|Overall Study|Adverse Event|0|||
160639314|NCT04380701|580062958|FG032|Overall Study|Adverse Event|0|||
160639315|NCT04380701|580062959|FG033|Overall Study|Adverse Event|0|||
160639316|NCT04380701|580062926|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
160639317|NCT04380701|580062927|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
160639318|NCT04380701|580062928|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
160639319|NCT04380701|580062929|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
160639320|NCT04380701|580062930|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
160639321|NCT04380701|580062931|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
160639322|NCT04380701|580062932|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
160639323|NCT04380701|580062933|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
160639324|NCT04380701|580062934|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
160639325|NCT04380701|580062935|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
160639326|NCT04380701|580062936|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
160639327|NCT04380701|580062937|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
160639328|NCT04380701|580062938|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
160639329|NCT04380701|580062939|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
160639330|NCT04380701|580062940|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
160639331|NCT04380701|580062941|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
160639332|NCT04380701|580062942|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
160639333|NCT04380701|580062943|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
160639334|NCT04380701|580062944|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
160639335|NCT04380701|580062945|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
160639336|NCT04380701|580062946|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
160639337|NCT04380701|580062947|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
160639338|NCT04380701|580062948|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
160639339|NCT04380701|580062949|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
160889639|NCT01975831|580989615|FG008|Overall Study|Death|0|||
160889640|NCT01975831|580989607|FG000|Overall Study|Progressive Disease|1|||
160889641|NCT01975831|580989608|FG001|Overall Study|Progressive Disease|3|||
160889642|NCT01975831|580989609|FG002|Overall Study|Progressive Disease|2|||
160889643|NCT01975831|580989610|FG003|Overall Study|Progressive Disease|4|||
160889644|NCT01975831|580989611|FG004|Overall Study|Progressive Disease|13|||
160889645|NCT01975831|580989612|FG005|Overall Study|Progressive Disease|9|||
160889646|NCT01975831|580989613|FG006|Overall Study|Progressive Disease|10|||
160889647|NCT01975831|580989614|FG007|Overall Study|Progressive Disease|8|||
160889648|NCT01975831|580989615|FG008|Overall Study|Progressive Disease|10|||
160889649|NCT01975831|580989607|FG000|Overall Study|Withdrawal by Subject|0|||
160889650|NCT01975831|580989608|FG001|Overall Study|Withdrawal by Subject|3|||
160889651|NCT01975831|580989609|FG002|Overall Study|Withdrawal by Subject|0|||
160889652|NCT01975831|580989610|FG003|Overall Study|Withdrawal by Subject|0|||
160889653|NCT01975831|580989611|FG004|Overall Study|Withdrawal by Subject|3|||
160889654|NCT01975831|580989612|FG005|Overall Study|Withdrawal by Subject|1|||
160889655|NCT01975831|580989613|FG006|Overall Study|Withdrawal by Subject|1|||
160889656|NCT01975831|580989614|FG007|Overall Study|Withdrawal by Subject|0|||
160889657|NCT01975831|580989615|FG008|Overall Study|Withdrawal by Subject|0|||
160889658|NCT01975831|580989607|FG000|Overall Study|Physician Decision|0|||
160889659|NCT01975831|580989608|FG001|Overall Study|Physician Decision|0|||
160889660|NCT01975831|580989609|FG002|Overall Study|Physician Decision|0|||
160889661|NCT01975831|580989610|FG003|Overall Study|Physician Decision|0|||
160889662|NCT01975831|580989611|FG004|Overall Study|Physician Decision|0|||
160889663|NCT01975831|580989612|FG005|Overall Study|Physician Decision|1|||
160889664|NCT01975831|580989613|FG006|Overall Study|Physician Decision|0|||
160889665|NCT01975831|580989614|FG007|Overall Study|Physician Decision|1|||
160639340|NCT04380701|580062950|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
160639341|NCT04380701|580062951|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
160781729|NCT00504309|580585145|FG002|Overall Study|Death|0|||
160781730|NCT00504309|580585146|FG003|Overall Study|Death|0|||
160781731|NCT00504309|580585147|FG004|Overall Study|Death|1|||
160781732|NCT00504309|580585148|FG005|Overall Study|Death|0|||
160781733|NCT00504309|580585143|FG000|Overall Study|Withdrawal by Subject|0|||
160781734|NCT00504309|580585144|FG001|Overall Study|Withdrawal by Subject|0|||
160781735|NCT00504309|580585145|FG002|Overall Study|Withdrawal by Subject|1|||
160781736|NCT00504309|580585146|FG003|Overall Study|Withdrawal by Subject|0|||
160781737|NCT00504309|580585147|FG004|Overall Study|Withdrawal by Subject|0|||
160781738|NCT00504309|580585148|FG005|Overall Study|Withdrawal by Subject|0|||
160781739|NCT03022630|580587145|FG000|Overall Study|Death|9|||
160781740|NCT03022630|580587146|FG001|Overall Study|Death|7|||
160781741|NCT03022630|580587145|FG000|Overall Study|Withdrawal by Subject|0|||
160781742|NCT03022630|580587146|FG001|Overall Study|Withdrawal by Subject|5|||
160781743|NCT00382070|580587147|FG000|Overall Study|No follow up data mapped to Other|17|||
160781744|NCT00382070|580587148|FG001|Overall Study|No follow up data mapped to Other|19|||
160781745|NCT00382070|580587147|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
160781746|NCT00382070|580587148|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
160781747|NCT00382070|580587147|FG000|Overall Study|No clinical assessment|9|||
160781748|NCT00382070|580587148|FG001|Overall Study|No clinical assessment|11|||
160781749|NCT01734928|580587149|FG000|Randomization|Physician Decision|0|||
160781750|NCT01734928|580587150|FG001|Randomization|Physician Decision|1|||
160781751|NCT01734928|580587149|FG000|Randomization|clinical progression|0|||
160781752|NCT01734928|580587150|FG001|Randomization|clinical progression|1|||
160781753|NCT01734928|580587149|FG000|Randomization|progressive disease|0|||
160781754|NCT01734928|580587150|FG001|Randomization|progressive disease|2|||
160781755|NCT01734928|580587149|FG000|Randomization|Withdrew informed consent|0|||
160781756|NCT01734928|580587150|FG001|Randomization|Withdrew informed consent|4|||
160781757|NCT01734928|580587149|FG000|Randomization|Death|1|||
160781758|NCT01734928|580587150|FG001|Randomization|Death|0|||
160781759|NCT01734928|580587149|FG000|Randomization|Randomization error|1|||
160781760|NCT01734928|580587150|FG001|Randomization|Randomization error|0|||
160781761|NCT01734928|580587149|FG000|Randomization|Lost to Follow-up|1|||
160781762|NCT01734928|580587150|FG001|Randomization|Lost to Follow-up|0|||
160781763|NCT01734928|580587149|FG000|Treatment Period|Lost to Follow-up|0|||
160639342|NCT04380701|580062952|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
160639343|NCT04380701|580062953|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
160639344|NCT04380701|580062954|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
160639345|NCT04380701|580062955|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
160639346|NCT04380701|580062956|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
160639347|NCT04380701|580062957|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
160639348|NCT04380701|580062958|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
160639349|NCT04380701|580062959|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
160639350|NCT04380701|580062926|FG000|Overall Study|Physician Decision|0|||
160639351|NCT04380701|580062927|FG001|Overall Study|Physician Decision|0|||
160639352|NCT04380701|580062928|FG002|Overall Study|Physician Decision|0|||
160639353|NCT04380701|580062929|FG003|Overall Study|Physician Decision|0|||
160639354|NCT04380701|580062930|FG004|Overall Study|Physician Decision|0|||
160639355|NCT04380701|580062931|FG005|Overall Study|Physician Decision|0|||
160639356|NCT04380701|580062932|FG006|Overall Study|Physician Decision|0|||
160639357|NCT04380701|580062933|FG007|Overall Study|Physician Decision|0|||
160639358|NCT04380701|580062934|FG008|Overall Study|Physician Decision|0|||
160639359|NCT04380701|580062935|FG009|Overall Study|Physician Decision|0|||
160781764|NCT01734928|580587150|FG001|Treatment Period|Lost to Follow-up|2|||
160781765|NCT01734928|580587149|FG000|Treatment Period|Progressive Disease|167|||
160639360|NCT04380701|580062936|FG010|Overall Study|Physician Decision|0|||
160639361|NCT04380701|580062937|FG011|Overall Study|Physician Decision|0|||
160639362|NCT04380701|580062938|FG012|Overall Study|Physician Decision|0|||
160781766|NCT01734928|580587150|FG001|Treatment Period|Progressive Disease|165|||
160781767|NCT01734928|580587149|FG000|Treatment Period|Adverse Event|39|||
160781768|NCT01734928|580587150|FG001|Treatment Period|Adverse Event|52|||
160781769|NCT01734928|580587149|FG000|Treatment Period|Withdrawal of Consent|25|||
160781770|NCT01734928|580587150|FG001|Treatment Period|Withdrawal of Consent|22|||
160781771|NCT01734928|580587149|FG000|Treatment Period|Death|20|||
160781772|NCT01734928|580587150|FG001|Treatment Period|Death|9|||
160781773|NCT01734928|580587149|FG000|Treatment Period|Other Reasons|27|||
160781774|NCT01734928|580587150|FG001|Treatment Period|Other Reasons|19|||
160781775|NCT01734928|580587149|FG000|Treatment Period|Pregnancy|0|||
160781776|NCT01734928|580587150|FG001|Treatment Period|Pregnancy|1|||
160781777|NCT01629563|580587151|FG000|Overall Study|Adverse Event|16|||
160781778|NCT01629563|580587152|FG001|Overall Study|Adverse Event|16|||
160781779|NCT01629563|580587151|FG000|Overall Study|Death|2|||
160781780|NCT01629563|580587152|FG001|Overall Study|Death|0|||
160781781|NCT01629563|580587151|FG000|Overall Study|Lack of Efficacy|2|||
160781782|NCT01629563|580587152|FG001|Overall Study|Lack of Efficacy|3|||
160781783|NCT01629563|580587151|FG000|Overall Study|Lost to Follow-up|1|||
160781784|NCT01629563|580587152|FG001|Overall Study|Lost to Follow-up|0|||
160781785|NCT01629563|580587151|FG000|Overall Study|Pregnancy|1|||
160781786|NCT01629563|580587152|FG001|Overall Study|Pregnancy|2|||
160781787|NCT01629563|580587151|FG000|Overall Study|Protocol Violation|0|||
160781788|NCT01629563|580587152|FG001|Overall Study|Protocol Violation|1|||
160781789|NCT01629563|580587151|FG000|Overall Study|Withdrawal by Subject|27|||
160781790|NCT01629563|580587152|FG001|Overall Study|Withdrawal by Subject|20|||
160781791|NCT01629563|580587151|FG000|Overall Study|surgery|0|||
160781792|NCT01629563|580587152|FG001|Overall Study|surgery|3|||
160781793|NCT01629563|580587151|FG000|Overall Study|Lack of return of menses|12|||
160781794|NCT01629563|580587152|FG001|Overall Study|Lack of return of menses|7|||
160781795|NCT01629563|580587151|FG000|Overall Study|Protocol Violation|0|||
160781796|NCT01629563|580587152|FG001|Overall Study|Protocol Violation|1|||
160781797|NCT00088881|580587154|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
160781798|NCT00088881|580587154|FG000|Step 1 - R-CHOP|Adverse Event|1|||
160781799|NCT00088881|580587154|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
160781800|NCT00088881|580587154|FG000|Step 1 - R-CHOP|Physician Decision|1|||
160781801|NCT00088881|580587154|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
160781802|NCT00088881|580587154|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
160781803|NCT00088881|580587154|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
160781804|NCT02370394|580587163|FG000|Overall Study|Lost to Follow-up|2|||
160781805|NCT02370394|580587164|FG001|Overall Study|Lost to Follow-up|1|||
160781806|NCT02370394|580587163|FG000|Overall Study|Withdrawal by Subject|0|||
160889666|NCT01975831|580989615|FG008|Overall Study|Physician Decision|0|||
160889667|NCT01975831|580989607|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
160889668|NCT01975831|580989608|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
160889669|NCT01975831|580989609|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
160889670|NCT01975831|580989610|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
160889671|NCT01975831|580989611|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
160889672|NCT01975831|580989612|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
160889673|NCT01975831|580989613|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
160889674|NCT01975831|580989614|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
160889675|NCT01975831|580989615|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
160889676|NCT01975831|580989607|FG000|Overall Study|Entered Hospice|0|||
160889677|NCT01975831|580989608|FG001|Overall Study|Entered Hospice|0|||
160889678|NCT01975831|580989609|FG002|Overall Study|Entered Hospice|0|||
160889679|NCT01975831|580989610|FG003|Overall Study|Entered Hospice|0|||
160889680|NCT01975831|580989611|FG004|Overall Study|Entered Hospice|0|||
160889681|NCT01975831|580989612|FG005|Overall Study|Entered Hospice|1|||
160889682|NCT01975831|580989613|FG006|Overall Study|Entered Hospice|0|||
160889683|NCT01975831|580989614|FG007|Overall Study|Entered Hospice|0|||
160889684|NCT01975831|580989615|FG008|Overall Study|Entered Hospice|0|||
160889685|NCT01975831|580989607|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889686|NCT01975831|580989608|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889687|NCT01975831|580989609|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889688|NCT01975831|580989610|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889689|NCT01975831|580989611|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
160781807|NCT02370394|580587164|FG001|Overall Study|Withdrawal by Subject|1|||
160781808|NCT03684057|580587165|FG000|Overall Study|Withdrawal by Subject|4|||
160781809|NCT03684057|580587166|FG001|Overall Study|Withdrawal by Subject|5|||
160889690|NCT01975831|580989612|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889691|NCT01975831|580989613|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
160781810|NCT02545127|580587167|FG000|Overall Study|Lost to Follow-up|1|||
160889692|NCT01975831|580989614|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889693|NCT01975831|580989615|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
160781811|NCT02545127|580587168|FG001|Overall Study|Lost to Follow-up|0|||
160781812|NCT03422718|580587169|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
160781813|NCT03422718|580587170|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
160781814|NCT03422718|580587171|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
160781815|NCT03422718|580587172|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
160781816|NCT03422718|580587173|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
160781817|NCT03422718|580587174|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
160542884|NCT00464334|579716379|FG009|Overall Study|Lack of Efficacy|0|||
160542885|NCT00464334|579716380|FG010|Overall Study|Lack of Efficacy|0|||
160542886|NCT00464334|579716370|FG000|Overall Study|Lost to Follow-up|0|||
160542887|NCT00464334|579716371|FG001|Overall Study|Lost to Follow-up|0|||
160542888|NCT00464334|579716372|FG002|Overall Study|Lost to Follow-up|1|||
160542889|NCT00464334|579716373|FG003|Overall Study|Lost to Follow-up|0|||
160542890|NCT00464334|579716374|FG004|Overall Study|Lost to Follow-up|1|||
160781818|NCT03422718|580587175|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
160781819|NCT03422718|580587176|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
160781820|NCT03422718|580587169|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
160781821|NCT03422718|580587170|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
160781822|NCT03422718|580587171|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
160781823|NCT03422718|580587172|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
160781824|NCT03422718|580587173|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
160781825|NCT03422718|580587174|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
160781826|NCT03422718|580587175|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
160781827|NCT03422718|580587176|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
160781828|NCT03422718|580587169|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
160781829|NCT03422718|580587170|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
160781830|NCT03422718|580587171|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
160781831|NCT03422718|580587172|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
160781832|NCT03422718|580587173|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
160781833|NCT03422718|580587174|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
160781834|NCT03422718|580587175|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
160781835|NCT03422718|580587176|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
160781836|NCT03422718|580587169|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
160781837|NCT03422718|580587170|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
160781838|NCT03422718|580587171|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
160781839|NCT03422718|580587172|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
160781840|NCT03422718|580587173|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
160781841|NCT03422718|580587174|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
160781842|NCT03422718|580587175|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
160781843|NCT03422718|580587176|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
160781844|NCT03422718|580587169|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
160781845|NCT03422718|580587170|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
160781846|NCT03422718|580587171|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
160781847|NCT03422718|580587172|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
160781848|NCT03422718|580587173|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
160781849|NCT03422718|580587174|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
160781850|NCT03422718|580587175|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
160781851|NCT03422718|580587176|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
160781852|NCT03422718|580587169|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
160781853|NCT03422718|580587170|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
160781854|NCT03422718|580587171|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
160781855|NCT03422718|580587172|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
160781856|NCT03422718|580587173|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
160781857|NCT03422718|580587174|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
160781858|NCT03422718|580587175|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
160781859|NCT03422718|580587176|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
160781860|NCT03309605|580587177|FG000|Overall Study|Adverse Event|0|||
160781861|NCT03309605|580587178|FG001|Overall Study|Adverse Event|0|||
160781862|NCT03309605|580587179|FG002|Overall Study|Adverse Event|0|||
160781863|NCT03309605|580587180|FG003|Overall Study|Adverse Event|1|||
160781864|NCT03309605|580587181|FG004|Overall Study|Adverse Event|0|||
160781865|NCT03309605|580587182|FG005|Overall Study|Adverse Event|0|||
160781866|NCT03309605|580587183|FG006|Overall Study|Adverse Event|2|||
160781867|NCT03309605|580587184|FG007|Overall Study|Adverse Event|1|||
160781868|NCT03309605|580587177|FG000|Overall Study|Withdrawal by Subject|0|||
160781869|NCT03309605|580587178|FG001|Overall Study|Withdrawal by Subject|0|||
160781870|NCT03309605|580587179|FG002|Overall Study|Withdrawal by Subject|0|||
160781871|NCT03309605|580587180|FG003|Overall Study|Withdrawal by Subject|0|||
160781872|NCT03309605|580587181|FG004|Overall Study|Withdrawal by Subject|1|||
160781873|NCT03309605|580587182|FG005|Overall Study|Withdrawal by Subject|0|||
160781874|NCT03309605|580587183|FG006|Overall Study|Withdrawal by Subject|1|||
160889694|NCT02925793|580989616|FG000|Overall Study|Adverse Event|3|||
160781875|NCT03309605|580587184|FG007|Overall Study|Withdrawal by Subject|1|||
160781876|NCT01129284|580587185|FG000|Overall Study|Adverse Event|2|||
160542891|NCT00464334|579716375|FG005|Overall Study|Lost to Follow-up|0|||
160542892|NCT00464334|579716376|FG006|Overall Study|Lost to Follow-up|1|||
160781877|NCT01129284|580587186|FG001|Overall Study|Adverse Event|0|||
160781878|NCT01129284|580587187|FG002|Overall Study|Adverse Event|1|||
160781879|NCT03197935|580587190|FG000|Overall Study|Death due to any cause|26|||
160781880|NCT03197935|580587191|FG001|Overall Study|Death due to any cause|15|||
160781881|NCT03197935|580587190|FG000|Overall Study|Lost to Follow-up|3|||
160781882|NCT03197935|580587191|FG001|Overall Study|Lost to Follow-up|5|||
160781883|NCT03197935|580587190|FG000|Overall Study|Physician Decision|2|||
160781884|NCT03197935|580587191|FG001|Overall Study|Physician Decision|1|||
160781885|NCT03197935|580587190|FG000|Overall Study|Withdrawal by Subject|16|||
160781886|NCT03197935|580587191|FG001|Overall Study|Withdrawal by Subject|8|||
160781887|NCT00960856|580587192|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
160781888|NCT00960856|580587193|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
160781889|NCT00960856|580587194|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
160781890|NCT00960856|580587195|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
160889695|NCT02925793|580989617|FG001|Overall Study|Adverse Event|3|||
160889696|NCT02925793|580989618|FG002|Overall Study|Adverse Event|6|||
160889697|NCT02925793|580989616|FG000|Overall Study|Withdrawal by Subject|16|||
160889698|NCT02925793|580989617|FG001|Overall Study|Withdrawal by Subject|15|||
160889699|NCT02925793|580989618|FG002|Overall Study|Withdrawal by Subject|13|||
160889700|NCT02925793|580989616|FG000|Overall Study|Investigator Discretion|0|||
160889701|NCT02925793|580989617|FG001|Overall Study|Investigator Discretion|1|||
160889702|NCT02925793|580989618|FG002|Overall Study|Investigator Discretion|1|||
160889703|NCT02925793|580989616|FG000|Overall Study|Lost to Follow-up|2|||
160889704|NCT02925793|580989617|FG001|Overall Study|Lost to Follow-up|3|||
160889705|NCT02925793|580989618|FG002|Overall Study|Lost to Follow-up|1|||
160889706|NCT02925793|580989616|FG000|Overall Study|Lack of Efficacy|2|||
160889707|NCT02925793|580989617|FG001|Overall Study|Lack of Efficacy|6|||
160889708|NCT02925793|580989618|FG002|Overall Study|Lack of Efficacy|4|||
160889709|NCT02925793|580989616|FG000|Overall Study|Other:|2|||
160889710|NCT02925793|580989617|FG001|Overall Study|Other:|1|||
160889711|NCT02925793|580989618|FG002|Overall Study|Other:|3|||
160889712|NCT03631355|580989621|FG000|Overall Study|Lost to Follow-up|1|||
160889713|NCT03631355|580989622|FG001|Overall Study|Lost to Follow-up|2|||
160889714|NCT00772070|580989628|FG000|Overall Study|Lost to Follow-up|0|||
160889715|NCT00772070|580989629|FG001|Overall Study|Lost to Follow-up|8|||
160889716|NCT00772070|580989628|FG000|Overall Study|Withdrawal by Subject|0|||
160889717|NCT00772070|580989629|FG001|Overall Study|Withdrawal by Subject|2|||
160889718|NCT00772070|580989628|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
160889719|NCT00772070|580989629|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
160889720|NCT01897714|580991496|FG000|Phase I (Dose Escalation)|Disease progression|3|||
160889721|NCT01897714|580991497|FG001|Phase I (Dose Escalation)|Disease progression|5|||
160889722|NCT01897714|580991498|FG002|Phase I (Dose Escalation)|Disease progression|1|||
160889723|NCT01897714|580991499|FG003|Phase I (Dose Escalation)|Disease progression|3|||
160889724|NCT01897714|580991500|FG004|Phase I (Dose Escalation)|Disease progression|0|||
160889725|NCT01897714|580991501|FG005|Phase I (Dose Escalation)|Disease progression|0|||
160889726|NCT01897714|580991496|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
160889727|NCT01897714|580991497|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
160889728|NCT01897714|580991498|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
160889729|NCT01897714|580991499|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
160889730|NCT01897714|580991500|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
160889731|NCT01897714|580991501|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
160889732|NCT01897714|580991496|FG000|Phase I (Dose Escalation)|Other|0|||
160889733|NCT01897714|580991497|FG001|Phase I (Dose Escalation)|Other|1|||
160889734|NCT01897714|580991498|FG002|Phase I (Dose Escalation)|Other|0|||
160889735|NCT01897714|580991499|FG003|Phase I (Dose Escalation)|Other|0|||
160889736|NCT01897714|580991500|FG004|Phase I (Dose Escalation)|Other|0|||
160889737|NCT01897714|580991501|FG005|Phase I (Dose Escalation)|Other|0|||
160889738|NCT01897714|580991496|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
160889739|NCT01897714|580991497|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
160889740|NCT01897714|580991498|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
160889741|NCT01897714|580991499|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
160889742|NCT01897714|580991500|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
160889743|NCT01897714|580991501|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
160781891|NCT00960856|580587192|FG000|Washout Period of 7 Days|Adverse Event|0|||
160781892|NCT00960856|580587193|FG001|Washout Period of 7 Days|Adverse Event|0|||
160889744|NCT01897714|580991496|FG000|Phase II (MTD)|Lost to Follow-up|0|||
160781893|NCT00960856|580587194|FG002|Washout Period of 7 Days|Adverse Event|1|||
160781894|NCT00960856|580587195|FG003|Washout Period of 7 Days|Adverse Event|0|||
160889745|NCT01897714|580991497|FG001|Phase II (MTD)|Lost to Follow-up|0|||
160542893|NCT00464334|579716377|FG007|Overall Study|Lost to Follow-up|0|||
160781895|NCT04027946|580587196|FG000|Overall Study|Screen failures|3|||
160889746|NCT01897714|580991498|FG002|Phase II (MTD)|Lost to Follow-up|0|||
160889747|NCT01897714|580991499|FG003|Phase II (MTD)|Lost to Follow-up|0|||
160889748|NCT01897714|580991500|FG004|Phase II (MTD)|Lost to Follow-up|1|||
160889749|NCT01897714|580991501|FG005|Phase II (MTD)|Lost to Follow-up|0|||
160889750|NCT01897714|580991496|FG000|Phase II (MTD)|Death|0|||
160889751|NCT01897714|580991497|FG001|Phase II (MTD)|Death|0|||
160781896|NCT00864513|580587197|FG000|Overall Study|Withdrawal by Subject|3|||
160781897|NCT00762788|580587198|FG000|Overall Study|Lost to Follow-up|26|||
160781898|NCT00762788|580587199|FG001|Overall Study|Lost to Follow-up|37|||
160781899|NCT00762788|580587200|FG002|Overall Study|Lost to Follow-up|21|||
160781900|NCT00762788|580587201|FG003|Overall Study|Lost to Follow-up|26|||
160781901|NCT00762788|580587202|FG004|Overall Study|Lost to Follow-up|13|||
160781902|NCT00762788|580587203|FG005|Overall Study|Lost to Follow-up|21|||
160781903|NCT05938010|580587204|FG000|Overall Study|Lost to Follow-up|2|||
160781904|NCT00985192|580587205|FG000|Overall Study|Withdrawal by Subject|1|||
160781905|NCT00985192|580587205|FG000|Overall Study|Disease Progression|1|||
160781906|NCT00985192|580587205|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
160781907|NCT01297244|580587208|FG000|Overall Study|Progressive disease|22|||
160781908|NCT01297244|580587209|FG001|Overall Study|Progressive disease|3|||
160781909|NCT01297244|580587208|FG000|Overall Study|Adverse Event|9|||
160781910|NCT01297244|580587209|FG001|Overall Study|Adverse Event|1|||
160781911|NCT01297244|580587208|FG000|Overall Study|Death|1|||
160781912|NCT01297244|580587209|FG001|Overall Study|Death|1|||
160781913|NCT01297244|580587208|FG000|Overall Study|Clinical progression|1|||
160781914|NCT01297244|580587209|FG001|Overall Study|Clinical progression|1|||
160781915|NCT01297244|580587208|FG000|Overall Study|Withdrawal by Subject|2|||
160781916|NCT01297244|580587209|FG001|Overall Study|Withdrawal by Subject|0|||
160781917|NCT02595749|580587210|FG000|Overall Study|Withdrawal by Subject|12|||
160781918|NCT02595749|580587211|FG001|Overall Study|Withdrawal by Subject|7|||
160781919|NCT01454063|580587212|FG000|Randomized|Adverse Event|1|||
160781920|NCT01454063|580587213|FG001|Randomized|Adverse Event|1|||
160781921|NCT01454063|580587212|FG000|Randomized|Protocol Violation|0|||
160781922|NCT01454063|580587213|FG001|Randomized|Protocol Violation|1|||
160781923|NCT00983957|580587219|FG000|Overall Study|Adverse Event|1|||
160781924|NCT00983957|580587219|FG000|Overall Study|Personal Reasons|1|||
160781925|NCT03055195|580587220|FG000|Overall Study|Lack of Efficacy|1|||
160781926|NCT03055195|580587221|FG001|Overall Study|Lack of Efficacy|0|||
160781927|NCT03055195|580587220|FG000|Overall Study|Withdrawal by Subject|6|||
160781928|NCT03055195|580587221|FG001|Overall Study|Withdrawal by Subject|7|||
160781929|NCT03055195|580587220|FG000|Overall Study|Study Terminated by Sponsor|2|||
160781930|NCT03055195|580587221|FG001|Overall Study|Study Terminated by Sponsor|6|||
160781931|NCT03055195|580587220|FG000|Overall Study|Protocol Violation|2|||
160781932|NCT03055195|580587221|FG001|Overall Study|Protocol Violation|1|||
160781933|NCT03055195|580587220|FG000|Overall Study|Physician Decision|1|||
160639363|NCT04380701|580062939|FG013|Overall Study|Physician Decision|0|||
160639364|NCT04380701|580062940|FG014|Overall Study|Physician Decision|0|||
160639365|NCT04380701|580062941|FG015|Overall Study|Physician Decision|0|||
160639366|NCT04380701|580062942|FG016|Overall Study|Physician Decision|0|||
160639367|NCT04380701|580062943|FG017|Overall Study|Physician Decision|0|||
160639368|NCT04380701|580062944|FG018|Overall Study|Physician Decision|0|||
160639369|NCT04380701|580062945|FG019|Overall Study|Physician Decision|0|||
160639370|NCT04380701|580062946|FG020|Overall Study|Physician Decision|0|||
160639371|NCT04380701|580062947|FG021|Overall Study|Physician Decision|0|||
160639372|NCT04380701|580062948|FG022|Overall Study|Physician Decision|0|||
160639373|NCT04380701|580062949|FG023|Overall Study|Physician Decision|0|||
160639374|NCT04380701|580062950|FG024|Overall Study|Physician Decision|2|||
160639375|NCT04380701|580062951|FG025|Overall Study|Physician Decision|0|||
160639376|NCT04380701|580062952|FG026|Overall Study|Physician Decision|0|||
160639377|NCT04380701|580062953|FG027|Overall Study|Physician Decision|0|||
160639378|NCT04380701|580062954|FG028|Overall Study|Physician Decision|0|||
160639379|NCT04380701|580062955|FG029|Overall Study|Physician Decision|0|||
160639380|NCT04380701|580062956|FG030|Overall Study|Physician Decision|0|||
160639381|NCT04380701|580062957|FG031|Overall Study|Physician Decision|0|||
160639382|NCT04380701|580062958|FG032|Overall Study|Physician Decision|0|||
160639383|NCT04380701|580062959|FG033|Overall Study|Physician Decision|0|||
160639384|NCT04380701|580062926|FG000|Overall Study|Death|0|||
160639385|NCT04380701|580062927|FG001|Overall Study|Death|0|||
160639386|NCT04380701|580062928|FG002|Overall Study|Death|0|||
160639387|NCT04380701|580062929|FG003|Overall Study|Death|0|||
160639388|NCT04380701|580062930|FG004|Overall Study|Death|0|||
160639389|NCT04380701|580062931|FG005|Overall Study|Death|0|||
160639390|NCT04380701|580062932|FG006|Overall Study|Death|0|||
160639391|NCT04380701|580062933|FG007|Overall Study|Death|0|||
160639392|NCT04380701|580062934|FG008|Overall Study|Death|0|||
160781934|NCT03055195|580587221|FG001|Overall Study|Physician Decision|0|||
160781935|NCT00986232|580587222|FG000|Overall Study|Adverse Event|1|||
160639393|NCT04380701|580062935|FG009|Overall Study|Death|0|||
160639394|NCT04380701|580062936|FG010|Overall Study|Death|0|||
160639395|NCT04380701|580062937|FG011|Overall Study|Death|0|||
160639396|NCT04380701|580062938|FG012|Overall Study|Death|0|||
160639397|NCT04380701|580062939|FG013|Overall Study|Death|0|||
160639398|NCT04380701|580062940|FG014|Overall Study|Death|0|||
160639399|NCT04380701|580062941|FG015|Overall Study|Death|0|||
160639400|NCT04380701|580062942|FG016|Overall Study|Death|0|||
160639401|NCT04380701|580062943|FG017|Overall Study|Death|0|||
160781936|NCT00986232|580587223|FG001|Overall Study|Adverse Event|2|||
160781937|NCT00986232|580587224|FG002|Overall Study|Adverse Event|3|||
160781938|NCT00986232|580587225|FG003|Overall Study|Adverse Event|0|||
160781939|NCT00986232|580587222|FG000|Overall Study|Lost to Follow-up|19|||
160781940|NCT00986232|580587223|FG001|Overall Study|Lost to Follow-up|12|||
160781941|NCT00986232|580587224|FG002|Overall Study|Lost to Follow-up|12|||
160781942|NCT00986232|580587225|FG003|Overall Study|Lost to Follow-up|7|||
160781943|NCT00986232|580587222|FG000|Overall Study|Protocol Violation|2|||
160781944|NCT00986232|580587223|FG001|Overall Study|Protocol Violation|3|||
160781945|NCT00986232|580587224|FG002|Overall Study|Protocol Violation|0|||
160781946|NCT00986232|580587225|FG003|Overall Study|Protocol Violation|1|||
160781947|NCT00986232|580587222|FG000|Overall Study|Withdrawal by Subject|13|||
160781948|NCT00986232|580587223|FG001|Overall Study|Withdrawal by Subject|16|||
160781949|NCT00986232|580587224|FG002|Overall Study|Withdrawal by Subject|12|||
160781950|NCT00986232|580587225|FG003|Overall Study|Withdrawal by Subject|3|||
160781951|NCT00986232|580587222|FG000|Overall Study|Missed one or more bleeds|13|||
160781952|NCT00986232|580587223|FG001|Overall Study|Missed one or more bleeds|10|||
160781953|NCT00986232|580587224|FG002|Overall Study|Missed one or more bleeds|6|||
160781954|NCT00986232|580587225|FG003|Overall Study|Missed one or more bleeds|7|||
160781955|NCT00986232|580587222|FG000|Overall Study|Incomplete safety follow-up|3|||
160781956|NCT00986232|580587223|FG001|Overall Study|Incomplete safety follow-up|7|||
160781957|NCT00986232|580587224|FG002|Overall Study|Incomplete safety follow-up|2|||
160781958|NCT00986232|580587225|FG003|Overall Study|Incomplete safety follow-up|2|||
160781959|NCT02568423|580587228|FG000|Overall Study|Lost to Follow-up|0|||
160781960|NCT02568423|580587229|FG001|Overall Study|Lost to Follow-up|2|||
160781961|NCT02568423|580587230|FG002|Overall Study|Lost to Follow-up|0|||
160781962|NCT02568423|580587231|FG003|Overall Study|Lost to Follow-up|0|||
160781963|NCT02568423|580587232|FG004|Overall Study|Lost to Follow-up|0|||
160781964|NCT02568423|580587233|FG005|Overall Study|Lost to Follow-up|0|||
160781965|NCT02568423|580587234|FG006|Overall Study|Lost to Follow-up|0|||
160781966|NCT02568423|580587235|FG007|Overall Study|Lost to Follow-up|0|||
160781967|NCT02568423|580587228|FG000|Overall Study|Physician Decision|0|||
160781968|NCT02568423|580587229|FG001|Overall Study|Physician Decision|0|||
160781969|NCT02568423|580587230|FG002|Overall Study|Physician Decision|0|||
160889752|NCT01897714|580991498|FG002|Phase II (MTD)|Death|0|||
160889753|NCT01897714|580991499|FG003|Phase II (MTD)|Death|0|||
160781970|NCT02568423|580587231|FG003|Overall Study|Physician Decision|0|||
160781971|NCT02568423|580587232|FG004|Overall Study|Physician Decision|0|||
160889754|NCT01897714|580991500|FG004|Phase II (MTD)|Death|25|||
160781972|NCT02568423|580587233|FG005|Overall Study|Physician Decision|1|||
160781973|NCT02568423|580587234|FG006|Overall Study|Physician Decision|0|||
160889755|NCT01897714|580991501|FG005|Phase II (MTD)|Death|10|||
160889756|NCT01897714|580991496|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
160889757|NCT01897714|580991497|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
160889758|NCT01897714|580991498|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
160889759|NCT01897714|580991499|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
160889760|NCT01897714|580991500|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
160889761|NCT01897714|580991501|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
160889762|NCT01897714|580991496|FG000|Phase II (MTD)|Other|0|||
160889763|NCT01897714|580991497|FG001|Phase II (MTD)|Other|0|||
160889764|NCT01897714|580991498|FG002|Phase II (MTD)|Other|0|||
160889765|NCT01897714|580991499|FG003|Phase II (MTD)|Other|0|||
160889766|NCT01897714|580991500|FG004|Phase II (MTD)|Other|3|||
160889767|NCT01897714|580991501|FG005|Phase II (MTD)|Other|0|||
160889768|NCT05828095|580991508|FG000|Overall Study|Lost to Follow-up|1|||
160889769|NCT05828095|580991509|FG001|Overall Study|Lost to Follow-up|0|||
160889770|NCT05828095|580991508|FG000|Overall Study|Reactogenicity symptom|0|||
160889771|NCT05828095|580991509|FG001|Overall Study|Reactogenicity symptom|1|||
160889772|NCT03206073|580991510|FG000|Overall Study|Participant Noncompliance|0|||
160889773|NCT03206073|580991511|FG001|Overall Study|Participant Noncompliance|1|||
160889774|NCT03206073|580991512|FG002|Overall Study|Participant Noncompliance|0|||
160889775|NCT03206073|580991513|FG003|Overall Study|Participant Noncompliance|0|||
160889776|NCT03206073|580991510|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
160889777|NCT03206073|580991511|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
160889778|NCT03206073|580991512|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
160889779|NCT03206073|580991513|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
160889780|NCT03206073|580991510|FG000|Overall Study|Death|0|||
160542894|NCT00464334|579716378|FG008|Overall Study|Lost to Follow-up|0|||
160542895|NCT00464334|579716379|FG009|Overall Study|Lost to Follow-up|0|||
160542896|NCT00464334|579716380|FG010|Overall Study|Lost to Follow-up|2|||
160542897|NCT00464334|579716370|FG000|Overall Study|Progressive Disease|0|||
160542898|NCT00464334|579716371|FG001|Overall Study|Progressive Disease|0|||
160542899|NCT00464334|579716372|FG002|Overall Study|Progressive Disease|0|||
160542900|NCT00464334|579716373|FG003|Overall Study|Progressive Disease|0|||
160542901|NCT00464334|579716374|FG004|Overall Study|Progressive Disease|0|||
160542902|NCT00464334|579716375|FG005|Overall Study|Progressive Disease|1|||
160542903|NCT00464334|579716376|FG006|Overall Study|Progressive Disease|0|||
160542904|NCT00464334|579716377|FG007|Overall Study|Progressive Disease|0|||
160542905|NCT00464334|579716378|FG008|Overall Study|Progressive Disease|1|||
160542906|NCT00464334|579716379|FG009|Overall Study|Progressive Disease|0|||
160542907|NCT00464334|579716380|FG010|Overall Study|Progressive Disease|0|||
160542908|NCT00464334|579716370|FG000|Overall Study|Study Terminated by Sponsor|0|||
160542909|NCT00464334|579716371|FG001|Overall Study|Study Terminated by Sponsor|0|||
160542910|NCT00464334|579716372|FG002|Overall Study|Study Terminated by Sponsor|0|||
160542911|NCT00464334|579716373|FG003|Overall Study|Study Terminated by Sponsor|1|||
160542912|NCT00464334|579716374|FG004|Overall Study|Study Terminated by Sponsor|0|||
160542913|NCT00464334|579716375|FG005|Overall Study|Study Terminated by Sponsor|0|||
160542914|NCT00464334|579716376|FG006|Overall Study|Study Terminated by Sponsor|0|||
160542915|NCT00464334|579716377|FG007|Overall Study|Study Terminated by Sponsor|0|||
160542916|NCT00464334|579716378|FG008|Overall Study|Study Terminated by Sponsor|0|||
160542917|NCT00464334|579716379|FG009|Overall Study|Study Terminated by Sponsor|0|||
160542918|NCT00464334|579716380|FG010|Overall Study|Study Terminated by Sponsor|0|||
160542919|NCT00464334|579716370|FG000|Overall Study|Withdrawal by Subject|1|||
160542920|NCT00464334|579716371|FG001|Overall Study|Withdrawal by Subject|7|||
160542921|NCT00464334|579716372|FG002|Overall Study|Withdrawal by Subject|4|||
160542922|NCT00464334|579716373|FG003|Overall Study|Withdrawal by Subject|2|||
160542923|NCT00464334|579716374|FG004|Overall Study|Withdrawal by Subject|2|||
160542924|NCT00464334|579716375|FG005|Overall Study|Withdrawal by Subject|2|||
160542925|NCT00464334|579716376|FG006|Overall Study|Withdrawal by Subject|2|||
160542926|NCT00464334|579716377|FG007|Overall Study|Withdrawal by Subject|1|||
160542927|NCT00464334|579716378|FG008|Overall Study|Withdrawal by Subject|3|||
160542928|NCT00464334|579716379|FG009|Overall Study|Withdrawal by Subject|0|||
160542929|NCT00464334|579716380|FG010|Overall Study|Withdrawal by Subject|0|||
160542930|NCT00906087|579716390|FG000|Initial Washout|Withdrawal by Subject|1|||
160542931|NCT00906087|579716390|FG000|Initial Washout|Physician Decision|1|||
160542932|NCT02898259|579716391|FG000|Overall Study|Adverse Event|0|||
160542933|NCT02898259|579716392|FG001|Overall Study|Adverse Event|0|||
160542934|NCT02898259|579716393|FG002|Overall Study|Adverse Event|1|||
160542935|NCT02898259|579716394|FG003|Overall Study|Adverse Event|0|||
160781974|NCT02568423|580587235|FG007|Overall Study|Physician Decision|0|||
160781975|NCT03794544|580587237|FG000|Overall Study|Withdrawal by Subject|1|||
160781976|NCT03794544|580587238|FG001|Overall Study|Withdrawal by Subject|1|||
160781977|NCT03794544|580587239|FG002|Overall Study|Withdrawal by Subject|0|||
160781978|NCT03794544|580587240|FG003|Overall Study|Withdrawal by Subject|0|||
160781979|NCT03794544|580587237|FG000|Overall Study|Death|0|||
160781980|NCT03794544|580587238|FG001|Overall Study|Death|0|||
160781981|NCT03794544|580587239|FG002|Overall Study|Death|0|||
160781982|NCT03794544|580587240|FG003|Overall Study|Death|1|||
160639402|NCT04380701|580062944|FG018|Overall Study|Death|0|||
160639403|NCT04380701|580062945|FG019|Overall Study|Death|0|||
160639404|NCT04380701|580062946|FG020|Overall Study|Death|0|||
160639405|NCT04380701|580062947|FG021|Overall Study|Death|0|||
160639406|NCT04380701|580062948|FG022|Overall Study|Death|0|||
160639407|NCT04380701|580062949|FG023|Overall Study|Death|0|||
160639408|NCT04380701|580062950|FG024|Overall Study|Death|1|||
160639409|NCT04380701|580062951|FG025|Overall Study|Death|0|||
160639410|NCT04380701|580062952|FG026|Overall Study|Death|0|||
160639411|NCT04380701|580062953|FG027|Overall Study|Death|0|||
160639412|NCT04380701|580062954|FG028|Overall Study|Death|0|||
160639413|NCT04380701|580062955|FG029|Overall Study|Death|0|||
160639414|NCT04380701|580062956|FG030|Overall Study|Death|0|||
160639415|NCT04380701|580062957|FG031|Overall Study|Death|0|||
160639416|NCT04380701|580062958|FG032|Overall Study|Death|0|||
160639417|NCT04380701|580062959|FG033|Overall Study|Death|0|||
160639418|NCT04380701|580062926|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639419|NCT04380701|580062927|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639420|NCT04380701|580062928|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639421|NCT04380701|580062929|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639422|NCT04380701|580062930|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639423|NCT04380701|580062931|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639424|NCT04380701|580062932|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639425|NCT04380701|580062933|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639426|NCT04380701|580062934|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639427|NCT04380701|580062935|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639428|NCT04380701|580062936|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639429|NCT04380701|580062937|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639430|NCT04380701|580062938|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639431|NCT04380701|580062939|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639432|NCT04380701|580062940|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639433|NCT04380701|580062941|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639434|NCT04380701|580062942|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639435|NCT04380701|580062943|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639436|NCT04380701|580062944|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639437|NCT04380701|580062945|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639438|NCT04380701|580062946|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639439|NCT04380701|580062947|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
160639440|NCT04380701|580062948|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
160639441|NCT04380701|580062949|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
160639442|NCT04380701|580062950|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
160639443|NCT04380701|580062951|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639444|NCT04380701|580062952|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639445|NCT04380701|580062953|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639446|NCT04380701|580062954|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639447|NCT04380701|580062955|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639448|NCT04380701|580062956|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639449|NCT04380701|580062957|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639450|NCT04380701|580062958|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160781983|NCT03794544|580587237|FG000|Overall Study|Lost to Follow-up|0|||
160781984|NCT03794544|580587238|FG001|Overall Study|Lost to Follow-up|1|||
160781985|NCT03794544|580587239|FG002|Overall Study|Lost to Follow-up|1|||
160781986|NCT03794544|580587240|FG003|Overall Study|Lost to Follow-up|0|||
160781987|NCT03794544|580587237|FG000|Overall Study|Other|0|||
160781988|NCT03794544|580587238|FG001|Overall Study|Other|1|||
160781989|NCT03794544|580587239|FG002|Overall Study|Other|0|||
160781990|NCT03794544|580587240|FG003|Overall Study|Other|0|||
160781991|NCT00421733|580587242|FG000|Overall Study|Adverse Event|4|||
160781992|NCT00421733|580587243|FG001|Overall Study|Adverse Event|9|||
160781993|NCT00421733|580587244|FG002|Overall Study|Adverse Event|2|||
160781994|NCT00421733|580587242|FG000|Overall Study|Lost to Follow-up|1|||
160781995|NCT00421733|580587243|FG001|Overall Study|Lost to Follow-up|2|||
160781996|NCT00421733|580587244|FG002|Overall Study|Lost to Follow-up|4|||
160781997|NCT00421733|580587242|FG000|Overall Study|Withdrawal by Subject|1|||
160781998|NCT00421733|580587243|FG001|Overall Study|Withdrawal by Subject|2|||
160781999|NCT00421733|580587244|FG002|Overall Study|Withdrawal by Subject|7|||
160782000|NCT00421733|580587242|FG000|Overall Study|Death|0|||
160782001|NCT00421733|580587243|FG001|Overall Study|Death|3|||
160782002|NCT00421733|580587244|FG002|Overall Study|Death|0|||
160782003|NCT00421733|580587242|FG000|Overall Study|Required dialysis|1|||
160782004|NCT00421733|580587243|FG001|Overall Study|Required dialysis|0|||
160782005|NCT00421733|580587244|FG002|Overall Study|Required dialysis|0|||
160782006|NCT00421733|580587242|FG000|Overall Study|Administrative|2|||
160782007|NCT00421733|580587243|FG001|Overall Study|Administrative|0|||
160782008|NCT00421733|580587244|FG002|Overall Study|Administrative|0|||
160782009|NCT00421733|580587242|FG000|Overall Study|Did not satisfy entry criteria|1|||
160782010|NCT00421733|580587243|FG001|Overall Study|Did not satisfy entry criteria|3|||
160782011|NCT00421733|580587244|FG002|Overall Study|Did not satisfy entry criteria|2|||
160782012|NCT00421733|580587242|FG000|Overall Study|Sponsor request|1|||
160782013|NCT00421733|580587243|FG001|Overall Study|Sponsor request|0|||
160782014|NCT00421733|580587244|FG002|Overall Study|Sponsor request|3|||
160782015|NCT00421733|580587242|FG000|Overall Study|Protocol deviation|4|||
160782016|NCT00421733|580587243|FG001|Overall Study|Protocol deviation|7|||
160782017|NCT00421733|580587244|FG002|Overall Study|Protocol deviation|2|||
160782018|NCT00790933|580587245|FG000|Overall Study|Adverse Event|94|||
160782019|NCT00790933|580587246|FG001|Overall Study|Adverse Event|119|||
160782020|NCT00790933|580587247|FG002|Overall Study|Adverse Event|65|||
160782021|NCT00790933|580587248|FG003|Overall Study|Adverse Event|5|||
160782022|NCT00790933|580587249|FG004|Overall Study|Adverse Event|69|||
160782023|NCT00790933|580587245|FG000|Overall Study|Protocol Violation(s)|8|||
160782024|NCT00790933|580587246|FG001|Overall Study|Protocol Violation(s)|18|||
160782025|NCT00790933|580587247|FG002|Overall Study|Protocol Violation(s)|7|||
160782026|NCT00790933|580587248|FG003|Overall Study|Protocol Violation(s)|0|||
160639451|NCT04380701|580062959|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
160639452|NCT03550794|580062960|FG000|Overall Study|No longer met inclusion criteria|1|||
160639453|NCT03550794|580062961|FG001|Overall Study|No longer met inclusion criteria|2|||
160639454|NCT03550794|580062960|FG000|Overall Study|Goals of care changed|1|||
160639455|NCT03550794|580062961|FG001|Overall Study|Goals of care changed|0|||
160639456|NCT03550794|580062960|FG000|Overall Study|Withdrawal by Subject|2|||
160639457|NCT03550794|580062961|FG001|Overall Study|Withdrawal by Subject|0|||
160639458|NCT03550794|580062960|FG000|Overall Study|Death|0|||
160639459|NCT03550794|580062961|FG001|Overall Study|Death|1|||
160639460|NCT01864525|580062962|FG000|Overall Study|Adverse Event|1|||
160639461|NCT01864525|580062963|FG001|Overall Study|Adverse Event|0|||
160639462|NCT01890785|580062964|FG000|Third Intervention|Withdrawal by Subject|0|||
160639463|NCT01890785|580062965|FG001|Third Intervention|Withdrawal by Subject|1|||
160639464|NCT01890785|580062966|FG002|Third Intervention|Withdrawal by Subject|0|||
160639465|NCT01890785|580062967|FG003|Third Intervention|Withdrawal by Subject|0|||
160639466|NCT01890785|580062968|FG004|Third Intervention|Withdrawal by Subject|0|||
160639467|NCT01890785|580062969|FG005|Third Intervention|Withdrawal by Subject|0|||
160639468|NCT03296553|580062970|FG000|Overall Study|Withdrawal by Subject|1|||
160639469|NCT03296553|580062971|FG001|Overall Study|Withdrawal by Subject|1|||
160639470|NCT03296553|580062970|FG000|Overall Study|Death|1|||
160639471|NCT03296553|580062971|FG001|Overall Study|Death|0|||
160639472|NCT00558519|580062972|FG000|Overall Study|Ph+|20|||
160639473|NCT00558519|580062972|FG000|Overall Study|Ineligible|1|||
160639474|NCT00558519|580062972|FG000|Overall Study|Insufficient data|1|||
160639475|NCT00558519|580062972|FG000|Overall Study|Never received treatment|1|||
160639476|NCT03001011|580062973|FG000|Overall Study|Adverse Event|9|||
160639477|NCT03001011|580062974|FG001|Overall Study|Adverse Event|3|||
160639478|NCT03001011|580062973|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
160639479|NCT03001011|580062974|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
160639480|NCT03001011|580062973|FG000|Overall Study|Other than specified above|3|||
160639481|NCT03001011|580062974|FG001|Overall Study|Other than specified above|8|||
160639482|NCT00065065|580062975|FG000|Overall Study|Adverse Event|3|||
160782027|NCT00790933|580587249|FG004|Overall Study|Protocol Violation(s)|12|||
160782028|NCT00790933|580587245|FG000|Overall Study|Lack of Efficacy|192|||
160782029|NCT00790933|580587246|FG001|Overall Study|Lack of Efficacy|176|||
160782030|NCT00790933|580587247|FG002|Overall Study|Lack of Efficacy|130|||
160782031|NCT00790933|580587248|FG003|Overall Study|Lack of Efficacy|1|||
160639483|NCT00065065|580062976|FG001|Overall Study|Adverse Event|2|||
160639484|NCT00065065|580062975|FG000|Overall Study|Withdrawal by Subject|1|||
160639485|NCT00065065|580062976|FG001|Overall Study|Withdrawal by Subject|5|||
160639486|NCT00065065|580062975|FG000|Overall Study|Lack of Efficacy|4|||
160639487|NCT00065065|580062976|FG001|Overall Study|Lack of Efficacy|11|||
160639488|NCT00065065|580062975|FG000|Overall Study|Other|2|||
160639489|NCT00065065|580062976|FG001|Overall Study|Other|2|||
160639490|NCT01050673|580062977|FG000|Overall Study|Physician Decision|4|||
160542936|NCT02898259|579716395|FG004|Overall Study|Adverse Event|0|||
160542937|NCT02898259|579716391|FG000|Overall Study|Lack of Efficacy|1|||
160542938|NCT02898259|579716392|FG001|Overall Study|Lack of Efficacy|1|||
160542939|NCT02898259|579716393|FG002|Overall Study|Lack of Efficacy|3|||
160542940|NCT02898259|579716394|FG003|Overall Study|Lack of Efficacy|0|||
160542941|NCT02898259|579716395|FG004|Overall Study|Lack of Efficacy|0|||
160542942|NCT02898259|579716391|FG000|Overall Study|Lost to Follow-up|0|||
160542943|NCT02898259|579716392|FG001|Overall Study|Lost to Follow-up|0|||
160542944|NCT02898259|579716393|FG002|Overall Study|Lost to Follow-up|1|||
160542945|NCT02898259|579716394|FG003|Overall Study|Lost to Follow-up|0|||
160542946|NCT02898259|579716395|FG004|Overall Study|Lost to Follow-up|0|||
160542947|NCT02898259|579716391|FG000|Overall Study|Transformation before study began|0|||
160542948|NCT02898259|579716392|FG001|Overall Study|Transformation before study began|0|||
160542949|NCT02898259|579716393|FG002|Overall Study|Transformation before study began|0|||
160542950|NCT02898259|579716394|FG003|Overall Study|Transformation before study began|1|||
160542951|NCT02898259|579716395|FG004|Overall Study|Transformation before study began|0|||
160542952|NCT03016325|579716411|FG000|Treatment Period|Participant withdrew consent|0|||
160782032|NCT00790933|580587249|FG004|Overall Study|Lack of Efficacy|121|||
160782033|NCT00790933|580587245|FG000|Overall Study|Study Terminated by Sponsor|0|||
160782034|NCT00790933|580587246|FG001|Overall Study|Study Terminated by Sponsor|0|||
160782035|NCT00790933|580587247|FG002|Overall Study|Study Terminated by Sponsor|1|||
160782036|NCT00790933|580587248|FG003|Overall Study|Study Terminated by Sponsor|0|||
160782037|NCT00790933|580587249|FG004|Overall Study|Study Terminated by Sponsor|0|||
160782038|NCT00790933|580587245|FG000|Overall Study|Withdrawal by Subject|123|||
160782039|NCT00790933|580587246|FG001|Overall Study|Withdrawal by Subject|120|||
160782040|NCT00790933|580587247|FG002|Overall Study|Withdrawal by Subject|52|||
160782041|NCT00790933|580587248|FG003|Overall Study|Withdrawal by Subject|6|||
160782042|NCT00790933|580587249|FG004|Overall Study|Withdrawal by Subject|50|||
160782043|NCT00790933|580587245|FG000|Overall Study|Lost to Follow-up|13|||
160782044|NCT00790933|580587246|FG001|Overall Study|Lost to Follow-up|31|||
160782045|NCT00790933|580587247|FG002|Overall Study|Lost to Follow-up|10|||
160782046|NCT00790933|580587248|FG003|Overall Study|Lost to Follow-up|1|||
160782047|NCT00790933|580587249|FG004|Overall Study|Lost to Follow-up|15|||
160782048|NCT00790933|580587245|FG000|Overall Study|Reason Not Specified|8|||
160782049|NCT00790933|580587246|FG001|Overall Study|Reason Not Specified|16|||
160782050|NCT00790933|580587247|FG002|Overall Study|Reason Not Specified|4|||
160782051|NCT00790933|580587248|FG003|Overall Study|Reason Not Specified|1|||
160782052|NCT00790933|580587249|FG004|Overall Study|Reason Not Specified|9|||
160782053|NCT00397930|580587252|FG000|Overall Study|Personal reasons|14|||
160782054|NCT00397930|580587253|FG001|Overall Study|Personal reasons|8|||
160782055|NCT00397930|580587252|FG000|Overall Study|Other medical|9|||
160782056|NCT00397930|580587253|FG001|Overall Study|Other medical|4|||
160782057|NCT00397930|580587252|FG000|Overall Study|Unknown reasons|9|||
160782058|NCT00397930|580587253|FG001|Overall Study|Unknown reasons|14|||
160782059|NCT00397930|580587252|FG000|Overall Study|Noncompliant|3|||
160782060|NCT00397930|580587253|FG001|Overall Study|Noncompliant|2|||
160782061|NCT00397930|580587252|FG000|Overall Study|Too time-consuming|2|||
160782062|NCT00397930|580587253|FG001|Overall Study|Too time-consuming|9|||
160782063|NCT00397930|580587252|FG000|Overall Study|Started own yoga program|1|||
160782064|NCT00397930|580587253|FG001|Overall Study|Started own yoga program|1|||
160782065|NCT00397930|580587252|FG000|Overall Study|Did not want to be in control group|0|||
160782066|NCT00397930|580587253|FG001|Overall Study|Did not want to be in control group|1|||
160782067|NCT00397930|580587252|FG000|Overall Study|Withdrawal by Subject|0|||
160782068|NCT00397930|580587253|FG001|Overall Study|Withdrawal by Subject|8|||
160782069|NCT00397930|580587252|FG000|Overall Study|Missing data|0|||
160782070|NCT00397930|580587253|FG001|Overall Study|Missing data|4|||
160782071|NCT01158404|580587254|FG000|Overall Study|Withdrawal by Subject|0|||
160782072|NCT01158404|580587255|FG001|Overall Study|Withdrawal by Subject|1|||
160782073|NCT01158404|580587256|FG002|Overall Study|Withdrawal by Subject|0|||
160782074|NCT01158404|580587257|FG003|Overall Study|Withdrawal by Subject|0|||
160782075|NCT01158404|580587258|FG004|Overall Study|Withdrawal by Subject|3|||
160782076|NCT01158404|580587259|FG005|Overall Study|Withdrawal by Subject|1|||
160782077|NCT01158404|580587260|FG006|Overall Study|Withdrawal by Subject|0|||
160782078|NCT01158404|580587261|FG007|Overall Study|Withdrawal by Subject|1|||
160782079|NCT01158404|580587254|FG000|Overall Study|Physician Decision|0|||
160782080|NCT01158404|580587255|FG001|Overall Study|Physician Decision|0|||
160782081|NCT01158404|580587256|FG002|Overall Study|Physician Decision|0|||
160782082|NCT01158404|580587257|FG003|Overall Study|Physician Decision|0|||
160782083|NCT01158404|580587258|FG004|Overall Study|Physician Decision|0|||
160782084|NCT01158404|580587259|FG005|Overall Study|Physician Decision|0|||
160782085|NCT01158404|580587260|FG006|Overall Study|Physician Decision|0|||
160782086|NCT01158404|580587261|FG007|Overall Study|Physician Decision|1|||
160782087|NCT01158404|580587254|FG000|Overall Study|Progressive Disease|0|||
160782088|NCT01158404|580587255|FG001|Overall Study|Progressive Disease|0|||
160542953|NCT03016325|579716412|FG001|Treatment Period|Participant withdrew consent|1|||
160542954|NCT03016325|579716413|FG002|Treatment Period|Participant withdrew consent|0|||
160639491|NCT01050673|580062978|FG001|Overall Study|Physician Decision|5|||
160782089|NCT01158404|580587256|FG002|Overall Study|Progressive Disease|0|||
160782090|NCT01158404|580587257|FG003|Overall Study|Progressive Disease|0|||
160782091|NCT01158404|580587258|FG004|Overall Study|Progressive Disease|0|||
160782092|NCT01158404|580587259|FG005|Overall Study|Progressive Disease|0|||
160782093|NCT01158404|580587260|FG006|Overall Study|Progressive Disease|1|||
160782094|NCT01158404|580587261|FG007|Overall Study|Progressive Disease|0|||
160782095|NCT02056288|580587262|FG000|In-Hospital Data|Surgery cancelled|1|||
160782096|NCT02056288|580587263|FG001|In-Hospital Data|Surgery cancelled|0|||
160782097|NCT02056288|580587262|FG000|In-Hospital Data|Protocol Violation|3|||
160782098|NCT02056288|580587263|FG001|In-Hospital Data|Protocol Violation|0|||
160782099|NCT02056288|580587262|FG000|In-Hospital Data|Physician Decision|1|||
160782100|NCT02056288|580587263|FG001|In-Hospital Data|Physician Decision|0|||
160782101|NCT02056288|580587262|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
160782102|NCT02056288|580587263|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
160782103|NCT02400580|580587266|FG000|Overall Study|Withdrawal by Subject|1|||
160782104|NCT02400580|580587267|FG001|Overall Study|Withdrawal by Subject|1|||
160782105|NCT02400580|580587266|FG000|Overall Study|Adverse Event|1|||
160782106|NCT02400580|580587267|FG001|Overall Study|Adverse Event|0|||
160782107|NCT00965094|580587268|FG000|Overall Study|Adverse Event|5|||
160782108|NCT00965094|580587269|FG001|Overall Study|Adverse Event|0|||
160782109|NCT00965094|580587268|FG000|Overall Study|Lost to Follow-up|0|||
160782110|NCT00965094|580587269|FG001|Overall Study|Lost to Follow-up|1|||
160782111|NCT01433978|580587270|FG000|Core Study|Adverse Event, Non-Fatal|0|||
160782112|NCT01433978|580587271|FG001|Core Study|Adverse Event, Non-Fatal|1|||
160782113|NCT01433978|580587272|FG002|Core Study|Adverse Event, Non-Fatal|0|||
160782114|NCT01433978|580587270|FG000|Core Study|Lack of Efficacy|5|||
160782115|NCT01433978|580587271|FG001|Core Study|Lack of Efficacy|1|||
160782116|NCT01433978|580587272|FG002|Core Study|Lack of Efficacy|0|||
160782117|NCT01433978|580587270|FG000|Core Study|Study Terminated by Sponsor|6|||
160782118|NCT01433978|580587271|FG001|Core Study|Study Terminated by Sponsor|9|||
160782119|NCT01433978|580587272|FG002|Core Study|Study Terminated by Sponsor|0|||
160782120|NCT01433978|580587270|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
160782121|NCT01433978|580587271|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
160782122|NCT01433978|580587272|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
160782123|NCT01433978|580587270|FG000|Extension Phase|Lack of Efficacy|0|||
160782124|NCT01433978|580587271|FG001|Extension Phase|Lack of Efficacy|0|||
160782125|NCT01433978|580587272|FG002|Extension Phase|Lack of Efficacy|1|||
160782126|NCT01433978|580587270|FG000|Extension Phase|Study Terminated by Sponsor|0|||
160782127|NCT01433978|580587271|FG001|Extension Phase|Study Terminated by Sponsor|0|||
160782128|NCT01433978|580587272|FG002|Extension Phase|Study Terminated by Sponsor|4|||
160782129|NCT01773889|580587273|FG000|Overall Study|lack of funding|2|||
160782130|NCT04233580|580587275|FG000|Overall Study|Adverse Event|3|||
160782131|NCT04233580|580587276|FG001|Overall Study|Adverse Event|3|||
160782132|NCT04233580|580587275|FG000|Overall Study|Withdrawal by Subject|2|||
160782133|NCT04233580|580587276|FG001|Overall Study|Withdrawal by Subject|1|||
160782134|NCT05156125|580587277|FG000|Overall Study|Lack of Efficacy|1|||
160782135|NCT05156125|580587278|FG001|Overall Study|Lack of Efficacy|1|||
160782136|NCT05156125|580587279|FG002|Overall Study|Lack of Efficacy|1|||
160782137|NCT05156125|580587277|FG000|Overall Study|Physician Decision|0|||
160782138|NCT05156125|580587278|FG001|Overall Study|Physician Decision|0|||
160782139|NCT05156125|580587279|FG002|Overall Study|Physician Decision|1|||
160782140|NCT05156125|580587277|FG000|Overall Study|Non-compliance|0|||
160782141|NCT05156125|580587278|FG001|Overall Study|Non-compliance|1|||
160782142|NCT05156125|580587279|FG002|Overall Study|Non-compliance|1|||
160782143|NCT05156125|580587277|FG000|Overall Study|Withdrawal by Subject|0|||
160782144|NCT05156125|580587278|FG001|Overall Study|Withdrawal by Subject|0|||
160782145|NCT05156125|580587279|FG002|Overall Study|Withdrawal by Subject|1|||
160782146|NCT05156125|580587277|FG000|Overall Study|Adverse Event|2|||
160782147|NCT05156125|580587278|FG001|Overall Study|Adverse Event|1|||
160782148|NCT05156125|580587279|FG002|Overall Study|Adverse Event|0|||
160782149|NCT03338023|580587282|FG000|Overall Study|Withdrawal by Subject|3|||
160782150|NCT03338023|580587283|FG001|Overall Study|Withdrawal by Subject|4|||
160782151|NCT03338023|580587282|FG000|Overall Study|Protocol Violation|3|||
160782152|NCT03338023|580587283|FG001|Overall Study|Protocol Violation|3|||
160782153|NCT03338023|580587282|FG000|Overall Study|Lost to Follow-up|2|||
160782154|NCT03338023|580587283|FG001|Overall Study|Lost to Follow-up|1|||
160782155|NCT03338023|580587282|FG000|Overall Study|Physician Decision|1|||
160782156|NCT03338023|580587283|FG001|Overall Study|Physician Decision|2|||
160782157|NCT00433290|580587284|FG000|Overall Study|Adverse Event|24|||
160782158|NCT00433290|580587285|FG001|Overall Study|Adverse Event|7|||
160782159|NCT00433290|580587284|FG000|Overall Study|Lack of Efficacy|1|||
160782160|NCT00433290|580587285|FG001|Overall Study|Lack of Efficacy|5|||
160782161|NCT00433290|580587284|FG000|Overall Study|Withdrawal by Subject|4|||
160782162|NCT00433290|580587285|FG001|Overall Study|Withdrawal by Subject|2|||
160782163|NCT00433290|580587284|FG000|Overall Study|Protocol Violation|3|||
160782164|NCT00433290|580587285|FG001|Overall Study|Protocol Violation|2|||
160639492|NCT04363736|580062979|FG000|Overall Study|Withdrawal by Subject|1|||
160639493|NCT04363736|580062980|FG001|Overall Study|Withdrawal by Subject|0|||
160639494|NCT04363736|580062979|FG000|Overall Study|Lost to Follow-up|10|||
160639495|NCT04363736|580062980|FG001|Overall Study|Lost to Follow-up|7|||
160782165|NCT00433290|580587284|FG000|Overall Study|Physician Decision|2|||
160782166|NCT00433290|580587285|FG001|Overall Study|Physician Decision|0|||
160782167|NCT00433290|580587284|FG000|Overall Study|Entry Criteria Not Met|0|||
160782168|NCT00433290|580587285|FG001|Overall Study|Entry Criteria Not Met|1|||
160782169|NCT00433290|580587284|FG000|Overall Study|Lost to Follow-up|1|||
160782170|NCT00433290|580587285|FG001|Overall Study|Lost to Follow-up|0|||
160782171|NCT00086307|580587286|FG000|Overall Study|Lack of Efficacy|1|||
160782172|NCT00086307|580587287|FG001|Overall Study|Lack of Efficacy|1|||
160782173|NCT00086307|580587288|FG002|Overall Study|Lack of Efficacy|2|||
160782174|NCT00086307|580587286|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
160782175|NCT00086307|580587287|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
160782176|NCT00086307|580587288|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
160782177|NCT00086307|580587286|FG000|Overall Study|Nausea and headaches|0|||
160782178|NCT00086307|580587287|FG001|Overall Study|Nausea and headaches|0|||
160782179|NCT00086307|580587288|FG002|Overall Study|Nausea and headaches|1|||
160782180|NCT00086307|580587286|FG000|Overall Study|Constipation and sleepiness|0|||
160782181|NCT00086307|580587287|FG001|Overall Study|Constipation and sleepiness|0|||
160782182|NCT00086307|580587288|FG002|Overall Study|Constipation and sleepiness|1|||
160782183|NCT00086307|580587286|FG000|Overall Study|Suicidal ideation|0|||
160782184|NCT00086307|580587287|FG001|Overall Study|Suicidal ideation|0|||
160782185|NCT00086307|580587288|FG002|Overall Study|Suicidal ideation|1|||
160782186|NCT00086307|580587286|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
160782187|NCT00086307|580587287|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
160782188|NCT00086307|580587288|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
160782189|NCT00086307|580587286|FG000|Overall Study|Withdrawal by Subject|0|||
160782190|NCT00086307|580587287|FG001|Overall Study|Withdrawal by Subject|0|||
160782191|NCT00086307|580587288|FG002|Overall Study|Withdrawal by Subject|2|||
160782192|NCT03158311|580587291|FG000|Overall Study|Subject/Guardian Decision|10|||
160782193|NCT03158311|580587292|FG001|Overall Study|Subject/Guardian Decision|6|||
160782194|NCT03158311|580587293|FG002|Overall Study|Subject/Guardian Decision|11|||
160782195|NCT03158311|580587291|FG000|Overall Study|Adverse Event|5|||
160782196|NCT03158311|580587292|FG001|Overall Study|Adverse Event|3|||
160782197|NCT03158311|580587293|FG002|Overall Study|Adverse Event|3|||
160782198|NCT03158311|580587291|FG000|Overall Study|Techinical Problems|3|||
160782199|NCT03158311|580587292|FG001|Overall Study|Techinical Problems|1|||
160782200|NCT03158311|580587293|FG002|Overall Study|Techinical Problems|5|||
160782201|NCT03158311|580587291|FG000|Overall Study|Physician Decision|2|||
160782202|NCT03158311|580587292|FG001|Overall Study|Physician Decision|3|||
160782203|NCT03158311|580587293|FG002|Overall Study|Physician Decision|7|||
160782204|NCT03158311|580587291|FG000|Overall Study|Lost to Follow-up|1|||
160782205|NCT03158311|580587292|FG001|Overall Study|Lost to Follow-up|1|||
160782206|NCT03158311|580587293|FG002|Overall Study|Lost to Follow-up|1|||
160782207|NCT03158311|580587291|FG000|Overall Study|Sponsor decision|1|||
160782208|NCT03158311|580587292|FG001|Overall Study|Sponsor decision|0|||
160782209|NCT03158311|580587293|FG002|Overall Study|Sponsor decision|0|||
160782210|NCT03158311|580587291|FG000|Overall Study|Pregnancy|0|||
160782211|NCT03158311|580587292|FG001|Overall Study|Pregnancy|2|||
160782212|NCT03158311|580587293|FG002|Overall Study|Pregnancy|0|||
160782213|NCT03158311|580587291|FG000|Overall Study|Randomized in error|0|||
160782214|NCT03158311|580587292|FG001|Overall Study|Randomized in error|0|||
160782215|NCT03158311|580587293|FG002|Overall Study|Randomized in error|1|||
160889781|NCT03206073|580991511|FG001|Overall Study|Death|0|||
160889782|NCT03206073|580991512|FG002|Overall Study|Death|1|||
160889783|NCT03206073|580991513|FG003|Overall Study|Death|0|||
160889784|NCT03206073|580991510|FG000|Overall Study|Taken off active treatment|0|||
160889785|NCT03206073|580991511|FG001|Overall Study|Taken off active treatment|0|||
160889786|NCT03206073|580991512|FG002|Overall Study|Taken off active treatment|3|||
160542955|NCT03016325|579716414|FG003|Treatment Period|Participant withdrew consent|0|||
160542956|NCT03016325|579716415|FG004|Treatment Period|Participant withdrew consent|0|||
160542957|NCT03016325|579716416|FG005|Treatment Period|Participant withdrew consent|0|||
160782216|NCT01018953|580587294|FG000|Overall Study|Adverse Event|2|||
160782217|NCT01018953|580587294|FG000|Overall Study|Withdrawal by Subject|1|||
160782218|NCT01018953|580587294|FG000|Overall Study|Study termination by sponsor|5|||
160782219|NCT00724503|580587295|FG000|Overall Study|Lost to Follow-up|4|||
160782220|NCT00724503|580587296|FG001|Overall Study|Lost to Follow-up|8|||
160782221|NCT00724503|580587295|FG000|Overall Study|Withdrawal by Subject|11|||
160782222|NCT00724503|580587296|FG001|Overall Study|Withdrawal by Subject|23|||
160782223|NCT00724503|580587295|FG000|Overall Study|Death|190|||
160782224|NCT00724503|580587296|FG001|Overall Study|Death|182|||
160782225|NCT00724503|580587295|FG000|Overall Study|Adverse Event|1|||
160542958|NCT03016325|579716417|FG006|Treatment Period|Participant withdrew consent|0|||
160782226|NCT00724503|580587296|FG001|Overall Study|Adverse Event|0|||
160782227|NCT00724503|580587295|FG000|Overall Study|Not otherwise specified|4|||
160782228|NCT00724503|580587296|FG001|Overall Study|Not otherwise specified|7|||
160782229|NCT01186419|580587297|FG000|Overall Study|Withdrawal by Subject|5|||
160889787|NCT03206073|580991513|FG003|Overall Study|Taken off active treatment|0|||
160889788|NCT05523323|580991514|FG000|Overall Study|Death|26|||
160889789|NCT05523323|580991515|FG001|Overall Study|Death|21|||
160782230|NCT01186419|580587298|FG001|Overall Study|Withdrawal by Subject|3|||
160782231|NCT01186419|580587297|FG000|Overall Study|Adverse Event|1|||
160782232|NCT01186419|580587298|FG001|Overall Study|Adverse Event|2|||
160782233|NCT01186419|580587297|FG000|Overall Study|Physician Decision|0|||
160782234|NCT01186419|580587298|FG001|Overall Study|Physician Decision|3|||
160782235|NCT01186419|580587297|FG000|Overall Study|Other|1|||
160782236|NCT01186419|580587298|FG001|Overall Study|Other|1|||
160782237|NCT01560416|580587310|FG000|Randomized Phase|Crossover Participants|7|||
160782238|NCT01560416|580587311|FG001|Randomized Phase|Crossover Participants|0|||
160782239|NCT01033071|580587312|FG000|Overall Study|Adverse Event|28|||
160782240|NCT01033071|580587313|FG001|Overall Study|Adverse Event|51|||
160782241|NCT01033071|580587314|FG002|Overall Study|Adverse Event|26|||
160782242|NCT01033071|580587312|FG000|Overall Study|Protocol Violation|0|||
160782243|NCT01033071|580587313|FG001|Overall Study|Protocol Violation|2|||
160782244|NCT01033071|580587314|FG002|Overall Study|Protocol Violation|1|||
160782245|NCT01033071|580587312|FG000|Overall Study|Lost to Follow-up|4|||
160782246|NCT01033071|580587313|FG001|Overall Study|Lost to Follow-up|5|||
160782247|NCT01033071|580587314|FG002|Overall Study|Lost to Follow-up|5|||
160782248|NCT01033071|580587312|FG000|Overall Study|Withdrawal by Subject|17|||
160782249|NCT01033071|580587313|FG001|Overall Study|Withdrawal by Subject|14|||
160782250|NCT01033071|580587314|FG002|Overall Study|Withdrawal by Subject|11|||
160782251|NCT01033071|580587312|FG000|Overall Study|Lack of Efficacy|0|||
160782252|NCT01033071|580587313|FG001|Overall Study|Lack of Efficacy|1|||
160782253|NCT01033071|580587314|FG002|Overall Study|Lack of Efficacy|1|||
160782254|NCT01033071|580587312|FG000|Overall Study|Other|6|||
160889790|NCT05523323|580991514|FG000|Overall Study|Ongoing participants|35|||
160889791|NCT05523323|580991515|FG001|Overall Study|Ongoing participants|30|||
160889792|NCT02428608|580991520|FG000|Overall Study|Pregnancy|2|||
160889793|NCT02428608|580991520|FG000|Overall Study|Lost to Follow-up|37|||
160889794|NCT02428608|580991520|FG000|Overall Study|Withdrawal by Subject|2|||
160889795|NCT02428608|580991520|FG000|Overall Study|scheduling conflicts|15|||
160889796|NCT02428608|580991520|FG000|Overall Study|moved away|10|||
160889797|NCT02428608|580991520|FG000|Overall Study|Death|1|||
160889798|NCT02428608|580991520|FG000|Overall Study|various|16|||
160889799|NCT01117051|580991526|FG000|Overall Study|Withdrawal by Subject|5|||
160889800|NCT01117051|580991527|FG001|Overall Study|Withdrawal by Subject|3|||
160889801|NCT01117051|580991526|FG000|Overall Study|Adverse Event|4|||
160889802|NCT01117051|580991527|FG001|Overall Study|Adverse Event|3|||
160889803|NCT01117051|580991526|FG000|Overall Study|Lost to Follow-up|0|||
160889804|NCT01117051|580991527|FG001|Overall Study|Lost to Follow-up|1|||
160889805|NCT01117051|580991526|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
160889806|NCT01117051|580991527|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
160889807|NCT01117051|580991526|FG000|Overall Study|Sponsor's decision|3|||
160889808|NCT01117051|580991527|FG001|Overall Study|Sponsor's decision|1|||
160889809|NCT01117051|580991526|FG000|Overall Study|Surgical procedure|0|||
160889810|NCT01117051|580991527|FG001|Overall Study|Surgical procedure|1|||
160889811|NCT01117051|580991526|FG000|Overall Study|Randomized by mistake|0|||
160889812|NCT01117051|580991527|FG001|Overall Study|Randomized by mistake|1|||
160889813|NCT01117051|580991526|FG000|Overall Study|Convenience issue|1|||
160889814|NCT01117051|580991527|FG001|Overall Study|Convenience issue|0|||
160889815|NCT00206076|580991529|FG000|Overall Study|Physician Decision|2|||
160889816|NCT00206076|580991530|FG001|Overall Study|Physician Decision|0|||
160889817|NCT00206076|580991529|FG000|Overall Study|Withdrawal by Subject|1|||
160889818|NCT00206076|580991530|FG001|Overall Study|Withdrawal by Subject|1|||
160782255|NCT01033071|580587313|FG001|Overall Study|Other|4|||
160782256|NCT01033071|580587314|FG002|Overall Study|Other|3|||
160782257|NCT00884949|580588880|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
160889819|NCT00427960|580991531|FG000|Overall Study|Adverse Event|2|||
160889820|NCT00427960|580991532|FG001|Overall Study|Adverse Event|0|||
160889821|NCT00427960|580991531|FG000|Overall Study|Withdrawal by Subject|0|||
160889822|NCT00427960|580991532|FG001|Overall Study|Withdrawal by Subject|3|||
160889823|NCT00427960|580991531|FG000|Overall Study|Other|0|||
160782258|NCT00884949|580588880|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
160782259|NCT00758043|580588881|FG000|Overall Study|Adverse Event|1|||
160782260|NCT00758043|580588882|FG001|Overall Study|Adverse Event|20|||
160782261|NCT00758043|580588883|FG002|Overall Study|Adverse Event|12|||
160782262|NCT00758043|580588884|FG003|Overall Study|Adverse Event|62|||
160782263|NCT00758043|580588881|FG000|Overall Study|Lack of Efficacy|0|||
160782264|NCT00758043|580588882|FG001|Overall Study|Lack of Efficacy|6|||
160782265|NCT00758043|580588883|FG002|Overall Study|Lack of Efficacy|18|||
160782266|NCT00758043|580588884|FG003|Overall Study|Lack of Efficacy|12|||
160782267|NCT00758043|580588881|FG000|Overall Study|Refused Further Treatment|0|||
160889824|NCT00427960|580991532|FG001|Overall Study|Other|1|||
160889825|NCT01142128|580991533|FG000|Overall Study|Physician Decision|1|||
160889826|NCT01142128|580991533|FG000|Overall Study|Lost to Follow-up|1|||
160889827|NCT01142128|580991533|FG000|Overall Study|Withdrawal by Subject|2|||
160889828|NCT03355664|580991534|FG000|Overall Study|Adverse Event|1|||
160889829|NCT03355664|580991535|FG001|Overall Study|Adverse Event|2|||
160889830|NCT03355664|580991534|FG000|Overall Study|Lost to Follow-up|11|||
160889831|NCT03355664|580991535|FG001|Overall Study|Lost to Follow-up|7|||
160782268|NCT00758043|580588882|FG001|Overall Study|Refused Further Treatment|11|||
160782269|NCT00758043|580588883|FG002|Overall Study|Refused Further Treatment|5|||
160782270|NCT00758043|580588884|FG003|Overall Study|Refused Further Treatment|8|||
160782271|NCT00758043|580588881|FG000|Overall Study|Lost to Follow-up|0|||
160782272|NCT00758043|580588882|FG001|Overall Study|Lost to Follow-up|2|||
160782273|NCT00758043|580588883|FG002|Overall Study|Lost to Follow-up|2|||
160782274|NCT00758043|580588884|FG003|Overall Study|Lost to Follow-up|5|||
160782275|NCT00758043|580588881|FG000|Overall Study|Withdrawal by Subject|0|||
160782276|NCT00758043|580588882|FG001|Overall Study|Withdrawal by Subject|1|||
160782277|NCT00758043|580588883|FG002|Overall Study|Withdrawal by Subject|1|||
160782278|NCT00758043|580588884|FG003|Overall Study|Withdrawal by Subject|4|||
160782279|NCT00758043|580588881|FG000|Overall Study|Required Prohibited Medication|0|||
160782280|NCT00758043|580588882|FG001|Overall Study|Required Prohibited Medication|0|||
160889832|NCT03355664|580991534|FG000|Overall Study|Protocol Violation|1|||
160889833|NCT03355664|580991535|FG001|Overall Study|Protocol Violation|2|||
160889834|NCT03355664|580991534|FG000|Overall Study|Withdrawal by Subject|2|||
160889835|NCT03355664|580991535|FG001|Overall Study|Withdrawal by Subject|1|||
160889836|NCT00521001|580991538|FG000|Overall Study|Ineligible|1|||
160889837|NCT02821910|580991539|FG000|Overall Study|Withdrawal by Subject|0|||
160889838|NCT02821910|580991540|FG001|Overall Study|Withdrawal by Subject|0|||
160889839|NCT02821910|580991541|FG002|Overall Study|Withdrawal by Subject|1|||
160889840|NCT02821910|580991542|FG003|Overall Study|Withdrawal by Subject|0|||
160889841|NCT02821910|580991543|FG004|Overall Study|Withdrawal by Subject|0|||
160889842|NCT02821910|580991544|FG005|Overall Study|Withdrawal by Subject|1|||
160889843|NCT02821910|580991539|FG000|Overall Study|Other than specified|1|||
160889844|NCT02821910|580991540|FG001|Overall Study|Other than specified|0|||
160889845|NCT02821910|580991541|FG002|Overall Study|Other than specified|1|||
160889846|NCT02821910|580991542|FG003|Overall Study|Other than specified|0|||
160889847|NCT02821910|580991543|FG004|Overall Study|Other than specified|0|||
160889848|NCT02821910|580991544|FG005|Overall Study|Other than specified|0|||
160889849|NCT00900601|580991547|FG000|Overall Study|Physician Decision|1|||
160889850|NCT01082640|580991549|FG000|Overall Study|Adverse Event|9|||
160889851|NCT01082640|580991550|FG001|Overall Study|Adverse Event|5|||
160889852|NCT01082640|580991551|FG002|Overall Study|Adverse Event|3|||
160889853|NCT01082640|580991549|FG000|Overall Study|Withdrawal by Subject|3|||
160889854|NCT01082640|580991550|FG001|Overall Study|Withdrawal by Subject|3|||
160889855|NCT01082640|580991551|FG002|Overall Study|Withdrawal by Subject|2|||
160889856|NCT01082640|580991549|FG000|Overall Study|Major protocol deviation|3|||
160889857|NCT01082640|580991550|FG001|Overall Study|Major protocol deviation|3|||
160889858|NCT01082640|580991551|FG002|Overall Study|Major protocol deviation|0|||
160889859|NCT01082640|580991549|FG000|Overall Study|Lost to Follow-up|0|||
160889860|NCT01082640|580991550|FG001|Overall Study|Lost to Follow-up|3|||
160889861|NCT01082640|580991551|FG002|Overall Study|Lost to Follow-up|0|||
160889862|NCT01082640|580991549|FG000|Overall Study|Other|2|||
160889863|NCT01082640|580991550|FG001|Overall Study|Other|1|||
160889864|NCT01082640|580991551|FG002|Overall Study|Other|3|||
160889865|NCT03823378|580991556|FG000|Overall Study|Adverse Event|2|||
160889866|NCT03823378|580991557|FG001|Overall Study|Adverse Event|2|||
160889867|NCT03823378|580991558|FG002|Overall Study|Adverse Event|0|||
160889868|NCT03823378|580991559|FG003|Overall Study|Adverse Event|0|||
160889869|NCT03823378|580991560|FG004|Overall Study|Adverse Event|0|||
160889870|NCT03823378|580991561|FG005|Overall Study|Adverse Event|0|||
160889871|NCT03823378|580991556|FG000|Overall Study|Lost to Follow-up|0|||
160889872|NCT03823378|580991557|FG001|Overall Study|Lost to Follow-up|1|||
160889873|NCT03823378|580991558|FG002|Overall Study|Lost to Follow-up|0|||
160889874|NCT03823378|580991559|FG003|Overall Study|Lost to Follow-up|0|||
160889875|NCT03823378|580991560|FG004|Overall Study|Lost to Follow-up|1|||
160889876|NCT03823378|580991561|FG005|Overall Study|Lost to Follow-up|0|||
160889877|NCT03823378|580991556|FG000|Overall Study|Withdrawal by Subject|0|||
160889878|NCT03823378|580991557|FG001|Overall Study|Withdrawal by Subject|1|||
160889879|NCT03823378|580991558|FG002|Overall Study|Withdrawal by Subject|4|||
160889880|NCT03823378|580991559|FG003|Overall Study|Withdrawal by Subject|2|||
160889881|NCT03823378|580991560|FG004|Overall Study|Withdrawal by Subject|0|||
160639496|NCT04363736|580062979|FG000|Overall Study|Death|8|||
160782281|NCT00758043|580588883|FG002|Overall Study|Required Prohibited Medication|1|||
160782282|NCT00758043|580588884|FG003|Overall Study|Required Prohibited Medication|3|||
160889882|NCT03823378|580991561|FG005|Overall Study|Withdrawal by Subject|1|||
160889883|NCT03823378|580991556|FG000|Overall Study|Other, not specified|19|||
160889884|NCT03823378|580991557|FG001|Overall Study|Other, not specified|12|||
160889885|NCT03823378|580991558|FG002|Overall Study|Other, not specified|6|||
160889886|NCT03823378|580991559|FG003|Overall Study|Other, not specified|8|||
160889887|NCT03823378|580991560|FG004|Overall Study|Other, not specified|17|||
160889888|NCT03823378|580991561|FG005|Overall Study|Other, not specified|7|||
160889889|NCT01052844|580991564|FG000|Overall Study|Adverse Event|0|||
160889890|NCT01052844|580991565|FG001|Overall Study|Adverse Event|1|||
160889891|NCT01289782|580991566|FG000|Overall Study|Lost to Follow-up|14|||
160889892|NCT01289782|580991567|FG001|Overall Study|Lost to Follow-up|7|||
160889893|NCT01289782|580991566|FG000|Overall Study|Protocol Violation|1|||
160782283|NCT00758043|580588881|FG000|Overall Study|Non-Compliant With study Drug|0|||
160782284|NCT00758043|580588882|FG001|Overall Study|Non-Compliant With study Drug|0|||
160782285|NCT00758043|580588883|FG002|Overall Study|Non-Compliant With study Drug|0|||
160782286|NCT00758043|580588884|FG003|Overall Study|Non-Compliant With study Drug|1|||
160782287|NCT00758043|580588881|FG000|Overall Study|Other Reasons|0|||
160782288|NCT00758043|580588882|FG001|Overall Study|Other Reasons|1|||
160782289|NCT00758043|580588883|FG002|Overall Study|Other Reasons|0|||
160782290|NCT00758043|580588884|FG003|Overall Study|Other Reasons|5|||
160782291|NCT03315689|580588895|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
160782292|NCT03315689|580588896|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
160782293|NCT03315689|580588895|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
160782294|NCT03315689|580588896|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
160782295|NCT03315689|580588895|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
160782296|NCT03315689|580588896|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
160782297|NCT03073109|580588897|FG000|Overall Study|Adverse Event|0|||
160782298|NCT03073109|580588898|FG001|Overall Study|Adverse Event|1|||
160782299|NCT03073109|580588897|FG000|Overall Study|Other|2|||
160782300|NCT03073109|580588898|FG001|Overall Study|Other|0|||
160782301|NCT03073109|580588897|FG000|Overall Study|Lost to Follow-up|8|||
160782302|NCT03073109|580588898|FG001|Overall Study|Lost to Follow-up|1|||
160782303|NCT00669331|580588899|FG000|Randomisation to First Dose|Adverse Event|1|||
160782304|NCT00669331|580588900|FG001|Randomisation to First Dose|Adverse Event|0|||
160782305|NCT00669331|580588899|FG000|Randomisation to First Dose|Protocol Violation|1|||
160782306|NCT00669331|580588900|FG001|Randomisation to First Dose|Protocol Violation|0|||
160782307|NCT00669331|580588899|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
160782308|NCT00669331|580588900|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
160782309|NCT00669331|580588899|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
160782310|NCT00669331|580588900|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
160782311|NCT00669331|580588899|FG000|Randomisation to First Dose|Death|1|||
160782312|NCT00669331|580588900|FG001|Randomisation to First Dose|Death|0|||
160782313|NCT00669331|580588899|FG000|Randomisation to First Dose|Sponsor decision|0|||
160782314|NCT00669331|580588900|FG001|Randomisation to First Dose|Sponsor decision|1|||
160782315|NCT00669331|580588899|FG000|Randomisation to First Dose|Randomised in error|3|||
160782316|NCT00669331|580588900|FG001|Randomisation to First Dose|Randomised in error|10|||
160782317|NCT00669331|580588899|FG000|Blinded Treatment Period|Adverse Event|16|||
160782318|NCT00669331|580588900|FG001|Blinded Treatment Period|Adverse Event|10|||
160782319|NCT00669331|580588899|FG000|Blinded Treatment Period|Protocol Violation|1|||
160782320|NCT00669331|580588900|FG001|Blinded Treatment Period|Protocol Violation|1|||
160782321|NCT00669331|580588899|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
160782322|NCT00669331|580588900|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
160782323|NCT00669331|580588899|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
160639497|NCT04363736|580062980|FG001|Overall Study|Death|6|||
160639498|NCT03797222|580062981|FG000|Overall Study|Withdrawal by Subject|1|||
160639499|NCT03077828|580062982|FG000|Treatment Cycles|Death|1|||
160639500|NCT03077828|580062982|FG000|Treatment Cycles|Withdrawal by Subject|1|||
160889894|NCT01289782|580991567|FG001|Overall Study|Protocol Violation|1|||
160889895|NCT01289782|580991566|FG000|Overall Study|Withdrawal by Subject|8|||
160889896|NCT01289782|580991567|FG001|Overall Study|Withdrawal by Subject|2|||
160889897|NCT01289782|580991566|FG000|Overall Study|Sponsor's Decision|1|||
160639501|NCT03077828|580062982|FG000|Treatment Cycles|Screen Fail|2|||
160782324|NCT00669331|580588900|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
160782325|NCT00669331|580588899|FG000|Blinded Treatment Period|Death|0|||
160782326|NCT00669331|580588900|FG001|Blinded Treatment Period|Death|2|||
160889898|NCT01289782|580991567|FG001|Overall Study|Sponsor's Decision|0|||
160889899|NCT01289782|580991566|FG000|Overall Study|Reason not specified|1|||
160639502|NCT03077828|580062982|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
160639503|NCT03077828|580062982|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
160639504|NCT03077828|580062982|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
160639505|NCT03077828|580062982|FG000|Follow-up|Patients still in follow-up|15|||
160639506|NCT00729365|580062984|FG000|Overall Study|Physician Decision|33|||
160639507|NCT00729365|580062985|FG001|Overall Study|Physician Decision|6|||
160639508|NCT00729365|580062986|FG002|Overall Study|Physician Decision|7|||
160639509|NCT03125915|580062987|FG000|1 Month Follow up|Lost to Follow-up|3|||
160782327|NCT00669331|580588899|FG000|Blinded Treatment Period|Physician Decision|3|||
160782328|NCT00669331|580588900|FG001|Blinded Treatment Period|Physician Decision|3|||
160782329|NCT00669331|580588899|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
160782330|NCT00669331|580588900|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
160782331|NCT03387046|580588901|FG000|Overall Study|Adverse Event|1|||
160889900|NCT01289782|580991567|FG001|Overall Study|Reason not specified|2|||
160889901|NCT02093026|580991568|FG000|Overall Study|Adverse Event|26|||
160889902|NCT02093026|580991568|FG000|Overall Study|Death|10|||
160639510|NCT03125915|580062988|FG001|1 Month Follow up|Lost to Follow-up|3|||
160639511|NCT03125915|580062989|FG002|1 Month Follow up|Lost to Follow-up|2|||
160639512|NCT03125915|580062990|FG003|1 Month Follow up|Lost to Follow-up|3|||
160981511|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160981512|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
160981513|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
160981514|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160981515|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160981516|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160981517|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160981518|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160639513|NCT03125915|580062987|FG000|3 Month Follow-up|Lost to Follow-up|6|||
160639514|NCT03125915|580062988|FG001|3 Month Follow-up|Lost to Follow-up|4|||
160981519|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
160981520|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
160981521|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
160782332|NCT03387046|580588902|FG001|Overall Study|Adverse Event|1|||
160782333|NCT00509600|580588903|FG000|Overall Study|Adverse Event|1|||
160782334|NCT01428713|580588906|FG000|Overall Study|Non-compliance|2|||
160782335|NCT01428713|580588907|FG001|Overall Study|Non-compliance|2|||
160782336|NCT01428713|580588906|FG000|Overall Study|Withdrawal by Subject|1|||
160782337|NCT01428713|580588907|FG001|Overall Study|Withdrawal by Subject|1|||
160782338|NCT01428713|580588906|FG000|Overall Study|Adverse Event|0|||
160782339|NCT01428713|580588907|FG001|Overall Study|Adverse Event|2|||
160782340|NCT00875667|580588910|FG000|Overall Study|Adverse Event|29|||
160782341|NCT00875667|580588911|FG001|Overall Study|Adverse Event|10|||
160782342|NCT00875667|580588910|FG000|Overall Study|Withdrawal by Subject|17|||
160782343|NCT00875667|580588911|FG001|Overall Study|Withdrawal by Subject|5|||
160782344|NCT00875667|580588910|FG000|Overall Study|Death|7|||
160782345|NCT00875667|580588911|FG001|Overall Study|Death|2|||
160782346|NCT00875667|580588910|FG000|Overall Study|Protocol Violation|2|||
160782347|NCT00875667|580588911|FG001|Overall Study|Protocol Violation|0|||
160782348|NCT00875667|580588910|FG000|Overall Study|Disease Progression|100|||
160782349|NCT00875667|580588911|FG001|Overall Study|Disease Progression|49|||
160782350|NCT00875667|580588910|FG000|Overall Study|Miscellaneous|12|||
160782351|NCT00875667|580588911|FG001|Overall Study|Miscellaneous|6|||
160782352|NCT00875667|580588910|FG000|Overall Study|Randomized but no Study Drug Given|3|||
160782353|NCT00875667|580588911|FG001|Overall Study|Randomized but no Study Drug Given|1|||
160782354|NCT00120250|580588912|FG000|Overall Study|Lost to Follow-up|1|||
160782355|NCT00120250|580588913|FG001|Overall Study|Lost to Follow-up|1|||
160782356|NCT00120250|580588912|FG000|Overall Study|Protocol Violation|0|||
160782357|NCT00120250|580588913|FG001|Overall Study|Protocol Violation|1|||
160782358|NCT01967277|580588914|FG000|Overall Study|Lost to Follow-up|1|||
160782359|NCT01967277|580588915|FG001|Overall Study|Lost to Follow-up|2|||
160782360|NCT01967277|580588914|FG000|Overall Study|Unrelated illness|0|||
160782361|NCT01967277|580588915|FG001|Overall Study|Unrelated illness|1|||
160782362|NCT00585585|580588918|FG000|Overall Study|Adverse Event|1|||
160782363|NCT02384460|580588931|FG000|Overall Study|Protocol Violation|0|||
160782364|NCT02384460|580588932|FG001|Overall Study|Protocol Violation|1|||
160782365|NCT02384460|580588931|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
160782366|NCT02384460|580588932|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
160782367|NCT02384460|580588931|FG000|Overall Study|Adverse Event|5|||
160782368|NCT02384460|580588932|FG001|Overall Study|Adverse Event|2|||
160782369|NCT02384460|580588931|FG000|Overall Study|Withdrawal by Subject|0|||
160782370|NCT02384460|580588932|FG001|Overall Study|Withdrawal by Subject|3|||
160782371|NCT02384460|580588931|FG000|Overall Study|Elective medical treatment|1|||
160782372|NCT02384460|580588932|FG001|Overall Study|Elective medical treatment|0|||
160782373|NCT02384460|580588931|FG000|Overall Study|Non-compliance|1|||
160782374|NCT02384460|580588932|FG001|Overall Study|Non-compliance|0|||
160782375|NCT02565186|580588937|FG000|Overall Study|Adverse Event|113|||
160782376|NCT02565186|580588938|FG001|Overall Study|Adverse Event|148|||
160782377|NCT02565186|580588937|FG000|Overall Study|Lost to Follow-up|102|||
160782378|NCT02565186|580588938|FG001|Overall Study|Lost to Follow-up|93|||
160782379|NCT02565186|580588937|FG000|Overall Study|Non-Compliance|57|||
160782380|NCT02565186|580588938|FG001|Overall Study|Non-Compliance|55|||
160782381|NCT02565186|580588937|FG000|Overall Study|Withdrawal by Subject|229|||
160782382|NCT02565186|580588938|FG001|Overall Study|Withdrawal by Subject|214|||
160782383|NCT02565186|580588937|FG000|Overall Study|Physician Decision|18|||
160782384|NCT02565186|580588938|FG001|Overall Study|Physician Decision|16|||
160782385|NCT02565186|580588937|FG000|Overall Study|Sponsor Request|5|||
160782386|NCT02565186|580588938|FG001|Overall Study|Sponsor Request|9|||
160782387|NCT02565186|580588937|FG000|Overall Study|Missing|1|||
160782388|NCT02565186|580588938|FG001|Overall Study|Missing|0|||
160782389|NCT02565186|580588937|FG000|Overall Study|Did Not Receive Study Drug|55|||
160782390|NCT02565186|580588938|FG001|Overall Study|Did Not Receive Study Drug|86|||
160782391|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
160782392|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
160782393|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
160782394|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
160782395|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
160782396|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
160782397|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
160782398|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
160889903|NCT02093026|580991568|FG000|Overall Study|Other|157|||
160889904|NCT01466595|580991581|FG000|Overall Study|Withdrawal by Subject|0|||
160889905|NCT01466595|580991582|FG001|Overall Study|Withdrawal by Subject|1|||
160889906|NCT00559754|580991585|FG000|Overall Study|Disease progression|1|||
160889907|NCT00559754|580991585|FG000|Overall Study|Adverse Event|5|||
160889908|NCT00559754|580991585|FG000|Overall Study|Protocol Violation|1|||
160889909|NCT00559754|580991585|FG000|Overall Study|Investigator criteria|2|||
160889910|NCT00559754|580991585|FG000|Overall Study|Withdrawal by Subject|2|||
160889911|NCT01264016|580991586|FG000|Overall Study|Withdrawal by Subject|1|||
160889912|NCT01264016|580991586|FG000|Overall Study|Felt faint at sight of blood|1|||
160889913|NCT01056380|580991587|FG000|Overall Study|Lost to Follow-up|2|||
160782399|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
160782400|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
160782401|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
160782402|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
160782403|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
160782404|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
160782405|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
160782406|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
160782407|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
160782408|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
160782409|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
160782410|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
160782411|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
160782412|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
160782413|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
160782414|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
160782415|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
160782416|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
160782417|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
160782418|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
160782419|NCT02217982|580588941|FG000|Overall Study|Trial discontinued|1|||
160782420|NCT02217982|580588942|FG001|Overall Study|Trial discontinued|0|||
160782421|NCT02217982|580588941|FG000|Overall Study|Adverse Event|0|||
160782422|NCT02217982|580588942|FG001|Overall Study|Adverse Event|1|||
160782423|NCT03791060|580588943|FG000|Overall Study|Withdrawal by Subject|1|||
160782424|NCT01623752|580588944|FG000|Phase 1 (78 Weeks)|No Data|249|||
160782425|NCT01623752|580588945|FG001|Phase 1 (78 Weeks)|No Data|66|||
160782426|NCT01623752|580588946|FG002|Phase 1 (78 Weeks)|No Data|2|||
160782427|NCT01623752|580588944|FG000|Phase 1 (78 Weeks)|Other|33|||
160782428|NCT01623752|580588945|FG001|Phase 1 (78 Weeks)|Other|20|||
160782429|NCT01623752|580588946|FG002|Phase 1 (78 Weeks)|Other|0|||
160782430|NCT01623752|580588944|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
160782431|NCT01623752|580588945|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
160782432|NCT01623752|580588946|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
160782433|NCT01623752|580588944|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
160782434|NCT01623752|580588945|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
160782435|NCT01623752|580588946|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
160782436|NCT01623752|580588944|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
160782437|NCT01623752|580588945|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
160782438|NCT01623752|580588946|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
160782439|NCT01623752|580588944|FG000|Phase 2 (78 Weeks)|Other|5|||
160782440|NCT01623752|580588945|FG001|Phase 2 (78 Weeks)|Other|1|||
160782441|NCT01623752|580588946|FG002|Phase 2 (78 Weeks)|Other|0|||
160782442|NCT01623752|580588944|FG000|Phase 2 (78 Weeks)|No Data|43|||
160782443|NCT01623752|580588945|FG001|Phase 2 (78 Weeks)|No Data|11|||
160782444|NCT01623752|580588946|FG002|Phase 2 (78 Weeks)|No Data|0|||
160782445|NCT01623752|580588944|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
160782446|NCT01623752|580588945|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
160782447|NCT01623752|580588946|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
160782448|NCT01814332|580588947|FG000|Overall Study|Adverse Event|8|||
160782449|NCT01814332|580588948|FG001|Overall Study|Adverse Event|3|||
160782450|NCT01814332|580588947|FG000|Overall Study|Withdrawal by Subject|3|||
160782451|NCT01814332|580588948|FG001|Overall Study|Withdrawal by Subject|8|||
160981522|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
160981523|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
160981524|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
160981525|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
160981526|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
160782452|NCT01814332|580588947|FG000|Overall Study|Protocol Violation|0|||
160782453|NCT01814332|580588948|FG001|Overall Study|Protocol Violation|4|||
160782454|NCT01814332|580588947|FG000|Overall Study|Lost to Follow-up|5|||
160782455|NCT01814332|580588948|FG001|Overall Study|Lost to Follow-up|1|||
160782456|NCT01755637|580588950|FG000|Period 1|Adverse Event|0|||
160782457|NCT01755637|580588951|FG001|Period 1|Adverse Event|1|||
160782458|NCT04389671|580588952|FG000|Overall Study|Death|7|||
160782459|NCT02287025|580588953|FG000|Overall Study|Not treated|2|||
160782460|NCT02287025|580588954|FG001|Overall Study|Not treated|0|||
160782461|NCT02287025|580588953|FG000|Overall Study|Progression of disease|3|||
160782462|NCT02287025|580588954|FG001|Overall Study|Progression of disease|2|||
160782463|NCT02287025|580588953|FG000|Overall Study|Adverse Event|2|||
160981527|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
160782464|NCT02287025|580588954|FG001|Overall Study|Adverse Event|4|||
160782465|NCT02287025|580588953|FG000|Overall Study|Withdrawal by Subject|2|||
160782466|NCT02287025|580588954|FG001|Overall Study|Withdrawal by Subject|2|||
160782467|NCT02287025|580588953|FG000|Overall Study|Screening failed|1|||
160782468|NCT02287025|580588954|FG001|Overall Study|Screening failed|1|||
160782469|NCT00899847|580588955|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
160782470|NCT05987540|580588956|FG000|Overall Study|Withdrawal by Subject|2|||
160782471|NCT05987540|580588956|FG000|Overall Study|Death|1|||
160782472|NCT05987540|580588956|FG000|Overall Study|Study Termination|1|||
160782473|NCT05987540|580588956|FG000|Overall Study|Adverse Event|2|||
160782474|NCT04996264|580588957|FG000|Overall Study|Lost to Follow-up|0|||
160782475|NCT04996264|580588958|FG001|Overall Study|Lost to Follow-up|1|||
160782476|NCT04996264|580588957|FG000|Overall Study|Withdrawal by Subject|4|||
160782477|NCT04996264|580588958|FG001|Overall Study|Withdrawal by Subject|3|||
160782478|NCT04996264|580588957|FG000|Overall Study|1 left AMA|0|||
160782479|NCT04996264|580588958|FG001|Overall Study|1 left AMA|1|||
160782480|NCT04996264|580588957|FG000|Overall Study|Subject changed hospitals|0|||
160782481|NCT04996264|580588958|FG001|Overall Study|Subject changed hospitals|1|||
160782482|NCT04996264|580588957|FG000|Overall Study|unable to complete due to work|0|||
160782483|NCT04996264|580588958|FG001|Overall Study|unable to complete due to work|1|||
160782484|NCT02030418|580588963|FG000|Overall Study|Death|78|||
160782485|NCT02030418|580588963|FG000|Overall Study|Missed 12-Month Visit|9|||
160782486|NCT02030418|580588963|FG000|Overall Study|Withdrawn|57|||
160782487|NCT01279200|580588970|FG000|Overall Study|Withdrawal by Subject|1|||
160782488|NCT01279200|580588971|FG001|Overall Study|Withdrawal by Subject|3|||
160782489|NCT01279200|580588970|FG000|Overall Study|Patient withdrawal due to high cost|0|||
160782490|NCT01279200|580588971|FG001|Overall Study|Patient withdrawal due to high cost|1|||
160782491|NCT01279200|580588970|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
160981528|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
160981529|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
160981530|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981531|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981532|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
160981533|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
160981534|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981535|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981536|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981537|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981538|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981539|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981540|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981541|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
160981542|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
160981543|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981544|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981545|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981546|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981547|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981548|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981549|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981550|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981551|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981552|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160782492|NCT01279200|580588971|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
160782493|NCT01279200|580588970|FG000|Overall Study|ultrasound screening failure|0|||
160981553|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
160981554|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981555|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981556|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981557|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160782494|NCT01279200|580588971|FG001|Overall Study|ultrasound screening failure|1|||
160782495|NCT01279200|580588970|FG000|Overall Study|Lost to Follow-up|0|||
160782496|NCT01279200|580588971|FG001|Overall Study|Lost to Follow-up|1|||
160782497|NCT01279200|580588970|FG000|Overall Study|Adverse Event|1|||
160782498|NCT01279200|580588971|FG001|Overall Study|Adverse Event|0|||
160782499|NCT01399099|580588972|FG000|Overall Study|Lost to Follow-up|14|||
160782500|NCT01399099|580588972|FG000|Overall Study|Physician Decision|1|||
160782501|NCT01399099|580588972|FG000|Overall Study|Protocol Violation|1|||
160782502|NCT01399099|580588972|FG000|Overall Study|Skin Irritation|13|||
160782503|NCT01399099|580588972|FG000|Overall Study|Infection|1|||
160782504|NCT01399099|580588972|FG000|Overall Study|Miscellaneous|4|||
160782505|NCT01179516|580588973|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
160782506|NCT01179516|580588974|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
160782507|NCT01179516|580588975|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
160782508|NCT01179516|580588973|FG000|Overall Study|Lack of Efficacy|4|||
160782509|NCT01179516|580588974|FG001|Overall Study|Lack of Efficacy|2|||
160782510|NCT01179516|580588975|FG002|Overall Study|Lack of Efficacy|0|||
160782511|NCT01179516|580588973|FG000|Overall Study|Noncompliance with Study Drug|2|||
160782512|NCT01179516|580588974|FG001|Overall Study|Noncompliance with Study Drug|0|||
160782513|NCT01179516|580588975|FG002|Overall Study|Noncompliance with Study Drug|1|||
160782514|NCT01179516|580588973|FG000|Overall Study|Protocol Deviations|4|||
160782515|NCT01179516|580588974|FG001|Overall Study|Protocol Deviations|3|||
160782516|NCT01179516|580588975|FG002|Overall Study|Protocol Deviations|3|||
160782517|NCT01179516|580588973|FG000|Overall Study|Withdrawal of Consent|2|||
160782518|NCT01179516|580588974|FG001|Overall Study|Withdrawal of Consent|6|||
160782519|NCT01179516|580588975|FG002|Overall Study|Withdrawal of Consent|10|||
160782520|NCT01179516|580588973|FG000|Overall Study|Lost to Follow-up|7|||
160782521|NCT01179516|580588974|FG001|Overall Study|Lost to Follow-up|7|||
160782522|NCT01179516|580588975|FG002|Overall Study|Lost to Follow-up|3|||
160782523|NCT01179516|580588973|FG000|Overall Study|Other|2|||
160782524|NCT01179516|580588974|FG001|Overall Study|Other|0|||
160782525|NCT01179516|580588975|FG002|Overall Study|Other|2|||
160782526|NCT01668537|580588976|FG000|Overall Study|Request to Discontinue Prematurely|1|||
160782527|NCT01668537|580588977|FG001|Overall Study|Request to Discontinue Prematurely|1|||
160782528|NCT01668537|580588976|FG000|Overall Study|Subject unwilling/unable to comply|5|||
160782529|NCT01668537|580588977|FG001|Overall Study|Subject unwilling/unable to comply|0|||
160782530|NCT01668537|580588976|FG000|Overall Study|Reason Precludes Participation|1|||
160782531|NCT01668537|580588977|FG001|Overall Study|Reason Precludes Participation|0|||
160782532|NCT01668537|580588976|FG000|Overall Study|Lost to Follow-up|13|||
160782533|NCT01668537|580588977|FG001|Overall Study|Lost to Follow-up|6|||
160782534|NCT01668537|580588976|FG000|Overall Study|Other|2|||
160782535|NCT01668537|580588977|FG001|Overall Study|Other|3|||
160782536|NCT05064800|580588980|FG000|Period 3|Withdrawal by Subject|0|||
160782537|NCT05064800|580588981|FG001|Period 3|Withdrawal by Subject|0|||
160782538|NCT05064800|580588982|FG002|Period 3|Withdrawal by Subject|0|||
160782539|NCT05064800|580588983|FG003|Period 3|Withdrawal by Subject|0|||
160782540|NCT05064800|580588984|FG004|Period 3|Withdrawal by Subject|1|||
160782541|NCT05064800|580588985|FG005|Period 3|Withdrawal by Subject|0|||
160782542|NCT03983109|580588990|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
160782543|NCT03983109|580588991|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
160782544|NCT00887588|580588994|FG000|Core Period|Death|1|||
160782545|NCT00887588|580588995|FG001|Core Period|Death|1|||
160782546|NCT00887588|580588994|FG000|Core Period|Lost to Follow-up|3|||
160782547|NCT00887588|580588995|FG001|Core Period|Lost to Follow-up|1|||
160782548|NCT00887588|580588994|FG000|Core Period|Withdrawal by Subject|6|||
160782549|NCT00887588|580588995|FG001|Core Period|Withdrawal by Subject|8|||
160782550|NCT00887588|580588994|FG000|Core Period|Adverse Event|9|||
160782551|NCT00887588|580588995|FG001|Core Period|Adverse Event|11|||
160782552|NCT00887588|580588994|FG000|Extension Period|Adverse Event|4|||
160782553|NCT00887588|580588995|FG001|Extension Period|Adverse Event|4|||
160782554|NCT00887588|580588994|FG000|Extension Period|Death|0|||
160782555|NCT00887588|580588995|FG001|Extension Period|Death|1|||
160782556|NCT00887588|580588994|FG000|Extension Period|Protocol deviation|1|||
160782557|NCT00887588|580588995|FG001|Extension Period|Protocol deviation|0|||
160782558|NCT00887588|580588994|FG000|Extension Period|Lost to Follow-up|1|||
160782559|NCT00887588|580588995|FG001|Extension Period|Lost to Follow-up|0|||
160782560|NCT00567112|580588996|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
160639515|NCT03125915|580062989|FG002|3 Month Follow-up|Lost to Follow-up|4|||
160639516|NCT03125915|580062990|FG003|3 Month Follow-up|Lost to Follow-up|2|||
160639517|NCT03125915|580062987|FG000|6 Month Follow-up|Lost to Follow-up|7|||
160639518|NCT03125915|580062988|FG001|6 Month Follow-up|Lost to Follow-up|3|||
160639519|NCT03125915|580062989|FG002|6 Month Follow-up|Lost to Follow-up|6|||
160639520|NCT03125915|580062990|FG003|6 Month Follow-up|Lost to Follow-up|3|||
160639521|NCT00295620|580062993|FG000|Overall Study|Lost to Follow-up|9|||
160639522|NCT00295620|580062994|FG001|Overall Study|Lost to Follow-up|5|||
160782561|NCT00567112|580588997|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
160782562|NCT00567112|580588998|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
160782563|NCT00567112|580588996|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
160782564|NCT00567112|580588997|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
160782565|NCT00567112|580588998|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
160782566|NCT00567112|580588996|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
160782567|NCT00567112|580588997|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
160639523|NCT00295620|580062993|FG000|Overall Study|Withdrawal by Subject|37|||
160782568|NCT00567112|580588998|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
160782569|NCT03753542|580589002|FG000|Overall Study|Lost to Follow-up|9|||
160782570|NCT03753542|580589003|FG001|Overall Study|Lost to Follow-up|14|||
160782571|NCT01068249|580589009|FG000|Overall Study|Death|1|||
160782572|NCT01068249|580589009|FG000|Overall Study|Withdrawal by Subject|3|||
160782573|NCT04180696|580589010|FG000|Overall Study|Death|5|||
160639524|NCT00295620|580062994|FG001|Overall Study|Withdrawal by Subject|50|||
160639525|NCT00295620|580062993|FG000|Overall Study|Death|206|||
160639526|NCT00295620|580062994|FG001|Overall Study|Death|207|||
160639527|NCT00295620|580062993|FG000|Overall Study|Other reasons|10|||
160639528|NCT00295620|580062994|FG001|Overall Study|Other reasons|9|||
160639529|NCT00295620|580062993|FG000|Overall Study|Discontinuation by sponsor|580|||
160639530|NCT00295620|580062994|FG001|Overall Study|Discontinuation by sponsor|593|||
160889914|NCT01056380|580991588|FG001|Overall Study|Lost to Follow-up|3|||
160889915|NCT01629706|580991589|FG000|Phase 1 PureVision|Screen Failure|4|||
160889916|NCT01629706|580991589|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
160889917|NCT01629706|580991589|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
160889918|NCT01629706|580991589|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
160889919|NCT01629706|580991589|FG000|Phase 2 Habitual|Screen Failure|6|||
160889920|NCT01629706|580991589|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
160889921|NCT01629706|580991589|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
160889922|NCT01629706|580991589|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
160889923|NCT01629706|580991589|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
160889924|NCT00048061|580991590|FG000|Overall Study|Adverse Event|41|||
160889925|NCT00048061|580991591|FG001|Overall Study|Adverse Event|32|||
160889926|NCT00048061|580991592|FG002|Overall Study|Adverse Event|44|||
160889927|NCT00048061|580991593|FG003|Overall Study|Adverse Event|37|||
160889928|NCT00048061|580991590|FG000|Overall Study|Lost to Follow-up|3|||
160889929|NCT00048061|580991591|FG001|Overall Study|Lost to Follow-up|2|||
160889930|NCT00048061|580991592|FG002|Overall Study|Lost to Follow-up|4|||
160889931|NCT00048061|580991593|FG003|Overall Study|Lost to Follow-up|5|||
160889932|NCT00048061|580991590|FG000|Overall Study|Withdrawal by Subject|20|||
160889933|NCT00048061|580991591|FG001|Overall Study|Withdrawal by Subject|29|||
160889934|NCT00048061|580991592|FG002|Overall Study|Withdrawal by Subject|29|||
160889935|NCT00048061|580991593|FG003|Overall Study|Withdrawal by Subject|32|||
160889936|NCT00048061|580991590|FG000|Overall Study|Did not follow-up|5|||
160889937|NCT00048061|580991591|FG001|Overall Study|Did not follow-up|5|||
160889938|NCT00048061|580991592|FG002|Overall Study|Did not follow-up|4|||
160889939|NCT00048061|580991593|FG003|Overall Study|Did not follow-up|5|||
160889940|NCT00048061|580991590|FG000|Overall Study|Early improvement|6|||
160889941|NCT00048061|580991591|FG001|Overall Study|Early improvement|5|||
160889942|NCT00048061|580991592|FG002|Overall Study|Early improvement|3|||
160889943|NCT00048061|580991593|FG003|Overall Study|Early improvement|0|||
160889944|NCT00393042|580991594|FG000|First Intervention|Withdrawal by Subject|1|||
160889945|NCT00393042|580991595|FG001|First Intervention|Withdrawal by Subject|2|||
160889946|NCT00393042|580991594|FG000|First Intervention|Lost to Follow-up|3|||
160889947|NCT00393042|580991595|FG001|First Intervention|Lost to Follow-up|3|||
160889948|NCT00393042|580991594|FG000|First Intervention|Protocol Violation|1|||
160889949|NCT00393042|580991595|FG001|First Intervention|Protocol Violation|0|||
160889950|NCT00393042|580991594|FG000|First Intervention|Adverse Event|0|||
160889951|NCT00393042|580991595|FG001|First Intervention|Adverse Event|1|||
160889952|NCT00393042|580991594|FG000|Second Intervetion|Adverse Event|0|||
160889953|NCT00393042|580991595|FG001|Second Intervetion|Adverse Event|3|||
160889954|NCT00393042|580991594|FG000|Second Intervetion|Withdrawal by Subject|0|||
160889955|NCT00393042|580991595|FG001|Second Intervetion|Withdrawal by Subject|2|||
160889956|NCT00393042|580991594|FG000|Second Intervetion|Lack of Efficacy|1|||
160889957|NCT00393042|580991595|FG001|Second Intervetion|Lack of Efficacy|0|||
160889958|NCT00393042|580991594|FG000|Second Intervetion|Lost to Follow-up|0|||
160889959|NCT00393042|580991595|FG001|Second Intervetion|Lost to Follow-up|2|||
160889960|NCT00393042|580991594|FG000|Second Intervetion|Protocol Violation|1|||
160889961|NCT00393042|580991595|FG001|Second Intervetion|Protocol Violation|1|||
160889962|NCT03475875|580991596|FG000|Period 1|Lost to Follow-up|1|||
160889963|NCT03475875|580991597|FG001|Period 1|Lost to Follow-up|0|||
160889964|NCT03475875|580991596|FG000|Period 1|Adverse Event|2|||
160889965|NCT03475875|580991597|FG001|Period 1|Adverse Event|1|||
160889966|NCT03475875|580991596|FG000|Period 2|Adverse Event|3|||
160889967|NCT03475875|580991597|FG001|Period 2|Adverse Event|0|||
160889968|NCT03475875|580991596|FG000|Period 2|Protocol Violation|0|||
160889969|NCT03475875|580991597|FG001|Period 2|Protocol Violation|1|||
160889970|NCT01642407|580991601|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
160889971|NCT01642407|580991601|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
160889972|NCT01642407|580991601|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
160889973|NCT02045303|580991602|FG000|Overall Study|Protocol Violation|2|||
160889974|NCT02045303|580991603|FG001|Overall Study|Protocol Violation|1|||
160889975|NCT02045303|580991604|FG002|Overall Study|Protocol Violation|0|||
160889976|NCT02045303|580991602|FG000|Overall Study|Withdrawal by Subject|0|||
160889977|NCT02045303|580991603|FG001|Overall Study|Withdrawal by Subject|2|||
160889978|NCT02045303|580991604|FG002|Overall Study|Withdrawal by Subject|0|||
160889979|NCT01856023|580991605|FG000|Overall Study|Death|1|||
160889980|NCT01856023|580991606|FG001|Overall Study|Death|2|||
160889981|NCT01856023|580991605|FG000|Overall Study|Adverse Event|2|||
160889982|NCT01856023|580991606|FG001|Overall Study|Adverse Event|1|||
160889983|NCT01856023|580991605|FG000|Overall Study|Lack of Efficacy|5|||
160782574|NCT04180696|580589011|FG001|Overall Study|Death|6|||
160782575|NCT04180696|580589010|FG000|Overall Study|Lost to Follow-up|1|||
160782576|NCT04180696|580589011|FG001|Overall Study|Lost to Follow-up|0|||
160782577|NCT04180696|580589010|FG000|Overall Study|Withdrawal by Subject|0|||
160782578|NCT04180696|580589011|FG001|Overall Study|Withdrawal by Subject|1|||
160782579|NCT01740427|580589012|FG000|Overall Study|Objective Progression or Relapse|286|||
160782580|NCT01740427|580589013|FG001|Overall Study|Objective Progression or Relapse|172|||
160782581|NCT01740427|580589012|FG000|Overall Study|Adverse Event|32|||
160782582|NCT01740427|580589013|FG001|Overall Study|Adverse Event|9|||
160782583|NCT01740427|580589012|FG000|Overall Study|Global Deterioration of Health Status|28|||
160782584|NCT01740427|580589013|FG001|Overall Study|Global Deterioration of Health Status|12|||
160782585|NCT01740427|580589012|FG000|Overall Study|Participant Refused Continued Treatment|27|||
160782586|NCT01740427|580589013|FG001|Overall Study|Participant Refused Continued Treatment|15|||
160782587|NCT01740427|580589012|FG000|Overall Study|Unspecified reasons|52|||
160782588|NCT01740427|580589013|FG001|Overall Study|Unspecified reasons|8|||
160782589|NCT01740427|580589012|FG000|Overall Study|Death|10|||
160782590|NCT01740427|580589013|FG001|Overall Study|Death|3|||
160782591|NCT01740427|580589012|FG000|Overall Study|Protocol Violation|5|||
160782592|NCT01740427|580589013|FG001|Overall Study|Protocol Violation|3|||
160782593|NCT01740427|580589012|FG000|Overall Study|Lost to Follow-up|3|||
160782594|NCT01740427|580589013|FG001|Overall Study|Lost to Follow-up|0|||
160782595|NCT01740427|580589012|FG000|Overall Study|Site Terminated by Sponsor|1|||
160782596|NCT01740427|580589013|FG001|Overall Study|Site Terminated by Sponsor|0|||
160782597|NCT04210375|580589015|FG000|Overall Study|Death|0|||
160782598|NCT04210375|580589016|FG001|Overall Study|Death|1|||
160782599|NCT04210375|580589017|FG002|Overall Study|Death|0|||
160782600|NCT04210375|580589018|FG003|Overall Study|Death|0|||
160782601|NCT05752487|580589021|FG000|Overall Study|Enrolled, not treated|9|||
160782602|NCT05752487|580589021|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
160782603|NCT05752487|580589021|FG000|Overall Study|Withdrawal by Subject|2|||
160782604|NCT04124965|580589023|FG000|Overall Study|Adverse event, non-fatal|3|||
160782605|NCT04124965|580589024|FG001|Overall Study|Adverse event, non-fatal|1|||
160782606|NCT04124965|580589023|FG000|Overall Study|Withdrawal by Subject|1|||
160782607|NCT04124965|580589024|FG001|Overall Study|Withdrawal by Subject|1|||
160782608|NCT04124965|580589023|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
160782609|NCT04124965|580589024|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
160782610|NCT04124965|580589023|FG000|Overall Study|Pregnancy|1|||
160782611|NCT04124965|580589024|FG001|Overall Study|Pregnancy|0|||
160782612|NCT04124965|580589023|FG000|Overall Study|Sponsor and participant decision|0|||
160782613|NCT04124965|580589024|FG001|Overall Study|Sponsor and participant decision|1|||
160782614|NCT04124965|580589023|FG000|Overall Study|Personal surgery|0|||
160782615|NCT04124965|580589024|FG001|Overall Study|Personal surgery|1|||
160782616|NCT04124965|580589023|FG000|Overall Study|Physician Decision|0|||
160782617|NCT04124965|580589024|FG001|Overall Study|Physician Decision|1|||
160782618|NCT02184156|580589025|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
160782619|NCT02184156|580589026|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
160782620|NCT02184156|580589025|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
160782621|NCT02184156|580589026|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
160639531|NCT00295620|580062993|FG000|Overall Study|Protocol Violation|30|||
160639532|NCT00295620|580062994|FG001|Overall Study|Protocol Violation|32|||
160639533|NCT01309828|580062995|FG000|Overall Study|Adverse Event|10|||
160639534|NCT01309828|580062996|FG001|Overall Study|Adverse Event|11|||
160639535|NCT01309828|580062995|FG000|Overall Study|Voluntary Withdrawal|5|||
160639536|NCT01309828|580062996|FG001|Overall Study|Voluntary Withdrawal|4|||
160639537|NCT01309828|580062995|FG000|Overall Study|Major Protocol Deviation|0|||
160639538|NCT01309828|580062996|FG001|Overall Study|Major Protocol Deviation|1|||
160639539|NCT01309828|580062995|FG000|Overall Study|Other|1|||
160782622|NCT01214720|580589028|FG000|Overall Study|Alive and still on treatment|34|||
160782623|NCT01214720|580589029|FG001|Overall Study|Alive and still on treatment|18|||
160639540|NCT01309828|580062996|FG001|Overall Study|Other|0|||
160782624|NCT01214720|580589028|FG000|Overall Study|Alive and in follow-up|45|||
160782625|NCT01214720|580589029|FG001|Overall Study|Alive and in follow-up|48|||
160782626|NCT01214720|580589028|FG000|Overall Study|Lost to Follow-up|6|||
160782627|NCT01214720|580589029|FG001|Overall Study|Lost to Follow-up|2|||
160782628|NCT01980888|580589030|FG000|Overall Study|Study Terminated by Sponsor|116|||
160782629|NCT01980888|580589031|FG001|Overall Study|Study Terminated by Sponsor|122|||
160782630|NCT01980888|580589030|FG000|Overall Study|Withdrew Consent|17|||
160782631|NCT01980888|580589031|FG001|Overall Study|Withdrew Consent|6|||
160782632|NCT01980888|580589030|FG000|Overall Study|Investigator's Discretion|8|||
160782633|NCT01980888|580589031|FG001|Overall Study|Investigator's Discretion|3|||
160782634|NCT01980888|580589030|FG000|Overall Study|Non-Compliance with Study Drug|3|||
160782635|NCT01980888|580589031|FG001|Overall Study|Non-Compliance with Study Drug|2|||
160782636|NCT04625972|580589032|FG000|Overall Study|Death|3|||
160782637|NCT04625972|580589033|FG001|Overall Study|Death|2|||
160782638|NCT04625972|580589032|FG000|Overall Study|Lost to Follow-up|82|||
160782639|NCT04625972|580589033|FG001|Overall Study|Lost to Follow-up|38|||
160782640|NCT04625972|580589032|FG000|Overall Study|Physician Decision|2|||
160782641|NCT04625972|580589033|FG001|Overall Study|Physician Decision|0|||
160782642|NCT04625972|580589032|FG000|Overall Study|Protocol Violation|0|||
160782643|NCT04625972|580589033|FG001|Overall Study|Protocol Violation|1|||
160782644|NCT04625972|580589032|FG000|Overall Study|Withdrawal by Subject|37|||
160782645|NCT04625972|580589033|FG001|Overall Study|Withdrawal by Subject|24|||
160782646|NCT04625972|580589032|FG000|Overall Study|Not specified elsewhere|8|||
160782647|NCT04625972|580589033|FG001|Overall Study|Not specified elsewhere|6|||
160782648|NCT05591755|580589034|FG000|Overall Study|Screen Failure|1|||
160782649|NCT05591755|580589035|FG001|Overall Study|Screen Failure|0|||
160782650|NCT05591755|580589036|FG002|Overall Study|Screen Failure|0|||
160782651|NCT05591755|580589037|FG003|Overall Study|Screen Failure|0|||
160782652|NCT05591755|580589034|FG000|Overall Study|Protocol Violation|0|||
160782653|NCT05591755|580589035|FG001|Overall Study|Protocol Violation|0|||
160782654|NCT05591755|580589036|FG002|Overall Study|Protocol Violation|2|||
160782655|NCT05591755|580589037|FG003|Overall Study|Protocol Violation|0|||
160782656|NCT05591755|580589034|FG000|Overall Study|Withdrawal by Subject|0|||
160782657|NCT05591755|580589035|FG001|Overall Study|Withdrawal by Subject|1|||
160782658|NCT05591755|580589036|FG002|Overall Study|Withdrawal by Subject|0|||
160782659|NCT05591755|580589037|FG003|Overall Study|Withdrawal by Subject|0|||
160782660|NCT02502383|580590514|FG000|Overall Study|Lost to Follow-up|130|||
160782661|NCT02502383|580590515|FG001|Overall Study|Lost to Follow-up|131|||
160782662|NCT02502383|580590514|FG000|Overall Study|Withdrawal by Subject|31|||
160782663|NCT02502383|580590515|FG001|Overall Study|Withdrawal by Subject|24|||
160782664|NCT01964560|580590520|FG000|Overall Study|Adverse Event|23|||
160782665|NCT01964560|580590520|FG000|Overall Study|Lack of Efficacy|46|||
160782666|NCT01964560|580590520|FG000|Overall Study|Protocol deviation|2|||
160782667|NCT01964560|580590520|FG000|Overall Study|Lost to Follow-up|4|||
160782668|NCT01964560|580590520|FG000|Overall Study|Withdrawal by Subject|64|||
160782669|NCT01964560|580590520|FG000|Overall Study|Surgery-hemispherotomy|1|||
160782670|NCT01964560|580590520|FG000|Overall Study|Surgery|1|||
160782671|NCT01964560|580590520|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
160782672|NCT01964560|580590520|FG000|Overall Study|Patient and Investigator choice|1|||
160782673|NCT01964560|580590520|FG000|Overall Study|Patient was prescribed CBD|1|||
160782674|NCT01964560|580590520|FG000|Overall Study|Participant moved to another country|1|||
160782675|NCT02301429|580590526|FG000|Overall Study|not acceptable vascular anatomy|3|||
160782676|NCT01011283|580590527|FG000|Overall Study|Adverse Event|4|||
160782677|NCT01011283|580590528|FG001|Overall Study|Adverse Event|2|||
160782678|NCT01011283|580590527|FG000|Overall Study|Progressive Disease|0|||
160782679|NCT01011283|580590528|FG001|Overall Study|Progressive Disease|2|||
160782680|NCT01011283|580590527|FG000|Overall Study|Terminated by Sponsor|5|||
160782681|NCT01011283|580590528|FG001|Overall Study|Terminated by Sponsor|5|||
160782682|NCT01011283|580590527|FG000|Overall Study|Other|2|||
160782683|NCT01011283|580590528|FG001|Overall Study|Other|2|||
160782684|NCT01717859|580590529|FG000|Overall Study|Adverse Event|5|||
160782685|NCT01717859|580590529|FG000|Overall Study|Moved out of state|1|||
160782686|NCT01717859|580590529|FG000|Overall Study|Patient concerned about mental health|1|||
160782687|NCT01717859|580590529|FG000|Overall Study|Lost to Follow-up|1|||
160782688|NCT01717859|580590529|FG000|Overall Study|Withdrawal by Subject|2|||
160782689|NCT04053452|580590531|FG000|Overall Study|Withdrawal by Subject|1|||
160782690|NCT04053452|580590532|FG001|Overall Study|Withdrawal by Subject|0|||
160782691|NCT04053452|580590531|FG000|Overall Study|Time restraint due to inpatient needs|1|||
160782692|NCT04053452|580590532|FG001|Overall Study|Time restraint due to inpatient needs|2|||
160782693|NCT01421134|580590533|FG000|Overall Study|Adverse Event|3|||
160782694|NCT01421134|580590534|FG001|Overall Study|Adverse Event|5|||
160782695|NCT01421134|580590533|FG000|Overall Study|Lack of Efficacy|2|||
160782696|NCT01421134|580590534|FG001|Overall Study|Lack of Efficacy|4|||
160889984|NCT01856023|580991606|FG001|Overall Study|Lack of Efficacy|5|||
160782697|NCT01421134|580590533|FG000|Overall Study|Protocol Violation|0|||
160782698|NCT01421134|580590534|FG001|Overall Study|Protocol Violation|3|||
160782699|NCT01421134|580590533|FG000|Overall Study|Withdrawal by Subject|1|||
160782700|NCT01421134|580590534|FG001|Overall Study|Withdrawal by Subject|1|||
160782701|NCT01421134|580590533|FG000|Overall Study|Administrative|0|||
160782702|NCT01421134|580590534|FG001|Overall Study|Administrative|1|||
160782703|NCT01421134|580590533|FG000|Overall Study|Lost to Follow-up|1|||
160782704|NCT01421134|580590534|FG001|Overall Study|Lost to Follow-up|1|||
160782705|NCT02959892|580590535|FG000|Overall Study|PET tracer synthesis failure|1|||
160782706|NCT02959892|580590536|FG001|Overall Study|PET tracer synthesis failure|0|||
160782707|NCT02959892|580590535|FG000|Overall Study|Study termination|0|||
160782708|NCT02959892|580590536|FG001|Overall Study|Study termination|1|||
160889985|NCT01856023|580991605|FG000|Overall Study|non compliance, study closure|1|||
160782709|NCT00122187|580590537|FG000|Overall Study|Withdrew because of resource limitations|2|||
160782710|NCT00122187|580590538|FG001|Overall Study|Withdrew because of resource limitations|2|||
160782711|NCT02061592|580590542|FG000|Period 1|Withdrawal by Subject|1|||
160782712|NCT02061592|580590543|FG001|Period 1|Withdrawal by Subject|0|||
160782713|NCT02061592|580590542|FG000|Period 1|Protocol Violation|1|||
160981558|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160639541|NCT00217971|580062997|FG000|Overall Study|Adverse Event|1|||
160639542|NCT00217971|580062998|FG001|Overall Study|Adverse Event|1|||
160639543|NCT00217971|580062997|FG000|Overall Study|Lost to Follow-up|15|||
160639544|NCT00217971|580062998|FG001|Overall Study|Lost to Follow-up|19|||
160639545|NCT00217971|580062997|FG000|Overall Study|Physician Decision|0|||
160639546|NCT00217971|580062998|FG001|Overall Study|Physician Decision|1|||
160639547|NCT00217971|580062997|FG000|Overall Study|Withdrawal by Subject|7|||
160639548|NCT00217971|580062998|FG001|Overall Study|Withdrawal by Subject|12|||
160639549|NCT00217971|580062997|FG000|Overall Study|non compliant|1|||
160639550|NCT00217971|580062998|FG001|Overall Study|non compliant|0|||
160639551|NCT02556632|580062999|FG000|Overall Study|Lost to Follow-up|1|||
160639552|NCT02556632|580063000|FG001|Overall Study|Lost to Follow-up|0|||
160639553|NCT02556632|580063001|FG002|Overall Study|Lost to Follow-up|0|||
160639554|NCT02556632|580062999|FG000|Overall Study|Disliked Intervention|1|||
160639555|NCT02556632|580063000|FG001|Overall Study|Disliked Intervention|1|||
160639556|NCT02556632|580063001|FG002|Overall Study|Disliked Intervention|1|||
160639557|NCT02556632|580062999|FG000|Overall Study|No Reason|1|||
160639558|NCT02556632|580063000|FG001|Overall Study|No Reason|0|||
160639559|NCT02556632|580063001|FG002|Overall Study|No Reason|1|||
160639560|NCT02556632|580062999|FG000|Overall Study|Personal Issues|0|||
160639561|NCT02556632|580063000|FG001|Overall Study|Personal Issues|1|||
160639562|NCT02556632|580063001|FG002|Overall Study|Personal Issues|1|||
160639563|NCT02556632|580062999|FG000|Overall Study|Changed Mind|0|||
160639564|NCT02556632|580063000|FG001|Overall Study|Changed Mind|1|||
160639565|NCT02556632|580063001|FG002|Overall Study|Changed Mind|0|||
160639566|NCT02556632|580062999|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
160639567|NCT02556632|580063000|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
160639568|NCT02556632|580063001|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
160639569|NCT02556632|580062999|FG000|Overall Study|Unrelated Adverse Event|1|||
160639570|NCT02556632|580063000|FG001|Overall Study|Unrelated Adverse Event|0|||
160639571|NCT02556632|580063001|FG002|Overall Study|Unrelated Adverse Event|3|||
160639572|NCT02556632|580062999|FG000|Overall Study|Related Adverse Event|0|||
160639573|NCT02556632|580063000|FG001|Overall Study|Related Adverse Event|1|||
160639574|NCT02556632|580063001|FG002|Overall Study|Related Adverse Event|0|||
160639575|NCT02556632|580062999|FG000|Overall Study|Possibly Related Adverse Event|0|||
160639576|NCT02556632|580063000|FG001|Overall Study|Possibly Related Adverse Event|0|||
160639577|NCT02556632|580063001|FG002|Overall Study|Possibly Related Adverse Event|1|||
160639578|NCT02556632|580062999|FG000|Overall Study|Did Not Start RT|0|||
160639579|NCT02556632|580063000|FG001|Overall Study|Did Not Start RT|1|||
160639580|NCT02556632|580063001|FG002|Overall Study|Did Not Start RT|0|||
160639581|NCT02556632|580062999|FG000|Overall Study|Ineligible|0|||
160639582|NCT02556632|580063000|FG001|Overall Study|Ineligible|1|||
160639583|NCT02556632|580063001|FG002|Overall Study|Ineligible|0|||
160639584|NCT02556632|580062999|FG000|Overall Study|Disliked Study Procedures|0|||
160639585|NCT02556632|580063000|FG001|Overall Study|Disliked Study Procedures|0|||
160639586|NCT02556632|580063001|FG002|Overall Study|Disliked Study Procedures|1|||
160639587|NCT02556632|580062999|FG000|Overall Study|Treatment or Change Delay|0|||
160981559|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160981560|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160981561|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160981562|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
160981563|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
160981564|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
160981565|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160639588|NCT02556632|580063000|FG001|Overall Study|Treatment or Change Delay|0|||
160639589|NCT02556632|580063001|FG002|Overall Study|Treatment or Change Delay|1|||
160639590|NCT00808015|580063004|FG000|Overall Study|Death|1|||
160981566|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160639591|NCT00808015|580063004|FG000|Overall Study|Lack of Efficacy|58|||
160639592|NCT00808015|580063004|FG000|Overall Study|Lost to Follow-up|76|||
160639593|NCT00808015|580063004|FG000|Overall Study|Participants not willing to participate|158|||
160639594|NCT00808015|580063004|FG000|Overall Study|Adverse Event|22|||
160639595|NCT00808015|580063004|FG000|Overall Study|Other|25|||
160639596|NCT00808015|580063004|FG000|Overall Study|Enrolled but not treated|4|||
160639597|NCT00084617|580063014|FG000|Overall Study|Withdrawal by Subject|7|||
160782714|NCT02061592|580590543|FG001|Period 1|Protocol Violation|0|||
160782715|NCT02061592|580590542|FG000|Period 2|Lost to Follow-up|0|||
160639598|NCT00084617|580063014|FG000|Overall Study|Lack of Efficacy|1|||
160639599|NCT00084617|580063014|FG000|Overall Study|Protocol Violation|1|||
160639600|NCT01625286|580063015|FG000|Overall Study|Adverse Event|0|||
160782716|NCT02061592|580590543|FG001|Period 2|Lost to Follow-up|1|||
160782717|NCT04433975|580590544|FG000|1-month Follow Up|Withdrawal by Subject|1|||
160782718|NCT04433975|580590545|FG001|1-month Follow Up|Withdrawal by Subject|1|||
160782719|NCT04433975|580590544|FG000|1-month Follow Up|Lost to Follow-up|21|||
160782720|NCT04433975|580590545|FG001|1-month Follow Up|Lost to Follow-up|25|||
160782721|NCT04433975|580590544|FG000|3-month Follow Up|Lost to Follow-up|20|||
160782722|NCT04433975|580590545|FG001|3-month Follow Up|Lost to Follow-up|24|||
160782723|NCT04433975|580590544|FG000|3-month Follow Up|Death|1|||
160782724|NCT04433975|580590545|FG001|3-month Follow Up|Death|0|||
160782725|NCT04433975|580590544|FG000|3-month Follow Up|Withdrawal by Subject|2|||
160782726|NCT04433975|580590545|FG001|3-month Follow Up|Withdrawal by Subject|0|||
160782727|NCT04433975|580590544|FG000|6-month Follow Up|Lost to Follow-up|23|||
160782728|NCT04433975|580590545|FG001|6-month Follow Up|Lost to Follow-up|28|||
160782729|NCT04433975|580590544|FG000|6-month Follow Up|Withdrawal by Subject|1|||
160782730|NCT04433975|580590545|FG001|6-month Follow Up|Withdrawal by Subject|1|||
160782731|NCT04433975|580590544|FG000|9-month Follow Up|Lost to Follow-up|27|||
160782732|NCT04433975|580590545|FG001|9-month Follow Up|Lost to Follow-up|36|||
160782733|NCT04433975|580590544|FG000|9-month Follow Up|Death|0|||
160782734|NCT04433975|580590545|FG001|9-month Follow Up|Death|1|||
160782735|NCT04433975|580590544|FG000|12-month Follow Up|Lost to Follow-up|27|||
160782736|NCT04433975|580590545|FG001|12-month Follow Up|Lost to Follow-up|31|||
160782737|NCT04392635|580590546|FG000|Overall Study|Lost to Follow-up|0|||
160782738|NCT04392635|580590547|FG001|Overall Study|Lost to Follow-up|1|||
160782739|NCT00724893|580590552|FG000|Overall Study|Adverse Event|76|||
160782740|NCT00724893|580590553|FG001|Overall Study|Adverse Event|142|||
160782741|NCT00724893|580590552|FG000|Overall Study|Withdrawal by Subject|0|||
160782742|NCT00724893|580590553|FG001|Overall Study|Withdrawal by Subject|1|||
160782743|NCT00724893|580590552|FG000|Overall Study|Lack of virologic response|94|||
160782744|NCT00724893|580590553|FG001|Overall Study|Lack of virologic response|202|||
160782745|NCT00724893|580590552|FG000|Overall Study|Reason not specified|193|||
160782746|NCT00724893|580590553|FG001|Overall Study|Reason not specified|7|||
160782747|NCT00724893|580590552|FG000|Overall Study|Patient choice|0|||
160782748|NCT00724893|580590553|FG001|Overall Study|Patient choice|26|||
160782749|NCT00724893|580590552|FG000|Overall Study|Geographic reasons|0|||
160782750|NCT00724893|580590553|FG001|Overall Study|Geographic reasons|11|||
160782751|NCT00724893|580590552|FG000|Overall Study|Incarceration|0|||
160782752|NCT00724893|580590553|FG001|Overall Study|Incarceration|9|||
160782753|NCT00724893|580590552|FG000|Overall Study|Substance abuse|0|||
160782754|NCT00724893|580590553|FG001|Overall Study|Substance abuse|3|||
160782755|NCT00724893|580590552|FG000|Overall Study|Financial reasons|0|||
160782756|NCT00724893|580590553|FG001|Overall Study|Financial reasons|2|||
160782757|NCT00724893|580590552|FG000|Overall Study|Assigned shorter treatment|0|||
160782758|NCT00724893|580590553|FG001|Overall Study|Assigned shorter treatment|2|||
160782759|NCT00724893|580590552|FG000|Overall Study|Lost to Follow-up|0|||
160782760|NCT00724893|580590553|FG001|Overall Study|Lost to Follow-up|52|||
160782761|NCT00724893|580590552|FG000|Overall Study|Unknown, missing data|1|||
160782762|NCT00724893|580590553|FG001|Overall Study|Unknown, missing data|1|||
160782763|NCT01290731|580590554|FG000|Overall Study|Withdrawal by Subject|1|||
160782764|NCT02181738|580590560|FG000|Overall Study|Participant Withdrew Consent|2|||
160782765|NCT02181738|580590561|FG001|Overall Study|Participant Withdrew Consent|1|||
160981567|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160981568|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160981569|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981570|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160782766|NCT02181738|580590562|FG002|Overall Study|Participant Withdrew Consent|1|||
160782767|NCT02181738|580590563|FG003|Overall Study|Participant Withdrew Consent|1|||
160782768|NCT02181738|580590560|FG000|Overall Study|Lost to Follow-up|1|||
160782769|NCT02181738|580590561|FG001|Overall Study|Lost to Follow-up|2|||
160782770|NCT02181738|580590562|FG002|Overall Study|Lost to Follow-up|1|||
160782771|NCT02181738|580590563|FG003|Overall Study|Lost to Follow-up|1|||
160782772|NCT02181738|580590560|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
160782773|NCT02181738|580590561|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
160981571|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981572|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
160782774|NCT02181738|580590562|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
160782775|NCT02181738|580590563|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
160782776|NCT02181738|580590560|FG000|Overall Study|Poor/Non-Compliance|1|||
160782777|NCT02181738|580590561|FG001|Overall Study|Poor/Non-Compliance|0|||
160782778|NCT02181738|580590562|FG002|Overall Study|Poor/Non-Compliance|2|||
160782779|NCT02181738|580590563|FG003|Overall Study|Poor/Non-Compliance|1|||
160782780|NCT02181738|580590560|FG000|Overall Study|Disease Progression|28|||
160782781|NCT02181738|580590561|FG001|Overall Study|Disease Progression|35|||
160782782|NCT02181738|580590562|FG002|Overall Study|Disease Progression|40|||
160782783|NCT02181738|580590563|FG003|Overall Study|Disease Progression|0|||
160782784|NCT02181738|580590560|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
160782785|NCT02181738|580590561|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
160782786|NCT02181738|580590562|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
160782787|NCT02181738|580590563|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
160782788|NCT02181738|580590560|FG000|Overall Study|Study Drug Toxicity|6|||
160782789|NCT02181738|580590561|FG001|Overall Study|Study Drug Toxicity|11|||
160981573|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
160981574|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981575|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981576|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981577|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981578|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981579|NCT02018861|581321704|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981580|NCT02018861|581321705|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981581|NCT02018861|581321706|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981582|NCT02018861|581321707|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981583|NCT02018861|581321708|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160782790|NCT02181738|580590562|FG002|Overall Study|Study Drug Toxicity|8|||
160782791|NCT02181738|580590563|FG003|Overall Study|Study Drug Toxicity|1|||
160782792|NCT02181738|580590560|FG000|Overall Study|Other Reasons|14|||
160782793|NCT02181738|580590561|FG001|Overall Study|Other Reasons|16|||
160782794|NCT02181738|580590562|FG002|Overall Study|Other Reasons|28|||
160782795|NCT02181738|580590563|FG003|Overall Study|Other Reasons|0|||
160782796|NCT02181738|580590560|FG000|Overall Study|Maximum Clinical Benefit|3|||
160782797|NCT02181738|580590561|FG001|Overall Study|Maximum Clinical Benefit|0|||
160782798|NCT02181738|580590562|FG002|Overall Study|Maximum Clinical Benefit|1|||
160782799|NCT02181738|580590563|FG003|Overall Study|Maximum Clinical Benefit|0|||
160782800|NCT02181738|580590560|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
160782801|NCT02181738|580590561|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
160782802|NCT02181738|580590562|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
160782803|NCT02181738|580590563|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160782804|NCT01149538|580590566|FG000|Overall Study|Lost to Follow-up|0|||
160782805|NCT01149538|580590567|FG001|Overall Study|Lost to Follow-up|1|||
160782806|NCT01149538|580590566|FG000|Overall Study|Withdrawal by Subject|5|||
160782807|NCT01149538|580590567|FG001|Overall Study|Withdrawal by Subject|3|||
160782808|NCT00888849|580590568|FG000|Overall Study|Death|4|||
160782809|NCT00888849|580590569|FG001|Overall Study|Death|7|||
160782810|NCT00888849|580590568|FG000|Overall Study|Lost to Follow-up|1|||
160782811|NCT00888849|580590569|FG001|Overall Study|Lost to Follow-up|2|||
160782812|NCT00629239|580590570|FG000|Overall Study|Adverse Event|7|||
160782813|NCT00629239|580590571|FG001|Overall Study|Adverse Event|4|||
160782814|NCT00629239|580590570|FG000|Overall Study|Physician Decision|1|||
160782815|NCT00629239|580590571|FG001|Overall Study|Physician Decision|0|||
160782816|NCT01851369|580590574|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782817|NCT01851369|580590575|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782818|NCT01851369|580590576|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782819|NCT01851369|580590577|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782820|NCT01851369|580590578|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160639601|NCT01625286|580063016|FG001|Overall Study|Adverse Event|0|||
160639602|NCT01625286|580063017|FG002|Overall Study|Adverse Event|0|||
160639603|NCT01625286|580063018|FG003|Overall Study|Adverse Event|0|||
160639604|NCT01625286|580063019|FG004|Overall Study|Adverse Event|1|||
160981584|NCT02018861|581321709|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981585|NCT02018861|581321710|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
160981586|NCT02018861|581321711|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
160782821|NCT01851369|580590579|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
160782822|NCT01851369|580590580|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782823|NCT01851369|580590581|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782824|NCT01851369|580590582|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782825|NCT01851369|580590583|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782826|NCT01851369|580590584|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782827|NCT01851369|580590585|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782828|NCT01851369|580590586|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782829|NCT00183391|580590587|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
160639605|NCT01625286|580063020|FG005|Overall Study|Adverse Event|2|||
160782830|NCT00183391|580590588|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
160782831|NCT00183391|580590587|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
160782832|NCT00183391|580590588|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
160639606|NCT01625286|580063021|FG006|Overall Study|Adverse Event|1|||
160782833|NCT02336503|580590589|FG000|Overall Study|Lost to Follow-up|0|||
160782834|NCT02336503|580590590|FG001|Overall Study|Lost to Follow-up|3|||
160782835|NCT02336503|580590591|FG002|Overall Study|Lost to Follow-up|0|||
160782836|NCT02336503|580590592|FG003|Overall Study|Lost to Follow-up|2|||
160782837|NCT02336503|580590589|FG000|Overall Study|Withdrawal by Subject|2|||
160782838|NCT02336503|580590590|FG001|Overall Study|Withdrawal by Subject|0|||
160782839|NCT02336503|580590591|FG002|Overall Study|Withdrawal by Subject|0|||
160782840|NCT02336503|580590592|FG003|Overall Study|Withdrawal by Subject|4|||
160782841|NCT02336503|580590589|FG000|Overall Study|Adverse Event|0|||
160782842|NCT02336503|580590590|FG001|Overall Study|Adverse Event|0|||
160782843|NCT02336503|580590591|FG002|Overall Study|Adverse Event|1|||
160782844|NCT02336503|580590592|FG003|Overall Study|Adverse Event|0|||
160782845|NCT00395512|580590593|FG000|Overall Study|Adverse Event|3|||
160782846|NCT00395512|580590594|FG001|Overall Study|Adverse Event|8|||
160782847|NCT00395512|580590595|FG002|Overall Study|Adverse Event|6|||
160782848|NCT00395512|580590596|FG003|Overall Study|Adverse Event|6|||
160782849|NCT00395512|580590593|FG000|Overall Study|Protocol Violation|2|||
160782850|NCT00395512|580590594|FG001|Overall Study|Protocol Violation|3|||
160782851|NCT00395512|580590595|FG002|Overall Study|Protocol Violation|6|||
160782852|NCT00395512|580590596|FG003|Overall Study|Protocol Violation|7|||
160782853|NCT00395512|580590593|FG000|Overall Study|Lost to Follow-up|2|||
160782854|NCT00395512|580590594|FG001|Overall Study|Lost to Follow-up|6|||
160782855|NCT00395512|580590595|FG002|Overall Study|Lost to Follow-up|5|||
160782856|NCT00395512|580590596|FG003|Overall Study|Lost to Follow-up|5|||
160782857|NCT00395512|580590593|FG000|Overall Study|Withdrawal by Subject|6|||
160782858|NCT00395512|580590594|FG001|Overall Study|Withdrawal by Subject|5|||
160782859|NCT00395512|580590595|FG002|Overall Study|Withdrawal by Subject|5|||
160782860|NCT00395512|580590596|FG003|Overall Study|Withdrawal by Subject|12|||
160782861|NCT00395512|580590593|FG000|Overall Study|Physician Decision|6|||
160782862|NCT00395512|580590594|FG001|Overall Study|Physician Decision|4|||
160782863|NCT00395512|580590595|FG002|Overall Study|Physician Decision|2|||
160782864|NCT00395512|580590596|FG003|Overall Study|Physician Decision|2|||
160782865|NCT00395512|580590593|FG000|Overall Study|Other|1|||
160782866|NCT00395512|580590594|FG001|Overall Study|Other|1|||
160782867|NCT00395512|580590595|FG002|Overall Study|Other|0|||
160782868|NCT00395512|580590596|FG003|Overall Study|Other|0|||
160782869|NCT00395512|580590593|FG000|Overall Study|Hyperglycemic Rescue|18|||
160782870|NCT00395512|580590594|FG001|Overall Study|Hyperglycemic Rescue|10|||
160782871|NCT00395512|580590595|FG002|Overall Study|Hyperglycemic Rescue|4|||
160782872|NCT00395512|580590596|FG003|Overall Study|Hyperglycemic Rescue|6|||
160782873|NCT04584554|580590597|FG000|Overall Study|Withdrawal by Subject|2|||
160782874|NCT04584554|580590598|FG001|Overall Study|Withdrawal by Subject|2|||
160782875|NCT01436500|580590603|FG000|Overall Study|Death|1|||
160782876|NCT01436500|580590604|FG001|Overall Study|Death|0|||
160782877|NCT01436500|580590605|FG002|Overall Study|Death|0|||
160782878|NCT01436500|580590606|FG003|Overall Study|Death|0|||
160782879|NCT01436500|580590607|FG004|Overall Study|Death|0|||
160782880|NCT01436500|580590603|FG000|Overall Study|Adverse Event|0|||
160782881|NCT01436500|580590604|FG001|Overall Study|Adverse Event|2|||
160782882|NCT01436500|580590605|FG002|Overall Study|Adverse Event|2|||
160782883|NCT01436500|580590606|FG003|Overall Study|Adverse Event|0|||
160782884|NCT01436500|580590607|FG004|Overall Study|Adverse Event|1|||
160782885|NCT01436500|580590603|FG000|Overall Study|Withdrawal by Subject|0|||
160782886|NCT01436500|580590604|FG001|Overall Study|Withdrawal by Subject|0|||
160782887|NCT01436500|580590605|FG002|Overall Study|Withdrawal by Subject|2|||
160782888|NCT01436500|580590606|FG003|Overall Study|Withdrawal by Subject|0|||
160782889|NCT01436500|580590607|FG004|Overall Study|Withdrawal by Subject|2|||
160782890|NCT01436500|580590603|FG000|Overall Study|Physician Decision|0|||
160782891|NCT01436500|580590604|FG001|Overall Study|Physician Decision|0|||
160782892|NCT01436500|580590605|FG002|Overall Study|Physician Decision|1|||
160889986|NCT01856023|580991606|FG001|Overall Study|non compliance, study closure|3|||
160889987|NCT01856023|580991605|FG000|Overall Study|Withdrawal by Subject|1|||
160889988|NCT01856023|580991606|FG001|Overall Study|Withdrawal by Subject|1|||
160889989|NCT00829283|580991607|FG000|Overall Study|Lost to Follow-up|7|||
160889990|NCT00829283|580991608|FG001|Overall Study|Lost to Follow-up|25|||
160889991|NCT00424255|580991609|FG000|Overall Study|Death|115|||
160889992|NCT00424255|580991610|FG001|Overall Study|Death|111|||
160889993|NCT00424255|580991609|FG000|Overall Study|Lost to Follow-up|26|||
160889994|NCT00424255|580991610|FG001|Overall Study|Lost to Follow-up|20|||
160889995|NCT00424255|580991609|FG000|Overall Study|Protocol Violation|0|||
160782893|NCT01436500|580590606|FG003|Overall Study|Physician Decision|0|||
160782894|NCT01436500|580590607|FG004|Overall Study|Physician Decision|0|||
160782895|NCT01436500|580590603|FG000|Overall Study|liver transplant|1|||
160782896|NCT01436500|580590604|FG001|Overall Study|liver transplant|0|||
160889996|NCT00424255|580991610|FG001|Overall Study|Protocol Violation|1|||
160782897|NCT01436500|580590605|FG002|Overall Study|liver transplant|0|||
160782898|NCT01436500|580590606|FG003|Overall Study|liver transplant|0|||
160782899|NCT01436500|580590607|FG004|Overall Study|liver transplant|0|||
160782900|NCT01436500|580590603|FG000|Overall Study|initiation of dialysis|0|||
160782901|NCT01436500|580590604|FG001|Overall Study|initiation of dialysis|0|||
160782902|NCT01436500|580590605|FG002|Overall Study|initiation of dialysis|0|||
160782903|NCT01436500|580590606|FG003|Overall Study|initiation of dialysis|0|||
160782904|NCT01436500|580590607|FG004|Overall Study|initiation of dialysis|1|||
160782905|NCT01436500|580590603|FG000|Overall Study|discontinued study drug|1|||
160782906|NCT01436500|580590604|FG001|Overall Study|discontinued study drug|0|||
160782907|NCT01436500|580590605|FG002|Overall Study|discontinued study drug|0|||
160782908|NCT01436500|580590606|FG003|Overall Study|discontinued study drug|0|||
160782909|NCT01436500|580590607|FG004|Overall Study|discontinued study drug|0|||
160782910|NCT01436500|580590603|FG000|Overall Study|Other|0|||
160782911|NCT01436500|580590604|FG001|Overall Study|Other|1|||
160782912|NCT01436500|580590605|FG002|Overall Study|Other|0|||
160782913|NCT01436500|580590606|FG003|Overall Study|Other|1|||
160782914|NCT01436500|580590607|FG004|Overall Study|Other|0|||
160782915|NCT02405962|580590610|FG000|Overall Study|Lost to Follow-up|1|||
160782916|NCT02405962|580590611|FG001|Overall Study|Lost to Follow-up|4|||
160782917|NCT02405962|580590610|FG000|Overall Study|A participant has moved to another place|0|||
160782918|NCT02405962|580590611|FG001|Overall Study|A participant has moved to another place|1|||
160782919|NCT00165698|580590612|FG000|Overall Study|Adverse Event|2|||
160782920|NCT00165698|580590613|FG001|Overall Study|Adverse Event|10|||
160782921|NCT00165698|580590612|FG000|Overall Study|Lost to Follow-up|2|||
160782922|NCT00165698|580590613|FG001|Overall Study|Lost to Follow-up|2|||
160782923|NCT00165698|580590612|FG000|Overall Study|Withdrawal by Subject|2|||
160782924|NCT00165698|580590613|FG001|Overall Study|Withdrawal by Subject|1|||
160782925|NCT00165698|580590612|FG000|Overall Study|Protocol Violation|1|||
160782926|NCT00165698|580590613|FG001|Overall Study|Protocol Violation|0|||
160782927|NCT00165698|580590612|FG000|Overall Study|Not Taken/Lost the medicine|1|||
160782928|NCT00165698|580590613|FG001|Overall Study|Not Taken/Lost the medicine|2|||
160782929|NCT01483651|580590614|FG000|Overall Study|Withdrawal by Subject|0|||
160782930|NCT01483651|580590615|FG001|Overall Study|Withdrawal by Subject|1|||
160782931|NCT01483651|580590616|FG002|Overall Study|Withdrawal by Subject|1|||
160782932|NCT01483651|580590617|FG003|Overall Study|Withdrawal by Subject|0|||
160782933|NCT01483651|580590618|FG004|Overall Study|Withdrawal by Subject|0|||
160782934|NCT01483651|580590619|FG005|Overall Study|Withdrawal by Subject|1|||
160782935|NCT02547935|580590626|FG000|Overall Study|Other|0|||
160782936|NCT02547935|580590627|FG001|Overall Study|Other|1|||
160782937|NCT02547935|580590628|FG002|Overall Study|Other|0|||
160782938|NCT02547935|580590626|FG000|Overall Study|Withdrawal by Subject|2|||
160782939|NCT02547935|580590627|FG001|Overall Study|Withdrawal by Subject|3|||
160782940|NCT02547935|580590628|FG002|Overall Study|Withdrawal by Subject|4|||
160782941|NCT02547935|580590626|FG000|Overall Study|Screen Failure|2|||
160782942|NCT02547935|580590627|FG001|Overall Study|Screen Failure|0|||
160782943|NCT02547935|580590628|FG002|Overall Study|Screen Failure|0|||
160782944|NCT02547935|580590626|FG000|Overall Study|Physician Decision|0|||
160782945|NCT02547935|580590627|FG001|Overall Study|Physician Decision|1|||
160782946|NCT02547935|580590628|FG002|Overall Study|Physician Decision|0|||
160782947|NCT02547935|580590626|FG000|Overall Study|Lost to Follow-up|0|||
160782948|NCT02547935|580590627|FG001|Overall Study|Lost to Follow-up|2|||
160782949|NCT02547935|580590628|FG002|Overall Study|Lost to Follow-up|1|||
160782950|NCT02547935|580590626|FG000|Overall Study|Death|1|||
160782951|NCT02547935|580590627|FG001|Overall Study|Death|1|||
160782952|NCT02547935|580590628|FG002|Overall Study|Death|0|||
160782953|NCT01184118|580590630|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
160782954|NCT01184118|580590630|FG000|Overall Study|No physiologic confirmation of asthma|8|||
160782955|NCT01184118|580590630|FG000|Overall Study|FEV1 <60% predicted|2|||
160782956|NCT01184118|580590630|FG000|Overall Study|Exclusionary medical condition|2|||
160782957|NCT01184118|580590630|FG000|Overall Study|Withdrawal by Subject|5|||
160782958|NCT01928771|580590633|FG000|Overall Study|Adverse Event|6|||
160782959|NCT01928771|580590634|FG001|Overall Study|Adverse Event|5|||
160639607|NCT01625286|580063015|FG000|Overall Study|Death|0|||
160639608|NCT01625286|580063016|FG001|Overall Study|Death|0|||
160639609|NCT01625286|580063017|FG002|Overall Study|Death|1|||
160782960|NCT01928771|580590635|FG002|Overall Study|Adverse Event|1|||
160782961|NCT01928771|580590633|FG000|Overall Study|Death|2|||
160782962|NCT01928771|580590634|FG001|Overall Study|Death|2|||
160639610|NCT01625286|580063018|FG003|Overall Study|Death|1|||
160782963|NCT01928771|580590635|FG002|Overall Study|Death|2|||
160782964|NCT01928771|580590633|FG000|Overall Study|Lost to Follow-up|5|||
160782965|NCT01928771|580590634|FG001|Overall Study|Lost to Follow-up|6|||
160782966|NCT01928771|580590635|FG002|Overall Study|Lost to Follow-up|3|||
160782967|NCT01928771|580590633|FG000|Overall Study|Withdrawal by Subject|20|||
160782968|NCT01928771|580590634|FG001|Overall Study|Withdrawal by Subject|15|||
160782969|NCT01928771|580590635|FG002|Overall Study|Withdrawal by Subject|17|||
160782970|NCT01928771|580590633|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
160782971|NCT01928771|580590634|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
160639611|NCT01625286|580063019|FG004|Overall Study|Death|0|||
160782972|NCT01928771|580590635|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
160782973|NCT01928771|580590633|FG000|Overall Study|Other Reasons|9|||
160782974|NCT01928771|580590634|FG001|Overall Study|Other Reasons|9|||
160782975|NCT01928771|580590635|FG002|Overall Study|Other Reasons|14|||
160782976|NCT01928771|580590633|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
160782977|NCT01928771|580590634|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
160782978|NCT01928771|580590635|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
160782979|NCT01937117|580590636|FG000|Overall Study|Disease Progression|7|||
160782980|NCT01937117|580590636|FG000|Overall Study|Physician Decision|4|||
160782981|NCT01937117|580590636|FG000|Overall Study|Adverse Event|2|||
160782982|NCT01407367|580590641|FG000|Overall Study|Death|24|||
160782983|NCT01407367|580590642|FG001|Overall Study|Death|32|||
160782984|NCT01407367|580590641|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
160782985|NCT01407367|580590642|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
160782986|NCT01407367|580590641|FG000|Overall Study|Withdrawal by Subject|4|||
160782987|NCT01407367|580590642|FG001|Overall Study|Withdrawal by Subject|15|||
160782988|NCT01407367|580590641|FG000|Overall Study|Lost to Follow-up|0|||
160782989|NCT01407367|580590642|FG001|Overall Study|Lost to Follow-up|2|||
160782990|NCT01695772|580590644|FG000|Overall Study|Withdrawal by Subject|18|||
160782991|NCT01695772|580590644|FG000|Overall Study|Progressive Disease|8|||
160782992|NCT01695772|580590644|FG000|Overall Study|Investigator Decision|5|||
160782993|NCT01695772|580590644|FG000|Overall Study|Lost to Follow-up|4|||
160782994|NCT01695772|580590644|FG000|Overall Study|Protocol Violation|2|||
160782995|NCT01695772|580590644|FG000|Overall Study|Unspecified Reason|1|||
160782996|NCT00004859|580590647|FG000|Overall Study|Lack of Efficacy|43|||
160782997|NCT00004859|580590648|FG001|Overall Study|Lack of Efficacy|113|||
160782998|NCT00004859|580590647|FG000|Overall Study|Adverse Event|31|||
160782999|NCT00004859|580590648|FG001|Overall Study|Adverse Event|93|||
160783000|NCT00004859|580590647|FG000|Overall Study|Death|5|||
160783001|NCT00004859|580590648|FG001|Overall Study|Death|5|||
160783002|NCT00004859|580590647|FG000|Overall Study|Withdrawal by Subject|7|||
160783003|NCT00004859|580590648|FG001|Overall Study|Withdrawal by Subject|33|||
160783004|NCT00004859|580590647|FG000|Overall Study|Protocol Violation|2|||
160783005|NCT00004859|580590648|FG001|Overall Study|Protocol Violation|2|||
160783006|NCT00004859|580590647|FG000|Overall Study|other disease|0|||
160783007|NCT00004859|580590648|FG001|Overall Study|other disease|3|||
160783008|NCT00004859|580590647|FG000|Overall Study|error|3|||
160783009|NCT00004859|580590648|FG001|Overall Study|error|1|||
160783010|NCT00004859|580590647|FG000|Overall Study|missing data|14|||
160783011|NCT00004859|580590648|FG001|Overall Study|missing data|11|||
160783012|NCT00004859|580590647|FG000|Overall Study|Other|13|||
160783013|NCT00004859|580590648|FG001|Overall Study|Other|21|||
160783014|NCT04073407|580590649|FG000|Part 1|Withdrawal by Subject|1|||
160783015|NCT04073407|580590650|FG001|Part 1|Withdrawal by Subject|0|||
160783016|NCT04073407|580590649|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
160783017|NCT04073407|580590650|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
160783018|NCT04073407|580590649|FG000|Part 2|Withdrawal by Subject|0|||
160783019|NCT04073407|580590650|FG001|Part 2|Withdrawal by Subject|1|||
160783020|NCT03882801|580592076|FG000|Period 1|Adverse Event|0|||
160783021|NCT03882801|580592077|FG001|Period 1|Adverse Event|1|||
160783022|NCT03882801|580592076|FG000|Period 1|Non-compliance with study drug|1|||
160783023|NCT03882801|580592077|FG001|Period 1|Non-compliance with study drug|1|||
160783024|NCT03882801|580592076|FG000|Period 1|Never treated with study drug|1|||
160783025|NCT03882801|580592077|FG001|Period 1|Never treated with study drug|0|||
160783026|NCT03882801|580592076|FG000|Washout Period|Physician Decision|0|||
160783027|NCT03882801|580592077|FG001|Washout Period|Physician Decision|1|||
160783028|NCT03882801|580592076|FG000|Period 2|Non-compliance with study drug|0|||
160783029|NCT03882801|580592077|FG001|Period 2|Non-compliance with study drug|1|||
160783030|NCT01793129|580592078|FG000|Overall Study|Lost to Follow-up|3|||
160783031|NCT01793129|580592079|FG001|Overall Study|Lost to Follow-up|7|||
160783032|NCT01793129|580592078|FG000|Overall Study|Withdrawal by Subject|0|||
160783033|NCT01793129|580592079|FG001|Overall Study|Withdrawal by Subject|2|||
160783034|NCT01567085|580592082|FG000|Overall Study|Death|6|||
160783035|NCT01567085|580592082|FG000|Overall Study|Adverse Event|6|||
160783036|NCT01567085|580592082|FG000|Overall Study|Lost to Follow-up|3|||
160783037|NCT01567085|580592082|FG000|Overall Study|Graft loss|2|||
160783038|NCT01567085|580592082|FG000|Overall Study|Renal transplantectomy|1|||
160783039|NCT01567085|580592082|FG000|Overall Study|Returned to chronic dialysis|1|||
160783040|NCT01567085|580592082|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
160783041|NCT04193176|580592083|FG000|Overall Study|Withdrawal by Subject|6|||
160783042|NCT04193176|580592084|FG001|Overall Study|Withdrawal by Subject|10|||
160783043|NCT00944645|580592085|FG000|Period 2|Adverse Event|1|||
160783044|NCT00944645|580592086|FG001|Period 2|Adverse Event|0|||
160783045|NCT00944645|580592085|FG000|Period 2|Lost to Follow-up|0|||
160783046|NCT00944645|580592086|FG001|Period 2|Lost to Follow-up|3|||
160783047|NCT00944645|580592085|FG000|Period 2|Withdrawal by Subject|7|||
160783048|NCT00944645|580592086|FG001|Period 2|Withdrawal by Subject|6|||
160783049|NCT03537729|580592090|FG000|Overall Study|Death|2|||
160783050|NCT03537729|580592091|FG001|Overall Study|Death|2|||
160783051|NCT03537729|580592092|FG002|Overall Study|Death|7|||
160783052|NCT03537729|580592090|FG000|Overall Study|Withdrawal by Subject|3|||
160783053|NCT03537729|580592091|FG001|Overall Study|Withdrawal by Subject|3|||
160783054|NCT03537729|580592092|FG002|Overall Study|Withdrawal by Subject|0|||
160639612|NCT01625286|580063020|FG005|Overall Study|Death|11|||
160639613|NCT01625286|580063021|FG006|Overall Study|Death|16|||
160639614|NCT01625286|580063015|FG000|Overall Study|Withdrawal by Subject|0|||
160639615|NCT01625286|580063016|FG001|Overall Study|Withdrawal by Subject|1|||
160639616|NCT01625286|580063017|FG002|Overall Study|Withdrawal by Subject|0|||
160639617|NCT01625286|580063018|FG003|Overall Study|Withdrawal by Subject|1|||
160639618|NCT01625286|580063019|FG004|Overall Study|Withdrawal by Subject|0|||
160639619|NCT01625286|580063020|FG005|Overall Study|Withdrawal by Subject|0|||
160639620|NCT01625286|580063021|FG006|Overall Study|Withdrawal by Subject|1|||
160639621|NCT01625286|580063015|FG000|Overall Study|Any reason not specifically recorded|0|||
160639622|NCT01625286|580063016|FG001|Overall Study|Any reason not specifically recorded|0|||
160639623|NCT01625286|580063017|FG002|Overall Study|Any reason not specifically recorded|0|||
160639624|NCT01625286|580063018|FG003|Overall Study|Any reason not specifically recorded|0|||
160783055|NCT03537729|580592090|FG000|Overall Study|Subject Moved|8|||
160542959|NCT03016325|579716418|FG007|Treatment Period|Participant withdrew consent|0|||
160542960|NCT03016325|579716411|FG000|Treatment Period|Death|0|||
160542961|NCT03016325|579716412|FG001|Treatment Period|Death|0|||
160542962|NCT03016325|579716413|FG002|Treatment Period|Death|0|||
160542963|NCT03016325|579716414|FG003|Treatment Period|Death|0|||
160542964|NCT03016325|579716415|FG004|Treatment Period|Death|2|||
160542965|NCT03016325|579716416|FG005|Treatment Period|Death|0|||
160542966|NCT03016325|579716417|FG006|Treatment Period|Death|0|||
160542967|NCT03016325|579716418|FG007|Treatment Period|Death|0|||
160783056|NCT03537729|580592091|FG001|Overall Study|Subject Moved|5|||
160783057|NCT03537729|580592092|FG002|Overall Study|Subject Moved|4|||
160783058|NCT03537729|580592090|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
160783059|NCT03537729|580592091|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
160783060|NCT03537729|580592092|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
160783061|NCT03537729|580592090|FG000|Overall Study|COVID-19 Site Restrictions|11|||
160783062|NCT03537729|580592091|FG001|Overall Study|COVID-19 Site Restrictions|15|||
160783063|NCT03537729|580592092|FG002|Overall Study|COVID-19 Site Restrictions|18|||
160783064|NCT03537729|580592090|FG000|Overall Study|Decline in Health|5|||
160783065|NCT03537729|580592091|FG001|Overall Study|Decline in Health|9|||
160783066|NCT03537729|580592092|FG002|Overall Study|Decline in Health|4|||
160783067|NCT03537729|580592090|FG000|Overall Study|Determined Ineligible|0|||
160783068|NCT03537729|580592091|FG001|Overall Study|Determined Ineligible|0|||
160783069|NCT03537729|580592092|FG002|Overall Study|Determined Ineligible|1|||
160783070|NCT01348698|580592098|FG000|Overall Study|Does not meet lesion size criteria|1|||
160783071|NCT01348698|580592098|FG000|Overall Study|Death|3|||
160783072|NCT01348698|580592098|FG000|Overall Study|PI decision to close study|68|||
160783073|NCT00504556|580592099|FG000|Overall Study|Adverse Event|11|||
160783074|NCT00504556|580592100|FG001|Overall Study|Adverse Event|11|||
160783075|NCT00504556|580592101|FG002|Overall Study|Adverse Event|14|||
160639625|NCT01625286|580063019|FG004|Overall Study|Any reason not specifically recorded|0|||
160639626|NCT01625286|580063020|FG005|Overall Study|Any reason not specifically recorded|1|||
160783076|NCT00504556|580592102|FG003|Overall Study|Adverse Event|13|||
160783077|NCT00504556|580592103|FG004|Overall Study|Adverse Event|5|||
160783078|NCT00504556|580592099|FG000|Overall Study|Death|3|||
160783079|NCT00504556|580592100|FG001|Overall Study|Death|3|||
160783080|NCT00504556|580592101|FG002|Overall Study|Death|1|||
160542968|NCT03016325|579716411|FG000|Treatment Period|Participant refuses assessments|0|||
160542969|NCT03016325|579716412|FG001|Treatment Period|Participant refuses assessments|0|||
160783081|NCT00504556|580592102|FG003|Overall Study|Death|0|||
160783082|NCT00504556|580592103|FG004|Overall Study|Death|2|||
160783083|NCT00504556|580592099|FG000|Overall Study|Protocol Violation|1|||
160783084|NCT00504556|580592100|FG001|Overall Study|Protocol Violation|3|||
160783085|NCT00504556|580592101|FG002|Overall Study|Protocol Violation|2|||
160783086|NCT00504556|580592102|FG003|Overall Study|Protocol Violation|1|||
160783087|NCT00504556|580592103|FG004|Overall Study|Protocol Violation|2|||
160783088|NCT00504556|580592099|FG000|Overall Study|Lost to Follow-up|0|||
160783089|NCT00504556|580592100|FG001|Overall Study|Lost to Follow-up|0|||
160783090|NCT00504556|580592101|FG002|Overall Study|Lost to Follow-up|1|||
160783091|NCT00504556|580592102|FG003|Overall Study|Lost to Follow-up|1|||
160783092|NCT00504556|580592103|FG004|Overall Study|Lost to Follow-up|1|||
160783093|NCT00504556|580592099|FG000|Overall Study|Withdrawal by Subject|16|||
160783094|NCT00504556|580592100|FG001|Overall Study|Withdrawal by Subject|16|||
160783095|NCT00504556|580592101|FG002|Overall Study|Withdrawal by Subject|7|||
160783096|NCT00504556|580592102|FG003|Overall Study|Withdrawal by Subject|8|||
160783097|NCT00504556|580592103|FG004|Overall Study|Withdrawal by Subject|12|||
160783098|NCT00504556|580592099|FG000|Overall Study|administrative reasons|0|||
160783099|NCT00504556|580592100|FG001|Overall Study|administrative reasons|2|||
160783100|NCT00504556|580592101|FG002|Overall Study|administrative reasons|2|||
160889997|NCT00424255|580991609|FG000|Overall Study|Withdrawal by Subject|34|||
160889998|NCT00424255|580991610|FG001|Overall Study|Withdrawal by Subject|38|||
160889999|NCT00424255|580991609|FG000|Overall Study|Physician Decision|3|||
160890000|NCT00424255|580991610|FG001|Overall Study|Physician Decision|7|||
160890001|NCT00424255|580991609|FG000|Overall Study|Cognitive Disturbance|1|||
160890002|NCT00424255|580991610|FG001|Overall Study|Cognitive Disturbance|0|||
160890003|NCT00424255|580991609|FG000|Overall Study|Non-compliance by Participants|1|||
160890004|NCT00424255|580991610|FG001|Overall Study|Non-compliance by Participants|0|||
160890005|NCT00424255|580991609|FG000|Overall Study|Fatigue|1|||
160890006|NCT00424255|580991610|FG001|Overall Study|Fatigue|0|||
160890007|NCT00424255|580991609|FG000|Overall Study|Disease Progression|0|||
160890008|NCT00424255|580991610|FG001|Overall Study|Disease Progression|2|||
160890009|NCT00424255|580991609|FG000|Overall Study|Sponsor Terminated Study|161|||
160890010|NCT00424255|580991610|FG001|Overall Study|Sponsor Terminated Study|167|||
160890011|NCT00256282|580991611|FG000|Overall Study|Disease progression, relapse during acti|12|||
160890012|NCT00256282|580991611|FG000|Overall Study|Adverse Event|3|||
160890013|NCT00256282|580991611|FG000|Overall Study|Physician Decision|1|||
160890014|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
160890015|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
160890016|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
160890017|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
160890018|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
160890019|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
160890020|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
160890021|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
160890022|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
160890023|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
160890024|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
160890025|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
160890026|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
160890027|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
160890028|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
160890029|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
160890030|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
160890031|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
160890032|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
160890033|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
160890034|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
160890035|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
160890036|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
160890037|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
160890038|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
160890039|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
160890040|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
160890041|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
160890042|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
160783101|NCT00504556|580592102|FG003|Overall Study|administrative reasons|1|||
160783102|NCT00504556|580592103|FG004|Overall Study|administrative reasons|2|||
160783103|NCT00504556|580592099|FG000|Overall Study|did not meet entry criteria|2|||
160783104|NCT00504556|580592100|FG001|Overall Study|did not meet entry criteria|0|||
160783105|NCT00504556|580592101|FG002|Overall Study|did not meet entry criteria|1|||
160783106|NCT00504556|580592102|FG003|Overall Study|did not meet entry criteria|1|||
160981587|NCT02018861|581321712|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981588|NCT02018861|581321713|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981589|NCT02018861|581321704|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981590|NCT02018861|581321705|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981591|NCT02018861|581321706|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981592|NCT02018861|581321707|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981593|NCT02018861|581321708|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981594|NCT02018861|581321709|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981595|NCT02018861|581321710|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
160981596|NCT02018861|581321711|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
160981597|NCT02018861|581321712|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981598|NCT02018861|581321713|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981599|NCT02018861|581321704|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981600|NCT02018861|581321705|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981601|NCT02018861|581321706|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981602|NCT02018861|581321707|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981603|NCT02018861|581321708|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981604|NCT02018861|581321709|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981605|NCT02018861|581321710|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981606|NCT02018861|581321711|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981607|NCT02018861|581321712|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
160981608|NCT02018861|581321713|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981609|NCT02018861|581321704|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160542970|NCT03016325|579716413|FG002|Treatment Period|Participant refuses assessments|1|||
160542971|NCT03016325|579716414|FG003|Treatment Period|Participant refuses assessments|0|||
160542972|NCT03016325|579716415|FG004|Treatment Period|Participant refuses assessments|0|||
160542973|NCT03016325|579716416|FG005|Treatment Period|Participant refuses assessments|0|||
160542974|NCT03016325|579716417|FG006|Treatment Period|Participant refuses assessments|0|||
160542975|NCT03016325|579716418|FG007|Treatment Period|Participant refuses assessments|0|||
160542976|NCT03016325|579716411|FG000|32-Day Follow-Up Period|Death|2|||
160542977|NCT03016325|579716412|FG001|32-Day Follow-Up Period|Death|0|||
160981610|NCT02018861|581321705|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981611|NCT02018861|581321706|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981612|NCT02018861|581321707|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981613|NCT02018861|581321708|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981614|NCT02018861|581321709|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981615|NCT02018861|581321710|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981616|NCT02018861|581321711|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981617|NCT02018861|581321712|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
160981618|NCT02018861|581321713|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981619|NCT02018861|581321704|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981620|NCT02018861|581321705|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981621|NCT02018861|581321706|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981622|NCT02018861|581321707|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981623|NCT02018861|581321708|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981624|NCT02018861|581321709|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981625|NCT02018861|581321710|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981626|NCT02018861|581321711|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981627|NCT02018861|581321712|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
160981628|NCT02018861|581321713|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981629|NCT00590980|581321721|FG000|Overall Study|Did not meet all inclusion criteria|10|||
160981630|NCT00504348|581321722|FG000|Overall Study|Adverse Event|3|||
160981631|NCT00504348|581321722|FG000|Overall Study|Lack of Efficacy|4|||
160981632|NCT00504348|581321722|FG000|Overall Study|Physician Decision|1|||
160981633|NCT00506285|581321725|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
160981634|NCT00506285|581321726|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
160981635|NCT00506285|581321725|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
160981636|NCT00506285|581321726|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
160981637|NCT00506285|581321725|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
160981638|NCT00506285|581321726|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
160981639|NCT00506285|581321725|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
160981640|NCT00506285|581321726|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
160981641|NCT00506285|581321725|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
160981642|NCT00506285|581321726|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
160981643|NCT00551213|581321729|FG000|Overall Study|Adverse Event|6|||
160542978|NCT03016325|579716413|FG002|32-Day Follow-Up Period|Death|5|||
160542979|NCT03016325|579716414|FG003|32-Day Follow-Up Period|Death|6|||
160542980|NCT03016325|579716415|FG004|32-Day Follow-Up Period|Death|3|||
160981644|NCT00551213|581321730|FG001|Overall Study|Adverse Event|3|||
160981645|NCT00551213|581321729|FG000|Overall Study|Progressive Disease|41|||
160981646|NCT00551213|581321730|FG001|Overall Study|Progressive Disease|12|||
160981647|NCT00551213|581321729|FG000|Overall Study|Withdrawal by Subject|2|||
160981648|NCT00551213|581321730|FG001|Overall Study|Withdrawal by Subject|0|||
160981649|NCT00551213|581321729|FG000|Overall Study|Not Treated|1|||
160981650|NCT00551213|581321730|FG001|Overall Study|Not Treated|2|||
160981651|NCT01890967|581321731|FG000|Overall Study|Adverse Event|3|||
160981652|NCT01890967|581321732|FG001|Overall Study|Adverse Event|3|||
160981653|NCT01890967|581321733|FG002|Overall Study|Adverse Event|3|||
160981654|NCT01890967|581321734|FG003|Overall Study|Adverse Event|2|||
160981655|NCT01890967|581321735|FG004|Overall Study|Adverse Event|1|||
160981656|NCT01890967|581321736|FG005|Overall Study|Adverse Event|7|||
160981657|NCT01890967|581321731|FG000|Overall Study|Death|1|||
160981658|NCT01890967|581321732|FG001|Overall Study|Death|0|||
160981659|NCT01890967|581321733|FG002|Overall Study|Death|0|||
160981660|NCT01890967|581321734|FG003|Overall Study|Death|0|||
160981661|NCT01890967|581321735|FG004|Overall Study|Death|0|||
160981662|NCT01890967|581321736|FG005|Overall Study|Death|0|||
160981663|NCT01890967|581321731|FG000|Overall Study|Lost to Follow-up|1|||
160981664|NCT01890967|581321732|FG001|Overall Study|Lost to Follow-up|1|||
160783107|NCT00504556|580592103|FG004|Overall Study|did not meet entry criteria|0|||
160783108|NCT00504556|580592099|FG000|Overall Study|data monitor committee decision|0|||
160981665|NCT01890967|581321733|FG002|Overall Study|Lost to Follow-up|1|||
160981666|NCT01890967|581321734|FG003|Overall Study|Lost to Follow-up|1|||
160981667|NCT01890967|581321735|FG004|Overall Study|Lost to Follow-up|0|||
160981668|NCT01890967|581321736|FG005|Overall Study|Lost to Follow-up|1|||
160981669|NCT01890967|581321731|FG000|Overall Study|Protocol Violation|0|||
160981670|NCT01890967|581321732|FG001|Overall Study|Protocol Violation|3|||
160783109|NCT00504556|580592100|FG001|Overall Study|data monitor committee decision|0|||
160783110|NCT00504556|580592101|FG002|Overall Study|data monitor committee decision|0|||
160783111|NCT00504556|580592102|FG003|Overall Study|data monitor committee decision|100|||
160783112|NCT00504556|580592103|FG004|Overall Study|data monitor committee decision|0|||
160783113|NCT00504556|580592099|FG000|Overall Study|Other|2|||
160783114|NCT00504556|580592100|FG001|Overall Study|Other|2|||
160783115|NCT00504556|580592101|FG002|Overall Study|Other|2|||
160783116|NCT00504556|580592102|FG003|Overall Study|Other|3|||
160783117|NCT00504556|580592103|FG004|Overall Study|Other|0|||
160783118|NCT00504556|580592099|FG000|Overall Study|not in safety analysis set|0|||
160783119|NCT00504556|580592100|FG001|Overall Study|not in safety analysis set|1|||
160783120|NCT00504556|580592101|FG002|Overall Study|not in safety analysis set|1|||
160783121|NCT00504556|580592102|FG003|Overall Study|not in safety analysis set|0|||
160783122|NCT00504556|580592103|FG004|Overall Study|not in safety analysis set|1|||
160783123|NCT03558672|580592104|FG000|Overall Study|Study Early Termination|10|||
160783124|NCT03607695|580592105|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
160783125|NCT03607695|580592105|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
160783126|NCT01027416|580592106|FG000|Overall Study|Withdrawal by Subject|0|||
160783127|NCT01027416|580592107|FG001|Overall Study|Withdrawal by Subject|1|||
160783128|NCT01027416|580592106|FG000|Overall Study|Physician Decision|1|||
160783129|NCT01027416|580592107|FG001|Overall Study|Physician Decision|4|||
160783130|NCT01560988|580592129|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
160783131|NCT01560988|580592130|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
160783132|NCT01560988|580592129|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
160783133|NCT01560988|580592130|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
160783134|NCT01560988|580592129|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
160783135|NCT01560988|580592130|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
160783136|NCT01441414|580592133|FG000|Overall Study|Participant died|9|||
160783137|NCT01441414|580592133|FG000|Overall Study|Other reasons|3|||
160783138|NCT01441414|580592133|FG000|Overall Study|Study terminated by sponsor|2|||
160783139|NCT01441414|580592133|FG000|Overall Study|Subject refused further follow-up|1|||
160783140|NCT00605657|580592134|FG000|Overall Study|Adverse Event|1|||
160783141|NCT00605657|580592134|FG000|Overall Study|Protocol Violation|1|||
160783142|NCT04535362|580592138|FG000|Overall Study|Lost to Follow-up|3|||
160981671|NCT01890967|581321733|FG002|Overall Study|Protocol Violation|3|||
160981672|NCT01890967|581321734|FG003|Overall Study|Protocol Violation|2|||
160981673|NCT01890967|581321735|FG004|Overall Study|Protocol Violation|4|||
160981674|NCT01890967|581321736|FG005|Overall Study|Protocol Violation|1|||
160981675|NCT01890967|581321731|FG000|Overall Study|Sponsor Decision|2|||
160981676|NCT01890967|581321732|FG001|Overall Study|Sponsor Decision|0|||
160783143|NCT04535362|580592139|FG001|Overall Study|Lost to Follow-up|1|||
160783144|NCT02018887|580592147|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
160783145|NCT02018887|580592148|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783146|NCT02018887|580592149|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783147|NCT02018887|580592150|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783148|NCT02018887|580592151|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783149|NCT02018887|580592152|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783150|NCT02018887|580592153|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783151|NCT02018887|580592154|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783152|NCT02018887|580592155|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783153|NCT02018887|580592156|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783154|NCT02018887|580592157|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783155|NCT02018887|580592147|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783156|NCT02018887|580592148|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783157|NCT02018887|580592149|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783158|NCT02018887|580592150|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783159|NCT02018887|580592151|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
160783160|NCT02018887|580592152|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783161|NCT02018887|580592153|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
160783162|NCT02018887|580592154|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
160783163|NCT02018887|580592155|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783164|NCT02018887|580592156|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783165|NCT02018887|580592157|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783166|NCT02018887|580592147|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
160783167|NCT02018887|580592148|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
160783168|NCT02018887|580592149|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
160783169|NCT02018887|580592150|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
160783170|NCT02018887|580592151|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
160783171|NCT02018887|580592152|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
160783172|NCT02018887|580592153|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
160783173|NCT02018887|580592154|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
160783174|NCT02018887|580592155|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
160783175|NCT02018887|580592156|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
160783176|NCT02018887|580592157|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
160783177|NCT02018887|580592147|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
160783178|NCT02018887|580592148|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
160783179|NCT02018887|580592149|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
160783180|NCT02018887|580592150|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
160783181|NCT02018887|580592151|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
160783182|NCT02018887|580592152|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
160783183|NCT02018887|580592153|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
160783184|NCT02018887|580592154|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
160783185|NCT02018887|580592155|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
160783186|NCT02018887|580592156|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
160783187|NCT02018887|580592157|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
160783188|NCT01058005|580592158|FG000|Overall Study|Adverse Event|0|||
160783189|NCT01058005|580592159|FG001|Overall Study|Adverse Event|2|||
160783190|NCT01058005|580592160|FG002|Overall Study|Adverse Event|1|||
160783191|NCT01058005|580592158|FG000|Overall Study|Physician Decision|2|||
160783192|NCT01058005|580592159|FG001|Overall Study|Physician Decision|2|||
160783193|NCT01058005|580592160|FG002|Overall Study|Physician Decision|0|||
160783194|NCT01058005|580592158|FG000|Overall Study|Withdrawal by Subject|4|||
160783195|NCT01058005|580592159|FG001|Overall Study|Withdrawal by Subject|5|||
160783196|NCT01058005|580592160|FG002|Overall Study|Withdrawal by Subject|11|||
160783197|NCT01058005|580592158|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
160783198|NCT01058005|580592159|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
160783199|NCT01058005|580592160|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
160783200|NCT01058005|580592158|FG000|Overall Study|Reason Missing|5|||
160783201|NCT01058005|580592159|FG001|Overall Study|Reason Missing|3|||
160783202|NCT01058005|580592160|FG002|Overall Study|Reason Missing|1|||
160783203|NCT02460380|580592165|FG000|Overall Study|Withdrawal by Subject|10|||
160783204|NCT02460380|580592166|FG001|Overall Study|Withdrawal by Subject|5|||
160783205|NCT00052715|580592176|FG000|Overall Study|wrong histology|1|||
160783206|NCT01936974|580592177|FG000|Overall Study|Physician Decision|2|||
160783207|NCT01936974|580592178|FG001|Overall Study|Physician Decision|5|||
160783208|NCT00063999|580592179|FG000|Overall Study|Withdrawal by Subject|1|||
160783209|NCT00063999|580592180|FG001|Overall Study|Withdrawal by Subject|0|||
160783210|NCT00063999|580592179|FG000|Overall Study|Ineligible|44|||
160783211|NCT00063999|580592180|FG001|Overall Study|Ineligible|24|||
160783212|NCT02497755|580592185|FG000|Overall Study|Protocol Violation|1|||
160783213|NCT02497755|580592186|FG001|Overall Study|Protocol Violation|0|||
160783214|NCT04560309|580592197|FG000|Overall Study|Meet drop out criteria|1|||
160783215|NCT04560309|580592198|FG001|Overall Study|Meet drop out criteria|1|||
160783216|NCT01860404|580592199|FG000|Overall Study|Lost to Follow-up|3|||
160783217|NCT01860404|580592200|FG001|Overall Study|Lost to Follow-up|4|||
160783218|NCT01860404|580592201|FG002|Overall Study|Lost to Follow-up|1|||
160783219|NCT01860404|580592202|FG003|Overall Study|Lost to Follow-up|6|||
160783220|NCT01860404|580592203|FG004|Overall Study|Lost to Follow-up|4|||
160783221|NCT01860404|580592199|FG000|Overall Study|Withdrawal by Subject|0|||
160783222|NCT01860404|580592200|FG001|Overall Study|Withdrawal by Subject|0|||
160783223|NCT01860404|580592201|FG002|Overall Study|Withdrawal by Subject|4|||
160783224|NCT01860404|580592202|FG003|Overall Study|Withdrawal by Subject|0|||
160783225|NCT01860404|580592203|FG004|Overall Study|Withdrawal by Subject|0|||
160783226|NCT00356421|580592205|FG000|Overall Study|Lack of Efficacy|3|||
160783227|NCT00356421|580592206|FG001|Overall Study|Lack of Efficacy|0|||
160783228|NCT00356421|580592205|FG000|Overall Study|Withdrawal by Subject|9|||
160783229|NCT00356421|580592206|FG001|Overall Study|Withdrawal by Subject|2|||
160783230|NCT00356421|580592205|FG000|Overall Study|Related to study drug|15|||
160783231|NCT00356421|580592206|FG001|Overall Study|Related to study drug|12|||
160783232|NCT00356421|580592205|FG000|Overall Study|Not related to study drug|5|||
160783233|NCT00356421|580592206|FG001|Overall Study|Not related to study drug|3|||
160783234|NCT04689009|580592207|FG000|Overall Study|Adverse Event|1|||
160783235|NCT04689009|580592208|FG001|Overall Study|Adverse Event|0|||
160783236|NCT04689009|580592207|FG000|Overall Study|Lost to Follow-up|1|||
160783237|NCT04689009|580592208|FG001|Overall Study|Lost to Follow-up|2|||
160783238|NCT04689009|580592207|FG000|Overall Study|Withdrawal by Subject|4|||
160783239|NCT04689009|580592208|FG001|Overall Study|Withdrawal by Subject|3|||
160783240|NCT04689009|580592207|FG000|Overall Study|Protocol Violation|1|||
160783241|NCT04689009|580592208|FG001|Overall Study|Protocol Violation|0|||
160783242|NCT03462563|580592211|FG000|Overall Study|Death|1|||
160783243|NCT03462563|580592212|FG001|Overall Study|Death|1|||
160783244|NCT03462563|580592211|FG000|Overall Study|Termination of study|2|||
160783245|NCT03462563|580592212|FG001|Overall Study|Termination of study|1|||
160783246|NCT03462563|580592211|FG000|Overall Study|Adverse Event|1|||
160783247|NCT03462563|580592212|FG001|Overall Study|Adverse Event|3|||
160783248|NCT03462563|580592211|FG000|Overall Study|Unspecified reason|10|||
160783249|NCT03462563|580592212|FG001|Overall Study|Unspecified reason|12|||
160783250|NCT03462563|580592211|FG000|Overall Study|Physician Decision|1|||
160783251|NCT03462563|580592212|FG001|Overall Study|Physician Decision|0|||
160783252|NCT05089357|580592213|FG000|Overall Study|Withdrawal by Subject|23|||
160783253|NCT05089357|580592213|FG000|Overall Study|Lost to Follow-up|6|||
160783254|NCT05089357|580592213|FG000|Overall Study|Medical reason|1|||
160783255|NCT05089357|580592213|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
160783256|NCT05089357|580592213|FG000|Overall Study|Pregnancy|2|||
160783257|NCT02021318|580592214|FG000|Overall Study|Adverse Event|2|||
160783258|NCT02021318|580592215|FG001|Overall Study|Adverse Event|1|||
160783259|NCT02021318|580592214|FG000|Overall Study|Death|33|||
160783260|NCT02021318|580592215|FG001|Overall Study|Death|34|||
160783261|NCT02021318|580592214|FG000|Overall Study|Lost to Follow-up|3|||
160783262|NCT02021318|580592215|FG001|Overall Study|Lost to Follow-up|3|||
160783263|NCT02021318|580592214|FG000|Overall Study|Progressive Disease|0|||
160783264|NCT02021318|580592215|FG001|Overall Study|Progressive Disease|1|||
160783265|NCT02021318|580592214|FG000|Overall Study|Withdrawal by Subject|30|||
160542981|NCT03016325|579716416|FG005|32-Day Follow-Up Period|Death|0|||
160542982|NCT03016325|579716417|FG006|32-Day Follow-Up Period|Death|0|||
160542983|NCT03016325|579716418|FG007|32-Day Follow-Up Period|Death|0|||
160542984|NCT03016325|579716411|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
160542985|NCT03016325|579716412|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
160542986|NCT03016325|579716413|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
160542987|NCT03016325|579716414|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
160542988|NCT03016325|579716415|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
160783266|NCT02021318|580592215|FG001|Overall Study|Withdrawal by Subject|18|||
160783267|NCT02021318|580592214|FG000|Overall Study|Physician Decision|3|||
160783268|NCT02021318|580592215|FG001|Overall Study|Physician Decision|3|||
160783269|NCT02021318|580592214|FG000|Overall Study|Miscellaneous|2|||
160783270|NCT02021318|580592215|FG001|Overall Study|Miscellaneous|3|||
160783271|NCT04796207|580592216|FG000|Overall Study|Lost to Follow-up|7|||
160783272|NCT04796207|580592217|FG001|Overall Study|Lost to Follow-up|2|||
160542989|NCT03016325|579716416|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
160783273|NCT01860989|580592220|FG000|Overall Study|Unsatisfactory therapeutic|5|||
160542990|NCT03016325|579716417|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
160542991|NCT03016325|579716418|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
160783274|NCT04739709|580592223|FG000|Overall Study|Physician Decision|1|||
160783275|NCT04739709|580592224|FG001|Overall Study|Physician Decision|0|||
160783276|NCT03003468|580592225|FG000|Overall Study|Withdrawal by Subject|0|||
160783277|NCT03003468|580592226|FG001|Overall Study|Withdrawal by Subject|0|||
160783278|NCT03003468|580592227|FG002|Overall Study|Withdrawal by Subject|1|||
160783279|NCT03003468|580592225|FG000|Overall Study|No measurable lesions|0|||
160783280|NCT03003468|580592226|FG001|Overall Study|No measurable lesions|0|||
160783281|NCT03003468|580592227|FG002|Overall Study|No measurable lesions|1|||
160783282|NCT00421993|580592230|FG000|Overall Study|Withdrawal by Subject|22|||
160783283|NCT00421993|580592231|FG001|Overall Study|Withdrawal by Subject|23|||
160783284|NCT00421993|580592232|FG002|Overall Study|Withdrawal by Subject|23|||
160783285|NCT00421993|580592233|FG003|Overall Study|Withdrawal by Subject|24|||
160783286|NCT00421993|580592230|FG000|Overall Study|Lost to Follow-up|18|||
160783287|NCT00421993|580592231|FG001|Overall Study|Lost to Follow-up|19|||
160783288|NCT00421993|580592232|FG002|Overall Study|Lost to Follow-up|22|||
160783289|NCT00421993|580592233|FG003|Overall Study|Lost to Follow-up|20|||
160783290|NCT00421993|580592230|FG000|Overall Study|Adverse Event|11|||
160783291|NCT00421993|580592231|FG001|Overall Study|Adverse Event|1|||
160783292|NCT00421993|580592232|FG002|Overall Study|Adverse Event|6|||
160783293|NCT00421993|580592233|FG003|Overall Study|Adverse Event|4|||
160783294|NCT00421993|580592230|FG000|Overall Study|Protocol Violation|2|||
160783295|NCT00421993|580592231|FG001|Overall Study|Protocol Violation|2|||
160783296|NCT00421993|580592232|FG002|Overall Study|Protocol Violation|0|||
160783297|NCT00421993|580592233|FG003|Overall Study|Protocol Violation|1|||
160783298|NCT00421993|580592230|FG000|Overall Study|Lack of Efficacy|0|||
160783299|NCT00421993|580592231|FG001|Overall Study|Lack of Efficacy|3|||
160783300|NCT00421993|580592232|FG002|Overall Study|Lack of Efficacy|0|||
160783301|NCT00421993|580592233|FG003|Overall Study|Lack of Efficacy|5|||
160783302|NCT00421993|580592230|FG000|Overall Study|Pregnancy|0|||
160783303|NCT00421993|580592231|FG001|Overall Study|Pregnancy|1|||
160783304|NCT00421993|580592232|FG002|Overall Study|Pregnancy|1|||
160783305|NCT00421993|580592233|FG003|Overall Study|Pregnancy|2|||
160783306|NCT00421993|580592230|FG000|Overall Study|Subject transportation issues|0|||
160783307|NCT00421993|580592231|FG001|Overall Study|Subject transportation issues|0|||
160783308|NCT00421993|580592232|FG002|Overall Study|Subject transportation issues|0|||
160783309|NCT00421993|580592233|FG003|Overall Study|Subject transportation issues|1|||
160783310|NCT01751685|580592235|FG000|6-mo Followup|Missed study visit|1|||
160783311|NCT01751685|580592236|FG001|6-mo Followup|Missed study visit|0|||
160783312|NCT01751685|580592235|FG000|6-mo Followup|Withdrawal by Subject|2|||
160783313|NCT01751685|580592236|FG001|6-mo Followup|Withdrawal by Subject|2|||
160783314|NCT01751685|580592235|FG000|6-mo Followup|Lost to Follow-up|0|||
160783315|NCT01751685|580592236|FG001|6-mo Followup|Lost to Follow-up|1|||
160783316|NCT01751685|580592235|FG000|12-mo Followup|Lost to Follow-up|5|||
160783317|NCT01751685|580592236|FG001|12-mo Followup|Lost to Follow-up|0|||
160783318|NCT03020888|580592241|FG000|Overall Study|Physician Decision|4|||
160783319|NCT03020888|580592241|FG000|Overall Study|Withdrawal by Subject|6|||
160783320|NCT03020888|580592241|FG000|Overall Study|Insurance coverage|2|||
160783321|NCT03020888|580592241|FG000|Overall Study|Lost to Follow-up|1|||
160783322|NCT00284934|580594196|FG000|Overall Study|Adverse Event|1|||
160783323|NCT00284934|580594197|FG001|Overall Study|Adverse Event|2|||
160783324|NCT00284934|580594196|FG000|Overall Study|Other reasons|3|||
160783325|NCT00284934|580594197|FG001|Overall Study|Other reasons|1|||
160783326|NCT00454142|580594198|FG000|Overall Study|Withdrawal by Subject|1|||
160783327|NCT01245751|580594199|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
160783328|NCT01245751|580594200|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
160783329|NCT01245751|580594201|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
160783330|NCT01245751|580594202|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
160783331|NCT01245751|580594199|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
160783332|NCT01245751|580594200|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
160783333|NCT01245751|580594201|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
160783334|NCT01245751|580594202|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
160783335|NCT01245751|580594199|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
160783336|NCT01245751|580594200|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
160783337|NCT01245751|580594201|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
160783338|NCT01245751|580594202|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
160783339|NCT01783015|580594205|FG000|Blinded Treatment|Adverse Event|0|||
160783340|NCT01783015|580594206|FG001|Blinded Treatment|Adverse Event|1|||
160783341|NCT01783015|580594207|FG002|Blinded Treatment|Adverse Event|0|||
160783342|NCT01783015|580594205|FG000|Blinded Treatment|Protocol Violation|0|||
160783343|NCT01783015|580594206|FG001|Blinded Treatment|Protocol Violation|1|||
160783344|NCT01783015|580594207|FG002|Blinded Treatment|Protocol Violation|0|||
160783345|NCT01783015|580594205|FG000|Blinded Treatment|Withdrawal by Subject|0|||
160783346|NCT01783015|580594206|FG001|Blinded Treatment|Withdrawal by Subject|1|||
160783347|NCT01783015|580594207|FG002|Blinded Treatment|Withdrawal by Subject|0|||
160783348|NCT01783015|580594205|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
160783349|NCT01783015|580594206|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
160783350|NCT01783015|580594207|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
160639627|NCT01625286|580063021|FG006|Overall Study|Any reason not specifically recorded|0|||
160639628|NCT01625286|580063015|FG000|Overall Study|Progressive disease|6|||
160639629|NCT01625286|580063016|FG001|Overall Study|Progressive disease|3|||
160639630|NCT01625286|580063017|FG002|Overall Study|Progressive disease|4|||
160639631|NCT01625286|580063018|FG003|Overall Study|Progressive disease|5|||
160639632|NCT01625286|580063019|FG004|Overall Study|Progressive disease|5|||
160639633|NCT01625286|580063020|FG005|Overall Study|Progressive disease|0|||
160639634|NCT01625286|580063021|FG006|Overall Study|Progressive disease|0|||
160639635|NCT01625286|580063015|FG000|Overall Study|Lost to Follow-up|0|||
160639636|NCT01625286|580063016|FG001|Overall Study|Lost to Follow-up|0|||
160639637|NCT01625286|580063017|FG002|Overall Study|Lost to Follow-up|0|||
160639638|NCT01625286|580063018|FG003|Overall Study|Lost to Follow-up|0|||
160639639|NCT01625286|580063019|FG004|Overall Study|Lost to Follow-up|0|||
160639640|NCT01625286|580063020|FG005|Overall Study|Lost to Follow-up|0|||
160639641|NCT01625286|580063021|FG006|Overall Study|Lost to Follow-up|1|||
160639642|NCT00928135|580063022|FG000|Overall Study|Withdrawal by Subject|1|||
160639643|NCT00928135|580063023|FG001|Overall Study|Withdrawal by Subject|0|||
160639644|NCT04355767|580063024|FG000|Overall Study|Withdrawal by Subject|2|||
160639645|NCT04355767|580063025|FG001|Overall Study|Withdrawal by Subject|2|||
160639646|NCT04355767|580063024|FG000|Overall Study|Death|5|||
160639647|NCT04355767|580063025|FG001|Overall Study|Death|1|||
160639648|NCT01999322|580063026|FG000|Overall Study|Adverse Event|1|||
160639649|NCT01999322|580063027|FG001|Overall Study|Adverse Event|0|||
160639650|NCT04523831|580063036|FG000|Overall Study|Lost to Follow-up|15|||
160639651|NCT04523831|580063037|FG001|Overall Study|Lost to Follow-up|17|||
160639652|NCT04523831|580063036|FG000|Overall Study|Death|0|||
160639653|NCT04523831|580063037|FG001|Overall Study|Death|3|||
160639654|NCT04523831|580063036|FG000|Overall Study|Adverse Event|2|||
160639655|NCT04523831|580063037|FG001|Overall Study|Adverse Event|0|||
160639656|NCT04242186|580064479|FG000|Overall Study|Death|5|||
160639657|NCT00550420|580064481|FG000|Overall Study|Adverse Event|28|||
160639658|NCT00550420|580064481|FG000|Overall Study|Lost to Follow-up|8|||
160639659|NCT00550420|580064481|FG000|Overall Study|Protocol Violation|11|||
160639660|NCT00550420|580064481|FG000|Overall Study|Withdrawal by Subject|30|||
160639661|NCT00550420|580064481|FG000|Overall Study|Still in study at termination|206|||
160639662|NCT00550420|580064481|FG000|Overall Study|Missing|2|||
160639663|NCT00550420|580064481|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
160639664|NCT00550420|580064481|FG000|Overall Study|Investigators opinion|1|||
160783351|NCT01783015|580594205|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
160890043|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
160639665|NCT00550420|580064481|FG000|Overall Study|Lack of curative effect|1|||
160639666|NCT00550420|580064481|FG000|Overall Study|Unethical stop of enrollment|2|||
160639667|NCT00550420|580064481|FG000|Overall Study|Caregiver's decision to withdraw|1|||
160639668|NCT00550420|580064481|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
160639669|NCT00550420|580064481|FG000|Overall Study|Exclusion criteria|1|||
160639670|NCT00550420|580064481|FG000|Overall Study|Prohibited medicine|1|||
160639671|NCT00782275|580064482|FG000|Overall Study|Adverse Event|11|||
160639672|NCT00782275|580064482|FG000|Overall Study|Withdrawal by Subject|1|||
160639673|NCT00782275|580064482|FG000|Overall Study|Progressive Disease|21|||
160639674|NCT00782275|580064482|FG000|Overall Study|Physician Decision|4|||
160639675|NCT00782275|580064482|FG000|Overall Study|Not started treatment|1|||
160639676|NCT00782275|580064482|FG000|Overall Study|Other|3|||
160639677|NCT04378010|580064483|FG000|Overall Study|Adverse Event|8|||
160639678|NCT04378010|580064484|FG001|Overall Study|Adverse Event|14|||
160639679|NCT04378010|580064485|FG002|Overall Study|Adverse Event|4|||
160639680|NCT04378010|580064483|FG000|Overall Study|Withdrawal by Subject|0|||
160639681|NCT04378010|580064484|FG001|Overall Study|Withdrawal by Subject|2|||
160639682|NCT04378010|580064485|FG002|Overall Study|Withdrawal by Subject|1|||
160639683|NCT04378010|580064483|FG000|Overall Study|Protocol Violation|2|||
160639684|NCT04378010|580064484|FG001|Overall Study|Protocol Violation|1|||
160639685|NCT04378010|580064485|FG002|Overall Study|Protocol Violation|4|||
160639686|NCT04378010|580064483|FG000|Overall Study|Study terminated by Sponsor|22|||
160639687|NCT04378010|580064484|FG001|Overall Study|Study terminated by Sponsor|16|||
160639688|NCT04378010|580064485|FG002|Overall Study|Study terminated by Sponsor|22|||
160639689|NCT04378010|580064483|FG000|Overall Study|Subject inability to complete study visit|0|||
160639690|NCT04378010|580064484|FG001|Overall Study|Subject inability to complete study visit|0|||
160783352|NCT01783015|580594206|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
160783353|NCT01783015|580594207|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
160783354|NCT02741193|580594208|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
160783355|NCT02741193|580594208|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
160783356|NCT00585169|580594209|FG000|Overall Study|Withdrawal by Subject|1|||
160783357|NCT02391584|580594213|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
160783358|NCT02391584|580594214|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
160783359|NCT02391584|580594213|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
160783360|NCT02391584|580594214|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
160783361|NCT02391584|580594213|FG000|3 Month|Lost to Follow-up|1|||
160783362|NCT02391584|580594214|FG001|3 Month|Lost to Follow-up|0|||
160783363|NCT02391584|580594213|FG000|6 Month|Withdrawal by Subject|1|||
160783364|NCT02391584|580594214|FG001|6 Month|Withdrawal by Subject|0|||
160783365|NCT02391584|580594213|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
160783366|NCT02391584|580594214|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
160783367|NCT01093885|580594215|FG000|Overall Study|Adverse Event|4|||
160783368|NCT01093885|580594215|FG000|Overall Study|Lost to Follow-up|1|||
160783369|NCT00292370|580594220|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
160783370|NCT00292370|580594221|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
160783371|NCT00292370|580594222|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
160783372|NCT00292370|580594220|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
160783373|NCT00292370|580594221|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
160783374|NCT00292370|580594222|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
160783375|NCT00292370|580594220|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
160783376|NCT00292370|580594221|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
160783377|NCT00292370|580594222|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
160783378|NCT00292370|580594220|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
160783379|NCT00292370|580594221|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
160783380|NCT00292370|580594222|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
160783381|NCT00292370|580594220|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
160783382|NCT00292370|580594221|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
160783383|NCT00292370|580594222|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
160783384|NCT00292370|580594220|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
160783385|NCT00292370|580594221|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
160783386|NCT00292370|580594222|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
160783387|NCT01301001|580594223|FG000|First Intervention|Lost to Follow-up|4|||
160783388|NCT01301001|580594224|FG001|First Intervention|Lost to Follow-up|4|||
160783389|NCT01301001|580594223|FG000|First Intervention|Withdrawal by Subject|1|||
160783390|NCT01301001|580594224|FG001|First Intervention|Withdrawal by Subject|4|||
160783391|NCT01301001|580594223|FG000|First Intervention|Adverse Event|5|||
160783392|NCT01301001|580594224|FG001|First Intervention|Adverse Event|0|||
160783393|NCT01301001|580594223|FG000|First Intervention|Protocol Violation|0|||
160783394|NCT01301001|580594224|FG001|First Intervention|Protocol Violation|1|||
160783395|NCT01301001|580594223|FG000|Second Intervention|Adverse Event|2|||
160783396|NCT01301001|580594224|FG001|Second Intervention|Adverse Event|0|||
160783397|NCT01301001|580594223|FG000|Second Intervention|Withdrawal by Subject|2|||
160783398|NCT01301001|580594224|FG001|Second Intervention|Withdrawal by Subject|0|||
160783399|NCT00500110|580594227|FG000|Overall Study|Withdrawal by Subject|3|||
160783400|NCT02619812|580594232|FG000|Overall Study|Withdrawal by Subject|0|||
160783401|NCT02619812|580594233|FG001|Overall Study|Withdrawal by Subject|0|||
160783402|NCT02619812|580594234|FG002|Overall Study|Withdrawal by Subject|1|||
160783403|NCT02619812|580594235|FG003|Overall Study|Withdrawal by Subject|2|||
160783404|NCT04865978|580594236|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
160783405|NCT04865978|580594237|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
160783406|NCT05587998|580594238|FG000|Overall Study|Withdrawal by Subject|1|||
160783407|NCT05587998|580594239|FG001|Overall Study|Withdrawal by Subject|1|||
160783408|NCT05587998|580594238|FG000|Overall Study|Not treated|3|||
160783409|NCT05587998|580594239|FG001|Overall Study|Not treated|1|||
160783410|NCT05587998|580594238|FG000|Overall Study|Non-compliance with study procedures|0|||
160783411|NCT05587998|580594239|FG001|Overall Study|Non-compliance with study procedures|1|||
160783412|NCT04882215|580594240|FG000|Overall Study|Withdrawal by Subject|5|||
160783413|NCT04882215|580594241|FG001|Overall Study|Withdrawal by Subject|0|||
160783414|NCT04263532|580594242|FG000|Overall Study|Withdrawal by Subject|2|||
160783415|NCT04263532|580594243|FG001|Overall Study|Withdrawal by Subject|0|||
160783416|NCT06083493|580594244|FG000|Overall Study|Technical issues with the interventional device|2|||
160783417|NCT06083493|580594245|FG001|Overall Study|Technical issues with the interventional device|2|||
160783418|NCT06083493|580594244|FG000|Overall Study|Performed incorrect visual task|1|||
160783419|NCT06083493|580594245|FG001|Overall Study|Performed incorrect visual task|0|||
160783420|NCT06083493|580594244|FG000|Overall Study|Insufficient baseline performance|0|||
160783421|NCT06083493|580594245|FG001|Overall Study|Insufficient baseline performance|1|||
160981677|NCT01890967|581321733|FG002|Overall Study|Sponsor Decision|1|||
160783422|NCT04098302|580594248|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
160783423|NCT04098302|580594249|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
160783424|NCT04098302|580594250|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
160783425|NCT04098302|580594251|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
160783426|NCT04098302|580594248|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
160783427|NCT04098302|580594249|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
160783428|NCT04098302|580594250|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
160783429|NCT04098302|580594251|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
160783430|NCT04098302|580594248|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
160783431|NCT04098302|580594249|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
160783432|NCT04098302|580594250|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
160783433|NCT04098302|580594251|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
160783434|NCT04098302|580594248|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
160783435|NCT04098302|580594249|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
160783436|NCT04098302|580594250|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
160783437|NCT04098302|580594251|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
160783438|NCT04098302|580594248|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
160783439|NCT04098302|580594249|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
160783440|NCT04098302|580594250|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
160783441|NCT04098302|580594251|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
160783442|NCT04098302|580594248|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
160783443|NCT04098302|580594249|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
160783444|NCT04098302|580594250|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
160783445|NCT04098302|580594251|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
160783446|NCT04098302|580594248|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
160783447|NCT04098302|580594249|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
160783448|NCT04098302|580594250|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
160783449|NCT04098302|580594251|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
160783450|NCT04098302|580594248|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
160783451|NCT04098302|580594249|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
160783452|NCT04098302|580594250|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
160783453|NCT04098302|580594251|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
160783454|NCT05061706|580594252|FG000|Overall Study|Adverse Event|29|||
160783455|NCT05061706|580594253|FG001|Overall Study|Adverse Event|1|||
160783456|NCT05061706|580594252|FG000|Overall Study|Lack of Efficacy|0|||
160783457|NCT05061706|580594253|FG001|Overall Study|Lack of Efficacy|1|||
160783458|NCT05061706|580594252|FG000|Overall Study|Lost to Follow-up|2|||
160783459|NCT05061706|580594253|FG001|Overall Study|Lost to Follow-up|2|||
160783460|NCT05061706|580594252|FG000|Overall Study|Protocol Violation|3|||
160783461|NCT05061706|580594253|FG001|Overall Study|Protocol Violation|1|||
160783462|NCT05061706|580594252|FG000|Overall Study|Withdrawal by Subject|3|||
160783463|NCT05061706|580594253|FG001|Overall Study|Withdrawal by Subject|9|||
160783464|NCT00191152|580594254|FG000|Initial Treatment|Adverse Event|43|||
160783465|NCT00191152|580594255|FG001|Initial Treatment|Adverse Event|67|||
160783466|NCT00191152|580594254|FG000|Initial Treatment|Physician Decision|40|||
160783467|NCT00191152|580594255|FG001|Initial Treatment|Physician Decision|31|||
160783468|NCT00191152|580594254|FG000|Initial Treatment|Withdrawal by Subject|40|||
160783469|NCT00191152|580594255|FG001|Initial Treatment|Withdrawal by Subject|28|||
160981678|NCT01890967|581321734|FG003|Overall Study|Sponsor Decision|3|||
160981679|NCT01890967|581321735|FG004|Overall Study|Sponsor Decision|2|||
160981680|NCT01890967|581321736|FG005|Overall Study|Sponsor Decision|3|||
160981681|NCT01890967|581321731|FG000|Overall Study|Withdrawal by Subject|3|||
160981682|NCT01890967|581321732|FG001|Overall Study|Withdrawal by Subject|4|||
160981683|NCT01890967|581321733|FG002|Overall Study|Withdrawal by Subject|2|||
160981684|NCT01890967|581321734|FG003|Overall Study|Withdrawal by Subject|3|||
160981685|NCT01890967|581321735|FG004|Overall Study|Withdrawal by Subject|3|||
160981686|NCT01890967|581321736|FG005|Overall Study|Withdrawal by Subject|1|||
160981687|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
160981688|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
160981689|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
160981690|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
160981691|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
160542992|NCT03016325|579716411|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
160783470|NCT00191152|580594254|FG000|Initial Treatment|Lost to Follow-up|0|||
160783471|NCT00191152|580594255|FG001|Initial Treatment|Lost to Follow-up|6|||
160783472|NCT00191152|580594254|FG000|Initial Treatment|Other|18|||
160783473|NCT00191152|580594255|FG001|Initial Treatment|Other|21|||
160783474|NCT00191152|580594254|FG000|Crossover Treatment|Adverse Event|8|||
160783475|NCT00191152|580594255|FG001|Crossover Treatment|Adverse Event|8|||
160783476|NCT00191152|580594254|FG000|Crossover Treatment|Physician Decision|7|||
160783477|NCT00191152|580594255|FG001|Crossover Treatment|Physician Decision|7|||
160783478|NCT00191152|580594254|FG000|Crossover Treatment|Withdrawal by Subject|6|||
160783479|NCT00191152|580594255|FG001|Crossover Treatment|Withdrawal by Subject|9|||
160783480|NCT00191152|580594254|FG000|Crossover Treatment|Lost to Follow-up|2|||
160783481|NCT00191152|580594255|FG001|Crossover Treatment|Lost to Follow-up|1|||
160783482|NCT00191152|580594254|FG000|Crossover Treatment|Other|4|||
160783483|NCT00191152|580594255|FG001|Crossover Treatment|Other|3|||
160783484|NCT00114777|580594256|FG000|Randomization to Month 36|Death|10|||
160783485|NCT00114777|580594257|FG001|Randomization to Month 36|Death|4|||
160783486|NCT00114777|580594258|FG002|Randomization to Month 36|Death|3|||
160783487|NCT00114777|580594256|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
160783488|NCT00114777|580594257|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
160783489|NCT00114777|580594258|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
160783490|NCT00114777|580594256|FG000|Randomization to Month 36|Lack of Efficacy|19|||
160783491|NCT00114777|580594257|FG001|Randomization to Month 36|Lack of Efficacy|15|||
160783492|NCT00114777|580594258|FG002|Randomization to Month 36|Lack of Efficacy|17|||
160783493|NCT00114777|580594256|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
160783494|NCT00114777|580594257|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
160783495|NCT00114777|580594258|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
160783496|NCT00114777|580594256|FG000|Randomization to Month 36|Adverse Event|34|||
160783497|NCT00114777|580594257|FG001|Randomization to Month 36|Adverse Event|35|||
160783498|NCT00114777|580594258|FG002|Randomization to Month 36|Adverse Event|44|||
160783499|NCT00114777|580594256|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
160783500|NCT00114777|580594257|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
160783501|NCT00114777|580594258|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
160783502|NCT00114777|580594256|FG000|Randomization to Month 36|Other|9|||
160783503|NCT00114777|580594257|FG001|Randomization to Month 36|Other|3|||
160783504|NCT00114777|580594258|FG002|Randomization to Month 36|Other|12|||
160783505|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Death|8|||
160783506|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Death|13|||
160783507|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Death|7|||
160783508|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
160783509|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
160783510|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
160783511|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
160783512|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
160783513|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
160783514|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
160783515|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
160783516|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
160783517|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
160783518|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
160783519|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
160783520|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
160783521|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
160783522|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
160783523|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
160783524|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
160783525|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
160783526|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
160783527|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
160783528|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
160890044|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
160890045|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
160890046|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
160890047|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
160890048|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
160890049|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
160890050|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
160890051|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
160890052|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
160890053|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
160890054|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
160890055|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
160890056|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
160890057|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
160890058|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Other|2|||
160890059|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Other|2|||
160890060|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Personal reasons|2|||
160890061|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Personal reasons|2|||
160890062|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
160890063|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
160890064|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
160890065|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
160890066|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
160890067|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
160890068|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
160890069|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
160890070|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
160890071|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
160890072|NCT00667446|580991615|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
160890073|NCT00667446|580991616|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
160890074|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
160542993|NCT03016325|579716412|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
160542994|NCT03016325|579716413|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
160890075|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
160542995|NCT03016325|579716414|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
160639691|NCT04378010|580064485|FG002|Overall Study|Subject inability to complete study visit|1|||
160639692|NCT04378010|580064483|FG000|Overall Study|Subject never dosed|0|||
160639693|NCT04378010|580064484|FG001|Overall Study|Subject never dosed|1|||
160639694|NCT04378010|580064485|FG002|Overall Study|Subject never dosed|0|||
160639695|NCT01792284|580064486|FG000|Lead-in Period|Adverse Event|15|||
160639696|NCT01792284|580064487|FG001|Lead-in Period|Adverse Event|0|||
160639697|NCT01792284|580064488|FG002|Lead-in Period|Adverse Event|0|||
160639698|NCT01792284|580064486|FG000|Lead-in Period|Lost to Follow-up|2|||
160639699|NCT01792284|580064487|FG001|Lead-in Period|Lost to Follow-up|0|||
160639700|NCT01792284|580064488|FG002|Lead-in Period|Lost to Follow-up|0|||
160639701|NCT01792284|580064486|FG000|Lead-in Period|Protocol Violation|1|||
160639702|NCT01792284|580064487|FG001|Lead-in Period|Protocol Violation|0|||
160639703|NCT01792284|580064488|FG002|Lead-in Period|Protocol Violation|0|||
160639704|NCT01792284|580064486|FG000|Lead-in Period|Withdrawal by Subject|10|||
160639705|NCT01792284|580064487|FG001|Lead-in Period|Withdrawal by Subject|0|||
160639706|NCT01792284|580064488|FG002|Lead-in Period|Withdrawal by Subject|0|||
160639707|NCT01792284|580064486|FG000|Lead-in Period|Physician Decision|1|||
160639708|NCT01792284|580064487|FG001|Lead-in Period|Physician Decision|0|||
160639709|NCT01792284|580064488|FG002|Lead-in Period|Physician Decision|0|||
160639710|NCT01792284|580064486|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
160639711|NCT01792284|580064487|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
160639712|NCT01792284|580064488|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
160639713|NCT01792284|580064486|FG000|Randomization Period 1|Withdrawal by Subject|0|||
160639714|NCT01792284|580064487|FG001|Randomization Period 1|Withdrawal by Subject|1|||
160639715|NCT01792284|580064488|FG002|Randomization Period 1|Withdrawal by Subject|1|||
160639716|NCT01792284|580064486|FG000|Randomization Period 1|Physician Decision|0|||
160639717|NCT01792284|580064487|FG001|Randomization Period 1|Physician Decision|1|||
160639718|NCT01792284|580064488|FG002|Randomization Period 1|Physician Decision|1|||
160639719|NCT01792284|580064486|FG000|Randomization Period 1|Adverse Event|0|||
160639720|NCT01792284|580064487|FG001|Randomization Period 1|Adverse Event|0|||
160639721|NCT01792284|580064488|FG002|Randomization Period 1|Adverse Event|2|||
160639722|NCT01792284|580064486|FG000|Randomization Period 1|Lost to Follow-up|0|||
160639723|NCT01792284|580064487|FG001|Randomization Period 1|Lost to Follow-up|0|||
160639724|NCT01792284|580064488|FG002|Randomization Period 1|Lost to Follow-up|1|||
160639725|NCT01792284|580064486|FG000|Randomization Period 2|Protocol Violation|0|||
160639726|NCT01792284|580064487|FG001|Randomization Period 2|Protocol Violation|1|||
160639727|NCT01792284|580064488|FG002|Randomization Period 2|Protocol Violation|0|||
160639728|NCT01792284|580064486|FG000|Randomization Period 2|Withdrawal by Subject|0|||
160639729|NCT01792284|580064487|FG001|Randomization Period 2|Withdrawal by Subject|2|||
160639730|NCT01792284|580064488|FG002|Randomization Period 2|Withdrawal by Subject|0|||
160639731|NCT02019979|580064489|FG000|Overall Study|study terminated|14|||
160639732|NCT00379587|580064495|FG000|Overall Study|Lost to Follow-up|2|||
160639733|NCT03237611|580064496|FG000|Overall Study|Withdrawal by Subject|1|||
160639734|NCT03237611|580064496|FG000|Overall Study|Ineligible|1|||
160639735|NCT00534092|580064500|FG000|Overall Study|Lost to Follow-up|1|||
160639736|NCT00534092|580064501|FG001|Overall Study|Lost to Follow-up|0|||
160639737|NCT00534092|580064500|FG000|Overall Study|personal reasons/family concerns|1|||
160639738|NCT00534092|580064501|FG001|Overall Study|personal reasons/family concerns|0|||
160639739|NCT01169649|580064502|FG000|Overall Study|Patient Not Treated|3|||
160639740|NCT02919475|580064503|FG000|Overall Study|Adverse Event|3|||
160783529|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Other|2|||
160783530|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Other|0|||
160783531|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Other|2|||
160783532|NCT01181128|580594262|FG000|Overall Study|Withdrawal by Subject|2|||
160783533|NCT01181128|580594263|FG001|Overall Study|Withdrawal by Subject|2|||
160783534|NCT01181128|580594264|FG002|Overall Study|Withdrawal by Subject|0|||
160783535|NCT01181128|580594262|FG000|Overall Study|Death|1|||
160783536|NCT01181128|580594263|FG001|Overall Study|Death|0|||
160783537|NCT01181128|580594264|FG002|Overall Study|Death|0|||
160783538|NCT01181128|580594262|FG000|Overall Study|Physician Decision|2|||
160783539|NCT01181128|580594263|FG001|Overall Study|Physician Decision|0|||
160783540|NCT01181128|580594264|FG002|Overall Study|Physician Decision|0|||
160783541|NCT01181128|580594262|FG000|Overall Study|Adverse Event|0|||
160783542|NCT01181128|580594263|FG001|Overall Study|Adverse Event|2|||
160783543|NCT01181128|580594264|FG002|Overall Study|Adverse Event|0|||
160783544|NCT01181128|580594262|FG000|Overall Study|Other|1|||
160783545|NCT01181128|580594263|FG001|Overall Study|Other|1|||
160783546|NCT01181128|580594264|FG002|Overall Study|Other|1|||
160783547|NCT04477486|580594267|FG000|Overall Study|Death|2|||
160783548|NCT04477486|580594267|FG000|Overall Study|Ongoing at Time of Analysis|11|||
160783549|NCT01543503|580594268|FG000|Overall Study|Lost to Follow-up|32|||
160783550|NCT01543503|580594269|FG001|Overall Study|Lost to Follow-up|36|||
160783551|NCT01543503|580594268|FG000|Overall Study|Adverse Event|9|||
160783552|NCT01543503|580594269|FG001|Overall Study|Adverse Event|13|||
160783553|NCT01543503|580594268|FG000|Overall Study|Lack of Efficacy|4|||
160783554|NCT01543503|580594269|FG001|Overall Study|Lack of Efficacy|16|||
160783555|NCT01543503|580594268|FG000|Overall Study|Participant withdrew informed consent|8|||
160783556|NCT01543503|580594269|FG001|Overall Study|Participant withdrew informed consent|10|||
160783557|NCT01543503|580594268|FG000|Overall Study|Change of jobs|0|||
160783558|NCT01543503|580594269|FG001|Overall Study|Change of jobs|1|||
160783559|NCT01543503|580594268|FG000|Overall Study|Intolerance to the biologic treatment|0|||
160783560|NCT01543503|580594269|FG001|Overall Study|Intolerance to the biologic treatment|1|||
160783561|NCT01543503|580594268|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
160783562|NCT01543503|580594269|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
160783563|NCT01543503|580594268|FG000|Overall Study|Participant did not complete last visit|0|||
160783564|NCT01543503|580594269|FG001|Overall Study|Participant did not complete last visit|2|||
160783565|NCT01543503|580594268|FG000|Overall Study|Refused to continue treatment|7|||
160783566|NCT01543503|580594269|FG001|Overall Study|Refused to continue treatment|0|||
160783567|NCT01543503|580594268|FG000|Overall Study|Incorrect medication received|1|||
160783568|NCT01543503|580594269|FG001|Overall Study|Incorrect medication received|0|||
160783569|NCT01543503|580594268|FG000|Overall Study|Participant moved to another city|2|||
160783570|NCT01543503|580594269|FG001|Overall Study|Participant moved to another city|0|||
160783571|NCT01543503|580594268|FG000|Overall Study|Participant will not return for visits|0|||
160783572|NCT01543503|580594269|FG001|Overall Study|Participant will not return for visits|2|||
160783573|NCT01543503|580594268|FG000|Overall Study|Participant transferred to another city|1|||
160783574|NCT01543503|580594269|FG001|Overall Study|Participant transferred to another city|0|||
160783575|NCT01543503|580594268|FG000|Overall Study|Participant moved to Scotland|1|||
160783576|NCT01543503|580594269|FG001|Overall Study|Participant moved to Scotland|0|||
160783577|NCT01543503|580594268|FG000|Overall Study|Participant decision to stop treatment|1|||
160783578|NCT01543503|580594269|FG001|Overall Study|Participant decision to stop treatment|0|||
160783579|NCT01543503|580594268|FG000|Overall Study|Investigator did not wish to participate|1|||
160783580|NCT01543503|580594269|FG001|Overall Study|Investigator did not wish to participate|1|||
160783581|NCT01543503|580594268|FG000|Overall Study|Participant recruited after closing date|0|||
160783582|NCT01543503|580594269|FG001|Overall Study|Participant recruited after closing date|1|||
160783583|NCT01543503|580594268|FG000|Overall Study|Site stopped participation|5|||
160783584|NCT01543503|580594269|FG001|Overall Study|Site stopped participation|1|||
160783585|NCT01543503|580594268|FG000|Overall Study|Participant did not attend a visit|1|||
160783586|NCT01543503|580594269|FG001|Overall Study|Participant did not attend a visit|0|||
160783587|NCT01543503|580594268|FG000|Overall Study|Moved to other rheumatologic site|0|||
160542996|NCT03016325|579716415|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
160783588|NCT01543503|580594269|FG001|Overall Study|Moved to other rheumatologic site|1|||
160783589|NCT01543503|580594268|FG000|Overall Study|Participant consented to another study|0|||
160783590|NCT01543503|580594269|FG001|Overall Study|Participant consented to another study|2|||
160783591|NCT01543503|580594268|FG000|Overall Study|Participant went to United States|1|||
160783592|NCT01543503|580594269|FG001|Overall Study|Participant went to United States|0|||
160783593|NCT01543503|580594268|FG000|Overall Study|Screen failure|1|||
160783594|NCT01543503|580594269|FG001|Overall Study|Screen failure|0|||
160783595|NCT01986751|580594271|FG000|Overall Study|improperly consented|10|||
160783596|NCT01986751|580594272|FG001|Overall Study|improperly consented|2|||
160783597|NCT01774370|580594278|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
160783598|NCT01774370|580594278|FG000|Overall Study|Administered prior to the contract date|4|||
160783599|NCT01774370|580594278|FG000|Overall Study|Subjects of contraindications|34|||
160783600|NCT01774370|580594278|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
160783601|NCT01774370|580594278|FG000|Overall Study|Follow-up failure|34|||
160783602|NCT00514917|580594281|FG000|Overall Study|Death|4|||
160783603|NCT00514917|580594282|FG001|Overall Study|Death|10|||
160783604|NCT00514917|580594281|FG000|Overall Study|Protocol Violation|1|||
160783605|NCT00514917|580594282|FG001|Overall Study|Protocol Violation|0|||
160783606|NCT00514917|580594281|FG000|Overall Study|Lost to Follow-up|4|||
160783607|NCT00514917|580594282|FG001|Overall Study|Lost to Follow-up|3|||
160783608|NCT00514917|580594281|FG000|Overall Study|Withdrawal by Subject|18|||
160783609|NCT00514917|580594282|FG001|Overall Study|Withdrawal by Subject|16|||
160783610|NCT00514917|580594281|FG000|Overall Study|Discontinued due to study closure|88|||
160783611|NCT00514917|580594282|FG001|Overall Study|Discontinued due to study closure|81|||
160783612|NCT00514917|580594281|FG000|Overall Study|Undefined|11|||
160783613|NCT00514917|580594282|FG001|Overall Study|Undefined|5|||
160783614|NCT04243837|580594283|FG000|Overall Study|Adverse Event|2|||
160783615|NCT04243837|580594284|FG001|Overall Study|Adverse Event|1|||
160783616|NCT04243837|580594283|FG000|Overall Study|Withdrawal by Subject|4|||
160783617|NCT04243837|580594284|FG001|Overall Study|Withdrawal by Subject|2|||
160783618|NCT04243837|580594283|FG000|Overall Study|Covid-19 lock down|1|||
160783619|NCT04243837|580594284|FG001|Overall Study|Covid-19 lock down|0|||
160783620|NCT04243837|580594283|FG000|Overall Study|Study Terminated by Sponsor|11|||
160783621|NCT04243837|580594284|FG001|Overall Study|Study Terminated by Sponsor|12|||
160783622|NCT02280499|580594285|FG000|Overall Study|Death|14|||
160783623|NCT02280499|580594285|FG000|Overall Study|Lost to Follow-up|42|||
160783624|NCT02280499|580594285|FG000|Overall Study|Adverse Event|5|||
160783625|NCT05085405|580594293|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
160783626|NCT05085405|580594294|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
160783627|NCT05085405|580594295|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
160783628|NCT05085405|580594296|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
160783629|NCT05085405|580594297|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
160783630|NCT05085405|580594298|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
160783631|NCT05085405|580594293|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
160783632|NCT05085405|580594294|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
160783633|NCT05085405|580594295|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
160783634|NCT05085405|580594296|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
160783635|NCT05085405|580594297|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
160783636|NCT05085405|580594298|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
160783637|NCT02187055|580594299|FG000|Overall Study|Lack of Efficacy|10|||
160783638|NCT02187055|580594300|FG001|Overall Study|Lack of Efficacy|3|||
160783639|NCT02187055|580594301|FG002|Overall Study|Lack of Efficacy|7|||
160783640|NCT02187055|580594299|FG000|Overall Study|Lost to Follow-up|2|||
160783641|NCT02187055|580594300|FG001|Overall Study|Lost to Follow-up|7|||
160783642|NCT02187055|580594301|FG002|Overall Study|Lost to Follow-up|3|||
160783643|NCT02187055|580594299|FG000|Overall Study|No longer meets eligibility criteria|0|||
160783644|NCT02187055|580594300|FG001|Overall Study|No longer meets eligibility criteria|2|||
160783645|NCT02187055|580594301|FG002|Overall Study|No longer meets eligibility criteria|0|||
160783646|NCT02187055|580594299|FG000|Overall Study|No longer willing to participate|6|||
160783647|NCT02187055|580594300|FG001|Overall Study|No longer willing to participate|8|||
160783648|NCT02187055|580594301|FG002|Overall Study|No longer willing to participate|10|||
160783649|NCT02187055|580594299|FG000|Overall Study|Other|5|||
160783650|NCT02187055|580594300|FG001|Overall Study|Other|6|||
160783651|NCT02187055|580594301|FG002|Overall Study|Other|3|||
160783652|NCT02187055|580594299|FG000|Overall Study|Protocol Violation|9|||
160783653|NCT02187055|580594300|FG001|Overall Study|Protocol Violation|9|||
160783654|NCT02187055|580594301|FG002|Overall Study|Protocol Violation|4|||
160783655|NCT02187055|580594299|FG000|Overall Study|Pregnancy|3|||
160783656|NCT02187055|580594300|FG001|Overall Study|Pregnancy|1|||
160639741|NCT02919475|580064504|FG001|Overall Study|Adverse Event|3|||
160783657|NCT02187055|580594301|FG002|Overall Study|Pregnancy|0|||
160890076|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
160890077|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
160783658|NCT02187055|580594299|FG000|Overall Study|Withdrawal by Subject|11|||
160783659|NCT02187055|580594300|FG001|Overall Study|Withdrawal by Subject|11|||
160783660|NCT02187055|580594301|FG002|Overall Study|Withdrawal by Subject|11|||
160783661|NCT02187055|580594299|FG000|Overall Study|Adverse Event|21|||
160890078|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
160890079|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
160890080|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
160890081|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
160890082|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
160890083|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
160890084|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
160890085|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
160890086|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
160783662|NCT02187055|580594300|FG001|Overall Study|Adverse Event|26|||
160783663|NCT02187055|580594301|FG002|Overall Study|Adverse Event|36|||
160783664|NCT02187055|580594299|FG000|Overall Study|Death|2|||
160783665|NCT02187055|580594300|FG001|Overall Study|Death|0|||
160783666|NCT02187055|580594301|FG002|Overall Study|Death|0|||
160783667|NCT00985790|580594304|FG000|Overall Study|Withdrawal by Subject|1|||
160783668|NCT00985790|580594305|FG001|Overall Study|Withdrawal by Subject|1|||
160783669|NCT00985790|580594304|FG000|Overall Study|Lost to Follow-up|6|||
160783670|NCT00985790|580594305|FG001|Overall Study|Lost to Follow-up|7|||
160783671|NCT01666314|580594306|FG000|Overall Study|Adverse Event|3|||
160783672|NCT01666314|580594307|FG001|Overall Study|Adverse Event|13|||
160783673|NCT01666314|580594308|FG002|Overall Study|Adverse Event|7|||
160783674|NCT01666314|580594309|FG003|Overall Study|Adverse Event|7|||
160783675|NCT01666314|580594306|FG000|Overall Study|Progressive Disease|11|||
160783676|NCT01666314|580594307|FG001|Overall Study|Progressive Disease|9|||
160783677|NCT01666314|580594308|FG002|Overall Study|Progressive Disease|19|||
160783678|NCT01666314|580594309|FG003|Overall Study|Progressive Disease|20|||
160783679|NCT01666314|580594306|FG000|Overall Study|Symptomatic Deterioration|1|||
160783680|NCT01666314|580594307|FG001|Overall Study|Symptomatic Deterioration|0|||
160783681|NCT01666314|580594308|FG002|Overall Study|Symptomatic Deterioration|2|||
160783682|NCT01666314|580594309|FG003|Overall Study|Symptomatic Deterioration|0|||
160783683|NCT01666314|580594306|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
160783684|NCT01666314|580594307|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
160783685|NCT01666314|580594308|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
160783686|NCT01666314|580594309|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
160783687|NCT01666314|580594306|FG000|Overall Study|Withdrawal by Subject|1|||
160783688|NCT01666314|580594307|FG001|Overall Study|Withdrawal by Subject|1|||
160783689|NCT01666314|580594308|FG002|Overall Study|Withdrawal by Subject|2|||
160783690|NCT01666314|580594309|FG003|Overall Study|Withdrawal by Subject|3|||
160783691|NCT01666314|580594306|FG000|Overall Study|Reason not Specified|10|||
160783692|NCT01666314|580594307|FG001|Overall Study|Reason not Specified|7|||
160783693|NCT01666314|580594308|FG002|Overall Study|Reason not Specified|5|||
160783694|NCT01666314|580594309|FG003|Overall Study|Reason not Specified|5|||
160783695|NCT00689052|580594311|FG000|Overall Study|Adverse Event|4|||
160783696|NCT00689052|580594312|FG001|Overall Study|Adverse Event|6|||
160783697|NCT00689052|580594311|FG000|Overall Study|Protocol Violation|1|||
160783698|NCT00689052|580594312|FG001|Overall Study|Protocol Violation|0|||
160783699|NCT00689052|580594311|FG000|Overall Study|Lost to Follow-up|2|||
160783700|NCT00689052|580594312|FG001|Overall Study|Lost to Follow-up|0|||
160783701|NCT00689052|580594311|FG000|Overall Study|Withdrawal by Subject|2|||
160783702|NCT00689052|580594312|FG001|Overall Study|Withdrawal by Subject|0|||
160783703|NCT00689052|580594311|FG000|Overall Study|Early termination of the trial|22|||
160783704|NCT00689052|580594312|FG001|Overall Study|Early termination of the trial|24|||
160783705|NCT01727154|580594316|FG000|Overall Study|Death|17|||
160783706|NCT01727154|580594316|FG000|Overall Study|Withdrawal by Subject|14|||
160783707|NCT01727154|580594316|FG000|Overall Study|Subject Withdrew Consent|18|||
160783708|NCT01727154|580594316|FG000|Overall Study|Study Terminated|6|||
160783709|NCT01727154|580594316|FG000|Overall Study|No Discontinuation Documentation|4|||
160783710|NCT00003474|580594317|FG000|Overall Study|Not Evaluable|14|||
160783711|NCT01198548|580594321|FG000|Overall Study|Disease Progression|9|||
160783712|NCT01198548|580594321|FG000|Overall Study|Administrative Decision|1|||
160783713|NCT02186171|580594323|FG000|Overall Study|Withdrawal by Subject|1|||
160783714|NCT02186171|580594324|FG001|Overall Study|Withdrawal by Subject|9|||
160783715|NCT02186171|580594323|FG000|Overall Study|Lost to Follow-up|2|||
160783716|NCT02186171|580594324|FG001|Overall Study|Lost to Follow-up|2|||
160639742|NCT02919475|580064505|FG002|Overall Study|Adverse Event|3|||
160639743|NCT02919475|580064506|FG003|Overall Study|Adverse Event|9|||
160639744|NCT02919475|580064507|FG004|Overall Study|Adverse Event|2|||
160639745|NCT02919475|580064503|FG000|Overall Study|Death|0|||
160639746|NCT02919475|580064504|FG001|Overall Study|Death|1|||
160639747|NCT02919475|580064505|FG002|Overall Study|Death|0|||
160783717|NCT02186171|580594323|FG000|Overall Study|Death|1|||
160783718|NCT02186171|580594324|FG001|Overall Study|Death|2|||
160783719|NCT02186171|580594323|FG000|Overall Study|Protocol-specified Criteria|0|||
160783720|NCT02186171|580594324|FG001|Overall Study|Protocol-specified Criteria|2|||
160783721|NCT01245062|580594325|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
160783722|NCT01245062|580594326|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
160783723|NCT01245062|580594327|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
160783724|NCT01245062|580594325|FG000|Randomization and Crossover Phase|Physician Decision|2|||
160783725|NCT01245062|580594326|FG001|Randomization and Crossover Phase|Physician Decision|4|||
160783726|NCT01245062|580594327|FG002|Randomization and Crossover Phase|Physician Decision|0|||
160783727|NCT01245062|580594325|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
160639748|NCT02919475|580064506|FG003|Overall Study|Death|0|||
160639749|NCT02919475|580064507|FG004|Overall Study|Death|0|||
160639750|NCT02919475|580064503|FG000|Overall Study|Lost to Follow-up|0|||
160639751|NCT02919475|580064504|FG001|Overall Study|Lost to Follow-up|0|||
160639752|NCT02919475|580064505|FG002|Overall Study|Lost to Follow-up|0|||
160639753|NCT02919475|580064506|FG003|Overall Study|Lost to Follow-up|1|||
160639754|NCT02919475|580064507|FG004|Overall Study|Lost to Follow-up|0|||
160639755|NCT02919475|580064503|FG000|Overall Study|Withdrawal by Subject|2|||
160639756|NCT02919475|580064504|FG001|Overall Study|Withdrawal by Subject|3|||
160639757|NCT02919475|580064505|FG002|Overall Study|Withdrawal by Subject|1|||
160639758|NCT02919475|580064506|FG003|Overall Study|Withdrawal by Subject|2|||
160639759|NCT02919475|580064507|FG004|Overall Study|Withdrawal by Subject|2|||
160639760|NCT02919475|580064503|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
160639761|NCT02919475|580064504|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
160639762|NCT02919475|580064505|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
160639763|NCT02919475|580064506|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
160639764|NCT02919475|580064507|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160639765|NCT02323295|580064508|FG000|Overall Study|Adverse Event|0|||
160639766|NCT02323295|580064509|FG001|Overall Study|Adverse Event|1|||
160639767|NCT02323295|580064508|FG000|Overall Study|Withdrawal by Subject|0|||
160639768|NCT02323295|580064509|FG001|Overall Study|Withdrawal by Subject|1|||
160639769|NCT02323295|580064508|FG000|Overall Study|Patient did not have surgery as planned.|0|||
160639770|NCT02323295|580064509|FG001|Overall Study|Patient did not have surgery as planned.|1|||
160639771|NCT02370784|580064510|FG000|Overall Study|Patient started prohibited medication|0|||
160639772|NCT02370784|580064511|FG001|Overall Study|Patient started prohibited medication|1|||
160639773|NCT01872689|580064516|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
160639774|NCT01872689|580064517|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
160639775|NCT01872689|580064518|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
160639776|NCT01872689|580064519|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
160639777|NCT01872689|580064516|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
160639778|NCT01872689|580064517|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
160639779|NCT01872689|580064518|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
160639780|NCT01872689|580064519|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
160639781|NCT01872689|580064516|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
160639782|NCT01872689|580064517|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
160639783|NCT01872689|580064518|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
160639784|NCT01872689|580064519|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
160639785|NCT01872689|580064516|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
160639786|NCT01872689|580064517|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
160639787|NCT01872689|580064518|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
160639788|NCT01872689|580064519|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
160639789|NCT01872689|580064516|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
160639790|NCT01872689|580064517|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
160639791|NCT01872689|580064518|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
160639792|NCT01872689|580064519|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
160639793|NCT01872689|580064516|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
160639794|NCT01872689|580064517|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
160639795|NCT01872689|580064518|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
160639796|NCT01872689|580064519|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
160639797|NCT01872689|580064516|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
160639798|NCT01872689|580064517|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
160639799|NCT01872689|580064518|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
160639800|NCT01872689|580064519|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
160639801|NCT01872689|580064516|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
160639802|NCT01872689|580064517|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
160639803|NCT01872689|580064518|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
160639804|NCT01872689|580064519|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
160639805|NCT01872689|580064516|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
160639806|NCT01872689|580064517|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
160639807|NCT01872689|580064518|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
160639808|NCT01872689|580064519|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
160639809|NCT01872689|580064516|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
160639810|NCT01872689|580064517|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
160639811|NCT01872689|580064518|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
160639812|NCT01872689|580064519|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
160639813|NCT01872689|580064516|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
160639814|NCT01872689|580064517|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
160639815|NCT01872689|580064518|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
160783728|NCT01245062|580594326|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
160783729|NCT01245062|580594327|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
160783730|NCT01245062|580594325|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
160783731|NCT01245062|580594326|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
160783732|NCT01245062|580594327|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
160783733|NCT01245062|580594325|FG000|Cross-over Phase|Lost to Follow-up|0|||
160783734|NCT01245062|580594326|FG001|Cross-over Phase|Lost to Follow-up|0|||
160783735|NCT01245062|580594327|FG002|Cross-over Phase|Lost to Follow-up|1|||
160783736|NCT01245062|580594325|FG000|Cross-over Phase|Physician Decision|0|||
160783737|NCT01245062|580594326|FG001|Cross-over Phase|Physician Decision|0|||
160783738|NCT01245062|580594327|FG002|Cross-over Phase|Physician Decision|1|||
160783739|NCT01245062|580594325|FG000|Cross-over Phase|Withdrew Consent|0|||
160783740|NCT01245062|580594326|FG001|Cross-over Phase|Withdrew Consent|0|||
160783741|NCT01245062|580594327|FG002|Cross-over Phase|Withdrew Consent|4|||
160783742|NCT01245062|580594325|FG000|Cross-over Phase|Study closed/ terminated|0|||
160783743|NCT01245062|580594326|FG001|Cross-over Phase|Study closed/ terminated|0|||
160783744|NCT01245062|580594327|FG002|Cross-over Phase|Study closed/ terminated|11|||
160783745|NCT06025695|580594329|FG000|Overall Study|Adverse Event|5|||
160783746|NCT06025695|580594330|FG001|Overall Study|Adverse Event|6|||
160783747|NCT06025695|580594329|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
160783748|NCT06025695|580594330|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
160783749|NCT06025695|580594329|FG000|Overall Study|Other|23|||
160783750|NCT06025695|580594330|FG001|Overall Study|Other|19|||
160783751|NCT06025695|580594329|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
160783752|NCT06025695|580594330|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
160783753|NCT01452347|580594331|FG000|Overall Study|Adverse Event|2|||
160783754|NCT01452347|580594332|FG001|Overall Study|Adverse Event|1|||
160783755|NCT01452347|580594331|FG000|Overall Study|Non compliance protocol|2|||
160783756|NCT01452347|580594332|FG001|Overall Study|Non compliance protocol|0|||
160783757|NCT01452347|580594331|FG000|Overall Study|Lost to Follow-up|2|||
160783758|NCT01452347|580594332|FG001|Overall Study|Lost to Follow-up|0|||
160783759|NCT01452347|580594331|FG000|Overall Study|Withdrawal by Subject|3|||
160783760|NCT01452347|580594332|FG001|Overall Study|Withdrawal by Subject|3|||
160783761|NCT01452347|580594331|FG000|Overall Study|Not treated|6|||
160783762|NCT01452347|580594332|FG001|Overall Study|Not treated|3|||
160783763|NCT01452347|580594331|FG000|Overall Study|Other reason not defined above|2|||
160783764|NCT01452347|580594332|FG001|Overall Study|Other reason not defined above|0|||
160783765|NCT05762744|580594333|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
160783766|NCT05762744|580594334|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
160783767|NCT05762744|580594333|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
160783768|NCT05762744|580594334|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
160783769|NCT01030900|580594335|FG000|Overall Study|Not treated due to congestive heart failure|1|||
160783770|NCT01030900|580594335|FG000|Overall Study|Not treated due to rapid disease|1|||
160783771|NCT00441896|580594336|FG000|Overall Study|Withdrawal by Subject|0|||
160783772|NCT00441896|580594337|FG001|Overall Study|Withdrawal by Subject|0|||
160783773|NCT00441896|580594338|FG002|Overall Study|Withdrawal by Subject|0|||
160783774|NCT00441896|580594339|FG003|Overall Study|Withdrawal by Subject|1|||
160783775|NCT00441896|580594340|FG004|Overall Study|Withdrawal by Subject|0|||
160783776|NCT00441896|580594341|FG005|Overall Study|Withdrawal by Subject|0|||
160783777|NCT00441896|580594342|FG006|Overall Study|Withdrawal by Subject|0|||
160783778|NCT00441896|580594343|FG007|Overall Study|Withdrawal by Subject|0|||
160783779|NCT00441896|580594344|FG008|Overall Study|Withdrawal by Subject|0|||
160783780|NCT00441896|580594345|FG009|Overall Study|Withdrawal by Subject|0|||
160783781|NCT00441896|580594336|FG000|Overall Study|Other|0|||
160783782|NCT00441896|580594337|FG001|Overall Study|Other|0|||
160783783|NCT00441896|580594338|FG002|Overall Study|Other|0|||
160783784|NCT00441896|580594339|FG003|Overall Study|Other|0|||
160783785|NCT00441896|580594340|FG004|Overall Study|Other|1|||
160783786|NCT00441896|580594341|FG005|Overall Study|Other|0|||
160783787|NCT00441896|580594342|FG006|Overall Study|Other|0|||
160783788|NCT00441896|580594343|FG007|Overall Study|Other|0|||
160783789|NCT00441896|580594344|FG008|Overall Study|Other|0|||
160783790|NCT00441896|580594345|FG009|Overall Study|Other|0|||
160783791|NCT01301092|580594346|FG000|Overall Study|Lost to Follow-up|0|||
160783792|NCT01301092|580594347|FG001|Overall Study|Lost to Follow-up|0|||
160783793|NCT01301092|580594348|FG002|Overall Study|Lost to Follow-up|1|||
160783794|NCT03334175|580594349|FG000|Overall Study|Lost to Follow-up|0|||
160783795|NCT03334175|580594350|FG001|Overall Study|Lost to Follow-up|1|||
160783796|NCT01350973|580594351|FG000|Overall Study|Adverse Event|4|||
160783797|NCT01350973|580594352|FG001|Overall Study|Adverse Event|7|||
160783798|NCT01350973|580594353|FG002|Overall Study|Adverse Event|7|||
160783799|NCT01350973|580594351|FG000|Overall Study|Voluntary Withdrawal|2|||
160783800|NCT01350973|580594352|FG001|Overall Study|Voluntary Withdrawal|1|||
160783801|NCT01350973|580594353|FG002|Overall Study|Voluntary Withdrawal|1|||
160783802|NCT02724644|580596249|FG000|Overall Study|Adverse Event|7|||
160783803|NCT02724644|580596250|FG001|Overall Study|Adverse Event|1|||
160783804|NCT02724644|580596249|FG000|Overall Study|Lost to Follow-up|6|||
160783805|NCT02724644|580596250|FG001|Overall Study|Lost to Follow-up|2|||
160783806|NCT02724644|580596249|FG000|Overall Study|Withdrawal by Subject|7|||
160783807|NCT02724644|580596250|FG001|Overall Study|Withdrawal by Subject|1|||
160783808|NCT02724644|580596249|FG000|Overall Study|Administrative|1|||
160783809|NCT02724644|580596250|FG001|Overall Study|Administrative|0|||
160783810|NCT01882829|580596251|FG000|Overall Study|Adverse Event|4|||
160783811|NCT01882829|580596251|FG000|Overall Study|Protocol Violation|1|||
160783812|NCT01882829|580596251|FG000|Overall Study|Withdrawal by Subject|1|||
160783813|NCT03312114|580596252|FG000|Overall Study|All the five enrolled dropped out of the|5|||
160783814|NCT00520572|580596256|FG000|Overall Study|Adverse Event|9|||
160783815|NCT00520572|580596257|FG001|Overall Study|Adverse Event|3|||
160783816|NCT00520572|580596258|FG002|Overall Study|Adverse Event|6|||
160783817|NCT00520572|580596259|FG003|Overall Study|Adverse Event|9|||
160783818|NCT00520572|580596260|FG004|Overall Study|Adverse Event|7|||
160783819|NCT00520572|580596261|FG005|Overall Study|Adverse Event|2|||
160783820|NCT00520572|580596256|FG000|Overall Study|Withdrawal by Subject|0|||
160783821|NCT00520572|580596257|FG001|Overall Study|Withdrawal by Subject|9|||
160783822|NCT00520572|580596258|FG002|Overall Study|Withdrawal by Subject|5|||
160783823|NCT00520572|580596259|FG003|Overall Study|Withdrawal by Subject|2|||
160783824|NCT00520572|580596260|FG004|Overall Study|Withdrawal by Subject|2|||
160783825|NCT00520572|580596261|FG005|Overall Study|Withdrawal by Subject|0|||
160783826|NCT00520572|580596256|FG000|Overall Study|Protocol Violation|0|||
160783827|NCT00520572|580596257|FG001|Overall Study|Protocol Violation|0|||
160783828|NCT00520572|580596258|FG002|Overall Study|Protocol Violation|1|||
160783829|NCT00520572|580596259|FG003|Overall Study|Protocol Violation|0|||
160783830|NCT00520572|580596260|FG004|Overall Study|Protocol Violation|0|||
160783831|NCT00520572|580596261|FG005|Overall Study|Protocol Violation|0|||
160783832|NCT00520572|580596256|FG000|Overall Study|Lack of Efficacy|1|||
160783833|NCT00520572|580596257|FG001|Overall Study|Lack of Efficacy|1|||
160783834|NCT00520572|580596258|FG002|Overall Study|Lack of Efficacy|1|||
160783835|NCT00520572|580596259|FG003|Overall Study|Lack of Efficacy|2|||
160783836|NCT00520572|580596260|FG004|Overall Study|Lack of Efficacy|1|||
160783837|NCT00520572|580596261|FG005|Overall Study|Lack of Efficacy|0|||
160783838|NCT00520572|580596256|FG000|Overall Study|Lost to Follow-up|0|||
160783839|NCT00520572|580596257|FG001|Overall Study|Lost to Follow-up|0|||
160783840|NCT00520572|580596258|FG002|Overall Study|Lost to Follow-up|0|||
160783841|NCT00520572|580596259|FG003|Overall Study|Lost to Follow-up|0|||
160783842|NCT00520572|580596260|FG004|Overall Study|Lost to Follow-up|1|||
160783843|NCT00520572|580596261|FG005|Overall Study|Lost to Follow-up|0|||
160783844|NCT00520572|580596256|FG000|Overall Study|Incorrect enrollment|1|||
160783845|NCT00520572|580596257|FG001|Overall Study|Incorrect enrollment|0|||
160783846|NCT00520572|580596258|FG002|Overall Study|Incorrect enrollment|1|||
160783847|NCT00520572|580596259|FG003|Overall Study|Incorrect enrollment|0|||
160783848|NCT00520572|580596260|FG004|Overall Study|Incorrect enrollment|1|||
160890087|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
160783849|NCT00520572|580596261|FG005|Overall Study|Incorrect enrollment|0|||
160783850|NCT00520572|580596256|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
160783851|NCT00520572|580596257|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
160783852|NCT00520572|580596258|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
160783853|NCT00520572|580596259|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
160783854|NCT00520572|580596260|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
160639816|NCT01872689|580064519|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
160639817|NCT01872689|580064516|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
160639818|NCT01872689|580064517|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
160639819|NCT01872689|580064518|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
160639820|NCT01872689|580064519|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
160639821|NCT01872689|580064516|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
160639822|NCT01872689|580064517|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
160639823|NCT01872689|580064518|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
160639824|NCT01872689|580064519|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
160639825|NCT01872689|580064516|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
160639826|NCT01872689|580064517|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
160639827|NCT01872689|580064518|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
160639828|NCT01872689|580064519|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
160639829|NCT01456052|580064520|FG000|Overall Study|Adverse Event|1|||
160639830|NCT01456052|580064521|FG001|Overall Study|Adverse Event|1|||
160639831|NCT01456052|580064522|FG002|Overall Study|Adverse Event|2|||
160639832|NCT01456052|580064520|FG000|Overall Study|Consent withdrawn|0|||
160639833|NCT01456052|580064521|FG001|Overall Study|Consent withdrawn|2|||
160639834|NCT01456052|580064522|FG002|Overall Study|Consent withdrawn|1|||
160639835|NCT01456052|580064520|FG000|Overall Study|Protocol Violation|0|||
160639836|NCT01456052|580064521|FG001|Overall Study|Protocol Violation|1|||
160639837|NCT01456052|580064522|FG002|Overall Study|Protocol Violation|0|||
160639838|NCT01456052|580064520|FG000|Overall Study|Physician Decision|1|||
160639839|NCT01456052|580064521|FG001|Overall Study|Physician Decision|0|||
160639840|NCT01456052|580064522|FG002|Overall Study|Physician Decision|1|||
160639841|NCT01456052|580064520|FG000|Overall Study|Treatment Failure|0|||
160639842|NCT01456052|580064521|FG001|Overall Study|Treatment Failure|1|||
160639843|NCT01456052|580064522|FG002|Overall Study|Treatment Failure|1|||
160639844|NCT02762565|580064525|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
160639845|NCT01113710|580064526|FG000|Overall Study|Adverse Event|64|||
160639846|NCT01113710|580064526|FG000|Overall Study|Lack of Efficacy|41|||
160639847|NCT01113710|580064526|FG000|Overall Study|No Information Available|40|||
160639848|NCT01113710|580064526|FG000|Overall Study|Withdrawal by Subject|28|||
160639849|NCT01113710|580064526|FG000|Overall Study|Lost to Follow-up|20|||
160639850|NCT01113710|580064526|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
160639851|NCT01113710|580064526|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
160639852|NCT01113710|580064526|FG000|Overall Study|Lack of Patient's Compliance|8|||
160639853|NCT01113710|580064526|FG000|Overall Study|Other|7|||
160639854|NCT01113710|580064526|FG000|Overall Study|Adverse Event/Other|5|||
160639855|NCT01113710|580064526|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
160639856|NCT01113710|580064526|FG000|Overall Study|Lack of Efficacy/Other|4|||
160639857|NCT01113710|580064526|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
160639858|NCT01113710|580064526|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
160639859|NCT01113710|580064526|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
160639860|NCT01113710|580064526|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
160639861|NCT01113710|580064526|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
160639862|NCT01113710|580064526|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
160639863|NCT01113710|580064526|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
160639864|NCT01113710|580064526|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
160639865|NCT01113710|580064526|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
160639866|NCT01113710|580064526|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
160639867|NCT01113710|580064526|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
160639868|NCT01113710|580064526|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
160639869|NCT01113710|580064526|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
160639870|NCT01042977|580064528|FG000|Overall Study|Adverse Event|4|||
160639871|NCT01042977|580064529|FG001|Overall Study|Adverse Event|12|||
160639872|NCT01042977|580064528|FG000|Overall Study|Death|2|||
160639873|NCT01042977|580064529|FG001|Overall Study|Death|1|||
160639874|NCT01042977|580064528|FG000|Overall Study|Withdrawal by Subject|8|||
160639875|NCT01042977|580064529|FG001|Overall Study|Withdrawal by Subject|16|||
160639876|NCT01042977|580064528|FG000|Overall Study|Lost to Follow-up|0|||
160639877|NCT01042977|580064529|FG001|Overall Study|Lost to Follow-up|2|||
160639878|NCT01042977|580064528|FG000|Overall Study|Poor/non-compliance|3|||
160639879|NCT01042977|580064529|FG001|Overall Study|Poor/non-compliance|4|||
160639880|NCT01042977|580064528|FG000|Overall Study|Subject no longer meets study criteria|15|||
160639881|NCT01042977|580064529|FG001|Overall Study|Subject no longer meets study criteria|13|||
160639882|NCT01042977|580064528|FG000|Overall Study|Incorrect enrollment|6|||
160639883|NCT01042977|580064529|FG001|Overall Study|Incorrect enrollment|4|||
160639884|NCT01042977|580064528|FG000|Overall Study|Safety|0|||
160639885|NCT01042977|580064529|FG001|Overall Study|Safety|2|||
160890088|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
160890089|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
160890090|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
160890091|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
160890092|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Other|4|||
160890093|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Other|9|||
160890094|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Other|4|||
160890095|NCT00591578|580991618|FG000|Open-Label Extension Phase|Adverse Event|3|||
160890096|NCT00591578|580991619|FG001|Open-Label Extension Phase|Adverse Event|5|||
160890097|NCT00591578|580991620|FG002|Open-Label Extension Phase|Adverse Event|0|||
160890098|NCT00591578|580991618|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
160890099|NCT00591578|580991619|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
160890100|NCT00591578|580991620|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
160890101|NCT00591578|580991618|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
160890102|NCT00591578|580991619|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
160890103|NCT00591578|580991620|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
160890104|NCT00591578|580991618|FG000|Open-Label Extension Phase|Other|1|||
160981692|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
160981693|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
160981694|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
160981695|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
160981696|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
160981697|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
160981698|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
160981699|NCT01646320|581321737|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
160981700|NCT01646320|581321738|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
160981701|NCT01646320|581321737|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
160639886|NCT01042977|580064528|FG000|Overall Study|Administrative reason by sponsor|0|||
160639887|NCT01042977|580064529|FG001|Overall Study|Administrative reason by sponsor|1|||
160639888|NCT01042977|580064528|FG000|Overall Study|Various|3|||
160639889|NCT01042977|580064529|FG001|Overall Study|Various|0|||
160639890|NCT02499354|580064530|FG000|Overall Study|Withdrawal by Subject|1|||
160639891|NCT02499354|580064531|FG001|Overall Study|Withdrawal by Subject|0|||
160639892|NCT01703741|580064534|FG000|Overall Study|Withdrawal by Subject|6|||
160639893|NCT01703741|580064534|FG000|Overall Study|Adverse Event|2|||
160639894|NCT01703741|580064534|FG000|Overall Study|Physician Decision|2|||
160639895|NCT01703741|580064534|FG000|Overall Study|Protocol Violation|1|||
160639896|NCT01703741|580064534|FG000|Overall Study|Lost to Follow-up|3|||
160639897|NCT01703741|580064534|FG000|Overall Study|Subject did not want to continue|2|||
160639898|NCT01703741|580064534|FG000|Overall Study|Subject cannot comply with study visits|1|||
160639899|NCT01703741|580064534|FG000|Overall Study|Subject started testosterone injections|1|||
160639900|NCT01170364|580064535|FG000|Overall Study|Protocol Violation|4|||
160639901|NCT01170364|580064536|FG001|Overall Study|Protocol Violation|1|||
160890105|NCT00591578|580991619|FG001|Open-Label Extension Phase|Other|0|||
160890106|NCT00591578|580991620|FG002|Open-Label Extension Phase|Other|0|||
160890107|NCT02810340|580991621|FG000|Overall Study|Withdrawal by Subject|1|||
160890108|NCT02810340|580991622|FG001|Overall Study|Withdrawal by Subject|0|||
160890109|NCT02810340|580991623|FG002|Overall Study|Withdrawal by Subject|0|||
160890110|NCT02810340|580991621|FG000|Overall Study|Incarceration|0|||
160890111|NCT02810340|580991622|FG001|Overall Study|Incarceration|1|||
160890112|NCT02810340|580991623|FG002|Overall Study|Incarceration|0|||
160890113|NCT02810340|580991621|FG000|Overall Study|Lost to Follow-up|0|||
160890114|NCT02810340|580991622|FG001|Overall Study|Lost to Follow-up|0|||
160981702|NCT01646320|581321738|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
160981703|NCT01646320|581321737|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
160981704|NCT01646320|581321738|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
160981705|NCT01646320|581321737|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
160981706|NCT01646320|581321738|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
160981707|NCT01646320|581321737|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
160981708|NCT01646320|581321738|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
160981709|NCT02892409|581321739|FG000|Overall Study|Adverse Event|1|||
160981710|NCT02892409|581321740|FG001|Overall Study|Adverse Event|0|||
160981711|NCT02892409|581321739|FG000|Overall Study|Withdrawal by Subject|2|||
160981712|NCT02892409|581321740|FG001|Overall Study|Withdrawal by Subject|1|||
160981713|NCT02406261|581321741|FG000|Period 1|Lost to Follow-up|2|||
160981714|NCT02406261|581321742|FG001|Period 1|Lost to Follow-up|0|||
160981715|NCT02406261|581321741|FG000|Period 1|Adverse Event|1|||
160981716|NCT02406261|581321742|FG001|Period 1|Adverse Event|0|||
160981717|NCT02406261|581321741|FG000|Period 2|Physician Decision|0|||
160981718|NCT02406261|581321742|FG001|Period 2|Physician Decision|1|||
160981719|NCT02406261|581321741|FG000|Period 2|Protocol Violation|0|||
160890115|NCT02810340|580991623|FG002|Overall Study|Lost to Follow-up|1|||
160639902|NCT04132232|580064537|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
160639903|NCT04132232|580064538|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
160639904|NCT04132232|580064537|FG000|Overall Study|Lost to Follow-up|6|||
160639905|NCT04132232|580064538|FG001|Overall Study|Lost to Follow-up|7|||
160639906|NCT00368537|580064540|FG000|Randomization|No study drug dosed|13|||
160783855|NCT00520572|580596261|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
160783856|NCT00520572|580596256|FG000|Overall Study|Long break in taking Medication|0|||
160783857|NCT00520572|580596257|FG001|Overall Study|Long break in taking Medication|0|||
160783858|NCT00520572|580596258|FG002|Overall Study|Long break in taking Medication|0|||
160783859|NCT00520572|580596259|FG003|Overall Study|Long break in taking Medication|1|||
160783860|NCT00520572|580596260|FG004|Overall Study|Long break in taking Medication|0|||
160783861|NCT00520572|580596261|FG005|Overall Study|Long break in taking Medication|0|||
160783862|NCT00520572|580596256|FG000|Overall Study|Did not receive Treatment|1|||
160783863|NCT00520572|580596257|FG001|Overall Study|Did not receive Treatment|0|||
160783864|NCT00520572|580596258|FG002|Overall Study|Did not receive Treatment|1|||
160783865|NCT00520572|580596259|FG003|Overall Study|Did not receive Treatment|0|||
160783866|NCT00520572|580596260|FG004|Overall Study|Did not receive Treatment|0|||
160783867|NCT00520572|580596261|FG005|Overall Study|Did not receive Treatment|0|||
160783868|NCT03548415|580596264|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
160783869|NCT03548415|580596265|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
160783870|NCT03548415|580596266|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
160783871|NCT03548415|580596267|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
160783872|NCT03548415|580596268|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
160783873|NCT04605588|580596269|FG000|Overall Study|Withdrawal by Subject|1|||
160783874|NCT04605588|580596270|FG001|Overall Study|Withdrawal by Subject|0|||
160783875|NCT01230814|580596271|FG000|Overall Study|Lost to Follow-up|11|||
160783876|NCT01230814|580596272|FG001|Overall Study|Lost to Follow-up|3|||
160783877|NCT01230814|580596271|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
160783878|NCT01230814|580596272|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
160783879|NCT01803737|580596273|FG000|Overall Study|Lack of Time|1|||
160783880|NCT01803737|580596274|FG001|Overall Study|Lack of Time|0|||
160783881|NCT01803737|580596273|FG000|Overall Study|Medical Reason|0|||
160783882|NCT01803737|580596274|FG001|Overall Study|Medical Reason|1|||
160783883|NCT01803737|580596273|FG000|Overall Study|Lost to Follow-up|0|||
160783884|NCT01803737|580596274|FG001|Overall Study|Lost to Follow-up|2|||
160783885|NCT01386645|580596277|FG000|Overall Study|Physician Decision|0|||
160783886|NCT01386645|580596278|FG001|Overall Study|Physician Decision|0|||
160783887|NCT01386645|580596279|FG002|Overall Study|Physician Decision|1|||
160783888|NCT01386645|580596277|FG000|Overall Study|Withdrawal by Subject|0|||
160783889|NCT01386645|580596278|FG001|Overall Study|Withdrawal by Subject|1|||
160783890|NCT01386645|580596279|FG002|Overall Study|Withdrawal by Subject|1|||
160783891|NCT00676052|580596281|FG000|Overall Study|Adverse Event|0|||
160783892|NCT00676052|580596282|FG001|Overall Study|Adverse Event|1|||
160783893|NCT00676052|580596283|FG002|Overall Study|Adverse Event|1|||
160783894|NCT00676052|580596284|FG003|Overall Study|Adverse Event|2|||
160783895|NCT00676052|580596285|FG004|Overall Study|Adverse Event|2|||
160783896|NCT00676052|580596286|FG005|Overall Study|Adverse Event|2|||
160783897|NCT00676052|580596281|FG000|Overall Study|Lack of Efficacy|2|||
160783898|NCT00676052|580596282|FG001|Overall Study|Lack of Efficacy|2|||
160783899|NCT00676052|580596283|FG002|Overall Study|Lack of Efficacy|1|||
160783900|NCT00676052|580596284|FG003|Overall Study|Lack of Efficacy|1|||
160783901|NCT00676052|580596285|FG004|Overall Study|Lack of Efficacy|2|||
160783902|NCT00676052|580596286|FG005|Overall Study|Lack of Efficacy|1|||
160783903|NCT00676052|580596281|FG000|Overall Study|Protocol Violation|5|||
160783904|NCT00676052|580596282|FG001|Overall Study|Protocol Violation|3|||
160783905|NCT00676052|580596283|FG002|Overall Study|Protocol Violation|2|||
160783906|NCT00676052|580596284|FG003|Overall Study|Protocol Violation|2|||
160783907|NCT00676052|580596285|FG004|Overall Study|Protocol Violation|1|||
160783908|NCT00676052|580596286|FG005|Overall Study|Protocol Violation|2|||
160783909|NCT00676052|580596281|FG000|Overall Study|Lost to Follow-up|0|||
160783910|NCT00676052|580596282|FG001|Overall Study|Lost to Follow-up|0|||
160783911|NCT00676052|580596283|FG002|Overall Study|Lost to Follow-up|0|||
160783912|NCT00676052|580596284|FG003|Overall Study|Lost to Follow-up|0|||
160783913|NCT00676052|580596285|FG004|Overall Study|Lost to Follow-up|1|||
160783914|NCT00676052|580596286|FG005|Overall Study|Lost to Follow-up|0|||
160783915|NCT00676052|580596281|FG000|Overall Study|Physician Decision|1|||
160783916|NCT00676052|580596282|FG001|Overall Study|Physician Decision|1|||
160639907|NCT00368537|580064541|FG001|Randomization|No study drug dosed|6|||
160639908|NCT00368537|580064540|FG000|Baseline Participants|Lost to Follow-up|16|||
160639909|NCT00368537|580064541|FG001|Baseline Participants|Lost to Follow-up|17|||
160783917|NCT00676052|580596283|FG002|Overall Study|Physician Decision|1|||
160783918|NCT00676052|580596284|FG003|Overall Study|Physician Decision|0|||
160783919|NCT00676052|580596285|FG004|Overall Study|Physician Decision|0|||
160783920|NCT00676052|580596286|FG005|Overall Study|Physician Decision|1|||
160783921|NCT00676052|580596281|FG000|Overall Study|Withdrawal by Subject|1|||
160783922|NCT00676052|580596282|FG001|Overall Study|Withdrawal by Subject|0|||
160783923|NCT00676052|580596283|FG002|Overall Study|Withdrawal by Subject|1|||
160783924|NCT00676052|580596284|FG003|Overall Study|Withdrawal by Subject|0|||
160783925|NCT00676052|580596285|FG004|Overall Study|Withdrawal by Subject|0|||
160783926|NCT00676052|580596286|FG005|Overall Study|Withdrawal by Subject|0|||
160783927|NCT02930941|580596287|FG000|Overall Study|Lost to Follow-up|1|||
160783928|NCT02930941|580596288|FG001|Overall Study|Lost to Follow-up|2|||
160981720|NCT02406261|581321742|FG001|Period 2|Protocol Violation|1|||
160981721|NCT02406261|581321741|FG000|Period 2|Withdrawal by Subject|0|||
160981722|NCT02406261|581321742|FG001|Period 2|Withdrawal by Subject|1|||
160981723|NCT01567163|581321746|FG000|Overall Study|Progressive Disease|2|||
160981724|NCT01567163|581321746|FG000|Overall Study|Lost to Follow-up|2|||
160981725|NCT01720797|581321747|FG000|Overall Study|Withdrawal by Subject|3|||
160981726|NCT01720797|581321748|FG001|Overall Study|Withdrawal by Subject|0|||
160981727|NCT00393094|581321751|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
160981728|NCT00393094|581321751|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
160981729|NCT01448044|581321752|FG000|Treatment Period|Adverse Event|4|||
160981730|NCT01448044|581321753|FG001|Treatment Period|Adverse Event|3|||
160981731|NCT01448044|581321752|FG000|Treatment Period|Lack of Efficacy|5|||
160981732|NCT01448044|581321753|FG001|Treatment Period|Lack of Efficacy|12|||
160639910|NCT00368537|580064540|FG000|Baseline Participants|Withdrawal by Subject|6|||
160639911|NCT00368537|580064541|FG001|Baseline Participants|Withdrawal by Subject|4|||
160639912|NCT00368537|580064540|FG000|Baseline Participants|Death|1|||
160639913|NCT00368537|580064541|FG001|Baseline Participants|Death|2|||
160639914|NCT00368537|580064540|FG000|Baseline Participants|No susceptibility|1|||
160639915|NCT00368537|580064541|FG001|Baseline Participants|No susceptibility|0|||
160639916|NCT00368537|580064540|FG000|Baseline Participants|Patient uncompliant|0|||
160639917|NCT00368537|580064541|FG001|Baseline Participants|Patient uncompliant|1|||
160639918|NCT01368276|580064553|FG000|Overall Study|Death|1|||
160639919|NCT01368276|580064554|FG001|Overall Study|Death|10|||
160639920|NCT02041494|580064555|FG000|Overall Study|Death|1|||
160639921|NCT02041494|580064556|FG001|Overall Study|Death|3|||
160639922|NCT02041494|580064555|FG000|Overall Study|Lost to Follow-up|2|||
160639923|NCT02041494|580064556|FG001|Overall Study|Lost to Follow-up|6|||
160639924|NCT02041494|580064555|FG000|Overall Study|study terminated|16|||
160639925|NCT02041494|580064556|FG001|Overall Study|study terminated|11|||
160639926|NCT03341273|580064557|FG000|Overall Study|Lost to Follow-up|7|||
160639927|NCT03341273|580064558|FG001|Overall Study|Lost to Follow-up|7|||
160639928|NCT03341273|580064557|FG000|Overall Study|Withdrawal by Subject|4|||
160639929|NCT03341273|580064558|FG001|Overall Study|Withdrawal by Subject|2|||
160639930|NCT03341273|580064557|FG000|Overall Study|Physician Decision|1|||
160639931|NCT03341273|580064558|FG001|Overall Study|Physician Decision|0|||
160639932|NCT03341273|580064557|FG000|Overall Study|Protocol Violation|0|||
160639933|NCT03341273|580064558|FG001|Overall Study|Protocol Violation|1|||
160639934|NCT03341273|580064557|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
160639935|NCT03341273|580064558|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
160639936|NCT03341273|580064557|FG000|Overall Study|Became ineligible after enrollment|1|||
160639937|NCT03341273|580064558|FG001|Overall Study|Became ineligible after enrollment|0|||
160639938|NCT03341273|580064557|FG000|Overall Study|Not Eligible at Enrollment|0|||
160639939|NCT03341273|580064558|FG001|Overall Study|Not Eligible at Enrollment|1|||
160639940|NCT03341273|580064557|FG000|Overall Study|Participant incarcerated|1|||
160639941|NCT03341273|580064558|FG001|Overall Study|Participant incarcerated|0|||
160639942|NCT01717456|580064566|FG000|End of Treatment|Physician Decision|0|||
160639943|NCT01717456|580064567|FG001|End of Treatment|Physician Decision|1|||
160639944|NCT01717456|580064566|FG000|End of Treatment|Lost to Follow-up|0|||
160639945|NCT01717456|580064567|FG001|End of Treatment|Lost to Follow-up|1|||
160639946|NCT01717456|580064566|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
160639947|NCT01717456|580064567|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
160639948|NCT00755937|580064570|FG000|Recruitment|Unknown if infliximab received|164|||
160639949|NCT00755937|580064570|FG000|Observational Follow-up|Lost to Follow-up|148|||
160639950|NCT02117479|580064573|FG000|Overall Study|Death|13|||
160639951|NCT02117479|580064574|FG001|Overall Study|Death|8|||
160639952|NCT02117479|580064573|FG000|Overall Study|Adverse Event|8|||
160639953|NCT02117479|580064574|FG001|Overall Study|Adverse Event|16|||
160639954|NCT02117479|580064573|FG000|Overall Study|Subject decision|8|||
160639955|NCT02117479|580064574|FG001|Overall Study|Subject decision|9|||
160639956|NCT02117479|580064573|FG000|Overall Study|Disease progression|104|||
160639957|NCT02117479|580064574|FG001|Overall Study|Disease progression|108|||
160639958|NCT02117479|580064573|FG000|Overall Study|Noncompliance with study treatment|1|||
160639959|NCT02117479|580064574|FG001|Overall Study|Noncompliance with study treatment|0|||
160639960|NCT02117479|580064573|FG000|Overall Study|Study terminated by the sponsor|4|||
160639961|NCT02117479|580064574|FG001|Overall Study|Study terminated by the sponsor|6|||
160639962|NCT02117479|580064573|FG000|Overall Study|Physician Decision|7|||
160639963|NCT02117479|580064574|FG001|Overall Study|Physician Decision|2|||
160639964|NCT02117479|580064573|FG000|Overall Study|Other unspecified|11|||
160639965|NCT02117479|580064574|FG001|Overall Study|Other unspecified|7|||
160639966|NCT00751998|580064581|FG000|Overall Study|Lost to Follow-up|7|||
160639967|NCT00751998|580064581|FG000|Overall Study|Death|11|||
160639968|NCT00751998|580064581|FG000|Overall Study|Withdrawal by Subject|2|||
160639969|NCT01223196|580064583|FG000|Overall Study|Lost to Follow-up|2|||
160639970|NCT01223196|580064584|FG001|Overall Study|Lost to Follow-up|0|||
160639971|NCT01223196|580064583|FG000|Overall Study|Physician Decision|1|||
160639972|NCT01223196|580064584|FG001|Overall Study|Physician Decision|0|||
160981733|NCT01448044|581321752|FG000|Treatment Period|Subject requested discontinue study drug|1|||
160783929|NCT00289978|580596289|FG000|Overall Study|Withdrawal by Subject|31|||
160783930|NCT00289978|580596290|FG001|Overall Study|Withdrawal by Subject|17|||
160783931|NCT00289978|580596291|FG002|Overall Study|Withdrawal by Subject|28|||
160783932|NCT00289978|580596289|FG000|Overall Study|Adverse Event|22|||
160783933|NCT00289978|580596290|FG001|Overall Study|Adverse Event|13|||
160783934|NCT00289978|580596291|FG002|Overall Study|Adverse Event|18|||
160783935|NCT00289978|580596289|FG000|Overall Study|Lack of Efficacy|13|||
160783936|NCT00289978|580596290|FG001|Overall Study|Lack of Efficacy|6|||
160783937|NCT00289978|580596291|FG002|Overall Study|Lack of Efficacy|25|||
160783938|NCT00289978|580596289|FG000|Overall Study|Abnormal laboratory value(s)|20|||
160783939|NCT00289978|580596290|FG001|Overall Study|Abnormal laboratory value(s)|9|||
160783940|NCT00289978|580596291|FG002|Overall Study|Abnormal laboratory value(s)|1|||
160783941|NCT00289978|580596289|FG000|Overall Study|Lost to Follow-up|3|||
160783942|NCT00289978|580596290|FG001|Overall Study|Lost to Follow-up|5|||
160783943|NCT00289978|580596291|FG002|Overall Study|Lost to Follow-up|7|||
160783944|NCT00289978|580596289|FG000|Overall Study|Protocol Violation|5|||
160783945|NCT00289978|580596290|FG001|Overall Study|Protocol Violation|5|||
160783946|NCT00289978|580596291|FG002|Overall Study|Protocol Violation|4|||
160783947|NCT00289978|580596289|FG000|Overall Study|Abnormal test procedure result(s)|2|||
160783948|NCT00289978|580596290|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160783949|NCT00289978|580596291|FG002|Overall Study|Abnormal test procedure result(s)|1|||
160783950|NCT00289978|580596289|FG000|Overall Study|Death|1|||
160783951|NCT00289978|580596290|FG001|Overall Study|Death|0|||
160783952|NCT00289978|580596291|FG002|Overall Study|Death|2|||
160783953|NCT00903344|580596292|FG000|Overall Study|Pregnancy|2|||
160783954|NCT00903344|580596293|FG001|Overall Study|Pregnancy|3|||
160783955|NCT00903344|580596292|FG000|Overall Study|Lost to Follow-up|3|||
160783956|NCT00903344|580596293|FG001|Overall Study|Lost to Follow-up|0|||
160783957|NCT00527748|580596306|FG000|Overall Study|Other|3|||
160783958|NCT03055221|580596307|FG000|Overall Study|Adverse Event|2|||
160783959|NCT03055221|580596307|FG000|Overall Study|Withdrawal by Subject|4|||
160783960|NCT03055221|580596307|FG000|Overall Study|Death|6|||
160783961|NCT03055221|580596307|FG000|Overall Study|Physician Decision|1|||
160783962|NCT03055221|580596307|FG000|Overall Study|Study terminated by Sponsor|3|||
160783963|NCT03055221|580596307|FG000|Overall Study|Lost to Follow-up|4|||
160783964|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
160783965|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
160783966|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
160783967|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
160783968|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
160783969|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
160783970|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
160783971|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
160783972|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
160783973|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
160783974|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
160783975|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
160783976|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
160783977|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
160783978|NCT01243424|580596308|FG000|Discontinuation From Treatment|Not treated|5|||
160783979|NCT01243424|580596309|FG001|Discontinuation From Treatment|Not treated|4|||
160783980|NCT01243424|580596308|FG000|Discontinuation From Treatment|Adverse Event|457|||
160783981|NCT01243424|580596309|FG001|Discontinuation From Treatment|Adverse Event|523|||
160783982|NCT01243424|580596308|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
160783983|NCT01243424|580596309|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
160783984|NCT01243424|580596308|FG000|Discontinuation From Treatment|Protocol Violation|46|||
160783985|NCT01243424|580596309|FG001|Discontinuation From Treatment|Protocol Violation|47|||
160639973|NCT01223196|580064583|FG000|Overall Study|Withdrawal by Subject|1|||
160639974|NCT01223196|580064584|FG001|Overall Study|Withdrawal by Subject|0|||
160639975|NCT02629133|580064585|FG000|Overall Study|Lost to Follow-up|3|||
160783986|NCT01243424|580596308|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
160783987|NCT01243424|580596309|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
160639976|NCT02629133|580064586|FG001|Overall Study|Lost to Follow-up|1|||
160783988|NCT01243424|580596308|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
160783989|NCT01243424|580596309|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
160783990|NCT01243424|580596308|FG000|Discontinuation From Treatment|Other than listed above|230|||
160783991|NCT01243424|580596309|FG001|Discontinuation From Treatment|Other than listed above|211|||
160783992|NCT04621786|580596312|FG000|Overall Study|Lost to Follow-up|9|||
160783993|NCT04621786|580596312|FG000|Overall Study|Protocol Violation|3|||
160783994|NCT00710554|580596313|FG000|Overall Study|Adverse Event|24|||
160783995|NCT00710554|580596314|FG001|Overall Study|Adverse Event|7|||
160783996|NCT00710554|580596313|FG000|Overall Study|Withdrawal by Subject|7|||
160783997|NCT00710554|580596314|FG001|Overall Study|Withdrawal by Subject|3|||
160783998|NCT00710554|580596313|FG000|Overall Study|Lost to Follow-up|7|||
160783999|NCT00710554|580596314|FG001|Overall Study|Lost to Follow-up|1|||
160784000|NCT00710554|580596313|FG000|Overall Study|Lack of Efficacy|11|||
160784001|NCT00710554|580596314|FG001|Overall Study|Lack of Efficacy|12|||
160784002|NCT00710554|580596313|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
160784003|NCT00710554|580596314|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
160784004|NCT01346709|580596315|FG000|Overall Study|Protocol Violation|35|||
160784005|NCT01346709|580596315|FG000|Overall Study|Lost to Follow-up|31|||
160784006|NCT01346709|580596315|FG000|Overall Study|Missing data in candidate risk factor|285|||
160784007|NCT01160744|580596319|FG000|Overall Study|Withdrawal by Subject|11|||
160784008|NCT01160744|580596320|FG001|Overall Study|Withdrawal by Subject|5|||
160784009|NCT01160744|580596321|FG002|Overall Study|Withdrawal by Subject|6|||
160784010|NCT01160744|580596322|FG003|Overall Study|Withdrawal by Subject|4|||
160784011|NCT01160744|580596319|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
160784012|NCT01160744|580596320|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
160784013|NCT01160744|580596321|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
160784014|NCT01160744|580596322|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
160981734|NCT01448044|581321753|FG001|Treatment Period|Subject requested discontinue study drug|0|||
160981735|NCT01448044|581321752|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
160981736|NCT01448044|581321753|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
160981737|NCT01448044|581321752|FG000|Treatment Period|Participant does not meet study criteria|1|||
160981738|NCT01448044|581321753|FG001|Treatment Period|Participant does not meet study criteria|0|||
160981739|NCT01448044|581321752|FG000|Treatment Period|Lost to Follow-up|2|||
160784015|NCT02365064|580596324|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
160784016|NCT02365064|580596325|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
160784017|NCT02365064|580596324|FG000|Overall Study|Withdrawal by Subject|6|||
160784018|NCT02365064|580596325|FG001|Overall Study|Withdrawal by Subject|9|||
160784019|NCT02365064|580596324|FG000|Overall Study|Treatment intolerance|2|||
160784020|NCT02365064|580596325|FG001|Overall Study|Treatment intolerance|4|||
160784021|NCT01502072|580596332|FG000|Overall Study|Withdrawal by Subject|1|||
160784022|NCT01502072|580596333|FG001|Overall Study|Withdrawal by Subject|0|||
160784023|NCT01502072|580596334|FG002|Overall Study|Withdrawal by Subject|0|||
160784024|NCT01502072|580596332|FG000|Overall Study|Death|0|||
160784025|NCT01502072|580596333|FG001|Overall Study|Death|1|||
160784026|NCT01502072|580596334|FG002|Overall Study|Death|0|||
160784027|NCT04821245|580596335|FG000|Overall Study|Withdrawal by Subject|3|||
160784028|NCT04821245|580596335|FG000|Overall Study|Physician Decision|1|||
160784029|NCT04821245|580596335|FG000|Overall Study|Protocol Violation|5|||
160784030|NCT02773537|580596343|FG000|Overall Study|Lost to Follow-up|0|||
160784031|NCT02773537|580596344|FG001|Overall Study|Lost to Follow-up|1|||
160784032|NCT02773537|580596345|FG002|Overall Study|Lost to Follow-up|4|||
160784033|NCT01840163|580596346|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
160784034|NCT01840163|580596347|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
160784035|NCT01840163|580596346|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
160784036|NCT01840163|580596347|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
160784037|NCT01840163|580596346|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
160784038|NCT01840163|580596347|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
160981740|NCT01448044|581321753|FG001|Treatment Period|Lost to Follow-up|1|||
160981741|NCT01448044|581321752|FG000|Treatment Period|Other reason|2|||
160981742|NCT01448044|581321753|FG001|Treatment Period|Other reason|0|||
160784039|NCT00662038|580596348|FG000|Overall Study|Reason not specified|3|||
160784040|NCT00662038|580596348|FG000|Overall Study|Withdrawn consent|22|||
160784041|NCT00662038|580596348|FG000|Overall Study|Withdrawal by Subject|83|||
160981743|NCT01448044|581321752|FG000|Follow Up Period|Withdrawal by Subject|1|||
160981744|NCT01448044|581321753|FG001|Follow Up Period|Withdrawal by Subject|1|||
160639977|NCT02629133|580064585|FG000|Overall Study|Withdrawal by Subject|1|||
160639978|NCT02629133|580064586|FG001|Overall Study|Withdrawal by Subject|1|||
160639979|NCT01238822|580064587|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
160639980|NCT02598193|580064588|FG000|Overall Study|Adverse Event|13|||
160784042|NCT00662038|580596348|FG000|Overall Study|Sponsor decision|1|||
160784043|NCT00662038|580596348|FG000|Overall Study|Physician Decision|19|||
160784044|NCT00662038|580596348|FG000|Overall Study|Lung transplantation|44|||
160784045|NCT00662038|580596348|FG000|Overall Study|Lost to Follow-up|1|||
160784046|NCT00662038|580596348|FG000|Overall Study|Death|95|||
160981745|NCT01448044|581321752|FG000|Follow Up Period|Lost to Follow-up|6|||
160639981|NCT02598193|580064588|FG000|Overall Study|Withdrawal by Subject|1|||
160981746|NCT01448044|581321753|FG001|Follow Up Period|Lost to Follow-up|2|||
160981747|NCT01448044|581321752|FG000|Follow Up Period|Other|5|||
160981748|NCT01448044|581321753|FG001|Follow Up Period|Other|11|||
160981749|NCT02372058|581321756|FG000|Overall Study|Withdrawal by Subject|3|||
160981750|NCT00318149|581321757|FG000|Overall Study|Adverse Event|0|||
160981751|NCT00318149|581321758|FG001|Overall Study|Adverse Event|0|||
160981752|NCT00318149|581321759|FG002|Overall Study|Adverse Event|0|||
160981753|NCT00318149|581321760|FG003|Overall Study|Adverse Event|0|||
160542997|NCT03016325|579716416|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
160542998|NCT03016325|579716417|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
160542999|NCT03016325|579716418|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
160543000|NCT03016325|579716411|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
160543001|NCT03016325|579716412|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
160543002|NCT03016325|579716413|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
160543003|NCT03016325|579716414|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
160543004|NCT03016325|579716415|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
160543005|NCT03016325|579716416|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
160543006|NCT03016325|579716417|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
160543007|NCT03016325|579716418|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
160543008|NCT03016325|579716411|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
160543009|NCT03016325|579716412|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
160543010|NCT03016325|579716413|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
160543011|NCT03016325|579716414|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
160543012|NCT03016325|579716415|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
160543013|NCT03016325|579716416|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
160543014|NCT03016325|579716417|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
160543015|NCT03016325|579716418|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
160543016|NCT03016325|579716411|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
160543017|NCT03016325|579716412|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
160543018|NCT03016325|579716413|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
160543019|NCT03016325|579716414|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
160543020|NCT03016325|579716415|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
160543021|NCT03016325|579716416|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
160543022|NCT03016325|579716417|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
160543023|NCT03016325|579716418|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
160543024|NCT03016325|579716411|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
160543025|NCT03016325|579716412|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
160543026|NCT03016325|579716413|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
160543027|NCT03016325|579716414|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
160543028|NCT03016325|579716415|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
160543029|NCT03016325|579716416|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
160543030|NCT03016325|579716417|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
160543031|NCT03016325|579716418|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
160543032|NCT03016325|579716411|FG000|182-Day Follow-Up Period|Death|3|||
160543033|NCT03016325|579716412|FG001|182-Day Follow-Up Period|Death|3|||
160543034|NCT03016325|579716413|FG002|182-Day Follow-Up Period|Death|11|||
160543035|NCT03016325|579716414|FG003|182-Day Follow-Up Period|Death|12|||
160543036|NCT03016325|579716415|FG004|182-Day Follow-Up Period|Death|9|||
160543037|NCT03016325|579716416|FG005|182-Day Follow-Up Period|Death|0|||
160543038|NCT03016325|579716417|FG006|182-Day Follow-Up Period|Death|0|||
160543039|NCT03016325|579716418|FG007|182-Day Follow-Up Period|Death|1|||
160543040|NCT03016325|579716411|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
160543041|NCT03016325|579716412|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
160543042|NCT03016325|579716413|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
160543043|NCT03016325|579716414|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
160543044|NCT03016325|579716415|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
160543045|NCT03016325|579716416|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
160543046|NCT03016325|579716417|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
160543047|NCT03016325|579716418|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
160543048|NCT03016325|579716411|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
160543049|NCT03016325|579716412|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
160543050|NCT03016325|579716413|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
160543051|NCT03016325|579716414|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
160543052|NCT03016325|579716415|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
160543053|NCT03016325|579716416|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
160543054|NCT03016325|579716417|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
160543055|NCT03016325|579716418|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
160639982|NCT02598193|580064588|FG000|Overall Study|Listed in active lung transplant list|1|||
160639983|NCT02598193|580064588|FG000|Overall Study|Does not want to take Nintedanib|1|||
160639984|NCT02487979|580064589|FG000|Overall Study|Physician Decision|2|||
160639985|NCT02487979|580064589|FG000|Overall Study|Withdrawal by Subject|2|||
160639986|NCT02487979|580064589|FG000|Overall Study|Progressive Disease|17|||
160639987|NCT02410837|580064590|FG000|Overall Study|Death|387|||
160639988|NCT02410837|580064590|FG000|Overall Study|Lost to Follow-up|50|||
160639989|NCT02410837|580064590|FG000|Overall Study|Withdrawal by Subject|44|||
160639990|NCT02410837|580064590|FG000|Overall Study|Physician Decision|6|||
160639991|NCT02410837|580064590|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
160639992|NCT00837577|580064591|FG000|Double-blind Period|Clinical Adverse Event|1|||
160639993|NCT00837577|580064592|FG001|Double-blind Period|Clinical Adverse Event|0|||
160639994|NCT00837577|580064591|FG000|Double-blind Period|Withdrawal by Subject|1|||
160639995|NCT00837577|580064592|FG001|Double-blind Period|Withdrawal by Subject|0|||
160639996|NCT00837577|580064591|FG000|Open-label Period|Clinical Adverse Event|2|||
160639997|NCT00837577|580064592|FG001|Open-label Period|Clinical Adverse Event|2|||
160639998|NCT00837577|580064591|FG000|Open-label Period|Laboratory Adverse Event|0|||
160639999|NCT00837577|580064592|FG001|Open-label Period|Laboratory Adverse Event|1|||
160640000|NCT00837577|580064591|FG000|Open-label Period|Lack of Efficacy|4|||
160640001|NCT00837577|580064592|FG001|Open-label Period|Lack of Efficacy|3|||
160640002|NCT00837577|580064591|FG000|Open-label Period|Withdrawal by Subject|1|||
160640003|NCT00837577|580064592|FG001|Open-label Period|Withdrawal by Subject|2|||
160640004|NCT00837577|580064591|FG000|Open-label Period|Other Reason|1|||
160640005|NCT00837577|580064592|FG001|Open-label Period|Other Reason|1|||
160640006|NCT00849524|580064597|FG000|Overall Study|Lack of Efficacy|3|||
160640007|NCT01825876|580064598|FG000|Period 2|Withdrawal by Subject|0|||
160640008|NCT01825876|580064599|FG001|Period 2|Withdrawal by Subject|1|||
160640009|NCT02555618|580064600|FG000|Overall Study|Sponsor's Circumstances|1|||
160640010|NCT02555618|580064601|FG001|Overall Study|Sponsor's Circumstances|0|||
160640011|NCT02217345|580064602|FG000|Overall Study|Lost to Follow-up|2|||
160640012|NCT02217345|580064603|FG001|Overall Study|Lost to Follow-up|1|||
160640013|NCT02217345|580064602|FG000|Overall Study|Withdrawal by Subject|3|||
160640014|NCT02217345|580064603|FG001|Overall Study|Withdrawal by Subject|2|||
160640015|NCT02217345|580064602|FG000|Overall Study|Adverse Event|2|||
160640016|NCT02217345|580064603|FG001|Overall Study|Adverse Event|1|||
160640017|NCT02217345|580064602|FG000|Overall Study|Physician Decision|0|||
160640018|NCT02217345|580064603|FG001|Overall Study|Physician Decision|1|||
160640019|NCT00971204|580064604|FG000|Overall Study|Did not meet all criteria-not treated|14|||
160640020|NCT00971204|580064604|FG000|Overall Study|Lost to Follow-up|10|||
160784047|NCT00662038|580596348|FG000|Overall Study|Adverse Event|358|||
160784048|NCT00662038|580596348|FG000|Overall Study|Continued treatment|5|||
160640021|NCT02624518|580064605|FG000|Overall Study|Physician Decision|1|||
160640022|NCT02729194|580064606|FG000|Overall Study|Withdrawal by Subject|3|||
160640023|NCT00845026|580064607|FG000|Study Period III|Adverse Event|23|||
160640024|NCT00845026|580064608|FG001|Study Period III|Adverse Event|19|||
160640025|NCT00845026|580064607|FG000|Study Period III|Perceived lack of efficacy|27|||
160640026|NCT00845026|580064608|FG001|Study Period III|Perceived lack of efficacy|15|||
160784049|NCT00397046|580596349|FG000|Overall Study|Disease Progression|3|||
160784050|NCT00397046|580596350|FG001|Overall Study|Disease Progression|3|||
160784051|NCT00397046|580596351|FG002|Overall Study|Disease Progression|10|||
160784052|NCT00397046|580596352|FG003|Overall Study|Disease Progression|5|||
160784053|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
160784054|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
160784055|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
160784056|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
160784057|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
160784058|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
160784059|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
160784060|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
160784061|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
160784062|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
160784063|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
160784064|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
160784065|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Other|6|||
160784066|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Other|3|||
160784067|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Other|0|||
160784068|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
160784069|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
160784070|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
160784071|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
160784072|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
160784073|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
160784074|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Adverse Event|0|||
160784075|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Adverse Event|0|||
160784076|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Adverse Event|21|||
160784077|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
160784078|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
160784079|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
160784080|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
160784081|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
160784082|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
160784083|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
160784084|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
160784085|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
160784086|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Administrative|0|||
160784087|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Administrative|0|||
160784088|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Administrative|36|||
160784089|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Other|0|||
160784090|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Other|0|||
160784091|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Other|9|||
160784092|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
160784093|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
160784094|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
160784095|NCT01975285|580596374|FG000|Overall Study|Failed Block and follow up|2|||
160784096|NCT01975285|580596375|FG001|Overall Study|Failed Block and follow up|2|||
160784097|NCT02421510|580596376|FG000|Overall Study|Other|4|||
160784098|NCT02421510|580596377|FG001|Overall Study|Other|2|||
160784099|NCT02421510|580596378|FG002|Overall Study|Other|3|||
160784100|NCT02421510|580596376|FG000|Overall Study|Protocol Violation|1|||
160784101|NCT02421510|580596377|FG001|Overall Study|Protocol Violation|2|||
160784102|NCT02421510|580596378|FG002|Overall Study|Protocol Violation|0|||
160784103|NCT02421510|580596376|FG000|Overall Study|Death|1|||
160784104|NCT02421510|580596377|FG001|Overall Study|Death|0|||
160784105|NCT02421510|580596378|FG002|Overall Study|Death|0|||
160784106|NCT02421510|580596376|FG000|Overall Study|Noncompliance with study drug|1|||
160784107|NCT02421510|580596377|FG001|Overall Study|Noncompliance with study drug|0|||
160784108|NCT02421510|580596378|FG002|Overall Study|Noncompliance with study drug|0|||
160784109|NCT02421510|580596376|FG000|Overall Study|Physician Decision|1|||
160890116|NCT01307020|580991626|FG000|Overall Study|Lost to Follow-up|0|||
160890117|NCT01307020|580991627|FG001|Overall Study|Lost to Follow-up|0|||
160890118|NCT01307020|580991628|FG002|Overall Study|Lost to Follow-up|1|||
160890119|NCT01307020|580991629|FG003|Overall Study|Lost to Follow-up|1|||
160784110|NCT02421510|580596377|FG001|Overall Study|Physician Decision|1|||
160784111|NCT02421510|580596378|FG002|Overall Study|Physician Decision|3|||
160784112|NCT02421510|580596376|FG000|Overall Study|Adverse Event|9|||
160784113|NCT02421510|580596377|FG001|Overall Study|Adverse Event|10|||
160784114|NCT02421510|580596378|FG002|Overall Study|Adverse Event|18|||
160784115|NCT02421510|580596376|FG000|Overall Study|Pregnancy|1|||
160784116|NCT02421510|580596377|FG001|Overall Study|Pregnancy|1|||
160784117|NCT02421510|580596378|FG002|Overall Study|Pregnancy|0|||
160784118|NCT02421510|580596376|FG000|Overall Study|Withdrawal by Subject|14|||
160890120|NCT01307020|580991630|FG004|Overall Study|Lost to Follow-up|0|||
160784119|NCT02421510|580596377|FG001|Overall Study|Withdrawal by Subject|18|||
160784120|NCT02421510|580596378|FG002|Overall Study|Withdrawal by Subject|12|||
160784121|NCT02421510|580596376|FG000|Overall Study|Lost to Follow-up|1|||
160784122|NCT02421510|580596377|FG001|Overall Study|Lost to Follow-up|1|||
160784123|NCT02421510|580596378|FG002|Overall Study|Lost to Follow-up|0|||
160784124|NCT02852434|580596379|FG000|Overall Study|Withdrawal by Subject|0|||
160784125|NCT02852434|580596380|FG001|Overall Study|Withdrawal by Subject|1|||
160784126|NCT02852434|580596379|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
160784127|NCT02852434|580596380|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
160784128|NCT03774810|580596383|FG000|Phase 1|Lack of Efficacy|21|||
160784129|NCT03774810|580596384|FG001|Phase 1|Lack of Efficacy|0|||
160784130|NCT03774810|580596385|FG002|Phase 1|Lack of Efficacy|0|||
160784131|NCT03774810|580596386|FG003|Phase 1|Lack of Efficacy|0|||
160784132|NCT03774810|580596387|FG004|Phase 1|Lack of Efficacy|0|||
160784133|NCT03774810|580596383|FG000|Phase 1|Withdrawal by Subject|9|||
160784134|NCT03774810|580596384|FG001|Phase 1|Withdrawal by Subject|0|||
160784135|NCT03774810|580596385|FG002|Phase 1|Withdrawal by Subject|0|||
160784136|NCT03774810|580596386|FG003|Phase 1|Withdrawal by Subject|0|||
160784137|NCT03774810|580596387|FG004|Phase 1|Withdrawal by Subject|0|||
160784138|NCT03774810|580596383|FG000|Phase 1|Lost to Follow-up|2|||
160784139|NCT03774810|580596384|FG001|Phase 1|Lost to Follow-up|0|||
160784140|NCT03774810|580596385|FG002|Phase 1|Lost to Follow-up|0|||
160784141|NCT03774810|580596386|FG003|Phase 1|Lost to Follow-up|0|||
160784142|NCT03774810|580596387|FG004|Phase 1|Lost to Follow-up|0|||
160784143|NCT03774810|580596383|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
160784144|NCT03774810|580596384|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
160784145|NCT03774810|580596385|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
160784146|NCT03774810|580596386|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
160784147|NCT03774810|580596387|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
160784148|NCT03774810|580596383|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
160784149|NCT03774810|580596384|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
160784150|NCT03774810|580596385|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
160784151|NCT03774810|580596386|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
160784152|NCT03774810|580596387|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
160784153|NCT03774810|580596383|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
160784154|NCT03774810|580596384|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
160784155|NCT03774810|580596385|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
160784156|NCT03774810|580596386|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
160784157|NCT03774810|580596387|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
160784158|NCT03774810|580596383|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
160784159|NCT03774810|580596384|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
160784160|NCT03774810|580596385|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
160784161|NCT03774810|580596386|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
160784162|NCT03774810|580596387|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
160784163|NCT03774810|580596383|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
160784164|NCT03774810|580596384|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
160890121|NCT01307020|580991631|FG005|Overall Study|Lost to Follow-up|0|||
160890122|NCT01307020|580991632|FG006|Overall Study|Lost to Follow-up|1|||
160890123|NCT01307020|580991633|FG007|Overall Study|Lost to Follow-up|0|||
160890124|NCT01307020|580991634|FG008|Overall Study|Lost to Follow-up|0|||
160890125|NCT01307020|580991635|FG009|Overall Study|Lost to Follow-up|0|||
160890126|NCT01307020|580991626|FG000|Overall Study|Electronic data capture failure|0|||
160890127|NCT01307020|580991627|FG001|Overall Study|Electronic data capture failure|1|||
160890128|NCT01307020|580991628|FG002|Overall Study|Electronic data capture failure|0|||
160890129|NCT01307020|580991629|FG003|Overall Study|Electronic data capture failure|0|||
160890130|NCT01307020|580991630|FG004|Overall Study|Electronic data capture failure|0|||
160890131|NCT01307020|580991631|FG005|Overall Study|Electronic data capture failure|0|||
160890132|NCT01307020|580991632|FG006|Overall Study|Electronic data capture failure|0|||
160890133|NCT01307020|580991633|FG007|Overall Study|Electronic data capture failure|0|||
160890134|NCT01307020|580991634|FG008|Overall Study|Electronic data capture failure|0|||
160890135|NCT01307020|580991635|FG009|Overall Study|Electronic data capture failure|0|||
160890136|NCT00523367|580991636|FG000|Overall Study|19 screen failures|19|||
160890137|NCT00523367|580991636|FG000|Overall Study|4 Withdrawn by PI|4|||
160890138|NCT02793128|580991637|FG000|Overall Study|Death|4|||
160890139|NCT02793128|580991637|FG000|Overall Study|Withdrawal by Subject|2|||
160890140|NCT02793128|580991637|FG000|Overall Study|Physician Decision|1|||
160890141|NCT02793128|580991637|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
160890142|NCT02793128|580991637|FG000|Overall Study|Patient elected nephroureterectomy|1|||
160890143|NCT02125604|580991638|FG000|Overall Study|Other|4|||
160890144|NCT02125604|580991638|FG000|Overall Study|Investigator Decision|1|||
160890145|NCT02125604|580991638|FG000|Overall Study|Lost to Follow-up|2|||
160890146|NCT02125604|580991638|FG000|Overall Study|Consent Withdrawn|4|||
160890147|NCT02125604|580991638|FG000|Overall Study|Adverse Event|20|||
160890148|NCT04480424|580991639|FG000|Overall Study|Withdrawal by Subject|0|||
160890149|NCT04480424|580991640|FG001|Overall Study|Withdrawal by Subject|2|||
160784165|NCT03774810|580596385|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
160784166|NCT03774810|580596386|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
160784167|NCT03774810|580596387|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
160784168|NCT03774810|580596383|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
160784169|NCT03774810|580596384|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
160784170|NCT03774810|580596385|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
160784171|NCT03774810|580596386|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
160784172|NCT03774810|580596387|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
160784173|NCT00927186|580596390|FG000|12 Months Primary Study|Adverse Event|5|||
160784174|NCT00927186|580596391|FG001|12 Months Primary Study|Adverse Event|2|||
160784175|NCT00927186|580596390|FG000|12 Months Primary Study|Lost to Follow-up|1|||
160784176|NCT00927186|580596391|FG001|12 Months Primary Study|Lost to Follow-up|0|||
160784177|NCT00927186|580596390|FG000|12 Months Primary Study|Protocol Violation|0|||
160784178|NCT00927186|580596391|FG001|12 Months Primary Study|Protocol Violation|1|||
160784179|NCT00927186|580596390|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
160784180|NCT00927186|580596391|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
160784181|NCT01145222|580596392|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
160784182|NCT01145222|580596393|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
160784183|NCT01145222|580596394|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
160784184|NCT01145222|580596395|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
160784185|NCT01145222|580596392|FG000|Overall Study|Poor bowel preparation|0|||
160784186|NCT01145222|580596393|FG001|Overall Study|Poor bowel preparation|0|||
160784187|NCT01145222|580596394|FG002|Overall Study|Poor bowel preparation|0|||
160784188|NCT01145222|580596395|FG003|Overall Study|Poor bowel preparation|1|||
160784189|NCT00604383|580596396|FG000|Overall Study|Withdrawal by Subject|33|||
160784190|NCT00604383|580596397|FG001|Overall Study|Withdrawal by Subject|31|||
160784191|NCT00604383|580596396|FG000|Overall Study|Lost to Follow-up|24|||
160640027|NCT00845026|580064607|FG000|Study Period III|Withdrawal by Subject|19|||
160640028|NCT00845026|580064608|FG001|Study Period III|Withdrawal by Subject|15|||
160640029|NCT00845026|580064607|FG000|Study Period III|Entry Criteria not met|8|||
160640030|NCT00845026|580064608|FG001|Study Period III|Entry Criteria not met|11|||
160640031|NCT00845026|580064607|FG000|Study Period III|Lost to Follow-up|4|||
160640032|NCT00845026|580064608|FG001|Study Period III|Lost to Follow-up|5|||
160640033|NCT00845026|580064607|FG000|Study Period III|Protocol Violation|8|||
160640034|NCT00845026|580064608|FG001|Study Period III|Protocol Violation|1|||
160640035|NCT00845026|580064607|FG000|Study Period III|Scheduled conflict|3|||
160640036|NCT00845026|580064608|FG001|Study Period III|Scheduled conflict|1|||
160640037|NCT00845026|580064607|FG000|Study Period III|Subject is moving or has moved|2|||
160640038|NCT00845026|580064608|FG001|Study Period III|Subject is moving or has moved|4|||
160640039|NCT00845026|580064607|FG000|Study Period III|Transportation issues|1|||
160640040|NCT00845026|580064608|FG001|Study Period III|Transportation issues|1|||
160640041|NCT00845026|580064607|FG000|Study Period IV|Adverse Event|4|||
160640042|NCT00845026|580064608|FG001|Study Period IV|Adverse Event|0|||
160640043|NCT00845026|580064607|FG000|Study Period IV|Perceived lack of efficacy|2|||
160640044|NCT00845026|580064608|FG001|Study Period IV|Perceived lack of efficacy|1|||
160640045|NCT00845026|580064607|FG000|Study Period IV|Protocol Violation|3|||
160640046|NCT00845026|580064608|FG001|Study Period IV|Protocol Violation|1|||
160640047|NCT00845026|580064607|FG000|Study Period IV|Lost to Follow-up|1|||
160640048|NCT00845026|580064608|FG001|Study Period IV|Lost to Follow-up|0|||
160640049|NCT00845026|580064607|FG000|Study Period IV|Withdrawal by Subject|4|||
160640050|NCT00845026|580064608|FG001|Study Period IV|Withdrawal by Subject|1|||
160640051|NCT00845026|580064607|FG000|Study Period IV|Entry Criteria Not Met|1|||
160640052|NCT00845026|580064608|FG001|Study Period IV|Entry Criteria Not Met|0|||
160640053|NCT00845026|580064607|FG000|Study Period IV|Subject is moving or has moved|0|||
160640054|NCT00845026|580064608|FG001|Study Period IV|Subject is moving or has moved|1|||
160640055|NCT00845026|580064607|FG000|Study Period IV|Scheduling conflict|1|||
160640056|NCT00845026|580064608|FG001|Study Period IV|Scheduling conflict|0|||
160640057|NCT01325532|580064609|FG000|Overall Study|Withdrawal by Subject|2|||
160640058|NCT01325532|580064610|FG001|Overall Study|Withdrawal by Subject|0|||
160640059|NCT00272961|580064611|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
160640060|NCT00272961|580064612|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
160640061|NCT00272961|580064613|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
160640062|NCT00272961|580064614|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
160640063|NCT00272961|580064615|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
160640064|NCT00272961|580064611|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
160640065|NCT00272961|580064612|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
160640066|NCT00272961|580064613|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
160640067|NCT00272961|580064614|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
160640068|NCT00272961|580064615|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
160640069|NCT00272961|580064611|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
160640070|NCT00272961|580064612|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
160640071|NCT00272961|580064613|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
160640072|NCT00272961|580064614|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
160640073|NCT00272961|580064615|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
160640074|NCT00272961|580064611|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
160640075|NCT00272961|580064612|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
160640076|NCT00272961|580064613|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
160640077|NCT00272961|580064614|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
160640078|NCT00272961|580064615|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
160640079|NCT00272961|580064611|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
160640080|NCT00272961|580064612|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
160640081|NCT00272961|580064613|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
160640082|NCT00272961|580064614|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
160640083|NCT00272961|580064615|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
160640084|NCT00272961|580064611|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
160640085|NCT00272961|580064612|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
160640086|NCT00272961|580064613|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
160640087|NCT00272961|580064614|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
160640088|NCT00272961|580064615|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
160640089|NCT00272961|580064611|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
160640090|NCT00272961|580064612|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
160640091|NCT00272961|580064613|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
160640092|NCT00272961|580064614|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
160640093|NCT00272961|580064615|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
160640094|NCT00272961|580064611|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
160640095|NCT00272961|580064612|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
160640096|NCT00272961|580064613|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
160640097|NCT00272961|580064614|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
160640098|NCT00272961|580064615|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
160640099|NCT04556838|580064618|FG000|Overall Study|Withdrawal by Subject|3|||
160640100|NCT04556838|580064619|FG001|Overall Study|Withdrawal by Subject|1|||
160640101|NCT04556838|580064620|FG002|Overall Study|Withdrawal by Subject|2|||
160640102|NCT04556838|580064618|FG000|Overall Study|Adverse Event|0|||
160640103|NCT04556838|580064619|FG001|Overall Study|Adverse Event|1|||
160640104|NCT04556838|580064620|FG002|Overall Study|Adverse Event|1|||
160640105|NCT04556838|580064618|FG000|Overall Study|Lost to Follow-up|0|||
160640106|NCT04556838|580064619|FG001|Overall Study|Lost to Follow-up|0|||
160640107|NCT04556838|580064620|FG002|Overall Study|Lost to Follow-up|2|||
160640108|NCT04556838|580064618|FG000|Overall Study|Subject travel|0|||
160640109|NCT04556838|580064619|FG001|Overall Study|Subject travel|1|||
160640110|NCT04556838|580064620|FG002|Overall Study|Subject travel|0|||
160640111|NCT04556838|580064618|FG000|Overall Study|Physician Decision|1|||
160640112|NCT04556838|580064619|FG001|Overall Study|Physician Decision|0|||
160640113|NCT04556838|580064620|FG002|Overall Study|Physician Decision|0|||
160640114|NCT01458119|580064621|FG000|Overall Study|Physician Decision|4|||
160640115|NCT01458119|580064621|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
160640116|NCT01458119|580064621|FG000|Overall Study|Pregnancy|1|||
160640117|NCT01458119|580064621|FG000|Overall Study|Death|2|||
160640118|NCT01458119|580064621|FG000|Overall Study|Adverse Event|1|||
160640119|NCT01458119|580064621|FG000|Overall Study|Consent Withdrawn by Participant|8|||
160640120|NCT01458119|580064621|FG000|Overall Study|Non-compliance With Study Drug|3|||
160640121|NCT01963676|580066564|FG000|Overall Study|Withdrawal by Subject|1|||
160640122|NCT01963676|580066565|FG001|Overall Study|Withdrawal by Subject|0|||
160640123|NCT00766506|580066566|FG000|Overall Study|Use rescue medication after 3 hours|3|||
160640124|NCT00766506|580066567|FG001|Overall Study|Use rescue medication after 3 hours|0|||
160640125|NCT00766506|580066566|FG000|Overall Study|Other|2|||
160640126|NCT00766506|580066567|FG001|Overall Study|Other|2|||
160640127|NCT03053622|580066568|FG000|Overall Study|Lost to Follow-up|0|||
160640128|NCT03053622|580066569|FG001|Overall Study|Lost to Follow-up|0|||
160640129|NCT03053622|580066570|FG002|Overall Study|Lost to Follow-up|0|||
160640130|NCT03053622|580066571|FG003|Overall Study|Lost to Follow-up|1|||
160640131|NCT01246986|580066572|FG000|Overall Study|Lost to Follow-up|0|||
160784192|NCT00604383|580596397|FG001|Overall Study|Lost to Follow-up|19|||
160784193|NCT00604383|580596396|FG000|Overall Study|Death|14|||
160784194|NCT00604383|580596397|FG001|Overall Study|Death|22|||
160784195|NCT00604383|580596396|FG000|Overall Study|Adverse Event|16|||
160784196|NCT00604383|580596397|FG001|Overall Study|Adverse Event|9|||
160784197|NCT00604383|580596396|FG000|Overall Study|Physician Decision|0|||
160784198|NCT00604383|580596397|FG001|Overall Study|Physician Decision|3|||
160784199|NCT01698008|580596398|FG000|Overall Study|Withdrawal by Subject|1|||
160784200|NCT01698008|580596399|FG001|Overall Study|Withdrawal by Subject|2|||
160784201|NCT01429623|580596403|FG000|Overall Study|Death|1|||
160784202|NCT01429623|580596404|FG001|Overall Study|Death|0|||
160784203|NCT01429623|580596403|FG000|Overall Study|Adverse Event|7|||
160784204|NCT01429623|580596404|FG001|Overall Study|Adverse Event|14|||
160784205|NCT01429623|580596403|FG000|Overall Study|Withdrawal by Subject|19|||
160784206|NCT01429623|580596404|FG001|Overall Study|Withdrawal by Subject|13|||
160784207|NCT01429623|580596403|FG000|Overall Study|Physician Decision|2|||
160784208|NCT01429623|580596404|FG001|Overall Study|Physician Decision|3|||
160784209|NCT01429623|580596403|FG000|Overall Study|Protocol Violation|3|||
160784210|NCT01429623|580596404|FG001|Overall Study|Protocol Violation|2|||
160784211|NCT01429623|580596403|FG000|Overall Study|Assorted|1|||
160784212|NCT01429623|580596404|FG001|Overall Study|Assorted|2|||
160784213|NCT01429623|580596403|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
160784214|NCT01429623|580596404|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
160784215|NCT01429623|580596403|FG000|Overall Study|No post baseline data|4|||
160784216|NCT01429623|580596404|FG001|Overall Study|No post baseline data|4|||
160784217|NCT04985682|580596415|FG000|Overall Study|Withdrawal by Subject|1|||
160784218|NCT00621322|580596416|FG000|Overall Study|Lost to Follow-up|0|||
160784219|NCT00621322|580596417|FG001|Overall Study|Lost to Follow-up|0|||
160784220|NCT00621322|580596418|FG002|Overall Study|Lost to Follow-up|0|||
160784221|NCT00621322|580596419|FG003|Overall Study|Lost to Follow-up|0|||
160784222|NCT00621322|580596420|FG004|Overall Study|Lost to Follow-up|1|||
160784223|NCT00621322|580596421|FG005|Overall Study|Lost to Follow-up|0|||
160784224|NCT00621322|580596416|FG000|Overall Study|Physician Decision|0|||
160784225|NCT00621322|580596417|FG001|Overall Study|Physician Decision|0|||
160784226|NCT00621322|580596418|FG002|Overall Study|Physician Decision|1|||
160784227|NCT00621322|580596419|FG003|Overall Study|Physician Decision|1|||
160784228|NCT00621322|580596420|FG004|Overall Study|Physician Decision|0|||
160784229|NCT00621322|580596421|FG005|Overall Study|Physician Decision|0|||
160784230|NCT00621322|580596416|FG000|Overall Study|Withdrawal by Subject|0|||
160784231|NCT00621322|580596417|FG001|Overall Study|Withdrawal by Subject|0|||
160784232|NCT00621322|580596418|FG002|Overall Study|Withdrawal by Subject|0|||
160784233|NCT00621322|580596419|FG003|Overall Study|Withdrawal by Subject|1|||
160784234|NCT00621322|580596420|FG004|Overall Study|Withdrawal by Subject|0|||
160784235|NCT00621322|580596421|FG005|Overall Study|Withdrawal by Subject|2|||
160784236|NCT00621322|580596416|FG000|Overall Study|Migrated/moved from study area|1|||
160784237|NCT00621322|580596417|FG001|Overall Study|Migrated/moved from study area|0|||
160784238|NCT00621322|580596418|FG002|Overall Study|Migrated/moved from study area|1|||
160784239|NCT00621322|580596419|FG003|Overall Study|Migrated/moved from study area|1|||
160784240|NCT00621322|580596420|FG004|Overall Study|Migrated/moved from study area|0|||
160784241|NCT00621322|580596421|FG005|Overall Study|Migrated/moved from study area|2|||
160784242|NCT00756444|580596428|FG000|Overall Study|Adverse Event|1|||
160784243|NCT00756444|580596429|FG001|Overall Study|Adverse Event|1|||
160784244|NCT00756444|580596428|FG000|Overall Study|Withdrawal by Subject|6|||
160784245|NCT00756444|580596429|FG001|Overall Study|Withdrawal by Subject|8|||
160784246|NCT00756444|580596428|FG000|Overall Study|Lost to Follow-up|0|||
160784247|NCT00756444|580596429|FG001|Overall Study|Lost to Follow-up|1|||
160784248|NCT00756444|580596428|FG000|Overall Study|Death|5|||
160784249|NCT00756444|580596429|FG001|Overall Study|Death|4|||
160784250|NCT00756444|580596428|FG000|Overall Study|Disease Progression|2|||
160784251|NCT00756444|580596429|FG001|Overall Study|Disease Progression|7|||
160784252|NCT00756444|580596428|FG000|Overall Study|Ineligibility Determined|1|||
160784253|NCT00756444|580596429|FG001|Overall Study|Ineligibility Determined|0|||
160981754|NCT00318149|581321761|FG004|Overall Study|Adverse Event|0|||
160784254|NCT00601107|580596430|FG000|Overall Study|Adverse Event|0|||
160784255|NCT00601107|580596431|FG001|Overall Study|Adverse Event|1|||
160784256|NCT00601107|580596432|FG002|Overall Study|Adverse Event|3|||
160784257|NCT00601107|580596433|FG003|Overall Study|Adverse Event|0|||
160784258|NCT00601107|580596430|FG000|Overall Study|Withdrawal by Subject|5|||
160784259|NCT00601107|580596431|FG001|Overall Study|Withdrawal by Subject|4|||
160784260|NCT00601107|580596432|FG002|Overall Study|Withdrawal by Subject|7|||
160784261|NCT00601107|580596433|FG003|Overall Study|Withdrawal by Subject|4|||
160784262|NCT00601107|580596430|FG000|Overall Study|Lost to Follow-up|3|||
160784263|NCT00601107|580596431|FG001|Overall Study|Lost to Follow-up|3|||
160784264|NCT00601107|580596432|FG002|Overall Study|Lost to Follow-up|0|||
160784265|NCT00601107|580596433|FG003|Overall Study|Lost to Follow-up|3|||
160784266|NCT00601107|580596430|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
160784267|NCT00601107|580596431|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
160784268|NCT00601107|580596432|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
160784269|NCT00601107|580596433|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
160784270|NCT00601107|580596430|FG000|Overall Study|Worsening of Psoriasis|4|||
160784271|NCT00601107|580596431|FG001|Overall Study|Worsening of Psoriasis|1|||
160784272|NCT00601107|580596432|FG002|Overall Study|Worsening of Psoriasis|1|||
160784273|NCT00601107|580596433|FG003|Overall Study|Worsening of Psoriasis|4|||
160784274|NCT00601107|580596430|FG000|Overall Study|Undefined|1|||
160784275|NCT00601107|580596431|FG001|Overall Study|Undefined|0|||
160784276|NCT00601107|580596432|FG002|Overall Study|Undefined|1|||
160784277|NCT00601107|580596433|FG003|Overall Study|Undefined|0|||
160890150|NCT04480424|580991639|FG000|Overall Study|Lost to Follow-up|3|||
160890151|NCT04480424|580991640|FG001|Overall Study|Lost to Follow-up|3|||
160890152|NCT04480424|580991639|FG000|Overall Study|Death|14|||
160890153|NCT04480424|580991640|FG001|Overall Study|Death|16|||
160890154|NCT04480424|580991639|FG000|Overall Study|Reason not Specified|5|||
160890155|NCT04480424|580991640|FG001|Overall Study|Reason not Specified|5|||
160890156|NCT00721123|580992961|FG000|Overall Study|Adverse Event|96|||
160890157|NCT00721123|580992961|FG000|Overall Study|Death|10|||
160890158|NCT00721123|580992961|FG000|Overall Study|Insufficient Therapeutic Response|21|||
160890159|NCT00721123|580992961|FG000|Overall Study|Protocol Violation|1|||
160890160|NCT00721123|580992961|FG000|Overall Study|Refused Treatment|41|||
160890161|NCT00721123|580992961|FG000|Overall Study|Failure to Return|9|||
160890162|NCT00721123|580992961|FG000|Overall Study|Withdrawal by Subject|5|||
160890163|NCT05007717|580992962|FG000|Overall Study|Death|3|||
160890164|NCT05007717|580992963|FG001|Overall Study|Death|2|||
160890165|NCT00423670|580992967|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
160890166|NCT00423670|580992968|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890167|NCT00423670|580992969|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890168|NCT00423670|580992970|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890169|NCT00423670|580992971|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890170|NCT00423670|580992972|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890171|NCT00423670|580992973|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890172|NCT00423670|580992974|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890173|NCT00423670|580992967|FG000|Treatment Period|Adverse Event|8|||
160890174|NCT00423670|580992968|FG001|Treatment Period|Adverse Event|12|||
160890175|NCT00423670|580992969|FG002|Treatment Period|Adverse Event|15|||
160890176|NCT00423670|580992970|FG003|Treatment Period|Adverse Event|20|||
160890177|NCT00423670|580992971|FG004|Treatment Period|Adverse Event|9|||
160890178|NCT00423670|580992972|FG005|Treatment Period|Adverse Event|4|||
160890179|NCT00423670|580992973|FG006|Treatment Period|Adverse Event|7|||
160890180|NCT00423670|580992974|FG007|Treatment Period|Adverse Event|2|||
160784278|NCT03892915|580596434|FG000|Overall Study|Lost to Follow-up|6|||
160784279|NCT03892915|580596435|FG001|Overall Study|Lost to Follow-up|12|||
160784280|NCT03892915|580596434|FG000|Overall Study|Death|0|||
160784281|NCT03892915|580596435|FG001|Overall Study|Death|2|||
160784282|NCT03892915|580596434|FG000|Overall Study|Withdrawal by Subject|1|||
160784283|NCT03892915|580596435|FG001|Overall Study|Withdrawal by Subject|1|||
160784284|NCT03892915|580596434|FG000|Overall Study|unsuccessful delivery|13|||
160784285|NCT03892915|580596435|FG001|Overall Study|unsuccessful delivery|18|||
160784286|NCT04576949|580596441|FG000|Overall Study|Adverse Event|1|||
160784287|NCT04576949|580596442|FG001|Overall Study|Adverse Event|3|||
160784288|NCT04576949|580596443|FG002|Overall Study|Adverse Event|2|||
160784289|NCT04576949|580596441|FG000|Overall Study|Withdrawal by Subject|41|||
160890181|NCT00423670|580992967|FG000|Treatment Period|Protocol-defined clinical event|0|||
160890182|NCT00423670|580992968|FG001|Treatment Period|Protocol-defined clinical event|7|||
160890183|NCT00423670|580992969|FG002|Treatment Period|Protocol-defined clinical event|4|||
160890184|NCT00423670|580992970|FG003|Treatment Period|Protocol-defined clinical event|12|||
160890185|NCT00423670|580992971|FG004|Treatment Period|Protocol-defined clinical event|5|||
160890186|NCT00423670|580992972|FG005|Treatment Period|Protocol-defined clinical event|4|||
160890187|NCT00423670|580992973|FG006|Treatment Period|Protocol-defined clinical event|16|||
160890188|NCT00423670|580992974|FG007|Treatment Period|Protocol-defined clinical event|15|||
160890189|NCT00423670|580992967|FG000|Treatment Period|Lost to Follow-up|2|||
160890190|NCT00423670|580992968|FG001|Treatment Period|Lost to Follow-up|1|||
160890191|NCT00423670|580992969|FG002|Treatment Period|Lost to Follow-up|3|||
160890192|NCT00423670|580992970|FG003|Treatment Period|Lost to Follow-up|1|||
160890193|NCT00423670|580992971|FG004|Treatment Period|Lost to Follow-up|6|||
160890194|NCT00423670|580992972|FG005|Treatment Period|Lost to Follow-up|0|||
160890195|NCT00423670|580992973|FG006|Treatment Period|Lost to Follow-up|3|||
160890196|NCT00423670|580992974|FG007|Treatment Period|Lost to Follow-up|1|||
160890197|NCT00423670|580992967|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
160890198|NCT00423670|580992968|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
160784290|NCT04576949|580596442|FG001|Overall Study|Withdrawal by Subject|26|||
160784291|NCT04576949|580596443|FG002|Overall Study|Withdrawal by Subject|18|||
160890199|NCT00423670|580992969|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
160890200|NCT00423670|580992970|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
160890201|NCT00423670|580992971|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
160784292|NCT04576949|580596441|FG000|Overall Study|Physician Decision|3|||
160784293|NCT04576949|580596442|FG001|Overall Study|Physician Decision|0|||
160784294|NCT04576949|580596443|FG002|Overall Study|Physician Decision|0|||
160784295|NCT04576949|580596441|FG000|Overall Study|Death|0|||
160784296|NCT04576949|580596442|FG001|Overall Study|Death|1|||
160784297|NCT04576949|580596443|FG002|Overall Study|Death|0|||
160784298|NCT04576949|580596441|FG000|Overall Study|Lost to Follow-up|29|||
160784299|NCT04576949|580596442|FG001|Overall Study|Lost to Follow-up|37|||
160784300|NCT04576949|580596443|FG002|Overall Study|Lost to Follow-up|24|||
160784301|NCT04576949|580596441|FG000|Overall Study|Other, Not Specified|2|||
160784302|NCT04576949|580596442|FG001|Overall Study|Other, Not Specified|3|||
160784303|NCT04576949|580596443|FG002|Overall Study|Other, Not Specified|1|||
160784304|NCT04576949|580596441|FG000|Overall Study|Other|1|||
160784305|NCT04576949|580596442|FG001|Overall Study|Other|0|||
160784306|NCT04576949|580596443|FG002|Overall Study|Other|0|||
160784307|NCT01078545|580596444|FG000|Overall Study|Lost to Follow-up|13|||
160784308|NCT01078545|580596444|FG000|Overall Study|Physician Decision|6|||
160784309|NCT01078545|580596444|FG000|Overall Study|Withdrawal by Subject|3|||
160784310|NCT01078545|580596444|FG000|Overall Study|Death|3|||
160784311|NCT01078545|580596444|FG000|Overall Study|Participant moved to another physician|1|||
160784312|NCT03501277|580596451|FG000|Intervention Period 1 (4 Days)|Other|0|||
160784313|NCT03501277|580596452|FG001|Intervention Period 1 (4 Days)|Other|0|||
160784314|NCT03501277|580596453|FG002|Intervention Period 1 (4 Days)|Other|1|||
160784315|NCT03501277|580596454|FG003|Intervention Period 1 (4 Days)|Other|0|||
160784316|NCT03501277|580596451|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
160784317|NCT03501277|580596452|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
160784318|NCT03501277|580596453|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
160784319|NCT03501277|580596454|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
160784320|NCT03501277|580596451|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
160784321|NCT03501277|580596452|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
160784322|NCT03501277|580596453|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
160784323|NCT03501277|580596454|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
160784324|NCT03501277|580596451|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
160784325|NCT03501277|580596452|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
160784326|NCT03501277|580596453|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
160784327|NCT03501277|580596454|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
160784328|NCT01489358|580596455|FG000|Overall Study|Lost to Follow-up|0|||
160784329|NCT01489358|580596456|FG001|Overall Study|Lost to Follow-up|0|||
160784330|NCT01489358|580596457|FG002|Overall Study|Lost to Follow-up|2|||
160784331|NCT01873833|580596458|FG000|Overall Study|Withdrawal by Subject|1|||
160784332|NCT01968785|580596459|FG000|Overall Study|Withdrawal by Subject|1|||
160784333|NCT01968785|580596460|FG001|Overall Study|Withdrawal by Subject|0|||
160784334|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Adverse Event|14|||
160784335|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Adverse Event|27|||
160784336|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Adverse Event|60|||
160784337|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Adverse Event|0|||
160784338|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Adverse Event|0|||
160784339|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Pregnancy|0|||
160784340|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Pregnancy|7|||
160784341|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Pregnancy|9|||
160784342|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Pregnancy|0|||
160784343|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Pregnancy|0|||
160784344|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
160784345|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
160784346|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
160784347|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
160784348|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
160784349|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
160784350|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
160784351|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
160784352|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
160784353|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
160890202|NCT00423670|580992972|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
160784354|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Death|1|||
160784355|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Death|2|||
160890203|NCT00423670|580992973|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
160784356|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Death|2|||
160784357|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Death|0|||
160784358|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Death|0|||
160784359|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
160784360|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
160784361|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
160784362|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
160784363|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
160784364|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
160784365|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
160784366|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
160784367|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
160784368|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
160784369|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
160784370|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
160784371|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
160784372|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
160784373|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
160784374|NCT00098293|580596461|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
160784375|NCT00098293|580596462|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
160784376|NCT00098293|580596463|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
160784377|NCT00098293|580596464|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
160784378|NCT00098293|580596465|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
160784379|NCT00098293|580596461|FG000|Open-label (OL) Phase|Adverse Event|0|||
160784380|NCT00098293|580596462|FG001|Open-label (OL) Phase|Adverse Event|3|||
160784381|NCT00098293|580596463|FG002|Open-label (OL) Phase|Adverse Event|7|||
160784382|NCT00098293|580596464|FG003|Open-label (OL) Phase|Adverse Event|6|||
160784383|NCT00098293|580596465|FG004|Open-label (OL) Phase|Adverse Event|0|||
160784384|NCT00098293|580596461|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
160784385|NCT00098293|580596462|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
160784386|NCT00098293|580596463|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
160784387|NCT00098293|580596464|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
160981755|NCT00318149|581321762|FG005|Overall Study|Adverse Event|2|||
160981756|NCT03541642|581321763|FG000|Overall Study|Withdrawal by Subject|1|||
160784388|NCT00098293|580596465|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
160784389|NCT00098293|580596461|FG000|Open-label (OL) Phase|Pregnancy|0|||
160784390|NCT00098293|580596462|FG001|Open-label (OL) Phase|Pregnancy|1|||
160784391|NCT00098293|580596463|FG002|Open-label (OL) Phase|Pregnancy|0|||
160784392|NCT00098293|580596464|FG003|Open-label (OL) Phase|Pregnancy|3|||
160784393|NCT00098293|580596465|FG004|Open-label (OL) Phase|Pregnancy|0|||
160784394|NCT00098293|580596461|FG000|Open-label (OL) Phase|Protocol Violation|0|||
160784395|NCT00098293|580596462|FG001|Open-label (OL) Phase|Protocol Violation|6|||
160784396|NCT00098293|580596463|FG002|Open-label (OL) Phase|Protocol Violation|13|||
160784397|NCT00098293|580596464|FG003|Open-label (OL) Phase|Protocol Violation|16|||
160784398|NCT00098293|580596465|FG004|Open-label (OL) Phase|Protocol Violation|0|||
160784399|NCT00098293|580596461|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
160784400|NCT00098293|580596462|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
160784401|NCT00098293|580596463|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
160784402|NCT00098293|580596464|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
160784403|NCT00098293|580596465|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
160784404|NCT00098293|580596461|FG000|Open-label (OL) Phase|Death|0|||
160784405|NCT00098293|580596462|FG001|Open-label (OL) Phase|Death|2|||
160784406|NCT00098293|580596463|FG002|Open-label (OL) Phase|Death|3|||
160784407|NCT00098293|580596464|FG003|Open-label (OL) Phase|Death|0|||
160784408|NCT00098293|580596465|FG004|Open-label (OL) Phase|Death|0|||
160784409|NCT00098293|580596461|FG000|Supplemental Phase (SP)|Death|0|||
160784410|NCT00098293|580596462|FG001|Supplemental Phase (SP)|Death|0|||
160784411|NCT00098293|580596463|FG002|Supplemental Phase (SP)|Death|0|||
160981757|NCT03541642|581321764|FG001|Overall Study|Withdrawal by Subject|2|||
160981758|NCT03541642|581321763|FG000|Overall Study|Lost to Follow-up|16|||
160981759|NCT03541642|581321764|FG001|Overall Study|Lost to Follow-up|12|||
160981760|NCT03541642|581321763|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
160981761|NCT03541642|581321764|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
160784412|NCT00098293|580596464|FG003|Supplemental Phase (SP)|Death|0|||
160784413|NCT00098293|580596465|FG004|Supplemental Phase (SP)|Death|1|||
160784414|NCT00098293|580596461|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
160784415|NCT00098293|580596462|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
160784416|NCT00098293|580596463|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
160784417|NCT00098293|580596464|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
160784418|NCT00098293|580596465|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
160784419|NCT00098293|580596461|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
160543056|NCT03016325|579716411|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
160784420|NCT00098293|580596462|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
160784421|NCT00098293|580596463|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
160981762|NCT03523871|581321765|FG000|Overall Study|Death|1|||
160784422|NCT00098293|580596464|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
160784423|NCT00098293|580596465|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
160784424|NCT00098293|580596461|FG000|Supplemental Phase (SP)|Other|0|||
160543057|NCT03016325|579716412|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
160784425|NCT00098293|580596462|FG001|Supplemental Phase (SP)|Other|0|||
160784426|NCT00098293|580596463|FG002|Supplemental Phase (SP)|Other|0|||
160784427|NCT00098293|580596464|FG003|Supplemental Phase (SP)|Other|0|||
160784428|NCT00098293|580596465|FG004|Supplemental Phase (SP)|Other|22|||
160784429|NCT01569763|580598206|FG000|Overall Study|Lack of Efficacy|2|||
160784430|NCT01569763|580598207|FG001|Overall Study|Lack of Efficacy|7|||
160784431|NCT01569763|580598206|FG000|Overall Study|Adverse Event|1|||
160784432|NCT01569763|580598207|FG001|Overall Study|Adverse Event|0|||
160784433|NCT01926509|580598208|FG000|Overall Study|vital sign met discontinuation criteria|1|||
160784434|NCT01926509|580598209|FG001|Overall Study|vital sign met discontinuation criteria|0|||
160784435|NCT01926509|580598210|FG002|Overall Study|vital sign met discontinuation criteria|0|||
160784436|NCT01926509|580598211|FG003|Overall Study|vital sign met discontinuation criteria|0|||
160784437|NCT02730169|580598212|FG000|Overall Study|Protocol Violation|1|||
160784438|NCT02730169|580598213|FG001|Overall Study|Protocol Violation|0|||
160784439|NCT02730169|580598214|FG002|Overall Study|Protocol Violation|0|||
160784440|NCT02730169|580598215|FG003|Overall Study|Protocol Violation|1|||
160784441|NCT02730169|580598212|FG000|Overall Study|Adverse Event|2|||
160784442|NCT02730169|580598213|FG001|Overall Study|Adverse Event|3|||
160784443|NCT02730169|580598214|FG002|Overall Study|Adverse Event|3|||
160784444|NCT02730169|580598215|FG003|Overall Study|Adverse Event|0|||
160784445|NCT02730169|580598212|FG000|Overall Study|Adverse Event of Special Interest|0|||
160784446|NCT02730169|580598213|FG001|Overall Study|Adverse Event of Special Interest|1|||
160784447|NCT02730169|580598214|FG002|Overall Study|Adverse Event of Special Interest|2|||
160784448|NCT02730169|580598215|FG003|Overall Study|Adverse Event of Special Interest|0|||
160784449|NCT02730169|580598212|FG000|Overall Study|Withdrawal by Subject|6|||
160784450|NCT02730169|580598213|FG001|Overall Study|Withdrawal by Subject|11|||
160784451|NCT02730169|580598214|FG002|Overall Study|Withdrawal by Subject|6|||
160784452|NCT02730169|580598215|FG003|Overall Study|Withdrawal by Subject|8|||
160784453|NCT02730169|580598212|FG000|Overall Study|Lost to Follow-up|5|||
160784454|NCT02730169|580598213|FG001|Overall Study|Lost to Follow-up|6|||
160784455|NCT02730169|580598214|FG002|Overall Study|Lost to Follow-up|5|||
160784456|NCT02730169|580598215|FG003|Overall Study|Lost to Follow-up|6|||
160784457|NCT02730169|580598212|FG000|Overall Study|Other|0|||
160784458|NCT02730169|580598213|FG001|Overall Study|Other|0|||
160784459|NCT02730169|580598214|FG002|Overall Study|Other|1|||
160784460|NCT02730169|580598215|FG003|Overall Study|Other|1|||
160784461|NCT03004183|580598216|FG000|Overall Study|Adverse Event|7|||
160784462|NCT03004183|580598216|FG000|Overall Study|Lost to Follow-up|1|||
160784463|NCT03004183|580598216|FG000|Overall Study|Physician Decision|40|||
160784464|NCT03004183|580598216|FG000|Overall Study|Withdrawal by Subject|1|||
160784465|NCT03004183|580598216|FG000|Overall Study|COVID-19|1|||
160784466|NCT02698787|580598220|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
160784467|NCT02698787|580598221|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
160784468|NCT02469961|580598229|FG000|Overall Study|Physician Decision|4|||
160784469|NCT02469961|580598230|FG001|Overall Study|Physician Decision|1|||
160784470|NCT01748552|580598237|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
160784471|NCT01748552|580598238|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
160784472|NCT01748552|580598239|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
160784473|NCT01748552|580598240|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
160784474|NCT01748552|580598241|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
160784475|NCT01748552|580598242|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
160784476|NCT01748552|580598243|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
160784477|NCT01748552|580598244|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
160784478|NCT01748552|580598245|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
160784479|NCT01748552|580598246|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
160784480|NCT01748552|580598247|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
160784481|NCT01748552|580598248|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
160784482|NCT01748552|580598237|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784483|NCT01748552|580598238|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784484|NCT01748552|580598239|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784485|NCT01748552|580598240|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784486|NCT01748552|580598241|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784487|NCT01748552|580598242|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784488|NCT01748552|580598243|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
160640132|NCT01246986|580066573|FG001|Overall Study|Lost to Follow-up|1|||
160640133|NCT01246986|580066574|FG002|Overall Study|Lost to Follow-up|3|||
160640134|NCT01246986|580066575|FG003|Overall Study|Lost to Follow-up|0|||
160640135|NCT01246986|580066576|FG004|Overall Study|Lost to Follow-up|0|||
160640136|NCT01246986|580066577|FG005|Overall Study|Lost to Follow-up|1|||
160640137|NCT01246986|580066578|FG006|Overall Study|Lost to Follow-up|0|||
160640138|NCT01246986|580066572|FG000|Overall Study|Withdrawal by Subject|3|||
160640139|NCT01246986|580066573|FG001|Overall Study|Withdrawal by Subject|4|||
160640140|NCT01246986|580066574|FG002|Overall Study|Withdrawal by Subject|3|||
160640141|NCT01246986|580066575|FG003|Overall Study|Withdrawal by Subject|0|||
160640142|NCT01246986|580066576|FG004|Overall Study|Withdrawal by Subject|4|||
160640143|NCT01246986|580066577|FG005|Overall Study|Withdrawal by Subject|0|||
160640144|NCT01246986|580066578|FG006|Overall Study|Withdrawal by Subject|0|||
160640145|NCT01440647|580066583|FG000|Overall Study|Death|2|||
160640146|NCT01440647|580066584|FG001|Overall Study|Death|3|||
160640147|NCT01406873|580066598|FG000|Overall Study|Withdrawal by Subject|1|||
160640148|NCT01406873|580066599|FG001|Overall Study|Withdrawal by Subject|1|||
160640149|NCT03990389|580066600|FG000|Overall Study|Lost to Follow-up|3|||
160640150|NCT03990389|580066601|FG001|Overall Study|Lost to Follow-up|0|||
160640151|NCT00207714|580066602|FG000|Overall Study|Adverse Event|6|||
160640152|NCT00207714|580066603|FG001|Overall Study|Adverse Event|2|||
160640153|NCT00207714|580066604|FG002|Overall Study|Adverse Event|4|||
160640154|NCT00207714|580066605|FG003|Overall Study|Adverse Event|3|||
160640155|NCT00207714|580066606|FG004|Overall Study|Adverse Event|1|||
160640156|NCT00207714|580066602|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
160640157|NCT00207714|580066603|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160640158|NCT00207714|580066604|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
160640159|NCT00207714|580066605|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
160640160|NCT00207714|580066606|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
160640161|NCT00207714|580066602|FG000|Overall Study|Other|3|||
160640162|NCT00207714|580066603|FG001|Overall Study|Other|2|||
160640163|NCT00207714|580066604|FG002|Overall Study|Other|5|||
160640164|NCT00207714|580066605|FG003|Overall Study|Other|1|||
160640165|NCT00207714|580066606|FG004|Overall Study|Other|0|||
160640166|NCT03627195|580066607|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
160640167|NCT03627195|580066608|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
160640168|NCT03627195|580066609|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
160640169|NCT03627195|580066610|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
160640170|NCT03627195|580066611|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
160640171|NCT03627195|580066612|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
160640172|NCT02595528|580066616|FG000|Overall Study|Withdrawal by Subject|1|||
160640173|NCT02595528|580066617|FG001|Overall Study|Withdrawal by Subject|2|||
160640174|NCT02595528|580066618|FG002|Overall Study|Withdrawal by Subject|1|||
160640175|NCT02595528|580066619|FG003|Overall Study|Withdrawal by Subject|3|||
160640176|NCT02595528|580066616|FG000|Overall Study|Lost to Follow-up|1|||
160640177|NCT02595528|580066617|FG001|Overall Study|Lost to Follow-up|1|||
160640178|NCT02595528|580066618|FG002|Overall Study|Lost to Follow-up|0|||
160640179|NCT02595528|580066619|FG003|Overall Study|Lost to Follow-up|1|||
160640180|NCT03202511|580066620|FG000|Overall Study|Withdrawal by Subject|1|||
160640181|NCT03202511|580066621|FG001|Overall Study|Withdrawal by Subject|0|||
160640182|NCT00382291|580066625|FG000|Overall Study|Adverse Event|1|||
160640183|NCT00382291|580066626|FG001|Overall Study|Adverse Event|2|||
160640184|NCT00382291|580066627|FG002|Overall Study|Adverse Event|2|||
160640185|NCT00382291|580066625|FG000|Overall Study|Protocol Violation|1|||
160640186|NCT00382291|580066626|FG001|Overall Study|Protocol Violation|0|||
160640187|NCT00382291|580066627|FG002|Overall Study|Protocol Violation|0|||
160640188|NCT00382291|580066625|FG000|Overall Study|Temporary study suspension|2|||
160640189|NCT00382291|580066626|FG001|Overall Study|Temporary study suspension|2|||
160640190|NCT00382291|580066627|FG002|Overall Study|Temporary study suspension|5|||
160640191|NCT00382291|580066625|FG000|Overall Study|Withdrawal by Subject|0|||
160640192|NCT00382291|580066626|FG001|Overall Study|Withdrawal by Subject|2|||
160640193|NCT00382291|580066627|FG002|Overall Study|Withdrawal by Subject|0|||
160640194|NCT00382291|580066625|FG000|Overall Study|Physician Decision|0|||
160640195|NCT00382291|580066626|FG001|Overall Study|Physician Decision|1|||
160640196|NCT00382291|580066627|FG002|Overall Study|Physician Decision|0|||
160640197|NCT00382291|580066625|FG000|Overall Study|Lack of Efficacy|0|||
160640198|NCT00382291|580066626|FG001|Overall Study|Lack of Efficacy|0|||
160640199|NCT00382291|580066627|FG002|Overall Study|Lack of Efficacy|1|||
160640200|NCT01326702|580066628|FG000|Overall Study|Other|1|||
160640201|NCT01326702|580066629|FG001|Overall Study|Other|0|||
160640202|NCT01326702|580066630|FG002|Overall Study|Other|0|||
160640203|NCT01326702|580066631|FG003|Overall Study|Other|0|||
160640204|NCT01326702|580066632|FG004|Overall Study|Other|0|||
160640205|NCT01326702|580066633|FG005|Overall Study|Other|1|||
160640206|NCT01326702|580066634|FG006|Overall Study|Other|0|||
160640207|NCT01326702|580066628|FG000|Overall Study|progressive disease|1|||
160640208|NCT01326702|580066629|FG001|Overall Study|progressive disease|1|||
160640209|NCT01326702|580066630|FG002|Overall Study|progressive disease|3|||
160640210|NCT01326702|580066631|FG003|Overall Study|progressive disease|1|||
160784489|NCT01748552|580598244|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
160784490|NCT01748552|580598245|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
160784491|NCT01748552|580598246|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784492|NCT01748552|580598247|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784493|NCT01748552|580598248|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784494|NCT03994120|580598249|FG000|Overall Study|Lost to Follow-up|3|||
160784495|NCT03994120|580598250|FG001|Overall Study|Lost to Follow-up|1|||
160784496|NCT00981175|580598251|FG000|Primary Dose Vaccination|Adverse Event|1|||
160784497|NCT00981175|580598252|FG001|Primary Dose Vaccination|Adverse Event|0|||
160784498|NCT00981175|580598251|FG000|Primary Dose Vaccination|Protocol Violation|0|||
160784499|NCT00981175|580598252|FG001|Primary Dose Vaccination|Protocol Violation|1|||
160784500|NCT00981175|580598251|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
160784501|NCT00981175|580598252|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
160784502|NCT00981175|580598251|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
160784503|NCT00981175|580598252|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
160784504|NCT03156621|580598256|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
160784505|NCT03156621|580598257|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
160784506|NCT03156621|580598256|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160784507|NCT03156621|580598257|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
160784508|NCT03016403|580598260|FG000|Baseline|Death|5|||
160784509|NCT03016403|580598261|FG001|Baseline|Death|8|||
160784510|NCT03016403|580598262|FG002|Baseline|Death|1|||
160784511|NCT03016403|580598263|FG003|Baseline|Death|0|||
160784512|NCT03016403|580598260|FG000|Baseline|Withdrawal by Subject|2|||
160784513|NCT03016403|580598261|FG001|Baseline|Withdrawal by Subject|8|||
160784514|NCT03016403|580598262|FG002|Baseline|Withdrawal by Subject|4|||
160784515|NCT03016403|580598263|FG003|Baseline|Withdrawal by Subject|10|||
160784516|NCT03016403|580598260|FG000|Baseline|Lost to Follow-up|9|||
160784517|NCT03016403|580598261|FG001|Baseline|Lost to Follow-up|11|||
160784518|NCT03016403|580598262|FG002|Baseline|Lost to Follow-up|6|||
160784519|NCT03016403|580598263|FG003|Baseline|Lost to Follow-up|24|||
160784520|NCT03016403|580598260|FG000|6-week Follow-up|Death|1|||
160784521|NCT03016403|580598261|FG001|6-week Follow-up|Death|4|||
160784522|NCT03016403|580598262|FG002|6-week Follow-up|Death|0|||
160784523|NCT03016403|580598263|FG003|6-week Follow-up|Death|0|||
160784524|NCT03016403|580598260|FG000|6-week Follow-up|Lost to Follow-up|2|||
160784525|NCT03016403|580598261|FG001|6-week Follow-up|Lost to Follow-up|7|||
160784526|NCT03016403|580598262|FG002|6-week Follow-up|Lost to Follow-up|4|||
160784527|NCT03016403|580598263|FG003|6-week Follow-up|Lost to Follow-up|8|||
160784528|NCT03016403|580598260|FG000|6-week Follow-up|Withdrawal by Subject|0|||
160784529|NCT03016403|580598261|FG001|6-week Follow-up|Withdrawal by Subject|2|||
160784530|NCT03016403|580598262|FG002|6-week Follow-up|Withdrawal by Subject|0|||
160784531|NCT03016403|580598263|FG003|6-week Follow-up|Withdrawal by Subject|1|||
160784532|NCT03016403|580598260|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
160784533|NCT03016403|580598261|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
160784534|NCT03016403|580598262|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
160784535|NCT03016403|580598263|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
160784536|NCT03016403|580598260|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
160784537|NCT03016403|580598261|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
160784538|NCT03016403|580598262|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
160784539|NCT03016403|580598263|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
160784540|NCT03016403|580598260|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
160784541|NCT03016403|580598261|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
160640211|NCT01326702|580066632|FG004|Overall Study|progressive disease|3|||
160640212|NCT01326702|580066633|FG005|Overall Study|progressive disease|2|||
160640213|NCT01326702|580066634|FG006|Overall Study|progressive disease|3|||
160640214|NCT01326702|580066628|FG000|Overall Study|Death|0|||
160784542|NCT03016403|580598262|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
160784543|NCT03016403|580598263|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
160784544|NCT00799864|580598264|FG000|Overall Study|Participant reached a virologic endpoint|9|||
160784545|NCT00799864|580598265|FG001|Overall Study|Participant reached a virologic endpoint|2|||
160784546|NCT00799864|580598266|FG002|Overall Study|Participant reached a virologic endpoint|2|||
160784547|NCT00799864|580598267|FG003|Overall Study|Participant reached a virologic endpoint|0|||
160784548|NCT00799864|580598268|FG004|Overall Study|Participant reached a virologic endpoint|0|||
160784549|NCT00799864|580598264|FG000|Overall Study|Other|2|||
160784550|NCT00799864|580598265|FG001|Overall Study|Other|1|||
160784551|NCT00799864|580598266|FG002|Overall Study|Other|0|||
160784552|NCT00799864|580598267|FG003|Overall Study|Other|0|||
160640215|NCT01326702|580066629|FG001|Overall Study|Death|1|||
160784553|NCT00799864|580598268|FG004|Overall Study|Other|0|||
160784554|NCT00576407|580598269|FG000|Overall Study|Death|7|||
160784555|NCT00576407|580598269|FG000|Overall Study|Physician Decision|1|||
160784556|NCT00225758|580598270|FG000|Overall Study|Adverse Event|4|||
160784557|NCT04641975|580598271|FG000|Overall Study|Protocol Violation|1|||
160640216|NCT01326702|580066630|FG002|Overall Study|Death|0|||
160784558|NCT04641975|580598272|FG001|Overall Study|Protocol Violation|2|||
160981763|NCT01083160|581321766|FG000|Overall Study|Adverse Event|1|||
160981764|NCT01951092|581321767|FG000|Overall Study|Lost to Follow-up|10|||
160981765|NCT01951092|581321767|FG000|Overall Study|Incarceration|1|||
160784559|NCT04641975|580598273|FG002|Overall Study|Protocol Violation|0|||
160784560|NCT04641975|580598274|FG003|Overall Study|Protocol Violation|0|||
160784561|NCT04641975|580598271|FG000|Overall Study|Adverse Event|0|||
160981766|NCT01951092|581321767|FG000|Overall Study|Transfer of Care|1|||
160981767|NCT01712789|581321768|FG000|Overall Study|Lack of Efficacy|2|||
160981768|NCT01712789|581321768|FG000|Overall Study|Lost to Follow-up|1|||
160981769|NCT01712789|581321768|FG000|Overall Study|Progressive Disease|504|||
160981770|NCT01712789|581321768|FG000|Overall Study|Death|57|||
160981771|NCT01712789|581321768|FG000|Overall Study|Adverse Event|52|||
160981772|NCT01712789|581321768|FG000|Overall Study|Miscellaneous|31|||
160981773|NCT01712789|581321768|FG000|Overall Study|Withdrawal by Subject|21|||
160981774|NCT01712789|581321768|FG000|Overall Study|Transition to Commercial Treatment|8|||
160981775|NCT01712789|581321768|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
160981776|NCT00219141|581321769|FG000|Overall Study|Adverse Event|4|||
160981777|NCT00219141|581321770|FG001|Overall Study|Adverse Event|10|||
160981778|NCT00219141|581321771|FG002|Overall Study|Adverse Event|5|||
160981779|NCT00219141|581321769|FG000|Overall Study|Lack of Efficacy|3|||
160981780|NCT00219141|581321770|FG001|Overall Study|Lack of Efficacy|2|||
160981781|NCT00219141|581321771|FG002|Overall Study|Lack of Efficacy|0|||
160981782|NCT00219141|581321769|FG000|Overall Study|Administrative problems|0|||
160981783|NCT00219141|581321770|FG001|Overall Study|Administrative problems|1|||
160981784|NCT00219141|581321771|FG002|Overall Study|Administrative problems|0|||
160981785|NCT00219141|581321769|FG000|Overall Study|Lost to Follow-up|2|||
160981786|NCT00219141|581321770|FG001|Overall Study|Lost to Follow-up|4|||
160981787|NCT00219141|581321771|FG002|Overall Study|Lost to Follow-up|1|||
160981788|NCT00219141|581321769|FG000|Overall Study|Protocol Violation|3|||
160981789|NCT00219141|581321770|FG001|Overall Study|Protocol Violation|1|||
160981790|NCT00219141|581321771|FG002|Overall Study|Protocol Violation|1|||
160981791|NCT00219141|581321769|FG000|Overall Study|Withdrawal by Subject|1|||
160981792|NCT00219141|581321770|FG001|Overall Study|Withdrawal by Subject|3|||
160981793|NCT00219141|581321771|FG002|Overall Study|Withdrawal by Subject|5|||
160981794|NCT00219141|581321769|FG000|Overall Study|Condition no longer requires study drug|1|||
160981795|NCT00219141|581321770|FG001|Overall Study|Condition no longer requires study drug|0|||
160981796|NCT00219141|581321771|FG002|Overall Study|Condition no longer requires study drug|0|||
160981797|NCT01994720|581321772|FG000|Overall Study|Withdrawal by Subject|46|||
160981798|NCT01994720|581321773|FG001|Overall Study|Withdrawal by Subject|56|||
160981799|NCT01991197|581321774|FG000|Overall Study|Lost to Follow-up|1|||
160981800|NCT01991197|581321775|FG001|Overall Study|Lost to Follow-up|1|||
160981801|NCT01991197|581321774|FG000|Overall Study|Physician Decision|0|||
160981802|NCT01991197|581321775|FG001|Overall Study|Physician Decision|2|||
160981803|NCT01991197|581321774|FG000|Overall Study|Withdrawal by Subject|2|||
160981804|NCT01991197|581321775|FG001|Overall Study|Withdrawal by Subject|0|||
160981805|NCT01010217|581321777|FG000|Overall Study|Lost to Follow-up|4|||
160981806|NCT01010217|581321778|FG001|Overall Study|Lost to Follow-up|5|||
160981807|NCT01010217|581321779|FG002|Overall Study|Lost to Follow-up|1|||
160981808|NCT01010217|581321780|FG003|Overall Study|Lost to Follow-up|0|||
160981809|NCT01010217|581321781|FG004|Overall Study|Lost to Follow-up|0|||
160981810|NCT01010217|581321777|FG000|Overall Study|Withdrawal by Subject|1|||
160981811|NCT01010217|581321778|FG001|Overall Study|Withdrawal by Subject|0|||
160981812|NCT01010217|581321779|FG002|Overall Study|Withdrawal by Subject|0|||
160981813|NCT01010217|581321780|FG003|Overall Study|Withdrawal by Subject|0|||
160981814|NCT01010217|581321781|FG004|Overall Study|Withdrawal by Subject|0|||
160981815|NCT01010217|581321777|FG000|Overall Study|Physician Decision|0|||
160981816|NCT01010217|581321778|FG001|Overall Study|Physician Decision|0|||
160981817|NCT01010217|581321779|FG002|Overall Study|Physician Decision|0|||
160981818|NCT01010217|581321780|FG003|Overall Study|Physician Decision|6|||
160981819|NCT01010217|581321781|FG004|Overall Study|Physician Decision|3|||
160981820|NCT02061761|581321782|FG000|Overall Study|Disease progression|2|||
160981821|NCT02061761|581321783|FG001|Overall Study|Disease progression|8|||
160981822|NCT02061761|581321784|FG002|Overall Study|Disease progression|4|||
160981823|NCT02061761|581321785|FG003|Overall Study|Disease progression|5|||
160981824|NCT02061761|581321786|FG004|Overall Study|Disease progression|9|||
160981825|NCT02061761|581321787|FG005|Overall Study|Disease progression|3|||
160981826|NCT02061761|581321788|FG006|Overall Study|Disease progression|1|||
160981827|NCT02061761|581321789|FG007|Overall Study|Disease progression|2|||
160981828|NCT02061761|581321790|FG008|Overall Study|Disease progression|28|||
160981829|NCT02061761|581321782|FG000|Overall Study|Study Drug toxicity|0|||
160981830|NCT02061761|581321783|FG001|Overall Study|Study Drug toxicity|0|||
160981831|NCT02061761|581321784|FG002|Overall Study|Study Drug toxicity|0|||
160981832|NCT02061761|581321785|FG003|Overall Study|Study Drug toxicity|0|||
160981833|NCT02061761|581321786|FG004|Overall Study|Study Drug toxicity|0|||
160784562|NCT04641975|580598272|FG001|Overall Study|Adverse Event|0|||
160981834|NCT02061761|581321787|FG005|Overall Study|Study Drug toxicity|1|||
160981835|NCT02061761|581321788|FG006|Overall Study|Study Drug toxicity|0|||
160981836|NCT02061761|581321789|FG007|Overall Study|Study Drug toxicity|2|||
160784563|NCT04641975|580598273|FG002|Overall Study|Adverse Event|1|||
160784564|NCT04641975|580598274|FG003|Overall Study|Adverse Event|1|||
160784565|NCT04641975|580598271|FG000|Overall Study|Withdrawal by Subject|1|||
160784566|NCT04641975|580598272|FG001|Overall Study|Withdrawal by Subject|0|||
160784567|NCT04641975|580598273|FG002|Overall Study|Withdrawal by Subject|0|||
160784568|NCT04641975|580598274|FG003|Overall Study|Withdrawal by Subject|0|||
160784569|NCT01259024|580598275|FG000|Overall Study|Physician Decision|1|||
160784570|NCT01657500|580598276|FG000|Overall Study|set impropperly matched|3|||
160784571|NCT01657500|580598277|FG001|Overall Study|set impropperly matched|3|||
160784572|NCT01657500|580598276|FG000|Overall Study|Lost to Follow-up|2|||
160784573|NCT01657500|580598277|FG001|Overall Study|Lost to Follow-up|2|||
160784574|NCT03528577|580598280|FG000|Sequence 1|Failed Spirometry|1|||
160784575|NCT03528577|580598280|FG000|Sequence 1|Restricted medication|1|||
160784576|NCT03528577|580598280|FG000|Sequence 2|Adverse Event|1|||
160784577|NCT03528577|580598280|FG000|Sequence 2|Withdrawal by Subject|1|||
160784578|NCT03528577|580598280|FG000|Sequence 2|Failed Spirometry|1|||
160784579|NCT03528577|580598280|FG000|Sequence 3|Failed Spirometry|1|||
160784580|NCT03528577|580598280|FG000|Sequence 4|Failed Spirometry|2|||
160784581|NCT03528577|580598280|FG000|Sequence 4|Adverse Event|1|||
160784582|NCT03835117|580598281|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
160784583|NCT03835117|580598282|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
160784584|NCT03225989|580598286|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
160784585|NCT03225989|580598287|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
160784586|NCT03225989|580598288|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
160784587|NCT03225989|580598286|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
160784588|NCT03225989|580598287|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
160784589|NCT03225989|580598288|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
160784590|NCT03225989|580598286|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
160784591|NCT03225989|580598287|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
160784592|NCT03225989|580598288|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
160784593|NCT03225989|580598286|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
160784594|NCT03225989|580598287|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
160784595|NCT03225989|580598288|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
160784596|NCT03225989|580598286|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
160784597|NCT03225989|580598287|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
160784598|NCT03225989|580598288|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
160784599|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
160784600|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
160784601|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
160784602|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
160784603|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
160784604|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
160784605|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
160981837|NCT02061761|581321790|FG008|Overall Study|Study Drug toxicity|6|||
160981838|NCT02061761|581321782|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
160981839|NCT02061761|581321783|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
160981840|NCT02061761|581321784|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
160981841|NCT02061761|581321785|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
160981842|NCT02061761|581321786|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
160981843|NCT02061761|581321787|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
160981844|NCT02061761|581321788|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
160981845|NCT02061761|581321789|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
160981846|NCT02061761|581321790|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
160981847|NCT02061761|581321782|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160981848|NCT02061761|581321783|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160981849|NCT02061761|581321784|FG002|Overall Study|Participant request to discontinue study treatment|2|||
160981850|NCT02061761|581321785|FG003|Overall Study|Participant request to discontinue study treatment|2|||
160981851|NCT02061761|581321786|FG004|Overall Study|Participant request to discontinue study treatment|0|||
160981852|NCT02061761|581321787|FG005|Overall Study|Participant request to discontinue study treatment|1|||
160981853|NCT02061761|581321788|FG006|Overall Study|Participant request to discontinue study treatment|0|||
160784606|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
160981854|NCT02061761|581321789|FG007|Overall Study|Participant request to discontinue study treatment|0|||
160981855|NCT02061761|581321790|FG008|Overall Study|Participant request to discontinue study treatment|2|||
160784607|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
160784608|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
160981856|NCT02061761|581321782|FG000|Overall Study|Withdrawal by Subject|0|||
160784609|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
160784610|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
160784611|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
160640217|NCT01326702|580066631|FG003|Overall Study|Death|0|||
160640218|NCT01326702|580066632|FG004|Overall Study|Death|0|||
160640219|NCT01326702|580066633|FG005|Overall Study|Death|0|||
160640220|NCT01326702|580066634|FG006|Overall Study|Death|0|||
160640221|NCT01326702|580066628|FG000|Overall Study|Adverse Event|0|||
160640222|NCT01326702|580066629|FG001|Overall Study|Adverse Event|0|||
160640223|NCT01326702|580066630|FG002|Overall Study|Adverse Event|1|||
160640224|NCT01326702|580066631|FG003|Overall Study|Adverse Event|1|||
160640225|NCT01326702|580066632|FG004|Overall Study|Adverse Event|0|||
160640226|NCT01326702|580066633|FG005|Overall Study|Adverse Event|3|||
160640227|NCT01326702|580066634|FG006|Overall Study|Adverse Event|1|||
160640228|NCT01326702|580066628|FG000|Overall Study|Withdrawal by Subject|0|||
160640229|NCT01326702|580066629|FG001|Overall Study|Withdrawal by Subject|0|||
160640230|NCT01326702|580066630|FG002|Overall Study|Withdrawal by Subject|1|||
160640231|NCT01326702|580066631|FG003|Overall Study|Withdrawal by Subject|0|||
160640232|NCT01326702|580066632|FG004|Overall Study|Withdrawal by Subject|1|||
160640233|NCT01326702|580066633|FG005|Overall Study|Withdrawal by Subject|1|||
160640234|NCT01326702|580066634|FG006|Overall Study|Withdrawal by Subject|3|||
160640235|NCT01326702|580066628|FG000|Overall Study|Not Treated|0|||
160640236|NCT01326702|580066629|FG001|Overall Study|Not Treated|0|||
160640237|NCT01326702|580066630|FG002|Overall Study|Not Treated|0|||
160640238|NCT01326702|580066631|FG003|Overall Study|Not Treated|1|||
160640239|NCT01326702|580066632|FG004|Overall Study|Not Treated|0|||
160640240|NCT01326702|580066633|FG005|Overall Study|Not Treated|1|||
160640241|NCT01326702|580066634|FG006|Overall Study|Not Treated|0|||
160640242|NCT02082912|580066635|FG000|Overall Study|Physician Decision|0|||
160640243|NCT02082912|580066636|FG001|Overall Study|Physician Decision|1|||
160640244|NCT02266706|580066637|FG000|Overall Study|Withdrawal by Subject|0|||
160640245|NCT02266706|580066638|FG001|Overall Study|Withdrawal by Subject|1|||
160640246|NCT02266706|580066639|FG002|Overall Study|Withdrawal by Subject|1|||
160640247|NCT02266706|580066640|FG003|Overall Study|Withdrawal by Subject|0|||
160640248|NCT02266706|580066641|FG004|Overall Study|Withdrawal by Subject|0|||
160640249|NCT02266706|580066642|FG005|Overall Study|Withdrawal by Subject|1|||
160640250|NCT02266706|580066643|FG006|Overall Study|Withdrawal by Subject|0|||
160640251|NCT02266706|580066644|FG007|Overall Study|Withdrawal by Subject|0|||
160640252|NCT02266706|580066645|FG008|Overall Study|Withdrawal by Subject|0|||
160640253|NCT02266706|580066637|FG000|Overall Study|Screen failure|0|||
160640254|NCT02266706|580066638|FG001|Overall Study|Screen failure|0|||
160640255|NCT02266706|580066639|FG002|Overall Study|Screen failure|0|||
160640256|NCT02266706|580066640|FG003|Overall Study|Screen failure|0|||
160640257|NCT02266706|580066641|FG004|Overall Study|Screen failure|0|||
160640258|NCT02266706|580066642|FG005|Overall Study|Screen failure|1|||
160640259|NCT02266706|580066643|FG006|Overall Study|Screen failure|1|||
160640260|NCT02266706|580066644|FG007|Overall Study|Screen failure|0|||
160640261|NCT02266706|580066645|FG008|Overall Study|Screen failure|0|||
160640262|NCT02266706|580066637|FG000|Overall Study|Enrollment in another study|0|||
160640263|NCT02266706|580066638|FG001|Overall Study|Enrollment in another study|0|||
160640264|NCT02266706|580066639|FG002|Overall Study|Enrollment in another study|0|||
160640265|NCT02266706|580066640|FG003|Overall Study|Enrollment in another study|1|||
160640266|NCT02266706|580066641|FG004|Overall Study|Enrollment in another study|0|||
160640267|NCT02266706|580066642|FG005|Overall Study|Enrollment in another study|0|||
160640268|NCT02266706|580066643|FG006|Overall Study|Enrollment in another study|0|||
160640269|NCT02266706|580066644|FG007|Overall Study|Enrollment in another study|0|||
160640270|NCT02266706|580066645|FG008|Overall Study|Enrollment in another study|0|||
160640271|NCT02614703|580066646|FG000|Overall Study|Withdrawal by Subject|7|||
160640272|NCT02614703|580066647|FG001|Overall Study|Withdrawal by Subject|1|||
160640273|NCT01977352|580066658|FG000|Overall Study|Lost to Follow-up|1|||
160640274|NCT01977352|580066659|FG001|Overall Study|Lost to Follow-up|2|||
160640275|NCT00409188|580066663|FG000|Overall Study|Ongoing at data cut-off|383|||
160640276|NCT00409188|580066664|FG001|Overall Study|Ongoing at data cut-off|175|||
160640277|NCT00856778|580066665|FG000|Overall Study|Adverse Event|7|||
160640278|NCT00856778|580066665|FG000|Overall Study|Withdrawal by Subject|10|||
160640279|NCT00856778|580066665|FG000|Overall Study|Study deviation|2|||
160640280|NCT00856778|580066665|FG000|Overall Study|Lost to Follow-up|5|||
160640281|NCT02270983|580066666|FG000|Overall Study|Adverse Event|3|||
160640282|NCT02270983|580066667|FG001|Overall Study|Adverse Event|2|||
160640283|NCT02270983|580066668|FG002|Overall Study|Adverse Event|6|||
160543058|NCT03016325|579716413|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
160543059|NCT03016325|579716414|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
160543060|NCT03016325|579716415|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
160543061|NCT03016325|579716416|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
160543062|NCT03016325|579716417|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
160543063|NCT03016325|579716418|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
160543064|NCT03016325|579716411|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
160543065|NCT03016325|579716412|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
160543066|NCT03016325|579716413|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
160543067|NCT03016325|579716414|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
160543068|NCT03016325|579716415|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
160543069|NCT03016325|579716416|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
160543070|NCT03016325|579716417|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
160543071|NCT03016325|579716418|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
160543072|NCT03016325|579716411|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
160543073|NCT03016325|579716412|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
160543074|NCT03016325|579716413|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
160543075|NCT03016325|579716414|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
160543076|NCT03016325|579716415|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
160543077|NCT03016325|579716416|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
160543078|NCT03016325|579716417|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
160543079|NCT03016325|579716418|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
160543080|NCT03016325|579716411|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
160543081|NCT03016325|579716412|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
160543082|NCT03016325|579716413|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
160543083|NCT03016325|579716414|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
160543084|NCT03016325|579716415|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
160543085|NCT03016325|579716416|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
160543086|NCT03016325|579716417|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
160543087|NCT03016325|579716418|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
160543088|NCT03016325|579716411|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
160543089|NCT03016325|579716412|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
160543090|NCT03016325|579716413|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
160543091|NCT03016325|579716414|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
160543092|NCT03016325|579716415|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
160543093|NCT03016325|579716416|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
160543094|NCT03016325|579716417|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
160543095|NCT03016325|579716418|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
160543096|NCT03681119|579716419|FG000|Overall Study|No specific reason|4|||
160543097|NCT03681119|579716420|FG001|Overall Study|No specific reason|0|||
160543098|NCT03681119|579716419|FG000|Overall Study|Sickness|2|||
160543099|NCT03681119|579716420|FG001|Overall Study|Sickness|0|||
160543100|NCT01152021|579716424|FG000|Overall Study|Adverse Event|4|||
160543101|NCT01152021|579716425|FG001|Overall Study|Adverse Event|4|||
160543102|NCT01152021|579716424|FG000|Overall Study|Study drug had expired|1|||
160543103|NCT01152021|579716425|FG001|Overall Study|Study drug had expired|0|||
160543104|NCT01152021|579716424|FG000|Overall Study|Physician Decision|1|||
160543105|NCT01152021|579716425|FG001|Overall Study|Physician Decision|1|||
160543106|NCT01152021|579716424|FG000|Overall Study|No access to study drug in Pharmacy|0|||
160543107|NCT01152021|579716425|FG001|Overall Study|No access to study drug in Pharmacy|1|||
160543108|NCT02595723|579716426|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
160890204|NCT00423670|580992974|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
160543109|NCT02595723|579716427|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
160543110|NCT02595723|579716428|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
160543111|NCT02595723|579716426|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
160543112|NCT02595723|579716427|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
160543113|NCT02595723|579716428|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
160543114|NCT04288154|579716429|FG000|Overall Study|Withdrawal by Subject|9|||
160543115|NCT04288154|579716430|FG001|Overall Study|Withdrawal by Subject|9|||
160543116|NCT01902290|579716431|FG000|Overall Study|Withdrawal by Subject|19|||
160543117|NCT01902290|579716432|FG001|Overall Study|Withdrawal by Subject|27|||
160543118|NCT01902290|579716431|FG000|Overall Study|Lost to Follow-up|2|||
160543119|NCT01902290|579716432|FG001|Overall Study|Lost to Follow-up|2|||
160543120|NCT01902290|579716431|FG000|Overall Study|Death|1|||
160543121|NCT01902290|579716432|FG001|Overall Study|Death|0|||
160543122|NCT01902290|579716431|FG000|Overall Study|Sponsor Decision|26|||
160543123|NCT01902290|579716432|FG001|Overall Study|Sponsor Decision|24|||
160543124|NCT00385255|579716433|FG000|Overall Study|Serious Adverse Event|1|||
160543125|NCT00385255|579716434|FG001|Overall Study|Serious Adverse Event|2|||
160890205|NCT00423670|580992967|FG000|Treatment Period|Investigator decision|0|||
160784612|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
160784613|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
160784614|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
160784615|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
160784616|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
160784617|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
160784618|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
160784619|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
160784620|NCT03093870|580598292|FG000|Overall Study|Withdrawal by Subject|2|||
160784621|NCT03093870|580598293|FG001|Overall Study|Withdrawal by Subject|6|||
160784622|NCT03093870|580598294|FG002|Overall Study|Withdrawal by Subject|5|||
160784623|NCT03093870|580598292|FG000|Overall Study|Death|1|||
160784624|NCT03093870|580598293|FG001|Overall Study|Death|35|||
160784625|NCT03093870|580598294|FG002|Overall Study|Death|35|||
160784626|NCT03093870|580598292|FG000|Overall Study|Radiographic disease progression|10|||
160784627|NCT03093870|580598293|FG001|Overall Study|Radiographic disease progression|0|||
160784628|NCT03093870|580598294|FG002|Overall Study|Radiographic disease progression|0|||
160784629|NCT03093870|580598292|FG000|Overall Study|Clinical disease progression|1|||
160784630|NCT03093870|580598293|FG001|Overall Study|Clinical disease progression|0|||
160784631|NCT03093870|580598294|FG002|Overall Study|Clinical disease progression|0|||
160784632|NCT03093870|580598292|FG000|Overall Study|Physician Decision|2|||
160784633|NCT03093870|580598293|FG001|Overall Study|Physician Decision|0|||
160784634|NCT03093870|580598294|FG002|Overall Study|Physician Decision|0|||
160784635|NCT03093870|580598292|FG000|Overall Study|Adverse Event|7|||
160784636|NCT03093870|580598293|FG001|Overall Study|Adverse Event|0|||
160784637|NCT03093870|580598294|FG002|Overall Study|Adverse Event|0|||
160640284|NCT02270983|580066666|FG000|Overall Study|Lack of Efficacy|2|||
160543126|NCT00385255|579716433|FG000|Overall Study|Protocol Violation|0|||
160543127|NCT00385255|579716434|FG001|Overall Study|Protocol Violation|4|||
160543128|NCT00385255|579716433|FG000|Overall Study|Withdrawal by Subject|0|||
160543129|NCT00385255|579716434|FG001|Overall Study|Withdrawal by Subject|8|||
160543130|NCT00385255|579716433|FG000|Overall Study|Migrated/moved from study area|0|||
160543131|NCT00385255|579716434|FG001|Overall Study|Migrated/moved from study area|1|||
160543132|NCT00385255|579716433|FG000|Overall Study|Lost to Follow-up|20|||
160543133|NCT00385255|579716434|FG001|Overall Study|Lost to Follow-up|58|||
160543134|NCT00835237|579716435|FG000|Overall Study|Lost to Follow-up|4|||
160543135|NCT00835237|579716436|FG001|Overall Study|Lost to Follow-up|0|||
160543136|NCT00835237|579716435|FG000|Overall Study|Withdrawal by Subject|2|||
160543137|NCT00835237|579716436|FG001|Overall Study|Withdrawal by Subject|0|||
160543138|NCT00606086|579716440|FG000|Overall Study|Adverse Event|1|||
160543139|NCT00606086|579716441|FG001|Overall Study|Adverse Event|1|||
160543140|NCT00606086|579716440|FG000|Overall Study|Lost to Follow-up|4|||
160543141|NCT00606086|579716441|FG001|Overall Study|Lost to Follow-up|8|||
160543142|NCT00606086|579716440|FG000|Overall Study|Protocol Violation|1|||
160543143|NCT00606086|579716441|FG001|Overall Study|Protocol Violation|0|||
160543144|NCT00606086|579716440|FG000|Overall Study|Withdrawal by Subject|5|||
160543145|NCT00606086|579716441|FG001|Overall Study|Withdrawal by Subject|3|||
160543146|NCT00606086|579716440|FG000|Overall Study|Non-compliance|0|||
160543147|NCT00606086|579716441|FG001|Overall Study|Non-compliance|1|||
160543148|NCT00606086|579716440|FG000|Overall Study|Randomized, not treated|1|||
160640285|NCT02270983|580066667|FG001|Overall Study|Lack of Efficacy|1|||
160640286|NCT02270983|580066668|FG002|Overall Study|Lack of Efficacy|1|||
160640287|NCT02270983|580066666|FG000|Overall Study|Withdrawal by Subject|1|||
160640288|NCT02270983|580066667|FG001|Overall Study|Withdrawal by Subject|0|||
160784638|NCT03093870|580598292|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
160784639|NCT03093870|580598293|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
160784640|NCT03093870|580598294|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
160543149|NCT00606086|579716441|FG001|Overall Study|Randomized, not treated|2|||
160543150|NCT01015768|579716444|FG000|Overall Study|Some subject data unuseable|4|||
160543151|NCT01015768|579716445|FG001|Overall Study|Some subject data unuseable|4|||
160640289|NCT02270983|580066668|FG002|Overall Study|Withdrawal by Subject|2|||
160784641|NCT03093870|580598292|FG000|Overall Study|Lost to Follow-up|0|||
160784642|NCT03093870|580598293|FG001|Overall Study|Lost to Follow-up|0|||
160890206|NCT00423670|580992968|FG001|Treatment Period|Investigator decision|0|||
160543152|NCT01627860|579716446|FG000|Overall Study|Adverse Event|9|||
160543153|NCT01627860|579716447|FG001|Overall Study|Adverse Event|4|||
160543154|NCT01627860|579716446|FG000|Overall Study|Withdrawal by Subject|2|||
160543155|NCT01627860|579716447|FG001|Overall Study|Withdrawal by Subject|1|||
160543156|NCT01627860|579716446|FG000|Overall Study|Seizure frequency doubled|0|||
160543157|NCT01627860|579716447|FG001|Overall Study|Seizure frequency doubled|1|||
160543158|NCT01627860|579716446|FG000|Overall Study|Protocol Violation|1|||
160784643|NCT03093870|580598294|FG002|Overall Study|Lost to Follow-up|1|||
160784644|NCT02829957|580598296|FG000|Overall Study|Lost to Follow-up|2|||
160784645|NCT02829957|580598297|FG001|Overall Study|Lost to Follow-up|1|||
160784646|NCT03511066|580598299|FG000|Overall Study|Withdrawal by Subject|1|||
160784647|NCT03511066|580598300|FG001|Overall Study|Withdrawal by Subject|2|||
160784648|NCT03511066|580598301|FG002|Overall Study|Withdrawal by Subject|3|||
160784649|NCT03511066|580598299|FG000|Overall Study|Lost to Follow-up|2|||
160784650|NCT03511066|580598300|FG001|Overall Study|Lost to Follow-up|3|||
160784651|NCT03511066|580598301|FG002|Overall Study|Lost to Follow-up|0|||
160784652|NCT04146909|580598302|FG000|Overall Study|Withdrawal by Subject|3|||
160784653|NCT04146909|580598302|FG000|Overall Study|Did not qualify after consented|1|||
160784654|NCT00345592|580598303|FG000|Overall Study|Death|14|||
160784655|NCT00345592|580598304|FG001|Overall Study|Death|16|||
160784656|NCT00345592|580598303|FG000|Overall Study|Withdrawal by Subject|11|||
160981857|NCT02061761|581321783|FG001|Overall Study|Withdrawal by Subject|0|||
160981858|NCT02061761|581321784|FG002|Overall Study|Withdrawal by Subject|0|||
160543159|NCT01627860|579716447|FG001|Overall Study|Protocol Violation|0|||
160543160|NCT01225731|579716448|FG000|Part 1|Did not meet eligibility criteria|1|||
160543161|NCT01225731|579716449|FG001|Part 1|Did not meet eligibility criteria|0|||
160543162|NCT01225731|579716450|FG002|Part 1|Did not meet eligibility criteria|0|||
160543163|NCT01225731|579716451|FG003|Part 1|Did not meet eligibility criteria|0|||
160543164|NCT01225731|579716452|FG004|Part 1|Did not meet eligibility criteria|1|||
160543165|NCT01225731|579716453|FG005|Part 1|Did not meet eligibility criteria|0|||
160543166|NCT01225731|579716454|FG006|Part 1|Did not meet eligibility criteria|0|||
160543167|NCT01225731|579716455|FG007|Part 1|Did not meet eligibility criteria|0|||
160543168|NCT01225731|579716456|FG008|Part 1|Did not meet eligibility criteria|0|||
160543169|NCT01225731|579716457|FG009|Part 1|Did not meet eligibility criteria|0|||
160543170|NCT01225731|579716458|FG010|Part 1|Did not meet eligibility criteria|0|||
160543171|NCT01225731|579716459|FG011|Part 1|Did not meet eligibility criteria|0|||
160543172|NCT01225731|579716460|FG012|Part 1|Did not meet eligibility criteria|0|||
160543173|NCT01225731|579716448|FG000|Part 1|Adverse Event|1|||
160543174|NCT01225731|579716449|FG001|Part 1|Adverse Event|2|||
160543175|NCT01225731|579716450|FG002|Part 1|Adverse Event|1|||
160543176|NCT01225731|579716451|FG003|Part 1|Adverse Event|1|||
160543177|NCT01225731|579716452|FG004|Part 1|Adverse Event|1|||
160543178|NCT01225731|579716453|FG005|Part 1|Adverse Event|0|||
160543179|NCT01225731|579716454|FG006|Part 1|Adverse Event|0|||
160543180|NCT01225731|579716455|FG007|Part 1|Adverse Event|0|||
160543181|NCT01225731|579716456|FG008|Part 1|Adverse Event|0|||
160543182|NCT01225731|579716457|FG009|Part 1|Adverse Event|0|||
160543183|NCT01225731|579716458|FG010|Part 1|Adverse Event|0|||
160543184|NCT01225731|579716459|FG011|Part 1|Adverse Event|0|||
160543185|NCT01225731|579716460|FG012|Part 1|Adverse Event|0|||
160543186|NCT01225731|579716448|FG000|Part 1|Withdrawal by Subject|0|||
160543187|NCT01225731|579716449|FG001|Part 1|Withdrawal by Subject|3|||
160543188|NCT01225731|579716450|FG002|Part 1|Withdrawal by Subject|0|||
160543189|NCT01225731|579716451|FG003|Part 1|Withdrawal by Subject|0|||
160543190|NCT01225731|579716452|FG004|Part 1|Withdrawal by Subject|4|||
160543191|NCT01225731|579716453|FG005|Part 1|Withdrawal by Subject|0|||
160543192|NCT01225731|579716454|FG006|Part 1|Withdrawal by Subject|0|||
160543193|NCT01225731|579716455|FG007|Part 1|Withdrawal by Subject|0|||
160543194|NCT01225731|579716456|FG008|Part 1|Withdrawal by Subject|0|||
160543195|NCT01225731|579716457|FG009|Part 1|Withdrawal by Subject|0|||
160543196|NCT01225731|579716458|FG010|Part 1|Withdrawal by Subject|0|||
160543197|NCT01225731|579716459|FG011|Part 1|Withdrawal by Subject|0|||
160543198|NCT01225731|579716460|FG012|Part 1|Withdrawal by Subject|0|||
160543199|NCT01225731|579716448|FG000|Part 1|Protocol Violation|0|||
160543200|NCT01225731|579716449|FG001|Part 1|Protocol Violation|0|||
160543201|NCT01225731|579716450|FG002|Part 1|Protocol Violation|0|||
160543202|NCT01225731|579716451|FG003|Part 1|Protocol Violation|1|||
160543203|NCT01225731|579716452|FG004|Part 1|Protocol Violation|0|||
160543204|NCT01225731|579716453|FG005|Part 1|Protocol Violation|0|||
160543205|NCT01225731|579716454|FG006|Part 1|Protocol Violation|0|||
160543206|NCT01225731|579716455|FG007|Part 1|Protocol Violation|0|||
160543207|NCT01225731|579716456|FG008|Part 1|Protocol Violation|0|||
160543208|NCT01225731|579716457|FG009|Part 1|Protocol Violation|0|||
160543209|NCT01225731|579716458|FG010|Part 1|Protocol Violation|0|||
160543210|NCT01225731|579716459|FG011|Part 1|Protocol Violation|0|||
160543211|NCT01225731|579716460|FG012|Part 1|Protocol Violation|0|||
160543212|NCT01225731|579716448|FG000|Part 2|Protocol Violation|0|||
160543213|NCT01225731|579716449|FG001|Part 2|Protocol Violation|0|||
160543214|NCT01225731|579716450|FG002|Part 2|Protocol Violation|0|||
160543215|NCT01225731|579716451|FG003|Part 2|Protocol Violation|0|||
160543216|NCT01225731|579716452|FG004|Part 2|Protocol Violation|0|||
160784657|NCT00345592|580598304|FG001|Overall Study|Withdrawal by Subject|8|||
160543217|NCT01225731|579716453|FG005|Part 2|Protocol Violation|1|||
160543218|NCT01225731|579716454|FG006|Part 2|Protocol Violation|0|||
160543219|NCT01225731|579716455|FG007|Part 2|Protocol Violation|0|||
160543220|NCT01225731|579716456|FG008|Part 2|Protocol Violation|1|||
160543221|NCT01225731|579716457|FG009|Part 2|Protocol Violation|0|||
160543222|NCT01225731|579716458|FG010|Part 2|Protocol Violation|0|||
160543223|NCT01225731|579716459|FG011|Part 2|Protocol Violation|0|||
160543224|NCT01225731|579716460|FG012|Part 2|Protocol Violation|0|||
160543225|NCT01225731|579716448|FG000|Part 2|Adverse Event|0|||
160543226|NCT01225731|579716449|FG001|Part 2|Adverse Event|0|||
160543227|NCT01225731|579716450|FG002|Part 2|Adverse Event|0|||
160543228|NCT01225731|579716451|FG003|Part 2|Adverse Event|0|||
160543229|NCT01225731|579716452|FG004|Part 2|Adverse Event|0|||
160543230|NCT01225731|579716453|FG005|Part 2|Adverse Event|0|||
160543231|NCT01225731|579716454|FG006|Part 2|Adverse Event|4|||
160543232|NCT01225731|579716455|FG007|Part 2|Adverse Event|4|||
160543233|NCT01225731|579716456|FG008|Part 2|Adverse Event|2|||
160543234|NCT01225731|579716457|FG009|Part 2|Adverse Event|0|||
160543235|NCT01225731|579716458|FG010|Part 2|Adverse Event|0|||
160543236|NCT01225731|579716459|FG011|Part 2|Adverse Event|0|||
160543237|NCT01225731|579716460|FG012|Part 2|Adverse Event|0|||
160543238|NCT01225731|579716448|FG000|Part 2|Lack of Efficacy|0|||
160543239|NCT01225731|579716449|FG001|Part 2|Lack of Efficacy|0|||
160543240|NCT01225731|579716450|FG002|Part 2|Lack of Efficacy|0|||
160543241|NCT01225731|579716451|FG003|Part 2|Lack of Efficacy|0|||
160640290|NCT02270983|580066666|FG000|Overall Study|Lost to Follow-up|1|||
160543242|NCT01225731|579716452|FG004|Part 2|Lack of Efficacy|0|||
160543243|NCT01225731|579716453|FG005|Part 2|Lack of Efficacy|1|||
160543244|NCT01225731|579716454|FG006|Part 2|Lack of Efficacy|0|||
160543245|NCT01225731|579716455|FG007|Part 2|Lack of Efficacy|12|||
160543246|NCT01225731|579716456|FG008|Part 2|Lack of Efficacy|3|||
160543247|NCT01225731|579716457|FG009|Part 2|Lack of Efficacy|0|||
160543248|NCT01225731|579716458|FG010|Part 2|Lack of Efficacy|0|||
160543249|NCT01225731|579716459|FG011|Part 2|Lack of Efficacy|0|||
160543250|NCT01225731|579716460|FG012|Part 2|Lack of Efficacy|0|||
160543251|NCT01225731|579716448|FG000|Part 2|Pregnancy|0|||
160640291|NCT02270983|580066667|FG001|Overall Study|Lost to Follow-up|1|||
160640292|NCT02270983|580066668|FG002|Overall Study|Lost to Follow-up|2|||
160640293|NCT02270983|580066666|FG000|Overall Study|Protocol Violation|1|||
160543252|NCT01225731|579716449|FG001|Part 2|Pregnancy|0|||
160543253|NCT01225731|579716450|FG002|Part 2|Pregnancy|0|||
160543254|NCT01225731|579716451|FG003|Part 2|Pregnancy|0|||
160543255|NCT01225731|579716452|FG004|Part 2|Pregnancy|0|||
160543256|NCT01225731|579716453|FG005|Part 2|Pregnancy|0|||
160543257|NCT01225731|579716454|FG006|Part 2|Pregnancy|1|||
160543258|NCT01225731|579716455|FG007|Part 2|Pregnancy|0|||
160543259|NCT01225731|579716456|FG008|Part 2|Pregnancy|1|||
160543260|NCT01225731|579716457|FG009|Part 2|Pregnancy|0|||
160543261|NCT01225731|579716458|FG010|Part 2|Pregnancy|0|||
160640294|NCT02270983|580066667|FG001|Overall Study|Protocol Violation|1|||
160543262|NCT01225731|579716459|FG011|Part 2|Pregnancy|0|||
160543263|NCT01225731|579716460|FG012|Part 2|Pregnancy|0|||
160543264|NCT01225731|579716448|FG000|Part 2|Lost to Follow-up|0|||
160543265|NCT01225731|579716449|FG001|Part 2|Lost to Follow-up|0|||
160543266|NCT01225731|579716450|FG002|Part 2|Lost to Follow-up|0|||
160543267|NCT01225731|579716451|FG003|Part 2|Lost to Follow-up|0|||
160543268|NCT01225731|579716452|FG004|Part 2|Lost to Follow-up|0|||
160543269|NCT01225731|579716453|FG005|Part 2|Lost to Follow-up|0|||
160543270|NCT01225731|579716454|FG006|Part 2|Lost to Follow-up|0|||
160543271|NCT01225731|579716455|FG007|Part 2|Lost to Follow-up|3|||
160543272|NCT01225731|579716456|FG008|Part 2|Lost to Follow-up|1|||
160543273|NCT01225731|579716457|FG009|Part 2|Lost to Follow-up|0|||
160543274|NCT01225731|579716458|FG010|Part 2|Lost to Follow-up|0|||
160543275|NCT01225731|579716459|FG011|Part 2|Lost to Follow-up|0|||
160543276|NCT01225731|579716460|FG012|Part 2|Lost to Follow-up|0|||
160543277|NCT01225731|579716448|FG000|Part 2|Physician Decision|0|||
160543278|NCT01225731|579716449|FG001|Part 2|Physician Decision|0|||
160543279|NCT01225731|579716450|FG002|Part 2|Physician Decision|0|||
160543280|NCT01225731|579716451|FG003|Part 2|Physician Decision|0|||
160543281|NCT01225731|579716452|FG004|Part 2|Physician Decision|0|||
160543282|NCT01225731|579716453|FG005|Part 2|Physician Decision|0|||
160543283|NCT01225731|579716454|FG006|Part 2|Physician Decision|0|||
160543284|NCT01225731|579716455|FG007|Part 2|Physician Decision|2|||
160543285|NCT01225731|579716456|FG008|Part 2|Physician Decision|2|||
160543286|NCT01225731|579716457|FG009|Part 2|Physician Decision|0|||
160640295|NCT02270983|580066668|FG002|Overall Study|Protocol Violation|1|||
160543287|NCT01225731|579716458|FG010|Part 2|Physician Decision|0|||
160543288|NCT01225731|579716459|FG011|Part 2|Physician Decision|0|||
160543289|NCT01225731|579716460|FG012|Part 2|Physician Decision|0|||
160543290|NCT01225731|579716448|FG000|Part 2|Withdrawal by Subject|0|||
160543291|NCT01225731|579716449|FG001|Part 2|Withdrawal by Subject|0|||
160543292|NCT01225731|579716450|FG002|Part 2|Withdrawal by Subject|0|||
160543293|NCT01225731|579716451|FG003|Part 2|Withdrawal by Subject|0|||
160543294|NCT01225731|579716452|FG004|Part 2|Withdrawal by Subject|0|||
160543295|NCT01225731|579716453|FG005|Part 2|Withdrawal by Subject|1|||
160543296|NCT01225731|579716454|FG006|Part 2|Withdrawal by Subject|3|||
160543297|NCT01225731|579716455|FG007|Part 2|Withdrawal by Subject|4|||
160543298|NCT01225731|579716456|FG008|Part 2|Withdrawal by Subject|1|||
160543299|NCT01225731|579716457|FG009|Part 2|Withdrawal by Subject|0|||
160543300|NCT01225731|579716458|FG010|Part 2|Withdrawal by Subject|0|||
160640296|NCT02270983|580066666|FG000|Overall Study|family emergency|0|||
160640297|NCT02270983|580066667|FG001|Overall Study|family emergency|1|||
160640298|NCT02270983|580066668|FG002|Overall Study|family emergency|0|||
160640299|NCT02270983|580066666|FG000|Overall Study|study procedure non-compliance|1|||
160640300|NCT02270983|580066667|FG001|Overall Study|study procedure non-compliance|0|||
160543301|NCT01225731|579716459|FG011|Part 2|Withdrawal by Subject|0|||
160543302|NCT01225731|579716460|FG012|Part 2|Withdrawal by Subject|0|||
160543303|NCT01225731|579716448|FG000|Part 3|Adverse Event|0|||
160543304|NCT01225731|579716449|FG001|Part 3|Adverse Event|0|||
160543305|NCT01225731|579716450|FG002|Part 3|Adverse Event|0|||
160543306|NCT01225731|579716451|FG003|Part 3|Adverse Event|0|||
160543307|NCT01225731|579716452|FG004|Part 3|Adverse Event|0|||
160543308|NCT01225731|579716453|FG005|Part 3|Adverse Event|0|||
160543309|NCT01225731|579716454|FG006|Part 3|Adverse Event|0|||
160543310|NCT01225731|579716455|FG007|Part 3|Adverse Event|0|||
160543311|NCT01225731|579716456|FG008|Part 3|Adverse Event|0|||
160543312|NCT01225731|579716457|FG009|Part 3|Adverse Event|0|||
160543313|NCT01225731|579716458|FG010|Part 3|Adverse Event|1|||
160543314|NCT01225731|579716459|FG011|Part 3|Adverse Event|1|||
160543315|NCT01225731|579716460|FG012|Part 3|Adverse Event|0|||
160543316|NCT01225731|579716448|FG000|Part 3|Lost to Follow-up|0|||
160543317|NCT01225731|579716449|FG001|Part 3|Lost to Follow-up|0|||
160640301|NCT02270983|580066668|FG002|Overall Study|study procedure non-compliance|0|||
160640302|NCT02270983|580066666|FG000|Overall Study|moved away from study site|0|||
160784658|NCT04193527|580598309|FG000|Overall Study|Other|1|||
160543318|NCT01225731|579716450|FG002|Part 3|Lost to Follow-up|0|||
160543319|NCT01225731|579716451|FG003|Part 3|Lost to Follow-up|0|||
160543320|NCT01225731|579716452|FG004|Part 3|Lost to Follow-up|0|||
160543321|NCT01225731|579716453|FG005|Part 3|Lost to Follow-up|0|||
160543322|NCT01225731|579716454|FG006|Part 3|Lost to Follow-up|0|||
160543323|NCT01225731|579716455|FG007|Part 3|Lost to Follow-up|0|||
160543324|NCT01225731|579716456|FG008|Part 3|Lost to Follow-up|0|||
160543325|NCT01225731|579716457|FG009|Part 3|Lost to Follow-up|0|||
160543326|NCT01225731|579716458|FG010|Part 3|Lost to Follow-up|1|||
160543327|NCT01225731|579716459|FG011|Part 3|Lost to Follow-up|2|||
160543328|NCT01225731|579716460|FG012|Part 3|Lost to Follow-up|1|||
160543329|NCT01225731|579716448|FG000|Part 3|Physician Decision|0|||
160543330|NCT01225731|579716449|FG001|Part 3|Physician Decision|0|||
160543331|NCT01225731|579716450|FG002|Part 3|Physician Decision|0|||
160543332|NCT01225731|579716451|FG003|Part 3|Physician Decision|0|||
160543333|NCT01225731|579716452|FG004|Part 3|Physician Decision|0|||
160543334|NCT01225731|579716453|FG005|Part 3|Physician Decision|0|||
160543335|NCT01225731|579716454|FG006|Part 3|Physician Decision|0|||
160543336|NCT01225731|579716455|FG007|Part 3|Physician Decision|0|||
160640303|NCT02270983|580066667|FG001|Overall Study|moved away from study site|1|||
160640304|NCT02270983|580066668|FG002|Overall Study|moved away from study site|0|||
160784659|NCT04193527|580598310|FG001|Overall Study|Other|1|||
160784660|NCT04193527|580598311|FG002|Overall Study|Other|0|||
160784661|NCT03808909|580598312|FG000|Overall Study|Lost to Follow-up|3|||
160784662|NCT03808909|580598313|FG001|Overall Study|Lost to Follow-up|0|||
160784663|NCT00676689|580598316|FG000|Overall Study|Screen Failure|2|||
160784664|NCT00676689|580598316|FG000|Overall Study|Death|2|||
160784665|NCT00676689|580598316|FG000|Overall Study|Lost to Follow-up|4|||
160784666|NCT00676689|580598316|FG000|Overall Study|Physician Decision|1|||
160784667|NCT00676689|580598316|FG000|Overall Study|Withdrawal by Subject|3|||
160784668|NCT00676689|580598316|FG000|Overall Study|Continuing FU|49|||
160784669|NCT01827943|580598317|FG000|Overall Study|Protocol Violation|8|||
160784670|NCT01827943|580598317|FG000|Overall Study|Never treated because of an rapid progression|1|||
160784671|NCT00501085|580598318|FG000|Overall Study|Lost to Follow-up|195|||
160784672|NCT00501085|580598318|FG000|Overall Study|Withdrawal by Subject|34|||
160784673|NCT00501085|580598318|FG000|Overall Study|Subject Decision|1|||
160784674|NCT00501085|580598318|FG000|Overall Study|Revision Surgery|7|||
160784675|NCT00501085|580598318|FG000|Overall Study|Explantation Surgery|26|||
160784676|NCT00501085|580598318|FG000|Overall Study|Adverse Event|4|||
160784677|NCT00501085|580598318|FG000|Overall Study|Non-Compliance|24|||
160784678|NCT00501085|580598318|FG000|Overall Study|Study closed by sponsor|109|||
160784679|NCT00501085|580598318|FG000|Overall Study|Other loss to follow-up|32|||
160784680|NCT01487161|580598319|FG000|Overall Study|Adverse Event|1|||
160784681|NCT01487161|580598320|FG001|Overall Study|Adverse Event|0|||
160784682|NCT01487161|580598321|FG002|Overall Study|Adverse Event|0|||
160784683|NCT01487161|580598322|FG003|Overall Study|Adverse Event|0|||
160784684|NCT01487161|580598319|FG000|Overall Study|Withdrawal by Subject|1|||
160784685|NCT01487161|580598320|FG001|Overall Study|Withdrawal by Subject|1|||
160784686|NCT01487161|580598321|FG002|Overall Study|Withdrawal by Subject|1|||
160784687|NCT01487161|580598322|FG003|Overall Study|Withdrawal by Subject|2|||
160784688|NCT01487161|580598319|FG000|Overall Study|missing data|0|||
160784689|NCT01487161|580598320|FG001|Overall Study|missing data|1|||
160784690|NCT01487161|580598321|FG002|Overall Study|missing data|0|||
160784691|NCT01487161|580598322|FG003|Overall Study|missing data|0|||
160784692|NCT00663351|580598323|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
160784693|NCT00663351|580598324|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
160784694|NCT00663351|580598323|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
160784695|NCT00663351|580598324|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
160784696|NCT00663351|580598323|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
160784697|NCT00663351|580598324|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
160784698|NCT00663351|580598323|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
160784699|NCT00663351|580598324|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
160784700|NCT00663351|580598323|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
160784701|NCT00663351|580598324|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
160784702|NCT00663351|580598323|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
160784703|NCT00663351|580598324|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
160784704|NCT03113136|580598325|FG000|Overall Study|Lost to Follow-up|22|||
160784705|NCT03113136|580598326|FG001|Overall Study|Lost to Follow-up|47|||
160784706|NCT03113136|580598327|FG002|Overall Study|Lost to Follow-up|54|||
160784707|NCT03113136|580598325|FG000|Overall Study|Withdrawal by Subject|4|||
160784708|NCT03113136|580598326|FG001|Overall Study|Withdrawal by Subject|13|||
160784709|NCT03113136|580598327|FG002|Overall Study|Withdrawal by Subject|14|||
160784710|NCT03113136|580598325|FG000|Overall Study|Ineligible|0|||
160784711|NCT03113136|580598326|FG001|Overall Study|Ineligible|2|||
160784712|NCT03113136|580598327|FG002|Overall Study|Ineligible|1|||
160784713|NCT03113136|580598325|FG000|Overall Study|Study Team Decision|1|||
160784714|NCT03113136|580598326|FG001|Overall Study|Study Team Decision|4|||
160784715|NCT03113136|580598327|FG002|Overall Study|Study Team Decision|0|||
160784716|NCT00977561|580598329|FG000|Overall Study|Death|3|||
160784717|NCT00977561|580598330|FG001|Overall Study|Death|2|||
160784718|NCT00977561|580598329|FG000|Overall Study|Study terminated|0|||
160784719|NCT00977561|580598330|FG001|Overall Study|Study terminated|2|||
160784720|NCT00977561|580598329|FG000|Overall Study|Other|2|||
160784721|NCT00977561|580598330|FG001|Overall Study|Other|0|||
160784722|NCT03336866|580598331|FG000|Overall Study|Lost to Follow-up|2|||
160784723|NCT03336866|580598332|FG001|Overall Study|Lost to Follow-up|0|||
160784724|NCT03336866|580598333|FG002|Overall Study|Lost to Follow-up|3|||
160784725|NCT03336866|580598331|FG000|Overall Study|Withdrawal by Subject|1|||
160784726|NCT03336866|580598332|FG001|Overall Study|Withdrawal by Subject|1|||
160784727|NCT03336866|580598333|FG002|Overall Study|Withdrawal by Subject|0|||
160543337|NCT01225731|579716456|FG008|Part 3|Physician Decision|0|||
160543338|NCT01225731|579716457|FG009|Part 3|Physician Decision|0|||
160543339|NCT01225731|579716458|FG010|Part 3|Physician Decision|0|||
160543340|NCT01225731|579716459|FG011|Part 3|Physician Decision|1|||
160543341|NCT01225731|579716460|FG012|Part 3|Physician Decision|2|||
160784728|NCT03336866|580598331|FG000|Overall Study|Noncompliance with clinic house rules|0|||
160784729|NCT03336866|580598332|FG001|Overall Study|Noncompliance with clinic house rules|0|||
160784730|NCT03336866|580598333|FG002|Overall Study|Noncompliance with clinic house rules|1|||
160784731|NCT02218268|580598335|FG000|24 Hour Washout|Physician Decision|11|||
160784732|NCT02218268|580598336|FG001|24 Hour Washout|Physician Decision|9|||
160784733|NCT03651336|580598337|FG000|Overall Study|Withdrawal by Subject|4|||
160784734|NCT01341990|580598338|FG000|Overall Study|Adverse Event|0|||
160784735|NCT01341990|580598339|FG001|Overall Study|Adverse Event|1|||
160784736|NCT01341990|580598338|FG000|Overall Study|Torn Study Lens|1|||
160784737|NCT01341990|580598339|FG001|Overall Study|Torn Study Lens|0|||
160784738|NCT01341990|580598338|FG000|Overall Study|Withdrawal by Subject|2|||
160784739|NCT01341990|580598339|FG001|Overall Study|Withdrawal by Subject|0|||
160784740|NCT01125748|580598341|FG000|Overall Study|Adverse Event|0|||
160784741|NCT01125748|580598342|FG001|Overall Study|Adverse Event|2|||
160784742|NCT01125748|580598341|FG000|Overall Study|Lost to Follow-up|0|||
160784743|NCT01125748|580598342|FG001|Overall Study|Lost to Follow-up|1|||
160784744|NCT01125748|580598341|FG000|Overall Study|Physician Decision|8|||
160784745|NCT01125748|580598342|FG001|Overall Study|Physician Decision|7|||
160784746|NCT01125748|580598341|FG000|Overall Study|Patient Decision to Withdraw|2|||
160784747|NCT01125748|580598342|FG001|Overall Study|Patient Decision to Withdraw|4|||
160784748|NCT01028391|580598343|FG000|Overall Study|Adverse Event|4|||
160784749|NCT01028391|580598344|FG001|Overall Study|Adverse Event|0|||
160784750|NCT01028391|580598343|FG000|Overall Study|Lack of Efficacy|0|||
160784751|NCT01028391|580598344|FG001|Overall Study|Lack of Efficacy|2|||
160784752|NCT01028391|580598343|FG000|Overall Study|Lost to Follow-up|3|||
160784753|NCT01028391|580598344|FG001|Overall Study|Lost to Follow-up|4|||
160784754|NCT01028391|580598343|FG000|Overall Study|Physician Decision|0|||
160784755|NCT01028391|580598344|FG001|Overall Study|Physician Decision|1|||
160784756|NCT01028391|580598343|FG000|Overall Study|Withdrawal by Subject|6|||
160784757|NCT01028391|580598344|FG001|Overall Study|Withdrawal by Subject|3|||
160784758|NCT01028391|580598343|FG000|Overall Study|Needed excluded medication|1|||
160784759|NCT01028391|580598344|FG001|Overall Study|Needed excluded medication|1|||
160784760|NCT01107457|580598345|FG000|Part A|Adverse Event|1|||
160784761|NCT01107457|580598346|FG001|Part A|Adverse Event|2|||
160784762|NCT01107457|580598347|FG002|Part A|Adverse Event|1|||
160784763|NCT01107457|580598348|FG003|Part A|Adverse Event|0|||
160784764|NCT01107457|580598349|FG004|Part A|Adverse Event|0|||
160784765|NCT01107457|580598350|FG005|Part A|Adverse Event|0|||
160784766|NCT01107457|580598345|FG000|Part A|Withdrawal by Subject|3|||
160784767|NCT01107457|580598346|FG001|Part A|Withdrawal by Subject|3|||
160784768|NCT01107457|580598347|FG002|Part A|Withdrawal by Subject|0|||
160784769|NCT01107457|580598348|FG003|Part A|Withdrawal by Subject|3|||
160784770|NCT01107457|580598349|FG004|Part A|Withdrawal by Subject|1|||
160784771|NCT01107457|580598350|FG005|Part A|Withdrawal by Subject|0|||
160784772|NCT01107457|580598345|FG000|Part A|Lost to Follow-up|0|||
160784773|NCT01107457|580598346|FG001|Part A|Lost to Follow-up|1|||
160784774|NCT01107457|580598347|FG002|Part A|Lost to Follow-up|0|||
160784775|NCT01107457|580598348|FG003|Part A|Lost to Follow-up|0|||
160784776|NCT01107457|580598349|FG004|Part A|Lost to Follow-up|0|||
160784777|NCT01107457|580598350|FG005|Part A|Lost to Follow-up|0|||
160784778|NCT01107457|580598345|FG000|Part A|Lack of Efficacy|1|||
160784779|NCT01107457|580598346|FG001|Part A|Lack of Efficacy|0|||
160784780|NCT01107457|580598347|FG002|Part A|Lack of Efficacy|0|||
160784781|NCT01107457|580598348|FG003|Part A|Lack of Efficacy|0|||
160784782|NCT01107457|580598349|FG004|Part A|Lack of Efficacy|0|||
160784783|NCT01107457|580598350|FG005|Part A|Lack of Efficacy|0|||
160784784|NCT01107457|580598345|FG000|Part A|Protocol Violation|0|||
160784785|NCT01107457|580598346|FG001|Part A|Protocol Violation|1|||
160784786|NCT01107457|580598347|FG002|Part A|Protocol Violation|0|||
160784787|NCT01107457|580598348|FG003|Part A|Protocol Violation|0|||
160784788|NCT01107457|580598349|FG004|Part A|Protocol Violation|0|||
160784789|NCT01107457|580598350|FG005|Part A|Protocol Violation|0|||
160890207|NCT00423670|580992969|FG002|Treatment Period|Investigator decision|0|||
160890208|NCT00423670|580992970|FG003|Treatment Period|Investigator decision|0|||
160640305|NCT00265083|580066669|FG000|Overall Study|Adverse Event|5|||
160640306|NCT00265083|580066670|FG001|Overall Study|Adverse Event|13|||
160640307|NCT00265083|580066671|FG002|Overall Study|Adverse Event|15|||
160640308|NCT00265083|580066669|FG000|Overall Study|Lost to Follow-up|3|||
160640309|NCT00265083|580066670|FG001|Overall Study|Lost to Follow-up|4|||
160640310|NCT00265083|580066671|FG002|Overall Study|Lost to Follow-up|4|||
160640311|NCT00265083|580066669|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
160640312|NCT00265083|580066670|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
160784790|NCT01107457|580598345|FG000|Part B and C|Adverse Event|0|||
160784791|NCT01107457|580598346|FG001|Part B and C|Adverse Event|0|||
160890209|NCT00423670|580992971|FG004|Treatment Period|Investigator decision|0|||
160784792|NCT01107457|580598347|FG002|Part B and C|Adverse Event|0|||
160784793|NCT01107457|580598348|FG003|Part B and C|Adverse Event|0|||
160784794|NCT01107457|580598349|FG004|Part B and C|Adverse Event|0|||
160784795|NCT01107457|580598350|FG005|Part B and C|Adverse Event|12|||
160784796|NCT01107457|580598345|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
160784797|NCT01107457|580598346|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
160784798|NCT01107457|580598347|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
160784799|NCT01107457|580598348|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
160784800|NCT01107457|580598349|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
160784801|NCT01107457|580598350|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
160784802|NCT01107457|580598345|FG000|Part B and C|Physician Decision|0|||
160784803|NCT01107457|580598346|FG001|Part B and C|Physician Decision|0|||
160784804|NCT01107457|580598347|FG002|Part B and C|Physician Decision|0|||
160784805|NCT01107457|580598348|FG003|Part B and C|Physician Decision|0|||
160784806|NCT01107457|580598349|FG004|Part B and C|Physician Decision|0|||
160784807|NCT01107457|580598350|FG005|Part B and C|Physician Decision|3|||
160784808|NCT01107457|580598345|FG000|Part B and C|Lack of Efficacy|0|||
160784809|NCT01107457|580598346|FG001|Part B and C|Lack of Efficacy|0|||
160784810|NCT01107457|580598347|FG002|Part B and C|Lack of Efficacy|0|||
160784811|NCT01107457|580598348|FG003|Part B and C|Lack of Efficacy|0|||
160784812|NCT01107457|580598349|FG004|Part B and C|Lack of Efficacy|0|||
160784813|NCT01107457|580598350|FG005|Part B and C|Lack of Efficacy|7|||
160784814|NCT01107457|580598345|FG000|Part B and C|Lost to Follow-up|0|||
160784815|NCT01107457|580598346|FG001|Part B and C|Lost to Follow-up|0|||
160784816|NCT01107457|580598347|FG002|Part B and C|Lost to Follow-up|0|||
160784817|NCT01107457|580598348|FG003|Part B and C|Lost to Follow-up|0|||
160784818|NCT01107457|580598349|FG004|Part B and C|Lost to Follow-up|0|||
160784819|NCT01107457|580598350|FG005|Part B and C|Lost to Follow-up|10|||
160784820|NCT01107457|580598345|FG000|Part B and C|Protocol Violation|0|||
160784821|NCT01107457|580598346|FG001|Part B and C|Protocol Violation|0|||
160784822|NCT01107457|580598347|FG002|Part B and C|Protocol Violation|0|||
160784823|NCT01107457|580598348|FG003|Part B and C|Protocol Violation|0|||
160784824|NCT01107457|580598349|FG004|Part B and C|Protocol Violation|0|||
160784825|NCT01107457|580598350|FG005|Part B and C|Protocol Violation|1|||
160784826|NCT01107457|580598345|FG000|Part B and C|Sponsor Decision|0|||
160784827|NCT01107457|580598346|FG001|Part B and C|Sponsor Decision|0|||
160784828|NCT01107457|580598347|FG002|Part B and C|Sponsor Decision|0|||
160784829|NCT01107457|580598348|FG003|Part B and C|Sponsor Decision|0|||
160784830|NCT01107457|580598349|FG004|Part B and C|Sponsor Decision|0|||
160784831|NCT01107457|580598350|FG005|Part B and C|Sponsor Decision|66|||
160784832|NCT01107457|580598345|FG000|Part B and C|Withdrawal by Subject|0|||
160784833|NCT01107457|580598346|FG001|Part B and C|Withdrawal by Subject|0|||
160784834|NCT01107457|580598347|FG002|Part B and C|Withdrawal by Subject|0|||
160784835|NCT01107457|580598348|FG003|Part B and C|Withdrawal by Subject|0|||
160784836|NCT01107457|580598349|FG004|Part B and C|Withdrawal by Subject|0|||
160784837|NCT01107457|580598350|FG005|Part B and C|Withdrawal by Subject|16|||
160784838|NCT01107457|580598345|FG000|Part B and C|Clinical Relapse|0|||
160784839|NCT01107457|580598346|FG001|Part B and C|Clinical Relapse|0|||
160640313|NCT00265083|580066671|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
160640314|NCT00265083|580066669|FG000|Overall Study|Other|1|||
160640315|NCT00265083|580066670|FG001|Overall Study|Other|12|||
160640316|NCT00265083|580066671|FG002|Overall Study|Other|9|||
160640317|NCT03208933|580066675|FG000|Overall Study|Death|3|||
160640318|NCT03208933|580066675|FG000|Overall Study|Withdrawal by Subject|3|||
160640319|NCT03208933|580066675|FG000|Overall Study|Adverse Event|1|||
160640320|NCT03208933|580066675|FG000|Overall Study|Lost to Follow-up|2|||
160784840|NCT01107457|580598347|FG002|Part B and C|Clinical Relapse|0|||
160543342|NCT01225731|579716448|FG000|Part 3|Withdrawal by Subject|0|||
160543343|NCT01225731|579716449|FG001|Part 3|Withdrawal by Subject|0|||
160543344|NCT01225731|579716450|FG002|Part 3|Withdrawal by Subject|0|||
160543345|NCT01225731|579716451|FG003|Part 3|Withdrawal by Subject|0|||
160543346|NCT01225731|579716452|FG004|Part 3|Withdrawal by Subject|0|||
160543347|NCT01225731|579716453|FG005|Part 3|Withdrawal by Subject|0|||
160784841|NCT01107457|580598348|FG003|Part B and C|Clinical Relapse|0|||
160784842|NCT01107457|580598349|FG004|Part B and C|Clinical Relapse|0|||
160784843|NCT01107457|580598350|FG005|Part B and C|Clinical Relapse|4|||
160543348|NCT01225731|579716454|FG006|Part 3|Withdrawal by Subject|0|||
160640321|NCT03208933|580066675|FG000|Overall Study|Physician Decision|3|||
160543349|NCT01225731|579716455|FG007|Part 3|Withdrawal by Subject|0|||
160543350|NCT01225731|579716456|FG008|Part 3|Withdrawal by Subject|0|||
160543351|NCT01225731|579716457|FG009|Part 3|Withdrawal by Subject|0|||
160640322|NCT03208933|580066675|FG000|Overall Study|Protocol Violation|1|||
160640323|NCT00854620|580066676|FG000|Overall Study|Adverse Event|1|||
160640324|NCT00275028|580066681|FG000|Overall Study|Withdrew consent before treatment began|1|||
160640325|NCT00275028|580066681|FG000|Overall Study|Withdrawal by Subject|5|||
160784844|NCT00694161|580598351|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
160784845|NCT00694161|580598351|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
160784846|NCT00694161|580598351|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
160784847|NCT03601052|580598352|FG000|Overall Study|Lost to Follow-up|2|||
160784848|NCT01227395|580598353|FG000|Overall Study|Protocol Violation|0|||
160784849|NCT01227395|580598354|FG001|Overall Study|Protocol Violation|1|||
160784850|NCT00683384|580598355|FG000|Overall Study|Death|1|||
160784851|NCT00683384|580598355|FG000|Overall Study|Adverse Event|1|||
160543352|NCT01225731|579716458|FG010|Part 3|Withdrawal by Subject|4|||
160543353|NCT01225731|579716459|FG011|Part 3|Withdrawal by Subject|6|||
160640326|NCT00275028|580066681|FG000|Overall Study|Adverse Event|9|||
160640327|NCT00275028|580066681|FG000|Overall Study|Progressive Disease|30|||
160543354|NCT01225731|579716460|FG012|Part 3|Withdrawal by Subject|4|||
160784852|NCT02015104|580598358|FG000|Overall Study|Withdrew consent after first dose drug|1|||
160784853|NCT02015104|580598359|FG001|Overall Study|Withdrew consent after first dose drug|0|||
160784854|NCT02015104|580598358|FG000|Overall Study|Withdrew consent prior to treatment|0|||
160784855|NCT02015104|580598359|FG001|Overall Study|Withdrew consent prior to treatment|1|||
160784856|NCT03011372|580598360|FG000|Overall Study|Death|16|||
160784857|NCT03011372|580598360|FG000|Overall Study|Lost to Follow-up|2|||
160784858|NCT03011372|580598360|FG000|Overall Study|Sponsor Decision|17|||
160784859|NCT03011372|580598360|FG000|Overall Study|Withdrawal by Subject|7|||
160784860|NCT03011372|580598360|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
160784861|NCT03011372|580598360|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
160784862|NCT03011372|580598360|FG000|Overall Study|Sponsor's Decision|2|||
160784863|NCT03572218|580598361|FG000|Overall Study|Lost to Follow-up|3|||
160784864|NCT03572218|580598362|FG001|Overall Study|Lost to Follow-up|2|||
160784865|NCT03572218|580598361|FG000|Overall Study|No longer available for study visits|2|||
160784866|NCT03572218|580598362|FG001|Overall Study|No longer available for study visits|1|||
160784867|NCT03572218|580598361|FG000|Overall Study|No longer interested|1|||
160784868|NCT03572218|580598362|FG001|Overall Study|No longer interested|2|||
160784869|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
160784870|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
160784871|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
160784872|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
160784873|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
160784874|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
160784875|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
160784876|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
160784877|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
160784878|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
160784879|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
160784880|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
160784881|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
160784882|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
160784883|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
160784884|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
160784885|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
160784886|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
160784887|NCT03738215|580598363|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
160784888|NCT03738215|580598364|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
160784889|NCT03738215|580598365|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
160784890|NCT03738215|580598363|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
160784891|NCT03738215|580598364|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
160784892|NCT03738215|580598365|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
160784893|NCT03738215|580598363|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
160784894|NCT03738215|580598364|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
160784895|NCT03738215|580598365|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
160784896|NCT03738215|580598363|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
160784897|NCT03738215|580598364|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
160784898|NCT03738215|580598365|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
160784899|NCT00853047|580598366|FG000|Core Phase|Participant Request|0|||
160784900|NCT00853047|580598367|FG001|Core Phase|Participant Request|0|||
160784901|NCT00853047|580598368|FG002|Core Phase|Participant Request|0|||
160784902|NCT00853047|580598369|FG003|Core Phase|Participant Request|1|||
160784903|NCT00853047|580598370|FG004|Core Phase|Participant Request|0|||
160784904|NCT00853047|580598371|FG005|Core Phase|Participant Request|0|||
160784905|NCT00853047|580598366|FG000|Open-Label Extension Phase|Participant Request|0|||
160784906|NCT00853047|580598367|FG001|Open-Label Extension Phase|Participant Request|0|||
160784907|NCT00853047|580598368|FG002|Open-Label Extension Phase|Participant Request|0|||
160784908|NCT00853047|580598369|FG003|Open-Label Extension Phase|Participant Request|0|||
160784909|NCT00853047|580598370|FG004|Open-Label Extension Phase|Participant Request|0|||
160784910|NCT00853047|580598371|FG005|Open-Label Extension Phase|Participant Request|7|||
160784911|NCT00853047|580598366|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
160784912|NCT00853047|580598367|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
160784913|NCT00853047|580598368|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
160784914|NCT00853047|580598369|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
160784915|NCT00853047|580598370|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
160784916|NCT00853047|580598371|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
160784917|NCT00853047|580598366|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
160784918|NCT00853047|580598367|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
160784919|NCT00853047|580598368|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
160784920|NCT00853047|580598369|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
160784921|NCT00853047|580598370|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
160784922|NCT00853047|580598371|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
160784923|NCT00853047|580598366|FG000|Open-Label Extension Phase|Investigator Decision|0|||
160784924|NCT00853047|580598367|FG001|Open-Label Extension Phase|Investigator Decision|0|||
160784925|NCT00853047|580598368|FG002|Open-Label Extension Phase|Investigator Decision|0|||
160784926|NCT00853047|580598369|FG003|Open-Label Extension Phase|Investigator Decision|0|||
160784927|NCT00853047|580598370|FG004|Open-Label Extension Phase|Investigator Decision|0|||
160784928|NCT00853047|580598371|FG005|Open-Label Extension Phase|Investigator Decision|1|||
160784929|NCT00853047|580598366|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
160784930|NCT00853047|580598367|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
160784931|NCT00853047|580598368|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
160784932|NCT00853047|580598369|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
160784933|NCT00853047|580598370|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
160784934|NCT00853047|580598371|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
160784935|NCT02638493|580598372|FG000|Overall Study|Inability to provide semen samples|2|||
160784936|NCT02638493|580598373|FG001|Overall Study|Inability to provide semen samples|0|||
160784937|NCT02638493|580598374|FG002|Overall Study|Inability to provide semen samples|0|||
160784938|NCT00394472|580600919|FG000|Overall Study|Protocol Violation|1|||
160784939|NCT00394472|580600920|FG001|Overall Study|Protocol Violation|3|||
160784940|NCT00394472|580600919|FG000|Overall Study|incorrect enrolment|4|||
160784941|NCT00394472|580600920|FG001|Overall Study|incorrect enrolment|2|||
160784942|NCT00394472|580600919|FG000|Overall Study|Adverse Event|4|||
160784943|NCT00394472|580600920|FG001|Overall Study|Adverse Event|2|||
160784944|NCT00394472|580600919|FG000|Overall Study|Withdrawal by Subject|0|||
160784945|NCT00394472|580600920|FG001|Overall Study|Withdrawal by Subject|2|||
160784946|NCT00394472|580600919|FG000|Overall Study|Physician Decision|0|||
160784947|NCT00394472|580600920|FG001|Overall Study|Physician Decision|1|||
160784948|NCT00394472|580600919|FG000|Overall Study|Lost to Follow-up|0|||
160784949|NCT00394472|580600920|FG001|Overall Study|Lost to Follow-up|1|||
160784950|NCT03211858|580600921|FG000|Overall Study|Adverse Event|8|||
160784951|NCT03211858|580600922|FG001|Overall Study|Adverse Event|6|||
160784952|NCT03211858|580600921|FG000|Overall Study|Lack of Efficacy|0|||
160784953|NCT03211858|580600922|FG001|Overall Study|Lack of Efficacy|4|||
160784954|NCT03211858|580600921|FG000|Overall Study|Poor compliance to protocol|6|||
160784955|NCT03211858|580600922|FG001|Overall Study|Poor compliance to protocol|2|||
160784956|NCT03211858|580600921|FG000|Overall Study|Non-serious Hypoglycemia|1|||
160784957|NCT03211858|580600922|FG001|Overall Study|Non-serious Hypoglycemia|0|||
160784958|NCT03211858|580600921|FG000|Overall Study|Other than specified above|22|||
160784959|NCT03211858|580600922|FG001|Overall Study|Other than specified above|21|||
160640328|NCT00275028|580066681|FG000|Overall Study|Physician Decision|2|||
160784960|NCT01529112|580600925|FG000|Overall Study|Adverse Event|2|||
160784961|NCT01529112|580600926|FG001|Overall Study|Adverse Event|0|||
160784962|NCT01529112|580600925|FG000|Overall Study|Death|59|||
160784963|NCT01529112|580600926|FG001|Overall Study|Death|38|||
160784964|NCT01529112|580600925|FG000|Overall Study|Protocol Violation|1|||
160784965|NCT01529112|580600926|FG001|Overall Study|Protocol Violation|0|||
160784966|NCT01529112|580600925|FG000|Overall Study|Withdrawal by Subject|7|||
160784967|NCT01529112|580600926|FG001|Overall Study|Withdrawal by Subject|3|||
160784968|NCT00004228|580600927|FG000|Overall Study|Adverse Event|0|||
160784969|NCT00004228|580600928|FG001|Overall Study|Adverse Event|1|||
160784970|NCT00004228|580600929|FG002|Overall Study|Adverse Event|0|||
160784971|NCT00004228|580600930|FG003|Overall Study|Adverse Event|0|||
160784972|NCT00004228|580600931|FG004|Overall Study|Adverse Event|1|||
160784973|NCT00004228|580600932|FG005|Overall Study|Adverse Event|0|||
160784974|NCT00004228|580600933|FG006|Overall Study|Adverse Event|0|||
160784975|NCT00004228|580600927|FG000|Overall Study|Death|0|||
160784976|NCT00004228|580600928|FG001|Overall Study|Death|1|||
160784977|NCT00004228|580600929|FG002|Overall Study|Death|2|||
160784978|NCT00004228|580600930|FG003|Overall Study|Death|0|||
160784979|NCT00004228|580600931|FG004|Overall Study|Death|1|||
160784980|NCT00004228|580600932|FG005|Overall Study|Death|0|||
160784981|NCT00004228|580600933|FG006|Overall Study|Death|0|||
160784982|NCT00004228|580600927|FG000|Overall Study|Lack of Efficacy|1|||
160784983|NCT00004228|580600928|FG001|Overall Study|Lack of Efficacy|6|||
160784984|NCT00004228|580600929|FG002|Overall Study|Lack of Efficacy|5|||
160784985|NCT00004228|580600930|FG003|Overall Study|Lack of Efficacy|3|||
160784986|NCT00004228|580600931|FG004|Overall Study|Lack of Efficacy|9|||
160784987|NCT00004228|580600932|FG005|Overall Study|Lack of Efficacy|8|||
160784988|NCT00004228|580600933|FG006|Overall Study|Lack of Efficacy|4|||
160784989|NCT00004228|580600927|FG000|Overall Study|Lost to Follow-up|0|||
160784990|NCT00004228|580600928|FG001|Overall Study|Lost to Follow-up|0|||
160784991|NCT00004228|580600929|FG002|Overall Study|Lost to Follow-up|1|||
160784992|NCT00004228|580600930|FG003|Overall Study|Lost to Follow-up|0|||
160784993|NCT00004228|580600931|FG004|Overall Study|Lost to Follow-up|0|||
160784994|NCT00004228|580600932|FG005|Overall Study|Lost to Follow-up|0|||
160784995|NCT00004228|580600933|FG006|Overall Study|Lost to Follow-up|0|||
160784996|NCT00004228|580600927|FG000|Overall Study|Physician Decision|1|||
160784997|NCT00004228|580600928|FG001|Overall Study|Physician Decision|0|||
160784998|NCT00004228|580600929|FG002|Overall Study|Physician Decision|3|||
160784999|NCT00004228|580600930|FG003|Overall Study|Physician Decision|2|||
160785000|NCT00004228|580600931|FG004|Overall Study|Physician Decision|1|||
160785001|NCT00004228|580600932|FG005|Overall Study|Physician Decision|1|||
160785002|NCT00004228|580600933|FG006|Overall Study|Physician Decision|1|||
160785003|NCT00004228|580600927|FG000|Overall Study|Protocol Violation|0|||
160785004|NCT00004228|580600928|FG001|Overall Study|Protocol Violation|5|||
160785005|NCT00004228|580600929|FG002|Overall Study|Protocol Violation|2|||
160785006|NCT00004228|580600930|FG003|Overall Study|Protocol Violation|1|||
160785007|NCT00004228|580600931|FG004|Overall Study|Protocol Violation|1|||
160785008|NCT00004228|580600932|FG005|Overall Study|Protocol Violation|2|||
160785009|NCT00004228|580600933|FG006|Overall Study|Protocol Violation|0|||
160785010|NCT00004228|580600927|FG000|Overall Study|Withdrawal by Subject|3|||
160785011|NCT00004228|580600928|FG001|Overall Study|Withdrawal by Subject|0|||
160785012|NCT00004228|580600929|FG002|Overall Study|Withdrawal by Subject|1|||
160785013|NCT00004228|580600930|FG003|Overall Study|Withdrawal by Subject|0|||
160785014|NCT00004228|580600931|FG004|Overall Study|Withdrawal by Subject|2|||
160785015|NCT00004228|580600932|FG005|Overall Study|Withdrawal by Subject|1|||
160785016|NCT00004228|580600933|FG006|Overall Study|Withdrawal by Subject|2|||
160785017|NCT00004228|580600927|FG000|Overall Study|Other|0|||
160785018|NCT00004228|580600928|FG001|Overall Study|Other|0|||
160785019|NCT00004228|580600929|FG002|Overall Study|Other|1|||
160785020|NCT00004228|580600930|FG003|Overall Study|Other|0|||
160785021|NCT00004228|580600931|FG004|Overall Study|Other|0|||
160785022|NCT00004228|580600932|FG005|Overall Study|Other|0|||
160785023|NCT00004228|580600933|FG006|Overall Study|Other|0|||
160785024|NCT00004228|580600927|FG000|Overall Study|ineligible|4|||
160785025|NCT00004228|580600928|FG001|Overall Study|ineligible|2|||
160785026|NCT00004228|580600929|FG002|Overall Study|ineligible|4|||
160785027|NCT00004228|580600930|FG003|Overall Study|ineligible|1|||
160785028|NCT00004228|580600931|FG004|Overall Study|ineligible|1|||
160785029|NCT00004228|580600932|FG005|Overall Study|ineligible|2|||
160785030|NCT00004228|580600933|FG006|Overall Study|ineligible|5|||
160785031|NCT02168439|580600934|FG000|Overall Study|Protocol Violation|0|||
160785032|NCT02168439|580600935|FG001|Overall Study|Protocol Violation|2|||
160785033|NCT02004275|580600936|FG000|Phase 1|Ineligible|0|||
160785034|NCT02004275|580600937|FG001|Phase 1|Ineligible|0|||
160785035|NCT02004275|580600938|FG002|Phase 1|Ineligible|0|||
160785036|NCT02004275|580600939|FG003|Phase 1|Ineligible|1|||
160785037|NCT02004275|580600940|FG004|Phase 1|Ineligible|1|||
160785038|NCT02004275|580600941|FG005|Phase 1|Ineligible|0|||
160785039|NCT02004275|580600936|FG000|Phase 1|Protocol Violation|0|||
160785040|NCT02004275|580600937|FG001|Phase 1|Protocol Violation|0|||
160785041|NCT02004275|580600938|FG002|Phase 1|Protocol Violation|0|||
160785042|NCT02004275|580600939|FG003|Phase 1|Protocol Violation|1|||
160785043|NCT02004275|580600940|FG004|Phase 1|Protocol Violation|0|||
160785044|NCT02004275|580600941|FG005|Phase 1|Protocol Violation|5|||
160785045|NCT02004275|580600936|FG000|Phase 2 Part 1|Ineligible|6|||
160785046|NCT02004275|580600937|FG001|Phase 2 Part 1|Ineligible|9|||
160785047|NCT02004275|580600938|FG002|Phase 2 Part 1|Ineligible|0|||
160785048|NCT02004275|580600939|FG003|Phase 2 Part 1|Ineligible|0|||
160785049|NCT02004275|580600940|FG004|Phase 2 Part 1|Ineligible|0|||
160785050|NCT02004275|580600941|FG005|Phase 2 Part 1|Ineligible|0|||
160785051|NCT02004275|580600936|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
160785052|NCT02004275|580600937|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
160785053|NCT02004275|580600938|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
160785054|NCT02004275|580600939|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
160543355|NCT00577642|579716461|FG000|Overall Study|Clinical Disease Progression|1|||
160543356|NCT00652366|579716470|FG000|Overall Study|Adverse Event|8|||
160543357|NCT00652366|579716471|FG001|Overall Study|Adverse Event|4|||
160543358|NCT00652366|579716472|FG002|Overall Study|Adverse Event|7|||
160543359|NCT00652366|579716473|FG003|Overall Study|Adverse Event|17|||
160543360|NCT00652366|579716474|FG004|Overall Study|Adverse Event|13|||
160543361|NCT00652366|579716470|FG000|Overall Study|Death|5|||
160543362|NCT00652366|579716471|FG001|Overall Study|Death|4|||
160543363|NCT00652366|579716472|FG002|Overall Study|Death|1|||
160543364|NCT00652366|579716473|FG003|Overall Study|Death|8|||
160543365|NCT00652366|579716474|FG004|Overall Study|Death|5|||
160543366|NCT00652366|579716470|FG000|Overall Study|Lack of Efficacy|84|||
160543367|NCT00652366|579716471|FG001|Overall Study|Lack of Efficacy|58|||
160640329|NCT00830063|580066687|FG000|Overall Study|Adverse Event|7|||
160543368|NCT00652366|579716472|FG002|Overall Study|Lack of Efficacy|53|||
160543369|NCT00652366|579716473|FG003|Overall Study|Lack of Efficacy|133|||
160543370|NCT00652366|579716474|FG004|Overall Study|Lack of Efficacy|13|||
160543371|NCT00652366|579716470|FG000|Overall Study|Violation of Selection Criteria|0|||
160543372|NCT00652366|579716471|FG001|Overall Study|Violation of Selection Criteria|0|||
160543373|NCT00652366|579716472|FG002|Overall Study|Violation of Selection Criteria|1|||
160543374|NCT00652366|579716473|FG003|Overall Study|Violation of Selection Criteria|0|||
160543375|NCT00652366|579716474|FG004|Overall Study|Violation of Selection Criteria|0|||
160543376|NCT00652366|579716470|FG000|Overall Study|Protocol Violation|1|||
160543377|NCT00652366|579716471|FG001|Overall Study|Protocol Violation|0|||
160543378|NCT00652366|579716472|FG002|Overall Study|Protocol Violation|0|||
160543379|NCT00652366|579716473|FG003|Overall Study|Protocol Violation|0|||
160543380|NCT00652366|579716474|FG004|Overall Study|Protocol Violation|0|||
160543381|NCT00652366|579716470|FG000|Overall Study|Refused treatment|3|||
160543382|NCT00652366|579716471|FG001|Overall Study|Refused treatment|7|||
160543383|NCT00652366|579716472|FG002|Overall Study|Refused treatment|6|||
160543384|NCT00652366|579716473|FG003|Overall Study|Refused treatment|17|||
160543385|NCT00652366|579716474|FG004|Overall Study|Refused treatment|5|||
160543386|NCT00652366|579716470|FG000|Overall Study|Other|5|||
160543387|NCT00652366|579716471|FG001|Overall Study|Other|2|||
160543388|NCT00652366|579716472|FG002|Overall Study|Other|3|||
160543389|NCT00652366|579716473|FG003|Overall Study|Other|4|||
160543390|NCT00652366|579716474|FG004|Overall Study|Other|0|||
160640330|NCT00830063|580066688|FG001|Overall Study|Adverse Event|13|||
160640331|NCT00830063|580066689|FG002|Overall Study|Adverse Event|16|||
160640332|NCT00830063|580066690|FG003|Overall Study|Adverse Event|13|||
160640333|NCT00830063|580066687|FG000|Overall Study|Death|1|||
160640334|NCT00830063|580066688|FG001|Overall Study|Death|0|||
160640335|NCT00830063|580066689|FG002|Overall Study|Death|0|||
160640336|NCT00830063|580066690|FG003|Overall Study|Death|0|||
160640337|NCT00830063|580066687|FG000|Overall Study|Lost to Follow-up|0|||
160640338|NCT00830063|580066688|FG001|Overall Study|Lost to Follow-up|0|||
160640339|NCT00830063|580066689|FG002|Overall Study|Lost to Follow-up|3|||
160640340|NCT00830063|580066690|FG003|Overall Study|Lost to Follow-up|1|||
160640341|NCT00830063|580066687|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
160640342|NCT00830063|580066688|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
160640343|NCT00830063|580066689|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
160640344|NCT00830063|580066690|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
160640345|NCT00830063|580066687|FG000|Overall Study|Lack of Efficacy|51|||
160640346|NCT00830063|580066688|FG001|Overall Study|Lack of Efficacy|23|||
160640347|NCT00830063|580066689|FG002|Overall Study|Lack of Efficacy|25|||
160640348|NCT00830063|580066690|FG003|Overall Study|Lack of Efficacy|32|||
160640349|NCT00830063|580066687|FG000|Overall Study|Other|5|||
160640350|NCT00830063|580066688|FG001|Overall Study|Other|5|||
160543391|NCT00542269|579716475|FG000|Overall Study|Adverse Event|10|||
160543392|NCT00542269|579716476|FG001|Overall Study|Adverse Event|4|||
160543393|NCT00542269|579716477|FG002|Overall Study|Adverse Event|5|||
160543394|NCT00542269|579716475|FG000|Overall Study|Protocol Violation|1|||
160543395|NCT00542269|579716476|FG001|Overall Study|Protocol Violation|1|||
160543396|NCT00542269|579716477|FG002|Overall Study|Protocol Violation|0|||
160543397|NCT00542269|579716475|FG000|Overall Study|Withdrawal by Subject|1|||
160543398|NCT00542269|579716476|FG001|Overall Study|Withdrawal by Subject|0|||
160543399|NCT00542269|579716477|FG002|Overall Study|Withdrawal by Subject|0|||
160543400|NCT00542269|579716475|FG000|Overall Study|Administrative problems|1|||
160543401|NCT00542269|579716476|FG001|Overall Study|Administrative problems|1|||
160543402|NCT00542269|579716477|FG002|Overall Study|Administrative problems|1|||
160543403|NCT02069899|579716478|FG000|Overall Study|Adverse Event|6|||
160543404|NCT02069899|579716479|FG001|Overall Study|Adverse Event|0|||
160543405|NCT02069899|579716480|FG002|Overall Study|Adverse Event|1|||
160543406|NCT02069899|579716478|FG000|Overall Study|Withdrawal by Participant|2|||
160640351|NCT00830063|580066689|FG002|Overall Study|Other|8|||
160640352|NCT00830063|580066690|FG003|Overall Study|Other|6|||
160543407|NCT02069899|579716479|FG001|Overall Study|Withdrawal by Participant|0|||
160543408|NCT02069899|579716480|FG002|Overall Study|Withdrawal by Participant|0|||
160543409|NCT02069899|579716478|FG000|Overall Study|Lost to Follow-up|1|||
160543410|NCT02069899|579716479|FG001|Overall Study|Lost to Follow-up|0|||
160785055|NCT02004275|580600940|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
160785056|NCT02004275|580600941|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
160785057|NCT00493285|580600946|FG000|Overall Study|Lost to Follow-up|0|||
160785058|NCT00493285|580600947|FG001|Overall Study|Lost to Follow-up|0|||
160785059|NCT00493285|580600948|FG002|Overall Study|Lost to Follow-up|0|||
160785060|NCT00493285|580600949|FG003|Overall Study|Lost to Follow-up|0|||
160785061|NCT00493285|580600950|FG004|Overall Study|Lost to Follow-up|1|||
160785062|NCT00493285|580600951|FG005|Overall Study|Lost to Follow-up|0|||
160785063|NCT03021005|580600952|FG000|Overall Study|Lost to Follow-up|39|||
160785064|NCT03021005|580600953|FG001|Overall Study|Lost to Follow-up|26|||
160785065|NCT03188705|580600954|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
160785066|NCT03188705|580600954|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
160785067|NCT01174459|580600958|FG000|Overall Study|case report form (CRF) not collected|5|||
160785068|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
160785069|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
160785070|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
160785071|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
160785072|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
160785073|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
160785074|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
160785075|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
160785076|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
160785077|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
160785078|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
160785079|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
160785080|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
160785081|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
160785082|NCT00290758|580600959|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
160640353|NCT00830063|580066687|FG000|Overall Study|Withdrawal by Subject|16|||
160640354|NCT00830063|580066688|FG001|Overall Study|Withdrawal by Subject|10|||
160640355|NCT00830063|580066689|FG002|Overall Study|Withdrawal by Subject|16|||
160640356|NCT00830063|580066690|FG003|Overall Study|Withdrawal by Subject|13|||
160640357|NCT00830063|580066687|FG000|Overall Study|Protocol Violation|1|||
160640358|NCT00830063|580066688|FG001|Overall Study|Protocol Violation|0|||
160640359|NCT00830063|580066689|FG002|Overall Study|Protocol Violation|3|||
160640360|NCT00830063|580066690|FG003|Overall Study|Protocol Violation|2|||
160640361|NCT00830063|580066687|FG000|Overall Study|Randomized But Not Treated|0|||
160640362|NCT00830063|580066688|FG001|Overall Study|Randomized But Not Treated|2|||
160640363|NCT00830063|580066689|FG002|Overall Study|Randomized But Not Treated|0|||
160640364|NCT00830063|580066690|FG003|Overall Study|Randomized But Not Treated|2|||
160640365|NCT01847313|580066693|FG000|Overall Study|Death|0|||
160640366|NCT01847313|580066694|FG001|Overall Study|Death|1|||
160640367|NCT01847313|580066693|FG000|Overall Study|Withdrawal by Subject|0|||
160640368|NCT01847313|580066694|FG001|Overall Study|Withdrawal by Subject|1|||
160640369|NCT02791659|580066695|FG000|Overall Study|Protocol Violation|0|||
160640370|NCT02791659|580066696|FG001|Overall Study|Protocol Violation|1|||
160640371|NCT04356573|580066699|FG000|Overall Study|Didn't Qualify|1|||
160640372|NCT04356573|580066700|FG001|Overall Study|Didn't Qualify|0|||
160640375|NCT01027884|580066706|FG000|Overall Study|Adverse Event|2|||
160640376|NCT01027884|580066707|FG001|Overall Study|Adverse Event|1|||
160640377|NCT01027884|580066706|FG000|Overall Study|Protocol Violation|1|||
160640378|NCT01027884|580066707|FG001|Overall Study|Protocol Violation|0|||
160640379|NCT01027884|580066706|FG000|Overall Study|Non-compliance|1|||
160640380|NCT01027884|580066707|FG001|Overall Study|Non-compliance|1|||
160640381|NCT01027884|580066706|FG000|Overall Study|Withdrawal by Subject|0|||
160640382|NCT01027884|580066707|FG001|Overall Study|Withdrawal by Subject|1|||
160640383|NCT01027884|580066706|FG000|Overall Study|Lost to Follow-up|0|||
160640384|NCT01027884|580066707|FG001|Overall Study|Lost to Follow-up|1|||
160640385|NCT01027884|580066706|FG000|Overall Study|Spinal fixation surgery|0|||
160785083|NCT00290758|580600960|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
160785084|NCT00474968|580600962|FG000|Overall Study|Withdrawal by Subject|8|||
160785085|NCT00474968|580600963|FG001|Overall Study|Withdrawal by Subject|7|||
160785086|NCT00474968|580600962|FG000|Overall Study|Protocol Violation|9|||
160785087|NCT00474968|580600963|FG001|Overall Study|Protocol Violation|8|||
160785088|NCT00474968|580600962|FG000|Overall Study|Sample not collected|1|||
160785089|NCT00474968|580600963|FG001|Overall Study|Sample not collected|1|||
160785090|NCT01111292|580600964|FG000|Treatment|Physician Decision|1|||
160640386|NCT01027884|580066707|FG001|Overall Study|Spinal fixation surgery|3|||
160640387|NCT03636542|580066711|FG000|Overall Study|Lost to Follow-up|1|||
160640388|NCT03636542|580066712|FG001|Overall Study|Lost to Follow-up|1|||
160640389|NCT03636542|580066711|FG000|Overall Study|Physician Decision|0|||
160640390|NCT03636542|580066712|FG001|Overall Study|Physician Decision|1|||
160640391|NCT03636542|580066711|FG000|Overall Study|Withdrawal by Subject|1|||
160785091|NCT01111292|580600965|FG001|Treatment|Physician Decision|1|||
160785092|NCT00215553|580600966|FG000|Overall Study|Adverse Event|0|||
160785093|NCT00215553|580600967|FG001|Overall Study|Adverse Event|1|||
160785094|NCT00215553|580600968|FG002|Overall Study|Adverse Event|2|||
160785095|NCT00215553|580600969|FG003|Overall Study|Adverse Event|1|||
160785096|NCT00215553|580600970|FG004|Overall Study|Adverse Event|2|||
160785097|NCT00215553|580600971|FG005|Overall Study|Adverse Event|6|||
160785098|NCT00215553|580600972|FG006|Overall Study|Adverse Event|0|||
160785099|NCT04914000|580600973|FG000|Overall Study|Lost to Follow-up|8|||
160785100|NCT04914000|580600973|FG000|Overall Study|Withdrawal by Subject|1|||
160785101|NCT01658735|580600978|FG000|Overall Study|Lack of Efficacy|1|||
160785102|NCT01658735|580600979|FG001|Overall Study|Lack of Efficacy|0|||
160785103|NCT01658735|580600980|FG002|Overall Study|Lack of Efficacy|1|||
160785104|NCT01658735|580600978|FG000|Overall Study|Lost to Follow-up|1|||
160785105|NCT01658735|580600979|FG001|Overall Study|Lost to Follow-up|1|||
160785106|NCT01658735|580600980|FG002|Overall Study|Lost to Follow-up|0|||
160785107|NCT01658735|580600978|FG000|Overall Study|Protocol Violation|0|||
160785108|NCT01658735|580600979|FG001|Overall Study|Protocol Violation|1|||
160785109|NCT01658735|580600980|FG002|Overall Study|Protocol Violation|0|||
160785110|NCT01658735|580600978|FG000|Overall Study|Withdrawal by Subject|3|||
160785111|NCT01658735|580600979|FG001|Overall Study|Withdrawal by Subject|5|||
160785112|NCT01658735|580600980|FG002|Overall Study|Withdrawal by Subject|3|||
160785113|NCT02264821|580600981|FG000|Overall Study|Protocol Violation|1|||
160785114|NCT02264821|580600982|FG001|Overall Study|Protocol Violation|3|||
160785115|NCT02264821|580600983|FG002|Overall Study|Protocol Violation|6|||
160785116|NCT03142334|580600984|FG000|Overall Study|Death|18|||
160785117|NCT03142334|580600985|FG001|Overall Study|Death|33|||
160785118|NCT03142334|580600984|FG000|Overall Study|Withdrawal by Subject|15|||
160785119|NCT03142334|580600985|FG001|Overall Study|Withdrawal by Subject|11|||
160785120|NCT03142334|580600984|FG000|Overall Study|Ongoing on trial follow up|463|||
160785121|NCT03142334|580600985|FG001|Overall Study|Ongoing on trial follow up|454|||
160785122|NCT01217047|580600986|FG000|Overall Study|Lost to Follow-up|0|||
160785123|NCT01217047|580600987|FG001|Overall Study|Lost to Follow-up|1|||
160785124|NCT01217047|580600988|FG002|Overall Study|Lost to Follow-up|0|||
160785125|NCT01530997|580600989|FG000|Overall Study|Physician Decision|1|||
160785126|NCT01530997|580600989|FG000|Overall Study|Withdrawal by Subject|1|||
160785127|NCT02318277|580600990|FG000|Overall Study|Physician Decision|0|||
160785128|NCT02318277|580600991|FG001|Overall Study|Physician Decision|0|||
160785129|NCT02318277|580600992|FG002|Overall Study|Physician Decision|0|||
160785130|NCT02318277|580600993|FG003|Overall Study|Physician Decision|0|||
160785131|NCT02318277|580600994|FG004|Overall Study|Physician Decision|0|||
160785132|NCT02318277|580600995|FG005|Overall Study|Physician Decision|0|||
160785133|NCT02318277|580600996|FG006|Overall Study|Physician Decision|0|||
160785134|NCT02318277|580600997|FG007|Overall Study|Physician Decision|1|||
160785135|NCT02318277|580600990|FG000|Overall Study|Other|0|||
160785136|NCT02318277|580600991|FG001|Overall Study|Other|0|||
160785137|NCT02318277|580600992|FG002|Overall Study|Other|0|||
160785138|NCT02318277|580600993|FG003|Overall Study|Other|0|||
160785139|NCT02318277|580600994|FG004|Overall Study|Other|0|||
160785140|NCT02318277|580600995|FG005|Overall Study|Other|0|||
160785141|NCT02318277|580600996|FG006|Overall Study|Other|1|||
160785142|NCT02318277|580600997|FG007|Overall Study|Other|0|||
160785143|NCT02318277|580600990|FG000|Overall Study|Withdrawal by Subject|0|||
160785144|NCT02318277|580600991|FG001|Overall Study|Withdrawal by Subject|0|||
160785145|NCT02318277|580600992|FG002|Overall Study|Withdrawal by Subject|1|||
160785146|NCT02318277|580600993|FG003|Overall Study|Withdrawal by Subject|0|||
160785147|NCT02318277|580600994|FG004|Overall Study|Withdrawal by Subject|1|||
160785148|NCT02318277|580600995|FG005|Overall Study|Withdrawal by Subject|1|||
160785149|NCT02318277|580600996|FG006|Overall Study|Withdrawal by Subject|6|||
160785150|NCT02318277|580600997|FG007|Overall Study|Withdrawal by Subject|14|||
160785151|NCT02318277|580600990|FG000|Overall Study|Participant trial terminated by sponsor|0|||
160785152|NCT02318277|580600991|FG001|Overall Study|Participant trial terminated by sponsor|0|||
160785153|NCT02318277|580600992|FG002|Overall Study|Participant trial terminated by sponsor|1|||
160785154|NCT02318277|580600993|FG003|Overall Study|Participant trial terminated by sponsor|0|||
160785155|NCT02318277|580600994|FG004|Overall Study|Participant trial terminated by sponsor|1|||
160785156|NCT02318277|580600995|FG005|Overall Study|Participant trial terminated by sponsor|2|||
160785157|NCT02318277|580600996|FG006|Overall Study|Participant trial terminated by sponsor|5|||
160785158|NCT02318277|580600997|FG007|Overall Study|Participant trial terminated by sponsor|16|||
160785159|NCT02318277|580600990|FG000|Overall Study|Lost to Follow-up|1|||
160785160|NCT02318277|580600991|FG001|Overall Study|Lost to Follow-up|0|||
160785161|NCT02318277|580600992|FG002|Overall Study|Lost to Follow-up|1|||
160785162|NCT02318277|580600993|FG003|Overall Study|Lost to Follow-up|0|||
160785163|NCT02318277|580600994|FG004|Overall Study|Lost to Follow-up|0|||
160785164|NCT02318277|580600995|FG005|Overall Study|Lost to Follow-up|0|||
160785165|NCT02318277|580600996|FG006|Overall Study|Lost to Follow-up|3|||
160785166|NCT02318277|580600997|FG007|Overall Study|Lost to Follow-up|4|||
160785167|NCT02318277|580600990|FG000|Overall Study|Death|5|||
160785168|NCT02318277|580600991|FG001|Overall Study|Death|3|||
160785169|NCT02318277|580600992|FG002|Overall Study|Death|1|||
160785170|NCT02318277|580600993|FG003|Overall Study|Death|4|||
160785171|NCT02318277|580600994|FG004|Overall Study|Death|6|||
160785172|NCT02318277|580600995|FG005|Overall Study|Death|5|||
160785173|NCT02318277|580600996|FG006|Overall Study|Death|34|||
160785174|NCT02318277|580600997|FG007|Overall Study|Death|58|||
160785175|NCT02318277|580600990|FG000|Overall Study|Transitioned to Hospice|0|||
160785176|NCT02318277|580600991|FG001|Overall Study|Transitioned to Hospice|0|||
160785177|NCT02318277|580600992|FG002|Overall Study|Transitioned to Hospice|0|||
160785178|NCT02318277|580600993|FG003|Overall Study|Transitioned to Hospice|0|||
160785179|NCT02318277|580600994|FG004|Overall Study|Transitioned to Hospice|0|||
160785180|NCT02318277|580600995|FG005|Overall Study|Transitioned to Hospice|1|||
160785181|NCT02318277|580600996|FG006|Overall Study|Transitioned to Hospice|0|||
160785182|NCT02318277|580600997|FG007|Overall Study|Transitioned to Hospice|0|||
160785183|NCT02453191|580600998|FG000|Overall Study|Withdrawal by Subject|1|||
160785184|NCT03364686|580600999|FG000|Overall Study|Physician Decision|2|||
160785185|NCT01520714|580601000|FG000|Overall Study|Protocol Violation|0|||
160785186|NCT01520714|580601001|FG001|Overall Study|Protocol Violation|3|||
160785187|NCT01520714|580601000|FG000|Overall Study|Adverse Event|0|||
160785188|NCT01520714|580601001|FG001|Overall Study|Adverse Event|2|||
160785189|NCT01520714|580601000|FG000|Overall Study|Lack of Efficacy|0|||
160785190|NCT01520714|580601001|FG001|Overall Study|Lack of Efficacy|1|||
160785191|NCT01478087|580601005|FG000|Overall Study|due to sponsor closing study|1|||
160785192|NCT03566550|580601006|FG000|Overall Study|Withdrawal by Subject|0|||
160785193|NCT03566550|580601007|FG001|Overall Study|Withdrawal by Subject|1|||
160785194|NCT03518203|580601009|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
160785195|NCT03518203|580601009|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
160785196|NCT01084135|580601010|FG000|20 Week|Physician Decision|0|||
160785197|NCT01084135|580601011|FG001|20 Week|Physician Decision|1|||
160785198|NCT02366130|580601012|FG000|Overall Study|Withdrawal by Subject|3|||
160543411|NCT02069899|579716480|FG002|Overall Study|Lost to Follow-up|1|||
160543412|NCT02069899|579716478|FG000|Overall Study|Other|4|||
160543413|NCT02069899|579716479|FG001|Overall Study|Other|0|||
160543414|NCT02069899|579716480|FG002|Overall Study|Other|0|||
160543415|NCT02069899|579716478|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
160543416|NCT02069899|579716479|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
160543417|NCT02069899|579716480|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
160543418|NCT02069899|579716478|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
160543419|NCT02069899|579716479|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
160543420|NCT02069899|579716480|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
160543421|NCT00490451|579716481|FG000|Overall Study|Adverse Event|3|||
160543422|NCT00490451|579716482|FG001|Overall Study|Adverse Event|3|||
160543423|NCT00490451|579716481|FG000|Overall Study|Death|3|||
160543424|NCT00490451|579716482|FG001|Overall Study|Death|1|||
160543425|NCT00490451|579716481|FG000|Overall Study|Withdrawal by Subject|2|||
160543426|NCT00490451|579716482|FG001|Overall Study|Withdrawal by Subject|0|||
160543427|NCT00490451|579716481|FG000|Overall Study|Investigator Decision|1|||
160543428|NCT00490451|579716482|FG001|Overall Study|Investigator Decision|0|||
160543429|NCT00490451|579716481|FG000|Overall Study|Protocol Violation|1|||
160543430|NCT00490451|579716482|FG001|Overall Study|Protocol Violation|0|||
160543431|NCT00490451|579716481|FG000|Overall Study|Progressive Disease|53|||
160543432|NCT00490451|579716482|FG001|Overall Study|Progressive Disease|34|||
160543433|NCT01181011|579716483|FG000|Overall Study|Adverse Event|2|||
160543434|NCT01181011|579716483|FG000|Overall Study|Lost to Follow-up|1|||
160543435|NCT00950664|579716486|FG000|First Intervention|Lost to Follow-up|1|||
160543436|NCT00950664|579716487|FG001|First Intervention|Lost to Follow-up|3|||
160543437|NCT00950664|579716486|FG000|First Intervention|Withdrawal by Subject|2|||
160785199|NCT02366130|580601012|FG000|Overall Study|Ineligible|6|||
160785200|NCT01065766|580601013|FG000|Overall Study|Assessed before the contracted date|1|||
160785201|NCT01065766|580601013|FG000|Overall Study|Contraindication to administration|6|||
160785202|NCT01065766|580601013|FG000|Overall Study|Violated dosage/administration|25|||
160785203|NCT01608308|580601017|FG000|Overall Study|pretreatment medical and billing reasons|0|||
160785204|NCT01608308|580601018|FG001|Overall Study|pretreatment medical and billing reasons|2|||
160543438|NCT00950664|579716487|FG001|First Intervention|Withdrawal by Subject|2|||
160543439|NCT00081159|579716488|FG000|Overall Study|Withdrawal by Subject|0|||
160543440|NCT00081159|579716489|FG001|Overall Study|Withdrawal by Subject|3|||
160543441|NCT00081159|579716488|FG000|Overall Study|Myelosuppression prior to treatment|0|||
160543442|NCT00081159|579716489|FG001|Overall Study|Myelosuppression prior to treatment|1|||
160543443|NCT00081159|579716488|FG000|Overall Study|Lost to Follow-up|2|||
160785205|NCT02362412|580601023|FG000|Treatment Period III|Lost to Follow-up|0|||
160785206|NCT02362412|580601024|FG001|Treatment Period III|Lost to Follow-up|1|||
160785207|NCT02675452|580601026|FG000|Overall Study|Sponsor decision|0|||
160785208|NCT02675452|580601027|FG001|Overall Study|Sponsor decision|0|||
160785209|NCT02675452|580601028|FG002|Overall Study|Sponsor decision|0|||
160785210|NCT02675452|580601029|FG003|Overall Study|Sponsor decision|0|||
160785211|NCT02675452|580601030|FG004|Overall Study|Sponsor decision|0|||
160785212|NCT02675452|580601031|FG005|Overall Study|Sponsor decision|0|||
160785213|NCT02675452|580601032|FG006|Overall Study|Sponsor decision|0|||
160785214|NCT02675452|580601033|FG007|Overall Study|Sponsor decision|0|||
160785215|NCT02675452|580601034|FG008|Overall Study|Sponsor decision|0|||
160785216|NCT02675452|580601035|FG009|Overall Study|Sponsor decision|1|||
160785217|NCT02675452|580601036|FG010|Overall Study|Sponsor decision|0|||
160785218|NCT02675452|580601037|FG011|Overall Study|Sponsor decision|0|||
160785219|NCT02675452|580601038|FG012|Overall Study|Sponsor decision|0|||
160785220|NCT02675452|580601039|FG013|Overall Study|Sponsor decision|2|||
160785221|NCT02675452|580601040|FG014|Overall Study|Sponsor decision|1|||
160785222|NCT02675452|580601041|FG015|Overall Study|Sponsor decision|0|||
160785223|NCT02675452|580601042|FG016|Overall Study|Sponsor decision|1|||
160785224|NCT02675452|580601043|FG017|Overall Study|Sponsor decision|0|||
160785225|NCT02675452|580601044|FG018|Overall Study|Sponsor decision|0|||
160785226|NCT02675452|580601045|FG019|Overall Study|Sponsor decision|0|||
160785227|NCT02675452|580601046|FG020|Overall Study|Sponsor decision|0|||
160785228|NCT02675452|580601047|FG021|Overall Study|Sponsor decision|0|||
160785229|NCT02675452|580601048|FG022|Overall Study|Sponsor decision|0|||
160785230|NCT02675452|580601049|FG023|Overall Study|Sponsor decision|0|||
160785231|NCT02675452|580601050|FG024|Overall Study|Sponsor decision|0|||
160785232|NCT02675452|580601051|FG025|Overall Study|Sponsor decision|0|||
160785233|NCT02675452|580601052|FG026|Overall Study|Sponsor decision|2|||
160785234|NCT02675452|580601053|FG027|Overall Study|Sponsor decision|0|||
160785235|NCT02675452|580601054|FG028|Overall Study|Sponsor decision|0|||
160785236|NCT02675452|580601026|FG000|Overall Study|Withdrawal by Subject|0|||
160785237|NCT02675452|580601027|FG001|Overall Study|Withdrawal by Subject|0|||
160785238|NCT02675452|580601028|FG002|Overall Study|Withdrawal by Subject|0|||
160785239|NCT02675452|580601029|FG003|Overall Study|Withdrawal by Subject|0|||
160785240|NCT02675452|580601030|FG004|Overall Study|Withdrawal by Subject|0|||
160785241|NCT02675452|580601031|FG005|Overall Study|Withdrawal by Subject|0|||
160785242|NCT02675452|580601032|FG006|Overall Study|Withdrawal by Subject|0|||
160785243|NCT02675452|580601033|FG007|Overall Study|Withdrawal by Subject|0|||
160785244|NCT02675452|580601034|FG008|Overall Study|Withdrawal by Subject|0|||
160785245|NCT02675452|580601035|FG009|Overall Study|Withdrawal by Subject|1|||
160785246|NCT02675452|580601036|FG010|Overall Study|Withdrawal by Subject|0|||
160785247|NCT02675452|580601037|FG011|Overall Study|Withdrawal by Subject|1|||
160785248|NCT02675452|580601038|FG012|Overall Study|Withdrawal by Subject|0|||
160785249|NCT02675452|580601039|FG013|Overall Study|Withdrawal by Subject|1|||
160785250|NCT02675452|580601040|FG014|Overall Study|Withdrawal by Subject|1|||
160785251|NCT02675452|580601041|FG015|Overall Study|Withdrawal by Subject|0|||
160785252|NCT02675452|580601042|FG016|Overall Study|Withdrawal by Subject|2|||
160785253|NCT02675452|580601043|FG017|Overall Study|Withdrawal by Subject|0|||
160785254|NCT02675452|580601044|FG018|Overall Study|Withdrawal by Subject|0|||
160785255|NCT02675452|580601045|FG019|Overall Study|Withdrawal by Subject|0|||
160785256|NCT02675452|580601046|FG020|Overall Study|Withdrawal by Subject|0|||
160785257|NCT02675452|580601047|FG021|Overall Study|Withdrawal by Subject|0|||
160785258|NCT02675452|580601048|FG022|Overall Study|Withdrawal by Subject|3|||
160785259|NCT02675452|580601049|FG023|Overall Study|Withdrawal by Subject|0|||
160785260|NCT02675452|580601050|FG024|Overall Study|Withdrawal by Subject|1|||
160785261|NCT02675452|580601051|FG025|Overall Study|Withdrawal by Subject|0|||
160785262|NCT02675452|580601052|FG026|Overall Study|Withdrawal by Subject|1|||
160785263|NCT02675452|580601053|FG027|Overall Study|Withdrawal by Subject|3|||
160785264|NCT02675452|580601054|FG028|Overall Study|Withdrawal by Subject|4|||
160785265|NCT02675452|580601026|FG000|Overall Study|Death|0|||
160785266|NCT02675452|580601027|FG001|Overall Study|Death|0|||
160785267|NCT02675452|580601028|FG002|Overall Study|Death|1|||
160890210|NCT00423670|580992972|FG005|Treatment Period|Investigator decision|0|||
160785268|NCT02675452|580601029|FG003|Overall Study|Death|0|||
160785269|NCT02675452|580601030|FG004|Overall Study|Death|0|||
160785270|NCT02675452|580601031|FG005|Overall Study|Death|1|||
160785271|NCT02675452|580601032|FG006|Overall Study|Death|0|||
160785272|NCT02675452|580601033|FG007|Overall Study|Death|0|||
160785273|NCT02675452|580601034|FG008|Overall Study|Death|1|||
160785274|NCT02675452|580601035|FG009|Overall Study|Death|0|||
160785275|NCT02675452|580601036|FG010|Overall Study|Death|0|||
160785276|NCT02675452|580601037|FG011|Overall Study|Death|0|||
160785277|NCT02675452|580601038|FG012|Overall Study|Death|1|||
160785278|NCT02675452|580601039|FG013|Overall Study|Death|0|||
160785279|NCT02675452|580601040|FG014|Overall Study|Death|0|||
160981859|NCT02061761|581321785|FG003|Overall Study|Withdrawal by Subject|0|||
160981860|NCT02061761|581321786|FG004|Overall Study|Withdrawal by Subject|0|||
160981861|NCT02061761|581321787|FG005|Overall Study|Withdrawal by Subject|0|||
160785280|NCT02675452|580601041|FG015|Overall Study|Death|2|||
160640392|NCT03636542|580066712|FG001|Overall Study|Withdrawal by Subject|0|||
160640393|NCT03670537|580066713|FG000|Overall Study|Protocol Violation|1|||
160640394|NCT03751020|580066714|FG000|Overall Study|Withdrawal by Subject|2|||
160640395|NCT03751020|580066715|FG001|Overall Study|Withdrawal by Subject|0|||
160640396|NCT03751020|580066716|FG002|Overall Study|Withdrawal by Subject|0|||
160640397|NCT03751020|580066714|FG000|Overall Study|Lost to Follow-up|7|||
160640398|NCT03751020|580066715|FG001|Overall Study|Lost to Follow-up|4|||
160640399|NCT03751020|580066716|FG002|Overall Study|Lost to Follow-up|10|||
160640400|NCT01889862|580066717|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
160640401|NCT01889862|580066718|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
160785281|NCT02675452|580601042|FG016|Overall Study|Death|0|||
160785282|NCT02675452|580601043|FG017|Overall Study|Death|0|||
160785283|NCT02675452|580601044|FG018|Overall Study|Death|4|||
160785284|NCT02675452|580601045|FG019|Overall Study|Death|3|||
160785285|NCT02675452|580601046|FG020|Overall Study|Death|3|||
160785286|NCT02675452|580601047|FG021|Overall Study|Death|3|||
160785287|NCT02675452|580601048|FG022|Overall Study|Death|7|||
160785288|NCT02675452|580601049|FG023|Overall Study|Death|5|||
160785289|NCT02675452|580601050|FG024|Overall Study|Death|3|||
160785290|NCT02675452|580601051|FG025|Overall Study|Death|4|||
160785291|NCT02675452|580601052|FG026|Overall Study|Death|7|||
160785292|NCT02675452|580601053|FG027|Overall Study|Death|6|||
160785293|NCT02675452|580601054|FG028|Overall Study|Death|9|||
160785294|NCT02675452|580601026|FG000|Overall Study|Lost to Follow-up|0|||
160785295|NCT02675452|580601027|FG001|Overall Study|Lost to Follow-up|1|||
160785296|NCT02675452|580601028|FG002|Overall Study|Lost to Follow-up|0|||
160785297|NCT02675452|580601029|FG003|Overall Study|Lost to Follow-up|0|||
160785298|NCT02675452|580601030|FG004|Overall Study|Lost to Follow-up|0|||
160640402|NCT01889862|580066719|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
160640403|NCT01889862|580066720|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
160785299|NCT02675452|580601031|FG005|Overall Study|Lost to Follow-up|0|||
160785300|NCT02675452|580601032|FG006|Overall Study|Lost to Follow-up|0|||
160785301|NCT02675452|580601033|FG007|Overall Study|Lost to Follow-up|0|||
160785302|NCT02675452|580601034|FG008|Overall Study|Lost to Follow-up|0|||
160785303|NCT02675452|580601035|FG009|Overall Study|Lost to Follow-up|0|||
160785304|NCT02675452|580601036|FG010|Overall Study|Lost to Follow-up|0|||
160785305|NCT02675452|580601037|FG011|Overall Study|Lost to Follow-up|0|||
160785306|NCT02675452|580601038|FG012|Overall Study|Lost to Follow-up|1|||
160785307|NCT02675452|580601039|FG013|Overall Study|Lost to Follow-up|0|||
160785308|NCT02675452|580601040|FG014|Overall Study|Lost to Follow-up|0|||
160785309|NCT02675452|580601041|FG015|Overall Study|Lost to Follow-up|0|||
160785310|NCT02675452|580601042|FG016|Overall Study|Lost to Follow-up|0|||
160785311|NCT02675452|580601043|FG017|Overall Study|Lost to Follow-up|0|||
160785312|NCT02675452|580601044|FG018|Overall Study|Lost to Follow-up|0|||
160785313|NCT02675452|580601045|FG019|Overall Study|Lost to Follow-up|0|||
160785314|NCT02675452|580601046|FG020|Overall Study|Lost to Follow-up|0|||
160785315|NCT02675452|580601047|FG021|Overall Study|Lost to Follow-up|0|||
160785316|NCT02675452|580601048|FG022|Overall Study|Lost to Follow-up|0|||
160785317|NCT02675452|580601049|FG023|Overall Study|Lost to Follow-up|0|||
160785318|NCT02675452|580601050|FG024|Overall Study|Lost to Follow-up|0|||
160785319|NCT02675452|580601051|FG025|Overall Study|Lost to Follow-up|0|||
160785320|NCT02675452|580601052|FG026|Overall Study|Lost to Follow-up|1|||
160785321|NCT02675452|580601053|FG027|Overall Study|Lost to Follow-up|0|||
160785322|NCT02675452|580601054|FG028|Overall Study|Lost to Follow-up|0|||
160785323|NCT02675452|580601026|FG000|Overall Study|Other|0|||
160785324|NCT02675452|580601027|FG001|Overall Study|Other|0|||
160785325|NCT02675452|580601028|FG002|Overall Study|Other|0|||
160785326|NCT02675452|580601029|FG003|Overall Study|Other|0|||
160785327|NCT02675452|580601030|FG004|Overall Study|Other|0|||
160785328|NCT02675452|580601031|FG005|Overall Study|Other|0|||
160785329|NCT02675452|580601032|FG006|Overall Study|Other|0|||
160785330|NCT02675452|580601033|FG007|Overall Study|Other|0|||
160785331|NCT02675452|580601034|FG008|Overall Study|Other|0|||
160785332|NCT02675452|580601035|FG009|Overall Study|Other|0|||
160785333|NCT02675452|580601036|FG010|Overall Study|Other|0|||
160785334|NCT02675452|580601037|FG011|Overall Study|Other|0|||
160785335|NCT02675452|580601038|FG012|Overall Study|Other|0|||
160785336|NCT02675452|580601039|FG013|Overall Study|Other|0|||
160785337|NCT02675452|580601040|FG014|Overall Study|Other|0|||
160785338|NCT02675452|580601041|FG015|Overall Study|Other|0|||
160785339|NCT02675452|580601042|FG016|Overall Study|Other|0|||
160785340|NCT02675452|580601043|FG017|Overall Study|Other|0|||
160785341|NCT02675452|580601044|FG018|Overall Study|Other|0|||
160785342|NCT02675452|580601045|FG019|Overall Study|Other|0|||
160785343|NCT02675452|580601046|FG020|Overall Study|Other|0|||
160785344|NCT02675452|580601047|FG021|Overall Study|Other|0|||
160785345|NCT02675452|580601048|FG022|Overall Study|Other|0|||
160785346|NCT02675452|580601049|FG023|Overall Study|Other|0|||
160785347|NCT02675452|580601050|FG024|Overall Study|Other|0|||
160785348|NCT02675452|580601051|FG025|Overall Study|Other|0|||
160785349|NCT02675452|580601052|FG026|Overall Study|Other|1|||
160785350|NCT02675452|580601053|FG027|Overall Study|Other|0|||
160785351|NCT02675452|580601054|FG028|Overall Study|Other|0|||
160785352|NCT03467945|580601055|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160640404|NCT01889862|580066721|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
160640405|NCT01889862|580066717|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
160640406|NCT01889862|580066718|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
160640407|NCT01889862|580066719|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
160640408|NCT01889862|580066720|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
160640409|NCT01889862|580066721|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
160640410|NCT01889862|580066717|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
160640411|NCT01889862|580066718|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
160640412|NCT01889862|580066719|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
160640413|NCT01889862|580066720|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
160640414|NCT01889862|580066721|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
160640415|NCT01889862|580066717|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
160640416|NCT01889862|580066718|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
160785353|NCT03467945|580601056|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160785354|NCT03467945|580601057|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160785355|NCT03467945|580601058|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160785356|NCT03467945|580601055|FG000|Treatment Period 3|Withdrawal by Subject|1|||
160785357|NCT03467945|580601056|FG001|Treatment Period 3|Withdrawal by Subject|0|||
160785358|NCT03467945|580601057|FG002|Treatment Period 3|Withdrawal by Subject|2|||
160785359|NCT03467945|580601058|FG003|Treatment Period 3|Withdrawal by Subject|1|||
160785360|NCT04595370|580601073|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
160785361|NCT04595370|580601074|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
160785362|NCT04595370|580601075|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
160785363|NCT04595370|580601076|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
160785364|NCT04595370|580601077|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
160785365|NCT04595370|580601078|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
160785366|NCT04595370|580601073|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
160785367|NCT04595370|580601074|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
160785368|NCT04595370|580601075|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
160785369|NCT04595370|580601076|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
160785370|NCT04595370|580601077|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
160785371|NCT04595370|580601078|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
160785372|NCT04595370|580601073|FG000|Overall Study|Adverse Event|0|||
160785373|NCT04595370|580601074|FG001|Overall Study|Adverse Event|4|||
160785374|NCT04595370|580601075|FG002|Overall Study|Adverse Event|3|||
160785375|NCT04595370|580601076|FG003|Overall Study|Adverse Event|1|||
160785376|NCT04595370|580601077|FG004|Overall Study|Adverse Event|1|||
160785377|NCT04595370|580601078|FG005|Overall Study|Adverse Event|1|||
160785378|NCT04595370|580601073|FG000|Overall Study|Withdrawal of Consent|1|||
160785379|NCT04595370|580601074|FG001|Overall Study|Withdrawal of Consent|1|||
160785380|NCT04595370|580601075|FG002|Overall Study|Withdrawal of Consent|1|||
160785381|NCT04595370|580601076|FG003|Overall Study|Withdrawal of Consent|0|||
160785382|NCT04595370|580601077|FG004|Overall Study|Withdrawal of Consent|0|||
160785383|NCT04595370|580601078|FG005|Overall Study|Withdrawal of Consent|0|||
160785384|NCT04595370|580601073|FG000|Overall Study|Death|0|||
160785385|NCT04595370|580601074|FG001|Overall Study|Death|1|||
160785386|NCT04595370|580601075|FG002|Overall Study|Death|0|||
160785387|NCT04595370|580601076|FG003|Overall Study|Death|0|||
160785388|NCT04595370|580601077|FG004|Overall Study|Death|1|||
160785389|NCT04595370|580601078|FG005|Overall Study|Death|0|||
160785390|NCT04595370|580601073|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160785391|NCT04595370|580601074|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160785392|NCT04595370|580601075|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
160785393|NCT04595370|580601076|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160785394|NCT04595370|580601077|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160785395|NCT04595370|580601078|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160785396|NCT04595370|580601073|FG000|Overall Study|Withdrawal by Subject|0|||
160785397|NCT04595370|580601074|FG001|Overall Study|Withdrawal by Subject|0|||
160785398|NCT04595370|580601075|FG002|Overall Study|Withdrawal by Subject|1|||
160543444|NCT00081159|579716489|FG001|Overall Study|Lost to Follow-up|1|||
160543445|NCT02457637|579716494|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
160543446|NCT01035905|579716496|FG000|Overall Study|Lack of Efficacy|1|||
160543447|NCT01035905|579716497|FG001|Overall Study|Lack of Efficacy|1|||
160543448|NCT01273883|579716498|FG000|First Intervention|Adverse Event|2|||
160543449|NCT01273883|579716499|FG001|First Intervention|Adverse Event|1|||
160543450|NCT01273883|579716498|FG000|Second Intervention|Lost to Follow-up|1|||
160543451|NCT01273883|579716499|FG001|Second Intervention|Lost to Follow-up|1|||
160543452|NCT01273883|579716498|FG000|Second Intervention|Lack of Efficacy|1|||
160543453|NCT01273883|579716499|FG001|Second Intervention|Lack of Efficacy|0|||
160543454|NCT04311502|579718212|FG000|Overall Study|Death|1|||
160543455|NCT04311502|579718213|FG001|Overall Study|Death|1|||
160543456|NCT04311502|579718214|FG002|Overall Study|Death|1|||
160543457|NCT04311502|579718212|FG000|Overall Study|Lost to Follow-up|2|||
160543458|NCT04311502|579718213|FG001|Overall Study|Lost to Follow-up|3|||
160543459|NCT04311502|579718214|FG002|Overall Study|Lost to Follow-up|0|||
160543460|NCT04311502|579718212|FG000|Overall Study|Participant is in prison|1|||
160543461|NCT04311502|579718213|FG001|Overall Study|Participant is in prison|0|||
160543462|NCT04311502|579718214|FG002|Overall Study|Participant is in prison|0|||
160543463|NCT04311502|579718212|FG000|Overall Study|Participant moved out of country|1|||
160543464|NCT04311502|579718213|FG001|Overall Study|Participant moved out of country|0|||
160543465|NCT04311502|579718214|FG002|Overall Study|Participant moved out of country|0|||
160543466|NCT04311502|579718212|FG000|Overall Study|Withdrawal by Subject|2|||
160543467|NCT04311502|579718213|FG001|Overall Study|Withdrawal by Subject|0|||
160543468|NCT04311502|579718214|FG002|Overall Study|Withdrawal by Subject|0|||
160543469|NCT04311502|579718212|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
160785399|NCT04595370|580601076|FG003|Overall Study|Withdrawal by Subject|0|||
160785400|NCT04595370|580601077|FG004|Overall Study|Withdrawal by Subject|2|||
160785401|NCT04595370|580601078|FG005|Overall Study|Withdrawal by Subject|0|||
160785402|NCT04595370|580601073|FG000|Overall Study|Lost to Follow-up|0|||
160785403|NCT04595370|580601074|FG001|Overall Study|Lost to Follow-up|0|||
160785404|NCT04595370|580601075|FG002|Overall Study|Lost to Follow-up|0|||
160785405|NCT04595370|580601076|FG003|Overall Study|Lost to Follow-up|0|||
160785406|NCT04595370|580601077|FG004|Overall Study|Lost to Follow-up|1|||
160785407|NCT04595370|580601078|FG005|Overall Study|Lost to Follow-up|0|||
160785408|NCT04595370|580601073|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
160785409|NCT04595370|580601074|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
160785410|NCT04595370|580601075|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
160785411|NCT04595370|580601076|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
160785412|NCT04595370|580601077|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
160785413|NCT04595370|580601078|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
160785414|NCT00541775|580601079|FG000|Overall Study|Adverse Event|3|||
160785415|NCT00541775|580601080|FG001|Overall Study|Adverse Event|2|||
160785416|NCT00541775|580601081|FG002|Overall Study|Adverse Event|1|||
160785417|NCT00541775|580601079|FG000|Overall Study|Lack of Efficacy|0|||
160785418|NCT00541775|580601080|FG001|Overall Study|Lack of Efficacy|0|||
160785419|NCT00541775|580601081|FG002|Overall Study|Lack of Efficacy|3|||
160785420|NCT00541775|580601079|FG000|Overall Study|Lost to Follow-up|0|||
160785421|NCT00541775|580601080|FG001|Overall Study|Lost to Follow-up|0|||
160785422|NCT00541775|580601081|FG002|Overall Study|Lost to Follow-up|2|||
160785423|NCT00541775|580601079|FG000|Overall Study|Protocol Violation|1|||
160785424|NCT00541775|580601080|FG001|Overall Study|Protocol Violation|0|||
160785425|NCT00541775|580601081|FG002|Overall Study|Protocol Violation|0|||
160640417|NCT01889862|580066719|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
160640418|NCT01889862|580066720|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
160640419|NCT01889862|580066721|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
160640420|NCT01889862|580066717|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
160640421|NCT01889862|580066718|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
160640422|NCT01889862|580066719|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
160640423|NCT01889862|580066720|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
160640424|NCT01889862|580066721|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
160640425|NCT01889862|580066717|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
160640426|NCT01889862|580066718|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
160640427|NCT01889862|580066719|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
160640428|NCT01889862|580066720|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
160640429|NCT01889862|580066721|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
160640430|NCT01889862|580066717|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
160640431|NCT01889862|580066718|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
160640432|NCT01889862|580066719|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
160640433|NCT01889862|580066720|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
160640434|NCT01889862|580066721|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
160640435|NCT01889862|580066717|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
160640436|NCT01889862|580066718|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
160640437|NCT01889862|580066719|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
160640438|NCT01889862|580066720|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
160640439|NCT01889862|580066721|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
160640440|NCT01889862|580066717|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
160640441|NCT01889862|580066718|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
160640442|NCT01889862|580066719|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
160640443|NCT01889862|580066720|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
160640444|NCT01889862|580066721|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
160640445|NCT01889862|580066717|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
160640446|NCT01889862|580066718|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
160640447|NCT01889862|580066719|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
160640448|NCT01889862|580066720|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
160640449|NCT01889862|580066721|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
160640450|NCT01507831|580066722|FG000|Overall Study|Randomized but not treated|0|||
160640451|NCT01507831|580066723|FG001|Overall Study|Randomized but not treated|3|||
160785426|NCT00541775|580601079|FG000|Overall Study|Withdrawal by Subject and Other|5|||
160785427|NCT00541775|580601080|FG001|Overall Study|Withdrawal by Subject and Other|0|||
160785428|NCT00541775|580601081|FG002|Overall Study|Withdrawal by Subject and Other|2|||
160785429|NCT01945242|580601082|FG000|Overall Study|Physician Decision|3|||
160785430|NCT01945242|580601083|FG001|Overall Study|Physician Decision|3|||
160785431|NCT00032487|580601084|FG000|Overall Study|Withdrawal by Subject|67|||
160785432|NCT00032487|580601085|FG001|Overall Study|Withdrawal by Subject|43|||
160785433|NCT00032487|580601084|FG000|Overall Study|Adverse Event|3|||
160640452|NCT01507831|580066722|FG000|Overall Study|Adverse Event|48|||
160640453|NCT01507831|580066723|FG001|Overall Study|Adverse Event|113|||
160640454|NCT01507831|580066722|FG000|Overall Study|Death|6|||
160785434|NCT00032487|580601085|FG001|Overall Study|Adverse Event|7|||
160785435|NCT00032487|580601084|FG000|Overall Study|Lost to Follow-up|57|||
160785436|NCT00032487|580601085|FG001|Overall Study|Lost to Follow-up|58|||
160785437|NCT00032487|580601084|FG000|Overall Study|Had other reason|12|||
160785438|NCT00032487|580601085|FG001|Overall Study|Had other reason|12|||
160785439|NCT04913675|580601087|FG000|Main Study (Up to Week 36)|Death|0|||
160785440|NCT04913675|580601088|FG001|Main Study (Up to Week 36)|Death|2|||
160785441|NCT04913675|580601089|FG002|Main Study (Up to Week 36)|Death|2|||
160785442|NCT04913675|580601090|FG003|Main Study (Up to Week 36)|Death|0|||
160785443|NCT04913675|580601087|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
160785444|NCT04913675|580601088|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
160785445|NCT04913675|580601089|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
160785446|NCT04913675|580601090|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
160785447|NCT04913675|580601087|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
160785448|NCT04913675|580601088|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
160785449|NCT04913675|580601089|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
160785450|NCT04913675|580601090|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
160785451|NCT04913675|580601087|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
160785452|NCT04913675|580601088|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
160785453|NCT04913675|580601089|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
160785454|NCT04913675|580601090|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
160785455|NCT04913675|580601087|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
160785456|NCT04913675|580601088|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
160785457|NCT04913675|580601089|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
160785458|NCT04913675|580601090|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
160785462|NCT01541254|580601094|FG000|Overall Study|Withdrawal by Subject|1|||
160785463|NCT01541254|580601094|FG000|Overall Study|excluded - metal allergy|1|||
160785464|NCT01541254|580601094|FG000|Overall Study|enrolled after study closed|1|||
160785465|NCT01541254|580601094|FG000|Overall Study|GI bleed prior to procedure|1|||
160785466|NCT01541254|580601094|FG000|Overall Study|stent not required|1|||
160785467|NCT01541254|580601094|FG000|Overall Study|alternate stent used|1|||
160785468|NCT05660538|580601095|FG000|Overall Study|Adverse Event|0|||
160785469|NCT05660538|580601096|FG001|Overall Study|Adverse Event|0|||
160785470|NCT05660538|580601097|FG002|Overall Study|Adverse Event|1|||
160785471|NCT05660538|580601098|FG003|Overall Study|Adverse Event|0|||
160785472|NCT05660538|580601095|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
160785473|NCT05660538|580601096|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
160785474|NCT05660538|580601097|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
160785475|NCT05660538|580601098|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
160785476|NCT05660538|580601095|FG000|Overall Study|Lost to Follow-up|0|||
160785477|NCT05660538|580601096|FG001|Overall Study|Lost to Follow-up|0|||
160785478|NCT05660538|580601097|FG002|Overall Study|Lost to Follow-up|1|||
160785479|NCT05660538|580601098|FG003|Overall Study|Lost to Follow-up|1|||
160785480|NCT05660538|580601095|FG000|Overall Study|Death|0|||
160785481|NCT05660538|580601096|FG001|Overall Study|Death|0|||
160785482|NCT05660538|580601097|FG002|Overall Study|Death|1|||
160785483|NCT05660538|580601098|FG003|Overall Study|Death|0|||
160785484|NCT05660538|580601095|FG000|Overall Study|Physician Decision|0|||
160785485|NCT05660538|580601096|FG001|Overall Study|Physician Decision|0|||
160785486|NCT05660538|580601097|FG002|Overall Study|Physician Decision|0|||
160785487|NCT05660538|580601098|FG003|Overall Study|Physician Decision|1|||
160785488|NCT05660538|580601095|FG000|Overall Study|Sponsor Decision|1|||
160785489|NCT05660538|580601096|FG001|Overall Study|Sponsor Decision|0|||
160785490|NCT05660538|580601097|FG002|Overall Study|Sponsor Decision|0|||
160785491|NCT05660538|580601098|FG003|Overall Study|Sponsor Decision|0|||
160785492|NCT05660538|580601095|FG000|Overall Study|Other|1|||
160785493|NCT05660538|580601096|FG001|Overall Study|Other|0|||
160785494|NCT05660538|580601097|FG002|Overall Study|Other|0|||
160785495|NCT05660538|580601098|FG003|Overall Study|Other|1|||
160785496|NCT05660538|580601095|FG000|Overall Study|Randomized but did not receive study drug|1|||
160785497|NCT05660538|580601096|FG001|Overall Study|Randomized but did not receive study drug|0|||
160785498|NCT05660538|580601097|FG002|Overall Study|Randomized but did not receive study drug|0|||
160785499|NCT05660538|580601098|FG003|Overall Study|Randomized but did not receive study drug|1|||
160785500|NCT05660538|580601095|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
160785501|NCT05660538|580601096|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
160785502|NCT05660538|580601097|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
160785503|NCT05660538|580601098|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
160785504|NCT04518410|580601099|FG000|Overall Study|Lost to Follow-up|1|||
160785505|NCT04518410|580601100|FG001|Overall Study|Lost to Follow-up|1|||
160785506|NCT04518410|580601101|FG002|Overall Study|Lost to Follow-up|8|||
160785507|NCT04518410|580601102|FG003|Overall Study|Lost to Follow-up|5|||
160785508|NCT04518410|580601103|FG004|Overall Study|Lost to Follow-up|92|||
160785509|NCT04518410|580601104|FG005|Overall Study|Lost to Follow-up|25|||
160785510|NCT04518410|580601105|FG006|Overall Study|Lost to Follow-up|25|||
160785511|NCT04518410|580601106|FG007|Overall Study|Lost to Follow-up|3|||
160785512|NCT04518410|580601107|FG008|Overall Study|Lost to Follow-up|2|||
160785513|NCT04518410|580601108|FG009|Overall Study|Lost to Follow-up|13|||
160785514|NCT04518410|580601109|FG010|Overall Study|Lost to Follow-up|9|||
160785515|NCT04518410|580601110|FG011|Overall Study|Lost to Follow-up|13|||
160785516|NCT04518410|580601111|FG012|Overall Study|Lost to Follow-up|9|||
160785517|NCT04518410|580601112|FG013|Overall Study|Lost to Follow-up|13|||
160785518|NCT04518410|580601113|FG014|Overall Study|Lost to Follow-up|8|||
160785519|NCT04518410|580601114|FG015|Overall Study|Lost to Follow-up|10|||
160785520|NCT04518410|580601115|FG016|Overall Study|Lost to Follow-up|6|||
160785521|NCT04518410|580601116|FG017|Overall Study|Lost to Follow-up|13|||
160785522|NCT04518410|580601117|FG018|Overall Study|Lost to Follow-up|21|||
160785523|NCT04518410|580601118|FG019|Overall Study|Lost to Follow-up|6|||
160785524|NCT04518410|580601119|FG020|Overall Study|Lost to Follow-up|7|||
160785525|NCT04518410|580601120|FG021|Overall Study|Lost to Follow-up|21|||
160785526|NCT04518410|580601121|FG022|Overall Study|Lost to Follow-up|1|||
160785527|NCT04518410|580601122|FG023|Overall Study|Lost to Follow-up|7|||
160785528|NCT04518410|580601123|FG024|Overall Study|Lost to Follow-up|6|||
160785529|NCT04518410|580601099|FG000|Overall Study|Withdrawal by Subject|1|||
160785530|NCT04518410|580601100|FG001|Overall Study|Withdrawal by Subject|2|||
160785531|NCT04518410|580601101|FG002|Overall Study|Withdrawal by Subject|2|||
160785532|NCT04518410|580601102|FG003|Overall Study|Withdrawal by Subject|3|||
160785533|NCT04518410|580601103|FG004|Overall Study|Withdrawal by Subject|20|||
160785534|NCT04518410|580601104|FG005|Overall Study|Withdrawal by Subject|20|||
160785535|NCT04518410|580601105|FG006|Overall Study|Withdrawal by Subject|25|||
160785536|NCT04518410|580601106|FG007|Overall Study|Withdrawal by Subject|6|||
160785537|NCT04518410|580601107|FG008|Overall Study|Withdrawal by Subject|1|||
160785538|NCT04518410|580601108|FG009|Overall Study|Withdrawal by Subject|12|||
160785539|NCT04518410|580601109|FG010|Overall Study|Withdrawal by Subject|5|||
160785540|NCT04518410|580601110|FG011|Overall Study|Withdrawal by Subject|7|||
160785541|NCT04518410|580601111|FG012|Overall Study|Withdrawal by Subject|2|||
160785542|NCT04518410|580601112|FG013|Overall Study|Withdrawal by Subject|13|||
160785543|NCT04518410|580601113|FG014|Overall Study|Withdrawal by Subject|4|||
160785544|NCT04518410|580601114|FG015|Overall Study|Withdrawal by Subject|9|||
160785545|NCT04518410|580601115|FG016|Overall Study|Withdrawal by Subject|0|||
160785546|NCT04518410|580601116|FG017|Overall Study|Withdrawal by Subject|15|||
160785547|NCT04518410|580601117|FG018|Overall Study|Withdrawal by Subject|12|||
160785548|NCT04518410|580601118|FG019|Overall Study|Withdrawal by Subject|9|||
160785549|NCT04518410|580601119|FG020|Overall Study|Withdrawal by Subject|14|||
160785550|NCT04518410|580601120|FG021|Overall Study|Withdrawal by Subject|3|||
160785551|NCT04518410|580601121|FG022|Overall Study|Withdrawal by Subject|2|||
160785552|NCT04518410|580601122|FG023|Overall Study|Withdrawal by Subject|9|||
160785553|NCT04518410|580601123|FG024|Overall Study|Withdrawal by Subject|8|||
160785554|NCT04518410|580601099|FG000|Overall Study|Other|1|||
160785555|NCT04518410|580601100|FG001|Overall Study|Other|0|||
160785556|NCT04518410|580601101|FG002|Overall Study|Other|0|||
160785557|NCT04518410|580601102|FG003|Overall Study|Other|1|||
160785558|NCT04518410|580601103|FG004|Overall Study|Other|6|||
160785559|NCT04518410|580601104|FG005|Overall Study|Other|6|||
160785560|NCT04518410|580601105|FG006|Overall Study|Other|5|||
160785561|NCT04518410|580601106|FG007|Overall Study|Other|2|||
160785562|NCT04518410|580601107|FG008|Overall Study|Other|0|||
160785563|NCT04518410|580601108|FG009|Overall Study|Other|1|||
160785564|NCT04518410|580601109|FG010|Overall Study|Other|0|||
160785565|NCT04518410|580601110|FG011|Overall Study|Other|2|||
160785566|NCT04518410|580601111|FG012|Overall Study|Other|0|||
160785567|NCT04518410|580601112|FG013|Overall Study|Other|0|||
160785568|NCT04518410|580601113|FG014|Overall Study|Other|0|||
160785569|NCT04518410|580601114|FG015|Overall Study|Other|3|||
160785570|NCT04518410|580601115|FG016|Overall Study|Other|1|||
160785571|NCT04518410|580601116|FG017|Overall Study|Other|1|||
160785572|NCT04518410|580601117|FG018|Overall Study|Other|1|||
160785573|NCT04518410|580601118|FG019|Overall Study|Other|0|||
160785574|NCT04518410|580601119|FG020|Overall Study|Other|1|||
160785575|NCT04518410|580601120|FG021|Overall Study|Other|0|||
160785576|NCT04518410|580601121|FG022|Overall Study|Other|1|||
160785577|NCT04518410|580601122|FG023|Overall Study|Other|2|||
160785578|NCT04518410|580601123|FG024|Overall Study|Other|2|||
160785579|NCT04518410|580601099|FG000|Overall Study|Protocol Violation|0|||
160785580|NCT04518410|580601100|FG001|Overall Study|Protocol Violation|0|||
160785581|NCT04518410|580601101|FG002|Overall Study|Protocol Violation|0|||
160785582|NCT04518410|580601102|FG003|Overall Study|Protocol Violation|2|||
160785583|NCT04518410|580601103|FG004|Overall Study|Protocol Violation|17|||
160785584|NCT04518410|580601104|FG005|Overall Study|Protocol Violation|1|||
160785585|NCT04518410|580601105|FG006|Overall Study|Protocol Violation|2|||
160785586|NCT04518410|580601106|FG007|Overall Study|Protocol Violation|1|||
160785587|NCT04518410|580601107|FG008|Overall Study|Protocol Violation|0|||
160785588|NCT04518410|580601108|FG009|Overall Study|Protocol Violation|0|||
160785589|NCT04518410|580601109|FG010|Overall Study|Protocol Violation|0|||
160785590|NCT04518410|580601110|FG011|Overall Study|Protocol Violation|0|||
160785591|NCT04518410|580601111|FG012|Overall Study|Protocol Violation|0|||
160785592|NCT04518410|580601112|FG013|Overall Study|Protocol Violation|0|||
160785593|NCT04518410|580601113|FG014|Overall Study|Protocol Violation|0|||
160785594|NCT04518410|580601114|FG015|Overall Study|Protocol Violation|0|||
160785595|NCT04518410|580601115|FG016|Overall Study|Protocol Violation|1|||
160785596|NCT04518410|580601116|FG017|Overall Study|Protocol Violation|1|||
160785597|NCT04518410|580601117|FG018|Overall Study|Protocol Violation|0|||
160785598|NCT04518410|580601118|FG019|Overall Study|Protocol Violation|0|||
160785599|NCT04518410|580601119|FG020|Overall Study|Protocol Violation|1|||
160785600|NCT04518410|580601120|FG021|Overall Study|Protocol Violation|2|||
160785601|NCT04518410|580601121|FG022|Overall Study|Protocol Violation|0|||
160785602|NCT04518410|580601122|FG023|Overall Study|Protocol Violation|3|||
160785603|NCT04518410|580601123|FG024|Overall Study|Protocol Violation|0|||
160785604|NCT04518410|580601099|FG000|Overall Study|Death|0|||
160785605|NCT04518410|580601100|FG001|Overall Study|Death|0|||
160785606|NCT04518410|580601101|FG002|Overall Study|Death|0|||
160785607|NCT04518410|580601102|FG003|Overall Study|Death|0|||
160785608|NCT04518410|580601103|FG004|Overall Study|Death|12|||
160785609|NCT04518410|580601104|FG005|Overall Study|Death|2|||
160785610|NCT04518410|580601105|FG006|Overall Study|Death|11|||
160785611|NCT04518410|580601106|FG007|Overall Study|Death|0|||
160785612|NCT04518410|580601107|FG008|Overall Study|Death|1|||
160785613|NCT04518410|580601108|FG009|Overall Study|Death|0|||
160785614|NCT04518410|580601109|FG010|Overall Study|Death|0|||
160785615|NCT04518410|580601110|FG011|Overall Study|Death|0|||
160785616|NCT04518410|580601111|FG012|Overall Study|Death|0|||
160785617|NCT04518410|580601112|FG013|Overall Study|Death|1|||
160785618|NCT04518410|580601113|FG014|Overall Study|Death|1|||
160785619|NCT04518410|580601114|FG015|Overall Study|Death|0|||
160785620|NCT04518410|580601115|FG016|Overall Study|Death|0|||
160785621|NCT04518410|580601116|FG017|Overall Study|Death|1|||
160785622|NCT04518410|580601117|FG018|Overall Study|Death|4|||
160785623|NCT04518410|580601118|FG019|Overall Study|Death|4|||
160785624|NCT04518410|580601119|FG020|Overall Study|Death|1|||
160785625|NCT04518410|580601120|FG021|Overall Study|Death|0|||
160785626|NCT04518410|580601121|FG022|Overall Study|Death|0|||
160785627|NCT04518410|580601122|FG023|Overall Study|Death|0|||
160785628|NCT04518410|580601123|FG024|Overall Study|Death|0|||
160785629|NCT04518410|580601099|FG000|Overall Study|Requirement to start alternative therapy|0|||
160785630|NCT04518410|580601100|FG001|Overall Study|Requirement to start alternative therapy|0|||
160785631|NCT04518410|580601101|FG002|Overall Study|Requirement to start alternative therapy|1|||
160785632|NCT04518410|580601102|FG003|Overall Study|Requirement to start alternative therapy|0|||
160785633|NCT04518410|580601103|FG004|Overall Study|Requirement to start alternative therapy|0|||
160785634|NCT04518410|580601104|FG005|Overall Study|Requirement to start alternative therapy|0|||
160785635|NCT04518410|580601105|FG006|Overall Study|Requirement to start alternative therapy|0|||
160785636|NCT04518410|580601106|FG007|Overall Study|Requirement to start alternative therapy|0|||
160785637|NCT04518410|580601107|FG008|Overall Study|Requirement to start alternative therapy|0|||
160785638|NCT04518410|580601108|FG009|Overall Study|Requirement to start alternative therapy|0|||
160785639|NCT04518410|580601109|FG010|Overall Study|Requirement to start alternative therapy|0|||
160640455|NCT01507831|580066723|FG001|Overall Study|Death|2|||
160640456|NCT01507831|580066722|FG000|Overall Study|Poor compliance to protocol|38|||
160640457|NCT01507831|580066723|FG001|Overall Study|Poor compliance to protocol|60|||
160640458|NCT01507831|580066722|FG000|Overall Study|Physician Decision|0|||
160640459|NCT01507831|580066723|FG001|Overall Study|Physician Decision|4|||
160640460|NCT01507831|580066722|FG000|Overall Study|Participant moved|5|||
160640461|NCT01507831|580066723|FG001|Overall Study|Participant moved|19|||
160640462|NCT01507831|580066722|FG000|Overall Study|Consent withdrawn by participant|34|||
160640463|NCT01507831|580066723|FG001|Overall Study|Consent withdrawn by participant|72|||
160785640|NCT04518410|580601110|FG011|Overall Study|Requirement to start alternative therapy|0|||
160785641|NCT04518410|580601111|FG012|Overall Study|Requirement to start alternative therapy|0|||
160785642|NCT04518410|580601112|FG013|Overall Study|Requirement to start alternative therapy|0|||
160640464|NCT01507831|580066722|FG000|Overall Study|Related to study drug administration|5|||
160640465|NCT01507831|580066723|FG001|Overall Study|Related to study drug administration|14|||
160785643|NCT04518410|580601113|FG014|Overall Study|Requirement to start alternative therapy|0|||
160785644|NCT04518410|580601114|FG015|Overall Study|Requirement to start alternative therapy|0|||
160785645|NCT04518410|580601115|FG016|Overall Study|Requirement to start alternative therapy|0|||
160785646|NCT04518410|580601116|FG017|Overall Study|Requirement to start alternative therapy|0|||
160785647|NCT04518410|580601117|FG018|Overall Study|Requirement to start alternative therapy|0|||
160785648|NCT04518410|580601118|FG019|Overall Study|Requirement to start alternative therapy|0|||
160785649|NCT04518410|580601119|FG020|Overall Study|Requirement to start alternative therapy|0|||
160785650|NCT04518410|580601120|FG021|Overall Study|Requirement to start alternative therapy|0|||
160640466|NCT01507831|580066722|FG000|Overall Study|Last visit outside protocol visit window|51|||
160785651|NCT04518410|580601121|FG022|Overall Study|Requirement to start alternative therapy|0|||
160785652|NCT04518410|580601122|FG023|Overall Study|Requirement to start alternative therapy|0|||
160785653|NCT04518410|580601123|FG024|Overall Study|Requirement to start alternative therapy|0|||
160785654|NCT04518410|580601099|FG000|Overall Study|Randomized but not treated|0|||
160785655|NCT04518410|580601100|FG001|Overall Study|Randomized but not treated|0|||
160785656|NCT04518410|580601101|FG002|Overall Study|Randomized but not treated|0|||
160785657|NCT04518410|580601102|FG003|Overall Study|Randomized but not treated|2|||
160785658|NCT04518410|580601103|FG004|Overall Study|Randomized but not treated|6|||
160785659|NCT04518410|580601104|FG005|Overall Study|Randomized but not treated|4|||
160785660|NCT04518410|580601105|FG006|Overall Study|Randomized but not treated|3|||
160785661|NCT04518410|580601106|FG007|Overall Study|Randomized but not treated|3|||
160785662|NCT04518410|580601107|FG008|Overall Study|Randomized but not treated|0|||
160785663|NCT04518410|580601108|FG009|Overall Study|Randomized but not treated|4|||
160785664|NCT04518410|580601109|FG010|Overall Study|Randomized but not treated|0|||
160785665|NCT04518410|580601110|FG011|Overall Study|Randomized but not treated|0|||
160785666|NCT04518410|580601111|FG012|Overall Study|Randomized but not treated|1|||
160785667|NCT04518410|580601112|FG013|Overall Study|Randomized but not treated|3|||
160785668|NCT04518410|580601113|FG014|Overall Study|Randomized but not treated|3|||
160785669|NCT04518410|580601114|FG015|Overall Study|Randomized but not treated|3|||
160785670|NCT04518410|580601115|FG016|Overall Study|Randomized but not treated|4|||
160785671|NCT04518410|580601116|FG017|Overall Study|Randomized but not treated|5|||
160785672|NCT04518410|580601117|FG018|Overall Study|Randomized but not treated|4|||
160785673|NCT04518410|580601118|FG019|Overall Study|Randomized but not treated|0|||
160785674|NCT04518410|580601119|FG020|Overall Study|Randomized but not treated|0|||
160785675|NCT04518410|580601120|FG021|Overall Study|Randomized but not treated|5|||
160785676|NCT04518410|580601121|FG022|Overall Study|Randomized but not treated|0|||
160785677|NCT04518410|580601122|FG023|Overall Study|Randomized but not treated|3|||
160785678|NCT04518410|580601123|FG024|Overall Study|Randomized but not treated|1|||
160785679|NCT04518410|580601099|FG000|Overall Study|Screen Fail but Randomized|0|||
160785680|NCT04518410|580601100|FG001|Overall Study|Screen Fail but Randomized|0|||
160785681|NCT04518410|580601101|FG002|Overall Study|Screen Fail but Randomized|0|||
160785682|NCT04518410|580601102|FG003|Overall Study|Screen Fail but Randomized|0|||
160785683|NCT04518410|580601103|FG004|Overall Study|Screen Fail but Randomized|2|||
160785684|NCT04518410|580601104|FG005|Overall Study|Screen Fail but Randomized|0|||
160785685|NCT04518410|580601105|FG006|Overall Study|Screen Fail but Randomized|0|||
160785686|NCT04518410|580601106|FG007|Overall Study|Screen Fail but Randomized|0|||
160785687|NCT04518410|580601107|FG008|Overall Study|Screen Fail but Randomized|0|||
160785688|NCT04518410|580601108|FG009|Overall Study|Screen Fail but Randomized|0|||
160785689|NCT04518410|580601109|FG010|Overall Study|Screen Fail but Randomized|0|||
160785690|NCT04518410|580601110|FG011|Overall Study|Screen Fail but Randomized|0|||
160785691|NCT04518410|580601111|FG012|Overall Study|Screen Fail but Randomized|0|||
160785692|NCT04518410|580601112|FG013|Overall Study|Screen Fail but Randomized|0|||
160785693|NCT04518410|580601113|FG014|Overall Study|Screen Fail but Randomized|0|||
160785694|NCT04518410|580601114|FG015|Overall Study|Screen Fail but Randomized|0|||
160785695|NCT04518410|580601115|FG016|Overall Study|Screen Fail but Randomized|0|||
160785696|NCT04518410|580601116|FG017|Overall Study|Screen Fail but Randomized|0|||
160785697|NCT04518410|580601117|FG018|Overall Study|Screen Fail but Randomized|0|||
160785698|NCT04518410|580601118|FG019|Overall Study|Screen Fail but Randomized|0|||
160785699|NCT04518410|580601119|FG020|Overall Study|Screen Fail but Randomized|0|||
160785700|NCT04518410|580601120|FG021|Overall Study|Screen Fail but Randomized|0|||
160785701|NCT04518410|580601121|FG022|Overall Study|Screen Fail but Randomized|0|||
160785702|NCT04518410|580601122|FG023|Overall Study|Screen Fail but Randomized|0|||
160785703|NCT04518410|580601123|FG024|Overall Study|Screen Fail but Randomized|0|||
160785704|NCT04518410|580601099|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785705|NCT04518410|580601100|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785706|NCT04518410|580601101|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785707|NCT04518410|580601102|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785708|NCT04518410|580601103|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
160785709|NCT04518410|580601104|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
160785710|NCT04518410|580601105|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
160785711|NCT04518410|580601106|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
160785712|NCT04518410|580601107|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
160785713|NCT04518410|580601108|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
160785714|NCT04518410|580601109|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
160981862|NCT02061761|581321788|FG006|Overall Study|Withdrawal by Subject|0|||
160981863|NCT02061761|581321789|FG007|Overall Study|Withdrawal by Subject|0|||
160981864|NCT02061761|581321790|FG008|Overall Study|Withdrawal by Subject|2|||
160785715|NCT04518410|580601110|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785716|NCT04518410|580601111|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785717|NCT04518410|580601112|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
160785718|NCT04518410|580601113|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785719|NCT04518410|580601114|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
160785720|NCT04518410|580601115|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
160785721|NCT04518410|580601116|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
160785722|NCT04518410|580601117|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
160785723|NCT04518410|580601118|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
160785724|NCT04518410|580601119|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
160785725|NCT04518410|580601120|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
160785726|NCT04518410|580601121|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
160785727|NCT04518410|580601122|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
160785728|NCT04518410|580601123|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
160785729|NCT04518410|580601099|FG000|Overall Study|Dual Enrolled Subject|0|||
160785730|NCT04518410|580601100|FG001|Overall Study|Dual Enrolled Subject|0|||
160785731|NCT04518410|580601101|FG002|Overall Study|Dual Enrolled Subject|0|||
160785732|NCT04518410|580601102|FG003|Overall Study|Dual Enrolled Subject|0|||
160785733|NCT04518410|580601103|FG004|Overall Study|Dual Enrolled Subject|0|||
160785734|NCT04518410|580601104|FG005|Overall Study|Dual Enrolled Subject|0|||
160785735|NCT04518410|580601105|FG006|Overall Study|Dual Enrolled Subject|0|||
160785736|NCT04518410|580601106|FG007|Overall Study|Dual Enrolled Subject|0|||
160785737|NCT04518410|580601107|FG008|Overall Study|Dual Enrolled Subject|0|||
160785738|NCT04518410|580601108|FG009|Overall Study|Dual Enrolled Subject|0|||
160785739|NCT04518410|580601109|FG010|Overall Study|Dual Enrolled Subject|0|||
160785740|NCT04518410|580601110|FG011|Overall Study|Dual Enrolled Subject|0|||
160785741|NCT04518410|580601111|FG012|Overall Study|Dual Enrolled Subject|0|||
160785742|NCT04518410|580601112|FG013|Overall Study|Dual Enrolled Subject|0|||
160785743|NCT04518410|580601113|FG014|Overall Study|Dual Enrolled Subject|0|||
160785744|NCT04518410|580601114|FG015|Overall Study|Dual Enrolled Subject|0|||
160785745|NCT04518410|580601115|FG016|Overall Study|Dual Enrolled Subject|0|||
160785746|NCT04518410|580601116|FG017|Overall Study|Dual Enrolled Subject|1|||
160785747|NCT04518410|580601117|FG018|Overall Study|Dual Enrolled Subject|0|||
160785748|NCT04518410|580601118|FG019|Overall Study|Dual Enrolled Subject|0|||
160785749|NCT04518410|580601119|FG020|Overall Study|Dual Enrolled Subject|0|||
160785750|NCT04518410|580601120|FG021|Overall Study|Dual Enrolled Subject|0|||
160785751|NCT04518410|580601121|FG022|Overall Study|Dual Enrolled Subject|0|||
160785752|NCT04518410|580601122|FG023|Overall Study|Dual Enrolled Subject|0|||
160785753|NCT04518410|580601123|FG024|Overall Study|Dual Enrolled Subject|0|||
160785754|NCT00837330|580601124|FG000|Overall Study|Lost to Follow-up|1|||
160785755|NCT00837330|580601125|FG001|Overall Study|Lost to Follow-up|3|||
160785756|NCT00694122|580601130|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
160785757|NCT00694122|580601131|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
160785758|NCT00694122|580601130|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
160785759|NCT00694122|580601131|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
160785760|NCT00694122|580601130|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
160785761|NCT00694122|580601131|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
160785762|NCT00105508|580601132|FG000|Overall Study|Prephase Dropout|1|||
160785763|NCT00105508|580601133|FG001|Overall Study|Prephase Dropout|0|||
160785764|NCT00105508|580601132|FG000|Overall Study|Adverse Event|16|||
160785765|NCT00105508|580601133|FG001|Overall Study|Adverse Event|19|||
160785766|NCT00105508|580601132|FG000|Overall Study|Insufficient Efficacy|1|||
160785767|NCT00105508|580601133|FG001|Overall Study|Insufficient Efficacy|0|||
160785768|NCT00105508|580601132|FG000|Overall Study|Withdrawal by Subject|10|||
160785769|NCT00105508|580601133|FG001|Overall Study|Withdrawal by Subject|6|||
160785770|NCT00105508|580601132|FG000|Overall Study|Lost to Follow-up|3|||
160785771|NCT00105508|580601133|FG001|Overall Study|Lost to Follow-up|0|||
160785772|NCT00105508|580601132|FG000|Overall Study|Protocol Violation|1|||
160785773|NCT00105508|580601133|FG001|Overall Study|Protocol Violation|2|||
160785774|NCT00105508|580601132|FG000|Overall Study|Other|8|||
160785775|NCT00105508|580601133|FG001|Overall Study|Other|9|||
160785776|NCT00120874|580601134|FG000|Overall Study|Death|0|||
160785777|NCT00120874|580601135|FG001|Overall Study|Death|1|||
160785778|NCT01108055|580601136|FG000|Overall Study|Ineligible|11|||
160785779|NCT01108055|580601136|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
160785780|NCT01348490|580601143|FG000|Overall Study|Death|1|||
160785781|NCT01348490|580601143|FG000|Overall Study|Adverse Event|3|||
160785782|NCT01348490|580601143|FG000|Overall Study|Consent withdrawn|7|||
160785783|NCT01348490|580601143|FG000|Overall Study|Disease progression|3|||
160785784|NCT01348490|580601143|FG000|Overall Study|Lost to Follow-up|1|||
160785785|NCT01348490|580601143|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
160785786|NCT01348490|580601143|FG000|Overall Study|Other Unspecified|8|||
160785787|NCT03632720|580601144|FG000|Overall Study|Adverse Event|2|||
160785788|NCT03632720|580601145|FG001|Overall Study|Adverse Event|0|||
160785789|NCT03632720|580601146|FG002|Overall Study|Adverse Event|0|||
160785790|NCT03632720|580601144|FG000|Overall Study|Lost to Follow-up|0|||
160785791|NCT03632720|580601145|FG001|Overall Study|Lost to Follow-up|1|||
160785792|NCT03632720|580601146|FG002|Overall Study|Lost to Follow-up|0|||
160785793|NCT03632720|580601144|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
160785794|NCT03632720|580601145|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
160785795|NCT03632720|580601146|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
160785796|NCT03632720|580601144|FG000|Overall Study|Screen failure|0|||
160785797|NCT03632720|580601145|FG001|Overall Study|Screen failure|1|||
160785798|NCT03632720|580601146|FG002|Overall Study|Screen failure|0|||
160785799|NCT01049828|580601147|FG000|Overall Study|Claustrophibia and Frustration|2|||
160785800|NCT00290238|580601148|FG000|Overall Study|Study terminated|27|||
160785801|NCT00290238|580601149|FG001|Overall Study|Study terminated|27|||
160785802|NCT00290238|580601148|FG000|Overall Study|Lost to Follow-up|0|||
160785803|NCT00290238|580601149|FG001|Overall Study|Lost to Follow-up|1|||
160785804|NCT00290238|580601148|FG000|Overall Study|Withdrawal by Subject|15|||
160785805|NCT00290238|580601149|FG001|Overall Study|Withdrawal by Subject|13|||
160785806|NCT03834883|580601150|FG000|Second Treatment|Withdrawal by Subject|1|||
160785807|NCT03834883|580601151|FG001|Second Treatment|Withdrawal by Subject|0|||
160785808|NCT03834883|580601152|FG002|Second Treatment|Withdrawal by Subject|0|||
160785809|NCT03834883|580601153|FG003|Second Treatment|Withdrawal by Subject|0|||
160785810|NCT03834883|580601150|FG000|Second Treatment|COVID-19 pandemic|1|||
160785811|NCT03834883|580601151|FG001|Second Treatment|COVID-19 pandemic|0|||
160785812|NCT03834883|580601152|FG002|Second Treatment|COVID-19 pandemic|1|||
160785813|NCT03834883|580601153|FG003|Second Treatment|COVID-19 pandemic|1|||
160785814|NCT01179399|580601154|FG000|Overall Study|Adverse Event|1|||
160785815|NCT01179399|580601154|FG000|Overall Study|Lack of Efficacy|30|||
160785816|NCT01179399|580601154|FG000|Overall Study|Withdrawal by Subject|1|||
160785817|NCT00090402|580602782|FG000|Overall Study|Death|1|||
160785818|NCT00090402|580602783|FG001|Overall Study|Death|1|||
160785819|NCT00090402|580602784|FG002|Overall Study|Death|0|||
160785820|NCT00090402|580602782|FG000|Overall Study|subject moved|0|||
160785821|NCT00090402|580602783|FG001|Overall Study|subject moved|1|||
160785822|NCT00090402|580602784|FG002|Overall Study|subject moved|0|||
160785823|NCT00090402|580602782|FG000|Overall Study|stopped taking study medication|1|||
160785824|NCT00090402|580602783|FG001|Overall Study|stopped taking study medication|0|||
160785825|NCT00090402|580602784|FG002|Overall Study|stopped taking study medication|1|||
160785826|NCT00862277|580602787|FG000|Overall Study|Protocol Violation|1|||
160785827|NCT00862277|580602788|FG001|Overall Study|Protocol Violation|2|||
160785828|NCT00862277|580602789|FG002|Overall Study|Protocol Violation|5|||
160785829|NCT02533674|580602790|FG000|Dose Level I|Progressive disease|1|||
160785830|NCT02533674|580602791|FG001|Dose Level I|Progressive disease|0|||
160785831|NCT02533674|580602792|FG002|Dose Level I|Progressive disease|0|||
160785832|NCT02533674|580602793|FG003|Dose Level I|Progressive disease|0|||
160785833|NCT02533674|580602794|FG004|Dose Level I|Progressive disease|0|||
160785834|NCT02533674|580602795|FG005|Dose Level I|Progressive disease|0|||
160785835|NCT02533674|580602796|FG006|Dose Level I|Progressive disease|0|||
160785836|NCT02533674|580602797|FG007|Dose Level I|Progressive disease|0|||
160785837|NCT02533674|580602790|FG000|Dose Level I|Withdrawal by Subject|1|||
160785838|NCT02533674|580602791|FG001|Dose Level I|Withdrawal by Subject|0|||
160785839|NCT02533674|580602792|FG002|Dose Level I|Withdrawal by Subject|0|||
160785840|NCT02533674|580602793|FG003|Dose Level I|Withdrawal by Subject|0|||
160785841|NCT02533674|580602794|FG004|Dose Level I|Withdrawal by Subject|0|||
160785842|NCT02533674|580602795|FG005|Dose Level I|Withdrawal by Subject|0|||
160785843|NCT02533674|580602796|FG006|Dose Level I|Withdrawal by Subject|0|||
160785844|NCT02533674|580602797|FG007|Dose Level I|Withdrawal by Subject|0|||
160785845|NCT02533674|580602790|FG000|Dose Level I|Physician Decision|1|||
160785846|NCT02533674|580602791|FG001|Dose Level I|Physician Decision|0|||
160785847|NCT02533674|580602792|FG002|Dose Level I|Physician Decision|0|||
160785848|NCT02533674|580602793|FG003|Dose Level I|Physician Decision|0|||
160785849|NCT02533674|580602794|FG004|Dose Level I|Physician Decision|0|||
160785850|NCT02533674|580602795|FG005|Dose Level I|Physician Decision|0|||
160785851|NCT02533674|580602796|FG006|Dose Level I|Physician Decision|0|||
160785852|NCT02533674|580602797|FG007|Dose Level I|Physician Decision|0|||
160785853|NCT02533674|580602790|FG000|Dose Level I|Death|1|||
160785854|NCT02533674|580602791|FG001|Dose Level I|Death|0|||
160785855|NCT02533674|580602792|FG002|Dose Level I|Death|0|||
160785856|NCT02533674|580602793|FG003|Dose Level I|Death|0|||
160785857|NCT02533674|580602794|FG004|Dose Level I|Death|0|||
160785858|NCT02533674|580602795|FG005|Dose Level I|Death|0|||
160785859|NCT02533674|580602796|FG006|Dose Level I|Death|0|||
160785860|NCT02533674|580602797|FG007|Dose Level I|Death|0|||
160785861|NCT02533674|580602790|FG000|Dose Level I|Never Treated|1|||
160785862|NCT02533674|580602791|FG001|Dose Level I|Never Treated|0|||
160785863|NCT02533674|580602792|FG002|Dose Level I|Never Treated|0|||
160785864|NCT02533674|580602793|FG003|Dose Level I|Never Treated|0|||
160785865|NCT02533674|580602794|FG004|Dose Level I|Never Treated|0|||
160785866|NCT02533674|580602795|FG005|Dose Level I|Never Treated|0|||
160785867|NCT02533674|580602796|FG006|Dose Level I|Never Treated|0|||
160785868|NCT02533674|580602797|FG007|Dose Level I|Never Treated|0|||
160785869|NCT02533674|580602790|FG000|Dose Level II|Progressive disease|0|||
160785870|NCT02533674|580602791|FG001|Dose Level II|Progressive disease|3|||
160785871|NCT02533674|580602792|FG002|Dose Level II|Progressive disease|0|||
160785872|NCT02533674|580602793|FG003|Dose Level II|Progressive disease|0|||
160785873|NCT02533674|580602794|FG004|Dose Level II|Progressive disease|0|||
160785874|NCT02533674|580602795|FG005|Dose Level II|Progressive disease|0|||
160785875|NCT02533674|580602796|FG006|Dose Level II|Progressive disease|0|||
160785876|NCT02533674|580602797|FG007|Dose Level II|Progressive disease|0|||
160785877|NCT02533674|580602790|FG000|Dose Level II|Withdrawal by Subject|0|||
160785878|NCT02533674|580602791|FG001|Dose Level II|Withdrawal by Subject|1|||
160785879|NCT02533674|580602792|FG002|Dose Level II|Withdrawal by Subject|0|||
160785880|NCT02533674|580602793|FG003|Dose Level II|Withdrawal by Subject|0|||
160785881|NCT02533674|580602794|FG004|Dose Level II|Withdrawal by Subject|0|||
160785882|NCT02533674|580602795|FG005|Dose Level II|Withdrawal by Subject|0|||
160785883|NCT02533674|580602796|FG006|Dose Level II|Withdrawal by Subject|0|||
160785884|NCT02533674|580602797|FG007|Dose Level II|Withdrawal by Subject|0|||
160785885|NCT02533674|580602790|FG000|Dose Level II|Treatment-related AE|0|||
160785886|NCT02533674|580602791|FG001|Dose Level II|Treatment-related AE|1|||
160785887|NCT02533674|580602792|FG002|Dose Level II|Treatment-related AE|0|||
160785888|NCT02533674|580602793|FG003|Dose Level II|Treatment-related AE|0|||
160785889|NCT02533674|580602794|FG004|Dose Level II|Treatment-related AE|0|||
160785890|NCT02533674|580602795|FG005|Dose Level II|Treatment-related AE|0|||
160785891|NCT02533674|580602796|FG006|Dose Level II|Treatment-related AE|0|||
160785892|NCT02533674|580602797|FG007|Dose Level II|Treatment-related AE|0|||
160785893|NCT02533674|580602790|FG000|Dose Level II|Physician Decision|0|||
160785894|NCT02533674|580602791|FG001|Dose Level II|Physician Decision|1|||
160785895|NCT02533674|580602792|FG002|Dose Level II|Physician Decision|0|||
160785896|NCT02533674|580602793|FG003|Dose Level II|Physician Decision|0|||
160785897|NCT02533674|580602794|FG004|Dose Level II|Physician Decision|0|||
160785898|NCT02533674|580602795|FG005|Dose Level II|Physician Decision|0|||
160785899|NCT02533674|580602796|FG006|Dose Level II|Physician Decision|0|||
160785900|NCT02533674|580602797|FG007|Dose Level II|Physician Decision|0|||
160785901|NCT02533674|580602790|FG000|Dose Level II|Non-treatment-related AE|0|||
160785902|NCT02533674|580602791|FG001|Dose Level II|Non-treatment-related AE|1|||
160785903|NCT02533674|580602792|FG002|Dose Level II|Non-treatment-related AE|0|||
160785904|NCT02533674|580602793|FG003|Dose Level II|Non-treatment-related AE|0|||
160785905|NCT02533674|580602794|FG004|Dose Level II|Non-treatment-related AE|0|||
160785906|NCT02533674|580602795|FG005|Dose Level II|Non-treatment-related AE|0|||
160640467|NCT01507831|580066723|FG001|Overall Study|Last visit outside protocol visit window|143|||
160640468|NCT01507831|580066722|FG000|Overall Study|Selection criteria finally not met|0|||
160640469|NCT01507831|580066723|FG001|Overall Study|Selection criteria finally not met|1|||
160640470|NCT01507831|580066722|FG000|Overall Study|Site closure|0|||
160640471|NCT01507831|580066723|FG001|Overall Study|Site closure|3|||
160640472|NCT01507831|580066722|FG000|Overall Study|Potential lost to follow-up|3|||
160785907|NCT02533674|580602796|FG006|Dose Level II|Non-treatment-related AE|0|||
160785908|NCT02533674|580602797|FG007|Dose Level II|Non-treatment-related AE|0|||
160785909|NCT02533674|580602790|FG000|Dose Level III|Progressive disease|0|||
160785910|NCT02533674|580602791|FG001|Dose Level III|Progressive disease|0|||
160785911|NCT02533674|580602792|FG002|Dose Level III|Progressive disease|2|||
160785912|NCT02533674|580602793|FG003|Dose Level III|Progressive disease|0|||
160785913|NCT02533674|580602794|FG004|Dose Level III|Progressive disease|0|||
160785914|NCT02533674|580602795|FG005|Dose Level III|Progressive disease|0|||
160785915|NCT02533674|580602796|FG006|Dose Level III|Progressive disease|0|||
160785916|NCT02533674|580602797|FG007|Dose Level III|Progressive disease|0|||
160785917|NCT02533674|580602790|FG000|Dose Level III|Withdrawal by Subject|0|||
160785918|NCT02533674|580602791|FG001|Dose Level III|Withdrawal by Subject|0|||
160785919|NCT02533674|580602792|FG002|Dose Level III|Withdrawal by Subject|1|||
160785920|NCT02533674|580602793|FG003|Dose Level III|Withdrawal by Subject|0|||
160785921|NCT02533674|580602794|FG004|Dose Level III|Withdrawal by Subject|0|||
160785922|NCT02533674|580602795|FG005|Dose Level III|Withdrawal by Subject|0|||
160785923|NCT02533674|580602796|FG006|Dose Level III|Withdrawal by Subject|0|||
160785924|NCT02533674|580602797|FG007|Dose Level III|Withdrawal by Subject|0|||
160785925|NCT02533674|580602790|FG000|Dose Level III|Treatment-related AE|0|||
160785926|NCT02533674|580602791|FG001|Dose Level III|Treatment-related AE|0|||
160785927|NCT02533674|580602792|FG002|Dose Level III|Treatment-related AE|1|||
160785928|NCT02533674|580602793|FG003|Dose Level III|Treatment-related AE|0|||
160785929|NCT02533674|580602794|FG004|Dose Level III|Treatment-related AE|0|||
160785930|NCT02533674|580602795|FG005|Dose Level III|Treatment-related AE|0|||
160785931|NCT02533674|580602796|FG006|Dose Level III|Treatment-related AE|0|||
160785932|NCT02533674|580602797|FG007|Dose Level III|Treatment-related AE|0|||
160785933|NCT02533674|580602790|FG000|Dose Level IV|Progressive disease|0|||
160785934|NCT02533674|580602791|FG001|Dose Level IV|Progressive disease|0|||
160785935|NCT02533674|580602792|FG002|Dose Level IV|Progressive disease|0|||
160785936|NCT02533674|580602793|FG003|Dose Level IV|Progressive disease|3|||
160785937|NCT02533674|580602794|FG004|Dose Level IV|Progressive disease|0|||
160785938|NCT02533674|580602795|FG005|Dose Level IV|Progressive disease|0|||
160785939|NCT02533674|580602796|FG006|Dose Level IV|Progressive disease|0|||
160785940|NCT02533674|580602797|FG007|Dose Level IV|Progressive disease|0|||
160785941|NCT02533674|580602790|FG000|Dose Level IV|Withdrawal by Subject|0|||
160785942|NCT02533674|580602791|FG001|Dose Level IV|Withdrawal by Subject|0|||
160785943|NCT02533674|580602792|FG002|Dose Level IV|Withdrawal by Subject|0|||
160785944|NCT02533674|580602793|FG003|Dose Level IV|Withdrawal by Subject|1|||
160785945|NCT02533674|580602794|FG004|Dose Level IV|Withdrawal by Subject|0|||
160785946|NCT02533674|580602795|FG005|Dose Level IV|Withdrawal by Subject|0|||
160785947|NCT02533674|580602796|FG006|Dose Level IV|Withdrawal by Subject|0|||
160785948|NCT02533674|580602797|FG007|Dose Level IV|Withdrawal by Subject|0|||
160785949|NCT02533674|580602790|FG000|Dose Level IV|Physician Decision|0|||
160785950|NCT02533674|580602791|FG001|Dose Level IV|Physician Decision|0|||
160785951|NCT02533674|580602792|FG002|Dose Level IV|Physician Decision|0|||
160785952|NCT02533674|580602793|FG003|Dose Level IV|Physician Decision|1|||
160785953|NCT02533674|580602794|FG004|Dose Level IV|Physician Decision|0|||
160785954|NCT02533674|580602795|FG005|Dose Level IV|Physician Decision|0|||
160785955|NCT02533674|580602796|FG006|Dose Level IV|Physician Decision|0|||
160785956|NCT02533674|580602797|FG007|Dose Level IV|Physician Decision|0|||
160785957|NCT02533674|580602790|FG000|Dose Level V|Progressive disease|0|||
160785958|NCT02533674|580602791|FG001|Dose Level V|Progressive disease|0|||
160785959|NCT02533674|580602792|FG002|Dose Level V|Progressive disease|0|||
160785960|NCT02533674|580602793|FG003|Dose Level V|Progressive disease|0|||
160785961|NCT02533674|580602794|FG004|Dose Level V|Progressive disease|3|||
160785962|NCT02533674|580602795|FG005|Dose Level V|Progressive disease|0|||
160785963|NCT02533674|580602796|FG006|Dose Level V|Progressive disease|0|||
160785964|NCT02533674|580602797|FG007|Dose Level V|Progressive disease|0|||
160785965|NCT02533674|580602790|FG000|Dose Level V|Withdrawal by Subject|0|||
160785966|NCT02533674|580602791|FG001|Dose Level V|Withdrawal by Subject|0|||
160785967|NCT02533674|580602792|FG002|Dose Level V|Withdrawal by Subject|0|||
160785968|NCT02533674|580602793|FG003|Dose Level V|Withdrawal by Subject|0|||
160785969|NCT02533674|580602794|FG004|Dose Level V|Withdrawal by Subject|1|||
160785970|NCT02533674|580602795|FG005|Dose Level V|Withdrawal by Subject|0|||
160785971|NCT02533674|580602796|FG006|Dose Level V|Withdrawal by Subject|0|||
160785972|NCT02533674|580602797|FG007|Dose Level V|Withdrawal by Subject|0|||
160785973|NCT02533674|580602790|FG000|Dose Level V|Physician Decision|0|||
160785974|NCT02533674|580602791|FG001|Dose Level V|Physician Decision|0|||
160785975|NCT02533674|580602792|FG002|Dose Level V|Physician Decision|0|||
160785976|NCT02533674|580602793|FG003|Dose Level V|Physician Decision|0|||
160785977|NCT02533674|580602794|FG004|Dose Level V|Physician Decision|1|||
160785978|NCT02533674|580602795|FG005|Dose Level V|Physician Decision|0|||
160785979|NCT02533674|580602796|FG006|Dose Level V|Physician Decision|0|||
160785980|NCT02533674|580602797|FG007|Dose Level V|Physician Decision|0|||
160785981|NCT02533674|580602790|FG000|Dose Level VI|Progressive disease|0|||
160785982|NCT02533674|580602791|FG001|Dose Level VI|Progressive disease|0|||
160785983|NCT02533674|580602792|FG002|Dose Level VI|Progressive disease|0|||
160785984|NCT02533674|580602793|FG003|Dose Level VI|Progressive disease|0|||
160785985|NCT02533674|580602794|FG004|Dose Level VI|Progressive disease|0|||
160785986|NCT02533674|580602795|FG005|Dose Level VI|Progressive disease|7|||
160981865|NCT02061761|581321782|FG000|Overall Study|Maximum clinical benefit|0|||
160785987|NCT02533674|580602796|FG006|Dose Level VI|Progressive disease|0|||
160785988|NCT02533674|580602797|FG007|Dose Level VI|Progressive disease|0|||
160785989|NCT02533674|580602790|FG000|Dose Level VI|Withdrawal by Subject|0|||
160785990|NCT02533674|580602791|FG001|Dose Level VI|Withdrawal by Subject|0|||
160785991|NCT02533674|580602792|FG002|Dose Level VI|Withdrawal by Subject|0|||
160785992|NCT02533674|580602793|FG003|Dose Level VI|Withdrawal by Subject|0|||
160785993|NCT02533674|580602794|FG004|Dose Level VI|Withdrawal by Subject|0|||
160785994|NCT02533674|580602795|FG005|Dose Level VI|Withdrawal by Subject|1|||
160785995|NCT02533674|580602796|FG006|Dose Level VI|Withdrawal by Subject|0|||
160785996|NCT02533674|580602797|FG007|Dose Level VI|Withdrawal by Subject|0|||
160785997|NCT02533674|580602790|FG000|Dose Level VI|Treatment-related AE|0|||
160785998|NCT02533674|580602791|FG001|Dose Level VI|Treatment-related AE|0|||
160785999|NCT02533674|580602792|FG002|Dose Level VI|Treatment-related AE|0|||
160786000|NCT02533674|580602793|FG003|Dose Level VI|Treatment-related AE|0|||
160786001|NCT02533674|580602794|FG004|Dose Level VI|Treatment-related AE|0|||
160786002|NCT02533674|580602795|FG005|Dose Level VI|Treatment-related AE|1|||
160786003|NCT02533674|580602796|FG006|Dose Level VI|Treatment-related AE|0|||
160786004|NCT02533674|580602797|FG007|Dose Level VI|Treatment-related AE|0|||
160786005|NCT02533674|580602790|FG000|Dose Level VII|Progressive disease|0|||
160786006|NCT02533674|580602791|FG001|Dose Level VII|Progressive disease|0|||
160786007|NCT02533674|580602792|FG002|Dose Level VII|Progressive disease|0|||
160786008|NCT02533674|580602793|FG003|Dose Level VII|Progressive disease|0|||
160786009|NCT02533674|580602794|FG004|Dose Level VII|Progressive disease|0|||
160786010|NCT02533674|580602795|FG005|Dose Level VII|Progressive disease|0|||
160786011|NCT02533674|580602796|FG006|Dose Level VII|Progressive disease|10|||
160786012|NCT02533674|580602797|FG007|Dose Level VII|Progressive disease|0|||
160786013|NCT02533674|580602790|FG000|Dose Level VII|Withdrawal by Subject|0|||
160786014|NCT02533674|580602791|FG001|Dose Level VII|Withdrawal by Subject|0|||
160786015|NCT02533674|580602792|FG002|Dose Level VII|Withdrawal by Subject|0|||
160786016|NCT02533674|580602793|FG003|Dose Level VII|Withdrawal by Subject|0|||
160786017|NCT02533674|580602794|FG004|Dose Level VII|Withdrawal by Subject|0|||
160786018|NCT02533674|580602795|FG005|Dose Level VII|Withdrawal by Subject|0|||
160786019|NCT02533674|580602796|FG006|Dose Level VII|Withdrawal by Subject|3|||
160786020|NCT02533674|580602797|FG007|Dose Level VII|Withdrawal by Subject|0|||
160786021|NCT02533674|580602790|FG000|Dose Level VII|Treatment-related AE|0|||
160786022|NCT02533674|580602791|FG001|Dose Level VII|Treatment-related AE|0|||
160786023|NCT02533674|580602792|FG002|Dose Level VII|Treatment-related AE|0|||
160786024|NCT02533674|580602793|FG003|Dose Level VII|Treatment-related AE|0|||
160786025|NCT02533674|580602794|FG004|Dose Level VII|Treatment-related AE|0|||
160786026|NCT02533674|580602795|FG005|Dose Level VII|Treatment-related AE|0|||
160786027|NCT02533674|580602796|FG006|Dose Level VII|Treatment-related AE|1|||
160786028|NCT02533674|580602797|FG007|Dose Level VII|Treatment-related AE|0|||
160786029|NCT02533674|580602790|FG000|Dose Level VII|Death|0|||
160786030|NCT02533674|580602791|FG001|Dose Level VII|Death|0|||
160786031|NCT02533674|580602792|FG002|Dose Level VII|Death|0|||
160786032|NCT02533674|580602793|FG003|Dose Level VII|Death|0|||
160786033|NCT02533674|580602794|FG004|Dose Level VII|Death|0|||
160786034|NCT02533674|580602795|FG005|Dose Level VII|Death|0|||
160786035|NCT02533674|580602796|FG006|Dose Level VII|Death|2|||
160786036|NCT02533674|580602797|FG007|Dose Level VII|Death|0|||
160786037|NCT02533674|580602790|FG000|Dose Level VIII|Progressive disease|0|||
160786038|NCT02533674|580602791|FG001|Dose Level VIII|Progressive disease|0|||
160786039|NCT02533674|580602792|FG002|Dose Level VIII|Progressive disease|0|||
160786040|NCT02533674|580602793|FG003|Dose Level VIII|Progressive disease|0|||
160786041|NCT02533674|580602794|FG004|Dose Level VIII|Progressive disease|0|||
160786042|NCT02533674|580602795|FG005|Dose Level VIII|Progressive disease|0|||
160786043|NCT02533674|580602796|FG006|Dose Level VIII|Progressive disease|0|||
160786044|NCT02533674|580602797|FG007|Dose Level VIII|Progressive disease|3|||
160786045|NCT02533674|580602790|FG000|Dose Level VIII|Withdrawal by Subject|0|||
160786046|NCT02533674|580602791|FG001|Dose Level VIII|Withdrawal by Subject|0|||
160786047|NCT02533674|580602792|FG002|Dose Level VIII|Withdrawal by Subject|0|||
160786048|NCT02533674|580602793|FG003|Dose Level VIII|Withdrawal by Subject|0|||
160640473|NCT01507831|580066723|FG001|Overall Study|Potential lost to follow-up|0|||
160640474|NCT01507831|580066722|FG000|Overall Study|Other|3|||
160640475|NCT01507831|580066723|FG001|Overall Study|Other|6|||
160640476|NCT01280981|580066728|FG000|Overall Study|Withdrawal by Subject|11|||
160640477|NCT01280981|580066728|FG000|Overall Study|Protocol Violation|2|||
160640478|NCT01280981|580066728|FG000|Overall Study|Lack of Efficacy|13|||
160640479|NCT01280981|580066728|FG000|Overall Study|Lost to Follow-up|3|||
160640480|NCT01280981|580066728|FG000|Overall Study|Adverse Event|6|||
160640481|NCT01280981|580066728|FG000|Overall Study|Irregular or discontinued menses|3|||
160786049|NCT02533674|580602794|FG004|Dose Level VIII|Withdrawal by Subject|0|||
160786050|NCT02533674|580602795|FG005|Dose Level VIII|Withdrawal by Subject|0|||
160786051|NCT02533674|580602796|FG006|Dose Level VIII|Withdrawal by Subject|0|||
160786052|NCT02533674|580602797|FG007|Dose Level VIII|Withdrawal by Subject|1|||
160786053|NCT02533674|580602790|FG000|Dose Level VIII|Treatment-related AE|0|||
160786054|NCT02533674|580602791|FG001|Dose Level VIII|Treatment-related AE|0|||
160640482|NCT01280981|580066728|FG000|Overall Study|Failed to return|45|||
160640483|NCT01280981|580066728|FG000|Overall Study|Non-compliance with protocol|3|||
160640484|NCT01280981|580066728|FG000|Overall Study|Withdrawal of consent|3|||
160640485|NCT01280981|580066728|FG000|Overall Study|Elective surgery|2|||
160640486|NCT01280981|580066728|FG000|Overall Study|Study site closure|1|||
160786055|NCT02533674|580602792|FG002|Dose Level VIII|Treatment-related AE|0|||
160786056|NCT02533674|580602793|FG003|Dose Level VIII|Treatment-related AE|0|||
160786057|NCT02533674|580602794|FG004|Dose Level VIII|Treatment-related AE|0|||
160786058|NCT02533674|580602795|FG005|Dose Level VIII|Treatment-related AE|0|||
160786059|NCT02533674|580602796|FG006|Dose Level VIII|Treatment-related AE|0|||
160786060|NCT02533674|580602797|FG007|Dose Level VIII|Treatment-related AE|1|||
160786061|NCT02533674|580602790|FG000|Dose Level VIII|Never treated|0|||
160786062|NCT02533674|580602791|FG001|Dose Level VIII|Never treated|0|||
160786063|NCT02533674|580602792|FG002|Dose Level VIII|Never treated|0|||
160786064|NCT02533674|580602793|FG003|Dose Level VIII|Never treated|0|||
160786065|NCT02533674|580602794|FG004|Dose Level VIII|Never treated|0|||
160786066|NCT02533674|580602795|FG005|Dose Level VIII|Never treated|0|||
160786067|NCT02533674|580602796|FG006|Dose Level VIII|Never treated|0|||
160786068|NCT02533674|580602797|FG007|Dose Level VIII|Never treated|1|||
160786069|NCT01908699|580602801|FG000|Overall Study|Adverse Event|8|||
160543470|NCT04311502|579718213|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
160543471|NCT04311502|579718214|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
160543472|NCT05032157|579718215|FG000|Overall Study|Adverse Event|12|||
160543473|NCT05032157|579718216|FG001|Overall Study|Adverse Event|7|||
160543474|NCT05032157|579718215|FG000|Overall Study|Pregnancy|0|||
160543475|NCT05032157|579718216|FG001|Overall Study|Pregnancy|2|||
160543476|NCT05032157|579718215|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160786070|NCT01908699|580602802|FG001|Overall Study|Adverse Event|12|||
160786071|NCT01908699|580602801|FG000|Overall Study|Lack of Efficacy|2|||
160786072|NCT01908699|580602802|FG001|Overall Study|Lack of Efficacy|2|||
160786073|NCT01908699|580602801|FG000|Overall Study|Lost to Follow-up|2|||
160786074|NCT01908699|580602802|FG001|Overall Study|Lost to Follow-up|4|||
160786075|NCT01908699|580602801|FG000|Overall Study|Physician Decision|8|||
160543477|NCT05032157|579718216|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
160543478|NCT05032157|579718215|FG000|Overall Study|Protocol Deviation|8|||
160786076|NCT01908699|580602802|FG001|Overall Study|Physician Decision|8|||
160786077|NCT01908699|580602801|FG000|Overall Study|Withdrawal by Subject|15|||
160786078|NCT01908699|580602802|FG001|Overall Study|Withdrawal by Subject|10|||
160786079|NCT01908699|580602801|FG000|Overall Study|Pregnancy|0|||
160786080|NCT01908699|580602802|FG001|Overall Study|Pregnancy|1|||
160786081|NCT01908699|580602801|FG000|Overall Study|Randomized in Error|1|||
160543479|NCT05032157|579718216|FG001|Overall Study|Protocol Deviation|4|||
160786082|NCT01908699|580602802|FG001|Overall Study|Randomized in Error|0|||
160786083|NCT01908699|580602801|FG000|Overall Study|Death|9|||
160543480|NCT05032157|579718215|FG000|Overall Study|Lost to Follow-up|1|||
160543481|NCT05032157|579718216|FG001|Overall Study|Lost to Follow-up|3|||
160543482|NCT05032157|579718215|FG000|Overall Study|Physician Decision|7|||
160786084|NCT01908699|580602802|FG001|Overall Study|Death|12|||
160786085|NCT01908699|580602801|FG000|Overall Study|Progressive Disease|30|||
160786086|NCT01908699|580602802|FG001|Overall Study|Progressive Disease|29|||
160786087|NCT01697501|580602803|FG000|Overall Study|Protocol Violation|2|||
160786088|NCT02242903|580602804|FG000|Overall Study|Withdrawal by Subject|1|||
160786089|NCT02242903|580602805|FG001|Overall Study|Withdrawal by Subject|0|||
160786090|NCT02242903|580602806|FG002|Overall Study|Withdrawal by Subject|0|||
160786091|NCT02242903|580602807|FG003|Overall Study|Withdrawal by Subject|0|||
160543483|NCT05032157|579718216|FG001|Overall Study|Physician Decision|2|||
160786092|NCT02242903|580602808|FG004|Overall Study|Withdrawal by Subject|0|||
160786093|NCT02242903|580602809|FG005|Overall Study|Withdrawal by Subject|0|||
160786094|NCT02242903|580602810|FG006|Overall Study|Withdrawal by Subject|0|||
160543484|NCT05032157|579718215|FG000|Overall Study|Patient Decision|38|||
160543485|NCT05032157|579718216|FG001|Overall Study|Patient Decision|19|||
160543486|NCT03451773|579718217|FG000|Overall Study|Death on study|1|||
160786095|NCT02105012|580602811|FG000|Overall Study|Withdrawal by Subject|11|||
160786096|NCT02105012|580602811|FG000|Overall Study|Protocol Specified Criteria|9|||
160786097|NCT02105012|580602811|FG000|Overall Study|Lost to Follow-up|4|||
160786098|NCT02105012|580602811|FG000|Overall Study|Protocol Violation|4|||
160786099|NCT02105012|580602811|FG000|Overall Study|Physician Decision|3|||
160786100|NCT02105012|580602811|FG000|Overall Study|Adverse Event|1|||
160786101|NCT02105012|580602811|FG000|Overall Study|Lack of Efficacy|1|||
160786102|NCT00779909|580602814|FG000|Overall Study|Lost to Follow-up|1|||
160786103|NCT00779909|580602815|FG001|Overall Study|Lost to Follow-up|0|||
160786104|NCT00779909|580602816|FG002|Overall Study|Lost to Follow-up|0|||
160786105|NCT00779909|580602817|FG003|Overall Study|Lost to Follow-up|1|||
160786106|NCT00779909|580602814|FG000|Overall Study|Withdrawal by Subject|0|||
160786107|NCT00779909|580602815|FG001|Overall Study|Withdrawal by Subject|1|||
160786108|NCT00779909|580602816|FG002|Overall Study|Withdrawal by Subject|0|||
160786109|NCT00779909|580602817|FG003|Overall Study|Withdrawal by Subject|0|||
160786110|NCT01096186|580602818|FG000|Overall Study|Adverse Event|16|||
160786111|NCT01096186|580602818|FG000|Overall Study|Death|4|||
160786112|NCT01096186|580602818|FG000|Overall Study|Lack of Efficacy|4|||
160786113|NCT01096186|580602818|FG000|Overall Study|Lost to Follow-up|2|||
160786114|NCT01096186|580602818|FG000|Overall Study|Withdrawal by Subject|22|||
160786115|NCT01096186|580602818|FG000|Overall Study|Physician Decision|1|||
160786116|NCT01096186|580602818|FG000|Overall Study|Noncompliance with study drug|1|||
160786117|NCT01750281|580602819|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
160786118|NCT01750281|580602820|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
160786119|NCT01750281|580602821|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
160786120|NCT01750281|580602819|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
160786121|NCT01750281|580602820|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
160786122|NCT01750281|580602821|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
160786123|NCT01750281|580602819|FG000|Overall Study|Did not receive treatment|0|||
160786124|NCT01750281|580602820|FG001|Overall Study|Did not receive treatment|1|||
160786125|NCT01750281|580602821|FG002|Overall Study|Did not receive treatment|0|||
160786126|NCT01896986|580602822|FG000|Overall Study|samples lost|14|||
160786127|NCT01896986|580602823|FG001|Overall Study|samples lost|23|||
160786128|NCT03302936|580602825|FG000|Overall Study|Protocol Violation|3|||
160786129|NCT03302936|580602826|FG001|Overall Study|Protocol Violation|4|||
160786130|NCT01379937|580602827|FG000|Overall Study|Protocol Violation|0|||
160786131|NCT01379937|580602828|FG001|Overall Study|Protocol Violation|0|||
160786132|NCT01379937|580602829|FG002|Overall Study|Protocol Violation|0|||
160786133|NCT01379937|580602830|FG003|Overall Study|Protocol Violation|1|||
160786134|NCT01379937|580602827|FG000|Overall Study|Consent withdrawal|0|||
160786135|NCT01379937|580602828|FG001|Overall Study|Consent withdrawal|1|||
160786136|NCT01379937|580602829|FG002|Overall Study|Consent withdrawal|0|||
160786137|NCT01379937|580602830|FG003|Overall Study|Consent withdrawal|0|||
160786138|NCT01379937|580602827|FG000|Overall Study|Lost to Follow-up|1|||
160786139|NCT01379937|580602828|FG001|Overall Study|Lost to Follow-up|2|||
160786140|NCT01379937|580602829|FG002|Overall Study|Lost to Follow-up|2|||
160786141|NCT01379937|580602830|FG003|Overall Study|Lost to Follow-up|0|||
160786142|NCT01122680|580602831|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
160786143|NCT01122680|580602832|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
160981866|NCT02061761|581321783|FG001|Overall Study|Maximum clinical benefit|0|||
160786144|NCT01122680|580602833|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
160786145|NCT01122680|580602834|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
160786146|NCT01122680|580602831|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
160786147|NCT01122680|580602832|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
160786148|NCT01122680|580602833|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
160786149|NCT01122680|580602834|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
160786150|NCT01122680|580602831|FG000|Period 1 (4 Weeks)|Other|1|||
160786151|NCT01122680|580602832|FG001|Period 1 (4 Weeks)|Other|1|||
160786152|NCT01122680|580602833|FG002|Period 1 (4 Weeks)|Other|0|||
160786153|NCT01122680|580602834|FG003|Period 1 (4 Weeks)|Other|0|||
160786154|NCT01122680|580602831|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
160786155|NCT01122680|580602832|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
160786156|NCT01122680|580602833|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
160786157|NCT01122680|580602834|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
160786158|NCT01122680|580602831|FG000|Period 2 (4 Weeks)|Other|1|||
160786159|NCT01122680|580602832|FG001|Period 2 (4 Weeks)|Other|0|||
160786160|NCT01122680|580602833|FG002|Period 2 (4 Weeks)|Other|0|||
160786161|NCT01122680|580602834|FG003|Period 2 (4 Weeks)|Other|0|||
160786162|NCT01122680|580602831|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
160786163|NCT01122680|580602832|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
160786164|NCT01122680|580602833|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
160786165|NCT01122680|580602834|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
160786166|NCT01122680|580602831|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
160786167|NCT01122680|580602832|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
160786168|NCT01122680|580602833|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
160786169|NCT01122680|580602834|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
160786170|NCT00079781|580602839|FG000|Pre-implant Period|Withdrawal by Subject|2|||
160786171|NCT00079781|580602840|FG001|Pre-implant Period|Withdrawal by Subject|0|||
160786172|NCT00079781|580602841|FG002|Pre-implant Period|Withdrawal by Subject|0|||
160786173|NCT00079781|580602839|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
160786174|NCT00079781|580602840|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
160786175|NCT00079781|580602841|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
160786176|NCT00079781|580602839|FG000|Follow-up Period|Withdrawal by Subject|3|||
160786177|NCT00079781|580602840|FG001|Follow-up Period|Withdrawal by Subject|0|||
160786178|NCT00079781|580602841|FG002|Follow-up Period|Withdrawal by Subject|1|||
160786179|NCT00079781|580602839|FG000|Follow-up Period|Lost to Follow-up|1|||
160786180|NCT00079781|580602840|FG001|Follow-up Period|Lost to Follow-up|0|||
160786181|NCT00079781|580602841|FG002|Follow-up Period|Lost to Follow-up|0|||
160786182|NCT00079781|580602839|FG000|Follow-up Period|Death|0|||
160786183|NCT00079781|580602840|FG001|Follow-up Period|Death|0|||
160786184|NCT00079781|580602841|FG002|Follow-up Period|Death|1|||
160786185|NCT00564070|580602842|FG000|Overall Study|Lost to Follow-up|9|||
160786186|NCT00564070|580602843|FG001|Overall Study|Lost to Follow-up|7|||
160786187|NCT00564070|580602842|FG000|Overall Study|Worsening depression, referred to care|3|||
160786188|NCT00564070|580602843|FG001|Overall Study|Worsening depression, referred to care|0|||
160786189|NCT00552279|580602844|FG000|Overall Study|Adverse Event|0|||
160786190|NCT00552279|580602845|FG001|Overall Study|Adverse Event|1|||
160786191|NCT00552279|580602844|FG000|Overall Study|Withdrawal by Subject|12|||
160786192|NCT00552279|580602845|FG001|Overall Study|Withdrawal by Subject|1|||
160786193|NCT00552279|580602844|FG000|Overall Study|Lost to Follow-up|1|||
160786194|NCT00552279|580602845|FG001|Overall Study|Lost to Follow-up|0|||
160786195|NCT00552279|580602844|FG000|Overall Study|Other|1|||
160786196|NCT00552279|580602845|FG001|Overall Study|Other|1|||
160786197|NCT01655069|580602847|FG000|Overall Study|Physician Decision|0|||
160786198|NCT01655069|580602848|FG001|Overall Study|Physician Decision|0|||
160786199|NCT01655069|580602849|FG002|Overall Study|Physician Decision|0|||
160786200|NCT01655069|580602850|FG003|Overall Study|Physician Decision|1|||
160786201|NCT01655069|580602847|FG000|Overall Study|Adverse Event|6|||
160786202|NCT01655069|580602848|FG001|Overall Study|Adverse Event|7|||
160786203|NCT01655069|580602849|FG002|Overall Study|Adverse Event|2|||
160786204|NCT01655069|580602850|FG003|Overall Study|Adverse Event|3|||
160786205|NCT01655069|580602847|FG000|Overall Study|Lack of Efficacy|0|||
160786206|NCT01655069|580602848|FG001|Overall Study|Lack of Efficacy|1|||
160786207|NCT01655069|580602849|FG002|Overall Study|Lack of Efficacy|0|||
160786208|NCT01655069|580602850|FG003|Overall Study|Lack of Efficacy|0|||
160786209|NCT01655069|580602847|FG000|Overall Study|No Treatment Needed|0|||
160786210|NCT01655069|580602848|FG001|Overall Study|No Treatment Needed|1|||
160786211|NCT01655069|580602849|FG002|Overall Study|No Treatment Needed|0|||
160786212|NCT01655069|580602850|FG003|Overall Study|No Treatment Needed|0|||
160786213|NCT01655069|580602847|FG000|Overall Study|Withdrawal by Subject|2|||
160786214|NCT01655069|580602848|FG001|Overall Study|Withdrawal by Subject|3|||
160786215|NCT01655069|580602849|FG002|Overall Study|Withdrawal by Subject|0|||
160786216|NCT01655069|580602850|FG003|Overall Study|Withdrawal by Subject|0|||
160786217|NCT02346370|580602851|FG000|Overall Study|Not treated|1|||
160786218|NCT02346370|580602852|FG001|Overall Study|Not treated|0|||
160786219|NCT02346370|580602853|FG002|Overall Study|Not treated|0|||
160786220|NCT02346370|580602851|FG000|Overall Study|Withdrawal of consent|1|||
160786221|NCT02346370|580602852|FG001|Overall Study|Withdrawal of consent|0|||
160786222|NCT02346370|580602853|FG002|Overall Study|Withdrawal of consent|0|||
160786223|NCT02346370|580602851|FG000|Overall Study|Death|1|||
160786224|NCT02346370|580602852|FG001|Overall Study|Death|3|||
160786225|NCT02346370|580602853|FG002|Overall Study|Death|1|||
160786226|NCT02346370|580602851|FG000|Overall Study|Sponsor discontinued study|5|||
160786227|NCT02346370|580602852|FG001|Overall Study|Sponsor discontinued study|0|||
160786228|NCT02346370|580602853|FG002|Overall Study|Sponsor discontinued study|2|||
160786229|NCT02346370|580602851|FG000|Overall Study|Radiologic progression|0|||
160786230|NCT02346370|580602852|FG001|Overall Study|Radiologic progression|0|||
160786231|NCT02346370|580602853|FG002|Overall Study|Radiologic progression|1|||
160786232|NCT02346370|580602851|FG000|Overall Study|Physician Decision|0|||
160786233|NCT02346370|580602852|FG001|Overall Study|Physician Decision|1|||
160786234|NCT02346370|580602853|FG002|Overall Study|Physician Decision|0|||
160786235|NCT01210443|580602856|FG000|Overall Study|Study terminated by sponsor|2|||
160786236|NCT02807181|580602859|FG000|Overall Study|Death|28|||
160786237|NCT02807181|580602860|FG001|Overall Study|Death|24|||
160786238|NCT02807181|580602859|FG000|Overall Study|Withdrawal by Subject|1|||
160786239|NCT02807181|580602860|FG001|Overall Study|Withdrawal by Subject|1|||
160786240|NCT02807181|580602859|FG000|Overall Study|Lost to Follow-up|0|||
160786241|NCT02807181|580602860|FG001|Overall Study|Lost to Follow-up|2|||
160786242|NCT02807181|580602859|FG000|Overall Study|Subject decision|1|||
160786243|NCT02807181|580602860|FG001|Overall Study|Subject decision|0|||
160786244|NCT02807181|580602859|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
160786245|NCT02807181|580602860|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
160786246|NCT02807181|580602859|FG000|Overall Study|In Study|3|||
160786247|NCT02807181|580602860|FG001|Overall Study|In Study|3|||
160786248|NCT02807181|580602859|FG000|Overall Study|Post Progression|3|||
160786249|NCT02807181|580602860|FG001|Overall Study|Post Progression|2|||
160786250|NCT01309100|580602861|FG000|Overall Study|Protocol Violation|1|||
160786251|NCT01309100|580602861|FG000|Overall Study|Positive Slit lamp finding|1|||
160786252|NCT01452789|580602862|FG000|Overall Study|Withdrawal by Subject|3|||
160786253|NCT01452789|580602863|FG001|Overall Study|Withdrawal by Subject|2|||
160786254|NCT00066170|580602864|FG000|Overall Study|Adverse Event|2|||
160786255|NCT00066170|580602865|FG001|Overall Study|Adverse Event|4|||
160786256|NCT00066170|580602866|FG002|Overall Study|Adverse Event|1|||
160786257|NCT00066170|580602867|FG003|Overall Study|Adverse Event|7|||
160786258|NCT00066170|580602864|FG000|Overall Study|Serious Adverse Event|0|||
160890211|NCT00423670|580992973|FG006|Treatment Period|Investigator decision|0|||
160640487|NCT01254045|580066731|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
160640488|NCT01254045|580066732|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
160640489|NCT01254045|580066733|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
160640490|NCT01254045|580066734|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
160640491|NCT01254045|580066735|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
160640492|NCT01254045|580066736|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
160640493|NCT00597207|580066737|FG000|Overall Study|Lost to Follow-up|5|||
160640494|NCT00597207|580066738|FG001|Overall Study|Lost to Follow-up|7|||
160640495|NCT00520351|580066739|FG000|First Intervention|Withdrawal by Subject|1|||
160640496|NCT00520351|580066740|FG001|First Intervention|Withdrawal by Subject|1|||
160640497|NCT04288115|580066746|FG000|Overall Study|Withdrawal by Subject|0|||
160640498|NCT04288115|580066747|FG001|Overall Study|Withdrawal by Subject|1|||
160640499|NCT04288115|580066746|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
160640500|NCT04288115|580066747|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
160640501|NCT02766400|580066748|FG000|Overall Study|Death|1|||
160640502|NCT02766400|580066749|FG001|Overall Study|Death|2|||
160640503|NCT02766400|580066748|FG000|Overall Study|Withdrawal by Subject|1|||
160640504|NCT02766400|580066749|FG001|Overall Study|Withdrawal by Subject|0|||
160640505|NCT03499249|580066754|FG000|Overall Study|Physician Decision|1|||
160786259|NCT00066170|580602865|FG001|Overall Study|Serious Adverse Event|0|||
160786260|NCT00066170|580602866|FG002|Overall Study|Serious Adverse Event|1|||
160786261|NCT00066170|580602867|FG003|Overall Study|Serious Adverse Event|1|||
160640506|NCT01374906|580066755|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160786262|NCT00066170|580602864|FG000|Overall Study|Lost to Follow-up|0|||
160786263|NCT00066170|580602865|FG001|Overall Study|Lost to Follow-up|1|||
160786264|NCT00066170|580602866|FG002|Overall Study|Lost to Follow-up|0|||
160786265|NCT00066170|580602867|FG003|Overall Study|Lost to Follow-up|0|||
160786266|NCT00066170|580602864|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
160786267|NCT00066170|580602865|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
160786268|NCT00066170|580602866|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
160786269|NCT00066170|580602867|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
160786270|NCT00066170|580602864|FG000|Overall Study|Protocol Violation|3|||
160786271|NCT00066170|580602865|FG001|Overall Study|Protocol Violation|0|||
160786272|NCT00066170|580602866|FG002|Overall Study|Protocol Violation|0|||
160786273|NCT00066170|580602867|FG003|Overall Study|Protocol Violation|0|||
160786274|NCT00066170|580602864|FG000|Overall Study|Other|1|||
160786275|NCT00066170|580602865|FG001|Overall Study|Other|5|||
160786276|NCT00066170|580602866|FG002|Overall Study|Other|2|||
160786277|NCT00066170|580602867|FG003|Overall Study|Other|0|||
160786278|NCT03722030|580602868|FG000|Overall Study|Withdrawal by Subject|1|||
160786279|NCT03722030|580602869|FG001|Overall Study|Withdrawal by Subject|0|||
160786280|NCT01663987|580602871|FG000|Overall Study|Adverse Event|7|||
160786281|NCT01663987|580602872|FG001|Overall Study|Adverse Event|2|||
160786282|NCT01663987|580602871|FG000|Overall Study|Lost to Follow-up|1|||
160786283|NCT01663987|580602872|FG001|Overall Study|Lost to Follow-up|1|||
160786284|NCT01663987|580602871|FG000|Overall Study|Withdrawal by Subject|2|||
160786285|NCT01663987|580602872|FG001|Overall Study|Withdrawal by Subject|3|||
160786286|NCT01663987|580602871|FG000|Overall Study|Other reason not defined above|3|||
160786287|NCT01663987|580602872|FG001|Overall Study|Other reason not defined above|0|||
160786288|NCT02006654|580602876|FG000|Overall Study|Withdrawal before treatment|4|||
160786289|NCT02006654|580602877|FG001|Overall Study|Withdrawal before treatment|2|||
160786290|NCT02006654|580602876|FG000|Overall Study|Adverse Event|16|||
160786291|NCT02006654|580602877|FG001|Overall Study|Adverse Event|17|||
160786292|NCT02006654|580602876|FG000|Overall Study|Death|1|||
160786293|NCT02006654|580602877|FG001|Overall Study|Death|0|||
160786294|NCT02006654|580602876|FG000|Overall Study|Withdrawal by Subject|14|||
160786295|NCT02006654|580602877|FG001|Overall Study|Withdrawal by Subject|12|||
160786296|NCT02006654|580602876|FG000|Overall Study|Protocol Violation|5|||
160786297|NCT02006654|580602877|FG001|Overall Study|Protocol Violation|8|||
160786298|NCT02006654|580602876|FG000|Overall Study|Lost to Follow-up|1|||
160786299|NCT02006654|580602877|FG001|Overall Study|Lost to Follow-up|0|||
160786300|NCT02006654|580602876|FG000|Overall Study|patient's will|2|||
160786301|NCT02006654|580602877|FG001|Overall Study|patient's will|1|||
160786302|NCT02006654|580602876|FG000|Overall Study|insufficient compliance|1|||
160786303|NCT02006654|580602877|FG001|Overall Study|insufficient compliance|0|||
160786304|NCT02006654|580602876|FG000|Overall Study|worsening cognitive condition|0|||
160786305|NCT02006654|580602877|FG001|Overall Study|worsening cognitive condition|1|||
160786306|NCT02006654|580602876|FG000|Overall Study|faecal incontinence|0|||
160786307|NCT02006654|580602877|FG001|Overall Study|faecal incontinence|1|||
160786308|NCT02006654|580602876|FG000|Overall Study|mood disorder|0|||
160786309|NCT02006654|580602877|FG001|Overall Study|mood disorder|1|||
160786310|NCT02006654|580602876|FG000|Overall Study|disallowed medication|1|||
160786311|NCT02006654|580602877|FG001|Overall Study|disallowed medication|0|||
160786312|NCT02006654|580602876|FG000|Overall Study|moving out of state|0|||
160786313|NCT02006654|580602877|FG001|Overall Study|moving out of state|1|||
160786314|NCT03520387|580602878|FG000|Pre-Randomization|Withdrawal by Subject|1|||
160786315|NCT03520387|580602879|FG001|Pre-Randomization|Withdrawal by Subject|0|||
160786316|NCT03520387|580602880|FG002|Pre-Randomization|Withdrawal by Subject|0|||
160786317|NCT03520387|580602881|FG003|Pre-Randomization|Withdrawal by Subject|0|||
160786318|NCT03520387|580602882|FG004|Pre-Randomization|Withdrawal by Subject|0|||
160786319|NCT03520387|580602878|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
160786320|NCT03520387|580602879|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
160786321|NCT03520387|580602880|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
160786322|NCT03520387|580602881|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
160786323|NCT03520387|580602882|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
160786324|NCT05737745|580602883|FG000|Overall Study|Withdrawal by Subject|0|||
160786325|NCT05737745|580602884|FG001|Overall Study|Withdrawal by Subject|6|||
160786326|NCT05737745|580602885|FG002|Overall Study|Withdrawal by Subject|1|||
160786327|NCT04648241|580602886|FG000|Overall Study|Lost to Follow-up|1|||
160786328|NCT04648241|580602887|FG001|Overall Study|Lost to Follow-up|0|||
160786329|NCT02569242|580602888|FG000|Overall Study|Death|1|||
160786330|NCT02569242|580602889|FG001|Overall Study|Death|0|||
160786331|NCT02569242|580602888|FG000|Overall Study|Withdrawal by Subject|0|||
160786332|NCT02569242|580602889|FG001|Overall Study|Withdrawal by Subject|1|||
160786333|NCT02057666|580602890|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
160786334|NCT02057666|580602891|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
160786335|NCT02057666|580602890|FG000|Double Blind Treatment Period|Poor tolerability|7|||
160786336|NCT02057666|580602891|FG001|Double Blind Treatment Period|Poor tolerability|2|||
160786337|NCT02057666|580602890|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
160786338|NCT02057666|580602891|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
160786339|NCT02057666|580602890|FG000|Double Blind Treatment Period|Physician Decision|1|||
160786340|NCT02057666|580602891|FG001|Double Blind Treatment Period|Physician Decision|0|||
160786341|NCT02057666|580602890|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
160786342|NCT02057666|580602891|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
160786343|NCT02057666|580602890|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
160786344|NCT02057666|580602891|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
160786345|NCT02057666|580602890|FG000|Double Blind Treatment Period|Sponsor's request|70|||
160786346|NCT02057666|580602891|FG001|Double Blind Treatment Period|Sponsor's request|34|||
160786347|NCT02057666|580602890|FG000|Open-Label Treatment Period|Poor tolerability|0|||
160786348|NCT02057666|580602891|FG001|Open-Label Treatment Period|Poor tolerability|1|||
160786349|NCT02057666|580602890|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
160786350|NCT02057666|580602891|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
160786351|NCT02057666|580602890|FG000|Open-Label Treatment Period|Sponsor's request|0|||
160786352|NCT02057666|580602891|FG001|Open-Label Treatment Period|Sponsor's request|4|||
160786353|NCT05661734|580602892|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
160786354|NCT05661734|580602892|FG000|Overall Study|Lost to Follow-up|13|||
160786355|NCT05661734|580602892|FG000|Overall Study|Enrolled but not dosed|2|||
160786356|NCT02489045|580602893|FG000|Overall Study|unable to collect usable data|53|||
160786357|NCT02489045|580602893|FG000|Follow-up|Lost to Follow-up|10|||
160786358|NCT02774278|580602896|FG000|Overall Study|Lack of Efficacy|199|||
160786359|NCT02774278|580602896|FG000|Overall Study|Death|29|||
160786360|NCT02774278|580602896|FG000|Overall Study|Adverse event/intercurrent illness|16|||
160786361|NCT02774278|580602896|FG000|Overall Study|Refused treatment/did not cooperate|9|||
160786362|NCT02774278|580602896|FG000|Overall Study|Administrative reasons|6|||
160786363|NCT02774278|580602896|FG000|Overall Study|Withdrawal by Subject|3|||
160786364|NCT02774278|580602896|FG000|Overall Study|Protocol Violation|2|||
160786365|NCT03259308|580602899|FG000|Overall Study|Adverse Event|5|||
160786366|NCT03259308|580602900|FG001|Overall Study|Adverse Event|4|||
160786367|NCT03259308|580602901|FG002|Overall Study|Adverse Event|1|||
160786368|NCT03259308|580602899|FG000|Overall Study|Withdrawal by Subject|2|||
160786369|NCT03259308|580602900|FG001|Overall Study|Withdrawal by Subject|1|||
160786370|NCT03259308|580602901|FG002|Overall Study|Withdrawal by Subject|3|||
160786371|NCT03259308|580602899|FG000|Overall Study|Lost to Follow-up|0|||
160786372|NCT03259308|580602900|FG001|Overall Study|Lost to Follow-up|0|||
160786373|NCT03259308|580602901|FG002|Overall Study|Lost to Follow-up|1|||
160786374|NCT03259308|580602899|FG000|Overall Study|Pregnancy|0|||
160786375|NCT03259308|580602900|FG001|Overall Study|Pregnancy|0|||
160786376|NCT03259308|580602901|FG002|Overall Study|Pregnancy|1|||
160786377|NCT03259308|580602899|FG000|Overall Study|Protocol Deviation|0|||
160786378|NCT03259308|580602900|FG001|Overall Study|Protocol Deviation|3|||
160786379|NCT03259308|580602901|FG002|Overall Study|Protocol Deviation|0|||
160786380|NCT03259308|580602899|FG000|Overall Study|Lack of Efficacy|0|||
160786381|NCT03259308|580602900|FG001|Overall Study|Lack of Efficacy|0|||
160786382|NCT03259308|580602901|FG002|Overall Study|Lack of Efficacy|1|||
160786383|NCT03339453|580602907|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
160786384|NCT03339453|580602908|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
160786385|NCT00300495|580602912|FG000|Overall Study|Protocol Violation|4|||
160786386|NCT00300495|580602913|FG001|Overall Study|Protocol Violation|1|||
160786387|NCT01117350|580602925|FG000|Comparative Period|Not Treated|5|||
160786388|NCT01117350|580602926|FG001|Comparative Period|Not Treated|8|||
160786389|NCT01117350|580602925|FG000|Comparative Period|Adverse Event|6|||
160786390|NCT01117350|580602926|FG001|Comparative Period|Adverse Event|33|||
160786391|NCT01117350|580602925|FG000|Comparative Period|Lost to Follow-up|11|||
160786392|NCT01117350|580602926|FG001|Comparative Period|Lost to Follow-up|7|||
160786393|NCT01117350|580602925|FG000|Comparative Period|Withdrawal by Subject|9|||
160786394|NCT01117350|580602926|FG001|Comparative Period|Withdrawal by Subject|13|||
160786395|NCT01117350|580602925|FG000|Comparative Period|Protocol Violation|8|||
160786396|NCT01117350|580602926|FG001|Comparative Period|Protocol Violation|12|||
160786397|NCT01117350|580602925|FG000|Comparative Period|Lack of Efficacy|1|||
160786398|NCT01117350|580602926|FG001|Comparative Period|Lack of Efficacy|0|||
160786399|NCT01117350|580602925|FG000|Comparative Period|Physician Decision|0|||
160786400|NCT01117350|580602926|FG001|Comparative Period|Physician Decision|1|||
160786401|NCT01117350|580602925|FG000|Comparative Period|Move to another city/country|2|||
160786402|NCT01117350|580602926|FG001|Comparative Period|Move to another city/country|1|||
160786403|NCT01117350|580602925|FG000|Extension Period|Not included in extension, not treated|0|||
160786404|NCT01117350|580602926|FG001|Extension Period|Not included in extension, not treated|50|||
160786405|NCT01117350|580602925|FG000|Extension Period|Adverse Event|0|||
160786406|NCT01117350|580602926|FG001|Extension Period|Adverse Event|2|||
160786407|NCT01117350|580602925|FG000|Extension Period|Protocol Violation|0|||
160786408|NCT01117350|580602926|FG001|Extension Period|Protocol Violation|2|||
160786409|NCT01117350|580602925|FG000|Extension Period|Lost to Follow-up|0|||
160786410|NCT01117350|580602926|FG001|Extension Period|Lost to Follow-up|2|||
160786411|NCT01117350|580602925|FG000|Extension Period|Withdrawal by Subject|0|||
160786412|NCT01117350|580602926|FG001|Extension Period|Withdrawal by Subject|3|||
160786413|NCT01117350|580602925|FG000|Extension Period|Lack of Efficacy|0|||
160786414|NCT01117350|580602926|FG001|Extension Period|Lack of Efficacy|2|||
160786415|NCT01117350|580602925|FG000|Extension Period|Inclusion criteria not respected|0|||
160786416|NCT01117350|580602926|FG001|Extension Period|Inclusion criteria not respected|1|||
160786417|NCT01117350|580602925|FG000|Extension Period|Prohibited medication|0|||
160786418|NCT01117350|580602926|FG001|Extension Period|Prohibited medication|1|||
160786419|NCT06868667|580602931|FG000|Overall Study|Death|0|||
160786420|NCT06868667|580602932|FG001|Overall Study|Death|4|||
160786421|NCT06868667|580602931|FG000|Overall Study|Lost to Follow-up|0|||
160786422|NCT06868667|580602932|FG001|Overall Study|Lost to Follow-up|1|||
160786423|NCT06868667|580602931|FG000|Overall Study|Withdrawal by Subject|1|||
160786424|NCT06868667|580602932|FG001|Overall Study|Withdrawal by Subject|0|||
160786425|NCT06868667|580602931|FG000|Overall Study|Ongoing|9|||
160786426|NCT06868667|580602932|FG001|Overall Study|Ongoing|9|||
160786427|NCT02487199|580602934|FG000|Overall Study|Withdrew Consent|0|||
160786428|NCT02487199|580602935|FG001|Overall Study|Withdrew Consent|1|||
160786429|NCT00286455|580602936|FG000|Overall Study|Hyperglycemia rescue|19|||
160786430|NCT00286455|580602937|FG001|Overall Study|Hyperglycemia rescue|13|||
160786431|NCT00286455|580602938|FG002|Overall Study|Hyperglycemia rescue|10|||
160786432|NCT00286455|580602936|FG000|Overall Study|Adverse Event|1|||
160786433|NCT00286455|580602937|FG001|Overall Study|Adverse Event|3|||
160786434|NCT00286455|580602938|FG002|Overall Study|Adverse Event|2|||
160786435|NCT00286455|580602936|FG000|Overall Study|Lost to Follow-up|0|||
160786436|NCT00286455|580602937|FG001|Overall Study|Lost to Follow-up|3|||
160786437|NCT00286455|580602938|FG002|Overall Study|Lost to Follow-up|3|||
160786438|NCT00286455|580602936|FG000|Overall Study|Physician Decision|3|||
160786439|NCT00286455|580602937|FG001|Overall Study|Physician Decision|0|||
160786440|NCT00286455|580602938|FG002|Overall Study|Physician Decision|2|||
160786441|NCT00286455|580602936|FG000|Overall Study|Protocol Violation|1|||
160786442|NCT00286455|580602937|FG001|Overall Study|Protocol Violation|1|||
160786443|NCT00286455|580602938|FG002|Overall Study|Protocol Violation|0|||
160786444|NCT00286455|580602936|FG000|Overall Study|Participant Non-compliance|1|||
160786445|NCT00286455|580602937|FG001|Overall Study|Participant Non-compliance|0|||
160786446|NCT00286455|580602938|FG002|Overall Study|Participant Non-compliance|0|||
160786447|NCT00286455|580602936|FG000|Overall Study|Withdrawal by Subject|0|||
160786448|NCT00286455|580602937|FG001|Overall Study|Withdrawal by Subject|8|||
160786449|NCT00286455|580602938|FG002|Overall Study|Withdrawal by Subject|7|||
160786450|NCT03681093|580604599|FG000|Overall Study|Subject decision|0|||
160786451|NCT03681093|580604600|FG001|Overall Study|Subject decision|2|||
160786452|NCT03681093|580604601|FG002|Overall Study|Subject decision|1|||
160786453|NCT01213251|580604602|FG000|Overall Study|Death|2|||
160786454|NCT01213251|580604603|FG001|Overall Study|Death|1|||
160786455|NCT01213251|580604604|FG002|Overall Study|Death|2|||
160786456|NCT01213251|580604602|FG000|Overall Study|Exit|3|||
160786457|NCT01213251|580604603|FG001|Overall Study|Exit|2|||
160786458|NCT01213251|580604604|FG002|Overall Study|Exit|8|||
160786459|NCT01213251|580604602|FG000|Overall Study|Protocol Violation|1|||
160786460|NCT01213251|580604603|FG001|Overall Study|Protocol Violation|1|||
160786461|NCT01213251|580604604|FG002|Overall Study|Protocol Violation|0|||
160786462|NCT01213251|580604602|FG000|Overall Study|Missed 18-Month Follow-up|0|||
160786463|NCT01213251|580604603|FG001|Overall Study|Missed 18-Month Follow-up|0|||
160786464|NCT01213251|580604604|FG002|Overall Study|Missed 18-Month Follow-up|1|||
160786465|NCT00326495|580604608|FG000|Overall Study|Switched to alternative treatment|1|||
160786466|NCT00326495|580604608|FG000|Overall Study|Disease progression before treatment|1|||
160786467|NCT00326495|580604608|FG000|Overall Study|Refused further treatment|2|||
160786468|NCT00326495|580604608|FG000|Overall Study|Subject off study before assessment|1|||
160786469|NCT02933151|580604609|FG000|Overall Study|Lost to Follow-up|19|||
160786470|NCT02933151|580604610|FG001|Overall Study|Lost to Follow-up|18|||
160786471|NCT02933151|580604609|FG000|Overall Study|Death|1732|||
160786472|NCT02933151|580604610|FG001|Overall Study|Death|1827|||
160786473|NCT02933151|580604609|FG000|Overall Study|Transplant|210|||
160786474|NCT02933151|580604610|FG001|Overall Study|Transplant|278|||
160786475|NCT02933151|580604609|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
160786476|NCT02933151|580604610|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
160786477|NCT02933151|580604609|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
160786478|NCT02933151|580604610|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
160786479|NCT02933151|580604609|FG000|Overall Study|Recovered Kidney Function|47|||
160786480|NCT02933151|580604610|FG001|Overall Study|Recovered Kidney Function|29|||
160786481|NCT01654250|580604611|FG000|Overall Study|Lost to Follow-up|1|||
160786482|NCT01654250|580604612|FG001|Overall Study|Lost to Follow-up|0|||
160786483|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
160786484|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
160786485|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
160786486|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
160786487|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
160786488|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
160786489|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
160786490|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
160786491|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
160786492|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
160786493|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
160786494|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
160786495|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
160786496|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
160786497|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
160786498|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
160786499|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
160786500|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
160786501|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
160786502|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
160786503|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
160786504|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
160786505|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
160786506|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
160786507|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
160786508|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
160786509|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
160786510|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
160786511|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
160786512|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
160786513|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
160786514|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
160786515|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
160786516|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
160786517|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
160786518|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
160786519|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
160786520|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
160786521|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
160786522|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
160786523|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
160786524|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
160786525|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
160786526|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
160786527|NCT03280615|580604617|FG000|Overall Study|Lost to Follow-up|1|||
160786528|NCT03280615|580604618|FG001|Overall Study|Lost to Follow-up|2|||
160786529|NCT03280615|580604617|FG000|Overall Study|Adverse Event|1|||
160786530|NCT03280615|580604618|FG001|Overall Study|Adverse Event|1|||
160786531|NCT03280615|580604617|FG000|Overall Study|Withdrawal by Subject|2|||
160786532|NCT03280615|580604618|FG001|Overall Study|Withdrawal by Subject|2|||
160786533|NCT00107614|580604621|FG000|Overall Study|Physician Decision|10|||
160786534|NCT00107614|580604621|FG000|Overall Study|Death|2|||
160786535|NCT01013870|580604622|FG000|Overall Study|Lost to Follow-up|1|||
160786536|NCT01013870|580604623|FG001|Overall Study|Lost to Follow-up|3|||
160786537|NCT02457546|580604625|FG000|Overall Study|Other reasons|4|||
160786538|NCT02457546|580604626|FG001|Overall Study|Other reasons|1|||
160786539|NCT02457546|580604625|FG000|Overall Study|Refused to complete study/procedures|1|||
160786540|NCT02457546|580604626|FG001|Overall Study|Refused to complete study/procedures|1|||
160786541|NCT02457546|580604625|FG000|Overall Study|Lost to Follow-up|4|||
160786542|NCT02457546|580604626|FG001|Overall Study|Lost to Follow-up|1|||
160786543|NCT02457546|580604625|FG000|Overall Study|Adverse Event|0|||
160786544|NCT02457546|580604626|FG001|Overall Study|Adverse Event|1|||
160786545|NCT01530256|580604627|FG000|Overall Study|Death|2|||
160786546|NCT04432298|580604630|FG000|Overall Study|Other than specified|1|||
160786547|NCT04432298|580604631|FG001|Overall Study|Other than specified|0|||
160786548|NCT04432298|580604630|FG000|Overall Study|Lost to Follow-up|0|||
160543487|NCT03451773|579718218|FG001|Overall Study|Death on study|5|||
160543488|NCT03451773|579718217|FG000|Overall Study|Death during follow-up period|0|||
160543489|NCT03451773|579718218|FG001|Overall Study|Death during follow-up period|1|||
160543490|NCT02627495|579718221|FG000|Overall Study|Withdrawal by Subject|4|||
160543491|NCT02543528|579718222|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
160543492|NCT02543528|579718223|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
160543493|NCT02543528|579718224|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
160543494|NCT02543528|579718225|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
160543495|NCT02543528|579718226|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
160543496|NCT02543528|579718222|FG000|Adaptation Period|Lens Handling Difficultes|0|||
160543497|NCT02543528|579718223|FG001|Adaptation Period|Lens Handling Difficultes|0|||
160543498|NCT02543528|579718224|FG002|Adaptation Period|Lens Handling Difficultes|0|||
160543499|NCT02543528|579718225|FG003|Adaptation Period|Lens Handling Difficultes|0|||
160543500|NCT02543528|579718226|FG004|Adaptation Period|Lens Handling Difficultes|8|||
160543501|NCT02543528|579718222|FG000|Adaptation Period|Lost to Follow-up|0|||
160543502|NCT02543528|579718223|FG001|Adaptation Period|Lost to Follow-up|0|||
160543503|NCT02543528|579718224|FG002|Adaptation Period|Lost to Follow-up|0|||
160543504|NCT02543528|579718225|FG003|Adaptation Period|Lost to Follow-up|0|||
160543505|NCT02543528|579718226|FG004|Adaptation Period|Lost to Follow-up|14|||
160543506|NCT02543528|579718222|FG000|Adaptation Period|Adverse Event|0|||
160543507|NCT02543528|579718223|FG001|Adaptation Period|Adverse Event|0|||
160543508|NCT02543528|579718224|FG002|Adaptation Period|Adverse Event|0|||
160543509|NCT02543528|579718225|FG003|Adaptation Period|Adverse Event|0|||
160543510|NCT02543528|579718226|FG004|Adaptation Period|Adverse Event|2|||
160543511|NCT02543528|579718222|FG000|Extended Wear Period|Adverse Event|17|||
160543512|NCT02543528|579718223|FG001|Extended Wear Period|Adverse Event|11|||
160543513|NCT02543528|579718224|FG002|Extended Wear Period|Adverse Event|16|||
160543514|NCT02543528|579718225|FG003|Extended Wear Period|Adverse Event|3|||
160543515|NCT02543528|579718226|FG004|Extended Wear Period|Adverse Event|0|||
160543516|NCT02543528|579718222|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
160543517|NCT02543528|579718223|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
160543518|NCT02543528|579718224|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
160543519|NCT02543528|579718225|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
160543520|NCT02543528|579718226|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
160543521|NCT02543528|579718222|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
160543522|NCT02543528|579718223|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
160543523|NCT02543528|579718224|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
160543524|NCT02543528|579718225|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
160543525|NCT02543528|579718226|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
160543526|NCT02543528|579718222|FG000|Extended Wear Period|Lost to Follow-up|0|||
160543527|NCT02543528|579718223|FG001|Extended Wear Period|Lost to Follow-up|1|||
160543528|NCT02543528|579718224|FG002|Extended Wear Period|Lost to Follow-up|2|||
160543529|NCT02543528|579718225|FG003|Extended Wear Period|Lost to Follow-up|1|||
160543530|NCT02543528|579718226|FG004|Extended Wear Period|Lost to Follow-up|0|||
160543531|NCT02543528|579718222|FG000|Extended Wear Period|Withdrawal by Subject|10|||
160543532|NCT02543528|579718223|FG001|Extended Wear Period|Withdrawal by Subject|9|||
160543533|NCT02543528|579718224|FG002|Extended Wear Period|Withdrawal by Subject|4|||
160543534|NCT02543528|579718225|FG003|Extended Wear Period|Withdrawal by Subject|5|||
160543535|NCT02543528|579718226|FG004|Extended Wear Period|Withdrawal by Subject|0|||
160543536|NCT01339559|579718228|FG000|Overall Study|Adverse Event|92|||
160543537|NCT01339559|579718228|FG000|Overall Study|Death|5|||
160543538|NCT01339559|579718228|FG000|Overall Study|Lack of Efficacy|164|||
160543539|NCT01339559|579718228|FG000|Overall Study|Lost to Follow-up|22|||
160543540|NCT01339559|579718228|FG000|Overall Study|Subject choice|89|||
160543541|NCT01339559|579718228|FG000|Overall Study|Protocol Violation|15|||
160543542|NCT01339559|579718228|FG000|Overall Study|Study closure at site|1|||
160543543|NCT01339559|579718228|FG000|Overall Study|Incarcerated|2|||
160543544|NCT01339559|579718228|FG000|Overall Study|Epilepsy surgery|1|||
160543545|NCT01339559|579718228|FG000|Overall Study|Pregnancy planned|2|||
160543546|NCT01339559|579718228|FG000|Overall Study|Left the country|1|||
160543547|NCT01339559|579718228|FG000|Overall Study|Investigator decision|2|||
160543548|NCT01339559|579718228|FG000|Overall Study|Patient didn't wish to continue|1|||
160543549|NCT01339559|579718228|FG000|Overall Study|PI decision|1|||
160543550|NCT00746252|579718232|FG000|Overall Study|weight gain >7.5 %|1|||
160543551|NCT00746252|579718233|FG001|Overall Study|weight gain >7.5 %|2|||
160543552|NCT01049035|579718234|FG000|Overall Study|Serious adverse event|0|||
160543553|NCT01049035|579718235|FG001|Overall Study|Serious adverse event|1|||
160543554|NCT01049035|579718236|FG002|Overall Study|Serious adverse event|1|||
160543555|NCT01049035|579718237|FG003|Overall Study|Serious adverse event|2|||
160543556|NCT01049035|579718238|FG004|Overall Study|Serious adverse event|0|||
160543557|NCT01049035|579718239|FG005|Overall Study|Serious adverse event|0|||
160543558|NCT01049035|579718240|FG006|Overall Study|Serious adverse event|0|||
160543559|NCT01049035|579718234|FG000|Overall Study|Other adverse event (AE)|0|||
160981867|NCT02061761|581321784|FG002|Overall Study|Maximum clinical benefit|0|||
160786549|NCT04432298|580604631|FG001|Overall Study|Lost to Follow-up|1|||
160786550|NCT04432298|580604630|FG000|Overall Study|Death|3|||
160786551|NCT04432298|580604631|FG001|Overall Study|Death|2|||
160786552|NCT04432298|580604630|FG000|Overall Study|Withdrawal by Subject|2|||
160786553|NCT04432298|580604631|FG001|Overall Study|Withdrawal by Subject|0|||
160786554|NCT02451007|580604634|FG000|Overall Study|Withdrawal by Subject|4|||
160786555|NCT02451007|580604634|FG000|Overall Study|Adverse Event|1|||
160786556|NCT02451007|580604634|FG000|Overall Study|Disease Progression|2|||
160786557|NCT01716559|580604635|FG000|Overall Study|Adverse Event|11|||
160786558|NCT01716559|580604635|FG000|Overall Study|Death|21|||
160786559|NCT01716559|580604635|FG000|Overall Study|Withdrawal by Subject|4|||
160786560|NCT01716559|580604635|FG000|Overall Study|Other withdrawal reason|75|||
160786561|NCT00348374|580604636|FG000|Overall Study|Adverse Event|1|||
160786562|NCT00348374|580604637|FG001|Overall Study|Adverse Event|4|||
160786563|NCT00348374|580604636|FG000|Overall Study|Lost to Follow-up|1|||
160786564|NCT00348374|580604637|FG001|Overall Study|Lost to Follow-up|3|||
160786565|NCT00348374|580604636|FG000|Overall Study|Withdrawal by Subject|5|||
160786566|NCT00348374|580604637|FG001|Overall Study|Withdrawal by Subject|5|||
160786567|NCT00348374|580604636|FG000|Overall Study|Other|11|||
160786568|NCT00348374|580604637|FG001|Overall Study|Other|12|||
160786569|NCT00348374|580604636|FG000|Overall Study|ongoing at date of cutoff|1|||
160786570|NCT00348374|580604637|FG001|Overall Study|ongoing at date of cutoff|1|||
160786571|NCT00348374|580604636|FG000|Overall Study|randomized but did not receive treatment|0|||
160786572|NCT00348374|580604637|FG001|Overall Study|randomized but did not receive treatment|7|||
160786573|NCT02123511|580604646|FG000|Overall Study|Cancelled treatment|1|||
160786574|NCT02123511|580604647|FG001|Overall Study|Cancelled treatment|0|||
160786575|NCT02123511|580604646|FG000|Overall Study|Incomplete data|1|||
160786576|NCT02123511|580604647|FG001|Overall Study|Incomplete data|3|||
160786577|NCT02123511|580604646|FG000|Overall Study|Ineligible|0|||
160786578|NCT02123511|580604647|FG001|Overall Study|Ineligible|1|||
160786579|NCT01423084|580604648|FG000|Overall Study|Adverse Event|0|||
160786580|NCT01423084|580604649|FG001|Overall Study|Adverse Event|1|||
160786581|NCT01423084|580604648|FG000|Overall Study|Withdrawal by Subject|2|||
160786582|NCT01423084|580604649|FG001|Overall Study|Withdrawal by Subject|3|||
160786583|NCT01133977|580604653|FG000|Overall Study|Adverse Event|0|||
160786584|NCT01133977|580604654|FG001|Overall Study|Adverse Event|0|||
160786585|NCT01133977|580604655|FG002|Overall Study|Adverse Event|1|||
160786586|NCT01133977|580604656|FG003|Overall Study|Adverse Event|0|||
160786587|NCT01133977|580604657|FG004|Overall Study|Adverse Event|0|||
160786588|NCT01133977|580604653|FG000|Overall Study|Death|1|||
160786589|NCT01133977|580604654|FG001|Overall Study|Death|1|||
160786590|NCT01133977|580604655|FG002|Overall Study|Death|1|||
160786591|NCT01133977|580604656|FG003|Overall Study|Death|7|||
160786592|NCT01133977|580604657|FG004|Overall Study|Death|3|||
160786593|NCT01133977|580604653|FG000|Overall Study|Started a New Line of Therapy|2|||
160786594|NCT01133977|580604654|FG001|Overall Study|Started a New Line of Therapy|6|||
160786595|NCT01133977|580604655|FG002|Overall Study|Started a New Line of Therapy|4|||
160786596|NCT01133977|580604656|FG003|Overall Study|Started a New Line of Therapy|25|||
160786597|NCT01133977|580604657|FG004|Overall Study|Started a New Line of Therapy|33|||
160786598|NCT01133977|580604653|FG000|Overall Study|Lost to Follow-up|0|||
160786599|NCT01133977|580604654|FG001|Overall Study|Lost to Follow-up|0|||
160786600|NCT01133977|580604655|FG002|Overall Study|Lost to Follow-up|0|||
160786601|NCT01133977|580604656|FG003|Overall Study|Lost to Follow-up|2|||
160786602|NCT01133977|580604657|FG004|Overall Study|Lost to Follow-up|1|||
160786603|NCT01133977|580604653|FG000|Overall Study|Withdrawal by Subject|0|||
160786604|NCT01133977|580604654|FG001|Overall Study|Withdrawal by Subject|0|||
160786605|NCT01133977|580604655|FG002|Overall Study|Withdrawal by Subject|0|||
160786606|NCT01133977|580604656|FG003|Overall Study|Withdrawal by Subject|5|||
160786607|NCT01133977|580604657|FG004|Overall Study|Withdrawal by Subject|1|||
160786608|NCT02462057|580604658|FG000|Overall Study|Left Vitality|32|||
160786609|NCT02462057|580604659|FG001|Overall Study|Left Vitality|27|||
160786610|NCT02462057|580604660|FG002|Overall Study|Left Vitality|23|||
160786611|NCT02462057|580604661|FG003|Overall Study|Left Vitality|35|||
160786612|NCT02462057|580604662|FG004|Overall Study|Left Vitality|33|||
160786613|NCT02462057|580604658|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
160786614|NCT02462057|580604659|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
160786615|NCT02462057|580604660|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
160786616|NCT02462057|580604661|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
160786617|NCT02462057|580604662|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
160786618|NCT00281580|580604665|FG000|Overall Study|Adverse Event|2|||
160786619|NCT00281580|580604666|FG001|Overall Study|Adverse Event|0|||
160786620|NCT00281580|580604667|FG002|Overall Study|Adverse Event|2|||
160786621|NCT00281580|580604668|FG003|Overall Study|Adverse Event|4|||
160786622|NCT00281580|580604669|FG004|Overall Study|Adverse Event|1|||
160786623|NCT00281580|580604670|FG005|Overall Study|Adverse Event|0|||
160786624|NCT00281580|580604671|FG006|Overall Study|Adverse Event|1|||
160786625|NCT00281580|580604672|FG007|Overall Study|Adverse Event|0|||
160786626|NCT00281580|580604673|FG008|Overall Study|Adverse Event|1|||
160786627|NCT00281580|580604674|FG009|Overall Study|Adverse Event|6|||
160786628|NCT00281580|580604675|FG010|Overall Study|Adverse Event|0|||
160786629|NCT00281580|580604676|FG011|Overall Study|Adverse Event|5|||
160786630|NCT00281580|580604677|FG012|Overall Study|Adverse Event|8|||
160786631|NCT00281580|580604678|FG013|Overall Study|Adverse Event|2|||
160786632|NCT00281580|580604679|FG014|Overall Study|Adverse Event|3|||
160786633|NCT00281580|580604680|FG015|Overall Study|Adverse Event|3|||
160786634|NCT00281580|580604665|FG000|Overall Study|Protocol Violation|0|||
160786635|NCT00281580|580604666|FG001|Overall Study|Protocol Violation|0|||
160786636|NCT00281580|580604667|FG002|Overall Study|Protocol Violation|1|||
160786637|NCT00281580|580604668|FG003|Overall Study|Protocol Violation|1|||
160786638|NCT00281580|580604669|FG004|Overall Study|Protocol Violation|0|||
160786639|NCT00281580|580604670|FG005|Overall Study|Protocol Violation|0|||
160786640|NCT00281580|580604671|FG006|Overall Study|Protocol Violation|1|||
160786641|NCT00281580|580604672|FG007|Overall Study|Protocol Violation|0|||
160786642|NCT00281580|580604673|FG008|Overall Study|Protocol Violation|2|||
160786643|NCT00281580|580604674|FG009|Overall Study|Protocol Violation|0|||
160786644|NCT00281580|580604675|FG010|Overall Study|Protocol Violation|1|||
160786645|NCT00281580|580604676|FG011|Overall Study|Protocol Violation|2|||
160786646|NCT00281580|580604677|FG012|Overall Study|Protocol Violation|0|||
160786647|NCT00281580|580604678|FG013|Overall Study|Protocol Violation|1|||
160786648|NCT00281580|580604679|FG014|Overall Study|Protocol Violation|1|||
160786649|NCT00281580|580604680|FG015|Overall Study|Protocol Violation|3|||
160786650|NCT00281580|580604665|FG000|Overall Study|Withdrawal by Subject|3|||
160786651|NCT00281580|580604666|FG001|Overall Study|Withdrawal by Subject|0|||
160786652|NCT00281580|580604667|FG002|Overall Study|Withdrawal by Subject|1|||
160786653|NCT00281580|580604668|FG003|Overall Study|Withdrawal by Subject|1|||
160786654|NCT00281580|580604669|FG004|Overall Study|Withdrawal by Subject|1|||
160786655|NCT00281580|580604670|FG005|Overall Study|Withdrawal by Subject|2|||
160786656|NCT00281580|580604671|FG006|Overall Study|Withdrawal by Subject|2|||
160786657|NCT00281580|580604672|FG007|Overall Study|Withdrawal by Subject|0|||
160786658|NCT00281580|580604673|FG008|Overall Study|Withdrawal by Subject|1|||
160786659|NCT00281580|580604674|FG009|Overall Study|Withdrawal by Subject|4|||
160786660|NCT00281580|580604675|FG010|Overall Study|Withdrawal by Subject|1|||
160786661|NCT00281580|580604676|FG011|Overall Study|Withdrawal by Subject|1|||
160786662|NCT00281580|580604677|FG012|Overall Study|Withdrawal by Subject|2|||
160786663|NCT00281580|580604678|FG013|Overall Study|Withdrawal by Subject|2|||
160786664|NCT00281580|580604679|FG014|Overall Study|Withdrawal by Subject|1|||
160786665|NCT00281580|580604680|FG015|Overall Study|Withdrawal by Subject|5|||
160786666|NCT00281580|580604665|FG000|Overall Study|Lack of Efficacy|2|||
160786667|NCT00281580|580604666|FG001|Overall Study|Lack of Efficacy|1|||
160786668|NCT00281580|580604667|FG002|Overall Study|Lack of Efficacy|1|||
160786669|NCT00281580|580604668|FG003|Overall Study|Lack of Efficacy|6|||
160786670|NCT00281580|580604669|FG004|Overall Study|Lack of Efficacy|2|||
160786671|NCT00281580|580604670|FG005|Overall Study|Lack of Efficacy|0|||
160786672|NCT00281580|580604671|FG006|Overall Study|Lack of Efficacy|0|||
160543560|NCT01049035|579718235|FG001|Overall Study|Other adverse event (AE)|0|||
160543561|NCT01049035|579718236|FG002|Overall Study|Other adverse event (AE)|0|||
160543562|NCT01049035|579718237|FG003|Overall Study|Other adverse event (AE)|1|||
160543563|NCT01049035|579718238|FG004|Overall Study|Other adverse event (AE)|0|||
160543564|NCT01049035|579718239|FG005|Overall Study|Other adverse event (AE)|0|||
160543565|NCT01049035|579718240|FG006|Overall Study|Other adverse event (AE)|0|||
160543566|NCT01049035|579718234|FG000|Overall Study|Non-compliance with the protocol|12|||
160543567|NCT01049035|579718235|FG001|Overall Study|Non-compliance with the protocol|6|||
160543568|NCT01049035|579718236|FG002|Overall Study|Non-compliance with the protocol|14|||
160543569|NCT01049035|579718237|FG003|Overall Study|Non-compliance with the protocol|5|||
160543570|NCT01049035|579718238|FG004|Overall Study|Non-compliance with the protocol|3|||
160786673|NCT00281580|580604672|FG007|Overall Study|Lack of Efficacy|0|||
160786674|NCT00281580|580604673|FG008|Overall Study|Lack of Efficacy|0|||
160786675|NCT00281580|580604674|FG009|Overall Study|Lack of Efficacy|0|||
160786676|NCT00281580|580604675|FG010|Overall Study|Lack of Efficacy|0|||
160890212|NCT00423670|580992974|FG007|Treatment Period|Investigator decision|1|||
160640507|NCT01374906|580066756|FG001|Overall Study|Abnormal laboratory value(s)|3|||
160640508|NCT01374906|580066755|FG000|Overall Study|Administrative problems|2|||
160640509|NCT01374906|580066756|FG001|Overall Study|Administrative problems|2|||
160640510|NCT01374906|580066755|FG000|Overall Study|Adverse Event|10|||
160640511|NCT01374906|580066756|FG001|Overall Study|Adverse Event|11|||
160640512|NCT01374906|580066755|FG000|Overall Study|Death|0|||
160640513|NCT01374906|580066756|FG001|Overall Study|Death|2|||
160640514|NCT01374906|580066755|FG000|Overall Study|Protocol Violation|2|||
160640515|NCT01374906|580066756|FG001|Overall Study|Protocol Violation|2|||
160640516|NCT01374906|580066755|FG000|Overall Study|Withdrawal by Subject|15|||
160640517|NCT01374906|580066756|FG001|Overall Study|Withdrawal by Subject|9|||
160640518|NCT01374906|580066755|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
160640519|NCT01374906|580066756|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
160640520|NCT00435825|580066761|FG000|Overall Study|Abnormality of Laboratory Test|0|||
160640521|NCT00435825|580066762|FG001|Overall Study|Abnormality of Laboratory Test|1|||
160640522|NCT00435825|580066763|FG002|Overall Study|Abnormality of Laboratory Test|0|||
160640523|NCT00435825|580066764|FG003|Overall Study|Abnormality of Laboratory Test|0|||
160640524|NCT00435825|580066761|FG000|Overall Study|Insufficient Therapeutic Response|3|||
160786677|NCT00281580|580604676|FG011|Overall Study|Lack of Efficacy|1|||
160786678|NCT00281580|580604677|FG012|Overall Study|Lack of Efficacy|0|||
160786679|NCT00281580|580604678|FG013|Overall Study|Lack of Efficacy|2|||
160786680|NCT00281580|580604679|FG014|Overall Study|Lack of Efficacy|1|||
160786681|NCT00281580|580604680|FG015|Overall Study|Lack of Efficacy|0|||
160786682|NCT00281580|580604665|FG000|Overall Study|Lost to Follow-up|0|||
160786683|NCT00281580|580604666|FG001|Overall Study|Lost to Follow-up|0|||
160786684|NCT00281580|580604667|FG002|Overall Study|Lost to Follow-up|0|||
160786685|NCT00281580|580604668|FG003|Overall Study|Lost to Follow-up|3|||
160786686|NCT00281580|580604669|FG004|Overall Study|Lost to Follow-up|0|||
160786687|NCT00281580|580604670|FG005|Overall Study|Lost to Follow-up|1|||
160786688|NCT00281580|580604671|FG006|Overall Study|Lost to Follow-up|0|||
160786689|NCT00281580|580604672|FG007|Overall Study|Lost to Follow-up|1|||
160786690|NCT00281580|580604673|FG008|Overall Study|Lost to Follow-up|2|||
160786691|NCT00281580|580604674|FG009|Overall Study|Lost to Follow-up|1|||
160786692|NCT00281580|580604675|FG010|Overall Study|Lost to Follow-up|1|||
160786693|NCT00281580|580604676|FG011|Overall Study|Lost to Follow-up|0|||
160786694|NCT00281580|580604677|FG012|Overall Study|Lost to Follow-up|1|||
160786695|NCT00281580|580604678|FG013|Overall Study|Lost to Follow-up|0|||
160786696|NCT00281580|580604679|FG014|Overall Study|Lost to Follow-up|0|||
160786697|NCT00281580|580604680|FG015|Overall Study|Lost to Follow-up|0|||
160786698|NCT00281580|580604665|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
160786699|NCT00281580|580604666|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
160786700|NCT00281580|580604667|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
160786701|NCT00281580|580604668|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
160786702|NCT00281580|580604669|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
160786703|NCT00281580|580604670|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
160786704|NCT00281580|580604671|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
160786705|NCT00281580|580604672|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
160786706|NCT00281580|580604673|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
160786707|NCT00281580|580604674|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
160786708|NCT00281580|580604675|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
160786709|NCT00281580|580604676|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
160786710|NCT00281580|580604677|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
160786711|NCT00281580|580604678|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
160786712|NCT00281580|580604679|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
160786713|NCT00281580|580604680|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
160786714|NCT02067156|580604685|FG000|Overall Study|Lost to Follow-up|4|||
160786715|NCT03596983|580604686|FG000|Overall Study|Withdrawal by Subject|3|||
160786716|NCT03071965|580604687|FG000|Overall Study|Adverse Event|0|||
160786717|NCT03071965|580604688|FG001|Overall Study|Adverse Event|0|||
160786718|NCT03071965|580604689|FG002|Overall Study|Adverse Event|1|||
160640525|NCT00435825|580066762|FG001|Overall Study|Insufficient Therapeutic Response|1|||
160640526|NCT00435825|580066763|FG002|Overall Study|Insufficient Therapeutic Response|0|||
160640527|NCT00435825|580066764|FG003|Overall Study|Insufficient Therapeutic Response|3|||
160640528|NCT00435825|580066761|FG000|Overall Study|Other Protocol Violation|1|||
160640529|NCT00435825|580066762|FG001|Overall Study|Other Protocol Violation|0|||
160640530|NCT00435825|580066763|FG002|Overall Study|Other Protocol Violation|0|||
160640531|NCT00435825|580066764|FG003|Overall Study|Other Protocol Violation|0|||
160640532|NCT00435825|580066761|FG000|Overall Study|Refused treatment|2|||
160640533|NCT00435825|580066762|FG001|Overall Study|Refused treatment|0|||
160640534|NCT00435825|580066763|FG002|Overall Study|Refused treatment|0|||
160640535|NCT00435825|580066764|FG003|Overall Study|Refused treatment|5|||
160640536|NCT00435825|580066761|FG000|Overall Study|Failure to return|5|||
160640537|NCT00435825|580066762|FG001|Overall Study|Failure to return|0|||
160640538|NCT00435825|580066763|FG002|Overall Study|Failure to return|4|||
160640539|NCT00435825|580066764|FG003|Overall Study|Failure to return|0|||
160640540|NCT00435825|580066761|FG000|Overall Study|Did not receive study drug|1|||
160640541|NCT00435825|580066762|FG001|Overall Study|Did not receive study drug|0|||
160640542|NCT00435825|580066763|FG002|Overall Study|Did not receive study drug|2|||
160640543|NCT00435825|580066764|FG003|Overall Study|Did not receive study drug|0|||
160640544|NCT00435825|580066761|FG000|Overall Study|Did not enter follow-up|0|||
160786719|NCT03071965|580604690|FG003|Overall Study|Adverse Event|0|||
160640545|NCT00435825|580066762|FG001|Overall Study|Did not enter follow-up|4|||
160786720|NCT03071965|580604687|FG000|Overall Study|Death|0|||
160640546|NCT00435825|580066763|FG002|Overall Study|Did not enter follow-up|1|||
160640547|NCT00435825|580066764|FG003|Overall Study|Did not enter follow-up|3|||
160640548|NCT00435825|580066761|FG000|Overall Study|Did not complete full follow-up period|6|||
160640549|NCT00435825|580066762|FG001|Overall Study|Did not complete full follow-up period|6|||
160640550|NCT00435825|580066763|FG002|Overall Study|Did not complete full follow-up period|4|||
160786721|NCT03071965|580604688|FG001|Overall Study|Death|0|||
160786722|NCT03071965|580604689|FG002|Overall Study|Death|1|||
160786723|NCT03071965|580604690|FG003|Overall Study|Death|1|||
160786724|NCT03071965|580604687|FG000|Overall Study|COVID-19|0|||
160640551|NCT00435825|580066764|FG003|Overall Study|Did not complete full follow-up period|5|||
160786725|NCT03071965|580604688|FG001|Overall Study|COVID-19|1|||
160786726|NCT03071965|580604689|FG002|Overall Study|COVID-19|0|||
160786727|NCT03071965|580604690|FG003|Overall Study|COVID-19|1|||
160786728|NCT03071965|580604687|FG000|Overall Study|Other Health Reason|0|||
160786729|NCT03071965|580604688|FG001|Overall Study|Other Health Reason|0|||
160786730|NCT03071965|580604689|FG002|Overall Study|Other Health Reason|0|||
160786731|NCT03071965|580604690|FG003|Overall Study|Other Health Reason|1|||
160786732|NCT01853280|580604691|FG000|Overall Study|Lack of Efficacy|2|||
160786733|NCT01853280|580604692|FG001|Overall Study|Lack of Efficacy|2|||
160786734|NCT01853280|580604691|FG000|Overall Study|Lost to Follow-up|0|||
160786735|NCT01853280|580604692|FG001|Overall Study|Lost to Follow-up|1|||
160786736|NCT01853280|580604691|FG000|Overall Study|Physician Decision|0|||
160786737|NCT01853280|580604692|FG001|Overall Study|Physician Decision|1|||
160786738|NCT01853280|580604691|FG000|Overall Study|Withdrawal by Subject|0|||
160786739|NCT01853280|580604692|FG001|Overall Study|Withdrawal by Subject|1|||
160786740|NCT01853280|580604691|FG000|Overall Study|Ineligible|0|||
160786741|NCT01853280|580604692|FG001|Overall Study|Ineligible|1|||
160786742|NCT00104884|580604693|FG000|Overall Study|Disease progression|4|||
160786743|NCT03654326|580604694|FG000|Overall Study|Withdrawal by Subject|5|||
160786744|NCT03654326|580604695|FG001|Overall Study|Withdrawal by Subject|3|||
160786745|NCT03654326|580604694|FG000|Overall Study|Physician Decision|0|||
160786746|NCT03654326|580604695|FG001|Overall Study|Physician Decision|1|||
160786747|NCT03654326|580604694|FG000|Overall Study|Unable to adhere to study schedule|0|||
160786748|NCT03654326|580604695|FG001|Overall Study|Unable to adhere to study schedule|1|||
160786749|NCT03654326|580604694|FG000|Overall Study|Lost to Follow-up|1|||
160786750|NCT03654326|580604695|FG001|Overall Study|Lost to Follow-up|1|||
160786751|NCT03473301|580604696|FG000|Overall Study|Protocol Violation|4|||
160786752|NCT03473301|580604697|FG001|Overall Study|Protocol Violation|0|||
160786753|NCT03473301|580604698|FG002|Overall Study|Protocol Violation|0|||
160786754|NCT03473301|580604696|FG000|Overall Study|Withdrawal by Subject|0|||
160786755|NCT03473301|580604697|FG001|Overall Study|Withdrawal by Subject|1|||
160786756|NCT03473301|580604698|FG002|Overall Study|Withdrawal by Subject|0|||
160786757|NCT03473301|580604696|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
160786758|NCT03473301|580604697|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
160786759|NCT03473301|580604698|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
160786760|NCT05287685|580604699|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
160786761|NCT05287685|580604700|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
160786762|NCT05287685|580604699|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
160786763|NCT05287685|580604700|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
160786764|NCT04829214|580604701|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
160786765|NCT04829214|580604702|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
160786766|NCT04829214|580604701|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
160786767|NCT04829214|580604702|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
160786768|NCT06399471|580604703|FG000|Overall Study|Withdrawal by Subject|1|||
160786769|NCT05529173|580604704|FG000|Overall Study|Physician Decision|3|||
160786770|NCT05529173|580604705|FG001|Overall Study|Physician Decision|6|||
160786771|NCT05529173|580604704|FG000|Overall Study|Sample shipment delay more than one day|4|||
160786772|NCT05529173|580604705|FG001|Overall Study|Sample shipment delay more than one day|0|||
160786773|NCT00835042|580604708|FG000|First Intervention|Withdrawal by Subject|3|||
160786774|NCT00835042|580604709|FG001|First Intervention|Withdrawal by Subject|0|||
160786775|NCT00835042|580604708|FG000|First Intervention|Adverse Event|1|||
160786776|NCT00835042|580604709|FG001|First Intervention|Adverse Event|2|||
160786777|NCT00835042|580604708|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
160786778|NCT00835042|580604709|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
160786779|NCT03760081|580604710|FG000|Overall Study|Miscellaneous|0|||
160786780|NCT03760081|580604711|FG001|Overall Study|Miscellaneous|1|||
160786781|NCT03760081|580604710|FG000|Overall Study|Progressive Disease|5|||
160786782|NCT03760081|580604711|FG001|Overall Study|Progressive Disease|10|||
160640552|NCT03033069|580066765|FG000|Overall Study|Adverse Event|6|||
160640553|NCT03033069|580066766|FG001|Overall Study|Adverse Event|7|||
160640554|NCT03033069|580066767|FG002|Overall Study|Adverse Event|4|||
160786783|NCT03760081|580604710|FG000|Overall Study|Death|1|||
160786784|NCT03760081|580604711|FG001|Overall Study|Death|1|||
160786785|NCT04034056|580604712|FG000|Overall Study|Withdrawal by Subject|2|||
160786786|NCT04034056|580604712|FG000|Overall Study|Reason Not Specified|13|||
160786787|NCT04034056|580604712|FG000|Overall Study|Adverse Event|56|||
160786788|NCT01362270|580604715|FG000|Overall Study|Withdrawal by Subject|1|||
160981868|NCT02061761|581321785|FG003|Overall Study|Maximum clinical benefit|1|||
160786789|NCT01362270|580604716|FG001|Overall Study|Withdrawal by Subject|0|||
160786790|NCT01362270|580604715|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
160786791|NCT01362270|580604716|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
160786792|NCT01362270|580604715|FG000|Overall Study|Met excl. criteria before 1st session|1|||
160786793|NCT01362270|580604716|FG001|Overall Study|Met excl. criteria before 1st session|1|||
160786794|NCT02571244|580604719|FG000|Overall Study|Lost to Follow-up|0|||
160786795|NCT02571244|580604720|FG001|Overall Study|Lost to Follow-up|1|||
160786796|NCT02571244|580604719|FG000|Overall Study|Unable to reach out post discharge|3|||
160786797|NCT02571244|580604720|FG001|Overall Study|Unable to reach out post discharge|0|||
160786798|NCT01696214|580604721|FG000|Overall Study|Lost to Follow-up|1|||
160786799|NCT01696214|580604722|FG001|Overall Study|Lost to Follow-up|0|||
160786800|NCT01696214|580604723|FG002|Overall Study|Lost to Follow-up|0|||
160786801|NCT01696214|580604724|FG003|Overall Study|Lost to Follow-up|0|||
160786802|NCT02134028|580604725|FG000|Overall Study|Lack of Efficacy|1|||
160786803|NCT02134028|580604726|FG001|Overall Study|Lack of Efficacy|0|||
160786804|NCT02134028|580604727|FG002|Overall Study|Lack of Efficacy|3|||
160786805|NCT02134028|580604728|FG003|Overall Study|Lack of Efficacy|2|||
160786806|NCT02134028|580604729|FG004|Overall Study|Lack of Efficacy|1|||
160786807|NCT02134028|580604730|FG005|Overall Study|Lack of Efficacy|2|||
160786808|NCT02134028|580604731|FG006|Overall Study|Lack of Efficacy|1|||
160786809|NCT02134028|580604732|FG007|Overall Study|Lack of Efficacy|0|||
160786810|NCT02134028|580604725|FG000|Overall Study|Poor compliance to protocol|1|||
160786811|NCT02134028|580604726|FG001|Overall Study|Poor compliance to protocol|1|||
160786812|NCT02134028|580604727|FG002|Overall Study|Poor compliance to protocol|3|||
160786813|NCT02134028|580604728|FG003|Overall Study|Poor compliance to protocol|7|||
160786814|NCT02134028|580604729|FG004|Overall Study|Poor compliance to protocol|1|||
160786815|NCT02134028|580604730|FG005|Overall Study|Poor compliance to protocol|1|||
160786816|NCT02134028|580604731|FG006|Overall Study|Poor compliance to protocol|0|||
160786817|NCT02134028|580604732|FG007|Overall Study|Poor compliance to protocol|0|||
160786818|NCT02134028|580604725|FG000|Overall Study|Other unspecified|4|||
160786819|NCT02134028|580604726|FG001|Overall Study|Other unspecified|22|||
160786820|NCT02134028|580604727|FG002|Overall Study|Other unspecified|33|||
160786821|NCT02134028|580604728|FG003|Overall Study|Other unspecified|64|||
160786822|NCT02134028|580604729|FG004|Overall Study|Other unspecified|8|||
160786823|NCT02134028|580604730|FG005|Overall Study|Other unspecified|6|||
160786824|NCT02134028|580604731|FG006|Overall Study|Other unspecified|2|||
160786825|NCT02134028|580604732|FG007|Overall Study|Other unspecified|1|||
160786826|NCT02134028|580604725|FG000|Overall Study|Adverse Event|3|||
160786827|NCT02134028|580604726|FG001|Overall Study|Adverse Event|19|||
160786828|NCT02134028|580604727|FG002|Overall Study|Adverse Event|13|||
160786829|NCT02134028|580604728|FG003|Overall Study|Adverse Event|32|||
160786830|NCT02134028|580604729|FG004|Overall Study|Adverse Event|4|||
160786831|NCT02134028|580604730|FG005|Overall Study|Adverse Event|5|||
160786832|NCT02134028|580604731|FG006|Overall Study|Adverse Event|1|||
160786833|NCT02134028|580604732|FG007|Overall Study|Adverse Event|2|||
160786834|NCT01370538|580604739|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
160786835|NCT01370538|580604740|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
160786836|NCT01370538|580604739|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160786837|NCT01370538|580604740|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160786838|NCT01370538|580604739|FG000|Overall Study|Adverse Event|1|||
160786839|NCT01370538|580604740|FG001|Overall Study|Adverse Event|0|||
160786840|NCT01370538|580604739|FG000|Overall Study|Protocol Violation|8|||
160786841|NCT01370538|580604740|FG001|Overall Study|Protocol Violation|5|||
160786842|NCT01370538|580604739|FG000|Overall Study|Development of study specific withdrawal|1|||
160786843|NCT01370538|580604740|FG001|Overall Study|Development of study specific withdrawal|1|||
160786844|NCT01370538|580604739|FG000|Overall Study|Lost to follow up|6|||
160786845|NCT01370538|580604740|FG001|Overall Study|Lost to follow up|10|||
160786846|NCT00309244|580604741|FG000|Overall Study|Adverse Event|29|||
160786847|NCT00309244|580604742|FG001|Overall Study|Adverse Event|12|||
160786848|NCT00309244|580604741|FG000|Overall Study|Lost to Follow-up|6|||
160786849|NCT00309244|580604742|FG001|Overall Study|Lost to Follow-up|22|||
160786850|NCT00309244|580604741|FG000|Overall Study|Physician Decision|5|||
160786851|NCT00309244|580604742|FG001|Overall Study|Physician Decision|8|||
160786852|NCT00309244|580604741|FG000|Overall Study|Protocol Violation|6|||
160786853|NCT00309244|580604742|FG001|Overall Study|Protocol Violation|3|||
160786854|NCT00309244|580604741|FG000|Overall Study|Withdrawal by Subject|50|||
160786855|NCT00309244|580604742|FG001|Overall Study|Withdrawal by Subject|32|||
160786856|NCT00309244|580604741|FG000|Overall Study|Various|7|||
160786857|NCT00309244|580604742|FG001|Overall Study|Various|7|||
160786858|NCT00309244|580604741|FG000|Overall Study|Randomized but not dosed|11|||
160786859|NCT00309244|580604742|FG001|Overall Study|Randomized but not dosed|12|||
160786860|NCT00309244|580604741|FG000|Overall Study|Death|4|||
160786861|NCT00309244|580604742|FG001|Overall Study|Death|1|||
160786862|NCT03438656|580604743|FG000|Overall Study|Lost to Follow-up|2|||
160786863|NCT03335566|580604744|FG000|Overall Study|Adverse Event|0|||
160786864|NCT03335566|580604745|FG001|Overall Study|Adverse Event|1|||
160786865|NCT03335566|580604744|FG000|Overall Study|Lost to Follow-up|1|||
160786866|NCT03335566|580604745|FG001|Overall Study|Lost to Follow-up|0|||
160786867|NCT03335566|580604744|FG000|Overall Study|Technical Problems|1|||
160786868|NCT03335566|580604745|FG001|Overall Study|Technical Problems|0|||
160786869|NCT03335566|580604744|FG000|Overall Study|Protocol Violation|1|||
160786870|NCT03335566|580604745|FG001|Overall Study|Protocol Violation|0|||
160786871|NCT03335566|580604744|FG000|Overall Study|Other than specified above|1|||
160786872|NCT03335566|580604745|FG001|Overall Study|Other than specified above|2|||
160786873|NCT04223687|580604746|FG000|Overall Study|Missing primary outcome|1|||
160786874|NCT04223687|580604747|FG001|Overall Study|Missing primary outcome|0|||
160786875|NCT02945046|580604749|FG000|Overall Study|Adverse Event|1|||
160786876|NCT02945046|580604750|FG001|Overall Study|Adverse Event|0|||
160786877|NCT02945046|580604751|FG002|Overall Study|Adverse Event|2|||
160786878|NCT02945046|580604749|FG000|Overall Study|Withdrawal by Subject|3|||
160786879|NCT02945046|580604750|FG001|Overall Study|Withdrawal by Subject|3|||
160786880|NCT02945046|580604751|FG002|Overall Study|Withdrawal by Subject|3|||
160786881|NCT02945046|580604749|FG000|Overall Study|Protocol Violation|2|||
160786882|NCT02945046|580604750|FG001|Overall Study|Protocol Violation|3|||
160786883|NCT02945046|580604751|FG002|Overall Study|Protocol Violation|2|||
160786884|NCT02945046|580604749|FG000|Overall Study|Lost to Follow-up|1|||
160786885|NCT02945046|580604750|FG001|Overall Study|Lost to Follow-up|1|||
160786886|NCT02945046|580604751|FG002|Overall Study|Lost to Follow-up|0|||
160786887|NCT02945046|580604749|FG000|Overall Study|Lack of Efficacy|1|||
160786888|NCT02945046|580604750|FG001|Overall Study|Lack of Efficacy|2|||
160786889|NCT02945046|580604751|FG002|Overall Study|Lack of Efficacy|1|||
160786890|NCT02945046|580604749|FG000|Overall Study|Other than specified|5|||
160786891|NCT02945046|580604750|FG001|Overall Study|Other than specified|4|||
160786892|NCT02945046|580604751|FG002|Overall Study|Other than specified|7|||
160786893|NCT00545948|580604753|FG000|Overall Study|Not Treated|1|||
160786894|NCT00545948|580604754|FG001|Overall Study|Not Treated|1|||
160786895|NCT00545948|580604755|FG002|Overall Study|Not Treated|7|||
160786896|NCT01251965|580607168|FG000|Overall Study|Participant/physician decision|1|||
160786897|NCT01251965|580607169|FG001|Overall Study|Participant/physician decision|2|||
160786898|NCT01251965|580607170|FG002|Overall Study|Participant/physician decision|0|||
160786899|NCT01251965|580607168|FG000|Overall Study|Death|0|||
160786900|NCT01251965|580607169|FG001|Overall Study|Death|0|||
160786901|NCT01251965|580607170|FG002|Overall Study|Death|11|||
160786902|NCT01027754|580607171|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
160786903|NCT01027754|580607172|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
160786904|NCT01027754|580607171|FG000|Overall Study|Withdrawal by Subject|0|||
160786905|NCT01027754|580607172|FG001|Overall Study|Withdrawal by Subject|5|||
160786906|NCT02529488|580607173|FG000|Overall Study|Adverse Event|1|||
160786907|NCT02529488|580607173|FG000|Overall Study|Death|3|||
160786908|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
160786909|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
160786910|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
160786911|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
160640555|NCT03033069|580066768|FG003|Overall Study|Adverse Event|6|||
160640556|NCT03033069|580066765|FG000|Overall Study|Lack of Efficacy|0|||
160640557|NCT03033069|580066766|FG001|Overall Study|Lack of Efficacy|0|||
160640558|NCT03033069|580066767|FG002|Overall Study|Lack of Efficacy|1|||
160640559|NCT03033069|580066768|FG003|Overall Study|Lack of Efficacy|0|||
160640560|NCT03033069|580066765|FG000|Overall Study|Lost to Follow-up|6|||
160640561|NCT03033069|580066766|FG001|Overall Study|Lost to Follow-up|5|||
160640562|NCT03033069|580066767|FG002|Overall Study|Lost to Follow-up|5|||
160640563|NCT03033069|580066768|FG003|Overall Study|Lost to Follow-up|6|||
160786912|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
160786913|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
160786914|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
160640564|NCT03033069|580066765|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160640565|NCT03033069|580066766|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160640566|NCT03033069|580066767|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160786915|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
160786916|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
160786917|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
160786918|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
160786919|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
160786920|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
160786921|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
160786922|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
160786923|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786924|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786925|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786926|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786927|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786928|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786929|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
160786930|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
160786931|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
160786932|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
160786933|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
160786934|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
160786935|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
160786936|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786937|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
160786938|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786939|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786940|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786941|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786942|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786943|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
160786944|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
160786945|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
160786946|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
160786947|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
160786948|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
160786949|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
160786950|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
160786951|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
160786952|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
160786953|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
160786954|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
160786955|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
160640567|NCT03033069|580066768|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160640568|NCT03033069|580066765|FG000|Overall Study|Protocol Deviation|0|||
160640569|NCT03033069|580066766|FG001|Overall Study|Protocol Deviation|1|||
160640570|NCT03033069|580066767|FG002|Overall Study|Protocol Deviation|0|||
160640571|NCT03033069|580066768|FG003|Overall Study|Protocol Deviation|0|||
160640572|NCT03033069|580066765|FG000|Overall Study|Withdrawal by Subject|10|||
160640573|NCT03033069|580066766|FG001|Overall Study|Withdrawal by Subject|10|||
160543571|NCT01049035|579718239|FG005|Overall Study|Non-compliance with the protocol|4|||
160543572|NCT01049035|579718240|FG006|Overall Study|Non-compliance with the protocol|10|||
160543573|NCT01049035|579718234|FG000|Overall Study|Lost to Follow-up|5|||
160543574|NCT01049035|579718235|FG001|Overall Study|Lost to Follow-up|4|||
160543575|NCT01049035|579718236|FG002|Overall Study|Lost to Follow-up|4|||
160543576|NCT01049035|579718237|FG003|Overall Study|Lost to Follow-up|1|||
160543577|NCT01049035|579718238|FG004|Overall Study|Lost to Follow-up|0|||
160543578|NCT01049035|579718239|FG005|Overall Study|Lost to Follow-up|3|||
160543579|NCT01049035|579718240|FG006|Overall Study|Lost to Follow-up|3|||
160543580|NCT01049035|579718234|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
160543581|NCT01049035|579718235|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
160543582|NCT01049035|579718236|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
160543583|NCT01049035|579718237|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
160543584|NCT01049035|579718238|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
160543585|NCT01049035|579718239|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
160786956|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
160786957|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
160786958|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
160786959|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
160786960|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
160786961|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
160543586|NCT01049035|579718240|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
160543587|NCT01137773|579718241|FG000|Overall Study|Death|3|||
160543588|NCT01137773|579718242|FG001|Overall Study|Death|3|||
160543589|NCT01137773|579718241|FG000|Overall Study|Lost to Follow-up|6|||
160543590|NCT01137773|579718242|FG001|Overall Study|Lost to Follow-up|0|||
160543591|NCT03548051|579718243|FG000|Overall Study|Death|1|||
160543592|NCT03548051|579718244|FG001|Overall Study|Death|1|||
160543593|NCT03548051|579718243|FG000|Overall Study|Withdrawal by Subject|1|||
160543594|NCT03548051|579718244|FG001|Overall Study|Withdrawal by Subject|0|||
160786962|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
160786963|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
160543595|NCT00082888|579718245|FG000|Overall Study|Ineligible|1|||
160543596|NCT00082888|579718246|FG001|Overall Study|Ineligible|0|||
160543597|NCT00082888|579718247|FG002|Overall Study|Ineligible|0|||
160543598|NCT00883337|579718248|FG000|Core Treatment Period|Adverse Event|9|||
160543599|NCT00883337|579718249|FG001|Core Treatment Period|Adverse Event|12|||
160543600|NCT00883337|579718250|FG002|Core Treatment Period|Adverse Event|22|||
160543601|NCT00883337|579718248|FG000|Core Treatment Period|Lack of Efficacy|7|||
160543602|NCT00883337|579718249|FG001|Core Treatment Period|Lack of Efficacy|4|||
160543603|NCT00883337|579718250|FG002|Core Treatment Period|Lack of Efficacy|2|||
160543604|NCT00883337|579718248|FG000|Core Treatment Period|Lost to Follow-up|1|||
160543605|NCT00883337|579718249|FG001|Core Treatment Period|Lost to Follow-up|1|||
160543606|NCT00883337|579718250|FG002|Core Treatment Period|Lost to Follow-up|0|||
160543607|NCT00883337|579718248|FG000|Core Treatment Period|Withdrawal by Subject|2|||
160543608|NCT00883337|579718249|FG001|Core Treatment Period|Withdrawal by Subject|2|||
160543609|NCT00883337|579718250|FG002|Core Treatment Period|Withdrawal by Subject|6|||
160543610|NCT00883337|579718248|FG000|Core Treatment Period|Wish to be pregnant|1|||
160543611|NCT00883337|579718249|FG001|Core Treatment Period|Wish to be pregnant|2|||
160543612|NCT00883337|579718250|FG002|Core Treatment Period|Wish to be pregnant|1|||
160543613|NCT00883337|579718248|FG000|Core Treatment Period|Poor compliance to protocol|0|||
160543614|NCT00883337|579718249|FG001|Core Treatment Period|Poor compliance to protocol|0|||
160543615|NCT00883337|579718250|FG002|Core Treatment Period|Poor compliance to protocol|1|||
160543616|NCT00883337|579718248|FG000|Core Treatment Period|Other than above|0|||
160543617|NCT00883337|579718249|FG001|Core Treatment Period|Other than above|1|||
160786964|NCT01557244|580607177|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
160786965|NCT01557244|580607178|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
160786966|NCT01557244|580607179|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
160786967|NCT01557244|580607180|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
160786968|NCT01557244|580607181|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
160786969|NCT01557244|580607182|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
160786970|NCT01557244|580607183|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
160786971|NCT01557244|580607177|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
160786972|NCT01557244|580607178|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
160786973|NCT01557244|580607179|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
160786974|NCT01557244|580607180|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
160543618|NCT00883337|579718250|FG002|Core Treatment Period|Other than above|1|||
160543619|NCT00883337|579718248|FG000|Extension Treatment Period|Adverse Event|8|||
160543620|NCT00883337|579718249|FG001|Extension Treatment Period|Adverse Event|5|||
160543621|NCT00883337|579718250|FG002|Extension Treatment Period|Adverse Event|5|||
160543622|NCT00883337|579718248|FG000|Extension Treatment Period|Lack of Efficacy|8|||
160543623|NCT00883337|579718249|FG001|Extension Treatment Period|Lack of Efficacy|8|||
160786975|NCT01557244|580607181|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
160543624|NCT00883337|579718250|FG002|Extension Treatment Period|Lack of Efficacy|8|||
160543625|NCT00883337|579718248|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
160543626|NCT00883337|579718249|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
160543627|NCT00883337|579718250|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
160543628|NCT00883337|579718248|FG000|Extension Treatment Period|Lost to Follow-up|1|||
160543629|NCT00883337|579718249|FG001|Extension Treatment Period|Lost to Follow-up|0|||
160543630|NCT00883337|579718250|FG002|Extension Treatment Period|Lost to Follow-up|0|||
160543631|NCT00883337|579718248|FG000|Extension Treatment Period|Other than above|10|||
160543632|NCT00883337|579718249|FG001|Extension Treatment Period|Other than above|9|||
160543633|NCT00883337|579718250|FG002|Extension Treatment Period|Other than above|5|||
160543634|NCT02669017|579718251|FG000|Overall Study|Death|1|||
160543635|NCT02669017|579718252|FG001|Overall Study|Death|2|||
160543636|NCT02669017|579718253|FG002|Overall Study|Death|2|||
160543637|NCT02669017|579718254|FG003|Overall Study|Death|3|||
160543638|NCT02669017|579718255|FG004|Overall Study|Death|8|||
160543639|NCT02669017|579718256|FG005|Overall Study|Death|18|||
160543640|NCT02669017|579718257|FG006|Overall Study|Death|10|||
160543641|NCT02669017|579718258|FG007|Overall Study|Death|47|||
160543642|NCT02669017|579718259|FG008|Overall Study|Death|20|||
160543643|NCT02669017|579718251|FG000|Overall Study|Withdrawal by Subject|0|||
160543644|NCT02669017|579718252|FG001|Overall Study|Withdrawal by Subject|0|||
160543645|NCT02669017|579718253|FG002|Overall Study|Withdrawal by Subject|0|||
160543646|NCT02669017|579718254|FG003|Overall Study|Withdrawal by Subject|1|||
160543647|NCT02669017|579718255|FG004|Overall Study|Withdrawal by Subject|2|||
160543648|NCT02669017|579718256|FG005|Overall Study|Withdrawal by Subject|0|||
160786976|NCT01557244|580607182|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
160786977|NCT01557244|580607183|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
160786978|NCT01557244|580607177|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160786979|NCT01557244|580607178|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160786980|NCT01557244|580607179|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160786981|NCT01557244|580607180|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
160786982|NCT01557244|580607181|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160543649|NCT02669017|579718257|FG006|Overall Study|Withdrawal by Subject|0|||
160543650|NCT02669017|579718258|FG007|Overall Study|Withdrawal by Subject|2|||
160543651|NCT02669017|579718259|FG008|Overall Study|Withdrawal by Subject|2|||
160543652|NCT02669017|579718251|FG000|Overall Study|Lost to Follow-up|0|||
160543653|NCT02669017|579718252|FG001|Overall Study|Lost to Follow-up|0|||
160543654|NCT02669017|579718253|FG002|Overall Study|Lost to Follow-up|0|||
160543655|NCT02669017|579718254|FG003|Overall Study|Lost to Follow-up|0|||
160543656|NCT02669017|579718255|FG004|Overall Study|Lost to Follow-up|0|||
160543657|NCT02669017|579718256|FG005|Overall Study|Lost to Follow-up|0|||
160543658|NCT02669017|579718257|FG006|Overall Study|Lost to Follow-up|0|||
160543659|NCT02669017|579718258|FG007|Overall Study|Lost to Follow-up|0|||
160543660|NCT02669017|579718259|FG008|Overall Study|Lost to Follow-up|1|||
160543661|NCT02669017|579718251|FG000|Overall Study|Miscellaneous|0|||
160543662|NCT02669017|579718252|FG001|Overall Study|Miscellaneous|0|||
160543663|NCT02669017|579718253|FG002|Overall Study|Miscellaneous|0|||
160543664|NCT02669017|579718254|FG003|Overall Study|Miscellaneous|0|||
160543665|NCT02669017|579718255|FG004|Overall Study|Miscellaneous|2|||
160543666|NCT02669017|579718256|FG005|Overall Study|Miscellaneous|1|||
160543667|NCT02669017|579718257|FG006|Overall Study|Miscellaneous|1|||
160543668|NCT02669017|579718258|FG007|Overall Study|Miscellaneous|13|||
160543669|NCT02669017|579718259|FG008|Overall Study|Miscellaneous|2|||
160543670|NCT02559687|579718260|FG000|Overall Study|Death|112|||
160543671|NCT02559687|579718260|FG000|Overall Study|Sponsor Decision|5|||
160543672|NCT02559687|579718260|FG000|Overall Study|Withdrawal by Subject|4|||
160543673|NCT03245450|579718262|FG000|Overall Study|Radiological disease progression|3|||
160543674|NCT03245450|579718263|FG001|Overall Study|Radiological disease progression|3|||
160543675|NCT03245450|579718264|FG002|Overall Study|Radiological disease progression|2|||
160543676|NCT03245450|579718265|FG003|Overall Study|Radiological disease progression|2|||
160543677|NCT03245450|579718266|FG004|Overall Study|Radiological disease progression|7|||
160543678|NCT03245450|579718267|FG005|Overall Study|Radiological disease progression|6|||
160543679|NCT03245450|579718268|FG006|Overall Study|Radiological disease progression|6|||
160543680|NCT03245450|579718262|FG000|Overall Study|Clinical disease progression|0|||
160543681|NCT03245450|579718263|FG001|Overall Study|Clinical disease progression|0|||
160543682|NCT03245450|579718264|FG002|Overall Study|Clinical disease progression|1|||
160543683|NCT03245450|579718265|FG003|Overall Study|Clinical disease progression|0|||
160543684|NCT03245450|579718266|FG004|Overall Study|Clinical disease progression|0|||
160543685|NCT03245450|579718267|FG005|Overall Study|Clinical disease progression|2|||
160543686|NCT03245450|579718268|FG006|Overall Study|Clinical disease progression|0|||
160543687|NCT03245450|579718262|FG000|Overall Study|Other|0|||
160543688|NCT03245450|579718263|FG001|Overall Study|Other|0|||
160543689|NCT03245450|579718264|FG002|Overall Study|Other|0|||
160543690|NCT03245450|579718265|FG003|Overall Study|Other|1|||
160786983|NCT01557244|580607182|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160786984|NCT01557244|580607183|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160786985|NCT01557244|580607177|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
160786986|NCT01557244|580607178|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
160786987|NCT01557244|580607179|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
160786988|NCT01557244|580607180|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
160786989|NCT01557244|580607181|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
160786990|NCT01557244|580607182|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
160786991|NCT01557244|580607183|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
160786992|NCT01313676|580607184|FG000|Overall Study|Adverse Event|395|||
160786993|NCT01313676|580607185|FG001|Overall Study|Adverse Event|365|||
160786994|NCT01313676|580607186|FG002|Overall Study|Adverse Event|372|||
160786995|NCT01313676|580607187|FG003|Overall Study|Adverse Event|333|||
160786996|NCT01313676|580607184|FG000|Overall Study|Lack of Efficacy|98|||
160786997|NCT01313676|580607185|FG001|Overall Study|Lack of Efficacy|90|||
160786998|NCT01313676|580607186|FG002|Overall Study|Lack of Efficacy|65|||
160786999|NCT01313676|580607187|FG003|Overall Study|Lack of Efficacy|46|||
160787000|NCT01313676|580607184|FG000|Overall Study|Protocol Violation|37|||
160787001|NCT01313676|580607185|FG001|Overall Study|Protocol Violation|44|||
160787002|NCT01313676|580607186|FG002|Overall Study|Protocol Violation|46|||
160787003|NCT01313676|580607187|FG003|Overall Study|Protocol Violation|44|||
160787004|NCT01313676|580607184|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
160787005|NCT01313676|580607185|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
160787006|NCT01313676|580607186|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
160787007|NCT01313676|580607187|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
160640574|NCT03033069|580066767|FG002|Overall Study|Withdrawal by Subject|11|||
160640575|NCT03033069|580066768|FG003|Overall Study|Withdrawal by Subject|6|||
160640576|NCT03033069|580066765|FG000|Overall Study|Withdrawal By Caregiver|1|||
160640577|NCT03033069|580066766|FG001|Overall Study|Withdrawal By Caregiver|0|||
160640578|NCT03033069|580066767|FG002|Overall Study|Withdrawal By Caregiver|0|||
160640579|NCT03033069|580066768|FG003|Overall Study|Withdrawal By Caregiver|0|||
160640580|NCT03033069|580066765|FG000|Overall Study|Reason not Specified|0|||
160640581|NCT03033069|580066766|FG001|Overall Study|Reason not Specified|1|||
160640582|NCT03033069|580066767|FG002|Overall Study|Reason not Specified|0|||
160640583|NCT03033069|580066768|FG003|Overall Study|Reason not Specified|1|||
160640584|NCT02367781|580066771|FG000|Overall Study|Withdrawal by Subject|20|||
160640585|NCT02367781|580066772|FG001|Overall Study|Withdrawal by Subject|13|||
160640586|NCT02367781|580066771|FG000|Overall Study|Protocol Violation|0|||
160640587|NCT02367781|580066772|FG001|Overall Study|Protocol Violation|1|||
160640588|NCT02367781|580066771|FG000|Overall Study|Physician Decision|7|||
160640589|NCT02367781|580066772|FG001|Overall Study|Physician Decision|0|||
160640590|NCT02367781|580066771|FG000|Overall Study|Randomized in Error|5|||
160640591|NCT02367781|580066772|FG001|Overall Study|Randomized in Error|4|||
160640592|NCT02367781|580066771|FG000|Overall Study|Non-Compliance|1|||
160640593|NCT02367781|580066772|FG001|Overall Study|Non-Compliance|0|||
160640594|NCT02367781|580066771|FG000|Overall Study|Lost to Follow-up|1|||
160640595|NCT02367781|580066772|FG001|Overall Study|Lost to Follow-up|2|||
160640596|NCT02367781|580066771|FG000|Overall Study|Death|330|||
160640597|NCT02367781|580066772|FG001|Overall Study|Death|176|||
160640598|NCT02367781|580066771|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
160640599|NCT02367781|580066772|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
160640600|NCT02367781|580066771|FG000|Overall Study|Prolonged Hospitalization|1|||
160640601|NCT02367781|580066772|FG001|Overall Study|Prolonged Hospitalization|0|||
160640602|NCT02367781|580066771|FG000|Overall Study|Death Prior First Dose|1|||
160640603|NCT02367781|580066772|FG001|Overall Study|Death Prior First Dose|0|||
160640604|NCT02367781|580066771|FG000|Overall Study|Administrative-Change Facility|1|||
160640605|NCT02367781|580066772|FG001|Overall Study|Administrative-Change Facility|0|||
160640606|NCT02367781|580066771|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
160640607|NCT02367781|580066772|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
160787008|NCT01313676|580607184|FG000|Overall Study|Study Closed/terminated|7|||
160787009|NCT01313676|580607185|FG001|Overall Study|Study Closed/terminated|6|||
160787010|NCT01313676|580607186|FG002|Overall Study|Study Closed/terminated|9|||
160787011|NCT01313676|580607187|FG003|Overall Study|Study Closed/terminated|9|||
160787012|NCT01313676|580607184|FG000|Overall Study|Lost to Follow-up|0|||
160787013|NCT01313676|580607185|FG001|Overall Study|Lost to Follow-up|0|||
160640608|NCT02367781|580066771|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
160640609|NCT02367781|580066772|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
160640610|NCT02367781|580066771|FG000|Overall Study|Study Terminated by Sponsor|3|||
160640611|NCT02367781|580066772|FG001|Overall Study|Study Terminated by Sponsor|1|||
160640612|NCT02367781|580066771|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
160640613|NCT02367781|580066772|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
160640614|NCT02367781|580066771|FG000|Overall Study|Sponsor Decision|2|||
160543691|NCT03245450|579718266|FG004|Overall Study|Other|1|||
160543692|NCT03245450|579718267|FG005|Overall Study|Other|1|||
160543693|NCT03245450|579718268|FG006|Overall Study|Other|1|||
160543694|NCT03245450|579718262|FG000|Overall Study|Withdrawal by Subject|0|||
160543695|NCT03245450|579718263|FG001|Overall Study|Withdrawal by Subject|1|||
160543696|NCT03245450|579718264|FG002|Overall Study|Withdrawal by Subject|0|||
160543697|NCT03245450|579718265|FG003|Overall Study|Withdrawal by Subject|0|||
160543698|NCT03245450|579718266|FG004|Overall Study|Withdrawal by Subject|0|||
160543699|NCT03245450|579718267|FG005|Overall Study|Withdrawal by Subject|0|||
160543700|NCT03245450|579718268|FG006|Overall Study|Withdrawal by Subject|0|||
160543701|NCT03245450|579718262|FG000|Overall Study|Adverse Event|0|||
160543702|NCT03245450|579718263|FG001|Overall Study|Adverse Event|0|||
160543703|NCT03245450|579718264|FG002|Overall Study|Adverse Event|0|||
160543704|NCT03245450|579718265|FG003|Overall Study|Adverse Event|0|||
160543705|NCT03245450|579718266|FG004|Overall Study|Adverse Event|1|||
160543706|NCT03245450|579718267|FG005|Overall Study|Adverse Event|0|||
160543707|NCT03245450|579718268|FG006|Overall Study|Adverse Event|2|||
160543708|NCT02429414|579718269|FG000|Overall Study|Physician Decision|0|||
160543709|NCT02429414|579718270|FG001|Overall Study|Physician Decision|1|||
160543710|NCT01098071|579718280|FG000|Overall Study|Surgery (adenoidectomy)|2|||
160787014|NCT01313676|580607186|FG002|Overall Study|Lost to Follow-up|1|||
160787015|NCT01313676|580607187|FG003|Overall Study|Lost to Follow-up|0|||
160787016|NCT01313676|580607184|FG000|Overall Study|Physician Decision|53|||
160787017|NCT01313676|580607185|FG001|Overall Study|Physician Decision|64|||
160787018|NCT01313676|580607186|FG002|Overall Study|Physician Decision|62|||
160787019|NCT01313676|580607187|FG003|Overall Study|Physician Decision|48|||
160787020|NCT01313676|580607184|FG000|Overall Study|Decision by Participant or Proxy|643|||
160787021|NCT01313676|580607185|FG001|Overall Study|Decision by Participant or Proxy|527|||
160787022|NCT01313676|580607186|FG002|Overall Study|Decision by Participant or Proxy|515|||
160787023|NCT01313676|580607187|FG003|Overall Study|Decision by Participant or Proxy|492|||
160543711|NCT01098071|579718280|FG000|Overall Study|Lost to Follow-up|13|||
160543712|NCT01604265|579718284|FG000|Overall Study|Adverse Event|1|||
160543713|NCT01604265|579718285|FG001|Overall Study|Adverse Event|0|||
160543714|NCT01604265|579718284|FG000|Overall Study|Withdrawal by Subject|1|||
160543715|NCT01604265|579718285|FG001|Overall Study|Withdrawal by Subject|0|||
160543716|NCT01903837|579718288|FG000|Part A|Withdrawal by Subject|4|||
160543717|NCT01903837|579718289|FG001|Part A|Withdrawal by Subject|9|||
160543718|NCT01903837|579718290|FG002|Part A|Withdrawal by Subject|8|||
160543719|NCT01903837|579718291|FG003|Part A|Withdrawal by Subject|5|||
160543720|NCT01903837|579718288|FG000|Part A|Adverse Event|3|||
160543721|NCT01903837|579718289|FG001|Part A|Adverse Event|6|||
160543722|NCT01903837|579718290|FG002|Part A|Adverse Event|9|||
160543723|NCT01903837|579718291|FG003|Part A|Adverse Event|6|||
160543724|NCT01903837|579718288|FG000|Part A|Lost to Follow-up|9|||
160543725|NCT01903837|579718289|FG001|Part A|Lost to Follow-up|7|||
160543726|NCT01903837|579718290|FG002|Part A|Lost to Follow-up|7|||
160543727|NCT01903837|579718291|FG003|Part A|Lost to Follow-up|2|||
160543728|NCT01903837|579718288|FG000|Part A|Non-compliance with study drug|1|||
160543729|NCT01903837|579718289|FG001|Part A|Non-compliance with study drug|4|||
160543730|NCT01903837|579718290|FG002|Part A|Non-compliance with study drug|4|||
160543731|NCT01903837|579718291|FG003|Part A|Non-compliance with study drug|0|||
160543732|NCT01903837|579718288|FG000|Part A|Physician Decision|1|||
160543733|NCT01903837|579718289|FG001|Part A|Physician Decision|1|||
160640615|NCT02367781|580066772|FG001|Overall Study|Sponsor Decision|0|||
160543734|NCT01903837|579718290|FG002|Part A|Physician Decision|0|||
160543735|NCT01903837|579718291|FG003|Part A|Physician Decision|0|||
160543736|NCT01903837|579718288|FG000|Part A|Protocol Violation|1|||
160543737|NCT01903837|579718289|FG001|Part A|Protocol Violation|1|||
160543738|NCT01903837|579718290|FG002|Part A|Protocol Violation|0|||
160543739|NCT01903837|579718291|FG003|Part A|Protocol Violation|0|||
160543740|NCT01903837|579718288|FG000|Part B|Lost to Follow-up|0|||
160543741|NCT01903837|579718289|FG001|Part B|Lost to Follow-up|3|||
160543742|NCT01903837|579718290|FG002|Part B|Lost to Follow-up|3|||
160543743|NCT01903837|579718291|FG003|Part B|Lost to Follow-up|4|||
160543744|NCT01903837|579718288|FG000|Part B|Withdrawal by Subject|1|||
160543745|NCT01903837|579718289|FG001|Part B|Withdrawal by Subject|2|||
160640616|NCT02367781|580066771|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
160543746|NCT01903837|579718290|FG002|Part B|Withdrawal by Subject|0|||
160543747|NCT01903837|579718291|FG003|Part B|Withdrawal by Subject|3|||
160543748|NCT01903837|579718288|FG000|Part B|Adverse Event|3|||
160543749|NCT01903837|579718289|FG001|Part B|Adverse Event|0|||
160543750|NCT01903837|579718290|FG002|Part B|Adverse Event|2|||
160543751|NCT01903837|579718291|FG003|Part B|Adverse Event|0|||
160787024|NCT01313676|580607184|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
160543752|NCT01903837|579718288|FG000|Part B|Non-compliance with study drug|2|||
160543753|NCT01903837|579718289|FG001|Part B|Non-compliance with study drug|0|||
160543754|NCT01903837|579718290|FG002|Part B|Non-compliance with study drug|0|||
160543755|NCT01903837|579718291|FG003|Part B|Non-compliance with study drug|1|||
160543756|NCT01903837|579718288|FG000|Part B|Incarceration|2|||
160543757|NCT01903837|579718289|FG001|Part B|Incarceration|0|||
160787025|NCT01313676|580607185|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
160787026|NCT01313676|580607186|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
160787027|NCT01313676|580607187|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
160787028|NCT01313676|580607184|FG000|Overall Study|Investigator Site Closed|12|||
160787029|NCT01313676|580607185|FG001|Overall Study|Investigator Site Closed|11|||
160787030|NCT01313676|580607186|FG002|Overall Study|Investigator Site Closed|15|||
160787031|NCT01313676|580607187|FG003|Overall Study|Investigator Site Closed|10|||
160787032|NCT01313676|580607184|FG000|Overall Study|Missing|1|||
160787033|NCT01313676|580607185|FG001|Overall Study|Missing|1|||
160787034|NCT01313676|580607186|FG002|Overall Study|Missing|1|||
160787035|NCT01313676|580607187|FG003|Overall Study|Missing|0|||
160787036|NCT01902303|580607188|FG000|Overall Study|Adverse Event|0|||
160787037|NCT01902303|580607189|FG001|Overall Study|Adverse Event|1|||
160787038|NCT01902303|580607188|FG000|Overall Study|Lost to Follow-up|0|||
160787039|NCT01902303|580607189|FG001|Overall Study|Lost to Follow-up|1|||
160787040|NCT01902303|580607188|FG000|Overall Study|Protocol Violation|2|||
160787041|NCT01902303|580607189|FG001|Overall Study|Protocol Violation|2|||
160787042|NCT01902303|580607188|FG000|Overall Study|subject lost investigational product|0|||
160787043|NCT01902303|580607189|FG001|Overall Study|subject lost investigational product|1|||
160787044|NCT01902303|580607188|FG000|Overall Study|Did not develop a cold sore|21|||
160787045|NCT01902303|580607189|FG001|Overall Study|Did not develop a cold sore|19|||
160787046|NCT05058456|580607190|FG000|Overall Study|Death|1|||
160787047|NCT05058456|580607190|FG000|Overall Study|End of Study data not yet due for release|34|||
160787048|NCT02802865|580607191|FG000|Overall Study|Pregnancy|1|||
160640617|NCT02367781|580066772|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
160640618|NCT05166421|580066773|FG000|Overall Study|Other|3|||
160640619|NCT05166421|580066774|FG001|Overall Study|Other|1|||
160640620|NCT05166421|580066775|FG002|Overall Study|Other|1|||
160640621|NCT05166421|580066773|FG000|Overall Study|Withdrawal by Subject|5|||
160640622|NCT05166421|580066774|FG001|Overall Study|Withdrawal by Subject|3|||
160640623|NCT05166421|580066775|FG002|Overall Study|Withdrawal by Subject|6|||
160640624|NCT05166421|580066773|FG000|Overall Study|Lost to Follow-up|4|||
160640625|NCT05166421|580066774|FG001|Overall Study|Lost to Follow-up|1|||
160640626|NCT05166421|580066775|FG002|Overall Study|Lost to Follow-up|7|||
160640627|NCT03770000|580068765|FG000|Overall Study|Premature discontinuation due to PD|0|||
160640628|NCT03770000|580068766|FG001|Overall Study|Premature discontinuation due to PD|0|||
160640629|NCT03770000|580068767|FG002|Overall Study|Premature discontinuation due to PD|1|||
160640630|NCT03770000|580068768|FG003|Overall Study|Premature discontinuation due to PD|3|||
160640631|NCT03770000|580068769|FG004|Overall Study|Premature discontinuation due to PD|2|||
160640632|NCT02290028|580068770|FG000|Overall Study|Death|217|||
160640633|NCT02290028|580068770|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
160640634|NCT02290028|580068770|FG000|Overall Study|No longer under care of study physician|76|||
160640635|NCT02290028|580068770|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
160640636|NCT02290028|580068770|FG000|Overall Study|Withdrawal by Subject|52|||
160640637|NCT02290028|580068770|FG000|Overall Study|Study site closure|44|||
160640638|NCT02290028|580068770|FG000|Overall Study|Lost to Follow-up|34|||
160640639|NCT02290028|580068770|FG000|Overall Study|Miscellaneous|10|||
160640640|NCT02290028|580068770|FG000|Overall Study|Transition to EP PASSION|1295|||
160640641|NCT02290028|580068770|FG000|Overall Study|Planned study completion at 12 months|257|||
160640642|NCT00833547|580068771|FG000|Overall Study|Withdrawal by Subject|2|||
160640643|NCT00833547|580068772|FG001|Overall Study|Withdrawal by Subject|2|||
160640644|NCT01375010|580068775|FG000|Overall Study|Lost to Follow-up|8|||
160640645|NCT01375010|580068776|FG001|Overall Study|Lost to Follow-up|2|||
160640646|NCT01375010|580068775|FG000|Overall Study|Withdrawal by Subject|4|||
160640647|NCT01375010|580068776|FG001|Overall Study|Withdrawal by Subject|2|||
160640648|NCT02402933|580068778|FG000|Overall Study|Withdrawal by Subject|4|||
160640649|NCT02402933|580068778|FG000|Overall Study|Discontinued; Site Termination|10|||
160640650|NCT00598559|580068779|FG000|Overall Study|Adverse Event|11|||
160640651|NCT00598559|580068780|FG001|Overall Study|Adverse Event|7|||
160640652|NCT00598559|580068781|FG002|Overall Study|Adverse Event|0|||
160640653|NCT00598559|580068779|FG000|Overall Study|Withdrawal by Subject|2|||
160640654|NCT00598559|580068780|FG001|Overall Study|Withdrawal by Subject|2|||
160640655|NCT00598559|580068781|FG002|Overall Study|Withdrawal by Subject|0|||
160787049|NCT02802865|580607192|FG001|Overall Study|Pregnancy|1|||
160787050|NCT02802865|580607191|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
160787051|NCT02802865|580607192|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
160787052|NCT01862029|580607193|FG000|Overall Study|Physician Decision|1|||
160787053|NCT03931785|580607194|FG000|Overall Study|Lost to Follow-up|4|||
160787054|NCT03931785|580607195|FG001|Overall Study|Lost to Follow-up|1|||
160787055|NCT03931785|580607196|FG002|Overall Study|Lost to Follow-up|4|||
160787056|NCT03931785|580607197|FG003|Overall Study|Lost to Follow-up|3|||
160787057|NCT03931785|580607194|FG000|Overall Study|Adverse Event|1|||
160787058|NCT03931785|580607195|FG001|Overall Study|Adverse Event|0|||
160787059|NCT03931785|580607196|FG002|Overall Study|Adverse Event|3|||
160787060|NCT03931785|580607197|FG003|Overall Study|Adverse Event|4|||
160543758|NCT01903837|579718290|FG002|Part B|Incarceration|0|||
160543759|NCT01903837|579718291|FG003|Part B|Incarceration|1|||
160543760|NCT01903837|579718288|FG000|Part B|Physician Decision|1|||
160543761|NCT01903837|579718289|FG001|Part B|Physician Decision|0|||
160543762|NCT01903837|579718290|FG002|Part B|Physician Decision|0|||
160543763|NCT01903837|579718291|FG003|Part B|Physician Decision|2|||
160543764|NCT01903837|579718288|FG000|Part B|Lack of Efficacy|0|||
160543765|NCT01903837|579718289|FG001|Part B|Lack of Efficacy|1|||
160543766|NCT01903837|579718290|FG002|Part B|Lack of Efficacy|0|||
160543767|NCT01903837|579718291|FG003|Part B|Lack of Efficacy|0|||
160543768|NCT02706873|579718292|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
160543769|NCT02706873|579718293|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
160543770|NCT02706873|579718294|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
160543771|NCT02706873|579718295|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
160543772|NCT02706873|579718292|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
160543773|NCT02706873|579718293|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
160543774|NCT02706873|579718294|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
160543775|NCT02706873|579718295|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
160543776|NCT02706873|579718292|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
160543777|NCT02706873|579718293|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
160543778|NCT02706873|579718294|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
160543779|NCT02706873|579718295|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
160543780|NCT02706873|579718292|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
160543781|NCT02706873|579718293|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
160543782|NCT02706873|579718294|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
160543783|NCT02706873|579718295|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
160543784|NCT02706873|579718292|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
160543785|NCT02706873|579718293|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
160543786|NCT02706873|579718294|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
160543787|NCT02706873|579718295|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
160543788|NCT02706873|579718292|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
160543789|NCT02706873|579718293|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
160543790|NCT02706873|579718294|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
160543791|NCT02706873|579718295|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
160543792|NCT02706873|579718292|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
160543793|NCT02706873|579718293|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
160543794|NCT02706873|579718294|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
160543795|NCT02706873|579718295|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
160543796|NCT02706873|579718292|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
160543797|NCT02706873|579718293|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
160543798|NCT02706873|579718294|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
160543799|NCT02706873|579718295|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
160543800|NCT02706873|579718292|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
160543801|NCT02706873|579718293|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
160543802|NCT02706873|579718294|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
160543803|NCT02706873|579718295|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
160543804|NCT02706873|579718292|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
160543805|NCT02706873|579718293|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
160787061|NCT03931785|580607194|FG000|Overall Study|Protocol Violation|0|||
160787062|NCT03931785|580607195|FG001|Overall Study|Protocol Violation|1|||
160543806|NCT02706873|579718294|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
160787063|NCT03931785|580607196|FG002|Overall Study|Protocol Violation|0|||
160543807|NCT02706873|579718295|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
160543808|NCT02706873|579718292|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
160543809|NCT02706873|579718293|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
160543810|NCT02706873|579718294|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
160543811|NCT02706873|579718295|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
160543812|NCT02706873|579718292|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
160543813|NCT02706873|579718293|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
160543814|NCT02706873|579718294|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
160543815|NCT02706873|579718295|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
160543816|NCT02706873|579718292|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
160543817|NCT02706873|579718293|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
160543818|NCT02706873|579718294|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
160543819|NCT02706873|579718295|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
160543820|NCT00705939|579718297|FG000|Overall Study|Protocol Violation|0|||
160543821|NCT00705939|579718298|FG001|Overall Study|Protocol Violation|0|||
160543822|NCT00705939|579718299|FG002|Overall Study|Protocol Violation|1|||
160543823|NCT00705939|579718297|FG000|Overall Study|Withdrawal by Subject|0|||
160543824|NCT00705939|579718298|FG001|Overall Study|Withdrawal by Subject|1|||
160543825|NCT00705939|579718299|FG002|Overall Study|Withdrawal by Subject|3|||
160543826|NCT00705939|579718297|FG000|Overall Study|Physician Decision|0|||
160543827|NCT00705939|579718298|FG001|Overall Study|Physician Decision|1|||
160543828|NCT00705939|579718299|FG002|Overall Study|Physician Decision|0|||
160543829|NCT05098041|579718300|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
160543830|NCT00797732|579718305|FG000|Overall Study|Withdrawal by Subject|3|||
160543831|NCT00797732|579718306|FG001|Overall Study|Withdrawal by Subject|3|||
160543832|NCT00797732|579718307|FG002|Overall Study|Withdrawal by Subject|0|||
160543833|NCT00797732|579718305|FG000|Overall Study|Lost to Follow-up|1|||
160543834|NCT00797732|579718306|FG001|Overall Study|Lost to Follow-up|0|||
160543835|NCT00797732|579718307|FG002|Overall Study|Lost to Follow-up|0|||
160543836|NCT00797732|579718305|FG000|Overall Study|Death|1|||
160543837|NCT00797732|579718306|FG001|Overall Study|Death|0|||
160543838|NCT00797732|579718307|FG002|Overall Study|Death|0|||
160543839|NCT00797732|579718305|FG000|Overall Study|Not meet inclusion criteria|0|||
160543840|NCT00797732|579718306|FG001|Overall Study|Not meet inclusion criteria|0|||
160543841|NCT00797732|579718307|FG002|Overall Study|Not meet inclusion criteria|7|||
160543842|NCT00797732|579718305|FG000|Overall Study|Excluded due to time constraints|0|||
160543843|NCT00797732|579718306|FG001|Overall Study|Excluded due to time constraints|0|||
160543844|NCT00797732|579718307|FG002|Overall Study|Excluded due to time constraints|24|||
160543845|NCT00797732|579718305|FG000|Overall Study|Refused to Participate|0|||
160543846|NCT00797732|579718306|FG001|Overall Study|Refused to Participate|0|||
160543847|NCT00797732|579718307|FG002|Overall Study|Refused to Participate|123|||
160543848|NCT03948178|579718308|FG000|Overall Study|Protocol Violation|1|||
160787064|NCT03931785|580607197|FG003|Overall Study|Protocol Violation|0|||
160787065|NCT03931785|580607194|FG000|Overall Study|Noncompliance With Study drug|0|||
160787066|NCT03931785|580607195|FG001|Overall Study|Noncompliance With Study drug|1|||
160787067|NCT03931785|580607196|FG002|Overall Study|Noncompliance With Study drug|0|||
160787068|NCT03931785|580607197|FG003|Overall Study|Noncompliance With Study drug|0|||
160787069|NCT03931785|580607194|FG000|Overall Study|Other Not specified|0|||
160787070|NCT03931785|580607195|FG001|Overall Study|Other Not specified|2|||
160787071|NCT03931785|580607196|FG002|Overall Study|Other Not specified|2|||
160787072|NCT03931785|580607197|FG003|Overall Study|Other Not specified|2|||
160787073|NCT03931785|580607194|FG000|Overall Study|Withdrawal by Subject|0|||
160787074|NCT03931785|580607195|FG001|Overall Study|Withdrawal by Subject|2|||
160787075|NCT03931785|580607196|FG002|Overall Study|Withdrawal by Subject|4|||
160787076|NCT03931785|580607197|FG003|Overall Study|Withdrawal by Subject|1|||
160787077|NCT03931785|580607194|FG000|Overall Study|Pregnancy|0|||
160787078|NCT03931785|580607195|FG001|Overall Study|Pregnancy|0|||
160787079|NCT03931785|580607196|FG002|Overall Study|Pregnancy|0|||
160787080|NCT03931785|580607197|FG003|Overall Study|Pregnancy|1|||
160787081|NCT01832038|580607198|FG000|Overall Study|Death|5|||
160787082|NCT01832038|580607198|FG000|Overall Study|Adverse Event|50|||
160787083|NCT01832038|580607198|FG000|Overall Study|Lack of Efficacy|81|||
160787084|NCT01832038|580607198|FG000|Overall Study|Protocol Violation|7|||
160787085|NCT01832038|580607198|FG000|Overall Study|Lost to Follow-up|10|||
160787086|NCT01832038|580607198|FG000|Overall Study|Withdrawal by Subject|49|||
160787087|NCT01832038|580607198|FG000|Overall Study|Visit non-compliance|2|||
160787088|NCT01832038|580607198|FG000|Overall Study|Subject refused to return visit|2|||
160543849|NCT03948178|579718308|FG000|Overall Study|Lost to Follow-up|2|||
160543850|NCT03948178|579718308|FG000|Overall Study|Withdrawal by Subject|2|||
160787089|NCT01832038|580607198|FG000|Overall Study|Not convenient to come back to site|2|||
160787090|NCT01832038|580607198|FG000|Overall Study|Participant was asked to quit|5|||
160787091|NCT01832038|580607198|FG000|Overall Study|Back home|1|||
160543851|NCT03948178|579718308|FG000|Overall Study|Reason not known|2|||
160543852|NCT03948178|579718308|FG000|Overall Study|Personal reason|14|||
160543853|NCT03948178|579718308|FG000|Overall Study|Disease progression|30|||
160543854|NCT03948178|579718308|FG000|Overall Study|Adverse Event|12|||
160543855|NCT03948178|579718308|FG000|Overall Study|Sponsor terminated study|164|||
160543856|NCT01297270|579718309|FG000|Overall Study|Adverse Event|19|||
160543857|NCT01297270|579718310|FG001|Overall Study|Adverse Event|32|||
160543858|NCT01297270|579718311|FG002|Overall Study|Adverse Event|5|||
160543859|NCT01297270|579718309|FG000|Overall Study|Lack of Efficacy|15|||
160543860|NCT01297270|579718310|FG001|Overall Study|Lack of Efficacy|17|||
160543861|NCT01297270|579718311|FG002|Overall Study|Lack of Efficacy|15|||
160543862|NCT01297270|579718309|FG000|Overall Study|Lost to Follow-up|1|||
160543863|NCT01297270|579718310|FG001|Overall Study|Lost to Follow-up|2|||
160543864|NCT01297270|579718311|FG002|Overall Study|Lost to Follow-up|1|||
160543865|NCT01297270|579718309|FG000|Overall Study|Protocol Violation|0|||
160543866|NCT01297270|579718310|FG001|Overall Study|Protocol Violation|2|||
160543867|NCT01297270|579718311|FG002|Overall Study|Protocol Violation|0|||
160543868|NCT01297270|579718309|FG000|Overall Study|Withdrawal by Subject|7|||
160543869|NCT01297270|579718310|FG001|Overall Study|Withdrawal by Subject|15|||
160543870|NCT01297270|579718311|FG002|Overall Study|Withdrawal by Subject|7|||
160543871|NCT01297270|579718309|FG000|Overall Study|Other reason not defined above|3|||
160543872|NCT01297270|579718310|FG001|Overall Study|Other reason not defined above|3|||
160543873|NCT01297270|579718311|FG002|Overall Study|Other reason not defined above|1|||
160543874|NCT01297270|579718309|FG000|Overall Study|Not treated|0|||
160543875|NCT01297270|579718310|FG001|Overall Study|Not treated|1|||
160543876|NCT01297270|579718311|FG002|Overall Study|Not treated|0|||
160543877|NCT01895322|579718312|FG000|Overall Study|Adverse Event|1|||
160543878|NCT01895322|579718312|FG000|Overall Study|Withdrawal by Subject|2|||
160543879|NCT01895322|579718312|FG000|Overall Study|Protocol Violation|10|||
160543880|NCT01857869|579718313|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
160543881|NCT01857869|579718314|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
160543882|NCT01857869|579718315|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
160543883|NCT01857869|579718316|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
160543884|NCT01857869|579718317|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
160543885|NCT01857869|579718318|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
160543886|NCT01857869|579718319|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
160543887|NCT01857869|579718320|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
160543888|NCT01857869|579718321|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
160543889|NCT01857869|579718322|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
160543890|NCT01857869|579718313|FG000|Primary/Challenge Phase|Pregnancy|1|||
160543891|NCT01857869|579718314|FG001|Primary/Challenge Phase|Pregnancy|0|||
160543892|NCT01857869|579718315|FG002|Primary/Challenge Phase|Pregnancy|0|||
160543893|NCT01857869|579718316|FG003|Primary/Challenge Phase|Pregnancy|0|||
160543894|NCT01857869|579718317|FG004|Primary/Challenge Phase|Pregnancy|0|||
160543895|NCT01857869|579718318|FG005|Primary/Challenge Phase|Pregnancy|0|||
160543896|NCT01857869|579718319|FG006|Primary/Challenge Phase|Pregnancy|0|||
160543897|NCT01857869|579718320|FG007|Primary/Challenge Phase|Pregnancy|0|||
160640656|NCT00598559|580068779|FG000|Overall Study|Protocol Non-compliance|1|||
160640657|NCT00598559|580068780|FG001|Overall Study|Protocol Non-compliance|0|||
160640658|NCT00598559|580068781|FG002|Overall Study|Protocol Non-compliance|0|||
160640659|NCT00598559|580068779|FG000|Overall Study|Early discharge from hospital|9|||
160640660|NCT00598559|580068780|FG001|Overall Study|Early discharge from hospital|12|||
160640661|NCT00598559|580068781|FG002|Overall Study|Early discharge from hospital|3|||
160640662|NCT00598559|580068779|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
160640663|NCT00598559|580068780|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
160640664|NCT00598559|580068781|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
160640665|NCT01059071|580068782|FG000|Overall Study|Lack of Efficacy|1|||
160640666|NCT01059071|580068783|FG001|Overall Study|Lack of Efficacy|4|||
160640667|NCT01059071|580068784|FG002|Overall Study|Lack of Efficacy|2|||
160640668|NCT01059071|580068785|FG003|Overall Study|Lack of Efficacy|3|||
160640669|NCT01059071|580068782|FG000|Overall Study|Withdrawal by Subject|1|||
160640670|NCT01059071|580068783|FG001|Overall Study|Withdrawal by Subject|0|||
160640671|NCT01059071|580068784|FG002|Overall Study|Withdrawal by Subject|0|||
160640672|NCT01059071|580068785|FG003|Overall Study|Withdrawal by Subject|2|||
160640673|NCT01059071|580068782|FG000|Overall Study|Physician Decision|0|||
160640674|NCT01059071|580068783|FG001|Overall Study|Physician Decision|0|||
160640675|NCT01059071|580068784|FG002|Overall Study|Physician Decision|0|||
160640676|NCT01059071|580068785|FG003|Overall Study|Physician Decision|1|||
160640677|NCT02962882|580068786|FG000|Overall Study|Adverse Event|2|||
160640678|NCT02962882|580068786|FG000|Overall Study|Withdrawal by Subject|2|||
160640679|NCT02962882|580068786|FG000|Overall Study|Transfer from ICU|32|||
160640680|NCT03763331|580068789|FG000|Overall Study|Lost to Follow-up|1|||
160640681|NCT03763331|580068790|FG001|Overall Study|Lost to Follow-up|0|||
160640682|NCT03763331|580068789|FG000|Overall Study|Withdrawal by Subject|1|||
160640683|NCT03763331|580068790|FG001|Overall Study|Withdrawal by Subject|0|||
160640684|NCT03763331|580068789|FG000|Overall Study|Non-compliance|0|||
160640685|NCT03763331|580068790|FG001|Overall Study|Non-compliance|3|||
160543898|NCT01857869|579718321|FG008|Primary/Challenge Phase|Pregnancy|0|||
160543899|NCT01857869|579718322|FG009|Primary/Challenge Phase|Pregnancy|0|||
160543900|NCT01857869|579718313|FG000|Primary/Challenge Phase|Protocol Violation|1|||
160543901|NCT01857869|579718314|FG001|Primary/Challenge Phase|Protocol Violation|0|||
160787092|NCT01832038|580607198|FG000|Overall Study|Pregnancy|1|||
160787093|NCT01832038|580607198|FG000|Overall Study|Low compliance|3|||
160787094|NCT01832038|580607198|FG000|Overall Study|Prohibit procedure|2|||
160787095|NCT01832038|580607198|FG000|Overall Study|Not possible to visit the hospital|1|||
160787096|NCT01832038|580607198|FG000|Overall Study|Changes of implementation system|3|||
160787097|NCT01832038|580607198|FG000|Overall Study|Plan to pregnancy|7|||
160787098|NCT01832038|580607198|FG000|Overall Study|Bad mood and has suicidal thought|1|||
160787099|NCT01832038|580607198|FG000|Overall Study|Prohibited concomitant medication|1|||
160543902|NCT01857869|579718315|FG002|Primary/Challenge Phase|Protocol Violation|0|||
160543903|NCT01857869|579718316|FG003|Primary/Challenge Phase|Protocol Violation|0|||
160543904|NCT01857869|579718317|FG004|Primary/Challenge Phase|Protocol Violation|0|||
160543905|NCT01857869|579718318|FG005|Primary/Challenge Phase|Protocol Violation|0|||
160543906|NCT01857869|579718319|FG006|Primary/Challenge Phase|Protocol Violation|0|||
160543907|NCT01857869|579718320|FG007|Primary/Challenge Phase|Protocol Violation|0|||
160543908|NCT01857869|579718321|FG008|Primary/Challenge Phase|Protocol Violation|0|||
160543909|NCT01857869|579718322|FG009|Primary/Challenge Phase|Protocol Violation|0|||
160543910|NCT01857869|579718313|FG000|Primary/Challenge Phase|Other|1|||
160543911|NCT01857869|579718314|FG001|Primary/Challenge Phase|Other|1|||
160543912|NCT01857869|579718315|FG002|Primary/Challenge Phase|Other|0|||
160543913|NCT01857869|579718316|FG003|Primary/Challenge Phase|Other|0|||
160543914|NCT01857869|579718317|FG004|Primary/Challenge Phase|Other|0|||
160543915|NCT01857869|579718318|FG005|Primary/Challenge Phase|Other|0|||
160543916|NCT01857869|579718319|FG006|Primary/Challenge Phase|Other|0|||
160543917|NCT01857869|579718320|FG007|Primary/Challenge Phase|Other|0|||
160543918|NCT01857869|579718321|FG008|Primary/Challenge Phase|Other|0|||
160543919|NCT01857869|579718322|FG009|Primary/Challenge Phase|Other|0|||
160543920|NCT01857869|579718313|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
160543921|NCT01857869|579718314|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
160543922|NCT01857869|579718315|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
160543923|NCT01857869|579718316|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
160543924|NCT01857869|579718317|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
160543925|NCT01857869|579718318|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
160543926|NCT01857869|579718319|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
160543927|NCT01857869|579718320|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
160543928|NCT01857869|579718321|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
160543929|NCT01857869|579718322|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
160543930|NCT01857869|579718313|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
160543931|NCT01857869|579718314|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
160543932|NCT01857869|579718315|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
160543933|NCT01857869|579718316|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
160543934|NCT01857869|579718317|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
160543935|NCT01857869|579718318|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
160543936|NCT01857869|579718319|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
160543937|NCT01857869|579718320|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
160543938|NCT01857869|579718321|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
160543939|NCT01857869|579718322|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
160543940|NCT01087905|579718329|FG000|Overall Study|Lost to Follow-up|24|||
160543941|NCT01087905|579718330|FG001|Overall Study|Lost to Follow-up|28|||
160543942|NCT01087905|579718331|FG002|Overall Study|Lost to Follow-up|18|||
160543943|NCT01087905|579718332|FG003|Overall Study|Lost to Follow-up|31|||
160543944|NCT01087905|579718333|FG004|Overall Study|Lost to Follow-up|27|||
160543945|NCT01087905|579718334|FG005|Overall Study|Lost to Follow-up|25|||
160543946|NCT01087905|579718335|FG006|Overall Study|Lost to Follow-up|20|||
160543947|NCT01087905|579718336|FG007|Overall Study|Lost to Follow-up|24|||
160543948|NCT01087905|579718329|FG000|Overall Study|Withdrawal by Subject|5|||
160543949|NCT01087905|579718330|FG001|Overall Study|Withdrawal by Subject|4|||
160543950|NCT01087905|579718331|FG002|Overall Study|Withdrawal by Subject|4|||
160543951|NCT01087905|579718332|FG003|Overall Study|Withdrawal by Subject|5|||
160543952|NCT01087905|579718333|FG004|Overall Study|Withdrawal by Subject|4|||
160543953|NCT01087905|579718334|FG005|Overall Study|Withdrawal by Subject|3|||
160543954|NCT01087905|579718335|FG006|Overall Study|Withdrawal by Subject|3|||
160543955|NCT01087905|579718336|FG007|Overall Study|Withdrawal by Subject|5|||
160543956|NCT00790907|579718337|FG000|Overall Study|Adverse Event|9|||
160543957|NCT00790907|579718338|FG001|Overall Study|Adverse Event|7|||
160543958|NCT00790907|579718339|FG002|Overall Study|Adverse Event|6|||
160640686|NCT01155063|580068791|FG000|Overall Study|Adverse Event|1|||
160543959|NCT00790907|579718337|FG000|Overall Study|Physician Decision|304|||
160543960|NCT00790907|579718338|FG001|Overall Study|Physician Decision|271|||
160543961|NCT00790907|579718339|FG002|Overall Study|Physician Decision|255|||
160640687|NCT01155063|580068791|FG000|Overall Study|Withdrawal by Subject|1|||
160640688|NCT01155063|580068791|FG000|Overall Study|Study terminated by sponsor|87|||
160640689|NCT00936884|580068792|FG000|Double-blind|Withdrawal by Subject|6|||
160640690|NCT00936884|580068793|FG001|Double-blind|Withdrawal by Subject|4|||
160640691|NCT00936884|580068794|FG002|Double-blind|Withdrawal by Subject|0|||
160640692|NCT00936884|580068792|FG000|Double-blind|Death|2|||
160640693|NCT00936884|580068793|FG001|Double-blind|Death|1|||
160640694|NCT00936884|580068794|FG002|Double-blind|Death|0|||
160640695|NCT00936884|580068792|FG000|Double-blind|Lack of Efficacy|1|||
160543962|NCT00790907|579718337|FG000|Overall Study|Withdrawal by Subject|1|||
160543963|NCT00790907|579718338|FG001|Overall Study|Withdrawal by Subject|7|||
160640696|NCT00936884|580068793|FG001|Double-blind|Lack of Efficacy|1|||
160640697|NCT00936884|580068794|FG002|Double-blind|Lack of Efficacy|0|||
160640698|NCT00936884|580068792|FG000|Double-blind|Adverse Event|1|||
160543964|NCT00790907|579718339|FG002|Overall Study|Withdrawal by Subject|5|||
160543965|NCT00790907|579718337|FG000|Overall Study|Bleeding Event|11|||
160543966|NCT00790907|579718338|FG001|Overall Study|Bleeding Event|16|||
160543967|NCT00790907|579718339|FG002|Overall Study|Bleeding Event|21|||
160543968|NCT00790907|579718337|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
160543969|NCT00790907|579718338|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
160543970|NCT00790907|579718339|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
160543971|NCT00790907|579718337|FG000|Overall Study|Qualifying Condition Not Present|29|||
160543972|NCT00790907|579718338|FG001|Overall Study|Qualifying Condition Not Present|14|||
160543973|NCT00790907|579718339|FG002|Overall Study|Qualifying Condition Not Present|16|||
160543974|NCT00790907|579718337|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
160543975|NCT00790907|579718338|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
160543976|NCT00790907|579718339|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
160543977|NCT00790907|579718337|FG000|Overall Study|Did Not Receive Study Drug|10|||
160543978|NCT00790907|579718338|FG001|Overall Study|Did Not Receive Study Drug|0|||
160543979|NCT00790907|579718339|FG002|Overall Study|Did Not Receive Study Drug|0|||
160543980|NCT00774345|579718340|FG000|Pre-treatment|Other reasons|2|||
160543981|NCT00774345|579718341|FG001|Pre-treatment|Other reasons|0|||
160543982|NCT00774345|579718340|FG000|Treatment|Adverse Event|61|||
160543983|NCT00774345|579718341|FG001|Treatment|Adverse Event|15|||
160543984|NCT00774345|579718340|FG000|Treatment|Progressive Disease without histologic transformation|51|||
160543985|NCT00774345|579718341|FG001|Treatment|Progressive Disease without histologic transformation|111|||
160543986|NCT00774345|579718340|FG000|Treatment|Progressive Disease with histologic transformation|4|||
160543987|NCT00774345|579718341|FG001|Treatment|Progressive Disease with histologic transformation|2|||
160543988|NCT00774345|579718340|FG000|Treatment|Withdrawal by Subject|5|||
160543989|NCT00774345|579718341|FG001|Treatment|Withdrawal by Subject|2|||
160543990|NCT00774345|579718340|FG000|Treatment|Lost to Follow-up|1|||
160543991|NCT00774345|579718341|FG001|Treatment|Lost to Follow-up|1|||
160543992|NCT00774345|579718340|FG000|Treatment|Death|4|||
160543993|NCT00774345|579718341|FG001|Treatment|Death|0|||
160543994|NCT00774345|579718340|FG000|Treatment|Other Reasons|32|||
160543995|NCT00774345|579718341|FG001|Treatment|Other Reasons|26|||
160543996|NCT03436862|579718342|FG000|Overall Study|Adverse Event|4|||
160543997|NCT03436862|579718342|FG000|Overall Study|Progressive Disease|2|||
160543998|NCT00391222|579718345|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
160543999|NCT00391222|579718346|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
160544000|NCT00391222|579718347|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
160544001|NCT00391222|579718348|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
160544002|NCT00391222|579718345|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
160544003|NCT00391222|579718346|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
160544004|NCT00391222|579718347|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
160544005|NCT00391222|579718348|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
160544006|NCT00391222|579718345|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
160544007|NCT00391222|579718346|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
160544008|NCT00391222|579718347|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
160544009|NCT00391222|579718348|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
160640699|NCT00936884|580068793|FG001|Double-blind|Adverse Event|0|||
160640700|NCT00936884|580068794|FG002|Double-blind|Adverse Event|0|||
160640701|NCT00936884|580068792|FG000|Double-blind|Physician Decision|1|||
160640702|NCT00936884|580068793|FG001|Double-blind|Physician Decision|0|||
160640703|NCT00936884|580068794|FG002|Double-blind|Physician Decision|0|||
160640704|NCT00936884|580068792|FG000|Double-blind|No post baseline diary entry|1|||
160640705|NCT00936884|580068793|FG001|Double-blind|No post baseline diary entry|0|||
160640706|NCT00936884|580068794|FG002|Double-blind|No post baseline diary entry|0|||
160640707|NCT00936884|580068792|FG000|Double-blind|Did not receive study drug|0|||
160640708|NCT00936884|580068793|FG001|Double-blind|Did not receive study drug|1|||
160640709|NCT00936884|580068794|FG002|Double-blind|Did not receive study drug|0|||
160640710|NCT04741503|580068795|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
160640711|NCT04741503|580068796|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
160640712|NCT04741503|580068797|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
160640713|NCT04741503|580068795|FG000|Initial Enrollment|Overquotas removed|0|||
160640714|NCT04741503|580068796|FG001|Initial Enrollment|Overquotas removed|0|||
160640715|NCT04741503|580068797|FG002|Initial Enrollment|Overquotas removed|186|||
160544010|NCT00391222|579718345|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
160544011|NCT00391222|579718346|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
160544012|NCT00391222|579718347|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
160544013|NCT00391222|579718348|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
160544014|NCT00391222|579718345|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
160544015|NCT00391222|579718346|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
160544016|NCT00391222|579718347|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
160653387|NCT04634409|580110526|FG026|Overall Study|Other - As reported by Investigator|0|||
160544017|NCT00391222|579718348|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
160544018|NCT00391222|579718345|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
160544019|NCT00391222|579718346|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
160544020|NCT00391222|579718347|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
160544021|NCT00391222|579718348|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
160544022|NCT00391222|579718345|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
160544023|NCT00391222|579718346|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
160544024|NCT00391222|579718347|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
160544025|NCT00391222|579718348|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
160544026|NCT00391222|579718345|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
160544027|NCT00391222|579718346|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
160544028|NCT00391222|579718347|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
160544029|NCT00391222|579718348|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
160544030|NCT00391222|579718345|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
160544031|NCT00391222|579718346|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
160544032|NCT00391222|579718347|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
160544033|NCT00391222|579718348|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
160544034|NCT00391222|579718345|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
160544035|NCT00391222|579718346|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
160544036|NCT00391222|579718347|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
160544037|NCT00391222|579718348|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
160544038|NCT00391222|579718345|FG000|Period III (Double-Blind Treatment)|Other|6|||
160544039|NCT00391222|579718346|FG001|Period III (Double-Blind Treatment)|Other|1|||
160544040|NCT00391222|579718347|FG002|Period III (Double-Blind Treatment)|Other|6|||
160544041|NCT00391222|579718348|FG003|Period III (Double-Blind Treatment)|Other|0|||
160544042|NCT01505634|579718349|FG000|Overall Study|Withdrawal by Subject|2|||
160544043|NCT01505634|579718350|FG001|Overall Study|Withdrawal by Subject|5|||
160544044|NCT01505634|579718351|FG002|Overall Study|Withdrawal by Subject|1|||
160544045|NCT01505634|579718349|FG000|Overall Study|Physician Decision|1|||
160544046|NCT01505634|579718350|FG001|Overall Study|Physician Decision|1|||
160544047|NCT01505634|579718351|FG002|Overall Study|Physician Decision|0|||
160544048|NCT01505634|579718349|FG000|Overall Study|Adverse Event|1|||
160544049|NCT01505634|579718350|FG001|Overall Study|Adverse Event|0|||
160544050|NCT01505634|579718351|FG002|Overall Study|Adverse Event|0|||
160544051|NCT01505634|579718349|FG000|Overall Study|Insufficient supply of drug at site|1|||
160544052|NCT01505634|579718350|FG001|Overall Study|Insufficient supply of drug at site|0|||
160544053|NCT01505634|579718351|FG002|Overall Study|Insufficient supply of drug at site|0|||
160544054|NCT01505634|579718349|FG000|Overall Study|Protocol Violation|2|||
160544055|NCT01505634|579718350|FG001|Overall Study|Protocol Violation|0|||
160544056|NCT01505634|579718351|FG002|Overall Study|Protocol Violation|0|||
160544057|NCT01505634|579718349|FG000|Overall Study|Lost to Follow-up|1|||
160544058|NCT01505634|579718350|FG001|Overall Study|Lost to Follow-up|4|||
160544059|NCT01505634|579718351|FG002|Overall Study|Lost to Follow-up|4|||
160544060|NCT01505634|579718349|FG000|Overall Study|Death|1|||
160544061|NCT01505634|579718350|FG001|Overall Study|Death|0|||
160544062|NCT01505634|579718351|FG002|Overall Study|Death|0|||
160544063|NCT01505634|579718349|FG000|Overall Study|In a conflict zone|0|||
160544064|NCT01505634|579718350|FG001|Overall Study|In a conflict zone|0|||
160544065|NCT01505634|579718351|FG002|Overall Study|In a conflict zone|1|||
160544066|NCT00960843|579718352|FG000|Overall Study|Lost to Follow-up|2|||
160544067|NCT00960843|579718353|FG001|Overall Study|Lost to Follow-up|0|||
160544068|NCT00960843|579718352|FG000|Overall Study|Protocol Violation|0|||
160544069|NCT00960843|579718353|FG001|Overall Study|Protocol Violation|4|||
160544070|NCT00960843|579718352|FG000|Overall Study|Repeated needle dislodgment|0|||
160544071|NCT00960843|579718353|FG001|Overall Study|Repeated needle dislodgment|1|||
160544072|NCT04703075|579718354|FG000|Overall Study|Adverse Event|11|||
160544073|NCT04703075|579718355|FG001|Overall Study|Adverse Event|7|||
160544074|NCT04703075|579718354|FG000|Overall Study|Lost to Follow-up|6|||
160544075|NCT04703075|579718355|FG001|Overall Study|Lost to Follow-up|12|||
160544076|NCT04703075|579718354|FG000|Overall Study|Physician Decision|3|||
160787100|NCT01832038|580607198|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
160787101|NCT01832038|580607198|FG000|Overall Study|Subject considered the efficacy was poor|1|||
160787102|NCT01897896|580607201|FG000|Overall Study|Death|1|||
160787103|NCT01897896|580607202|FG001|Overall Study|Death|0|||
160787104|NCT01897896|580607201|FG000|Overall Study|Adverse Event|11|||
160787105|NCT01897896|580607202|FG001|Overall Study|Adverse Event|1|||
160787106|NCT01897896|580607201|FG000|Overall Study|Lost to Follow-up|1|||
160787107|NCT01897896|580607202|FG001|Overall Study|Lost to Follow-up|0|||
160787108|NCT01897896|580607201|FG000|Overall Study|Non-compliance with study drug dosing|1|||
160890213|NCT00423670|580992967|FG000|Treatment Period|Non-compliance with protocol|3|||
160544077|NCT04703075|579718355|FG001|Overall Study|Physician Decision|0|||
160544078|NCT04703075|579718354|FG000|Overall Study|Moved|0|||
160544079|NCT04703075|579718355|FG001|Overall Study|Moved|2|||
160544080|NCT04703075|579718354|FG000|Overall Study|Index INH Resistant|0|||
160544081|NCT04703075|579718355|FG001|Overall Study|Index INH Resistant|1|||
160787109|NCT01897896|580607202|FG001|Overall Study|Non-compliance with study drug dosing|1|||
160787110|NCT01897896|580607201|FG000|Overall Study|Withdrawal by Subject|7|||
160787111|NCT01897896|580607202|FG001|Overall Study|Withdrawal by Subject|1|||
160787112|NCT01897896|580607201|FG000|Overall Study|Require drug that interfere with study|1|||
160787113|NCT01897896|580607202|FG001|Overall Study|Require drug that interfere with study|4|||
160787114|NCT01897896|580607201|FG000|Overall Study|Protocol Violation|1|||
160787115|NCT01897896|580607202|FG001|Overall Study|Protocol Violation|1|||
160787116|NCT01897896|580607201|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
160787117|NCT01897896|580607202|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
160787118|NCT01897896|580607201|FG000|Overall Study|Caregiver can no longer participate|0|||
160787119|NCT01897896|580607202|FG001|Overall Study|Caregiver can no longer participate|2|||
160787120|NCT01897896|580607201|FG000|Overall Study|Other than specified|2|||
160787121|NCT01897896|580607202|FG001|Overall Study|Other than specified|1|||
160787122|NCT01292473|580607212|FG000|Overall Study|Adverse Event|1|||
160787123|NCT01292473|580607213|FG001|Overall Study|Adverse Event|0|||
160787124|NCT01292473|580607214|FG002|Overall Study|Adverse Event|1|||
160787125|NCT01292473|580607215|FG003|Overall Study|Adverse Event|1|||
160787126|NCT01292473|580607212|FG000|Overall Study|Lost to Follow-up|1|||
160787127|NCT01292473|580607213|FG001|Overall Study|Lost to Follow-up|1|||
160787128|NCT01292473|580607214|FG002|Overall Study|Lost to Follow-up|2|||
160787129|NCT01292473|580607215|FG003|Overall Study|Lost to Follow-up|2|||
160787130|NCT01292473|580607212|FG000|Overall Study|Withdrawal by Subject|3|||
160787131|NCT01292473|580607213|FG001|Overall Study|Withdrawal by Subject|4|||
160787132|NCT01292473|580607214|FG002|Overall Study|Withdrawal by Subject|3|||
160787133|NCT01292473|580607215|FG003|Overall Study|Withdrawal by Subject|3|||
160787134|NCT01292473|580607212|FG000|Overall Study|Physician Decision|0|||
160787135|NCT01292473|580607213|FG001|Overall Study|Physician Decision|1|||
160787136|NCT01292473|580607214|FG002|Overall Study|Physician Decision|0|||
160787137|NCT01292473|580607215|FG003|Overall Study|Physician Decision|0|||
160787138|NCT01292473|580607212|FG000|Overall Study|Disease Progression|0|||
160787139|NCT01292473|580607213|FG001|Overall Study|Disease Progression|1|||
160787140|NCT01292473|580607214|FG002|Overall Study|Disease Progression|3|||
160787141|NCT01292473|580607215|FG003|Overall Study|Disease Progression|6|||
160787142|NCT00458705|580607218|FG000|Overall Study|Adverse Event|4|||
160787143|NCT00458705|580607218|FG000|Overall Study|Not Treated|1|||
160787144|NCT02180672|580607219|FG000|Overall Study|Lost to Follow-up|5|||
160787145|NCT02180672|580607220|FG001|Overall Study|Lost to Follow-up|7|||
160787146|NCT00378560|580607224|FG000|Overall Study|Adverse Event|1|||
160787147|NCT00378560|580607225|FG001|Overall Study|Adverse Event|0|||
160787148|NCT00378560|580607224|FG000|Overall Study|Lost to Follow-up|24|||
160787149|NCT00378560|580607225|FG001|Overall Study|Lost to Follow-up|29|||
160787150|NCT00378560|580607224|FG000|Overall Study|Protocol Violation|2|||
160787151|NCT00378560|580607225|FG001|Overall Study|Protocol Violation|0|||
160787152|NCT00378560|580607224|FG000|Overall Study|Withdrawal by Subject|17|||
160787153|NCT00378560|580607225|FG001|Overall Study|Withdrawal by Subject|21|||
160787154|NCT00378560|580607224|FG000|Overall Study|Moved|4|||
160787155|NCT00378560|580607225|FG001|Overall Study|Moved|3|||
160787156|NCT00378560|580607224|FG000|Overall Study|Pregnancy|7|||
160787157|NCT00378560|580607225|FG001|Overall Study|Pregnancy|5|||
160787158|NCT00378560|580607224|FG000|Overall Study|Laboratory test values abnormal|1|||
160787159|NCT00378560|580607225|FG001|Overall Study|Laboratory test values abnormal|0|||
160787160|NCT02070380|580607226|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
160787161|NCT02070380|580607227|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
160787162|NCT02070380|580607228|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
160787163|NCT02070380|580607229|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
160787164|NCT02070380|580607226|FG000|Second Injection|Image sets missing or technically inadeq|0|||
160787165|NCT02070380|580607227|FG001|Second Injection|Image sets missing or technically inadeq|1|||
160787166|NCT02070380|580607228|FG002|Second Injection|Image sets missing or technically inadeq|0|||
160787167|NCT02070380|580607229|FG003|Second Injection|Image sets missing or technically inadeq|0|||
160544082|NCT04703075|579718354|FG000|Overall Study|Lack of Efficacy|6|||
160544083|NCT04703075|579718355|FG001|Overall Study|Lack of Efficacy|18|||
160544084|NCT00254501|579718356|FG000|Overall Study|Lost to Follow-up|1|||
160544085|NCT00254501|579718357|FG001|Overall Study|Lost to Follow-up|1|||
160544086|NCT00550680|579718358|FG000|Overall Study|Administrative Reasons|1|||
160544087|NCT00550680|579718358|FG000|Overall Study|Adverse Event|5|||
160544088|NCT00550680|579718358|FG000|Overall Study|Death|3|||
160544089|NCT00550680|579718358|FG000|Overall Study|Early Improvement|1|||
160544090|NCT00550680|579718358|FG000|Overall Study|Lost to Follow-up|3|||
160544091|NCT00550680|579718358|FG000|Overall Study|Lack of Efficacy|1|||
160544092|NCT00550680|579718358|FG000|Overall Study|Other|10|||
160544093|NCT00550680|579718358|FG000|Overall Study|Protocol Violation|7|||
160544094|NCT00550680|579718358|FG000|Overall Study|Refused Treatment|19|||
160544095|NCT00550680|579718358|FG000|Overall Study|Screen Failure|6|||
160544096|NCT01119248|579718359|FG000|Overall Study|Physician Decision|5|||
160544097|NCT01967550|579718360|FG000|Overall Study|Withdrawal by Subject|1|||
160544098|NCT01967550|579718361|FG001|Overall Study|Withdrawal by Subject|0|||
160544099|NCT01967550|579718360|FG000|Overall Study|Adverse Event|2|||
160544100|NCT01967550|579718361|FG001|Overall Study|Adverse Event|0|||
160544101|NCT01967550|579718360|FG000|Overall Study|Protocol Violation|2|||
160544102|NCT01967550|579718361|FG001|Overall Study|Protocol Violation|1|||
160544103|NCT01967550|579718360|FG000|Overall Study|Non Compliance|0|||
160544104|NCT01967550|579718361|FG001|Overall Study|Non Compliance|1|||
160544105|NCT01100437|579718363|FG000|Titration/Stabilization|Adverse Event|0|||
160544106|NCT01100437|579718364|FG001|Titration/Stabilization|Adverse Event|0|||
160544107|NCT01100437|579718365|FG002|Titration/Stabilization|Adverse Event|4|||
160544108|NCT01100437|579718363|FG000|Titration/Stabilization|Non-compliance|0|||
160544109|NCT01100437|579718364|FG001|Titration/Stabilization|Non-compliance|0|||
160544110|NCT01100437|579718365|FG002|Titration/Stabilization|Non-compliance|1|||
160544111|NCT01100437|579718363|FG000|Titration/Stabilization|Sponsor canceled study|0|||
160544112|NCT01100437|579718364|FG001|Titration/Stabilization|Sponsor canceled study|0|||
160544113|NCT01100437|579718365|FG002|Titration/Stabilization|Sponsor canceled study|1|||
160544114|NCT01100437|579718363|FG000|Maintenance|Withdrawal by Subject|0|||
160544115|NCT01100437|579718364|FG001|Maintenance|Withdrawal by Subject|0|||
160544116|NCT01100437|579718365|FG002|Maintenance|Withdrawal by Subject|1|||
160544117|NCT01100437|579718363|FG000|Maintenance|Sponsor termination of study|0|||
160544118|NCT01100437|579718364|FG001|Maintenance|Sponsor termination of study|0|||
160544119|NCT01100437|579718365|FG002|Maintenance|Sponsor termination of study|1|||
160544120|NCT01014689|579718368|FG000|Overall Study|Lack of Efficacy|0|||
160544121|NCT01014689|579718369|FG001|Overall Study|Lack of Efficacy|1|||
160544122|NCT01014689|579718368|FG000|Overall Study|Adverse Event|3|||
160544123|NCT01014689|579718369|FG001|Overall Study|Adverse Event|0|||
160544124|NCT01014689|579718368|FG000|Overall Study|Withdrawal by Subject|5|||
160544125|NCT01014689|579718369|FG001|Overall Study|Withdrawal by Subject|4|||
160544126|NCT01014689|579718368|FG000|Overall Study|Protocol Violation|1|||
160544127|NCT01014689|579718369|FG001|Overall Study|Protocol Violation|1|||
160544128|NCT01014689|579718368|FG000|Overall Study|Lost to Follow-up|3|||
160544129|NCT01014689|579718369|FG001|Overall Study|Lost to Follow-up|7|||
160544130|NCT01014689|579718368|FG000|Overall Study|Pregnancy|1|||
160544131|NCT01014689|579718369|FG001|Overall Study|Pregnancy|0|||
160544132|NCT00333359|579718375|FG000|Overall Study|Adverse Event|29|||
160544133|NCT00333359|579718376|FG001|Overall Study|Adverse Event|35|||
160544134|NCT00333359|579718375|FG000|Overall Study|Withdrawal by Subject|19|||
160544135|NCT00333359|579718376|FG001|Overall Study|Withdrawal by Subject|37|||
160544136|NCT00333359|579718375|FG000|Overall Study|Physician Decision|2|||
160544137|NCT00333359|579718376|FG001|Overall Study|Physician Decision|2|||
160544138|NCT00333359|579718375|FG000|Overall Study|Protocol Non-compliance|2|||
160544139|NCT00333359|579718376|FG001|Overall Study|Protocol Non-compliance|8|||
160544140|NCT00333359|579718375|FG000|Overall Study|Lost to Follow-up|15|||
160544141|NCT00333359|579718376|FG001|Overall Study|Lost to Follow-up|25|||
160544142|NCT00333359|579718375|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
160544143|NCT00333359|579718376|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
160544144|NCT00333359|579718375|FG000|Overall Study|Treatment Failure|3|||
160544145|NCT00333359|579718376|FG001|Overall Study|Treatment Failure|8|||
160544146|NCT00333359|579718375|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
160544147|NCT00333359|579718376|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
160544148|NCT02867995|579718381|FG000|Overall Study|Withdrawal by Subject|0|||
160544149|NCT02867995|579718382|FG001|Overall Study|Withdrawal by Subject|1|||
160544150|NCT02867995|579718381|FG000|Overall Study|Lost to Follow-up|0|||
160544151|NCT02867995|579718382|FG001|Overall Study|Lost to Follow-up|2|||
160544152|NCT01534533|579718383|FG000|Overall Study|Lost to Follow-up|3|||
160544153|NCT01534533|579718384|FG001|Overall Study|Lost to Follow-up|0|||
160544154|NCT01534533|579718385|FG002|Overall Study|Lost to Follow-up|4|||
160544155|NCT01534533|579718386|FG003|Overall Study|Lost to Follow-up|3|||
160544156|NCT01534533|579718383|FG000|Overall Study|Withdrawal by Subject|5|||
160544157|NCT01534533|579718384|FG001|Overall Study|Withdrawal by Subject|3|||
160544158|NCT01534533|579718385|FG002|Overall Study|Withdrawal by Subject|4|||
160544159|NCT01534533|579718386|FG003|Overall Study|Withdrawal by Subject|1|||
160544160|NCT03315871|579718389|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
160544161|NCT03315871|579718390|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
160544162|NCT03315871|579718391|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
160544163|NCT03315871|579718389|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
160544164|NCT03315871|579718390|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
160544165|NCT03315871|579718391|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
160544166|NCT03315871|579718389|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
160544167|NCT03315871|579718390|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
160544168|NCT03315871|579718391|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
160544169|NCT03315871|579718389|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
160544170|NCT03315871|579718390|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
160544171|NCT03315871|579718391|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
160544172|NCT03315871|579718389|FG000|PROSTVAC + CV301|Progressive disease|0|||
160544173|NCT03315871|579718390|FG001|PROSTVAC + CV301|Progressive disease|0|||
160544174|NCT03315871|579718391|FG002|PROSTVAC + CV301|Progressive disease|1|||
160544175|NCT03315871|579718389|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
160544176|NCT03315871|579718390|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
160544177|NCT03315871|579718391|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
160544178|NCT04099251|579720008|FG000|Pre-Treatment|Other reasons|1|||
160544179|NCT04099251|579720009|FG001|Pre-Treatment|Other reasons|0|||
160544180|NCT04099251|579720008|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
160544181|NCT04099251|579720009|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
160544182|NCT04099251|579720008|FG000|Blinded Treatment Phase|Other reasons|16|||
160544183|NCT04099251|579720009|FG001|Blinded Treatment Phase|Other reasons|7|||
160544184|NCT04099251|579720008|FG000|Blinded Treatment Phase|Disease recurrence|26|||
160544185|NCT04099251|579720009|FG001|Blinded Treatment Phase|Disease recurrence|41|||
160544186|NCT04099251|579720008|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
160544187|NCT04099251|579720009|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
160544188|NCT04099251|579720008|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
160544189|NCT04099251|579720009|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
160544190|NCT04099251|579720008|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
160544191|NCT04099251|579720009|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
160544192|NCT04099251|579720008|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
160544193|NCT04099251|579720009|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
160544194|NCT04099251|579720008|FG000|Blinded Treatment Phase|Death|6|||
160544195|NCT04099251|579720009|FG001|Blinded Treatment Phase|Death|2|||
160544196|NCT04099251|579720008|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
160544197|NCT04099251|579720009|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
160544198|NCT04099251|579720008|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
160544199|NCT04099251|579720009|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
160544200|NCT04099251|579720008|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
160544201|NCT04099251|579720009|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
160544202|NCT04099251|579720008|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
160544203|NCT04099251|579720009|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
160544204|NCT04099251|579720008|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
160544205|NCT04099251|579720009|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
160544206|NCT04099251|579720008|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
160544207|NCT04099251|579720009|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
160544208|NCT04099251|579720008|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
160544209|NCT04099251|579720009|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
160544210|NCT04099251|579720008|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
160544211|NCT04099251|579720009|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
160544212|NCT04099251|579720008|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
160544213|NCT04099251|579720009|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
160544214|NCT01408147|579720016|FG000|Overall Study|Withdrawal by Subject|0|||
160544215|NCT01408147|579720017|FG001|Overall Study|Withdrawal by Subject|1|||
160544216|NCT01042600|579720018|FG000|Overall Study|Ineligible|1|||
160544217|NCT01042600|579720019|FG001|Overall Study|Ineligible|0|||
160544218|NCT00621504|579720020|FG000|Overall Study|Adverse Event|1|||
160544219|NCT00621504|579720021|FG001|Overall Study|Adverse Event|3|||
160544220|NCT00621504|579720020|FG000|Overall Study|At the request of sponsor/investigator|1|||
160544221|NCT00621504|579720021|FG001|Overall Study|At the request of sponsor/investigator|0|||
160544222|NCT00621504|579720020|FG000|Overall Study|Withdrew consent|9|||
160544223|NCT00621504|579720021|FG001|Overall Study|Withdrew consent|6|||
160544224|NCT00621504|579720020|FG000|Overall Study|Lost to Follow-up|8|||
160544225|NCT00621504|579720021|FG001|Overall Study|Lost to Follow-up|10|||
160544226|NCT00621504|579720020|FG000|Overall Study|Other|1|||
160544227|NCT00621504|579720021|FG001|Overall Study|Other|0|||
160544228|NCT00621504|579720020|FG000|Overall Study|Death|6|||
160544229|NCT00621504|579720021|FG001|Overall Study|Death|6|||
160544230|NCT03311711|579720024|FG000|Overall Study|Death|1|||
160544231|NCT03311711|579720025|FG001|Overall Study|Death|0|||
160544232|NCT03311711|579720026|FG002|Overall Study|Death|0|||
160544233|NCT03311711|579720027|FG003|Overall Study|Death|0|||
160544234|NCT03311711|579720028|FG004|Overall Study|Death|0|||
160544235|NCT03311711|579720029|FG005|Overall Study|Death|0|||
160544236|NCT03311711|579720030|FG006|Overall Study|Death|1|||
160544237|NCT03311711|579720031|FG007|Overall Study|Death|0|||
160544238|NCT03311711|579720032|FG008|Overall Study|Death|1|||
160544239|NCT03311711|579720033|FG009|Overall Study|Death|0|||
160544240|NCT03311711|579720024|FG000|Overall Study|Death of dyad partner|0|||
160544241|NCT03311711|579720025|FG001|Overall Study|Death of dyad partner|1|||
160544242|NCT03311711|579720026|FG002|Overall Study|Death of dyad partner|0|||
160544243|NCT03311711|579720027|FG003|Overall Study|Death of dyad partner|0|||
160544244|NCT03311711|579720028|FG004|Overall Study|Death of dyad partner|0|||
160544245|NCT03311711|579720029|FG005|Overall Study|Death of dyad partner|0|||
160544246|NCT03311711|579720030|FG006|Overall Study|Death of dyad partner|0|||
160544247|NCT03311711|579720031|FG007|Overall Study|Death of dyad partner|1|||
160544248|NCT03311711|579720032|FG008|Overall Study|Death of dyad partner|0|||
160544249|NCT03311711|579720033|FG009|Overall Study|Death of dyad partner|1|||
160544250|NCT03311711|579720024|FG000|Overall Study|Lost to Follow-up|2|||
160640716|NCT04741503|580068795|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
160640717|NCT04741503|580068796|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
160544251|NCT03311711|579720025|FG001|Overall Study|Lost to Follow-up|2|||
160544252|NCT03311711|579720026|FG002|Overall Study|Lost to Follow-up|0|||
160544253|NCT03311711|579720027|FG003|Overall Study|Lost to Follow-up|0|||
160544254|NCT03311711|579720028|FG004|Overall Study|Lost to Follow-up|0|||
160544255|NCT03311711|579720029|FG005|Overall Study|Lost to Follow-up|0|||
160544256|NCT03311711|579720030|FG006|Overall Study|Lost to Follow-up|1|||
160544257|NCT03311711|579720031|FG007|Overall Study|Lost to Follow-up|1|||
160544258|NCT03311711|579720032|FG008|Overall Study|Lost to Follow-up|0|||
160544259|NCT03311711|579720033|FG009|Overall Study|Lost to Follow-up|0|||
160544260|NCT03311711|579720024|FG000|Overall Study|Withdrawal by Subject|1|||
160544261|NCT03311711|579720025|FG001|Overall Study|Withdrawal by Subject|1|||
160544262|NCT03311711|579720026|FG002|Overall Study|Withdrawal by Subject|0|||
160544263|NCT03311711|579720027|FG003|Overall Study|Withdrawal by Subject|0|||
160787168|NCT02070380|580607226|FG000|Second Injection|Protocol Violation|0|||
160787169|NCT02070380|580607227|FG001|Second Injection|Protocol Violation|1|||
160544264|NCT03311711|579720028|FG004|Overall Study|Withdrawal by Subject|0|||
160544265|NCT03311711|579720029|FG005|Overall Study|Withdrawal by Subject|0|||
160787170|NCT02070380|580607228|FG002|Second Injection|Protocol Violation|1|||
160787171|NCT02070380|580607229|FG003|Second Injection|Protocol Violation|5|||
160787172|NCT01682603|580607240|FG000|Overall Study|Lost to Follow-up|3|||
160544266|NCT03311711|579720030|FG006|Overall Study|Withdrawal by Subject|3|||
160544267|NCT03311711|579720031|FG007|Overall Study|Withdrawal by Subject|3|||
160544268|NCT03311711|579720032|FG008|Overall Study|Withdrawal by Subject|0|||
160544269|NCT03311711|579720033|FG009|Overall Study|Withdrawal by Subject|0|||
160544270|NCT02229552|579720034|FG000|Baseline|Withdrawal by Subject|6|||
160544271|NCT02229552|579720034|FG000|1-year Follow up|Withdrawal by Subject|7|||
160544272|NCT02229552|579720034|FG000|1-year Follow up|Lost to Follow-up|18|||
160544273|NCT02229552|579720034|FG000|2-Year Follow up|Withdrawal by Subject|9|||
160544274|NCT02229552|579720034|FG000|2-Year Follow up|Lost to Follow-up|17|||
160544275|NCT00706134|579720035|FG000|Overall Study|Adverse Event|8|||
160544276|NCT00706134|579720036|FG001|Overall Study|Adverse Event|7|||
160544277|NCT00706134|579720037|FG002|Overall Study|Adverse Event|2|||
160544278|NCT00706134|579720038|FG003|Overall Study|Adverse Event|3|||
160544279|NCT00706134|579720035|FG000|Overall Study|Lost to Follow-up|0|||
160544280|NCT00706134|579720036|FG001|Overall Study|Lost to Follow-up|1|||
160544281|NCT00706134|579720037|FG002|Overall Study|Lost to Follow-up|0|||
160544282|NCT00706134|579720038|FG003|Overall Study|Lost to Follow-up|0|||
160544283|NCT00706134|579720035|FG000|Overall Study|Protocol Violation|0|||
160544284|NCT00706134|579720036|FG001|Overall Study|Protocol Violation|6|||
160544285|NCT00706134|579720037|FG002|Overall Study|Protocol Violation|0|||
160544286|NCT00706134|579720038|FG003|Overall Study|Protocol Violation|3|||
160544287|NCT00706134|579720035|FG000|Overall Study|Withdrawal by Subject|1|||
160544288|NCT00706134|579720036|FG001|Overall Study|Withdrawal by Subject|2|||
160544289|NCT00706134|579720037|FG002|Overall Study|Withdrawal by Subject|1|||
160544290|NCT00706134|579720038|FG003|Overall Study|Withdrawal by Subject|0|||
160544291|NCT00706134|579720035|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
160544292|NCT00706134|579720036|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160544293|NCT00706134|579720037|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
160544294|NCT00706134|579720038|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
160544295|NCT00706134|579720035|FG000|Overall Study|Did not meet study criteria|2|||
160544296|NCT00706134|579720036|FG001|Overall Study|Did not meet study criteria|0|||
160544297|NCT00706134|579720037|FG002|Overall Study|Did not meet study criteria|0|||
160544298|NCT00706134|579720038|FG003|Overall Study|Did not meet study criteria|0|||
160544299|NCT00971945|579720044|FG000|Overall Study|Progressive Disease|3|||
160544300|NCT00971945|579720044|FG000|Overall Study|Change in treatment policy|1|||
160544301|NCT00971945|579720044|FG000|Overall Study|Other reasons|2|||
160544302|NCT01391000|579720046|FG000|Overall Study|Lost to Follow-up|2|||
160787173|NCT01791205|580607241|FG000|Phase II|Lack of Efficacy|6|||
160787174|NCT01791205|580607242|FG001|Phase II|Lack of Efficacy|0|||
160787175|NCT01791205|580607241|FG000|Phase II|Adverse Event|2|||
160787176|NCT01791205|580607242|FG001|Phase II|Adverse Event|0|||
160787177|NCT01791205|580607241|FG000|Phase II|Safety|1|||
160787178|NCT01791205|580607242|FG001|Phase II|Safety|0|||
160787179|NCT01791205|580607241|FG000|Phase II|Lost to Follow-up|1|||
160787180|NCT01791205|580607242|FG001|Phase II|Lost to Follow-up|0|||
160787181|NCT01791205|580607241|FG000|Phase II|Remission of disease|1|||
160787182|NCT01791205|580607242|FG001|Phase II|Remission of disease|0|||
160787183|NCT01791205|580607241|FG000|Phase II|Physician's decision|1|||
160787184|NCT01791205|580607242|FG001|Phase II|Physician's decision|0|||
160787185|NCT05345405|580607255|FG000|Overall Study|Withdrawal by Subject|2|||
160544303|NCT01391000|579720047|FG001|Overall Study|Lost to Follow-up|0|||
160544304|NCT03860961|579720051|FG000|Overall Study|Withdrawal by Subject|6|||
160544305|NCT03860961|579720052|FG001|Overall Study|Withdrawal by Subject|11|||
160544306|NCT03860961|579720051|FG000|Overall Study|Death|10|||
160640718|NCT04741503|580068797|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
160544307|NCT03860961|579720052|FG001|Overall Study|Death|6|||
160640719|NCT01663714|580068800|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
160640720|NCT01663714|580068800|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
160640721|NCT01663714|580068800|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
160787186|NCT05345405|580607256|FG001|Overall Study|Withdrawal by Subject|0|||
160787187|NCT05345405|580607257|FG002|Overall Study|Withdrawal by Subject|0|||
160787188|NCT05345405|580607255|FG000|Overall Study|Did not meet eligibility criteria|0|||
160787189|NCT05345405|580607256|FG001|Overall Study|Did not meet eligibility criteria|2|||
160544308|NCT03860961|579720051|FG000|Overall Study|Incomplete two-year data|4|||
160544309|NCT03860961|579720052|FG001|Overall Study|Incomplete two-year data|0|||
160787190|NCT05345405|580607257|FG002|Overall Study|Did not meet eligibility criteria|0|||
160544310|NCT00817531|579720054|FG000|Overall Study|Adverse Event|1|||
160544311|NCT00817531|579720054|FG000|Overall Study|Lack of Efficacy|1|||
160787191|NCT05345405|580607255|FG000|Overall Study|Lost to Follow-up|0|||
160787192|NCT05345405|580607256|FG001|Overall Study|Lost to Follow-up|0|||
160787193|NCT05345405|580607257|FG002|Overall Study|Lost to Follow-up|1|||
160787194|NCT04189588|580607258|FG000|Overall Study|Death|0|||
160787195|NCT04189588|580607259|FG001|Overall Study|Death|1|||
160787196|NCT04189588|580607258|FG000|Overall Study|Lost to Follow-up|0|||
160787197|NCT04189588|580607259|FG001|Overall Study|Lost to Follow-up|1|||
160787198|NCT03757715|580607262|FG000|Overall Study|Lost to Follow-up|4|||
160787199|NCT03757715|580607263|FG001|Overall Study|Lost to Follow-up|9|||
160787200|NCT03757715|580607262|FG000|Overall Study|Withdrawal by Subject|1|||
160787201|NCT03757715|580607263|FG001|Overall Study|Withdrawal by Subject|1|||
160787202|NCT05463705|580607264|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
160787203|NCT05463705|580607265|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
160787204|NCT05463705|580607266|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
160787205|NCT05463705|580607267|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
160787206|NCT05463705|580607268|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
160787207|NCT05463705|580607269|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
160787208|NCT02662582|580607274|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
160787209|NCT02662582|580607275|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
160787210|NCT02662582|580607274|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
160787211|NCT02662582|580607275|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
160787212|NCT02662582|580607274|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
160787213|NCT02662582|580607275|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
160787214|NCT02662582|580607274|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160787215|NCT02662582|580607275|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160787216|NCT04135352|580607276|FG000|Overall Study|Not treated-randomization error|0|||
160787217|NCT04135352|580607277|FG001|Overall Study|Not treated-randomization error|0|||
160787218|NCT04135352|580607278|FG002|Overall Study|Not treated-randomization error|1|||
160544312|NCT00812214|579720055|FG000|Overall Study|Lost to Follow-up|3|||
160544313|NCT00812214|579720056|FG001|Overall Study|Lost to Follow-up|1|||
160544314|NCT03325673|579720059|FG000|Overall Study|Adverse Event|4|||
160544315|NCT03325673|579720060|FG001|Overall Study|Adverse Event|0|||
160787219|NCT04135352|580607279|FG003|Overall Study|Not treated-randomization error|0|||
160787220|NCT04135352|580607280|FG004|Overall Study|Not treated-randomization error|0|||
160787221|NCT04135352|580607281|FG005|Overall Study|Not treated-randomization error|0|||
160787222|NCT04135352|580607282|FG006|Overall Study|Not treated-randomization error|0|||
160787223|NCT04135352|580607283|FG007|Overall Study|Not treated-randomization error|0|||
160787224|NCT04135352|580607276|FG000|Overall Study|Withdrawal by Subject|0|||
160787225|NCT04135352|580607277|FG001|Overall Study|Withdrawal by Subject|0|||
160787226|NCT04135352|580607278|FG002|Overall Study|Withdrawal by Subject|2|||
160640722|NCT01663714|580068800|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
160640723|NCT01663714|580068800|FG000|Long-Term Follow-Up|Death|4|||
160640724|NCT01663714|580068800|FG000|Long-Term Follow-Up|Non-compliance|1|||
160640725|NCT00597584|580068801|FG000|Overall Study|Adverse Event|4|||
160640726|NCT00597584|580068802|FG001|Overall Study|Adverse Event|2|||
160640727|NCT00597584|580068801|FG000|Overall Study|Death|53|||
160640728|NCT00597584|580068802|FG001|Overall Study|Death|30|||
160787227|NCT04135352|580607279|FG003|Overall Study|Withdrawal by Subject|0|||
160640729|NCT00597584|580068801|FG000|Overall Study|Lack of Efficacy|1|||
160640730|NCT00597584|580068802|FG001|Overall Study|Lack of Efficacy|0|||
160640731|NCT00597584|580068801|FG000|Overall Study|Lost to Follow-up|2|||
160640732|NCT00597584|580068802|FG001|Overall Study|Lost to Follow-up|4|||
160640733|NCT00597584|580068801|FG000|Overall Study|Physician Decision|3|||
160640734|NCT00597584|580068802|FG001|Overall Study|Physician Decision|0|||
160640735|NCT00597584|580068801|FG000|Overall Study|Pregnancy|2|||
160640736|NCT00597584|580068802|FG001|Overall Study|Pregnancy|0|||
160640737|NCT00597584|580068801|FG000|Overall Study|Withdrawal by Subject|44|||
160640738|NCT00597584|580068802|FG001|Overall Study|Withdrawal by Subject|12|||
160640739|NCT00597584|580068801|FG000|Overall Study|Discontinued Dialysis|0|||
160640740|NCT00597584|580068802|FG001|Overall Study|Discontinued Dialysis|1|||
160640741|NCT00597584|580068801|FG000|Overall Study|Lost ability to consent|1|||
160640742|NCT00597584|580068802|FG001|Overall Study|Lost ability to consent|1|||
160640743|NCT00597584|580068801|FG000|Overall Study|Never dosed|1|||
160640744|NCT00597584|580068802|FG001|Overall Study|Never dosed|0|||
160640745|NCT00597584|580068801|FG000|Overall Study|Relocation|8|||
160787228|NCT04135352|580607280|FG004|Overall Study|Withdrawal by Subject|0|||
160787229|NCT04135352|580607281|FG005|Overall Study|Withdrawal by Subject|0|||
160640746|NCT00597584|580068802|FG001|Overall Study|Relocation|6|||
160640747|NCT00597584|580068801|FG000|Overall Study|Renal transplant|9|||
160640748|NCT00597584|580068802|FG001|Overall Study|Renal transplant|7|||
160640749|NCT02280421|580068803|FG000|Washout (2 Weeks)|Adverse Event|0|||
160640750|NCT02280421|580068804|FG001|Washout (2 Weeks)|Adverse Event|1|||
160640751|NCT02280421|580068803|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
160544316|NCT02684981|579720061|FG000|Overall Study|Permanently discontinued the treatment|157|||
160544317|NCT02684981|579720062|FG001|Overall Study|Permanently discontinued the treatment|161|||
160544318|NCT02684981|579720063|FG002|Overall Study|Permanently discontinued the treatment|110|||
160544319|NCT02684981|579720061|FG000|Overall Study|Other|83|||
160544320|NCT02684981|579720062|FG001|Overall Study|Other|49|||
160544321|NCT02684981|579720063|FG002|Overall Study|Other|17|||
160544322|NCT00820898|579720066|FG000|Overall Study|Inelgible - wrong primary site|1|||
160544323|NCT00452699|579720069|FG000|Overall Study|Adverse Event|10|||
160544324|NCT00452699|579720070|FG001|Overall Study|Adverse Event|3|||
160544325|NCT00452699|579720069|FG000|Overall Study|Lack of Efficacy|6|||
160544326|NCT00452699|579720070|FG001|Overall Study|Lack of Efficacy|4|||
160544327|NCT00452699|579720069|FG000|Overall Study|Lost to Follow-up|6|||
160544328|NCT00452699|579720070|FG001|Overall Study|Lost to Follow-up|9|||
160544329|NCT00452699|579720069|FG000|Overall Study|Protocol Violation|21|||
160544330|NCT00452699|579720070|FG001|Overall Study|Protocol Violation|25|||
160544331|NCT00452699|579720069|FG000|Overall Study|Withdrawal by Subject|26|||
160544332|NCT00452699|579720070|FG001|Overall Study|Withdrawal by Subject|25|||
160544333|NCT00452699|579720069|FG000|Overall Study|Other|12|||
160544334|NCT00452699|579720070|FG001|Overall Study|Other|7|||
160544335|NCT00272038|579720073|FG000|Overall Study|withdrew before they received 2 cycles|7|||
160544336|NCT00493870|579720074|FG000|Overall Study|Lost to Follow-up|12|||
160544337|NCT00493870|579720075|FG001|Overall Study|Lost to Follow-up|15|||
160544338|NCT03189446|579720076|FG000|Overall Study|Adverse Event|2|||
160544339|NCT03189446|579720076|FG000|Overall Study|Withdrawal by Subject|2|||
160544340|NCT03189446|579720076|FG000|Overall Study|Physician Decision|1|||
160544341|NCT03548558|579720078|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
160544342|NCT03548558|579720079|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
160544343|NCT03548558|579720080|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
160544344|NCT03548558|579720081|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
160544345|NCT03548558|579720082|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
160544346|NCT03548558|579720083|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
160544347|NCT03548558|579720084|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
160544348|NCT03548558|579720078|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
160544349|NCT03548558|579720079|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
160544350|NCT03548558|579720080|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
160544351|NCT03548558|579720081|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
160544352|NCT03548558|579720082|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
160544353|NCT03548558|579720083|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
160544354|NCT03548558|579720084|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
160544355|NCT03548558|579720078|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
160544356|NCT03548558|579720079|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
160544357|NCT03548558|579720080|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
160544358|NCT03548558|579720081|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
160544359|NCT03548558|579720082|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
160544360|NCT03548558|579720083|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
160544361|NCT03548558|579720084|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
160544362|NCT03548558|579720078|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
160544363|NCT03548558|579720079|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
160544364|NCT03548558|579720080|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
160544365|NCT03548558|579720081|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
160544366|NCT03548558|579720082|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
160544367|NCT03548558|579720083|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
160544368|NCT03548558|579720084|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
160544369|NCT03548558|579720078|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
160544370|NCT03548558|579720079|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
160544371|NCT03548558|579720080|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
160544372|NCT03548558|579720081|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
160544373|NCT03548558|579720082|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
160544374|NCT03548558|579720083|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
160544375|NCT03548558|579720084|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
160544376|NCT03548558|579720078|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
160544377|NCT03548558|579720079|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
160544378|NCT03548558|579720080|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
160544379|NCT03548558|579720081|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
160653388|NCT02683187|580110527|FG000|Overall Study|Failed IV access|3|||
160544380|NCT03548558|579720082|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
160544381|NCT03548558|579720083|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
160544382|NCT03548558|579720084|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
160544383|NCT00763815|579720090|FG000|Overall Study|Adverse Event|14|||
160544384|NCT00763815|579720091|FG001|Overall Study|Adverse Event|29|||
160544385|NCT00763815|579720090|FG000|Overall Study|Lack of Efficacy|10|||
160544386|NCT00763815|579720091|FG001|Overall Study|Lack of Efficacy|11|||
160544387|NCT00763815|579720090|FG000|Overall Study|Poor Compliance to Protocol|6|||
160544388|NCT00763815|579720091|FG001|Overall Study|Poor Compliance to Protocol|6|||
160544389|NCT00763815|579720090|FG000|Overall Study|Lost to Follow-up|2|||
160544390|NCT00763815|579720091|FG001|Overall Study|Lost to Follow-up|4|||
160544391|NCT00763815|579720090|FG000|Overall Study|Early Termination|1|||
160544392|NCT00763815|579720091|FG001|Overall Study|Early Termination|0|||
160544393|NCT00763815|579720090|FG000|Overall Study|Familial and Personal Reasons|9|||
160544394|NCT00763815|579720091|FG001|Overall Study|Familial and Personal Reasons|16|||
160544395|NCT00763815|579720090|FG000|Overall Study|Physician Decision|1|||
160544396|NCT00763815|579720091|FG001|Overall Study|Physician Decision|0|||
160544397|NCT00763815|579720090|FG000|Overall Study|Withdrawal by Subject|7|||
160544398|NCT00763815|579720091|FG001|Overall Study|Withdrawal by Subject|12|||
160544399|NCT00763815|579720090|FG000|Overall Study|Protocol Violation|2|||
160544400|NCT00763815|579720091|FG001|Overall Study|Protocol Violation|5|||
160544401|NCT00763815|579720090|FG000|Overall Study|Sponsor's Decision|0|||
160544402|NCT00763815|579720091|FG001|Overall Study|Sponsor's Decision|1|||
160544403|NCT04951037|579720092|FG000|Overall Study|Lost to Follow-up|16|||
160544404|NCT04951037|579720092|FG000|Overall Study|Withdrawal by Subject|5|||
160544405|NCT04951037|579720092|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
160544406|NCT05630937|579720093|FG000|Overall Study|Study terminated by sponsor|1|||
160544407|NCT05630937|579720094|FG001|Overall Study|Study terminated by sponsor|1|||
160544408|NCT05630937|579720095|FG002|Overall Study|Study terminated by sponsor|8|||
160544409|NCT05630937|579720096|FG003|Overall Study|Study terminated by sponsor|0|||
160544410|NCT05630937|579720093|FG000|Overall Study|Lost to Follow-up|0|||
160544411|NCT05630937|579720094|FG001|Overall Study|Lost to Follow-up|0|||
160544412|NCT05630937|579720095|FG002|Overall Study|Lost to Follow-up|1|||
160544413|NCT05630937|579720096|FG003|Overall Study|Lost to Follow-up|0|||
160544414|NCT05630937|579720093|FG000|Overall Study|Enrolled but not treated|0|||
160544415|NCT05630937|579720094|FG001|Overall Study|Enrolled but not treated|0|||
160544416|NCT05630937|579720095|FG002|Overall Study|Enrolled but not treated|0|||
160544417|NCT05630937|579720096|FG003|Overall Study|Enrolled but not treated|1|||
160544418|NCT00267748|579720098|FG000|Non-randomized Period|Progressive disease|10|||
160544419|NCT00267748|579720099|FG001|Non-randomized Period|Progressive disease|0|||
160544420|NCT00267748|579720100|FG002|Non-randomized Period|Progressive disease|0|||
160544421|NCT00267748|579720098|FG000|Non-randomized Period|Adverse Event|8|||
160544422|NCT00267748|579720099|FG001|Non-randomized Period|Adverse Event|0|||
160544423|NCT00267748|579720100|FG002|Non-randomized Period|Adverse Event|0|||
160544424|NCT00267748|579720098|FG000|Non-randomized Period|Death|1|||
160544425|NCT00267748|579720099|FG001|Non-randomized Period|Death|0|||
160544426|NCT00267748|579720100|FG002|Non-randomized Period|Death|0|||
160544427|NCT00267748|579720098|FG000|Non-randomized Period|Participant not willing to participate|1|||
160544428|NCT00267748|579720099|FG001|Non-randomized Period|Participant not willing to participate|0|||
160544429|NCT00267748|579720100|FG002|Non-randomized Period|Participant not willing to participate|0|||
160544430|NCT00267748|579720098|FG000|Non-randomized Period|Other|3|||
160544431|NCT00267748|579720099|FG001|Non-randomized Period|Other|0|||
160544432|NCT00267748|579720100|FG002|Non-randomized Period|Other|0|||
160544433|NCT00267748|579720098|FG000|Randomized Period|Death|0|||
160544434|NCT00267748|579720099|FG001|Randomized Period|Death|2|||
160544435|NCT00267748|579720100|FG002|Randomized Period|Death|3|||
160544436|NCT00267748|579720098|FG000|Randomized Period|Adverse Event|0|||
160544437|NCT00267748|579720099|FG001|Randomized Period|Adverse Event|23|||
160544438|NCT00267748|579720100|FG002|Randomized Period|Adverse Event|25|||
160544439|NCT00267748|579720098|FG000|Randomized Period|Global deterioration of health status|0|||
160544440|NCT00267748|579720099|FG001|Randomized Period|Global deterioration of health status|6|||
160544441|NCT00267748|579720100|FG002|Randomized Period|Global deterioration of health status|7|||
160544442|NCT00267748|579720098|FG000|Randomized Period|Lost to Follow-up|0|||
160544443|NCT00267748|579720099|FG001|Randomized Period|Lost to Follow-up|1|||
160544444|NCT00267748|579720100|FG002|Randomized Period|Lost to Follow-up|0|||
160544445|NCT00267748|579720098|FG000|Randomized Period|Objective progression or relapse|0|||
160640752|NCT02280421|580068804|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
160544446|NCT00267748|579720099|FG001|Randomized Period|Objective progression or relapse|77|||
160544447|NCT00267748|579720100|FG002|Randomized Period|Objective progression or relapse|86|||
160544448|NCT00267748|579720098|FG000|Randomized Period|Withdrawal by Subject|0|||
160640753|NCT00515073|580068816|FG000|Overall Study|Withdrawal by Subject|1|||
160544449|NCT00267748|579720099|FG001|Randomized Period|Withdrawal by Subject|9|||
160544450|NCT00267748|579720100|FG002|Randomized Period|Withdrawal by Subject|2|||
160544451|NCT00267748|579720098|FG000|Randomized Period|Other|0|||
160544452|NCT00267748|579720099|FG001|Randomized Period|Other|9|||
160640754|NCT00515073|580068816|FG000|Overall Study|Physician Decision|1|||
160544453|NCT00267748|579720100|FG002|Randomized Period|Other|6|||
160544454|NCT00267748|579720098|FG000|Randomized Period|randomized but not treated|0|||
160544455|NCT00267748|579720099|FG001|Randomized Period|randomized but not treated|0|||
160544456|NCT00267748|579720100|FG002|Randomized Period|randomized but not treated|3|||
160544457|NCT02432235|579720105|FG000|Overall Study|Death|1|||
160544458|NCT02432235|579720106|FG001|Overall Study|Death|1|||
160544459|NCT02432235|579720107|FG002|Overall Study|Death|2|||
160544460|NCT02432235|579720108|FG003|Overall Study|Death|2|||
160544461|NCT02432235|579720109|FG004|Overall Study|Death|1|||
160544462|NCT02432235|579720110|FG005|Overall Study|Death|3|||
160544463|NCT02432235|579720111|FG006|Overall Study|Death|11|||
160544464|NCT02432235|579720112|FG007|Overall Study|Death|15|||
160544465|NCT02432235|579720113|FG008|Overall Study|Death|15|||
160544466|NCT02432235|579720114|FG009|Overall Study|Death|3|||
160544467|NCT02432235|579720115|FG010|Overall Study|Death|1|||
160544468|NCT02432235|579720116|FG011|Overall Study|Death|0|||
160544469|NCT02432235|579720105|FG000|Overall Study|Withdrawal by Subject|0|||
160544470|NCT02432235|579720106|FG001|Overall Study|Withdrawal by Subject|1|||
160544471|NCT02432235|579720107|FG002|Overall Study|Withdrawal by Subject|0|||
160544472|NCT02432235|579720108|FG003|Overall Study|Withdrawal by Subject|0|||
160544473|NCT02432235|579720109|FG004|Overall Study|Withdrawal by Subject|0|||
160544474|NCT02432235|579720110|FG005|Overall Study|Withdrawal by Subject|2|||
160544475|NCT02432235|579720111|FG006|Overall Study|Withdrawal by Subject|5|||
160544476|NCT02432235|579720112|FG007|Overall Study|Withdrawal by Subject|3|||
160544477|NCT02432235|579720113|FG008|Overall Study|Withdrawal by Subject|1|||
160544478|NCT02432235|579720114|FG009|Overall Study|Withdrawal by Subject|0|||
160544479|NCT02432235|579720115|FG010|Overall Study|Withdrawal by Subject|0|||
160544480|NCT02432235|579720116|FG011|Overall Study|Withdrawal by Subject|0|||
160544481|NCT02432235|579720105|FG000|Overall Study|Lost to Follow-up|0|||
160544482|NCT02432235|579720106|FG001|Overall Study|Lost to Follow-up|0|||
160544483|NCT02432235|579720107|FG002|Overall Study|Lost to Follow-up|0|||
160544484|NCT02432235|579720108|FG003|Overall Study|Lost to Follow-up|0|||
160544485|NCT02432235|579720109|FG004|Overall Study|Lost to Follow-up|0|||
160544486|NCT02432235|579720110|FG005|Overall Study|Lost to Follow-up|1|||
160544487|NCT02432235|579720111|FG006|Overall Study|Lost to Follow-up|0|||
160544488|NCT02432235|579720112|FG007|Overall Study|Lost to Follow-up|0|||
160544489|NCT02432235|579720113|FG008|Overall Study|Lost to Follow-up|1|||
160544490|NCT02432235|579720114|FG009|Overall Study|Lost to Follow-up|0|||
160544491|NCT02432235|579720115|FG010|Overall Study|Lost to Follow-up|0|||
160787230|NCT04135352|580607282|FG006|Overall Study|Withdrawal by Subject|0|||
160787231|NCT04135352|580607283|FG007|Overall Study|Withdrawal by Subject|0|||
160787232|NCT04135352|580607276|FG000|Overall Study|Sponsor Decision|0|||
160787233|NCT04135352|580607277|FG001|Overall Study|Sponsor Decision|0|||
160787234|NCT04135352|580607278|FG002|Overall Study|Sponsor Decision|2|||
160787235|NCT04135352|580607279|FG003|Overall Study|Sponsor Decision|5|||
160787236|NCT04135352|580607280|FG004|Overall Study|Sponsor Decision|1|||
160544492|NCT02432235|579720116|FG011|Overall Study|Lost to Follow-up|0|||
160544493|NCT02432235|579720105|FG000|Overall Study|Miscellaneous|0|||
160544494|NCT02432235|579720106|FG001|Overall Study|Miscellaneous|0|||
160544495|NCT02432235|579720107|FG002|Overall Study|Miscellaneous|0|||
160544496|NCT02432235|579720108|FG003|Overall Study|Miscellaneous|0|||
160544497|NCT02432235|579720109|FG004|Overall Study|Miscellaneous|1|||
160787237|NCT04135352|580607281|FG005|Overall Study|Sponsor Decision|4|||
160544498|NCT02432235|579720110|FG005|Overall Study|Miscellaneous|6|||
160544499|NCT02432235|579720111|FG006|Overall Study|Miscellaneous|2|||
160544500|NCT02432235|579720112|FG007|Overall Study|Miscellaneous|2|||
160544501|NCT02432235|579720113|FG008|Overall Study|Miscellaneous|4|||
160544502|NCT02432235|579720114|FG009|Overall Study|Miscellaneous|0|||
160544503|NCT02432235|579720115|FG010|Overall Study|Miscellaneous|0|||
160544504|NCT02432235|579720116|FG011|Overall Study|Miscellaneous|1|||
160544505|NCT00401752|579720117|FG000|Overall Study|Adverse Event|2|||
160544506|NCT00401752|579720118|FG001|Overall Study|Adverse Event|5|||
160640755|NCT02764489|580068817|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
160640756|NCT02764489|580068818|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
160544507|NCT00401752|579720117|FG000|Overall Study|Withdrawal by Subject|2|||
160544508|NCT00401752|579720118|FG001|Overall Study|Withdrawal by Subject|6|||
160544509|NCT00401752|579720117|FG000|Overall Study|Lost to Follow-up|1|||
160544510|NCT00401752|579720118|FG001|Overall Study|Lost to Follow-up|4|||
160544511|NCT00401752|579720117|FG000|Overall Study|Development of any exclusion criteria|4|||
160544512|NCT00401752|579720118|FG001|Overall Study|Development of any exclusion criteria|2|||
160544513|NCT00401752|579720117|FG000|Overall Study|Physician Decision|1|||
160544514|NCT00401752|579720118|FG001|Overall Study|Physician Decision|1|||
160544515|NCT02728830|579720125|FG000|Overall Study|Exclusionary Surgery|9|||
160544516|NCT02728830|579720125|FG000|Overall Study|Exclusionary Pathology|6|||
160544517|NCT02728830|579720125|FG000|Overall Study|Physician Decision|3|||
160544518|NCT02728830|579720125|FG000|Overall Study|Withdrawal by Subject|2|||
160544519|NCT02728830|579720125|FG000|Overall Study|Lost to Follow-up|1|||
160544520|NCT02728830|579720125|FG000|Overall Study|Exclusionary Lab Values|1|||
160544521|NCT02728830|579720125|FG000|Overall Study|Contraindicated Illness|1|||
160544522|NCT02728830|579720125|FG000|Overall Study|Language Barrier|1|||
160544523|NCT01347554|579720126|FG000|Overall Study|Lack of Efficacy|7|||
160544524|NCT01347554|579720127|FG001|Overall Study|Lack of Efficacy|11|||
160544525|NCT03603496|579720128|FG000|Overall Study|Death|19|||
160544526|NCT03603496|579720129|FG001|Overall Study|Death|24|||
160544527|NCT03603496|579720128|FG000|Overall Study|Lost to Follow-up|141|||
160544528|NCT03603496|579720129|FG001|Overall Study|Lost to Follow-up|141|||
160544529|NCT03603496|579720128|FG000|Overall Study|Withdrawal by Subject|26|||
160544530|NCT03603496|579720129|FG001|Overall Study|Withdrawal by Subject|20|||
160640757|NCT02764489|580068817|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
160640758|NCT02764489|580068818|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
160640759|NCT02764489|580068817|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
160640760|NCT02764489|580068818|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
160640761|NCT02764489|580068817|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
160640762|NCT02764489|580068818|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
160640763|NCT00881959|580068819|FG000|Overall Study|Lost to Follow-up|2|||
160640764|NCT00881959|580068820|FG001|Overall Study|Lost to Follow-up|4|||
160640765|NCT03840811|580068821|FG000|Overall Study|Lost to Follow-up|0|||
160640766|NCT03840811|580068822|FG001|Overall Study|Lost to Follow-up|0|||
160640767|NCT03840811|580068823|FG002|Overall Study|Lost to Follow-up|1|||
160640768|NCT01904383|580068824|FG000|Overall Study|CRF not collected|117|||
160640769|NCT01904383|580068824|FG000|Overall Study|Reason not listed|147|||
160544531|NCT00004259|579720130|FG000|Overall Study|Protocol Violation|1|||
160544532|NCT00004259|579720131|FG001|Overall Study|Protocol Violation|2|||
160544533|NCT00004259|579720132|FG002|Overall Study|Protocol Violation|0|||
160544534|NCT00004259|579720133|FG003|Overall Study|Protocol Violation|0|||
160544535|NCT00004259|579720130|FG000|Overall Study|Withdrawal by Subject|0|||
160544536|NCT00004259|579720131|FG001|Overall Study|Withdrawal by Subject|2|||
160544537|NCT00004259|579720132|FG002|Overall Study|Withdrawal by Subject|0|||
160544538|NCT00004259|579720133|FG003|Overall Study|Withdrawal by Subject|0|||
160544539|NCT03594227|579720134|FG000|Overall Study|Adverse Event|2|||
160640770|NCT01904383|580068824|FG000|Overall Study|Lost to Follow-up|674|||
160640771|NCT01904383|580068824|FG000|Overall Study|Lack of Efficacy|370|||
160640772|NCT01904383|580068824|FG000|Overall Study|Improvement|141|||
160544540|NCT03594227|579720135|FG001|Overall Study|Adverse Event|1|||
160544541|NCT03594227|579720136|FG002|Overall Study|Adverse Event|0|||
160544542|NCT03594227|579720137|FG003|Overall Study|Adverse Event|2|||
160544543|NCT03594227|579720134|FG000|Overall Study|Lost to Follow-up|1|||
160544544|NCT03594227|579720135|FG001|Overall Study|Lost to Follow-up|1|||
160544545|NCT03594227|579720136|FG002|Overall Study|Lost to Follow-up|1|||
160544546|NCT03594227|579720137|FG003|Overall Study|Lost to Follow-up|0|||
160544547|NCT03594227|579720134|FG000|Overall Study|Withdrawal by Subject|1|||
160544548|NCT03594227|579720135|FG001|Overall Study|Withdrawal by Subject|1|||
160544549|NCT03594227|579720136|FG002|Overall Study|Withdrawal by Subject|1|||
160544550|NCT03594227|579720137|FG003|Overall Study|Withdrawal by Subject|1|||
160544551|NCT03594227|579720134|FG000|Overall Study|Pregnancy|0|||
160544552|NCT03594227|579720135|FG001|Overall Study|Pregnancy|1|||
160544553|NCT03594227|579720136|FG002|Overall Study|Pregnancy|0|||
160544554|NCT03594227|579720137|FG003|Overall Study|Pregnancy|0|||
160544555|NCT03594227|579720134|FG000|Overall Study|Sponsor Decision|0|||
160544556|NCT03594227|579720135|FG001|Overall Study|Sponsor Decision|0|||
160544557|NCT03594227|579720136|FG002|Overall Study|Sponsor Decision|0|||
160544558|NCT03594227|579720137|FG003|Overall Study|Sponsor Decision|1|||
160544559|NCT03594227|579720134|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
160544560|NCT03594227|579720135|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
160544561|NCT03594227|579720136|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
160544562|NCT03594227|579720137|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
160544563|NCT01618214|579720143|FG000|Overall Study|Adverse Event|3|||
160544564|NCT01618214|579720144|FG001|Overall Study|Adverse Event|1|||
160544565|NCT01618214|579720143|FG000|Overall Study|Lack of Efficacy|1|||
160544566|NCT01618214|579720144|FG001|Overall Study|Lack of Efficacy|1|||
160544567|NCT01618214|579720143|FG000|Overall Study|Protocol Violation|1|||
160544568|NCT01618214|579720144|FG001|Overall Study|Protocol Violation|4|||
160544569|NCT01618214|579720143|FG000|Overall Study|Withdrawal Criteria|1|||
160544570|NCT01618214|579720144|FG001|Overall Study|Withdrawal Criteria|2|||
160544571|NCT01618214|579720143|FG000|Overall Study|Unclassified|4|||
160544572|NCT01618214|579720144|FG001|Overall Study|Unclassified|5|||
160544573|NCT02873936|579720150|FG000|Overall Study|Withdrew Consent|4|||
160544574|NCT02873936|579720151|FG001|Overall Study|Withdrew Consent|11|||
160544575|NCT02873936|579720152|FG002|Overall Study|Withdrew Consent|20|||
160544576|NCT02873936|579720150|FG000|Overall Study|Investigator's Discretion|3|||
160544577|NCT02873936|579720151|FG001|Overall Study|Investigator's Discretion|5|||
160544578|NCT02873936|579720152|FG002|Overall Study|Investigator's Discretion|4|||
160544579|NCT02873936|579720150|FG000|Overall Study|Adverse Event|3|||
160544580|NCT02873936|579720151|FG001|Overall Study|Adverse Event|5|||
160544581|NCT02873936|579720152|FG002|Overall Study|Adverse Event|3|||
160544582|NCT02873936|579720150|FG000|Overall Study|Protocol Violation|0|||
160544583|NCT02873936|579720151|FG001|Overall Study|Protocol Violation|1|||
160544584|NCT02873936|579720152|FG002|Overall Study|Protocol Violation|3|||
160544585|NCT02873936|579720150|FG000|Overall Study|Lost to Follow-up|1|||
160544586|NCT02873936|579720151|FG001|Overall Study|Lost to Follow-up|1|||
160544587|NCT02873936|579720152|FG002|Overall Study|Lost to Follow-up|1|||
160544588|NCT02873936|579720150|FG000|Overall Study|Non-compliance With Study Drug|1|||
160544589|NCT02873936|579720151|FG001|Overall Study|Non-compliance With Study Drug|0|||
160544590|NCT02873936|579720152|FG002|Overall Study|Non-compliance With Study Drug|1|||
160544591|NCT02873936|579720150|FG000|Overall Study|Randomized but not Dosed|1|||
160544592|NCT02873936|579720151|FG001|Overall Study|Randomized but not Dosed|0|||
160544593|NCT02873936|579720152|FG002|Overall Study|Randomized but not Dosed|0|||
160544594|NCT02054897|579720154|FG000|Overall Study|Withdrawal by Subject|2|||
160544595|NCT02054897|579720155|FG001|Overall Study|Withdrawal by Subject|0|||
160544596|NCT02054897|579720156|FG002|Overall Study|Withdrawal by Subject|2|||
160544597|NCT02054897|579720154|FG000|Overall Study|Missing follow-up information|3|||
160544598|NCT02054897|579720155|FG001|Overall Study|Missing follow-up information|5|||
160544599|NCT02054897|579720156|FG002|Overall Study|Missing follow-up information|3|||
160544600|NCT02054897|579720154|FG000|Overall Study|Lost to Follow-up|4|||
160544601|NCT02054897|579720155|FG001|Overall Study|Lost to Follow-up|2|||
160544602|NCT02054897|579720156|FG002|Overall Study|Lost to Follow-up|7|||
160544603|NCT02054897|579720154|FG000|Overall Study|Randomized but not exposed|1|||
160544604|NCT02054897|579720155|FG001|Overall Study|Randomized but not exposed|0|||
160544605|NCT02054897|579720156|FG002|Overall Study|Randomized but not exposed|0|||
160544606|NCT00250835|579720159|FG000|Overall Study|Withdrawal by Subject|1|||
160544607|NCT00879697|579720162|FG000|Overall Study|Physician Decision|2|||
160544608|NCT00879697|579720163|FG001|Overall Study|Physician Decision|2|||
160544609|NCT01836783|579720166|FG000|Overall Study|Withdrawal by Subject|0|||
160544610|NCT01836783|579720167|FG001|Overall Study|Withdrawal by Subject|2|||
160544611|NCT04489888|579720171|FG000|Overall Study|Death|75|||
160544612|NCT04489888|579720171|FG000|Overall Study|Sponsor Decision|26|||
160544613|NCT01452152|579720179|FG000|Overall Study|Study termination by sponsor|5|||
160544614|NCT01452152|579720180|FG001|Overall Study|Study termination by sponsor|0|||
160544615|NCT01452152|579720181|FG002|Overall Study|Study termination by sponsor|4|||
160544616|NCT00328627|579723195|FG000|Overall Study|Hyperglycemic Rescue|41|||
160544617|NCT00328627|579723196|FG001|Overall Study|Hyperglycemic Rescue|18|||
160544618|NCT00328627|579723197|FG002|Overall Study|Hyperglycemic Rescue|16|||
160544619|NCT00328627|579723198|FG003|Overall Study|Hyperglycemic Rescue|13|||
160544620|NCT00328627|579723199|FG004|Overall Study|Hyperglycemic Rescue|6|||
160544621|NCT00328627|579723200|FG005|Overall Study|Hyperglycemic Rescue|5|||
160544622|NCT00328627|579723201|FG006|Overall Study|Hyperglycemic Rescue|19|||
160544623|NCT00328627|579723202|FG007|Overall Study|Hyperglycemic Rescue|6|||
160544624|NCT00328627|579723203|FG008|Overall Study|Hyperglycemic Rescue|6|||
160544625|NCT00328627|579723204|FG009|Overall Study|Hyperglycemic Rescue|11|||
160544626|NCT00328627|579723205|FG010|Overall Study|Hyperglycemic Rescue|3|||
160544627|NCT00328627|579723206|FG011|Overall Study|Hyperglycemic Rescue|2|||
160544628|NCT00328627|579723195|FG000|Overall Study|Adverse Event|3|||
160544629|NCT00328627|579723196|FG001|Overall Study|Adverse Event|1|||
160544630|NCT00328627|579723197|FG002|Overall Study|Adverse Event|2|||
160544631|NCT00328627|579723198|FG003|Overall Study|Adverse Event|3|||
160544632|NCT00328627|579723199|FG004|Overall Study|Adverse Event|1|||
160544633|NCT00328627|579723200|FG005|Overall Study|Adverse Event|2|||
160544634|NCT00328627|579723201|FG006|Overall Study|Adverse Event|1|||
160544635|NCT00328627|579723202|FG007|Overall Study|Adverse Event|2|||
160544636|NCT00328627|579723203|FG008|Overall Study|Adverse Event|0|||
160544637|NCT00328627|579723204|FG009|Overall Study|Adverse Event|7|||
160544638|NCT00328627|579723205|FG010|Overall Study|Adverse Event|5|||
160544639|NCT00328627|579723206|FG011|Overall Study|Adverse Event|4|||
160544640|NCT00328627|579723195|FG000|Overall Study|Protocol Violation|2|||
160544641|NCT00328627|579723196|FG001|Overall Study|Protocol Violation|2|||
160544642|NCT00328627|579723197|FG002|Overall Study|Protocol Violation|2|||
160544643|NCT00328627|579723198|FG003|Overall Study|Protocol Violation|8|||
160544644|NCT00328627|579723199|FG004|Overall Study|Protocol Violation|5|||
160544645|NCT00328627|579723200|FG005|Overall Study|Protocol Violation|5|||
160544646|NCT00328627|579723201|FG006|Overall Study|Protocol Violation|6|||
160544647|NCT00328627|579723202|FG007|Overall Study|Protocol Violation|2|||
160544648|NCT00328627|579723203|FG008|Overall Study|Protocol Violation|1|||
160544649|NCT00328627|579723204|FG009|Overall Study|Protocol Violation|4|||
160544650|NCT00328627|579723205|FG010|Overall Study|Protocol Violation|6|||
160544651|NCT00328627|579723206|FG011|Overall Study|Protocol Violation|2|||
160544652|NCT00328627|579723195|FG000|Overall Study|Lost to Follow-up|4|||
160544653|NCT00328627|579723196|FG001|Overall Study|Lost to Follow-up|2|||
160544654|NCT00328627|579723197|FG002|Overall Study|Lost to Follow-up|2|||
160544655|NCT00328627|579723198|FG003|Overall Study|Lost to Follow-up|4|||
160544656|NCT00328627|579723199|FG004|Overall Study|Lost to Follow-up|0|||
160787238|NCT04135352|580607282|FG006|Overall Study|Sponsor Decision|0|||
160544657|NCT00328627|579723200|FG005|Overall Study|Lost to Follow-up|2|||
160544658|NCT00328627|579723201|FG006|Overall Study|Lost to Follow-up|3|||
160544659|NCT00328627|579723202|FG007|Overall Study|Lost to Follow-up|0|||
160544660|NCT00328627|579723203|FG008|Overall Study|Lost to Follow-up|3|||
160544661|NCT00328627|579723204|FG009|Overall Study|Lost to Follow-up|2|||
160544662|NCT00328627|579723205|FG010|Overall Study|Lost to Follow-up|0|||
160544663|NCT00328627|579723206|FG011|Overall Study|Lost to Follow-up|1|||
160544664|NCT00328627|579723195|FG000|Overall Study|Withdrawal by Subject|5|||
160544665|NCT00328627|579723196|FG001|Overall Study|Withdrawal by Subject|4|||
160544666|NCT00328627|579723197|FG002|Overall Study|Withdrawal by Subject|5|||
160544667|NCT00328627|579723198|FG003|Overall Study|Withdrawal by Subject|6|||
160544668|NCT00328627|579723199|FG004|Overall Study|Withdrawal by Subject|2|||
160544669|NCT00328627|579723200|FG005|Overall Study|Withdrawal by Subject|5|||
160787239|NCT04135352|580607283|FG007|Overall Study|Sponsor Decision|0|||
160787240|NCT04135352|580607276|FG000|Overall Study|Physician Decision|0|||
160787241|NCT04135352|580607277|FG001|Overall Study|Physician Decision|0|||
160787242|NCT04135352|580607278|FG002|Overall Study|Physician Decision|1|||
160787243|NCT04135352|580607279|FG003|Overall Study|Physician Decision|0|||
160544670|NCT00328627|579723201|FG006|Overall Study|Withdrawal by Subject|4|||
160544671|NCT00328627|579723202|FG007|Overall Study|Withdrawal by Subject|4|||
160787244|NCT04135352|580607280|FG004|Overall Study|Physician Decision|1|||
160787245|NCT04135352|580607281|FG005|Overall Study|Physician Decision|0|||
160787246|NCT04135352|580607282|FG006|Overall Study|Physician Decision|0|||
160544672|NCT00328627|579723203|FG008|Overall Study|Withdrawal by Subject|4|||
160544673|NCT00328627|579723204|FG009|Overall Study|Withdrawal by Subject|5|||
160544674|NCT00328627|579723205|FG010|Overall Study|Withdrawal by Subject|2|||
160544675|NCT00328627|579723206|FG011|Overall Study|Withdrawal by Subject|7|||
160544676|NCT00328627|579723195|FG000|Overall Study|Pregnancy|0|||
160544677|NCT00328627|579723196|FG001|Overall Study|Pregnancy|1|||
160544678|NCT00328627|579723197|FG002|Overall Study|Pregnancy|0|||
160544679|NCT00328627|579723198|FG003|Overall Study|Pregnancy|0|||
160544680|NCT00328627|579723199|FG004|Overall Study|Pregnancy|0|||
160544681|NCT00328627|579723200|FG005|Overall Study|Pregnancy|0|||
160544682|NCT00328627|579723201|FG006|Overall Study|Pregnancy|0|||
160544683|NCT00328627|579723202|FG007|Overall Study|Pregnancy|0|||
160544684|NCT00328627|579723203|FG008|Overall Study|Pregnancy|0|||
160544685|NCT00328627|579723204|FG009|Overall Study|Pregnancy|0|||
160787247|NCT04135352|580607283|FG007|Overall Study|Physician Decision|0|||
160787248|NCT04135352|580607276|FG000|Overall Study|Death|3|||
160787249|NCT04135352|580607277|FG001|Overall Study|Death|4|||
160544686|NCT00328627|579723205|FG010|Overall Study|Pregnancy|0|||
160544687|NCT00328627|579723206|FG011|Overall Study|Pregnancy|0|||
160544688|NCT00328627|579723195|FG000|Overall Study|Physician Decision|4|||
160544689|NCT00328627|579723196|FG001|Overall Study|Physician Decision|3|||
160544690|NCT00328627|579723197|FG002|Overall Study|Physician Decision|1|||
160544691|NCT00328627|579723198|FG003|Overall Study|Physician Decision|2|||
160544692|NCT00328627|579723199|FG004|Overall Study|Physician Decision|1|||
160544693|NCT00328627|579723200|FG005|Overall Study|Physician Decision|1|||
160544694|NCT00328627|579723201|FG006|Overall Study|Physician Decision|1|||
160544695|NCT00328627|579723202|FG007|Overall Study|Physician Decision|0|||
160544696|NCT00328627|579723203|FG008|Overall Study|Physician Decision|3|||
160544697|NCT00328627|579723204|FG009|Overall Study|Physician Decision|2|||
160544698|NCT00328627|579723205|FG010|Overall Study|Physician Decision|1|||
160544699|NCT00328627|579723206|FG011|Overall Study|Physician Decision|0|||
160544700|NCT00328627|579723195|FG000|Overall Study|Other|0|||
160544701|NCT00328627|579723196|FG001|Overall Study|Other|0|||
160544702|NCT00328627|579723197|FG002|Overall Study|Other|0|||
160544703|NCT00328627|579723198|FG003|Overall Study|Other|1|||
160544704|NCT00328627|579723199|FG004|Overall Study|Other|0|||
160544705|NCT00328627|579723200|FG005|Overall Study|Other|0|||
160544706|NCT00328627|579723201|FG006|Overall Study|Other|1|||
160544707|NCT00328627|579723202|FG007|Overall Study|Other|0|||
160544708|NCT00328627|579723203|FG008|Overall Study|Other|0|||
160544709|NCT00328627|579723204|FG009|Overall Study|Other|1|||
160544710|NCT00328627|579723205|FG010|Overall Study|Other|1|||
160544711|NCT00328627|579723206|FG011|Overall Study|Other|0|||
160544712|NCT02049944|579723207|FG000|Overall Study|Protocol Violation|2|||
160544713|NCT01982292|579723209|FG000|Overall Study|Adverse Event|2|||
160544714|NCT01982292|579723210|FG001|Overall Study|Adverse Event|0|||
160544715|NCT01982292|579723209|FG000|Overall Study|Death|1|||
160544716|NCT01982292|579723210|FG001|Overall Study|Death|0|||
160544717|NCT01982292|579723209|FG000|Overall Study|Lost to Follow-up|2|||
160544718|NCT01982292|579723210|FG001|Overall Study|Lost to Follow-up|0|||
160544719|NCT01982292|579723209|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
160544720|NCT01982292|579723210|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
160544721|NCT01982292|579723209|FG000|Overall Study|Protocol Deviation|1|||
160544722|NCT01982292|579723210|FG001|Overall Study|Protocol Deviation|0|||
160544723|NCT01982292|579723209|FG000|Overall Study|Patient/Guardian Decision|3|||
160544724|NCT01982292|579723210|FG001|Overall Study|Patient/Guardian Decision|1|||
160544725|NCT01982292|579723209|FG000|Overall Study|Technical Problems|2|||
160544726|NCT01982292|579723210|FG001|Overall Study|Technical Problems|0|||
160544727|NCT03691974|579723212|FG000|Overall Study|Physician Decision|1|||
160544728|NCT03691974|579723213|FG001|Overall Study|Physician Decision|0|||
160544729|NCT03691974|579723212|FG000|Overall Study|Adverse Event|1|||
160544730|NCT03691974|579723213|FG001|Overall Study|Adverse Event|0|||
160544731|NCT03691974|579723212|FG000|Overall Study|Withdrawal by Subject|11|||
160544732|NCT03691974|579723213|FG001|Overall Study|Withdrawal by Subject|9|||
160544733|NCT03691974|579723212|FG000|Overall Study|Protocol Violation|1|||
160544734|NCT03691974|579723213|FG001|Overall Study|Protocol Violation|0|||
160544735|NCT03691974|579723212|FG000|Overall Study|Lost to Follow-up|8|||
160544736|NCT03691974|579723213|FG001|Overall Study|Lost to Follow-up|7|||
160544737|NCT00513409|579723214|FG000|Overall Study|Adverse Event|0|||
160544738|NCT00513409|579723215|FG001|Overall Study|Adverse Event|1|||
160544739|NCT00513409|579723214|FG000|Overall Study|Withdrawal by Subject|0|||
160544740|NCT00513409|579723215|FG001|Overall Study|Withdrawal by Subject|2|||
160544741|NCT00513409|579723214|FG000|Overall Study|Lost to Follow-up|0|||
160544742|NCT00513409|579723215|FG001|Overall Study|Lost to Follow-up|1|||
160544743|NCT00513409|579723214|FG000|Overall Study|Physician Decision|1|||
160544744|NCT00513409|579723215|FG001|Overall Study|Physician Decision|0|||
160544745|NCT00513409|579723214|FG000|Overall Study|Visit 3 not done|1|||
160544746|NCT00513409|579723215|FG001|Overall Study|Visit 3 not done|2|||
160544747|NCT00691483|579723216|FG000|Overall Study|Adverse Event|14|||
160544748|NCT00691483|579723217|FG001|Overall Study|Adverse Event|6|||
160544749|NCT00691483|579723216|FG000|Overall Study|Lost to Follow-up|17|||
160544750|NCT00691483|579723217|FG001|Overall Study|Lost to Follow-up|10|||
160544751|NCT00691483|579723216|FG000|Overall Study|Withdrawal by Subject|24|||
160544752|NCT00691483|579723217|FG001|Overall Study|Withdrawal by Subject|7|||
160544753|NCT00691483|579723216|FG000|Overall Study|Other known cause|6|||
160544754|NCT00691483|579723217|FG001|Overall Study|Other known cause|1|||
160544755|NCT00691483|579723216|FG000|Overall Study|Randomized by not treated|7|||
160544756|NCT00691483|579723217|FG001|Overall Study|Randomized by not treated|1|||
160544757|NCT04623242|579723218|FG000|Overall Study|Withdrawal by Subject|7|||
160544758|NCT04623242|579723219|FG001|Overall Study|Withdrawal by Subject|12|||
160544759|NCT04623242|579723220|FG002|Overall Study|Withdrawal by Subject|5|||
160544760|NCT04623242|579723221|FG003|Overall Study|Withdrawal by Subject|7|||
160544761|NCT04623242|579723222|FG004|Overall Study|Withdrawal by Subject|0|||
160544762|NCT04623242|579723218|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
160544763|NCT04623242|579723219|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
160544764|NCT04623242|579723220|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
160544765|NCT04623242|579723221|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
160544766|NCT04623242|579723222|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
160544767|NCT04623242|579723218|FG000|Overall Study|Subject unblinded to mutation status|0|||
160544768|NCT04623242|579723219|FG001|Overall Study|Subject unblinded to mutation status|0|||
160544769|NCT04623242|579723220|FG002|Overall Study|Subject unblinded to mutation status|0|||
160544770|NCT04623242|579723221|FG003|Overall Study|Subject unblinded to mutation status|13|||
160544771|NCT04623242|579723222|FG004|Overall Study|Subject unblinded to mutation status|0|||
160544772|NCT02921971|579723225|FG000|Overall Study|Adverse Event|1|||
160544773|NCT02921971|579723226|FG001|Overall Study|Adverse Event|2|||
160544774|NCT02921971|579723225|FG000|Overall Study|Lack of Efficacy|3|||
160544775|NCT02921971|579723226|FG001|Overall Study|Lack of Efficacy|1|||
160787250|NCT04135352|580607278|FG002|Overall Study|Death|7|||
160787251|NCT04135352|580607279|FG003|Overall Study|Death|0|||
160787252|NCT04135352|580607280|FG004|Overall Study|Death|3|||
160787253|NCT04135352|580607281|FG005|Overall Study|Death|1|||
160787254|NCT04135352|580607282|FG006|Overall Study|Death|0|||
160787255|NCT04135352|580607283|FG007|Overall Study|Death|0|||
160787256|NCT00609973|580607284|FG000|Overall Study|Adverse Event|2|||
160787257|NCT00609973|580607285|FG001|Overall Study|Adverse Event|1|||
160787258|NCT00609973|580607284|FG000|Overall Study|Protocol Violation|4|||
160787259|NCT00609973|580607285|FG001|Overall Study|Protocol Violation|3|||
160787260|NCT00609973|580607284|FG000|Overall Study|Lost to Follow-up|2|||
160787261|NCT00609973|580607285|FG001|Overall Study|Lost to Follow-up|1|||
160787262|NCT00609973|580607284|FG000|Overall Study|Withdrawal by Subject|0|||
160787263|NCT00609973|580607285|FG001|Overall Study|Withdrawal by Subject|1|||
160787264|NCT01691482|580607286|FG000|Treatment Period 2|Adverse Event|0|||
160787265|NCT01691482|580607287|FG001|Treatment Period 2|Adverse Event|1|||
160787266|NCT01691482|580607286|FG000|Treatment Period 2|Protocol Violation|1|||
160787267|NCT01691482|580607287|FG001|Treatment Period 2|Protocol Violation|1|||
160787268|NCT01392495|580607288|FG000|Overall Study|Death|3|||
160787269|NCT01392495|580607288|FG000|Overall Study|Administrative problems|8|||
160787270|NCT01392495|580607288|FG000|Overall Study|Withdrawal by Subject|2|||
160787271|NCT01392495|580607288|FG000|Overall Study|Adverse Event|3|||
160787272|NCT01570192|580607289|FG000|Overall Study|no qualifying organism|6|||
160787273|NCT01570192|580607290|FG001|Overall Study|no qualifying organism|12|||
160544776|NCT02921971|579723225|FG000|Overall Study|Other than specified above|2|||
160544777|NCT02921971|579723226|FG001|Overall Study|Other than specified above|1|||
160544778|NCT02105454|579723227|FG000|Overall Study|Withdrawal by Subject|1|||
160544779|NCT00326898|579723228|FG000|Overall Study|Disease progression|52|||
160544780|NCT00326898|579723229|FG001|Overall Study|Disease progression|54|||
160544781|NCT00326898|579723230|FG002|Overall Study|Disease progression|102|||
160544782|NCT00326898|579723228|FG000|Overall Study|Adverse Event|124|||
160544783|NCT00326898|579723229|FG001|Overall Study|Adverse Event|128|||
160544784|NCT00326898|579723230|FG002|Overall Study|Adverse Event|33|||
160544785|NCT00326898|579723228|FG000|Overall Study|Death|2|||
160544786|NCT00326898|579723229|FG001|Overall Study|Death|0|||
160544787|NCT00326898|579723230|FG002|Overall Study|Death|0|||
160544788|NCT00326898|579723228|FG000|Overall Study|Withdrawal by Subject|134|||
160544789|NCT00326898|579723229|FG001|Overall Study|Withdrawal by Subject|128|||
160544790|NCT00326898|579723230|FG002|Overall Study|Withdrawal by Subject|32|||
160544791|NCT00326898|579723228|FG000|Overall Study|Alternative therapy|1|||
160544792|NCT00326898|579723229|FG001|Overall Study|Alternative therapy|0|||
160544793|NCT00326898|579723230|FG002|Overall Study|Alternative therapy|0|||
160544794|NCT00326898|579723228|FG000|Overall Study|Other complicating disease|5|||
160544795|NCT00326898|579723229|FG001|Overall Study|Other complicating disease|5|||
160544796|NCT00326898|579723230|FG002|Overall Study|Other complicating disease|4|||
160544797|NCT00326898|579723228|FG000|Overall Study|Other/Missing/Unknown|33|||
160544798|NCT00326898|579723229|FG001|Overall Study|Other/Missing/Unknown|28|||
160787274|NCT01570192|580607289|FG000|Overall Study|changed to palliative care|1|||
160787275|NCT01570192|580607290|FG001|Overall Study|changed to palliative care|0|||
160787276|NCT01570192|580607289|FG000|Overall Study|Physician Decision|0|||
160544799|NCT00326898|579723230|FG002|Overall Study|Other/Missing/Unknown|32|||
160787277|NCT01570192|580607290|FG001|Overall Study|Physician Decision|1|||
160787278|NCT02965976|580607291|FG000|Overall Study|Withdrawal by Subject|2|||
160544800|NCT03847987|579723231|FG000|Overall Study|Lost to Follow-up|1|||
160544801|NCT03847987|579723232|FG001|Overall Study|Lost to Follow-up|0|||
160544802|NCT03847987|579723231|FG000|Overall Study|Adverse Event|2|||
160544803|NCT03847987|579723232|FG001|Overall Study|Adverse Event|0|||
160544804|NCT02721355|579723235|FG000|Overall Study|Lost to Follow-up|6|||
160544805|NCT02721355|579723236|FG001|Overall Study|Lost to Follow-up|1|||
160544806|NCT00356278|579723237|FG000|Overall Study|Withdrawal by Subject|25|||
160787279|NCT02965976|580607292|FG001|Overall Study|Withdrawal by Subject|0|||
160787280|NCT00806026|580607293|FG000|Overall Study|Death|0|||
160787281|NCT00806026|580607294|FG001|Overall Study|Death|0|||
160787282|NCT00806026|580607295|FG002|Overall Study|Death|0|||
160787283|NCT00806026|580607296|FG003|Overall Study|Death|1|||
160787284|NCT00806026|580607297|FG004|Overall Study|Death|0|||
160787285|NCT00806026|580607298|FG005|Overall Study|Death|0|||
160787286|NCT00806026|580607293|FG000|Overall Study|Did not meet entrance criteria|4|||
160787287|NCT00806026|580607294|FG001|Overall Study|Did not meet entrance criteria|1|||
160787288|NCT00806026|580607295|FG002|Overall Study|Did not meet entrance criteria|2|||
160787289|NCT00806026|580607296|FG003|Overall Study|Did not meet entrance criteria|1|||
160787290|NCT00806026|580607297|FG004|Overall Study|Did not meet entrance criteria|0|||
160787291|NCT00806026|580607298|FG005|Overall Study|Did not meet entrance criteria|0|||
160787292|NCT00806026|580607293|FG000|Overall Study|Lack of Efficacy|5|||
160787293|NCT00806026|580607294|FG001|Overall Study|Lack of Efficacy|18|||
160787294|NCT00806026|580607295|FG002|Overall Study|Lack of Efficacy|13|||
160787295|NCT00806026|580607296|FG003|Overall Study|Lack of Efficacy|4|||
160787296|NCT00806026|580607297|FG004|Overall Study|Lack of Efficacy|8|||
160787297|NCT00806026|580607298|FG005|Overall Study|Lack of Efficacy|7|||
160787298|NCT00806026|580607293|FG000|Overall Study|Lost to Follow-up|8|||
160787299|NCT00806026|580607294|FG001|Overall Study|Lost to Follow-up|15|||
160787300|NCT00806026|580607295|FG002|Overall Study|Lost to Follow-up|8|||
160787301|NCT00806026|580607296|FG003|Overall Study|Lost to Follow-up|2|||
160787302|NCT00806026|580607297|FG004|Overall Study|Lost to Follow-up|6|||
160787303|NCT00806026|580607298|FG005|Overall Study|Lost to Follow-up|6|||
160787304|NCT00806026|580607293|FG000|Overall Study|Withdrawal by Subject|14|||
160787305|NCT00806026|580607294|FG001|Overall Study|Withdrawal by Subject|17|||
160787306|NCT00806026|580607295|FG002|Overall Study|Withdrawal by Subject|9|||
160787307|NCT00806026|580607296|FG003|Overall Study|Withdrawal by Subject|2|||
160787308|NCT00806026|580607297|FG004|Overall Study|Withdrawal by Subject|5|||
160787309|NCT00806026|580607298|FG005|Overall Study|Withdrawal by Subject|3|||
160787310|NCT00806026|580607293|FG000|Overall Study|Other|3|||
160787311|NCT00806026|580607294|FG001|Overall Study|Other|6|||
160787312|NCT00806026|580607295|FG002|Overall Study|Other|8|||
160787313|NCT00806026|580607296|FG003|Overall Study|Other|2|||
160787314|NCT00806026|580607297|FG004|Overall Study|Other|0|||
160787315|NCT00806026|580607298|FG005|Overall Study|Other|4|||
160787316|NCT00806026|580607293|FG000|Overall Study|Protocol Violation|6|||
160787317|NCT00806026|580607294|FG001|Overall Study|Protocol Violation|9|||
160787318|NCT00806026|580607295|FG002|Overall Study|Protocol Violation|9|||
160787319|NCT00806026|580607296|FG003|Overall Study|Protocol Violation|0|||
160787320|NCT00806026|580607297|FG004|Overall Study|Protocol Violation|2|||
160787321|NCT00806026|580607298|FG005|Overall Study|Protocol Violation|3|||
160787322|NCT00806026|580607293|FG000|Overall Study|Adverse Event|52|||
160787323|NCT00806026|580607294|FG001|Overall Study|Adverse Event|35|||
160787324|NCT00806026|580607295|FG002|Overall Study|Adverse Event|44|||
160787325|NCT00806026|580607296|FG003|Overall Study|Adverse Event|17|||
160787326|NCT00806026|580607297|FG004|Overall Study|Adverse Event|9|||
160544807|NCT00356278|579723238|FG001|Overall Study|Withdrawal by Subject|15|||
160544808|NCT00356278|579723239|FG002|Overall Study|Withdrawal by Subject|19|||
160544809|NCT00527605|579723244|FG000|Overall Study|Adverse Event|3|||
160544810|NCT00527605|579723245|FG001|Overall Study|Adverse Event|0|||
160640773|NCT01904383|580068824|FG000|Overall Study|Adverse Event|271|||
160640774|NCT01904383|580068824|FG000|Overall Study|No patient visit after entry|54|||
160640775|NCT01294592|580068825|FG000|Overall Study|Adverse Event|28|||
160640776|NCT01294592|580068826|FG001|Overall Study|Adverse Event|13|||
160640777|NCT01294592|580068825|FG000|Overall Study|Lack of Efficacy|7|||
160640778|NCT01294592|580068826|FG001|Overall Study|Lack of Efficacy|5|||
160640779|NCT01294592|580068825|FG000|Overall Study|Protocol Violation|1|||
160544811|NCT00527605|579723244|FG000|Overall Study|Withdrawal by Subject|3|||
160544812|NCT00527605|579723245|FG001|Overall Study|Withdrawal by Subject|7|||
160544813|NCT00527605|579723244|FG000|Overall Study|Lost to Follow-up|6|||
160544814|NCT00527605|579723245|FG001|Overall Study|Lost to Follow-up|2|||
160544815|NCT00527605|579723244|FG000|Overall Study|Protocol Violation|1|||
160544816|NCT00527605|579723245|FG001|Overall Study|Protocol Violation|2|||
160544817|NCT01363986|579723251|FG000|Overall Study|Disease progression|1|||
160544818|NCT01637142|579723252|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
160544819|NCT02111564|579723255|FG000|Overall Study|Death|109|||
160544820|NCT02111564|579723256|FG001|Overall Study|Death|120|||
160544821|NCT02111564|579723255|FG000|Overall Study|Lost to Follow-up|2|||
160544822|NCT02111564|579723256|FG001|Overall Study|Lost to Follow-up|3|||
160544823|NCT02111564|579723255|FG000|Overall Study|Withdrawal by Subject|20|||
160544824|NCT02111564|579723256|FG001|Overall Study|Withdrawal by Subject|20|||
160640780|NCT01294592|580068826|FG001|Overall Study|Protocol Violation|7|||
160640781|NCT01294592|580068825|FG000|Overall Study|Lost to Follow-up|7|||
160787327|NCT00806026|580607298|FG005|Overall Study|Adverse Event|9|||
160787328|NCT00819832|580607299|FG000|Overall Study|Sponsor Termination of Study|3|||
160787329|NCT00819832|580607300|FG001|Overall Study|Sponsor Termination of Study|0|||
160787330|NCT00819832|580607301|FG002|Overall Study|Sponsor Termination of Study|0|||
160787331|NCT00819832|580607302|FG003|Overall Study|Sponsor Termination of Study|0|||
160787332|NCT00819832|580607303|FG004|Overall Study|Sponsor Termination of Study|0|||
160787333|NCT00819832|580607304|FG005|Overall Study|Sponsor Termination of Study|0|||
160787334|NCT01063881|580607307|FG000|Overall Study|Adverse Event|12|||
160787335|NCT01063881|580607308|FG001|Overall Study|Adverse Event|2|||
160787336|NCT01063881|580607309|FG002|Overall Study|Adverse Event|0|||
160787337|NCT01063881|580607307|FG000|Overall Study|Lost to Follow-up|13|||
160787338|NCT01063881|580607308|FG001|Overall Study|Lost to Follow-up|7|||
160787339|NCT01063881|580607309|FG002|Overall Study|Lost to Follow-up|1|||
160787340|NCT01063881|580607307|FG000|Overall Study|Withdrawal by Subject|25|||
160787341|NCT01063881|580607308|FG001|Overall Study|Withdrawal by Subject|1|||
160787342|NCT01063881|580607309|FG002|Overall Study|Withdrawal by Subject|0|||
160787343|NCT01063881|580607307|FG000|Overall Study|Reason for not completed not specified|5|||
160787344|NCT01063881|580607308|FG001|Overall Study|Reason for not completed not specified|1|||
160787345|NCT01063881|580607309|FG002|Overall Study|Reason for not completed not specified|0|||
160787346|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
160787347|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
160787348|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
160787349|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
160787350|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
160787351|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
160787352|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
160787353|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
160787354|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
160787355|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
160787356|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
160787357|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
160787358|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
160787359|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
160787360|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
160787361|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
160787362|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
160787363|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
160640782|NCT01294592|580068826|FG001|Overall Study|Lost to Follow-up|9|||
160640783|NCT01294592|580068825|FG000|Overall Study|Physician Decision|6|||
160640784|NCT01294592|580068826|FG001|Overall Study|Physician Decision|11|||
160640785|NCT01294592|580068825|FG000|Overall Study|Withdrawal by Subject|28|||
160640786|NCT01294592|580068826|FG001|Overall Study|Withdrawal by Subject|28|||
160640787|NCT00693784|580068827|FG000|Overall Study|Lost to Follow-up|2|||
160640788|NCT00693784|580068827|FG000|Overall Study|Withdrawal by Subject|2|||
160640789|NCT04313283|580068828|FG000|Overall Study|did not complete intervention|4|||
160640790|NCT04126733|580068829|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
160640791|NCT04126733|580068829|FG000|Treatment Period|Adverse Event|8|||
160640792|NCT04126733|580068829|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
160640793|NCT04126733|580068829|FG000|Treatment Period|Physician Decision|5|||
160640794|NCT04126733|580068829|FG000|Treatment Period|Death|1|||
160640795|NCT04126733|580068829|FG000|Treatment Period|Other Reasons|2|||
160640796|NCT04126733|580068829|FG000|Active Follow-up Period|Death|13|||
160640797|NCT04126733|580068829|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
160640798|NCT04126733|580068829|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
160640799|NCT04126733|580068829|FG000|Active Follow-up Period|Other Reasons|1|||
160787364|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
160787365|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
160787366|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
160787367|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
160787368|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
160787369|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
160787370|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
160787371|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
160787372|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
160787373|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
160787374|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
160787375|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
160787376|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
160787377|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
160787378|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
160787379|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
160787380|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
160787381|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
160787382|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
160787383|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
160787384|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
160787385|NCT01370642|580607314|FG000|Overall Study|Adverse Event|2|||
160787386|NCT01370642|580607315|FG001|Overall Study|Adverse Event|1|||
160787387|NCT01370642|580607316|FG002|Overall Study|Adverse Event|1|||
160787388|NCT01370642|580607314|FG000|Overall Study|Detectable HCV RNA|0|||
160787389|NCT01370642|580607315|FG001|Overall Study|Detectable HCV RNA|0|||
160787390|NCT01370642|580607316|FG002|Overall Study|Detectable HCV RNA|22|||
160787391|NCT01370642|580607314|FG000|Overall Study|Lost to Follow-up|0|||
160787392|NCT01370642|580607315|FG001|Overall Study|Lost to Follow-up|0|||
160787393|NCT01370642|580607316|FG002|Overall Study|Lost to Follow-up|1|||
160787394|NCT01370642|580607314|FG000|Overall Study|Physician Decision|4|||
160787395|NCT01370642|580607315|FG001|Overall Study|Physician Decision|1|||
160787396|NCT01370642|580607316|FG002|Overall Study|Physician Decision|2|||
160787397|NCT01370642|580607314|FG000|Overall Study|Withdrawal by Subject|2|||
160787398|NCT01370642|580607315|FG001|Overall Study|Withdrawal by Subject|4|||
160787399|NCT01370642|580607316|FG002|Overall Study|Withdrawal by Subject|3|||
160787400|NCT00147537|580607323|FG000|Phase 1b|Death|0|||
160787401|NCT00147537|580607324|FG001|Phase 1b|Death|1|||
160787402|NCT00147537|580607325|FG002|Phase 1b|Death|2|||
160787403|NCT00147537|580607326|FG003|Phase 1b|Death|1|||
160787404|NCT00147537|580607327|FG004|Phase 1b|Death|2|||
160787405|NCT00147537|580607328|FG005|Phase 1b|Death|2|||
160787406|NCT00147537|580607329|FG006|Phase 1b|Death|1|||
160787407|NCT00147537|580607330|FG007|Phase 1b|Death|3|||
160787408|NCT00147537|580607331|FG008|Phase 1b|Death|9|||
160787409|NCT00147537|580607332|FG009|Phase 1b|Death|0|||
160787410|NCT00147537|580607333|FG010|Phase 1b|Death|0|||
160787411|NCT00147537|580607323|FG000|Phase 1b|Lost to Follow-up|2|||
160787412|NCT00147537|580607324|FG001|Phase 1b|Lost to Follow-up|1|||
160787413|NCT00147537|580607325|FG002|Phase 1b|Lost to Follow-up|0|||
160787414|NCT00147537|580607326|FG003|Phase 1b|Lost to Follow-up|0|||
160787415|NCT00147537|580607327|FG004|Phase 1b|Lost to Follow-up|0|||
160787416|NCT00147537|580607328|FG005|Phase 1b|Lost to Follow-up|0|||
160787417|NCT00147537|580607329|FG006|Phase 1b|Lost to Follow-up|2|||
160787418|NCT00147537|580607330|FG007|Phase 1b|Lost to Follow-up|0|||
160787419|NCT00147537|580607331|FG008|Phase 1b|Lost to Follow-up|1|||
160787420|NCT00147537|580607332|FG009|Phase 1b|Lost to Follow-up|0|||
160787421|NCT00147537|580607333|FG010|Phase 1b|Lost to Follow-up|0|||
160787422|NCT00147537|580607323|FG000|Phase 1b|Other|0|||
160787423|NCT00147537|580607324|FG001|Phase 1b|Other|0|||
160787424|NCT00147537|580607325|FG002|Phase 1b|Other|2|||
160787425|NCT00147537|580607326|FG003|Phase 1b|Other|1|||
160787426|NCT00147537|580607327|FG004|Phase 1b|Other|1|||
160787427|NCT00147537|580607328|FG005|Phase 1b|Other|1|||
160787428|NCT00147537|580607329|FG006|Phase 1b|Other|14|||
160787429|NCT00147537|580607330|FG007|Phase 1b|Other|4|||
160787430|NCT00147537|580607331|FG008|Phase 1b|Other|4|||
160787431|NCT00147537|580607332|FG009|Phase 1b|Other|0|||
160787432|NCT00147537|580607333|FG010|Phase 1b|Other|0|||
160787433|NCT00147537|580607323|FG000|Phase 1b|Withdrawal by Subject|0|||
160787434|NCT00147537|580607324|FG001|Phase 1b|Withdrawal by Subject|0|||
160787435|NCT00147537|580607325|FG002|Phase 1b|Withdrawal by Subject|0|||
160787436|NCT00147537|580607326|FG003|Phase 1b|Withdrawal by Subject|0|||
160787437|NCT00147537|580607327|FG004|Phase 1b|Withdrawal by Subject|0|||
160787438|NCT00147537|580607328|FG005|Phase 1b|Withdrawal by Subject|0|||
160787439|NCT00147537|580607329|FG006|Phase 1b|Withdrawal by Subject|0|||
160787440|NCT00147537|580607330|FG007|Phase 1b|Withdrawal by Subject|0|||
160787441|NCT00147537|580607331|FG008|Phase 1b|Withdrawal by Subject|2|||
160787442|NCT00147537|580607332|FG009|Phase 1b|Withdrawal by Subject|0|||
160787443|NCT00147537|580607333|FG010|Phase 1b|Withdrawal by Subject|0|||
160787444|NCT00147537|580607323|FG000|Phase 1b|Randomized but not treated|0|||
160787445|NCT00147537|580607324|FG001|Phase 1b|Randomized but not treated|0|||
160787446|NCT00147537|580607325|FG002|Phase 1b|Randomized but not treated|0|||
160787447|NCT00147537|580607326|FG003|Phase 1b|Randomized but not treated|0|||
160787448|NCT00147537|580607327|FG004|Phase 1b|Randomized but not treated|0|||
160787449|NCT00147537|580607328|FG005|Phase 1b|Randomized but not treated|0|||
160787450|NCT00147537|580607329|FG006|Phase 1b|Randomized but not treated|1|||
160787451|NCT00147537|580607330|FG007|Phase 1b|Randomized but not treated|0|||
160787452|NCT00147537|580607331|FG008|Phase 1b|Randomized but not treated|1|||
160787453|NCT00147537|580607332|FG009|Phase 1b|Randomized but not treated|0|||
160787454|NCT00147537|580607333|FG010|Phase 1b|Randomized but not treated|0|||
160787455|NCT00147537|580607323|FG000|Phase 2|Death|0|||
160787456|NCT00147537|580607324|FG001|Phase 2|Death|0|||
160787457|NCT00147537|580607325|FG002|Phase 2|Death|0|||
160787458|NCT00147537|580607326|FG003|Phase 2|Death|0|||
160787459|NCT00147537|580607327|FG004|Phase 2|Death|0|||
160787460|NCT00147537|580607328|FG005|Phase 2|Death|0|||
160787461|NCT00147537|580607329|FG006|Phase 2|Death|0|||
160787462|NCT00147537|580607330|FG007|Phase 2|Death|0|||
160787463|NCT00147537|580607331|FG008|Phase 2|Death|0|||
160787464|NCT00147537|580607332|FG009|Phase 2|Death|85|||
160787465|NCT00147537|580607333|FG010|Phase 2|Death|31|||
160787466|NCT00147537|580607323|FG000|Phase 2|Lost to Follow-up|0|||
160787467|NCT00147537|580607324|FG001|Phase 2|Lost to Follow-up|0|||
160787468|NCT00147537|580607325|FG002|Phase 2|Lost to Follow-up|0|||
160787469|NCT00147537|580607326|FG003|Phase 2|Lost to Follow-up|0|||
160787470|NCT00147537|580607327|FG004|Phase 2|Lost to Follow-up|0|||
160787471|NCT00147537|580607328|FG005|Phase 2|Lost to Follow-up|0|||
160787472|NCT00147537|580607329|FG006|Phase 2|Lost to Follow-up|0|||
160787473|NCT00147537|580607330|FG007|Phase 2|Lost to Follow-up|0|||
160787474|NCT00147537|580607331|FG008|Phase 2|Lost to Follow-up|0|||
160787475|NCT00147537|580607332|FG009|Phase 2|Lost to Follow-up|12|||
160787476|NCT00147537|580607333|FG010|Phase 2|Lost to Follow-up|4|||
160787477|NCT00147537|580607323|FG000|Phase 2|Other|0|||
160787478|NCT00147537|580607324|FG001|Phase 2|Other|0|||
160787479|NCT00147537|580607325|FG002|Phase 2|Other|0|||
160787480|NCT00147537|580607326|FG003|Phase 2|Other|0|||
160787481|NCT00147537|580607327|FG004|Phase 2|Other|0|||
160787482|NCT00147537|580607328|FG005|Phase 2|Other|0|||
160787483|NCT00147537|580607329|FG006|Phase 2|Other|0|||
160787484|NCT00147537|580607330|FG007|Phase 2|Other|0|||
160787485|NCT00147537|580607331|FG008|Phase 2|Other|0|||
160787486|NCT00147537|580607332|FG009|Phase 2|Other|47|||
160787487|NCT00147537|580607333|FG010|Phase 2|Other|12|||
160787488|NCT00147537|580607323|FG000|Phase 2|Withdrawal by Subject|0|||
160787489|NCT00147537|580607324|FG001|Phase 2|Withdrawal by Subject|0|||
160787490|NCT00147537|580607325|FG002|Phase 2|Withdrawal by Subject|0|||
160787491|NCT00147537|580607326|FG003|Phase 2|Withdrawal by Subject|0|||
160787492|NCT00147537|580607327|FG004|Phase 2|Withdrawal by Subject|0|||
160787493|NCT00147537|580607328|FG005|Phase 2|Withdrawal by Subject|0|||
160787494|NCT00147537|580607329|FG006|Phase 2|Withdrawal by Subject|0|||
160544825|NCT00687362|579723257|FG000|Overall Study|Protocol Violation|2|||
160544826|NCT00687362|579723257|FG000|Overall Study|Withdrawal by Subject|1|||
160544827|NCT03704194|579723259|FG000|Overall Study|Withdrawal by Subject|0|||
160544828|NCT03704194|579723260|FG001|Overall Study|Withdrawal by Subject|1|||
160544829|NCT00925015|579723261|FG000|Overall Study|Adverse Event|1|||
160544830|NCT00925015|579723262|FG001|Overall Study|Adverse Event|2|||
160544831|NCT00925015|579723263|FG002|Overall Study|Adverse Event|1|||
160544832|NCT00925015|579723261|FG000|Overall Study|Physician Decision|0|||
160544833|NCT00925015|579723262|FG001|Overall Study|Physician Decision|1|||
160544834|NCT00925015|579723263|FG002|Overall Study|Physician Decision|0|||
160787495|NCT00147537|580607330|FG007|Phase 2|Withdrawal by Subject|0|||
160787496|NCT00147537|580607331|FG008|Phase 2|Withdrawal by Subject|0|||
160787497|NCT00147537|580607332|FG009|Phase 2|Withdrawal by Subject|16|||
160787498|NCT00147537|580607333|FG010|Phase 2|Withdrawal by Subject|4|||
160787499|NCT00147537|580607323|FG000|Phase 2|Randomized but not treated|0|||
160787500|NCT00147537|580607324|FG001|Phase 2|Randomized but not treated|0|||
160787501|NCT00147537|580607325|FG002|Phase 2|Randomized but not treated|0|||
160544835|NCT00925015|579723261|FG000|Overall Study|Progressive Disease|7|||
160544836|NCT00925015|579723262|FG001|Overall Study|Progressive Disease|3|||
160544837|NCT00925015|579723263|FG002|Overall Study|Progressive Disease|4|||
160787502|NCT00147537|580607326|FG003|Phase 2|Randomized but not treated|0|||
160787503|NCT00147537|580607327|FG004|Phase 2|Randomized but not treated|0|||
160544838|NCT00925015|579723261|FG000|Overall Study|Withdrawal by Subject|0|||
160640800|NCT04126733|580068829|FG000|Long-term Follow-up Period|Death|22|||
160787504|NCT00147537|580607328|FG005|Phase 2|Randomized but not treated|0|||
160787505|NCT00147537|580607329|FG006|Phase 2|Randomized but not treated|0|||
160787506|NCT00147537|580607330|FG007|Phase 2|Randomized but not treated|0|||
160787507|NCT00147537|580607331|FG008|Phase 2|Randomized but not treated|0|||
160787508|NCT00147537|580607332|FG009|Phase 2|Randomized but not treated|1|||
160787509|NCT00147537|580607333|FG010|Phase 2|Randomized but not treated|1|||
160787510|NCT00987935|580607334|FG000|Overall Study|Progressive disease|3|||
160544839|NCT00925015|579723262|FG001|Overall Study|Withdrawal by Subject|0|||
160544840|NCT00925015|579723263|FG002|Overall Study|Withdrawal by Subject|1|||
160544841|NCT04986202|579723266|FG000|Overall Study|Death|10|||
160544842|NCT04986202|579723267|FG001|Overall Study|Death|3|||
160544843|NCT04986202|579723268|FG002|Overall Study|Death|10|||
160544844|NCT04986202|579723266|FG000|Overall Study|Physician Decision|3|||
160544845|NCT04986202|579723267|FG001|Overall Study|Physician Decision|1|||
160544846|NCT04986202|579723268|FG002|Overall Study|Physician Decision|2|||
160640801|NCT04126733|580068829|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
160640802|NCT04126733|580068829|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
160640803|NCT03870997|580068830|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
160640804|NCT03870997|580068831|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
160640805|NCT03870997|580068832|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
160640806|NCT03870997|580068833|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
160640807|NCT03870997|580068834|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
160640808|NCT03870997|580068835|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
160640809|NCT02059187|580068840|FG000|Overall Study|Adverse Event|0|||
160640810|NCT02059187|580068841|FG001|Overall Study|Adverse Event|3|||
160640811|NCT02059187|580068840|FG000|Overall Study|Death|1|||
160640812|NCT02059187|580068841|FG001|Overall Study|Death|1|||
160640813|NCT02059187|580068840|FG000|Overall Study|Lost to Follow-up|9|||
160640814|NCT02059187|580068841|FG001|Overall Study|Lost to Follow-up|8|||
160640815|NCT02059187|580068840|FG000|Overall Study|Non-compliance with study drug|1|||
160544847|NCT04986202|579723266|FG000|Overall Study|Withdrawal by Subject|4|||
160544848|NCT04986202|579723267|FG001|Overall Study|Withdrawal by Subject|2|||
160544849|NCT04986202|579723268|FG002|Overall Study|Withdrawal by Subject|4|||
160544850|NCT05131204|579723269|FG000|Overall Study|Sponsor request|2|||
160544851|NCT05131204|579723270|FG001|Overall Study|Sponsor request|1|||
160544852|NCT05882318|579723272|FG000|Overall Study|Withdrawal by Subject|1|||
160544853|NCT05882318|579723273|FG001|Overall Study|Withdrawal by Subject|0|||
160544854|NCT05882318|579723272|FG000|Overall Study|Protocol Violation|0|||
160544855|NCT05882318|579723273|FG001|Overall Study|Protocol Violation|1|||
160544856|NCT03042468|579723274|FG000|Overall Study|Death|0|||
160544857|NCT03042468|579723275|FG001|Overall Study|Death|1|||
160544858|NCT03042468|579723276|FG002|Overall Study|Death|1|||
160544859|NCT03042468|579723277|FG003|Overall Study|Death|0|||
160544860|NCT03042468|579723278|FG004|Overall Study|Death|0|||
160544861|NCT03042468|579723279|FG005|Overall Study|Death|0|||
160544862|NCT03042468|579723274|FG000|Overall Study|Withdrawal by Subject|0|||
160544863|NCT03042468|579723275|FG001|Overall Study|Withdrawal by Subject|0|||
160544864|NCT03042468|579723276|FG002|Overall Study|Withdrawal by Subject|0|||
160544865|NCT03042468|579723277|FG003|Overall Study|Withdrawal by Subject|0|||
160544866|NCT03042468|579723278|FG004|Overall Study|Withdrawal by Subject|0|||
160544867|NCT03042468|579723279|FG005|Overall Study|Withdrawal by Subject|1|||
160544868|NCT03042468|579723274|FG000|Overall Study|Lost to Follow-up|0|||
160544869|NCT03042468|579723275|FG001|Overall Study|Lost to Follow-up|0|||
160544870|NCT03042468|579723276|FG002|Overall Study|Lost to Follow-up|0|||
160544871|NCT03042468|579723277|FG003|Overall Study|Lost to Follow-up|0|||
160544872|NCT03042468|579723278|FG004|Overall Study|Lost to Follow-up|1|||
160544873|NCT03042468|579723279|FG005|Overall Study|Lost to Follow-up|1|||
160544874|NCT01485627|579723282|FG000|Overall Study|Patient withdrew|6|||
160544875|NCT01485627|579723283|FG001|Overall Study|Patient withdrew|5|||
160544876|NCT01485627|579723282|FG000|Overall Study|Patient died|3|||
160544877|NCT01485627|579723283|FG001|Overall Study|Patient died|1|||
160544878|NCT01485627|579723282|FG000|Overall Study|Patient lost to followup|0|||
160544879|NCT01485627|579723283|FG001|Overall Study|Patient lost to followup|1|||
160544880|NCT01485627|579723282|FG000|Overall Study|Caregiver withdrew|3|||
160544881|NCT01485627|579723283|FG001|Overall Study|Caregiver withdrew|3|||
160544882|NCT01485627|579723282|FG000|Overall Study|Caregiver lost to follow up|11|||
160544883|NCT01485627|579723283|FG001|Overall Study|Caregiver lost to follow up|12|||
160544884|NCT01485627|579723282|FG000|Overall Study|Caregiver died|1|||
160544885|NCT01485627|579723283|FG001|Overall Study|Caregiver died|0|||
160544886|NCT01485627|579723282|FG000|Overall Study|caregiver was not bereaved|42|||
160544887|NCT01485627|579723283|FG001|Overall Study|caregiver was not bereaved|35|||
160544888|NCT01709149|579723284|FG000|Open-label Lead-in Phase|Adverse Event|109|||
160544889|NCT01709149|579723285|FG001|Open-label Lead-in Phase|Adverse Event|0|||
160544890|NCT01709149|579723286|FG002|Open-label Lead-in Phase|Adverse Event|0|||
160544891|NCT01709149|579723284|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
160544892|NCT01709149|579723285|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
160544893|NCT01709149|579723286|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
160544894|NCT01709149|579723284|FG000|Open-label Lead-in Phase|Death|1|||
160544895|NCT01709149|579723285|FG001|Open-label Lead-in Phase|Death|0|||
160544896|NCT01709149|579723286|FG002|Open-label Lead-in Phase|Death|0|||
160544897|NCT01709149|579723284|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
160544898|NCT01709149|579723285|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
160544899|NCT01709149|579723286|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
160544900|NCT01709149|579723284|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
160544901|NCT01709149|579723285|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
160544902|NCT01709149|579723286|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
160544903|NCT01709149|579723284|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160544904|NCT01709149|579723285|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
160544905|NCT01709149|579723286|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
160544906|NCT01709149|579723284|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160544907|NCT01709149|579723285|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
160544908|NCT01709149|579723286|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
160544909|NCT01709149|579723284|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
160544910|NCT01709149|579723285|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
160544911|NCT01709149|579723286|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
160544912|NCT01709149|579723284|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
160544913|NCT01709149|579723285|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
160544914|NCT01709149|579723286|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
160544915|NCT01709149|579723284|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160544916|NCT01709149|579723285|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
160544917|NCT01709149|579723286|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160544918|NCT03509350|579723287|FG000|Overall Study|Withdrawal by Subject|0|||
160544919|NCT03509350|579723288|FG001|Overall Study|Withdrawal by Subject|2|||
160544920|NCT00290433|579723291|FG000|Overall Study|Disease Progression|13|||
160544921|NCT00290433|579723291|FG000|Overall Study|Adverse Event|14|||
160544922|NCT00290433|579723291|FG000|Overall Study|Withdrawal by Subject|1|||
160544923|NCT00290433|579723291|FG000|Overall Study|Non-Compliance|1|||
160544924|NCT00290433|579723291|FG000|Overall Study|Congestive Heart Failure|1|||
160544925|NCT00290433|579723291|FG000|Overall Study|Transplant in CR|5|||
160544926|NCT00290433|579723291|FG000|Overall Study|Unrelated Infection/Death|1|||
160544927|NCT02275338|579723296|FG000|Overall Study|Adverse Event|15|||
160544928|NCT02275338|579723296|FG000|Overall Study|Lack of Efficacy|3|||
160544929|NCT02275338|579723296|FG000|Overall Study|Withdrawal by Subject|4|||
160544930|NCT02275338|579723296|FG000|Overall Study|Disease progression (death)|1|||
160640816|NCT02059187|580068841|FG001|Overall Study|Non-compliance with study drug|0|||
160544931|NCT02275338|579723296|FG000|Overall Study|Ineligible to start Phase 2|4|||
160544932|NCT02275338|579723296|FG000|Overall Study|Reason not specified|5|||
160544933|NCT02275338|579723296|FG000|Overall Study|Does not meet entry criteria|1|||
160544934|NCT01665807|579723300|FG000|Overall Study|Withdrawal by Subject|2|||
160544935|NCT01665807|579723301|FG001|Overall Study|Withdrawal by Subject|0|||
160544936|NCT01665807|579723302|FG002|Overall Study|Withdrawal by Subject|1|||
160544937|NCT02937818|579723311|FG000|Overall Study|Participants decision|2|||
160544938|NCT02937818|579723312|FG001|Overall Study|Participants decision|1|||
160544939|NCT02937818|579723313|FG002|Overall Study|Participants decision|1|||
160544940|NCT02937818|579723314|FG003|Overall Study|Participants decision|1|||
160544941|NCT02937818|579723311|FG000|Overall Study|Adverse Event|2|||
160544942|NCT02937818|579723312|FG001|Overall Study|Adverse Event|4|||
160544943|NCT02937818|579723313|FG002|Overall Study|Adverse Event|1|||
160544944|NCT02937818|579723314|FG003|Overall Study|Adverse Event|1|||
160544945|NCT02937818|579723311|FG000|Overall Study|Disease progression|17|||
160544946|NCT02937818|579723312|FG001|Overall Study|Disease progression|15|||
160544947|NCT02937818|579723313|FG002|Overall Study|Disease progression|7|||
160544948|NCT02937818|579723314|FG003|Overall Study|Disease progression|19|||
160544949|NCT02937818|579723311|FG000|Overall Study|Condition under investigation worsened|0|||
160544950|NCT02937818|579723312|FG001|Overall Study|Condition under investigation worsened|0|||
160544951|NCT02937818|579723313|FG002|Overall Study|Condition under investigation worsened|1|||
160544952|NCT02937818|579723314|FG003|Overall Study|Condition under investigation worsened|0|||
160544953|NCT00889265|579723315|FG000|Overall Study|Adverse Event|1|||
160544954|NCT00889265|579723315|FG000|Overall Study|Lost to Follow-up|5|||
160544955|NCT00889265|579723315|FG000|Overall Study|Protocol Violation|1|||
160544956|NCT03028870|579723316|FG000|Overall Study|Adverse Event|7|||
160544957|NCT03028870|579723317|FG001|Overall Study|Adverse Event|4|||
160544958|NCT03028870|579723318|FG002|Overall Study|Adverse Event|3|||
160544959|NCT03028870|579723319|FG003|Overall Study|Adverse Event|3|||
160544960|NCT03028870|579723316|FG000|Overall Study|Withdrawal by Subject|1|||
160544961|NCT03028870|579723317|FG001|Overall Study|Withdrawal by Subject|1|||
160544962|NCT03028870|579723318|FG002|Overall Study|Withdrawal by Subject|1|||
160544963|NCT03028870|579723319|FG003|Overall Study|Withdrawal by Subject|2|||
160544964|NCT03028870|579723316|FG000|Overall Study|Lost to Follow-up|1|||
160544965|NCT03028870|579723317|FG001|Overall Study|Lost to Follow-up|0|||
160544966|NCT03028870|579723318|FG002|Overall Study|Lost to Follow-up|0|||
160544967|NCT03028870|579723319|FG003|Overall Study|Lost to Follow-up|0|||
160544968|NCT03028870|579723316|FG000|Overall Study|Lack of Efficacy|3|||
160544969|NCT03028870|579723317|FG001|Overall Study|Lack of Efficacy|0|||
160544970|NCT03028870|579723318|FG002|Overall Study|Lack of Efficacy|0|||
160544971|NCT03028870|579723319|FG003|Overall Study|Lack of Efficacy|0|||
160544972|NCT03028870|579723316|FG000|Overall Study|Administrative|5|||
160544973|NCT03028870|579723317|FG001|Overall Study|Administrative|5|||
160544974|NCT03028870|579723318|FG002|Overall Study|Administrative|12|||
160544975|NCT03028870|579723319|FG003|Overall Study|Administrative|4|||
160544976|NCT01967537|579723322|FG000|Overall Study|Withdrawal by Subject|52|||
160544977|NCT01967537|579723322|FG000|Overall Study|Refuse treatment|2|||
160544978|NCT01967537|579723322|FG000|Overall Study|Lost to Follow-up|6|||
160640817|NCT02059187|580068840|FG000|Overall Study|Physician Decision|1|||
160640818|NCT02059187|580068841|FG001|Overall Study|Physician Decision|2|||
160640819|NCT02059187|580068840|FG000|Overall Study|Protocol Violation|1|||
160640820|NCT02059187|580068841|FG001|Overall Study|Protocol Violation|0|||
160640821|NCT02059187|580068840|FG000|Overall Study|Withdrawal by Subject|12|||
160640822|NCT02059187|580068841|FG001|Overall Study|Withdrawal by Subject|8|||
160640823|NCT00033631|580068842|FG000|Overall Study|Protocol Violation|14|||
160640824|NCT00033631|580068843|FG001|Overall Study|Protocol Violation|11|||
160640825|NCT00033631|580068842|FG000|Overall Study|Withdrawal by Subject|4|||
160640826|NCT00033631|580068843|FG001|Overall Study|Withdrawal by Subject|4|||
160640827|NCT00528879|580068844|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
160640828|NCT00528879|580068845|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
160640829|NCT00528879|580068846|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
160640830|NCT00528879|580068847|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
160640831|NCT00528879|580068844|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
160640832|NCT00528879|580068845|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
160640833|NCT00528879|580068846|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
160640834|NCT00528879|580068847|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
160640835|NCT00528879|580068844|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
160640836|NCT00528879|580068845|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
160640837|NCT00528879|580068846|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
160640838|NCT00528879|580068847|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
160640839|NCT00528879|580068844|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
160640840|NCT00528879|580068845|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
160640841|NCT00528879|580068846|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
160640842|NCT00528879|580068847|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
160640843|NCT00528879|580068844|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
160640844|NCT00528879|580068845|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
160640845|NCT00528879|580068846|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
160544979|NCT01508702|579723327|FG000|Overall Study|Adverse Event|7|||
160544980|NCT01508702|579723328|FG001|Overall Study|Adverse Event|3|||
160544981|NCT01508702|579723327|FG000|Overall Study|Gout flare|2|||
160544982|NCT01508702|579723328|FG001|Overall Study|Gout flare|0|||
160640846|NCT00528879|580068847|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
160640847|NCT00528879|580068844|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
160544983|NCT01508702|579723327|FG000|Overall Study|Protocol Violation|2|||
160544984|NCT01508702|579723328|FG001|Overall Study|Protocol Violation|1|||
160544985|NCT01508702|579723327|FG000|Overall Study|Lost to Follow-up|1|||
160544986|NCT01508702|579723328|FG001|Overall Study|Lost to Follow-up|2|||
160640848|NCT00528879|580068845|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
160640849|NCT00528879|580068846|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
160544987|NCT01508702|579723327|FG000|Overall Study|Withdrawal by Subject|11|||
160544988|NCT01508702|579723328|FG001|Overall Study|Withdrawal by Subject|7|||
160544989|NCT04472429|579723329|FG000|Randomized Period|Ongoing|90|||
160544990|NCT04472429|579723330|FG001|Randomized Period|Ongoing|40|||
160544991|NCT04472429|579723331|FG002|Randomized Period|Ongoing|0|||
160544992|NCT04472429|579723329|FG000|Randomized Period|Death|52|||
160640850|NCT00528879|580068847|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
160640851|NCT00528879|580068844|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
160640852|NCT00528879|580068845|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
160640853|NCT00528879|580068846|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
160640854|NCT00528879|580068847|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
160640855|NCT00528879|580068844|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
160640856|NCT00528879|580068845|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
160640857|NCT00528879|580068846|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
160640858|NCT00528879|580068847|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
160640859|NCT00528879|580068844|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
160640860|NCT00528879|580068845|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
160640861|NCT00528879|580068846|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
160640862|NCT00528879|580068847|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
160640863|NCT00528879|580068844|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
160640864|NCT00528879|580068845|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
160640865|NCT00528879|580068846|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
160640866|NCT00528879|580068847|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
160640867|NCT00528879|580068844|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
160640868|NCT00528879|580068845|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
160640869|NCT00528879|580068846|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
160640870|NCT00528879|580068847|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
160640871|NCT00528879|580068844|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
160640872|NCT00528879|580068845|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
160640873|NCT00528879|580068846|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
160640874|NCT00528879|580068847|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
160640875|NCT00528879|580068844|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
160640876|NCT00528879|580068845|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
160640877|NCT00528879|580068846|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
160640878|NCT00528879|580068847|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
160640879|NCT00528879|580068844|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
160640880|NCT00528879|580068845|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
160640881|NCT00528879|580068846|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
160640882|NCT00528879|580068847|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
160640883|NCT00528879|580068844|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
160640884|NCT00528879|580068845|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
160640885|NCT00528879|580068846|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
160544993|NCT04472429|579723330|FG001|Randomized Period|Death|37|||
160544994|NCT04472429|579723331|FG002|Randomized Period|Death|0|||
160544995|NCT04472429|579723329|FG000|Randomized Period|Lost to Follow-up|4|||
160544996|NCT04472429|579723330|FG001|Randomized Period|Lost to Follow-up|0|||
160544997|NCT04472429|579723331|FG002|Randomized Period|Lost to Follow-up|0|||
160544998|NCT04472429|579723329|FG000|Randomized Period|Physician Decision|1|||
160544999|NCT04472429|579723330|FG001|Randomized Period|Physician Decision|2|||
160545000|NCT04472429|579723331|FG002|Randomized Period|Physician Decision|0|||
160545001|NCT04472429|579723329|FG000|Randomized Period|Withdrawal by Subject|6|||
160545002|NCT04472429|579723330|FG001|Randomized Period|Withdrawal by Subject|5|||
160545003|NCT04472429|579723331|FG002|Randomized Period|Withdrawal by Subject|0|||
160545004|NCT04472429|579723329|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
160545005|NCT04472429|579723330|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
160545006|NCT04472429|579723331|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
160545007|NCT04472429|579723329|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
160545008|NCT04472429|579723330|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
160545009|NCT04472429|579723331|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
160545010|NCT04472429|579723329|FG000|Open-label Monotherapy Period|Ongoing|0|||
160545011|NCT04472429|579723330|FG001|Open-label Monotherapy Period|Ongoing|0|||
160545012|NCT04472429|579723331|FG002|Open-label Monotherapy Period|Ongoing|32|||
160545013|NCT04472429|579723329|FG000|Open-label Monotherapy Period|Death|0|||
160545014|NCT04472429|579723330|FG001|Open-label Monotherapy Period|Death|0|||
160545015|NCT04472429|579723331|FG002|Open-label Monotherapy Period|Death|35|||
160545016|NCT04472429|579723329|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
160545017|NCT04472429|579723330|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
160545018|NCT04472429|579723331|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
160545019|NCT01180660|579723332|FG000|Overall Study|Changed to open surgery|1|||
160545020|NCT01180660|579723333|FG001|Overall Study|Changed to open surgery|0|||
160545021|NCT03461757|579723334|FG000|Overall Study|Adverse Event|1|||
160545022|NCT03461757|579723335|FG001|Overall Study|Adverse Event|0|||
160545023|NCT03461757|579723334|FG000|Overall Study|Lost to Follow-up|13|||
160545024|NCT03461757|579723335|FG001|Overall Study|Lost to Follow-up|7|||
160545025|NCT03461757|579723334|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
160545026|NCT03461757|579723335|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
160545027|NCT03461757|579723334|FG000|Overall Study|Non-compliance with study treatment|0|||
160545028|NCT03461757|579723335|FG001|Overall Study|Non-compliance with study treatment|1|||
160545029|NCT03461757|579723334|FG000|Overall Study|Pregnancy|2|||
160545030|NCT03461757|579723335|FG001|Overall Study|Pregnancy|0|||
160545031|NCT03461757|579723334|FG000|Overall Study|Protocol Violation|1|||
160545032|NCT03461757|579723335|FG001|Overall Study|Protocol Violation|1|||
160545033|NCT03461757|579723334|FG000|Overall Study|Withdrawal by Subject|7|||
160545034|NCT03461757|579723335|FG001|Overall Study|Withdrawal by Subject|7|||
160545035|NCT03461757|579723334|FG000|Overall Study|Other Reasons|1|||
160545036|NCT03461757|579723335|FG001|Overall Study|Other Reasons|4|||
160545037|NCT03861559|579723336|FG000|Overall Study|Adverse Event|0|||
160545038|NCT03861559|579723337|FG001|Overall Study|Adverse Event|2|||
160545039|NCT03861559|579723336|FG000|Overall Study|Treatment failure|0|||
160545040|NCT03861559|579723337|FG001|Overall Study|Treatment failure|2|||
160545041|NCT03861559|579723336|FG000|Overall Study|Noncompliance|1|||
160545042|NCT03861559|579723337|FG001|Overall Study|Noncompliance|1|||
160545043|NCT03861559|579723336|FG000|Overall Study|Did not meet eligibility requirements|1|||
160545044|NCT03861559|579723337|FG001|Overall Study|Did not meet eligibility requirements|0|||
160545045|NCT02500121|579723338|FG000|Overall Study|Lost to Follow-up|0|||
160545046|NCT02500121|579723339|FG001|Overall Study|Lost to Follow-up|1|||
160545047|NCT02500121|579723338|FG000|Overall Study|Withdrawal by Subject|1|||
160545048|NCT02500121|579723339|FG001|Overall Study|Withdrawal by Subject|1|||
160545049|NCT02500121|579723338|FG000|Overall Study|Death|26|||
160545050|NCT02500121|579723339|FG001|Overall Study|Death|24|||
160545051|NCT02124564|579723343|FG000|Treatment Period|Adverse Event|2|||
160545052|NCT02124564|579723343|FG000|Treatment Period|Lack of Efficacy|3|||
160545053|NCT02124564|579723343|FG000|Treatment Period|Withdrawal by Subject|2|||
160545054|NCT03829657|579723347|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
160545055|NCT03829657|579723348|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
160545056|NCT03829657|579723349|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
160545057|NCT03829657|579723350|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
160545058|NCT03829657|579723351|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
160545059|NCT03829657|579723347|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
160640886|NCT00528879|580068847|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
160640887|NCT00528879|580068844|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
160640888|NCT00528879|580068845|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
160640889|NCT00528879|580068846|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
160640890|NCT00528879|580068847|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
160640891|NCT01159769|580068850|FG000|Overall Study|Adverse Event|1|||
160787511|NCT00987935|580607335|FG001|Overall Study|Progressive disease|2|||
160545060|NCT03829657|579723348|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
160545061|NCT03829657|579723349|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
160545062|NCT03829657|579723350|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
160545063|NCT03829657|579723351|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
160545064|NCT03829657|579723347|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
160545065|NCT03829657|579723348|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
160545066|NCT03829657|579723349|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
160545067|NCT03829657|579723350|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
160545068|NCT03829657|579723351|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
160640892|NCT01361607|580068851|FG000|Overall Study|Adverse Event|38|||
160640893|NCT01361607|580068852|FG001|Overall Study|Adverse Event|29|||
160640894|NCT01361607|580068851|FG000|Overall Study|Withdrawal by Subject|19|||
160640895|NCT01361607|580068852|FG001|Overall Study|Withdrawal by Subject|8|||
160640896|NCT01361607|580068851|FG000|Overall Study|Withdrawal by Investigator|5|||
160640897|NCT01361607|580068852|FG001|Overall Study|Withdrawal by Investigator|3|||
160640898|NCT01361607|580068851|FG000|Overall Study|Lost to Follow-up|1|||
160640899|NCT01361607|580068852|FG001|Overall Study|Lost to Follow-up|0|||
160640900|NCT01361607|580068851|FG000|Overall Study|Met Withdrawal Criteria|1|||
160640901|NCT01361607|580068852|FG001|Overall Study|Met Withdrawal Criteria|1|||
160640902|NCT03652961|580068856|FG000|Overall Study|Lost to Follow-up|3|||
160640903|NCT03652961|580068856|FG000|Overall Study|Screen Failure|1|||
160640904|NCT01953783|580068857|FG000|Overall Study|Progressive disease|2|||
160640905|NCT01789281|580068860|FG000|Overall Study|Disease progression|15|||
160640906|NCT01789281|580068861|FG001|Overall Study|Disease progression|4|||
160640907|NCT01789281|580068860|FG000|Overall Study|Adverse Event|5|||
160640908|NCT01789281|580068861|FG001|Overall Study|Adverse Event|5|||
160640909|NCT01789281|580068860|FG000|Overall Study|Withdrawal by Subject|1|||
160640910|NCT01789281|580068861|FG001|Overall Study|Withdrawal by Subject|0|||
160640911|NCT01789281|580068860|FG000|Overall Study|Lost to Follow-up|1|||
160640912|NCT01789281|580068861|FG001|Overall Study|Lost to Follow-up|0|||
160640913|NCT01789281|580068860|FG000|Overall Study|Administrative problems|0|||
160640914|NCT01789281|580068861|FG001|Overall Study|Administrative problems|1|||
160640915|NCT01252238|580068862|FG000|Overall Study|Sponsor terminated study|4|||
160640916|NCT01252238|580068863|FG001|Overall Study|Sponsor terminated study|4|||
160640917|NCT01252238|580068864|FG002|Overall Study|Sponsor terminated study|4|||
160640918|NCT01610167|580068867|FG000|Overall Study|Scheduling conflict.|0|||
160640919|NCT01610167|580068868|FG001|Overall Study|Scheduling conflict.|0|||
160640920|NCT01610167|580068869|FG002|Overall Study|Scheduling conflict.|2|||
160640921|NCT03276962|580068875|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
160640922|NCT03276962|580068876|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
160640923|NCT03276962|580068877|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
160640924|NCT03276962|580068878|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
160640925|NCT03276962|580068879|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
160640926|NCT03276962|580068875|FG000|Overall Study|Protocol Deviation|2|||
160640927|NCT03276962|580068876|FG001|Overall Study|Protocol Deviation|0|||
160640928|NCT03276962|580068877|FG002|Overall Study|Protocol Deviation|1|||
160640929|NCT03276962|580068878|FG003|Overall Study|Protocol Deviation|2|||
160640930|NCT03276962|580068879|FG004|Overall Study|Protocol Deviation|1|||
160640931|NCT03276962|580068875|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
160640932|NCT03276962|580068876|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
160640933|NCT03276962|580068877|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
160640934|NCT03276962|580068878|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
160640935|NCT03276962|580068879|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
160640936|NCT03276962|580068875|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
160640937|NCT03276962|580068876|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
160640938|NCT03276962|580068877|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
160640939|NCT03276962|580068878|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
160640940|NCT03276962|580068879|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
160640941|NCT03276962|580068875|FG000|Overall Study|Lost to Follow-up|10|||
160640942|NCT03276962|580068876|FG001|Overall Study|Lost to Follow-up|10|||
160640943|NCT03276962|580068877|FG002|Overall Study|Lost to Follow-up|4|||
160640944|NCT03276962|580068878|FG003|Overall Study|Lost to Follow-up|6|||
160640945|NCT03276962|580068879|FG004|Overall Study|Lost to Follow-up|10|||
160640946|NCT03276962|580068875|FG000|Overall Study|Other|0|||
160640947|NCT03276962|580068876|FG001|Overall Study|Other|2|||
160640948|NCT03276962|580068877|FG002|Overall Study|Other|0|||
160640949|NCT03276962|580068878|FG003|Overall Study|Other|2|||
160640950|NCT03276962|580068879|FG004|Overall Study|Other|1|||
160640951|NCT00411762|580068880|FG000|Overall Study|Withdrawal by Subject|5|||
160640952|NCT01358708|580068881|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
160640953|NCT01358708|580068882|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160640954|NCT01358708|580068881|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
160640955|NCT01358708|580068882|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
160640956|NCT03056001|580068886|FG000|Overall Study|Death|24|||
160640957|NCT01364298|580068887|FG000|Overall Study|Adverse Event|3|||
160640958|NCT01364298|580068888|FG001|Overall Study|Adverse Event|4|||
160640959|NCT01364298|580068887|FG000|Overall Study|Lack of adherence to treatment|1|||
160640960|NCT01364298|580068888|FG001|Overall Study|Lack of adherence to treatment|3|||
160640961|NCT01364298|580068887|FG000|Overall Study|Lack of Efficacy|1|||
160640962|NCT01364298|580068888|FG001|Overall Study|Lack of Efficacy|0|||
160640963|NCT01364298|580068887|FG000|Overall Study|Lost to Follow-up|5|||
160640964|NCT01364298|580068888|FG001|Overall Study|Lost to Follow-up|10|||
160640965|NCT01364298|580068887|FG000|Overall Study|Withdrawal by Subject|3|||
160545069|NCT03829657|579723347|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
160545070|NCT03829657|579723348|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
160545071|NCT03829657|579723349|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
160545072|NCT03829657|579723350|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
160545073|NCT03829657|579723351|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
160545074|NCT03829657|579723347|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
160545075|NCT03829657|579723348|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
160545076|NCT03829657|579723349|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
160545077|NCT03829657|579723350|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
160545078|NCT03829657|579723351|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
160545079|NCT03829657|579723347|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
160545080|NCT03829657|579723348|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
160545081|NCT03829657|579723349|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
160545082|NCT03829657|579723350|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
160545083|NCT03829657|579723351|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
160545084|NCT03829657|579723347|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
160545085|NCT03829657|579723348|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
160545086|NCT03829657|579723349|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
160545087|NCT03829657|579723350|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
160545088|NCT03829657|579723351|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
160545089|NCT03829657|579723347|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
160545090|NCT03829657|579723348|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
160545091|NCT03829657|579723349|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
160545092|NCT03829657|579723350|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
160545093|NCT03829657|579723351|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
160545094|NCT03829657|579723347|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
160545095|NCT03829657|579723348|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
160545096|NCT03829657|579723349|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
160545097|NCT03829657|579723350|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
160545098|NCT03829657|579723351|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
160545099|NCT03829657|579723347|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
160545100|NCT03829657|579723348|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
160545101|NCT03829657|579723349|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
160545102|NCT03829657|579723350|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
160545103|NCT03829657|579723351|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
160545104|NCT04418076|579723352|FG000|Overall Study|Death|1|||
160545105|NCT04418076|579723353|FG001|Overall Study|Death|0|||
160545106|NCT04418076|579723354|FG002|Overall Study|Death|0|||
160545107|NCT04418076|579723355|FG003|Overall Study|Death|0|||
160545108|NCT04418076|579723352|FG000|Overall Study|Lost to Follow-up|2|||
160545109|NCT04418076|579723353|FG001|Overall Study|Lost to Follow-up|5|||
160545110|NCT04418076|579723354|FG002|Overall Study|Lost to Follow-up|1|||
160545111|NCT04418076|579723355|FG003|Overall Study|Lost to Follow-up|2|||
160545112|NCT04418076|579723352|FG000|Overall Study|Withdrawal by Subject|1|||
160545113|NCT04418076|579723353|FG001|Overall Study|Withdrawal by Subject|0|||
160545114|NCT04418076|579723354|FG002|Overall Study|Withdrawal by Subject|1|||
160545115|NCT04418076|579723355|FG003|Overall Study|Withdrawal by Subject|1|||
160640966|NCT01364298|580068888|FG001|Overall Study|Withdrawal by Subject|3|||
160640967|NCT01364298|580068887|FG000|Overall Study|Other|1|||
160640968|NCT01364298|580068888|FG001|Overall Study|Other|3|||
160640969|NCT03712228|580068889|FG000|Treatment Period 1|Lack of Efficacy|0|||
160640970|NCT03712228|580068890|FG001|Treatment Period 1|Lack of Efficacy|0|||
160640971|NCT03712228|580068891|FG002|Treatment Period 1|Lack of Efficacy|0|||
160640972|NCT03712228|580068892|FG003|Treatment Period 1|Lack of Efficacy|0|||
160640973|NCT03712228|580068893|FG004|Treatment Period 1|Lack of Efficacy|0|||
160640974|NCT03712228|580068894|FG005|Treatment Period 1|Lack of Efficacy|1|||
160640975|NCT03712228|580068889|FG000|Treatment Period 2|Pregnancy|0|||
160640976|NCT03712228|580068890|FG001|Treatment Period 2|Pregnancy|0|||
160640977|NCT03712228|580068891|FG002|Treatment Period 2|Pregnancy|0|||
160545116|NCT04418076|579723352|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
160545117|NCT04418076|579723353|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
160545118|NCT04418076|579723354|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
160545119|NCT04418076|579723355|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
160545120|NCT00562588|579723356|FG000|Overall Study|Adverse Event|40|||
160545121|NCT00562588|579723357|FG001|Overall Study|Adverse Event|58|||
160640978|NCT03712228|580068892|FG003|Treatment Period 2|Pregnancy|1|||
160640979|NCT03712228|580068893|FG004|Treatment Period 2|Pregnancy|0|||
160640980|NCT03712228|580068894|FG005|Treatment Period 2|Pregnancy|0|||
160640981|NCT03712228|580068889|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160545122|NCT00562588|579723356|FG000|Overall Study|Protocol Violation|30|||
160545123|NCT00562588|579723357|FG001|Overall Study|Protocol Violation|26|||
160545124|NCT00562588|579723356|FG000|Overall Study|Lost to Follow-up|12|||
160545125|NCT00562588|579723357|FG001|Overall Study|Lost to Follow-up|4|||
160545126|NCT00562588|579723356|FG000|Overall Study|Withdrawal by Subject|10|||
160545127|NCT00562588|579723357|FG001|Overall Study|Withdrawal by Subject|9|||
160545128|NCT00562588|579723356|FG000|Overall Study|Other|0|||
160545129|NCT00562588|579723357|FG001|Overall Study|Other|2|||
160545130|NCT03368170|579725036|FG000|Overall Study|Adverse Event|2|||
160545131|NCT03368170|579725037|FG001|Overall Study|Adverse Event|1|||
160545132|NCT03047980|579725038|FG000|Overall Study|Adverse Event|1|||
160545133|NCT02164981|579725039|FG000|Started|Withdrawal by Subject|2|||
160545134|NCT02164981|579725040|FG001|Started|Withdrawal by Subject|1|||
160545135|NCT02164981|579725041|FG002|Started|Withdrawal by Subject|0|||
160545136|NCT02164981|579725039|FG000|Started|Protocol Violation|2|||
160545137|NCT02164981|579725040|FG001|Started|Protocol Violation|0|||
160545138|NCT02164981|579725041|FG002|Started|Protocol Violation|0|||
160545139|NCT02164981|579725039|FG000|Started|Adverse Event|1|||
160545140|NCT02164981|579725040|FG001|Started|Adverse Event|2|||
160545141|NCT02164981|579725041|FG002|Started|Adverse Event|0|||
160545142|NCT02164981|579725039|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
160545143|NCT02164981|579725040|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
160545144|NCT02164981|579725041|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
160545145|NCT02164981|579725039|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
160545146|NCT02164981|579725040|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
160545147|NCT02164981|579725041|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
160545148|NCT02164981|579725039|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
160545149|NCT02164981|579725040|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
160545150|NCT02164981|579725041|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
160545151|NCT01761266|579725047|FG000|Overall Study|Death|415|||
160640982|NCT03712228|580068890|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160640983|NCT03712228|580068891|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160640984|NCT03712228|580068892|FG003|Treatment Period 2|Withdrawal by Subject|1|||
160640985|NCT03712228|580068893|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160640986|NCT03712228|580068894|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160640987|NCT01964105|580068895|FG000|Overall Study|Lost to Follow-up|2|||
160640988|NCT01964105|580068896|FG001|Overall Study|Lost to Follow-up|13|||
160640989|NCT01964105|580068897|FG002|Overall Study|Lost to Follow-up|0|||
160640990|NCT02875067|580068898|FG000|Overall Study|Withdrawal by Subject|1|||
160640991|NCT02875067|580068898|FG000|Overall Study|Withdrawal by Termination of Study|5|||
160640992|NCT03056352|580068899|FG000|Overall Study|Lost to Follow-up|1|||
160640993|NCT02475980|580068916|FG000|Overall Study|Lost to Follow-up|4|||
160640994|NCT02475980|580068916|FG000|Overall Study|Withdrawal by Subject|1|||
160640995|NCT00430638|580068922|FG000|Overall Study|Adverse Event|15|||
160640996|NCT00430638|580068923|FG001|Overall Study|Adverse Event|15|||
160640997|NCT00430638|580068922|FG000|Overall Study|Uncontrolled blood pressure|48|||
160640998|NCT00430638|580068923|FG001|Overall Study|Uncontrolled blood pressure|13|||
160640999|NCT00430638|580068922|FG000|Overall Study|Lost to Follow-up|1|||
160641000|NCT00430638|580068923|FG001|Overall Study|Lost to Follow-up|7|||
160641001|NCT00430638|580068922|FG000|Overall Study|Protocol Violation|6|||
160641002|NCT00430638|580068923|FG001|Overall Study|Protocol Violation|4|||
160641003|NCT00430638|580068922|FG000|Overall Study|Withdrawal by Subject|4|||
160641004|NCT00430638|580068923|FG001|Overall Study|Withdrawal by Subject|6|||
160641005|NCT00430638|580068922|FG000|Overall Study|Non-compliant|2|||
160641006|NCT00430638|580068923|FG001|Overall Study|Non-compliant|1|||
160641007|NCT00430638|580068922|FG000|Overall Study|Other|2|||
160641008|NCT00430638|580068923|FG001|Overall Study|Other|2|||
160545152|NCT01761266|579725048|FG001|Overall Study|Death|402|||
160641009|NCT01529749|580068924|FG000|Overall Study|Lost to Follow-up|0|||
160545153|NCT01761266|579725047|FG000|Overall Study|Lost to Follow-up|8|||
160545154|NCT01761266|579725048|FG001|Overall Study|Lost to Follow-up|12|||
160545155|NCT01761266|579725047|FG000|Overall Study|Withdrawal by Subject|14|||
160545156|NCT01761266|579725048|FG001|Overall Study|Withdrawal by Subject|10|||
160545157|NCT01761266|579725047|FG000|Overall Study|Sponsor Decision|41|||
160545158|NCT01761266|579725048|FG001|Overall Study|Sponsor Decision|52|||
160545159|NCT01662440|579725049|FG000|Overall Study|Adverse Event|1|||
160545160|NCT01662440|579725050|FG001|Overall Study|Adverse Event|0|||
160641010|NCT01529749|580068925|FG001|Overall Study|Lost to Follow-up|1|||
160641011|NCT01529749|580068926|FG002|Overall Study|Lost to Follow-up|1|||
160641012|NCT01529749|580068927|FG003|Overall Study|Lost to Follow-up|0|||
160641013|NCT01529749|580068924|FG000|Overall Study|Physician Decision|0|||
160641014|NCT01529749|580068925|FG001|Overall Study|Physician Decision|0|||
160641015|NCT01529749|580068926|FG002|Overall Study|Physician Decision|0|||
160641016|NCT01529749|580068927|FG003|Overall Study|Physician Decision|1|||
160641017|NCT01529749|580068924|FG000|Overall Study|Withdrawal by Subject|0|||
160545161|NCT01662440|579725051|FG002|Overall Study|Adverse Event|0|||
160545162|NCT01662440|579725052|FG003|Overall Study|Adverse Event|1|||
160545163|NCT01662440|579725049|FG000|Overall Study|Death|0|||
160545164|NCT01662440|579725050|FG001|Overall Study|Death|1|||
160545165|NCT01662440|579725051|FG002|Overall Study|Death|0|||
160545166|NCT01662440|579725052|FG003|Overall Study|Death|0|||
160545167|NCT01662440|579725049|FG000|Overall Study|Lost to Follow-up|2|||
160545168|NCT01662440|579725050|FG001|Overall Study|Lost to Follow-up|2|||
160545169|NCT01662440|579725051|FG002|Overall Study|Lost to Follow-up|4|||
160545170|NCT01662440|579725052|FG003|Overall Study|Lost to Follow-up|1|||
160545171|NCT01662440|579725049|FG000|Overall Study|Subject moved to another country.|0|||
160545172|NCT01662440|579725050|FG001|Overall Study|Subject moved to another country.|1|||
160545173|NCT01662440|579725051|FG002|Overall Study|Subject moved to another country.|0|||
160545174|NCT01662440|579725052|FG003|Overall Study|Subject moved to another country.|0|||
160545175|NCT01662440|579725049|FG000|Overall Study|Protocol Violation|1|||
160545176|NCT01662440|579725050|FG001|Overall Study|Protocol Violation|0|||
160545177|NCT01662440|579725051|FG002|Overall Study|Protocol Violation|0|||
160545178|NCT01662440|579725052|FG003|Overall Study|Protocol Violation|0|||
160545179|NCT01662440|579725049|FG000|Overall Study|Withdrawal by Subject|5|||
160545180|NCT01662440|579725050|FG001|Overall Study|Withdrawal by Subject|2|||
160545181|NCT01662440|579725051|FG002|Overall Study|Withdrawal by Subject|2|||
160545182|NCT01662440|579725052|FG003|Overall Study|Withdrawal by Subject|2|||
160545183|NCT02600507|579725053|FG000|Overall Study|Adverse Event|3|||
160545184|NCT02600507|579725054|FG001|Overall Study|Adverse Event|15|||
160545185|NCT02600507|579725055|FG002|Overall Study|Adverse Event|5|||
160545186|NCT02600507|579725053|FG000|Overall Study|Lack of Efficacy|3|||
160545187|NCT02600507|579725054|FG001|Overall Study|Lack of Efficacy|8|||
160545188|NCT02600507|579725055|FG002|Overall Study|Lack of Efficacy|5|||
160545189|NCT02600507|579725053|FG000|Overall Study|Lost to Follow-up|3|||
160545190|NCT02600507|579725054|FG001|Overall Study|Lost to Follow-up|5|||
160545191|NCT02600507|579725055|FG002|Overall Study|Lost to Follow-up|2|||
160545192|NCT02600507|579725053|FG000|Overall Study|Protocol Violation|12|||
160545193|NCT02600507|579725054|FG001|Overall Study|Protocol Violation|4|||
160641018|NCT01529749|580068925|FG001|Overall Study|Withdrawal by Subject|1|||
160641019|NCT01529749|580068926|FG002|Overall Study|Withdrawal by Subject|1|||
160641020|NCT01529749|580068927|FG003|Overall Study|Withdrawal by Subject|0|||
160545194|NCT02600507|579725055|FG002|Overall Study|Protocol Violation|4|||
160641021|NCT01529749|580068924|FG000|Overall Study|Protocol Violation|0|||
160641022|NCT01529749|580068925|FG001|Overall Study|Protocol Violation|0|||
160641023|NCT01529749|580068926|FG002|Overall Study|Protocol Violation|0|||
160641024|NCT01529749|580068927|FG003|Overall Study|Protocol Violation|1|||
160641025|NCT00789828|580068928|FG000|Core Period (48 Weeks)|Administrative problems|0|||
160641026|NCT00789828|580068929|FG001|Core Period (48 Weeks)|Administrative problems|1|||
160641027|NCT00789828|580068928|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
160545195|NCT02600507|579725053|FG000|Overall Study|Physician Decision|1|||
160545196|NCT02600507|579725054|FG001|Overall Study|Physician Decision|0|||
160545197|NCT02600507|579725055|FG002|Overall Study|Physician Decision|1|||
160545198|NCT02600507|579725053|FG000|Overall Study|Withdrawal by Subject|7|||
160545199|NCT02600507|579725054|FG001|Overall Study|Withdrawal by Subject|11|||
160545200|NCT02600507|579725055|FG002|Overall Study|Withdrawal by Subject|7|||
160545201|NCT02600507|579725053|FG000|Overall Study|Other|0|||
160545202|NCT02600507|579725054|FG001|Overall Study|Other|1|||
160545203|NCT02600507|579725055|FG002|Overall Study|Other|1|||
160545204|NCT05048719|579725060|FG000|Overall Study|Withdrawal by Subject|2|||
160545205|NCT05048719|579725061|FG001|Overall Study|Withdrawal by Subject|1|||
160545206|NCT05048719|579725062|FG002|Overall Study|Withdrawal by Subject|3|||
160545207|NCT05048719|579725063|FG003|Overall Study|Withdrawal by Subject|1|||
160545208|NCT05048719|579725064|FG004|Overall Study|Withdrawal by Subject|0|||
160545209|NCT05048719|579725065|FG005|Overall Study|Withdrawal by Subject|2|||
160545210|NCT05048719|579725066|FG006|Overall Study|Withdrawal by Subject|1|||
160545211|NCT05048719|579725067|FG007|Overall Study|Withdrawal by Subject|1|||
160545212|NCT05048719|579725068|FG008|Overall Study|Withdrawal by Subject|0|||
160545213|NCT05048719|579725060|FG000|Overall Study|Death|1|||
160545214|NCT05048719|579725061|FG001|Overall Study|Death|0|||
160545215|NCT05048719|579725062|FG002|Overall Study|Death|0|||
160545216|NCT05048719|579725063|FG003|Overall Study|Death|0|||
160545217|NCT05048719|579725064|FG004|Overall Study|Death|0|||
160545218|NCT05048719|579725065|FG005|Overall Study|Death|0|||
160545219|NCT05048719|579725066|FG006|Overall Study|Death|0|||
160545220|NCT05048719|579725067|FG007|Overall Study|Death|0|||
160545221|NCT05048719|579725068|FG008|Overall Study|Death|0|||
160545222|NCT05048719|579725060|FG000|Overall Study|Adverse Event|0|||
160545223|NCT05048719|579725061|FG001|Overall Study|Adverse Event|1|||
160545224|NCT05048719|579725062|FG002|Overall Study|Adverse Event|2|||
160545225|NCT05048719|579725063|FG003|Overall Study|Adverse Event|0|||
160545226|NCT05048719|579725064|FG004|Overall Study|Adverse Event|1|||
160545227|NCT05048719|579725065|FG005|Overall Study|Adverse Event|0|||
160641028|NCT00789828|580068929|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
160641029|NCT00789828|580068928|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
160545228|NCT05048719|579725066|FG006|Overall Study|Adverse Event|0|||
160545229|NCT05048719|579725067|FG007|Overall Study|Adverse Event|0|||
160545230|NCT05048719|579725068|FG008|Overall Study|Adverse Event|0|||
160545231|NCT05048719|579725060|FG000|Overall Study|Lost to Follow-up|0|||
160545232|NCT05048719|579725061|FG001|Overall Study|Lost to Follow-up|0|||
160545233|NCT05048719|579725062|FG002|Overall Study|Lost to Follow-up|1|||
160545234|NCT05048719|579725063|FG003|Overall Study|Lost to Follow-up|3|||
160545235|NCT05048719|579725064|FG004|Overall Study|Lost to Follow-up|1|||
160545236|NCT05048719|579725065|FG005|Overall Study|Lost to Follow-up|1|||
160545237|NCT05048719|579725066|FG006|Overall Study|Lost to Follow-up|1|||
160545238|NCT05048719|579725067|FG007|Overall Study|Lost to Follow-up|1|||
160545239|NCT05048719|579725068|FG008|Overall Study|Lost to Follow-up|0|||
160545240|NCT05048719|579725060|FG000|Overall Study|Physician Decision|0|||
160545241|NCT05048719|579725061|FG001|Overall Study|Physician Decision|0|||
160545242|NCT05048719|579725062|FG002|Overall Study|Physician Decision|0|||
160545243|NCT05048719|579725063|FG003|Overall Study|Physician Decision|0|||
160545244|NCT05048719|579725064|FG004|Overall Study|Physician Decision|0|||
160545245|NCT05048719|579725065|FG005|Overall Study|Physician Decision|0|||
160545246|NCT05048719|579725066|FG006|Overall Study|Physician Decision|0|||
160545247|NCT05048719|579725067|FG007|Overall Study|Physician Decision|1|||
160545248|NCT05048719|579725068|FG008|Overall Study|Physician Decision|1|||
160545249|NCT05048719|579725060|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
160545250|NCT05048719|579725061|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
160545251|NCT05048719|579725062|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
160545252|NCT05048719|579725063|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
160545253|NCT05048719|579725064|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
160545254|NCT05048719|579725065|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
160545255|NCT05048719|579725066|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
160545256|NCT05048719|579725067|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
160545257|NCT05048719|579725068|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
160545258|NCT05048719|579725060|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
160545259|NCT05048719|579725061|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
160545260|NCT05048719|579725062|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
160545261|NCT05048719|579725063|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
160545262|NCT05048719|579725064|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
160545263|NCT05048719|579725065|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
160545264|NCT05048719|579725066|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
160545265|NCT05048719|579725067|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
160545266|NCT05048719|579725068|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
160545267|NCT05048719|579725060|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
160545268|NCT05048719|579725061|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
160545269|NCT05048719|579725062|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
160545270|NCT05048719|579725063|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
160545271|NCT05048719|579725064|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
160545272|NCT05048719|579725065|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
160545273|NCT05048719|579725066|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
160545274|NCT05048719|579725067|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
160545275|NCT05048719|579725068|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
160545276|NCT05048719|579725060|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
160545277|NCT05048719|579725061|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
160545278|NCT05048719|579725062|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
160545279|NCT05048719|579725063|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
160545280|NCT05048719|579725064|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
160545281|NCT05048719|579725065|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
160545282|NCT05048719|579725066|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
160545283|NCT05048719|579725067|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
160545284|NCT05048719|579725068|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
160545285|NCT05048719|579725060|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
160545286|NCT05048719|579725061|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
160545287|NCT05048719|579725062|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
160545288|NCT05048719|579725063|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
160545289|NCT05048719|579725064|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
160545290|NCT05048719|579725065|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
160545291|NCT05048719|579725066|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
160571830|NCT01633060|579816839|FG001|Treatment Phase|Study Terminated by sponsor|3|||
160545292|NCT05048719|579725067|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
160545293|NCT05048719|579725068|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
160545294|NCT04541004|579725069|FG000|Overall Study|Adverse Event|2|||
160545295|NCT00605085|579725070|FG000|Overall Study|Withdrawal by Subject|8|||
160545296|NCT00605085|579725071|FG001|Overall Study|Withdrawal by Subject|5|||
160545297|NCT00605085|579725070|FG000|Overall Study|Adverse Event|9|||
160545298|NCT00605085|579725071|FG001|Overall Study|Adverse Event|5|||
160545299|NCT00605085|579725070|FG000|Overall Study|Pregnancy|2|||
160545300|NCT00605085|579725071|FG001|Overall Study|Pregnancy|0|||
160545301|NCT00605085|579725070|FG000|Overall Study|Protocol Violation|3|||
160545302|NCT00605085|579725071|FG001|Overall Study|Protocol Violation|2|||
160545303|NCT00605085|579725070|FG000|Overall Study|Lost to Follow-up|10|||
160545304|NCT00605085|579725071|FG001|Overall Study|Lost to Follow-up|5|||
160545305|NCT00605085|579725070|FG000|Overall Study|administrative reasons|18|||
160545306|NCT00605085|579725071|FG001|Overall Study|administrative reasons|8|||
160545307|NCT03257267|579725072|FG000|Overall Study|Adverse Event|17|||
160545308|NCT03257267|579725073|FG001|Overall Study|Adverse Event|7|||
160545309|NCT03257267|579725072|FG000|Overall Study|Death|96|||
160545310|NCT03257267|579725073|FG001|Overall Study|Death|98|||
160545311|NCT03257267|579725072|FG000|Overall Study|Lost to Follow-up|2|||
160545312|NCT03257267|579725073|FG001|Overall Study|Lost to Follow-up|2|||
160545313|NCT03257267|579725072|FG000|Overall Study|Non-compliance with Study Drug|0|||
160545314|NCT03257267|579725073|FG001|Overall Study|Non-compliance with Study Drug|2|||
160545315|NCT03257267|579725072|FG000|Overall Study|Participant Decision|35|||
160545316|NCT03257267|579725073|FG001|Overall Study|Participant Decision|43|||
160545317|NCT03257267|579725072|FG000|Overall Study|Sponsor Decision|1|||
160545318|NCT03257267|579725073|FG001|Overall Study|Sponsor Decision|0|||
160545319|NCT03257267|579725072|FG000|Overall Study|Physician Decision|1|||
160545320|NCT03257267|579725073|FG001|Overall Study|Physician Decision|3|||
160545321|NCT03257267|579725072|FG000|Overall Study|Disease Progression|109|||
160545322|NCT03257267|579725073|FG001|Overall Study|Disease Progression|121|||
160545323|NCT03257267|579725072|FG000|Overall Study|Withdrawal by Subject|8|||
160545324|NCT03257267|579725073|FG001|Overall Study|Withdrawal by Subject|26|||
160545325|NCT03257267|579725072|FG000|Overall Study|Other|0|||
160545326|NCT03257267|579725073|FG001|Overall Study|Other|2|||
160545327|NCT03445000|579725074|FG000|Overall Study|Disease progression|8|||
160545328|NCT03445000|579725074|FG000|Overall Study|Adverse Event|3|||
160545329|NCT03445000|579725074|FG000|Overall Study|Death|2|||
160545330|NCT03445000|579725074|FG000|Overall Study|Physician Decision|1|||
160545331|NCT04872101|579725075|FG000|Overall Study|Withdrawal by Subject|10|||
160545332|NCT04872101|579725076|FG001|Overall Study|Withdrawal by Subject|16|||
160545333|NCT04872101|579725075|FG000|Overall Study|Lack of Efficacy|6|||
160545334|NCT04872101|579725076|FG001|Overall Study|Lack of Efficacy|14|||
160545335|NCT04872101|579725075|FG000|Overall Study|Adverse Event|1|||
160545336|NCT04872101|579725076|FG001|Overall Study|Adverse Event|6|||
160545337|NCT04872101|579725075|FG000|Overall Study|Lost to Follow-up|2|||
160545338|NCT04872101|579725076|FG001|Overall Study|Lost to Follow-up|1|||
160545339|NCT04872101|579725075|FG000|Overall Study|Pregnancy|2|||
160545340|NCT04872101|579725076|FG001|Overall Study|Pregnancy|0|||
160545341|NCT04872101|579725075|FG000|Overall Study|Prohibited Medication|1|||
160545342|NCT04872101|579725076|FG001|Overall Study|Prohibited Medication|0|||
160545343|NCT04872101|579725075|FG000|Overall Study|Not dosed|1|||
160545344|NCT04872101|579725076|FG001|Overall Study|Not dosed|0|||
160545345|NCT00879229|579725077|FG000|Overall Study|Study terminated by Sponsor|13|||
160545346|NCT00879229|579725078|FG001|Overall Study|Study terminated by Sponsor|12|||
160545347|NCT00879229|579725077|FG000|Overall Study|Death|4|||
160545348|NCT00879229|579725078|FG001|Overall Study|Death|2|||
160545349|NCT00879229|579725077|FG000|Overall Study|Adverse Event|2|||
160545350|NCT00879229|579725078|FG001|Overall Study|Adverse Event|0|||
160545351|NCT00879229|579725077|FG000|Overall Study|Withdrawal by Subject|1|||
160545352|NCT00879229|579725078|FG001|Overall Study|Withdrawal by Subject|0|||
160545353|NCT00879229|579725077|FG000|Overall Study|Clinical status did not improve|1|||
160545354|NCT00879229|579725078|FG001|Overall Study|Clinical status did not improve|0|||
160545355|NCT00879229|579725077|FG000|Overall Study|Other|1|||
160545356|NCT00879229|579725078|FG001|Overall Study|Other|0|||
160545357|NCT00264004|579725079|FG000|Overall Study|Adverse Event|2|||
160545358|NCT00264004|579725080|FG001|Overall Study|Adverse Event|3|||
160545359|NCT00264004|579725081|FG002|Overall Study|Adverse Event|6|||
160545360|NCT00264004|579725082|FG003|Overall Study|Adverse Event|4|||
160545361|NCT00264004|579725079|FG000|Overall Study|Withdrawal by Subject|0|||
160545362|NCT00264004|579725080|FG001|Overall Study|Withdrawal by Subject|1|||
160545363|NCT00264004|579725081|FG002|Overall Study|Withdrawal by Subject|2|||
160545364|NCT00264004|579725082|FG003|Overall Study|Withdrawal by Subject|2|||
160545365|NCT00264004|579725079|FG000|Overall Study|Other|2|||
160545366|NCT00264004|579725080|FG001|Overall Study|Other|2|||
160545367|NCT00264004|579725081|FG002|Overall Study|Other|0|||
160545368|NCT00264004|579725082|FG003|Overall Study|Other|3|||
160545369|NCT00264004|579725079|FG000|Overall Study|Development study specific disc. crit.|1|||
160545370|NCT00264004|579725080|FG001|Overall Study|Development study specific disc. crit.|0|||
160545371|NCT00264004|579725081|FG002|Overall Study|Development study specific disc. crit.|1|||
160545372|NCT00264004|579725082|FG003|Overall Study|Development study specific disc. crit.|0|||
160545373|NCT00264004|579725079|FG000|Overall Study|Cond. under inv. worsened|9|||
160545374|NCT00264004|579725080|FG001|Overall Study|Cond. under inv. worsened|5|||
160545375|NCT00264004|579725081|FG002|Overall Study|Cond. under inv. worsened|3|||
160545376|NCT00264004|579725082|FG003|Overall Study|Cond. under inv. worsened|4|||
160545377|NCT00264004|579725079|FG000|Overall Study|Not treated|3|||
160545378|NCT00264004|579725080|FG001|Overall Study|Not treated|0|||
160545379|NCT00264004|579725081|FG002|Overall Study|Not treated|2|||
160545380|NCT00264004|579725082|FG003|Overall Study|Not treated|2|||
160545381|NCT02475681|579725083|FG000|Overall Study|Death|16|||
160545382|NCT02475681|579725084|FG001|Overall Study|Death|6|||
160545383|NCT02475681|579725085|FG002|Overall Study|Death|9|||
160545384|NCT02475681|579725083|FG000|Overall Study|Physician Decision|0|||
160545385|NCT02475681|579725084|FG001|Overall Study|Physician Decision|3|||
160545386|NCT02475681|579725085|FG002|Overall Study|Physician Decision|1|||
160545387|NCT02475681|579725083|FG000|Overall Study|Withdrawal by Subject|12|||
160545388|NCT02475681|579725084|FG001|Overall Study|Withdrawal by Subject|6|||
160545389|NCT02475681|579725085|FG002|Overall Study|Withdrawal by Subject|9|||
160545390|NCT02475681|579725083|FG000|Overall Study|Lost to Follow-up|2|||
160545391|NCT02475681|579725084|FG001|Overall Study|Lost to Follow-up|1|||
160545392|NCT02475681|579725085|FG002|Overall Study|Lost to Follow-up|3|||
160545393|NCT02475681|579725083|FG000|Overall Study|Ongoing in Study|0|||
160545394|NCT02475681|579725084|FG001|Overall Study|Ongoing in Study|163|||
160545395|NCT02475681|579725085|FG002|Overall Study|Ongoing in Study|157|||
160545396|NCT02475681|579725083|FG000|Overall Study|Reasons other than above listed|2|||
160545397|NCT02475681|579725084|FG001|Overall Study|Reasons other than above listed|0|||
160545398|NCT02475681|579725085|FG002|Overall Study|Reasons other than above listed|0|||
160545399|NCT01592760|579725095|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
160545400|NCT01592760|579725096|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
160545401|NCT01592760|579725097|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
160545402|NCT04312009|579725098|FG000|Overall Study|Withdrawal by Subject|2|||
160545403|NCT04312009|579725099|FG001|Overall Study|Withdrawal by Subject|1|||
160545404|NCT02605642|579725102|FG000|Overall Study|Other|11|||
160545405|NCT02605642|579725103|FG001|Overall Study|Other|1|||
160545406|NCT02605642|579725102|FG000|Overall Study|Participant non-compliance|2|||
160545407|NCT02605642|579725103|FG001|Overall Study|Participant non-compliance|4|||
160545408|NCT02605642|579725102|FG000|Overall Study|Physician Decision|10|||
160545409|NCT02605642|579725103|FG001|Overall Study|Physician Decision|0|||
160545410|NCT02605642|579725102|FG000|Overall Study|Lost to Follow-up|12|||
160545411|NCT02605642|579725103|FG001|Overall Study|Lost to Follow-up|1|||
160545412|NCT02605642|579725102|FG000|Overall Study|Adverse Event|14|||
160545413|NCT02605642|579725103|FG001|Overall Study|Adverse Event|2|||
160545414|NCT02605642|579725102|FG000|Overall Study|Withdrawal by Subject|23|||
160545415|NCT02605642|579725103|FG001|Overall Study|Withdrawal by Subject|2|||
160545416|NCT02605642|579725102|FG000|Overall Study|Lack of response|24|||
160545417|NCT02605642|579725103|FG001|Overall Study|Lack of response|11|||
160545418|NCT02354703|579725104|FG000|Overall Study|Withdrawal by Subject|1|||
160545419|NCT02354703|579725105|FG001|Overall Study|Withdrawal by Subject|1|||
160545420|NCT02354703|579725106|FG002|Overall Study|Withdrawal by Subject|1|||
160545421|NCT02354703|579725107|FG003|Overall Study|Withdrawal by Subject|1|||
160545422|NCT02354703|579725104|FG000|Overall Study|Lost to Follow-up|2|||
160545423|NCT02354703|579725105|FG001|Overall Study|Lost to Follow-up|7|||
160545424|NCT02354703|579725106|FG002|Overall Study|Lost to Follow-up|9|||
160545425|NCT02354703|579725107|FG003|Overall Study|Lost to Follow-up|2|||
160545426|NCT02354703|579725104|FG000|Overall Study|Adverse Event|0|||
160545427|NCT02354703|579725105|FG001|Overall Study|Adverse Event|0|||
160545428|NCT02354703|579725106|FG002|Overall Study|Adverse Event|1|||
160545429|NCT02354703|579725107|FG003|Overall Study|Adverse Event|0|||
160641030|NCT00789828|580068929|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
160641031|NCT00789828|580068928|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
160641032|NCT00789828|580068929|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
160641033|NCT00789828|580068928|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
160641034|NCT00789828|580068929|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
160641035|NCT00789828|580068928|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
160641036|NCT00789828|580068929|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
160641037|NCT00789828|580068928|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
160641038|NCT00789828|580068929|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
160641039|NCT00789828|580068928|FG000|Open-label Extension Period (4 Years)|Death|1|||
160641040|NCT00789828|580068929|FG001|Open-label Extension Period (4 Years)|Death|0|||
160641041|NCT00789828|580068928|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
160641042|NCT00789828|580068929|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
160641043|NCT00789828|580068928|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
160641044|NCT00789828|580068929|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
160641045|NCT02623426|580068930|FG000|Overall Study|Lost to Follow-up|0|||
160641046|NCT02623426|580068931|FG001|Overall Study|Lost to Follow-up|0|||
160641047|NCT02623426|580068932|FG002|Overall Study|Lost to Follow-up|1|||
160641048|NCT02623426|580068930|FG000|Overall Study|Withdrawal by Subject|1|||
160641049|NCT02623426|580068931|FG001|Overall Study|Withdrawal by Subject|2|||
160641050|NCT02623426|580068932|FG002|Overall Study|Withdrawal by Subject|2|||
160641051|NCT02094937|580068933|FG000|8 Weeks in Period 1|Adverse Event|9|||
160641052|NCT02094937|580068934|FG001|8 Weeks in Period 1|Adverse Event|0|||
160641053|NCT02094937|580068935|FG002|8 Weeks in Period 1|Adverse Event|0|||
160641054|NCT02094937|580068936|FG003|8 Weeks in Period 1|Adverse Event|0|||
160641055|NCT02094937|580068933|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
160545430|NCT01268293|579725111|FG000|Overall Study|Disease progression|7|||
160545431|NCT01268293|579725111|FG000|Overall Study|Adverse Event|1|||
160545432|NCT01268293|579725111|FG000|Overall Study|Subject choice|1|||
160545433|NCT02597855|579725112|FG000|Overall Study|Lost to Follow-up|2|||
160545434|NCT02597855|579725113|FG001|Overall Study|Lost to Follow-up|1|||
160545435|NCT00179309|579725121|FG000|Treatment|Toxicity|2|||
160545436|NCT00179309|579725122|FG001|Treatment|Toxicity|3|||
160545437|NCT00179309|579725121|FG000|Treatment|Withdrawal by Subject|1|||
160641056|NCT02094937|580068934|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
160641057|NCT02094937|580068935|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
160641058|NCT02094937|580068936|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
160641059|NCT02094937|580068933|FG000|8 Weeks in Period 1|Protocol Violation|2|||
160641060|NCT02094937|580068934|FG001|8 Weeks in Period 1|Protocol Violation|0|||
160641061|NCT02094937|580068935|FG002|8 Weeks in Period 1|Protocol Violation|0|||
160641062|NCT02094937|580068936|FG003|8 Weeks in Period 1|Protocol Violation|0|||
160641063|NCT02094937|580068933|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
160641064|NCT02094937|580068934|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
160641065|NCT02094937|580068935|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
160641066|NCT02094937|580068936|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
160641067|NCT02094937|580068933|FG000|8 Weeks in Period 1|Physician Decision|1|||
160641068|NCT02094937|580068934|FG001|8 Weeks in Period 1|Physician Decision|0|||
160641069|NCT02094937|580068935|FG002|8 Weeks in Period 1|Physician Decision|0|||
160641070|NCT02094937|580068936|FG003|8 Weeks in Period 1|Physician Decision|0|||
160641071|NCT02094937|580068933|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
160641072|NCT02094937|580068934|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
160641073|NCT02094937|580068935|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
160641074|NCT02094937|580068936|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
160641075|NCT02094937|580068933|FG000|12 Weeks in Period 2|Adverse Event|0|||
160641076|NCT02094937|580068934|FG001|12 Weeks in Period 2|Adverse Event|2|||
160641077|NCT02094937|580068935|FG002|12 Weeks in Period 2|Adverse Event|4|||
160641078|NCT02094937|580068936|FG003|12 Weeks in Period 2|Adverse Event|1|||
160641079|NCT02094937|580068933|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
160641080|NCT02094937|580068934|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
160641081|NCT02094937|580068935|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
160641082|NCT02094937|580068936|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
160641083|NCT02094937|580068933|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
160641084|NCT02094937|580068934|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
160981869|NCT02061761|581321786|FG004|Overall Study|Maximum clinical benefit|0|||
160545438|NCT00179309|579725122|FG001|Treatment|Withdrawal by Subject|2|||
160545439|NCT00179309|579725121|FG000|Treatment|Allergy|1|||
160545440|NCT00179309|579725122|FG001|Treatment|Allergy|0|||
160545441|NCT04681170|579725123|FG000|Stratified Enrolment & run-in|Death|1|||
160545442|NCT04681170|579725124|FG001|Stratified Enrolment & run-in|Death|0|||
160641085|NCT02094937|580068935|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
160641086|NCT02094937|580068936|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
160641087|NCT02094937|580068933|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
160545443|NCT04681170|579725123|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
160545444|NCT04681170|579725124|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
160545445|NCT04681170|579725123|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
160545446|NCT04681170|579725124|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
160545447|NCT04681170|579725123|FG000|Open Label Efficacy Phase|Adverse Event|0|||
160545448|NCT04681170|579725124|FG001|Open Label Efficacy Phase|Adverse Event|2|||
160545449|NCT04681170|579725123|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
160545450|NCT04681170|579725124|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
160545451|NCT04681170|579725123|FG000|Open Label Safety Phase|AEs and none compliance|0|||
160545452|NCT04681170|579725124|FG001|Open Label Safety Phase|AEs and none compliance|1|||
160545453|NCT02468648|579725129|FG000|Overall Study|Death|1|||
160545454|NCT01368835|579725130|FG000|Overall Study|Inclusion criteria/photography quality|22|||
160545455|NCT01368835|579725130|FG000|Overall Study|Lost to Follow-up|11|||
160545456|NCT01777152|579725135|FG000|Overall Study|Withdrawal by Subject|22|||
160545457|NCT01777152|579725136|FG001|Overall Study|Withdrawal by Subject|16|||
160545458|NCT01777152|579725135|FG000|Overall Study|Lost to Follow-up|3|||
160545459|NCT01777152|579725136|FG001|Overall Study|Lost to Follow-up|5|||
160545460|NCT01777152|579725135|FG000|Overall Study|Death|68|||
160545461|NCT01777152|579725136|FG001|Overall Study|Death|89|||
160545462|NCT01777152|579725135|FG000|Overall Study|Not eligible, no study drug received|1|||
160545463|NCT01777152|579725136|FG001|Overall Study|Not eligible, no study drug received|0|||
160545464|NCT01777152|579725135|FG000|Overall Study|Change of diagnosis|1|||
160545465|NCT01777152|579725136|FG001|Overall Study|Change of diagnosis|0|||
160545466|NCT02469090|579725139|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
160545467|NCT02469090|579725140|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
160545468|NCT02469090|579725141|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
160545469|NCT02469090|579725139|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
160545470|NCT02469090|579725140|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
160545471|NCT02469090|579725141|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
160545472|NCT02469090|579725139|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
160545473|NCT02469090|579725140|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
160545474|NCT02469090|579725141|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
160545475|NCT02469090|579725139|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
160545476|NCT02469090|579725140|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
160545477|NCT02469090|579725141|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
160545478|NCT02469090|579725139|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
160545479|NCT02469090|579725140|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
160545480|NCT02469090|579725141|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
160545481|NCT02469090|579725139|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
160545482|NCT02469090|579725140|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
160545483|NCT02469090|579725141|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
160545484|NCT02469090|579725139|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
160545485|NCT02469090|579725140|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
160545486|NCT02469090|579725141|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
160545487|NCT02469090|579725139|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
160545488|NCT02469090|579725140|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
160545489|NCT02469090|579725141|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
160545490|NCT03806127|579725142|FG000|Overall Study|Withdrawal by Subject|4|||
160545491|NCT03806127|579725143|FG001|Overall Study|Withdrawal by Subject|5|||
160545492|NCT03806127|579725142|FG000|Overall Study|Protocol Violation|3|||
160545493|NCT03806127|579725143|FG001|Overall Study|Protocol Violation|1|||
160545494|NCT03806127|579725142|FG000|Overall Study|Adverse Event|3|||
160545495|NCT03806127|579725143|FG001|Overall Study|Adverse Event|0|||
160545496|NCT03806127|579725142|FG000|Overall Study|Unable to Complete Procedures|0|||
160545497|NCT03806127|579725143|FG001|Overall Study|Unable to Complete Procedures|1|||
160545498|NCT03806127|579725142|FG000|Overall Study|Pregnancy|0|||
160545499|NCT03806127|579725143|FG001|Overall Study|Pregnancy|1|||
160545500|NCT03806127|579725142|FG000|Overall Study|Lost to Follow-up|5|||
160545501|NCT03806127|579725143|FG001|Overall Study|Lost to Follow-up|1|||
160545502|NCT03806127|579725142|FG000|Overall Study|Physician Decision|1|||
160545503|NCT03806127|579725143|FG001|Overall Study|Physician Decision|1|||
160545504|NCT03806127|579725142|FG000|Overall Study|Could Not Come Due to Covid|1|||
160545505|NCT03806127|579725143|FG001|Overall Study|Could Not Come Due to Covid|0|||
160545506|NCT03806127|579725142|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
160545507|NCT03806127|579725143|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
160545508|NCT03806127|579725142|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
160545509|NCT03806127|579725143|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
160545510|NCT03806127|579725142|FG000|Overall Study|Covid 19 Restrictions|2|||
160545511|NCT03806127|579725143|FG001|Overall Study|Covid 19 Restrictions|0|||
160545512|NCT03806127|579725142|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
160545513|NCT03806127|579725143|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
160545514|NCT03806127|579725142|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
160545515|NCT03806127|579725143|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
160545516|NCT03823391|579725150|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
160545517|NCT03823391|579725151|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
160545518|NCT03823391|579725150|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
160545519|NCT03823391|579725151|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
160545520|NCT01289015|579725154|FG000|Overall Study|Protocol Violation|12|||
160545521|NCT01289015|579725155|FG001|Overall Study|Protocol Violation|9|||
160545522|NCT01289015|579725154|FG000|Overall Study|Adverse Event|3|||
160545523|NCT01289015|579725155|FG001|Overall Study|Adverse Event|0|||
160545524|NCT01289015|579725154|FG000|Overall Study|Lost to Follow-up|33|||
160545525|NCT01289015|579725155|FG001|Overall Study|Lost to Follow-up|17|||
160545526|NCT01289015|579725154|FG000|Overall Study|Withdrawal by Subject|17|||
160545527|NCT01289015|579725155|FG001|Overall Study|Withdrawal by Subject|8|||
160545528|NCT01289015|579725154|FG000|Overall Study|Disease progression|1|||
160545529|NCT01289015|579725155|FG001|Overall Study|Disease progression|0|||
160545530|NCT01289015|579725154|FG000|Overall Study|Negative baseline culture and others|33|||
160545531|NCT01289015|579725155|FG001|Overall Study|Negative baseline culture and others|20|||
160545532|NCT05030311|579725160|FG000|Overall Study|Technical problems|0|||
160545533|NCT05030311|579725161|FG001|Overall Study|Technical problems|1|||
160545534|NCT05030311|579725160|FG000|Overall Study|Withdrawal by Subject|31|||
160545535|NCT05030311|579725161|FG001|Overall Study|Withdrawal by Subject|17|||
160545536|NCT05030311|579725160|FG000|Overall Study|Adverse Event|13|||
160545537|NCT05030311|579725161|FG001|Overall Study|Adverse Event|5|||
160545538|NCT05030311|579725160|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160545539|NCT05030311|579725161|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160545540|NCT05030311|579725160|FG000|Overall Study|Physician Decision|5|||
160545541|NCT05030311|579725161|FG001|Overall Study|Physician Decision|2|||
160545542|NCT05030311|579725160|FG000|Overall Study|Lost to Follow-up|5|||
160545543|NCT05030311|579725161|FG001|Overall Study|Lost to Follow-up|1|||
160545544|NCT05030311|579725160|FG000|Overall Study|Protocol Violation|4|||
160545545|NCT05030311|579725161|FG001|Overall Study|Protocol Violation|4|||
160545546|NCT01425203|579725162|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
160545547|NCT01425203|579725163|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
160545548|NCT01425203|579725164|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
160545549|NCT01425203|579725162|FG000|Treatment Phase|Failure at futility timepoint|8|||
160545550|NCT01425203|579725163|FG001|Treatment Phase|Failure at futility timepoint|27|||
160545551|NCT01425203|579725164|FG002|Treatment Phase|Failure at futility timepoint|0|||
160545552|NCT01425203|579725162|FG000|Treatment Phase|Other virologic failure criteria|5|||
160545553|NCT01425203|579725163|FG001|Treatment Phase|Other virologic failure criteria|3|||
160545554|NCT01425203|579725164|FG002|Treatment Phase|Other virologic failure criteria|0|||
160545555|NCT01425203|579725162|FG000|Treatment Phase|Unidentified reasons|11|||
160545556|NCT01425203|579725163|FG001|Treatment Phase|Unidentified reasons|5|||
160545557|NCT01425203|579725164|FG002|Treatment Phase|Unidentified reasons|0|||
160545558|NCT01425203|579725162|FG000|Treatment Phase|Did not receive treatment|0|||
160545559|NCT01425203|579725163|FG001|Treatment Phase|Did not receive treatment|1|||
160545560|NCT01425203|579725164|FG002|Treatment Phase|Did not receive treatment|0|||
160545561|NCT01425203|579725162|FG000|Crossover Phase|Failure at futility timepoint|0|||
160545562|NCT01425203|579725163|FG001|Crossover Phase|Failure at futility timepoint|0|||
160545563|NCT01425203|579725164|FG002|Crossover Phase|Failure at futility timepoint|3|||
160545564|NCT01425203|579725162|FG000|Crossover Phase|Other virologic failure criteria|0|||
160545565|NCT01425203|579725163|FG001|Crossover Phase|Other virologic failure criteria|0|||
160545566|NCT01425203|579725164|FG002|Crossover Phase|Other virologic failure criteria|3|||
160545567|NCT00109707|579725171|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
160545568|NCT00109707|579725172|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
160545569|NCT00109707|579725173|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
160545570|NCT00109707|579725171|FG000|Overall Study|Abnormal laboratory values|1|||
160545571|NCT00109707|579725172|FG001|Overall Study|Abnormal laboratory values|0|||
160545572|NCT00109707|579725173|FG002|Overall Study|Abnormal laboratory values|0|||
160545573|NCT00109707|579725171|FG000|Overall Study|Administrative problems|2|||
160545574|NCT00109707|579725172|FG001|Overall Study|Administrative problems|0|||
160545575|NCT00109707|579725173|FG002|Overall Study|Administrative problems|1|||
160545576|NCT00109707|579725171|FG000|Overall Study|Adverse Event|10|||
160545577|NCT00109707|579725172|FG001|Overall Study|Adverse Event|2|||
160641088|NCT02094937|580068934|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
160641089|NCT02094937|580068935|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
160641090|NCT02094937|580068936|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
160641091|NCT02094937|580068933|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
160545578|NCT00109707|579725173|FG002|Overall Study|Adverse Event|3|||
160545579|NCT00109707|579725171|FG000|Overall Study|Death|4|||
160545580|NCT00109707|579725172|FG001|Overall Study|Death|0|||
160545581|NCT00109707|579725173|FG002|Overall Study|Death|0|||
160545582|NCT00109707|579725171|FG000|Overall Study|Disease progression|12|||
160545583|NCT00109707|579725172|FG001|Overall Study|Disease progression|4|||
160641092|NCT02094937|580068934|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
160545584|NCT00109707|579725173|FG002|Overall Study|Disease progression|3|||
160545585|NCT00109707|579725171|FG000|Overall Study|Lost to Follow-up|3|||
160545586|NCT00109707|579725172|FG001|Overall Study|Lost to Follow-up|0|||
160545587|NCT00109707|579725173|FG002|Overall Study|Lost to Follow-up|0|||
160545588|NCT00109707|579725171|FG000|Overall Study|Protocol Violation|1|||
160545589|NCT00109707|579725172|FG001|Overall Study|Protocol Violation|0|||
160545590|NCT00109707|579725173|FG002|Overall Study|Protocol Violation|0|||
160545591|NCT00109707|579725171|FG000|Overall Study|Patient withdrew consent|6|||
160545592|NCT00109707|579725172|FG001|Overall Study|Patient withdrew consent|1|||
160545593|NCT00109707|579725173|FG002|Overall Study|Patient withdrew consent|0|||
160545594|NCT02199080|579725174|FG000|Overall Study|Protocol Violation|12|||
160545595|NCT02228590|579725175|FG000|Overall Study|Withdrawal by Subject|1|||
160545596|NCT02109484|579725176|FG000|Overall Study|Lost to Follow-up|0|||
160545597|NCT02109484|579725177|FG001|Overall Study|Lost to Follow-up|0|||
160545598|NCT02109484|579725178|FG002|Overall Study|Lost to Follow-up|0|||
160545599|NCT02109484|579725179|FG003|Overall Study|Lost to Follow-up|1|||
160545600|NCT02109484|579725180|FG004|Overall Study|Lost to Follow-up|1|||
160545601|NCT02109484|579725181|FG005|Overall Study|Lost to Follow-up|0|||
160545602|NCT02109484|579725182|FG006|Overall Study|Lost to Follow-up|1|||
160545603|NCT02109484|579725183|FG007|Overall Study|Lost to Follow-up|0|||
160545604|NCT02109484|579725176|FG000|Overall Study|Withdrawal by Subject|0|||
160545605|NCT02109484|579725177|FG001|Overall Study|Withdrawal by Subject|0|||
160545606|NCT02109484|579725178|FG002|Overall Study|Withdrawal by Subject|0|||
160545607|NCT02109484|579725179|FG003|Overall Study|Withdrawal by Subject|0|||
160545608|NCT02109484|579725180|FG004|Overall Study|Withdrawal by Subject|1|||
160545609|NCT02109484|579725181|FG005|Overall Study|Withdrawal by Subject|1|||
160545610|NCT02109484|579725182|FG006|Overall Study|Withdrawal by Subject|1|||
160545611|NCT02109484|579725183|FG007|Overall Study|Withdrawal by Subject|0|||
160545612|NCT02109484|579725176|FG000|Overall Study|Physician Decision|0|||
160545613|NCT02109484|579725177|FG001|Overall Study|Physician Decision|0|||
160545614|NCT02109484|579725178|FG002|Overall Study|Physician Decision|0|||
160545615|NCT02109484|579725179|FG003|Overall Study|Physician Decision|0|||
160545616|NCT02109484|579725180|FG004|Overall Study|Physician Decision|2|||
160545617|NCT02109484|579725181|FG005|Overall Study|Physician Decision|0|||
160545618|NCT02109484|579725182|FG006|Overall Study|Physician Decision|0|||
160545619|NCT02109484|579725183|FG007|Overall Study|Physician Decision|0|||
160545620|NCT02109484|579725176|FG000|Overall Study|Death|0|||
160545621|NCT02109484|579725177|FG001|Overall Study|Death|0|||
160545622|NCT02109484|579725178|FG002|Overall Study|Death|0|||
160545623|NCT02109484|579725179|FG003|Overall Study|Death|0|||
160545624|NCT02109484|579725180|FG004|Overall Study|Death|0|||
160545625|NCT02109484|579725181|FG005|Overall Study|Death|0|||
160545626|NCT02109484|579725182|FG006|Overall Study|Death|0|||
160545627|NCT02109484|579725183|FG007|Overall Study|Death|2|||
160545628|NCT02109484|579725176|FG000|Overall Study|Moved away from study area|0|||
160641093|NCT02094937|580068935|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
160641094|NCT02094937|580068936|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
160641095|NCT01133392|580068937|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
160641096|NCT01133392|580068938|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
160641097|NCT01133392|580068937|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
160641098|NCT01133392|580068938|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
160641099|NCT03751124|580068939|FG000|Overall Study|Adverse Event|4|||
160641100|NCT03751124|580068940|FG001|Overall Study|Adverse Event|3|||
160641101|NCT03751124|580068939|FG000|Overall Study|Protocol Deviation|0|||
160641102|NCT03751124|580068940|FG001|Overall Study|Protocol Deviation|1|||
160641103|NCT03751124|580068939|FG000|Overall Study|Lost to Follow-up|6|||
160641104|NCT03751124|580068940|FG001|Overall Study|Lost to Follow-up|4|||
160641105|NCT03751124|580068939|FG000|Overall Study|Withdrawal by Subject|6|||
160641106|NCT03751124|580068940|FG001|Overall Study|Withdrawal by Subject|8|||
160641107|NCT03751124|580068939|FG000|Overall Study|Lack of Efficacy|1|||
160641108|NCT03751124|580068940|FG001|Overall Study|Lack of Efficacy|1|||
160641109|NCT03751124|580068939|FG000|Overall Study|Pregnancy|0|||
160641110|NCT03751124|580068940|FG001|Overall Study|Pregnancy|1|||
160641111|NCT03751124|580068939|FG000|Overall Study|Other|9|||
160641112|NCT03751124|580068940|FG001|Overall Study|Other|9|||
160641113|NCT03751124|580068939|FG000|Overall Study|Participants who did not receive any study drug|0|||
160641114|NCT03751124|580068940|FG001|Overall Study|Participants who did not receive any study drug|1|||
160641115|NCT00555399|580068943|FG000|Overall Study|Withdrawal by Subject|0|||
160641116|NCT00555399|580068944|FG001|Overall Study|Withdrawal by Subject|0|||
160545629|NCT02109484|579725177|FG001|Overall Study|Moved away from study area|0|||
160545630|NCT02109484|579725178|FG002|Overall Study|Moved away from study area|0|||
160545631|NCT02109484|579725179|FG003|Overall Study|Moved away from study area|0|||
160545632|NCT02109484|579725180|FG004|Overall Study|Moved away from study area|0|||
160545633|NCT02109484|579725181|FG005|Overall Study|Moved away from study area|0|||
160545634|NCT02109484|579725182|FG006|Overall Study|Moved away from study area|1|||
160545635|NCT02109484|579725183|FG007|Overall Study|Moved away from study area|1|||
160641117|NCT00555399|580068945|FG002|Overall Study|Withdrawal by Subject|1|||
160641118|NCT00555399|580068946|FG003|Overall Study|Withdrawal by Subject|0|||
160641119|NCT00555399|580068947|FG004|Overall Study|Withdrawal by Subject|0|||
160641120|NCT00555399|580068948|FG005|Overall Study|Withdrawal by Subject|0|||
160641121|NCT00555399|580068949|FG006|Overall Study|Withdrawal by Subject|0|||
160641122|NCT00555399|580068950|FG007|Overall Study|Withdrawal by Subject|0|||
160545636|NCT01400451|579725196|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
160545637|NCT01400451|579725197|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
160545638|NCT01400451|579725198|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
160545639|NCT01400451|579725196|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
160545640|NCT01400451|579725197|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
160545641|NCT01400451|579725198|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
160545642|NCT01400451|579725196|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
160545643|NCT01400451|579725197|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
160545644|NCT01400451|579725198|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
160545645|NCT01400451|579725196|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
160545646|NCT01400451|579725197|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
160545647|NCT01400451|579725198|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
160545648|NCT01400451|579725196|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
160545649|NCT01400451|579725197|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
160545650|NCT01400451|579725198|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
160545651|NCT00574275|579725199|FG000|Overall Study|Randomized but not treated|2|||
160545652|NCT00574275|579725200|FG001|Overall Study|Randomized but not treated|3|||
160545653|NCT00574275|579725199|FG000|Overall Study|Adverse Event|32|||
160545654|NCT00574275|579725200|FG001|Overall Study|Adverse Event|76|||
160545655|NCT00574275|579725199|FG000|Overall Study|Disease progression|160|||
160545656|NCT00574275|579725200|FG001|Overall Study|Disease progression|146|||
160545657|NCT00574275|579725199|FG000|Overall Study|Lost to Follow-up|2|||
160545658|NCT00574275|579725200|FG001|Overall Study|Lost to Follow-up|1|||
160545659|NCT00574275|579725199|FG000|Overall Study|Study stopped based on DMC decision|62|||
160545660|NCT00574275|579725200|FG001|Overall Study|Study stopped based on DMC decision|23|||
160545661|NCT00574275|579725199|FG000|Overall Study|Withdrawal by Subject|15|||
160545662|NCT00574275|579725200|FG001|Overall Study|Withdrawal by Subject|17|||
160545663|NCT00574275|579725199|FG000|Overall Study|Error calculating tumor measurement|1|||
160545664|NCT00574275|579725200|FG001|Overall Study|Error calculating tumor measurement|0|||
160545665|NCT00574275|579725199|FG000|Overall Study|Physician Decision|1|||
160545666|NCT00574275|579725200|FG001|Overall Study|Physician Decision|1|||
160545667|NCT00574275|579725199|FG000|Overall Study|Protocol Violation|0|||
160545668|NCT00574275|579725200|FG001|Overall Study|Protocol Violation|1|||
160545669|NCT00574275|579725199|FG000|Overall Study|Patient and Investigator decision|0|||
160545670|NCT00574275|579725200|FG001|Overall Study|Patient and Investigator decision|1|||
160641123|NCT00555399|580068951|FG008|Overall Study|Withdrawal by Subject|0|||
160641124|NCT00555399|580068952|FG009|Overall Study|Withdrawal by Subject|0|||
160641125|NCT00555399|580068953|FG010|Overall Study|Withdrawal by Subject|0|||
160641126|NCT00555399|580068954|FG011|Overall Study|Withdrawal by Subject|1|||
160890214|NCT00423670|580992968|FG001|Treatment Period|Non-compliance with protocol|1|||
160890215|NCT00423670|580992969|FG002|Treatment Period|Non-compliance with protocol|1|||
160890216|NCT00423670|580992970|FG003|Treatment Period|Non-compliance with protocol|3|||
160545671|NCT00574275|579725199|FG000|Overall Study|Insurance change|0|||
160545672|NCT00574275|579725200|FG001|Overall Study|Insurance change|1|||
160545673|NCT00574275|579725199|FG000|Overall Study|Operation for curative intent|0|||
160545674|NCT00574275|579725200|FG001|Overall Study|Operation for curative intent|1|||
160545675|NCT00317109|579725204|FG000|Overall Study|Withdrawal by Subject|2|||
160545676|NCT00317109|579725205|FG001|Overall Study|Withdrawal by Subject|0|||
160545677|NCT00317109|579725204|FG000|Overall Study|Migated/moved from study area|1|||
160545678|NCT00317109|579725205|FG001|Overall Study|Migated/moved from study area|0|||
160545679|NCT02425826|579725207|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
160545680|NCT02425826|579725208|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
160545681|NCT02425826|579725209|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
160545682|NCT02425826|579725207|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
160545683|NCT02425826|579725208|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
160545684|NCT02425826|579725209|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
160545685|NCT02425826|579725207|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
160545686|NCT02425826|579725208|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
160545687|NCT02425826|579725209|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
160545688|NCT02425826|579725207|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
160545689|NCT02425826|579725208|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
160545690|NCT02425826|579725209|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
160545691|NCT02425826|579725207|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
160545692|NCT02425826|579725208|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
160545693|NCT02425826|579725209|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
160545694|NCT02425826|579725207|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
160545695|NCT02425826|579725208|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
160545696|NCT02425826|579725209|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
160545697|NCT02425826|579725207|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
160545698|NCT02425826|579725208|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
160545699|NCT02425826|579725209|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
160545700|NCT02425826|579725207|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
160545701|NCT02425826|579725208|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
160545702|NCT02425826|579725209|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
160545703|NCT02425826|579725207|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
160545704|NCT02425826|579725208|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
160545705|NCT02425826|579725209|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
160545706|NCT02425826|579725207|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
160545707|NCT02425826|579725208|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
160545708|NCT02425826|579725209|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
160545709|NCT04942925|579725210|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
160545710|NCT04942925|579725211|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
160545711|NCT04942925|579725210|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
160545712|NCT04942925|579725211|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
160545713|NCT01344876|579725212|FG000|Overall Study|Adverse Event|0|||
160545714|NCT01344876|579725213|FG001|Overall Study|Adverse Event|0|||
160890217|NCT00423670|580992971|FG004|Treatment Period|Non-compliance with protocol|2|||
160545715|NCT01344876|579725214|FG002|Overall Study|Adverse Event|0|||
160545716|NCT01344876|579725215|FG003|Overall Study|Adverse Event|0|||
160545717|NCT01344876|579725216|FG004|Overall Study|Adverse Event|1|||
160545718|NCT01344876|579725212|FG000|Overall Study|Withdrawal by Subject|0|||
160545719|NCT01344876|579725213|FG001|Overall Study|Withdrawal by Subject|0|||
160545720|NCT01344876|579725214|FG002|Overall Study|Withdrawal by Subject|1|||
160545721|NCT01344876|579725215|FG003|Overall Study|Withdrawal by Subject|0|||
160545722|NCT01344876|579725216|FG004|Overall Study|Withdrawal by Subject|0|||
160545723|NCT01344876|579725212|FG000|Overall Study|Definite progression of primary disease|1|||
160545724|NCT01344876|579725213|FG001|Overall Study|Definite progression of primary disease|0|||
160545725|NCT01344876|579725214|FG002|Overall Study|Definite progression of primary disease|0|||
160545726|NCT01344876|579725215|FG003|Overall Study|Definite progression of primary disease|3|||
160545727|NCT01344876|579725216|FG004|Overall Study|Definite progression of primary disease|0|||
160545728|NCT05107765|579725217|FG000|Overall Study|Lost to Follow-up|4|||
160545729|NCT05107765|579725218|FG001|Overall Study|Lost to Follow-up|1|||
160545730|NCT05107765|579725217|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
160545731|NCT05107765|579725218|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
160545732|NCT05107765|579725217|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
160545733|NCT05107765|579725218|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
160545734|NCT00112905|579726653|FG000|Overall Study|Adverse Event|4|||
160545735|NCT00112905|579726653|FG000|Overall Study|Death|1|||
160545736|NCT00112905|579726653|FG000|Overall Study|Ineligibility|5|||
160545737|NCT00112905|579726653|FG000|Overall Study|Alternative treatment|1|||
160545738|NCT00112905|579726653|FG000|Overall Study|performance status was deteiorating|1|||
160545739|NCT01765673|579726654|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
160545740|NCT03409744|579726655|FG000|Overall Study|Death|2|||
160545741|NCT03409744|579726655|FG000|Overall Study|Physician Decision|5|||
160545742|NCT03409744|579726655|FG000|Overall Study|Pregnancy|1|||
160545743|NCT03409744|579726655|FG000|Overall Study|Lost to Follow-up|1|||
160545744|NCT03409744|579726655|FG000|Overall Study|Protocol Violation|1|||
160545745|NCT05804877|579726656|FG000|Overall Study|Lost to Follow-up|1|||
160545746|NCT05804877|579726657|FG001|Overall Study|Lost to Follow-up|3|||
160545747|NCT05804877|579726656|FG000|Overall Study|Withdrawal by Subject|1|||
160545748|NCT05804877|579726657|FG001|Overall Study|Withdrawal by Subject|0|||
160545749|NCT05804877|579726656|FG000|Overall Study|Withdrawal by Subject|1|||
160545750|NCT05804877|579726657|FG001|Overall Study|Withdrawal by Subject|0|||
160545751|NCT01262365|579726658|FG000|Overall Study|Lack of Efficacy|35|||
160545752|NCT01262365|579726659|FG001|Overall Study|Lack of Efficacy|30|||
160545753|NCT01262365|579726660|FG002|Overall Study|Lack of Efficacy|47|||
160545754|NCT01262365|579726658|FG000|Overall Study|Protocol Violation|3|||
160545755|NCT01262365|579726659|FG001|Overall Study|Protocol Violation|1|||
160545756|NCT01262365|579726660|FG002|Overall Study|Protocol Violation|1|||
160545757|NCT01262365|579726658|FG000|Overall Study|Lost to Follow-up|3|||
160545758|NCT01262365|579726659|FG001|Overall Study|Lost to Follow-up|7|||
160545759|NCT01262365|579726660|FG002|Overall Study|Lost to Follow-up|6|||
160545760|NCT01262365|579726658|FG000|Overall Study|Withdrawal by Subject|17|||
160545761|NCT01262365|579726659|FG001|Overall Study|Withdrawal by Subject|22|||
160545762|NCT01262365|579726660|FG002|Overall Study|Withdrawal by Subject|22|||
160545763|NCT01262365|579726658|FG000|Overall Study|Death|1|||
160545764|NCT01262365|579726659|FG001|Overall Study|Death|2|||
160545765|NCT01262365|579726660|FG002|Overall Study|Death|1|||
160545766|NCT01262365|579726658|FG000|Overall Study|Adverse Event|26|||
160545767|NCT01262365|579726659|FG001|Overall Study|Adverse Event|16|||
160545768|NCT01262365|579726660|FG002|Overall Study|Adverse Event|11|||
160545769|NCT01262365|579726658|FG000|Overall Study|sponsor decision|1|||
160545770|NCT01262365|579726659|FG001|Overall Study|sponsor decision|1|||
160545771|NCT01262365|579726660|FG002|Overall Study|sponsor decision|0|||
160545772|NCT01262365|579726658|FG000|Overall Study|Randomization error|1|||
160545773|NCT01262365|579726659|FG001|Overall Study|Randomization error|0|||
160545774|NCT01262365|579726660|FG002|Overall Study|Randomization error|2|||
160545775|NCT01262365|579726658|FG000|Overall Study|Non-compliance|1|||
160545776|NCT01262365|579726659|FG001|Overall Study|Non-compliance|0|||
160545777|NCT01262365|579726660|FG002|Overall Study|Non-compliance|2|||
160545778|NCT01262365|579726658|FG000|Overall Study|Suspected pregnancy|1|||
160545779|NCT01262365|579726659|FG001|Overall Study|Suspected pregnancy|0|||
160545780|NCT01262365|579726660|FG002|Overall Study|Suspected pregnancy|0|||
160545781|NCT01262365|579726658|FG000|Overall Study|Patient pregnant|1|||
160545782|NCT01262365|579726659|FG001|Overall Study|Patient pregnant|0|||
160545783|NCT01262365|579726660|FG002|Overall Study|Patient pregnant|1|||
160545784|NCT01262365|579726658|FG000|Overall Study|Toxicity related to study drug|0|||
160545785|NCT01262365|579726659|FG001|Overall Study|Toxicity related to study drug|1|||
160545786|NCT01262365|579726660|FG002|Overall Study|Toxicity related to study drug|0|||
160545787|NCT01262365|579726658|FG000|Overall Study|Cannot tolerate the protocol|0|||
160545788|NCT01262365|579726659|FG001|Overall Study|Cannot tolerate the protocol|1|||
160545789|NCT01262365|579726660|FG002|Overall Study|Cannot tolerate the protocol|0|||
160545790|NCT01262365|579726658|FG000|Overall Study|Patient unavailable|0|||
160545791|NCT01262365|579726659|FG001|Overall Study|Patient unavailable|0|||
160545792|NCT01262365|579726660|FG002|Overall Study|Patient unavailable|1|||
160545793|NCT00494091|579726661|FG000|Overall Study|Death|5|||
160545794|NCT00494091|579726662|FG001|Overall Study|Death|54|||
160545795|NCT00494091|579726661|FG000|Overall Study|Lost to Follow-up|0|||
160545796|NCT00494091|579726662|FG001|Overall Study|Lost to Follow-up|4|||
160545797|NCT00494091|579726661|FG000|Overall Study|Other|1|||
160545798|NCT00494091|579726662|FG001|Overall Study|Other|11|||
160545799|NCT00494091|579726661|FG000|Overall Study|Withdrawal by Subject|0|||
160545800|NCT00494091|579726662|FG001|Overall Study|Withdrawal by Subject|7|||
160545801|NCT01652287|579726667|FG000|Overall Study|Withdrawal by Subject|2|||
160545802|NCT01652287|579726668|FG001|Overall Study|Withdrawal by Subject|0|||
160545803|NCT00699348|579726673|FG000|Overall Study|Death|6|||
160545804|NCT00699348|579726673|FG000|Overall Study|Adverse Event|15|||
160545805|NCT00699348|579726673|FG000|Overall Study|Withdrawal by Subject|11|||
160545806|NCT00699348|579726673|FG000|Overall Study|Protocol Violation|10|||
160545807|NCT00699348|579726673|FG000|Overall Study|Lack of Efficacy|8|||
160545808|NCT00699348|579726673|FG000|Overall Study|Failure to return|1|||
160545809|NCT00699348|579726673|FG000|Overall Study|Blood transfusion|24|||
160545810|NCT00699348|579726673|FG000|Overall Study|Renal transplantation|10|||
160545811|NCT00699348|579726673|FG000|Overall Study|Other|5|||
160545812|NCT00122135|579726674|FG000|Overall Study|Withdrawal by Subject|3|||
160545813|NCT00122135|579726675|FG001|Overall Study|Withdrawal by Subject|0|||
160545814|NCT02118792|579726681|FG000|Overall Study|Withdrawal by Subject|6|||
160545815|NCT02118792|579726682|FG001|Overall Study|Withdrawal by Subject|3|||
160545816|NCT02118792|579726681|FG000|Overall Study|Lost to Follow-up|4|||
160545817|NCT02118792|579726682|FG001|Overall Study|Lost to Follow-up|4|||
160545818|NCT02118792|579726681|FG000|Overall Study|Adverse Event|5|||
160545819|NCT02118792|579726682|FG001|Overall Study|Adverse Event|4|||
160545820|NCT02118792|579726681|FG000|Overall Study|Withdrawal by parent/guardian|14|||
160545821|NCT02118792|579726682|FG001|Overall Study|Withdrawal by parent/guardian|20|||
160545822|NCT02118792|579726681|FG000|Overall Study|Other|1|||
160545823|NCT02118792|579726682|FG001|Overall Study|Other|6|||
160545824|NCT02118792|579726681|FG000|Overall Study|Randomised but not treated|1|||
160545825|NCT02118792|579726682|FG001|Overall Study|Randomised but not treated|0|||
160545826|NCT00488982|579726683|FG000|Course 1|Physician Decision|0|||
160545827|NCT00488982|579726684|FG001|Course 1|Physician Decision|2|||
160545828|NCT00488982|579726685|FG002|Course 1|Physician Decision|4|||
160545829|NCT00488982|579726683|FG000|Course 1|Withdrawal by Subject|0|||
160545830|NCT00488982|579726684|FG001|Course 1|Withdrawal by Subject|8|||
160545831|NCT00488982|579726685|FG002|Course 1|Withdrawal by Subject|2|||
160545832|NCT00488982|579726683|FG000|Course 1|nonprotocol therapy|0|||
160545833|NCT00488982|579726684|FG001|Course 1|nonprotocol therapy|2|||
160545834|NCT00488982|579726685|FG002|Course 1|nonprotocol therapy|2|||
160545835|NCT00488982|579726683|FG000|Course 1|Adverse Event|0|||
160545836|NCT00488982|579726684|FG001|Course 1|Adverse Event|0|||
160545837|NCT00488982|579726685|FG002|Course 1|Adverse Event|6|||
160545838|NCT01678144|579726686|FG000|Stage 1: MAR Classic|Adverse Event|1|||
160545839|NCT02754726|579726687|FG000|Overall Study|Progressive Disease by RECIST|13|||
160545840|NCT02754726|579726687|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
160545841|NCT02754726|579726687|FG000|Overall Study|Clinical Disease Progression|5|||
160545842|NCT02754726|579726687|FG000|Overall Study|Adverse Event|3|||
160545843|NCT02754726|579726687|FG000|Overall Study|Withdrawal by Subject|1|||
160545844|NCT02754726|579726687|FG000|Overall Study|Tolerability|1|||
160545845|NCT01885000|579726688|FG000|Overall Study|Adverse Event|1|||
160545846|NCT01885000|579726689|FG001|Overall Study|Adverse Event|0|||
160545847|NCT01885000|579726688|FG000|Overall Study|Withdrawal by Subject|1|||
160545848|NCT01885000|579726689|FG001|Overall Study|Withdrawal by Subject|1|||
160545849|NCT01885000|579726688|FG000|Overall Study|Protocol Violation|0|||
160641127|NCT00555399|580068943|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
160641128|NCT00555399|580068944|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
160641129|NCT00555399|580068945|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
160641130|NCT00555399|580068946|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
160641131|NCT00555399|580068947|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
160641132|NCT00555399|580068948|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
160641133|NCT00555399|580068949|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
160641134|NCT00555399|580068950|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
160641135|NCT00555399|580068951|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
160641136|NCT00555399|580068952|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
160641137|NCT00555399|580068953|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
160641138|NCT00555399|580068954|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
160545850|NCT01885000|579726689|FG001|Overall Study|Protocol Violation|1|||
160641139|NCT05458895|580068955|FG000|Overall Study|Withdrawal by Subject|8|||
160641140|NCT05458895|580068955|FG000|Overall Study|Lost to Follow-up|17|||
160641141|NCT05458895|580068955|FG000|Overall Study|Pregnancy|2|||
160641142|NCT05458895|580068955|FG000|Overall Study|Withdrawal by Study Team|1|||
160653389|NCT02683187|580110527|FG000|Overall Study|Withdrawal by Subject|5|||
160545851|NCT03446885|579726694|FG000|Overall Study|Lost to Follow-up|1|||
160545852|NCT03446885|579726695|FG001|Overall Study|Lost to Follow-up|0|||
160545853|NCT03446885|579726694|FG000|Overall Study|Did not complete entire visit|1|||
160545854|NCT03446885|579726695|FG001|Overall Study|Did not complete entire visit|0|||
160545855|NCT03557359|579726698|FG000|Dose 1: 240 mg|Adverse Event|1|||
160545856|NCT03557359|579726699|FG001|Dose 1: 240 mg|Adverse Event|0|||
160545857|NCT05980299|579726704|FG000|Overall Study|Death|28|||
160545858|NCT05980299|579726705|FG001|Overall Study|Death|0|||
160545859|NCT05980299|579726704|FG000|Overall Study|Discharged from Nursing Home|9|||
160545860|NCT05980299|579726705|FG001|Overall Study|Discharged from Nursing Home|0|||
160545861|NCT05980299|579726704|FG000|Overall Study|Lost to Follow-up|0|||
160545862|NCT05980299|579726705|FG001|Overall Study|Lost to Follow-up|10|||
160545863|NCT02264990|579726706|FG000|Overall Study|Death|255|||
160545864|NCT02264990|579726707|FG001|Overall Study|Death|250|||
160545865|NCT02264990|579726706|FG000|Overall Study|Withdrawal by Subject|4|||
160545866|NCT02264990|579726707|FG001|Overall Study|Withdrawal by Subject|5|||
160545867|NCT02264990|579726706|FG000|Overall Study|Lost to Follow-up|1|||
160545868|NCT02264990|579726707|FG001|Overall Study|Lost to Follow-up|3|||
160545869|NCT02264990|579726706|FG000|Overall Study|Other|0|||
160545870|NCT02264990|579726707|FG001|Overall Study|Other|1|||
160545871|NCT03031301|579726709|FG000|Overall Study|Protocol Violation|4|||
160545872|NCT03031301|579726710|FG001|Overall Study|Protocol Violation|8|||
160545873|NCT03031301|579726709|FG000|Overall Study|Withdrawal by Subject|7|||
160545874|NCT03031301|579726710|FG001|Overall Study|Withdrawal by Subject|4|||
160545875|NCT03031301|579726709|FG000|Overall Study|Lost to Follow-up|4|||
160545876|NCT03031301|579726710|FG001|Overall Study|Lost to Follow-up|12|||
160545877|NCT03031301|579726709|FG000|Overall Study|Noncompliance|1|||
160545878|NCT03031301|579726710|FG001|Overall Study|Noncompliance|3|||
160545879|NCT03031301|579726709|FG000|Overall Study|Technical issue|1|||
160545880|NCT03031301|579726710|FG001|Overall Study|Technical issue|1|||
160545881|NCT03031301|579726709|FG000|Overall Study|Adverse Event|1|||
160545882|NCT03031301|579726710|FG001|Overall Study|Adverse Event|0|||
160545883|NCT01100944|579726712|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
160545884|NCT01100944|579726713|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
160545885|NCT01100944|579726714|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
160545886|NCT01100944|579726712|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
160545887|NCT01100944|579726713|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
160545888|NCT01100944|579726714|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
160545889|NCT01100944|579726712|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
160545890|NCT01100944|579726713|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
160545891|NCT01100944|579726714|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
160545892|NCT01100944|579726712|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
160545893|NCT01100944|579726713|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
160545894|NCT01100944|579726714|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
160545895|NCT04607733|579726715|FG000|Overall Study|Lost to Follow-up|1|||
160545896|NCT04607733|579726716|FG001|Overall Study|Lost to Follow-up|0|||
160545897|NCT04607733|579726717|FG002|Overall Study|Lost to Follow-up|0|||
160545898|NCT04607733|579726718|FG003|Overall Study|Lost to Follow-up|1|||
160545899|NCT04607733|579726719|FG004|Overall Study|Lost to Follow-up|1|||
160545900|NCT04607733|579726720|FG005|Overall Study|Lost to Follow-up|0|||
160545901|NCT04607733|579726715|FG000|Overall Study|Withdrawal by Subject|0|||
160545902|NCT04607733|579726716|FG001|Overall Study|Withdrawal by Subject|0|||
160545903|NCT04607733|579726717|FG002|Overall Study|Withdrawal by Subject|0|||
160545904|NCT04607733|579726718|FG003|Overall Study|Withdrawal by Subject|0|||
160545905|NCT04607733|579726719|FG004|Overall Study|Withdrawal by Subject|1|||
160545906|NCT04607733|579726720|FG005|Overall Study|Withdrawal by Subject|0|||
160545907|NCT02296242|579726723|FG000|Overall Study|Death|1|||
160545908|NCT02296242|579726724|FG001|Overall Study|Death|1|||
160545909|NCT02296242|579726725|FG002|Overall Study|Death|1|||
160545910|NCT02296242|579726726|FG003|Overall Study|Death|1|||
160545911|NCT02296242|579726727|FG004|Overall Study|Death|1|||
160545912|NCT02296242|579726723|FG000|Overall Study|Withdrawal by Subject|0|||
160545913|NCT02296242|579726724|FG001|Overall Study|Withdrawal by Subject|0|||
160545914|NCT02296242|579726725|FG002|Overall Study|Withdrawal by Subject|1|||
160545915|NCT02296242|579726726|FG003|Overall Study|Withdrawal by Subject|1|||
160545916|NCT02296242|579726727|FG004|Overall Study|Withdrawal by Subject|3|||
160545917|NCT02296242|579726723|FG000|Overall Study|Disease Progression|1|||
160545918|NCT02296242|579726724|FG001|Overall Study|Disease Progression|3|||
160545919|NCT02296242|579726725|FG002|Overall Study|Disease Progression|2|||
160545920|NCT02296242|579726726|FG003|Overall Study|Disease Progression|8|||
160545921|NCT02296242|579726727|FG004|Overall Study|Disease Progression|11|||
160545922|NCT02296242|579726723|FG000|Overall Study|Unacceptable Toxicity|0|||
160545923|NCT02296242|579726724|FG001|Overall Study|Unacceptable Toxicity|0|||
160545924|NCT02296242|579726725|FG002|Overall Study|Unacceptable Toxicity|0|||
160545925|NCT02296242|579726726|FG003|Overall Study|Unacceptable Toxicity|0|||
160545926|NCT02296242|579726727|FG004|Overall Study|Unacceptable Toxicity|1|||
160545927|NCT02296242|579726723|FG000|Overall Study|Patient Condition Changed|0|||
160545928|NCT02296242|579726724|FG001|Overall Study|Patient Condition Changed|0|||
160545929|NCT02296242|579726725|FG002|Overall Study|Patient Condition Changed|2|||
160545930|NCT02296242|579726726|FG003|Overall Study|Patient Condition Changed|0|||
160545931|NCT02296242|579726727|FG004|Overall Study|Patient Condition Changed|1|||
160545932|NCT02296242|579726723|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
160545933|NCT02296242|579726724|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
160545934|NCT02296242|579726725|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
160545935|NCT02296242|579726726|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
160545936|NCT02296242|579726727|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
160545937|NCT02296242|579726723|FG000|Overall Study|Lost to Follow-up|1|||
160545938|NCT02296242|579726724|FG001|Overall Study|Lost to Follow-up|0|||
160545939|NCT02296242|579726725|FG002|Overall Study|Lost to Follow-up|0|||
160545940|NCT02296242|579726726|FG003|Overall Study|Lost to Follow-up|0|||
160545941|NCT02296242|579726727|FG004|Overall Study|Lost to Follow-up|0|||
160545942|NCT02296242|579726723|FG000|Overall Study|Need for Hydroxyurea|2|||
160545943|NCT02296242|579726724|FG001|Overall Study|Need for Hydroxyurea|0|||
160545944|NCT02296242|579726725|FG002|Overall Study|Need for Hydroxyurea|0|||
160545945|NCT02296242|579726726|FG003|Overall Study|Need for Hydroxyurea|0|||
160545946|NCT02296242|579726727|FG004|Overall Study|Need for Hydroxyurea|0|||
160545947|NCT02296242|579726723|FG000|Overall Study|Screened for Other Protocol|0|||
160545948|NCT02296242|579726724|FG001|Overall Study|Screened for Other Protocol|1|||
160545949|NCT02296242|579726725|FG002|Overall Study|Screened for Other Protocol|0|||
160545950|NCT02296242|579726726|FG003|Overall Study|Screened for Other Protocol|0|||
160545951|NCT02296242|579726727|FG004|Overall Study|Screened for Other Protocol|0|||
160545952|NCT02296242|579726723|FG000|Overall Study|Physician Decision|0|||
160545953|NCT02296242|579726724|FG001|Overall Study|Physician Decision|1|||
160545954|NCT02296242|579726725|FG002|Overall Study|Physician Decision|0|||
160545955|NCT02296242|579726726|FG003|Overall Study|Physician Decision|1|||
160545956|NCT02296242|579726727|FG004|Overall Study|Physician Decision|0|||
160545957|NCT02296242|579726723|FG000|Overall Study|Alternative Treatment|0|||
160545958|NCT02296242|579726724|FG001|Overall Study|Alternative Treatment|0|||
160545959|NCT02296242|579726725|FG002|Overall Study|Alternative Treatment|0|||
160545960|NCT02296242|579726726|FG003|Overall Study|Alternative Treatment|1|||
160545961|NCT02296242|579726727|FG004|Overall Study|Alternative Treatment|0|||
160545962|NCT02296242|579726723|FG000|Overall Study|Adverse Event|0|||
160545963|NCT02296242|579726724|FG001|Overall Study|Adverse Event|0|||
160545964|NCT02296242|579726725|FG002|Overall Study|Adverse Event|0|||
160545965|NCT02296242|579726726|FG003|Overall Study|Adverse Event|1|||
160545966|NCT02296242|579726727|FG004|Overall Study|Adverse Event|0|||
160545967|NCT02296242|579726723|FG000|Overall Study|Lack of Efficacy|0|||
160545968|NCT02296242|579726724|FG001|Overall Study|Lack of Efficacy|0|||
160545969|NCT02296242|579726725|FG002|Overall Study|Lack of Efficacy|0|||
160545970|NCT02296242|579726726|FG003|Overall Study|Lack of Efficacy|0|||
160545971|NCT02296242|579726727|FG004|Overall Study|Lack of Efficacy|3|||
160545972|NCT01639833|579726728|FG000|Overall Study|Death|4|||
160545973|NCT01639833|579726729|FG001|Overall Study|Death|2|||
160545974|NCT01639833|579726728|FG000|Overall Study|Withdrawal by Subject|2|||
160545975|NCT01639833|579726729|FG001|Overall Study|Withdrawal by Subject|2|||
160545976|NCT03504397|579726735|FG000|Overall Study|Progressive Disease|151|||
160545977|NCT03504397|579726736|FG001|Overall Study|Progressive Disease|199|||
160545978|NCT03504397|579726735|FG000|Overall Study|Withdrawal by Subject|29|||
160545979|NCT03504397|579726736|FG001|Overall Study|Withdrawal by Subject|17|||
160545980|NCT03504397|579726735|FG000|Overall Study|Lost to Follow-up|1|||
160545981|NCT03504397|579726736|FG001|Overall Study|Lost to Follow-up|0|||
160545982|NCT03504397|579726735|FG000|Overall Study|Death|14|||
160545983|NCT03504397|579726736|FG001|Overall Study|Death|16|||
160545984|NCT03504397|579726735|FG000|Overall Study|Adverse Event|40|||
160545985|NCT03504397|579726736|FG001|Overall Study|Adverse Event|14|||
160545986|NCT03504397|579726735|FG000|Overall Study|miscellaneous|17|||
160545987|NCT03504397|579726736|FG001|Overall Study|miscellaneous|15|||
160545988|NCT03504397|579726735|FG000|Overall Study|Protocol deviation|1|||
160545989|NCT03504397|579726736|FG001|Overall Study|Protocol deviation|0|||
160545990|NCT03504397|579726735|FG000|Overall Study|Participants who did not take the study drug|4|||
160641143|NCT04639310|580068956|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
160641144|NCT04639310|580068957|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
160641145|NCT03262233|580070550|FG000|Overall Study|Withdrawal by Subject|12|||
160641146|NCT03262233|580070551|FG001|Overall Study|Withdrawal by Subject|8|||
160641147|NCT03262233|580070552|FG002|Overall Study|Withdrawal by Subject|21|||
160641148|NCT03262233|580070553|FG003|Overall Study|Withdrawal by Subject|13|||
160641149|NCT03262233|580070550|FG000|Overall Study|Declined due to shock|1|||
160641150|NCT03262233|580070551|FG001|Overall Study|Declined due to shock|2|||
160890218|NCT00423670|580992972|FG005|Treatment Period|Non-compliance with protocol|0|||
160545991|NCT03504397|579726736|FG001|Overall Study|Participants who did not take the study drug|4|||
160545992|NCT00070941|579726737|FG000|Overall Study|Adverse Event|10|||
160545993|NCT00070941|579726738|FG001|Overall Study|Adverse Event|8|||
160545994|NCT00070941|579726739|FG002|Overall Study|Adverse Event|4|||
160545995|NCT01888640|579726741|FG000|Overall Study|Lost to Follow-up|1|||
160545996|NCT01888640|579726742|FG001|Overall Study|Lost to Follow-up|2|||
160545997|NCT01888640|579726743|FG002|Overall Study|Lost to Follow-up|0|||
160545998|NCT01888640|579726741|FG000|Overall Study|Withdrawal by Subject|15|||
160545999|NCT01888640|579726742|FG001|Overall Study|Withdrawal by Subject|11|||
160546000|NCT01888640|579726743|FG002|Overall Study|Withdrawal by Subject|4|||
160641151|NCT03262233|580070552|FG002|Overall Study|Declined due to shock|2|||
160641152|NCT03262233|580070553|FG003|Overall Study|Declined due to shock|3|||
160890219|NCT00423670|580992973|FG006|Treatment Period|Non-compliance with protocol|2|||
160546001|NCT01888640|579726741|FG000|Overall Study|Minimum dose not met|10|||
160546002|NCT01888640|579726742|FG001|Overall Study|Minimum dose not met|16|||
160546003|NCT01888640|579726743|FG002|Overall Study|Minimum dose not met|0|||
160546004|NCT01888640|579726741|FG000|Overall Study|Given wrong unit (placebo)|1|||
160546005|NCT01888640|579726742|FG001|Overall Study|Given wrong unit (placebo)|0|||
160546006|NCT01888640|579726743|FG002|Overall Study|Given wrong unit (placebo)|0|||
160546007|NCT01888640|579726741|FG000|Overall Study|Excluded for prior TENS|0|||
160546008|NCT01888640|579726742|FG001|Overall Study|Excluded for prior TENS|1|||
160546009|NCT01888640|579726743|FG002|Overall Study|Excluded for prior TENS|0|||
160546010|NCT01888640|579726741|FG000|Overall Study|Researcher Termination of Participant|0|||
160546011|NCT01888640|579726742|FG001|Overall Study|Researcher Termination of Participant|1|||
160546012|NCT01888640|579726743|FG002|Overall Study|Researcher Termination of Participant|1|||
160546013|NCT02443883|579726744|FG000|Overall Study|Adverse Event|0|||
160546014|NCT02443883|579726745|FG001|Overall Study|Adverse Event|1|||
160546015|NCT02443883|579726746|FG002|Overall Study|Adverse Event|0|||
160546016|NCT02443883|579726747|FG003|Overall Study|Adverse Event|0|||
160546017|NCT02443883|579726744|FG000|Overall Study|Lost to Follow-up|3|||
160546018|NCT02443883|579726745|FG001|Overall Study|Lost to Follow-up|2|||
160546019|NCT02443883|579726746|FG002|Overall Study|Lost to Follow-up|1|||
160546020|NCT02443883|579726747|FG003|Overall Study|Lost to Follow-up|0|||
160546021|NCT02443883|579726744|FG000|Overall Study|Physician Decision|1|||
160546022|NCT02443883|579726745|FG001|Overall Study|Physician Decision|1|||
160546023|NCT02443883|579726746|FG002|Overall Study|Physician Decision|0|||
160546024|NCT02443883|579726747|FG003|Overall Study|Physician Decision|3|||
160546025|NCT02443883|579726744|FG000|Overall Study|Withdrawal by Subject|1|||
160546026|NCT02443883|579726745|FG001|Overall Study|Withdrawal by Subject|0|||
160546027|NCT02443883|579726746|FG002|Overall Study|Withdrawal by Subject|0|||
160546028|NCT02443883|579726747|FG003|Overall Study|Withdrawal by Subject|2|||
160546029|NCT02443883|579726744|FG000|Overall Study|Randomized, but never treated|1|||
160546030|NCT02443883|579726745|FG001|Overall Study|Randomized, but never treated|0|||
160546031|NCT02443883|579726746|FG002|Overall Study|Randomized, but never treated|0|||
160546032|NCT02443883|579726747|FG003|Overall Study|Randomized, but never treated|0|||
160546033|NCT01277549|579726748|FG000|Overall Study|Failed to meet eligibility criteria|13|||
160546034|NCT01277549|579726749|FG001|Overall Study|Failed to meet eligibility criteria|9|||
160546035|NCT01277549|579726748|FG000|Overall Study|Withdrawal by Subject|1|||
160546036|NCT01277549|579726749|FG001|Overall Study|Withdrawal by Subject|3|||
160546037|NCT01277549|579726748|FG000|Overall Study|Protocol Violation|10|||
160546038|NCT01277549|579726749|FG001|Overall Study|Protocol Violation|1|||
160546039|NCT01277549|579726748|FG000|Overall Study|Physician Decision|2|||
160546040|NCT01277549|579726749|FG001|Overall Study|Physician Decision|1|||
160546041|NCT00623428|579726752|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
160546042|NCT00623428|579726753|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
160546043|NCT00623428|579726752|FG000|Treatment Period|Death|0|||
160546044|NCT00623428|579726753|FG001|Treatment Period|Death|1|||
160546045|NCT00623428|579726752|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
160546046|NCT00623428|579726753|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
160546047|NCT00623428|579726752|FG000|Treatment Period|Insufficient therapeutic response|0|||
160546048|NCT00623428|579726753|FG001|Treatment Period|Insufficient therapeutic response|2|||
160546049|NCT00623428|579726752|FG000|Treatment Period|Other|0|||
160546050|NCT00623428|579726753|FG001|Treatment Period|Other|1|||
160546051|NCT00623428|579726752|FG000|Treatment Period|Withdrawal by Subject|0|||
160546052|NCT00623428|579726753|FG001|Treatment Period|Withdrawal by Subject|1|||
160546053|NCT00623428|579726752|FG000|Follow-up Period|Relapse post-treatment|11|||
160546054|NCT00623428|579726753|FG001|Follow-up Period|Relapse post-treatment|3|||
160546055|NCT00623428|579726752|FG000|Follow-up Period|Failure to return|10|||
160546056|NCT00623428|579726753|FG001|Follow-up Period|Failure to return|2|||
160546057|NCT00623428|579726752|FG000|Follow-up Period|Patient withdrew consent|5|||
160546058|NCT00623428|579726753|FG001|Follow-up Period|Patient withdrew consent|4|||
160546059|NCT00623428|579726752|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
160546060|NCT00623428|579726753|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
160546061|NCT00623428|579726752|FG000|Follow-up Period|Did not cooperate|0|||
160546062|NCT00623428|579726753|FG001|Follow-up Period|Did not cooperate|3|||
160546063|NCT00623428|579726752|FG000|Follow-up Period|Reason not specified|1|||
160546064|NCT00623428|579726753|FG001|Follow-up Period|Reason not specified|1|||
160546065|NCT00623428|579726752|FG000|Follow-up Period|Death|0|||
160546066|NCT00623428|579726753|FG001|Follow-up Period|Death|1|||
160546067|NCT01692301|579726754|FG000|Overall Study|Adverse Event|15|||
160546068|NCT01692301|579726755|FG001|Overall Study|Adverse Event|12|||
160546069|NCT01692301|579726754|FG000|Overall Study|Death|1|||
160546070|NCT01692301|579726755|FG001|Overall Study|Death|2|||
160546071|NCT01692301|579726754|FG000|Overall Study|Lack of Efficacy|0|||
160546072|NCT01692301|579726755|FG001|Overall Study|Lack of Efficacy|5|||
160546073|NCT01692301|579726754|FG000|Overall Study|Non-compliance with study treatment|1|||
160546074|NCT01692301|579726755|FG001|Overall Study|Non-compliance with study treatment|2|||
160546075|NCT01692301|579726754|FG000|Overall Study|Protocol deviation|9|||
160546076|NCT01692301|579726755|FG001|Overall Study|Protocol deviation|2|||
160546077|NCT01692301|579726754|FG000|Overall Study|Patient/guardian decision|16|||
160546078|NCT01692301|579726755|FG001|Overall Study|Patient/guardian decision|15|||
160546079|NCT01692301|579726754|FG000|Overall Study|Technical problems|0|||
160546080|NCT01692301|579726755|FG001|Overall Study|Technical problems|1|||
160546081|NCT01692301|579726754|FG000|Overall Study|Physician Decision|2|||
160546082|NCT01692301|579726755|FG001|Overall Study|Physician Decision|2|||
160546083|NCT01692301|579726754|FG000|Overall Study|Lost to Follow-up|1|||
160546084|NCT01692301|579726755|FG001|Overall Study|Lost to Follow-up|1|||
160546085|NCT01142726|579726756|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
160546086|NCT01142726|579726757|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
160546087|NCT01142726|579726758|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
160546088|NCT01142726|579726756|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
160546089|NCT01142726|579726757|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
160546090|NCT01142726|579726758|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
160546091|NCT01142726|579726756|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
160546092|NCT01142726|579726757|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
160546093|NCT01142726|579726758|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
160546094|NCT01142726|579726756|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
160546095|NCT01142726|579726757|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
160546096|NCT01142726|579726758|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
160546097|NCT01142726|579726756|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
160546098|NCT01142726|579726757|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
160546099|NCT01142726|579726758|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
160546100|NCT01142726|579726756|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
160546101|NCT01142726|579726757|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
160546102|NCT01142726|579726758|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
160546103|NCT01142726|579726756|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
160546104|NCT01142726|579726757|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
160546105|NCT01142726|579726758|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
160546106|NCT01142726|579726756|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
160546107|NCT01142726|579726757|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
160546108|NCT01142726|579726758|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
160546109|NCT01142726|579726756|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
160546110|NCT01142726|579726757|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
160546111|NCT01142726|579726758|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
160546112|NCT01142726|579726756|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
160546113|NCT01142726|579726757|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
160546114|NCT01142726|579726758|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
160546115|NCT01142726|579726756|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
160546116|NCT01142726|579726757|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
160546117|NCT01142726|579726758|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
160546118|NCT01142726|579726756|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
160546119|NCT01142726|579726757|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
160546120|NCT01142726|579726758|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
160546121|NCT01142726|579726756|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
160546122|NCT01142726|579726757|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
160546123|NCT01142726|579726758|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
160546124|NCT01142726|579726756|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
160546125|NCT01142726|579726757|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
160546126|NCT01142726|579726758|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
160546127|NCT01142726|579726756|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
160546128|NCT01142726|579726757|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
160546129|NCT01142726|579726758|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
160546130|NCT01142726|579726756|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
160546131|NCT01142726|579726757|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
160546132|NCT01142726|579726758|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
160546133|NCT01568593|579726759|FG000|Overall Study|Lack of Efficacy|4|||
160546134|NCT01568593|579726760|FG001|Overall Study|Lack of Efficacy|1|||
160546135|NCT01568593|579726759|FG000|Overall Study|Adverse Event|3|||
160546136|NCT01568593|579726760|FG001|Overall Study|Adverse Event|2|||
160546137|NCT02111993|579726761|FG000|Overall Study|Physician Decision|5|||
160546138|NCT02111993|579726762|FG001|Overall Study|Physician Decision|4|||
160546139|NCT00419380|579726763|FG000|Overall Study|Lack of Efficacy|1|||
160546140|NCT00419380|579726764|FG001|Overall Study|Lack of Efficacy|7|||
160546141|NCT00419380|579726763|FG000|Overall Study|Physician Decision|0|||
160546142|NCT00419380|579726764|FG001|Overall Study|Physician Decision|1|||
160546143|NCT00419380|579726763|FG000|Overall Study|Lost to Follow-up|0|||
160546144|NCT00419380|579726764|FG001|Overall Study|Lost to Follow-up|1|||
160546145|NCT00419380|579726763|FG000|Overall Study|Withdrawal by Subject|0|||
160546146|NCT00419380|579726764|FG001|Overall Study|Withdrawal by Subject|1|||
160546147|NCT00796315|579726765|FG000|Overall Study|Protocol Violation|0|||
160546148|NCT00796315|579726766|FG001|Overall Study|Protocol Violation|1|||
160546149|NCT00796315|579726767|FG002|Overall Study|Protocol Violation|0|||
160546150|NCT01026831|579726772|FG000|Overall Study|Adverse Event|4|||
160546151|NCT01026831|579726773|FG001|Overall Study|Adverse Event|3|||
160546152|NCT01026831|579726772|FG000|Overall Study|Lost to Follow-up|2|||
160546153|NCT01026831|579726773|FG001|Overall Study|Lost to Follow-up|0|||
160546154|NCT01026831|579726772|FG000|Overall Study|Physician Decision|1|||
160546155|NCT01026831|579726773|FG001|Overall Study|Physician Decision|1|||
160546156|NCT01026831|579726772|FG000|Overall Study|Protocol Violation|0|||
160546157|NCT01026831|579726773|FG001|Overall Study|Protocol Violation|2|||
160546158|NCT01026831|579726772|FG000|Overall Study|Withdrawal by Subject|7|||
160546159|NCT01026831|579726773|FG001|Overall Study|Withdrawal by Subject|5|||
160546160|NCT01079182|579726774|FG000|Overall Study|Lost to Follow-up|1634|||
160546161|NCT01079182|579726774|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
160546162|NCT01079182|579726774|FG000|Overall Study|Lack of Efficacy|514|||
160546163|NCT01079182|579726774|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
160546164|NCT01079182|579726774|FG000|Overall Study|Reasons not Evaluated|271|||
160546165|NCT00371865|579726783|FG000|Overall Study|Lack of Efficacy|0|||
160546166|NCT00371865|579726784|FG001|Overall Study|Lack of Efficacy|2|||
160546167|NCT00371865|579726783|FG000|Overall Study|Protocol Violation|3|||
160546168|NCT00371865|579726784|FG001|Overall Study|Protocol Violation|2|||
160546169|NCT00371865|579726783|FG000|Overall Study|Withdrawal by Subject|12|||
160546170|NCT00371865|579726784|FG001|Overall Study|Withdrawal by Subject|10|||
160546171|NCT01627899|579726786|FG000|Overall Study|Study terminated early by sponsor.|5|||
160546172|NCT01430455|579726793|FG000|Overall Study|Withdrawal by Subject|1|||
160546173|NCT01430455|579726793|FG000|Overall Study|Switched to follow-up phase|1|||
160546174|NCT01425008|579726794|FG000|Dose Escalation Phase|Progressive Disease|2|||
160546175|NCT01425008|579726795|FG001|Dose Escalation Phase|Progressive Disease|3|||
160546176|NCT01425008|579726796|FG002|Dose Escalation Phase|Progressive Disease|2|||
160546177|NCT01425008|579726797|FG003|Dose Escalation Phase|Progressive Disease|3|||
160546178|NCT01425008|579726798|FG004|Dose Escalation Phase|Progressive Disease|5|||
160546179|NCT01425008|579726799|FG005|Dose Escalation Phase|Progressive Disease|4|||
160546180|NCT01425008|579726800|FG006|Dose Escalation Phase|Progressive Disease|0|||
160546181|NCT01425008|579726801|FG007|Dose Escalation Phase|Progressive Disease|2|||
160546182|NCT01425008|579726802|FG008|Dose Escalation Phase|Progressive Disease|6|||
160546183|NCT01425008|579726803|FG009|Dose Escalation Phase|Progressive Disease|2|||
160546184|NCT01425008|579726804|FG010|Dose Escalation Phase|Progressive Disease|0|||
160546185|NCT01425008|579726805|FG011|Dose Escalation Phase|Progressive Disease|0|||
160546186|NCT01425008|579726806|FG012|Dose Escalation Phase|Progressive Disease|0|||
160546187|NCT01425008|579726807|FG013|Dose Escalation Phase|Progressive Disease|0|||
160546188|NCT01425008|579726808|FG014|Dose Escalation Phase|Progressive Disease|0|||
160546189|NCT01425008|579726809|FG015|Dose Escalation Phase|Progressive Disease|0|||
160546190|NCT01425008|579726810|FG016|Dose Escalation Phase|Progressive Disease|0|||
160546191|NCT01425008|579726811|FG017|Dose Escalation Phase|Progressive Disease|0|||
160546192|NCT01425008|579726812|FG018|Dose Escalation Phase|Progressive Disease|0|||
160546193|NCT01425008|579726794|FG000|Dose Escalation Phase|Adverse Event|2|||
160546194|NCT01425008|579726795|FG001|Dose Escalation Phase|Adverse Event|0|||
160546195|NCT01425008|579726796|FG002|Dose Escalation Phase|Adverse Event|0|||
160546196|NCT01425008|579726797|FG003|Dose Escalation Phase|Adverse Event|0|||
160546197|NCT01425008|579726798|FG004|Dose Escalation Phase|Adverse Event|0|||
160546198|NCT01425008|579726799|FG005|Dose Escalation Phase|Adverse Event|2|||
160546199|NCT01425008|579726800|FG006|Dose Escalation Phase|Adverse Event|0|||
160546200|NCT01425008|579726801|FG007|Dose Escalation Phase|Adverse Event|0|||
160546201|NCT01425008|579726802|FG008|Dose Escalation Phase|Adverse Event|2|||
160546202|NCT01425008|579726803|FG009|Dose Escalation Phase|Adverse Event|0|||
160546203|NCT01425008|579726804|FG010|Dose Escalation Phase|Adverse Event|0|||
160546204|NCT01425008|579726805|FG011|Dose Escalation Phase|Adverse Event|0|||
160546205|NCT01425008|579726806|FG012|Dose Escalation Phase|Adverse Event|0|||
160546206|NCT01425008|579726807|FG013|Dose Escalation Phase|Adverse Event|0|||
160546207|NCT01425008|579726808|FG014|Dose Escalation Phase|Adverse Event|0|||
160546208|NCT01425008|579726809|FG015|Dose Escalation Phase|Adverse Event|0|||
160546209|NCT01425008|579726810|FG016|Dose Escalation Phase|Adverse Event|0|||
160546210|NCT01425008|579726811|FG017|Dose Escalation Phase|Adverse Event|0|||
160546211|NCT01425008|579726812|FG018|Dose Escalation Phase|Adverse Event|0|||
160546212|NCT01425008|579726794|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546213|NCT01425008|579726795|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546214|NCT01425008|579726796|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546215|NCT01425008|579726797|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546216|NCT01425008|579726798|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
160546217|NCT01425008|579726799|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546218|NCT01425008|579726800|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
160546219|NCT01425008|579726801|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
160546220|NCT01425008|579726802|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
160546221|NCT01425008|579726803|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546222|NCT01425008|579726804|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546223|NCT01425008|579726805|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546224|NCT01425008|579726806|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546225|NCT01425008|579726807|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160641153|NCT03262233|580070550|FG000|Overall Study|Protocol Violation|5|||
160641154|NCT03262233|580070551|FG001|Overall Study|Protocol Violation|10|||
160546226|NCT01425008|579726808|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546227|NCT01425008|579726809|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546228|NCT01425008|579726810|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546229|NCT01425008|579726811|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160641155|NCT03262233|580070552|FG002|Overall Study|Protocol Violation|2|||
160641156|NCT03262233|580070553|FG003|Overall Study|Protocol Violation|13|||
160641157|NCT03262233|580070550|FG000|Overall Study|data collection artifact|0|||
160641158|NCT03262233|580070551|FG001|Overall Study|data collection artifact|1|||
160641159|NCT03262233|580070552|FG002|Overall Study|data collection artifact|0|||
160641160|NCT03262233|580070553|FG003|Overall Study|data collection artifact|0|||
160641161|NCT03877237|580070554|FG000|Overall Study|Adverse Event|1|||
160641162|NCT03877237|580070555|FG001|Overall Study|Adverse Event|2|||
160641163|NCT03877237|580070554|FG000|Overall Study|Death|3|||
160641164|NCT03877237|580070555|FG001|Overall Study|Death|2|||
160641165|NCT03877237|580070554|FG000|Overall Study|Physician Decision|1|||
160641166|NCT03877237|580070555|FG001|Overall Study|Physician Decision|0|||
160641167|NCT03877237|580070554|FG000|Overall Study|Withdrawal by Subject|0|||
160641168|NCT03877237|580070555|FG001|Overall Study|Withdrawal by Subject|2|||
160641169|NCT00566098|580070557|FG000|Collection of MILs|Withdrawal by Subject|1|||
160641170|NCT00566098|580070557|FG000|Collection of MILs|Relapsed|1|||
160641171|NCT00566098|580070557|FG000|Generation of MILs Product|Relapsed|1|||
160641172|NCT00566098|580070557|FG000|Administration of ASCT+MILs|Death|10|||
160641173|NCT00566098|580070557|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
160641174|NCT02236754|580070558|FG000|Overall Study|Withdrawal by Subject|1|||
160641175|NCT02236754|580070559|FG001|Overall Study|Withdrawal by Subject|0|||
160641176|NCT01270841|580070560|FG000|Overall Study|Adverse Event|0|||
160641177|NCT01270841|580070561|FG001|Overall Study|Adverse Event|1|||
160641178|NCT01270841|580070562|FG002|Overall Study|Adverse Event|0|||
160641179|NCT01270841|580070563|FG003|Overall Study|Adverse Event|3|||
160641180|NCT01270841|580070560|FG000|Overall Study|Withdrawal by Subject|3|||
160641181|NCT01270841|580070561|FG001|Overall Study|Withdrawal by Subject|2|||
160641182|NCT01270841|580070562|FG002|Overall Study|Withdrawal by Subject|3|||
160641183|NCT01270841|580070563|FG003|Overall Study|Withdrawal by Subject|3|||
160641184|NCT01270841|580070560|FG000|Overall Study|Lost to Follow-up|3|||
160641185|NCT01270841|580070561|FG001|Overall Study|Lost to Follow-up|1|||
160641186|NCT01270841|580070562|FG002|Overall Study|Lost to Follow-up|4|||
160641187|NCT01270841|580070563|FG003|Overall Study|Lost to Follow-up|2|||
160641188|NCT01270841|580070560|FG000|Overall Study|Physician Decision|0|||
160641189|NCT01270841|580070561|FG001|Overall Study|Physician Decision|1|||
160641190|NCT01270841|580070562|FG002|Overall Study|Physician Decision|0|||
160641191|NCT01270841|580070563|FG003|Overall Study|Physician Decision|0|||
160641192|NCT01270841|580070560|FG000|Overall Study|Did not qualify|6|||
160641193|NCT01270841|580070561|FG001|Overall Study|Did not qualify|3|||
160641194|NCT01270841|580070562|FG002|Overall Study|Did not qualify|4|||
160641195|NCT01270841|580070563|FG003|Overall Study|Did not qualify|5|||
160641196|NCT01270841|580070560|FG000|Overall Study|Protocol Violation|1|||
160641197|NCT01270841|580070561|FG001|Overall Study|Protocol Violation|5|||
160641198|NCT01270841|580070562|FG002|Overall Study|Protocol Violation|0|||
160641199|NCT01270841|580070563|FG003|Overall Study|Protocol Violation|0|||
160641200|NCT01270841|580070560|FG000|Overall Study|Enrolled in error|0|||
160546230|NCT01425008|579726812|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160546231|NCT01425008|579726794|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
160546232|NCT01425008|579726795|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
160641201|NCT01270841|580070561|FG001|Overall Study|Enrolled in error|1|||
160641202|NCT01270841|580070562|FG002|Overall Study|Enrolled in error|0|||
160641203|NCT01270841|580070563|FG003|Overall Study|Enrolled in error|0|||
160641204|NCT02092961|580070564|FG000|Overall Study|Not reported|1|||
160641205|NCT02092961|580070565|FG001|Overall Study|Not reported|0|||
160641206|NCT02092961|580070566|FG002|Overall Study|Not reported|1|||
160546233|NCT01425008|579726796|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
160546234|NCT01425008|579726797|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160546235|NCT01425008|579726798|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
160546236|NCT01425008|579726799|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
160546237|NCT01425008|579726800|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
160546238|NCT01425008|579726801|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
160546239|NCT01425008|579726802|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
160546240|NCT01425008|579726803|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
160546241|NCT01425008|579726804|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
160546242|NCT01425008|579726805|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
160546243|NCT01425008|579726806|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
160546244|NCT01425008|579726807|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
160641207|NCT02092961|580070564|FG000|Overall Study|Study stopped|13|||
160641208|NCT02092961|580070565|FG001|Overall Study|Study stopped|9|||
160546245|NCT01425008|579726808|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
160546246|NCT01425008|579726809|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
160546247|NCT01425008|579726810|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
160546248|NCT01425008|579726811|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
160546249|NCT01425008|579726812|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
160546250|NCT01425008|579726794|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546251|NCT01425008|579726795|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546252|NCT01425008|579726796|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
160546253|NCT01425008|579726797|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546254|NCT01425008|579726798|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546255|NCT01425008|579726799|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546256|NCT01425008|579726800|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546257|NCT01425008|579726801|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546258|NCT01425008|579726802|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
160546259|NCT01425008|579726803|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
160546260|NCT01425008|579726804|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546261|NCT01425008|579726805|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546262|NCT01425008|579726806|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546263|NCT01425008|579726807|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546264|NCT01425008|579726808|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546265|NCT01425008|579726809|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546266|NCT01425008|579726810|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546267|NCT01425008|579726811|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546268|NCT01425008|579726812|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
160546269|NCT01425008|579726794|FG000|Dose Escalation Phase|Other|0|||
160546270|NCT01425008|579726795|FG001|Dose Escalation Phase|Other|0|||
160546271|NCT01425008|579726796|FG002|Dose Escalation Phase|Other|0|||
160546272|NCT01425008|579726797|FG003|Dose Escalation Phase|Other|0|||
160546273|NCT01425008|579726798|FG004|Dose Escalation Phase|Other|0|||
160546274|NCT01425008|579726799|FG005|Dose Escalation Phase|Other|0|||
160546275|NCT01425008|579726800|FG006|Dose Escalation Phase|Other|0|||
160546276|NCT01425008|579726801|FG007|Dose Escalation Phase|Other|0|||
160546277|NCT01425008|579726802|FG008|Dose Escalation Phase|Other|1|||
160546278|NCT01425008|579726803|FG009|Dose Escalation Phase|Other|0|||
160546279|NCT01425008|579726804|FG010|Dose Escalation Phase|Other|0|||
160546280|NCT01425008|579726805|FG011|Dose Escalation Phase|Other|0|||
160546281|NCT01425008|579726806|FG012|Dose Escalation Phase|Other|0|||
160546282|NCT01425008|579726807|FG013|Dose Escalation Phase|Other|0|||
160546283|NCT01425008|579726808|FG014|Dose Escalation Phase|Other|0|||
160546284|NCT01425008|579726809|FG015|Dose Escalation Phase|Other|0|||
160546285|NCT01425008|579726810|FG016|Dose Escalation Phase|Other|0|||
160546286|NCT01425008|579726811|FG017|Dose Escalation Phase|Other|0|||
160546287|NCT01425008|579726812|FG018|Dose Escalation Phase|Other|0|||
160546288|NCT01425008|579726794|FG000|Dose Expansion Phase|Progressive Disease|0|||
160546289|NCT01425008|579726795|FG001|Dose Expansion Phase|Progressive Disease|0|||
160546290|NCT01425008|579726796|FG002|Dose Expansion Phase|Progressive Disease|0|||
160546291|NCT01425008|579726797|FG003|Dose Expansion Phase|Progressive Disease|0|||
160546292|NCT01425008|579726798|FG004|Dose Expansion Phase|Progressive Disease|0|||
160546293|NCT01425008|579726799|FG005|Dose Expansion Phase|Progressive Disease|0|||
160546294|NCT01425008|579726800|FG006|Dose Expansion Phase|Progressive Disease|0|||
160546295|NCT01425008|579726801|FG007|Dose Expansion Phase|Progressive Disease|0|||
160641209|NCT02092961|580070566|FG002|Overall Study|Study stopped|12|||
160641210|NCT02092961|580070564|FG000|Overall Study|Lack of therapeutic response|2|||
160546296|NCT01425008|579726802|FG008|Dose Expansion Phase|Progressive Disease|0|||
160546297|NCT01425008|579726803|FG009|Dose Expansion Phase|Progressive Disease|0|||
160546298|NCT01425008|579726804|FG010|Dose Expansion Phase|Progressive Disease|10|||
160546299|NCT01425008|579726805|FG011|Dose Expansion Phase|Progressive Disease|4|||
160546300|NCT01425008|579726806|FG012|Dose Expansion Phase|Progressive Disease|12|||
160546301|NCT01425008|579726807|FG013|Dose Expansion Phase|Progressive Disease|1|||
160546302|NCT01425008|579726808|FG014|Dose Expansion Phase|Progressive Disease|5|||
160641211|NCT02092961|580070565|FG001|Overall Study|Lack of therapeutic response|1|||
160641212|NCT02092961|580070566|FG002|Overall Study|Lack of therapeutic response|3|||
160641213|NCT02092961|580070564|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
160641214|NCT02092961|580070565|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
160641215|NCT02092961|580070566|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
160641216|NCT02092961|580070564|FG000|Overall Study|Adverse Event|2|||
160641217|NCT02092961|580070565|FG001|Overall Study|Adverse Event|4|||
160641218|NCT02092961|580070566|FG002|Overall Study|Adverse Event|0|||
160641219|NCT01623830|580070569|FG000|Overall Study|Withdrawal by Subject|6|||
160641220|NCT01623830|580070570|FG001|Overall Study|Withdrawal by Subject|7|||
160641221|NCT01623830|580070569|FG000|Overall Study|Exclusion from Study|1|||
160641222|NCT01623830|580070570|FG001|Overall Study|Exclusion from Study|2|||
160641223|NCT01605461|580070571|FG000|Overall Study|Lost to Follow-up|3|||
160641224|NCT01605461|580070571|FG000|Overall Study|Withdrawal by Subject|1|||
160641225|NCT01625845|580070574|FG000|Overall Study|Adverse Event|1|||
160641226|NCT01625845|580070575|FG001|Overall Study|Adverse Event|2|||
160641227|NCT01625845|580070574|FG000|Overall Study|Lost to Follow-up|2|||
160641228|NCT01625845|580070575|FG001|Overall Study|Lost to Follow-up|1|||
160641229|NCT01625845|580070574|FG000|Overall Study|Withdrawal by Subject|2|||
160641230|NCT01625845|580070575|FG001|Overall Study|Withdrawal by Subject|0|||
160641231|NCT02853929|580070576|FG000|Overall Study|Lost to Follow-up|3|||
160641232|NCT02853929|580070577|FG001|Overall Study|Lost to Follow-up|0|||
160641233|NCT02853929|580070576|FG000|Overall Study|Withdrawal by Subject|1|||
160641234|NCT02853929|580070577|FG001|Overall Study|Withdrawal by Subject|0|||
160641235|NCT02853929|580070576|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
160641236|NCT02853929|580070577|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
160641237|NCT02265952|580070578|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
160641238|NCT02265952|580070579|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
160641239|NCT02265952|580070578|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
160546303|NCT01425008|579726809|FG015|Dose Expansion Phase|Progressive Disease|8|||
160546304|NCT01425008|579726810|FG016|Dose Expansion Phase|Progressive Disease|9|||
160546305|NCT01425008|579726811|FG017|Dose Expansion Phase|Progressive Disease|2|||
160546306|NCT01425008|579726812|FG018|Dose Expansion Phase|Progressive Disease|10|||
160546307|NCT01425008|579726794|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
160546308|NCT01425008|579726795|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
160546309|NCT01425008|579726796|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
160546310|NCT01425008|579726797|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
160546311|NCT01425008|579726798|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
160546312|NCT01425008|579726799|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
160546313|NCT01425008|579726800|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
160546314|NCT01425008|579726801|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
160546315|NCT01425008|579726802|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
160546316|NCT01425008|579726803|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
160546317|NCT01425008|579726804|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
160546318|NCT01425008|579726805|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
160546319|NCT01425008|579726806|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
160546320|NCT01425008|579726807|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
160546321|NCT01425008|579726808|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
160546322|NCT01425008|579726809|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
160546323|NCT01425008|579726810|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
160546324|NCT01425008|579726811|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
160546325|NCT01425008|579726812|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
160546326|NCT01425008|579726794|FG000|Dose Expansion Phase|Other|0|||
160546327|NCT01425008|579726795|FG001|Dose Expansion Phase|Other|0|||
160546328|NCT01425008|579726796|FG002|Dose Expansion Phase|Other|0|||
160546329|NCT01425008|579726797|FG003|Dose Expansion Phase|Other|0|||
160546330|NCT01425008|579726798|FG004|Dose Expansion Phase|Other|0|||
160546331|NCT01425008|579726799|FG005|Dose Expansion Phase|Other|0|||
160546332|NCT01425008|579726800|FG006|Dose Expansion Phase|Other|0|||
160546333|NCT01425008|579726801|FG007|Dose Expansion Phase|Other|0|||
160546334|NCT01425008|579726802|FG008|Dose Expansion Phase|Other|0|||
160546335|NCT01425008|579726803|FG009|Dose Expansion Phase|Other|0|||
160641240|NCT02265952|580070579|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
160546336|NCT01425008|579726804|FG010|Dose Expansion Phase|Other|0|||
160546337|NCT01425008|579726805|FG011|Dose Expansion Phase|Other|0|||
160546338|NCT01425008|579726806|FG012|Dose Expansion Phase|Other|1|||
160641241|NCT00326885|580070582|FG000|Overall Study|Adverse Event|1|||
160641242|NCT00326885|580070582|FG000|Overall Study|Withdrawal by Subject|3|||
160641243|NCT00326885|580070582|FG000|Overall Study|Physician Decision|1|||
160641244|NCT00326885|580070582|FG000|Overall Study|Hospice withdrew consent|2|||
160787512|NCT00987935|580607336|FG002|Overall Study|Progressive disease|3|||
160546339|NCT01425008|579726807|FG013|Dose Expansion Phase|Other|0|||
160546340|NCT01425008|579726808|FG014|Dose Expansion Phase|Other|0|||
160546341|NCT01425008|579726809|FG015|Dose Expansion Phase|Other|0|||
160546342|NCT01425008|579726810|FG016|Dose Expansion Phase|Other|2|||
160546343|NCT01425008|579726811|FG017|Dose Expansion Phase|Other|0|||
160546344|NCT01425008|579726812|FG018|Dose Expansion Phase|Other|4|||
160546345|NCT01425008|579726794|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
160787513|NCT00987935|580607337|FG003|Overall Study|Progressive disease|2|||
160787514|NCT00987935|580607338|FG004|Overall Study|Progressive disease|5|||
160787515|NCT00987935|580607339|FG005|Overall Study|Progressive disease|3|||
160787516|NCT00987935|580607340|FG006|Overall Study|Progressive disease|9|||
160787517|NCT00987935|580607341|FG007|Overall Study|Progressive disease|48|||
160787518|NCT00987935|580607342|FG008|Overall Study|Progressive disease|23|||
160787519|NCT00987935|580607334|FG000|Overall Study|Adverse Event|0|||
160787520|NCT00987935|580607335|FG001|Overall Study|Adverse Event|1|||
160787521|NCT00987935|580607336|FG002|Overall Study|Adverse Event|0|||
160787522|NCT00987935|580607337|FG003|Overall Study|Adverse Event|1|||
160787523|NCT00987935|580607338|FG004|Overall Study|Adverse Event|1|||
160787524|NCT00987935|580607339|FG005|Overall Study|Adverse Event|0|||
160787525|NCT00987935|580607340|FG006|Overall Study|Adverse Event|2|||
160641245|NCT00472446|580070583|FG000|Overall Study|Protocol Violation|0|||
160641246|NCT00472446|580070584|FG001|Overall Study|Protocol Violation|0|||
160641247|NCT00472446|580070585|FG002|Overall Study|Protocol Violation|0|||
160546346|NCT01425008|579726795|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546347|NCT01425008|579726796|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546348|NCT01425008|579726797|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546349|NCT01425008|579726798|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546350|NCT01425008|579726799|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546351|NCT01425008|579726800|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546352|NCT01425008|579726801|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546353|NCT01425008|579726802|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546354|NCT01425008|579726803|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546355|NCT01425008|579726804|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
160546356|NCT01425008|579726805|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
160546357|NCT01425008|579726806|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546358|NCT01425008|579726807|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
160787526|NCT00987935|580607341|FG007|Overall Study|Adverse Event|10|||
160787527|NCT00987935|580607342|FG008|Overall Study|Adverse Event|6|||
160787528|NCT00987935|580607334|FG000|Overall Study|Refused to continue taking trial med.|1|||
160787529|NCT00987935|580607335|FG001|Overall Study|Refused to continue taking trial med.|0|||
160546359|NCT01425008|579726808|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546360|NCT01425008|579726809|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
160546361|NCT01425008|579726810|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
160546362|NCT01425008|579726811|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
160546363|NCT01425008|579726812|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
160546364|NCT01425008|579726794|FG000|Dose Expansion Phase|Adverse Event|0|||
160546365|NCT01425008|579726795|FG001|Dose Expansion Phase|Adverse Event|0|||
160546366|NCT01425008|579726796|FG002|Dose Expansion Phase|Adverse Event|0|||
160546367|NCT01425008|579726797|FG003|Dose Expansion Phase|Adverse Event|0|||
160546368|NCT01425008|579726798|FG004|Dose Expansion Phase|Adverse Event|0|||
160546369|NCT01425008|579726799|FG005|Dose Expansion Phase|Adverse Event|0|||
160546370|NCT01425008|579726800|FG006|Dose Expansion Phase|Adverse Event|0|||
160787530|NCT00987935|580607336|FG002|Overall Study|Refused to continue taking trial med.|0|||
160787531|NCT00987935|580607337|FG003|Overall Study|Refused to continue taking trial med.|0|||
160787532|NCT00987935|580607338|FG004|Overall Study|Refused to continue taking trial med.|1|||
160787533|NCT00987935|580607339|FG005|Overall Study|Refused to continue taking trial med.|0|||
160787534|NCT00987935|580607340|FG006|Overall Study|Refused to continue taking trial med.|4|||
160787535|NCT00987935|580607341|FG007|Overall Study|Refused to continue taking trial med.|4|||
160787536|NCT00987935|580607342|FG008|Overall Study|Refused to continue taking trial med.|2|||
160787537|NCT00987935|580607334|FG000|Overall Study|Reason other than those specified above|0|||
160787538|NCT00987935|580607335|FG001|Overall Study|Reason other than those specified above|0|||
160787539|NCT00987935|580607336|FG002|Overall Study|Reason other than those specified above|0|||
160787540|NCT00987935|580607337|FG003|Overall Study|Reason other than those specified above|0|||
160787541|NCT00987935|580607338|FG004|Overall Study|Reason other than those specified above|0|||
160787542|NCT00987935|580607339|FG005|Overall Study|Reason other than those specified above|0|||
160787543|NCT00987935|580607340|FG006|Overall Study|Reason other than those specified above|0|||
160787544|NCT00987935|580607341|FG007|Overall Study|Reason other than those specified above|0|||
160787545|NCT00987935|580607342|FG008|Overall Study|Reason other than those specified above|1|||
160787546|NCT01089543|580607343|FG000|Overall Study|Withdrawal by Subject|2|||
160787547|NCT01089543|580607344|FG001|Overall Study|Withdrawal by Subject|3|||
160787548|NCT01089543|580607345|FG002|Overall Study|Withdrawal by Subject|3|||
160787549|NCT01089543|580607346|FG003|Overall Study|Withdrawal by Subject|1|||
160787550|NCT01089543|580607343|FG000|Overall Study|Physician Decision|1|||
160787551|NCT01089543|580607344|FG001|Overall Study|Physician Decision|0|||
160787552|NCT01089543|580607345|FG002|Overall Study|Physician Decision|0|||
160787553|NCT01089543|580607346|FG003|Overall Study|Physician Decision|1|||
160787554|NCT01089543|580607343|FG000|Overall Study|Adverse Event|0|||
160787555|NCT01089543|580607344|FG001|Overall Study|Adverse Event|1|||
160787556|NCT01089543|580607345|FG002|Overall Study|Adverse Event|0|||
160787557|NCT01089543|580607346|FG003|Overall Study|Adverse Event|0|||
160787558|NCT00452530|580607347|FG000|Overall Study|Death|1|||
160787559|NCT00452530|580607348|FG001|Overall Study|Death|0|||
160787560|NCT00452530|580607347|FG000|Overall Study|Adverse Event|40|||
160787561|NCT00452530|580607348|FG001|Overall Study|Adverse Event|44|||
160787562|NCT00452530|580607347|FG000|Overall Study|Withdrawal by Subject|68|||
160787563|NCT00452530|580607348|FG001|Overall Study|Withdrawal by Subject|57|||
160546371|NCT01425008|579726801|FG007|Dose Expansion Phase|Adverse Event|0|||
160546372|NCT01425008|579726802|FG008|Dose Expansion Phase|Adverse Event|0|||
160641248|NCT00472446|580070586|FG003|Overall Study|Protocol Violation|1|||
160787564|NCT00452530|580607347|FG000|Overall Study|Lost to Follow-up|1|||
160787565|NCT00452530|580607348|FG001|Overall Study|Lost to Follow-up|0|||
160787566|NCT00452530|580607347|FG000|Overall Study|Poor compliance/noncompliance|1|||
160787567|NCT00452530|580607348|FG001|Overall Study|Poor compliance/noncompliance|2|||
160787568|NCT00452530|580607347|FG000|Overall Study|No longer met study criteria|18|||
160787569|NCT00452530|580607348|FG001|Overall Study|No longer met study criteria|22|||
160787570|NCT00452530|580607347|FG000|Overall Study|Other|7|||
160787571|NCT00452530|580607348|FG001|Overall Study|Other|11|||
160787572|NCT00754559|580607350|FG000|Overall Study|Adverse Event|15|||
160787573|NCT00754559|580607350|FG000|Overall Study|Protocol Violation|11|||
160787574|NCT00754559|580607350|FG000|Overall Study|Lack of Efficacy|10|||
160787575|NCT00754559|580607350|FG000|Overall Study|Lost to Follow-up|2|||
160787576|NCT00754559|580607350|FG000|Overall Study|Administrative reason|1|||
160546373|NCT01425008|579726803|FG009|Dose Expansion Phase|Adverse Event|0|||
160546374|NCT01425008|579726804|FG010|Dose Expansion Phase|Adverse Event|2|||
160546375|NCT01425008|579726805|FG011|Dose Expansion Phase|Adverse Event|3|||
160546376|NCT01425008|579726806|FG012|Dose Expansion Phase|Adverse Event|3|||
160546377|NCT01425008|579726807|FG013|Dose Expansion Phase|Adverse Event|0|||
160546378|NCT01425008|579726808|FG014|Dose Expansion Phase|Adverse Event|1|||
160546379|NCT01425008|579726809|FG015|Dose Expansion Phase|Adverse Event|1|||
160546380|NCT01425008|579726810|FG016|Dose Expansion Phase|Adverse Event|5|||
160546381|NCT01425008|579726811|FG017|Dose Expansion Phase|Adverse Event|0|||
160546382|NCT01425008|579726812|FG018|Dose Expansion Phase|Adverse Event|3|||
160546383|NCT01425008|579726794|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
160546384|NCT01425008|579726795|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
160546385|NCT01425008|579726796|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
160546386|NCT01425008|579726797|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
160546387|NCT01425008|579726798|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
160546388|NCT01425008|579726799|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
160546389|NCT01425008|579726800|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
160546390|NCT01425008|579726801|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
160546391|NCT01425008|579726802|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
160546392|NCT01425008|579726803|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
160546393|NCT01425008|579726804|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
160546394|NCT01425008|579726805|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
160546395|NCT01425008|579726806|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
160546396|NCT01425008|579726807|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
160546397|NCT01425008|579726808|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
160546398|NCT01425008|579726809|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
160546399|NCT01425008|579726810|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
160641249|NCT00472446|580070583|FG000|Overall Study|Reintervention|0|||
160641250|NCT00472446|580070584|FG001|Overall Study|Reintervention|0|||
160641251|NCT00472446|580070585|FG002|Overall Study|Reintervention|1|||
160641252|NCT00472446|580070586|FG003|Overall Study|Reintervention|1|||
160641253|NCT00472446|580070583|FG000|Overall Study|Questionnaires not returned|5|||
160641254|NCT00472446|580070584|FG001|Overall Study|Questionnaires not returned|6|||
160641255|NCT00472446|580070585|FG002|Overall Study|Questionnaires not returned|6|||
160641256|NCT00472446|580070586|FG003|Overall Study|Questionnaires not returned|4|||
160641257|NCT03211156|580070588|FG000|Overall Study|Withdrawal by Subject|0|||
160641258|NCT03211156|580070589|FG001|Overall Study|Withdrawal by Subject|2|||
160641259|NCT03211156|580070588|FG000|Overall Study|Lost to Follow-up|1|||
160641260|NCT03211156|580070589|FG001|Overall Study|Lost to Follow-up|1|||
160641261|NCT03211156|580070588|FG000|Overall Study|Adverse Event|1|||
160641262|NCT03211156|580070589|FG001|Overall Study|Adverse Event|0|||
160641263|NCT00738673|580070592|FG000|Overall Study|Adverse Event|1|||
160641264|NCT00738673|580070593|FG001|Overall Study|Adverse Event|0|||
160641265|NCT00738673|580070592|FG000|Overall Study|Lack of Efficacy|19|||
160641266|NCT00738673|580070593|FG001|Overall Study|Lack of Efficacy|8|||
160641267|NCT00738673|580070592|FG000|Overall Study|Protocol Violation|1|||
160641268|NCT00738673|580070593|FG001|Overall Study|Protocol Violation|2|||
160641269|NCT00738673|580070592|FG000|Overall Study|Withdrawal by Subject|3|||
160641270|NCT00738673|580070593|FG001|Overall Study|Withdrawal by Subject|1|||
160641271|NCT02736227|580070594|FG000|Overall Study|Withdrawal by Subject|0|||
160641272|NCT02736227|580070595|FG001|Overall Study|Withdrawal by Subject|0|||
160641273|NCT02736227|580070596|FG002|Overall Study|Withdrawal by Subject|1|||
160641274|NCT02736227|580070594|FG000|Overall Study|Physician Decision|0|||
160641275|NCT02736227|580070595|FG001|Overall Study|Physician Decision|0|||
160641276|NCT02736227|580070596|FG002|Overall Study|Physician Decision|5|||
160641277|NCT02736227|580070594|FG000|Overall Study|Non Compliant|0|||
160641278|NCT02736227|580070595|FG001|Overall Study|Non Compliant|0|||
160641279|NCT02736227|580070596|FG002|Overall Study|Non Compliant|2|||
160641280|NCT03726437|580070610|FG000|Overall Study|Lost to Follow-up|85|||
160641281|NCT03726437|580070611|FG001|Overall Study|Lost to Follow-up|76|||
160641282|NCT01205529|580070618|FG000|Overall Study|Procedure Cancelled|4|||
160641283|NCT01205529|580070618|FG000|Overall Study|Withdrawal by Subject|2|||
160641284|NCT01205529|580070618|FG000|Overall Study|Physician Decision|4|||
160641285|NCT01205529|580070618|FG000|Overall Study|Unstable post op|15|||
160641286|NCT01205529|580070618|FG000|Overall Study|No longer met criteria|30|||
160641287|NCT00667719|580070619|FG000|Overall Study|Adverse Event|39|||
160641288|NCT00667719|580070619|FG000|Overall Study|Abnormal Test Procedure|1|||
160641289|NCT00667719|580070619|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160641290|NCT00667719|580070619|FG000|Overall Study|Protocol Violation|3|||
160641291|NCT00667719|580070619|FG000|Overall Study|Withdrawal by Subject|17|||
160641292|NCT00667719|580070619|FG000|Overall Study|Lost to Follow-up|8|||
160641293|NCT04133519|580070620|FG000|Overall Study|Withdrawal by Subject|5|||
160641294|NCT04133519|580070621|FG001|Overall Study|Withdrawal by Subject|4|||
160641295|NCT04133519|580070620|FG000|Overall Study|Protocol Violation|0|||
160641296|NCT04133519|580070621|FG001|Overall Study|Protocol Violation|1|||
160641297|NCT04133519|580070620|FG000|Overall Study|Never started treatment|1|||
160641298|NCT04133519|580070621|FG001|Overall Study|Never started treatment|1|||
160641299|NCT03840135|580070622|FG000|Overall Study|Protocol Violation|6|||
160641300|NCT03840135|580070623|FG001|Overall Study|Protocol Violation|1|||
160641301|NCT03840135|580070622|FG000|Overall Study|Withdrawal by Subject|1|||
160641302|NCT03840135|580070623|FG001|Overall Study|Withdrawal by Subject|0|||
160641303|NCT00323609|580070624|FG000|Overall Study|Death|16|||
160641304|NCT00323609|580070625|FG001|Overall Study|Death|21|||
160641305|NCT00323609|580070626|FG002|Overall Study|Death|0|||
160641306|NCT00323609|580070627|FG003|Overall Study|Death|0|||
160641307|NCT00323609|580070624|FG000|Overall Study|Lost to Follow-up|9|||
160641308|NCT00323609|580070625|FG001|Overall Study|Lost to Follow-up|10|||
160641309|NCT00323609|580070626|FG002|Overall Study|Lost to Follow-up|0|||
160641310|NCT00323609|580070627|FG003|Overall Study|Lost to Follow-up|0|||
160641311|NCT00323609|580070624|FG000|Overall Study|Physician Decision|2|||
160641312|NCT00323609|580070625|FG001|Overall Study|Physician Decision|0|||
160641313|NCT00323609|580070626|FG002|Overall Study|Physician Decision|0|||
160641314|NCT00323609|580070627|FG003|Overall Study|Physician Decision|1|||
160641315|NCT00323609|580070624|FG000|Overall Study|Withdrawal by Subject|11|||
160641316|NCT00323609|580070625|FG001|Overall Study|Withdrawal by Subject|23|||
160641317|NCT00323609|580070626|FG002|Overall Study|Withdrawal by Subject|4|||
160641318|NCT00323609|580070627|FG003|Overall Study|Withdrawal by Subject|4|||
160641319|NCT00323609|580070624|FG000|Overall Study|Other non-VCF-related medical condition|3|||
160641320|NCT00323609|580070625|FG001|Overall Study|Other non-VCF-related medical condition|2|||
160641321|NCT00323609|580070626|FG002|Overall Study|Other non-VCF-related medical condition|0|||
160641322|NCT00323609|580070627|FG003|Overall Study|Other non-VCF-related medical condition|0|||
160641323|NCT00323609|580070624|FG000|Overall Study|Sponsor discontinued trial|29|||
160641324|NCT00323609|580070625|FG001|Overall Study|Sponsor discontinued trial|29|||
160641325|NCT00323609|580070626|FG002|Overall Study|Sponsor discontinued trial|0|||
160641326|NCT00323609|580070627|FG003|Overall Study|Sponsor discontinued trial|0|||
160787577|NCT00754559|580607350|FG000|Overall Study|Other|5|||
160787578|NCT00754559|580607350|FG000|Overall Study|Withdrawal by Subject|3|||
160787579|NCT01248468|580607351|FG000|Overall Study|Administrative problem|1|||
160787580|NCT01248468|580607352|FG001|Overall Study|Administrative problem|0|||
160641327|NCT00323609|580070624|FG000|Overall Study|Unrelenting or severe back pain|1|||
160641328|NCT00323609|580070625|FG001|Overall Study|Unrelenting or severe back pain|1|||
160641329|NCT00323609|580070626|FG002|Overall Study|Unrelenting or severe back pain|0|||
160641330|NCT00323609|580070627|FG003|Overall Study|Unrelenting or severe back pain|0|||
160641331|NCT00323609|580070624|FG000|Overall Study|Logistical withdrawal|9|||
160641332|NCT00323609|580070625|FG001|Overall Study|Logistical withdrawal|5|||
160641333|NCT00323609|580070626|FG002|Overall Study|Logistical withdrawal|0|||
160641334|NCT00323609|580070627|FG003|Overall Study|Logistical withdrawal|1|||
160641335|NCT00323609|580070624|FG000|Overall Study|Other reason|11|||
160641336|NCT00323609|580070625|FG001|Overall Study|Other reason|8|||
160641337|NCT00323609|580070626|FG002|Overall Study|Other reason|4|||
160641338|NCT00323609|580070627|FG003|Overall Study|Other reason|9|||
160787581|NCT01248468|580607353|FG002|Overall Study|Administrative problem|0|||
160787582|NCT01248468|580607351|FG000|Overall Study|Lost to Follow-up|9|||
160787583|NCT01248468|580607352|FG001|Overall Study|Lost to Follow-up|12|||
160787584|NCT01248468|580607353|FG002|Overall Study|Lost to Follow-up|4|||
160787585|NCT01248468|580607351|FG000|Overall Study|Pregnancy|1|||
160787586|NCT01248468|580607352|FG001|Overall Study|Pregnancy|0|||
160787587|NCT01248468|580607353|FG002|Overall Study|Pregnancy|0|||
160787588|NCT01248468|580607351|FG000|Overall Study|Withdrawal by Subject|4|||
160787589|NCT01248468|580607352|FG001|Overall Study|Withdrawal by Subject|2|||
160787590|NCT01248468|580607353|FG002|Overall Study|Withdrawal by Subject|0|||
160787591|NCT02191397|580607354|FG000|Overall Study|Adverse Event|28|||
160787592|NCT02191397|580607355|FG001|Overall Study|Adverse Event|17|||
160787593|NCT02191397|580607354|FG000|Overall Study|Lack of Efficacy|10|||
160787594|NCT02191397|580607355|FG001|Overall Study|Lack of Efficacy|5|||
160787595|NCT02191397|580607354|FG000|Overall Study|Protocol Violation|0|||
160787596|NCT02191397|580607355|FG001|Overall Study|Protocol Violation|3|||
160787597|NCT02191397|580607354|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
160787598|NCT02191397|580607355|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
160787599|NCT02191397|580607354|FG000|Overall Study|Lost to Follow-up|10|||
160787600|NCT02191397|580607355|FG001|Overall Study|Lost to Follow-up|11|||
160787601|NCT02191397|580607354|FG000|Overall Study|Physician Decision|8|||
160787602|NCT02191397|580607355|FG001|Overall Study|Physician Decision|3|||
160787603|NCT02191397|580607354|FG000|Overall Study|Withdrawal by Subject|22|||
160787604|NCT02191397|580607355|FG001|Overall Study|Withdrawal by Subject|27|||
160787605|NCT00468546|580607357|FG000|Week 24 Analysis|Lack of Efficacy|83|||
160787606|NCT00468546|580607358|FG001|Week 24 Analysis|Lack of Efficacy|37|||
160787607|NCT00468546|580607357|FG000|Week 24 Analysis|Refused treatment|5|||
160787608|NCT00468546|580607358|FG001|Week 24 Analysis|Refused treatment|5|||
160787609|NCT00468546|580607357|FG000|Week 24 Analysis|Adverse Event|1|||
160787610|NCT00468546|580607358|FG001|Week 24 Analysis|Adverse Event|8|||
160787611|NCT00468546|580607357|FG000|Week 24 Analysis|Failure to return|3|||
160787612|NCT00468546|580607358|FG001|Week 24 Analysis|Failure to return|4|||
160787613|NCT00468546|580607357|FG000|Week 24 Analysis|Rescue therapy|2|||
160787614|NCT00468546|580607358|FG001|Week 24 Analysis|Rescue therapy|0|||
160787615|NCT00468546|580607357|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
160787616|NCT00468546|580607358|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
160787617|NCT00468546|580607357|FG000|Week 24 Analysis|Due to clinical hold|1|||
160787618|NCT00468546|580607358|FG001|Week 24 Analysis|Due to clinical hold|0|||
160787619|NCT00468546|580607357|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
160787620|NCT00468546|580607358|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
160787621|NCT00468546|580607357|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
160787622|NCT00468546|580607358|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
160787623|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
160787624|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
160787625|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Death|1|||
160787626|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Death|0|||
160787627|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
160787628|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
160787629|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
160787630|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
160641339|NCT01827371|580070628|FG000|Overall Study|Adverse Event|0|||
160641340|NCT01827371|580070629|FG001|Overall Study|Adverse Event|0|||
160787631|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
160787632|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
160787633|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
160787634|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
160787635|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
160787636|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
160787637|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Other|17|||
160787638|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Other|14|||
160787639|NCT04000724|580607359|FG000|Overall Study|Withdrawal by Subject|5|||
160787640|NCT04000724|580607360|FG001|Overall Study|Withdrawal by Subject|3|||
160787641|NCT04000724|580607361|FG002|Overall Study|Withdrawal by Subject|4|||
160787642|NCT04000724|580607359|FG000|Overall Study|Lost to Follow-up|11|||
160787643|NCT04000724|580607360|FG001|Overall Study|Lost to Follow-up|7|||
160787644|NCT04000724|580607361|FG002|Overall Study|Lost to Follow-up|13|||
160787645|NCT00455455|580607362|FG000|Washout|Withdrawal by Subject|0|||
160787646|NCT00455455|580607363|FG001|Washout|Withdrawal by Subject|1|||
160787647|NCT00455455|580607362|FG000|Washout|Withdrawal by Subject|1|||
160787648|NCT00455455|580607363|FG001|Washout|Withdrawal by Subject|0|||
160787649|NCT00472641|580607364|FG000|Overall Study|Lack of Efficacy|3|||
160787650|NCT00472641|580607364|FG000|Overall Study|Adverse Event|3|||
160787651|NCT00472641|580607364|FG000|Overall Study|Lost to Follow-up|1|||
160641341|NCT01827371|580070630|FG002|Overall Study|Adverse Event|4|||
160641342|NCT01827371|580070631|FG003|Overall Study|Adverse Event|2|||
160641343|NCT01827371|580070628|FG000|Overall Study|Lost to Follow-up|0|||
160641344|NCT01827371|580070629|FG001|Overall Study|Lost to Follow-up|2|||
160546400|NCT01425008|579726811|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
160546401|NCT01425008|579726812|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
160546402|NCT01425008|579726794|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546403|NCT01425008|579726795|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546404|NCT01425008|579726796|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546405|NCT01425008|579726797|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160787652|NCT01905267|580607365|FG000|Overall Study|Physician Decision|2|||
160787653|NCT01905267|580607366|FG001|Overall Study|Physician Decision|2|||
160787654|NCT01064622|580607371|FG000|Randomized Phase II|Withdrawal by Subject|2|||
160787655|NCT01064622|580607372|FG001|Randomized Phase II|Withdrawal by Subject|2|||
160787656|NCT01064622|580607371|FG000|Randomized Phase II|Protocol Violation|0|||
160787657|NCT01064622|580607372|FG001|Randomized Phase II|Protocol Violation|1|||
160787658|NCT05330429|580607373|FG000|Overall Study|Study Terminated by Sponsor|4|||
160641345|NCT01827371|580070630|FG002|Overall Study|Lost to Follow-up|0|||
160641346|NCT01827371|580070631|FG003|Overall Study|Lost to Follow-up|4|||
160641347|NCT01827371|580070628|FG000|Overall Study|Protocol Violation|1|||
160641348|NCT01827371|580070629|FG001|Overall Study|Protocol Violation|0|||
160641349|NCT01827371|580070630|FG002|Overall Study|Protocol Violation|0|||
160641350|NCT01827371|580070631|FG003|Overall Study|Protocol Violation|0|||
160641351|NCT01827371|580070628|FG000|Overall Study|Withdrawal by Subject|1|||
160641352|NCT01827371|580070629|FG001|Overall Study|Withdrawal by Subject|2|||
160641353|NCT01827371|580070630|FG002|Overall Study|Withdrawal by Subject|2|||
160641354|NCT01827371|580070631|FG003|Overall Study|Withdrawal by Subject|3|||
160787659|NCT05330429|580607374|FG001|Overall Study|Study Terminated by Sponsor|33|||
160787660|NCT05330429|580607375|FG002|Overall Study|Study Terminated by Sponsor|12|||
160787661|NCT05330429|580607373|FG000|Overall Study|Death|5|||
160787662|NCT05330429|580607374|FG001|Overall Study|Death|2|||
160787663|NCT05330429|580607375|FG002|Overall Study|Death|4|||
160546406|NCT01425008|579726798|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546407|NCT01425008|579726799|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160787664|NCT05330429|580607373|FG000|Overall Study|Withdrew Consent|0|||
160787665|NCT05330429|580607374|FG001|Overall Study|Withdrew Consent|5|||
160787666|NCT05330429|580607375|FG002|Overall Study|Withdrew Consent|4|||
160787667|NCT05330429|580607373|FG000|Overall Study|Investigator's Discretion|0|||
160787668|NCT05330429|580607374|FG001|Overall Study|Investigator's Discretion|1|||
160787669|NCT05330429|580607375|FG002|Overall Study|Investigator's Discretion|3|||
160787670|NCT05330429|580607373|FG000|Overall Study|Subject Decision|1|||
160787671|NCT05330429|580607374|FG001|Overall Study|Subject Decision|2|||
160787672|NCT05330429|580607375|FG002|Overall Study|Subject Decision|0|||
160787673|NCT05330429|580607373|FG000|Overall Study|Lost to Follow-up|0|||
160787674|NCT05330429|580607374|FG001|Overall Study|Lost to Follow-up|1|||
160787675|NCT05330429|580607375|FG002|Overall Study|Lost to Follow-up|0|||
160787676|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
160787677|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
160787678|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
160787679|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Adverse Event|5|||
160787680|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Adverse Event|1|||
160787681|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Adverse Event|0|||
160787682|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
160787683|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
160787684|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
160787685|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Death|8|||
160787686|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Death|24|||
160787687|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Death|0|||
160787688|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
160787689|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
160787690|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
160787691|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
160787692|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
160641355|NCT01827371|580070628|FG000|Overall Study|Physician Decision|0|||
160641356|NCT01827371|580070629|FG001|Overall Study|Physician Decision|1|||
160641357|NCT01827371|580070630|FG002|Overall Study|Physician Decision|0|||
160641358|NCT01827371|580070631|FG003|Overall Study|Physician Decision|1|||
160641359|NCT01827371|580070628|FG000|Overall Study|Temporary study halt to vaccinations|11|||
160787693|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
160787694|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
160787695|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
160787696|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
160787697|NCT02931539|580607379|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
160787698|NCT02931539|580607380|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
160787699|NCT02931539|580607381|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
160787700|NCT06097273|580607384|FG000|Overall Study|Death|2|||
160787701|NCT06097273|580607385|FG001|Overall Study|Death|1|||
160787702|NCT06097273|580607386|FG002|Overall Study|Death|2|||
160787703|NCT06097273|580607387|FG003|Overall Study|Death|2|||
160787704|NCT06097273|580607384|FG000|Overall Study|Lost to Follow-up|27|||
160787705|NCT06097273|580607385|FG001|Overall Study|Lost to Follow-up|18|||
160787706|NCT06097273|580607386|FG002|Overall Study|Lost to Follow-up|36|||
160787707|NCT06097273|580607387|FG003|Overall Study|Lost to Follow-up|31|||
160787708|NCT06097273|580607384|FG000|Overall Study|Physician Decision|0|||
160787709|NCT06097273|580607385|FG001|Overall Study|Physician Decision|1|||
160787710|NCT06097273|580607386|FG002|Overall Study|Physician Decision|0|||
160787711|NCT06097273|580607387|FG003|Overall Study|Physician Decision|3|||
160787712|NCT06097273|580607384|FG000|Overall Study|Protocol Violation|1|||
160787713|NCT06097273|580607385|FG001|Overall Study|Protocol Violation|1|||
160787714|NCT06097273|580607386|FG002|Overall Study|Protocol Violation|2|||
160787715|NCT06097273|580607387|FG003|Overall Study|Protocol Violation|1|||
160787716|NCT06097273|580607384|FG000|Overall Study|Withdrawal by Subject|14|||
160787717|NCT06097273|580607385|FG001|Overall Study|Withdrawal by Subject|11|||
160787718|NCT06097273|580607386|FG002|Overall Study|Withdrawal by Subject|14|||
160787719|NCT06097273|580607387|FG003|Overall Study|Withdrawal by Subject|15|||
160787720|NCT06097273|580607384|FG000|Overall Study|Other Than Specified|7|||
160787721|NCT06097273|580607385|FG001|Overall Study|Other Than Specified|3|||
160787722|NCT06097273|580607386|FG002|Overall Study|Other Than Specified|11|||
160787723|NCT06097273|580607387|FG003|Overall Study|Other Than Specified|6|||
160787724|NCT02562040|580608985|FG000|Overall Study|Lost to Follow-up|20|||
160787725|NCT02562040|580608986|FG001|Overall Study|Lost to Follow-up|28|||
160787726|NCT02562040|580608985|FG000|Overall Study|Withdrawal by Subject|8|||
160787727|NCT02562040|580608986|FG001|Overall Study|Withdrawal by Subject|7|||
160787728|NCT02562040|580608985|FG000|Overall Study|Adverse Event|1|||
160787729|NCT02562040|580608986|FG001|Overall Study|Adverse Event|0|||
160787730|NCT00368849|580608990|FG000|Overall Study|Withdrawal by Subject|0|||
160641360|NCT01827371|580070629|FG001|Overall Study|Temporary study halt to vaccinations|2|||
160641361|NCT01827371|580070630|FG002|Overall Study|Temporary study halt to vaccinations|5|||
160641362|NCT01827371|580070631|FG003|Overall Study|Temporary study halt to vaccinations|13|||
160641363|NCT00950599|580070632|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
160641364|NCT00950599|580070633|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
160641365|NCT00950599|580070634|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
160641366|NCT00950599|580070635|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
160641367|NCT00950599|580070636|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
160641368|NCT00950599|580070637|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
160641369|NCT00950599|580070638|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
160641370|NCT00950599|580070639|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
160641371|NCT00950599|580070640|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
160641372|NCT00950599|580070641|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
160641373|NCT00950599|580070632|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160641374|NCT00950599|580070633|FG001|Double-Blind Treatment Period|Adverse Event|1|||
160641375|NCT00950599|580070634|FG002|Double-Blind Treatment Period|Adverse Event|1|||
160641376|NCT00950599|580070635|FG003|Double-Blind Treatment Period|Adverse Event|1|||
160641377|NCT00950599|580070636|FG004|Double-Blind Treatment Period|Adverse Event|1|||
160641378|NCT00950599|580070637|FG005|Double-Blind Treatment Period|Adverse Event|1|||
160641379|NCT00950599|580070638|FG006|Double-Blind Treatment Period|Adverse Event|0|||
160641380|NCT00950599|580070639|FG007|Double-Blind Treatment Period|Adverse Event|0|||
160641381|NCT00950599|580070640|FG008|Double-Blind Treatment Period|Adverse Event|0|||
160641382|NCT00950599|580070641|FG009|Double-Blind Treatment Period|Adverse Event|0|||
160641383|NCT00950599|580070632|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
160641384|NCT00950599|580070633|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
160641385|NCT00950599|580070634|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
160641386|NCT00950599|580070635|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
160641387|NCT00950599|580070636|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
160641388|NCT00950599|580070637|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
160641389|NCT00950599|580070638|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
160787731|NCT00368849|580608991|FG001|Overall Study|Withdrawal by Subject|1|||
160641390|NCT00950599|580070639|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
160787732|NCT00368849|580608990|FG000|Overall Study|Physician Decision|0|||
160787733|NCT00368849|580608991|FG001|Overall Study|Physician Decision|1|||
160787734|NCT01699685|580608993|FG000|Period 1|Adverse Event|1|||
160787735|NCT01699685|580608994|FG001|Period 1|Adverse Event|1|||
160787736|NCT01699685|580608993|FG000|Period 1|Medical or ethical, noncompliance|2|||
160787737|NCT01699685|580608994|FG001|Period 1|Medical or ethical, noncompliance|0|||
160787738|NCT01699685|580608993|FG000|Period 1|Other|0|||
160787739|NCT01699685|580608994|FG001|Period 1|Other|1|||
160787740|NCT01699685|580608993|FG000|Period 1|Patient request|0|||
160787741|NCT01699685|580608994|FG001|Period 1|Patient request|1|||
160787742|NCT01699685|580608993|FG000|Period 2|Lost to Follow-up|1|||
160787743|NCT01699685|580608994|FG001|Period 2|Lost to Follow-up|0|||
160787744|NCT03635996|580608995|FG000|Overall Study|Study terminated by Sponsor|94|||
160787745|NCT03635996|580608995|FG000|Overall Study|Withdrawal by Subject|20|||
160787746|NCT03635996|580608995|FG000|Overall Study|Ablation|26|||
160641391|NCT00950599|580070640|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
160641392|NCT00950599|580070641|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
160641393|NCT00950599|580070632|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160641394|NCT00950599|580070633|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
160546408|NCT01425008|579726800|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546409|NCT01425008|579726801|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546410|NCT01425008|579726802|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546411|NCT01425008|579726803|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546412|NCT01425008|579726804|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546413|NCT01425008|579726805|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546414|NCT01425008|579726806|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546415|NCT01425008|579726807|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546416|NCT01425008|579726808|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546417|NCT01425008|579726809|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546418|NCT01425008|579726810|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546419|NCT01425008|579726811|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160546420|NCT01425008|579726812|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
160546421|NCT04818593|579726813|FG000|Overall Study|Low Oocyte Yield|8|||
160546422|NCT04818593|579726814|FG001|Overall Study|Low Oocyte Yield|8|||
160546423|NCT04818593|579726813|FG000|Overall Study|Not ICSI Insemination|7|||
160546424|NCT04818593|579726814|FG001|Overall Study|Not ICSI Insemination|7|||
160546425|NCT04818593|579726813|FG000|Overall Study|Poor Sperm Quality|2|||
160546426|NCT04818593|579726814|FG001|Overall Study|Poor Sperm Quality|2|||
160787747|NCT03635996|580608995|FG000|Overall Study|Adverse Event|7|||
160787748|NCT03635996|580608995|FG000|Overall Study|Physician Decision|3|||
160546427|NCT04818593|579726813|FG000|Overall Study|Withdrawal by Subject|2|||
160641395|NCT00950599|580070634|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
160641396|NCT00950599|580070635|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
160641397|NCT00950599|580070636|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
160641398|NCT00950599|580070637|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
160641399|NCT00950599|580070638|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
160641400|NCT00950599|580070639|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
160641401|NCT00950599|580070640|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
160641402|NCT00950599|580070641|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
160641403|NCT00950599|580070632|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
160641404|NCT00950599|580070633|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
160641405|NCT00950599|580070634|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
160641406|NCT00950599|580070635|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
160641407|NCT00950599|580070636|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
160641408|NCT00950599|580070637|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
160641409|NCT00950599|580070638|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
160641410|NCT00950599|580070639|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
160641411|NCT00950599|580070640|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
160641412|NCT00950599|580070641|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
160641413|NCT00950599|580070632|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
160641414|NCT00950599|580070633|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
160641415|NCT00950599|580070634|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
160641416|NCT00950599|580070635|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
160641417|NCT00950599|580070636|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
160641418|NCT00950599|580070637|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
160641419|NCT00950599|580070638|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
160641420|NCT00950599|580070639|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
160546428|NCT04818593|579726814|FG001|Overall Study|Withdrawal by Subject|2|||
160546429|NCT04818593|579726813|FG000|Overall Study|Conversion to IUI due to low response|1|||
160546430|NCT04818593|579726814|FG001|Overall Study|Conversion to IUI due to low response|1|||
160546431|NCT05061719|579726815|FG000|Overall Study|Adverse Event|60|||
160546432|NCT05061719|579726815|FG000|Overall Study|Death|1|||
160546433|NCT05061719|579726815|FG000|Overall Study|Lack of Efficacy|7|||
160641421|NCT00950599|580070640|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
160787749|NCT03635996|580608995|FG000|Overall Study|Prohibited medication|5|||
160787750|NCT03635996|580608995|FG000|Overall Study|Did not meet eligibility criteria|5|||
160787751|NCT03635996|580608995|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
160546434|NCT05061719|579726815|FG000|Overall Study|Lost to Follow-up|5|||
160546435|NCT05061719|579726815|FG000|Overall Study|Pregnancy|1|||
160787752|NCT03635996|580608995|FG000|Overall Study|Protocol Violation|1|||
160787753|NCT03635996|580608995|FG000|Overall Study|Lost to Follow-up|1|||
160787754|NCT02821000|580608996|FG000|Overall Study|Death|89|||
160787755|NCT02821000|580608996|FG000|Overall Study|Sponsor Decision|12|||
160787756|NCT02821000|580608996|FG000|Overall Study|Withdrawal by Subject|2|||
160787757|NCT04359680|580608997|FG000|Overall Study|Withdrawal by Subject|29|||
160787758|NCT04359680|580608998|FG001|Overall Study|Withdrawal by Subject|24|||
160787759|NCT04359680|580608997|FG000|Overall Study|Adverse Event|6|||
160787760|NCT04359680|580608998|FG001|Overall Study|Adverse Event|2|||
160787761|NCT04359680|580608997|FG000|Overall Study|Lost to Follow-up|56|||
160787762|NCT04359680|580608998|FG001|Overall Study|Lost to Follow-up|59|||
160787763|NCT04359680|580608997|FG000|Overall Study|Protocol Violation|3|||
160787764|NCT04359680|580608998|FG001|Overall Study|Protocol Violation|5|||
160787765|NCT04359680|580608997|FG000|Overall Study|Physician Decision|1|||
160787766|NCT04359680|580608998|FG001|Overall Study|Physician Decision|1|||
160787767|NCT04359680|580608997|FG000|Overall Study|Sponsor Decision|0|||
160641422|NCT00950599|580070641|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
160641423|NCT00950599|580070632|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
160641424|NCT00950599|580070633|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
160787768|NCT04359680|580608998|FG001|Overall Study|Sponsor Decision|1|||
160787769|NCT00449787|580609000|FG000|Overall Study|Lost to Follow-up|10|||
160787770|NCT00449787|580609001|FG001|Overall Study|Lost to Follow-up|8|||
160787771|NCT00449787|580609000|FG000|Overall Study|Did not require medication|95|||
160787772|NCT00449787|580609001|FG001|Overall Study|Did not require medication|92|||
160641425|NCT00950599|580070634|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
160641426|NCT00950599|580070635|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
160641427|NCT00950599|580070636|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
160641428|NCT00950599|580070637|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
160641429|NCT00950599|580070638|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
160641430|NCT00950599|580070639|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
160641431|NCT00950599|580070640|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
160787773|NCT03574389|580609006|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
160787774|NCT03574389|580609007|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
160787775|NCT03574389|580609008|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
160787776|NCT03574389|580609009|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
160641432|NCT00950599|580070641|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
160641433|NCT00950599|580070632|FG000|Follow-Up Period|Adverse Event|0|||
160641434|NCT00950599|580070633|FG001|Follow-Up Period|Adverse Event|0|||
160641435|NCT00950599|580070634|FG002|Follow-Up Period|Adverse Event|0|||
160641436|NCT00950599|580070635|FG003|Follow-Up Period|Adverse Event|0|||
160641437|NCT00950599|580070636|FG004|Follow-Up Period|Adverse Event|0|||
160641438|NCT00950599|580070637|FG005|Follow-Up Period|Adverse Event|0|||
160641439|NCT00950599|580070638|FG006|Follow-Up Period|Adverse Event|0|||
160641440|NCT00950599|580070639|FG007|Follow-Up Period|Adverse Event|0|||
160641441|NCT00950599|580070640|FG008|Follow-Up Period|Adverse Event|1|||
160641442|NCT00950599|580070641|FG009|Follow-Up Period|Adverse Event|0|||
160641443|NCT00950599|580070632|FG000|Follow-Up Period|Lack of Efficacy|0|||
160641444|NCT00950599|580070633|FG001|Follow-Up Period|Lack of Efficacy|0|||
160641445|NCT00950599|580070634|FG002|Follow-Up Period|Lack of Efficacy|0|||
160641446|NCT00950599|580070635|FG003|Follow-Up Period|Lack of Efficacy|0|||
160641447|NCT00950599|580070636|FG004|Follow-Up Period|Lack of Efficacy|0|||
160641448|NCT00950599|580070637|FG005|Follow-Up Period|Lack of Efficacy|0|||
160641449|NCT00950599|580070638|FG006|Follow-Up Period|Lack of Efficacy|0|||
160641450|NCT00950599|580070639|FG007|Follow-Up Period|Lack of Efficacy|0|||
160641451|NCT00950599|580070640|FG008|Follow-Up Period|Lack of Efficacy|3|||
160641452|NCT00950599|580070641|FG009|Follow-Up Period|Lack of Efficacy|0|||
160641453|NCT00950599|580070632|FG000|Follow-Up Period|Lost to Follow-up|0|||
160641454|NCT00950599|580070633|FG001|Follow-Up Period|Lost to Follow-up|0|||
160641455|NCT00950599|580070634|FG002|Follow-Up Period|Lost to Follow-up|0|||
160641456|NCT00950599|580070635|FG003|Follow-Up Period|Lost to Follow-up|0|||
160641457|NCT00950599|580070636|FG004|Follow-Up Period|Lost to Follow-up|0|||
160641458|NCT00950599|580070637|FG005|Follow-Up Period|Lost to Follow-up|0|||
160641459|NCT00950599|580070638|FG006|Follow-Up Period|Lost to Follow-up|0|||
160641460|NCT00950599|580070639|FG007|Follow-Up Period|Lost to Follow-up|0|||
160641461|NCT00950599|580070640|FG008|Follow-Up Period|Lost to Follow-up|5|||
160641462|NCT00950599|580070641|FG009|Follow-Up Period|Lost to Follow-up|1|||
160641463|NCT00950599|580070632|FG000|Follow-Up Period|Physician Decision|0|||
160641464|NCT00950599|580070633|FG001|Follow-Up Period|Physician Decision|0|||
160653390|NCT05665595|580112377|FG000|Overall Study|Ongoing|692|||
160787777|NCT03574389|580609010|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
160787778|NCT03574389|580609011|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
160787779|NCT03574389|580609012|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
160787780|NCT03574389|580609006|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
160787781|NCT03574389|580609007|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
160641465|NCT00950599|580070634|FG002|Follow-Up Period|Physician Decision|0|||
160641466|NCT00950599|580070635|FG003|Follow-Up Period|Physician Decision|0|||
160641467|NCT00950599|580070636|FG004|Follow-Up Period|Physician Decision|0|||
160641468|NCT00950599|580070637|FG005|Follow-Up Period|Physician Decision|0|||
160641469|NCT00950599|580070638|FG006|Follow-Up Period|Physician Decision|0|||
160641470|NCT00950599|580070639|FG007|Follow-Up Period|Physician Decision|0|||
160641471|NCT00950599|580070640|FG008|Follow-Up Period|Physician Decision|1|||
160641472|NCT00950599|580070641|FG009|Follow-Up Period|Physician Decision|0|||
160641473|NCT00950599|580070632|FG000|Follow-Up Period|Poor/Noncompliance|0|||
160641474|NCT00950599|580070633|FG001|Follow-Up Period|Poor/Noncompliance|0|||
160641475|NCT00950599|580070634|FG002|Follow-Up Period|Poor/Noncompliance|0|||
160641476|NCT00950599|580070635|FG003|Follow-Up Period|Poor/Noncompliance|0|||
160641477|NCT00950599|580070636|FG004|Follow-Up Period|Poor/Noncompliance|0|||
160641478|NCT00950599|580070637|FG005|Follow-Up Period|Poor/Noncompliance|0|||
160641479|NCT00950599|580070638|FG006|Follow-Up Period|Poor/Noncompliance|0|||
160641480|NCT00950599|580070639|FG007|Follow-Up Period|Poor/Noncompliance|0|||
160641481|NCT00950599|580070640|FG008|Follow-Up Period|Poor/Noncompliance|1|||
160641482|NCT00950599|580070641|FG009|Follow-Up Period|Poor/Noncompliance|0|||
160641483|NCT00950599|580070632|FG000|Follow-Up Period|Subject withdrew Consent|0|||
160641484|NCT00950599|580070633|FG001|Follow-Up Period|Subject withdrew Consent|0|||
160641485|NCT00950599|580070634|FG002|Follow-Up Period|Subject withdrew Consent|0|||
160641486|NCT00950599|580070635|FG003|Follow-Up Period|Subject withdrew Consent|0|||
160787782|NCT03574389|580609008|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
160787783|NCT03574389|580609009|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
160641487|NCT00950599|580070636|FG004|Follow-Up Period|Subject withdrew Consent|0|||
160641488|NCT00950599|580070637|FG005|Follow-Up Period|Subject withdrew Consent|0|||
160641489|NCT00950599|580070638|FG006|Follow-Up Period|Subject withdrew Consent|0|||
160641490|NCT00950599|580070639|FG007|Follow-Up Period|Subject withdrew Consent|0|||
160641491|NCT00950599|580070640|FG008|Follow-Up Period|Subject withdrew Consent|2|||
160641492|NCT00950599|580070641|FG009|Follow-Up Period|Subject withdrew Consent|1|||
160641493|NCT02741271|580070651|FG000|Overall Study|Lost to Follow-up|2|||
160641494|NCT02741271|580070652|FG001|Overall Study|Lost to Follow-up|0|||
160641495|NCT02741271|580070651|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160641496|NCT02741271|580070652|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
160641497|NCT00373685|580070653|FG000|Overall Study|Death|2|||
160641498|NCT00373685|580070654|FG001|Overall Study|Death|1|||
160641499|NCT00373685|580070653|FG000|Overall Study|Adverse Event|278|||
160641500|NCT00373685|580070654|FG001|Overall Study|Adverse Event|253|||
160641501|NCT00373685|580070653|FG000|Overall Study|Insufficient clinical response|169|||
160787784|NCT03574389|580609010|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
160787785|NCT03574389|580609011|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
160787786|NCT03574389|580609012|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
160787787|NCT03574389|580609006|FG000|Vaccination Period|Other|6|||
160787788|NCT03574389|580609007|FG001|Vaccination Period|Other|0|||
160787789|NCT03574389|580609008|FG002|Vaccination Period|Other|0|||
160787790|NCT03574389|580609009|FG003|Vaccination Period|Other|0|||
160787791|NCT03574389|580609010|FG004|Vaccination Period|Other|0|||
160787792|NCT03574389|580609011|FG005|Vaccination Period|Other|0|||
160787793|NCT03574389|580609012|FG006|Vaccination Period|Other|0|||
160787794|NCT03574389|580609006|FG000|Vaccination Period|Adverse Event|0|||
160787795|NCT03574389|580609007|FG001|Vaccination Period|Adverse Event|1|||
160787796|NCT03574389|580609008|FG002|Vaccination Period|Adverse Event|0|||
160787797|NCT03574389|580609009|FG003|Vaccination Period|Adverse Event|0|||
160787798|NCT03574389|580609010|FG004|Vaccination Period|Adverse Event|0|||
160787799|NCT03574389|580609011|FG005|Vaccination Period|Adverse Event|0|||
160787800|NCT03574389|580609012|FG006|Vaccination Period|Adverse Event|0|||
160787801|NCT03574389|580609006|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
160787802|NCT03574389|580609007|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
160787803|NCT03574389|580609008|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
160787804|NCT03574389|580609009|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
160787805|NCT03574389|580609010|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
160787806|NCT03574389|580609011|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
160787807|NCT03574389|580609012|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
160641502|NCT00373685|580070654|FG001|Overall Study|Insufficient clinical response|119|||
160641503|NCT00373685|580070653|FG000|Overall Study|Did not meet entrance criteria|167|||
160641504|NCT00373685|580070654|FG001|Overall Study|Did not meet entrance criteria|184|||
160641505|NCT00373685|580070653|FG000|Overall Study|Lost to follow up|83|||
160641506|NCT00373685|580070654|FG001|Overall Study|Lost to follow up|103|||
160641507|NCT00373685|580070653|FG000|Overall Study|No longer willing to participate|337|||
160787808|NCT00337194|580609017|FG000|Overall Study|Adverse Event|5|||
160787809|NCT00337194|580609018|FG001|Overall Study|Adverse Event|1|||
160787810|NCT00337194|580609017|FG000|Overall Study|Death|2|||
160787811|NCT00337194|580609018|FG001|Overall Study|Death|0|||
160787812|NCT00337194|580609017|FG000|Overall Study|Withdrawal by Subject|1|||
160787813|NCT00337194|580609018|FG001|Overall Study|Withdrawal by Subject|0|||
160641508|NCT00373685|580070654|FG001|Overall Study|No longer willing to participate|352|||
160641509|NCT00373685|580070653|FG000|Overall Study|Other|149|||
160641510|NCT00373685|580070654|FG001|Overall Study|Other|146|||
160641511|NCT00373685|580070653|FG000|Overall Study|Protocol Violation|191|||
160641512|NCT00373685|580070654|FG001|Overall Study|Protocol Violation|182|||
160641513|NCT00373685|580070653|FG000|Overall Study|Final Status Unknown|12|||
160641514|NCT00373685|580070654|FG001|Overall Study|Final Status Unknown|4|||
160641515|NCT00373685|580070653|FG000|Overall Study|Randomized, not treated|51|||
160641516|NCT00373685|580070654|FG001|Overall Study|Randomized, not treated|77|||
160641517|NCT02570165|580070655|FG000|Overall Study|Adverse Event|1|||
160641518|NCT02570165|580070656|FG001|Overall Study|Adverse Event|0|||
160641519|NCT02570165|580070657|FG002|Overall Study|Adverse Event|2|||
160641520|NCT02570165|580070658|FG003|Overall Study|Adverse Event|0|||
160641521|NCT02570165|580070659|FG004|Overall Study|Adverse Event|0|||
160641522|NCT02570165|580070660|FG005|Overall Study|Adverse Event|0|||
160641523|NCT02570165|580070661|FG006|Overall Study|Adverse Event|0|||
160641524|NCT02570165|580070655|FG000|Overall Study|Lack of Efficacy|0|||
160641525|NCT02570165|580070656|FG001|Overall Study|Lack of Efficacy|1|||
160641526|NCT02570165|580070657|FG002|Overall Study|Lack of Efficacy|0|||
160641527|NCT02570165|580070658|FG003|Overall Study|Lack of Efficacy|0|||
160641528|NCT02570165|580070659|FG004|Overall Study|Lack of Efficacy|4|||
160641529|NCT02570165|580070660|FG005|Overall Study|Lack of Efficacy|0|||
160641530|NCT02570165|580070661|FG006|Overall Study|Lack of Efficacy|0|||
160641531|NCT02570165|580070655|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
160641532|NCT02570165|580070656|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
160641533|NCT02570165|580070657|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
160641534|NCT02570165|580070658|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
160641535|NCT02570165|580070659|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
160641536|NCT02570165|580070660|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
160641537|NCT02570165|580070661|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
160641538|NCT02570165|580070655|FG000|Overall Study|Lost to Follow-up|0|||
160641539|NCT02570165|580070656|FG001|Overall Study|Lost to Follow-up|0|||
160641540|NCT02570165|580070657|FG002|Overall Study|Lost to Follow-up|1|||
160641541|NCT02570165|580070658|FG003|Overall Study|Lost to Follow-up|1|||
160641542|NCT02570165|580070659|FG004|Overall Study|Lost to Follow-up|0|||
160641543|NCT02570165|580070660|FG005|Overall Study|Lost to Follow-up|0|||
160641544|NCT02570165|580070661|FG006|Overall Study|Lost to Follow-up|0|||
160641545|NCT02570165|580070655|FG000|Overall Study|Physician Decision|0|||
160641546|NCT02570165|580070656|FG001|Overall Study|Physician Decision|1|||
160641547|NCT02570165|580070657|FG002|Overall Study|Physician Decision|0|||
160641548|NCT02570165|580070658|FG003|Overall Study|Physician Decision|0|||
160641549|NCT02570165|580070659|FG004|Overall Study|Physician Decision|0|||
160641550|NCT02570165|580070660|FG005|Overall Study|Physician Decision|0|||
160641551|NCT02570165|580070661|FG006|Overall Study|Physician Decision|0|||
160641552|NCT02570165|580070655|FG000|Overall Study|Withdrawal by Subject|0|||
160641553|NCT02570165|580070656|FG001|Overall Study|Withdrawal by Subject|0|||
160641554|NCT02570165|580070657|FG002|Overall Study|Withdrawal by Subject|0|||
160641555|NCT02570165|580070658|FG003|Overall Study|Withdrawal by Subject|2|||
160641556|NCT02570165|580070659|FG004|Overall Study|Withdrawal by Subject|1|||
160641557|NCT02570165|580070660|FG005|Overall Study|Withdrawal by Subject|0|||
160641558|NCT02570165|580070661|FG006|Overall Study|Withdrawal by Subject|0|||
160641559|NCT02570165|580070655|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
160641560|NCT02570165|580070656|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
160641561|NCT02570165|580070657|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
160641562|NCT02570165|580070658|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
160641563|NCT02570165|580070659|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
160641564|NCT02570165|580070660|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
160641565|NCT02570165|580070661|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
160641566|NCT02570165|580070655|FG000|Overall Study|Withdrawal Request by GSK|0|||
160641567|NCT02570165|580070656|FG001|Overall Study|Withdrawal Request by GSK|0|||
160641568|NCT02570165|580070657|FG002|Overall Study|Withdrawal Request by GSK|2|||
160641569|NCT02570165|580070658|FG003|Overall Study|Withdrawal Request by GSK|0|||
160641570|NCT02570165|580070659|FG004|Overall Study|Withdrawal Request by GSK|0|||
160641571|NCT02570165|580070660|FG005|Overall Study|Withdrawal Request by GSK|0|||
160641572|NCT02570165|580070661|FG006|Overall Study|Withdrawal Request by GSK|0|||
160641573|NCT04428502|580070662|FG000|Overall Study|Did not meet entrance criteria|14|||
160641574|NCT02295280|580070664|FG000|Overall Study|Adverse Event|0|||
160641575|NCT02295280|580070665|FG001|Overall Study|Adverse Event|1|||
160641576|NCT01430104|580070666|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
160787814|NCT00337194|580609017|FG000|Overall Study|Disease progression|1|||
160641577|NCT02713243|580070668|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
160641578|NCT02713243|580070669|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
160787815|NCT00337194|580609018|FG001|Overall Study|Disease progression|2|||
160641579|NCT02713243|580070668|FG000|Overall Study|Administrative problems|0|||
160641580|NCT02713243|580070669|FG001|Overall Study|Administrative problems|1|||
160641581|NCT02713243|580070668|FG000|Overall Study|Protocol deviation|0|||
160641582|NCT02713243|580070669|FG001|Overall Study|Protocol deviation|1|||
160641583|NCT02971605|580070670|FG000|Overall Study|Withdrawal by Subject|1|||
160641584|NCT00869089|580070672|FG000|Overall Study|Lost to Follow-up|1|||
160641585|NCT00869089|580070672|FG000|Overall Study|Withdrawal by Subject|1|||
160641586|NCT00869089|580070672|FG000|Overall Study|Screen Fail|1|||
160641587|NCT05003167|580070673|FG000|Overall Study|Withdrawal by Subject|1|||
160641588|NCT00623623|580072050|FG000|Overall Study|Previous enrolment into this study|1|||
160787816|NCT00337194|580609017|FG000|Overall Study|Subsequent non-protocol therapy|3|||
160787817|NCT00337194|580609018|FG001|Overall Study|Subsequent non-protocol therapy|1|||
160787818|NCT01061710|580609019|FG000|Overall Study|Protocol Violation|14|||
160787819|NCT01903720|580609020|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
160787820|NCT01903720|580609020|FG000|Overall Study|Adverse Event|1|||
160787821|NCT01903720|580609020|FG000|Overall Study|Rescinding of informed consent|2|||
160787822|NCT01903720|580609020|FG000|Overall Study|Lost to Follow-up|2|||
160787823|NCT01903720|580609020|FG000|Overall Study|Treatment with alternative drug|1|||
160787824|NCT01104870|580609021|FG000|Overall Study|Adverse Event|1|||
160787825|NCT01104870|580609022|FG001|Overall Study|Adverse Event|1|||
160787826|NCT01104870|580609023|FG002|Overall Study|Adverse Event|0|||
160787827|NCT01104870|580609021|FG000|Overall Study|Death|0|||
160787828|NCT01104870|580609022|FG001|Overall Study|Death|0|||
160787829|NCT01104870|580609023|FG002|Overall Study|Death|1|||
160787830|NCT01104870|580609021|FG000|Overall Study|Withdrawal by Subject|0|||
160787831|NCT01104870|580609022|FG001|Overall Study|Withdrawal by Subject|0|||
160641589|NCT00623623|580072051|FG001|Overall Study|Previous enrolment into this study|1|||
160641590|NCT00606684|580072052|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
160641591|NCT00606684|580072053|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
160641592|NCT00606684|580072054|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
160641593|NCT00606684|580072055|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
160641594|NCT00606684|580072056|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
160641595|NCT00606684|580072057|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
160641596|NCT00606684|580072058|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
160641597|NCT00606684|580072052|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
160641598|NCT00606684|580072053|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
160641599|NCT00606684|580072054|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
160641600|NCT00606684|580072055|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
160641601|NCT00606684|580072056|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
160641602|NCT00606684|580072057|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
160641603|NCT00606684|580072058|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
160641604|NCT00606684|580072052|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
160641605|NCT00606684|580072053|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
160641606|NCT00606684|580072054|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
160641607|NCT00606684|580072055|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
160641608|NCT00606684|580072056|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
160641609|NCT00606684|580072057|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
160641610|NCT00606684|580072058|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
160641611|NCT00606684|580072052|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
160641612|NCT00606684|580072053|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
160641613|NCT00606684|580072054|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
160641614|NCT00606684|580072055|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
160787832|NCT01104870|580609023|FG002|Overall Study|Withdrawal by Subject|1|||
160787833|NCT02771145|580609027|FG000|Overall Study|Adverse Event|3|||
160787834|NCT02771145|580609027|FG000|Overall Study|Lost to Follow-up|1|||
160641615|NCT00606684|580072056|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
160641616|NCT00606684|580072057|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
160641617|NCT00606684|580072058|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
160641618|NCT00606684|580072052|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
160641619|NCT00606684|580072053|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
160641620|NCT00606684|580072054|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
160641621|NCT00606684|580072055|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
160641622|NCT00606684|580072056|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
160641623|NCT00606684|580072057|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
160641624|NCT00606684|580072058|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
160641625|NCT00606684|580072052|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
160641626|NCT00606684|580072053|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
160641627|NCT00606684|580072054|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
160641628|NCT00606684|580072055|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
160641629|NCT00606684|580072056|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
160641630|NCT00606684|580072057|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
160641631|NCT00606684|580072058|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
160641632|NCT00606684|580072052|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
160641633|NCT00606684|580072053|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
160641634|NCT00606684|580072054|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
160641635|NCT00606684|580072055|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
160641636|NCT00606684|580072056|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
160641637|NCT00606684|580072057|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
160641638|NCT00606684|580072058|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
160641639|NCT00606684|580072052|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160641640|NCT00606684|580072053|FG001|Double-Blind Treatment Period|Adverse Event|3|||
160641641|NCT00606684|580072054|FG002|Double-Blind Treatment Period|Adverse Event|2|||
160641642|NCT00606684|580072055|FG003|Double-Blind Treatment Period|Adverse Event|4|||
160641643|NCT00606684|580072056|FG004|Double-Blind Treatment Period|Adverse Event|2|||
160641644|NCT00606684|580072057|FG005|Double-Blind Treatment Period|Adverse Event|0|||
160641645|NCT00606684|580072058|FG006|Double-Blind Treatment Period|Adverse Event|1|||
160641646|NCT00606684|580072052|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
160641647|NCT00606684|580072053|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
160641648|NCT00606684|580072054|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
160641649|NCT00606684|580072055|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
160641650|NCT00606684|580072056|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
160641651|NCT00606684|580072057|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
160641652|NCT00606684|580072058|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
160641653|NCT00606684|580072052|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
160641654|NCT00606684|580072053|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
160641655|NCT00606684|580072054|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
160641656|NCT00606684|580072055|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
160641657|NCT00606684|580072056|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
160641658|NCT00606684|580072057|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
160641659|NCT00606684|580072058|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
160641660|NCT00606684|580072052|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
160641661|NCT00606684|580072053|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
160641662|NCT00606684|580072054|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
160641663|NCT00606684|580072055|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
160641664|NCT00606684|580072056|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
160641665|NCT00606684|580072057|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
160641666|NCT00606684|580072058|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
160641667|NCT00606684|580072052|FG000|Double-Blind Treatment Period|Physician Decision|0|||
160641668|NCT00606684|580072053|FG001|Double-Blind Treatment Period|Physician Decision|5|||
160641669|NCT00606684|580072054|FG002|Double-Blind Treatment Period|Physician Decision|1|||
160641670|NCT00606684|580072055|FG003|Double-Blind Treatment Period|Physician Decision|0|||
160641671|NCT00606684|580072056|FG004|Double-Blind Treatment Period|Physician Decision|3|||
160641672|NCT00606684|580072057|FG005|Double-Blind Treatment Period|Physician Decision|1|||
160641673|NCT00606684|580072058|FG006|Double-Blind Treatment Period|Physician Decision|2|||
160641674|NCT00606684|580072052|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160641675|NCT00606684|580072053|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160641676|NCT00606684|580072054|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160641677|NCT00606684|580072055|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
160641678|NCT00606684|580072056|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160641679|NCT00606684|580072057|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
160641680|NCT00606684|580072058|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160641681|NCT03568500|580072059|FG000|Overall Study|Lost to Follow-up|1|||
160641682|NCT03568500|580072060|FG001|Overall Study|Lost to Follow-up|1|||
160641683|NCT03568500|580072061|FG002|Overall Study|Lost to Follow-up|2|||
160787835|NCT00276380|580609028|FG000|Overall Study|Adverse Event|5|||
160641684|NCT03568500|580072059|FG000|Overall Study|Adverse Event|1|||
160641685|NCT03568500|580072060|FG001|Overall Study|Adverse Event|1|||
160641686|NCT03568500|580072061|FG002|Overall Study|Adverse Event|2|||
160641687|NCT03568500|580072059|FG000|Overall Study|Physician Decision|1|||
160641688|NCT03568500|580072060|FG001|Overall Study|Physician Decision|0|||
160641689|NCT03568500|580072061|FG002|Overall Study|Physician Decision|0|||
160641690|NCT03568500|580072059|FG000|Overall Study|Withdrawal by Subject|4|||
160641691|NCT03568500|580072060|FG001|Overall Study|Withdrawal by Subject|2|||
160641692|NCT03568500|580072061|FG002|Overall Study|Withdrawal by Subject|0|||
160641693|NCT03568500|580072059|FG000|Overall Study|Technical Problems|2|||
160641694|NCT03568500|580072060|FG001|Overall Study|Technical Problems|1|||
160641695|NCT03568500|580072061|FG002|Overall Study|Technical Problems|0|||
160641696|NCT03568500|580072059|FG000|Overall Study|Participant Noncompliance|1|||
160641697|NCT03568500|580072060|FG001|Overall Study|Participant Noncompliance|1|||
160641698|NCT03568500|580072061|FG002|Overall Study|Participant Noncompliance|0|||
160641699|NCT03377556|580072075|FG000|Overall Study|Adverse Event|5|||
160641700|NCT03377556|580072075|FG000|Overall Study|Refusal unrelated to adverse events|1|||
160641701|NCT03377556|580072075|FG000|Overall Study|Progression/relapse|38|||
160641702|NCT03377556|580072075|FG000|Overall Study|Death|3|||
160641703|NCT00447603|580072076|FG000|Screening|Withdrawal by Subject|1|||
160641704|NCT00447603|580072077|FG001|Screening|Withdrawal by Subject|0|||
160641705|NCT00447603|580072078|FG002|Screening|Withdrawal by Subject|0|||
160641706|NCT00447603|580072076|FG000|Screening|Protocol Violation|1|||
160641707|NCT00447603|580072077|FG001|Screening|Protocol Violation|0|||
160641708|NCT00447603|580072078|FG002|Screening|Protocol Violation|0|||
160641709|NCT00447603|580072076|FG000|Screening|Screen Failure|4|||
160641710|NCT00447603|580072077|FG001|Screening|Screen Failure|0|||
160641711|NCT00447603|580072078|FG002|Screening|Screen Failure|0|||
160641712|NCT00447603|580072076|FG000|Screening|Study Terminated by Sponsor|15|||
160641713|NCT00447603|580072077|FG001|Screening|Study Terminated by Sponsor|0|||
160641714|NCT00447603|580072078|FG002|Screening|Study Terminated by Sponsor|0|||
160641715|NCT00447603|580072076|FG000|Filter Period|Adverse Event|0|||
160787836|NCT00276380|580609029|FG001|Overall Study|Adverse Event|3|||
160787837|NCT00276380|580609028|FG000|Overall Study|Lost to Follow-up|1|||
160787838|NCT00276380|580609029|FG001|Overall Study|Lost to Follow-up|1|||
160787839|NCT00276380|580609028|FG000|Overall Study|Withdrawal by Subject|3|||
160787840|NCT00276380|580609029|FG001|Overall Study|Withdrawal by Subject|6|||
160787841|NCT00276380|580609028|FG000|Overall Study|Death|5|||
160787842|NCT00276380|580609029|FG001|Overall Study|Death|3|||
160787843|NCT00276380|580609028|FG000|Overall Study|Abnormal aPPT Levels|0|||
160787844|NCT00276380|580609029|FG001|Overall Study|Abnormal aPPT Levels|1|||
160787845|NCT02150863|580609030|FG000|Overall Study|Lost to Follow-up|0|||
160787846|NCT02150863|580609031|FG001|Overall Study|Lost to Follow-up|1|||
160787847|NCT02150863|580609032|FG002|Overall Study|Lost to Follow-up|0|||
160787848|NCT01651208|580609033|FG000|Overall Study|Lost to Follow-up|14|||
160787849|NCT01651208|580609034|FG001|Overall Study|Lost to Follow-up|16|||
160787850|NCT00835549|580609038|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
160787851|NCT00835549|580609039|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
160641716|NCT00447603|580072077|FG001|Filter Period|Adverse Event|0|||
160641717|NCT00447603|580072078|FG002|Filter Period|Adverse Event|1|||
160641718|NCT00447603|580072076|FG000|Filter Period|Screen Failure|0|||
160787852|NCT00986102|580609053|FG000|Overall Study|Lost to Follow-up|0|||
160787853|NCT00986102|580609054|FG001|Overall Study|Lost to Follow-up|1|||
160787854|NCT00986102|580609055|FG002|Overall Study|Lost to Follow-up|0|||
160787855|NCT00986102|580609056|FG003|Overall Study|Lost to Follow-up|1|||
160641719|NCT00447603|580072077|FG001|Filter Period|Screen Failure|3|||
160787856|NCT00986102|580609053|FG000|Overall Study|Withdrawal by Subject|1|||
160641720|NCT00447603|580072078|FG002|Filter Period|Screen Failure|4|||
160641721|NCT00447603|580072076|FG000|Filter Period|Study terminated by Sponsor|0|||
160641722|NCT00447603|580072077|FG001|Filter Period|Study terminated by Sponsor|1|||
160641723|NCT00447603|580072078|FG002|Filter Period|Study terminated by Sponsor|10|||
160641724|NCT00295854|580072083|FG000|Overall Study|Adverse Event|7|||
160641725|NCT00295854|580072084|FG001|Overall Study|Adverse Event|7|||
160641726|NCT00295854|580072085|FG002|Overall Study|Adverse Event|6|||
160641727|NCT00295854|580072083|FG000|Overall Study|Protocol Violation|1|||
160641728|NCT00295854|580072084|FG001|Overall Study|Protocol Violation|1|||
160641729|NCT00295854|580072085|FG002|Overall Study|Protocol Violation|1|||
160641730|NCT00295854|580072083|FG000|Overall Study|Lost to Follow-up|2|||
160641731|NCT00295854|580072084|FG001|Overall Study|Lost to Follow-up|0|||
160641732|NCT00295854|580072085|FG002|Overall Study|Lost to Follow-up|1|||
160641733|NCT00295854|580072083|FG000|Overall Study|Withdrawal by Subject|3|||
160641734|NCT00295854|580072084|FG001|Overall Study|Withdrawal by Subject|7|||
160641735|NCT00295854|580072085|FG002|Overall Study|Withdrawal by Subject|4|||
160641736|NCT00295854|580072083|FG000|Overall Study|did not continue to meet criteria|1|||
160641737|NCT00295854|580072084|FG001|Overall Study|did not continue to meet criteria|1|||
160641738|NCT00295854|580072085|FG002|Overall Study|did not continue to meet criteria|2|||
160641739|NCT00295854|580072083|FG000|Overall Study|required a prohibited medication|1|||
160641740|NCT00295854|580072084|FG001|Overall Study|required a prohibited medication|0|||
160641741|NCT00295854|580072085|FG002|Overall Study|required a prohibited medication|0|||
160641742|NCT00295854|580072083|FG000|Overall Study|Other|3|||
160641743|NCT00295854|580072084|FG001|Overall Study|Other|5|||
160641744|NCT00295854|580072085|FG002|Overall Study|Other|1|||
160641745|NCT04120194|580072087|FG000|Overall Study|Lost to Follow-up|11|||
160641746|NCT04120194|580072088|FG001|Overall Study|Lost to Follow-up|8|||
160641747|NCT04120194|580072087|FG000|Overall Study|Adverse Event|4|||
160641748|NCT04120194|580072088|FG001|Overall Study|Adverse Event|5|||
160641749|NCT04120194|580072087|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
160641750|NCT04120194|580072088|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
160641751|NCT04120194|580072087|FG000|Overall Study|Miscellaneous|4|||
160641752|NCT04120194|580072088|FG001|Overall Study|Miscellaneous|5|||
160641753|NCT02622074|580072089|FG000|Overall Study|Death|4|||
160641754|NCT02622074|580072090|FG001|Overall Study|Death|0|||
160641755|NCT02622074|580072091|FG002|Overall Study|Death|0|||
160641756|NCT02622074|580072092|FG003|Overall Study|Death|1|||
160641757|NCT02622074|580072093|FG004|Overall Study|Death|1|||
160641758|NCT02622074|580072094|FG005|Overall Study|Death|0|||
160641759|NCT02622074|580072089|FG000|Overall Study|Withdrawal by Subject|0|||
160641760|NCT02622074|580072090|FG001|Overall Study|Withdrawal by Subject|1|||
160641761|NCT02622074|580072091|FG002|Overall Study|Withdrawal by Subject|0|||
160641762|NCT02622074|580072092|FG003|Overall Study|Withdrawal by Subject|0|||
160641763|NCT02622074|580072093|FG004|Overall Study|Withdrawal by Subject|0|||
160641764|NCT02622074|580072094|FG005|Overall Study|Withdrawal by Subject|0|||
160641765|NCT02114931|580072095|FG000|Overall Study|Withdrawal by Subject|15|||
160641766|NCT02114931|580072096|FG001|Overall Study|Withdrawal by Subject|18|||
160641767|NCT02114931|580072095|FG000|Overall Study|Adverse Event|4|||
160641768|NCT02114931|580072096|FG001|Overall Study|Adverse Event|6|||
160641769|NCT02114931|580072095|FG000|Overall Study|Lost to Follow-up|3|||
160641770|NCT02114931|580072096|FG001|Overall Study|Lost to Follow-up|3|||
160641771|NCT02114931|580072095|FG000|Overall Study|Physician Decision|1|||
160641772|NCT02114931|580072096|FG001|Overall Study|Physician Decision|2|||
160641773|NCT02114931|580072095|FG000|Overall Study|Other|2|||
160641774|NCT02114931|580072096|FG001|Overall Study|Other|1|||
160641775|NCT03565211|580072100|FG000|Overall Study|Withdrawal by Subject|2|||
160641776|NCT03565211|580072100|FG000|Overall Study|Lost to Follow-up|1|||
160641777|NCT03565211|580072100|FG000|Overall Study|Adverse Event|44|||
160641778|NCT03565211|580072100|FG000|Overall Study|Personal issues|1|||
160641779|NCT00986154|580072101|FG000|Overall Study|Death|136|||
160641780|NCT00986154|580072102|FG001|Overall Study|Death|127|||
160641781|NCT00986154|580072101|FG000|Overall Study|Lost to Follow-up|7|||
160641782|NCT00986154|580072102|FG001|Overall Study|Lost to Follow-up|4|||
160641783|NCT00986154|580072101|FG000|Overall Study|Withdrawal by Subject|32|||
160641784|NCT00986154|580072102|FG001|Overall Study|Withdrawal by Subject|33|||
160641785|NCT00986154|580072101|FG000|Overall Study|investigator/subject decide not continue|6|||
160641786|NCT00986154|580072102|FG001|Overall Study|investigator/subject decide not continue|3|||
160641787|NCT00986154|580072101|FG000|Overall Study|never received study drug|25|||
160641788|NCT00986154|580072102|FG001|Overall Study|never received study drug|27|||
160641789|NCT00267007|580072103|FG000|Overall Study|Withdrawal by Subject|6|||
160641790|NCT00267007|580072104|FG001|Overall Study|Withdrawal by Subject|0|||
160641791|NCT00267007|580072103|FG000|Overall Study|Lost to Follow-up|1|||
160641792|NCT00267007|580072104|FG001|Overall Study|Lost to Follow-up|0|||
160641793|NCT00267007|580072103|FG000|Overall Study|Non-compliance|0|||
160641794|NCT00267007|580072104|FG001|Overall Study|Non-compliance|1|||
160641795|NCT00267007|580072103|FG000|Overall Study|Adverse Event|1|||
160641796|NCT00267007|580072104|FG001|Overall Study|Adverse Event|0|||
160641797|NCT03063632|580072111|FG000|Overall Study|Death|4|||
160641798|NCT03063632|580072112|FG001|Overall Study|Death|6|||
160641799|NCT03063632|580072111|FG000|Overall Study|Lost to Follow-up|0|||
160641800|NCT03063632|580072112|FG001|Overall Study|Lost to Follow-up|1|||
160641801|NCT03063632|580072111|FG000|Overall Study|Withdrawal by Subject|0|||
160641802|NCT03063632|580072112|FG001|Overall Study|Withdrawal by Subject|2|||
160641803|NCT03063632|580072111|FG000|Overall Study|Physician Decision|2|||
160641804|NCT03063632|580072112|FG001|Overall Study|Physician Decision|0|||
160641805|NCT03063632|580072111|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
160641806|NCT03063632|580072112|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
160641807|NCT01612156|580072113|FG000|Overall Study|Protocol Violation|2|||
160641808|NCT01612156|580072114|FG001|Overall Study|Protocol Violation|0|||
160641809|NCT00410410|580072115|FG000|Induction Period (IP)|Death|1|||
160641810|NCT00410410|580072116|FG001|Induction Period (IP)|Death|0|||
160641811|NCT00410410|580072117|FG002|Induction Period (IP)|Death|0|||
160641812|NCT00410410|580072118|FG003|Induction Period (IP)|Death|0|||
160641813|NCT00410410|580072119|FG004|Induction Period (IP)|Death|0|||
160641814|NCT00410410|580072120|FG005|Induction Period (IP)|Death|0|||
160641815|NCT00410410|580072121|FG006|Induction Period (IP)|Death|0|||
160641816|NCT00410410|580072122|FG007|Induction Period (IP)|Death|0|||
160641817|NCT00410410|580072123|FG008|Induction Period (IP)|Death|0|||
160641818|NCT00410410|580072115|FG000|Induction Period (IP)|Adverse Event|3|||
160641819|NCT00410410|580072116|FG001|Induction Period (IP)|Adverse Event|4|||
160641820|NCT00410410|580072117|FG002|Induction Period (IP)|Adverse Event|2|||
160641821|NCT00410410|580072118|FG003|Induction Period (IP)|Adverse Event|4|||
160641822|NCT00410410|580072119|FG004|Induction Period (IP)|Adverse Event|1|||
160641823|NCT00410410|580072120|FG005|Induction Period (IP)|Adverse Event|0|||
160641824|NCT00410410|580072121|FG006|Induction Period (IP)|Adverse Event|0|||
160641825|NCT00410410|580072122|FG007|Induction Period (IP)|Adverse Event|0|||
160641826|NCT00410410|580072123|FG008|Induction Period (IP)|Adverse Event|0|||
160641827|NCT00410410|580072115|FG000|Induction Period (IP)|Lack of Efficacy|26|||
160641828|NCT00410410|580072116|FG001|Induction Period (IP)|Lack of Efficacy|24|||
160641829|NCT00410410|580072117|FG002|Induction Period (IP)|Lack of Efficacy|8|||
160641830|NCT00410410|580072118|FG003|Induction Period (IP)|Lack of Efficacy|8|||
160641831|NCT00410410|580072119|FG004|Induction Period (IP)|Lack of Efficacy|7|||
160641832|NCT00410410|580072120|FG005|Induction Period (IP)|Lack of Efficacy|7|||
160641833|NCT00410410|580072121|FG006|Induction Period (IP)|Lack of Efficacy|0|||
160641834|NCT00410410|580072122|FG007|Induction Period (IP)|Lack of Efficacy|0|||
160641835|NCT00410410|580072123|FG008|Induction Period (IP)|Lack of Efficacy|0|||
160641836|NCT00410410|580072115|FG000|Induction Period (IP)|Lost to Follow-up|2|||
160641837|NCT00410410|580072116|FG001|Induction Period (IP)|Lost to Follow-up|2|||
160641838|NCT00410410|580072117|FG002|Induction Period (IP)|Lost to Follow-up|2|||
160641839|NCT00410410|580072118|FG003|Induction Period (IP)|Lost to Follow-up|3|||
160641840|NCT00410410|580072119|FG004|Induction Period (IP)|Lost to Follow-up|0|||
160641841|NCT00410410|580072120|FG005|Induction Period (IP)|Lost to Follow-up|1|||
160641842|NCT00410410|580072121|FG006|Induction Period (IP)|Lost to Follow-up|0|||
160641843|NCT00410410|580072122|FG007|Induction Period (IP)|Lost to Follow-up|0|||
160641844|NCT00410410|580072123|FG008|Induction Period (IP)|Lost to Follow-up|0|||
160641845|NCT00410410|580072115|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
160641846|NCT00410410|580072116|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
160641847|NCT00410410|580072117|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
160641848|NCT00410410|580072118|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
160641849|NCT00410410|580072119|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
160641850|NCT00410410|580072120|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
160641851|NCT00410410|580072121|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
160641852|NCT00410410|580072122|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
160641853|NCT00410410|580072123|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
160641854|NCT00410410|580072115|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
160641855|NCT00410410|580072116|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
160641856|NCT00410410|580072117|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
160641857|NCT00410410|580072118|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
160641858|NCT00410410|580072119|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
160641859|NCT00410410|580072120|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
160641860|NCT00410410|580072121|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
160641861|NCT00410410|580072122|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
160641862|NCT00410410|580072123|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
160641863|NCT00410410|580072115|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
160641864|NCT00410410|580072116|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
160641865|NCT00410410|580072117|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
160641866|NCT00410410|580072118|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
160641867|NCT00410410|580072119|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
160641868|NCT00410410|580072120|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
160641869|NCT00410410|580072121|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
160641870|NCT00410410|580072122|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
160641871|NCT00410410|580072123|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
160641872|NCT00410410|580072115|FG000|Induction Period (IP)|Other|0|||
160641873|NCT00410410|580072116|FG001|Induction Period (IP)|Other|0|||
160641874|NCT00410410|580072117|FG002|Induction Period (IP)|Other|1|||
160641875|NCT00410410|580072118|FG003|Induction Period (IP)|Other|0|||
160641876|NCT00410410|580072119|FG004|Induction Period (IP)|Other|0|||
160641877|NCT00410410|580072120|FG005|Induction Period (IP)|Other|0|||
160641878|NCT00410410|580072121|FG006|Induction Period (IP)|Other|0|||
160641879|NCT00410410|580072122|FG007|Induction Period (IP)|Other|0|||
160641880|NCT00410410|580072123|FG008|Induction Period (IP)|Other|0|||
160641881|NCT00410410|580072115|FG000|Maintenance Period (MP)|Death|0|||
160641882|NCT00410410|580072116|FG001|Maintenance Period (MP)|Death|0|||
160641883|NCT00410410|580072117|FG002|Maintenance Period (MP)|Death|0|||
160641884|NCT00410410|580072118|FG003|Maintenance Period (MP)|Death|0|||
160641885|NCT00410410|580072119|FG004|Maintenance Period (MP)|Death|0|||
160641886|NCT00410410|580072120|FG005|Maintenance Period (MP)|Death|0|||
160641887|NCT00410410|580072121|FG006|Maintenance Period (MP)|Death|1|||
160641888|NCT00410410|580072122|FG007|Maintenance Period (MP)|Death|0|||
160641889|NCT00410410|580072123|FG008|Maintenance Period (MP)|Death|0|||
160641890|NCT00410410|580072115|FG000|Maintenance Period (MP)|Adverse Event|0|||
160641891|NCT00410410|580072116|FG001|Maintenance Period (MP)|Adverse Event|0|||
160641892|NCT00410410|580072117|FG002|Maintenance Period (MP)|Adverse Event|0|||
160641893|NCT00410410|580072118|FG003|Maintenance Period (MP)|Adverse Event|0|||
160641894|NCT00410410|580072119|FG004|Maintenance Period (MP)|Adverse Event|0|||
160641895|NCT00410410|580072120|FG005|Maintenance Period (MP)|Adverse Event|0|||
160641896|NCT00410410|580072121|FG006|Maintenance Period (MP)|Adverse Event|1|||
160641897|NCT00410410|580072122|FG007|Maintenance Period (MP)|Adverse Event|3|||
160641898|NCT00410410|580072123|FG008|Maintenance Period (MP)|Adverse Event|0|||
160641899|NCT00410410|580072115|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
160641900|NCT00410410|580072116|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
160641901|NCT00410410|580072117|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
160641902|NCT00410410|580072118|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
160641903|NCT00410410|580072119|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
160641904|NCT00410410|580072120|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
160641905|NCT00410410|580072121|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
160641906|NCT00410410|580072122|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
160641907|NCT00410410|580072123|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
160641908|NCT00410410|580072115|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
160641909|NCT00410410|580072116|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
160641910|NCT00410410|580072117|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
160641911|NCT00410410|580072118|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
160641912|NCT00410410|580072119|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
160641913|NCT00410410|580072120|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
160641914|NCT00410410|580072121|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
160641915|NCT00410410|580072122|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
160641916|NCT00410410|580072123|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
160641917|NCT00410410|580072115|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
160641918|NCT00410410|580072116|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
160641919|NCT00410410|580072117|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
160641920|NCT00410410|580072118|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
160641921|NCT00410410|580072119|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
160641922|NCT00410410|580072120|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
160641923|NCT00410410|580072121|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
160641924|NCT00410410|580072122|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
160641925|NCT00410410|580072123|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
160641926|NCT00410410|580072115|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
160641927|NCT00410410|580072116|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
160641928|NCT00410410|580072117|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
160641929|NCT00410410|580072118|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
160641930|NCT00410410|580072119|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
160641931|NCT00410410|580072120|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
160641932|NCT00410410|580072121|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
160641933|NCT00410410|580072122|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
160641934|NCT00410410|580072123|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
160641935|NCT00410410|580072115|FG000|Open-Label Period (OL)|Death|0|||
160641936|NCT00410410|580072116|FG001|Open-Label Period (OL)|Death|0|||
160641937|NCT00410410|580072117|FG002|Open-Label Period (OL)|Death|0|||
160641938|NCT00410410|580072118|FG003|Open-Label Period (OL)|Death|0|||
160641939|NCT00410410|580072119|FG004|Open-Label Period (OL)|Death|0|||
160641940|NCT00410410|580072120|FG005|Open-Label Period (OL)|Death|0|||
160641941|NCT00410410|580072121|FG006|Open-Label Period (OL)|Death|0|||
160641942|NCT00410410|580072122|FG007|Open-Label Period (OL)|Death|0|||
160641943|NCT00410410|580072123|FG008|Open-Label Period (OL)|Death|1|||
160641944|NCT00410410|580072115|FG000|Open-Label Period (OL)|Adverse Event|0|||
160641945|NCT00410410|580072116|FG001|Open-Label Period (OL)|Adverse Event|0|||
160641946|NCT00410410|580072117|FG002|Open-Label Period (OL)|Adverse Event|0|||
160641947|NCT00410410|580072118|FG003|Open-Label Period (OL)|Adverse Event|0|||
160641948|NCT00410410|580072119|FG004|Open-Label Period (OL)|Adverse Event|0|||
160641949|NCT00410410|580072120|FG005|Open-Label Period (OL)|Adverse Event|0|||
160641950|NCT00410410|580072121|FG006|Open-Label Period (OL)|Adverse Event|0|||
160641951|NCT00410410|580072122|FG007|Open-Label Period (OL)|Adverse Event|0|||
160641952|NCT00410410|580072123|FG008|Open-Label Period (OL)|Adverse Event|10|||
160641953|NCT00410410|580072115|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
160641954|NCT00410410|580072116|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
160641955|NCT00410410|580072117|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
160641956|NCT00410410|580072118|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
160641957|NCT00410410|580072119|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
160641958|NCT00410410|580072120|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
160641959|NCT00410410|580072121|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
160641960|NCT00410410|580072122|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
160641961|NCT00410410|580072123|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
160641962|NCT00410410|580072115|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
160641963|NCT00410410|580072116|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
160641964|NCT00410410|580072117|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
160641965|NCT00410410|580072118|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
160641966|NCT00410410|580072119|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
160641967|NCT00410410|580072120|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
160641968|NCT00410410|580072121|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
160641969|NCT00410410|580072122|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
160641970|NCT00410410|580072123|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
160641971|NCT00410410|580072115|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
160641972|NCT00410410|580072116|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
160641973|NCT00410410|580072117|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
160641974|NCT00410410|580072118|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
160641975|NCT00410410|580072119|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
160641976|NCT00410410|580072120|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
160641977|NCT00410410|580072121|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
160641978|NCT00410410|580072122|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
160641979|NCT00410410|580072123|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
160641980|NCT00410410|580072115|FG000|Open-Label Period (OL)|Pregnancy|0|||
160641981|NCT00410410|580072116|FG001|Open-Label Period (OL)|Pregnancy|0|||
160641982|NCT00410410|580072117|FG002|Open-Label Period (OL)|Pregnancy|0|||
160641983|NCT00410410|580072118|FG003|Open-Label Period (OL)|Pregnancy|0|||
160641984|NCT00410410|580072119|FG004|Open-Label Period (OL)|Pregnancy|0|||
160641985|NCT00410410|580072120|FG005|Open-Label Period (OL)|Pregnancy|0|||
160641986|NCT00410410|580072121|FG006|Open-Label Period (OL)|Pregnancy|0|||
160641987|NCT00410410|580072122|FG007|Open-Label Period (OL)|Pregnancy|0|||
160641988|NCT00410410|580072123|FG008|Open-Label Period (OL)|Pregnancy|1|||
160641989|NCT00410410|580072115|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
160641990|NCT00410410|580072116|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
160641991|NCT00410410|580072117|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
160641992|NCT00410410|580072118|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
160641993|NCT00410410|580072119|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
160641994|NCT00410410|580072120|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
160641995|NCT00410410|580072121|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
160641996|NCT00410410|580072122|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
160641997|NCT00410410|580072123|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
160641998|NCT00410410|580072115|FG000|Open-Label Period (OL)|Other|0|||
160641999|NCT00410410|580072116|FG001|Open-Label Period (OL)|Other|0|||
160642000|NCT00410410|580072117|FG002|Open-Label Period (OL)|Other|0|||
160642001|NCT00410410|580072118|FG003|Open-Label Period (OL)|Other|0|||
160642002|NCT00410410|580072119|FG004|Open-Label Period (OL)|Other|0|||
160642003|NCT00410410|580072120|FG005|Open-Label Period (OL)|Other|0|||
160642004|NCT00410410|580072121|FG006|Open-Label Period (OL)|Other|0|||
160642005|NCT00410410|580072122|FG007|Open-Label Period (OL)|Other|0|||
160642006|NCT00410410|580072123|FG008|Open-Label Period (OL)|Other|7|||
160642007|NCT01783496|580072124|FG000|Overall Study|Lost to Follow-up|0|||
160642008|NCT01783496|580072125|FG001|Overall Study|Lost to Follow-up|0|||
160642009|NCT01783496|580072126|FG002|Overall Study|Lost to Follow-up|0|||
160642010|NCT01783496|580072127|FG003|Overall Study|Lost to Follow-up|2|||
160642011|NCT01783496|580072128|FG004|Overall Study|Lost to Follow-up|0|||
160642012|NCT01783496|580072129|FG005|Overall Study|Lost to Follow-up|1|||
160642013|NCT01783496|580072124|FG000|Overall Study|Withdrawal by Subject|1|||
160642014|NCT01783496|580072125|FG001|Overall Study|Withdrawal by Subject|0|||
160642015|NCT01783496|580072126|FG002|Overall Study|Withdrawal by Subject|0|||
160642016|NCT01783496|580072127|FG003|Overall Study|Withdrawal by Subject|0|||
160642017|NCT01783496|580072128|FG004|Overall Study|Withdrawal by Subject|0|||
160642018|NCT01783496|580072129|FG005|Overall Study|Withdrawal by Subject|0|||
160642019|NCT01023269|580072130|FG000|Overall Study|early termination of the study|2|||
160642020|NCT01023269|580072131|FG001|Overall Study|early termination of the study|0|||
160546436|NCT05061719|579726815|FG000|Overall Study|Protocol Violation|8|||
160546437|NCT05061719|579726815|FG000|Overall Study|Withdrawal by Subject|41|||
160546438|NCT05061719|579726815|FG000|Overall Study|Site Closure|2|||
160546439|NCT00984204|579728034|FG000|Overall Study|Death|1|||
160546440|NCT00984204|579728034|FG000|Overall Study|Lost to Follow-up|4|||
160546441|NCT00984204|579728034|FG000|Overall Study|Lack of Efficacy|10|||
160546442|NCT04478708|579728037|FG000|Overall Study|Lost to Follow-up|0|||
160546443|NCT04478708|579728038|FG001|Overall Study|Lost to Follow-up|0|||
160546444|NCT04478708|579728039|FG002|Overall Study|Lost to Follow-up|0|||
160546445|NCT04478708|579728040|FG003|Overall Study|Lost to Follow-up|0|||
160546446|NCT04478708|579728041|FG004|Overall Study|Lost to Follow-up|0|||
160546447|NCT04478708|579728042|FG005|Overall Study|Lost to Follow-up|0|||
160546448|NCT04478708|579728043|FG006|Overall Study|Lost to Follow-up|0|||
160546449|NCT04478708|579728044|FG007|Overall Study|Lost to Follow-up|0|||
160546450|NCT04478708|579728045|FG008|Overall Study|Lost to Follow-up|1|||
160546451|NCT04478708|579728046|FG009|Overall Study|Lost to Follow-up|1|||
160546452|NCT04478708|579728047|FG010|Overall Study|Lost to Follow-up|1|||
160546453|NCT04478708|579728048|FG011|Overall Study|Lost to Follow-up|2|||
160546454|NCT04478708|579728049|FG012|Overall Study|Lost to Follow-up|1|||
160546455|NCT04478708|579728050|FG013|Overall Study|Lost to Follow-up|0|||
160546456|NCT04478708|579728051|FG014|Overall Study|Lost to Follow-up|0|||
160546457|NCT04478708|579728052|FG015|Overall Study|Lost to Follow-up|0|||
160546458|NCT04478708|579728053|FG016|Overall Study|Lost to Follow-up|0|||
160546459|NCT04478708|579728037|FG000|Overall Study|Withdrawal of consent from study|0|||
160546460|NCT04478708|579728038|FG001|Overall Study|Withdrawal of consent from study|1|||
160546461|NCT04478708|579728039|FG002|Overall Study|Withdrawal of consent from study|2|||
160546462|NCT04478708|579728040|FG003|Overall Study|Withdrawal of consent from study|0|||
160546463|NCT04478708|579728041|FG004|Overall Study|Withdrawal of consent from study|1|||
160546464|NCT04478708|579728042|FG005|Overall Study|Withdrawal of consent from study|1|||
160546465|NCT04478708|579728043|FG006|Overall Study|Withdrawal of consent from study|1|||
160546466|NCT04478708|579728044|FG007|Overall Study|Withdrawal of consent from study|0|||
160546467|NCT04478708|579728045|FG008|Overall Study|Withdrawal of consent from study|0|||
160546468|NCT04478708|579728046|FG009|Overall Study|Withdrawal of consent from study|0|||
160546469|NCT04478708|579728047|FG010|Overall Study|Withdrawal of consent from study|4|||
160546470|NCT04478708|579728048|FG011|Overall Study|Withdrawal of consent from study|3|||
160546471|NCT04478708|579728049|FG012|Overall Study|Withdrawal of consent from study|0|||
160546472|NCT04478708|579728050|FG013|Overall Study|Withdrawal of consent from study|0|||
160546473|NCT04478708|579728051|FG014|Overall Study|Withdrawal of consent from study|1|||
160546474|NCT04478708|579728052|FG015|Overall Study|Withdrawal of consent from study|0|||
160546475|NCT04478708|579728053|FG016|Overall Study|Withdrawal of consent from study|4|||
160546476|NCT01869114|579728054|FG000|Overall Study|Death|19|||
160546477|NCT01869114|579728055|FG001|Overall Study|Death|18|||
160546478|NCT01869114|579728056|FG002|Overall Study|Death|8|||
160546479|NCT01869114|579728054|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
160546480|NCT01869114|579728055|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
160546481|NCT01869114|579728056|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
160546482|NCT01869114|579728054|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
160546483|NCT01869114|579728055|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
160546484|NCT01869114|579728056|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
160546485|NCT01869114|579728054|FG000|Overall Study|Withdrawal by Subject|0|||
160546486|NCT01869114|579728055|FG001|Overall Study|Withdrawal by Subject|3|||
160546487|NCT01869114|579728056|FG002|Overall Study|Withdrawal by Subject|0|||
160546488|NCT01869114|579728054|FG000|Overall Study|Disease Progression|0|||
160546489|NCT01869114|579728055|FG001|Overall Study|Disease Progression|1|||
160546490|NCT01869114|579728056|FG002|Overall Study|Disease Progression|0|||
160546491|NCT00559507|579728057|FG000|Overall Study|Not treated, patient ineligible|3|||
160546492|NCT01407926|579728058|FG000|Overall Study|Lost to Follow-up|55|||
160546493|NCT04232696|579728060|FG000|Overall Study|Implant attempted but not completed|5|||
160546494|NCT04232696|579728061|FG001|Overall Study|Implant attempted but not completed|2|||
160546495|NCT04232696|579728060|FG000|Overall Study|Not satisfied with therapy outcome|0|||
160546496|NCT04232696|579728061|FG001|Overall Study|Not satisfied with therapy outcome|8|||
160546497|NCT04232696|579728060|FG000|Overall Study|Adverse Event|0|||
160546498|NCT04232696|579728061|FG001|Overall Study|Adverse Event|3|||
160546499|NCT04232696|579728060|FG000|Overall Study|Withdrawal by Subject|0|||
160546500|NCT04232696|579728061|FG001|Overall Study|Withdrawal by Subject|3|||
160546501|NCT04232696|579728060|FG000|Overall Study|Missed Visit|0|||
160546502|NCT04232696|579728061|FG001|Overall Study|Missed Visit|2|||
160546503|NCT04232696|579728060|FG000|Overall Study|Other reason|0|||
160546504|NCT04232696|579728061|FG001|Overall Study|Other reason|1|||
160546505|NCT03118297|579728062|FG000|Overall Study|Lost to Follow-up|0|||
160546506|NCT03118297|579728063|FG001|Overall Study|Lost to Follow-up|2|||
160546507|NCT02792842|579728066|FG000|Overall Study|Adverse Event|4|||
160546508|NCT02792842|579728067|FG001|Overall Study|Adverse Event|2|||
160546509|NCT02792842|579728068|FG002|Overall Study|Adverse Event|3|||
160546510|NCT02792842|579728066|FG000|Overall Study|Withdrawal by Subject|0|||
160653391|NCT05665595|580112378|FG001|Overall Study|Ongoing|698|||
160642021|NCT05266456|580072132|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
160642022|NCT05266456|580072133|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
160642023|NCT05266456|580072134|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
160642024|NCT05266456|580072135|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
160642025|NCT05266456|580072132|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
160642026|NCT05266456|580072133|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
160642027|NCT05266456|580072134|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
160642028|NCT05266456|580072135|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
160642029|NCT05266456|580072132|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
160642030|NCT05266456|580072133|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
160642031|NCT05266456|580072134|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
160642032|NCT05266456|580072135|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
160642033|NCT05266456|580072132|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
160642034|NCT05266456|580072133|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
160642035|NCT05266456|580072134|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
160642036|NCT05266456|580072135|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
160642037|NCT05266456|580072132|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
160642038|NCT05266456|580072133|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
160642039|NCT05266456|580072134|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
160642040|NCT05266456|580072135|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
160642041|NCT00068237|580072136|FG000|Overall Study|Ineligible|3|||
160642042|NCT00068237|580072136|FG000|Overall Study|No protocol treatment received|2|||
160642043|NCT02746705|580072139|FG000|Overall Study|Physician Decision|1|||
160642044|NCT02746705|580072140|FG001|Overall Study|Physician Decision|1|||
160642045|NCT02746705|580072139|FG000|Overall Study|Lost to Follow-up|1|||
160642046|NCT02746705|580072140|FG001|Overall Study|Lost to Follow-up|0|||
160642047|NCT02746705|580072139|FG000|Overall Study|outlier scores deemed not valid|0|||
160642048|NCT02746705|580072140|FG001|Overall Study|outlier scores deemed not valid|1|||
160642049|NCT00479401|580072141|FG000|Overall Study|Adverse Event|24|||
160642050|NCT00479401|580072142|FG001|Overall Study|Adverse Event|20|||
160642051|NCT00479401|580072143|FG002|Overall Study|Adverse Event|4|||
160642052|NCT00479401|580072141|FG000|Overall Study|Lack of Efficacy|2|||
160642053|NCT00479401|580072142|FG001|Overall Study|Lack of Efficacy|2|||
160642054|NCT00479401|580072143|FG002|Overall Study|Lack of Efficacy|4|||
160642055|NCT00479401|580072141|FG000|Overall Study|Protocol Violation|2|||
160642056|NCT00479401|580072142|FG001|Overall Study|Protocol Violation|1|||
160642057|NCT00479401|580072143|FG002|Overall Study|Protocol Violation|1|||
160642058|NCT00479401|580072141|FG000|Overall Study|Lost to Follow-up|1|||
160642059|NCT00479401|580072142|FG001|Overall Study|Lost to Follow-up|1|||
160642060|NCT00479401|580072143|FG002|Overall Study|Lost to Follow-up|1|||
160642061|NCT00479401|580072141|FG000|Overall Study|Withdrawal by Subject|16|||
160642062|NCT00479401|580072142|FG001|Overall Study|Withdrawal by Subject|10|||
160642063|NCT00479401|580072143|FG002|Overall Study|Withdrawal by Subject|2|||
160642064|NCT00479401|580072141|FG000|Overall Study|Exclusion criteria, relocation|4|||
160642065|NCT00479401|580072142|FG001|Overall Study|Exclusion criteria, relocation|3|||
160642066|NCT00479401|580072143|FG002|Overall Study|Exclusion criteria, relocation|0|||
160642067|NCT05288673|580072144|FG000|Overall Study|Consent withdrawn by subject|0|||
160642068|NCT05288673|580072145|FG001|Overall Study|Consent withdrawn by subject|0|||
160642069|NCT05288673|580072146|FG002|Overall Study|Consent withdrawn by subject|1|||
160642070|NCT01504867|580072147|FG000|Overall Study|Inclusion criteria not met|2|||
160642071|NCT01504867|580072148|FG001|Overall Study|Inclusion criteria not met|2|||
160642072|NCT01504867|580072147|FG000|Overall Study|Consent revoked|5|||
160642073|NCT01504867|580072148|FG001|Overall Study|Consent revoked|1|||
160642074|NCT00571922|580072149|FG000|Overall Study|Completion unknown|36|||
160642075|NCT00571922|580072150|FG001|Overall Study|Completion unknown|36|||
160642076|NCT01154153|580072155|FG000|Overall Study|Poor compliance to protocol|2|||
160642077|NCT01154153|580072156|FG001|Overall Study|Poor compliance to protocol|0|||
160642078|NCT01154153|580072155|FG000|Overall Study|Unable to use labs|2|||
160642079|NCT01154153|580072156|FG001|Overall Study|Unable to use labs|3|||
160642080|NCT01154153|580072155|FG000|Overall Study|Withdrew consent|1|||
160642081|NCT01154153|580072156|FG001|Overall Study|Withdrew consent|0|||
160642082|NCT02473510|580072157|FG000|Overall Study|Lost to Follow-up|1|||
160642083|NCT02473510|580072158|FG001|Overall Study|Lost to Follow-up|2|||
160642084|NCT00964223|580072159|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
160642085|NCT03439293|580072160|FG000|Overall Study|Death|22|||
160642086|NCT03439293|580072160|FG000|Overall Study|Withdrawal by Subject|8|||
160642087|NCT03439293|580072160|FG000|Overall Study|Lost to Follow-up|2|||
160642088|NCT03439293|580072160|FG000|Overall Study|Reason Not Specified|28|||
160642089|NCT03439293|580072160|FG000|Overall Study|Missing|1|||
160642090|NCT03404206|580072162|FG000|Overall Study|Withdrawal by Subject|1|||
160642091|NCT03404206|580072163|FG001|Overall Study|Withdrawal by Subject|1|||
160642092|NCT03404206|580072164|FG002|Overall Study|Withdrawal by Subject|0|||
160642093|NCT03404206|580072162|FG000|Overall Study|Lost to Follow-up|3|||
160642094|NCT03404206|580072163|FG001|Overall Study|Lost to Follow-up|1|||
160642095|NCT03404206|580072164|FG002|Overall Study|Lost to Follow-up|0|||
160546511|NCT02792842|579728067|FG001|Overall Study|Withdrawal by Subject|1|||
160546512|NCT02792842|579728068|FG002|Overall Study|Withdrawal by Subject|2|||
160546513|NCT02792842|579728066|FG000|Overall Study|Lost to Follow-up|0|||
160546514|NCT02792842|579728067|FG001|Overall Study|Lost to Follow-up|0|||
160546515|NCT02792842|579728068|FG002|Overall Study|Lost to Follow-up|1|||
160546516|NCT02792842|579728066|FG000|Overall Study|Schedule delay|0|||
160546517|NCT02792842|579728067|FG001|Overall Study|Schedule delay|1|||
160546518|NCT02792842|579728068|FG002|Overall Study|Schedule delay|1|||
160546519|NCT02363686|579728071|FG000|Overall Study|Withdrawal by Subject|22|||
160546520|NCT02363686|579728071|FG000|Overall Study|incomplete FEES examinations|13|||
160546521|NCT01294800|579728076|FG000|Overall Study|Adverse Event|7|||
160546522|NCT01294800|579728077|FG001|Overall Study|Adverse Event|6|||
160546523|NCT01294800|579728078|FG002|Overall Study|Adverse Event|12|||
160546524|NCT01294800|579728079|FG003|Overall Study|Adverse Event|5|||
160546525|NCT01294800|579728076|FG000|Overall Study|Subject Withdrew Consent|2|||
160546526|NCT01294800|579728077|FG001|Overall Study|Subject Withdrew Consent|2|||
160546527|NCT01294800|579728078|FG002|Overall Study|Subject Withdrew Consent|2|||
160546528|NCT01294800|579728079|FG003|Overall Study|Subject Withdrew Consent|11|||
160546529|NCT01294800|579728076|FG000|Overall Study|Lost to Follow-up|0|||
160546530|NCT01294800|579728077|FG001|Overall Study|Lost to Follow-up|0|||
160546531|NCT01294800|579728078|FG002|Overall Study|Lost to Follow-up|1|||
160546532|NCT01294800|579728079|FG003|Overall Study|Lost to Follow-up|0|||
160546533|NCT01294800|579728076|FG000|Overall Study|Non-compliance With Protocol|0|||
160546534|NCT01294800|579728077|FG001|Overall Study|Non-compliance With Protocol|1|||
160546535|NCT01294800|579728078|FG002|Overall Study|Non-compliance With Protocol|1|||
160546536|NCT01294800|579728079|FG003|Overall Study|Non-compliance With Protocol|0|||
160546537|NCT01294800|579728076|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
160546538|NCT01294800|579728077|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
160546539|NCT01294800|579728078|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
160546540|NCT01294800|579728079|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
160546541|NCT01662895|579728080|FG000|Overall Study|Lost to Follow-up|0|||
160546542|NCT01662895|579728081|FG001|Overall Study|Lost to Follow-up|1|||
160546543|NCT05048342|579728082|FG000|Overall Study|Adverse Event|1|||
160546544|NCT05048342|579728082|FG000|Overall Study|Subject decision|2|||
160546545|NCT00493038|579728083|FG000|Treatment|Adverse Event|8|||
160546546|NCT00493038|579728084|FG001|Treatment|Adverse Event|4|||
160546547|NCT00493038|579728083|FG000|Treatment|Lost to Follow-up|5|||
160546548|NCT00493038|579728084|FG001|Treatment|Lost to Follow-up|3|||
160546549|NCT00493038|579728083|FG000|Treatment|Withdrawal by Subject|11|||
160546550|NCT00493038|579728084|FG001|Treatment|Withdrawal by Subject|12|||
160546551|NCT00493038|579728083|FG000|Treatment|Other|0|||
160546552|NCT00493038|579728084|FG001|Treatment|Other|1|||
160546553|NCT00493038|579728083|FG000|Follow-up|Lost to Follow-up|1|||
160546554|NCT00493038|579728084|FG001|Follow-up|Lost to Follow-up|0|||
160546555|NCT01441063|579728085|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
160546556|NCT01441063|579728085|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
160546557|NCT03345472|579728087|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
160546558|NCT03345472|579728087|FG000|Implant to 3 Months|Physician Decision|1|||
160546559|NCT03345472|579728087|FG000|Implant to 3 Months|Adverse Event|1|||
160546560|NCT03345472|579728087|FG000|3 Months to 12 Months|Physician Decision|3|||
160546561|NCT03345472|579728087|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
160546562|NCT03345472|579728087|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
160546563|NCT03345472|579728087|FG000|3 Months to 12 Months|Adverse Event|1|||
160546564|NCT03345472|579728087|FG000|3 Months to 12 Months|Death|1|||
160546565|NCT01097863|579728119|FG000|Overall Study|Discomfort|1|||
160546566|NCT01097863|579728120|FG001|Overall Study|Discomfort|0|||
160546567|NCT01097863|579728121|FG002|Overall Study|Discomfort|1|||
160546568|NCT01097863|579728119|FG000|Overall Study|Did not return for final visit|0|||
160546569|NCT01097863|579728120|FG001|Overall Study|Did not return for final visit|0|||
160546570|NCT01097863|579728121|FG002|Overall Study|Did not return for final visit|1|||
160546571|NCT03099707|579728122|FG000|Overall Study|Withdrawal by Subject|0|||
160546572|NCT03099707|579728123|FG001|Overall Study|Withdrawal by Subject|3|||
160546573|NCT03099707|579728122|FG000|Overall Study|Lost to Follow-up|0|||
160546574|NCT03099707|579728123|FG001|Overall Study|Lost to Follow-up|1|||
160546575|NCT03167073|579728124|FG000|Overall Study|Stillbirth|1|||
160546576|NCT03167073|579728125|FG001|Overall Study|Stillbirth|0|||
160546577|NCT01294579|579728131|FG000|Overall Study|Disease progression|12|||
160546578|NCT01294579|579728131|FG000|Overall Study|Adverse Event|11|||
160546579|NCT01294579|579728131|FG000|Overall Study|Study closed/terminated|3|||
160546580|NCT01294579|579728131|FG000|Overall Study|Lost to Follow-up|1|||
160546581|NCT01294579|579728131|FG000|Overall Study|Physician Decision|3|||
160546582|NCT01294579|579728131|FG000|Overall Study|Withdrawal by Subject|5|||
160546583|NCT02788747|579728132|FG000|Overall Study|Adverse Event|1|||
160546584|NCT02788747|579728133|FG001|Overall Study|Adverse Event|0|||
160546585|NCT02788747|579728134|FG002|Overall Study|Adverse Event|0|||
160546586|NCT00562354|579728135|FG000|Overall Study|Physician Decision|0|||
160546587|NCT00562354|579728136|FG001|Overall Study|Physician Decision|1|||
160546588|NCT00562354|579728135|FG000|Overall Study|Lost to Follow-up|0|||
160642096|NCT05478603|580072165|FG000|Overall Study|Withdrawal by Subject|0|||
160642097|NCT05478603|580072166|FG001|Overall Study|Withdrawal by Subject|1|||
160642098|NCT05478603|580072167|FG002|Overall Study|Withdrawal by Subject|0|||
160642099|NCT05478603|580072168|FG003|Overall Study|Withdrawal by Subject|0|||
160642100|NCT03634488|580072171|FG000|Overall Study|Death|1|||
160642101|NCT03634488|580072172|FG001|Overall Study|Death|0|||
160642102|NCT03634488|580072173|FG002|Overall Study|Death|0|||
160642103|NCT03634488|580072171|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
160642104|NCT03634488|580072172|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
160642105|NCT03634488|580072173|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
160642106|NCT01169844|580072181|FG000|Overall Study|Adverse Event|0|||
160642107|NCT01169844|580072182|FG001|Overall Study|Adverse Event|1|||
160642108|NCT01169844|580072181|FG000|Overall Study|Patient withdrew consent|4|||
160642109|NCT01169844|580072182|FG001|Overall Study|Patient withdrew consent|0|||
160642110|NCT01169844|580072181|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160642111|NCT01169844|580072182|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160642112|NCT00990093|580072185|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
160642113|NCT00990093|580072186|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
160642114|NCT00990093|580072185|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
160642115|NCT00990093|580072186|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
160642116|NCT00990093|580072185|FG000|Test Period 1 (1-14 Days)|Other|1|||
160642117|NCT00990093|580072186|FG001|Test Period 1 (1-14 Days)|Other|0|||
160642118|NCT00990093|580072185|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
160642119|NCT00990093|580072186|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
160642120|NCT00990093|580072185|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
160642121|NCT00990093|580072186|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
160642122|NCT00990093|580072185|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
160642123|NCT00990093|580072186|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
160642124|NCT00990093|580072185|FG000|Test Period 2 (15-28 Days)|Other|0|||
160642125|NCT00990093|580072186|FG001|Test Period 2 (15-28 Days)|Other|1|||
160642126|NCT01010230|580072188|FG000|Overall Study|Withdrawal by Subject|6|||
160642127|NCT01010230|580072189|FG001|Overall Study|Withdrawal by Subject|5|||
160642128|NCT01010230|580072188|FG000|Overall Study|Lost to Follow-up|4|||
160642129|NCT01010230|580072189|FG001|Overall Study|Lost to Follow-up|2|||
160642130|NCT00530439|580072190|FG000|Overall Study|GDM|9|||
160642131|NCT00530439|580072191|FG001|Overall Study|GDM|3|||
160642132|NCT00530439|580072190|FG000|Overall Study|Withdraw|18|||
160642133|NCT00530439|580072191|FG001|Overall Study|Withdraw|14|||
160642134|NCT00530439|580072190|FG000|Overall Study|Missed abortion|1|||
160642135|NCT00530439|580072191|FG001|Overall Study|Missed abortion|4|||
160642136|NCT00530439|580072190|FG000|Overall Study|Misclassification|2|||
160642137|NCT00530439|580072191|FG001|Overall Study|Misclassification|0|||
160642138|NCT00530439|580072190|FG000|Overall Study|Twin pregnancy|0|||
160642139|NCT00530439|580072191|FG001|Overall Study|Twin pregnancy|2|||
160642140|NCT00530439|580072190|FG000|Overall Study|Severe malformation/abortion|0|||
160642141|NCT00530439|580072191|FG001|Overall Study|Severe malformation/abortion|3|||
160642142|NCT00378482|580072196|FG000|Overall Study|Lost to Follow-up|1|||
160890220|NCT00423670|580992974|FG007|Treatment Period|Non-compliance with protocol|2|||
160642143|NCT00378482|580072196|FG000|Overall Study|Lack of Efficacy|8|||
160642144|NCT00378482|580072196|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
160642145|NCT00378482|580072196|FG000|Overall Study|Withdrawal by Subject|4|||
160642146|NCT00378482|580072196|FG000|Overall Study|Adverse Event|9|||
160642147|NCT03185949|580072197|FG000|ITT Analysis|Withdrawal by Subject|4|||
160642148|NCT03185949|580072198|FG001|ITT Analysis|Withdrawal by Subject|3|||
160642149|NCT03185949|580072197|FG000|PP Analysis|Protocol Violation|2|||
160642150|NCT03185949|580072198|FG001|PP Analysis|Protocol Violation|2|||
160642151|NCT03185949|580072197|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
160642152|NCT03185949|580072198|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
160642153|NCT00343642|580074207|FG000|Overall Study|Lost to Follow-up|0|||
160642154|NCT00343642|580074208|FG001|Overall Study|Lost to Follow-up|1|||
160642155|NCT00343642|580074209|FG002|Overall Study|Lost to Follow-up|0|||
160642156|NCT00343642|580074207|FG000|Overall Study|Pregnancy|1|||
160642157|NCT00343642|580074208|FG001|Overall Study|Pregnancy|0|||
160642158|NCT00343642|580074209|FG002|Overall Study|Pregnancy|2|||
160642159|NCT00343642|580074207|FG000|Overall Study|Withdrawal by Subject|2|||
160642160|NCT00343642|580074208|FG001|Overall Study|Withdrawal by Subject|3|||
160642161|NCT00343642|580074209|FG002|Overall Study|Withdrawal by Subject|4|||
160642162|NCT00343642|580074207|FG000|Overall Study|Adverse Event|0|||
160642163|NCT00343642|580074208|FG001|Overall Study|Adverse Event|0|||
160642164|NCT00343642|580074209|FG002|Overall Study|Adverse Event|1|||
160642165|NCT00343642|580074207|FG000|Overall Study|Flare up|6|||
160546589|NCT00562354|579728136|FG001|Overall Study|Lost to Follow-up|1|||
160546590|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
160642166|NCT00343642|580074208|FG001|Overall Study|Flare up|4|||
160642167|NCT00343642|580074209|FG002|Overall Study|Flare up|0|||
160642168|NCT00860574|580074212|FG000|Overall Study|Death|2|||
160642169|NCT00860574|580074212|FG000|Overall Study|Relapse|1|||
160642170|NCT02496221|580074213|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
160642171|NCT02496221|580074214|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
160642172|NCT02496221|580074213|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
160642173|NCT02496221|580074214|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
160642174|NCT02496221|580074213|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
160890221|NCT00423670|580992967|FG000|Follow-up Period|Lost to Follow-up|0|||
160890222|NCT00423670|580992968|FG001|Follow-up Period|Lost to Follow-up|12|||
160890223|NCT00423670|580992969|FG002|Follow-up Period|Lost to Follow-up|8|||
160890224|NCT00423670|580992970|FG003|Follow-up Period|Lost to Follow-up|3|||
160890225|NCT00423670|580992971|FG004|Follow-up Period|Lost to Follow-up|1|||
160890226|NCT00423670|580992972|FG005|Follow-up Period|Lost to Follow-up|0|||
160890227|NCT00423670|580992973|FG006|Follow-up Period|Lost to Follow-up|5|||
160890228|NCT00423670|580992974|FG007|Follow-up Period|Lost to Follow-up|0|||
160890229|NCT00423670|580992967|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
160890230|NCT00423670|580992968|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
160890231|NCT00423670|580992969|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
160890232|NCT00423670|580992970|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
160546591|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
160546592|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
160546593|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
160546594|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
160546595|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
160546596|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
160546597|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
160546598|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
160546599|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
160546600|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
160546601|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
160546602|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
160546603|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
160546604|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
160546605|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
160890233|NCT00423670|580992971|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
160890234|NCT00423670|580992972|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
160642175|NCT02496221|580074214|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
160642176|NCT01335399|580074215|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
160642177|NCT01335399|580074216|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
160642178|NCT01335399|580074215|FG000|Pre-treatment Period|Participant request to discontinue|0|||
160642179|NCT01335399|580074216|FG001|Pre-treatment Period|Participant request to discontinue|1|||
160642180|NCT01335399|580074215|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
160642181|NCT01335399|580074216|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
160642182|NCT01335399|580074215|FG000|Pre-treatment Period|Consent withdrawal|3|||
160642183|NCT01335399|580074216|FG001|Pre-treatment Period|Consent withdrawal|0|||
160642184|NCT01335399|580074215|FG000|Treatment Period|Disease progression|117|||
160642185|NCT01335399|580074216|FG001|Treatment Period|Disease progression|145|||
160546606|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
160546607|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
160546608|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
160546609|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
160546610|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
160546611|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
160546612|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
160546613|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
160546614|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
160546615|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
160546616|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
160546617|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
160546618|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
160546619|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
160546620|NCT00784654|579728137|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
160546621|NCT00784654|579728138|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
160546622|NCT00784654|579728139|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
160546623|NCT00784654|579728137|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
160546624|NCT00784654|579728138|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
160546625|NCT00784654|579728139|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
160546626|NCT00784654|579728137|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
160546627|NCT00784654|579728138|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
160546628|NCT00784654|579728139|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
160546629|NCT00784654|579728137|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160546630|NCT00784654|579728138|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
160546631|NCT00784654|579728139|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
160546632|NCT00784654|579728137|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
160546633|NCT00784654|579728138|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
160546634|NCT00784654|579728139|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
160546635|NCT00784654|579728137|FG000|Randomized Withdrawal Period|Adverse Event|0|||
160546636|NCT00784654|579728138|FG001|Randomized Withdrawal Period|Adverse Event|1|||
160546637|NCT00784654|579728139|FG002|Randomized Withdrawal Period|Adverse Event|1|||
160546638|NCT00784654|579728137|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
160546639|NCT00784654|579728138|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
160546640|NCT00784654|579728139|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
160546641|NCT00784654|579728137|FG000|Randomized Withdrawal Period|Family reasons|0|||
160546642|NCT00784654|579728138|FG001|Randomized Withdrawal Period|Family reasons|0|||
160546643|NCT00784654|579728139|FG002|Randomized Withdrawal Period|Family reasons|1|||
160546644|NCT04417894|579728140|FG000|Overall Study|Lost to Follow-up|3|||
160546645|NCT04417894|579728141|FG001|Overall Study|Lost to Follow-up|0|||
160546646|NCT04417894|579728140|FG000|Overall Study|Withdrawal by Subject|7|||
160546647|NCT04417894|579728141|FG001|Overall Study|Withdrawal by Subject|6|||
160546648|NCT04417894|579728140|FG000|Overall Study|Lack of Efficacy|3|||
160546649|NCT04417894|579728141|FG001|Overall Study|Lack of Efficacy|1|||
160546650|NCT00262873|579728142|FG000|Overall Study|Adverse Event|3|||
160546651|NCT00262873|579728142|FG000|Overall Study|Withdrawal by Subject|5|||
160546652|NCT00844753|579728143|FG000|Overall Study|Lack of Efficacy|1|||
160546653|NCT00844753|579728144|FG001|Overall Study|Lack of Efficacy|0|||
160546654|NCT00844753|579728145|FG002|Overall Study|Lack of Efficacy|2|||
160546655|NCT00844753|579728146|FG003|Overall Study|Lack of Efficacy|2|||
160546656|NCT00844753|579728143|FG000|Overall Study|Adverse Event|3|||
160546657|NCT00844753|579728144|FG001|Overall Study|Adverse Event|2|||
160546658|NCT00844753|579728145|FG002|Overall Study|Adverse Event|5|||
160546659|NCT00844753|579728146|FG003|Overall Study|Adverse Event|5|||
160546660|NCT00844753|579728143|FG000|Overall Study|Lost to Follow-up|1|||
160546661|NCT00844753|579728144|FG001|Overall Study|Lost to Follow-up|1|||
160546662|NCT00844753|579728145|FG002|Overall Study|Lost to Follow-up|0|||
160890235|NCT00423670|580992973|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
160890236|NCT00423670|580992974|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
160890237|NCT00423670|580992967|FG000|Follow-up Period|Non-compliance with protocol|2|||
160890238|NCT00423670|580992968|FG001|Follow-up Period|Non-compliance with protocol|0|||
160890239|NCT00423670|580992969|FG002|Follow-up Period|Non-compliance with protocol|1|||
160890240|NCT00423670|580992970|FG003|Follow-up Period|Non-compliance with protocol|1|||
160546663|NCT00844753|579728146|FG003|Overall Study|Lost to Follow-up|1|||
160890241|NCT00423670|580992971|FG004|Follow-up Period|Non-compliance with protocol|0|||
160546664|NCT00844753|579728143|FG000|Overall Study|could not swallow medication|2|||
160546665|NCT00844753|579728144|FG001|Overall Study|could not swallow medication|0|||
160546666|NCT00844753|579728145|FG002|Overall Study|could not swallow medication|0|||
160546667|NCT00844753|579728146|FG003|Overall Study|could not swallow medication|0|||
160546668|NCT00844753|579728143|FG000|Overall Study|Withdrawal by Subject|1|||
160546669|NCT00844753|579728144|FG001|Overall Study|Withdrawal by Subject|0|||
160546670|NCT00844753|579728145|FG002|Overall Study|Withdrawal by Subject|0|||
160546671|NCT00844753|579728146|FG003|Overall Study|Withdrawal by Subject|3|||
160546672|NCT00903175|579728147|FG000|Period 1 - First Line|Adverse Event|36|||
160546673|NCT00903175|579728148|FG001|Period 1 - First Line|Adverse Event|50|||
160546674|NCT00903175|579728147|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
160546675|NCT00903175|579728148|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
160546676|NCT00903175|579728147|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
160546677|NCT00903175|579728148|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
160546678|NCT00903175|579728147|FG000|Period 1 - First Line|Protocol Violation|3|||
160546679|NCT00903175|579728148|FG001|Period 1 - First Line|Protocol Violation|3|||
160546680|NCT00903175|579728147|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
160546681|NCT00903175|579728148|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
160546682|NCT00903175|579728147|FG000|Period 1 - First Line|Administrative problems|12|||
160546683|NCT00903175|579728148|FG001|Period 1 - First Line|Administrative problems|13|||
160546684|NCT00903175|579728147|FG000|Period 1 - First Line|Death|17|||
160546685|NCT00903175|579728148|FG001|Period 1 - First Line|Death|10|||
160546686|NCT00903175|579728147|FG000|Period 2 - Second Line|Missing|1|||
160546687|NCT00903175|579728148|FG001|Period 2 - Second Line|Missing|0|||
160546688|NCT00903175|579728147|FG000|Period 2 - Second Line|Adverse Event|16|||
160546689|NCT00903175|579728148|FG001|Period 2 - Second Line|Adverse Event|20|||
160546690|NCT00903175|579728147|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
160546691|NCT00903175|579728148|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
160546692|NCT00903175|579728147|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
160546693|NCT00903175|579728148|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
160787857|NCT00986102|580609054|FG001|Overall Study|Withdrawal by Subject|1|||
160787858|NCT00986102|580609055|FG002|Overall Study|Withdrawal by Subject|0|||
160787859|NCT00986102|580609056|FG003|Overall Study|Withdrawal by Subject|0|||
160787860|NCT04008069|580609057|FG000|Open-Label Period|Adverse Event|1|||
160787861|NCT04008069|580609058|FG001|Open-Label Period|Adverse Event|0|||
160787862|NCT04008069|580609059|FG002|Open-Label Period|Adverse Event|0|||
160787863|NCT04008069|580609057|FG000|Open-Label Period|Lack of Efficacy|4|||
160787864|NCT04008069|580609058|FG001|Open-Label Period|Lack of Efficacy|0|||
160787865|NCT04008069|580609059|FG002|Open-Label Period|Lack of Efficacy|0|||
160787866|NCT04008069|580609057|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
160787867|NCT04008069|580609058|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
160787868|NCT04008069|580609059|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
160787869|NCT04008069|580609057|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
160787870|NCT04008069|580609058|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
160787871|NCT04008069|580609059|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
160787872|NCT00511199|580609060|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
160787873|NCT00511199|580609061|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
160787874|NCT00511199|580609060|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
160787875|NCT00511199|580609061|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
160787876|NCT00511199|580609060|FG000|Overall Study|Withdrawal of Informed Consent|19|||
160787877|NCT00511199|580609061|FG001|Overall Study|Withdrawal of Informed Consent|4|||
160787878|NCT00511199|580609060|FG000|Overall Study|Pregnancy|6|||
160787879|NCT00511199|580609061|FG001|Overall Study|Pregnancy|3|||
160787880|NCT00511199|580609060|FG000|Overall Study|Pregnancy Wish|16|||
160787881|NCT00511199|580609061|FG001|Overall Study|Pregnancy Wish|8|||
160787882|NCT00511199|580609060|FG000|Overall Study|Lost to Follow-up|40|||
160787883|NCT00511199|580609061|FG001|Overall Study|Lost to Follow-up|17|||
160787884|NCT00511199|580609060|FG000|Overall Study|Other Reason|78|||
160787885|NCT00511199|580609061|FG001|Overall Study|Other Reason|37|||
160787886|NCT01953354|580609069|FG000|Overall Study|Withdrawal by Subject|0|||
160787887|NCT01953354|580609070|FG001|Overall Study|Withdrawal by Subject|1|||
160787888|NCT01953354|580609069|FG000|Overall Study|Decision of Sponsor|0|||
160787889|NCT01953354|580609070|FG001|Overall Study|Decision of Sponsor|1|||
160787890|NCT01953354|580609069|FG000|Overall Study|Disease Exacerbation|1|||
160787891|NCT01953354|580609070|FG001|Overall Study|Disease Exacerbation|0|||
160787892|NCT01927861|580609071|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
160787893|NCT01927861|580609072|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
160787894|NCT01927861|580609071|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
160787895|NCT01927861|580609072|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
160787896|NCT00728182|580609074|FG000|Overall Study|Adverse Event|1|||
160787897|NCT00728182|580609075|FG001|Overall Study|Adverse Event|0|||
160787898|NCT00728182|580609074|FG000|Overall Study|Lost to Follow-up|2|||
160787899|NCT00728182|580609075|FG001|Overall Study|Lost to Follow-up|0|||
160787900|NCT00728182|580609074|FG000|Overall Study|Death|0|||
160787901|NCT00728182|580609075|FG001|Overall Study|Death|2|||
160787902|NCT00728182|580609074|FG000|Overall Study|Protocol Noncompliance|0|||
160787903|NCT00728182|580609075|FG001|Overall Study|Protocol Noncompliance|1|||
160787904|NCT01898091|580609079|FG000|Overall Study|Lost to Follow-up|1|||
160890242|NCT00423670|580992972|FG005|Follow-up Period|Non-compliance with protocol|0|||
160890243|NCT00423670|580992973|FG006|Follow-up Period|Non-compliance with protocol|3|||
160890244|NCT00423670|580992974|FG007|Follow-up Period|Non-compliance with protocol|2|||
160890245|NCT03190369|580992975|FG000|Overall Study|Poor compliance to protocol|0|||
160890246|NCT03190369|580992976|FG001|Overall Study|Poor compliance to protocol|1|||
160890247|NCT03190369|580992975|FG000|Overall Study|Withdraw before treatment|1|||
160890248|NCT03190369|580992976|FG001|Overall Study|Withdraw before treatment|5|||
160890249|NCT03190369|580992975|FG000|Overall Study|Randomized but not treated|0|||
160890250|NCT03190369|580992976|FG001|Overall Study|Randomized but not treated|2|||
160890251|NCT02131532|580992977|FG000|Overall Study|Withdrawal by Subject|1|||
160890252|NCT02131532|580992977|FG000|Overall Study|Physician Decision|1|||
160890253|NCT02131532|580992977|FG000|Overall Study|Other health conditions|2|||
160890254|NCT01241240|580992978|FG000|Overall Study|Adverse Event|5|||
160890255|NCT01241240|580992979|FG001|Overall Study|Adverse Event|4|||
160890256|NCT01241240|580992978|FG000|Overall Study|Lost to Follow-up|2|||
160890257|NCT01241240|580992979|FG001|Overall Study|Lost to Follow-up|4|||
160890258|NCT01241240|580992978|FG000|Overall Study|Personal Reasons|1|||
160890259|NCT01241240|580992979|FG001|Overall Study|Personal Reasons|1|||
160890260|NCT01369485|580992980|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
160890261|NCT01369485|580992981|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
160890262|NCT01369485|580992980|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
160890263|NCT01369485|580992981|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
160890264|NCT01369485|580992980|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
160890265|NCT01369485|580992981|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
160890266|NCT01369485|580992980|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
160890267|NCT01369485|580992981|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
160890268|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
160890269|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
160890270|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
160890271|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
160890272|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
160890273|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
160890274|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
160890275|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
160890276|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
160890277|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
160890278|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
160890279|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
160890280|NCT02942576|580992982|FG000|Overall Study|Adverse Event|28|||
160890281|NCT02942576|580992983|FG001|Overall Study|Adverse Event|6|||
160890282|NCT02942576|580992982|FG000|Overall Study|Withdrawal by Subject|7|||
160890283|NCT02942576|580992983|FG001|Overall Study|Withdrawal by Subject|5|||
160890284|NCT02942576|580992982|FG000|Overall Study|Physician Decision|1|||
160890285|NCT02942576|580992983|FG001|Overall Study|Physician Decision|4|||
160890286|NCT02942576|580992982|FG000|Overall Study|Other|10|||
160890287|NCT02942576|580992983|FG001|Overall Study|Other|8|||
160890288|NCT00769483|580992984|FG000|Overall Study|Withdrawal by Subject|0|||
160890289|NCT00769483|580992985|FG001|Overall Study|Withdrawal by Subject|1|||
160890290|NCT00769483|580992986|FG002|Overall Study|Withdrawal by Subject|0|||
160890291|NCT00769483|580992987|FG003|Overall Study|Withdrawal by Subject|0|||
160890292|NCT00769483|580992988|FG004|Overall Study|Withdrawal by Subject|1|||
160890293|NCT00769483|580992989|FG005|Overall Study|Withdrawal by Subject|0|||
160890294|NCT01306877|580992990|FG000|Overall Study|Lost to Follow-up|3|||
160890295|NCT01306877|580992991|FG001|Overall Study|Lost to Follow-up|3|||
160890296|NCT01306877|580992990|FG000|Overall Study|Physician Decision|0|||
160890297|NCT01306877|580992991|FG001|Overall Study|Physician Decision|1|||
160890298|NCT00006389|580992992|FG000|Overall Study|Adverse Event|1|||
160890299|NCT01309308|580993000|FG000|Overall Study|Lost to Follow-up|6|||
160890300|NCT01309308|580993001|FG001|Overall Study|Lost to Follow-up|4|||
160890301|NCT00473746|580993002|FG000|Period 1 (Phase 1)|Adverse Event|1|||
160890302|NCT00473746|580993003|FG001|Period 1 (Phase 1)|Adverse Event|0|||
160890303|NCT00473746|580993004|FG002|Period 1 (Phase 1)|Adverse Event|0|||
160890304|NCT00473746|580993005|FG003|Period 1 (Phase 1)|Adverse Event|0|||
160890305|NCT00473746|580993006|FG004|Period 1 (Phase 1)|Adverse Event|0|||
160890306|NCT00473746|580993002|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
160890307|NCT00473746|580993003|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
160890308|NCT00473746|580993004|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
160890309|NCT00473746|580993005|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
160890310|NCT00473746|580993006|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
160890311|NCT00473746|580993002|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
160890312|NCT00473746|580993003|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
160890313|NCT00473746|580993004|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
160890314|NCT00473746|580993005|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
160890315|NCT00473746|580993006|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
160890316|NCT00473746|580993002|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
160890317|NCT00473746|580993003|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
160890318|NCT00473746|580993004|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
160890319|NCT00473746|580993005|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
160890320|NCT00473746|580993006|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
160890321|NCT00473746|580993002|FG000|Period 1 (Phase 1)|Reason not specified|0|||
160890322|NCT00473746|580993003|FG001|Period 1 (Phase 1)|Reason not specified|1|||
160890323|NCT00473746|580993004|FG002|Period 1 (Phase 1)|Reason not specified|0|||
160890324|NCT00473746|580993005|FG003|Period 1 (Phase 1)|Reason not specified|0|||
160890325|NCT00473746|580993006|FG004|Period 1 (Phase 1)|Reason not specified|0|||
160890326|NCT00473746|580993002|FG000|Period 2 (Phase 2)|Adverse Event|0|||
160890327|NCT00473746|580993003|FG001|Period 2 (Phase 2)|Adverse Event|0|||
160890328|NCT00473746|580993004|FG002|Period 2 (Phase 2)|Adverse Event|0|||
160890329|NCT00473746|580993005|FG003|Period 2 (Phase 2)|Adverse Event|0|||
160890330|NCT00473746|580993006|FG004|Period 2 (Phase 2)|Adverse Event|3|||
160890331|NCT00473746|580993002|FG000|Period 2 (Phase 2)|Death|0|||
160890332|NCT00473746|580993003|FG001|Period 2 (Phase 2)|Death|0|||
160890333|NCT00473746|580993004|FG002|Period 2 (Phase 2)|Death|0|||
160890334|NCT00473746|580993005|FG003|Period 2 (Phase 2)|Death|0|||
160890335|NCT00473746|580993006|FG004|Period 2 (Phase 2)|Death|1|||
160890336|NCT00473746|580993002|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
160890337|NCT00473746|580993003|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
160890338|NCT00473746|580993004|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
160890339|NCT00473746|580993005|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
160890340|NCT00473746|580993006|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
160890341|NCT00473746|580993002|FG000|Period 2 (Phase 2)|Reason not specified|0|||
160890342|NCT00473746|580993003|FG001|Period 2 (Phase 2)|Reason not specified|0|||
160890343|NCT00473746|580993004|FG002|Period 2 (Phase 2)|Reason not specified|0|||
160890344|NCT00473746|580993005|FG003|Period 2 (Phase 2)|Reason not specified|0|||
160890345|NCT00473746|580993006|FG004|Period 2 (Phase 2)|Reason not specified|3|||
160890346|NCT01017575|580993009|FG000|Overall Study|Lack of Efficacy|0|||
160890347|NCT01017575|580993010|FG001|Overall Study|Lack of Efficacy|1|||
160890348|NCT01017575|580993011|FG002|Overall Study|Lack of Efficacy|0|||
160890349|NCT01017575|580993012|FG003|Overall Study|Lack of Efficacy|1|||
160890350|NCT01017575|580993013|FG004|Overall Study|Lack of Efficacy|1|||
160890351|NCT01017575|580993009|FG000|Overall Study|Adverse Event|0|||
160890352|NCT01017575|580993010|FG001|Overall Study|Adverse Event|1|||
160890353|NCT01017575|580993011|FG002|Overall Study|Adverse Event|0|||
160890354|NCT01017575|580993012|FG003|Overall Study|Adverse Event|0|||
160890355|NCT01017575|580993013|FG004|Overall Study|Adverse Event|2|||
160890356|NCT01017575|580993009|FG000|Overall Study|Withdrawal by Subject|1|||
160890357|NCT01017575|580993010|FG001|Overall Study|Withdrawal by Subject|0|||
160890358|NCT01017575|580993011|FG002|Overall Study|Withdrawal by Subject|0|||
160890359|NCT01017575|580993012|FG003|Overall Study|Withdrawal by Subject|0|||
160890360|NCT01017575|580993013|FG004|Overall Study|Withdrawal by Subject|0|||
160890361|NCT01962922|580993014|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
160890362|NCT01962922|580993015|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
160890363|NCT01962922|580993014|FG000|PK Portion Day 7|non-compliance|1|||
160890364|NCT01962922|580993015|FG001|PK Portion Day 7|non-compliance|0|||
160890365|NCT01962922|580993014|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
160890366|NCT01962922|580993015|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
160890367|NCT01962922|580993014|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
160890368|NCT01962922|580993015|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
160890369|NCT00976573|580993026|FG000|Overall Study|Ineligible|0|||
160890370|NCT00976573|580993027|FG001|Overall Study|Ineligible|1|||
160890371|NCT00976573|580993026|FG000|Overall Study|Cancel prior to receiving treatment|4|||
160890372|NCT00976573|580993027|FG001|Overall Study|Cancel prior to receiving treatment|2|||
160890373|NCT02730208|580993028|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
160890374|NCT02730208|580993029|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
160890375|NCT00995865|580993034|FG000|Overall Study|Protocol Violation|2|||
160890376|NCT00995865|580993035|FG001|Overall Study|Protocol Violation|0|||
160890377|NCT00995865|580993036|FG002|Overall Study|Protocol Violation|0|||
160890378|NCT00995865|580993034|FG000|Overall Study|Lost to Follow-up|0|||
160890379|NCT00995865|580993035|FG001|Overall Study|Lost to Follow-up|0|||
160890380|NCT00995865|580993036|FG002|Overall Study|Lost to Follow-up|1|||
160890381|NCT02021656|580993042|FG000|Overall Study|Adverse Event|1|||
160890382|NCT02021656|580993042|FG000|Overall Study|Lack of Efficacy|2|||
160890383|NCT02021656|580993042|FG000|Overall Study|Lost to Follow-up|1|||
160890384|NCT02021656|580993042|FG000|Overall Study|Withdrew Consent|2|||
160890385|NCT00510952|580993045|FG000|Overall Study|Adverse Event|1|||
160890386|NCT00510952|580993046|FG001|Overall Study|Adverse Event|0|||
160890387|NCT00510952|580993045|FG000|Overall Study|Entry Criteria Not Met|3|||
160890388|NCT00510952|580993046|FG001|Overall Study|Entry Criteria Not Met|1|||
160546694|NCT00903175|579728147|FG000|Period 2 - Second Line|Administrative problems|19|||
160787905|NCT01898091|580609080|FG001|Overall Study|Lost to Follow-up|1|||
160890389|NCT00510952|580993045|FG000|Overall Study|Lost to Follow-up|5|||
160890390|NCT00510952|580993046|FG001|Overall Study|Lost to Follow-up|3|||
160890391|NCT00510952|580993045|FG000|Overall Study|Physician Decision|1|||
160890392|NCT00510952|580993046|FG001|Overall Study|Physician Decision|1|||
160890393|NCT00510952|580993045|FG000|Overall Study|Protocol Violation|7|||
160890394|NCT00510952|580993046|FG001|Overall Study|Protocol Violation|4|||
160890395|NCT00510952|580993045|FG000|Overall Study|Sponsor Decision|1|||
160890396|NCT00510952|580993046|FG001|Overall Study|Sponsor Decision|0|||
160890397|NCT00510952|580993045|FG000|Overall Study|Withdrawal by Subject|6|||
160890398|NCT00510952|580993046|FG001|Overall Study|Withdrawal by Subject|7|||
160890399|NCT00510952|580993045|FG000|Overall Study|Did Not Receive Study Drug|2|||
160890400|NCT00510952|580993046|FG001|Overall Study|Did Not Receive Study Drug|0|||
160890401|NCT00817479|580993053|FG000|Overall Study|Physician Decision|1|||
160890402|NCT00817479|580993054|FG001|Overall Study|Physician Decision|1|||
160890403|NCT05985980|580993057|FG000|Overall Study|Withdrawal by Subject|1|||
160890404|NCT05985980|580993057|FG000|Overall Study|Withdrawal by Subject|1|||
160890405|NCT05985980|580993057|FG000|Overall Study|Withdrawal by Subject|1|||
160890406|NCT05985980|580993057|FG000|Overall Study|Withdrawal by Subject|1|||
160890407|NCT02359851|580993061|FG000|Overall Study|Death|1|||
160890408|NCT02359851|580993061|FG000|Overall Study|Disease progression|1|||
160890409|NCT00055471|580993062|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
160890410|NCT00055471|580993063|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
160890411|NCT00055471|580993064|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
160890412|NCT00055471|580993062|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
160890413|NCT00055471|580993063|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
160890414|NCT00055471|580993064|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
160890415|NCT00055471|580993062|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
160890416|NCT00055471|580993063|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
160890417|NCT00055471|580993064|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
160890418|NCT01854944|580993065|FG000|Overall Study|Withdrawal by Subject|0|||
160787906|NCT01898091|580609079|FG000|Overall Study|Withdrawal by Subject|1|||
160787907|NCT01898091|580609080|FG001|Overall Study|Withdrawal by Subject|5|||
160787908|NCT03888482|580609083|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
160787909|NCT03888482|580609084|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
160787910|NCT03888482|580609083|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
160787911|NCT03888482|580609084|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
160787912|NCT02294019|580609085|FG000|Overall Study|Adverse Event|2|||
160787913|NCT02294019|580609085|FG000|Overall Study|Protocol Violation|68|||
160787914|NCT02294019|580609085|FG000|Overall Study|Lost to Follow-up|31|||
160787915|NCT02294019|580609085|FG000|Overall Study|Other|1|||
160787916|NCT02294019|580609085|FG000|Overall Study|Withdrawal by Subject|1|||
160787917|NCT01189227|580609087|FG000|Overall Study|Study terminated due to low accrual|6|||
160787918|NCT01189227|580609088|FG001|Overall Study|Study terminated due to low accrual|3|||
160787919|NCT04818086|580609091|FG000|Overall Study|Physician Decision|1|||
160787920|NCT04818086|580609092|FG001|Overall Study|Physician Decision|0|||
160787921|NCT04818086|580609091|FG000|Overall Study|Withdrawal by Subject|0|||
160787922|NCT04818086|580609092|FG001|Overall Study|Withdrawal by Subject|1|||
160787923|NCT04128228|580609094|FG000|Overall Study|Withdrawal by Subject|3|||
160787924|NCT04128228|580609095|FG001|Overall Study|Withdrawal by Subject|3|||
160787925|NCT04128228|580609096|FG002|Overall Study|Withdrawal by Subject|0|||
160787926|NCT04128228|580609097|FG003|Overall Study|Withdrawal by Subject|0|||
160787927|NCT04128228|580609094|FG000|Overall Study|noncompliance|2|||
160787928|NCT04128228|580609095|FG001|Overall Study|noncompliance|2|||
160787929|NCT04128228|580609096|FG002|Overall Study|noncompliance|0|||
160787930|NCT04128228|580609097|FG003|Overall Study|noncompliance|0|||
160787931|NCT01016015|580609098|FG000|Overall Study|Not Treated|3|||
160787932|NCT01016015|580609098|FG000|Overall Study|Withdrawal by Subject|1|||
160787933|NCT01016015|580609098|FG000|Overall Study|Adverse Event|15|||
160787934|NCT03163264|580609099|FG000|Overall Study|Withdrawal by Subject|13|||
160787935|NCT03163264|580609100|FG001|Overall Study|Withdrawal by Subject|3|||
160787936|NCT03163264|580609101|FG002|Overall Study|Withdrawal by Subject|4|||
160787937|NCT03163264|580609102|FG003|Overall Study|Withdrawal by Subject|2|||
160787938|NCT03163264|580609099|FG000|Overall Study|Lost to Follow-up|17|||
160787939|NCT03163264|580609100|FG001|Overall Study|Lost to Follow-up|20|||
160787940|NCT03163264|580609101|FG002|Overall Study|Lost to Follow-up|0|||
160787941|NCT03163264|580609102|FG003|Overall Study|Lost to Follow-up|0|||
160787942|NCT03163264|580609099|FG000|Overall Study|Death|0|||
160787943|NCT03163264|580609100|FG001|Overall Study|Death|2|||
160787944|NCT03163264|580609101|FG002|Overall Study|Death|0|||
160787945|NCT03163264|580609102|FG003|Overall Study|Death|0|||
160787946|NCT00362609|580609108|FG000|Overall Study|Withdrawal by Subject|0|||
160787947|NCT00362609|580609109|FG001|Overall Study|Withdrawal by Subject|1|||
160787948|NCT00362609|580609108|FG000|Overall Study|Protocol Violation|0|||
160787949|NCT00362609|580609109|FG001|Overall Study|Protocol Violation|1|||
160546695|NCT00903175|579728148|FG001|Period 2 - Second Line|Administrative problems|9|||
160546696|NCT00903175|579728147|FG000|Period 2 - Second Line|Death|5|||
160546697|NCT00903175|579728148|FG001|Period 2 - Second Line|Death|2|||
160546698|NCT03074474|579728149|FG000|Overall Study|Lost to Follow-up|10|||
160546699|NCT03074474|579728149|FG000|Overall Study|Withdrawal by Subject|10|||
160546700|NCT03074474|579728149|FG000|Overall Study|Death|4|||
160546701|NCT03074474|579728149|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
160546702|NCT05073458|579728161|FG000|24-week Double-blind Period|Adverse Event|1|||
160546703|NCT05073458|579728162|FG001|24-week Double-blind Period|Adverse Event|0|||
160546704|NCT05073458|579728161|FG000|24-week Double-blind Period|Physician Decision|1|||
160546705|NCT05073458|579728162|FG001|24-week Double-blind Period|Physician Decision|0|||
160546706|NCT05073458|579728161|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
160546707|NCT05073458|579728162|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
160546708|NCT05073458|579728161|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
160546709|NCT05073458|579728162|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
160546710|NCT05073458|579728161|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
160546711|NCT05073458|579728162|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
160546712|NCT05073458|579728161|FG000|24-week Open-label Period|Adverse Event|1|||
160546713|NCT05073458|579728162|FG001|24-week Open-label Period|Adverse Event|2|||
160546714|NCT05103332|579728170|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546715|NCT05103332|579728171|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
160546716|NCT05103332|579728172|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
160546717|NCT05103332|579728173|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546718|NCT05103332|579728174|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546719|NCT05103332|579728175|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
160546720|NCT05103332|579728176|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546721|NCT05103332|579728177|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160787950|NCT02205359|580609110|FG000|Overall Study|Death|293|||
160787951|NCT02205359|580609111|FG001|Overall Study|Death|327|||
160787952|NCT02205359|580609110|FG000|Overall Study|Lost to Follow-up|182|||
160787953|NCT02205359|580609111|FG001|Overall Study|Lost to Follow-up|162|||
160787954|NCT02205359|580609110|FG000|Overall Study|Physician Decision|51|||
160787955|NCT02205359|580609111|FG001|Overall Study|Physician Decision|53|||
160787956|NCT02205359|580609110|FG000|Overall Study|Withdrawal by Subject|167|||
160787957|NCT02205359|580609111|FG001|Overall Study|Withdrawal by Subject|169|||
160787958|NCT00236197|580609112|FG000|Overall Study|Withdrawal by Subject|3|||
160787959|NCT00236197|580609113|FG001|Overall Study|Withdrawal by Subject|2|||
160787960|NCT00236197|580609112|FG000|Overall Study|Lost to Follow-up|1|||
160787961|NCT00236197|580609113|FG001|Overall Study|Lost to Follow-up|5|||
160787962|NCT00236197|580609112|FG000|Overall Study|Protocol Violation|0|||
160787963|NCT00236197|580609113|FG001|Overall Study|Protocol Violation|3|||
160787964|NCT00236197|580609112|FG000|Overall Study|Medication non-compliance|1|||
160787965|NCT00236197|580609113|FG001|Overall Study|Medication non-compliance|2|||
160787966|NCT00236197|580609112|FG000|Overall Study|Other|0|||
160787967|NCT00236197|580609113|FG001|Overall Study|Other|2|||
160787968|NCT00480025|580609114|FG000|Overall Study|Protocol Violation|12|||
160787969|NCT00480025|580609115|FG001|Overall Study|Protocol Violation|7|||
160787970|NCT00480025|580609114|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
160787971|NCT00480025|580609115|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
160787972|NCT00480025|580609114|FG000|Overall Study|Disease Progression / Recurrence|449|||
160787973|NCT00480025|580609115|FG001|Overall Study|Disease Progression / Recurrence|224|||
160787974|NCT00480025|580609114|FG000|Overall Study|Adverse Event|44|||
160787975|NCT00480025|580609115|FG001|Overall Study|Adverse Event|12|||
160787976|NCT00480025|580609114|FG000|Overall Study|Other|70|||
160787977|NCT00480025|580609115|FG001|Overall Study|Other|29|||
160787978|NCT00480025|580609114|FG000|Overall Study|SAE including intercurrent illness|76|||
160787979|NCT00480025|580609115|FG001|Overall Study|SAE including intercurrent illness|42|||
160787980|NCT03760666|580609116|FG000|Overall Study|Adverse Event|2|||
160787981|NCT03760666|580609117|FG001|Overall Study|Adverse Event|4|||
160787982|NCT03760666|580609118|FG002|Overall Study|Adverse Event|1|||
160787983|NCT03760666|580609116|FG000|Overall Study|AML Disease Progression|3|||
160787984|NCT03760666|580609117|FG001|Overall Study|AML Disease Progression|3|||
160787985|NCT03760666|580609118|FG002|Overall Study|AML Disease Progression|0|||
160787986|NCT03760666|580609116|FG000|Overall Study|Physician Decision|0|||
160787987|NCT03760666|580609117|FG001|Overall Study|Physician Decision|3|||
160787988|NCT03760666|580609118|FG002|Overall Study|Physician Decision|0|||
160787989|NCT03760666|580609116|FG000|Overall Study|Withdrawal by Subject|0|||
160787990|NCT03760666|580609117|FG001|Overall Study|Withdrawal by Subject|1|||
160787991|NCT03760666|580609118|FG002|Overall Study|Withdrawal by Subject|0|||
160787992|NCT01800058|580609124|FG000|Overall Study|Lost to Follow-up|1|||
160787993|NCT03810365|580610773|FG000|Overall Study|Lost to Follow-up|2|||
160787994|NCT03810365|580610774|FG001|Overall Study|Lost to Follow-up|2|||
160787995|NCT03810365|580610773|FG000|Overall Study|Withdrawal by Subject|4|||
160787996|NCT03810365|580610774|FG001|Overall Study|Withdrawal by Subject|5|||
160890419|NCT01854944|580993066|FG001|Overall Study|Withdrawal by Subject|0|||
160890420|NCT01854944|580993067|FG002|Overall Study|Withdrawal by Subject|1|||
160890421|NCT00282347|580993070|FG000|Treatment Period|Death|2|||
160890422|NCT00282347|580993071|FG001|Treatment Period|Death|0|||
160890423|NCT00282347|580993070|FG000|Treatment Period|Lost to Follow-up|2|||
160890424|NCT00282347|580993071|FG001|Treatment Period|Lost to Follow-up|5|||
160890425|NCT00282347|580993070|FG000|Treatment Period|Withdrawal by Subject|1|||
160890426|NCT00282347|580993071|FG001|Treatment Period|Withdrawal by Subject|3|||
160890427|NCT00282347|580993070|FG000|Treatment Period|Physician Decision|0|||
160890428|NCT00282347|580993071|FG001|Treatment Period|Physician Decision|1|||
160890429|NCT00282347|580993070|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
160890430|NCT00282347|580993071|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
160890431|NCT00282347|580993070|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
160890432|NCT00282347|580993071|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
160890433|NCT00282347|580993070|FG000|Safety Follow-up Period|Physician Decision|1|||
160890434|NCT00282347|580993071|FG001|Safety Follow-up Period|Physician Decision|1|||
160890435|NCT00282347|580993070|FG000|Safety Follow-up Period|Protocol Deviation|0|||
160890436|NCT00282347|580993071|FG001|Safety Follow-up Period|Protocol Deviation|2|||
160890437|NCT00282347|580993070|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
160890438|NCT00282347|580993071|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
160890439|NCT00282347|580993070|FG000|B Cell Follow-up Period|Physician Decision|1|||
160890440|NCT00282347|580993071|FG001|B Cell Follow-up Period|Physician Decision|0|||
160890441|NCT00282347|580993070|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
160890442|NCT00282347|580993071|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
160890443|NCT02101112|580993072|FG000|Overall Study|Adverse Event|0|||
160890444|NCT02101112|580993073|FG001|Overall Study|Adverse Event|0|||
160890445|NCT02101112|580993074|FG002|Overall Study|Adverse Event|1|||
160890446|NCT02101112|580993075|FG003|Overall Study|Adverse Event|0|||
160890447|NCT02101112|580993076|FG004|Overall Study|Adverse Event|0|||
160890448|NCT02101112|580993077|FG005|Overall Study|Adverse Event|0|||
160890449|NCT02101112|580993072|FG000|Overall Study|Withdrawal by Subject|0|||
160890450|NCT02101112|580993073|FG001|Overall Study|Withdrawal by Subject|0|||
160890451|NCT02101112|580993074|FG002|Overall Study|Withdrawal by Subject|0|||
160890452|NCT02101112|580993075|FG003|Overall Study|Withdrawal by Subject|0|||
160890453|NCT02101112|580993076|FG004|Overall Study|Withdrawal by Subject|1|||
160890454|NCT02101112|580993077|FG005|Overall Study|Withdrawal by Subject|0|||
160890455|NCT04340063|580993078|FG000|Overall Study|Withdrawal by Subject|1|||
160890456|NCT04340063|580993079|FG001|Overall Study|Withdrawal by Subject|2|||
160890457|NCT04340063|580993078|FG000|Overall Study|Lost to Follow-up|3|||
160890458|NCT04340063|580993079|FG001|Overall Study|Lost to Follow-up|1|||
160890459|NCT04340063|580993078|FG000|Overall Study|Protocol Violation|0|||
160890460|NCT04340063|580993079|FG001|Overall Study|Protocol Violation|1|||
160890461|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
160890462|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
160890463|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
160890464|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
160890465|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
160890466|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
160890467|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
160890468|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
160787997|NCT02255279|580610775|FG000|Overall Study|Lost to Follow-up|2|||
160787998|NCT02255279|580610776|FG001|Overall Study|Lost to Follow-up|2|||
160787999|NCT02255279|580610775|FG000|Overall Study|Protocol Violation|0|||
160788000|NCT02255279|580610776|FG001|Overall Study|Protocol Violation|1|||
160788001|NCT02255279|580610775|FG000|Overall Study|Withdrawal by Subject|3|||
160788002|NCT02255279|580610776|FG001|Overall Study|Withdrawal by Subject|6|||
160788003|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
160890469|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
160890470|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
160890471|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
160890472|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
160890473|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
160890474|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
160890475|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
160890476|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
160890477|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
160890478|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
160890479|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
160890480|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
160890481|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
160890482|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
160890483|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
160890484|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
160890485|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
160890486|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
160890487|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
160890488|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
160890489|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
160890490|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
160890491|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
160890492|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
160890493|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
160890494|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
160890495|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
160890496|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
160890497|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
160890498|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
160890499|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
160890500|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
160890501|NCT00782795|580993084|FG000|Overall Study|Withdrawal by Subject|1|||
160890502|NCT00782795|580993085|FG001|Overall Study|Withdrawal by Subject|2|||
160890503|NCT02782923|580993086|FG000|Overall Study|Lost to Follow-up|15|||
160890504|NCT00993044|580993087|FG000|Irinotecan 50 mg|Physician Decision|1|||
160890505|NCT00734747|580993089|FG000|SRS Procedure|No staples placed|3|||
160890506|NCT00734747|580993089|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
160890507|NCT05063318|580993095|FG000|Overall Study|Progressive disease|2|||
160890508|NCT05063318|580993096|FG001|Overall Study|Progressive disease|0|||
160890509|NCT05063318|580993097|FG002|Overall Study|Progressive disease|3|||
160890510|NCT05063318|580993095|FG000|Overall Study|Compassionate use|1|||
160890511|NCT05063318|580993096|FG001|Overall Study|Compassionate use|3|||
160890512|NCT05063318|580993097|FG002|Overall Study|Compassionate use|3|||
160890513|NCT05063318|580993095|FG000|Overall Study|Adverse Event|0|||
160890514|NCT05063318|580993096|FG001|Overall Study|Adverse Event|1|||
160890515|NCT05063318|580993097|FG002|Overall Study|Adverse Event|0|||
160890516|NCT05063318|580993095|FG000|Overall Study|Withdrawal by Subject|0|||
160890517|NCT05063318|580993096|FG001|Overall Study|Withdrawal by Subject|1|||
160890518|NCT05063318|580993097|FG002|Overall Study|Withdrawal by Subject|0|||
160788004|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
160788005|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
160788006|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
160546722|NCT05103332|579728178|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546723|NCT05103332|579728179|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546724|NCT05103332|579728180|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546725|NCT05103332|579728181|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546726|NCT05103332|579728182|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546727|NCT05103332|579728183|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546728|NCT05103332|579728184|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160890519|NCT03287635|580993098|FG000|Overall Study|Lost to Follow-up|5|||
160890520|NCT03287635|580993098|FG000|Overall Study|Withdrawal by Subject|1|||
160890521|NCT03287635|580993098|FG000|Overall Study|Physician Decision|1|||
160890522|NCT00920829|580995081|FG000|Allocation|No post randomization data|3|||
160890523|NCT00920829|580995082|FG001|Allocation|No post randomization data|1|||
160890524|NCT00920829|580995083|FG002|Allocation|No post randomization data|0|||
160890525|NCT00920829|580995084|FG003|Allocation|No post randomization data|2|||
160890526|NCT00920829|580995081|FG000|Available for Analysis|Withdrawal by Subject|6|||
160890527|NCT00920829|580995082|FG001|Available for Analysis|Withdrawal by Subject|6|||
160890528|NCT00920829|580995083|FG002|Available for Analysis|Withdrawal by Subject|6|||
160890529|NCT00920829|580995084|FG003|Available for Analysis|Withdrawal by Subject|10|||
160890530|NCT00920829|580995081|FG000|Available for Analysis|Required Medical Treatment|0|||
160890531|NCT00920829|580995082|FG001|Available for Analysis|Required Medical Treatment|1|||
160890532|NCT00920829|580995083|FG002|Available for Analysis|Required Medical Treatment|2|||
160890533|NCT00920829|580995084|FG003|Available for Analysis|Required Medical Treatment|0|||
160890534|NCT00920829|580995081|FG000|Available for Analysis|Adverse Event|1|||
160890535|NCT00920829|580995082|FG001|Available for Analysis|Adverse Event|2|||
160890536|NCT00920829|580995083|FG002|Available for Analysis|Adverse Event|1|||
160890537|NCT00920829|580995084|FG003|Available for Analysis|Adverse Event|0|||
160890538|NCT00920829|580995081|FG000|Available for Analysis|Death|1|||
160890539|NCT00920829|580995082|FG001|Available for Analysis|Death|0|||
160890540|NCT00920829|580995083|FG002|Available for Analysis|Death|0|||
160890541|NCT00920829|580995084|FG003|Available for Analysis|Death|0|||
160890542|NCT00920829|580995081|FG000|Available for Analysis|Protocol Violation|0|||
160890543|NCT00920829|580995082|FG001|Available for Analysis|Protocol Violation|0|||
160890544|NCT00920829|580995083|FG002|Available for Analysis|Protocol Violation|1|||
160890545|NCT00920829|580995084|FG003|Available for Analysis|Protocol Violation|0|||
160890546|NCT00920829|580995081|FG000|Available for Analysis|Required more treatment|0|||
160890547|NCT00920829|580995082|FG001|Available for Analysis|Required more treatment|2|||
160890548|NCT00920829|580995083|FG002|Available for Analysis|Required more treatment|0|||
160890549|NCT00920829|580995084|FG003|Available for Analysis|Required more treatment|1|||
160890550|NCT03875118|580995085|FG000|Overall Study|Withdrawal by Subject|4|||
160890551|NCT03875118|580995086|FG001|Overall Study|Withdrawal by Subject|4|||
160890552|NCT02237911|580995087|FG000|Overall Study|Withdrawal by Subject|4|||
160890553|NCT02237911|580995088|FG001|Overall Study|Withdrawal by Subject|7|||
160890554|NCT02237911|580995089|FG002|Overall Study|Withdrawal by Subject|2|||
160890555|NCT02237911|580995087|FG000|Overall Study|Lost to Follow-up|3|||
160890556|NCT02237911|580995088|FG001|Overall Study|Lost to Follow-up|1|||
160890557|NCT02237911|580995089|FG002|Overall Study|Lost to Follow-up|1|||
160890558|NCT03468985|580995090|FG000|Overall Study|Adverse Event|0|||
160890559|NCT03468985|580995091|FG001|Overall Study|Adverse Event|2|||
160890560|NCT03468985|580995092|FG002|Overall Study|Adverse Event|0|||
160890561|NCT03468985|580995093|FG003|Overall Study|Adverse Event|0|||
160890562|NCT03468985|580995090|FG000|Overall Study|Withdrawal by Subject|0|||
160890563|NCT03468985|580995091|FG001|Overall Study|Withdrawal by Subject|0|||
160890564|NCT03468985|580995092|FG002|Overall Study|Withdrawal by Subject|0|||
160890565|NCT03468985|580995093|FG003|Overall Study|Withdrawal by Subject|1|||
160890566|NCT03981822|580995094|FG000|Overall Study|Lost to Follow-up|0|||
160890567|NCT03981822|580995095|FG001|Overall Study|Lost to Follow-up|1|||
160890568|NCT03981822|580995096|FG002|Overall Study|Lost to Follow-up|1|||
160890569|NCT03981822|580995097|FG003|Overall Study|Lost to Follow-up|0|||
160890570|NCT03981822|580995098|FG004|Overall Study|Lost to Follow-up|6|||
160890571|NCT03981822|580995099|FG005|Overall Study|Lost to Follow-up|4|||
160890572|NCT03981822|580995100|FG006|Overall Study|Lost to Follow-up|4|||
160890573|NCT03981822|580995101|FG007|Overall Study|Lost to Follow-up|2|||
160890574|NCT03981822|580995094|FG000|Overall Study|Withdrawal by Subject|0|||
160890575|NCT03981822|580995095|FG001|Overall Study|Withdrawal by Subject|1|||
160546729|NCT05103332|579728185|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160890576|NCT03981822|580995096|FG002|Overall Study|Withdrawal by Subject|0|||
160890577|NCT03981822|580995097|FG003|Overall Study|Withdrawal by Subject|0|||
160890578|NCT03981822|580995098|FG004|Overall Study|Withdrawal by Subject|0|||
160890579|NCT03981822|580995099|FG005|Overall Study|Withdrawal by Subject|1|||
160890580|NCT03981822|580995100|FG006|Overall Study|Withdrawal by Subject|0|||
160890581|NCT03981822|580995101|FG007|Overall Study|Withdrawal by Subject|2|||
160890582|NCT03981822|580995094|FG000|Overall Study|COVID-19 Related|0|||
160890583|NCT03981822|580995095|FG001|Overall Study|COVID-19 Related|0|||
160890584|NCT03981822|580995096|FG002|Overall Study|COVID-19 Related|0|||
160890585|NCT03981822|580995097|FG003|Overall Study|COVID-19 Related|0|||
160890586|NCT03981822|580995098|FG004|Overall Study|COVID-19 Related|2|||
160890587|NCT03981822|580995099|FG005|Overall Study|COVID-19 Related|1|||
160890588|NCT03981822|580995100|FG006|Overall Study|COVID-19 Related|2|||
160890589|NCT03981822|580995101|FG007|Overall Study|COVID-19 Related|1|||
160890590|NCT00397943|580995102|FG000|Overall Study|Unspecified reasons|12|||
160890591|NCT00397943|580995103|FG001|Overall Study|Unspecified reasons|9|||
160890592|NCT00397943|580995104|FG002|Overall Study|Unspecified reasons|0|||
160890593|NCT00397943|580995105|FG003|Overall Study|Unspecified reasons|0|||
160890594|NCT00397943|580995106|FG004|Overall Study|Unspecified reasons|0|||
160890595|NCT04521777|580995108|FG000|Overall Study|Death|2|||
160890596|NCT04521777|580995108|FG000|Overall Study|Withdrawal by Subject|2|||
160890597|NCT02376829|580995116|FG000|Overall Study|Withdrawal by Subject|27|||
160890598|NCT02376829|580995117|FG001|Overall Study|Withdrawal by Subject|44|||
160890599|NCT00057954|580995118|FG000|Overall Study|Death|1|||
160890600|NCT00057954|580995118|FG000|Overall Study|Disease progression|1|||
160890601|NCT01251744|580995119|FG000|Overall Study|Lost to Follow-up|1|||
160890602|NCT01251744|580995120|FG001|Overall Study|Lost to Follow-up|0|||
160890603|NCT03170232|580995121|FG000|Overall Study|Adverse Event|0|||
160890604|NCT03170232|580995122|FG001|Overall Study|Adverse Event|1|||
160890605|NCT03170232|580995121|FG000|Overall Study|Protocol Violation|0|||
160890606|NCT03170232|580995122|FG001|Overall Study|Protocol Violation|1|||
160890607|NCT03170232|580995121|FG000|Overall Study|Lack of Efficacy|0|||
160890608|NCT03170232|580995122|FG001|Overall Study|Lack of Efficacy|1|||
160890609|NCT03170232|580995121|FG000|Overall Study|Study closed/terminated|26|||
160890610|NCT03170232|580995122|FG001|Overall Study|Study closed/terminated|23|||
160890611|NCT03170232|580995121|FG000|Overall Study|Lost to Follow-up|1|||
160890612|NCT03170232|580995122|FG001|Overall Study|Lost to Follow-up|0|||
160890613|NCT03170232|580995121|FG000|Overall Study|Withdrawal by Subject|0|||
160890614|NCT03170232|580995122|FG001|Overall Study|Withdrawal by Subject|1|||
160890615|NCT02663687|580995123|FG000|Overall Study|Adverse Event|1|||
160890616|NCT02663687|580995124|FG001|Overall Study|Adverse Event|0|||
160890617|NCT02663687|580995125|FG002|Overall Study|Adverse Event|0|||
160890618|NCT02663687|580995126|FG003|Overall Study|Adverse Event|0|||
160890619|NCT02663687|580995127|FG004|Overall Study|Adverse Event|0|||
160890620|NCT02663687|580995123|FG000|Overall Study|Other|1|||
160890621|NCT02663687|580995124|FG001|Overall Study|Other|0|||
160890622|NCT02663687|580995125|FG002|Overall Study|Other|1|||
160890623|NCT02663687|580995126|FG003|Overall Study|Other|0|||
160890624|NCT02663687|580995127|FG004|Overall Study|Other|0|||
160890625|NCT01323946|580995128|FG000|Overall Study|Lost to Follow-up|0|||
160890626|NCT01323946|580995129|FG001|Overall Study|Lost to Follow-up|1|||
160890627|NCT01323946|580995130|FG002|Overall Study|Lost to Follow-up|0|||
160890628|NCT01323946|580995128|FG000|Overall Study|Parents refused the last blood draw|1|||
160890629|NCT01323946|580995129|FG001|Overall Study|Parents refused the last blood draw|0|||
160890630|NCT01323946|580995130|FG002|Overall Study|Parents refused the last blood draw|0|||
160890631|NCT01323946|580995128|FG000|Overall Study|Withdrawal by Subject|2|||
160890632|NCT01323946|580995129|FG001|Overall Study|Withdrawal by Subject|2|||
160890633|NCT01323946|580995130|FG002|Overall Study|Withdrawal by Subject|0|||
160890634|NCT03583073|580995131|FG000|Overall Study|Lost to Follow-up|8|||
160890635|NCT03583073|580995132|FG001|Overall Study|Lost to Follow-up|12|||
160890636|NCT03189381|580995136|FG000|Overall Study|Death|1|||
160890637|NCT03189381|580995137|FG001|Overall Study|Death|0|||
160890638|NCT00107952|580995138|FG000|Overall Study|Death|75|||
160890639|NCT00107952|580995139|FG001|Overall Study|Death|61|||
160890640|NCT00107952|580995138|FG000|Overall Study|Lost to Follow-up|0|||
160890641|NCT00107952|580995139|FG001|Overall Study|Lost to Follow-up|3|||
160890642|NCT00107952|580995138|FG000|Overall Study|Withdrawal by Subject|9|||
160890643|NCT00107952|580995139|FG001|Overall Study|Withdrawal by Subject|6|||
160890644|NCT00107952|580995138|FG000|Overall Study|Other|2|||
160890645|NCT00107952|580995139|FG001|Overall Study|Other|5|||
160890646|NCT00107952|580995138|FG000|Overall Study|Never received study treatment|9|||
160890647|NCT00107952|580995139|FG001|Overall Study|Never received study treatment|6|||
160890648|NCT00251004|580995140|FG000|Overall Study|Withdrawal by Subject|23|||
160890649|NCT00251004|580995141|FG001|Overall Study|Withdrawal by Subject|16|||
160890650|NCT00251004|580995142|FG002|Overall Study|Withdrawal by Subject|14|||
160890651|NCT00251004|580995140|FG000|Overall Study|Death|9|||
160890652|NCT00251004|580995141|FG001|Overall Study|Death|10|||
160890653|NCT00251004|580995142|FG002|Overall Study|Death|8|||
160890654|NCT00251004|580995140|FG000|Overall Study|Lost to Follow-up|1|||
160890655|NCT00251004|580995141|FG001|Overall Study|Lost to Follow-up|2|||
160890656|NCT00251004|580995142|FG002|Overall Study|Lost to Follow-up|1|||
160890657|NCT00251004|580995140|FG000|Overall Study|Graft Loss|12|||
160890658|NCT00251004|580995141|FG001|Overall Study|Graft Loss|13|||
160890659|NCT00251004|580995142|FG002|Overall Study|Graft Loss|8|||
160890660|NCT00887744|580995143|FG000|Overall Study|Adverse Event|3|||
160890661|NCT00887744|580995143|FG000|Overall Study|Death|1|||
160890662|NCT00887744|580995143|FG000|Overall Study|Lost to Follow-up|3|||
160890663|NCT00887744|580995143|FG000|Overall Study|Withdrawal by Subject|18|||
160890664|NCT00887744|580995143|FG000|Overall Study|Various reasons|9|||
160890665|NCT01569464|580995144|FG000|Overall Study|Adverse Event|4|||
160890666|NCT01569464|580995145|FG001|Overall Study|Adverse Event|0|||
160890667|NCT01569464|580995144|FG000|Overall Study|Lack of Efficacy|1|||
160890668|NCT01569464|580995145|FG001|Overall Study|Lack of Efficacy|0|||
160890669|NCT01569464|580995144|FG000|Overall Study|Protocol Violation|1|||
160890670|NCT01569464|580995145|FG001|Overall Study|Protocol Violation|0|||
160890671|NCT01569464|580995144|FG000|Overall Study|Lost to Follow-up|2|||
160890672|NCT01569464|580995145|FG001|Overall Study|Lost to Follow-up|3|||
160890673|NCT01569464|580995144|FG000|Overall Study|Withdrawal by Subject|1|||
160890674|NCT01569464|580995145|FG001|Overall Study|Withdrawal by Subject|1|||
160890675|NCT01569464|580995144|FG000|Overall Study|Other|1|||
160890676|NCT01569464|580995145|FG001|Overall Study|Other|1|||
160890677|NCT04025710|580995151|FG000|Overall Study|Death|3|||
160890678|NCT04025710|580995151|FG000|Overall Study|Lost to Follow-up|5|||
160890679|NCT04025710|580995151|FG000|Overall Study|Withdrawal by Subject|1|||
160890680|NCT04025710|580995151|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
160890681|NCT04025710|580995151|FG000|Overall Study|Drop-out according to protocol|34|||
160890682|NCT03533686|580995154|FG000|Overall Study|Withdrawal by Subject|1|||
160890683|NCT03533686|580995155|FG001|Overall Study|Withdrawal by Subject|0|||
160890684|NCT03533686|580995156|FG002|Overall Study|Withdrawal by Subject|0|||
160890685|NCT03533686|580995157|FG003|Overall Study|Withdrawal by Subject|3|||
160890686|NCT03533686|580995158|FG004|Overall Study|Withdrawal by Subject|5|||
160890687|NCT03533686|580995159|FG005|Overall Study|Withdrawal by Subject|1|||
160890688|NCT03533686|580995154|FG000|Overall Study|Lost to Follow-up|0|||
160890689|NCT03533686|580995155|FG001|Overall Study|Lost to Follow-up|1|||
160890690|NCT03533686|580995156|FG002|Overall Study|Lost to Follow-up|0|||
160890691|NCT03533686|580995157|FG003|Overall Study|Lost to Follow-up|0|||
160890692|NCT03533686|580995158|FG004|Overall Study|Lost to Follow-up|2|||
160890693|NCT03533686|580995159|FG005|Overall Study|Lost to Follow-up|0|||
160890694|NCT03533686|580995154|FG000|Overall Study|Screen Failure|0|||
160890695|NCT03533686|580995155|FG001|Overall Study|Screen Failure|0|||
160890696|NCT03533686|580995156|FG002|Overall Study|Screen Failure|0|||
160890697|NCT03533686|580995157|FG003|Overall Study|Screen Failure|2|||
160890698|NCT03533686|580995158|FG004|Overall Study|Screen Failure|0|||
160890699|NCT03533686|580995159|FG005|Overall Study|Screen Failure|0|||
160890700|NCT02632838|580995160|FG000|Overall Study|Withdrawal by Subject|3|||
160890701|NCT02632838|580995161|FG001|Overall Study|Withdrawal by Subject|0|||
160890702|NCT02632838|580995160|FG000|Overall Study|Lost to Follow-up|0|||
160890703|NCT02632838|580995161|FG001|Overall Study|Lost to Follow-up|2|||
160890704|NCT01343901|580995162|FG000|Overall Study|Death|85|||
160890705|NCT01343901|580995162|FG000|Overall Study|Physician Decision|4|||
160890706|NCT01343901|580995162|FG000|Overall Study|Lost to Follow-up|12|||
160890707|NCT01343901|580995162|FG000|Overall Study|Management by another medical team|11|||
160890708|NCT01343901|580995162|FG000|Overall Study|Participant decision|1|||
160890709|NCT03945175|580995163|FG000|Overall Study|Did not meet inclusion criteria|31|||
160890710|NCT03945175|580995163|FG000|Overall Study|Withdrew consent|2|||
160890711|NCT03945175|580995163|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
160890712|NCT03945175|580995163|FG000|Overall Study|Early termination during Mydayis treatment|1|||
160890713|NCT00870233|580995167|FG000|Overall Study|Withdrawal by Subject|18|||
160890714|NCT00870233|580995167|FG000|Overall Study|Did not undergo laparotomy|3|||
160890715|NCT00870233|580995167|FG000|Overall Study|Incompatible internet browser|2|||
160890716|NCT00870233|580995167|FG000|Overall Study|Death|1|||
160890717|NCT03370289|580995172|FG000|Overall Study|Screen Failure|1|||
160890718|NCT03370289|580995172|FG000|Overall Study|Sample Size Sufficient|4|||
160890719|NCT05308290|580995189|FG000|Overall Study|Death|1|||
160890720|NCT05308290|580995190|FG001|Overall Study|Death|0|||
160890721|NCT05308290|580995189|FG000|Overall Study|Lost to Follow-up|2|||
160890722|NCT05308290|580995190|FG001|Overall Study|Lost to Follow-up|1|||
160890723|NCT05308290|580995189|FG000|Overall Study|still in study followup|0|||
160890724|NCT05308290|580995190|FG001|Overall Study|still in study followup|1|||
160890725|NCT01285960|580995191|FG000|Overall Study|Withdrawal by Subject|2|||
160890726|NCT01285960|580995191|FG000|Overall Study|Lost to Follow-up|2|||
160890727|NCT01285960|580995191|FG000|Overall Study|2 subjects received less 10 sonications|2|||
160890728|NCT03500679|580995192|FG000|Overall Study|Lost to Follow-up|6|||
160890729|NCT03500679|580995193|FG001|Overall Study|Lost to Follow-up|3|||
160890730|NCT03500679|580995192|FG000|Overall Study|Withdrawal by Subject|3|||
160890731|NCT03500679|580995193|FG001|Overall Study|Withdrawal by Subject|0|||
160890732|NCT04706416|580995194|FG000|Overall Study|Lost to Follow-up|2|||
160890733|NCT04706416|580995195|FG001|Overall Study|Lost to Follow-up|0|||
160890734|NCT01484054|580995196|FG000|Period 1|Withdrawal by Subject|0|||
160890735|NCT01484054|580995197|FG001|Period 1|Withdrawal by Subject|1|||
160890736|NCT02117427|580995200|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
160890737|NCT02117427|580995201|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
160890738|NCT02117427|580995202|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
160890739|NCT02117427|580995200|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
160890740|NCT02117427|580995201|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
160788007|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
160788008|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
160788009|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
160788010|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
160788011|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
160890741|NCT02117427|580995202|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
160890742|NCT02117427|580995200|FG000|Overall Study|Physician Decision|0|||
160890743|NCT02117427|580995201|FG001|Overall Study|Physician Decision|2|||
160890744|NCT02117427|580995202|FG002|Overall Study|Physician Decision|0|||
160890745|NCT02117427|580995200|FG000|Overall Study|No longer meets inclusion criteria|0|||
160890746|NCT02117427|580995201|FG001|Overall Study|No longer meets inclusion criteria|1|||
160890747|NCT02117427|580995202|FG002|Overall Study|No longer meets inclusion criteria|0|||
160890748|NCT02117427|580995200|FG000|Overall Study|Death|0|||
160890749|NCT02117427|580995201|FG001|Overall Study|Death|1|||
160890750|NCT02117427|580995202|FG002|Overall Study|Death|0|||
160890751|NCT05281601|580995203|FG000|Overall Study|Physician Decision|2|||
160890752|NCT05281601|580995204|FG001|Overall Study|Physician Decision|0|||
160890753|NCT05281601|580995203|FG000|Overall Study|Lost to Follow-up|2|||
160890754|NCT05281601|580995204|FG001|Overall Study|Lost to Follow-up|0|||
160890755|NCT05281601|580995203|FG000|Overall Study|Death|1|||
160890756|NCT05281601|580995204|FG001|Overall Study|Death|0|||
160890757|NCT05281601|580995203|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160890758|NCT05281601|580995204|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160890759|NCT00410202|580995208|FG000|On-Treatment|Continuing treatment|69|||
160890760|NCT00410202|580995209|FG001|On-Treatment|Continuing treatment|71|||
160890761|NCT00410202|580995210|FG002|On-Treatment|Continuing treatment|66|||
160890762|NCT00410202|580995208|FG000|On-Treatment|Adverse Event|1|||
160890763|NCT00410202|580995209|FG001|On-Treatment|Adverse Event|3|||
160890764|NCT00410202|580995210|FG002|On-Treatment|Adverse Event|2|||
160890765|NCT00410202|580995208|FG000|On-Treatment|Death|1|||
160890766|NCT00410202|580995209|FG001|On-Treatment|Death|0|||
160890767|NCT00410202|580995210|FG002|On-Treatment|Death|0|||
160890768|NCT00410202|580995208|FG000|On-Treatment|Lost to Follow-up|1|||
160890769|NCT00410202|580995209|FG001|On-Treatment|Lost to Follow-up|0|||
160890770|NCT00410202|580995210|FG002|On-Treatment|Lost to Follow-up|1|||
160890771|NCT00410202|580995208|FG000|On-Treatment|Lack of Efficacy|1|||
160890772|NCT00410202|580995209|FG001|On-Treatment|Lack of Efficacy|4|||
160890773|NCT00410202|580995210|FG002|On-Treatment|Lack of Efficacy|0|||
160890774|NCT00410202|580995208|FG000|On-Treatment|Withdrawal by Subject|2|||
160890775|NCT00410202|580995209|FG001|On-Treatment|Withdrawal by Subject|1|||
160890776|NCT00410202|580995210|FG002|On-Treatment|Withdrawal by Subject|1|||
160890777|NCT00410202|580995208|FG000|On-Treatment|Other Reason|0|||
160890778|NCT00410202|580995209|FG001|On-Treatment|Other Reason|0|||
160890779|NCT00410202|580995210|FG002|On-Treatment|Other Reason|1|||
160890780|NCT00410202|580995208|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
160788012|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
160788013|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
160788014|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
160788015|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
160788016|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
160788017|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
160788018|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
160788019|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
160788020|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
160788021|NCT01755156|580610778|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
160788022|NCT01755156|580610779|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
160788023|NCT01755156|580610778|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
160788024|NCT01755156|580610779|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
160788025|NCT01052428|580610782|FG000|Overall Study|Death|1|||
160788026|NCT01052428|580610783|FG001|Overall Study|Death|0|||
160788027|NCT01052428|580610782|FG000|Overall Study|Withdrawal by Subject|0|||
160788028|NCT01052428|580610783|FG001|Overall Study|Withdrawal by Subject|1|||
160788029|NCT00382863|580610784|FG000|Overall Study|Death|9|||
160788030|NCT00382863|580610785|FG001|Overall Study|Death|9|||
160890781|NCT00410202|580995209|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
160890782|NCT00410202|580995210|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
160890783|NCT00410202|580995208|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
160890784|NCT00410202|580995209|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
160890785|NCT00410202|580995210|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
160890786|NCT00410202|580995208|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
160890787|NCT00410202|580995209|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
160890788|NCT00410202|580995210|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
160890789|NCT01178073|580995211|FG000|Overall Study|Adverse Event|34|||
160788031|NCT00382863|580610784|FG000|Overall Study|Lost to Follow-up|1|||
160788032|NCT00382863|580610785|FG001|Overall Study|Lost to Follow-up|2|||
160788033|NCT00382863|580610784|FG000|Overall Study|Withdrawal by Subject|5|||
160890790|NCT01178073|580995212|FG001|Overall Study|Adverse Event|27|||
160890791|NCT01178073|580995213|FG002|Overall Study|Adverse Event|24|||
160890792|NCT01178073|580995211|FG000|Overall Study|Protocol Violation|1|||
160890793|NCT01178073|580995212|FG001|Overall Study|Protocol Violation|1|||
160890794|NCT01178073|580995213|FG002|Overall Study|Protocol Violation|1|||
160890795|NCT01178073|580995211|FG000|Overall Study|Lost to Follow-up|2|||
160890796|NCT01178073|580995212|FG001|Overall Study|Lost to Follow-up|0|||
160890797|NCT01178073|580995213|FG002|Overall Study|Lost to Follow-up|3|||
160890798|NCT01178073|580995211|FG000|Overall Study|Physician Decision|14|||
160890799|NCT01178073|580995212|FG001|Overall Study|Physician Decision|10|||
160890800|NCT01178073|580995213|FG002|Overall Study|Physician Decision|10|||
160890801|NCT01178073|580995211|FG000|Overall Study|Withdrawal by Subject|10|||
160890802|NCT01178073|580995212|FG001|Overall Study|Withdrawal by Subject|6|||
160890803|NCT01178073|580995213|FG002|Overall Study|Withdrawal by Subject|8|||
160890804|NCT01178073|580995211|FG000|Overall Study|Missing Completion Status|1|||
160890805|NCT01178073|580995212|FG001|Overall Study|Missing Completion Status|0|||
160890806|NCT01178073|580995213|FG002|Overall Study|Missing Completion Status|0|||
160890807|NCT01674634|580995216|FG000|Overall Study|Withdrawal by Subject|3|||
160890808|NCT01674634|580995216|FG000|Overall Study|Lost to Follow-up|3|||
160890809|NCT00937391|580995217|FG000|Stage 2|Withdrawal by Subject|1|||
160890810|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
160890811|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
160890812|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
160890813|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
160890814|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
160890815|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
160890816|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
160890817|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
160890818|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
160890819|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
160890820|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
160890821|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
160890822|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
160890823|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
160890824|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
160890825|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
160890826|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
160890827|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
160890828|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
160890829|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
160890830|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
160890831|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
160890832|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
160890833|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
160890834|NCT01226043|580995227|FG000|6-week Re-randomization Phase|Adverse Event|0|||
160890835|NCT01226043|580995228|FG001|6-week Re-randomization Phase|Adverse Event|0|||
160890836|NCT01226043|580995229|FG002|6-week Re-randomization Phase|Adverse Event|1|||
160890837|NCT01226043|580995230|FG003|6-week Re-randomization Phase|Adverse Event|1|||
160890838|NCT01226043|580995227|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
160890839|NCT01226043|580995228|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
160890840|NCT01226043|580995229|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
160890841|NCT01226043|580995230|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
160890842|NCT01226043|580995227|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
160890843|NCT01226043|580995228|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
160890844|NCT01226043|580995229|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
160890845|NCT01226043|580995230|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
160890846|NCT01226043|580995227|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
160890847|NCT01226043|580995228|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
160890848|NCT01226043|580995229|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
160890849|NCT01226043|580995230|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
160890850|NCT01226043|580995227|FG000|6-week Re-randomization Phase|Physician Decision|0|||
160890851|NCT01226043|580995228|FG001|6-week Re-randomization Phase|Physician Decision|0|||
160890852|NCT01226043|580995229|FG002|6-week Re-randomization Phase|Physician Decision|3|||
160890853|NCT01226043|580995230|FG003|6-week Re-randomization Phase|Physician Decision|2|||
160890854|NCT01226043|580995227|FG000|6-week Re-randomization Phase|completed in error|0|||
160890855|NCT01226043|580995228|FG001|6-week Re-randomization Phase|completed in error|0|||
160890856|NCT01226043|580995229|FG002|6-week Re-randomization Phase|completed in error|0|||
160890857|NCT01226043|580995230|FG003|6-week Re-randomization Phase|completed in error|1|||
160890858|NCT01226043|580995227|FG000|30-week Observational Phase|Adverse Event|0|||
160890859|NCT01226043|580995228|FG001|30-week Observational Phase|Adverse Event|0|||
160890860|NCT01226043|580995229|FG002|30-week Observational Phase|Adverse Event|1|||
160890861|NCT01226043|580995230|FG003|30-week Observational Phase|Adverse Event|1|||
160890862|NCT01226043|580995227|FG000|30-week Observational Phase|Protocol Violation|0|||
160890863|NCT01226043|580995228|FG001|30-week Observational Phase|Protocol Violation|0|||
160890864|NCT01226043|580995229|FG002|30-week Observational Phase|Protocol Violation|0|||
160890865|NCT01226043|580995230|FG003|30-week Observational Phase|Protocol Violation|1|||
160890866|NCT01226043|580995227|FG000|30-week Observational Phase|Lost to Follow-up|0|||
160890867|NCT01226043|580995228|FG001|30-week Observational Phase|Lost to Follow-up|0|||
160890868|NCT01226043|580995229|FG002|30-week Observational Phase|Lost to Follow-up|2|||
160890869|NCT01226043|580995230|FG003|30-week Observational Phase|Lost to Follow-up|2|||
160890870|NCT01226043|580995227|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
160890871|NCT01226043|580995228|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
160890872|NCT01226043|580995229|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
160890873|NCT01226043|580995230|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
160890874|NCT01226043|580995227|FG000|30-week Observational Phase|Physician Decision|0|||
160890875|NCT01226043|580995228|FG001|30-week Observational Phase|Physician Decision|0|||
160890876|NCT01226043|580995229|FG002|30-week Observational Phase|Physician Decision|2|||
160890877|NCT01226043|580995230|FG003|30-week Observational Phase|Physician Decision|2|||
160890878|NCT00596362|580995241|FG000|Overall Study|Progressive Disease|1|||
160890879|NCT02418156|580995242|FG000|Overall Study|Lost to Follow-up|12|||
160890880|NCT02418156|580995242|FG000|Overall Study|Death|2|||
160890881|NCT02418156|580995242|FG000|Overall Study|Physician Decision|1|||
160890882|NCT02418156|580995242|FG000|Overall Study|Withdrawal by Subject|1|||
160890883|NCT02418156|580995242|FG000|Overall Study|Subject refused to return|1|||
160890884|NCT00323869|580995245|FG000|Overall Study|Death|1|||
160890885|NCT04090957|580995246|FG000|Overall Study|Lost to Follow-up|22|||
160890886|NCT04090957|580995247|FG001|Overall Study|Lost to Follow-up|25|||
160890887|NCT04090957|580995248|FG002|Overall Study|Lost to Follow-up|25|||
160890888|NCT04090957|580995249|FG003|Overall Study|Lost to Follow-up|36|||
160890889|NCT04090957|580995246|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
160890890|NCT04090957|580995247|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
160890891|NCT04090957|580995248|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
160890892|NCT04090957|580995249|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
160890893|NCT04090957|580995246|FG000|Overall Study|Adverse Event|19|||
160890894|NCT04090957|580995247|FG001|Overall Study|Adverse Event|25|||
160890895|NCT04090957|580995248|FG002|Overall Study|Adverse Event|8|||
160890896|NCT04090957|580995249|FG003|Overall Study|Adverse Event|104|||
160890897|NCT04090957|580995246|FG000|Overall Study|Other|10|||
160890898|NCT04090957|580995247|FG001|Overall Study|Other|6|||
160890899|NCT04090957|580995248|FG002|Overall Study|Other|5|||
160890900|NCT04090957|580995249|FG003|Overall Study|Other|12|||
160890901|NCT04090957|580995246|FG000|Overall Study|Serious Adverse Event|7|||
160890902|NCT04090957|580995247|FG001|Overall Study|Serious Adverse Event|11|||
160890903|NCT04090957|580995248|FG002|Overall Study|Serious Adverse Event|1|||
160890904|NCT04090957|580995249|FG003|Overall Study|Serious Adverse Event|32|||
160890905|NCT04090957|580995246|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
160890906|NCT04090957|580995247|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
160890907|NCT04090957|580995248|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
160890908|NCT04090957|580995249|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
160890909|NCT04090957|580995246|FG000|Overall Study|Lack of Efficacy|1|||
160890910|NCT04090957|580995247|FG001|Overall Study|Lack of Efficacy|1|||
160890911|NCT04090957|580995248|FG002|Overall Study|Lack of Efficacy|9|||
160890912|NCT04090957|580995249|FG003|Overall Study|Lack of Efficacy|0|||
160890913|NCT04090957|580995246|FG000|Overall Study|Protocol Violation|3|||
160890914|NCT04090957|580995247|FG001|Overall Study|Protocol Violation|5|||
160890915|NCT04090957|580995248|FG002|Overall Study|Protocol Violation|2|||
160890916|NCT04090957|580995249|FG003|Overall Study|Protocol Violation|1|||
160890917|NCT04090957|580995246|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
160890918|NCT04090957|580995247|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
160890919|NCT04090957|580995248|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
160890920|NCT04090957|580995249|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
160890921|NCT04090957|580995246|FG000|Overall Study|COVID-19|2|||
160890922|NCT04090957|580995247|FG001|Overall Study|COVID-19|2|||
160890923|NCT04090957|580995248|FG002|Overall Study|COVID-19|3|||
160890924|NCT04090957|580995249|FG003|Overall Study|COVID-19|7|||
160890925|NCT04090957|580995246|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
160890926|NCT04090957|580995247|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
160890927|NCT04090957|580995248|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
160890928|NCT04090957|580995249|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
160890929|NCT04090957|580995246|FG000|Overall Study|Physician Decision|2|||
160890930|NCT04090957|580995247|FG001|Overall Study|Physician Decision|1|||
160890931|NCT04090957|580995248|FG002|Overall Study|Physician Decision|1|||
160890932|NCT04090957|580995249|FG003|Overall Study|Physician Decision|5|||
160890933|NCT04090957|580995246|FG000|Overall Study|Sponsor Decision|1|||
160890934|NCT04090957|580995247|FG001|Overall Study|Sponsor Decision|1|||
160890935|NCT04090957|580995248|FG002|Overall Study|Sponsor Decision|1|||
160890936|NCT04090957|580995249|FG003|Overall Study|Sponsor Decision|3|||
160890937|NCT04090957|580995246|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
160890938|NCT04090957|580995247|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
160890939|NCT04090957|580995248|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
160890940|NCT04090957|580995249|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
160890941|NCT04090957|580995246|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
160890942|NCT04090957|580995247|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
160890943|NCT04090957|580995248|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
160890944|NCT04090957|580995249|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
160890945|NCT04090957|580995246|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
160890946|NCT04090957|580995247|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
160890947|NCT04090957|580995248|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
160890948|NCT04090957|580995249|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
160890949|NCT04090957|580995246|FG000|Overall Study|Death|1|||
160890950|NCT04090957|580995247|FG001|Overall Study|Death|0|||
160890951|NCT04090957|580995248|FG002|Overall Study|Death|0|||
160890952|NCT04090957|580995249|FG003|Overall Study|Death|0|||
160890953|NCT04090957|580995246|FG000|Overall Study|No Treatment Administered|2|||
160890954|NCT04090957|580995247|FG001|Overall Study|No Treatment Administered|1|||
160890955|NCT04090957|580995248|FG002|Overall Study|No Treatment Administered|2|||
160788034|NCT00382863|580610785|FG001|Overall Study|Withdrawal by Subject|25|||
160788035|NCT02094885|580610786|FG000|Overall Study|Death|1|||
160788036|NCT02094885|580610787|FG001|Overall Study|Death|5|||
160788037|NCT02094885|580610786|FG000|Overall Study|Withdrawn due to age|1|||
160788038|NCT02094885|580610787|FG001|Overall Study|Withdrawn due to age|0|||
160788039|NCT00159874|580610790|FG000|Overall Study|Adverse Event|2|||
160788040|NCT00159874|580610791|FG001|Overall Study|Adverse Event|2|||
160788041|NCT00159874|580610792|FG002|Overall Study|Adverse Event|5|||
160788042|NCT00159874|580610793|FG003|Overall Study|Adverse Event|1|||
160788043|NCT00159874|580610794|FG004|Overall Study|Adverse Event|1|||
160788044|NCT00159874|580610795|FG005|Overall Study|Adverse Event|2|||
160788045|NCT00159874|580610796|FG006|Overall Study|Adverse Event|0|||
160788046|NCT00159874|580610790|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
160788047|NCT00159874|580610791|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
160788048|NCT00159874|580610792|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
160788049|NCT00159874|580610793|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
160788050|NCT00159874|580610794|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
160788051|NCT00159874|580610795|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
160788052|NCT00159874|580610796|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
160788053|NCT00159874|580610790|FG000|Overall Study|Lack of Efficacy|2|||
160788054|NCT00159874|580610791|FG001|Overall Study|Lack of Efficacy|0|||
160788055|NCT00159874|580610792|FG002|Overall Study|Lack of Efficacy|1|||
160788056|NCT00159874|580610793|FG003|Overall Study|Lack of Efficacy|1|||
160788057|NCT00159874|580610794|FG004|Overall Study|Lack of Efficacy|0|||
160788058|NCT00159874|580610795|FG005|Overall Study|Lack of Efficacy|3|||
160788059|NCT00159874|580610796|FG006|Overall Study|Lack of Efficacy|0|||
160788060|NCT00159874|580610790|FG000|Overall Study|Lost to Follow-up|1|||
160788061|NCT00159874|580610791|FG001|Overall Study|Lost to Follow-up|0|||
160788062|NCT00159874|580610792|FG002|Overall Study|Lost to Follow-up|3|||
160788063|NCT00159874|580610793|FG003|Overall Study|Lost to Follow-up|0|||
160788064|NCT00159874|580610794|FG004|Overall Study|Lost to Follow-up|1|||
160788065|NCT00159874|580610795|FG005|Overall Study|Lost to Follow-up|2|||
160788066|NCT00159874|580610796|FG006|Overall Study|Lost to Follow-up|1|||
160788067|NCT00159874|580610790|FG000|Overall Study|Other|8|||
160788068|NCT00159874|580610791|FG001|Overall Study|Other|8|||
160788069|NCT00159874|580610792|FG002|Overall Study|Other|8|||
160788070|NCT00159874|580610793|FG003|Overall Study|Other|0|||
160788071|NCT00159874|580610794|FG004|Overall Study|Other|2|||
160788072|NCT00159874|580610795|FG005|Overall Study|Other|1|||
160788073|NCT00159874|580610796|FG006|Overall Study|Other|3|||
160788074|NCT00159874|580610790|FG000|Overall Study|Protocol Violation|0|||
160788075|NCT00159874|580610791|FG001|Overall Study|Protocol Violation|5|||
160788076|NCT00159874|580610792|FG002|Overall Study|Protocol Violation|2|||
160788077|NCT00159874|580610793|FG003|Overall Study|Protocol Violation|0|||
160788078|NCT00159874|580610794|FG004|Overall Study|Protocol Violation|0|||
160788079|NCT00159874|580610795|FG005|Overall Study|Protocol Violation|0|||
160788080|NCT00159874|580610796|FG006|Overall Study|Protocol Violation|0|||
160788081|NCT00159874|580610790|FG000|Overall Study|Death|3|||
160788082|NCT00159874|580610791|FG001|Overall Study|Death|8|||
160788083|NCT00159874|580610792|FG002|Overall Study|Death|15|||
160788084|NCT00159874|580610793|FG003|Overall Study|Death|0|||
160890956|NCT04090957|580995249|FG003|Overall Study|No Treatment Administered|1|||
160890957|NCT01909453|580995250|FG000|Overall Study|Ongoing|118|||
160890958|NCT01909453|580995251|FG001|Overall Study|Ongoing|103|||
160890959|NCT01909453|580995252|FG002|Overall Study|Ongoing|83|||
160890960|NCT01909453|580995253|FG003|Overall Study|Ongoing|164|||
160890961|NCT01909453|580995254|FG004|Overall Study|Ongoing|50|||
160890962|NCT01909453|580995250|FG000|Overall Study|Death|69|||
160788085|NCT00159874|580610794|FG004|Overall Study|Death|1|||
160788086|NCT00159874|580610795|FG005|Overall Study|Death|2|||
160788087|NCT00159874|580610796|FG006|Overall Study|Death|0|||
160788088|NCT00159874|580610790|FG000|Overall Study|Withdrawal by Subject|2|||
160788089|NCT00159874|580610791|FG001|Overall Study|Withdrawal by Subject|6|||
160788090|NCT00159874|580610792|FG002|Overall Study|Withdrawal by Subject|8|||
160788091|NCT00159874|580610793|FG003|Overall Study|Withdrawal by Subject|4|||
160788092|NCT00159874|580610794|FG004|Overall Study|Withdrawal by Subject|3|||
160788093|NCT00159874|580610795|FG005|Overall Study|Withdrawal by Subject|2|||
160788094|NCT00159874|580610796|FG006|Overall Study|Withdrawal by Subject|1|||
160788095|NCT00159874|580610790|FG000|Overall Study|Pregnancy|1|||
160788096|NCT00159874|580610791|FG001|Overall Study|Pregnancy|1|||
160788097|NCT00159874|580610792|FG002|Overall Study|Pregnancy|0|||
160788098|NCT00159874|580610793|FG003|Overall Study|Pregnancy|0|||
160788099|NCT00159874|580610794|FG004|Overall Study|Pregnancy|0|||
160788100|NCT00159874|580610795|FG005|Overall Study|Pregnancy|0|||
160788101|NCT00159874|580610796|FG006|Overall Study|Pregnancy|0|||
160788102|NCT02314247|580610799|FG000|Overall Study|Adverse Event|2|||
160788103|NCT02314247|580610800|FG001|Overall Study|Adverse Event|1|||
160788104|NCT02314247|580610801|FG002|Overall Study|Adverse Event|0|||
160788105|NCT02314247|580610799|FG000|Overall Study|Withdrawal by Subject|1|||
160788106|NCT02314247|580610800|FG001|Overall Study|Withdrawal by Subject|3|||
160788107|NCT02314247|580610801|FG002|Overall Study|Withdrawal by Subject|1|||
160788108|NCT02314247|580610799|FG000|Overall Study|Progression of Disease|6|||
160788109|NCT02314247|580610800|FG001|Overall Study|Progression of Disease|2|||
160788110|NCT02314247|580610801|FG002|Overall Study|Progression of Disease|0|||
160788111|NCT00489359|580610809|FG000|Overall Study|Death|0|||
160788112|NCT00489359|580610810|FG001|Overall Study|Death|2|||
160788113|NCT00489359|580610809|FG000|Overall Study|Progressive Disease|5|||
160788114|NCT00489359|580610810|FG001|Overall Study|Progressive Disease|6|||
160788115|NCT00489359|580610809|FG000|Overall Study|Lost to Follow-up|1|||
160788116|NCT00489359|580610810|FG001|Overall Study|Lost to Follow-up|0|||
160788117|NCT00489359|580610809|FG000|Overall Study|Withdrawal by Subject|1|||
160788118|NCT00489359|580610810|FG001|Overall Study|Withdrawal by Subject|5|||
160890963|NCT01909453|580995251|FG001|Overall Study|Death|74|||
160890964|NCT01909453|580995252|FG002|Overall Study|Death|88|||
160890965|NCT01909453|580995253|FG003|Overall Study|Death|86|||
160890966|NCT01909453|580995254|FG004|Overall Study|Death|29|||
160890967|NCT01909453|580995250|FG000|Overall Study|Lost to Follow-up|3|||
160890968|NCT01909453|580995251|FG001|Overall Study|Lost to Follow-up|4|||
160890969|NCT01909453|580995252|FG002|Overall Study|Lost to Follow-up|4|||
160890970|NCT01909453|580995253|FG003|Overall Study|Lost to Follow-up|3|||
160890971|NCT01909453|580995254|FG004|Overall Study|Lost to Follow-up|3|||
160890972|NCT01909453|580995250|FG000|Overall Study|Withdrawal by Subject|2|||
160890973|NCT01909453|580995251|FG001|Overall Study|Withdrawal by Subject|13|||
160890974|NCT01909453|580995252|FG002|Overall Study|Withdrawal by Subject|16|||
160890975|NCT01909453|580995253|FG003|Overall Study|Withdrawal by Subject|5|||
160890976|NCT01909453|580995254|FG004|Overall Study|Withdrawal by Subject|4|||
160890977|NCT02247531|580996792|FG000|Overall Study|Adverse Event|3|||
160890978|NCT02247531|580996793|FG001|Overall Study|Adverse Event|4|||
160890979|NCT02247531|580996794|FG002|Overall Study|Adverse Event|9|||
160890980|NCT02247531|580996792|FG000|Overall Study|Death|8|||
160788119|NCT00489359|580610809|FG000|Overall Study|Adverse Event|0|||
160788120|NCT00489359|580610810|FG001|Overall Study|Adverse Event|16|||
160788121|NCT03180138|580610811|FG000|Overall Study|Mobile-phone could not be verified|2|||
160788122|NCT03180138|580610812|FG001|Overall Study|Mobile-phone could not be verified|13|||
160788123|NCT03180138|580610813|FG002|Overall Study|Mobile-phone could not be verified|15|||
160788124|NCT03180138|580610811|FG000|Overall Study|No prior immunization records|17|||
160890981|NCT02247531|580996793|FG001|Overall Study|Death|9|||
160890982|NCT02247531|580996794|FG002|Overall Study|Death|5|||
160890983|NCT02247531|580996792|FG000|Overall Study|Lost to Follow-up|1|||
160890984|NCT02247531|580996793|FG001|Overall Study|Lost to Follow-up|8|||
160890985|NCT02247531|580996794|FG002|Overall Study|Lost to Follow-up|3|||
160890986|NCT02247531|580996792|FG000|Overall Study|Non-compliance|2|||
160890987|NCT02247531|580996793|FG001|Overall Study|Non-compliance|2|||
160890988|NCT02247531|580996794|FG002|Overall Study|Non-compliance|0|||
160890989|NCT02247531|580996792|FG000|Overall Study|Withdrawal by Subject|26|||
160546730|NCT05103332|579728186|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546731|NCT05103332|579728187|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160890990|NCT02247531|580996793|FG001|Overall Study|Withdrawal by Subject|31|||
160788125|NCT03180138|580610812|FG001|Overall Study|No prior immunization records|0|||
160788126|NCT03180138|580610813|FG002|Overall Study|No prior immunization records|6|||
160788127|NCT03180138|580610811|FG000|Overall Study|Found to be >24 mon after randomization|3|||
160788128|NCT03180138|580610812|FG001|Overall Study|Found to be >24 mon after randomization|0|||
160788129|NCT03180138|580610813|FG002|Overall Study|Found to be >24 mon after randomization|3|||
160788130|NCT01260311|580610816|FG000|Overall Study|Adverse Event|11|||
160788131|NCT01260311|580610816|FG000|Overall Study|Lack of Efficacy|4|||
160788132|NCT01260311|580610816|FG000|Overall Study|Lost to Follow-up|25|||
160788133|NCT01260311|580610816|FG000|Overall Study|Withdrawal by Subject|6|||
160788134|NCT01260311|580610816|FG000|Overall Study|Financial Constraints|77|||
160788135|NCT01260311|580610816|FG000|Overall Study|Gone to Province|2|||
160788136|NCT01260311|580610816|FG000|Overall Study|Medication Stopped|1|||
160788137|NCT01260311|580610816|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
160788138|NCT01340170|580610817|FG000|Overall Study|Lost to Follow-up|2|||
160788139|NCT01340170|580610818|FG001|Overall Study|Lost to Follow-up|4|||
160788140|NCT01340170|580610819|FG002|Overall Study|Lost to Follow-up|0|||
160788141|NCT01340170|580610817|FG000|Overall Study|Implant failure|1|||
160788142|NCT01340170|580610818|FG001|Overall Study|Implant failure|3|||
160788143|NCT01340170|580610819|FG002|Overall Study|Implant failure|0|||
160788144|NCT03878602|580610820|FG000|Overall Study|cord blood donation|7|||
160788145|NCT03878602|580610821|FG001|Overall Study|cord blood donation|1|||
160788146|NCT03878602|580610820|FG000|Overall Study|incomplete data collection|2|||
160788147|NCT03878602|580610821|FG001|Overall Study|incomplete data collection|0|||
160788148|NCT00736476|580610822|FG000|Overall Study|Adverse Event|1|||
160788149|NCT00736476|580610823|FG001|Overall Study|Adverse Event|0|||
160788150|NCT01796470|580610824|FG000|Overall Study|Adverse Event|4|||
160788151|NCT01796470|580610825|FG001|Overall Study|Adverse Event|2|||
160788152|NCT01796470|580610826|FG002|Overall Study|Adverse Event|2|||
160788153|NCT01796470|580610827|FG003|Overall Study|Adverse Event|1|||
160788154|NCT01796470|580610828|FG004|Overall Study|Adverse Event|3|||
160788155|NCT01796470|580610824|FG000|Overall Study|Death|2|||
160788156|NCT01796470|580610825|FG001|Overall Study|Death|0|||
160788157|NCT01796470|580610826|FG002|Overall Study|Death|0|||
160788158|NCT01796470|580610827|FG003|Overall Study|Death|0|||
160788159|NCT01796470|580610828|FG004|Overall Study|Death|1|||
160788160|NCT01796470|580610824|FG000|Overall Study|Initiated New Therapy|9|||
160788161|NCT01796470|580610825|FG001|Overall Study|Initiated New Therapy|0|||
160788162|NCT01796470|580610826|FG002|Overall Study|Initiated New Therapy|0|||
160788163|NCT01796470|580610827|FG003|Overall Study|Initiated New Therapy|0|||
160788164|NCT01796470|580610828|FG004|Overall Study|Initiated New Therapy|2|||
160788165|NCT01796470|580610824|FG000|Overall Study|Lost to Follow-up|0|||
160788166|NCT01796470|580610825|FG001|Overall Study|Lost to Follow-up|1|||
160788167|NCT01796470|580610826|FG002|Overall Study|Lost to Follow-up|0|||
160788168|NCT01796470|580610827|FG003|Overall Study|Lost to Follow-up|0|||
160788169|NCT01796470|580610828|FG004|Overall Study|Lost to Follow-up|0|||
160788170|NCT01796470|580610824|FG000|Overall Study|Physician Decision|5|||
160788171|NCT01796470|580610825|FG001|Overall Study|Physician Decision|4|||
160788172|NCT01796470|580610826|FG002|Overall Study|Physician Decision|1|||
160788173|NCT01796470|580610827|FG003|Overall Study|Physician Decision|0|||
160788174|NCT01796470|580610828|FG004|Overall Study|Physician Decision|1|||
160788175|NCT01796470|580610824|FG000|Overall Study|Progressive Disease|7|||
160788176|NCT01796470|580610825|FG001|Overall Study|Progressive Disease|7|||
160788177|NCT01796470|580610826|FG002|Overall Study|Progressive Disease|3|||
160788178|NCT01796470|580610827|FG003|Overall Study|Progressive Disease|2|||
160788179|NCT01796470|580610828|FG004|Overall Study|Progressive Disease|0|||
160788180|NCT01796470|580610824|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
160788181|NCT01796470|580610825|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
160788182|NCT01796470|580610826|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
160788183|NCT01796470|580610827|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
160788184|NCT01796470|580610828|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
160788185|NCT01796470|580610824|FG000|Overall Study|Withdrawal by Subject|7|||
160788186|NCT01796470|580610825|FG001|Overall Study|Withdrawal by Subject|0|||
160788187|NCT01796470|580610826|FG002|Overall Study|Withdrawal by Subject|0|||
160788188|NCT01796470|580610827|FG003|Overall Study|Withdrawal by Subject|0|||
160788189|NCT01796470|580610828|FG004|Overall Study|Withdrawal by Subject|1|||
160788190|NCT02633527|580610829|FG000|Overall Study|Failed to meet eligibility|0|||
160546732|NCT05103332|579728170|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546733|NCT05103332|579728171|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
160546734|NCT05103332|579728172|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546735|NCT05103332|579728173|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
160546736|NCT05103332|579728174|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546737|NCT05103332|579728175|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546738|NCT05103332|579728176|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546739|NCT05103332|579728177|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546740|NCT05103332|579728178|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546741|NCT05103332|579728179|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546742|NCT05103332|579728180|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546743|NCT05103332|579728181|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546744|NCT05103332|579728182|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546745|NCT05103332|579728183|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546746|NCT05103332|579728184|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546747|NCT05103332|579728185|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546748|NCT05103332|579728186|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546749|NCT05103332|579728187|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
160546750|NCT05103332|579728170|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
160546751|NCT05103332|579728171|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
160546752|NCT05103332|579728172|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
160546753|NCT05103332|579728173|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
160546754|NCT05103332|579728174|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
160546755|NCT05103332|579728175|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
160546756|NCT05103332|579728176|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546757|NCT05103332|579728177|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546758|NCT05103332|579728178|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546759|NCT05103332|579728179|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546760|NCT05103332|579728180|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546761|NCT05103332|579728181|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546762|NCT05103332|579728182|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546763|NCT05103332|579728183|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546764|NCT05103332|579728184|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546765|NCT05103332|579728185|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546766|NCT05103332|579728186|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546767|NCT05103332|579728187|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546768|NCT05103332|579728170|FG000|DB Period (6 Months=168 Days)|Other|0|||
160546769|NCT05103332|579728171|FG001|DB Period (6 Months=168 Days)|Other|0|||
160546770|NCT05103332|579728172|FG002|DB Period (6 Months=168 Days)|Other|0|||
160546771|NCT05103332|579728173|FG003|DB Period (6 Months=168 Days)|Other|1|||
160546772|NCT05103332|579728174|FG004|DB Period (6 Months=168 Days)|Other|0|||
160546773|NCT05103332|579728175|FG005|DB Period (6 Months=168 Days)|Other|0|||
160546774|NCT05103332|579728176|FG006|DB Period (6 Months=168 Days)|Other|0|||
160546775|NCT05103332|579728177|FG007|DB Period (6 Months=168 Days)|Other|0|||
160546776|NCT05103332|579728178|FG008|DB Period (6 Months=168 Days)|Other|0|||
160546777|NCT05103332|579728179|FG009|DB Period (6 Months=168 Days)|Other|0|||
160546778|NCT05103332|579728180|FG010|DB Period (6 Months=168 Days)|Other|0|||
160546779|NCT05103332|579728181|FG011|DB Period (6 Months=168 Days)|Other|0|||
160546780|NCT05103332|579728182|FG012|DB Period (6 Months=168 Days)|Other|0|||
160546781|NCT05103332|579728183|FG013|DB Period (6 Months=168 Days)|Other|0|||
160546782|NCT05103332|579728184|FG014|DB Period (6 Months=168 Days)|Other|0|||
160546783|NCT05103332|579728185|FG015|DB Period (6 Months=168 Days)|Other|0|||
160546784|NCT05103332|579728186|FG016|DB Period (6 Months=168 Days)|Other|0|||
160546785|NCT05103332|579728187|FG017|DB Period (6 Months=168 Days)|Other|0|||
160546786|NCT05103332|579728170|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546787|NCT05103332|579728171|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546788|NCT05103332|579728172|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546789|NCT05103332|579728173|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546790|NCT05103332|579728174|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546791|NCT05103332|579728175|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546792|NCT05103332|579728176|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546793|NCT05103332|579728177|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546794|NCT05103332|579728178|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546795|NCT05103332|579728179|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546796|NCT05103332|579728180|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
160890991|NCT02247531|580996794|FG002|Overall Study|Withdrawal by Subject|25|||
160788191|NCT02633527|580610830|FG001|Overall Study|Failed to meet eligibility|1|||
160788192|NCT02633527|580610831|FG002|Overall Study|Failed to meet eligibility|1|||
160788193|NCT02633527|580610832|FG003|Overall Study|Failed to meet eligibility|0|||
160788194|NCT02633527|580610833|FG004|Overall Study|Failed to meet eligibility|1|||
160788195|NCT02633527|580610829|FG000|Overall Study|Adverse Event|0|||
160788196|NCT02633527|580610830|FG001|Overall Study|Adverse Event|4|||
160788197|NCT02633527|580610831|FG002|Overall Study|Adverse Event|3|||
160788198|NCT02633527|580610832|FG003|Overall Study|Adverse Event|1|||
160788199|NCT02633527|580610833|FG004|Overall Study|Adverse Event|5|||
160788200|NCT02633527|580610829|FG000|Overall Study|Lost to Follow-up|1|||
160788201|NCT02633527|580610830|FG001|Overall Study|Lost to Follow-up|2|||
160788202|NCT02633527|580610831|FG002|Overall Study|Lost to Follow-up|5|||
160788203|NCT02633527|580610832|FG003|Overall Study|Lost to Follow-up|5|||
160788204|NCT02633527|580610833|FG004|Overall Study|Lost to Follow-up|4|||
160788205|NCT02633527|580610829|FG000|Overall Study|Withdrawal by Subject|0|||
160788206|NCT02633527|580610830|FG001|Overall Study|Withdrawal by Subject|3|||
160788207|NCT02633527|580610831|FG002|Overall Study|Withdrawal by Subject|5|||
160546797|NCT05103332|579728181|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546798|NCT05103332|579728182|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546799|NCT05103332|579728183|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546800|NCT05103332|579728184|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160788208|NCT02633527|580610832|FG003|Overall Study|Withdrawal by Subject|4|||
160788209|NCT02633527|580610833|FG004|Overall Study|Withdrawal by Subject|4|||
160788210|NCT02633527|580610829|FG000|Overall Study|Protocol Violation|0|||
160788211|NCT02633527|580610830|FG001|Overall Study|Protocol Violation|1|||
160788212|NCT02633527|580610831|FG002|Overall Study|Protocol Violation|1|||
160788213|NCT02633527|580610832|FG003|Overall Study|Protocol Violation|1|||
160788214|NCT02633527|580610833|FG004|Overall Study|Protocol Violation|1|||
160788215|NCT02633527|580610829|FG000|Overall Study|Physician Decision|0|||
160788216|NCT02633527|580610830|FG001|Overall Study|Physician Decision|0|||
160788217|NCT02633527|580610831|FG002|Overall Study|Physician Decision|0|||
160788218|NCT02633527|580610832|FG003|Overall Study|Physician Decision|0|||
160788219|NCT02633527|580610833|FG004|Overall Study|Physician Decision|1|||
160788220|NCT02633527|580610829|FG000|Overall Study|Administrative reason|1|||
160788221|NCT02633527|580610830|FG001|Overall Study|Administrative reason|0|||
160788222|NCT02633527|580610831|FG002|Overall Study|Administrative reason|0|||
160788223|NCT02633527|580610832|FG003|Overall Study|Administrative reason|1|||
160788224|NCT02633527|580610833|FG004|Overall Study|Administrative reason|0|||
160788225|NCT02633527|580610829|FG000|Overall Study|Multiple reasons|1|||
160788226|NCT02633527|580610830|FG001|Overall Study|Multiple reasons|0|||
160788227|NCT02633527|580610831|FG002|Overall Study|Multiple reasons|2|||
160788228|NCT02633527|580610832|FG003|Overall Study|Multiple reasons|2|||
160788229|NCT02633527|580610833|FG004|Overall Study|Multiple reasons|1|||
160788230|NCT06091956|580610834|FG000|Overall Study|Withdrawal by Subject|1|||
160788231|NCT06091956|580610834|FG000|Overall Study|Complicating Disease|1|||
160788232|NCT02176525|580610837|FG000|Overall Study|Adverse Event|0|||
160788233|NCT02176525|580610838|FG001|Overall Study|Adverse Event|0|||
160788234|NCT02176525|580610839|FG002|Overall Study|Adverse Event|0|||
160788235|NCT02176525|580610840|FG003|Overall Study|Adverse Event|1|||
160788236|NCT02176525|580610841|FG004|Overall Study|Adverse Event|1|||
160788237|NCT02176525|580610842|FG005|Overall Study|Adverse Event|0|||
160788238|NCT02176525|580610843|FG006|Overall Study|Adverse Event|1|||
160788239|NCT02176525|580610844|FG007|Overall Study|Adverse Event|0|||
160788240|NCT02176525|580610837|FG000|Overall Study|not treated|1|||
160788241|NCT02176525|580610838|FG001|Overall Study|not treated|0|||
160788242|NCT02176525|580610839|FG002|Overall Study|not treated|0|||
160788243|NCT02176525|580610840|FG003|Overall Study|not treated|0|||
160788244|NCT02176525|580610841|FG004|Overall Study|not treated|0|||
160788245|NCT02176525|580610842|FG005|Overall Study|not treated|1|||
160788246|NCT02176525|580610843|FG006|Overall Study|not treated|0|||
160788247|NCT02176525|580610844|FG007|Overall Study|not treated|0|||
160788248|NCT02100644|580610847|FG000|LTG Escalation Phase|Adverse Event|9|||
160788249|NCT02100644|580610848|FG001|LTG Escalation Phase|Adverse Event|0|||
160788250|NCT02100644|580610849|FG002|LTG Escalation Phase|Adverse Event|0|||
160788251|NCT02100644|580610847|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
160788252|NCT02100644|580610848|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
160788253|NCT02100644|580610849|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
160788254|NCT02100644|580610847|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
160788255|NCT02100644|580610848|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
160788256|NCT02100644|580610849|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
160788257|NCT00478140|580610850|FG000|Overall Study|Clinical Disease Progression|1|||
160788258|NCT05652140|580610855|FG000|Overall Study|Lost to Follow-up|7|||
160788259|NCT05652140|580610856|FG001|Overall Study|Lost to Follow-up|16|||
160788260|NCT05652140|580610857|FG002|Overall Study|Lost to Follow-up|22|||
160788261|NCT05652140|580610858|FG003|Overall Study|Lost to Follow-up|31|||
160788262|NCT06048705|580610863|FG000|Overall Study|Physician Decision|1|||
160788263|NCT06048705|580610864|FG001|Overall Study|Physician Decision|0|||
160788264|NCT06048705|580610865|FG002|Overall Study|Physician Decision|0|||
160788265|NCT06048705|580610863|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
160788266|NCT06048705|580610864|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
160788267|NCT06048705|580610865|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
160788268|NCT06048705|580610863|FG000|Overall Study|Death prior to lymphodepletion|0|||
160788269|NCT06048705|580610864|FG001|Overall Study|Death prior to lymphodepletion|0|||
160546801|NCT05103332|579728185|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546802|NCT05103332|579728186|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160788270|NCT06048705|580610865|FG002|Overall Study|Death prior to lymphodepletion|1|||
160788271|NCT02614066|580610866|FG000|Overall Study|Death|6|||
160546803|NCT05103332|579728187|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160546804|NCT05103332|579728170|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546805|NCT05103332|579728171|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546806|NCT05103332|579728172|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546807|NCT05103332|579728173|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546808|NCT05103332|579728174|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546809|NCT05103332|579728175|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546810|NCT05103332|579728176|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546811|NCT05103332|579728177|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546812|NCT05103332|579728178|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
160546813|NCT05103332|579728179|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546814|NCT05103332|579728180|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546815|NCT05103332|579728181|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546816|NCT05103332|579728182|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546817|NCT05103332|579728183|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546818|NCT05103332|579728184|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546819|NCT05103332|579728185|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546820|NCT05103332|579728186|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546821|NCT05103332|579728187|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
160546822|NCT05103332|579728170|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546823|NCT05103332|579728171|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546824|NCT05103332|579728172|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546825|NCT05103332|579728173|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546826|NCT05103332|579728174|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546827|NCT05103332|579728175|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546828|NCT05103332|579728176|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546829|NCT05103332|579728177|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546830|NCT05103332|579728178|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546831|NCT05103332|579728179|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546832|NCT05103332|579728180|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546833|NCT05103332|579728181|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
160546834|NCT05103332|579728182|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546835|NCT05103332|579728183|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546836|NCT05103332|579728184|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546837|NCT05103332|579728185|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546838|NCT05103332|579728186|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546839|NCT05103332|579728187|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
160546840|NCT05103332|579728170|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546841|NCT05103332|579728171|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546842|NCT05103332|579728172|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546843|NCT05103332|579728173|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546844|NCT05103332|579728174|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546845|NCT05103332|579728175|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546846|NCT05103332|579728176|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
160546847|NCT05103332|579728177|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
160788272|NCT02614066|580610867|FG001|Overall Study|Death|14|||
160788273|NCT02614066|580610868|FG002|Overall Study|Death|11|||
160788274|NCT02614066|580610869|FG003|Overall Study|Death|29|||
160788275|NCT02614066|580610866|FG000|Overall Study|Full consent withdrawn|0|||
160788276|NCT02614066|580610867|FG001|Overall Study|Full consent withdrawn|1|||
160788277|NCT02614066|580610868|FG002|Overall Study|Full consent withdrawn|0|||
160546848|NCT05103332|579728178|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546849|NCT05103332|579728179|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
160546850|NCT05103332|579728180|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
160546851|NCT05103332|579728181|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
160546852|NCT05103332|579728182|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546853|NCT05103332|579728183|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160788278|NCT02614066|580610869|FG003|Overall Study|Full consent withdrawn|8|||
160788279|NCT02614066|580610866|FG000|Overall Study|Lost to Follow-up|0|||
160788280|NCT02614066|580610867|FG001|Overall Study|Lost to Follow-up|2|||
160788281|NCT02614066|580610868|FG002|Overall Study|Lost to Follow-up|2|||
160788282|NCT02614066|580610869|FG003|Overall Study|Lost to Follow-up|2|||
160788283|NCT02614066|580610866|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
160788284|NCT02614066|580610867|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
160788285|NCT02614066|580610868|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
160788286|NCT02614066|580610869|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
160788287|NCT02614066|580610866|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
160788288|NCT02614066|580610867|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
160788289|NCT02614066|580610868|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
160788290|NCT02614066|580610869|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
160788291|NCT02614066|580610866|FG000|Overall Study|Reason not specified|0|||
160788292|NCT02614066|580610867|FG001|Overall Study|Reason not specified|2|||
160788293|NCT02614066|580610868|FG002|Overall Study|Reason not specified|1|||
160546854|NCT05103332|579728184|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546855|NCT05103332|579728185|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546856|NCT05103332|579728186|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546857|NCT05103332|579728187|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
160546858|NCT05103332|579728170|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546859|NCT05103332|579728171|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546860|NCT05103332|579728172|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546861|NCT05103332|579728173|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546862|NCT05103332|579728174|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546863|NCT05103332|579728175|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546864|NCT05103332|579728176|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546865|NCT05103332|579728177|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546866|NCT05103332|579728178|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546867|NCT05103332|579728179|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546868|NCT05103332|579728180|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546869|NCT05103332|579728181|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
160546870|NCT05103332|579728182|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
160546871|NCT05103332|579728183|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
160546872|NCT05103332|579728184|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
160546873|NCT05103332|579728185|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
160546874|NCT05103332|579728186|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
160546875|NCT05103332|579728187|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
160546876|NCT05103332|579728170|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546877|NCT05103332|579728171|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546878|NCT05103332|579728172|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546879|NCT05103332|579728173|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546880|NCT05103332|579728174|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546881|NCT05103332|579728175|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546882|NCT05103332|579728176|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546883|NCT05103332|579728177|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546884|NCT05103332|579728178|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546885|NCT05103332|579728179|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546886|NCT05103332|579728180|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546887|NCT05103332|579728181|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546888|NCT05103332|579728182|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546889|NCT05103332|579728183|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546890|NCT05103332|579728184|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546891|NCT05103332|579728185|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546892|NCT05103332|579728186|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
160546893|NCT05103332|579728187|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
160546894|NCT05103332|579728170|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546895|NCT05103332|579728171|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546896|NCT05103332|579728172|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546897|NCT05103332|579728173|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546898|NCT05103332|579728174|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546899|NCT05103332|579728175|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546900|NCT05103332|579728176|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546901|NCT05103332|579728177|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546902|NCT05103332|579728178|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546903|NCT05103332|579728179|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160546904|NCT05103332|579728180|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160788294|NCT02614066|580610869|FG003|Overall Study|Reason not specified|1|||
160788295|NCT04565756|580610870|FG000|Overall Study|Withdrawal by Subject|0|||
160788296|NCT04565756|580610871|FG001|Overall Study|Withdrawal by Subject|0|||
160788297|NCT04565756|580610872|FG002|Overall Study|Withdrawal by Subject|0|||
160788298|NCT04565756|580610873|FG003|Overall Study|Withdrawal by Subject|0|||
160788299|NCT04565756|580610874|FG004|Overall Study|Withdrawal by Subject|1|||
160788300|NCT04565756|580610875|FG005|Overall Study|Withdrawal by Subject|0|||
160788301|NCT04565756|580610870|FG000|Overall Study|Protocol Violation|0|||
160788302|NCT04565756|580610871|FG001|Overall Study|Protocol Violation|0|||
160788303|NCT04565756|580610872|FG002|Overall Study|Protocol Violation|0|||
160788304|NCT04565756|580610873|FG003|Overall Study|Protocol Violation|0|||
160788305|NCT04565756|580610874|FG004|Overall Study|Protocol Violation|0|||
160546905|NCT05103332|579728181|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160788306|NCT04565756|580610875|FG005|Overall Study|Protocol Violation|1|||
160788307|NCT00968968|580610880|FG000|Overall Study|Study closed/terminated|10|||
160788308|NCT00968968|580610881|FG001|Overall Study|Study closed/terminated|10|||
160788309|NCT00968968|580610880|FG000|Overall Study|Protocol defined stopping criteria|3|||
160546906|NCT05103332|579728182|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
160546907|NCT05103332|579728183|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
160546908|NCT05103332|579728184|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
160546909|NCT05103332|579728185|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
160546910|NCT05103332|579728186|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
160546911|NCT05103332|579728187|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
160546912|NCT05103332|579728170|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546913|NCT05103332|579728171|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546914|NCT05103332|579728172|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546915|NCT05103332|579728173|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546916|NCT05103332|579728174|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546917|NCT05103332|579728175|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546918|NCT05103332|579728176|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546919|NCT05103332|579728177|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546920|NCT05103332|579728178|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546921|NCT05103332|579728179|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546922|NCT05103332|579728180|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546923|NCT05103332|579728181|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546924|NCT05103332|579728182|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546925|NCT05103332|579728183|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546926|NCT05103332|579728184|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
160546927|NCT05103332|579728185|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
160546928|NCT05103332|579728186|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
160546929|NCT05103332|579728187|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
160546930|NCT05103332|579728170|FG000|SFU Period (6 Months=168 Days)|Death|0|||
160546931|NCT05103332|579728171|FG001|SFU Period (6 Months=168 Days)|Death|0|||
160546932|NCT05103332|579728172|FG002|SFU Period (6 Months=168 Days)|Death|0|||
160546933|NCT05103332|579728173|FG003|SFU Period (6 Months=168 Days)|Death|0|||
160546934|NCT05103332|579728174|FG004|SFU Period (6 Months=168 Days)|Death|0|||
160546935|NCT05103332|579728175|FG005|SFU Period (6 Months=168 Days)|Death|0|||
160546936|NCT05103332|579728176|FG006|SFU Period (6 Months=168 Days)|Death|0|||
160546937|NCT05103332|579728177|FG007|SFU Period (6 Months=168 Days)|Death|0|||
160546938|NCT05103332|579728178|FG008|SFU Period (6 Months=168 Days)|Death|0|||
160546939|NCT05103332|579728179|FG009|SFU Period (6 Months=168 Days)|Death|0|||
160546940|NCT05103332|579728180|FG010|SFU Period (6 Months=168 Days)|Death|0|||
160546941|NCT05103332|579728181|FG011|SFU Period (6 Months=168 Days)|Death|0|||
160546942|NCT05103332|579728182|FG012|SFU Period (6 Months=168 Days)|Death|0|||
160546943|NCT05103332|579728183|FG013|SFU Period (6 Months=168 Days)|Death|0|||
160546944|NCT05103332|579728184|FG014|SFU Period (6 Months=168 Days)|Death|1|||
160546945|NCT05103332|579728185|FG015|SFU Period (6 Months=168 Days)|Death|0|||
160546946|NCT05103332|579728186|FG016|SFU Period (6 Months=168 Days)|Death|0|||
160546947|NCT05103332|579728187|FG017|SFU Period (6 Months=168 Days)|Death|1|||
160546948|NCT02043548|579728188|FG000|Overall Study|Lack of Efficacy|1|||
160546949|NCT02043548|579728189|FG001|Overall Study|Lack of Efficacy|0|||
160546950|NCT02043548|579728188|FG000|Overall Study|Adverse Event|0|||
160788310|NCT00968968|580610881|FG001|Overall Study|Protocol defined stopping criteria|1|||
160788311|NCT00968968|580610880|FG000|Overall Study|Withdrawal by Subject|2|||
160788312|NCT00968968|580610881|FG001|Overall Study|Withdrawal by Subject|0|||
160788313|NCT00968968|580610880|FG000|Overall Study|Physician Decision|1|||
160788314|NCT00968968|580610881|FG001|Overall Study|Physician Decision|2|||
160788315|NCT00968968|580610880|FG000|Overall Study|Lost to Follow-up|0|||
160642186|NCT01335399|580074215|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
160642187|NCT01335399|580074216|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
160788316|NCT00968968|580610881|FG001|Overall Study|Lost to Follow-up|1|||
160546951|NCT02043548|579728189|FG001|Overall Study|Adverse Event|1|||
160546952|NCT00264238|579728191|FG000|Overall Study|Protocol Violation|1|||
160546953|NCT04179175|579730121|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
160546954|NCT04179175|579730122|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
160546955|NCT04179175|579730123|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
160546956|NCT04179175|579730124|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
160546957|NCT04179175|579730125|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
160546958|NCT04179175|579730126|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
160546959|NCT04179175|579730121|FG000|Overall Study|Adverse Event|5|||
160546960|NCT04179175|579730122|FG001|Overall Study|Adverse Event|3|||
160546961|NCT04179175|579730123|FG002|Overall Study|Adverse Event|3|||
160642188|NCT01335399|580074215|FG000|Treatment Period|Study drug toxicity|52|||
160788317|NCT04401293|580610882|FG000|Overall Study|Withdrawal by Subject|1|||
160788318|NCT04401293|580610883|FG001|Overall Study|Withdrawal by Subject|3|||
160788319|NCT01026038|580610884|FG000|Overall Study|Lost to Follow-up|1|||
160788320|NCT01026038|580610885|FG001|Overall Study|Lost to Follow-up|1|||
160788321|NCT01026038|580610886|FG002|Overall Study|Lost to Follow-up|0|||
160788322|NCT03679884|580610887|FG000|Overall Study|Other|12|||
160788323|NCT03679884|580610888|FG001|Overall Study|Other|12|||
160788324|NCT03679884|580610889|FG002|Overall Study|Other|12|||
160788325|NCT03679884|580610890|FG003|Overall Study|Other|7|||
160788326|NCT03679884|580610891|FG004|Overall Study|Other|8|||
160788327|NCT03679884|580610887|FG000|Overall Study|Lack of Efficacy|15|||
160788328|NCT03679884|580610888|FG001|Overall Study|Lack of Efficacy|29|||
160788329|NCT03679884|580610889|FG002|Overall Study|Lack of Efficacy|13|||
160788330|NCT03679884|580610890|FG003|Overall Study|Lack of Efficacy|29|||
160788331|NCT03679884|580610891|FG004|Overall Study|Lack of Efficacy|10|||
160546962|NCT04179175|579730124|FG003|Overall Study|Adverse Event|4|||
160546963|NCT04179175|579730125|FG004|Overall Study|Adverse Event|6|||
160546964|NCT04179175|579730126|FG005|Overall Study|Adverse Event|6|||
160546965|NCT04179175|579730121|FG000|Overall Study|Lack of Efficacy|5|||
160546966|NCT04179175|579730122|FG001|Overall Study|Lack of Efficacy|1|||
160546967|NCT04179175|579730123|FG002|Overall Study|Lack of Efficacy|3|||
160546968|NCT04179175|579730124|FG003|Overall Study|Lack of Efficacy|2|||
160546969|NCT04179175|579730125|FG004|Overall Study|Lack of Efficacy|18|||
160546970|NCT04179175|579730126|FG005|Overall Study|Lack of Efficacy|7|||
160546971|NCT04179175|579730121|FG000|Overall Study|Lost to Follow-up|5|||
160546972|NCT04179175|579730122|FG001|Overall Study|Lost to Follow-up|3|||
160546973|NCT04179175|579730123|FG002|Overall Study|Lost to Follow-up|2|||
160546974|NCT04179175|579730124|FG003|Overall Study|Lost to Follow-up|2|||
160546975|NCT04179175|579730125|FG004|Overall Study|Lost to Follow-up|4|||
160546976|NCT04179175|579730126|FG005|Overall Study|Lost to Follow-up|5|||
160546977|NCT04179175|579730121|FG000|Overall Study|Physician Decision|2|||
160546978|NCT04179175|579730122|FG001|Overall Study|Physician Decision|0|||
160546979|NCT04179175|579730123|FG002|Overall Study|Physician Decision|2|||
160546980|NCT04179175|579730124|FG003|Overall Study|Physician Decision|3|||
160546981|NCT04179175|579730125|FG004|Overall Study|Physician Decision|1|||
160546982|NCT04179175|579730126|FG005|Overall Study|Physician Decision|1|||
160546983|NCT04179175|579730121|FG000|Overall Study|Pregnancy|3|||
160546984|NCT04179175|579730122|FG001|Overall Study|Pregnancy|0|||
160546985|NCT04179175|579730123|FG002|Overall Study|Pregnancy|3|||
160546986|NCT04179175|579730124|FG003|Overall Study|Pregnancy|0|||
160546987|NCT04179175|579730125|FG004|Overall Study|Pregnancy|1|||
160546988|NCT04179175|579730126|FG005|Overall Study|Pregnancy|2|||
160546989|NCT04179175|579730121|FG000|Overall Study|Withdrawal by Subject|22|||
160546990|NCT04179175|579730122|FG001|Overall Study|Withdrawal by Subject|10|||
160546991|NCT04179175|579730123|FG002|Overall Study|Withdrawal by Subject|12|||
160546992|NCT04179175|579730124|FG003|Overall Study|Withdrawal by Subject|8|||
160546993|NCT04179175|579730125|FG004|Overall Study|Withdrawal by Subject|23|||
160546994|NCT04179175|579730126|FG005|Overall Study|Withdrawal by Subject|31|||
160546995|NCT04179175|579730121|FG000|Overall Study|Technical problems|0|||
160546996|NCT04179175|579730122|FG001|Overall Study|Technical problems|0|||
160546997|NCT04179175|579730123|FG002|Overall Study|Technical problems|1|||
160546998|NCT04179175|579730124|FG003|Overall Study|Technical problems|1|||
160546999|NCT04179175|579730125|FG004|Overall Study|Technical problems|0|||
160547000|NCT04179175|579730126|FG005|Overall Study|Technical problems|0|||
160547001|NCT03215030|579730128|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
160547002|NCT03215030|579730129|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
160547003|NCT03215030|579730130|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
160547004|NCT03215030|579730131|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
160547005|NCT03215030|579730132|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
160547006|NCT03215030|579730133|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
160547007|NCT03215030|579730134|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
160547008|NCT03215030|579730135|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
160547009|NCT03215030|579730136|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
160547010|NCT03215030|579730137|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
160547011|NCT03215030|579730138|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
160547012|NCT03215030|579730139|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
160547013|NCT03215030|579730128|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
160547014|NCT03215030|579730129|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160547015|NCT03215030|579730130|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160547016|NCT03215030|579730131|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
160642189|NCT01335399|580074216|FG001|Treatment Period|Study drug toxicity|64|||
160547017|NCT03215030|579730132|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160547018|NCT03215030|579730133|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160547019|NCT03215030|579730134|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160547020|NCT03215030|579730135|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160642190|NCT01335399|580074215|FG000|Treatment Period|Participant request to discontinue|30|||
160642191|NCT01335399|580074216|FG001|Treatment Period|Participant request to discontinue|22|||
160642192|NCT01335399|580074215|FG000|Treatment Period|Other reasons|30|||
160642193|NCT01335399|580074216|FG001|Treatment Period|Other reasons|30|||
160642194|NCT01335399|580074215|FG000|Treatment Period|Consent withdrawal|10|||
160642195|NCT01335399|580074216|FG001|Treatment Period|Consent withdrawal|7|||
160642196|NCT01335399|580074215|FG000|Treatment Period|Death|7|||
160642197|NCT01335399|580074216|FG001|Treatment Period|Death|6|||
160642198|NCT01335399|580074215|FG000|Treatment Period|Poor/Non-compliance|3|||
160890992|NCT02247531|580996792|FG000|Overall Study|Study Terminated by Sponsor|64|||
160642199|NCT01335399|580074216|FG001|Treatment Period|Poor/Non-compliance|4|||
160642200|NCT01335399|580074215|FG000|Treatment Period|Lost to Follow-up|2|||
160642201|NCT01335399|580074216|FG001|Treatment Period|Lost to Follow-up|2|||
160642202|NCT01335399|580074215|FG000|Treatment Period|Maximum clinical benefit|1|||
160547021|NCT03215030|579730136|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160547022|NCT03215030|579730137|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160642203|NCT01335399|580074216|FG001|Treatment Period|Maximum clinical benefit|1|||
160547023|NCT03215030|579730138|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160547024|NCT03215030|579730139|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160547025|NCT03215030|579730128|FG000|Part 1: Dose Escalation|Death|15|||
160547026|NCT03215030|579730129|FG001|Part 1: Dose Escalation|Death|6|||
160547027|NCT03215030|579730130|FG002|Part 1: Dose Escalation|Death|6|||
160547028|NCT03215030|579730131|FG003|Part 1: Dose Escalation|Death|8|||
160547029|NCT03215030|579730132|FG004|Part 1: Dose Escalation|Death|0|||
160547030|NCT03215030|579730133|FG005|Part 1: Dose Escalation|Death|0|||
160547031|NCT03215030|579730134|FG006|Part 1: Dose Escalation|Death|0|||
160547032|NCT03215030|579730135|FG007|Part 1: Dose Escalation|Death|0|||
160547033|NCT03215030|579730136|FG008|Part 1: Dose Escalation|Death|0|||
160547034|NCT03215030|579730137|FG009|Part 1: Dose Escalation|Death|0|||
160547035|NCT03215030|579730138|FG010|Part 1: Dose Escalation|Death|0|||
160547036|NCT03215030|579730139|FG011|Part 1: Dose Escalation|Death|0|||
160547037|NCT03215030|579730128|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
160547038|NCT03215030|579730129|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
160547039|NCT03215030|579730130|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
160547040|NCT03215030|579730131|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
160547041|NCT03215030|579730132|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
160547042|NCT03215030|579730133|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
160547043|NCT03215030|579730134|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
160547044|NCT03215030|579730135|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
160547045|NCT03215030|579730136|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
160547046|NCT03215030|579730137|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
160547047|NCT03215030|579730138|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
160547048|NCT03215030|579730139|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
160547049|NCT03215030|579730128|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160547050|NCT03215030|579730129|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160547051|NCT03215030|579730130|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160547052|NCT03215030|579730131|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160547053|NCT03215030|579730132|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160547054|NCT03215030|579730133|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160890993|NCT02247531|580996793|FG001|Overall Study|Study Terminated by Sponsor|66|||
160890994|NCT02247531|580996794|FG002|Overall Study|Study Terminated by Sponsor|62|||
160890995|NCT02247531|580996792|FG000|Overall Study|Physician Decision|0|||
160890996|NCT02247531|580996793|FG001|Overall Study|Physician Decision|2|||
160890997|NCT02247531|580996794|FG002|Overall Study|Physician Decision|2|||
160890998|NCT02247531|580996792|FG000|Overall Study|Unspecified Reason|2|||
160890999|NCT02247531|580996793|FG001|Overall Study|Unspecified Reason|3|||
160891000|NCT02247531|580996794|FG002|Overall Study|Unspecified Reason|4|||
160891001|NCT01751802|580996806|FG000|Overall Study|Adverse Event|4|||
160891002|NCT01751802|580996807|FG001|Overall Study|Adverse Event|2|||
160891003|NCT01229397|580996808|FG000|Overall Study|Withdrawal by Subject|3|||
160547055|NCT03215030|579730134|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160547056|NCT03215030|579730135|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
160547057|NCT03215030|579730136|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160547058|NCT03215030|579730137|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160547059|NCT03215030|579730138|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160547060|NCT03215030|579730139|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
160547061|NCT03215030|579730128|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160547062|NCT03215030|579730129|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160547063|NCT03215030|579730130|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160547064|NCT03215030|579730131|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160547065|NCT03215030|579730132|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
160547066|NCT03215030|579730133|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
160547067|NCT03215030|579730134|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
160547068|NCT03215030|579730135|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
160642204|NCT01335399|580074215|FG000|Treatment Period|No longer meet study criteria|1|||
160642205|NCT01335399|580074216|FG001|Treatment Period|No longer meet study criteria|1|||
160642206|NCT01335399|580074215|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
160642207|NCT01335399|580074216|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
160642208|NCT01120600|580074219|FG000|Overall Study|Adverse Event|7|||
160642209|NCT01120600|580074220|FG001|Overall Study|Adverse Event|7|||
160642210|NCT01120600|580074219|FG000|Overall Study|Excessive Bone Loss|0|||
160642211|NCT01120600|580074220|FG001|Overall Study|Excessive Bone Loss|4|||
160891004|NCT01229397|580996809|FG001|Overall Study|Withdrawal by Subject|3|||
160891005|NCT01229397|580996808|FG000|Overall Study|Lost to Follow-up|7|||
160891006|NCT01229397|580996809|FG001|Overall Study|Lost to Follow-up|6|||
160642212|NCT01120600|580074219|FG000|Overall Study|Lost to Follow-up|1|||
160891007|NCT01229397|580996808|FG000|Overall Study|Migrated/moved from study area|1|||
160547069|NCT03215030|579730136|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160547070|NCT03215030|579730137|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160642213|NCT01120600|580074220|FG001|Overall Study|Lost to Follow-up|3|||
160642214|NCT01120600|580074219|FG000|Overall Study|Physician Decision|1|||
160642215|NCT01120600|580074220|FG001|Overall Study|Physician Decision|3|||
160642216|NCT01120600|580074219|FG000|Overall Study|Protocol Violation|0|||
160891008|NCT01229397|580996809|FG001|Overall Study|Migrated/moved from study area|0|||
160642217|NCT01120600|580074220|FG001|Overall Study|Protocol Violation|4|||
160642218|NCT01120600|580074219|FG000|Overall Study|Withdrawal by Subject|10|||
160642219|NCT01120600|580074220|FG001|Overall Study|Withdrawal by Subject|11|||
160642220|NCT01165242|580074223|FG000|Overall Study|Unreachable Subjects|1|||
160642221|NCT01165242|580074224|FG001|Overall Study|Unreachable Subjects|0|||
160642222|NCT01165242|580074225|FG002|Overall Study|Unreachable Subjects|0|||
160642223|NCT01165242|580074223|FG000|Overall Study|Incarcerated Subjects|0|||
160642224|NCT01165242|580074224|FG001|Overall Study|Incarcerated Subjects|1|||
160642225|NCT01165242|580074225|FG002|Overall Study|Incarcerated Subjects|0|||
160642226|NCT01165242|580074223|FG000|Overall Study|Visit 2 Declined by Subject|0|||
160642227|NCT01165242|580074224|FG001|Overall Study|Visit 2 Declined by Subject|0|||
160642228|NCT01165242|580074225|FG002|Overall Study|Visit 2 Declined by Subject|1|||
160642229|NCT01165242|580074223|FG000|Overall Study|Withdrawal by Subject|0|||
160642230|NCT01165242|580074224|FG001|Overall Study|Withdrawal by Subject|2|||
160642231|NCT01165242|580074225|FG002|Overall Study|Withdrawal by Subject|2|||
160642232|NCT01165242|580074223|FG000|Overall Study|Extended Holiday|0|||
160642233|NCT01165242|580074224|FG001|Overall Study|Extended Holiday|0|||
160642234|NCT01165242|580074225|FG002|Overall Study|Extended Holiday|1|||
160642235|NCT01165242|580074223|FG000|Overall Study|Lost to Follow-up|9|||
160891009|NCT00608543|580996810|FG000|Overall Study|Adverse Event|4|||
160891010|NCT01143207|580996812|FG000|Overall Study|Lost to Follow-up|2|||
160642236|NCT01165242|580074224|FG001|Overall Study|Lost to Follow-up|7|||
160891011|NCT01869725|580996813|FG000|Overall Study|ineligible after registration|1|||
160642237|NCT01165242|580074225|FG002|Overall Study|Lost to Follow-up|10|||
160642238|NCT03372083|580074226|FG000|Overall Study|Adverse Event|3|||
160642239|NCT03372083|580074226|FG000|Overall Study|Physician Decision|1|||
160547071|NCT03215030|579730138|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160547072|NCT03215030|579730139|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160547073|NCT03215030|579730128|FG000|Part 2: Dose Expansion|Death|0|||
160547074|NCT03215030|579730129|FG001|Part 2: Dose Expansion|Death|0|||
160547075|NCT03215030|579730130|FG002|Part 2: Dose Expansion|Death|0|||
160547076|NCT03215030|579730131|FG003|Part 2: Dose Expansion|Death|0|||
160547077|NCT03215030|579730132|FG004|Part 2: Dose Expansion|Death|3|||
160547078|NCT03215030|579730133|FG005|Part 2: Dose Expansion|Death|1|||
160547079|NCT03215030|579730134|FG006|Part 2: Dose Expansion|Death|5|||
160547080|NCT03215030|579730135|FG007|Part 2: Dose Expansion|Death|4|||
160547081|NCT03215030|579730136|FG008|Part 2: Dose Expansion|Death|0|||
160547082|NCT03215030|579730137|FG009|Part 2: Dose Expansion|Death|0|||
160547083|NCT03215030|579730138|FG010|Part 2: Dose Expansion|Death|0|||
160547084|NCT03215030|579730139|FG011|Part 2: Dose Expansion|Death|0|||
160547085|NCT03215030|579730128|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
160547086|NCT03215030|579730129|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
160547087|NCT03215030|579730130|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
160547088|NCT03215030|579730131|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
160547089|NCT03215030|579730132|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
160547090|NCT03215030|579730133|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
160547091|NCT03215030|579730134|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
160547092|NCT03215030|579730135|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
160547093|NCT03215030|579730136|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
160547094|NCT03215030|579730137|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
160547095|NCT03215030|579730138|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
160547096|NCT03215030|579730139|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
160547097|NCT03215030|579730128|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
160547098|NCT03215030|579730129|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
160547099|NCT03215030|579730130|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
160547100|NCT03215030|579730131|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
160547101|NCT03215030|579730132|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
160547102|NCT03215030|579730133|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
160547103|NCT03215030|579730134|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
160547104|NCT03215030|579730135|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
160547105|NCT03215030|579730136|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
160547106|NCT03215030|579730137|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
160547107|NCT03215030|579730138|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
160547108|NCT03215030|579730139|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
160547109|NCT03215030|579730128|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160547110|NCT03215030|579730129|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160547111|NCT03215030|579730130|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160547112|NCT03215030|579730131|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160547113|NCT03215030|579730132|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160547114|NCT03215030|579730133|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160547115|NCT03215030|579730134|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160547116|NCT03215030|579730135|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160891012|NCT01869725|580996813|FG000|Overall Study|Death|1|||
160547117|NCT03215030|579730136|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
160547118|NCT03215030|579730137|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
160547119|NCT03215030|579730138|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160547120|NCT03215030|579730139|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160547121|NCT03215030|579730128|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
160547122|NCT03215030|579730129|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
160547123|NCT03215030|579730130|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
160547124|NCT03215030|579730131|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
160547125|NCT03215030|579730132|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
160547126|NCT03215030|579730133|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
160547127|NCT03215030|579730134|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
160547128|NCT03215030|579730135|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
160547129|NCT03215030|579730136|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
160547130|NCT03215030|579730137|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
160547131|NCT03215030|579730138|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
160547132|NCT03215030|579730139|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
160547133|NCT03215030|579730128|FG000|Part 3: Dose Extension|Death|0|||
160547134|NCT03215030|579730129|FG001|Part 3: Dose Extension|Death|0|||
160547135|NCT03215030|579730130|FG002|Part 3: Dose Extension|Death|0|||
160547136|NCT03215030|579730131|FG003|Part 3: Dose Extension|Death|0|||
160547137|NCT03215030|579730132|FG004|Part 3: Dose Extension|Death|0|||
160547138|NCT03215030|579730133|FG005|Part 3: Dose Extension|Death|0|||
160547139|NCT03215030|579730134|FG006|Part 3: Dose Extension|Death|0|||
160547140|NCT03215030|579730135|FG007|Part 3: Dose Extension|Death|0|||
160891013|NCT01869725|580996813|FG000|Overall Study|Lost to Follow-up|2|||
160547141|NCT03215030|579730136|FG008|Part 3: Dose Extension|Death|19|||
160547142|NCT03215030|579730137|FG009|Part 3: Dose Extension|Death|20|||
160547143|NCT03215030|579730138|FG010|Part 3: Dose Extension|Death|0|||
160547144|NCT03215030|579730139|FG011|Part 3: Dose Extension|Death|0|||
160547145|NCT03215030|579730128|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
160547146|NCT03215030|579730129|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
160547147|NCT03215030|579730130|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
160547148|NCT03215030|579730131|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
160547149|NCT03215030|579730132|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
160547150|NCT03215030|579730133|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
160547151|NCT03215030|579730134|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
160547152|NCT03215030|579730135|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
160547153|NCT03215030|579730136|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
160547154|NCT03215030|579730137|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
160547155|NCT03215030|579730138|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
160547156|NCT03215030|579730139|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
160547157|NCT03215030|579730128|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
160547158|NCT03215030|579730129|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
160547159|NCT03215030|579730130|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
160547160|NCT03215030|579730131|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
160547161|NCT03215030|579730132|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
160547162|NCT03215030|579730133|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
160547163|NCT03215030|579730134|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
160547164|NCT03215030|579730135|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
160788332|NCT03679884|580610887|FG000|Overall Study|Death|1|||
160788333|NCT03679884|580610888|FG001|Overall Study|Death|0|||
160788334|NCT03679884|580610889|FG002|Overall Study|Death|0|||
160788335|NCT03679884|580610890|FG003|Overall Study|Death|0|||
160788336|NCT03679884|580610891|FG004|Overall Study|Death|0|||
160788337|NCT03679884|580610887|FG000|Overall Study|Adverse Event|2|||
160788338|NCT03679884|580610888|FG001|Overall Study|Adverse Event|10|||
160788339|NCT03679884|580610889|FG002|Overall Study|Adverse Event|9|||
160788340|NCT03679884|580610890|FG003|Overall Study|Adverse Event|6|||
160788341|NCT03679884|580610891|FG004|Overall Study|Adverse Event|6|||
160788342|NCT03679884|580610887|FG000|Overall Study|Withdrawal by Subject|12|||
160788343|NCT03679884|580610888|FG001|Overall Study|Withdrawal by Subject|23|||
160788344|NCT03679884|580610889|FG002|Overall Study|Withdrawal by Subject|8|||
160788345|NCT03679884|580610890|FG003|Overall Study|Withdrawal by Subject|8|||
160547165|NCT03215030|579730136|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
160547166|NCT03215030|579730137|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
160547167|NCT03215030|579730138|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
160547168|NCT03215030|579730139|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
160547169|NCT01745146|579730140|FG000|Overall Study|Withdrawal by Subject|1|||
160547170|NCT01745146|579730141|FG001|Overall Study|Withdrawal by Subject|3|||
160547171|NCT01745146|579730140|FG000|Overall Study|Lost to Follow-up|2|||
160788346|NCT03679884|580610891|FG004|Overall Study|Withdrawal by Subject|9|||
160788347|NCT03679884|580610887|FG000|Overall Study|Lost to Follow-up|1|||
160788348|NCT03679884|580610888|FG001|Overall Study|Lost to Follow-up|4|||
160788349|NCT03679884|580610889|FG002|Overall Study|Lost to Follow-up|2|||
160788350|NCT03679884|580610890|FG003|Overall Study|Lost to Follow-up|0|||
160788351|NCT03679884|580610891|FG004|Overall Study|Lost to Follow-up|3|||
160547172|NCT01745146|579730141|FG001|Overall Study|Lost to Follow-up|0|||
160547173|NCT00130832|579730142|FG000|Overall Study|Adverse Event|1|||
160547174|NCT00130832|579730143|FG001|Overall Study|Adverse Event|1|||
160547175|NCT00130832|579730142|FG000|Overall Study|Lost to Follow-up|1|||
160547176|NCT00130832|579730143|FG001|Overall Study|Lost to Follow-up|2|||
160547177|NCT00130832|579730142|FG000|Overall Study|Protocol Violation|6|||
160788352|NCT00930176|580610895|FG000|Overall Study|Death|1|||
160788353|NCT02792257|580610898|FG000|Overall Study|Lost to Follow-up|3|||
160788354|NCT02792257|580610899|FG001|Overall Study|Lost to Follow-up|4|||
160547178|NCT00130832|579730143|FG001|Overall Study|Protocol Violation|8|||
160547179|NCT00130832|579730142|FG000|Overall Study|Withdrawal by Subject|6|||
160547180|NCT00130832|579730143|FG001|Overall Study|Withdrawal by Subject|1|||
160547181|NCT00130832|579730142|FG000|Overall Study|Moved|2|||
160547182|NCT00130832|579730143|FG001|Overall Study|Moved|2|||
160547183|NCT00130832|579730142|FG000|Overall Study|Other|0|||
160788355|NCT02792257|580610898|FG000|Overall Study|Allergy|0|||
160547184|NCT00130832|579730143|FG001|Overall Study|Other|3|||
160547185|NCT05617911|579730146|FG000|Overall Study|Withdrawal by Subject|1|||
160547186|NCT05617911|579730147|FG001|Overall Study|Withdrawal by Subject|0|||
160547187|NCT03975647|579730148|FG000|Overall Study|Death|71|||
160788356|NCT02792257|580610899|FG001|Overall Study|Allergy|1|||
160788357|NCT02792257|580610898|FG000|Overall Study|Protocol Violation|2|||
160788358|NCT02792257|580610899|FG001|Overall Study|Protocol Violation|0|||
160788359|NCT02792257|580610898|FG000|Overall Study|Excessive Agitation|0|||
160788360|NCT02792257|580610899|FG001|Overall Study|Excessive Agitation|1|||
160788361|NCT02792257|580610898|FG000|Overall Study|Not Feeling Well|0|||
160788362|NCT02792257|580610899|FG001|Overall Study|Not Feeling Well|1|||
160788363|NCT00992394|580610903|FG000|Overall Study|Lack of Efficacy|6|||
160547188|NCT03975647|579730149|FG001|Overall Study|Death|63|||
160547189|NCT03975647|579730148|FG000|Overall Study|Lost to Follow-up|2|||
160547190|NCT03975647|579730149|FG001|Overall Study|Lost to Follow-up|2|||
160547191|NCT03975647|579730148|FG000|Overall Study|Subject withdrawal of consent|7|||
160547192|NCT03975647|579730149|FG001|Overall Study|Subject withdrawal of consent|11|||
160547193|NCT04868903|579730150|FG000|Overall Study|Adverse Event|0|||
160547194|NCT04868903|579730151|FG001|Overall Study|Adverse Event|0|||
160547195|NCT04868903|579730152|FG002|Overall Study|Adverse Event|0|||
160547196|NCT04868903|579730153|FG003|Overall Study|Adverse Event|1|||
160547197|NCT04868903|579730150|FG000|Overall Study|Withdrawal by Subject|29|||
160547198|NCT04868903|579730151|FG001|Overall Study|Withdrawal by Subject|44|||
160547199|NCT04868903|579730152|FG002|Overall Study|Withdrawal by Subject|17|||
160547200|NCT04868903|579730153|FG003|Overall Study|Withdrawal by Subject|12|||
160547201|NCT04868903|579730150|FG000|Overall Study|Hyperparathyroidism|3|||
160547202|NCT04868903|579730151|FG001|Overall Study|Hyperparathyroidism|5|||
160547203|NCT04868903|579730152|FG002|Overall Study|Hyperparathyroidism|2|||
160547204|NCT04868903|579730153|FG003|Overall Study|Hyperparathyroidism|3|||
160547205|NCT03735667|579730154|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
160547206|NCT03735667|579730155|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
160547207|NCT03735667|579730156|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
160547208|NCT03735667|579730154|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
160547209|NCT03735667|579730155|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
160547210|NCT03735667|579730156|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
160547211|NCT03735667|579730154|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
160547212|NCT03735667|579730155|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
160547213|NCT03735667|579730156|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
160547214|NCT03735667|579730154|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
160547215|NCT03735667|579730155|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
160547216|NCT03735667|579730156|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
160547217|NCT03735667|579730154|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
160547218|NCT03735667|579730155|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
160547219|NCT03735667|579730156|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
160547220|NCT03735667|579730154|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
160547221|NCT03735667|579730155|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
160547222|NCT03735667|579730156|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
160547223|NCT03735667|579730154|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
160547224|NCT03735667|579730155|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
160547225|NCT03735667|579730156|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
160547226|NCT03735667|579730154|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
160547227|NCT03735667|579730155|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
160547228|NCT03735667|579730156|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
160547229|NCT03735667|579730154|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
160547230|NCT03735667|579730155|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
160547231|NCT03735667|579730156|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
160547232|NCT03735667|579730154|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
160547233|NCT03735667|579730155|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
160642240|NCT03372083|580074226|FG000|Overall Study|Withdrawal by Subject|1|||
160642241|NCT01690520|580074227|FG000|Overall Study|Death|25|||
160642242|NCT01690520|580074228|FG001|Overall Study|Death|21|||
160642243|NCT01690520|580074227|FG000|Overall Study|Lost to Follow-up|2|||
160642244|NCT01690520|580074228|FG001|Overall Study|Lost to Follow-up|3|||
160642245|NCT01690520|580074227|FG000|Overall Study|Withdrawal by Subject|2|||
160642246|NCT01690520|580074228|FG001|Overall Study|Withdrawal by Subject|0|||
160642247|NCT01690520|580074227|FG000|Overall Study|Relapse|0|||
160642248|NCT01690520|580074228|FG001|Overall Study|Relapse|1|||
160642249|NCT01690520|580074227|FG000|Overall Study|Other|0|||
160642250|NCT01690520|580074228|FG001|Overall Study|Other|1|||
160642251|NCT01690520|580074227|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
160642252|NCT01690520|580074228|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
160642253|NCT02544633|580074231|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
160642254|NCT02544633|580074232|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
160642255|NCT02544633|580074233|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
160642256|NCT02544633|580074234|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
160642257|NCT02544633|580074231|FG000|Treatment Period|Adverse Event|7|||
160642258|NCT02544633|580074232|FG001|Treatment Period|Adverse Event|4|||
160642259|NCT02544633|580074233|FG002|Treatment Period|Adverse Event|0|||
160642260|NCT02544633|580074234|FG003|Treatment Period|Adverse Event|5|||
160547234|NCT03735667|579730156|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
160547235|NCT03735667|579730154|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
160642261|NCT02544633|580074231|FG000|Treatment Period|Lack of Efficacy|17|||
160642262|NCT02544633|580074232|FG001|Treatment Period|Lack of Efficacy|11|||
160642263|NCT02544633|580074233|FG002|Treatment Period|Lack of Efficacy|5|||
160642264|NCT02544633|580074234|FG003|Treatment Period|Lack of Efficacy|5|||
160547236|NCT03735667|579730155|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
160547237|NCT03735667|579730156|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
160547238|NCT03735667|579730154|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
160547239|NCT03735667|579730155|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
160547240|NCT03735667|579730156|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
160547241|NCT03092726|579730157|FG000|Overall Study|Adverse Event|3|||
160547242|NCT03092726|579730158|FG001|Overall Study|Adverse Event|10|||
160547243|NCT03092726|579730157|FG000|Overall Study|Lack of Efficacy|0|||
160547244|NCT03092726|579730158|FG001|Overall Study|Lack of Efficacy|1|||
160547245|NCT03092726|579730157|FG000|Overall Study|Lost to Follow-up|1|||
160547246|NCT03092726|579730158|FG001|Overall Study|Lost to Follow-up|0|||
160547247|NCT03092726|579730157|FG000|Overall Study|Withdrawal by Subject|5|||
160547248|NCT03092726|579730158|FG001|Overall Study|Withdrawal by Subject|3|||
160547249|NCT04418765|579730163|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
160547250|NCT04418765|579730164|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
160788364|NCT00992394|580610904|FG001|Overall Study|Lack of Efficacy|3|||
160788365|NCT00992394|580610903|FG000|Overall Study|Adverse Event|4|||
160788366|NCT00992394|580610904|FG001|Overall Study|Adverse Event|5|||
160547251|NCT04418765|579730165|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
160788367|NCT00992394|580610903|FG000|Overall Study|Withdrawal by Subject|8|||
160547252|NCT04418765|579730163|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
160547253|NCT04418765|579730164|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
160547254|NCT04418765|579730165|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
160547255|NCT04418765|579730163|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
160547256|NCT04418765|579730164|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
160547257|NCT04418765|579730165|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
160547258|NCT04418765|579730163|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
160547259|NCT04418765|579730164|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
160547260|NCT04418765|579730165|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
160547261|NCT04418765|579730163|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
160547262|NCT04418765|579730164|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
160547263|NCT04418765|579730165|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
160547264|NCT04418765|579730163|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
160547265|NCT04418765|579730164|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
160547266|NCT04418765|579730165|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
160547267|NCT04418765|579730163|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
160547268|NCT04418765|579730164|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
160547269|NCT04418765|579730165|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
160547270|NCT04418765|579730163|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
160547271|NCT04418765|579730164|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
160547272|NCT04418765|579730165|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
160547273|NCT04418765|579730163|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
160547274|NCT04418765|579730164|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
160547275|NCT04418765|579730165|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
160547276|NCT04418765|579730163|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
160547277|NCT04418765|579730164|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
160547278|NCT04418765|579730165|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
160547279|NCT04418765|579730163|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
160547280|NCT04418765|579730164|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
160547281|NCT04418765|579730165|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
160547282|NCT04418765|579730163|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
160547283|NCT04418765|579730164|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
160547284|NCT04418765|579730165|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
160547285|NCT04418765|579730163|FG000|Extension Period (48 Weeks)|Other than specified|0|||
160547286|NCT04418765|579730164|FG001|Extension Period (48 Weeks)|Other than specified|5|||
160788368|NCT00992394|580610904|FG001|Overall Study|Withdrawal by Subject|2|||
160788369|NCT00992394|580610903|FG000|Overall Study|Physician Decision|1|||
160788370|NCT00992394|580610904|FG001|Overall Study|Physician Decision|0|||
160788371|NCT00992394|580610903|FG000|Overall Study|Protocol Violation|2|||
160788372|NCT00992394|580610904|FG001|Overall Study|Protocol Violation|4|||
160788373|NCT00992394|580610903|FG000|Overall Study|Lost to Follow-up|2|||
160788374|NCT00992394|580610904|FG001|Overall Study|Lost to Follow-up|0|||
160788375|NCT00992394|580610903|FG000|Overall Study|Other event|1|||
160788376|NCT00992394|580610904|FG001|Overall Study|Other event|0|||
160788377|NCT01245049|580610905|FG000|Overall Study|Migrated/moved from study area|0|||
160788378|NCT01245049|580610906|FG001|Overall Study|Migrated/moved from study area|1|||
160547287|NCT04418765|579730165|FG002|Extension Period (48 Weeks)|Other than specified|2|||
160547288|NCT01121393|579730169|FG000|Overall Study|Progressive disease|201|||
160788379|NCT01245049|580610905|FG000|Overall Study|Withdrawal by Subject|0|||
160788380|NCT01245049|580610906|FG001|Overall Study|Withdrawal by Subject|1|||
160788381|NCT01245049|580610905|FG000|Overall Study|Lost to Follow-up|1|||
160788382|NCT01245049|580610906|FG001|Overall Study|Lost to Follow-up|2|||
160788383|NCT00450749|580610907|FG000|Overall Study|Withdrawal by Subject|0|||
160788384|NCT00450749|580610908|FG001|Overall Study|Withdrawal by Subject|0|||
160788385|NCT00450749|580610909|FG002|Overall Study|Withdrawal by Subject|2|||
160788386|NCT00450749|580610907|FG000|Overall Study|Noncompliant|0|||
160788387|NCT00450749|580610908|FG001|Overall Study|Noncompliant|1|||
160788388|NCT00450749|580610909|FG002|Overall Study|Noncompliant|0|||
160788389|NCT02151604|580610910|FG000|Overall Study|Lost to Follow-up|3|||
160788390|NCT02151604|580610910|FG000|Overall Study|Withdrawal by Subject|2|||
160547289|NCT01121393|579730170|FG001|Overall Study|Progressive disease|20|||
160547290|NCT01121393|579730169|FG000|Overall Study|Other Adverse events|24|||
160547291|NCT01121393|579730170|FG001|Overall Study|Other Adverse events|45|||
160547292|NCT01121393|579730169|FG000|Overall Study|Non-compliant with protocol|0|||
160547293|NCT01121393|579730170|FG001|Overall Study|Non-compliant with protocol|3|||
160547294|NCT01121393|579730169|FG000|Overall Study|Lost to Follow-up|1|||
160547295|NCT01121393|579730170|FG001|Overall Study|Lost to Follow-up|0|||
160547296|NCT01121393|579730169|FG000|Overall Study|Refused cont. medication|7|||
160547297|NCT01121393|579730170|FG001|Overall Study|Refused cont. medication|7|||
160547298|NCT01121393|579730169|FG000|Overall Study|Not treated|3|||
160547299|NCT01121393|579730170|FG001|Overall Study|Not treated|9|||
160547300|NCT01121393|579730169|FG000|Overall Study|Other than listed|6|||
160547301|NCT01121393|579730170|FG001|Overall Study|Other than listed|0|||
160547302|NCT01926782|579730171|FG000|Overall Study|Participant moved|2|||
160547303|NCT01926782|579730172|FG001|Overall Study|Participant moved|0|||
160547304|NCT01926782|579730173|FG002|Overall Study|Participant moved|1|||
160547305|NCT01926782|579730174|FG003|Overall Study|Participant moved|1|||
160547306|NCT01926782|579730175|FG004|Overall Study|Participant moved|0|||
160547307|NCT01926782|579730176|FG005|Overall Study|Participant moved|3|||
160547308|NCT01926782|579730171|FG000|Overall Study|Physician Decision|0|||
160547309|NCT01926782|579730172|FG001|Overall Study|Physician Decision|2|||
160547310|NCT01926782|579730173|FG002|Overall Study|Physician Decision|1|||
160547311|NCT01926782|579730174|FG003|Overall Study|Physician Decision|1|||
160547312|NCT01926782|579730175|FG004|Overall Study|Physician Decision|0|||
160547313|NCT01926782|579730176|FG005|Overall Study|Physician Decision|0|||
160547314|NCT01926782|579730171|FG000|Overall Study|Other than specified|2|||
160547315|NCT01926782|579730172|FG001|Overall Study|Other than specified|3|||
160547316|NCT01926782|579730173|FG002|Overall Study|Other than specified|5|||
160547317|NCT01926782|579730174|FG003|Overall Study|Other than specified|12|||
160547318|NCT01926782|579730175|FG004|Overall Study|Other than specified|4|||
160547319|NCT01926782|579730176|FG005|Overall Study|Other than specified|11|||
160547320|NCT01926782|579730171|FG000|Overall Study|Adverse Event|13|||
160547321|NCT01926782|579730172|FG001|Overall Study|Adverse Event|4|||
160547322|NCT01926782|579730173|FG002|Overall Study|Adverse Event|17|||
160547323|NCT01926782|579730174|FG003|Overall Study|Adverse Event|4|||
160547324|NCT01926782|579730175|FG004|Overall Study|Adverse Event|3|||
160547325|NCT01926782|579730176|FG005|Overall Study|Adverse Event|14|||
160547326|NCT01926782|579730171|FG000|Overall Study|Poor compliance to protocol|5|||
160547327|NCT01926782|579730172|FG001|Overall Study|Poor compliance to protocol|3|||
160547328|NCT01926782|579730173|FG002|Overall Study|Poor compliance to protocol|8|||
160547329|NCT01926782|579730174|FG003|Overall Study|Poor compliance to protocol|0|||
160547330|NCT01926782|579730175|FG004|Overall Study|Poor compliance to protocol|1|||
160547331|NCT01926782|579730176|FG005|Overall Study|Poor compliance to protocol|6|||
160547332|NCT01926782|579730171|FG000|Overall Study|Randomized and not treated|0|||
160547333|NCT01926782|579730172|FG001|Overall Study|Randomized and not treated|0|||
160547334|NCT01926782|579730173|FG002|Overall Study|Randomized and not treated|0|||
160547335|NCT01926782|579730174|FG003|Overall Study|Randomized and not treated|1|||
160547336|NCT01926782|579730175|FG004|Overall Study|Randomized and not treated|0|||
160547337|NCT01926782|579730176|FG005|Overall Study|Randomized and not treated|0|||
160547338|NCT01926782|579730171|FG000|Overall Study|Withdrawal by Subject|6|||
160547339|NCT01926782|579730172|FG001|Overall Study|Withdrawal by Subject|1|||
160547340|NCT01926782|579730173|FG002|Overall Study|Withdrawal by Subject|8|||
160547341|NCT01926782|579730174|FG003|Overall Study|Withdrawal by Subject|1|||
160547342|NCT01926782|579730175|FG004|Overall Study|Withdrawal by Subject|0|||
160547343|NCT01926782|579730176|FG005|Overall Study|Withdrawal by Subject|5|||
160547344|NCT01926782|579730171|FG000|Overall Study|Related to study drug administration|0|||
160547345|NCT01926782|579730172|FG001|Overall Study|Related to study drug administration|0|||
160547346|NCT01926782|579730173|FG002|Overall Study|Related to study drug administration|0|||
160547347|NCT01926782|579730174|FG003|Overall Study|Related to study drug administration|0|||
160547348|NCT01926782|579730175|FG004|Overall Study|Related to study drug administration|0|||
160547349|NCT01926782|579730176|FG005|Overall Study|Related to study drug administration|2|||
160547350|NCT00577993|579730182|FG000|Overall Study|Adverse Event|1|||
160547351|NCT00577993|579730183|FG001|Overall Study|Adverse Event|0|||
160547352|NCT00577993|579730184|FG002|Overall Study|Adverse Event|0|||
160547353|NCT00577993|579730182|FG000|Overall Study|Death|0|||
160547354|NCT00577993|579730183|FG001|Overall Study|Death|1|||
160547355|NCT00577993|579730184|FG002|Overall Study|Death|1|||
160547356|NCT00577993|579730182|FG000|Overall Study|Lack of Efficacy|0|||
160547357|NCT00577993|579730183|FG001|Overall Study|Lack of Efficacy|1|||
160547358|NCT00577993|579730184|FG002|Overall Study|Lack of Efficacy|0|||
160547359|NCT00577993|579730182|FG000|Overall Study|Protocol Violation|2|||
160547360|NCT00577993|579730183|FG001|Overall Study|Protocol Violation|3|||
160547361|NCT00577993|579730184|FG002|Overall Study|Protocol Violation|0|||
160547362|NCT00577993|579730182|FG000|Overall Study|Withdrawal by Subject|1|||
160547363|NCT00577993|579730183|FG001|Overall Study|Withdrawal by Subject|0|||
160547364|NCT00577993|579730184|FG002|Overall Study|Withdrawal by Subject|2|||
160547365|NCT00577993|579730182|FG000|Overall Study|Conversion|2|||
160547366|NCT00577993|579730183|FG001|Overall Study|Conversion|5|||
160547367|NCT00577993|579730184|FG002|Overall Study|Conversion|0|||
160547368|NCT00577993|579730182|FG000|Overall Study|Uninsured|1|||
160547369|NCT00577993|579730183|FG001|Overall Study|Uninsured|0|||
160547370|NCT00577993|579730184|FG002|Overall Study|Uninsured|0|||
160547371|NCT02217566|579730185|FG000|Overall Study|Lost to Follow-up|2|||
160547372|NCT02217566|579730185|FG000|Overall Study|Death|3|||
160547373|NCT02217566|579730185|FG000|Overall Study|Early study termination|6|||
160547374|NCT02064387|579730190|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
160547375|NCT02064387|579730191|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
160547376|NCT02064387|579730192|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
160547377|NCT02064387|579730193|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
160547378|NCT02064387|579730194|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
160547379|NCT02064387|579730195|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
160547380|NCT02064387|579730196|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
160547381|NCT02064387|579730197|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
160547382|NCT02064387|579730198|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
160547383|NCT02064387|579730199|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
160547384|NCT02064387|579730200|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
160547385|NCT02064387|579730201|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
160547386|NCT02064387|579730190|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547387|NCT02064387|579730191|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547388|NCT02064387|579730192|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547389|NCT02064387|579730193|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547390|NCT02064387|579730194|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547391|NCT02064387|579730195|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547392|NCT02064387|579730196|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547393|NCT02064387|579730197|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
160547394|NCT02064387|579730198|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547395|NCT02064387|579730199|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547396|NCT02064387|579730200|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547397|NCT02064387|579730201|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
160547398|NCT02064387|579730190|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547399|NCT02064387|579730191|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547400|NCT02064387|579730192|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547401|NCT02064387|579730193|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547402|NCT02064387|579730194|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547403|NCT02064387|579730195|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547404|NCT02064387|579730196|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547405|NCT02064387|579730197|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547406|NCT02064387|579730198|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
160547407|NCT02064387|579730199|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547408|NCT02064387|579730200|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547409|NCT02064387|579730201|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160547410|NCT02064387|579730190|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
160547411|NCT02064387|579730191|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
160547412|NCT02064387|579730192|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
160547413|NCT02064387|579730193|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
160547414|NCT02064387|579730194|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
160547415|NCT02064387|579730195|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
160547416|NCT02064387|579730196|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
160547417|NCT02064387|579730197|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
160547418|NCT02064387|579730198|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
160547419|NCT02064387|579730199|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
160547420|NCT02064387|579730200|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
160547421|NCT02064387|579730201|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
160547422|NCT02064387|579730190|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547423|NCT02064387|579730191|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547424|NCT02064387|579730192|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547425|NCT02064387|579730193|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547426|NCT02064387|579730194|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547427|NCT02064387|579730195|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547428|NCT02064387|579730196|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547429|NCT02064387|579730197|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547430|NCT02064387|579730198|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547431|NCT02064387|579730199|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547432|NCT02064387|579730200|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
160547433|NCT02064387|579730201|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160547434|NCT02436876|579730205|FG000|Overall Study|Lost to Follow-up|0|||
160547435|NCT02436876|579730206|FG001|Overall Study|Lost to Follow-up|1|||
160547436|NCT02436876|579730207|FG002|Overall Study|Lost to Follow-up|1|||
160547437|NCT02436876|579730208|FG003|Overall Study|Lost to Follow-up|1|||
160547438|NCT02436876|579730205|FG000|Overall Study|Withdrawal by Subject|1|||
160547439|NCT02436876|579730206|FG001|Overall Study|Withdrawal by Subject|0|||
160547440|NCT02436876|579730207|FG002|Overall Study|Withdrawal by Subject|0|||
160547441|NCT02436876|579730208|FG003|Overall Study|Withdrawal by Subject|1|||
160547442|NCT02436876|579730205|FG000|Overall Study|Physician Decision|0|||
160547443|NCT02436876|579730206|FG001|Overall Study|Physician Decision|2|||
160891014|NCT03416374|580996818|FG000|Between Treatment Period I and II|Other|0|||
160891015|NCT03416374|580996819|FG001|Between Treatment Period I and II|Other|9|||
160891016|NCT03416374|580996818|FG000|Treatment Period II|Lack of Efficacy|3|||
160891017|NCT03416374|580996819|FG001|Treatment Period II|Lack of Efficacy|11|||
160891018|NCT03416374|580996818|FG000|Treatment Period II|Adverse Event|1|||
160891019|NCT03416374|580996819|FG001|Treatment Period II|Adverse Event|4|||
160891020|NCT03416374|580996818|FG000|Treatment Period II|Death|0|||
160891021|NCT03416374|580996819|FG001|Treatment Period II|Death|1|||
160891022|NCT03416374|580996818|FG000|Treatment Period II|Other|0|||
160891023|NCT03416374|580996819|FG001|Treatment Period II|Other|2|||
160891024|NCT03463031|580996822|FG000|Overall Study|Withdrawal by Subject|4|||
160891025|NCT03463031|580996823|FG001|Overall Study|Withdrawal by Subject|2|||
160891026|NCT03463031|580996822|FG000|Overall Study|Investigator/Sponsor Decision|0|||
160891027|NCT03463031|580996823|FG001|Overall Study|Investigator/Sponsor Decision|1|||
160891028|NCT03463031|580996822|FG000|Overall Study|Lost to Follow-up|1|||
160891029|NCT03463031|580996823|FG001|Overall Study|Lost to Follow-up|1|||
160891030|NCT03463031|580996822|FG000|Overall Study|Adverse Event|4|||
160891031|NCT03463031|580996823|FG001|Overall Study|Adverse Event|1|||
160891032|NCT03463031|580996822|FG000|Overall Study|Use of prohibited medication by subject|1|||
160891033|NCT03463031|580996823|FG001|Overall Study|Use of prohibited medication by subject|0|||
160891034|NCT01025154|580996824|FG000|Overall Study|Lost to Follow-up|1|||
160891035|NCT01025154|580996824|FG000|Overall Study|Withdrawal by Subject|1|||
160891036|NCT01810432|580996825|FG000|Washout|Protocol Violation|0|||
160891037|NCT01810432|580996826|FG001|Washout|Protocol Violation|1|||
160891038|NCT01810432|580996825|FG000|Washout|Adverse Event|1|||
160891039|NCT01810432|580996826|FG001|Washout|Adverse Event|0|||
160891040|NCT01810432|580996825|FG000|Period 2|Withdrawal by Subject|2|||
160891041|NCT01810432|580996826|FG001|Period 2|Withdrawal by Subject|1|||
160891042|NCT01810432|580996825|FG000|Period 2|Physician Decision|1|||
160891043|NCT01810432|580996826|FG001|Period 2|Physician Decision|0|||
160891044|NCT01810432|580996825|FG000|Period 2|Lost to Follow-up|1|||
160891045|NCT01810432|580996826|FG001|Period 2|Lost to Follow-up|1|||
160891046|NCT02147184|580996827|FG000|Overall Study|Lost to Follow-up|28|||
160891047|NCT02147184|580996828|FG001|Overall Study|Lost to Follow-up|15|||
160891048|NCT02147184|580996827|FG000|Overall Study|Study Burden|11|||
160891049|NCT02147184|580996828|FG001|Overall Study|Study Burden|7|||
160891050|NCT02147184|580996827|FG000|Overall Study|Pregnancy|6|||
160891051|NCT02147184|580996828|FG001|Overall Study|Pregnancy|0|||
160547444|NCT02436876|579730207|FG002|Overall Study|Physician Decision|1|||
160547445|NCT02436876|579730208|FG003|Overall Study|Physician Decision|0|||
160547446|NCT02436876|579730205|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
160547447|NCT02436876|579730206|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
160547448|NCT02436876|579730207|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
160547449|NCT02436876|579730208|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
160547450|NCT00999908|579730209|FG000|Treatment Period 1|Subject withdrew consent|2|||
160547451|NCT00999908|579730210|FG001|Treatment Period 1|Subject withdrew consent|0|||
160547452|NCT00999908|579730211|FG002|Treatment Period 1|Subject withdrew consent|0|||
160547453|NCT00999908|579730209|FG000|Treatment Period 2|Protocol Violation|1|||
160547454|NCT00999908|579730210|FG001|Treatment Period 2|Protocol Violation|0|||
160547455|NCT00999908|579730211|FG002|Treatment Period 2|Protocol Violation|0|||
160547456|NCT00075504|579730212|FG000|Overall Study|Withdrawal by Subject|9|||
160547457|NCT00075504|579730213|FG001|Overall Study|Withdrawal by Subject|7|||
160571831|NCT01633060|579816838|FG000|Treatment Phase|Subject/guardian decision|25|||
160891052|NCT02147184|580996827|FG000|Overall Study|Moved out of state|3|||
160891053|NCT02147184|580996828|FG001|Overall Study|Moved out of state|3|||
160891054|NCT02147184|580996827|FG000|Overall Study|Physician Decision|0|||
160891055|NCT02147184|580996828|FG001|Overall Study|Physician Decision|2|||
160547458|NCT01290692|579730214|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
160547459|NCT02780648|579730216|FG000|Overall Study|Disease Progression|1|||
160547460|NCT02780648|579730217|FG001|Overall Study|Disease Progression|0|||
160547461|NCT03215771|579730218|FG000|Overall Study|Withdrawal by Subject|2|||
160547462|NCT03215771|579730218|FG000|Overall Study|Physician Decision|1|||
160547463|NCT03127384|579730223|FG000|Overall Study|Lost to Follow-up|4|||
160547464|NCT03127384|579730223|FG000|Overall Study|Subject request|2|||
160547465|NCT00689871|579730224|FG000|Overall Study|Lost to Follow-up|123|||
160547466|NCT00689871|579730225|FG001|Overall Study|Lost to Follow-up|13|||
160547467|NCT00689871|579730226|FG002|Overall Study|Lost to Follow-up|37|||
160547468|NCT00689871|579730227|FG003|Overall Study|Lost to Follow-up|1|||
160547469|NCT00689871|579730224|FG000|Overall Study|Explanted of All Study Devices|36|||
160547470|NCT00689871|579730225|FG001|Overall Study|Explanted of All Study Devices|25|||
160547471|NCT00689871|579730226|FG002|Overall Study|Explanted of All Study Devices|29|||
160547472|NCT00689871|579730227|FG003|Overall Study|Explanted of All Study Devices|3|||
160547473|NCT00689871|579730224|FG000|Overall Study|Withdrawal by Subject|13|||
160547474|NCT00689871|579730225|FG001|Overall Study|Withdrawal by Subject|3|||
160547475|NCT00689871|579730226|FG002|Overall Study|Withdrawal by Subject|4|||
160547476|NCT00689871|579730227|FG003|Overall Study|Withdrawal by Subject|1|||
160547477|NCT00689871|579730224|FG000|Overall Study|Death|1|||
160547478|NCT00689871|579730225|FG001|Overall Study|Death|10|||
160547479|NCT00689871|579730226|FG002|Overall Study|Death|2|||
160547480|NCT00689871|579730227|FG003|Overall Study|Death|2|||
160547481|NCT00689871|579730224|FG000|Overall Study|Physician Decision|2|||
160547482|NCT00689871|579730225|FG001|Overall Study|Physician Decision|1|||
160547483|NCT00689871|579730226|FG002|Overall Study|Physician Decision|1|||
160547484|NCT00689871|579730227|FG003|Overall Study|Physician Decision|0|||
160547485|NCT02703311|579730228|FG000|Overall Study|Death|5|||
160547486|NCT02703311|579730228|FG000|Overall Study|Withdrawal by Subject|3|||
160547487|NCT00343889|579730229|FG000|Overall Study|Lost to Follow-up|2|||
160547488|NCT00343889|579730230|FG001|Overall Study|Lost to Follow-up|0|||
160547489|NCT00343889|579730229|FG000|Overall Study|Withdrawal by Subject|0|||
160547490|NCT00343889|579730230|FG001|Overall Study|Withdrawal by Subject|1|||
160547491|NCT00343889|579730229|FG000|Overall Study|Protocol Violation|1|||
160547492|NCT00343889|579730230|FG001|Overall Study|Protocol Violation|0|||
160547493|NCT05913232|579730234|FG000|Overall Study|Adverse Event|0|||
160547494|NCT05913232|579730235|FG001|Overall Study|Adverse Event|2|||
160547495|NCT05913232|579730236|FG002|Overall Study|Adverse Event|1|||
160547496|NCT05913232|579730237|FG003|Overall Study|Adverse Event|1|||
160547497|NCT04428476|579730240|FG000|Overall Study|Withdrawal by Subject|1|||
160547498|NCT04428476|579730240|FG000|Overall Study|Still on treatment|12|||
160547499|NCT04518462|579730247|FG000|Overall Study|Withdrawal by Subject|0|||
160547500|NCT04518462|579730248|FG001|Overall Study|Withdrawal by Subject|0|||
160547501|NCT04518462|579730249|FG002|Overall Study|Withdrawal by Subject|1|||
160547502|NCT04518462|579730247|FG000|Overall Study|Physician Decision|1|||
160547503|NCT04518462|579730248|FG001|Overall Study|Physician Decision|1|||
160547504|NCT04518462|579730249|FG002|Overall Study|Physician Decision|0|||
160547505|NCT00271817|579730250|FG000|Part 1|Adverse Event|68|||
160547506|NCT00271817|579730251|FG001|Part 1|Adverse Event|25|||
160547507|NCT00271817|579730252|FG002|Part 1|Adverse Event|156|||
160547508|NCT00271817|579730250|FG000|Part 1|Lost to Follow-up|6|||
160547509|NCT00271817|579730251|FG001|Part 1|Lost to Follow-up|8|||
160547510|NCT00271817|579730252|FG002|Part 1|Lost to Follow-up|24|||
160547511|NCT00271817|579730250|FG000|Part 1|Protocol Violation|5|||
160547512|NCT00271817|579730251|FG001|Part 1|Protocol Violation|4|||
160547513|NCT00271817|579730252|FG002|Part 1|Protocol Violation|7|||
160547514|NCT00271817|579730250|FG000|Part 1|Patient Moved|3|||
160547515|NCT00271817|579730251|FG001|Part 1|Patient Moved|1|||
160547516|NCT00271817|579730252|FG002|Part 1|Patient Moved|5|||
160547517|NCT00271817|579730250|FG000|Part 1|Withdrawal by Subject|23|||
160547518|NCT00271817|579730251|FG001|Part 1|Withdrawal by Subject|17|||
160547519|NCT00271817|579730252|FG002|Part 1|Withdrawal by Subject|45|||
160547520|NCT00271817|579730250|FG000|Part 1|LDL < 50 mg/dL|1|||
160547521|NCT00271817|579730251|FG001|Part 1|LDL < 50 mg/dL|4|||
160547522|NCT00271817|579730252|FG002|Part 1|LDL < 50 mg/dL|48|||
160547523|NCT00271817|579730250|FG000|Part 2|Adverse Event|0|||
160547524|NCT00271817|579730251|FG001|Part 2|Adverse Event|17|||
160547525|NCT00271817|579730252|FG002|Part 2|Adverse Event|33|||
160547526|NCT00271817|579730250|FG000|Part 2|Lack of Efficacy|0|||
160547527|NCT00271817|579730251|FG001|Part 2|Lack of Efficacy|1|||
160547528|NCT00271817|579730252|FG002|Part 2|Lack of Efficacy|6|||
160547529|NCT00271817|579730250|FG000|Part 2|Lost to Follow-up|0|||
160547530|NCT00271817|579730251|FG001|Part 2|Lost to Follow-up|6|||
160547531|NCT00271817|579730252|FG002|Part 2|Lost to Follow-up|18|||
160547532|NCT00271817|579730250|FG000|Part 2|Protocol Violation|0|||
160547533|NCT00271817|579730251|FG001|Part 2|Protocol Violation|3|||
160547534|NCT00271817|579730252|FG002|Part 2|Protocol Violation|5|||
160547535|NCT00271817|579730250|FG000|Part 2|Patient Moved|0|||
160547536|NCT00271817|579730251|FG001|Part 2|Patient Moved|0|||
160547537|NCT00271817|579730252|FG002|Part 2|Patient Moved|5|||
160547538|NCT00271817|579730250|FG000|Part 2|Withdrawal by Subject|0|||
160547539|NCT00271817|579730251|FG001|Part 2|Withdrawal by Subject|2|||
160642265|NCT02544633|580074231|FG000|Treatment Period|Global Deterioration of Health|3|||
160547540|NCT00271817|579730252|FG002|Part 2|Withdrawal by Subject|13|||
160547541|NCT00271817|579730250|FG000|Part 2|LDL < 50 mg/dL|0|||
160547542|NCT00271817|579730251|FG001|Part 2|LDL < 50 mg/dL|3|||
160547543|NCT00271817|579730252|FG002|Part 2|LDL < 50 mg/dL|4|||
160547544|NCT01564862|579730255|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
160547545|NCT01564862|579730256|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
160547546|NCT01564862|579730257|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
160547547|NCT01564862|579730255|FG000|Overall Study|Major Protocol Deviation|3|||
160547548|NCT01564862|579730256|FG001|Overall Study|Major Protocol Deviation|3|||
160547549|NCT01564862|579730257|FG002|Overall Study|Major Protocol Deviation|4|||
160547550|NCT01564862|579730255|FG000|Overall Study|Lost to Follow-up|10|||
160547551|NCT01564862|579730256|FG001|Overall Study|Lost to Follow-up|8|||
160547552|NCT01564862|579730257|FG002|Overall Study|Lost to Follow-up|6|||
160547553|NCT01564862|579730255|FG000|Overall Study|Voluntary Withdrawal|9|||
160547554|NCT01564862|579730256|FG001|Overall Study|Voluntary Withdrawal|6|||
160547555|NCT01564862|579730257|FG002|Overall Study|Voluntary Withdrawal|8|||
160547556|NCT01564862|579730255|FG000|Overall Study|Lack of Efficacy|1|||
160547557|NCT01564862|579730256|FG001|Overall Study|Lack of Efficacy|5|||
160547558|NCT01564862|579730257|FG002|Overall Study|Lack of Efficacy|6|||
160547559|NCT01564862|579730255|FG000|Overall Study|Other reason(s)|1|||
160547560|NCT01564862|579730256|FG001|Overall Study|Other reason(s)|0|||
160547561|NCT01564862|579730257|FG002|Overall Study|Other reason(s)|0|||
160547562|NCT03809611|579730258|FG000|Overall Study|Withdrawal by Subject|1|||
160547563|NCT03809611|579730259|FG001|Overall Study|Withdrawal by Subject|1|||
160547564|NCT02600494|579730260|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
160547565|NCT02600494|579730261|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
160547566|NCT02600494|579730262|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
160547567|NCT02600494|579730260|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
160547568|NCT02600494|579730261|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
160547569|NCT02600494|579730262|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
160547570|NCT02600494|579730260|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
160547571|NCT02600494|579730261|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
160547572|NCT02600494|579730262|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
160547573|NCT02600494|579730260|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
160547574|NCT02600494|579730261|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
160547575|NCT02600494|579730262|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
160547576|NCT02600494|579730260|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
160547577|NCT02600494|579730261|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
160547578|NCT02600494|579730262|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
160547579|NCT02600494|579730260|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
160547580|NCT02600494|579730261|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
160547581|NCT02600494|579730262|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
160547582|NCT02600494|579730260|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
160547583|NCT02600494|579730261|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
160547584|NCT02600494|579730262|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
160788391|NCT02151604|580610910|FG000|Overall Study|Physician Decision|3|||
160788392|NCT02151604|580610910|FG000|Overall Study|Death|1|||
160788393|NCT00537082|580610912|FG000|Overall Study|Adverse Event|6|||
160547585|NCT02600494|579730260|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
160547586|NCT02600494|579730261|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
160547587|NCT02600494|579730262|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
160547588|NCT02600494|579730260|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
160642266|NCT02544633|580074232|FG001|Treatment Period|Global Deterioration of Health|3|||
160642267|NCT02544633|580074233|FG002|Treatment Period|Global Deterioration of Health|0|||
160642268|NCT02544633|580074234|FG003|Treatment Period|Global Deterioration of Health|1|||
160642269|NCT02544633|580074231|FG000|Treatment Period|Withdrawal by Subject|1|||
160642270|NCT02544633|580074232|FG001|Treatment Period|Withdrawal by Subject|0|||
160642271|NCT02544633|580074233|FG002|Treatment Period|Withdrawal by Subject|0|||
160642272|NCT02544633|580074234|FG003|Treatment Period|Withdrawal by Subject|0|||
160642273|NCT02544633|580074231|FG000|Treatment Period|Lost to Follow-up|0|||
160642274|NCT02544633|580074232|FG001|Treatment Period|Lost to Follow-up|1|||
160642275|NCT02544633|580074233|FG002|Treatment Period|Lost to Follow-up|0|||
160642276|NCT02544633|580074234|FG003|Treatment Period|Lost to Follow-up|0|||
160642277|NCT02544633|580074231|FG000|Treatment Period|Death|0|||
160642278|NCT02544633|580074232|FG001|Treatment Period|Death|0|||
160642279|NCT02544633|580074233|FG002|Treatment Period|Death|1|||
160642280|NCT02544633|580074234|FG003|Treatment Period|Death|0|||
160642281|NCT02544633|580074231|FG000|Treatment Period|Non-compliance|0|||
160642282|NCT02544633|580074232|FG001|Treatment Period|Non-compliance|0|||
160642283|NCT02544633|580074233|FG002|Treatment Period|Non-compliance|1|||
160642284|NCT02544633|580074234|FG003|Treatment Period|Non-compliance|0|||
160788394|NCT00537082|580610913|FG001|Overall Study|Adverse Event|6|||
160788395|NCT00537082|580610914|FG002|Overall Study|Adverse Event|3|||
160547589|NCT02600494|579730261|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
160547590|NCT02600494|579730262|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
160547591|NCT02600494|579730260|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
160547592|NCT02600494|579730261|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
160547593|NCT02600494|579730262|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
160547594|NCT02600494|579730260|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
160547595|NCT02600494|579730261|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
160547596|NCT02600494|579730262|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
160547597|NCT02600494|579730260|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
160547598|NCT02600494|579730261|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
160547599|NCT02600494|579730262|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
160547600|NCT02600494|579730260|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
160547601|NCT02600494|579730261|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
160547602|NCT02600494|579730262|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
160891056|NCT02147184|580996827|FG000|Overall Study|Other|1|||
160891057|NCT02147184|580996828|FG001|Overall Study|Other|0|||
160891058|NCT02117414|580996829|FG000|Overall Study|Death|5|||
160891059|NCT02117414|580996830|FG001|Overall Study|Death|2|||
160891060|NCT02117414|580996829|FG000|Overall Study|Withdrawal by Subject|10|||
160891061|NCT02117414|580996830|FG001|Overall Study|Withdrawal by Subject|4|||
160891062|NCT02537574|580996832|FG000|Overall Study|Adverse Event|1|||
160891063|NCT02537574|580996833|FG001|Overall Study|Adverse Event|3|||
160891064|NCT02537574|580996834|FG002|Overall Study|Adverse Event|2|||
160891065|NCT02537574|580996832|FG000|Overall Study|Lost to Follow-up|40|||
160891066|NCT02537574|580996833|FG001|Overall Study|Lost to Follow-up|51|||
160891067|NCT02537574|580996834|FG002|Overall Study|Lost to Follow-up|55|||
160891068|NCT02537574|580996832|FG000|Overall Study|Noncompliance with study drug|0|||
160891069|NCT02537574|580996833|FG001|Overall Study|Noncompliance with study drug|1|||
160891070|NCT02537574|580996834|FG002|Overall Study|Noncompliance with study drug|1|||
160891071|NCT02537574|580996832|FG000|Overall Study|Physician Decision|2|||
160891072|NCT02537574|580996833|FG001|Overall Study|Physician Decision|0|||
160891073|NCT02537574|580996834|FG002|Overall Study|Physician Decision|0|||
160891074|NCT02537574|580996832|FG000|Overall Study|Protocol Violation|4|||
160891075|NCT02537574|580996833|FG001|Overall Study|Protocol Violation|2|||
160891076|NCT02537574|580996834|FG002|Overall Study|Protocol Violation|3|||
160891077|NCT02537574|580996832|FG000|Overall Study|Withdrawal by Subject|37|||
160891078|NCT02537574|580996833|FG001|Overall Study|Withdrawal by Subject|27|||
160891079|NCT02537574|580996834|FG002|Overall Study|Withdrawal by Subject|29|||
160891080|NCT02537574|580996832|FG000|Overall Study|Lack of Efficacy|14|||
160891081|NCT02537574|580996833|FG001|Overall Study|Lack of Efficacy|16|||
160891082|NCT02537574|580996834|FG002|Overall Study|Lack of Efficacy|15|||
160891083|NCT02537574|580996832|FG000|Overall Study|Duplicate Patient|1|||
160891084|NCT02537574|580996833|FG001|Overall Study|Duplicate Patient|0|||
160891085|NCT02537574|580996834|FG002|Overall Study|Duplicate Patient|0|||
160891086|NCT02537574|580996832|FG000|Overall Study|Patient not Stable|0|||
160891087|NCT02537574|580996833|FG001|Overall Study|Patient not Stable|1|||
160891088|NCT02537574|580996834|FG002|Overall Study|Patient not Stable|0|||
160547603|NCT03124563|579730264|FG000|Overall Study|Lost to Follow-up|1|||
160547604|NCT03124563|579730265|FG001|Overall Study|Lost to Follow-up|1|||
160547605|NCT03124563|579730264|FG000|Overall Study|Withdrawal by Subject|1|||
160547606|NCT03124563|579730265|FG001|Overall Study|Withdrawal by Subject|1|||
160547607|NCT05593016|579732400|FG000|Overall Study|Death|1|||
160547608|NCT05593016|579732401|FG001|Overall Study|Death|1|||
160547609|NCT05593016|579732402|FG002|Overall Study|Death|1|||
160547610|NCT05593016|579732403|FG003|Overall Study|Death|0|||
160547611|NCT05593016|579732404|FG004|Overall Study|Death|0|||
160547612|NCT05593016|579732400|FG000|Overall Study|Lost to Follow-up|1|||
160547613|NCT05593016|579732401|FG001|Overall Study|Lost to Follow-up|1|||
160547614|NCT05593016|579732402|FG002|Overall Study|Lost to Follow-up|1|||
160547615|NCT05593016|579732403|FG003|Overall Study|Lost to Follow-up|2|||
160547616|NCT05593016|579732404|FG004|Overall Study|Lost to Follow-up|0|||
160547617|NCT05416138|579732405|FG000|Overall Study|Withdrawal by Subject|2|||
160547618|NCT05416138|579732406|FG001|Overall Study|Withdrawal by Subject|1|||
160547619|NCT04705051|579732407|FG000|Overall Study|Enrolled but not treated|1|||
160547620|NCT04705051|579732407|FG000|Overall Study|Study terminated by sponsor|23|||
160547621|NCT03686397|579732408|FG000|Overall Study|Lack of Efficacy|3|||
160547622|NCT03686397|579732409|FG001|Overall Study|Lack of Efficacy|5|||
160547623|NCT03686397|579732408|FG000|Overall Study|Adverse Event|0|||
160547624|NCT03686397|579732409|FG001|Overall Study|Adverse Event|1|||
160547625|NCT03686397|579732408|FG000|Overall Study|Protocol Violation|0|||
160547626|NCT03686397|579732409|FG001|Overall Study|Protocol Violation|1|||
160547627|NCT03686397|579732408|FG000|Overall Study|Withdrawal by Subject|0|||
160547628|NCT03686397|579732409|FG001|Overall Study|Withdrawal by Subject|1|||
160547629|NCT03686397|579732408|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
160891089|NCT02537574|580996832|FG000|Overall Study|Incarceration|0|||
160891090|NCT02537574|580996833|FG001|Overall Study|Incarceration|1|||
160891091|NCT02537574|580996834|FG002|Overall Study|Incarceration|0|||
160547630|NCT03686397|579732409|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
160547631|NCT04316585|579732412|FG000|Overall Study|Adverse Event|2|||
160547632|NCT04316585|579732413|FG001|Overall Study|Adverse Event|1|||
160547633|NCT04316585|579732412|FG000|Overall Study|Lost to Follow-up|1|||
160547634|NCT04316585|579732413|FG001|Overall Study|Lost to Follow-up|0|||
160547635|NCT04316585|579732412|FG000|Overall Study|Withdrawal by Subject|2|||
160547636|NCT04316585|579732413|FG001|Overall Study|Withdrawal by Subject|3|||
160547637|NCT04316585|579732412|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
160547638|NCT04316585|579732413|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
160547639|NCT04316585|579732412|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
160547640|NCT04316585|579732413|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
160547641|NCT03269344|579732415|FG000|Overall Study|Protocol Violation|4|||
160547642|NCT03269344|579732416|FG001|Overall Study|Protocol Violation|3|||
160547643|NCT02770326|579732417|FG000|Overall Study|Death|3|||
160547644|NCT02770326|579732417|FG000|Overall Study|Lost to Follow-up|1|||
160547645|NCT02814565|579732421|FG000|Overall Study|Lack of Efficacy|0|||
160547646|NCT02814565|579732422|FG001|Overall Study|Lack of Efficacy|1|||
160547647|NCT02814565|579732421|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
160547648|NCT02814565|579732422|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
160547649|NCT05289830|579732425|FG000|Overall Study|Lost to Follow-up|1|||
160547650|NCT05289830|579732426|FG001|Overall Study|Lost to Follow-up|1|||
160547651|NCT05289830|579732425|FG000|Overall Study|Physician Decision|0|||
160547652|NCT05289830|579732426|FG001|Overall Study|Physician Decision|1|||
160547653|NCT01046825|579732427|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
160547654|NCT01046825|579732428|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
160547655|NCT01046825|579732429|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
160547656|NCT01046825|579732430|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
160547657|NCT01046825|579732431|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
160547658|NCT01046825|579732427|FG000|Overall Study|Physician Decision|0|||
160547659|NCT01046825|579732428|FG001|Overall Study|Physician Decision|1|||
160547660|NCT01046825|579732429|FG002|Overall Study|Physician Decision|2|||
160547661|NCT01046825|579732430|FG003|Overall Study|Physician Decision|0|||
160547662|NCT01046825|579732431|FG004|Overall Study|Physician Decision|0|||
160547663|NCT01046825|579732427|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
160547664|NCT01046825|579732428|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
160547665|NCT01046825|579732429|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
160547666|NCT01046825|579732430|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
160547667|NCT01046825|579732431|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
160547668|NCT01046825|579732427|FG000|Overall Study|Found to be ineligible|0|||
160547669|NCT01046825|579732428|FG001|Overall Study|Found to be ineligible|1|||
160547670|NCT01046825|579732429|FG002|Overall Study|Found to be ineligible|0|||
160547671|NCT01046825|579732430|FG003|Overall Study|Found to be ineligible|0|||
160547672|NCT01046825|579732431|FG004|Overall Study|Found to be ineligible|0|||
160547673|NCT01046825|579732427|FG000|Overall Study|Death|0|||
160547674|NCT01046825|579732428|FG001|Overall Study|Death|0|||
160547675|NCT01046825|579732429|FG002|Overall Study|Death|0|||
160547676|NCT01046825|579732430|FG003|Overall Study|Death|1|||
160547677|NCT01046825|579732431|FG004|Overall Study|Death|0|||
160547678|NCT01046825|579732427|FG000|Overall Study|Did not submit biology samples|0|||
160547679|NCT01046825|579732428|FG001|Overall Study|Did not submit biology samples|0|||
160547680|NCT01046825|579732429|FG002|Overall Study|Did not submit biology samples|0|||
160547681|NCT01046825|579732430|FG003|Overall Study|Did not submit biology samples|0|||
160547682|NCT01046825|579732431|FG004|Overall Study|Did not submit biology samples|13|||
160547683|NCT02872311|579732432|FG000|Overall Study|Death|2|||
160547684|NCT02872311|579732433|FG001|Overall Study|Death|0|||
160547685|NCT02872311|579732434|FG002|Overall Study|Death|0|||
160547686|NCT02872311|579732435|FG003|Overall Study|Death|0|||
160547687|NCT02872311|579732436|FG004|Overall Study|Death|0|||
160547688|NCT02872311|579732432|FG000|Overall Study|Lost to Follow-up|2|||
160547689|NCT02872311|579732433|FG001|Overall Study|Lost to Follow-up|0|||
160547690|NCT02872311|579732434|FG002|Overall Study|Lost to Follow-up|0|||
160547691|NCT02872311|579732435|FG003|Overall Study|Lost to Follow-up|0|||
160547692|NCT02872311|579732436|FG004|Overall Study|Lost to Follow-up|0|||
160547693|NCT02872311|579732432|FG000|Overall Study|Protocol Violation|0|||
160547694|NCT02872311|579732433|FG001|Overall Study|Protocol Violation|2|||
160547695|NCT02872311|579732434|FG002|Overall Study|Protocol Violation|1|||
160788396|NCT00537082|580610912|FG000|Overall Study|Protocol Violation|0|||
160788397|NCT00537082|580610913|FG001|Overall Study|Protocol Violation|2|||
160547696|NCT02872311|579732435|FG003|Overall Study|Protocol Violation|0|||
160547697|NCT02872311|579732436|FG004|Overall Study|Protocol Violation|0|||
160547698|NCT04735653|579732437|FG000|Overall Study|Lost to Follow-up|17|||
160547699|NCT04735653|579732438|FG001|Overall Study|Lost to Follow-up|7|||
160547700|NCT04735653|579732437|FG000|Overall Study|Withdrawal by Subject|8|||
160547701|NCT04735653|579732438|FG001|Overall Study|Withdrawal by Subject|2|||
160547702|NCT04735653|579732437|FG000|Overall Study|Death|0|||
160547703|NCT04735653|579732438|FG001|Overall Study|Death|2|||
160547704|NCT04735653|579732437|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
160547705|NCT04735653|579732438|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
160547706|NCT00608985|579732442|FG000|Overall Study|Adverse Event|2|||
160547707|NCT00608985|579732443|FG001|Overall Study|Adverse Event|7|||
160547708|NCT00608985|579732444|FG002|Overall Study|Adverse Event|4|||
160547709|NCT00608985|579732445|FG003|Overall Study|Adverse Event|6|||
160547710|NCT00608985|579732442|FG000|Overall Study|Administrative/Other|7|||
160547711|NCT00608985|579732443|FG001|Overall Study|Administrative/Other|4|||
160547712|NCT00608985|579732444|FG002|Overall Study|Administrative/Other|1|||
160547713|NCT00608985|579732445|FG003|Overall Study|Administrative/Other|2|||
160547714|NCT00608985|579732442|FG000|Overall Study|Withdrawal of Consent|5|||
160547715|NCT00608985|579732443|FG001|Overall Study|Withdrawal of Consent|1|||
160547716|NCT00608985|579732444|FG002|Overall Study|Withdrawal of Consent|1|||
160547717|NCT00608985|579732445|FG003|Overall Study|Withdrawal of Consent|1|||
160547718|NCT00608985|579732442|FG000|Overall Study|Lost to Follow-up|2|||
160547719|NCT00608985|579732443|FG001|Overall Study|Lost to Follow-up|1|||
160547720|NCT00608985|579732444|FG002|Overall Study|Lost to Follow-up|0|||
160547721|NCT00608985|579732445|FG003|Overall Study|Lost to Follow-up|0|||
160547722|NCT00661271|579732446|FG000|Overall Study|Lost to Follow-up|28|||
160547723|NCT00661271|579732447|FG001|Overall Study|Lost to Follow-up|25|||
160547724|NCT00953758|579732448|FG000|Overall Study|Death|2|||
160547725|NCT00953758|579732449|FG001|Overall Study|Death|0|||
160547726|NCT00953758|579732450|FG002|Overall Study|Death|1|||
160547727|NCT00953758|579732451|FG003|Overall Study|Death|1|||
160547728|NCT00953758|579732452|FG004|Overall Study|Death|1|||
160547729|NCT00953758|579732453|FG005|Overall Study|Death|1|||
160547730|NCT00953758|579732454|FG006|Overall Study|Death|1|||
160547731|NCT00953758|579732455|FG007|Overall Study|Death|3|||
160547732|NCT00953758|579732456|FG008|Overall Study|Death|1|||
160547733|NCT00953758|579732457|FG009|Overall Study|Death|0|||
160547734|NCT00953758|579732448|FG000|Overall Study|Participant refused further follow-up|0|||
160547735|NCT00953758|579732449|FG001|Overall Study|Participant refused further follow-up|0|||
160547736|NCT00953758|579732450|FG002|Overall Study|Participant refused further follow-up|1|||
160547737|NCT00953758|579732451|FG003|Overall Study|Participant refused further follow-up|0|||
160547738|NCT00953758|579732452|FG004|Overall Study|Participant refused further follow-up|3|||
160642285|NCT02544633|580074231|FG000|Treatment Period|Clinical Disease Progression|0|||
160642286|NCT02544633|580074232|FG001|Treatment Period|Clinical Disease Progression|0|||
160642287|NCT02544633|580074233|FG002|Treatment Period|Clinical Disease Progression|0|||
160642288|NCT02544633|580074234|FG003|Treatment Period|Clinical Disease Progression|1|||
160642289|NCT02544633|580074231|FG000|Survival Follow-up Period|Death|12|||
160642290|NCT02544633|580074232|FG001|Survival Follow-up Period|Death|14|||
160642291|NCT02544633|580074233|FG002|Survival Follow-up Period|Death|3|||
160642292|NCT02544633|580074234|FG003|Survival Follow-up Period|Death|9|||
160642293|NCT02544633|580074231|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
160642294|NCT02544633|580074232|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
160642295|NCT02544633|580074233|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
160642296|NCT02544633|580074234|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
160642297|NCT02544633|580074231|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
160891092|NCT02537574|580996832|FG000|Overall Study|Failed Naloxone Challenge|0|||
160891093|NCT02537574|580996833|FG001|Overall Study|Failed Naloxone Challenge|1|||
160891094|NCT02537574|580996834|FG002|Overall Study|Failed Naloxone Challenge|0|||
160642298|NCT02544633|580074232|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
160642299|NCT02544633|580074233|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
160642300|NCT02544633|580074234|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
160642301|NCT02544633|580074231|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
160642302|NCT02544633|580074232|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
160642303|NCT02544633|580074233|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
160891095|NCT02537574|580996832|FG000|Overall Study|Transportation Issues|0|||
160547739|NCT00953758|579732453|FG005|Overall Study|Participant refused further follow-up|0|||
160547740|NCT00953758|579732454|FG006|Overall Study|Participant refused further follow-up|0|||
160547741|NCT00953758|579732455|FG007|Overall Study|Participant refused further follow-up|0|||
160547742|NCT00953758|579732456|FG008|Overall Study|Participant refused further follow-up|1|||
160547743|NCT00953758|579732457|FG009|Overall Study|Participant refused further follow-up|0|||
160547744|NCT00953758|579732448|FG000|Overall Study|Lost to Follow-up|0|||
160547745|NCT00953758|579732449|FG001|Overall Study|Lost to Follow-up|0|||
160642304|NCT02544633|580074234|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
160642305|NCT00928252|580074237|FG000|Overall Study|Physician Decision|3|||
160642306|NCT02257632|580074238|FG000|Overall Study|Withdrawal by Subject|0|||
160547746|NCT00953758|579732450|FG002|Overall Study|Lost to Follow-up|0|||
160547747|NCT00953758|579732451|FG003|Overall Study|Lost to Follow-up|1|||
160547748|NCT00953758|579732452|FG004|Overall Study|Lost to Follow-up|0|||
160547749|NCT00953758|579732453|FG005|Overall Study|Lost to Follow-up|0|||
160547750|NCT00953758|579732454|FG006|Overall Study|Lost to Follow-up|0|||
160547751|NCT00953758|579732455|FG007|Overall Study|Lost to Follow-up|1|||
160547752|NCT00953758|579732456|FG008|Overall Study|Lost to Follow-up|0|||
160891096|NCT02537574|580996833|FG001|Overall Study|Transportation Issues|0|||
160891097|NCT02537574|580996834|FG002|Overall Study|Transportation Issues|1|||
160891098|NCT02537574|580996832|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
160891099|NCT02537574|580996833|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
160891100|NCT02537574|580996834|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
160891101|NCT02537574|580996832|FG000|Overall Study|Noncompliance with Protocol|0|||
160891102|NCT02537574|580996833|FG001|Overall Study|Noncompliance with Protocol|0|||
160891103|NCT02537574|580996834|FG002|Overall Study|Noncompliance with Protocol|1|||
160891104|NCT01151098|580996835|FG000|Overall Study|Adverse Event|82|||
160891105|NCT01151098|580996835|FG000|Overall Study|Lost to Follow-up|6|||
160891106|NCT01151098|580996835|FG000|Overall Study|Lack of Efficacy|15|||
160891107|NCT01151098|580996835|FG000|Overall Study|Protocol Violation|1|||
160891108|NCT01151098|580996835|FG000|Overall Study|Miscellaneous|13|||
160891109|NCT00417482|580996836|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
160891110|NCT00417482|580996837|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
160891111|NCT00417482|580996838|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
160891112|NCT00417482|580996836|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
160891113|NCT00417482|580996837|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
160891114|NCT00417482|580996838|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
160891115|NCT00417482|580996836|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
160891116|NCT00417482|580996837|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
160891117|NCT00417482|580996838|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
160891118|NCT00417482|580996836|FG000|Phase B 1st 16 Weeks|Death|1|||
160891119|NCT00417482|580996837|FG001|Phase B 1st 16 Weeks|Death|0|||
160891120|NCT00417482|580996838|FG002|Phase B 1st 16 Weeks|Death|0|||
160891121|NCT00417482|580996836|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
160891122|NCT00417482|580996837|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
160891123|NCT00417482|580996838|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
160891124|NCT00417482|580996836|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
160891125|NCT00417482|580996837|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
160891126|NCT00417482|580996838|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
160891127|NCT00417482|580996836|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
160891128|NCT00417482|580996837|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
160891129|NCT00417482|580996838|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
160891130|NCT00417482|580996836|FG000|Phase B 2nd 16 Weeks|Death|1|||
160891131|NCT00417482|580996837|FG001|Phase B 2nd 16 Weeks|Death|1|||
160891132|NCT00417482|580996838|FG002|Phase B 2nd 16 Weeks|Death|0|||
160891133|NCT02140775|580996841|FG000|Overall Study|Withdrawal by Subject|30|||
160891134|NCT02140775|580996842|FG001|Overall Study|Withdrawal by Subject|7|||
160891135|NCT00938964|580996844|FG000|Overall Study|Death|3|||
160891136|NCT00938964|580996845|FG001|Overall Study|Death|3|||
160891137|NCT00938964|580996844|FG000|Overall Study|Lost to Follow-up|2|||
160891138|NCT00938964|580996845|FG001|Overall Study|Lost to Follow-up|3|||
160891139|NCT00938964|580996844|FG000|Overall Study|Withdrawal by Subject|22|||
160891140|NCT00938964|580996845|FG001|Overall Study|Withdrawal by Subject|18|||
160891141|NCT00938964|580996844|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
160891142|NCT00938964|580996845|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
160891143|NCT01858636|580996846|FG000|Overall Study|No Device Deployment Attempted|24|||
160891144|NCT01858636|580996846|FG000|Overall Study|Physician Decision|1|||
160891145|NCT01858636|580996846|FG000|Overall Study|Death|1|||
160891146|NCT01858636|580996846|FG000|Overall Study|Lost to Follow-up|1|||
160891147|NCT01858636|580996846|FG000|Overall Study|Withdrawal by Subject|1|||
160891148|NCT01227564|580996852|FG000|Overall Study|No Longer Willing to Participate|4|||
160891149|NCT01227564|580996853|FG001|Overall Study|No Longer Willing to Participate|2|||
160891150|NCT01227564|580996854|FG002|Overall Study|No Longer Willing to Participate|5|||
160891151|NCT01227564|580996852|FG000|Overall Study|Participant moved to another town|0|||
160891152|NCT01227564|580996853|FG001|Overall Study|Participant moved to another town|0|||
160891153|NCT01227564|580996854|FG002|Overall Study|Participant moved to another town|1|||
160891154|NCT00999921|580996869|FG000|Overall Study|Lost to Follow-up|10|||
160891155|NCT00999921|580996870|FG001|Overall Study|Lost to Follow-up|19|||
160891156|NCT04650854|580996871|FG000|Overall Study|Adverse Event|1|||
160891157|NCT04650854|580996872|FG001|Overall Study|Adverse Event|12|||
160891158|NCT04650854|580996873|FG002|Overall Study|Adverse Event|14|||
160891159|NCT04650854|580996871|FG000|Overall Study|Lack of Efficacy|1|||
160891160|NCT04650854|580996872|FG001|Overall Study|Lack of Efficacy|3|||
160891161|NCT04650854|580996873|FG002|Overall Study|Lack of Efficacy|6|||
160891162|NCT04650854|580996871|FG000|Overall Study|Lost to Follow-up|1|||
160891163|NCT04650854|580996872|FG001|Overall Study|Lost to Follow-up|1|||
160891164|NCT04650854|580996873|FG002|Overall Study|Lost to Follow-up|0|||
160788398|NCT00537082|580610914|FG002|Overall Study|Protocol Violation|1|||
160788399|NCT00537082|580610912|FG000|Overall Study|Lack of Efficacy|0|||
160788400|NCT00537082|580610913|FG001|Overall Study|Lack of Efficacy|0|||
160788401|NCT00537082|580610914|FG002|Overall Study|Lack of Efficacy|2|||
160788402|NCT00537082|580610912|FG000|Overall Study|Withdrawal by Subject|0|||
160788403|NCT00537082|580610913|FG001|Overall Study|Withdrawal by Subject|1|||
160891165|NCT04650854|580996871|FG000|Overall Study|Withdrawal by Subject|2|||
160891166|NCT04650854|580996872|FG001|Overall Study|Withdrawal by Subject|17|||
160891167|NCT04650854|580996873|FG002|Overall Study|Withdrawal by Subject|9|||
160891168|NCT04650854|580996871|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
160891169|NCT04650854|580996872|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
160891170|NCT04650854|580996873|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
160891171|NCT04650854|580996871|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
160891172|NCT04650854|580996872|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
160891173|NCT04650854|580996873|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
160891174|NCT04650854|580996871|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
160891175|NCT04650854|580996872|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
160891176|NCT04650854|580996873|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
160891177|NCT04650854|580996871|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
160891178|NCT04650854|580996872|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
160891179|NCT04650854|580996873|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
160891180|NCT04650854|580996871|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
160891181|NCT04650854|580996872|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
160891182|NCT04650854|580996873|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
160891183|NCT04650854|580996871|FG000|Overall Study|Use of Rescue Medication|0|||
160891184|NCT04650854|580996872|FG001|Overall Study|Use of Rescue Medication|0|||
160891185|NCT04650854|580996873|FG002|Overall Study|Use of Rescue Medication|1|||
160547753|NCT00953758|579732457|FG009|Overall Study|Lost to Follow-up|1|||
160891186|NCT04650854|580996871|FG000|Overall Study|Last Treatment Per Sponsor|0|||
160891187|NCT04650854|580996872|FG001|Overall Study|Last Treatment Per Sponsor|0|||
160891188|NCT04650854|580996873|FG002|Overall Study|Last Treatment Per Sponsor|2|||
160891189|NCT04650854|580996871|FG000|Overall Study|Rescue Medication|0|||
160891190|NCT04650854|580996872|FG001|Overall Study|Rescue Medication|0|||
160891191|NCT04650854|580996873|FG002|Overall Study|Rescue Medication|1|||
160891192|NCT04650854|580996871|FG000|Overall Study|Participant Want to Start a Family|0|||
160891193|NCT04650854|580996872|FG001|Overall Study|Participant Want to Start a Family|0|||
160891194|NCT04650854|580996873|FG002|Overall Study|Participant Want to Start a Family|1|||
160891195|NCT04650854|580996871|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
160891196|NCT04650854|580996872|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
160891197|NCT04650854|580996873|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
160891198|NCT04650854|580996871|FG000|Overall Study|Participant Screened For MG0020|0|||
160891199|NCT04650854|580996872|FG001|Overall Study|Participant Screened For MG0020|2|||
160547754|NCT00953758|579732448|FG000|Overall Study|Physician Decision|0|||
160547755|NCT00953758|579732449|FG001|Overall Study|Physician Decision|0|||
160547756|NCT00953758|579732450|FG002|Overall Study|Physician Decision|0|||
160547757|NCT00953758|579732451|FG003|Overall Study|Physician Decision|0|||
160547758|NCT00953758|579732452|FG004|Overall Study|Physician Decision|1|||
160788404|NCT00537082|580610914|FG002|Overall Study|Withdrawal by Subject|0|||
160788405|NCT00537082|580610912|FG000|Overall Study|Discontinued before initiating treatment|3|||
160788406|NCT00537082|580610913|FG001|Overall Study|Discontinued before initiating treatment|0|||
160788407|NCT00537082|580610914|FG002|Overall Study|Discontinued before initiating treatment|0|||
160788408|NCT02568254|580610915|FG000|Period 2|Adverse Event|0|||
160788409|NCT02568254|580610916|FG001|Period 2|Adverse Event|0|||
160788410|NCT02568254|580610917|FG002|Period 2|Adverse Event|1|||
160788411|NCT02568254|580610918|FG003|Period 2|Adverse Event|0|||
160788412|NCT02568254|580610919|FG004|Period 2|Adverse Event|0|||
160788413|NCT02568254|580610920|FG005|Period 2|Adverse Event|0|||
160788414|NCT02568254|580610915|FG000|Period 3|Unstatisfactory Lens fitting|0|||
160788415|NCT02568254|580610916|FG001|Period 3|Unstatisfactory Lens fitting|0|||
160547759|NCT00953758|579732453|FG005|Overall Study|Physician Decision|0|||
160547760|NCT00953758|579732454|FG006|Overall Study|Physician Decision|0|||
160788416|NCT02568254|580610917|FG002|Period 3|Unstatisfactory Lens fitting|0|||
160788417|NCT02568254|580610918|FG003|Period 3|Unstatisfactory Lens fitting|0|||
160788418|NCT02568254|580610919|FG004|Period 3|Unstatisfactory Lens fitting|1|||
160891200|NCT04650854|580996873|FG002|Overall Study|Participant Screened For MG0020|3|||
160547761|NCT00953758|579732455|FG007|Overall Study|Physician Decision|0|||
160891201|NCT04650854|580996871|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
160891202|NCT04650854|580996872|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
160891203|NCT04650854|580996873|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
160891204|NCT04650854|580996871|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
160891205|NCT04650854|580996872|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
160891206|NCT04650854|580996873|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
160891207|NCT04650854|580996871|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
160891208|NCT04650854|580996872|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
160891209|NCT04650854|580996873|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
160891210|NCT04650854|580996871|FG000|Overall Study|End Of Study|0|||
160891211|NCT04650854|580996872|FG001|Overall Study|End Of Study|2|||
160891212|NCT04650854|580996873|FG002|Overall Study|End Of Study|1|||
160891213|NCT04650854|580996871|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
160891214|NCT04650854|580996872|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
160891215|NCT04650854|580996873|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
160891216|NCT04650854|580996871|FG000|Overall Study|Participant Received Rescue Medication|0|||
160891217|NCT04650854|580996872|FG001|Overall Study|Participant Received Rescue Medication|1|||
160891218|NCT04650854|580996873|FG002|Overall Study|Participant Received Rescue Medication|0|||
160891219|NCT04650854|580996871|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
160891220|NCT04650854|580996872|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
160891221|NCT04650854|580996873|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
160891222|NCT04650854|580996871|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
160891223|NCT04650854|580996872|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
160891224|NCT04650854|580996873|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
160891225|NCT04650854|580996871|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
160891226|NCT04650854|580996872|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
160891227|NCT04650854|580996873|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
160891228|NCT04650854|580996871|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
160891229|NCT04650854|580996872|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
160891230|NCT04650854|580996873|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
160891231|NCT04650854|580996871|FG000|Overall Study|Enrollment Cup|0|||
160891232|NCT04650854|580996872|FG001|Overall Study|Enrollment Cup|0|||
160891233|NCT04650854|580996873|FG002|Overall Study|Enrollment Cup|1|||
160891234|NCT00704808|580996888|FG000|Overall Study|Discontinued prior to starting treatment|14|||
160891235|NCT00704808|580996888|FG000|Overall Study|Death|7|||
160891236|NCT00704808|580996888|FG000|Overall Study|Tumor progression|80|||
160891237|NCT00704808|580996888|FG000|Overall Study|Patient's decision|11|||
160891238|NCT00704808|580996888|FG000|Overall Study|Early therapy discontinuation|16|||
160891239|NCT00704808|580996888|FG000|Overall Study|Adverse Event|1|||
160891240|NCT00704808|580996888|FG000|Overall Study|Lost to Follow-up|1|||
160891241|NCT00704808|580996888|FG000|Overall Study|Treatment change|1|||
160891242|NCT00667420|580996893|FG000|Overall Study|Adverse Event|2|||
160891243|NCT00667420|580996893|FG000|Overall Study|Lack of Efficacy|5|||
160891244|NCT00667420|580996893|FG000|Overall Study|Physician Decision|1|||
160891245|NCT00667420|580996893|FG000|Overall Study|Withdrawal by Subject|2|||
160891246|NCT04437368|580996897|FG000|Overall Study|Death|3|||
160891247|NCT04437368|580996898|FG001|Overall Study|Death|0|||
160891248|NCT04437368|580996899|FG002|Overall Study|Death|2|||
160891249|NCT04437368|580996897|FG000|Overall Study|Study terminated by sponsor|16|||
160891250|NCT04437368|580996898|FG001|Overall Study|Study terminated by sponsor|1|||
160891251|NCT04437368|580996899|FG002|Overall Study|Study terminated by sponsor|25|||
160891252|NCT04437368|580996897|FG000|Overall Study|Withdrawal by Subject|4|||
160891253|NCT04437368|580996898|FG001|Overall Study|Withdrawal by Subject|0|||
160891254|NCT04437368|580996899|FG002|Overall Study|Withdrawal by Subject|3|||
160788419|NCT02568254|580610920|FG005|Period 3|Unstatisfactory Lens fitting|0|||
160788420|NCT04495478|580610921|FG000|Overall Study|Withdrawal by Subject|0|||
160788421|NCT04495478|580610922|FG001|Overall Study|Withdrawal by Subject|0|||
160788422|NCT04495478|580610923|FG002|Overall Study|Withdrawal by Subject|0|||
160788423|NCT04495478|580610924|FG003|Overall Study|Withdrawal by Subject|1|||
160788424|NCT04495478|580610925|FG004|Overall Study|Withdrawal by Subject|0|||
160788425|NCT04495478|580610926|FG005|Overall Study|Withdrawal by Subject|0|||
160788426|NCT04495478|580610927|FG006|Overall Study|Withdrawal by Subject|0|||
160788427|NCT04495478|580610921|FG000|Overall Study|Physician Decision|0|||
160788428|NCT04495478|580610922|FG001|Overall Study|Physician Decision|1|||
160788429|NCT04495478|580610923|FG002|Overall Study|Physician Decision|0|||
160788430|NCT04495478|580610924|FG003|Overall Study|Physician Decision|0|||
160891255|NCT04437368|580996897|FG000|Overall Study|Sponsor instructions|23|||
160891256|NCT04437368|580996898|FG001|Overall Study|Sponsor instructions|0|||
160891257|NCT04437368|580996899|FG002|Overall Study|Sponsor instructions|0|||
160891258|NCT01982331|580996900|FG000|Received Vaccination 2|Adverse Event|1|||
160891259|NCT01982331|580996901|FG001|Received Vaccination 2|Adverse Event|2|||
160788431|NCT04495478|580610925|FG004|Overall Study|Physician Decision|1|||
160891260|NCT01982331|580996900|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
160891261|NCT01982331|580996901|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
160891262|NCT01982331|580996900|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
160891263|NCT01982331|580996901|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
160891264|NCT00095628|580996903|FG000|Overall Study|Disease progression prior to treatment|1|||
160891265|NCT00744471|580996904|FG000|Overall Study|Randomized but not treated|1|||
160891266|NCT00744471|580996905|FG001|Overall Study|Randomized but not treated|1|||
160891267|NCT00744471|580996906|FG002|Overall Study|Randomized but not treated|4|||
160891268|NCT00744471|580996907|FG003|Overall Study|Randomized but not treated|0|||
160891269|NCT00744471|580996904|FG000|Overall Study|Death|0|||
160891270|NCT00744471|580996905|FG001|Overall Study|Death|0|||
160891271|NCT00744471|580996906|FG002|Overall Study|Death|0|||
160891272|NCT00744471|580996907|FG003|Overall Study|Death|1|||
160891273|NCT00744471|580996904|FG000|Overall Study|Adverse Event|6|||
160891274|NCT00744471|580996905|FG001|Overall Study|Adverse Event|7|||
160891275|NCT00744471|580996906|FG002|Overall Study|Adverse Event|5|||
160891276|NCT00744471|580996907|FG003|Overall Study|Adverse Event|9|||
160891277|NCT00744471|580996904|FG000|Overall Study|Withdrawal by Subject|9|||
160891278|NCT00744471|580996905|FG001|Overall Study|Withdrawal by Subject|9|||
160891279|NCT00744471|580996906|FG002|Overall Study|Withdrawal by Subject|15|||
160891280|NCT00744471|580996907|FG003|Overall Study|Withdrawal by Subject|12|||
160891281|NCT00744471|580996904|FG000|Overall Study|Protocol Violation|1|||
160891282|NCT00744471|580996905|FG001|Overall Study|Protocol Violation|4|||
160891283|NCT00744471|580996906|FG002|Overall Study|Protocol Violation|1|||
160891284|NCT00744471|580996907|FG003|Overall Study|Protocol Violation|2|||
160891285|NCT00744471|580996904|FG000|Overall Study|Entered extension study|41|||
160891286|NCT00744471|580996905|FG001|Overall Study|Entered extension study|84|||
160891287|NCT00744471|580996906|FG002|Overall Study|Entered extension study|100|||
160891288|NCT00744471|580996907|FG003|Overall Study|Entered extension study|91|||
160891289|NCT00744471|580996904|FG000|Overall Study|Other|2|||
160891290|NCT00744471|580996905|FG001|Overall Study|Other|3|||
160891291|NCT00744471|580996906|FG002|Overall Study|Other|6|||
160891292|NCT00744471|580996907|FG003|Overall Study|Other|2|||
160891293|NCT00744471|580996904|FG000|Overall Study|Lack of Efficacy|83|||
160891294|NCT00744471|580996905|FG001|Overall Study|Lack of Efficacy|37|||
160891295|NCT00744471|580996906|FG002|Overall Study|Lack of Efficacy|19|||
160891296|NCT00744471|580996907|FG003|Overall Study|Lack of Efficacy|31|||
160891297|NCT00744471|580996904|FG000|Overall Study|Lost to Follow-up|0|||
160891298|NCT00744471|580996905|FG001|Overall Study|Lost to Follow-up|0|||
160891299|NCT00744471|580996906|FG002|Overall Study|Lost to Follow-up|2|||
160891300|NCT00744471|580996907|FG003|Overall Study|Lost to Follow-up|0|||
160891301|NCT03224546|580996908|FG000|Overall Study|Lost to Follow-up|9|||
160891302|NCT03224546|580996909|FG001|Overall Study|Lost to Follow-up|8|||
160891303|NCT03224546|580996910|FG002|Overall Study|Lost to Follow-up|3|||
160891304|NCT03224546|580996908|FG000|Overall Study|Withdrawal by Subject|7|||
160891305|NCT03224546|580996909|FG001|Overall Study|Withdrawal by Subject|14|||
160891306|NCT03224546|580996910|FG002|Overall Study|Withdrawal by Subject|12|||
160891307|NCT01280955|580996913|FG000|Overall Study|Death|2|||
160891308|NCT01280955|580996913|FG000|Overall Study|Withdrawal by Subject|1|||
160891309|NCT04223232|580996914|FG000|Overall Study|Withdrawal by Subject|1|||
160891310|NCT00901927|580996917|FG000|Overall Study|Lack of Efficacy|1|||
160891311|NCT00901927|580996917|FG000|Overall Study|Protocol Violation|3|||
160891312|NCT00901927|580996917|FG000|Overall Study|Withdrawal by Subject|2|||
160891313|NCT03119701|580996927|FG000|6-day Dosing|Death|4|||
160891314|NCT03119701|580996928|FG001|6-day Dosing|Death|1|||
160891315|NCT03119701|580996927|FG000|6-day Dosing|Adverse Event|3|||
160891316|NCT03119701|580996928|FG001|6-day Dosing|Adverse Event|0|||
160891317|NCT03119701|580996927|FG000|6-day Dosing|Physician Decision|0|||
160891318|NCT03119701|580996928|FG001|6-day Dosing|Physician Decision|1|||
160891319|NCT03119701|580996927|FG000|6-day Dosing|Withdrawal by Subject|0|||
160891320|NCT03119701|580996928|FG001|6-day Dosing|Withdrawal by Subject|1|||
160891321|NCT03119701|580996927|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
160891322|NCT03119701|580996928|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
160891323|NCT03172910|580998741|FG000|Overall Study|Adverse Event|0|||
160891324|NCT03172910|580998742|FG001|Overall Study|Adverse Event|0|||
160891325|NCT03172910|580998743|FG002|Overall Study|Adverse Event|0|||
160891326|NCT03172910|580998744|FG003|Overall Study|Adverse Event|0|||
160642307|NCT02257632|580074239|FG001|Overall Study|Withdrawal by Subject|1|||
160642308|NCT02257632|580074238|FG000|Overall Study|Adverse Event|1|||
160642309|NCT02257632|580074239|FG001|Overall Study|Adverse Event|2|||
160642310|NCT02468557|580074240|FG000|Overall Study|Adverse Event|1|||
160642311|NCT02468557|580074240|FG000|Overall Study|Death|1|||
160891327|NCT03172910|580998745|FG004|Overall Study|Adverse Event|1|||
160891328|NCT01659658|580998746|FG000|Overall Study|Withdrawal by Patient|18|||
160891329|NCT01659658|580998747|FG001|Overall Study|Withdrawal by Patient|4|||
160891330|NCT01659658|580998748|FG002|Overall Study|Withdrawal by Patient|2|||
160891331|NCT01659658|580998749|FG003|Overall Study|Withdrawal by Patient|0|||
160891332|NCT01659658|580998750|FG004|Overall Study|Withdrawal by Patient|11|||
160891333|NCT01659658|580998746|FG000|Overall Study|Study Terminated by Sponsor|9|||
160547762|NCT00953758|579732456|FG008|Overall Study|Physician Decision|0|||
160547763|NCT00953758|579732457|FG009|Overall Study|Physician Decision|0|||
160547764|NCT00953758|579732448|FG000|Overall Study|Disease progression|0|||
160547765|NCT00953758|579732449|FG001|Overall Study|Disease progression|0|||
160547766|NCT00953758|579732450|FG002|Overall Study|Disease progression|0|||
160547767|NCT00953758|579732451|FG003|Overall Study|Disease progression|0|||
160547768|NCT00953758|579732452|FG004|Overall Study|Disease progression|1|||
160547769|NCT00953758|579732453|FG005|Overall Study|Disease progression|0|||
160547770|NCT00953758|579732454|FG006|Overall Study|Disease progression|0|||
160547771|NCT00953758|579732455|FG007|Overall Study|Disease progression|0|||
160547772|NCT00953758|579732456|FG008|Overall Study|Disease progression|0|||
160547773|NCT00953758|579732457|FG009|Overall Study|Disease progression|0|||
160547774|NCT00953758|579732448|FG000|Overall Study|Participant went for transplant|0|||
160547775|NCT00953758|579732449|FG001|Overall Study|Participant went for transplant|0|||
160547776|NCT00953758|579732450|FG002|Overall Study|Participant went for transplant|0|||
160547777|NCT00953758|579732451|FG003|Overall Study|Participant went for transplant|0|||
160547778|NCT00953758|579732452|FG004|Overall Study|Participant went for transplant|0|||
160547779|NCT00953758|579732453|FG005|Overall Study|Participant went for transplant|0|||
160547780|NCT00953758|579732454|FG006|Overall Study|Participant went for transplant|0|||
160547781|NCT00953758|579732455|FG007|Overall Study|Participant went for transplant|0|||
160547782|NCT00953758|579732456|FG008|Overall Study|Participant went for transplant|1|||
160547783|NCT00953758|579732457|FG009|Overall Study|Participant went for transplant|0|||
160547784|NCT00293579|579732458|FG000|Overall Study|Withdrawal by Subject|1|||
160547785|NCT01276236|579732459|FG000|Overall Study|Lack of Efficacy|2|||
160642312|NCT02468557|580074240|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
160642313|NCT02468557|580074240|FG000|Overall Study|All Enrolled but Never Dosed|4|||
160642314|NCT02024698|580074244|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
160642315|NCT02024698|580074245|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
160642316|NCT03322462|580074246|FG000|Overall Study|Technical difficulties|2|||
160642317|NCT03322462|580074246|FG000|Overall Study|Other|1|||
160642318|NCT01393990|580074247|FG000|Overall Study|Adverse Event|0|||
160642319|NCT01393990|580074248|FG001|Overall Study|Adverse Event|0|||
160642320|NCT01393990|580074249|FG002|Overall Study|Adverse Event|0|||
160642321|NCT01393990|580074250|FG003|Overall Study|Adverse Event|0|||
160642322|NCT01393990|580074251|FG004|Overall Study|Adverse Event|0|||
160642323|NCT01393990|580074252|FG005|Overall Study|Adverse Event|0|||
160642324|NCT01393990|580074253|FG006|Overall Study|Adverse Event|0|||
160642325|NCT01393990|580074254|FG007|Overall Study|Adverse Event|0|||
160788432|NCT04495478|580610926|FG005|Overall Study|Physician Decision|0|||
160788433|NCT04495478|580610927|FG006|Overall Study|Physician Decision|0|||
160547786|NCT01276236|579732459|FG000|Overall Study|Withdrawal by Subject|4|||
160547787|NCT00137111|579732469|FG000|Total Therapy|Death|35|||
160547788|NCT00137111|579732470|FG001|Total Therapy|Death|0|||
160547789|NCT00137111|579732471|FG002|Total Therapy|Death|0|||
160547790|NCT00137111|579732472|FG003|Total Therapy|Death|0|||
160547791|NCT00137111|579732469|FG000|Total Therapy|Non Compliance|5|||
160642326|NCT01393990|580074255|FG008|Overall Study|Adverse Event|0|||
160642327|NCT01393990|580074256|FG009|Overall Study|Adverse Event|0|||
160642328|NCT01393990|580074257|FG010|Overall Study|Adverse Event|0|||
160788434|NCT00655746|580610928|FG000|Overall Study|Withdrawal by Subject|1|||
160788435|NCT00561821|580610929|FG000|Overall Study|Not treated|0|||
160788436|NCT00561821|580610930|FG001|Overall Study|Not treated|0|||
160788437|NCT00561821|580610931|FG002|Overall Study|Not treated|1|||
160788438|NCT00561821|580610932|FG003|Overall Study|Not treated|0|||
160788439|NCT00561821|580610929|FG000|Overall Study|Withdrawal by Subject|0|||
160788440|NCT00561821|580610930|FG001|Overall Study|Withdrawal by Subject|1|||
160788441|NCT00561821|580610931|FG002|Overall Study|Withdrawal by Subject|0|||
160788442|NCT00561821|580610932|FG003|Overall Study|Withdrawal by Subject|2|||
160788443|NCT00561821|580610929|FG000|Overall Study|Reasons not related to trial|2|||
160788444|NCT00561821|580610930|FG001|Overall Study|Reasons not related to trial|1|||
160788445|NCT00561821|580610931|FG002|Overall Study|Reasons not related to trial|0|||
160788446|NCT00561821|580610932|FG003|Overall Study|Reasons not related to trial|0|||
160788447|NCT00561821|580610929|FG000|Overall Study|Other (reason not specified)|1|||
160788448|NCT00561821|580610930|FG001|Overall Study|Other (reason not specified)|1|||
160788449|NCT00561821|580610931|FG002|Overall Study|Other (reason not specified)|0|||
160788450|NCT00561821|580610932|FG003|Overall Study|Other (reason not specified)|0|||
160788451|NCT00561821|580610929|FG000|Overall Study|Adverse Event|2|||
160788452|NCT00561821|580610930|FG001|Overall Study|Adverse Event|3|||
160788453|NCT00561821|580610931|FG002|Overall Study|Adverse Event|1|||
160788454|NCT00561821|580610932|FG003|Overall Study|Adverse Event|1|||
160788455|NCT03178942|580610933|FG000|Overall Study|Withdrawal by Subject|2|||
160788456|NCT03178942|580610934|FG001|Overall Study|Withdrawal by Subject|0|||
160788457|NCT03178942|580610933|FG000|Overall Study|Lost to Follow-up|1|||
160547792|NCT00137111|579732470|FG001|Total Therapy|Non Compliance|0|||
160547793|NCT00137111|579732471|FG002|Total Therapy|Non Compliance|0|||
160547794|NCT00137111|579732472|FG003|Total Therapy|Non Compliance|0|||
160788458|NCT03178942|580610934|FG001|Overall Study|Lost to Follow-up|2|||
160891334|NCT01659658|580998747|FG001|Overall Study|Study Terminated by Sponsor|7|||
160891335|NCT01659658|580998748|FG002|Overall Study|Study Terminated by Sponsor|0|||
160891336|NCT01659658|580998749|FG003|Overall Study|Study Terminated by Sponsor|1|||
160891337|NCT01659658|580998750|FG004|Overall Study|Study Terminated by Sponsor|4|||
160891338|NCT01659658|580998746|FG000|Overall Study|Reason not Specified|61|||
160891339|NCT01659658|580998747|FG001|Overall Study|Reason not Specified|15|||
160891340|NCT01659658|580998748|FG002|Overall Study|Reason not Specified|8|||
160891341|NCT01659658|580998749|FG003|Overall Study|Reason not Specified|1|||
160891342|NCT01659658|580998750|FG004|Overall Study|Reason not Specified|34|||
160891343|NCT01659658|580998746|FG000|Overall Study|Lost to Follow-up|2|||
160891344|NCT01659658|580998747|FG001|Overall Study|Lost to Follow-up|0|||
160891345|NCT01659658|580998748|FG002|Overall Study|Lost to Follow-up|0|||
160891346|NCT01659658|580998749|FG003|Overall Study|Lost to Follow-up|0|||
160891347|NCT01659658|580998750|FG004|Overall Study|Lost to Follow-up|0|||
160891348|NCT00122278|580998753|FG000|Overall Study|Lost to Follow-up|2|||
160891349|NCT00122278|580998754|FG001|Overall Study|Lost to Follow-up|0|||
160891350|NCT01002482|580998755|FG000|Overall Study|Withdrawal by Subject|14|||
160891351|NCT01002482|580998756|FG001|Overall Study|Withdrawal by Subject|21|||
160891352|NCT01002482|580998755|FG000|Overall Study|Included twice|1|||
160891353|NCT01002482|580998756|FG001|Overall Study|Included twice|0|||
160891354|NCT04879225|580998757|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
160891355|NCT04879225|580998757|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
160891356|NCT00736957|580998760|FG000|Overall Study|Adverse Event|43|||
160891357|NCT00736957|580998760|FG000|Overall Study|Withdrawal by Subject|49|||
160891358|NCT00736957|580998760|FG000|Overall Study|violation of eligibility criteria|2|||
160891359|NCT00736957|580998760|FG000|Overall Study|did not attend hospital appointments|1|||
160547795|NCT03440814|579732473|FG000|Overall Study|Adverse Event|2|||
160547796|NCT03440814|579732474|FG001|Overall Study|Adverse Event|1|||
160547797|NCT03440814|579732473|FG000|Overall Study|Lost to Follow-up|2|||
160547798|NCT03440814|579732474|FG001|Overall Study|Lost to Follow-up|0|||
160891360|NCT00736957|580998760|FG000|Overall Study|not eligible for Treatment Period I|22|||
160891361|NCT00736957|580998760|FG000|Overall Study|Physician Decision|5|||
160891362|NCT03646643|580998761|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
160891363|NCT03646643|580998762|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
160891364|NCT03646643|580998761|FG000|Overall Study|Lost to Follow-up|0|||
160891365|NCT03646643|580998762|FG001|Overall Study|Lost to Follow-up|1|||
160891366|NCT02806973|580998763|FG000|Period 1|Withdrawal by Subject|0|||
160891367|NCT02806973|580998764|FG001|Period 1|Withdrawal by Subject|2|||
160891368|NCT02806973|580998765|FG002|Period 1|Withdrawal by Subject|1|||
160891369|NCT02806973|580998766|FG003|Period 1|Withdrawal by Subject|1|||
160891370|NCT02806973|580998763|FG000|Period 1|Adverse Event|0|||
160891371|NCT02806973|580998764|FG001|Period 1|Adverse Event|0|||
160891372|NCT02806973|580998765|FG002|Period 1|Adverse Event|0|||
160891373|NCT02806973|580998766|FG003|Period 1|Adverse Event|1|||
160891374|NCT02806973|580998763|FG000|Period 3|Withdrawal by Subject|0|||
160891375|NCT02806973|580998764|FG001|Period 3|Withdrawal by Subject|0|||
160547799|NCT03440814|579732473|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
160547800|NCT03440814|579732474|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
160547801|NCT00088374|579732475|FG000|Overall Study|patient did not receive any 17AAG|1|||
160547802|NCT00088374|579732475|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
160547803|NCT00852995|579732476|FG000|Overall Study|Adverse Event|1|||
160547804|NCT00852995|579732477|FG001|Overall Study|Adverse Event|0|||
160547805|NCT00852995|579732478|FG002|Overall Study|Adverse Event|4|||
160547806|NCT00852995|579732479|FG003|Overall Study|Adverse Event|0|||
160547807|NCT00852995|579732480|FG004|Overall Study|Adverse Event|0|||
160547808|NCT00852995|579732476|FG000|Overall Study|Lost to Follow-up|0|||
160547809|NCT00852995|579732477|FG001|Overall Study|Lost to Follow-up|1|||
160547810|NCT00852995|579732478|FG002|Overall Study|Lost to Follow-up|1|||
160547811|NCT00852995|579732479|FG003|Overall Study|Lost to Follow-up|0|||
160547812|NCT00852995|579732480|FG004|Overall Study|Lost to Follow-up|0|||
160547813|NCT00852995|579732476|FG000|Overall Study|Withdrawal by Subject|4|||
160547814|NCT00852995|579732477|FG001|Overall Study|Withdrawal by Subject|0|||
160891376|NCT02806973|580998765|FG002|Period 3|Withdrawal by Subject|0|||
160891377|NCT02806973|580998766|FG003|Period 3|Withdrawal by Subject|3|||
160891378|NCT02806973|580998763|FG000|Period 3|Adverse Event|0|||
160891379|NCT02806973|580998764|FG001|Period 3|Adverse Event|0|||
160891380|NCT02806973|580998765|FG002|Period 3|Adverse Event|1|||
160547815|NCT00852995|579732478|FG002|Overall Study|Withdrawal by Subject|0|||
160547816|NCT00852995|579732479|FG003|Overall Study|Withdrawal by Subject|1|||
160891381|NCT02806973|580998766|FG003|Period 3|Adverse Event|0|||
160891382|NCT04209426|580998769|FG000|Overall Study|Lost to Follow-up|3|||
160891383|NCT04209426|580998770|FG001|Overall Study|Lost to Follow-up|2|||
160891384|NCT04060862|580998771|FG000|Overall Study|Symptomatic Deterioration|1|||
160891385|NCT04060862|580998771|FG000|Overall Study|Un-specified|6|||
160891386|NCT04060862|580998771|FG000|Overall Study|Progressive disease|12|||
160891387|NCT04060862|580998771|FG000|Overall Study|Physician Decision|1|||
160891388|NCT00214500|580998774|FG000|Treatment Period|Adverse Event|1|||
160891389|NCT00214500|580998774|FG000|Extension Period|Withdrawal by Subject|2|||
160891390|NCT01068652|580998775|FG000|Overall Study|Adverse Event|4|||
160891391|NCT01068652|580998776|FG001|Overall Study|Adverse Event|0|||
160891392|NCT01068652|580998775|FG000|Overall Study|Lack of Efficacy|0|||
160891393|NCT01068652|580998776|FG001|Overall Study|Lack of Efficacy|2|||
160891394|NCT01068652|580998775|FG000|Overall Study|Lost to Follow-up|2|||
160891395|NCT01068652|580998776|FG001|Overall Study|Lost to Follow-up|1|||
160891396|NCT01068652|580998775|FG000|Overall Study|Protocol Violation|3|||
160891397|NCT01068652|580998776|FG001|Overall Study|Protocol Violation|6|||
160891398|NCT01068652|580998775|FG000|Overall Study|Withdrawal criteria|1|||
160891399|NCT01068652|580998776|FG001|Overall Study|Withdrawal criteria|2|||
160891400|NCT01068652|580998775|FG000|Overall Study|Patient was not eligible|1|||
160891401|NCT01068652|580998776|FG001|Overall Study|Patient was not eligible|0|||
160891402|NCT01068652|580998775|FG000|Overall Study|Unclassified|7|||
160891403|NCT01068652|580998776|FG001|Overall Study|Unclassified|4|||
160891404|NCT00147251|580998777|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
160891405|NCT00147251|580998778|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
160891406|NCT03343067|580998781|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
160891407|NCT03343067|580998782|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
160891408|NCT03343067|580998783|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
160891409|NCT00542451|580998784|FG000|Overall Study|Adverse Event|31|||
160891410|NCT00542451|580998784|FG000|Overall Study|Withdrawal by Subject|30|||
160891411|NCT00542451|580998784|FG000|Overall Study|Physician Decision|4|||
160891412|NCT00542451|580998784|FG000|Overall Study|Recurrent disease|1|||
160891413|NCT00542451|580998784|FG000|Overall Study|unknown reason|1|||
160891414|NCT00542451|580998784|FG000|Overall Study|Death|2|||
160891415|NCT00542451|580998784|FG000|Overall Study|Lost to Follow-up|10|||
160891416|NCT00116168|580998785|FG000|Overall Study|Lost to Follow-up|6|||
160891417|NCT00116168|580998786|FG001|Overall Study|Lost to Follow-up|5|||
160891418|NCT00116168|580998787|FG002|Overall Study|Lost to Follow-up|0|||
160891419|NCT00116168|580998788|FG003|Overall Study|Lost to Follow-up|0|||
160891420|NCT03555435|580998789|FG000|Overall Study|Lost to Follow-up|17|||
160891421|NCT03555435|580998790|FG001|Overall Study|Lost to Follow-up|19|||
160891422|NCT03555435|580998791|FG002|Overall Study|Lost to Follow-up|8|||
160891423|NCT02964507|580998796|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891424|NCT02964507|580998797|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
160891425|NCT02964507|580998798|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891426|NCT02964507|580998799|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891427|NCT02964507|580998800|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
160891428|NCT02964507|580998801|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891429|NCT02964507|580998802|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891430|NCT02964507|580998803|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891431|NCT02964507|580998796|FG000|Overall Study|Study terminated by Sponsor|9|||
160891432|NCT02964507|580998797|FG001|Overall Study|Study terminated by Sponsor|1|||
160891433|NCT02964507|580998798|FG002|Overall Study|Study terminated by Sponsor|9|||
160891434|NCT02964507|580998799|FG003|Overall Study|Study terminated by Sponsor|3|||
160891435|NCT02964507|580998800|FG004|Overall Study|Study terminated by Sponsor|3|||
160891436|NCT02964507|580998801|FG005|Overall Study|Study terminated by Sponsor|2|||
160891437|NCT02964507|580998802|FG006|Overall Study|Study terminated by Sponsor|0|||
160891438|NCT02964507|580998803|FG007|Overall Study|Study terminated by Sponsor|0|||
160891439|NCT02964507|580998796|FG000|Overall Study|Other|3|||
160891440|NCT02964507|580998797|FG001|Overall Study|Other|0|||
160891441|NCT02964507|580998798|FG002|Overall Study|Other|0|||
160891442|NCT02964507|580998799|FG003|Overall Study|Other|0|||
160891443|NCT02964507|580998800|FG004|Overall Study|Other|1|||
160891444|NCT02964507|580998801|FG005|Overall Study|Other|0|||
160891445|NCT02964507|580998802|FG006|Overall Study|Other|0|||
160891446|NCT02964507|580998803|FG007|Overall Study|Other|0|||
160891447|NCT02964507|580998796|FG000|Overall Study|Death|11|||
160891448|NCT02964507|580998797|FG001|Overall Study|Death|9|||
160891449|NCT02964507|580998798|FG002|Overall Study|Death|12|||
160891450|NCT02964507|580998799|FG003|Overall Study|Death|2|||
160891451|NCT02964507|580998800|FG004|Overall Study|Death|10|||
160891452|NCT02964507|580998801|FG005|Overall Study|Death|5|||
160891453|NCT02964507|580998802|FG006|Overall Study|Death|0|||
160891454|NCT02964507|580998803|FG007|Overall Study|Death|0|||
160891455|NCT02964507|580998796|FG000|Overall Study|Withdrawal by Subject|1|||
160891456|NCT02964507|580998797|FG001|Overall Study|Withdrawal by Subject|0|||
160891457|NCT02964507|580998798|FG002|Overall Study|Withdrawal by Subject|1|||
160891458|NCT02964507|580998799|FG003|Overall Study|Withdrawal by Subject|1|||
160891459|NCT02964507|580998800|FG004|Overall Study|Withdrawal by Subject|0|||
160891460|NCT02964507|580998801|FG005|Overall Study|Withdrawal by Subject|1|||
160891461|NCT02964507|580998802|FG006|Overall Study|Withdrawal by Subject|0|||
160891462|NCT02964507|580998803|FG007|Overall Study|Withdrawal by Subject|0|||
160642329|NCT01393990|580074258|FG011|Overall Study|Adverse Event|0|||
160891463|NCT02964507|580998796|FG000|Overall Study|Physician Decision|2|||
160891464|NCT02964507|580998797|FG001|Overall Study|Physician Decision|0|||
160891465|NCT02964507|580998798|FG002|Overall Study|Physician Decision|3|||
160547817|NCT00852995|579732480|FG004|Overall Study|Withdrawal by Subject|2|||
160547818|NCT00852995|579732476|FG000|Overall Study|Non-Compliance|0|||
160547819|NCT00852995|579732477|FG001|Overall Study|Non-Compliance|0|||
160547820|NCT00852995|579732478|FG002|Overall Study|Non-Compliance|0|||
160547821|NCT00852995|579732479|FG003|Overall Study|Non-Compliance|2|||
160547822|NCT00852995|579732480|FG004|Overall Study|Non-Compliance|0|||
160547823|NCT00852995|579732476|FG000|Overall Study|Progressive Disease|1|||
160547824|NCT00852995|579732477|FG001|Overall Study|Progressive Disease|0|||
160547825|NCT00852995|579732478|FG002|Overall Study|Progressive Disease|0|||
160547826|NCT00852995|579732479|FG003|Overall Study|Progressive Disease|2|||
160547827|NCT00852995|579732480|FG004|Overall Study|Progressive Disease|1|||
160547828|NCT00852995|579732476|FG000|Overall Study|Physician Decision|1|||
160547829|NCT00852995|579732477|FG001|Overall Study|Physician Decision|0|||
160547830|NCT00852995|579732478|FG002|Overall Study|Physician Decision|0|||
160547831|NCT00852995|579732479|FG003|Overall Study|Physician Decision|0|||
160547832|NCT00852995|579732480|FG004|Overall Study|Physician Decision|0|||
160547833|NCT00852995|579732476|FG000|Overall Study|Protocol Violation|0|||
160547834|NCT00852995|579732477|FG001|Overall Study|Protocol Violation|0|||
160788459|NCT03142451|580612629|FG000|Overall Study|Adverse Event|5|||
160788460|NCT03142451|580612630|FG001|Overall Study|Adverse Event|2|||
160788461|NCT03142451|580612629|FG000|Overall Study|Lost to Follow-up|25|||
160788462|NCT03142451|580612630|FG001|Overall Study|Lost to Follow-up|8|||
160788463|NCT03142451|580612629|FG000|Overall Study|Participant request|24|||
160788464|NCT03142451|580612630|FG001|Overall Study|Participant request|12|||
160788465|NCT03142451|580612629|FG000|Overall Study|Protocol Violation|3|||
160788466|NCT03142451|580612630|FG001|Overall Study|Protocol Violation|1|||
160788467|NCT03142451|580612629|FG000|Overall Study|Other|1|||
160788468|NCT03142451|580612630|FG001|Overall Study|Other|1|||
160788469|NCT05333965|580612631|FG000|First Intervention|Adverse Event|0|||
160788470|NCT05333965|580612632|FG001|First Intervention|Adverse Event|1|||
160788471|NCT05333965|580612631|FG000|First Intervention|Withdrawal by Subject|0|||
160788472|NCT05333965|580612632|FG001|First Intervention|Withdrawal by Subject|1|||
160788473|NCT03048019|580612633|FG000|Overall Study|Adverse Event|1|||
160788474|NCT03048019|580612634|FG001|Overall Study|Adverse Event|0|||
160788475|NCT01730729|580612635|FG000|Overall Study|Adverse Event|1|||
160788476|NCT01730729|580612635|FG000|Overall Study|Death|1|||
160788477|NCT01730729|580612635|FG000|Overall Study|Progressive Disease|12|||
160788478|NCT00871000|580612636|FG000|Overall Study|Withdrawal by Subject|1|||
160788479|NCT00871000|580612637|FG001|Overall Study|Withdrawal by Subject|0|||
160788480|NCT03400787|580612638|FG000|Overall Study|Lost to Follow-up|1|||
160788481|NCT03400787|580612639|FG001|Overall Study|Lost to Follow-up|0|||
160788482|NCT03400787|580612638|FG000|Overall Study|Death|1|||
160788483|NCT03400787|580612639|FG001|Overall Study|Death|0|||
160788484|NCT03400787|580612638|FG000|Overall Study|Protocol Violation|0|||
160788485|NCT03400787|580612639|FG001|Overall Study|Protocol Violation|2|||
160788486|NCT03400787|580612638|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
160788487|NCT03400787|580612639|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
160788488|NCT00203242|580612644|FG000|Overall Study|Lost to Follow-up|1|||
160788489|NCT02595437|580612646|FG000|Triferic Via IV|Withdrawal by Subject|1|||
160788490|NCT02837952|580612648|FG000|Overall Study|Adverse Event|0|||
160788491|NCT02837952|580612649|FG001|Overall Study|Adverse Event|1|||
160788492|NCT02837952|580612648|FG000|Overall Study|Withdrawal by Subject|4|||
160788493|NCT02837952|580612649|FG001|Overall Study|Withdrawal by Subject|5|||
160788494|NCT02837952|580612648|FG000|Overall Study|Medication Error|1|||
160788495|NCT02837952|580612649|FG001|Overall Study|Medication Error|0|||
160788496|NCT01959919|580612650|FG000|Overall Study|Did not meet the eligibility criteria|2|||
160788497|NCT03439072|580612653|FG000|Overall Study|Withdrawal by Subject|2|||
160788498|NCT03439072|580612654|FG001|Overall Study|Withdrawal by Subject|3|||
160788499|NCT03439072|580612653|FG000|Overall Study|Physician Decision|0|||
160788500|NCT03439072|580612654|FG001|Overall Study|Physician Decision|1|||
160788501|NCT02003898|580612656|FG000|Overall Study|Death|3|||
160788502|NCT02003898|580612656|FG000|Overall Study|Lost to Follow-up|12|||
160788503|NCT02003898|580612656|FG000|Overall Study|Withdrawal by Subject|52|||
160788504|NCT01537432|580612657|FG000|Overall Study|Lost to Follow-up|3|||
160788505|NCT01537432|580612658|FG001|Overall Study|Lost to Follow-up|1|||
160788506|NCT01537432|580612657|FG000|Overall Study|Withdrawal by Subject|0|||
160788507|NCT01537432|580612658|FG001|Overall Study|Withdrawal by Subject|1|||
160788508|NCT01537432|580612657|FG000|Overall Study|Administrative problems|1|||
160788509|NCT01537432|580612658|FG001|Overall Study|Administrative problems|0|||
160788510|NCT01537432|580612657|FG000|Overall Study|Adverse Event|1|||
160788511|NCT01537432|580612658|FG001|Overall Study|Adverse Event|0|||
160788512|NCT01537432|580612657|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160788513|NCT01537432|580612658|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160788514|NCT03682367|580612661|FG000|Overall Study|Protocol Violation|2|||
160788515|NCT03682367|580612662|FG001|Overall Study|Protocol Violation|1|||
160788516|NCT03682367|580612661|FG000|Overall Study|Closed Study Early|0|||
160788517|NCT03682367|580612662|FG001|Overall Study|Closed Study Early|3|||
160788518|NCT00128492|580612663|FG000|Overall Study|AE unrelated to study|2|||
160788519|NCT00128492|580612664|FG001|Overall Study|AE unrelated to study|9|||
160788520|NCT00128492|580612663|FG000|Overall Study|Study drug intolerance (AE)|2|||
160788521|NCT00128492|580612664|FG001|Overall Study|Study drug intolerance (AE)|8|||
160788522|NCT00128492|580612663|FG000|Overall Study|AE related to study|1|||
160788523|NCT00128492|580612664|FG001|Overall Study|AE related to study|4|||
160788524|NCT00128492|580612663|FG000|Overall Study|Death|1|||
160788525|NCT00128492|580612664|FG001|Overall Study|Death|0|||
160788526|NCT00128492|580612663|FG000|Overall Study|Lost to Follow-up|1|||
160642330|NCT01393990|580074259|FG012|Overall Study|Adverse Event|0|||
160642331|NCT01393990|580074260|FG013|Overall Study|Adverse Event|0|||
160642332|NCT01393990|580074261|FG014|Overall Study|Adverse Event|1|||
160642333|NCT01393990|580074262|FG015|Overall Study|Adverse Event|1|||
160547835|NCT00852995|579732478|FG002|Overall Study|Protocol Violation|0|||
160547836|NCT00852995|579732479|FG003|Overall Study|Protocol Violation|0|||
160547837|NCT00852995|579732480|FG004|Overall Study|Protocol Violation|1|||
160547838|NCT00852995|579732476|FG000|Overall Study|Moved Out of Area|1|||
160547839|NCT00852995|579732477|FG001|Overall Study|Moved Out of Area|0|||
160891466|NCT02964507|580998799|FG003|Overall Study|Physician Decision|0|||
160891467|NCT02964507|580998800|FG004|Overall Study|Physician Decision|1|||
160891468|NCT02964507|580998801|FG005|Overall Study|Physician Decision|0|||
160891469|NCT02964507|580998802|FG006|Overall Study|Physician Decision|0|||
160891470|NCT02964507|580998803|FG007|Overall Study|Physician Decision|0|||
160891471|NCT04341662|580998805|FG000|Overall Study|Did not have source-verified blood loss data|423|||
160891472|NCT04341662|580998806|FG001|Overall Study|Did not have source-verified blood loss data|514|||
160891473|NCT00245583|580998807|FG000|Overall Study|Lost to Follow-up|1|||
160891474|NCT00245583|580998808|FG001|Overall Study|Lost to Follow-up|5|||
160891475|NCT00245583|580998807|FG000|Overall Study|Adverse Event|2|||
160891476|NCT00245583|580998808|FG001|Overall Study|Adverse Event|1|||
160891477|NCT00245583|580998807|FG000|Overall Study|Lack of Efficacy|1|||
160891478|NCT00245583|580998808|FG001|Overall Study|Lack of Efficacy|0|||
160891479|NCT00245583|580998807|FG000|Overall Study|Withdrawal by Subject|2|||
160891480|NCT00245583|580998808|FG001|Overall Study|Withdrawal by Subject|3|||
160891481|NCT04718103|580998809|FG000|Overall Study|Adverse Event|1|||
160891482|NCT04718103|580998810|FG001|Overall Study|Adverse Event|1|||
160891483|NCT04718103|580998809|FG000|Overall Study|Lack of Efficacy|4|||
160891484|NCT04718103|580998810|FG001|Overall Study|Lack of Efficacy|1|||
160891485|NCT04718103|580998809|FG000|Overall Study|Lost to Follow-up|2|||
160891486|NCT04718103|580998810|FG001|Overall Study|Lost to Follow-up|2|||
160891487|NCT04718103|580998809|FG000|Overall Study|Physician Decision|2|||
160891488|NCT04718103|580998810|FG001|Overall Study|Physician Decision|0|||
160891489|NCT04718103|580998809|FG000|Overall Study|Pregnancy|0|||
160891490|NCT04718103|580998810|FG001|Overall Study|Pregnancy|1|||
160891491|NCT04718103|580998809|FG000|Overall Study|Withdrawal by Subject|10|||
160891492|NCT04718103|580998810|FG001|Overall Study|Withdrawal by Subject|6|||
160891493|NCT04718103|580998809|FG000|Overall Study|Randomized, not treated|4|||
160891494|NCT04718103|580998810|FG001|Overall Study|Randomized, not treated|1|||
160891495|NCT04718103|580998809|FG000|Overall Study|GCP violations|7|||
160891496|NCT04718103|580998810|FG001|Overall Study|GCP violations|5|||
160891497|NCT01309893|580998811|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
160891498|NCT01309893|580998812|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
160891499|NCT01309893|580998811|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
160891500|NCT01309893|580998812|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
160891501|NCT02017171|580998813|FG000|Overall Study|Death|10|||
160642334|NCT01393990|580074263|FG016|Overall Study|Adverse Event|0|||
160891502|NCT02017171|580998814|FG001|Overall Study|Death|4|||
160891503|NCT02017171|580998813|FG000|Overall Study|Withdrawal by Subject|23|||
160891504|NCT02017171|580998814|FG001|Overall Study|Withdrawal by Subject|17|||
160891505|NCT02017171|580998813|FG000|Overall Study|Lost to Follow-up|21|||
160891506|NCT02017171|580998814|FG001|Overall Study|Lost to Follow-up|20|||
160891507|NCT02017171|580998813|FG000|Overall Study|ESKD|6|||
160891508|NCT02017171|580998814|FG001|Overall Study|ESKD|2|||
160547840|NCT00852995|579732478|FG002|Overall Study|Moved Out of Area|0|||
160547841|NCT00852995|579732479|FG003|Overall Study|Moved Out of Area|0|||
160547842|NCT00852995|579732480|FG004|Overall Study|Moved Out of Area|0|||
160547843|NCT01110200|579732481|FG000|Overall Study|Adverse Event|28|||
160642335|NCT01393990|580074264|FG017|Overall Study|Adverse Event|0|||
160642336|NCT01393990|580074247|FG000|Overall Study|Progressive Disease|1|||
160788527|NCT00128492|580612664|FG001|Overall Study|Lost to Follow-up|5|||
160788528|NCT00128492|580612663|FG000|Overall Study|Noncompliance|0|||
160788529|NCT00128492|580612664|FG001|Overall Study|Noncompliance|5|||
160788530|NCT00128492|580612663|FG000|Overall Study|Personal or administrative|10|||
160788531|NCT00128492|580612664|FG001|Overall Study|Personal or administrative|22|||
160788532|NCT00128492|580612663|FG000|Overall Study|Withdrawal by Subject|3|||
160891509|NCT02017171|580998813|FG000|Overall Study|Miscellaneous|2|||
160891510|NCT02017171|580998814|FG001|Overall Study|Miscellaneous|3|||
160891511|NCT01562873|580998815|FG000|Overall Study|Disease Progression per RECIST|10|||
160891512|NCT01562873|580998816|FG001|Overall Study|Disease Progression per RECIST|0|||
160891513|NCT01562873|580998815|FG000|Overall Study|Adverse Event|1|||
160891514|NCT01562873|580998816|FG001|Overall Study|Adverse Event|0|||
160642337|NCT01393990|580074248|FG001|Overall Study|Progressive Disease|0|||
160547844|NCT01110200|579732482|FG001|Overall Study|Adverse Event|28|||
160547845|NCT01110200|579732481|FG000|Overall Study|Withdrawal by Subject|25|||
160547846|NCT01110200|579732482|FG001|Overall Study|Withdrawal by Subject|32|||
160547847|NCT01110200|579732481|FG000|Overall Study|Lack of Efficacy|16|||
160547848|NCT01110200|579732482|FG001|Overall Study|Lack of Efficacy|25|||
160547849|NCT01110200|579732481|FG000|Overall Study|Protocol Violation|14|||
160891515|NCT01562873|580998815|FG000|Overall Study|Clinical Disease Progression|9|||
160891516|NCT01562873|580998816|FG001|Overall Study|Clinical Disease Progression|0|||
160891517|NCT01562873|580998815|FG000|Overall Study|Clinical PD and adverse event|1|||
160891518|NCT01562873|580998816|FG001|Overall Study|Clinical PD and adverse event|0|||
160891519|NCT02220998|580998817|FG000|Overall Study|Randomized but Never Treated|1|||
160891520|NCT02220998|580998818|FG001|Overall Study|Randomized but Never Treated|2|||
160891521|NCT02220998|580998817|FG000|Overall Study|Death|2|||
160891522|NCT02220998|580998818|FG001|Overall Study|Death|0|||
160891523|NCT02220998|580998817|FG000|Overall Study|Lack of Efficacy|0|||
160891524|NCT02220998|580998818|FG001|Overall Study|Lack of Efficacy|5|||
160891525|NCT02220998|580998817|FG000|Overall Study|Lost to Follow-up|4|||
160891526|NCT02220998|580998818|FG001|Overall Study|Lost to Follow-up|4|||
160891527|NCT03309046|580998819|FG000|Overall Study|Withdrawal by Subject|4|||
160891528|NCT03309046|580998820|FG001|Overall Study|Withdrawal by Subject|17|||
160891529|NCT00873860|580998821|FG000|Overall Study|Lost to Follow-up|1|||
160891530|NCT00873860|580998822|FG001|Overall Study|Lost to Follow-up|0|||
160891531|NCT00873860|580998823|FG002|Overall Study|Lost to Follow-up|0|||
160891532|NCT00873860|580998824|FG003|Overall Study|Lost to Follow-up|1|||
160891533|NCT00873860|580998821|FG000|Overall Study|Withdrawal by Subject|1|||
160891534|NCT00873860|580998822|FG001|Overall Study|Withdrawal by Subject|0|||
160891535|NCT00873860|580998823|FG002|Overall Study|Withdrawal by Subject|2|||
160891536|NCT00873860|580998824|FG003|Overall Study|Withdrawal by Subject|0|||
160891537|NCT00873860|580998821|FG000|Overall Study|Death|1|||
160891538|NCT00873860|580998822|FG001|Overall Study|Death|0|||
160891539|NCT00873860|580998823|FG002|Overall Study|Death|0|||
160891540|NCT00873860|580998824|FG003|Overall Study|Death|0|||
160891541|NCT00873860|580998821|FG000|Overall Study|Other|1|||
160891542|NCT00873860|580998822|FG001|Overall Study|Other|0|||
160891543|NCT00873860|580998823|FG002|Overall Study|Other|1|||
160891544|NCT00873860|580998824|FG003|Overall Study|Other|0|||
160891545|NCT02764190|580998825|FG000|Overall Study|Lost to Follow-up|17|||
160891546|NCT02764190|580998826|FG001|Overall Study|Lost to Follow-up|13|||
160891547|NCT01484938|580998827|FG000|Overall Study|Adverse Event|2|||
160891548|NCT01484938|580998827|FG000|Overall Study|Lost to Follow-up|1|||
160891549|NCT01484938|580998827|FG000|Overall Study|Noncompliance|1|||
160891550|NCT01172275|580998831|FG000|Overall Study|Lost to Follow-up|1|||
160891551|NCT01172275|580998832|FG001|Overall Study|Lost to Follow-up|0|||
160891552|NCT01172275|580998831|FG000|Overall Study|Protocol Violation|1|||
160891553|NCT01172275|580998832|FG001|Overall Study|Protocol Violation|0|||
160891554|NCT02862600|580998833|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
160891555|NCT02862600|580998833|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
160891556|NCT02862600|580998833|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
160891557|NCT02862600|580998833|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
160891558|NCT00194675|580998834|FG000|Overall Study|Lost to Follow-up|1|||
160891559|NCT00194675|580998835|FG001|Overall Study|Lost to Follow-up|1|||
160891560|NCT00194675|580998834|FG000|Overall Study|lack of interest|1|||
160891561|NCT00194675|580998835|FG001|Overall Study|lack of interest|1|||
160891562|NCT00194675|580998834|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
160891563|NCT00194675|580998835|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
160891564|NCT00194675|580998834|FG000|Overall Study|Protocol Violation|1|||
160891565|NCT00194675|580998835|FG001|Overall Study|Protocol Violation|0|||
160891566|NCT00194675|580998834|FG000|Overall Study|Death|1|||
160891567|NCT00194675|580998835|FG001|Overall Study|Death|0|||
160891568|NCT04271280|580998836|FG000|Overall Study|Lost to Follow-up|300|||
160891569|NCT04271280|580998836|FG000|Overall Study|Death|153|||
160891570|NCT04271280|580998836|FG000|Overall Study|Withdrawal of consent by patient|59|||
160891571|NCT04271280|580998836|FG000|Overall Study|Other|51|||
160891572|NCT04271280|580998836|FG000|Overall Study|No end of study information|42|||
160891573|NCT00495131|580998837|FG000|Overall Study|Adverse Event|6|||
160891574|NCT00495131|580998838|FG001|Overall Study|Adverse Event|2|||
160891575|NCT00495131|580998837|FG000|Overall Study|Lack of Efficacy|0|||
160891576|NCT00495131|580998838|FG001|Overall Study|Lack of Efficacy|2|||
160891577|NCT00495131|580998837|FG000|Overall Study|Lost to Follow-up|0|||
160981870|NCT02061761|581321787|FG005|Overall Study|Maximum clinical benefit|0|||
160981871|NCT02061761|581321788|FG006|Overall Study|Maximum clinical benefit|0|||
160547850|NCT01110200|579732482|FG001|Overall Study|Protocol Violation|12|||
160547851|NCT01110200|579732481|FG000|Overall Study|Physician Decision|13|||
160547852|NCT01110200|579732482|FG001|Overall Study|Physician Decision|17|||
160547853|NCT01110200|579732481|FG000|Overall Study|Lost to Follow-up|10|||
160547854|NCT01110200|579732482|FG001|Overall Study|Lost to Follow-up|7|||
160891578|NCT00495131|580998838|FG001|Overall Study|Lost to Follow-up|2|||
160891579|NCT00495131|580998837|FG000|Overall Study|Withdrawal by Subject|1|||
160891580|NCT00495131|580998838|FG001|Overall Study|Withdrawal by Subject|0|||
160891581|NCT01539317|580998841|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
160891582|NCT01539317|580998842|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
160891589|NCT00364130|580998845|FG000|Intervention Period|Lost to Follow-up|4|||
160891590|NCT00364130|580998846|FG001|Intervention Period|Lost to Follow-up|3|||
160891591|NCT00364130|580998845|FG000|Intervention Period|Pregnancy|1|||
160891592|NCT00364130|580998846|FG001|Intervention Period|Pregnancy|0|||
160891593|NCT00364130|580998845|FG000|Intervention Period|Withdrawal by Subject|4|||
160891594|NCT00364130|580998846|FG001|Intervention Period|Withdrawal by Subject|5|||
160891595|NCT00364130|580998845|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
160891596|NCT00364130|580998846|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
160891597|NCT00586846|580998854|FG000|Overall Study|Physician Decision|1|||
160891598|NCT00586846|580998854|FG000|Overall Study|Death|1|||
160891599|NCT00586846|580998854|FG000|Overall Study|Evaluable for Toxicity Only|4|||
160891600|NCT01702571|580998861|FG000|Overall Study|Death|1067|||
160891601|NCT01702571|580998862|FG001|Overall Study|Death|76|||
160891602|NCT01702571|580998861|FG000|Overall Study|Lost to Follow-up|144|||
160891603|NCT01702571|580998862|FG001|Overall Study|Lost to Follow-up|10|||
160891604|NCT01702571|580998861|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
160891605|NCT01702571|580998862|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
160891606|NCT01702571|580998861|FG000|Overall Study|Investigator Decision|5|||
160891607|NCT01702571|580998862|FG001|Overall Study|Investigator Decision|0|||
160642338|NCT01393990|580074249|FG002|Overall Study|Progressive Disease|0|||
160642339|NCT01393990|580074250|FG003|Overall Study|Progressive Disease|1|||
160642340|NCT01393990|580074251|FG004|Overall Study|Progressive Disease|1|||
160642341|NCT01393990|580074252|FG005|Overall Study|Progressive Disease|1|||
160642342|NCT01393990|580074253|FG006|Overall Study|Progressive Disease|1|||
160642343|NCT01393990|580074254|FG007|Overall Study|Progressive Disease|1|||
160642344|NCT01393990|580074255|FG008|Overall Study|Progressive Disease|3|||
160642345|NCT01393990|580074256|FG009|Overall Study|Progressive Disease|1|||
160642346|NCT01393990|580074257|FG010|Overall Study|Progressive Disease|0|||
160642347|NCT01393990|580074258|FG011|Overall Study|Progressive Disease|0|||
160642348|NCT01393990|580074259|FG012|Overall Study|Progressive Disease|0|||
160642349|NCT01393990|580074260|FG013|Overall Study|Progressive Disease|1|||
160642350|NCT01393990|580074261|FG014|Overall Study|Progressive Disease|6|||
160642351|NCT01393990|580074262|FG015|Overall Study|Progressive Disease|1|||
160642352|NCT01393990|580074263|FG016|Overall Study|Progressive Disease|0|||
160642353|NCT01393990|580074264|FG017|Overall Study|Progressive Disease|0|||
160642354|NCT01393990|580074247|FG000|Overall Study|Death|0|||
160642355|NCT01393990|580074248|FG001|Overall Study|Death|0|||
160642356|NCT01393990|580074249|FG002|Overall Study|Death|0|||
160642357|NCT01393990|580074250|FG003|Overall Study|Death|0|||
160642358|NCT01393990|580074251|FG004|Overall Study|Death|1|||
160642359|NCT01393990|580074252|FG005|Overall Study|Death|0|||
160642360|NCT01393990|580074253|FG006|Overall Study|Death|0|||
160642361|NCT01393990|580074254|FG007|Overall Study|Death|0|||
160642362|NCT01393990|580074255|FG008|Overall Study|Death|0|||
160642363|NCT01393990|580074256|FG009|Overall Study|Death|0|||
160642364|NCT01393990|580074257|FG010|Overall Study|Death|0|||
160642365|NCT01393990|580074258|FG011|Overall Study|Death|0|||
160642366|NCT01393990|580074259|FG012|Overall Study|Death|0|||
160642367|NCT01393990|580074260|FG013|Overall Study|Death|1|||
160642368|NCT01393990|580074261|FG014|Overall Study|Death|1|||
160642369|NCT01393990|580074262|FG015|Overall Study|Death|0|||
160642370|NCT01393990|580074263|FG016|Overall Study|Death|0|||
160642371|NCT01393990|580074264|FG017|Overall Study|Death|0|||
160891608|NCT01702571|580998861|FG000|Overall Study|Not Classifiable|1|||
160891609|NCT01702571|580998862|FG001|Overall Study|Not Classifiable|0|||
160891610|NCT01702571|580998861|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
160891611|NCT01702571|580998862|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
160891612|NCT01702571|580998861|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
160891613|NCT01702571|580998862|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
160891614|NCT01702571|580998861|FG000|Overall Study|Progressive Disease|3|||
160891615|NCT01702571|580998862|FG001|Overall Study|Progressive Disease|0|||
160642372|NCT01393990|580074247|FG000|Overall Study|Withdrawal by Subject|0|||
160642373|NCT01393990|580074248|FG001|Overall Study|Withdrawal by Subject|0|||
160642374|NCT01393990|580074249|FG002|Overall Study|Withdrawal by Subject|0|||
160642375|NCT01393990|580074250|FG003|Overall Study|Withdrawal by Subject|0|||
160642376|NCT01393990|580074251|FG004|Overall Study|Withdrawal by Subject|0|||
160642377|NCT01393990|580074252|FG005|Overall Study|Withdrawal by Subject|0|||
160642378|NCT01393990|580074253|FG006|Overall Study|Withdrawal by Subject|0|||
160642379|NCT01393990|580074254|FG007|Overall Study|Withdrawal by Subject|0|||
160642380|NCT01393990|580074255|FG008|Overall Study|Withdrawal by Subject|0|||
160891616|NCT01702571|580998861|FG000|Overall Study|Protocol Violation|2|||
160891617|NCT01702571|580998862|FG001|Overall Study|Protocol Violation|0|||
160547855|NCT03205995|579732485|FG000|Overall Study|Adverse Event|1|||
160547856|NCT03205995|579732485|FG000|Overall Study|Death|1|||
160547857|NCT03205995|579732485|FG000|Overall Study|Physician Decision|2|||
160547858|NCT03205995|579732485|FG000|Overall Study|Protocol Violation|2|||
160547859|NCT01358864|579732496|FG000|Overall Study|Adverse Event|0|||
160891618|NCT01702571|580998861|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
160891619|NCT01702571|580998862|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
160891620|NCT01702571|580998861|FG000|Overall Study|Termination By Sponsor|4|||
160891621|NCT01702571|580998862|FG001|Overall Study|Termination By Sponsor|0|||
160891622|NCT01702571|580998861|FG000|Overall Study|Withdrawal by Subject|177|||
160891623|NCT01702571|580998862|FG001|Overall Study|Withdrawal by Subject|29|||
160891624|NCT03004443|580998863|FG000|Overall Study|Pregnancy|0|||
160891625|NCT03004443|580998864|FG001|Overall Study|Pregnancy|1|||
160891626|NCT00828854|580998865|FG000|Overall Study|Disease Progression|17|||
160891627|NCT00828854|580998865|FG000|Overall Study|Adverse Event|9|||
160891628|NCT00828854|580998865|FG000|Overall Study|Reason not Specified|1|||
160891629|NCT04221230|580998866|FG000|Overall Study|Lost to Follow-up|12|||
160891630|NCT04221230|580998867|FG001|Overall Study|Lost to Follow-up|12|||
160891631|NCT04221230|580998866|FG000|Overall Study|Protocol Violation|2|||
160891632|NCT04221230|580998867|FG001|Overall Study|Protocol Violation|2|||
160891633|NCT04221230|580998866|FG000|Overall Study|Adverse Event|0|||
160891634|NCT04221230|580998867|FG001|Overall Study|Adverse Event|8|||
160891635|NCT04221230|580998866|FG000|Overall Study|Physician Decision|1|||
160891636|NCT04221230|580998867|FG001|Overall Study|Physician Decision|0|||
160891637|NCT04221230|580998866|FG000|Overall Study|Withdrawal by Subject|13|||
160891638|NCT04221230|580998867|FG001|Overall Study|Withdrawal by Subject|11|||
160891639|NCT04221230|580998866|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160891640|NCT04221230|580998867|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160891641|NCT04221230|580998866|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160891642|NCT04221230|580998867|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
160891643|NCT04221230|580998866|FG000|Overall Study|Pregnancy|0|||
160891644|NCT04221230|580998867|FG001|Overall Study|Pregnancy|1|||
160891645|NCT04221230|580998866|FG000|Overall Study|Other|1|||
160891646|NCT04221230|580998867|FG001|Overall Study|Other|2|||
160891647|NCT00915356|580998868|FG000|Overall Study|Withdrawal by Subject|1|||
160891648|NCT00915356|580998869|FG001|Overall Study|Withdrawal by Subject|0|||
160891649|NCT00915356|580998870|FG002|Overall Study|Withdrawal by Subject|0|||
160891650|NCT00915356|580998871|FG003|Overall Study|Withdrawal by Subject|0|||
160891651|NCT00915356|580998872|FG004|Overall Study|Withdrawal by Subject|0|||
160891652|NCT00191646|580998874|FG000|Overall Study|Toxicity|26|||
160891653|NCT00191646|580998875|FG001|Overall Study|Toxicity|37|||
160891654|NCT00191646|580998874|FG000|Overall Study|Disease Progression|5|||
160891655|NCT00191646|580998875|FG001|Overall Study|Disease Progression|6|||
160891656|NCT00191646|580998874|FG000|Overall Study|Physician Decision|20|||
160891657|NCT00191646|580998875|FG001|Overall Study|Physician Decision|11|||
160891658|NCT00191646|580998874|FG000|Overall Study|Withdrawal by Subject|58|||
160891659|NCT00191646|580998875|FG001|Overall Study|Withdrawal by Subject|39|||
160891660|NCT00191646|580998874|FG000|Overall Study|Protocol Violation|5|||
160891661|NCT00191646|580998875|FG001|Overall Study|Protocol Violation|7|||
160891662|NCT00191646|580998874|FG000|Overall Study|Death|6|||
160891663|NCT00191646|580998875|FG001|Overall Study|Death|8|||
160891664|NCT00191646|580998874|FG000|Overall Study|Other|33|||
160891665|NCT00191646|580998875|FG001|Overall Study|Other|34|||
160891666|NCT00191646|580998874|FG000|Overall Study|Missing Data|18|||
160891667|NCT00191646|580998875|FG001|Overall Study|Missing Data|11|||
160891668|NCT05211284|580998881|FG000|Overall Study|Study Terminated|3|||
160891669|NCT05211284|580998882|FG001|Overall Study|Study Terminated|1|||
160891670|NCT00406718|580998891|FG000|Overall Study|Withdrawal by Subject|2|||
160891671|NCT00406718|580998892|FG001|Overall Study|Withdrawal by Subject|9|||
160891672|NCT00406718|580998893|FG002|Overall Study|Withdrawal by Subject|4|||
160891673|NCT00406718|580998891|FG000|Overall Study|Lost to Follow-up|2|||
160891674|NCT00406718|580998892|FG001|Overall Study|Lost to Follow-up|5|||
160891675|NCT00406718|580998893|FG002|Overall Study|Lost to Follow-up|4|||
160891676|NCT01888003|580998896|FG000|Overall Study|Study Terminated|5|||
160891677|NCT01888003|580998897|FG001|Overall Study|Study Terminated|6|||
160891678|NCT01888003|580998898|FG002|Overall Study|Study Terminated|40|||
160891679|NCT03187756|580998899|FG000|Overall Study|Termination of study|4|||
160891680|NCT01397201|581000404|FG000|Overall Study|Not treated|0|||
160891681|NCT01397201|581000405|FG001|Overall Study|Not treated|0|||
160891682|NCT01397201|581000406|FG002|Overall Study|Not treated|1|||
160891683|NCT01397201|581000407|FG003|Overall Study|Not treated|0|||
160891684|NCT01397201|581000408|FG004|Overall Study|Not treated|0|||
160891685|NCT01397201|581000404|FG000|Overall Study|Not yet defined|3|||
160891686|NCT01397201|581000405|FG001|Overall Study|Not yet defined|6|||
160891687|NCT01397201|581000406|FG002|Overall Study|Not yet defined|5|||
160547860|NCT01358864|579732497|FG001|Overall Study|Adverse Event|6|||
160891688|NCT01397201|581000407|FG003|Overall Study|Not yet defined|5|||
160891689|NCT01397201|581000408|FG004|Overall Study|Not yet defined|4|||
160891690|NCT01397201|581000404|FG000|Overall Study|Adverse Event|2|||
160891691|NCT01397201|581000405|FG001|Overall Study|Adverse Event|0|||
160891692|NCT01397201|581000406|FG002|Overall Study|Adverse Event|0|||
160547861|NCT01358864|579732498|FG002|Overall Study|Adverse Event|9|||
160547862|NCT01358864|579732499|FG003|Overall Study|Adverse Event|0|||
160547863|NCT01358864|579732500|FG004|Overall Study|Adverse Event|4|||
160547864|NCT01358864|579732501|FG005|Overall Study|Adverse Event|8|||
160547865|NCT01358864|579732502|FG006|Overall Study|Adverse Event|12|||
160547866|NCT01358864|579732503|FG007|Overall Study|Adverse Event|7|||
160547867|NCT01358864|579732496|FG000|Overall Study|Lack of Efficacy|26|||
160547868|NCT01358864|579732497|FG001|Overall Study|Lack of Efficacy|3|||
160547869|NCT01358864|579732498|FG002|Overall Study|Lack of Efficacy|4|||
160547870|NCT01358864|579732499|FG003|Overall Study|Lack of Efficacy|19|||
160547871|NCT01358864|579732500|FG004|Overall Study|Lack of Efficacy|7|||
160547872|NCT01358864|579732501|FG005|Overall Study|Lack of Efficacy|4|||
160547873|NCT01358864|579732502|FG006|Overall Study|Lack of Efficacy|49|||
160547874|NCT01358864|579732503|FG007|Overall Study|Lack of Efficacy|44|||
160547875|NCT01358864|579732496|FG000|Overall Study|Lost to Follow-up|0|||
160547876|NCT01358864|579732497|FG001|Overall Study|Lost to Follow-up|0|||
160547877|NCT01358864|579732498|FG002|Overall Study|Lost to Follow-up|1|||
160547878|NCT01358864|579732499|FG003|Overall Study|Lost to Follow-up|0|||
160547879|NCT01358864|579732500|FG004|Overall Study|Lost to Follow-up|0|||
160547880|NCT01358864|579732501|FG005|Overall Study|Lost to Follow-up|0|||
160547881|NCT01358864|579732502|FG006|Overall Study|Lost to Follow-up|0|||
160547882|NCT01358864|579732503|FG007|Overall Study|Lost to Follow-up|1|||
160547883|NCT01358864|579732496|FG000|Overall Study|Withdrawal by Subject|3|||
160547884|NCT01358864|579732497|FG001|Overall Study|Withdrawal by Subject|4|||
160547885|NCT01358864|579732498|FG002|Overall Study|Withdrawal by Subject|2|||
160547886|NCT01358864|579732499|FG003|Overall Study|Withdrawal by Subject|0|||
160547887|NCT01358864|579732500|FG004|Overall Study|Withdrawal by Subject|0|||
160547888|NCT01358864|579732501|FG005|Overall Study|Withdrawal by Subject|1|||
160547889|NCT01358864|579732502|FG006|Overall Study|Withdrawal by Subject|1|||
160547890|NCT01358864|579732503|FG007|Overall Study|Withdrawal by Subject|3|||
160547891|NCT01358864|579732496|FG000|Overall Study|Other reason not defined above|2|||
160547892|NCT01358864|579732497|FG001|Overall Study|Other reason not defined above|0|||
160547893|NCT01358864|579732498|FG002|Overall Study|Other reason not defined above|0|||
160547894|NCT01358864|579732499|FG003|Overall Study|Other reason not defined above|0|||
160547895|NCT01358864|579732500|FG004|Overall Study|Other reason not defined above|0|||
160547896|NCT01358864|579732501|FG005|Overall Study|Other reason not defined above|0|||
160547897|NCT01358864|579732502|FG006|Overall Study|Other reason not defined above|2|||
160547898|NCT01358864|579732503|FG007|Overall Study|Other reason not defined above|0|||
160547899|NCT01358864|579732496|FG000|Overall Study|Not treated|0|||
160547900|NCT01358864|579732497|FG001|Overall Study|Not treated|0|||
160547901|NCT01358864|579732498|FG002|Overall Study|Not treated|0|||
160547902|NCT01358864|579732499|FG003|Overall Study|Not treated|0|||
160547903|NCT01358864|579732500|FG004|Overall Study|Not treated|0|||
160547904|NCT01358864|579732501|FG005|Overall Study|Not treated|0|||
160547905|NCT01358864|579732502|FG006|Overall Study|Not treated|1|||
160547906|NCT01358864|579732503|FG007|Overall Study|Not treated|0|||
160547907|NCT04042103|579732509|FG000|Overall Study|Lost to Follow-up|1|||
160547908|NCT04042103|579732509|FG000|Overall Study|Withdrawal by Subject|1|||
160547909|NCT04209855|579732510|FG000|Overall Study|Death|161|||
160547910|NCT04209855|579732511|FG001|Overall Study|Death|177|||
160547911|NCT04209855|579732510|FG000|Overall Study|PI Discretion|1|||
160547912|NCT04209855|579732511|FG001|Overall Study|PI Discretion|1|||
160547913|NCT04209855|579732510|FG000|Overall Study|Lost to Follow-up|5|||
160547914|NCT04209855|579732511|FG001|Overall Study|Lost to Follow-up|2|||
160547915|NCT04209855|579732510|FG000|Overall Study|Withdrew consent|10|||
160547916|NCT04209855|579732511|FG001|Overall Study|Withdrew consent|24|||
160547917|NCT04209855|579732510|FG000|Overall Study|Sponsor decision|44|||
160547918|NCT04209855|579732511|FG001|Overall Study|Sponsor decision|18|||
160547919|NCT04209855|579732510|FG000|Overall Study|Other than specified|6|||
160547920|NCT04209855|579732511|FG001|Overall Study|Other than specified|4|||
160547921|NCT02289950|579732512|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
160547922|NCT02289950|579732513|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
160547923|NCT02289950|579732512|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
160547924|NCT02289950|579732513|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
160547925|NCT02289950|579732512|FG000|Overall Study|Lost to Follow-up|1|||
160547926|NCT02289950|579732513|FG001|Overall Study|Lost to Follow-up|0|||
160547927|NCT02289950|579732512|FG000|Overall Study|Physician Decision|9|||
160547928|NCT02289950|579732513|FG001|Overall Study|Physician Decision|3|||
160547929|NCT02289950|579732512|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
160547930|NCT02289950|579732513|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
160547931|NCT02289950|579732512|FG000|Overall Study|Withdrawal by Subject|1|||
160547932|NCT02289950|579732513|FG001|Overall Study|Withdrawal by Subject|3|||
160547933|NCT02289950|579732512|FG000|Overall Study|Test article held for greater than 28 days|0|||
160547934|NCT02289950|579732513|FG001|Overall Study|Test article held for greater than 28 days|1|||
160547935|NCT02289950|579732512|FG000|Overall Study|Adverse Event|11|||
160547936|NCT02289950|579732513|FG001|Overall Study|Adverse Event|3|||
160547937|NCT02289950|579732512|FG000|Overall Study|Death|1|||
160547938|NCT02289950|579732513|FG001|Overall Study|Death|1|||
160547939|NCT02289950|579732512|FG000|Overall Study|Other|5|||
160547940|NCT02289950|579732513|FG001|Overall Study|Other|2|||
160547941|NCT02289950|579732512|FG000|Overall Study|Not Treated|2|||
160547942|NCT02289950|579732513|FG001|Overall Study|Not Treated|1|||
160547943|NCT01003210|579732514|FG000|Overall Study|Lost to Follow-up|1|||
160547944|NCT01003210|579732515|FG001|Overall Study|Lost to Follow-up|3|||
160547945|NCT01471782|579732517|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
160547946|NCT01471782|579732518|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
160547947|NCT01471782|579732519|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
160547948|NCT01471782|579732520|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
160547949|NCT01471782|579732521|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
160547950|NCT01471782|579732522|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
160547951|NCT01471782|579732517|FG000|Overall Study|Lack of Efficacy|1|||
160547952|NCT01471782|579732518|FG001|Overall Study|Lack of Efficacy|2|||
160547953|NCT01471782|579732519|FG002|Overall Study|Lack of Efficacy|1|||
160642381|NCT01393990|580074256|FG009|Overall Study|Withdrawal by Subject|0|||
160642382|NCT01393990|580074257|FG010|Overall Study|Withdrawal by Subject|0|||
160642383|NCT01393990|580074258|FG011|Overall Study|Withdrawal by Subject|0|||
160642384|NCT01393990|580074259|FG012|Overall Study|Withdrawal by Subject|0|||
160642385|NCT01393990|580074260|FG013|Overall Study|Withdrawal by Subject|0|||
160642386|NCT01393990|580074261|FG014|Overall Study|Withdrawal by Subject|1|||
160642387|NCT01393990|580074262|FG015|Overall Study|Withdrawal by Subject|1|||
160642388|NCT01393990|580074263|FG016|Overall Study|Withdrawal by Subject|0|||
160642389|NCT01393990|580074264|FG017|Overall Study|Withdrawal by Subject|0|||
160547954|NCT01471782|579732520|FG003|Overall Study|Lack of Efficacy|1|||
160547955|NCT01471782|579732521|FG004|Overall Study|Lack of Efficacy|5|||
160547956|NCT01471782|579732522|FG005|Overall Study|Lack of Efficacy|18|||
160547957|NCT01471782|579732517|FG000|Overall Study|Adverse Event|1|||
160547958|NCT01471782|579732518|FG001|Overall Study|Adverse Event|1|||
160547959|NCT01471782|579732519|FG002|Overall Study|Adverse Event|2|||
160547960|NCT01471782|579732520|FG003|Overall Study|Adverse Event|2|||
160547961|NCT01471782|579732521|FG004|Overall Study|Adverse Event|3|||
160547962|NCT01471782|579732522|FG005|Overall Study|Adverse Event|1|||
160547963|NCT01471782|579732517|FG000|Overall Study|Other|0|||
160547964|NCT01471782|579732518|FG001|Overall Study|Other|0|||
160547965|NCT01471782|579732519|FG002|Overall Study|Other|1|||
160547966|NCT01471782|579732520|FG003|Overall Study|Other|1|||
160547967|NCT01471782|579732521|FG004|Overall Study|Other|6|||
160547968|NCT01471782|579732522|FG005|Overall Study|Other|5|||
160547969|NCT01471782|579732517|FG000|Overall Study|Change of Chemotherapy|1|||
160547970|NCT01471782|579732518|FG001|Overall Study|Change of Chemotherapy|1|||
160547971|NCT01471782|579732519|FG002|Overall Study|Change of Chemotherapy|0|||
160547972|NCT01471782|579732520|FG003|Overall Study|Change of Chemotherapy|0|||
160547973|NCT01471782|579732521|FG004|Overall Study|Change of Chemotherapy|1|||
160547974|NCT01471782|579732522|FG005|Overall Study|Change of Chemotherapy|4|||
160547975|NCT01471782|579732517|FG000|Overall Study|Disease Relapse|0|||
160547976|NCT01471782|579732518|FG001|Overall Study|Disease Relapse|0|||
160547977|NCT01471782|579732519|FG002|Overall Study|Disease Relapse|0|||
160547978|NCT01471782|579732520|FG003|Overall Study|Disease Relapse|1|||
160547979|NCT01471782|579732521|FG004|Overall Study|Disease Relapse|2|||
160547980|NCT01471782|579732522|FG005|Overall Study|Disease Relapse|1|||
160547981|NCT01471782|579732517|FG000|Overall Study|Physician Decision|0|||
160547982|NCT01471782|579732518|FG001|Overall Study|Physician Decision|0|||
160547983|NCT01471782|579732519|FG002|Overall Study|Physician Decision|0|||
160547984|NCT01471782|579732520|FG003|Overall Study|Physician Decision|0|||
160642390|NCT00331630|580074273|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
160547985|NCT01471782|579732521|FG004|Overall Study|Physician Decision|3|||
160547986|NCT01471782|579732522|FG005|Overall Study|Physician Decision|8|||
160547987|NCT01471782|579732517|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160547988|NCT01471782|579732518|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160547989|NCT01471782|579732519|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160547990|NCT01471782|579732520|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160547991|NCT01471782|579732521|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
160547992|NCT01471782|579732522|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
160547993|NCT01471782|579732517|FG000|Overall Study|Death|0|||
160547994|NCT01471782|579732518|FG001|Overall Study|Death|0|||
160547995|NCT01471782|579732519|FG002|Overall Study|Death|0|||
160547996|NCT01471782|579732520|FG003|Overall Study|Death|0|||
160547997|NCT01471782|579732521|FG004|Overall Study|Death|0|||
160642391|NCT00331630|580074273|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
160642392|NCT00331630|580074273|FG000|Follow up for 5 Years|Death|5|||
160547998|NCT01471782|579732522|FG005|Overall Study|Death|1|||
160547999|NCT00936208|579732523|FG000|Overall Study|Protocol Violation|37|||
160548000|NCT00936208|579732524|FG001|Overall Study|Protocol Violation|22|||
160548001|NCT00861744|579732525|FG000|Overall Study|Adverse Event|0|||
160548002|NCT00861744|579732526|FG001|Overall Study|Adverse Event|0|||
160891693|NCT01397201|581000407|FG003|Overall Study|Adverse Event|0|||
160891694|NCT01397201|581000408|FG004|Overall Study|Adverse Event|0|||
160891695|NCT00398411|581000412|FG000|Overall Study|Death|0|||
160891696|NCT00398411|581000413|FG001|Overall Study|Death|1|||
160891697|NCT00401531|581000414|FG000|Overall Study|Adverse Event|2|||
160891698|NCT00401531|581000415|FG001|Overall Study|Adverse Event|0|||
160891699|NCT00401531|581000414|FG000|Overall Study|Protocol Violation|3|||
160891700|NCT00401531|581000415|FG001|Overall Study|Protocol Violation|7|||
160891701|NCT00401531|581000414|FG000|Overall Study|Lost to Follow-up|1|||
160891702|NCT00401531|581000415|FG001|Overall Study|Lost to Follow-up|1|||
160891703|NCT00401531|581000414|FG000|Overall Study|Withdrawal by Subject|3|||
160891704|NCT00401531|581000415|FG001|Overall Study|Withdrawal by Subject|2|||
160891705|NCT03403374|581000418|FG000|Overall Study|Lost to Follow-up|1|||
160891706|NCT05314478|581000422|FG000|Overall Study|Physician Decision|1|||
160891707|NCT00145600|581000423|FG000|Overall Study|Death|1|||
160891708|NCT00145600|581000424|FG001|Overall Study|Death|2|||
160891709|NCT00145600|581000425|FG002|Overall Study|Death|2|||
160891710|NCT00145600|581000426|FG003|Overall Study|Death|6|||
160891711|NCT00145600|581000423|FG000|Overall Study|Ineligible|3|||
160891712|NCT00145600|581000424|FG001|Overall Study|Ineligible|0|||
160891713|NCT00145600|581000425|FG002|Overall Study|Ineligible|1|||
160891714|NCT00145600|581000426|FG003|Overall Study|Ineligible|5|||
160891715|NCT00145600|581000423|FG000|Overall Study|Lost to Follow-up|2|||
160891716|NCT00145600|581000424|FG001|Overall Study|Lost to Follow-up|6|||
160891717|NCT00145600|581000425|FG002|Overall Study|Lost to Follow-up|2|||
160891718|NCT00145600|581000426|FG003|Overall Study|Lost to Follow-up|4|||
160891719|NCT00145600|581000423|FG000|Overall Study|Noncompliance|1|||
160891720|NCT00145600|581000424|FG001|Overall Study|Noncompliance|0|||
160891721|NCT00145600|581000425|FG002|Overall Study|Noncompliance|0|||
160891722|NCT00145600|581000426|FG003|Overall Study|Noncompliance|0|||
160891723|NCT00145600|581000423|FG000|Overall Study|Withdrawal by Subject|1|||
160891724|NCT00145600|581000424|FG001|Overall Study|Withdrawal by Subject|2|||
160891725|NCT00145600|581000425|FG002|Overall Study|Withdrawal by Subject|0|||
160891726|NCT00145600|581000426|FG003|Overall Study|Withdrawal by Subject|1|||
160891727|NCT03583164|581000430|FG000|Overall Study|Death in Main Phase|35|||
160891728|NCT03583164|581000430|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
160891729|NCT03583164|581000430|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
160891730|NCT03583164|581000430|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
160891731|NCT03583164|581000430|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
160891732|NCT03583164|581000430|FG000|Overall Study|Physician decision in Main Phase|1|||
160891733|NCT03583164|581000430|FG000|Overall Study|Physician decision in Extended Phase|2|||
160891734|NCT03583164|581000430|FG000|Overall Study|Death in Extended Phase|13|||
160891735|NCT03583164|581000430|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
160891736|NCT03583164|581000430|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
160891737|NCT03583164|581000430|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
160891738|NCT03583164|581000430|FG000|Overall Study|Treatment failure in Main Phase|2|||
160891739|NCT03583164|581000430|FG000|Overall Study|Treatment failure in Extended Phase|4|||
160891740|NCT03583164|581000430|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
160891741|NCT03583164|581000430|FG000|Overall Study|Other not specified reason in Main Phase|2|||
160891742|NCT01031381|581000431|FG000|Overall Study|Physician Decision|3|||
160891743|NCT01031381|581000431|FG000|Overall Study|Withdrawal by Subject|6|||
160891744|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
160891745|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
160891746|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
160891747|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
160891748|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
160891749|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
160891750|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
160891751|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
160891752|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
160891753|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
160891754|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
160891755|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
160891756|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
160891757|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
160548003|NCT00861744|579732527|FG002|Overall Study|Adverse Event|0|||
160548004|NCT00861744|579732528|FG003|Overall Study|Adverse Event|1|||
160548005|NCT00861744|579732525|FG000|Overall Study|Lost to Follow-up|7|||
160548006|NCT00861744|579732526|FG001|Overall Study|Lost to Follow-up|19|||
160548007|NCT00861744|579732527|FG002|Overall Study|Lost to Follow-up|17|||
160548008|NCT00861744|579732528|FG003|Overall Study|Lost to Follow-up|12|||
160548009|NCT00861744|579732525|FG000|Overall Study|Withdrawal by Subject|10|||
160548010|NCT00861744|579732526|FG001|Overall Study|Withdrawal by Subject|6|||
160548011|NCT00861744|579732527|FG002|Overall Study|Withdrawal by Subject|6|||
160548012|NCT00861744|579732528|FG003|Overall Study|Withdrawal by Subject|19|||
160548013|NCT00861744|579732525|FG000|Overall Study|Protocol Violation|0|||
160548014|NCT00861744|579732526|FG001|Overall Study|Protocol Violation|1|||
160548015|NCT00861744|579732527|FG002|Overall Study|Protocol Violation|0|||
160548016|NCT00861744|579732528|FG003|Overall Study|Protocol Violation|0|||
160548017|NCT00861744|579732525|FG000|Overall Study|Migration from study area|0|||
160548018|NCT00861744|579732526|FG001|Overall Study|Migration from study area|3|||
160891758|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
160891759|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
160891760|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Program Termination|3|||
160891761|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Program Termination|0|||
160891762|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Program Termination|1|||
160891763|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Program Termination|1|||
160891764|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
160891765|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
160891766|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
160891767|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
160891768|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
160891769|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
160891770|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
160891771|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
160642393|NCT00331630|580074273|FG000|Follow up for 5 Years|Data collection was stopped|24|||
160642394|NCT00720798|580074274|FG000|Overall Study|Adverse Event|304|||
160642395|NCT00720798|580074274|FG000|Overall Study|Death|39|||
160642396|NCT00720798|580074274|FG000|Overall Study|Insufficient Therapeutic Response|129|||
160642397|NCT00720798|580074274|FG000|Overall Study|Protocol Violation|4|||
160642398|NCT00720798|580074274|FG000|Overall Study|Refused Treatment|151|||
160642399|NCT00720798|580074274|FG000|Overall Study|Failure to Return|46|||
160642400|NCT00720798|580074274|FG000|Overall Study|Reason not Specified|83|||
160891772|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
160891773|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
160891774|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
160891775|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
160891776|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
160891777|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
160891778|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
160891779|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
160548019|NCT00861744|579732527|FG002|Overall Study|Migration from study area|1|||
160548020|NCT00861744|579732528|FG003|Overall Study|Migration from study area|0|||
160642401|NCT01312779|580074278|FG000|Overall Study|Withdrawal by Subject|2|||
160642402|NCT01312779|580074278|FG000|Overall Study|Death|3|||
160891780|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
160891781|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
160891782|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
160891783|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
160891784|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
160891785|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
160891786|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
160891787|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
160891788|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
160891789|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
160891790|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
160891791|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
160891792|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
160891793|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
160891794|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
160788533|NCT00128492|580612664|FG001|Overall Study|Withdrawal by Subject|5|||
160788534|NCT00128492|580612663|FG000|Overall Study|Pregnancy|0|||
160891795|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
160891796|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
160891797|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
160891798|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
160788535|NCT00128492|580612664|FG001|Overall Study|Pregnancy|1|||
160788536|NCT03436420|580612666|FG000|Overall Study|Lack of Efficacy|3|||
160788537|NCT00756314|580612667|FG000|Overall Study|Lost to Follow-up|2|||
160788538|NCT00756314|580612668|FG001|Overall Study|Lost to Follow-up|59|||
160891799|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
160891800|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
160788539|NCT02605967|580612669|FG000|Overall Study|subject / guardian decision|1|||
160788540|NCT02605967|580612670|FG001|Overall Study|subject / guardian decision|2|||
160788541|NCT02605967|580612669|FG000|Overall Study|Physician Decision|10|||
160788542|NCT02605967|580612670|FG001|Overall Study|Physician Decision|1|||
160788543|NCT02605967|580612669|FG000|Overall Study|Death|4|||
160788544|NCT02605967|580612670|FG001|Overall Study|Death|2|||
160788545|NCT02605967|580612669|FG000|Overall Study|Adverse Event|1|||
160788546|NCT02605967|580612670|FG001|Overall Study|Adverse Event|0|||
160788547|NCT02605967|580612669|FG000|Overall Study|progressive disease|66|||
160788548|NCT02605967|580612670|FG001|Overall Study|progressive disease|35|||
160788549|NCT03627468|580612671|FG000|Overall Study|Adverse Event|5|||
160788550|NCT03627468|580612672|FG001|Overall Study|Adverse Event|33|||
160788551|NCT03627468|580612671|FG000|Overall Study|Withdrawal by Subject|13|||
160788552|NCT03627468|580612672|FG001|Overall Study|Withdrawal by Subject|23|||
160788553|NCT03627468|580612671|FG000|Overall Study|Physician Decision|1|||
160788554|NCT03627468|580612672|FG001|Overall Study|Physician Decision|0|||
160788555|NCT03627468|580612671|FG000|Overall Study|Protocol Violation|0|||
160788556|NCT03627468|580612672|FG001|Overall Study|Protocol Violation|2|||
160788557|NCT03627468|580612671|FG000|Overall Study|Lost to Follow-up|10|||
160788558|NCT03627468|580612672|FG001|Overall Study|Lost to Follow-up|16|||
160788559|NCT03627468|580612671|FG000|Overall Study|Death|1|||
160788560|NCT03627468|580612672|FG001|Overall Study|Death|0|||
160788561|NCT03627468|580612671|FG000|Overall Study|Pregnancy|1|||
160788562|NCT03627468|580612672|FG001|Overall Study|Pregnancy|1|||
160788563|NCT03627468|580612671|FG000|Overall Study|Lack of Efficacy|0|||
160788564|NCT03627468|580612672|FG001|Overall Study|Lack of Efficacy|2|||
160788565|NCT03627468|580612671|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
160788566|NCT03627468|580612672|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
160788567|NCT01475825|580612676|FG000|Overall Study|Adverse Event|41|||
160788568|NCT01475825|580612677|FG001|Overall Study|Adverse Event|15|||
160788569|NCT01475825|580612678|FG002|Overall Study|Adverse Event|27|||
160788570|NCT01475825|580612679|FG003|Overall Study|Adverse Event|11|||
160788571|NCT01475825|580612676|FG000|Overall Study|Death|1|||
160788572|NCT01475825|580612677|FG001|Overall Study|Death|0|||
160788573|NCT01475825|580612678|FG002|Overall Study|Death|1|||
160788574|NCT01475825|580612679|FG003|Overall Study|Death|0|||
160788575|NCT01475825|580612676|FG000|Overall Study|Lack of Efficacy|0|||
160788576|NCT01475825|580612677|FG001|Overall Study|Lack of Efficacy|0|||
160788577|NCT01475825|580612678|FG002|Overall Study|Lack of Efficacy|1|||
160788578|NCT01475825|580612679|FG003|Overall Study|Lack of Efficacy|0|||
160788579|NCT01475825|580612676|FG000|Overall Study|Lost to Follow-up|0|||
160788580|NCT01475825|580612677|FG001|Overall Study|Lost to Follow-up|0|||
160788581|NCT01475825|580612678|FG002|Overall Study|Lost to Follow-up|3|||
160788582|NCT01475825|580612679|FG003|Overall Study|Lost to Follow-up|1|||
160788583|NCT01475825|580612676|FG000|Overall Study|Non-compliance with Study Drug|1|||
160788584|NCT01475825|580612677|FG001|Overall Study|Non-compliance with Study Drug|2|||
160788585|NCT01475825|580612678|FG002|Overall Study|Non-compliance with Study Drug|4|||
160788586|NCT01475825|580612679|FG003|Overall Study|Non-compliance with Study Drug|0|||
160788587|NCT01475825|580612676|FG000|Overall Study|Other: Not available|0|||
160788588|NCT01475825|580612677|FG001|Overall Study|Other: Not available|0|||
160788589|NCT01475825|580612678|FG002|Overall Study|Other: Not available|2|||
160788590|NCT01475825|580612679|FG003|Overall Study|Other: Not available|0|||
160891801|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
160891802|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
160891803|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
160891804|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
160891805|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
160891806|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
160891807|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
160891808|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
160891809|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
160891810|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
160891811|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
160891812|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
160891813|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
160891814|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
160891815|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
160891816|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
160891817|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
160891818|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
160891819|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
160891820|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
160891821|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
160891822|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
160891823|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
160891824|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
160891825|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
160891826|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
160891827|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
160891828|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
160891829|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
160891830|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
160891831|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
160891832|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
160981872|NCT02061761|581321789|FG007|Overall Study|Maximum clinical benefit|0|||
160788591|NCT01475825|580612676|FG000|Overall Study|Protocol Violation|1|||
160788592|NCT01475825|580612677|FG001|Overall Study|Protocol Violation|0|||
160788593|NCT01475825|580612678|FG002|Overall Study|Protocol Violation|0|||
160548021|NCT00861744|579732525|FG000|Overall Study|Blood draws|0|||
160548022|NCT00861744|579732526|FG001|Overall Study|Blood draws|0|||
160788594|NCT01475825|580612679|FG003|Overall Study|Protocol Violation|0|||
160788595|NCT01475825|580612676|FG000|Overall Study|Physician Decision|0|||
160788596|NCT01475825|580612677|FG001|Overall Study|Physician Decision|1|||
160788597|NCT01475825|580612678|FG002|Overall Study|Physician Decision|0|||
160788598|NCT01475825|580612679|FG003|Overall Study|Physician Decision|0|||
160788599|NCT01475825|580612676|FG000|Overall Study|Withdrawal by Subject|8|||
160788600|NCT01475825|580612677|FG001|Overall Study|Withdrawal by Subject|3|||
160788601|NCT01475825|580612678|FG002|Overall Study|Withdrawal by Subject|11|||
160548023|NCT00861744|579732527|FG002|Overall Study|Blood draws|0|||
160548024|NCT00861744|579732528|FG003|Overall Study|Blood draws|1|||
160548025|NCT04428424|579732529|FG000|Overall Study|Does not meet entrance criteria|132|||
160548026|NCT04428424|579732529|FG000|Overall Study|Lost to Follow-up|115|||
160788602|NCT01475825|580612679|FG003|Overall Study|Withdrawal by Subject|7|||
160788603|NCT01475825|580612676|FG000|Overall Study|Did not enter OLC|15|||
160788604|NCT01475825|580612677|FG001|Overall Study|Did not enter OLC|11|||
160788605|NCT01475825|580612678|FG002|Overall Study|Did not enter OLC|15|||
160548027|NCT03359759|579732530|FG000|Overall Study|Death|3|||
160788606|NCT01475825|580612679|FG003|Overall Study|Did not enter OLC|11|||
160788607|NCT01714063|580612682|FG000|Overall Study|Equipment malfunction|2|||
160788608|NCT03721107|580612683|FG000|Overall Study|Adverse Event|1|||
160788609|NCT03721107|580612684|FG001|Overall Study|Adverse Event|1|||
160788610|NCT03721107|580612685|FG002|Overall Study|Adverse Event|6|||
160788611|NCT03721107|580612686|FG003|Overall Study|Adverse Event|5|||
160788612|NCT03721107|580612683|FG000|Overall Study|Lost to Follow-up|2|||
160788613|NCT03721107|580612684|FG001|Overall Study|Lost to Follow-up|0|||
160788614|NCT03721107|580612685|FG002|Overall Study|Lost to Follow-up|3|||
160788615|NCT03721107|580612686|FG003|Overall Study|Lost to Follow-up|0|||
160788616|NCT03721107|580612683|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
160788617|NCT03721107|580612684|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
160788618|NCT03721107|580612685|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
160788619|NCT03721107|580612686|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
160788620|NCT03721107|580612683|FG000|Overall Study|Physician Decision|0|||
160788621|NCT03721107|580612684|FG001|Overall Study|Physician Decision|1|||
160788622|NCT03721107|580612685|FG002|Overall Study|Physician Decision|0|||
160788623|NCT03721107|580612686|FG003|Overall Study|Physician Decision|0|||
160788624|NCT03721107|580612683|FG000|Overall Study|Pregnancy|0|||
160642403|NCT01312779|580074278|FG000|Overall Study|Not Implanted with Device|27|||
160642404|NCT00506753|580074279|FG000|Overall Study|Lost to Follow-up|21|||
160642405|NCT00506753|580074280|FG001|Overall Study|Lost to Follow-up|15|||
160642406|NCT01859390|580074281|FG000|Overall Study|Insufficient Sputum Collected|1|||
160642407|NCT01859390|580074282|FG001|Overall Study|Insufficient Sputum Collected|3|||
160642408|NCT01859390|580074281|FG000|Overall Study|Sample Missing Collection Date|0|||
160642409|NCT01859390|580074282|FG001|Overall Study|Sample Missing Collection Date|1|||
160642410|NCT01859390|580074281|FG000|Overall Study|Tube Cracked|0|||
160642411|NCT01859390|580074282|FG001|Overall Study|Tube Cracked|2|||
160642412|NCT01859390|580074281|FG000|Overall Study|Shipment Error|0|||
160642413|NCT01859390|580074282|FG001|Overall Study|Shipment Error|1|||
160642414|NCT02451670|580074283|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
160642415|NCT02451670|580074284|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
160788625|NCT03721107|580612684|FG001|Overall Study|Pregnancy|0|||
160788626|NCT03721107|580612685|FG002|Overall Study|Pregnancy|1|||
160891833|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
160891834|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
160891835|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
160891836|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
160891837|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
160891838|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
160642416|NCT03549130|580074290|FG000|Overall Study|Adverse Event|0|||
160642417|NCT03549130|580074291|FG001|Overall Study|Adverse Event|1|||
160788627|NCT03721107|580612686|FG003|Overall Study|Pregnancy|0|||
160788628|NCT03721107|580612683|FG000|Overall Study|Withdrawal by Subject|1|||
160788629|NCT03721107|580612684|FG001|Overall Study|Withdrawal by Subject|1|||
160788630|NCT03721107|580612685|FG002|Overall Study|Withdrawal by Subject|5|||
160788631|NCT03721107|580612686|FG003|Overall Study|Withdrawal by Subject|5|||
160788632|NCT03721107|580612683|FG000|Overall Study|Other|1|||
160548028|NCT03359759|579732530|FG000|Overall Study|Lost to Follow-up|2|||
160788633|NCT03721107|580612684|FG001|Overall Study|Other|0|||
160788634|NCT03721107|580612685|FG002|Overall Study|Other|0|||
160788635|NCT03721107|580612686|FG003|Overall Study|Other|1|||
160548029|NCT01411085|579732531|FG000|Overall Study|Physician Decision|1|||
160548030|NCT01411085|579732531|FG000|Overall Study|Protocol Violation|1|||
160548031|NCT01411085|579732531|FG000|Overall Study|Adverse Event|1|||
160548032|NCT02193074|579732534|FG000|Overall Study|Withdrawal by Subject|1|||
160548033|NCT02193074|579732535|FG001|Overall Study|Withdrawal by Subject|2|||
160548034|NCT02193074|579732534|FG000|Overall Study|Adverse Event|16|||
160548035|NCT02193074|579732535|FG001|Overall Study|Adverse Event|13|||
160548036|NCT05036083|579732543|FG000|Overall Study|Physician Decision|1|||
160548037|NCT05036083|579732543|FG000|Overall Study|Withdrawal by Subject|1|||
160548038|NCT05036083|579732543|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
160548039|NCT05036083|579732543|FG000|Overall Study|IV not sustainable|1|||
160548040|NCT04745689|579732544|FG000|Overall Study|Death|9|||
160548041|NCT04745689|579732545|FG001|Overall Study|Death|6|||
160548042|NCT04745689|579732544|FG000|Overall Study|Lost to Follow-up|1|||
160548043|NCT04745689|579732545|FG001|Overall Study|Lost to Follow-up|0|||
160548044|NCT04745689|579732544|FG000|Overall Study|Withdrawal by Subject|2|||
160548045|NCT04745689|579732545|FG001|Overall Study|Withdrawal by Subject|0|||
160788636|NCT02369159|580612689|FG000|Overall Study|Adverse Event|0|||
160788637|NCT02369159|580612690|FG001|Overall Study|Adverse Event|1|||
160788638|NCT02369159|580612689|FG000|Overall Study|Lost to Follow-up|1|||
160788639|NCT02369159|580612690|FG001|Overall Study|Lost to Follow-up|1|||
160981873|NCT02061761|581321790|FG008|Overall Study|Maximum clinical benefit|6|||
160981874|NCT02061761|581321782|FG000|Overall Study|Participant no longer meets study criteria|0|||
160981875|NCT02061761|581321783|FG001|Overall Study|Participant no longer meets study criteria|0|||
160788640|NCT02369159|580612689|FG000|Overall Study|Withdrawal by Subject|7|||
160788641|NCT02369159|580612690|FG001|Overall Study|Withdrawal by Subject|0|||
160788642|NCT00563316|580612693|FG000|Overall Study|Adverse Event|2|||
160788643|NCT00563316|580612693|FG000|Overall Study|Physician Decision|1|||
160788644|NCT00563316|580612693|FG000|Overall Study|Lost to Follow-up|2|||
160788645|NCT00563316|580612693|FG000|Overall Study|Death|1|||
160788646|NCT00563316|580612693|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
160788647|NCT00563316|580612693|FG000|Overall Study|Other|1|||
160788648|NCT02991859|580612697|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788649|NCT02991859|580612698|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
160788650|NCT02991859|580612699|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788651|NCT02991859|580612700|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788652|NCT02991859|580612701|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
160788653|NCT02991859|580612702|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788654|NCT02991859|580612703|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788655|NCT02991859|580612704|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788656|NCT02991859|580612705|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788657|NCT02991859|580612706|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788658|NCT02991859|580612707|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788659|NCT02991859|580612708|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788660|NCT02991859|580612709|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788661|NCT02991859|580612710|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788662|NCT02991859|580612711|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788663|NCT02991859|580612712|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788664|NCT02991859|580612713|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788665|NCT02991859|580612697|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788666|NCT02991859|580612698|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788667|NCT02991859|580612699|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788668|NCT02991859|580612700|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788669|NCT02991859|580612701|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788670|NCT02991859|580612702|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788671|NCT02991859|580612703|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788672|NCT02991859|580612704|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788673|NCT02991859|580612705|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788674|NCT02991859|580612706|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788675|NCT02991859|580612707|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788676|NCT02991859|580612708|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788677|NCT02991859|580612709|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
160788678|NCT02991859|580612710|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
160548046|NCT04745689|579732544|FG000|Overall Study|Study terminated by sponsor|10|||
160548047|NCT04745689|579732545|FG001|Overall Study|Study terminated by sponsor|3|||
160548048|NCT07099521|579732546|FG000|Overall Study|Incompeleted stimulus program|1|||
160548049|NCT07099521|579732547|FG001|Overall Study|Incompeleted stimulus program|0|||
160548050|NCT07099521|579732546|FG000|Overall Study|Non-social anxiety symtpoms|0|||
160548051|NCT07099521|579732547|FG001|Overall Study|Non-social anxiety symtpoms|1|||
160891839|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
160891840|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
160891841|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
160788679|NCT02991859|580612711|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788680|NCT02991859|580612712|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788681|NCT02991859|580612713|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788682|NCT02991859|580612697|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788683|NCT02991859|580612698|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788684|NCT02991859|580612699|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788685|NCT02991859|580612700|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788686|NCT02991859|580612701|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788687|NCT02991859|580612702|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
160788688|NCT02991859|580612703|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788689|NCT02991859|580612704|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788690|NCT02991859|580612705|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788691|NCT02991859|580612706|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788692|NCT02991859|580612707|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788693|NCT02991859|580612708|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788694|NCT02991859|580612709|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788695|NCT02991859|580612710|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788696|NCT02991859|580612711|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788697|NCT02991859|580612712|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788698|NCT02991859|580612713|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788699|NCT02991859|580612697|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788700|NCT02991859|580612698|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788701|NCT02991859|580612699|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160891842|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
160891843|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
160891844|NCT05153473|581000438|FG000|Overall Study|Death|46|||
160891845|NCT05153473|581000438|FG000|Overall Study|Lost to Follow-up|3|||
160891846|NCT02788474|581000439|FG000|Double Blind Treatment Period|Not treated|1|||
160891847|NCT02788474|581000440|FG001|Double Blind Treatment Period|Not treated|0|||
160891848|NCT02788474|581000439|FG000|Double Blind Treatment Period|Patient's refusal|3|||
160891849|NCT02788474|581000440|FG001|Double Blind Treatment Period|Patient's refusal|0|||
160891850|NCT02788474|581000439|FG000|Double Blind Treatment Period|Adverse Event|6|||
160891851|NCT02788474|581000440|FG001|Double Blind Treatment Period|Adverse Event|4|||
160891852|NCT02788474|581000439|FG000|Open Label Treatment Period|Adverse Event|29|||
160891853|NCT02788474|581000440|FG001|Open Label Treatment Period|Adverse Event|9|||
160891854|NCT02788474|581000439|FG000|Open Label Treatment Period|Other than reason specified|1|||
160891855|NCT02788474|581000440|FG001|Open Label Treatment Period|Other than reason specified|0|||
160891856|NCT02788474|581000439|FG000|Open Label Treatment Period|Patient's refusal|1|||
160891857|NCT02788474|581000440|FG001|Open Label Treatment Period|Patient's refusal|3|||
160891858|NCT02788474|581000439|FG000|Open Label Treatment Period|Non-compliance|1|||
160891859|NCT02788474|581000440|FG001|Open Label Treatment Period|Non-compliance|0|||
160891860|NCT02694523|581000441|FG000|Part A|Adverse Event|7|||
160891861|NCT02694523|581000442|FG001|Part A|Adverse Event|3|||
160891862|NCT02694523|581000443|FG002|Part A|Adverse Event|0|||
160891863|NCT02694523|581000444|FG003|Part A|Adverse Event|0|||
160981876|NCT02061761|581321784|FG002|Overall Study|Participant no longer meets study criteria|0|||
160981877|NCT02061761|581321785|FG003|Overall Study|Participant no longer meets study criteria|0|||
160981878|NCT02061761|581321786|FG004|Overall Study|Participant no longer meets study criteria|0|||
160981879|NCT02061761|581321787|FG005|Overall Study|Participant no longer meets study criteria|0|||
160981880|NCT02061761|581321788|FG006|Overall Study|Participant no longer meets study criteria|0|||
160981881|NCT02061761|581321789|FG007|Overall Study|Participant no longer meets study criteria|0|||
160981882|NCT02061761|581321790|FG008|Overall Study|Participant no longer meets study criteria|1|||
160981883|NCT02061761|581321782|FG000|Overall Study|Other reasons|0|||
160981884|NCT02061761|581321783|FG001|Overall Study|Other reasons|0|||
160981885|NCT02061761|581321784|FG002|Overall Study|Other reasons|0|||
160981886|NCT02061761|581321785|FG003|Overall Study|Other reasons|0|||
160981887|NCT02061761|581321786|FG004|Overall Study|Other reasons|2|||
160981888|NCT02061761|581321787|FG005|Overall Study|Other reasons|0|||
160981889|NCT02061761|581321788|FG006|Overall Study|Other reasons|0|||
160981890|NCT02061761|581321789|FG007|Overall Study|Other reasons|0|||
160642418|NCT03549130|580074290|FG000|Overall Study|Lost to Follow-up|0|||
160788702|NCT02991859|580612700|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160891864|NCT02694523|581000445|FG004|Part A|Adverse Event|0|||
160891865|NCT02694523|581000446|FG005|Part A|Adverse Event|0|||
160788703|NCT02991859|580612701|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788704|NCT02991859|580612702|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160891866|NCT02694523|581000447|FG006|Part A|Adverse Event|0|||
160891867|NCT02694523|581000441|FG000|Part A|Protocol Violation|1|||
160788705|NCT02991859|580612703|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788706|NCT02991859|580612704|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788707|NCT02991859|580612705|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788708|NCT02991859|580612706|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
160788709|NCT02991859|580612707|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788710|NCT02991859|580612708|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788711|NCT02991859|580612709|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788712|NCT02991859|580612710|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788713|NCT02991859|580612711|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788714|NCT02991859|580612712|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788715|NCT02991859|580612713|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788716|NCT02991859|580612697|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788717|NCT02991859|580612698|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788718|NCT02991859|580612699|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788719|NCT02991859|580612700|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788720|NCT02991859|580612701|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788721|NCT02991859|580612702|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788722|NCT02991859|580612703|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160548052|NCT07099521|579732546|FG000|Overall Study|Extreme values|2|||
160548053|NCT07099521|579732547|FG001|Overall Study|Extreme values|4|||
160788723|NCT02991859|580612704|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788724|NCT02991859|580612705|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
160788725|NCT02991859|580612706|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788726|NCT02991859|580612707|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788727|NCT02991859|580612708|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788728|NCT02991859|580612709|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788729|NCT02991859|580612710|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160891868|NCT02694523|581000442|FG001|Part A|Protocol Violation|0|||
160891869|NCT02694523|581000443|FG002|Part A|Protocol Violation|0|||
160891870|NCT02694523|581000444|FG003|Part A|Protocol Violation|0|||
160891871|NCT02694523|581000445|FG004|Part A|Protocol Violation|0|||
160891872|NCT02694523|581000446|FG005|Part A|Protocol Violation|0|||
160788730|NCT02991859|580612711|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160891873|NCT02694523|581000447|FG006|Part A|Protocol Violation|0|||
160891874|NCT02694523|581000441|FG000|Part A|Lost to Follow-up|1|||
160891875|NCT02694523|581000442|FG001|Part A|Lost to Follow-up|2|||
160891876|NCT02694523|581000443|FG002|Part A|Lost to Follow-up|0|||
160891877|NCT02694523|581000444|FG003|Part A|Lost to Follow-up|0|||
160891878|NCT02694523|581000445|FG004|Part A|Lost to Follow-up|0|||
160891879|NCT02694523|581000446|FG005|Part A|Lost to Follow-up|0|||
160891880|NCT02694523|581000447|FG006|Part A|Lost to Follow-up|0|||
160891881|NCT02694523|581000441|FG000|Part A|Withdrawal by Subject|3|||
160891882|NCT02694523|581000442|FG001|Part A|Withdrawal by Subject|1|||
160891883|NCT02694523|581000443|FG002|Part A|Withdrawal by Subject|0|||
160891884|NCT02694523|581000444|FG003|Part A|Withdrawal by Subject|0|||
160891885|NCT02694523|581000445|FG004|Part A|Withdrawal by Subject|0|||
160891886|NCT02694523|581000446|FG005|Part A|Withdrawal by Subject|0|||
160891887|NCT02694523|581000447|FG006|Part A|Withdrawal by Subject|0|||
160891888|NCT02694523|581000441|FG000|Part A|Other|1|||
160891889|NCT02694523|581000442|FG001|Part A|Other|1|||
160891890|NCT02694523|581000443|FG002|Part A|Other|0|||
160891891|NCT02694523|581000444|FG003|Part A|Other|0|||
160788731|NCT02991859|580612712|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788732|NCT02991859|580612713|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788733|NCT00425854|580612721|FG000|Overall Study|Progressive Disease|19|||
160788734|NCT00425854|580612722|FG001|Overall Study|Progressive Disease|12|||
160788735|NCT00425854|580612721|FG000|Overall Study|Dose reduction toxicity AE|8|||
160788736|NCT00425854|580612722|FG001|Overall Study|Dose reduction toxicity AE|7|||
160788737|NCT00425854|580612721|FG000|Overall Study|Other Adverse Event|2|||
160788738|NCT00425854|580612722|FG001|Overall Study|Other Adverse Event|2|||
160788739|NCT01630811|580612723|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
160788740|NCT01630811|580612724|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
160788741|NCT01725308|580612727|FG000|Treatment Period I|Did Not Receive Drug|1|||
160788742|NCT01725308|580612728|FG001|Treatment Period I|Did Not Receive Drug|0|||
160788743|NCT01725308|580612729|FG002|Treatment Period I|Did Not Receive Drug|0|||
160788744|NCT01725308|580612727|FG000|Treatment Period I|Adverse Event|5|||
160788745|NCT01725308|580612728|FG001|Treatment Period I|Adverse Event|4|||
160788746|NCT01725308|580612729|FG002|Treatment Period I|Adverse Event|21|||
160788747|NCT01725308|580612727|FG000|Treatment Period I|Insufficient Response|7|||
160788748|NCT01725308|580612728|FG001|Treatment Period I|Insufficient Response|0|||
160891892|NCT02694523|581000445|FG004|Part A|Other|0|||
160891893|NCT02694523|581000446|FG005|Part A|Other|0|||
160891894|NCT02694523|581000447|FG006|Part A|Other|0|||
160891895|NCT02694523|581000441|FG000|Part B|Adverse Event|0|||
160891896|NCT02694523|581000442|FG001|Part B|Adverse Event|0|||
160891897|NCT02694523|581000443|FG002|Part B|Adverse Event|7|||
160891898|NCT02694523|581000444|FG003|Part B|Adverse Event|1|||
160891899|NCT02694523|581000445|FG004|Part B|Adverse Event|1|||
160891900|NCT02694523|581000446|FG005|Part B|Adverse Event|2|||
160788749|NCT01725308|580612729|FG002|Treatment Period I|Insufficient Response|5|||
160788750|NCT01725308|580612727|FG000|Treatment Period I|Worsening of the Target Disease|8|||
160788751|NCT01725308|580612728|FG001|Treatment Period I|Worsening of the Target Disease|0|||
160788752|NCT01725308|580612729|FG002|Treatment Period I|Worsening of the Target Disease|2|||
160788753|NCT01725308|580612727|FG000|Treatment Period I|Changes in the Episodes|3|||
160788754|NCT01725308|580612728|FG001|Treatment Period I|Changes in the Episodes|0|||
160788755|NCT01725308|580612729|FG002|Treatment Period I|Changes in the Episodes|2|||
160788756|NCT01725308|580612727|FG000|Treatment Period I|Withdrawal of Consent|12|||
160788757|NCT01725308|580612728|FG001|Treatment Period I|Withdrawal of Consent|7|||
160788758|NCT01725308|580612729|FG002|Treatment Period I|Withdrawal of Consent|5|||
160891901|NCT02694523|581000447|FG006|Part B|Adverse Event|0|||
160891902|NCT02694523|581000441|FG000|Part B|Protocol Violation|0|||
160891903|NCT02694523|581000442|FG001|Part B|Protocol Violation|0|||
160891904|NCT02694523|581000443|FG002|Part B|Protocol Violation|1|||
160891905|NCT02694523|581000444|FG003|Part B|Protocol Violation|0|||
160891906|NCT02694523|581000445|FG004|Part B|Protocol Violation|0|||
160891907|NCT02694523|581000446|FG005|Part B|Protocol Violation|0|||
160891908|NCT02694523|581000447|FG006|Part B|Protocol Violation|0|||
160891909|NCT02694523|581000441|FG000|Part B|Lost to Follow-up|0|||
160891910|NCT02694523|581000442|FG001|Part B|Lost to Follow-up|0|||
160891911|NCT02694523|581000443|FG002|Part B|Lost to Follow-up|2|||
160788759|NCT01725308|580612727|FG000|Treatment Period I|Lost to Follow-up|3|||
160788760|NCT01725308|580612728|FG001|Treatment Period I|Lost to Follow-up|2|||
160788761|NCT01725308|580612729|FG002|Treatment Period I|Lost to Follow-up|2|||
160788762|NCT01725308|580612727|FG000|Treatment Period I|Protocol Deviations|3|||
160788763|NCT01725308|580612728|FG001|Treatment Period I|Protocol Deviations|1|||
160788764|NCT01725308|580612729|FG002|Treatment Period I|Protocol Deviations|1|||
160788765|NCT01725308|580612727|FG000|Treatment Period I|Miscellaneous|2|||
160788766|NCT01725308|580612728|FG001|Treatment Period I|Miscellaneous|0|||
160788767|NCT01725308|580612729|FG002|Treatment Period I|Miscellaneous|3|||
160788768|NCT01725308|580612727|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
160788769|NCT01725308|580612728|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
160788770|NCT01725308|580612729|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
160788771|NCT01725308|580612727|FG000|Treatment Period II|Did Not Receive Drug|4|||
160788772|NCT01725308|580612728|FG001|Treatment Period II|Did Not Receive Drug|0|||
160788773|NCT01725308|580612729|FG002|Treatment Period II|Did Not Receive Drug|0|||
160788774|NCT01725308|580612727|FG000|Treatment Period II|Adverse Event|13|||
160788775|NCT01725308|580612728|FG001|Treatment Period II|Adverse Event|8|||
160788776|NCT01725308|580612729|FG002|Treatment Period II|Adverse Event|20|||
160788777|NCT01725308|580612727|FG000|Treatment Period II|Insufficient Response|2|||
160788778|NCT01725308|580612728|FG001|Treatment Period II|Insufficient Response|4|||
160788779|NCT01725308|580612729|FG002|Treatment Period II|Insufficient Response|6|||
160788780|NCT01725308|580612727|FG000|Treatment Period II|Worsening of the Target Disease|1|||
160788781|NCT01725308|580612728|FG001|Treatment Period II|Worsening of the Target Disease|4|||
160788782|NCT01725308|580612729|FG002|Treatment Period II|Worsening of the Target Disease|2|||
160788783|NCT01725308|580612727|FG000|Treatment Period II|Changes in the Episodes|1|||
160788784|NCT01725308|580612728|FG001|Treatment Period II|Changes in the Episodes|0|||
160788785|NCT01725308|580612729|FG002|Treatment Period II|Changes in the Episodes|5|||
160788786|NCT01725308|580612727|FG000|Treatment Period II|Withdrawal of Consent|28|||
160788787|NCT01725308|580612728|FG001|Treatment Period II|Withdrawal of Consent|2|||
160788788|NCT01725308|580612729|FG002|Treatment Period II|Withdrawal of Consent|16|||
160788789|NCT01725308|580612727|FG000|Treatment Period II|Lost to Follow-up|1|||
160788790|NCT01725308|580612728|FG001|Treatment Period II|Lost to Follow-up|5|||
160788791|NCT01725308|580612729|FG002|Treatment Period II|Lost to Follow-up|3|||
160788792|NCT01725308|580612727|FG000|Treatment Period II|Protocol Deviations|0|||
160788793|NCT01725308|580612728|FG001|Treatment Period II|Protocol Deviations|0|||
160788794|NCT01725308|580612729|FG002|Treatment Period II|Protocol Deviations|1|||
160788795|NCT01725308|580612727|FG000|Treatment Period II|Miscellaneous|5|||
160788796|NCT01725308|580612728|FG001|Treatment Period II|Miscellaneous|3|||
160788797|NCT01725308|580612729|FG002|Treatment Period II|Miscellaneous|7|||
160788798|NCT01783938|580612737|FG000|Overall Study|Disease Progression|18|||
160788799|NCT01783938|580612738|FG001|Overall Study|Disease Progression|41|||
160788800|NCT01783938|580612737|FG000|Overall Study|Study Drug Toxicity|27|||
160788801|NCT01783938|580612738|FG001|Overall Study|Study Drug Toxicity|14|||
160788802|NCT01783938|580612737|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
160788803|NCT01783938|580612738|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
160788804|NCT01783938|580612737|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
160891912|NCT02694523|581000444|FG003|Part B|Lost to Follow-up|3|||
160891913|NCT02694523|581000445|FG004|Part B|Lost to Follow-up|2|||
160891914|NCT02694523|581000446|FG005|Part B|Lost to Follow-up|0|||
160891915|NCT02694523|581000447|FG006|Part B|Lost to Follow-up|1|||
160891916|NCT02694523|581000441|FG000|Part B|Withdrawal by Subject|0|||
160891917|NCT02694523|581000442|FG001|Part B|Withdrawal by Subject|0|||
160891918|NCT02694523|581000443|FG002|Part B|Withdrawal by Subject|9|||
160981891|NCT02061761|581321790|FG008|Overall Study|Other reasons|6|||
160788805|NCT01783938|580612738|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
160788806|NCT01783938|580612737|FG000|Overall Study|Participant Withdrew Consent|2|||
160788807|NCT01783938|580612738|FG001|Overall Study|Participant Withdrew Consent|0|||
160788808|NCT01783938|580612737|FG000|Overall Study|Maximum Clinical Benefit|1|||
160788809|NCT01783938|580612738|FG001|Overall Study|Maximum Clinical Benefit|0|||
160788810|NCT01783938|580612737|FG000|Overall Study|Other Reasons|3|||
160788811|NCT01783938|580612738|FG001|Overall Study|Other Reasons|1|||
160788812|NCT01712074|580612741|FG000|Placebo Run-in Period|Adverse Event|2|||
160788813|NCT01712074|580612742|FG001|Placebo Run-in Period|Adverse Event|0|||
160788814|NCT01712074|580612743|FG002|Placebo Run-in Period|Adverse Event|0|||
160788815|NCT01712074|580612741|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
160788816|NCT01712074|580612742|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
160788817|NCT01712074|580612743|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
160788818|NCT01712074|580612741|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
160788819|NCT01712074|580612742|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
160891919|NCT02694523|581000444|FG003|Part B|Withdrawal by Subject|0|||
160891920|NCT02694523|581000445|FG004|Part B|Withdrawal by Subject|1|||
160981892|NCT01024751|581321791|FG000|Enrolled Participants|Ineligible at baseline|3|||
160788820|NCT01712074|580612743|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
160891921|NCT02694523|581000446|FG005|Part B|Withdrawal by Subject|3|||
160891922|NCT02694523|581000447|FG006|Part B|Withdrawal by Subject|0|||
160788821|NCT01712074|580612741|FG000|Placebo Run-in Period|Other|1|||
160788822|NCT01712074|580612742|FG001|Placebo Run-in Period|Other|0|||
160788823|NCT01712074|580612743|FG002|Placebo Run-in Period|Other|0|||
160788824|NCT01712074|580612741|FG000|Placebo Run-in Period|No longer willing to participate|1|||
160788825|NCT01712074|580612742|FG001|Placebo Run-in Period|No longer willing to participate|0|||
160788826|NCT01712074|580612743|FG002|Placebo Run-in Period|No longer willing to participate|0|||
160788827|NCT01712074|580612741|FG000|Double Blind Period|Adverse Event|0|||
160788828|NCT01712074|580612742|FG001|Double Blind Period|Adverse Event|2|||
160788829|NCT01712074|580612743|FG002|Double Blind Period|Adverse Event|1|||
160788830|NCT01712074|580612741|FG000|Double Blind Period|No longer willing to participate|0|||
160788831|NCT01712074|580612742|FG001|Double Blind Period|No longer willing to participate|2|||
160788832|NCT01712074|580612743|FG002|Double Blind Period|No longer willing to participate|4|||
160788833|NCT01712074|580612741|FG000|Double Blind Period|Death|0|||
160788834|NCT01712074|580612742|FG001|Double Blind Period|Death|1|||
160788835|NCT01712074|580612743|FG002|Double Blind Period|Death|0|||
160788836|NCT01712074|580612741|FG000|Double Blind Period|Lost to Follow-up|0|||
160788837|NCT01712074|580612742|FG001|Double Blind Period|Lost to Follow-up|2|||
160788838|NCT01712074|580612743|FG002|Double Blind Period|Lost to Follow-up|1|||
160788839|NCT01712074|580612741|FG000|Double Blind Period|Other|0|||
160788840|NCT01712074|580612742|FG001|Double Blind Period|Other|4|||
160788841|NCT01712074|580612743|FG002|Double Blind Period|Other|1|||
160788842|NCT01712074|580612741|FG000|Double Blind Period|Protocol Violation|0|||
160788843|NCT01712074|580612742|FG001|Double Blind Period|Protocol Violation|0|||
160788844|NCT01712074|580612743|FG002|Double Blind Period|Protocol Violation|1|||
160788845|NCT01712074|580612741|FG000|Double Blind Period|No longer met eligibility criteria|0|||
160788846|NCT01712074|580612742|FG001|Double Blind Period|No longer met eligibility criteria|3|||
160788847|NCT01712074|580612743|FG002|Double Blind Period|No longer met eligibility criteria|0|||
160788848|NCT03478787|580612744|FG000|Overall Study|Adverse Event|5|||
160788849|NCT03478787|580612745|FG001|Overall Study|Adverse Event|1|||
160788850|NCT03478787|580612744|FG000|Overall Study|Protocol Violation|3|||
160788851|NCT03478787|580612745|FG001|Overall Study|Protocol Violation|0|||
160788852|NCT03478787|580612744|FG000|Overall Study|Lack of Efficacy|7|||
160788853|NCT03478787|580612745|FG001|Overall Study|Lack of Efficacy|1|||
160788854|NCT03478787|580612744|FG000|Overall Study|Lost to Follow-up|9|||
160788855|NCT03478787|580612745|FG001|Overall Study|Lost to Follow-up|5|||
160788856|NCT03478787|580612744|FG000|Overall Study|Withdrawal by Subject|2|||
160788857|NCT03478787|580612745|FG001|Overall Study|Withdrawal by Subject|6|||
160788858|NCT03478787|580612744|FG000|Overall Study|Other, Not Specified|3|||
160788859|NCT03478787|580612745|FG001|Overall Study|Other, Not Specified|0|||
160788860|NCT03378635|580612748|FG000|Overall Study|Adverse Event|1|||
160788861|NCT03378635|580612749|FG001|Overall Study|Adverse Event|0|||
160788862|NCT03378635|580612750|FG002|Overall Study|Adverse Event|0|||
160788863|NCT03378635|580612748|FG000|Overall Study|Withdrawal by Subject|1|||
160788864|NCT03378635|580612749|FG001|Overall Study|Withdrawal by Subject|0|||
160788865|NCT03378635|580612750|FG002|Overall Study|Withdrawal by Subject|0|||
160788866|NCT02413346|580612751|FG000|Overall Study|Adverse Event|6|||
160788867|NCT02413346|580612752|FG001|Overall Study|Adverse Event|6|||
160788868|NCT02413346|580612751|FG000|Overall Study|Withdrawal by Subject|30|||
160788869|NCT02413346|580612752|FG001|Overall Study|Withdrawal by Subject|40|||
160788870|NCT02413346|580612751|FG000|Overall Study|Lost to Follow-up|17|||
160788871|NCT02413346|580612752|FG001|Overall Study|Lost to Follow-up|21|||
160788872|NCT02413346|580612751|FG000|Overall Study|Protocol Violation|2|||
160788873|NCT02413346|580612752|FG001|Overall Study|Protocol Violation|0|||
160788874|NCT02413346|580612751|FG000|Overall Study|Other Miscellaneous Reasons|4|||
160788875|NCT02413346|580612752|FG001|Overall Study|Other Miscellaneous Reasons|3|||
160788876|NCT01835431|580612755|FG000|Overall Study|Adverse Event|1|||
160788877|NCT01835431|580612756|FG001|Overall Study|Adverse Event|0|||
160788878|NCT01835431|580612755|FG000|Overall Study|other|0|||
160788879|NCT01835431|580612756|FG001|Overall Study|other|2|||
160788880|NCT01835431|580612755|FG000|Overall Study|Withdrawal by Subject|6|||
160788881|NCT01835431|580612756|FG001|Overall Study|Withdrawal by Subject|10|||
160788882|NCT01835431|580612755|FG000|Overall Study|Protocol Violation|1|||
160788883|NCT01835431|580612756|FG001|Overall Study|Protocol Violation|0|||
160788884|NCT00562861|580612759|FG000|Overall Study|Adverse Event|1|||
160788885|NCT00562861|580612760|FG001|Overall Study|Adverse Event|1|||
160788886|NCT00562861|580612759|FG000|Overall Study|Lack of Efficacy|5|||
160788887|NCT00562861|580612760|FG001|Overall Study|Lack of Efficacy|5|||
160548054|NCT02396589|579732550|FG000|Intervention|Lost to Follow-up|1|||
160788888|NCT00562861|580612759|FG000|Overall Study|noncompliance, moved|7|||
160788889|NCT00562861|580612760|FG001|Overall Study|noncompliance, moved|2|||
160891923|NCT02694523|581000441|FG000|Part B|Other|0|||
160891924|NCT02694523|581000442|FG001|Part B|Other|0|||
160788890|NCT00562861|580612759|FG000|Overall Study|Lost to Follow-up|7|||
160788891|NCT00562861|580612760|FG001|Overall Study|Lost to Follow-up|3|||
160788892|NCT00655356|580612761|FG000|Overall Study|Withdrawal by Subject|3|||
160788893|NCT00655356|580612762|FG001|Overall Study|Withdrawal by Subject|4|||
160788894|NCT00655356|580612761|FG000|Overall Study|Sponsor Request|10|||
160891925|NCT02694523|581000443|FG002|Part B|Other|1|||
160788895|NCT00655356|580612762|FG001|Overall Study|Sponsor Request|4|||
160788896|NCT00655356|580612761|FG000|Overall Study|Adverse Event|1|||
160788897|NCT00655356|580612762|FG001|Overall Study|Adverse Event|1|||
160788898|NCT00655356|580612761|FG000|Overall Study|Protocol Violation|2|||
160788899|NCT00655356|580612762|FG001|Overall Study|Protocol Violation|1|||
160788900|NCT00655356|580612761|FG000|Overall Study|Other Reason|1|||
160788901|NCT00655356|580612762|FG001|Overall Study|Other Reason|0|||
160788902|NCT02766478|580612772|FG000|Overall Study|Withdrawal by Subject|1|||
160788903|NCT02766478|580612773|FG001|Overall Study|Withdrawal by Subject|1|||
160788904|NCT05626686|580612774|FG000|Overall Study|Protocol Violation|3|||
160788905|NCT05626686|580612774|FG000|Overall Study|Withdrawal by Subject|3|||
160788906|NCT01093573|580612775|FG000|Overall Study|Physician Decision|0|||
160788907|NCT01093573|580612776|FG001|Overall Study|Physician Decision|0|||
160788908|NCT01093573|580612777|FG002|Overall Study|Physician Decision|1|||
160788909|NCT01093573|580612775|FG000|Overall Study|Insurance Denied|0|||
160788910|NCT01093573|580612776|FG001|Overall Study|Insurance Denied|0|||
160788911|NCT01093573|580612777|FG002|Overall Study|Insurance Denied|1|||
160788912|NCT00682435|580612778|FG000|Overall Study|Insufficient data|5|||
160788913|NCT00682435|580612778|FG000|Overall Study|Erroneously enrolled twice|2|||
160788914|NCT00089583|580612779|FG000|Overall Study|Adverse Event|0|||
160788915|NCT00089583|580612780|FG001|Overall Study|Adverse Event|3|||
160788916|NCT00089583|580612779|FG000|Overall Study|Insufficient Viral Load Response|5|||
160788917|NCT00089583|580612780|FG001|Overall Study|Insufficient Viral Load Response|5|||
160788918|NCT00089583|580612779|FG000|Overall Study|Withdrawal by Subject|0|||
160788919|NCT00089583|580612780|FG001|Overall Study|Withdrawal by Subject|4|||
160788920|NCT00089583|580612779|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
160788921|NCT00089583|580612780|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
160788922|NCT00089583|580612779|FG000|Overall Study|Participant Refused Study Medication|0|||
160788923|NCT00089583|580612780|FG001|Overall Study|Participant Refused Study Medication|2|||
160788924|NCT00089583|580612779|FG000|Overall Study|Non-Compliance|0|||
160788925|NCT00089583|580612780|FG001|Overall Study|Non-Compliance|4|||
160788926|NCT00089583|580612779|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
160788927|NCT00089583|580612780|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
160891926|NCT02694523|581000444|FG003|Part B|Other|0|||
160891927|NCT02694523|581000445|FG004|Part B|Other|0|||
160891928|NCT02694523|581000446|FG005|Part B|Other|0|||
160891929|NCT02694523|581000447|FG006|Part B|Other|1|||
160891930|NCT01058265|581000449|FG000|Overall Study|Lost to Follow-up|11|||
160788928|NCT00089583|580612779|FG000|Overall Study|Participant Management Criteria Met|0|||
160891931|NCT01058265|581000450|FG001|Overall Study|Lost to Follow-up|12|||
160891932|NCT01243671|581000451|FG000|Overall Study|Adverse Event|3|||
160891933|NCT01243671|581000451|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
160891934|NCT01243671|581000451|FG000|Overall Study|Other|1|||
160891935|NCT02869438|581000452|FG000|Overall Study|Lost to Follow-up|1|||
160891936|NCT02869438|581000453|FG001|Overall Study|Lost to Follow-up|0|||
160891937|NCT02869438|581000452|FG000|Overall Study|Adverse Event|1|||
160891938|NCT02869438|581000453|FG001|Overall Study|Adverse Event|0|||
160891939|NCT02869438|581000452|FG000|Overall Study|Withdrawal by Subject|1|||
160891940|NCT02869438|581000453|FG001|Overall Study|Withdrawal by Subject|2|||
160891941|NCT02962765|581000454|FG000|Overall Study|Protocol Violation|9|||
160891942|NCT02962765|581000454|FG000|Overall Study|Withdrawal by Subject|3|||
160891943|NCT02962765|581000454|FG000|Overall Study|Lost to Follow-up|1|||
160891944|NCT02962765|581000454|FG000|Overall Study|Death|1|||
160788929|NCT00089583|580612780|FG001|Overall Study|Participant Management Criteria Met|1|||
160788930|NCT00089583|580612779|FG000|Overall Study|Reason Not Provided|0|||
160788931|NCT00089583|580612780|FG001|Overall Study|Reason Not Provided|1|||
160788932|NCT00089583|580612779|FG000|Overall Study|Protocol Violation|0|||
160788933|NCT00089583|580612780|FG001|Overall Study|Protocol Violation|3|||
160788934|NCT00089583|580612779|FG000|Overall Study|Principal Investigator Decision|0|||
160788935|NCT00089583|580612780|FG001|Overall Study|Principal Investigator Decision|10|||
160891945|NCT02962765|581000454|FG000|Overall Study|Limited access to study medication|3|||
160891946|NCT02169284|581000457|FG000|Overall Study|Physician Decision|0|||
160788936|NCT00089583|580612779|FG000|Overall Study|Start of Disallowed Medication|0|||
160788937|NCT00089583|580612780|FG001|Overall Study|Start of Disallowed Medication|1|||
160891947|NCT02169284|581000458|FG001|Overall Study|Physician Decision|1|||
160891948|NCT01367119|581000459|FG000|Overall Study|Adverse Event|1|||
160891949|NCT01367119|581000460|FG001|Overall Study|Adverse Event|0|||
160891950|NCT01367119|581000459|FG000|Overall Study|Withdrawal by Subject|1|||
160891951|NCT01367119|581000460|FG001|Overall Study|Withdrawal by Subject|1|||
160788938|NCT00089583|580612779|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
160788939|NCT00089583|580612780|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
160891952|NCT02675231|581000461|FG000|Overall Study|Withdrawal by Subject|2|||
160788940|NCT00089583|580612779|FG000|Overall Study|Participant Incarcerated|0|||
160788941|NCT00089583|580612780|FG001|Overall Study|Participant Incarcerated|1|||
160788942|NCT01412983|580612781|FG000|1st Period|Ineligible|0|||
160788943|NCT01412983|580612782|FG001|1st Period|Ineligible|1|||
160788944|NCT01412983|580612781|FG000|1st Period|Positive slit lamp finding|0|||
160788945|NCT01412983|580612782|FG001|1st Period|Positive slit lamp finding|1|||
160788946|NCT01412983|580612781|FG000|1st Period|Unacceptable lens movement|0|||
160788947|NCT01412983|580612782|FG001|1st Period|Unacceptable lens movement|1|||
160788948|NCT01412983|580612781|FG000|1st Period|Inability to maintain wear|0|||
160788949|NCT01412983|580612782|FG001|1st Period|Inability to maintain wear|1|||
160788950|NCT01623154|580612783|FG000|Overall Study|Did not drink Pranactin Citric|4|||
160788951|NCT04349098|580612784|FG000|Overall Study|Death|16|||
160788952|NCT04349098|580612785|FG001|Overall Study|Death|8|||
160788953|NCT04349098|580612784|FG000|Overall Study|Lost to Follow-up|11|||
160788954|NCT04349098|580612785|FG001|Overall Study|Lost to Follow-up|8|||
160788955|NCT04349098|580612784|FG000|Overall Study|Withdrawal by Subject|8|||
160788956|NCT04349098|580612785|FG001|Overall Study|Withdrawal by Subject|5|||
160788957|NCT04349098|580612784|FG000|Overall Study|Other|3|||
160788958|NCT04349098|580612785|FG001|Overall Study|Other|5|||
160788959|NCT00800384|580612786|FG000|Overall Study|Withdrawal by Subject|24|||
160788960|NCT00800384|580612787|FG001|Overall Study|Withdrawal by Subject|17|||
160788961|NCT00800384|580612786|FG000|Overall Study|Lost to Follow-up|17|||
160788962|NCT00800384|580612787|FG001|Overall Study|Lost to Follow-up|26|||
160788963|NCT02946996|580612788|FG000|Overall Study|non-evaluable|3|||
160788964|NCT02946996|580612789|FG001|Overall Study|non-evaluable|6|||
160788965|NCT02946996|580612790|FG002|Overall Study|non-evaluable|5|||
160788966|NCT00176254|580612791|FG000|Overall Study|Lost to Follow-up|1|||
160788967|NCT03289741|580612792|FG000|Overall Study|Adverse Event|1|||
160788968|NCT03289741|580612793|FG001|Overall Study|Adverse Event|1|||
160788969|NCT03289741|580612792|FG000|Overall Study|Physician Decision|2|||
160788970|NCT03289741|580612793|FG001|Overall Study|Physician Decision|2|||
160788971|NCT03289741|580612792|FG000|Overall Study|Withdrawal by Subject|1|||
160788972|NCT03289741|580612793|FG001|Overall Study|Withdrawal by Subject|0|||
160788973|NCT01197300|580614672|FG000|Overall Study|Lost to Follow-up|0|||
160788974|NCT01197300|580614673|FG001|Overall Study|Lost to Follow-up|1|||
160788975|NCT01197300|580614672|FG000|Overall Study|Protocol Violation|0|||
160788976|NCT01197300|580614673|FG001|Overall Study|Protocol Violation|1|||
160788977|NCT02113878|580614676|FG000|Overall Study|Adverse Event|1|||
160788978|NCT02113878|580614677|FG001|Overall Study|Adverse Event|0|||
160788979|NCT02113878|580614676|FG000|Overall Study|Withdrawal by Subject|1|||
160788980|NCT02113878|580614677|FG001|Overall Study|Withdrawal by Subject|0|||
160788981|NCT02113878|580614676|FG000|Overall Study|patient non-compliance|1|||
160788982|NCT02113878|580614677|FG001|Overall Study|patient non-compliance|0|||
160891953|NCT02675231|581000462|FG001|Overall Study|Withdrawal by Subject|4|||
160788983|NCT04744831|580614678|FG000|Overall Study|Progressive Disease|31|||
160788984|NCT04744831|580614679|FG001|Overall Study|Progressive Disease|27|||
160788985|NCT04744831|580614680|FG002|Overall Study|Progressive Disease|25|||
160788986|NCT04744831|580614678|FG000|Overall Study|Adverse Event|3|||
160788987|NCT04744831|580614679|FG001|Overall Study|Adverse Event|3|||
160548055|NCT02396589|579732551|FG001|Intervention|Lost to Follow-up|0|||
160548056|NCT02396589|579732550|FG000|6 Month Follow-up|change in health status|0|||
160548057|NCT02396589|579732551|FG001|6 Month Follow-up|change in health status|1|||
160788988|NCT04744831|580614680|FG002|Overall Study|Adverse Event|3|||
160788989|NCT04744831|580614678|FG000|Overall Study|Clinical Progression|3|||
160788990|NCT04744831|580614679|FG001|Overall Study|Clinical Progression|2|||
160788991|NCT04744831|580614680|FG002|Overall Study|Clinical Progression|5|||
160788992|NCT04744831|580614678|FG000|Overall Study|Other|0|||
160788993|NCT04744831|580614679|FG001|Overall Study|Other|2|||
160788994|NCT04744831|580614680|FG002|Overall Study|Other|1|||
160788995|NCT04744831|580614678|FG000|Overall Study|Death|0|||
160788996|NCT04744831|580614679|FG001|Overall Study|Death|2|||
160788997|NCT04744831|580614680|FG002|Overall Study|Death|1|||
160788998|NCT04280783|580614685|FG000|Overall Study|Family issues unrelated to the study.|1|||
160788999|NCT04280783|580614686|FG001|Overall Study|Family issues unrelated to the study.|0|||
160789000|NCT04280783|580614685|FG000|Overall Study|Withdrawal by Subject|0|||
160789001|NCT04280783|580614686|FG001|Overall Study|Withdrawal by Subject|1|||
160789002|NCT03443401|580614693|FG000|Overall Study|Lost to Follow-up|13|||
160789003|NCT03443401|580614693|FG000|Overall Study|Influential outlier|1|||
160789004|NCT02363283|580614694|FG000|Overall Study|Withdrawal by Subject|1|||
160789005|NCT02363283|580614694|FG000|Overall Study|Not eligible due to transaminitis|1|||
160789006|NCT00530257|580614700|FG000|Overall Study|Lost to Follow-up|1|||
160789007|NCT01394185|580614704|FG000|Overall Study|Withdrawal by Subject|2|||
160789008|NCT01394185|580614705|FG001|Overall Study|Withdrawal by Subject|0|||
160789009|NCT01394185|580614706|FG002|Overall Study|Withdrawal by Subject|0|||
160789010|NCT01394185|580614707|FG003|Overall Study|Withdrawal by Subject|0|||
160789011|NCT01394185|580614708|FG004|Overall Study|Withdrawal by Subject|1|||
160789012|NCT01394185|580614709|FG005|Overall Study|Withdrawal by Subject|0|||
160789013|NCT01394185|580614704|FG000|Overall Study|Change in protocol|3|||
160789014|NCT01394185|580614705|FG001|Overall Study|Change in protocol|0|||
160789015|NCT01394185|580614706|FG002|Overall Study|Change in protocol|0|||
160789016|NCT01394185|580614707|FG003|Overall Study|Change in protocol|0|||
160789017|NCT01394185|580614708|FG004|Overall Study|Change in protocol|3|||
160789018|NCT01394185|580614709|FG005|Overall Study|Change in protocol|0|||
160789019|NCT01394185|580614704|FG000|Overall Study|Protocol Violation|1|||
160789020|NCT01394185|580614705|FG001|Overall Study|Protocol Violation|0|||
160789021|NCT01394185|580614706|FG002|Overall Study|Protocol Violation|0|||
160789022|NCT01394185|580614707|FG003|Overall Study|Protocol Violation|1|||
160789023|NCT01394185|580614708|FG004|Overall Study|Protocol Violation|0|||
160789024|NCT01394185|580614709|FG005|Overall Study|Protocol Violation|1|||
160789025|NCT04110145|580614710|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
160789026|NCT04110145|580614711|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
160789027|NCT04110145|580614712|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
160789028|NCT04110145|580614713|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
160789029|NCT04110145|580614714|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
160789030|NCT05401409|580614715|FG000|Overall Study|Lost to Follow-up|1|||
160789031|NCT05401409|580614716|FG001|Overall Study|Lost to Follow-up|0|||
160789032|NCT02371889|580614717|FG000|Overall Study|Adverse medication effect|11|||
160789033|NCT02371889|580614718|FG001|Overall Study|Adverse medication effect|2|||
160789034|NCT02371889|580614717|FG000|Overall Study|Lost to Follow-up|6|||
160789035|NCT02371889|580614718|FG001|Overall Study|Lost to Follow-up|5|||
160789036|NCT02371889|580614717|FG000|Overall Study|Personal time constraints|2|||
160789037|NCT02371889|580614718|FG001|Overall Study|Personal time constraints|4|||
160789038|NCT02371889|580614717|FG000|Overall Study|Lack of Efficacy|0|||
160789039|NCT02371889|580614718|FG001|Overall Study|Lack of Efficacy|2|||
160789040|NCT02371889|580614717|FG000|Overall Study|Relapse|0|||
160789041|NCT02371889|580614718|FG001|Overall Study|Relapse|1|||
160789042|NCT02410200|580614722|FG000|Overall Study|Adverse Event|2|||
160789043|NCT00432991|580614723|FG000|Overall Study|Protocol Violation|7|||
160789044|NCT00432991|580614724|FG001|Overall Study|Protocol Violation|12|||
160789045|NCT00363467|580614725|FG000|Overall Study|Physician Decision|1|||
160789046|NCT03160573|580614728|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
160789047|NCT03160573|580614729|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
160891954|NCT02675231|581000463|FG002|Overall Study|Withdrawal by Subject|2|||
160891955|NCT02675231|581000461|FG000|Overall Study|Lost to Follow-up|3|||
160891956|NCT02675231|581000462|FG001|Overall Study|Lost to Follow-up|4|||
160891957|NCT02675231|581000463|FG002|Overall Study|Lost to Follow-up|3|||
160891958|NCT05323656|581000464|FG000|Overall Study|Still On-Treatment|6|||
160891959|NCT05323656|581000465|FG001|Overall Study|Still On-Treatment|6|||
160789048|NCT03160573|580614730|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
160789049|NCT03160573|580614731|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
160891960|NCT05323656|581000464|FG000|Overall Study|Progressive Disease|15|||
160891961|NCT05323656|581000465|FG001|Overall Study|Progressive Disease|14|||
160548058|NCT02396589|579732550|FG000|9 Month Follow-up|Death|0|||
160789050|NCT00101400|580614732|FG000|Survival Follow-Up|Alive|7|||
160789051|NCT02144337|580614757|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
160789052|NCT02144337|580614758|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
160789053|NCT02144337|580614757|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
160789054|NCT02144337|580614758|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
160891962|NCT05323656|581000464|FG000|Overall Study|Adverse Event|2|||
160789055|NCT02144337|580614757|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
160789056|NCT02144337|580614758|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
160789057|NCT02144337|580614757|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
160789058|NCT02144337|580614758|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
160789059|NCT02144337|580614757|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
160789060|NCT02144337|580614758|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
160789061|NCT02402907|580614759|FG000|Overall Study|Delivered vaginally|9|||
160789062|NCT02402907|580614760|FG001|Overall Study|Delivered vaginally|3|||
160789063|NCT02402907|580614759|FG000|Overall Study|Delivered outside of Sinai|1|||
160789064|NCT02402907|580614760|FG001|Overall Study|Delivered outside of Sinai|1|||
160789065|NCT02402907|580614759|FG000|Overall Study|Lost to follow up after C-Section|10|||
160789066|NCT02402907|580614760|FG001|Overall Study|Lost to follow up after C-Section|23|||
160789067|NCT05166902|580614761|FG000|First Intervention|Lost to Follow-up|0|||
160789068|NCT05166902|580614762|FG001|First Intervention|Lost to Follow-up|1|||
160789069|NCT02244957|580614763|FG000|Overall Study|Lack of Efficacy|1|||
160789070|NCT02244957|580614764|FG001|Overall Study|Lack of Efficacy|0|||
160789071|NCT02624687|580614766|FG000|Overall Study|Withdrawal by Subject|1|||
160789072|NCT02624687|580614767|FG001|Overall Study|Withdrawal by Subject|1|||
160789073|NCT02624687|580614766|FG000|Overall Study|medical leave from work|0|||
160789074|NCT02624687|580614767|FG001|Overall Study|medical leave from work|1|||
160789075|NCT03111108|580614768|FG000|Overall Study|Death|0|||
160789076|NCT03111108|580614769|FG001|Overall Study|Death|1|||
160789077|NCT03111108|580614768|FG000|Overall Study|Withdrawal by Subject|1|||
160789078|NCT03111108|580614769|FG001|Overall Study|Withdrawal by Subject|0|||
160789079|NCT01514357|580614770|FG000|Overall Study|Screen failure|2|||
160789080|NCT01514357|580614771|FG001|Overall Study|Screen failure|0|||
160789081|NCT01514357|580614770|FG000|Overall Study|Withdrawal by Subject|2|||
160789082|NCT01514357|580614771|FG001|Overall Study|Withdrawal by Subject|0|||
160789083|NCT04691115|580614774|FG000|Overall Study|Withdrawal by Subject|0|||
160789084|NCT04691115|580614775|FG001|Overall Study|Withdrawal by Subject|0|||
160789085|NCT04691115|580614776|FG002|Overall Study|Withdrawal by Subject|0|||
160789086|NCT04691115|580614777|FG003|Overall Study|Withdrawal by Subject|0|||
160891963|NCT05323656|581000465|FG001|Overall Study|Adverse Event|3|||
160891964|NCT05323656|581000464|FG000|Overall Study|Death|1|||
160642419|NCT03549130|580074291|FG001|Overall Study|Lost to Follow-up|1|||
160642420|NCT01078623|580074292|FG000|Treatment Period 1|Adverse Event|1|||
160891965|NCT05323656|581000465|FG001|Overall Study|Death|2|||
160642421|NCT01078623|580074293|FG001|Treatment Period 1|Adverse Event|1|||
160642422|NCT01078623|580074294|FG002|Treatment Period 1|Adverse Event|1|||
160548059|NCT02396589|579732551|FG001|9 Month Follow-up|Death|1|||
160548060|NCT02396589|579732550|FG000|12 Month Follow up|Lost to Follow-up|0|||
160548061|NCT02396589|579732551|FG001|12 Month Follow up|Lost to Follow-up|2|||
160548062|NCT04381650|579732552|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
160548063|NCT04381650|579732553|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
160548064|NCT04381650|579732554|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
160548065|NCT04381650|579732555|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
160548066|NCT04381650|579732556|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
160548067|NCT04381650|579732557|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
160548068|NCT04381650|579732558|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
160548069|NCT04381650|579732559|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
160642423|NCT01078623|580074295|FG003|Treatment Period 1|Adverse Event|0|||
160642424|NCT01078623|580074296|FG004|Treatment Period 1|Adverse Event|0|||
160789087|NCT04691115|580614778|FG004|Overall Study|Withdrawal by Subject|0|||
160789088|NCT04691115|580614779|FG005|Overall Study|Withdrawal by Subject|1|||
160789089|NCT04691115|580614780|FG006|Overall Study|Withdrawal by Subject|0|||
160789090|NCT04691115|580614781|FG007|Overall Study|Withdrawal by Subject|0|||
160789091|NCT04691115|580614782|FG008|Overall Study|Withdrawal by Subject|0|||
160891966|NCT05323656|581000464|FG000|Overall Study|Withdrawal by Subject|1|||
160642425|NCT01078623|580074297|FG005|Treatment Period 1|Adverse Event|0|||
160642426|NCT01078623|580074298|FG006|Treatment Period 1|Adverse Event|1|||
160642427|NCT01078623|580074299|FG007|Treatment Period 1|Adverse Event|0|||
160642428|NCT01078623|580074300|FG008|Treatment Period 1|Adverse Event|1|||
160789092|NCT04691115|580614783|FG009|Overall Study|Withdrawal by Subject|0|||
160642429|NCT01078623|580074301|FG009|Treatment Period 1|Adverse Event|1|||
160789093|NCT04691115|580614784|FG010|Overall Study|Withdrawal by Subject|0|||
160789094|NCT04691115|580614785|FG011|Overall Study|Withdrawal by Subject|0|||
160789095|NCT04691115|580614786|FG012|Overall Study|Withdrawal by Subject|0|||
160789096|NCT04691115|580614787|FG013|Overall Study|Withdrawal by Subject|0|||
160789097|NCT00830336|580614791|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
160789098|NCT00830336|580614792|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
160642430|NCT01078623|580074302|FG010|Treatment Period 1|Adverse Event|0|||
160789099|NCT00867334|580614793|FG000|Overall Study|Withdrawal by Subject|0|||
160789100|NCT00867334|580614794|FG001|Overall Study|Withdrawal by Subject|1|||
160789101|NCT00867334|580614793|FG000|Overall Study|Withdrawal by Subject|1|||
160789102|NCT00867334|580614794|FG001|Overall Study|Withdrawal by Subject|0|||
160789103|NCT00867334|580614793|FG000|Overall Study|Withdrawal by Subject|1|||
160789104|NCT00867334|580614794|FG001|Overall Study|Withdrawal by Subject|0|||
160789105|NCT00347269|580614799|FG000|Overall Study|Lost to Follow-up|74|||
160789106|NCT00347269|580614800|FG001|Overall Study|Lost to Follow-up|65|||
160789107|NCT00347269|580614799|FG000|Overall Study|Withdrawal by Subject|18|||
160789108|NCT00347269|580614800|FG001|Overall Study|Withdrawal by Subject|38|||
160789109|NCT00347269|580614799|FG000|Overall Study|Death|2|||
160789110|NCT00347269|580614800|FG001|Overall Study|Death|3|||
160789111|NCT04893811|580614801|FG000|Vaccination Phase|Death|1|||
160789112|NCT04893811|580614802|FG001|Vaccination Phase|Death|0|||
160642431|NCT01078623|580074303|FG011|Treatment Period 1|Adverse Event|0|||
160789113|NCT04893811|580614801|FG000|Vaccination Phase|Lost to Follow-up|1|||
160789114|NCT04893811|580614802|FG001|Vaccination Phase|Lost to Follow-up|1|||
160789115|NCT04893811|580614801|FG000|Vaccination Phase|Protocol Violation|2|||
160789116|NCT04893811|580614802|FG001|Vaccination Phase|Protocol Violation|0|||
160789117|NCT04893811|580614801|FG000|Vaccination Phase|Withdrawal by Subject|2|||
160789118|NCT04893811|580614802|FG001|Vaccination Phase|Withdrawal by Subject|1|||
160789119|NCT04893811|580614801|FG000|Vaccination Phase|Other|0|||
160789120|NCT04893811|580614802|FG001|Vaccination Phase|Other|1|||
160789121|NCT04893811|580614801|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
160789122|NCT04893811|580614802|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
160789123|NCT04893811|580614801|FG000|Follow-up Phase|Lost to Follow-up|0|||
160789124|NCT04893811|580614802|FG001|Follow-up Phase|Lost to Follow-up|1|||
160789125|NCT03268499|580614803|FG000|Overall Study|Withdrawal by Subject|2|||
160789126|NCT03268499|580614804|FG001|Overall Study|Withdrawal by Subject|1|||
160789127|NCT05071027|580614805|FG000|Overall Study|Lost to Follow-up|1|||
160789128|NCT05071027|580614806|FG001|Overall Study|Lost to Follow-up|4|||
160789129|NCT02739828|580614807|FG000|Overall Study|Adverse Event|1|||
160789130|NCT02739828|580614807|FG000|Overall Study|Lost to Follow-up|4|||
160789131|NCT04191733|580614809|FG000|Overall Study|Withdrawn due to study closure|13|||
160789132|NCT04191733|580614810|FG001|Overall Study|Withdrawn due to study closure|14|||
160789133|NCT04191733|580614809|FG000|Overall Study|Withdrawal by Subject|2|||
160789134|NCT04191733|580614810|FG001|Overall Study|Withdrawal by Subject|4|||
160789135|NCT04191733|580614809|FG000|Overall Study|Physician Decision|1|||
160789136|NCT04191733|580614810|FG001|Overall Study|Physician Decision|1|||
160789137|NCT04191733|580614809|FG000|Overall Study|Lost to Follow-up|5|||
160789138|NCT04191733|580614810|FG001|Overall Study|Lost to Follow-up|6|||
160789139|NCT04191733|580614809|FG000|Overall Study|Death|0|||
160789140|NCT04191733|580614810|FG001|Overall Study|Death|1|||
160789141|NCT01903733|580614811|FG000|Overall Study|Death|23|||
160789142|NCT01903733|580614812|FG001|Overall Study|Death|54|||
160642432|NCT01078623|580074304|FG012|Treatment Period 1|Adverse Event|0|||
160642433|NCT01078623|580074305|FG013|Treatment Period 1|Adverse Event|0|||
160642434|NCT01078623|580074306|FG014|Treatment Period 1|Adverse Event|0|||
160642435|NCT01078623|580074307|FG015|Treatment Period 1|Adverse Event|0|||
160642436|NCT01078623|580074308|FG016|Treatment Period 1|Adverse Event|0|||
160642437|NCT01078623|580074309|FG017|Treatment Period 1|Adverse Event|0|||
160642438|NCT01078623|580074310|FG018|Treatment Period 1|Adverse Event|0|||
160642439|NCT01078623|580074311|FG019|Treatment Period 1|Adverse Event|0|||
160642440|NCT01078623|580074292|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160789143|NCT01903733|580614813|FG002|Overall Study|Death|30|||
160789144|NCT01903733|580614814|FG003|Overall Study|Death|98|||
160789145|NCT01903733|580614811|FG000|Overall Study|Participant refused further follow-up|35|||
160789146|NCT01903733|580614812|FG001|Overall Study|Participant refused further follow-up|38|||
160789147|NCT01903733|580614813|FG002|Overall Study|Participant refused further follow-up|13|||
160789148|NCT01903733|580614814|FG003|Overall Study|Participant refused further follow-up|9|||
160789149|NCT01903733|580614811|FG000|Overall Study|Lost to Follow-up|18|||
160789150|NCT01903733|580614812|FG001|Overall Study|Lost to Follow-up|19|||
160789151|NCT01903733|580614813|FG002|Overall Study|Lost to Follow-up|6|||
160789152|NCT01903733|580614814|FG003|Overall Study|Lost to Follow-up|9|||
160789153|NCT01903733|580614811|FG000|Overall Study|Other|10|||
160789154|NCT01903733|580614812|FG001|Overall Study|Other|15|||
160789155|NCT01903733|580614813|FG002|Overall Study|Other|12|||
160789156|NCT01903733|580614814|FG003|Overall Study|Other|3|||
160789157|NCT01903733|580614811|FG000|Overall Study|Missing|2|||
160789158|NCT01903733|580614812|FG001|Overall Study|Missing|0|||
160789159|NCT01903733|580614813|FG002|Overall Study|Missing|0|||
160789160|NCT01903733|580614814|FG003|Overall Study|Missing|0|||
160789161|NCT01903733|580614811|FG000|Overall Study|Investigator request|18|||
160789162|NCT01903733|580614812|FG001|Overall Study|Investigator request|0|||
160789163|NCT01903733|580614813|FG002|Overall Study|Investigator request|0|||
160789164|NCT01903733|580614814|FG003|Overall Study|Investigator request|0|||
160789165|NCT02202577|580614815|FG000|Overall Study|Lost to Follow-up|6|||
160642441|NCT01078623|580074293|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160789166|NCT02202577|580614816|FG001|Overall Study|Lost to Follow-up|16|||
160789167|NCT02202577|580614815|FG000|Overall Study|Protocol Violation|7|||
160789168|NCT02202577|580614816|FG001|Overall Study|Protocol Violation|3|||
160789169|NCT01514422|580614817|FG000|Overall Study|Lost to Follow-up|1|||
160789170|NCT03511209|580614818|FG000|Overall Study|Withdrawal by Subject|2|||
160789171|NCT03511209|580614819|FG001|Overall Study|Withdrawal by Subject|4|||
160789172|NCT03511209|580614818|FG000|Overall Study|Death|1|||
160789173|NCT03511209|580614819|FG001|Overall Study|Death|0|||
160789174|NCT03511209|580614818|FG000|Overall Study|Lost to Follow-up|0|||
160789175|NCT03511209|580614819|FG001|Overall Study|Lost to Follow-up|2|||
160789176|NCT02757963|580614823|FG000|Overall Study|Adverse Event|3|||
160789177|NCT02757963|580614823|FG000|Overall Study|Reached Stopping Criteria|1054|||
160789178|NCT02757963|580614823|FG000|Overall Study|Lost to Follow-up|5|||
160789179|NCT02757963|580614823|FG000|Overall Study|Physician Decision|1|||
160789180|NCT02757963|580614823|FG000|Overall Study|Withdrawal by Subject|34|||
160789181|NCT02971137|580614824|FG000|Overall Study|Lost to Follow-up|44|||
160789182|NCT02971137|580614825|FG001|Overall Study|Lost to Follow-up|56|||
160789183|NCT00215657|580614826|FG000|Overall Study|Adverse Event|5|||
160789184|NCT00215657|580614827|FG001|Overall Study|Adverse Event|1|||
160789185|NCT00215657|580614828|FG002|Overall Study|Adverse Event|3|||
160789186|NCT00215657|580614829|FG003|Overall Study|Adverse Event|0|||
160789187|NCT00215657|580614830|FG004|Overall Study|Adverse Event|3|||
160789188|NCT00215657|580614831|FG005|Overall Study|Adverse Event|1|||
160789189|NCT00215657|580614832|FG006|Overall Study|Adverse Event|0|||
160789190|NCT00215657|580614833|FG007|Overall Study|Adverse Event|3|||
160789191|NCT00215657|580614826|FG000|Overall Study|Withdrawal by Subject|6|||
160789192|NCT00215657|580614827|FG001|Overall Study|Withdrawal by Subject|3|||
160789193|NCT00215657|580614828|FG002|Overall Study|Withdrawal by Subject|3|||
160789194|NCT00215657|580614829|FG003|Overall Study|Withdrawal by Subject|1|||
160789195|NCT00215657|580614830|FG004|Overall Study|Withdrawal by Subject|6|||
160789196|NCT00215657|580614831|FG005|Overall Study|Withdrawal by Subject|1|||
160789197|NCT00215657|580614832|FG006|Overall Study|Withdrawal by Subject|10|||
160789198|NCT00215657|580614833|FG007|Overall Study|Withdrawal by Subject|3|||
160789199|NCT00215657|580614826|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
160789200|NCT00215657|580614827|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
160789201|NCT00215657|580614828|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
160789202|NCT00215657|580614829|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
160789203|NCT00215657|580614830|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
160789204|NCT00215657|580614831|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
160789205|NCT00215657|580614832|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
160789206|NCT00215657|580614833|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
160789207|NCT00215657|580614826|FG000|Overall Study|Insufficient testosterone response|5|||
160789208|NCT00215657|580614827|FG001|Overall Study|Insufficient testosterone response|4|||
160789209|NCT00215657|580614828|FG002|Overall Study|Insufficient testosterone response|1|||
160789210|NCT00215657|580614829|FG003|Overall Study|Insufficient testosterone response|12|||
160789211|NCT00215657|580614830|FG004|Overall Study|Insufficient testosterone response|8|||
160789212|NCT00215657|580614831|FG005|Overall Study|Insufficient testosterone response|12|||
160789213|NCT00215657|580614832|FG006|Overall Study|Insufficient testosterone response|4|||
160789214|NCT00215657|580614833|FG007|Overall Study|Insufficient testosterone response|7|||
160789215|NCT00215657|580614826|FG000|Overall Study|Other|3|||
160789216|NCT00215657|580614827|FG001|Overall Study|Other|1|||
160789217|NCT00215657|580614828|FG002|Overall Study|Other|2|||
160789218|NCT00215657|580614829|FG003|Overall Study|Other|3|||
160789219|NCT00215657|580614830|FG004|Overall Study|Other|5|||
160789220|NCT00215657|580614831|FG005|Overall Study|Other|4|||
160789221|NCT00215657|580614832|FG006|Overall Study|Other|6|||
160789222|NCT00215657|580614833|FG007|Overall Study|Other|1|||
160789223|NCT03769467|580614837|FG000|Overall Study|Adverse Event|1|||
160789224|NCT03769467|580614838|FG001|Overall Study|Adverse Event|1|||
160789225|NCT03769467|580614839|FG002|Overall Study|Adverse Event|0|||
160789226|NCT03769467|580614837|FG000|Overall Study|Death|3|||
160789227|NCT03769467|580614838|FG001|Overall Study|Death|3|||
160789228|NCT03769467|580614839|FG002|Overall Study|Death|0|||
160789229|NCT03769467|580614837|FG000|Overall Study|Study Terminated By Sponsor|2|||
160789230|NCT03769467|580614838|FG001|Overall Study|Study Terminated By Sponsor|1|||
160789231|NCT03769467|580614839|FG002|Overall Study|Study Terminated By Sponsor|0|||
160891967|NCT05323656|581000465|FG001|Overall Study|Withdrawal by Subject|0|||
160891968|NCT05323656|581000464|FG000|Overall Study|Clinical disease progression|0|||
160789232|NCT03769467|580614837|FG000|Overall Study|Withdrawal by Subject|0|||
160789233|NCT03769467|580614838|FG001|Overall Study|Withdrawal by Subject|1|||
160789234|NCT03769467|580614839|FG002|Overall Study|Withdrawal by Subject|0|||
160789235|NCT00289900|580614840|FG000|Overall Study|Adverse Event|28|||
160789236|NCT00289900|580614841|FG001|Overall Study|Adverse Event|40|||
160789237|NCT00289900|580614842|FG002|Overall Study|Adverse Event|13|||
160789238|NCT00289900|580614843|FG003|Overall Study|Adverse Event|19|||
160789239|NCT00289900|580614844|FG004|Overall Study|Adverse Event|20|||
160789240|NCT00289900|580614845|FG005|Overall Study|Adverse Event|33|||
160789241|NCT00289900|580614840|FG000|Overall Study|Lost to Follow-up|7|||
160789242|NCT00289900|580614841|FG001|Overall Study|Lost to Follow-up|7|||
160789243|NCT00289900|580614842|FG002|Overall Study|Lost to Follow-up|8|||
160789244|NCT00289900|580614843|FG003|Overall Study|Lost to Follow-up|8|||
160789245|NCT00289900|580614844|FG004|Overall Study|Lost to Follow-up|4|||
160789246|NCT00289900|580614845|FG005|Overall Study|Lost to Follow-up|8|||
160789247|NCT00289900|580614840|FG000|Overall Study|Participant had flushing|18|||
160789248|NCT00289900|580614841|FG001|Overall Study|Participant had flushing|42|||
160789249|NCT00289900|580614842|FG002|Overall Study|Participant had flushing|1|||
160789250|NCT00289900|580614843|FG003|Overall Study|Participant had flushing|2|||
160789251|NCT00289900|580614844|FG004|Overall Study|Participant had flushing|0|||
160789252|NCT00289900|580614845|FG005|Overall Study|Participant had flushing|4|||
160789253|NCT00289900|580614840|FG000|Overall Study|Other|0|||
160789254|NCT00289900|580614841|FG001|Overall Study|Other|0|||
160789255|NCT00289900|580614842|FG002|Overall Study|Other|0|||
160789256|NCT00289900|580614843|FG003|Overall Study|Other|5|||
160789257|NCT00289900|580614844|FG004|Overall Study|Other|1|||
160789258|NCT00289900|580614845|FG005|Overall Study|Other|0|||
160789259|NCT00289900|580614840|FG000|Overall Study|Participant moved|1|||
160789260|NCT00289900|580614841|FG001|Overall Study|Participant moved|0|||
160789261|NCT00289900|580614842|FG002|Overall Study|Participant moved|0|||
160789262|NCT00289900|580614843|FG003|Overall Study|Participant moved|1|||
160789263|NCT00289900|580614844|FG004|Overall Study|Participant moved|1|||
160789264|NCT00289900|580614845|FG005|Overall Study|Participant moved|1|||
160789265|NCT00289900|580614840|FG000|Overall Study|Withdrawal by Subject|10|||
160789266|NCT00289900|580614841|FG001|Overall Study|Withdrawal by Subject|21|||
160789267|NCT00289900|580614842|FG002|Overall Study|Withdrawal by Subject|8|||
160789268|NCT00289900|580614843|FG003|Overall Study|Withdrawal by Subject|18|||
160789269|NCT00289900|580614844|FG004|Overall Study|Withdrawal by Subject|12|||
160789270|NCT00289900|580614845|FG005|Overall Study|Withdrawal by Subject|11|||
160789271|NCT00289900|580614840|FG000|Overall Study|Protocol Violation|3|||
160789272|NCT00289900|580614841|FG001|Overall Study|Protocol Violation|9|||
160789273|NCT00289900|580614842|FG002|Overall Study|Protocol Violation|2|||
160789274|NCT00289900|580614843|FG003|Overall Study|Protocol Violation|6|||
160789275|NCT00289900|580614844|FG004|Overall Study|Protocol Violation|7|||
160789276|NCT00289900|580614845|FG005|Overall Study|Protocol Violation|4|||
160789277|NCT00289900|580614840|FG000|Overall Study|site terminated|1|||
160789278|NCT00289900|580614841|FG001|Overall Study|site terminated|0|||
160789279|NCT00289900|580614842|FG002|Overall Study|site terminated|1|||
160789280|NCT00289900|580614843|FG003|Overall Study|site terminated|0|||
160891969|NCT05323656|581000465|FG001|Overall Study|Clinical disease progression|1|||
160891970|NCT05323656|581000464|FG000|Overall Study|Patient and Investigator decision|1|||
160891971|NCT05323656|581000465|FG001|Overall Study|Patient and Investigator decision|0|||
160891972|NCT05323656|581000464|FG000|Overall Study|Physician Decision|0|||
160891973|NCT05323656|581000465|FG001|Overall Study|Physician Decision|1|||
160891974|NCT03953183|581000466|FG000|Overall Study|Physician Decision|0|||
160891975|NCT03953183|581000467|FG001|Overall Study|Physician Decision|1|||
160891976|NCT03953183|581000466|FG000|Overall Study|Withdrawal by Subject|0|||
160891977|NCT03953183|581000467|FG001|Overall Study|Withdrawal by Subject|1|||
160789281|NCT00289900|580614844|FG004|Overall Study|site terminated|0|||
160789282|NCT00289900|580614845|FG005|Overall Study|site terminated|0|||
160789283|NCT00289900|580614840|FG000|Overall Study|Not treated|0|||
160891978|NCT01115803|581000478|FG000|Overall Study|Withdrawal by Subject|0|||
160891979|NCT01115803|581000479|FG001|Overall Study|Withdrawal by Subject|0|||
160891980|NCT01115803|581000480|FG002|Overall Study|Withdrawal by Subject|0|||
160891981|NCT01115803|581000481|FG003|Overall Study|Withdrawal by Subject|0|||
160789284|NCT00289900|580614841|FG001|Overall Study|Not treated|1|||
160789285|NCT00289900|580614842|FG002|Overall Study|Not treated|0|||
160789286|NCT00289900|580614843|FG003|Overall Study|Not treated|0|||
160789287|NCT00289900|580614844|FG004|Overall Study|Not treated|0|||
160789288|NCT00289900|580614845|FG005|Overall Study|Not treated|0|||
160891982|NCT01115803|581000482|FG004|Overall Study|Withdrawal by Subject|0|||
160891983|NCT01115803|581000483|FG005|Overall Study|Withdrawal by Subject|0|||
160891984|NCT01115803|581000484|FG006|Overall Study|Withdrawal by Subject|1|||
160891985|NCT01115803|581000478|FG000|Overall Study|Lost to Follow-up|0|||
160891986|NCT01115803|581000479|FG001|Overall Study|Lost to Follow-up|0|||
160891987|NCT01115803|581000480|FG002|Overall Study|Lost to Follow-up|1|||
160789289|NCT01703221|580614846|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
160891988|NCT01115803|581000481|FG003|Overall Study|Lost to Follow-up|0|||
160789290|NCT01703221|580614847|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
160789291|NCT01703221|580614848|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
160789292|NCT01703221|580614846|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
160789293|NCT01703221|580614847|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
160789294|NCT01703221|580614848|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
160789295|NCT01703221|580614846|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
160789296|NCT01703221|580614847|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160891989|NCT01115803|581000482|FG004|Overall Study|Lost to Follow-up|0|||
160891990|NCT01115803|581000483|FG005|Overall Study|Lost to Follow-up|0|||
160891991|NCT01115803|581000484|FG006|Overall Study|Lost to Follow-up|0|||
160891992|NCT01115803|581000478|FG000|Overall Study|Progressive Disease during Cycle1|0|||
160789297|NCT01703221|580614848|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160789298|NCT01703221|580614846|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
160789299|NCT01703221|580614847|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
160789300|NCT01703221|580614848|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
160789301|NCT01703221|580614846|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160789302|NCT01703221|580614847|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160789303|NCT01703221|580614848|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
160789304|NCT01703221|580614846|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
160789305|NCT01703221|580614847|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
160789306|NCT01703221|580614848|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
160789307|NCT01703221|580614846|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
160789308|NCT01703221|580614847|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
160789309|NCT01703221|580614848|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
160789310|NCT01703221|580614846|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
160789311|NCT01703221|580614847|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
160789312|NCT01703221|580614848|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
160789313|NCT01152385|580614849|FG000|Overall Study|Withdrawal by Subject|3|||
160789314|NCT01152385|580614850|FG001|Overall Study|Withdrawal by Subject|1|||
160789315|NCT01152385|580614851|FG002|Overall Study|Withdrawal by Subject|1|||
160789316|NCT01152385|580614852|FG003|Overall Study|Withdrawal by Subject|1|||
160789317|NCT01152385|580614849|FG000|Overall Study|Protocol Violation|0|||
160789318|NCT01152385|580614850|FG001|Overall Study|Protocol Violation|0|||
160789319|NCT01152385|580614851|FG002|Overall Study|Protocol Violation|0|||
160789320|NCT01152385|580614852|FG003|Overall Study|Protocol Violation|1|||
160789321|NCT01152385|580614849|FG000|Overall Study|Adverse Event|1|||
160789322|NCT01152385|580614850|FG001|Overall Study|Adverse Event|1|||
160789323|NCT01152385|580614851|FG002|Overall Study|Adverse Event|0|||
160789324|NCT01152385|580614852|FG003|Overall Study|Adverse Event|0|||
160789325|NCT01152385|580614849|FG000|Overall Study|Study-specific withdrawal criteria|1|||
160789326|NCT01152385|580614850|FG001|Overall Study|Study-specific withdrawal criteria|1|||
160789327|NCT01152385|580614851|FG002|Overall Study|Study-specific withdrawal criteria|2|||
160789328|NCT01152385|580614852|FG003|Overall Study|Study-specific withdrawal criteria|0|||
160789329|NCT01152385|580614849|FG000|Overall Study|Other|4|||
160789330|NCT01152385|580614850|FG001|Overall Study|Other|3|||
160789331|NCT01152385|580614851|FG002|Overall Study|Other|2|||
160789332|NCT01152385|580614852|FG003|Overall Study|Other|3|||
160789333|NCT02656173|580614853|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
160789334|NCT02656173|580614854|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
160789335|NCT02656173|580614853|FG000|Overall Study|Adverse Event|7|||
160789336|NCT02656173|580614854|FG001|Overall Study|Adverse Event|5|||
160789337|NCT02656173|580614853|FG000|Overall Study|Withdrawal by Subject|1|||
160789338|NCT02656173|580614854|FG001|Overall Study|Withdrawal by Subject|3|||
160789339|NCT02656173|580614853|FG000|Overall Study|Protocol Violation|0|||
160789340|NCT02656173|580614854|FG001|Overall Study|Protocol Violation|1|||
160789341|NCT02656173|580614853|FG000|Overall Study|Miscellaneous|2|||
160789342|NCT02656173|580614854|FG001|Overall Study|Miscellaneous|0|||
160789343|NCT03927846|580614858|FG000|Overall Study|Lost to Follow-up|10|||
160789344|NCT03927846|580614859|FG001|Overall Study|Lost to Follow-up|11|||
160789345|NCT03061214|580614862|FG000|Overall Study|Withdrawal by Subject|21|||
160789346|NCT03061214|580614863|FG001|Overall Study|Withdrawal by Subject|26|||
160789347|NCT03061214|580614864|FG002|Overall Study|Withdrawal by Subject|9|||
160789348|NCT03061214|580614862|FG000|Overall Study|Lost to Follow-up|3|||
160789349|NCT03061214|580614863|FG001|Overall Study|Lost to Follow-up|1|||
160789350|NCT03061214|580614864|FG002|Overall Study|Lost to Follow-up|1|||
160789351|NCT03061214|580614862|FG000|Overall Study|Death|1|||
160789352|NCT03061214|580614863|FG001|Overall Study|Death|1|||
160789353|NCT03061214|580614864|FG002|Overall Study|Death|0|||
160789354|NCT05130281|580616606|FG000|Overall Study|Withdrawal by Subject|0|||
160789355|NCT05130281|580616607|FG001|Overall Study|Withdrawal by Subject|0|||
160789356|NCT05130281|580616608|FG002|Overall Study|Withdrawal by Subject|1|||
160789357|NCT06844812|580616609|FG000|Overall Study|Lost to Follow-up|5|||
160789358|NCT06844812|580616609|FG000|Overall Study|stigmatization concerns|2|||
160789359|NCT06844812|580616609|FG000|Overall Study|medication refusal|2|||
160789360|NCT06844812|580616609|FG000|Overall Study|concerns about possible side effects|2|||
160789361|NCT06844812|580616609|FG000|Overall Study|wanting to seek another specialist opinion|2|||
160789362|NCT06844812|580616609|FG000|Overall Study|side effects (dizziness)|1|||
160789363|NCT05520333|580616613|FG000|Overall Study|Lost to Follow-up|3|||
160789364|NCT05520333|580616614|FG001|Overall Study|Lost to Follow-up|6|||
160789365|NCT05069415|580616620|FG000|Overall Study|Withdrawal by Subject|2|||
160789366|NCT05069415|580616621|FG001|Overall Study|Withdrawal by Subject|0|||
160789367|NCT05069415|580616620|FG000|Overall Study|Adverse Event|2|||
160789368|NCT05069415|580616621|FG001|Overall Study|Adverse Event|0|||
160789369|NCT03701074|580616622|FG000|Overall Study|Physician Decision|1|||
160789370|NCT03701074|580616623|FG001|Overall Study|Physician Decision|0|||
160789371|NCT01500135|580616624|FG000|Overall Study|Withdrawal of Consent|4|||
160789372|NCT01500135|580616625|FG001|Overall Study|Withdrawal of Consent|0|||
160789373|NCT01500135|580616624|FG000|Overall Study|Lost to Follow-up|6|||
160789374|NCT01500135|580616625|FG001|Overall Study|Lost to Follow-up|4|||
160789375|NCT01500135|580616624|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
160789376|NCT01500135|580616625|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
160789377|NCT01500135|580616624|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
160789378|NCT01500135|580616625|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
160789379|NCT01500135|580616624|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
160789380|NCT01500135|580616625|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
160789381|NCT01500135|580616624|FG000|Overall Study|Participant was a Safety Concern|1|||
160789382|NCT01500135|580616625|FG001|Overall Study|Participant was a Safety Concern|0|||
160789383|NCT01500135|580616624|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
160789384|NCT01500135|580616625|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
160789385|NCT01661595|580616626|FG000|Phase 1: Week 0-4|Adverse Event|1|||
160789386|NCT01661595|580616627|FG001|Phase 1: Week 0-4|Adverse Event|0|||
160789387|NCT01661595|580616628|FG002|Phase 1: Week 0-4|Adverse Event|0|||
160789388|NCT01661595|580616629|FG003|Phase 1: Week 0-4|Adverse Event|0|||
160789389|NCT01661595|580616626|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
160789390|NCT01661595|580616627|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
160789391|NCT01661595|580616628|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
160789392|NCT01661595|580616629|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
160789393|NCT00661687|580616630|FG000|Overall Study|Study related symptoms and complaints|5|||
160789394|NCT00661687|580616630|FG000|Overall Study|Positive slit lamp findings|4|||
160789395|NCT00661687|580616630|FG000|Overall Study|Inability to maintain wearing schedule|3|||
160789396|NCT00661687|580616630|FG000|Overall Study|Physician Decision|1|||
160789397|NCT00661687|580616630|FG000|Overall Study|Adverse Event|2|||
160789398|NCT00912509|580616631|FG000|Overall Study|Lost to Follow-up|1|||
160789399|NCT00912509|580616632|FG001|Overall Study|Lost to Follow-up|0|||
160789400|NCT00912509|580616631|FG000|Overall Study|Lack of Efficacy|4|||
160789401|NCT00912509|580616632|FG001|Overall Study|Lack of Efficacy|3|||
160789402|NCT05538728|580616633|FG000|Overall Study|Withdrawal by Subject|1|||
160789403|NCT05538728|580616634|FG001|Overall Study|Withdrawal by Subject|1|||
160789404|NCT01362530|580616636|FG000|Base Study (Cycle 1)|Adverse Event|2|||
160789405|NCT01362530|580616637|FG001|Base Study (Cycle 1)|Adverse Event|0|||
160891993|NCT01115803|581000479|FG001|Overall Study|Progressive Disease during Cycle1|0|||
160891994|NCT01115803|581000480|FG002|Overall Study|Progressive Disease during Cycle1|0|||
160891995|NCT01115803|581000481|FG003|Overall Study|Progressive Disease during Cycle1|0|||
160891996|NCT01115803|581000482|FG004|Overall Study|Progressive Disease during Cycle1|0|||
160891997|NCT01115803|581000483|FG005|Overall Study|Progressive Disease during Cycle1|0|||
160891998|NCT01115803|581000484|FG006|Overall Study|Progressive Disease during Cycle1|1|||
160891999|NCT00064298|581000485|FG000|Overall Study|Withdrawal by Subject|2|||
160892000|NCT00064298|581000486|FG001|Overall Study|Withdrawal by Subject|1|||
160892001|NCT00064298|581000485|FG000|Overall Study|Lost to Follow-up|2|||
160892002|NCT00064298|581000486|FG001|Overall Study|Lost to Follow-up|2|||
160892003|NCT00064298|581000485|FG000|Overall Study|Death|0|||
160892004|NCT00064298|581000486|FG001|Overall Study|Death|1|||
160892005|NCT00064298|581000485|FG000|Overall Study|Disease Progression|2|||
160892006|NCT00064298|581000486|FG001|Overall Study|Disease Progression|1|||
160892007|NCT03063203|581000487|FG000|Overall Study|Chose alternative therapy|3|||
160892008|NCT03063203|581000487|FG000|Overall Study|Death|2|||
160789406|NCT01362530|580616636|FG000|Base Study (Cycle 1)|Physician Decision|0|||
160789407|NCT01362530|580616637|FG001|Base Study (Cycle 1)|Physician Decision|1|||
160789408|NCT01362530|580616636|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
160789409|NCT01362530|580616637|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
160789410|NCT01362530|580616636|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
160789411|NCT01362530|580616637|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
160892009|NCT03063203|581000487|FG000|Overall Study|Disease progression|4|||
160892010|NCT03063203|581000487|FG000|Overall Study|Physician Decision|5|||
160892011|NCT00591266|581000488|FG000|Overall Study|Adverse Event|2|||
160892012|NCT00591266|581000489|FG001|Overall Study|Adverse Event|2|||
160789412|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
160789413|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
160789414|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
160789415|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
160789416|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
160789417|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
160789418|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
160789419|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
160789420|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
160789421|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
160789422|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
160789423|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
160789424|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
160789425|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
160789426|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
160789427|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
160789428|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
160789429|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
160789430|NCT02715856|580616638|FG000|Overall Study|Software Issues|12|||
160789431|NCT02715856|580616639|FG001|Overall Study|Software Issues|7|||
160789432|NCT02715856|580616638|FG000|Overall Study|Death|6|||
160789433|NCT02715856|580616639|FG001|Overall Study|Death|5|||
160789434|NCT02715856|580616638|FG000|Overall Study|Non- Compliant|0|||
160789435|NCT02715856|580616639|FG001|Overall Study|Non- Compliant|40|||
160789436|NCT01517178|580616640|FG000|Period 1|Adverse Event|1|||
160789437|NCT01517178|580616641|FG001|Period 1|Adverse Event|2|||
160789438|NCT01517178|580616640|FG000|Period 1|Lack of Efficacy|0|||
160789439|NCT01517178|580616641|FG001|Period 1|Lack of Efficacy|1|||
160789440|NCT01517178|580616640|FG000|Period 1|E.g. study termination|3|||
160789441|NCT01517178|580616641|FG001|Period 1|E.g. study termination|1|||
160789442|NCT01517178|580616640|FG000|Period 1|Withdrawal by Subject|0|||
160789443|NCT01517178|580616641|FG001|Period 1|Withdrawal by Subject|1|||
160789444|NCT01517178|580616640|FG000|Period 2|Adverse Event|1|||
160789445|NCT01517178|580616641|FG001|Period 2|Adverse Event|0|||
160789446|NCT01517178|580616640|FG000|Period 2|Withdrawal by Subject|3|||
160789447|NCT01517178|580616641|FG001|Period 2|Withdrawal by Subject|0|||
160789448|NCT01517178|580616640|FG000|Period 2|E.g. study termination|2|||
160789449|NCT01517178|580616641|FG001|Period 2|E.g. study termination|2|||
160789450|NCT01557569|580616642|FG000|Overall Study|Adverse Event|2|||
160789451|NCT01557569|580616643|FG001|Overall Study|Adverse Event|0|||
160789452|NCT01557569|580616642|FG000|Overall Study|high blood pressure|0|||
160789453|NCT01557569|580616643|FG001|Overall Study|high blood pressure|1|||
160789454|NCT01557569|580616642|FG000|Overall Study|Withdrawal by Subject|3|||
160789455|NCT01557569|580616643|FG001|Overall Study|Withdrawal by Subject|5|||
160789456|NCT01557569|580616642|FG000|Overall Study|noncompliance with rules of residential|0|||
160789457|NCT01557569|580616643|FG001|Overall Study|noncompliance with rules of residential|1|||
160789458|NCT02254460|580616644|FG000|Overall Study|Adverse Event|1|||
160789459|NCT02254460|580616645|FG001|Overall Study|Adverse Event|0|||
160789460|NCT01050218|580616646|FG000|Overall Study|Adverse Event|37|||
160789461|NCT01050218|580616646|FG000|Overall Study|Lack of Efficacy|8|||
160789462|NCT01050218|580616646|FG000|Overall Study|Protocol Violation|3|||
160789463|NCT01050218|580616646|FG000|Overall Study|Withdrawal by Subject|18|||
160892013|NCT00591266|581000490|FG002|Overall Study|Adverse Event|3|||
160892014|NCT00591266|581000488|FG000|Overall Study|Lost to Follow-up|0|||
160892015|NCT00591266|581000489|FG001|Overall Study|Lost to Follow-up|1|||
160892016|NCT00591266|581000490|FG002|Overall Study|Lost to Follow-up|0|||
160892017|NCT00591266|581000488|FG000|Overall Study|Protocol Violation|0|||
160892018|NCT00591266|581000489|FG001|Overall Study|Protocol Violation|0|||
160892019|NCT00591266|581000490|FG002|Overall Study|Protocol Violation|1|||
160892020|NCT00591266|581000488|FG000|Overall Study|Withdrawal by Subject|6|||
160892021|NCT00591266|581000489|FG001|Overall Study|Withdrawal by Subject|2|||
160789464|NCT01050218|580616646|FG000|Overall Study|Discontinued by sponsor|18|||
160789465|NCT01050218|580616646|FG000|Overall Study|Compliance|2|||
160789466|NCT01050218|580616646|FG000|Overall Study|Failed to return|7|||
160789467|NCT01050218|580616646|FG000|Overall Study|Serious Adverse Event|1|||
160789468|NCT01050218|580616646|FG000|Overall Study|Family emergency|1|||
160789469|NCT02336555|580616647|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160789470|NCT02336555|580616648|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
160789471|NCT02336555|580616647|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
160789472|NCT02336555|580616648|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
160892022|NCT00591266|581000490|FG002|Overall Study|Withdrawal by Subject|5|||
160892023|NCT00591266|581000488|FG000|Overall Study|Lack of Efficacy|0|||
160789473|NCT02336555|580616647|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
160789474|NCT02336555|580616648|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
160789475|NCT01772693|580616649|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
160789476|NCT01772693|580616650|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
160789477|NCT01772693|580616649|FG000|Overall Study|Withdrawal by Subject|2|||
160789478|NCT01772693|580616650|FG001|Overall Study|Withdrawal by Subject|0|||
160789479|NCT01772693|580616649|FG000|Overall Study|Alternative Treatment|2|||
160789480|NCT01772693|580616650|FG001|Overall Study|Alternative Treatment|0|||
160789481|NCT02872142|580616654|FG000|Overall Study|Adverse Event|2|||
160789482|NCT02872142|580616654|FG000|Overall Study|Death|1|||
160789483|NCT02872142|580616654|FG000|Overall Study|Participant Decision|3|||
160789484|NCT01550965|580616660|FG000|Overall Study|Adverse Event|26|||
160789485|NCT01550965|580616660|FG000|Overall Study|Withdrawal by Subject|10|||
160789486|NCT01550965|580616660|FG000|Overall Study|Lost to Follow-up|2|||
160789487|NCT01550965|580616660|FG000|Overall Study|Lack of Efficacy|59|||
160789488|NCT01550965|580616660|FG000|Overall Study|Other|13|||
160789489|NCT04157738|580616663|FG000|Overall Study|Moved out of state|0|||
160789490|NCT04157738|580616664|FG001|Overall Study|Moved out of state|2|||
160789491|NCT04157738|580616663|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
160789492|NCT04157738|580616664|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
160789493|NCT00309946|580616665|FG000|Overall Study|Withdrawal by Subject|1|||
160789494|NCT01347086|580616666|FG000|Overall Study|failed screening visit|0|||
160789495|NCT01347086|580616667|FG001|Overall Study|failed screening visit|0|||
160789496|NCT01347086|580616668|FG002|Overall Study|failed screening visit|1|||
160789497|NCT01347086|580616669|FG003|Overall Study|failed screening visit|0|||
160789498|NCT01347086|580616670|FG004|Overall Study|failed screening visit|0|||
160789499|NCT01347086|580616671|FG005|Overall Study|failed screening visit|0|||
160789500|NCT01347086|580616672|FG006|Overall Study|failed screening visit|1|||
160789501|NCT01347086|580616673|FG007|Overall Study|failed screening visit|1|||
160789502|NCT01347086|580616674|FG008|Overall Study|failed screening visit|0|||
160789503|NCT01347086|580616675|FG009|Overall Study|failed screening visit|1|||
160789504|NCT01689649|580616677|FG000|Overall Study|Lack of Efficacy|3|||
160789505|NCT01689649|580616677|FG000|Overall Study|Non-compliance|11|||
160789506|NCT01689649|580616677|FG000|Overall Study|Protocol Violation|3|||
160789507|NCT01689649|580616677|FG000|Overall Study|Lost to Follow-up|5|||
160789508|NCT01725282|580616682|FG000|Overall Study|Adverse Event|1|||
160789509|NCT01725282|580616683|FG001|Overall Study|Adverse Event|3|||
160789510|NCT01725282|580616684|FG002|Overall Study|Adverse Event|6|||
160789511|NCT01725282|580616685|FG003|Overall Study|Adverse Event|4|||
160789512|NCT01725282|580616682|FG000|Overall Study|Exacerbation of Target Disease|1|||
160789513|NCT01725282|580616683|FG001|Overall Study|Exacerbation of Target Disease|0|||
160789514|NCT01725282|580616684|FG002|Overall Study|Exacerbation of Target Disease|0|||
160789515|NCT01725282|580616685|FG003|Overall Study|Exacerbation of Target Disease|1|||
160789516|NCT01725282|580616682|FG000|Overall Study|Met Exclusion Criteria|0|||
160789517|NCT01725282|580616683|FG001|Overall Study|Met Exclusion Criteria|0|||
160789518|NCT01725282|580616684|FG002|Overall Study|Met Exclusion Criteria|1|||
160789519|NCT01725282|580616685|FG003|Overall Study|Met Exclusion Criteria|0|||
160789520|NCT01725282|580616682|FG000|Overall Study|Study Site Withdrawal|0|||
160789521|NCT01725282|580616683|FG001|Overall Study|Study Site Withdrawal|1|||
160789522|NCT01725282|580616684|FG002|Overall Study|Study Site Withdrawal|0|||
160789523|NCT01725282|580616685|FG003|Overall Study|Study Site Withdrawal|0|||
160789524|NCT01725282|580616682|FG000|Overall Study|Withdrawal by Subject|0|||
160789525|NCT01725282|580616683|FG001|Overall Study|Withdrawal by Subject|0|||
160789526|NCT01725282|580616684|FG002|Overall Study|Withdrawal by Subject|1|||
160789527|NCT01725282|580616685|FG003|Overall Study|Withdrawal by Subject|1|||
160789528|NCT01725282|580616682|FG000|Overall Study|Lack of Efficacy|0|||
160789529|NCT01725282|580616683|FG001|Overall Study|Lack of Efficacy|1|||
160789530|NCT01725282|580616684|FG002|Overall Study|Lack of Efficacy|0|||
160789531|NCT01725282|580616685|FG003|Overall Study|Lack of Efficacy|1|||
160789532|NCT04064567|580616686|FG000|Overall Study|Lost to Follow-up|23|||
160789533|NCT04064567|580616687|FG001|Overall Study|Lost to Follow-up|22|||
160789534|NCT04064567|580616686|FG000|Overall Study|Withdrawal by Subject|0|||
160789535|NCT04064567|580616687|FG001|Overall Study|Withdrawal by Subject|1|||
160789536|NCT04064567|580616686|FG000|Overall Study|Reincarcerated|7|||
160789537|NCT04064567|580616687|FG001|Overall Study|Reincarcerated|10|||
160789538|NCT04064567|580616686|FG000|Overall Study|Moved out of U.S.|0|||
160789539|NCT04064567|580616687|FG001|Overall Study|Moved out of U.S.|1|||
160789540|NCT04576481|580616688|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
160789541|NCT04576481|580616689|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
160789542|NCT04576481|580616690|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
160789543|NCT04576481|580616691|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
160789544|NCT03464461|580616697|FG000|Overall Study|exclusionary medication given ,|1|||
160789545|NCT03464461|580616698|FG001|Overall Study|exclusionary medication given ,|2|||
160789546|NCT03464461|580616699|FG002|Overall Study|exclusionary medication given ,|0|||
160789547|NCT03464461|580616697|FG000|Overall Study|Physician Decision|0|||
160789548|NCT03464461|580616698|FG001|Overall Study|Physician Decision|1|||
160789549|NCT03464461|580616699|FG002|Overall Study|Physician Decision|0|||
160789550|NCT05524948|580616700|FG000|Overall Study|Withdrawal by Subject|1|||
160789551|NCT05524948|580616701|FG001|Overall Study|Withdrawal by Subject|0|||
160789552|NCT05524948|580616700|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
160789553|NCT05524948|580616701|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
160789554|NCT05463952|580616704|FG000|Treatment|Progressive disease|4|||
160789555|NCT05463952|580616704|FG000|Treatment|Ongoing|2|||
160789556|NCT01646216|580616708|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
160789557|NCT01646216|580616709|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
160789558|NCT01646216|580616708|FG000|Overall Study|Did not complete training|0|||
160789559|NCT01646216|580616709|FG001|Overall Study|Did not complete training|2|||
160789560|NCT01646216|580616708|FG000|Overall Study|Investigator decision|1|||
160789561|NCT01646216|580616709|FG001|Overall Study|Investigator decision|1|||
160789562|NCT05259722|580616714|FG000|Overall Study|Adverse Event|2|||
160789563|NCT05259722|580616715|FG001|Overall Study|Adverse Event|24|||
160789564|NCT05259722|580616714|FG000|Overall Study|Lost to Follow-up|5|||
160789565|NCT05259722|580616715|FG001|Overall Study|Lost to Follow-up|1|||
160789566|NCT05259722|580616714|FG000|Overall Study|Lack of Efficacy|8|||
160789567|NCT05259722|580616715|FG001|Overall Study|Lack of Efficacy|26|||
160789568|NCT05259722|580616714|FG000|Overall Study|Withdrawal by Subject|15|||
160789569|NCT05259722|580616715|FG001|Overall Study|Withdrawal by Subject|33|||
160789570|NCT05259722|580616714|FG000|Overall Study|Various reasons|3|||
160789571|NCT05259722|580616715|FG001|Overall Study|Various reasons|9|||
160789572|NCT05259722|580616714|FG000|Overall Study|Not exposed to IMP|1|||
160789573|NCT05259722|580616715|FG001|Overall Study|Not exposed to IMP|12|||
160789574|NCT05259722|580616714|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
160789575|NCT05259722|580616715|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
160789576|NCT01887600|580616716|FG000|Overall Study|Death|39|||
160789577|NCT01887600|580616717|FG001|Overall Study|Death|16|||
160789578|NCT01887600|580616716|FG000|Overall Study|Lack of Efficacy|3|||
160789579|NCT01887600|580616717|FG001|Overall Study|Lack of Efficacy|26|||
160789580|NCT01887600|580616716|FG000|Overall Study|Lost to Follow-up|5|||
160789581|NCT01887600|580616717|FG001|Overall Study|Lost to Follow-up|1|||
160789582|NCT01887600|580616716|FG000|Overall Study|Physician Decision|7|||
160789583|NCT01887600|580616717|FG001|Overall Study|Physician Decision|8|||
160789584|NCT01887600|580616716|FG000|Overall Study|Protocol Deviation|3|||
160789585|NCT01887600|580616717|FG001|Overall Study|Protocol Deviation|0|||
160789586|NCT01887600|580616716|FG000|Overall Study|Withdrawal by Subject|58|||
160789587|NCT01887600|580616717|FG001|Overall Study|Withdrawal by Subject|52|||
160789588|NCT01887600|580616716|FG000|Overall Study|Adverse Event|21|||
160789589|NCT01887600|580616717|FG001|Overall Study|Adverse Event|9|||
160789590|NCT01887600|580616716|FG000|Overall Study|Non-compliance with study drug|3|||
160789591|NCT01887600|580616717|FG001|Overall Study|Non-compliance with study drug|0|||
160789592|NCT01887600|580616716|FG000|Overall Study|Miscellaneous|6|||
160789593|NCT01887600|580616717|FG001|Overall Study|Miscellaneous|2|||
160789594|NCT01887600|580616716|FG000|Overall Study|Progressive Disease|1|||
160789595|NCT01887600|580616717|FG001|Overall Study|Progressive Disease|0|||
160789596|NCT03688139|580616718|FG000|Overall Study|Lost to Follow-up|2|||
160789597|NCT03688139|580616719|FG001|Overall Study|Lost to Follow-up|0|||
160892024|NCT00591266|581000489|FG001|Overall Study|Lack of Efficacy|2|||
160892025|NCT00591266|581000490|FG002|Overall Study|Lack of Efficacy|0|||
160892026|NCT00591266|581000488|FG000|Overall Study|Other|1|||
160892027|NCT00591266|581000489|FG001|Overall Study|Other|4|||
160548070|NCT04381650|579732560|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
160789598|NCT03688139|580616718|FG000|Overall Study|Physician Decision|0|||
160892028|NCT00591266|581000490|FG002|Overall Study|Other|5|||
160892029|NCT03488927|581000491|FG000|Overall Study|Withdrawal by Subject|44|||
160789599|NCT03688139|580616719|FG001|Overall Study|Physician Decision|1|||
160789600|NCT03688139|580616718|FG000|Overall Study|Withdrawal by Subject|2|||
160789601|NCT03688139|580616719|FG001|Overall Study|Withdrawal by Subject|3|||
160892030|NCT03488927|581000492|FG001|Overall Study|Withdrawal by Subject|118|||
160892031|NCT03488927|581000493|FG002|Overall Study|Withdrawal by Subject|217|||
160789602|NCT01185366|580616725|FG000|First Line Therapy|Insurance Coverage Denied|1|||
160981893|NCT01024751|581321792|FG001|Enrolled Participants|Ineligible at baseline|4|||
160789603|NCT01185366|580616726|FG001|First Line Therapy|Insurance Coverage Denied|1|||
160789604|NCT01185366|580616725|FG000|First Line Therapy|Withdrawal by Subject|1|||
160789605|NCT01185366|580616726|FG001|First Line Therapy|Withdrawal by Subject|0|||
160789606|NCT01185366|580616725|FG000|First Line Therapy|Lack of Metastatic Site|1|||
160789607|NCT01185366|580616726|FG001|First Line Therapy|Lack of Metastatic Site|0|||
160789608|NCT01185366|580616725|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
160789609|NCT01185366|580616726|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
160789610|NCT01185366|580616725|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
160892032|NCT05080660|581000494|FG000|Overall Study|Adverse Event|4|||
160892033|NCT05080660|581000495|FG001|Overall Study|Adverse Event|0|||
160789611|NCT01185366|580616726|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
160789612|NCT01185366|580616725|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
160789613|NCT01185366|580616726|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
160789614|NCT01185366|580616725|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
160789615|NCT01185366|580616726|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
160789616|NCT00127933|580616727|FG000|Overall Study|Randomized but not dosed|1|||
160789617|NCT00127933|580616728|FG001|Overall Study|Randomized but not dosed|0|||
160789618|NCT00498485|580616729|FG000|Overall Study|Adverse Event|1|||
160789619|NCT00498485|580616730|FG001|Overall Study|Adverse Event|5|||
160789620|NCT03072875|580616731|FG000|Overall Study|Lost to Follow-up|1|||
160789621|NCT03111732|580616735|FG000|Overall Study|Enrolled in different study|1|||
160789622|NCT03111732|580616735|FG000|Overall Study|Progressive disease|3|||
160789623|NCT03111732|580616735|FG000|Overall Study|Withdrawal by Subject|1|||
160789624|NCT00452400|580616736|FG000|Overall Study|Adverse Event|1|||
160789625|NCT00452400|580616737|FG001|Overall Study|Adverse Event|1|||
160789626|NCT00452400|580616738|FG002|Overall Study|Adverse Event|5|||
160789627|NCT00452400|580616739|FG003|Overall Study|Adverse Event|0|||
160789628|NCT00452400|580616740|FG004|Overall Study|Adverse Event|2|||
160789629|NCT00452400|580616736|FG000|Overall Study|Protocol Violation|0|||
160789630|NCT00452400|580616737|FG001|Overall Study|Protocol Violation|0|||
160789631|NCT00452400|580616738|FG002|Overall Study|Protocol Violation|1|||
160789632|NCT00452400|580616739|FG003|Overall Study|Protocol Violation|0|||
160789633|NCT00452400|580616740|FG004|Overall Study|Protocol Violation|0|||
160789634|NCT00452400|580616736|FG000|Overall Study|Lost to Follow-up|1|||
160789635|NCT00452400|580616737|FG001|Overall Study|Lost to Follow-up|0|||
160789636|NCT00452400|580616738|FG002|Overall Study|Lost to Follow-up|0|||
160789637|NCT00452400|580616739|FG003|Overall Study|Lost to Follow-up|0|||
160789638|NCT00452400|580616740|FG004|Overall Study|Lost to Follow-up|0|||
160789639|NCT00452400|580616736|FG000|Overall Study|Withdrawal by Subject|1|||
160789640|NCT00452400|580616737|FG001|Overall Study|Withdrawal by Subject|0|||
160789641|NCT00452400|580616738|FG002|Overall Study|Withdrawal by Subject|1|||
160789642|NCT00452400|580616739|FG003|Overall Study|Withdrawal by Subject|0|||
160789643|NCT00452400|580616740|FG004|Overall Study|Withdrawal by Subject|0|||
160789644|NCT00452400|580616736|FG000|Overall Study|Lack of Efficacy|2|||
160789645|NCT00452400|580616737|FG001|Overall Study|Lack of Efficacy|0|||
160789646|NCT00452400|580616738|FG002|Overall Study|Lack of Efficacy|0|||
160789647|NCT00452400|580616739|FG003|Overall Study|Lack of Efficacy|0|||
160789648|NCT00452400|580616740|FG004|Overall Study|Lack of Efficacy|0|||
160789649|NCT00452400|580616736|FG000|Overall Study|Other reasons not listed above|0|||
160789650|NCT00452400|580616737|FG001|Overall Study|Other reasons not listed above|0|||
160789651|NCT00452400|580616738|FG002|Overall Study|Other reasons not listed above|0|||
160789652|NCT00452400|580616739|FG003|Overall Study|Other reasons not listed above|1|||
160789653|NCT00452400|580616740|FG004|Overall Study|Other reasons not listed above|1|||
160789654|NCT01943825|580616743|FG000|Overall Study|Lost to Follow-up|9|||
160789655|NCT01943825|580616744|FG001|Overall Study|Lost to Follow-up|3|||
160789656|NCT01943825|580616745|FG002|Overall Study|Lost to Follow-up|12|||
160789657|NCT01943825|580616746|FG003|Overall Study|Lost to Follow-up|8|||
160789658|NCT01943825|580616743|FG000|Overall Study|Withdrawal by Subject|1|||
160789659|NCT01943825|580616744|FG001|Overall Study|Withdrawal by Subject|0|||
160789660|NCT01943825|580616745|FG002|Overall Study|Withdrawal by Subject|3|||
160789661|NCT01943825|580616746|FG003|Overall Study|Withdrawal by Subject|2|||
160892034|NCT05080660|581000494|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
160892035|NCT05080660|581000495|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
160892036|NCT05080660|581000494|FG000|Overall Study|Physician Decision|1|||
160892037|NCT05080660|581000495|FG001|Overall Study|Physician Decision|0|||
160892038|NCT05080660|581000494|FG000|Overall Study|Protocol Deviation|2|||
160892039|NCT05080660|581000495|FG001|Overall Study|Protocol Deviation|0|||
160892040|NCT05080660|581000494|FG000|Overall Study|Withdrawal by Subject|5|||
160892041|NCT05080660|581000495|FG001|Overall Study|Withdrawal by Subject|2|||
160892042|NCT03497676|581000496|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
160892043|NCT03497676|581000497|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
160892044|NCT03497676|581000498|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
160892045|NCT03497676|581000499|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
160892046|NCT03497676|581000496|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
160981894|NCT01024751|581321791|FG000|Eligible Participants|Withdrawal by Subject|0|||
160892047|NCT03497676|581000497|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
160981895|NCT01024751|581321792|FG001|Eligible Participants|Withdrawal by Subject|1|||
160789662|NCT01943825|580616743|FG000|Overall Study|Other than specified above|0|||
160789663|NCT01943825|580616744|FG001|Overall Study|Other than specified above|1|||
160789664|NCT01943825|580616745|FG002|Overall Study|Other than specified above|0|||
160789665|NCT01943825|580616746|FG003|Overall Study|Other than specified above|1|||
160789666|NCT01472835|580616749|FG000|Overall Study|Lost to Follow-up|2|||
160789667|NCT01472835|580616750|FG001|Overall Study|Lost to Follow-up|0|||
160789668|NCT02539394|580616751|FG000|Overall Study|Protocol Violation|1|||
160789669|NCT02539394|580616752|FG001|Overall Study|Protocol Violation|3|||
160789670|NCT02539394|580616751|FG000|Overall Study|Lost to Follow-up|1|||
160789671|NCT02539394|580616752|FG001|Overall Study|Lost to Follow-up|2|||
160789672|NCT02539394|580616751|FG000|Overall Study|Incomplete dataset|6|||
160789673|NCT02539394|580616752|FG001|Overall Study|Incomplete dataset|6|||
160789674|NCT01316900|580616771|FG000|Overall Study|Adverse Event|10|||
160789675|NCT01316900|580616772|FG001|Overall Study|Adverse Event|10|||
160789676|NCT01316900|580616773|FG002|Overall Study|Adverse Event|15|||
160789677|NCT01316900|580616774|FG003|Overall Study|Adverse Event|9|||
160789678|NCT01316900|580616771|FG000|Overall Study|Lack of Efficacy|17|||
160789679|NCT01316900|580616772|FG001|Overall Study|Lack of Efficacy|9|||
160789680|NCT01316900|580616773|FG002|Overall Study|Lack of Efficacy|5|||
160789681|NCT01316900|580616774|FG003|Overall Study|Lack of Efficacy|7|||
160789682|NCT01316900|580616771|FG000|Overall Study|Protocol Violation|7|||
160789683|NCT01316900|580616772|FG001|Overall Study|Protocol Violation|1|||
160789684|NCT01316900|580616773|FG002|Overall Study|Protocol Violation|4|||
160789685|NCT01316900|580616774|FG003|Overall Study|Protocol Violation|0|||
160789686|NCT01316900|580616771|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
160789687|NCT01316900|580616772|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
160789688|NCT01316900|580616773|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
160789689|NCT01316900|580616774|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
160789690|NCT01316900|580616771|FG000|Overall Study|Lost to Follow-up|1|||
160789691|NCT01316900|580616772|FG001|Overall Study|Lost to Follow-up|0|||
160789692|NCT01316900|580616773|FG002|Overall Study|Lost to Follow-up|1|||
160789693|NCT01316900|580616774|FG003|Overall Study|Lost to Follow-up|1|||
160789694|NCT01316900|580616771|FG000|Overall Study|Withdrawal by Subject|7|||
160789695|NCT01316900|580616772|FG001|Overall Study|Withdrawal by Subject|8|||
160789696|NCT01316900|580616773|FG002|Overall Study|Withdrawal by Subject|6|||
160789697|NCT01316900|580616774|FG003|Overall Study|Withdrawal by Subject|9|||
160789698|NCT01684033|580616775|FG000|Period 1, First 30 Days|Adverse Event|1|||
160789699|NCT01684033|580616776|FG001|Period 1, First 30 Days|Adverse Event|1|||
160789700|NCT01684033|580616775|FG000|Period 1, First 30 Days|Noncompliance|1|||
160789701|NCT01684033|580616776|FG001|Period 1, First 30 Days|Noncompliance|0|||
160789702|NCT01684033|580616775|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
160789703|NCT01684033|580616776|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
160789704|NCT01684033|580616775|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
160789705|NCT01684033|580616776|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
160789706|NCT01684033|580616775|FG000|Period 2, Second 30 Days|Adverse Event|1|||
160789707|NCT01684033|580616776|FG001|Period 2, Second 30 Days|Adverse Event|0|||
160789708|NCT05346640|580616777|FG000|Overall Study|Lack of Efficacy|2|||
160789709|NCT05346640|580616777|FG000|Overall Study|Lost to Follow-up|14|||
160789710|NCT05346640|580616777|FG000|Overall Study|Protocol Violation|4|||
160789711|NCT05346640|580616777|FG000|Overall Study|Withdrawal by Subject|2|||
160789712|NCT05346640|580616777|FG000|Overall Study|Physiological Complications|3|||
160789713|NCT05346640|580616777|FG000|Overall Study|Other Reason|3|||
160789714|NCT02496156|580616778|FG000|Overall Study|Lost to Follow-up|5|||
160789715|NCT02496156|580616779|FG001|Overall Study|Lost to Follow-up|0|||
160789716|NCT02496156|580616778|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
160789717|NCT02496156|580616779|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
160789718|NCT03449147|580616780|FG000|52-week Treatment Period|Death|0|||
160789719|NCT03449147|580616781|FG001|52-week Treatment Period|Death|1|||
160789720|NCT03449147|580616782|FG002|52-week Treatment Period|Death|0|||
160789721|NCT03449147|580616780|FG000|52-week Treatment Period|Lost to Follow-up|6|||
160789722|NCT03449147|580616781|FG001|52-week Treatment Period|Lost to Follow-up|2|||
160789723|NCT03449147|580616782|FG002|52-week Treatment Period|Lost to Follow-up|5|||
160789724|NCT03449147|580616780|FG000|52-week Treatment Period|Other|0|||
160789725|NCT03449147|580616781|FG001|52-week Treatment Period|Other|1|||
160789726|NCT03449147|580616782|FG002|52-week Treatment Period|Other|2|||
160789727|NCT03449147|580616780|FG000|52-week Treatment Period|Physician Decision|1|||
160789728|NCT03449147|580616781|FG001|52-week Treatment Period|Physician Decision|0|||
160789729|NCT03449147|580616782|FG002|52-week Treatment Period|Physician Decision|3|||
160789730|NCT03449147|580616780|FG000|52-week Treatment Period|Screen Failure|1|||
160789731|NCT03449147|580616781|FG001|52-week Treatment Period|Screen Failure|2|||
160789732|NCT03449147|580616782|FG002|52-week Treatment Period|Screen Failure|0|||
160789733|NCT03449147|580616780|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
160789734|NCT03449147|580616781|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
160789735|NCT03449147|580616782|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
160789736|NCT03449147|580616780|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
160789737|NCT03449147|580616781|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
160789738|NCT03449147|580616782|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
160789739|NCT03449147|580616780|FG000|12-Week Off-Treatment Durability Period|Other|0|||
160789740|NCT03449147|580616781|FG001|12-Week Off-Treatment Durability Period|Other|1|||
160789741|NCT03449147|580616782|FG002|12-Week Off-Treatment Durability Period|Other|0|||
160789742|NCT00954538|580616784|FG000|Part III|Withdrawal by Subject|0|||
160789743|NCT00954538|580616785|FG001|Part III|Withdrawal by Subject|0|||
160789744|NCT00954538|580616786|FG002|Part III|Withdrawal by Subject|0|||
160789745|NCT00954538|580616787|FG003|Part III|Withdrawal by Subject|0|||
160789746|NCT00954538|580616788|FG004|Part III|Withdrawal by Subject|1|||
160789747|NCT00954538|580616789|FG005|Part III|Withdrawal by Subject|0|||
160789748|NCT01905683|580616790|FG000|Overall Study|Protocol Violation|1|||
160789749|NCT01905683|580616790|FG000|Overall Study|Re-injection criteria not met; others|13|||
160789750|NCT01905683|580616790|FG000|Overall Study|Physician Decision|1|||
160789751|NCT01905683|580616790|FG000|Overall Study|Lack of Efficacy|8|||
160789752|NCT01905683|580616790|FG000|Overall Study|Withdrawal by Subject|20|||
160789753|NCT01905683|580616790|FG000|Overall Study|Adverse Event|4|||
160789754|NCT01905683|580616790|FG000|Overall Study|Lost to Follow-up|4|||
160789755|NCT02037984|580616793|FG000|Overall Study|Lack of Efficacy|0|||
160789756|NCT02037984|580616794|FG001|Overall Study|Lack of Efficacy|0|||
160789757|NCT02037984|580616795|FG002|Overall Study|Lack of Efficacy|3|||
160789758|NCT02037984|580616796|FG003|Overall Study|Lack of Efficacy|10|||
160789759|NCT02037984|580616797|FG004|Overall Study|Lack of Efficacy|2|||
160789760|NCT02037984|580616798|FG005|Overall Study|Lack of Efficacy|2|||
160789761|NCT02037984|580616799|FG006|Overall Study|Lack of Efficacy|4|||
160789762|NCT02037984|580616800|FG007|Overall Study|Lack of Efficacy|3|||
160789763|NCT02037984|580616793|FG000|Overall Study|Lost to Follow-up|1|||
160789764|NCT02037984|580616794|FG001|Overall Study|Lost to Follow-up|0|||
160789765|NCT02037984|580616795|FG002|Overall Study|Lost to Follow-up|3|||
160789766|NCT02037984|580616796|FG003|Overall Study|Lost to Follow-up|5|||
160789767|NCT02037984|580616797|FG004|Overall Study|Lost to Follow-up|2|||
160789768|NCT02037984|580616798|FG005|Overall Study|Lost to Follow-up|2|||
160789769|NCT02037984|580616799|FG006|Overall Study|Lost to Follow-up|2|||
160789770|NCT02037984|580616800|FG007|Overall Study|Lost to Follow-up|4|||
160789771|NCT02037984|580616793|FG000|Overall Study|Physician Decision|0|||
160789772|NCT02037984|580616794|FG001|Overall Study|Physician Decision|0|||
160789773|NCT02037984|580616795|FG002|Overall Study|Physician Decision|0|||
160789774|NCT02037984|580616796|FG003|Overall Study|Physician Decision|0|||
160789775|NCT02037984|580616797|FG004|Overall Study|Physician Decision|0|||
160789776|NCT02037984|580616798|FG005|Overall Study|Physician Decision|0|||
160789777|NCT02037984|580616799|FG006|Overall Study|Physician Decision|1|||
160789778|NCT02037984|580616800|FG007|Overall Study|Physician Decision|0|||
160789779|NCT02037984|580616793|FG000|Overall Study|Protocol Violation|0|||
160789780|NCT02037984|580616794|FG001|Overall Study|Protocol Violation|0|||
160789781|NCT02037984|580616795|FG002|Overall Study|Protocol Violation|0|||
160789782|NCT02037984|580616796|FG003|Overall Study|Protocol Violation|0|||
160789783|NCT02037984|580616797|FG004|Overall Study|Protocol Violation|0|||
160789784|NCT02037984|580616798|FG005|Overall Study|Protocol Violation|1|||
160789785|NCT02037984|580616799|FG006|Overall Study|Protocol Violation|2|||
160789786|NCT02037984|580616800|FG007|Overall Study|Protocol Violation|0|||
160789787|NCT02037984|580616793|FG000|Overall Study|Technical Problems|0|||
160789788|NCT02037984|580616794|FG001|Overall Study|Technical Problems|0|||
160789789|NCT02037984|580616795|FG002|Overall Study|Technical Problems|3|||
160789790|NCT02037984|580616796|FG003|Overall Study|Technical Problems|3|||
160789791|NCT02037984|580616797|FG004|Overall Study|Technical Problems|2|||
160789792|NCT02037984|580616798|FG005|Overall Study|Technical Problems|3|||
160789793|NCT02037984|580616799|FG006|Overall Study|Technical Problems|4|||
160789794|NCT02037984|580616800|FG007|Overall Study|Technical Problems|2|||
160789795|NCT02037984|580616793|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160789796|NCT02037984|580616794|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160789797|NCT02037984|580616795|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
160789798|NCT02037984|580616796|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
160789799|NCT02037984|580616797|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
160789800|NCT02037984|580616798|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
160789801|NCT02037984|580616799|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
160789802|NCT02037984|580616800|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
160789803|NCT02037984|580616793|FG000|Overall Study|Withdrawal by Subject|0|||
160789804|NCT02037984|580616794|FG001|Overall Study|Withdrawal by Subject|0|||
160789805|NCT02037984|580616795|FG002|Overall Study|Withdrawal by Subject|0|||
160789806|NCT02037984|580616796|FG003|Overall Study|Withdrawal by Subject|1|||
160789807|NCT02037984|580616797|FG004|Overall Study|Withdrawal by Subject|1|||
160789808|NCT02037984|580616798|FG005|Overall Study|Withdrawal by Subject|3|||
160789809|NCT02037984|580616799|FG006|Overall Study|Withdrawal by Subject|0|||
160789810|NCT02037984|580616800|FG007|Overall Study|Withdrawal by Subject|1|||
160789811|NCT00974233|580616804|FG000|Induction Chemoimmunotherapy|Death|2|||
160789812|NCT00974233|580616804|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
160789813|NCT00974233|580616804|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
160789814|NCT00974233|580616804|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
160789815|NCT00974233|580616804|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
160789816|NCT00974233|580616804|FG000|Maintenance Lenalidomide|Adverse Event|8|||
160789817|NCT01691092|580616805|FG000|Overall Study|Lost to Follow-up|10|||
160789818|NCT01691092|580616805|FG000|Overall Study|Physician Decision|4|||
160789819|NCT01691092|580616805|FG000|Overall Study|Withdrawal by Subject|3|||
160789820|NCT01691092|580616805|FG000|Overall Study|non-compliance|3|||
160789821|NCT01691092|580616805|FG000|Overall Study|used for different study|2|||
160789822|NCT01691092|580616805|FG000|Overall Study|screen fail|19|||
160789823|NCT01657942|580616806|FG000|Overall Study|Alternative Treatment|7|||
160789824|NCT01657942|580616806|FG000|Overall Study|Lost to Follow-up|1|||
160789825|NCT01633112|580618429|FG000|Overall Study|Lack of Efficacy|1|||
160789826|NCT01633112|580618430|FG001|Overall Study|Lack of Efficacy|6|||
160789827|NCT01633112|580618431|FG002|Overall Study|Lack of Efficacy|13|||
160789828|NCT01633112|580618429|FG000|Overall Study|Abnormal laboratory value(s)|3|||
160789829|NCT01633112|580618430|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160789830|NCT01633112|580618431|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160789831|NCT01633112|580618429|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160789832|NCT01633112|580618430|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160789833|NCT01633112|580618431|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160789834|NCT01633112|580618429|FG000|Overall Study|Administrative problems|1|||
160789835|NCT01633112|580618430|FG001|Overall Study|Administrative problems|2|||
160789836|NCT01633112|580618431|FG002|Overall Study|Administrative problems|5|||
160789837|NCT01633112|580618429|FG000|Overall Study|Adverse Event|16|||
160789838|NCT01633112|580618430|FG001|Overall Study|Adverse Event|18|||
160789839|NCT01633112|580618431|FG002|Overall Study|Adverse Event|20|||
160789840|NCT01633112|580618429|FG000|Overall Study|Lost to Follow-up|7|||
160789841|NCT01633112|580618430|FG001|Overall Study|Lost to Follow-up|19|||
160789842|NCT01633112|580618431|FG002|Overall Study|Lost to Follow-up|6|||
160789843|NCT01633112|580618429|FG000|Overall Study|Protocol Violation|4|||
160789844|NCT01633112|580618430|FG001|Overall Study|Protocol Violation|0|||
160789845|NCT01633112|580618431|FG002|Overall Study|Protocol Violation|2|||
160789846|NCT01633112|580618429|FG000|Overall Study|Subject no longer requires study drug|0|||
160789847|NCT01633112|580618430|FG001|Overall Study|Subject no longer requires study drug|0|||
160789848|NCT01633112|580618431|FG002|Overall Study|Subject no longer requires study drug|1|||
160789849|NCT01633112|580618429|FG000|Overall Study|Withdrawal by Subject|20|||
160789850|NCT01633112|580618430|FG001|Overall Study|Withdrawal by Subject|12|||
160789851|NCT01633112|580618431|FG002|Overall Study|Withdrawal by Subject|41|||
160789852|NCT01633112|580618429|FG000|Overall Study|missing Study Completion CRF|1|||
160789853|NCT01633112|580618430|FG001|Overall Study|missing Study Completion CRF|1|||
160789854|NCT01633112|580618431|FG002|Overall Study|missing Study Completion CRF|4|||
160789855|NCT00889005|580618442|FG000|Overall Study|Lost to Follow-up|4|||
160789856|NCT00889005|580618443|FG001|Overall Study|Lost to Follow-up|2|||
160789857|NCT00889005|580618442|FG000|Overall Study|Withdrawal by Subject|4|||
160789858|NCT00889005|580618443|FG001|Overall Study|Withdrawal by Subject|0|||
160789859|NCT01998477|580618444|FG000|Overall Study|Lost to Follow-up|4|||
160789860|NCT01998477|580618445|FG001|Overall Study|Lost to Follow-up|5|||
160789861|NCT01998477|580618444|FG000|Overall Study|Withdrawal by Subject|6|||
160789862|NCT01998477|580618445|FG001|Overall Study|Withdrawal by Subject|0|||
160789863|NCT00129974|580618446|FG000|Overall Study|Other|1|||
160789864|NCT00160563|580618447|FG000|Overall Study|Adverse Event|1|||
160789865|NCT00160563|580618448|FG001|Overall Study|Adverse Event|1|||
160789866|NCT00160563|580618449|FG002|Overall Study|Adverse Event|1|||
160789867|NCT00160563|580618447|FG000|Overall Study|Lost to Follow-up|1|||
160789868|NCT00160563|580618448|FG001|Overall Study|Lost to Follow-up|1|||
160789869|NCT00160563|580618449|FG002|Overall Study|Lost to Follow-up|2|||
160789870|NCT00160563|580618447|FG000|Overall Study|Protocol Violation|0|||
160789871|NCT00160563|580618448|FG001|Overall Study|Protocol Violation|0|||
160789872|NCT00160563|580618449|FG002|Overall Study|Protocol Violation|3|||
160789873|NCT00160563|580618447|FG000|Overall Study|Withdrawal by Subject|1|||
160789874|NCT00160563|580618448|FG001|Overall Study|Withdrawal by Subject|2|||
160789875|NCT00160563|580618449|FG002|Overall Study|Withdrawal by Subject|3|||
160789876|NCT00160563|580618447|FG000|Overall Study|Other (listed in the study report)|48|||
160789877|NCT00160563|580618448|FG001|Overall Study|Other (listed in the study report)|40|||
160789878|NCT00160563|580618449|FG002|Overall Study|Other (listed in the study report)|81|||
160789879|NCT00160563|580618447|FG000|Overall Study|Missing reason|0|||
160789880|NCT00160563|580618448|FG001|Overall Study|Missing reason|1|||
160789881|NCT00160563|580618449|FG002|Overall Study|Missing reason|0|||
160789882|NCT00395447|580618455|FG000|Overall Study|Death|37|||
160789883|NCT00395447|580618456|FG001|Overall Study|Death|32|||
160789884|NCT00395447|580618455|FG000|Overall Study|Lost to Follow-up|52|||
160789885|NCT00395447|580618456|FG001|Overall Study|Lost to Follow-up|43|||
160892048|NCT03497676|581000498|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
160789886|NCT00395447|580618455|FG000|Overall Study|Withdrawal by Subject|24|||
160789887|NCT00395447|580618456|FG001|Overall Study|Withdrawal by Subject|19|||
160789888|NCT00395447|580618455|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
160789889|NCT00395447|580618456|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
160789890|NCT03766906|580618457|FG000|Overall Study|Withdrawal by Subject|6|||
160789891|NCT00836901|580618458|FG000|First Intervention|Withdrawal by Subject|1|||
160789892|NCT00836901|580618459|FG001|First Intervention|Withdrawal by Subject|0|||
160789893|NCT01148771|580618462|FG000|Washout Period|Withdrawal by Subject|0|||
160789894|NCT01148771|580618463|FG001|Washout Period|Withdrawal by Subject|1|||
160789895|NCT01437189|580618464|FG000|Overall Study|Adverse Event|3|||
160789896|NCT01437189|580618464|FG000|Overall Study|Lack of Efficacy|4|||
160789897|NCT01437189|580618464|FG000|Overall Study|Withdrawal by Subject|8|||
160789898|NCT00595075|580618467|FG000|Overall Study|Withdrawal by Subject|1|||
160789899|NCT00595075|580618468|FG001|Overall Study|Withdrawal by Subject|0|||
160789900|NCT05261490|580618470|FG000|Overall Study|Other|1|||
160789901|NCT05261490|580618471|FG001|Overall Study|Other|0|||
160789902|NCT05261490|580618472|FG002|Overall Study|Other|0|||
160789903|NCT05261490|580618470|FG000|Overall Study|Study Terminated by Sponsor|1|||
160789904|NCT05261490|580618471|FG001|Overall Study|Study Terminated by Sponsor|1|||
160789905|NCT05261490|580618472|FG002|Overall Study|Study Terminated by Sponsor|4|||
160789906|NCT05261490|580618470|FG000|Overall Study|Death|1|||
160789907|NCT05261490|580618471|FG001|Overall Study|Death|2|||
160789908|NCT05261490|580618472|FG002|Overall Study|Death|0|||
160789909|NCT00113373|580618474|FG000|Overall Study|Ineligible: wrong primary|1|||
160789910|NCT00113373|580618474|FG000|Overall Study|Ineligible: second primary|1|||
160789911|NCT00113373|580618474|FG000|Overall Study|Never Treated|1|||
160789912|NCT04629521|580618475|FG000|Overall Study|Death|1|||
160789913|NCT04629521|580618475|FG000|Overall Study|Lost to Follow-up|3|||
160789914|NCT04629521|580618475|FG000|Overall Study|Subject withdrew consent|3|||
160789915|NCT04629521|580618475|FG000|Overall Study|Enrolled in error|1|||
160789916|NCT03163667|580618476|FG000|Overall Study|Death|15|||
160789917|NCT03163667|580618477|FG001|Overall Study|Death|27|||
160789918|NCT03163667|580618476|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
160789919|NCT03163667|580618477|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
160789920|NCT01335685|580618480|FG000|Overall Study|Study Terminated by Sponsor|2|||
160789921|NCT01335685|580618481|FG001|Overall Study|Study Terminated by Sponsor|1|||
160789922|NCT01335685|580618482|FG002|Overall Study|Study Terminated by Sponsor|1|||
160789923|NCT01335685|580618483|FG003|Overall Study|Study Terminated by Sponsor|10|||
160789924|NCT01335685|580618484|FG004|Overall Study|Study Terminated by Sponsor|0|||
160789925|NCT01335685|580618485|FG005|Overall Study|Study Terminated by Sponsor|4|||
160789926|NCT01335685|580618486|FG006|Overall Study|Study Terminated by Sponsor|2|||
160789927|NCT01335685|580618487|FG007|Overall Study|Study Terminated by Sponsor|3|||
160789928|NCT01335685|580618480|FG000|Overall Study|Withdrawal by Subject|1|||
160789929|NCT01335685|580618481|FG001|Overall Study|Withdrawal by Subject|0|||
160789930|NCT01335685|580618482|FG002|Overall Study|Withdrawal by Subject|0|||
160789931|NCT01335685|580618483|FG003|Overall Study|Withdrawal by Subject|1|||
160789932|NCT01335685|580618484|FG004|Overall Study|Withdrawal by Subject|0|||
160789933|NCT01335685|580618485|FG005|Overall Study|Withdrawal by Subject|0|||
160789934|NCT01335685|580618486|FG006|Overall Study|Withdrawal by Subject|0|||
160789935|NCT01335685|580618487|FG007|Overall Study|Withdrawal by Subject|0|||
160789936|NCT01335685|580618480|FG000|Overall Study|Reason not Specified|0|||
160789937|NCT01335685|580618481|FG001|Overall Study|Reason not Specified|0|||
160789938|NCT01335685|580618482|FG002|Overall Study|Reason not Specified|1|||
160789939|NCT01335685|580618483|FG003|Overall Study|Reason not Specified|0|||
160789940|NCT01335685|580618484|FG004|Overall Study|Reason not Specified|0|||
160789941|NCT01335685|580618485|FG005|Overall Study|Reason not Specified|1|||
160789942|NCT01335685|580618486|FG006|Overall Study|Reason not Specified|0|||
160789943|NCT01335685|580618487|FG007|Overall Study|Reason not Specified|0|||
160789944|NCT02554474|580618490|FG000|Overall Study|Protocol Violation|1|||
160789945|NCT02554474|580618491|FG001|Overall Study|Protocol Violation|1|||
160789946|NCT02554474|580618490|FG000|Overall Study|Health issue not related to the study|1|||
160789947|NCT02554474|580618491|FG001|Overall Study|Health issue not related to the study|0|||
160789948|NCT02554474|580618490|FG000|Overall Study|Withdrawal by Subject|1|||
160789949|NCT02554474|580618491|FG001|Overall Study|Withdrawal by Subject|1|||
160789950|NCT03211832|580618492|FG000|Overall Study|No longer with agency|32|||
160789951|NCT03211832|580618493|FG001|Overall Study|No longer with agency|49|||
160789952|NCT03211832|580618494|FG002|Overall Study|No longer with agency|30|||
160789953|NCT03211832|580618492|FG000|Overall Study|Declined survey|3|||
160789954|NCT03211832|580618493|FG001|Overall Study|Declined survey|3|||
160789955|NCT03211832|580618494|FG002|Overall Study|Declined survey|2|||
160789956|NCT03211832|580618492|FG000|Overall Study|Not available during data collection|1|||
160789957|NCT03211832|580618493|FG001|Overall Study|Not available during data collection|0|||
160789958|NCT03211832|580618494|FG002|Overall Study|Not available during data collection|2|||
160789959|NCT00855166|580618495|FG000|Overall Study|Adverse Event|0|||
160789960|NCT00855166|580618496|FG001|Overall Study|Adverse Event|2|||
160789961|NCT00855166|580618495|FG000|Overall Study|Death|0|||
160789962|NCT00855166|580618496|FG001|Overall Study|Death|1|||
160789963|NCT00855166|580618495|FG000|Overall Study|Withdrawal by Subject|1|||
160789964|NCT00855166|580618496|FG001|Overall Study|Withdrawal by Subject|4|||
160892049|NCT03497676|581000499|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
160789965|NCT00855166|580618495|FG000|Overall Study|Poor/non-compliance|2|||
160789966|NCT00855166|580618496|FG001|Overall Study|Poor/non-compliance|0|||
160789967|NCT00855166|580618495|FG000|Overall Study|Administrative reasons by sponsor|1|||
160789968|NCT00855166|580618496|FG001|Overall Study|Administrative reasons by sponsor|0|||
160789969|NCT00855166|580618495|FG000|Overall Study|Subject no longer meets study criteria|1|||
160789970|NCT00855166|580618496|FG001|Overall Study|Subject no longer meets study criteria|1|||
160789971|NCT03777020|580618500|FG000|Overall Study|Withdrawal by Subject|4|||
160789972|NCT03777020|580618501|FG001|Overall Study|Withdrawal by Subject|4|||
160789973|NCT03777020|580618500|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
160789974|NCT03777020|580618501|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
160789975|NCT00489476|580618502|FG000|Overall Study|Lost to Follow-up|0|||
160789976|NCT00489476|580618503|FG001|Overall Study|Lost to Follow-up|1|||
160789977|NCT00489476|580618504|FG002|Overall Study|Lost to Follow-up|0|||
160789978|NCT00489476|580618505|FG003|Overall Study|Lost to Follow-up|0|||
160789979|NCT03460704|580618506|FG000|Overall Study|Withdrawal by Subject|11|||
160789980|NCT03460704|580618507|FG001|Overall Study|Withdrawal by Subject|14|||
160789981|NCT03460704|580618506|FG000|Overall Study|Study terminated by the Sponsor|29|||
160789982|NCT03460704|580618507|FG001|Overall Study|Study terminated by the Sponsor|19|||
160789983|NCT03460704|580618506|FG000|Overall Study|Adverse Event|10|||
160789984|NCT03460704|580618507|FG001|Overall Study|Adverse Event|5|||
160789985|NCT03460704|580618506|FG000|Overall Study|Death|3|||
160789986|NCT03460704|580618507|FG001|Overall Study|Death|2|||
160789987|NCT03460704|580618506|FG000|Overall Study|Non-Compliance with Study Drug|3|||
160789988|NCT03460704|580618507|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160789989|NCT03460704|580618506|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160789990|NCT03460704|580618507|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
160789991|NCT03460704|580618506|FG000|Overall Study|Other|2|||
160789992|NCT03460704|580618507|FG001|Overall Study|Other|1|||
160789993|NCT02913326|580618508|FG000|Overall Study|Reason not listed|0|||
160789994|NCT02913326|580618509|FG001|Overall Study|Reason not listed|1|||
160789995|NCT02913326|580618508|FG000|Overall Study|Lost to Follow-up|0|||
160789996|NCT02913326|580618509|FG001|Overall Study|Lost to Follow-up|1|||
160789997|NCT02913326|580618508|FG000|Overall Study|Adverse Event|1|||
160789998|NCT02913326|580618509|FG001|Overall Study|Adverse Event|0|||
160789999|NCT01767857|580618510|FG000|Overall Study|Adverse Event|27|||
160790000|NCT01767857|580618511|FG001|Overall Study|Adverse Event|7|||
160790001|NCT01767857|580618510|FG000|Overall Study|Death|28|||
160790002|NCT01767857|580618511|FG001|Overall Study|Death|13|||
160790003|NCT01767857|580618510|FG000|Overall Study|Lack of Efficacy|299|||
160790004|NCT01767857|580618511|FG001|Overall Study|Lack of Efficacy|151|||
160790005|NCT01767857|580618510|FG000|Overall Study|Lost to Follow-up|1|||
160790006|NCT01767857|580618511|FG001|Overall Study|Lost to Follow-up|1|||
160790007|NCT01767857|580618510|FG000|Overall Study|Withdrawal by Subject|38|||
160790008|NCT01767857|580618511|FG001|Overall Study|Withdrawal by Subject|18|||
160790009|NCT01767857|580618510|FG000|Overall Study|Physician Decision|17|||
160790010|NCT01767857|580618511|FG001|Overall Study|Physician Decision|10|||
160790011|NCT01767857|580618510|FG000|Overall Study|Protocol Terminated|1|||
160790012|NCT01767857|580618511|FG001|Overall Study|Protocol Terminated|0|||
160790013|NCT01767857|580618510|FG000|Overall Study|Randomized But Never Treated|19|||
160790014|NCT01767857|580618511|FG001|Overall Study|Randomized But Never Treated|13|||
160790015|NCT01421459|580618512|FG000|Overall Study|Adverse Event|6|||
160790016|NCT01421459|580618513|FG001|Overall Study|Adverse Event|10|||
160790017|NCT01421459|580618512|FG000|Overall Study|Death|1|||
160790018|NCT01421459|580618513|FG001|Overall Study|Death|1|||
160790019|NCT01421459|580618512|FG000|Overall Study|Lack of Efficacy|1|||
160790020|NCT01421459|580618513|FG001|Overall Study|Lack of Efficacy|2|||
160790021|NCT01421459|580618512|FG000|Overall Study|Lost to Follow-up|8|||
160790022|NCT01421459|580618513|FG001|Overall Study|Lost to Follow-up|9|||
160790023|NCT01421459|580618512|FG000|Overall Study|Physician Decision|9|||
160790024|NCT01421459|580618513|FG001|Overall Study|Physician Decision|9|||
160790025|NCT01421459|580618512|FG000|Overall Study|Protocol Violation|8|||
160790026|NCT01421459|580618513|FG001|Overall Study|Protocol Violation|5|||
160790027|NCT01421459|580618512|FG000|Overall Study|Withdrawal by Subject|12|||
160790028|NCT01421459|580618513|FG001|Overall Study|Withdrawal by Subject|16|||
160790029|NCT01422382|580618514|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
160790030|NCT00967499|580618517|FG000|Overall Study|Adverse Event|0|||
160790031|NCT00967499|580618518|FG001|Overall Study|Adverse Event|1|||
160790032|NCT00967499|580618517|FG000|Overall Study|Protocol Violation|1|||
160790033|NCT00967499|580618518|FG001|Overall Study|Protocol Violation|0|||
160790034|NCT00967499|580618517|FG000|Overall Study|Sponsor Decision|1|||
160790035|NCT00967499|580618518|FG001|Overall Study|Sponsor Decision|0|||
160790036|NCT00967499|580618517|FG000|Overall Study|Randomized but not treated|63|||
160790037|NCT00967499|580618518|FG001|Overall Study|Randomized but not treated|59|||
160790038|NCT04003389|580618519|FG000|Overall Study|Adverse Event|27|||
160790039|NCT04003389|580618520|FG001|Overall Study|Adverse Event|34|||
160790040|NCT04003389|580618521|FG002|Overall Study|Adverse Event|28|||
160790041|NCT04003389|580618519|FG000|Overall Study|Lost to Follow-up|39|||
160790042|NCT04003389|580618520|FG001|Overall Study|Lost to Follow-up|30|||
160790043|NCT04003389|580618521|FG002|Overall Study|Lost to Follow-up|33|||
160790044|NCT04003389|580618519|FG000|Overall Study|Protocol Violation|1|||
160790045|NCT04003389|580618520|FG001|Overall Study|Protocol Violation|6|||
160790046|NCT04003389|580618521|FG002|Overall Study|Protocol Violation|5|||
160790047|NCT04003389|580618519|FG000|Overall Study|Withdrawal by Subject|119|||
160790048|NCT04003389|580618520|FG001|Overall Study|Withdrawal by Subject|79|||
160790049|NCT04003389|580618521|FG002|Overall Study|Withdrawal by Subject|85|||
160790050|NCT04003389|580618519|FG000|Overall Study|Miscellaneous|14|||
160790051|NCT04003389|580618520|FG001|Overall Study|Miscellaneous|11|||
160790052|NCT04003389|580618521|FG002|Overall Study|Miscellaneous|14|||
160790053|NCT04003389|580618519|FG000|Overall Study|Participant did not receive study drug|1|||
160790054|NCT04003389|580618520|FG001|Overall Study|Participant did not receive study drug|0|||
160790055|NCT04003389|580618521|FG002|Overall Study|Participant did not receive study drug|0|||
160790056|NCT02899754|580618522|FG000|Overall Study|Lost to Follow-up|7|||
160790057|NCT02899754|580618523|FG001|Overall Study|Lost to Follow-up|9|||
160790058|NCT04818229|580618524|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
160790059|NCT04818229|580618525|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
160790060|NCT04818229|580618526|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
160790061|NCT04818229|580618524|FG000|Overall Study|Adverse Event|3|||
160790062|NCT04818229|580618525|FG001|Overall Study|Adverse Event|1|||
160790063|NCT04818229|580618526|FG002|Overall Study|Adverse Event|1|||
160790064|NCT04818229|580618524|FG000|Overall Study|Withdrawal by Subject|0|||
160790065|NCT04818229|580618525|FG001|Overall Study|Withdrawal by Subject|0|||
160790066|NCT04818229|580618526|FG002|Overall Study|Withdrawal by Subject|2|||
160790067|NCT04818229|580618524|FG000|Overall Study|Lost to Follow-up|0|||
160790068|NCT04818229|580618525|FG001|Overall Study|Lost to Follow-up|0|||
160790069|NCT04818229|580618526|FG002|Overall Study|Lost to Follow-up|1|||
160790070|NCT04082364|580618527|FG000|Overall Study|Death|23|||
160790071|NCT04082364|580618528|FG001|Overall Study|Death|1|||
160790072|NCT04082364|580618529|FG002|Overall Study|Death|1|||
160790073|NCT04082364|580618530|FG003|Overall Study|Death|2|||
160790074|NCT04082364|580618531|FG004|Overall Study|Death|1|||
160790075|NCT04082364|580618527|FG000|Overall Study|Lost to Follow-up|1|||
160790076|NCT04082364|580618528|FG001|Overall Study|Lost to Follow-up|0|||
160790077|NCT04082364|580618529|FG002|Overall Study|Lost to Follow-up|0|||
160790078|NCT04082364|580618530|FG003|Overall Study|Lost to Follow-up|0|||
160790079|NCT04082364|580618531|FG004|Overall Study|Lost to Follow-up|1|||
160790080|NCT04082364|580618527|FG000|Overall Study|Physician Decision|1|||
160790081|NCT04082364|580618528|FG001|Overall Study|Physician Decision|1|||
160790082|NCT04082364|580618529|FG002|Overall Study|Physician Decision|0|||
160790083|NCT04082364|580618530|FG003|Overall Study|Physician Decision|2|||
160790084|NCT04082364|580618531|FG004|Overall Study|Physician Decision|1|||
160790085|NCT04082364|580618527|FG000|Overall Study|Withdrawal by Subject|1|||
160790086|NCT04082364|580618528|FG001|Overall Study|Withdrawal by Subject|1|||
160790087|NCT04082364|580618529|FG002|Overall Study|Withdrawal by Subject|0|||
160790088|NCT04082364|580618530|FG003|Overall Study|Withdrawal by Subject|0|||
160790089|NCT04082364|580618531|FG004|Overall Study|Withdrawal by Subject|1|||
160790090|NCT04082364|580618527|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
160790091|NCT04082364|580618528|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
160790092|NCT04082364|580618529|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
160790093|NCT04082364|580618530|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
160790094|NCT04082364|580618531|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
160790095|NCT04082364|580618527|FG000|Overall Study|Disease progression|0|||
160790096|NCT04082364|580618528|FG001|Overall Study|Disease progression|0|||
160790097|NCT04082364|580618529|FG002|Overall Study|Disease progression|0|||
160790098|NCT04082364|580618530|FG003|Overall Study|Disease progression|1|||
160790099|NCT04082364|580618531|FG004|Overall Study|Disease progression|0|||
160790100|NCT03186378|580618534|FG000|Overall Study|Lost to Follow-up|1|||
160790101|NCT03186378|580618535|FG001|Overall Study|Lost to Follow-up|0|||
160790102|NCT03769116|580618538|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
160790103|NCT03769116|580618539|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
160790104|NCT03769116|580618538|FG000|Part 3 - Open Label|Physician Decision|1|||
160790105|NCT03769116|580618539|FG001|Part 3 - Open Label|Physician Decision|0|||
160790106|NCT03769116|580618538|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
160790107|NCT03769116|580618539|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
160790108|NCT02514746|580618541|FG000|Overall Study|Chronically Ill|1|||
160790109|NCT02514746|580618542|FG001|Overall Study|Chronically Ill|2|||
160790110|NCT02514746|580618541|FG000|Overall Study|Physician Decision|4|||
160892050|NCT03497676|581000496|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
160790111|NCT02514746|580618542|FG001|Overall Study|Physician Decision|2|||
160790112|NCT02514746|580618541|FG000|Overall Study|Withdrawal by Subject|12|||
160790113|NCT02514746|580618542|FG001|Overall Study|Withdrawal by Subject|10|||
160790114|NCT02514746|580618541|FG000|Overall Study|Other|5|||
160790115|NCT02514746|580618542|FG001|Overall Study|Other|1|||
160790116|NCT03382873|580618547|FG000|Overall Study|Lost to Follow-up|9|||
160790117|NCT03382873|580618548|FG001|Overall Study|Lost to Follow-up|10|||
160790118|NCT03382873|580618547|FG000|Overall Study|Withdrawal by Subject|6|||
160892051|NCT03497676|581000497|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
160790119|NCT03382873|580618548|FG001|Overall Study|Withdrawal by Subject|11|||
160790120|NCT03382873|580618547|FG000|Overall Study|Visit not completed due to pandemic|16|||
160790121|NCT03382873|580618548|FG001|Overall Study|Visit not completed due to pandemic|41|||
160790122|NCT03247673|580618549|FG000|Overall Study|Withdrawal by Subject|1|||
160790123|NCT03247673|580618550|FG001|Overall Study|Withdrawal by Subject|0|||
160790124|NCT03247673|580618551|FG002|Overall Study|Withdrawal by Subject|3|||
160790125|NCT03247673|580618549|FG000|Overall Study|Lost to Follow-up|0|||
160790126|NCT03247673|580618550|FG001|Overall Study|Lost to Follow-up|0|||
160790127|NCT03247673|580618551|FG002|Overall Study|Lost to Follow-up|1|||
160790128|NCT04755231|580618554|FG000|Overall Study|Lost to Follow-up|5|||
160790129|NCT04755231|580618554|FG000|Overall Study|Withdrawal by Subject|5|||
160790130|NCT04754399|580618555|FG000|Overall Study|Adverse Event|5|||
160790131|NCT04754399|580618555|FG000|Overall Study|Withdrawal by Subject|6|||
160790132|NCT00962650|580618556|FG000|Overall Study|Transgastric DP was not completed|2|||
160790133|NCT00231465|580618557|FG000|Overall Study|Completed only one cycle|1|||
160790134|NCT00231465|580618557|FG000|Overall Study|Did not have follow up CT scans|1|||
160790135|NCT00420056|580618558|FG000|Overall Study|Objective progression or relapse|17|||
160790136|NCT03624036|580618561|FG000|Overall Study|Death|2|||
160790137|NCT03624036|580618562|FG001|Overall Study|Death|3|||
160790138|NCT03624036|580618563|FG002|Overall Study|Death|0|||
160790139|NCT03624036|580618564|FG003|Overall Study|Death|1|||
160790140|NCT03624036|580618561|FG000|Overall Study|Withdrawal by Subject|1|||
160790141|NCT03624036|580618562|FG001|Overall Study|Withdrawal by Subject|0|||
160790142|NCT03624036|580618563|FG002|Overall Study|Withdrawal by Subject|1|||
160790143|NCT03624036|580618564|FG003|Overall Study|Withdrawal by Subject|0|||
160790144|NCT03624036|580618561|FG000|Overall Study|Enrolled but Never Treated|1|||
160790145|NCT03624036|580618562|FG001|Overall Study|Enrolled but Never Treated|0|||
160790146|NCT03624036|580618563|FG002|Overall Study|Enrolled but Never Treated|0|||
160790147|NCT03624036|580618564|FG003|Overall Study|Enrolled but Never Treated|0|||
160790148|NCT03624036|580618561|FG000|Overall Study|Reason not Specified|3|||
160790149|NCT03624036|580618562|FG001|Overall Study|Reason not Specified|0|||
160790150|NCT03624036|580618563|FG002|Overall Study|Reason not Specified|2|||
160790151|NCT03624036|580618564|FG003|Overall Study|Reason not Specified|2|||
160790152|NCT02268851|580618572|FG000|Overall Study|Death|0|||
160790153|NCT02268851|580618573|FG001|Overall Study|Death|0|||
160790154|NCT02268851|580618574|FG002|Overall Study|Death|0|||
160790155|NCT02268851|580618575|FG003|Overall Study|Death|1|||
160790156|NCT02268851|580618576|FG004|Overall Study|Death|2|||
160790157|NCT02268851|580618577|FG005|Overall Study|Death|1|||
160790158|NCT02268851|580618572|FG000|Overall Study|Adverse Event|0|||
160790159|NCT02268851|580618573|FG001|Overall Study|Adverse Event|0|||
160790160|NCT02268851|580618574|FG002|Overall Study|Adverse Event|0|||
160790161|NCT02268851|580618575|FG003|Overall Study|Adverse Event|0|||
160790162|NCT02268851|580618576|FG004|Overall Study|Adverse Event|2|||
160790163|NCT02268851|580618577|FG005|Overall Study|Adverse Event|2|||
160790164|NCT02268851|580618572|FG000|Overall Study|Withdrawal by Subject|0|||
160790165|NCT02268851|580618573|FG001|Overall Study|Withdrawal by Subject|0|||
160790166|NCT02268851|580618574|FG002|Overall Study|Withdrawal by Subject|0|||
160790167|NCT02268851|580618575|FG003|Overall Study|Withdrawal by Subject|2|||
160790168|NCT02268851|580618576|FG004|Overall Study|Withdrawal by Subject|0|||
160790169|NCT02268851|580618577|FG005|Overall Study|Withdrawal by Subject|1|||
160790170|NCT02268851|580618572|FG000|Overall Study|Progressive Disease|1|||
160790171|NCT02268851|580618573|FG001|Overall Study|Progressive Disease|3|||
160790172|NCT02268851|580618574|FG002|Overall Study|Progressive Disease|0|||
160790173|NCT02268851|580618575|FG003|Overall Study|Progressive Disease|0|||
160790174|NCT02268851|580618576|FG004|Overall Study|Progressive Disease|1|||
160790175|NCT02268851|580618577|FG005|Overall Study|Progressive Disease|4|||
160790176|NCT02268851|580618572|FG000|Overall Study|Physician Decision|0|||
160790177|NCT02268851|580618573|FG001|Overall Study|Physician Decision|0|||
160790178|NCT02268851|580618574|FG002|Overall Study|Physician Decision|1|||
160790179|NCT02268851|580618575|FG003|Overall Study|Physician Decision|0|||
160790180|NCT02268851|580618576|FG004|Overall Study|Physician Decision|0|||
160790181|NCT02268851|580618577|FG005|Overall Study|Physician Decision|1|||
160790182|NCT02268851|580618572|FG000|Overall Study|Patient Compliance|0|||
160790183|NCT02268851|580618573|FG001|Overall Study|Patient Compliance|0|||
160790184|NCT02268851|580618574|FG002|Overall Study|Patient Compliance|0|||
160790185|NCT02268851|580618575|FG003|Overall Study|Patient Compliance|0|||
160790186|NCT02268851|580618576|FG004|Overall Study|Patient Compliance|1|||
160790187|NCT02268851|580618577|FG005|Overall Study|Patient Compliance|1|||
160790188|NCT02268851|580618572|FG000|Overall Study|Co-Morbid Condition|0|||
160790189|NCT02268851|580618573|FG001|Overall Study|Co-Morbid Condition|0|||
160790190|NCT02268851|580618574|FG002|Overall Study|Co-Morbid Condition|0|||
160790191|NCT02268851|580618575|FG003|Overall Study|Co-Morbid Condition|0|||
160790192|NCT02268851|580618576|FG004|Overall Study|Co-Morbid Condition|1|||
160790193|NCT02268851|580618577|FG005|Overall Study|Co-Morbid Condition|1|||
160790194|NCT03425188|580618579|FG000|Overall Study|Withdrawal by Subject|1|||
160790195|NCT03726879|580618580|FG000|Overall Study|Death|11|||
160790196|NCT03726879|580618581|FG001|Overall Study|Death|13|||
160790197|NCT03726879|580618580|FG000|Overall Study|Physician Decision|0|||
160790198|NCT03726879|580618581|FG001|Overall Study|Physician Decision|2|||
160790199|NCT03726879|580618580|FG000|Overall Study|Protocol Violation|0|||
160790200|NCT03726879|580618581|FG001|Overall Study|Protocol Violation|1|||
160790201|NCT03726879|580618580|FG000|Overall Study|Withdrawal by Subject|5|||
160790202|NCT03726879|580618581|FG001|Overall Study|Withdrawal by Subject|6|||
160790203|NCT03726879|580618580|FG000|Overall Study|TSH result is unstable|0|||
160790204|NCT03726879|580618581|FG001|Overall Study|TSH result is unstable|1|||
160790205|NCT03726879|580618580|FG000|Overall Study|Disease relapse|1|||
160790206|NCT03726879|580618581|FG001|Overall Study|Disease relapse|0|||
160790207|NCT03726879|580618580|FG000|Overall Study|Lost to Follow-up|3|||
160790208|NCT03726879|580618581|FG001|Overall Study|Lost to Follow-up|0|||
160642442|NCT01078623|580074294|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160642443|NCT01078623|580074295|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160642444|NCT01078623|580074296|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160790209|NCT00507507|580618583|FG000|Treatment Period|Lost to Follow-up|0|||
160790210|NCT00507507|580618584|FG001|Treatment Period|Lost to Follow-up|2|||
160790211|NCT00507507|580618583|FG000|Treatment Period|Physician Decision|4|||
160790212|NCT00507507|580618584|FG001|Treatment Period|Physician Decision|1|||
160790213|NCT00507507|580618583|FG000|Treatment Period|Protocol Violation|1|||
160790214|NCT00507507|580618584|FG001|Treatment Period|Protocol Violation|2|||
160790215|NCT00507507|580618583|FG000|Treatment Period|Adverse Event|1|||
160790216|NCT00507507|580618584|FG001|Treatment Period|Adverse Event|1|||
160790217|NCT00507507|580618583|FG000|Treatment Period|Withdrawal by Subject|46|||
160790218|NCT00507507|580618584|FG001|Treatment Period|Withdrawal by Subject|47|||
160790219|NCT00507507|580618583|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
160790220|NCT00507507|580618584|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
160790221|NCT00507507|580618583|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
160790222|NCT00507507|580618584|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
160790223|NCT00507507|580618583|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
160790224|NCT00507507|580618584|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
160790225|NCT03249558|580618587|FG000|Overall Study|Lost to Follow-up|2|||
160790226|NCT03249558|580618588|FG001|Overall Study|Lost to Follow-up|1|||
160790227|NCT03249558|580618589|FG002|Overall Study|Lost to Follow-up|4|||
160790228|NCT03249558|580618587|FG000|Overall Study|Physician Decision|1|||
160790229|NCT03249558|580618588|FG001|Overall Study|Physician Decision|0|||
160790230|NCT03249558|580618589|FG002|Overall Study|Physician Decision|0|||
160790231|NCT03249558|580618587|FG000|Overall Study|Withdrawal by Subject|6|||
160790232|NCT03249558|580618588|FG001|Overall Study|Withdrawal by Subject|5|||
160790233|NCT03249558|580618589|FG002|Overall Study|Withdrawal by Subject|7|||
160790234|NCT03249558|580618587|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
160790235|NCT03249558|580618588|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
160790236|NCT03249558|580618589|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
160790237|NCT03249558|580618587|FG000|Overall Study|Protocol Violation|1|||
160790238|NCT03249558|580618588|FG001|Overall Study|Protocol Violation|1|||
160790239|NCT03249558|580618589|FG002|Overall Study|Protocol Violation|2|||
160790240|NCT00834587|580618590|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
160790241|NCT00834587|580618591|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
160790242|NCT02536339|580618593|FG000|Overall Study|Death|20|||
160790243|NCT02536339|580618593|FG000|Overall Study|Withdrawal by Subject|3|||
160790244|NCT02536339|580618593|FG000|Overall Study|Lost to Follow-up|2|||
160790245|NCT02536339|580618593|FG000|Overall Study|Treatment discontinued|2|||
160892052|NCT03497676|581000498|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
160892053|NCT03497676|581000499|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
160892054|NCT03497676|581000496|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
160892055|NCT03497676|581000497|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
160892056|NCT03497676|581000498|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
160892057|NCT03497676|581000499|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
160892058|NCT03497676|581000496|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
160892059|NCT03497676|581000497|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
160892060|NCT03497676|581000498|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
160892061|NCT03497676|581000499|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
160892062|NCT03497676|581000496|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
160790246|NCT02536339|580618593|FG000|Overall Study|Physician Decision|1|||
160790247|NCT00581100|580620023|FG000|Overall Study|Death|1|||
160790248|NCT00581100|580620024|FG001|Overall Study|Death|0|||
160790249|NCT00581100|580620023|FG000|Overall Study|Adverse Event|2|||
160790250|NCT00581100|580620024|FG001|Overall Study|Adverse Event|1|||
160790251|NCT00581100|580620023|FG000|Overall Study|Withdrawal by Subject|1|||
160790252|NCT00581100|580620024|FG001|Overall Study|Withdrawal by Subject|4|||
160790253|NCT00581100|580620023|FG000|Overall Study|Other|3|||
160790254|NCT00581100|580620024|FG001|Overall Study|Other|0|||
160790255|NCT04129398|580620025|FG000|Overall Study|Physician Decision|2|||
160790256|NCT00590317|580620026|FG000|Overall Study|Lack of Efficacy|1|||
160642445|NCT01078623|580074297|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160790257|NCT00590317|580620027|FG001|Overall Study|Lack of Efficacy|5|||
160892063|NCT03497676|581000497|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
160892064|NCT03497676|581000498|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
160892065|NCT03497676|581000499|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
160892066|NCT03497676|581000496|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
160892067|NCT03497676|581000497|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
160892068|NCT03497676|581000498|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
160642446|NCT01078623|580074298|FG006|Treatment Period 1|Withdrawal by Subject|0|||
160642447|NCT01078623|580074299|FG007|Treatment Period 1|Withdrawal by Subject|1|||
160642448|NCT01078623|580074300|FG008|Treatment Period 1|Withdrawal by Subject|0|||
160642449|NCT01078623|580074301|FG009|Treatment Period 1|Withdrawal by Subject|0|||
160642450|NCT01078623|580074302|FG010|Treatment Period 1|Withdrawal by Subject|1|||
160642451|NCT01078623|580074303|FG011|Treatment Period 1|Withdrawal by Subject|0|||
160642452|NCT01078623|580074304|FG012|Treatment Period 1|Withdrawal by Subject|0|||
160642453|NCT01078623|580074305|FG013|Treatment Period 1|Withdrawal by Subject|0|||
160642454|NCT01078623|580074306|FG014|Treatment Period 1|Withdrawal by Subject|0|||
160642455|NCT01078623|580074307|FG015|Treatment Period 1|Withdrawal by Subject|0|||
160642456|NCT01078623|580074308|FG016|Treatment Period 1|Withdrawal by Subject|0|||
160642457|NCT01078623|580074309|FG017|Treatment Period 1|Withdrawal by Subject|0|||
160642458|NCT01078623|580074310|FG018|Treatment Period 1|Withdrawal by Subject|0|||
160642459|NCT01078623|580074311|FG019|Treatment Period 1|Withdrawal by Subject|0|||
160642460|NCT01078623|580074292|FG000|Treatment Period 1|Protocol Violation|0|||
160642461|NCT01078623|580074293|FG001|Treatment Period 1|Protocol Violation|0|||
160642462|NCT01078623|580074294|FG002|Treatment Period 1|Protocol Violation|0|||
160642463|NCT01078623|580074295|FG003|Treatment Period 1|Protocol Violation|0|||
160642464|NCT01078623|580074296|FG004|Treatment Period 1|Protocol Violation|0|||
160642465|NCT01078623|580074297|FG005|Treatment Period 1|Protocol Violation|1|||
160642466|NCT01078623|580074298|FG006|Treatment Period 1|Protocol Violation|0|||
160642467|NCT01078623|580074299|FG007|Treatment Period 1|Protocol Violation|0|||
160642468|NCT01078623|580074300|FG008|Treatment Period 1|Protocol Violation|0|||
160642469|NCT01078623|580074301|FG009|Treatment Period 1|Protocol Violation|0|||
160642470|NCT01078623|580074302|FG010|Treatment Period 1|Protocol Violation|0|||
160642471|NCT01078623|580074303|FG011|Treatment Period 1|Protocol Violation|0|||
160642472|NCT01078623|580074304|FG012|Treatment Period 1|Protocol Violation|0|||
160642473|NCT01078623|580074305|FG013|Treatment Period 1|Protocol Violation|0|||
160642474|NCT01078623|580074306|FG014|Treatment Period 1|Protocol Violation|0|||
160642475|NCT01078623|580074307|FG015|Treatment Period 1|Protocol Violation|0|||
160642476|NCT01078623|580074308|FG016|Treatment Period 1|Protocol Violation|0|||
160642477|NCT01078623|580074309|FG017|Treatment Period 1|Protocol Violation|0|||
160642478|NCT01078623|580074310|FG018|Treatment Period 1|Protocol Violation|0|||
160642479|NCT01078623|580074311|FG019|Treatment Period 1|Protocol Violation|0|||
160642480|NCT01078623|580074292|FG000|Treatment Period 2|Adverse Event|0|||
160642481|NCT01078623|580074293|FG001|Treatment Period 2|Adverse Event|0|||
160642482|NCT01078623|580074294|FG002|Treatment Period 2|Adverse Event|0|||
160642483|NCT01078623|580074295|FG003|Treatment Period 2|Adverse Event|0|||
160642484|NCT01078623|580074296|FG004|Treatment Period 2|Adverse Event|0|||
160642485|NCT01078623|580074297|FG005|Treatment Period 2|Adverse Event|0|||
160642486|NCT01078623|580074298|FG006|Treatment Period 2|Adverse Event|1|||
160642487|NCT01078623|580074299|FG007|Treatment Period 2|Adverse Event|0|||
160642488|NCT01078623|580074300|FG008|Treatment Period 2|Adverse Event|0|||
160642489|NCT01078623|580074301|FG009|Treatment Period 2|Adverse Event|0|||
160642490|NCT01078623|580074302|FG010|Treatment Period 2|Adverse Event|0|||
160642491|NCT01078623|580074303|FG011|Treatment Period 2|Adverse Event|0|||
160642492|NCT01078623|580074304|FG012|Treatment Period 2|Adverse Event|0|||
160642493|NCT01078623|580074305|FG013|Treatment Period 2|Adverse Event|0|||
160642494|NCT01078623|580074306|FG014|Treatment Period 2|Adverse Event|0|||
160642495|NCT01078623|580074307|FG015|Treatment Period 2|Adverse Event|0|||
160642496|NCT01078623|580074308|FG016|Treatment Period 2|Adverse Event|0|||
160642497|NCT01078623|580074309|FG017|Treatment Period 2|Adverse Event|0|||
160642498|NCT01078623|580074310|FG018|Treatment Period 2|Adverse Event|1|||
160642499|NCT01078623|580074311|FG019|Treatment Period 2|Adverse Event|0|||
160642500|NCT01078623|580074292|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160642501|NCT01078623|580074293|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160642502|NCT01078623|580074294|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160642503|NCT01078623|580074295|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160642504|NCT01078623|580074296|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160642505|NCT01078623|580074297|FG005|Treatment Period 2|Withdrawal by Subject|1|||
160642506|NCT01078623|580074298|FG006|Treatment Period 2|Withdrawal by Subject|0|||
160642507|NCT01078623|580074299|FG007|Treatment Period 2|Withdrawal by Subject|0|||
160642508|NCT01078623|580074300|FG008|Treatment Period 2|Withdrawal by Subject|0|||
160642509|NCT01078623|580074301|FG009|Treatment Period 2|Withdrawal by Subject|0|||
160642510|NCT01078623|580074302|FG010|Treatment Period 2|Withdrawal by Subject|0|||
160642511|NCT01078623|580074303|FG011|Treatment Period 2|Withdrawal by Subject|0|||
160642512|NCT01078623|580074304|FG012|Treatment Period 2|Withdrawal by Subject|0|||
160642513|NCT01078623|580074305|FG013|Treatment Period 2|Withdrawal by Subject|0|||
160642514|NCT01078623|580074306|FG014|Treatment Period 2|Withdrawal by Subject|0|||
160892069|NCT03497676|581000499|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
160892070|NCT03497676|581000496|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
160892071|NCT03497676|581000497|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
160892072|NCT03497676|581000498|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
160892073|NCT03497676|581000499|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
160892074|NCT01977937|581000500|FG000|Overall Study|Withdrawal by Subject|2|||
160892075|NCT01977937|581000501|FG001|Overall Study|Withdrawal by Subject|1|||
160892076|NCT01977937|581000500|FG000|Overall Study|Adverse Event|1|||
160892077|NCT01977937|581000501|FG001|Overall Study|Adverse Event|0|||
160892078|NCT01977937|581000500|FG000|Overall Study|Physician Decision|0|||
160892079|NCT01977937|581000501|FG001|Overall Study|Physician Decision|1|||
160642515|NCT01078623|580074307|FG015|Treatment Period 2|Withdrawal by Subject|0|||
160642516|NCT01078623|580074308|FG016|Treatment Period 2|Withdrawal by Subject|0|||
160642517|NCT01078623|580074309|FG017|Treatment Period 2|Withdrawal by Subject|0|||
160642518|NCT01078623|580074310|FG018|Treatment Period 2|Withdrawal by Subject|0|||
160642519|NCT01078623|580074311|FG019|Treatment Period 2|Withdrawal by Subject|0|||
160642520|NCT01078623|580074292|FG000|Treatment Period 3|Adverse Event|0|||
160642521|NCT01078623|580074293|FG001|Treatment Period 3|Adverse Event|0|||
160642522|NCT01078623|580074294|FG002|Treatment Period 3|Adverse Event|0|||
160642523|NCT01078623|580074295|FG003|Treatment Period 3|Adverse Event|0|||
160642524|NCT01078623|580074296|FG004|Treatment Period 3|Adverse Event|1|||
160642525|NCT01078623|580074297|FG005|Treatment Period 3|Adverse Event|0|||
160642526|NCT01078623|580074298|FG006|Treatment Period 3|Adverse Event|0|||
160642527|NCT01078623|580074299|FG007|Treatment Period 3|Adverse Event|0|||
160642528|NCT01078623|580074300|FG008|Treatment Period 3|Adverse Event|0|||
160642529|NCT01078623|580074301|FG009|Treatment Period 3|Adverse Event|0|||
160642530|NCT01078623|580074302|FG010|Treatment Period 3|Adverse Event|0|||
160642531|NCT01078623|580074303|FG011|Treatment Period 3|Adverse Event|0|||
160642532|NCT01078623|580074304|FG012|Treatment Period 3|Adverse Event|0|||
160642533|NCT01078623|580074305|FG013|Treatment Period 3|Adverse Event|1|||
160642534|NCT01078623|580074306|FG014|Treatment Period 3|Adverse Event|0|||
160642535|NCT01078623|580074307|FG015|Treatment Period 3|Adverse Event|0|||
160642536|NCT01078623|580074308|FG016|Treatment Period 3|Adverse Event|0|||
160892080|NCT03194490|581000508|FG000|Overall Study|Lost to Follow-up|1|||
160892081|NCT03194490|581000509|FG001|Overall Study|Lost to Follow-up|3|||
160892082|NCT03194490|581000508|FG000|Overall Study|participant developed specific neck pain|1|||
160892083|NCT03194490|581000509|FG001|Overall Study|participant developed specific neck pain|0|||
160642537|NCT01078623|580074309|FG017|Treatment Period 3|Adverse Event|0|||
160642538|NCT01078623|580074310|FG018|Treatment Period 3|Adverse Event|0|||
160642539|NCT01078623|580074311|FG019|Treatment Period 3|Adverse Event|0|||
160642540|NCT01078623|580074292|FG000|Treatment Period 4|Adverse Event|0|||
160642541|NCT01078623|580074293|FG001|Treatment Period 4|Adverse Event|0|||
160642542|NCT01078623|580074294|FG002|Treatment Period 4|Adverse Event|1|||
160642543|NCT01078623|580074295|FG003|Treatment Period 4|Adverse Event|0|||
160642544|NCT01078623|580074296|FG004|Treatment Period 4|Adverse Event|0|||
160642545|NCT01078623|580074297|FG005|Treatment Period 4|Adverse Event|0|||
160642546|NCT01078623|580074298|FG006|Treatment Period 4|Adverse Event|0|||
160642547|NCT01078623|580074299|FG007|Treatment Period 4|Adverse Event|0|||
160642548|NCT01078623|580074300|FG008|Treatment Period 4|Adverse Event|0|||
160642549|NCT01078623|580074301|FG009|Treatment Period 4|Adverse Event|0|||
160642550|NCT01078623|580074302|FG010|Treatment Period 4|Adverse Event|0|||
160642551|NCT01078623|580074303|FG011|Treatment Period 4|Adverse Event|0|||
160642552|NCT01078623|580074304|FG012|Treatment Period 4|Adverse Event|0|||
160642553|NCT01078623|580074305|FG013|Treatment Period 4|Adverse Event|0|||
160642554|NCT01078623|580074306|FG014|Treatment Period 4|Adverse Event|0|||
160642555|NCT01078623|580074307|FG015|Treatment Period 4|Adverse Event|0|||
160642556|NCT01078623|580074308|FG016|Treatment Period 4|Adverse Event|0|||
160642557|NCT01078623|580074309|FG017|Treatment Period 4|Adverse Event|0|||
160642558|NCT01078623|580074310|FG018|Treatment Period 4|Adverse Event|0|||
160642559|NCT01078623|580074311|FG019|Treatment Period 4|Adverse Event|0|||
160642560|NCT01078623|580074292|FG000|Treatment Period 4|Withdrawal by Subject|0|||
160642561|NCT01078623|580074293|FG001|Treatment Period 4|Withdrawal by Subject|0|||
160642562|NCT01078623|580074294|FG002|Treatment Period 4|Withdrawal by Subject|0|||
160642563|NCT01078623|580074295|FG003|Treatment Period 4|Withdrawal by Subject|0|||
160642564|NCT01078623|580074296|FG004|Treatment Period 4|Withdrawal by Subject|0|||
160642565|NCT01078623|580074297|FG005|Treatment Period 4|Withdrawal by Subject|0|||
160642566|NCT01078623|580074298|FG006|Treatment Period 4|Withdrawal by Subject|0|||
160642567|NCT01078623|580074299|FG007|Treatment Period 4|Withdrawal by Subject|0|||
160642568|NCT01078623|580074300|FG008|Treatment Period 4|Withdrawal by Subject|0|||
160642569|NCT01078623|580074301|FG009|Treatment Period 4|Withdrawal by Subject|0|||
160642570|NCT01078623|580074302|FG010|Treatment Period 4|Withdrawal by Subject|0|||
160642571|NCT01078623|580074303|FG011|Treatment Period 4|Withdrawal by Subject|0|||
160642572|NCT01078623|580074304|FG012|Treatment Period 4|Withdrawal by Subject|0|||
160642573|NCT01078623|580074305|FG013|Treatment Period 4|Withdrawal by Subject|0|||
160642574|NCT01078623|580074306|FG014|Treatment Period 4|Withdrawal by Subject|0|||
160642575|NCT01078623|580074307|FG015|Treatment Period 4|Withdrawal by Subject|1|||
160642576|NCT01078623|580074308|FG016|Treatment Period 4|Withdrawal by Subject|0|||
160642577|NCT01078623|580074309|FG017|Treatment Period 4|Withdrawal by Subject|0|||
160790258|NCT02904265|580620029|FG000|Overall Study|Physician Decision|1|||
160790259|NCT02904265|580620030|FG001|Overall Study|Physician Decision|2|||
160790260|NCT00185614|580620033|FG000|Inter-treatment Period|Physician Decision|1|||
160790261|NCT00185614|580620033|FG000|Inter-treatment Period|Relapse|2|||
160790262|NCT00185614|580620033|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
160790263|NCT01034657|580620044|FG000|Core Phase|Withdrawal by Subject|1|||
160642578|NCT01078623|580074310|FG018|Treatment Period 4|Withdrawal by Subject|0|||
160790264|NCT01034657|580620045|FG001|Core Phase|Withdrawal by Subject|0|||
160790265|NCT01034657|580620046|FG002|Core Phase|Withdrawal by Subject|0|||
160642579|NCT01078623|580074311|FG019|Treatment Period 4|Withdrawal by Subject|0|||
160642580|NCT00463866|580074312|FG000|Overall Study|Adverse Event|70|||
160642581|NCT00463866|580074313|FG001|Overall Study|Adverse Event|93|||
160642582|NCT00463866|580074312|FG000|Overall Study|Withdrawal by Subject|81|||
160642583|NCT00463866|580074313|FG001|Overall Study|Withdrawal by Subject|79|||
160642584|NCT00463866|580074312|FG000|Overall Study|Lost to Follow-up|46|||
160642585|NCT00463866|580074313|FG001|Overall Study|Lost to Follow-up|55|||
160642586|NCT00463866|580074312|FG000|Overall Study|Incorrect Enrolment|64|||
160642587|NCT00463866|580074313|FG001|Overall Study|Incorrect Enrolment|66|||
160642588|NCT00463866|580074312|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
160642589|NCT00463866|580074313|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
160642590|NCT00463866|580074312|FG000|Overall Study|Safety Reason|1|||
160790266|NCT01034657|580620044|FG000|Core Phase|Lack of Efficacy|2|||
160790267|NCT01034657|580620045|FG001|Core Phase|Lack of Efficacy|0|||
160790268|NCT01034657|580620046|FG002|Core Phase|Lack of Efficacy|0|||
160892084|NCT03911843|581000510|FG000|Overall Study|Adverse Event|2|||
160642591|NCT00463866|580074313|FG001|Overall Study|Safety Reason|3|||
160642592|NCT00463866|580074312|FG000|Overall Study|Mis-Randomization of subject|0|||
160642593|NCT00463866|580074313|FG001|Overall Study|Mis-Randomization of subject|1|||
160642594|NCT00463866|580074312|FG000|Overall Study|Other|22|||
160642595|NCT00463866|580074313|FG001|Overall Study|Other|22|||
160642596|NCT01084005|580074315|FG000|Overall Study|Adverse Event|1|||
160642597|NCT01084005|580074316|FG001|Overall Study|Adverse Event|8|||
160642598|NCT01084005|580074315|FG000|Overall Study|Protocol Violation|3|||
160642599|NCT01084005|580074316|FG001|Overall Study|Protocol Violation|7|||
160642600|NCT01084005|580074315|FG000|Overall Study|Withdrawal by Subject|1|||
160642601|NCT01084005|580074316|FG001|Overall Study|Withdrawal by Subject|1|||
160642602|NCT01759381|580074318|FG000|Overall Study|Death|1|||
160642603|NCT01759381|580074319|FG001|Overall Study|Death|0|||
160642604|NCT00827827|580074320|FG000|Overall Study|Lost to Follow-up|3|||
160642605|NCT00827827|580074321|FG001|Overall Study|Lost to Follow-up|0|||
160642606|NCT00827827|580074320|FG000|Overall Study|Fall at home- hospitalization|1|||
160642607|NCT00827827|580074321|FG001|Overall Study|Fall at home- hospitalization|0|||
160642608|NCT00827827|580074320|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
160892085|NCT03911843|581000511|FG001|Overall Study|Adverse Event|0|||
160892086|NCT03911843|581000510|FG000|Overall Study|Protocol Violation|2|||
160642609|NCT00827827|580074321|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
160642610|NCT00827827|580074320|FG000|Overall Study|Gout|1|||
160642611|NCT00827827|580074321|FG001|Overall Study|Gout|0|||
160790269|NCT01034657|580620044|FG000|Core Phase|Abnormal laboratory value|1|||
160790270|NCT01034657|580620045|FG001|Core Phase|Abnormal laboratory value|0|||
160790271|NCT01034657|580620046|FG002|Core Phase|Abnormal laboratory value|0|||
160790272|NCT01034657|580620044|FG000|Core Phase|Adverse Event|8|||
160892087|NCT03911843|581000511|FG001|Overall Study|Protocol Violation|0|||
160892088|NCT03911843|581000510|FG000|Overall Study|Lost to Follow-up|0|||
160892089|NCT03911843|581000511|FG001|Overall Study|Lost to Follow-up|1|||
160892090|NCT02819518|581000512|FG000|Overall Study|Death|9|||
160892091|NCT02819518|581000513|FG001|Overall Study|Death|12|||
160892092|NCT02819518|581000514|FG002|Overall Study|Death|9|||
160892093|NCT02819518|581000515|FG003|Overall Study|Death|475|||
160892094|NCT02819518|581000516|FG004|Overall Study|Death|244|||
160892095|NCT02819518|581000512|FG000|Overall Study|Withdrawal by Subject|0|||
160892096|NCT02819518|581000513|FG001|Overall Study|Withdrawal by Subject|0|||
160892097|NCT02819518|581000514|FG002|Overall Study|Withdrawal by Subject|0|||
160892098|NCT02819518|581000515|FG003|Overall Study|Withdrawal by Subject|25|||
160892099|NCT02819518|581000516|FG004|Overall Study|Withdrawal by Subject|8|||
160892100|NCT02819518|581000512|FG000|Overall Study|Lost to Follow-up|0|||
160892101|NCT02819518|581000513|FG001|Overall Study|Lost to Follow-up|0|||
160892102|NCT02819518|581000514|FG002|Overall Study|Lost to Follow-up|0|||
160892103|NCT02819518|581000515|FG003|Overall Study|Lost to Follow-up|0|||
160892104|NCT02819518|581000516|FG004|Overall Study|Lost to Follow-up|1|||
160642612|NCT00827827|580074320|FG000|Overall Study|Transportation issues|1|||
160642613|NCT00827827|580074321|FG001|Overall Study|Transportation issues|0|||
160642614|NCT00827827|580074320|FG000|Overall Study|Burned with water at home|1|||
160642615|NCT00827827|580074321|FG001|Overall Study|Burned with water at home|0|||
160642616|NCT01967888|580074322|FG000|Overall Study|Lost to Follow-up|6|||
160642617|NCT01967888|580074323|FG001|Overall Study|Lost to Follow-up|4|||
160642618|NCT01967888|580074322|FG000|Overall Study|Withdrawal by Subject|1|||
160790273|NCT01034657|580620045|FG001|Core Phase|Adverse Event|0|||
160892105|NCT02819518|581000512|FG000|Overall Study|Sponsor Decision|1|||
160790274|NCT01034657|580620046|FG002|Core Phase|Adverse Event|0|||
160790275|NCT01034657|580620044|FG000|Core Phase|Protocol Violation|2|||
160790276|NCT01034657|580620045|FG001|Core Phase|Protocol Violation|0|||
160790277|NCT01034657|580620046|FG002|Core Phase|Protocol Violation|0|||
160790278|NCT01034657|580620044|FG000|Randomized Phase|Withdrawal by Subject|0|||
160790279|NCT01034657|580620045|FG001|Randomized Phase|Withdrawal by Subject|2|||
160790280|NCT01034657|580620046|FG002|Randomized Phase|Withdrawal by Subject|0|||
160790281|NCT01034657|580620044|FG000|Randomized Phase|Lack of Efficacy|5|||
160790282|NCT01034657|580620045|FG001|Randomized Phase|Lack of Efficacy|1|||
160790283|NCT01034657|580620046|FG002|Randomized Phase|Lack of Efficacy|0|||
160790284|NCT01034657|580620044|FG000|Randomized Phase|Abnormal laboratory value|0|||
160790285|NCT01034657|580620045|FG001|Randomized Phase|Abnormal laboratory value|1|||
160642619|NCT01967888|580074323|FG001|Overall Study|Withdrawal by Subject|1|||
160642620|NCT01967888|580074322|FG000|Overall Study|Did Not Have Transplant|1|||
160642621|NCT01967888|580074323|FG001|Overall Study|Did Not Have Transplant|0|||
160642622|NCT01967888|580074322|FG000|Overall Study|Research visit not done, data recorded|1|||
160642623|NCT01967888|580074323|FG001|Overall Study|Research visit not done, data recorded|0|||
160642624|NCT01967888|580074322|FG000|Overall Study|Subject excluded after randomization|1|||
160642625|NCT01967888|580074323|FG001|Overall Study|Subject excluded after randomization|0|||
160790286|NCT01034657|580620046|FG002|Randomized Phase|Abnormal laboratory value|0|||
160790287|NCT01034657|580620044|FG000|Randomized Phase|Adverse Event|0|||
160790288|NCT01034657|580620045|FG001|Randomized Phase|Adverse Event|2|||
160790289|NCT01034657|580620046|FG002|Randomized Phase|Adverse Event|1|||
160790290|NCT01225952|580620048|FG000|Overall Study|Lost to Follow-up|1|||
160642626|NCT01967888|580074322|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
160642627|NCT01967888|580074323|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
160642628|NCT01967888|580074322|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
160642629|NCT01967888|580074323|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
160642630|NCT03175120|580074327|FG000|Overall Study|Adverse Event|2|||
160642631|NCT03175120|580074328|FG001|Overall Study|Adverse Event|2|||
160642632|NCT03175120|580074327|FG000|Overall Study|Protocol Violation|5|||
160642633|NCT03175120|580074328|FG001|Overall Study|Protocol Violation|2|||
160642634|NCT03175120|580074327|FG000|Overall Study|Lost to Follow-up|1|||
160642635|NCT03175120|580074328|FG001|Overall Study|Lost to Follow-up|0|||
160642636|NCT03175120|580074327|FG000|Overall Study|Withdrawal by Subject|2|||
160642637|NCT03175120|580074328|FG001|Overall Study|Withdrawal by Subject|5|||
160642638|NCT03175120|580074327|FG000|Overall Study|Other|2|||
160642639|NCT03175120|580074328|FG001|Overall Study|Other|3|||
160642640|NCT01684722|580074329|FG000|Overall Study|Lost to Follow-up|78|||
160642641|NCT01684722|580074330|FG001|Overall Study|Lost to Follow-up|56|||
160642642|NCT01684722|580074331|FG002|Overall Study|Lost to Follow-up|75|||
160642643|NCT01684722|580074332|FG003|Overall Study|Lost to Follow-up|89|||
160642644|NCT01684722|580074329|FG000|Overall Study|Death|19|||
160642645|NCT01684722|580074330|FG001|Overall Study|Death|21|||
160642646|NCT01684722|580074331|FG002|Overall Study|Death|19|||
160642647|NCT01684722|580074332|FG003|Overall Study|Death|21|||
160642648|NCT01664494|580074333|FG000|Overall Study|Withdrawal by Subject|27|||
160642649|NCT01664494|580074333|FG000|Overall Study|Death|18|||
160642650|NCT01664494|580074333|FG000|Overall Study|Other|49|||
160642651|NCT01664494|580074333|FG000|Overall Study|Lost to Follow-up|99|||
160642652|NCT00219557|580074334|FG000|Phase 1|Lack of Efficacy|3|||
160642653|NCT00219557|580074335|FG001|Phase 1|Lack of Efficacy|0|||
160642654|NCT00219557|580074336|FG002|Phase 1|Lack of Efficacy|0|||
160642655|NCT00219557|580074334|FG000|Phase 1|Adverse Event|2|||
160642656|NCT00219557|580074335|FG001|Phase 1|Adverse Event|0|||
160642657|NCT00219557|580074336|FG002|Phase 1|Adverse Event|0|||
160642658|NCT00219557|580074334|FG000|Phase 1|Withdrawal by Subject|1|||
160642659|NCT00219557|580074335|FG001|Phase 1|Withdrawal by Subject|0|||
160642660|NCT00219557|580074336|FG002|Phase 1|Withdrawal by Subject|0|||
160642661|NCT00219557|580074334|FG000|Phase 1|Started chemotherapy at other institute|1|||
160642662|NCT00219557|580074335|FG001|Phase 1|Started chemotherapy at other institute|0|||
160642663|NCT00219557|580074336|FG002|Phase 1|Started chemotherapy at other institute|0|||
160642664|NCT00219557|580074334|FG000|Phase 2|Lack of Efficacy|0|||
160790291|NCT01225952|580620049|FG001|Overall Study|Lost to Follow-up|0|||
160892106|NCT02819518|581000513|FG001|Overall Study|Sponsor Decision|1|||
160642665|NCT00219557|580074335|FG001|Phase 2|Lack of Efficacy|21|||
160790292|NCT01225952|580620050|FG002|Overall Study|Lost to Follow-up|0|||
160790293|NCT01225952|580620048|FG000|Overall Study|Study Eye Explanted|0|||
160790294|NCT01225952|580620049|FG001|Overall Study|Study Eye Explanted|0|||
160790295|NCT01225952|580620050|FG002|Overall Study|Study Eye Explanted|1|||
160790296|NCT01225952|580620048|FG000|Overall Study|Withdrawal by Subject|4|||
160642666|NCT00219557|580074336|FG002|Phase 2|Lack of Efficacy|15|||
160642667|NCT00219557|580074334|FG000|Phase 2|Adverse Event|0|||
160642668|NCT00219557|580074335|FG001|Phase 2|Adverse Event|22|||
160642669|NCT00219557|580074336|FG002|Phase 2|Adverse Event|2|||
160642670|NCT00219557|580074334|FG000|Phase 2|Death|0|||
160642671|NCT00219557|580074335|FG001|Phase 2|Death|8|||
160642672|NCT00219557|580074336|FG002|Phase 2|Death|2|||
160642673|NCT00219557|580074334|FG000|Phase 2|Other|0|||
160642674|NCT00219557|580074335|FG001|Phase 2|Other|8|||
160790297|NCT01225952|580620049|FG001|Overall Study|Withdrawal by Subject|4|||
160790298|NCT01225952|580620050|FG002|Overall Study|Withdrawal by Subject|5|||
160790299|NCT01225952|580620048|FG000|Overall Study|Surgical complications|1|||
160790300|NCT01225952|580620049|FG001|Overall Study|Surgical complications|0|||
160790301|NCT01225952|580620050|FG002|Overall Study|Surgical complications|0|||
160790302|NCT05122143|580620053|FG000|Overall Study|Adverse Event|1|||
160790303|NCT05122143|580620054|FG001|Overall Study|Adverse Event|0|||
160790304|NCT05122143|580620055|FG002|Overall Study|Adverse Event|0|||
160790305|NCT05122143|580620056|FG003|Overall Study|Adverse Event|0|||
160790306|NCT05122143|580620057|FG004|Overall Study|Adverse Event|1|||
160790307|NCT05122143|580620058|FG005|Overall Study|Adverse Event|0|||
160790308|NCT05122143|580620053|FG000|Overall Study|Protocol non-compliance|0|||
160790309|NCT05122143|580620054|FG001|Overall Study|Protocol non-compliance|0|||
160790310|NCT05122143|580620055|FG002|Overall Study|Protocol non-compliance|1|||
160790311|NCT05122143|580620056|FG003|Overall Study|Protocol non-compliance|0|||
160790312|NCT05122143|580620057|FG004|Overall Study|Protocol non-compliance|0|||
160790313|NCT05122143|580620058|FG005|Overall Study|Protocol non-compliance|0|||
160790314|NCT05122143|580620053|FG000|Overall Study|Covid contact|0|||
160790315|NCT05122143|580620054|FG001|Overall Study|Covid contact|0|||
160790316|NCT05122143|580620055|FG002|Overall Study|Covid contact|0|||
160790317|NCT05122143|580620056|FG003|Overall Study|Covid contact|0|||
160790318|NCT05122143|580620057|FG004|Overall Study|Covid contact|1|||
160790319|NCT05122143|580620058|FG005|Overall Study|Covid contact|0|||
160790320|NCT00692237|580620059|FG000|Overall Study|Withdrawal by Subject|1|||
160790321|NCT00692237|580620060|FG001|Overall Study|Withdrawal by Subject|3|||
160790322|NCT00692237|580620059|FG000|Overall Study|Adverse Event|0|||
160790323|NCT00692237|580620060|FG001|Overall Study|Adverse Event|1|||
160790324|NCT01047540|580620061|FG000|Overall Study|Protocol Violation|1|||
160790325|NCT01047540|580620062|FG001|Overall Study|Protocol Violation|0|||
160790326|NCT01047540|580620063|FG002|Overall Study|Protocol Violation|0|||
160790327|NCT01047540|580620064|FG003|Overall Study|Protocol Violation|0|||
160790328|NCT01047540|580620065|FG004|Overall Study|Protocol Violation|0|||
160790329|NCT01047540|580620061|FG000|Overall Study|Lost to Follow-up|1|||
160790330|NCT01047540|580620062|FG001|Overall Study|Lost to Follow-up|0|||
160790331|NCT01047540|580620063|FG002|Overall Study|Lost to Follow-up|0|||
160790332|NCT01047540|580620064|FG003|Overall Study|Lost to Follow-up|0|||
160790333|NCT01047540|580620065|FG004|Overall Study|Lost to Follow-up|0|||
160790334|NCT01047540|580620061|FG000|Overall Study|Withdrawal by Subject|1|||
160790335|NCT01047540|580620062|FG001|Overall Study|Withdrawal by Subject|0|||
160790336|NCT01047540|580620063|FG002|Overall Study|Withdrawal by Subject|3|||
160790337|NCT01047540|580620064|FG003|Overall Study|Withdrawal by Subject|0|||
160790338|NCT01047540|580620065|FG004|Overall Study|Withdrawal by Subject|1|||
160790339|NCT01047540|580620061|FG000|Overall Study|Pregnancy|1|||
160790340|NCT01047540|580620062|FG001|Overall Study|Pregnancy|0|||
160790341|NCT01047540|580620063|FG002|Overall Study|Pregnancy|0|||
160790342|NCT01047540|580620064|FG003|Overall Study|Pregnancy|0|||
160790343|NCT01047540|580620065|FG004|Overall Study|Pregnancy|0|||
160790344|NCT01047540|580620061|FG000|Overall Study|Adverse Event|1|||
160790345|NCT01047540|580620062|FG001|Overall Study|Adverse Event|0|||
160642675|NCT00219557|580074336|FG002|Phase 2|Other|6|||
160642676|NCT00219557|580074334|FG000|Phase 2|Withdrawal by Subject|0|||
160642677|NCT00219557|580074335|FG001|Phase 2|Withdrawal by Subject|9|||
160642678|NCT00219557|580074336|FG002|Phase 2|Withdrawal by Subject|5|||
160642679|NCT00219557|580074334|FG000|Phase 2|Treatment not received|0|||
160790346|NCT01047540|580620063|FG002|Overall Study|Adverse Event|0|||
160790347|NCT01047540|580620064|FG003|Overall Study|Adverse Event|0|||
160790348|NCT01047540|580620065|FG004|Overall Study|Adverse Event|0|||
160790349|NCT03032484|580620071|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
160790350|NCT03032484|580620072|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
160790351|NCT03032484|580620071|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
160790352|NCT03032484|580620072|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
160790353|NCT05451329|580620082|FG000|Overall Study|Adverse Event|1|||
160790354|NCT05451329|580620083|FG001|Overall Study|Adverse Event|1|||
160790355|NCT05451329|580620084|FG002|Overall Study|Adverse Event|0|||
160790356|NCT05451329|580620082|FG000|Overall Study|Withdrawal by Subject|1|||
160790357|NCT05451329|580620083|FG001|Overall Study|Withdrawal by Subject|0|||
160790358|NCT05451329|580620084|FG002|Overall Study|Withdrawal by Subject|0|||
160790359|NCT05451329|580620082|FG000|Overall Study|Investigational Product Lot exchange|1|||
160892107|NCT02819518|581000514|FG002|Overall Study|Sponsor Decision|0|||
160790360|NCT05451329|580620083|FG001|Overall Study|Investigational Product Lot exchange|1|||
160790361|NCT05451329|580620084|FG002|Overall Study|Investigational Product Lot exchange|0|||
160790362|NCT00069953|580620085|FG000|Overall Study|Protocol Violation|2|||
160790363|NCT02395627|580620088|FG000|Overall Study|Withdrawal by Subject|0|||
160790364|NCT02395627|580620089|FG001|Overall Study|Withdrawal by Subject|2|||
160790365|NCT02395627|580620090|FG002|Overall Study|Withdrawal by Subject|0|||
160790366|NCT02395627|580620088|FG000|Overall Study|Did not receive pembrolizumab|3|||
160790367|NCT02395627|580620089|FG001|Overall Study|Did not receive pembrolizumab|1|||
160790368|NCT02395627|580620090|FG002|Overall Study|Did not receive pembrolizumab|0|||
160790369|NCT03253627|580620091|FG000|Overall Study|Lost to Follow-up|1|||
160790370|NCT03253627|580620092|FG001|Overall Study|Lost to Follow-up|2|||
160790371|NCT03253627|580620091|FG000|Overall Study|Withdrawal by Subject|0|||
160790372|NCT03253627|580620092|FG001|Overall Study|Withdrawal by Subject|2|||
160790373|NCT03253627|580620091|FG000|Overall Study|Inability to complete MRI|1|||
160790374|NCT03253627|580620092|FG001|Overall Study|Inability to complete MRI|0|||
160790375|NCT03829683|580620093|FG000|Overall Study|Lost to Follow-up|1|||
160790376|NCT03829683|580620094|FG001|Overall Study|Lost to Follow-up|0|||
160790377|NCT03829683|580620093|FG000|Overall Study|Physician Decision|3|||
160790378|NCT03829683|580620094|FG001|Overall Study|Physician Decision|1|||
160790379|NCT03829683|580620093|FG000|Overall Study|Withdrawal by Subject|0|||
160790380|NCT03829683|580620094|FG001|Overall Study|Withdrawal by Subject|1|||
160790381|NCT03829683|580620093|FG000|Overall Study|Discharge from hospital|1|||
160790382|NCT03829683|580620094|FG001|Overall Study|Discharge from hospital|0|||
160790383|NCT04003142|580620104|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
160790384|NCT04003142|580620105|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
160790385|NCT04003142|580620106|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
160790386|NCT04003142|580620107|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
160790387|NCT04003142|580620108|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
160642680|NCT00219557|580074335|FG001|Phase 2|Treatment not received|1|||
160642681|NCT00219557|580074336|FG002|Phase 2|Treatment not received|3|||
160642682|NCT00106028|580074337|FG000|Overall Study|Adverse Event|3|||
160642683|NCT00106028|580074338|FG001|Overall Study|Adverse Event|2|||
160642684|NCT00106028|580074337|FG000|Overall Study|Protocol Violation|1|||
160642685|NCT00106028|580074338|FG001|Overall Study|Protocol Violation|1|||
160642686|NCT00106028|580074337|FG000|Overall Study|Withdrawal by Subject|2|||
160642687|NCT00106028|580074338|FG001|Overall Study|Withdrawal by Subject|8|||
160642688|NCT00106028|580074337|FG000|Overall Study|Lost to Follow-up|0|||
160642689|NCT00106028|580074338|FG001|Overall Study|Lost to Follow-up|1|||
160642690|NCT00947011|580074339|FG000|Overall Study|Study was terminated,PI left institution|12|||
160642691|NCT02124746|580074346|FG000|Overall Study|Adverse Event|2|||
160790388|NCT04003142|580620104|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
160790389|NCT04003142|580620105|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
160790390|NCT04003142|580620106|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
160790391|NCT04003142|580620107|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
160790392|NCT04003142|580620108|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
160790393|NCT04003142|580620104|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
160790394|NCT04003142|580620105|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
160790395|NCT04003142|580620106|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
160790396|NCT04003142|580620107|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
160790397|NCT04003142|580620108|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
160790398|NCT04003142|580620104|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
160790399|NCT04003142|580620105|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
160790400|NCT04003142|580620106|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
160790401|NCT04003142|580620107|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
160790402|NCT04003142|580620108|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
160790403|NCT04003142|580620104|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
160790404|NCT04003142|580620105|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
160790405|NCT04003142|580620106|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
160790406|NCT04003142|580620107|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
160790407|NCT04003142|580620108|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
160790408|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
160642692|NCT02124746|580074347|FG001|Overall Study|Adverse Event|1|||
160642693|NCT02124746|580074348|FG002|Overall Study|Adverse Event|2|||
160642694|NCT02124746|580074346|FG000|Overall Study|Death|2|||
160642695|NCT02124746|580074347|FG001|Overall Study|Death|1|||
160642696|NCT02124746|580074348|FG002|Overall Study|Death|3|||
160790409|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
160642697|NCT02124746|580074346|FG000|Overall Study|Lack of Efficacy|3|||
160790410|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
160790411|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
160790412|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
160790413|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Death|0|||
160790414|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Death|0|||
160642698|NCT02124746|580074347|FG001|Overall Study|Lack of Efficacy|2|||
160642699|NCT02124746|580074348|FG002|Overall Study|Lack of Efficacy|2|||
160892108|NCT02819518|581000515|FG003|Overall Study|Sponsor Decision|34|||
160642700|NCT02124746|580074346|FG000|Overall Study|Physician Decision|6|||
160642701|NCT02124746|580074347|FG001|Overall Study|Physician Decision|4|||
160642702|NCT02124746|580074348|FG002|Overall Study|Physician Decision|5|||
160642703|NCT02124746|580074346|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160642704|NCT02124746|580074347|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160642705|NCT02124746|580074348|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160642706|NCT02124746|580074346|FG000|Overall Study|Withdrawal by Subject|3|||
160642707|NCT02124746|580074347|FG001|Overall Study|Withdrawal by Subject|3|||
160642708|NCT02124746|580074348|FG002|Overall Study|Withdrawal by Subject|0|||
160790415|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Death|0|||
160790416|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Death|0|||
160790417|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Death|1|||
160790418|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
160790419|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
160790420|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
160790421|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
160790422|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
160790423|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
160790424|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
160790425|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
160790426|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
160790427|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
160790428|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
160790429|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
160790430|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
160790431|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
160790432|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
160790433|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
160790434|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
160790435|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
160790436|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
160790437|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
160790438|NCT04806373|580620109|FG000|Overall Study|Withdrawal by Subject|1|||
160790439|NCT04806373|580620110|FG001|Overall Study|Withdrawal by Subject|1|||
160790440|NCT05810597|580620111|FG000|Period 1|Adverse Event|2|||
160790441|NCT05810597|580620112|FG001|Period 1|Adverse Event|0|||
160790442|NCT05810597|580620111|FG000|Period 1|Physician Decision|1|||
160790443|NCT05810597|580620112|FG001|Period 1|Physician Decision|0|||
160790444|NCT01450631|580620113|FG000|Overall Study|Lost to Follow-up|2|||
160790445|NCT01450631|580620114|FG001|Overall Study|Lost to Follow-up|4|||
160790446|NCT01450631|580620113|FG000|Overall Study|Withdrawal by Subject|1|||
160790447|NCT01450631|580620114|FG001|Overall Study|Withdrawal by Subject|0|||
160790448|NCT04903093|580620115|FG000|Overall Study|Withdrawal by Subject|0|||
160790449|NCT04903093|580620116|FG001|Overall Study|Withdrawal by Subject|0|||
160790450|NCT04903093|580620117|FG002|Overall Study|Withdrawal by Subject|0|||
160790451|NCT04903093|580620118|FG003|Overall Study|Withdrawal by Subject|1|||
160790452|NCT04903093|580620119|FG004|Overall Study|Withdrawal by Subject|0|||
160790453|NCT04903093|580620120|FG005|Overall Study|Withdrawal by Subject|0|||
160790454|NCT01390584|580620129|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
160790455|NCT01390584|580620130|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
160790456|NCT01390584|580620131|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
160790457|NCT00025233|580620132|FG000|Overall Study|Ineligible: wrong cell type|1|||
160790458|NCT00025233|580620132|FG000|Overall Study|Ineligible: wrong primary|1|||
160790459|NCT00025233|580620132|FG000|Overall Study|Ineligible: improper prior treatment|1|||
160790460|NCT00025233|580620132|FG000|Overall Study|Never treated|1|||
160790461|NCT00401830|580620133|FG000|Overall Study|Adverse Event|10|||
160790462|NCT00401830|580620134|FG001|Overall Study|Adverse Event|18|||
160790463|NCT00401830|580620133|FG000|Overall Study|Lack of Efficacy|11|||
160790464|NCT00401830|580620134|FG001|Overall Study|Lack of Efficacy|5|||
160790465|NCT00401830|580620133|FG000|Overall Study|Withdrawal by Subject|4|||
160790466|NCT00401830|580620134|FG001|Overall Study|Withdrawal by Subject|3|||
160790467|NCT00401830|580620133|FG000|Overall Study|Protocol Violation|3|||
160790468|NCT00401830|580620134|FG001|Overall Study|Protocol Violation|3|||
160790469|NCT00401830|580620133|FG000|Overall Study|Non-compliance with drug study|1|||
160790470|NCT00401830|580620134|FG001|Overall Study|Non-compliance with drug study|0|||
160790471|NCT00401830|580620133|FG000|Overall Study|Lost to Follow-up|1|||
160790472|NCT00401830|580620134|FG001|Overall Study|Lost to Follow-up|3|||
160790473|NCT00401830|580620133|FG000|Overall Study|Other: Personal / Family problems|1|||
160790474|NCT00401830|580620134|FG001|Overall Study|Other: Personal / Family problems|0|||
160790475|NCT01720602|580620135|FG000|Overall Study|Adverse Event|3|||
160790476|NCT01720602|580620135|FG000|Overall Study|Progressive disease on therapy|2|||
160892109|NCT02819518|581000516|FG004|Overall Study|Sponsor Decision|17|||
160892110|NCT02819518|581000512|FG000|Overall Study|Transferred to extension study|1|||
160892111|NCT02819518|581000513|FG001|Overall Study|Transferred to extension study|1|||
160892112|NCT02819518|581000514|FG002|Overall Study|Transferred to extension study|1|||
160892113|NCT02819518|581000515|FG003|Overall Study|Transferred to extension study|32|||
160892114|NCT02819518|581000516|FG004|Overall Study|Transferred to extension study|11|||
160892115|NCT00880165|581000517|FG000|Overall Study|Withdrawal by Subject|27|||
160892116|NCT00880165|581000518|FG001|Overall Study|Withdrawal by Subject|23|||
160892117|NCT00880165|581000517|FG000|Overall Study|Not diagnosed with OSA|14|||
160892118|NCT00880165|581000518|FG001|Overall Study|Not diagnosed with OSA|8|||
160892119|NCT00880165|581000517|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
160892120|NCT00880165|581000518|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
160892121|NCT00880165|581000517|FG000|Overall Study|Lost to follow|9|||
160892122|NCT00880165|581000518|FG001|Overall Study|Lost to follow|15|||
160892123|NCT01505647|581000519|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
160892124|NCT01505647|581000520|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
160892125|NCT01505647|581000519|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
160892126|NCT01505647|581000520|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
160892127|NCT01505647|581000519|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
160892128|NCT01505647|581000520|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
160892129|NCT01505647|581000519|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
160892130|NCT01505647|581000520|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
160892131|NCT01505647|581000519|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
160892132|NCT01505647|581000520|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
160892133|NCT00395538|581000522|FG000|Overall Study|Did not re-consent to revised protocol|1|||
160892134|NCT00395538|581000523|FG001|Overall Study|Did not re-consent to revised protocol|10|||
160892135|NCT00395538|581000524|FG002|Overall Study|Did not re-consent to revised protocol|0|||
160892136|NCT00395538|581000522|FG000|Overall Study|FDA partial hold on PTH|0|||
160892137|NCT00395538|581000523|FG001|Overall Study|FDA partial hold on PTH|0|||
160892138|NCT00395538|581000524|FG002|Overall Study|FDA partial hold on PTH|11|||
160892139|NCT00395538|581000522|FG000|Overall Study|Failed screening|0|||
160892140|NCT00395538|581000523|FG001|Overall Study|Failed screening|0|||
160892141|NCT00395538|581000524|FG002|Overall Study|Failed screening|4|||
160548071|NCT04381650|579732561|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
160548072|NCT04381650|579732562|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
160548073|NCT04381650|579732552|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
160548074|NCT04381650|579732553|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
160642709|NCT02124746|580074346|FG000|Overall Study|Study Terminated by Sponsor|0|||
160642710|NCT02124746|580074347|FG001|Overall Study|Study Terminated by Sponsor|0|||
160548075|NCT04381650|579732554|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
160548076|NCT04381650|579732555|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
160548077|NCT04381650|579732556|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
160548078|NCT04381650|579732557|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
160548079|NCT04381650|579732558|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
160548080|NCT04381650|579732559|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
160548081|NCT04381650|579732560|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
160548082|NCT04381650|579732561|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
160642711|NCT02124746|580074348|FG002|Overall Study|Study Terminated by Sponsor|6|||
160642712|NCT02124746|580074346|FG000|Overall Study|Disease Progression|3|||
160642713|NCT02124746|580074347|FG001|Overall Study|Disease Progression|6|||
160892142|NCT00395538|581000522|FG000|Overall Study|Switch to Natpara|0|||
160548083|NCT04381650|579732562|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
160548084|NCT04381650|579732552|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
160548085|NCT04381650|579732553|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
160548086|NCT04381650|579732554|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
160548087|NCT04381650|579732555|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
160548088|NCT04381650|579732556|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
160548089|NCT04381650|579732557|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
160548090|NCT04381650|579732558|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
160548091|NCT04381650|579732559|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
160548092|NCT04381650|579732560|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
160548093|NCT04381650|579732561|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
160548094|NCT04381650|579732562|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
160548095|NCT04381650|579732552|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
160548096|NCT04381650|579732553|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
160548097|NCT04381650|579732554|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
160548098|NCT04381650|579732555|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
160548099|NCT04381650|579732556|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
160548100|NCT04381650|579732557|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
160548101|NCT04381650|579732558|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
160548102|NCT04381650|579732559|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
160548103|NCT04381650|579732560|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
160548104|NCT04381650|579732561|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
160548105|NCT04381650|579732562|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
160548106|NCT04381650|579732552|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
160548107|NCT04381650|579732553|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
160548108|NCT04381650|579732554|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
160548109|NCT04381650|579732555|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
160548110|NCT04381650|579732556|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
160548111|NCT04381650|579732557|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
160548112|NCT04381650|579732558|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
160548113|NCT04381650|579732559|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
160548114|NCT04381650|579732560|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
160548115|NCT04381650|579732561|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
160548116|NCT04381650|579732562|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
160548117|NCT04381650|579732552|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
160548118|NCT04381650|579732553|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
160548119|NCT04381650|579732554|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
160548120|NCT04381650|579732555|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
160548121|NCT04381650|579732556|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
160548122|NCT04381650|579732557|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
160548123|NCT04381650|579732558|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
160548124|NCT04381650|579732559|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
160548125|NCT04381650|579732560|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
160548126|NCT04381650|579732561|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
160548127|NCT04381650|579732562|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
160548128|NCT04381650|579732552|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160548129|NCT04381650|579732553|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160548130|NCT04381650|579732554|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160548131|NCT04381650|579732555|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160548132|NCT04381650|579732556|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160548133|NCT04381650|579732557|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160548134|NCT04381650|579732558|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160790477|NCT01539525|580620136|FG000|Overall Study|Lost to Follow-up|19|||
160790478|NCT01539525|580620137|FG001|Overall Study|Lost to Follow-up|12|||
160790479|NCT01539525|580620138|FG002|Overall Study|Lost to Follow-up|11|||
160790480|NCT01539525|580620136|FG000|Overall Study|Withdrawal by Subject|0|||
160790481|NCT01539525|580620137|FG001|Overall Study|Withdrawal by Subject|3|||
160790482|NCT01539525|580620138|FG002|Overall Study|Withdrawal by Subject|2|||
160790483|NCT01539525|580620136|FG000|Overall Study|Protocol Violation|1|||
160548135|NCT04381650|579732559|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
160548136|NCT04381650|579732560|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
160548137|NCT04381650|579732561|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
160548138|NCT04381650|579732562|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160548139|NCT04381650|579732552|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
160548140|NCT04381650|579732553|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
160548141|NCT04381650|579732554|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
160548142|NCT04381650|579732555|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
160548143|NCT04381650|579732556|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
160790484|NCT01539525|580620137|FG001|Overall Study|Protocol Violation|1|||
160790485|NCT01539525|580620138|FG002|Overall Study|Protocol Violation|4|||
160790486|NCT02184442|580620141|FG000|Overall Study|Death|61|||
160790487|NCT02184442|580620142|FG001|Overall Study|Death|65|||
160790488|NCT02184442|580620141|FG000|Overall Study|Withdrawal by Subject|3|||
160790489|NCT02184442|580620142|FG001|Overall Study|Withdrawal by Subject|11|||
160790490|NCT01044459|580620143|FG000|Overall Study|Withdrawal by Subject|21|||
160790491|NCT01044459|580620144|FG001|Overall Study|Withdrawal by Subject|28|||
160790492|NCT01044459|580620143|FG000|Overall Study|Terminated by Sponsor|22|||
160790493|NCT01044459|580620144|FG001|Overall Study|Terminated by Sponsor|21|||
160790494|NCT01044459|580620143|FG000|Overall Study|Adverse Event|22|||
160790495|NCT01044459|580620144|FG001|Overall Study|Adverse Event|20|||
160790496|NCT01044459|580620143|FG000|Overall Study|Lack of Efficacy|23|||
160790497|NCT01044459|580620144|FG001|Overall Study|Lack of Efficacy|12|||
160790498|NCT01044459|580620143|FG000|Overall Study|Protocol Violation|11|||
160790499|NCT01044459|580620144|FG001|Overall Study|Protocol Violation|16|||
160790500|NCT01044459|580620143|FG000|Overall Study|Other Reason|7|||
160790501|NCT01044459|580620144|FG001|Overall Study|Other Reason|14|||
160790502|NCT01044459|580620143|FG000|Overall Study|COPD exacerbation|9|||
160790503|NCT01044459|580620144|FG001|Overall Study|COPD exacerbation|8|||
160790504|NCT01044459|580620143|FG000|Overall Study|Lost to Follow-up|18|||
160790505|NCT01044459|580620144|FG001|Overall Study|Lost to Follow-up|12|||
160790506|NCT02691494|580620147|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
160790507|NCT02691494|580620148|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
160790508|NCT02691494|580620149|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
160790509|NCT02691494|580620147|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
160790510|NCT02691494|580620148|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
160790511|NCT02691494|580620149|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
160790512|NCT02691494|580620147|FG000|Post-Treatment Follow-Up Period|Other|2|||
160892143|NCT00395538|581000523|FG001|Overall Study|Switch to Natpara|0|||
160892144|NCT00395538|581000524|FG002|Overall Study|Switch to Natpara|3|||
160892145|NCT00395538|581000522|FG000|Overall Study|Adverse Event|1|||
160892146|NCT00395538|581000523|FG001|Overall Study|Adverse Event|0|||
160892147|NCT00395538|581000524|FG002|Overall Study|Adverse Event|2|||
160790513|NCT02691494|580620148|FG001|Post-Treatment Follow-Up Period|Other|1|||
160790514|NCT02691494|580620149|FG002|Post-Treatment Follow-Up Period|Other|1|||
160790515|NCT02691494|580620147|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
160790516|NCT02691494|580620148|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
160790517|NCT02691494|580620149|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
160790518|NCT02691494|580620147|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
160892148|NCT00395538|581000522|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
160892149|NCT00395538|581000523|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
160892150|NCT00395538|581000524|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
160892151|NCT00395538|581000522|FG000|Overall Study|Non-compliance with study protocol|0|||
160892152|NCT00395538|581000523|FG001|Overall Study|Non-compliance with study protocol|1|||
160892153|NCT00395538|581000524|FG002|Overall Study|Non-compliance with study protocol|0|||
160892154|NCT00395538|581000522|FG000|Overall Study|PTH resistance|0|||
160892155|NCT00395538|581000523|FG001|Overall Study|PTH resistance|0|||
160548144|NCT04381650|579732557|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
160548145|NCT04381650|579732558|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
160548146|NCT04381650|579732559|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
160548147|NCT04381650|579732560|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
160548148|NCT04381650|579732561|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
160548149|NCT04381650|579732562|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
160548150|NCT04381650|579732552|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
160548151|NCT04381650|579732553|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
160548152|NCT04381650|579732554|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
160548153|NCT04381650|579732555|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
160548154|NCT04381650|579732556|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
160548155|NCT04381650|579732557|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
160790519|NCT02691494|580620148|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
160892156|NCT00395538|581000524|FG002|Overall Study|PTH resistance|1|||
160892157|NCT00395538|581000522|FG000|Overall Study|Pregnancy|1|||
160548156|NCT04381650|579732558|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
160790520|NCT02691494|580620149|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
160790521|NCT04634331|580620150|FG000|Overall Study|Withdrawal by Subject|2|||
160790522|NCT04634331|580620151|FG001|Overall Study|Withdrawal by Subject|2|||
160642714|NCT02124746|580074348|FG002|Overall Study|Disease Progression|4|||
160642715|NCT03124381|580074354|FG000|Overall Study|Lost to Follow-up|1|||
160642716|NCT03124381|580074355|FG001|Overall Study|Lost to Follow-up|1|||
160642717|NCT03124381|580074354|FG000|Overall Study|Withdrawal by Subject|6|||
160790523|NCT00553475|580620152|FG000|Overall Study|Adverse Event|7|||
160790524|NCT00553475|580620153|FG001|Overall Study|Adverse Event|17|||
160790525|NCT00553475|580620154|FG002|Overall Study|Adverse Event|13|||
160790526|NCT00553475|580620152|FG000|Overall Study|Lack of Efficacy|7|||
160790527|NCT00553475|580620153|FG001|Overall Study|Lack of Efficacy|1|||
160790528|NCT00553475|580620154|FG002|Overall Study|Lack of Efficacy|0|||
160790529|NCT00553475|580620152|FG000|Overall Study|Withdrawal by Subject|1|||
160790530|NCT00553475|580620153|FG001|Overall Study|Withdrawal by Subject|1|||
160790531|NCT00553475|580620154|FG002|Overall Study|Withdrawal by Subject|0|||
160790532|NCT00553475|580620152|FG000|Overall Study|Physician Decision|1|||
160790533|NCT00553475|580620153|FG001|Overall Study|Physician Decision|0|||
160790534|NCT00553475|580620154|FG002|Overall Study|Physician Decision|0|||
160790535|NCT00553475|580620152|FG000|Overall Study|Due to moving|0|||
160892158|NCT00395538|581000523|FG001|Overall Study|Pregnancy|0|||
160642718|NCT03124381|580074355|FG001|Overall Study|Withdrawal by Subject|3|||
160642719|NCT03124381|580074354|FG000|Overall Study|Protocol Violation|0|||
160642720|NCT03124381|580074355|FG001|Overall Study|Protocol Violation|1|||
160642721|NCT03124381|580074354|FG000|Overall Study|Adverse Event|1|||
160642722|NCT03124381|580074355|FG001|Overall Study|Adverse Event|1|||
160642723|NCT03124381|580074354|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
160642724|NCT03124381|580074355|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
160642725|NCT02533999|580074361|FG000|Overall Study|Lost to Follow-up|3|||
160642726|NCT02533999|580074362|FG001|Overall Study|Lost to Follow-up|5|||
160642727|NCT02533999|580074361|FG000|Overall Study|Protocol Violation|3|||
160642728|NCT02533999|580074362|FG001|Overall Study|Protocol Violation|0|||
160642729|NCT02533999|580074361|FG000|Overall Study|Adverse Event|0|||
160642730|NCT02533999|580074362|FG001|Overall Study|Adverse Event|1|||
160642731|NCT02533999|580074361|FG000|Overall Study|Randomized but intervention not received|0|||
160642732|NCT02533999|580074362|FG001|Overall Study|Randomized but intervention not received|1|||
160642733|NCT03210259|580074363|FG000|12-Week Run-in Period|Adverse Event|1|||
160642734|NCT03210259|580074364|FG001|12-Week Run-in Period|Adverse Event|0|||
160642735|NCT03210259|580074365|FG002|12-Week Run-in Period|Adverse Event|0|||
160642736|NCT03210259|580074363|FG000|12-Week Run-in Period|Death|1|||
160642737|NCT03210259|580074364|FG001|12-Week Run-in Period|Death|0|||
160642738|NCT03210259|580074365|FG002|12-Week Run-in Period|Death|0|||
160642739|NCT03210259|580074363|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
160642740|NCT03210259|580074364|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
160642741|NCT03210259|580074365|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
160642742|NCT03210259|580074363|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
160642743|NCT03210259|580074364|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
160790536|NCT00553475|580620153|FG001|Overall Study|Due to moving|1|||
160790537|NCT00553475|580620154|FG002|Overall Study|Due to moving|0|||
160790538|NCT02916433|580620155|FG000|Overall Study|Withdrawal by Subject|1|||
160642744|NCT03210259|580074365|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
160642745|NCT03210259|580074363|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
160642746|NCT03210259|580074364|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
160790539|NCT02916433|580620156|FG001|Overall Study|Withdrawal by Subject|0|||
160892159|NCT00395538|581000524|FG002|Overall Study|Pregnancy|0|||
160548157|NCT04381650|579732559|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
160548158|NCT04381650|579732560|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
160548159|NCT04381650|579732561|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
160548160|NCT04381650|579732562|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
160548161|NCT04381650|579732552|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
160548162|NCT04381650|579732553|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
160548163|NCT04381650|579732554|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
160548164|NCT04381650|579732555|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
160548165|NCT04381650|579732556|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
160548166|NCT04381650|579732557|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
160548167|NCT04381650|579732558|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
160548168|NCT04381650|579732559|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
160548169|NCT04381650|579732560|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
160548170|NCT04381650|579732561|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
160548171|NCT04381650|579732562|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
160548172|NCT00482014|579734041|FG000|Overall Study|Withdrawal by Subject|1|||
160548173|NCT00482014|579734042|FG001|Overall Study|Withdrawal by Subject|2|||
160548174|NCT00482014|579734043|FG002|Overall Study|Withdrawal by Subject|3|||
160548175|NCT00482014|579734044|FG003|Overall Study|Withdrawal by Subject|4|||
160790540|NCT02916433|580620155|FG000|Overall Study|Physician Decision|1|||
160790541|NCT02916433|580620156|FG001|Overall Study|Physician Decision|0|||
160790542|NCT01694771|580620157|FG000|Overall Study|Adverse Event|18|||
160790543|NCT01694771|580620158|FG001|Overall Study|Adverse Event|16|||
160790544|NCT01694771|580620157|FG000|Overall Study|Lack of Efficacy|1|||
160548176|NCT00482014|579734041|FG000|Overall Study|Adverse Event|3|||
160548177|NCT00482014|579734042|FG001|Overall Study|Adverse Event|0|||
160548178|NCT00482014|579734043|FG002|Overall Study|Adverse Event|2|||
160548179|NCT00482014|579734044|FG003|Overall Study|Adverse Event|8|||
160548180|NCT00482014|579734041|FG000|Overall Study|Death|1|||
160548181|NCT00482014|579734042|FG001|Overall Study|Death|2|||
160548182|NCT00482014|579734043|FG002|Overall Study|Death|1|||
160548183|NCT00482014|579734044|FG003|Overall Study|Death|4|||
160548184|NCT00482014|579734041|FG000|Overall Study|Lack of Efficacy|1|||
160548185|NCT00482014|579734042|FG001|Overall Study|Lack of Efficacy|0|||
160548186|NCT00482014|579734043|FG002|Overall Study|Lack of Efficacy|4|||
160548187|NCT00482014|579734044|FG003|Overall Study|Lack of Efficacy|6|||
160548188|NCT00482014|579734041|FG000|Overall Study|Sponsor Decision|1|||
160548189|NCT00482014|579734042|FG001|Overall Study|Sponsor Decision|2|||
160548190|NCT00482014|579734043|FG002|Overall Study|Sponsor Decision|1|||
160548191|NCT00482014|579734044|FG003|Overall Study|Sponsor Decision|1|||
160548192|NCT01284114|579734047|FG000|Overall Study|viral infection|1|||
160548193|NCT01284114|579734047|FG000|Overall Study|From the results of ALLTITUDE study|1|||
160548194|NCT01284114|579734047|FG000|Overall Study|Symptomatic hypotension|1|||
160548195|NCT01284114|579734047|FG000|Overall Study|dizziness|1|||
160548196|NCT00598975|579734048|FG000|Overall Study|Adverse Event|1|||
160548197|NCT00598975|579734049|FG001|Overall Study|Adverse Event|1|||
160548198|NCT00598975|579734048|FG000|Overall Study|Brain metastases|1|||
160548199|NCT00598975|579734049|FG001|Overall Study|Brain metastases|0|||
160548200|NCT00598975|579734048|FG000|Overall Study|Withdrawal by Subject|1|||
160548201|NCT00598975|579734049|FG001|Overall Study|Withdrawal by Subject|1|||
160548202|NCT00598975|579734048|FG000|Overall Study|Withdrawal of consent|0|||
160548203|NCT00598975|579734049|FG001|Overall Study|Withdrawal of consent|1|||
160548204|NCT00598975|579734048|FG000|Overall Study|Disease progression|8|||
160548205|NCT00598975|579734049|FG001|Overall Study|Disease progression|3|||
160548206|NCT00598975|579734048|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
160548207|NCT00598975|579734049|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
160548208|NCT03733392|579734056|FG000|Overall Study|Withdrawal by Subject|11|||
160790545|NCT01694771|580620158|FG001|Overall Study|Lack of Efficacy|0|||
160790546|NCT01694771|580620157|FG000|Overall Study|Non compliance protocol|7|||
160790547|NCT01694771|580620158|FG001|Overall Study|Non compliance protocol|6|||
160790548|NCT01694771|580620157|FG000|Overall Study|Lost to Follow-up|2|||
160548209|NCT03733392|579734057|FG001|Overall Study|Withdrawal by Subject|1|||
160548210|NCT03733392|579734056|FG000|Overall Study|Death|1|||
160548211|NCT03733392|579734057|FG001|Overall Study|Death|0|||
160548212|NCT03733392|579734056|FG000|Overall Study|Lost to Follow-up|5|||
160548213|NCT03733392|579734057|FG001|Overall Study|Lost to Follow-up|0|||
160548214|NCT03733392|579734056|FG000|Overall Study|Protocol Violation|0|||
160548215|NCT03733392|579734057|FG001|Overall Study|Protocol Violation|1|||
160790549|NCT01694771|580620158|FG001|Overall Study|Lost to Follow-up|3|||
160790550|NCT01694771|580620157|FG000|Overall Study|Consent withdrawn|7|||
160790551|NCT01694771|580620158|FG001|Overall Study|Consent withdrawn|9|||
160790552|NCT01694771|580620157|FG000|Overall Study|Other reasons|5|||
160790553|NCT01694771|580620158|FG001|Overall Study|Other reasons|6|||
160790554|NCT00890097|580620159|FG000|Overall Study|Adverse Event|21|||
160790555|NCT00890097|580620160|FG001|Overall Study|Adverse Event|32|||
160548216|NCT03733392|579734056|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
160790556|NCT00890097|580620161|FG002|Overall Study|Adverse Event|28|||
160790557|NCT00890097|580620159|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
160790558|NCT00890097|580620160|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
160790559|NCT00890097|580620161|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
160790560|NCT00890097|580620159|FG000|Overall Study|Withdrew Consent|9|||
160790561|NCT00890097|580620160|FG001|Overall Study|Withdrew Consent|6|||
160790562|NCT00890097|580620161|FG002|Overall Study|Withdrew Consent|9|||
160790563|NCT00890097|580620159|FG000|Overall Study|Lost to Follow-up|5|||
160790564|NCT00890097|580620160|FG001|Overall Study|Lost to Follow-up|5|||
160790565|NCT00890097|580620161|FG002|Overall Study|Lost to Follow-up|5|||
160790566|NCT00890097|580620159|FG000|Overall Study|Noncompliance|0|||
160790567|NCT00890097|580620160|FG001|Overall Study|Noncompliance|4|||
160790568|NCT00890097|580620161|FG002|Overall Study|Noncompliance|4|||
160790569|NCT00890097|580620159|FG000|Overall Study|Sponsor Decision|7|||
160790570|NCT00890097|580620160|FG001|Overall Study|Sponsor Decision|11|||
160790571|NCT00890097|580620161|FG002|Overall Study|Sponsor Decision|7|||
160790572|NCT00890097|580620159|FG000|Overall Study|Did not attend final visit|2|||
160790573|NCT00890097|580620160|FG001|Overall Study|Did not attend final visit|3|||
160790574|NCT00890097|580620161|FG002|Overall Study|Did not attend final visit|0|||
160790575|NCT00890097|580620159|FG000|Overall Study|Subject Decision|3|||
160790576|NCT00890097|580620160|FG001|Overall Study|Subject Decision|2|||
160790577|NCT00890097|580620161|FG002|Overall Study|Subject Decision|6|||
160790578|NCT00890097|580620159|FG000|Overall Study|Randomization Error|2|||
160790579|NCT00890097|580620160|FG001|Overall Study|Randomization Error|0|||
160790580|NCT00890097|580620161|FG002|Overall Study|Randomization Error|0|||
160790581|NCT00890097|580620159|FG000|Overall Study|Failed inclusion criteria|3|||
160790582|NCT00890097|580620160|FG001|Overall Study|Failed inclusion criteria|4|||
160790583|NCT00890097|580620161|FG002|Overall Study|Failed inclusion criteria|0|||
160790584|NCT00890097|580620159|FG000|Overall Study|Transportation|0|||
160790585|NCT00890097|580620160|FG001|Overall Study|Transportation|2|||
160790586|NCT00890097|580620161|FG002|Overall Study|Transportation|0|||
160790587|NCT00890097|580620159|FG000|Overall Study|Subject Moved|0|||
160790588|NCT00890097|580620160|FG001|Overall Study|Subject Moved|4|||
160790589|NCT00890097|580620161|FG002|Overall Study|Subject Moved|0|||
160790590|NCT00890097|580620159|FG000|Overall Study|Protocol Deviation|1|||
160790591|NCT00890097|580620160|FG001|Overall Study|Protocol Deviation|1|||
160790592|NCT00890097|580620161|FG002|Overall Study|Protocol Deviation|1|||
160790593|NCT03878069|580620162|FG000|Overall Study|Death|0|||
160790594|NCT03878069|580620163|FG001|Overall Study|Death|1|||
160790595|NCT03878069|580620164|FG002|Overall Study|Death|0|||
160790596|NCT03810495|580620165|FG000|Overall Study|Lost to Follow-up|2|||
160790597|NCT03810495|580620165|FG000|Overall Study|Withdrawal by Subject|1|||
160790598|NCT04101331|580621496|FG000|Overall Study|Adverse Event|9|||
160790599|NCT04101331|580621496|FG000|Overall Study|Disease progression|82|||
160790600|NCT04101331|580621496|FG000|Overall Study|Withdrawal by Subject|1|||
160790601|NCT04101331|580621496|FG000|Overall Study|Investigator decision|6|||
160790602|NCT04101331|580621496|FG000|Overall Study|Death|6|||
160790603|NCT04101331|580621496|FG000|Overall Study|Allogenic transplant|1|||
160790604|NCT00866775|580621500|FG000|Overall Study|Adverse Event|5|||
160790605|NCT00866775|580621501|FG001|Overall Study|Adverse Event|19|||
160790606|NCT00866775|580621500|FG000|Overall Study|Death|1|||
160790607|NCT00866775|580621501|FG001|Overall Study|Death|0|||
160790608|NCT00866775|580621500|FG000|Overall Study|Lost to Follow-up|0|||
160790609|NCT00866775|580621501|FG001|Overall Study|Lost to Follow-up|4|||
160790610|NCT00866775|580621500|FG000|Overall Study|Physician Decision|0|||
160790611|NCT00866775|580621501|FG001|Overall Study|Physician Decision|3|||
160790612|NCT00866775|580621500|FG000|Overall Study|Protocol Violation|3|||
160892160|NCT00395538|581000522|FG000|Overall Study|Partial recovery of parathyroid function|0|||
160892161|NCT00395538|581000523|FG001|Overall Study|Partial recovery of parathyroid function|0|||
160892162|NCT00395538|581000524|FG002|Overall Study|Partial recovery of parathyroid function|1|||
160892163|NCT00395538|581000522|FG000|Overall Study|Participant elected to discontinue|0|||
160892164|NCT00395538|581000523|FG001|Overall Study|Participant elected to discontinue|0|||
160892165|NCT00395538|581000524|FG002|Overall Study|Participant elected to discontinue|1|||
160892166|NCT01074047|581000531|FG000|Treatment Phase|Adverse Event|89|||
160892167|NCT01074047|581000532|FG001|Treatment Phase|Adverse Event|66|||
160892168|NCT01074047|581000531|FG000|Treatment Phase|Disease Progression|16|||
160892169|NCT01074047|581000532|FG001|Treatment Phase|Disease Progression|21|||
160892170|NCT01074047|581000531|FG000|Treatment Phase|Withdrawal by Subject|27|||
160892171|NCT01074047|581000532|FG001|Treatment Phase|Withdrawal by Subject|48|||
160892172|NCT01074047|581000531|FG000|Treatment Phase|Death|53|||
160892173|NCT01074047|581000532|FG001|Treatment Phase|Death|58|||
160892174|NCT01074047|581000531|FG000|Treatment Phase|Lost to Follow-up|0|||
160892175|NCT01074047|581000532|FG001|Treatment Phase|Lost to Follow-up|1|||
160892176|NCT01074047|581000531|FG000|Treatment Phase|Protocol Violation|0|||
160892177|NCT01074047|581000532|FG001|Treatment Phase|Protocol Violation|1|||
160892178|NCT01074047|581000531|FG000|Treatment Phase|Miscellaneous|32|||
160892179|NCT01074047|581000532|FG001|Treatment Phase|Miscellaneous|39|||
160892180|NCT01074047|581000531|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
160892181|NCT01074047|581000532|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
160892182|NCT01074047|581000531|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
160892183|NCT01074047|581000532|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
160892184|NCT01074047|581000531|FG000|Survival Follow-Up Phase|Death|116|||
160892185|NCT01074047|581000532|FG001|Survival Follow-Up Phase|Death|124|||
160892186|NCT01074047|581000531|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
160892187|NCT01074047|581000532|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
160892188|NCT01074047|581000531|FG000|Extension Phase|Physician Decision|1|||
160892189|NCT01074047|581000532|FG001|Extension Phase|Physician Decision|0|||
160892190|NCT01074047|581000531|FG000|Extension Phase|Adverse Event|5|||
160892191|NCT01074047|581000532|FG001|Extension Phase|Adverse Event|0|||
160892192|NCT01074047|581000531|FG000|Extension Phase|Disease Progression|9|||
160892193|NCT01074047|581000532|FG001|Extension Phase|Disease Progression|0|||
160892194|NCT01074047|581000531|FG000|Extension Phase|Withdrawal by Subject|2|||
160892195|NCT01074047|581000532|FG001|Extension Phase|Withdrawal by Subject|0|||
160892196|NCT01074047|581000531|FG000|Extension Phase|Death|5|||
160892197|NCT01074047|581000532|FG001|Extension Phase|Death|0|||
160892198|NCT02211638|581000533|FG000|Overall Study|Case Report Forms Uncollected|291|||
160892199|NCT02211638|581000533|FG000|Overall Study|Protocol Violation|692|||
160892200|NCT03120624|581000535|FG000|Overall Study|Withdrawal by Subject|0|||
160892201|NCT03120624|581000536|FG001|Overall Study|Withdrawal by Subject|1|||
160892202|NCT03120624|581000537|FG002|Overall Study|Withdrawal by Subject|0|||
160892203|NCT03120624|581000538|FG003|Overall Study|Withdrawal by Subject|0|||
160892204|NCT03120624|581000539|FG004|Overall Study|Withdrawal by Subject|0|||
160892205|NCT03120624|581000540|FG005|Overall Study|Withdrawal by Subject|0|||
160892206|NCT03120624|581000541|FG006|Overall Study|Withdrawal by Subject|0|||
160892207|NCT03120624|581000542|FG007|Overall Study|Withdrawal by Subject|0|||
160892208|NCT05140382|581000543|FG000|Overall Study|Death|3|||
160548217|NCT03733392|579734057|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
160548218|NCT03733392|579734056|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
160790613|NCT00866775|580621501|FG001|Overall Study|Protocol Violation|4|||
160790614|NCT00866775|580621500|FG000|Overall Study|Withdrawal by Subject|4|||
160790615|NCT00866775|580621501|FG001|Overall Study|Withdrawal by Subject|4|||
160790616|NCT00866775|580621500|FG000|Overall Study|met exit criteria|23|||
160790617|NCT00866775|580621501|FG001|Overall Study|met exit criteria|17|||
160790618|NCT00866775|580621500|FG000|Overall Study|discontinued due to communication error|0|||
160790619|NCT00866775|580621501|FG001|Overall Study|discontinued due to communication error|1|||
160790620|NCT00833703|580621502|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
160790621|NCT00833703|580621503|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
160790622|NCT00003907|580621504|FG000|Overall Study|Adverse Event|2|||
160790623|NCT00003907|580621505|FG001|Overall Study|Adverse Event|11|||
160790624|NCT00003907|580621504|FG000|Overall Study|Death|2|||
160790625|NCT00003907|580621505|FG001|Overall Study|Death|0|||
160790626|NCT00003907|580621504|FG000|Overall Study|Withdrawal by Subject|1|||
160790627|NCT00003907|580621505|FG001|Overall Study|Withdrawal by Subject|3|||
160790628|NCT00003907|580621504|FG000|Overall Study|Progressive disease|4|||
160790629|NCT00003907|580621505|FG001|Overall Study|Progressive disease|4|||
160790630|NCT00003907|580621504|FG000|Overall Study|Complicating disease|1|||
160790631|NCT00003907|580621505|FG001|Overall Study|Complicating disease|0|||
160790632|NCT00003907|580621504|FG000|Overall Study|Other|1|||
160790633|NCT00003907|580621505|FG001|Overall Study|Other|3|||
160790634|NCT00003907|580621504|FG000|Overall Study|ineligible or not treated|2|||
160790635|NCT00003907|580621505|FG001|Overall Study|ineligible or not treated|2|||
160790636|NCT00993473|580621508|FG000|Overall Study|Adverse Event|0|||
160790637|NCT00993473|580621509|FG001|Overall Study|Adverse Event|2|||
160790638|NCT00993473|580621508|FG000|Overall Study|Protocol Violation|1|||
160790639|NCT00993473|580621509|FG001|Overall Study|Protocol Violation|2|||
160790640|NCT00993473|580621508|FG000|Overall Study|Lost to Follow-up|1|||
160790641|NCT00993473|580621509|FG001|Overall Study|Lost to Follow-up|0|||
160790642|NCT00993473|580621508|FG000|Overall Study|Withdrawal by Subject|1|||
160790643|NCT00993473|580621509|FG001|Overall Study|Withdrawal by Subject|5|||
160790644|NCT00993473|580621508|FG000|Overall Study|Technical problem with CGM device|0|||
160790645|NCT00993473|580621509|FG001|Overall Study|Technical problem with CGM device|1|||
160790646|NCT00993473|580621508|FG000|Overall Study|Family event|1|||
160790647|NCT00993473|580621509|FG001|Overall Study|Family event|0|||
160790648|NCT02439957|580621520|FG000|Overall Study|Study Terminated|3|||
160790649|NCT02439957|580621521|FG001|Overall Study|Study Terminated|3|||
160790650|NCT00770679|580621522|FG000|Overall Study|Lost to Follow-up|3|||
160790651|NCT00770679|580621522|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
160790652|NCT00831389|580621523|FG000|Overall Study|Withdrawal by Subject|0|||
160790653|NCT00831389|580621524|FG001|Overall Study|Withdrawal by Subject|1|||
160790654|NCT00752219|580621526|FG000|Overall Study|Clinical failure|0|||
160790655|NCT00752219|580621527|FG001|Overall Study|Clinical failure|1|||
160790656|NCT00752219|580621526|FG000|Overall Study|Adverse Event|5|||
160790657|NCT00752219|580621527|FG001|Overall Study|Adverse Event|3|||
160790658|NCT00752219|580621526|FG000|Overall Study|Protocol deviation|1|||
160790659|NCT00752219|580621527|FG001|Overall Study|Protocol deviation|0|||
160790660|NCT00752219|580621526|FG000|Overall Study|Lost to Follow-up|1|||
160790661|NCT00752219|580621527|FG001|Overall Study|Lost to Follow-up|2|||
160790662|NCT00752219|580621526|FG000|Overall Study|Randomized but not treated|1|||
160790663|NCT00752219|580621527|FG001|Overall Study|Randomized but not treated|0|||
160790664|NCT00752219|580621526|FG000|Overall Study|Other|3|||
160642747|NCT03210259|580074365|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
160642748|NCT03210259|580074363|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
160790665|NCT00752219|580621527|FG001|Overall Study|Other|0|||
160790666|NCT01682720|580621538|FG000|Overall Study|Randomized but Not Treated|0|||
160790667|NCT01682720|580621539|FG001|Overall Study|Randomized but Not Treated|1|||
160790668|NCT01682720|580621540|FG002|Overall Study|Randomized but Not Treated|1|||
160790669|NCT01682720|580621541|FG003|Overall Study|Randomized but Not Treated|0|||
160790670|NCT01682720|580621538|FG000|Overall Study|Terminated by Sponsor|83|||
160790671|NCT01682720|580621539|FG001|Overall Study|Terminated by Sponsor|0|||
160790672|NCT01682720|580621540|FG002|Overall Study|Terminated by Sponsor|0|||
160790673|NCT01682720|580621541|FG003|Overall Study|Terminated by Sponsor|0|||
160790674|NCT01682720|580621538|FG000|Overall Study|Efficacy Failure|0|||
160790675|NCT01682720|580621539|FG001|Overall Study|Efficacy Failure|3|||
160790676|NCT01682720|580621540|FG002|Overall Study|Efficacy Failure|3|||
160790677|NCT01682720|580621541|FG003|Overall Study|Efficacy Failure|30|||
160548219|NCT03733392|579734057|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
160548220|NCT03733392|579734056|FG000|Overall Study|Patient Non-Compliance|2|||
160548221|NCT03733392|579734057|FG001|Overall Study|Patient Non-Compliance|1|||
160548222|NCT03733392|579734056|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
160548223|NCT03733392|579734057|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
160790678|NCT01682720|580621538|FG000|Overall Study|Lost to Follow-up|1|||
160790679|NCT01682720|580621539|FG001|Overall Study|Lost to Follow-up|1|||
160790680|NCT01682720|580621540|FG002|Overall Study|Lost to Follow-up|0|||
160790681|NCT01682720|580621541|FG003|Overall Study|Lost to Follow-up|6|||
160790682|NCT01682720|580621538|FG000|Overall Study|Subject Withdrew Consent|0|||
160790683|NCT01682720|580621539|FG001|Overall Study|Subject Withdrew Consent|0|||
160790684|NCT01682720|580621540|FG002|Overall Study|Subject Withdrew Consent|2|||
160790685|NCT01682720|580621541|FG003|Overall Study|Subject Withdrew Consent|2|||
160790686|NCT01682720|580621538|FG000|Overall Study|Adverse Event|1|||
160790687|NCT01682720|580621539|FG001|Overall Study|Adverse Event|0|||
160790688|NCT01682720|580621540|FG002|Overall Study|Adverse Event|1|||
160790689|NCT01682720|580621541|FG003|Overall Study|Adverse Event|1|||
160548224|NCT03733392|579734056|FG000|Overall Study|Withdrawal prior to procedure|5|||
160548225|NCT03733392|579734057|FG001|Overall Study|Withdrawal prior to procedure|2|||
160548226|NCT02740478|579734058|FG000|Overall Study|Withdrawal by Subject|1|||
160548227|NCT03124784|579734059|FG000|Overall Study|Adverse Event|1|||
160548228|NCT03124784|579734059|FG000|Overall Study|Computer/Equip Malfunction|1|||
160790690|NCT01687595|580621542|FG000|Overall Study|Withdrawal by Subject|8|||
160790691|NCT01687595|580621543|FG001|Overall Study|Withdrawal by Subject|0|||
160790692|NCT01687595|580621542|FG000|Overall Study|Lost to Follow-up|3|||
160790693|NCT01687595|580621543|FG001|Overall Study|Lost to Follow-up|1|||
160790694|NCT01687595|580621542|FG000|Overall Study|Investigator's decision|1|||
160790695|NCT01687595|580621543|FG001|Overall Study|Investigator's decision|0|||
160790696|NCT01687595|580621542|FG000|Overall Study|Sponsor's decision|1|||
160790697|NCT01687595|580621543|FG001|Overall Study|Sponsor's decision|0|||
160790698|NCT01687595|580621542|FG000|Overall Study|Noncompliance|1|||
160790699|NCT01687595|580621543|FG001|Overall Study|Noncompliance|2|||
160790700|NCT01687595|580621542|FG000|Overall Study|Other than specified|56|||
160790701|NCT01687595|580621543|FG001|Overall Study|Other than specified|7|||
160790702|NCT04204902|580621544|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
160790703|NCT04204902|580621545|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
160790704|NCT00979407|580621548|FG000|Overall Study|Withdrawal by Subject|3|||
160790705|NCT00979407|580621549|FG001|Overall Study|Withdrawal by Subject|4|||
160790706|NCT00979407|580621548|FG000|Overall Study|Lost to Follow-up|3|||
160790707|NCT00979407|580621549|FG001|Overall Study|Lost to Follow-up|3|||
160790708|NCT02940223|580621550|FG000|Overall Study|Failed Requirement|2|||
160790709|NCT02940223|580621551|FG001|Overall Study|Failed Requirement|0|||
160790710|NCT00803049|580621553|FG000|Overall Study|Adverse Event|21|||
160790711|NCT00803049|580621554|FG001|Overall Study|Adverse Event|33|||
160790712|NCT00803049|580621555|FG002|Overall Study|Adverse Event|13|||
160790713|NCT00803049|580621556|FG003|Overall Study|Adverse Event|27|||
160790714|NCT00803049|580621553|FG000|Overall Study|Lack of Efficacy|10|||
160790715|NCT00803049|580621554|FG001|Overall Study|Lack of Efficacy|19|||
160790716|NCT00803049|580621555|FG002|Overall Study|Lack of Efficacy|6|||
160790717|NCT00803049|580621556|FG003|Overall Study|Lack of Efficacy|13|||
160790718|NCT00803049|580621553|FG000|Overall Study|Lost to Follow-up|0|||
160790719|NCT00803049|580621554|FG001|Overall Study|Lost to Follow-up|2|||
160790720|NCT00803049|580621555|FG002|Overall Study|Lost to Follow-up|0|||
160790721|NCT00803049|580621556|FG003|Overall Study|Lost to Follow-up|3|||
160790722|NCT00803049|580621553|FG000|Overall Study|Death|2|||
160790723|NCT00803049|580621554|FG001|Overall Study|Death|1|||
160790724|NCT00803049|580621555|FG002|Overall Study|Death|0|||
160790725|NCT00803049|580621556|FG003|Overall Study|Death|2|||
160790726|NCT00803049|580621553|FG000|Overall Study|Progressive Disease|6|||
160790727|NCT00803049|580621554|FG001|Overall Study|Progressive Disease|10|||
160790728|NCT00803049|580621555|FG002|Overall Study|Progressive Disease|6|||
160790729|NCT00803049|580621556|FG003|Overall Study|Progressive Disease|6|||
160790730|NCT00803049|580621553|FG000|Overall Study|Withdrawal by Subject|19|||
160790731|NCT00803049|580621554|FG001|Overall Study|Withdrawal by Subject|43|||
160790732|NCT00803049|580621555|FG002|Overall Study|Withdrawal by Subject|16|||
160790733|NCT00803049|580621556|FG003|Overall Study|Withdrawal by Subject|44|||
160790734|NCT00803049|580621553|FG000|Overall Study|Protocol Violation|0|||
160790735|NCT00803049|580621554|FG001|Overall Study|Protocol Violation|1|||
160790736|NCT00803049|580621555|FG002|Overall Study|Protocol Violation|1|||
160790737|NCT00803049|580621556|FG003|Overall Study|Protocol Violation|0|||
160790738|NCT00803049|580621553|FG000|Overall Study|Randomized and Not Treated|0|||
160790739|NCT00803049|580621554|FG001|Overall Study|Randomized and Not Treated|0|||
160790740|NCT00803049|580621555|FG002|Overall Study|Randomized and Not Treated|0|||
160790741|NCT00803049|580621556|FG003|Overall Study|Randomized and Not Treated|2|||
160790742|NCT00803049|580621553|FG000|Overall Study|Other than Specified Above|3|||
160790743|NCT00803049|580621554|FG001|Overall Study|Other than Specified Above|9|||
160790744|NCT00803049|580621555|FG002|Overall Study|Other than Specified Above|2|||
160790745|NCT00803049|580621556|FG003|Overall Study|Other than Specified Above|5|||
160790746|NCT03773562|580621557|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
160790747|NCT03773562|580621557|FG000|Overall Study|Lost to Follow-up|10|||
160790748|NCT03773562|580621557|FG000|Overall Study|Withdrawal by Subject|1|||
160790749|NCT01272219|580621558|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
160790750|NCT01272219|580621559|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
160790751|NCT01272219|580621560|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
160790752|NCT01272219|580621561|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
160790753|NCT01272219|580621562|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
160790754|NCT01272219|580621563|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
160790755|NCT01272219|580621558|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
160548229|NCT05702515|579734060|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
160548230|NCT02847624|579734063|FG000|Overall Study|Lost to Follow-up|28|||
160548231|NCT02847624|579734063|FG000|Overall Study|Protocol Violation|98|||
160548232|NCT02847624|579734063|FG000|Overall Study|Case report failures|4|||
160548233|NCT04142983|579734075|FG000|Overall Study|Lost to Follow-up|73|||
160548234|NCT04142983|579734075|FG000|Overall Study|Withdrawal by Subject|10|||
160548235|NCT04142983|579734075|FG000|Overall Study|Physician Decision|1|||
160548236|NCT04142983|579734075|FG000|Overall Study|Adverse Event|1|||
160548237|NCT04142983|579734075|FG000|Overall Study|No longer eligible|4|||
160548238|NCT04142983|579734075|FG000|Overall Study|Screen Failure|10|||
160790756|NCT01272219|580621559|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
160790757|NCT01272219|580621560|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
160790758|NCT01272219|580621561|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
160548239|NCT04372927|579734076|FG000|Overall Study|Death|1|||
160548240|NCT03033745|579734077|FG000|Overall Study|Protocol Violation|0|||
160790759|NCT01272219|580621562|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
160790760|NCT01272219|580621563|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
160790761|NCT01272219|580621558|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
160790762|NCT01272219|580621559|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
160790763|NCT01272219|580621560|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
160790764|NCT01272219|580621561|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
160790765|NCT01272219|580621562|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
160790766|NCT01272219|580621563|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
160790767|NCT01272219|580621558|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
160790768|NCT01272219|580621559|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
160790769|NCT01272219|580621560|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
160790770|NCT01272219|580621561|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
160790771|NCT01272219|580621562|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
160790772|NCT01272219|580621563|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
160790773|NCT01272219|580621558|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
160790774|NCT01272219|580621559|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
160790775|NCT01272219|580621560|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
160790776|NCT01272219|580621561|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
160790777|NCT01272219|580621562|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
160790778|NCT01272219|580621563|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
160790779|NCT01272219|580621558|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
160790780|NCT01272219|580621559|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
160790781|NCT01272219|580621560|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
160790782|NCT01272219|580621561|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
160790783|NCT01272219|580621562|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
160790784|NCT01272219|580621563|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
160790785|NCT01272219|580621558|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
160790786|NCT01272219|580621559|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
160790787|NCT01272219|580621560|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
160790788|NCT01272219|580621561|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
160790789|NCT01272219|580621562|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
160790790|NCT01272219|580621563|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
160790791|NCT01272219|580621558|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
160790792|NCT01272219|580621559|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
160790793|NCT01272219|580621560|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
160790794|NCT01272219|580621561|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
160790795|NCT01272219|580621562|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
160790796|NCT01272219|580621563|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
160790797|NCT01272219|580621558|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
160790798|NCT01272219|580621559|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
160790799|NCT01272219|580621560|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
160790800|NCT01272219|580621561|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
160790801|NCT01272219|580621562|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
160790802|NCT01272219|580621563|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
160790803|NCT01272219|580621558|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
160790804|NCT01272219|580621559|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
160790805|NCT01272219|580621560|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
160790806|NCT01272219|580621561|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
160790807|NCT01272219|580621562|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
160790808|NCT01272219|580621563|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
160790809|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
160790810|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
160790811|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
160790812|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
160790813|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
160790814|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
160790815|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
160790816|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
160790817|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
160548241|NCT03033745|579734078|FG001|Overall Study|Protocol Violation|0|||
160790818|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
160790819|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
160790820|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
160548242|NCT03033745|579734079|FG002|Overall Study|Protocol Violation|1|||
160548243|NCT03033745|579734077|FG000|Overall Study|Adverse Event|1|||
160548244|NCT03033745|579734078|FG001|Overall Study|Adverse Event|0|||
160548245|NCT03033745|579734079|FG002|Overall Study|Adverse Event|1|||
160548246|NCT03033745|579734077|FG000|Overall Study|Withdrawal by Subject|0|||
160548247|NCT03033745|579734078|FG001|Overall Study|Withdrawal by Subject|1|||
160548248|NCT03033745|579734079|FG002|Overall Study|Withdrawal by Subject|0|||
160548249|NCT01999582|579734080|FG000|Overall Study|Withdrawal by Subject|0|||
160548250|NCT01999582|579734081|FG001|Overall Study|Withdrawal by Subject|0|||
160548251|NCT01999582|579734082|FG002|Overall Study|Withdrawal by Subject|0|||
160548252|NCT01999582|579734083|FG003|Overall Study|Withdrawal by Subject|1|||
160548253|NCT01999582|579734084|FG004|Overall Study|Withdrawal by Subject|0|||
160548254|NCT01999582|579734085|FG005|Overall Study|Withdrawal by Subject|0|||
160790821|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
160790822|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
160790823|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
160790824|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
160790825|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
160790826|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
160790827|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
160790828|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
160790829|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
160790830|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
160790831|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
160790832|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
160892209|NCT05140382|581000544|FG001|Overall Study|Death|0|||
160892210|NCT05140382|581000545|FG002|Overall Study|Death|0|||
160892211|NCT05140382|581000543|FG000|Overall Study|Investigator decision|1|||
160892212|NCT05140382|581000544|FG001|Overall Study|Investigator decision|0|||
160892213|NCT05140382|581000545|FG002|Overall Study|Investigator decision|0|||
160892214|NCT05140382|581000543|FG000|Overall Study|Other|4|||
160892215|NCT05140382|581000544|FG001|Overall Study|Other|0|||
160892216|NCT05140382|581000545|FG002|Overall Study|Other|1|||
160892217|NCT05140382|581000543|FG000|Overall Study|Progressive disease|20|||
160892218|NCT05140382|581000544|FG001|Overall Study|Progressive disease|1|||
160892219|NCT05140382|581000545|FG002|Overall Study|Progressive disease|12|||
160548255|NCT01999582|579734080|FG000|Overall Study|Adverse Event|0|||
160548256|NCT01999582|579734081|FG001|Overall Study|Adverse Event|0|||
160548257|NCT01999582|579734082|FG002|Overall Study|Adverse Event|3|||
160548258|NCT01999582|579734083|FG003|Overall Study|Adverse Event|0|||
160548259|NCT01999582|579734084|FG004|Overall Study|Adverse Event|1|||
160548260|NCT01999582|579734085|FG005|Overall Study|Adverse Event|0|||
160548261|NCT01999582|579734080|FG000|Overall Study|Other Reasons|1|||
160548262|NCT01999582|579734081|FG001|Overall Study|Other Reasons|0|||
160548263|NCT01999582|579734082|FG002|Overall Study|Other Reasons|3|||
160548264|NCT01999582|579734083|FG003|Overall Study|Other Reasons|1|||
160548265|NCT01999582|579734084|FG004|Overall Study|Other Reasons|1|||
160548266|NCT01999582|579734085|FG005|Overall Study|Other Reasons|2|||
160548267|NCT01999582|579734080|FG000|Overall Study|Protocol Violation|1|||
160548268|NCT01999582|579734081|FG001|Overall Study|Protocol Violation|0|||
160548269|NCT01999582|579734082|FG002|Overall Study|Protocol Violation|0|||
160548270|NCT01999582|579734083|FG003|Overall Study|Protocol Violation|0|||
160548271|NCT01999582|579734084|FG004|Overall Study|Protocol Violation|0|||
160548272|NCT01999582|579734085|FG005|Overall Study|Protocol Violation|1|||
160548273|NCT01999582|579734080|FG000|Overall Study|Lack of Efficacy|1|||
160548274|NCT01999582|579734081|FG001|Overall Study|Lack of Efficacy|3|||
160548275|NCT01999582|579734082|FG002|Overall Study|Lack of Efficacy|0|||
160548276|NCT01999582|579734083|FG003|Overall Study|Lack of Efficacy|1|||
160548277|NCT01999582|579734084|FG004|Overall Study|Lack of Efficacy|0|||
160548278|NCT01999582|579734085|FG005|Overall Study|Lack of Efficacy|0|||
160548279|NCT03728309|579734090|FG000|Overall Study|Randomized but not Treated|0|||
160548280|NCT03728309|579734091|FG001|Overall Study|Randomized but not Treated|1|||
160548281|NCT03728309|579734090|FG000|Overall Study|Adverse Event|0|||
160548282|NCT03728309|579734091|FG001|Overall Study|Adverse Event|1|||
160548283|NCT03728309|579734090|FG000|Overall Study|Withdrawal by Subject|2|||
160548284|NCT03728309|579734091|FG001|Overall Study|Withdrawal by Subject|8|||
160548285|NCT03728309|579734090|FG000|Overall Study|Lost to Follow-up|9|||
160548286|NCT03728309|579734091|FG001|Overall Study|Lost to Follow-up|10|||
160548287|NCT03728309|579734090|FG000|Overall Study|Protocol Deviation|0|||
160548288|NCT03728309|579734091|FG001|Overall Study|Protocol Deviation|1|||
160548289|NCT03728309|579734090|FG000|Overall Study|Due to COVID|1|||
160548290|NCT03728309|579734091|FG001|Overall Study|Due to COVID|3|||
160548291|NCT03847610|579734092|FG000|Overall Study|Withdrawal by Subject|1|||
160548292|NCT02004873|579734093|FG000|Overall Study|Implant unsuccessful|6|||
160548293|NCT02004873|579734093|FG000|Overall Study|Awaiting 6-month visit|390|||
160548294|NCT02004873|579734093|FG000|Overall Study|Missed 6-month visit|4|||
160548295|NCT02004873|579734093|FG000|Overall Study|Death|23|||
160548296|NCT02004873|579734093|FG000|Overall Study|Withdrawal by Subject|1|||
160548297|NCT01445769|579734095|FG000|Overall Study|Consent Withdrawn|2|||
160548298|NCT01445769|579734095|FG000|Overall Study|Disease Progression|1|||
160548299|NCT01445769|579734095|FG000|Overall Study|Lost to Follow-up|5|||
160790833|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
160790834|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
160892220|NCT05140382|581000543|FG000|Overall Study|Subjective disease progression|2|||
160892221|NCT05140382|581000544|FG001|Overall Study|Subjective disease progression|1|||
160548300|NCT00044512|579734098|FG000|Follow Up|Lost to Follow-up|2|||
160548301|NCT02799069|579734099|FG000|Overall Study|Adverse Event|0|||
160548302|NCT02799069|579734100|FG001|Overall Study|Adverse Event|2|||
160548303|NCT02799069|579734101|FG002|Overall Study|Adverse Event|2|||
160892222|NCT05140382|581000545|FG002|Overall Study|Subjective disease progression|0|||
160790835|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
160790836|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
160790837|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
160790838|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
160790839|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
160790840|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
160790841|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
160790842|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
160790843|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
160790844|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
160790845|NCT05021224|580621574|FG000|Overall Study|Did not complete all survey items|4|||
160790846|NCT05021224|580621575|FG001|Overall Study|Did not complete all survey items|1|||
160790847|NCT05021224|580621576|FG002|Overall Study|Did not complete all survey items|0|||
160790848|NCT05021224|580621577|FG003|Overall Study|Did not complete all survey items|2|||
160790849|NCT03996395|580621578|FG000|Overall Study|Lost to Follow-up|4|||
160790850|NCT03996395|580621578|FG000|Overall Study|Withdrawal by Subject|1|||
160790851|NCT03996395|580621578|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
160790852|NCT03973489|580621590|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
160790853|NCT03973489|580621591|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790854|NCT03973489|580621592|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790855|NCT03973489|580621593|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790856|NCT03973489|580621594|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
160790857|NCT03973489|580621595|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790858|NCT03973489|580621596|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790859|NCT03973489|580621597|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790860|NCT03973489|580621590|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160790861|NCT03973489|580621591|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160790862|NCT03973489|580621592|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160790863|NCT03973489|580621593|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
160790864|NCT03973489|580621594|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
160548304|NCT02799069|579734099|FG000|Overall Study|Lack of Efficacy|2|||
160548305|NCT02799069|579734100|FG001|Overall Study|Lack of Efficacy|0|||
160548306|NCT02799069|579734101|FG002|Overall Study|Lack of Efficacy|0|||
160548307|NCT02799069|579734099|FG000|Overall Study|Lost to Follow-up|1|||
160548308|NCT02799069|579734100|FG001|Overall Study|Lost to Follow-up|1|||
160548309|NCT02799069|579734101|FG002|Overall Study|Lost to Follow-up|0|||
160548310|NCT02799069|579734099|FG000|Overall Study|Withdrawal by Subject|4|||
160548311|NCT02799069|579734100|FG001|Overall Study|Withdrawal by Subject|4|||
160548312|NCT02799069|579734101|FG002|Overall Study|Withdrawal by Subject|3|||
160548313|NCT02799069|579734099|FG000|Overall Study|Protocol Violation|1|||
160548314|NCT02799069|579734100|FG001|Overall Study|Protocol Violation|0|||
160548315|NCT02799069|579734101|FG002|Overall Study|Protocol Violation|2|||
160548316|NCT05130463|579734112|FG000|Overall Study|Unspecified reasons|2|||
160548317|NCT05130463|579734112|FG000|Overall Study|off-label indication dose|435|||
160548318|NCT03652662|579734114|FG000|Overall Study|Withdrawal by Subject|2|||
160548319|NCT03652662|579734115|FG001|Overall Study|Withdrawal by Subject|1|||
160548320|NCT03652662|579734114|FG000|Overall Study|Lost to Follow-up|1|||
160548321|NCT03652662|579734115|FG001|Overall Study|Lost to Follow-up|0|||
160548322|NCT00487539|579734116|FG000|Overall Study|Adverse Event|3|||
160548323|NCT00487539|579734117|FG001|Overall Study|Adverse Event|2|||
160548324|NCT00487539|579734118|FG002|Overall Study|Adverse Event|1|||
160548325|NCT00487539|579734119|FG003|Overall Study|Adverse Event|1|||
160548326|NCT00487539|579734116|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160548327|NCT00487539|579734117|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160790865|NCT03973489|580621595|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160790866|NCT03973489|580621596|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160548328|NCT00487539|579734118|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160548329|NCT00487539|579734119|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
160548330|NCT00487539|579734116|FG000|Overall Study|Other|3|||
160892223|NCT05140382|581000543|FG000|Overall Study|Unknown at data cut-off|0|||
160892224|NCT05140382|581000544|FG001|Overall Study|Unknown at data cut-off|0|||
160892225|NCT05140382|581000545|FG002|Overall Study|Unknown at data cut-off|1|||
160892226|NCT05140382|581000543|FG000|Overall Study|Withdrawal by Subject|1|||
160892227|NCT05140382|581000544|FG001|Overall Study|Withdrawal by Subject|0|||
160892228|NCT05140382|581000545|FG002|Overall Study|Withdrawal by Subject|4|||
160892229|NCT05140382|581000543|FG000|Overall Study|Withdrawal of consent|0|||
160892230|NCT05140382|581000544|FG001|Overall Study|Withdrawal of consent|0|||
160892231|NCT05140382|581000545|FG002|Overall Study|Withdrawal of consent|1|||
160917926|NCT02673489|581094149|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
160917927|NCT02673489|581094148|FG000|Follow Up Period|Unable to return for follow-up|0|||
160917928|NCT02673489|581094149|FG001|Follow Up Period|Unable to return for follow-up|1|||
160917929|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
160917930|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
160917931|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
160917932|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
160917933|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
160892232|NCT01927341|581002126|FG000|Phase 1b|Lost to Follow-up|1|||
160892233|NCT01927341|581002127|FG001|Phase 1b|Lost to Follow-up|0|||
160790867|NCT03973489|580621597|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160790868|NCT03973489|580621590|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790869|NCT03973489|580621591|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790870|NCT03973489|580621592|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790871|NCT03973489|580621593|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790872|NCT03973489|580621594|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
160790873|NCT03973489|580621595|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790874|NCT03973489|580621596|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
160790875|NCT03973489|580621597|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790876|NCT03973489|580621590|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
160790877|NCT03973489|580621591|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790878|NCT03973489|580621592|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790879|NCT03973489|580621593|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
160790880|NCT03973489|580621594|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790881|NCT03973489|580621595|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790882|NCT03973489|580621596|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790883|NCT03973489|580621597|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790884|NCT03973489|580621590|FG000|Second Intervention (1 Day)|Adverse Event|0|||
160790885|NCT03973489|580621591|FG001|Second Intervention (1 Day)|Adverse Event|0|||
160790886|NCT03973489|580621592|FG002|Second Intervention (1 Day)|Adverse Event|0|||
160790887|NCT03973489|580621593|FG003|Second Intervention (1 Day)|Adverse Event|1|||
160790888|NCT03973489|580621594|FG004|Second Intervention (1 Day)|Adverse Event|0|||
160790889|NCT03973489|580621595|FG005|Second Intervention (1 Day)|Adverse Event|0|||
160790890|NCT03973489|580621596|FG006|Second Intervention (1 Day)|Adverse Event|0|||
160790891|NCT03973489|580621597|FG007|Second Intervention (1 Day)|Adverse Event|0|||
160790892|NCT03301415|580621598|FG000|Overall Study|Lost to Follow-up|2|||
160790893|NCT03301415|580621598|FG000|Overall Study|Unable to comply with visit schedule|2|||
160790894|NCT00392288|580621599|FG000|Overall Study|Adverse Event|17|||
160790895|NCT00392288|580621600|FG001|Overall Study|Adverse Event|7|||
160790896|NCT00392288|580621601|FG002|Overall Study|Adverse Event|8|||
160790897|NCT00392288|580621599|FG000|Overall Study|Lack of Efficacy|8|||
160790898|NCT00392288|580621600|FG001|Overall Study|Lack of Efficacy|5|||
160790899|NCT00392288|580621601|FG002|Overall Study|Lack of Efficacy|3|||
160790900|NCT00392288|580621599|FG000|Overall Study|Protocol Violation|1|||
160790901|NCT00392288|580621600|FG001|Overall Study|Protocol Violation|3|||
160790902|NCT00392288|580621601|FG002|Overall Study|Protocol Violation|1|||
160790903|NCT00392288|580621599|FG000|Overall Study|Lost to Follow-up|1|||
160790904|NCT00392288|580621600|FG001|Overall Study|Lost to Follow-up|1|||
160790905|NCT00392288|580621601|FG002|Overall Study|Lost to Follow-up|1|||
160790906|NCT00392288|580621599|FG000|Overall Study|Withdrawal by Subject|1|||
160790907|NCT00392288|580621600|FG001|Overall Study|Withdrawal by Subject|0|||
160790908|NCT00392288|580621601|FG002|Overall Study|Withdrawal by Subject|2|||
160790909|NCT00392288|580621599|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
160790910|NCT00392288|580621600|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
160790911|NCT00392288|580621601|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
160790912|NCT00392288|580621599|FG000|Overall Study|Other|3|||
160790913|NCT00392288|580621600|FG001|Overall Study|Other|4|||
160790914|NCT00392288|580621601|FG002|Overall Study|Other|1|||
160790915|NCT02544763|580621602|FG000|Overall Study|Adverse Event|8|||
160790916|NCT02544763|580621603|FG001|Overall Study|Adverse Event|8|||
160790917|NCT02544763|580621604|FG002|Overall Study|Adverse Event|0|||
160892234|NCT01927341|581002128|FG002|Phase 1b|Lost to Follow-up|0|||
160892235|NCT01927341|581002129|FG003|Phase 1b|Lost to Follow-up|0|||
160892236|NCT01927341|581002130|FG004|Phase 1b|Lost to Follow-up|0|||
160892237|NCT01927341|581002126|FG000|Phase 1b|Death|2|||
160892238|NCT01927341|581002127|FG001|Phase 1b|Death|0|||
160892239|NCT01927341|581002128|FG002|Phase 1b|Death|0|||
160790918|NCT02544763|580621602|FG000|Overall Study|Withdrawn by parent/guardian|1|||
160790919|NCT02544763|580621603|FG001|Overall Study|Withdrawn by parent/guardian|1|||
160892240|NCT01927341|581002129|FG003|Phase 1b|Death|0|||
160790920|NCT02544763|580621604|FG002|Overall Study|Withdrawn by parent/guardian|1|||
160790921|NCT02544763|580621602|FG000|Overall Study|Met withdrawal criteria|0|||
160790922|NCT02544763|580621603|FG001|Overall Study|Met withdrawal criteria|2|||
160790923|NCT02544763|580621604|FG002|Overall Study|Met withdrawal criteria|0|||
160892241|NCT01927341|581002130|FG004|Phase 1b|Death|0|||
160790924|NCT02544763|580621602|FG000|Overall Study|Physician Decision|0|||
160790925|NCT02544763|580621603|FG001|Overall Study|Physician Decision|1|||
160892242|NCT01927341|581002126|FG000|Phase 1b|Follow-up completed|7|||
160790926|NCT02544763|580621604|FG002|Overall Study|Physician Decision|0|||
160790927|NCT02544763|580621602|FG000|Overall Study|Difficulties taking IMP|1|||
160790928|NCT02544763|580621603|FG001|Overall Study|Difficulties taking IMP|0|||
160892243|NCT01927341|581002127|FG001|Phase 1b|Follow-up completed|0|||
160790929|NCT02544763|580621604|FG002|Overall Study|Difficulties taking IMP|0|||
160790930|NCT02097225|580621605|FG000|Dose Level 4|Adverse Event|0|||
160790931|NCT02097225|580621606|FG001|Dose Level 4|Adverse Event|0|||
160790932|NCT02097225|580621607|FG002|Dose Level 4|Adverse Event|0|||
160790933|NCT02097225|580621608|FG003|Dose Level 4|Adverse Event|0|||
160790934|NCT02097225|580621609|FG004|Dose Level 4|Adverse Event|1|||
160790935|NCT00911157|580621612|FG000|Overall Study|Adverse Event|4|||
160790936|NCT00911157|580621613|FG001|Overall Study|Adverse Event|1|||
160790937|NCT00911157|580621612|FG000|Overall Study|Withdrawal by Subject|1|||
160790938|NCT00911157|580621613|FG001|Overall Study|Withdrawal by Subject|1|||
160790939|NCT00911157|580621612|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
160790940|NCT00911157|580621613|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
160790941|NCT00911157|580621612|FG000|Overall Study|Need to treat for lung cancer|1|||
160790942|NCT00911157|580621613|FG001|Overall Study|Need to treat for lung cancer|0|||
160790943|NCT00787800|580621616|FG000|Overall Study|Withdrawal by Subject|3|||
160790944|NCT00787800|580621617|FG001|Overall Study|Withdrawal by Subject|5|||
160790945|NCT00787800|580621616|FG000|Overall Study|Death|0|||
160790946|NCT00787800|580621617|FG001|Overall Study|Death|2|||
160790947|NCT00461812|580621624|FG000|Overall Study|study terminated|10|||
160790948|NCT02579759|580623715|FG000|Overall Study|Protocol Violation|2|||
160790949|NCT02579759|580623716|FG001|Overall Study|Protocol Violation|0|||
160790950|NCT02579759|580623717|FG002|Overall Study|Protocol Violation|0|||
160790951|NCT02579759|580623715|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
160790952|NCT02579759|580623716|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
160790953|NCT02579759|580623717|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
160790954|NCT02579759|580623715|FG000|Overall Study|BfArM hold|13|||
160790955|NCT02579759|580623716|FG001|Overall Study|BfArM hold|12|||
160790956|NCT02579759|580623717|FG002|Overall Study|BfArM hold|12|||
160790957|NCT02579759|580623715|FG000|Overall Study|Sponsor stopped Dose 2|0|||
160790958|NCT02579759|580623716|FG001|Overall Study|Sponsor stopped Dose 2|41|||
160790959|NCT02579759|580623717|FG002|Overall Study|Sponsor stopped Dose 2|0|||
160790960|NCT02579759|580623715|FG000|Overall Study|Non compliance|0|||
160790961|NCT02579759|580623716|FG001|Overall Study|Non compliance|1|||
160790962|NCT02579759|580623717|FG002|Overall Study|Non compliance|0|||
160790963|NCT02579759|580623715|FG000|Overall Study|Pregnancy|0|||
160790964|NCT02579759|580623716|FG001|Overall Study|Pregnancy|1|||
160790965|NCT02579759|580623717|FG002|Overall Study|Pregnancy|0|||
160790966|NCT02579759|580623715|FG000|Overall Study|Inclusion/exclusion criteria|0|||
160790967|NCT02579759|580623716|FG001|Overall Study|Inclusion/exclusion criteria|0|||
160790968|NCT02579759|580623717|FG002|Overall Study|Inclusion/exclusion criteria|1|||
160790969|NCT02579759|580623715|FG000|Overall Study|Adverse Event|4|||
160790970|NCT02579759|580623716|FG001|Overall Study|Adverse Event|3|||
160790971|NCT02579759|580623717|FG002|Overall Study|Adverse Event|1|||
160790972|NCT02579759|580623715|FG000|Overall Study|Withdrawal by Subject|3|||
160790973|NCT02579759|580623716|FG001|Overall Study|Withdrawal by Subject|3|||
160790974|NCT02579759|580623717|FG002|Overall Study|Withdrawal by Subject|5|||
160790975|NCT02579759|580623715|FG000|Overall Study|Lost to Follow-up|2|||
160790976|NCT02579759|580623716|FG001|Overall Study|Lost to Follow-up|2|||
160790977|NCT02579759|580623717|FG002|Overall Study|Lost to Follow-up|2|||
160790978|NCT01904279|580623724|FG000|Overall Study|Lack of Efficacy|2|||
160790979|NCT01904279|580623725|FG001|Overall Study|Lack of Efficacy|3|||
160790980|NCT01904279|580623724|FG000|Overall Study|Withdrawal by Subject|1|||
160790981|NCT01904279|580623725|FG001|Overall Study|Withdrawal by Subject|0|||
160790982|NCT03283241|580623726|FG000|Overall Study|Adverse Event|4|||
160790983|NCT03283241|580623727|FG001|Overall Study|Adverse Event|1|||
160790984|NCT03283241|580623726|FG000|Overall Study|Withdrawal by Subject|0|||
160790985|NCT03283241|580623727|FG001|Overall Study|Withdrawal by Subject|1|||
160790986|NCT03283241|580623726|FG000|Overall Study|Subject relocated to Finland|0|||
160790987|NCT03283241|580623727|FG001|Overall Study|Subject relocated to Finland|1|||
160790988|NCT00666263|580623728|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
160790989|NCT00666263|580623729|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
160790990|NCT00666263|580623728|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
160790991|NCT00666263|580623729|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
160790992|NCT00666263|580623728|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
160790993|NCT00666263|580623729|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
160790994|NCT00586157|580623730|FG000|First Intervention|Worsening behavior|1|||
160790995|NCT00586157|580623731|FG001|First Intervention|Worsening behavior|0|||
160790996|NCT00586157|580623730|FG000|Second Intervention|Withdrawal by Subject|1|||
160790997|NCT00586157|580623731|FG001|Second Intervention|Withdrawal by Subject|0|||
160790998|NCT00586157|580623730|FG000|Second Intervention|Worsening behavior|1|||
160790999|NCT00586157|580623731|FG001|Second Intervention|Worsening behavior|0|||
160791000|NCT00586157|580623730|FG000|Second Intervention|Adverse Event|0|||
160791001|NCT00586157|580623731|FG001|Second Intervention|Adverse Event|1|||
160791002|NCT00278161|580623733|FG000|Overall Study|Death|11|||
160892244|NCT01927341|581002128|FG002|Phase 1b|Follow-up completed|0|||
160892245|NCT01927341|581002129|FG003|Phase 1b|Follow-up completed|0|||
160892246|NCT01927341|581002130|FG004|Phase 1b|Follow-up completed|0|||
160892247|NCT01927341|581002126|FG000|Phase 2|Lost to Follow-up|0|||
160892248|NCT01927341|581002127|FG001|Phase 2|Lost to Follow-up|1|||
160892249|NCT01927341|581002128|FG002|Phase 2|Lost to Follow-up|0|||
160892250|NCT01927341|581002129|FG003|Phase 2|Lost to Follow-up|0|||
160892251|NCT01927341|581002130|FG004|Phase 2|Lost to Follow-up|0|||
160892252|NCT01927341|581002126|FG000|Phase 2|Participant withdrew consent|0|||
160892253|NCT01927341|581002127|FG001|Phase 2|Participant withdrew consent|2|||
160892254|NCT01927341|581002128|FG002|Phase 2|Participant withdrew consent|1|||
160791003|NCT01817777|580623734|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
160791004|NCT01817777|580623735|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
160791005|NCT01817777|580623736|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
160791006|NCT01817777|580623734|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
160791007|NCT01817777|580623735|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
160791008|NCT01817777|580623736|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
160791009|NCT01817777|580623734|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
160892255|NCT01927341|581002129|FG003|Phase 2|Participant withdrew consent|2|||
160892256|NCT01927341|581002130|FG004|Phase 2|Participant withdrew consent|3|||
160892257|NCT01927341|581002126|FG000|Phase 2|Death|0|||
160892258|NCT01927341|581002127|FG001|Phase 2|Death|4|||
160892259|NCT01927341|581002128|FG002|Phase 2|Death|0|||
160892260|NCT01927341|581002129|FG003|Phase 2|Death|3|||
160892261|NCT01927341|581002130|FG004|Phase 2|Death|2|||
160892262|NCT01927341|581002126|FG000|Phase 2|New cancer therapy|0|||
160892263|NCT01927341|581002127|FG001|Phase 2|New cancer therapy|1|||
160892264|NCT01927341|581002128|FG002|Phase 2|New cancer therapy|0|||
160892265|NCT01927341|581002129|FG003|Phase 2|New cancer therapy|4|||
160892266|NCT01927341|581002130|FG004|Phase 2|New cancer therapy|1|||
160892267|NCT01927341|581002126|FG000|Phase 2|Disease progression|0|||
160981896|NCT01024751|581321791|FG000|Eligible Participants|Lost to Follow-up|0|||
160981897|NCT01024751|581321792|FG001|Eligible Participants|Lost to Follow-up|1|||
160981898|NCT01024751|581321791|FG000|Eligible Participants|Ineligible|0|||
160981899|NCT01024751|581321792|FG001|Eligible Participants|Ineligible|1|||
160981900|NCT00577720|581321797|FG000|Overall Study|Adverse Event|2|||
160981901|NCT00577720|581321798|FG001|Overall Study|Adverse Event|1|||
160981902|NCT00577720|581321799|FG002|Overall Study|Adverse Event|0|||
160981903|NCT00577720|581321800|FG003|Overall Study|Adverse Event|4|||
160981904|NCT00577720|581321797|FG000|Overall Study|Lost to Follow-up|0|||
160981905|NCT00577720|581321798|FG001|Overall Study|Lost to Follow-up|0|||
160981906|NCT00577720|581321799|FG002|Overall Study|Lost to Follow-up|1|||
160981907|NCT00577720|581321800|FG003|Overall Study|Lost to Follow-up|0|||
160981908|NCT00577720|581321797|FG000|Overall Study|Protocol Violation|0|||
160981909|NCT00577720|581321798|FG001|Overall Study|Protocol Violation|0|||
160981910|NCT00577720|581321799|FG002|Overall Study|Protocol Violation|0|||
160981911|NCT00577720|581321800|FG003|Overall Study|Protocol Violation|1|||
160981912|NCT00577720|581321797|FG000|Overall Study|Withdrawal by Subject|2|||
160981913|NCT00577720|581321798|FG001|Overall Study|Withdrawal by Subject|0|||
160981914|NCT00577720|581321799|FG002|Overall Study|Withdrawal by Subject|0|||
160981915|NCT00577720|581321800|FG003|Overall Study|Withdrawal by Subject|2|||
160981916|NCT03246672|581321801|FG000|Overall Study|Lost to Follow-up|2|||
160981917|NCT03260504|581321802|FG000|Overall Study|Adverse Event|0|||
160981918|NCT03260504|581321803|FG001|Overall Study|Adverse Event|1|||
160981919|NCT00967018|581321804|FG000|Overall Study|Adverse Event|2|||
160981920|NCT00967018|581321804|FG000|Overall Study|Physician Decision|7|||
160981921|NCT00967018|581321804|FG000|Overall Study|Lost to Follow-up|2|||
160981922|NCT00967018|581321804|FG000|Overall Study|Withdrawal by Subject|1|||
160981923|NCT00967018|581321804|FG000|Overall Study|Miscellaneous Reasons|9|||
160981924|NCT01932996|581321805|FG000|Overall Study|Protocol Violation|2|||
160981925|NCT01932996|581321806|FG001|Overall Study|Protocol Violation|0|||
160981926|NCT00846742|581321809|FG000|Overall Study|Withdrawal by Subject|1|||
160981927|NCT04170296|581321825|FG000|Overall Study|Adverse Event|1|||
160981928|NCT04170296|581321826|FG001|Overall Study|Adverse Event|0|||
160791010|NCT01817777|580623735|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
160892268|NCT01927341|581002127|FG001|Phase 2|Disease progression|1|||
160892269|NCT01927341|581002128|FG002|Phase 2|Disease progression|1|||
160892270|NCT01927341|581002129|FG003|Phase 2|Disease progression|1|||
160892271|NCT01927341|581002130|FG004|Phase 2|Disease progression|0|||
160892272|NCT01927341|581002126|FG000|Phase 2|Follow-up completed|0|||
160892273|NCT01927341|581002127|FG001|Phase 2|Follow-up completed|6|||
160981929|NCT04170296|581321825|FG000|Overall Study|Withdrawal by Subject|3|||
160981930|NCT04170296|581321826|FG001|Overall Study|Withdrawal by Subject|2|||
160981931|NCT04170296|581321825|FG000|Overall Study|Lost to Follow-up|4|||
160981932|NCT04170296|581321826|FG001|Overall Study|Lost to Follow-up|2|||
160981933|NCT03567993|581321827|FG000|Overall Study|Lost to Follow-up|4|||
160791011|NCT01817777|580623736|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
160892274|NCT01927341|581002128|FG002|Phase 2|Follow-up completed|3|||
160892275|NCT01927341|581002129|FG003|Phase 2|Follow-up completed|5|||
160791012|NCT01817777|580623734|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
160791013|NCT01817777|580623735|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
160791014|NCT01817777|580623736|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
160791015|NCT01817777|580623734|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
160791016|NCT01817777|580623735|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
160791017|NCT01817777|580623736|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
160791018|NCT00414609|580623737|FG000|Core Study|Adverse Event|9|||
160791019|NCT00414609|580623738|FG001|Core Study|Adverse Event|11|||
160791020|NCT00414609|580623739|FG002|Core Study|Adverse Event|0|||
160791021|NCT00414609|580623737|FG000|Core Study|Abnormal laboratory values|0|||
160791022|NCT00414609|580623738|FG001|Core Study|Abnormal laboratory values|1|||
160791023|NCT00414609|580623739|FG002|Core Study|Abnormal laboratory values|0|||
160791024|NCT00414609|580623737|FG000|Core Study|Abnormal test procedure results|1|||
160791025|NCT00414609|580623738|FG001|Core Study|Abnormal test procedure results|1|||
160892276|NCT01927341|581002130|FG004|Phase 2|Follow-up completed|2|||
160892277|NCT01104701|581002131|FG000|Overall Study|Withdrawal by Subject|0|||
160892278|NCT01104701|581002132|FG001|Overall Study|Withdrawal by Subject|1|||
160892279|NCT01104701|581002133|FG002|Overall Study|Withdrawal by Subject|2|||
160892280|NCT01104701|581002134|FG003|Overall Study|Withdrawal by Subject|1|||
160892281|NCT01104701|581002131|FG000|Overall Study|Adverse Event|0|||
160892282|NCT01104701|581002132|FG001|Overall Study|Adverse Event|0|||
160892283|NCT01104701|581002133|FG002|Overall Study|Adverse Event|0|||
160892284|NCT01104701|581002134|FG003|Overall Study|Adverse Event|1|||
160892285|NCT01104701|581002131|FG000|Overall Study|Physician Decision|0|||
160892286|NCT01104701|581002132|FG001|Overall Study|Physician Decision|2|||
160892287|NCT01104701|581002133|FG002|Overall Study|Physician Decision|0|||
160892288|NCT01104701|581002134|FG003|Overall Study|Physician Decision|0|||
160892289|NCT00423722|581002135|FG000|Overall Study|Death|4|||
160892290|NCT00423722|581002136|FG001|Overall Study|Death|4|||
160892291|NCT00423722|581002135|FG000|Overall Study|Declined to participate|2|||
160892292|NCT00423722|581002136|FG001|Overall Study|Declined to participate|3|||
160892293|NCT00423722|581002135|FG000|Overall Study|Unable to complete questionnaires|4|||
160892294|NCT00423722|581002136|FG001|Overall Study|Unable to complete questionnaires|4|||
160892295|NCT00423722|581002135|FG000|Overall Study|Withdrawal by Subject|4|||
160892296|NCT00423722|581002136|FG001|Overall Study|Withdrawal by Subject|2|||
160892297|NCT00674973|581002137|FG000|Overall Study|Insufficient Therapeutic Response|77|||
160892298|NCT00674973|581002138|FG001|Overall Study|Insufficient Therapeutic Response|72|||
160892299|NCT00674973|581002137|FG000|Overall Study|Refused Treatment|1|||
160892300|NCT00674973|581002138|FG001|Overall Study|Refused Treatment|5|||
160892301|NCT00674973|581002137|FG000|Overall Study|Failure to Return|1|||
160892302|NCT00674973|581002138|FG001|Overall Study|Failure to Return|0|||
160892303|NCT00674973|581002137|FG000|Overall Study|Adverse Event|2|||
160892304|NCT00674973|581002138|FG001|Overall Study|Adverse Event|9|||
160892305|NCT00674973|581002137|FG000|Overall Study|Death|19|||
160892306|NCT00674973|581002138|FG001|Overall Study|Death|15|||
160892307|NCT00674973|581002137|FG000|Overall Study|Protocol Violation|0|||
160892308|NCT00674973|581002138|FG001|Overall Study|Protocol Violation|1|||
160892309|NCT00451451|581002139|FG000|Overall Study|Adverse Event|11|||
160892310|NCT00451451|581002140|FG001|Overall Study|Adverse Event|21|||
160892311|NCT00451451|581002141|FG002|Overall Study|Adverse Event|26|||
160892312|NCT00451451|581002142|FG003|Overall Study|Adverse Event|10|||
160892313|NCT00451451|581002139|FG000|Overall Study|Lost to Follow-up|11|||
160892314|NCT00451451|581002140|FG001|Overall Study|Lost to Follow-up|9|||
160892315|NCT00451451|581002141|FG002|Overall Study|Lost to Follow-up|8|||
160892316|NCT00451451|581002142|FG003|Overall Study|Lost to Follow-up|11|||
160892317|NCT00451451|581002139|FG000|Overall Study|Consent Withdrawn|14|||
160892318|NCT00451451|581002140|FG001|Overall Study|Consent Withdrawn|9|||
160892319|NCT00451451|581002141|FG002|Overall Study|Consent Withdrawn|17|||
160892320|NCT00451451|581002142|FG003|Overall Study|Consent Withdrawn|17|||
160892321|NCT00451451|581002139|FG000|Overall Study|Investigator Decision|6|||
160892322|NCT00451451|581002140|FG001|Overall Study|Investigator Decision|2|||
160892323|NCT00451451|581002141|FG002|Overall Study|Investigator Decision|1|||
160892324|NCT00451451|581002142|FG003|Overall Study|Investigator Decision|2|||
160892325|NCT00451451|581002139|FG000|Overall Study|Subject Non-Compliance|8|||
160892326|NCT00451451|581002140|FG001|Overall Study|Subject Non-Compliance|4|||
160892327|NCT00451451|581002141|FG002|Overall Study|Subject Non-Compliance|3|||
160892328|NCT00451451|581002142|FG003|Overall Study|Subject Non-Compliance|3|||
160892329|NCT00451451|581002139|FG000|Overall Study|Death|1|||
160892330|NCT00451451|581002140|FG001|Overall Study|Death|0|||
160892331|NCT00451451|581002141|FG002|Overall Study|Death|0|||
160892332|NCT00451451|581002142|FG003|Overall Study|Death|1|||
160892333|NCT00451451|581002139|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
160892334|NCT00451451|581002140|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
160892335|NCT00451451|581002141|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
160892336|NCT00451451|581002142|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
160981934|NCT03567993|581321828|FG001|Overall Study|Lost to Follow-up|2|||
160981935|NCT03567993|581321827|FG000|Overall Study|Death|1|||
160981936|NCT03567993|581321828|FG001|Overall Study|Death|1|||
160981937|NCT03567993|581321827|FG000|Overall Study|Withdrawal by Subject|1|||
160981938|NCT03567993|581321828|FG001|Overall Study|Withdrawal by Subject|0|||
160981939|NCT02044458|581321833|FG000|Overall Study|Protocol Violation|3|||
160981940|NCT02044458|581321834|FG001|Overall Study|Protocol Violation|8|||
160981941|NCT02819479|581323356|FG000|Overall Study|Adverse Event|2|||
160981942|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
160981943|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
160981944|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
160981945|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
160981946|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
160981947|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
160981948|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
160981949|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
160981950|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
160981951|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
160981952|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
160981953|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
160981954|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
160981955|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
160981956|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
160981957|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
160981958|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
160981959|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
160981960|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
160981961|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
160981962|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
160981963|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Other|2|||
160981964|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Other|0|||
160981965|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Other|1|||
160981966|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Adverse Event|21|||
160981967|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Adverse Event|26|||
160981968|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Adverse Event|0|||
160981969|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
160981970|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
160981971|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
160981972|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
160981973|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
160981974|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
160981975|NCT02718417|581323357|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
160981976|NCT02718417|581323358|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
160981977|NCT02718417|581323359|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
160981978|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Physician's decision|6|||
160981979|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Physician's decision|7|||
160981980|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Physician's decision|0|||
160981981|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Progressive disease|100|||
160981982|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Progressive disease|88|||
160981983|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Progressive disease|0|||
160981984|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Other|2|||
160981985|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Other|1|||
160981986|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Other|0|||
160981987|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
160981988|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
160981989|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
160981990|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
160981991|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
160981992|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
160981993|NCT02718417|581323357|FG000|Observation Phase (OP)|Adverse Event|0|||
160981994|NCT02718417|581323358|FG001|Observation Phase (OP)|Adverse Event|0|||
160981995|NCT02718417|581323359|FG002|Observation Phase (OP)|Adverse Event|1|||
160981996|NCT02718417|581323357|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
160981997|NCT02718417|581323358|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
160981998|NCT02718417|581323359|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
160981999|NCT02718417|581323357|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
160642749|NCT03210259|580074364|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
160982000|NCT02718417|581323358|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
160982001|NCT02718417|581323359|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
160982002|NCT02718417|581323357|FG000|Observation Phase (OP)|Physician Decision|0|||
160791026|NCT00414609|580623739|FG002|Core Study|Abnormal test procedure results|0|||
160791027|NCT00414609|580623737|FG000|Core Study|Protocol deviation|0|||
160791028|NCT00414609|580623738|FG001|Core Study|Protocol deviation|1|||
160791029|NCT00414609|580623739|FG002|Core Study|Protocol deviation|0|||
160791030|NCT00414609|580623737|FG000|Core Study|Patient withdrew consent|10|||
160791031|NCT00414609|580623738|FG001|Core Study|Patient withdrew consent|11|||
160791032|NCT00414609|580623739|FG002|Core Study|Patient withdrew consent|0|||
160791033|NCT00414609|580623737|FG000|Core Study|Lost to Follow-up|7|||
160791034|NCT00414609|580623738|FG001|Core Study|Lost to Follow-up|4|||
160791035|NCT00414609|580623739|FG002|Core Study|Lost to Follow-up|0|||
160791036|NCT00414609|580623737|FG000|Core Study|Administrative problems|0|||
160791037|NCT00414609|580623738|FG001|Core Study|Administrative problems|2|||
160791038|NCT00414609|580623739|FG002|Core Study|Administrative problems|0|||
160791039|NCT00414609|580623737|FG000|Core Study|Death|7|||
160791040|NCT00414609|580623738|FG001|Core Study|Death|14|||
160791041|NCT00414609|580623739|FG002|Core Study|Death|0|||
160791042|NCT00414609|580623737|FG000|Extension Study|Adverse Event|0|||
160791043|NCT00414609|580623738|FG001|Extension Study|Adverse Event|0|||
160982003|NCT02718417|581323358|FG001|Observation Phase (OP)|Physician Decision|0|||
160982004|NCT02718417|581323359|FG002|Observation Phase (OP)|Physician Decision|9|||
160982005|NCT02718417|581323357|FG000|Observation Phase (OP)|Progressive disease|0|||
160982006|NCT02718417|581323358|FG001|Observation Phase (OP)|Progressive disease|0|||
160982007|NCT02718417|581323359|FG002|Observation Phase (OP)|Progressive disease|92|||
160791044|NCT00414609|580623739|FG002|Extension Study|Adverse Event|14|||
160791045|NCT00414609|580623737|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
160791046|NCT00414609|580623738|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
160791047|NCT00414609|580623739|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
160791048|NCT00414609|580623737|FG000|Extension Study|Withdrawal by Subject|0|||
160791049|NCT00414609|580623738|FG001|Extension Study|Withdrawal by Subject|0|||
160791050|NCT00414609|580623739|FG002|Extension Study|Withdrawal by Subject|13|||
160791051|NCT00414609|580623737|FG000|Extension Study|Lost to Follow-up|0|||
160791052|NCT00414609|580623738|FG001|Extension Study|Lost to Follow-up|0|||
160791053|NCT00414609|580623739|FG002|Extension Study|Lost to Follow-up|10|||
160791054|NCT00414609|580623737|FG000|Extension Study|Administrative problems|0|||
160791055|NCT00414609|580623738|FG001|Extension Study|Administrative problems|0|||
160791056|NCT00414609|580623739|FG002|Extension Study|Administrative problems|1|||
160791057|NCT00414609|580623737|FG000|Extension Study|Death|0|||
160791058|NCT00414609|580623738|FG001|Extension Study|Death|0|||
160791059|NCT00414609|580623739|FG002|Extension Study|Death|17|||
160791060|NCT01592747|580623745|FG000|Overall Study|Loss of Therapeutic Response|107|||
160791061|NCT01592747|580623746|FG001|Overall Study|Loss of Therapeutic Response|108|||
160791062|NCT01592747|580623747|FG002|Overall Study|Loss of Therapeutic Response|100|||
160791063|NCT01592747|580623745|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
160791064|NCT01592747|580623746|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
160791065|NCT01592747|580623747|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
160791066|NCT01592747|580623745|FG000|Overall Study|Adverse Event|1|||
160791067|NCT01592747|580623746|FG001|Overall Study|Adverse Event|0|||
160791068|NCT01592747|580623747|FG002|Overall Study|Adverse Event|0|||
160791069|NCT01592747|580623745|FG000|Overall Study|Protocol Violation|4|||
160791070|NCT01592747|580623746|FG001|Overall Study|Protocol Violation|0|||
160791071|NCT01592747|580623747|FG002|Overall Study|Protocol Violation|4|||
160791072|NCT01592747|580623745|FG000|Overall Study|Lack of Efficacy|0|||
160791073|NCT01592747|580623746|FG001|Overall Study|Lack of Efficacy|1|||
160791074|NCT01592747|580623747|FG002|Overall Study|Lack of Efficacy|0|||
160791075|NCT01592747|580623745|FG000|Overall Study|Withdrawal by Subject|2|||
160791076|NCT01592747|580623746|FG001|Overall Study|Withdrawal by Subject|0|||
160791077|NCT01592747|580623747|FG002|Overall Study|Withdrawal by Subject|2|||
160791078|NCT01592747|580623745|FG000|Overall Study|Lost to Follow-up|1|||
160791079|NCT01592747|580623746|FG001|Overall Study|Lost to Follow-up|0|||
160791080|NCT01592747|580623747|FG002|Overall Study|Lost to Follow-up|1|||
160791081|NCT01592747|580623745|FG000|Overall Study|Other Reasons|1|||
160791082|NCT01592747|580623746|FG001|Overall Study|Other Reasons|1|||
160791083|NCT01592747|580623747|FG002|Overall Study|Other Reasons|0|||
160791084|NCT00266032|580623748|FG000|Treatment|Adverse Event|42|||
160791085|NCT00266032|580623749|FG001|Treatment|Adverse Event|26|||
160791086|NCT00266032|580623750|FG002|Treatment|Adverse Event|10|||
160791087|NCT00266032|580623748|FG000|Treatment|Lost to Follow-up|19|||
160791088|NCT00266032|580623749|FG001|Treatment|Lost to Follow-up|4|||
160791089|NCT00266032|580623750|FG002|Treatment|Lost to Follow-up|2|||
160791090|NCT00266032|580623748|FG000|Treatment|Pregnancy|3|||
160791091|NCT00266032|580623749|FG001|Treatment|Pregnancy|2|||
160791092|NCT00266032|580623750|FG002|Treatment|Pregnancy|2|||
160791093|NCT00266032|580623748|FG000|Treatment|Protocol Violation|6|||
160791094|NCT00266032|580623749|FG001|Treatment|Protocol Violation|14|||
160791095|NCT00266032|580623750|FG002|Treatment|Protocol Violation|13|||
160791096|NCT00266032|580623748|FG000|Treatment|Withdrawal by Subject|28|||
160791097|NCT00266032|580623749|FG001|Treatment|Withdrawal by Subject|13|||
160791098|NCT00266032|580623750|FG002|Treatment|Withdrawal by Subject|12|||
160791099|NCT00266032|580623748|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
160791100|NCT00266032|580623749|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
160791101|NCT00266032|580623750|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
160791102|NCT00266032|580623748|FG000|Open-label Safety Extension|Adverse Event|5|||
160791103|NCT00266032|580623749|FG001|Open-label Safety Extension|Adverse Event|0|||
160791104|NCT00266032|580623750|FG002|Open-label Safety Extension|Adverse Event|4|||
160791105|NCT00266032|580623748|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
160791106|NCT00266032|580623749|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
160791107|NCT00266032|580623750|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
160791108|NCT00266032|580623748|FG000|Open-label Safety Extension|Pregnancy|4|||
160791109|NCT00266032|580623749|FG001|Open-label Safety Extension|Pregnancy|1|||
160791110|NCT00266032|580623750|FG002|Open-label Safety Extension|Pregnancy|2|||
160892337|NCT02598960|581002148|FG000|Treatment Period|Disease Progression|4|||
160892338|NCT02598960|581002149|FG001|Treatment Period|Disease Progression|4|||
160892339|NCT02598960|581002150|FG002|Treatment Period|Disease Progression|4|||
160892340|NCT02598960|581002151|FG003|Treatment Period|Disease Progression|6|||
160892341|NCT02598960|581002152|FG004|Treatment Period|Disease Progression|8|||
160892342|NCT02598960|581002153|FG005|Treatment Period|Disease Progression|2|||
160892343|NCT02598960|581002154|FG006|Treatment Period|Disease Progression|2|||
160892344|NCT02598960|581002155|FG007|Treatment Period|Disease Progression|3|||
160892345|NCT02598960|581002156|FG008|Treatment Period|Disease Progression|7|||
160892346|NCT02598960|581002157|FG009|Treatment Period|Disease Progression|9|||
160892347|NCT02598960|581002158|FG010|Treatment Period|Disease Progression|7|||
160642750|NCT03210259|580074365|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
160892348|NCT02598960|581002159|FG011|Treatment Period|Disease Progression|143|||
160892349|NCT02598960|581002160|FG012|Treatment Period|Disease Progression|23|||
160892350|NCT02598960|581002148|FG000|Treatment Period|Study drug toxicity|0|||
160892351|NCT02598960|581002149|FG001|Treatment Period|Study drug toxicity|0|||
160892352|NCT02598960|581002150|FG002|Treatment Period|Study drug toxicity|0|||
160642751|NCT03210259|580074363|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
160642752|NCT03210259|580074364|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
160642753|NCT03210259|580074365|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
160642754|NCT03210259|580074363|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
160642755|NCT03210259|580074364|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
160642756|NCT03210259|580074365|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
160642757|NCT03210259|580074363|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
160642758|NCT03210259|580074364|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
160642759|NCT03210259|580074365|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
160642760|NCT03210259|580074363|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
160642761|NCT03210259|580074364|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
160642762|NCT03210259|580074365|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
160642763|NCT03210259|580074363|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
160642764|NCT03210259|580074364|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
160642765|NCT03210259|580074365|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
160642766|NCT05017493|580074366|FG000|Overall Study|Withdrawal by Subject|26|||
160642767|NCT05017493|580074367|FG001|Overall Study|Withdrawal by Subject|0|||
160642768|NCT05017493|580074366|FG000|Overall Study|Physician Decision|15|||
160642769|NCT05017493|580074367|FG001|Overall Study|Physician Decision|0|||
160642770|NCT05017493|580074366|FG000|Overall Study|Protocol Violation|81|||
160642771|NCT05017493|580074367|FG001|Overall Study|Protocol Violation|0|||
160642772|NCT03940586|580074371|FG000|Overall Study|Death|3|||
160642773|NCT03940586|580074372|FG001|Overall Study|Death|2|||
160642774|NCT03940586|580074373|FG002|Overall Study|Death|0|||
160642775|NCT03940586|580074371|FG000|Overall Study|Physician Decision|1|||
160642776|NCT03940586|580074372|FG001|Overall Study|Physician Decision|0|||
160642777|NCT03940586|580074373|FG002|Overall Study|Physician Decision|1|||
160642778|NCT03940586|580074371|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
160642779|NCT03940586|580074372|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
160642780|NCT03940586|580074373|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
160642781|NCT03940586|580074371|FG000|Overall Study|Not Treated|0|||
160642782|NCT03940586|580074372|FG001|Overall Study|Not Treated|2|||
160642783|NCT03940586|580074373|FG002|Overall Study|Not Treated|0|||
160642784|NCT02006147|580074374|FG000|Overall Study|Protocol Violation|1|||
160642785|NCT02006147|580074375|FG001|Overall Study|Protocol Violation|1|||
160642786|NCT02006147|580074376|FG002|Overall Study|Protocol Violation|0|||
160642787|NCT02006147|580074377|FG003|Overall Study|Protocol Violation|0|||
160642788|NCT02006147|580074374|FG000|Overall Study|Withdrawal by Subject|0|||
160892353|NCT02598960|581002151|FG003|Treatment Period|Study drug toxicity|0|||
160892354|NCT02598960|581002152|FG004|Treatment Period|Study drug toxicity|0|||
160892355|NCT02598960|581002153|FG005|Treatment Period|Study drug toxicity|0|||
160892356|NCT02598960|581002154|FG006|Treatment Period|Study drug toxicity|0|||
160642789|NCT02006147|580074375|FG001|Overall Study|Withdrawal by Subject|1|||
160791111|NCT00266032|580623748|FG000|Open-label Safety Extension|Protocol Violation|1|||
160642790|NCT02006147|580074376|FG002|Overall Study|Withdrawal by Subject|0|||
160791112|NCT00266032|580623749|FG001|Open-label Safety Extension|Protocol Violation|3|||
160791113|NCT00266032|580623750|FG002|Open-label Safety Extension|Protocol Violation|2|||
160791114|NCT00266032|580623748|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
160791115|NCT00266032|580623749|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
160791116|NCT00266032|580623750|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
160791117|NCT00266032|580623748|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
160791118|NCT00266032|580623749|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
160791119|NCT00266032|580623750|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
160791120|NCT00124657|580623751|FG000|Overall Study|Toxicity|0|||
160791121|NCT00124657|580623752|FG001|Overall Study|Toxicity|0|||
160791122|NCT00124657|580623753|FG002|Overall Study|Toxicity|1|||
160791123|NCT00124657|580623751|FG000|Overall Study|Non-compliance|1|||
160791124|NCT00124657|580623752|FG001|Overall Study|Non-compliance|0|||
160791125|NCT00124657|580623753|FG002|Overall Study|Non-compliance|4|||
160791126|NCT00124657|580623751|FG000|Overall Study|Progressive disease|14|||
160791127|NCT00124657|580623752|FG001|Overall Study|Progressive disease|5|||
160791128|NCT00124657|580623753|FG002|Overall Study|Progressive disease|27|||
160791129|NCT00124657|580623751|FG000|Overall Study|Intercurrent illness|1|||
160791130|NCT00124657|580623752|FG001|Overall Study|Intercurrent illness|0|||
160791131|NCT00124657|580623753|FG002|Overall Study|Intercurrent illness|0|||
160791132|NCT01935947|580623758|FG000|Overall Study|Adverse Event|0|||
160791133|NCT01935947|580623759|FG001|Overall Study|Adverse Event|2|||
160791134|NCT01935947|580623760|FG002|Overall Study|Adverse Event|0|||
160791135|NCT01935947|580623758|FG000|Overall Study|Diease Progression|2|||
160791136|NCT01935947|580623759|FG001|Overall Study|Diease Progression|2|||
160791137|NCT01935947|580623760|FG002|Overall Study|Diease Progression|2|||
160791138|NCT01935947|580623758|FG000|Overall Study|Death|1|||
160791139|NCT01935947|580623759|FG001|Overall Study|Death|0|||
160791140|NCT01935947|580623760|FG002|Overall Study|Death|0|||
160791141|NCT02367885|580623761|FG000|Overall Study|Lost to Follow-up|1|||
160791142|NCT02367885|580623762|FG001|Overall Study|Lost to Follow-up|0|||
160791143|NCT02367885|580623763|FG002|Overall Study|Lost to Follow-up|0|||
160791144|NCT02367885|580623761|FG000|Overall Study|Withdrawal by Subject|1|||
160791145|NCT02367885|580623762|FG001|Overall Study|Withdrawal by Subject|0|||
160791146|NCT02367885|580623763|FG002|Overall Study|Withdrawal by Subject|0|||
160791147|NCT01378195|580623764|FG000|Overall Study|Lost to Follow-up|29|||
160791148|NCT01378195|580623765|FG001|Overall Study|Lost to Follow-up|18|||
160791149|NCT03533491|580623768|FG000|Overall Study|Lost to Follow-up|2|||
160791150|NCT05418426|580623774|FG000|Overall Study|Adverse Event|0|||
160791151|NCT05418426|580623775|FG001|Overall Study|Adverse Event|1|||
160791152|NCT05418426|580623776|FG002|Overall Study|Adverse Event|0|||
160791153|NCT05418426|580623774|FG000|Overall Study|Withdrawal by Subject|0|||
160791154|NCT05418426|580623775|FG001|Overall Study|Withdrawal by Subject|1|||
160791155|NCT05418426|580623776|FG002|Overall Study|Withdrawal by Subject|0|||
160791156|NCT05418426|580623774|FG000|Overall Study|Protocol Violation|0|||
160791157|NCT05418426|580623775|FG001|Overall Study|Protocol Violation|0|||
160791158|NCT05418426|580623776|FG002|Overall Study|Protocol Violation|1|||
160791159|NCT02758626|580623779|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
160791160|NCT02758626|580623780|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
160791161|NCT02758626|580623779|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
160791162|NCT02758626|580623780|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
160791163|NCT02758626|580623779|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
160791164|NCT02758626|580623780|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
160791165|NCT02758626|580623779|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
160791166|NCT02758626|580623780|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
160791167|NCT00456365|580623783|FG000|Overall Study|Lost to Follow-up|1|||
160791168|NCT00456365|580623784|FG001|Overall Study|Lost to Follow-up|3|||
160791169|NCT00456365|580623783|FG000|Overall Study|Withdrawal by Subject|4|||
160982008|NCT02718417|581323357|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
160982009|NCT02718417|581323358|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
160982010|NCT02718417|581323359|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
160791170|NCT00456365|580623784|FG001|Overall Study|Withdrawal by Subject|7|||
160791171|NCT00456365|580623783|FG000|Overall Study|Pregnancy|1|||
160791172|NCT00456365|580623784|FG001|Overall Study|Pregnancy|1|||
160982011|NCT02718417|581323357|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
160791173|NCT00456365|580623783|FG000|Overall Study|oncologic diagnosis|1|||
160791174|NCT00456365|580623784|FG001|Overall Study|oncologic diagnosis|1|||
160791175|NCT02096354|580623788|FG000|Overall Study|Physician Decision|4|||
160791176|NCT02096354|580623789|FG001|Overall Study|Physician Decision|5|||
160791177|NCT02096354|580623790|FG002|Overall Study|Physician Decision|0|||
160791178|NCT02096354|580623788|FG000|Overall Study|Withdrawal by Subject|3|||
160791179|NCT02096354|580623789|FG001|Overall Study|Withdrawal by Subject|1|||
160791180|NCT02096354|580623790|FG002|Overall Study|Withdrawal by Subject|0|||
160791181|NCT02096354|580623788|FG000|Overall Study|Adverse Event|7|||
160791182|NCT02096354|580623789|FG001|Overall Study|Adverse Event|4|||
160791183|NCT02096354|580623790|FG002|Overall Study|Adverse Event|0|||
160791184|NCT02096354|580623788|FG000|Overall Study|Ineligible|0|||
160791185|NCT02096354|580623789|FG001|Overall Study|Ineligible|0|||
160791186|NCT02096354|580623790|FG002|Overall Study|Ineligible|11|||
160791187|NCT03715829|580623791|FG000|Dose Ranging Period|Adverse Event|2|||
160791188|NCT03715829|580623792|FG001|Dose Ranging Period|Adverse Event|4|||
160791189|NCT03715829|580623793|FG002|Dose Ranging Period|Adverse Event|5|||
160791190|NCT03715829|580623794|FG003|Dose Ranging Period|Adverse Event|2|||
160791191|NCT03715829|580623795|FG004|Dose Ranging Period|Adverse Event|3|||
160791192|NCT03715829|580623796|FG005|Dose Ranging Period|Adverse Event|3|||
160791193|NCT03715829|580623797|FG006|Dose Ranging Period|Adverse Event|0|||
160791194|NCT03715829|580623798|FG007|Dose Ranging Period|Adverse Event|0|||
160791195|NCT03715829|580623799|FG008|Dose Ranging Period|Adverse Event|0|||
160791196|NCT03715829|580623800|FG009|Dose Ranging Period|Adverse Event|0|||
160791197|NCT03715829|580623801|FG010|Dose Ranging Period|Adverse Event|0|||
160791198|NCT03715829|580623791|FG000|Dose Ranging Period|Lack of Efficacy|0|||
160791199|NCT03715829|580623792|FG001|Dose Ranging Period|Lack of Efficacy|1|||
160791200|NCT03715829|580623793|FG002|Dose Ranging Period|Lack of Efficacy|0|||
160791201|NCT03715829|580623794|FG003|Dose Ranging Period|Lack of Efficacy|1|||
160791202|NCT03715829|580623795|FG004|Dose Ranging Period|Lack of Efficacy|0|||
160791203|NCT03715829|580623796|FG005|Dose Ranging Period|Lack of Efficacy|0|||
160791204|NCT03715829|580623797|FG006|Dose Ranging Period|Lack of Efficacy|0|||
160791205|NCT03715829|580623798|FG007|Dose Ranging Period|Lack of Efficacy|0|||
160791206|NCT03715829|580623799|FG008|Dose Ranging Period|Lack of Efficacy|0|||
160791207|NCT03715829|580623800|FG009|Dose Ranging Period|Lack of Efficacy|0|||
160791208|NCT03715829|580623801|FG010|Dose Ranging Period|Lack of Efficacy|0|||
160791209|NCT03715829|580623791|FG000|Dose Ranging Period|Lost to Follow-up|2|||
160791210|NCT03715829|580623792|FG001|Dose Ranging Period|Lost to Follow-up|0|||
160791211|NCT03715829|580623793|FG002|Dose Ranging Period|Lost to Follow-up|1|||
160791212|NCT03715829|580623794|FG003|Dose Ranging Period|Lost to Follow-up|1|||
160791213|NCT03715829|580623795|FG004|Dose Ranging Period|Lost to Follow-up|1|||
160791214|NCT03715829|580623796|FG005|Dose Ranging Period|Lost to Follow-up|2|||
160791215|NCT03715829|580623797|FG006|Dose Ranging Period|Lost to Follow-up|0|||
160791216|NCT03715829|580623798|FG007|Dose Ranging Period|Lost to Follow-up|0|||
160791217|NCT03715829|580623799|FG008|Dose Ranging Period|Lost to Follow-up|0|||
160791218|NCT03715829|580623800|FG009|Dose Ranging Period|Lost to Follow-up|0|||
160791219|NCT03715829|580623801|FG010|Dose Ranging Period|Lost to Follow-up|0|||
160791220|NCT03715829|580623791|FG000|Dose Ranging Period|Protocol Violation|0|||
160791221|NCT03715829|580623792|FG001|Dose Ranging Period|Protocol Violation|0|||
160791222|NCT03715829|580623793|FG002|Dose Ranging Period|Protocol Violation|0|||
160791223|NCT03715829|580623794|FG003|Dose Ranging Period|Protocol Violation|1|||
160791224|NCT03715829|580623795|FG004|Dose Ranging Period|Protocol Violation|0|||
160791225|NCT03715829|580623796|FG005|Dose Ranging Period|Protocol Violation|0|||
160791226|NCT03715829|580623797|FG006|Dose Ranging Period|Protocol Violation|0|||
160791227|NCT03715829|580623798|FG007|Dose Ranging Period|Protocol Violation|0|||
160791228|NCT03715829|580623799|FG008|Dose Ranging Period|Protocol Violation|0|||
160791229|NCT03715829|580623800|FG009|Dose Ranging Period|Protocol Violation|0|||
160791230|NCT03715829|580623801|FG010|Dose Ranging Period|Protocol Violation|0|||
160791231|NCT03715829|580623791|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
160791232|NCT03715829|580623792|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
160791233|NCT03715829|580623793|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
160791234|NCT03715829|580623794|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
160791235|NCT03715829|580623795|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
160791236|NCT03715829|580623796|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
160791237|NCT03715829|580623797|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
160791238|NCT03715829|580623798|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
160791239|NCT03715829|580623799|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
160791240|NCT03715829|580623800|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
160791241|NCT03715829|580623801|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
160791242|NCT03715829|580623791|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791243|NCT03715829|580623792|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791244|NCT03715829|580623793|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
160791245|NCT03715829|580623794|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791246|NCT03715829|580623795|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791247|NCT03715829|580623796|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791248|NCT03715829|580623797|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791249|NCT03715829|580623798|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791250|NCT03715829|580623799|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791251|NCT03715829|580623800|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791252|NCT03715829|580623801|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791253|NCT03715829|580623791|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791254|NCT03715829|580623792|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791255|NCT03715829|580623793|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
160982012|NCT02718417|581323358|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
160982013|NCT02718417|581323359|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
160982014|NCT02718417|581323357|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
160982015|NCT02718417|581323358|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
160982016|NCT02718417|581323359|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
160982017|NCT02718417|581323357|FG000|Observation Phase (OP)|Other|0|||
160982018|NCT02718417|581323358|FG001|Observation Phase (OP)|Other|0|||
160982019|NCT02718417|581323359|FG002|Observation Phase (OP)|Other|7|||
160982020|NCT02718417|581323357|FG000|Follow-up Phase|Adverse Event|3|||
160982021|NCT02718417|581323358|FG001|Follow-up Phase|Adverse Event|1|||
160982022|NCT02718417|581323359|FG002|Follow-up Phase|Adverse Event|1|||
160982023|NCT02718417|581323357|FG000|Follow-up Phase|Other|4|||
160982024|NCT02718417|581323358|FG001|Follow-up Phase|Other|6|||
160982025|NCT02718417|581323359|FG002|Follow-up Phase|Other|4|||
160791256|NCT03715829|580623794|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791257|NCT03715829|580623795|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
160791258|NCT03715829|580623796|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791259|NCT03715829|580623797|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791260|NCT03715829|580623798|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791261|NCT03715829|580623799|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791262|NCT03715829|580623800|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791263|NCT03715829|580623801|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791264|NCT03715829|580623791|FG000|Dose Ranging Period|Other|0|||
160791265|NCT03715829|580623792|FG001|Dose Ranging Period|Other|0|||
160791266|NCT03715829|580623793|FG002|Dose Ranging Period|Other|2|||
160791267|NCT03715829|580623794|FG003|Dose Ranging Period|Other|0|||
160791268|NCT03715829|580623795|FG004|Dose Ranging Period|Other|0|||
160791269|NCT03715829|580623796|FG005|Dose Ranging Period|Other|3|||
160791270|NCT03715829|580623797|FG006|Dose Ranging Period|Other|0|||
160791271|NCT03715829|580623798|FG007|Dose Ranging Period|Other|0|||
160791272|NCT03715829|580623799|FG008|Dose Ranging Period|Other|0|||
160791273|NCT03715829|580623800|FG009|Dose Ranging Period|Other|0|||
160791274|NCT03715829|580623801|FG010|Dose Ranging Period|Other|0|||
160791275|NCT03715829|580623791|FG000|Extension Period|Adverse Event|0|||
160791276|NCT03715829|580623792|FG001|Extension Period|Adverse Event|0|||
160791277|NCT03715829|580623793|FG002|Extension Period|Adverse Event|0|||
160791278|NCT03715829|580623794|FG003|Extension Period|Adverse Event|0|||
160791279|NCT03715829|580623795|FG004|Extension Period|Adverse Event|0|||
160791280|NCT03715829|580623796|FG005|Extension Period|Adverse Event|0|||
160791281|NCT03715829|580623797|FG006|Extension Period|Adverse Event|3|||
160791282|NCT03715829|580623798|FG007|Extension Period|Adverse Event|1|||
160791283|NCT03715829|580623799|FG008|Extension Period|Adverse Event|6|||
160791284|NCT03715829|580623800|FG009|Extension Period|Adverse Event|0|||
160791285|NCT03715829|580623801|FG010|Extension Period|Adverse Event|0|||
160791286|NCT03715829|580623791|FG000|Extension Period|Lack of Efficacy|0|||
160791287|NCT03715829|580623792|FG001|Extension Period|Lack of Efficacy|0|||
160791288|NCT03715829|580623793|FG002|Extension Period|Lack of Efficacy|0|||
160791289|NCT03715829|580623794|FG003|Extension Period|Lack of Efficacy|0|||
160791290|NCT03715829|580623795|FG004|Extension Period|Lack of Efficacy|0|||
160791291|NCT03715829|580623796|FG005|Extension Period|Lack of Efficacy|0|||
160791292|NCT03715829|580623797|FG006|Extension Period|Lack of Efficacy|1|||
160791293|NCT03715829|580623798|FG007|Extension Period|Lack of Efficacy|9|||
160791294|NCT03715829|580623799|FG008|Extension Period|Lack of Efficacy|2|||
160791295|NCT03715829|580623800|FG009|Extension Period|Lack of Efficacy|0|||
160791296|NCT03715829|580623801|FG010|Extension Period|Lack of Efficacy|0|||
160791297|NCT03715829|580623791|FG000|Extension Period|Lost to Follow-up|0|||
160791298|NCT03715829|580623792|FG001|Extension Period|Lost to Follow-up|0|||
160791299|NCT03715829|580623793|FG002|Extension Period|Lost to Follow-up|0|||
160791300|NCT03715829|580623794|FG003|Extension Period|Lost to Follow-up|0|||
160791301|NCT03715829|580623795|FG004|Extension Period|Lost to Follow-up|0|||
160791302|NCT03715829|580623796|FG005|Extension Period|Lost to Follow-up|0|||
160791303|NCT03715829|580623797|FG006|Extension Period|Lost to Follow-up|0|||
160982026|NCT02718417|581323357|FG000|Follow-up Phase|Withdrawal by Subject|19|||
160982027|NCT02718417|581323358|FG001|Follow-up Phase|Withdrawal by Subject|17|||
160982028|NCT02718417|581323359|FG002|Follow-up Phase|Withdrawal by Subject|5|||
160982029|NCT02718417|581323357|FG000|Follow-up Phase|Study terminated by sponsor|100|||
160791304|NCT03715829|580623798|FG007|Extension Period|Lost to Follow-up|0|||
160791305|NCT03715829|580623799|FG008|Extension Period|Lost to Follow-up|2|||
160791306|NCT03715829|580623800|FG009|Extension Period|Lost to Follow-up|0|||
160791307|NCT03715829|580623801|FG010|Extension Period|Lost to Follow-up|0|||
160791308|NCT03715829|580623791|FG000|Extension Period|Protocol Violation|0|||
160791309|NCT03715829|580623792|FG001|Extension Period|Protocol Violation|0|||
160982030|NCT02718417|581323358|FG001|Follow-up Phase|Study terminated by sponsor|138|||
160791310|NCT03715829|580623793|FG002|Extension Period|Protocol Violation|0|||
160791311|NCT03715829|580623794|FG003|Extension Period|Protocol Violation|0|||
160791312|NCT03715829|580623795|FG004|Extension Period|Protocol Violation|0|||
160791313|NCT03715829|580623796|FG005|Extension Period|Protocol Violation|0|||
160791314|NCT03715829|580623797|FG006|Extension Period|Protocol Violation|0|||
160791315|NCT03715829|580623798|FG007|Extension Period|Protocol Violation|0|||
160791316|NCT03715829|580623799|FG008|Extension Period|Protocol Violation|1|||
160791317|NCT03715829|580623800|FG009|Extension Period|Protocol Violation|0|||
160791318|NCT03715829|580623801|FG010|Extension Period|Protocol Violation|0|||
160791319|NCT03715829|580623791|FG000|Extension Period|Withdrawal by Subject|0|||
160791320|NCT03715829|580623792|FG001|Extension Period|Withdrawal by Subject|0|||
160791321|NCT03715829|580623793|FG002|Extension Period|Withdrawal by Subject|0|||
160791322|NCT03715829|580623794|FG003|Extension Period|Withdrawal by Subject|0|||
160791323|NCT03715829|580623795|FG004|Extension Period|Withdrawal by Subject|0|||
160791324|NCT03715829|580623796|FG005|Extension Period|Withdrawal by Subject|0|||
160791325|NCT03715829|580623797|FG006|Extension Period|Withdrawal by Subject|3|||
160791326|NCT03715829|580623798|FG007|Extension Period|Withdrawal by Subject|3|||
160791327|NCT03715829|580623799|FG008|Extension Period|Withdrawal by Subject|12|||
160791328|NCT03715829|580623800|FG009|Extension Period|Withdrawal by Subject|3|||
160791329|NCT03715829|580623801|FG010|Extension Period|Withdrawal by Subject|0|||
160791330|NCT03715829|580623791|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791331|NCT03715829|580623792|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791332|NCT03715829|580623793|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791333|NCT03715829|580623794|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791334|NCT03715829|580623795|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791335|NCT03715829|580623796|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791336|NCT03715829|580623797|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791337|NCT03715829|580623798|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
160791338|NCT03715829|580623799|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
160791339|NCT03715829|580623800|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791340|NCT03715829|580623801|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791341|NCT03715829|580623791|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791342|NCT03715829|580623792|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791343|NCT03715829|580623793|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791344|NCT03715829|580623794|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791345|NCT03715829|580623795|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791346|NCT03715829|580623796|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
160982031|NCT02718417|581323359|FG002|Follow-up Phase|Study terminated by sponsor|6|||
160982032|NCT02718417|581323357|FG000|Follow-up Phase|Lost to Follow-up|2|||
160548331|NCT00487539|579734117|FG001|Overall Study|Other|1|||
160548332|NCT00487539|579734118|FG002|Overall Study|Other|2|||
160791347|NCT03715829|580623797|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791348|NCT03715829|580623798|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791349|NCT03715829|580623799|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
160791350|NCT03715829|580623800|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791351|NCT03715829|580623801|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791352|NCT03715829|580623791|FG000|Extension Period|Other|0|||
160791353|NCT03715829|580623792|FG001|Extension Period|Other|0|||
160791354|NCT03715829|580623793|FG002|Extension Period|Other|0|||
160791355|NCT03715829|580623794|FG003|Extension Period|Other|0|||
160791356|NCT03715829|580623795|FG004|Extension Period|Other|0|||
160791357|NCT03715829|580623796|FG005|Extension Period|Other|0|||
160791358|NCT03715829|580623797|FG006|Extension Period|Other|1|||
160791359|NCT03715829|580623798|FG007|Extension Period|Other|2|||
160791360|NCT03715829|580623799|FG008|Extension Period|Other|4|||
160791361|NCT03715829|580623800|FG009|Extension Period|Other|0|||
160791362|NCT03715829|580623801|FG010|Extension Period|Other|0|||
160791363|NCT03647137|580623803|FG000|Overall Study|Scan Limitation|2|||
160791364|NCT03647137|580623804|FG001|Overall Study|Scan Limitation|1|||
160791365|NCT03647137|580623805|FG002|Overall Study|Scan Limitation|1|||
160791366|NCT03647137|580623806|FG003|Overall Study|Scan Limitation|2|||
160791367|NCT01554904|580623808|FG000|Overall Study|Withdrawal by Subject|3|||
160791368|NCT01554904|580623808|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
160791369|NCT01051661|580623811|FG000|Overall Study|Adverse Event|1|||
160791370|NCT01051661|580623812|FG001|Overall Study|Adverse Event|1|||
160791371|NCT01051661|580623813|FG002|Overall Study|Adverse Event|1|||
160791372|NCT01051661|580623814|FG003|Overall Study|Adverse Event|1|||
160791373|NCT01051661|580623815|FG004|Overall Study|Adverse Event|0|||
160791374|NCT01051661|580623816|FG005|Overall Study|Adverse Event|0|||
160791375|NCT01051661|580623811|FG000|Overall Study|Lost to Follow-up|13|||
160791376|NCT01051661|580623812|FG001|Overall Study|Lost to Follow-up|22|||
160548333|NCT00487539|579734119|FG003|Overall Study|Other|2|||
160982033|NCT02718417|581323358|FG001|Follow-up Phase|Lost to Follow-up|3|||
160548334|NCT01437397|579734120|FG000|Overall Study|Lost to Follow-up|9|||
160982034|NCT02718417|581323359|FG002|Follow-up Phase|Lost to Follow-up|0|||
160982035|NCT02718417|581323357|FG000|Follow-up Phase|Death leading to discontinuation|7|||
160548335|NCT01437397|579734121|FG001|Overall Study|Lost to Follow-up|4|||
160548336|NCT01437397|579734122|FG002|Overall Study|Lost to Follow-up|2|||
160548337|NCT01437397|579734123|FG003|Overall Study|Lost to Follow-up|4|||
160982036|NCT02718417|581323358|FG001|Follow-up Phase|Death leading to discontinuation|7|||
160982037|NCT02718417|581323359|FG002|Follow-up Phase|Death leading to discontinuation|3|||
160982038|NCT02718417|581323357|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
160982039|NCT02718417|581323358|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
160982040|NCT02718417|581323359|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
160982041|NCT02718417|581323357|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
160982042|NCT02718417|581323358|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
160548338|NCT01437397|579734124|FG004|Overall Study|Lost to Follow-up|5|||
160982043|NCT02718417|581323359|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
160982044|NCT02718417|581323357|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
160982045|NCT02718417|581323358|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
160982046|NCT02718417|581323359|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
160982047|NCT02718417|581323357|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
160982048|NCT02718417|581323358|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
160982049|NCT02718417|581323359|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
160982050|NCT02718417|581323357|FG000|Long-term Follow-up Phase|Other|0|||
160982051|NCT02718417|581323358|FG001|Long-term Follow-up Phase|Other|2|||
160982052|NCT02718417|581323359|FG002|Long-term Follow-up Phase|Other|0|||
160982053|NCT00724061|581323365|FG000|Dose Escalation Phase|Adverse Event|2|||
160982054|NCT00724061|581323365|FG000|Dose Escalation Phase|Disease Progression|3|||
160982055|NCT01536145|581323368|FG000|Overall Study|Progressive disease|3|||
160982056|NCT01536145|581323369|FG001|Overall Study|Progressive disease|4|||
160982057|NCT01536145|581323370|FG002|Overall Study|Progressive disease|1|||
160982058|NCT01536145|581323371|FG003|Overall Study|Progressive disease|2|||
160982059|NCT01536145|581323372|FG004|Overall Study|Progressive disease|1|||
160982060|NCT01536145|581323373|FG005|Overall Study|Progressive disease|2|||
160982061|NCT01536145|581323374|FG006|Overall Study|Progressive disease|1|||
160982062|NCT01536145|581323375|FG007|Overall Study|Progressive disease|2|||
160982063|NCT01536145|581323376|FG008|Overall Study|Progressive disease|1|||
160982064|NCT01536145|581323377|FG009|Overall Study|Progressive disease|3|||
160982065|NCT01536145|581323378|FG010|Overall Study|Progressive disease|3|||
160982066|NCT01536145|581323368|FG000|Overall Study|Withdrawal by Subject|0|||
160982067|NCT01536145|581323369|FG001|Overall Study|Withdrawal by Subject|0|||
160982068|NCT01536145|581323370|FG002|Overall Study|Withdrawal by Subject|1|||
160548339|NCT01437397|579734120|FG000|Overall Study|Withdrawal by Subject|11|||
160548340|NCT01437397|579734121|FG001|Overall Study|Withdrawal by Subject|12|||
160548341|NCT01437397|579734122|FG002|Overall Study|Withdrawal by Subject|24|||
160548342|NCT01437397|579734123|FG003|Overall Study|Withdrawal by Subject|11|||
160548343|NCT01437397|579734124|FG004|Overall Study|Withdrawal by Subject|22|||
160548344|NCT01437397|579734120|FG000|Overall Study|Protocol Violation|10|||
160982069|NCT01536145|581323371|FG003|Overall Study|Withdrawal by Subject|0|||
160982070|NCT01536145|581323372|FG004|Overall Study|Withdrawal by Subject|0|||
160982071|NCT01536145|581323373|FG005|Overall Study|Withdrawal by Subject|1|||
160982072|NCT01536145|581323374|FG006|Overall Study|Withdrawal by Subject|0|||
160982073|NCT01536145|581323375|FG007|Overall Study|Withdrawal by Subject|0|||
160982074|NCT01536145|581323376|FG008|Overall Study|Withdrawal by Subject|2|||
160982075|NCT01536145|581323377|FG009|Overall Study|Withdrawal by Subject|0|||
160982076|NCT01536145|581323378|FG010|Overall Study|Withdrawal by Subject|2|||
160548345|NCT01437397|579734121|FG001|Overall Study|Protocol Violation|12|||
160548346|NCT01437397|579734122|FG002|Overall Study|Protocol Violation|13|||
160548347|NCT01437397|579734123|FG003|Overall Study|Protocol Violation|21|||
160642791|NCT02006147|580074377|FG003|Overall Study|Withdrawal by Subject|0|||
160642792|NCT02006147|580074374|FG000|Overall Study|Withdrawal by Sponsor|1|||
160642793|NCT02006147|580074375|FG001|Overall Study|Withdrawal by Sponsor|0|||
160642794|NCT02006147|580074376|FG002|Overall Study|Withdrawal by Sponsor|0|||
160642795|NCT02006147|580074377|FG003|Overall Study|Withdrawal by Sponsor|0|||
160642796|NCT00345683|580074378|FG000|Overall Study|Lost to Follow-up|19|||
160642797|NCT00345683|580074379|FG001|Overall Study|Lost to Follow-up|7|||
160642798|NCT00345683|580074378|FG000|Overall Study|Other|6|||
160642799|NCT00345683|580074379|FG001|Overall Study|Other|2|||
160642800|NCT03182686|580074380|FG000|Overall Study|Lost to Follow-up|2|||
160642801|NCT03182686|580074381|FG001|Overall Study|Lost to Follow-up|0|||
160642802|NCT03182686|580074380|FG000|Overall Study|Adverse Event|2|||
160642803|NCT03182686|580074381|FG001|Overall Study|Adverse Event|0|||
160642804|NCT03182686|580074380|FG000|Overall Study|Withdrawal by Subject|3|||
160791377|NCT01051661|580623813|FG002|Overall Study|Lost to Follow-up|15|||
160982077|NCT01536145|581323368|FG000|Overall Study|Other|0|||
160982078|NCT01536145|581323369|FG001|Overall Study|Other|0|||
160982079|NCT01536145|581323370|FG002|Overall Study|Other|0|||
160982080|NCT01536145|581323371|FG003|Overall Study|Other|0|||
160982081|NCT01536145|581323372|FG004|Overall Study|Other|1|||
160548348|NCT01437397|579734124|FG004|Overall Study|Protocol Violation|19|||
160982082|NCT01536145|581323373|FG005|Overall Study|Other|0|||
160982083|NCT01536145|581323374|FG006|Overall Study|Other|0|||
160982084|NCT01536145|581323375|FG007|Overall Study|Other|0|||
160791378|NCT01051661|580623814|FG003|Overall Study|Lost to Follow-up|17|||
160791379|NCT01051661|580623815|FG004|Overall Study|Lost to Follow-up|10|||
160791380|NCT01051661|580623816|FG005|Overall Study|Lost to Follow-up|24|||
160791381|NCT01051661|580623811|FG000|Overall Study|Migrated/moved from study area|1|||
160791382|NCT01051661|580623812|FG001|Overall Study|Migrated/moved from study area|6|||
160791383|NCT01051661|580623813|FG002|Overall Study|Migrated/moved from study area|6|||
160791384|NCT01051661|580623814|FG003|Overall Study|Migrated/moved from study area|8|||
160791385|NCT01051661|580623815|FG004|Overall Study|Migrated/moved from study area|7|||
160791386|NCT01051661|580623816|FG005|Overall Study|Migrated/moved from study area|3|||
160791387|NCT01051661|580623811|FG000|Overall Study|Refused blood sampling|0|||
160791388|NCT01051661|580623812|FG001|Overall Study|Refused blood sampling|0|||
160791389|NCT01051661|580623813|FG002|Overall Study|Refused blood sampling|0|||
160791390|NCT01051661|580623814|FG003|Overall Study|Refused blood sampling|0|||
160791391|NCT01051661|580623815|FG004|Overall Study|Refused blood sampling|0|||
160791392|NCT01051661|580623816|FG005|Overall Study|Refused blood sampling|1|||
160791393|NCT01051661|580623811|FG000|Overall Study|Data not reliable|1|||
160791394|NCT01051661|580623812|FG001|Overall Study|Data not reliable|0|||
160791395|NCT01051661|580623813|FG002|Overall Study|Data not reliable|0|||
160791396|NCT01051661|580623814|FG003|Overall Study|Data not reliable|0|||
160791397|NCT01051661|580623815|FG004|Overall Study|Data not reliable|0|||
160791398|NCT01051661|580623816|FG005|Overall Study|Data not reliable|1|||
160791399|NCT01051661|580623811|FG000|Overall Study|Unable to attend visit(s)|2|||
160791400|NCT01051661|580623812|FG001|Overall Study|Unable to attend visit(s)|4|||
160791401|NCT01051661|580623813|FG002|Overall Study|Unable to attend visit(s)|2|||
160791402|NCT01051661|580623814|FG003|Overall Study|Unable to attend visit(s)|1|||
160892357|NCT02598960|581002155|FG007|Treatment Period|Study drug toxicity|0|||
160892358|NCT02598960|581002156|FG008|Treatment Period|Study drug toxicity|0|||
160892359|NCT02598960|581002157|FG009|Treatment Period|Study drug toxicity|1|||
160892360|NCT02598960|581002158|FG010|Treatment Period|Study drug toxicity|0|||
160892361|NCT02598960|581002159|FG011|Treatment Period|Study drug toxicity|3|||
160982085|NCT01536145|581323376|FG008|Overall Study|Other|0|||
160892362|NCT02598960|581002160|FG012|Treatment Period|Study drug toxicity|0|||
160892363|NCT02598960|581002148|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
160892364|NCT02598960|581002149|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
160892365|NCT02598960|581002150|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
160892366|NCT02598960|581002151|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
160892367|NCT02598960|581002152|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
160892368|NCT02598960|581002153|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
160892369|NCT02598960|581002154|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
160892370|NCT02598960|581002155|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
160892371|NCT02598960|581002156|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
160892372|NCT02598960|581002157|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
160892373|NCT02598960|581002158|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
160892374|NCT02598960|581002159|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
160892375|NCT02598960|581002160|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
160892376|NCT02598960|581002148|FG000|Treatment Period|participant request to discontinue|0|||
160892377|NCT02598960|581002149|FG001|Treatment Period|participant request to discontinue|1|||
160892378|NCT02598960|581002150|FG002|Treatment Period|participant request to discontinue|0|||
160892379|NCT02598960|581002151|FG003|Treatment Period|participant request to discontinue|0|||
160892380|NCT02598960|581002152|FG004|Treatment Period|participant request to discontinue|1|||
160892381|NCT02598960|581002153|FG005|Treatment Period|participant request to discontinue|0|||
160892382|NCT02598960|581002154|FG006|Treatment Period|participant request to discontinue|0|||
160892383|NCT02598960|581002155|FG007|Treatment Period|participant request to discontinue|0|||
160892384|NCT02598960|581002156|FG008|Treatment Period|participant request to discontinue|0|||
160892385|NCT02598960|581002157|FG009|Treatment Period|participant request to discontinue|0|||
160982086|NCT01536145|581323377|FG009|Overall Study|Other|3|||
160982087|NCT01536145|581323378|FG010|Overall Study|Other|2|||
160982088|NCT01536145|581323368|FG000|Overall Study|Death|0|||
160791403|NCT01051661|580623815|FG004|Overall Study|Unable to attend visit(s)|3|||
160791404|NCT01051661|580623816|FG005|Overall Study|Unable to attend visit(s)|2|||
160791405|NCT01051661|580623811|FG000|Overall Study|Consent not received from both parents|0|||
160791406|NCT01051661|580623812|FG001|Overall Study|Consent not received from both parents|0|||
160982089|NCT01536145|581323369|FG001|Overall Study|Death|0|||
160791407|NCT01051661|580623813|FG002|Overall Study|Consent not received from both parents|0|||
160791408|NCT01051661|580623814|FG003|Overall Study|Consent not received from both parents|0|||
160791409|NCT01051661|580623815|FG004|Overall Study|Consent not received from both parents|0|||
160791410|NCT01051661|580623816|FG005|Overall Study|Consent not received from both parents|1|||
160791411|NCT01051661|580623811|FG000|Overall Study|Failure to comply with protocol|0|||
160791412|NCT01051661|580623812|FG001|Overall Study|Failure to comply with protocol|0|||
160791413|NCT01051661|580623813|FG002|Overall Study|Failure to comply with protocol|2|||
160791414|NCT01051661|580623814|FG003|Overall Study|Failure to comply with protocol|0|||
160791415|NCT01051661|580623815|FG004|Overall Study|Failure to comply with protocol|0|||
160791416|NCT01051661|580623816|FG005|Overall Study|Failure to comply with protocol|0|||
160791417|NCT01051661|580623811|FG000|Overall Study|Subject lost legal representation|0|||
160791418|NCT01051661|580623812|FG001|Overall Study|Subject lost legal representation|0|||
160791419|NCT01051661|580623813|FG002|Overall Study|Subject lost legal representation|0|||
160791420|NCT01051661|580623814|FG003|Overall Study|Subject lost legal representation|0|||
160791421|NCT01051661|580623815|FG004|Overall Study|Subject lost legal representation|1|||
160791422|NCT01051661|580623816|FG005|Overall Study|Subject lost legal representation|0|||
160791423|NCT01051661|580623811|FG000|Overall Study|Protocol Violation|0|||
160791424|NCT01051661|580623812|FG001|Overall Study|Protocol Violation|0|||
160791425|NCT01051661|580623813|FG002|Overall Study|Protocol Violation|0|||
160791426|NCT01051661|580623814|FG003|Overall Study|Protocol Violation|1|||
160791427|NCT01051661|580623815|FG004|Overall Study|Protocol Violation|2|||
160791428|NCT01051661|580623816|FG005|Overall Study|Protocol Violation|1|||
160791429|NCT01051661|580623811|FG000|Overall Study|Withdrawal by Subject|16|||
160791430|NCT01051661|580623812|FG001|Overall Study|Withdrawal by Subject|30|||
160791431|NCT01051661|580623813|FG002|Overall Study|Withdrawal by Subject|13|||
160791432|NCT01051661|580623814|FG003|Overall Study|Withdrawal by Subject|28|||
160791433|NCT01051661|580623815|FG004|Overall Study|Withdrawal by Subject|12|||
160791434|NCT01051661|580623816|FG005|Overall Study|Withdrawal by Subject|34|||
160791435|NCT04525183|580623817|FG000|Overall Study|Withdrawal by Subject|0|||
160791436|NCT04525183|580623818|FG001|Overall Study|Withdrawal by Subject|0|||
160791437|NCT04525183|580623819|FG002|Overall Study|Withdrawal by Subject|3|||
160791438|NCT04525183|580623817|FG000|Overall Study|Study non-compliance|0|||
160791439|NCT04525183|580623818|FG001|Overall Study|Study non-compliance|0|||
160791440|NCT04525183|580623819|FG002|Overall Study|Study non-compliance|1|||
160791441|NCT04525183|580623817|FG000|Overall Study|Recurrent disease before starting on study|0|||
160791442|NCT04525183|580623818|FG001|Overall Study|Recurrent disease before starting on study|0|||
160791443|NCT04525183|580623819|FG002|Overall Study|Recurrent disease before starting on study|1|||
160791444|NCT01922895|580623820|FG000|Overall Study|Death|0|||
160791445|NCT01922895|580623821|FG001|Overall Study|Death|1|||
160791446|NCT01922895|580623820|FG000|Overall Study|Withdrawal by Subject|1|||
160791447|NCT01922895|580623821|FG001|Overall Study|Withdrawal by Subject|2|||
160791448|NCT01922895|580623820|FG000|Overall Study|Lost to Follow-up|5|||
160791449|NCT01922895|580623821|FG001|Overall Study|Lost to Follow-up|11|||
160791450|NCT05142306|580623822|FG000|Overall Study|Withdrawal by Subject|0|||
160791451|NCT05142306|580623823|FG001|Overall Study|Withdrawal by Subject|0|||
160791452|NCT05142306|580623824|FG002|Overall Study|Withdrawal by Subject|1|||
160791453|NCT04079920|580623825|FG000|Overall Study|Adverse event, not related to study drug|2|||
160791454|NCT04079920|580623825|FG000|Overall Study|Adverse event related to study drug|10|||
160791455|NCT04079920|580623825|FG000|Overall Study|Death|2|||
160791456|NCT04079920|580623825|FG000|Overall Study|Lost to Follow-up|22|||
160791457|NCT04079920|580623825|FG000|Overall Study|Physician Decision|1|||
160791458|NCT04079920|580623825|FG000|Overall Study|Withdrawal by Subject|11|||
160791459|NCT05430919|580623826|FG000|Overall Study|Protocol Violation|0|||
160791460|NCT05430919|580623827|FG001|Overall Study|Protocol Violation|0|||
160791461|NCT05430919|580623828|FG002|Overall Study|Protocol Violation|1|||
160791462|NCT05430919|580623829|FG003|Overall Study|Protocol Violation|0|||
160791463|NCT05430919|580623826|FG000|Overall Study|Lost to Follow-up|0|||
160791464|NCT05430919|580623827|FG001|Overall Study|Lost to Follow-up|1|||
160791465|NCT05430919|580623828|FG002|Overall Study|Lost to Follow-up|0|||
160791466|NCT05430919|580623829|FG003|Overall Study|Lost to Follow-up|0|||
160791467|NCT05430919|580623826|FG000|Overall Study|Withdrawal by Subject|3|||
160791468|NCT05430919|580623827|FG001|Overall Study|Withdrawal by Subject|0|||
160791469|NCT05430919|580623828|FG002|Overall Study|Withdrawal by Subject|0|||
160791470|NCT05430919|580623829|FG003|Overall Study|Withdrawal by Subject|1|||
160791471|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
160791472|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
160791473|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
160892386|NCT02598960|581002158|FG010|Treatment Period|participant request to discontinue|1|||
160892387|NCT02598960|581002159|FG011|Treatment Period|participant request to discontinue|4|||
160892388|NCT02598960|581002160|FG012|Treatment Period|participant request to discontinue|0|||
160892389|NCT02598960|581002148|FG000|Treatment Period|participant withdrew consent|0|||
160892390|NCT02598960|581002149|FG001|Treatment Period|participant withdrew consent|0|||
160892391|NCT02598960|581002150|FG002|Treatment Period|participant withdrew consent|0|||
160791474|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
160791475|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
160791476|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
160791477|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
160791478|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
160791479|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
160892392|NCT02598960|581002151|FG003|Treatment Period|participant withdrew consent|0|||
160982090|NCT01536145|581323370|FG002|Overall Study|Death|0|||
160982091|NCT01536145|581323371|FG003|Overall Study|Death|0|||
160982092|NCT01536145|581323372|FG004|Overall Study|Death|0|||
160982093|NCT01536145|581323373|FG005|Overall Study|Death|0|||
160982094|NCT01536145|581323374|FG006|Overall Study|Death|1|||
160982095|NCT01536145|581323375|FG007|Overall Study|Death|0|||
160982096|NCT01536145|581323376|FG008|Overall Study|Death|0|||
160982097|NCT01536145|581323377|FG009|Overall Study|Death|0|||
160982098|NCT01536145|581323378|FG010|Overall Study|Death|0|||
160982099|NCT01536145|581323368|FG000|Overall Study|Adverse Event|0|||
160982100|NCT01536145|581323369|FG001|Overall Study|Adverse Event|0|||
160982101|NCT01536145|581323370|FG002|Overall Study|Adverse Event|0|||
160548349|NCT01437397|579734120|FG000|Overall Study|Lack of Efficacy|5|||
160548350|NCT01437397|579734121|FG001|Overall Study|Lack of Efficacy|4|||
160548351|NCT01437397|579734122|FG002|Overall Study|Lack of Efficacy|8|||
160548352|NCT01437397|579734123|FG003|Overall Study|Lack of Efficacy|10|||
160548353|NCT01437397|579734124|FG004|Overall Study|Lack of Efficacy|20|||
160548354|NCT01437397|579734120|FG000|Overall Study|Adverse Event|21|||
160548355|NCT01437397|579734121|FG001|Overall Study|Adverse Event|22|||
160548356|NCT01437397|579734122|FG002|Overall Study|Adverse Event|16|||
160548357|NCT01437397|579734123|FG003|Overall Study|Adverse Event|14|||
160548358|NCT01437397|579734124|FG004|Overall Study|Adverse Event|21|||
160548359|NCT01437397|579734120|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
160548360|NCT01437397|579734121|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
160548361|NCT01437397|579734122|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
160548362|NCT01437397|579734123|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
160548363|NCT01437397|579734124|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
160548364|NCT00866307|579734126|FG000|Induction|Adverse Event|5|||
160982102|NCT01536145|581323371|FG003|Overall Study|Adverse Event|0|||
160982103|NCT01536145|581323372|FG004|Overall Study|Adverse Event|0|||
160982104|NCT01536145|581323373|FG005|Overall Study|Adverse Event|0|||
160982105|NCT01536145|581323374|FG006|Overall Study|Adverse Event|0|||
160982106|NCT01536145|581323375|FG007|Overall Study|Adverse Event|2|||
160982107|NCT01536145|581323376|FG008|Overall Study|Adverse Event|0|||
160548365|NCT00866307|579734127|FG001|Induction|Adverse Event|0|||
160642805|NCT03182686|580074381|FG001|Overall Study|Withdrawal by Subject|0|||
160791480|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
160982108|NCT01536145|581323377|FG009|Overall Study|Adverse Event|0|||
160548366|NCT00866307|579734128|FG002|Induction|Adverse Event|0|||
160642806|NCT01154127|580074382|FG000|Period 1 (21 Days)|Adverse Event|3|||
160642807|NCT01154127|580074383|FG001|Period 1 (21 Days)|Adverse Event|4|||
160642808|NCT01154127|580074382|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
160642809|NCT01154127|580074383|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
160642810|NCT01154127|580074382|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
160642811|NCT01154127|580074383|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
160642812|NCT01154127|580074382|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
160642813|NCT01154127|580074383|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
160642814|NCT01154127|580074382|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
160642815|NCT01154127|580074383|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
160642816|NCT01697449|580074384|FG000|Overall Study|Disease progression|47|||
160642817|NCT01697449|580074384|FG000|Overall Study|Adverse Event|7|||
160642818|NCT01697449|580074384|FG000|Overall Study|Lost to Follow-up|5|||
160642819|NCT01697449|580074384|FG000|Overall Study|Withdrawal by Subject|2|||
160642820|NCT01697449|580074384|FG000|Overall Study|Physician Decision|1|||
160642821|NCT01697449|580074384|FG000|Overall Study|Death|2|||
160642822|NCT01697449|580074384|FG000|Overall Study|Other|1|||
160642823|NCT01697449|580074384|FG000|Overall Study|Missing|25|||
160642824|NCT05037409|580074385|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
160642825|NCT05037409|580074386|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
160642826|NCT05037409|580074387|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
160642827|NCT04147611|580074389|FG000|Overall Study|Physician Decision|0|||
160642828|NCT04147611|580074390|FG001|Overall Study|Physician Decision|1|||
160642829|NCT01585831|580074393|FG000|Overall Study|Physician Decision|0|||
160642830|NCT01585831|580074394|FG001|Overall Study|Physician Decision|1|||
160642831|NCT01585831|580074393|FG000|Overall Study|Withdrawal by Subject|2|||
160642832|NCT01585831|580074394|FG001|Overall Study|Withdrawal by Subject|1|||
160642833|NCT01123980|580074395|FG000|Overall Study|Adverse Event|1|||
160642834|NCT01123980|580074396|FG001|Overall Study|Adverse Event|1|||
160642835|NCT01123980|580074395|FG000|Overall Study|Lack of Efficacy|1|||
160642836|NCT01123980|580074396|FG001|Overall Study|Lack of Efficacy|0|||
160642837|NCT01123980|580074395|FG000|Overall Study|Physician Decision|0|||
160642838|NCT01123980|580074396|FG001|Overall Study|Physician Decision|1|||
160642839|NCT01123980|580074395|FG000|Overall Study|Lost to Follow-up|0|||
160642840|NCT01123980|580074396|FG001|Overall Study|Lost to Follow-up|6|||
160642841|NCT01123980|580074395|FG000|Overall Study|Protocol Violation|6|||
160642842|NCT01123980|580074396|FG001|Overall Study|Protocol Violation|6|||
160982109|NCT01536145|581323378|FG010|Overall Study|Adverse Event|3|||
160982110|NCT00088205|581323381|FG000|Overall Study|Adverse Event|4|||
160982111|NCT00088205|581323381|FG000|Overall Study|Progressive Disease|51|||
160548367|NCT00866307|579734126|FG000|Induction|Death|2|||
160548368|NCT00866307|579734127|FG001|Induction|Death|0|||
160548369|NCT00866307|579734128|FG002|Induction|Death|0|||
160548370|NCT00866307|579734126|FG000|Induction|Physician Decision|5|||
160548371|NCT00866307|579734127|FG001|Induction|Physician Decision|0|||
160548372|NCT00866307|579734128|FG002|Induction|Physician Decision|0|||
160548373|NCT00866307|579734126|FG000|Induction|Progressive Disease|1|||
160548374|NCT00866307|579734127|FG001|Induction|Progressive Disease|0|||
160548375|NCT00866307|579734128|FG002|Induction|Progressive Disease|0|||
160548376|NCT00866307|579734126|FG000|Induction|Identification of Patients with Day 29 M|3|||
160548377|NCT00866307|579734127|FG001|Induction|Identification of Patients with Day 29 M|0|||
160548378|NCT00866307|579734128|FG002|Induction|Identification of Patients with Day 29 M|0|||
160548379|NCT00866307|579734126|FG000|Induction|Inadequate cytognetic samples th|1|||
160548380|NCT00866307|579734127|FG001|Induction|Inadequate cytognetic samples th|0|||
160548381|NCT00866307|579734128|FG002|Induction|Inadequate cytognetic samples th|0|||
160548382|NCT00866307|579734126|FG000|Induction|Improper post-induction consent|2|||
160548383|NCT00866307|579734127|FG001|Induction|Improper post-induction consent|0|||
160548384|NCT00866307|579734128|FG002|Induction|Improper post-induction consent|0|||
160548385|NCT00866307|579734126|FG000|Induction|Study was closed at the time|1|||
160548386|NCT00866307|579734127|FG001|Induction|Study was closed at the time|0|||
160548387|NCT00866307|579734128|FG002|Induction|Study was closed at the time|0|||
160548388|NCT00866307|579734126|FG000|Consolidation/Maintenance|Adverse Event|0|||
160548389|NCT00866307|579734127|FG001|Consolidation/Maintenance|Adverse Event|0|||
160548390|NCT00866307|579734128|FG002|Consolidation/Maintenance|Adverse Event|8|||
160548391|NCT00866307|579734126|FG000|Consolidation/Maintenance|Death|0|||
160548392|NCT00866307|579734127|FG001|Consolidation/Maintenance|Death|0|||
160548393|NCT00866307|579734128|FG002|Consolidation/Maintenance|Death|1|||
160548394|NCT00866307|579734126|FG000|Consolidation/Maintenance|Physician Decision|0|||
160548395|NCT00866307|579734127|FG001|Consolidation/Maintenance|Physician Decision|3|||
160548396|NCT00866307|579734128|FG002|Consolidation/Maintenance|Physician Decision|2|||
160548397|NCT00866307|579734126|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
160548398|NCT00866307|579734127|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
160548399|NCT00866307|579734128|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
160548400|NCT00866307|579734126|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
160642843|NCT01123980|580074395|FG000|Overall Study|Withdrawal by Subject|5|||
160642844|NCT01123980|580074396|FG001|Overall Study|Withdrawal by Subject|3|||
160642845|NCT01123980|580074395|FG000|Overall Study|Unclassified|6|||
160642846|NCT01123980|580074396|FG001|Overall Study|Unclassified|7|||
160642847|NCT04385199|580074397|FG000|Overall Study|Withdrawal by Subject|1|||
160642848|NCT04385199|580074398|FG001|Overall Study|Withdrawal by Subject|0|||
160642849|NCT04444752|580074399|FG000|Overall Study|Adverse Event|1|||
160642850|NCT04444752|580074400|FG001|Overall Study|Adverse Event|0|||
160642851|NCT04444752|580074401|FG002|Overall Study|Adverse Event|0|||
160642852|NCT04444752|580074402|FG003|Overall Study|Adverse Event|2|||
160642853|NCT04444752|580074399|FG000|Overall Study|Lost to Follow-up|2|||
160642854|NCT04444752|580074400|FG001|Overall Study|Lost to Follow-up|6|||
160892393|NCT02598960|581002152|FG004|Treatment Period|participant withdrew consent|0|||
160892394|NCT02598960|581002153|FG005|Treatment Period|participant withdrew consent|0|||
160892395|NCT02598960|581002154|FG006|Treatment Period|participant withdrew consent|0|||
160892396|NCT02598960|581002155|FG007|Treatment Period|participant withdrew consent|0|||
160892397|NCT02598960|581002156|FG008|Treatment Period|participant withdrew consent|0|||
160892398|NCT02598960|581002157|FG009|Treatment Period|participant withdrew consent|0|||
160642855|NCT04444752|580074401|FG002|Overall Study|Lost to Follow-up|2|||
160642856|NCT04444752|580074402|FG003|Overall Study|Lost to Follow-up|5|||
160642857|NCT04444752|580074399|FG000|Overall Study|Physician Decision|0|||
160892399|NCT02598960|581002158|FG010|Treatment Period|participant withdrew consent|0|||
160892400|NCT02598960|581002159|FG011|Treatment Period|participant withdrew consent|3|||
160892401|NCT02598960|581002160|FG012|Treatment Period|participant withdrew consent|0|||
160892402|NCT02598960|581002148|FG000|Treatment Period|No longer meets study criteria|0|||
160892403|NCT02598960|581002149|FG001|Treatment Period|No longer meets study criteria|0|||
160892404|NCT02598960|581002150|FG002|Treatment Period|No longer meets study criteria|0|||
160892405|NCT02598960|581002151|FG003|Treatment Period|No longer meets study criteria|0|||
160892406|NCT02598960|581002152|FG004|Treatment Period|No longer meets study criteria|0|||
160892407|NCT02598960|581002153|FG005|Treatment Period|No longer meets study criteria|0|||
160892408|NCT02598960|581002154|FG006|Treatment Period|No longer meets study criteria|0|||
160892409|NCT02598960|581002155|FG007|Treatment Period|No longer meets study criteria|0|||
160892410|NCT02598960|581002156|FG008|Treatment Period|No longer meets study criteria|0|||
160892411|NCT02598960|581002157|FG009|Treatment Period|No longer meets study criteria|0|||
160548401|NCT00866307|579734127|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
160642858|NCT04444752|580074400|FG001|Overall Study|Physician Decision|0|||
160642859|NCT04444752|580074401|FG002|Overall Study|Physician Decision|0|||
160642860|NCT04444752|580074402|FG003|Overall Study|Physician Decision|2|||
160892412|NCT02598960|581002158|FG010|Treatment Period|No longer meets study criteria|0|||
160892413|NCT02598960|581002159|FG011|Treatment Period|No longer meets study criteria|1|||
160791481|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
160791482|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
160791483|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
160791484|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
160791485|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
160791486|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
160791487|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
160791488|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
160791489|NCT05014919|580623830|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
160791490|NCT05014919|580623831|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
160791491|NCT05014919|580623832|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
160791492|NCT05014919|580623830|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
160791493|NCT05014919|580623831|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
160791494|NCT05014919|580623832|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
160791495|NCT04126174|580623838|FG000|Overall Study|Lost to Follow-up|3|||
160791496|NCT04126174|580623839|FG001|Overall Study|Lost to Follow-up|3|||
160791497|NCT05305651|580623850|FG000|Overall Study|Death|1|||
160791498|NCT05305651|580623850|FG000|Overall Study|Withdrawal by Subject|4|||
160791499|NCT05305651|580623850|FG000|Overall Study|Lost to Follow-up|4|||
160791500|NCT01491919|580623853|FG000|Overall Study|Insufficient PK sampling|1|||
160791501|NCT01491919|580623854|FG001|Overall Study|Insufficient PK sampling|2|||
160791502|NCT01491919|580623855|FG002|Overall Study|Insufficient PK sampling|1|||
160791503|NCT04439903|580623856|FG000|Overall Study|Withdrawal by Subject|2|||
160791504|NCT04439903|580623856|FG000|Overall Study|Screen Failure|1|||
160791505|NCT05375929|580623859|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
160791506|NCT05375929|580623860|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
160791507|NCT05375929|580623861|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
160791508|NCT05375929|580623862|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
160791509|NCT05375929|580623859|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
160791510|NCT05375929|580623860|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
160791511|NCT05375929|580623861|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
160791512|NCT05375929|580623862|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
160791513|NCT05375929|580623859|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
160791514|NCT05375929|580623860|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
160791515|NCT05375929|580623861|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
160791516|NCT05375929|580623862|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
160791517|NCT05375929|580623859|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
160791518|NCT05375929|580623860|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
160982112|NCT00088205|581323381|FG000|Overall Study|Physician Decision|1|||
160791519|NCT05375929|580623861|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
160791520|NCT05375929|580623862|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
160791521|NCT05375929|580623859|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
160791522|NCT05375929|580623860|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
160791523|NCT05375929|580623861|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
160791524|NCT05375929|580623862|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
160791525|NCT05375929|580623859|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
160791526|NCT05375929|580623860|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
160791527|NCT05375929|580623861|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
160791528|NCT05375929|580623862|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
160791529|NCT05375929|580623859|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
160791530|NCT05375929|580623860|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
160791531|NCT05375929|580623861|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
160791532|NCT05375929|580623862|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
160791533|NCT05375929|580623859|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
160791534|NCT05375929|580623860|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
160791535|NCT05375929|580623861|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
160791536|NCT05375929|580623862|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
160791537|NCT05375929|580623859|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
160791538|NCT05375929|580623860|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
160791539|NCT05375929|580623861|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
160791540|NCT05375929|580623862|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
160791541|NCT05375929|580623859|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
160791542|NCT05375929|580623860|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
160791543|NCT05375929|580623861|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
160791544|NCT05375929|580623862|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
160791545|NCT02528305|580623863|FG000|Overall Study|Withdrawal by Subject|1|||
160791546|NCT02528305|580623863|FG000|Overall Study|Adverse Event|1|||
160791547|NCT02528305|580623863|FG000|Overall Study|Physician Decision|1|||
160791548|NCT01852214|580623864|FG000|Period 1|Adverse Event|1|||
160791549|NCT01852214|580623865|FG001|Period 1|Adverse Event|2|||
160791550|NCT01852214|580623864|FG000|Period 1|Withdrawal by Subject|0|||
160791551|NCT01852214|580623865|FG001|Period 1|Withdrawal by Subject|1|||
160791552|NCT01852214|580623864|FG000|Washout Period|Withdrawal by Subject|0|||
160791553|NCT01852214|580623865|FG001|Washout Period|Withdrawal by Subject|1|||
160791554|NCT04091438|580623866|FG000|Treatment Period 1 (1 Day)|Other|1|||
160791555|NCT04091438|580623867|FG001|Treatment Period 1 (1 Day)|Other|0|||
160791556|NCT04091438|580623866|FG000|Washout Period (1 Day)|Protocol deviation|0|||
160791557|NCT04091438|580623867|FG001|Washout Period (1 Day)|Protocol deviation|1|||
160791558|NCT04091438|580623866|FG000|Washout Period (1 Day)|Other|0|||
160791559|NCT04091438|580623867|FG001|Washout Period (1 Day)|Other|1|||
160791560|NCT00421408|580623868|FG000|Overall Study|Lost to Follow-up|30|||
160791561|NCT00421408|580623869|FG001|Overall Study|Lost to Follow-up|20|||
160791562|NCT00421408|580623868|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
160791563|NCT00421408|580623869|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
160791564|NCT04105725|580623870|FG000|Primary Intervention|Lost to Follow-up|0|||
160791565|NCT04105725|580623871|FG001|Primary Intervention|Lost to Follow-up|2|||
160791566|NCT04105725|580623870|FG000|Primary Intervention|Withdrawal by Subject|0|||
160791567|NCT04105725|580623871|FG001|Primary Intervention|Withdrawal by Subject|1|||
160791568|NCT00773461|580623874|FG000|Overall Study|Adverse Event|1|||
160791569|NCT00773461|580623875|FG001|Overall Study|Adverse Event|3|||
160791570|NCT00773461|580623874|FG000|Overall Study|Withdrawal by Subject|4|||
160791571|NCT00773461|580623875|FG001|Overall Study|Withdrawal by Subject|1|||
160791572|NCT01308788|580623876|FG000|2-year Treatment|medication change by treating physician|4|||
160791573|NCT01308788|580623877|FG001|2-year Treatment|medication change by treating physician|11|||
160791574|NCT00322218|580623878|FG000|Overall Study|Death|3|||
160791575|NCT00322218|580623879|FG001|Overall Study|Death|6|||
160791576|NCT03379870|580625312|FG000|Overall Study|Lost to Follow-up|1|||
160791577|NCT03379870|580625313|FG001|Overall Study|Lost to Follow-up|0|||
160791578|NCT03379870|580625312|FG000|Overall Study|Protocol Violation|1|||
160791579|NCT03379870|580625313|FG001|Overall Study|Protocol Violation|1|||
160791580|NCT00003645|580625314|FG000|Overall Study|Death|4|||
160791581|NCT00003645|580625315|FG001|Overall Study|Death|1|||
160791582|NCT00003645|580625314|FG000|Overall Study|Lost to Follow-up|7|||
160791583|NCT00003645|580625315|FG001|Overall Study|Lost to Follow-up|8|||
160791584|NCT00003645|580625314|FG000|Overall Study|Withdrawal by Subject|1|||
160791585|NCT00003645|580625315|FG001|Overall Study|Withdrawal by Subject|3|||
160791586|NCT04616196|580625316|FG000|Overall Study|Progressive Disease|3|||
160791587|NCT04616196|580625317|FG001|Overall Study|Progressive Disease|0|||
160791588|NCT04616196|580625318|FG002|Overall Study|Progressive Disease|4|||
160791589|NCT04616196|580625319|FG003|Overall Study|Progressive Disease|1|||
160791590|NCT04616196|580625316|FG000|Overall Study|Death|2|||
160791591|NCT04616196|580625317|FG001|Overall Study|Death|4|||
160548402|NCT00866307|579734128|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
160548403|NCT00866307|579734126|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
160548404|NCT00866307|579734127|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
160548405|NCT00866307|579734128|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
160548406|NCT00866307|579734126|FG000|Consolidation/Maintenance|Therapy error|0|||
160548407|NCT00866307|579734127|FG001|Consolidation/Maintenance|Therapy error|1|||
160548408|NCT00866307|579734128|FG002|Consolidation/Maintenance|Therapy error|0|||
160791592|NCT04616196|580625318|FG002|Overall Study|Death|1|||
160791593|NCT04616196|580625319|FG003|Overall Study|Death|0|||
160791594|NCT04616196|580625316|FG000|Overall Study|Withdrawal by Subject|0|||
160791595|NCT04616196|580625317|FG001|Overall Study|Withdrawal by Subject|2|||
160791596|NCT04616196|580625318|FG002|Overall Study|Withdrawal by Subject|0|||
160791597|NCT04616196|580625319|FG003|Overall Study|Withdrawal by Subject|0|||
160791598|NCT04616196|580625316|FG000|Overall Study|Lost to Follow-up|1|||
160791599|NCT04616196|580625317|FG001|Overall Study|Lost to Follow-up|0|||
160791600|NCT04616196|580625318|FG002|Overall Study|Lost to Follow-up|0|||
160791601|NCT04616196|580625319|FG003|Overall Study|Lost to Follow-up|0|||
160791602|NCT04616196|580625316|FG000|Overall Study|Sponsor request|2|||
160791603|NCT04616196|580625317|FG001|Overall Study|Sponsor request|1|||
160791604|NCT04616196|580625318|FG002|Overall Study|Sponsor request|1|||
160791605|NCT04616196|580625319|FG003|Overall Study|Sponsor request|2|||
160791606|NCT02254291|580625320|FG000|Overall Study|Withdrawal by Subject|0|||
160791607|NCT02254291|580625321|FG001|Overall Study|Withdrawal by Subject|3|||
160791608|NCT02254291|580625322|FG002|Overall Study|Withdrawal by Subject|1|||
160791609|NCT02254291|580625320|FG000|Overall Study|Missing follow-up information|0|||
160791610|NCT02254291|580625321|FG001|Overall Study|Missing follow-up information|0|||
160791611|NCT02254291|580625322|FG002|Overall Study|Missing follow-up information|1|||
160791612|NCT06790303|580625323|FG000|Overall Study|Study Terminated by sponsor|4|||
160791613|NCT06790303|580625323|FG000|Overall Study|Death|4|||
160791614|NCT03436732|580625326|FG000|Overall Study|Not treated-enrolled in different study|1|||
160791615|NCT03436732|580625327|FG001|Overall Study|Not treated-enrolled in different study|0|||
160791616|NCT03436732|580625326|FG000|Overall Study|Off study after cycle 1|1|||
160791617|NCT03436732|580625327|FG001|Overall Study|Off study after cycle 1|0|||
160791618|NCT03436732|580625326|FG000|Overall Study|Adverse Event|2|||
160791619|NCT03436732|580625327|FG001|Overall Study|Adverse Event|0|||
160791620|NCT03436732|580625326|FG000|Overall Study|Death|0|||
160791621|NCT03436732|580625327|FG001|Overall Study|Death|1|||
160791622|NCT00668642|580625337|FG000|First Off-cycle|Cancer progression|1|||
160791623|NCT00668642|580625338|FG001|First Off-cycle|Cancer progression|0|||
160791624|NCT00668642|580625337|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
160791625|NCT00668642|580625338|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
160791626|NCT00337168|580625343|FG000|Overall Study|Death|5|||
160791627|NCT00337168|580625343|FG000|Overall Study|Not protocol specified|2|||
160791628|NCT00337168|580625343|FG000|Overall Study|Did not start therapy|1|||
160791629|NCT01230060|580625346|FG000|Overall Study|Withdrawal by Subject|1|||
160791630|NCT00443456|580625347|FG000|Overall Study|Adverse Event|16|||
160791631|NCT00443456|580625347|FG000|Overall Study|Move|1|||
160791632|NCT00443456|580625347|FG000|Overall Study|Withdrawal by Subject|1|||
160791633|NCT03242434|580625348|FG000|Overall Study|Death|0|||
160791634|NCT03242434|580625349|FG001|Overall Study|Death|2|||
160791635|NCT02157610|580625350|FG000|Overall Study|Death|4|||
160791636|NCT02157610|580625351|FG001|Overall Study|Death|4|||
160791637|NCT00814983|580625352|FG000|Overall Study|Screen failure|1|||
160791638|NCT00814983|580625353|FG001|Overall Study|Screen failure|0|||
160791639|NCT00814983|580625352|FG000|Overall Study|Withdrawal by Subject|1|||
160791640|NCT00814983|580625353|FG001|Overall Study|Withdrawal by Subject|0|||
160791641|NCT00814983|580625352|FG000|Overall Study|Graft failure|1|||
160791642|NCT00814983|580625353|FG001|Overall Study|Graft failure|0|||
160791643|NCT02853136|580625354|FG000|Wash-out|Adverse Event|0|||
160791644|NCT02853136|580625355|FG001|Wash-out|Adverse Event|0|||
160791645|NCT02853136|580625356|FG002|Wash-out|Adverse Event|0|||
160791646|NCT02853136|580625357|FG003|Wash-out|Adverse Event|1|||
160791647|NCT00841815|580625358|FG000|Washout|Withdrawal by Subject|0|||
160548409|NCT00866307|579734126|FG000|Consolidation/Maintenance|Non-compliance|0|||
160548410|NCT00866307|579734127|FG001|Consolidation/Maintenance|Non-compliance|0|||
160791648|NCT00841815|580625359|FG001|Washout|Withdrawal by Subject|1|||
160791649|NCT02327169|580625360|FG000|Overall Study|Progressive Disease|1|||
160548411|NCT00866307|579734128|FG002|Consolidation/Maintenance|Non-compliance|1|||
160791650|NCT02327169|580625361|FG001|Overall Study|Progressive Disease|3|||
160791651|NCT02327169|580625362|FG002|Overall Study|Progressive Disease|4|||
160642861|NCT04444752|580074399|FG000|Overall Study|Pregnancy|0|||
160791652|NCT02327169|580625363|FG003|Overall Study|Progressive Disease|3|||
160791653|NCT02327169|580625364|FG004|Overall Study|Progressive Disease|4|||
160791654|NCT02327169|580625365|FG005|Overall Study|Progressive Disease|3|||
160791655|NCT02327169|580625366|FG006|Overall Study|Progressive Disease|3|||
160791656|NCT02327169|580625367|FG007|Overall Study|Progressive Disease|3|||
160791657|NCT02327169|580625368|FG008|Overall Study|Progressive Disease|4|||
160791658|NCT02327169|580625369|FG009|Overall Study|Progressive Disease|4|||
160791659|NCT02327169|580625370|FG010|Overall Study|Progressive Disease|4|||
160791660|NCT02327169|580625371|FG011|Overall Study|Progressive Disease|3|||
160791661|NCT02327169|580625372|FG012|Overall Study|Progressive Disease|1|||
160791662|NCT02327169|580625373|FG013|Overall Study|Progressive Disease|3|||
160791663|NCT02327169|580625374|FG014|Overall Study|Progressive Disease|3|||
160791664|NCT02327169|580625360|FG000|Overall Study|Adverse Event|2|||
160791665|NCT02327169|580625361|FG001|Overall Study|Adverse Event|0|||
160791666|NCT02327169|580625362|FG002|Overall Study|Adverse Event|1|||
160791667|NCT02327169|580625363|FG003|Overall Study|Adverse Event|0|||
160791668|NCT02327169|580625364|FG004|Overall Study|Adverse Event|1|||
160791669|NCT02327169|580625365|FG005|Overall Study|Adverse Event|0|||
160791670|NCT02327169|580625366|FG006|Overall Study|Adverse Event|0|||
160791671|NCT02327169|580625367|FG007|Overall Study|Adverse Event|0|||
160791672|NCT02327169|580625368|FG008|Overall Study|Adverse Event|0|||
160791673|NCT02327169|580625369|FG009|Overall Study|Adverse Event|2|||
160791674|NCT02327169|580625370|FG010|Overall Study|Adverse Event|0|||
160791675|NCT02327169|580625371|FG011|Overall Study|Adverse Event|3|||
160791676|NCT02327169|580625372|FG012|Overall Study|Adverse Event|0|||
160791677|NCT02327169|580625373|FG013|Overall Study|Adverse Event|2|||
160791678|NCT02327169|580625374|FG014|Overall Study|Adverse Event|1|||
160791679|NCT02327169|580625360|FG000|Overall Study|Symptomatic Deterioration|0|||
160791680|NCT02327169|580625361|FG001|Overall Study|Symptomatic Deterioration|0|||
160791681|NCT02327169|580625362|FG002|Overall Study|Symptomatic Deterioration|1|||
160791682|NCT02327169|580625363|FG003|Overall Study|Symptomatic Deterioration|0|||
160791683|NCT02327169|580625364|FG004|Overall Study|Symptomatic Deterioration|1|||
160791684|NCT02327169|580625365|FG005|Overall Study|Symptomatic Deterioration|1|||
160791685|NCT02327169|580625366|FG006|Overall Study|Symptomatic Deterioration|0|||
160791686|NCT02327169|580625367|FG007|Overall Study|Symptomatic Deterioration|0|||
160791687|NCT02327169|580625368|FG008|Overall Study|Symptomatic Deterioration|2|||
160791688|NCT02327169|580625369|FG009|Overall Study|Symptomatic Deterioration|1|||
160791689|NCT02327169|580625370|FG010|Overall Study|Symptomatic Deterioration|0|||
160791690|NCT02327169|580625371|FG011|Overall Study|Symptomatic Deterioration|0|||
160791691|NCT02327169|580625372|FG012|Overall Study|Symptomatic Deterioration|0|||
160791692|NCT02327169|580625373|FG013|Overall Study|Symptomatic Deterioration|2|||
160791693|NCT02327169|580625374|FG014|Overall Study|Symptomatic Deterioration|1|||
160791694|NCT02327169|580625360|FG000|Overall Study|Reason Not Specified|0|||
160791695|NCT02327169|580625361|FG001|Overall Study|Reason Not Specified|0|||
160791696|NCT02327169|580625362|FG002|Overall Study|Reason Not Specified|1|||
160791697|NCT02327169|580625363|FG003|Overall Study|Reason Not Specified|0|||
160791698|NCT02327169|580625364|FG004|Overall Study|Reason Not Specified|0|||
160791699|NCT02327169|580625365|FG005|Overall Study|Reason Not Specified|0|||
160791700|NCT02327169|580625366|FG006|Overall Study|Reason Not Specified|0|||
160791701|NCT02327169|580625367|FG007|Overall Study|Reason Not Specified|0|||
160791702|NCT02327169|580625368|FG008|Overall Study|Reason Not Specified|0|||
160791703|NCT02327169|580625369|FG009|Overall Study|Reason Not Specified|1|||
160791704|NCT02327169|580625370|FG010|Overall Study|Reason Not Specified|2|||
160791705|NCT02327169|580625371|FG011|Overall Study|Reason Not Specified|1|||
160791706|NCT02327169|580625372|FG012|Overall Study|Reason Not Specified|0|||
160791707|NCT02327169|580625373|FG013|Overall Study|Reason Not Specified|0|||
160791708|NCT02327169|580625374|FG014|Overall Study|Reason Not Specified|2|||
160791709|NCT02327169|580625360|FG000|Overall Study|Withdrawal by Subject|1|||
160791710|NCT02327169|580625361|FG001|Overall Study|Withdrawal by Subject|0|||
160791711|NCT02327169|580625362|FG002|Overall Study|Withdrawal by Subject|0|||
160791712|NCT02327169|580625363|FG003|Overall Study|Withdrawal by Subject|0|||
160892414|NCT02598960|581002160|FG012|Treatment Period|No longer meets study criteria|0|||
160892415|NCT02598960|581002148|FG000|Treatment Period|Other Reasons|0|||
160892416|NCT02598960|581002149|FG001|Treatment Period|Other Reasons|0|||
160892417|NCT02598960|581002150|FG002|Treatment Period|Other Reasons|0|||
160892418|NCT02598960|581002151|FG003|Treatment Period|Other Reasons|0|||
160892419|NCT02598960|581002152|FG004|Treatment Period|Other Reasons|0|||
160791713|NCT02327169|580625364|FG004|Overall Study|Withdrawal by Subject|1|||
160892420|NCT02598960|581002153|FG005|Treatment Period|Other Reasons|0|||
160892421|NCT02598960|581002154|FG006|Treatment Period|Other Reasons|0|||
160892422|NCT02598960|581002155|FG007|Treatment Period|Other Reasons|0|||
160791714|NCT02327169|580625365|FG005|Overall Study|Withdrawal by Subject|0|||
160892423|NCT02598960|581002156|FG008|Treatment Period|Other Reasons|0|||
160791715|NCT02327169|580625366|FG006|Overall Study|Withdrawal by Subject|0|||
160892424|NCT02598960|581002157|FG009|Treatment Period|Other Reasons|0|||
160892425|NCT02598960|581002158|FG010|Treatment Period|Other Reasons|0|||
160642862|NCT04444752|580074400|FG001|Overall Study|Pregnancy|0|||
160791716|NCT02327169|580625367|FG007|Overall Study|Withdrawal by Subject|1|||
160791717|NCT02327169|580625368|FG008|Overall Study|Withdrawal by Subject|0|||
160791718|NCT02327169|580625369|FG009|Overall Study|Withdrawal by Subject|0|||
160791719|NCT02327169|580625370|FG010|Overall Study|Withdrawal by Subject|0|||
160791720|NCT02327169|580625371|FG011|Overall Study|Withdrawal by Subject|0|||
160791721|NCT02327169|580625372|FG012|Overall Study|Withdrawal by Subject|0|||
160791722|NCT02327169|580625373|FG013|Overall Study|Withdrawal by Subject|0|||
160892426|NCT02598960|581002159|FG011|Treatment Period|Other Reasons|0|||
160791723|NCT02327169|580625374|FG014|Overall Study|Withdrawal by Subject|3|||
160791724|NCT02327169|580625360|FG000|Overall Study|Lost to Follow-up|0|||
160791725|NCT02327169|580625361|FG001|Overall Study|Lost to Follow-up|0|||
160791726|NCT02327169|580625362|FG002|Overall Study|Lost to Follow-up|0|||
160791727|NCT02327169|580625363|FG003|Overall Study|Lost to Follow-up|0|||
160791728|NCT02327169|580625364|FG004|Overall Study|Lost to Follow-up|1|||
160791729|NCT02327169|580625365|FG005|Overall Study|Lost to Follow-up|0|||
160791730|NCT02327169|580625366|FG006|Overall Study|Lost to Follow-up|0|||
160791731|NCT02327169|580625367|FG007|Overall Study|Lost to Follow-up|0|||
160791732|NCT02327169|580625368|FG008|Overall Study|Lost to Follow-up|0|||
160982113|NCT00088205|581323381|FG000|Overall Study|Death Due to Study Disease|4|||
160982114|NCT05199233|581323382|FG000|Overall Study|Lack of Efficacy|1|||
160982115|NCT00688259|581323383|FG000|Overall Study|Lost to Follow-up|2|||
160982116|NCT00688259|581323384|FG001|Overall Study|Lost to Follow-up|4|||
160982117|NCT00688259|581323383|FG000|Overall Study|Physician Decision|1|||
160982118|NCT00688259|581323384|FG001|Overall Study|Physician Decision|0|||
160982119|NCT00688259|581323383|FG000|Overall Study|Withdrawal by Subject|2|||
160982120|NCT00688259|581323384|FG001|Overall Study|Withdrawal by Subject|0|||
160982121|NCT00688259|581323383|FG000|Overall Study|Declined Interview|2|||
160982122|NCT00688259|581323384|FG001|Overall Study|Declined Interview|3|||
160982123|NCT00688259|581323383|FG000|Overall Study|Hospitalized at Follow-up|0|||
160982124|NCT00688259|581323384|FG001|Overall Study|Hospitalized at Follow-up|1|||
160982125|NCT02982720|581323387|FG000|Overall Study|Adverse Event|3|||
160982126|NCT02982720|581323387|FG000|Overall Study|Death|1|||
160982127|NCT01734850|581323392|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
160982128|NCT01734850|581323393|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
160982129|NCT01734850|581323394|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
160982130|NCT01734850|581323392|FG000|Overall Study|Not infused due to manufacturing failure|0|||
160982131|NCT01734850|581323393|FG001|Overall Study|Not infused due to manufacturing failure|0|||
160982132|NCT01734850|581323394|FG002|Overall Study|Not infused due to manufacturing failure|1|||
160982133|NCT03824938|581323395|FG000|Overall Study|Withdrawal by Subject|2|||
160791733|NCT02327169|580625369|FG009|Overall Study|Lost to Follow-up|0|||
160791734|NCT02327169|580625370|FG010|Overall Study|Lost to Follow-up|0|||
160791735|NCT02327169|580625371|FG011|Overall Study|Lost to Follow-up|0|||
160791736|NCT02327169|580625372|FG012|Overall Study|Lost to Follow-up|0|||
160791737|NCT02327169|580625373|FG013|Overall Study|Lost to Follow-up|0|||
160791738|NCT02327169|580625374|FG014|Overall Study|Lost to Follow-up|0|||
160791739|NCT03787615|580625375|FG000|Overall Study|Withdrawal by Subject|2|||
160791740|NCT03787615|580625375|FG000|Overall Study|Lost to Follow-up|2|||
160791741|NCT01229111|580625377|FG000|Overall Study|Death|1|||
160791742|NCT04102514|580625378|FG000|Overall Study|Death|3|||
160791743|NCT04102514|580625379|FG001|Overall Study|Death|0|||
160791744|NCT04102514|580625380|FG002|Overall Study|Death|0|||
160791745|NCT04102514|580625381|FG003|Overall Study|Death|0|||
160791746|NCT04102514|580625378|FG000|Overall Study|Lost to Follow-up|0|||
160791747|NCT04102514|580625379|FG001|Overall Study|Lost to Follow-up|0|||
160791748|NCT04102514|580625380|FG002|Overall Study|Lost to Follow-up|3|||
160791749|NCT04102514|580625381|FG003|Overall Study|Lost to Follow-up|0|||
160791750|NCT04102514|580625378|FG000|Overall Study|Physician Decision|0|||
160791751|NCT04102514|580625379|FG001|Overall Study|Physician Decision|0|||
160791752|NCT04102514|580625380|FG002|Overall Study|Physician Decision|1|||
160791753|NCT04102514|580625381|FG003|Overall Study|Physician Decision|0|||
160791754|NCT04102514|580625378|FG000|Overall Study|Withdrawal by Subject|7|||
160791755|NCT04102514|580625379|FG001|Overall Study|Withdrawal by Subject|13|||
160791756|NCT04102514|580625380|FG002|Overall Study|Withdrawal by Subject|7|||
160791757|NCT04102514|580625381|FG003|Overall Study|Withdrawal by Subject|14|||
160791758|NCT04102514|580625378|FG000|Overall Study|Moved to longterm care facility|6|||
160791759|NCT04102514|580625379|FG001|Overall Study|Moved to longterm care facility|0|||
160791760|NCT04102514|580625380|FG002|Overall Study|Moved to longterm care facility|4|||
160791761|NCT04102514|580625381|FG003|Overall Study|Moved to longterm care facility|0|||
160791762|NCT00619918|580625382|FG000|Overall Study|Withdrawal by Subject|4|||
160791763|NCT00619918|580625383|FG001|Overall Study|Withdrawal by Subject|3|||
160791764|NCT00619918|580625382|FG000|Overall Study|Physician Decision|2|||
160791765|NCT00619918|580625383|FG001|Overall Study|Physician Decision|4|||
160791766|NCT00619918|580625382|FG000|Overall Study|Transfer to outside facility|3|||
160791767|NCT00619918|580625383|FG001|Overall Study|Transfer to outside facility|3|||
160791768|NCT00619918|580625382|FG000|Overall Study|Left before receiving first dose|7|||
160791769|NCT00619918|580625383|FG001|Overall Study|Left before receiving first dose|6|||
160791770|NCT00619918|580625382|FG000|Overall Study|ICU admission|4|||
160791771|NCT00619918|580625383|FG001|Overall Study|ICU admission|6|||
160791772|NCT03579719|580625389|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
160791773|NCT01443026|580625390|FG000|Overall Study|Physician Decision|1|||
160791774|NCT01443026|580625391|FG001|Overall Study|Physician Decision|0|||
160791775|NCT01443026|580625390|FG000|Overall Study|Death|0|||
160791776|NCT01443026|580625391|FG001|Overall Study|Death|1|||
160791777|NCT01443026|580625390|FG000|Overall Study|Withdrawal by Subject|0|||
160791778|NCT01443026|580625391|FG001|Overall Study|Withdrawal by Subject|3|||
160791779|NCT01443026|580625390|FG000|Overall Study|Lost to Follow-up|2|||
160791780|NCT01443026|580625391|FG001|Overall Study|Lost to Follow-up|1|||
160791781|NCT03900650|580625392|FG000|Overall Study|Withdrawal by Subject|1|||
160791782|NCT03900650|580625393|FG001|Overall Study|Withdrawal by Subject|1|||
160791783|NCT03900650|580625394|FG002|Overall Study|Withdrawal by Subject|0|||
160791784|NCT03900650|580625395|FG003|Overall Study|Withdrawal by Subject|0|||
160791785|NCT03900650|580625392|FG000|Overall Study|Withdrawn by staff|1|||
160791786|NCT03900650|580625393|FG001|Overall Study|Withdrawn by staff|0|||
160791787|NCT03900650|580625394|FG002|Overall Study|Withdrawn by staff|0|||
160791788|NCT03900650|580625395|FG003|Overall Study|Withdrawn by staff|0|||
160791789|NCT00829868|580625400|FG000|Washout|Physician Decision|1|||
160791790|NCT00829868|580625401|FG001|Washout|Physician Decision|0|||
160791791|NCT01969409|580625402|FG000|Overall Study|Death|2|||
160791792|NCT01969409|580625403|FG001|Overall Study|Death|2|||
160791793|NCT01969409|580625402|FG000|Overall Study|Transplant|1|||
160791794|NCT01969409|580625403|FG001|Overall Study|Transplant|1|||
160791795|NCT01969409|580625402|FG000|Overall Study|Withdrawal by Subject|0|||
160791796|NCT01969409|580625403|FG001|Overall Study|Withdrawal by Subject|1|||
160791797|NCT00721110|580625404|FG000|Overall Study|Ultram use|1|||
160791798|NCT00721110|580625405|FG001|Overall Study|Ultram use|0|||
160791799|NCT00721110|580625406|FG002|Overall Study|Ultram use|0|||
160791800|NCT00721110|580625407|FG003|Overall Study|Ultram use|0|||
160791801|NCT00721110|580625404|FG000|Overall Study|vertical incision|0|||
160791802|NCT00721110|580625405|FG001|Overall Study|vertical incision|0|||
160791803|NCT00721110|580625406|FG002|Overall Study|vertical incision|1|||
160791804|NCT00721110|580625407|FG003|Overall Study|vertical incision|0|||
160791805|NCT02799043|580625410|FG000|Overall Study|Adverse Event|0|||
160791806|NCT02799043|580625411|FG001|Overall Study|Adverse Event|1|||
160791807|NCT02799043|580625410|FG000|Overall Study|Death|1|||
160791808|NCT02799043|580625411|FG001|Overall Study|Death|1|||
160791809|NCT02799043|580625410|FG000|Overall Study|Lost to Follow-up|3|||
160791810|NCT02799043|580625411|FG001|Overall Study|Lost to Follow-up|6|||
160791811|NCT02799043|580625410|FG000|Overall Study|Withdrawal by Subject|4|||
160791812|NCT02799043|580625411|FG001|Overall Study|Withdrawal by Subject|4|||
160791813|NCT02799043|580625410|FG000|Overall Study|Moved to different country|0|||
160791814|NCT02799043|580625411|FG001|Overall Study|Moved to different country|1|||
160791815|NCT02799043|580625410|FG000|Overall Study|Trial Screen Failure|1|||
160791816|NCT02799043|580625411|FG001|Overall Study|Trial Screen Failure|0|||
160791817|NCT02799043|580625410|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
160791818|NCT02799043|580625411|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
160791819|NCT01681849|580625414|FG000|Overall Study|Protocol Violation|2|||
160791820|NCT01681849|580625415|FG001|Overall Study|Protocol Violation|0|||
160791821|NCT01681849|580625416|FG002|Overall Study|Protocol Violation|0|||
160791822|NCT01681849|580625414|FG000|Overall Study|Withdrawal by Subject|3|||
160791823|NCT01681849|580625415|FG001|Overall Study|Withdrawal by Subject|5|||
160791824|NCT01681849|580625416|FG002|Overall Study|Withdrawal by Subject|33|||
160791825|NCT01681849|580625414|FG000|Overall Study|Lost to Follow-up|3|||
160791826|NCT01681849|580625415|FG001|Overall Study|Lost to Follow-up|2|||
160791827|NCT01681849|580625416|FG002|Overall Study|Lost to Follow-up|6|||
160791828|NCT02852005|580625420|FG000|Overall Study|Lost to Follow-up|0|||
160791829|NCT02852005|580625421|FG001|Overall Study|Lost to Follow-up|0|||
160791830|NCT02852005|580625422|FG002|Overall Study|Lost to Follow-up|0|||
160791831|NCT02852005|580625423|FG003|Overall Study|Lost to Follow-up|0|||
160791832|NCT02852005|580625424|FG004|Overall Study|Lost to Follow-up|1|||
160791833|NCT02852005|580625420|FG000|Overall Study|Withdrawal by Subject|1|||
160791834|NCT02852005|580625421|FG001|Overall Study|Withdrawal by Subject|0|||
160791835|NCT02852005|580625422|FG002|Overall Study|Withdrawal by Subject|0|||
160791836|NCT02852005|580625423|FG003|Overall Study|Withdrawal by Subject|0|||
160791837|NCT02852005|580625424|FG004|Overall Study|Withdrawal by Subject|0|||
160791838|NCT01916226|580625425|FG000|Overall Study|Adverse Event|1|||
160791839|NCT01916226|580625426|FG001|Overall Study|Adverse Event|0|||
160791840|NCT01916226|580625427|FG002|Overall Study|Adverse Event|1|||
160791841|NCT01916226|580625428|FG003|Overall Study|Adverse Event|1|||
160791842|NCT01916226|580625425|FG000|Overall Study|Lack of Efficacy|0|||
160791843|NCT01916226|580625426|FG001|Overall Study|Lack of Efficacy|0|||
160791844|NCT01916226|580625427|FG002|Overall Study|Lack of Efficacy|2|||
160791845|NCT01916226|580625428|FG003|Overall Study|Lack of Efficacy|1|||
160791846|NCT01916226|580625425|FG000|Overall Study|Protocol Violation|0|||
160791847|NCT01916226|580625426|FG001|Overall Study|Protocol Violation|1|||
160791848|NCT01916226|580625427|FG002|Overall Study|Protocol Violation|0|||
160791849|NCT01916226|580625428|FG003|Overall Study|Protocol Violation|1|||
160791850|NCT01916226|580625425|FG000|Overall Study|Physician Decision|0|||
160791851|NCT01916226|580625426|FG001|Overall Study|Physician Decision|0|||
160791852|NCT01916226|580625427|FG002|Overall Study|Physician Decision|0|||
160791853|NCT01916226|580625428|FG003|Overall Study|Physician Decision|1|||
160791854|NCT01166646|580625432|FG000|Overall Study|Protocol Violation|0|||
160791855|NCT01166646|580625433|FG001|Overall Study|Protocol Violation|1|||
160791856|NCT01166646|580625432|FG000|Overall Study|Adverse Event|1|||
160791857|NCT01166646|580625433|FG001|Overall Study|Adverse Event|0|||
160791858|NCT03760068|580625434|FG000|Overall Study|Withdrawal by Subject|7|||
160791859|NCT03760068|580625435|FG001|Overall Study|Withdrawal by Subject|8|||
160791860|NCT03760068|580625434|FG000|Overall Study|Adverse Event|1|||
160791861|NCT03760068|580625435|FG001|Overall Study|Adverse Event|2|||
160791862|NCT03760068|580625434|FG000|Overall Study|Administrative Decision by Sponsor|0|||
160791863|NCT03760068|580625435|FG001|Overall Study|Administrative Decision by Sponsor|2|||
160791864|NCT03760068|580625434|FG000|Overall Study|Physician Decision|1|||
160791865|NCT03760068|580625435|FG001|Overall Study|Physician Decision|2|||
160791866|NCT03760068|580625434|FG000|Overall Study|Lost to Follow-up|4|||
160791867|NCT03760068|580625435|FG001|Overall Study|Lost to Follow-up|9|||
160791868|NCT03760068|580625434|FG000|Overall Study|Subject Moved Out of State|1|||
160791869|NCT03760068|580625435|FG001|Overall Study|Subject Moved Out of State|0|||
160791870|NCT01618708|580625436|FG000|Overall Study|Adverse Event|10|||
160791871|NCT01618708|580625437|FG001|Overall Study|Adverse Event|10|||
160791872|NCT01618708|580625436|FG000|Overall Study|Lost to Follow-up|3|||
160791873|NCT01618708|580625437|FG001|Overall Study|Lost to Follow-up|3|||
160892427|NCT02598960|581002160|FG012|Treatment Period|Other Reasons|1|||
160892428|NCT02598960|581002148|FG000|Participants Entering Follow Up Period|Death|1|||
160892429|NCT02598960|581002149|FG001|Participants Entering Follow Up Period|Death|0|||
160982134|NCT03824938|581323396|FG001|Overall Study|Withdrawal by Subject|1|||
160982135|NCT03824938|581323397|FG002|Overall Study|Withdrawal by Subject|0|||
160982136|NCT03824938|581323398|FG003|Overall Study|Withdrawal by Subject|2|||
160982137|NCT03824938|581323399|FG004|Overall Study|Withdrawal by Subject|0|||
160892430|NCT02598960|581002150|FG002|Participants Entering Follow Up Period|Death|0|||
160892431|NCT02598960|581002151|FG003|Participants Entering Follow Up Period|Death|0|||
160892432|NCT02598960|581002152|FG004|Participants Entering Follow Up Period|Death|0|||
160892433|NCT02598960|581002153|FG005|Participants Entering Follow Up Period|Death|0|||
160892434|NCT02598960|581002154|FG006|Participants Entering Follow Up Period|Death|0|||
160892435|NCT02598960|581002155|FG007|Participants Entering Follow Up Period|Death|0|||
160892436|NCT02598960|581002156|FG008|Participants Entering Follow Up Period|Death|0|||
160892437|NCT02598960|581002157|FG009|Participants Entering Follow Up Period|Death|1|||
160892438|NCT02598960|581002158|FG010|Participants Entering Follow Up Period|Death|0|||
160892439|NCT02598960|581002159|FG011|Participants Entering Follow Up Period|Death|11|||
160892440|NCT02598960|581002160|FG012|Participants Entering Follow Up Period|Death|2|||
160892441|NCT02598960|581002148|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892442|NCT02598960|581002149|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892443|NCT02598960|581002150|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892444|NCT02598960|581002151|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892445|NCT02598960|581002152|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892446|NCT02598960|581002153|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892447|NCT02598960|581002154|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892448|NCT02598960|581002155|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892449|NCT02598960|581002156|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892450|NCT02598960|581002157|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892451|NCT02598960|581002158|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892452|NCT02598960|581002159|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
160892453|NCT02598960|581002160|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892454|NCT02598960|581002148|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
160892455|NCT02598960|581002149|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
160892456|NCT02598960|581002150|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
160892457|NCT02598960|581002151|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
160892458|NCT02598960|581002152|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
160892459|NCT02598960|581002153|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
160892460|NCT02598960|581002154|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
160892461|NCT02598960|581002155|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
160892462|NCT02598960|581002156|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
160892463|NCT02598960|581002157|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
160892464|NCT02598960|581002158|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
160892465|NCT02598960|581002159|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
160892466|NCT02598960|581002160|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
160982138|NCT03824938|581323400|FG005|Overall Study|Withdrawal by Subject|1|||
160982139|NCT03824938|581323395|FG000|Overall Study|Lost to Follow-up|0|||
160982140|NCT03824938|581323396|FG001|Overall Study|Lost to Follow-up|1|||
160791874|NCT01618708|580625436|FG000|Overall Study|Withdrawal by Subject|17|||
160791875|NCT01618708|580625437|FG001|Overall Study|Withdrawal by Subject|22|||
160791876|NCT01618708|580625436|FG000|Overall Study|Lack of Efficacy|8|||
160791877|NCT01618708|580625437|FG001|Overall Study|Lack of Efficacy|8|||
160791878|NCT01618708|580625436|FG000|Overall Study|Technical problems|2|||
160791879|NCT01618708|580625437|FG001|Overall Study|Technical problems|0|||
160791880|NCT01618708|580625436|FG000|Overall Study|Other than specified above|1|||
160791881|NCT01618708|580625437|FG001|Overall Study|Other than specified above|1|||
160791882|NCT01618708|580625436|FG000|Overall Study|Randomized but not treated|3|||
160791883|NCT01618708|580625437|FG001|Overall Study|Randomized but not treated|2|||
160791884|NCT03131479|580625442|FG000|Overall Study|Adverse Event|0|||
160791885|NCT03131479|580625443|FG001|Overall Study|Adverse Event|0|||
160791886|NCT03131479|580625444|FG002|Overall Study|Adverse Event|1|||
160791887|NCT03131479|580625445|FG003|Overall Study|Adverse Event|1|||
160791888|NCT03131479|580625446|FG004|Overall Study|Adverse Event|0|||
160791889|NCT03131479|580625442|FG000|Overall Study|Subject/Guardian Decision|0|||
160791890|NCT03131479|580625443|FG001|Overall Study|Subject/Guardian Decision|0|||
160791891|NCT03131479|580625444|FG002|Overall Study|Subject/Guardian Decision|0|||
160791892|NCT03131479|580625445|FG003|Overall Study|Subject/Guardian Decision|1|||
160791893|NCT03131479|580625446|FG004|Overall Study|Subject/Guardian Decision|0|||
160791894|NCT04309500|580625458|FG000|Overall Study|Lost to Follow-up|1|||
160791895|NCT04309500|580625459|FG001|Overall Study|Lost to Follow-up|0|||
160791896|NCT04309500|580625460|FG002|Overall Study|Lost to Follow-up|0|||
160791897|NCT04309500|580625461|FG003|Overall Study|Lost to Follow-up|0|||
160791898|NCT00913835|580625462|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
160791899|NCT00913835|580625463|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
160982141|NCT03824938|581323397|FG002|Overall Study|Lost to Follow-up|0|||
160982142|NCT03824938|581323398|FG003|Overall Study|Lost to Follow-up|0|||
160982143|NCT03824938|581323399|FG004|Overall Study|Lost to Follow-up|1|||
160982144|NCT03824938|581323400|FG005|Overall Study|Lost to Follow-up|0|||
160982145|NCT00287469|581323401|FG000|Overall Study|serious adverse event|1|||
160982146|NCT00287469|581323402|FG001|Overall Study|serious adverse event|6|||
160982147|NCT00287469|581323401|FG000|Overall Study|Adverse Event|1|||
160982148|NCT00287469|581323402|FG001|Overall Study|Adverse Event|1|||
160982149|NCT00287469|581323401|FG000|Overall Study|moved from area|144|||
160982150|NCT00287469|581323402|FG001|Overall Study|moved from area|138|||
160982151|NCT00287469|581323401|FG000|Overall Study|Lost to Follow-up|74|||
160982152|NCT00287469|581323402|FG001|Overall Study|Lost to Follow-up|69|||
160982153|NCT02019602|581323406|FG000|Screening Period|Ineligibility|4|||
160982154|NCT02019602|581323407|FG001|Screening Period|Ineligibility|0|||
160982155|NCT02019602|581323406|FG000|Screening Period|Adverse Event|1|||
160982156|NCT02019602|581323407|FG001|Screening Period|Adverse Event|0|||
160982157|NCT01058863|581323410|FG000|Overall Study|Lost to Follow-up|1|||
160982158|NCT01058863|581323410|FG000|Overall Study|Withdrawal by Subject|1|||
160982159|NCT01058863|581323410|FG000|Overall Study|Sponsor requested withdrawal|1|||
160982160|NCT01058863|581323410|FG000|Overall Study|Randomized in error|1|||
160982161|NCT03653416|581323411|FG000|Overall Study|Protocol Violation|6|||
160982162|NCT03653416|581323412|FG001|Overall Study|Protocol Violation|1|||
160982163|NCT03207711|581323413|FG000|Overall Study|Withdrawal by Subject|1|||
160982164|NCT03207711|581323414|FG001|Overall Study|Withdrawal by Subject|2|||
160982165|NCT02788006|581323418|FG000|Overall Study|Patient not treated|1|||
160982166|NCT03050398|581323425|FG000|Overall Study|Study terminated by sponsor|8|||
160982167|NCT05108649|581323426|FG000|Overall Study|Lost to Follow-up|0|||
160642863|NCT04444752|580074401|FG002|Overall Study|Pregnancy|0|||
160791900|NCT00913835|580625462|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
160791901|NCT00913835|580625463|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
160791902|NCT00913835|580625462|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
160791903|NCT00913835|580625463|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
160791904|NCT00913835|580625462|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
160791905|NCT00913835|580625463|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
160791906|NCT00913835|580625462|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
160791907|NCT00913835|580625463|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
160791908|NCT02657356|580626767|FG000|Overall Study|Death|1|||
160791909|NCT02657356|580626768|FG001|Overall Study|Death|0|||
160791910|NCT02657356|580626767|FG000|Overall Study|Withdrawal by Subject|5|||
160791911|NCT02657356|580626768|FG001|Overall Study|Withdrawal by Subject|6|||
160791912|NCT02657356|580626767|FG000|Overall Study|Terminated by Sponsor|8|||
160791913|NCT02657356|580626768|FG001|Overall Study|Terminated by Sponsor|5|||
160791914|NCT02657356|580626767|FG000|Overall Study|Rolled over to EAP study|6|||
160791915|NCT02657356|580626768|FG001|Overall Study|Rolled over to EAP study|4|||
160791916|NCT03058952|580626771|FG000|Overall Study|Adverse Event|1|||
160791917|NCT03058952|580626772|FG001|Overall Study|Adverse Event|0|||
160791918|NCT03058952|580626771|FG000|Overall Study|Lost to Follow-up|15|||
160791919|NCT03058952|580626772|FG001|Overall Study|Lost to Follow-up|15|||
160791920|NCT03058952|580626771|FG000|Overall Study|Withdrawal by Subject|7|||
160791921|NCT03058952|580626772|FG001|Overall Study|Withdrawal by Subject|11|||
160791922|NCT01373281|580626775|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
160791923|NCT01373281|580626776|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
160791924|NCT01373281|580626775|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
160791925|NCT01373281|580626776|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
160791926|NCT01373281|580626775|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
160791927|NCT01373281|580626776|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
160791928|NCT01373281|580626775|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
160791929|NCT01373281|580626776|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
160791930|NCT01373281|580626775|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
160791931|NCT01373281|580626776|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
160791932|NCT01373281|580626775|FG000|Surveillance Expansion Period|Protocol Violation|9|||
160791933|NCT01373281|580626776|FG001|Surveillance Expansion Period|Protocol Violation|1|||
160791934|NCT01373281|580626775|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
160791935|NCT01373281|580626776|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
160791936|NCT01373281|580626775|FG000|Surveillance Expansion Period|Serious adverse event|3|||
160791937|NCT01373281|580626776|FG001|Surveillance Expansion Period|Serious adverse event|4|||
160791938|NCT01397253|580626777|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
160892467|NCT02598960|581002148|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160982168|NCT05108649|581323427|FG001|Overall Study|Lost to Follow-up|4|||
160982169|NCT05108649|581323428|FG002|Overall Study|Lost to Follow-up|3|||
160982170|NCT05108649|581323429|FG003|Overall Study|Lost to Follow-up|6|||
160892468|NCT02598960|581002149|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892469|NCT02598960|581002150|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892470|NCT02598960|581002151|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892471|NCT02598960|581002152|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892472|NCT02598960|581002153|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892473|NCT02598960|581002154|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892474|NCT02598960|581002155|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892475|NCT02598960|581002156|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892476|NCT02598960|581002157|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892477|NCT02598960|581002158|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892478|NCT02598960|581002159|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
160892479|NCT02598960|581002160|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892480|NCT02598960|581002148|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
160892481|NCT02598960|581002149|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
160892482|NCT02598960|581002150|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
160892483|NCT02598960|581002151|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
160892484|NCT02598960|581002152|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
160892485|NCT02598960|581002153|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
160892486|NCT02598960|581002154|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
160892487|NCT02598960|581002155|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
160892488|NCT02598960|581002156|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
160892489|NCT02598960|581002157|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
160892490|NCT02598960|581002158|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
160892491|NCT02598960|581002159|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
160892492|NCT02598960|581002160|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
160892493|NCT01614600|581002164|FG000|Overall Study|Unacceptable fit|1|||
160892494|NCT01614600|581002164|FG000|Overall Study|Discomfort|1|||
160892495|NCT01614600|581002164|FG000|Overall Study|Unable to remove lens at the end of day|1|||
160892496|NCT01614600|581002164|FG000|Overall Study|Protocol deviation|1|||
160892497|NCT00137631|581002165|FG000|Overall Study|Lost to Follow-up|37|||
160892498|NCT00137631|581002166|FG001|Overall Study|Lost to Follow-up|41|||
160892499|NCT02395666|581002167|FG000|Overall Study|Physician Decision|3|||
160892500|NCT02395666|581002168|FG001|Overall Study|Physician Decision|0|||
160892501|NCT02395666|581002167|FG000|Overall Study|Lost to Follow-up|1|||
160892502|NCT02395666|581002168|FG001|Overall Study|Lost to Follow-up|0|||
160892503|NCT02395666|581002167|FG000|Overall Study|Withdrawal by Subject|2|||
160892504|NCT02395666|581002168|FG001|Overall Study|Withdrawal by Subject|1|||
160892505|NCT02611960|581002169|FG000|Overall Study|Adverse Event|7|||
160892506|NCT02611960|581002170|FG001|Overall Study|Adverse Event|8|||
160892507|NCT02611960|581002169|FG000|Overall Study|Death|98|||
160982171|NCT05108649|581323426|FG000|Overall Study|Not Interested|1|||
160791939|NCT01397253|580626778|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
160791940|NCT02296476|580626779|FG000|Overall Study|Disease Progression|6|||
160791941|NCT02296476|580626780|FG001|Overall Study|Disease Progression|4|||
160791942|NCT02296476|580626781|FG002|Overall Study|Disease Progression|2|||
160791943|NCT00980044|580626786|FG000|Overall Study|Withdrawal by Subject|5|||
160791944|NCT00980044|580626787|FG001|Overall Study|Withdrawal by Subject|7|||
160791945|NCT00980044|580626788|FG002|Overall Study|Withdrawal by Subject|3|||
160791946|NCT00980044|580626786|FG000|Overall Study|Protocol Violation|0|||
160892508|NCT02611960|581002170|FG001|Overall Study|Death|92|||
160982172|NCT05108649|581323427|FG001|Overall Study|Not Interested|1|||
160982173|NCT05108649|581323428|FG002|Overall Study|Not Interested|0|||
160791947|NCT00980044|580626787|FG001|Overall Study|Protocol Violation|0|||
160791948|NCT00980044|580626788|FG002|Overall Study|Protocol Violation|2|||
160791949|NCT03502681|580626789|FG000|Overall Study|Adverse Event|1|||
160791950|NCT03502681|580626790|FG001|Overall Study|Adverse Event|1|||
160791951|NCT03502681|580626789|FG000|Overall Study|Disease Progression|2|||
160791952|NCT03502681|580626790|FG001|Overall Study|Disease Progression|1|||
160791953|NCT00442702|580626791|FG000|Titration Period|Adverse Event|2|||
160791954|NCT00442702|580626792|FG001|Titration Period|Adverse Event|0|||
160791955|NCT00442702|580626791|FG000|Titration Period|Death|3|||
160791956|NCT00442702|580626792|FG001|Titration Period|Death|2|||
160791957|NCT00442702|580626791|FG000|Titration Period|Insufficient Therapeutic Response|1|||
160791958|NCT00442702|580626792|FG001|Titration Period|Insufficient Therapeutic Response|0|||
160791959|NCT00442702|580626791|FG000|Titration Period|Refused Treatment|4|||
160791960|NCT00442702|580626792|FG001|Titration Period|Refused Treatment|1|||
160791961|NCT00442702|580626791|FG000|Titration Period|Failure to return|1|||
160791962|NCT00442702|580626792|FG001|Titration Period|Failure to return|0|||
160791963|NCT00442702|580626791|FG000|Titration Period|Hospitalized in another hospital|1|||
160791964|NCT00442702|580626792|FG001|Titration Period|Hospitalized in another hospital|0|||
160791965|NCT00442702|580626791|FG000|Evaluation Period|Adverse Event|1|||
160791966|NCT00442702|580626792|FG001|Evaluation Period|Adverse Event|0|||
160791967|NCT00442702|580626791|FG000|Evaluation Period|Death|1|||
160791968|NCT00442702|580626792|FG001|Evaluation Period|Death|1|||
160791969|NCT00442702|580626791|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
160791970|NCT00442702|580626792|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
160791971|NCT00442702|580626791|FG000|Evaluation Period|Refused treatment|1|||
160791972|NCT00442702|580626792|FG001|Evaluation Period|Refused treatment|1|||
160791973|NCT00442702|580626791|FG000|Evaluation Period|Renal transplant|0|||
160791974|NCT00442702|580626792|FG001|Evaluation Period|Renal transplant|1|||
160791975|NCT00442702|580626791|FG000|Evaluation Period|Failure to return|1|||
160791976|NCT00442702|580626792|FG001|Evaluation Period|Failure to return|0|||
160791977|NCT00442702|580626791|FG000|Evaluation Period|Site closure|0|||
160791978|NCT00442702|580626792|FG001|Evaluation Period|Site closure|1|||
160791979|NCT01444781|580626793|FG000|Overall Study|Lost to Follow-up|0|||
160791980|NCT01444781|580626794|FG001|Overall Study|Lost to Follow-up|3|||
160791981|NCT01444781|580626795|FG002|Overall Study|Lost to Follow-up|1|||
160791982|NCT01444781|580626793|FG000|Overall Study|Withdrawal by Subject|3|||
160791983|NCT01444781|580626794|FG001|Overall Study|Withdrawal by Subject|1|||
160791984|NCT01444781|580626795|FG002|Overall Study|Withdrawal by Subject|2|||
160791985|NCT00321932|580626797|FG000|Overall Study|Death|3|||
160791986|NCT00321932|580626798|FG001|Overall Study|Death|6|||
160791987|NCT00321932|580626797|FG000|Overall Study|Withdrawal by Subject|3|||
160791988|NCT00321932|580626798|FG001|Overall Study|Withdrawal by Subject|6|||
160791989|NCT00321932|580626797|FG000|Overall Study|Early relapse|2|||
160791990|NCT00321932|580626798|FG001|Overall Study|Early relapse|8|||
160791991|NCT00321932|580626797|FG000|Overall Study|Missing data|2|||
160791992|NCT00321932|580626798|FG001|Overall Study|Missing data|1|||
160791993|NCT03257657|580626801|FG000|Overall Study|Lost to Follow-up|0|||
160791994|NCT03257657|580626802|FG001|Overall Study|Lost to Follow-up|3|||
160791995|NCT03257657|580626801|FG000|Overall Study|Withdrawn|0|||
160791996|NCT03257657|580626802|FG001|Overall Study|Withdrawn|1|||
160791997|NCT03257657|580626801|FG000|Overall Study|Noted not eligible right after enrolled|0|||
160791998|NCT03257657|580626802|FG001|Overall Study|Noted not eligible right after enrolled|1|||
160791999|NCT02801578|580626803|FG000|Overall Study|Adverse Event|2|||
160792000|NCT00137449|580626804|FG000|Overall Study|Disease Progression|8|||
160548412|NCT00866307|579734126|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
160792001|NCT00137449|580626805|FG001|Overall Study|Disease Progression|13|||
160792002|NCT00137449|580626804|FG000|Overall Study|Death|4|||
160792003|NCT00137449|580626805|FG001|Overall Study|Death|3|||
160792004|NCT00137449|580626804|FG000|Overall Study|Adverse Event|3|||
160792005|NCT00137449|580626805|FG001|Overall Study|Adverse Event|1|||
160792006|NCT00137449|580626804|FG000|Overall Study|Withdrawal by Subject|1|||
160792007|NCT00137449|580626805|FG001|Overall Study|Withdrawal by Subject|1|||
160792008|NCT01356940|580626806|FG000|First Intervention (28 Days)|Adverse Event|1|||
160792009|NCT01356940|580626807|FG001|First Intervention (28 Days)|Adverse Event|0|||
160792010|NCT01356940|580626806|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
160792011|NCT01356940|580626807|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
160792012|NCT03412591|580626808|FG000|Overall Study|Withdrawal by Subject|1|||
160792013|NCT03412591|580626809|FG001|Overall Study|Withdrawal by Subject|8|||
160792014|NCT03412591|580626808|FG000|Overall Study|Adverse Event|0|||
160792015|NCT03412591|580626809|FG001|Overall Study|Adverse Event|1|||
160792016|NCT02272985|580626810|FG000|Overall Study|Withdrawal by Subject|1|||
160792017|NCT02272985|580626810|FG000|Overall Study|hip fracture|1|||
160792018|NCT02272985|580626810|FG000|Overall Study|kidney transplantation|1|||
160792019|NCT02263547|580626813|FG000|Overall Study|Adverse Event|1|||
160792020|NCT02263547|580626813|FG000|Overall Study|Lost to Follow-up|2|||
160792021|NCT00505687|580626816|FG000|Overall Study|Important protocol violation|2|||
160792022|NCT00505687|580626816|FG000|Overall Study|Lack of Efficacy|15|||
160792023|NCT00505687|580626816|FG000|Overall Study|Adverse Event|48|||
160792024|NCT00505687|580626816|FG000|Overall Study|Subject withdrew consent|15|||
160792025|NCT00505687|580626816|FG000|Overall Study|Lost to Follow-up|1|||
160792026|NCT00505687|580626816|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
160792027|NCT00505687|580626816|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
160792028|NCT00505687|580626816|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
160792029|NCT00505687|580626816|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
160792030|NCT00505687|580626816|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
160792031|NCT00505687|580626816|FG000|Overall Study|Other: Disease Progression|1|||
160792032|NCT00505687|580626816|FG000|Overall Study|Other: As Per Sponsor|8|||
160792033|NCT03707821|580626817|FG000|Overall Study|Protocol Violation|0|||
160792034|NCT03707821|580626818|FG001|Overall Study|Protocol Violation|1|||
160792035|NCT03707821|580626817|FG000|Overall Study|Unsatisfactory Visual Response|1|||
160792036|NCT03707821|580626818|FG001|Overall Study|Unsatisfactory Visual Response|0|||
160792037|NCT03707821|580626817|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
160792038|NCT03707821|580626818|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
160792039|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
160792040|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
160792041|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
160792042|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
160792043|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
160792044|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
160792045|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
160792046|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
160792047|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
160792048|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
160792049|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
160792050|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
160792051|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
160792052|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
160792053|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
160792054|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
160792055|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
160792056|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
160792057|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
160792058|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
160792059|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
160792060|NCT01432444|580626819|FG000|Treatment Phase|Lost to Follow-up|0|||
160792061|NCT01432444|580626820|FG001|Treatment Phase|Lost to Follow-up|33|||
160792062|NCT01432444|580626821|FG002|Treatment Phase|Lost to Follow-up|0|||
160792063|NCT01432444|580626819|FG000|Treatment Phase|Adverse Event|0|||
160792064|NCT01432444|580626820|FG001|Treatment Phase|Adverse Event|37|||
160792065|NCT01432444|580626821|FG002|Treatment Phase|Adverse Event|0|||
160792066|NCT01432444|580626819|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
160792067|NCT01432444|580626820|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
160792068|NCT01432444|580626821|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
160792069|NCT01432444|580626819|FG000|Treatment Phase|Physician Decision|0|||
160792070|NCT01432444|580626820|FG001|Treatment Phase|Physician Decision|5|||
160792071|NCT01432444|580626821|FG002|Treatment Phase|Physician Decision|0|||
160792072|NCT01432444|580626819|FG000|Treatment Phase|Withdrawal by Subject|0|||
160792073|NCT01432444|580626820|FG001|Treatment Phase|Withdrawal by Subject|41|||
160792074|NCT01432444|580626821|FG002|Treatment Phase|Withdrawal by Subject|0|||
160642864|NCT04444752|580074402|FG003|Overall Study|Pregnancy|1|||
160792075|NCT01432444|580626819|FG000|Treatment Phase|Protocol Deviation|0|||
160792076|NCT01432444|580626820|FG001|Treatment Phase|Protocol Deviation|3|||
160792077|NCT01432444|580626821|FG002|Treatment Phase|Protocol Deviation|0|||
160792078|NCT01432444|580626819|FG000|Treatment Phase|Lack of Efficacy|0|||
160792079|NCT01432444|580626820|FG001|Treatment Phase|Lack of Efficacy|10|||
160792080|NCT01432444|580626821|FG002|Treatment Phase|Lack of Efficacy|0|||
160792081|NCT01432444|580626819|FG000|Extension Phase|Lost to Follow-up|0|||
160792082|NCT01432444|580626820|FG001|Extension Phase|Lost to Follow-up|0|||
160792083|NCT01432444|580626821|FG002|Extension Phase|Lost to Follow-up|17|||
160792084|NCT01432444|580626819|FG000|Extension Phase|Adverse Event|0|||
160792085|NCT01432444|580626820|FG001|Extension Phase|Adverse Event|0|||
160792086|NCT01432444|580626821|FG002|Extension Phase|Adverse Event|10|||
160792087|NCT01432444|580626819|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
160792088|NCT01432444|580626820|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
160792089|NCT01432444|580626821|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
160792090|NCT01432444|580626819|FG000|Extension Phase|Met Withdrawal Criteria|0|||
160792091|NCT01432444|580626820|FG001|Extension Phase|Met Withdrawal Criteria|0|||
160792092|NCT01432444|580626821|FG002|Extension Phase|Met Withdrawal Criteria|144|||
160792093|NCT01432444|580626819|FG000|Extension Phase|Physician Decision|0|||
160792094|NCT01432444|580626820|FG001|Extension Phase|Physician Decision|0|||
160792095|NCT01432444|580626821|FG002|Extension Phase|Physician Decision|1|||
160792096|NCT01432444|580626819|FG000|Extension Phase|Withdrawal by Subject|0|||
160792097|NCT01432444|580626820|FG001|Extension Phase|Withdrawal by Subject|0|||
160792098|NCT01432444|580626821|FG002|Extension Phase|Withdrawal by Subject|13|||
160792099|NCT02301897|580626822|FG000|Treatment Course 1|Non-Compliance|0|||
160792100|NCT02301897|580626823|FG001|Treatment Course 1|Non-Compliance|0|||
160792101|NCT02301897|580626824|FG002|Treatment Course 1|Non-Compliance|1|||
160792102|NCT02301897|580626822|FG000|Treatment Course 1|Adverse Event|1|||
160792103|NCT02301897|580626823|FG001|Treatment Course 1|Adverse Event|1|||
160792104|NCT02301897|580626824|FG002|Treatment Course 1|Adverse Event|0|||
160792105|NCT02301897|580626822|FG000|Treatment Course 1|Lost to Follow-up|1|||
160792106|NCT02301897|580626823|FG001|Treatment Course 1|Lost to Follow-up|2|||
160792107|NCT02301897|580626824|FG002|Treatment Course 1|Lost to Follow-up|1|||
160792108|NCT02301897|580626822|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
160792109|NCT02301897|580626823|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
160792110|NCT02301897|580626824|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
160792111|NCT02301897|580626822|FG000|Treatment Course 1|Withdrawal by Subject|0|||
160792112|NCT02301897|580626823|FG001|Treatment Course 1|Withdrawal by Subject|0|||
160792113|NCT02301897|580626824|FG002|Treatment Course 1|Withdrawal by Subject|2|||
160792114|NCT02301897|580626822|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
160792115|NCT02301897|580626823|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
160792116|NCT02301897|580626824|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
160792117|NCT02301897|580626822|FG000|Treatment Course 2|Lost to Follow-up|0|||
160792118|NCT02301897|580626823|FG001|Treatment Course 2|Lost to Follow-up|2|||
160792119|NCT02301897|580626824|FG002|Treatment Course 2|Lost to Follow-up|0|||
160792120|NCT02301897|580626822|FG000|Treatment Course 2|Pregnancy|0|||
160792121|NCT02301897|580626823|FG001|Treatment Course 2|Pregnancy|1|||
160892509|NCT02611960|581002169|FG000|Overall Study|Withdrawal by Subject|1|||
160892510|NCT02611960|581002170|FG001|Overall Study|Withdrawal by Subject|5|||
160892511|NCT02611960|581002169|FG000|Overall Study|Sponsor Decision|11|||
160892512|NCT02611960|581002170|FG001|Overall Study|Sponsor Decision|11|||
160892513|NCT01229371|581002182|FG000|Overall Study|Withdrawal by Subject|0|||
160892514|NCT01229371|581002183|FG001|Overall Study|Withdrawal by Subject|1|||
160892515|NCT01229371|581002184|FG002|Overall Study|Withdrawal by Subject|0|||
160892516|NCT01229371|581002185|FG003|Overall Study|Withdrawal by Subject|0|||
160892517|NCT00736879|581002190|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
160792122|NCT02301897|580626824|FG002|Treatment Course 2|Pregnancy|1|||
160792123|NCT02301897|580626822|FG000|Treatment Course 2|Withdrawal by Subject|0|||
160792124|NCT02301897|580626823|FG001|Treatment Course 2|Withdrawal by Subject|2|||
160792125|NCT02301897|580626824|FG002|Treatment Course 2|Withdrawal by Subject|0|||
160792126|NCT02301897|580626822|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
160792127|NCT02301897|580626823|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
160792128|NCT02301897|580626824|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
160792129|NCT03673176|580626825|FG000|Overall Study|Death prior to intervention|1|||
160792130|NCT03673176|580626825|FG000|Overall Study|Death following intervention|3|||
160792131|NCT03673176|580626825|FG000|Overall Study|Withdrawal by Subject|1|||
160792132|NCT02378480|580626826|FG000|Overall Study|Physician Decision|1|||
160792133|NCT02378480|580626827|FG001|Overall Study|Physician Decision|1|||
160792134|NCT02378480|580626826|FG000|Overall Study|Death|1|||
160792135|NCT02378480|580626827|FG001|Overall Study|Death|2|||
160792136|NCT02378480|580626826|FG000|Overall Study|Randomized, but Not Treated|6|||
160792137|NCT02378480|580626827|FG001|Overall Study|Randomized, but Not Treated|4|||
160792138|NCT02378480|580626826|FG000|Overall Study|Adverse Event|0|||
160792139|NCT02378480|580626827|FG001|Overall Study|Adverse Event|1|||
160892518|NCT00736879|581002191|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
160792140|NCT02378480|580626826|FG000|Overall Study|Missed EOT/PTE Visit|1|||
160792141|NCT02378480|580626827|FG001|Overall Study|Missed EOT/PTE Visit|2|||
160792142|NCT02378480|580626826|FG000|Overall Study|Withdrawal by Subject|9|||
160792143|NCT02378480|580626827|FG001|Overall Study|Withdrawal by Subject|4|||
160792144|NCT02378480|580626826|FG000|Overall Study|Lost to Follow-up|10|||
160792145|NCT02378480|580626827|FG001|Overall Study|Lost to Follow-up|18|||
160792146|NCT02014467|580626831|FG000|Overall Study|Adverse Event|4|||
160792147|NCT02014467|580626832|FG001|Overall Study|Adverse Event|0|||
160792148|NCT02014467|580626831|FG000|Overall Study|Protocol Violation|3|||
160792149|NCT02014467|580626832|FG001|Overall Study|Protocol Violation|0|||
160792150|NCT02014467|580626831|FG000|Overall Study|Physician Decision|2|||
160792151|NCT02014467|580626832|FG001|Overall Study|Physician Decision|3|||
160792152|NCT02014467|580626831|FG000|Overall Study|Withdrawal by Subject|16|||
160792153|NCT02014467|580626832|FG001|Overall Study|Withdrawal by Subject|4|||
160792154|NCT01217892|580626834|FG000|Overall Study|Adverse Event|1|||
160792155|NCT01217892|580626835|FG001|Overall Study|Adverse Event|1|||
160792156|NCT01217892|580626836|FG002|Overall Study|Adverse Event|1|||
160792157|NCT01217892|580626837|FG003|Overall Study|Adverse Event|0|||
160792158|NCT01217892|580626834|FG000|Overall Study|Withdrawal by Subject|0|||
160792159|NCT01217892|580626835|FG001|Overall Study|Withdrawal by Subject|2|||
160792160|NCT01217892|580626836|FG002|Overall Study|Withdrawal by Subject|1|||
160792161|NCT01217892|580626837|FG003|Overall Study|Withdrawal by Subject|0|||
160792162|NCT01217892|580626834|FG000|Overall Study|Lab value|1|||
160792163|NCT01217892|580626835|FG001|Overall Study|Lab value|0|||
160792164|NCT01217892|580626836|FG002|Overall Study|Lab value|1|||
160792165|NCT01217892|580626837|FG003|Overall Study|Lab value|0|||
160792166|NCT01217892|580626834|FG000|Overall Study|Subject no longer meets study criteria|5|||
160792167|NCT01217892|580626835|FG001|Overall Study|Subject no longer meets study criteria|2|||
160792168|NCT01217892|580626836|FG002|Overall Study|Subject no longer meets study criteria|4|||
160792169|NCT01217892|580626837|FG003|Overall Study|Subject no longer meets study criteria|8|||
160792170|NCT01217892|580626834|FG000|Overall Study|Incorrect enrollment|0|||
160792171|NCT01217892|580626835|FG001|Overall Study|Incorrect enrollment|1|||
160792172|NCT01217892|580626836|FG002|Overall Study|Incorrect enrollment|1|||
160792173|NCT01217892|580626837|FG003|Overall Study|Incorrect enrollment|0|||
160792174|NCT01217892|580626834|FG000|Overall Study|Poor/Non-Compliance|0|||
160792175|NCT01217892|580626835|FG001|Overall Study|Poor/Non-Compliance|0|||
160792176|NCT01217892|580626836|FG002|Overall Study|Poor/Non-Compliance|1|||
160792177|NCT01217892|580626837|FG003|Overall Study|Poor/Non-Compliance|0|||
160892519|NCT00736879|581002192|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
160892520|NCT00736879|581002193|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
160892521|NCT00736879|581002190|FG000|Double Blind Treatment Period|Adverse Event|0|||
160892522|NCT00736879|581002191|FG001|Double Blind Treatment Period|Adverse Event|1|||
160892523|NCT00736879|581002192|FG002|Double Blind Treatment Period|Adverse Event|1|||
160892524|NCT00736879|581002193|FG003|Double Blind Treatment Period|Adverse Event|0|||
160892525|NCT00736879|581002190|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
160892526|NCT00736879|581002191|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
160892527|NCT00736879|581002192|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
160892528|NCT00736879|581002193|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
160892529|NCT00736879|581002190|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
160892530|NCT00736879|581002191|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
160892531|NCT00736879|581002192|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
160892532|NCT00736879|581002193|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
160892533|NCT00736879|581002190|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
160892534|NCT00736879|581002191|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
160892535|NCT00736879|581002192|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
160892536|NCT00736879|581002193|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
160892537|NCT00736879|581002190|FG000|Double Blind Treatment Period|No longer met criteria|0|||
160892538|NCT00736879|581002191|FG001|Double Blind Treatment Period|No longer met criteria|1|||
160892539|NCT00736879|581002192|FG002|Double Blind Treatment Period|No longer met criteria|0|||
160892540|NCT00736879|581002193|FG003|Double Blind Treatment Period|No longer met criteria|0|||
160892541|NCT00736879|581002190|FG000|Double Blind Treatment Period|non-specified|0|||
160892542|NCT00736879|581002191|FG001|Double Blind Treatment Period|non-specified|1|||
160892543|NCT00736879|581002192|FG002|Double Blind Treatment Period|non-specified|0|||
160892544|NCT00736879|581002193|FG003|Double Blind Treatment Period|non-specified|0|||
160892545|NCT00736879|581002190|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
160892546|NCT00736879|581002191|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
160892547|NCT00736879|581002192|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
160892548|NCT00736879|581002193|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
160892549|NCT00736879|581002190|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
160892550|NCT00736879|581002191|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
160892551|NCT00736879|581002192|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
160892552|NCT00736879|581002193|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
160892553|NCT00735254|581002196|FG000|Overall Study|Protocol Violation|1|||
160892554|NCT00735254|581002197|FG001|Overall Study|Protocol Violation|1|||
160792178|NCT03802916|580626839|FG000|Overall Study|Adverse Event|0|||
160982174|NCT05108649|581323429|FG003|Overall Study|Not Interested|1|||
160982175|NCT05108649|581323426|FG000|Overall Study|Out of area|0|||
160982176|NCT05108649|581323427|FG001|Overall Study|Out of area|0|||
160982177|NCT05108649|581323428|FG002|Overall Study|Out of area|0|||
160982178|NCT05108649|581323429|FG003|Overall Study|Out of area|1|||
160982179|NCT05108649|581323426|FG000|Overall Study|PI decision|1|||
160982180|NCT05108649|581323427|FG001|Overall Study|PI decision|0|||
160982181|NCT05108649|581323428|FG002|Overall Study|PI decision|0|||
160982182|NCT05108649|581323429|FG003|Overall Study|PI decision|0|||
160982183|NCT05108649|581323426|FG000|Overall Study|Significant Non-Compliance|0|||
160982184|NCT05108649|581323427|FG001|Overall Study|Significant Non-Compliance|1|||
160982185|NCT05108649|581323428|FG002|Overall Study|Significant Non-Compliance|0|||
160982186|NCT05108649|581323429|FG003|Overall Study|Significant Non-Compliance|0|||
160982187|NCT05108649|581323426|FG000|Overall Study|Unable to adhere to study protocol|0|||
160982188|NCT05108649|581323427|FG001|Overall Study|Unable to adhere to study protocol|2|||
160982189|NCT05108649|581323428|FG002|Overall Study|Unable to adhere to study protocol|0|||
160982190|NCT05108649|581323429|FG003|Overall Study|Unable to adhere to study protocol|0|||
160982191|NCT00918749|581323430|FG000|Overall Study|Adverse Event|1|||
160982192|NCT00918749|581323431|FG001|Overall Study|Adverse Event|0|||
160982193|NCT00918749|581323432|FG002|Overall Study|Adverse Event|1|||
160982194|NCT00918749|581323430|FG000|Overall Study|Lost to Follow-up|0|||
160982195|NCT00918749|581323431|FG001|Overall Study|Lost to Follow-up|0|||
160982196|NCT00918749|581323432|FG002|Overall Study|Lost to Follow-up|1|||
160982197|NCT00918749|581323430|FG000|Overall Study|Withdrawal by Subject|5|||
160982198|NCT00918749|581323431|FG001|Overall Study|Withdrawal by Subject|3|||
160982199|NCT00918749|581323432|FG002|Overall Study|Withdrawal by Subject|5|||
160982200|NCT00918749|581323430|FG000|Overall Study|No Study Medication Taken|1|||
160892555|NCT00735254|581002198|FG002|Overall Study|Protocol Violation|1|||
160892556|NCT00735254|581002199|FG003|Overall Study|Protocol Violation|0|||
160892557|NCT03880461|581002207|FG000|Overall Study|Determined ineligible after enrollment|45|||
160892558|NCT03880461|581002208|FG001|Overall Study|Determined ineligible after enrollment|44|||
160982201|NCT00918749|581323431|FG001|Overall Study|No Study Medication Taken|0|||
160892559|NCT03880461|581002207|FG000|Overall Study|No weight measurement after enrollment|24|||
160892560|NCT03880461|581002208|FG001|Overall Study|No weight measurement after enrollment|17|||
160892561|NCT02652767|581002210|FG000|Overall Study|Death|2|||
160892562|NCT02652767|581002210|FG000|Overall Study|Lost to Follow-up|1|||
160892563|NCT02652767|581002210|FG000|Overall Study|Withdrawal by Subject|1|||
160892564|NCT02273739|581002214|FG000|Overall Study|Progression of Disease|3|||
160892565|NCT02273739|581002215|FG001|Overall Study|Progression of Disease|4|||
160892566|NCT02273739|581002216|FG002|Overall Study|Progression of Disease|5|||
160892567|NCT02273739|581002217|FG003|Overall Study|Progression of Disease|2|||
160892568|NCT02273739|581002214|FG000|Overall Study|Death|0|||
160892569|NCT02273739|581002215|FG001|Overall Study|Death|0|||
160892570|NCT02273739|581002216|FG002|Overall Study|Death|0|||
160982202|NCT00918749|581323432|FG002|Overall Study|No Study Medication Taken|0|||
160982203|NCT00972179|581323433|FG000|Overall Study|Noncompliance|1|||
160982204|NCT00972179|581323434|FG001|Overall Study|Noncompliance|0|||
160982205|NCT00972179|581323435|FG002|Overall Study|Noncompliance|0|||
160982206|NCT00972179|581323436|FG003|Overall Study|Noncompliance|0|||
160982207|NCT00972179|581323437|FG004|Overall Study|Noncompliance|1|||
160982208|NCT00972179|581323438|FG005|Overall Study|Noncompliance|0|||
160982209|NCT00972179|581323439|FG006|Overall Study|Noncompliance|1|||
160792179|NCT03802916|580626840|FG001|Overall Study|Adverse Event|1|||
160792180|NCT03802916|580626839|FG000|Overall Study|Withdrawal by Subject|0|||
160792181|NCT03802916|580626840|FG001|Overall Study|Withdrawal by Subject|1|||
160792182|NCT00480532|580626841|FG000|Overall Study|Withdrawal by Subject|2|||
160792183|NCT00480532|580626842|FG001|Overall Study|Withdrawal by Subject|4|||
160792184|NCT00480532|580626843|FG002|Overall Study|Withdrawal by Subject|3|||
160792185|NCT00480532|580626844|FG003|Overall Study|Withdrawal by Subject|1|||
160792186|NCT00480532|580626841|FG000|Overall Study|Protocol Violation|0|||
160792187|NCT00480532|580626842|FG001|Overall Study|Protocol Violation|0|||
160792188|NCT00480532|580626843|FG002|Overall Study|Protocol Violation|1|||
160792189|NCT00480532|580626844|FG003|Overall Study|Protocol Violation|0|||
160792190|NCT01285102|580626845|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
160792191|NCT00557440|580626846|FG000|Treatment Period 1|Adverse Event|0|||
160792192|NCT00557440|580626847|FG001|Treatment Period 1|Adverse Event|0|||
160792193|NCT00557440|580626848|FG002|Treatment Period 1|Adverse Event|1|||
160792194|NCT01946880|580626851|FG000|Overall Study|Lost to Follow-up|1|||
160792195|NCT01946880|580626852|FG001|Overall Study|Lost to Follow-up|0|||
160792196|NCT01946880|580626851|FG000|Overall Study|Physician Decision|1|||
160792197|NCT01946880|580626852|FG001|Overall Study|Physician Decision|1|||
160792198|NCT01946880|580626851|FG000|Overall Study|Withdrawal by Subject|3|||
160792199|NCT01946880|580626852|FG001|Overall Study|Withdrawal by Subject|2|||
160792200|NCT01946880|580626851|FG000|Overall Study|Met Primary Endpoint|1|||
160792201|NCT01946880|580626852|FG001|Overall Study|Met Primary Endpoint|0|||
160792202|NCT01946880|580626851|FG000|Overall Study|Personal and Family Issues|1|||
160792203|NCT01946880|580626852|FG001|Overall Study|Personal and Family Issues|0|||
160792204|NCT02951819|580626853|FG000|Overall Study|Death|9|||
160792205|NCT02951819|580626854|FG001|Overall Study|Death|7|||
160792206|NCT02951819|580626853|FG000|Overall Study|Withdrawal by Subject|3|||
160792207|NCT02951819|580626854|FG001|Overall Study|Withdrawal by Subject|0|||
160792208|NCT02951819|580626853|FG000|Overall Study|Adverse Event|1|||
160792209|NCT02951819|580626854|FG001|Overall Study|Adverse Event|0|||
160792210|NCT02951819|580626853|FG000|Overall Study|Lack of Efficacy|4|||
160792211|NCT02951819|580626854|FG001|Overall Study|Lack of Efficacy|0|||
160792212|NCT02951819|580626853|FG000|Overall Study|Lost to Follow-up|1|||
160792213|NCT02951819|580626854|FG001|Overall Study|Lost to Follow-up|0|||
160792214|NCT02951819|580626853|FG000|Overall Study|Progressive Disease|1|||
160792215|NCT02951819|580626854|FG001|Overall Study|Progressive Disease|0|||
160792216|NCT02951819|580626853|FG000|Overall Study|Other|9|||
160792217|NCT02951819|580626854|FG001|Overall Study|Other|0|||
160792218|NCT02420314|580626858|FG000|Overall Study|Withdrawal by Subject|1|||
160792219|NCT02420314|580626858|FG000|Overall Study|Protocol Violation|1|||
160792220|NCT00680914|580626859|FG000|Overall Study|Consent withdrawal|6|||
160792221|NCT00680914|580626860|FG001|Overall Study|Consent withdrawal|3|||
160792222|NCT00680914|580626859|FG000|Overall Study|Lost to Follow-up|4|||
160792223|NCT00680914|580626860|FG001|Overall Study|Lost to Follow-up|0|||
160792224|NCT00680914|580626859|FG000|Overall Study|serious adverse event (SAE)|0|||
160792225|NCT00680914|580626860|FG001|Overall Study|serious adverse event (SAE)|1|||
160792226|NCT03204812|580626861|FG000|Overall Study|Adverse Event|3|||
160792227|NCT02412436|580626862|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
160792228|NCT02412436|580626862|FG000|Overall Study|Lost to Follow-up|6|||
160792229|NCT02412436|580626862|FG000|Overall Study|Unable to get to clinic|3|||
160792230|NCT02412436|580626862|FG000|Overall Study|Death|1|||
160792231|NCT02412436|580626862|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
160792232|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
160792233|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160792234|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160792235|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160792236|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160792237|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
160792238|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160792239|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160792240|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160792241|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160792242|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
160792243|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160792244|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160792245|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160792246|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160792247|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
160792248|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
160792249|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
160792250|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
160792251|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
160792252|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
160792253|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
160792254|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
160548413|NCT00866307|579734127|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
160548414|NCT00866307|579734128|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
160548415|NCT01681433|579734129|FG000|Overall Study|Lack of Efficacy|23|||
160548416|NCT01681433|579734130|FG001|Overall Study|Lack of Efficacy|23|||
160548417|NCT01681433|579734129|FG000|Overall Study|Withdrawal by Subject|5|||
160548418|NCT01681433|579734130|FG001|Overall Study|Withdrawal by Subject|5|||
160548419|NCT01681433|579734129|FG000|Overall Study|Protocol Violation|2|||
160548420|NCT01681433|579734130|FG001|Overall Study|Protocol Violation|0|||
160548421|NCT01681433|579734129|FG000|Overall Study|Adverse Event|2|||
160548422|NCT01681433|579734130|FG001|Overall Study|Adverse Event|4|||
160548423|NCT01681433|579734129|FG000|Overall Study|Lost to Follow-up|0|||
160548424|NCT01681433|579734130|FG001|Overall Study|Lost to Follow-up|1|||
160548425|NCT01844895|579734131|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
160548426|NCT01844895|579734131|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
160548427|NCT01844895|579734131|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
160548428|NCT01844895|579734131|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
160548429|NCT01844895|579734131|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
160982210|NCT00972179|581323433|FG000|Overall Study|Withdrawal by Subject|0|||
160982211|NCT00972179|581323434|FG001|Overall Study|Withdrawal by Subject|3|||
160982212|NCT00972179|581323435|FG002|Overall Study|Withdrawal by Subject|0|||
160982213|NCT00972179|581323436|FG003|Overall Study|Withdrawal by Subject|1|||
160982214|NCT00972179|581323437|FG004|Overall Study|Withdrawal by Subject|0|||
160982215|NCT00972179|581323438|FG005|Overall Study|Withdrawal by Subject|0|||
160982216|NCT00972179|581323439|FG006|Overall Study|Withdrawal by Subject|2|||
160982217|NCT00972179|581323433|FG000|Overall Study|Administrative Decision|0|||
160982218|NCT00972179|581323434|FG001|Overall Study|Administrative Decision|0|||
160982219|NCT00972179|581323435|FG002|Overall Study|Administrative Decision|0|||
160982220|NCT00972179|581323436|FG003|Overall Study|Administrative Decision|0|||
160982221|NCT00972179|581323437|FG004|Overall Study|Administrative Decision|1|||
160982222|NCT00972179|581323438|FG005|Overall Study|Administrative Decision|0|||
160982223|NCT00972179|581323439|FG006|Overall Study|Administrative Decision|0|||
160982224|NCT00972179|581323433|FG000|Overall Study|Lost to Follow-up|0|||
160982225|NCT00972179|581323434|FG001|Overall Study|Lost to Follow-up|0|||
160982226|NCT00972179|581323435|FG002|Overall Study|Lost to Follow-up|1|||
160982227|NCT00972179|581323436|FG003|Overall Study|Lost to Follow-up|0|||
160892571|NCT02273739|581002217|FG003|Overall Study|Death|2|||
160892572|NCT02273739|581002214|FG000|Overall Study|Adverse Event|0|||
160892573|NCT02273739|581002215|FG001|Overall Study|Adverse Event|0|||
160892574|NCT02273739|581002216|FG002|Overall Study|Adverse Event|0|||
160892575|NCT02273739|581002217|FG003|Overall Study|Adverse Event|1|||
160892576|NCT02273739|581002214|FG000|Overall Study|Withdrawal by Subject|0|||
160892577|NCT02273739|581002215|FG001|Overall Study|Withdrawal by Subject|0|||
160892578|NCT02273739|581002216|FG002|Overall Study|Withdrawal by Subject|2|||
160892579|NCT02273739|581002217|FG003|Overall Study|Withdrawal by Subject|1|||
160892580|NCT02273739|581002214|FG000|Overall Study|Physician Decision|0|||
160892581|NCT02273739|581002215|FG001|Overall Study|Physician Decision|0|||
160892582|NCT02273739|581002216|FG002|Overall Study|Physician Decision|0|||
160892583|NCT02273739|581002217|FG003|Overall Study|Physician Decision|1|||
160892584|NCT02280473|581002219|FG000|Overall Study|Adverse Event|1|||
160892585|NCT02280473|581002220|FG001|Overall Study|Adverse Event|1|||
160892586|NCT02280473|581002219|FG000|Overall Study|Lack of Efficacy|0|||
160892587|NCT02280473|581002220|FG001|Overall Study|Lack of Efficacy|1|||
160892588|NCT02280473|581002219|FG000|Overall Study|Lost to Follow-up|0|||
160892589|NCT02280473|581002220|FG001|Overall Study|Lost to Follow-up|1|||
160892590|NCT02393690|581002221|FG000|Overall Study|Ineligible|0|||
160892591|NCT02393690|581002222|FG001|Overall Study|Ineligible|1|||
160892592|NCT05298306|581002223|FG000|Overall Study|Physician Decision|0|||
160892593|NCT05298306|581002224|FG001|Overall Study|Physician Decision|0|||
160892594|NCT05298306|581002225|FG002|Overall Study|Physician Decision|0|||
160892595|NCT05298306|581002226|FG003|Overall Study|Physician Decision|1|||
160892596|NCT05298306|581002227|FG004|Overall Study|Physician Decision|0|||
160892597|NCT05298306|581002228|FG005|Overall Study|Physician Decision|0|||
160892598|NCT00144027|581002230|FG000|Overall Study|Lost to Follow-up|1|||
160892599|NCT00144027|581002231|FG001|Overall Study|Lost to Follow-up|3|||
160892600|NCT00144027|581002230|FG000|Overall Study|Withdrawal by Subject|2|||
160892601|NCT00144027|581002231|FG001|Overall Study|Withdrawal by Subject|2|||
160892602|NCT00144027|581002230|FG000|Overall Study|did not complete baseline assessment|0|||
160892603|NCT00144027|581002231|FG001|Overall Study|did not complete baseline assessment|6|||
160892604|NCT00237185|581002232|FG000|Core|Adverse Event|3|||
160892605|NCT00237185|581002233|FG001|Core|Adverse Event|4|||
160892606|NCT00237185|581002232|FG000|Core|Abnormal laboratory value|0|||
160892607|NCT00237185|581002233|FG001|Core|Abnormal laboratory value|4|||
160892608|NCT00237185|581002232|FG000|Core|Abnormal test procedure results|1|||
160892609|NCT00237185|581002233|FG001|Core|Abnormal test procedure results|0|||
160892610|NCT00237185|581002232|FG000|Core|Lack of Efficacy|30|||
160892611|NCT00237185|581002233|FG001|Core|Lack of Efficacy|23|||
160982228|NCT00972179|581323437|FG004|Overall Study|Lost to Follow-up|0|||
160892612|NCT00237185|581002232|FG000|Core|Protocol Violation|1|||
160892613|NCT00237185|581002233|FG001|Core|Protocol Violation|1|||
160892614|NCT00237185|581002232|FG000|Core|Withdrawal by Subject|4|||
160982229|NCT00972179|581323438|FG005|Overall Study|Lost to Follow-up|3|||
160892615|NCT00237185|581002233|FG001|Core|Withdrawal by Subject|4|||
160892616|NCT00237185|581002232|FG000|Core|Administrative problems|0|||
160892617|NCT00237185|581002233|FG001|Core|Administrative problems|1|||
160982230|NCT00972179|581323439|FG006|Overall Study|Lost to Follow-up|1|||
160642865|NCT04444752|580074399|FG000|Overall Study|Withdrawal by Subject|6|||
160892618|NCT00237185|581002232|FG000|Core|Death|4|||
160892619|NCT00237185|581002233|FG001|Core|Death|0|||
160892620|NCT00237185|581002232|FG000|Core|Determined ineligible post randomization|1|||
160892621|NCT00237185|581002233|FG001|Core|Determined ineligible post randomization|0|||
160892622|NCT00237185|581002232|FG000|Extension|Adverse Event|1|||
160892623|NCT00237185|581002233|FG001|Extension|Adverse Event|0|||
160982231|NCT03018106|581323440|FG000|Overall Study|Lost to Follow-up|0|||
160982232|NCT03018106|581323441|FG001|Overall Study|Lost to Follow-up|1|||
160982233|NCT03055832|581323442|FG000|Week 2|Withdrawal by Subject|1|||
160982234|NCT03055832|581323443|FG001|Week 2|Withdrawal by Subject|0|||
160792255|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
160792256|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
160792257|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
160792258|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
160792259|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
160792260|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
160792261|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
160792262|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
160792263|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160792264|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160792265|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160792266|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160792267|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
160792268|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
160792269|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
160892624|NCT00237185|581002232|FG000|Extension|Abnormal laboratory value|0|||
160892625|NCT00237185|581002233|FG001|Extension|Abnormal laboratory value|1|||
160892626|NCT00237185|581002232|FG000|Extension|Lack of Efficacy|9|||
160892627|NCT00237185|581002233|FG001|Extension|Lack of Efficacy|14|||
160892628|NCT00237185|581002232|FG000|Extension|Condition no longer required study drug|0|||
160892629|NCT00237185|581002233|FG001|Extension|Condition no longer required study drug|1|||
160892630|NCT00237185|581002232|FG000|Extension|Withdrawal by Subject|3|||
160892631|NCT00237185|581002233|FG001|Extension|Withdrawal by Subject|2|||
160892632|NCT00237185|581002232|FG000|Extension|Lost to Follow-up|1|||
160892633|NCT00237185|581002233|FG001|Extension|Lost to Follow-up|0|||
160892634|NCT00237185|581002232|FG000|Extension|Administrative problems|1|||
160892635|NCT00237185|581002233|FG001|Extension|Administrative problems|0|||
160892636|NCT00237185|581002232|FG000|Extension|Death|1|||
160892637|NCT00237185|581002233|FG001|Extension|Death|1|||
160892638|NCT02204007|581002234|FG000|Overall Study|Surgery Canceled|1|||
160892639|NCT02204007|581002235|FG001|Overall Study|Surgery Canceled|1|||
160892640|NCT00910988|581002236|FG000|Overall Study|Lost to Follow-up|2|||
160892641|NCT00910988|581002237|FG001|Overall Study|Lost to Follow-up|4|||
160892642|NCT00910988|581002238|FG002|Overall Study|Lost to Follow-up|3|||
160892643|NCT00910988|581002239|FG003|Overall Study|Lost to Follow-up|0|||
160892644|NCT02766465|581002240|FG000|Overall Study|Withdrawal by Subject|0|||
160892645|NCT02766465|581002241|FG001|Overall Study|Withdrawal by Subject|10|||
160892646|NCT01907100|581002242|FG000|Overall Study|PD based on modified RECIST criteria|31|||
160892647|NCT01907100|581002243|FG001|Overall Study|PD based on modified RECIST criteria|32|||
160892648|NCT01907100|581002244|FG002|Overall Study|PD based on modified RECIST criteria|95|||
160892649|NCT01907100|581002245|FG003|Overall Study|PD based on modified RECIST criteria|92|||
160892650|NCT01907100|581002242|FG000|Overall Study|Withdrawal by Subject|2|||
160892651|NCT01907100|581002243|FG001|Overall Study|Withdrawal by Subject|5|||
160892652|NCT01907100|581002244|FG002|Overall Study|Withdrawal by Subject|10|||
160892653|NCT01907100|581002245|FG003|Overall Study|Withdrawal by Subject|13|||
160892654|NCT01907100|581002242|FG000|Overall Study|Protocol Violation|0|||
160892655|NCT01907100|581002243|FG001|Overall Study|Protocol Violation|0|||
160892656|NCT01907100|581002244|FG002|Overall Study|Protocol Violation|1|||
160892657|NCT01907100|581002245|FG003|Overall Study|Protocol Violation|1|||
160892658|NCT01907100|581002242|FG000|Overall Study|Lost to Follow-up|0|||
160892659|NCT01907100|581002243|FG001|Overall Study|Lost to Follow-up|0|||
160892660|NCT01907100|581002244|FG002|Overall Study|Lost to Follow-up|0|||
160892661|NCT01907100|581002245|FG003|Overall Study|Lost to Follow-up|1|||
160892662|NCT01907100|581002242|FG000|Overall Study|Not treated|2|||
160892663|NCT01907100|581002243|FG001|Overall Study|Not treated|0|||
160892664|NCT01907100|581002244|FG002|Overall Study|Not treated|1|||
160892665|NCT01907100|581002245|FG003|Overall Study|Not treated|2|||
160892666|NCT01907100|581002242|FG000|Overall Study|Other than reasons specified|1|||
160892667|NCT01907100|581002243|FG001|Overall Study|Other than reasons specified|0|||
160892668|NCT01907100|581002244|FG002|Overall Study|Other than reasons specified|10|||
160982235|NCT00136916|581323444|FG000|Overall Study|Never received study treatment|3|||
160982236|NCT00136916|581323445|FG001|Overall Study|Never received study treatment|5|||
160892669|NCT01907100|581002245|FG003|Overall Study|Other than reasons specified|6|||
160892670|NCT01907100|581002242|FG000|Overall Study|Adverse event (AE)|6|||
160892671|NCT01907100|581002243|FG001|Overall Study|Adverse event (AE)|3|||
160892672|NCT01907100|581002244|FG002|Overall Study|Adverse event (AE)|22|||
160892673|NCT01907100|581002245|FG003|Overall Study|Adverse event (AE)|23|||
160892674|NCT01907100|581002242|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
160892675|NCT01907100|581002243|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
160892676|NCT01907100|581002244|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
160892677|NCT01907100|581002245|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
160892678|NCT01758289|581002246|FG000|Overall Study|Premature Study Termination|44|||
160892679|NCT01758289|581002246|FG000|Overall Study|Adverse Event|9|||
160892680|NCT01574079|581002247|FG000|Overall Study|Physician Decision|0|||
160792270|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
160792271|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
160792272|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160792273|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160792274|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160792275|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
160792276|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160792277|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
160792278|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
160792279|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
160792280|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
160792281|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
160792282|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
160792283|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
160792284|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
160792285|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
160792286|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
160792287|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
160792288|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
160792289|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
160792290|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
160792291|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
160792292|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
160792293|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
160792294|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
160792295|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
160792296|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
160792297|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160792298|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160792299|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
160792300|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160792301|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160792302|NCT01027351|580626869|FG000|Overall Study|Withdrawal by Subject|1|||
160792303|NCT01027351|580626870|FG001|Overall Study|Withdrawal by Subject|0|||
160792304|NCT01027351|580626871|FG002|Overall Study|Withdrawal by Subject|1|||
160792305|NCT01027351|580626872|FG003|Overall Study|Withdrawal by Subject|0|||
160792306|NCT01027351|580626873|FG004|Overall Study|Withdrawal by Subject|3|||
160792307|NCT01027351|580626874|FG005|Overall Study|Withdrawal by Subject|5|||
160792308|NCT01027351|580626869|FG000|Overall Study|Lost to Follow-up|1|||
160792309|NCT01027351|580626870|FG001|Overall Study|Lost to Follow-up|1|||
160792310|NCT01027351|580626871|FG002|Overall Study|Lost to Follow-up|0|||
160792311|NCT01027351|580626872|FG003|Overall Study|Lost to Follow-up|1|||
160792312|NCT01027351|580626873|FG004|Overall Study|Lost to Follow-up|6|||
160792313|NCT01027351|580626874|FG005|Overall Study|Lost to Follow-up|0|||
160792314|NCT01027351|580626869|FG000|Overall Study|Inappropriate enrollment|0|||
160792315|NCT01027351|580626870|FG001|Overall Study|Inappropriate enrollment|0|||
160792316|NCT01027351|580626871|FG002|Overall Study|Inappropriate enrollment|0|||
160792317|NCT01027351|580626872|FG003|Overall Study|Inappropriate enrollment|0|||
160792318|NCT01027351|580626873|FG004|Overall Study|Inappropriate enrollment|1|||
160792319|NCT01027351|580626874|FG005|Overall Study|Inappropriate enrollment|0|||
160792320|NCT01027351|580626869|FG000|Overall Study|Protocol Violation|1|||
160792321|NCT01027351|580626870|FG001|Overall Study|Protocol Violation|0|||
160792322|NCT01027351|580626871|FG002|Overall Study|Protocol Violation|0|||
160792323|NCT01027351|580626872|FG003|Overall Study|Protocol Violation|1|||
160792324|NCT01027351|580626873|FG004|Overall Study|Protocol Violation|1|||
160792325|NCT01027351|580626874|FG005|Overall Study|Protocol Violation|0|||
160792326|NCT04650893|580626875|FG000|Overall Study|Lost to Follow-up|11|||
160792327|NCT04650893|580626876|FG001|Overall Study|Lost to Follow-up|10|||
160892681|NCT01574079|581002248|FG001|Overall Study|Physician Decision|2|||
160892682|NCT01574079|581002247|FG000|Overall Study|Lost to Follow-up|1|||
160892683|NCT01574079|581002248|FG001|Overall Study|Lost to Follow-up|0|||
160892684|NCT02059005|581002251|FG000|Overall Study|Death|1|||
160892685|NCT02059005|581002252|FG001|Overall Study|Death|3|||
160892686|NCT02059005|581002251|FG000|Overall Study|Lost to Follow-up|19|||
160892687|NCT02059005|581002252|FG001|Overall Study|Lost to Follow-up|19|||
160892688|NCT02059005|581002251|FG000|Overall Study|Incarceration|0|||
160892689|NCT02059005|581002252|FG001|Overall Study|Incarceration|1|||
160892690|NCT02059005|581002251|FG000|Overall Study|Inpatient|0|||
160892691|NCT02059005|581002252|FG001|Overall Study|Inpatient|1|||
160792328|NCT04650893|580626877|FG002|Overall Study|Lost to Follow-up|11|||
160792329|NCT00637156|580626878|FG000|Overall Study|Withdrawal by Subject|0|||
160792330|NCT00637156|580626879|FG001|Overall Study|Withdrawal by Subject|7|||
160982237|NCT00136916|581323444|FG000|Overall Study|Death|1|||
160792331|NCT00637156|580626878|FG000|Overall Study|Death|0|||
160792332|NCT00637156|580626879|FG001|Overall Study|Death|1|||
160792333|NCT00637156|580626878|FG000|Overall Study|Lost to Follow-up|10|||
160792334|NCT00637156|580626879|FG001|Overall Study|Lost to Follow-up|16|||
160792335|NCT02679274|580626880|FG000|Overall Study|Withdrawal by Subject|1|||
160792336|NCT02679274|580626881|FG001|Overall Study|Withdrawal by Subject|0|||
160792337|NCT03193437|580626888|FG000|Overall Study|Adverse Event|4|||
160792338|NCT03193437|580626888|FG000|Overall Study|Withdrawal by Subject|2|||
160792339|NCT03193437|580626888|FG000|Overall Study|Disease Progression|2|||
160792340|NCT04976855|580626889|FG000|Part I|Withdrawal by Subject|0|||
160792341|NCT04976855|580626890|FG001|Part I|Withdrawal by Subject|1|||
160792342|NCT04976855|580626891|FG002|Part I|Withdrawal by Subject|0|||
160792343|NCT04976855|580626892|FG003|Part I|Withdrawal by Subject|0|||
160792344|NCT04976855|580626893|FG004|Part I|Withdrawal by Subject|0|||
160792345|NCT04976855|580626894|FG005|Part I|Withdrawal by Subject|0|||
160792346|NCT04976855|580626895|FG006|Part I|Withdrawal by Subject|0|||
160792347|NCT04976855|580626889|FG000|Part II|Adverse Event|0|||
160792348|NCT04976855|580626890|FG001|Part II|Adverse Event|0|||
160792349|NCT04976855|580626891|FG002|Part II|Adverse Event|0|||
160792350|NCT04976855|580626892|FG003|Part II|Adverse Event|1|||
160792351|NCT04976855|580626893|FG004|Part II|Adverse Event|0|||
160792352|NCT04976855|580626894|FG005|Part II|Adverse Event|0|||
160792353|NCT04976855|580626895|FG006|Part II|Adverse Event|0|||
160792354|NCT04976855|580626889|FG000|Part II|Withdrawal by Subject|0|||
160792355|NCT04976855|580626890|FG001|Part II|Withdrawal by Subject|0|||
160792356|NCT04976855|580626891|FG002|Part II|Withdrawal by Subject|0|||
160792357|NCT04976855|580626892|FG003|Part II|Withdrawal by Subject|0|||
160792358|NCT04976855|580626893|FG004|Part II|Withdrawal by Subject|1|||
160792359|NCT04976855|580626894|FG005|Part II|Withdrawal by Subject|0|||
160792360|NCT04976855|580626895|FG006|Part II|Withdrawal by Subject|0|||
160792361|NCT04976855|580626889|FG000|Part II|Lost to Follow-up|0|||
160792362|NCT04976855|580626890|FG001|Part II|Lost to Follow-up|0|||
160792363|NCT04976855|580626891|FG002|Part II|Lost to Follow-up|0|||
160792364|NCT04976855|580626892|FG003|Part II|Lost to Follow-up|0|||
160792365|NCT04976855|580626893|FG004|Part II|Lost to Follow-up|0|||
160792366|NCT04976855|580626894|FG005|Part II|Lost to Follow-up|1|||
160792367|NCT04976855|580626895|FG006|Part II|Lost to Follow-up|0|||
160792368|NCT02038036|580626896|FG000|Core Study|Adverse Event|7|||
160792369|NCT02038036|580626897|FG001|Core Study|Adverse Event|7|||
160792370|NCT02038036|580626896|FG000|Core Study|Death|1|||
160792371|NCT02038036|580626897|FG001|Core Study|Death|1|||
160792372|NCT02038036|580626896|FG000|Core Study|Disease progression|2|||
160792373|NCT02038036|580626897|FG001|Core Study|Disease progression|2|||
160792374|NCT02038036|580626896|FG000|Core Study|Lost to Follow-up|0|||
160792375|NCT02038036|580626897|FG001|Core Study|Lost to Follow-up|1|||
160792376|NCT02038036|580626896|FG000|Core Study|Physician Decision|2|||
160792377|NCT02038036|580626897|FG001|Core Study|Physician Decision|1|||
160792378|NCT02038036|580626896|FG000|Core Study|Subject/guardian decision|0|||
160792379|NCT02038036|580626897|FG001|Core Study|Subject/guardian decision|1|||
160792380|NCT02038036|580626896|FG000|Core Study|Withdrawal by Subject|3|||
160792381|NCT02038036|580626897|FG001|Core Study|Withdrawal by Subject|1|||
160792382|NCT02038036|580626896|FG000|Crossover Period|Withdrawal by Subject|0|||
160792383|NCT02038036|580626897|FG001|Crossover Period|Withdrawal by Subject|3|||
160792384|NCT02038036|580626896|FG000|Crossover Period|Adverse Event|0|||
160792385|NCT02038036|580626897|FG001|Crossover Period|Adverse Event|9|||
160792386|NCT02038036|580626896|FG000|Crossover Period|Death|0|||
160982238|NCT00136916|581323445|FG001|Overall Study|Death|3|||
160982239|NCT00136916|581323444|FG000|Overall Study|Adverse Event|27|||
160982240|NCT00136916|581323445|FG001|Overall Study|Adverse Event|8|||
160792387|NCT02038036|580626897|FG001|Crossover Period|Death|2|||
160792388|NCT02038036|580626896|FG000|Crossover Period|Disease progression|0|||
160792389|NCT02038036|580626897|FG001|Crossover Period|Disease progression|3|||
160792390|NCT02038036|580626896|FG000|Crossover Period|Lost to Follow-up|0|||
160792391|NCT02038036|580626897|FG001|Crossover Period|Lost to Follow-up|1|||
160792392|NCT02038036|580626896|FG000|Crossover Period|Physician Decision|0|||
160792393|NCT02038036|580626897|FG001|Crossover Period|Physician Decision|2|||
160792394|NCT00908141|580626906|FG000|Overall Study|Withdrawal by Subject|0|||
160792395|NCT00908141|580626907|FG001|Overall Study|Withdrawal by Subject|1|||
160792396|NCT03514134|580628191|FG000|Overall Study|Lost to Follow-up|0|||
160792397|NCT03514134|580628192|FG001|Overall Study|Lost to Follow-up|1|||
160792398|NCT03768336|580628194|FG000|Overall Study|Lost to Follow-up|3|||
160792399|NCT03768336|580628195|FG001|Overall Study|Lost to Follow-up|2|||
160792400|NCT03768336|580628194|FG000|Overall Study|Became Ineligible|2|||
160792401|NCT03768336|580628195|FG001|Overall Study|Became Ineligible|0|||
160792402|NCT03768336|580628194|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
160792403|NCT03768336|580628195|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
160792404|NCT03768336|580628194|FG000|Overall Study|Missed final survey (post-treatment|0|||
160982241|NCT00136916|581323444|FG000|Overall Study|Laboratory abnormality|0|||
160792405|NCT03768336|580628195|FG001|Overall Study|Missed final survey (post-treatment|1|||
160792406|NCT05654181|580628196|FG000|Overall Study|Adverse Event|1|||
160792407|NCT05654181|580628197|FG001|Overall Study|Adverse Event|0|||
160792408|NCT05654181|580628198|FG002|Overall Study|Adverse Event|0|||
160792409|NCT05654181|580628199|FG003|Overall Study|Adverse Event|0|||
160792410|NCT05654181|580628200|FG004|Overall Study|Adverse Event|0|||
160792411|NCT05654181|580628201|FG005|Overall Study|Adverse Event|0|||
160792412|NCT05654181|580628202|FG006|Overall Study|Adverse Event|0|||
160792413|NCT05654181|580628203|FG007|Overall Study|Adverse Event|1|||
160792414|NCT05654181|580628204|FG008|Overall Study|Adverse Event|0|||
160792415|NCT05654181|580628205|FG009|Overall Study|Adverse Event|0|||
160792416|NCT05654181|580628196|FG000|Overall Study|Withdrawal by Subject|0|||
160792417|NCT05654181|580628197|FG001|Overall Study|Withdrawal by Subject|0|||
160792418|NCT05654181|580628198|FG002|Overall Study|Withdrawal by Subject|0|||
160792419|NCT05654181|580628199|FG003|Overall Study|Withdrawal by Subject|0|||
160792420|NCT05654181|580628200|FG004|Overall Study|Withdrawal by Subject|0|||
160792421|NCT05654181|580628201|FG005|Overall Study|Withdrawal by Subject|0|||
160792422|NCT05654181|580628202|FG006|Overall Study|Withdrawal by Subject|0|||
160792423|NCT05654181|580628203|FG007|Overall Study|Withdrawal by Subject|1|||
160792424|NCT05654181|580628204|FG008|Overall Study|Withdrawal by Subject|0|||
160792425|NCT05654181|580628205|FG009|Overall Study|Withdrawal by Subject|0|||
160792426|NCT05654181|580628196|FG000|Overall Study|Other|0|||
160792427|NCT05654181|580628197|FG001|Overall Study|Other|0|||
160792428|NCT05654181|580628198|FG002|Overall Study|Other|0|||
160792429|NCT05654181|580628199|FG003|Overall Study|Other|0|||
160792430|NCT05654181|580628200|FG004|Overall Study|Other|1|||
160792431|NCT05654181|580628201|FG005|Overall Study|Other|1|||
160792432|NCT05654181|580628202|FG006|Overall Study|Other|0|||
160792433|NCT05654181|580628203|FG007|Overall Study|Other|0|||
160792434|NCT05654181|580628204|FG008|Overall Study|Other|0|||
160792435|NCT05654181|580628205|FG009|Overall Study|Other|0|||
160792436|NCT02278003|580628207|FG000|Overall Study|Withdrawal by Subject|11|||
160792437|NCT02278003|580628208|FG001|Overall Study|Withdrawal by Subject|0|||
160792438|NCT02278003|580628207|FG000|Overall Study|Not Treated|1|||
160792439|NCT02278003|580628208|FG001|Overall Study|Not Treated|0|||
160792440|NCT02278003|580628207|FG000|Overall Study|Recognition task improperly completed|7|||
160792441|NCT02278003|580628208|FG001|Overall Study|Recognition task improperly completed|0|||
160792442|NCT00500331|580628212|FG000|Overall Study|Adverse Event|0|||
160792443|NCT00500331|580628213|FG001|Overall Study|Adverse Event|2|||
160792444|NCT00500331|580628214|FG002|Overall Study|Adverse Event|0|||
160792445|NCT00500331|580628215|FG003|Overall Study|Adverse Event|1|||
160792446|NCT00500331|580628216|FG004|Overall Study|Adverse Event|2|||
160792447|NCT00500331|580628217|FG005|Overall Study|Adverse Event|2|||
160792448|NCT00500331|580628218|FG006|Overall Study|Adverse Event|0|||
160792449|NCT00500331|580628212|FG000|Overall Study|Lost to Follow-up|1|||
160792450|NCT00500331|580628213|FG001|Overall Study|Lost to Follow-up|1|||
160792451|NCT00500331|580628214|FG002|Overall Study|Lost to Follow-up|1|||
160792452|NCT00500331|580628215|FG003|Overall Study|Lost to Follow-up|2|||
160792453|NCT00500331|580628216|FG004|Overall Study|Lost to Follow-up|1|||
160792454|NCT00500331|580628217|FG005|Overall Study|Lost to Follow-up|0|||
160792455|NCT00500331|580628218|FG006|Overall Study|Lost to Follow-up|0|||
160792456|NCT00500331|580628212|FG000|Overall Study|Protocol Violation|3|||
160792457|NCT00500331|580628213|FG001|Overall Study|Protocol Violation|1|||
160792458|NCT00500331|580628214|FG002|Overall Study|Protocol Violation|1|||
160792459|NCT00500331|580628215|FG003|Overall Study|Protocol Violation|0|||
160792460|NCT00500331|580628216|FG004|Overall Study|Protocol Violation|1|||
160792461|NCT00500331|580628217|FG005|Overall Study|Protocol Violation|1|||
160982242|NCT00136916|581323445|FG001|Overall Study|Laboratory abnormality|1|||
160982243|NCT00136916|581323444|FG000|Overall Study|Lack of Efficacy|13|||
160982244|NCT00136916|581323445|FG001|Overall Study|Lack of Efficacy|3|||
160982245|NCT00136916|581323444|FG000|Overall Study|Lost to Follow-up|12|||
160548430|NCT01844895|579734131|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
160548431|NCT01844895|579734131|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
160548432|NCT00626093|579734134|FG000|Overall Study|Lost to Follow-up|5|||
160792462|NCT00500331|580628218|FG006|Overall Study|Protocol Violation|1|||
160792463|NCT00500331|580628212|FG000|Overall Study|Withdrawal by Subject|4|||
160792464|NCT00500331|580628213|FG001|Overall Study|Withdrawal by Subject|0|||
160792465|NCT00500331|580628214|FG002|Overall Study|Withdrawal by Subject|1|||
160792466|NCT00500331|580628215|FG003|Overall Study|Withdrawal by Subject|5|||
160792467|NCT00500331|580628216|FG004|Overall Study|Withdrawal by Subject|0|||
160792468|NCT00500331|580628217|FG005|Overall Study|Withdrawal by Subject|1|||
160792469|NCT00500331|580628218|FG006|Overall Study|Withdrawal by Subject|1|||
160792470|NCT00500331|580628212|FG000|Overall Study|Lack of Efficacy|3|||
160792471|NCT00500331|580628213|FG001|Overall Study|Lack of Efficacy|1|||
160792472|NCT00500331|580628214|FG002|Overall Study|Lack of Efficacy|0|||
160792473|NCT00500331|580628215|FG003|Overall Study|Lack of Efficacy|0|||
160792474|NCT00500331|580628216|FG004|Overall Study|Lack of Efficacy|0|||
160792475|NCT00500331|580628217|FG005|Overall Study|Lack of Efficacy|0|||
160982246|NCT00136916|581323445|FG001|Overall Study|Lost to Follow-up|14|||
160982247|NCT00136916|581323444|FG000|Overall Study|Withdrawal by Subject|44|||
160982248|NCT00136916|581323445|FG001|Overall Study|Withdrawal by Subject|46|||
160982249|NCT00136916|581323444|FG000|Overall Study|Other|22|||
160982250|NCT00136916|581323445|FG001|Overall Study|Other|24|||
160982251|NCT00136916|581323444|FG000|Overall Study|Discontinued in follow up period|3|||
160982252|NCT00136916|581323445|FG001|Overall Study|Discontinued in follow up period|0|||
160982253|NCT03619174|581323446|FG000|Overall Study|Lost to Follow-up|3|||
160982254|NCT03619174|581323447|FG001|Overall Study|Lost to Follow-up|0|||
160982255|NCT03619174|581323446|FG000|Overall Study|Withdrawal by Subject|4|||
160982256|NCT03619174|581323447|FG001|Overall Study|Withdrawal by Subject|3|||
160982257|NCT03619174|581323446|FG000|Overall Study|Pregnancy|1|||
160982258|NCT03619174|581323447|FG001|Overall Study|Pregnancy|1|||
160982259|NCT03619174|581323446|FG000|Overall Study|Discomfort during treatment|1|||
160792476|NCT00500331|580628218|FG006|Overall Study|Lack of Efficacy|0|||
160792477|NCT00500331|580628212|FG000|Overall Study|Liver function test abnormality|0|||
160792478|NCT00500331|580628213|FG001|Overall Study|Liver function test abnormality|0|||
160792479|NCT00500331|580628214|FG002|Overall Study|Liver function test abnormality|1|||
160792480|NCT00500331|580628215|FG003|Overall Study|Liver function test abnormality|0|||
160792481|NCT00500331|580628216|FG004|Overall Study|Liver function test abnormality|0|||
160792482|NCT00500331|580628217|FG005|Overall Study|Liver function test abnormality|0|||
160792483|NCT00500331|580628218|FG006|Overall Study|Liver function test abnormality|0|||
160792484|NCT00500331|580628212|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
160792485|NCT00500331|580628213|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
160792486|NCT00500331|580628214|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
160792487|NCT00500331|580628215|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
160792488|NCT00500331|580628216|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
160792489|NCT00500331|580628217|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
160792490|NCT00500331|580628218|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
160792491|NCT00500331|580628212|FG000|Overall Study|Didn't return for continuation of study|1|||
160792492|NCT00500331|580628213|FG001|Overall Study|Didn't return for continuation of study|0|||
160792493|NCT00500331|580628214|FG002|Overall Study|Didn't return for continuation of study|0|||
160792494|NCT00500331|580628215|FG003|Overall Study|Didn't return for continuation of study|0|||
160792495|NCT00500331|580628216|FG004|Overall Study|Didn't return for continuation of study|0|||
160792496|NCT00500331|580628217|FG005|Overall Study|Didn't return for continuation of study|0|||
160792497|NCT00500331|580628218|FG006|Overall Study|Didn't return for continuation of study|0|||
160792498|NCT00500331|580628212|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
160792499|NCT00500331|580628213|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792500|NCT00500331|580628214|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792501|NCT00500331|580628215|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792502|NCT00500331|580628216|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792503|NCT00500331|580628217|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792504|NCT00500331|580628218|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792505|NCT00500331|580628212|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
160792506|NCT00500331|580628213|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
160792507|NCT00500331|580628214|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
160792508|NCT00500331|580628215|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
160792509|NCT00500331|580628216|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
160792510|NCT00500331|580628217|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
160792511|NCT00500331|580628218|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
160792512|NCT00500331|580628212|FG000|Overall Study|Participant was randomized by mistake|1|||
160792513|NCT00500331|580628213|FG001|Overall Study|Participant was randomized by mistake|0|||
160982260|NCT03619174|581323447|FG001|Overall Study|Discomfort during treatment|0|||
160982261|NCT01012973|581323450|FG000|Overall Study|Adverse Event|5|||
160792514|NCT00500331|580628214|FG002|Overall Study|Participant was randomized by mistake|0|||
160792515|NCT00500331|580628215|FG003|Overall Study|Participant was randomized by mistake|0|||
160792516|NCT00500331|580628216|FG004|Overall Study|Participant was randomized by mistake|0|||
160792517|NCT00500331|580628217|FG005|Overall Study|Participant was randomized by mistake|0|||
160792518|NCT00500331|580628218|FG006|Overall Study|Participant was randomized by mistake|0|||
160982262|NCT01012973|581323451|FG001|Overall Study|Adverse Event|5|||
160982263|NCT01012973|581323450|FG000|Overall Study|Lack of Efficacy|0|||
160792519|NCT00500331|580628212|FG000|Overall Study|Diabetologist nurse in the study|0|||
160792520|NCT00500331|580628213|FG001|Overall Study|Diabetologist nurse in the study|0|||
160792521|NCT00500331|580628214|FG002|Overall Study|Diabetologist nurse in the study|1|||
160792522|NCT00500331|580628215|FG003|Overall Study|Diabetologist nurse in the study|0|||
160792523|NCT00500331|580628216|FG004|Overall Study|Diabetologist nurse in the study|0|||
160792524|NCT00500331|580628217|FG005|Overall Study|Diabetologist nurse in the study|0|||
160792525|NCT00500331|580628218|FG006|Overall Study|Diabetologist nurse in the study|0|||
160792526|NCT00500331|580628212|FG000|Overall Study|State ban of biological samples export|0|||
160792527|NCT00500331|580628213|FG001|Overall Study|State ban of biological samples export|0|||
160792528|NCT00500331|580628214|FG002|Overall Study|State ban of biological samples export|0|||
160792529|NCT00500331|580628215|FG003|Overall Study|State ban of biological samples export|1|||
160792530|NCT00500331|580628216|FG004|Overall Study|State ban of biological samples export|0|||
160792531|NCT00500331|580628217|FG005|Overall Study|State ban of biological samples export|0|||
160792532|NCT00500331|580628218|FG006|Overall Study|State ban of biological samples export|0|||
160792533|NCT00500331|580628212|FG000|Overall Study|Protocol violated|0|||
160792534|NCT00500331|580628213|FG001|Overall Study|Protocol violated|0|||
160792535|NCT00500331|580628214|FG002|Overall Study|Protocol violated|0|||
160792536|NCT00500331|580628215|FG003|Overall Study|Protocol violated|1|||
160792537|NCT00500331|580628216|FG004|Overall Study|Protocol violated|0|||
160792538|NCT00500331|580628217|FG005|Overall Study|Protocol violated|0|||
160792539|NCT00500331|580628218|FG006|Overall Study|Protocol violated|0|||
160792540|NCT03345550|580628219|FG000|Overall Study|Withdrawal by Subject|1|||
160792541|NCT03345550|580628220|FG001|Overall Study|Withdrawal by Subject|0|||
160792542|NCT03345550|580628219|FG000|Overall Study|Lost to Follow-up|4|||
160792543|NCT03345550|580628220|FG001|Overall Study|Lost to Follow-up|5|||
160792544|NCT03033784|580628223|FG000|Overall Study|Anxiety related to MRI scanner|0|||
160792545|NCT03033784|580628224|FG001|Overall Study|Anxiety related to MRI scanner|1|||
160792546|NCT03033784|580628225|FG002|Overall Study|Anxiety related to MRI scanner|0|||
160792547|NCT03033784|580628226|FG003|Overall Study|Anxiety related to MRI scanner|0|||
160792548|NCT03033784|580628227|FG004|Overall Study|Anxiety related to MRI scanner|0|||
160792549|NCT03033784|580628228|FG005|Overall Study|Anxiety related to MRI scanner|0|||
160792550|NCT03033784|580628229|FG006|Overall Study|Anxiety related to MRI scanner|0|||
160792551|NCT03033784|580628230|FG007|Overall Study|Anxiety related to MRI scanner|0|||
160792552|NCT03033784|580628231|FG008|Overall Study|Anxiety related to MRI scanner|0|||
160792553|NCT03033784|580628232|FG009|Overall Study|Anxiety related to MRI scanner|0|||
160792554|NCT03033784|580628233|FG010|Overall Study|Anxiety related to MRI scanner|0|||
160792555|NCT03033784|580628234|FG011|Overall Study|Anxiety related to MRI scanner|0|||
160792556|NCT03033784|580628235|FG012|Overall Study|Anxiety related to MRI scanner|0|||
160792557|NCT03033784|580628223|FG000|Overall Study|Withdrawal by Subject|0|||
160792558|NCT03033784|580628224|FG001|Overall Study|Withdrawal by Subject|0|||
160792559|NCT03033784|580628225|FG002|Overall Study|Withdrawal by Subject|0|||
160792560|NCT03033784|580628226|FG003|Overall Study|Withdrawal by Subject|0|||
160792561|NCT03033784|580628227|FG004|Overall Study|Withdrawal by Subject|0|||
160792562|NCT03033784|580628228|FG005|Overall Study|Withdrawal by Subject|0|||
160548433|NCT00626093|579734134|FG000|Overall Study|Death|1|||
160548434|NCT00626093|579734134|FG000|Overall Study|Physician Decision|4|||
160548435|NCT00626093|579734134|FG000|Overall Study|Withdrawal by Subject|6|||
160548436|NCT00626093|579734134|FG000|Overall Study|Protocol Violation|1|||
160792563|NCT03033784|580628229|FG006|Overall Study|Withdrawal by Subject|0|||
160982264|NCT01012973|581323451|FG001|Overall Study|Lack of Efficacy|5|||
160982265|NCT01012973|581323450|FG000|Overall Study|Lost to Follow-up|1|||
160982266|NCT01012973|581323451|FG001|Overall Study|Lost to Follow-up|0|||
160982267|NCT01012973|581323450|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
160982268|NCT01012973|581323451|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
160548437|NCT00626093|579734134|FG000|Overall Study|One of the required devices not implante|6|||
160548438|NCT02508194|579734135|FG000|Overall Study|Death|5|||
160792564|NCT03033784|580628230|FG007|Overall Study|Withdrawal by Subject|0|||
160792565|NCT03033784|580628231|FG008|Overall Study|Withdrawal by Subject|0|||
160792566|NCT03033784|580628232|FG009|Overall Study|Withdrawal by Subject|0|||
160792567|NCT03033784|580628233|FG010|Overall Study|Withdrawal by Subject|0|||
160792568|NCT03033784|580628234|FG011|Overall Study|Withdrawal by Subject|0|||
160792569|NCT03033784|580628235|FG012|Overall Study|Withdrawal by Subject|2|||
160792570|NCT03014089|580628237|FG000|Overall Study|Withdrawal by Subject|0|||
160792571|NCT03014089|580628238|FG001|Overall Study|Withdrawal by Subject|1|||
160792572|NCT03014089|580628239|FG002|Overall Study|Withdrawal by Subject|1|||
160792573|NCT03014089|580628240|FG003|Overall Study|Withdrawal by Subject|1|||
160792574|NCT03014089|580628237|FG000|Overall Study|Lost to Follow-up|1|||
160792575|NCT03014089|580628238|FG001|Overall Study|Lost to Follow-up|0|||
160792576|NCT03014089|580628239|FG002|Overall Study|Lost to Follow-up|0|||
160792577|NCT03014089|580628240|FG003|Overall Study|Lost to Follow-up|0|||
160792578|NCT03014089|580628237|FG000|Overall Study|Adverse Event|1|||
160792579|NCT03014089|580628238|FG001|Overall Study|Adverse Event|0|||
160792580|NCT03014089|580628239|FG002|Overall Study|Adverse Event|1|||
160982269|NCT01012973|581323450|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
160792581|NCT03014089|580628240|FG003|Overall Study|Adverse Event|0|||
160792582|NCT01149460|580628241|FG000|Overall Study|Withdrawal by Subject|0|||
160792583|NCT01149460|580628242|FG001|Overall Study|Withdrawal by Subject|2|||
160792584|NCT00734032|580628243|FG000|Overall Study|Adverse Event|0|||
160792585|NCT00734032|580628244|FG001|Overall Study|Adverse Event|1|||
160792586|NCT00734032|580628245|FG002|Overall Study|Adverse Event|0|||
160792587|NCT00734032|580628246|FG003|Overall Study|Adverse Event|0|||
160792588|NCT03468998|580628247|FG000|Overall Study|Withdrawal by Subject|1|||
160792589|NCT03468998|580628248|FG001|Overall Study|Withdrawal by Subject|1|||
160792590|NCT03468998|580628249|FG002|Overall Study|Withdrawal by Subject|0|||
160792591|NCT03468998|580628250|FG003|Overall Study|Withdrawal by Subject|4|||
160792592|NCT03468998|580628251|FG004|Overall Study|Withdrawal by Subject|1|||
160792593|NCT03468998|580628252|FG005|Overall Study|Withdrawal by Subject|0|||
160792594|NCT01892189|580628253|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
160792595|NCT01892189|580628254|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
160792596|NCT01892189|580628255|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
160792597|NCT01892189|580628256|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
160792598|NCT01892189|580628257|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
160792599|NCT01892189|580628258|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
160792600|NCT01892189|580628259|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
160792601|NCT01892189|580628260|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
160792602|NCT01892189|580628261|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
160792603|NCT01892189|580628253|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160792604|NCT01892189|580628254|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160792605|NCT01892189|580628255|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
160792606|NCT01892189|580628256|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
160792607|NCT01892189|580628257|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160792608|NCT01892189|580628258|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160792609|NCT01892189|580628259|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
160792610|NCT01892189|580628260|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160792611|NCT01892189|580628261|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
160792612|NCT01892189|580628253|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792613|NCT01892189|580628254|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792614|NCT01892189|580628255|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792615|NCT01892189|580628256|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792616|NCT01892189|580628257|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792617|NCT01892189|580628258|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
160792618|NCT01892189|580628259|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792619|NCT01892189|580628260|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792620|NCT01892189|580628261|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792621|NCT02489279|580628264|FG000|Overall Study|Lost to Follow-up|12|||
160792622|NCT02489279|580628265|FG001|Overall Study|Lost to Follow-up|10|||
160792623|NCT03440411|580628266|FG000|Overall Study|Adverse Event|0|||
160792624|NCT03440411|580628267|FG001|Overall Study|Adverse Event|0|||
160792625|NCT03440411|580628268|FG002|Overall Study|Adverse Event|1|||
160792626|NCT03440411|580628269|FG003|Overall Study|Adverse Event|0|||
160792627|NCT03440411|580628266|FG000|Overall Study|PD|2|||
160792628|NCT03440411|580628267|FG001|Overall Study|PD|1|||
160792629|NCT03440411|580628268|FG002|Overall Study|PD|1|||
160792630|NCT03440411|580628269|FG003|Overall Study|PD|1|||
160792631|NCT03440411|580628266|FG000|Overall Study|Withdrawal by Subject|1|||
160792632|NCT03440411|580628267|FG001|Overall Study|Withdrawal by Subject|0|||
160792633|NCT03440411|580628268|FG002|Overall Study|Withdrawal by Subject|0|||
160792634|NCT03440411|580628269|FG003|Overall Study|Withdrawal by Subject|0|||
160792635|NCT03440411|580628266|FG000|Overall Study|Closed study by sponsor|0|||
160792636|NCT03440411|580628267|FG001|Overall Study|Closed study by sponsor|0|||
160792637|NCT03440411|580628268|FG002|Overall Study|Closed study by sponsor|0|||
160792638|NCT03440411|580628269|FG003|Overall Study|Closed study by sponsor|1|||
160792639|NCT02332928|580628270|FG000|Overall Study|Withdrawal by Subject|0|||
160792640|NCT02332928|580628271|FG001|Overall Study|Withdrawal by Subject|2|||
160792641|NCT02332928|580628270|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
160792642|NCT02332928|580628271|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
160792643|NCT00565747|580628272|FG000|Overall Study|No embryo transfer|67|||
160792644|NCT00565747|580628273|FG001|Overall Study|No embryo transfer|73|||
160792645|NCT01052779|580628274|FG000|Overall Study|Adverse Event|1|||
160792646|NCT01052779|580628275|FG001|Overall Study|Adverse Event|4|||
160792647|NCT01052779|580628274|FG000|Overall Study|Withdrawal by Subject|1|||
160792648|NCT01052779|580628275|FG001|Overall Study|Withdrawal by Subject|2|||
160792649|NCT01052779|580628274|FG000|Overall Study|Other-Protocol Violation|1|||
160792650|NCT01052779|580628275|FG001|Overall Study|Other-Protocol Violation|1|||
160792651|NCT01052779|580628274|FG000|Overall Study|Other-Surgery|0|||
160792652|NCT01052779|580628275|FG001|Overall Study|Other-Surgery|2|||
160792653|NCT01052779|580628274|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
160792654|NCT01052779|580628275|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
160792655|NCT03663582|580628276|FG000|Overall Study|Physician Decision|1|||
160792656|NCT05763381|580628279|FG000|Overall Study|Lost to Follow-up|2|||
160792657|NCT05763381|580628280|FG001|Overall Study|Lost to Follow-up|3|||
160792658|NCT05763381|580628279|FG000|Overall Study|Withdrawal by Subject|1|||
160792659|NCT05763381|580628280|FG001|Overall Study|Withdrawal by Subject|2|||
160792660|NCT02697448|580628285|FG000|Overall Study|Protocol Violation|2|||
160792661|NCT02697448|580628286|FG001|Overall Study|Protocol Violation|4|||
160792662|NCT02697448|580628285|FG000|Overall Study|Clinical concerns during ablation|1|||
160792663|NCT02697448|580628286|FG001|Overall Study|Clinical concerns during ablation|1|||
160792664|NCT02697448|580628285|FG000|Overall Study|No data collected|2|||
160792665|NCT02697448|580628286|FG001|Overall Study|No data collected|0|||
160792666|NCT05473715|580628287|FG000|Overall Study|Trial terminate|2|||
160792667|NCT05473715|580628288|FG001|Overall Study|Trial terminate|1|||
160892692|NCT00908011|581002253|FG000|Overall Study|Withdrawal by Subject|2|||
160892693|NCT00908011|581002254|FG001|Overall Study|Withdrawal by Subject|2|||
160892694|NCT00843726|581002255|FG000|Overall Study|Death|1|||
160892695|NCT00843726|581002256|FG001|Overall Study|Death|0|||
160892696|NCT00843726|581002255|FG000|Overall Study|Withdrawal by Subject|0|||
160892697|NCT00843726|581002256|FG001|Overall Study|Withdrawal by Subject|1|||
160892698|NCT00667602|581002257|FG000|Overall Study|Withdrawal by Subject|4|||
160892699|NCT00667602|581002258|FG001|Overall Study|Withdrawal by Subject|9|||
160892700|NCT00667602|581002259|FG002|Overall Study|Withdrawal by Subject|10|||
160892701|NCT00667602|581002257|FG000|Overall Study|Lost to Follow-up|4|||
160892702|NCT00667602|581002258|FG001|Overall Study|Lost to Follow-up|5|||
160892703|NCT00667602|581002259|FG002|Overall Study|Lost to Follow-up|6|||
160892704|NCT00667602|581002257|FG000|Overall Study|Administrative reason|0|||
160892705|NCT00667602|581002258|FG001|Overall Study|Administrative reason|0|||
160892706|NCT00667602|581002259|FG002|Overall Study|Administrative reason|2|||
160892707|NCT00667602|581002257|FG000|Overall Study|Protocol Violation|0|||
160892708|NCT00667602|581002258|FG001|Overall Study|Protocol Violation|1|||
160892709|NCT00667602|581002259|FG002|Overall Study|Protocol Violation|0|||
160892710|NCT03640559|581002260|FG000|Overall Study|Physician Decision|1|||
160892711|NCT03640559|581002261|FG001|Overall Study|Physician Decision|1|||
160892712|NCT03640559|581002260|FG000|Overall Study|Withdrawal by Subject|1|||
160892713|NCT03640559|581002261|FG001|Overall Study|Withdrawal by Subject|0|||
160892714|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
160892715|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
160892716|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
160892717|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
160892718|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
160892719|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
160892720|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
160892721|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
160892722|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
160892723|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
160892724|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
160892725|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
160892726|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
160892727|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
160892728|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
160892729|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Other|107|||
160892730|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Other|0|||
160892731|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Other|0|||
160892732|NCT01436162|581002262|FG000|Randomized Phase|Adverse Event|1|||
160892733|NCT01436162|581002263|FG001|Randomized Phase|Adverse Event|5|||
160892734|NCT01436162|581002264|FG002|Randomized Phase|Adverse Event|6|||
160892735|NCT01436162|581002262|FG000|Randomized Phase|Protocol Violation|4|||
160892736|NCT01436162|581002263|FG001|Randomized Phase|Protocol Violation|4|||
160892737|NCT01436162|581002264|FG002|Randomized Phase|Protocol Violation|2|||
160892738|NCT01436162|581002262|FG000|Randomized Phase|Withdrawal by Subject|16|||
160892739|NCT01436162|581002263|FG001|Randomized Phase|Withdrawal by Subject|9|||
160892740|NCT01436162|581002264|FG002|Randomized Phase|Withdrawal by Subject|8|||
160892741|NCT01436162|581002262|FG000|Randomized Phase|Lost to Follow-up|17|||
160892742|NCT01436162|581002263|FG001|Randomized Phase|Lost to Follow-up|5|||
160892743|NCT01436162|581002264|FG002|Randomized Phase|Lost to Follow-up|4|||
160892744|NCT01436162|581002262|FG000|Randomized Phase|Lack of Efficacy|0|||
160892745|NCT01436162|581002263|FG001|Randomized Phase|Lack of Efficacy|1|||
160892746|NCT01436162|581002264|FG002|Randomized Phase|Lack of Efficacy|1|||
160792668|NCT02592863|580628290|FG000|Overall Study|Withdrawal by Subject|2|||
160892747|NCT01436162|581002262|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
160548439|NCT02508194|579734136|FG001|Overall Study|Death|3|||
160792669|NCT02592863|580628291|FG001|Overall Study|Withdrawal by Subject|2|||
160792670|NCT02592863|580628290|FG000|Overall Study|Lost to Follow-up|1|||
160792671|NCT02592863|580628291|FG001|Overall Study|Lost to Follow-up|1|||
160892748|NCT01436162|581002263|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
160892749|NCT01436162|581002264|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
160892750|NCT01436162|581002262|FG000|Randomized Phase|Other|2|||
160792672|NCT02743221|580628292|FG000|Overall Study|Progressive disease|29|||
160792673|NCT02743221|580628293|FG001|Overall Study|Progressive disease|38|||
160792674|NCT02743221|580628292|FG000|Overall Study|Adverse Event|17|||
160792675|NCT02743221|580628293|FG001|Overall Study|Adverse Event|14|||
160792676|NCT02743221|580628292|FG000|Overall Study|non medical reason|8|||
160792677|NCT02743221|580628293|FG001|Overall Study|non medical reason|2|||
160792678|NCT02743221|580628292|FG000|Overall Study|Physician Decision|2|||
160792679|NCT02743221|580628293|FG001|Overall Study|Physician Decision|5|||
160792680|NCT02743221|580628292|FG000|Overall Study|Patient not eligible, not treated|0|||
160792681|NCT02743221|580628293|FG001|Overall Study|Patient not eligible, not treated|1|||
160792682|NCT02609503|580628296|FG000|Overall Study|Adverse Event|1|||
160792683|NCT02609503|580628296|FG000|Overall Study|Death|1|||
160792684|NCT02609503|580628296|FG000|Overall Study|Withdrawal by Subject|1|||
160792685|NCT02609503|580628296|FG000|Overall Study|Disease progression|1|||
160792686|NCT04642079|580628297|FG000|Overall Study|Lost to Follow-up|2|||
160792687|NCT04642079|580628298|FG001|Overall Study|Lost to Follow-up|5|||
160792688|NCT04642079|580628299|FG002|Overall Study|Lost to Follow-up|2|||
160792689|NCT04642079|580628300|FG003|Overall Study|Lost to Follow-up|0|||
160792690|NCT04642079|580628297|FG000|Overall Study|Withdrawal by Subject|0|||
160792691|NCT04642079|580628298|FG001|Overall Study|Withdrawal by Subject|4|||
160792692|NCT04642079|580628299|FG002|Overall Study|Withdrawal by Subject|1|||
160792693|NCT04642079|580628300|FG003|Overall Study|Withdrawal by Subject|2|||
160792694|NCT04642079|580628297|FG000|Overall Study|Other|0|||
160792695|NCT04642079|580628298|FG001|Overall Study|Other|0|||
160792696|NCT04642079|580628299|FG002|Overall Study|Other|0|||
160792697|NCT04642079|580628300|FG003|Overall Study|Other|1|||
160792698|NCT04642079|580628297|FG000|Overall Study|No longer met eligibility criteria|1|||
160792699|NCT04642079|580628298|FG001|Overall Study|No longer met eligibility criteria|0|||
160792700|NCT04642079|580628299|FG002|Overall Study|No longer met eligibility criteria|1|||
160792701|NCT04642079|580628300|FG003|Overall Study|No longer met eligibility criteria|1|||
160792702|NCT02226653|580628301|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
160892751|NCT01436162|581002263|FG001|Randomized Phase|Other|5|||
160982270|NCT01012973|581323451|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
160982271|NCT01012973|581323450|FG000|Overall Study|Protocol Violation|5|||
160982272|NCT01012973|581323451|FG001|Overall Study|Protocol Violation|2|||
160982273|NCT01012973|581323450|FG000|Overall Study|Withdrawal by Subject|4|||
160982274|NCT01012973|581323451|FG001|Overall Study|Withdrawal by Subject|6|||
160982275|NCT02213055|581323452|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
160982276|NCT02213055|581323453|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
160982277|NCT02213055|581323452|FG000|Overall Study|Protocol was not Followed during Study|1|||
160982278|NCT02213055|581323453|FG001|Overall Study|Protocol was not Followed during Study|0|||
160982279|NCT02213055|581323452|FG000|Overall Study|Documentation Issue at Enrollment|1|||
160982280|NCT02213055|581323453|FG001|Overall Study|Documentation Issue at Enrollment|0|||
160982281|NCT02213055|581323452|FG000|Overall Study|Documentation Issue during Study|10|||
160982282|NCT02213055|581323453|FG001|Overall Study|Documentation Issue during Study|0|||
160982283|NCT02213055|581323452|FG000|Overall Study|Did not have Live Lice|8|||
160982284|NCT02213055|581323453|FG001|Overall Study|Did not have Live Lice|0|||
160982285|NCT02213055|581323452|FG000|Overall Study|Had another Treatment during the Study|3|||
160982286|NCT02213055|581323453|FG001|Overall Study|Had another Treatment during the Study|0|||
160982287|NCT02213055|581323452|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
160982288|NCT02213055|581323453|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
160982289|NCT02213055|581323452|FG000|Overall Study|Did not Return to School|5|||
160982290|NCT02213055|581323453|FG001|Overall Study|Did not Return to School|0|||
160982291|NCT05868954|581323460|FG000|Overall Study|Lost to Follow-up|0|||
160982292|NCT05868954|581323461|FG001|Overall Study|Lost to Follow-up|1|||
160982293|NCT05868954|581323460|FG000|Overall Study|Withdrawal by Subject|2|||
160982294|NCT05868954|581323461|FG001|Overall Study|Withdrawal by Subject|2|||
160982295|NCT05868954|581323460|FG000|Overall Study|Participant delivered|1|||
160982296|NCT05868954|581323461|FG001|Overall Study|Participant delivered|1|||
160982297|NCT05868954|581323460|FG000|Overall Study|Miscarriage|0|||
160982298|NCT05868954|581323461|FG001|Overall Study|Miscarriage|1|||
160982299|NCT01435798|581323464|FG000|Overall Study|Withdrawal by Subject|1|||
160982300|NCT03257995|581323465|FG000|Overall Study|Adverse Event|0|||
160982301|NCT03257995|581323466|FG001|Overall Study|Adverse Event|1|||
160982302|NCT03257995|581323467|FG002|Overall Study|Adverse Event|0|||
160982303|NCT03257995|581323468|FG003|Overall Study|Adverse Event|0|||
160982304|NCT03257995|581323469|FG004|Overall Study|Adverse Event|0|||
160982305|NCT03257995|581323470|FG005|Overall Study|Adverse Event|0|||
160982306|NCT03257995|581323465|FG000|Overall Study|Protocol deviation|0|||
160792703|NCT02226653|580628302|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
160792704|NCT02226653|580628301|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
160792705|NCT02226653|580628302|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
160792706|NCT00759395|580628304|FG000|Overall Study|Adverse Event|1|||
160792707|NCT00759395|580628305|FG001|Overall Study|Adverse Event|0|||
160792708|NCT00759395|580628304|FG000|Overall Study|Withdrawal by Subject|1|||
160792709|NCT00759395|580628305|FG001|Overall Study|Withdrawal by Subject|0|||
160792710|NCT00759395|580628304|FG000|Overall Study|Lack of Efficacy|0|||
160792711|NCT00759395|580628305|FG001|Overall Study|Lack of Efficacy|2|||
160792712|NCT01848457|580628306|FG000|Overall Study|Death|1|||
160792713|NCT01848457|580628307|FG001|Overall Study|Death|0|||
160792714|NCT01848457|580628308|FG002|Overall Study|Death|0|||
160792715|NCT01848457|580628309|FG003|Overall Study|Death|0|||
160792716|NCT02181413|580628310|FG000|Overall Study|Withdrawal by Subject|45|||
160548440|NCT02508194|579734135|FG000|Overall Study|Lost to Follow-up|25|||
160792717|NCT02181413|580628311|FG001|Overall Study|Withdrawal by Subject|61|||
160792718|NCT02181413|580628310|FG000|Overall Study|Reason Not Specified|2|||
160792719|NCT02181413|580628311|FG001|Overall Study|Reason Not Specified|5|||
160792720|NCT02181413|580628310|FG000|Overall Study|Lost to Follow-up|8|||
160982307|NCT03257995|581323466|FG001|Overall Study|Protocol deviation|0|||
160982308|NCT03257995|581323467|FG002|Overall Study|Protocol deviation|0|||
160982309|NCT03257995|581323468|FG003|Overall Study|Protocol deviation|0|||
160982310|NCT03257995|581323469|FG004|Overall Study|Protocol deviation|0|||
160982311|NCT03257995|581323470|FG005|Overall Study|Protocol deviation|2|||
160982312|NCT00903786|581323471|FG000|Overall Study|Physician Decision|6|||
160982313|NCT00903786|581323471|FG000|Overall Study|Lack of Efficacy|5|||
160982314|NCT00903786|581323471|FG000|Overall Study|Reason other than lack of efficacy|4|||
160982315|NCT04759885|581323472|FG000|Overall Study|Other|1|||
160982316|NCT04759885|581323473|FG001|Overall Study|Other|0|||
160982317|NCT04759885|581323474|FG002|Overall Study|Other|2|||
160982318|NCT04759885|581323475|FG003|Overall Study|Other|0|||
160982319|NCT04759885|581323476|FG004|Overall Study|Other|0|||
160982320|NCT04759885|581323472|FG000|Overall Study|Withdrawal by Subject|0|||
160982321|NCT04759885|581323473|FG001|Overall Study|Withdrawal by Subject|0|||
160982322|NCT04759885|581323474|FG002|Overall Study|Withdrawal by Subject|1|||
160982323|NCT04759885|581323475|FG003|Overall Study|Withdrawal by Subject|9|||
160982324|NCT04759885|581323476|FG004|Overall Study|Withdrawal by Subject|6|||
160982325|NCT04759885|581323472|FG000|Overall Study|Adverse Event|0|||
160982326|NCT04759885|581323473|FG001|Overall Study|Adverse Event|0|||
160982327|NCT04759885|581323474|FG002|Overall Study|Adverse Event|0|||
160982328|NCT04759885|581323475|FG003|Overall Study|Adverse Event|3|||
160982329|NCT04759885|581323476|FG004|Overall Study|Adverse Event|0|||
160982330|NCT04759885|581323472|FG000|Overall Study|Physician Decision|0|||
160982331|NCT04759885|581323473|FG001|Overall Study|Physician Decision|0|||
160982332|NCT04759885|581323474|FG002|Overall Study|Physician Decision|0|||
160982333|NCT04759885|581323475|FG003|Overall Study|Physician Decision|2|||
160982334|NCT04759885|581323476|FG004|Overall Study|Physician Decision|0|||
160982335|NCT02285595|581323477|FG000|Overall Study|Lost to Follow-up|14|||
160982336|NCT02285595|581323477|FG000|Overall Study|Withdrawal by Subject|1|||
160982337|NCT01960790|581323478|FG000|Overall Study|Survey forms could not be recovered|3|||
160982338|NCT01960790|581323478|FG000|Overall Study|Treat with Humira outside survey period|3|||
160982339|NCT01960790|581323478|FG000|Overall Study|Transferred to another hospital|4|||
160982340|NCT01960790|581323478|FG000|Overall Study|Unevaluable for safety|1|||
160792721|NCT02181413|580628311|FG001|Overall Study|Lost to Follow-up|7|||
160792722|NCT02298946|580628313|FG000|Overall Study|Did not receive treatment|2|||
160792723|NCT02298946|580628314|FG001|Overall Study|Did not receive treatment|0|||
160792724|NCT02298946|580628313|FG000|Overall Study|Unevaluable|2|||
160982341|NCT01267253|581323481|FG000|Overall Study|Ineligible - required test not done|1|||
160982342|NCT01267253|581323481|FG000|Overall Study|Inevaluable-never received study treatme|2|||
160982343|NCT00996580|581323482|FG000|Overall Study|Adverse Event|466|||
160982344|NCT00996580|581323482|FG000|Overall Study|Lost to Follow-up|480|||
160982345|NCT00996580|581323482|FG000|Overall Study|Noncompliance with the protocol|137|||
160792725|NCT02298946|580628314|FG001|Overall Study|Unevaluable|1|||
160792726|NCT03034044|580628315|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
160792727|NCT04042311|580628319|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
160792728|NCT04042311|580628319|FG000|Overall Study|Unable to tolerate|4|||
160792729|NCT04042311|580628319|FG000|Overall Study|Concurrent illness|2|||
160792730|NCT04042311|580628319|FG000|Overall Study|Adverse Event|2|||
160792731|NCT04042311|580628319|FG000|Overall Study|No longer meeting inclusion criteria|2|||
160792732|NCT04042311|580628319|FG000|Overall Study|No reason given|1|||
160792733|NCT04042311|580628319|FG000|Overall Study|Withdrawal by Subject|4|||
160792734|NCT03518060|580628320|FG000|Overall Study|Death|1|||
160792735|NCT03518060|580628320|FG000|Overall Study|Poor adherence|1|||
160792736|NCT03518060|580628320|FG000|Overall Study|Withdrawal of informed consent|2|||
160792737|NCT03518060|580628320|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
160792738|NCT03518060|580628320|FG000|Overall Study|Physician Decision|7|||
160792739|NCT03518060|580628320|FG000|Overall Study|Adverse drug reactions|23|||
160792740|NCT03518060|580628320|FG000|Overall Study|Withdrawal by Subject|25|||
160792741|NCT03518060|580628320|FG000|Overall Study|Lost to Follow-up|13|||
160792742|NCT00323622|580628321|FG000|Overall Study|Other|30|||
160982346|NCT00996580|581323482|FG000|Overall Study|Physician Decision|5|||
160982347|NCT00996580|581323482|FG000|Overall Study|Pregnancy|68|||
160982348|NCT00996580|581323482|FG000|Overall Study|Protocol Violation|16|||
160982349|NCT00996580|581323482|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
160982350|NCT00996580|581323482|FG000|Overall Study|Withdrawal by Subject|217|||
160982351|NCT00996580|581323482|FG000|Overall Study|Other|29|||
160982352|NCT00064025|581323483|FG000|Overall Study|Ineligible|4|||
160982353|NCT00064025|581323483|FG000|Overall Study|Inevaluable|3|||
160982354|NCT02468934|581323484|FG000|Overall Study|Withdrawal by Subject|4|||
160982355|NCT02468934|581323484|FG000|Overall Study|Screen Failure|3|||
160792743|NCT00323622|580628322|FG001|Overall Study|Other|91|||
160792744|NCT00323622|580628323|FG002|Overall Study|Other|4|||
160792745|NCT00323622|580628324|FG003|Overall Study|Other|12|||
160792746|NCT00323622|580628325|FG004|Overall Study|Other|32|||
160792747|NCT00323622|580628326|FG005|Overall Study|Other|74|||
160792748|NCT00323622|580628327|FG006|Overall Study|Other|5|||
160792749|NCT00323622|580628328|FG007|Overall Study|Other|13|||
160792750|NCT00323622|580628321|FG000|Overall Study|Death|1|||
160792751|NCT00323622|580628322|FG001|Overall Study|Death|1|||
160792752|NCT00323622|580628323|FG002|Overall Study|Death|0|||
160792753|NCT00323622|580628324|FG003|Overall Study|Death|0|||
160792754|NCT00323622|580628325|FG004|Overall Study|Death|7|||
160792755|NCT00323622|580628326|FG005|Overall Study|Death|0|||
160792756|NCT00323622|580628327|FG006|Overall Study|Death|0|||
160792757|NCT00323622|580628328|FG007|Overall Study|Death|2|||
160792758|NCT03709472|580628329|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
160792759|NCT03709472|580628330|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
160792760|NCT03709472|580628329|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
160792761|NCT03709472|580628330|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
160792762|NCT01385995|580628338|FG000|Period 1, 2 Months|Physician Decision|1|||
160792763|NCT01385995|580628339|FG001|Period 1, 2 Months|Physician Decision|0|||
160792764|NCT04976777|580629845|FG000|Overall Study|COVID-19 Infection|1|||
160792765|NCT04976777|580629846|FG001|Overall Study|COVID-19 Infection|0|||
160792766|NCT00462826|580629847|FG000|Overall Study|Ineligible - second primary|1|||
160792767|NCT00462826|580629847|FG000|Overall Study|Ineligible - wrong cell type|1|||
160792768|NCT00462826|580629847|FG000|Overall Study|Ineligible - wrong primary|2|||
160792769|NCT00462826|580629847|FG000|Overall Study|Never treated|1|||
160792770|NCT00267488|580629848|FG000|Overall Study|Sponsor Terminated Study|9|||
160792771|NCT00267488|580629848|FG000|Overall Study|Protocol Violation|1|||
160792772|NCT00267488|580629848|FG000|Overall Study|Other (Disease Progression)|1|||
160792773|NCT02093520|580629849|FG000|Overall Study|Not treated|6|||
160792774|NCT02093520|580629850|FG001|Overall Study|Not treated|22|||
160792775|NCT00856557|580629851|FG000|Overall Study|No patients with contextual flags|12|||
160792776|NCT00856557|580629852|FG001|Overall Study|No patients with contextual flags|16|||
160792777|NCT02684461|580629853|FG000|Overall Study|Adverse Event|1|||
160792778|NCT02684461|580629854|FG001|Overall Study|Adverse Event|0|||
160792779|NCT02684461|580629855|FG002|Overall Study|Adverse Event|0|||
160792780|NCT02684461|580629853|FG000|Overall Study|Lack of Efficacy|1|||
160792781|NCT02684461|580629854|FG001|Overall Study|Lack of Efficacy|2|||
160792782|NCT02684461|580629855|FG002|Overall Study|Lack of Efficacy|0|||
160792783|NCT03524157|580629865|FG000|Overall Study|cytology not readable|0|||
160792784|NCT03524157|580629866|FG001|Overall Study|cytology not readable|0|||
160792785|NCT03524157|580629867|FG002|Overall Study|cytology not readable|1|||
160792786|NCT04507763|580629868|FG000|Overall Study|Participants did not meet entrance criteria|201|||
160792787|NCT03322566|580629869|FG000|Overall Study|Death|34|||
160792788|NCT03322566|580629870|FG001|Overall Study|Death|35|||
160792789|NCT03322566|580629871|FG002|Overall Study|Death|23|||
160792790|NCT03322566|580629869|FG000|Overall Study|Physician Decision|6|||
160792791|NCT03322566|580629870|FG001|Overall Study|Physician Decision|7|||
160792792|NCT03322566|580629871|FG002|Overall Study|Physician Decision|2|||
160792793|NCT03322566|580629869|FG000|Overall Study|Withdrawal by Subject|4|||
160792794|NCT03322566|580629870|FG001|Overall Study|Withdrawal by Subject|3|||
160792795|NCT03322566|580629871|FG002|Overall Study|Withdrawal by Subject|6|||
160792796|NCT03322566|580629869|FG000|Overall Study|Lost to Follow-up|0|||
160792797|NCT03322566|580629870|FG001|Overall Study|Lost to Follow-up|0|||
160792798|NCT03322566|580629871|FG002|Overall Study|Lost to Follow-up|1|||
160792799|NCT03322566|580629869|FG000|Overall Study|Study terminated by sponsor|1|||
160792800|NCT03322566|580629870|FG001|Overall Study|Study terminated by sponsor|0|||
160792801|NCT03322566|580629871|FG002|Overall Study|Study terminated by sponsor|1|||
160892752|NCT01436162|581002264|FG002|Randomized Phase|Other|4|||
160892753|NCT02750943|581002269|FG000|Overall Study|Lost to Follow-up|1|||
160792802|NCT01602484|580629872|FG000|Overall Study|Airway issues unrelated to study|0|||
160792803|NCT01602484|580629873|FG001|Overall Study|Airway issues unrelated to study|1|||
160792804|NCT00425555|580629876|FG000|Overall Study|Withdrawal by Subject|11|||
160792805|NCT00425555|580629877|FG001|Overall Study|Withdrawal by Subject|8|||
160792806|NCT00425555|580629876|FG000|Overall Study|Lost to Follow-up|0|||
160792807|NCT00425555|580629877|FG001|Overall Study|Lost to Follow-up|1|||
160792808|NCT00425555|580629876|FG000|Overall Study|Administrative problems|3|||
160792809|NCT00425555|580629877|FG001|Overall Study|Administrative problems|0|||
160792810|NCT00425555|580629876|FG000|Overall Study|Death|1|||
160792811|NCT00425555|580629877|FG001|Overall Study|Death|2|||
160792812|NCT00425555|580629876|FG000|Overall Study|New cancer therapy|2|||
160792813|NCT00425555|580629877|FG001|Overall Study|New cancer therapy|1|||
160792814|NCT00425555|580629876|FG000|Overall Study|Disease progression|36|||
160892754|NCT02750943|581002270|FG001|Overall Study|Lost to Follow-up|2|||
160792815|NCT00425555|580629877|FG001|Overall Study|Disease progression|33|||
160792816|NCT00425555|580629876|FG000|Overall Study|Adverse Event|25|||
160792817|NCT00425555|580629877|FG001|Overall Study|Adverse Event|15|||
160792818|NCT00425555|580629876|FG000|Overall Study|Protocol Violation|1|||
160792819|NCT00425555|580629877|FG001|Overall Study|Protocol Violation|0|||
160792820|NCT06582732|580629879|FG000|Initial Study Period|Adverse Event|0|||
160792821|NCT06582732|580629880|FG001|Initial Study Period|Adverse Event|0|||
160792822|NCT06582732|580629881|FG002|Initial Study Period|Adverse Event|0|||
160792823|NCT06582732|580629882|FG003|Initial Study Period|Adverse Event|2|||
160792824|NCT06582732|580629883|FG004|Initial Study Period|Adverse Event|0|||
160792825|NCT06582732|580629884|FG005|Initial Study Period|Adverse Event|0|||
160792826|NCT06582732|580629885|FG006|Initial Study Period|Adverse Event|0|||
160792827|NCT06582732|580629879|FG000|Initial Study Period|Death|1|||
160792828|NCT06582732|580629880|FG001|Initial Study Period|Death|0|||
160792829|NCT06582732|580629881|FG002|Initial Study Period|Death|0|||
160792830|NCT06582732|580629882|FG003|Initial Study Period|Death|0|||
160792831|NCT06582732|580629883|FG004|Initial Study Period|Death|1|||
160792832|NCT06582732|580629884|FG005|Initial Study Period|Death|0|||
160792833|NCT06582732|580629885|FG006|Initial Study Period|Death|0|||
160792834|NCT06582732|580629879|FG000|Initial Study Period|Lost to Follow-up|0|||
160792835|NCT06582732|580629880|FG001|Initial Study Period|Lost to Follow-up|0|||
160792836|NCT06582732|580629881|FG002|Initial Study Period|Lost to Follow-up|2|||
160792837|NCT06582732|580629882|FG003|Initial Study Period|Lost to Follow-up|0|||
160792838|NCT06582732|580629883|FG004|Initial Study Period|Lost to Follow-up|0|||
160792839|NCT06582732|580629884|FG005|Initial Study Period|Lost to Follow-up|0|||
160792840|NCT06582732|580629885|FG006|Initial Study Period|Lost to Follow-up|0|||
160792841|NCT06582732|580629879|FG000|Initial Study Period|Withdrawal by Subject|0|||
160792842|NCT06582732|580629880|FG001|Initial Study Period|Withdrawal by Subject|1|||
160792843|NCT06582732|580629881|FG002|Initial Study Period|Withdrawal by Subject|0|||
160792844|NCT06582732|580629882|FG003|Initial Study Period|Withdrawal by Subject|1|||
160792845|NCT06582732|580629883|FG004|Initial Study Period|Withdrawal by Subject|3|||
160792846|NCT06582732|580629884|FG005|Initial Study Period|Withdrawal by Subject|1|||
160792847|NCT06582732|580629885|FG006|Initial Study Period|Withdrawal by Subject|2|||
160792848|NCT06582732|580629879|FG000|Initial Study Period|Moved Away|0|||
160792849|NCT06582732|580629880|FG001|Initial Study Period|Moved Away|0|||
160792850|NCT06582732|580629881|FG002|Initial Study Period|Moved Away|0|||
160792851|NCT06582732|580629882|FG003|Initial Study Period|Moved Away|0|||
160792852|NCT06582732|580629883|FG004|Initial Study Period|Moved Away|1|||
160792853|NCT06582732|580629884|FG005|Initial Study Period|Moved Away|0|||
160792854|NCT06582732|580629885|FG006|Initial Study Period|Moved Away|0|||
160792855|NCT03931330|580629886|FG000|Overall Study|Physician Decision|1|||
160792856|NCT03412929|580629887|FG000|Overall Study|Protocol Violation|3|||
160792857|NCT01381679|580629888|FG000|Overall Study|Adverse Event|3|||
160792858|NCT01381679|580629888|FG000|Overall Study|Lost to Follow-up|885|||
160792859|NCT02919618|580629892|FG000|Overall Study|Death|1|||
160792860|NCT03528902|580629893|FG000|Overall Study|Adverse Event|1|||
160792861|NCT03528902|580629894|FG001|Overall Study|Adverse Event|0|||
160792862|NCT03411044|580629895|FG000|Overall Study|Death|30|||
160792863|NCT03411044|580629895|FG000|Overall Study|Withdrawal by Subject|48|||
160792864|NCT03411044|580629895|FG000|Overall Study|Lost to Follow-up|78|||
160792865|NCT03411044|580629895|FG000|Overall Study|Adverse Event|30|||
160792866|NCT03411044|580629895|FG000|Overall Study|Missing status|4|||
160792867|NCT01674062|580629903|FG000|Overall Study|Insufficient Therapeutic Response|56|||
160792868|NCT01674062|580629904|FG001|Overall Study|Insufficient Therapeutic Response|26|||
160792869|NCT01674062|580629903|FG000|Overall Study|Other|8|||
160792870|NCT01674062|580629904|FG001|Overall Study|Other|1|||
160792871|NCT01674062|580629903|FG000|Overall Study|Adverse Event|1|||
160792872|NCT01674062|580629904|FG001|Overall Study|Adverse Event|1|||
160792873|NCT01674062|580629903|FG000|Overall Study|Death|0|||
160892755|NCT02750943|581002269|FG000|Overall Study|Withdrawal by Subject|5|||
160892756|NCT02750943|581002270|FG001|Overall Study|Withdrawal by Subject|7|||
160892757|NCT04597918|581002271|FG000|Overall Study|Withdrawal by Subject|6|||
160792874|NCT01674062|580629904|FG001|Overall Study|Death|1|||
160792875|NCT01674062|580629903|FG000|Overall Study|Programming Error|1|||
160792876|NCT01674062|580629904|FG001|Overall Study|Programming Error|0|||
160792877|NCT04661839|580629905|FG000|Overall Study|Not Treated|0|||
160792878|NCT04661839|580629906|FG001|Overall Study|Not Treated|0|||
160792879|NCT04661839|580629907|FG002|Overall Study|Not Treated|1|||
160792880|NCT04661839|580629908|FG003|Overall Study|Not Treated|0|||
160792881|NCT04661839|580629905|FG000|Overall Study|Lost to Follow-up|1|||
160792882|NCT04661839|580629906|FG001|Overall Study|Lost to Follow-up|0|||
160792883|NCT04661839|580629907|FG002|Overall Study|Lost to Follow-up|0|||
160792884|NCT04661839|580629908|FG003|Overall Study|Lost to Follow-up|1|||
160792885|NCT03895372|580629909|FG000|Investigational Treatment Period|Adverse Event|1|||
160892758|NCT04597918|581002271|FG000|Overall Study|Lost to Follow-up|3|||
160792886|NCT03895372|580629910|FG001|Investigational Treatment Period|Adverse Event|0|||
160792887|NCT03895372|580629911|FG002|Investigational Treatment Period|Adverse Event|0|||
160792888|NCT03895372|580629912|FG003|Investigational Treatment Period|Adverse Event|0|||
160892759|NCT04597918|581002271|FG000|Overall Study|Death|1|||
160982356|NCT02036515|581323489|FG000|Overall Study|Adverse Event|1|||
160982357|NCT02036515|581323490|FG001|Overall Study|Adverse Event|1|||
160982358|NCT02036515|581323491|FG002|Overall Study|Adverse Event|2|||
160982359|NCT02036515|581323489|FG000|Overall Study|Lost to Follow-up|0|||
160792889|NCT03895372|580629913|FG004|Investigational Treatment Period|Adverse Event|0|||
160792890|NCT03895372|580629914|FG005|Investigational Treatment Period|Adverse Event|0|||
160792891|NCT03895372|580629915|FG006|Investigational Treatment Period|Adverse Event|4|||
160792892|NCT03895372|580629916|FG007|Investigational Treatment Period|Adverse Event|3|||
160792893|NCT03895372|580629909|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
160792894|NCT03895372|580629910|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
160792895|NCT03895372|580629911|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
160792896|NCT03895372|580629912|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
160792897|NCT03895372|580629913|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
160792898|NCT03895372|580629914|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
160792899|NCT03895372|580629915|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
160792900|NCT03895372|580629916|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
160792901|NCT03895372|580629909|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
160982360|NCT02036515|581323490|FG001|Overall Study|Lost to Follow-up|2|||
160982361|NCT02036515|581323491|FG002|Overall Study|Lost to Follow-up|0|||
160982362|NCT02036515|581323489|FG000|Overall Study|Non-compliance with study drug|0|||
160982363|NCT02036515|581323490|FG001|Overall Study|Non-compliance with study drug|0|||
160982364|NCT02036515|581323491|FG002|Overall Study|Non-compliance with study drug|2|||
160982365|NCT02036515|581323489|FG000|Overall Study|Screen failure|0|||
160982366|NCT02036515|581323490|FG001|Overall Study|Screen failure|2|||
160982367|NCT02036515|581323491|FG002|Overall Study|Screen failure|0|||
160982368|NCT02036515|581323489|FG000|Overall Study|Withdrawal by Subject|4|||
160982369|NCT02036515|581323490|FG001|Overall Study|Withdrawal by Subject|7|||
160982370|NCT02036515|581323491|FG002|Overall Study|Withdrawal by Subject|9|||
160982371|NCT02036515|581323489|FG000|Overall Study|Hyperglycemia|0|||
160792902|NCT03895372|580629910|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
160792903|NCT03895372|580629911|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
160792904|NCT03895372|580629912|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
160792905|NCT03895372|580629913|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
160792906|NCT03895372|580629914|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
160792907|NCT03895372|580629915|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
160792908|NCT03895372|580629916|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
160792909|NCT03895372|580629909|FG000|Investigational Treatment Period|Other|0|||
160792910|NCT03895372|580629910|FG001|Investigational Treatment Period|Other|0|||
160982372|NCT02036515|581323490|FG001|Overall Study|Hyperglycemia|0|||
160982373|NCT02036515|581323491|FG002|Overall Study|Hyperglycemia|1|||
160982374|NCT00547911|581323492|FG000|Overall Study|Adverse Event|0|||
160982375|NCT00547911|581323493|FG001|Overall Study|Adverse Event|0|||
160982376|NCT00547911|581323494|FG002|Overall Study|Adverse Event|0|||
160982377|NCT00547911|581323495|FG003|Overall Study|Adverse Event|1|||
160792911|NCT03895372|580629911|FG002|Investigational Treatment Period|Other|0|||
160982378|NCT00547911|581323496|FG004|Overall Study|Adverse Event|0|||
160982379|NCT00547911|581323497|FG005|Overall Study|Adverse Event|0|||
160982380|NCT02133924|581323498|FG000|Overall Study|Death|38|||
160982381|NCT02133924|581323498|FG000|Overall Study|Physician Decision|1|||
160982382|NCT02133924|581323498|FG000|Overall Study|Withdrawal by Subject|3|||
160982383|NCT01644474|581323500|FG000|Overall Study|Poor compliance to protocol|1|||
160792912|NCT03895372|580629912|FG003|Investigational Treatment Period|Other|0|||
160792913|NCT03895372|580629913|FG004|Investigational Treatment Period|Other|0|||
160792914|NCT03895372|580629914|FG005|Investigational Treatment Period|Other|1|||
160792915|NCT03895372|580629915|FG006|Investigational Treatment Period|Other|0|||
160792916|NCT03895372|580629916|FG007|Investigational Treatment Period|Other|2|||
160792917|NCT03895372|580629909|FG000|Investigational Treatment Period|Protocol Violation|0|||
160792918|NCT03895372|580629910|FG001|Investigational Treatment Period|Protocol Violation|0|||
160792919|NCT03895372|580629911|FG002|Investigational Treatment Period|Protocol Violation|0|||
160792920|NCT03895372|580629912|FG003|Investigational Treatment Period|Protocol Violation|1|||
160792921|NCT03895372|580629913|FG004|Investigational Treatment Period|Protocol Violation|0|||
160982384|NCT01644474|581323501|FG001|Overall Study|Poor compliance to protocol|0|||
160982385|NCT01644474|581323500|FG000|Overall Study|Consent withdrawn by participant|0|||
160792922|NCT03895372|580629914|FG005|Investigational Treatment Period|Protocol Violation|0|||
160792923|NCT03895372|580629915|FG006|Investigational Treatment Period|Protocol Violation|0|||
160792924|NCT03895372|580629916|FG007|Investigational Treatment Period|Protocol Violation|0|||
160792925|NCT03895372|580629909|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
160792926|NCT03895372|580629910|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
160982386|NCT01644474|581323501|FG001|Overall Study|Consent withdrawn by participant|1|||
160982387|NCT01644474|581323500|FG000|Overall Study|Participant moved|0|||
160982388|NCT01644474|581323501|FG001|Overall Study|Participant moved|1|||
160982389|NCT01644474|581323500|FG000|Overall Study|Adverse Event|4|||
160982390|NCT01644474|581323501|FG001|Overall Study|Adverse Event|5|||
160982391|NCT01644474|581323500|FG000|Overall Study|Site scheduling error|1|||
160982392|NCT01644474|581323501|FG001|Overall Study|Site scheduling error|1|||
160982393|NCT01644474|581323500|FG000|Overall Study|Protocol Violation|1|||
160982394|NCT01644474|581323501|FG001|Overall Study|Protocol Violation|0|||
160982395|NCT01163747|581323503|FG000|Overall Study|Adverse Event|0|||
160982396|NCT01163747|581323504|FG001|Overall Study|Adverse Event|5|||
160982397|NCT01163747|581323503|FG000|Overall Study|Insufficient Therapeutic Response|0|||
160982398|NCT01163747|581323504|FG001|Overall Study|Insufficient Therapeutic Response|1|||
160982399|NCT01163747|581323503|FG000|Overall Study|Protocol Violation|0|||
160982400|NCT01163747|581323504|FG001|Overall Study|Protocol Violation|1|||
160982401|NCT01163747|581323503|FG000|Overall Study|Refused Treatment|6|||
160982402|NCT01163747|581323504|FG001|Overall Study|Refused Treatment|4|||
160982403|NCT02924389|581323506|FG000|Overall Study|Lost to Follow-up|1|||
160982404|NCT02924389|581323507|FG001|Overall Study|Lost to Follow-up|0|||
160982405|NCT02924389|581323506|FG000|Overall Study|Physician Decision|2|||
160982406|NCT02924389|581323507|FG001|Overall Study|Physician Decision|0|||
160982407|NCT02924389|581323506|FG000|Overall Study|Withdrawal by Subject|3|||
160982408|NCT02924389|581323507|FG001|Overall Study|Withdrawal by Subject|0|||
160982409|NCT02924389|581323506|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
160982410|NCT02924389|581323507|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
160982411|NCT01268059|581324941|FG000|Overall Study|Lost to Follow-up|0|||
160982412|NCT01268059|581324942|FG001|Overall Study|Lost to Follow-up|1|||
160982413|NCT01268059|581324943|FG002|Overall Study|Lost to Follow-up|0|||
160982414|NCT01268059|581324944|FG003|Overall Study|Lost to Follow-up|0|||
160982415|NCT01268059|581324941|FG000|Overall Study|Withdrawal by Subject|7|||
160982416|NCT01268059|581324942|FG001|Overall Study|Withdrawal by Subject|4|||
160982417|NCT01268059|581324943|FG002|Overall Study|Withdrawal by Subject|0|||
160982418|NCT01268059|581324944|FG003|Overall Study|Withdrawal by Subject|0|||
160982419|NCT01268059|581324941|FG000|Overall Study|Death|20|||
160982420|NCT01268059|581324942|FG001|Overall Study|Death|30|||
160982421|NCT01268059|581324943|FG002|Overall Study|Death|3|||
160982422|NCT01268059|581324944|FG003|Overall Study|Death|5|||
160982423|NCT01268059|581324941|FG000|Overall Study|Progression of disease|1|||
160982424|NCT01268059|581324942|FG001|Overall Study|Progression of disease|0|||
160982425|NCT01268059|581324943|FG002|Overall Study|Progression of disease|0|||
160982426|NCT01268059|581324944|FG003|Overall Study|Progression of disease|0|||
160792927|NCT03895372|580629911|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
160792928|NCT03895372|580629912|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
160982427|NCT03660943|581324945|FG000|Overall Study|Adverse Event|5|||
160792929|NCT03895372|580629913|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
160982428|NCT03660943|581324946|FG001|Overall Study|Adverse Event|3|||
160982429|NCT03660943|581324945|FG000|Overall Study|Death|0|||
160982430|NCT03660943|581324946|FG001|Overall Study|Death|2|||
160982431|NCT03660943|581324945|FG000|Overall Study|Lost to Follow-up|7|||
160982432|NCT03660943|581324946|FG001|Overall Study|Lost to Follow-up|3|||
160982433|NCT03660943|581324945|FG000|Overall Study|Protocol Violation|3|||
160982434|NCT03660943|581324946|FG001|Overall Study|Protocol Violation|5|||
160982435|NCT03660943|581324945|FG000|Overall Study|Withdrawal by Subject|8|||
160982436|NCT03660943|581324946|FG001|Overall Study|Withdrawal by Subject|15|||
160982437|NCT03660943|581324945|FG000|Overall Study|Lack of Efficacy|9|||
160982438|NCT03660943|581324946|FG001|Overall Study|Lack of Efficacy|12|||
160982439|NCT03660943|581324945|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
160982440|NCT03660943|581324946|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
160982441|NCT03699124|581324947|FG000|Overall Study|Adverse Event|6|||
160982442|NCT03699124|581324948|FG001|Overall Study|Adverse Event|5|||
160982443|NCT03699124|581324949|FG002|Overall Study|Adverse Event|2|||
160982444|NCT03699124|581324947|FG000|Overall Study|Death|0|||
160982445|NCT03699124|581324948|FG001|Overall Study|Death|2|||
160982446|NCT03699124|581324949|FG002|Overall Study|Death|0|||
160982447|NCT03699124|581324947|FG000|Overall Study|Lost to Follow-up|20|||
160982448|NCT03699124|581324948|FG001|Overall Study|Lost to Follow-up|16|||
160982449|NCT03699124|581324949|FG002|Overall Study|Lost to Follow-up|15|||
160982450|NCT03699124|581324947|FG000|Overall Study|Protocol Violation|1|||
160982451|NCT03699124|581324948|FG001|Overall Study|Protocol Violation|0|||
160982452|NCT03699124|581324949|FG002|Overall Study|Protocol Violation|0|||
160792930|NCT03895372|580629914|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
160792931|NCT03895372|580629915|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
160792932|NCT03895372|580629916|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
160792933|NCT03895372|580629909|FG000|Extension Treatment Period|Adverse Event|0|||
160792934|NCT03895372|580629910|FG001|Extension Treatment Period|Adverse Event|1|||
160792935|NCT03895372|580629911|FG002|Extension Treatment Period|Adverse Event|0|||
160792936|NCT03895372|580629912|FG003|Extension Treatment Period|Adverse Event|1|||
160792937|NCT03895372|580629913|FG004|Extension Treatment Period|Adverse Event|0|||
160792938|NCT03895372|580629914|FG005|Extension Treatment Period|Adverse Event|0|||
160792939|NCT03895372|580629915|FG006|Extension Treatment Period|Adverse Event|3|||
160792940|NCT03895372|580629916|FG007|Extension Treatment Period|Adverse Event|3|||
160792941|NCT03895372|580629909|FG000|Extension Treatment Period|Other|1|||
160792942|NCT03895372|580629910|FG001|Extension Treatment Period|Other|3|||
160792943|NCT03895372|580629911|FG002|Extension Treatment Period|Other|0|||
160792944|NCT03895372|580629912|FG003|Extension Treatment Period|Other|0|||
160792945|NCT03895372|580629913|FG004|Extension Treatment Period|Other|1|||
160792946|NCT03895372|580629914|FG005|Extension Treatment Period|Other|0|||
160792947|NCT03895372|580629915|FG006|Extension Treatment Period|Other|0|||
160792948|NCT03895372|580629916|FG007|Extension Treatment Period|Other|2|||
160792949|NCT03895372|580629909|FG000|Extension Treatment Period|Pregnancy|0|||
160792950|NCT03895372|580629910|FG001|Extension Treatment Period|Pregnancy|0|||
160792951|NCT03895372|580629911|FG002|Extension Treatment Period|Pregnancy|0|||
160792952|NCT03895372|580629912|FG003|Extension Treatment Period|Pregnancy|0|||
160792953|NCT03895372|580629913|FG004|Extension Treatment Period|Pregnancy|1|||
160792954|NCT03895372|580629914|FG005|Extension Treatment Period|Pregnancy|0|||
160792955|NCT03895372|580629915|FG006|Extension Treatment Period|Pregnancy|0|||
160792956|NCT03895372|580629916|FG007|Extension Treatment Period|Pregnancy|0|||
160792957|NCT03895372|580629909|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
160792958|NCT03895372|580629910|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
160792959|NCT03895372|580629911|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
160792960|NCT03895372|580629912|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
160792961|NCT03895372|580629913|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
160792962|NCT03895372|580629914|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
160792963|NCT03895372|580629915|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
160792964|NCT03895372|580629916|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
160792965|NCT03685149|580629917|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
160792966|NCT03685149|580629918|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
160792967|NCT03685149|580629917|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160792968|NCT03685149|580629918|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
160792969|NCT03685149|580629917|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
160792970|NCT03685149|580629918|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
160792971|NCT02034565|580629925|FG000|Overall Study|Adverse Event|1|||
160792972|NCT02034565|580629926|FG001|Overall Study|Adverse Event|0|||
160792973|NCT00581919|580629927|FG000|Overall Study|Adverse Event|8|||
160792974|NCT00581919|580629927|FG000|Overall Study|Death|1|||
160792975|NCT00581919|580629927|FG000|Overall Study|Disease Progression|10|||
160792976|NCT00581919|580629927|FG000|Overall Study|Physician Decision|1|||
160792977|NCT00581919|580629927|FG000|Overall Study|Other Complicating Disease|1|||
160892760|NCT05169567|581002274|FG000|Overall Study|On study treatment|116|||
160892761|NCT05169567|581002275|FG001|Overall Study|On study treatment|128|||
160892762|NCT05169567|581002274|FG000|Overall Study|Lost to Follow-up|1|||
160892763|NCT05169567|581002275|FG001|Overall Study|Lost to Follow-up|0|||
160892764|NCT05169567|581002274|FG000|Overall Study|Withdrawal by Subject|25|||
160892765|NCT05169567|581002275|FG001|Overall Study|Withdrawal by Subject|21|||
160892766|NCT04382755|581002276|FG000|Overall Study|Withdrawal by Subject|1|||
160892767|NCT04382755|581002277|FG001|Overall Study|Withdrawal by Subject|0|||
160892768|NCT04382755|581002276|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
160792978|NCT00581919|580629927|FG000|Overall Study|Started Non-Protocol Therapy|2|||
160792979|NCT00581919|580629927|FG000|Overall Study|Withdrawal by Subject|1|||
160792980|NCT03232567|580629930|FG000|Overall Study|Withdrawal by Subject|0|||
160792981|NCT03232567|580629931|FG001|Overall Study|Withdrawal by Subject|1|||
160792982|NCT03232567|580629932|FG002|Overall Study|Withdrawal by Subject|0|||
160792983|NCT03232567|580629933|FG003|Overall Study|Withdrawal by Subject|0|||
160792984|NCT02655601|580629934|FG000|Overall Study|Adverse Event|0|||
160792985|NCT02655601|580629935|FG001|Overall Study|Adverse Event|0|||
160792986|NCT02655601|580629936|FG002|Overall Study|Adverse Event|0|||
160792987|NCT02655601|580629937|FG003|Overall Study|Adverse Event|1|||
160792988|NCT02655601|580629938|FG004|Overall Study|Adverse Event|1|||
160792989|NCT02655601|580629939|FG005|Overall Study|Adverse Event|0|||
160792990|NCT02655601|580629934|FG000|Overall Study|Physician Decision|0|||
160792991|NCT02655601|580629935|FG001|Overall Study|Physician Decision|0|||
160792992|NCT02655601|580629936|FG002|Overall Study|Physician Decision|0|||
160792993|NCT02655601|580629937|FG003|Overall Study|Physician Decision|0|||
160792994|NCT02655601|580629938|FG004|Overall Study|Physician Decision|1|||
160792995|NCT02655601|580629939|FG005|Overall Study|Physician Decision|1|||
160792996|NCT02655601|580629934|FG000|Overall Study|Withdrawal by Subject|0|||
160792997|NCT02655601|580629935|FG001|Overall Study|Withdrawal by Subject|0|||
160792998|NCT02655601|580629936|FG002|Overall Study|Withdrawal by Subject|0|||
160792999|NCT02655601|580629937|FG003|Overall Study|Withdrawal by Subject|0|||
160793000|NCT02655601|580629938|FG004|Overall Study|Withdrawal by Subject|4|||
160793001|NCT02655601|580629939|FG005|Overall Study|Withdrawal by Subject|8|||
160793002|NCT02655601|580629934|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
160793003|NCT02655601|580629935|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
160793004|NCT02655601|580629936|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
160793005|NCT02655601|580629937|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
160793006|NCT02655601|580629938|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
160793007|NCT02655601|580629939|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
160793008|NCT05837481|580629940|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
160793009|NCT05837481|580629941|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
160548441|NCT02508194|579734136|FG001|Overall Study|Lost to Follow-up|18|||
160548442|NCT02508194|579734135|FG000|Overall Study|Withdrawal by Subject|20|||
160548443|NCT02508194|579734136|FG001|Overall Study|Withdrawal by Subject|18|||
160548444|NCT02508194|579734135|FG000|Overall Study|Error in Randomization|1|||
160793010|NCT00427700|580629942|FG000|Overall Study|Lost to Follow-up|2|||
160793011|NCT00427700|580629943|FG001|Overall Study|Lost to Follow-up|5|||
160793012|NCT00427700|580629942|FG000|Overall Study|no induction of menses|1|||
160793013|NCT00427700|580629943|FG001|Overall Study|no induction of menses|4|||
160793014|NCT00427700|580629942|FG000|Overall Study|Pregnancy|0|||
160793015|NCT00427700|580629943|FG001|Overall Study|Pregnancy|2|||
160793016|NCT02014376|580629944|FG000|Overall Study|Adverse Event|1|||
160793017|NCT02014376|580629945|FG001|Overall Study|Adverse Event|1|||
160793018|NCT02014376|580629946|FG002|Overall Study|Adverse Event|0|||
160793019|NCT02014376|580629944|FG000|Overall Study|Lost to Follow-up|2|||
160793020|NCT02014376|580629945|FG001|Overall Study|Lost to Follow-up|0|||
160793021|NCT02014376|580629946|FG002|Overall Study|Lost to Follow-up|0|||
160793022|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
160793023|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
160793024|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
160793025|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
160793026|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
160793027|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
160793028|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
160793029|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
160793030|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
160793031|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
160793032|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
160793033|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
160793034|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
160793035|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
160793036|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
160793037|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
160793038|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
160793039|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
160793040|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
160793041|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
160793042|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
160793043|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
160793044|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
160548445|NCT02508194|579734136|FG001|Overall Study|Error in Randomization|3|||
160982453|NCT03699124|581324947|FG000|Overall Study|Withdrawal by Subject|13|||
160982454|NCT03699124|581324948|FG001|Overall Study|Withdrawal by Subject|14|||
160982455|NCT03699124|581324949|FG002|Overall Study|Withdrawal by Subject|13|||
160982456|NCT03699124|581324947|FG000|Overall Study|Other reasons|5|||
160982457|NCT03699124|581324948|FG001|Overall Study|Other reasons|3|||
160982458|NCT03699124|581324949|FG002|Overall Study|Other reasons|10|||
160982459|NCT03595683|581324950|FG000|Overall Study|Adverse Event|1|||
160982460|NCT03595683|581324951|FG001|Overall Study|Adverse Event|0|||
160982461|NCT03595683|581324950|FG000|Overall Study|Pursue alternative therapy|1|||
160982462|NCT03595683|581324951|FG001|Overall Study|Pursue alternative therapy|1|||
160982463|NCT03595683|581324950|FG000|Overall Study|Progressive disease|1|||
160982464|NCT03595683|581324951|FG001|Overall Study|Progressive disease|3|||
160982465|NCT01021878|581324952|FG000|Overall Study|Lost to Follow-up|4|||
160982466|NCT01021878|581324953|FG001|Overall Study|Lost to Follow-up|3|||
160982467|NCT01021878|581324952|FG000|Overall Study|Death|0|||
160982468|NCT01021878|581324953|FG001|Overall Study|Death|1|||
160982469|NCT01021878|581324952|FG000|Overall Study|Adverse Event|6|||
160982470|NCT01021878|581324953|FG001|Overall Study|Adverse Event|5|||
160982471|NCT01021878|581324952|FG000|Overall Study|Transplantation|6|||
160982472|NCT01021878|581324953|FG001|Overall Study|Transplantation|1|||
160982473|NCT03158948|581324955|FG000|Overall Study|Death|1|||
160982474|NCT03158948|581324956|FG001|Overall Study|Death|1|||
160982475|NCT03158948|581324957|FG002|Overall Study|Death|3|||
160982476|NCT03158948|581324958|FG003|Overall Study|Death|2|||
160982477|NCT03158948|581324955|FG000|Overall Study|Physician Decision|0|||
160982478|NCT03158948|581324956|FG001|Overall Study|Physician Decision|0|||
160982479|NCT03158948|581324957|FG002|Overall Study|Physician Decision|0|||
160982480|NCT03158948|581324958|FG003|Overall Study|Physician Decision|1|||
160982481|NCT03415022|581324961|FG000|Overall Study|Withdrawal by Subject|1|||
160982482|NCT03415022|581324962|FG001|Overall Study|Withdrawal by Subject|2|||
160982483|NCT03415022|581324961|FG000|Overall Study|COVID-19 Suspension|2|||
160982484|NCT03415022|581324962|FG001|Overall Study|COVID-19 Suspension|3|||
160982485|NCT03415022|581324961|FG000|Overall Study|Lost to Follow-up|2|||
160982486|NCT03415022|581324962|FG001|Overall Study|Lost to Follow-up|0|||
160982487|NCT02086552|581324965|FG000|Overall Study|Withdrawal by Subject|1|||
160982488|NCT02206152|581324966|FG000|Pre-Randomization|Withdrawal by Subject|2|||
160982489|NCT00478608|581324967|FG000|Overall Study|Adverse Event|1|||
160982490|NCT00478608|581324967|FG000|Overall Study|Serious Adverse Event|14|||
160982491|NCT00478608|581324967|FG000|Overall Study|Withdrawal by Subject|2|||
160982492|NCT00478608|581324967|FG000|Overall Study|Protocol Violation|3|||
160982493|NCT03583541|581324968|FG000|Overall Study|Lost to Follow-up|31|||
160982494|NCT03583541|581324969|FG001|Overall Study|Lost to Follow-up|65|||
160982495|NCT01094171|581324971|FG000|Overall Study|Lost to Follow-up|2|||
160982496|NCT01094171|581324971|FG000|Overall Study|Informed consent withdrawal|4|||
160982497|NCT01094171|581324971|FG000|Overall Study|Migration from the study area|3|||
160982498|NCT01094171|581324971|FG000|Overall Study|Other|1|||
160982499|NCT00594932|581324972|FG000|First 3 Months|Withdrawal by Subject|1|||
160982500|NCT00594932|581324973|FG001|First 3 Months|Withdrawal by Subject|3|||
160982501|NCT00594932|581324972|FG000|Final 3 Months|Withdrawal by Subject|4|||
160982502|NCT00594932|581324973|FG001|Final 3 Months|Withdrawal by Subject|3|||
160982503|NCT02491892|581324978|FG000|Overall Study|Adverse Event|1|||
160982504|NCT02491892|581324979|FG001|Overall Study|Adverse Event|1|||
160642866|NCT04444752|580074400|FG001|Overall Study|Withdrawal by Subject|5|||
160642867|NCT04444752|580074401|FG002|Overall Study|Withdrawal by Subject|3|||
160642868|NCT04444752|580074402|FG003|Overall Study|Withdrawal by Subject|4|||
160642869|NCT04444752|580074399|FG000|Overall Study|Protocol Violation|1|||
160642870|NCT04444752|580074400|FG001|Overall Study|Protocol Violation|1|||
160642871|NCT04444752|580074401|FG002|Overall Study|Protocol Violation|0|||
160642872|NCT04444752|580074402|FG003|Overall Study|Protocol Violation|0|||
160642873|NCT04444752|580074399|FG000|Overall Study|Patient moving out of town|1|||
160642874|NCT04444752|580074400|FG001|Overall Study|Patient moving out of town|0|||
160642875|NCT04444752|580074401|FG002|Overall Study|Patient moving out of town|0|||
160642876|NCT04444752|580074402|FG003|Overall Study|Patient moving out of town|1|||
160642877|NCT04444752|580074399|FG000|Overall Study|Lack of Efficacy|0|||
160982505|NCT02491892|581324978|FG000|Overall Study|Death|1|||
160982506|NCT02491892|581324979|FG001|Overall Study|Death|1|||
160982507|NCT02491892|581324978|FG000|Overall Study|Lack of Efficacy|37|||
160982508|NCT02491892|581324979|FG001|Overall Study|Lack of Efficacy|36|||
160982509|NCT02491892|581324978|FG000|Overall Study|Refused Treatment|1|||
160982510|NCT02491892|581324979|FG001|Overall Study|Refused Treatment|0|||
160982511|NCT02491892|581324978|FG000|Overall Study|Lost to Follow-up|1|||
160982512|NCT02491892|581324979|FG001|Overall Study|Lost to Follow-up|0|||
160982513|NCT00681187|581324983|FG000|Overall Study|Withdrawal by Subject|1|||
160982514|NCT00681187|581324984|FG001|Overall Study|Withdrawal by Subject|0|||
160982515|NCT00681187|581324983|FG000|Overall Study|Death|0|||
160642878|NCT04444752|580074400|FG001|Overall Study|Lack of Efficacy|0|||
160982516|NCT00681187|581324984|FG001|Overall Study|Death|1|||
160982517|NCT00681187|581324983|FG000|Overall Study|Adverse Event|0|||
160982518|NCT00681187|581324984|FG001|Overall Study|Adverse Event|1|||
160982519|NCT02448719|581324989|FG000|Overall Study|Withdrawal by Subject|0|||
160982520|NCT02448719|581324990|FG001|Overall Study|Withdrawal by Subject|0|||
160982521|NCT02448719|581324991|FG002|Overall Study|Withdrawal by Subject|0|||
160982522|NCT02448719|581324992|FG003|Overall Study|Withdrawal by Subject|0|||
160982523|NCT02448719|581324993|FG004|Overall Study|Withdrawal by Subject|1|||
160982524|NCT02448719|581324994|FG005|Overall Study|Withdrawal by Subject|0|||
160982525|NCT02448719|581324995|FG006|Overall Study|Withdrawal by Subject|0|||
160982526|NCT02448719|581324996|FG007|Overall Study|Withdrawal by Subject|0|||
160982527|NCT02448719|581324997|FG008|Overall Study|Withdrawal by Subject|0|||
160982528|NCT02448719|581324998|FG009|Overall Study|Withdrawal by Subject|0|||
160982529|NCT02448719|581324999|FG010|Overall Study|Withdrawal by Subject|0|||
160982530|NCT01406717|581325003|FG000|Overall Study|Subject non-compliance|4|||
160982531|NCT01406717|581325004|FG001|Overall Study|Subject non-compliance|3|||
160982532|NCT01406717|581325003|FG000|Overall Study|Protocol Violation|5|||
160982533|NCT01406717|581325004|FG001|Overall Study|Protocol Violation|1|||
160982534|NCT01406717|581325003|FG000|Overall Study|Lost to Follow-up|14|||
160982535|NCT01406717|581325004|FG001|Overall Study|Lost to Follow-up|8|||
160982536|NCT01406717|581325003|FG000|Overall Study|Withdrawal by Subject|19|||
160982537|NCT01406717|581325004|FG001|Overall Study|Withdrawal by Subject|15|||
160982538|NCT01406717|581325003|FG000|Overall Study|Adverse Event|1|||
160982539|NCT01406717|581325004|FG001|Overall Study|Adverse Event|2|||
160982540|NCT01406717|581325003|FG000|Overall Study|Lack of Efficacy|0|||
160982541|NCT01406717|581325004|FG001|Overall Study|Lack of Efficacy|1|||
160982542|NCT01406717|581325003|FG000|Overall Study|Non-completion of visit activity|0|||
160982543|NCT01406717|581325004|FG001|Overall Study|Non-completion of visit activity|1|||
160982544|NCT02275533|581325005|FG000|Overall Study|Protocol Violation|2|||
160982545|NCT02275533|581325006|FG001|Overall Study|Protocol Violation|0|||
160793045|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
160793046|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
160793047|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
160793048|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
160793049|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
160793050|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
160982546|NCT02275533|581325005|FG000|Overall Study|Never received study treatment|1|||
160982547|NCT02275533|581325006|FG001|Overall Study|Never received study treatment|0|||
160982548|NCT01570868|581325007|FG000|Overall Study|Adverse Event|8|||
160861886|NCT02531802|580887861|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
160982549|NCT01570868|581325008|FG001|Overall Study|Adverse Event|1|||
160982550|NCT01570868|581325007|FG000|Overall Study|FDA Recommendation|23|||
160982551|NCT01570868|581325008|FG001|Overall Study|FDA Recommendation|3|||
160982552|NCT01570868|581325007|FG000|Overall Study|Physician Decision|10|||
160982553|NCT01570868|581325008|FG001|Overall Study|Physician Decision|4|||
160982554|NCT01570868|581325007|FG000|Overall Study|Lost to Follow-up|1|||
160982555|NCT01570868|581325008|FG001|Overall Study|Lost to Follow-up|0|||
160861887|NCT02531802|580887862|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
160861888|NCT02531802|580887863|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
160861889|NCT02531802|580887864|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
160861890|NCT02531802|580887865|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
160861891|NCT00482053|580887866|FG000|Inter-treatment Period|Disease progression|1|||
160861892|NCT04842747|580887870|FG000|Overall Study|Withdrawal by Subject|6|||
160861893|NCT04842747|580887871|FG001|Overall Study|Withdrawal by Subject|2|||
160861894|NCT04842747|580887870|FG000|Overall Study|Lost to Follow-up|1|||
160861895|NCT04842747|580887871|FG001|Overall Study|Lost to Follow-up|2|||
160861896|NCT04842747|580887870|FG000|Overall Study|Physician Decision|1|||
160861897|NCT04842747|580887871|FG001|Overall Study|Physician Decision|0|||
160861898|NCT04842747|580887870|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
160861899|NCT04842747|580887871|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
160861900|NCT02559622|580887873|FG000|Overall Study|Progressive disease|0|||
160861901|NCT02559622|580887874|FG001|Overall Study|Progressive disease|1|||
160861902|NCT02559622|580887875|FG002|Overall Study|Progressive disease|0|||
160861903|NCT02559622|580887876|FG003|Overall Study|Progressive disease|0|||
160861904|NCT02559622|580887873|FG000|Overall Study|Adverse Event|0|||
160861905|NCT02559622|580887874|FG001|Overall Study|Adverse Event|2|||
160861906|NCT02559622|580887875|FG002|Overall Study|Adverse Event|2|||
160861907|NCT02559622|580887876|FG003|Overall Study|Adverse Event|2|||
160861908|NCT02559622|580887873|FG000|Overall Study|Patient/guardian decision|1|||
160861909|NCT02559622|580887874|FG001|Overall Study|Patient/guardian decision|2|||
160861910|NCT02559622|580887875|FG002|Overall Study|Patient/guardian decision|0|||
160861911|NCT02559622|580887876|FG003|Overall Study|Patient/guardian decision|1|||
160861912|NCT04011540|580887877|FG000|Overall Study|Lost to Follow-up|9|||
160861913|NCT04011540|580887878|FG001|Overall Study|Lost to Follow-up|6|||
160861914|NCT00449696|580887879|FG000|Overall Study|Other Treatment Required|6|||
160861915|NCT00449696|580887880|FG001|Overall Study|Other Treatment Required|1|||
160793051|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
160793052|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
160793053|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
160793054|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
160793055|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
160793056|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
160793057|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
160793058|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
160793059|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
160793060|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
160793061|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
160793062|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
160793063|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
160793064|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
160793065|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
160793066|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
160793067|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
160793068|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
160793069|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
160793070|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
160793071|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
160793072|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
160793073|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
160793074|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
160793075|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
160793076|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
160793077|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
160793078|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
160793079|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
160793080|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
160793081|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
160793082|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
160793083|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
160793084|NCT02251041|580629952|FG000|Overall Study|Did not receive intervention|15|||
160793085|NCT02251041|580629953|FG001|Overall Study|Did not receive intervention|4|||
160793086|NCT00050011|580629957|FG000|Overall Study|Adverse Event|41|||
160793087|NCT00050011|580629958|FG001|Overall Study|Adverse Event|46|||
160793088|NCT00050011|580629957|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160793089|NCT00050011|580629958|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160793090|NCT00050011|580629957|FG000|Overall Study|Abnormal test procedure results|0|||
160892769|NCT04382755|581002277|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
160892770|NCT04382755|581002276|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
160892771|NCT04382755|581002277|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
160892772|NCT04041700|581002284|FG000|Overall Study|Pregnancy|1|||
160892773|NCT04041700|581002284|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
160892774|NCT00458536|581002288|FG000|Overall Study|Disease progression prior to treatment|7|||
160892775|NCT00458536|581002288|FG000|Overall Study|Unable to make vaccine|3|||
160892776|NCT00458536|581002288|FG000|Overall Study|No measurable disease after surgery|2|||
160892777|NCT00458536|581002288|FG000|Overall Study|Did not have renal cell carcinoma|2|||
160892778|NCT00458536|581002288|FG000|Overall Study|Patient did not have surgery|1|||
160892779|NCT00458536|581002288|FG000|Overall Study|Ineligible due to toxicity|1|||
160892780|NCT00458536|581002288|FG000|Overall Study|Withdrawal by Subject|1|||
160892781|NCT00458536|581002288|FG000|Overall Study|Progressive disease during treatment|2|||
160892782|NCT00285207|581002289|FG000|Overall Study|Lost to Follow-up|3|||
160892783|NCT00285207|581002290|FG001|Overall Study|Lost to Follow-up|2|||
160892784|NCT00285207|581002289|FG000|Overall Study|Withdrawal by Subject|5|||
160892785|NCT00285207|581002290|FG001|Overall Study|Withdrawal by Subject|2|||
160892786|NCT00285207|581002289|FG000|Overall Study|Pregnancy|1|||
160892787|NCT00285207|581002290|FG001|Overall Study|Pregnancy|1|||
160892788|NCT00285207|581002289|FG000|Overall Study|non-compliance|0|||
160892789|NCT00285207|581002290|FG001|Overall Study|non-compliance|1|||
160892790|NCT05419908|581002291|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
160793091|NCT00050011|580629958|FG001|Overall Study|Abnormal test procedure results|1|||
160793092|NCT00050011|580629957|FG000|Overall Study|Lack of Efficacy|16|||
160793093|NCT00050011|580629958|FG001|Overall Study|Lack of Efficacy|21|||
160793094|NCT00050011|580629957|FG000|Overall Study|Participant condition no longer required|1|||
160793095|NCT00050011|580629958|FG001|Overall Study|Participant condition no longer required|0|||
160793096|NCT00050011|580629957|FG000|Overall Study|Protocol Violation|4|||
160892791|NCT05419908|581002292|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
160892792|NCT05419908|581002291|FG000|Overall Study|Serious Adverse Event|0|||
160892793|NCT05419908|581002292|FG001|Overall Study|Serious Adverse Event|2|||
160892794|NCT05419908|581002291|FG000|Overall Study|Withdrawal by Subject|2|||
160892795|NCT05419908|581002292|FG001|Overall Study|Withdrawal by Subject|0|||
160892796|NCT05419908|581002291|FG000|Overall Study|Miscellaneous|1|||
160892797|NCT05419908|581002292|FG001|Overall Study|Miscellaneous|1|||
160892798|NCT03670836|581002293|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
160892799|NCT03670836|581002294|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
160892800|NCT03670836|581002293|FG000|Per Protocol Population (PP)|Physician Decision|9|||
160892801|NCT03670836|581002294|FG001|Per Protocol Population (PP)|Physician Decision|10|||
160892802|NCT03670836|581002293|FG000|Per Protocol Population (PP)|Physician Decision|4|||
160892803|NCT03670836|581002294|FG001|Per Protocol Population (PP)|Physician Decision|6|||
160892804|NCT03670836|581002293|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
160892805|NCT03670836|581002294|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
160892806|NCT00215683|581003726|FG000|Overall Study|Adverse Event|15|||
160892807|NCT00215683|581003727|FG001|Overall Study|Adverse Event|16|||
160892808|NCT00215683|581003728|FG002|Overall Study|Adverse Event|15|||
160892809|NCT00215683|581003726|FG000|Overall Study|Lack of Efficacy|5|||
160892810|NCT00215683|581003727|FG001|Overall Study|Lack of Efficacy|1|||
160892811|NCT00215683|581003728|FG002|Overall Study|Lack of Efficacy|2|||
160892812|NCT00215683|581003726|FG000|Overall Study|Lost to Follow-up|0|||
160892813|NCT00215683|581003727|FG001|Overall Study|Lost to Follow-up|2|||
160892814|NCT00215683|581003728|FG002|Overall Study|Lost to Follow-up|1|||
160892815|NCT00215683|581003726|FG000|Overall Study|Withdrawal by Subject|9|||
160892816|NCT00215683|581003727|FG001|Overall Study|Withdrawal by Subject|4|||
160892817|NCT00215683|581003728|FG002|Overall Study|Withdrawal by Subject|13|||
160892818|NCT00215683|581003726|FG000|Overall Study|Physician Decision|0|||
160892819|NCT00215683|581003727|FG001|Overall Study|Physician Decision|0|||
160892820|NCT00215683|581003728|FG002|Overall Study|Physician Decision|1|||
160892821|NCT00215683|581003726|FG000|Overall Study|Difficult to attend visits|0|||
160892822|NCT00215683|581003727|FG001|Overall Study|Difficult to attend visits|1|||
160892823|NCT00215683|581003728|FG002|Overall Study|Difficult to attend visits|0|||
160892824|NCT00215683|581003726|FG000|Overall Study|No study drug available|0|||
160892825|NCT00215683|581003727|FG001|Overall Study|No study drug available|1|||
160892826|NCT00215683|581003728|FG002|Overall Study|No study drug available|0|||
160892827|NCT00215683|581003726|FG000|Overall Study|Intermittent therapy required|0|||
160892828|NCT00215683|581003727|FG001|Overall Study|Intermittent therapy required|1|||
160892829|NCT00215683|581003728|FG002|Overall Study|Intermittent therapy required|0|||
160892830|NCT02171065|581003729|FG000|Overall Study|Withdrawal by Subject|1|||
160892831|NCT02171065|581003730|FG001|Overall Study|Withdrawal by Subject|0|||
160892832|NCT02171065|581003731|FG002|Overall Study|Withdrawal by Subject|0|||
160892833|NCT02171065|581003729|FG000|Overall Study|Lost to Follow-up|0|||
160892834|NCT02171065|581003730|FG001|Overall Study|Lost to Follow-up|0|||
160892835|NCT02171065|581003731|FG002|Overall Study|Lost to Follow-up|1|||
160892836|NCT00084838|581003733|FG000|Overall Study|Death|1|||
160892837|NCT00084838|581003733|FG000|Overall Study|Adverse Event|2|||
160892838|NCT00084838|581003733|FG000|Overall Study|Withdrawal by Subject|1|||
160892839|NCT00084838|581003733|FG000|Overall Study|Progressive Disease|4|||
160892840|NCT00084838|581003733|FG000|Overall Study|Pt Non-Compliance|1|||
160892841|NCT00084838|581003733|FG000|Overall Study|Ineligible|4|||
160892842|NCT00518687|581003734|FG000|Overall Study|Adverse Event|201|||
160892843|NCT00518687|581003735|FG001|Overall Study|Adverse Event|177|||
160892844|NCT00518687|581003734|FG000|Overall Study|Lost to Follow-up|144|||
160892845|NCT00518687|581003735|FG001|Overall Study|Lost to Follow-up|155|||
160892846|NCT00518687|581003734|FG000|Overall Study|Physician Decision|42|||
160892847|NCT00518687|581003735|FG001|Overall Study|Physician Decision|48|||
160892848|NCT00518687|581003734|FG000|Overall Study|Progressive disease|2|||
160892849|NCT00518687|581003735|FG001|Overall Study|Progressive disease|2|||
160892850|NCT00518687|581003734|FG000|Overall Study|Protocol Violation|8|||
160892851|NCT00518687|581003735|FG001|Overall Study|Protocol Violation|10|||
160892852|NCT00518687|581003734|FG000|Overall Study|Study terminated by sponsor|930|||
160892853|NCT00518687|581003735|FG001|Overall Study|Study terminated by sponsor|918|||
160892854|NCT00518687|581003734|FG000|Overall Study|Withdrawal by Subject|110|||
160892855|NCT00518687|581003735|FG001|Overall Study|Withdrawal by Subject|110|||
160892856|NCT00851630|581003736|FG000|Overall Study|Death|2|||
160892857|NCT00851630|581003737|FG001|Overall Study|Death|1|||
160892858|NCT00851630|581003736|FG000|Overall Study|Clinical failure|0|||
160892859|NCT00851630|581003737|FG001|Overall Study|Clinical failure|1|||
160892860|NCT01442038|581003740|FG000|Overall Study|Death|35|||
160892861|NCT01442038|581003741|FG001|Overall Study|Death|29|||
160892862|NCT01442038|581003740|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
160642879|NCT04444752|580074401|FG002|Overall Study|Lack of Efficacy|0|||
160892863|NCT01442038|581003741|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
160892864|NCT01442038|581003740|FG000|Overall Study|Participant Withdrew Consent|137|||
160892865|NCT01442038|581003741|FG001|Overall Study|Participant Withdrew Consent|102|||
160892866|NCT01442038|581003740|FG000|Overall Study|Lost to Follow-up|37|||
160892867|NCT01442038|581003741|FG001|Overall Study|Lost to Follow-up|51|||
160892868|NCT01442038|581003740|FG000|Overall Study|Adverse Event|26|||
160892869|NCT01442038|581003741|FG001|Overall Study|Adverse Event|15|||
160892870|NCT01442038|581003740|FG000|Overall Study|Protocol Deviation|9|||
160892871|NCT01442038|581003741|FG001|Overall Study|Protocol Deviation|20|||
160892872|NCT01442038|581003740|FG000|Overall Study|Investigator's Discretion|13|||
160892873|NCT01442038|581003741|FG001|Overall Study|Investigator's Discretion|16|||
160892874|NCT01442038|581003740|FG000|Overall Study|Study Terminated By Sponsor|2|||
160892875|NCT01442038|581003741|FG001|Overall Study|Study Terminated By Sponsor|3|||
160892876|NCT00089284|581003742|FG000|Overall Study|Adverse event before starting treatment|0|||
160892877|NCT00089284|581003743|FG001|Overall Study|Adverse event before starting treatment|0|||
160892878|NCT00089284|581003744|FG002|Overall Study|Adverse event before starting treatment|0|||
160892879|NCT00089284|581003745|FG003|Overall Study|Adverse event before starting treatment|0|||
160892880|NCT00089284|581003746|FG004|Overall Study|Adverse event before starting treatment|0|||
160892881|NCT00089284|581003747|FG005|Overall Study|Adverse event before starting treatment|0|||
160892882|NCT00089284|581003748|FG006|Overall Study|Adverse event before starting treatment|1|||
160892883|NCT03956056|581003749|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
160892884|NCT03956056|581003749|FG000|Overall Study|Lack of Efficacy|1|||
160892885|NCT00595465|581003750|FG000|Overall Study|Adverse Event|4|||
160892886|NCT00595465|581003751|FG001|Overall Study|Adverse Event|3|||
160892887|NCT00595465|581003752|FG002|Overall Study|Adverse Event|3|||
160892888|NCT00595465|581003750|FG000|Overall Study|Pregnancy|0|||
160892889|NCT00595465|581003751|FG001|Overall Study|Pregnancy|0|||
160892890|NCT00595465|581003752|FG002|Overall Study|Pregnancy|1|||
160892891|NCT00595465|581003750|FG000|Overall Study|Protocol Violation|2|||
160892892|NCT00595465|581003751|FG001|Overall Study|Protocol Violation|1|||
160892893|NCT00595465|581003752|FG002|Overall Study|Protocol Violation|0|||
160892894|NCT00595465|581003750|FG000|Overall Study|Lost to Follow-up|0|||
160892895|NCT00595465|581003751|FG001|Overall Study|Lost to Follow-up|0|||
160892896|NCT00595465|581003752|FG002|Overall Study|Lost to Follow-up|2|||
160892897|NCT00595465|581003750|FG000|Overall Study|administrative reason|0|||
160892898|NCT00595465|581003751|FG001|Overall Study|administrative reason|0|||
160892899|NCT00595465|581003752|FG002|Overall Study|administrative reason|1|||
160892900|NCT00107783|581003753|FG000|Overall Study|Adverse Event|0|||
160892901|NCT00107783|581003754|FG001|Overall Study|Adverse Event|2|||
160892902|NCT00107783|581003753|FG000|Overall Study|Death|0|||
160892903|NCT00107783|581003754|FG001|Overall Study|Death|1|||
160892904|NCT00107783|581003753|FG000|Overall Study|Withdrawal by Subject|2|||
160892905|NCT00107783|581003754|FG001|Overall Study|Withdrawal by Subject|0|||
160892906|NCT00107783|581003753|FG000|Overall Study|Second hip replacement|1|||
160892907|NCT00107783|581003754|FG001|Overall Study|Second hip replacement|1|||
160892908|NCT01298531|581003755|FG000|Overall Study|Lack of Efficacy|0|||
160892909|NCT01298531|581003756|FG001|Overall Study|Lack of Efficacy|1|||
160642880|NCT04444752|580074402|FG003|Overall Study|Lack of Efficacy|1|||
160892910|NCT01298531|581003755|FG000|Overall Study|Lost to Follow-up|2|||
160892911|NCT01298531|581003756|FG001|Overall Study|Lost to Follow-up|0|||
160892912|NCT01298531|581003755|FG000|Overall Study|Protocol Violation|1|||
160892913|NCT01298531|581003756|FG001|Overall Study|Protocol Violation|1|||
160892914|NCT01298531|581003755|FG000|Overall Study|Adverse Event|4|||
160892915|NCT01298531|581003756|FG001|Overall Study|Adverse Event|3|||
160642881|NCT04444752|580074399|FG000|Overall Study|Death|0|||
160642882|NCT04444752|580074400|FG001|Overall Study|Death|0|||
160892916|NCT01298531|581003755|FG000|Overall Study|Does not meet entrance criteria|0|||
160892917|NCT01298531|581003756|FG001|Overall Study|Does not meet entrance criteria|1|||
160892918|NCT01298531|581003755|FG000|Overall Study|Other|2|||
160892919|NCT01298531|581003756|FG001|Overall Study|Other|1|||
160892920|NCT00422097|581003757|FG000|Dose Level 2|Still on treatment|0|||
160892921|NCT00422097|581003758|FG001|Dose Level 2|Still on treatment|1|||
160892922|NCT00422097|581003759|FG002|Dose Level 2|Still on treatment|0|||
160892923|NCT00422097|581003760|FG003|Dose Level 2|Still on treatment|0|||
160892924|NCT00422097|581003761|FG004|Dose Level 2|Still on treatment|0|||
160793097|NCT00050011|580629958|FG001|Overall Study|Protocol Violation|10|||
160793098|NCT00050011|580629957|FG000|Overall Study|Withdrawal by Subject|34|||
160793099|NCT00050011|580629958|FG001|Overall Study|Withdrawal by Subject|26|||
160793100|NCT00050011|580629957|FG000|Overall Study|Lost to Follow-up|7|||
160793101|NCT00050011|580629958|FG001|Overall Study|Lost to Follow-up|9|||
160793102|NCT00050011|580629957|FG000|Overall Study|Administrative problems|10|||
160793103|NCT00050011|580629958|FG001|Overall Study|Administrative problems|6|||
160793104|NCT00050011|580629957|FG000|Overall Study|Death|7|||
160793105|NCT00050011|580629958|FG001|Overall Study|Death|4|||
160793106|NCT00050011|580629957|FG000|Overall Study|Unknown - Reason is missing|0|||
160793107|NCT00050011|580629958|FG001|Overall Study|Unknown - Reason is missing|2|||
160793108|NCT03312543|580629959|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
160793109|NCT03312543|580629960|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
160793110|NCT03312543|580629959|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
160793111|NCT03312543|580629960|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
160793112|NCT03312543|580629959|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
160793113|NCT03312543|580629960|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
160982556|NCT01570868|581325007|FG000|Overall Study|Withdrawal by Subject|1|||
160982557|NCT01570868|581325008|FG001|Overall Study|Withdrawal by Subject|0|||
160982558|NCT01556763|581325012|FG000|Overall Study|Withdrawal by Subject|0|||
160642883|NCT04444752|580074401|FG002|Overall Study|Death|1|||
160793114|NCT03312543|580629959|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
160793115|NCT03312543|580629960|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
160793116|NCT03312543|580629959|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
160793117|NCT03312543|580629960|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
160793118|NCT03312543|580629959|FG000|Regression (Week 12 to Week 24)|Death|0|||
160793119|NCT03312543|580629960|FG001|Regression (Week 12 to Week 24)|Death|1|||
160793120|NCT04507269|580629961|FG000|Overall Study|Withdrawal by Subject|1|||
160793121|NCT04507269|580629962|FG001|Overall Study|Withdrawal by Subject|1|||
160793122|NCT04507269|580629963|FG002|Overall Study|Withdrawal by Subject|0|||
160793123|NCT04507269|580629964|FG003|Overall Study|Withdrawal by Subject|0|||
160793124|NCT04507269|580629965|FG004|Overall Study|Withdrawal by Subject|0|||
160793125|NCT04507269|580629966|FG005|Overall Study|Withdrawal by Subject|0|||
160793126|NCT04507269|580629961|FG000|Overall Study|Lost to Follow-up|0|||
160793127|NCT04507269|580629962|FG001|Overall Study|Lost to Follow-up|0|||
160793128|NCT04507269|580629963|FG002|Overall Study|Lost to Follow-up|0|||
160793129|NCT04507269|580629964|FG003|Overall Study|Lost to Follow-up|0|||
160793130|NCT04507269|580629965|FG004|Overall Study|Lost to Follow-up|1|||
160793131|NCT04507269|580629966|FG005|Overall Study|Lost to Follow-up|0|||
160793132|NCT04197583|580629967|FG000|Overall Study|Study Stent Replacement|34|||
160793133|NCT04197583|580629968|FG001|Overall Study|Study Stent Replacement|8|||
160793134|NCT04197583|580629967|FG000|Overall Study|Lost to Follow-up|14|||
160793135|NCT04197583|580629968|FG001|Overall Study|Lost to Follow-up|3|||
160793136|NCT04197583|580629967|FG000|Overall Study|Death|3|||
160793137|NCT04197583|580629968|FG001|Overall Study|Death|0|||
160793138|NCT04197583|580629967|FG000|Overall Study|Physician Decision|1|||
160793139|NCT04197583|580629968|FG001|Overall Study|Physician Decision|0|||
160793140|NCT04197583|580629967|FG000|Overall Study|Withdrawal by Subject|1|||
160793141|NCT04197583|580629968|FG001|Overall Study|Withdrawal by Subject|1|||
160793142|NCT04197583|580629967|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
160793143|NCT04197583|580629968|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
160793144|NCT04197583|580629967|FG000|Overall Study|Screen Failure|0|||
160793145|NCT04197583|580629968|FG001|Overall Study|Screen Failure|20|||
160793146|NCT04134936|580629969|FG000|Overall Study|Adverse Event|3|||
160793147|NCT04134936|580629970|FG001|Overall Study|Adverse Event|2|||
160793148|NCT04134936|580629969|FG000|Overall Study|Withdrawal by Subject|2|||
160793149|NCT04134936|580629970|FG001|Overall Study|Withdrawal by Subject|3|||
160793150|NCT04134936|580629969|FG000|Overall Study|Physician Decision|0|||
160793151|NCT04134936|580629970|FG001|Overall Study|Physician Decision|1|||
160793152|NCT04134936|580629969|FG000|Overall Study|Progressive disease, joined another trial|1|||
160793153|NCT04134936|580629970|FG001|Overall Study|Progressive disease, joined another trial|0|||
160793154|NCT04134936|580629969|FG000|Overall Study|Progressive disease|1|||
160793155|NCT04134936|580629970|FG001|Overall Study|Progressive disease|0|||
160793156|NCT04629196|580629971|FG000|Overall Study|Subject discontinued study drug|1|||
160793157|NCT04629196|580629972|FG001|Overall Study|Subject discontinued study drug|0|||
160793158|NCT04629196|580629971|FG000|Overall Study|Subject study drug dosing increased|1|||
160793159|NCT04629196|580629972|FG001|Overall Study|Subject study drug dosing increased|1|||
160793160|NCT04629196|580629971|FG000|Overall Study|Withdrawal by Subject|1|||
160793161|NCT04629196|580629972|FG001|Overall Study|Withdrawal by Subject|2|||
160793162|NCT02061085|580629978|FG000|Overall Study|Adverse Event|8|||
160793163|NCT05487378|580629985|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
160793164|NCT05487378|580629986|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
160793165|NCT05487378|580629985|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
160793166|NCT05487378|580629986|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
160793167|NCT02414841|580629988|FG000|Overall Study|Withdrawal by Subject|7|||
160793168|NCT02414841|580629989|FG001|Overall Study|Withdrawal by Subject|5|||
160793169|NCT02414841|580629988|FG000|Overall Study|Lost to Follow-up|13|||
160793170|NCT02414841|580629989|FG001|Overall Study|Lost to Follow-up|6|||
160793171|NCT02414841|580629988|FG000|Overall Study|Death|17|||
160793172|NCT02414841|580629989|FG001|Overall Study|Death|14|||
160793173|NCT02414841|580629988|FG000|Overall Study|Received a Kidney Transplant|13|||
160793174|NCT02414841|580629989|FG001|Overall Study|Received a Kidney Transplant|4|||
160793175|NCT02414841|580629988|FG000|Overall Study|Randomized But Not Treated|6|||
160793176|NCT02414841|580629989|FG001|Overall Study|Randomized But Not Treated|4|||
160793177|NCT00112385|580629990|FG000|Overall Study|Lost to Follow-up|1|||
160793178|NCT00112385|580629991|FG001|Overall Study|Lost to Follow-up|0|||
160892925|NCT00422097|581003762|FG005|Dose Level 2|Still on treatment|0|||
160793179|NCT00112385|580629990|FG000|Overall Study|Withdrawal by Subject|0|||
160793180|NCT00112385|580629991|FG001|Overall Study|Withdrawal by Subject|1|||
160793181|NCT02613507|580629997|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
160793182|NCT02613507|580629998|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
160793183|NCT02613507|580629997|FG000|Pre-Treamtent|Participant withdrew consent|0|||
160793184|NCT02613507|580629998|FG001|Pre-Treamtent|Participant withdrew consent|4|||
160793185|NCT02613507|580629997|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
160793186|NCT02613507|580629998|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
160793187|NCT02613507|580629997|FG000|Treatment|Not reported|3|||
160793188|NCT02613507|580629998|FG001|Treatment|Not reported|0|||
160793189|NCT02613507|580629997|FG000|Treatment|Other reasons|8|||
160793190|NCT02613507|580629998|FG001|Treatment|Other reasons|0|||
160793191|NCT02613507|580629997|FG000|Treatment|Participant no longer meets criteria|3|||
160793192|NCT02613507|580629998|FG001|Treatment|Participant no longer meets criteria|0|||
160793193|NCT02613507|580629997|FG000|Treatment|Maximum clinical benefit|5|||
160793194|NCT02613507|580629998|FG001|Treatment|Maximum clinical benefit|10|||
160793195|NCT02613507|580629997|FG000|Treatment|Lost to Follow-up|1|||
160793196|NCT02613507|580629998|FG001|Treatment|Lost to Follow-up|0|||
160793197|NCT02613507|580629997|FG000|Treatment|Participant withdrew consent|0|||
160793198|NCT02613507|580629998|FG001|Treatment|Participant withdrew consent|2|||
160793199|NCT02613507|580629997|FG000|Treatment|Participant request to discontinue study treatment|13|||
160793200|NCT02613507|580629998|FG001|Treatment|Participant request to discontinue study treatment|17|||
160793201|NCT02613507|580629997|FG000|Treatment|Adverse event unrelated to study drug|20|||
160793202|NCT02613507|580629998|FG001|Treatment|Adverse event unrelated to study drug|3|||
160793203|NCT02613507|580629997|FG000|Treatment|Death|2|||
160793204|NCT02613507|580629998|FG001|Treatment|Death|0|||
160793205|NCT02613507|580629997|FG000|Treatment|Study drug toxicity|19|||
160793206|NCT02613507|580629998|FG001|Treatment|Study drug toxicity|14|||
160793207|NCT02613507|580629997|FG000|Treatment|Disease progression|263|||
160793208|NCT02613507|580629998|FG001|Treatment|Disease progression|110|||
160793209|NCT02471144|580631620|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
160793210|NCT02471144|580631621|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
160793211|NCT02471144|580631622|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
160793212|NCT02471144|580631623|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
160793213|NCT02471144|580631624|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
160793214|NCT02471144|580631625|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
160793215|NCT02471144|580631626|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
160793216|NCT02471144|580631627|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
160793217|NCT02471144|580631628|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
160793218|NCT02471144|580631629|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
160793219|NCT02471144|580631630|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
160793220|NCT02471144|580631620|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793221|NCT02471144|580631621|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793222|NCT02471144|580631622|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793223|NCT02471144|580631623|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
160793224|NCT02471144|580631624|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793225|NCT02471144|580631625|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793226|NCT02471144|580631626|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793227|NCT02471144|580631627|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793228|NCT02471144|580631628|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793229|NCT02471144|580631629|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793230|NCT02471144|580631630|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793231|NCT02471144|580631620|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160892926|NCT00422097|581003763|FG006|Dose Level 2|Still on treatment|0|||
160892927|NCT00422097|581003764|FG007|Dose Level 2|Still on treatment|0|||
160892928|NCT02360995|581003765|FG000|Overall Study|Lost to Follow-up|2|||
160892929|NCT02360995|581003766|FG001|Overall Study|Lost to Follow-up|0|||
160892930|NCT02360995|581003767|FG002|Overall Study|Lost to Follow-up|2|||
160892931|NCT02360995|581003765|FG000|Overall Study|Withdrawal by Subject|0|||
160892932|NCT02360995|581003766|FG001|Overall Study|Withdrawal by Subject|1|||
160892933|NCT02360995|581003767|FG002|Overall Study|Withdrawal by Subject|0|||
160892934|NCT02231918|581003768|FG000|Overall Study|Withdrawal by Subject|0|||
160892935|NCT02231918|581003769|FG001|Overall Study|Withdrawal by Subject|1|||
160892936|NCT02231918|581003770|FG002|Overall Study|Withdrawal by Subject|0|||
160892937|NCT02231918|581003768|FG000|Overall Study|Adverse Event|0|||
160892938|NCT02231918|581003769|FG001|Overall Study|Adverse Event|0|||
160892939|NCT02231918|581003770|FG002|Overall Study|Adverse Event|1|||
160892940|NCT01092507|581003771|FG000|Overall Study|Withdrawal by Subject|2|||
160892941|NCT01092507|581003772|FG001|Overall Study|Withdrawal by Subject|0|||
160892942|NCT00085709|581003773|FG000|Overall Study|Adverse Event|8|||
160892943|NCT00085709|581003774|FG001|Overall Study|Adverse Event|0|||
160892944|NCT00085709|581003773|FG000|Overall Study|Death|8|||
160892945|NCT00085709|581003774|FG001|Overall Study|Death|2|||
160793232|NCT02471144|580631621|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793233|NCT02471144|580631622|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
160793234|NCT02471144|580631623|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160892946|NCT00085709|581003773|FG000|Overall Study|Refusal unrelated to adverse events|1|||
160892947|NCT00085709|581003774|FG001|Overall Study|Refusal unrelated to adverse events|2|||
160892948|NCT00085709|581003773|FG000|Overall Study|Progression|3|||
160892949|NCT00085709|581003774|FG001|Overall Study|Progression|4|||
160548446|NCT02508194|579734135|FG000|Overall Study|Principal Investigator Decision|1|||
160548447|NCT02508194|579734136|FG001|Overall Study|Principal Investigator Decision|2|||
160548448|NCT00511355|579734137|FG000|Overall Study|Adverse Event|4|||
160548449|NCT00511355|579734138|FG001|Overall Study|Adverse Event|4|||
160548450|NCT00511355|579734137|FG000|Overall Study|Pregnancy Wish|1|||
160892950|NCT00085709|581003773|FG000|Overall Study|Not protocol specified|12|||
160892951|NCT00085709|581003774|FG001|Overall Study|Not protocol specified|22|||
160793235|NCT02471144|580631624|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793236|NCT02471144|580631625|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793237|NCT02471144|580631626|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793238|NCT02471144|580631627|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793239|NCT02471144|580631628|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793240|NCT02471144|580631629|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793241|NCT02471144|580631630|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793242|NCT02471144|580631620|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
160793243|NCT02471144|580631621|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
160793244|NCT02471144|580631622|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793245|NCT02471144|580631623|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793246|NCT02471144|580631624|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793247|NCT02471144|580631625|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793248|NCT02471144|580631626|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160892952|NCT00085709|581003773|FG000|Overall Study|Not eligible|19|||
160892953|NCT00085709|581003774|FG001|Overall Study|Not eligible|19|||
160892954|NCT00085709|581003773|FG000|Overall Study|Withdrawal by Subject|2|||
160892955|NCT00085709|581003774|FG001|Overall Study|Withdrawal by Subject|1|||
160892956|NCT04131556|581003775|FG000|Overall Study|Adverse Event|1|||
160793249|NCT02471144|580631627|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160892957|NCT04131556|581003775|FG000|Overall Study|Withdrawal by Subject|1|||
160892958|NCT04622735|581003778|FG000|Overall Study|Lost to Follow-up|1|||
160892959|NCT04622735|581003779|FG001|Overall Study|Lost to Follow-up|2|||
160892960|NCT04622735|581003780|FG002|Overall Study|Lost to Follow-up|1|||
160892961|NCT04622735|581003778|FG000|Overall Study|Adverse Event|0|||
160892962|NCT04622735|581003779|FG001|Overall Study|Adverse Event|0|||
160892963|NCT04622735|581003780|FG002|Overall Study|Adverse Event|1|||
160892964|NCT04622735|581003778|FG000|Overall Study|Protocol Violation|1|||
160892965|NCT04622735|581003779|FG001|Overall Study|Protocol Violation|0|||
160892966|NCT04622735|581003780|FG002|Overall Study|Protocol Violation|0|||
160892967|NCT04629508|581003782|FG000|Overall Study|Adverse Event|1|||
160892968|NCT04629508|581003782|FG000|Overall Study|Death|2|||
160892969|NCT04629508|581003782|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
160892970|NCT04073368|581003787|FG000|Overall Study|Adverse Event|2|||
160892971|NCT04073368|581003788|FG001|Overall Study|Adverse Event|0|||
160892972|NCT04073368|581003789|FG002|Overall Study|Adverse Event|1|||
160892973|NCT04073368|581003790|FG003|Overall Study|Adverse Event|1|||
160892974|NCT04073368|581003787|FG000|Overall Study|Withdrawal by Subject|2|||
160892975|NCT04073368|581003788|FG001|Overall Study|Withdrawal by Subject|2|||
160892976|NCT04073368|581003789|FG002|Overall Study|Withdrawal by Subject|1|||
160892977|NCT04073368|581003790|FG003|Overall Study|Withdrawal by Subject|1|||
160892978|NCT04073368|581003787|FG000|Overall Study|Lost to Follow-up|1|||
160892979|NCT04073368|581003788|FG001|Overall Study|Lost to Follow-up|1|||
160892980|NCT04073368|581003789|FG002|Overall Study|Lost to Follow-up|1|||
160892981|NCT04073368|581003790|FG003|Overall Study|Lost to Follow-up|0|||
160892982|NCT04073368|581003787|FG000|Overall Study|Protocol Violation|0|||
160892983|NCT04073368|581003788|FG001|Overall Study|Protocol Violation|1|||
160892984|NCT04073368|581003789|FG002|Overall Study|Protocol Violation|0|||
160892985|NCT04073368|581003790|FG003|Overall Study|Protocol Violation|0|||
160892986|NCT04073368|581003787|FG000|Overall Study|Subject noncompliance|7|||
160892987|NCT04073368|581003788|FG001|Overall Study|Subject noncompliance|4|||
160892988|NCT04073368|581003789|FG002|Overall Study|Subject noncompliance|0|||
160892989|NCT04073368|581003790|FG003|Overall Study|Subject noncompliance|0|||
160892990|NCT03026088|581003791|FG000|Overall Study|Study termination|20|||
160892991|NCT06400979|581003798|FG000|Overall Study|Lost to Follow-up|29|||
160892992|NCT06400979|581003798|FG000|Overall Study|Withdrawal by Subject|1|||
160892993|NCT01028378|581003802|FG000|Overall Study|Lost to Follow-up|12|||
160892994|NCT01028378|581003802|FG000|Overall Study|Withdrawal by Subject|1|||
160892995|NCT01028378|581003802|FG000|Overall Study|Adminstrative Reasons|4|||
160892996|NCT00450385|581003803|FG000|Overall Study|Death|3|||
160892997|NCT00450385|581003803|FG000|Overall Study|Protocol Violation|1|||
160892998|NCT00450385|581003803|FG000|Overall Study|Withdrawal by Subject|2|||
160892999|NCT00450385|581003803|FG000|Overall Study|Lack of Efficacy|2|||
160893000|NCT00450385|581003803|FG000|Overall Study|Adverse Event|1|||
160893001|NCT00450385|581003803|FG000|Overall Study|Physician Decision|1|||
160893002|NCT00450385|581003803|FG000|Overall Study|Other|3|||
160893003|NCT03091777|581003806|FG000|Overall Study|Pregnancy|2|||
160548451|NCT00511355|579734138|FG001|Overall Study|Pregnancy Wish|0|||
160893004|NCT03091777|581003807|FG001|Overall Study|Pregnancy|1|||
160893005|NCT03091777|581003808|FG002|Overall Study|Pregnancy|0|||
160893006|NCT03091777|581003806|FG000|Overall Study|Adverse Event|2|||
160893007|NCT03091777|581003807|FG001|Overall Study|Adverse Event|1|||
160893008|NCT03091777|581003808|FG002|Overall Study|Adverse Event|4|||
160893009|NCT03091777|581003806|FG000|Overall Study|Withdrawal by Subject|4|||
160893010|NCT03091777|581003807|FG001|Overall Study|Withdrawal by Subject|2|||
160893011|NCT03091777|581003808|FG002|Overall Study|Withdrawal by Subject|6|||
160793250|NCT02471144|580631628|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793251|NCT02471144|580631629|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793252|NCT02471144|580631630|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793253|NCT02471144|580631620|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793254|NCT02471144|580631621|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793255|NCT02471144|580631622|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793256|NCT02471144|580631623|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793257|NCT02471144|580631624|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
160793258|NCT02471144|580631625|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793259|NCT02471144|580631626|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
160793260|NCT02471144|580631627|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793261|NCT02471144|580631628|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
160793262|NCT02471144|580631629|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793263|NCT02471144|580631630|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793264|NCT02471144|580631620|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793265|NCT02471144|580631621|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793266|NCT02471144|580631622|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793267|NCT02471144|580631623|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793268|NCT02471144|580631624|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793269|NCT02471144|580631625|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
160793270|NCT02471144|580631626|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793271|NCT02471144|580631627|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793272|NCT02471144|580631628|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
160793273|NCT02471144|580631629|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793274|NCT02471144|580631630|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793275|NCT02471144|580631620|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793276|NCT02471144|580631621|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793277|NCT02471144|580631622|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160548452|NCT00511355|579734137|FG000|Overall Study|Lost to Follow-up|2|||
160893012|NCT03091777|581003806|FG000|Overall Study|Protocol Violation|2|||
160893013|NCT03091777|581003807|FG001|Overall Study|Protocol Violation|1|||
160893014|NCT03091777|581003808|FG002|Overall Study|Protocol Violation|1|||
160893015|NCT03091777|581003806|FG000|Overall Study|Lost to Follow-up|12|||
160893016|NCT03091777|581003807|FG001|Overall Study|Lost to Follow-up|14|||
160893017|NCT03091777|581003808|FG002|Overall Study|Lost to Follow-up|7|||
160893018|NCT03091777|581003806|FG000|Overall Study|Lack of Efficacy|0|||
160893019|NCT03091777|581003807|FG001|Overall Study|Lack of Efficacy|0|||
160893020|NCT03091777|581003808|FG002|Overall Study|Lack of Efficacy|5|||
160893021|NCT03091777|581003806|FG000|Overall Study|Noncompliance with study drug|2|||
160893022|NCT03091777|581003807|FG001|Overall Study|Noncompliance with study drug|3|||
160893023|NCT03091777|581003808|FG002|Overall Study|Noncompliance with study drug|1|||
160893024|NCT03091777|581003806|FG000|Overall Study|Physician Decision|1|||
160893025|NCT03091777|581003807|FG001|Overall Study|Physician Decision|0|||
160893026|NCT03091777|581003808|FG002|Overall Study|Physician Decision|1|||
160893027|NCT03091777|581003806|FG000|Overall Study|Abnormal Laboratory Value|7|||
160893028|NCT03091777|581003807|FG001|Overall Study|Abnormal Laboratory Value|11|||
160893029|NCT03091777|581003808|FG002|Overall Study|Abnormal Laboratory Value|12|||
160893030|NCT02536833|581003809|FG000|Overall Study|Discontinued Before Treatment|0|||
160893031|NCT02536833|581003810|FG001|Overall Study|Discontinued Before Treatment|0|||
160893032|NCT02536833|581003811|FG002|Overall Study|Discontinued Before Treatment|1|||
160893033|NCT02536833|581003812|FG003|Overall Study|Discontinued Before Treatment|2|||
160893034|NCT02536833|581003809|FG000|Overall Study|Adverse Event|1|||
160893035|NCT02536833|581003810|FG001|Overall Study|Adverse Event|3|||
160893036|NCT02536833|581003811|FG002|Overall Study|Adverse Event|4|||
160893037|NCT02536833|581003812|FG003|Overall Study|Adverse Event|1|||
160893038|NCT02536833|581003809|FG000|Overall Study|Lost to Follow-up|2|||
160893039|NCT02536833|581003810|FG001|Overall Study|Lost to Follow-up|1|||
160893040|NCT02536833|581003811|FG002|Overall Study|Lost to Follow-up|2|||
160893041|NCT02536833|581003812|FG003|Overall Study|Lost to Follow-up|2|||
160893042|NCT02536833|581003809|FG000|Overall Study|Physician Decision|0|||
160893043|NCT02536833|581003810|FG001|Overall Study|Physician Decision|0|||
160893044|NCT02536833|581003811|FG002|Overall Study|Physician Decision|0|||
160893045|NCT02536833|581003812|FG003|Overall Study|Physician Decision|1|||
160893046|NCT02536833|581003809|FG000|Overall Study|Site Terminated by Sponsor|2|||
160893047|NCT02536833|581003810|FG001|Overall Study|Site Terminated by Sponsor|2|||
160893048|NCT02536833|581003811|FG002|Overall Study|Site Terminated by Sponsor|2|||
160893049|NCT02536833|581003812|FG003|Overall Study|Site Terminated by Sponsor|2|||
160893050|NCT02536833|581003809|FG000|Overall Study|Subject Non-Compliance|0|||
160893051|NCT02536833|581003810|FG001|Overall Study|Subject Non-Compliance|1|||
160893052|NCT02536833|581003811|FG002|Overall Study|Subject Non-Compliance|1|||
160893053|NCT02536833|581003812|FG003|Overall Study|Subject Non-Compliance|0|||
160893054|NCT02536833|581003809|FG000|Overall Study|Withdrawal by Subject|4|||
160893055|NCT02536833|581003810|FG001|Overall Study|Withdrawal by Subject|3|||
160893056|NCT02536833|581003811|FG002|Overall Study|Withdrawal by Subject|5|||
160893057|NCT02536833|581003812|FG003|Overall Study|Withdrawal by Subject|11|||
160893058|NCT00089674|581003813|FG000|Overall Study|Physician Decision|4|||
160893059|NCT00089674|581003814|FG001|Overall Study|Physician Decision|2|||
160893060|NCT00089674|581003813|FG000|Overall Study|Adverse Event|23|||
160893061|NCT00089674|581003814|FG001|Overall Study|Adverse Event|29|||
160893062|NCT00089674|581003813|FG000|Overall Study|Withdrawal by Subject|143|||
160548453|NCT00511355|579734138|FG001|Overall Study|Lost to Follow-up|1|||
160548454|NCT00511355|579734137|FG000|Overall Study|Other Reason|0|||
160548455|NCT00511355|579734138|FG001|Overall Study|Other Reason|1|||
160893063|NCT00089674|581003814|FG001|Overall Study|Withdrawal by Subject|127|||
160893064|NCT00089674|581003813|FG000|Overall Study|Death|43|||
160893065|NCT00089674|581003814|FG001|Overall Study|Death|43|||
160893066|NCT00089674|581003813|FG000|Overall Study|Disease progression|21|||
160893067|NCT00089674|581003814|FG001|Overall Study|Disease progression|23|||
160893068|NCT00089674|581003813|FG000|Overall Study|Ineligibility determined|8|||
160893069|NCT00089674|581003814|FG001|Overall Study|Ineligibility determined|10|||
160893070|NCT00089674|581003813|FG000|Overall Study|Lost to Follow-up|21|||
160893071|NCT00089674|581003814|FG001|Overall Study|Lost to Follow-up|17|||
160893072|NCT00089674|581003813|FG000|Overall Study|Noncompliance|7|||
160893073|NCT00089674|581003814|FG001|Overall Study|Noncompliance|3|||
160893074|NCT00089674|581003813|FG000|Overall Study|Other|5|||
160793278|NCT02471144|580631623|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793279|NCT02471144|580631624|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793280|NCT02471144|580631625|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793281|NCT02471144|580631626|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793282|NCT02471144|580631627|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793283|NCT02471144|580631628|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
160793284|NCT02471144|580631629|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793285|NCT02471144|580631630|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793286|NCT02471144|580631620|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793287|NCT02471144|580631621|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793288|NCT02471144|580631622|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793289|NCT02471144|580631623|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793290|NCT02471144|580631624|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793291|NCT02471144|580631625|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793292|NCT02471144|580631626|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793293|NCT02471144|580631627|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
160793294|NCT02471144|580631628|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
160793295|NCT02471144|580631629|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793296|NCT02471144|580631630|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793297|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793298|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793299|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793300|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793301|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793302|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793303|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793304|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793305|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793306|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
160793307|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
160793308|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793309|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793310|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793311|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793312|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793313|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793314|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793315|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793316|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793317|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
160793318|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793319|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793320|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793321|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793322|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793323|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793324|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793325|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793326|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793327|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793328|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793329|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
160793330|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793331|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793332|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793333|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793334|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793335|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793336|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793337|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793338|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793339|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
160793340|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
160793341|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793342|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793343|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160982559|NCT01556763|581325013|FG001|Overall Study|Withdrawal by Subject|1|||
160982560|NCT01556763|581325014|FG002|Overall Study|Withdrawal by Subject|0|||
160982561|NCT02258464|581325015|FG000|Overall Study|Progressive disease (PD)|9|||
160982562|NCT02258464|581325016|FG001|Overall Study|Progressive disease (PD)|17|||
160982563|NCT02258464|581325015|FG000|Overall Study|Study drug never administered|1|||
160982564|NCT02258464|581325016|FG001|Overall Study|Study drug never administered|1|||
160982565|NCT02258464|581325015|FG000|Overall Study|AE not related to clinical PD|1|||
160982566|NCT02258464|581325016|FG001|Overall Study|AE not related to clinical PD|3|||
160982567|NCT02258464|581325015|FG000|Overall Study|Withdrawal by Subject|5|||
160982568|NCT02258464|581325016|FG001|Overall Study|Withdrawal by Subject|4|||
160982569|NCT02258464|581325015|FG000|Overall Study|AE related to clinical PD|1|||
160982570|NCT02258464|581325016|FG001|Overall Study|AE related to clinical PD|0|||
160982571|NCT00932646|581325017|FG000|Overall Study|Adverse Event|2|||
160982572|NCT00932646|581325018|FG001|Overall Study|Adverse Event|1|||
160982573|NCT00932646|581325019|FG002|Overall Study|Adverse Event|1|||
160982574|NCT00932646|581325020|FG003|Overall Study|Adverse Event|1|||
160982575|NCT00932646|581325017|FG000|Overall Study|Lost to Follow-up|2|||
160982576|NCT00932646|581325018|FG001|Overall Study|Lost to Follow-up|1|||
160982577|NCT00932646|581325019|FG002|Overall Study|Lost to Follow-up|0|||
160982578|NCT00932646|581325020|FG003|Overall Study|Lost to Follow-up|0|||
160982579|NCT00932646|581325017|FG000|Overall Study|Withdrawal by Subject|1|||
160982580|NCT00932646|581325018|FG001|Overall Study|Withdrawal by Subject|1|||
160982581|NCT00932646|581325019|FG002|Overall Study|Withdrawal by Subject|3|||
160982582|NCT00932646|581325020|FG003|Overall Study|Withdrawal by Subject|0|||
160982583|NCT00653263|581325021|FG000|Overall Study|Withdrawal by Subject|1|||
160982584|NCT00653263|581325021|FG000|Overall Study|Physician Decision|1|||
160982585|NCT00776100|581325022|FG000|Overall Study|Disease Progression|1|||
160982586|NCT00776100|581325023|FG001|Overall Study|Disease Progression|0|||
160982587|NCT03500172|581325028|FG000|Period 1: Baseline Randomization|Death|0|||
160982588|NCT03500172|581325029|FG001|Period 1: Baseline Randomization|Death|0|||
160982589|NCT03500172|581325030|FG002|Period 1: Baseline Randomization|Death|0|||
160982590|NCT03500172|581325031|FG003|Period 1: Baseline Randomization|Death|0|||
160982591|NCT03500172|581325032|FG004|Period 1: Baseline Randomization|Death|0|||
160982592|NCT03500172|581325033|FG005|Period 1: Baseline Randomization|Death|0|||
160982593|NCT03500172|581325034|FG006|Period 1: Baseline Randomization|Death|0|||
160982594|NCT03500172|581325035|FG007|Period 1: Baseline Randomization|Death|0|||
160982595|NCT03500172|581325036|FG008|Period 1: Baseline Randomization|Death|0|||
160982596|NCT03500172|581325037|FG009|Period 1: Baseline Randomization|Death|2|||
160982597|NCT03500172|581325038|FG010|Period 1: Baseline Randomization|Death|0|||
160982598|NCT03500172|581325028|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
160982599|NCT03500172|581325029|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
160982600|NCT03500172|581325030|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
160982601|NCT03500172|581325031|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
160982602|NCT03500172|581325032|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
160982603|NCT03500172|581325033|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
160982604|NCT03500172|581325034|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
160982605|NCT03500172|581325035|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
160982606|NCT03500172|581325036|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
160982607|NCT03500172|581325037|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
160982608|NCT03500172|581325038|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
160982609|NCT03500172|581325028|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
160982610|NCT03500172|581325029|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
160982611|NCT03500172|581325030|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
160982612|NCT03500172|581325031|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
160982613|NCT03500172|581325032|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
160982614|NCT03500172|581325033|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
160982615|NCT03500172|581325034|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
160982616|NCT03500172|581325035|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
160982617|NCT03500172|581325036|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
160982618|NCT03500172|581325037|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
160982619|NCT03500172|581325038|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
160982620|NCT03500172|581325028|FG000|Period 2: Re-Randomization|Death|0|||
160982621|NCT03500172|581325029|FG001|Period 2: Re-Randomization|Death|0|||
160982622|NCT03500172|581325030|FG002|Period 2: Re-Randomization|Death|0|||
160982623|NCT03500172|581325031|FG003|Period 2: Re-Randomization|Death|4|||
160982624|NCT03500172|581325032|FG004|Period 2: Re-Randomization|Death|2|||
160982625|NCT03500172|581325033|FG005|Period 2: Re-Randomization|Death|0|||
160982626|NCT03500172|581325034|FG006|Period 2: Re-Randomization|Death|5|||
160982627|NCT03500172|581325035|FG007|Period 2: Re-Randomization|Death|2|||
160982628|NCT03500172|581325036|FG008|Period 2: Re-Randomization|Death|0|||
160982629|NCT03500172|581325037|FG009|Period 2: Re-Randomization|Death|0|||
160982630|NCT03500172|581325038|FG010|Period 2: Re-Randomization|Death|0|||
160982631|NCT00195715|581325041|FG000|Overall Study|Adverse Event|122|||
160982632|NCT00195715|581325041|FG000|Overall Study|Withdrawal by Subject|58|||
160893075|NCT00089674|581003814|FG001|Overall Study|Other|9|||
160893076|NCT00089674|581003813|FG000|Overall Study|Requirement for alternative therapy|14|||
160893077|NCT00089674|581003814|FG001|Overall Study|Requirement for alternative therapy|4|||
160893078|NCT01462227|581003815|FG000|Second Assignment|Lost to Follow-up|1|||
160893079|NCT01462227|581003816|FG001|Second Assignment|Lost to Follow-up|0|||
160893080|NCT01462227|581003817|FG002|Second Assignment|Lost to Follow-up|0|||
160893081|NCT01462227|581003818|FG003|Second Assignment|Lost to Follow-up|0|||
160893082|NCT01462227|581003815|FG000|Second Assignment|Protocol Violation|0|||
160893083|NCT01462227|581003816|FG001|Second Assignment|Protocol Violation|1|||
160893084|NCT01462227|581003817|FG002|Second Assignment|Protocol Violation|1|||
160893085|NCT01462227|581003818|FG003|Second Assignment|Protocol Violation|0|||
160893086|NCT00586066|581003821|FG000|Overall Study|Lost to Follow-up|6|||
160893087|NCT00586066|581003822|FG001|Overall Study|Lost to Follow-up|3|||
160893088|NCT00586066|581003821|FG000|Overall Study|Lack of Efficacy|5|||
160893089|NCT00586066|581003822|FG001|Overall Study|Lack of Efficacy|3|||
160893090|NCT00586066|581003821|FG000|Overall Study|Adverse Event|2|||
160893091|NCT00586066|581003822|FG001|Overall Study|Adverse Event|2|||
160893092|NCT00586066|581003821|FG000|Overall Study|Physician Decision|1|||
160893093|NCT00586066|581003822|FG001|Overall Study|Physician Decision|0|||
160893094|NCT00586066|581003821|FG000|Overall Study|Withdrawal of consent|4|||
160893095|NCT00586066|581003822|FG001|Overall Study|Withdrawal of consent|2|||
160893096|NCT00760084|581003826|FG000|Overall Study|Physician Decision|5|||
160893097|NCT00760084|581003826|FG000|Overall Study|Withdrawal by Subject|2|||
160893098|NCT00760084|581003826|FG000|Overall Study|Progressive Disease|3|||
160893099|NCT02567552|581003827|FG000|Overall Study|Adverse Event|0|||
160893100|NCT02567552|581003828|FG001|Overall Study|Adverse Event|1|||
160893101|NCT02301988|581003829|FG000|Overall Study|Withdrawal by Subject|2|||
160893102|NCT02301988|581003830|FG001|Overall Study|Withdrawal by Subject|1|||
160893103|NCT02301988|581003829|FG000|Overall Study|Physician Decision|2|||
160893104|NCT02301988|581003830|FG001|Overall Study|Physician Decision|2|||
160893105|NCT02301988|581003829|FG000|Overall Study|Unknown Reason|1|||
160893106|NCT02301988|581003830|FG001|Overall Study|Unknown Reason|3|||
160893107|NCT02301988|581003829|FG000|Overall Study|Lack of Efficacy|3|||
160893108|NCT02301988|581003830|FG001|Overall Study|Lack of Efficacy|2|||
160893109|NCT02301988|581003829|FG000|Overall Study|Death|1|||
160893110|NCT02301988|581003830|FG001|Overall Study|Death|0|||
160893111|NCT02301988|581003829|FG000|Overall Study|Adverse Event|1|||
160893112|NCT02301988|581003830|FG001|Overall Study|Adverse Event|1|||
160893113|NCT02891161|581003833|FG000|Study Treatment|Disease Progression|2|||
160893114|NCT02891161|581003834|FG001|Study Treatment|Disease Progression|4|||
160893115|NCT02891161|581003833|FG000|Study Treatment|AE/Side Effects/Complications|1|||
160893116|NCT02891161|581003834|FG001|Study Treatment|AE/Side Effects/Complications|5|||
160893117|NCT02891161|581003833|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
160893118|NCT02891161|581003834|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
160893119|NCT02891161|581003833|FG000|Follow up|Death|4|||
160893120|NCT02891161|581003834|FG001|Follow up|Death|8|||
160893121|NCT02891161|581003833|FG000|Follow up|Refused to Follow up|0|||
160893122|NCT02891161|581003834|FG001|Follow up|Refused to Follow up|2|||
160893123|NCT02891161|581003833|FG000|Follow up|Symptomatic deterioration|0|||
160893124|NCT02891161|581003834|FG001|Follow up|Symptomatic deterioration|1|||
160893125|NCT02891161|581003833|FG000|Follow up|Study terminated|0|||
160893126|NCT02891161|581003834|FG001|Follow up|Study terminated|6|||
160893127|NCT01931202|581003836|FG000|Overall Study|Withdrawal by Subject|0|||
160893128|NCT01931202|581003837|FG001|Overall Study|Withdrawal by Subject|0|||
160893129|NCT01931202|581003838|FG002|Overall Study|Withdrawal by Subject|2|||
160893130|NCT01931202|581003836|FG000|Overall Study|Lost to Follow-up|0|||
160893131|NCT01931202|581003837|FG001|Overall Study|Lost to Follow-up|5|||
160893132|NCT01931202|581003838|FG002|Overall Study|Lost to Follow-up|2|||
160893133|NCT00171054|581003839|FG000|Overall Study|Protocol Violation|1|||
160893134|NCT00171054|581003840|FG001|Overall Study|Protocol Violation|2|||
160893135|NCT00171054|581003839|FG000|Overall Study|Patient withdrew consent|1|||
160893136|NCT00171054|581003840|FG001|Overall Study|Patient withdrew consent|0|||
160893137|NCT00171054|581003839|FG000|Overall Study|Lost to Follow-up|0|||
160893138|NCT00171054|581003840|FG001|Overall Study|Lost to Follow-up|1|||
160893139|NCT00171054|581003839|FG000|Overall Study|Adverse Event|8|||
160893140|NCT00171054|581003840|FG001|Overall Study|Adverse Event|8|||
160893141|NCT00171054|581003839|FG000|Overall Study|Condition no longer required study drug|0|||
160893142|NCT00171054|581003840|FG001|Overall Study|Condition no longer required study drug|1|||
160893143|NCT04669535|581003841|FG000|Overall Study|Death|1|||
160893144|NCT04669535|581003842|FG001|Overall Study|Death|1|||
160893145|NCT04669535|581003843|FG002|Overall Study|Death|0|||
160893146|NCT04669535|581003844|FG003|Overall Study|Death|0|||
160893147|NCT01876810|581003845|FG000|Overall Study|Physician Decision|0|||
160893148|NCT01876810|581003846|FG001|Overall Study|Physician Decision|1|||
160893149|NCT01857583|581003848|FG000|Overall Study|Adverse Event|0|||
160893150|NCT01857583|581003849|FG001|Overall Study|Adverse Event|0|||
160893151|NCT01857583|581003850|FG002|Overall Study|Adverse Event|1|||
160893152|NCT01857583|581003851|FG003|Overall Study|Adverse Event|1|||
160893153|NCT01857583|581003848|FG000|Overall Study|Death|0|||
160982633|NCT00195715|581325041|FG000|Overall Study|Lost to Follow-up|27|||
160982634|NCT00195715|581325041|FG000|Overall Study|Protocol Violation|13|||
160982635|NCT00195715|581325041|FG000|Overall Study|Lack of Efficacy|93|||
160982636|NCT00195715|581325041|FG000|Overall Study|Pregnancy|14|||
160982637|NCT00195715|581325041|FG000|Overall Study|Investigative site closure|8|||
160982638|NCT00195715|581325041|FG000|Overall Study|Subject moved/relocated|7|||
160982639|NCT00195715|581325041|FG000|Overall Study|Subject non-compliance|6|||
160982640|NCT00195715|581325041|FG000|Overall Study|Subject started commercial Humira|5|||
160982641|NCT00195715|581325041|FG000|Overall Study|Subject choice|3|||
160982642|NCT00195715|581325041|FG000|Overall Study|Loss of response/no improvement|3|||
160982643|NCT00195715|581325041|FG000|Overall Study|Sponsor stopped study|1|||
160982644|NCT00195715|581325041|FG000|Overall Study|Administrative reasons|2|||
160982645|NCT00195715|581325041|FG000|Overall Study|Investigator's decision|2|||
160982646|NCT00195715|581325041|FG000|Overall Study|Subject wants to get pregnant|4|||
160982647|NCT00195715|581325041|FG000|Overall Study|Use of prohibited medication|2|||
160982648|NCT00195715|581325041|FG000|Overall Study|Planned surgery|2|||
160982649|NCT00195715|581325041|FG000|Overall Study|Increased infection rate|1|||
160982650|NCT00195715|581325041|FG000|Overall Study|Ineligible|1|||
160982651|NCT00195715|581325041|FG000|Overall Study|Colonic stricture|1|||
160982652|NCT00195715|581325041|FG000|Overall Study|Sponsor discontinued trial|1|||
160982653|NCT00195715|581325041|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
160982654|NCT05822921|581325046|FG000|Overall Study|Lost to Follow-up|1|||
160982655|NCT05822921|581325047|FG001|Overall Study|Lost to Follow-up|1|||
160982656|NCT02218489|581325054|FG000|Overall Study|Withdrawal by Subject|4|||
160982657|NCT02218489|581325055|FG001|Overall Study|Withdrawal by Subject|3|||
160982658|NCT02218489|581325054|FG000|Overall Study|Lost to Follow-up|1|||
160982659|NCT02218489|581325055|FG001|Overall Study|Lost to Follow-up|0|||
160982660|NCT04039503|581325056|FG000|Overall Study|Adverse Event|3|||
160982661|NCT04039503|581325057|FG001|Overall Study|Adverse Event|0|||
160982662|NCT04039503|581325058|FG002|Overall Study|Adverse Event|2|||
160982663|NCT04039503|581325059|FG003|Overall Study|Adverse Event|0|||
160982664|NCT04039503|581325056|FG000|Overall Study|Lost to Follow-up|0|||
160982665|NCT04039503|581325057|FG001|Overall Study|Lost to Follow-up|0|||
160982666|NCT04039503|581325058|FG002|Overall Study|Lost to Follow-up|1|||
160982667|NCT04039503|581325059|FG003|Overall Study|Lost to Follow-up|0|||
160982668|NCT04039503|581325056|FG000|Overall Study|Protocol Violation|0|||
160982669|NCT04039503|581325057|FG001|Overall Study|Protocol Violation|1|||
160982670|NCT04039503|581325058|FG002|Overall Study|Protocol Violation|2|||
160982671|NCT04039503|581325059|FG003|Overall Study|Protocol Violation|1|||
160982672|NCT04039503|581325056|FG000|Overall Study|Withdrawal by Subject|4|||
160982673|NCT04039503|581325057|FG001|Overall Study|Withdrawal by Subject|3|||
160982674|NCT04039503|581325058|FG002|Overall Study|Withdrawal by Subject|5|||
160982675|NCT04039503|581325059|FG003|Overall Study|Withdrawal by Subject|2|||
160982676|NCT02601937|581325066|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982677|NCT02601937|581325067|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982678|NCT02601937|581325068|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982679|NCT02601937|581325069|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
160548456|NCT00511355|579734137|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
160548457|NCT00511355|579734138|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
160548458|NCT00511355|579734137|FG000|Overall Study|Withdrawal of informed consent|0|||
160548459|NCT00511355|579734138|FG001|Overall Study|Withdrawal of informed consent|1|||
160548460|NCT00511355|579734137|FG000|Overall Study|Other reason pre-treatment|0|||
160548461|NCT00511355|579734138|FG001|Overall Study|Other reason pre-treatment|1|||
160548462|NCT01632566|579734140|FG000|Overall Study|Withdrawal by Subject|0|||
160548463|NCT01632566|579734141|FG001|Overall Study|Withdrawal by Subject|1|||
160548464|NCT01632566|579734142|FG002|Overall Study|Withdrawal by Subject|0|||
160548465|NCT01632566|579734143|FG003|Overall Study|Withdrawal by Subject|0|||
160548466|NCT01632566|579734144|FG004|Overall Study|Withdrawal by Subject|0|||
160548467|NCT01632566|579734140|FG000|Overall Study|Sponsor Decision|0|||
160548468|NCT01632566|579734141|FG001|Overall Study|Sponsor Decision|2|||
160548469|NCT01632566|579734142|FG002|Overall Study|Sponsor Decision|9|||
160548470|NCT01632566|579734143|FG003|Overall Study|Sponsor Decision|2|||
160642884|NCT04444752|580074402|FG003|Overall Study|Death|0|||
160548471|NCT01632566|579734144|FG004|Overall Study|Sponsor Decision|2|||
160982680|NCT02601937|581325070|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982681|NCT02601937|581325071|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
160982682|NCT02601937|581325072|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982683|NCT02601937|581325073|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982684|NCT02601937|581325074|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982685|NCT02601937|581325075|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982686|NCT02601937|581325076|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982687|NCT02601937|581325066|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
160982688|NCT02601937|581325067|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982689|NCT02601937|581325068|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160996827|NCT03536884|581373709|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160793344|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793345|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793346|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793347|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793348|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793349|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793350|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
160793351|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793352|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793353|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793354|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793355|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793356|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793357|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793358|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793359|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793360|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793361|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
160793362|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
160793363|NCT03977155|580631634|FG000|Overall Study|Adverse Event|3|||
160793364|NCT03977155|580631635|FG001|Overall Study|Adverse Event|0|||
160793365|NCT03977155|580631636|FG002|Overall Study|Adverse Event|0|||
160793366|NCT03977155|580631634|FG000|Overall Study|Lost to Follow-up|0|||
160793367|NCT03977155|580631635|FG001|Overall Study|Lost to Follow-up|1|||
160793368|NCT03977155|580631636|FG002|Overall Study|Lost to Follow-up|0|||
160793369|NCT03977155|580631634|FG000|Overall Study|Withdrawal by Subject|1|||
160793370|NCT03977155|580631635|FG001|Overall Study|Withdrawal by Subject|1|||
160793371|NCT03977155|580631636|FG002|Overall Study|Withdrawal by Subject|2|||
160793372|NCT03977155|580631634|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
160793373|NCT03977155|580631635|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
160793374|NCT03977155|580631636|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
160793375|NCT00936936|580631637|FG000|Overall Study|Adverse Event|7|||
160793376|NCT00936936|580631638|FG001|Overall Study|Adverse Event|1|||
160793377|NCT00936936|580631637|FG000|Overall Study|Disease Progression|2|||
160793378|NCT00936936|580631638|FG001|Overall Study|Disease Progression|2|||
160793379|NCT00936936|580631637|FG000|Overall Study|Unrelated|3|||
160793380|NCT00936936|580631638|FG001|Overall Study|Unrelated|1|||
160793381|NCT03440385|580631647|FG000|Overall Study|Other Reason|4|||
160793382|NCT03440385|580631648|FG001|Overall Study|Other Reason|1|||
160793383|NCT03440385|580631647|FG000|Overall Study|Site Closed|1|||
160793384|NCT03440385|580631648|FG001|Overall Study|Site Closed|0|||
160793385|NCT03440385|580631647|FG000|Overall Study|Lost to Follow-up|2|||
160793386|NCT03440385|580631648|FG001|Overall Study|Lost to Follow-up|0|||
160793387|NCT03440385|580631647|FG000|Overall Study|Withdrawal by Subject|12|||
160793388|NCT03440385|580631648|FG001|Overall Study|Withdrawal by Subject|6|||
160793389|NCT03440385|580631647|FG000|Overall Study|Lack of Efficacy|9|||
160793390|NCT03440385|580631648|FG001|Overall Study|Lack of Efficacy|2|||
160793391|NCT03440385|580631647|FG000|Overall Study|Adverse Event|15|||
160793392|NCT03440385|580631648|FG001|Overall Study|Adverse Event|11|||
160793393|NCT00488293|580631649|FG000|Overall Study|Lost to Follow-up|28|||
160793394|NCT00488293|580631650|FG001|Overall Study|Lost to Follow-up|25|||
160793395|NCT00488293|580631649|FG000|Overall Study|Withdrawal by Subject|5|||
160793396|NCT00488293|580631650|FG001|Overall Study|Withdrawal by Subject|3|||
160793397|NCT00488293|580631649|FG000|Overall Study|Death|2|||
160793398|NCT00488293|580631650|FG001|Overall Study|Death|1|||
160793399|NCT00488293|580631649|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
160793400|NCT00488293|580631650|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
160793401|NCT00939185|580631651|FG000|Overall Study|Adverse Event|3|||
160793402|NCT00939185|580631651|FG000|Overall Study|Lack of Efficacy|1|||
160793403|NCT00939185|580631651|FG000|Overall Study|Lost to Follow-up|6|||
160793404|NCT00939185|580631651|FG000|Overall Study|Other|3|||
160793405|NCT00939185|580631651|FG000|Overall Study|Withdrawal by Subject|2|||
160793406|NCT00939185|580631651|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
160793407|NCT00363298|580631652|FG000|First Study Week|Lack of Efficacy|6|||
160793408|NCT00363298|580631653|FG001|First Study Week|Lack of Efficacy|5|||
160793409|NCT00363298|580631652|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
160793410|NCT00363298|580631653|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
160793411|NCT02374255|580631655|FG000|Overall Study|Withdrawal by Subject|2|||
160793412|NCT02374255|580631656|FG001|Overall Study|Withdrawal by Subject|0|||
160793413|NCT02374255|580631657|FG002|Overall Study|Withdrawal by Subject|0|||
160793414|NCT02374255|580631658|FG003|Overall Study|Withdrawal by Subject|0|||
160793415|NCT00851084|580631659|FG000|Overall Study|Randomized but not treated|1|||
160793416|NCT00851084|580631660|FG001|Overall Study|Randomized but not treated|0|||
160642885|NCT00579254|580074403|FG000|Overall Study|Lost to Follow-up|39|||
160793417|NCT00851084|580631659|FG000|Overall Study|Adverse Event|26|||
160793418|NCT00851084|580631660|FG001|Overall Study|Adverse Event|36|||
160982690|NCT02601937|581325069|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982691|NCT02601937|581325070|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982692|NCT02601937|581325071|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982693|NCT02601937|581325072|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
160982694|NCT02601937|581325073|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982695|NCT02601937|581325074|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982696|NCT02601937|581325075|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982697|NCT02601937|581325076|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982698|NCT02601937|581325066|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982699|NCT02601937|581325067|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982700|NCT02601937|581325068|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
160982701|NCT02601937|581325069|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982702|NCT02601937|581325070|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982703|NCT02601937|581325071|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982704|NCT02601937|581325072|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160793419|NCT00851084|580631659|FG000|Overall Study|Disease progression|52|||
160793420|NCT00851084|580631660|FG001|Overall Study|Disease progression|47|||
160793421|NCT00851084|580631659|FG000|Overall Study|Poor compliance to protocol|1|||
160793422|NCT00851084|580631660|FG001|Overall Study|Poor compliance to protocol|1|||
160793423|NCT00851084|580631659|FG000|Overall Study|Physician Decision|13|||
160793424|NCT00851084|580631660|FG001|Overall Study|Physician Decision|14|||
160793425|NCT00851084|580631659|FG000|Overall Study|Consent withdrawn|0|||
160793426|NCT00851084|580631660|FG001|Overall Study|Consent withdrawn|2|||
160793427|NCT00851084|580631659|FG000|Overall Study|Withdrawal by Subject|11|||
160793428|NCT00851084|580631660|FG001|Overall Study|Withdrawal by Subject|12|||
160793429|NCT00851084|580631659|FG000|Overall Study|Metastatic surgery|6|||
160793430|NCT00851084|580631660|FG001|Overall Study|Metastatic surgery|6|||
160793431|NCT00851084|580631659|FG000|Overall Study|Other|7|||
160793432|NCT00851084|580631660|FG001|Overall Study|Other|1|||
160793433|NCT00095576|580631663|FG000|Overall Study|Adverse Event|5|||
160793434|NCT00095576|580631664|FG001|Overall Study|Adverse Event|3|||
160793435|NCT00095576|580631663|FG000|Overall Study|Lost to Follow-up|233|||
160793436|NCT00095576|580631664|FG001|Overall Study|Lost to Follow-up|229|||
160793437|NCT00095576|580631663|FG000|Overall Study|Protocol Violation|1|||
160793438|NCT00095576|580631664|FG001|Overall Study|Protocol Violation|0|||
160793439|NCT00095576|580631663|FG000|Overall Study|Withdrawal by Subject|34|||
160793440|NCT00095576|580631664|FG001|Overall Study|Withdrawal by Subject|47|||
160793441|NCT00095576|580631663|FG000|Overall Study|Option to switch to a rollover study|1097|||
160793442|NCT00095576|580631664|FG001|Overall Study|Option to switch to a rollover study|1099|||
160793443|NCT00095576|580631663|FG000|Overall Study|Site terminated|75|||
160793444|NCT00095576|580631664|FG001|Overall Study|Site terminated|67|||
160893154|NCT01857583|581003849|FG001|Overall Study|Death|1|||
160893155|NCT01857583|581003850|FG002|Overall Study|Death|1|||
160893156|NCT01857583|581003851|FG003|Overall Study|Death|0|||
160893157|NCT01857583|581003848|FG000|Overall Study|Physician Decision|0|||
160893158|NCT01857583|581003849|FG001|Overall Study|Physician Decision|0|||
160893159|NCT01857583|581003850|FG002|Overall Study|Physician Decision|0|||
160893160|NCT01857583|581003851|FG003|Overall Study|Physician Decision|1|||
160893161|NCT01857583|581003848|FG000|Overall Study|Withdrawal by Subject|1|||
160893162|NCT01857583|581003849|FG001|Overall Study|Withdrawal by Subject|0|||
160893163|NCT01857583|581003850|FG002|Overall Study|Withdrawal by Subject|1|||
160982705|NCT02601937|581325073|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160793445|NCT00095576|580631663|FG000|Overall Study|Subject moved|30|||
160793446|NCT00095576|580631664|FG001|Overall Study|Subject moved|36|||
160793447|NCT01497197|580631667|FG000|Overall Study|Lost to Follow-up|1|||
160793448|NCT01497197|580631668|FG001|Overall Study|Lost to Follow-up|0|||
160893164|NCT01857583|581003851|FG003|Overall Study|Withdrawal by Subject|2|||
160642886|NCT00579254|580074403|FG000|Overall Study|Discontinued when study terminated|73|||
160893165|NCT02775903|581003854|FG000|Overall Study|Death|7|||
160893166|NCT02775903|581003855|FG001|Overall Study|Death|11|||
160793449|NCT01497197|580631667|FG000|Overall Study|Protocol Violation|0|||
160793450|NCT01497197|580631668|FG001|Overall Study|Protocol Violation|2|||
160793451|NCT01497197|580631667|FG000|Overall Study|Withdrawal by Subject|2|||
160793452|NCT01497197|580631668|FG001|Overall Study|Withdrawal by Subject|1|||
160793453|NCT01497197|580631667|FG000|Overall Study|Excessive/lack of response to treatment|1|||
160793454|NCT01497197|580631668|FG001|Overall Study|Excessive/lack of response to treatment|0|||
160793455|NCT01497197|580631667|FG000|Overall Study|Risk of OHSS|1|||
160793456|NCT01497197|580631668|FG001|Overall Study|Risk of OHSS|0|||
160793457|NCT01497197|580631667|FG000|Overall Study|No oocytes retrieved|3|||
160793458|NCT01497197|580631668|FG001|Overall Study|No oocytes retrieved|2|||
160793459|NCT01497197|580631667|FG000|Overall Study|No fertilisation|6|||
160793460|NCT01497197|580631668|FG001|Overall Study|No fertilisation|5|||
160793461|NCT01497197|580631667|FG000|Overall Study|Intention to freeze all embryos|0|||
160793462|NCT01497197|580631668|FG001|Overall Study|Intention to freeze all embryos|1|||
160793463|NCT01497197|580631667|FG000|Overall Study|All embryos discarded|0|||
160642887|NCT02557672|580074404|FG000|Overall Study|Withdrawal by Subject|4|||
160642888|NCT02557672|580074405|FG001|Overall Study|Withdrawal by Subject|2|||
160793464|NCT01497197|580631668|FG001|Overall Study|All embryos discarded|3|||
160793465|NCT01497197|580631667|FG000|Overall Study|Other|3|||
160793466|NCT01497197|580631668|FG001|Overall Study|Other|1|||
160793467|NCT04484857|580631670|FG000|Overall Study|Adverse Event|2|||
160793468|NCT04484857|580631670|FG000|Overall Study|Death|10|||
160793469|NCT04484857|580631670|FG000|Overall Study|Withdrawal by Subject|3|||
160793470|NCT04484857|580631670|FG000|Overall Study|Transferred/Relocation|5|||
160793471|NCT04484857|580631670|FG000|Overall Study|Kidney Transplant|7|||
160793472|NCT04484857|580631670|FG000|Overall Study|Other than specified|4|||
160793473|NCT04484857|580631670|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
160793474|NCT01425814|580631671|FG000|Period 1|Stability criteria not fulfilled|0|||
160793475|NCT01425814|580631672|FG001|Period 1|Stability criteria not fulfilled|1|||
160793476|NCT01425814|580631673|FG002|Period 1|Stability criteria not fulfilled|0|||
160793477|NCT01425814|580631674|FG003|Period 1|Stability criteria not fulfilled|0|||
160793478|NCT01425814|580631675|FG004|Period 1|Stability criteria not fulfilled|0|||
160793479|NCT01425814|580631676|FG005|Period 1|Stability criteria not fulfilled|0|||
160793480|NCT01425814|580631671|FG000|Period 2|Stability criteria not fulfilled|0|||
160793481|NCT01425814|580631672|FG001|Period 2|Stability criteria not fulfilled|1|||
160793482|NCT01425814|580631673|FG002|Period 2|Stability criteria not fulfilled|0|||
160793483|NCT01425814|580631674|FG003|Period 2|Stability criteria not fulfilled|0|||
160793484|NCT01425814|580631675|FG004|Period 2|Stability criteria not fulfilled|0|||
160793485|NCT01425814|580631676|FG005|Period 2|Stability criteria not fulfilled|0|||
160793486|NCT01425814|580631671|FG000|Period 3|Adverse Event|0|||
160793487|NCT01425814|580631672|FG001|Period 3|Adverse Event|0|||
160793488|NCT01425814|580631673|FG002|Period 3|Adverse Event|0|||
160793489|NCT01425814|580631674|FG003|Period 3|Adverse Event|0|||
160793490|NCT01425814|580631675|FG004|Period 3|Adverse Event|0|||
160793491|NCT01425814|580631676|FG005|Period 3|Adverse Event|1|||
160793492|NCT01425814|580631671|FG000|Period 4|Adverse Event|1|||
160793493|NCT01425814|580631672|FG001|Period 4|Adverse Event|0|||
160793494|NCT01425814|580631673|FG002|Period 4|Adverse Event|1|||
160793495|NCT01425814|580631674|FG003|Period 4|Adverse Event|0|||
160893167|NCT02775903|581003856|FG002|Overall Study|Death|12|||
160893168|NCT02775903|581003857|FG003|Overall Study|Death|11|||
160893169|NCT02775903|581003854|FG000|Overall Study|Adverse Event|0|||
160893170|NCT02775903|581003855|FG001|Overall Study|Adverse Event|1|||
160893171|NCT02775903|581003856|FG002|Overall Study|Adverse Event|12|||
160893172|NCT02775903|581003857|FG003|Overall Study|Adverse Event|3|||
160893173|NCT02775903|581003854|FG000|Overall Study|Progressive disease|15|||
160893174|NCT02775903|581003855|FG001|Overall Study|Progressive disease|14|||
160893175|NCT02775903|581003856|FG002|Overall Study|Progressive disease|30|||
160893176|NCT02775903|581003857|FG003|Overall Study|Progressive disease|20|||
160893177|NCT02775903|581003854|FG000|Overall Study|Lack of Efficacy|2|||
160893178|NCT02775903|581003855|FG001|Overall Study|Lack of Efficacy|2|||
160893179|NCT02775903|581003856|FG002|Overall Study|Lack of Efficacy|2|||
160893180|NCT02775903|581003857|FG003|Overall Study|Lack of Efficacy|6|||
160642889|NCT03705169|580074406|FG000|Overall Study|Lost to Follow-up|0|||
160793496|NCT01425814|580631675|FG004|Period 4|Adverse Event|0|||
160793497|NCT01425814|580631676|FG005|Period 4|Adverse Event|0|||
160793498|NCT01425814|580631671|FG000|Period 5|Stability criteria not fulfilled|0|||
160793499|NCT01425814|580631672|FG001|Period 5|Stability criteria not fulfilled|0|||
160793500|NCT01425814|580631673|FG002|Period 5|Stability criteria not fulfilled|1|||
160793501|NCT01425814|580631674|FG003|Period 5|Stability criteria not fulfilled|0|||
160793502|NCT01425814|580631675|FG004|Period 5|Stability criteria not fulfilled|0|||
160793503|NCT01425814|580631676|FG005|Period 5|Stability criteria not fulfilled|1|||
160793504|NCT03580044|580631677|FG000|Overall Study|Death|2|||
160793505|NCT03580044|580631678|FG001|Overall Study|Death|1|||
160793506|NCT03580044|580631677|FG000|Overall Study|Withdrawal by Subject|1|||
160893181|NCT02775903|581003854|FG000|Overall Study|Withdrawal by Subject|7|||
160893182|NCT02775903|581003855|FG001|Overall Study|Withdrawal by Subject|5|||
160893183|NCT02775903|581003856|FG002|Overall Study|Withdrawal by Subject|5|||
160893184|NCT02775903|581003857|FG003|Overall Study|Withdrawal by Subject|8|||
160982706|NCT02601937|581325074|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982707|NCT02601937|581325075|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160793507|NCT03580044|580631678|FG001|Overall Study|Withdrawal by Subject|1|||
160793508|NCT03427619|580631679|FG000|Overall Study|Physician Decision|3|||
160793509|NCT03427619|580631679|FG000|Overall Study|Withdrawal by Subject|4|||
160793510|NCT03427619|580631679|FG000|Overall Study|Lost to Follow-up|5|||
160793511|NCT03427619|580631679|FG000|Overall Study|Administrative|4|||
160793512|NCT03427619|580631679|FG000|Overall Study|Other|2|||
160793513|NCT03427619|580631679|FG000|Overall Study|Unknown or Missing Completion Status|48|||
160793514|NCT02743962|580631684|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
160793515|NCT02743962|580631685|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
160793516|NCT03729609|580631686|FG000|Overall Study|Protocol Violation|1|||
160982708|NCT02601937|581325076|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982709|NCT02601937|581325066|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
160982710|NCT02601937|581325067|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
160982711|NCT02601937|581325068|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
160982712|NCT02601937|581325069|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
160982713|NCT02601937|581325070|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
160548472|NCT00454805|579734145|FG000|Overall Study|Withdrawal by Subject|9|||
160793517|NCT01055028|580631695|FG000|Screening|Screen Failure|1|||
160793518|NCT01055028|580631696|FG001|Screening|Screen Failure|1|||
160793519|NCT01055028|580631695|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
160793520|NCT01055028|580631696|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
160793521|NCT01055028|580631695|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
160793522|NCT01055028|580631696|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
160793523|NCT01055028|580631695|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
160793524|NCT01055028|580631696|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
160793525|NCT04770285|580631699|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
160793526|NCT04770285|580631700|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
160793527|NCT04770285|580631699|FG000|Overall Study|Lack of Efficacy|0|||
160793528|NCT04770285|580631700|FG001|Overall Study|Lack of Efficacy|1|||
160793529|NCT04770285|580631699|FG000|Overall Study|Lost to Follow-up|11|||
160793530|NCT04770285|580631700|FG001|Overall Study|Lost to Follow-up|8|||
160793531|NCT04770285|580631699|FG000|Overall Study|Protocol Deviation|6|||
160793532|NCT04770285|580631700|FG001|Overall Study|Protocol Deviation|6|||
160793533|NCT04770285|580631699|FG000|Overall Study|Technical Problem|0|||
160793534|NCT04770285|580631700|FG001|Overall Study|Technical Problem|1|||
160793535|NCT04770285|580631699|FG000|Overall Study|Withdrawal by Subject|9|||
160793536|NCT04770285|580631700|FG001|Overall Study|Withdrawal by Subject|8|||
160793537|NCT04770285|580631699|FG000|Overall Study|Reason Not Specified|0|||
160793538|NCT04770285|580631700|FG001|Overall Study|Reason Not Specified|1|||
160793539|NCT04620668|580631701|FG000|Overall Study|Withdrawal by Subject|2|||
160793540|NCT04620668|580631702|FG001|Overall Study|Withdrawal by Subject|0|||
160793541|NCT04620668|580631701|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
160793542|NCT04620668|580631702|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
160793543|NCT04620668|580631701|FG000|Overall Study|Removed before analysis: missing data|2|||
160793544|NCT04620668|580631702|FG001|Overall Study|Removed before analysis: missing data|0|||
160793545|NCT04620668|580631701|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
160793546|NCT04620668|580631702|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
160793547|NCT04620668|580631701|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
160793548|NCT04620668|580631702|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
160793549|NCT04581395|580631709|FG000|Overall Study|Protocol Violation|4|||
160793550|NCT04581395|580631710|FG001|Overall Study|Protocol Violation|3|||
160793551|NCT04581395|580631711|FG002|Overall Study|Protocol Violation|2|||
160793552|NCT04581395|580631709|FG000|Overall Study|Physician Decision|0|||
160793553|NCT04581395|580631710|FG001|Overall Study|Physician Decision|1|||
160793554|NCT04581395|580631711|FG002|Overall Study|Physician Decision|0|||
160793555|NCT00815633|580631716|FG000|Overall Study|study terminated|1|||
160793556|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
160793557|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793558|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793559|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793560|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793561|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793562|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793563|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
160793564|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
160793565|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
160793566|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
160793567|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
160793568|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
160793569|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
160793570|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
160793571|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
160793572|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
160793573|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
160793574|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
160793575|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
160793576|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
160793577|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
160793578|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
160793579|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
160793580|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
160793581|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
160793582|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
160793583|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
160793584|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
160793585|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
160793586|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
160893185|NCT02775903|581003854|FG000|Overall Study|Other reasons|7|||
160893186|NCT02775903|581003855|FG001|Overall Study|Other reasons|8|||
160893187|NCT02775903|581003856|FG002|Overall Study|Other reasons|2|||
160893188|NCT02775903|581003857|FG003|Overall Study|Other reasons|12|||
160893189|NCT03552965|581003861|FG000|Overall Study|Death|1|||
160893190|NCT03552965|581003862|FG001|Overall Study|Death|1|||
160893191|NCT03552965|581003861|FG000|Overall Study|Lost to Follow-up|1|||
160893192|NCT03552965|581003862|FG001|Overall Study|Lost to Follow-up|1|||
160893193|NCT03552965|581003861|FG000|Overall Study|Physician Decision|1|||
160893194|NCT03552965|581003862|FG001|Overall Study|Physician Decision|1|||
160893195|NCT03552965|581003861|FG000|Overall Study|Withdrawal by Subject|0|||
160893196|NCT03552965|581003862|FG001|Overall Study|Withdrawal by Subject|2|||
160893197|NCT03552965|581003861|FG000|Overall Study|Continuation not in patient best interest|1|||
160893198|NCT03552965|581003862|FG001|Overall Study|Continuation not in patient best interest|0|||
160893199|NCT03552965|581003861|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
160893200|NCT03552965|581003862|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
160893201|NCT02160782|581004909|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
160893202|NCT02160782|581004910|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
160893203|NCT02160782|581004911|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
160893204|NCT02160782|581004912|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
160893205|NCT02160782|581004913|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
160893206|NCT02160782|581004909|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
160893207|NCT02160782|581004910|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
160893208|NCT02160782|581004911|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
160893209|NCT02160782|581004912|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
160893210|NCT02160782|581004913|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
160893211|NCT02160782|581004909|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
160893212|NCT02160782|581004910|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
160893213|NCT02160782|581004911|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
160893214|NCT02160782|581004912|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
160893215|NCT02160782|581004913|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
160893216|NCT02160782|581004909|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
160893217|NCT02160782|581004910|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
160893218|NCT02160782|581004911|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
160893219|NCT02160782|581004912|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
160893220|NCT02160782|581004913|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
160893221|NCT02160782|581004909|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
160893222|NCT02160782|581004910|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
160893223|NCT02160782|581004911|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
160893224|NCT02160782|581004912|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
160893225|NCT02160782|581004913|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
160893226|NCT02160782|581004909|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
160893227|NCT02160782|581004910|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
160893228|NCT02160782|581004911|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
160642890|NCT03705169|580074407|FG001|Overall Study|Lost to Follow-up|0|||
160793587|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
160893229|NCT02160782|581004912|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
160893230|NCT02160782|581004913|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
160893231|NCT02160782|581004909|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
160893232|NCT02160782|581004910|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
160893233|NCT02160782|581004911|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
160893234|NCT02160782|581004912|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
160893235|NCT02160782|581004913|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
160893236|NCT03061097|581004923|FG000|Overall Study|Withdrawal by Subject|0|||
160893237|NCT03061097|581004924|FG001|Overall Study|Withdrawal by Subject|3|||
160893238|NCT02437513|581004925|FG000|Overall Study|Withdrawal by Subject|2|||
160893239|NCT00761579|581004931|FG000|Overall Study|Adverse Event|10|||
160893240|NCT00761579|581004931|FG000|Overall Study|Death|2|||
160893241|NCT00761579|581004931|FG000|Overall Study|Lack of Efficacy|21|||
160893242|NCT00761579|581004931|FG000|Overall Study|Lost to Follow-up|16|||
160893243|NCT00761579|581004931|FG000|Overall Study|Pregnancy|1|||
160893244|NCT00761579|581004931|FG000|Overall Study|Withdrawal by Subject|34|||
160893245|NCT00761579|581004931|FG000|Overall Study|Lack of compliance|2|||
160893246|NCT00761579|581004931|FG000|Overall Study|Protocol deviation|1|||
160893247|NCT00761579|581004931|FG000|Overall Study|Drug overdose|1|||
160893248|NCT00761579|581004931|FG000|Overall Study|Aggravation of depression|1|||
160893249|NCT00761579|581004931|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
160893250|NCT00761579|581004931|FG000|Overall Study|Lost survey form|1|||
160893251|NCT00761579|581004931|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
160893252|NCT00950911|581004932|FG000|Overall Study|Adverse Event|0|||
160893253|NCT00950911|581004933|FG001|Overall Study|Adverse Event|2|||
160893254|NCT00950911|581004932|FG000|Overall Study|Death|4|||
160893255|NCT00950911|581004933|FG001|Overall Study|Death|6|||
160893256|NCT00950911|581004932|FG000|Overall Study|Disease progression|2|||
160893257|NCT00950911|581004933|FG001|Overall Study|Disease progression|2|||
160893258|NCT00950911|581004932|FG000|Overall Study|Consent withdrawn|1|||
160893259|NCT00950911|581004933|FG001|Overall Study|Consent withdrawn|3|||
160893260|NCT00950911|581004932|FG000|Overall Study|Administrative decision|3|||
160893261|NCT00950911|581004933|FG001|Overall Study|Administrative decision|1|||
160893262|NCT00950911|581004932|FG000|Overall Study|Ineligibility determined|1|||
160893263|NCT00950911|581004933|FG001|Overall Study|Ineligibility determined|0|||
160893264|NCT00950911|581004932|FG000|Overall Study|Noncompliance|1|||
160893265|NCT00950911|581004933|FG001|Overall Study|Noncompliance|0|||
160893266|NCT00950911|581004932|FG000|Overall Study|Poor performance status|0|||
160893267|NCT00950911|581004933|FG001|Overall Study|Poor performance status|1|||
160893268|NCT02600351|581004934|FG000|Overall Study|Lack of Efficacy|3|||
160893269|NCT02600351|581004935|FG001|Overall Study|Lack of Efficacy|0|||
160893270|NCT02600351|581004936|FG002|Overall Study|Lack of Efficacy|5|||
160893271|NCT02600351|581004937|FG003|Overall Study|Lack of Efficacy|2|||
160893272|NCT02600351|581004934|FG000|Overall Study|Lost to Follow-up|1|||
160893273|NCT02600351|581004935|FG001|Overall Study|Lost to Follow-up|0|||
160893274|NCT02600351|581004936|FG002|Overall Study|Lost to Follow-up|0|||
160893275|NCT02600351|581004937|FG003|Overall Study|Lost to Follow-up|0|||
160893276|NCT02600351|581004934|FG000|Overall Study|Randomized but Not Treated|1|||
160893277|NCT02600351|581004935|FG001|Overall Study|Randomized but Not Treated|0|||
160893278|NCT02600351|581004936|FG002|Overall Study|Randomized but Not Treated|1|||
160893279|NCT02600351|581004937|FG003|Overall Study|Randomized but Not Treated|3|||
160893280|NCT02063880|581004938|FG000|Overall Study|Death|21|||
160893281|NCT02063880|581004939|FG001|Overall Study|Death|18|||
160893282|NCT02063880|581004938|FG000|Overall Study|Lost to Follow-up|7|||
160893283|NCT02063880|581004939|FG001|Overall Study|Lost to Follow-up|7|||
160893284|NCT02063880|581004938|FG000|Overall Study|Ineligible|0|||
160893285|NCT02063880|581004939|FG001|Overall Study|Ineligible|2|||
160893286|NCT00567593|581004940|FG000|Overall Study|Adverse Event|1|||
160893287|NCT00567593|581004940|FG000|Overall Study|Physician Decision|1|||
160893288|NCT02106910|581004943|FG000|Overall Study|Lost to Follow-up|1|||
160893289|NCT02106910|581004944|FG001|Overall Study|Lost to Follow-up|1|||
160893290|NCT04087213|581004945|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
160893291|NCT04087213|581004945|FG000|In-Facility Introduction|Adverse Event|1|||
160893292|NCT04087213|581004945|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
160893293|NCT04087213|581004945|FG000|Assisted Evaluable Period|Personal reasons|3|||
160893294|NCT04087213|581004945|FG000|Transition Period B|Renal Transplantation|1|||
160893295|NCT02476422|581004946|FG000|Overall Study|Subject/guardian decision|0|||
160893296|NCT02476422|581004947|FG001|Overall Study|Subject/guardian decision|1|||
160893297|NCT03960554|581004954|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
160893298|NCT03960554|581004955|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
160893299|NCT02545075|581004956|FG000|Randomization|Lost to Follow-up|0|||
160893300|NCT02545075|581004957|FG001|Randomization|Lost to Follow-up|1|||
160893301|NCT02545075|581004956|FG000|Randomization|Withdrawal by Subject|0|||
160893302|NCT02545075|581004957|FG001|Randomization|Withdrawal by Subject|6|||
160893303|NCT02545075|581004956|FG000|Treatment|Disease progression|71|||
160793588|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
160793589|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
160793590|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
160793591|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
160793592|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
160642891|NCT03705169|580074408|FG002|Overall Study|Lost to Follow-up|0|||
160642892|NCT03705169|580074409|FG003|Overall Study|Lost to Follow-up|2|||
160793593|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
160793594|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
160793595|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
160793596|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
160793597|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
160793598|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
160793599|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793600|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793601|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793602|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793603|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793604|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793605|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793606|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
160793607|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793608|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793609|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793610|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793611|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793612|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Death on study|0|||
160793613|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Death on study|0|||
160793614|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Death on study|0|||
160793615|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Death on study|1|||
160793616|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Death on study|0|||
160793617|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Death on study|0|||
160793618|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Death on study|0|||
160793619|NCT01362790|580631717|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
160793620|NCT01362790|580631718|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
160793621|NCT01362790|580631719|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
160793622|NCT01362790|580631720|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
160793623|NCT01362790|580631721|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
160793624|NCT01362790|580631722|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
160793625|NCT01362790|580631723|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
160793626|NCT01362790|580631717|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793627|NCT01362790|580631718|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793628|NCT01362790|580631719|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793629|NCT01362790|580631720|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793630|NCT01362790|580631721|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
160793631|NCT01362790|580631722|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793632|NCT01362790|580631723|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793633|NCT01362790|580631717|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
160793634|NCT01362790|580631718|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
160548473|NCT00454805|579734146|FG001|Overall Study|Withdrawal by Subject|2|||
160548474|NCT00454805|579734145|FG000|Overall Study|Death|0|||
160548475|NCT00454805|579734146|FG001|Overall Study|Death|2|||
160548476|NCT00454805|579734145|FG000|Overall Study|Disease progression|16|||
160548477|NCT00454805|579734146|FG001|Overall Study|Disease progression|19|||
160548478|NCT00454805|579734145|FG000|Overall Study|In order to begin radiotherapy|1|||
160548479|NCT00454805|579734146|FG001|Overall Study|In order to begin radiotherapy|0|||
160548480|NCT00217087|579734147|FG000|Overall Study|decided to have esophagectomy|1|||
160893304|NCT02545075|581004957|FG001|Treatment|Disease progression|32|||
160893305|NCT02545075|581004956|FG000|Treatment|Participant dicontinued study treatment|7|||
160893306|NCT02545075|581004957|FG001|Treatment|Participant dicontinued study treatment|9|||
160893307|NCT02545075|581004956|FG000|Treatment|Withdrawal by Subject|1|||
160893308|NCT02545075|581004957|FG001|Treatment|Withdrawal by Subject|0|||
160893309|NCT02545075|581004956|FG000|Treatment|Adverse event not related to study drug|1|||
160893310|NCT02545075|581004957|FG001|Treatment|Adverse event not related to study drug|0|||
160893311|NCT02545075|581004956|FG000|Treatment|Death|1|||
160893312|NCT02545075|581004957|FG001|Treatment|Death|0|||
160893313|NCT02545075|581004956|FG000|Treatment|Participant drug toxicity|1|||
160893314|NCT02545075|581004957|FG001|Treatment|Participant drug toxicity|0|||
160893315|NCT02545075|581004956|FG000|Treatment|Completed treatment|40|||
160893316|NCT02545075|581004957|FG001|Treatment|Completed treatment|12|||
160893317|NCT01272661|581004959|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
160893318|NCT01272661|581004960|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
160893319|NCT01272661|581004961|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
160893320|NCT01086423|581004962|FG000|Overall Study|Protocol Violation|0|||
160893321|NCT01086423|581004963|FG001|Overall Study|Protocol Violation|0|||
160893322|NCT01086423|581004964|FG002|Overall Study|Protocol Violation|1|||
160893323|NCT01086423|581004962|FG000|Overall Study|Migrated/moved from study area|2|||
160893324|NCT01086423|581004963|FG001|Overall Study|Migrated/moved from study area|0|||
160893325|NCT01086423|581004964|FG002|Overall Study|Migrated/moved from study area|4|||
160893326|NCT01086423|581004962|FG000|Overall Study|Adverse event, fatal|1|||
160893327|NCT01086423|581004963|FG001|Overall Study|Adverse event, fatal|1|||
160893328|NCT01086423|581004964|FG002|Overall Study|Adverse event, fatal|0|||
160893329|NCT01086423|581004962|FG000|Overall Study|Adverse event, non-fatal|2|||
160893330|NCT01086423|581004963|FG001|Overall Study|Adverse event, non-fatal|1|||
160893331|NCT01086423|581004964|FG002|Overall Study|Adverse event, non-fatal|0|||
160893332|NCT01086423|581004962|FG000|Overall Study|Withdrawal by Subject|5|||
160893333|NCT01086423|581004963|FG001|Overall Study|Withdrawal by Subject|1|||
160893334|NCT01086423|581004964|FG002|Overall Study|Withdrawal by Subject|3|||
160893335|NCT01086423|581004962|FG000|Overall Study|Lost to Follow-up|0|||
160893336|NCT01086423|581004963|FG001|Overall Study|Lost to Follow-up|0|||
160893337|NCT01086423|581004964|FG002|Overall Study|Lost to Follow-up|1|||
160893338|NCT00750880|581004968|FG000|Overall Study|Adverse Event|76|||
160893339|NCT00750880|581004968|FG000|Overall Study|Death|4|||
160893340|NCT00750880|581004968|FG000|Overall Study|Lack of Efficacy|46|||
160893341|NCT00750880|581004968|FG000|Overall Study|Lost to Follow-up|10|||
160893342|NCT00750880|581004968|FG000|Overall Study|Protocol Violation|15|||
160893343|NCT00750880|581004968|FG000|Overall Study|Withdrawal by Subject|33|||
160893344|NCT00750880|581004968|FG000|Overall Study|Physician Decision|20|||
160893345|NCT00750880|581004968|FG000|Overall Study|Administrative|11|||
160893346|NCT00925990|581004969|FG000|Overall Study|Adverse Event|1|||
160893347|NCT00925990|581004970|FG001|Overall Study|Adverse Event|3|||
160893348|NCT00925990|581004969|FG000|Overall Study|Withdrawal by Subject|2|||
160893349|NCT00925990|581004970|FG001|Overall Study|Withdrawal by Subject|2|||
160893350|NCT00925990|581004969|FG000|Overall Study|Lost to Follow-up|1|||
160893351|NCT00925990|581004970|FG001|Overall Study|Lost to Follow-up|3|||
160893352|NCT00925990|581004969|FG000|Overall Study|Physician Decision|1|||
160893353|NCT00925990|581004970|FG001|Overall Study|Physician Decision|1|||
160893354|NCT00925990|581004969|FG000|Overall Study|moved out of state, missed medication|0|||
160893355|NCT00925990|581004970|FG001|Overall Study|moved out of state, missed medication|2|||
160893356|NCT00573248|581004979|FG000|Overall Study|scheduling conflicts|15|||
160893357|NCT00573248|581004980|FG001|Overall Study|scheduling conflicts|11|||
160893358|NCT05342532|581004981|FG000|Overall Study|Adverse Event|5|||
160893359|NCT05342532|581004982|FG001|Overall Study|Adverse Event|20|||
160893360|NCT05342532|581004981|FG000|Overall Study|Lost to Follow-up|10|||
160548481|NCT00217087|579734148|FG001|Overall Study|decided to have esophagectomy|2|||
160548482|NCT00217087|579734147|FG000|Overall Study|completed less than 12 months return|10|||
160893361|NCT05342532|581004982|FG001|Overall Study|Lost to Follow-up|15|||
160893362|NCT02057393|581004983|FG000|Overall Study|Withdrawal by Subject|1|||
160893363|NCT02057393|581004983|FG000|Overall Study|Patient did not meet criteria|1|||
160893364|NCT01130103|581004990|FG000|Randomized Treatment|Adverse Event|1|||
160893365|NCT01130103|581004991|FG001|Randomized Treatment|Adverse Event|1|||
160893366|NCT01130103|581004990|FG000|Randomized Treatment|Lost to Follow-up|1|||
160893367|NCT01130103|581004991|FG001|Randomized Treatment|Lost to Follow-up|0|||
160893368|NCT01130103|581004990|FG000|Randomized Treatment|Protocol Violation|3|||
160893369|NCT01130103|581004991|FG001|Randomized Treatment|Protocol Violation|2|||
160893370|NCT01130103|581004990|FG000|Randomized Treatment|Withdrawal by Subject|1|||
160893371|NCT01130103|581004991|FG001|Randomized Treatment|Withdrawal by Subject|2|||
160893372|NCT01130103|581004990|FG000|Maintenance Treatment|Lack of Efficacy|0|||
160893373|NCT01130103|581004991|FG001|Maintenance Treatment|Lack of Efficacy|1|||
160893374|NCT01130103|581004990|FG000|Maintenance Treatment|Lost to Follow-up|1|||
160893375|NCT01130103|581004991|FG001|Maintenance Treatment|Lost to Follow-up|1|||
160893376|NCT01130103|581004990|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
160893377|NCT01130103|581004991|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
160893378|NCT00249288|581004992|FG000|Overall Study|Lost to Follow-up|3|||
160893379|NCT00249288|581004993|FG001|Overall Study|Lost to Follow-up|3|||
160893380|NCT00249288|581004992|FG000|Overall Study|Withdrawal by Subject|2|||
160982714|NCT02601937|581325071|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
160982715|NCT02601937|581325072|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
160982716|NCT02601937|581325073|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
160893381|NCT00249288|581004993|FG001|Overall Study|Withdrawal by Subject|2|||
160893382|NCT01437878|581004994|FG000|Overall Study|Withdrawal by Subject|1|||
160893383|NCT01437878|581004995|FG001|Overall Study|Withdrawal by Subject|0|||
160893384|NCT01476644|581005002|FG000|Overall Study|Death|5|||
160893385|NCT01476644|581005002|FG000|Overall Study|moved to another state|2|||
160893386|NCT01476644|581005002|FG000|Overall Study|Lost to Follow-up|19|||
160893387|NCT01476644|581005002|FG000|Overall Study|Withdrawal by Subject|13|||
160893388|NCT00471146|581005004|FG000|Overall Study|Adverse Event|32|||
160893389|NCT00471146|581005005|FG001|Overall Study|Adverse Event|33|||
160893390|NCT00471146|581005004|FG000|Overall Study|Withdrawal by Subject|14|||
160893391|NCT00471146|581005005|FG001|Overall Study|Withdrawal by Subject|11|||
160893392|NCT00471146|581005004|FG000|Overall Study|Death|11|||
160893393|NCT00471146|581005005|FG001|Overall Study|Death|12|||
160893394|NCT00471146|581005004|FG000|Overall Study|Lost to Follow-up|4|||
160893395|NCT00471146|581005005|FG001|Overall Study|Lost to Follow-up|2|||
160893396|NCT00471146|581005004|FG000|Overall Study|Protocol Violation|2|||
160893397|NCT00471146|581005005|FG001|Overall Study|Protocol Violation|2|||
160893398|NCT00471146|581005004|FG000|Overall Study|Objective progression or relapse|84|||
160893399|NCT00471146|581005005|FG001|Overall Study|Objective progression or relapse|87|||
160893400|NCT00471146|581005004|FG000|Overall Study|Global deterioration of health status|12|||
160893401|NCT00471146|581005005|FG001|Overall Study|Global deterioration of health status|14|||
160893402|NCT00471146|581005004|FG000|Overall Study|Randomized but not treated|9|||
160893403|NCT00471146|581005005|FG001|Overall Study|Randomized but not treated|8|||
160893404|NCT00471146|581005004|FG000|Overall Study|Other|4|||
160893405|NCT00471146|581005005|FG001|Overall Study|Other|5|||
160893406|NCT00467610|581005008|FG000|Overall Study|Withdrawal by Subject|1|||
160893407|NCT02676466|581005010|FG000|Overall Study|Death|0|||
160893408|NCT02676466|581005011|FG001|Overall Study|Death|2|||
160893409|NCT02676466|581005012|FG002|Overall Study|Death|1|||
160893410|NCT02676466|581005013|FG003|Overall Study|Death|0|||
160893411|NCT02676466|581005014|FG004|Overall Study|Death|0|||
160893412|NCT02676466|581005015|FG005|Overall Study|Death|0|||
160893413|NCT02676466|581005016|FG006|Overall Study|Death|0|||
160893414|NCT02676466|581005017|FG007|Overall Study|Death|0|||
160893415|NCT02676466|581005010|FG000|Overall Study|Withdrawal by Subject|4|||
160982717|NCT02601937|581325074|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
160982718|NCT02601937|581325075|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
160982719|NCT02601937|581325076|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
160982720|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982721|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982722|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982723|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982724|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982725|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982726|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982727|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982728|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982729|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
160893416|NCT02676466|581005011|FG001|Overall Study|Withdrawal by Subject|3|||
160893417|NCT02676466|581005012|FG002|Overall Study|Withdrawal by Subject|1|||
160893418|NCT02676466|581005013|FG003|Overall Study|Withdrawal by Subject|0|||
160893419|NCT02676466|581005014|FG004|Overall Study|Withdrawal by Subject|3|||
160893420|NCT02676466|581005015|FG005|Overall Study|Withdrawal by Subject|1|||
160893421|NCT02676466|581005016|FG006|Overall Study|Withdrawal by Subject|1|||
160893422|NCT02676466|581005017|FG007|Overall Study|Withdrawal by Subject|1|||
160893423|NCT01460368|581005018|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160893424|NCT01460368|581005019|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160893425|NCT01460368|581005020|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160982730|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160893426|NCT01460368|581005021|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160893427|NCT01460368|581005022|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
160893428|NCT01460368|581005023|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160893429|NCT01460368|581005024|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160893430|NCT01460368|581005018|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
160893431|NCT01460368|581005019|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
160893432|NCT01460368|581005020|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
160893433|NCT01460368|581005021|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
160893434|NCT01460368|581005022|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
160893435|NCT01460368|581005023|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
160893436|NCT01460368|581005024|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
160893437|NCT01460368|581005018|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893438|NCT01460368|581005019|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
160893439|NCT01460368|581005020|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893440|NCT01460368|581005021|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893441|NCT01460368|581005022|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893442|NCT01460368|581005023|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893443|NCT01460368|581005024|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893444|NCT01460368|581005018|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893445|NCT01460368|581005019|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893446|NCT01460368|581005020|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
160893447|NCT01460368|581005021|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893448|NCT01460368|581005022|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893449|NCT01460368|581005023|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893450|NCT01460368|581005024|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893451|NCT01460368|581005018|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
160893452|NCT01460368|581005019|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
160893453|NCT01460368|581005020|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
160893454|NCT01460368|581005021|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
160893455|NCT01460368|581005022|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
160893456|NCT01460368|581005023|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
160893457|NCT01460368|581005024|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
160893458|NCT01090973|581005025|FG000|Overall Study|Disease progression|1|||
160893459|NCT00445978|581005026|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
160893460|NCT00445978|581005026|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
160893461|NCT00445978|581005026|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
160893462|NCT00445978|581005026|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
160893463|NCT00445978|581005026|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
160893464|NCT00445978|581005026|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
160893465|NCT00445978|581005026|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
160893466|NCT00445978|581005026|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
160893467|NCT00445978|581005026|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
160893468|NCT00739596|581005027|FG000|Overall Study|Adverse Event|12|||
160893469|NCT00739596|581005028|FG001|Overall Study|Adverse Event|6|||
160893470|NCT00739596|581005027|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
160893471|NCT00739596|581005028|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160893472|NCT00739596|581005027|FG000|Overall Study|Patient Withdrew Consent|8|||
160893473|NCT00739596|581005028|FG001|Overall Study|Patient Withdrew Consent|8|||
160893474|NCT00739596|581005027|FG000|Overall Study|Lost to Follow-up|0|||
160893475|NCT00739596|581005028|FG001|Overall Study|Lost to Follow-up|2|||
160893476|NCT00739596|581005027|FG000|Overall Study|Protocol Deviation|1|||
160893477|NCT00739596|581005028|FG001|Overall Study|Protocol Deviation|1|||
160893478|NCT02520661|581005029|FG000|Overall Study|Lost to Follow-up|7|||
160893479|NCT02520661|581005030|FG001|Overall Study|Lost to Follow-up|3|||
160893480|NCT02520661|581005029|FG000|Overall Study|Admitted from ED|49|||
160893481|NCT02520661|581005030|FG001|Overall Study|Admitted from ED|48|||
160893482|NCT02520661|581005029|FG000|Overall Study|ED greater than 24 hours|29|||
160893483|NCT02520661|581005030|FG001|Overall Study|ED greater than 24 hours|38|||
160893484|NCT02520661|581005029|FG000|Overall Study|other ineligibility|14|||
160893485|NCT02520661|581005030|FG001|Overall Study|other ineligibility|22|||
160893486|NCT02520661|581005029|FG000|Overall Study|Withdrawal by Subject|7|||
160893487|NCT02520661|581005030|FG001|Overall Study|Withdrawal by Subject|16|||
160893488|NCT01414608|581005037|FG000|Overall Study|Ineligible|5|||
160893489|NCT01414608|581005038|FG001|Overall Study|Ineligible|2|||
160642893|NCT03705169|580074410|FG004|Overall Study|Lost to Follow-up|0|||
160893490|NCT00891462|581006304|FG000|Overall Study|Withdrawal by Subject|9|||
160893491|NCT00891462|581006305|FG001|Overall Study|Withdrawal by Subject|6|||
160893492|NCT00891462|581006306|FG002|Overall Study|Withdrawal by Subject|7|||
160893493|NCT00891462|581006304|FG000|Overall Study|Adverse Event|7|||
160893494|NCT00891462|581006305|FG001|Overall Study|Adverse Event|8|||
160893495|NCT00891462|581006306|FG002|Overall Study|Adverse Event|7|||
160793635|NCT01362790|580631719|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
160793636|NCT01362790|580631720|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
160793637|NCT01362790|580631721|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
160793638|NCT01362790|580631722|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
160793639|NCT01362790|580631723|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
160793640|NCT03485157|580631724|FG000|Double Blind Phase|Lost to Follow-up|4|||
160793641|NCT03485157|580631725|FG001|Double Blind Phase|Lost to Follow-up|4|||
160793642|NCT03485157|580631724|FG000|Double Blind Phase|Adverse Event|2|||
160793643|NCT03485157|580631725|FG001|Double Blind Phase|Adverse Event|1|||
160793644|NCT03485157|580631724|FG000|Double Blind Phase|Withdrawal by Subject|6|||
160793645|NCT03485157|580631725|FG001|Double Blind Phase|Withdrawal by Subject|9|||
160793646|NCT03485157|580631724|FG000|Double Blind Phase|Removal by PI|3|||
160793647|NCT03485157|580631725|FG001|Double Blind Phase|Removal by PI|7|||
160793648|NCT03485157|580631724|FG000|Open Label Phase|Lost to Follow-up|1|||
160793649|NCT03485157|580631725|FG001|Open Label Phase|Lost to Follow-up|2|||
160793650|NCT03485157|580631724|FG000|Open Label Phase|Adverse Event|0|||
160793651|NCT03485157|580631725|FG001|Open Label Phase|Adverse Event|1|||
160793652|NCT03485157|580631724|FG000|Open Label Phase|Withdrawal by Subject|1|||
160793653|NCT03485157|580631725|FG001|Open Label Phase|Withdrawal by Subject|2|||
160793654|NCT03485157|580631724|FG000|Open Label Phase|Removal by PI|2|||
160793655|NCT03485157|580631725|FG001|Open Label Phase|Removal by PI|0|||
160793656|NCT04347538|580631731|FG000|Overall Study|Lost to Follow-up|4|||
160793657|NCT04347538|580631732|FG001|Overall Study|Lost to Follow-up|5|||
160793658|NCT04347538|580631733|FG002|Overall Study|Lost to Follow-up|7|||
160793659|NCT02135133|580631734|FG000|Overall Study|Adverse Event|10|||
160793660|NCT02135133|580631734|FG000|Overall Study|regulatory mandate|5|||
160793661|NCT02259231|580631735|FG000|Overall Study|Adverse Event|1|||
160793662|NCT02259231|580631736|FG001|Overall Study|Adverse Event|1|||
160793663|NCT02259231|580631737|FG002|Overall Study|Adverse Event|2|||
160793664|NCT02259231|580631738|FG003|Overall Study|Adverse Event|0|||
160793665|NCT02259231|580631739|FG004|Overall Study|Adverse Event|0|||
160793666|NCT02259231|580631740|FG005|Overall Study|Adverse Event|0|||
160793667|NCT02259231|580631741|FG006|Overall Study|Adverse Event|0|||
160793668|NCT02259231|580631735|FG000|Overall Study|Progressive Disease|4|||
160793669|NCT02259231|580631736|FG001|Overall Study|Progressive Disease|5|||
160793670|NCT02259231|580631737|FG002|Overall Study|Progressive Disease|4|||
160793671|NCT02259231|580631738|FG003|Overall Study|Progressive Disease|5|||
160793672|NCT02259231|580631739|FG004|Overall Study|Progressive Disease|4|||
160793673|NCT02259231|580631740|FG005|Overall Study|Progressive Disease|5|||
160793674|NCT02259231|580631741|FG006|Overall Study|Progressive Disease|4|||
160793675|NCT02259231|580631735|FG000|Overall Study|Sponsor termination of study|1|||
160793676|NCT02259231|580631736|FG001|Overall Study|Sponsor termination of study|0|||
160793677|NCT02259231|580631737|FG002|Overall Study|Sponsor termination of study|0|||
160793678|NCT02259231|580631738|FG003|Overall Study|Sponsor termination of study|1|||
160793679|NCT02259231|580631739|FG004|Overall Study|Sponsor termination of study|2|||
160793680|NCT02259231|580631740|FG005|Overall Study|Sponsor termination of study|1|||
160793681|NCT02259231|580631741|FG006|Overall Study|Sponsor termination of study|1|||
160793682|NCT05081843|580631742|FG000|Overall Study|Lost to Follow-up|135|||
160793683|NCT05081843|580631743|FG001|Overall Study|Lost to Follow-up|145|||
160793684|NCT05852340|580631754|FG000|Period 5|Not completing the meal|0|||
160793685|NCT05852340|580631755|FG001|Period 5|Not completing the meal|1|||
160793686|NCT05852340|580631756|FG002|Period 5|Not completing the meal|0|||
160793687|NCT05852340|580631757|FG003|Period 5|Not completing the meal|0|||
160793688|NCT05852340|580631754|FG000|Period 5|Adverse Event|0|||
160793689|NCT05852340|580631755|FG001|Period 5|Adverse Event|0|||
160793690|NCT05852340|580631756|FG002|Period 5|Adverse Event|0|||
160793691|NCT05852340|580631757|FG003|Period 5|Adverse Event|1|||
160793692|NCT00071032|580631760|FG000|Overall Study|Lost to Follow-up|1|||
160793693|NCT00071032|580631761|FG001|Overall Study|Lost to Follow-up|1|||
160793694|NCT00071032|580631760|FG000|Overall Study|Withdrawal by Subject|8|||
160793695|NCT00071032|580631761|FG001|Overall Study|Withdrawal by Subject|6|||
160793696|NCT00071032|580631760|FG000|Overall Study|Missing Primary Outcome|0|||
160793697|NCT00071032|580631761|FG001|Overall Study|Missing Primary Outcome|1|||
160793698|NCT03648372|580631771|FG000|Overall Study|Withdrawal by Subject|2|||
160793699|NCT03648372|580631772|FG001|Overall Study|Withdrawal by Subject|0|||
160793700|NCT03648372|580631773|FG002|Overall Study|Withdrawal by Subject|0|||
160793701|NCT03648372|580631774|FG003|Overall Study|Withdrawal by Subject|0|||
160793702|NCT03648372|580631775|FG004|Overall Study|Withdrawal by Subject|0|||
160793703|NCT03648372|580631776|FG005|Overall Study|Withdrawal by Subject|1|||
160793704|NCT03648372|580631777|FG006|Overall Study|Withdrawal by Subject|2|||
160793705|NCT03648372|580631778|FG007|Overall Study|Withdrawal by Subject|0|||
160793706|NCT03648372|580631779|FG008|Overall Study|Withdrawal by Subject|0|||
160793707|NCT03648372|580631780|FG009|Overall Study|Withdrawal by Subject|0|||
160793708|NCT03648372|580631781|FG010|Overall Study|Withdrawal by Subject|2|||
160793709|NCT03648372|580631782|FG011|Overall Study|Withdrawal by Subject|0|||
160793710|NCT03648372|580631783|FG012|Overall Study|Withdrawal by Subject|2|||
160793711|NCT03648372|580631784|FG013|Overall Study|Withdrawal by Subject|0|||
160793712|NCT03648372|580631785|FG014|Overall Study|Withdrawal by Subject|0|||
160793713|NCT03648372|580631786|FG015|Overall Study|Withdrawal by Subject|0|||
160793714|NCT03648372|580631787|FG016|Overall Study|Withdrawal by Subject|1|||
160793715|NCT03648372|580631788|FG017|Overall Study|Withdrawal by Subject|0|||
160793716|NCT03648372|580631789|FG018|Overall Study|Withdrawal by Subject|0|||
160793717|NCT03648372|580631790|FG019|Overall Study|Withdrawal by Subject|0|||
160793718|NCT03648372|580631791|FG020|Overall Study|Withdrawal by Subject|0|||
160793719|NCT03648372|580631771|FG000|Overall Study|Progressive Disease|2|||
160793720|NCT03648372|580631772|FG001|Overall Study|Progressive Disease|3|||
160793721|NCT03648372|580631773|FG002|Overall Study|Progressive Disease|4|||
160793722|NCT03648372|580631774|FG003|Overall Study|Progressive Disease|3|||
160793723|NCT03648372|580631775|FG004|Overall Study|Progressive Disease|2|||
160793724|NCT03648372|580631776|FG005|Overall Study|Progressive Disease|2|||
160793725|NCT03648372|580631777|FG006|Overall Study|Progressive Disease|3|||
160793726|NCT03648372|580631778|FG007|Overall Study|Progressive Disease|3|||
160793727|NCT03648372|580631779|FG008|Overall Study|Progressive Disease|5|||
160793728|NCT03648372|580631780|FG009|Overall Study|Progressive Disease|5|||
160793729|NCT03648372|580631781|FG010|Overall Study|Progressive Disease|2|||
160793730|NCT03648372|580631782|FG011|Overall Study|Progressive Disease|3|||
160793731|NCT03648372|580631783|FG012|Overall Study|Progressive Disease|3|||
160793732|NCT03648372|580631784|FG013|Overall Study|Progressive Disease|3|||
160793733|NCT03648372|580631785|FG014|Overall Study|Progressive Disease|6|||
160793734|NCT03648372|580631786|FG015|Overall Study|Progressive Disease|0|||
160793735|NCT03648372|580631787|FG016|Overall Study|Progressive Disease|0|||
160793736|NCT03648372|580631788|FG017|Overall Study|Progressive Disease|0|||
160793737|NCT03648372|580631789|FG018|Overall Study|Progressive Disease|0|||
160793738|NCT03648372|580631790|FG019|Overall Study|Progressive Disease|0|||
160793739|NCT03648372|580631791|FG020|Overall Study|Progressive Disease|0|||
160793740|NCT03648372|580631771|FG000|Overall Study|Other|0|||
160793741|NCT03648372|580631772|FG001|Overall Study|Other|0|||
160793742|NCT03648372|580631773|FG002|Overall Study|Other|0|||
160793743|NCT03648372|580631774|FG003|Overall Study|Other|0|||
160982731|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160793744|NCT03648372|580631775|FG004|Overall Study|Other|1|||
160793745|NCT03648372|580631776|FG005|Overall Study|Other|0|||
160793746|NCT03648372|580631777|FG006|Overall Study|Other|0|||
160793747|NCT03648372|580631778|FG007|Overall Study|Other|0|||
160793748|NCT03648372|580631779|FG008|Overall Study|Other|0|||
160793749|NCT03648372|580631780|FG009|Overall Study|Other|0|||
160793750|NCT03648372|580631781|FG010|Overall Study|Other|1|||
160793751|NCT03648372|580631782|FG011|Overall Study|Other|2|||
160982732|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982733|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982734|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982735|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982736|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982737|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982738|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
160793752|NCT03648372|580631783|FG012|Overall Study|Other|1|||
160793753|NCT03648372|580631784|FG013|Overall Study|Other|3|||
160793754|NCT03648372|580631785|FG014|Overall Study|Other|0|||
160793755|NCT03648372|580631786|FG015|Overall Study|Other|5|||
160793756|NCT03648372|580631787|FG016|Overall Study|Other|1|||
160793757|NCT03648372|580631788|FG017|Overall Study|Other|5|||
160793758|NCT03648372|580631789|FG018|Overall Study|Other|0|||
160793759|NCT03648372|580631790|FG019|Overall Study|Other|1|||
160793760|NCT03648372|580631791|FG020|Overall Study|Other|0|||
160793761|NCT03648372|580631771|FG000|Overall Study|Lost to Follow-up|0|||
160793762|NCT03648372|580631772|FG001|Overall Study|Lost to Follow-up|0|||
160793763|NCT03648372|580631773|FG002|Overall Study|Lost to Follow-up|0|||
160793764|NCT03648372|580631774|FG003|Overall Study|Lost to Follow-up|0|||
160793765|NCT03648372|580631775|FG004|Overall Study|Lost to Follow-up|0|||
160793766|NCT03648372|580631776|FG005|Overall Study|Lost to Follow-up|0|||
160793767|NCT03648372|580631777|FG006|Overall Study|Lost to Follow-up|0|||
160793768|NCT03648372|580631778|FG007|Overall Study|Lost to Follow-up|0|||
160793769|NCT03648372|580631779|FG008|Overall Study|Lost to Follow-up|0|||
160982739|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160642894|NCT03705169|580074411|FG005|Overall Study|Lost to Follow-up|2|||
160793770|NCT03648372|580631780|FG009|Overall Study|Lost to Follow-up|0|||
160793771|NCT03648372|580631781|FG010|Overall Study|Lost to Follow-up|0|||
160793772|NCT03648372|580631782|FG011|Overall Study|Lost to Follow-up|0|||
160793773|NCT03648372|580631783|FG012|Overall Study|Lost to Follow-up|0|||
160793774|NCT03648372|580631784|FG013|Overall Study|Lost to Follow-up|1|||
160793775|NCT03648372|580631785|FG014|Overall Study|Lost to Follow-up|0|||
160793776|NCT03648372|580631786|FG015|Overall Study|Lost to Follow-up|1|||
160793777|NCT03648372|580631787|FG016|Overall Study|Lost to Follow-up|0|||
160793778|NCT03648372|580631788|FG017|Overall Study|Lost to Follow-up|1|||
160793779|NCT03648372|580631789|FG018|Overall Study|Lost to Follow-up|0|||
160793780|NCT03648372|580631790|FG019|Overall Study|Lost to Follow-up|0|||
160793781|NCT03648372|580631791|FG020|Overall Study|Lost to Follow-up|0|||
160793782|NCT03648372|580631771|FG000|Overall Study|Start of a New Systemic Treatment|0|||
160793783|NCT03648372|580631772|FG001|Overall Study|Start of a New Systemic Treatment|0|||
160793784|NCT03648372|580631773|FG002|Overall Study|Start of a New Systemic Treatment|0|||
160793785|NCT03648372|580631774|FG003|Overall Study|Start of a New Systemic Treatment|0|||
160793786|NCT03648372|580631775|FG004|Overall Study|Start of a New Systemic Treatment|0|||
160793787|NCT03648372|580631776|FG005|Overall Study|Start of a New Systemic Treatment|0|||
160793788|NCT03648372|580631777|FG006|Overall Study|Start of a New Systemic Treatment|0|||
160793789|NCT03648372|580631778|FG007|Overall Study|Start of a New Systemic Treatment|2|||
160793790|NCT03648372|580631779|FG008|Overall Study|Start of a New Systemic Treatment|0|||
160793791|NCT03648372|580631780|FG009|Overall Study|Start of a New Systemic Treatment|0|||
160793792|NCT03648372|580631781|FG010|Overall Study|Start of a New Systemic Treatment|1|||
160793793|NCT03648372|580631782|FG011|Overall Study|Start of a New Systemic Treatment|0|||
160793794|NCT03648372|580631783|FG012|Overall Study|Start of a New Systemic Treatment|0|||
160793795|NCT03648372|580631784|FG013|Overall Study|Start of a New Systemic Treatment|0|||
160793796|NCT03648372|580631785|FG014|Overall Study|Start of a New Systemic Treatment|0|||
160793797|NCT03648372|580631786|FG015|Overall Study|Start of a New Systemic Treatment|0|||
160793798|NCT03648372|580631787|FG016|Overall Study|Start of a New Systemic Treatment|0|||
160793799|NCT03648372|580631788|FG017|Overall Study|Start of a New Systemic Treatment|0|||
160793800|NCT03648372|580631789|FG018|Overall Study|Start of a New Systemic Treatment|0|||
160793801|NCT03648372|580631790|FG019|Overall Study|Start of a New Systemic Treatment|0|||
160793802|NCT03648372|580631791|FG020|Overall Study|Start of a New Systemic Treatment|0|||
160793803|NCT00730327|580633215|FG000|Overall Study|Lost to Follow-up|14|||
160793804|NCT00730327|580633216|FG001|Overall Study|Lost to Follow-up|16|||
160793805|NCT00730327|580633215|FG000|Overall Study|Adverse Event|8|||
160793806|NCT00730327|580633216|FG001|Overall Study|Adverse Event|1|||
160793807|NCT00730327|580633215|FG000|Overall Study|Withdrawal by Subject|3|||
160793808|NCT00730327|580633216|FG001|Overall Study|Withdrawal by Subject|13|||
160793809|NCT00730327|580633215|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
160793810|NCT00730327|580633216|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
160793811|NCT04507204|580633217|FG000|Overall Study|Adverse Event|8|||
160793812|NCT04507204|580633218|FG001|Overall Study|Adverse Event|13|||
160793813|NCT04507204|580633217|FG000|Overall Study|Death|0|||
160793814|NCT04507204|580633218|FG001|Overall Study|Death|1|||
160793815|NCT04507204|580633217|FG000|Overall Study|Lost to Follow-up|15|||
160793816|NCT04507204|580633218|FG001|Overall Study|Lost to Follow-up|14|||
160793817|NCT04507204|580633217|FG000|Overall Study|Poor Compliance with Protocol|2|||
160793818|NCT04507204|580633218|FG001|Overall Study|Poor Compliance with Protocol|4|||
160793819|NCT04507204|580633217|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
160793820|NCT04507204|580633218|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
160793821|NCT04507204|580633217|FG000|Overall Study|Withdrawal of Patient Consent|21|||
160793822|NCT04507204|580633218|FG001|Overall Study|Withdrawal of Patient Consent|13|||
160793823|NCT01358734|580633221|FG000|Overall Study|Adverse Event|4|||
160793824|NCT01358734|580633222|FG001|Overall Study|Adverse Event|7|||
160793825|NCT01358734|580633223|FG002|Overall Study|Adverse Event|3|||
160793826|NCT01358734|580633221|FG000|Overall Study|Lack of Efficacy|0|||
160793827|NCT01358734|580633222|FG001|Overall Study|Lack of Efficacy|1|||
160793828|NCT01358734|580633223|FG002|Overall Study|Lack of Efficacy|3|||
160793829|NCT01358734|580633221|FG000|Overall Study|Withdrawal by Subject|1|||
160793830|NCT01358734|580633222|FG001|Overall Study|Withdrawal by Subject|6|||
160793831|NCT01358734|580633223|FG002|Overall Study|Withdrawal by Subject|3|||
160642895|NCT03705169|580074412|FG006|Overall Study|Lost to Follow-up|1|||
160793832|NCT01358734|580633221|FG000|Overall Study|Death|3|||
160793833|NCT01358734|580633222|FG001|Overall Study|Death|7|||
160793834|NCT01358734|580633223|FG002|Overall Study|Death|2|||
160793835|NCT01358734|580633221|FG000|Overall Study|Progressive Disease|5|||
160793836|NCT01358734|580633222|FG001|Overall Study|Progressive Disease|13|||
160793837|NCT01358734|580633223|FG002|Overall Study|Progressive Disease|16|||
160793838|NCT01358734|580633221|FG000|Overall Study|Non-compliance with study drug|0|||
160793839|NCT01358734|580633222|FG001|Overall Study|Non-compliance with study drug|0|||
160793840|NCT01358734|580633223|FG002|Overall Study|Non-compliance with study drug|1|||
160793841|NCT01358734|580633221|FG000|Overall Study|Other|2|||
160793842|NCT01358734|580633222|FG001|Overall Study|Other|5|||
160793843|NCT01358734|580633223|FG002|Overall Study|Other|4|||
160793844|NCT01358734|580633221|FG000|Overall Study|Protocol Violation|0|||
160793845|NCT01358734|580633222|FG001|Overall Study|Protocol Violation|0|||
160793846|NCT01358734|580633223|FG002|Overall Study|Protocol Violation|2|||
160793847|NCT01905540|580633226|FG000|Period 3|Other|1|||
160793848|NCT01905540|580633227|FG001|Period 3|Other|0|||
160793849|NCT01905540|580633228|FG002|Period 3|Other|1|||
160793850|NCT01905540|580633229|FG003|Period 3|Other|1|||
160793851|NCT00725985|580633232|FG000|ITP- Treatment Disposition|Adverse Event|20|||
160793852|NCT00725985|580633233|FG001|ITP- Treatment Disposition|Adverse Event|10|||
160793853|NCT00725985|580633234|FG002|ITP- Treatment Disposition|Adverse Event|5|||
160793854|NCT00725985|580633235|FG003|ITP- Treatment Disposition|Adverse Event|0|||
160982740|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982741|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982742|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160793855|NCT00725985|580633236|FG004|ITP- Treatment Disposition|Adverse Event|0|||
160793856|NCT00725985|580633237|FG005|ITP- Treatment Disposition|Adverse Event|0|||
160793857|NCT00725985|580633238|FG006|ITP- Treatment Disposition|Adverse Event|0|||
160793858|NCT00725985|580633239|FG007|ITP- Treatment Disposition|Adverse Event|0|||
160793859|NCT00725985|580633240|FG008|ITP- Treatment Disposition|Adverse Event|0|||
160793860|NCT00725985|580633241|FG009|ITP- Treatment Disposition|Adverse Event|0|||
160793861|NCT00725985|580633242|FG010|ITP- Treatment Disposition|Adverse Event|0|||
160793862|NCT00725985|580633243|FG011|ITP- Treatment Disposition|Adverse Event|0|||
160793863|NCT00725985|580633232|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793864|NCT00725985|580633233|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793865|NCT00725985|580633234|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
160793866|NCT00725985|580633235|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793867|NCT00725985|580633236|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793868|NCT00725985|580633237|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793869|NCT00725985|580633238|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793870|NCT00725985|580633239|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793871|NCT00725985|580633240|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793872|NCT00725985|580633241|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793873|NCT00725985|580633242|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793874|NCT00725985|580633243|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793875|NCT00725985|580633232|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
160793876|NCT00725985|580633233|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
160793877|NCT00725985|580633234|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
160793878|NCT00725985|580633235|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
160793879|NCT00725985|580633236|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
160793880|NCT00725985|580633237|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
160793881|NCT00725985|580633238|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
160793882|NCT00725985|580633239|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
160793883|NCT00725985|580633240|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
160793884|NCT00725985|580633241|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
160793885|NCT00725985|580633242|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
160793886|NCT00725985|580633243|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
160793887|NCT00725985|580633232|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
160793888|NCT00725985|580633233|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
160793889|NCT00725985|580633234|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
160793890|NCT00725985|580633235|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
160793891|NCT00725985|580633236|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
160793892|NCT00725985|580633237|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
160793893|NCT00725985|580633238|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
160793894|NCT00725985|580633239|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
160793895|NCT00725985|580633240|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
160793896|NCT00725985|580633241|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
160793897|NCT00725985|580633242|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
160793898|NCT00725985|580633243|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
160793899|NCT00725985|580633232|FG000|ITP- Treatment Disposition|Other|50|||
160793900|NCT00725985|580633233|FG001|ITP- Treatment Disposition|Other|38|||
160793901|NCT00725985|580633234|FG002|ITP- Treatment Disposition|Other|24|||
160793902|NCT00725985|580633235|FG003|ITP- Treatment Disposition|Other|0|||
160793903|NCT00725985|580633236|FG004|ITP- Treatment Disposition|Other|0|||
160793904|NCT00725985|580633237|FG005|ITP- Treatment Disposition|Other|0|||
160793905|NCT00725985|580633238|FG006|ITP- Treatment Disposition|Other|0|||
160793906|NCT00725985|580633239|FG007|ITP- Treatment Disposition|Other|0|||
160793907|NCT00725985|580633240|FG008|ITP- Treatment Disposition|Other|0|||
160793908|NCT00725985|580633241|FG009|ITP- Treatment Disposition|Other|0|||
160793909|NCT00725985|580633242|FG010|ITP- Treatment Disposition|Other|0|||
160793910|NCT00725985|580633243|FG011|ITP- Treatment Disposition|Other|0|||
160793911|NCT00725985|580633232|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793912|NCT00725985|580633233|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793913|NCT00725985|580633234|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793914|NCT00725985|580633235|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
160793915|NCT00725985|580633236|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
160793916|NCT00725985|580633237|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
160793917|NCT00725985|580633238|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793918|NCT00725985|580633239|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793919|NCT00725985|580633240|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793920|NCT00725985|580633241|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793921|NCT00725985|580633242|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793922|NCT00725985|580633243|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793923|NCT00725985|580633232|FG000|OLMP (Up to 96 Weeks)|Death|0|||
160793924|NCT00725985|580633233|FG001|OLMP (Up to 96 Weeks)|Death|0|||
160793925|NCT00725985|580633234|FG002|OLMP (Up to 96 Weeks)|Death|0|||
160793926|NCT00725985|580633235|FG003|OLMP (Up to 96 Weeks)|Death|0|||
160793927|NCT00725985|580633236|FG004|OLMP (Up to 96 Weeks)|Death|1|||
160793928|NCT00725985|580633237|FG005|OLMP (Up to 96 Weeks)|Death|0|||
160793929|NCT00725985|580633238|FG006|OLMP (Up to 96 Weeks)|Death|0|||
160793930|NCT00725985|580633239|FG007|OLMP (Up to 96 Weeks)|Death|0|||
160793931|NCT00725985|580633240|FG008|OLMP (Up to 96 Weeks)|Death|0|||
160793932|NCT00725985|580633241|FG009|OLMP (Up to 96 Weeks)|Death|0|||
160793933|NCT00725985|580633242|FG010|OLMP (Up to 96 Weeks)|Death|0|||
160793934|NCT00725985|580633243|FG011|OLMP (Up to 96 Weeks)|Death|0|||
160793935|NCT00725985|580633232|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793936|NCT00725985|580633233|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793937|NCT00725985|580633234|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793938|NCT00725985|580633235|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
160793939|NCT00725985|580633236|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793940|NCT00725985|580633237|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793941|NCT00725985|580633238|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793942|NCT00725985|580633239|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793943|NCT00725985|580633240|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793944|NCT00725985|580633241|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793945|NCT00725985|580633242|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793946|NCT00725985|580633243|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793947|NCT00725985|580633232|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793948|NCT00725985|580633233|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793949|NCT00725985|580633234|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793950|NCT00725985|580633235|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793951|NCT00725985|580633236|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793952|NCT00725985|580633237|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
160793953|NCT00725985|580633238|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793954|NCT00725985|580633239|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793955|NCT00725985|580633240|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793956|NCT00725985|580633241|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793957|NCT00725985|580633242|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793958|NCT00725985|580633243|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793959|NCT00725985|580633232|FG000|OLMP (Up to 96 Weeks)|Other|0|||
160642896|NCT03705169|580074413|FG007|Overall Study|Lost to Follow-up|0|||
160793960|NCT00725985|580633233|FG001|OLMP (Up to 96 Weeks)|Other|0|||
160793961|NCT00725985|580633234|FG002|OLMP (Up to 96 Weeks)|Other|0|||
160793962|NCT00725985|580633235|FG003|OLMP (Up to 96 Weeks)|Other|15|||
160793963|NCT00725985|580633236|FG004|OLMP (Up to 96 Weeks)|Other|20|||
160793964|NCT00725985|580633237|FG005|OLMP (Up to 96 Weeks)|Other|44|||
160793965|NCT00725985|580633238|FG006|OLMP (Up to 96 Weeks)|Other|0|||
160793966|NCT00725985|580633239|FG007|OLMP (Up to 96 Weeks)|Other|0|||
160793967|NCT00725985|580633240|FG008|OLMP (Up to 96 Weeks)|Other|0|||
160793968|NCT00725985|580633241|FG009|OLMP (Up to 96 Weeks)|Other|0|||
160793969|NCT00725985|580633242|FG010|OLMP (Up to 96 Weeks)|Other|0|||
160793970|NCT00725985|580633243|FG011|OLMP (Up to 96 Weeks)|Other|0|||
160793971|NCT00725985|580633232|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793972|NCT00725985|580633233|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793973|NCT00725985|580633234|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793974|NCT00725985|580633235|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793975|NCT00725985|580633236|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793976|NCT00725985|580633237|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793977|NCT00725985|580633238|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793978|NCT00725985|580633239|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
160793979|NCT00725985|580633240|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793980|NCT00725985|580633241|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793981|NCT00725985|580633242|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793982|NCT00725985|580633243|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793983|NCT00725985|580633232|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793984|NCT00725985|580633233|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793985|NCT00725985|580633234|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160642897|NCT03705169|580074414|FG008|Overall Study|Lost to Follow-up|0|||
160793986|NCT00725985|580633235|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793987|NCT00725985|580633236|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793988|NCT00725985|580633237|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793989|NCT00725985|580633238|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793990|NCT00725985|580633239|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793991|NCT00725985|580633240|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
160793992|NCT00725985|580633241|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793993|NCT00725985|580633242|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793994|NCT00725985|580633243|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160893496|NCT00891462|581006304|FG000|Overall Study|Lack of Efficacy|10|||
160793995|NCT00725985|580633232|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160793996|NCT00725985|580633233|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160793997|NCT00725985|580633234|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160793998|NCT00725985|580633235|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160793999|NCT00725985|580633236|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160794000|NCT00725985|580633237|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160794001|NCT00725985|580633238|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
160794002|NCT00725985|580633239|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
160794003|NCT00725985|580633240|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
160794004|NCT00725985|580633241|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160794005|NCT00725985|580633242|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160794006|NCT00725985|580633243|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160794007|NCT00725985|580633232|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794008|NCT00725985|580633233|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794009|NCT00725985|580633234|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794010|NCT00725985|580633235|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794011|NCT00725985|580633236|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794012|NCT00725985|580633237|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794013|NCT00725985|580633238|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794014|NCT00725985|580633239|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794015|NCT00725985|580633240|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794016|NCT00725985|580633241|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
160794017|NCT00725985|580633242|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
160794018|NCT00725985|580633243|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
160794019|NCT01182350|580633244|FG000|Overall Study|Adverse Event|5|||
160794020|NCT01182350|580633245|FG001|Overall Study|Adverse Event|0|||
160794021|NCT01182350|580633246|FG002|Overall Study|Adverse Event|0|||
160794022|NCT01182350|580633247|FG003|Overall Study|Adverse Event|0|||
160794023|NCT01182350|580633248|FG004|Overall Study|Adverse Event|0|||
160794024|NCT01182350|580633244|FG000|Overall Study|Disease Progression|15|||
160794025|NCT01182350|580633245|FG001|Overall Study|Disease Progression|12|||
160794026|NCT01182350|580633246|FG002|Overall Study|Disease Progression|0|||
160794027|NCT01182350|580633247|FG003|Overall Study|Disease Progression|1|||
160794028|NCT01182350|580633248|FG004|Overall Study|Disease Progression|0|||
160794029|NCT01182350|580633244|FG000|Overall Study|Death|0|||
160794030|NCT01182350|580633245|FG001|Overall Study|Death|1|||
160794031|NCT01182350|580633246|FG002|Overall Study|Death|1|||
160794032|NCT01182350|580633247|FG003|Overall Study|Death|0|||
160794033|NCT01182350|580633248|FG004|Overall Study|Death|0|||
160794034|NCT01182350|580633244|FG000|Overall Study|Withdrawal by Subject|3|||
160794035|NCT01182350|580633245|FG001|Overall Study|Withdrawal by Subject|1|||
160794036|NCT01182350|580633246|FG002|Overall Study|Withdrawal by Subject|0|||
160794037|NCT01182350|580633247|FG003|Overall Study|Withdrawal by Subject|1|||
160794038|NCT01182350|580633248|FG004|Overall Study|Withdrawal by Subject|0|||
160794039|NCT01182350|580633244|FG000|Overall Study|Alternative Therapy|2|||
160794040|NCT01182350|580633245|FG001|Overall Study|Alternative Therapy|0|||
160794041|NCT01182350|580633246|FG002|Overall Study|Alternative Therapy|1|||
160794042|NCT01182350|580633247|FG003|Overall Study|Alternative Therapy|0|||
160794043|NCT01182350|580633248|FG004|Overall Study|Alternative Therapy|0|||
160794044|NCT01182350|580633244|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
160794045|NCT01182350|580633245|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
160794046|NCT01182350|580633246|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
160794047|NCT01182350|580633247|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
160794048|NCT01182350|580633248|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
160794049|NCT01182350|580633244|FG000|Overall Study|Unevaluable for Biopsy|0|||
160794050|NCT01182350|580633245|FG001|Overall Study|Unevaluable for Biopsy|0|||
160794051|NCT01182350|580633246|FG002|Overall Study|Unevaluable for Biopsy|0|||
160794052|NCT01182350|580633247|FG003|Overall Study|Unevaluable for Biopsy|0|||
160794053|NCT01182350|580633248|FG004|Overall Study|Unevaluable for Biopsy|3|||
160794054|NCT00605189|580633249|FG000|Overall Study|Adverse Event|1|||
160794055|NCT00605189|580633250|FG001|Overall Study|Adverse Event|0|||
160794056|NCT00605189|580633251|FG002|Overall Study|Adverse Event|0|||
160794057|NCT00605189|580633249|FG000|Overall Study|Other|2|||
160794058|NCT00605189|580633250|FG001|Overall Study|Other|2|||
160794059|NCT00605189|580633251|FG002|Overall Study|Other|0|||
160794060|NCT05030766|580633252|FG000|Phase 1 Participants|Lost to Follow-up|12|||
160794061|NCT05030766|580633253|FG001|Phase 1 Participants|Lost to Follow-up|22|||
160794062|NCT05030766|580633254|FG002|Phase 1 Participants|Lost to Follow-up|0|||
160794063|NCT05030766|580633255|FG003|Phase 1 Participants|Lost to Follow-up|0|||
160893497|NCT00891462|581006305|FG001|Overall Study|Lack of Efficacy|5|||
160893498|NCT00891462|581006306|FG002|Overall Study|Lack of Efficacy|1|||
160794064|NCT05030766|580633252|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
160794065|NCT05030766|580633253|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
160794066|NCT05030766|580633254|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
160893499|NCT00891462|581006304|FG000|Overall Study|COPD exacerbation|7|||
160794067|NCT05030766|580633255|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
160794068|NCT05030766|580633252|FG000|Phase 2 Participants|Lost to Follow-up|0|||
160794069|NCT05030766|580633253|FG001|Phase 2 Participants|Lost to Follow-up|0|||
160794070|NCT05030766|580633254|FG002|Phase 2 Participants|Lost to Follow-up|6|||
160794071|NCT05030766|580633255|FG003|Phase 2 Participants|Lost to Follow-up|2|||
160794072|NCT00645658|580633256|FG000|Overall Study|Withdrawal by Subject|1|||
160794073|NCT00645658|580633257|FG001|Overall Study|Withdrawal by Subject|0|||
160794074|NCT00645658|580633256|FG000|Overall Study|Did not complete all assesments|0|||
160794075|NCT00645658|580633257|FG001|Overall Study|Did not complete all assesments|2|||
160794076|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
160794077|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
160794078|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
160794079|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
160794080|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
160794081|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
160794082|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
160794083|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
160794084|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
160794085|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
160794086|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
160794087|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
160794088|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
160794089|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
160794090|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
160794091|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
160794092|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
160794093|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
160794094|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
160548483|NCT00217087|579734148|FG001|Overall Study|completed less than 12 months return|18|||
160794095|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
160794096|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
160794097|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
160794098|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
160794099|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
160794100|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
160794101|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
160893500|NCT00891462|581006305|FG001|Overall Study|COPD exacerbation|4|||
160893501|NCT00891462|581006306|FG002|Overall Study|COPD exacerbation|1|||
160893502|NCT00891462|581006304|FG000|Overall Study|Other Reason|2|||
160893503|NCT00891462|581006305|FG001|Overall Study|Other Reason|5|||
160893504|NCT00891462|581006306|FG002|Overall Study|Other Reason|3|||
160893505|NCT00891462|581006304|FG000|Overall Study|Protocol Violation|2|||
160893506|NCT00891462|581006305|FG001|Overall Study|Protocol Violation|1|||
160893507|NCT00891462|581006306|FG002|Overall Study|Protocol Violation|3|||
160548484|NCT03208231|579734153|FG000|Overall Study|Death|1|||
160548485|NCT03208231|579734154|FG001|Overall Study|Death|2|||
160794102|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
160794103|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
160794104|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
160548486|NCT03208231|579734153|FG000|Overall Study|Moved and unable to get to clinic|1|||
160548487|NCT03208231|579734154|FG001|Overall Study|Moved and unable to get to clinic|0|||
160548488|NCT03208231|579734153|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
160794105|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
160794106|NCT03093415|580633260|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
160794107|NCT03093415|580633261|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
160893508|NCT00891462|581006304|FG000|Overall Study|Inclusion/exclusion criteria|0|||
160893509|NCT00891462|581006305|FG001|Overall Study|Inclusion/exclusion criteria|2|||
160893510|NCT00891462|581006306|FG002|Overall Study|Inclusion/exclusion criteria|2|||
160548489|NCT03208231|579734154|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
160548490|NCT04947800|579734157|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
160548491|NCT04947800|579734158|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
160548492|NCT04947800|579734159|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
160548493|NCT03892746|579734160|FG000|Overall Study|Withdrawal by Subject|2|||
160642898|NCT03705169|580074415|FG009|Overall Study|Lost to Follow-up|1|||
160642899|NCT03705169|580074406|FG000|Overall Study|Adverse Event|0|||
160642900|NCT03705169|580074407|FG001|Overall Study|Adverse Event|0|||
160893511|NCT00891462|581006304|FG000|Overall Study|Lost to Follow-up|0|||
160893512|NCT00891462|581006305|FG001|Overall Study|Lost to Follow-up|2|||
160893513|NCT00891462|581006306|FG002|Overall Study|Lost to Follow-up|0|||
160893514|NCT01083485|581006307|FG000|Overall Study|Adverse Event|0|||
160893515|NCT01083485|581006308|FG001|Overall Study|Adverse Event|1|||
160893516|NCT01083485|581006307|FG000|Overall Study|Protocol Violation|1|||
160893517|NCT01083485|581006308|FG001|Overall Study|Protocol Violation|0|||
160893518|NCT01083485|581006307|FG000|Overall Study|Withdrawal by Subject|5|||
160893519|NCT01083485|581006308|FG001|Overall Study|Withdrawal by Subject|2|||
160893520|NCT01083485|581006307|FG000|Overall Study|Other|1|||
160893521|NCT01083485|581006308|FG001|Overall Study|Other|0|||
160893522|NCT05108922|581006309|FG000|Overall Study|Adverse Event|2|||
160893523|NCT05108922|581006310|FG001|Overall Study|Adverse Event|3|||
160893524|NCT05108922|581006309|FG000|Overall Study|Lost to Follow-up|2|||
160893525|NCT05108922|581006310|FG001|Overall Study|Lost to Follow-up|1|||
160893526|NCT05108922|581006309|FG000|Overall Study|Inadvertent enrollment|0|||
160893527|NCT05108922|581006310|FG001|Overall Study|Inadvertent enrollment|1|||
160893528|NCT05108922|581006309|FG000|Overall Study|Physician Decision|2|||
160893529|NCT05108922|581006310|FG001|Overall Study|Physician Decision|3|||
160893530|NCT05108922|581006309|FG000|Overall Study|Protocol deviation|1|||
160893531|NCT05108922|581006310|FG001|Overall Study|Protocol deviation|0|||
160893532|NCT05108922|581006309|FG000|Overall Study|Screen failure|1|||
160893533|NCT05108922|581006310|FG001|Overall Study|Screen failure|0|||
160893534|NCT05108922|581006309|FG000|Overall Study|Withdrawal by Subject|11|||
160893535|NCT05108922|581006310|FG001|Overall Study|Withdrawal by Subject|8|||
160893536|NCT05036369|581006311|FG000|Overall Study|Run In non compliance|1|||
160893537|NCT05036369|581006312|FG001|Overall Study|Run In non compliance|2|||
160893538|NCT05036369|581006311|FG000|Overall Study|Change in eligibility criteria|0|||
160893539|NCT05036369|581006312|FG001|Overall Study|Change in eligibility criteria|1|||
160893540|NCT01846104|581006313|FG000|Overall Study|Withdrawal by Subject|1|||
160893541|NCT01854658|581006318|FG000|Overall Study|Protocol Violation|6|||
160893542|NCT01854658|581006319|FG001|Overall Study|Protocol Violation|2|||
160893543|NCT01854658|581006320|FG002|Overall Study|Protocol Violation|2|||
160893544|NCT01854658|581006321|FG003|Overall Study|Protocol Violation|1|||
160893545|NCT01854658|581006318|FG000|Overall Study|Physician Decision|7|||
160893546|NCT01854658|581006319|FG001|Overall Study|Physician Decision|5|||
160893547|NCT01854658|581006320|FG002|Overall Study|Physician Decision|2|||
160893548|NCT01854658|581006321|FG003|Overall Study|Physician Decision|4|||
160893549|NCT01854658|581006318|FG000|Overall Study|Lost to Follow-up|8|||
160893550|NCT01854658|581006319|FG001|Overall Study|Lost to Follow-up|9|||
160893551|NCT01854658|581006320|FG002|Overall Study|Lost to Follow-up|8|||
160893552|NCT01854658|581006321|FG003|Overall Study|Lost to Follow-up|4|||
160893553|NCT01854658|581006318|FG000|Overall Study|Withdrawal by Subject|28|||
160893554|NCT01854658|581006319|FG001|Overall Study|Withdrawal by Subject|21|||
160893555|NCT01854658|581006320|FG002|Overall Study|Withdrawal by Subject|29|||
160893556|NCT01854658|581006321|FG003|Overall Study|Withdrawal by Subject|15|||
160893557|NCT01854658|581006318|FG000|Overall Study|Protocol-specified criteria|15|||
160893558|NCT01854658|581006319|FG001|Overall Study|Protocol-specified criteria|15|||
160893559|NCT01854658|581006320|FG002|Overall Study|Protocol-specified criteria|10|||
160893560|NCT01854658|581006321|FG003|Overall Study|Protocol-specified criteria|7|||
160893561|NCT01854658|581006318|FG000|Overall Study|Lack of Efficacy|3|||
160893562|NCT01854658|581006319|FG001|Overall Study|Lack of Efficacy|8|||
160893563|NCT01854658|581006320|FG002|Overall Study|Lack of Efficacy|4|||
160893564|NCT01854658|581006321|FG003|Overall Study|Lack of Efficacy|7|||
160893565|NCT01854658|581006318|FG000|Overall Study|Adverse Event|21|||
160893566|NCT01854658|581006319|FG001|Overall Study|Adverse Event|14|||
160893567|NCT01854658|581006320|FG002|Overall Study|Adverse Event|23|||
160893568|NCT01854658|581006321|FG003|Overall Study|Adverse Event|19|||
160893569|NCT01854658|581006318|FG000|Overall Study|Administrative reasons|5|||
160642901|NCT03705169|580074408|FG002|Overall Study|Adverse Event|0|||
160893570|NCT01854658|581006319|FG001|Overall Study|Administrative reasons|1|||
160893571|NCT01854658|581006320|FG002|Overall Study|Administrative reasons|2|||
160893572|NCT01854658|581006321|FG003|Overall Study|Administrative reasons|2|||
160893573|NCT03906461|581006322|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
160893574|NCT03906461|581006322|FG000|Completed 12-month Follow-up|Missed Visit|6|||
160893575|NCT01795638|581006325|FG000|Overall Study|Death|0|||
160893576|NCT01795638|581006326|FG001|Overall Study|Death|3|||
160893577|NCT01795638|581006325|FG000|Overall Study|transferred to quaternary hospital|2|||
160893578|NCT01795638|581006326|FG001|Overall Study|transferred to quaternary hospital|3|||
160893579|NCT01795638|581006325|FG000|Overall Study|Protocol Violation|3|||
160893580|NCT01795638|581006326|FG001|Overall Study|Protocol Violation|0|||
160893581|NCT01795638|581006325|FG000|Overall Study|discharged from hospital|7|||
160893582|NCT01795638|581006326|FG001|Overall Study|discharged from hospital|5|||
160893583|NCT01795638|581006325|FG000|Overall Study|Withdrawal by Subject|1|||
160893584|NCT01795638|581006326|FG001|Overall Study|Withdrawal by Subject|0|||
160893585|NCT00331864|581006335|FG000|Overall Study|Adverse Event|30|||
160893586|NCT00331864|581006336|FG001|Overall Study|Adverse Event|1|||
160794108|NCT03093415|580633262|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
160794109|NCT03559530|580633263|FG000|Overall Study|non-location of medical records|44|||
160794110|NCT03559530|580633264|FG001|Overall Study|non-location of medical records|0|||
160794111|NCT03559530|580633263|FG000|Overall Study|culture results not considered for treat|29|||
160794112|NCT03559530|580633264|FG001|Overall Study|culture results not considered for treat|0|||
160794113|NCT03559530|580633263|FG000|Overall Study|duplicate cases|8|||
160794114|NCT03559530|580633264|FG001|Overall Study|duplicate cases|0|||
160794115|NCT03559530|580633263|FG000|Overall Study|other species of Acinetobacte|7|||
160794116|NCT03559530|580633264|FG001|Overall Study|other species of Acinetobacte|0|||
160794117|NCT03559530|580633263|FG000|Overall Study|contamination / colonization|3|||
160794118|NCT03559530|580633264|FG001|Overall Study|contamination / colonization|0|||
160794119|NCT02457065|580633265|FG000|Overall Study|Lost to Follow-up|9|||
160794120|NCT02457065|580633266|FG001|Overall Study|Lost to Follow-up|11|||
160794121|NCT03038087|580633267|FG000|Overall Study|lost data|1|||
160794122|NCT00654355|580633268|FG000|Overall Study|Lost to Follow-up|2|||
160794123|NCT00654355|580633269|FG001|Overall Study|Lost to Follow-up|2|||
160794124|NCT01435356|580633271|FG000|Overall Study|Adverse Event|2|||
160794125|NCT01435356|580633272|FG001|Overall Study|Adverse Event|0|||
160794126|NCT01435356|580633271|FG000|Overall Study|Disease progression/recurrence|17|||
160794127|NCT01435356|580633272|FG001|Overall Study|Disease progression/recurrence|10|||
160794128|NCT01435356|580633271|FG000|Overall Study|Protocol Violation|0|||
160794129|NCT01435356|580633272|FG001|Overall Study|Protocol Violation|1|||
160794130|NCT01435356|580633271|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
160794131|NCT01435356|580633272|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
160794132|NCT01435356|580633271|FG000|Overall Study|Withdrawal by Subject|1|||
160794133|NCT01435356|580633272|FG001|Overall Study|Withdrawal by Subject|1|||
160794134|NCT01435356|580633271|FG000|Overall Study|Facial palsy|1|||
160794135|NCT01435356|580633272|FG001|Overall Study|Facial palsy|0|||
160794136|NCT01435356|580633271|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
160794137|NCT01435356|580633272|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
160794138|NCT01435356|580633271|FG000|Overall Study|Physician Decision|1|||
160794139|NCT01435356|580633272|FG001|Overall Study|Physician Decision|0|||
160794140|NCT01435356|580633271|FG000|Overall Study|Patient decision|3|||
160794141|NCT01435356|580633272|FG001|Overall Study|Patient decision|0|||
160794142|NCT01435356|580633271|FG000|Overall Study|Patient moved to another city|1|||
160794143|NCT01435356|580633272|FG001|Overall Study|Patient moved to another city|1|||
160794144|NCT02796651|580633273|FG000|Overall Study|Adverse Event|6|||
160794145|NCT02796651|580633273|FG000|Overall Study|Lost to Follow-up|1|||
160794146|NCT02796651|580633273|FG000|Overall Study|Withdrawal by Subject|4|||
160794147|NCT02796651|580633273|FG000|Overall Study|Protocol Violation|4|||
160794148|NCT02796651|580633273|FG000|Overall Study|Lack of Efficacy|1|||
160794149|NCT02796651|580633273|FG000|Overall Study|Other|10|||
160794150|NCT04875533|580633274|FG000|Overall Study|Adverse Event|6|||
160794151|NCT04875533|580633275|FG001|Overall Study|Adverse Event|4|||
160794152|NCT04875533|580633274|FG000|Overall Study|Protocol Violation|4|||
160893587|NCT00331864|581006335|FG000|Overall Study|Lack of Efficacy|4|||
160893588|NCT00331864|581006336|FG001|Overall Study|Lack of Efficacy|0|||
160893589|NCT00331864|581006335|FG000|Overall Study|Protocol Violation|3|||
160893590|NCT00331864|581006336|FG001|Overall Study|Protocol Violation|0|||
160893591|NCT00331864|581006335|FG000|Overall Study|Withdrawal by Subject|10|||
160893592|NCT00331864|581006336|FG001|Overall Study|Withdrawal by Subject|0|||
160893593|NCT00331864|581006335|FG000|Overall Study|Lost to Follow-up|4|||
160893594|NCT00331864|581006336|FG001|Overall Study|Lost to Follow-up|3|||
160893595|NCT00331864|581006335|FG000|Overall Study|Administrative Problems|1|||
160893596|NCT00331864|581006336|FG001|Overall Study|Administrative Problems|0|||
160893597|NCT00331864|581006335|FG000|Overall Study|Death|6|||
160893598|NCT00331864|581006336|FG001|Overall Study|Death|0|||
160893599|NCT01409434|581006338|FG000|Overall Study|Protocol Violation|4|||
160893600|NCT00293215|581006339|FG000|Overall Study|Progressive disease|3|||
160893601|NCT00293215|581006340|FG001|Overall Study|Progressive disease|1|||
160893602|NCT00293215|581006339|FG000|Overall Study|Adverse Event|2|||
160893603|NCT00293215|581006340|FG001|Overall Study|Adverse Event|2|||
160893604|NCT02213042|581006341|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
160642902|NCT03705169|580074409|FG003|Overall Study|Adverse Event|1|||
160794153|NCT04875533|580633275|FG001|Overall Study|Protocol Violation|0|||
160794154|NCT04875533|580633274|FG000|Overall Study|Withdrawal by Subject|8|||
160794155|NCT04875533|580633275|FG001|Overall Study|Withdrawal by Subject|5|||
160794156|NCT04875533|580633274|FG000|Overall Study|No longer meets eligibility criteria|1|||
160794157|NCT04875533|580633275|FG001|Overall Study|No longer meets eligibility criteria|0|||
160794158|NCT04875533|580633274|FG000|Overall Study|Other|0|||
160794159|NCT04875533|580633275|FG001|Overall Study|Other|2|||
160794160|NCT04918771|580633276|FG000|Overall Study|Withdrawal by Subject|4|||
160794161|NCT04918771|580633277|FG001|Overall Study|Withdrawal by Subject|5|||
160794162|NCT04918771|580633276|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
160794163|NCT04918771|580633277|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
160794164|NCT02971163|580633278|FG000|Overall Study|Lost to Follow-up|4|||
160794165|NCT02971163|580633279|FG001|Overall Study|Lost to Follow-up|2|||
160794166|NCT01849276|580633280|FG000|Followed for Survival for 5 Years|Death|1|||
160794167|NCT01849276|580633280|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
160794168|NCT00539500|580633281|FG000|Overall Study|Disease Progression|1|||
160794169|NCT00539500|580633281|FG000|Overall Study|Lost to Follow-up|2|||
160794170|NCT02657343|580633284|FG000|Overall Study|Death|0|||
160794171|NCT02657343|580633285|FG001|Overall Study|Death|2|||
160794172|NCT02657343|580633286|FG002|Overall Study|Death|0|||
160794173|NCT02657343|580633287|FG003|Overall Study|Death|0|||
160794174|NCT02657343|580633288|FG004|Overall Study|Death|0|||
160794175|NCT02657343|580633289|FG005|Overall Study|Death|0|||
160794176|NCT02657343|580633284|FG000|Overall Study|Patient went to hospice|1|||
160794177|NCT02657343|580633285|FG001|Overall Study|Patient went to hospice|0|||
160794178|NCT02657343|580633286|FG002|Overall Study|Patient went to hospice|0|||
160794179|NCT02657343|580633287|FG003|Overall Study|Patient went to hospice|0|||
160794180|NCT02657343|580633288|FG004|Overall Study|Patient went to hospice|0|||
160794181|NCT02657343|580633289|FG005|Overall Study|Patient went to hospice|0|||
160794182|NCT02657343|580633284|FG000|Overall Study|Withdrawal by Subject|0|||
160794183|NCT02657343|580633285|FG001|Overall Study|Withdrawal by Subject|0|||
160794184|NCT02657343|580633286|FG002|Overall Study|Withdrawal by Subject|0|||
160794185|NCT02657343|580633287|FG003|Overall Study|Withdrawal by Subject|0|||
160794186|NCT02657343|580633288|FG004|Overall Study|Withdrawal by Subject|1|||
160794187|NCT02657343|580633289|FG005|Overall Study|Withdrawal by Subject|0|||
160794188|NCT02011542|580633297|FG000|Overall Study|Physician Decision|1|||
160794189|NCT01813357|580633298|FG000|Overall Study|Lost to Follow-up|5|||
160794190|NCT01813357|580633299|FG001|Overall Study|Lost to Follow-up|6|||
160794191|NCT00526799|580633303|FG000|Overall Study|Withdrawal by Subject|1|||
160794192|NCT00526799|580633304|FG001|Overall Study|Withdrawal by Subject|0|||
160794193|NCT00526799|580633303|FG000|Overall Study|Intercurrent Complicating Disease|0|||
160794194|NCT00526799|580633304|FG001|Overall Study|Intercurrent Complicating Disease|1|||
160794195|NCT02607722|580633311|FG000|Overall Study|No data reliability|1|||
160893605|NCT02213042|581006342|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
160893606|NCT02213042|581006343|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
160893607|NCT02213042|581006341|FG000|Overall Study|Adverse Event|2|||
160893608|NCT02213042|581006342|FG001|Overall Study|Adverse Event|1|||
160893609|NCT02213042|581006343|FG002|Overall Study|Adverse Event|0|||
160893610|NCT02213042|581006341|FG000|Overall Study|Withdrawal by Subject|0|||
160893611|NCT02213042|581006342|FG001|Overall Study|Withdrawal by Subject|1|||
160642903|NCT03705169|580074410|FG004|Overall Study|Adverse Event|0|||
160642904|NCT03705169|580074411|FG005|Overall Study|Adverse Event|0|||
160642905|NCT03705169|580074412|FG006|Overall Study|Adverse Event|0|||
160642906|NCT03705169|580074413|FG007|Overall Study|Adverse Event|0|||
160642907|NCT03705169|580074414|FG008|Overall Study|Adverse Event|0|||
160642908|NCT03705169|580074415|FG009|Overall Study|Adverse Event|0|||
160642909|NCT03705169|580074406|FG000|Overall Study|Site Closure|0|||
160642910|NCT03705169|580074407|FG001|Overall Study|Site Closure|0|||
160642911|NCT03705169|580074408|FG002|Overall Study|Site Closure|0|||
160642912|NCT03705169|580074409|FG003|Overall Study|Site Closure|1|||
160642913|NCT03705169|580074410|FG004|Overall Study|Site Closure|0|||
160642914|NCT03705169|580074411|FG005|Overall Study|Site Closure|0|||
160642915|NCT03705169|580074412|FG006|Overall Study|Site Closure|0|||
160642916|NCT03705169|580074413|FG007|Overall Study|Site Closure|0|||
160642917|NCT03705169|580074414|FG008|Overall Study|Site Closure|0|||
160642918|NCT03705169|580074415|FG009|Overall Study|Site Closure|0|||
160642919|NCT03705169|580074406|FG000|Overall Study|Did not receive study treatment|0|||
160642920|NCT03705169|580074407|FG001|Overall Study|Did not receive study treatment|0|||
160642921|NCT03705169|580074408|FG002|Overall Study|Did not receive study treatment|0|||
160642922|NCT03705169|580074409|FG003|Overall Study|Did not receive study treatment|1|||
160642923|NCT03705169|580074410|FG004|Overall Study|Did not receive study treatment|0|||
160642924|NCT03705169|580074411|FG005|Overall Study|Did not receive study treatment|0|||
160893612|NCT02213042|581006343|FG002|Overall Study|Withdrawal by Subject|1|||
160893613|NCT02213042|581006341|FG000|Overall Study|Protocol Violation|1|||
160893614|NCT02213042|581006342|FG001|Overall Study|Protocol Violation|0|||
160893615|NCT02213042|581006343|FG002|Overall Study|Protocol Violation|0|||
160893616|NCT02213042|581006341|FG000|Overall Study|Investigator discretion|0|||
160642925|NCT03705169|580074412|FG006|Overall Study|Did not receive study treatment|0|||
160642926|NCT03705169|580074413|FG007|Overall Study|Did not receive study treatment|0|||
160642927|NCT03705169|580074414|FG008|Overall Study|Did not receive study treatment|0|||
160893617|NCT02213042|581006342|FG001|Overall Study|Investigator discretion|0|||
160548494|NCT03892746|579734161|FG001|Overall Study|Withdrawal by Subject|1|||
160548495|NCT03892746|579734160|FG000|Overall Study|Lost to Follow-up|2|||
160548496|NCT03892746|579734161|FG001|Overall Study|Lost to Follow-up|0|||
160548497|NCT02158091|579734162|FG000|Overall Study|DLT|2|||
160548498|NCT02158091|579734163|FG001|Overall Study|DLT|1|||
160548499|NCT02158091|579734164|FG002|Overall Study|DLT|0|||
160548500|NCT03977467|579734165|FG000|Overall Study|Disease Progression|1|||
160548501|NCT03977467|579734166|FG001|Overall Study|Disease Progression|1|||
160548502|NCT03977467|579734167|FG002|Overall Study|Disease Progression|30|||
160548503|NCT03977467|579734168|FG003|Overall Study|Disease Progression|0|||
160548504|NCT03977467|579734165|FG000|Overall Study|Adverse Event|0|||
160548505|NCT03977467|579734166|FG001|Overall Study|Adverse Event|1|||
160548506|NCT03977467|579734167|FG002|Overall Study|Adverse Event|0|||
160548507|NCT03977467|579734168|FG003|Overall Study|Adverse Event|0|||
160548508|NCT03977467|579734165|FG000|Overall Study|Death|0|||
160548509|NCT03977467|579734166|FG001|Overall Study|Death|0|||
160548510|NCT03977467|579734167|FG002|Overall Study|Death|3|||
160548511|NCT03977467|579734168|FG003|Overall Study|Death|0|||
160548512|NCT03977467|579734165|FG000|Overall Study|Lack of Efficacy|0|||
160548513|NCT03977467|579734166|FG001|Overall Study|Lack of Efficacy|0|||
160548514|NCT03977467|579734167|FG002|Overall Study|Lack of Efficacy|1|||
160548515|NCT03977467|579734168|FG003|Overall Study|Lack of Efficacy|0|||
160548516|NCT03977467|579734165|FG000|Overall Study|Withdrawal by Subject|2|||
160548517|NCT03977467|579734166|FG001|Overall Study|Withdrawal by Subject|1|||
160548518|NCT03977467|579734167|FG002|Overall Study|Withdrawal by Subject|4|||
160548519|NCT03977467|579734168|FG003|Overall Study|Withdrawal by Subject|0|||
160548520|NCT03977467|579734165|FG000|Overall Study|Study Terminated|1|||
160548521|NCT03977467|579734166|FG001|Overall Study|Study Terminated|0|||
160548522|NCT03977467|579734167|FG002|Overall Study|Study Terminated|0|||
160548523|NCT03977467|579734168|FG003|Overall Study|Study Terminated|1|||
160548524|NCT01318109|579734169|FG000|Overall Study|Adverse Event|0|||
160548525|NCT01318109|579734170|FG001|Overall Study|Adverse Event|2|||
160548526|NCT01318109|579734171|FG002|Overall Study|Adverse Event|0|||
160548527|NCT01318109|579734169|FG000|Overall Study|Withdrawal by Subject|1|||
160548528|NCT01318109|579734170|FG001|Overall Study|Withdrawal by Subject|0|||
160548529|NCT01318109|579734171|FG002|Overall Study|Withdrawal by Subject|0|||
160548530|NCT01318109|579734169|FG000|Overall Study|Schedule Conflict|0|||
160548531|NCT01318109|579734170|FG001|Overall Study|Schedule Conflict|1|||
160548532|NCT01318109|579734171|FG002|Overall Study|Schedule Conflict|0|||
160548533|NCT01328951|579734172|FG000|Overall Study|Disease Progression|17|||
160548534|NCT01328951|579734173|FG001|Overall Study|Disease Progression|14|||
160548535|NCT01328951|579734172|FG000|Overall Study|Adverse Event|2|||
160548536|NCT01328951|579734173|FG001|Overall Study|Adverse Event|0|||
160548537|NCT01328951|579734172|FG000|Overall Study|Death|243|||
160548538|NCT01328951|579734173|FG001|Overall Study|Death|258|||
160548539|NCT01328951|579734172|FG000|Overall Study|Lost to Follow-up|6|||
160548540|NCT01328951|579734173|FG001|Overall Study|Lost to Follow-up|7|||
160548541|NCT01328951|579734172|FG000|Overall Study|Withdrawal by Subject|6|||
160548542|NCT01328951|579734173|FG001|Overall Study|Withdrawal by Subject|6|||
160548543|NCT01328951|579734172|FG000|Overall Study|Study Closed by the Sponsor|36|||
160548544|NCT01328951|579734173|FG001|Overall Study|Study Closed by the Sponsor|31|||
160548545|NCT01328951|579734172|FG000|Overall Study|Other|11|||
160548546|NCT01328951|579734173|FG001|Overall Study|Other|6|||
160548547|NCT04982250|579734178|FG000|Overall Study|Lost to Follow-up|0|||
160548548|NCT04982250|579734179|FG001|Overall Study|Lost to Follow-up|26|||
160548549|NCT04982250|579734180|FG002|Overall Study|Lost to Follow-up|0|||
160548550|NCT04982250|579734181|FG003|Overall Study|Lost to Follow-up|0|||
160548551|NCT04982250|579734182|FG004|Overall Study|Lost to Follow-up|72|||
160548552|NCT04982250|579734183|FG005|Overall Study|Lost to Follow-up|69|||
160548553|NCT04982250|579734178|FG000|Overall Study|Not Eligible to Enroll|0|||
160548554|NCT04982250|579734179|FG001|Overall Study|Not Eligible to Enroll|0|||
160548555|NCT04982250|579734180|FG002|Overall Study|Not Eligible to Enroll|0|||
160548556|NCT04982250|579734181|FG003|Overall Study|Not Eligible to Enroll|0|||
160548557|NCT04982250|579734182|FG004|Overall Study|Not Eligible to Enroll|10|||
160548558|NCT04982250|579734183|FG005|Overall Study|Not Eligible to Enroll|7|||
160893618|NCT02213042|581006343|FG002|Overall Study|Investigator discretion|1|||
160893619|NCT02007512|581006344|FG000|Double Blind Treatment Period|Adverse Event|4|||
160893620|NCT02007512|581006345|FG001|Double Blind Treatment Period|Adverse Event|6|||
160893621|NCT02007512|581006346|FG002|Double Blind Treatment Period|Adverse Event|2|||
160893622|NCT02007512|581006347|FG003|Double Blind Treatment Period|Adverse Event|2|||
160893623|NCT02007512|581006344|FG000|Double Blind Treatment Period|Death|1|||
160893624|NCT02007512|581006345|FG001|Double Blind Treatment Period|Death|0|||
160893625|NCT02007512|581006346|FG002|Double Blind Treatment Period|Death|0|||
160893626|NCT02007512|581006347|FG003|Double Blind Treatment Period|Death|0|||
160893627|NCT02007512|581006344|FG000|Double Blind Treatment Period|Disease progression|51|||
160893628|NCT02007512|581006345|FG001|Double Blind Treatment Period|Disease progression|50|||
160893629|NCT02007512|581006346|FG002|Double Blind Treatment Period|Disease progression|57|||
160893630|NCT02007512|581006347|FG003|Double Blind Treatment Period|Disease progression|52|||
160893631|NCT02007512|581006344|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
160982743|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982744|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982745|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982746|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160642928|NCT03705169|580074415|FG009|Overall Study|Did not receive study treatment|0|||
160642929|NCT03705169|580074406|FG000|Overall Study|Concerns about study visit compliance|0|||
160642930|NCT03705169|580074407|FG001|Overall Study|Concerns about study visit compliance|0|||
160642931|NCT03705169|580074408|FG002|Overall Study|Concerns about study visit compliance|0|||
160642932|NCT03705169|580074409|FG003|Overall Study|Concerns about study visit compliance|1|||
160642933|NCT03705169|580074410|FG004|Overall Study|Concerns about study visit compliance|0|||
160642934|NCT03705169|580074411|FG005|Overall Study|Concerns about study visit compliance|0|||
160642935|NCT03705169|580074412|FG006|Overall Study|Concerns about study visit compliance|0|||
160642936|NCT03705169|580074413|FG007|Overall Study|Concerns about study visit compliance|0|||
160642937|NCT03705169|580074414|FG008|Overall Study|Concerns about study visit compliance|0|||
160642938|NCT03705169|580074415|FG009|Overall Study|Concerns about study visit compliance|0|||
160642939|NCT02806232|580076482|FG000|Overall Study|Lost to Follow-up|1|||
160642940|NCT02806232|580076483|FG001|Overall Study|Lost to Follow-up|2|||
160642941|NCT02806232|580076484|FG002|Overall Study|Lost to Follow-up|1|||
160642942|NCT02806232|580076485|FG003|Overall Study|Lost to Follow-up|0|||
160642943|NCT02806232|580076486|FG004|Overall Study|Lost to Follow-up|0|||
160642944|NCT02806232|580076487|FG005|Overall Study|Lost to Follow-up|1|||
160642945|NCT02806232|580076488|FG006|Overall Study|Lost to Follow-up|0|||
160642946|NCT02806232|580076489|FG007|Overall Study|Lost to Follow-up|0|||
160642947|NCT02806232|580076490|FG008|Overall Study|Lost to Follow-up|0|||
160642948|NCT02806232|580076482|FG000|Overall Study|Withdrawal by Subject|0|||
160642949|NCT02806232|580076483|FG001|Overall Study|Withdrawal by Subject|2|||
160642950|NCT02806232|580076484|FG002|Overall Study|Withdrawal by Subject|0|||
160642951|NCT02806232|580076485|FG003|Overall Study|Withdrawal by Subject|0|||
160642952|NCT02806232|580076486|FG004|Overall Study|Withdrawal by Subject|2|||
160642953|NCT02806232|580076487|FG005|Overall Study|Withdrawal by Subject|1|||
160642954|NCT02806232|580076488|FG006|Overall Study|Withdrawal by Subject|0|||
160642955|NCT02806232|580076489|FG007|Overall Study|Withdrawal by Subject|0|||
160642956|NCT02806232|580076490|FG008|Overall Study|Withdrawal by Subject|0|||
160642957|NCT01133821|580076491|FG000|Overall Study|Lost to Follow-up|8|||
160642958|NCT01133821|580076492|FG001|Overall Study|Lost to Follow-up|11|||
160642959|NCT01133821|580076491|FG000|Overall Study|Withdrawal by Subject|8|||
160642960|NCT01133821|580076492|FG001|Overall Study|Withdrawal by Subject|3|||
160642961|NCT01133821|580076491|FG000|Overall Study|preferred other treatment|1|||
160642962|NCT01133821|580076492|FG001|Overall Study|preferred other treatment|1|||
160642963|NCT01133821|580076491|FG000|Overall Study|Protocol Violation|0|||
160642964|NCT01133821|580076492|FG001|Overall Study|Protocol Violation|1|||
160642965|NCT01133821|580076491|FG000|Overall Study|Refused participation|1|||
160642966|NCT01133821|580076492|FG001|Overall Study|Refused participation|3|||
160893632|NCT02007512|581006345|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
160893633|NCT02007512|581006346|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
160893634|NCT02007512|581006347|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
160893635|NCT02007512|581006344|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160893636|NCT02007512|581006345|FG001|Double Blind Treatment Period|Protocol Violation|0|||
160893637|NCT02007512|581006346|FG002|Double Blind Treatment Period|Protocol Violation|0|||
160893638|NCT02007512|581006347|FG003|Double Blind Treatment Period|Protocol Violation|1|||
160982747|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982748|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982749|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982750|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160642967|NCT00434161|580076493|FG000|Overall Study|Adverse Event|5|||
160642968|NCT00434161|580076494|FG001|Overall Study|Adverse Event|1|||
160642969|NCT00434161|580076495|FG002|Overall Study|Adverse Event|4|||
160642970|NCT00434161|580076493|FG000|Overall Study|Lost to Follow-up|0|||
160893639|NCT02007512|581006344|FG000|Double Blind Treatment Period|Other|2|||
160893640|NCT02007512|581006345|FG001|Double Blind Treatment Period|Other|1|||
160893641|NCT02007512|581006346|FG002|Double Blind Treatment Period|Other|1|||
160893642|NCT02007512|581006347|FG003|Double Blind Treatment Period|Other|2|||
160893643|NCT02007512|581006344|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
160893644|NCT02007512|581006345|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
160893645|NCT02007512|581006346|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
160893646|NCT02007512|581006347|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
160893647|NCT02007512|581006344|FG000|Open Label Treatment Period|Adverse Event|1|||
160893648|NCT02007512|581006345|FG001|Open Label Treatment Period|Adverse Event|0|||
160893649|NCT02007512|581006346|FG002|Open Label Treatment Period|Adverse Event|0|||
160893650|NCT02007512|581006347|FG003|Open Label Treatment Period|Adverse Event|0|||
160893651|NCT02007512|581006344|FG000|Open Label Treatment Period|Other|1|||
160893652|NCT02007512|581006345|FG001|Open Label Treatment Period|Other|1|||
160794196|NCT02607722|580633311|FG000|Overall Study|no patient visit|18|||
160794197|NCT02607722|580633311|FG000|Overall Study|missing info in CRF|13|||
160794198|NCT02607722|580633311|FG000|Overall Study|Withdrawal by Subject|616|||
160794199|NCT02607722|580633311|FG000|Overall Study|Lost to Follow-up|312|||
160794200|NCT02607722|580633311|FG000|Overall Study|Improved|22|||
160893653|NCT02007512|581006346|FG002|Open Label Treatment Period|Other|0|||
160893654|NCT02007512|581006347|FG003|Open Label Treatment Period|Other|0|||
160893655|NCT02007512|581006344|FG000|Open Label Treatment Period|Disease progression|23|||
160893656|NCT02007512|581006345|FG001|Open Label Treatment Period|Disease progression|11|||
160893657|NCT02007512|581006346|FG002|Open Label Treatment Period|Disease progression|0|||
160893658|NCT02007512|581006347|FG003|Open Label Treatment Period|Disease progression|0|||
160893659|NCT01225887|581006350|FG000|Overall Study|Ineligible:required test not done|2|||
160893660|NCT01225887|581006350|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
160893661|NCT01225887|581006350|FG000|Overall Study|Ineligible:inadequate pathology|2|||
160893662|NCT04505540|581006353|FG000|Baseline|Protocol Violation|10|||
160893663|NCT04505540|581006353|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
160893664|NCT04505540|581006353|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
160893665|NCT04505540|581006353|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
160893666|NCT04505540|581006353|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
160893667|NCT04505540|581006353|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
160893668|NCT04505540|581006353|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
160893669|NCT04505540|581006353|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
160893670|NCT04505540|581006353|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
160893671|NCT04505540|581006353|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
160893672|NCT04505540|581006353|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
160893673|NCT04505540|581006353|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
160893674|NCT04505540|581006353|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
160893675|NCT01123850|581006360|FG000|Overall Study|Slow enrollment|45|||
160893676|NCT03180684|581006361|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
160893677|NCT03180684|581006362|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
160893678|NCT03180684|581006361|FG000|Overall Study|Physician Decision|1|||
160893679|NCT03180684|581006362|FG001|Overall Study|Physician Decision|0|||
160893680|NCT03180684|581006361|FG000|Overall Study|Lost to Follow-up|1|||
160893681|NCT03180684|581006362|FG001|Overall Study|Lost to Follow-up|0|||
160893682|NCT03180684|581006361|FG000|Overall Study|Progressive Disease|1|||
160893683|NCT03180684|581006362|FG001|Overall Study|Progressive Disease|0|||
160893684|NCT02495233|581006363|FG000|Overall Study|Miscellaneous|0|||
160893685|NCT02495233|581006364|FG001|Overall Study|Miscellaneous|1|||
160893686|NCT04508140|581006366|FG000|Overall Study|Adverse Event|2|||
160893687|NCT04508140|581006367|FG001|Overall Study|Adverse Event|2|||
160893688|NCT04508140|581006366|FG000|Overall Study|Withdrawal by Subject|0|||
160893689|NCT04508140|581006367|FG001|Overall Study|Withdrawal by Subject|2|||
160893690|NCT04508140|581006366|FG000|Overall Study|progressive disease|9|||
160893691|NCT04508140|581006367|FG001|Overall Study|progressive disease|3|||
160893692|NCT01822678|581006368|FG000|Overall Study|Withdrawal by Subject|5|||
160893693|NCT01822678|581006369|FG001|Overall Study|Withdrawal by Subject|4|||
160982751|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
160794201|NCT02607722|580633311|FG000|Overall Study|Lack of Efficacy|316|||
160794202|NCT02607722|580633311|FG000|Overall Study|Adverse Event|2553|||
160794203|NCT02607722|580633311|FG000|Overall Study|Not treated|1|||
160794204|NCT02607722|580633311|FG000|Overall Study|No CRF collected|138|||
160794205|NCT02607722|580633311|FG000|Overall Study|without CRF|4225|||
160794206|NCT02607722|580633311|FG000|Overall Study|Physician Decision|367|||
160794207|NCT02871219|580633312|FG000|Overall Study|Adverse Event|15|||
160794208|NCT02871219|580633312|FG000|Overall Study|Death|3|||
160794209|NCT02871219|580633312|FG000|Overall Study|Progression|3|||
160794210|NCT02871219|580633312|FG000|Overall Study|Infections|7|||
160794211|NCT02871219|580633312|FG000|Overall Study|Infusion Related|4|||
160794212|NCT03238196|580633313|FG000|Overall Study|Adverse Event|3|||
160893694|NCT01822678|581006370|FG002|Overall Study|Withdrawal by Subject|4|||
160893695|NCT01822678|581006368|FG000|Overall Study|Adverse Event|4|||
160893696|NCT01822678|581006369|FG001|Overall Study|Adverse Event|3|||
160794213|NCT03238196|580633314|FG001|Overall Study|Adverse Event|0|||
160794214|NCT03238196|580633315|FG002|Overall Study|Adverse Event|2|||
160794215|NCT03238196|580633316|FG003|Overall Study|Adverse Event|2|||
160794216|NCT03238196|580633313|FG000|Overall Study|Withdrawal by Subject|4|||
160794217|NCT03238196|580633314|FG001|Overall Study|Withdrawal by Subject|1|||
160794218|NCT03238196|580633315|FG002|Overall Study|Withdrawal by Subject|1|||
160982752|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
160982753|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982754|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982755|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982756|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982757|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982758|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982759|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982760|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
160982761|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
160982762|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
160982763|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
160982764|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Other|0|||
160982765|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Other|0|||
160982766|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Other|0|||
160982767|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Other|0|||
160982768|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Other|0|||
160982769|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Other|0|||
160982770|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Other|0|||
160982771|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Other|0|||
160982772|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Other|2|||
160982773|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Other|2|||
160982774|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Other|0|||
160982775|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Death|0|||
160982776|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Death|0|||
160982777|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Death|0|||
160982778|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Death|0|||
160982779|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Death|0|||
160982780|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Death|0|||
160982781|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Death|0|||
160982782|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Death|0|||
160982783|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Death|1|||
160982784|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Death|0|||
160982785|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Death|0|||
160982786|NCT05567952|581326861|FG000|Overall Study|Lost to Follow-up|3|||
160982787|NCT05567952|581326862|FG001|Overall Study|Lost to Follow-up|2|||
160982788|NCT05567952|581326861|FG000|Overall Study|Withdrawal by Subject|6|||
160982789|NCT05567952|581326862|FG001|Overall Study|Withdrawal by Subject|3|||
160982790|NCT05567952|581326861|FG000|Overall Study|Other|3|||
160982791|NCT05567952|581326862|FG001|Overall Study|Other|1|||
160982792|NCT03280563|581326864|FG000|Stage 1|Death|2|||
160982793|NCT03280563|581326865|FG001|Stage 1|Death|1|||
160982794|NCT03280563|581326866|FG002|Stage 1|Death|0|||
160982795|NCT03280563|581326867|FG003|Stage 1|Death|0|||
160982796|NCT03280563|581326868|FG004|Stage 1|Death|0|||
160982797|NCT03280563|581326869|FG005|Stage 1|Death|3|||
160982798|NCT03280563|581326870|FG006|Stage 1|Death|0|||
160982799|NCT03280563|581326871|FG007|Stage 1|Death|0|||
160982800|NCT03280563|581326872|FG008|Stage 1|Death|0|||
160982801|NCT03280563|581326864|FG000|Stage 1|Study Ended by Sponsor|0|||
160982802|NCT03280563|581326865|FG001|Stage 1|Study Ended by Sponsor|0|||
160982803|NCT03280563|581326866|FG002|Stage 1|Study Ended by Sponsor|1|||
160982804|NCT03280563|581326867|FG003|Stage 1|Study Ended by Sponsor|0|||
160982805|NCT03280563|581326868|FG004|Stage 1|Study Ended by Sponsor|0|||
160982806|NCT03280563|581326869|FG005|Stage 1|Study Ended by Sponsor|1|||
160982807|NCT03280563|581326870|FG006|Stage 1|Study Ended by Sponsor|0|||
160982808|NCT03280563|581326871|FG007|Stage 1|Study Ended by Sponsor|0|||
160982809|NCT03280563|581326872|FG008|Stage 1|Study Ended by Sponsor|0|||
160982810|NCT03280563|581326864|FG000|Stage 1|Withdrawal by Subject|5|||
160982811|NCT03280563|581326865|FG001|Stage 1|Withdrawal by Subject|1|||
160982812|NCT03280563|581326866|FG002|Stage 1|Withdrawal by Subject|2|||
160982813|NCT03280563|581326867|FG003|Stage 1|Withdrawal by Subject|0|||
160982814|NCT03280563|581326868|FG004|Stage 1|Withdrawal by Subject|0|||
160982815|NCT03280563|581326869|FG005|Stage 1|Withdrawal by Subject|2|||
160982816|NCT03280563|581326870|FG006|Stage 1|Withdrawal by Subject|0|||
160982817|NCT03280563|581326871|FG007|Stage 1|Withdrawal by Subject|0|||
160982818|NCT03280563|581326872|FG008|Stage 1|Withdrawal by Subject|0|||
160982819|NCT03280563|581326864|FG000|Stage 1|Reason Not Specified|0|||
160982820|NCT03280563|581326865|FG001|Stage 1|Reason Not Specified|0|||
160982821|NCT03280563|581326866|FG002|Stage 1|Reason Not Specified|0|||
160982822|NCT03280563|581326867|FG003|Stage 1|Reason Not Specified|0|||
160982823|NCT03280563|581326868|FG004|Stage 1|Reason Not Specified|0|||
160982824|NCT03280563|581326869|FG005|Stage 1|Reason Not Specified|1|||
160982825|NCT03280563|581326870|FG006|Stage 1|Reason Not Specified|0|||
160982826|NCT03280563|581326871|FG007|Stage 1|Reason Not Specified|0|||
160982827|NCT03280563|581326872|FG008|Stage 1|Reason Not Specified|0|||
160982828|NCT03280563|581326864|FG000|Stage 1|Physician Decision|0|||
160982829|NCT03280563|581326865|FG001|Stage 1|Physician Decision|1|||
160982830|NCT03280563|581326866|FG002|Stage 1|Physician Decision|0|||
160982831|NCT03280563|581326867|FG003|Stage 1|Physician Decision|0|||
160982832|NCT03280563|581326868|FG004|Stage 1|Physician Decision|0|||
160982833|NCT03280563|581326869|FG005|Stage 1|Physician Decision|0|||
160982834|NCT03280563|581326870|FG006|Stage 1|Physician Decision|0|||
160982835|NCT03280563|581326871|FG007|Stage 1|Physician Decision|0|||
160982836|NCT03280563|581326872|FG008|Stage 1|Physician Decision|0|||
160982837|NCT03280563|581326864|FG000|Stage 2|Death|0|||
160982838|NCT03280563|581326865|FG001|Stage 2|Death|0|||
160982839|NCT03280563|581326866|FG002|Stage 2|Death|0|||
160982840|NCT03280563|581326867|FG003|Stage 2|Death|0|||
160982841|NCT03280563|581326868|FG004|Stage 2|Death|0|||
160982842|NCT03280563|581326869|FG005|Stage 2|Death|0|||
160982843|NCT03280563|581326870|FG006|Stage 2|Death|0|||
160982844|NCT03280563|581326871|FG007|Stage 2|Death|1|||
160982845|NCT03280563|581326872|FG008|Stage 2|Death|0|||
160982846|NCT03280563|581326864|FG000|Stage 2|Progressive Disease|0|||
160982847|NCT03280563|581326865|FG001|Stage 2|Progressive Disease|0|||
160982848|NCT03280563|581326866|FG002|Stage 2|Progressive Disease|0|||
160982849|NCT03280563|581326867|FG003|Stage 2|Progressive Disease|0|||
160982850|NCT03280563|581326868|FG004|Stage 2|Progressive Disease|0|||
160982851|NCT03280563|581326869|FG005|Stage 2|Progressive Disease|0|||
160982852|NCT03280563|581326870|FG006|Stage 2|Progressive Disease|2|||
160982853|NCT03280563|581326871|FG007|Stage 2|Progressive Disease|0|||
160982854|NCT03280563|581326872|FG008|Stage 2|Progressive Disease|0|||
160982855|NCT03280563|581326864|FG000|Long-term Survival Follow-up|Death|10|||
160982856|NCT03280563|581326865|FG001|Long-term Survival Follow-up|Death|14|||
160982857|NCT03280563|581326866|FG002|Long-term Survival Follow-up|Death|15|||
160982858|NCT03280563|581326867|FG003|Long-term Survival Follow-up|Death|3|||
160982859|NCT03280563|581326868|FG004|Long-term Survival Follow-up|Death|6|||
160982860|NCT03280563|581326869|FG005|Long-term Survival Follow-up|Death|18|||
160982861|NCT03280563|581326870|FG006|Long-term Survival Follow-up|Death|11|||
160982862|NCT03280563|581326871|FG007|Long-term Survival Follow-up|Death|1|||
160982863|NCT03280563|581326872|FG008|Long-term Survival Follow-up|Death|3|||
160982864|NCT03280563|581326864|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
160982865|NCT03280563|581326865|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
160982866|NCT03280563|581326866|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
160982867|NCT03280563|581326867|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
160982868|NCT03280563|581326868|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
160982869|NCT03280563|581326869|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
160982870|NCT03280563|581326870|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
160982871|NCT03280563|581326871|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
160982872|NCT03280563|581326872|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
160982873|NCT03280563|581326864|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
160982874|NCT03280563|581326865|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
160982875|NCT03280563|581326866|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
160982876|NCT03280563|581326867|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
160982877|NCT03280563|581326868|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
160982878|NCT03280563|581326869|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
160982879|NCT03280563|581326870|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
160982880|NCT03280563|581326871|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
160982881|NCT03280563|581326872|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
160982882|NCT03280563|581326864|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
160982883|NCT03280563|581326865|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
160982884|NCT03280563|581326866|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
160982885|NCT03280563|581326867|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
160982886|NCT03280563|581326868|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
160982887|NCT03280563|581326869|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
160982888|NCT03280563|581326870|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
160982889|NCT03280563|581326871|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
160982890|NCT03280563|581326872|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
160982891|NCT03038672|581326873|FG000|Initial Treatment|Unacceptable chemistry|0|||
160982892|NCT03038672|581326874|FG001|Initial Treatment|Unacceptable chemistry|1|||
160982893|NCT03038672|581326873|FG000|Initial Treatment|Progression prior to treatment|1|||
160982894|NCT03038672|581326874|FG001|Initial Treatment|Progression prior to treatment|0|||
160982895|NCT03038672|581326873|FG000|Initial Treatment|No treatment per protocol|1|||
160982896|NCT03038672|581326874|FG001|Initial Treatment|No treatment per protocol|0|||
160982897|NCT04423393|581326875|FG000|Overall Study|Withdrawal by Subject|0|||
160982898|NCT04423393|581326876|FG001|Overall Study|Withdrawal by Subject|0|||
160982899|NCT04423393|581326877|FG002|Overall Study|Withdrawal by Subject|0|||
160982900|NCT04423393|581326878|FG003|Overall Study|Withdrawal by Subject|0|||
160982901|NCT04423393|581326879|FG004|Overall Study|Withdrawal by Subject|0|||
160982902|NCT04423393|581326880|FG005|Overall Study|Withdrawal by Subject|1|||
160982903|NCT04423393|581326881|FG006|Overall Study|Withdrawal by Subject|0|||
160982904|NCT04423393|581326882|FG007|Overall Study|Withdrawal by Subject|0|||
160982905|NCT04423393|581326883|FG008|Overall Study|Withdrawal by Subject|0|||
160982906|NCT04423393|581326884|FG009|Overall Study|Withdrawal by Subject|0|||
160982907|NCT04423393|581326885|FG010|Overall Study|Withdrawal by Subject|0|||
160982908|NCT04423393|581326886|FG011|Overall Study|Withdrawal by Subject|0|||
160982909|NCT04423393|581326887|FG012|Overall Study|Withdrawal by Subject|0|||
160982910|NCT04423393|581326888|FG013|Overall Study|Withdrawal by Subject|1|||
160982911|NCT04423393|581326889|FG014|Overall Study|Withdrawal by Subject|0|||
160982912|NCT04423393|581326890|FG015|Overall Study|Withdrawal by Subject|0|||
160982913|NCT04423393|581326891|FG016|Overall Study|Withdrawal by Subject|0|||
160982914|NCT04423393|581326892|FG017|Overall Study|Withdrawal by Subject|0|||
160982915|NCT04423393|581326875|FG000|Overall Study|Sponsor Decision|0|||
160982916|NCT04423393|581326876|FG001|Overall Study|Sponsor Decision|0|||
160982917|NCT04423393|581326877|FG002|Overall Study|Sponsor Decision|0|||
160982918|NCT04423393|581326878|FG003|Overall Study|Sponsor Decision|0|||
160982919|NCT04423393|581326879|FG004|Overall Study|Sponsor Decision|0|||
160982920|NCT04423393|581326880|FG005|Overall Study|Sponsor Decision|0|||
160982921|NCT04423393|581326881|FG006|Overall Study|Sponsor Decision|0|||
160982922|NCT04423393|581326882|FG007|Overall Study|Sponsor Decision|0|||
160982923|NCT04423393|581326883|FG008|Overall Study|Sponsor Decision|0|||
160893697|NCT01822678|581006370|FG002|Overall Study|Adverse Event|1|||
160893698|NCT01822678|581006368|FG000|Overall Study|Lack of Efficacy|3|||
160893699|NCT01822678|581006369|FG001|Overall Study|Lack of Efficacy|6|||
160893700|NCT01822678|581006370|FG002|Overall Study|Lack of Efficacy|5|||
160893701|NCT01822678|581006368|FG000|Overall Study|Lost to Follow-up|0|||
160893702|NCT01822678|581006369|FG001|Overall Study|Lost to Follow-up|2|||
160893703|NCT01822678|581006370|FG002|Overall Study|Lost to Follow-up|1|||
160893704|NCT02456103|581006371|FG000|Overall Study|Study Closure|207|||
160893705|NCT02456103|581006371|FG000|Overall Study|Physician Decision|1|||
160893706|NCT02456103|581006371|FG000|Overall Study|Required prohibited medications|5|||
160893707|NCT02456103|581006371|FG000|Overall Study|Protocol Violation|1|||
160893708|NCT02456103|581006371|FG000|Overall Study|Adverse Event|5|||
160893709|NCT02456103|581006371|FG000|Overall Study|Abnormal Laboratory Value|2|||
160893710|NCT02456103|581006371|FG000|Overall Study|Lost to Follow-up|1|||
160893711|NCT02456103|581006371|FG000|Overall Study|Withdrawal by Subject|24|||
160893712|NCT03614975|581006372|FG000|Overall Study|Physician Decision|7|||
160893713|NCT03614975|581006373|FG001|Overall Study|Physician Decision|5|||
160893714|NCT03614975|581006372|FG000|Overall Study|Withdrawal by Subject|2|||
160893715|NCT03614975|581006373|FG001|Overall Study|Withdrawal by Subject|2|||
160893716|NCT03614975|581006372|FG000|Overall Study|Specimens not in lab batch shipment|1|||
160893717|NCT03614975|581006373|FG001|Overall Study|Specimens not in lab batch shipment|1|||
160893718|NCT01390220|581006374|FG000|Test Dose Phase|Adverse Event|17|||
160893719|NCT01390220|581006375|FG001|Test Dose Phase|Adverse Event|0|||
160893720|NCT01390220|581006376|FG002|Test Dose Phase|Adverse Event|0|||
160893721|NCT01390220|581006374|FG000|Test Dose Phase|Withdrawal by Subject|8|||
160893722|NCT01390220|581006375|FG001|Test Dose Phase|Withdrawal by Subject|0|||
160893723|NCT01390220|581006376|FG002|Test Dose Phase|Withdrawal by Subject|0|||
160893724|NCT01390220|581006374|FG000|Test Dose Phase|Lost to Follow-up|2|||
160982924|NCT04423393|581326884|FG009|Overall Study|Sponsor Decision|0|||
160982925|NCT04423393|581326885|FG010|Overall Study|Sponsor Decision|0|||
160982926|NCT04423393|581326886|FG011|Overall Study|Sponsor Decision|0|||
160893725|NCT01390220|581006375|FG001|Test Dose Phase|Lost to Follow-up|0|||
160893726|NCT01390220|581006376|FG002|Test Dose Phase|Lost to Follow-up|0|||
160982927|NCT04423393|581326887|FG012|Overall Study|Sponsor Decision|0|||
160982928|NCT04423393|581326888|FG013|Overall Study|Sponsor Decision|1|||
160982929|NCT04423393|581326889|FG014|Overall Study|Sponsor Decision|0|||
160982930|NCT04423393|581326890|FG015|Overall Study|Sponsor Decision|0|||
160982931|NCT04423393|581326891|FG016|Overall Study|Sponsor Decision|0|||
160982932|NCT04423393|581326892|FG017|Overall Study|Sponsor Decision|0|||
160982933|NCT05220501|581326893|FG000|Overall Study|Withdrawal by Subject|11|||
160982934|NCT05220501|581326894|FG001|Overall Study|Withdrawal by Subject|21|||
160982935|NCT05220501|581326895|FG002|Overall Study|Withdrawal by Subject|32|||
160982936|NCT05220501|581326893|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
160982937|NCT05220501|581326894|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
160982938|NCT05220501|581326895|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
160982939|NCT02692235|581326896|FG000|Overall Study|Withdrawal by Subject|2|||
160982940|NCT02692235|581326897|FG001|Overall Study|Withdrawal by Subject|1|||
160982941|NCT02692235|581326896|FG000|Overall Study|Adverse Event|1|||
160982942|NCT02692235|581326897|FG001|Overall Study|Adverse Event|2|||
160982943|NCT00802841|581326898|FG000|Overall Study|Administrative problems|1|||
160982944|NCT00802841|581326899|FG001|Overall Study|Administrative problems|0|||
160982945|NCT00802841|581326898|FG000|Overall Study|Lost to Follow-up|2|||
160982946|NCT00802841|581326899|FG001|Overall Study|Lost to Follow-up|1|||
160982947|NCT00802841|581326898|FG000|Overall Study|Death|1|||
160982948|NCT00802841|581326899|FG001|Overall Study|Death|2|||
160982949|NCT00802841|581326898|FG000|Overall Study|Adverse Event|8|||
160982950|NCT00802841|581326899|FG001|Overall Study|Adverse Event|2|||
160982951|NCT00802841|581326898|FG000|Overall Study|Disease progression|7|||
160982952|NCT00802841|581326899|FG001|Overall Study|Disease progression|3|||
160982953|NCT00802841|581326898|FG000|Overall Study|Withdrawal by Subject|9|||
160982954|NCT00802841|581326899|FG001|Overall Study|Withdrawal by Subject|5|||
160982955|NCT00802841|581326898|FG000|Overall Study|Protocol deviation|2|||
160982956|NCT00802841|581326899|FG001|Overall Study|Protocol deviation|6|||
160982957|NCT00802841|581326898|FG000|Overall Study|Treatment duration completed|66|||
160982958|NCT00802841|581326899|FG001|Overall Study|Treatment duration completed|76|||
160982959|NCT00432159|581326900|FG000|Overall Study|Death|0|||
160982960|NCT00432159|581326901|FG001|Overall Study|Death|1|||
160982961|NCT00432159|581326902|FG002|Overall Study|Death|0|||
160982962|NCT00432159|581326903|FG003|Overall Study|Death|0|||
160982963|NCT00432159|581326904|FG004|Overall Study|Death|0|||
160982964|NCT00432159|581326900|FG000|Overall Study|Failure|9|||
160982965|NCT00432159|581326901|FG001|Overall Study|Failure|5|||
160982966|NCT00432159|581326902|FG002|Overall Study|Failure|3|||
160982967|NCT00432159|581326903|FG003|Overall Study|Failure|2|||
160982968|NCT00432159|581326904|FG004|Overall Study|Failure|3|||
160982969|NCT00432159|581326900|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
160548559|NCT05568888|579734186|FG000|Overall Study|Physician Decision|1|||
160548560|NCT05568888|579734187|FG001|Overall Study|Physician Decision|0|||
160982970|NCT00432159|581326901|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
160982971|NCT00432159|581326902|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
160982972|NCT00432159|581326903|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
160982973|NCT00432159|581326904|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
160982974|NCT01929993|581326906|FG000|Overall Study|Protocol Violation|4|||
160548561|NCT05568888|579734186|FG000|Overall Study|Protocol Deviation|2|||
160982975|NCT01929993|581326907|FG001|Overall Study|Protocol Violation|6|||
160982976|NCT01929993|581326906|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
160982977|NCT01929993|581326907|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
160982978|NCT00107380|581326908|FG000|Overall Study|Adverse Event|7|||
160982979|NCT00107380|581326908|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
160893727|NCT01390220|581006374|FG000|Test Dose Phase|Protocol Violation|8|||
160893728|NCT01390220|581006375|FG001|Test Dose Phase|Protocol Violation|0|||
160893729|NCT01390220|581006376|FG002|Test Dose Phase|Protocol Violation|0|||
160893730|NCT01390220|581006374|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
160893731|NCT01390220|581006375|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
160893732|NCT01390220|581006376|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
160893733|NCT01390220|581006374|FG000|Test Dose Phase|Study/Site closure|6|||
160893734|NCT01390220|581006375|FG001|Test Dose Phase|Study/Site closure|0|||
160893735|NCT01390220|581006376|FG002|Test Dose Phase|Study/Site closure|0|||
160893736|NCT01390220|581006374|FG000|Test Dose Phase|Caregiver no longer available|5|||
160893737|NCT01390220|581006375|FG001|Test Dose Phase|Caregiver no longer available|0|||
160893738|NCT01390220|581006376|FG002|Test Dose Phase|Caregiver no longer available|0|||
160893739|NCT01390220|581006374|FG000|Test Dose Phase|Noncompliance|2|||
160893740|NCT01390220|581006375|FG001|Test Dose Phase|Noncompliance|0|||
160893741|NCT01390220|581006376|FG002|Test Dose Phase|Noncompliance|0|||
160893742|NCT01390220|581006374|FG000|Test Dose Phase|Logistical|6|||
160893743|NCT01390220|581006375|FG001|Test Dose Phase|Logistical|0|||
160893744|NCT01390220|581006376|FG002|Test Dose Phase|Logistical|0|||
160893745|NCT01390220|581006374|FG000|Comparative Phase|Withdrawal by Subject|0|||
160893746|NCT01390220|581006375|FG001|Comparative Phase|Withdrawal by Subject|1|||
160893747|NCT01390220|581006376|FG002|Comparative Phase|Withdrawal by Subject|0|||
160893748|NCT03059446|581006377|FG000|Overall Study|Adverse Event|11|||
160893749|NCT03059446|581006377|FG000|Overall Study|Withdrawal of Consent|16|||
160893750|NCT03059446|581006377|FG000|Overall Study|Lost to Follow-up|3|||
160893751|NCT03059446|581006377|FG000|Overall Study|Protocol Violation|1|||
160893752|NCT03059446|581006377|FG000|Overall Study|Study Terminated by Sponsor|131|||
160893753|NCT03059446|581006377|FG000|Overall Study|Reason not Specified|5|||
160893754|NCT00136604|581006378|FG000|Overall Study|Lost to Follow-up|1|||
160893755|NCT00136604|581006379|FG001|Overall Study|Lost to Follow-up|0|||
160893756|NCT00136604|581006380|FG002|Overall Study|Lost to Follow-up|0|||
160893757|NCT00136604|581006381|FG003|Overall Study|Lost to Follow-up|0|||
160893758|NCT00136604|581006382|FG004|Overall Study|Lost to Follow-up|1|||
160893759|NCT00136604|581006378|FG000|Overall Study|Migrated/moved from study area|0|||
160893760|NCT00136604|581006379|FG001|Overall Study|Migrated/moved from study area|1|||
160893761|NCT00136604|581006380|FG002|Overall Study|Migrated/moved from study area|0|||
160893762|NCT00136604|581006381|FG003|Overall Study|Migrated/moved from study area|0|||
160893763|NCT00136604|581006382|FG004|Overall Study|Migrated/moved from study area|0|||
160893764|NCT00470847|581006383|FG000|Overall Study|Pt still receiving treatment|1|||
160794219|NCT03238196|580633316|FG003|Overall Study|Withdrawal by Subject|0|||
160794220|NCT03238196|580633313|FG000|Overall Study|Disease progression|14|||
160794221|NCT03238196|580633314|FG001|Overall Study|Disease progression|2|||
160794222|NCT03238196|580633315|FG002|Overall Study|Disease progression|3|||
160794223|NCT03238196|580633316|FG003|Overall Study|Disease progression|2|||
160794224|NCT03238196|580633313|FG000|Overall Study|Still on treatment|1|||
160794225|NCT03238196|580633314|FG001|Overall Study|Still on treatment|0|||
160794226|NCT03238196|580633315|FG002|Overall Study|Still on treatment|0|||
160794227|NCT03238196|580633316|FG003|Overall Study|Still on treatment|0|||
160794228|NCT00835354|580633317|FG000|First Intervention|Adverse Event|0|||
160794229|NCT00835354|580633318|FG001|First Intervention|Adverse Event|1|||
160794230|NCT03559556|580633324|FG000|Overall Study|Withdrawal by Subject|1|||
160794231|NCT02496000|580633325|FG000|Overall Study|Withdrawal by Subject|1|||
160794232|NCT02496000|580633326|FG001|Overall Study|Withdrawal by Subject|2|||
160794233|NCT02496000|580633327|FG002|Overall Study|Withdrawal by Subject|0|||
160794234|NCT02496000|580633325|FG000|Overall Study|Lost to Follow-up|1|||
160893765|NCT01369615|581006385|FG000|Overall Study|Withdrawal by Subject|0|||
160893766|NCT01369615|581006386|FG001|Overall Study|Withdrawal by Subject|1|||
160893767|NCT01369615|581006385|FG000|Overall Study|Lost to Follow-up|0|||
160893768|NCT01369615|581006386|FG001|Overall Study|Lost to Follow-up|1|||
160893769|NCT04263454|581006387|FG000|Overall Study|Adverse Event|0|||
160893770|NCT04263454|581006388|FG001|Overall Study|Adverse Event|2|||
160982980|NCT00107380|581326908|FG000|Overall Study|Progression/relapse|4|||
160982981|NCT00107380|581326908|FG000|Overall Study|Death|3|||
160893771|NCT04263454|581006387|FG000|Overall Study|Physician Decision|3|||
160893772|NCT04263454|581006388|FG001|Overall Study|Physician Decision|5|||
160893773|NCT04263454|581006387|FG000|Overall Study|Poor Data Quality|0|||
160893774|NCT04263454|581006388|FG001|Overall Study|Poor Data Quality|1|||
160893775|NCT00986479|581006389|FG000|Period 1|Improved mood|1|||
160893776|NCT00986479|581006390|FG001|Period 1|Improved mood|0|||
160893777|NCT00986479|581006389|FG000|Period 1|Administrative reasons|1|||
160893778|NCT00986479|581006390|FG001|Period 1|Administrative reasons|0|||
160893779|NCT01721070|581006391|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
160893780|NCT02035475|581006392|FG000|Overall Study|Withdrawal by Subject|4|||
160893781|NCT02035475|581006392|FG000|Overall Study|Physician Decision|1|||
160893782|NCT02035475|581006392|FG000|Overall Study|Equipment Error|1|||
160893783|NCT01231347|581006393|FG000|Overall Study|Full Consent withdrawn|19|||
160893784|NCT01231347|581006394|FG001|Overall Study|Full Consent withdrawn|19|||
160893785|NCT01231347|581006395|FG002|Overall Study|Full Consent withdrawn|11|||
160893786|NCT01231347|581006393|FG000|Overall Study|Lost to Follow-up|4|||
160893787|NCT01231347|581006394|FG001|Overall Study|Lost to Follow-up|2|||
160893788|NCT01231347|581006395|FG002|Overall Study|Lost to Follow-up|2|||
160893789|NCT01231347|581006393|FG000|Overall Study|Death|202|||
160893790|NCT01231347|581006394|FG001|Overall Study|Death|210|||
160893791|NCT01231347|581006395|FG002|Overall Study|Death|101|||
160893792|NCT01231347|581006393|FG000|Overall Study|other event|7|||
160893793|NCT01231347|581006394|FG001|Overall Study|other event|9|||
160893794|NCT01231347|581006395|FG002|Overall Study|other event|3|||
160893795|NCT02047227|581006396|FG000|Overall Study|Adverse Event|2|||
160893796|NCT02047227|581006397|FG001|Overall Study|Adverse Event|4|||
160893797|NCT02047227|581006396|FG000|Overall Study|Lost to Follow-up|0|||
160893798|NCT02047227|581006397|FG001|Overall Study|Lost to Follow-up|3|||
160893799|NCT02047227|581006396|FG000|Overall Study|Protocol Violation|1|||
160893800|NCT02047227|581006397|FG001|Overall Study|Protocol Violation|0|||
160893801|NCT02047227|581006396|FG000|Overall Study|Spontaneous pregnancy|1|||
160893802|NCT02047227|581006397|FG001|Overall Study|Spontaneous pregnancy|0|||
160893803|NCT02047227|581006396|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
160893804|NCT02047227|581006397|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
160893805|NCT02047227|581006396|FG000|Overall Study|No oocytes retrieved|21|||
160893806|NCT02047227|581006397|FG001|Overall Study|No oocytes retrieved|20|||
160893807|NCT02047227|581006396|FG000|Overall Study|No fertilization|61|||
160893808|NCT02047227|581006397|FG001|Overall Study|No fertilization|51|||
160893809|NCT02047227|581006396|FG000|Overall Study|Intention to freeze all embryos|1|||
160893810|NCT02047227|581006397|FG001|Overall Study|Intention to freeze all embryos|0|||
160893811|NCT02047227|581006396|FG000|Overall Study|All embryos discarded|12|||
160893812|NCT02047227|581006397|FG001|Overall Study|All embryos discarded|11|||
160893813|NCT02047227|581006396|FG000|Overall Study|Other|10|||
160893814|NCT02047227|581006397|FG001|Overall Study|Other|9|||
160893815|NCT01385371|581006410|FG000|Overall Study|Adverse Event|54|||
160893816|NCT01385371|581006411|FG001|Overall Study|Adverse Event|19|||
160893817|NCT01385371|581006410|FG000|Overall Study|Lost to Follow-up|16|||
160893818|NCT01385371|581006411|FG001|Overall Study|Lost to Follow-up|16|||
160893819|NCT01385371|581006410|FG000|Overall Study|Withdrawal by Subject|52|||
160893820|NCT01385371|581006411|FG001|Overall Study|Withdrawal by Subject|39|||
160893821|NCT01385371|581006410|FG000|Overall Study|Protocol Violation|25|||
160893822|NCT01385371|581006411|FG001|Overall Study|Protocol Violation|21|||
160893823|NCT01385371|581006410|FG000|Overall Study|Administrative|2|||
160893824|NCT01385371|581006411|FG001|Overall Study|Administrative|2|||
160893825|NCT02001181|581006420|FG000|Overall Study|Adverse Event|0|||
160893826|NCT02001181|581006421|FG001|Overall Study|Adverse Event|2|||
160893827|NCT02001181|581006420|FG000|Overall Study|Lost to Follow-up|1|||
160893828|NCT02001181|581006421|FG001|Overall Study|Lost to Follow-up|0|||
160893829|NCT02001181|581006420|FG000|Overall Study|Withdrawal by Subject|0|||
160893830|NCT02001181|581006421|FG001|Overall Study|Withdrawal by Subject|1|||
160893831|NCT03635788|581006431|FG000|Step 1|Death|1|||
160893832|NCT03635788|581006432|FG001|Step 1|Death|0|||
160893833|NCT03635788|581006433|FG002|Step 1|Death|0|||
160893834|NCT03635788|581006431|FG000|Step 1|Lost to Follow-up|31|||
160982982|NCT00107380|581326908|FG000|Overall Study|Other - not protocol specified|7|||
160982983|NCT00107380|581326908|FG000|Overall Study|Ineligible|2|||
160893835|NCT03635788|581006432|FG001|Step 1|Lost to Follow-up|0|||
160893836|NCT03635788|581006433|FG002|Step 1|Lost to Follow-up|0|||
160893837|NCT03635788|581006431|FG000|Step 1|Pregnancy|1|||
160893838|NCT03635788|581006432|FG001|Step 1|Pregnancy|0|||
160893839|NCT03635788|581006433|FG002|Step 1|Pregnancy|0|||
160893840|NCT03635788|581006431|FG000|Step 1|Protocol Violation|8|||
160893841|NCT03635788|581006432|FG001|Step 1|Protocol Violation|0|||
160893842|NCT03635788|581006433|FG002|Step 1|Protocol Violation|0|||
160893843|NCT03635788|581006431|FG000|Step 1|Withdrawal by Subject|13|||
160893844|NCT03635788|581006432|FG001|Step 1|Withdrawal by Subject|0|||
160893845|NCT03635788|581006433|FG002|Step 1|Withdrawal by Subject|0|||
160893846|NCT03635788|581006431|FG000|Step 1|Other reasons|12|||
160893847|NCT03635788|581006432|FG001|Step 1|Other reasons|0|||
160893848|NCT03635788|581006433|FG002|Step 1|Other reasons|0|||
160893849|NCT03635788|581006431|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
160794235|NCT02496000|580633326|FG001|Overall Study|Lost to Follow-up|0|||
160794236|NCT02496000|580633327|FG002|Overall Study|Lost to Follow-up|1|||
160794237|NCT02496000|580633325|FG000|Overall Study|Protocol Violation|0|||
160982984|NCT03673098|581326909|FG000|Overall Study|Lost to Follow-up|2|||
160982985|NCT03673098|581326910|FG001|Overall Study|Lost to Follow-up|3|||
160982986|NCT03673098|581326909|FG000|Overall Study|Withdrawal by Subject|6|||
160982987|NCT03673098|581326910|FG001|Overall Study|Withdrawal by Subject|1|||
160982988|NCT03673098|581326909|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
160982989|NCT03673098|581326910|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
160982990|NCT03850444|581326911|FG000|Overall Study|Adverse Event|16|||
160982991|NCT03850444|581326912|FG001|Overall Study|Adverse Event|10|||
160982992|NCT03850444|581326911|FG000|Overall Study|Death|87|||
160982993|NCT03850444|581326912|FG001|Overall Study|Death|107|||
160982994|NCT03850444|581326911|FG000|Overall Study|Lost to Follow-up|1|||
160982995|NCT03850444|581326912|FG001|Overall Study|Lost to Follow-up|1|||
160982996|NCT03850444|581326911|FG000|Overall Study|Withdrawal by Subject|1|||
160982997|NCT03850444|581326912|FG001|Overall Study|Withdrawal by Subject|5|||
160982998|NCT03850444|581326911|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
160982999|NCT03850444|581326912|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
160983000|NCT01155726|581326914|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
160983001|NCT01155726|581326915|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
160983002|NCT01155726|581326916|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
160983003|NCT01155726|581326917|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
160983004|NCT02561455|581326918|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
160983005|NCT02561455|581326919|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
160983006|NCT02561455|581326920|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
160983007|NCT02561455|581326921|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
160983008|NCT02561455|581326918|FG000|Overall Study|Withdrawal by Subject|1|||
160983009|NCT02561455|581326919|FG001|Overall Study|Withdrawal by Subject|0|||
160983010|NCT02561455|581326920|FG002|Overall Study|Withdrawal by Subject|1|||
160983011|NCT02561455|581326921|FG003|Overall Study|Withdrawal by Subject|0|||
160983012|NCT02561455|581326918|FG000|Overall Study|Disease Progression|0|||
160983013|NCT02561455|581326919|FG001|Overall Study|Disease Progression|1|||
160983014|NCT02561455|581326920|FG002|Overall Study|Disease Progression|0|||
160983015|NCT02561455|581326921|FG003|Overall Study|Disease Progression|0|||
160983016|NCT03639675|581326924|FG000|Overall Study|Withdrawal by Subject|1|||
160983017|NCT00472186|581326928|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
160983018|NCT00472186|581326929|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
160983019|NCT01254565|581326930|FG000|Overall Study|Non-compliance to Study Procedures|0|||
160983020|NCT01254565|581326931|FG001|Overall Study|Non-compliance to Study Procedures|0|||
160983021|NCT01254565|581326932|FG002|Overall Study|Non-compliance to Study Procedures|0|||
160983022|NCT01254565|581326933|FG003|Overall Study|Non-compliance to Study Procedures|0|||
160983023|NCT01254565|581326934|FG004|Overall Study|Non-compliance to Study Procedures|1|||
160983024|NCT01254565|581326935|FG005|Overall Study|Non-compliance to Study Procedures|0|||
160983025|NCT01254565|581326930|FG000|Overall Study|Did not Receive Treatment|1|||
160983026|NCT01254565|581326931|FG001|Overall Study|Did not Receive Treatment|1|||
160983027|NCT01254565|581326932|FG002|Overall Study|Did not Receive Treatment|0|||
160983028|NCT01254565|581326933|FG003|Overall Study|Did not Receive Treatment|0|||
160983029|NCT01254565|581326934|FG004|Overall Study|Did not Receive Treatment|3|||
160983030|NCT01254565|581326935|FG005|Overall Study|Did not Receive Treatment|4|||
160983031|NCT01254565|581326930|FG000|Overall Study|Other|0|||
160983032|NCT01254565|581326931|FG001|Overall Study|Other|0|||
160983033|NCT01254565|581326932|FG002|Overall Study|Other|0|||
160983034|NCT01254565|581326933|FG003|Overall Study|Other|1|||
160983035|NCT01254565|581326934|FG004|Overall Study|Other|0|||
160548562|NCT05568888|579734187|FG001|Overall Study|Protocol Deviation|1|||
160794238|NCT02496000|580633326|FG001|Overall Study|Protocol Violation|0|||
160548563|NCT05568888|579734186|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
160548564|NCT05568888|579734187|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
160548565|NCT05568888|579734186|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
160548566|NCT05568888|579734187|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
160548567|NCT05568888|579734186|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
160548568|NCT05568888|579734187|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
160548569|NCT02028455|579734190|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
160548570|NCT02028455|579734191|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
160794239|NCT02496000|580633327|FG002|Overall Study|Protocol Violation|1|||
160794240|NCT02496000|580633325|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
160794241|NCT02496000|580633326|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
160794242|NCT02496000|580633327|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
160794243|NCT02496000|580633325|FG000|Overall Study|undetermined|0|||
160794244|NCT02496000|580633326|FG001|Overall Study|undetermined|1|||
160794245|NCT02496000|580633327|FG002|Overall Study|undetermined|0|||
160794246|NCT01877278|580633328|FG000|Overall Study|Lost to Follow-up|3|||
160794247|NCT01877278|580633329|FG001|Overall Study|Lost to Follow-up|3|||
160794248|NCT01969058|580633330|FG000|Overall Study|Withdrawal by Subject|2|||
160794249|NCT01969058|580633331|FG001|Overall Study|Withdrawal by Subject|0|||
160794250|NCT01969058|580633330|FG000|Overall Study|Adverse Event|1|||
160794251|NCT01969058|580633331|FG001|Overall Study|Adverse Event|0|||
160794252|NCT04090749|580633332|FG000|Open Label Pilot|Lost to Follow-up|1|||
160794253|NCT04090749|580633333|FG001|Open Label Pilot|Lost to Follow-up|0|||
160794254|NCT04090749|580633334|FG002|Open Label Pilot|Lost to Follow-up|0|||
160794255|NCT04090749|580633332|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
160794256|NCT04090749|580633333|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
160794257|NCT04090749|580633334|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
160794258|NCT04090749|580633332|FG000|Pilot Trial|Lost to Follow-up|0|||
160794259|NCT04090749|580633333|FG001|Pilot Trial|Lost to Follow-up|1|||
160794260|NCT04090749|580633334|FG002|Pilot Trial|Lost to Follow-up|1|||
160794261|NCT03510715|580633335|FG000|Overall Study|Adverse Event|1|||
160794262|NCT03510715|580633336|FG001|Overall Study|Adverse Event|0|||
160794263|NCT01972659|580633338|FG000|Overall Study|Protocol Violation|2|||
160794264|NCT01972659|580633339|FG001|Overall Study|Protocol Violation|2|||
160794265|NCT01972659|580633338|FG000|Overall Study|problems realted to acceleromyograph|2|||
160794266|NCT01972659|580633339|FG001|Overall Study|problems realted to acceleromyograph|1|||
160794267|NCT02457793|580633341|FG000|Overall Study|Reason not specified|0|||
160794268|NCT02457793|580633342|FG001|Overall Study|Reason not specified|0|||
160893850|NCT03635788|581006432|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
160893851|NCT03635788|581006433|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
160893852|NCT03635788|581006431|FG000|Step 2|Lost to Follow-up|0|||
160893853|NCT03635788|581006432|FG001|Step 2|Lost to Follow-up|8|||
160893854|NCT03635788|581006433|FG002|Step 2|Lost to Follow-up|15|||
160893855|NCT03635788|581006431|FG000|Step 2|Withdrawal by Subject|0|||
160893856|NCT03635788|581006432|FG001|Step 2|Withdrawal by Subject|6|||
160893857|NCT03635788|581006433|FG002|Step 2|Withdrawal by Subject|6|||
160893858|NCT03635788|581006431|FG000|Step 2|Death|0|||
160893859|NCT03635788|581006432|FG001|Step 2|Death|2|||
160893860|NCT03635788|581006433|FG002|Step 2|Death|0|||
160893861|NCT03635788|581006431|FG000|Step 2|Incarceration|0|||
160893862|NCT03635788|581006432|FG001|Step 2|Incarceration|2|||
160893863|NCT03635788|581006433|FG002|Step 2|Incarceration|0|||
160893864|NCT03635788|581006431|FG000|Step 2|Non-Compliance With Study Requirements|0|||
160893865|NCT03635788|581006432|FG001|Step 2|Non-Compliance With Study Requirements|1|||
160893866|NCT03635788|581006433|FG002|Step 2|Non-Compliance With Study Requirements|1|||
160893867|NCT03635788|581006431|FG000|Step 2|Confounding Medical Condition|0|||
160893868|NCT03635788|581006432|FG001|Step 2|Confounding Medical Condition|0|||
160893869|NCT03635788|581006433|FG002|Step 2|Confounding Medical Condition|1|||
160893870|NCT03635788|581006431|FG000|Step 2|Out Of State With No Plan To Return|0|||
160893871|NCT03635788|581006432|FG001|Step 2|Out Of State With No Plan To Return|1|||
160893872|NCT03635788|581006433|FG002|Step 2|Out Of State With No Plan To Return|0|||
160893873|NCT03635788|581006431|FG000|Step 2|Switched To Injectables|0|||
160893874|NCT03635788|581006432|FG001|Step 2|Switched To Injectables|0|||
160893875|NCT03635788|581006433|FG002|Step 2|Switched To Injectables|1|||
160893876|NCT03635788|581006431|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
160893877|NCT03635788|581006432|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
160893878|NCT03635788|581006433|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
160893879|NCT04571515|581006435|FG000|Overall Study|Physician Decision|0|||
160893880|NCT04571515|581006436|FG001|Overall Study|Physician Decision|0|||
160893881|NCT04571515|581006437|FG002|Overall Study|Physician Decision|0|||
160893882|NCT04571515|581006438|FG003|Overall Study|Physician Decision|0|||
160893883|NCT04571515|581006439|FG004|Overall Study|Physician Decision|1|||
160893884|NCT04571515|581006435|FG000|Overall Study|Withdrawal by Subject|0|||
160893885|NCT04571515|581006436|FG001|Overall Study|Withdrawal by Subject|0|||
160893886|NCT04571515|581006437|FG002|Overall Study|Withdrawal by Subject|0|||
160983036|NCT01254565|581326935|FG005|Overall Study|Other|0|||
160983037|NCT03354637|581326940|FG000|Double-blind Period|Protocol Violation|2|||
160983038|NCT03354637|581326941|FG001|Double-blind Period|Protocol Violation|0|||
160983039|NCT03354637|581326942|FG002|Double-blind Period|Protocol Violation|0|||
160983040|NCT03354637|581326940|FG000|Double-blind Period|Adverse Event|1|||
160983041|NCT03354637|581326941|FG001|Double-blind Period|Adverse Event|2|||
160983042|NCT03354637|581326942|FG002|Double-blind Period|Adverse Event|0|||
160983043|NCT03354637|581326940|FG000|Double-blind Period|Lost to Follow-up|3|||
160983044|NCT03354637|581326941|FG001|Double-blind Period|Lost to Follow-up|4|||
160983045|NCT03354637|581326942|FG002|Double-blind Period|Lost to Follow-up|3|||
160983046|NCT03354637|581326940|FG000|Double-blind Period|Withdrawal by Subject|10|||
160983047|NCT03354637|581326941|FG001|Double-blind Period|Withdrawal by Subject|6|||
160983048|NCT03354637|581326942|FG002|Double-blind Period|Withdrawal by Subject|4|||
160983049|NCT03354637|581326940|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
160983050|NCT03354637|581326941|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
160642971|NCT00434161|580076494|FG001|Overall Study|Lost to Follow-up|1|||
160893887|NCT04571515|581006438|FG003|Overall Study|Withdrawal by Subject|0|||
160893888|NCT04571515|581006439|FG004|Overall Study|Withdrawal by Subject|1|||
160893889|NCT04571515|581006435|FG000|Overall Study|insufficient pain|1|||
160893890|NCT04571515|581006436|FG001|Overall Study|insufficient pain|0|||
160893891|NCT04571515|581006437|FG002|Overall Study|insufficient pain|0|||
160893892|NCT04571515|581006438|FG003|Overall Study|insufficient pain|0|||
160893893|NCT04571515|581006439|FG004|Overall Study|insufficient pain|1|||
160893894|NCT02095223|581008225|FG000|Overall Study|Withdrawal by Subject|1|||
160893895|NCT02095223|581008226|FG001|Overall Study|Withdrawal by Subject|0|||
160893896|NCT01859143|581008228|FG000|Overall Study|Lost to Follow-up|2|||
160893897|NCT01859143|581008229|FG001|Overall Study|Lost to Follow-up|0|||
160893898|NCT00760214|581008230|FG000|Overall Study|Adverse Event|8|||
160893899|NCT00760214|581008231|FG001|Overall Study|Adverse Event|9|||
160983051|NCT03354637|581326942|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
160983052|NCT03354637|581326940|FG000|Open Label Extension|Adverse Event|0|||
160983053|NCT03354637|581326941|FG001|Open Label Extension|Adverse Event|0|||
160983054|NCT03354637|581326942|FG002|Open Label Extension|Adverse Event|1|||
160983055|NCT03354637|581326940|FG000|Open Label Extension|Lost to Follow-up|0|||
160983056|NCT03354637|581326941|FG001|Open Label Extension|Lost to Follow-up|0|||
160983057|NCT03354637|581326942|FG002|Open Label Extension|Lost to Follow-up|2|||
160983058|NCT03354637|581326940|FG000|Open Label Extension|Withdrawal by Subject|0|||
160983059|NCT03354637|581326941|FG001|Open Label Extension|Withdrawal by Subject|0|||
160983060|NCT03354637|581326942|FG002|Open Label Extension|Withdrawal by Subject|5|||
160983061|NCT03354637|581326940|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
160983062|NCT03354637|581326941|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
160983063|NCT03354637|581326942|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
160983064|NCT03354637|581326940|FG000|Open Label Extension|Subject Noncompliance|0|||
160983065|NCT03354637|581326941|FG001|Open Label Extension|Subject Noncompliance|0|||
160983066|NCT03354637|581326942|FG002|Open Label Extension|Subject Noncompliance|1|||
160893900|NCT00760214|581008232|FG002|Overall Study|Adverse Event|12|||
160642972|NCT00434161|580076495|FG002|Overall Study|Lost to Follow-up|0|||
160893901|NCT00760214|581008230|FG000|Overall Study|Protocol Violation|3|||
160893902|NCT00760214|581008231|FG001|Overall Study|Protocol Violation|0|||
160893903|NCT00760214|581008232|FG002|Overall Study|Protocol Violation|3|||
160893904|NCT00760214|581008230|FG000|Overall Study|Lost to Follow-up|0|||
160983067|NCT03354637|581326940|FG000|Open Label Extension|Lack of Efficacy|0|||
160642973|NCT00434161|580076493|FG000|Overall Study|Death|1|||
160794269|NCT02457793|580633343|FG002|Overall Study|Reason not specified|0|||
160794270|NCT02457793|580633344|FG003|Overall Study|Reason not specified|1|||
160794271|NCT02457793|580633345|FG004|Overall Study|Reason not specified|1|||
160794272|NCT02457793|580633346|FG005|Overall Study|Reason not specified|1|||
160794273|NCT02457793|580633341|FG000|Overall Study|Withdrawal by Subject|0|||
160794274|NCT02457793|580633342|FG001|Overall Study|Withdrawal by Subject|4|||
160794275|NCT02457793|580633343|FG002|Overall Study|Withdrawal by Subject|2|||
160794276|NCT02457793|580633344|FG003|Overall Study|Withdrawal by Subject|2|||
160794277|NCT02457793|580633345|FG004|Overall Study|Withdrawal by Subject|2|||
160794278|NCT02457793|580633346|FG005|Overall Study|Withdrawal by Subject|2|||
160794279|NCT02457793|580633341|FG000|Overall Study|Adverse Event|0|||
160794280|NCT02457793|580633342|FG001|Overall Study|Adverse Event|0|||
160794281|NCT02457793|580633343|FG002|Overall Study|Adverse Event|0|||
160794282|NCT02457793|580633344|FG003|Overall Study|Adverse Event|1|||
160794283|NCT02457793|580633345|FG004|Overall Study|Adverse Event|0|||
160794284|NCT02457793|580633346|FG005|Overall Study|Adverse Event|0|||
160794285|NCT02457793|580633341|FG000|Overall Study|Physician Decision|1|||
160794286|NCT02457793|580633342|FG001|Overall Study|Physician Decision|0|||
160794287|NCT02457793|580633343|FG002|Overall Study|Physician Decision|1|||
160794288|NCT02457793|580633344|FG003|Overall Study|Physician Decision|1|||
160794289|NCT02457793|580633345|FG004|Overall Study|Physician Decision|1|||
160794290|NCT02457793|580633346|FG005|Overall Study|Physician Decision|3|||
160794291|NCT00835172|580633351|FG000|Washout|Protocol Violation|0|||
160794292|NCT00835172|580633352|FG001|Washout|Protocol Violation|1|||
160794293|NCT03164356|580633353|FG000|Overall Study|Lost to Follow-up|1|||
160794294|NCT03164356|580633354|FG001|Overall Study|Lost to Follow-up|1|||
160642974|NCT00434161|580076494|FG001|Overall Study|Death|0|||
160642975|NCT00434161|580076495|FG002|Overall Study|Death|1|||
160642976|NCT00434161|580076493|FG000|Overall Study|Non-Compliance|1|||
160642977|NCT00434161|580076494|FG001|Overall Study|Non-Compliance|1|||
160794295|NCT03164356|580633355|FG002|Overall Study|Lost to Follow-up|2|||
160794296|NCT03164356|580633356|FG003|Overall Study|Lost to Follow-up|1|||
160794297|NCT03164356|580633353|FG000|Overall Study|Physician Decision|0|||
160794298|NCT03164356|580633354|FG001|Overall Study|Physician Decision|0|||
160794299|NCT03164356|580633355|FG002|Overall Study|Physician Decision|3|||
160794300|NCT03164356|580633356|FG003|Overall Study|Physician Decision|0|||
160794301|NCT03164356|580633353|FG000|Overall Study|Protocol Violation|2|||
160794302|NCT03164356|580633354|FG001|Overall Study|Protocol Violation|1|||
160794303|NCT03164356|580633355|FG002|Overall Study|Protocol Violation|0|||
160794304|NCT03164356|580633356|FG003|Overall Study|Protocol Violation|0|||
160794305|NCT03164356|580633353|FG000|Overall Study|Withdrawal by Subject|1|||
160794306|NCT03164356|580633354|FG001|Overall Study|Withdrawal by Subject|0|||
160794307|NCT03164356|580633355|FG002|Overall Study|Withdrawal by Subject|0|||
160794308|NCT03164356|580633356|FG003|Overall Study|Withdrawal by Subject|0|||
160794309|NCT03164356|580633353|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
160794310|NCT03164356|580633354|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
160794311|NCT03164356|580633355|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
160794312|NCT03164356|580633356|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
160794313|NCT03164356|580633353|FG000|Overall Study|Subject Incarcerated|0|||
160794314|NCT03164356|580633354|FG001|Overall Study|Subject Incarcerated|1|||
160794315|NCT03164356|580633355|FG002|Overall Study|Subject Incarcerated|0|||
160794316|NCT03164356|580633356|FG003|Overall Study|Subject Incarcerated|0|||
160794317|NCT03164356|580633353|FG000|Overall Study|Prosthetist unable to participate|0|||
160794318|NCT03164356|580633354|FG001|Overall Study|Prosthetist unable to participate|2|||
160794319|NCT03164356|580633355|FG002|Overall Study|Prosthetist unable to participate|1|||
160794320|NCT03164356|580633356|FG003|Overall Study|Prosthetist unable to participate|0|||
160794321|NCT00791648|580635239|FG000|Overall Study|Physician Decision|0|||
160794322|NCT00791648|580635240|FG001|Overall Study|Physician Decision|1|||
160794323|NCT00791648|580635239|FG000|Overall Study|Withdrawal by Subject|0|||
160794324|NCT00791648|580635240|FG001|Overall Study|Withdrawal by Subject|1|||
160794325|NCT04123704|580635251|FG000|Overall Study|Disease progression|2|||
160794326|NCT03332056|580635254|FG000|Overall Study|Incomplete questionnaires|8|||
160794327|NCT03332056|580635255|FG001|Overall Study|Incomplete questionnaires|9|||
160794328|NCT03332056|580635254|FG000|Overall Study|Passed stone prior to surgery date|1|||
160794329|NCT03332056|580635255|FG001|Overall Study|Passed stone prior to surgery date|0|||
160794330|NCT03332056|580635254|FG000|Overall Study|Did not require a ureteral stent|0|||
160794331|NCT03332056|580635255|FG001|Overall Study|Did not require a ureteral stent|1|||
160794332|NCT03360344|580635258|FG000|Overall Study|Withdrawal by Subject|0|||
160794333|NCT03360344|580635259|FG001|Overall Study|Withdrawal by Subject|1|||
160794334|NCT03360344|580635260|FG002|Overall Study|Withdrawal by Subject|1|||
160642978|NCT00434161|580076495|FG002|Overall Study|Non-Compliance|0|||
160642979|NCT00434161|580076493|FG000|Overall Study|Withdrawal by Subject|2|||
160642980|NCT00434161|580076494|FG001|Overall Study|Withdrawal by Subject|0|||
160794335|NCT00133705|580635265|FG000|Overall Study|Withdrawal by Subject|2|||
160794336|NCT00133705|580635266|FG001|Overall Study|Withdrawal by Subject|3|||
160794337|NCT00959049|580635267|FG000|Overall Study|Adverse Event|1|||
160794338|NCT00959049|580635268|FG001|Overall Study|Adverse Event|0|||
160794339|NCT00959049|580635269|FG002|Overall Study|Adverse Event|0|||
160794340|NCT00959049|580635270|FG003|Overall Study|Adverse Event|0|||
160794341|NCT00959049|580635271|FG004|Overall Study|Adverse Event|0|||
160794342|NCT00959049|580635272|FG005|Overall Study|Adverse Event|0|||
160794343|NCT00959049|580635267|FG000|Overall Study|Lost to Follow-up|17|||
160548571|NCT02028455|579734192|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
160794344|NCT00959049|580635268|FG001|Overall Study|Lost to Follow-up|5|||
160794345|NCT00959049|580635269|FG002|Overall Study|Lost to Follow-up|1|||
160794346|NCT00959049|580635270|FG003|Overall Study|Lost to Follow-up|10|||
160794347|NCT00959049|580635271|FG004|Overall Study|Lost to Follow-up|9|||
160794348|NCT00959049|580635272|FG005|Overall Study|Lost to Follow-up|1|||
160794349|NCT00959049|580635267|FG000|Overall Study|Contraindicated medication|0|||
160794350|NCT00959049|580635268|FG001|Overall Study|Contraindicated medication|0|||
160794351|NCT00959049|580635269|FG002|Overall Study|Contraindicated medication|0|||
160893905|NCT00760214|581008231|FG001|Overall Study|Lost to Follow-up|0|||
160893906|NCT00760214|581008232|FG002|Overall Study|Lost to Follow-up|1|||
160893907|NCT00760214|581008230|FG000|Overall Study|Withdrawal by Subject|12|||
160893908|NCT00760214|581008231|FG001|Overall Study|Withdrawal by Subject|14|||
160893909|NCT00760214|581008232|FG002|Overall Study|Withdrawal by Subject|13|||
160893910|NCT00760214|581008230|FG000|Overall Study|Lack of Efficacy|3|||
160893911|NCT00760214|581008231|FG001|Overall Study|Lack of Efficacy|2|||
160893912|NCT00760214|581008232|FG002|Overall Study|Lack of Efficacy|4|||
160893913|NCT00760214|581008230|FG000|Overall Study|Pregnancy|0|||
160893914|NCT00760214|581008231|FG001|Overall Study|Pregnancy|0|||
160893915|NCT00760214|581008232|FG002|Overall Study|Pregnancy|1|||
160893916|NCT00760214|581008230|FG000|Overall Study|Physician Decision|1|||
160893917|NCT00760214|581008231|FG001|Overall Study|Physician Decision|1|||
160893918|NCT00760214|581008232|FG002|Overall Study|Physician Decision|1|||
160893919|NCT00760214|581008230|FG000|Overall Study|Other|3|||
160893920|NCT00760214|581008231|FG001|Overall Study|Other|4|||
160893921|NCT00760214|581008232|FG002|Overall Study|Other|6|||
160893922|NCT00700570|581008233|FG000|Overall Study|Adverse Event|2|||
160893923|NCT00700570|581008234|FG001|Overall Study|Adverse Event|6|||
160893924|NCT00700570|581008233|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
160893925|NCT00700570|581008234|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
160893926|NCT00700570|581008233|FG000|Overall Study|Disease Progression|8|||
160893927|NCT00700570|581008234|FG001|Overall Study|Disease Progression|11|||
160893928|NCT00700570|581008233|FG000|Overall Study|Withdrawal by Subject|1|||
160893929|NCT00700570|581008234|FG001|Overall Study|Withdrawal by Subject|6|||
160893930|NCT01134315|581008235|FG000|Overall Study|Adverse Event|1|||
160893931|NCT01134315|581008236|FG001|Overall Study|Adverse Event|2|||
160893932|NCT01134315|581008235|FG000|Overall Study|Other Reason|8|||
160893933|NCT01134315|581008236|FG001|Overall Study|Other Reason|17|||
160893934|NCT04587271|581008239|FG000|Overall Study|Lost to Follow-up|2|||
160893935|NCT04587271|581008240|FG001|Overall Study|Lost to Follow-up|2|||
160893936|NCT04587271|581008241|FG002|Overall Study|Lost to Follow-up|0|||
160893937|NCT04587271|581008242|FG003|Overall Study|Lost to Follow-up|2|||
160893938|NCT04587271|581008243|FG004|Overall Study|Lost to Follow-up|2|||
160893939|NCT04587271|581008244|FG005|Overall Study|Lost to Follow-up|0|||
160794352|NCT00959049|580635270|FG003|Overall Study|Contraindicated medication|1|||
160893940|NCT04587271|581008239|FG000|Overall Study|Caregiver brought child to visits|0|||
160893941|NCT04587271|581008240|FG001|Overall Study|Caregiver brought child to visits|0|||
160893942|NCT04587271|581008241|FG002|Overall Study|Caregiver brought child to visits|0|||
160893943|NCT04587271|581008242|FG003|Overall Study|Caregiver brought child to visits|1|||
160893944|NCT04587271|581008243|FG004|Overall Study|Caregiver brought child to visits|0|||
160983068|NCT03354637|581326941|FG001|Open Label Extension|Lack of Efficacy|0|||
160983069|NCT03354637|581326942|FG002|Open Label Extension|Lack of Efficacy|1|||
160794353|NCT00959049|580635271|FG004|Overall Study|Contraindicated medication|0|||
160983070|NCT03354637|581326940|FG000|Open Label Extension|Physician Decision|0|||
160983071|NCT03354637|581326941|FG001|Open Label Extension|Physician Decision|0|||
160983072|NCT03354637|581326942|FG002|Open Label Extension|Physician Decision|1|||
160794354|NCT00959049|580635272|FG005|Overall Study|Contraindicated medication|0|||
160794355|NCT00959049|580635267|FG000|Overall Study|Withdrawal by Subject|0|||
160794356|NCT00959049|580635268|FG001|Overall Study|Withdrawal by Subject|2|||
160794357|NCT00959049|580635269|FG002|Overall Study|Withdrawal by Subject|0|||
160794358|NCT00959049|580635270|FG003|Overall Study|Withdrawal by Subject|0|||
160794359|NCT00959049|580635271|FG004|Overall Study|Withdrawal by Subject|0|||
160794360|NCT00959049|580635272|FG005|Overall Study|Withdrawal by Subject|0|||
160794361|NCT00836706|580635280|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
160893945|NCT04587271|581008244|FG005|Overall Study|Caregiver brought child to visits|0|||
160893946|NCT02360111|581008245|FG000|Overall Study|Death|2|||
160893947|NCT00611533|581008246|FG000|First Intervention (6 Weeks)|Never started study|0|||
160893948|NCT00611533|581008247|FG001|First Intervention (6 Weeks)|Never started study|1|||
160893949|NCT00611533|581008246|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
160893950|NCT00611533|581008247|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
160794362|NCT00836706|580635281|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
160794363|NCT02989857|580635282|FG000|Randomization Phase|Not Treated|3|||
160794364|NCT02989857|580635283|FG001|Randomization Phase|Not Treated|2|||
160794365|NCT02989857|580635284|FG002|Randomization Phase|Not Treated|0|||
160794366|NCT01992757|580635285|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
160794367|NCT00688740|580635289|FG000|Overall Study|Adverse Event|45|||
160794368|NCT00688740|580635290|FG001|Overall Study|Adverse Event|8|||
160794369|NCT00688740|580635289|FG000|Overall Study|Death|2|||
160794370|NCT00688740|580635290|FG001|Overall Study|Death|2|||
160794371|NCT00688740|580635289|FG000|Overall Study|Lost to Follow-up|0|||
160794372|NCT00688740|580635290|FG001|Overall Study|Lost to Follow-up|1|||
160794373|NCT00688740|580635289|FG000|Overall Study|Consent Withdrawn|17|||
160794374|NCT00688740|580635290|FG001|Overall Study|Consent Withdrawn|17|||
160794375|NCT00688740|580635289|FG000|Overall Study|Breast Cancer Relapse|1|||
160794376|NCT00688740|580635290|FG001|Overall Study|Breast Cancer Relapse|4|||
160794377|NCT00688740|580635289|FG000|Overall Study|Violation of Inclusion Criteria|1|||
160794378|NCT00688740|580635290|FG001|Overall Study|Violation of Inclusion Criteria|3|||
160794379|NCT01344356|580635291|FG000|Overall Study|Physician Decision|0|||
160794380|NCT01344356|580635292|FG001|Overall Study|Physician Decision|3|||
160794381|NCT01344356|580635291|FG000|Overall Study|Lost to Follow-up|0|||
160794382|NCT01344356|580635292|FG001|Overall Study|Lost to Follow-up|6|||
160794383|NCT02390076|580635295|FG000|Overall Study|Lost to Follow-up|2|||
160794384|NCT02390076|580635296|FG001|Overall Study|Lost to Follow-up|1|||
160794385|NCT02390076|580635297|FG002|Overall Study|Lost to Follow-up|4|||
160794386|NCT01206517|580635298|FG000|Overall Study|Withdrawal by Subject|0|||
160794387|NCT01206517|580635299|FG001|Overall Study|Withdrawal by Subject|0|||
160794388|NCT01206517|580635300|FG002|Overall Study|Withdrawal by Subject|2|||
160794389|NCT01206517|580635301|FG003|Overall Study|Withdrawal by Subject|0|||
160794390|NCT01206517|580635302|FG004|Overall Study|Withdrawal by Subject|1|||
160794391|NCT01206517|580635303|FG005|Overall Study|Withdrawal by Subject|0|||
160794392|NCT04023487|580635304|FG000|Overall Study|Lost to Follow-up|5|||
160794393|NCT04023487|580635305|FG001|Overall Study|Lost to Follow-up|4|||
160794394|NCT04023487|580635304|FG000|Overall Study|Pregnancy|1|||
160794395|NCT04023487|580635305|FG001|Overall Study|Pregnancy|2|||
160794396|NCT04023487|580635304|FG000|Overall Study|Withdrawal by Subject|4|||
160794397|NCT04023487|580635305|FG001|Overall Study|Withdrawal by Subject|5|||
160794398|NCT04023487|580635304|FG000|Overall Study|Partially completed testing|8|||
160794399|NCT04023487|580635305|FG001|Overall Study|Partially completed testing|4|||
160794400|NCT03898180|580635306|FG000|Overall Study|Death|178|||
160794401|NCT03898180|580635307|FG001|Overall Study|Death|173|||
160794402|NCT03898180|580635306|FG000|Overall Study|Physician Decision|1|||
160794403|NCT03898180|580635307|FG001|Overall Study|Physician Decision|0|||
160794404|NCT03898180|580635306|FG000|Overall Study|Sponsor Decision|3|||
160794405|NCT03898180|580635307|FG001|Overall Study|Sponsor Decision|0|||
160794406|NCT03898180|580635306|FG000|Overall Study|Lost to Follow-up|1|||
160794407|NCT03898180|580635307|FG001|Overall Study|Lost to Follow-up|0|||
160794408|NCT03898180|580635306|FG000|Overall Study|Withdrawal by Subject|5|||
160794409|NCT03898180|580635307|FG001|Overall Study|Withdrawal by Subject|4|||
160794410|NCT01472185|580635308|FG000|Overall Study|Randomized but Not Treated|0|||
160794411|NCT01472185|580635309|FG001|Overall Study|Randomized but Not Treated|1|||
160794412|NCT01472185|580635308|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
160794413|NCT01472185|580635309|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
160794414|NCT01472185|580635308|FG000|Overall Study|Hyperglycemia|5|||
160794415|NCT01472185|580635309|FG001|Overall Study|Hyperglycemia|2|||
160794416|NCT01472185|580635308|FG000|Overall Study|Investigator's Discretion|3|||
160794417|NCT01472185|580635309|FG001|Overall Study|Investigator's Discretion|1|||
160794418|NCT01472185|580635308|FG000|Overall Study|Lost to Follow-up|4|||
160794419|NCT01472185|580635309|FG001|Overall Study|Lost to Follow-up|1|||
160794420|NCT01472185|580635308|FG000|Overall Study|Protocol Violation|5|||
160794421|NCT01472185|580635309|FG001|Overall Study|Protocol Violation|1|||
160794422|NCT01472185|580635308|FG000|Overall Study|Subject Noncompliance|8|||
160794423|NCT01472185|580635309|FG001|Overall Study|Subject Noncompliance|15|||
160893951|NCT00611533|581008246|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
160893952|NCT00611533|581008247|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
160794424|NCT01472185|580635308|FG000|Overall Study|Subject Withdrew Consent|6|||
160893953|NCT02180165|581008248|FG000|Overall Study|Not Treated|0|||
160794425|NCT01472185|580635309|FG001|Overall Study|Subject Withdrew Consent|3|||
160794426|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794427|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
160893954|NCT02180165|581008249|FG001|Overall Study|Not Treated|0|||
160794428|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794429|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
160893955|NCT02180165|581008250|FG002|Overall Study|Not Treated|1|||
160983073|NCT02726399|581326945|FG000|Overall Study|Participant Non-Compliance|1|||
160983074|NCT02726399|581326945|FG000|Overall Study|Adverse Event|2|||
160983075|NCT02726399|581326945|FG000|Overall Study|Progression of disease|4|||
160983076|NCT04006366|581326948|FG000|Overall Study|Withdrawal by Subject|1|||
160983077|NCT03468426|581326949|FG000|Overall Study|Progressive disease|3|||
160983078|NCT03468426|581326950|FG001|Overall Study|Progressive disease|0|||
160983079|NCT03468426|581326951|FG002|Overall Study|Progressive disease|4|||
160983080|NCT03468426|581326952|FG003|Overall Study|Progressive disease|20|||
160983081|NCT03468426|581326953|FG004|Overall Study|Progressive disease|23|||
160983082|NCT03468426|581326954|FG005|Overall Study|Progressive disease|15|||
160983083|NCT03468426|581326955|FG006|Overall Study|Progressive disease|24|||
160983084|NCT03468426|581326956|FG007|Overall Study|Progressive disease|27|||
160983085|NCT03468426|581326957|FG008|Overall Study|Progressive disease|13|||
160893956|NCT02180165|581008251|FG003|Overall Study|Not Treated|0|||
160893957|NCT02180165|581008248|FG000|Overall Study|Adverse Event|7|||
160983086|NCT03468426|581326958|FG009|Overall Study|Progressive disease|13|||
160983087|NCT03468426|581326959|FG010|Overall Study|Progressive disease|0|||
160983088|NCT03468426|581326949|FG000|Overall Study|Other adverse event or clinical progression|0|||
160893958|NCT02180165|581008249|FG001|Overall Study|Adverse Event|0|||
160893959|NCT02180165|581008250|FG002|Overall Study|Adverse Event|18|||
160893960|NCT02180165|581008251|FG003|Overall Study|Adverse Event|3|||
160893961|NCT02180165|581008248|FG000|Overall Study|Lack of Efficacy|0|||
160983089|NCT03468426|581326950|FG001|Overall Study|Other adverse event or clinical progression|1|||
160983090|NCT03468426|581326951|FG002|Overall Study|Other adverse event or clinical progression|3|||
160983091|NCT03468426|581326952|FG003|Overall Study|Other adverse event or clinical progression|14|||
160983092|NCT03468426|581326953|FG004|Overall Study|Other adverse event or clinical progression|10|||
160983093|NCT03468426|581326954|FG005|Overall Study|Other adverse event or clinical progression|8|||
160983094|NCT03468426|581326955|FG006|Overall Study|Other adverse event or clinical progression|5|||
160983095|NCT03468426|581326956|FG007|Overall Study|Other adverse event or clinical progression|4|||
160983096|NCT03468426|581326957|FG008|Overall Study|Other adverse event or clinical progression|6|||
160893962|NCT02180165|581008249|FG001|Overall Study|Lack of Efficacy|1|||
160893963|NCT02180165|581008250|FG002|Overall Study|Lack of Efficacy|3|||
160893964|NCT02180165|581008251|FG003|Overall Study|Lack of Efficacy|2|||
160893965|NCT02180165|581008248|FG000|Overall Study|Physician Decision|1|||
160893966|NCT02180165|581008249|FG001|Overall Study|Physician Decision|0|||
160893967|NCT02180165|581008250|FG002|Overall Study|Physician Decision|5|||
160893968|NCT02180165|581008251|FG003|Overall Study|Physician Decision|0|||
160893969|NCT02180165|581008248|FG000|Overall Study|Withdrawal by Subject|3|||
160893970|NCT02180165|581008249|FG001|Overall Study|Withdrawal by Subject|0|||
160893971|NCT02180165|581008250|FG002|Overall Study|Withdrawal by Subject|2|||
160893972|NCT02180165|581008251|FG003|Overall Study|Withdrawal by Subject|1|||
160893973|NCT01933217|581008252|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
160893974|NCT01933217|581008253|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
160893975|NCT01933217|581008252|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
160893976|NCT01933217|581008253|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
160893977|NCT03923738|581008257|FG000|Period 1|Adverse Event|1|||
160893978|NCT03923738|581008257|FG000|Period 1|Withdrawal by Subject|1|||
160893979|NCT05246397|581008258|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
160893980|NCT03875768|581008260|FG000|Overall Study|Lost to Follow-up|16|||
160893981|NCT03875768|581008261|FG001|Overall Study|Lost to Follow-up|13|||
160893982|NCT03875768|581008260|FG000|Overall Study|Withdrawal by Subject|10|||
160893983|NCT03875768|581008261|FG001|Overall Study|Withdrawal by Subject|21|||
160893984|NCT03875768|581008260|FG000|Overall Study|Did not complete assessment|21|||
160893985|NCT03875768|581008261|FG001|Overall Study|Did not complete assessment|12|||
160893986|NCT03875768|581008260|FG000|Overall Study|Became ineligible|1|||
160893987|NCT03875768|581008261|FG001|Overall Study|Became ineligible|0|||
160983097|NCT03468426|581326958|FG009|Overall Study|Other adverse event or clinical progression|11|||
160983098|NCT03468426|581326959|FG010|Overall Study|Other adverse event or clinical progression|0|||
160983099|NCT03468426|581326949|FG000|Overall Study|Refused to continue taking trial medication|0|||
160983100|NCT03468426|581326950|FG001|Overall Study|Refused to continue taking trial medication|0|||
160983101|NCT03468426|581326951|FG002|Overall Study|Refused to continue taking trial medication|0|||
160983102|NCT03468426|581326952|FG003|Overall Study|Refused to continue taking trial medication|2|||
160983103|NCT03468426|581326953|FG004|Overall Study|Refused to continue taking trial medication|0|||
160983104|NCT03468426|581326954|FG005|Overall Study|Refused to continue taking trial medication|3|||
160983105|NCT03468426|581326955|FG006|Overall Study|Refused to continue taking trial medication|0|||
160983106|NCT03468426|581326956|FG007|Overall Study|Refused to continue taking trial medication|0|||
160893988|NCT01925274|581008262|FG000|Overall Study|Death|1|||
160893989|NCT01925274|581008263|FG001|Overall Study|Death|0|||
160893990|NCT01925274|581008264|FG002|Overall Study|Death|0|||
160893991|NCT01925274|581008262|FG000|Overall Study|Lost to Follow-up|0|||
160893992|NCT01925274|581008263|FG001|Overall Study|Lost to Follow-up|1|||
160794430|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
160794431|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
160794432|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
160794433|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794434|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794435|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794436|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794437|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794438|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794439|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794440|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794441|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794442|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
160794443|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
160794444|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
160794445|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
160794446|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
160794447|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
160794448|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
160794449|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
160794450|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
160794451|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
160794452|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
160794453|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
160794454|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
160794455|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
160794456|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
160794457|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
160794458|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
160794459|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
160794460|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794461|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794462|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794463|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794464|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794465|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794466|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794467|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794468|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794469|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794470|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794471|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794472|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794473|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794474|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
160794475|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794476|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
160794477|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
160794478|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
160794479|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
160794480|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
160794481|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794482|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794483|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794484|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794485|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794486|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794487|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794488|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794489|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794490|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794491|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794492|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794493|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
160794494|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794495|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794496|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
160893993|NCT01925274|581008264|FG002|Overall Study|Lost to Follow-up|0|||
160983107|NCT03468426|581326957|FG008|Overall Study|Refused to continue taking trial medication|1|||
160983108|NCT03468426|581326958|FG009|Overall Study|Refused to continue taking trial medication|0|||
160983109|NCT03468426|581326959|FG010|Overall Study|Refused to continue taking trial medication|0|||
160983110|NCT03468426|581326949|FG000|Overall Study|Other than listed|0|||
160983111|NCT03468426|581326950|FG001|Overall Study|Other than listed|1|||
160983112|NCT03468426|581326951|FG002|Overall Study|Other than listed|0|||
160983113|NCT03468426|581326952|FG003|Overall Study|Other than listed|0|||
160983114|NCT03468426|581326953|FG004|Overall Study|Other than listed|2|||
160983115|NCT03468426|581326954|FG005|Overall Study|Other than listed|2|||
160983116|NCT03468426|581326955|FG006|Overall Study|Other than listed|0|||
160983117|NCT03468426|581326956|FG007|Overall Study|Other than listed|0|||
160983118|NCT03468426|581326957|FG008|Overall Study|Other than listed|4|||
160983119|NCT03468426|581326958|FG009|Overall Study|Other than listed|4|||
160983120|NCT03468426|581326959|FG010|Overall Study|Other than listed|1|||
160983121|NCT03468426|581326949|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983122|NCT03468426|581326950|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983123|NCT03468426|581326951|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160983124|NCT03468426|581326952|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983125|NCT03468426|581326953|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983126|NCT03468426|581326954|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983127|NCT03468426|581326955|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983128|NCT03468426|581326956|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983129|NCT03468426|581326957|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983130|NCT03468426|581326958|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983131|NCT03468426|581326959|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983132|NCT03468426|581326949|FG000|Overall Study|missing reason|0|||
160983133|NCT03468426|581326950|FG001|Overall Study|missing reason|0|||
160983134|NCT03468426|581326951|FG002|Overall Study|missing reason|0|||
160983135|NCT03468426|581326952|FG003|Overall Study|missing reason|0|||
160983136|NCT03468426|581326953|FG004|Overall Study|missing reason|0|||
160983137|NCT03468426|581326954|FG005|Overall Study|missing reason|0|||
160983138|NCT03468426|581326955|FG006|Overall Study|missing reason|0|||
160983139|NCT03468426|581326956|FG007|Overall Study|missing reason|0|||
160983140|NCT03468426|581326957|FG008|Overall Study|missing reason|0|||
160983141|NCT03468426|581326958|FG009|Overall Study|missing reason|1|||
160983142|NCT03468426|581326959|FG010|Overall Study|missing reason|0|||
160983143|NCT05876351|581326961|FG000|Overall Study|Other than specified|2|||
160983144|NCT05876351|581326961|FG000|Overall Study|Study specific discontinuation criteria|1|||
160983145|NCT01440049|581326962|FG000|Overall Study|Adverse Event|5|||
160983146|NCT02268552|581326963|FG000|Part 1|Death|1|||
160983147|NCT02268552|581326964|FG001|Part 1|Death|1|||
160983148|NCT02268552|581326965|FG002|Part 1|Death|1|||
160983149|NCT02268552|581326966|FG003|Part 1|Death|2|||
160983150|NCT02268552|581326967|FG004|Part 1|Death|0|||
160983151|NCT02268552|581326968|FG005|Part 1|Death|0|||
160983152|NCT02268552|581326969|FG006|Part 1|Death|0|||
160983153|NCT02268552|581326963|FG000|Part 1|Subject/guardian decision|0|||
160983154|NCT02268552|581326964|FG001|Part 1|Subject/guardian decision|0|||
160983155|NCT02268552|581326965|FG002|Part 1|Subject/guardian decision|0|||
160983156|NCT02268552|581326966|FG003|Part 1|Subject/guardian decision|1|||
160983157|NCT02268552|581326967|FG004|Part 1|Subject/guardian decision|0|||
160983158|NCT02268552|581326968|FG005|Part 1|Subject/guardian decision|0|||
160983159|NCT02268552|581326969|FG006|Part 1|Subject/guardian decision|0|||
160983160|NCT02268552|581326963|FG000|Part 2|Death|0|||
160983161|NCT02268552|581326964|FG001|Part 2|Death|0|||
160983162|NCT02268552|581326965|FG002|Part 2|Death|0|||
160983163|NCT02268552|581326966|FG003|Part 2|Death|0|||
160983164|NCT02268552|581326967|FG004|Part 2|Death|0|||
160983165|NCT02268552|581326968|FG005|Part 2|Death|0|||
160983166|NCT02268552|581326969|FG006|Part 2|Death|2|||
160983167|NCT02268552|581326963|FG000|Part 2|Subject/guardian decision|0|||
160642981|NCT00434161|580076495|FG002|Overall Study|Withdrawal by Subject|3|||
160642982|NCT00434161|580076493|FG000|Overall Study|Logistical error study assessments|1|||
160983168|NCT02268552|581326964|FG001|Part 2|Subject/guardian decision|0|||
160983169|NCT02268552|581326965|FG002|Part 2|Subject/guardian decision|0|||
160983170|NCT02268552|581326966|FG003|Part 2|Subject/guardian decision|0|||
160983171|NCT02268552|581326967|FG004|Part 2|Subject/guardian decision|0|||
160983172|NCT02268552|581326968|FG005|Part 2|Subject/guardian decision|0|||
160983173|NCT02268552|581326969|FG006|Part 2|Subject/guardian decision|1|||
160983174|NCT02268552|581326963|FG000|Part 3 Extension|Death|0|||
160983175|NCT02268552|581326964|FG001|Part 3 Extension|Death|1|||
160983176|NCT02268552|581326965|FG002|Part 3 Extension|Death|1|||
160983177|NCT02268552|581326966|FG003|Part 3 Extension|Death|1|||
160983178|NCT02268552|581326967|FG004|Part 3 Extension|Death|1|||
160983179|NCT02268552|581326968|FG005|Part 3 Extension|Death|1|||
160983180|NCT02268552|581326969|FG006|Part 3 Extension|Death|0|||
160983181|NCT02268552|581326963|FG000|Part 3 Extension|Early termination of trial|1|||
160983182|NCT02268552|581326964|FG001|Part 3 Extension|Early termination of trial|0|||
160983183|NCT02268552|581326965|FG002|Part 3 Extension|Early termination of trial|0|||
160983184|NCT02268552|581326966|FG003|Part 3 Extension|Early termination of trial|0|||
160983185|NCT02268552|581326967|FG004|Part 3 Extension|Early termination of trial|2|||
160794497|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794498|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794499|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794500|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794501|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794502|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794503|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794504|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794505|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794506|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794507|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794508|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
160794509|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794510|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794511|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794512|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794513|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794514|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794515|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794516|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794517|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794518|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794519|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794520|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794521|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794522|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
160794523|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
160794524|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
160794525|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794526|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794527|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794528|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794529|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794530|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794531|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794532|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794533|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794534|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794535|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794536|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794537|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794538|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
160893994|NCT01925274|581008262|FG000|Overall Study|Withdrawal by Subject|1|||
160893995|NCT01925274|581008263|FG001|Overall Study|Withdrawal by Subject|2|||
160893996|NCT01925274|581008264|FG002|Overall Study|Withdrawal by Subject|0|||
160893997|NCT01925274|581008262|FG000|Overall Study|Study terminated by sponsor|4|||
160893998|NCT01925274|581008263|FG001|Overall Study|Study terminated by sponsor|0|||
160893999|NCT01925274|581008264|FG002|Overall Study|Study terminated by sponsor|0|||
160894000|NCT01925274|581008262|FG000|Overall Study|Protocol amendment|1|||
160894001|NCT01925274|581008263|FG001|Overall Study|Protocol amendment|3|||
160983186|NCT02268552|581326968|FG005|Part 3 Extension|Early termination of trial|9|||
160794539|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
160794540|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
160794541|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
160794542|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
160794543|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
160794544|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
160794545|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
160794546|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
160794547|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
160794548|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
160794549|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
160794550|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
160794551|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
160794552|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
160794553|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
160794554|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794555|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794556|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794557|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794558|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
160794559|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794560|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794561|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160894002|NCT01925274|581008264|FG002|Overall Study|Protocol amendment|6|||
160894003|NCT04327674|581008266|FG000|Overall Study|Protocol Violation|19|||
160794562|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794563|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794564|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794565|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794566|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160894004|NCT00723398|581008271|FG000|Overall Study|Withdrawal by Subject|2|||
160894005|NCT00723398|581008272|FG001|Overall Study|Withdrawal by Subject|6|||
160894006|NCT00723398|581008273|FG002|Overall Study|Withdrawal by Subject|4|||
160894007|NCT00723398|581008274|FG003|Overall Study|Withdrawal by Subject|4|||
160894008|NCT00723398|581008275|FG004|Overall Study|Withdrawal by Subject|4|||
160894009|NCT00723398|581008271|FG000|Overall Study|Protocol Violation|2|||
160894010|NCT00723398|581008272|FG001|Overall Study|Protocol Violation|1|||
160894011|NCT00723398|581008273|FG002|Overall Study|Protocol Violation|5|||
160894012|NCT00723398|581008274|FG003|Overall Study|Protocol Violation|0|||
160894013|NCT00723398|581008275|FG004|Overall Study|Protocol Violation|0|||
160894014|NCT00723398|581008271|FG000|Overall Study|Physician Decision|2|||
160894015|NCT00723398|581008272|FG001|Overall Study|Physician Decision|2|||
160894016|NCT00723398|581008273|FG002|Overall Study|Physician Decision|5|||
160894017|NCT00723398|581008274|FG003|Overall Study|Physician Decision|0|||
160894018|NCT00723398|581008275|FG004|Overall Study|Physician Decision|1|||
160894019|NCT00723398|581008271|FG000|Overall Study|Adverse Event|0|||
160894020|NCT00723398|581008272|FG001|Overall Study|Adverse Event|5|||
160894021|NCT00723398|581008273|FG002|Overall Study|Adverse Event|3|||
160894022|NCT00723398|581008274|FG003|Overall Study|Adverse Event|1|||
160894023|NCT00723398|581008275|FG004|Overall Study|Adverse Event|4|||
160894024|NCT00723398|581008271|FG000|Overall Study|Lost to Follow-up|0|||
160894025|NCT00723398|581008272|FG001|Overall Study|Lost to Follow-up|1|||
160894026|NCT00723398|581008273|FG002|Overall Study|Lost to Follow-up|0|||
160894027|NCT00723398|581008274|FG003|Overall Study|Lost to Follow-up|0|||
160894028|NCT00723398|581008275|FG004|Overall Study|Lost to Follow-up|0|||
160894029|NCT00267189|581008276|FG000|Overall Study|Patient withdrew consent|1|||
160894030|NCT00267189|581008277|FG001|Overall Study|Patient withdrew consent|1|||
160894031|NCT00267189|581008276|FG000|Overall Study|Death|1|||
160894032|NCT00267189|581008277|FG001|Overall Study|Death|0|||
160894033|NCT00267189|581008276|FG000|Overall Study|Missing|3|||
160983187|NCT02268552|581326969|FG006|Part 3 Extension|Early termination of trial|11|||
160794567|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160894034|NCT00267189|581008277|FG001|Overall Study|Missing|0|||
160794568|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160894035|NCT00751621|581008278|FG000|Overall Study|Adverse Event|1|||
160894036|NCT00751621|581008278|FG000|Overall Study|Withdrawal by Subject|1|||
160894037|NCT00751621|581008278|FG000|Overall Study|Subject moved to another country|1|||
160894038|NCT00751621|581008278|FG000|Overall Study|Poor adherence to asthma treatment|1|||
160894039|NCT03719586|581008281|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
160894040|NCT03719586|581008282|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
160894041|NCT03719586|581008283|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
160894042|NCT03719586|581008284|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
160794569|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794570|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160894043|NCT02791594|581008285|FG000|Overall Study|Physician Decision|2|||
160894044|NCT01400815|581008286|FG000|Overall Study|Adverse Event|3|||
160894045|NCT01400815|581008287|FG001|Overall Study|Adverse Event|0|||
160894046|NCT01400815|581008286|FG000|Overall Study|Death|0|||
160894047|NCT01400815|581008287|FG001|Overall Study|Death|1|||
160894048|NCT01400815|581008286|FG000|Overall Study|Lost to Follow-up|18|||
160894049|NCT01400815|581008287|FG001|Overall Study|Lost to Follow-up|11|||
160894050|NCT01400815|581008286|FG000|Overall Study|Protocol Violation|0|||
160894051|NCT01400815|581008287|FG001|Overall Study|Protocol Violation|1|||
160894052|NCT01400815|581008286|FG000|Overall Study|Physician Decision|1|||
160894053|NCT01400815|581008287|FG001|Overall Study|Physician Decision|0|||
160894054|NCT01400815|581008286|FG000|Overall Study|Withdrawal by Subject|15|||
160894055|NCT01400815|581008287|FG001|Overall Study|Withdrawal by Subject|8|||
160894056|NCT01400815|581008286|FG000|Overall Study|Subject in jail|1|||
160894057|NCT01400815|581008287|FG001|Overall Study|Subject in jail|0|||
160894058|NCT02310321|581008289|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
160894059|NCT02310321|581008290|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
160894060|NCT02310321|581008291|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
160894061|NCT02310321|581008289|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
160894062|NCT02310321|581008290|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
160894063|NCT02310321|581008291|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
160794571|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794572|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794573|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794574|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794575|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794576|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794577|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
160794578|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
160794579|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
160794580|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794581|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
160794582|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
160794583|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
160794584|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
160794585|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
160794586|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794587|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794588|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794589|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794590|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794591|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794592|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794593|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794594|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
160794595|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
160794596|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794597|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
160794598|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794599|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
160794600|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794601|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
160794602|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794603|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794604|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794605|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794606|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794607|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794608|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794609|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160894064|NCT02310321|581008289|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
160794610|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160894065|NCT02310321|581008290|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
160894066|NCT02310321|581008291|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
160894067|NCT02310321|581008289|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
160894068|NCT02310321|581008290|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
160894069|NCT02310321|581008291|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
160894070|NCT02310321|581008289|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
160794611|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
160794612|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794613|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794614|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794615|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794616|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794617|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
160794618|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794619|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794620|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794621|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794622|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794623|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794624|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794625|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794626|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794627|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794628|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794629|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
160794630|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
160794631|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
160794632|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
160794633|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
160794634|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
160794635|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
160794636|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
160794637|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
160794638|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
160794639|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
160794640|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
160794641|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
160794642|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
160794643|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
160794644|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
160794645|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
160794646|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
160794647|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
160794648|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
160794649|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
160794650|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794651|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794652|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794653|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794654|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794655|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794656|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794657|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794658|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794659|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794660|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794661|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794662|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794663|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
160794664|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794665|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794666|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794667|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794668|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794669|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794670|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794671|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794672|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794673|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794674|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794675|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794676|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794677|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794678|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794679|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
160794680|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794681|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794682|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794683|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794684|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794685|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794686|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794687|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794688|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794689|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794690|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794691|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
160794692|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794693|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794694|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794695|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794696|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794697|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794698|NCT02661815|580635326|FG000|Overall Study|Withdrawal by Subject|1|||
160794699|NCT02661815|580635327|FG001|Overall Study|Withdrawal by Subject|0|||
160794700|NCT02661815|580635328|FG002|Overall Study|Withdrawal by Subject|0|||
160794701|NCT02661815|580635329|FG003|Overall Study|Withdrawal by Subject|0|||
160794702|NCT00635050|580635332|FG000|Overall Study|Withdrawal by Subject|1|||
160794703|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Adverse Event|3|||
160794704|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Adverse Event|0|||
160794705|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Adverse Event|0|||
160794706|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
160794707|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
160794708|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
160794709|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
160794710|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
160794711|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
160794712|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
160794713|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
160794714|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
160794715|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
160794716|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
160794717|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
160794718|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
160794719|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
160794720|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
160794721|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160794722|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Adverse Event|1|||
160794723|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Adverse Event|14|||
160794724|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
160794725|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
160794726|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
160794727|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
160794728|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
160794729|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
160794730|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
160794731|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
160794732|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
160794733|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
160794734|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
160794735|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
160794736|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
160794737|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
160794738|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
160794739|NCT00209131|580635340|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
160794740|NCT00209131|580635341|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
160794741|NCT05360784|580635342|FG000|Overall Study|Discontinued|25|||
160794742|NCT05360784|580635343|FG001|Overall Study|Discontinued|11|||
160794743|NCT00437073|580635344|FG000|Overall Study|Sponsor Terminated Study|1|||
160794744|NCT00437073|580635345|FG001|Overall Study|Sponsor Terminated Study|0|||
160794745|NCT00437073|580635344|FG000|Overall Study|Physician Decision|0|||
160794746|NCT00437073|580635345|FG001|Overall Study|Physician Decision|1|||
160794747|NCT01299961|580635346|FG000|Overall Study|Adverse Event|3|||
160794748|NCT01299961|580635346|FG000|Overall Study|Lack of Efficacy|2|||
160794749|NCT01299961|580635346|FG000|Overall Study|Lost to Follow-up|1|||
160794750|NCT02904096|580635347|FG000|Overall Study|Adverse Event|1|||
160794751|NCT02904096|580635348|FG001|Overall Study|Adverse Event|0|||
160794752|NCT02904096|580635347|FG000|Overall Study|Withdrawal by Subject|4|||
160794753|NCT02904096|580635348|FG001|Overall Study|Withdrawal by Subject|3|||
160794754|NCT02904096|580635347|FG000|Overall Study|Lost to Follow-up|10|||
160794755|NCT02904096|580635348|FG001|Overall Study|Lost to Follow-up|17|||
160794756|NCT02904096|580635347|FG000|Overall Study|Non-compliant|3|||
160794757|NCT02904096|580635348|FG001|Overall Study|Non-compliant|1|||
160794758|NCT02904096|580635347|FG000|Overall Study|Sponsor instructed|1|||
160794759|NCT02904096|580635348|FG001|Overall Study|Sponsor instructed|0|||
160794760|NCT00980798|580635349|FG000|Overall Study|Adverse Event|7|||
160794761|NCT00980798|580635350|FG001|Overall Study|Adverse Event|36|||
160794762|NCT00980798|580635349|FG000|Overall Study|Lack of Efficacy|16|||
160794763|NCT00980798|580635350|FG001|Overall Study|Lack of Efficacy|5|||
160794764|NCT00980798|580635349|FG000|Overall Study|Lost to Follow-up|0|||
160794765|NCT00980798|580635350|FG001|Overall Study|Lost to Follow-up|1|||
160894071|NCT02310321|581008290|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
160894072|NCT02310321|581008291|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
160894073|NCT02310321|581008289|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
160894074|NCT02310321|581008290|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
160894075|NCT02310321|581008291|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
160894076|NCT02310321|581008289|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
160894077|NCT02310321|581008290|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
160894078|NCT02310321|581008291|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
160894079|NCT02310321|581008289|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
160894080|NCT02310321|581008290|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
160894081|NCT02310321|581008291|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
160894082|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
160894083|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
160894084|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
160894085|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
160894086|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
160894087|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
160894088|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
160894089|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
160894090|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
160894091|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
160894092|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
160894093|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
160894094|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
160894095|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
160894096|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
160894097|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
160983188|NCT02268552|581326963|FG000|Part 3 Extension|Subject/guardian decision|0|||
160983189|NCT02268552|581326964|FG001|Part 3 Extension|Subject/guardian decision|0|||
160983190|NCT02268552|581326965|FG002|Part 3 Extension|Subject/guardian decision|0|||
160983191|NCT02268552|581326966|FG003|Part 3 Extension|Subject/guardian decision|0|||
160794766|NCT00980798|580635349|FG000|Overall Study|Physician Decision|2|||
160794767|NCT00980798|580635350|FG001|Overall Study|Physician Decision|1|||
160794768|NCT00980798|580635349|FG000|Overall Study|Withdrawal by Subject|8|||
160794769|NCT00980798|580635350|FG001|Overall Study|Withdrawal by Subject|11|||
160794770|NCT00980798|580635349|FG000|Overall Study|Other|0|||
160794771|NCT00980798|580635350|FG001|Overall Study|Other|1|||
160794772|NCT04938427|580635351|FG000|Overall Study|Adverse Event|5|||
160794773|NCT04938427|580635352|FG001|Overall Study|Adverse Event|19|||
160794774|NCT04938427|580635351|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160794775|NCT04938427|580635352|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160794776|NCT04938427|580635351|FG000|Overall Study|Withdrawal by Subject|1|||
160894098|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
160794777|NCT04938427|580635352|FG001|Overall Study|Withdrawal by Subject|0|||
160794778|NCT04938427|580635351|FG000|Overall Study|Reason Not Specified|2|||
160794779|NCT04938427|580635352|FG001|Overall Study|Reason Not Specified|1|||
160794780|NCT03633058|580635353|FG000|Overall Study|Adverse Event|0|||
160794781|NCT03633058|580635354|FG001|Overall Study|Adverse Event|0|||
160794782|NCT03633058|580635355|FG002|Overall Study|Adverse Event|1|||
160794783|NCT03633058|580635356|FG003|Overall Study|Adverse Event|0|||
160794784|NCT01107496|580635357|FG000|Overall Study|Adverse Event|1|||
160794785|NCT01107496|580635358|FG001|Overall Study|Adverse Event|0|||
160794786|NCT01107496|580635357|FG000|Overall Study|Lack of Efficacy|1|||
160794787|NCT01107496|580635358|FG001|Overall Study|Lack of Efficacy|0|||
160794788|NCT01107496|580635357|FG000|Overall Study|Protocol Violation|0|||
160794789|NCT01107496|580635358|FG001|Overall Study|Protocol Violation|1|||
160794790|NCT01107496|580635357|FG000|Overall Study|Lost to Follow-up|0|||
160794791|NCT01107496|580635358|FG001|Overall Study|Lost to Follow-up|1|||
160794792|NCT03909971|580635359|FG000|Overall Study|Participant transition to rollover study|26|||
160794793|NCT03909971|580635360|FG001|Overall Study|Participant transition to rollover study|9|||
160794794|NCT03909971|580635359|FG000|Overall Study|Global Deterioration of Health Status|2|||
160794795|NCT03909971|580635360|FG001|Overall Study|Global Deterioration of Health Status|2|||
160794796|NCT03909971|580635359|FG000|Overall Study|Progressive Disease|28|||
160794797|NCT03909971|580635360|FG001|Overall Study|Progressive Disease|21|||
160794798|NCT03909971|580635359|FG000|Overall Study|Death|6|||
160794799|NCT03909971|580635360|FG001|Overall Study|Death|6|||
160794800|NCT03909971|580635359|FG000|Overall Study|Adverse Event|1|||
160794801|NCT03909971|580635360|FG001|Overall Study|Adverse Event|2|||
160794802|NCT03909971|580635359|FG000|Overall Study|Withdrawal by Subject|2|||
160794803|NCT03909971|580635360|FG001|Overall Study|Withdrawal by Subject|1|||
160794804|NCT03909971|580635359|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
160794805|NCT03909971|580635360|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
160794806|NCT03909971|580635359|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
160794807|NCT03909971|580635360|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
160794808|NCT04727151|580635364|FG000|Overall Study|Death|0|||
160794809|NCT04727151|580635365|FG001|Overall Study|Death|0|||
160794810|NCT04727151|580635366|FG002|Overall Study|Death|0|||
160794811|NCT04727151|580635367|FG003|Overall Study|Death|0|||
160794812|NCT04727151|580635368|FG004|Overall Study|Death|3|||
160794813|NCT04727151|580635364|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
160794814|NCT04727151|580635365|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
160794815|NCT04727151|580635366|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
160794816|NCT04727151|580635367|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
160794817|NCT04727151|580635368|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
160794818|NCT01587196|580635369|FG000|Overall Study|Lost to Follow-up|50|||
160794819|NCT01587196|580635369|FG000|Overall Study|Withdrawal by Subject|4|||
160794820|NCT00642759|580635372|FG000|Overall Study|Protocol Violation|1|||
160794821|NCT03537508|580635377|FG000|Overall Study|Adverse Event|2|||
160794822|NCT03537508|580635378|FG001|Overall Study|Adverse Event|1|||
160794823|NCT03537508|580635377|FG000|Overall Study|Protocol Violation|65|||
160794824|NCT03537508|580635378|FG001|Overall Study|Protocol Violation|48|||
160794825|NCT03537508|580635377|FG000|Overall Study|Lost to Follow-up|86|||
160794826|NCT03537508|580635378|FG001|Overall Study|Lost to Follow-up|60|||
160794827|NCT03537508|580635377|FG000|Overall Study|Withdrawal by parent/guardian|263|||
160794828|NCT03537508|580635378|FG001|Overall Study|Withdrawal by parent/guardian|149|||
160794829|NCT03814044|580635382|FG000|Overall Study|Protocol deviation|1|||
160894099|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
160894100|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
160794830|NCT02757768|580635383|FG000|Overall Study|Randomized Never Received Study Drug|3|||
160894101|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
160642983|NCT00434161|580076494|FG001|Overall Study|Logistical error study assessments|0|||
160794831|NCT02757768|580635384|FG001|Overall Study|Randomized Never Received Study Drug|4|||
160794832|NCT02757768|580635383|FG000|Overall Study|Adverse Event|5|||
160794833|NCT02757768|580635384|FG001|Overall Study|Adverse Event|3|||
160794834|NCT02757768|580635383|FG000|Overall Study|Lack of Efficacy|2|||
160794835|NCT02757768|580635384|FG001|Overall Study|Lack of Efficacy|1|||
160794836|NCT02757768|580635383|FG000|Overall Study|Lost to Follow-up|1|||
160794837|NCT02757768|580635384|FG001|Overall Study|Lost to Follow-up|0|||
160894102|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
160794838|NCT02757768|580635383|FG000|Overall Study|Protocol Deviation|2|||
160794839|NCT02757768|580635384|FG001|Overall Study|Protocol Deviation|9|||
160794840|NCT02757768|580635383|FG000|Overall Study|Withdrawal by Subject|16|||
160794841|NCT02757768|580635384|FG001|Overall Study|Withdrawal by Subject|9|||
160894103|NCT02310321|581008289|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
160794842|NCT02757768|580635383|FG000|Overall Study|Miscellaneous|4|||
160794843|NCT02757768|580635384|FG001|Overall Study|Miscellaneous|2|||
160794844|NCT00835367|580635396|FG000|Washout|Adverse Event|2|||
160794845|NCT00835367|580635397|FG001|Washout|Adverse Event|0|||
160794846|NCT00835367|580635396|FG000|Washout|Withdrawal by Subject|1|||
160794847|NCT00835367|580635397|FG001|Washout|Withdrawal by Subject|0|||
160794848|NCT00835367|580635396|FG000|Second Intervention|Adverse Event|1|||
160794849|NCT00835367|580635397|FG001|Second Intervention|Adverse Event|1|||
160794850|NCT05929326|580635398|FG000|Overall Study|unqualified sample|2|||
160794851|NCT05929326|580635399|FG001|Overall Study|unqualified sample|3|||
160794852|NCT05929326|580635400|FG002|Overall Study|unqualified sample|7|||
160794853|NCT03941093|580635411|FG000|Overall Study|Protocol Violation|0|||
160794854|NCT03941093|580635412|FG001|Overall Study|Protocol Violation|1|||
160794855|NCT03941093|580635411|FG000|Overall Study|Withdrawal by Subject|9|||
160794856|NCT03941093|580635412|FG001|Overall Study|Withdrawal by Subject|6|||
160794857|NCT02495883|580635415|FG000|Overall Study|Excessive head motion|1|||
160794858|NCT02495883|580635416|FG001|Overall Study|Excessive head motion|0|||
160794859|NCT00964678|580635420|FG000|Overall Study|Physician Decision|4|||
160794860|NCT03359395|580635421|FG000|First Intervention A / B|Withdrawal by Subject|1|||
160794861|NCT03359395|580635422|FG001|First Intervention A / B|Withdrawal by Subject|0|||
160794862|NCT03359395|580635421|FG000|First Intervention A / B|Lost to Follow-up|2|||
160794863|NCT03359395|580635422|FG001|First Intervention A / B|Lost to Follow-up|3|||
160794864|NCT03359395|580635421|FG000|Second Intervention B/A|Exclusion criteria|0|||
160794865|NCT03359395|580635422|FG001|Second Intervention B/A|Exclusion criteria|1|||
160794866|NCT03359395|580635421|FG000|Second Intervention B/A|Lost to Follow-up|3|||
160794867|NCT03359395|580635422|FG001|Second Intervention B/A|Lost to Follow-up|2|||
160794868|NCT03396445|580637851|FG000|Treatment Period|Death|2|||
160794869|NCT03396445|580637852|FG001|Treatment Period|Death|2|||
160794870|NCT03396445|580637853|FG002|Treatment Period|Death|1|||
160794871|NCT03396445|580637854|FG003|Treatment Period|Death|1|||
160794872|NCT03396445|580637855|FG004|Treatment Period|Death|3|||
160794873|NCT03396445|580637856|FG005|Treatment Period|Death|2|||
160794874|NCT03396445|580637857|FG006|Treatment Period|Death|5|||
160794875|NCT03396445|580637858|FG007|Treatment Period|Death|3|||
160794876|NCT03396445|580637859|FG008|Treatment Period|Death|3|||
160794877|NCT03396445|580637860|FG009|Treatment Period|Death|3|||
160794878|NCT03396445|580637861|FG010|Treatment Period|Death|7|||
160794879|NCT03396445|580637862|FG011|Treatment Period|Death|12|||
160794880|NCT03396445|580637863|FG012|Treatment Period|Death|28|||
160794881|NCT03396445|580637864|FG013|Treatment Period|Death|14|||
160794882|NCT03396445|580637865|FG014|Treatment Period|Death|10|||
160794883|NCT03396445|580637866|FG015|Treatment Period|Death|8|||
160794884|NCT03396445|580637867|FG016|Treatment Period|Death|18|||
160794885|NCT03396445|580637868|FG017|Treatment Period|Death|0|||
160794886|NCT03396445|580637869|FG018|Treatment Period|Death|0|||
160794887|NCT03396445|580637870|FG019|Treatment Period|Death|0|||
160794888|NCT03396445|580637871|FG020|Treatment Period|Death|0|||
160794889|NCT03396445|580637872|FG021|Treatment Period|Death|0|||
160794890|NCT03396445|580637873|FG022|Treatment Period|Death|0|||
160794891|NCT03396445|580637874|FG023|Treatment Period|Death|0|||
160794892|NCT03396445|580637875|FG024|Treatment Period|Death|0|||
160794893|NCT03396445|580637876|FG025|Treatment Period|Death|0|||
160794894|NCT03396445|580637851|FG000|Treatment Period|Lost to Follow-up|0|||
160794895|NCT03396445|580637852|FG001|Treatment Period|Lost to Follow-up|0|||
160794896|NCT03396445|580637853|FG002|Treatment Period|Lost to Follow-up|0|||
160794897|NCT03396445|580637854|FG003|Treatment Period|Lost to Follow-up|0|||
160794898|NCT03396445|580637855|FG004|Treatment Period|Lost to Follow-up|0|||
160794899|NCT03396445|580637856|FG005|Treatment Period|Lost to Follow-up|0|||
160794900|NCT03396445|580637857|FG006|Treatment Period|Lost to Follow-up|0|||
160794901|NCT03396445|580637858|FG007|Treatment Period|Lost to Follow-up|0|||
160794902|NCT03396445|580637859|FG008|Treatment Period|Lost to Follow-up|0|||
160794903|NCT03396445|580637860|FG009|Treatment Period|Lost to Follow-up|0|||
160794904|NCT03396445|580637861|FG010|Treatment Period|Lost to Follow-up|0|||
160794905|NCT03396445|580637862|FG011|Treatment Period|Lost to Follow-up|0|||
160794906|NCT03396445|580637863|FG012|Treatment Period|Lost to Follow-up|1|||
160794907|NCT03396445|580637864|FG013|Treatment Period|Lost to Follow-up|0|||
160794908|NCT03396445|580637865|FG014|Treatment Period|Lost to Follow-up|1|||
160794909|NCT03396445|580637866|FG015|Treatment Period|Lost to Follow-up|0|||
160794910|NCT03396445|580637867|FG016|Treatment Period|Lost to Follow-up|0|||
160794911|NCT03396445|580637868|FG017|Treatment Period|Lost to Follow-up|0|||
160894104|NCT02310321|581008290|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
160894105|NCT02310321|581008291|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
160894106|NCT02310321|581008289|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
160894107|NCT02310321|581008290|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
160894108|NCT02310321|581008291|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
160894109|NCT02310321|581008289|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
160894110|NCT02310321|581008290|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
160894111|NCT02310321|581008291|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
160983192|NCT02268552|581326967|FG004|Part 3 Extension|Subject/guardian decision|0|||
160983193|NCT02268552|581326968|FG005|Part 3 Extension|Subject/guardian decision|0|||
160983194|NCT02268552|581326969|FG006|Part 3 Extension|Subject/guardian decision|1|||
160983195|NCT04168385|581326971|FG000|Overall Study|Withdrawal by Subject|1|||
160983196|NCT04168385|581326972|FG001|Overall Study|Withdrawal by Subject|0|||
160642984|NCT00434161|580076495|FG002|Overall Study|Logistical error study assessments|3|||
160642985|NCT03342898|580076496|FG000|Overall Study|Adverse Event|3|||
160642986|NCT03342898|580076497|FG001|Overall Study|Adverse Event|1|||
160642987|NCT03342898|580076498|FG002|Overall Study|Adverse Event|0|||
160642988|NCT03342898|580076496|FG000|Overall Study|Lost to Follow-up|44|||
160642989|NCT03342898|580076497|FG001|Overall Study|Lost to Follow-up|40|||
160642990|NCT03342898|580076498|FG002|Overall Study|Lost to Follow-up|42|||
160642991|NCT03342898|580076496|FG000|Overall Study|Withdrawal of Consent|5|||
160642992|NCT03342898|580076497|FG001|Overall Study|Withdrawal of Consent|9|||
160642993|NCT03342898|580076498|FG002|Overall Study|Withdrawal of Consent|11|||
160642994|NCT03342898|580076496|FG000|Overall Study|Death|0|||
160642995|NCT03342898|580076497|FG001|Overall Study|Death|1|||
160642996|NCT03342898|580076498|FG002|Overall Study|Death|1|||
160642997|NCT03342898|580076496|FG000|Overall Study|Reason not Specified|2|||
160642998|NCT03342898|580076497|FG001|Overall Study|Reason not Specified|2|||
160642999|NCT03342898|580076498|FG002|Overall Study|Reason not Specified|0|||
160643000|NCT01387282|580076499|FG000|Overall Study|Death|47|||
160643001|NCT01387282|580076500|FG001|Overall Study|Death|16|||
160643002|NCT01387282|580076499|FG000|Overall Study|Other|5|||
160643003|NCT01387282|580076500|FG001|Overall Study|Other|1|||
160643004|NCT01387282|580076499|FG000|Overall Study|Unrelated AE|6|||
160643005|NCT01387282|580076500|FG001|Overall Study|Unrelated AE|4|||
160643006|NCT01387282|580076499|FG000|Overall Study|Withdrawal by patient|33|||
160643007|NCT01387282|580076500|FG001|Overall Study|Withdrawal by patient|23|||
160643008|NCT01387282|580076499|FG000|Overall Study|Study drug-related AE|2|||
160643009|NCT01387282|580076500|FG001|Overall Study|Study drug-related AE|2|||
160894112|NCT02310321|581008289|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
160983197|NCT04168385|581326971|FG000|Overall Study|Adverse Event|2|||
160983198|NCT04168385|581326972|FG001|Overall Study|Adverse Event|1|||
160983199|NCT04168385|581326971|FG000|Overall Study|Liver transplant|3|||
160983200|NCT04168385|581326972|FG001|Overall Study|Liver transplant|1|||
160983201|NCT04168385|581326971|FG000|Overall Study|Listed for liver transplant|1|||
160983202|NCT04168385|581326972|FG001|Overall Study|Listed for liver transplant|0|||
160983203|NCT02139982|581326973|FG000|Overall Study|Lack of Efficacy|0|||
160983204|NCT02139982|581326974|FG001|Overall Study|Lack of Efficacy|1|||
160983205|NCT02139982|581326975|FG002|Overall Study|Lack of Efficacy|0|||
160983206|NCT02139982|581326976|FG003|Overall Study|Lack of Efficacy|1|||
160983207|NCT02139982|581326977|FG004|Overall Study|Lack of Efficacy|0|||
160983208|NCT02139982|581326978|FG005|Overall Study|Lack of Efficacy|0|||
160983209|NCT02139982|581326979|FG006|Overall Study|Lack of Efficacy|0|||
160983210|NCT02139982|581326980|FG007|Overall Study|Lack of Efficacy|0|||
160983211|NCT02139982|581326981|FG008|Overall Study|Lack of Efficacy|0|||
160548572|NCT02028455|579734193|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
160548573|NCT02028455|579734194|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
160548574|NCT02028455|579734195|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
160548575|NCT02028455|579734196|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
160548576|NCT02028455|579734197|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
160548577|NCT02028455|579734190|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
160548578|NCT02028455|579734191|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
160643010|NCT01387282|580076499|FG000|Overall Study|Lost to Follow-up|4|||
160643011|NCT01387282|580076500|FG001|Overall Study|Lost to Follow-up|1|||
160643012|NCT03997448|580076501|FG000|Study Treatment|Disease Progression|1|||
160643013|NCT03997448|580076501|FG000|Study Treatment|Symptomatic Deterioration|1|||
160643014|NCT03997448|580076501|FG000|Follow up|Death|2|||
160643015|NCT03997448|580076501|FG000|Follow up|study terminated|1|||
160894113|NCT02310321|581008290|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
160983212|NCT02139982|581326982|FG009|Overall Study|Lack of Efficacy|0|||
160983213|NCT02748512|581326985|FG000|Overall Study|Lost to Follow-up|1|||
160983214|NCT02748512|581326986|FG001|Overall Study|Lost to Follow-up|1|||
160983215|NCT00997243|581326989|FG000|Overall Study|Early termination of study by sponsor|7|||
160983216|NCT01349907|581326998|FG000|Overall Study|Adverse Event|37|||
160794912|NCT03396445|580637869|FG018|Treatment Period|Lost to Follow-up|0|||
160794913|NCT03396445|580637870|FG019|Treatment Period|Lost to Follow-up|0|||
160794914|NCT03396445|580637871|FG020|Treatment Period|Lost to Follow-up|0|||
160794915|NCT03396445|580637872|FG021|Treatment Period|Lost to Follow-up|0|||
160983217|NCT01349907|581326999|FG001|Overall Study|Adverse Event|11|||
160983218|NCT01349907|581326998|FG000|Overall Study|Treatment failure|13|||
160983219|NCT01349907|581326999|FG001|Overall Study|Treatment failure|4|||
160983220|NCT01349907|581326998|FG000|Overall Study|Lost to Follow-up|25|||
160983221|NCT01349907|581326999|FG001|Overall Study|Lost to Follow-up|6|||
160983222|NCT01349907|581326998|FG000|Overall Study|Withdrawal by Subject|30|||
160983223|NCT01349907|581326999|FG001|Overall Study|Withdrawal by Subject|8|||
160983224|NCT01349907|581326998|FG000|Overall Study|Protocol Violation|33|||
160983225|NCT01349907|581326999|FG001|Overall Study|Protocol Violation|13|||
160983226|NCT01349907|581326998|FG000|Overall Study|Administrative|1|||
160983227|NCT01349907|581326999|FG001|Overall Study|Administrative|1|||
160983228|NCT00884286|581327009|FG000|Overall Study|Progressive disease|21|||
160983229|NCT00884286|581327010|FG001|Overall Study|Progressive disease|28|||
160983230|NCT00884286|581327009|FG000|Overall Study|Toxicity|4|||
160983231|NCT00884286|581327010|FG001|Overall Study|Toxicity|1|||
160983232|NCT00884286|581327009|FG000|Overall Study|Death|2|||
160983233|NCT00884286|581327010|FG001|Overall Study|Death|2|||
160983234|NCT00884286|581327009|FG000|Overall Study|Physician Decision|1|||
160983235|NCT00884286|581327010|FG001|Overall Study|Physician Decision|0|||
160983236|NCT00884286|581327009|FG000|Overall Study|Septic shock|1|||
160983237|NCT00884286|581327010|FG001|Overall Study|Septic shock|0|||
160983238|NCT00884286|581327009|FG000|Overall Study|Thrombus in right auricle|1|||
160983239|NCT00884286|581327010|FG001|Overall Study|Thrombus in right auricle|0|||
160983240|NCT00884286|581327009|FG000|Overall Study|Not treated|2|||
160983241|NCT00884286|581327010|FG001|Overall Study|Not treated|1|||
160794916|NCT03396445|580637873|FG022|Treatment Period|Lost to Follow-up|0|||
160794917|NCT03396445|580637874|FG023|Treatment Period|Lost to Follow-up|0|||
160794918|NCT03396445|580637875|FG024|Treatment Period|Lost to Follow-up|0|||
160794919|NCT03396445|580637876|FG025|Treatment Period|Lost to Follow-up|0|||
160794920|NCT03396445|580637851|FG000|Treatment Period|Physician Decision|0|||
160794921|NCT03396445|580637852|FG001|Treatment Period|Physician Decision|0|||
160794922|NCT03396445|580637853|FG002|Treatment Period|Physician Decision|0|||
160794923|NCT03396445|580637854|FG003|Treatment Period|Physician Decision|0|||
160794924|NCT03396445|580637855|FG004|Treatment Period|Physician Decision|1|||
160794925|NCT03396445|580637856|FG005|Treatment Period|Physician Decision|0|||
160983242|NCT00884286|581327009|FG000|Overall Study|Comprised lung carcinoma|0|||
160983243|NCT00884286|581327010|FG001|Overall Study|Comprised lung carcinoma|1|||
160983244|NCT01196104|581327011|FG000|Overall Study|Lost to Follow-up|1|||
160983245|NCT01196104|581327012|FG001|Overall Study|Lost to Follow-up|0|||
160983246|NCT01196104|581327011|FG000|Overall Study|Physician Decision|0|||
160983247|NCT01196104|581327012|FG001|Overall Study|Physician Decision|1|||
160983248|NCT01196104|581327011|FG000|Overall Study|Withdrawal by Subject|3|||
160794926|NCT03396445|580637857|FG006|Treatment Period|Physician Decision|0|||
160794927|NCT03396445|580637858|FG007|Treatment Period|Physician Decision|0|||
160794928|NCT03396445|580637859|FG008|Treatment Period|Physician Decision|0|||
160794929|NCT03396445|580637860|FG009|Treatment Period|Physician Decision|1|||
160794930|NCT03396445|580637861|FG010|Treatment Period|Physician Decision|0|||
160794931|NCT03396445|580637862|FG011|Treatment Period|Physician Decision|0|||
160794932|NCT03396445|580637863|FG012|Treatment Period|Physician Decision|0|||
160794933|NCT03396445|580637864|FG013|Treatment Period|Physician Decision|0|||
160794934|NCT03396445|580637865|FG014|Treatment Period|Physician Decision|0|||
160794935|NCT03396445|580637866|FG015|Treatment Period|Physician Decision|0|||
160794936|NCT03396445|580637867|FG016|Treatment Period|Physician Decision|0|||
160794937|NCT03396445|580637868|FG017|Treatment Period|Physician Decision|0|||
160794938|NCT03396445|580637869|FG018|Treatment Period|Physician Decision|0|||
160794939|NCT03396445|580637870|FG019|Treatment Period|Physician Decision|0|||
160794940|NCT03396445|580637871|FG020|Treatment Period|Physician Decision|0|||
160794941|NCT03396445|580637872|FG021|Treatment Period|Physician Decision|0|||
160794942|NCT03396445|580637873|FG022|Treatment Period|Physician Decision|0|||
160983249|NCT01196104|581327012|FG001|Overall Study|Withdrawal by Subject|3|||
160983250|NCT01196104|581327011|FG000|Overall Study|Various|0|||
160983251|NCT01196104|581327012|FG001|Overall Study|Various|1|||
160983252|NCT00065468|581327018|FG000|Overall Study|Death|172|||
160983253|NCT00065468|581327019|FG001|Overall Study|Death|169|||
160983254|NCT00065468|581327020|FG002|Overall Study|Death|171|||
160983255|NCT00065468|581327018|FG000|Overall Study|Withdrawal by Subject|3|||
160794943|NCT03396445|580637874|FG023|Treatment Period|Physician Decision|0|||
160794944|NCT03396445|580637875|FG024|Treatment Period|Physician Decision|0|||
160983256|NCT00065468|581327019|FG001|Overall Study|Withdrawal by Subject|4|||
160794945|NCT03396445|580637876|FG025|Treatment Period|Physician Decision|0|||
160983257|NCT00065468|581327020|FG002|Overall Study|Withdrawal by Subject|5|||
160794946|NCT03396445|580637851|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794947|NCT03396445|580637852|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794948|NCT03396445|580637853|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794949|NCT03396445|580637854|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794950|NCT03396445|580637855|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794951|NCT03396445|580637856|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794952|NCT03396445|580637857|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794953|NCT03396445|580637858|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794954|NCT03396445|580637859|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794955|NCT03396445|580637860|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794956|NCT03396445|580637861|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794957|NCT03396445|580637862|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794958|NCT03396445|580637863|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
160794959|NCT03396445|580637864|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794960|NCT03396445|580637865|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
160794961|NCT03396445|580637866|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794962|NCT03396445|580637867|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794963|NCT03396445|580637868|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794964|NCT03396445|580637869|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794965|NCT03396445|580637870|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794966|NCT03396445|580637871|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794967|NCT03396445|580637872|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794968|NCT03396445|580637873|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794969|NCT03396445|580637874|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794970|NCT03396445|580637875|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794971|NCT03396445|580637876|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794972|NCT03396445|580637851|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
160794973|NCT03396445|580637852|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
160794974|NCT03396445|580637853|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
160794975|NCT03396445|580637854|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
160794976|NCT03396445|580637855|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
160794977|NCT03396445|580637856|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794978|NCT03396445|580637857|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
160794979|NCT03396445|580637858|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794980|NCT03396445|580637859|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794981|NCT03396445|580637860|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794982|NCT03396445|580637861|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794983|NCT03396445|580637862|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794984|NCT03396445|580637863|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794985|NCT03396445|580637864|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794986|NCT03396445|580637865|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160894114|NCT02310321|581008291|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
160894115|NCT02310321|581008289|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
160894116|NCT02310321|581008290|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
160894117|NCT02310321|581008291|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
160894118|NCT02310321|581008289|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
160894119|NCT02310321|581008290|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
160894120|NCT02310321|581008291|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
160894121|NCT02310321|581008289|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
160894122|NCT02310321|581008290|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
160894123|NCT02310321|581008291|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
160894124|NCT02310321|581008289|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
160794987|NCT03396445|580637866|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794988|NCT03396445|580637867|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794989|NCT03396445|580637868|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794990|NCT03396445|580637869|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794991|NCT03396445|580637870|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794992|NCT03396445|580637871|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794993|NCT03396445|580637872|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794994|NCT03396445|580637873|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794995|NCT03396445|580637874|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794996|NCT03396445|580637875|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794997|NCT03396445|580637876|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794998|NCT03396445|580637851|FG000|Treatment Period|Withdrawal by Subject|0|||
160794999|NCT03396445|580637852|FG001|Treatment Period|Withdrawal by Subject|0|||
160795000|NCT03396445|580637853|FG002|Treatment Period|Withdrawal by Subject|0|||
160795001|NCT03396445|580637854|FG003|Treatment Period|Withdrawal by Subject|0|||
160795002|NCT03396445|580637855|FG004|Treatment Period|Withdrawal by Subject|0|||
160795003|NCT03396445|580637856|FG005|Treatment Period|Withdrawal by Subject|0|||
160795004|NCT03396445|580637857|FG006|Treatment Period|Withdrawal by Subject|0|||
160795005|NCT03396445|580637858|FG007|Treatment Period|Withdrawal by Subject|0|||
160795006|NCT03396445|580637859|FG008|Treatment Period|Withdrawal by Subject|0|||
160795007|NCT03396445|580637860|FG009|Treatment Period|Withdrawal by Subject|0|||
160795008|NCT03396445|580637861|FG010|Treatment Period|Withdrawal by Subject|0|||
160795009|NCT03396445|580637862|FG011|Treatment Period|Withdrawal by Subject|0|||
160795010|NCT03396445|580637863|FG012|Treatment Period|Withdrawal by Subject|0|||
160795011|NCT03396445|580637864|FG013|Treatment Period|Withdrawal by Subject|0|||
160795012|NCT03396445|580637865|FG014|Treatment Period|Withdrawal by Subject|1|||
160795013|NCT03396445|580637866|FG015|Treatment Period|Withdrawal by Subject|0|||
160795014|NCT03396445|580637867|FG016|Treatment Period|Withdrawal by Subject|1|||
160795015|NCT03396445|580637868|FG017|Treatment Period|Withdrawal by Subject|0|||
160795016|NCT03396445|580637869|FG018|Treatment Period|Withdrawal by Subject|0|||
160795017|NCT03396445|580637870|FG019|Treatment Period|Withdrawal by Subject|0|||
160795018|NCT03396445|580637871|FG020|Treatment Period|Withdrawal by Subject|0|||
160795019|NCT03396445|580637872|FG021|Treatment Period|Withdrawal by Subject|0|||
160795020|NCT03396445|580637873|FG022|Treatment Period|Withdrawal by Subject|0|||
160795021|NCT03396445|580637874|FG023|Treatment Period|Withdrawal by Subject|0|||
160795022|NCT03396445|580637875|FG024|Treatment Period|Withdrawal by Subject|0|||
160795023|NCT03396445|580637876|FG025|Treatment Period|Withdrawal by Subject|0|||
160795024|NCT03396445|580637851|FG000|Switch-over Period|Death|0|||
160795025|NCT03396445|580637852|FG001|Switch-over Period|Death|0|||
160795026|NCT03396445|580637853|FG002|Switch-over Period|Death|0|||
160795027|NCT03396445|580637854|FG003|Switch-over Period|Death|0|||
160795028|NCT03396445|580637855|FG004|Switch-over Period|Death|0|||
160795029|NCT03396445|580637856|FG005|Switch-over Period|Death|0|||
160795030|NCT03396445|580637857|FG006|Switch-over Period|Death|0|||
160795031|NCT03396445|580637858|FG007|Switch-over Period|Death|0|||
160795032|NCT03396445|580637859|FG008|Switch-over Period|Death|0|||
160795033|NCT03396445|580637860|FG009|Switch-over Period|Death|0|||
160795034|NCT03396445|580637861|FG010|Switch-over Period|Death|0|||
160795035|NCT03396445|580637862|FG011|Switch-over Period|Death|0|||
160795036|NCT03396445|580637863|FG012|Switch-over Period|Death|0|||
160795037|NCT03396445|580637864|FG013|Switch-over Period|Death|0|||
160795038|NCT03396445|580637865|FG014|Switch-over Period|Death|0|||
160795039|NCT03396445|580637866|FG015|Switch-over Period|Death|0|||
160795040|NCT03396445|580637867|FG016|Switch-over Period|Death|0|||
160795041|NCT03396445|580637868|FG017|Switch-over Period|Death|0|||
160795042|NCT03396445|580637869|FG018|Switch-over Period|Death|1|||
160795043|NCT03396445|580637870|FG019|Switch-over Period|Death|2|||
160795044|NCT03396445|580637871|FG020|Switch-over Period|Death|2|||
160795045|NCT03396445|580637872|FG021|Switch-over Period|Death|1|||
160795046|NCT03396445|580637873|FG022|Switch-over Period|Death|2|||
160795047|NCT03396445|580637874|FG023|Switch-over Period|Death|0|||
160795048|NCT03396445|580637875|FG024|Switch-over Period|Death|1|||
160795049|NCT03396445|580637876|FG025|Switch-over Period|Death|6|||
160795050|NCT03396445|580637851|FG000|Switch-over Period|Lost to Follow-up|0|||
160795051|NCT03396445|580637852|FG001|Switch-over Period|Lost to Follow-up|0|||
160795052|NCT03396445|580637853|FG002|Switch-over Period|Lost to Follow-up|0|||
160795053|NCT03396445|580637854|FG003|Switch-over Period|Lost to Follow-up|0|||
160795054|NCT03396445|580637855|FG004|Switch-over Period|Lost to Follow-up|0|||
160795055|NCT03396445|580637856|FG005|Switch-over Period|Lost to Follow-up|0|||
160795056|NCT03396445|580637857|FG006|Switch-over Period|Lost to Follow-up|0|||
160795057|NCT03396445|580637858|FG007|Switch-over Period|Lost to Follow-up|0|||
160795058|NCT03396445|580637859|FG008|Switch-over Period|Lost to Follow-up|0|||
160983258|NCT00065468|581327018|FG000|Overall Study|Lost to Follow-up|5|||
160548579|NCT02028455|579734192|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
160548580|NCT02028455|579734193|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
160548581|NCT02028455|579734194|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
160548582|NCT02028455|579734195|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
160548583|NCT02028455|579734196|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
160548584|NCT02028455|579734197|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
160548585|NCT02028455|579734190|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
160548586|NCT02028455|579734191|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
160548587|NCT02028455|579734192|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
160548588|NCT02028455|579734193|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
160548589|NCT02028455|579734194|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
160548590|NCT02028455|579734195|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
160894125|NCT02310321|581008290|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
160894126|NCT02310321|581008291|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
160894127|NCT04950166|581008292|FG000|Overall Study|Withdrawal by Subject|1|||
160894128|NCT01698905|581008293|FG000|Overall Study|Adverse Event|4|||
160894129|NCT01698905|581008293|FG000|Overall Study|Physician Decision|2|||
160894130|NCT01698905|581008293|FG000|Overall Study|Pregnancy|1|||
160894131|NCT01698905|581008293|FG000|Overall Study|Protocol Violation|1|||
160894132|NCT01698905|581008293|FG000|Overall Study|Subject/guardian decision|2|||
160894133|NCT01698905|581008293|FG000|Overall Study|Death|1|||
160894134|NCT05896748|581008294|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
160894135|NCT05896748|581008294|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
160894136|NCT05896748|581008294|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
160983259|NCT00065468|581327019|FG001|Overall Study|Lost to Follow-up|3|||
160795059|NCT03396445|580637860|FG009|Switch-over Period|Lost to Follow-up|0|||
160795060|NCT03396445|580637861|FG010|Switch-over Period|Lost to Follow-up|0|||
160795061|NCT03396445|580637862|FG011|Switch-over Period|Lost to Follow-up|0|||
160795062|NCT03396445|580637863|FG012|Switch-over Period|Lost to Follow-up|0|||
160795063|NCT03396445|580637864|FG013|Switch-over Period|Lost to Follow-up|0|||
160795064|NCT03396445|580637865|FG014|Switch-over Period|Lost to Follow-up|0|||
160894137|NCT05896748|581008294|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
160894138|NCT05896748|581008294|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
160894139|NCT00857415|581008301|FG000|Overall Study|Image acquisition failure|2|||
160894140|NCT00857415|581008302|FG001|Overall Study|Image acquisition failure|0|||
160894141|NCT00857415|581008301|FG000|Overall Study|Invalid image or not imaged|3|||
160894142|NCT00857415|581008302|FG001|Overall Study|Invalid image or not imaged|0|||
160894143|NCT00857415|581008301|FG000|Overall Study|Subject still living at end of study|110|||
160894144|NCT00857415|581008302|FG001|Overall Study|Subject still living at end of study|0|||
160894145|NCT00857415|581008301|FG000|Overall Study|Deceased with no autopsy|2|||
160894146|NCT00857415|581008302|FG001|Overall Study|Deceased with no autopsy|0|||
160894147|NCT00764504|581008303|FG000|Overall Study|Death|12|||
160894148|NCT00764504|581008304|FG001|Overall Study|Death|6|||
160894149|NCT00764504|581008305|FG002|Overall Study|Death|13|||
160894150|NCT00764504|581008303|FG000|Overall Study|Revision of Device|12|||
160894151|NCT00764504|581008304|FG001|Overall Study|Revision of Device|23|||
160894152|NCT00764504|581008305|FG002|Overall Study|Revision of Device|14|||
160894153|NCT00764504|581008303|FG000|Overall Study|Physician Decision|1|||
160894154|NCT00764504|581008304|FG001|Overall Study|Physician Decision|0|||
160894155|NCT00764504|581008305|FG002|Overall Study|Physician Decision|0|||
160894156|NCT00764504|581008303|FG000|Overall Study|Withdrawal by Subject|1|||
160894157|NCT00764504|581008304|FG001|Overall Study|Withdrawal by Subject|7|||
160894158|NCT00764504|581008305|FG002|Overall Study|Withdrawal by Subject|4|||
160894159|NCT00764504|581008303|FG000|Overall Study|Lost to Follow-up|40|||
160894160|NCT00764504|581008304|FG001|Overall Study|Lost to Follow-up|34|||
160894161|NCT00764504|581008305|FG002|Overall Study|Lost to Follow-up|72|||
160894162|NCT01465191|581008309|FG000|Overall Study|Protocol Violation|6|||
160894163|NCT01465191|581008310|FG001|Overall Study|Protocol Violation|3|||
160894164|NCT01465191|581008311|FG002|Overall Study|Protocol Violation|3|||
160894165|NCT01465191|581008309|FG000|Overall Study|Lost to Follow-up|3|||
160894166|NCT01465191|581008310|FG001|Overall Study|Lost to Follow-up|6|||
160894167|NCT01465191|581008311|FG002|Overall Study|Lost to Follow-up|4|||
160894168|NCT00943124|581008312|FG000|Period 1|Withdrawal by Subject|1|||
160894169|NCT00943124|581008313|FG001|Period 1|Withdrawal by Subject|1|||
160894170|NCT00943124|581008312|FG000|Period 1|Did Not Follow Study Procedures|1|||
160894171|NCT00943124|581008313|FG001|Period 1|Did Not Follow Study Procedures|0|||
160894172|NCT00943124|581008312|FG000|Period 1|Personal Reasons|0|||
160894173|NCT00943124|581008313|FG001|Period 1|Personal Reasons|1|||
160894174|NCT02992132|581008314|FG000|Overall Study|Adverse Event|4|||
160894175|NCT02992132|581008315|FG001|Overall Study|Adverse Event|1|||
160894176|NCT02992132|581008316|FG002|Overall Study|Adverse Event|3|||
160894177|NCT02992132|581008314|FG000|Overall Study|Lack of Efficacy|2|||
160894178|NCT02992132|581008315|FG001|Overall Study|Lack of Efficacy|0|||
160894179|NCT02992132|581008316|FG002|Overall Study|Lack of Efficacy|0|||
160894180|NCT02992132|581008314|FG000|Overall Study|Non-compliance with study drug|2|||
160894181|NCT02992132|581008315|FG001|Overall Study|Non-compliance with study drug|0|||
160894182|NCT02992132|581008316|FG002|Overall Study|Non-compliance with study drug|0|||
160894183|NCT02992132|581008314|FG000|Overall Study|Progressive disease|1|||
160894184|NCT02992132|581008315|FG001|Overall Study|Progressive disease|0|||
160894185|NCT02992132|581008316|FG002|Overall Study|Progressive disease|0|||
160894186|NCT02992132|581008314|FG000|Overall Study|Protocol Violation|2|||
160894187|NCT02992132|581008315|FG001|Overall Study|Protocol Violation|2|||
160894188|NCT02992132|581008316|FG002|Overall Study|Protocol Violation|0|||
160894189|NCT02992132|581008314|FG000|Overall Study|Caregiver withdrew consent|2|||
160795065|NCT03396445|580637866|FG015|Switch-over Period|Lost to Follow-up|0|||
160795066|NCT03396445|580637867|FG016|Switch-over Period|Lost to Follow-up|0|||
160795067|NCT03396445|580637868|FG017|Switch-over Period|Lost to Follow-up|0|||
160795068|NCT03396445|580637869|FG018|Switch-over Period|Lost to Follow-up|0|||
160795069|NCT03396445|580637870|FG019|Switch-over Period|Lost to Follow-up|0|||
160795070|NCT03396445|580637871|FG020|Switch-over Period|Lost to Follow-up|0|||
160795071|NCT03396445|580637872|FG021|Switch-over Period|Lost to Follow-up|0|||
160894190|NCT02992132|581008315|FG001|Overall Study|Caregiver withdrew consent|3|||
160894191|NCT02992132|581008316|FG002|Overall Study|Caregiver withdrew consent|2|||
160894192|NCT02992132|581008314|FG000|Overall Study|Withdrawal by Subject|0|||
160894193|NCT02992132|581008315|FG001|Overall Study|Withdrawal by Subject|2|||
160894194|NCT02992132|581008316|FG002|Overall Study|Withdrawal by Subject|1|||
160894195|NCT02992132|581008314|FG000|Overall Study|Physician Decision|0|||
160894196|NCT02992132|581008315|FG001|Overall Study|Physician Decision|0|||
160894197|NCT02992132|581008316|FG002|Overall Study|Physician Decision|1|||
160894198|NCT02448810|581008317|FG000|Overall Study|Adverse Event|0|||
160894199|NCT02448810|581008318|FG001|Overall Study|Adverse Event|0|||
160643016|NCT01621490|580076504|FG000|Overall Study|Subject no longer meets study criteria|0|||
160643017|NCT01621490|580076505|FG001|Overall Study|Subject no longer meets study criteria|0|||
160643018|NCT01621490|580076506|FG002|Overall Study|Subject no longer meets study criteria|0|||
160643019|NCT01621490|580076507|FG003|Overall Study|Subject no longer meets study criteria|0|||
160643020|NCT01621490|580076508|FG004|Overall Study|Subject no longer meets study criteria|1|||
160643021|NCT01621490|580076509|FG005|Overall Study|Subject no longer meets study criteria|0|||
160643022|NCT01621490|580076510|FG006|Overall Study|Subject no longer meets study criteria|0|||
160643023|NCT01621490|580076511|FG007|Overall Study|Subject no longer meets study criteria|0|||
160643024|NCT01621490|580076512|FG008|Overall Study|Subject no longer meets study criteria|0|||
160643025|NCT01621490|580076513|FG009|Overall Study|Subject no longer meets study criteria|0|||
160643026|NCT01621490|580076514|FG010|Overall Study|Subject no longer meets study criteria|0|||
160795072|NCT03396445|580637873|FG022|Switch-over Period|Lost to Follow-up|0|||
160795073|NCT03396445|580637874|FG023|Switch-over Period|Lost to Follow-up|1|||
160795074|NCT03396445|580637875|FG024|Switch-over Period|Lost to Follow-up|0|||
160795075|NCT03396445|580637876|FG025|Switch-over Period|Lost to Follow-up|0|||
160795076|NCT00366457|580637890|FG000|Overall Study|never began study therapy|2|||
160795077|NCT02829996|580637891|FG000|Overall Study|Withdrawal by Subject|1|||
160795078|NCT02829996|580637892|FG001|Overall Study|Withdrawal by Subject|0|||
160795079|NCT02829996|580637893|FG002|Overall Study|Withdrawal by Subject|0|||
160795080|NCT02829996|580637894|FG003|Overall Study|Withdrawal by Subject|0|||
160795081|NCT02829996|580637895|FG004|Overall Study|Withdrawal by Subject|0|||
160795082|NCT00183248|580637909|FG000|Overall Study|Lost to Follow-up|0|||
160795083|NCT00183248|580637910|FG001|Overall Study|Lost to Follow-up|1|||
160795084|NCT00183248|580637909|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
160795085|NCT00183248|580637910|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
160795086|NCT04734210|580637911|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
160795087|NCT04734210|580637912|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
160795088|NCT04734210|580637913|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
160795089|NCT04734210|580637911|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
160795090|NCT04734210|580637912|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
160795091|NCT04734210|580637913|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
160795092|NCT04734210|580637911|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
160795093|NCT04734210|580637912|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
160795094|NCT04734210|580637913|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
160795095|NCT04734210|580637911|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
160795096|NCT04734210|580637912|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
160795097|NCT04734210|580637913|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
160795098|NCT01822925|580637914|FG000|Overall Study|Adverse Event|1|||
160795099|NCT01822925|580637915|FG001|Overall Study|Adverse Event|1|||
160795100|NCT01822925|580637916|FG002|Overall Study|Adverse Event|1|||
160795101|NCT01822925|580637917|FG003|Overall Study|Adverse Event|1|||
160795102|NCT01822925|580637914|FG000|Overall Study|Lost to Follow-up|0|||
160795103|NCT01822925|580637915|FG001|Overall Study|Lost to Follow-up|1|||
160795104|NCT01822925|580637916|FG002|Overall Study|Lost to Follow-up|0|||
160795105|NCT01822925|580637917|FG003|Overall Study|Lost to Follow-up|0|||
160795106|NCT01822925|580637914|FG000|Overall Study|Protocol Violation|1|||
160795107|NCT01822925|580637915|FG001|Overall Study|Protocol Violation|0|||
160795108|NCT01822925|580637916|FG002|Overall Study|Protocol Violation|0|||
160795109|NCT01822925|580637917|FG003|Overall Study|Protocol Violation|1|||
160795110|NCT01822925|580637914|FG000|Overall Study|Withdrawal by Subject|2|||
160795111|NCT01822925|580637915|FG001|Overall Study|Withdrawal by Subject|0|||
160795112|NCT01822925|580637916|FG002|Overall Study|Withdrawal by Subject|2|||
160795113|NCT01822925|580637917|FG003|Overall Study|Withdrawal by Subject|2|||
160795114|NCT01822925|580637914|FG000|Overall Study|Taking prohibited medication|2|||
160795115|NCT01822925|580637915|FG001|Overall Study|Taking prohibited medication|0|||
160795116|NCT01822925|580637916|FG002|Overall Study|Taking prohibited medication|0|||
160795117|NCT01822925|580637917|FG003|Overall Study|Taking prohibited medication|1|||
160795118|NCT03243084|580637919|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
160795119|NCT03243084|580637920|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
160795120|NCT02095106|580637925|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
160795121|NCT02095106|580637926|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
160795122|NCT00553254|580637934|FG000|Overall Study|Death|3|||
160795123|NCT00553254|580637935|FG001|Overall Study|Death|6|||
160795124|NCT00553254|580637936|FG002|Overall Study|Death|25|||
160795125|NCT00553254|580637934|FG000|Overall Study|Lost to Follow-up|0|||
160795126|NCT00553254|580637935|FG001|Overall Study|Lost to Follow-up|0|||
160795127|NCT00553254|580637936|FG002|Overall Study|Lost to Follow-up|2|||
160795128|NCT00553254|580637934|FG000|Overall Study|Withdrawal by Subject|2|||
160795129|NCT00553254|580637935|FG001|Overall Study|Withdrawal by Subject|0|||
160795130|NCT00553254|580637936|FG002|Overall Study|Withdrawal by Subject|2|||
160795131|NCT00553254|580637934|FG000|Overall Study|Study terminated by Sponsor|0|||
160795132|NCT00553254|580637935|FG001|Overall Study|Study terminated by Sponsor|0|||
160795133|NCT00553254|580637936|FG002|Overall Study|Study terminated by Sponsor|1|||
160795134|NCT00553254|580637934|FG000|Overall Study|Other|1|||
160795135|NCT00553254|580637935|FG001|Overall Study|Other|0|||
160795136|NCT00553254|580637936|FG002|Overall Study|Other|13|||
160795137|NCT02314923|580637939|FG000|Overall Study|Death|0|||
160795138|NCT02314923|580637940|FG001|Overall Study|Death|0|||
160795139|NCT02314923|580637941|FG002|Overall Study|Death|0|||
160795140|NCT02314923|580637942|FG003|Overall Study|Death|1|||
160795141|NCT02314923|580637943|FG004|Overall Study|Death|0|||
160795142|NCT02314923|580637944|FG005|Overall Study|Death|0|||
160795143|NCT02314923|580637945|FG006|Overall Study|Death|0|||
160795144|NCT02314923|580637946|FG007|Overall Study|Death|0|||
160795145|NCT02314923|580637947|FG008|Overall Study|Death|0|||
160795146|NCT02314923|580637948|FG009|Overall Study|Death|0|||
160795147|NCT02314923|580637939|FG000|Overall Study|Lost to Follow-up|2|||
160795148|NCT02314923|580637940|FG001|Overall Study|Lost to Follow-up|3|||
160795149|NCT02314923|580637941|FG002|Overall Study|Lost to Follow-up|1|||
160795150|NCT02314923|580637942|FG003|Overall Study|Lost to Follow-up|0|||
160795151|NCT02314923|580637943|FG004|Overall Study|Lost to Follow-up|0|||
160795152|NCT02314923|580637944|FG005|Overall Study|Lost to Follow-up|0|||
160795153|NCT02314923|580637945|FG006|Overall Study|Lost to Follow-up|3|||
160795154|NCT02314923|580637946|FG007|Overall Study|Lost to Follow-up|4|||
160795155|NCT02314923|580637947|FG008|Overall Study|Lost to Follow-up|2|||
160795156|NCT02314923|580637948|FG009|Overall Study|Lost to Follow-up|0|||
160795157|NCT02314923|580637939|FG000|Overall Study|Withdrawal by Subject|0|||
160795158|NCT02314923|580637940|FG001|Overall Study|Withdrawal by Subject|0|||
160795159|NCT02314923|580637941|FG002|Overall Study|Withdrawal by Subject|1|||
160795160|NCT02314923|580637942|FG003|Overall Study|Withdrawal by Subject|0|||
160795161|NCT02314923|580637943|FG004|Overall Study|Withdrawal by Subject|1|||
160795162|NCT02314923|580637944|FG005|Overall Study|Withdrawal by Subject|0|||
160795163|NCT02314923|580637945|FG006|Overall Study|Withdrawal by Subject|1|||
160795164|NCT02314923|580637946|FG007|Overall Study|Withdrawal by Subject|0|||
160795165|NCT02314923|580637947|FG008|Overall Study|Withdrawal by Subject|0|||
160795166|NCT02314923|580637948|FG009|Overall Study|Withdrawal by Subject|0|||
160795167|NCT02314923|580637939|FG000|Overall Study|Physician Decision|0|||
160795168|NCT02314923|580637940|FG001|Overall Study|Physician Decision|1|||
160795169|NCT02314923|580637941|FG002|Overall Study|Physician Decision|0|||
160795170|NCT02314923|580637942|FG003|Overall Study|Physician Decision|0|||
160795171|NCT02314923|580637943|FG004|Overall Study|Physician Decision|0|||
160795172|NCT02314923|580637944|FG005|Overall Study|Physician Decision|0|||
160795173|NCT02314923|580637945|FG006|Overall Study|Physician Decision|0|||
160795174|NCT02314923|580637946|FG007|Overall Study|Physician Decision|0|||
160795175|NCT02314923|580637947|FG008|Overall Study|Physician Decision|0|||
160795176|NCT02314923|580637948|FG009|Overall Study|Physician Decision|0|||
160795177|NCT02314923|580637939|FG000|Overall Study|Participant unavailable|0|||
160795178|NCT02314923|580637940|FG001|Overall Study|Participant unavailable|0|||
160795179|NCT02314923|580637941|FG002|Overall Study|Participant unavailable|0|||
160795180|NCT02314923|580637942|FG003|Overall Study|Participant unavailable|0|||
160795181|NCT02314923|580637943|FG004|Overall Study|Participant unavailable|0|||
160795182|NCT02314923|580637944|FG005|Overall Study|Participant unavailable|1|||
160894200|NCT02448810|581008319|FG002|Overall Study|Adverse Event|1|||
160894201|NCT02448810|581008320|FG003|Overall Study|Adverse Event|0|||
160548591|NCT02028455|579734196|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
160548592|NCT02028455|579734197|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
160548593|NCT02028455|579734190|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
160548594|NCT02028455|579734191|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
160894202|NCT02448810|581008321|FG004|Overall Study|Adverse Event|0|||
160548595|NCT02028455|579734192|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
160571832|NCT01633060|579816839|FG001|Treatment Phase|Subject/guardian decision|4|||
160795183|NCT02314923|580637945|FG006|Overall Study|Participant unavailable|0|||
160795184|NCT02314923|580637946|FG007|Overall Study|Participant unavailable|0|||
160795185|NCT02314923|580637947|FG008|Overall Study|Participant unavailable|0|||
160795186|NCT02314923|580637948|FG009|Overall Study|Participant unavailable|0|||
160795187|NCT02314923|580637939|FG000|Overall Study|Screen failure|0|||
160795188|NCT02314923|580637940|FG001|Overall Study|Screen failure|0|||
160795189|NCT02314923|580637941|FG002|Overall Study|Screen failure|0|||
160795190|NCT02314923|580637942|FG003|Overall Study|Screen failure|0|||
160795191|NCT02314923|580637943|FG004|Overall Study|Screen failure|0|||
160795192|NCT02314923|580637944|FG005|Overall Study|Screen failure|0|||
160795193|NCT02314923|580637945|FG006|Overall Study|Screen failure|1|||
160795194|NCT02314923|580637946|FG007|Overall Study|Screen failure|0|||
160795195|NCT02314923|580637947|FG008|Overall Study|Screen failure|0|||
160795196|NCT02314923|580637948|FG009|Overall Study|Screen failure|0|||
160894203|NCT02448810|581008322|FG005|Overall Study|Adverse Event|0|||
160795197|NCT02314923|580637939|FG000|Overall Study|Participant relocation|1|||
160795198|NCT02314923|580637940|FG001|Overall Study|Participant relocation|0|||
160795199|NCT02314923|580637941|FG002|Overall Study|Participant relocation|0|||
160795200|NCT02314923|580637942|FG003|Overall Study|Participant relocation|0|||
160795201|NCT02314923|580637943|FG004|Overall Study|Participant relocation|0|||
160795202|NCT02314923|580637944|FG005|Overall Study|Participant relocation|0|||
160795203|NCT02314923|580637945|FG006|Overall Study|Participant relocation|0|||
160795204|NCT02314923|580637946|FG007|Overall Study|Participant relocation|1|||
160795205|NCT02314923|580637947|FG008|Overall Study|Participant relocation|0|||
160795206|NCT02314923|580637948|FG009|Overall Study|Participant relocation|0|||
160795207|NCT02546323|580637949|FG000|Overall Study|Withdrawal by Subject|36|||
160795208|NCT02546323|580637950|FG001|Overall Study|Withdrawal by Subject|33|||
160795209|NCT02546323|580637949|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
160795210|NCT02546323|580637950|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
160795211|NCT02546323|580637949|FG000|Overall Study|Adverse Event|17|||
160795212|NCT02546323|580637950|FG001|Overall Study|Adverse Event|11|||
160795213|NCT02546323|580637949|FG000|Overall Study|Patient Specific Reasons|1|||
160795214|NCT02546323|580637950|FG001|Overall Study|Patient Specific Reasons|2|||
160795215|NCT02546323|580637949|FG000|Overall Study|Lost to Follow-up|2|||
160795216|NCT02546323|580637950|FG001|Overall Study|Lost to Follow-up|3|||
160795217|NCT02546323|580637949|FG000|Overall Study|Non-compliance with Study Drug|2|||
160795218|NCT02546323|580637950|FG001|Overall Study|Non-compliance with Study Drug|2|||
160795219|NCT02546323|580637949|FG000|Overall Study|Met Withdrawal Criteria|2|||
160795220|NCT02546323|580637950|FG001|Overall Study|Met Withdrawal Criteria|14|||
160795221|NCT04476784|580637951|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
160795222|NCT04476784|580637952|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
160795223|NCT00863304|580637956|FG000|Overall Study|Adverse Event|10|||
160795224|NCT00863304|580637957|FG001|Overall Study|Adverse Event|4|||
160795225|NCT00863304|580637958|FG002|Overall Study|Adverse Event|14|||
160795226|NCT00863304|580637959|FG003|Overall Study|Adverse Event|16|||
160795227|NCT00863304|580637956|FG000|Overall Study|Lost to Follow-up|1|||
160795228|NCT00863304|580637957|FG001|Overall Study|Lost to Follow-up|5|||
160795229|NCT00863304|580637958|FG002|Overall Study|Lost to Follow-up|4|||
160795230|NCT00863304|580637959|FG003|Overall Study|Lost to Follow-up|2|||
160795231|NCT00863304|580637956|FG000|Overall Study|Lack of Efficacy|57|||
160795232|NCT00863304|580637957|FG001|Overall Study|Lack of Efficacy|26|||
160795233|NCT00863304|580637958|FG002|Overall Study|Lack of Efficacy|30|||
160795234|NCT00863304|580637959|FG003|Overall Study|Lack of Efficacy|28|||
160795235|NCT00863304|580637956|FG000|Overall Study|Withdrawal by Subject|19|||
160795236|NCT00863304|580637957|FG001|Overall Study|Withdrawal by Subject|14|||
160795237|NCT00863304|580637958|FG002|Overall Study|Withdrawal by Subject|20|||
160795238|NCT00863304|580637959|FG003|Overall Study|Withdrawal by Subject|18|||
160795239|NCT00863304|580637956|FG000|Overall Study|Other|1|||
160795240|NCT00863304|580637957|FG001|Overall Study|Other|0|||
160795241|NCT00863304|580637958|FG002|Overall Study|Other|0|||
160795242|NCT00863304|580637959|FG003|Overall Study|Other|1|||
160795243|NCT00863304|580637956|FG000|Overall Study|Protocol Violation|2|||
160795244|NCT00863304|580637957|FG001|Overall Study|Protocol Violation|6|||
160795245|NCT00863304|580637958|FG002|Overall Study|Protocol Violation|2|||
160795246|NCT00863304|580637959|FG003|Overall Study|Protocol Violation|0|||
160795247|NCT00863304|580637956|FG000|Overall Study|Randomized, but not Treated|3|||
160795248|NCT00863304|580637957|FG001|Overall Study|Randomized, but not Treated|1|||
160795249|NCT00863304|580637958|FG002|Overall Study|Randomized, but not Treated|4|||
160795250|NCT00863304|580637959|FG003|Overall Study|Randomized, but not Treated|1|||
160795251|NCT00863304|580637956|FG000|Overall Study|Entered extension study|101|||
160795252|NCT00863304|580637957|FG001|Overall Study|Entered extension study|129|||
160795253|NCT00863304|580637958|FG002|Overall Study|Entered extension study|113|||
160795254|NCT00863304|580637959|FG003|Overall Study|Entered extension study|125|||
160795255|NCT00478257|580637960|FG000|Overall Study|Withdrawal by Subject|8|||
160795256|NCT00478257|580637961|FG001|Overall Study|Withdrawal by Subject|3|||
160795257|NCT00806585|580637962|FG000|Overall Study|Study terminated by Sponsor|0|||
160795258|NCT00806585|580637963|FG001|Overall Study|Study terminated by Sponsor|0|||
160795259|NCT00806585|580637964|FG002|Overall Study|Study terminated by Sponsor|1|||
160795260|NCT00806585|580637965|FG003|Overall Study|Study terminated by Sponsor|2|||
160795261|NCT00806585|580637966|FG004|Overall Study|Study terminated by Sponsor|0|||
160795262|NCT00806585|580637962|FG000|Overall Study|Protocol Violation|3|||
160795263|NCT00806585|580637963|FG001|Overall Study|Protocol Violation|1|||
160795264|NCT00806585|580637964|FG002|Overall Study|Protocol Violation|2|||
160795265|NCT00806585|580637965|FG003|Overall Study|Protocol Violation|0|||
160795266|NCT00806585|580637966|FG004|Overall Study|Protocol Violation|0|||
160795267|NCT00806585|580637962|FG000|Overall Study|Physician Decision|0|||
160795268|NCT00806585|580637963|FG001|Overall Study|Physician Decision|2|||
160795269|NCT00806585|580637964|FG002|Overall Study|Physician Decision|3|||
160795270|NCT00806585|580637965|FG003|Overall Study|Physician Decision|0|||
160795271|NCT00806585|580637966|FG004|Overall Study|Physician Decision|1|||
160795272|NCT00806585|580637962|FG000|Overall Study|Lost to Follow-up|2|||
160795273|NCT00806585|580637963|FG001|Overall Study|Lost to Follow-up|1|||
160795274|NCT00806585|580637964|FG002|Overall Study|Lost to Follow-up|2|||
160795275|NCT00806585|580637965|FG003|Overall Study|Lost to Follow-up|2|||
160795276|NCT00806585|580637966|FG004|Overall Study|Lost to Follow-up|5|||
160795277|NCT00806585|580637962|FG000|Overall Study|Lack of Efficacy|1|||
160795278|NCT00806585|580637963|FG001|Overall Study|Lack of Efficacy|0|||
160795279|NCT00806585|580637964|FG002|Overall Study|Lack of Efficacy|0|||
160795280|NCT00806585|580637965|FG003|Overall Study|Lack of Efficacy|0|||
160795281|NCT00806585|580637966|FG004|Overall Study|Lack of Efficacy|0|||
160795282|NCT00806585|580637962|FG000|Overall Study|Adverse Event|1|||
160795283|NCT00806585|580637963|FG001|Overall Study|Adverse Event|5|||
160795284|NCT00806585|580637964|FG002|Overall Study|Adverse Event|3|||
160795285|NCT00806585|580637965|FG003|Overall Study|Adverse Event|4|||
160795286|NCT00806585|580637966|FG004|Overall Study|Adverse Event|2|||
160795287|NCT00806585|580637962|FG000|Overall Study|Withdrawal by Subject|10|||
160795288|NCT00806585|580637963|FG001|Overall Study|Withdrawal by Subject|8|||
160795289|NCT00806585|580637964|FG002|Overall Study|Withdrawal by Subject|9|||
160795290|NCT00806585|580637965|FG003|Overall Study|Withdrawal by Subject|3|||
160795291|NCT00806585|580637966|FG004|Overall Study|Withdrawal by Subject|11|||
160795292|NCT00806585|580637962|FG000|Overall Study|Completion status unknown|15|||
160795293|NCT00806585|580637963|FG001|Overall Study|Completion status unknown|14|||
160795294|NCT00806585|580637964|FG002|Overall Study|Completion status unknown|12|||
160795295|NCT00806585|580637965|FG003|Overall Study|Completion status unknown|4|||
160795296|NCT00806585|580637966|FG004|Overall Study|Completion status unknown|12|||
160795297|NCT02507934|580637968|FG000|Overall Study|Lost to Follow-up|2|||
160795298|NCT02507934|580637969|FG001|Overall Study|Lost to Follow-up|0|||
160795299|NCT02507934|580637968|FG000|Overall Study|Withdrawal by Subject|2|||
160795300|NCT02507934|580637969|FG001|Overall Study|Withdrawal by Subject|0|||
160795301|NCT03766399|580637971|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795302|NCT03766399|580637972|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795303|NCT03766399|580637973|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795304|NCT03766399|580637974|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795305|NCT03766399|580637975|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795306|NCT03766399|580637976|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795307|NCT03766399|580637977|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795308|NCT03766399|580637978|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795309|NCT03766399|580637979|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795310|NCT03766399|580637980|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795311|NCT03766399|580637981|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795312|NCT03766399|580637982|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795313|NCT03766399|580637983|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795314|NCT03766399|580637984|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
160795315|NCT03766399|580637985|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795316|NCT03766399|580637986|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795317|NCT03766399|580637987|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795318|NCT03766399|580637988|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795319|NCT01309230|580637989|FG000|Overall Study|Withdrawal by Subject|0|||
160795320|NCT01309230|580637990|FG001|Overall Study|Withdrawal by Subject|2|||
160795321|NCT01309230|580637989|FG000|Overall Study|Observation arm closed|0|||
160894204|NCT02448810|581008323|FG006|Overall Study|Adverse Event|0|||
160894205|NCT02448810|581008324|FG007|Overall Study|Adverse Event|0|||
160894206|NCT02448810|581008317|FG000|Overall Study|Withdrawal by Subject|0|||
160894207|NCT02448810|581008318|FG001|Overall Study|Withdrawal by Subject|0|||
160894208|NCT02448810|581008319|FG002|Overall Study|Withdrawal by Subject|1|||
160894209|NCT02448810|581008320|FG003|Overall Study|Withdrawal by Subject|0|||
160795322|NCT01309230|580637990|FG001|Overall Study|Observation arm closed|2|||
160795323|NCT01767987|580637991|FG000|Overall Study|Physician Decision|4|||
160795324|NCT01767987|580637992|FG001|Overall Study|Physician Decision|1|||
160795325|NCT01153516|580637993|FG000|Overall Study|Both subjects refused surgery|2|||
160795326|NCT01153516|580637994|FG001|Overall Study|Both subjects refused surgery|0|||
160894210|NCT02448810|581008321|FG004|Overall Study|Withdrawal by Subject|3|||
160983260|NCT00065468|581327020|FG002|Overall Study|Lost to Follow-up|2|||
160795327|NCT01605097|580638002|FG000|Overall Study|Protocol Violation|1|||
160894211|NCT02448810|581008322|FG005|Overall Study|Withdrawal by Subject|5|||
160983261|NCT00065468|581327018|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
160795328|NCT03261505|580638018|FG000|Overall Study|Withdrawal by Subject|2|||
160795329|NCT03261505|580638019|FG001|Overall Study|Withdrawal by Subject|3|||
160795330|NCT03261505|580638020|FG002|Overall Study|Withdrawal by Subject|4|||
160795331|NCT03261505|580638021|FG003|Overall Study|Withdrawal by Subject|3|||
160795332|NCT03261505|580638018|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
160795333|NCT03261505|580638019|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
160795334|NCT03261505|580638020|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
160795335|NCT03261505|580638021|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
160795336|NCT03261505|580638018|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
160795337|NCT03261505|580638019|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
160795338|NCT03261505|580638020|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
160795339|NCT03261505|580638021|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
160795340|NCT03261505|580638018|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
160795341|NCT03261505|580638019|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
160795342|NCT03261505|580638020|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
160795343|NCT03261505|580638021|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
160795344|NCT00663260|580638022|FG000|Overall Study|Lack of Efficacy|2|||
160795345|NCT00663260|580638023|FG001|Overall Study|Lack of Efficacy|0|||
160795346|NCT00663260|580638024|FG002|Overall Study|Lack of Efficacy|0|||
160795347|NCT00663260|580638022|FG000|Overall Study|Adverse Event|12|||
160795348|NCT00663260|580638023|FG001|Overall Study|Adverse Event|7|||
160795349|NCT00663260|580638024|FG002|Overall Study|Adverse Event|6|||
160795350|NCT00663260|580638022|FG000|Overall Study|Withdrawal by Subject|3|||
160795351|NCT00663260|580638023|FG001|Overall Study|Withdrawal by Subject|1|||
160795352|NCT00663260|580638024|FG002|Overall Study|Withdrawal by Subject|6|||
160795353|NCT00663260|580638022|FG000|Overall Study|Death|1|||
160795354|NCT00663260|580638023|FG001|Overall Study|Death|0|||
160795355|NCT00663260|580638024|FG002|Overall Study|Death|1|||
160795356|NCT00663260|580638022|FG000|Overall Study|Lost to Follow-up|0|||
160795357|NCT00663260|580638023|FG001|Overall Study|Lost to Follow-up|1|||
160795358|NCT00663260|580638024|FG002|Overall Study|Lost to Follow-up|0|||
160795359|NCT00663260|580638022|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
160795360|NCT00663260|580638023|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
160795361|NCT00663260|580638024|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
160795362|NCT01506726|580638025|FG000|Overall Study|Adverse Event|1|||
160894212|NCT02448810|581008323|FG006|Overall Study|Withdrawal by Subject|0|||
160894213|NCT02448810|581008324|FG007|Overall Study|Withdrawal by Subject|2|||
160894214|NCT02448810|581008317|FG000|Overall Study|Other (study terminated by sponsor)|0|||
160894215|NCT02448810|581008318|FG001|Overall Study|Other (study terminated by sponsor)|0|||
160894216|NCT02448810|581008319|FG002|Overall Study|Other (study terminated by sponsor)|0|||
160894217|NCT02448810|581008320|FG003|Overall Study|Other (study terminated by sponsor)|0|||
160894218|NCT02448810|581008321|FG004|Overall Study|Other (study terminated by sponsor)|4|||
160894219|NCT02448810|581008322|FG005|Overall Study|Other (study terminated by sponsor)|2|||
160894220|NCT02448810|581008323|FG006|Overall Study|Other (study terminated by sponsor)|2|||
160894221|NCT02448810|581008324|FG007|Overall Study|Other (study terminated by sponsor)|1|||
160894222|NCT02448810|581008317|FG000|Overall Study|Death|1|||
160894223|NCT02448810|581008318|FG001|Overall Study|Death|0|||
160894224|NCT02448810|581008319|FG002|Overall Study|Death|1|||
160894225|NCT02448810|581008320|FG003|Overall Study|Death|0|||
160894226|NCT02448810|581008321|FG004|Overall Study|Death|1|||
160894227|NCT02448810|581008322|FG005|Overall Study|Death|0|||
160894228|NCT02448810|581008323|FG006|Overall Study|Death|0|||
160894229|NCT02448810|581008324|FG007|Overall Study|Death|0|||
160894230|NCT02448810|581008317|FG000|Overall Study|Other (Progressive disease)|2|||
160894231|NCT02448810|581008318|FG001|Overall Study|Other (Progressive disease)|2|||
160894232|NCT02448810|581008319|FG002|Overall Study|Other (Progressive disease)|0|||
160894233|NCT02448810|581008320|FG003|Overall Study|Other (Progressive disease)|3|||
160548596|NCT02028455|579734193|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
160548597|NCT02028455|579734194|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
160894234|NCT02448810|581008321|FG004|Overall Study|Other (Progressive disease)|23|||
160894235|NCT02448810|581008322|FG005|Overall Study|Other (Progressive disease)|9|||
160571833|NCT01633060|579816838|FG000|Treatment Phase|Death|4|||
160795363|NCT01506726|580638026|FG001|Overall Study|Adverse Event|2|||
160894236|NCT02448810|581008323|FG006|Overall Study|Other (Progressive disease)|14|||
160894237|NCT02448810|581008324|FG007|Overall Study|Other (Progressive disease)|5|||
160894238|NCT02448810|581008317|FG000|Overall Study|Lost to Follow-up|0|||
160894239|NCT02448810|581008318|FG001|Overall Study|Lost to Follow-up|1|||
160894240|NCT02448810|581008319|FG002|Overall Study|Lost to Follow-up|0|||
160894241|NCT02448810|581008320|FG003|Overall Study|Lost to Follow-up|0|||
160894242|NCT02448810|581008321|FG004|Overall Study|Lost to Follow-up|0|||
160894243|NCT02448810|581008322|FG005|Overall Study|Lost to Follow-up|0|||
160894244|NCT02448810|581008323|FG006|Overall Study|Lost to Follow-up|0|||
160894245|NCT02448810|581008324|FG007|Overall Study|Lost to Follow-up|0|||
160983262|NCT00065468|581327019|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
160983263|NCT00065468|581327020|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
160983264|NCT00065468|581327018|FG000|Overall Study|Disease progression|0|||
160983265|NCT00065468|581327019|FG001|Overall Study|Disease progression|0|||
160983266|NCT00065468|581327020|FG002|Overall Study|Disease progression|1|||
160983267|NCT00065468|581327018|FG000|Overall Study|Other|14|||
160983268|NCT00065468|581327019|FG001|Overall Study|Other|24|||
160983269|NCT00065468|581327020|FG002|Overall Study|Other|18|||
160983270|NCT04496167|581327021|FG000|Overall Study|Adverse Event|6|||
160983271|NCT04496167|581327022|FG001|Overall Study|Adverse Event|2|||
160983272|NCT04496167|581327021|FG000|Overall Study|Withdrawal by Subject|7|||
160983273|NCT04496167|581327022|FG001|Overall Study|Withdrawal by Subject|6|||
160983274|NCT04496167|581327021|FG000|Overall Study|Lost to Follow-up|3|||
160983275|NCT04496167|581327022|FG001|Overall Study|Lost to Follow-up|5|||
160983276|NCT04496167|581327021|FG000|Overall Study|Not Treated|1|||
160983277|NCT04496167|581327022|FG001|Overall Study|Not Treated|2|||
160983278|NCT04496167|581327021|FG000|Overall Study|Other Than Specified|1|||
160983279|NCT04496167|581327022|FG001|Overall Study|Other Than Specified|1|||
160983280|NCT00598481|581327023|FG000|Treatment|Physician Decision|1|||
160983281|NCT02500316|581327024|FG000|Overall Study|Adverse Event|3|||
160983282|NCT02500316|581327024|FG000|Overall Study|Lost to Follow-up|2|||
160983283|NCT02500316|581327024|FG000|Overall Study|Protocol Violation|1|||
160983284|NCT02500316|581327024|FG000|Overall Study|Withdrawal by Subject|15|||
160983285|NCT02500316|581327024|FG000|Overall Study|Final height achieved|5|||
160983286|NCT02500316|581327024|FG000|Overall Study|Due to war activity|1|||
160983287|NCT02040090|581327025|FG000|Overall Study|Adverse Event|2|||
160983288|NCT02040090|581327026|FG001|Overall Study|Adverse Event|0|||
160983289|NCT02040090|581327025|FG000|Overall Study|Physician Decision|1|||
160983290|NCT02040090|581327026|FG001|Overall Study|Physician Decision|0|||
160983291|NCT02040090|581327025|FG000|Overall Study|Withdrawal by Subject|0|||
160983292|NCT02040090|581327026|FG001|Overall Study|Withdrawal by Subject|1|||
160983293|NCT02040090|581327025|FG000|Overall Study|Lost to Follow-up|0|||
160983294|NCT02040090|581327026|FG001|Overall Study|Lost to Follow-up|1|||
160983295|NCT03370276|581327027|FG000|Overall Study|Death|0|||
160983296|NCT03370276|581327028|FG001|Overall Study|Death|2|||
160983297|NCT03370276|581327029|FG002|Overall Study|Death|5|||
160983298|NCT00895843|581327033|FG000|Overall Study|Protocol Violation|12|||
160983299|NCT00895843|581327034|FG001|Overall Study|Protocol Violation|12|||
160983300|NCT04963062|581327035|FG000|Overall Study|withdrew by the study team|4|||
160983301|NCT04963062|581327036|FG001|Overall Study|withdrew by the study team|2|||
160983302|NCT00544544|581327037|FG000|Overall Study|Withdrawal by Subject|1|||
160983303|NCT00544544|581327037|FG000|Overall Study|Adverse Event|1|||
160983304|NCT00544544|581327037|FG000|Overall Study|Lost to Follow-up|1|||
160983305|NCT04145349|581328603|FG000|Overall Study|Withdrawal by Subject|3|||
160983306|NCT04145349|581328604|FG001|Overall Study|Withdrawal by Subject|0|||
160983307|NCT04145349|581328603|FG000|Overall Study|Lost to Follow-up|0|||
160983308|NCT04145349|581328604|FG001|Overall Study|Lost to Follow-up|1|||
160983309|NCT04145349|581328603|FG000|Overall Study|On study treatment (Ongoing)|0|||
160983310|NCT04145349|581328604|FG001|Overall Study|On study treatment (Ongoing)|1|||
160983311|NCT01518257|581328605|FG000|Overall Study|Lost to Follow-up|1|||
160983312|NCT01518257|581328606|FG001|Overall Study|Lost to Follow-up|0|||
160983313|NCT01518257|581328605|FG000|Overall Study|Other Miscellaneous Reason|1|||
160983314|NCT01518257|581328606|FG001|Overall Study|Other Miscellaneous Reason|0|||
160983315|NCT02424344|581328612|FG000|Overall Study|Lack of Efficacy|0|||
160983316|NCT02424344|581328613|FG001|Overall Study|Lack of Efficacy|1|||
160983317|NCT02424344|581328612|FG000|Overall Study|Withdrawal by Subject|2|||
160983318|NCT02424344|581328613|FG001|Overall Study|Withdrawal by Subject|1|||
160983319|NCT02424344|581328612|FG000|Overall Study|Lost to Follow-up|1|||
160983320|NCT02424344|581328613|FG001|Overall Study|Lost to Follow-up|0|||
160983321|NCT02424344|581328612|FG000|Overall Study|Adverse Event|4|||
160983322|NCT02424344|581328613|FG001|Overall Study|Adverse Event|8|||
160983323|NCT04730947|581328614|FG000|Overall Study|Withdrawal by Subject|0|||
160983324|NCT04730947|581328615|FG001|Overall Study|Withdrawal by Subject|1|||
160983325|NCT02123966|581328616|FG000|Overall Study|Intercurrent Illness|1|||
160983326|NCT05257837|581328617|FG000|Overall Study|Excluded (did not find the guns)|4|||
160983327|NCT05257837|581328618|FG001|Overall Study|Excluded (did not find the guns)|2|||
160983328|NCT05257837|581328619|FG002|Overall Study|Excluded (did not find the guns)|4|||
160983329|NCT05257837|581328620|FG003|Overall Study|Excluded (did not find the guns)|0|||
160983330|NCT05675709|581328621|FG000|Overall Study|incomplete outcome data|2|||
160983331|NCT05675709|581328622|FG001|Overall Study|incomplete outcome data|8|||
160983332|NCT05343455|581328623|FG000|Overall Study|Withdrawal by Subject|4|||
160983333|NCT05343455|581328624|FG001|Overall Study|Withdrawal by Subject|9|||
160983334|NCT05343455|581328625|FG002|Overall Study|Withdrawal by Subject|7|||
160983335|NCT05343455|581328623|FG000|Overall Study|Adverse Event|2|||
160983336|NCT05343455|581328624|FG001|Overall Study|Adverse Event|1|||
160983337|NCT05343455|581328625|FG002|Overall Study|Adverse Event|2|||
160983338|NCT05343455|581328623|FG000|Overall Study|Lost to Follow-up|1|||
160983339|NCT05343455|581328624|FG001|Overall Study|Lost to Follow-up|1|||
160795364|NCT02303821|580638027|FG000|Overall Study|Withdrawal by Subject|0|||
160795365|NCT02303821|580638028|FG001|Overall Study|Withdrawal by Subject|0|||
160795366|NCT02303821|580638029|FG002|Overall Study|Withdrawal by Subject|0|||
160795367|NCT02303821|580638030|FG003|Overall Study|Withdrawal by Subject|0|||
160795368|NCT02303821|580638031|FG004|Overall Study|Withdrawal by Subject|0|||
160795369|NCT02303821|580638032|FG005|Overall Study|Withdrawal by Subject|0|||
160795370|NCT02303821|580638033|FG006|Overall Study|Withdrawal by Subject|0|||
160795371|NCT02303821|580638034|FG007|Overall Study|Withdrawal by Subject|2|||
160795372|NCT02303821|580638027|FG000|Overall Study|Death|0|||
160795373|NCT02303821|580638028|FG001|Overall Study|Death|2|||
160795374|NCT02303821|580638029|FG002|Overall Study|Death|0|||
160795375|NCT02303821|580638030|FG003|Overall Study|Death|0|||
160795376|NCT02303821|580638031|FG004|Overall Study|Death|0|||
160643027|NCT01621490|580076504|FG000|Overall Study|Maximum clinical benefit|3|||
160643028|NCT01621490|580076505|FG001|Overall Study|Maximum clinical benefit|2|||
160643029|NCT01621490|580076506|FG002|Overall Study|Maximum clinical benefit|0|||
160643030|NCT01621490|580076507|FG003|Overall Study|Maximum clinical benefit|0|||
160643031|NCT01621490|580076508|FG004|Overall Study|Maximum clinical benefit|0|||
160643032|NCT01621490|580076509|FG005|Overall Study|Maximum clinical benefit|0|||
160643033|NCT01621490|580076510|FG006|Overall Study|Maximum clinical benefit|1|||
160643034|NCT01621490|580076511|FG007|Overall Study|Maximum clinical benefit|2|||
160643035|NCT01621490|580076512|FG008|Overall Study|Maximum clinical benefit|2|||
160643036|NCT01621490|580076513|FG009|Overall Study|Maximum clinical benefit|0|||
160643037|NCT01621490|580076514|FG010|Overall Study|Maximum clinical benefit|0|||
160643038|NCT01621490|580076504|FG000|Overall Study|Withdrawal by Subject|1|||
160643039|NCT01621490|580076505|FG001|Overall Study|Withdrawal by Subject|0|||
160643040|NCT01621490|580076506|FG002|Overall Study|Withdrawal by Subject|0|||
160643041|NCT01621490|580076507|FG003|Overall Study|Withdrawal by Subject|0|||
160643042|NCT01621490|580076508|FG004|Overall Study|Withdrawal by Subject|0|||
160894246|NCT02448810|581008317|FG000|Overall Study|Other (unspecified)|0|||
160894247|NCT02448810|581008318|FG001|Overall Study|Other (unspecified)|0|||
160894248|NCT02448810|581008319|FG002|Overall Study|Other (unspecified)|0|||
160894249|NCT02448810|581008320|FG003|Overall Study|Other (unspecified)|0|||
160894250|NCT02448810|581008321|FG004|Overall Study|Other (unspecified)|0|||
160894251|NCT02448810|581008322|FG005|Overall Study|Other (unspecified)|0|||
160894252|NCT02448810|581008323|FG006|Overall Study|Other (unspecified)|2|||
160894253|NCT02448810|581008324|FG007|Overall Study|Other (unspecified)|0|||
160894254|NCT04795622|581008327|FG000|Overall Study|Adverse Event|1|||
160894255|NCT04795622|581008328|FG001|Overall Study|Adverse Event|0|||
160894256|NCT04795622|581008327|FG000|Overall Study|Withdrawal by Subject|3|||
160894257|NCT04795622|581008328|FG001|Overall Study|Withdrawal by Subject|3|||
160894258|NCT04795622|581008327|FG000|Overall Study|Protocol Violation|0|||
160894259|NCT04795622|581008328|FG001|Overall Study|Protocol Violation|2|||
160894260|NCT04795622|581008327|FG000|Overall Study|Lost to Follow-up|2|||
160894261|NCT04795622|581008328|FG001|Overall Study|Lost to Follow-up|3|||
160894262|NCT04795622|581008327|FG000|Overall Study|Other|7|||
160894263|NCT04795622|581008328|FG001|Overall Study|Other|8|||
160894264|NCT02314143|581008329|FG000|Overall Study|Adverse Event|0|||
160894265|NCT02314143|581008330|FG001|Overall Study|Adverse Event|6|||
160894266|NCT02314143|581008331|FG002|Overall Study|Adverse Event|4|||
160894267|NCT02314143|581008329|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
160894268|NCT02314143|581008330|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
160894269|NCT02314143|581008331|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
160894270|NCT02314143|581008329|FG000|Overall Study|Physician Decision|2|||
160894271|NCT02314143|581008330|FG001|Overall Study|Physician Decision|1|||
160894272|NCT02314143|581008331|FG002|Overall Study|Physician Decision|0|||
160894273|NCT02314143|581008329|FG000|Overall Study|Withdrawal by Subject|1|||
160894274|NCT02314143|581008330|FG001|Overall Study|Withdrawal by Subject|0|||
160894275|NCT02314143|581008331|FG002|Overall Study|Withdrawal by Subject|1|||
160894276|NCT03963401|581008335|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
160894277|NCT03963401|581008336|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
160894278|NCT03963401|581008337|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
160894279|NCT03963401|581008338|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
160894280|NCT03963401|581008339|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
160894281|NCT03963401|581008340|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
160643043|NCT01621490|580076509|FG005|Overall Study|Withdrawal by Subject|1|||
160643044|NCT01621490|580076510|FG006|Overall Study|Withdrawal by Subject|0|||
160795377|NCT02303821|580638032|FG005|Overall Study|Death|3|||
160894282|NCT03963401|581008335|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
160894283|NCT03963401|581008336|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
160894284|NCT03963401|581008337|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
160894285|NCT03963401|581008338|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
160795378|NCT02303821|580638033|FG006|Overall Study|Death|41|||
160795379|NCT02303821|580638034|FG007|Overall Study|Death|29|||
160795380|NCT02303821|580638027|FG000|Overall Study|Lost to Follow-up|0|||
160795381|NCT02303821|580638028|FG001|Overall Study|Lost to Follow-up|0|||
160795382|NCT02303821|580638029|FG002|Overall Study|Lost to Follow-up|0|||
160795383|NCT02303821|580638030|FG003|Overall Study|Lost to Follow-up|0|||
160795384|NCT02303821|580638031|FG004|Overall Study|Lost to Follow-up|0|||
160795385|NCT02303821|580638032|FG005|Overall Study|Lost to Follow-up|0|||
160795386|NCT02303821|580638033|FG006|Overall Study|Lost to Follow-up|1|||
160795387|NCT02303821|580638034|FG007|Overall Study|Lost to Follow-up|0|||
160795388|NCT02303821|580638027|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795389|NCT02303821|580638028|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795390|NCT02303821|580638029|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795391|NCT02303821|580638030|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795392|NCT02303821|580638031|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795393|NCT02303821|580638032|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795394|NCT02303821|580638033|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
160795395|NCT02303821|580638034|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795396|NCT02303821|580638027|FG000|Overall Study|Decision by sponsor|0|||
160795397|NCT02303821|580638028|FG001|Overall Study|Decision by sponsor|0|||
160795398|NCT02303821|580638029|FG002|Overall Study|Decision by sponsor|0|||
160795399|NCT02303821|580638030|FG003|Overall Study|Decision by sponsor|0|||
160795400|NCT02303821|580638031|FG004|Overall Study|Decision by sponsor|0|||
160795401|NCT02303821|580638032|FG005|Overall Study|Decision by sponsor|1|||
160795402|NCT02303821|580638033|FG006|Overall Study|Decision by sponsor|0|||
160795403|NCT02303821|580638034|FG007|Overall Study|Decision by sponsor|0|||
160795404|NCT02303821|580638027|FG000|Overall Study|Protocol-specified criteria|0|||
160795405|NCT02303821|580638028|FG001|Overall Study|Protocol-specified criteria|1|||
160795406|NCT02303821|580638029|FG002|Overall Study|Protocol-specified criteria|0|||
160795407|NCT02303821|580638030|FG003|Overall Study|Protocol-specified criteria|0|||
160795408|NCT02303821|580638031|FG004|Overall Study|Protocol-specified criteria|0|||
160795409|NCT02303821|580638032|FG005|Overall Study|Protocol-specified criteria|1|||
160795410|NCT02303821|580638033|FG006|Overall Study|Protocol-specified criteria|0|||
160795411|NCT02303821|580638034|FG007|Overall Study|Protocol-specified criteria|0|||
160795412|NCT04562090|580638035|FG000|Overall Study|Withdrawal by Subject|3|||
160795413|NCT04562090|580638036|FG001|Overall Study|Withdrawal by Subject|4|||
160795414|NCT04562090|580638035|FG000|Overall Study|Protocol Violation|2|||
160795415|NCT04562090|580638036|FG001|Overall Study|Protocol Violation|0|||
160795416|NCT04562090|580638035|FG000|Overall Study|Lack of Efficacy|0|||
160795417|NCT04562090|580638036|FG001|Overall Study|Lack of Efficacy|1|||
160795418|NCT04562090|580638035|FG000|Overall Study|Adverse Event|1|||
160795419|NCT04562090|580638036|FG001|Overall Study|Adverse Event|4|||
160795420|NCT04562090|580638035|FG000|Overall Study|Miscellaneous|0|||
160795421|NCT04562090|580638036|FG001|Overall Study|Miscellaneous|3|||
160795422|NCT00847730|580638037|FG000|Overall Study|Multiple interruptions in therapy|8|||
160548598|NCT02028455|579734195|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
160548599|NCT02028455|579734196|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
160548600|NCT02028455|579734197|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
160548601|NCT02392429|579736203|FG000|Screening|Screen failure|15|||
160548602|NCT02392429|579736203|FG000|Enrolled Participants|Ineligible due to disease|3|||
160548603|NCT02392429|579736203|FG000|Enrolled Participants|Withdrawal by Subject|4|||
160548604|NCT02392429|579736203|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
160795423|NCT00210132|580638038|FG000|Overall Study|Protocol Violation|1|||
160795424|NCT00210132|580638039|FG001|Overall Study|Protocol Violation|4|||
160795425|NCT02711202|580638042|FG000|Overall Study|Adverse Event|3|||
160795426|NCT02711202|580638043|FG001|Overall Study|Adverse Event|0|||
160795427|NCT02711202|580638042|FG000|Overall Study|graft loss|1|||
160548605|NCT02392429|579736203|FG000|Evaluable|Death|5|||
160548606|NCT02392429|579736203|FG000|Evaluable|Withdrawal by Subject|1|||
160548607|NCT02392429|579736203|FG000|Evaluable|Adverse Event|1|||
160548608|NCT02392429|579736203|FG000|Evaluable|remission bone marrow biopsy|3|||
160548609|NCT00542997|579736206|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
160548610|NCT00542997|579736206|FG000|Wash in / Wash Out Period|Adverse Event|3|||
160548611|NCT00542997|579736206|FG000|Efficacy Period|Adverse Event|3|||
160548612|NCT01178138|579736209|FG000|Overall Study|Lost to Follow-up|8|||
160548613|NCT01178138|579736209|FG000|Overall Study|Withdrawal by Subject|7|||
160548614|NCT01178138|579736209|FG000|Overall Study|Physician Decision|8|||
160548615|NCT03160560|579736210|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
160548616|NCT03160560|579736211|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
160548617|NCT03160560|579736212|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
160795428|NCT02711202|580638043|FG001|Overall Study|graft loss|0|||
160795429|NCT00432965|580638044|FG000|Overall Study|Lost to Follow-up|22|||
160795430|NCT00432965|580638045|FG001|Overall Study|Lost to Follow-up|19|||
160795431|NCT00432965|580638044|FG000|Overall Study|Withdrawal by Subject|13|||
160548618|NCT03160560|579736213|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
160571834|NCT01633060|579816839|FG001|Treatment Phase|Death|3|||
160795432|NCT00432965|580638045|FG001|Overall Study|Withdrawal by Subject|13|||
160795433|NCT00432965|580638044|FG000|Overall Study|Physician Decision|14|||
160795434|NCT00432965|580638045|FG001|Overall Study|Physician Decision|13|||
160795435|NCT00432965|580638044|FG000|Overall Study|Lack of Efficacy|8|||
160795436|NCT00432965|580638045|FG001|Overall Study|Lack of Efficacy|13|||
160795437|NCT00432965|580638044|FG000|Overall Study|Non-compliance|7|||
160795438|NCT00432965|580638045|FG001|Overall Study|Non-compliance|0|||
160795439|NCT00432965|580638044|FG000|Overall Study|Adverse Event|22|||
160795440|NCT00432965|580638045|FG001|Overall Study|Adverse Event|19|||
160795441|NCT00432965|580638044|FG000|Overall Study|Death|3|||
160795442|NCT00432965|580638045|FG001|Overall Study|Death|4|||
160795443|NCT00432965|580638044|FG000|Overall Study|Exclusionary Methods|1|||
160795444|NCT00432965|580638045|FG001|Overall Study|Exclusionary Methods|2|||
160795445|NCT00432965|580638044|FG000|Overall Study|Incomplete Data|4|||
160795446|NCT00432965|580638045|FG001|Overall Study|Incomplete Data|3|||
160795447|NCT02402647|580638046|FG000|Overall Study|Lost to Follow-up|13|||
160795448|NCT02402647|580638047|FG001|Overall Study|Lost to Follow-up|7|||
160795449|NCT02402647|580638046|FG000|Overall Study|Protocol Violation|1|||
160795450|NCT02402647|580638047|FG001|Overall Study|Protocol Violation|1|||
160795451|NCT02402647|580638046|FG000|Overall Study|scheduled and timed out|2|||
160795452|NCT02402647|580638047|FG001|Overall Study|scheduled and timed out|1|||
160795453|NCT02402647|580638046|FG000|Overall Study|medical illness|2|||
160795454|NCT02402647|580638047|FG001|Overall Study|medical illness|4|||
160795455|NCT02402647|580638046|FG000|Overall Study|Moved|2|||
160795456|NCT02402647|580638047|FG001|Overall Study|Moved|0|||
160795457|NCT02402647|580638046|FG000|Overall Study|loved one illness|1|||
160795458|NCT02402647|580638047|FG001|Overall Study|loved one illness|0|||
160795459|NCT02402647|580638046|FG000|Overall Study|deceased preexisting condition|2|||
160795460|NCT02402647|580638047|FG001|Overall Study|deceased preexisting condition|0|||
160795461|NCT02402647|580638046|FG000|Overall Study|Other|2|||
160795462|NCT02402647|580638047|FG001|Overall Study|Other|1|||
160795463|NCT01903863|580638048|FG000|Overall Study|Physician Decision|2|||
160795464|NCT01903863|580638049|FG001|Overall Study|Physician Decision|0|||
160795465|NCT01722669|580638056|FG000|Overall Study|Withdrawal by Subject|0|||
160795466|NCT01722669|580638057|FG001|Overall Study|Withdrawal by Subject|0|||
160795467|NCT01722669|580638058|FG002|Overall Study|Withdrawal by Subject|0|||
160795468|NCT01722669|580638059|FG003|Overall Study|Withdrawal by Subject|0|||
160795469|NCT01722669|580638060|FG004|Overall Study|Withdrawal by Subject|0|||
160795470|NCT01722669|580638061|FG005|Overall Study|Withdrawal by Subject|2|||
160795471|NCT01344226|580638062|FG000|Overall Study|Protocol Violation|2|||
160795472|NCT01344226|580638062|FG000|Overall Study|Withdrawal by Subject|3|||
160795473|NCT01344226|580638062|FG000|Overall Study|Lack of Efficacy|3|||
160795474|NCT02255656|580638069|FG000|Overall Study|Adverse Event|11|||
160795475|NCT02255656|580638069|FG000|Overall Study|Poor compliance to protocol|3|||
160795476|NCT02255656|580638069|FG000|Overall Study|Lost to Follow-up|30|||
160795477|NCT02255656|580638069|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
160795478|NCT02255656|580638069|FG000|Overall Study|Other|126|||
160795479|NCT03734536|580638070|FG000|Overall Study|Withdrew Consent|1|||
160795480|NCT03734536|580638071|FG001|Overall Study|Withdrew Consent|5|||
160795481|NCT03734536|580638070|FG000|Overall Study|Lost to Follow-up|10|||
160795482|NCT03734536|580638071|FG001|Overall Study|Lost to Follow-up|7|||
160795483|NCT03448393|580638072|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795484|NCT03448393|580638073|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795485|NCT03448393|580638074|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
160894286|NCT03963401|581008339|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
160894287|NCT03963401|581008340|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
160894288|NCT03963401|581008335|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
160894289|NCT03963401|581008336|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
160894290|NCT03963401|581008337|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
160894291|NCT03963401|581008338|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
160894292|NCT03963401|581008339|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
160894293|NCT03963401|581008340|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
160894294|NCT03963401|581008335|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
160894295|NCT03963401|581008336|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
160795486|NCT03448393|580638075|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795487|NCT03448393|580638076|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795488|NCT03448393|580638077|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795489|NCT03448393|580638078|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795490|NCT03448393|580638079|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795491|NCT03448393|580638080|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
160795492|NCT03448393|580638072|FG000|Dose Expansion|Not treated - screen failure|0|||
160795493|NCT03448393|580638073|FG001|Dose Expansion|Not treated - screen failure|0|||
160795494|NCT03448393|580638074|FG002|Dose Expansion|Not treated - screen failure|0|||
160983340|NCT05343455|581328625|FG002|Overall Study|Lost to Follow-up|3|||
160548619|NCT03160560|579736210|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
160548620|NCT03160560|579736211|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
160548621|NCT03160560|579736212|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
160548622|NCT03160560|579736213|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
160548623|NCT01241708|579736214|FG000|Overall Study|Withdrawal by Subject|6|||
160548624|NCT01241708|579736214|FG000|Overall Study|Screen Failure|6|||
160548625|NCT01241708|579736214|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
160548626|NCT01241708|579736214|FG000|Overall Study|Lost to Follow-up|5|||
160548627|NCT04137887|579736217|FG000|Overall Study|Death|102|||
160548628|NCT04137887|579736218|FG001|Overall Study|Death|92|||
160548629|NCT04137887|579736217|FG000|Overall Study|Withdrawal by Subject|2|||
160548630|NCT04137887|579736218|FG001|Overall Study|Withdrawal by Subject|3|||
160548631|NCT04137887|579736217|FG000|Overall Study|Randomized but not treated|0|||
160548632|NCT04137887|579736218|FG001|Overall Study|Randomized but not treated|1|||
160548633|NCT01790503|579736221|FG000|Overall Study|Adverse Event|1|||
160548634|NCT01790503|579736222|FG001|Overall Study|Adverse Event|0|||
160548635|NCT01790503|579736223|FG002|Overall Study|Adverse Event|0|||
160548636|NCT01790503|579736224|FG003|Overall Study|Adverse Event|0|||
160548637|NCT01790503|579736225|FG004|Overall Study|Adverse Event|0|||
160548638|NCT01790503|579736226|FG005|Overall Study|Adverse Event|2|||
160548639|NCT01790503|579736227|FG006|Overall Study|Adverse Event|0|||
160548640|NCT01790503|579736228|FG007|Overall Study|Adverse Event|0|||
160548641|NCT01790503|579736229|FG008|Overall Study|Adverse Event|2|||
160548642|NCT01790503|579736230|FG009|Overall Study|Adverse Event|4|||
160548643|NCT01790503|579736231|FG010|Overall Study|Adverse Event|7|||
160548644|NCT01790503|579736221|FG000|Overall Study|Withdrawal by Subject|0|||
160548645|NCT01790503|579736222|FG001|Overall Study|Withdrawal by Subject|0|||
160548646|NCT01790503|579736223|FG002|Overall Study|Withdrawal by Subject|1|||
160548647|NCT01790503|579736224|FG003|Overall Study|Withdrawal by Subject|1|||
160548648|NCT01790503|579736225|FG004|Overall Study|Withdrawal by Subject|1|||
160548649|NCT01790503|579736226|FG005|Overall Study|Withdrawal by Subject|2|||
160548650|NCT01790503|579736227|FG006|Overall Study|Withdrawal by Subject|1|||
160548651|NCT01790503|579736228|FG007|Overall Study|Withdrawal by Subject|0|||
160548652|NCT01790503|579736229|FG008|Overall Study|Withdrawal by Subject|0|||
160548653|NCT01790503|579736230|FG009|Overall Study|Withdrawal by Subject|0|||
160548654|NCT01790503|579736231|FG010|Overall Study|Withdrawal by Subject|1|||
160548655|NCT01790503|579736221|FG000|Overall Study|Disease progression|2|||
160548656|NCT01790503|579736222|FG001|Overall Study|Disease progression|1|||
160548657|NCT01790503|579736223|FG002|Overall Study|Disease progression|0|||
160548658|NCT01790503|579736224|FG003|Overall Study|Disease progression|1|||
160548659|NCT01790503|579736225|FG004|Overall Study|Disease progression|2|||
160548660|NCT01790503|579736226|FG005|Overall Study|Disease progression|1|||
160548661|NCT01790503|579736227|FG006|Overall Study|Disease progression|0|||
160548662|NCT01790503|579736228|FG007|Overall Study|Disease progression|1|||
160548663|NCT01790503|579736229|FG008|Overall Study|Disease progression|0|||
160548664|NCT01790503|579736230|FG009|Overall Study|Disease progression|17|||
160548665|NCT01790503|579736231|FG010|Overall Study|Disease progression|7|||
160894296|NCT03963401|581008337|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
160894297|NCT03963401|581008338|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
160894298|NCT03963401|581008339|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
160894299|NCT03963401|581008340|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
160894300|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
160548666|NCT01790503|579736221|FG000|Overall Study|Protocol Violation|0|||
160548667|NCT01790503|579736222|FG001|Overall Study|Protocol Violation|0|||
160548668|NCT01790503|579736223|FG002|Overall Study|Protocol Violation|0|||
160548669|NCT01790503|579736224|FG003|Overall Study|Protocol Violation|0|||
160548670|NCT01790503|579736225|FG004|Overall Study|Protocol Violation|0|||
160548671|NCT01790503|579736226|FG005|Overall Study|Protocol Violation|0|||
160548672|NCT01790503|579736227|FG006|Overall Study|Protocol Violation|0|||
160548673|NCT01790503|579736228|FG007|Overall Study|Protocol Violation|0|||
160894301|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
160894302|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
160894303|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
160548674|NCT01790503|579736229|FG008|Overall Study|Protocol Violation|0|||
160548675|NCT01790503|579736230|FG009|Overall Study|Protocol Violation|1|||
160548676|NCT01790503|579736231|FG010|Overall Study|Protocol Violation|0|||
160894304|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
160894305|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
160894306|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
160548677|NCT01790503|579736221|FG000|Overall Study|Physician Decision|0|||
160548678|NCT01790503|579736222|FG001|Overall Study|Physician Decision|0|||
160548679|NCT01790503|579736223|FG002|Overall Study|Physician Decision|0|||
160548680|NCT01790503|579736224|FG003|Overall Study|Physician Decision|0|||
160548681|NCT01790503|579736225|FG004|Overall Study|Physician Decision|0|||
160548682|NCT01790503|579736226|FG005|Overall Study|Physician Decision|0|||
160548683|NCT01790503|579736227|FG006|Overall Study|Physician Decision|0|||
160894307|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
160894308|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
160894309|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
160894310|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
160894311|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
160894312|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
160894313|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
160894314|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
160894315|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
160894316|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
160894317|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
160894318|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
160894319|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
160894320|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
160894321|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
160894322|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
160894323|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
160894324|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
160894325|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
160894326|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
160894327|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
160894328|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
160894329|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
160894330|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
160894331|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
160548684|NCT01790503|579736228|FG007|Overall Study|Physician Decision|0|||
160894332|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
160548685|NCT01790503|579736229|FG008|Overall Study|Physician Decision|0|||
160548686|NCT01790503|579736230|FG009|Overall Study|Physician Decision|1|||
160548687|NCT01790503|579736231|FG010|Overall Study|Physician Decision|1|||
160548688|NCT01790503|579736221|FG000|Overall Study|Death|0|||
160548689|NCT01790503|579736222|FG001|Overall Study|Death|0|||
160548690|NCT01790503|579736223|FG002|Overall Study|Death|0|||
160548691|NCT01790503|579736224|FG003|Overall Study|Death|0|||
160548692|NCT01790503|579736225|FG004|Overall Study|Death|0|||
160548693|NCT01790503|579736226|FG005|Overall Study|Death|0|||
160548694|NCT01790503|579736227|FG006|Overall Study|Death|0|||
160548695|NCT01790503|579736228|FG007|Overall Study|Death|0|||
160548696|NCT01790503|579736229|FG008|Overall Study|Death|0|||
160548697|NCT01790503|579736230|FG009|Overall Study|Death|1|||
160548698|NCT01790503|579736231|FG010|Overall Study|Death|0|||
160548699|NCT01790503|579736221|FG000|Overall Study|Non Compliance|0|||
160548700|NCT01790503|579736222|FG001|Overall Study|Non Compliance|0|||
160548701|NCT01790503|579736223|FG002|Overall Study|Non Compliance|0|||
160548702|NCT01790503|579736224|FG003|Overall Study|Non Compliance|0|||
160548703|NCT01790503|579736225|FG004|Overall Study|Non Compliance|1|||
160548704|NCT01790503|579736226|FG005|Overall Study|Non Compliance|0|||
160548705|NCT01790503|579736227|FG006|Overall Study|Non Compliance|0|||
160548706|NCT01790503|579736228|FG007|Overall Study|Non Compliance|0|||
160548707|NCT01790503|579736229|FG008|Overall Study|Non Compliance|0|||
160548708|NCT01790503|579736230|FG009|Overall Study|Non Compliance|0|||
160548709|NCT01790503|579736231|FG010|Overall Study|Non Compliance|0|||
160548710|NCT01790503|579736221|FG000|Overall Study|Other|0|||
160548711|NCT01790503|579736222|FG001|Overall Study|Other|0|||
160548712|NCT01790503|579736223|FG002|Overall Study|Other|0|||
160548713|NCT01790503|579736224|FG003|Overall Study|Other|0|||
160548714|NCT01790503|579736225|FG004|Overall Study|Other|1|||
160548715|NCT01790503|579736226|FG005|Overall Study|Other|0|||
160548716|NCT01790503|579736227|FG006|Overall Study|Other|0|||
160548717|NCT01790503|579736228|FG007|Overall Study|Other|0|||
160548718|NCT01790503|579736229|FG008|Overall Study|Other|1|||
160548719|NCT01790503|579736230|FG009|Overall Study|Other|2|||
160548720|NCT01790503|579736231|FG010|Overall Study|Other|0|||
160548721|NCT04183335|579736232|FG000|Overall Study|Adverse Event|1|||
160548722|NCT04183335|579736233|FG001|Overall Study|Adverse Event|0|||
160548723|NCT04183335|579736232|FG000|Overall Study|Withdrawal by Subject|12|||
160548724|NCT04183335|579736233|FG001|Overall Study|Withdrawal by Subject|3|||
160548725|NCT00049673|579736234|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
160548726|NCT00049673|579736235|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
160548727|NCT02322710|579736241|FG000|Overall Study|No efficacy assessment post-baseline|0|||
160548728|NCT02322710|579736242|FG001|Overall Study|No efficacy assessment post-baseline|1|||
160548729|NCT02322710|579736241|FG000|Overall Study|Protocol Violation|20|||
160548730|NCT02322710|579736242|FG001|Overall Study|Protocol Violation|25|||
160795495|NCT03448393|580638075|FG003|Dose Expansion|Not treated - screen failure|0|||
160795496|NCT03448393|580638076|FG004|Dose Expansion|Not treated - screen failure|0|||
160795497|NCT03448393|580638077|FG005|Dose Expansion|Not treated - screen failure|0|||
160795498|NCT03448393|580638078|FG006|Dose Expansion|Not treated - screen failure|0|||
160795499|NCT03448393|580638079|FG007|Dose Expansion|Not treated - screen failure|0|||
160795500|NCT03448393|580638080|FG008|Dose Expansion|Not treated - screen failure|7|||
160795501|NCT03612570|580638084|FG000|Overall Study|Lost to Follow-up|1|||
160795502|NCT05318287|580638089|FG000|Overall Study|Lost to Follow-up|8|||
160795503|NCT05185453|580638090|FG000|Overall Study|Lost to Follow-up|13|||
160795504|NCT05185453|580638091|FG001|Overall Study|Lost to Follow-up|3|||
160795505|NCT01323192|580639573|FG000|Overall Study|Adverse Event|6|||
160795506|NCT01323192|580639574|FG001|Overall Study|Adverse Event|1|||
160795507|NCT01323192|580639573|FG000|Overall Study|Withdrawal by Subject|3|||
160795508|NCT01323192|580639574|FG001|Overall Study|Withdrawal by Subject|1|||
160795509|NCT01323192|580639573|FG000|Overall Study|Noncompliance with study medication|0|||
160795510|NCT01323192|580639574|FG001|Overall Study|Noncompliance with study medication|3|||
160795511|NCT01323192|580639573|FG000|Overall Study|Nonmedical reasons|0|||
160795512|NCT01323192|580639574|FG001|Overall Study|Nonmedical reasons|1|||
160795513|NCT03122184|580639575|FG000|Overall Study|Lost to Follow-up|4|||
160795514|NCT03122184|580639576|FG001|Overall Study|Lost to Follow-up|6|||
160795515|NCT03122184|580639575|FG000|Overall Study|Withdrawal by Subject|3|||
160795516|NCT03122184|580639576|FG001|Overall Study|Withdrawal by Subject|0|||
160795517|NCT03122184|580639575|FG000|Overall Study|Terminated due to cognitive problem|1|||
160795518|NCT03122184|580639576|FG001|Overall Study|Terminated due to cognitive problem|0|||
160795519|NCT00633126|580639577|FG000|Overall Study|Did not receive full dose|1|||
160795520|NCT01276704|580639580|FG000|Overall Study|Lost to Follow-up|2|||
160795521|NCT01276704|580639581|FG001|Overall Study|Lost to Follow-up|3|||
160795522|NCT01276704|580639580|FG000|Overall Study|Non-compliant|2|||
160795523|NCT01276704|580639581|FG001|Overall Study|Non-compliant|2|||
160795524|NCT01276704|580639580|FG000|Overall Study|Withdrawal by Subject|7|||
160795525|NCT01276704|580639581|FG001|Overall Study|Withdrawal by Subject|1|||
160795526|NCT01276704|580639580|FG000|Overall Study|Physician Decision|3|||
160795527|NCT01276704|580639581|FG001|Overall Study|Physician Decision|5|||
160795528|NCT01168596|580639582|FG000|Overall Study|Withdrawal by Subject|3|||
160795529|NCT01168596|580639583|FG001|Overall Study|Withdrawal by Subject|1|||
160795530|NCT02297516|580639584|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
160795531|NCT02297516|580639585|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
160795532|NCT02297516|580639584|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
160795533|NCT02297516|580639585|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
160795534|NCT02297516|580639584|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
160795535|NCT02297516|580639585|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
160795536|NCT00710593|580639586|FG000|Overall Study|Incarceration|1|||
160795537|NCT00710593|580639587|FG001|Overall Study|Incarceration|0|||
160795538|NCT00710593|580639586|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
160795539|NCT00710593|580639587|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
160795540|NCT00710593|580639586|FG000|Overall Study|Lost to Follow-up|3|||
160795541|NCT00710593|580639587|FG001|Overall Study|Lost to Follow-up|1|||
160795542|NCT00710593|580639586|FG000|Overall Study|Moved out of area|1|||
160548731|NCT04161131|579736243|FG000|Overall Study|Ineligible|2|||
160548732|NCT04161131|579736243|FG000|Overall Study|Lost to Follow-up|4|||
160548733|NCT01934140|579736250|FG000|Persistence Phase (Year 6-10)|Other|24|||
160548734|NCT01934140|579736251|FG001|Persistence Phase (Year 6-10)|Other|6|||
160548735|NCT01934140|579736250|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
160643045|NCT01621490|580076511|FG007|Overall Study|Withdrawal by Subject|0|||
160643046|NCT01621490|580076512|FG008|Overall Study|Withdrawal by Subject|0|||
160643047|NCT01621490|580076513|FG009|Overall Study|Withdrawal by Subject|0|||
160643048|NCT01621490|580076514|FG010|Overall Study|Withdrawal by Subject|0|||
160643049|NCT01621490|580076504|FG000|Overall Study|Subject request to discontinue study|1|||
160643050|NCT01621490|580076505|FG001|Overall Study|Subject request to discontinue study|3|||
160643051|NCT01621490|580076506|FG002|Overall Study|Subject request to discontinue study|1|||
160643052|NCT01621490|580076507|FG003|Overall Study|Subject request to discontinue study|1|||
160643053|NCT01621490|580076508|FG004|Overall Study|Subject request to discontinue study|0|||
160643054|NCT01621490|580076509|FG005|Overall Study|Subject request to discontinue study|2|||
160643055|NCT01621490|580076510|FG006|Overall Study|Subject request to discontinue study|1|||
160548736|NCT01934140|579736251|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
160548737|NCT01934140|579736250|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
160548738|NCT01934140|579736251|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
160548739|NCT01934140|579736250|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
160643056|NCT01621490|580076511|FG007|Overall Study|Subject request to discontinue study|0|||
160548740|NCT01934140|579736251|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
160643057|NCT01621490|580076512|FG008|Overall Study|Subject request to discontinue study|1|||
160643058|NCT01621490|580076513|FG009|Overall Study|Subject request to discontinue study|0|||
160643059|NCT01621490|580076514|FG010|Overall Study|Subject request to discontinue study|0|||
160643060|NCT01621490|580076504|FG000|Overall Study|Adverse event unrelated to study drug|1|||
160643061|NCT01621490|580076505|FG001|Overall Study|Adverse event unrelated to study drug|1|||
160643062|NCT01621490|580076506|FG002|Overall Study|Adverse event unrelated to study drug|0|||
160643063|NCT01621490|580076507|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160643064|NCT01621490|580076508|FG004|Overall Study|Adverse event unrelated to study drug|0|||
160643065|NCT01621490|580076509|FG005|Overall Study|Adverse event unrelated to study drug|0|||
160643066|NCT01621490|580076510|FG006|Overall Study|Adverse event unrelated to study drug|0|||
160643067|NCT01621490|580076511|FG007|Overall Study|Adverse event unrelated to study drug|2|||
160643068|NCT01621490|580076512|FG008|Overall Study|Adverse event unrelated to study drug|0|||
160643069|NCT01621490|580076513|FG009|Overall Study|Adverse event unrelated to study drug|0|||
160643070|NCT01621490|580076514|FG010|Overall Study|Adverse event unrelated to study drug|0|||
160643071|NCT01621490|580076504|FG000|Overall Study|Disease progression|27|||
160643072|NCT01621490|580076505|FG001|Overall Study|Disease progression|28|||
160643073|NCT01621490|580076506|FG002|Overall Study|Disease progression|1|||
160643074|NCT01621490|580076507|FG003|Overall Study|Disease progression|5|||
160643075|NCT01621490|580076508|FG004|Overall Study|Disease progression|3|||
160643076|NCT01621490|580076509|FG005|Overall Study|Disease progression|8|||
160643077|NCT01621490|580076510|FG006|Overall Study|Disease progression|7|||
160643078|NCT01621490|580076511|FG007|Overall Study|Disease progression|1|||
160643079|NCT01621490|580076512|FG008|Overall Study|Disease progression|4|||
160643080|NCT01621490|580076513|FG009|Overall Study|Disease progression|1|||
160643081|NCT01621490|580076514|FG010|Overall Study|Disease progression|1|||
160643082|NCT01621490|580076504|FG000|Overall Study|Study drug toxicity|1|||
160643083|NCT01621490|580076505|FG001|Overall Study|Study drug toxicity|4|||
160643084|NCT01621490|580076506|FG002|Overall Study|Study drug toxicity|5|||
160643085|NCT01621490|580076507|FG003|Overall Study|Study drug toxicity|3|||
160643086|NCT01621490|580076508|FG004|Overall Study|Study drug toxicity|1|||
160643087|NCT01621490|580076509|FG005|Overall Study|Study drug toxicity|10|||
160643088|NCT01621490|580076510|FG006|Overall Study|Study drug toxicity|1|||
160643089|NCT01621490|580076511|FG007|Overall Study|Study drug toxicity|4|||
160643090|NCT01621490|580076512|FG008|Overall Study|Study drug toxicity|1|||
160643091|NCT01621490|580076513|FG009|Overall Study|Study drug toxicity|0|||
160643092|NCT01621490|580076514|FG010|Overall Study|Study drug toxicity|0|||
160643093|NCT01621490|580076504|FG000|Overall Study|Death|0|||
160643094|NCT01621490|580076505|FG001|Overall Study|Death|0|||
160643095|NCT01621490|580076506|FG002|Overall Study|Death|0|||
160643096|NCT01621490|580076507|FG003|Overall Study|Death|0|||
160643097|NCT01621490|580076508|FG004|Overall Study|Death|0|||
160643098|NCT01621490|580076509|FG005|Overall Study|Death|0|||
160643099|NCT01621490|580076510|FG006|Overall Study|Death|0|||
160643100|NCT01621490|580076511|FG007|Overall Study|Death|0|||
160643101|NCT01621490|580076512|FG008|Overall Study|Death|1|||
160643102|NCT01621490|580076513|FG009|Overall Study|Death|0|||
160643103|NCT01621490|580076514|FG010|Overall Study|Death|0|||
160548741|NCT01934140|579736250|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
160643104|NCT01621490|580076504|FG000|Overall Study|Other reasons|7|||
160643105|NCT01621490|580076505|FG001|Overall Study|Other reasons|6|||
160643106|NCT01621490|580076506|FG002|Overall Study|Other reasons|4|||
160643107|NCT01621490|580076507|FG003|Overall Study|Other reasons|1|||
160548742|NCT01934140|579736251|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
160548743|NCT01934140|579736250|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
160548744|NCT01934140|579736251|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
160548745|NCT01934140|579736250|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
160548746|NCT01934140|579736251|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
160983341|NCT05343455|581328623|FG000|Overall Study|Pregnancy|1|||
160983342|NCT05343455|581328624|FG001|Overall Study|Pregnancy|0|||
160983343|NCT05343455|581328625|FG002|Overall Study|Pregnancy|0|||
160983344|NCT05343455|581328623|FG000|Overall Study|Physician Decision|0|||
160983345|NCT05343455|581328624|FG001|Overall Study|Physician Decision|0|||
160983346|NCT05343455|581328625|FG002|Overall Study|Physician Decision|1|||
160983347|NCT05343455|581328623|FG000|Overall Study|Protocol Violation|0|||
160983348|NCT05343455|581328624|FG001|Overall Study|Protocol Violation|1|||
160983349|NCT05343455|581328625|FG002|Overall Study|Protocol Violation|1|||
160983350|NCT01310868|581328626|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
160983351|NCT01708187|581328629|FG000|Overall Study|Lost to Follow-up|0|||
160983352|NCT01708187|581328630|FG001|Overall Study|Lost to Follow-up|1|||
160983353|NCT02408549|581328632|FG000|Overall Study|Adverse Event|15|||
160983354|NCT02408549|581328632|FG000|Overall Study|Death|4|||
160983355|NCT02408549|581328632|FG000|Overall Study|Lack of Efficacy|17|||
160983356|NCT02408549|581328632|FG000|Overall Study|Protocol Violation|4|||
160983357|NCT02408549|581328632|FG000|Overall Study|Lost to Follow-up|6|||
160983358|NCT02408549|581328632|FG000|Overall Study|Consent withdrawn|30|||
160983359|NCT02408549|581328632|FG000|Overall Study|Neurology research program closing at site|1|||
160983360|NCT02408549|581328632|FG000|Overall Study|Site closure|1|||
160548747|NCT01934140|579736250|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
160548748|NCT01934140|579736251|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
160548749|NCT00808444|579736257|FG000|Overall Study|Withdrawal by Subject|1|||
160983361|NCT02408549|581328632|FG000|Overall Study|Pregnancy|1|||
160983362|NCT02408549|581328632|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
160983363|NCT02408549|581328632|FG000|Overall Study|Subject moved to another place, far from site|1|||
160983364|NCT02408549|581328632|FG000|Overall Study|Study terminated at site|1|||
160983365|NCT00231894|581328633|FG000|Overall Study|Withdrawal by Subject|1|||
160983366|NCT00231894|581328634|FG001|Overall Study|Withdrawal by Subject|1|||
160983367|NCT02025205|581328635|FG000|Overall Study|Withdrawal by Subject|1|||
160983368|NCT02025205|581328636|FG001|Overall Study|Withdrawal by Subject|1|||
160983369|NCT02025205|581328635|FG000|Overall Study|Protocol Violation|2|||
160983370|NCT02025205|581328636|FG001|Overall Study|Protocol Violation|1|||
160983371|NCT02025205|581328635|FG000|Overall Study|Death|0|||
160983372|NCT02025205|581328636|FG001|Overall Study|Death|1|||
160983373|NCT01232556|581328639|FG000|Overall Study|Withdrawal by Subject|21|||
160983374|NCT01232556|581328640|FG001|Overall Study|Withdrawal by Subject|17|||
160983375|NCT01232556|581328639|FG000|Overall Study|Death|97|||
160983376|NCT01232556|581328640|FG001|Overall Study|Death|97|||
160983377|NCT01232556|581328639|FG000|Overall Study|Lost to Follow-up|0|||
160983378|NCT01232556|581328640|FG001|Overall Study|Lost to Follow-up|2|||
160983379|NCT01232556|581328639|FG000|Overall Study|Terminated by Sponsor|35|||
160983380|NCT01232556|581328640|FG001|Overall Study|Terminated by Sponsor|51|||
160983381|NCT01232556|581328639|FG000|Overall Study|Other|6|||
160983382|NCT01232556|581328640|FG001|Overall Study|Other|4|||
160983383|NCT04707391|581328641|FG000|Overall Study|Adverse Event|5|||
160983384|NCT04707391|581328642|FG001|Overall Study|Adverse Event|8|||
160983385|NCT04707391|581328641|FG000|Overall Study|Lost to Follow-up|44|||
160983386|NCT04707391|581328642|FG001|Overall Study|Lost to Follow-up|31|||
160983387|NCT04707391|581328641|FG000|Overall Study|Protocol Violation|1|||
160983388|NCT04707391|581328642|FG001|Overall Study|Protocol Violation|5|||
160548750|NCT00808444|579736258|FG001|Overall Study|Withdrawal by Subject|0|||
160548751|NCT00808444|579736257|FG000|Overall Study|Lost to Follow-up|0|||
160548752|NCT00808444|579736258|FG001|Overall Study|Lost to Follow-up|1|||
160548753|NCT01461044|579736259|FG000|Overall Study|Death|58|||
160548754|NCT01461044|579736260|FG001|Overall Study|Death|35|||
160548755|NCT01461044|579736259|FG000|Overall Study|Lost to Follow-up|12|||
160548756|NCT01461044|579736260|FG001|Overall Study|Lost to Follow-up|5|||
160795543|NCT00710593|580639587|FG001|Overall Study|Moved out of area|0|||
160983389|NCT04707391|581328641|FG000|Overall Study|Withdrawal by Subject|27|||
160795544|NCT00710593|580639586|FG000|Overall Study|Failure to adhere or complete study eval|1|||
160983390|NCT04707391|581328642|FG001|Overall Study|Withdrawal by Subject|25|||
160983391|NCT04707391|581328641|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
160983392|NCT04707391|581328642|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
160983393|NCT04707391|581328641|FG000|Overall Study|Other|0|||
160983394|NCT04707391|581328642|FG001|Overall Study|Other|2|||
160983395|NCT03785340|581328643|FG000|Overall Study|Lost to Follow-up|2|||
160983396|NCT03785340|581328644|FG001|Overall Study|Lost to Follow-up|0|||
160983397|NCT03785340|581328643|FG000|Overall Study|Adverse Event|1|||
160983398|NCT03785340|581328644|FG001|Overall Study|Adverse Event|0|||
160983399|NCT01848834|581328645|FG000|Overall Study|Adverse Event|3|||
160983400|NCT01848834|581328646|FG001|Overall Study|Adverse Event|11|||
160983401|NCT01848834|581328647|FG002|Overall Study|Adverse Event|3|||
160983402|NCT01848834|581328648|FG003|Overall Study|Adverse Event|5|||
160983403|NCT01848834|581328649|FG004|Overall Study|Adverse Event|9|||
160983404|NCT01848834|581328645|FG000|Overall Study|Death|2|||
160983405|NCT01848834|581328646|FG001|Overall Study|Death|11|||
160983406|NCT01848834|581328647|FG002|Overall Study|Death|1|||
160983407|NCT01848834|581328648|FG003|Overall Study|Death|8|||
160983408|NCT01848834|581328649|FG004|Overall Study|Death|27|||
160983409|NCT01848834|581328645|FG000|Overall Study|Excluded Medication|5|||
160983410|NCT01848834|581328646|FG001|Overall Study|Excluded Medication|4|||
160983411|NCT01848834|581328647|FG002|Overall Study|Excluded Medication|3|||
160983412|NCT01848834|581328648|FG003|Overall Study|Excluded Medication|6|||
160983413|NCT01848834|581328649|FG004|Overall Study|Excluded Medication|6|||
160983414|NCT01848834|581328645|FG000|Overall Study|Lost to Follow-up|5|||
160983415|NCT01848834|581328646|FG001|Overall Study|Lost to Follow-up|5|||
160983416|NCT01848834|581328647|FG002|Overall Study|Lost to Follow-up|3|||
160983417|NCT01848834|581328648|FG003|Overall Study|Lost to Follow-up|0|||
160983418|NCT01848834|581328649|FG004|Overall Study|Lost to Follow-up|3|||
160983419|NCT01848834|581328645|FG000|Overall Study|Physician Decision|1|||
160983420|NCT01848834|581328646|FG001|Overall Study|Physician Decision|3|||
160983421|NCT01848834|581328647|FG002|Overall Study|Physician Decision|4|||
160983422|NCT01848834|581328648|FG003|Overall Study|Physician Decision|0|||
160983423|NCT01848834|581328649|FG004|Overall Study|Physician Decision|11|||
160983424|NCT01848834|581328645|FG000|Overall Study|Protocol Violation|0|||
160983425|NCT01848834|581328646|FG001|Overall Study|Protocol Violation|0|||
160983426|NCT01848834|581328647|FG002|Overall Study|Protocol Violation|0|||
160983427|NCT01848834|581328648|FG003|Overall Study|Protocol Violation|0|||
160983428|NCT01848834|581328649|FG004|Overall Study|Protocol Violation|1|||
160983429|NCT01848834|581328645|FG000|Overall Study|Sponsor Decision|1|||
160983430|NCT01848834|581328646|FG001|Overall Study|Sponsor Decision|1|||
160983431|NCT01848834|581328647|FG002|Overall Study|Sponsor Decision|0|||
160983432|NCT01848834|581328648|FG003|Overall Study|Sponsor Decision|1|||
160983433|NCT01848834|581328649|FG004|Overall Study|Sponsor Decision|1|||
160983434|NCT01848834|581328645|FG000|Overall Study|Withdrawal by Subject|2|||
160983435|NCT01848834|581328646|FG001|Overall Study|Withdrawal by Subject|13|||
160983436|NCT01848834|581328647|FG002|Overall Study|Withdrawal by Subject|10|||
160983437|NCT01848834|581328648|FG003|Overall Study|Withdrawal by Subject|6|||
160983438|NCT01848834|581328649|FG004|Overall Study|Withdrawal by Subject|36|||
160983439|NCT02584855|581328654|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
160983440|NCT02584855|581328655|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
160983441|NCT02584855|581328656|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
160983442|NCT02584855|581328657|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
160983443|NCT02584855|581328658|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
160983444|NCT02584855|581328659|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
160983445|NCT02584855|581328654|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
160983446|NCT02584855|581328655|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
160983447|NCT02584855|581328656|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
160983448|NCT02584855|581328657|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
160983449|NCT02584855|581328658|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
160983450|NCT02584855|581328659|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
160983451|NCT02584855|581328654|FG000|Open-Label Treatment Period|Adverse Event|14|||
160983452|NCT02584855|581328655|FG001|Open-Label Treatment Period|Adverse Event|0|||
160983453|NCT02584855|581328656|FG002|Open-Label Treatment Period|Adverse Event|0|||
160983454|NCT02584855|581328657|FG003|Open-Label Treatment Period|Adverse Event|0|||
160983455|NCT02584855|581328658|FG004|Open-Label Treatment Period|Adverse Event|0|||
160983456|NCT02584855|581328659|FG005|Open-Label Treatment Period|Adverse Event|0|||
160983457|NCT02584855|581328654|FG000|Open-Label Treatment Period|Death|2|||
160983458|NCT02584855|581328655|FG001|Open-Label Treatment Period|Death|0|||
160983459|NCT02584855|581328656|FG002|Open-Label Treatment Period|Death|0|||
160548757|NCT00618748|579736261|FG000|Overall Study|Adverse Event|4|||
160548758|NCT00618748|579736262|FG001|Overall Study|Adverse Event|3|||
160548759|NCT00618748|579736263|FG002|Overall Study|Adverse Event|8|||
160548760|NCT00618748|579736261|FG000|Overall Study|Physician Decision|3|||
160548761|NCT00618748|579736262|FG001|Overall Study|Physician Decision|1|||
160548762|NCT00618748|579736263|FG002|Overall Study|Physician Decision|1|||
160983460|NCT02584855|581328657|FG003|Open-Label Treatment Period|Death|0|||
160983461|NCT02584855|581328658|FG004|Open-Label Treatment Period|Death|0|||
160983462|NCT02584855|581328659|FG005|Open-Label Treatment Period|Death|0|||
160983463|NCT02584855|581328654|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
160548763|NCT00618748|579736261|FG000|Overall Study|Withdrawal by Subject|4|||
160548764|NCT00618748|579736262|FG001|Overall Study|Withdrawal by Subject|1|||
160983464|NCT02584855|581328655|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
160983465|NCT02584855|581328656|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
160983466|NCT02584855|581328657|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
160983467|NCT02584855|581328658|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
160983468|NCT02584855|581328659|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
160548765|NCT00618748|579736263|FG002|Overall Study|Withdrawal by Subject|5|||
160983469|NCT02584855|581328654|FG000|Open-Label Treatment Period|Protocol Violation|1|||
160795545|NCT00710593|580639587|FG001|Overall Study|Failure to adhere or complete study eval|1|||
160795546|NCT00710593|580639586|FG000|Overall Study|Protocol Violation|1|||
160795547|NCT00710593|580639587|FG001|Overall Study|Protocol Violation|1|||
160795548|NCT00710593|580639586|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
160795549|NCT00710593|580639587|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
160795550|NCT04490278|580639588|FG000|Overall Study|Lost to Follow-up|6|||
160795551|NCT03801525|580639591|FG000|Overall Study|Adverse Event|17|||
160795552|NCT03801525|580639592|FG001|Overall Study|Adverse Event|1|||
160795553|NCT03801525|580639593|FG002|Overall Study|Adverse Event|0|||
160795554|NCT03801525|580639591|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
160795555|NCT03801525|580639592|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
160795556|NCT03801525|580639593|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
160795557|NCT03801525|580639591|FG000|Overall Study|Death|29|||
160795558|NCT03801525|580639592|FG001|Overall Study|Death|1|||
160795559|NCT03801525|580639593|FG002|Overall Study|Death|4|||
160795560|NCT03801525|580639591|FG000|Overall Study|Disease Progression|6|||
160795561|NCT03801525|580639592|FG001|Overall Study|Disease Progression|0|||
160795562|NCT03801525|580639593|FG002|Overall Study|Disease Progression|1|||
160795563|NCT03801525|580639591|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
160795564|NCT03801525|580639592|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
160795565|NCT03801525|580639593|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
160795566|NCT03801525|580639591|FG000|Overall Study|Investigator Decision|18|||
160795567|NCT03801525|580639592|FG001|Overall Study|Investigator Decision|1|||
160795568|NCT03801525|580639593|FG002|Overall Study|Investigator Decision|0|||
160795569|NCT03801525|580639591|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
160795570|NCT03801525|580639592|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
160795571|NCT03801525|580639593|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
160795572|NCT03801525|580639591|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
160795573|NCT03801525|580639592|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
160795574|NCT03801525|580639593|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
160795575|NCT03801525|580639591|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
160795576|NCT03801525|580639592|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
160795577|NCT03801525|580639593|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
160795578|NCT03801525|580639591|FG000|Overall Study|Withdrawal of Subject Consent|38|||
160795579|NCT03801525|580639592|FG001|Overall Study|Withdrawal of Subject Consent|2|||
160795580|NCT03801525|580639593|FG002|Overall Study|Withdrawal of Subject Consent|1|||
160795581|NCT03801525|580639591|FG000|Overall Study|Reason not Specified|4|||
160795582|NCT03801525|580639592|FG001|Overall Study|Reason not Specified|0|||
160795583|NCT03801525|580639593|FG002|Overall Study|Reason not Specified|4|||
160795584|NCT03309202|580639594|FG000|Overall Study|Lost to Follow-up|1|||
160795585|NCT03309202|580639595|FG001|Overall Study|Lost to Follow-up|0|||
160795586|NCT03309202|580639596|FG002|Overall Study|Lost to Follow-up|0|||
160795587|NCT03309202|580639597|FG003|Overall Study|Lost to Follow-up|0|||
160795588|NCT00573768|580639598|FG000|Overall Study|Adverse Event|1|||
160795589|NCT00573768|580639599|FG001|Overall Study|Adverse Event|1|||
160795590|NCT00573768|580639600|FG002|Overall Study|Adverse Event|2|||
160795591|NCT00573768|580639598|FG000|Overall Study|Protocol Violation|1|||
160795592|NCT00573768|580639599|FG001|Overall Study|Protocol Violation|0|||
160795593|NCT00573768|580639600|FG002|Overall Study|Protocol Violation|1|||
160795594|NCT00573768|580639598|FG000|Overall Study|Withdrawal by Subject|0|||
160795595|NCT00573768|580639599|FG001|Overall Study|Withdrawal by Subject|1|||
160795596|NCT00573768|580639600|FG002|Overall Study|Withdrawal by Subject|0|||
160795597|NCT00573768|580639598|FG000|Overall Study|Lost to Follow-up|0|||
160795598|NCT00573768|580639599|FG001|Overall Study|Lost to Follow-up|0|||
160795599|NCT00573768|580639600|FG002|Overall Study|Lost to Follow-up|1|||
160795600|NCT03847519|580639604|FG000|Overall Study|Death|5|||
160795601|NCT03847519|580639605|FG001|Overall Study|Death|8|||
160795602|NCT03847519|580639606|FG002|Overall Study|Death|1|||
160795603|NCT03847519|580639604|FG000|Overall Study|Lost to Follow-up|1|||
160795604|NCT03847519|580639605|FG001|Overall Study|Lost to Follow-up|2|||
160795605|NCT03847519|580639606|FG002|Overall Study|Lost to Follow-up|0|||
160894333|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
160894334|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
160894335|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
160894336|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
160795606|NCT03847519|580639604|FG000|Overall Study|Study Terminated by Sponsor|0|||
160795607|NCT03847519|580639605|FG001|Overall Study|Study Terminated by Sponsor|3|||
160795608|NCT03847519|580639606|FG002|Overall Study|Study Terminated by Sponsor|2|||
160795609|NCT01500317|580639611|FG000|Overall Study|Withdrawal by Subject|3|||
160795610|NCT01500317|580639612|FG001|Overall Study|Withdrawal by Subject|2|||
160795611|NCT01500317|580639613|FG002|Overall Study|Withdrawal by Subject|0|||
160795612|NCT00976456|580639614|FG000|Overall Study|Adverse Event|17|||
160548766|NCT02889796|579736271|FG000|Overall Study|Withdrew Consent|18|||
160795613|NCT00976456|580639615|FG001|Overall Study|Adverse Event|22|||
160795614|NCT00976456|580639614|FG000|Overall Study|Death|7|||
160795615|NCT00976456|580639615|FG001|Overall Study|Death|9|||
160795616|NCT00976456|580639614|FG000|Overall Study|Lack of Efficacy|5|||
160894337|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
160894338|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
160894339|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
160894340|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
160894341|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
160894342|NCT01070043|581008352|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
160894343|NCT01070043|581008353|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
160894344|NCT01070043|581008354|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
160894345|NCT01070043|581008352|FG000|Double-Blind Treatment|Adverse Event|0|||
160894346|NCT01070043|581008353|FG001|Double-Blind Treatment|Adverse Event|0|||
160894347|NCT01070043|581008354|FG002|Double-Blind Treatment|Adverse Event|2|||
160894348|NCT01528215|581008355|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
160894349|NCT01528215|581008356|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
160894350|NCT01528215|581008355|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
160894351|NCT01528215|581008356|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
160894352|NCT01528215|581008355|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
160894353|NCT01528215|581008356|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
160894354|NCT01528215|581008355|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
160894355|NCT01528215|581008356|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
160894356|NCT01610271|581008359|FG000|Overall Study|Surgery not complete|0|||
160983470|NCT02584855|581328655|FG001|Open-Label Treatment Period|Protocol Violation|0|||
160983471|NCT02584855|581328656|FG002|Open-Label Treatment Period|Protocol Violation|0|||
160983472|NCT02584855|581328657|FG003|Open-Label Treatment Period|Protocol Violation|0|||
160795617|NCT00976456|580639615|FG001|Overall Study|Lack of Efficacy|2|||
160795618|NCT00976456|580639614|FG000|Overall Study|Withdrawal by Subject|3|||
160795619|NCT00976456|580639615|FG001|Overall Study|Withdrawal by Subject|1|||
160795620|NCT00976456|580639614|FG000|Overall Study|screening failure, unknown|11|||
160795621|NCT00976456|580639615|FG001|Overall Study|screening failure, unknown|4|||
160795622|NCT00335829|580639616|FG000|Overall Study|Withdrawal by Subject|1|||
160795623|NCT00335829|580639616|FG000|Overall Study|Lost to Follow-up|1|||
160795624|NCT00335829|580639616|FG000|Overall Study|Adverse Event|1|||
160795625|NCT04562116|580639617|FG000|Overall Study|Lost to Follow-up|1|||
160795626|NCT04562116|580639617|FG000|Overall Study|Withdrawal by Subject|3|||
160795627|NCT03331354|580639618|FG000|Overall Study|Withdrawal by Subject|1|||
160795628|NCT03331354|580639619|FG001|Overall Study|Withdrawal by Subject|3|||
160795629|NCT03331354|580639618|FG000|Overall Study|Lost to Follow-up|3|||
160795630|NCT03331354|580639619|FG001|Overall Study|Lost to Follow-up|3|||
160795631|NCT03331354|580639618|FG000|Overall Study|Found employment before initiated active intervention|0|||
160795632|NCT03331354|580639619|FG001|Overall Study|Found employment before initiated active intervention|4|||
160795633|NCT01559935|580639622|FG000|Car Phase|Toxicity|4|||
160795634|NCT01559935|580639622|FG000|Car Phase|Death|1|||
160795635|NCT01559935|580639622|FG000|Car Phase|Lack of Efficacy|2|||
160795636|NCT01559935|580639622|FG000|Car Phase|Lost to Follow-up|1|||
160795637|NCT01559935|580639622|FG000|Car Phase|Physician Decision|1|||
160795638|NCT01559935|580639622|FG000|Car Phase|Withdrawal by Subject|2|||
160795639|NCT01559935|580639622|FG000|Car Phase|Per protocol|1|||
160795640|NCT01559935|580639622|FG000|Car Phase|Insurance|1|||
160795641|NCT01559935|580639622|FG000|Car Phase|non-compliance|1|||
160795642|NCT01559935|580639622|FG000|BiRD Phase|Toxicity|1|||
160795643|NCT01559935|580639622|FG000|BiRD Phase|Lack of Efficacy|1|||
160795644|NCT01559935|580639622|FG000|BiRD Phase|Withdrawal by Subject|2|||
160795645|NCT01559935|580639622|FG000|Maintenance Phase|Remains on study|28|||
160795646|NCT01559935|580639622|FG000|Maintenance Phase|Toxicity|1|||
160795647|NCT01559935|580639622|FG000|Maintenance Phase|Lack of Efficacy|18|||
160795648|NCT01559935|580639622|FG000|Maintenance Phase|Withdrawal by Subject|5|||
160795649|NCT01559935|580639622|FG000|Maintenance Phase|Non-compliance|2|||
160795650|NCT05889468|580639624|FG000|Overall Study|Lost to Follow-up|9|||
160795651|NCT05889468|580639625|FG001|Overall Study|Lost to Follow-up|2|||
160795652|NCT05889468|580639624|FG000|Overall Study|Withdrawal by Subject|2|||
160795653|NCT05889468|580639625|FG001|Overall Study|Withdrawal by Subject|2|||
160894357|NCT01610271|581008360|FG001|Overall Study|Surgery not complete|1|||
160983473|NCT02584855|581328658|FG004|Open-Label Treatment Period|Protocol Violation|0|||
160795654|NCT02284893|580639631|FG000|26 Week (Short Term)|Adverse Event|1|||
160795655|NCT02284893|580639632|FG001|26 Week (Short Term)|Adverse Event|9|||
160795656|NCT02284893|580639631|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
160795657|NCT02284893|580639632|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
160795658|NCT02284893|580639631|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
160795659|NCT02284893|580639632|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
160795660|NCT02284893|580639631|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
160795661|NCT02284893|580639632|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
160795662|NCT02284893|580639631|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
160795663|NCT02284893|580639632|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
160548767|NCT02889796|579736272|FG001|Overall Study|Withdrew Consent|29|||
160548768|NCT02889796|579736273|FG002|Overall Study|Withdrew Consent|20|||
160548769|NCT02889796|579736274|FG003|Overall Study|Withdrew Consent|1|||
160548770|NCT02889796|579736275|FG004|Overall Study|Withdrew Consent|2|||
160548771|NCT02889796|579736276|FG005|Overall Study|Withdrew Consent|35|||
160795664|NCT02284893|580639631|FG000|26 Week (Short Term)|Other|1|||
160795665|NCT02284893|580639632|FG001|26 Week (Short Term)|Other|1|||
160795666|NCT02284893|580639631|FG000|52 Week (Long Term)|Adverse Event|3|||
160795667|NCT02284893|580639632|FG001|52 Week (Long Term)|Adverse Event|1|||
160795668|NCT02284893|580639631|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
160795669|NCT02284893|580639632|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
160795670|NCT02284893|580639631|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
160795671|NCT02284893|580639632|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
160795672|NCT02284893|580639631|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
160795673|NCT02284893|580639632|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
160795674|NCT02284893|580639631|FG000|52 Week (Long Term)|Non-Compliance|2|||
160795675|NCT02284893|580639632|FG001|52 Week (Long Term)|Non-Compliance|3|||
160795676|NCT03078868|580639635|FG000|Overall Study|Physician Decision|3|||
160795677|NCT03038620|580639636|FG000|Overall Study|Lost to Follow-up|18|||
160795678|NCT03038620|580639637|FG001|Overall Study|Lost to Follow-up|23|||
160795679|NCT03038620|580639636|FG000|Overall Study|Withdrawal by Subject|0|||
160795680|NCT03038620|580639637|FG001|Overall Study|Withdrawal by Subject|15|||
160795681|NCT03038620|580639636|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
160795682|NCT03038620|580639637|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
160795683|NCT02082977|580639638|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
160795684|NCT02082977|580639639|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
160795685|NCT02082977|580639640|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
160795686|NCT02082977|580639641|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
160795687|NCT02082977|580639642|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
160795688|NCT02082977|580639643|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
160795689|NCT02082977|580639644|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
160795690|NCT02082977|580639645|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
160795691|NCT02082977|580639646|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
160795692|NCT02082977|580639647|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
160795693|NCT02082977|580639638|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795694|NCT02082977|580639639|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795695|NCT02082977|580639640|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795696|NCT02082977|580639641|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795697|NCT02082977|580639642|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795698|NCT02082977|580639643|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795699|NCT02082977|580639644|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795700|NCT02082977|580639645|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
160795701|NCT02082977|580639646|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795702|NCT02082977|580639647|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795703|NCT02082977|580639638|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795704|NCT02082977|580639639|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795705|NCT02082977|580639640|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795706|NCT02082977|580639641|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795707|NCT02082977|580639642|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795708|NCT02082977|580639643|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
160795709|NCT02082977|580639644|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795710|NCT02082977|580639645|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795711|NCT02082977|580639646|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795712|NCT02082977|580639647|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795713|NCT02082977|580639638|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
160795714|NCT02082977|580639639|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
160795715|NCT02082977|580639640|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
160795716|NCT02082977|580639641|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
160795717|NCT02082977|580639642|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
160795718|NCT02082977|580639643|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
160795719|NCT02082977|580639644|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
160795720|NCT02082977|580639645|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
160795721|NCT02082977|580639646|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
160795722|NCT02082977|580639647|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
160795723|NCT02082977|580639638|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795724|NCT02082977|580639639|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795725|NCT02082977|580639640|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795726|NCT02082977|580639641|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160548772|NCT02889796|579736271|FG000|Overall Study|Investigator's Discretion|10|||
160548773|NCT02889796|579736272|FG001|Overall Study|Investigator's Discretion|9|||
160983474|NCT02584855|581328659|FG005|Open-Label Treatment Period|Protocol Violation|0|||
160983475|NCT02584855|581328654|FG000|Open-Label Treatment Period|No PI Available|2|||
160983476|NCT02584855|581328655|FG001|Open-Label Treatment Period|No PI Available|0|||
160983477|NCT02584855|581328656|FG002|Open-Label Treatment Period|No PI Available|0|||
160983478|NCT02584855|581328657|FG003|Open-Label Treatment Period|No PI Available|0|||
160983479|NCT02584855|581328658|FG004|Open-Label Treatment Period|No PI Available|0|||
160983480|NCT02584855|581328659|FG005|Open-Label Treatment Period|No PI Available|0|||
160983481|NCT02584855|581328654|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
160983482|NCT02584855|581328655|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
160983483|NCT02584855|581328656|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
160983484|NCT02584855|581328657|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
160983485|NCT02584855|581328658|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
160983486|NCT02584855|581328659|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
160983487|NCT02584855|581328654|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
160983488|NCT02584855|581328655|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
160983489|NCT02584855|581328656|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
160983490|NCT02584855|581328657|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
160983491|NCT02584855|581328658|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
160983492|NCT02584855|581328659|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
160983493|NCT02584855|581328654|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
160983494|NCT02584855|581328655|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
160983495|NCT02584855|581328656|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
160983496|NCT02584855|581328657|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
160983497|NCT02584855|581328658|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
160983498|NCT02584855|581328659|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
160983499|NCT02584855|581328654|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
160983500|NCT02584855|581328655|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
160983501|NCT02584855|581328656|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
160983502|NCT02584855|581328657|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
160983503|NCT02584855|581328658|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
160983504|NCT02584855|581328659|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
160983505|NCT02584855|581328654|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
160983506|NCT02584855|581328655|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
160983507|NCT02584855|581328656|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
160983508|NCT02584855|581328657|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
160983509|NCT02584855|581328658|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
160983510|NCT02584855|581328659|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
160983511|NCT02584855|581328654|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160983512|NCT02584855|581328655|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160983513|NCT02584855|581328656|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160983514|NCT02584855|581328657|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160983515|NCT02584855|581328658|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
160983516|NCT02584855|581328659|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160983517|NCT02584855|581328654|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
160983518|NCT02584855|581328655|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
160983519|NCT02584855|581328656|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
160983520|NCT02584855|581328657|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
160983521|NCT02584855|581328658|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
160983522|NCT02584855|581328659|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
160983523|NCT02337478|581328660|FG000|Overall Study|Lack of Efficacy|5|||
160983524|NCT02611830|581328661|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
160983525|NCT02611830|581328662|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
160983526|NCT02611830|581328663|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
160983527|NCT02611830|581328664|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
160983528|NCT02611830|581328661|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
160983529|NCT02611830|581328662|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
160983530|NCT02611830|581328663|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
160983531|NCT02611830|581328664|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
160983532|NCT02611830|581328661|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
160983533|NCT02611830|581328662|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
160983534|NCT02611830|581328663|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
160983535|NCT02611830|581328664|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
160983536|NCT02611830|581328661|FG000|OL Induction Phase|Lack of Efficacy|9|||
160983537|NCT02611830|581328662|FG001|OL Induction Phase|Lack of Efficacy|0|||
160983538|NCT02611830|581328663|FG002|OL Induction Phase|Lack of Efficacy|0|||
160983539|NCT02611830|581328664|FG003|OL Induction Phase|Lack of Efficacy|0|||
160643108|NCT01621490|580076508|FG004|Overall Study|Other reasons|1|||
160795727|NCT02082977|580639642|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795728|NCT02082977|580639643|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795729|NCT02082977|580639644|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795730|NCT02082977|580639645|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
160795731|NCT02082977|580639646|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795732|NCT02082977|580639647|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795733|NCT00105066|580639648|FG000|Overall Study|Adverse Event|2|||
160795734|NCT00105066|580639649|FG001|Overall Study|Adverse Event|5|||
160795735|NCT01979185|580639661|FG000|Period 2|Other|0|||
160795736|NCT01979185|580639662|FG001|Period 2|Other|1|||
160795737|NCT00522379|580639663|FG000|Overall Study|Adverse Event|12|||
160795738|NCT00522379|580639664|FG001|Overall Study|Adverse Event|15|||
160795739|NCT00522379|580639665|FG002|Overall Study|Adverse Event|12|||
160795740|NCT00522379|580639666|FG003|Overall Study|Adverse Event|5|||
160795741|NCT00522379|580639667|FG004|Overall Study|Adverse Event|17|||
160795742|NCT00522379|580639663|FG000|Overall Study|Lack of Efficacy|3|||
160795743|NCT00522379|580639664|FG001|Overall Study|Lack of Efficacy|0|||
160795744|NCT00522379|580639665|FG002|Overall Study|Lack of Efficacy|2|||
160795745|NCT00522379|580639666|FG003|Overall Study|Lack of Efficacy|2|||
160795746|NCT00522379|580639667|FG004|Overall Study|Lack of Efficacy|7|||
160795747|NCT00522379|580639663|FG000|Overall Study|Withdrawal by Subject|2|||
160795748|NCT00522379|580639664|FG001|Overall Study|Withdrawal by Subject|3|||
160795749|NCT00522379|580639665|FG002|Overall Study|Withdrawal by Subject|1|||
160795750|NCT00522379|580639666|FG003|Overall Study|Withdrawal by Subject|2|||
160795751|NCT00522379|580639667|FG004|Overall Study|Withdrawal by Subject|0|||
160795752|NCT00522379|580639663|FG000|Overall Study|Protocol Violation|1|||
160795753|NCT00522379|580639664|FG001|Overall Study|Protocol Violation|1|||
160795754|NCT00522379|580639665|FG002|Overall Study|Protocol Violation|2|||
160795755|NCT00522379|580639666|FG003|Overall Study|Protocol Violation|0|||
160795756|NCT00522379|580639667|FG004|Overall Study|Protocol Violation|0|||
160795757|NCT00522379|580639663|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
160795758|NCT00522379|580639664|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
160795759|NCT00522379|580639665|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
160795760|NCT00522379|580639666|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
160795761|NCT00522379|580639667|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
160795762|NCT00522379|580639663|FG000|Overall Study|Lost to Follow-up|1|||
160795763|NCT00522379|580639664|FG001|Overall Study|Lost to Follow-up|0|||
160795764|NCT00522379|580639665|FG002|Overall Study|Lost to Follow-up|4|||
160795765|NCT00522379|580639666|FG003|Overall Study|Lost to Follow-up|2|||
160795766|NCT00522379|580639667|FG004|Overall Study|Lost to Follow-up|2|||
160795767|NCT00522379|580639663|FG000|Overall Study|Randomization error|0|||
160795768|NCT00522379|580639664|FG001|Overall Study|Randomization error|0|||
160795769|NCT00522379|580639665|FG002|Overall Study|Randomization error|0|||
160795770|NCT00522379|580639666|FG003|Overall Study|Randomization error|0|||
160795771|NCT00522379|580639667|FG004|Overall Study|Randomization error|1|||
160795772|NCT00522379|580639663|FG000|Overall Study|Dispensing error|1|||
160795773|NCT00522379|580639664|FG001|Overall Study|Dispensing error|0|||
160795774|NCT00522379|580639665|FG002|Overall Study|Dispensing error|0|||
160795775|NCT00522379|580639666|FG003|Overall Study|Dispensing error|1|||
160795776|NCT00522379|580639667|FG004|Overall Study|Dispensing error|0|||
160795777|NCT00522379|580639663|FG000|Overall Study|Subject Moved|1|||
160795778|NCT00522379|580639664|FG001|Overall Study|Subject Moved|1|||
160795779|NCT00522379|580639665|FG002|Overall Study|Subject Moved|0|||
160795780|NCT00522379|580639666|FG003|Overall Study|Subject Moved|0|||
160795781|NCT00522379|580639667|FG004|Overall Study|Subject Moved|0|||
160795782|NCT00522379|580639663|FG000|Overall Study|Sponsor Request|0|||
160795783|NCT00522379|580639664|FG001|Overall Study|Sponsor Request|1|||
160795784|NCT00522379|580639665|FG002|Overall Study|Sponsor Request|0|||
160795785|NCT00522379|580639666|FG003|Overall Study|Sponsor Request|0|||
160795786|NCT00522379|580639667|FG004|Overall Study|Sponsor Request|0|||
160795787|NCT00522379|580639663|FG000|Overall Study|Family Problem|0|||
160795788|NCT00522379|580639664|FG001|Overall Study|Family Problem|0|||
160795789|NCT00522379|580639665|FG002|Overall Study|Family Problem|1|||
160795790|NCT00522379|580639666|FG003|Overall Study|Family Problem|0|||
160795791|NCT00522379|580639667|FG004|Overall Study|Family Problem|0|||
160795792|NCT00522379|580639663|FG000|Overall Study|Site Closed|0|||
160795793|NCT00522379|580639664|FG001|Overall Study|Site Closed|0|||
160795794|NCT00522379|580639665|FG002|Overall Study|Site Closed|0|||
160795795|NCT00522379|580639666|FG003|Overall Study|Site Closed|1|||
160795796|NCT00522379|580639667|FG004|Overall Study|Site Closed|0|||
160795797|NCT00522379|580639663|FG000|Overall Study|Subject Withdrawal|0|||
160795798|NCT00522379|580639664|FG001|Overall Study|Subject Withdrawal|0|||
160795799|NCT00522379|580639665|FG002|Overall Study|Subject Withdrawal|0|||
160795800|NCT00522379|580639666|FG003|Overall Study|Subject Withdrawal|1|||
160795801|NCT00522379|580639667|FG004|Overall Study|Subject Withdrawal|0|||
160795802|NCT03213509|580639668|FG000|Overall Study|Did not consent for verbal autopsy|4|||
160795803|NCT03213509|580639669|FG001|Overall Study|Did not consent for verbal autopsy|5|||
160795804|NCT04079738|580639670|FG000|Study Treatment|Death|1|||
160795805|NCT04079738|580639671|FG001|Study Treatment|Death|0|||
160795806|NCT04079738|580639672|FG002|Study Treatment|Death|0|||
160795807|NCT04079738|580639673|FG003|Study Treatment|Death|0|||
160795808|NCT04079738|580639670|FG000|Study Treatment|Adverse Event|2|||
160795809|NCT04079738|580639671|FG001|Study Treatment|Adverse Event|0|||
160795810|NCT04079738|580639672|FG002|Study Treatment|Adverse Event|0|||
160795811|NCT04079738|580639673|FG003|Study Treatment|Adverse Event|0|||
160795812|NCT04079738|580639670|FG000|Study Treatment|withdrawal before treatment|1|||
160795813|NCT04079738|580639671|FG001|Study Treatment|withdrawal before treatment|0|||
160795814|NCT04079738|580639672|FG002|Study Treatment|withdrawal before treatment|0|||
160795815|NCT04079738|580639673|FG003|Study Treatment|withdrawal before treatment|0|||
160795816|NCT04079738|580639670|FG000|Study Treatment|symptomatic deterioration|2|||
160795817|NCT04079738|580639671|FG001|Study Treatment|symptomatic deterioration|0|||
160795818|NCT04079738|580639672|FG002|Study Treatment|symptomatic deterioration|0|||
160795819|NCT04079738|580639673|FG003|Study Treatment|symptomatic deterioration|0|||
160795820|NCT04079738|580639670|FG000|Study Treatment|Disease Progression|1|||
160795821|NCT04079738|580639671|FG001|Study Treatment|Disease Progression|0|||
160795822|NCT04079738|580639672|FG002|Study Treatment|Disease Progression|0|||
160795823|NCT04079738|580639673|FG003|Study Treatment|Disease Progression|0|||
160795824|NCT04079738|580639670|FG000|Study Treatment|withdrawal after treatment|1|||
160795825|NCT04079738|580639671|FG001|Study Treatment|withdrawal after treatment|0|||
160795826|NCT04079738|580639672|FG002|Study Treatment|withdrawal after treatment|0|||
160795827|NCT04079738|580639673|FG003|Study Treatment|withdrawal after treatment|0|||
160795828|NCT04079738|580639670|FG000|Follow up|Withdrawal by Subject|3|||
160795829|NCT04079738|580639671|FG001|Follow up|Withdrawal by Subject|0|||
160795830|NCT04079738|580639672|FG002|Follow up|Withdrawal by Subject|0|||
160795831|NCT04079738|580639673|FG003|Follow up|Withdrawal by Subject|0|||
160795832|NCT04079738|580639670|FG000|Follow up|Death|5|||
160795833|NCT04079738|580639671|FG001|Follow up|Death|0|||
160795834|NCT04079738|580639672|FG002|Follow up|Death|0|||
160795835|NCT04079738|580639673|FG003|Follow up|Death|0|||
160795836|NCT03620981|580639674|FG000|Overall Study|Adverse Event|14|||
160795837|NCT03620981|580639675|FG001|Overall Study|Adverse Event|38|||
160795838|NCT03620981|580639676|FG002|Overall Study|Adverse Event|25|||
160795839|NCT03620981|580639674|FG000|Overall Study|Lack of Efficacy|2|||
160795840|NCT03620981|580639675|FG001|Overall Study|Lack of Efficacy|1|||
160795841|NCT03620981|580639676|FG002|Overall Study|Lack of Efficacy|1|||
160795842|NCT03620981|580639674|FG000|Overall Study|Physician Decision|7|||
160795843|NCT03620981|580639675|FG001|Overall Study|Physician Decision|4|||
160795844|NCT03620981|580639676|FG002|Overall Study|Physician Decision|4|||
160795845|NCT03620981|580639674|FG000|Overall Study|Protocol Violation|1|||
160795846|NCT03620981|580639675|FG001|Overall Study|Protocol Violation|2|||
160795847|NCT03620981|580639676|FG002|Overall Study|Protocol Violation|1|||
160795848|NCT03620981|580639674|FG000|Overall Study|Withdrawal by Legal Representative|2|||
160795849|NCT03620981|580639675|FG001|Overall Study|Withdrawal by Legal Representative|1|||
160795850|NCT03620981|580639676|FG002|Overall Study|Withdrawal by Legal Representative|1|||
160795851|NCT03620981|580639674|FG000|Overall Study|Withdrawal by Care Giver|2|||
160795852|NCT03620981|580639675|FG001|Overall Study|Withdrawal by Care Giver|0|||
160795853|NCT03620981|580639676|FG002|Overall Study|Withdrawal by Care Giver|1|||
160795854|NCT03620981|580639674|FG000|Overall Study|Non-compliance with Study Drug|1|||
160795855|NCT03620981|580639675|FG001|Overall Study|Non-compliance with Study Drug|1|||
160795856|NCT03620981|580639676|FG002|Overall Study|Non-compliance with Study Drug|0|||
160795857|NCT05552859|580639679|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
160795858|NCT05552859|580639680|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
160795859|NCT01380080|580639681|FG000|Overall Study|Death|36|||
160795860|NCT01380080|580639682|FG001|Overall Study|Death|44|||
160795861|NCT01380080|580639681|FG000|Overall Study|Site is closing|28|||
160795862|NCT01380080|580639682|FG001|Overall Study|Site is closing|31|||
160795863|NCT01380080|580639681|FG000|Overall Study|Not able to get to clinic|7|||
160795864|NCT01380080|580639682|FG001|Overall Study|Not able to get to clinic|1|||
160795865|NCT01380080|580639681|FG000|Overall Study|Not willing to adhere to requirements|6|||
160795866|NCT01380080|580639682|FG001|Overall Study|Not willing to adhere to requirements|2|||
160795867|NCT01380080|580639681|FG000|Overall Study|Withdrawal by Subject|5|||
160795868|NCT01380080|580639682|FG001|Overall Study|Withdrawal by Subject|2|||
160795869|NCT01380080|580639681|FG000|Overall Study|Lost to Follow-up|3|||
160795870|NCT01380080|580639682|FG001|Overall Study|Lost to Follow-up|3|||
160795871|NCT01889251|580639686|FG000|Overall Study|Adverse Event|1|||
160795872|NCT01889251|580639687|FG001|Overall Study|Adverse Event|0|||
160795873|NCT05852470|580639688|FG000|Overall Study|Withdrawal by Subject|0|||
160795874|NCT05852470|580639689|FG001|Overall Study|Withdrawal by Subject|1|||
160795875|NCT05484895|580641124|FG000|Overall Study|Lost to Follow-up|63|||
160795876|NCT05484895|580641125|FG001|Overall Study|Lost to Follow-up|64|||
160795877|NCT04795531|580641126|FG000|Overall Study|Withdrawal by Subject|4|||
160795878|NCT04795531|580641127|FG001|Overall Study|Withdrawal by Subject|4|||
160795879|NCT04795531|580641126|FG000|Overall Study|Lost to Follow-up|0|||
160795880|NCT04795531|580641127|FG001|Overall Study|Lost to Follow-up|1|||
160795881|NCT04795531|580641126|FG000|Overall Study|Physician Decision|0|||
160795882|NCT04795531|580641127|FG001|Overall Study|Physician Decision|2|||
160795883|NCT04795531|580641126|FG000|Overall Study|Death|2|||
160795884|NCT04795531|580641127|FG001|Overall Study|Death|1|||
160795885|NCT03698279|580641128|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160795886|NCT03698279|580641129|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160795887|NCT03698279|580641130|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160795888|NCT03698279|580641131|FG003|Overall Study|Withdrawal by parent/guardian|1|||
160795889|NCT03698279|580641132|FG004|Overall Study|Withdrawal by parent/guardian|0|||
160795890|NCT03698279|580641133|FG005|Overall Study|Withdrawal by parent/guardian|0|||
160795891|NCT03698279|580641128|FG000|Overall Study|Protocol deviation|1|||
160795892|NCT03698279|580641129|FG001|Overall Study|Protocol deviation|0|||
160795893|NCT03698279|580641130|FG002|Overall Study|Protocol deviation|1|||
160795894|NCT03698279|580641131|FG003|Overall Study|Protocol deviation|0|||
160795895|NCT03698279|580641132|FG004|Overall Study|Protocol deviation|0|||
160795896|NCT03698279|580641133|FG005|Overall Study|Protocol deviation|0|||
160795897|NCT03698279|580641128|FG000|Overall Study|Withdrawal by Subject|0|||
160795898|NCT03698279|580641129|FG001|Overall Study|Withdrawal by Subject|0|||
160795899|NCT03698279|580641130|FG002|Overall Study|Withdrawal by Subject|1|||
160795900|NCT03698279|580641131|FG003|Overall Study|Withdrawal by Subject|0|||
160795901|NCT03698279|580641132|FG004|Overall Study|Withdrawal by Subject|0|||
160795902|NCT03698279|580641133|FG005|Overall Study|Withdrawal by Subject|0|||
160795903|NCT03698279|580641128|FG000|Overall Study|Lost to Follow-up|3|||
160795904|NCT03698279|580641129|FG001|Overall Study|Lost to Follow-up|1|||
160643109|NCT01621490|580076509|FG005|Overall Study|Other reasons|3|||
160795905|NCT03698279|580641130|FG002|Overall Study|Lost to Follow-up|4|||
160795906|NCT03698279|580641131|FG003|Overall Study|Lost to Follow-up|5|||
160795907|NCT03698279|580641132|FG004|Overall Study|Lost to Follow-up|0|||
160795908|NCT03698279|580641133|FG005|Overall Study|Lost to Follow-up|0|||
160795909|NCT03552029|580641134|FG000|Overall Study|Death|3|||
160795910|NCT03552029|580641135|FG001|Overall Study|Death|0|||
160795911|NCT03552029|580641134|FG000|Overall Study|Adverse Event|1|||
160795912|NCT03552029|580641135|FG001|Overall Study|Adverse Event|0|||
160795913|NCT03552029|580641134|FG000|Overall Study|Lack of Efficacy|0|||
160795914|NCT03552029|580641135|FG001|Overall Study|Lack of Efficacy|2|||
160795915|NCT03552029|580641134|FG000|Overall Study|Physician Decision|0|||
160795916|NCT03552029|580641135|FG001|Overall Study|Physician Decision|1|||
160795917|NCT03552029|580641134|FG000|Overall Study|Study terminated by Sponsor|0|||
160795918|NCT03552029|580641135|FG001|Overall Study|Study terminated by Sponsor|1|||
160795919|NCT03552029|580641134|FG000|Overall Study|Other|0|||
160795920|NCT03552029|580641135|FG001|Overall Study|Other|2|||
160795921|NCT02552225|580641136|FG000|Overall Study|Withdrawal by Subject|1|||
160795922|NCT02552225|580641137|FG001|Overall Study|Withdrawal by Subject|0|||
160795923|NCT00876447|580641138|FG000|Overall Study|Other miscellaneous reasons|3|||
160795924|NCT00876447|580641139|FG001|Overall Study|Other miscellaneous reasons|8|||
160795925|NCT00876447|580641138|FG000|Overall Study|Site closure|19|||
160795926|NCT00876447|580641139|FG001|Overall Study|Site closure|14|||
160795927|NCT00876447|580641138|FG000|Overall Study|Protocol Violation|9|||
160795928|NCT00876447|580641139|FG001|Overall Study|Protocol Violation|3|||
160795929|NCT00876447|580641138|FG000|Overall Study|Personal reasons|30|||
160795930|NCT00876447|580641139|FG001|Overall Study|Personal reasons|28|||
160795931|NCT00876447|580641138|FG000|Overall Study|Lost to Follow-up|6|||
160795932|NCT00876447|580641139|FG001|Overall Study|Lost to Follow-up|15|||
160643110|NCT01621490|580076510|FG006|Overall Study|Other reasons|1|||
160795933|NCT00876447|580641138|FG000|Overall Study|Pregnancy|4|||
160795934|NCT00876447|580641139|FG001|Overall Study|Pregnancy|2|||
160795935|NCT00876447|580641138|FG000|Overall Study|Lack of Efficacy|5|||
160795936|NCT00876447|580641139|FG001|Overall Study|Lack of Efficacy|3|||
160795937|NCT00876447|580641138|FG000|Overall Study|Adverse Event|4|||
160795938|NCT00876447|580641139|FG001|Overall Study|Adverse Event|8|||
160894358|NCT01610271|581008359|FG000|Overall Study|Prosthesis not implanted|2|||
160894359|NCT01610271|581008360|FG001|Overall Study|Prosthesis not implanted|3|||
160894360|NCT01638819|581008361|FG000|Overall Study|Lost to Follow-up|1|||
160894361|NCT01638819|581008362|FG001|Overall Study|Lost to Follow-up|0|||
160894362|NCT00923936|581008363|FG000|Overall Study|progressive disease on study|2|||
160795939|NCT00567502|580641140|FG000|Overall Study|Lost to Follow-up|91|||
160795940|NCT00567502|580641141|FG001|Overall Study|Lost to Follow-up|14|||
160795941|NCT00567502|580641142|FG002|Overall Study|Lost to Follow-up|351|||
160643111|NCT01621490|580076511|FG007|Overall Study|Other reasons|1|||
160795942|NCT00567502|580641143|FG003|Overall Study|Lost to Follow-up|2|||
160795943|NCT00567502|580641140|FG000|Overall Study|Death|65|||
160795944|NCT00567502|580641141|FG001|Overall Study|Death|16|||
160795945|NCT00567502|580641142|FG002|Overall Study|Death|360|||
160894363|NCT00923936|581008364|FG001|Overall Study|progressive disease on study|1|||
160795946|NCT00567502|580641143|FG003|Overall Study|Death|5|||
160795947|NCT00567502|580641140|FG000|Overall Study|Other|64|||
160795948|NCT00567502|580641141|FG001|Overall Study|Other|2|||
160795949|NCT00567502|580641142|FG002|Overall Study|Other|134|||
160795950|NCT00567502|580641143|FG003|Overall Study|Other|6|||
160795951|NCT00567502|580641140|FG000|Overall Study|Participant request|12|||
160795952|NCT00567502|580641141|FG001|Overall Study|Participant request|1|||
160795953|NCT00567502|580641142|FG002|Overall Study|Participant request|33|||
160795954|NCT00567502|580641143|FG003|Overall Study|Participant request|1|||
160795955|NCT00567502|580641140|FG000|Overall Study|Sponsor request|9|||
160795956|NCT00567502|580641141|FG001|Overall Study|Sponsor request|0|||
160795957|NCT00567502|580641142|FG002|Overall Study|Sponsor request|30|||
160795958|NCT00567502|580641143|FG003|Overall Study|Sponsor request|1|||
160795959|NCT00567502|580641140|FG000|Overall Study|Never Initiated Treatment|0|||
160795960|NCT00567502|580641141|FG001|Overall Study|Never Initiated Treatment|0|||
160795961|NCT00567502|580641142|FG002|Overall Study|Never Initiated Treatment|0|||
160795962|NCT00567502|580641143|FG003|Overall Study|Never Initiated Treatment|72|||
160795963|NCT03728933|580641144|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160795964|NCT03728933|580641145|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160795965|NCT03728933|580641146|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160795966|NCT03728933|580641144|FG000|Overall Study|Withdrawal by Subject|0|||
160795967|NCT03728933|580641145|FG001|Overall Study|Withdrawal by Subject|0|||
160643112|NCT01621490|580076512|FG008|Overall Study|Other reasons|1|||
160795968|NCT03728933|580641146|FG002|Overall Study|Withdrawal by Subject|1|||
160795969|NCT03728933|580641144|FG000|Overall Study|Lost to Follow-up|0|||
160894364|NCT00923936|581008363|FG000|Overall Study|Adverse Event|2|||
160894365|NCT00923936|581008364|FG001|Overall Study|Adverse Event|1|||
160795970|NCT03728933|580641145|FG001|Overall Study|Lost to Follow-up|1|||
160795971|NCT03728933|580641146|FG002|Overall Study|Lost to Follow-up|0|||
160795972|NCT03728933|580641144|FG000|Overall Study|Adverse Event|1|||
160795973|NCT03728933|580641145|FG001|Overall Study|Adverse Event|0|||
160795974|NCT03728933|580641146|FG002|Overall Study|Adverse Event|0|||
160795975|NCT02835690|580641147|FG000|Overall Study|Death|12|||
160795976|NCT02835690|580641148|FG001|Overall Study|Death|11|||
160795977|NCT02835690|580641149|FG002|Overall Study|Death|13|||
160795978|NCT02835690|580641147|FG000|Overall Study|Transferred to Extension Study|2|||
160795979|NCT02835690|580641148|FG001|Overall Study|Transferred to Extension Study|2|||
160795980|NCT02835690|580641149|FG002|Overall Study|Transferred to Extension Study|1|||
160894366|NCT00923936|581008363|FG000|Overall Study|Lost to follow up|2|||
160894367|NCT00923936|581008364|FG001|Overall Study|Lost to follow up|0|||
160894368|NCT00923936|581008363|FG000|Overall Study|Continuing in follow up period|2|||
160894369|NCT00923936|581008364|FG001|Overall Study|Continuing in follow up period|1|||
160894370|NCT02038452|581008365|FG000|Overall Study|Withdrawal by Subject|7|||
160894371|NCT02038452|581008366|FG001|Overall Study|Withdrawal by Subject|9|||
160894372|NCT02038452|581008365|FG000|Overall Study|Lost to Follow-up|31|||
160894373|NCT02038452|581008366|FG001|Overall Study|Lost to Follow-up|28|||
160894374|NCT01626495|581008368|FG000|Overall Study|Adverse Event|3|||
160643113|NCT01621490|580076513|FG009|Overall Study|Other reasons|0|||
160643114|NCT01621490|580076514|FG010|Overall Study|Other reasons|0|||
160643115|NCT00461500|580076515|FG000|Overall Study|Adverse Event|1|||
160643116|NCT00461500|580076516|FG001|Overall Study|Adverse Event|0|||
160643117|NCT00461500|580076515|FG000|Overall Study|Lack of Efficacy|0|||
160643118|NCT00461500|580076516|FG001|Overall Study|Lack of Efficacy|1|||
160643119|NCT00461500|580076515|FG000|Overall Study|Expired Drug Treatment|1|||
160643120|NCT00461500|580076516|FG001|Overall Study|Expired Drug Treatment|1|||
160643121|NCT00461500|580076515|FG000|Overall Study|Study Stopped|1|||
160643122|NCT00461500|580076516|FG001|Overall Study|Study Stopped|2|||
160643123|NCT00461500|580076515|FG000|Overall Study|Drug Treatment Misuse|1|||
160643124|NCT00461500|580076516|FG001|Overall Study|Drug Treatment Misuse|0|||
160643125|NCT00461500|580076515|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
160643126|NCT00461500|580076516|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
160643127|NCT00461500|580076515|FG000|Overall Study|Lost to Follow-up|2|||
160643128|NCT00461500|580076516|FG001|Overall Study|Lost to Follow-up|2|||
160643129|NCT01513551|580076517|FG000|Overall Study|Death|0|||
160643130|NCT01513551|580076518|FG001|Overall Study|Death|1|||
160643131|NCT01513551|580076519|FG002|Overall Study|Death|0|||
160643132|NCT01513551|580076517|FG000|Overall Study|Lost to Follow-up|3|||
160643133|NCT01513551|580076518|FG001|Overall Study|Lost to Follow-up|5|||
160643134|NCT01513551|580076519|FG002|Overall Study|Lost to Follow-up|2|||
160643135|NCT01513551|580076517|FG000|Overall Study|Withdrawal by Subject|1|||
160643136|NCT01513551|580076518|FG001|Overall Study|Withdrawal by Subject|0|||
160643137|NCT01513551|580076519|FG002|Overall Study|Withdrawal by Subject|2|||
160643138|NCT01513551|580076517|FG000|Overall Study|Randomized but not vaccinated|0|||
160643139|NCT01513551|580076518|FG001|Overall Study|Randomized but not vaccinated|0|||
160643140|NCT01513551|580076519|FG002|Overall Study|Randomized but not vaccinated|1|||
160643141|NCT02482805|580076525|FG000|Overall Study|Lost to Follow-up|4|||
160643142|NCT02482805|580076526|FG001|Overall Study|Lost to Follow-up|4|||
160643143|NCT02482805|580076527|FG002|Overall Study|Lost to Follow-up|0|||
160643144|NCT01806597|580076528|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
160643145|NCT01806597|580076529|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
160643146|NCT01806597|580076530|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
160643147|NCT01806597|580076531|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
160643148|NCT01806597|580076532|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
160643149|NCT01806597|580076533|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
160643150|NCT01806597|580076528|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
160643151|NCT01806597|580076529|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
160643152|NCT01806597|580076530|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
160643153|NCT01806597|580076531|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
160643154|NCT01806597|580076532|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
160643155|NCT01806597|580076533|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
160643156|NCT01806597|580076528|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
160643157|NCT01806597|580076529|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
160643158|NCT01806597|580076530|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
160643159|NCT01806597|580076531|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
160795981|NCT02835690|580641147|FG000|Overall Study|Did Not Continue on Extension Study|0|||
160643160|NCT01806597|580076532|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
160643161|NCT01806597|580076533|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
160795982|NCT02835690|580641148|FG001|Overall Study|Did Not Continue on Extension Study|0|||
160795983|NCT02835690|580641149|FG002|Overall Study|Did Not Continue on Extension Study|1|||
160795984|NCT02835690|580641147|FG000|Overall Study|Not Treated|0|||
160643162|NCT01806597|580076528|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
160643163|NCT01806597|580076529|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
160643164|NCT01806597|580076530|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
160894375|NCT01626495|581008368|FG000|Overall Study|Disease progression|27|||
160894376|NCT01626495|581008368|FG000|Overall Study|Withdrawal by Subject|1|||
160643165|NCT01806597|580076531|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
160643166|NCT01806597|580076532|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
160643167|NCT01806597|580076533|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
160643168|NCT01806597|580076528|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
160643169|NCT01806597|580076529|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
160643170|NCT01806597|580076530|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
160643171|NCT01806597|580076531|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
160643172|NCT01806597|580076532|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
160643173|NCT01806597|580076533|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
160643174|NCT01806597|580076528|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
160643175|NCT01806597|580076529|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
160643176|NCT01806597|580076530|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
160643177|NCT01806597|580076531|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
160643178|NCT01806597|580076532|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
160643179|NCT01806597|580076533|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
160643180|NCT01806597|580076528|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
160643181|NCT01806597|580076529|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
160643182|NCT01806597|580076530|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
160643183|NCT01806597|580076531|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
160643184|NCT01806597|580076532|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
160643185|NCT01806597|580076533|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
160643186|NCT01806597|580076528|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
160643187|NCT01806597|580076529|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
160643188|NCT01806597|580076530|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
160643189|NCT01806597|580076531|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
160643190|NCT01806597|580076532|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
160643191|NCT01806597|580076533|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
160643192|NCT01806597|580076528|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
160643193|NCT01806597|580076529|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
160643194|NCT01806597|580076530|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
160643195|NCT01806597|580076531|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
160643196|NCT01806597|580076532|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
160643197|NCT01806597|580076533|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
160643198|NCT01806597|580076528|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
160643199|NCT01806597|580076529|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
160643200|NCT01806597|580076530|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
160643201|NCT01806597|580076531|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
160643202|NCT01806597|580076532|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
160643203|NCT01806597|580076533|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
160643204|NCT01806597|580076528|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
160643205|NCT01806597|580076529|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
160643206|NCT01806597|580076530|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
160643207|NCT01806597|580076531|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
160643208|NCT01806597|580076532|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
160643209|NCT01806597|580076533|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
160643210|NCT01806597|580076528|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
160643211|NCT01806597|580076529|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
160643212|NCT01806597|580076530|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
160643213|NCT01806597|580076531|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
160643214|NCT01806597|580076532|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
160643215|NCT01806597|580076533|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
160643216|NCT01806597|580076528|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
160643217|NCT01806597|580076529|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
160643218|NCT01806597|580076530|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
160643219|NCT01806597|580076531|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
160643220|NCT01806597|580076532|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
160643221|NCT01806597|580076533|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
160643222|NCT01806597|580076528|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
160643223|NCT01806597|580076529|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
160643224|NCT01806597|580076530|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
160894377|NCT01626495|581008368|FG000|Overall Study|Administrative problem|1|||
160643225|NCT01806597|580076531|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
160795985|NCT02835690|580641148|FG001|Overall Study|Not Treated|2|||
160795986|NCT02835690|580641149|FG002|Overall Study|Not Treated|0|||
160795987|NCT02538614|580641152|FG000|Overall Study|Progressive Disease|2|||
160795988|NCT00582907|580641153|FG000|1st Course|Withdrawal by Subject|1|||
160795989|NCT00582907|580641154|FG001|1st Course|Withdrawal by Subject|0|||
160795990|NCT00582907|580641155|FG002|1st Course|Withdrawal by Subject|0|||
160795991|NCT00582907|580641156|FG003|1st Course|Withdrawal by Subject|0|||
160795992|NCT00582907|580641153|FG000|1st Course|Lost to Follow-up|0|||
160795993|NCT00582907|580641154|FG001|1st Course|Lost to Follow-up|0|||
160795994|NCT00582907|580641155|FG002|1st Course|Lost to Follow-up|0|||
160795995|NCT00582907|580641156|FG003|1st Course|Lost to Follow-up|1|||
160795996|NCT00582907|580641153|FG000|2nd Course|Lack of Efficacy|1|||
160795997|NCT00582907|580641154|FG001|2nd Course|Lack of Efficacy|0|||
160795998|NCT00582907|580641155|FG002|2nd Course|Lack of Efficacy|0|||
160795999|NCT00582907|580641156|FG003|2nd Course|Lack of Efficacy|0|||
160796000|NCT01441960|580641158|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
160796001|NCT01441960|580641159|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
160796002|NCT01441960|580641158|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
160796003|NCT01441960|580641159|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
160796004|NCT01441960|580641158|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
160796005|NCT01441960|580641159|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
160796006|NCT00189423|580641160|FG000|Overall Study|Death|746|||
160796007|NCT00189423|580641161|FG001|Overall Study|Death|747|||
160796008|NCT00189423|580641160|FG000|Overall Study|Withdrawal by Subject|9|||
160796009|NCT00189423|580641161|FG001|Overall Study|Withdrawal by Subject|9|||
160796010|NCT00189423|580641160|FG000|Overall Study|Lost to Follow-up|10|||
160796011|NCT00189423|580641161|FG001|Overall Study|Lost to Follow-up|10|||
160796012|NCT00415636|580641167|FG000|Overall Study|Symptomatic deterioration|1|||
160796013|NCT00415636|580641168|FG001|Overall Study|Symptomatic deterioration|0|||
160796014|NCT00415636|580641169|FG002|Overall Study|Symptomatic deterioration|1|||
160796015|NCT00415636|580641170|FG003|Overall Study|Symptomatic deterioration|2|||
160796016|NCT00415636|580641171|FG004|Overall Study|Symptomatic deterioration|0|||
160796017|NCT00415636|580641172|FG005|Overall Study|Symptomatic deterioration|1|||
160796018|NCT00415636|580641167|FG000|Overall Study|Adverse Event|0|||
160796019|NCT00415636|580641168|FG001|Overall Study|Adverse Event|0|||
160796020|NCT00415636|580641169|FG002|Overall Study|Adverse Event|0|||
160796021|NCT00415636|580641170|FG003|Overall Study|Adverse Event|1|||
160796022|NCT00415636|580641171|FG004|Overall Study|Adverse Event|1|||
160796023|NCT00415636|580641172|FG005|Overall Study|Adverse Event|0|||
160796024|NCT00415636|580641167|FG000|Overall Study|Withdrawal by Subject|0|||
160796025|NCT00415636|580641168|FG001|Overall Study|Withdrawal by Subject|0|||
160796026|NCT00415636|580641169|FG002|Overall Study|Withdrawal by Subject|0|||
160796027|NCT00415636|580641170|FG003|Overall Study|Withdrawal by Subject|0|||
160796028|NCT00415636|580641171|FG004|Overall Study|Withdrawal by Subject|1|||
160796029|NCT00415636|580641172|FG005|Overall Study|Withdrawal by Subject|0|||
160796030|NCT00415636|580641167|FG000|Overall Study|Disease progression|0|||
160796031|NCT00415636|580641168|FG001|Overall Study|Disease progression|0|||
160796032|NCT00415636|580641169|FG002|Overall Study|Disease progression|0|||
160796033|NCT00415636|580641170|FG003|Overall Study|Disease progression|3|||
160796034|NCT00415636|580641171|FG004|Overall Study|Disease progression|0|||
160796035|NCT00415636|580641172|FG005|Overall Study|Disease progression|1|||
160796036|NCT01263119|580641173|FG000|Period 1|Protocol Violation|2|||
160796037|NCT01263119|580641173|FG000|Period 2|Adverse Event|2|||
160796038|NCT02138825|580641174|FG000|Main Study Treatment|Adverse Event|11|||
160796039|NCT02138825|580641175|FG001|Main Study Treatment|Adverse Event|3|||
160796040|NCT02138825|580641174|FG000|Main Study Treatment|Death|1|||
160796041|NCT02138825|580641175|FG001|Main Study Treatment|Death|2|||
160796042|NCT02138825|580641174|FG000|Main Study Treatment|Protocol Violation|2|||
160796043|NCT02138825|580641175|FG001|Main Study Treatment|Protocol Violation|2|||
160796044|NCT02138825|580641174|FG000|Main Study Treatment|Sponsor decision|12|||
160796045|NCT02138825|580641175|FG001|Main Study Treatment|Sponsor decision|18|||
160796046|NCT02138825|580641174|FG000|Main Study Treatment|Study terminated by sponsor|10|||
160796047|NCT02138825|580641175|FG001|Main Study Treatment|Study terminated by sponsor|9|||
160796048|NCT02138825|580641174|FG000|Main Study Treatment|Withdrawal by Subject|3|||
160796049|NCT02138825|580641175|FG001|Main Study Treatment|Withdrawal by Subject|1|||
160796050|NCT02138825|580641174|FG000|Main Study Treatment|Medical decision|1|||
160796051|NCT02138825|580641175|FG001|Main Study Treatment|Medical decision|0|||
160796052|NCT02138825|580641174|FG000|Long-term Extension|Study termination by sponsor|32|||
160796053|NCT02138825|580641175|FG001|Long-term Extension|Study termination by sponsor|38|||
160796054|NCT02138825|580641174|FG000|Safety Follow-up|Adverse Event|4|||
160894378|NCT01626495|581008368|FG000|Overall Study|Death|2|||
160894379|NCT01626495|581008368|FG000|Overall Study|Physician Decision|1|||
160796055|NCT02138825|580641175|FG001|Safety Follow-up|Adverse Event|3|||
160796056|NCT02138825|580641174|FG000|Safety Follow-up|Death|11|||
160894380|NCT01626495|581008368|FG000|Overall Study|New cancer therapy|16|||
160796057|NCT02138825|580641175|FG001|Safety Follow-up|Death|5|||
160796058|NCT02138825|580641174|FG000|Safety Follow-up|Withdrawal by Subject|5|||
160796059|NCT02138825|580641175|FG001|Safety Follow-up|Withdrawal by Subject|3|||
160796060|NCT02138825|580641174|FG000|Safety Follow-up|clinic worsening|1|||
160796061|NCT02138825|580641175|FG001|Safety Follow-up|clinic worsening|0|||
160796062|NCT02138825|580641174|FG000|Safety Follow-up|withdrawal by PI|1|||
160796063|NCT02138825|580641175|FG001|Safety Follow-up|withdrawal by PI|0|||
160796064|NCT02138825|580641174|FG000|Safety Follow-up|logistical difficulties|0|||
160796065|NCT02138825|580641175|FG001|Safety Follow-up|logistical difficulties|1|||
160796066|NCT02138825|580641174|FG000|Safety Follow-up|progressive disease|0|||
160796067|NCT02138825|580641175|FG001|Safety Follow-up|progressive disease|2|||
160796068|NCT02138825|580641174|FG000|Safety Follow-up|too unwell to attend the visit|0|||
160796069|NCT02138825|580641175|FG001|Safety Follow-up|too unwell to attend the visit|1|||
160796070|NCT02138825|580641174|FG000|Safety Follow-up|treatment unblinded|0|||
160796071|NCT02138825|580641175|FG001|Safety Follow-up|treatment unblinded|1|||
160796072|NCT02138825|580641174|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
160796073|NCT02138825|580641175|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
160796074|NCT01702298|580641181|FG000|Overall Study|Withdrawal by Subject|1|||
160796075|NCT02090764|580641189|FG000|Overall Study|Adverse Event|1|||
160796076|NCT02090764|580641190|FG001|Overall Study|Adverse Event|3|||
160796077|NCT02090764|580641189|FG000|Overall Study|Lack of Efficacy|0|||
160796078|NCT02090764|580641190|FG001|Overall Study|Lack of Efficacy|13|||
160796079|NCT02090764|580641189|FG000|Overall Study|Withdrawal by Subject|2|||
160796080|NCT02090764|580641190|FG001|Overall Study|Withdrawal by Subject|1|||
160796081|NCT02090764|580641189|FG000|Overall Study|Intercurrent illness and other|1|||
160796082|NCT02090764|580641190|FG001|Overall Study|Intercurrent illness and other|1|||
160796083|NCT02090764|580641189|FG000|Overall Study|Lost to Follow-up|2|||
160796084|NCT02090764|580641190|FG001|Overall Study|Lost to Follow-up|2|||
160796085|NCT03605693|580641193|FG000|Overall Study|Lost to Follow-up|4|||
160796086|NCT03605693|580641194|FG001|Overall Study|Lost to Follow-up|0|||
160796087|NCT03605693|580641193|FG000|Overall Study|Physician Decision|1|||
160796088|NCT03605693|580641194|FG001|Overall Study|Physician Decision|0|||
160796089|NCT04752566|580641195|FG000|Overall Study|Protocol Violation|0|||
160796090|NCT04752566|580641196|FG001|Overall Study|Protocol Violation|1|||
160796091|NCT04752566|580641195|FG000|Overall Study|Death|1|||
160796092|NCT04752566|580641196|FG001|Overall Study|Death|0|||
160796093|NCT04752566|580641195|FG000|Overall Study|Adverse Event|1|||
160796094|NCT04752566|580641196|FG001|Overall Study|Adverse Event|0|||
160796095|NCT04752566|580641195|FG000|Overall Study|Withdrawal by Subject|2|||
160796096|NCT04752566|580641196|FG001|Overall Study|Withdrawal by Subject|0|||
160796097|NCT04752566|580641195|FG000|Overall Study|Physician Decision|1|||
160796098|NCT04752566|580641196|FG001|Overall Study|Physician Decision|1|||
160796099|NCT05134649|580641197|FG000|Overall Study|Lost to Follow-up|12|||
160796100|NCT05134649|580641197|FG000|Overall Study|Withdrawal by Subject|14|||
160796101|NCT05134649|580641197|FG000|Overall Study|Pregnancy|1|||
160796102|NCT05134649|580641197|FG000|Overall Study|Other, not specified|3|||
160796103|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
160796104|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
160796105|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
160796106|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
160796107|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
160796108|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
160796109|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
160796110|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
160796111|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
160796112|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
160796113|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
160796114|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
160796115|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
160796116|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
160796117|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
160796118|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
160796119|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
160796120|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
160796121|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
160894381|NCT01626495|581008368|FG000|Overall Study|Manufacturing failure|1|||
160894382|NCT01278160|581008369|FG000|Overall Study|Adverse Event|1|||
160894383|NCT01278160|581008370|FG001|Overall Study|Adverse Event|1|||
160894384|NCT01278160|581008369|FG000|Overall Study|Lost to Follow-up|0|||
160796122|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
160796123|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
160894385|NCT01278160|581008370|FG001|Overall Study|Lost to Follow-up|1|||
160894386|NCT01278160|581008369|FG000|Overall Study|Withdrawal by Subject|3|||
160894387|NCT01278160|581008370|FG001|Overall Study|Withdrawal by Subject|2|||
160796124|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
160796125|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
160796126|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
160796127|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
160796128|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
160796129|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
160796130|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
160796131|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
160796132|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
160796133|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
160796134|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
160796135|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
160796136|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
160796137|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
160796138|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
160796139|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
160796140|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
160796141|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
160796142|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
160796143|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
160796144|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
160796145|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
160796146|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
160796147|NCT04392154|580641200|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
160796148|NCT04392154|580641201|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
160796149|NCT04392154|580641202|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
160796150|NCT04392154|580641203|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
160796151|NCT04392154|580641200|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
160796152|NCT04392154|580641201|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
160796153|NCT04392154|580641202|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
160796154|NCT04392154|580641203|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
160796155|NCT04392154|580641200|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
160796156|NCT04392154|580641201|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
160796157|NCT04392154|580641202|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
160796158|NCT04392154|580641203|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
160796159|NCT00023595|580641206|FG000|5 Year Follow up|Lost to Follow-up|2|||
160796160|NCT00023595|580641207|FG001|5 Year Follow up|Lost to Follow-up|2|||
160796161|NCT00023595|580641208|FG002|5 Year Follow up|Lost to Follow-up|1|||
160796162|NCT00023595|580641209|FG003|5 Year Follow up|Lost to Follow-up|7|||
160796163|NCT00023595|580641210|FG004|5 Year Follow up|Lost to Follow-up|3|||
160796164|NCT00023595|580641206|FG000|10 Year Follow up|Lost to Follow-up|12|||
160796165|NCT00023595|580641207|FG001|10 Year Follow up|Lost to Follow-up|10|||
160796166|NCT00023595|580641208|FG002|10 Year Follow up|Lost to Follow-up|3|||
160796167|NCT00023595|580641209|FG003|10 Year Follow up|Lost to Follow-up|0|||
160796168|NCT00023595|580641210|FG004|10 Year Follow up|Lost to Follow-up|0|||
160796169|NCT02231580|580641220|FG000|Overall Study|Adverse Event|5|||
160796170|NCT02231580|580641221|FG001|Overall Study|Adverse Event|0|||
160796171|NCT04144517|580641227|FG000|Overall Study|Physician Decision|0|||
160796172|NCT04144517|580641228|FG001|Overall Study|Physician Decision|1|||
160796173|NCT04144517|580641227|FG000|Overall Study|Other|2|||
160796174|NCT04144517|580641228|FG001|Overall Study|Other|2|||
160796175|NCT04144517|580641227|FG000|Overall Study|Death|6|||
160796176|NCT04144517|580641228|FG001|Overall Study|Death|3|||
160796177|NCT05212168|580641231|FG000|Overall Study|Lost to Follow-up|0|||
160796178|NCT05212168|580641232|FG001|Overall Study|Lost to Follow-up|3|||
160796179|NCT05212168|580641231|FG000|Overall Study|Study terminated by sponsor|30|||
160796180|NCT05212168|580641232|FG001|Overall Study|Study terminated by sponsor|27|||
160796181|NCT05212168|580641231|FG000|Overall Study|Other|4|||
160796182|NCT05212168|580641232|FG001|Overall Study|Other|7|||
160796183|NCT03557502|580641235|FG000|Protocol 2|Withdrawal by Subject|1|||
160796184|NCT03557502|580641236|FG001|Protocol 2|Withdrawal by Subject|1|||
160796185|NCT03557502|580641235|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
160796186|NCT03557502|580641236|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
160796187|NCT00618787|580641244|FG000|Overall Study|Adverse Event|0|||
160796188|NCT00618787|580641245|FG001|Overall Study|Adverse Event|1|||
160894388|NCT01278160|581008369|FG000|Overall Study|Unclassified|1|||
160643226|NCT01806597|580076532|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
160796189|NCT00618787|580641244|FG000|Overall Study|Withdrawal by Subject|2|||
160796190|NCT00618787|580641245|FG001|Overall Study|Withdrawal by Subject|1|||
160796191|NCT00618787|580641244|FG000|Overall Study|Lost to Follow-up|1|||
160796192|NCT00618787|580641245|FG001|Overall Study|Lost to Follow-up|0|||
160894389|NCT01278160|581008370|FG001|Overall Study|Unclassified|2|||
160643227|NCT01806597|580076533|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
160643228|NCT01806597|580076528|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
160643229|NCT01806597|580076529|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
160643230|NCT01806597|580076530|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
160643231|NCT01806597|580076531|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
160643232|NCT01806597|580076532|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
160643233|NCT01806597|580076533|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
160643234|NCT01806597|580076528|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
160643235|NCT01806597|580076529|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
160643236|NCT01806597|580076530|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
160643237|NCT01806597|580076531|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
160643238|NCT01806597|580076532|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
160643239|NCT01806597|580076533|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
160643240|NCT01806597|580076528|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
160643241|NCT01806597|580076529|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
160643242|NCT01806597|580076530|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
160643243|NCT01806597|580076531|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
160643244|NCT01806597|580076532|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
160643245|NCT01806597|580076533|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
160643246|NCT01806597|580076528|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
160643247|NCT01806597|580076529|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
160643248|NCT01806597|580076530|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
160643249|NCT01806597|580076531|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
160643250|NCT01806597|580076532|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
160643251|NCT01806597|580076533|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
160643252|NCT01806597|580076528|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
160643253|NCT01806597|580076529|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
160643254|NCT01806597|580076530|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
160643255|NCT01806597|580076531|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
160643256|NCT01806597|580076532|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
160643257|NCT01806597|580076533|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
160643258|NCT01144663|580076534|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
160643259|NCT01144663|580076535|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
160643260|NCT01144663|580076536|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
160643261|NCT01144663|580076537|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
160643262|NCT01144663|580076534|FG000|Primary Vaccination Phase|Adverse Event|1|||
160643263|NCT01144663|580076535|FG001|Primary Vaccination Phase|Adverse Event|0|||
160643264|NCT01144663|580076536|FG002|Primary Vaccination Phase|Adverse Event|0|||
160643265|NCT01144663|580076537|FG003|Primary Vaccination Phase|Adverse Event|1|||
160643266|NCT01144663|580076534|FG000|Primary Vaccination Phase|Protocol Violation|2|||
160643267|NCT01144663|580076535|FG001|Primary Vaccination Phase|Protocol Violation|0|||
160643268|NCT01144663|580076536|FG002|Primary Vaccination Phase|Protocol Violation|1|||
160643269|NCT01144663|580076537|FG003|Primary Vaccination Phase|Protocol Violation|0|||
160643270|NCT01144663|580076534|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
160643271|NCT01144663|580076535|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
160643272|NCT01144663|580076536|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
160643273|NCT01144663|580076537|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
160643274|NCT01144663|580076534|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
160643275|NCT01144663|580076535|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
160643276|NCT01144663|580076536|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
160643277|NCT01144663|580076537|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
160643278|NCT01144663|580076534|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
160643279|NCT01144663|580076535|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
160643280|NCT01144663|580076536|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
160643281|NCT01144663|580076537|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
160643282|NCT01144663|580076534|FG000|Primary Vaccination Phase|Other|0|||
160643283|NCT01144663|580076535|FG001|Primary Vaccination Phase|Other|1|||
160643284|NCT01144663|580076536|FG002|Primary Vaccination Phase|Other|0|||
160894390|NCT00304239|581008371|FG000|Overall Study|Protocol Deviations/Violations|15|||
160894391|NCT00304239|581008372|FG001|Overall Study|Protocol Deviations/Violations|0|||
160894392|NCT00304239|581008371|FG000|Overall Study|Adverse Event|2|||
160894393|NCT00304239|581008372|FG001|Overall Study|Adverse Event|0|||
160894394|NCT02979197|581008373|FG000|Overall Study|Adverse Event|4|||
160894395|NCT02979197|581008374|FG001|Overall Study|Adverse Event|2|||
160894396|NCT02979197|581008375|FG002|Overall Study|Adverse Event|0|||
160548774|NCT02889796|579736273|FG002|Overall Study|Investigator's Discretion|10|||
160548775|NCT02889796|579736274|FG003|Overall Study|Investigator's Discretion|3|||
160548776|NCT02889796|579736275|FG004|Overall Study|Investigator's Discretion|0|||
160548777|NCT02889796|579736276|FG005|Overall Study|Investigator's Discretion|15|||
160796193|NCT01107886|580641246|FG000|Overall Study|Lost to Follow-up|15|||
160548778|NCT02889796|579736271|FG000|Overall Study|Adverse Event|17|||
160548779|NCT02889796|579736272|FG001|Overall Study|Adverse Event|8|||
160548780|NCT02889796|579736273|FG002|Overall Study|Adverse Event|8|||
160548781|NCT02889796|579736274|FG003|Overall Study|Adverse Event|4|||
160548782|NCT02889796|579736275|FG004|Overall Study|Adverse Event|1|||
160548783|NCT02889796|579736276|FG005|Overall Study|Adverse Event|7|||
160548784|NCT02889796|579736271|FG000|Overall Study|Lost to Follow-up|5|||
160548785|NCT02889796|579736272|FG001|Overall Study|Lost to Follow-up|7|||
160548786|NCT02889796|579736273|FG002|Overall Study|Lost to Follow-up|2|||
160548787|NCT02889796|579736274|FG003|Overall Study|Lost to Follow-up|0|||
160548788|NCT02889796|579736275|FG004|Overall Study|Lost to Follow-up|2|||
160548789|NCT02889796|579736276|FG005|Overall Study|Lost to Follow-up|6|||
160548790|NCT02889796|579736271|FG000|Overall Study|Protocol Violation|0|||
160548791|NCT02889796|579736272|FG001|Overall Study|Protocol Violation|1|||
160548792|NCT02889796|579736273|FG002|Overall Study|Protocol Violation|3|||
160548793|NCT02889796|579736274|FG003|Overall Study|Protocol Violation|0|||
160548794|NCT02889796|579736275|FG004|Overall Study|Protocol Violation|0|||
160548795|NCT02889796|579736276|FG005|Overall Study|Protocol Violation|4|||
160548796|NCT02889796|579736271|FG000|Overall Study|Non-compliance With Study Drug|0|||
160548797|NCT02889796|579736272|FG001|Overall Study|Non-compliance With Study Drug|2|||
160548798|NCT02889796|579736273|FG002|Overall Study|Non-compliance With Study Drug|0|||
160548799|NCT02889796|579736274|FG003|Overall Study|Non-compliance With Study Drug|0|||
160548800|NCT02889796|579736275|FG004|Overall Study|Non-compliance With Study Drug|1|||
160548801|NCT02889796|579736276|FG005|Overall Study|Non-compliance With Study Drug|2|||
160548802|NCT02889796|579736271|FG000|Overall Study|Death|1|||
160548803|NCT02889796|579736272|FG001|Overall Study|Death|1|||
160548804|NCT02889796|579736273|FG002|Overall Study|Death|0|||
160548805|NCT02889796|579736274|FG003|Overall Study|Death|1|||
160548806|NCT02889796|579736275|FG004|Overall Study|Death|0|||
160548807|NCT02889796|579736276|FG005|Overall Study|Death|1|||
160548808|NCT02889796|579736271|FG000|Overall Study|Pregnancy|0|||
160548809|NCT02889796|579736272|FG001|Overall Study|Pregnancy|1|||
160548810|NCT02889796|579736273|FG002|Overall Study|Pregnancy|1|||
160548811|NCT02889796|579736274|FG003|Overall Study|Pregnancy|0|||
160548812|NCT02889796|579736275|FG004|Overall Study|Pregnancy|0|||
160548813|NCT02889796|579736276|FG005|Overall Study|Pregnancy|0|||
160548814|NCT02889796|579736271|FG000|Overall Study|Randomized but not Dosed|2|||
160548815|NCT02889796|579736272|FG001|Overall Study|Randomized but not Dosed|0|||
160548816|NCT02889796|579736273|FG002|Overall Study|Randomized but not Dosed|0|||
160548817|NCT02889796|579736274|FG003|Overall Study|Randomized but not Dosed|0|||
160548818|NCT02889796|579736275|FG004|Overall Study|Randomized but not Dosed|0|||
160548819|NCT02889796|579736276|FG005|Overall Study|Randomized but not Dosed|2|||
160548820|NCT04294459|579736277|FG000|Overall Study|Adverse Event|0|||
160548821|NCT04294459|579736278|FG001|Overall Study|Adverse Event|1|||
160548822|NCT02787863|579736279|FG000|Overall Study|Death|1|||
160548823|NCT02787863|579736280|FG001|Overall Study|Death|0|||
160548824|NCT02787863|579736281|FG002|Overall Study|Death|1|||
160548825|NCT02787863|579736282|FG003|Overall Study|Death|0|||
160548826|NCT02787863|579736283|FG004|Overall Study|Death|0|||
160548827|NCT02787863|579736284|FG005|Overall Study|Death|0|||
160548828|NCT02787863|579736285|FG006|Overall Study|Death|0|||
160548829|NCT02787863|579736286|FG007|Overall Study|Death|0|||
160548830|NCT02787863|579736279|FG000|Overall Study|Withdrawal by Subject|0|||
160548831|NCT02787863|579736280|FG001|Overall Study|Withdrawal by Subject|1|||
160548832|NCT02787863|579736281|FG002|Overall Study|Withdrawal by Subject|1|||
160548833|NCT02787863|579736282|FG003|Overall Study|Withdrawal by Subject|0|||
160548834|NCT02787863|579736283|FG004|Overall Study|Withdrawal by Subject|0|||
160548835|NCT02787863|579736284|FG005|Overall Study|Withdrawal by Subject|0|||
160548836|NCT02787863|579736285|FG006|Overall Study|Withdrawal by Subject|0|||
160548837|NCT02787863|579736286|FG007|Overall Study|Withdrawal by Subject|0|||
160548838|NCT01414257|579736287|FG000|Overall Study|No Visit After First Day of Treatment|12|||
160548839|NCT01414257|579736287|FG000|Overall Study|Protocol Violation|10|||
160548840|NCT02479802|579736288|FG000|Overall Study|Lost to Follow-up|1|||
160548841|NCT02479802|579736288|FG000|Overall Study|Adverse Event|1|||
160796194|NCT01107886|580641247|FG001|Overall Study|Lost to Follow-up|13|||
160548842|NCT02421887|579736289|FG000|Overall Study|Lost to Follow-up|5|||
160548843|NCT02421887|579736290|FG001|Overall Study|Lost to Follow-up|0|||
160548844|NCT02421887|579736289|FG000|Overall Study|Withdrawal by Subject|8|||
160548845|NCT02421887|579736290|FG001|Overall Study|Withdrawal by Subject|5|||
160548846|NCT02421887|579736289|FG000|Overall Study|Physician Decision|2|||
160548847|NCT02421887|579736290|FG001|Overall Study|Physician Decision|4|||
160548848|NCT02421887|579736289|FG000|Overall Study|Adverse Event|2|||
160548849|NCT02421887|579736290|FG001|Overall Study|Adverse Event|0|||
160548850|NCT01882907|579736291|FG000|Overall Study|Adverse Event|3|||
160548851|NCT01882907|579736292|FG001|Overall Study|Adverse Event|1|||
160796195|NCT01107886|580641246|FG000|Overall Study|Withdrawal by Subject|180|||
160796196|NCT01107886|580641247|FG001|Overall Study|Withdrawal by Subject|196|||
160796197|NCT01107886|580641246|FG000|Overall Study|Administrative withdrawal of consent|7|||
160796198|NCT01107886|580641247|FG001|Overall Study|Administrative withdrawal of consent|5|||
160796199|NCT01346176|580641248|FG000|Recruited|Protocol Violation|1|||
160796200|NCT01346176|580641249|FG001|Recruited|Protocol Violation|0|||
160796201|NCT01346176|580641250|FG002|Recruited|Protocol Violation|0|||
160796202|NCT01346176|580641248|FG000|Completed Advance Directive|Death|3|||
160796203|NCT01346176|580641249|FG001|Completed Advance Directive|Death|2|||
160796204|NCT01346176|580641250|FG002|Completed Advance Directive|Death|2|||
160796205|NCT01346176|580641248|FG000|Completed Advance Directive|Became Ineligible|3|||
160796206|NCT01346176|580641249|FG001|Completed Advance Directive|Became Ineligible|0|||
160796207|NCT01346176|580641250|FG002|Completed Advance Directive|Became Ineligible|1|||
160796208|NCT01346176|580641248|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
160796209|NCT01346176|580641249|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
160796210|NCT01346176|580641250|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
160796211|NCT01346176|580641248|FG000|Completed Satisfaction Survey|Death|3|||
160796212|NCT01346176|580641249|FG001|Completed Satisfaction Survey|Death|0|||
160796213|NCT01346176|580641250|FG002|Completed Satisfaction Survey|Death|2|||
160796214|NCT01346176|580641248|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
160796215|NCT01346176|580641249|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
160796216|NCT01346176|580641250|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
160796217|NCT01994876|580641251|FG000|Test Period 1|Withdrawal by Subject|0|||
160796218|NCT01994876|580641252|FG001|Test Period 1|Withdrawal by Subject|1|||
160796219|NCT01994876|580641251|FG000|Test Period 1|Adverse Event|0|||
160796220|NCT01994876|580641252|FG001|Test Period 1|Adverse Event|1|||
160796221|NCT01994876|580641251|FG000|Test Period 2|Adverse Event|1|||
160796222|NCT01994876|580641252|FG001|Test Period 2|Adverse Event|0|||
160796223|NCT01994876|580641251|FG000|Test Period 2|Protocol Violation|0|||
160796224|NCT01994876|580641252|FG001|Test Period 2|Protocol Violation|1|||
160796225|NCT05819398|580641253|FG000|Overall Study|Withdrawal by Subject|11|||
160796226|NCT05819398|580641254|FG001|Overall Study|Withdrawal by Subject|7|||
160796227|NCT05819398|580641255|FG002|Overall Study|Withdrawal by Subject|6|||
160796228|NCT05819398|580641256|FG003|Overall Study|Withdrawal by Subject|6|||
160796229|NCT05819398|580641253|FG000|Overall Study|Lost to Follow-up|0|||
160796230|NCT05819398|580641254|FG001|Overall Study|Lost to Follow-up|2|||
160796231|NCT05819398|580641255|FG002|Overall Study|Lost to Follow-up|0|||
160796232|NCT05819398|580641256|FG003|Overall Study|Lost to Follow-up|1|||
160796233|NCT05819398|580641253|FG000|Overall Study|Adverse Event|1|||
160796234|NCT05819398|580641254|FG001|Overall Study|Adverse Event|3|||
160894397|NCT02979197|581008373|FG000|Overall Study|Protocol Violation|0|||
160894398|NCT02979197|581008374|FG001|Overall Study|Protocol Violation|1|||
160894399|NCT02979197|581008375|FG002|Overall Study|Protocol Violation|0|||
160894400|NCT02979197|581008373|FG000|Overall Study|Subject unable to commit to study dates|0|||
160894401|NCT02979197|581008374|FG001|Overall Study|Subject unable to commit to study dates|1|||
160894402|NCT02979197|581008375|FG002|Overall Study|Subject unable to commit to study dates|0|||
160894403|NCT02435069|581008376|FG000|Dose Response - First Intervention|Adverse Event|0|||
160894404|NCT02435069|581008377|FG001|Dose Response - First Intervention|Adverse Event|1|||
160894405|NCT02435069|581008378|FG002|Dose Response - First Intervention|Adverse Event|1|||
160894406|NCT02435069|581008379|FG003|Dose Response - First Intervention|Adverse Event|0|||
160894407|NCT02435069|581008380|FG004|Dose Response - First Intervention|Adverse Event|0|||
160894408|NCT02435069|581008376|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
160894409|NCT02435069|581008377|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
160894410|NCT02435069|581008378|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
160894411|NCT02435069|581008379|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
160894412|NCT02435069|581008380|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
160894413|NCT03112590|581008381|FG000|Overall Study|Adverse Event|0|||
160894414|NCT03112590|581008382|FG001|Overall Study|Adverse Event|1|||
160894415|NCT03112590|581008383|FG002|Overall Study|Adverse Event|0|||
160894416|NCT02436681|581008384|FG000|Overall Study|Lost to Follow-up|10|||
160894417|NCT02436681|581008384|FG000|Overall Study|Withdrawal by Subject|2|||
160894418|NCT02436681|581008384|FG000|Overall Study|Death|2|||
160894419|NCT03148275|581008391|FG000|Overall Study|Death|6|||
160983540|NCT02611830|581328661|FG000|OL Induction Phase|Reason not specified|3|||
160983541|NCT02611830|581328662|FG001|OL Induction Phase|Reason not specified|0|||
160983542|NCT02611830|581328663|FG002|OL Induction Phase|Reason not specified|0|||
160548852|NCT01882907|579736291|FG000|Overall Study|Lack of Efficacy|0|||
160796235|NCT05819398|580641255|FG002|Overall Study|Adverse Event|4|||
160796236|NCT05819398|580641256|FG003|Overall Study|Adverse Event|5|||
160796237|NCT05819398|580641253|FG000|Overall Study|Other than listed|0|||
160796238|NCT05819398|580641254|FG001|Overall Study|Other than listed|2|||
160796239|NCT05819398|580641255|FG002|Overall Study|Other than listed|2|||
160894420|NCT03148275|581008391|FG000|Overall Study|Adverse Event|3|||
160894421|NCT03148275|581008391|FG000|Overall Study|Liver transplant|2|||
160894422|NCT03148275|581008391|FG000|Overall Study|Patient decision|5|||
160894423|NCT03148275|581008391|FG000|Overall Study|transition to commercial drug|1|||
160894424|NCT03148275|581008391|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
160894425|NCT05098938|581008392|FG000|Overall Study|Adverse Event|4|||
160894426|NCT05098938|581008393|FG001|Overall Study|Adverse Event|3|||
160894427|NCT05098938|581008392|FG000|Overall Study|inclusion/exclusion criteria change|11|||
160894428|NCT05098938|581008393|FG001|Overall Study|inclusion/exclusion criteria change|5|||
160894429|NCT05098938|581008392|FG000|Overall Study|lack of compliance|26|||
160894430|NCT05098938|581008393|FG001|Overall Study|lack of compliance|19|||
160894431|NCT05098938|581008392|FG000|Overall Study|Lost to Follow-up|37|||
160894432|NCT05098938|581008393|FG001|Overall Study|Lost to Follow-up|40|||
160894433|NCT05098938|581008392|FG000|Overall Study|Lost in treatment period|17|||
160894434|NCT05098938|581008393|FG001|Overall Study|Lost in treatment period|13|||
160894435|NCT05098938|581008392|FG000|Overall Study|Met an exclusion criterion|0|||
160894436|NCT05098938|581008393|FG001|Overall Study|Met an exclusion criterion|3|||
160894437|NCT05098938|581008392|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
160894438|NCT05098938|581008393|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
160894439|NCT05098938|581008392|FG000|Overall Study|Physician Decision|25|||
160894440|NCT05098938|581008393|FG001|Overall Study|Physician Decision|32|||
160894441|NCT05098938|581008392|FG000|Overall Study|Run in failure in treatment phase|1|||
160894442|NCT05098938|581008393|FG001|Overall Study|Run in failure in treatment phase|1|||
160894443|NCT05098938|581008392|FG000|Overall Study|Withdrawal by Subject|0|||
160894444|NCT05098938|581008393|FG001|Overall Study|Withdrawal by Subject|3|||
160894445|NCT05098938|581008392|FG000|Overall Study|Run-in Failure in early study|505|||
160894446|NCT05098938|581008393|FG001|Overall Study|Run-in Failure in early study|514|||
160894447|NCT05098938|581008392|FG000|Overall Study|IMP delivery missed|1|||
160894448|NCT05098938|581008393|FG001|Overall Study|IMP delivery missed|5|||
160894449|NCT05098938|581008392|FG000|Overall Study|6 months visit was missed|2|||
160894450|NCT05098938|581008393|FG001|Overall Study|6 months visit was missed|0|||
160894451|NCT05098938|581008392|FG000|Overall Study|fit for use was not completed within window|3|||
160894452|NCT05098938|581008393|FG001|Overall Study|fit for use was not completed within window|0|||
160894453|NCT05098938|581008392|FG000|Overall Study|V2 visit was not completed within window|0|||
160894454|NCT05098938|581008393|FG001|Overall Study|V2 visit was not completed within window|1|||
160894455|NCT05098938|581008392|FG000|Overall Study|exclusionary medication use|1|||
160894456|NCT05098938|581008393|FG001|Overall Study|exclusionary medication use|2|||
160894457|NCT05098938|581008392|FG000|Overall Study|change in medication|1|||
160894458|NCT05098938|581008393|FG001|Overall Study|change in medication|0|||
160894459|NCT05098938|581008392|FG000|Overall Study|treatment failure|2|||
160894460|NCT05098938|581008393|FG001|Overall Study|treatment failure|1|||
160894461|NCT01828320|581008394|FG000|Overall Study|Lost to Follow-up|1|||
160548853|NCT01882907|579736292|FG001|Overall Study|Lack of Efficacy|3|||
160548854|NCT01882907|579736291|FG000|Overall Study|Lost to Follow-up|1|||
160548855|NCT01882907|579736292|FG001|Overall Study|Lost to Follow-up|4|||
160548856|NCT01882907|579736291|FG000|Overall Study|Protocol Violation|10|||
160548857|NCT01882907|579736292|FG001|Overall Study|Protocol Violation|14|||
160548858|NCT01882907|579736291|FG000|Overall Study|Withdrawal by Subject|0|||
160548859|NCT01882907|579736292|FG001|Overall Study|Withdrawal by Subject|6|||
160548860|NCT01978093|579736293|FG000|Overall Study|Death|1|||
160548861|NCT01978093|579736294|FG001|Overall Study|Death|0|||
160548862|NCT01978093|579736293|FG000|Overall Study|Adverse Event|0|||
160548863|NCT01978093|579736294|FG001|Overall Study|Adverse Event|5|||
160548864|NCT01978093|579736293|FG000|Overall Study|Protocol Violation|8|||
160548865|NCT01978093|579736294|FG001|Overall Study|Protocol Violation|2|||
160548866|NCT01978093|579736293|FG000|Overall Study|Withdrawal by Subject|29|||
160548867|NCT01978093|579736294|FG001|Overall Study|Withdrawal by Subject|25|||
160548868|NCT01978093|579736293|FG000|Overall Study|Lost to Follow-up|11|||
160548869|NCT01978093|579736294|FG001|Overall Study|Lost to Follow-up|15|||
160548870|NCT01978093|579736293|FG000|Overall Study|Migrated/moved from study area|11|||
160548871|NCT01978093|579736294|FG001|Overall Study|Migrated/moved from study area|13|||
160548872|NCT01978093|579736293|FG000|Overall Study|Loss of kaiser coverage|4|||
160548873|NCT01978093|579736294|FG001|Overall Study|Loss of kaiser coverage|10|||
160548874|NCT01978093|579736293|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
160548875|NCT01978093|579736294|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
160548876|NCT01978093|579736293|FG000|Overall Study|Mother lost custody of child|0|||
160548877|NCT01978093|579736294|FG001|Overall Study|Mother lost custody of child|1|||
160796240|NCT05819398|580641256|FG003|Overall Study|Other than listed|0|||
160796241|NCT05819398|580641253|FG000|Overall Study|Lack of Efficacy|0|||
160796242|NCT05819398|580641254|FG001|Overall Study|Lack of Efficacy|1|||
160796243|NCT05819398|580641255|FG002|Overall Study|Lack of Efficacy|0|||
160796244|NCT05819398|580641256|FG003|Overall Study|Lack of Efficacy|0|||
160796245|NCT05819398|580641253|FG000|Overall Study|Study terminated by sponsor|20|||
160796246|NCT05819398|580641254|FG001|Overall Study|Study terminated by sponsor|18|||
160796247|NCT05819398|580641255|FG002|Overall Study|Study terminated by sponsor|20|||
160796248|NCT05819398|580641256|FG003|Overall Study|Study terminated by sponsor|22|||
160894462|NCT01828320|581008395|FG001|Overall Study|Lost to Follow-up|3|||
160894463|NCT01828320|581008394|FG000|Overall Study|Withdrawal by Subject|7|||
160894464|NCT01828320|581008395|FG001|Overall Study|Withdrawal by Subject|2|||
160894465|NCT01397162|581010809|FG000|Overall Study|Adverse Event|4|||
160894466|NCT01397162|581010810|FG001|Overall Study|Adverse Event|0|||
160894467|NCT01397162|581010811|FG002|Overall Study|Adverse Event|0|||
160894468|NCT01397162|581010812|FG003|Overall Study|Adverse Event|0|||
160894469|NCT01397162|581010813|FG004|Overall Study|Adverse Event|0|||
160548878|NCT01978093|579736293|FG000|Overall Study|Child was in care of grandmother|0|||
160548879|NCT01978093|579736294|FG001|Overall Study|Child was in care of grandmother|1|||
160548880|NCT01978093|579736293|FG000|Overall Study|N/A for vaccine administration|0|||
160548881|NCT01978093|579736294|FG001|Overall Study|N/A for vaccine administration|1|||
160548882|NCT02162732|579736299|FG000|Overall Study|Biopsy not performed.|18|||
160548883|NCT01784965|579736300|FG000|Overall Study|Withdrawal by Subject|6|||
160548884|NCT01784965|579736301|FG001|Overall Study|Withdrawal by Subject|3|||
160548885|NCT01784965|579736300|FG000|Overall Study|Adverse Event|0|||
160548886|NCT01784965|579736301|FG001|Overall Study|Adverse Event|8|||
160548887|NCT03757988|579736304|FG000|Overall Study|Withdrawal by Subject|1|||
160548888|NCT05587296|579736305|FG000|Overall Study|Adverse Event|15|||
160548889|NCT05587296|579736306|FG001|Overall Study|Adverse Event|7|||
160548890|NCT05587296|579736305|FG000|Overall Study|Lack of Efficacy|2|||
160548891|NCT05587296|579736306|FG001|Overall Study|Lack of Efficacy|0|||
160548892|NCT05587296|579736305|FG000|Overall Study|Lost to Follow-up|1|||
160548893|NCT05587296|579736306|FG001|Overall Study|Lost to Follow-up|0|||
160548894|NCT05587296|579736305|FG000|Overall Study|Withdrawal by Subject|14|||
160548895|NCT05587296|579736306|FG001|Overall Study|Withdrawal by Subject|4|||
160548896|NCT05587296|579736305|FG000|Overall Study|miscellaneous|3|||
160548897|NCT05587296|579736306|FG001|Overall Study|miscellaneous|6|||
160548898|NCT05587296|579736305|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
160548899|NCT05587296|579736306|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
160548900|NCT00927095|579736309|FG000|Overall Study|Adverse Event|3|||
160548901|NCT00927095|579736310|FG001|Overall Study|Adverse Event|1|||
160548902|NCT00927095|579736311|FG002|Overall Study|Adverse Event|0|||
160548903|NCT00927095|579736309|FG000|Overall Study|Withdrawal by Subject|2|||
160548904|NCT00927095|579736310|FG001|Overall Study|Withdrawal by Subject|1|||
160548905|NCT00927095|579736311|FG002|Overall Study|Withdrawal by Subject|1|||
160548906|NCT00927095|579736309|FG000|Overall Study|Physician Decision|1|||
160548907|NCT00927095|579736310|FG001|Overall Study|Physician Decision|2|||
160548908|NCT00927095|579736311|FG002|Overall Study|Physician Decision|1|||
160548909|NCT03403205|579736318|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
160548910|NCT03403205|579736319|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
160548911|NCT03403205|579736320|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
160548912|NCT03403205|579736321|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
160548913|NCT03403205|579736322|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
160548914|NCT03403205|579736323|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
160548915|NCT03403205|579736318|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
160548916|NCT03403205|579736319|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
160548917|NCT03403205|579736320|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
160548918|NCT03403205|579736321|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
160548919|NCT03403205|579736322|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
160548920|NCT03403205|579736323|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
160548921|NCT03403205|579736318|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
160548922|NCT03403205|579736319|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
160548923|NCT03403205|579736320|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
160548924|NCT03403205|579736321|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
160548925|NCT03403205|579736322|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
160548926|NCT03403205|579736323|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
160643285|NCT01144663|580076537|FG003|Primary Vaccination Phase|Other|2|||
160796249|NCT02520154|580641257|FG000|Overall Study|Death|1|||
160796250|NCT02520154|580641257|FG000|Overall Study|Withdrawal by Subject|2|||
160796251|NCT02520154|580641257|FG000|Overall Study|Physician Decision|2|||
160796252|NCT06022107|580641258|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
160796253|NCT06022107|580641258|FG000|Overall Study|Dropped out of study for higher level of care|1|||
160894470|NCT01397162|581010809|FG000|Overall Study|Not yet defined|3|||
160796254|NCT06022107|580641258|FG000|Overall Study|Lost to Follow-up|2|||
160796255|NCT05943990|580641259|FG000|Overall Study|Study Terminated by Sponsor|0|||
160796256|NCT05943990|580641260|FG001|Overall Study|Study Terminated by Sponsor|0|||
160796257|NCT05943990|580641261|FG002|Overall Study|Study Terminated by Sponsor|1|||
160796258|NCT02333799|580643563|FG000|Treatment Period|Withdrawal by Subject|1|||
160796259|NCT02333799|580643563|FG000|Treatment Period|Death|6|||
160796260|NCT02333799|580643563|FG000|6 Month Follow Up Period|Physician Decision|1|||
160796261|NCT02333799|580643563|FG000|6 Month Follow Up Period|Death|1|||
160796262|NCT02333799|580643563|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
160796263|NCT02333799|580643563|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
160796264|NCT05847686|580643564|FG000|Overall Study|Withdrawal by Subject|3|||
160796265|NCT03716830|580643565|FG000|Overall Study|Withdrawal by Subject|2|||
160796266|NCT03716830|580643566|FG001|Overall Study|Withdrawal by Subject|2|||
160548927|NCT03403205|579736318|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
160796267|NCT03716830|580643567|FG002|Overall Study|Withdrawal by Subject|6|||
160796268|NCT03716830|580643568|FG003|Overall Study|Withdrawal by Subject|5|||
160796269|NCT03716830|580643565|FG000|Overall Study|Adverse Event|1|||
160796270|NCT03716830|580643566|FG001|Overall Study|Adverse Event|2|||
160796271|NCT03716830|580643567|FG002|Overall Study|Adverse Event|0|||
160796272|NCT03716830|580643568|FG003|Overall Study|Adverse Event|1|||
160796273|NCT03716830|580643565|FG000|Overall Study|Lost to Follow-up|1|||
160796274|NCT03716830|580643566|FG001|Overall Study|Lost to Follow-up|1|||
160796275|NCT03716830|580643567|FG002|Overall Study|Lost to Follow-up|0|||
160796276|NCT03716830|580643568|FG003|Overall Study|Lost to Follow-up|0|||
160796277|NCT04887831|580643570|FG000|Overall Study|Death|26|||
160796278|NCT04887831|580643571|FG001|Overall Study|Death|26|||
160796279|NCT04887831|580643570|FG000|Overall Study|Lost to Follow-up|0|||
160796280|NCT04887831|580643571|FG001|Overall Study|Lost to Follow-up|1|||
160796281|NCT04887831|580643570|FG000|Overall Study|Withdrawal by Subject|2|||
160796282|NCT04887831|580643571|FG001|Overall Study|Withdrawal by Subject|1|||
160796283|NCT04887831|580643570|FG000|Overall Study|Study Terminated by Sponsor|18|||
160796284|NCT04887831|580643571|FG001|Overall Study|Study Terminated by Sponsor|17|||
160796285|NCT04887831|580643570|FG000|Overall Study|Other|1|||
160796286|NCT04887831|580643571|FG001|Overall Study|Other|0|||
160796287|NCT02276040|580643574|FG000|Overall Study|Physician Decision|15|||
160796288|NCT03674281|580643575|FG000|Overall Study|screen failure|2|||
160796289|NCT03674281|580643576|FG001|Overall Study|screen failure|0|||
160796290|NCT03674281|580643577|FG002|Overall Study|screen failure|0|||
160796291|NCT03674281|580643575|FG000|Overall Study|Withdrawal by Subject|1|||
160796292|NCT03674281|580643576|FG001|Overall Study|Withdrawal by Subject|3|||
160796293|NCT03674281|580643577|FG002|Overall Study|Withdrawal by Subject|3|||
160796294|NCT04622592|580643578|FG000|Overall Study|Death|0|||
160796295|NCT04622592|580643579|FG001|Overall Study|Death|0|||
160796296|NCT04622592|580643580|FG002|Overall Study|Death|1|||
160796297|NCT04622592|580643581|FG003|Overall Study|Death|0|||
160796298|NCT04622592|580643582|FG004|Overall Study|Death|0|||
160796299|NCT04622592|580643583|FG005|Overall Study|Death|0|||
160796300|NCT04622592|580643584|FG006|Overall Study|Death|0|||
160796301|NCT04622592|580643585|FG007|Overall Study|Death|1|||
160796302|NCT04622592|580643578|FG000|Overall Study|Lost to Follow-up|0|||
160796303|NCT04622592|580643579|FG001|Overall Study|Lost to Follow-up|0|||
160796304|NCT04622592|580643580|FG002|Overall Study|Lost to Follow-up|0|||
160796305|NCT04622592|580643581|FG003|Overall Study|Lost to Follow-up|3|||
160796306|NCT04622592|580643582|FG004|Overall Study|Lost to Follow-up|1|||
160796307|NCT04622592|580643583|FG005|Overall Study|Lost to Follow-up|0|||
160548928|NCT03403205|579736319|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
160796308|NCT04622592|580643584|FG006|Overall Study|Lost to Follow-up|2|||
160796309|NCT04622592|580643585|FG007|Overall Study|Lost to Follow-up|2|||
160796310|NCT04622592|580643578|FG000|Overall Study|Physician Decision|0|||
160796311|NCT04622592|580643579|FG001|Overall Study|Physician Decision|0|||
160796312|NCT04622592|580643580|FG002|Overall Study|Physician Decision|0|||
160796313|NCT04622592|580643581|FG003|Overall Study|Physician Decision|0|||
160796314|NCT04622592|580643582|FG004|Overall Study|Physician Decision|1|||
160796315|NCT04622592|580643583|FG005|Overall Study|Physician Decision|0|||
160796316|NCT04622592|580643584|FG006|Overall Study|Physician Decision|0|||
160796317|NCT04622592|580643585|FG007|Overall Study|Physician Decision|0|||
160548929|NCT03403205|579736320|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
160796318|NCT04622592|580643578|FG000|Overall Study|Withdrawal by Subject|1|||
160796319|NCT04622592|580643579|FG001|Overall Study|Withdrawal by Subject|0|||
160894471|NCT01397162|581010810|FG001|Overall Study|Not yet defined|4|||
160894472|NCT01397162|581010811|FG002|Overall Study|Not yet defined|3|||
160796320|NCT04622592|580643580|FG002|Overall Study|Withdrawal by Subject|2|||
160796321|NCT04622592|580643581|FG003|Overall Study|Withdrawal by Subject|0|||
160796322|NCT04622592|580643582|FG004|Overall Study|Withdrawal by Subject|0|||
160796323|NCT04622592|580643583|FG005|Overall Study|Withdrawal by Subject|0|||
160796324|NCT04622592|580643584|FG006|Overall Study|Withdrawal by Subject|1|||
160796325|NCT04622592|580643585|FG007|Overall Study|Withdrawal by Subject|4|||
160796326|NCT04622592|580643578|FG000|Overall Study|Other than specified above|0|||
160894473|NCT01397162|581010812|FG003|Overall Study|Not yet defined|5|||
160796327|NCT04622592|580643579|FG001|Overall Study|Other than specified above|0|||
160796328|NCT04622592|580643580|FG002|Overall Study|Other than specified above|1|||
160796329|NCT04622592|580643581|FG003|Overall Study|Other than specified above|0|||
160796330|NCT04622592|580643582|FG004|Overall Study|Other than specified above|0|||
160796331|NCT04622592|580643583|FG005|Overall Study|Other than specified above|0|||
160796332|NCT04622592|580643584|FG006|Overall Study|Other than specified above|0|||
160796333|NCT04622592|580643585|FG007|Overall Study|Other than specified above|0|||
160796334|NCT00276419|580643588|FG000|First Intervention|Adverse Event|1|||
160796335|NCT00276419|580643589|FG001|First Intervention|Adverse Event|0|||
160796336|NCT00276419|580643588|FG000|First Intervention|Withdrawal by Subject|0|||
160796337|NCT00276419|580643589|FG001|First Intervention|Withdrawal by Subject|2|||
160796338|NCT01645176|580643594|FG000|Overall Study|Lack of Efficacy|4|||
160796339|NCT01645176|580643594|FG000|Overall Study|did not complete final MRI|1|||
160796340|NCT02569853|580643595|FG000|Overall Study|Adverse Event|2|||
160796341|NCT02569853|580643596|FG001|Overall Study|Adverse Event|0|||
160796342|NCT02569853|580643595|FG000|Overall Study|Withdrawal by Subject|3|||
160796343|NCT02569853|580643596|FG001|Overall Study|Withdrawal by Subject|2|||
160796344|NCT02569853|580643595|FG000|Overall Study|Lost to Follow-up|3|||
160796345|NCT02569853|580643596|FG001|Overall Study|Lost to Follow-up|3|||
160796346|NCT02569853|580643595|FG000|Overall Study|Protocol Violation|1|||
160796347|NCT02569853|580643596|FG001|Overall Study|Protocol Violation|1|||
160796348|NCT02569853|580643595|FG000|Overall Study|Did not experience migraine attack|10|||
160796349|NCT02569853|580643596|FG001|Overall Study|Did not experience migraine attack|7|||
160796350|NCT02569853|580643595|FG000|Overall Study|Physician Decision|1|||
160796351|NCT02569853|580643596|FG001|Overall Study|Physician Decision|1|||
160796352|NCT00402987|580643597|FG000|Overall Study|Lack of Efficacy|0|||
160796353|NCT00402987|580643598|FG001|Overall Study|Lack of Efficacy|0|||
160796354|NCT00402987|580643599|FG002|Overall Study|Lack of Efficacy|1|||
160796355|NCT00402987|580643600|FG003|Overall Study|Lack of Efficacy|0|||
160796356|NCT01668004|580643601|FG000|Overall Study|Adverse Event|7|||
160796357|NCT01668004|580643601|FG000|Overall Study|Withdrawal by Subject|2|||
160796358|NCT01668004|580643601|FG000|Overall Study|Lost to Follow-up|5|||
160796359|NCT01668004|580643601|FG000|Overall Study|Lack of Efficacy|9|||
160796360|NCT01668004|580643601|FG000|Overall Study|Non-compliance with treatment|2|||
160796361|NCT02448381|580643603|FG000|Overall Study|Adverse Event|2|||
160796362|NCT02448381|580643604|FG001|Overall Study|Adverse Event|0|||
160796363|NCT02448381|580643603|FG000|Overall Study|Lost to Follow-up|16|||
160796364|NCT02448381|580643604|FG001|Overall Study|Lost to Follow-up|9|||
160796365|NCT02448381|580643603|FG000|Overall Study|Physician Decision|1|||
160796366|NCT02448381|580643604|FG001|Overall Study|Physician Decision|1|||
160796367|NCT02448381|580643603|FG000|Overall Study|Pregnancy|1|||
160796368|NCT02448381|580643604|FG001|Overall Study|Pregnancy|0|||
160796369|NCT02448381|580643603|FG000|Overall Study|Withdrawal by Subject|13|||
160796370|NCT02448381|580643604|FG001|Overall Study|Withdrawal by Subject|9|||
160796371|NCT02448381|580643603|FG000|Overall Study|Noncompliance with Study Procedures|2|||
160796372|NCT02448381|580643604|FG001|Overall Study|Noncompliance with Study Procedures|0|||
160796373|NCT02300233|580643610|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
160796374|NCT02300233|580643611|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
160796375|NCT02300233|580643612|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
160796376|NCT02300233|580643610|FG000|Overall Study|Withdrawal by Subject|1|||
160796377|NCT02300233|580643611|FG001|Overall Study|Withdrawal by Subject|0|||
160796378|NCT02300233|580643612|FG002|Overall Study|Withdrawal by Subject|3|||
160796379|NCT02300233|580643610|FG000|Overall Study|Investigator Judgement|0|||
160796380|NCT02300233|580643611|FG001|Overall Study|Investigator Judgement|0|||
160796381|NCT02300233|580643612|FG002|Overall Study|Investigator Judgement|1|||
160796382|NCT02300233|580643610|FG000|Overall Study|Reason Not Specified|0|||
160796383|NCT02300233|580643611|FG001|Overall Study|Reason Not Specified|0|||
160796384|NCT02300233|580643612|FG002|Overall Study|Reason Not Specified|5|||
160796385|NCT00833690|580643613|FG000|Overall Study|Withdrawal by Subject|1|||
160796386|NCT00833690|580643614|FG001|Overall Study|Withdrawal by Subject|0|||
160796387|NCT00833690|580643615|FG002|Overall Study|Withdrawal by Subject|0|||
160796388|NCT00833690|580643613|FG000|Overall Study|Discontinued study drug|3|||
160796389|NCT00833690|580643614|FG001|Overall Study|Discontinued study drug|2|||
160796390|NCT00833690|580643615|FG002|Overall Study|Discontinued study drug|0|||
160796391|NCT00744861|580643616|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
160796392|NCT00744861|580643617|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
160796393|NCT00744861|580643618|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
160796394|NCT00744861|580643619|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
160796395|NCT00744861|580643616|FG000|Feasibility Stage 1|Pregnancy|0|||
160796396|NCT00744861|580643617|FG001|Feasibility Stage 1|Pregnancy|1|||
160796397|NCT00744861|580643618|FG002|Feasibility Stage 1|Pregnancy|0|||
160796398|NCT00744861|580643619|FG003|Feasibility Stage 1|Pregnancy|0|||
160796399|NCT00744861|580643616|FG000|Pivotal Stage 2|Adverse Event|0|||
160796400|NCT00744861|580643617|FG001|Pivotal Stage 2|Adverse Event|0|||
160796401|NCT00744861|580643618|FG002|Pivotal Stage 2|Adverse Event|6|||
160796402|NCT00744861|580643619|FG003|Pivotal Stage 2|Adverse Event|11|||
160796403|NCT00744861|580643616|FG000|Pivotal Stage 2|Death|0|||
160796404|NCT00744861|580643617|FG001|Pivotal Stage 2|Death|0|||
160796405|NCT00744861|580643618|FG002|Pivotal Stage 2|Death|0|||
160796406|NCT00744861|580643619|FG003|Pivotal Stage 2|Death|1|||
160796407|NCT00744861|580643616|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
160796408|NCT00744861|580643617|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
160796409|NCT00744861|580643618|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
160796410|NCT00744861|580643619|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
160796411|NCT00744861|580643616|FG000|Pivotal Stage 2|Physician Decision|0|||
160796412|NCT00744861|580643617|FG001|Pivotal Stage 2|Physician Decision|0|||
160796413|NCT00744861|580643618|FG002|Pivotal Stage 2|Physician Decision|3|||
160796414|NCT00744861|580643619|FG003|Pivotal Stage 2|Physician Decision|1|||
160796415|NCT00744861|580643616|FG000|Pivotal Stage 2|Protocol Violation|0|||
160796416|NCT00744861|580643617|FG001|Pivotal Stage 2|Protocol Violation|0|||
160796417|NCT00744861|580643618|FG002|Pivotal Stage 2|Protocol Violation|0|||
160796418|NCT00744861|580643619|FG003|Pivotal Stage 2|Protocol Violation|1|||
160796419|NCT00744861|580643616|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
160796420|NCT00744861|580643617|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
160796421|NCT00744861|580643618|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
160796422|NCT00744861|580643619|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
160796423|NCT00744861|580643616|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
160796424|NCT00744861|580643617|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
160796425|NCT00744861|580643618|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
160796426|NCT00744861|580643619|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
160796427|NCT04856527|580643620|FG000|Overall Study|Unable to complete experimental task|2|||
160796428|NCT04856527|580643621|FG001|Overall Study|Unable to complete experimental task|0|||
160796429|NCT02115321|580643622|FG000|Overall Study|Death|1|||
160796430|NCT02115321|580643623|FG001|Overall Study|Death|0|||
160796431|NCT04403919|580643628|FG000|Overall Study|Lost to Follow-up|0|||
160796432|NCT04403919|580643629|FG001|Overall Study|Lost to Follow-up|0|||
160796433|NCT04403919|580643630|FG002|Overall Study|Lost to Follow-up|0|||
160796434|NCT04403919|580643631|FG003|Overall Study|Lost to Follow-up|1|||
160796435|NCT02038647|580643633|FG000|Overall Study|Progressive Disease|50|||
160796436|NCT02038647|580643634|FG001|Overall Study|Progressive Disease|59|||
160796437|NCT02038647|580643633|FG000|Overall Study|Adverse Event|18|||
160796438|NCT02038647|580643634|FG001|Overall Study|Adverse Event|10|||
160796439|NCT02038647|580643633|FG000|Overall Study|Symptomatic Deterioration|7|||
160796440|NCT02038647|580643634|FG001|Overall Study|Symptomatic Deterioration|7|||
160796441|NCT02038647|580643633|FG000|Overall Study|Withdrawal by Subject|5|||
160796442|NCT02038647|580643634|FG001|Overall Study|Withdrawal by Subject|2|||
160796443|NCT02038647|580643633|FG000|Overall Study|Not Reported|0|||
160796444|NCT02038647|580643634|FG001|Overall Study|Not Reported|1|||
160796445|NCT02038647|580643633|FG000|Overall Study|Ongoing at Datacut|9|||
160796446|NCT02038647|580643634|FG001|Overall Study|Ongoing at Datacut|10|||
160796447|NCT02757430|580643635|FG000|Overall Study|Physician Decision|6|||
160796448|NCT02757430|580643635|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
160796449|NCT02757430|580643635|FG000|Overall Study|No informed consent|1|||
160796450|NCT02757430|580643635|FG000|Overall Study|No procedure performed|2|||
160796451|NCT01983111|580643636|FG000|Overall Study|Withdrawal by Subject|8|||
160796452|NCT01983111|580643637|FG001|Overall Study|Withdrawal by Subject|6|||
160796453|NCT01983111|580643636|FG000|Overall Study|Adverse Event|4|||
160983543|NCT02611830|581328664|FG003|OL Induction Phase|Reason not specified|0|||
160983544|NCT02611830|581328661|FG000|Maintenance Phase|Lack of Efficacy|0|||
160983545|NCT02611830|581328662|FG001|Maintenance Phase|Lack of Efficacy|29|||
160796454|NCT01983111|580643637|FG001|Overall Study|Adverse Event|0|||
160796455|NCT01983111|580643636|FG000|Overall Study|Protocol Violation|0|||
160796456|NCT01983111|580643637|FG001|Overall Study|Protocol Violation|1|||
160796457|NCT03502200|580643638|FG000|Overall Study|Adverse Event|1|||
160796458|NCT03502200|580643639|FG001|Overall Study|Adverse Event|0|||
160796459|NCT03502200|580643638|FG000|Overall Study|Lost to Follow-up|36|||
160796460|NCT03502200|580643639|FG001|Overall Study|Lost to Follow-up|38|||
160796461|NCT03502200|580643638|FG000|Overall Study|Study Team Decision|1|||
160796462|NCT03502200|580643639|FG001|Overall Study|Study Team Decision|1|||
160796463|NCT03502200|580643638|FG000|Overall Study|Withdrawal by Subject|5|||
160983546|NCT02611830|581328663|FG002|Maintenance Phase|Lack of Efficacy|18|||
160796464|NCT03502200|580643639|FG001|Overall Study|Withdrawal by Subject|7|||
160796465|NCT03502200|580643638|FG000|Overall Study|Death|0|||
160796466|NCT03502200|580643639|FG001|Overall Study|Death|2|||
160796467|NCT00855335|580643640|FG000|Overall Study|Lost to Follow-up|0|||
160796468|NCT00855335|580643641|FG001|Overall Study|Lost to Follow-up|0|||
160796469|NCT00855335|580643642|FG002|Overall Study|Lost to Follow-up|3|||
160796470|NCT00855335|580643643|FG003|Overall Study|Lost to Follow-up|1|||
160796471|NCT00855335|580643644|FG004|Overall Study|Lost to Follow-up|0|||
160796472|NCT00855335|580643640|FG000|Overall Study|Withdrawal by Subject|0|||
160796473|NCT00855335|580643641|FG001|Overall Study|Withdrawal by Subject|0|||
160796474|NCT00855335|580643642|FG002|Overall Study|Withdrawal by Subject|0|||
160796475|NCT00855335|580643643|FG003|Overall Study|Withdrawal by Subject|1|||
160796476|NCT00855335|580643644|FG004|Overall Study|Withdrawal by Subject|0|||
160796477|NCT00855335|580643640|FG000|Overall Study|Adverse Event|2|||
160796478|NCT00855335|580643641|FG001|Overall Study|Adverse Event|0|||
160796479|NCT00855335|580643642|FG002|Overall Study|Adverse Event|0|||
160796480|NCT00855335|580643643|FG003|Overall Study|Adverse Event|0|||
160796481|NCT00855335|580643644|FG004|Overall Study|Adverse Event|0|||
160796482|NCT00855335|580643640|FG000|Overall Study|Physician Decision|1|||
160796483|NCT00855335|580643641|FG001|Overall Study|Physician Decision|1|||
160796484|NCT00855335|580643642|FG002|Overall Study|Physician Decision|0|||
160796485|NCT00855335|580643643|FG003|Overall Study|Physician Decision|0|||
160796486|NCT00855335|580643644|FG004|Overall Study|Physician Decision|0|||
160796487|NCT00855335|580643640|FG000|Overall Study|Other|2|||
160894474|NCT01397162|581010813|FG004|Overall Study|Not yet defined|3|||
160894475|NCT01507298|581010814|FG000|Overall Study|Protocol Violation|0|||
160894476|NCT01507298|581010815|FG001|Overall Study|Protocol Violation|6|||
160894477|NCT01920555|581010816|FG000|Overall Study|Physician Decision|1|||
160894478|NCT01920555|581010817|FG001|Overall Study|Physician Decision|2|||
160894479|NCT01920555|581010818|FG002|Overall Study|Physician Decision|1|||
160894480|NCT01920555|581010819|FG003|Overall Study|Physician Decision|2|||
160894481|NCT01920555|581010820|FG004|Overall Study|Physician Decision|0|||
160894482|NCT01920555|581010816|FG000|Overall Study|Lack of Efficacy|2|||
160894483|NCT01920555|581010817|FG001|Overall Study|Lack of Efficacy|0|||
160894484|NCT01920555|581010818|FG002|Overall Study|Lack of Efficacy|0|||
160894485|NCT01920555|581010819|FG003|Overall Study|Lack of Efficacy|0|||
160894486|NCT01920555|581010820|FG004|Overall Study|Lack of Efficacy|0|||
160894487|NCT01920555|581010816|FG000|Overall Study|Travel Difficulties|1|||
160894488|NCT01920555|581010817|FG001|Overall Study|Travel Difficulties|1|||
160894489|NCT01920555|581010818|FG002|Overall Study|Travel Difficulties|0|||
160894490|NCT01920555|581010819|FG003|Overall Study|Travel Difficulties|0|||
160894491|NCT01920555|581010820|FG004|Overall Study|Travel Difficulties|1|||
160894492|NCT01920555|581010816|FG000|Overall Study|Lost to Follow-up|0|||
160894493|NCT01920555|581010817|FG001|Overall Study|Lost to Follow-up|1|||
160894494|NCT01920555|581010818|FG002|Overall Study|Lost to Follow-up|0|||
160894495|NCT01920555|581010819|FG003|Overall Study|Lost to Follow-up|1|||
160894496|NCT01920555|581010820|FG004|Overall Study|Lost to Follow-up|0|||
160894497|NCT00195273|581010821|FG000|Overall Study|Adverse Event|9|||
160894498|NCT00195273|581010822|FG001|Overall Study|Adverse Event|9|||
160894499|NCT00195273|581010821|FG000|Overall Study|Protocol deviation|0|||
160894500|NCT00195273|581010822|FG001|Overall Study|Protocol deviation|1|||
160894501|NCT00195273|581010821|FG000|Overall Study|Lack of Efficacy|3|||
160894502|NCT00195273|581010822|FG001|Overall Study|Lack of Efficacy|1|||
160894503|NCT00195273|581010821|FG000|Overall Study|Procedural complications|9|||
160894504|NCT00195273|581010822|FG001|Overall Study|Procedural complications|3|||
160894505|NCT02367131|581010823|FG000|Overall Study|Adverse Event|64|||
160894506|NCT02367131|581010823|FG000|Overall Study|No visit since the first visit|3|||
160894507|NCT02367131|581010823|FG000|Overall Study|Request by patient|53|||
160894508|NCT02367131|581010823|FG000|Overall Study|Improvement/remission|2|||
160894509|NCT02367131|581010823|FG000|Overall Study|No change/progressive disease|78|||
160894510|NCT02367131|581010823|FG000|Overall Study|Other than stated above|20|||
160894511|NCT02367131|581010823|FG000|Overall Study|Not treated|2|||
160894512|NCT00810108|581010829|FG000|Overall Study|Withdrawal by Subject|1|||
160894513|NCT00810108|581010830|FG001|Overall Study|Withdrawal by Subject|0|||
160894514|NCT01051466|581010831|FG000|Overall Study|Adverse Event|1|||
160796488|NCT00855335|580643641|FG001|Overall Study|Other|1|||
160796489|NCT00855335|580643642|FG002|Overall Study|Other|2|||
160796490|NCT00855335|580643643|FG003|Overall Study|Other|5|||
160796491|NCT00855335|580643644|FG004|Overall Study|Other|1|||
160796492|NCT03097289|580643646|FG000|Overall Study|Adverse Event|1|||
160796493|NCT03097289|580643646|FG000|Overall Study|Equipment failure|2|||
160796494|NCT03097289|580643646|FG000|Overall Study|Collected platelet product unusable|3|||
160796495|NCT02526290|580643649|FG000|Overall Study|Adverse Event|3|||
160894515|NCT01051466|581010832|FG001|Overall Study|Adverse Event|0|||
160894516|NCT01051466|581010831|FG000|Overall Study|Lost to Follow-up|1|||
160894517|NCT01051466|581010832|FG001|Overall Study|Lost to Follow-up|1|||
160894518|NCT01051466|581010831|FG000|Overall Study|Withdrawal by Subject|5|||
160894519|NCT01051466|581010832|FG001|Overall Study|Withdrawal by Subject|1|||
160894520|NCT01051466|581010831|FG000|Overall Study|Entry Criteria Not Met|0|||
160894521|NCT01051466|581010832|FG001|Overall Study|Entry Criteria Not Met|3|||
160796496|NCT02526290|580643649|FG000|Overall Study|Withdrawal by Subject|4|||
160796497|NCT02526290|580643649|FG000|Overall Study|Physician Decision|1|||
160894522|NCT01051466|581010831|FG000|Overall Study|Physician Decision|1|||
160894523|NCT01051466|581010832|FG001|Overall Study|Physician Decision|0|||
160796498|NCT00049543|580643652|FG000|Overall Study|still on treatment|2|||
160796499|NCT00049543|580643653|FG001|Overall Study|still on treatment|9|||
160796500|NCT02106832|580643654|FG000|Overall Study|Adverse Event|1|||
160796501|NCT02106832|580643655|FG001|Overall Study|Adverse Event|2|||
160796502|NCT02106832|580643656|FG002|Overall Study|Adverse Event|3|||
160796503|NCT02106832|580643657|FG003|Overall Study|Adverse Event|0|||
160796504|NCT02106832|580643654|FG000|Overall Study|Death|4|||
160796505|NCT02106832|580643655|FG001|Overall Study|Death|4|||
160796506|NCT02106832|580643656|FG002|Overall Study|Death|1|||
160796507|NCT02106832|580643657|FG003|Overall Study|Death|4|||
160796508|NCT02106832|580643654|FG000|Overall Study|Deterioration of general conditions|0|||
160796509|NCT02106832|580643655|FG001|Overall Study|Deterioration of general conditions|0|||
160796510|NCT02106832|580643656|FG002|Overall Study|Deterioration of general conditions|1|||
160796511|NCT02106832|580643657|FG003|Overall Study|Deterioration of general conditions|0|||
160796512|NCT02106832|580643654|FG000|Overall Study|Lost to Follow-up|0|||
160796513|NCT02106832|580643655|FG001|Overall Study|Lost to Follow-up|1|||
160796514|NCT02106832|580643656|FG002|Overall Study|Lost to Follow-up|1|||
160796515|NCT02106832|580643657|FG003|Overall Study|Lost to Follow-up|3|||
160796516|NCT02106832|580643654|FG000|Overall Study|Physician Decision|1|||
160796517|NCT02106832|580643655|FG001|Overall Study|Physician Decision|0|||
160796518|NCT02106832|580643656|FG002|Overall Study|Physician Decision|0|||
160796519|NCT02106832|580643657|FG003|Overall Study|Physician Decision|0|||
160796520|NCT02106832|580643654|FG000|Overall Study|Protocol Violation|0|||
160796521|NCT02106832|580643655|FG001|Overall Study|Protocol Violation|0|||
160796522|NCT02106832|580643656|FG002|Overall Study|Protocol Violation|0|||
160796523|NCT02106832|580643657|FG003|Overall Study|Protocol Violation|1|||
160796524|NCT02106832|580643654|FG000|Overall Study|Withdrawal by Subject|17|||
160796525|NCT02106832|580643655|FG001|Overall Study|Withdrawal by Subject|17|||
160796526|NCT02106832|580643656|FG002|Overall Study|Withdrawal by Subject|10|||
160796527|NCT02106832|580643657|FG003|Overall Study|Withdrawal by Subject|7|||
160796528|NCT02106832|580643654|FG000|Overall Study|Technical problems|0|||
160796529|NCT02106832|580643655|FG001|Overall Study|Technical problems|1|||
160796530|NCT02106832|580643656|FG002|Overall Study|Technical problems|0|||
160796531|NCT02106832|580643657|FG003|Overall Study|Technical problems|0|||
160796532|NCT00619866|580643676|FG000|Weeks 1 - 12|Adverse Event|0|||
160796533|NCT00619866|580643677|FG001|Weeks 1 - 12|Adverse Event|1|||
160796534|NCT00619866|580643678|FG002|Weeks 1 - 12|Adverse Event|2|||
160796535|NCT00619866|580643679|FG003|Weeks 1 - 12|Adverse Event|0|||
160796536|NCT00619866|580643680|FG004|Weeks 1 - 12|Adverse Event|0|||
160796537|NCT00619866|580643676|FG000|Weeks 1 - 12|Non-compliance|0|||
160796538|NCT00619866|580643677|FG001|Weeks 1 - 12|Non-compliance|0|||
160796539|NCT00619866|580643678|FG002|Weeks 1 - 12|Non-compliance|1|||
160796540|NCT00619866|580643679|FG003|Weeks 1 - 12|Non-compliance|0|||
160796541|NCT00619866|580643680|FG004|Weeks 1 - 12|Non-compliance|0|||
160796542|NCT00619866|580643676|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
160983547|NCT02611830|581328664|FG003|Maintenance Phase|Lack of Efficacy|6|||
160983548|NCT02611830|581328661|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
160983549|NCT02611830|581328662|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
160983550|NCT02611830|581328663|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
160983551|NCT02611830|581328664|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
160983552|NCT02611830|581328661|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
160983553|NCT02611830|581328662|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
160983554|NCT02611830|581328663|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
160983555|NCT02611830|581328664|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
160983556|NCT02611830|581328661|FG000|Maintenance Phase|Lost to Follow-up|0|||
160983557|NCT02611830|581328662|FG001|Maintenance Phase|Lost to Follow-up|0|||
160983558|NCT02611830|581328663|FG002|Maintenance Phase|Lost to Follow-up|0|||
160983559|NCT02611830|581328664|FG003|Maintenance Phase|Lost to Follow-up|1|||
160983560|NCT02611830|581328661|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
160983561|NCT02611830|581328662|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
160983562|NCT02611830|581328663|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
160643286|NCT01144663|580076534|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
160983563|NCT02611830|581328664|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
160796543|NCT00619866|580643677|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
160796544|NCT00619866|580643678|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
160796545|NCT00619866|580643679|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
160796546|NCT00619866|580643680|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
160796547|NCT00619866|580643676|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
160796548|NCT00619866|580643677|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
160796549|NCT00619866|580643678|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
160796550|NCT00619866|580643679|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
160796551|NCT00619866|580643680|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
160796552|NCT00619866|580643676|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
160796553|NCT00619866|580643677|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
160796554|NCT00619866|580643678|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
160796555|NCT00619866|580643679|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
160796556|NCT00619866|580643680|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
160796557|NCT00619866|580643676|FG000|Weeks 1 - 12|Sponsor Decision|0|||
160796558|NCT00619866|580643677|FG001|Weeks 1 - 12|Sponsor Decision|1|||
160796559|NCT00619866|580643678|FG002|Weeks 1 - 12|Sponsor Decision|0|||
160796560|NCT00619866|580643679|FG003|Weeks 1 - 12|Sponsor Decision|0|||
160796561|NCT00619866|580643680|FG004|Weeks 1 - 12|Sponsor Decision|0|||
160796562|NCT00619866|580643676|FG000|Weeks 13 - 24|Adverse Event|0|||
160796563|NCT00619866|580643677|FG001|Weeks 13 - 24|Adverse Event|0|||
160796564|NCT00619866|580643678|FG002|Weeks 13 - 24|Adverse Event|2|||
160796565|NCT00619866|580643679|FG003|Weeks 13 - 24|Adverse Event|1|||
160796566|NCT00619866|580643680|FG004|Weeks 13 - 24|Adverse Event|0|||
160796567|NCT00619866|580643676|FG000|Weeks 13 - 24|Protocol Deviation|0|||
160796568|NCT00619866|580643677|FG001|Weeks 13 - 24|Protocol Deviation|0|||
160796569|NCT00619866|580643678|FG002|Weeks 13 - 24|Protocol Deviation|0|||
160796570|NCT00619866|580643679|FG003|Weeks 13 - 24|Protocol Deviation|1|||
160796571|NCT00619866|580643680|FG004|Weeks 13 - 24|Protocol Deviation|0|||
160796572|NCT00619866|580643676|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
160796573|NCT00619866|580643677|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
160796574|NCT00619866|580643678|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
160796575|NCT00619866|580643679|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
160796576|NCT00619866|580643680|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
160796577|NCT00619866|580643676|FG000|Weeks 13 - 24|Non-compliance|0|||
160796578|NCT00619866|580643677|FG001|Weeks 13 - 24|Non-compliance|1|||
160796579|NCT00619866|580643678|FG002|Weeks 13 - 24|Non-compliance|1|||
160796580|NCT00619866|580643679|FG003|Weeks 13 - 24|Non-compliance|0|||
160796581|NCT00619866|580643680|FG004|Weeks 13 - 24|Non-compliance|0|||
160796582|NCT00619866|580643676|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
160796583|NCT00619866|580643677|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
160796584|NCT00619866|580643678|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
160796585|NCT00619866|580643679|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
160796586|NCT00619866|580643680|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
160796587|NCT04716894|580643681|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
160796588|NCT04716894|580643681|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
160796589|NCT05205616|580643688|FG000|Overall Study|Lost to Follow-up|4|||
160796590|NCT05205616|580643689|FG001|Overall Study|Lost to Follow-up|4|||
160796591|NCT01467466|580643692|FG000|Overall Study|Withdrawal by Subject|15|||
160796592|NCT01467466|580643693|FG001|Overall Study|Withdrawal by Subject|18|||
160796593|NCT01467466|580643694|FG002|Overall Study|Withdrawal by Subject|13|||
160796594|NCT01467466|580643695|FG003|Overall Study|Withdrawal by Subject|11|||
160796595|NCT01467466|580643692|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
160796596|NCT01467466|580643693|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
160796597|NCT01467466|580643694|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
160796598|NCT01467466|580643695|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
160796599|NCT01467466|580643692|FG000|Overall Study|Procedure Cancelled|46|||
160796600|NCT01467466|580643693|FG001|Overall Study|Procedure Cancelled|45|||
160796601|NCT01467466|580643694|FG002|Overall Study|Procedure Cancelled|25|||
160796602|NCT01467466|580643695|FG003|Overall Study|Procedure Cancelled|29|||
160796603|NCT01467466|580643692|FG000|Overall Study|No Endpoint Blood Draw|38|||
160796604|NCT01467466|580643693|FG001|Overall Study|No Endpoint Blood Draw|32|||
160796605|NCT01467466|580643694|FG002|Overall Study|No Endpoint Blood Draw|51|||
160796606|NCT01467466|580643695|FG003|Overall Study|No Endpoint Blood Draw|43|||
160796607|NCT00787150|580643696|FG000|Overall Study|Adverse Event|4|||
160796608|NCT00787150|580643697|FG001|Overall Study|Adverse Event|4|||
160796609|NCT00787150|580643698|FG002|Overall Study|Adverse Event|4|||
160796610|NCT00787150|580643696|FG000|Overall Study|Physician Decision|1|||
160796611|NCT00787150|580643697|FG001|Overall Study|Physician Decision|2|||
160796612|NCT00787150|580643698|FG002|Overall Study|Physician Decision|1|||
160796613|NCT00787150|580643696|FG000|Overall Study|Withdrawal by Subject|2|||
160796614|NCT00787150|580643697|FG001|Overall Study|Withdrawal by Subject|1|||
160983564|NCT02611830|581328661|FG000|Maintenance Phase|Pregnancy|0|||
160643287|NCT01144663|580076535|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
160796615|NCT00787150|580643698|FG002|Overall Study|Withdrawal by Subject|0|||
160796616|NCT00787150|580643696|FG000|Overall Study|Dosing incorrect study durg|2|||
160796617|NCT00787150|580643697|FG001|Overall Study|Dosing incorrect study durg|0|||
160796618|NCT00787150|580643698|FG002|Overall Study|Dosing incorrect study durg|0|||
160796619|NCT00982280|580643705|FG000|Observation Period|Not eligible to be dosed|19|||
160796620|NCT00982280|580643705|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
160796621|NCT00982280|580643705|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
160796622|NCT00982280|580643705|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
160796623|NCT00982280|580643705|FG000|Maintenance Period|Adverse Event|1|||
160796624|NCT06028464|580643713|FG000|Washout|Positive drug test.|1|||
160796625|NCT03636022|580643714|FG000|Overall Study|Withdrawal by Subject|1|||
160796626|NCT03636022|580643715|FG001|Overall Study|Withdrawal by Subject|3|||
160796627|NCT03330847|580643716|FG000|Overall Study|Patients ongoing study|62|||
160796628|NCT03330847|580643717|FG001|Overall Study|Patients ongoing study|65|||
160796629|NCT03330847|580643718|FG002|Overall Study|Patients ongoing study|15|||
160796630|NCT03274466|580643721|FG000|Overall Study|Withdrawal by Subject|7|||
160796631|NCT03274466|580643722|FG001|Overall Study|Withdrawal by Subject|3|||
160796632|NCT03274466|580643721|FG000|Overall Study|Protocol Specified Withdrawal|5|||
160796633|NCT03274466|580643722|FG001|Overall Study|Protocol Specified Withdrawal|11|||
160796634|NCT03274466|580643721|FG000|Overall Study|Lost to Follow-up|5|||
160796635|NCT03274466|580643722|FG001|Overall Study|Lost to Follow-up|7|||
160796636|NCT03274466|580643721|FG000|Overall Study|Subject Non-compliance|0|||
160796637|NCT03274466|580643722|FG001|Overall Study|Subject Non-compliance|1|||
160796638|NCT03274466|580643721|FG000|Overall Study|Adverse Event|3|||
160796639|NCT03274466|580643722|FG001|Overall Study|Adverse Event|3|||
160796640|NCT03274466|580643721|FG000|Overall Study|Physician Decision|0|||
160796641|NCT03274466|580643722|FG001|Overall Study|Physician Decision|1|||
160796642|NCT03274466|580643721|FG000|Overall Study|Protocol Violation|3|||
160796643|NCT03274466|580643722|FG001|Overall Study|Protocol Violation|3|||
160796644|NCT02581930|580643730|FG000|Overall Study|Withdrawal by Subject|1|||
160796645|NCT02581930|580643730|FG000|Overall Study|patient declined further treatment|1|||
160796646|NCT02776735|580643731|FG000|Overall Study|Adverse Event|0|||
160796647|NCT02776735|580643732|FG001|Overall Study|Adverse Event|0|||
160796648|NCT02776735|580643733|FG002|Overall Study|Adverse Event|0|||
160796649|NCT02776735|580643734|FG003|Overall Study|Adverse Event|1|||
160796650|NCT02776735|580643735|FG004|Overall Study|Adverse Event|0|||
160796651|NCT02776735|580643736|FG005|Overall Study|Adverse Event|1|||
160796652|NCT02776735|580643731|FG000|Overall Study|Lost to Follow-up|0|||
160796653|NCT02776735|580643732|FG001|Overall Study|Lost to Follow-up|0|||
160796654|NCT02776735|580643733|FG002|Overall Study|Lost to Follow-up|0|||
160796655|NCT02776735|580643734|FG003|Overall Study|Lost to Follow-up|1|||
160796656|NCT02776735|580643735|FG004|Overall Study|Lost to Follow-up|0|||
160796657|NCT02776735|580643736|FG005|Overall Study|Lost to Follow-up|0|||
160796658|NCT02776735|580643731|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160796659|NCT02776735|580643732|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160796660|NCT02776735|580643733|FG002|Overall Study|Withdrawal by parent/guardian|2|||
160796661|NCT02776735|580643734|FG003|Overall Study|Withdrawal by parent/guardian|2|||
160796662|NCT02776735|580643735|FG004|Overall Study|Withdrawal by parent/guardian|0|||
160796663|NCT02776735|580643736|FG005|Overall Study|Withdrawal by parent/guardian|0|||
160796664|NCT02776735|580643731|FG000|Overall Study|Withdrawal by Subject|1|||
160796665|NCT02776735|580643732|FG001|Overall Study|Withdrawal by Subject|0|||
160796666|NCT02776735|580643733|FG002|Overall Study|Withdrawal by Subject|0|||
160796667|NCT02776735|580643734|FG003|Overall Study|Withdrawal by Subject|0|||
160796668|NCT02776735|580643735|FG004|Overall Study|Withdrawal by Subject|0|||
160796669|NCT02776735|580643736|FG005|Overall Study|Withdrawal by Subject|1|||
160796670|NCT02776735|580643731|FG000|Overall Study|Other|0|||
160796671|NCT02776735|580643732|FG001|Overall Study|Other|0|||
160796672|NCT02776735|580643733|FG002|Overall Study|Other|3|||
160796673|NCT02776735|580643734|FG003|Overall Study|Other|0|||
160796674|NCT02776735|580643735|FG004|Overall Study|Other|0|||
160796675|NCT02776735|580643736|FG005|Overall Study|Other|0|||
160796676|NCT00560508|580645271|FG000|12 Week Double-blind Period|Adverse Event|3|||
160796677|NCT00560508|580645272|FG001|12 Week Double-blind Period|Adverse Event|2|||
160796678|NCT00560508|580645271|FG000|12 Week Double-blind Period|Protocol Violation|1|||
160796679|NCT00560508|580645272|FG001|12 Week Double-blind Period|Protocol Violation|0|||
160796680|NCT00560508|580645271|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
160796681|NCT00560508|580645272|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
160796682|NCT00560508|580645271|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
160796683|NCT00560508|580645272|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
160796684|NCT00560508|580645271|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
160796685|NCT00560508|580645272|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
160796686|NCT00560508|580645271|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
160796687|NCT00560508|580645272|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
160796688|NCT00560508|580645271|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
160796689|NCT00560508|580645272|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
160796690|NCT03493958|580645273|FG000|Overall Study|Withdrawal by Subject|6|||
160796691|NCT03493958|580645273|FG000|Overall Study|Lost to Follow-up|7|||
160796692|NCT03493958|580645273|FG000|Overall Study|Did not complete all required study procedures|2|||
160796693|NCT02367456|580645274|FG000|Overall Study|Death|8|||
160796694|NCT02367456|580645275|FG001|Overall Study|Death|24|||
160796695|NCT02367456|580645276|FG002|Overall Study|Death|17|||
160796696|NCT02367456|580645274|FG000|Overall Study|Lost to Follow-up|1|||
160796697|NCT02367456|580645275|FG001|Overall Study|Lost to Follow-up|3|||
160796698|NCT02367456|580645276|FG002|Overall Study|Lost to Follow-up|1|||
160796699|NCT02367456|580645274|FG000|Overall Study|Other reason|3|||
160796700|NCT02367456|580645275|FG001|Overall Study|Other reason|3|||
160796701|NCT02367456|580645276|FG002|Overall Study|Other reason|9|||
160796702|NCT02367456|580645274|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
160796703|NCT02367456|580645275|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
160796704|NCT02367456|580645276|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
160796705|NCT04617860|580645278|FG000|Overall Study|Adverse Event|0|||
160796706|NCT04617860|580645279|FG001|Overall Study|Adverse Event|2|||
160796707|NCT04617860|580645280|FG002|Overall Study|Adverse Event|2|||
160796708|NCT04617860|580645278|FG000|Overall Study|Withdrawal by Subject|0|||
160796709|NCT04617860|580645279|FG001|Overall Study|Withdrawal by Subject|0|||
160796710|NCT04617860|580645280|FG002|Overall Study|Withdrawal by Subject|2|||
160796711|NCT04617860|580645278|FG000|Overall Study|Physician Decision|0|||
160796712|NCT04617860|580645279|FG001|Overall Study|Physician Decision|1|||
160796713|NCT04617860|580645280|FG002|Overall Study|Physician Decision|0|||
160796714|NCT04617860|580645278|FG000|Overall Study|Sponsor Decision|0|||
160796715|NCT04617860|580645279|FG001|Overall Study|Sponsor Decision|3|||
160796716|NCT04617860|580645280|FG002|Overall Study|Sponsor Decision|1|||
160796717|NCT04617860|580645278|FG000|Overall Study|Termination of Study by Sponsor|8|||
160796718|NCT04617860|580645279|FG001|Overall Study|Termination of Study by Sponsor|4|||
160796719|NCT04617860|580645280|FG002|Overall Study|Termination of Study by Sponsor|13|||
160796720|NCT02735200|580645285|FG000|Overall Study|Lost to Follow-up|0|||
160796721|NCT02735200|580645286|FG001|Overall Study|Lost to Follow-up|5|||
160796722|NCT02735200|580645285|FG000|Overall Study|Withdrawal by Subject|8|||
160796723|NCT02735200|580645286|FG001|Overall Study|Withdrawal by Subject|0|||
160796724|NCT01493414|580645287|FG000|Overall Study|Adverse Event|405|||
160796725|NCT01493414|580645287|FG000|Overall Study|Disease progression|204|||
160796726|NCT01493414|580645287|FG000|Overall Study|Death|101|||
160796727|NCT01493414|580645287|FG000|Overall Study|Physician Decision|93|||
160796728|NCT01493414|580645287|FG000|Overall Study|Withdrawal by Subject|79|||
160796729|NCT01493414|580645287|FG000|Overall Study|Protocol deviation|27|||
160796730|NCT01493414|580645287|FG000|Overall Study|Administrative problems|25|||
160796731|NCT01493414|580645287|FG000|Overall Study|Lost to Follow-up|16|||
160796732|NCT05448950|580645298|FG000|Overall Study|Death|2|||
160796733|NCT05448950|580645298|FG000|Overall Study|Withdrawal by Subject|1|||
160796734|NCT05448950|580645298|FG000|Overall Study|AVG abandoned|4|||
160796735|NCT02706392|580645314|FG000|Overall Study|Death|1|||
160796736|NCT02706392|580645315|FG001|Overall Study|Death|0|||
160796737|NCT02706392|580645316|FG002|Overall Study|Death|2|||
160796738|NCT02706392|580645317|FG003|Overall Study|Death|2|||
160796739|NCT02706392|580645318|FG004|Overall Study|Death|5|||
160796740|NCT02706392|580645319|FG005|Overall Study|Death|2|||
160796741|NCT01656161|580645322|FG000|Overall Study|Death|3|||
160796742|NCT01656161|580645322|FG000|Overall Study|Adverse Event|2|||
160796743|NCT01656161|580645322|FG000|Overall Study|Protocol Violation|1|||
160796744|NCT01656161|580645322|FG000|Overall Study|Withdrawal by Subject|1|||
160796745|NCT03510273|580645327|FG000|Overall Study|Withdrawal by Subject|2|||
160643288|NCT01144663|580076536|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
160643289|NCT01144663|580076537|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
160643290|NCT01144663|580076534|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
160643291|NCT01144663|580076535|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
160643292|NCT01144663|580076536|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
160643293|NCT01144663|580076537|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
160643294|NCT01144663|580076534|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
160643295|NCT01144663|580076535|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
160643296|NCT01144663|580076536|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
160796746|NCT03510273|580645327|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
160894524|NCT02570074|581010840|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
160643297|NCT01144663|580076537|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
160796747|NCT03510273|580645327|FG000|Overall Study|Moved away from study area|4|||
160796748|NCT00265122|580645331|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
160796749|NCT00265122|580645332|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
160796750|NCT00265122|580645333|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
160796751|NCT00265122|580645334|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
160796752|NCT00265122|580645335|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
160796753|NCT00265122|580645336|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
160796754|NCT00265122|580645331|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
160796755|NCT00265122|580645332|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
160796756|NCT00265122|580645333|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
160796757|NCT00265122|580645334|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
160796758|NCT00265122|580645335|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
160796759|NCT00265122|580645336|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
160796760|NCT00265122|580645331|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
160796761|NCT00265122|580645332|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
160796762|NCT00265122|580645333|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
160796763|NCT00265122|580645334|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
160796764|NCT00265122|580645335|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
160796765|NCT00265122|580645336|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
160796766|NCT00265122|580645331|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
160796767|NCT00265122|580645332|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
160796768|NCT00265122|580645333|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
160796769|NCT00265122|580645334|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
160796770|NCT00265122|580645335|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
160796771|NCT00265122|580645336|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
160796772|NCT00265122|580645331|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
160796773|NCT00265122|580645332|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
160796774|NCT00265122|580645333|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
160796775|NCT00265122|580645334|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
160796776|NCT00265122|580645335|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
160796777|NCT00265122|580645336|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
160796778|NCT00265122|580645331|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
160796779|NCT00265122|580645332|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
160796780|NCT00265122|580645333|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
160796781|NCT00265122|580645334|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
160796782|NCT00265122|580645335|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
160796783|NCT00265122|580645336|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
160796784|NCT02589938|580645337|FG000|Overall Study|Withdrawal by Subject|11|||
160796785|NCT02589938|580645338|FG001|Overall Study|Withdrawal by Subject|5|||
160796786|NCT02589938|580645339|FG002|Overall Study|Withdrawal by Subject|6|||
160796787|NCT02589938|580645337|FG000|Overall Study|Lost to Follow-up|3|||
160796788|NCT02589938|580645338|FG001|Overall Study|Lost to Follow-up|3|||
160796789|NCT02589938|580645339|FG002|Overall Study|Lost to Follow-up|3|||
160796790|NCT02589938|580645337|FG000|Overall Study|Death|1|||
160796791|NCT02589938|580645338|FG001|Overall Study|Death|0|||
160796792|NCT02589938|580645339|FG002|Overall Study|Death|1|||
160796793|NCT02589938|580645337|FG000|Overall Study|Protocol Violation|6|||
160796794|NCT02589938|580645338|FG001|Overall Study|Protocol Violation|2|||
160796795|NCT02589938|580645339|FG002|Overall Study|Protocol Violation|3|||
160796796|NCT02589938|580645337|FG000|Overall Study|Physician Decision|1|||
160796797|NCT02589938|580645338|FG001|Overall Study|Physician Decision|0|||
160796798|NCT02589938|580645339|FG002|Overall Study|Physician Decision|0|||
160796799|NCT02589938|580645337|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
160796800|NCT02589938|580645338|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
160796801|NCT02589938|580645339|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
160796802|NCT01121757|580645350|FG000|First Drug|Death|1|||
160796803|NCT01121757|580645351|FG001|First Drug|Death|0|||
160796804|NCT01121757|580645350|FG000|First Drug|Disease Progression|0|||
160796805|NCT01121757|580645351|FG001|First Drug|Disease Progression|2|||
160796806|NCT01121757|580645350|FG000|Combination|Physician Decision|0|||
160796807|NCT01121757|580645351|FG001|Combination|Physician Decision|1|||
160796808|NCT01121757|580645350|FG000|Combination|Disease Progression|2|||
160796809|NCT01121757|580645351|FG001|Combination|Disease Progression|0|||
160796810|NCT03773484|580645352|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
160796811|NCT04724837|580645353|FG000|Overall Study|Other|4|||
160796812|NCT04724837|580645354|FG001|Overall Study|Other|16|||
160796813|NCT04724837|580645355|FG002|Overall Study|Other|0|||
160796814|NCT04724837|580645353|FG000|Overall Study|Withdrawal by Subject|2|||
160796815|NCT04724837|580645354|FG001|Overall Study|Withdrawal by Subject|9|||
160796816|NCT04724837|580645355|FG002|Overall Study|Withdrawal by Subject|9|||
160796817|NCT04724837|580645353|FG000|Overall Study|Adverse Event|2|||
160796818|NCT04724837|580645354|FG001|Overall Study|Adverse Event|7|||
160796819|NCT04724837|580645355|FG002|Overall Study|Adverse Event|4|||
160796820|NCT04724837|580645353|FG000|Overall Study|Lost to Follow-up|0|||
160796821|NCT04724837|580645354|FG001|Overall Study|Lost to Follow-up|1|||
160796822|NCT04724837|580645355|FG002|Overall Study|Lost to Follow-up|3|||
160796823|NCT04724837|580645353|FG000|Overall Study|Physician Decision|1|||
160796824|NCT04724837|580645354|FG001|Overall Study|Physician Decision|2|||
160796825|NCT04724837|580645355|FG002|Overall Study|Physician Decision|0|||
160796826|NCT04724837|580645353|FG000|Overall Study|Death|0|||
160796827|NCT04724837|580645354|FG001|Overall Study|Death|0|||
160796828|NCT04724837|580645355|FG002|Overall Study|Death|1|||
160796829|NCT04724837|580645353|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
160796830|NCT04724837|580645354|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
160796831|NCT04724837|580645355|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
160796832|NCT04724837|580645353|FG000|Overall Study|Study Terminated by Sponsor|0|||
160796833|NCT04724837|580645354|FG001|Overall Study|Study Terminated by Sponsor|1|||
160796834|NCT04724837|580645355|FG002|Overall Study|Study Terminated by Sponsor|0|||
160796835|NCT04222673|580645356|FG000|Overall Study|Lost to Follow-up|5|||
160796836|NCT04251533|580645373|FG000|Overall Study|Progressive disease|33|||
160796837|NCT04251533|580645374|FG001|Overall Study|Progressive disease|29|||
160796838|NCT04251533|580645375|FG002|Overall Study|Progressive disease|22|||
160796839|NCT04251533|580645373|FG000|Overall Study|Death|5|||
160796840|NCT04251533|580645374|FG001|Overall Study|Death|1|||
160796841|NCT04251533|580645375|FG002|Overall Study|Death|3|||
160796842|NCT04251533|580645373|FG000|Overall Study|Physician Decision|3|||
160796843|NCT04251533|580645374|FG001|Overall Study|Physician Decision|2|||
160796844|NCT04251533|580645375|FG002|Overall Study|Physician Decision|4|||
160796845|NCT04251533|580645373|FG000|Overall Study|Participant decision|1|||
160796846|NCT04251533|580645374|FG001|Overall Study|Participant decision|3|||
160796847|NCT04251533|580645375|FG002|Overall Study|Participant decision|1|||
160796848|NCT04251533|580645373|FG000|Overall Study|Adverse Event|2|||
160796849|NCT04251533|580645374|FG001|Overall Study|Adverse Event|1|||
160796850|NCT04251533|580645375|FG002|Overall Study|Adverse Event|1|||
160796851|NCT06071104|580645376|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
160796852|NCT02420717|580645379|FG000|Overall Study|Did not receive all study medication|2|||
160796853|NCT02420717|580645380|FG001|Overall Study|Did not receive all study medication|0|||
160796854|NCT02420717|580645381|FG002|Overall Study|Did not receive all study medication|0|||
160796855|NCT04116489|580645382|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
160796856|NCT04116489|580645382|FG000|Overall Study|Withdrawal by Subject|1|||
160796857|NCT03781570|580645383|FG000|Overall Study|Technical Issues (equipment failure)|31|||
160796858|NCT03781570|580645383|FG000|Overall Study|Withdrawal by Subject|7|||
160796859|NCT03781570|580645383|FG000|Overall Study|Physical Constraints|11|||
160796860|NCT03138564|580645384|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
160796861|NCT03138564|580645385|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
160796862|NCT03138564|580645384|FG000|Overall Study|Lost to Follow-up|16|||
160796863|NCT03138564|580645385|FG001|Overall Study|Lost to Follow-up|2|||
160796864|NCT03138564|580645384|FG000|Overall Study|Withdrawal by Subject|48|||
160796865|NCT03138564|580645385|FG001|Overall Study|Withdrawal by Subject|4|||
160796866|NCT03138564|580645384|FG000|Overall Study|No longer met eligibility criteria|2|||
160796867|NCT03138564|580645385|FG001|Overall Study|No longer met eligibility criteria|0|||
160796868|NCT03138564|580645384|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
160796869|NCT03138564|580645385|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
160796870|NCT03138564|580645384|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
160796871|NCT03138564|580645385|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
160796872|NCT03138564|580645384|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
160983565|NCT02611830|581328662|FG001|Maintenance Phase|Pregnancy|0|||
160796873|NCT03138564|580645385|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
160796874|NCT03138564|580645384|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
160796875|NCT03138564|580645385|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
160796876|NCT05177354|580645387|FG000|Implant to 30-day Visit|Physician Decision|1|||
160796877|NCT05177354|580645387|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
160796878|NCT05177354|580645387|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
160796879|NCT05177354|580645387|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
160796880|NCT02769481|580645393|FG000|Overall Study|Protocol Violation|1|||
160796881|NCT02769481|580645394|FG001|Overall Study|Protocol Violation|0|||
160796882|NCT02769481|580645393|FG000|Overall Study|Adverse Event|3|||
160796883|NCT02769481|580645394|FG001|Overall Study|Adverse Event|6|||
160796884|NCT02769481|580645393|FG000|Overall Study|Entry Criteria Not Met|1|||
160796885|NCT02769481|580645394|FG001|Overall Study|Entry Criteria Not Met|2|||
160796886|NCT02769481|580645393|FG000|Overall Study|Withdrawal by Subject|14|||
160796887|NCT02769481|580645394|FG001|Overall Study|Withdrawal by Subject|16|||
160796888|NCT02769481|580645393|FG000|Overall Study|Lost to Follow-up|9|||
160796889|NCT02769481|580645394|FG001|Overall Study|Lost to Follow-up|9|||
160796890|NCT02769481|580645393|FG000|Overall Study|Physician Decision|0|||
160796891|NCT02769481|580645394|FG001|Overall Study|Physician Decision|1|||
160796892|NCT02769481|580645393|FG000|Overall Study|Terminated by Sponsor|1|||
160796893|NCT02769481|580645394|FG001|Overall Study|Terminated by Sponsor|0|||
160796894|NCT02769481|580645393|FG000|Overall Study|Death|0|||
160796895|NCT02769481|580645394|FG001|Overall Study|Death|1|||
160796896|NCT02769481|580645393|FG000|Overall Study|Undefined|4|||
160796897|NCT02769481|580645394|FG001|Overall Study|Undefined|1|||
160796898|NCT01346592|580645395|FG000|Overall Study|Lost to Follow-up|62|||
160796899|NCT01346592|580645396|FG001|Overall Study|Lost to Follow-up|29|||
160796900|NCT01346592|580645397|FG002|Overall Study|Lost to Follow-up|29|||
160796901|NCT01346592|580645395|FG000|Overall Study|Protocol Violation|2|||
160796902|NCT01346592|580645396|FG001|Overall Study|Protocol Violation|1|||
160796903|NCT01346592|580645397|FG002|Overall Study|Protocol Violation|0|||
160796904|NCT01346592|580645395|FG000|Overall Study|Death|1|||
160796905|NCT01346592|580645396|FG001|Overall Study|Death|3|||
160796906|NCT01346592|580645397|FG002|Overall Study|Death|4|||
160796907|NCT01346592|580645395|FG000|Overall Study|Adverse Event|0|||
160796908|NCT01346592|580645396|FG001|Overall Study|Adverse Event|1|||
160796909|NCT01346592|580645397|FG002|Overall Study|Adverse Event|0|||
160796910|NCT01346592|580645395|FG000|Overall Study|Withdrawal by Subject|77|||
160796911|NCT01346592|580645396|FG001|Overall Study|Withdrawal by Subject|51|||
160796912|NCT01346592|580645397|FG002|Overall Study|Withdrawal by Subject|38|||
160796913|NCT01346592|580645395|FG000|Overall Study|Inappropriate enrollment|3|||
160643298|NCT01144663|580076534|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
160643299|NCT01144663|580076535|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
160643300|NCT01144663|580076536|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
160643301|NCT01144663|580076537|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
160643302|NCT01144663|580076534|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
160643303|NCT01144663|580076535|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
160796914|NCT01346592|580645396|FG001|Overall Study|Inappropriate enrollment|1|||
160796915|NCT01346592|580645397|FG002|Overall Study|Inappropriate enrollment|1|||
160796916|NCT01346592|580645395|FG000|Overall Study|Administrative reason|1|||
160796917|NCT01346592|580645396|FG001|Overall Study|Administrative reason|0|||
160796918|NCT01346592|580645397|FG002|Overall Study|Administrative reason|0|||
160796919|NCT01346592|580645395|FG000|Overall Study|Unable to Classify|7|||
160796920|NCT01346592|580645396|FG001|Overall Study|Unable to Classify|3|||
160796921|NCT01346592|580645397|FG002|Overall Study|Unable to Classify|6|||
160796922|NCT00643279|580645400|FG000|Overall Study|Death|13|||
160796923|NCT00643279|580645401|FG001|Overall Study|Death|11|||
160796924|NCT00643279|580645400|FG000|Overall Study|Withdrawal by Subject|3|||
160643304|NCT01144663|580076536|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
160796925|NCT00643279|580645401|FG001|Overall Study|Withdrawal by Subject|0|||
160796926|NCT00643279|580645400|FG000|Overall Study|Lost to Follow-up|0|||
160796927|NCT00643279|580645401|FG001|Overall Study|Lost to Follow-up|1|||
160796928|NCT00643279|580645400|FG000|Overall Study|Physician Decision|0|||
160796929|NCT00643279|580645401|FG001|Overall Study|Physician Decision|1|||
160796930|NCT06272383|580645402|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
160796931|NCT06272383|580645403|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
160796932|NCT05715827|580645404|FG000|Overall Study|Physician Decision|0|||
160796933|NCT05715827|580645405|FG001|Overall Study|Physician Decision|1|||
160796934|NCT05715827|580645404|FG000|Overall Study|console communication error|0|||
160796935|NCT05715827|580645405|FG001|Overall Study|console communication error|1|||
160796936|NCT04846868|580645406|FG000|Overall Study|Adverse Event|12|||
160796937|NCT04846868|580645407|FG001|Overall Study|Adverse Event|11|||
160796938|NCT04846868|580645406|FG000|Overall Study|Protocol deviation|6|||
160796939|NCT04846868|580645407|FG001|Overall Study|Protocol deviation|2|||
160796940|NCT04846868|580645406|FG000|Overall Study|Perceived lack of efficacy|3|||
160796941|NCT04846868|580645407|FG001|Overall Study|Perceived lack of efficacy|2|||
160796942|NCT04846868|580645406|FG000|Overall Study|Change of residence|2|||
160796943|NCT04846868|580645407|FG001|Overall Study|Change of residence|3|||
160796944|NCT04846868|580645406|FG000|Overall Study|Burden of study procedures|1|||
160796945|NCT04846868|580645407|FG001|Overall Study|Burden of study procedures|1|||
160796946|NCT04846868|580645406|FG000|Overall Study|No reason available|2|||
160796947|NCT04846868|580645407|FG001|Overall Study|No reason available|5|||
160796948|NCT04846868|580645406|FG000|Overall Study|Other reason listed|20|||
160796949|NCT04846868|580645407|FG001|Overall Study|Other reason listed|10|||
160796950|NCT04846868|580645406|FG000|Overall Study|Not treated|0|||
160796951|NCT04846868|580645407|FG001|Overall Study|Not treated|1|||
160796952|NCT04398706|580645408|FG000|Overall Study|Adverse Event|0|||
160796953|NCT04398706|580645409|FG001|Overall Study|Adverse Event|0|||
160796954|NCT04398706|580645410|FG002|Overall Study|Adverse Event|0|||
160796955|NCT04398706|580645411|FG003|Overall Study|Adverse Event|0|||
160796956|NCT04398706|580645412|FG004|Overall Study|Adverse Event|0|||
160796957|NCT04398706|580645413|FG005|Overall Study|Adverse Event|1|||
160796958|NCT04398706|580645414|FG006|Overall Study|Adverse Event|1|||
160796959|NCT04398706|580645415|FG007|Overall Study|Adverse Event|0|||
160796960|NCT04398706|580645408|FG000|Overall Study|Lost to Follow-up|0|||
160796961|NCT04398706|580645409|FG001|Overall Study|Lost to Follow-up|1|||
160796962|NCT04398706|580645410|FG002|Overall Study|Lost to Follow-up|2|||
160796963|NCT04398706|580645411|FG003|Overall Study|Lost to Follow-up|1|||
160796964|NCT04398706|580645412|FG004|Overall Study|Lost to Follow-up|6|||
160548930|NCT03403205|579736321|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
160796965|NCT04398706|580645413|FG005|Overall Study|Lost to Follow-up|3|||
160796966|NCT04398706|580645414|FG006|Overall Study|Lost to Follow-up|8|||
160548931|NCT03403205|579736322|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
160548932|NCT03403205|579736323|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
160796967|NCT04398706|580645415|FG007|Overall Study|Lost to Follow-up|2|||
160796968|NCT04398706|580645408|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160796969|NCT04398706|580645409|FG001|Overall Study|Withdrawal by parent/guardian|2|||
160796970|NCT04398706|580645410|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160796971|NCT04398706|580645411|FG003|Overall Study|Withdrawal by parent/guardian|2|||
160548933|NCT03403205|579736318|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
160548934|NCT03403205|579736319|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
160548935|NCT03403205|579736320|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
160548936|NCT03403205|579736321|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
160548937|NCT03403205|579736322|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
160796972|NCT04398706|580645412|FG004|Overall Study|Withdrawal by parent/guardian|19|||
160796973|NCT04398706|580645413|FG005|Overall Study|Withdrawal by parent/guardian|23|||
160796974|NCT04398706|580645414|FG006|Overall Study|Withdrawal by parent/guardian|13|||
160796975|NCT04398706|580645415|FG007|Overall Study|Withdrawal by parent/guardian|11|||
160796976|NCT04398706|580645408|FG000|Overall Study|Protocol deviation|0|||
160796977|NCT04398706|580645409|FG001|Overall Study|Protocol deviation|1|||
160796978|NCT04398706|580645410|FG002|Overall Study|Protocol deviation|0|||
160796979|NCT04398706|580645411|FG003|Overall Study|Protocol deviation|0|||
160548938|NCT03403205|579736323|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
160548939|NCT03403205|579736318|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
160796980|NCT04398706|580645412|FG004|Overall Study|Protocol deviation|6|||
160796981|NCT04398706|580645413|FG005|Overall Study|Protocol deviation|4|||
160796982|NCT04398706|580645414|FG006|Overall Study|Protocol deviation|6|||
160796983|NCT04398706|580645415|FG007|Overall Study|Protocol deviation|3|||
160796984|NCT04890509|580645416|FG000|Overall Study|Death|4|||
160796985|NCT04890509|580645417|FG001|Overall Study|Death|4|||
160796986|NCT04116853|580645418|FG000|Overall Study|Adverse Event|1|||
160796987|NCT04116853|580645419|FG001|Overall Study|Adverse Event|3|||
160796988|NCT04116853|580645418|FG000|Overall Study|Lost to Follow-up|2|||
160796989|NCT04116853|580645419|FG001|Overall Study|Lost to Follow-up|0|||
160796990|NCT04116853|580645418|FG000|Overall Study|Incarceration|0|||
160796991|NCT04116853|580645419|FG001|Overall Study|Incarceration|1|||
160796992|NCT04116853|580645418|FG000|Overall Study|Pregnancy|1|||
160796993|NCT04116853|580645419|FG001|Overall Study|Pregnancy|1|||
160796994|NCT04116853|580645418|FG000|Overall Study|Began Other Weight Loss program|4|||
160796995|NCT04116853|580645419|FG001|Overall Study|Began Other Weight Loss program|8|||
160796996|NCT04116853|580645418|FG000|Overall Study|Began Anti-Obesity Medication|3|||
160796997|NCT04116853|580645419|FG001|Overall Study|Began Anti-Obesity Medication|3|||
160796998|NCT04116853|580645418|FG000|Overall Study|Protocol Violation|0|||
160796999|NCT04116853|580645419|FG001|Overall Study|Protocol Violation|1|||
160797000|NCT04522973|580645420|FG000|Overall Study|Lost to Follow-up|4|||
160797001|NCT04522973|580645420|FG000|Overall Study|Could not adhere to study schedule|1|||
160797002|NCT04696146|580647203|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
160797003|NCT04696146|580647204|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
160797004|NCT04696146|580647203|FG000|Overall Study|Off hours issue with product|1|||
160797005|NCT04696146|580647204|FG001|Overall Study|Off hours issue with product|0|||
160797006|NCT01576783|580647210|FG000|Overall Study|Change in Medical Care|1|||
160797007|NCT01576783|580647211|FG001|Overall Study|Change in Medical Care|0|||
160797008|NCT01576783|580647210|FG000|Overall Study|Lost to Follow-up|14|||
160797009|NCT01576783|580647211|FG001|Overall Study|Lost to Follow-up|16|||
160797010|NCT01576783|580647210|FG000|Overall Study|Withdrawal by Subject|5|||
160797011|NCT01576783|580647211|FG001|Overall Study|Withdrawal by Subject|1|||
160797012|NCT05489328|580647213|FG000|Overall Study|Lost to Follow-up|0|||
160797013|NCT05489328|580647214|FG001|Overall Study|Lost to Follow-up|0|||
160797014|NCT05489328|580647215|FG002|Overall Study|Lost to Follow-up|1|||
160797015|NCT05489328|580647216|FG003|Overall Study|Lost to Follow-up|0|||
160983566|NCT02611830|581328663|FG002|Maintenance Phase|Pregnancy|1|||
160797016|NCT05489328|580647217|FG004|Overall Study|Lost to Follow-up|2|||
160797017|NCT05489328|580647218|FG005|Overall Study|Lost to Follow-up|0|||
160797018|NCT05489328|580647219|FG006|Overall Study|Lost to Follow-up|0|||
160797019|NCT05489328|580647220|FG007|Overall Study|Lost to Follow-up|1|||
160983567|NCT02611830|581328664|FG003|Maintenance Phase|Pregnancy|0|||
160983568|NCT02611830|581328661|FG000|Maintenance Phase|Reason not specified|0|||
160983569|NCT02611830|581328662|FG001|Maintenance Phase|Reason not specified|1|||
160983570|NCT02611830|581328663|FG002|Maintenance Phase|Reason not specified|4|||
160983571|NCT02611830|581328664|FG003|Maintenance Phase|Reason not specified|0|||
160983572|NCT01987830|581328675|FG000|Overall Study|Never received baseline scan|1|||
160983573|NCT05764239|581328678|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
160983574|NCT05764239|581328678|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
160548940|NCT03403205|579736319|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
160797020|NCT05489328|580647221|FG008|Overall Study|Lost to Follow-up|0|||
160797021|NCT05489328|580647213|FG000|Overall Study|Withdrawal by Subject|0|||
160797022|NCT05489328|580647214|FG001|Overall Study|Withdrawal by Subject|0|||
160797023|NCT05489328|580647215|FG002|Overall Study|Withdrawal by Subject|0|||
160797024|NCT05489328|580647216|FG003|Overall Study|Withdrawal by Subject|0|||
160797025|NCT05489328|580647217|FG004|Overall Study|Withdrawal by Subject|0|||
160797026|NCT05489328|580647218|FG005|Overall Study|Withdrawal by Subject|0|||
160797027|NCT05489328|580647219|FG006|Overall Study|Withdrawal by Subject|1|||
160797028|NCT05489328|580647220|FG007|Overall Study|Withdrawal by Subject|1|||
160797029|NCT05489328|580647221|FG008|Overall Study|Withdrawal by Subject|0|||
160797030|NCT05489328|580647213|FG000|Overall Study|Other|0|||
160797031|NCT05489328|580647214|FG001|Overall Study|Other|0|||
160797032|NCT05489328|580647215|FG002|Overall Study|Other|0|||
160797033|NCT05489328|580647216|FG003|Overall Study|Other|0|||
160797034|NCT05489328|580647217|FG004|Overall Study|Other|0|||
160797035|NCT05489328|580647218|FG005|Overall Study|Other|0|||
160797036|NCT05489328|580647219|FG006|Overall Study|Other|0|||
160797037|NCT05489328|580647220|FG007|Overall Study|Other|1|||
160797038|NCT05489328|580647221|FG008|Overall Study|Other|1|||
160797039|NCT01083602|580647222|FG000|Overall Study|Adverse Event|11|||
160797040|NCT01083602|580647222|FG000|Overall Study|New Cancer Therapy|2|||
160797041|NCT01083602|580647222|FG000|Overall Study|Death|1|||
160797042|NCT01083602|580647222|FG000|Overall Study|Withdrawal by Subject|5|||
160983575|NCT05764239|581328678|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
160983576|NCT05764239|581328678|FG000|DEP (Part 1)|Adverse Event|1|||
160983577|NCT05764239|581328678|FG000|DEP (Part 1)|Lost to Follow-up|1|||
160548941|NCT03403205|579736320|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
160548942|NCT03403205|579736321|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
160548943|NCT03403205|579736322|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
160548944|NCT03403205|579736323|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
160548945|NCT03403205|579736318|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
160548946|NCT03403205|579736319|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
160797043|NCT01083602|580647222|FG000|Overall Study|Lack of Efficacy|36|||
160983578|NCT05764239|581328678|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
160983579|NCT05764239|581328678|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
160983580|NCT05764239|581328678|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
160797044|NCT01657370|580647224|FG000|Overall Study|Withdrawal by Subject|0|||
160797045|NCT01657370|580647225|FG001|Overall Study|Withdrawal by Subject|0|||
160797046|NCT01657370|580647226|FG002|Overall Study|Withdrawal by Subject|1|||
160797047|NCT01657370|580647227|FG003|Overall Study|Withdrawal by Subject|0|||
160797048|NCT01657370|580647228|FG004|Overall Study|Withdrawal by Subject|0|||
160797049|NCT01657370|580647229|FG005|Overall Study|Withdrawal by Subject|1|||
160797050|NCT01657370|580647224|FG000|Overall Study|Physician Decision|2|||
160797051|NCT01657370|580647225|FG001|Overall Study|Physician Decision|3|||
160797052|NCT01657370|580647226|FG002|Overall Study|Physician Decision|1|||
160797053|NCT01657370|580647227|FG003|Overall Study|Physician Decision|2|||
160797054|NCT01657370|580647228|FG004|Overall Study|Physician Decision|5|||
160797055|NCT01657370|580647229|FG005|Overall Study|Physician Decision|0|||
160797056|NCT01657370|580647224|FG000|Overall Study|Lack of Qualifying Event|1|||
160797057|NCT01657370|580647225|FG001|Overall Study|Lack of Qualifying Event|0|||
160797058|NCT01657370|580647226|FG002|Overall Study|Lack of Qualifying Event|3|||
160797059|NCT01657370|580647227|FG003|Overall Study|Lack of Qualifying Event|2|||
160797060|NCT01657370|580647228|FG004|Overall Study|Lack of Qualifying Event|1|||
160797061|NCT01657370|580647229|FG005|Overall Study|Lack of Qualifying Event|2|||
160797062|NCT01657370|580647224|FG000|Overall Study|Adverse Event|0|||
160797063|NCT01657370|580647225|FG001|Overall Study|Adverse Event|0|||
160797064|NCT01657370|580647226|FG002|Overall Study|Adverse Event|0|||
160797065|NCT01657370|580647227|FG003|Overall Study|Adverse Event|0|||
160797066|NCT01657370|580647228|FG004|Overall Study|Adverse Event|1|||
160797067|NCT01657370|580647229|FG005|Overall Study|Adverse Event|0|||
160797068|NCT01657370|580647224|FG000|Overall Study|Protocol Violation|1|||
160797069|NCT01657370|580647225|FG001|Overall Study|Protocol Violation|1|||
160797070|NCT01657370|580647226|FG002|Overall Study|Protocol Violation|1|||
160797071|NCT01657370|580647227|FG003|Overall Study|Protocol Violation|1|||
160797072|NCT01657370|580647228|FG004|Overall Study|Protocol Violation|0|||
160797073|NCT01657370|580647229|FG005|Overall Study|Protocol Violation|0|||
160797074|NCT01657370|580647224|FG000|Overall Study|Lost to Follow-up|2|||
160797075|NCT01657370|580647225|FG001|Overall Study|Lost to Follow-up|0|||
160797076|NCT01657370|580647226|FG002|Overall Study|Lost to Follow-up|1|||
160797077|NCT01657370|580647227|FG003|Overall Study|Lost to Follow-up|0|||
160797078|NCT01657370|580647228|FG004|Overall Study|Lost to Follow-up|0|||
160797079|NCT01657370|580647229|FG005|Overall Study|Lost to Follow-up|1|||
160797080|NCT02777086|580647230|FG000|Overall Study|Lost to Follow-up|96|||
160797081|NCT02777086|580647231|FG001|Overall Study|Lost to Follow-up|99|||
160797082|NCT01133665|580647232|FG000|Overall Study|Physician Decision|2|||
160797083|NCT01819272|580647233|FG000|Overall Study|Adverse Event|1|||
160797084|NCT01819272|580647234|FG001|Overall Study|Adverse Event|0|||
160797085|NCT01819272|580647235|FG002|Overall Study|Adverse Event|0|||
160797086|NCT01819272|580647236|FG003|Overall Study|Adverse Event|2|||
160797087|NCT01819272|580647237|FG004|Overall Study|Adverse Event|0|||
160797088|NCT01819272|580647238|FG005|Overall Study|Adverse Event|0|||
160797089|NCT01819272|580647233|FG000|Overall Study|Lost to Follow-up|3|||
160797090|NCT01819272|580647234|FG001|Overall Study|Lost to Follow-up|0|||
160797091|NCT01819272|580647235|FG002|Overall Study|Lost to Follow-up|1|||
160797092|NCT01819272|580647236|FG003|Overall Study|Lost to Follow-up|0|||
160797093|NCT01819272|580647237|FG004|Overall Study|Lost to Follow-up|0|||
160797094|NCT01819272|580647238|FG005|Overall Study|Lost to Follow-up|3|||
160797095|NCT01819272|580647233|FG000|Overall Study|Protocol Violation|0|||
160797096|NCT01819272|580647234|FG001|Overall Study|Protocol Violation|0|||
160797097|NCT01819272|580647235|FG002|Overall Study|Protocol Violation|0|||
160797098|NCT01819272|580647236|FG003|Overall Study|Protocol Violation|1|||
160797099|NCT01819272|580647237|FG004|Overall Study|Protocol Violation|2|||
160797100|NCT01819272|580647238|FG005|Overall Study|Protocol Violation|3|||
160797101|NCT01819272|580647233|FG000|Overall Study|Physician Decision|0|||
160797102|NCT01819272|580647234|FG001|Overall Study|Physician Decision|1|||
160797103|NCT01819272|580647235|FG002|Overall Study|Physician Decision|0|||
160797104|NCT01819272|580647236|FG003|Overall Study|Physician Decision|0|||
160797105|NCT01819272|580647237|FG004|Overall Study|Physician Decision|0|||
160797106|NCT01819272|580647238|FG005|Overall Study|Physician Decision|0|||
160797107|NCT01819272|580647233|FG000|Overall Study|Withdrawal of Consent|0|||
160797108|NCT01819272|580647234|FG001|Overall Study|Withdrawal of Consent|1|||
160797109|NCT01819272|580647235|FG002|Overall Study|Withdrawal of Consent|2|||
160797110|NCT01819272|580647236|FG003|Overall Study|Withdrawal of Consent|1|||
160797111|NCT01819272|580647237|FG004|Overall Study|Withdrawal of Consent|0|||
160797112|NCT01819272|580647238|FG005|Overall Study|Withdrawal of Consent|1|||
160797113|NCT01819272|580647233|FG000|Overall Study|Loss of Glucose Control|2|||
160797114|NCT01819272|580647234|FG001|Overall Study|Loss of Glucose Control|1|||
160797115|NCT01819272|580647235|FG002|Overall Study|Loss of Glucose Control|0|||
160797116|NCT01819272|580647236|FG003|Overall Study|Loss of Glucose Control|1|||
160797117|NCT01819272|580647237|FG004|Overall Study|Loss of Glucose Control|2|||
160797118|NCT01819272|580647238|FG005|Overall Study|Loss of Glucose Control|0|||
160797119|NCT03021486|580647239|FG000|Overall Study|Withdrawal by Subject|1|||
160797120|NCT03021486|580647240|FG001|Overall Study|Withdrawal by Subject|1|||
160797121|NCT03021486|580647241|FG002|Overall Study|Withdrawal by Subject|3|||
160797122|NCT03021486|580647239|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
160797123|NCT03021486|580647240|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
160797124|NCT03021486|580647241|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
160797125|NCT04043286|580647242|FG000|Overall Study|Withdrawal by Subject|2|||
160797126|NCT04043286|580647243|FG001|Overall Study|Withdrawal by Subject|2|||
160797127|NCT03376516|580647244|FG000|Overall Study|Not treated|1|||
160797128|NCT03376516|580647244|FG000|Overall Study|Consent withdrawn|1|||
160797129|NCT01581684|580647245|FG000|Overall Study|Other reason not defined|0|||
160797130|NCT01581684|580647246|FG001|Overall Study|Other reason not defined|0|||
160797131|NCT01581684|580647247|FG002|Overall Study|Other reason not defined|0|||
160797132|NCT01581684|580647248|FG003|Overall Study|Other reason not defined|0|||
160797133|NCT01581684|580647249|FG004|Overall Study|Other reason not defined|0|||
160797134|NCT01581684|580647250|FG005|Overall Study|Other reason not defined|0|||
160797135|NCT01581684|580647251|FG006|Overall Study|Other reason not defined|0|||
160797136|NCT01581684|580647252|FG007|Overall Study|Other reason not defined|0|||
160797137|NCT01581684|580647253|FG008|Overall Study|Other reason not defined|1|||
160797138|NCT01581684|580647254|FG009|Overall Study|Other reason not defined|0|||
160797139|NCT03186638|580647255|FG000|Overall Study|Withdrawal by Subject|4|||
160797140|NCT03186638|580647256|FG001|Overall Study|Withdrawal by Subject|4|||
160797141|NCT03186638|580647255|FG000|Overall Study|Withdrawn due to medical problem|3|||
160797142|NCT03186638|580647256|FG001|Overall Study|Withdrawn due to medical problem|2|||
160797143|NCT03186638|580647255|FG000|Overall Study|Lost to Follow-up|1|||
160797144|NCT03186638|580647256|FG001|Overall Study|Lost to Follow-up|0|||
160797145|NCT01664624|580647259|FG000|Overall Study|Adverse Event|0|||
160797146|NCT01664624|580647260|FG001|Overall Study|Adverse Event|1|||
160797147|NCT01664624|580647261|FG002|Overall Study|Adverse Event|0|||
160797148|NCT01664624|580647262|FG003|Overall Study|Adverse Event|0|||
160797149|NCT01029535|580647263|FG000|Overall Study|Lost to Follow-up|24|||
160797150|NCT01029535|580647263|FG000|Overall Study|Protocol Violation|2|||
160797151|NCT01029535|580647263|FG000|Overall Study|Participant Withdrew Consent|2|||
160797152|NCT01029535|580647263|FG000|Overall Study|Adverse Event|1|||
160797153|NCT01029535|580647263|FG000|Overall Study|Use of Another Treatment|1|||
160797154|NCT01029535|580647263|FG000|Overall Study|Death|1|||
160797155|NCT02410772|580647269|FG000|Overall Study|Death|3|||
160797156|NCT02410772|580647270|FG001|Overall Study|Death|4|||
160797157|NCT02410772|580647271|FG002|Overall Study|Death|8|||
160797158|NCT02410772|580647269|FG000|Overall Study|Lost to Follow-up|31|||
160797159|NCT02410772|580647270|FG001|Overall Study|Lost to Follow-up|23|||
160797160|NCT02410772|580647271|FG002|Overall Study|Lost to Follow-up|22|||
160797161|NCT02410772|580647269|FG000|Overall Study|Pregnancy|8|||
160797162|NCT02410772|580647270|FG001|Overall Study|Pregnancy|4|||
160797163|NCT02410772|580647271|FG002|Overall Study|Pregnancy|5|||
160797164|NCT02410772|580647269|FG000|Overall Study|Protocol Violation|8|||
160797165|NCT02410772|580647270|FG001|Overall Study|Protocol Violation|8|||
160797166|NCT02410772|580647271|FG002|Overall Study|Protocol Violation|4|||
160797167|NCT02410772|580647269|FG000|Overall Study|Baseline Drug Resistance|49|||
160797168|NCT02410772|580647270|FG001|Overall Study|Baseline Drug Resistance|40|||
160797169|NCT02410772|580647271|FG002|Overall Study|Baseline Drug Resistance|51|||
160797170|NCT02410772|580647269|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
160797171|NCT02410772|580647270|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
160797172|NCT02410772|580647271|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
160797173|NCT02410772|580647269|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
160797174|NCT02410772|580647270|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
160797175|NCT02410772|580647271|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
160797176|NCT01870869|580647276|FG000|Overall Study|Implanted with nonstudy device|1|||
160797177|NCT01870869|580647277|FG001|Overall Study|Implanted with nonstudy device|3|||
160797178|NCT01870869|580647278|FG002|Overall Study|Implanted with nonstudy device|14|||
160797179|NCT01870869|580647279|FG003|Overall Study|Implanted with nonstudy device|4|||
160643305|NCT01144663|580076537|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
160643306|NCT01144663|580076534|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
160643307|NCT01144663|580076535|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
160643308|NCT01144663|580076536|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
160643309|NCT01144663|580076537|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
160643310|NCT01267266|580076540|FG000|Enrollment Phase|Withdrawal by Subject|2|||
160797180|NCT01870869|580647276|FG000|Overall Study|Death|0|||
160797181|NCT01870869|580647277|FG001|Overall Study|Death|0|||
160797182|NCT01870869|580647278|FG002|Overall Study|Death|7|||
160797183|NCT01870869|580647279|FG003|Overall Study|Death|1|||
160797184|NCT01870869|580647276|FG000|Overall Study|Subject choice|6|||
160797185|NCT01870869|580647277|FG001|Overall Study|Subject choice|2|||
160797186|NCT01870869|580647278|FG002|Overall Study|Subject choice|22|||
160797187|NCT01870869|580647279|FG003|Overall Study|Subject choice|8|||
160797188|NCT01870869|580647276|FG000|Overall Study|Lost to Follow-up|10|||
160797189|NCT01870869|580647277|FG001|Overall Study|Lost to Follow-up|2|||
160797190|NCT01870869|580647278|FG002|Overall Study|Lost to Follow-up|25|||
160797191|NCT01870869|580647279|FG003|Overall Study|Lost to Follow-up|3|||
160797192|NCT01870869|580647276|FG000|Overall Study|Reason not Specified|1|||
160797193|NCT01870869|580647277|FG001|Overall Study|Reason not Specified|2|||
160797194|NCT01870869|580647278|FG002|Overall Study|Reason not Specified|20|||
160797195|NCT01870869|580647279|FG003|Overall Study|Reason not Specified|4|||
160797196|NCT01870869|580647276|FG000|Overall Study|Not evaluable|10|||
160797197|NCT01870869|580647277|FG001|Overall Study|Not evaluable|5|||
160797198|NCT01870869|580647278|FG002|Overall Study|Not evaluable|42|||
160797199|NCT01870869|580647279|FG003|Overall Study|Not evaluable|10|||
160797200|NCT00904371|580647280|FG000|Overall Study|Adverse Event|2|||
160797201|NCT00904371|580647280|FG000|Overall Study|Lost to Follow-up|4|||
160797202|NCT00904371|580647280|FG000|Overall Study|Discontinued at target blood pressure|2|||
160797203|NCT00904371|580647280|FG000|Overall Study|Continued with Tritace|1|||
160797204|NCT00419744|580647283|FG000|Overall Study|Adverse Event|39|||
160797205|NCT00419744|580647284|FG001|Overall Study|Adverse Event|40|||
160797206|NCT00419744|580647285|FG002|Overall Study|Adverse Event|50|||
160797207|NCT00419744|580647283|FG000|Overall Study|Withdrawal by Subject|45|||
160797208|NCT00419744|580647284|FG001|Overall Study|Withdrawal by Subject|49|||
160797209|NCT00419744|580647285|FG002|Overall Study|Withdrawal by Subject|52|||
160797210|NCT00419744|580647283|FG000|Overall Study|Lost to Follow-up|8|||
160797211|NCT00419744|580647284|FG001|Overall Study|Lost to Follow-up|10|||
160797212|NCT00419744|580647285|FG002|Overall Study|Lost to Follow-up|6|||
160797213|NCT00419744|580647283|FG000|Overall Study|Protocol Violation|4|||
160797214|NCT00419744|580647284|FG001|Overall Study|Protocol Violation|7|||
160797215|NCT00419744|580647285|FG002|Overall Study|Protocol Violation|8|||
160797216|NCT00419744|580647283|FG000|Overall Study|Randomized in error|9|||
160797217|NCT00419744|580647284|FG001|Overall Study|Randomized in error|6|||
160797218|NCT00419744|580647285|FG002|Overall Study|Randomized in error|7|||
160797219|NCT00419744|580647283|FG000|Overall Study|Moving out of state|2|||
160797220|NCT00419744|580647284|FG001|Overall Study|Moving out of state|0|||
160797221|NCT00419744|580647285|FG002|Overall Study|Moving out of state|1|||
160797222|NCT00419744|580647283|FG000|Overall Study|Physician Decision|10|||
160797223|NCT00419744|580647284|FG001|Overall Study|Physician Decision|5|||
160797224|NCT00419744|580647285|FG002|Overall Study|Physician Decision|6|||
160797225|NCT00419744|580647283|FG000|Overall Study|Spirometry mouthpiece issues|0|||
160797226|NCT00419744|580647284|FG001|Overall Study|Spirometry mouthpiece issues|1|||
160548947|NCT03403205|579736320|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
160548948|NCT03403205|579736321|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
160548949|NCT03403205|579736322|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
160548950|NCT03403205|579736323|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
160548951|NCT03403205|579736318|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
160548952|NCT03403205|579736319|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
160548953|NCT03403205|579736320|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
160548954|NCT03403205|579736321|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
160548955|NCT03403205|579736322|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
160797227|NCT00419744|580647285|FG002|Overall Study|Spirometry mouthpiece issues|2|||
160797228|NCT00419744|580647283|FG000|Overall Study|Incorrect medication kit dispensed|0|||
160797229|NCT00419744|580647284|FG001|Overall Study|Incorrect medication kit dispensed|0|||
160797230|NCT00419744|580647285|FG002|Overall Study|Incorrect medication kit dispensed|1|||
160797231|NCT00673920|580647287|FG000|Baseline up to Week 48|Withdrew consent|1|||
160797232|NCT00673920|580647288|FG001|Baseline up to Week 48|Withdrew consent|0|||
160797233|NCT00673920|580647289|FG002|Baseline up to Week 48|Withdrew consent|2|||
160797234|NCT00673920|580647290|FG003|Baseline up to Week 48|Withdrew consent|0|||
160797235|NCT00673920|580647291|FG004|Baseline up to Week 48|Withdrew consent|0|||
160797236|NCT00673920|580647292|FG005|Baseline up to Week 48|Withdrew consent|0|||
160797237|NCT00673920|580647293|FG006|Baseline up to Week 48|Withdrew consent|0|||
160797238|NCT00673920|580647294|FG007|Baseline up to Week 48|Withdrew consent|0|||
160797239|NCT00673920|580647287|FG000|Baseline up to Week 48|Refused treatment|1|||
160797240|NCT00673920|580647288|FG001|Baseline up to Week 48|Refused treatment|0|||
160797241|NCT00673920|580647289|FG002|Baseline up to Week 48|Refused treatment|0|||
160797242|NCT00673920|580647290|FG003|Baseline up to Week 48|Refused treatment|0|||
160797243|NCT00673920|580647291|FG004|Baseline up to Week 48|Refused treatment|0|||
160797244|NCT00673920|580647292|FG005|Baseline up to Week 48|Refused treatment|0|||
160797245|NCT00673920|580647293|FG006|Baseline up to Week 48|Refused treatment|0|||
160797246|NCT00673920|580647294|FG007|Baseline up to Week 48|Refused treatment|0|||
160548956|NCT03403205|579736323|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
160643311|NCT01267266|580076541|FG001|Enrollment Phase|Withdrawal by Subject|0|||
160643312|NCT01267266|580076540|FG000|Lead-in Phase|Lack of Efficacy|20|||
160643313|NCT01267266|580076541|FG001|Lead-in Phase|Lack of Efficacy|0|||
160797247|NCT00673920|580647287|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
160797248|NCT00673920|580647288|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
160797249|NCT00673920|580647289|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797250|NCT00673920|580647290|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797251|NCT00673920|580647291|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797252|NCT00673920|580647292|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797253|NCT00673920|580647293|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797254|NCT00673920|580647294|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797255|NCT00673920|580647287|FG000|Baseline up to Week 48|Protocol Violation|0|||
160797256|NCT00673920|580647288|FG001|Baseline up to Week 48|Protocol Violation|0|||
160797257|NCT00673920|580647289|FG002|Baseline up to Week 48|Protocol Violation|1|||
160797258|NCT00673920|580647290|FG003|Baseline up to Week 48|Protocol Violation|0|||
160797259|NCT00673920|580647291|FG004|Baseline up to Week 48|Protocol Violation|0|||
160797260|NCT00673920|580647292|FG005|Baseline up to Week 48|Protocol Violation|0|||
160797261|NCT00673920|580647293|FG006|Baseline up to Week 48|Protocol Violation|0|||
160797262|NCT00673920|580647294|FG007|Baseline up to Week 48|Protocol Violation|0|||
160797263|NCT00673920|580647287|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797264|NCT00673920|580647288|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797265|NCT00673920|580647289|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
160797266|NCT00673920|580647290|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797267|NCT00673920|580647291|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797268|NCT00673920|580647292|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797269|NCT00673920|580647293|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797270|NCT00673920|580647294|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797271|NCT00673920|580647287|FG000|Baseline up to Week 48|Administrative/Other|0|||
160797272|NCT00673920|580647288|FG001|Baseline up to Week 48|Administrative/Other|1|||
160797273|NCT00673920|580647289|FG002|Baseline up to Week 48|Administrative/Other|2|||
160797274|NCT00673920|580647290|FG003|Baseline up to Week 48|Administrative/Other|0|||
160797275|NCT00673920|580647291|FG004|Baseline up to Week 48|Administrative/Other|0|||
160797276|NCT00673920|580647292|FG005|Baseline up to Week 48|Administrative/Other|0|||
160797277|NCT00673920|580647293|FG006|Baseline up to Week 48|Administrative/Other|0|||
160797278|NCT00673920|580647294|FG007|Baseline up to Week 48|Administrative/Other|0|||
160797279|NCT00673920|580647287|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797280|NCT00673920|580647288|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
160797281|NCT00673920|580647289|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
160797282|NCT00673920|580647290|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797283|NCT00673920|580647291|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797284|NCT00673920|580647292|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797285|NCT00673920|580647293|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797286|NCT00673920|580647294|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797287|NCT00673920|580647287|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797288|NCT00673920|580647288|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160894525|NCT02570074|581010841|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
160894526|NCT03793556|581010844|FG000|Overall Study|Withdrawal by Subject|12|||
160797289|NCT00673920|580647289|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797290|NCT00673920|580647290|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797291|NCT00673920|580647291|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797292|NCT00673920|580647292|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797293|NCT00673920|580647293|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
160797294|NCT00673920|580647294|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797295|NCT00673920|580647287|FG000|Week 24 to Week 48|Failure to return|0|||
160797296|NCT00673920|580647288|FG001|Week 24 to Week 48|Failure to return|0|||
160797297|NCT00673920|580647289|FG002|Week 24 to Week 48|Failure to return|0|||
160797298|NCT00673920|580647290|FG003|Week 24 to Week 48|Failure to return|0|||
160797299|NCT00673920|580647291|FG004|Week 24 to Week 48|Failure to return|0|||
160797300|NCT00673920|580647292|FG005|Week 24 to Week 48|Failure to return|1|||
160797301|NCT00673920|580647293|FG006|Week 24 to Week 48|Failure to return|0|||
160797302|NCT00673920|580647294|FG007|Week 24 to Week 48|Failure to return|0|||
160797303|NCT00673920|580647287|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797304|NCT00673920|580647288|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797305|NCT00673920|580647289|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797306|NCT00673920|580647290|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797307|NCT00673920|580647291|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797308|NCT00673920|580647292|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
160797309|NCT00673920|580647293|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797310|NCT00673920|580647294|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797311|NCT00673920|580647287|FG000|Week 24 to Week 48|Death|0|||
160797312|NCT00673920|580647288|FG001|Week 24 to Week 48|Death|0|||
160797313|NCT00673920|580647289|FG002|Week 24 to Week 48|Death|0|||
160797314|NCT00673920|580647290|FG003|Week 24 to Week 48|Death|0|||
160797315|NCT00673920|580647291|FG004|Week 24 to Week 48|Death|0|||
160797316|NCT00673920|580647292|FG005|Week 24 to Week 48|Death|1|||
160797317|NCT00673920|580647293|FG006|Week 24 to Week 48|Death|0|||
160797318|NCT00673920|580647294|FG007|Week 24 to Week 48|Death|0|||
160797319|NCT00673920|580647287|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
160797320|NCT00673920|580647288|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
160797321|NCT00673920|580647289|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
160797322|NCT00673920|580647290|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
160797323|NCT00673920|580647291|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
160797324|NCT00673920|580647292|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
160797325|NCT00673920|580647293|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
160797326|NCT00673920|580647294|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
160797327|NCT02493764|580647295|FG000|Overall Study|Adverse Event|2|||
160797328|NCT02493764|580647296|FG001|Overall Study|Adverse Event|2|||
160797329|NCT02493764|580647295|FG000|Overall Study|Death|44|||
160797330|NCT02493764|580647296|FG001|Overall Study|Death|58|||
160797331|NCT02493764|580647295|FG000|Overall Study|Lost to Follow-up|2|||
160797332|NCT02493764|580647296|FG001|Overall Study|Lost to Follow-up|1|||
160797333|NCT02493764|580647295|FG000|Overall Study|Protocol Violation|6|||
160797334|NCT02493764|580647296|FG001|Overall Study|Protocol Violation|7|||
160894527|NCT03793556|581010845|FG001|Overall Study|Withdrawal by Subject|1|||
160894528|NCT03793556|581010844|FG000|Overall Study|Lost to Follow-up|1|||
160894529|NCT03793556|581010845|FG001|Overall Study|Lost to Follow-up|1|||
160643314|NCT01267266|580076540|FG000|Lead-in Phase|Adverse Event|2|||
160797335|NCT02493764|580647295|FG000|Overall Study|Physician Decision|1|||
160797336|NCT02493764|580647296|FG001|Overall Study|Physician Decision|1|||
160797337|NCT02493764|580647295|FG000|Overall Study|Participant moved|17|||
160548957|NCT03403205|579736318|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
160548958|NCT03403205|579736319|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
160894530|NCT01325623|581010846|FG000|Overall Study|Withdrawal by Subject|3|||
160894531|NCT02556203|581010855|FG000|Overall Study|Withdrawal by Subject|21|||
160894532|NCT02556203|581010856|FG001|Overall Study|Withdrawal by Subject|21|||
160894533|NCT02556203|581010855|FG000|Overall Study|Lost to Follow-up|5|||
160894534|NCT02556203|581010856|FG001|Overall Study|Lost to Follow-up|5|||
160894535|NCT02556203|581010855|FG000|Overall Study|Adverse Event|1|||
160894536|NCT02556203|581010856|FG001|Overall Study|Adverse Event|0|||
160894537|NCT02943460|581010861|FG000|Blinded Study Phase|Adverse Event|3|||
160894538|NCT02943460|581010862|FG001|Blinded Study Phase|Adverse Event|0|||
160894539|NCT02943460|581010863|FG002|Blinded Study Phase|Adverse Event|0|||
160894540|NCT02943460|581010861|FG000|Blinded Study Phase|Withdrew Consent|0|||
160894541|NCT02943460|581010862|FG001|Blinded Study Phase|Withdrew Consent|1|||
160894542|NCT02943460|581010863|FG002|Blinded Study Phase|Withdrew Consent|0|||
160894543|NCT02943460|581010861|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
160894544|NCT02943460|581010862|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
160894545|NCT02943460|581010863|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
160894546|NCT02943460|581010861|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
160894547|NCT02943460|581010862|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
160894548|NCT02943460|581010863|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
160894549|NCT02943460|581010861|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
160894550|NCT02943460|581010862|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
160894551|NCT02943460|581010863|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
160894552|NCT04171765|581010864|FG000|Overall Study|Adverse Event|2|||
160894553|NCT04171765|581010865|FG001|Overall Study|Adverse Event|0|||
160894554|NCT04171765|581010866|FG002|Overall Study|Adverse Event|1|||
160894555|NCT04171765|581010867|FG003|Overall Study|Adverse Event|0|||
160894556|NCT04171765|581010864|FG000|Overall Study|Lost to Follow-up|0|||
160894557|NCT04171765|581010865|FG001|Overall Study|Lost to Follow-up|2|||
160894558|NCT04171765|581010866|FG002|Overall Study|Lost to Follow-up|2|||
160894559|NCT04171765|581010867|FG003|Overall Study|Lost to Follow-up|2|||
160894560|NCT04171765|581010864|FG000|Overall Study|Week 58 visit missed|0|||
160894561|NCT04171765|581010865|FG001|Overall Study|Week 58 visit missed|0|||
160894562|NCT04171765|581010866|FG002|Overall Study|Week 58 visit missed|1|||
160894563|NCT04171765|581010867|FG003|Overall Study|Week 58 visit missed|0|||
160894564|NCT04171765|581010864|FG000|Overall Study|Study terminated by sponsor|2|||
160894565|NCT04171765|581010865|FG001|Overall Study|Study terminated by sponsor|0|||
160894566|NCT04171765|581010866|FG002|Overall Study|Study terminated by sponsor|0|||
160894567|NCT04171765|581010867|FG003|Overall Study|Study terminated by sponsor|0|||
160894568|NCT04171765|581010864|FG000|Overall Study|Withdrawal by Subject|1|||
160894569|NCT04171765|581010865|FG001|Overall Study|Withdrawal by Subject|0|||
160894570|NCT04171765|581010866|FG002|Overall Study|Withdrawal by Subject|0|||
160894571|NCT04171765|581010867|FG003|Overall Study|Withdrawal by Subject|3|||
160894572|NCT00809354|581010868|FG000|Overall Study|Adverse Event|32|||
160894573|NCT00809354|581010869|FG001|Overall Study|Adverse Event|45|||
160894574|NCT00809354|581010870|FG002|Overall Study|Adverse Event|37|||
160894575|NCT00809354|581010871|FG003|Overall Study|Adverse Event|53|||
160894576|NCT00809354|581010872|FG004|Overall Study|Adverse Event|26|||
160894577|NCT00809354|581010873|FG005|Overall Study|Adverse Event|33|||
160894578|NCT00809354|581010874|FG006|Overall Study|Adverse Event|44|||
160894579|NCT00809354|581010875|FG007|Overall Study|Adverse Event|40|||
160548959|NCT03403205|579736320|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
160548960|NCT03403205|579736321|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
160548961|NCT03403205|579736322|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
160548962|NCT03403205|579736323|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
160548963|NCT03403205|579736318|FG000|Extension Period (Up to 60 Months)|Death|1|||
160548964|NCT03403205|579736319|FG001|Extension Period (Up to 60 Months)|Death|0|||
160548965|NCT03403205|579736320|FG002|Extension Period (Up to 60 Months)|Death|0|||
160548966|NCT03403205|579736321|FG003|Extension Period (Up to 60 Months)|Death|0|||
160548967|NCT03403205|579736322|FG004|Extension Period (Up to 60 Months)|Death|0|||
160548968|NCT03403205|579736323|FG005|Extension Period (Up to 60 Months)|Death|0|||
160548969|NCT03403205|579736318|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
160548970|NCT03403205|579736319|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
160548971|NCT03403205|579736320|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
160548972|NCT03403205|579736321|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
160548973|NCT03403205|579736322|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
160548974|NCT03403205|579736323|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
160548975|NCT03403205|579736318|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
160643315|NCT01267266|580076541|FG001|Lead-in Phase|Adverse Event|0|||
160894580|NCT00809354|581010876|FG008|Overall Study|Adverse Event|46|||
160894581|NCT00809354|581010877|FG009|Overall Study|Adverse Event|26|||
160894582|NCT00809354|581010868|FG000|Overall Study|Lack of Efficacy|23|||
160894583|NCT00809354|581010869|FG001|Overall Study|Lack of Efficacy|23|||
160894584|NCT00809354|581010870|FG002|Overall Study|Lack of Efficacy|22|||
160894585|NCT00809354|581010871|FG003|Overall Study|Lack of Efficacy|15|||
160894586|NCT00809354|581010872|FG004|Overall Study|Lack of Efficacy|40|||
160894587|NCT00809354|581010873|FG005|Overall Study|Lack of Efficacy|19|||
160894588|NCT00809354|581010874|FG006|Overall Study|Lack of Efficacy|21|||
160894589|NCT00809354|581010875|FG007|Overall Study|Lack of Efficacy|15|||
160894590|NCT00809354|581010876|FG008|Overall Study|Lack of Efficacy|18|||
160894591|NCT00809354|581010877|FG009|Overall Study|Lack of Efficacy|38|||
160894592|NCT00809354|581010868|FG000|Overall Study|Lost to Follow-up|10|||
160894593|NCT00809354|581010869|FG001|Overall Study|Lost to Follow-up|11|||
160894594|NCT00809354|581010870|FG002|Overall Study|Lost to Follow-up|8|||
160894595|NCT00809354|581010871|FG003|Overall Study|Lost to Follow-up|13|||
160894596|NCT00809354|581010872|FG004|Overall Study|Lost to Follow-up|6|||
160894597|NCT00809354|581010873|FG005|Overall Study|Lost to Follow-up|2|||
160894598|NCT00809354|581010874|FG006|Overall Study|Lost to Follow-up|0|||
160894599|NCT00809354|581010875|FG007|Overall Study|Lost to Follow-up|5|||
160894600|NCT00809354|581010876|FG008|Overall Study|Lost to Follow-up|4|||
160797338|NCT02493764|580647296|FG001|Overall Study|Participant moved|5|||
160797339|NCT02493764|580647295|FG000|Overall Study|Withdrawal parent/guardian|0|||
160797340|NCT02493764|580647296|FG001|Overall Study|Withdrawal parent/guardian|1|||
160797341|NCT02493764|580647295|FG000|Overall Study|Withdrawal by Subject|11|||
160797342|NCT02493764|580647296|FG001|Overall Study|Withdrawal by Subject|7|||
160797343|NCT01463527|580647298|FG000|Overall Study|Protocol Violation|1|||
160797344|NCT01463527|580647299|FG001|Overall Study|Protocol Violation|1|||
160797345|NCT01463527|580647298|FG000|Overall Study|Crying >20% of sedation|5|||
160797346|NCT01463527|580647299|FG001|Overall Study|Crying >20% of sedation|6|||
160797347|NCT01977222|580647302|FG000|Overall Study|Withdrawal by Subject|1|||
160797348|NCT04846231|580647303|FG000|Overall Study|Lost to Follow-up|1|||
160797349|NCT04846231|580647304|FG001|Overall Study|Lost to Follow-up|0|||
160797350|NCT04846231|580647305|FG002|Overall Study|Lost to Follow-up|0|||
160797351|NCT04846231|580647306|FG003|Overall Study|Lost to Follow-up|0|||
160797352|NCT04846231|580647307|FG004|Overall Study|Lost to Follow-up|0|||
160797353|NCT04846231|580647308|FG005|Overall Study|Lost to Follow-up|0|||
160797354|NCT04846231|580647309|FG006|Overall Study|Lost to Follow-up|0|||
160797355|NCT04846231|580647310|FG007|Overall Study|Lost to Follow-up|1|||
160797356|NCT04846231|580647303|FG000|Overall Study|Withdrawal by Subject|0|||
160797357|NCT04846231|580647304|FG001|Overall Study|Withdrawal by Subject|1|||
160797358|NCT04846231|580647305|FG002|Overall Study|Withdrawal by Subject|2|||
160797359|NCT04846231|580647306|FG003|Overall Study|Withdrawal by Subject|1|||
160797360|NCT04846231|580647307|FG004|Overall Study|Withdrawal by Subject|0|||
160797361|NCT04846231|580647308|FG005|Overall Study|Withdrawal by Subject|0|||
160797362|NCT04846231|580647309|FG006|Overall Study|Withdrawal by Subject|0|||
160797363|NCT04846231|580647310|FG007|Overall Study|Withdrawal by Subject|0|||
160797364|NCT04846231|580647303|FG000|Overall Study|Protocol Violation|0|||
160797365|NCT04846231|580647304|FG001|Overall Study|Protocol Violation|1|||
160797366|NCT04846231|580647305|FG002|Overall Study|Protocol Violation|0|||
160797367|NCT04846231|580647306|FG003|Overall Study|Protocol Violation|0|||
160797368|NCT04846231|580647307|FG004|Overall Study|Protocol Violation|0|||
160797369|NCT04846231|580647308|FG005|Overall Study|Protocol Violation|0|||
160797370|NCT04846231|580647309|FG006|Overall Study|Protocol Violation|0|||
160797371|NCT04846231|580647310|FG007|Overall Study|Protocol Violation|0|||
160797372|NCT04846231|580647303|FG000|Overall Study|Adverse Event|0|||
160797373|NCT04846231|580647304|FG001|Overall Study|Adverse Event|0|||
160797374|NCT04846231|580647305|FG002|Overall Study|Adverse Event|0|||
160797375|NCT04846231|580647306|FG003|Overall Study|Adverse Event|0|||
160797376|NCT04846231|580647307|FG004|Overall Study|Adverse Event|0|||
160797377|NCT04846231|580647308|FG005|Overall Study|Adverse Event|0|||
160797378|NCT04846231|580647309|FG006|Overall Study|Adverse Event|1|||
160797379|NCT04846231|580647310|FG007|Overall Study|Adverse Event|1|||
160797380|NCT02980107|580647311|FG000|Overall Study|Withdrawal by Subject|51|||
160797381|NCT02980107|580647312|FG001|Overall Study|Withdrawal by Subject|62|||
160797382|NCT03746015|580647313|FG000|Overall Study|Withdrawal of Consent|1|||
160797383|NCT03746015|580647314|FG001|Overall Study|Withdrawal of Consent|0|||
160797384|NCT03746015|580647315|FG002|Overall Study|Withdrawal of Consent|0|||
160797385|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
160797386|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
160797387|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
160894601|NCT00809354|581010877|FG009|Overall Study|Lost to Follow-up|0|||
160548976|NCT03403205|579736319|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
160548977|NCT03403205|579736320|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
160548978|NCT03403205|579736321|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
160548979|NCT03403205|579736322|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
160548980|NCT03403205|579736323|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
160548981|NCT03403205|579736318|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
160548982|NCT03403205|579736319|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
160894602|NCT00809354|581010868|FG000|Overall Study|Protocol Violation|7|||
160894603|NCT00809354|581010869|FG001|Overall Study|Protocol Violation|14|||
160894604|NCT00809354|581010870|FG002|Overall Study|Protocol Violation|14|||
160894605|NCT00809354|581010871|FG003|Overall Study|Protocol Violation|12|||
160643316|NCT01267266|580076540|FG000|Lead-in Phase|Withdrawal by Subject|1|||
160643317|NCT01267266|580076541|FG001|Lead-in Phase|Withdrawal by Subject|0|||
160643318|NCT01335477|580076543|FG000|Overall Study|Adverse Event|30|||
160894606|NCT00809354|581010872|FG004|Overall Study|Protocol Violation|14|||
160894607|NCT00809354|581010873|FG005|Overall Study|Protocol Violation|6|||
160894608|NCT00809354|581010874|FG006|Overall Study|Protocol Violation|4|||
160894609|NCT00809354|581010875|FG007|Overall Study|Protocol Violation|6|||
160894610|NCT00809354|581010876|FG008|Overall Study|Protocol Violation|9|||
160894611|NCT00809354|581010877|FG009|Overall Study|Protocol Violation|3|||
160894612|NCT00809354|581010868|FG000|Overall Study|Withdrawal by Subject|32|||
160894613|NCT00809354|581010869|FG001|Overall Study|Withdrawal by Subject|27|||
160894614|NCT00809354|581010870|FG002|Overall Study|Withdrawal by Subject|31|||
160894615|NCT00809354|581010871|FG003|Overall Study|Withdrawal by Subject|33|||
160894616|NCT00809354|581010872|FG004|Overall Study|Withdrawal by Subject|34|||
160894617|NCT00809354|581010873|FG005|Overall Study|Withdrawal by Subject|29|||
160894618|NCT00809354|581010874|FG006|Overall Study|Withdrawal by Subject|27|||
160894619|NCT00809354|581010875|FG007|Overall Study|Withdrawal by Subject|19|||
160894620|NCT00809354|581010876|FG008|Overall Study|Withdrawal by Subject|18|||
160894621|NCT00809354|581010877|FG009|Overall Study|Withdrawal by Subject|20|||
160894622|NCT00809354|581010868|FG000|Overall Study|Other|10|||
160894623|NCT00809354|581010869|FG001|Overall Study|Other|2|||
160894624|NCT00809354|581010870|FG002|Overall Study|Other|7|||
160894625|NCT00809354|581010871|FG003|Overall Study|Other|10|||
160894626|NCT00809354|581010872|FG004|Overall Study|Other|5|||
160894627|NCT00809354|581010873|FG005|Overall Study|Other|3|||
160894628|NCT00809354|581010874|FG006|Overall Study|Other|2|||
160894629|NCT00809354|581010875|FG007|Overall Study|Other|3|||
160643319|NCT01335477|580076544|FG001|Overall Study|Adverse Event|42|||
160894630|NCT00809354|581010876|FG008|Overall Study|Other|4|||
160894631|NCT00809354|581010877|FG009|Overall Study|Other|3|||
160643320|NCT01335477|580076543|FG000|Overall Study|Non compliant with protocol|0|||
160643321|NCT01335477|580076544|FG001|Overall Study|Non compliant with protocol|2|||
160643322|NCT01335477|580076543|FG000|Overall Study|Lost to Follow-up|1|||
160643323|NCT01335477|580076544|FG001|Overall Study|Lost to Follow-up|2|||
160643324|NCT01335477|580076543|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
160643325|NCT01335477|580076544|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
160643326|NCT01335477|580076543|FG000|Overall Study|Not treated|1|||
160643327|NCT01335477|580076544|FG001|Overall Study|Not treated|2|||
160643328|NCT01335477|580076543|FG000|Overall Study|Reason other than those stated above|2|||
160643329|NCT01335477|580076544|FG001|Overall Study|Reason other than those stated above|2|||
160643330|NCT02038634|580076546|FG000|Overall Study|Lost to Follow-up|0|||
160643331|NCT02038634|580076547|FG001|Overall Study|Lost to Follow-up|1|||
160643332|NCT01706198|580076549|FG000|Overall Study|Adverse Event|12|||
160643333|NCT01706198|580076550|FG001|Overall Study|Adverse Event|15|||
160643334|NCT01706198|580076549|FG000|Overall Study|Protocol Violation|7|||
160643335|NCT01706198|580076550|FG001|Overall Study|Protocol Violation|5|||
160643336|NCT01706198|580076549|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
160643337|NCT01706198|580076550|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
160643338|NCT01706198|580076549|FG000|Overall Study|Lost to Follow-up|97|||
160643339|NCT01706198|580076550|FG001|Overall Study|Lost to Follow-up|93|||
160643340|NCT01706198|580076549|FG000|Overall Study|Physician Decision|23|||
160643341|NCT01706198|580076550|FG001|Overall Study|Physician Decision|37|||
160643342|NCT01706198|580076549|FG000|Overall Study|Withdrawal by Subject|23|||
160643343|NCT01706198|580076550|FG001|Overall Study|Withdrawal by Subject|31|||
160643344|NCT02480010|580076555|FG000|Overall Study|Adverse Event|3|||
160643345|NCT02480010|580076556|FG001|Overall Study|Adverse Event|1|||
160643346|NCT02480010|580076555|FG000|Overall Study|Death|1|||
160643347|NCT02480010|580076556|FG001|Overall Study|Death|0|||
160643348|NCT02480010|580076555|FG000|Overall Study|Insufficient therapeutic response|31|||
160643349|NCT02480010|580076556|FG001|Overall Study|Insufficient therapeutic response|29|||
160643350|NCT02480010|580076555|FG000|Overall Study|Refused Treatment|0|||
160643351|NCT02480010|580076556|FG001|Overall Study|Refused Treatment|3|||
160643352|NCT02763579|580076557|FG000|Global Period|Death|167|||
160643353|NCT02763579|580076558|FG001|Global Period|Death|151|||
160643354|NCT02763579|580076559|FG002|Global Period|Death|0|||
160643355|NCT02763579|580076560|FG003|Global Period|Death|0|||
160643356|NCT02763579|580076557|FG000|Global Period|Lost to Follow-up|2|||
160643357|NCT02763579|580076558|FG001|Global Period|Lost to Follow-up|4|||
160643358|NCT02763579|580076559|FG002|Global Period|Lost to Follow-up|0|||
160643359|NCT02763579|580076560|FG003|Global Period|Lost to Follow-up|0|||
160643360|NCT02763579|580076557|FG000|Global Period|Physician Decision|0|||
160643361|NCT02763579|580076558|FG001|Global Period|Physician Decision|2|||
160894632|NCT00809354|581010868|FG000|Overall Study|Study terminated by sponsor|138|||
160894633|NCT00809354|581010869|FG001|Overall Study|Study terminated by sponsor|134|||
160894634|NCT00809354|581010870|FG002|Overall Study|Study terminated by sponsor|129|||
160894635|NCT00809354|581010871|FG003|Overall Study|Study terminated by sponsor|120|||
160894636|NCT00809354|581010872|FG004|Overall Study|Study terminated by sponsor|126|||
160894637|NCT00809354|581010873|FG005|Overall Study|Study terminated by sponsor|133|||
160548983|NCT03403205|579736320|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
160548984|NCT03403205|579736321|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
160548985|NCT03403205|579736322|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
160548986|NCT03403205|579736323|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
160548987|NCT03403205|579736318|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
160548988|NCT03403205|579736319|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
160548989|NCT03403205|579736320|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
160548990|NCT03403205|579736321|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
160548991|NCT03403205|579736322|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
160548992|NCT03403205|579736323|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
160548993|NCT03403205|579736318|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
160548994|NCT03403205|579736319|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
160548995|NCT03403205|579736320|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
160548996|NCT03403205|579736321|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
160548997|NCT03403205|579736322|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
160548998|NCT03403205|579736323|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
160548999|NCT03403205|579736318|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
160549000|NCT03403205|579736319|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
160549001|NCT03403205|579736320|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
160549002|NCT03403205|579736321|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
160549003|NCT03403205|579736322|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
160549004|NCT03403205|579736323|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
160549005|NCT00706030|579736324|FG000|Overall Study|Disease Progression|4|||
160549006|NCT00706030|579736325|FG001|Overall Study|Disease Progression|6|||
160549007|NCT00706030|579736326|FG002|Overall Study|Disease Progression|46|||
160549008|NCT00706030|579736327|FG003|Overall Study|Disease Progression|12|||
160549009|NCT00706030|579736324|FG000|Overall Study|Adverse Event|1|||
160549010|NCT00706030|579736325|FG001|Overall Study|Adverse Event|0|||
160549011|NCT00706030|579736326|FG002|Overall Study|Adverse Event|4|||
160549012|NCT00706030|579736327|FG003|Overall Study|Adverse Event|2|||
160549013|NCT00706030|579736324|FG000|Overall Study|Withdrawal by Subject|1|||
160549014|NCT00706030|579736325|FG001|Overall Study|Withdrawal by Subject|0|||
160549015|NCT00706030|579736326|FG002|Overall Study|Withdrawal by Subject|2|||
160549016|NCT00706030|579736327|FG003|Overall Study|Withdrawal by Subject|0|||
160549017|NCT00706030|579736324|FG000|Overall Study|Physician Decision|0|||
160549018|NCT00706030|579736325|FG001|Overall Study|Physician Decision|0|||
160549019|NCT00706030|579736326|FG002|Overall Study|Physician Decision|2|||
160549020|NCT00706030|579736327|FG003|Overall Study|Physician Decision|0|||
160549021|NCT00706030|579736324|FG000|Overall Study|Not recorded|0|||
160549022|NCT00706030|579736325|FG001|Overall Study|Not recorded|0|||
160549023|NCT00706030|579736326|FG002|Overall Study|Not recorded|2|||
160549024|NCT00706030|579736327|FG003|Overall Study|Not recorded|0|||
160549025|NCT00706030|579736324|FG000|Overall Study|Protocol Violation|0|||
160549026|NCT00706030|579736325|FG001|Overall Study|Protocol Violation|0|||
160549027|NCT00706030|579736326|FG002|Overall Study|Protocol Violation|1|||
160549028|NCT00706030|579736327|FG003|Overall Study|Protocol Violation|1|||
160549029|NCT00706030|579736324|FG000|Overall Study|Failed to return|0|||
160549030|NCT00706030|579736325|FG001|Overall Study|Failed to return|0|||
160549031|NCT00706030|579736326|FG002|Overall Study|Failed to return|1|||
160549032|NCT00706030|579736327|FG003|Overall Study|Failed to return|0|||
160549033|NCT00706030|579736324|FG000|Overall Study|Symptomatic Deterioration|0|||
160549034|NCT00706030|579736325|FG001|Overall Study|Symptomatic Deterioration|0|||
160549035|NCT00706030|579736326|FG002|Overall Study|Symptomatic Deterioration|1|||
160549036|NCT00706030|579736327|FG003|Overall Study|Symptomatic Deterioration|0|||
160549037|NCT00706030|579736324|FG000|Overall Study|No treatment received|0|||
160549038|NCT00706030|579736325|FG001|Overall Study|No treatment received|0|||
160549039|NCT00706030|579736326|FG002|Overall Study|No treatment received|0|||
160549040|NCT00706030|579736327|FG003|Overall Study|No treatment received|1|||
160549041|NCT00706030|579736324|FG000|Overall Study|Death|0|||
160549042|NCT00706030|579736325|FG001|Overall Study|Death|0|||
160549043|NCT00706030|579736326|FG002|Overall Study|Death|1|||
160549044|NCT00706030|579736327|FG003|Overall Study|Death|0|||
160549045|NCT05779072|579736328|FG000|Overall Study|Lost to Follow-up|0|||
160549046|NCT05779072|579736329|FG001|Overall Study|Lost to Follow-up|1|||
160549047|NCT05779072|579736328|FG000|Overall Study|Withdrawal by Subject|1|||
160549048|NCT05779072|579736329|FG001|Overall Study|Withdrawal by Subject|5|||
160549049|NCT03870555|579736330|FG000|Period 3 (2 Days)|Adverse Event|1|||
160549050|NCT03870555|579736331|FG001|Period 3 (2 Days)|Adverse Event|0|||
160549051|NCT03870555|579736332|FG002|Period 3 (2 Days)|Adverse Event|0|||
160549052|NCT02751502|579736335|FG000|Overall Study|Lack of funding|4|||
160549053|NCT02695628|579736336|FG000|Overall Study|Withdrawal by Subject|1|||
160549054|NCT02678390|579736337|FG000|AE (1 Day)|Withdrawal by Subject|0|||
160549055|NCT02678390|579736338|FG001|AE (1 Day)|Withdrawal by Subject|1|||
160549056|NCT03499028|579736339|FG000|Overall Study|Lost to Follow-up|12|||
160549057|NCT03499028|579736340|FG001|Overall Study|Lost to Follow-up|9|||
160549058|NCT03499028|579736339|FG000|Overall Study|Withdrawal by Subject|5|||
160549059|NCT03499028|579736340|FG001|Overall Study|Withdrawal by Subject|8|||
160549060|NCT03499028|579736339|FG000|Overall Study|Unplanned SNF discharge|5|||
160549061|NCT03499028|579736340|FG001|Overall Study|Unplanned SNF discharge|8|||
160549062|NCT02925156|579736341|FG000|Overall Study|Lost to Follow-up|27|||
160549063|NCT02925156|579736342|FG001|Overall Study|Lost to Follow-up|53|||
160549064|NCT02925156|579736343|FG002|Overall Study|Lost to Follow-up|51|||
160549065|NCT02925156|579736344|FG003|Overall Study|Lost to Follow-up|59|||
160549066|NCT02925156|579736345|FG004|Overall Study|Lost to Follow-up|89|||
160549067|NCT02925156|579736346|FG005|Overall Study|Lost to Follow-up|107|||
160549068|NCT02925156|579736347|FG006|Overall Study|Lost to Follow-up|34|||
160549069|NCT02925156|579736348|FG007|Overall Study|Lost to Follow-up|36|||
160549070|NCT02925156|579736349|FG008|Overall Study|Lost to Follow-up|73|||
160549071|NCT02925156|579736350|FG009|Overall Study|Lost to Follow-up|34|||
160549072|NCT02573155|579736353|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
160797388|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
160797389|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
160797390|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
160797391|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
160797392|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
160797393|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
160797394|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
160797395|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
160797396|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
160797397|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160797398|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
160797399|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160797400|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160797401|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
160797402|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
160797403|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
160797404|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
160797405|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
160797406|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
160797407|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
160797408|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
160549073|NCT02573155|579736354|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
160549074|NCT02573155|579736353|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
160549075|NCT02573155|579736354|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
160549076|NCT02573155|579736353|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
160797409|NCT02836249|580647318|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
160797410|NCT02836249|580647319|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
160797411|NCT02836249|580647320|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
160797412|NCT02836249|580647321|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
160797413|NCT02836249|580647318|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
160797414|NCT02836249|580647319|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
160797415|NCT02836249|580647320|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
160549077|NCT02573155|579736354|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
160797416|NCT02836249|580647321|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
160797417|NCT02836249|580647318|FG000|Open-Label TAF Treatment Phase|Death|0|||
160797418|NCT02836249|580647319|FG001|Open-Label TAF Treatment Phase|Death|0|||
160797419|NCT02836249|580647320|FG002|Open-Label TAF Treatment Phase|Death|1|||
160797420|NCT02836249|580647321|FG003|Open-Label TAF Treatment Phase|Death|0|||
160797421|NCT02836249|580647318|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
160797422|NCT02836249|580647319|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
160797423|NCT02836249|580647320|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
160797424|NCT02836249|580647321|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
160797425|NCT02836249|580647318|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
160797426|NCT02836249|580647319|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
160549078|NCT02573155|579736353|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
160797427|NCT02836249|580647320|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
160797428|NCT02836249|580647321|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
160797429|NCT01646827|580647322|FG000|Overall Study|Lost to Follow-up|0|||
160549079|NCT02573155|579736354|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
160549080|NCT02573155|579736353|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
160549081|NCT02573155|579736354|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
160549082|NCT02573155|579736353|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
160549083|NCT02573155|579736354|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
160549084|NCT02573155|579736353|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
160643362|NCT02763579|580076559|FG002|Global Period|Physician Decision|0|||
160797430|NCT01646827|580647323|FG001|Overall Study|Lost to Follow-up|3|||
160797431|NCT01646827|580647322|FG000|Overall Study|Physician Decision|1|||
160797432|NCT01646827|580647323|FG001|Overall Study|Physician Decision|2|||
160797433|NCT01646827|580647322|FG000|Overall Study|Withdrawal by Subject|1|||
160797434|NCT01646827|580647323|FG001|Overall Study|Withdrawal by Subject|0|||
160797435|NCT00928668|580647324|FG000|Overall Study|Adverse Event|1|||
160797436|NCT00928668|580647325|FG001|Overall Study|Adverse Event|0|||
160797437|NCT00928668|580647326|FG002|Overall Study|Adverse Event|0|||
160797438|NCT00928668|580647327|FG003|Overall Study|Adverse Event|0|||
160797439|NCT00928668|580647328|FG004|Overall Study|Adverse Event|0|||
160797440|NCT00928668|580647324|FG000|Overall Study|Protocol Violation|0|||
160797441|NCT00928668|580647325|FG001|Overall Study|Protocol Violation|0|||
160797442|NCT00928668|580647326|FG002|Overall Study|Protocol Violation|0|||
160797443|NCT00928668|580647327|FG003|Overall Study|Protocol Violation|0|||
160797444|NCT00928668|580647328|FG004|Overall Study|Protocol Violation|1|||
160797445|NCT00928668|580647324|FG000|Overall Study|Withdrawal by Subject|0|||
160797446|NCT00928668|580647325|FG001|Overall Study|Withdrawal by Subject|1|||
160797447|NCT00928668|580647326|FG002|Overall Study|Withdrawal by Subject|1|||
160797448|NCT00928668|580647327|FG003|Overall Study|Withdrawal by Subject|0|||
160797449|NCT00928668|580647328|FG004|Overall Study|Withdrawal by Subject|0|||
160894638|NCT00809354|581010874|FG006|Overall Study|Study terminated by sponsor|124|||
160894639|NCT00809354|581010875|FG007|Overall Study|Study terminated by sponsor|148|||
160797450|NCT00928668|580647324|FG000|Overall Study|Other reasons not listed above|0|||
160797451|NCT00928668|580647325|FG001|Overall Study|Other reasons not listed above|0|||
160894640|NCT00809354|581010876|FG008|Overall Study|Study terminated by sponsor|127|||
160549085|NCT02573155|579736354|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
160549086|NCT02573155|579736353|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
160549087|NCT02573155|579736354|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
160549088|NCT00903929|579736355|FG000|Overall Study|Withdrawal by Subject|0|||
160549089|NCT00903929|579736356|FG001|Overall Study|Withdrawal by Subject|0|||
160549090|NCT00903929|579736357|FG002|Overall Study|Withdrawal by Subject|1|||
160549091|NCT00903929|579736358|FG003|Overall Study|Withdrawal by Subject|2|||
160549092|NCT00903929|579736355|FG000|Overall Study|Adverse Event|0|||
160549093|NCT00903929|579736356|FG001|Overall Study|Adverse Event|0|||
160549094|NCT00903929|579736357|FG002|Overall Study|Adverse Event|0|||
160549095|NCT00903929|579736358|FG003|Overall Study|Adverse Event|1|||
160549096|NCT04153188|579736367|FG000|Overall Study|Lost to Follow-up|1|||
160549097|NCT04153188|579736368|FG001|Overall Study|Lost to Follow-up|1|||
160549098|NCT04153188|579736367|FG000|Overall Study|Withdrawal by Subject|2|||
160549099|NCT04153188|579736368|FG001|Overall Study|Withdrawal by Subject|0|||
160549100|NCT04153188|579736367|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
160549101|NCT04153188|579736368|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
160549102|NCT01489527|579736369|FG000|Overall Study|Pregnancy|9|||
160549103|NCT01489527|579736370|FG001|Overall Study|Pregnancy|14|||
160549104|NCT01489527|579736369|FG000|Overall Study|Participant moved|6|||
160549105|NCT01489527|579736370|FG001|Overall Study|Participant moved|7|||
160549106|NCT01489527|579736369|FG000|Overall Study|Withdrawal by Subject|0|||
160549107|NCT01489527|579736370|FG001|Overall Study|Withdrawal by Subject|4|||
160549108|NCT01489527|579736369|FG000|Overall Study|Lost to Follow-up|5|||
160549109|NCT01489527|579736370|FG001|Overall Study|Lost to Follow-up|1|||
160549110|NCT01489527|579736369|FG000|Overall Study|Procedures|1|||
160549111|NCT01489527|579736370|FG001|Overall Study|Procedures|0|||
160549112|NCT01489527|579736369|FG000|Overall Study|Not compliant|1|||
160549113|NCT01489527|579736370|FG001|Overall Study|Not compliant|0|||
160549114|NCT00700271|579736371|FG000|Overall Study|Adverse Event|4|||
160549115|NCT00700271|579736372|FG001|Overall Study|Adverse Event|6|||
160549116|NCT00700271|579736371|FG000|Overall Study|Protocol Violation|1|||
160549117|NCT00700271|579736372|FG001|Overall Study|Protocol Violation|0|||
160549118|NCT00700271|579736371|FG000|Overall Study|Administrative Reasons|1|||
160549119|NCT00700271|579736372|FG001|Overall Study|Administrative Reasons|0|||
160549120|NCT00700271|579736371|FG000|Overall Study|Withdrawal by Subject|6|||
160549121|NCT00700271|579736372|FG001|Overall Study|Withdrawal by Subject|4|||
160549122|NCT00700271|579736371|FG000|Overall Study|Lost to Follow-up|2|||
160549123|NCT00700271|579736372|FG001|Overall Study|Lost to Follow-up|2|||
160549124|NCT02926950|579736373|FG000|Overall Study|Adverse Event|4|||
160797452|NCT00928668|580647326|FG002|Overall Study|Other reasons not listed above|0|||
160894641|NCT00809354|581010877|FG009|Overall Study|Study terminated by sponsor|135|||
160549125|NCT02926950|579736374|FG001|Overall Study|Adverse Event|6|||
160549126|NCT02926950|579736373|FG000|Overall Study|At the participant's own request|21|||
160549127|NCT02926950|579736374|FG001|Overall Study|At the participant's own request|25|||
160549128|NCT02926950|579736373|FG000|Overall Study|Reason not Specified|17|||
160549129|NCT02926950|579736374|FG001|Overall Study|Reason not Specified|9|||
160549130|NCT02926950|579736373|FG000|Overall Study|Lost to Follow-up|7|||
160549131|NCT02926950|579736374|FG001|Overall Study|Lost to Follow-up|8|||
160797453|NCT00928668|580647327|FG003|Overall Study|Other reasons not listed above|1|||
160894642|NCT00809354|581010868|FG000|Overall Study|Withdrawn due to pregnancy|0|||
160894643|NCT00809354|581010869|FG001|Overall Study|Withdrawn due to pregnancy|1|||
160797454|NCT00928668|580647328|FG004|Overall Study|Other reasons not listed above|0|||
160797455|NCT01143402|580647331|FG000|Overall Study|Rapid clinical decline|1|||
160797456|NCT01143402|580647332|FG001|Overall Study|Rapid clinical decline|1|||
160797457|NCT01143402|580647333|FG002|Overall Study|Rapid clinical decline|0|||
160797458|NCT01143402|580647331|FG000|Overall Study|Not Treated|0|||
160797459|NCT01143402|580647332|FG001|Overall Study|Not Treated|0|||
160797460|NCT01143402|580647333|FG002|Overall Study|Not Treated|1|||
160797461|NCT04462471|580647334|FG000|Overall Study|Adverse Event|0|||
160983581|NCT05764239|581328678|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
160983582|NCT00057811|581328682|FG000|Overall Study|Lack of Efficacy|1|||
160983583|NCT00057811|581328683|FG001|Overall Study|Lack of Efficacy|4|||
160983584|NCT00057811|581328682|FG000|Overall Study|Physician Decision|1|||
160983585|NCT00057811|581328683|FG001|Overall Study|Physician Decision|0|||
160983586|NCT00057811|581328682|FG000|Overall Study|Withdrawal by Subject|3|||
160983587|NCT00057811|581328683|FG001|Overall Study|Withdrawal by Subject|4|||
160983588|NCT00057811|581328682|FG000|Overall Study|Ineligible|4|||
160983589|NCT00057811|581328683|FG001|Overall Study|Ineligible|2|||
160983590|NCT00057811|581328682|FG000|Overall Study|Inevaluable|1|||
160983591|NCT00057811|581328683|FG001|Overall Study|Inevaluable|2|||
160983592|NCT00556374|581328684|FG000|Overall Study|Withdrawal by Subject|235|||
160983593|NCT00556374|581328685|FG001|Overall Study|Withdrawal by Subject|205|||
160983594|NCT00556374|581328684|FG000|Overall Study|Death|158|||
160983595|NCT00556374|581328685|FG001|Overall Study|Death|127|||
160983596|NCT00556374|581328684|FG000|Overall Study|Lost to Follow-up|24|||
160983597|NCT00556374|581328685|FG001|Overall Study|Lost to Follow-up|17|||
160983598|NCT00556374|581328684|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
160983599|NCT00556374|581328685|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
160983600|NCT00442286|581328686|FG000|Overall Study|Death|2|||
160983601|NCT00442286|581328687|FG001|Overall Study|Death|2|||
160983602|NCT00442286|581328686|FG000|Overall Study|Lost to Follow-up|1|||
160983603|NCT00442286|581328687|FG001|Overall Study|Lost to Follow-up|0|||
160983604|NCT00442286|581328686|FG000|Overall Study|Withdrawal by Subject|2|||
160983605|NCT00442286|581328687|FG001|Overall Study|Withdrawal by Subject|0|||
160983606|NCT00442286|581328686|FG000|Overall Study|System explanted|1|||
160983607|NCT00442286|581328687|FG001|Overall Study|System explanted|0|||
160983608|NCT00442286|581328686|FG000|Overall Study|Patient Injury|1|||
160643363|NCT02763579|580076560|FG003|Global Period|Physician Decision|0|||
160643364|NCT02763579|580076557|FG000|Global Period|Study Terminated By Sponsor|21|||
160643365|NCT02763579|580076558|FG001|Global Period|Study Terminated By Sponsor|26|||
160643366|NCT02763579|580076559|FG002|Global Period|Study Terminated By Sponsor|0|||
160643367|NCT02763579|580076560|FG003|Global Period|Study Terminated By Sponsor|0|||
160643368|NCT02763579|580076557|FG000|Global Period|Withdrawal by Subject|12|||
160643369|NCT02763579|580076558|FG001|Global Period|Withdrawal by Subject|18|||
160983609|NCT00442286|581328687|FG001|Overall Study|Patient Injury|0|||
160983610|NCT00641186|581328688|FG000|Overall Study|Adverse Event|3|||
160983611|NCT05221749|581328691|FG000|Overall Study|Lost to Follow-up|2|||
160983612|NCT05221749|581328692|FG001|Overall Study|Lost to Follow-up|3|||
160983613|NCT03428815|581328693|FG000|Overall Study|Lost to Follow-up|2|||
160983614|NCT03428815|581328694|FG001|Overall Study|Lost to Follow-up|2|||
160983615|NCT03428815|581328693|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
160983616|NCT03428815|581328694|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
160983617|NCT03428815|581328693|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
160983618|NCT03428815|581328694|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
160983619|NCT01700348|581328697|FG000|Overall Study|Withdrawal by Subject|22|||
160983620|NCT01700348|581328697|FG000|Overall Study|Lost to Follow-up|1|||
160983621|NCT02404493|581328698|FG000|Overall Study|Adverse Event|1|||
160983622|NCT02404493|581328699|FG001|Overall Study|Adverse Event|1|||
160643370|NCT02763579|580076559|FG002|Global Period|Withdrawal by Subject|0|||
160643371|NCT02763579|580076560|FG003|Global Period|Withdrawal by Subject|0|||
160643372|NCT02763579|580076557|FG000|China Period|Death|0|||
160797462|NCT04462471|580647335|FG001|Overall Study|Adverse Event|1|||
160797463|NCT04462471|580647336|FG002|Overall Study|Adverse Event|0|||
160797464|NCT04462471|580647337|FG003|Overall Study|Adverse Event|0|||
160797465|NCT04462471|580647334|FG000|Overall Study|Disease progression|1|||
160797466|NCT04462471|580647335|FG001|Overall Study|Disease progression|0|||
160643373|NCT02763579|580076558|FG001|China Period|Death|0|||
160643374|NCT02763579|580076559|FG002|China Period|Death|46|||
160797467|NCT04462471|580647336|FG002|Overall Study|Disease progression|0|||
160797468|NCT04462471|580647337|FG003|Overall Study|Disease progression|0|||
160797469|NCT01276106|580647340|FG000|Overall Study|Adverse Event|3|||
160983623|NCT02102464|581328700|FG000|Randomized Study|Withdrawal by Subject|0|||
160983624|NCT02102464|581328701|FG001|Randomized Study|Withdrawal by Subject|1|||
160983625|NCT02102464|581328702|FG002|Randomized Study|Withdrawal by Subject|0|||
160983626|NCT04140890|581328703|FG000|Overall Study|Withdrawal by Subject|0|||
160983627|NCT04140890|581328704|FG001|Overall Study|Withdrawal by Subject|1|||
160643375|NCT02763579|580076560|FG003|China Period|Death|48|||
160983628|NCT02388074|581328705|FG000|Overall Study|Lost in Transit|2|||
160983629|NCT02388074|581328705|FG000|Overall Study|Sample Not Returned|1|||
160894644|NCT00809354|581010870|FG002|Overall Study|Withdrawn due to pregnancy|0|||
160894645|NCT00809354|581010871|FG003|Overall Study|Withdrawn due to pregnancy|0|||
160894646|NCT00809354|581010872|FG004|Overall Study|Withdrawn due to pregnancy|0|||
160894647|NCT00809354|581010873|FG005|Overall Study|Withdrawn due to pregnancy|0|||
160894648|NCT00809354|581010874|FG006|Overall Study|Withdrawn due to pregnancy|0|||
160894649|NCT00809354|581010875|FG007|Overall Study|Withdrawn due to pregnancy|0|||
160894650|NCT00809354|581010876|FG008|Overall Study|Withdrawn due to pregnancy|0|||
160894651|NCT00809354|581010877|FG009|Overall Study|Withdrawn due to pregnancy|0|||
160894652|NCT00809354|581010868|FG000|Overall Study|Randomized but not Treated|3|||
160894653|NCT00809354|581010869|FG001|Overall Study|Randomized but not Treated|1|||
160894654|NCT00809354|581010870|FG002|Overall Study|Randomized but not Treated|6|||
160894655|NCT00809354|581010871|FG003|Overall Study|Randomized but not Treated|0|||
160894656|NCT00809354|581010872|FG004|Overall Study|Randomized but not Treated|5|||
160894657|NCT00809354|581010873|FG005|Overall Study|Randomized but not Treated|0|||
160894658|NCT00809354|581010874|FG006|Overall Study|Randomized but not Treated|1|||
160894659|NCT00809354|581010875|FG007|Overall Study|Randomized but not Treated|1|||
160894660|NCT00809354|581010876|FG008|Overall Study|Randomized but not Treated|2|||
160894661|NCT00809354|581010877|FG009|Overall Study|Randomized but not Treated|1|||
160894662|NCT00809354|581010868|FG000|Overall Study|Death|0|||
160894663|NCT00809354|581010869|FG001|Overall Study|Death|0|||
160894664|NCT00809354|581010870|FG002|Overall Study|Death|0|||
160894665|NCT00809354|581010871|FG003|Overall Study|Death|0|||
160894666|NCT00809354|581010872|FG004|Overall Study|Death|0|||
160894667|NCT00809354|581010873|FG005|Overall Study|Death|0|||
160894668|NCT00809354|581010874|FG006|Overall Study|Death|0|||
160894669|NCT00809354|581010875|FG007|Overall Study|Death|1|||
160894670|NCT00809354|581010876|FG008|Overall Study|Death|0|||
160894671|NCT00809354|581010877|FG009|Overall Study|Death|0|||
160894672|NCT04137224|581010880|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
160894673|NCT04137224|581010881|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
160894674|NCT04137224|581010880|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
160549132|NCT01844986|579736375|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
160549133|NCT01844986|579736376|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
160549134|NCT01844986|579736375|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
160549135|NCT01844986|579736376|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
160549136|NCT01844986|579736375|FG000|Overall Study (Global Cohort)|Death|55|||
160549137|NCT01844986|579736376|FG001|Overall Study (Global Cohort)|Death|26|||
160549138|NCT01844986|579736375|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
160549139|NCT01844986|579736376|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
160549140|NCT01844986|579736375|FG000|Overall Study (China Cohort)|Death|10|||
160549141|NCT01844986|579736376|FG001|Overall Study (China Cohort)|Death|6|||
160571835|NCT01633060|579816838|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
160571836|NCT01633060|579816839|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160571837|NCT01633060|579816838|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
160571838|NCT01633060|579816839|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
160571839|NCT01633060|579816838|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
160571840|NCT01633060|579816839|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
160571841|NCT01633060|579816838|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
160571842|NCT01633060|579816839|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
160571843|NCT01633060|579816838|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
160571844|NCT01633060|579816839|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
160571845|NCT01633060|579816838|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
160571846|NCT01633060|579816839|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
160571847|NCT03233048|579816842|FG000|Overall Study|Withdrawal by Subject|1|||
160571848|NCT01856673|579816843|FG000|Overall Study|Withdrawal by Subject|44|||
160571849|NCT01856673|579816844|FG001|Overall Study|Withdrawal by Subject|50|||
160571850|NCT01856673|579816845|FG002|Overall Study|Withdrawal by Subject|33|||
160571851|NCT01856673|579816843|FG000|Overall Study|Lost to Follow-up|31|||
160571852|NCT01856673|579816844|FG001|Overall Study|Lost to Follow-up|34|||
160571853|NCT01856673|579816845|FG002|Overall Study|Lost to Follow-up|0|||
160571854|NCT01856673|579816843|FG000|Overall Study|Unknown reasons|9|||
160571855|NCT01856673|579816844|FG001|Overall Study|Unknown reasons|0|||
160571856|NCT01856673|579816845|FG002|Overall Study|Unknown reasons|0|||
160571857|NCT01856673|579816843|FG000|Overall Study|Psychologist decision|1|||
160571858|NCT01856673|579816844|FG001|Overall Study|Psychologist decision|0|||
160571859|NCT01856673|579816845|FG002|Overall Study|Psychologist decision|0|||
160571860|NCT01856673|579816843|FG000|Overall Study|Paperwork errors|8|||
160571861|NCT01856673|579816844|FG001|Overall Study|Paperwork errors|0|||
160571862|NCT01856673|579816845|FG002|Overall Study|Paperwork errors|0|||
160571863|NCT01856673|579816843|FG000|Overall Study|Death|1|||
160571864|NCT01856673|579816844|FG001|Overall Study|Death|1|||
160571865|NCT01856673|579816845|FG002|Overall Study|Death|0|||
160571866|NCT01856673|579816843|FG000|Overall Study|Protocol Violation|1|||
160797470|NCT01276106|580647341|FG001|Overall Study|Adverse Event|3|||
160797471|NCT01276106|580647342|FG002|Overall Study|Adverse Event|11|||
160894675|NCT04137224|581010881|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
160894676|NCT04137224|581010880|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
160894677|NCT04137224|581010881|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
160894678|NCT01669928|581010882|FG000|First Intervention|Withdrawal by Subject|3|||
160894679|NCT01669928|581010883|FG001|First Intervention|Withdrawal by Subject|5|||
160894680|NCT05085730|581010889|FG000|Overall Study|Withdrawal by Subject|4|||
160894681|NCT05085730|581010889|FG000|Overall Study|Physician Decision|1|||
160894682|NCT01199731|581010890|FG000|Overall Study|Adverse Event|0|||
160894683|NCT01199731|581010891|FG001|Overall Study|Adverse Event|1|||
160894684|NCT01199731|581010892|FG002|Overall Study|Adverse Event|0|||
160894685|NCT01199731|581010890|FG000|Overall Study|Study closed/terminated|7|||
160797472|NCT01276106|580647343|FG003|Overall Study|Adverse Event|3|||
160797473|NCT01276106|580647340|FG000|Overall Study|Withdrawal by Subject|6|||
160797474|NCT01276106|580647341|FG001|Overall Study|Withdrawal by Subject|3|||
160797475|NCT01276106|580647342|FG002|Overall Study|Withdrawal by Subject|1|||
160797476|NCT01276106|580647343|FG003|Overall Study|Withdrawal by Subject|6|||
160797477|NCT01276106|580647340|FG000|Overall Study|Lack of Efficacy|0|||
160797478|NCT01276106|580647341|FG001|Overall Study|Lack of Efficacy|1|||
160797479|NCT01276106|580647342|FG002|Overall Study|Lack of Efficacy|0|||
160894686|NCT01199731|581010891|FG001|Overall Study|Study closed/terminated|9|||
160894687|NCT01199731|581010892|FG002|Overall Study|Study closed/terminated|7|||
160894688|NCT01199731|581010890|FG000|Overall Study|Lost to Follow-up|0|||
160894689|NCT01199731|581010891|FG001|Overall Study|Lost to Follow-up|0|||
160894690|NCT01199731|581010892|FG002|Overall Study|Lost to Follow-up|2|||
160894691|NCT01199731|581010890|FG000|Overall Study|Physician Decision|0|||
160549142|NCT00403260|579737730|FG000|Overall Study|Adverse Event|5|||
160797480|NCT01276106|580647343|FG003|Overall Study|Lack of Efficacy|1|||
160797481|NCT01276106|580647340|FG000|Overall Study|Lost to Follow-up|2|||
160797482|NCT01276106|580647341|FG001|Overall Study|Lost to Follow-up|1|||
160797483|NCT01276106|580647342|FG002|Overall Study|Lost to Follow-up|1|||
160797484|NCT01276106|580647343|FG003|Overall Study|Lost to Follow-up|0|||
160797485|NCT01276106|580647340|FG000|Overall Study|Physician Decision|0|||
160797486|NCT01276106|580647341|FG001|Overall Study|Physician Decision|0|||
160797487|NCT01276106|580647342|FG002|Overall Study|Physician Decision|1|||
160797488|NCT01276106|580647343|FG003|Overall Study|Physician Decision|1|||
160797489|NCT01276106|580647340|FG000|Overall Study|Protocol Violation|1|||
160797490|NCT01276106|580647341|FG001|Overall Study|Protocol Violation|1|||
160797491|NCT01276106|580647342|FG002|Overall Study|Protocol Violation|0|||
160797492|NCT01276106|580647343|FG003|Overall Study|Protocol Violation|2|||
160797493|NCT01276106|580647340|FG000|Overall Study|Insufficient therapeutic effects|0|||
160797494|NCT01276106|580647341|FG001|Overall Study|Insufficient therapeutic effects|0|||
160797495|NCT01276106|580647342|FG002|Overall Study|Insufficient therapeutic effects|2|||
160797496|NCT01276106|580647343|FG003|Overall Study|Insufficient therapeutic effects|0|||
160797497|NCT02936323|580647350|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797498|NCT02936323|580647351|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
160797499|NCT02936323|580647352|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797500|NCT02936323|580647353|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
160797501|NCT02936323|580647354|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
160797502|NCT02936323|580647355|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
160797503|NCT02936323|580647356|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797504|NCT02936323|580647357|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797505|NCT02936323|580647358|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797506|NCT02936323|580647359|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797507|NCT02936323|580647350|FG000|Phase 1 Dose Escalation|Death|2|||
160797508|NCT02936323|580647351|FG001|Phase 1 Dose Escalation|Death|1|||
160797509|NCT02936323|580647352|FG002|Phase 1 Dose Escalation|Death|3|||
160797510|NCT02936323|580647353|FG003|Phase 1 Dose Escalation|Death|1|||
160894692|NCT01199731|581010891|FG001|Overall Study|Physician Decision|1|||
160894693|NCT01199731|581010892|FG002|Overall Study|Physician Decision|1|||
160549143|NCT00403260|579737731|FG001|Overall Study|Adverse Event|4|||
160549144|NCT00403260|579737730|FG000|Overall Study|Withdrawal by Subject|5|||
160549145|NCT00403260|579737731|FG001|Overall Study|Withdrawal by Subject|6|||
160549146|NCT00403260|579737730|FG000|Overall Study|Lost to Follow-up|49|||
160549147|NCT00403260|579737731|FG001|Overall Study|Lost to Follow-up|25|||
160549148|NCT00403260|579737730|FG000|Overall Study|Re-appearance of P. falciparum|34|||
160549149|NCT00403260|579737731|FG001|Overall Study|Re-appearance of P. falciparum|25|||
160894694|NCT01199731|581010890|FG000|Overall Study|Withdrawal by Subject|2|||
160894695|NCT01199731|581010891|FG001|Overall Study|Withdrawal by Subject|0|||
160983630|NCT01778062|581328708|FG000|Overall Study|Adverse Event|1|||
160797511|NCT02936323|580647354|FG004|Phase 1 Dose Escalation|Death|2|||
160797512|NCT02936323|580647355|FG005|Phase 1 Dose Escalation|Death|3|||
160797513|NCT02936323|580647356|FG006|Phase 1 Dose Escalation|Death|3|||
160797514|NCT02936323|580647357|FG007|Phase 1 Dose Escalation|Death|0|||
160797515|NCT02936323|580647358|FG008|Phase 1 Dose Escalation|Death|0|||
160643376|NCT02763579|580076557|FG000|China Period|Lost to Follow-up|0|||
160894696|NCT01199731|581010892|FG002|Overall Study|Withdrawal by Subject|0|||
160894697|NCT01916967|581010895|FG000|Overall Study|Adverse Event|0|||
160894698|NCT01916967|581010896|FG001|Overall Study|Adverse Event|0|||
160894699|NCT01916967|581010897|FG002|Overall Study|Adverse Event|2|||
160894700|NCT01916967|581010895|FG000|Overall Study|Lack of Efficacy|0|||
160643377|NCT02763579|580076558|FG001|China Period|Lost to Follow-up|0|||
160643378|NCT02763579|580076559|FG002|China Period|Lost to Follow-up|1|||
160643379|NCT02763579|580076560|FG003|China Period|Lost to Follow-up|1|||
160643380|NCT02763579|580076557|FG000|China Period|Physician Decision|0|||
160643381|NCT02763579|580076558|FG001|China Period|Physician Decision|0|||
160643382|NCT02763579|580076559|FG002|China Period|Physician Decision|0|||
160643383|NCT02763579|580076560|FG003|China Period|Physician Decision|1|||
160643384|NCT02763579|580076557|FG000|China Period|Study Terminated By Sponsor|0|||
160643385|NCT02763579|580076558|FG001|China Period|Study Terminated By Sponsor|0|||
160643386|NCT02763579|580076559|FG002|China Period|Study Terminated By Sponsor|3|||
160643387|NCT02763579|580076560|FG003|China Period|Study Terminated By Sponsor|4|||
160643388|NCT02763579|580076557|FG000|China Period|Withdrawal by Subject|0|||
160643389|NCT02763579|580076558|FG001|China Period|Withdrawal by Subject|0|||
160643390|NCT02763579|580076559|FG002|China Period|Withdrawal by Subject|3|||
160643391|NCT02763579|580076560|FG003|China Period|Withdrawal by Subject|3|||
160643392|NCT03572933|580076564|FG000|Overall Study|Adverse Event|4|||
160643393|NCT03572933|580076565|FG001|Overall Study|Adverse Event|1|||
160643394|NCT03572933|580076564|FG000|Overall Study|Withdrawal by Subject|0|||
160643395|NCT03572933|580076565|FG001|Overall Study|Withdrawal by Subject|1|||
160643396|NCT01764854|580076571|FG000|Overall Study|Adverse Event|0|||
160643397|NCT01764854|580076572|FG001|Overall Study|Adverse Event|0|||
160643398|NCT01764854|580076573|FG002|Overall Study|Adverse Event|2|||
160643399|NCT01764854|580076574|FG003|Overall Study|Adverse Event|0|||
160643400|NCT01764854|580076571|FG000|Overall Study|Withdrawal by Subject|0|||
160643401|NCT01764854|580076572|FG001|Overall Study|Withdrawal by Subject|0|||
160643402|NCT01764854|580076573|FG002|Overall Study|Withdrawal by Subject|1|||
160643403|NCT01764854|580076574|FG003|Overall Study|Withdrawal by Subject|0|||
160643404|NCT01764854|580076571|FG000|Overall Study|relocation|0|||
160643405|NCT01764854|580076572|FG001|Overall Study|relocation|0|||
160643406|NCT01764854|580076573|FG002|Overall Study|relocation|2|||
160643407|NCT01764854|580076574|FG003|Overall Study|relocation|0|||
160643408|NCT01764854|580076571|FG000|Overall Study|Protocol Violation|0|||
160643409|NCT01764854|580076572|FG001|Overall Study|Protocol Violation|0|||
160643410|NCT01764854|580076573|FG002|Overall Study|Protocol Violation|1|||
160643411|NCT01764854|580076574|FG003|Overall Study|Protocol Violation|2|||
160643412|NCT00910858|580076587|FG000|Pharmacokinetic Phase|Adverse Event|1|||
160643413|NCT00910858|580076588|FG001|Pharmacokinetic Phase|Adverse Event|0|||
160643414|NCT00910858|580076589|FG002|Pharmacokinetic Phase|Adverse Event|0|||
160643415|NCT00910858|580076587|FG000|Monotherapy Phase|Adverse Event|3|||
160643416|NCT00910858|580076588|FG001|Monotherapy Phase|Adverse Event|2|||
160643417|NCT00910858|580076589|FG002|Monotherapy Phase|Adverse Event|0|||
160643418|NCT00910858|580076587|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
160643419|NCT00910858|580076588|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
160643420|NCT00910858|580076589|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
160643421|NCT00910858|580076587|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
160643422|NCT00910858|580076588|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
160643423|NCT00910858|580076589|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
160643424|NCT00910858|580076587|FG000|Monotherapy Phase|Protocol Violation|1|||
160643425|NCT00910858|580076588|FG001|Monotherapy Phase|Protocol Violation|0|||
160643426|NCT00910858|580076589|FG002|Monotherapy Phase|Protocol Violation|0|||
160643427|NCT00910858|580076587|FG000|Monotherapy Phase|Other|3|||
160643428|NCT00910858|580076588|FG001|Monotherapy Phase|Other|4|||
160643429|NCT00910858|580076589|FG002|Monotherapy Phase|Other|2|||
160643430|NCT00910858|580076587|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
160643431|NCT00910858|580076588|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
160643432|NCT00910858|580076589|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
160643433|NCT00910858|580076587|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
160643434|NCT00910858|580076588|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
160643435|NCT00910858|580076589|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
160643436|NCT00910858|580076587|FG000|Combined Treatment Phase|Protocol Violation|1|||
160643437|NCT00910858|580076588|FG001|Combined Treatment Phase|Protocol Violation|0|||
160643438|NCT00910858|580076589|FG002|Combined Treatment Phase|Protocol Violation|0|||
160894701|NCT01916967|581010896|FG001|Overall Study|Lack of Efficacy|0|||
160643439|NCT00910858|580076587|FG000|Combined Treatment Phase|Other|0|||
160643440|NCT00910858|580076588|FG001|Combined Treatment Phase|Other|2|||
160643441|NCT00910858|580076589|FG002|Combined Treatment Phase|Other|1|||
160643442|NCT01907737|580076602|FG000|Overall Study|Withdrawal by Subject|1|||
160643443|NCT01165684|580076603|FG000|Overall Study|Adverse Event|1|||
160643444|NCT01165684|580076604|FG001|Overall Study|Adverse Event|1|||
160643445|NCT01165684|580076603|FG000|Overall Study|Lack of Efficacy|2|||
160643446|NCT01165684|580076604|FG001|Overall Study|Lack of Efficacy|1|||
160894702|NCT01916967|581010897|FG002|Overall Study|Lack of Efficacy|6|||
160643447|NCT01165684|580076603|FG000|Overall Study|Protocol Violation|7|||
160643448|NCT01165684|580076604|FG001|Overall Study|Protocol Violation|15|||
160643449|NCT01165684|580076603|FG000|Overall Study|Withdrawal Criteria|2|||
160643450|NCT01165684|580076604|FG001|Overall Study|Withdrawal Criteria|13|||
160643451|NCT01165684|580076603|FG000|Overall Study|Unclassified|16|||
160643452|NCT01165684|580076604|FG001|Overall Study|Unclassified|22|||
160643453|NCT01886300|580076625|FG000|Overall Study|Trial terminated by sponsor|16|||
160643454|NCT00901628|580076626|FG000|Overall Study|disconnection of catheter|4|||
160643455|NCT00901628|580076627|FG001|Overall Study|disconnection of catheter|8|||
160643456|NCT00901628|580076626|FG000|Overall Study|disconnection of drain|0|||
160643457|NCT00901628|580076627|FG001|Overall Study|disconnection of drain|1|||
160643458|NCT00901628|580076626|FG000|Overall Study|peroneal nerve palsy|0|||
160643459|NCT00901628|580076627|FG001|Overall Study|peroneal nerve palsy|1|||
160643460|NCT00608205|580076628|FG000|Overall Study|Adverse Event|3|||
160643461|NCT00608205|580076629|FG001|Overall Study|Adverse Event|2|||
160643462|NCT00608205|580076628|FG000|Overall Study|Patient non-compliant|0|||
160643463|NCT00608205|580076629|FG001|Overall Study|Patient non-compliant|1|||
160643464|NCT02008721|580076632|FG000|Overall Study|Withdrawal by Subject|5|||
160643465|NCT02008721|580076633|FG001|Overall Study|Withdrawal by Subject|1|||
160643466|NCT02008721|580076632|FG000|Overall Study|Death|4|||
160643467|NCT02008721|580076633|FG001|Overall Study|Death|2|||
160643468|NCT02008721|580076632|FG000|Overall Study|Adverse Event|3|||
160643469|NCT02008721|580076633|FG001|Overall Study|Adverse Event|5|||
160643470|NCT02008721|580076632|FG000|Overall Study|Protocol Violation|3|||
160643471|NCT02008721|580076633|FG001|Overall Study|Protocol Violation|2|||
160643472|NCT01797120|580076636|FG000|Overall Study|Disesae progression|37|||
160643473|NCT01797120|580076637|FG001|Overall Study|Disesae progression|49|||
160643474|NCT01797120|580076636|FG000|Overall Study|Adverse Event|13|||
160643475|NCT01797120|580076637|FG001|Overall Study|Adverse Event|5|||
160643476|NCT01797120|580076636|FG000|Overall Study|Withdrawal by Subject|6|||
160643477|NCT01797120|580076637|FG001|Overall Study|Withdrawal by Subject|6|||
160643478|NCT01797120|580076636|FG000|Overall Study|Symptomatic progression|2|||
160643479|NCT01797120|580076637|FG001|Overall Study|Symptomatic progression|1|||
160643480|NCT01797120|580076636|FG000|Overall Study|Non-compliance|1|||
160643481|NCT01797120|580076637|FG001|Overall Study|Non-compliance|0|||
160643482|NCT01797120|580076636|FG000|Overall Study|Physician Decision|3|||
160643483|NCT01797120|580076637|FG001|Overall Study|Physician Decision|0|||
160643484|NCT01797120|580076636|FG000|Overall Study|still on treatment|2|||
160643485|NCT01797120|580076637|FG001|Overall Study|still on treatment|4|||
160643486|NCT01797120|580076636|FG000|Overall Study|never start protocol therapy|2|||
160643487|NCT01797120|580076637|FG001|Overall Study|never start protocol therapy|0|||
160643488|NCT01003886|580076638|FG000|Overall Study|Lack of Efficacy|5|||
160643489|NCT01003886|580076638|FG000|Overall Study|Lost to Follow-up|169|||
160643490|NCT01003886|580076638|FG000|Overall Study|Withdrawal by Subject|39|||
160643491|NCT01003886|580076638|FG000|Overall Study|Other|14|||
160797516|NCT02936323|580647359|FG009|Phase 1 Dose Escalation|Death|0|||
160797517|NCT02936323|580647350|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797518|NCT02936323|580647351|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797519|NCT02936323|580647352|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797520|NCT02936323|580647353|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797521|NCT02936323|580647354|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797522|NCT02936323|580647355|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
160797523|NCT02936323|580647356|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797524|NCT02936323|580647357|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797525|NCT02936323|580647358|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797526|NCT02936323|580647359|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797527|NCT02936323|580647350|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160797528|NCT02936323|580647351|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160797529|NCT02936323|580647352|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160797530|NCT02936323|580647353|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160797531|NCT02936323|580647354|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160797532|NCT02936323|580647355|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160643492|NCT01003886|580076638|FG000|Overall Study|Adverse Event|3|||
160643493|NCT00909727|580076656|FG000|Overall Study|Adverse Event|1|||
160643494|NCT00909727|580076657|FG001|Overall Study|Adverse Event|0|||
160643495|NCT00909727|580076656|FG000|Overall Study|Wrong Genotype|1|||
160643496|NCT00909727|580076657|FG001|Overall Study|Wrong Genotype|0|||
160643497|NCT00909727|580076656|FG000|Overall Study|Withdrawal of Consent|1|||
160643498|NCT00909727|580076657|FG001|Overall Study|Withdrawal of Consent|0|||
160643499|NCT00909727|580076656|FG000|Overall Study|Prohibited Medication|1|||
160643500|NCT00909727|580076657|FG001|Overall Study|Prohibited Medication|0|||
160797533|NCT02936323|580647356|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160643501|NCT05751629|580076658|FG000|Overall Study|Withdrawal by Subject|6|||
160643502|NCT05751629|580076658|FG000|Overall Study|Death|25|||
160643503|NCT05751629|580076658|FG000|Overall Study|Study Site Closed|9|||
160549150|NCT00403260|579737730|FG000|Overall Study|P. vivax infection|26|||
160549151|NCT00403260|579737731|FG001|Overall Study|P. vivax infection|4|||
160549152|NCT00403260|579737730|FG000|Overall Study|Mixed infection with P. vivax|2|||
160549153|NCT00403260|579737731|FG001|Overall Study|Mixed infection with P. vivax|0|||
160549154|NCT00403260|579737730|FG000|Overall Study|Mixed infection with P. falciparum|1|||
160549155|NCT00403260|579737731|FG001|Overall Study|Mixed infection with P. falciparum|0|||
160549156|NCT00403260|579737730|FG000|Overall Study|P. vivax infection at screening|1|||
160549157|NCT00403260|579737731|FG001|Overall Study|P. vivax infection at screening|0|||
160549158|NCT00403260|579737730|FG000|Overall Study|P. ovale infection|1|||
160549159|NCT00403260|579737731|FG001|Overall Study|P. ovale infection|0|||
160549160|NCT00403260|579737730|FG000|Overall Study|Gametocyte re-appearance|1|||
160549161|NCT00403260|579737731|FG001|Overall Study|Gametocyte re-appearance|1|||
160549162|NCT00403260|579737730|FG000|Overall Study|Withdrawn from study accidentally|0|||
160549163|NCT00403260|579737731|FG001|Overall Study|Withdrawn from study accidentally|1|||
160549164|NCT01535729|579737732|FG000|Overall Study|Withdrawal by Subject|2|||
160549165|NCT01535729|579737732|FG000|Overall Study|Disease progression|230|||
160549166|NCT01535729|579737732|FG000|Overall Study|Discontinued treatment|25|||
160549167|NCT01535729|579737732|FG000|Overall Study|Lost to Follow-up|8|||
160549168|NCT01535729|579737732|FG000|Overall Study|Death|52|||
160549169|NCT01535729|579737732|FG000|Overall Study|Other|19|||
160549170|NCT01535729|579737732|FG000|Overall Study|Did not sign informed consent|1|||
160549171|NCT01535729|579737732|FG000|Overall Study|No previous chemotherapy|33|||
160549172|NCT01535729|579737732|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
160549173|NCT01535729|579737732|FG000|Overall Study|Protocol Violation|11|||
160549174|NCT01535729|579737732|FG000|Overall Study|Screening failure|1|||
160549175|NCT01535729|579737732|FG000|Overall Study|Not treated|9|||
160549176|NCT01535729|579737732|FG000|Overall Study|No participant record available|5|||
160549177|NCT05064059|579737733|FG000|Overall Study|Death|199|||
160549178|NCT05064059|579737734|FG001|Overall Study|Death|196|||
160549179|NCT05064059|579737733|FG000|Overall Study|Physician Decision|4|||
160549180|NCT05064059|579737734|FG001|Overall Study|Physician Decision|2|||
160549181|NCT05064059|579737733|FG000|Overall Study|Sponsor Decision|14|||
160549182|NCT05064059|579737734|FG001|Overall Study|Sponsor Decision|11|||
160549183|NCT05064059|579737733|FG000|Overall Study|Withdrawal by Subject|4|||
160549184|NCT05064059|579737734|FG001|Overall Study|Withdrawal by Subject|11|||
160549185|NCT02615990|579737735|FG000|Overall Study|study terminated|1|||
160549186|NCT02615990|579737736|FG001|Overall Study|study terminated|1|||
160549187|NCT04401267|579737737|FG000|Overall Study|Death|0|||
160549188|NCT04401267|579737738|FG001|Overall Study|Death|1|||
160549189|NCT04401267|579737737|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
160549190|NCT04401267|579737738|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
160894703|NCT01916967|581010895|FG000|Overall Study|Physician Decision|0|||
160894704|NCT01916967|581010896|FG001|Overall Study|Physician Decision|0|||
160894705|NCT01916967|581010897|FG002|Overall Study|Physician Decision|1|||
160894706|NCT01916967|581010895|FG000|Overall Study|Protocol Violation|0|||
160894707|NCT01916967|581010896|FG001|Overall Study|Protocol Violation|1|||
160894708|NCT01916967|581010897|FG002|Overall Study|Protocol Violation|0|||
160894709|NCT02337738|581010898|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
160894710|NCT02337738|581010899|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
160549191|NCT04401267|579737737|FG000|Overall Study|Found to be Ineligible|1|||
160549192|NCT04401267|579737738|FG001|Overall Study|Found to be Ineligible|0|||
160549193|NCT00200850|579737739|FG000|Overall Study|relocation|1|||
160549194|NCT00200850|579737740|FG001|Overall Study|relocation|0|||
160549195|NCT00200850|579737741|FG002|Overall Study|relocation|1|||
160549196|NCT00200850|579737739|FG000|Overall Study|too busy|1|||
160549197|NCT00200850|579737740|FG001|Overall Study|too busy|0|||
160549198|NCT00200850|579737741|FG002|Overall Study|too busy|0|||
160549199|NCT00200850|579737739|FG000|Overall Study|Pregnancy|0|||
160549200|NCT00200850|579737740|FG001|Overall Study|Pregnancy|0|||
160549201|NCT00200850|579737741|FG002|Overall Study|Pregnancy|1|||
160549202|NCT00200850|579737739|FG000|Overall Study|Poor adherence|0|||
160549203|NCT00200850|579737740|FG001|Overall Study|Poor adherence|0|||
160549204|NCT00200850|579737741|FG002|Overall Study|Poor adherence|1|||
160549205|NCT00200850|579737739|FG000|Overall Study|optic neuritis|0|||
160549206|NCT00200850|579737740|FG001|Overall Study|optic neuritis|0|||
160549207|NCT00200850|579737741|FG002|Overall Study|optic neuritis|1|||
160549208|NCT00200850|579737739|FG000|Overall Study|Adverse Event|1|||
160549209|NCT00200850|579737740|FG001|Overall Study|Adverse Event|1|||
160549210|NCT00200850|579737741|FG002|Overall Study|Adverse Event|2|||
160549211|NCT01396005|579737744|FG000|Overall Study|Withdrawal by Subject|0|||
160549212|NCT01396005|579737745|FG001|Overall Study|Withdrawal by Subject|1|||
160549213|NCT01396005|579737744|FG000|Overall Study|Non-compliance with protocol|0|||
160549214|NCT01396005|579737745|FG001|Overall Study|Non-compliance with protocol|1|||
160549215|NCT01467492|579737746|FG000|Overall Study|Withdrawal by Subject|6|||
160549216|NCT01467492|579737747|FG001|Overall Study|Withdrawal by Subject|4|||
160549217|NCT01467492|579737746|FG000|Overall Study|Study Terminated by Sponsor|6|||
160549218|NCT01467492|579737747|FG001|Overall Study|Study Terminated by Sponsor|4|||
160894711|NCT02337738|581010900|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
160894712|NCT02337738|581010898|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
160894713|NCT02337738|581010899|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
160894714|NCT02337738|581010900|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
160894715|NCT02337738|581010898|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
160894716|NCT02337738|581010899|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
160894717|NCT02337738|581010900|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
160894718|NCT02337738|581010898|FG000|Overall Study|Voluntary Withdrawal|10|||
160894719|NCT02337738|581010899|FG001|Overall Study|Voluntary Withdrawal|5|||
160894720|NCT02337738|581010900|FG002|Overall Study|Voluntary Withdrawal|2|||
160894721|NCT02337738|581010898|FG000|Overall Study|Lack of Efficacy|2|||
160894722|NCT02337738|581010899|FG001|Overall Study|Lack of Efficacy|4|||
160894723|NCT02337738|581010900|FG002|Overall Study|Lack of Efficacy|0|||
160894724|NCT02337738|581010898|FG000|Overall Study|Investigator's Judgment|1|||
160894725|NCT02337738|581010899|FG001|Overall Study|Investigator's Judgment|1|||
160894726|NCT02337738|581010900|FG002|Overall Study|Investigator's Judgment|3|||
160894727|NCT02322021|581010901|FG000|Core Phase|Adverse Event|1|||
160894728|NCT02322021|581010902|FG001|Core Phase|Adverse Event|3|||
160894729|NCT02322021|581010903|FG002|Core Phase|Adverse Event|4|||
160894730|NCT02322021|581010904|FG003|Core Phase|Adverse Event|2|||
160894731|NCT02322021|581010905|FG004|Core Phase|Adverse Event|0|||
160894732|NCT02322021|581010901|FG000|Core Phase|Participant Choice|4|||
160894733|NCT02322021|581010902|FG001|Core Phase|Participant Choice|5|||
160894734|NCT02322021|581010903|FG002|Core Phase|Participant Choice|4|||
160894735|NCT02322021|581010904|FG003|Core Phase|Participant Choice|2|||
160894736|NCT02322021|581010905|FG004|Core Phase|Participant Choice|0|||
160894737|NCT02322021|581010901|FG000|Core Phase|Lost to Follow-up|0|||
160894738|NCT02322021|581010902|FG001|Core Phase|Lost to Follow-up|0|||
160894739|NCT02322021|581010903|FG002|Core Phase|Lost to Follow-up|0|||
160894740|NCT02322021|581010904|FG003|Core Phase|Lost to Follow-up|1|||
160894741|NCT02322021|581010905|FG004|Core Phase|Lost to Follow-up|0|||
160894742|NCT02322021|581010901|FG000|Core Phase|Other|0|||
160894743|NCT02322021|581010902|FG001|Core Phase|Other|0|||
160894744|NCT02322021|581010903|FG002|Core Phase|Other|1|||
160894745|NCT02322021|581010904|FG003|Core Phase|Other|0|||
160894746|NCT02322021|581010905|FG004|Core Phase|Other|0|||
160894747|NCT02322021|581010901|FG000|Extension Phase|Adverse Event|0|||
160894748|NCT02322021|581010902|FG001|Extension Phase|Adverse Event|0|||
160894749|NCT02322021|581010903|FG002|Extension Phase|Adverse Event|0|||
160894750|NCT02322021|581010904|FG003|Extension Phase|Adverse Event|0|||
160894751|NCT02322021|581010905|FG004|Extension Phase|Adverse Event|3|||
160894752|NCT02322021|581010901|FG000|Extension Phase|Participant Choice|0|||
160894753|NCT02322021|581010902|FG001|Extension Phase|Participant Choice|0|||
160894754|NCT02322021|581010903|FG002|Extension Phase|Participant Choice|0|||
160894755|NCT02322021|581010904|FG003|Extension Phase|Participant Choice|0|||
160894756|NCT02322021|581010905|FG004|Extension Phase|Participant Choice|6|||
160894757|NCT02322021|581010901|FG000|Extension Phase|Other|0|||
160894758|NCT02322021|581010902|FG001|Extension Phase|Other|0|||
160894759|NCT02322021|581010903|FG002|Extension Phase|Other|0|||
160894760|NCT02322021|581010904|FG003|Extension Phase|Other|0|||
160894761|NCT02322021|581010905|FG004|Extension Phase|Other|3|||
160894762|NCT02322021|581010901|FG000|Extension Phase|Lost to Follow-up|0|||
160894763|NCT02322021|581010902|FG001|Extension Phase|Lost to Follow-up|0|||
160894764|NCT02322021|581010903|FG002|Extension Phase|Lost to Follow-up|0|||
160894765|NCT02322021|581010904|FG003|Extension Phase|Lost to Follow-up|0|||
160894766|NCT02322021|581010905|FG004|Extension Phase|Lost to Follow-up|1|||
160894767|NCT02322021|581010901|FG000|Extension Phase|Study terminated by sponsor|0|||
160894768|NCT02322021|581010902|FG001|Extension Phase|Study terminated by sponsor|0|||
160894769|NCT02322021|581010903|FG002|Extension Phase|Study terminated by sponsor|0|||
160894770|NCT02322021|581010904|FG003|Extension Phase|Study terminated by sponsor|0|||
160894771|NCT02322021|581010905|FG004|Extension Phase|Study terminated by sponsor|28|||
160894772|NCT01565642|581010912|FG000|Overall Study|Withdrawal by Subject|2|||
160894773|NCT01565642|581010913|FG001|Overall Study|Withdrawal by Subject|1|||
160894774|NCT01934972|581010914|FG000|Overall Study|Withdrawal by Subject|9|||
160983631|NCT01778062|581328709|FG001|Overall Study|Adverse Event|3|||
160894775|NCT01934972|581010915|FG001|Overall Study|Withdrawal by Subject|6|||
160894776|NCT03438383|581010921|FG000|Overall Study|Protocol Violation|9|||
160894777|NCT03438383|581010922|FG001|Overall Study|Protocol Violation|3|||
160894778|NCT01528033|581010923|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
160983632|NCT01778062|581328708|FG000|Overall Study|Consent Withdrawal|1|||
160797534|NCT02936323|580647357|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
160797535|NCT02936323|580647358|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
160797536|NCT02936323|580647359|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
160797537|NCT02936323|580647350|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
160797538|NCT02936323|580647351|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
160797539|NCT02936323|580647352|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
160797540|NCT02936323|580647353|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
160797541|NCT02936323|580647354|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
160797542|NCT02936323|580647355|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
160797543|NCT02936323|580647356|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
160797544|NCT02936323|580647357|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
160797545|NCT02936323|580647358|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
160797546|NCT02936323|580647359|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
160797547|NCT02936323|580647350|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797548|NCT02936323|580647351|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797549|NCT02936323|580647352|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797550|NCT02936323|580647353|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797551|NCT02936323|580647354|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797552|NCT02936323|580647355|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797553|NCT02936323|580647356|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797554|NCT02936323|580647357|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
160797555|NCT02936323|580647358|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
160797556|NCT02936323|580647359|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797557|NCT02936323|580647350|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797558|NCT02936323|580647351|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797559|NCT02936323|580647352|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797560|NCT02936323|580647353|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797561|NCT02936323|580647354|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797562|NCT02936323|580647355|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797563|NCT02936323|580647356|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797564|NCT02936323|580647357|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797565|NCT02936323|580647358|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797566|NCT02936323|580647359|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
160797567|NCT02936323|580647350|FG000|Phase 2a Dose Expansion|Death|0|||
160797568|NCT02936323|580647351|FG001|Phase 2a Dose Expansion|Death|0|||
160797569|NCT02936323|580647352|FG002|Phase 2a Dose Expansion|Death|0|||
160797570|NCT02936323|580647353|FG003|Phase 2a Dose Expansion|Death|0|||
160797571|NCT02936323|580647354|FG004|Phase 2a Dose Expansion|Death|0|||
160797572|NCT02936323|580647355|FG005|Phase 2a Dose Expansion|Death|0|||
160797573|NCT02936323|580647356|FG006|Phase 2a Dose Expansion|Death|0|||
160797574|NCT02936323|580647357|FG007|Phase 2a Dose Expansion|Death|4|||
160797575|NCT02936323|580647358|FG008|Phase 2a Dose Expansion|Death|8|||
160797576|NCT02936323|580647359|FG009|Phase 2a Dose Expansion|Death|10|||
160797577|NCT02781558|580647360|FG000|Overall Study|Lost to Follow-up|2|||
160797578|NCT02781558|580647361|FG001|Overall Study|Lost to Follow-up|2|||
160797579|NCT02781558|580647360|FG000|Overall Study|Adverse Event|1|||
160797580|NCT02781558|580647361|FG001|Overall Study|Adverse Event|0|||
160797581|NCT01334918|580649227|FG000|Overall Study|Did not receive study drug|6|||
160797582|NCT01334918|580649228|FG001|Overall Study|Did not receive study drug|0|||
160797583|NCT01334918|580649227|FG000|Overall Study|Adverse Event|2|||
160797584|NCT01334918|580649228|FG001|Overall Study|Adverse Event|0|||
160797585|NCT01334918|580649227|FG000|Overall Study|Withdrawal by Subject|0|||
160797586|NCT01334918|580649228|FG001|Overall Study|Withdrawal by Subject|1|||
160797587|NCT01732536|580649229|FG000|Overall Study|Withdrawal by Subject|1|||
160797588|NCT01732536|580649230|FG001|Overall Study|Withdrawal by Subject|1|||
160797589|NCT00370292|580649233|FG000|Overall Study|Disease Progression|4|||
160797590|NCT00370292|580649233|FG000|Overall Study|Adverse Event|7|||
160797591|NCT00370292|580649233|FG000|Overall Study|Physician Decision|2|||
160797592|NCT02986074|580649234|FG000|First Trial Period|Adverse Event|1|||
160797593|NCT02986074|580649235|FG001|First Trial Period|Adverse Event|0|||
160797594|NCT02986074|580649236|FG002|First Trial Period|Adverse Event|0|||
160797595|NCT02986074|580649237|FG003|First Trial Period|Adverse Event|0|||
160797596|NCT02986074|580649234|FG000|Follow up Period|system explant|0|||
160797597|NCT02986074|580649235|FG001|Follow up Period|system explant|0|||
160797598|NCT02986074|580649236|FG002|Follow up Period|system explant|1|||
160797599|NCT02986074|580649237|FG003|Follow up Period|system explant|2|||
160797600|NCT02986074|580649234|FG000|Follow up Period|Physician Decision|0|||
160797601|NCT02986074|580649235|FG001|Follow up Period|Physician Decision|0|||
160797602|NCT02986074|580649236|FG002|Follow up Period|Physician Decision|0|||
160797603|NCT02986074|580649237|FG003|Follow up Period|Physician Decision|1|||
160797604|NCT04099277|580649240|FG000|Overall Study|Physician Decision|1|||
160797605|NCT04099277|580649240|FG000|Overall Study|Withdrawal by Subject|1|||
160894779|NCT01528033|581010924|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
160894780|NCT01528033|581010923|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
160894781|NCT01528033|581010924|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
160894782|NCT01528033|581010923|FG000|Primary Endpoint Assessment ITT|Death|2|||
160894783|NCT01528033|581010924|FG001|Primary Endpoint Assessment ITT|Death|2|||
160894784|NCT01528033|581010923|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
160894785|NCT01528033|581010924|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
160894786|NCT01528033|581010923|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
160894787|NCT01528033|581010924|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
160894788|NCT01528033|581010923|FG000|Follow Up|No data available|46|||
160894789|NCT01528033|581010924|FG001|Follow Up|No data available|44|||
160894790|NCT02030938|581010927|FG000|Overall Study|Lost to Follow-up|4|||
160894791|NCT02030938|581010927|FG000|Overall Study|Withdrawal by Subject|1|||
160894792|NCT03954132|581010929|FG000|Overall Study|Adverse Event|2|||
160894793|NCT03954132|581010930|FG001|Overall Study|Adverse Event|0|||
160894794|NCT03954132|581010929|FG000|Overall Study|Patient's wish|5|||
160894795|NCT03954132|581010930|FG001|Overall Study|Patient's wish|0|||
160894796|NCT03954132|581010929|FG000|Overall Study|Lost to Follow-up|10|||
160894797|NCT03954132|581010930|FG001|Overall Study|Lost to Follow-up|0|||
160894798|NCT03954132|581010929|FG000|Overall Study|Screening failure|0|||
160894799|NCT03954132|581010930|FG001|Overall Study|Screening failure|1|||
160894800|NCT03954132|581010929|FG000|Overall Study|No registration after Visit 1|5|||
160894801|NCT03954132|581010930|FG001|Overall Study|No registration after Visit 1|2|||
160894802|NCT03954132|581010929|FG000|Overall Study|Other reason than listed|2|||
160894803|NCT03954132|581010930|FG001|Overall Study|Other reason than listed|2|||
160894804|NCT03954132|581010929|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
160894805|NCT03954132|581010930|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
160894806|NCT03954132|581010929|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
160894807|NCT03954132|581010930|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
160894808|NCT00932737|581010933|FG000|Overall Study|Not treated in second episode|1|||
160894809|NCT00932737|581010934|FG001|Overall Study|Not treated in second episode|0|||
160894810|NCT00932737|581010933|FG000|Overall Study|Adverse Event|0|||
160894811|NCT00932737|581010934|FG001|Overall Study|Adverse Event|1|||
160894812|NCT02949700|581010937|FG000|Phase I|Withdrawal by Subject|1|||
160894813|NCT02949700|581010938|FG001|Phase I|Withdrawal by Subject|1|||
160894814|NCT02949700|581010939|FG002|Phase I|Withdrawal by Subject|0|||
160894815|NCT02949700|581010940|FG003|Phase I|Withdrawal by Subject|0|||
160894816|NCT02949700|581010937|FG000|Phase I|Protocol Violation|1|||
160894817|NCT02949700|581010938|FG001|Phase I|Protocol Violation|0|||
160894818|NCT02949700|581010939|FG002|Phase I|Protocol Violation|0|||
160894819|NCT02949700|581010940|FG003|Phase I|Protocol Violation|0|||
160894820|NCT02949700|581010937|FG000|Phase II|Withdrawal by Subject|0|||
160894821|NCT02949700|581010938|FG001|Phase II|Withdrawal by Subject|0|||
160894822|NCT02949700|581010939|FG002|Phase II|Withdrawal by Subject|0|||
160894823|NCT02949700|581010940|FG003|Phase II|Withdrawal by Subject|2|||
160894824|NCT02949700|581010937|FG000|Phase II|Protocol Violation|0|||
160894825|NCT02949700|581010938|FG001|Phase II|Protocol Violation|0|||
160894826|NCT02949700|581010939|FG002|Phase II|Protocol Violation|1|||
160894827|NCT02949700|581010940|FG003|Phase II|Protocol Violation|3|||
160894828|NCT05156073|581010941|FG000|Overall Study|Patient canceled appointment with PCP|1|||
160894829|NCT00973349|581010942|FG000|Overall Study|Adverse Event|0|||
160894830|NCT00973349|581010943|FG001|Overall Study|Adverse Event|0|||
160894831|NCT00973349|581010944|FG002|Overall Study|Adverse Event|0|||
160894832|NCT00973349|581010945|FG003|Overall Study|Adverse Event|0|||
160549219|NCT01467492|579737746|FG000|Overall Study|Adverse Event|4|||
160549220|NCT01467492|579737747|FG001|Overall Study|Adverse Event|3|||
160549221|NCT01467492|579737746|FG000|Overall Study|Lost to Follow-up|3|||
160549222|NCT01467492|579737747|FG001|Overall Study|Lost to Follow-up|2|||
160549223|NCT01467492|579737746|FG000|Overall Study|Undefined|2|||
160549224|NCT01467492|579737747|FG001|Overall Study|Undefined|0|||
160549225|NCT01467492|579737746|FG000|Overall Study|Enrolled But Not Treated|1|||
160549226|NCT01467492|579737747|FG001|Overall Study|Enrolled But Not Treated|0|||
160549227|NCT02450487|579737751|FG000|Overall Study|Lost to Follow-up|3|||
160549228|NCT04269395|579737752|FG000|Overall Study|Lost to Follow-up|1|||
160549229|NCT04269395|579737753|FG001|Overall Study|Lost to Follow-up|0|||
160549230|NCT04269395|579737752|FG000|Overall Study|Study terminated by Sponsor|13|||
160549231|NCT04269395|579737753|FG001|Overall Study|Study terminated by Sponsor|10|||
160549232|NCT04161495|579737754|FG000|Overall Study|Withdrawal by Subject|3|||
160549233|NCT04161495|579737755|FG001|Overall Study|Withdrawal by Subject|0|||
160894833|NCT00973349|581010946|FG004|Overall Study|Adverse Event|1|||
160894834|NCT00973349|581010947|FG005|Overall Study|Adverse Event|0|||
160894835|NCT00973349|581010948|FG006|Overall Study|Adverse Event|0|||
160894836|NCT00973349|581010949|FG007|Overall Study|Adverse Event|0|||
160894837|NCT00973349|581010950|FG008|Overall Study|Adverse Event|1|||
160894838|NCT00973349|581010951|FG009|Overall Study|Adverse Event|0|||
160894839|NCT00973349|581010952|FG010|Overall Study|Adverse Event|0|||
160549234|NCT04161495|579737754|FG000|Overall Study|Protocol Violation|1|||
160549235|NCT04161495|579737755|FG001|Overall Study|Protocol Violation|0|||
160549236|NCT04161495|579737754|FG000|Overall Study|Prohibited concomitant medication|3|||
160549237|NCT04161495|579737755|FG001|Overall Study|Prohibited concomitant medication|0|||
160549238|NCT04161495|579737754|FG000|Overall Study|Adverse Event|1|||
160549239|NCT04161495|579737755|FG001|Overall Study|Adverse Event|0|||
160549240|NCT04161495|579737754|FG000|Overall Study|Other - Unspecified|1|||
160549241|NCT04161495|579737755|FG001|Overall Study|Other - Unspecified|0|||
160549242|NCT04161495|579737754|FG000|Overall Study|Death|0|||
160549243|NCT04161495|579737755|FG001|Overall Study|Death|1|||
160549244|NCT00252057|579737758|FG000|Overall Study|Withdrawal by Subject|2|||
160549245|NCT00252057|579737759|FG001|Overall Study|Withdrawal by Subject|5|||
160549246|NCT00252057|579737758|FG000|Overall Study|Death|1|||
160549247|NCT00252057|579737759|FG001|Overall Study|Death|2|||
160549248|NCT00252057|579737758|FG000|Overall Study|Participant previously enrolled|0|||
160549249|NCT00252057|579737759|FG001|Overall Study|Participant previously enrolled|1|||
160549250|NCT02926209|579737760|FG000|Study Cohort|Poor Bowel Preparation|1|||
160549251|NCT02926209|579737761|FG001|Study Cohort|Poor Bowel Preparation|0|||
160549252|NCT01340209|579737762|FG000|Overall Study|Adverse Event|1|||
160549253|NCT01340209|579737763|FG001|Overall Study|Adverse Event|1|||
160549254|NCT01340209|579737764|FG002|Overall Study|Adverse Event|2|||
160549255|NCT01340209|579737762|FG000|Overall Study|Protocol Violation|1|||
160549256|NCT01340209|579737763|FG001|Overall Study|Protocol Violation|2|||
160797606|NCT00524121|580649247|FG000|Overall Study|Disease progression|6|||
160797607|NCT00524121|580649247|FG000|Overall Study|Adverse Event|4|||
160797608|NCT00524121|580649247|FG000|Overall Study|Patient refused|2|||
160797609|NCT00524121|580649247|FG000|Overall Study|Other|1|||
160797610|NCT00524121|580649247|FG000|Overall Study|Death|1|||
160797611|NCT00524121|580649247|FG000|Overall Study|Not treated (became ineligible)|4|||
160797612|NCT00524121|580649247|FG000|Overall Study|Not treated (changed mind)|1|||
160797613|NCT02862574|580649248|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160797614|NCT02862574|580649249|FG001|Double-Blind Treatment Period|Adverse Event|1|||
160797615|NCT02862574|580649250|FG002|Double-Blind Treatment Period|Adverse Event|0|||
160797616|NCT02862574|580649248|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
160797617|NCT02862574|580649249|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
160797618|NCT02862574|580649250|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
160797619|NCT02862574|580649248|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
160797620|NCT02862574|580649249|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
160797621|NCT02862574|580649250|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
160797622|NCT00583219|580649256|FG000|Phase 2|Withdrawal by Subject|1|||
160797623|NCT02037529|580649257|FG000|Overall Study|Withdrawal by Subject|1|||
160797624|NCT02037529|580649258|FG001|Overall Study|Withdrawal by Subject|3|||
160797625|NCT02037529|580649257|FG000|Overall Study|Adverse Event|0|||
160797626|NCT02037529|580649258|FG001|Overall Study|Adverse Event|1|||
160797627|NCT02131766|580649259|FG000|Overall Study|Withdrawal by Subject|4|||
160797628|NCT00754572|580649260|FG000|Overall Study|Adverse Event|19|||
160797629|NCT00754572|580649260|FG000|Overall Study|Other|39|||
160797630|NCT00754572|580649260|FG000|Overall Study|Protocol Violation|3|||
160797631|NCT00754572|580649260|FG000|Overall Study|Withdrawal by Subject|3|||
160797632|NCT00754572|580649260|FG000|Overall Study|Lack of Efficacy|2|||
160797633|NCT00754572|580649260|FG000|Overall Study|Death|1|||
160797634|NCT00754572|580649260|FG000|Overall Study|Administrative Reason|3|||
160797635|NCT00754572|580649260|FG000|Overall Study|Lost to Follow-up|1|||
160797636|NCT00718315|580649261|FG000|Overall Study|Adverse Event|1|||
160797637|NCT00718315|580649262|FG001|Overall Study|Adverse Event|2|||
160797638|NCT00718315|580649263|FG002|Overall Study|Adverse Event|3|||
160797639|NCT00718315|580649261|FG000|Overall Study|Death|6|||
160797640|NCT00718315|580649262|FG001|Overall Study|Death|6|||
160797641|NCT00718315|580649263|FG002|Overall Study|Death|5|||
160797642|NCT00718315|580649261|FG000|Overall Study|Lost to Follow-up|2|||
160797643|NCT00718315|580649262|FG001|Overall Study|Lost to Follow-up|3|||
160797644|NCT00718315|580649263|FG002|Overall Study|Lost to Follow-up|4|||
160797645|NCT00718315|580649261|FG000|Overall Study|Protocol Violation|5|||
160797646|NCT00718315|580649262|FG001|Overall Study|Protocol Violation|5|||
160797647|NCT00718315|580649263|FG002|Overall Study|Protocol Violation|3|||
160797648|NCT00718315|580649261|FG000|Overall Study|Erlotinib dose decreased|4|||
160797649|NCT00718315|580649262|FG001|Overall Study|Erlotinib dose decreased|3|||
160797650|NCT00718315|580649263|FG002|Overall Study|Erlotinib dose decreased|1|||
160797651|NCT00718315|580649261|FG000|Overall Study|Use of Minocyclin|1|||
160797652|NCT00718315|580649262|FG001|Overall Study|Use of Minocyclin|1|||
160797653|NCT00718315|580649263|FG002|Overall Study|Use of Minocyclin|1|||
160797654|NCT00718315|580649261|FG000|Overall Study|Disease progression|0|||
160797655|NCT00718315|580649262|FG001|Overall Study|Disease progression|1|||
160797656|NCT00718315|580649263|FG002|Overall Study|Disease progression|1|||
160797657|NCT00718315|580649261|FG000|Overall Study|Other|0|||
160797658|NCT00718315|580649262|FG001|Overall Study|Other|0|||
160797659|NCT00718315|580649263|FG002|Overall Study|Other|1|||
160894840|NCT00973349|581010953|FG011|Overall Study|Adverse Event|0|||
160894841|NCT00973349|581010954|FG012|Overall Study|Adverse Event|0|||
160983633|NCT01778062|581328709|FG001|Overall Study|Consent Withdrawal|5|||
160983634|NCT01778062|581328708|FG000|Overall Study|major protocol deviation|4|||
160983635|NCT01778062|581328709|FG001|Overall Study|major protocol deviation|3|||
160983636|NCT03958630|581328714|FG000|Overall Study|Withdrawal by Subject|0|||
160983637|NCT03958630|581328715|FG001|Overall Study|Withdrawal by Subject|0|||
160983638|NCT03958630|581328716|FG002|Overall Study|Withdrawal by Subject|1|||
160983639|NCT03958630|581328714|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
160983640|NCT03958630|581328715|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
160983641|NCT03958630|581328716|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
160983642|NCT01824472|581328719|FG000|Overall Study|Lost to Follow-up|0|||
160983643|NCT01824472|581328720|FG001|Overall Study|Lost to Follow-up|0|||
160983644|NCT01824472|581328721|FG002|Overall Study|Lost to Follow-up|1|||
160983645|NCT01824472|581328719|FG000|Overall Study|Withdrawal by Subject|1|||
160983646|NCT01824472|581328720|FG001|Overall Study|Withdrawal by Subject|5|||
160983647|NCT01824472|581328721|FG002|Overall Study|Withdrawal by Subject|3|||
160983648|NCT01824472|581328719|FG000|Overall Study|Ineligible post randomization&screening|0|||
160983649|NCT01824472|581328720|FG001|Overall Study|Ineligible post randomization&screening|2|||
160983650|NCT01824472|581328721|FG002|Overall Study|Ineligible post randomization&screening|0|||
160983651|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
160983652|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
160983653|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
160983654|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
160983655|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
160983656|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
160983657|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
160983658|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
160983659|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
160983660|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
160983661|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
160983662|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
160983663|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
160983664|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
160983665|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
160983666|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
160983667|NCT01815736|581328722|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
160983668|NCT01815736|581328723|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
160983669|NCT01815736|581328722|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
160983670|NCT01815736|581328723|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
160983671|NCT01815736|581328722|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
160983672|NCT01815736|581328723|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
160983673|NCT01815736|581328722|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
160983674|NCT01815736|581328723|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
160983675|NCT01815736|581328722|FG000|Extension Treatment Phase- After Week 96|Death|1|||
160983676|NCT01815736|581328723|FG001|Extension Treatment Phase- After Week 96|Death|0|||
160983677|NCT03387514|581328725|FG000|Overall Study|Withdrawal by Subject|2|||
160983678|NCT03387514|581328725|FG000|Overall Study|Physician Decision|1|||
160983679|NCT03387514|581328725|FG000|Overall Study|Lost to Follow-up|2|||
160983680|NCT03040687|581328732|FG000|Overall Study|Withdrawal by Subject|1|||
160983681|NCT03040687|581328733|FG001|Overall Study|Withdrawal by Subject|0|||
160983682|NCT03040687|581328734|FG002|Overall Study|Withdrawal by Subject|0|||
160983683|NCT04157686|581328735|FG000|Overall Study|Adverse Event|1|||
160983684|NCT04157686|581328736|FG001|Overall Study|Adverse Event|0|||
160983685|NCT04157686|581328737|FG002|Overall Study|Adverse Event|1|||
160983686|NCT04157686|581328738|FG003|Overall Study|Adverse Event|0|||
160983687|NCT04157686|581328739|FG004|Overall Study|Adverse Event|1|||
160983688|NCT04157686|581328740|FG005|Overall Study|Adverse Event|0|||
160983689|NCT04157686|581328741|FG006|Overall Study|Adverse Event|0|||
160983690|NCT04157686|581328742|FG007|Overall Study|Adverse Event|0|||
160983691|NCT04157686|581328735|FG000|Overall Study|Pregnancy|0|||
160549257|NCT01340209|579737764|FG002|Overall Study|Protocol Violation|1|||
160549258|NCT01340209|579737762|FG000|Overall Study|Withdrawal by Subject|0|||
160549259|NCT01340209|579737763|FG001|Overall Study|Withdrawal by Subject|0|||
160549260|NCT01340209|579737764|FG002|Overall Study|Withdrawal by Subject|1|||
160549261|NCT01340209|579737762|FG000|Overall Study|Other reason not defined above|3|||
160549262|NCT01340209|579737763|FG001|Overall Study|Other reason not defined above|5|||
160983692|NCT04157686|581328736|FG001|Overall Study|Pregnancy|1|||
160549263|NCT01340209|579737764|FG002|Overall Study|Other reason not defined above|4|||
160549264|NCT00429858|579737765|FG000|Overall Study|Withdrawal by Subject|1|||
160983693|NCT04157686|581328737|FG002|Overall Study|Pregnancy|3|||
160549265|NCT00429858|579737765|FG000|Overall Study|Study Termination|1|||
160571867|NCT01856673|579816844|FG001|Overall Study|Protocol Violation|0|||
160797660|NCT00718315|580649261|FG000|Overall Study|Use of ATB and Corticoids|0|||
160797661|NCT00718315|580649262|FG001|Overall Study|Use of ATB and Corticoids|1|||
160797662|NCT00718315|580649263|FG002|Overall Study|Use of ATB and Corticoids|2|||
160797663|NCT02271880|580649266|FG000|Overall Study|Premature discontinuation of study|3|||
160797664|NCT02271880|580649267|FG001|Overall Study|Premature discontinuation of study|4|||
160797665|NCT00474903|580649269|FG000|Overall Study|Protocol Violation|1|||
160797666|NCT00474903|580649270|FG001|Overall Study|Protocol Violation|5|||
160797667|NCT00474903|580649271|FG002|Overall Study|Protocol Violation|2|||
160797668|NCT02519842|580649274|FG000|Base Study: Cycle 1|Screening Failure|1|||
160797669|NCT02519842|580649275|FG001|Base Study: Cycle 1|Screening Failure|1|||
160797670|NCT02519842|580649276|FG002|Base Study: Cycle 1|Screening Failure|0|||
160797671|NCT02519842|580649274|FG000|Base Study: Cycle 1|Adverse Event|1|||
160797672|NCT02519842|580649275|FG001|Base Study: Cycle 1|Adverse Event|0|||
160797673|NCT02519842|580649276|FG002|Base Study: Cycle 1|Adverse Event|0|||
160797674|NCT02519842|580649274|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
160797675|NCT02519842|580649275|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
160797676|NCT02519842|580649276|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
160797677|NCT02519842|580649274|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
160797678|NCT02519842|580649275|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
160797679|NCT02519842|580649276|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
160797680|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
160797681|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
160797682|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
160797683|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
160797684|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
160797685|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
160797686|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
160797687|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
160797688|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
160797689|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
160797690|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
160797691|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
160797692|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Death|0|||
160797693|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Death|0|||
160797694|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Death|1|||
160797695|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
160797696|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
160797697|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
160797698|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
160797699|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
160797700|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
160797701|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
160797702|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
160797703|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
160797704|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
160797705|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
160797706|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
160797707|NCT01561976|580649277|FG000|Period 1|Adverse Event|0|||
160797708|NCT01561976|580649278|FG001|Period 1|Adverse Event|0|||
160797709|NCT01561976|580649279|FG002|Period 1|Adverse Event|1|||
160797710|NCT01561976|580649280|FG003|Period 1|Adverse Event|0|||
160797711|NCT01561976|580649281|FG004|Period 1|Adverse Event|0|||
160797712|NCT01561976|580649282|FG005|Period 1|Adverse Event|0|||
160797713|NCT01561976|580649277|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
160797714|NCT01561976|580649278|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
160797715|NCT01561976|580649279|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
160797716|NCT01561976|580649280|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
160797717|NCT01561976|580649281|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
160797718|NCT01561976|580649282|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
160797719|NCT01561976|580649277|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160797720|NCT01561976|580649278|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160797721|NCT01561976|580649279|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160797722|NCT01561976|580649280|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160797723|NCT01561976|580649281|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160797724|NCT01561976|580649282|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
160797725|NCT01561976|580649277|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
160797726|NCT01561976|580649278|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
160797727|NCT01561976|580649279|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
160797728|NCT01561976|580649280|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
160797729|NCT01561976|580649281|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
160797730|NCT01561976|580649282|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
160643504|NCT05751629|580076658|FG000|Overall Study|Physician Decision|1|||
160643505|NCT01909466|580076660|FG000|Overall Study|Lost to Follow-up|5|||
160643506|NCT01909466|580076661|FG001|Overall Study|Lost to Follow-up|7|||
160643507|NCT01909466|580076660|FG000|Overall Study|Adverse Event|3|||
160643508|NCT01909466|580076661|FG001|Overall Study|Adverse Event|4|||
160643509|NCT01909466|580076660|FG000|Overall Study|Met Withdrawal Criteria|0|||
160643510|NCT01909466|580076661|FG001|Overall Study|Met Withdrawal Criteria|3|||
160797731|NCT02303262|580649283|FG000|Overall Study|Withdrawal by Subject|2|||
160797732|NCT02943473|580649284|FG000|Overall Study|enrolled but not dosed|1|||
160797733|NCT02943473|580649284|FG000|Overall Study|screen failure|1|||
160797734|NCT02943473|580649284|FG000|Overall Study|Physician Decision|4|||
160797735|NCT01728246|580649285|FG000|Overall Study|Participant needed rescue medication|1|||
160797736|NCT01728246|580649286|FG001|Overall Study|Participant needed rescue medication|5|||
160797737|NCT01728246|580649285|FG000|Overall Study|Protocol Violation|1|||
160797738|NCT01728246|580649286|FG001|Overall Study|Protocol Violation|0|||
160797739|NCT01728246|580649285|FG000|Overall Study|Withdrawal by Subject|2|||
160797740|NCT01728246|580649286|FG001|Overall Study|Withdrawal by Subject|3|||
160797741|NCT01728246|580649285|FG000|Overall Study|Lost to Follow-up|23|||
160797742|NCT01728246|580649286|FG001|Overall Study|Lost to Follow-up|22|||
160797743|NCT01728246|580649285|FG000|Overall Study|Lack of Efficacy|1|||
160797744|NCT01728246|580649286|FG001|Overall Study|Lack of Efficacy|1|||
160797745|NCT01728246|580649285|FG000|Overall Study|Adverse Event|8|||
160797746|NCT01728246|580649286|FG001|Overall Study|Adverse Event|5|||
160797747|NCT05805150|580649287|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
160797748|NCT05805150|580649288|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
160797749|NCT04138056|580649291|FG000|Primary Study|Lost to Follow-up|3|||
160797750|NCT04138056|580649292|FG001|Primary Study|Lost to Follow-up|4|||
160797751|NCT04138056|580649293|FG002|Primary Study|Lost to Follow-up|1|||
160797752|NCT04138056|580649294|FG003|Primary Study|Lost to Follow-up|1|||
160797753|NCT04138056|580649295|FG004|Primary Study|Lost to Follow-up|4|||
160797754|NCT04138056|580649291|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
160797755|NCT04138056|580649292|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
160797756|NCT04138056|580649293|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
160797757|NCT04138056|580649294|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
160797758|NCT04138056|580649295|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
160797759|NCT04138056|580649291|FG000|Extension Study|Lost to Follow-up|1|||
160797760|NCT04138056|580649292|FG001|Extension Study|Lost to Follow-up|2|||
160797761|NCT04138056|580649293|FG002|Extension Study|Lost to Follow-up|1|||
160797762|NCT04138056|580649294|FG003|Extension Study|Lost to Follow-up|0|||
160797763|NCT04138056|580649295|FG004|Extension Study|Lost to Follow-up|1|||
160797764|NCT01968980|580649299|FG000|Overall Study|Death|0|||
160797765|NCT01968980|580649300|FG001|Overall Study|Death|1|||
160797766|NCT01968980|580649299|FG000|Overall Study|Adverse Event|1|||
160797767|NCT01968980|580649300|FG001|Overall Study|Adverse Event|3|||
160797768|NCT01968980|580649299|FG000|Overall Study|Does not meet entry criteria|1|||
160797769|NCT01968980|580649300|FG001|Overall Study|Does not meet entry criteria|3|||
160797770|NCT01968980|580649299|FG000|Overall Study|Withdrawal by Subject|13|||
160797771|NCT01968980|580649300|FG001|Overall Study|Withdrawal by Subject|5|||
160797772|NCT01968980|580649299|FG000|Overall Study|Other unspecified|1|||
160797773|NCT01968980|580649300|FG001|Overall Study|Other unspecified|2|||
160797774|NCT01242514|580649301|FG000|Overall Study|e.g., project closure|1042|||
160797775|NCT01242514|580649302|FG001|Overall Study|e.g., project closure|305|||
160797776|NCT01242514|580649303|FG002|Overall Study|e.g., project closure|171|||
160797777|NCT01242514|580649301|FG000|Overall Study|Subject decision|33|||
160797778|NCT01242514|580649302|FG001|Overall Study|Subject decision|8|||
160797779|NCT01242514|580649303|FG002|Overall Study|Subject decision|2|||
160797780|NCT01242514|580649301|FG000|Overall Study|Severe non-compliance to protocol|5|||
160797781|NCT01242514|580649302|FG001|Overall Study|Severe non-compliance to protocol|2|||
160797782|NCT01242514|580649303|FG002|Overall Study|Severe non-compliance to protocol|1|||
160797783|NCT01242514|580649301|FG000|Overall Study|Lack of therapeutic response|99|||
160797784|NCT01242514|580649302|FG001|Overall Study|Lack of therapeutic response|16|||
160797785|NCT01242514|580649303|FG002|Overall Study|Lack of therapeutic response|10|||
160797786|NCT01242514|580649301|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
160643511|NCT01909466|580076660|FG000|Overall Study|Physician Decision|2|||
160797787|NCT01242514|580649302|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
160797788|NCT01242514|580649303|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
160797789|NCT01242514|580649301|FG000|Overall Study|Lost to Follow-up|14|||
160797790|NCT01242514|580649302|FG001|Overall Study|Lost to Follow-up|5|||
160894842|NCT00973349|581010955|FG013|Overall Study|Adverse Event|0|||
160643512|NCT01909466|580076661|FG001|Overall Study|Physician Decision|0|||
160797791|NCT01242514|580649303|FG002|Overall Study|Lost to Follow-up|4|||
160797792|NCT01242514|580649301|FG000|Overall Study|Adverse Event|129|||
160797793|NCT01242514|580649302|FG001|Overall Study|Adverse Event|18|||
160797794|NCT01242514|580649303|FG002|Overall Study|Adverse Event|19|||
160894843|NCT00973349|581010956|FG014|Overall Study|Adverse Event|1|||
160894844|NCT00973349|581010957|FG015|Overall Study|Adverse Event|0|||
160643513|NCT01909466|580076660|FG000|Overall Study|Withdrawal by Subject|11|||
160643514|NCT01909466|580076661|FG001|Overall Study|Withdrawal by Subject|9|||
160643515|NCT01909466|580076660|FG000|Overall Study|Lack of Efficacy|1|||
160643516|NCT01909466|580076661|FG001|Overall Study|Lack of Efficacy|0|||
160643517|NCT00672620|580076667|FG000|Overall Study|Adverse Event|7|||
160643518|NCT00672620|580076668|FG001|Overall Study|Adverse Event|7|||
160643519|NCT00672620|580076669|FG002|Overall Study|Adverse Event|12|||
160643520|NCT00672620|580076670|FG003|Overall Study|Adverse Event|17|||
160643521|NCT00672620|580076667|FG000|Overall Study|Lack of Efficacy|1|||
160643522|NCT00672620|580076668|FG001|Overall Study|Lack of Efficacy|2|||
160643523|NCT00672620|580076669|FG002|Overall Study|Lack of Efficacy|2|||
160643524|NCT00672620|580076670|FG003|Overall Study|Lack of Efficacy|0|||
160643525|NCT00672620|580076667|FG000|Overall Study|Noncompliance with Study Drug|3|||
160643526|NCT00672620|580076668|FG001|Overall Study|Noncompliance with Study Drug|4|||
160643527|NCT00672620|580076669|FG002|Overall Study|Noncompliance with Study Drug|0|||
160643528|NCT00672620|580076670|FG003|Overall Study|Noncompliance with Study Drug|2|||
160643529|NCT00672620|580076667|FG000|Overall Study|Protocol Deviations|5|||
160643530|NCT00672620|580076668|FG001|Overall Study|Protocol Deviations|7|||
160643531|NCT00672620|580076669|FG002|Overall Study|Protocol Deviations|2|||
160643532|NCT00672620|580076670|FG003|Overall Study|Protocol Deviations|5|||
160643533|NCT00672620|580076667|FG000|Overall Study|Withdrawal of Consent|6|||
160643534|NCT00672620|580076668|FG001|Overall Study|Withdrawal of Consent|12|||
160643535|NCT00672620|580076669|FG002|Overall Study|Withdrawal of Consent|5|||
160643536|NCT00672620|580076670|FG003|Overall Study|Withdrawal of Consent|6|||
160643537|NCT00672620|580076667|FG000|Overall Study|Lost to Follow-up|8|||
160643538|NCT00672620|580076668|FG001|Overall Study|Lost to Follow-up|19|||
160643539|NCT00672620|580076669|FG002|Overall Study|Lost to Follow-up|8|||
160643540|NCT00672620|580076670|FG003|Overall Study|Lost to Follow-up|11|||
160643541|NCT00672620|580076667|FG000|Overall Study|Reason not Specified|3|||
160643542|NCT00672620|580076668|FG001|Overall Study|Reason not Specified|3|||
160643543|NCT00672620|580076669|FG002|Overall Study|Reason not Specified|2|||
160643544|NCT00672620|580076670|FG003|Overall Study|Reason not Specified|1|||
160643545|NCT00772577|580076671|FG000|Overall Study|Adverse Event|6|||
160643546|NCT00772577|580076672|FG001|Overall Study|Adverse Event|3|||
160643547|NCT00772577|580076671|FG000|Overall Study|Abnormal laboratory values|0|||
160643548|NCT00772577|580076672|FG001|Overall Study|Abnormal laboratory values|1|||
160643549|NCT00772577|580076671|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160643550|NCT00772577|580076672|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
160643551|NCT00772577|580076671|FG000|Overall Study|Patient withdrew consent|8|||
160643552|NCT00772577|580076672|FG001|Overall Study|Patient withdrew consent|5|||
160643553|NCT00772577|580076671|FG000|Overall Study|Lost to Follow-up|4|||
160643554|NCT00772577|580076672|FG001|Overall Study|Lost to Follow-up|3|||
160643555|NCT00772577|580076671|FG000|Overall Study|Administrative problems|2|||
160643556|NCT00772577|580076672|FG001|Overall Study|Administrative problems|1|||
160643557|NCT00772577|580076671|FG000|Overall Study|Protocol Deviation|3|||
160643558|NCT00772577|580076672|FG001|Overall Study|Protocol Deviation|2|||
160643559|NCT02965820|580076673|FG000|Period 2, Second 30 Days|Adverse Event|1|||
160643560|NCT02965820|580076674|FG001|Period 2, Second 30 Days|Adverse Event|1|||
160643561|NCT01567306|580076675|FG000|Overall Study|Protocol Violation|2|||
160894845|NCT00973349|581010942|FG000|Overall Study|Withdrawal by Subject|1|||
160894846|NCT00973349|581010943|FG001|Overall Study|Withdrawal by Subject|2|||
160894847|NCT00973349|581010944|FG002|Overall Study|Withdrawal by Subject|2|||
160894848|NCT00973349|581010945|FG003|Overall Study|Withdrawal by Subject|3|||
160643562|NCT01567306|580076676|FG001|Overall Study|Protocol Violation|2|||
160643563|NCT01567306|580076677|FG002|Overall Study|Protocol Violation|0|||
160643564|NCT01567306|580076678|FG003|Overall Study|Protocol Violation|3|||
160643565|NCT01567306|580076679|FG004|Overall Study|Protocol Violation|1|||
160643566|NCT01567306|580076680|FG005|Overall Study|Protocol Violation|1|||
160643567|NCT01567306|580076675|FG000|Overall Study|Change site living|1|||
160643568|NCT01567306|580076676|FG001|Overall Study|Change site living|0|||
160643569|NCT01567306|580076677|FG002|Overall Study|Change site living|0|||
160643570|NCT01567306|580076678|FG003|Overall Study|Change site living|0|||
160643571|NCT01567306|580076679|FG004|Overall Study|Change site living|0|||
160643572|NCT01567306|580076680|FG005|Overall Study|Change site living|0|||
160643573|NCT01567306|580076675|FG000|Overall Study|Adverse Event|0|||
160643574|NCT01567306|580076676|FG001|Overall Study|Adverse Event|0|||
160643575|NCT01567306|580076677|FG002|Overall Study|Adverse Event|0|||
160643576|NCT01567306|580076678|FG003|Overall Study|Adverse Event|2|||
160643577|NCT01567306|580076679|FG004|Overall Study|Adverse Event|4|||
160894849|NCT00973349|581010946|FG004|Overall Study|Withdrawal by Subject|2|||
160643578|NCT01567306|580076680|FG005|Overall Study|Adverse Event|1|||
160643579|NCT01567306|580076675|FG000|Overall Study|Lost to Follow-up|0|||
160643580|NCT01567306|580076676|FG001|Overall Study|Lost to Follow-up|0|||
160643581|NCT01567306|580076677|FG002|Overall Study|Lost to Follow-up|0|||
160643582|NCT01567306|580076678|FG003|Overall Study|Lost to Follow-up|0|||
160643583|NCT01567306|580076679|FG004|Overall Study|Lost to Follow-up|2|||
160643584|NCT01567306|580076680|FG005|Overall Study|Lost to Follow-up|0|||
160643585|NCT01567306|580076675|FG000|Overall Study|Withdrawal by Subject|0|||
160643586|NCT01567306|580076676|FG001|Overall Study|Withdrawal by Subject|0|||
160643587|NCT01567306|580076677|FG002|Overall Study|Withdrawal by Subject|0|||
160643588|NCT01567306|580076678|FG003|Overall Study|Withdrawal by Subject|0|||
160643589|NCT01567306|580076679|FG004|Overall Study|Withdrawal by Subject|0|||
160643590|NCT01567306|580076680|FG005|Overall Study|Withdrawal by Subject|1|||
160643591|NCT04272775|580076688|FG000|Overall Study|Study Terminated by Sponsor|1|||
160643592|NCT04272775|580076689|FG001|Overall Study|Study Terminated by Sponsor|0|||
160643593|NCT04272775|580076688|FG000|Overall Study|Protocol Violation|0|||
160643594|NCT04272775|580076689|FG001|Overall Study|Protocol Violation|1|||
160643595|NCT04272775|580076688|FG000|Overall Study|Symptomatic Deterioration|1|||
160894850|NCT00973349|581010947|FG005|Overall Study|Withdrawal by Subject|0|||
160894851|NCT00973349|581010948|FG006|Overall Study|Withdrawal by Subject|2|||
160894852|NCT00973349|581010949|FG007|Overall Study|Withdrawal by Subject|2|||
160894853|NCT00973349|581010950|FG008|Overall Study|Withdrawal by Subject|0|||
160643596|NCT04272775|580076689|FG001|Overall Study|Symptomatic Deterioration|1|||
160643597|NCT04272775|580076688|FG000|Overall Study|Withdrawal by Subject|1|||
160643598|NCT04272775|580076689|FG001|Overall Study|Withdrawal by Subject|2|||
160643599|NCT04272775|580076688|FG000|Overall Study|Adverse Event|1|||
160643600|NCT04272775|580076689|FG001|Overall Study|Adverse Event|2|||
160643601|NCT04272775|580076688|FG000|Overall Study|Progressive Disease|3|||
160643602|NCT04272775|580076689|FG001|Overall Study|Progressive Disease|1|||
160643603|NCT02063698|580076696|FG000|Overall Study|did not complete booklet for days 2-8|1|||
160643604|NCT02063698|580076697|FG001|Overall Study|did not complete booklet for days 2-8|2|||
160643605|NCT01225991|580076700|FG000|Overall Study|Withdrawal by Subject|6|||
160643606|NCT01473758|580078792|FG000|Cycle 1|Adverse Event|10|||
160894854|NCT00973349|581010951|FG009|Overall Study|Withdrawal by Subject|2|||
160894855|NCT00973349|581010952|FG010|Overall Study|Withdrawal by Subject|0|||
160894856|NCT00973349|581010953|FG011|Overall Study|Withdrawal by Subject|1|||
160894857|NCT00973349|581010954|FG012|Overall Study|Withdrawal by Subject|0|||
160894858|NCT00973349|581010955|FG013|Overall Study|Withdrawal by Subject|0|||
160894859|NCT00973349|581010956|FG014|Overall Study|Withdrawal by Subject|0|||
160894860|NCT00973349|581010957|FG015|Overall Study|Withdrawal by Subject|0|||
160894861|NCT00973349|581010942|FG000|Overall Study|Lost to Follow-up|3|||
160894862|NCT00973349|581010943|FG001|Overall Study|Lost to Follow-up|1|||
160894863|NCT00973349|581010944|FG002|Overall Study|Lost to Follow-up|2|||
160894864|NCT00973349|581010945|FG003|Overall Study|Lost to Follow-up|2|||
160894865|NCT00973349|581010946|FG004|Overall Study|Lost to Follow-up|1|||
160894866|NCT00973349|581010947|FG005|Overall Study|Lost to Follow-up|3|||
160894867|NCT00973349|581010948|FG006|Overall Study|Lost to Follow-up|0|||
160894868|NCT00973349|581010949|FG007|Overall Study|Lost to Follow-up|1|||
160894869|NCT00973349|581010950|FG008|Overall Study|Lost to Follow-up|2|||
160894870|NCT00973349|581010951|FG009|Overall Study|Lost to Follow-up|1|||
160894871|NCT00973349|581010952|FG010|Overall Study|Lost to Follow-up|0|||
160894872|NCT00973349|581010953|FG011|Overall Study|Lost to Follow-up|1|||
160894873|NCT00973349|581010954|FG012|Overall Study|Lost to Follow-up|0|||
160643607|NCT01473758|580078793|FG001|Cycle 1|Adverse Event|2|||
160643608|NCT01473758|580078794|FG002|Cycle 1|Adverse Event|0|||
160643609|NCT01473758|580078795|FG003|Cycle 1|Adverse Event|0|||
160643610|NCT01473758|580078792|FG000|Cycle 1|Withdrawal by Subject|1|||
160643611|NCT01473758|580078793|FG001|Cycle 1|Withdrawal by Subject|1|||
160643612|NCT01473758|580078794|FG002|Cycle 1|Withdrawal by Subject|0|||
160643613|NCT01473758|580078795|FG003|Cycle 1|Withdrawal by Subject|0|||
160643614|NCT01473758|580078792|FG000|Cycle 2|Adverse Event|0|||
160894874|NCT00973349|581010955|FG013|Overall Study|Lost to Follow-up|0|||
160894875|NCT00973349|581010956|FG014|Overall Study|Lost to Follow-up|0|||
160894876|NCT00973349|581010957|FG015|Overall Study|Lost to Follow-up|1|||
160894877|NCT00973349|581010942|FG000|Overall Study|Inappropriate enrolment|0|||
160549266|NCT01587079|579737766|FG000|Overall Study|Protocol-specified criteria|9|||
160549267|NCT01587079|579737766|FG000|Overall Study|Protocol Violation|5|||
160549268|NCT01587079|579737766|FG000|Overall Study|Lost to Follow-up|2|||
160549269|NCT01587079|579737766|FG000|Overall Study|Physician Decision|2|||
160549270|NCT01587079|579737766|FG000|Overall Study|Withdrawal by Subject|7|||
160549271|NCT01587079|579737766|FG000|Overall Study|Adverse Event|14|||
160549272|NCT01239160|579737767|FG000|Overall Study|Lost to Follow-up|3|||
160549273|NCT01239160|579737768|FG001|Overall Study|Lost to Follow-up|5|||
160894878|NCT00973349|581010943|FG001|Overall Study|Inappropriate enrolment|0|||
160894879|NCT00973349|581010944|FG002|Overall Study|Inappropriate enrolment|1|||
160894880|NCT00973349|581010945|FG003|Overall Study|Inappropriate enrolment|0|||
160894881|NCT00973349|581010946|FG004|Overall Study|Inappropriate enrolment|0|||
160894882|NCT00973349|581010947|FG005|Overall Study|Inappropriate enrolment|0|||
160894883|NCT00973349|581010948|FG006|Overall Study|Inappropriate enrolment|0|||
160894884|NCT00973349|581010949|FG007|Overall Study|Inappropriate enrolment|0|||
160894885|NCT00973349|581010950|FG008|Overall Study|Inappropriate enrolment|0|||
160894886|NCT00973349|581010951|FG009|Overall Study|Inappropriate enrolment|2|||
160894887|NCT00973349|581010952|FG010|Overall Study|Inappropriate enrolment|0|||
160894888|NCT00973349|581010953|FG011|Overall Study|Inappropriate enrolment|0|||
160894889|NCT00973349|581010954|FG012|Overall Study|Inappropriate enrolment|1|||
160894890|NCT00973349|581010955|FG013|Overall Study|Inappropriate enrolment|0|||
160894891|NCT00973349|581010956|FG014|Overall Study|Inappropriate enrolment|1|||
160894892|NCT00973349|581010957|FG015|Overall Study|Inappropriate enrolment|1|||
160894893|NCT00973349|581010942|FG000|Overall Study|Protocol Violation|0|||
160894894|NCT00973349|581010943|FG001|Overall Study|Protocol Violation|0|||
160894895|NCT00973349|581010944|FG002|Overall Study|Protocol Violation|0|||
160894896|NCT00973349|581010945|FG003|Overall Study|Protocol Violation|0|||
160894897|NCT00973349|581010946|FG004|Overall Study|Protocol Violation|0|||
160894898|NCT00973349|581010947|FG005|Overall Study|Protocol Violation|0|||
160894899|NCT00973349|581010948|FG006|Overall Study|Protocol Violation|0|||
160894900|NCT00973349|581010949|FG007|Overall Study|Protocol Violation|0|||
160894901|NCT00973349|581010950|FG008|Overall Study|Protocol Violation|1|||
160894902|NCT00973349|581010951|FG009|Overall Study|Protocol Violation|0|||
160894903|NCT00973349|581010952|FG010|Overall Study|Protocol Violation|0|||
160894904|NCT00973349|581010953|FG011|Overall Study|Protocol Violation|0|||
160894905|NCT00973349|581010954|FG012|Overall Study|Protocol Violation|0|||
160894906|NCT00973349|581010955|FG013|Overall Study|Protocol Violation|0|||
160894907|NCT00973349|581010956|FG014|Overall Study|Protocol Violation|0|||
160894908|NCT00973349|581010957|FG015|Overall Study|Protocol Violation|0|||
160894909|NCT00973349|581010942|FG000|Overall Study|Unable to classify|0|||
160894910|NCT00973349|581010943|FG001|Overall Study|Unable to classify|0|||
160894911|NCT00973349|581010944|FG002|Overall Study|Unable to classify|0|||
160549274|NCT01239160|579737769|FG002|Overall Study|Lost to Follow-up|0|||
160549275|NCT01239160|579737767|FG000|Overall Study|Withdrawal by Subject|17|||
160549276|NCT01239160|579737768|FG001|Overall Study|Withdrawal by Subject|6|||
160549277|NCT01239160|579737769|FG002|Overall Study|Withdrawal by Subject|2|||
160549278|NCT01239160|579737767|FG000|Overall Study|Physician Decision|5|||
160549279|NCT01239160|579737768|FG001|Overall Study|Physician Decision|7|||
160549280|NCT01239160|579737769|FG002|Overall Study|Physician Decision|2|||
160549281|NCT01239160|579737767|FG000|Overall Study|Early Termination Due to Study Closure|0|||
160549282|NCT01239160|579737768|FG001|Overall Study|Early Termination Due to Study Closure|1|||
160549283|NCT01239160|579737769|FG002|Overall Study|Early Termination Due to Study Closure|6|||
160549284|NCT01764633|579737770|FG000|Overall Study|Withdrawal by Subject|105|||
160549285|NCT01764633|579737771|FG001|Overall Study|Withdrawal by Subject|88|||
160549286|NCT01764633|579737770|FG000|Overall Study|Lost to Follow-up|13|||
160549287|NCT01764633|579737771|FG001|Overall Study|Lost to Follow-up|5|||
160549288|NCT02268058|579737772|FG000|Overall Study|Protocol Violation|1|||
160549289|NCT02268058|579737773|FG001|Overall Study|Protocol Violation|0|||
160549290|NCT02268058|579737774|FG002|Overall Study|Protocol Violation|0|||
160549291|NCT02268058|579737775|FG003|Overall Study|Protocol Violation|0|||
160549292|NCT04781816|579737780|FG000|Overall Study|Adverse Event|0|||
160549293|NCT04781816|579737781|FG001|Overall Study|Adverse Event|1|||
160549294|NCT04781816|579737780|FG000|Overall Study|Withdrawal by Subject|1|||
160549295|NCT04781816|579737781|FG001|Overall Study|Withdrawal by Subject|1|||
160549296|NCT04781816|579737780|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
160549297|NCT04781816|579737781|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
160549298|NCT01789970|579737782|FG000|Open-label Titration Period|Adverse Event|68|||
160549299|NCT01789970|579737783|FG001|Open-label Titration Period|Adverse Event|0|||
160549300|NCT01789970|579737784|FG002|Open-label Titration Period|Adverse Event|0|||
160549301|NCT01789970|579737782|FG000|Open-label Titration Period|Lack of Efficacy|31|||
160549302|NCT01789970|579737783|FG001|Open-label Titration Period|Lack of Efficacy|0|||
160549303|NCT01789970|579737784|FG002|Open-label Titration Period|Lack of Efficacy|0|||
160549304|NCT01789970|579737782|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
160549305|NCT01789970|579737783|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
160894912|NCT00973349|581010945|FG003|Overall Study|Unable to classify|0|||
160894913|NCT00973349|581010946|FG004|Overall Study|Unable to classify|1|||
160894914|NCT00973349|581010947|FG005|Overall Study|Unable to classify|1|||
160894915|NCT00973349|581010948|FG006|Overall Study|Unable to classify|0|||
160894916|NCT00973349|581010949|FG007|Overall Study|Unable to classify|0|||
160894917|NCT00973349|581010950|FG008|Overall Study|Unable to classify|0|||
160894918|NCT00973349|581010951|FG009|Overall Study|Unable to classify|1|||
160894919|NCT00973349|581010952|FG010|Overall Study|Unable to classify|0|||
160894920|NCT00973349|581010953|FG011|Overall Study|Unable to classify|0|||
160894921|NCT00973349|581010954|FG012|Overall Study|Unable to classify|0|||
160894922|NCT00973349|581010955|FG013|Overall Study|Unable to classify|0|||
160894923|NCT00973349|581010956|FG014|Overall Study|Unable to classify|0|||
160894924|NCT00973349|581010957|FG015|Overall Study|Unable to classify|0|||
160894925|NCT02898116|581010958|FG000|Overall Study|Adverse Event|1|||
160894926|NCT02898116|581010958|FG000|Overall Study|Progressive disease|1|||
160894927|NCT05430022|581010976|FG000|Overall Study|Withdrawal by Subject|4|||
160894928|NCT05430022|581010977|FG001|Overall Study|Withdrawal by Subject|4|||
160894929|NCT05521906|581010978|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
160894930|NCT05521906|581010979|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
160894931|NCT02452697|581010982|FG000|Overall Study|Physician Decision|4|||
160894932|NCT02452697|581010983|FG001|Overall Study|Physician Decision|4|||
160894933|NCT02452697|581010984|FG002|Overall Study|Physician Decision|3|||
160894934|NCT02452697|581010985|FG003|Overall Study|Physician Decision|2|||
160894935|NCT02452697|581010982|FG000|Overall Study|Withdrawal by Subject|1|||
160894936|NCT02452697|581010983|FG001|Overall Study|Withdrawal by Subject|0|||
160894937|NCT02452697|581010984|FG002|Overall Study|Withdrawal by Subject|0|||
160894938|NCT02452697|581010985|FG003|Overall Study|Withdrawal by Subject|0|||
160894939|NCT02452697|581010982|FG000|Overall Study|still in follow-up|2|||
160894940|NCT02452697|581010983|FG001|Overall Study|still in follow-up|2|||
160894941|NCT02452697|581010984|FG002|Overall Study|still in follow-up|1|||
160894942|NCT02452697|581010985|FG003|Overall Study|still in follow-up|3|||
160894943|NCT00560885|581010988|FG000|Overall Study|Death|7|||
160894944|NCT00560885|581010988|FG000|Overall Study|Withdrawal by Subject|1|||
160894945|NCT03803683|581010989|FG000|Overall Study|Lost to Follow-up|41|||
160894946|NCT03803683|581010990|FG001|Overall Study|Lost to Follow-up|18|||
160894947|NCT03803683|581010991|FG002|Overall Study|Lost to Follow-up|12|||
160894948|NCT03803683|581010989|FG000|Overall Study|Withdrawal by Subject|9|||
160894949|NCT03803683|581010990|FG001|Overall Study|Withdrawal by Subject|1|||
160894950|NCT03803683|581010991|FG002|Overall Study|Withdrawal by Subject|4|||
160894951|NCT00866788|581012784|FG000|Overall Study|Adverse Event|0|||
160894952|NCT00866788|581012785|FG001|Overall Study|Adverse Event|2|||
160894953|NCT00866788|581012786|FG002|Overall Study|Adverse Event|0|||
160894954|NCT00866788|581012787|FG003|Overall Study|Adverse Event|1|||
160894955|NCT00866788|581012784|FG000|Overall Study|Lost to Follow-up|1|||
160894956|NCT00866788|581012785|FG001|Overall Study|Lost to Follow-up|1|||
160983694|NCT04157686|581328738|FG003|Overall Study|Pregnancy|0|||
160983695|NCT04157686|581328739|FG004|Overall Study|Pregnancy|0|||
160983696|NCT04157686|581328740|FG005|Overall Study|Pregnancy|0|||
160894957|NCT00866788|581012786|FG002|Overall Study|Lost to Follow-up|0|||
160894958|NCT00866788|581012787|FG003|Overall Study|Lost to Follow-up|2|||
160894959|NCT00866788|581012784|FG000|Overall Study|Withdrawal by Subject|2|||
160894960|NCT00866788|581012785|FG001|Overall Study|Withdrawal by Subject|1|||
160894961|NCT00866788|581012786|FG002|Overall Study|Withdrawal by Subject|0|||
160894962|NCT00866788|581012787|FG003|Overall Study|Withdrawal by Subject|1|||
160894963|NCT00866788|581012784|FG000|Overall Study|Pregnancy|0|||
160894964|NCT00866788|581012785|FG001|Overall Study|Pregnancy|1|||
160894965|NCT00866788|581012786|FG002|Overall Study|Pregnancy|0|||
160894966|NCT00866788|581012787|FG003|Overall Study|Pregnancy|0|||
160894967|NCT00866788|581012784|FG000|Overall Study|Disease progression|3|||
160894968|NCT00866788|581012785|FG001|Overall Study|Disease progression|1|||
160894969|NCT00866788|581012786|FG002|Overall Study|Disease progression|1|||
160894970|NCT00866788|581012787|FG003|Overall Study|Disease progression|0|||
160894971|NCT00866788|581012784|FG000|Overall Study|Physician Decision|0|||
160894972|NCT00866788|581012785|FG001|Overall Study|Physician Decision|0|||
160894973|NCT00866788|581012786|FG002|Overall Study|Physician Decision|1|||
160894974|NCT00866788|581012787|FG003|Overall Study|Physician Decision|1|||
160894975|NCT02349061|581012788|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
160894976|NCT02349061|581012789|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
160894977|NCT02349061|581012790|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
160894978|NCT02349061|581012788|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
160894979|NCT02349061|581012789|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
160894980|NCT02349061|581012790|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
160894981|NCT02349061|581012788|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
160894982|NCT02349061|581012789|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
160894983|NCT02349061|581012790|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
160894984|NCT02349061|581012788|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
160894985|NCT02349061|581012789|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
160643615|NCT01473758|580078793|FG001|Cycle 2|Adverse Event|0|||
160643616|NCT01473758|580078794|FG002|Cycle 2|Adverse Event|5|||
160643617|NCT01473758|580078795|FG003|Cycle 2|Adverse Event|0|||
160797795|NCT00862940|580649308|FG000|Overall Study|Adverse Event|15|||
160797796|NCT00862940|580649309|FG001|Overall Study|Adverse Event|12|||
160797797|NCT00862940|580649308|FG000|Overall Study|Lack of Efficacy|1|||
160797798|NCT00862940|580649309|FG001|Overall Study|Lack of Efficacy|3|||
160797799|NCT00862940|580649308|FG000|Overall Study|Protocol Violation|2|||
160797800|NCT00862940|580649309|FG001|Overall Study|Protocol Violation|5|||
160797801|NCT00862940|580649308|FG000|Overall Study|Withdrawal by Subject|4|||
160797802|NCT00862940|580649309|FG001|Overall Study|Withdrawal by Subject|6|||
160797803|NCT00862940|580649308|FG000|Overall Study|Non-compliance|4|||
160797804|NCT00862940|580649309|FG001|Overall Study|Non-compliance|0|||
160797805|NCT00862940|580649308|FG000|Overall Study|Lost to Follow-up|0|||
160797806|NCT00862940|580649309|FG001|Overall Study|Lost to Follow-up|1|||
160797807|NCT00862940|580649308|FG000|Overall Study|Administrative or other reason(s)|4|||
160797808|NCT00862940|580649309|FG001|Overall Study|Administrative or other reason(s)|3|||
160797809|NCT00485173|580649310|FG000|Overall Study|Death|4|||
160797810|NCT00485173|580649311|FG001|Overall Study|Death|3|||
160797811|NCT00485173|580649310|FG000|Overall Study|Lost to Follow-up|32|||
160797812|NCT00485173|580649311|FG001|Overall Study|Lost to Follow-up|61|||
160797813|NCT00879398|580649314|FG000|Overall Study|Visit Stop|399|||
160797814|NCT00879398|580649314|FG000|Overall Study|Lack of Efficacy|64|||
160797815|NCT00879398|580649314|FG000|Overall Study|Adverse Event|41|||
160797816|NCT00879398|580649314|FG000|Overall Study|Other Reasons|171|||
160797817|NCT00829244|580649315|FG000|Overall Study|Adverse Event|1|||
160797818|NCT00829244|580649316|FG001|Overall Study|Adverse Event|3|||
160797819|NCT00829244|580649315|FG000|Overall Study|Protocol Violation|1|||
160797820|NCT00829244|580649316|FG001|Overall Study|Protocol Violation|0|||
160797821|NCT00829244|580649315|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
160797822|NCT00829244|580649316|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
160797823|NCT00829244|580649315|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
160797824|NCT00829244|580649316|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
160797825|NCT00829244|580649315|FG000|Overall Study|No fertilization|2|||
160797826|NCT00829244|580649316|FG001|Overall Study|No fertilization|2|||
160797827|NCT00829244|580649315|FG000|Overall Study|All embryos discarded|0|||
160797828|NCT00829244|580649316|FG001|Overall Study|All embryos discarded|3|||
160797829|NCT00829244|580649315|FG000|Overall Study|No embryo cleavage|0|||
160797830|NCT00829244|580649316|FG001|Overall Study|No embryo cleavage|2|||
160797831|NCT05901636|580649323|FG000|Overall Study|Lost to Follow-up|0|||
160797832|NCT05901636|580649324|FG001|Overall Study|Lost to Follow-up|1|||
160797833|NCT05901636|580649325|FG002|Overall Study|Lost to Follow-up|0|||
160797834|NCT05901636|580649326|FG003|Overall Study|Lost to Follow-up|1|||
160797835|NCT05901636|580649327|FG004|Overall Study|Lost to Follow-up|1|||
160797836|NCT05901636|580649328|FG005|Overall Study|Lost to Follow-up|3|||
160894986|NCT02349061|581012790|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
160894987|NCT02349061|581012788|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
160894988|NCT02349061|581012789|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
160894989|NCT02349061|581012790|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
160894990|NCT02349061|581012788|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
160894991|NCT02349061|581012789|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
160894992|NCT02349061|581012790|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
160894993|NCT02349061|581012788|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
160894994|NCT02349061|581012789|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
160894995|NCT02349061|581012790|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
160797837|NCT05901636|580649329|FG006|Overall Study|Lost to Follow-up|1|||
160797838|NCT05901636|580649323|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
160894996|NCT02349061|581012788|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
160894997|NCT02349061|581012789|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
160894998|NCT02349061|581012790|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
160894999|NCT02349061|581012788|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
160895000|NCT02349061|581012789|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
160895001|NCT02349061|581012790|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
160643618|NCT01034137|580078806|FG000|Overall Study|Adverse Event|9|||
160797839|NCT05901636|580649324|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
160797840|NCT05901636|580649325|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
160797841|NCT05901636|580649326|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
160797842|NCT05901636|580649327|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
160797843|NCT05901636|580649328|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
160797844|NCT05901636|580649329|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
160643619|NCT01034137|580078807|FG001|Overall Study|Adverse Event|10|||
160643620|NCT01034137|580078808|FG002|Overall Study|Adverse Event|8|||
160797845|NCT05901636|580649323|FG000|Overall Study|Withdrawal by Subject|1|||
160797846|NCT05901636|580649324|FG001|Overall Study|Withdrawal by Subject|1|||
160797847|NCT05901636|580649325|FG002|Overall Study|Withdrawal by Subject|0|||
160797848|NCT05901636|580649326|FG003|Overall Study|Withdrawal by Subject|0|||
160797849|NCT05901636|580649327|FG004|Overall Study|Withdrawal by Subject|1|||
160797850|NCT05901636|580649328|FG005|Overall Study|Withdrawal by Subject|1|||
160797851|NCT05901636|580649329|FG006|Overall Study|Withdrawal by Subject|0|||
160797852|NCT05901636|580649323|FG000|Overall Study|Other|0|||
160797853|NCT05901636|580649324|FG001|Overall Study|Other|0|||
160797854|NCT05901636|580649325|FG002|Overall Study|Other|1|||
160797855|NCT05901636|580649326|FG003|Overall Study|Other|1|||
160797856|NCT05901636|580649327|FG004|Overall Study|Other|0|||
160797857|NCT05901636|580649328|FG005|Overall Study|Other|0|||
160797858|NCT05901636|580649329|FG006|Overall Study|Other|0|||
160797859|NCT04583618|580649337|FG000|Overall Study|Adverse Event|0|||
160797860|NCT04583618|580649338|FG001|Overall Study|Adverse Event|0|||
160797861|NCT04583618|580649339|FG002|Overall Study|Adverse Event|1|||
160797862|NCT04583618|580649340|FG003|Overall Study|Adverse Event|0|||
160797863|NCT04583618|580649341|FG004|Overall Study|Adverse Event|0|||
160797864|NCT04583618|580649337|FG000|Overall Study|Protocol deviation|1|||
160797865|NCT04583618|580649338|FG001|Overall Study|Protocol deviation|1|||
160797866|NCT04583618|580649339|FG002|Overall Study|Protocol deviation|1|||
160797867|NCT04583618|580649340|FG003|Overall Study|Protocol deviation|0|||
160797868|NCT04583618|580649341|FG004|Overall Study|Protocol deviation|0|||
160797869|NCT04583618|580649337|FG000|Overall Study|Withdrawal by Subject|2|||
160797870|NCT04583618|580649338|FG001|Overall Study|Withdrawal by Subject|1|||
160797871|NCT04583618|580649339|FG002|Overall Study|Withdrawal by Subject|3|||
160797872|NCT04583618|580649340|FG003|Overall Study|Withdrawal by Subject|1|||
160797873|NCT04583618|580649341|FG004|Overall Study|Withdrawal by Subject|1|||
160797874|NCT04583618|580649337|FG000|Overall Study|Lost to Follow-up|0|||
160797875|NCT04583618|580649338|FG001|Overall Study|Lost to Follow-up|1|||
160797876|NCT04583618|580649339|FG002|Overall Study|Lost to Follow-up|3|||
160797877|NCT04583618|580649340|FG003|Overall Study|Lost to Follow-up|1|||
160797878|NCT04583618|580649341|FG004|Overall Study|Lost to Follow-up|1|||
160797879|NCT02302222|580649342|FG000|Overall Study|Physician Decision|0|||
160797880|NCT02302222|580649343|FG001|Overall Study|Physician Decision|4|||
160797881|NCT02302222|580649342|FG000|Overall Study|Lost to Follow-up|1|||
160797882|NCT02302222|580649343|FG001|Overall Study|Lost to Follow-up|0|||
160797883|NCT02302222|580649342|FG000|Overall Study|Treatment discontinued before day 5|0|||
160797884|NCT02302222|580649343|FG001|Overall Study|Treatment discontinued before day 5|1|||
160797885|NCT02302222|580649342|FG000|Overall Study|Withdrawn prior to any treatment|0|||
160797886|NCT02302222|580649343|FG001|Overall Study|Withdrawn prior to any treatment|1|||
160549306|NCT01789970|579737784|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
160797887|NCT00016354|580649344|FG000|Overall Study|Lack of Efficacy|0|||
160797888|NCT00016354|580649345|FG001|Overall Study|Lack of Efficacy|0|||
160797889|NCT00016354|580649346|FG002|Overall Study|Lack of Efficacy|0|||
160797890|NCT00016354|580649347|FG003|Overall Study|Lack of Efficacy|0|||
160797891|NCT00016354|580649348|FG004|Overall Study|Lack of Efficacy|0|||
160797892|NCT00016354|580649349|FG005|Overall Study|Lack of Efficacy|0|||
160797893|NCT00016354|580649350|FG006|Overall Study|Lack of Efficacy|0|||
160797894|NCT00016354|580649351|FG007|Overall Study|Lack of Efficacy|1|||
160797895|NCT03193801|580649352|FG000|Overall Study|Physician Decision|2|||
160797896|NCT03193801|580649352|FG000|Overall Study|Withdrawal by Subject|1|||
160797897|NCT03110562|580649353|FG000|Initial Treatment Period|Disease Progression|1|||
160797898|NCT03110562|580649354|FG001|Initial Treatment Period|Disease Progression|1|||
160797899|NCT03110562|580649355|FG002|Initial Treatment Period|Disease Progression|0|||
160797900|NCT03110562|580649356|FG003|Initial Treatment Period|Disease Progression|0|||
160797901|NCT03110562|580649353|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
160797902|NCT03110562|580649354|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
160797903|NCT03110562|580649355|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
160797904|NCT03110562|580649356|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
160797905|NCT03110562|580649353|FG000|Initial Treatment Period|Adverse Event|1|||
160797906|NCT03110562|580649354|FG001|Initial Treatment Period|Adverse Event|0|||
160797907|NCT03110562|580649355|FG002|Initial Treatment Period|Adverse Event|0|||
160895002|NCT02349061|581012788|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
160549307|NCT01789970|579737782|FG000|Open-label Titration Period|Protocol Violation|18|||
160549308|NCT01789970|579737783|FG001|Open-label Titration Period|Protocol Violation|0|||
160549309|NCT01789970|579737784|FG002|Open-label Titration Period|Protocol Violation|0|||
160797908|NCT03110562|580649356|FG003|Initial Treatment Period|Adverse Event|0|||
160797909|NCT03110562|580649353|FG000|Initial Treatment Period|Death|74|||
160797910|NCT03110562|580649354|FG001|Initial Treatment Period|Death|82|||
160797911|NCT03110562|580649355|FG002|Initial Treatment Period|Death|0|||
160797912|NCT03110562|580649356|FG003|Initial Treatment Period|Death|0|||
160797913|NCT03110562|580649353|FG000|Initial Treatment Period|Lost to Follow-up|13|||
160797914|NCT03110562|580649354|FG001|Initial Treatment Period|Lost to Follow-up|8|||
160797915|NCT03110562|580649355|FG002|Initial Treatment Period|Lost to Follow-up|0|||
160797916|NCT03110562|580649356|FG003|Initial Treatment Period|Lost to Follow-up|0|||
160797917|NCT03110562|580649353|FG000|Initial Treatment Period|Protocol Deviation|1|||
160895003|NCT02349061|581012789|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
160797918|NCT03110562|580649354|FG001|Initial Treatment Period|Protocol Deviation|0|||
160797919|NCT03110562|580649355|FG002|Initial Treatment Period|Protocol Deviation|0|||
160797920|NCT03110562|580649356|FG003|Initial Treatment Period|Protocol Deviation|0|||
160797921|NCT03110562|580649353|FG000|Initial Treatment Period|Physician Decision|2|||
160797922|NCT03110562|580649354|FG001|Initial Treatment Period|Physician Decision|1|||
160797923|NCT03110562|580649355|FG002|Initial Treatment Period|Physician Decision|0|||
160797924|NCT03110562|580649356|FG003|Initial Treatment Period|Physician Decision|0|||
160797925|NCT03110562|580649353|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
160797926|NCT03110562|580649354|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
160797927|NCT03110562|580649355|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
160797928|NCT03110562|580649356|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
160797929|NCT03110562|580649353|FG000|Initial Treatment Period|Other|5|||
160797930|NCT03110562|580649354|FG001|Initial Treatment Period|Other|4|||
160797931|NCT03110562|580649355|FG002|Initial Treatment Period|Other|0|||
160797932|NCT03110562|580649356|FG003|Initial Treatment Period|Other|0|||
160797933|NCT03110562|580649353|FG000|Initial Treatment Period|Randomized but never treated|0|||
160797934|NCT03110562|580649354|FG001|Initial Treatment Period|Randomized but never treated|3|||
160797935|NCT03110562|580649355|FG002|Initial Treatment Period|Randomized but never treated|0|||
160797936|NCT03110562|580649356|FG003|Initial Treatment Period|Randomized but never treated|0|||
160549310|NCT01789970|579737782|FG000|Open-label Titration Period|Lost to Follow-up|5|||
160797937|NCT03110562|580649353|FG000|Crossover Period|Disease Progression|0|||
160797938|NCT03110562|580649354|FG001|Crossover Period|Disease Progression|0|||
160797939|NCT03110562|580649355|FG002|Crossover Period|Disease Progression|1|||
160797940|NCT03110562|580649356|FG003|Crossover Period|Disease Progression|0|||
160797941|NCT03110562|580649353|FG000|Crossover Period|Withdrawal by Subject|0|||
160797942|NCT03110562|580649354|FG001|Crossover Period|Withdrawal by Subject|0|||
160797943|NCT03110562|580649355|FG002|Crossover Period|Withdrawal by Subject|8|||
160797944|NCT03110562|580649356|FG003|Crossover Period|Withdrawal by Subject|6|||
160797945|NCT03110562|580649353|FG000|Crossover Period|Death|0|||
160797946|NCT03110562|580649354|FG001|Crossover Period|Death|0|||
160797947|NCT03110562|580649355|FG002|Crossover Period|Death|37|||
160797948|NCT03110562|580649356|FG003|Crossover Period|Death|3|||
160797949|NCT03110562|580649353|FG000|Crossover Period|Lost to Follow-up|0|||
160797950|NCT03110562|580649354|FG001|Crossover Period|Lost to Follow-up|0|||
160797951|NCT03110562|580649355|FG002|Crossover Period|Lost to Follow-up|0|||
160797952|NCT03110562|580649356|FG003|Crossover Period|Lost to Follow-up|1|||
160797953|NCT03110562|580649353|FG000|Crossover Period|Other|0|||
160797954|NCT03110562|580649354|FG001|Crossover Period|Other|0|||
160797955|NCT03110562|580649355|FG002|Crossover Period|Other|1|||
160797956|NCT03110562|580649356|FG003|Crossover Period|Other|1|||
160797957|NCT03110562|580649353|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
160797958|NCT03110562|580649354|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
160797959|NCT03110562|580649355|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
160797960|NCT03110562|580649356|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
160797961|NCT03189719|580649362|FG000|Overall Study|Death|325|||
160797962|NCT03189719|580649363|FG001|Overall Study|Death|361|||
160797963|NCT03189719|580649362|FG000|Overall Study|Physician Decision|1|||
160797964|NCT03189719|580649363|FG001|Overall Study|Physician Decision|0|||
160797965|NCT03189719|580649362|FG000|Overall Study|Sponsor Decision|40|||
160797966|NCT03189719|580649363|FG001|Overall Study|Sponsor Decision|12|||
160797967|NCT03189719|580649362|FG000|Overall Study|Withdrawal by Subject|7|||
160797968|NCT03189719|580649363|FG001|Overall Study|Withdrawal by Subject|3|||
160797969|NCT05211596|580649364|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
160797970|NCT05211596|580649364|FG000|Baseline to 6 Months|Death|1|||
160797971|NCT05211596|580649364|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
160797972|NCT05211596|580649364|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
160797973|NCT02293551|580649365|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
160797974|NCT02293551|580649366|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
160797975|NCT02293551|580649367|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
160797976|NCT02293551|580649368|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
160797977|NCT02293551|580649369|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
160797978|NCT02293551|580649370|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
160797979|NCT02293551|580649365|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
160797980|NCT02293551|580649366|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
160797981|NCT02293551|580649367|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
160797982|NCT02293551|580649368|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
160797983|NCT02293551|580649369|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
160797984|NCT02293551|580649370|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
160797985|NCT02293551|580649365|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
160797986|NCT02293551|580649366|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
160549311|NCT01789970|579737783|FG001|Open-label Titration Period|Lost to Follow-up|0|||
160797987|NCT02293551|580649367|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
160797988|NCT02293551|580649368|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
160797989|NCT02293551|580649369|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
160797990|NCT02293551|580649370|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
160983697|NCT04157686|581328741|FG006|Overall Study|Pregnancy|3|||
160983698|NCT04157686|581328742|FG007|Overall Study|Pregnancy|0|||
160983699|NCT04157686|581328735|FG000|Overall Study|Lost to Follow-up|1|||
160983700|NCT04157686|581328736|FG001|Overall Study|Lost to Follow-up|2|||
160983701|NCT04157686|581328737|FG002|Overall Study|Lost to Follow-up|8|||
160983702|NCT04157686|581328738|FG003|Overall Study|Lost to Follow-up|6|||
160983703|NCT04157686|581328739|FG004|Overall Study|Lost to Follow-up|6|||
160983704|NCT04157686|581328740|FG005|Overall Study|Lost to Follow-up|3|||
160983705|NCT04157686|581328741|FG006|Overall Study|Lost to Follow-up|7|||
160983706|NCT04157686|581328742|FG007|Overall Study|Lost to Follow-up|9|||
160983707|NCT04157686|581328735|FG000|Overall Study|Lack of Efficacy|0|||
160983708|NCT04157686|581328736|FG001|Overall Study|Lack of Efficacy|0|||
160983709|NCT04157686|581328737|FG002|Overall Study|Lack of Efficacy|0|||
160983710|NCT04157686|581328738|FG003|Overall Study|Lack of Efficacy|0|||
160983711|NCT04157686|581328739|FG004|Overall Study|Lack of Efficacy|0|||
160983712|NCT04157686|581328740|FG005|Overall Study|Lack of Efficacy|2|||
160983713|NCT04157686|581328741|FG006|Overall Study|Lack of Efficacy|0|||
160983714|NCT04157686|581328742|FG007|Overall Study|Lack of Efficacy|1|||
160983715|NCT04157686|581328735|FG000|Overall Study|Withdrawal by Subject|10|||
160983716|NCT04157686|581328736|FG001|Overall Study|Withdrawal by Subject|10|||
160983717|NCT04157686|581328737|FG002|Overall Study|Withdrawal by Subject|12|||
160983718|NCT04157686|581328738|FG003|Overall Study|Withdrawal by Subject|20|||
160983719|NCT04157686|581328739|FG004|Overall Study|Withdrawal by Subject|12|||
160983720|NCT04157686|581328740|FG005|Overall Study|Withdrawal by Subject|11|||
160983721|NCT04157686|581328741|FG006|Overall Study|Withdrawal by Subject|18|||
160983722|NCT04157686|581328742|FG007|Overall Study|Withdrawal by Subject|24|||
160983723|NCT04157686|581328735|FG000|Overall Study|Physician Decision|0|||
160983724|NCT04157686|581328736|FG001|Overall Study|Physician Decision|0|||
160983725|NCT04157686|581328737|FG002|Overall Study|Physician Decision|1|||
160983726|NCT04157686|581328738|FG003|Overall Study|Physician Decision|0|||
160983727|NCT04157686|581328739|FG004|Overall Study|Physician Decision|1|||
160983728|NCT04157686|581328740|FG005|Overall Study|Physician Decision|0|||
160983729|NCT04157686|581328741|FG006|Overall Study|Physician Decision|3|||
160983730|NCT04157686|581328742|FG007|Overall Study|Physician Decision|0|||
160983731|NCT04157686|581328735|FG000|Overall Study|Death|0|||
160983732|NCT04157686|581328736|FG001|Overall Study|Death|0|||
160983733|NCT04157686|581328737|FG002|Overall Study|Death|0|||
160983734|NCT04157686|581328738|FG003|Overall Study|Death|2|||
160983735|NCT04157686|581328739|FG004|Overall Study|Death|0|||
160797991|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
160797992|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
160797993|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
160797994|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
160797995|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
160895004|NCT02349061|581012790|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
160895005|NCT02349061|581012788|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
160895006|NCT02349061|581012789|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
160983736|NCT04157686|581328740|FG005|Overall Study|Death|0|||
160983737|NCT04157686|581328741|FG006|Overall Study|Death|0|||
160983738|NCT04157686|581328742|FG007|Overall Study|Death|0|||
160797996|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
160797997|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
160797998|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
160895007|NCT02349061|581012790|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
160895008|NCT02349061|581012788|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
160895009|NCT02349061|581012789|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
160895010|NCT02349061|581012790|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
160895011|NCT02349061|581012788|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
160983739|NCT04157686|581328735|FG000|Overall Study|Protocol Violation|0|||
160983740|NCT04157686|581328736|FG001|Overall Study|Protocol Violation|0|||
160797999|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
160983741|NCT04157686|581328737|FG002|Overall Study|Protocol Violation|0|||
160983742|NCT04157686|581328738|FG003|Overall Study|Protocol Violation|0|||
160983743|NCT04157686|581328739|FG004|Overall Study|Protocol Violation|1|||
160895012|NCT02349061|581012789|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
160895013|NCT02349061|581012790|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
160895014|NCT02339285|581012791|FG000|Overall Study|Withdrawal by Subject|0|||
160895015|NCT02339285|581012792|FG001|Overall Study|Withdrawal by Subject|1|||
160895016|NCT02339285|581012793|FG002|Overall Study|Withdrawal by Subject|1|||
160983744|NCT04157686|581328740|FG005|Overall Study|Protocol Violation|0|||
160983745|NCT04157686|581328741|FG006|Overall Study|Protocol Violation|0|||
160983746|NCT04157686|581328742|FG007|Overall Study|Protocol Violation|0|||
160983747|NCT04157686|581328735|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
160983748|NCT04157686|581328736|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
160983749|NCT04157686|581328737|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
160983750|NCT04157686|581328738|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
160798000|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
160798001|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
160798002|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
160798003|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
160798004|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
160798005|NCT04532749|580649371|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
160798006|NCT04532749|580649372|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
160798007|NCT04532749|580649371|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
160798008|NCT04532749|580649372|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
160798009|NCT04532749|580649371|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
160798010|NCT04532749|580649372|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
160798011|NCT05239221|580649373|FG000|Overall Study|Adverse Event|0|||
160798012|NCT05239221|580649374|FG001|Overall Study|Adverse Event|0|||
160798013|NCT05239221|580649375|FG002|Overall Study|Adverse Event|0|||
160798014|NCT05239221|580649376|FG003|Overall Study|Adverse Event|0|||
160798015|NCT05239221|580649377|FG004|Overall Study|Adverse Event|0|||
160798016|NCT05239221|580649378|FG005|Overall Study|Adverse Event|0|||
160798017|NCT05239221|580649379|FG006|Overall Study|Adverse Event|1|||
160798018|NCT05239221|580649380|FG007|Overall Study|Adverse Event|0|||
160798019|NCT05239221|580649381|FG008|Overall Study|Adverse Event|0|||
160798020|NCT05239221|580649382|FG009|Overall Study|Adverse Event|0|||
160798021|NCT05239221|580649383|FG010|Overall Study|Adverse Event|1|||
160798022|NCT05239221|580649384|FG011|Overall Study|Adverse Event|1|||
160798023|NCT05239221|580649385|FG012|Overall Study|Adverse Event|0|||
160798024|NCT05239221|580649386|FG013|Overall Study|Adverse Event|0|||
160798025|NCT05239221|580649387|FG014|Overall Study|Adverse Event|0|||
160798026|NCT05239221|580649388|FG015|Overall Study|Adverse Event|0|||
160798027|NCT05239221|580649373|FG000|Overall Study|Withdrawal by Subject|0|||
160798028|NCT05239221|580649374|FG001|Overall Study|Withdrawal by Subject|0|||
160798029|NCT05239221|580649375|FG002|Overall Study|Withdrawal by Subject|0|||
160798030|NCT05239221|580649376|FG003|Overall Study|Withdrawal by Subject|0|||
160798031|NCT05239221|580649377|FG004|Overall Study|Withdrawal by Subject|0|||
160798032|NCT05239221|580649378|FG005|Overall Study|Withdrawal by Subject|0|||
160798033|NCT05239221|580649379|FG006|Overall Study|Withdrawal by Subject|0|||
160798034|NCT05239221|580649380|FG007|Overall Study|Withdrawal by Subject|0|||
160798035|NCT05239221|580649381|FG008|Overall Study|Withdrawal by Subject|0|||
160798036|NCT05239221|580649382|FG009|Overall Study|Withdrawal by Subject|0|||
160798037|NCT05239221|580649383|FG010|Overall Study|Withdrawal by Subject|1|||
160798038|NCT05239221|580649384|FG011|Overall Study|Withdrawal by Subject|0|||
160798039|NCT05239221|580649385|FG012|Overall Study|Withdrawal by Subject|0|||
160798040|NCT05239221|580649386|FG013|Overall Study|Withdrawal by Subject|0|||
160798041|NCT05239221|580649387|FG014|Overall Study|Withdrawal by Subject|0|||
160798042|NCT05239221|580649388|FG015|Overall Study|Withdrawal by Subject|1|||
160798043|NCT01400412|580649389|FG000|Overall Study|Lost to Follow-up|4|||
160798044|NCT01400412|580649390|FG001|Overall Study|Lost to Follow-up|7|||
160798045|NCT01400412|580649389|FG000|Overall Study|Withdrawal by Subject|3|||
160798046|NCT01400412|580649390|FG001|Overall Study|Withdrawal by Subject|4|||
160798047|NCT01400412|580649389|FG000|Overall Study|Unable to complete|3|||
160798048|NCT01400412|580649390|FG001|Overall Study|Unable to complete|3|||
160798049|NCT01400412|580649389|FG000|Overall Study|Never started study treatment|0|||
160549312|NCT01789970|579737784|FG002|Open-label Titration Period|Lost to Follow-up|0|||
160549313|NCT01789970|579737782|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
160798050|NCT01400412|580649390|FG001|Overall Study|Never started study treatment|3|||
160798051|NCT01649869|580649391|FG000|Overall Study|Family member illness|1|||
160798052|NCT01649869|580649392|FG001|Overall Study|Family member illness|0|||
160798053|NCT01649869|580649391|FG000|Overall Study|Required treatment outside protocol|1|||
160798054|NCT01649869|580649392|FG001|Overall Study|Required treatment outside protocol|0|||
160798055|NCT01649869|580649391|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
160798056|NCT01649869|580649392|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
160798057|NCT02114177|580650979|FG000|Overall Study|Lost to Follow-up|1|||
160798058|NCT02114177|580650980|FG001|Overall Study|Lost to Follow-up|2|||
160798059|NCT02114177|580650979|FG000|Overall Study|Withdrawal by Subject|6|||
160798060|NCT02114177|580650980|FG001|Overall Study|Withdrawal by Subject|1|||
160798061|NCT02114177|580650979|FG000|Overall Study|Other|2|||
160798062|NCT02114177|580650980|FG001|Overall Study|Other|1|||
160798063|NCT01897493|580650981|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
160798064|NCT00805389|580650986|FG000|Overall Study|Adverse Event|0|||
160798065|NCT00805389|580650987|FG001|Overall Study|Adverse Event|0|||
160798066|NCT00805389|580650988|FG002|Overall Study|Adverse Event|1|||
160798067|NCT00805389|580650989|FG003|Overall Study|Adverse Event|2|||
160798068|NCT00805389|580650990|FG004|Overall Study|Adverse Event|0|||
160798069|NCT00805389|580650986|FG000|Overall Study|Lost to Follow-up|4|||
160798070|NCT00805389|580650987|FG001|Overall Study|Lost to Follow-up|3|||
160798071|NCT00805389|580650988|FG002|Overall Study|Lost to Follow-up|6|||
160798072|NCT00805389|580650989|FG003|Overall Study|Lost to Follow-up|10|||
160798073|NCT00805389|580650990|FG004|Overall Study|Lost to Follow-up|9|||
160549314|NCT01789970|579737783|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
160549315|NCT01789970|579737784|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
160549316|NCT01789970|579737782|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
160549317|NCT01789970|579737783|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
160549318|NCT01789970|579737784|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
160549319|NCT01789970|579737782|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
160549320|NCT01789970|579737783|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
160549321|NCT01789970|579737784|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
160549322|NCT01789970|579737782|FG000|Open-label Titration Period|Pregnancy|2|||
160549323|NCT01789970|579737783|FG001|Open-label Titration Period|Pregnancy|0|||
160549324|NCT01789970|579737784|FG002|Open-label Titration Period|Pregnancy|0|||
160798074|NCT00805389|580650986|FG000|Overall Study|Protocol Violation|0|||
160798075|NCT00805389|580650987|FG001|Overall Study|Protocol Violation|0|||
160798076|NCT00805389|580650988|FG002|Overall Study|Protocol Violation|1|||
160798077|NCT00805389|580650989|FG003|Overall Study|Protocol Violation|0|||
160798078|NCT00805389|580650990|FG004|Overall Study|Protocol Violation|0|||
160798079|NCT00805389|580650986|FG000|Overall Study|Withdrawal by Subject|3|||
160798080|NCT00805389|580650987|FG001|Overall Study|Withdrawal by Subject|2|||
160798081|NCT00805389|580650988|FG002|Overall Study|Withdrawal by Subject|4|||
160798082|NCT00805389|580650989|FG003|Overall Study|Withdrawal by Subject|5|||
160798083|NCT00805389|580650990|FG004|Overall Study|Withdrawal by Subject|4|||
160798084|NCT01246960|580650991|FG000|Overall Study|Lost to Follow-up|3|||
160798085|NCT01246960|580650992|FG001|Overall Study|Lost to Follow-up|1|||
160798086|NCT01246960|580650991|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
160798087|NCT01246960|580650992|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
160798088|NCT05111145|580650995|FG000|Overall Study|Commercial drug is available for participant|76|||
160798089|NCT05111145|580650995|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
160798090|NCT02336815|580650996|FG000|Overall Study|Disease Progression|45|||
160798091|NCT02336815|580650997|FG001|Overall Study|Disease Progression|70|||
160798092|NCT02336815|580650996|FG000|Overall Study|Adverse Event|18|||
160798093|NCT02336815|580650997|FG001|Overall Study|Adverse Event|39|||
160798094|NCT02336815|580650996|FG000|Overall Study|Physician Decision|11|||
160798095|NCT02336815|580650997|FG001|Overall Study|Physician Decision|4|||
160798096|NCT02336815|580650996|FG000|Overall Study|Withdrawal by Subject|3|||
160798097|NCT02336815|580650997|FG001|Overall Study|Withdrawal by Subject|2|||
160798098|NCT02336815|580650996|FG000|Overall Study|Lost to Follow-up|1|||
160798099|NCT02336815|580650997|FG001|Overall Study|Lost to Follow-up|3|||
160798100|NCT02336815|580650996|FG000|Overall Study|Other|1|||
160798101|NCT02336815|580650997|FG001|Overall Study|Other|5|||
160798102|NCT02239926|580650998|FG000|Overall Study|Withdrawal by Subject|0|||
160798103|NCT02239926|580650999|FG001|Overall Study|Withdrawal by Subject|1|||
160798104|NCT00598650|580651000|FG000|Overall Study|Withdrawal by Subject|3|||
160798105|NCT00598650|580651000|FG000|Overall Study|Adverse Event|18|||
160798106|NCT00598650|580651000|FG000|Overall Study|No treatment for 3 weeks|1|||
160798107|NCT00598650|580651000|FG000|Overall Study|Not eligible|1|||
160798108|NCT00598650|580651000|FG000|Overall Study|Prohibited Concomitant Medication|2|||
160798109|NCT00598650|580651000|FG000|Overall Study|Physician Decision|2|||
160798110|NCT01628913|580651001|FG000|Overall Study|Adverse Event|12|||
160798111|NCT01628913|580651002|FG001|Overall Study|Adverse Event|5|||
160798112|NCT01628913|580651001|FG000|Overall Study|Disease Progression|11|||
160798113|NCT01628913|580651002|FG001|Overall Study|Disease Progression|14|||
160798114|NCT01628913|580651001|FG000|Overall Study|Protocol Violation|1|||
160798115|NCT01628913|580651002|FG001|Overall Study|Protocol Violation|0|||
160798116|NCT01628913|580651001|FG000|Overall Study|Death|1|||
160798117|NCT01628913|580651002|FG001|Overall Study|Death|0|||
160798118|NCT01628913|580651001|FG000|Overall Study|study terminated by Sponsor|4|||
160798119|NCT01628913|580651002|FG001|Overall Study|study terminated by Sponsor|9|||
160798120|NCT01628913|580651001|FG000|Overall Study|Withdrawal by Subject|1|||
160798121|NCT01628913|580651002|FG001|Overall Study|Withdrawal by Subject|0|||
160798122|NCT01628913|580651001|FG000|Overall Study|Physician Decision|1|||
160798123|NCT01628913|580651002|FG001|Overall Study|Physician Decision|3|||
160798124|NCT05201807|580651006|FG000|Overall Study|Adverse Event|1|||
160798125|NCT05201807|580651006|FG000|Overall Study|COVID-19 Related|1|||
160798126|NCT00105534|580651007|FG000|Overall Study|Adverse Event|2|||
160798127|NCT00105534|580651008|FG001|Overall Study|Adverse Event|5|||
160798128|NCT00105534|580651007|FG000|Overall Study|Protocol Violation|1|||
160798129|NCT00105534|580651008|FG001|Overall Study|Protocol Violation|4|||
160798130|NCT00105534|580651007|FG000|Overall Study|Withdrawal by Subject|6|||
160798131|NCT00105534|580651008|FG001|Overall Study|Withdrawal by Subject|6|||
160798132|NCT00105534|580651007|FG000|Overall Study|Lost to Follow-up|5|||
160798133|NCT00105534|580651008|FG001|Overall Study|Lost to Follow-up|1|||
160798134|NCT00105534|580651007|FG000|Overall Study|Lack of Efficacy|7|||
160798135|NCT00105534|580651008|FG001|Overall Study|Lack of Efficacy|15|||
160798136|NCT00105534|580651007|FG000|Overall Study|Treatment unmasked|1|||
160798137|NCT00105534|580651008|FG001|Overall Study|Treatment unmasked|0|||
160798138|NCT00105534|580651007|FG000|Overall Study|Other Reason|0|||
160798139|NCT00105534|580651008|FG001|Overall Study|Other Reason|2|||
160798140|NCT02465931|580651009|FG000|Overall Study|Lost to Follow-up|9|||
160798141|NCT02465931|580651010|FG001|Overall Study|Lost to Follow-up|11|||
160798142|NCT02465931|580651009|FG000|Overall Study|Protocol Violation|1|||
160798143|NCT02465931|580651010|FG001|Overall Study|Protocol Violation|0|||
160798144|NCT02465931|580651009|FG000|Overall Study|Withdrawal by Subject|1|||
160798145|NCT02465931|580651010|FG001|Overall Study|Withdrawal by Subject|0|||
160798146|NCT03423121|580651012|FG000|Overall Study|Lost to Follow-up|2|||
160798147|NCT03423121|580651013|FG001|Overall Study|Lost to Follow-up|6|||
160798148|NCT03423121|580651012|FG000|Overall Study|Adverse Event|1|||
160798149|NCT03423121|580651013|FG001|Overall Study|Adverse Event|0|||
160798150|NCT03289143|580651018|FG000|Overall Study|Caregiver Unavailability|1|||
160798151|NCT03289143|580651019|FG001|Overall Study|Caregiver Unavailability|1|||
160798152|NCT03289143|580651020|FG002|Overall Study|Caregiver Unavailability|0|||
160798153|NCT03289143|580651021|FG003|Overall Study|Caregiver Unavailability|0|||
160798154|NCT03289143|580651018|FG000|Overall Study|Research Department Closure|0|||
160798155|NCT03289143|580651019|FG001|Overall Study|Research Department Closure|0|||
160798156|NCT03289143|580651020|FG002|Overall Study|Research Department Closure|1|||
160798157|NCT03289143|580651021|FG003|Overall Study|Research Department Closure|0|||
160798158|NCT03289143|580651018|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
160798159|NCT03289143|580651019|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
160798160|NCT03289143|580651020|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
160798161|NCT03289143|580651021|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
160798162|NCT03289143|580651018|FG000|Overall Study|Medical Monitor Decision|1|||
160798163|NCT03289143|580651019|FG001|Overall Study|Medical Monitor Decision|0|||
160798164|NCT03289143|580651020|FG002|Overall Study|Medical Monitor Decision|0|||
160895017|NCT02339285|581012791|FG000|Overall Study|Lost to Follow-up|1|||
160895018|NCT02339285|581012792|FG001|Overall Study|Lost to Follow-up|1|||
160895019|NCT02339285|581012793|FG002|Overall Study|Lost to Follow-up|1|||
160895020|NCT02339285|581012791|FG000|Overall Study|Protocol Deviation|0|||
160895021|NCT02339285|581012792|FG001|Overall Study|Protocol Deviation|1|||
160798165|NCT03289143|580651021|FG003|Overall Study|Medical Monitor Decision|0|||
160798166|NCT03289143|580651018|FG000|Overall Study|Participant Non-Compliance|0|||
160798167|NCT03289143|580651019|FG001|Overall Study|Participant Non-Compliance|0|||
160798168|NCT03289143|580651020|FG002|Overall Study|Participant Non-Compliance|1|||
160798169|NCT03289143|580651021|FG003|Overall Study|Participant Non-Compliance|0|||
160798170|NCT03289143|580651018|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
160798171|NCT03289143|580651019|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
160798172|NCT03289143|580651020|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
160798173|NCT03289143|580651021|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
160798174|NCT03289143|580651018|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
160798175|NCT03289143|580651019|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
160798176|NCT03289143|580651020|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
160798177|NCT03289143|580651021|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
160798178|NCT03289143|580651018|FG000|Overall Study|Caregiver Passed Away|1|||
160798179|NCT03289143|580651019|FG001|Overall Study|Caregiver Passed Away|0|||
160798180|NCT03289143|580651020|FG002|Overall Study|Caregiver Passed Away|0|||
160798181|NCT03289143|580651021|FG003|Overall Study|Caregiver Passed Away|0|||
160798182|NCT03289143|580651018|FG000|Overall Study|Physician Decision|0|||
160798183|NCT03289143|580651019|FG001|Overall Study|Physician Decision|2|||
160798184|NCT03289143|580651020|FG002|Overall Study|Physician Decision|2|||
160798185|NCT03289143|580651021|FG003|Overall Study|Physician Decision|2|||
160798186|NCT03289143|580651018|FG000|Overall Study|Protocol Deviation|2|||
160798187|NCT03289143|580651019|FG001|Overall Study|Protocol Deviation|1|||
160798188|NCT03289143|580651020|FG002|Overall Study|Protocol Deviation|3|||
160798189|NCT03289143|580651021|FG003|Overall Study|Protocol Deviation|1|||
160798190|NCT03289143|580651018|FG000|Overall Study|Study Terminated By Sponsor|101|||
160798191|NCT03289143|580651019|FG001|Overall Study|Study Terminated By Sponsor|75|||
160798192|NCT03289143|580651020|FG002|Overall Study|Study Terminated By Sponsor|100|||
160798193|NCT03289143|580651021|FG003|Overall Study|Study Terminated By Sponsor|69|||
160798194|NCT03289143|580651018|FG000|Overall Study|Withdrawal by Subject|14|||
160798195|NCT03289143|580651019|FG001|Overall Study|Withdrawal by Subject|6|||
160798196|NCT03289143|580651020|FG002|Overall Study|Withdrawal by Subject|14|||
160798197|NCT03289143|580651021|FG003|Overall Study|Withdrawal by Subject|12|||
160895022|NCT02339285|581012793|FG002|Overall Study|Protocol Deviation|0|||
160895023|NCT00282412|581012796|FG000|Overall Study|Death|2|||
160895024|NCT01193660|581012797|FG000|Overall Study|Withdrawal by Subject|2|||
160895025|NCT01193660|581012798|FG001|Overall Study|Withdrawal by Subject|3|||
160983751|NCT04157686|581328739|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
160798198|NCT03289143|580651018|FG000|Overall Study|Adverse Event|10|||
160798199|NCT03289143|580651019|FG001|Overall Study|Adverse Event|7|||
160798200|NCT03289143|580651020|FG002|Overall Study|Adverse Event|6|||
160798201|NCT03289143|580651021|FG003|Overall Study|Adverse Event|5|||
160798202|NCT03289143|580651018|FG000|Overall Study|Death|2|||
160895026|NCT01193660|581012799|FG002|Overall Study|Withdrawal by Subject|1|||
160798203|NCT03289143|580651019|FG001|Overall Study|Death|0|||
160798204|NCT03289143|580651020|FG002|Overall Study|Death|2|||
160798205|NCT03289143|580651021|FG003|Overall Study|Death|1|||
160798206|NCT03289143|580651018|FG000|Overall Study|Lost to Follow-up|2|||
160798207|NCT03289143|580651019|FG001|Overall Study|Lost to Follow-up|1|||
160798208|NCT03289143|580651020|FG002|Overall Study|Lost to Follow-up|1|||
160798209|NCT03289143|580651021|FG003|Overall Study|Lost to Follow-up|0|||
160798210|NCT03289143|580651018|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
160798211|NCT03289143|580651019|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
160798212|NCT03289143|580651020|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
160798213|NCT03289143|580651021|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
160798214|NCT03289143|580651018|FG000|Overall Study|Withdrawal by Caregiver|0|||
160798215|NCT03289143|580651019|FG001|Overall Study|Withdrawal by Caregiver|1|||
160798216|NCT03289143|580651020|FG002|Overall Study|Withdrawal by Caregiver|0|||
160798217|NCT03289143|580651021|FG003|Overall Study|Withdrawal by Caregiver|0|||
160798218|NCT03289143|580651018|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
160798219|NCT03289143|580651019|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
160798220|NCT03289143|580651020|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
160798221|NCT03289143|580651021|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
160798222|NCT03289143|580651018|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
160798223|NCT03289143|580651019|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
160798224|NCT03289143|580651020|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
160798225|NCT03289143|580651021|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
160798226|NCT00730756|580651022|FG000|Overall Study|Adverse Event|2|||
160798227|NCT00730756|580651023|FG001|Overall Study|Adverse Event|0|||
160798228|NCT00730756|580651022|FG000|Overall Study|Lack of Efficacy|1|||
160798229|NCT00730756|580651023|FG001|Overall Study|Lack of Efficacy|1|||
160798230|NCT00730756|580651022|FG000|Overall Study|Protocol Deviation|1|||
160798231|NCT00730756|580651023|FG001|Overall Study|Protocol Deviation|2|||
160798232|NCT00730756|580651022|FG000|Overall Study|Lost to Follow-up|0|||
160798233|NCT00730756|580651023|FG001|Overall Study|Lost to Follow-up|1|||
160798234|NCT00730756|580651022|FG000|Overall Study|Withdrew Consent|0|||
160798235|NCT00730756|580651023|FG001|Overall Study|Withdrew Consent|1|||
160798236|NCT00948688|580651024|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
160798237|NCT00948688|580651025|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
160798238|NCT00948688|580651024|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
160798239|NCT00948688|580651025|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
160798240|NCT00948688|580651024|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
160798241|NCT00948688|580651025|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
160798242|NCT04388826|580651026|FG000|Overall Study|Lost to Follow-up|3|||
160798243|NCT04388826|580651027|FG001|Overall Study|Lost to Follow-up|2|||
160798244|NCT04388826|580651026|FG000|Overall Study|Adverse Event|1|||
160798245|NCT04388826|580651027|FG001|Overall Study|Adverse Event|0|||
160798246|NCT01840943|580651028|FG000|Overall Study|Withdrawal by Subject|5|||
160798247|NCT01840943|580651029|FG001|Overall Study|Withdrawal by Subject|6|||
160798248|NCT01840943|580651028|FG000|Overall Study|Physician Decision|4|||
160798249|NCT01840943|580651029|FG001|Overall Study|Physician Decision|2|||
160798250|NCT01840943|580651028|FG000|Overall Study|Lost to Follow-up|4|||
160798251|NCT01840943|580651029|FG001|Overall Study|Lost to Follow-up|4|||
160798252|NCT04573972|580651035|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
160798253|NCT04573972|580651036|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
160798254|NCT05067335|580651039|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
160798255|NCT05067335|580651040|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
160798256|NCT05067335|580651041|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
160798257|NCT05067335|580651042|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
160798258|NCT05067335|580651039|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
160798259|NCT05067335|580651040|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
160798260|NCT05067335|580651041|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
160549325|NCT01789970|579737782|FG000|Open-label Titration Period|Other|76|||
160549326|NCT01789970|579737783|FG001|Open-label Titration Period|Other|0|||
160549327|NCT01789970|579737784|FG002|Open-label Titration Period|Other|0|||
160549328|NCT01789970|579737782|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
160549329|NCT01789970|579737783|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
160798261|NCT05067335|580651042|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
160798262|NCT05067335|580651039|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
160798263|NCT05067335|580651040|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
160798264|NCT05067335|580651041|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
160798265|NCT05067335|580651042|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
160798266|NCT05067335|580651039|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
160798267|NCT05067335|580651040|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
160549330|NCT01789970|579737784|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
160798268|NCT05067335|580651041|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
160798269|NCT05067335|580651042|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
160798270|NCT05067335|580651039|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
160798271|NCT05067335|580651040|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
160798272|NCT05067335|580651041|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
160798273|NCT05067335|580651042|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
160798274|NCT05067335|580651039|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
160798275|NCT05067335|580651040|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
160798276|NCT05067335|580651041|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
160798277|NCT05067335|580651042|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
160798278|NCT05067335|580651039|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
160798279|NCT05067335|580651040|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
160798280|NCT05067335|580651041|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
160798281|NCT05067335|580651042|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
160798282|NCT05067335|580651039|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
160798283|NCT05067335|580651040|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
160798284|NCT05067335|580651041|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
160798285|NCT05067335|580651042|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
160798286|NCT05067335|580651039|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
160798287|NCT05067335|580651040|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
160798288|NCT05067335|580651041|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
160798289|NCT05067335|580651042|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
160798290|NCT05067335|580651039|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
160798291|NCT05067335|580651040|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
160798292|NCT05067335|580651041|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
160798293|NCT05067335|580651042|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
160798294|NCT02724839|580651043|FG000|Overall Study|Withdrawal by Subject|1|||
160798295|NCT02724839|580651044|FG001|Overall Study|Withdrawal by Subject|1|||
160798296|NCT02724839|580651045|FG002|Overall Study|Withdrawal by Subject|0|||
160798297|NCT02724839|580651043|FG000|Overall Study|Lost to Follow-up|0|||
160798298|NCT02724839|580651044|FG001|Overall Study|Lost to Follow-up|3|||
160798299|NCT02724839|580651045|FG002|Overall Study|Lost to Follow-up|2|||
160798300|NCT02724839|580651043|FG000|Overall Study|Physician Decision|0|||
160798301|NCT02724839|580651044|FG001|Overall Study|Physician Decision|0|||
160798302|NCT02724839|580651045|FG002|Overall Study|Physician Decision|3|||
160798303|NCT03610048|580651046|FG000|Overall Study|Study terminated by sponsor|84|||
160798304|NCT03610048|580651046|FG000|Overall Study|Adverse Event|32|||
160798305|NCT03610048|580651046|FG000|Overall Study|Withdrawal by Subject|31|||
160798306|NCT03610048|580651046|FG000|Overall Study|Lost to Follow-up|8|||
160798307|NCT03610048|580651046|FG000|Overall Study|Other|4|||
160798308|NCT03610048|580651046|FG000|Overall Study|Physician Decision|1|||
160798309|NCT03610048|580651046|FG000|Overall Study|Pregnancy|1|||
160798310|NCT01155050|580651048|FG000|Overall Study|Lost to Follow-up|15|||
160798311|NCT01155050|580651049|FG001|Overall Study|Lost to Follow-up|20|||
160798312|NCT01155050|580651050|FG002|Overall Study|Lost to Follow-up|19|||
160798313|NCT01155050|580651051|FG003|Overall Study|Lost to Follow-up|22|||
160798314|NCT01146613|580651052|FG000|Overall Study|Lost to Follow-up|3|||
160798315|NCT01146613|580651053|FG001|Overall Study|Lost to Follow-up|8|||
160798316|NCT01146613|580651052|FG000|Overall Study|Lack of Efficacy|0|||
160798317|NCT01146613|580651053|FG001|Overall Study|Lack of Efficacy|1|||
160798318|NCT01146613|580651052|FG000|Overall Study|Death|1|||
160798319|NCT01146613|580651053|FG001|Overall Study|Death|0|||
160798320|NCT01146613|580651052|FG000|Overall Study|Physician Decision|1|||
160798321|NCT01146613|580651053|FG001|Overall Study|Physician Decision|0|||
160798322|NCT01146613|580651052|FG000|Overall Study|Withdrawal by Subject|0|||
160798323|NCT01146613|580651053|FG001|Overall Study|Withdrawal by Subject|3|||
160798324|NCT01146613|580651052|FG000|Overall Study|schedule conflict|1|||
160798325|NCT01146613|580651053|FG001|Overall Study|schedule conflict|0|||
160798326|NCT01146613|580651052|FG000|Overall Study|Outpatient detox|1|||
160798327|NCT01146613|580651053|FG001|Overall Study|Outpatient detox|0|||
160571868|NCT01856673|579816845|FG002|Overall Study|Protocol Violation|1|||
160798328|NCT02136914|580651054|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
160798329|NCT02136914|580651055|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
160798330|NCT02136914|580651054|FG000|Overall Study|Withdrawal by Subject|3|||
160798331|NCT02136914|580651055|FG001|Overall Study|Withdrawal by Subject|10|||
160798332|NCT02136914|580651054|FG000|Overall Study|Subject Unwilling to Proceed|7|||
160798333|NCT02136914|580651055|FG001|Overall Study|Subject Unwilling to Proceed|2|||
160798334|NCT02136914|580651054|FG000|Overall Study|Lost to Follow-up|1|||
160798335|NCT02136914|580651055|FG001|Overall Study|Lost to Follow-up|1|||
160798336|NCT02136914|580651054|FG000|Overall Study|Did Not Receive Study Drug|2|||
160798337|NCT02136914|580651055|FG001|Overall Study|Did Not Receive Study Drug|0|||
160798338|NCT02136914|580651054|FG000|Overall Study|Lack of Efficacy|1|||
160798339|NCT02136914|580651055|FG001|Overall Study|Lack of Efficacy|0|||
160798340|NCT02136914|580651054|FG000|Overall Study|Death|0|||
160798341|NCT02136914|580651055|FG001|Overall Study|Death|1|||
160798342|NCT05878067|580651058|FG000|Overall Study|Lost to Follow-up|2|||
160798343|NCT00949533|580651059|FG000|Overall Study|Lost to Follow-up|0|||
160798344|NCT00949533|580651060|FG001|Overall Study|Lost to Follow-up|1|||
160798345|NCT01493089|580651063|FG000|Overall Study|Protocol Violation|2|||
160798346|NCT01493089|580651064|FG001|Overall Study|Protocol Violation|2|||
160798347|NCT01493089|580651063|FG000|Overall Study|Withdrawal by Subject|1|||
160798348|NCT01493089|580651064|FG001|Overall Study|Withdrawal by Subject|0|||
160798349|NCT01493089|580651063|FG000|Overall Study|Physician Decision|0|||
160798350|NCT01493089|580651064|FG001|Overall Study|Physician Decision|1|||
160798351|NCT02234362|580651065|FG000|Overall Study|Not eligible after first screening visit|17|||
160798352|NCT02234362|580651065|FG000|Overall Study|Lost to Follow-up|6|||
160798353|NCT02234362|580651065|FG000|Overall Study|Withdrawal by Subject|3|||
160798354|NCT00329030|580651066|FG000|Overall Study|Withdrawal by Subject|1|||
160549331|NCT01789970|579737782|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
160549332|NCT01789970|579737783|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
160549333|NCT01789970|579737784|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
160549334|NCT01789970|579737782|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
160549335|NCT01789970|579737783|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
160549336|NCT01789970|579737784|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
160549337|NCT01789970|579737782|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160549338|NCT01789970|579737783|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
160549339|NCT01789970|579737784|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
160549340|NCT01789970|579737782|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
160549341|NCT01789970|579737783|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
160549342|NCT01789970|579737784|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
160549343|NCT01789970|579737782|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
160549344|NCT01789970|579737783|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
160549345|NCT01789970|579737784|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
160549346|NCT01789970|579737782|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
160798355|NCT00329030|580651067|FG001|Overall Study|Withdrawal by Subject|3|||
160798356|NCT00329030|580651066|FG000|Overall Study|Progressive Disease|6|||
160798357|NCT00329030|580651067|FG001|Overall Study|Progressive Disease|2|||
160798358|NCT00329030|580651066|FG000|Overall Study|Ineligible Pathology|1|||
160798359|NCT00329030|580651067|FG001|Overall Study|Ineligible Pathology|1|||
160798360|NCT00560417|580651075|FG000|Overall Study|Adverse Event|3|||
160798361|NCT00560417|580651076|FG001|Overall Study|Adverse Event|2|||
160798362|NCT00560417|580651075|FG000|Overall Study|Entry Criteria Not Met|1|||
160798363|NCT00560417|580651076|FG001|Overall Study|Entry Criteria Not Met|0|||
160798364|NCT00560417|580651075|FG000|Overall Study|Lost to Follow-up|0|||
160798365|NCT00560417|580651076|FG001|Overall Study|Lost to Follow-up|1|||
160798366|NCT00560417|580651075|FG000|Overall Study|Physician Decision|2|||
160798367|NCT00560417|580651076|FG001|Overall Study|Physician Decision|6|||
160798368|NCT00560417|580651075|FG000|Overall Study|Protocol Violation|6|||
160895027|NCT01193660|581012797|FG000|Overall Study|Death|1|||
160895028|NCT01193660|581012798|FG001|Overall Study|Death|0|||
160895029|NCT01193660|581012799|FG002|Overall Study|Death|0|||
160895030|NCT01193660|581012797|FG000|Overall Study|Physician Decision|1|||
160895031|NCT01193660|581012798|FG001|Overall Study|Physician Decision|0|||
160895032|NCT01193660|581012799|FG002|Overall Study|Physician Decision|1|||
160895033|NCT01886716|581012800|FG000|Week 1|Lost to Follow-up|0|||
160895034|NCT01886716|581012801|FG001|Week 1|Lost to Follow-up|0|||
160895035|NCT01886716|581012802|FG002|Week 1|Lost to Follow-up|2|||
160895036|NCT01886716|581012803|FG003|Week 1|Lost to Follow-up|2|||
160895037|NCT01886716|581012800|FG000|Week 2|Lost to Follow-up|3|||
160895038|NCT01886716|581012801|FG001|Week 2|Lost to Follow-up|2|||
160895039|NCT01886716|581012802|FG002|Week 2|Lost to Follow-up|1|||
160895040|NCT01886716|581012803|FG003|Week 2|Lost to Follow-up|3|||
160895041|NCT01886716|581012800|FG000|Week 3|Lost to Follow-up|1|||
160895042|NCT01886716|581012801|FG001|Week 3|Lost to Follow-up|1|||
160895043|NCT01886716|581012802|FG002|Week 3|Lost to Follow-up|0|||
160895044|NCT01886716|581012803|FG003|Week 3|Lost to Follow-up|1|||
160895045|NCT04806503|581012808|FG000|Overall Study|Lost to Follow-up|0|||
160895046|NCT04806503|581012809|FG001|Overall Study|Lost to Follow-up|0|||
160895047|NCT04806503|581012810|FG002|Overall Study|Lost to Follow-up|1|||
160895048|NCT04806503|581012811|FG003|Overall Study|Lost to Follow-up|0|||
160798369|NCT00560417|580651076|FG001|Overall Study|Protocol Violation|5|||
160798370|NCT00560417|580651075|FG000|Overall Study|Sponsor Decision|2|||
160895049|NCT04806503|581012812|FG004|Overall Study|Lost to Follow-up|0|||
160895050|NCT04806503|581012808|FG000|Overall Study|Withdrawal by Subject|1|||
160549347|NCT01789970|579737783|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
160549348|NCT01789970|579737784|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
160549349|NCT01789970|579737782|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160549350|NCT01789970|579737783|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
160549351|NCT01789970|579737784|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
160549352|NCT01789970|579737782|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
160549353|NCT01789970|579737783|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
160549354|NCT01789970|579737784|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
160549355|NCT01789970|579737782|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
160549356|NCT01789970|579737783|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
160549357|NCT01789970|579737784|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
160549358|NCT01789970|579737782|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
160549359|NCT01789970|579737783|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
160549360|NCT01789970|579737784|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
160549361|NCT00643994|579737785|FG000|Overall Study|Death|24|||
160549362|NCT00643994|579737785|FG000|Overall Study|Lost to Follow-up|72|||
160549363|NCT01847885|579737795|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
160549364|NCT01847885|579737796|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
160549365|NCT01847885|579737797|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
160549366|NCT01847885|579737795|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
160549367|NCT01847885|579737796|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
160549368|NCT01847885|579737797|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
160549369|NCT01847885|579737795|FG000|Initial Enrollment (Consented)|Screen failure|39|||
160549370|NCT01847885|579737796|FG001|Initial Enrollment (Consented)|Screen failure|0|||
160549371|NCT01847885|579737797|FG002|Initial Enrollment (Consented)|Screen failure|0|||
160549372|NCT01847885|579737795|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
160549373|NCT01847885|579737796|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
160549374|NCT01847885|579737797|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
160549375|NCT01847885|579737795|FG000|Randomization|Protocol Violation|0|||
160643621|NCT01034137|580078806|FG000|Overall Study|Withdrawal by Subject|4|||
160643622|NCT01034137|580078807|FG001|Overall Study|Withdrawal by Subject|3|||
160643623|NCT01034137|580078808|FG002|Overall Study|Withdrawal by Subject|3|||
160895051|NCT04806503|581012809|FG001|Overall Study|Withdrawal by Subject|0|||
160895052|NCT04806503|581012810|FG002|Overall Study|Withdrawal by Subject|1|||
160895053|NCT04806503|581012811|FG003|Overall Study|Withdrawal by Subject|1|||
160895054|NCT04806503|581012812|FG004|Overall Study|Withdrawal by Subject|1|||
160895055|NCT04806503|581012808|FG000|Overall Study|Adverse Event|1|||
160895056|NCT04806503|581012809|FG001|Overall Study|Adverse Event|1|||
160895057|NCT04806503|581012810|FG002|Overall Study|Adverse Event|0|||
160895058|NCT04806503|581012811|FG003|Overall Study|Adverse Event|1|||
160895059|NCT04806503|581012812|FG004|Overall Study|Adverse Event|0|||
160895060|NCT03589469|581012813|FG000|Overall Study|Withdrawal by Subject|8|||
160895061|NCT03589469|581012813|FG000|Overall Study|Physician Decision|20|||
160895062|NCT03589469|581012813|FG000|Overall Study|Death|97|||
160895063|NCT03589469|581012813|FG000|Overall Study|Lost to Follow-up|8|||
160895064|NCT03589469|581012813|FG000|Overall Study|Miscellaneous|1|||
160895065|NCT00639678|581012818|FG000|Overall Study|Withdrawal by Subject|3|||
160895066|NCT00639678|581012819|FG001|Overall Study|Withdrawal by Subject|0|||
160895067|NCT00639678|581012820|FG002|Overall Study|Withdrawal by Subject|4|||
160895068|NCT00639678|581012821|FG003|Overall Study|Withdrawal by Subject|0|||
160895069|NCT00639678|581012818|FG000|Overall Study|Lost to Follow-up|1|||
160895070|NCT00639678|581012819|FG001|Overall Study|Lost to Follow-up|0|||
160895071|NCT00639678|581012820|FG002|Overall Study|Lost to Follow-up|6|||
160895072|NCT00639678|581012821|FG003|Overall Study|Lost to Follow-up|0|||
160895073|NCT00639678|581012818|FG000|Overall Study|Adverse Event|0|||
160895074|NCT00639678|581012819|FG001|Overall Study|Adverse Event|1|||
160895075|NCT00639678|581012820|FG002|Overall Study|Adverse Event|0|||
160895076|NCT00639678|581012821|FG003|Overall Study|Adverse Event|0|||
160895077|NCT00639678|581012818|FG000|Overall Study|Lack of Compliance|0|||
160895078|NCT00639678|581012819|FG001|Overall Study|Lack of Compliance|0|||
160895079|NCT00639678|581012820|FG002|Overall Study|Lack of Compliance|1|||
160895080|NCT00639678|581012821|FG003|Overall Study|Lack of Compliance|0|||
160895081|NCT01973569|581012822|FG000|Overall Study|Adverse Event|9|||
160895082|NCT01973569|581012823|FG001|Overall Study|Adverse Event|2|||
160895083|NCT01973569|581012824|FG002|Overall Study|Adverse Event|4|||
160895084|NCT01973569|581012822|FG000|Overall Study|Protocol Violation|2|||
160895085|NCT01973569|581012823|FG001|Overall Study|Protocol Violation|1|||
160895086|NCT01973569|581012824|FG002|Overall Study|Protocol Violation|3|||
160895087|NCT01973569|581012822|FG000|Overall Study|Withdrawal by Subject|7|||
160895088|NCT01973569|581012823|FG001|Overall Study|Withdrawal by Subject|5|||
160895089|NCT01973569|581012824|FG002|Overall Study|Withdrawal by Subject|2|||
160895090|NCT01973569|581012822|FG000|Overall Study|Invasive dental treatment|3|||
160895091|NCT01973569|581012823|FG001|Overall Study|Invasive dental treatment|5|||
160549376|NCT01847885|579737796|FG001|Randomization|Protocol Violation|1|||
160549377|NCT01847885|579737797|FG002|Randomization|Protocol Violation|0|||
160549378|NCT01847885|579737795|FG000|Randomization|Withdrawal by Subject|0|||
160549379|NCT01847885|579737796|FG001|Randomization|Withdrawal by Subject|0|||
160549380|NCT01847885|579737797|FG002|Randomization|Withdrawal by Subject|2|||
160549381|NCT01847885|579737795|FG000|Randomization|Screen Failure|0|||
160549382|NCT01847885|579737796|FG001|Randomization|Screen Failure|3|||
160549383|NCT01847885|579737797|FG002|Randomization|Screen Failure|0|||
160549384|NCT04016311|579737801|FG000|Overall Study|Withdrawal by Subject|1|||
160549385|NCT04016311|579737802|FG001|Overall Study|Withdrawal by Subject|0|||
160549386|NCT02706730|579737807|FG000|Overall Study|Adverse Event|3|||
160549387|NCT02706730|579737807|FG000|Overall Study|Lack of Efficacy|5|||
160549388|NCT02706730|579737807|FG000|Overall Study|Withdrawal by Subject|11|||
160549389|NCT02706730|579737807|FG000|Overall Study|Study Terminated by Sponsor|11|||
160549390|NCT02706730|579737807|FG000|Overall Study|Subject chose not to receive injection|3|||
160549391|NCT02499029|579737808|FG000|Overall Study|Lost to Follow-up|2|||
160549392|NCT02499029|579737809|FG001|Overall Study|Lost to Follow-up|2|||
160549393|NCT02499029|579737808|FG000|Overall Study|Physician Decision|2|||
160549394|NCT02499029|579737809|FG001|Overall Study|Physician Decision|1|||
160549395|NCT02499029|579737808|FG000|Overall Study|Death|1|||
160549396|NCT02499029|579737809|FG001|Overall Study|Death|0|||
160549397|NCT00094055|579737810|FG000|Overall Study|Adverse Event|11|||
160549398|NCT00094055|579737810|FG000|Overall Study|Death|4|||
160549399|NCT00094055|579737810|FG000|Overall Study|Lack of Efficacy|17|||
160549400|NCT00094055|579737810|FG000|Overall Study|Lost to Follow-up|2|||
160549401|NCT00094055|579737810|FG000|Overall Study|progressive disease|2|||
160549402|NCT00094055|579737810|FG000|Overall Study|clinical progression|1|||
160549403|NCT00094055|579737810|FG000|Overall Study|roll-over to another study|14|||
160549404|NCT00094055|579737810|FG000|Overall Study|Withdrawal by Subject|9|||
160549405|NCT00756938|579737811|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
160798371|NCT00560417|580651076|FG001|Overall Study|Sponsor Decision|0|||
160798372|NCT00560417|580651075|FG000|Overall Study|Withdrawal by Subject|3|||
160798373|NCT00560417|580651076|FG001|Overall Study|Withdrawal by Subject|3|||
160798374|NCT02164864|580651079|FG000|Overall Study|Trial disease worsening|7|||
160798375|NCT02164864|580651080|FG001|Overall Study|Trial disease worsening|5|||
160798376|NCT02164864|580651081|FG002|Overall Study|Trial disease worsening|1|||
160798377|NCT02164864|580651079|FG000|Overall Study|Other pre-existing disease worsening|6|||
160798378|NCT02164864|580651080|FG001|Overall Study|Other pre-existing disease worsening|4|||
160798379|NCT02164864|580651081|FG002|Overall Study|Other pre-existing disease worsening|9|||
160798380|NCT02164864|580651079|FG000|Overall Study|Other Adverse Event (AE)|52|||
160798381|NCT02164864|580651080|FG001|Overall Study|Other Adverse Event (AE)|32|||
160798382|NCT02164864|580651081|FG002|Overall Study|Other Adverse Event (AE)|49|||
160798383|NCT02164864|580651079|FG000|Overall Study|Protocol Violation|2|||
160798384|NCT02164864|580651080|FG001|Overall Study|Protocol Violation|4|||
160798385|NCT02164864|580651081|FG002|Overall Study|Protocol Violation|1|||
160798386|NCT02164864|580651079|FG000|Overall Study|Lost to Follow-up|4|||
160798387|NCT02164864|580651080|FG001|Overall Study|Lost to Follow-up|3|||
160549406|NCT00756938|579737812|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
160549407|NCT00756938|579737813|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
160549408|NCT00756938|579737814|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
160895092|NCT01973569|581012824|FG002|Overall Study|Invasive dental treatment|6|||
160895093|NCT01973569|581012822|FG000|Overall Study|Prohibited concomitant d|1|||
160895094|NCT01973569|581012823|FG001|Overall Study|Prohibited concomitant d|5|||
160895095|NCT01973569|581012824|FG002|Overall Study|Prohibited concomitant d|0|||
160549409|NCT00756938|579737811|FG000|12-week Base Study|Protocol Violation|0|||
160549410|NCT00756938|579737812|FG001|12-week Base Study|Protocol Violation|0|||
160798388|NCT02164864|580651081|FG002|Overall Study|Lost to Follow-up|2|||
160798389|NCT02164864|580651079|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
160895096|NCT01973569|581012822|FG000|Overall Study|Disease progression|0|||
160798390|NCT02164864|580651080|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
160549411|NCT00756938|579737813|FG002|12-week Base Study|Protocol Violation|1|||
160549412|NCT00756938|579737814|FG003|12-week Base Study|Protocol Violation|0|||
160549413|NCT00756938|579737811|FG000|12-week Base Study|Lost to Follow-up|1|||
160549414|NCT00756938|579737812|FG001|12-week Base Study|Lost to Follow-up|0|||
160549415|NCT00756938|579737813|FG002|12-week Base Study|Lost to Follow-up|0|||
160549416|NCT00756938|579737814|FG003|12-week Base Study|Lost to Follow-up|0|||
160549417|NCT00756938|579737811|FG000|Optional Extension|Lack of Efficacy|0|||
160549418|NCT00756938|579737812|FG001|Optional Extension|Lack of Efficacy|0|||
160549419|NCT00756938|579737813|FG002|Optional Extension|Lack of Efficacy|0|||
160549420|NCT00756938|579737814|FG003|Optional Extension|Lack of Efficacy|1|||
160549421|NCT00756938|579737811|FG000|Optional Extension|End of Study|0|||
160549422|NCT00756938|579737812|FG001|Optional Extension|End of Study|0|||
160549423|NCT00756938|579737813|FG002|Optional Extension|End of Study|0|||
160549424|NCT00756938|579737814|FG003|Optional Extension|End of Study|11|||
160549425|NCT00756938|579737811|FG000|Optional Extension|Protocol-specific criteria met|0|||
160549426|NCT00756938|579737812|FG001|Optional Extension|Protocol-specific criteria met|0|||
160549427|NCT00756938|579737813|FG002|Optional Extension|Protocol-specific criteria met|0|||
160549428|NCT00756938|579737814|FG003|Optional Extension|Protocol-specific criteria met|9|||
160549429|NCT00756938|579737811|FG000|Optional Extension|Physician Decision|0|||
160549430|NCT00756938|579737812|FG001|Optional Extension|Physician Decision|0|||
160549431|NCT00756938|579737813|FG002|Optional Extension|Physician Decision|0|||
160643624|NCT01034137|580078806|FG000|Overall Study|Lack of Efficacy|9|||
160643625|NCT01034137|580078807|FG001|Overall Study|Lack of Efficacy|4|||
160643626|NCT01034137|580078808|FG002|Overall Study|Lack of Efficacy|13|||
160643627|NCT01034137|580078806|FG000|Overall Study|Protocol Violation|2|||
160643628|NCT01034137|580078807|FG001|Overall Study|Protocol Violation|2|||
160643629|NCT01034137|580078808|FG002|Overall Study|Protocol Violation|1|||
160643630|NCT01034137|580078806|FG000|Overall Study|Refused treatment or did not cooperate|2|||
160643631|NCT01034137|580078807|FG001|Overall Study|Refused treatment or did not cooperate|0|||
160643632|NCT01034137|580078808|FG002|Overall Study|Refused treatment or did not cooperate|1|||
160643633|NCT01034137|580078806|FG000|Overall Study|Administrative or other|2|||
160643634|NCT01034137|580078807|FG001|Overall Study|Administrative or other|3|||
160643635|NCT01034137|580078808|FG002|Overall Study|Administrative or other|4|||
160643636|NCT01399723|580078809|FG000|Overall Study|Lost to Follow-up|0|||
160643637|NCT01399723|580078810|FG001|Overall Study|Lost to Follow-up|1|||
160643638|NCT00829413|580078811|FG000|Overall Study|No study drug admimnistered|13|||
160643639|NCT00829413|580078811|FG000|Overall Study|Training Patients|67|||
160643640|NCT00829413|580078811|FG000|Overall Study|No truth standard procedure available|9|||
160643641|NCT00829413|580078811|FG000|Overall Study|Technically inadequate truth standard|2|||
160643642|NCT00829413|580078811|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
160643643|NCT00268346|580078818|FG000|Overall Study|Adverse Event|0|||
160643644|NCT00268346|580078819|FG001|Overall Study|Adverse Event|1|||
160643645|NCT00268346|580078818|FG000|Overall Study|Death|0|||
160643646|NCT00268346|580078819|FG001|Overall Study|Death|1|||
160643647|NCT00268346|580078818|FG000|Overall Study|Withdrawal by Subject|0|||
160643648|NCT00268346|580078819|FG001|Overall Study|Withdrawal by Subject|1|||
160643649|NCT00294723|580078825|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
160643650|NCT00294723|580078826|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
160643651|NCT00294723|580078827|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
160643652|NCT00294723|580078825|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
160643653|NCT00294723|580078826|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
160643654|NCT00294723|580078827|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
160895097|NCT01973569|581012823|FG001|Overall Study|Disease progression|3|||
160549432|NCT00756938|579737814|FG003|Optional Extension|Physician Decision|3|||
160549433|NCT00756938|579737811|FG000|Optional Extension|Lost to Follow-up|0|||
160549434|NCT00756938|579737812|FG001|Optional Extension|Lost to Follow-up|0|||
160643655|NCT00294723|580078825|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
160643656|NCT00294723|580078826|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
160643657|NCT00294723|580078827|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
160643658|NCT00294723|580078825|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
160643659|NCT00294723|580078826|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
160798391|NCT02164864|580651081|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
160798392|NCT02164864|580651079|FG000|Overall Study|Other than stated|3|||
160798393|NCT02164864|580651080|FG001|Overall Study|Other than stated|4|||
160798394|NCT02164864|580651081|FG002|Overall Study|Other than stated|14|||
160798395|NCT03036852|580651082|FG000|Overall Study|Death|2|||
160798396|NCT03036852|580651082|FG000|Overall Study|Lack of Efficacy|2|||
160798397|NCT03036852|580651082|FG000|Overall Study|Adverse Event|1|||
160798398|NCT03036852|580651082|FG000|Overall Study|Lost to Follow-up|1|||
160798399|NCT00652834|580651083|FG000|Overall Study|Withdrawal by Subject|3|||
160798400|NCT00652834|580651083|FG000|Overall Study|Lost to Follow-up|2|||
160798401|NCT00320606|580651084|FG000|Overall Study|Adverse Event|1|||
160798402|NCT00320606|580651084|FG000|Overall Study|Protocol Violation|1|||
160798403|NCT00320606|580651084|FG000|Overall Study|Withdrawal by Subject|1|||
160798404|NCT03984825|580651085|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
160895098|NCT01973569|581012824|FG002|Overall Study|Disease progression|0|||
160895099|NCT01973569|581012822|FG000|Overall Study|Other|1|||
160895100|NCT01973569|581012823|FG001|Overall Study|Other|1|||
160895101|NCT01973569|581012824|FG002|Overall Study|Other|0|||
160895102|NCT01973569|581012822|FG000|Overall Study|Did not receive study drug|6|||
160895103|NCT01973569|581012823|FG001|Overall Study|Did not receive study drug|3|||
160895104|NCT01973569|581012824|FG002|Overall Study|Did not receive study drug|3|||
160895105|NCT00371826|581012825|FG000|Core Phase (12 Months)|Adverse Event|15|||
160895106|NCT00371826|581012826|FG001|Core Phase (12 Months)|Adverse Event|4|||
160895107|NCT00371826|581012827|FG002|Core Phase (12 Months)|Adverse Event|9|||
160895108|NCT00371826|581012825|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
160895109|NCT00371826|581012826|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
160571869|NCT00491530|579816846|FG000|Overall Study|Adverse Event|6|||
160895110|NCT00371826|581012827|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
160549435|NCT00756938|579737813|FG002|Optional Extension|Lost to Follow-up|0|||
160549436|NCT00756938|579737814|FG003|Optional Extension|Lost to Follow-up|1|||
160549437|NCT00756938|579737811|FG000|Optional Extension|Protocol Violation|0|||
160549438|NCT00756938|579737812|FG001|Optional Extension|Protocol Violation|0|||
160549439|NCT00756938|579737813|FG002|Optional Extension|Protocol Violation|0|||
160549440|NCT00756938|579737814|FG003|Optional Extension|Protocol Violation|1|||
160549441|NCT00756938|579737811|FG000|Optional Extension|Withdrawal by Subject|0|||
160549442|NCT00756938|579737812|FG001|Optional Extension|Withdrawal by Subject|0|||
160549443|NCT00756938|579737813|FG002|Optional Extension|Withdrawal by Subject|0|||
160549444|NCT00756938|579737814|FG003|Optional Extension|Withdrawal by Subject|10|||
160549445|NCT00756938|579737811|FG000|Optional Extension|Adverse Event|0|||
160798405|NCT03984825|580651085|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
160798406|NCT03984825|580651085|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
160643660|NCT00294723|580078827|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
160895111|NCT00371826|581012825|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
160895112|NCT00371826|581012826|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
160895113|NCT00371826|581012827|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
160895114|NCT00371826|581012825|FG000|Core Phase (12 Months)|Protocol Violation|1|||
160895115|NCT00371826|581012826|FG001|Core Phase (12 Months)|Protocol Violation|0|||
160895116|NCT00371826|581012827|FG002|Core Phase (12 Months)|Protocol Violation|1|||
160895117|NCT00371826|581012825|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
160895118|NCT00371826|581012826|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
160895119|NCT00371826|581012827|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
160895120|NCT00371826|581012825|FG000|Core Phase (12 Months)|Administrative problems|1|||
160895121|NCT00371826|581012826|FG001|Core Phase (12 Months)|Administrative problems|0|||
160895122|NCT00371826|581012827|FG002|Core Phase (12 Months)|Administrative problems|8|||
160895123|NCT00371826|581012825|FG000|Core Phase (12 Months)|Graft Loss|0|||
160895124|NCT00371826|581012826|FG001|Core Phase (12 Months)|Graft Loss|1|||
160895125|NCT00371826|581012827|FG002|Core Phase (12 Months)|Graft Loss|0|||
160895126|NCT00371826|581012825|FG000|Extension Phase (24 Months)|Adverse Event|4|||
160895127|NCT00371826|581012826|FG001|Extension Phase (24 Months)|Adverse Event|5|||
160895128|NCT00371826|581012827|FG002|Extension Phase (24 Months)|Adverse Event|0|||
160895129|NCT00371826|581012825|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
160895130|NCT00371826|581012826|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
160895131|NCT00371826|581012827|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
160895132|NCT00371826|581012825|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
160895133|NCT00371826|581012826|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
160895134|NCT00371826|581012827|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
160895135|NCT00371826|581012825|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
160895136|NCT00371826|581012826|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
160895137|NCT00371826|581012827|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
160895138|NCT00371826|581012825|FG000|Extension Phase (24 Months)|Administrative problems|0|||
160798407|NCT00261833|580651086|FG000|Overall Study|Death|1|||
160798408|NCT00261833|580651087|FG001|Overall Study|Death|3|||
160798409|NCT00261833|580651086|FG000|Overall Study|Adverse Event|1|||
160798410|NCT00261833|580651087|FG001|Overall Study|Adverse Event|4|||
160798411|NCT00261833|580651086|FG000|Overall Study|Withdrawal by Subject|5|||
160798412|NCT00261833|580651087|FG001|Overall Study|Withdrawal by Subject|7|||
160798413|NCT00261833|580651086|FG000|Overall Study|Protocol Violation|0|||
160798414|NCT00261833|580651087|FG001|Overall Study|Protocol Violation|1|||
160798415|NCT00261833|580651086|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
160798416|NCT00261833|580651087|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
160798417|NCT00261833|580651086|FG000|Overall Study|Lung transplantation|1|||
160798418|NCT00261833|580651087|FG001|Overall Study|Lung transplantation|1|||
160798419|NCT00261833|580651086|FG000|Overall Study|Missing reason|1|||
160798420|NCT00261833|580651087|FG001|Overall Study|Missing reason|0|||
160798421|NCT00261833|580651086|FG000|Overall Study|Not interested in being participant|0|||
160798422|NCT00261833|580651087|FG001|Overall Study|Not interested in being participant|1|||
160798423|NCT00622726|580651088|FG000|March, 2008 to August, 2010|Death|5|||
160798424|NCT00622726|580651089|FG001|March, 2008 to August, 2010|Death|2|||
160798425|NCT00622726|580651088|FG000|August, 2010 to April, 2013|Death|1|||
160798426|NCT00622726|580651089|FG001|August, 2010 to April, 2013|Death|5|||
160895139|NCT00371826|581012826|FG001|Extension Phase (24 Months)|Administrative problems|0|||
160798427|NCT01948427|580651092|FG000|Overall Study|Serious Adverse Event|3|||
160798428|NCT01948427|580651093|FG001|Overall Study|Serious Adverse Event|0|||
160798429|NCT01948427|580651094|FG002|Overall Study|Serious Adverse Event|0|||
160798430|NCT01948427|580651095|FG003|Overall Study|Serious Adverse Event|0|||
160895140|NCT00371826|581012827|FG002|Extension Phase (24 Months)|Administrative problems|2|||
160895141|NCT05061966|581012828|FG000|Overall Study|Lost to Follow-up|13|||
160895142|NCT05061966|581012829|FG001|Overall Study|Lost to Follow-up|13|||
160895143|NCT02923427|581012830|FG000|Overall Study|convert to laparatomy|2|||
160798431|NCT01948427|580651096|FG004|Overall Study|Serious Adverse Event|1|||
160798432|NCT01948427|580651092|FG000|Overall Study|Investigator Request|0|||
160549446|NCT00756938|579737812|FG001|Optional Extension|Adverse Event|0|||
160549447|NCT00756938|579737813|FG002|Optional Extension|Adverse Event|0|||
160549448|NCT00756938|579737814|FG003|Optional Extension|Adverse Event|1|||
160549449|NCT00441545|579737815|FG000|First Intervention|Adverse Event|6|||
160549450|NCT00441545|579737816|FG001|First Intervention|Adverse Event|5|||
160549451|NCT00441545|579737815|FG000|First Intervention|Protocol Violation|2|||
160549452|NCT00441545|579737816|FG001|First Intervention|Protocol Violation|2|||
160549453|NCT00441545|579737815|FG000|First Intervention|Withdrawal by Subject|3|||
160549454|NCT00441545|579737816|FG001|First Intervention|Withdrawal by Subject|3|||
160549455|NCT00441545|579737815|FG000|First Intervention|Kidney transplant|1|||
160549456|NCT00441545|579737816|FG001|First Intervention|Kidney transplant|1|||
160549457|NCT00441545|579737815|FG000|First Intervention|Lack of Efficacy|2|||
160549458|NCT00441545|579737816|FG001|First Intervention|Lack of Efficacy|0|||
160549459|NCT00441545|579737815|FG000|First Intervention|Subject exceeded safety criteria|0|||
160549460|NCT00441545|579737816|FG001|First Intervention|Subject exceeded safety criteria|1|||
160549461|NCT00441545|579737815|FG000|First Intervention|Subject met an exclusionary criteria|1|||
160549462|NCT00441545|579737816|FG001|First Intervention|Subject met an exclusionary criteria|0|||
160549463|NCT00441545|579737815|FG000|First Intervention|Extended hospitalization|1|||
160549464|NCT00441545|579737816|FG001|First Intervention|Extended hospitalization|0|||
160549465|NCT00441545|579737815|FG000|First Intervention|Site error|1|||
160549466|NCT00441545|579737816|FG001|First Intervention|Site error|0|||
160549467|NCT00441545|579737815|FG000|First Intervention|Sponsor's request|1|||
160549468|NCT00441545|579737816|FG001|First Intervention|Sponsor's request|0|||
160549469|NCT00441545|579737815|FG000|Second Intervention|Adverse Event|5|||
160549470|NCT00441545|579737816|FG001|Second Intervention|Adverse Event|2|||
160549471|NCT00441545|579737815|FG000|Second Intervention|Protocol Violation|4|||
160549472|NCT00441545|579737816|FG001|Second Intervention|Protocol Violation|1|||
160549473|NCT00441545|579737815|FG000|Second Intervention|Withdrawal by Subject|1|||
160549474|NCT00441545|579737816|FG001|Second Intervention|Withdrawal by Subject|1|||
160549475|NCT00441545|579737815|FG000|Second Intervention|Kidney Transplant|1|||
160549476|NCT00441545|579737816|FG001|Second Intervention|Kidney Transplant|1|||
160549477|NCT00441545|579737815|FG000|Second Intervention|Lack of Efficacy|0|||
160549478|NCT00441545|579737816|FG001|Second Intervention|Lack of Efficacy|1|||
160549479|NCT00441545|579737815|FG000|Second Intervention|Subject exceeded safety criteria|1|||
160549480|NCT00441545|579737816|FG001|Second Intervention|Subject exceeded safety criteria|0|||
160549481|NCT00441545|579737815|FG000|Second Intervention|Subject moved|0|||
160549482|NCT00441545|579737816|FG001|Second Intervention|Subject moved|1|||
160549483|NCT00411554|579737819|FG000|Overall Study|Adverse Event|2|||
160549484|NCT00411554|579737820|FG001|Overall Study|Adverse Event|4|||
160549485|NCT00411554|579737819|FG000|Overall Study|Lack of Efficacy|2|||
160549486|NCT00411554|579737820|FG001|Overall Study|Lack of Efficacy|5|||
160549487|NCT00411554|579737819|FG000|Overall Study|Withdrawal by Subject|3|||
160549488|NCT00411554|579737820|FG001|Overall Study|Withdrawal by Subject|0|||
160549489|NCT00411554|579737819|FG000|Overall Study|Patient Moved|1|||
160549490|NCT00411554|579737820|FG001|Overall Study|Patient Moved|0|||
160549491|NCT01081795|579737825|FG000|Overall Study|Adverse Event|18|||
160549492|NCT01081795|579737826|FG001|Overall Study|Adverse Event|23|||
160549493|NCT01081795|579737827|FG002|Overall Study|Adverse Event|6|||
160643661|NCT00294723|580078825|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
160798433|NCT01948427|580651093|FG001|Overall Study|Investigator Request|8|||
160798434|NCT01948427|580651094|FG002|Overall Study|Investigator Request|0|||
160798435|NCT01948427|580651095|FG003|Overall Study|Investigator Request|0|||
160798436|NCT01948427|580651096|FG004|Overall Study|Investigator Request|6|||
160798437|NCT01948427|580651092|FG000|Overall Study|Lost to Follow-up|1|||
160798438|NCT01948427|580651093|FG001|Overall Study|Lost to Follow-up|0|||
160798439|NCT01948427|580651094|FG002|Overall Study|Lost to Follow-up|0|||
160798440|NCT01948427|580651095|FG003|Overall Study|Lost to Follow-up|0|||
160798441|NCT01948427|580651096|FG004|Overall Study|Lost to Follow-up|4|||
160798442|NCT01948427|580651092|FG000|Overall Study|Withdrawal by Subject|2|||
160798443|NCT01948427|580651093|FG001|Overall Study|Withdrawal by Subject|0|||
160798444|NCT01948427|580651094|FG002|Overall Study|Withdrawal by Subject|0|||
160798445|NCT01948427|580651095|FG003|Overall Study|Withdrawal by Subject|0|||
160798446|NCT01948427|580651096|FG004|Overall Study|Withdrawal by Subject|1|||
160798447|NCT01948427|580651092|FG000|Overall Study|Other, Not Specified|1|||
160798448|NCT01948427|580651093|FG001|Overall Study|Other, Not Specified|9|||
160798449|NCT01948427|580651094|FG002|Overall Study|Other, Not Specified|0|||
160798450|NCT01948427|580651095|FG003|Overall Study|Other, Not Specified|0|||
160798451|NCT01948427|580651096|FG004|Overall Study|Other, Not Specified|2|||
160798452|NCT00399529|580651097|FG000|Overall Study|Off Study Prior to Treatment|2|||
160798453|NCT02006927|580651098|FG000|Overall Study|Adverse Event|2|||
160798454|NCT02006927|580651098|FG000|Overall Study|Withdrawal by Subject|1|||
160798455|NCT01164007|580651099|FG000|Overall Study|Adverse Event|5|||
160798456|NCT01164007|580651099|FG000|Overall Study|Progression of Disease|30|||
160798457|NCT01164007|580651099|FG000|Overall Study|Protocol Violation|1|||
160549494|NCT01081795|579737825|FG000|Overall Study|Lack of Efficacy|7|||
160549495|NCT01081795|579737826|FG001|Overall Study|Lack of Efficacy|5|||
160549496|NCT01081795|579737827|FG002|Overall Study|Lack of Efficacy|19|||
160549497|NCT01081795|579737825|FG000|Overall Study|Subject's schedule|1|||
160549498|NCT01081795|579737826|FG001|Overall Study|Subject's schedule|1|||
160798458|NCT01164007|580651099|FG000|Overall Study|Withdrawal by Subject|1|||
160798459|NCT01164007|580651099|FG000|Overall Study|Medical Decision|3|||
160983752|NCT04157686|581328740|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
160983753|NCT04157686|581328741|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
160983754|NCT04157686|581328742|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
160983755|NCT04445155|581328743|FG000|Overall Study|Lost to Follow-up|11|||
160983756|NCT04445155|581328744|FG001|Overall Study|Lost to Follow-up|2|||
160983757|NCT04445155|581328745|FG002|Overall Study|Lost to Follow-up|3|||
160983758|NCT04445155|581328746|FG003|Overall Study|Lost to Follow-up|0|||
160983759|NCT04445155|581328743|FG000|Overall Study|Withdrawal by Subject|8|||
160983760|NCT04445155|581328744|FG001|Overall Study|Withdrawal by Subject|0|||
160983761|NCT04445155|581328745|FG002|Overall Study|Withdrawal by Subject|0|||
160983762|NCT04445155|581328746|FG003|Overall Study|Withdrawal by Subject|0|||
160798460|NCT03218917|580651100|FG000|Overall Study|Adverse Event|3|||
160798461|NCT03218917|580651101|FG001|Overall Study|Adverse Event|3|||
160798462|NCT03218917|580651102|FG002|Overall Study|Adverse Event|2|||
160983763|NCT04445155|581328743|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
160983764|NCT04445155|581328744|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
160549499|NCT01081795|579737827|FG002|Overall Study|Subject's schedule|2|||
160549500|NCT01081795|579737825|FG000|Overall Study|Revocation of informed consent|2|||
160549501|NCT01081795|579737826|FG001|Overall Study|Revocation of informed consent|0|||
160549502|NCT01081795|579737827|FG002|Overall Study|Revocation of informed consent|0|||
160549503|NCT01081795|579737825|FG000|Overall Study|Ineligible for participation|1|||
160549504|NCT01081795|579737826|FG001|Overall Study|Ineligible for participation|0|||
160549505|NCT01081795|579737827|FG002|Overall Study|Ineligible for participation|0|||
160549506|NCT01081795|579737825|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
160549507|NCT01081795|579737826|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
160549508|NCT01081795|579737827|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
160549509|NCT01081795|579737825|FG000|Overall Study|Using drug with restricted days of use|2|||
160549510|NCT01081795|579737826|FG001|Overall Study|Using drug with restricted days of use|3|||
160549511|NCT01081795|579737827|FG002|Overall Study|Using drug with restricted days of use|2|||
160549512|NCT01081795|579737825|FG000|Overall Study|Other|1|||
160549513|NCT01081795|579737826|FG001|Overall Study|Other|2|||
160549514|NCT01081795|579737827|FG002|Overall Study|Other|0|||
160549515|NCT01707693|579737828|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
160549516|NCT01707693|579737829|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
160549517|NCT01707693|579737828|FG000|Overall Study Allocation|Protocol Violation|4|||
160549518|NCT01707693|579737829|FG001|Overall Study Allocation|Protocol Violation|3|||
160549519|NCT01707693|579737828|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
160549520|NCT01707693|579737829|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
160549521|NCT01707693|579737828|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
160549522|NCT01707693|579737829|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
160549523|NCT00143455|579737832|FG000|Cohort 1|Adverse Event|8|||
160549524|NCT00143455|579737833|FG001|Cohort 1|Adverse Event|4|||
160549525|NCT00143455|579737834|FG002|Cohort 1|Adverse Event|0|||
160549526|NCT00143455|579737835|FG003|Cohort 1|Adverse Event|0|||
160549527|NCT00143455|579737832|FG000|Cohort 1|Death|5|||
160549528|NCT00143455|579737833|FG001|Cohort 1|Death|2|||
160549529|NCT00143455|579737834|FG002|Cohort 1|Death|0|||
160549530|NCT00143455|579737835|FG003|Cohort 1|Death|0|||
160549531|NCT00143455|579737832|FG000|Cohort 1|Progressive Disease|0|||
160549532|NCT00143455|579737833|FG001|Cohort 1|Progressive Disease|6|||
160549533|NCT00143455|579737834|FG002|Cohort 1|Progressive Disease|0|||
160549534|NCT00143455|579737835|FG003|Cohort 1|Progressive Disease|0|||
160549535|NCT00143455|579737832|FG000|Cohort 1|Withdrawal by Subject|1|||
160549536|NCT00143455|579737833|FG001|Cohort 1|Withdrawal by Subject|4|||
160549537|NCT00143455|579737834|FG002|Cohort 1|Withdrawal by Subject|0|||
160549538|NCT00143455|579737835|FG003|Cohort 1|Withdrawal by Subject|0|||
160549539|NCT00143455|579737832|FG000|Cohort 1|Randomized But Not Treated|0|||
160549540|NCT00143455|579737833|FG001|Cohort 1|Randomized But Not Treated|1|||
160549541|NCT00143455|579737834|FG002|Cohort 1|Randomized But Not Treated|0|||
160549542|NCT00143455|579737835|FG003|Cohort 1|Randomized But Not Treated|0|||
160549543|NCT00143455|579737832|FG000|Cohort 2|Adverse Event|0|||
160549544|NCT00143455|579737833|FG001|Cohort 2|Adverse Event|0|||
160549545|NCT00143455|579737834|FG002|Cohort 2|Adverse Event|42|||
160549546|NCT00143455|579737835|FG003|Cohort 2|Adverse Event|30|||
160549547|NCT00143455|579737832|FG000|Cohort 2|No Longer Required Study Treatment|0|||
160549548|NCT00143455|579737833|FG001|Cohort 2|No Longer Required Study Treatment|0|||
160549549|NCT00143455|579737834|FG002|Cohort 2|No Longer Required Study Treatment|1|||
160549550|NCT00143455|579737835|FG003|Cohort 2|No Longer Required Study Treatment|0|||
160549551|NCT00143455|579737832|FG000|Cohort 2|Protocol Violation|0|||
160549552|NCT00143455|579737833|FG001|Cohort 2|Protocol Violation|0|||
160549553|NCT00143455|579737834|FG002|Cohort 2|Protocol Violation|1|||
160549554|NCT00143455|579737835|FG003|Cohort 2|Protocol Violation|1|||
160549555|NCT00143455|579737832|FG000|Cohort 2|Lost to Follow-up|0|||
160549556|NCT00143455|579737833|FG001|Cohort 2|Lost to Follow-up|0|||
160549557|NCT00143455|579737834|FG002|Cohort 2|Lost to Follow-up|1|||
160549558|NCT00143455|579737835|FG003|Cohort 2|Lost to Follow-up|4|||
160549559|NCT00143455|579737832|FG000|Cohort 2|Death|0|||
160549560|NCT00143455|579737833|FG001|Cohort 2|Death|0|||
160549561|NCT00143455|579737834|FG002|Cohort 2|Death|20|||
160549562|NCT00143455|579737835|FG003|Cohort 2|Death|12|||
160549563|NCT00143455|579737832|FG000|Cohort 2|Progressive Disease|0|||
160549564|NCT00143455|579737833|FG001|Cohort 2|Progressive Disease|0|||
160549565|NCT00143455|579737834|FG002|Cohort 2|Progressive Disease|20|||
160549566|NCT00143455|579737835|FG003|Cohort 2|Progressive Disease|27|||
160549567|NCT00143455|579737832|FG000|Cohort 2|Withdrawal by Subject|0|||
160549568|NCT00143455|579737833|FG001|Cohort 2|Withdrawal by Subject|0|||
160549569|NCT00143455|579737834|FG002|Cohort 2|Withdrawal by Subject|13|||
160549570|NCT00143455|579737835|FG003|Cohort 2|Withdrawal by Subject|12|||
160549571|NCT00143455|579737832|FG000|Cohort 2|Other|0|||
160549572|NCT00143455|579737833|FG001|Cohort 2|Other|0|||
160549573|NCT00143455|579737834|FG002|Cohort 2|Other|7|||
160549574|NCT00143455|579737835|FG003|Cohort 2|Other|6|||
160549575|NCT00143455|579737832|FG000|Cohort 2|Randomized But Not Treated|0|||
160549576|NCT00143455|579737833|FG001|Cohort 2|Randomized But Not Treated|0|||
160549577|NCT00143455|579737834|FG002|Cohort 2|Randomized But Not Treated|1|||
160549578|NCT00143455|579737835|FG003|Cohort 2|Randomized But Not Treated|1|||
160549579|NCT02682901|579737836|FG000|Overall Study|Adverse Event|10|||
160549580|NCT02682901|579737837|FG001|Overall Study|Adverse Event|3|||
160643662|NCT00294723|580078826|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
160643663|NCT00294723|580078827|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
160643664|NCT00294723|580078825|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
160643665|NCT00294723|580078826|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
160643666|NCT00294723|580078827|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
160643667|NCT00294723|580078825|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
160643668|NCT00294723|580078826|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
160643669|NCT00294723|580078827|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
160643670|NCT00294723|580078825|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
160643671|NCT00294723|580078826|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
160643672|NCT00294723|580078827|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
160643673|NCT00294723|580078825|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
160643674|NCT00294723|580078826|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
160643675|NCT00294723|580078827|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
160643676|NCT00294723|580078825|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
160643677|NCT00294723|580078826|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
160643678|NCT00294723|580078827|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
160643679|NCT00294723|580078825|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
160643680|NCT00294723|580078826|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
160643681|NCT00294723|580078827|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
160643682|NCT00294723|580078825|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
160643683|NCT00294723|580078826|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
160643684|NCT00294723|580078827|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
160643685|NCT00891774|580078828|FG000|Overall Study|Lost to Follow-up|5|||
160643686|NCT00891774|580078828|FG000|Overall Study|Illness (Self/Mother)|3|||
160643687|NCT00891774|580078828|FG000|Overall Study|Withdrawal by Subject|2|||
160643688|NCT00891774|580078828|FG000|Overall Study|Protocol Violation|4|||
160643689|NCT01977092|580078831|FG000|Overall Study|Death|3|||
160643690|NCT01977092|580078832|FG001|Overall Study|Death|4|||
160643691|NCT01977092|580078831|FG000|Overall Study|Lost to Follow-up|23|||
160643692|NCT01977092|580078832|FG001|Overall Study|Lost to Follow-up|14|||
160643693|NCT01977092|580078831|FG000|Overall Study|Withdrawal by Subject|2|||
160643694|NCT01977092|580078832|FG001|Overall Study|Withdrawal by Subject|1|||
160643695|NCT01977092|580078831|FG000|Overall Study|In prison|3|||
160643696|NCT01977092|580078832|FG001|Overall Study|In prison|11|||
160643697|NCT01958281|580078833|FG000|Overall Study|Lack of Efficacy|5|||
160643698|NCT01958281|580078834|FG001|Overall Study|Lack of Efficacy|2|||
160643699|NCT01958281|580078835|FG002|Overall Study|Lack of Efficacy|0|||
160643700|NCT01958281|580078833|FG000|Overall Study|Adverse Event|0|||
160643701|NCT01958281|580078834|FG001|Overall Study|Adverse Event|2|||
160643702|NCT01958281|580078835|FG002|Overall Study|Adverse Event|0|||
160643703|NCT01958281|580078833|FG000|Overall Study|Withdrew Consent|1|||
160643704|NCT01958281|580078834|FG001|Overall Study|Withdrew Consent|0|||
160643705|NCT01958281|580078835|FG002|Overall Study|Withdrew Consent|0|||
160643706|NCT03038113|580078836|FG000|Overall Study|Withdrawal by Subject|0|||
160643707|NCT03038113|580078837|FG001|Overall Study|Withdrawal by Subject|0|||
160549581|NCT02682901|579737836|FG000|Overall Study|Lack of Efficacy|0|||
160549582|NCT02682901|579737837|FG001|Overall Study|Lack of Efficacy|1|||
160549583|NCT03713944|579737838|FG000|Study Treatment|Patient non-compliance|1|||
160798463|NCT03218917|580651100|FG000|Overall Study|Subject withdrew consent|2|||
160798464|NCT03218917|580651101|FG001|Overall Study|Subject withdrew consent|4|||
160798465|NCT03218917|580651102|FG002|Overall Study|Subject withdrew consent|10|||
160798466|NCT03218917|580651100|FG000|Overall Study|Physician Decision|0|||
160798467|NCT03218917|580651101|FG001|Overall Study|Physician Decision|1|||
160549584|NCT03713944|579737838|FG000|Study Treatment|Alternative Cancer Therapy|3|||
160549585|NCT03713944|579737838|FG000|Study Treatment|Disease Progression|18|||
160549586|NCT03713944|579737838|FG000|Study Treatment|AE/Side Effects/Complications|2|||
160549587|NCT03713944|579737838|FG000|Study Treatment|Death|2|||
160549588|NCT03713944|579737838|FG000|Study Treatment|Withdrawal by Subject|1|||
160549589|NCT03713944|579737838|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
160549590|NCT03713944|579737838|FG000|Study Treatment|Symptomatic Deterioration|2|||
160549591|NCT03713944|579737838|FG000|Follow up|Withdrawal by Subject|2|||
160549592|NCT03713944|579737838|FG000|Follow up|Death|11|||
160549593|NCT03713944|579737838|FG000|Follow up|Study Terminated|3|||
160549594|NCT00720109|579737855|FG000|Induction Period|Did not meet eligibility criteria|3|||
160549595|NCT00720109|579737856|FG001|Induction Period|Did not meet eligibility criteria|0|||
160549596|NCT00720109|579737857|FG002|Induction Period|Did not meet eligibility criteria|0|||
160549597|NCT00720109|579737855|FG000|Induction Period|Bone Marrow Transplant|2|||
160549598|NCT00720109|579737856|FG001|Induction Period|Bone Marrow Transplant|0|||
160549599|NCT00720109|579737857|FG002|Induction Period|Bone Marrow Transplant|0|||
160549600|NCT00720109|579737855|FG000|Induction Period|Physician Decision|1|||
160549601|NCT00720109|579737856|FG001|Induction Period|Physician Decision|0|||
160549602|NCT00720109|579737857|FG002|Induction Period|Physician Decision|0|||
160549603|NCT00720109|579737855|FG000|Risk Stratification Period|Adverse Event|0|||
160549604|NCT00720109|579737856|FG001|Risk Stratification Period|Adverse Event|1|||
160549605|NCT00720109|579737857|FG002|Risk Stratification Period|Adverse Event|0|||
160549606|NCT00720109|579737855|FG000|Risk Stratification Period|Physician Decision|0|||
160549607|NCT00720109|579737856|FG001|Risk Stratification Period|Physician Decision|2|||
160549608|NCT00720109|579737857|FG002|Risk Stratification Period|Physician Decision|1|||
160549609|NCT00720109|579737855|FG000|Risk Stratification Period|Bone marrow transplant|0|||
160549610|NCT00720109|579737856|FG001|Risk Stratification Period|Bone marrow transplant|9|||
160549611|NCT00720109|579737857|FG002|Risk Stratification Period|Bone marrow transplant|7|||
160549612|NCT00720109|579737855|FG000|Risk Stratification Period|Disease progression or relapse|0|||
160549613|NCT00720109|579737856|FG001|Risk Stratification Period|Disease progression or relapse|2|||
160549614|NCT00720109|579737857|FG002|Risk Stratification Period|Disease progression or relapse|0|||
160549615|NCT00720109|579737855|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
160549616|NCT00720109|579737856|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
160549617|NCT00720109|579737857|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
160549618|NCT02665286|579737860|FG000|Overall Study|Lost to Follow-up|3|||
160549619|NCT02665286|579737861|FG001|Overall Study|Lost to Follow-up|2|||
160549620|NCT02665286|579737862|FG002|Overall Study|Lost to Follow-up|1|||
160549621|NCT04899232|579737872|FG000|Screening Period|Physician Decision|1|||
160549622|NCT04899232|579737873|FG001|Screening Period|Physician Decision|0|||
160549623|NCT04899232|579737874|FG002|Screening Period|Physician Decision|0|||
160549624|NCT04899232|579737872|FG000|Screening Period|Withdrawal by Subject|1|||
160549625|NCT04899232|579737873|FG001|Screening Period|Withdrawal by Subject|0|||
160549626|NCT04899232|579737874|FG002|Screening Period|Withdrawal by Subject|0|||
160549627|NCT04899232|579737872|FG000|Screening Period|Participant discharged before receiving intervention|3|||
160549628|NCT04899232|579737873|FG001|Screening Period|Participant discharged before receiving intervention|0|||
160549629|NCT04899232|579737874|FG002|Screening Period|Participant discharged before receiving intervention|0|||
160549630|NCT02553460|579737875|FG000|Overall Study|Death|3|||
160549631|NCT02553460|579737875|FG000|Overall Study|Withdrawal by Subject|1|||
160549632|NCT02553460|579737875|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
160549633|NCT02553460|579737875|FG000|Overall Study|Relapse or Transplant|14|||
160549634|NCT02553460|579737875|FG000|Overall Study|No response to treatment|2|||
160549635|NCT02553460|579737875|FG000|Overall Study|CAR T cells|2|||
160549636|NCT03505021|579737876|FG000|Overall Study|Protocol Violation|1|||
160549637|NCT03505021|579737877|FG001|Overall Study|Protocol Violation|0|||
160549638|NCT03505021|579737876|FG000|Overall Study|Death|9|||
160549639|NCT03505021|579737877|FG001|Overall Study|Death|8|||
160549640|NCT03505021|579737876|FG000|Overall Study|Consent withdrawn by subject|6|||
160549641|NCT03505021|579737877|FG001|Overall Study|Consent withdrawn by subject|1|||
160549642|NCT03505021|579737876|FG000|Overall Study|Lost to Follow-up|5|||
160549643|NCT03505021|579737877|FG001|Overall Study|Lost to Follow-up|3|||
160549644|NCT03505021|579737876|FG000|Overall Study|Adverse Event|26|||
160549645|NCT03505021|579737877|FG001|Overall Study|Adverse Event|9|||
160549646|NCT03505021|579737876|FG000|Overall Study|Disease progression|33|||
160549647|NCT03505021|579737877|FG001|Overall Study|Disease progression|17|||
160549648|NCT03505021|579737876|FG000|Overall Study|Other|11|||
160798468|NCT03218917|580651102|FG002|Overall Study|Physician Decision|1|||
160549649|NCT03505021|579737877|FG001|Overall Study|Other|5|||
160798469|NCT03218917|580651100|FG000|Overall Study|Lost to Follow-up|1|||
160798470|NCT03218917|580651101|FG001|Overall Study|Lost to Follow-up|0|||
160549650|NCT03505021|579737876|FG000|Overall Study|Personal reason|21|||
160549651|NCT03505021|579737877|FG001|Overall Study|Personal reason|12|||
160549652|NCT03087955|579740058|FG000|Overall Study|Death|4|||
160549653|NCT03087955|579740059|FG001|Overall Study|Death|0|||
160549654|NCT03087955|579740058|FG000|Overall Study|Lack of Efficacy|2|||
160549655|NCT03087955|579740059|FG001|Overall Study|Lack of Efficacy|0|||
160549656|NCT03087955|579740058|FG000|Overall Study|Lost to Follow-up|1|||
160798471|NCT03218917|580651102|FG002|Overall Study|Lost to Follow-up|0|||
160798472|NCT03218917|580651100|FG000|Overall Study|Reason Missing|0|||
160798473|NCT03218917|580651101|FG001|Overall Study|Reason Missing|2|||
160798474|NCT03218917|580651102|FG002|Overall Study|Reason Missing|0|||
160798475|NCT03218917|580651100|FG000|Overall Study|Death|0|||
160798476|NCT03218917|580651101|FG001|Overall Study|Death|1|||
160798477|NCT03218917|580651102|FG002|Overall Study|Death|0|||
160798478|NCT03218917|580651100|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160549657|NCT03087955|579740059|FG001|Overall Study|Lost to Follow-up|0|||
160549658|NCT03266016|579740066|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
160549659|NCT03266016|579740067|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
160549660|NCT03266016|579740068|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
160549661|NCT03266016|579740069|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
160549662|NCT03266016|579740066|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
160549663|NCT03266016|579740067|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
160549664|NCT03266016|579740068|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
160549665|NCT03266016|579740069|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
160549666|NCT05280756|579740070|FG000|Overall Study|Lost to Follow-up|1|||
160549667|NCT05280756|579740071|FG001|Overall Study|Lost to Follow-up|1|||
160549668|NCT00768898|579740072|FG000|Overall Study|Unrelated injury|1|||
160549669|NCT00768898|579740072|FG000|Overall Study|Headache|1|||
160549670|NCT01777763|579740085|FG000|Overall Study|Adverse Event|2|||
160549671|NCT01777763|579740086|FG001|Overall Study|Adverse Event|32|||
160549672|NCT01777763|579740085|FG000|Overall Study|Protocol Violation|1|||
160798479|NCT03218917|580651101|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160798480|NCT03218917|580651102|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160798481|NCT01908140|580651103|FG000|Overall Study|Other or Progressive Disease|5|||
160798482|NCT01908140|580651104|FG001|Overall Study|Other or Progressive Disease|12|||
160798483|NCT01908140|580651103|FG000|Overall Study|Lack of Efficacy|7|||
160798484|NCT01908140|580651104|FG001|Overall Study|Lack of Efficacy|5|||
160798485|NCT01908140|580651103|FG000|Overall Study|Withdrawal by Subject|23|||
160798486|NCT01908140|580651104|FG001|Overall Study|Withdrawal by Subject|24|||
160798487|NCT01908140|580651103|FG000|Overall Study|Lost to Follow-up|1|||
160798488|NCT01908140|580651104|FG001|Overall Study|Lost to Follow-up|6|||
160798489|NCT01908140|580651103|FG000|Overall Study|Protocol Violation|8|||
160798490|NCT01908140|580651104|FG001|Overall Study|Protocol Violation|9|||
160798491|NCT01908140|580651103|FG000|Overall Study|Adverse Event|22|||
160798492|NCT01908140|580651104|FG001|Overall Study|Adverse Event|23|||
160798493|NCT02639390|580651105|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
160798494|NCT02639390|580651106|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
160798495|NCT02412670|580651107|FG000|Overall Study|Adverse Event|4|||
160798496|NCT02412670|580651108|FG001|Overall Study|Adverse Event|1|||
160798497|NCT02412670|580651107|FG000|Overall Study|Physician Decision|1|||
160798498|NCT02412670|580651108|FG001|Overall Study|Physician Decision|0|||
160895144|NCT02923427|581012831|FG001|Overall Study|convert to laparatomy|2|||
160895145|NCT02923427|581012830|FG000|Overall Study|destaturation|1|||
160895146|NCT02923427|581012831|FG001|Overall Study|destaturation|0|||
160549673|NCT01777763|579740086|FG001|Overall Study|Protocol Violation|7|||
160549674|NCT01777763|579740085|FG000|Overall Study|Withdrawal by Subject|0|||
160895147|NCT02923427|581012830|FG000|Overall Study|can not replace LMA|1|||
160895148|NCT02923427|581012831|FG001|Overall Study|can not replace LMA|0|||
160895149|NCT01539642|581012836|FG000|Overall Study|Lack of Efficacy|20|||
160895150|NCT01539642|581012837|FG001|Overall Study|Lack of Efficacy|18|||
160895151|NCT01539642|581012836|FG000|Overall Study|Patient ready for early discharge|8|||
160798499|NCT02412670|580651107|FG000|Overall Study|Withdrawal by Subject|1|||
160895152|NCT01539642|581012837|FG001|Overall Study|Patient ready for early discharge|7|||
160895153|NCT01539642|581012836|FG000|Overall Study|Adverse Event|6|||
160895154|NCT01539642|581012837|FG001|Overall Study|Adverse Event|4|||
160549675|NCT01777763|579740086|FG001|Overall Study|Withdrawal by Subject|2|||
160549676|NCT01777763|579740085|FG000|Overall Study|Treatment Failure|1|||
160549677|NCT01777763|579740086|FG001|Overall Study|Treatment Failure|6|||
160549678|NCT02968810|579740090|FG000|Overall Study|Lost to Follow-up|1|||
160549679|NCT02968810|579740091|FG001|Overall Study|Lost to Follow-up|0|||
160549680|NCT02968810|579740090|FG000|Overall Study|Physician Decision|1|||
160549681|NCT02968810|579740091|FG001|Overall Study|Physician Decision|0|||
160798500|NCT02412670|580651108|FG001|Overall Study|Withdrawal by Subject|0|||
160798501|NCT02412670|580651107|FG000|Overall Study|Ineligible|1|||
160798502|NCT02412670|580651108|FG001|Overall Study|Ineligible|0|||
160798503|NCT00431964|580651112|FG000|Overall Study|Adverse Event|1|||
160895155|NCT01539642|581012836|FG000|Overall Study|Withdrawal by Subject|2|||
160798504|NCT00431964|580651113|FG001|Overall Study|Adverse Event|0|||
160798505|NCT00431964|580651112|FG000|Overall Study|Lost to Follow-up|1|||
160798506|NCT00431964|580651113|FG001|Overall Study|Lost to Follow-up|2|||
160549682|NCT02968810|579740090|FG000|Overall Study|Withdrawal by Subject|1|||
160549683|NCT02968810|579740091|FG001|Overall Study|Withdrawal by Subject|3|||
160549684|NCT02968810|579740090|FG000|Overall Study|Disease Progression|0|||
160549685|NCT02968810|579740091|FG001|Overall Study|Disease Progression|1|||
160549686|NCT02787850|579740093|FG000|Overall Study|Withdrawal by Subject|0|||
160549687|NCT02787850|579740094|FG001|Overall Study|Withdrawal by Subject|1|||
160549688|NCT03718143|579740095|FG000|Overall Study|Death|1|||
160549689|NCT03718143|579740096|FG001|Overall Study|Death|0|||
160549690|NCT03718143|579740097|FG002|Overall Study|Death|0|||
160549691|NCT03718143|579740095|FG000|Overall Study|Progression of Disease|1|||
160798507|NCT00431964|580651112|FG000|Overall Study|Physician Decision|2|||
160549692|NCT03718143|579740096|FG001|Overall Study|Progression of Disease|0|||
160549693|NCT03718143|579740097|FG002|Overall Study|Progression of Disease|0|||
160798508|NCT00431964|580651113|FG001|Overall Study|Physician Decision|2|||
160798509|NCT00431964|580651112|FG000|Overall Study|Withdrawal by Subject|2|||
160798510|NCT00431964|580651113|FG001|Overall Study|Withdrawal by Subject|1|||
160798511|NCT00431964|580651112|FG000|Overall Study|Parental Consent Withdrawn|0|||
160798512|NCT00431964|580651113|FG001|Overall Study|Parental Consent Withdrawn|2|||
160798513|NCT00431964|580651112|FG000|Overall Study|Due to Unstable Health|0|||
160798514|NCT00431964|580651113|FG001|Overall Study|Due to Unstable Health|1|||
160549694|NCT03718143|579740095|FG000|Overall Study|Withdrawal of Informed Consent|1|||
160549695|NCT03718143|579740096|FG001|Overall Study|Withdrawal of Informed Consent|2|||
160549696|NCT03718143|579740097|FG002|Overall Study|Withdrawal of Informed Consent|1|||
160549697|NCT03905863|579740098|FG000|Overall Study|Adverse Event|2|||
160549698|NCT03905863|579740099|FG001|Overall Study|Adverse Event|4|||
160549699|NCT03905863|579740098|FG000|Overall Study|Withdrawal by Subject|2|||
160643708|NCT03038113|580078838|FG002|Overall Study|Withdrawal by Subject|1|||
160643709|NCT03038113|580078839|FG003|Overall Study|Withdrawal by Subject|0|||
160643710|NCT03038113|580078840|FG004|Overall Study|Withdrawal by Subject|0|||
160643711|NCT03038113|580078841|FG005|Overall Study|Withdrawal by Subject|0|||
160643712|NCT03038113|580078842|FG006|Overall Study|Withdrawal by Subject|0|||
160643713|NCT03038113|580078843|FG007|Overall Study|Withdrawal by Subject|0|||
160643714|NCT03038113|580078844|FG008|Overall Study|Withdrawal by Subject|0|||
160643715|NCT03038113|580078845|FG009|Overall Study|Withdrawal by Subject|0|||
160643716|NCT03038113|580078846|FG010|Overall Study|Withdrawal by Subject|0|||
160643717|NCT03038113|580078847|FG011|Overall Study|Withdrawal by Subject|0|||
160643718|NCT03038113|580078848|FG012|Overall Study|Withdrawal by Subject|0|||
160643719|NCT03038113|580078849|FG013|Overall Study|Withdrawal by Subject|1|||
160643720|NCT03038113|580078836|FG000|Overall Study|Lost to Follow-up|0|||
160643721|NCT03038113|580078837|FG001|Overall Study|Lost to Follow-up|0|||
160643722|NCT03038113|580078838|FG002|Overall Study|Lost to Follow-up|0|||
160798515|NCT00397540|580651114|FG000|Overall Study|short follow-up duration < 12 months|1|||
160798516|NCT00397540|580651115|FG001|Overall Study|short follow-up duration < 12 months|0|||
160895156|NCT01539642|581012837|FG001|Overall Study|Withdrawal by Subject|2|||
160895157|NCT03611010|581012838|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
160895158|NCT03611010|581012839|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
160895159|NCT03611010|581012840|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
160895160|NCT03611010|581012841|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
160895161|NCT00598702|581012842|FG000|Overall Study|Other|0|||
160895162|NCT00598702|581012843|FG001|Overall Study|Other|2|||
160895163|NCT00598702|581012844|FG002|Overall Study|Other|0|||
160895164|NCT00598702|581012845|FG003|Overall Study|Other|0|||
160895165|NCT00598702|581012846|FG004|Overall Study|Other|0|||
160895166|NCT00598702|581012847|FG005|Overall Study|Other|1|||
160549700|NCT03905863|579740099|FG001|Overall Study|Withdrawal by Subject|2|||
160549701|NCT03905863|579740098|FG000|Overall Study|Physician Decision|0|||
160549702|NCT03905863|579740099|FG001|Overall Study|Physician Decision|3|||
160643723|NCT03038113|580078839|FG003|Overall Study|Lost to Follow-up|0|||
160798517|NCT00776230|580651119|FG000|Overall Study|Lost to Follow-up|2|||
160895167|NCT00598702|581012848|FG006|Overall Study|Other|0|||
160549703|NCT03905863|579740098|FG000|Overall Study|Lost to Follow-up|1|||
160549704|NCT03905863|579740099|FG001|Overall Study|Lost to Follow-up|0|||
160549705|NCT03905863|579740098|FG000|Overall Study|Protocol Violation|0|||
160895168|NCT00598702|581012849|FG007|Overall Study|Other|0|||
160549706|NCT03905863|579740099|FG001|Overall Study|Protocol Violation|2|||
160549707|NCT03905863|579740098|FG000|Overall Study|Death|0|||
160643724|NCT03038113|580078840|FG004|Overall Study|Lost to Follow-up|0|||
160643725|NCT03038113|580078841|FG005|Overall Study|Lost to Follow-up|0|||
160643726|NCT03038113|580078842|FG006|Overall Study|Lost to Follow-up|1|||
160643727|NCT03038113|580078843|FG007|Overall Study|Lost to Follow-up|0|||
160798518|NCT00776230|580651120|FG001|Overall Study|Lost to Follow-up|1|||
160895169|NCT00598702|581012842|FG000|Overall Study|Early discharge from hospital|0|||
160895170|NCT00598702|581012843|FG001|Overall Study|Early discharge from hospital|0|||
160895171|NCT00598702|581012844|FG002|Overall Study|Early discharge from hospital|2|||
160895172|NCT00598702|581012845|FG003|Overall Study|Early discharge from hospital|5|||
160798519|NCT00776230|580651121|FG002|Overall Study|Lost to Follow-up|5|||
160798520|NCT00776230|580651119|FG000|Overall Study|Not vaccinated at Day 0|1|||
160798521|NCT00776230|580651120|FG001|Overall Study|Not vaccinated at Day 0|0|||
160798522|NCT00776230|580651121|FG002|Overall Study|Not vaccinated at Day 0|0|||
160798523|NCT00776230|580651119|FG000|Overall Study|Withdrawal by Subject|0|||
160798524|NCT00776230|580651120|FG001|Overall Study|Withdrawal by Subject|1|||
160798525|NCT00776230|580651121|FG002|Overall Study|Withdrawal by Subject|0|||
160798526|NCT00776230|580651119|FG000|Overall Study|Subject missed Visit 4|0|||
160798527|NCT00776230|580651120|FG001|Overall Study|Subject missed Visit 4|1|||
160798528|NCT00776230|580651121|FG002|Overall Study|Subject missed Visit 4|0|||
160798529|NCT01215851|580651122|FG000|Treatment Period|Adverse Event|1|||
160895173|NCT00598702|581012846|FG004|Overall Study|Early discharge from hospital|0|||
160895174|NCT00598702|581012847|FG005|Overall Study|Early discharge from hospital|10|||
160895175|NCT00598702|581012848|FG006|Overall Study|Early discharge from hospital|1|||
160895176|NCT00598702|581012849|FG007|Overall Study|Early discharge from hospital|0|||
160895177|NCT00598702|581012842|FG000|Overall Study|Adverse Event|0|||
160895178|NCT00598702|581012843|FG001|Overall Study|Adverse Event|0|||
160895179|NCT00598702|581012844|FG002|Overall Study|Adverse Event|0|||
160895180|NCT00598702|581012845|FG003|Overall Study|Adverse Event|1|||
160895181|NCT00598702|581012846|FG004|Overall Study|Adverse Event|0|||
160895182|NCT00598702|581012847|FG005|Overall Study|Adverse Event|0|||
160549708|NCT03905863|579740099|FG001|Overall Study|Death|1|||
160549709|NCT02944448|579740100|FG000|Overall Study|Adverse Event|37|||
160549710|NCT02944448|579740101|FG001|Overall Study|Adverse Event|6|||
160549711|NCT02944448|579740100|FG000|Overall Study|Lack of Efficacy|8|||
160549712|NCT02944448|579740101|FG001|Overall Study|Lack of Efficacy|5|||
160549713|NCT02944448|579740100|FG000|Overall Study|Lost to Follow-up|3|||
160549714|NCT02944448|579740101|FG001|Overall Study|Lost to Follow-up|1|||
160549715|NCT02944448|579740100|FG000|Overall Study|Protocol Violation|25|||
160549716|NCT02944448|579740101|FG001|Overall Study|Protocol Violation|7|||
160549717|NCT02944448|579740100|FG000|Overall Study|Withdrawal by Subject|14|||
160549718|NCT02944448|579740101|FG001|Overall Study|Withdrawal by Subject|4|||
160549719|NCT02944448|579740100|FG000|Overall Study|Sponsor did not supply drug in time|0|||
160549720|NCT02944448|579740101|FG001|Overall Study|Sponsor did not supply drug in time|1|||
160895183|NCT00598702|581012848|FG006|Overall Study|Adverse Event|0|||
160895184|NCT00598702|581012849|FG007|Overall Study|Adverse Event|0|||
160895185|NCT00598702|581012842|FG000|Overall Study|Withdrawal by Subject|0|||
160895186|NCT00598702|581012843|FG001|Overall Study|Withdrawal by Subject|0|||
160895187|NCT00598702|581012844|FG002|Overall Study|Withdrawal by Subject|0|||
160895188|NCT00598702|581012845|FG003|Overall Study|Withdrawal by Subject|1|||
160895189|NCT00598702|581012846|FG004|Overall Study|Withdrawal by Subject|1|||
160895190|NCT00598702|581012847|FG005|Overall Study|Withdrawal by Subject|0|||
160895191|NCT00598702|581012848|FG006|Overall Study|Withdrawal by Subject|0|||
160895192|NCT00598702|581012849|FG007|Overall Study|Withdrawal by Subject|0|||
160895193|NCT00598702|581012842|FG000|Overall Study|Physician Decision|0|||
160895194|NCT00598702|581012843|FG001|Overall Study|Physician Decision|0|||
160895195|NCT00598702|581012844|FG002|Overall Study|Physician Decision|0|||
160895196|NCT00598702|581012845|FG003|Overall Study|Physician Decision|0|||
160895197|NCT00598702|581012846|FG004|Overall Study|Physician Decision|1|||
160549721|NCT02944448|579740100|FG000|Overall Study|Noncompliant with dosing|1|||
160549722|NCT02944448|579740101|FG001|Overall Study|Noncompliant with dosing|0|||
160549723|NCT02944448|579740100|FG000|Overall Study|Abnormal laboratory values|1|||
160549724|NCT02944448|579740101|FG001|Overall Study|Abnormal laboratory values|0|||
160549725|NCT01449708|579740111|FG000|Overall Study|Protocol Violation|0|||
160549726|NCT01449708|579740112|FG001|Overall Study|Protocol Violation|1|||
160549727|NCT01449708|579740111|FG000|Overall Study|surgical complication|1|||
160549728|NCT01449708|579740112|FG001|Overall Study|surgical complication|2|||
160549729|NCT01449708|579740111|FG000|Overall Study|respiratory failure|1|||
160643728|NCT03038113|580078844|FG008|Overall Study|Lost to Follow-up|0|||
160895198|NCT00598702|581012847|FG005|Overall Study|Physician Decision|0|||
160895199|NCT00598702|581012848|FG006|Overall Study|Physician Decision|0|||
160895200|NCT00598702|581012849|FG007|Overall Study|Physician Decision|0|||
160895201|NCT00598702|581012842|FG000|Overall Study|Dose limiting toxicity|0|||
160895202|NCT00598702|581012843|FG001|Overall Study|Dose limiting toxicity|0|||
160895203|NCT00598702|581012844|FG002|Overall Study|Dose limiting toxicity|0|||
160895204|NCT00598702|581012845|FG003|Overall Study|Dose limiting toxicity|1|||
160895205|NCT00598702|581012846|FG004|Overall Study|Dose limiting toxicity|1|||
160895206|NCT00598702|581012847|FG005|Overall Study|Dose limiting toxicity|1|||
160895207|NCT00598702|581012848|FG006|Overall Study|Dose limiting toxicity|0|||
160895208|NCT00598702|581012849|FG007|Overall Study|Dose limiting toxicity|0|||
160549730|NCT01449708|579740112|FG001|Overall Study|respiratory failure|0|||
160549731|NCT02397473|579740117|FG000|Treatment Phase|Adverse Event|1|||
160798530|NCT01215851|580651123|FG001|Treatment Period|Adverse Event|1|||
160895209|NCT02413372|581012853|FG000|Treatment|Lost to Follow-up|0|||
160549732|NCT02397473|579740118|FG001|Treatment Phase|Adverse Event|2|||
160549733|NCT02397473|579740117|FG000|Treatment Phase|Lack of Efficacy|8|||
160798531|NCT01215851|580651124|FG002|Treatment Period|Adverse Event|1|||
160895210|NCT02413372|581012854|FG001|Treatment|Lost to Follow-up|2|||
160643729|NCT03038113|580078845|FG009|Overall Study|Lost to Follow-up|0|||
160643730|NCT03038113|580078846|FG010|Overall Study|Lost to Follow-up|0|||
160643731|NCT03038113|580078847|FG011|Overall Study|Lost to Follow-up|0|||
160643732|NCT03038113|580078848|FG012|Overall Study|Lost to Follow-up|0|||
160643733|NCT03038113|580078849|FG013|Overall Study|Lost to Follow-up|0|||
160643734|NCT02784106|580078850|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
160643735|NCT02784106|580078851|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
160643736|NCT02784106|580078852|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
160643737|NCT02784106|580078853|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
160643738|NCT02784106|580078850|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
160643739|NCT02784106|580078851|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
160643740|NCT02784106|580078852|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160643741|NCT02784106|580078853|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160643742|NCT02784106|580078850|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
160643743|NCT02784106|580078851|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
160643744|NCT02784106|580078852|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
160643745|NCT02784106|580078853|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
160643746|NCT02784106|580078850|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
160643747|NCT02784106|580078851|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
160643748|NCT02784106|580078852|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
160643749|NCT02784106|580078853|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
160643750|NCT02784106|580078850|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
160643751|NCT02784106|580078851|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
160643752|NCT02784106|580078852|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
160643753|NCT02784106|580078853|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
160643754|NCT02784106|580078850|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
160643755|NCT02784106|580078851|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
160643756|NCT02784106|580078852|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
160643757|NCT02784106|580078853|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
160643758|NCT02927847|580078854|FG000|Overall Study|Lost to Follow-up|1|||
160643759|NCT02927847|580078855|FG001|Overall Study|Lost to Follow-up|0|||
160643760|NCT02927847|580078854|FG000|Overall Study|Withdrawal by Subject|4|||
160643761|NCT02927847|580078855|FG001|Overall Study|Withdrawal by Subject|2|||
160643762|NCT02927847|580078854|FG000|Overall Study|PI withdrawn due to missed visits|1|||
160643763|NCT02927847|580078855|FG001|Overall Study|PI withdrawn due to missed visits|1|||
160643764|NCT00553540|580078856|FG000|Overall Study|discharged after first visit|2|||
160643765|NCT00553540|580078857|FG001|Overall Study|discharged after first visit|5|||
160643766|NCT01755858|580078860|FG000|Overall Study|Adverse Event|1|||
160983765|NCT04445155|581328745|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
160983766|NCT04445155|581328746|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
160549734|NCT02397473|579740118|FG001|Treatment Phase|Lack of Efficacy|1|||
160549735|NCT02397473|579740117|FG000|Treatment Phase|Lost to Follow-up|1|||
160549736|NCT02397473|579740118|FG001|Treatment Phase|Lost to Follow-up|0|||
160549737|NCT02397473|579740117|FG000|Treatment Phase|Withdrawal by Subject|2|||
160549738|NCT02397473|579740118|FG001|Treatment Phase|Withdrawal by Subject|1|||
160549739|NCT02397473|579740117|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
160549740|NCT02397473|579740118|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
160549741|NCT02397473|579740117|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
160549742|NCT02397473|579740118|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
160549743|NCT02397473|579740117|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
160549744|NCT02397473|579740118|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
160549745|NCT02397473|579740117|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
160549746|NCT02397473|579740118|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
160549747|NCT02397473|579740117|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
160549748|NCT02397473|579740118|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
160549749|NCT01790048|579740119|FG000|Overall Study|Incorrect Age|9|||
160549750|NCT01790048|579740120|FG001|Overall Study|Incorrect Age|14|||
160549751|NCT01790048|579740119|FG000|Overall Study|data entry error|0|||
160549752|NCT01790048|579740120|FG001|Overall Study|data entry error|1|||
160549753|NCT01790048|579740119|FG000|Overall Study|Other|0|||
160643767|NCT01755858|580078861|FG001|Overall Study|Adverse Event|1|||
160643768|NCT03882047|580078862|FG000|Overall Study|Adverse Event|0|||
160643769|NCT03882047|580078863|FG001|Overall Study|Adverse Event|2|||
160643770|NCT03882047|580078864|FG002|Overall Study|Adverse Event|2|||
160643771|NCT03882047|580078862|FG000|Overall Study|Treatment Failure|3|||
160643772|NCT03882047|580078863|FG001|Overall Study|Treatment Failure|3|||
160643773|NCT03882047|580078864|FG002|Overall Study|Treatment Failure|12|||
160643774|NCT03882047|580078862|FG000|Overall Study|Lost to Follow-up|0|||
160549754|NCT01790048|579740120|FG001|Overall Study|Other|2|||
160549755|NCT01790048|579740119|FG000|Overall Study|SAM at Enrollment|2|||
160549756|NCT01790048|579740120|FG001|Overall Study|SAM at Enrollment|0|||
160549757|NCT01790048|579740119|FG000|Overall Study|Measurement error|1|||
160549758|NCT01790048|579740120|FG001|Overall Study|Measurement error|0|||
160549759|NCT01491178|579740121|FG000|Overall Study|Adverse Event|1016|||
160549760|NCT01491178|579740121|FG000|Overall Study|Improvement of NVAF|210|||
160549761|NCT01491178|579740121|FG000|Overall Study|To conduct invasive treatment|59|||
160549762|NCT01491178|579740121|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
160549763|NCT01491178|579740121|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
160549764|NCT01491178|579740121|FG000|Overall Study|To take a contraindication|20|||
160643775|NCT03882047|580078863|FG001|Overall Study|Lost to Follow-up|1|||
160643776|NCT03882047|580078864|FG002|Overall Study|Lost to Follow-up|0|||
160798532|NCT01215851|580651125|FG003|Treatment Period|Adverse Event|3|||
160798533|NCT01215851|580651126|FG004|Treatment Period|Adverse Event|0|||
160798534|NCT01215851|580651127|FG005|Treatment Period|Adverse Event|1|||
160798535|NCT01215851|580651122|FG000|Follow up Period|Lost to Follow-up|0|||
160798536|NCT01215851|580651123|FG001|Follow up Period|Lost to Follow-up|0|||
160798537|NCT01215851|580651124|FG002|Follow up Period|Lost to Follow-up|0|||
160798538|NCT01215851|580651125|FG003|Follow up Period|Lost to Follow-up|0|||
160798539|NCT01215851|580651126|FG004|Follow up Period|Lost to Follow-up|0|||
160798540|NCT01215851|580651127|FG005|Follow up Period|Lost to Follow-up|1|||
160798541|NCT02297412|580651128|FG000|Overall Study|Canceled|1|||
160798542|NCT02297412|580651129|FG001|Overall Study|Canceled|1|||
160798543|NCT03012880|580651130|FG000|Overall Study|Withdrawal by Subject|1|||
160798544|NCT03012880|580651131|FG001|Overall Study|Withdrawal by Subject|0|||
160798545|NCT03012880|580651130|FG000|Overall Study|Ineligible|1|||
160798546|NCT03012880|580651131|FG001|Overall Study|Ineligible|0|||
160798547|NCT00529633|580653018|FG000|Overall Study|Withdrawal by Subject|1|||
160798548|NCT00529633|580653019|FG001|Overall Study|Withdrawal by Subject|1|||
160798549|NCT01359956|580653020|FG000|Overall Study|Death|58|||
160798550|NCT01359956|580653021|FG001|Overall Study|Death|60|||
160798551|NCT01359956|580653022|FG002|Overall Study|Death|66|||
160798552|NCT01359956|580653023|FG003|Overall Study|Death|57|||
160798553|NCT01359956|580653020|FG000|Overall Study|Lost to Follow-up|3|||
160798554|NCT01359956|580653021|FG001|Overall Study|Lost to Follow-up|4|||
160798555|NCT01359956|580653022|FG002|Overall Study|Lost to Follow-up|1|||
160798556|NCT01359956|580653023|FG003|Overall Study|Lost to Follow-up|1|||
160798557|NCT01784029|580653024|FG000|Overall Study|Lost to Follow-up|19|||
160798558|NCT01784029|580653025|FG001|Overall Study|Lost to Follow-up|20|||
160798559|NCT01784029|580653026|FG002|Overall Study|Lost to Follow-up|22|||
160798560|NCT03235050|580653029|FG000|Overall Study|Adverse Event|0|||
160798561|NCT03235050|580653030|FG001|Overall Study|Adverse Event|0|||
160798562|NCT03235050|580653031|FG002|Overall Study|Adverse Event|1|||
160798563|NCT03235050|580653032|FG003|Overall Study|Adverse Event|4|||
160798564|NCT03235050|580653033|FG004|Overall Study|Adverse Event|1|||
160798565|NCT03235050|580653029|FG000|Overall Study|Death|0|||
160798566|NCT03235050|580653030|FG001|Overall Study|Death|0|||
160798567|NCT03235050|580653031|FG002|Overall Study|Death|0|||
160798568|NCT03235050|580653032|FG003|Overall Study|Death|2|||
160798569|NCT03235050|580653033|FG004|Overall Study|Death|1|||
160798570|NCT03235050|580653029|FG000|Overall Study|Lost to Follow-up|1|||
160798571|NCT03235050|580653030|FG001|Overall Study|Lost to Follow-up|2|||
160798572|NCT03235050|580653031|FG002|Overall Study|Lost to Follow-up|1|||
160798573|NCT03235050|580653032|FG003|Overall Study|Lost to Follow-up|2|||
160798574|NCT03235050|580653033|FG004|Overall Study|Lost to Follow-up|0|||
160798575|NCT03235050|580653029|FG000|Overall Study|Withdrawal by Subject|3|||
160798576|NCT03235050|580653030|FG001|Overall Study|Withdrawal by Subject|2|||
160798577|NCT03235050|580653031|FG002|Overall Study|Withdrawal by Subject|2|||
160798578|NCT03235050|580653032|FG003|Overall Study|Withdrawal by Subject|5|||
160798579|NCT03235050|580653033|FG004|Overall Study|Withdrawal by Subject|7|||
160798580|NCT03235050|580653029|FG000|Overall Study|Other reasons|0|||
160798581|NCT03235050|580653030|FG001|Overall Study|Other reasons|1|||
160798582|NCT03235050|580653031|FG002|Overall Study|Other reasons|0|||
160798583|NCT03235050|580653032|FG003|Overall Study|Other reasons|1|||
160798584|NCT03235050|580653033|FG004|Overall Study|Other reasons|2|||
160798585|NCT00069641|580653034|FG000|Overall Study|Death|1|||
160798586|NCT00069641|580653035|FG001|Overall Study|Death|0|||
160798587|NCT00069641|580653036|FG002|Overall Study|Death|1|||
160798588|NCT02704208|580653037|FG000|Overall Study|Lost to Follow-up|42|||
160798589|NCT02704208|580653038|FG001|Overall Study|Lost to Follow-up|37|||
160798590|NCT03545672|580653039|FG000|Overall Study|Uncertain diagnosis|2|||
160798591|NCT03545672|580653040|FG001|Overall Study|Uncertain diagnosis|1|||
160798592|NCT03545672|580653039|FG000|Overall Study|Protocol Violation|2|||
160798593|NCT03545672|580653040|FG001|Overall Study|Protocol Violation|2|||
160798594|NCT02415556|580653041|FG000|Overall Study|Adverse Event|3|||
160549765|NCT01491178|579740121|FG000|Overall Study|Other than specified above|657|||
160549766|NCT05689047|579740124|FG000|Overall Study|Lost to Follow-up|0|||
160798595|NCT02415556|580653042|FG001|Overall Study|Adverse Event|4|||
160798596|NCT02415556|580653043|FG002|Overall Study|Adverse Event|2|||
160798597|NCT02415556|580653044|FG003|Overall Study|Adverse Event|4|||
160798598|NCT02415556|580653041|FG000|Overall Study|Lost to Follow-up|4|||
160798599|NCT02415556|580653042|FG001|Overall Study|Lost to Follow-up|5|||
160643777|NCT03882047|580078862|FG000|Overall Study|Did Not Wish to Continue|1|||
160643778|NCT03882047|580078863|FG001|Overall Study|Did Not Wish to Continue|4|||
160643779|NCT03882047|580078864|FG002|Overall Study|Did Not Wish to Continue|1|||
160643780|NCT03882047|580078862|FG000|Overall Study|Noncompliance With Protocol|2|||
160643781|NCT03882047|580078863|FG001|Overall Study|Noncompliance With Protocol|0|||
160643782|NCT03882047|580078864|FG002|Overall Study|Noncompliance With Protocol|0|||
160643783|NCT03882047|580078862|FG000|Overall Study|Did Not Meet Eligibility|0|||
160643784|NCT03882047|580078863|FG001|Overall Study|Did Not Meet Eligibility|0|||
160643785|NCT03882047|580078864|FG002|Overall Study|Did Not Meet Eligibility|1|||
160643786|NCT00475852|580078868|FG000|Overall Study|Death|444|||
160798600|NCT02415556|580653043|FG002|Overall Study|Lost to Follow-up|4|||
160643787|NCT00475852|580078869|FG001|Overall Study|Death|456|||
160798601|NCT02415556|580653044|FG003|Overall Study|Lost to Follow-up|1|||
160798602|NCT02415556|580653041|FG000|Overall Study|Withdrawal by Subject|13|||
160798603|NCT02415556|580653042|FG001|Overall Study|Withdrawal by Subject|4|||
160798604|NCT02415556|580653043|FG002|Overall Study|Withdrawal by Subject|14|||
160798605|NCT02415556|580653044|FG003|Overall Study|Withdrawal by Subject|12|||
160798606|NCT02415556|580653041|FG000|Overall Study|Physician Decision|1|||
160798607|NCT02415556|580653042|FG001|Overall Study|Physician Decision|3|||
160798608|NCT02415556|580653043|FG002|Overall Study|Physician Decision|1|||
160798609|NCT02415556|580653044|FG003|Overall Study|Physician Decision|2|||
160798610|NCT02415556|580653041|FG000|Overall Study|Censored - study completion|4|||
160798611|NCT02415556|580653042|FG001|Overall Study|Censored - study completion|5|||
160798612|NCT02415556|580653043|FG002|Overall Study|Censored - study completion|1|||
160798613|NCT02415556|580653044|FG003|Overall Study|Censored - study completion|0|||
160798614|NCT02415556|580653041|FG000|Overall Study|Family-related issues|0|||
160798615|NCT02415556|580653042|FG001|Overall Study|Family-related issues|0|||
160798616|NCT02415556|580653043|FG002|Overall Study|Family-related issues|0|||
160798617|NCT02415556|580653044|FG003|Overall Study|Family-related issues|1|||
160798618|NCT01209767|580653045|FG000|Overall Study|Withdrawal by Subject|1|||
160798619|NCT01209767|580653045|FG000|Overall Study|Lost to Follow-up|3|||
160798620|NCT01621178|580653046|FG000|Overall Study|Adverse Event|5|||
160798621|NCT01621178|580653047|FG001|Overall Study|Adverse Event|2|||
160798622|NCT01621178|580653048|FG002|Overall Study|Adverse Event|8|||
160798623|NCT01621178|580653046|FG000|Overall Study|Death|6|||
160798624|NCT01621178|580653047|FG001|Overall Study|Death|7|||
160798625|NCT01621178|580653048|FG002|Overall Study|Death|2|||
160798626|NCT01621178|580653046|FG000|Overall Study|Lost to Follow-up|1|||
160798627|NCT01621178|580653047|FG001|Overall Study|Lost to Follow-up|2|||
160798628|NCT01621178|580653048|FG002|Overall Study|Lost to Follow-up|1|||
160798629|NCT01621178|580653046|FG000|Overall Study|Withdrawal by Subject|14|||
160798630|NCT01621178|580653047|FG001|Overall Study|Withdrawal by Subject|17|||
160798631|NCT01621178|580653048|FG002|Overall Study|Withdrawal by Subject|18|||
160798632|NCT01621178|580653046|FG000|Overall Study|Physician Decision|5|||
160798633|NCT01621178|580653047|FG001|Overall Study|Physician Decision|2|||
160798634|NCT01621178|580653048|FG002|Overall Study|Physician Decision|7|||
160798635|NCT02935192|580653049|FG000|Overall Study|Withdrawal by Subject|8|||
160798636|NCT02935192|580653050|FG001|Overall Study|Withdrawal by Subject|4|||
160798637|NCT00492557|580653052|FG000|Overall Study|Subject request|12|||
160798638|NCT00492557|580653053|FG001|Overall Study|Subject request|11|||
160798639|NCT00492557|580653052|FG000|Overall Study|Protocol Violation|7|||
160798640|NCT00492557|580653053|FG001|Overall Study|Protocol Violation|8|||
160798641|NCT00492557|580653052|FG000|Overall Study|Other|2|||
160798642|NCT00492557|580653053|FG001|Overall Study|Other|2|||
160798643|NCT00492557|580653052|FG000|Overall Study|Death|1|||
160798644|NCT00492557|580653053|FG001|Overall Study|Death|1|||
160798645|NCT00492557|580653052|FG000|Overall Study|Adverse Event|1|||
160798646|NCT00492557|580653053|FG001|Overall Study|Adverse Event|0|||
160798647|NCT00492557|580653052|FG000|Overall Study|Failed to return|1|||
160798648|NCT00492557|580653053|FG001|Overall Study|Failed to return|0|||
160798649|NCT00492557|580653052|FG000|Overall Study|Lost to Follow-up|0|||
160798650|NCT00492557|580653053|FG001|Overall Study|Lost to Follow-up|1|||
160798651|NCT04778592|580653057|FG000|Overall Study|Adverse Event|1|||
160798652|NCT04778592|580653058|FG001|Overall Study|Adverse Event|2|||
160798653|NCT04778592|580653057|FG000|Overall Study|Withdrawal by Subject|1|||
160798654|NCT04778592|580653058|FG001|Overall Study|Withdrawal by Subject|2|||
160798655|NCT01354223|580653060|FG000|Overall Study|Withdrawal by Subject|3|||
160798656|NCT01354223|580653061|FG001|Overall Study|Withdrawal by Subject|1|||
160798657|NCT04102007|580653065|FG000|Overall Study|Adverse Event|4|||
160798658|NCT04102007|580653065|FG000|Overall Study|Lost to Follow-up|3|||
160798659|NCT04102007|580653065|FG000|Overall Study|Withdrawal by Subject|12|||
160798660|NCT04102007|580653065|FG000|Overall Study|Eligibility Violation|5|||
160798661|NCT04102007|580653065|FG000|Overall Study|Lack of Efficacy|6|||
160643788|NCT00475852|580078868|FG000|Overall Study|Withdrawal by Subject|19|||
160643789|NCT00475852|580078869|FG001|Overall Study|Withdrawal by Subject|24|||
160643790|NCT00475852|580078868|FG000|Overall Study|Lost to Follow-up|54|||
160798662|NCT04102007|580653065|FG000|Overall Study|Protocol Deviation|5|||
160798663|NCT04102007|580653065|FG000|Overall Study|Protocol Compliance|1|||
160798664|NCT04102007|580653065|FG000|Overall Study|Withdrew Treatment|2|||
160549767|NCT05689047|579740125|FG001|Overall Study|Lost to Follow-up|1|||
160549768|NCT05689047|579740124|FG000|Overall Study|Protocol Deviation|1|||
160549769|NCT05689047|579740125|FG001|Overall Study|Protocol Deviation|0|||
160549770|NCT01604512|579740126|FG000|Overall Study|Withdrawal by Subject|3|||
160549771|NCT01604512|579740126|FG000|Overall Study|Not treated|4|||
160549772|NCT03132636|579740127|FG000|Overall Study|Adverse Event|1|||
160549773|NCT03132636|579740128|FG001|Overall Study|Adverse Event|2|||
160549774|NCT03132636|579740127|FG000|Overall Study|Death|4|||
160549775|NCT03132636|579740128|FG001|Overall Study|Death|7|||
160549776|NCT03132636|579740127|FG000|Overall Study|Lost to Follow-up|3|||
160549777|NCT03132636|579740128|FG001|Overall Study|Lost to Follow-up|2|||
160549778|NCT03132636|579740127|FG000|Overall Study|Non compliance with protocol by participant|1|||
160549779|NCT03132636|579740128|FG001|Overall Study|Non compliance with protocol by participant|1|||
160549780|NCT03132636|579740127|FG000|Overall Study|Subject decision|1|||
160549781|NCT03132636|579740128|FG001|Overall Study|Subject decision|9|||
160549782|NCT03132636|579740127|FG000|Overall Study|Sponsor decision|0|||
160549783|NCT03132636|579740128|FG001|Overall Study|Sponsor decision|1|||
160549784|NCT03132636|579740127|FG000|Overall Study|Physician Decision|1|||
160549785|NCT03132636|579740128|FG001|Overall Study|Physician Decision|0|||
160549786|NCT03132636|579740127|FG000|Overall Study|Progressive disease|33|||
160549787|NCT03132636|579740128|FG001|Overall Study|Progressive disease|36|||
160549788|NCT03132636|579740127|FG000|Overall Study|Withdrawal of consent|2|||
160549789|NCT03132636|579740128|FG001|Overall Study|Withdrawal of consent|5|||
160549790|NCT03132636|579740127|FG000|Overall Study|Did not re-consent|1|||
160549791|NCT03132636|579740128|FG001|Overall Study|Did not re-consent|0|||
160549792|NCT03132636|579740127|FG000|Overall Study|Lost insurance coverage|1|||
160549793|NCT03132636|579740128|FG001|Overall Study|Lost insurance coverage|0|||
160549794|NCT03132636|579740127|FG000|Overall Study|Related to radiological outcomes|0|||
160549795|NCT03132636|579740128|FG001|Overall Study|Related to radiological outcomes|1|||
160549796|NCT03132636|579740127|FG000|Overall Study|Unable to come to site for continued visits|0|||
160549797|NCT03132636|579740128|FG001|Overall Study|Unable to come to site for continued visits|1|||
160549798|NCT01415752|579740129|FG000|Induction (Step 1)|Ineligible|4|||
160549799|NCT01415752|579740130|FG001|Induction (Step 1)|Ineligible|3|||
160549800|NCT01415752|579740131|FG002|Induction (Step 1)|Ineligible|4|||
160549801|NCT01415752|579740132|FG003|Induction (Step 1)|Ineligible|4|||
160549802|NCT01415752|579740129|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
160549803|NCT01415752|579740130|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
160549804|NCT01415752|579740131|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
160549805|NCT01415752|579740132|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
160549806|NCT01415752|579740129|FG000|Maintenance (Step 2)|Adverse Event|3|||
160549807|NCT01415752|579740130|FG001|Maintenance (Step 2)|Adverse Event|4|||
160549808|NCT01415752|579740131|FG002|Maintenance (Step 2)|Adverse Event|9|||
160549809|NCT01415752|579740132|FG003|Maintenance (Step 2)|Adverse Event|6|||
160549810|NCT01415752|579740129|FG000|Maintenance (Step 2)|Death|1|||
160549811|NCT01415752|579740130|FG001|Maintenance (Step 2)|Death|1|||
160549812|NCT01415752|579740131|FG002|Maintenance (Step 2)|Death|2|||
160549813|NCT01415752|579740132|FG003|Maintenance (Step 2)|Death|0|||
160798665|NCT04102007|580653065|FG000|Overall Study|Pregnancy|1|||
160549814|NCT01415752|579740129|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
160549815|NCT01415752|579740130|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
160549816|NCT01415752|579740131|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
160549817|NCT01415752|579740132|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
160549818|NCT01415752|579740129|FG000|Maintenance (Step 2)|Alternative therapy|0|||
160549819|NCT01415752|579740130|FG001|Maintenance (Step 2)|Alternative therapy|1|||
160549820|NCT01415752|579740131|FG002|Maintenance (Step 2)|Alternative therapy|0|||
160549821|NCT01415752|579740132|FG003|Maintenance (Step 2)|Alternative therapy|0|||
160549822|NCT01415752|579740129|FG000|Maintenance (Step 2)|Other reasons|3|||
160549823|NCT01415752|579740130|FG001|Maintenance (Step 2)|Other reasons|6|||
160549824|NCT01415752|579740131|FG002|Maintenance (Step 2)|Other reasons|4|||
160549825|NCT01415752|579740132|FG003|Maintenance (Step 2)|Other reasons|6|||
160549826|NCT01415752|579740129|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
160798666|NCT05173974|580653066|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
160798667|NCT05173974|580653067|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
160798668|NCT05173974|580653068|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
160549827|NCT01415752|579740130|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
160549828|NCT01415752|579740131|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
160549829|NCT01415752|579740132|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
160549830|NCT01415752|579740129|FG000|Maintenance (Step 2)|ineligible|1|||
160549831|NCT01415752|579740130|FG001|Maintenance (Step 2)|ineligible|1|||
160549832|NCT01415752|579740131|FG002|Maintenance (Step 2)|ineligible|1|||
160549833|NCT01415752|579740132|FG003|Maintenance (Step 2)|ineligible|0|||
160549834|NCT01415752|579740129|FG000|Maintenance (Step 2)|Missing|4|||
160549835|NCT01415752|579740130|FG001|Maintenance (Step 2)|Missing|1|||
160549836|NCT01415752|579740131|FG002|Maintenance (Step 2)|Missing|4|||
160549837|NCT01415752|579740132|FG003|Maintenance (Step 2)|Missing|3|||
160549838|NCT03083886|579740133|FG000|Overall Study|Withdrawal by Subject|51|||
160798669|NCT05173974|580653069|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
160798670|NCT05173974|580653066|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
160798671|NCT05173974|580653067|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
160798672|NCT05173974|580653068|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
160798673|NCT05173974|580653069|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
160798674|NCT04047446|580653070|FG000|Overall Study|Physician Decision|1|||
160798675|NCT04047446|580653071|FG001|Overall Study|Physician Decision|0|||
160798676|NCT00329420|580653072|FG000|Re-induction Phase|Lack of Efficacy|0|||
160798677|NCT00329420|580653073|FG001|Re-induction Phase|Lack of Efficacy|1|||
160798678|NCT00329420|580653074|FG002|Re-induction Phase|Lack of Efficacy|0|||
160798679|NCT00329420|580653072|FG000|Re-induction Phase|Withdrawal of Consent|0|||
160798680|NCT00329420|580653073|FG001|Re-induction Phase|Withdrawal of Consent|0|||
160798681|NCT00329420|580653074|FG002|Re-induction Phase|Withdrawal of Consent|1|||
160798682|NCT00329420|580653072|FG000|Re-induction Phase|Did not respond to re-induction|6|||
160798683|NCT00329420|580653073|FG001|Re-induction Phase|Did not respond to re-induction|5|||
160798684|NCT00329420|580653074|FG002|Re-induction Phase|Did not respond to re-induction|7|||
160798685|NCT00329420|580653072|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
160798686|NCT00329420|580653073|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
160798687|NCT00329420|580653074|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
160798688|NCT00329420|580653072|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
160798689|NCT00329420|580653073|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
160798690|NCT00329420|580653074|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
160798691|NCT00329420|580653072|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
160798692|NCT00329420|580653073|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
160798693|NCT00329420|580653074|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
160798694|NCT01446874|580653075|FG000|Overall Study|Not eligible|1|||
160798695|NCT01446874|580653076|FG001|Overall Study|Not eligible|0|||
160798696|NCT01446874|580653077|FG002|Overall Study|Not eligible|0|||
160798697|NCT01446874|580653075|FG000|Overall Study|No surgery/No qualifying surgery|1|||
160798698|NCT01446874|580653076|FG001|Overall Study|No surgery/No qualifying surgery|0|||
160798699|NCT01446874|580653077|FG002|Overall Study|No surgery/No qualifying surgery|12|||
160798700|NCT01446874|580653075|FG000|Overall Study|Non-compliance|0|||
160798701|NCT01446874|580653076|FG001|Overall Study|Non-compliance|4|||
160798702|NCT01446874|580653077|FG002|Overall Study|Non-compliance|0|||
160895211|NCT02413372|581012855|FG002|Treatment|Lost to Follow-up|1|||
160895212|NCT02413372|581012853|FG000|Treatment|Withdrawal by Subject|1|||
160895213|NCT02413372|581012854|FG001|Treatment|Withdrawal by Subject|0|||
160895214|NCT02413372|581012855|FG002|Treatment|Withdrawal by Subject|0|||
160895215|NCT02413372|581012853|FG000|Follow-up|Lost to Follow-up|1|||
160895216|NCT02413372|581012854|FG001|Follow-up|Lost to Follow-up|1|||
160571870|NCT00491530|579816847|FG001|Overall Study|Adverse Event|1|||
160798703|NCT01446874|580653075|FG000|Overall Study|Antibiotics for pre-op infection|0|||
160798704|NCT01446874|580653076|FG001|Overall Study|Antibiotics for pre-op infection|0|||
160798705|NCT01446874|580653077|FG002|Overall Study|Antibiotics for pre-op infection|2|||
160895217|NCT02413372|581012855|FG002|Follow-up|Lost to Follow-up|0|||
160895218|NCT02413372|581012853|FG000|Follow-up|Subject Withdrew Consent|1|||
160895219|NCT02413372|581012854|FG001|Follow-up|Subject Withdrew Consent|0|||
160895220|NCT02413372|581012855|FG002|Follow-up|Subject Withdrew Consent|1|||
160798706|NCT01446874|580653075|FG000|Overall Study|Withdrawal by Subject|0|||
160798707|NCT01446874|580653076|FG001|Overall Study|Withdrawal by Subject|0|||
160798708|NCT01446874|580653077|FG002|Overall Study|Withdrawal by Subject|4|||
160798709|NCT01977898|580653078|FG000|Overall Study|Non functioning catheter|1|||
160798710|NCT01977898|580653079|FG001|Overall Study|Non functioning catheter|1|||
160798711|NCT03386773|580653080|FG000|Overall Study|Lost to Follow-up|24|||
160798712|NCT03386773|580653081|FG001|Overall Study|Lost to Follow-up|33|||
160798713|NCT03386773|580653080|FG000|Overall Study|Withdrawal by Subject|3|||
160798714|NCT03386773|580653081|FG001|Overall Study|Withdrawal by Subject|2|||
160798715|NCT03983421|580653082|FG000|Overall Study|Lost to Follow-up|1|||
160798716|NCT03639610|580653083|FG000|Overall Study|Adverse Event|7|||
160798717|NCT03639610|580653084|FG001|Overall Study|Adverse Event|1|||
160798718|NCT03639610|580653085|FG002|Overall Study|Adverse Event|0|||
160798719|NCT03639610|580653083|FG000|Overall Study|Physician Decision|3|||
160798720|NCT03639610|580653084|FG001|Overall Study|Physician Decision|1|||
160798721|NCT03639610|580653085|FG002|Overall Study|Physician Decision|0|||
160798722|NCT03639610|580653083|FG000|Overall Study|Disease progression|8|||
160798723|NCT03639610|580653084|FG001|Overall Study|Disease progression|5|||
160798724|NCT03639610|580653085|FG002|Overall Study|Disease progression|3|||
160798725|NCT03639610|580653083|FG000|Overall Study|Study terminated by sponsor|2|||
160798726|NCT03639610|580653084|FG001|Overall Study|Study terminated by sponsor|1|||
160798727|NCT03639610|580653085|FG002|Overall Study|Study terminated by sponsor|1|||
160798728|NCT03639610|580653083|FG000|Overall Study|Patient request to stop treatment|1|||
160798729|NCT03639610|580653084|FG001|Overall Study|Patient request to stop treatment|2|||
160798730|NCT03639610|580653085|FG002|Overall Study|Patient request to stop treatment|0|||
160798731|NCT02660229|580653086|FG000|Overall Study|Adverse Event|2|||
160798732|NCT02660229|580653087|FG001|Overall Study|Adverse Event|0|||
160798733|NCT02660229|580653086|FG000|Overall Study|Withdrawal by Subject|0|||
160798734|NCT02660229|580653087|FG001|Overall Study|Withdrawal by Subject|1|||
160798735|NCT02727322|580653091|FG000|Overall Study|Withdrawal by Subject|1|||
160798736|NCT02727322|580653092|FG001|Overall Study|Withdrawal by Subject|1|||
160798737|NCT02727322|580653091|FG000|Overall Study|Protocol Violation|1|||
160798738|NCT02727322|580653092|FG001|Overall Study|Protocol Violation|0|||
160798739|NCT01049373|580653093|FG000|Overall Study|Protocol Violation|9|||
160798740|NCT01049373|580653094|FG001|Overall Study|Protocol Violation|9|||
160798741|NCT01049373|580653093|FG000|Overall Study|Withdrawal by Subject|8|||
160798742|NCT01049373|580653094|FG001|Overall Study|Withdrawal by Subject|5|||
160798743|NCT01049373|580653093|FG000|Overall Study|Adverse Event|3|||
160798744|NCT01049373|580653094|FG001|Overall Study|Adverse Event|3|||
160798745|NCT01049373|580653093|FG000|Overall Study|Lost to Follow-up|9|||
160798746|NCT01049373|580653094|FG001|Overall Study|Lost to Follow-up|4|||
160798747|NCT01049373|580653093|FG000|Overall Study|no evaluable study values|9|||
160798748|NCT01049373|580653094|FG001|Overall Study|no evaluable study values|21|||
160798749|NCT01049373|580653093|FG000|Overall Study|Other|1|||
160798750|NCT01049373|580653094|FG001|Overall Study|Other|1|||
160798751|NCT01049373|580653093|FG000|Overall Study|Non-cooperation|0|||
160798752|NCT01049373|580653094|FG001|Overall Study|Non-cooperation|1|||
160798753|NCT01517984|580653095|FG000|Overall Study|Lost to Follow-up|0|||
160798754|NCT01517984|580653096|FG001|Overall Study|Lost to Follow-up|1|||
160798755|NCT01517984|580653097|FG002|Overall Study|Lost to Follow-up|0|||
160798756|NCT01517984|580653098|FG003|Overall Study|Lost to Follow-up|0|||
160798757|NCT01517984|580653095|FG000|Overall Study|Withdrawal by Subject|1|||
160798758|NCT01517984|580653096|FG001|Overall Study|Withdrawal by Subject|8|||
160798759|NCT01517984|580653097|FG002|Overall Study|Withdrawal by Subject|4|||
160798760|NCT01517984|580653098|FG003|Overall Study|Withdrawal by Subject|1|||
160798761|NCT01517984|580653095|FG000|Overall Study|Screen Failure|4|||
160798762|NCT01517984|580653096|FG001|Overall Study|Screen Failure|0|||
160798763|NCT01517984|580653097|FG002|Overall Study|Screen Failure|0|||
160798764|NCT01517984|580653098|FG003|Overall Study|Screen Failure|0|||
160798765|NCT01517984|580653095|FG000|Overall Study|Ineligible for randomization|0|||
160798766|NCT01517984|580653096|FG001|Overall Study|Ineligible for randomization|14|||
160798767|NCT01517984|580653097|FG002|Overall Study|Ineligible for randomization|0|||
160798768|NCT01517984|580653098|FG003|Overall Study|Ineligible for randomization|0|||
160798769|NCT01198587|580653101|FG000|Overall Study|Lost to Follow-up|8|||
160798770|NCT01198587|580653102|FG001|Overall Study|Lost to Follow-up|0|||
160798771|NCT01198587|580653103|FG002|Overall Study|Lost to Follow-up|9|||
160798772|NCT01198587|580653104|FG003|Overall Study|Lost to Follow-up|0|||
160798773|NCT01496287|580653105|FG000|Overall Study|Lost to Follow-up|1|||
160798774|NCT01496287|580653105|FG000|Overall Study|Incomplete anesthesia|5|||
160798775|NCT01959529|580653106|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
160798776|NCT01959529|580653107|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
160798777|NCT01959529|580653106|FG000|Overall Study|Lost to Follow-up|4|||
160798778|NCT01959529|580653107|FG001|Overall Study|Lost to Follow-up|1|||
160798779|NCT01959529|580653106|FG000|Overall Study|Other|70|||
160571871|NCT00491530|579816848|FG002|Overall Study|Adverse Event|2|||
160798780|NCT01959529|580653107|FG001|Overall Study|Other|68|||
160798781|NCT01959529|580653106|FG000|Overall Study|Hypoglycaemia|1|||
160798782|NCT01959529|580653107|FG001|Overall Study|Hypoglycaemia|1|||
160798783|NCT01959529|580653106|FG000|Overall Study|Lack of glycaemic control|1|||
160798784|NCT01959529|580653107|FG001|Overall Study|Lack of glycaemic control|1|||
160798785|NCT00557193|580653108|FG000|Induction|Adverse Event|2|||
160798786|NCT00557193|580653109|FG001|Induction|Adverse Event|0|||
160798787|NCT00557193|580653110|FG002|Induction|Adverse Event|0|||
160798788|NCT00557193|580653111|FG003|Induction|Adverse Event|0|||
160798789|NCT00557193|580653112|FG004|Induction|Adverse Event|0|||
160798790|NCT00557193|580653113|FG005|Induction|Adverse Event|0|||
160798791|NCT00557193|580653108|FG000|Induction|Death|6|||
160798792|NCT00557193|580653109|FG001|Induction|Death|0|||
160798793|NCT00557193|580653110|FG002|Induction|Death|0|||
160798794|NCT00557193|580653111|FG003|Induction|Death|0|||
160798795|NCT00557193|580653112|FG004|Induction|Death|0|||
160798796|NCT00557193|580653113|FG005|Induction|Death|0|||
160798797|NCT00557193|580653108|FG000|Induction|Physician Decision|3|||
160798798|NCT00557193|580653109|FG001|Induction|Physician Decision|0|||
160798799|NCT00557193|580653110|FG002|Induction|Physician Decision|0|||
160798800|NCT00557193|580653111|FG003|Induction|Physician Decision|0|||
160798801|NCT00557193|580653112|FG004|Induction|Physician Decision|0|||
160798802|NCT00557193|580653113|FG005|Induction|Physician Decision|0|||
160798803|NCT00557193|580653108|FG000|Induction|Withdrawal by Subject|1|||
160798804|NCT00557193|580653109|FG001|Induction|Withdrawal by Subject|0|||
160798805|NCT00557193|580653110|FG002|Induction|Withdrawal by Subject|0|||
160798806|NCT00557193|580653111|FG003|Induction|Withdrawal by Subject|0|||
160798807|NCT00557193|580653112|FG004|Induction|Withdrawal by Subject|0|||
160798808|NCT00557193|580653113|FG005|Induction|Withdrawal by Subject|0|||
160798809|NCT00557193|580653108|FG000|Induction|Refusal of Further Protocol Therapy|2|||
160798810|NCT00557193|580653109|FG001|Induction|Refusal of Further Protocol Therapy|0|||
160798811|NCT00557193|580653110|FG002|Induction|Refusal of Further Protocol Therapy|0|||
160798812|NCT00557193|580653111|FG003|Induction|Refusal of Further Protocol Therapy|0|||
160895221|NCT02413372|581012853|FG000|Follow-up|Subject unable to return for visit|0|||
160895222|NCT02413372|581012854|FG001|Follow-up|Subject unable to return for visit|0|||
160895223|NCT02413372|581012855|FG002|Follow-up|Subject unable to return for visit|1|||
160895224|NCT00369122|581012857|FG000|Overall Study|Ineligible|10|||
160895225|NCT00369122|581012857|FG000|Overall Study|No protocol treatment|1|||
160895226|NCT03633617|581012859|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
160895227|NCT03633617|581012860|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
160895228|NCT03633617|581012861|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895229|NCT03633617|581012862|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895230|NCT03633617|581012863|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895231|NCT03633617|581012864|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895232|NCT03633617|581012865|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895233|NCT03633617|581012866|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895234|NCT03633617|581012867|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895235|NCT03633617|581012868|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895236|NCT03633617|581012869|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895237|NCT03633617|581012859|FG000|Part A|Unconfirmed early termination visit|1|||
160895238|NCT03633617|581012860|FG001|Part A|Unconfirmed early termination visit|0|||
160895239|NCT03633617|581012861|FG002|Part A|Unconfirmed early termination visit|0|||
160895240|NCT03633617|581012862|FG003|Part A|Unconfirmed early termination visit|0|||
160895241|NCT03633617|581012863|FG004|Part A|Unconfirmed early termination visit|0|||
160895242|NCT03633617|581012864|FG005|Part A|Unconfirmed early termination visit|0|||
160895243|NCT03633617|581012865|FG006|Part A|Unconfirmed early termination visit|0|||
160895244|NCT03633617|581012866|FG007|Part A|Unconfirmed early termination visit|0|||
160895245|NCT03633617|581012867|FG008|Part A|Unconfirmed early termination visit|0|||
160895246|NCT03633617|581012868|FG009|Part A|Unconfirmed early termination visit|0|||
160895247|NCT03633617|581012869|FG010|Part A|Unconfirmed early termination visit|0|||
160895248|NCT03633617|581012859|FG000|Part A|Adverse Event|0|||
160549839|NCT03083886|579740134|FG001|Overall Study|Withdrawal by Subject|73|||
160549840|NCT03083886|579740135|FG002|Overall Study|Withdrawal by Subject|104|||
160549841|NCT03083886|579740133|FG000|Overall Study|Missing Baseline data|43|||
160798813|NCT00557193|580653112|FG004|Induction|Refusal of Further Protocol Therapy|0|||
160798814|NCT00557193|580653113|FG005|Induction|Refusal of Further Protocol Therapy|0|||
160798815|NCT00557193|580653108|FG000|Induction|Ineligible|8|||
160798816|NCT00557193|580653109|FG001|Induction|Ineligible|0|||
160798817|NCT00557193|580653110|FG002|Induction|Ineligible|0|||
160798818|NCT00557193|580653111|FG003|Induction|Ineligible|0|||
160798819|NCT00557193|580653112|FG004|Induction|Ineligible|0|||
160798820|NCT00557193|580653113|FG005|Induction|Ineligible|0|||
160798821|NCT00557193|580653108|FG000|Induction|Inevaluable for post Induction|2|||
160549842|NCT03083886|579740134|FG001|Overall Study|Missing Baseline data|42|||
160798822|NCT00557193|580653109|FG001|Induction|Inevaluable for post Induction|0|||
160798823|NCT00557193|580653110|FG002|Induction|Inevaluable for post Induction|0|||
160798824|NCT00557193|580653111|FG003|Induction|Inevaluable for post Induction|0|||
160798825|NCT00557193|580653112|FG004|Induction|Inevaluable for post Induction|0|||
160798826|NCT00557193|580653113|FG005|Induction|Inevaluable for post Induction|0|||
160798827|NCT00557193|580653108|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
160798828|NCT00557193|580653109|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
160798829|NCT00557193|580653110|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
160798830|NCT00557193|580653111|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
160798831|NCT00557193|580653112|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
160798832|NCT00557193|580653113|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
160798833|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
160798834|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
160798835|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
160798836|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
160549843|NCT03083886|579740135|FG002|Overall Study|Missing Baseline data|31|||
160549844|NCT03083886|579740133|FG000|Overall Study|Investigator terminated|1|||
160549845|NCT03083886|579740134|FG001|Overall Study|Investigator terminated|6|||
160549846|NCT03083886|579740135|FG002|Overall Study|Investigator terminated|3|||
160549847|NCT03286842|579740136|FG000|Overall Study|Patients rolled over to another study|80|||
160549848|NCT01391507|579740137|FG000|Overall Study|Death|0|||
160549849|NCT01391507|579740138|FG001|Overall Study|Death|0|||
160549850|NCT01391507|579740139|FG002|Overall Study|Death|0|||
160549851|NCT01391507|579740140|FG003|Overall Study|Death|1|||
160549852|NCT01391507|579740137|FG000|Overall Study|Adverse Event|1|||
160549853|NCT01391507|579740138|FG001|Overall Study|Adverse Event|1|||
160549854|NCT01391507|579740139|FG002|Overall Study|Adverse Event|2|||
160549855|NCT01391507|579740140|FG003|Overall Study|Adverse Event|2|||
160549856|NCT01391507|579740137|FG000|Overall Study|Withdrawal by Subject|1|||
160549857|NCT01391507|579740138|FG001|Overall Study|Withdrawal by Subject|2|||
160549858|NCT01391507|579740139|FG002|Overall Study|Withdrawal by Subject|1|||
160798837|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
160798838|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
160798839|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
160798840|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
160798841|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
160549859|NCT01391507|579740140|FG003|Overall Study|Withdrawal by Subject|1|||
160549860|NCT01391507|579740137|FG000|Overall Study|Lack of Efficacy|0|||
160549861|NCT01391507|579740138|FG001|Overall Study|Lack of Efficacy|0|||
160549862|NCT01391507|579740139|FG002|Overall Study|Lack of Efficacy|0|||
160549863|NCT01391507|579740140|FG003|Overall Study|Lack of Efficacy|1|||
160549864|NCT01391507|579740137|FG000|Overall Study|Protocol Violation|2|||
160549865|NCT01391507|579740138|FG001|Overall Study|Protocol Violation|1|||
160549866|NCT01391507|579740139|FG002|Overall Study|Protocol Violation|1|||
160549867|NCT01391507|579740140|FG003|Overall Study|Protocol Violation|2|||
160549868|NCT01453855|579740141|FG000|Overall Study|Adverse Event|3|||
160549869|NCT01453855|579740142|FG001|Overall Study|Adverse Event|4|||
160549870|NCT01453855|579740141|FG000|Overall Study|Lost to Follow-up|2|||
160549871|NCT01453855|579740142|FG001|Overall Study|Lost to Follow-up|1|||
160549872|NCT01453855|579740141|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
160549873|NCT01453855|579740142|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
160549874|NCT01453855|579740141|FG000|Overall Study|Noncompliance|1|||
160549875|NCT01453855|579740142|FG001|Overall Study|Noncompliance|0|||
160549876|NCT01453855|579740141|FG000|Overall Study|Inadequate Control of IOP|1|||
160549877|NCT01453855|579740142|FG001|Overall Study|Inadequate Control of IOP|5|||
160549878|NCT01453855|579740141|FG000|Overall Study|Other|0|||
160549879|NCT01453855|579740142|FG001|Overall Study|Other|1|||
160798842|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
160798843|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
160895249|NCT03633617|581012860|FG001|Part A|Adverse Event|1|||
160895250|NCT03633617|581012861|FG002|Part A|Adverse Event|0|||
160895251|NCT03633617|581012862|FG003|Part A|Adverse Event|0|||
160895252|NCT03633617|581012863|FG004|Part A|Adverse Event|0|||
160895253|NCT03633617|581012864|FG005|Part A|Adverse Event|0|||
160895254|NCT03633617|581012865|FG006|Part A|Adverse Event|0|||
160895255|NCT03633617|581012866|FG007|Part A|Adverse Event|0|||
160895256|NCT03633617|581012867|FG008|Part A|Adverse Event|0|||
160895257|NCT03633617|581012868|FG009|Part A|Adverse Event|0|||
160895258|NCT03633617|581012869|FG010|Part A|Adverse Event|0|||
160895259|NCT03633617|581012859|FG000|Part A|Pregnancy|1|||
160895260|NCT03633617|581012860|FG001|Part A|Pregnancy|0|||
160549880|NCT01285908|579740145|FG000|Baseline Measurement|unable to insert catheter|1|||
160549881|NCT01285908|579740146|FG001|Baseline Measurement|unable to insert catheter|0|||
160549882|NCT01285908|579740147|FG002|Baseline Measurement|unable to insert catheter|0|||
160549883|NCT01285908|579740145|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
160549884|NCT01285908|579740146|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
160549885|NCT01285908|579740147|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
160549886|NCT01285908|579740145|FG000|Baseline Measurement|unable to tolerate procedure|1|||
160643791|NCT00475852|580078869|FG001|Overall Study|Lost to Follow-up|68|||
160895261|NCT03633617|581012861|FG002|Part A|Pregnancy|0|||
160798844|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
160798845|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
160798846|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
160798847|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
160798848|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
160798849|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
160798850|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
160798851|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
160798852|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
160798853|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
160798854|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
160798855|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
160798856|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
160798857|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
160798858|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
160798859|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
160798860|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
160798861|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
160798862|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
160798863|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
160798864|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
160895262|NCT03633617|581012862|FG003|Part A|Pregnancy|0|||
160895263|NCT03633617|581012863|FG004|Part A|Pregnancy|0|||
160895264|NCT03633617|581012864|FG005|Part A|Pregnancy|0|||
160895265|NCT03633617|581012865|FG006|Part A|Pregnancy|0|||
160895266|NCT03633617|581012866|FG007|Part A|Pregnancy|0|||
160895267|NCT03633617|581012867|FG008|Part A|Pregnancy|0|||
160895268|NCT03633617|581012868|FG009|Part A|Pregnancy|0|||
160549887|NCT01285908|579740146|FG001|Baseline Measurement|unable to tolerate procedure|0|||
160549888|NCT01285908|579740147|FG002|Baseline Measurement|unable to tolerate procedure|0|||
160549889|NCT01562548|579740148|FG000|Overall Study|Lost to Follow-up|0|||
160549890|NCT01562548|579740149|FG001|Overall Study|Lost to Follow-up|0|||
160549891|NCT01562548|579740150|FG002|Overall Study|Lost to Follow-up|1|||
160549892|NCT01562548|579740151|FG003|Overall Study|Lost to Follow-up|0|||
160549893|NCT03529773|579740152|FG000|Overall Study|Adverse Event|0|||
160549894|NCT03529773|579740153|FG001|Overall Study|Adverse Event|0|||
160549895|NCT03529773|579740154|FG002|Overall Study|Adverse Event|0|||
160549896|NCT03529773|579740155|FG003|Overall Study|Adverse Event|0|||
160549897|NCT03529773|579740156|FG004|Overall Study|Adverse Event|0|||
160549898|NCT03529773|579740157|FG005|Overall Study|Adverse Event|0|||
160549899|NCT03529773|579740158|FG006|Overall Study|Adverse Event|0|||
160549900|NCT03529773|579740159|FG007|Overall Study|Adverse Event|0|||
160549901|NCT03529773|579740160|FG008|Overall Study|Adverse Event|0|||
160549902|NCT03529773|579740161|FG009|Overall Study|Adverse Event|0|||
160549903|NCT03529773|579740162|FG010|Overall Study|Adverse Event|0|||
160549904|NCT03529773|579740163|FG011|Overall Study|Adverse Event|0|||
160549905|NCT03529773|579740164|FG012|Overall Study|Adverse Event|0|||
160549906|NCT03529773|579740165|FG013|Overall Study|Adverse Event|0|||
160549907|NCT03529773|579740166|FG014|Overall Study|Adverse Event|0|||
160549908|NCT03529773|579740167|FG015|Overall Study|Adverse Event|0|||
160549909|NCT03529773|579740168|FG016|Overall Study|Adverse Event|0|||
160549910|NCT03529773|579740169|FG017|Overall Study|Adverse Event|0|||
160549911|NCT03529773|579740170|FG018|Overall Study|Adverse Event|0|||
160549912|NCT03529773|579740171|FG019|Overall Study|Adverse Event|0|||
160549913|NCT03529773|579740172|FG020|Overall Study|Adverse Event|0|||
160549914|NCT03529773|579740173|FG021|Overall Study|Adverse Event|0|||
160549915|NCT03529773|579740174|FG022|Overall Study|Adverse Event|0|||
160549916|NCT03529773|579740175|FG023|Overall Study|Adverse Event|0|||
160549917|NCT03529773|579740176|FG024|Overall Study|Adverse Event|0|||
160549918|NCT03529773|579740177|FG025|Overall Study|Adverse Event|0|||
160549919|NCT03529773|579740178|FG026|Overall Study|Adverse Event|0|||
160549920|NCT03529773|579740179|FG027|Overall Study|Adverse Event|0|||
160549921|NCT03529773|579740180|FG028|Overall Study|Adverse Event|0|||
160549922|NCT03529773|579740181|FG029|Overall Study|Adverse Event|0|||
160549923|NCT03529773|579740182|FG030|Overall Study|Adverse Event|1|||
160549924|NCT03529773|579740183|FG031|Overall Study|Adverse Event|0|||
160549925|NCT03529773|579740184|FG032|Overall Study|Adverse Event|0|||
160549926|NCT03529773|579740185|FG033|Overall Study|Adverse Event|0|||
160798865|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
160798866|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
160798867|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
160798868|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
160798869|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
160798870|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
160798871|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
160798872|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
160798873|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
160798874|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
160798875|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
160798876|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
160798877|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
160798878|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
160798879|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
160798880|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
160798881|NCT02434081|580653116|FG000|Overall Study|Death (never started treatment)|2|||
160798882|NCT02434081|580653116|FG000|Overall Study|Death|2|||
160798883|NCT02434081|580653116|FG000|Overall Study|Progression|20|||
160895269|NCT03633617|581012869|FG010|Part A|Pregnancy|0|||
160549927|NCT03529773|579740186|FG034|Overall Study|Adverse Event|0|||
160549928|NCT03529773|579740187|FG035|Overall Study|Adverse Event|1|||
160549929|NCT03529773|579740188|FG036|Overall Study|Adverse Event|0|||
160549930|NCT03529773|579740189|FG037|Overall Study|Adverse Event|0|||
160549931|NCT03529773|579740190|FG038|Overall Study|Adverse Event|1|||
160895270|NCT03633617|581012859|FG000|Part A|Withdrawal by Subject|0|||
160549932|NCT03529773|579740191|FG039|Overall Study|Adverse Event|1|||
160549933|NCT03529773|579740152|FG000|Overall Study|Death|0|||
160549934|NCT03529773|579740153|FG001|Overall Study|Death|0|||
160549935|NCT03529773|579740154|FG002|Overall Study|Death|0|||
160549936|NCT03529773|579740155|FG003|Overall Study|Death|0|||
160798884|NCT02434081|580653116|FG000|Overall Study|Adverse Event|20|||
160895271|NCT03633617|581012860|FG001|Part A|Withdrawal by Subject|1|||
160549937|NCT03529773|579740156|FG004|Overall Study|Death|0|||
160549938|NCT03529773|579740157|FG005|Overall Study|Death|0|||
160643792|NCT03255031|580078870|FG000|Overall Study|Adverse Event|5|||
160643793|NCT03255031|580078871|FG001|Overall Study|Adverse Event|3|||
160643794|NCT03255031|580078870|FG000|Overall Study|Physician Decision|2|||
160643795|NCT03255031|580078871|FG001|Overall Study|Physician Decision|1|||
160643796|NCT03255031|580078870|FG000|Overall Study|Withdrawal by Subject|9|||
160643797|NCT03255031|580078871|FG001|Overall Study|Withdrawal by Subject|3|||
160643798|NCT01809314|580078872|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
160643799|NCT01809314|580078872|FG000|Overall Study|Adverse Event|6|||
160643800|NCT01809314|580078872|FG000|Overall Study|Insufficient Therapeutic Response|14|||
160643801|NCT01809314|580078872|FG000|Overall Study|Lost to Follow-up|724|||
160643802|NCT00297479|580078873|FG000|Overall Study|Lost to Follow-up|37|||
160643803|NCT00297479|580078874|FG001|Overall Study|Lost to Follow-up|54|||
160643804|NCT00297479|580078875|FG002|Overall Study|Lost to Follow-up|51|||
160643805|NCT01092702|580078876|FG000|Overall Study|Withdrawal by Subject|7|||
160895272|NCT03633617|581012861|FG002|Part A|Withdrawal by Subject|0|||
160895273|NCT03633617|581012862|FG003|Part A|Withdrawal by Subject|0|||
160895274|NCT03633617|581012863|FG004|Part A|Withdrawal by Subject|0|||
160895275|NCT03633617|581012864|FG005|Part A|Withdrawal by Subject|0|||
160895276|NCT03633617|581012865|FG006|Part A|Withdrawal by Subject|0|||
160895277|NCT03633617|581012866|FG007|Part A|Withdrawal by Subject|0|||
160895278|NCT03633617|581012867|FG008|Part A|Withdrawal by Subject|0|||
160895279|NCT03633617|581012868|FG009|Part A|Withdrawal by Subject|0|||
160895280|NCT03633617|581012869|FG010|Part A|Withdrawal by Subject|0|||
160895281|NCT03633617|581012859|FG000|Part B|Adverse Event|0|||
160895282|NCT03633617|581012860|FG001|Part B|Adverse Event|0|||
160895283|NCT03633617|581012861|FG002|Part B|Adverse Event|2|||
160895284|NCT03633617|581012862|FG003|Part B|Adverse Event|2|||
160895285|NCT03633617|581012863|FG004|Part B|Adverse Event|1|||
160643806|NCT01092702|580078876|FG000|Overall Study|Lost to Follow-up|2|||
160895286|NCT03633617|581012864|FG005|Part B|Adverse Event|0|||
160895287|NCT03633617|581012865|FG006|Part B|Adverse Event|0|||
160895288|NCT03633617|581012866|FG007|Part B|Adverse Event|0|||
160895289|NCT03633617|581012867|FG008|Part B|Adverse Event|0|||
160643807|NCT03263819|580078877|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
160895290|NCT03633617|581012868|FG009|Part B|Adverse Event|0|||
160895291|NCT03633617|581012869|FG010|Part B|Adverse Event|0|||
160895292|NCT03633617|581012859|FG000|Part B|Withdrawal by Subject|0|||
160549939|NCT03529773|579740158|FG006|Overall Study|Death|0|||
160549940|NCT03529773|579740159|FG007|Overall Study|Death|0|||
160549941|NCT03529773|579740160|FG008|Overall Study|Death|0|||
160549942|NCT03529773|579740161|FG009|Overall Study|Death|0|||
160549943|NCT03529773|579740162|FG010|Overall Study|Death|0|||
160549944|NCT03529773|579740163|FG011|Overall Study|Death|0|||
160549945|NCT03529773|579740164|FG012|Overall Study|Death|1|||
160549946|NCT03529773|579740165|FG013|Overall Study|Death|0|||
160549947|NCT03529773|579740166|FG014|Overall Study|Death|0|||
160549948|NCT03529773|579740167|FG015|Overall Study|Death|0|||
160549949|NCT03529773|579740168|FG016|Overall Study|Death|0|||
160549950|NCT03529773|579740169|FG017|Overall Study|Death|0|||
160549951|NCT03529773|579740170|FG018|Overall Study|Death|0|||
160643808|NCT03263819|580078878|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
160798885|NCT02434081|580653116|FG000|Overall Study|Physician Decision|2|||
160798886|NCT02434081|580653116|FG000|Overall Study|Withdrawal by Subject|1|||
160798887|NCT02434081|580653116|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
160798888|NCT00854360|580653125|FG000|Overall Study|Adverse Event|0|||
160798889|NCT00854360|580653126|FG001|Overall Study|Adverse Event|1|||
160798890|NCT00854360|580653127|FG002|Overall Study|Adverse Event|2|||
160798891|NCT00854360|580653128|FG003|Overall Study|Adverse Event|6|||
160983767|NCT04445155|581328743|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
160983768|NCT04445155|581328744|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
160983769|NCT04445155|581328745|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
160983770|NCT04445155|581328746|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
160983771|NCT01556243|581328751|FG000|Overall Study|Ineligible|34|||
160983772|NCT01556243|581328751|FG000|Overall Study|Converted to mastectomy|14|||
160983773|NCT01556243|581328751|FG000|Overall Study|Unable to achieve negative margins|2|||
160983774|NCT01556243|581328751|FG000|Overall Study|Withdrawal by Subject|16|||
160983775|NCT01671748|581328752|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
160983776|NCT01671748|581328753|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
160983777|NCT01671748|581328752|FG000|4 Week run-in Phase|Adverse Event|1|||
160983778|NCT01671748|581328753|FG001|4 Week run-in Phase|Adverse Event|0|||
160983779|NCT01671748|581328752|FG000|4 Week run-in Phase|Not eligible|9|||
160983780|NCT01671748|581328753|FG001|4 Week run-in Phase|Not eligible|0|||
160549952|NCT03529773|579740171|FG019|Overall Study|Death|1|||
160643809|NCT00863057|580078879|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
160798892|NCT00854360|580653125|FG000|Overall Study|Withdrawal by Subject|0|||
160798893|NCT00854360|580653126|FG001|Overall Study|Withdrawal by Subject|0|||
160895293|NCT03633617|581012860|FG001|Part B|Withdrawal by Subject|0|||
160895294|NCT03633617|581012861|FG002|Part B|Withdrawal by Subject|1|||
160895295|NCT03633617|581012862|FG003|Part B|Withdrawal by Subject|0|||
160895296|NCT03633617|581012863|FG004|Part B|Withdrawal by Subject|2|||
160895297|NCT03633617|581012864|FG005|Part B|Withdrawal by Subject|0|||
160895298|NCT03633617|581012865|FG006|Part B|Withdrawal by Subject|0|||
160895299|NCT03633617|581012866|FG007|Part B|Withdrawal by Subject|0|||
160895300|NCT03633617|581012867|FG008|Part B|Withdrawal by Subject|0|||
160895301|NCT03633617|581012868|FG009|Part B|Withdrawal by Subject|0|||
160895302|NCT03633617|581012869|FG010|Part B|Withdrawal by Subject|0|||
160895303|NCT03633617|581012859|FG000|Part B|Lost to Follow-up|0|||
160895304|NCT03633617|581012860|FG001|Part B|Lost to Follow-up|0|||
160895305|NCT03633617|581012861|FG002|Part B|Lost to Follow-up|0|||
160895306|NCT03633617|581012862|FG003|Part B|Lost to Follow-up|0|||
160895307|NCT03633617|581012863|FG004|Part B|Lost to Follow-up|1|||
160895308|NCT03633617|581012864|FG005|Part B|Lost to Follow-up|0|||
160895309|NCT03633617|581012865|FG006|Part B|Lost to Follow-up|0|||
160895310|NCT03633617|581012866|FG007|Part B|Lost to Follow-up|0|||
160895311|NCT03633617|581012867|FG008|Part B|Lost to Follow-up|0|||
160895312|NCT03633617|581012868|FG009|Part B|Lost to Follow-up|0|||
160798894|NCT00854360|580653127|FG002|Overall Study|Withdrawal by Subject|0|||
160798895|NCT00854360|580653128|FG003|Overall Study|Withdrawal by Subject|1|||
160549953|NCT03529773|579740172|FG020|Overall Study|Death|0|||
160549954|NCT03529773|579740173|FG021|Overall Study|Death|0|||
160549955|NCT03529773|579740174|FG022|Overall Study|Death|1|||
160798896|NCT00854360|580653125|FG000|Overall Study|Pregnancy|0|||
160798897|NCT00854360|580653126|FG001|Overall Study|Pregnancy|1|||
160895313|NCT03633617|581012869|FG010|Part B|Lost to Follow-up|0|||
160895314|NCT03633617|581012859|FG000|Part B|Physician Decision|0|||
160895315|NCT03633617|581012860|FG001|Part B|Physician Decision|0|||
160895316|NCT03633617|581012861|FG002|Part B|Physician Decision|0|||
160549956|NCT03529773|579740175|FG023|Overall Study|Death|0|||
160549957|NCT03529773|579740176|FG024|Overall Study|Death|0|||
160895317|NCT03633617|581012862|FG003|Part B|Physician Decision|0|||
160895318|NCT03633617|581012863|FG004|Part B|Physician Decision|1|||
160798898|NCT00854360|580653127|FG002|Overall Study|Pregnancy|0|||
160798899|NCT00854360|580653128|FG003|Overall Study|Pregnancy|0|||
160798900|NCT00854360|580653125|FG000|Overall Study|Lack of Efficacy|2|||
160798901|NCT00854360|580653126|FG001|Overall Study|Lack of Efficacy|1|||
160798902|NCT00854360|580653127|FG002|Overall Study|Lack of Efficacy|0|||
160798903|NCT00854360|580653128|FG003|Overall Study|Lack of Efficacy|0|||
160798904|NCT00854360|580653125|FG000|Overall Study|Other|0|||
160798905|NCT00854360|580653126|FG001|Overall Study|Other|0|||
160798906|NCT00854360|580653127|FG002|Overall Study|Other|0|||
160798907|NCT00854360|580653128|FG003|Overall Study|Other|3|||
160798908|NCT01076010|580653135|FG000|Overall Study|Death|15|||
160895319|NCT03633617|581012864|FG005|Part B|Physician Decision|0|||
160895320|NCT03633617|581012865|FG006|Part B|Physician Decision|0|||
160895321|NCT03633617|581012866|FG007|Part B|Physician Decision|0|||
160895322|NCT03633617|581012867|FG008|Part B|Physician Decision|0|||
160895323|NCT03633617|581012868|FG009|Part B|Physician Decision|0|||
160895324|NCT03633617|581012869|FG010|Part B|Physician Decision|0|||
160895325|NCT03633617|581012859|FG000|Part B|COVID-19 Restrictions|0|||
160895326|NCT03633617|581012860|FG001|Part B|COVID-19 Restrictions|0|||
160895327|NCT03633617|581012861|FG002|Part B|COVID-19 Restrictions|1|||
160895328|NCT03633617|581012862|FG003|Part B|COVID-19 Restrictions|0|||
160895329|NCT03633617|581012863|FG004|Part B|COVID-19 Restrictions|0|||
160895330|NCT03633617|581012864|FG005|Part B|COVID-19 Restrictions|0|||
160895331|NCT03633617|581012865|FG006|Part B|COVID-19 Restrictions|0|||
160895332|NCT03633617|581012866|FG007|Part B|COVID-19 Restrictions|0|||
160895333|NCT03633617|581012867|FG008|Part B|COVID-19 Restrictions|0|||
160895334|NCT03633617|581012868|FG009|Part B|COVID-19 Restrictions|0|||
160895335|NCT03633617|581012869|FG010|Part B|COVID-19 Restrictions|0|||
160895336|NCT03633617|581012859|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895337|NCT03633617|581012860|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895338|NCT03633617|581012861|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
160895339|NCT03633617|581012862|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895340|NCT03633617|581012863|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895341|NCT03633617|581012864|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895342|NCT03633617|581012865|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895343|NCT03633617|581012866|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895344|NCT03633617|581012867|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895345|NCT03633617|581012868|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895346|NCT03633617|581012869|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895347|NCT03633617|581012859|FG000|Part C (& Follow-up)|Adverse Event|0|||
160895348|NCT03633617|581012860|FG001|Part C (& Follow-up)|Adverse Event|0|||
160895349|NCT03633617|581012861|FG002|Part C (& Follow-up)|Adverse Event|0|||
160895350|NCT03633617|581012862|FG003|Part C (& Follow-up)|Adverse Event|0|||
160895351|NCT03633617|581012863|FG004|Part C (& Follow-up)|Adverse Event|0|||
160895352|NCT03633617|581012864|FG005|Part C (& Follow-up)|Adverse Event|1|||
160895353|NCT03633617|581012865|FG006|Part C (& Follow-up)|Adverse Event|0|||
160895354|NCT03633617|581012866|FG007|Part C (& Follow-up)|Adverse Event|1|||
160895355|NCT03633617|581012867|FG008|Part C (& Follow-up)|Adverse Event|0|||
160895356|NCT03633617|581012868|FG009|Part C (& Follow-up)|Adverse Event|0|||
160895357|NCT03633617|581012869|FG010|Part C (& Follow-up)|Adverse Event|0|||
160895358|NCT03633617|581012859|FG000|Part C (& Follow-up)|Pregnancy|0|||
160895359|NCT03633617|581012860|FG001|Part C (& Follow-up)|Pregnancy|0|||
160895360|NCT03633617|581012861|FG002|Part C (& Follow-up)|Pregnancy|0|||
160895361|NCT03633617|581012862|FG003|Part C (& Follow-up)|Pregnancy|0|||
160895362|NCT03633617|581012863|FG004|Part C (& Follow-up)|Pregnancy|0|||
160895363|NCT03633617|581012864|FG005|Part C (& Follow-up)|Pregnancy|0|||
160895364|NCT03633617|581012865|FG006|Part C (& Follow-up)|Pregnancy|0|||
160895365|NCT03633617|581012866|FG007|Part C (& Follow-up)|Pregnancy|0|||
160895366|NCT03633617|581012867|FG008|Part C (& Follow-up)|Pregnancy|0|||
160895367|NCT03633617|581012868|FG009|Part C (& Follow-up)|Pregnancy|1|||
160895368|NCT03633617|581012869|FG010|Part C (& Follow-up)|Pregnancy|0|||
160895369|NCT03633617|581012859|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895370|NCT03633617|581012860|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895371|NCT03633617|581012861|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895372|NCT03633617|581012862|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895373|NCT03633617|581012863|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895374|NCT03633617|581012864|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
160895375|NCT03633617|581012865|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
160895376|NCT03633617|581012866|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895377|NCT03633617|581012867|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
160798909|NCT01076010|580653136|FG001|Overall Study|Death|1|||
160798910|NCT01076010|580653137|FG002|Overall Study|Death|0|||
160798911|NCT01076010|580653135|FG000|Overall Study|Adverse Event|7|||
160798912|NCT01076010|580653136|FG001|Overall Study|Adverse Event|2|||
160983789|NCT04191135|581328756|FG000|Induction Treatment|Not Treated|2|||
160983790|NCT04191135|581328757|FG001|Induction Treatment|Not Treated|0|||
160798913|NCT01076010|580653137|FG002|Overall Study|Adverse Event|0|||
160798914|NCT01076010|580653135|FG000|Overall Study|Progressive disease|90|||
160798915|NCT01076010|580653136|FG001|Overall Study|Progressive disease|30|||
160798916|NCT01076010|580653137|FG002|Overall Study|Progressive disease|1|||
160798917|NCT01076010|580653135|FG000|Overall Study|Lack of Efficacy|4|||
160798918|NCT01076010|580653136|FG001|Overall Study|Lack of Efficacy|0|||
160798919|NCT01076010|580653137|FG002|Overall Study|Lack of Efficacy|0|||
160798920|NCT01076010|580653135|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
160798921|NCT01076010|580653136|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
160798922|NCT01076010|580653137|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
160798923|NCT01076010|580653135|FG000|Overall Study|Significant Surgical Procedure|0|||
160798924|NCT01076010|580653136|FG001|Overall Study|Significant Surgical Procedure|1|||
160798925|NCT01076010|580653137|FG002|Overall Study|Significant Surgical Procedure|0|||
160798926|NCT01076010|580653135|FG000|Overall Study|Protocol Violation|0|||
160798927|NCT01076010|580653136|FG001|Overall Study|Protocol Violation|1|||
160798928|NCT01076010|580653137|FG002|Overall Study|Protocol Violation|0|||
160798929|NCT01076010|580653135|FG000|Overall Study|Noncompliance|1|||
160798930|NCT01076010|580653136|FG001|Overall Study|Noncompliance|1|||
160798931|NCT01076010|580653137|FG002|Overall Study|Noncompliance|0|||
160798932|NCT01076010|580653135|FG000|Overall Study|Withdrawal by Subject|3|||
160798933|NCT01076010|580653136|FG001|Overall Study|Withdrawal by Subject|0|||
160798934|NCT01076010|580653137|FG002|Overall Study|Withdrawal by Subject|1|||
160798935|NCT01076010|580653135|FG000|Overall Study|Other|5|||
160798936|NCT01076010|580653136|FG001|Overall Study|Other|2|||
160983791|NCT04191135|581328758|FG002|Induction Treatment|Not Treated|0|||
160983792|NCT04191135|581328756|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
160983793|NCT04191135|581328757|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
160983794|NCT04191135|581328758|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
160983795|NCT04191135|581328756|FG000|Induction Treatment|Adverse Event|25|||
160983796|NCT04191135|581328757|FG001|Induction Treatment|Adverse Event|0|||
160983797|NCT04191135|581328758|FG002|Induction Treatment|Adverse Event|0|||
160983798|NCT04191135|581328756|FG000|Induction Treatment|Clinical Progression|8|||
160983799|NCT04191135|581328757|FG001|Induction Treatment|Clinical Progression|0|||
160983800|NCT04191135|581328758|FG002|Induction Treatment|Clinical Progression|0|||
160983801|NCT04191135|581328756|FG000|Induction Treatment|Excluded Medication|1|||
160983802|NCT04191135|581328757|FG001|Induction Treatment|Excluded Medication|0|||
160983803|NCT04191135|581328758|FG002|Induction Treatment|Excluded Medication|0|||
160983804|NCT04191135|581328756|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
160983805|NCT04191135|581328757|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
160983806|NCT04191135|581328758|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
160983807|NCT04191135|581328756|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
160983808|NCT04191135|581328757|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
160798937|NCT01076010|580653137|FG002|Overall Study|Other|0|||
160798938|NCT05200845|580653140|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
160798939|NCT05200845|580653141|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
160798940|NCT05200845|580653142|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
160798941|NCT05200845|580653143|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
160798942|NCT05200845|580653140|FG000|Overall Study|Withdrawal by Subject|0|||
160798943|NCT05200845|580653141|FG001|Overall Study|Withdrawal by Subject|1|||
160798944|NCT05200845|580653142|FG002|Overall Study|Withdrawal by Subject|1|||
160798945|NCT05200845|580653143|FG003|Overall Study|Withdrawal by Subject|0|||
160798946|NCT01959932|580653150|FG000|Overall Study|Withdrawal by Subject|1|||
160983809|NCT04191135|581328758|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
160983810|NCT04191135|581328756|FG000|Induction Treatment|Physician Decision|2|||
160798947|NCT01959932|580653151|FG001|Overall Study|Withdrawal by Subject|0|||
160983811|NCT04191135|581328757|FG001|Induction Treatment|Physician Decision|0|||
160983812|NCT04191135|581328758|FG002|Induction Treatment|Physician Decision|0|||
160798948|NCT01959932|580653152|FG002|Overall Study|Withdrawal by Subject|0|||
160798949|NCT00060944|580653155|FG000|Overall Study|Adverse Event|12|||
160798950|NCT00060944|580653156|FG001|Overall Study|Adverse Event|10|||
160798951|NCT00060944|580653155|FG000|Overall Study|Death|2|||
160798952|NCT00060944|580653156|FG001|Overall Study|Death|3|||
160983813|NCT04191135|581328756|FG000|Induction Treatment|Progressive Disease|135|||
160798953|NCT00060944|580653155|FG000|Overall Study|Withdrawal by Subject|18|||
160798954|NCT00060944|580653156|FG001|Overall Study|Withdrawal by Subject|5|||
160798955|NCT00060944|580653155|FG000|Overall Study|Disease Progression|93|||
160798956|NCT00060944|580653156|FG001|Overall Study|Disease Progression|94|||
160798957|NCT00060944|580653155|FG000|Overall Study|Lost to Follow-up|1|||
160895378|NCT03633617|581012868|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
160895379|NCT03633617|581012869|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
160895380|NCT03633617|581012859|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
160895381|NCT03633617|581012860|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
160895382|NCT03633617|581012861|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
160895383|NCT03633617|581012862|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
160895384|NCT03633617|581012863|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
160895385|NCT03633617|581012864|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
160895386|NCT03633617|581012865|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
160895387|NCT03633617|581012866|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
160895388|NCT03633617|581012867|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
160895389|NCT03633617|581012868|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
160895390|NCT03633617|581012869|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
160895391|NCT03633617|581012859|FG000|Part C (& Follow-up)|Physician Decision|0|||
160895392|NCT03633617|581012860|FG001|Part C (& Follow-up)|Physician Decision|0|||
160895393|NCT03633617|581012861|FG002|Part C (& Follow-up)|Physician Decision|0|||
160895394|NCT03633617|581012862|FG003|Part C (& Follow-up)|Physician Decision|0|||
160895395|NCT03633617|581012863|FG004|Part C (& Follow-up)|Physician Decision|0|||
160895396|NCT03633617|581012864|FG005|Part C (& Follow-up)|Physician Decision|0|||
160895397|NCT03633617|581012865|FG006|Part C (& Follow-up)|Physician Decision|0|||
160895398|NCT03633617|581012866|FG007|Part C (& Follow-up)|Physician Decision|1|||
160895399|NCT03633617|581012867|FG008|Part C (& Follow-up)|Physician Decision|0|||
160895400|NCT03633617|581012868|FG009|Part C (& Follow-up)|Physician Decision|0|||
160895401|NCT03633617|581012869|FG010|Part C (& Follow-up)|Physician Decision|1|||
160895402|NCT03633617|581012859|FG000|Part C (& Follow-up)|COVID-19 related|0|||
160895403|NCT03633617|581012860|FG001|Part C (& Follow-up)|COVID-19 related|0|||
160895404|NCT03633617|581012861|FG002|Part C (& Follow-up)|COVID-19 related|0|||
160895405|NCT03633617|581012862|FG003|Part C (& Follow-up)|COVID-19 related|0|||
160895406|NCT03633617|581012863|FG004|Part C (& Follow-up)|COVID-19 related|0|||
160895407|NCT03633617|581012864|FG005|Part C (& Follow-up)|COVID-19 related|1|||
160895408|NCT03633617|581012865|FG006|Part C (& Follow-up)|COVID-19 related|0|||
160895409|NCT03633617|581012866|FG007|Part C (& Follow-up)|COVID-19 related|0|||
160895410|NCT03633617|581012867|FG008|Part C (& Follow-up)|COVID-19 related|0|||
160895411|NCT03633617|581012868|FG009|Part C (& Follow-up)|COVID-19 related|0|||
160895412|NCT03633617|581012869|FG010|Part C (& Follow-up)|COVID-19 related|0|||
160895413|NCT03633617|581012859|FG000|Part C (& Follow-up)|Protocol Violation|0|||
160895414|NCT03633617|581012860|FG001|Part C (& Follow-up)|Protocol Violation|0|||
160895415|NCT03633617|581012861|FG002|Part C (& Follow-up)|Protocol Violation|0|||
160895416|NCT03633617|581012862|FG003|Part C (& Follow-up)|Protocol Violation|0|||
160895417|NCT03633617|581012863|FG004|Part C (& Follow-up)|Protocol Violation|0|||
160895418|NCT03633617|581012864|FG005|Part C (& Follow-up)|Protocol Violation|0|||
160895419|NCT03633617|581012865|FG006|Part C (& Follow-up)|Protocol Violation|0|||
160895420|NCT03633617|581012866|FG007|Part C (& Follow-up)|Protocol Violation|0|||
160895421|NCT03633617|581012867|FG008|Part C (& Follow-up)|Protocol Violation|0|||
160895422|NCT03633617|581012868|FG009|Part C (& Follow-up)|Protocol Violation|3|||
160895423|NCT03633617|581012869|FG010|Part C (& Follow-up)|Protocol Violation|1|||
160895424|NCT03633617|581012859|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
160895425|NCT03633617|581012860|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
160895426|NCT03633617|581012861|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
160895427|NCT03633617|581012862|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
160895428|NCT03633617|581012863|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
160895429|NCT03633617|581012864|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
160895430|NCT03633617|581012865|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
160895431|NCT03633617|581012866|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
160895432|NCT03633617|581012867|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
160895433|NCT03633617|581012868|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
160895434|NCT03633617|581012869|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
160895435|NCT03161093|581012882|FG000|Overall Study|Protocol Violation|11|||
160895436|NCT03161093|581012883|FG001|Overall Study|Protocol Violation|14|||
160895437|NCT03161093|581012884|FG002|Overall Study|Protocol Violation|6|||
160895438|NCT03161093|581012885|FG003|Overall Study|Protocol Violation|13|||
160895439|NCT03161093|581012886|FG004|Overall Study|Protocol Violation|1|||
160895440|NCT03161093|581012887|FG005|Overall Study|Protocol Violation|0|||
160895441|NCT03161093|581012882|FG000|Overall Study|Adverse Event|5|||
160895442|NCT03161093|581012883|FG001|Overall Study|Adverse Event|21|||
160895443|NCT03161093|581012884|FG002|Overall Study|Adverse Event|16|||
160895444|NCT03161093|581012885|FG003|Overall Study|Adverse Event|35|||
160895445|NCT03161093|581012886|FG004|Overall Study|Adverse Event|2|||
160895446|NCT03161093|581012887|FG005|Overall Study|Adverse Event|1|||
160895447|NCT03161093|581012882|FG000|Overall Study|Lack of Efficacy|9|||
160895448|NCT03161093|581012883|FG001|Overall Study|Lack of Efficacy|13|||
160895449|NCT03161093|581012884|FG002|Overall Study|Lack of Efficacy|9|||
160895450|NCT03161093|581012885|FG003|Overall Study|Lack of Efficacy|24|||
160895451|NCT03161093|581012886|FG004|Overall Study|Lack of Efficacy|4|||
160895452|NCT03161093|581012887|FG005|Overall Study|Lack of Efficacy|1|||
160895453|NCT03161093|581012882|FG000|Overall Study|Physician Decision|0|||
160798958|NCT00060944|580653156|FG001|Overall Study|Lost to Follow-up|0|||
160798959|NCT00060944|580653155|FG000|Overall Study|Subject Ineligible To Continue|2|||
160798960|NCT00060944|580653156|FG001|Overall Study|Subject Ineligible To Continue|1|||
160798961|NCT00060944|580653155|FG000|Overall Study|Treatment Switch|0|||
160983814|NCT04191135|581328757|FG001|Induction Treatment|Progressive Disease|0|||
160983815|NCT04191135|581328758|FG002|Induction Treatment|Progressive Disease|0|||
160983816|NCT04191135|581328756|FG000|Induction Treatment|Protocol Violation|10|||
160983817|NCT04191135|581328757|FG001|Induction Treatment|Protocol Violation|0|||
160983818|NCT04191135|581328758|FG002|Induction Treatment|Protocol Violation|0|||
160983819|NCT04191135|581328756|FG000|Induction Treatment|Withdrawal by Subject|4|||
160983820|NCT04191135|581328757|FG001|Induction Treatment|Withdrawal by Subject|0|||
160983821|NCT04191135|581328758|FG002|Induction Treatment|Withdrawal by Subject|0|||
160983822|NCT04191135|581328756|FG000|Randomized Treatment|Death|0|||
160983823|NCT04191135|581328757|FG001|Randomized Treatment|Death|50|||
160983824|NCT04191135|581328758|FG002|Randomized Treatment|Death|54|||
160983825|NCT04191135|581328756|FG000|Randomized Treatment|Lost to Follow-up|0|||
160983826|NCT04191135|581328757|FG001|Randomized Treatment|Lost to Follow-up|0|||
160983827|NCT04191135|581328758|FG002|Randomized Treatment|Lost to Follow-up|1|||
160983828|NCT04191135|581328756|FG000|Randomized Treatment|Withdrawal by Subject|0|||
160983829|NCT04191135|581328757|FG001|Randomized Treatment|Withdrawal by Subject|2|||
160983830|NCT04191135|581328758|FG002|Randomized Treatment|Withdrawal by Subject|0|||
160983831|NCT04191135|581328756|FG000|Randomized Treatment|Ongoing in Trial|0|||
160983832|NCT04191135|581328757|FG001|Randomized Treatment|Ongoing in Trial|83|||
160983833|NCT04191135|581328758|FG002|Randomized Treatment|Ongoing in Trial|81|||
160983834|NCT02107274|581330110|FG000|Treatment vs. Placebo|Adverse Event|3|||
160983835|NCT02107274|581330111|FG001|Treatment vs. Placebo|Adverse Event|0|||
160983836|NCT02107274|581330110|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
160983837|NCT02107274|581330111|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
160983838|NCT02107274|581330110|FG000|Control Phase|Lost to Follow-up|1|||
160983839|NCT02107274|581330111|FG001|Control Phase|Lost to Follow-up|1|||
160983840|NCT02107274|581330110|FG000|Control Phase|Death|2|||
160983841|NCT02107274|581330111|FG001|Control Phase|Death|0|||
160983842|NCT02107274|581330110|FG000|Control Phase|Adverse Event|0|||
160983843|NCT02107274|581330111|FG001|Control Phase|Adverse Event|1|||
160983844|NCT05305040|581330114|FG000|Overall Study|Not Dosed|37|||
160983845|NCT05305040|581330115|FG001|Overall Study|Not Dosed|37|||
160983846|NCT05305040|581330114|FG000|Overall Study|Study Closure|34|||
160983847|NCT05305040|581330115|FG001|Overall Study|Study Closure|46|||
160983848|NCT05305040|581330114|FG000|Overall Study|Death|14|||
160983849|NCT05305040|581330115|FG001|Overall Study|Death|13|||
160983850|NCT05305040|581330114|FG000|Overall Study|Withdrawal by Subject|15|||
160983851|NCT05305040|581330115|FG001|Overall Study|Withdrawal by Subject|10|||
160983852|NCT05305040|581330114|FG000|Overall Study|Other|13|||
160983853|NCT05305040|581330115|FG001|Overall Study|Other|10|||
160983854|NCT05305040|581330114|FG000|Overall Study|Primary Malignancy Relapse|3|||
160983855|NCT05305040|581330115|FG001|Overall Study|Primary Malignancy Relapse|4|||
160983856|NCT05305040|581330114|FG000|Overall Study|Adverse Event|3|||
160983857|NCT05305040|581330115|FG001|Overall Study|Adverse Event|3|||
160983858|NCT05305040|581330114|FG000|Overall Study|Lost to Follow-up|2|||
160983859|NCT05305040|581330115|FG001|Overall Study|Lost to Follow-up|1|||
160983860|NCT05305040|581330114|FG000|Overall Study|Graft versus host disease|2|||
160983861|NCT05305040|581330115|FG001|Overall Study|Graft versus host disease|0|||
160983862|NCT05305040|581330114|FG000|Overall Study|Investigator's Decision|1|||
160983863|NCT05305040|581330115|FG001|Overall Study|Investigator's Decision|1|||
160798962|NCT00060944|580653156|FG001|Overall Study|Treatment Switch|13|||
160798963|NCT00060944|580653155|FG000|Overall Study|Other|2|||
160798964|NCT00060944|580653156|FG001|Overall Study|Other|4|||
160798965|NCT00060944|580653155|FG000|Overall Study|randomized but not treated|6|||
160798966|NCT00060944|580653156|FG001|Overall Study|randomized but not treated|4|||
160798967|NCT04756531|580653160|FG000|Overall Study|Adverse Event|0|||
160798968|NCT04756531|580653161|FG001|Overall Study|Adverse Event|0|||
160798969|NCT04756531|580653162|FG002|Overall Study|Adverse Event|0|||
160798970|NCT04756531|580653163|FG003|Overall Study|Adverse Event|0|||
160798971|NCT04756531|580653164|FG004|Overall Study|Adverse Event|1|||
160798972|NCT04756531|580653165|FG005|Overall Study|Adverse Event|0|||
160983864|NCT05305040|581330114|FG000|Overall Study|COVID-19 Reasons|1|||
160983865|NCT05305040|581330115|FG001|Overall Study|COVID-19 Reasons|0|||
160983866|NCT02206685|581330116|FG000|Overall Study|Surgery cancelled/changed|2|||
160983867|NCT02206685|581330117|FG001|Overall Study|Surgery cancelled/changed|3|||
160983868|NCT02206685|581330116|FG000|Overall Study|Withdrawal by Subject|1|||
160983869|NCT02206685|581330117|FG001|Overall Study|Withdrawal by Subject|2|||
160983870|NCT02206685|581330116|FG000|Overall Study|Protocol Violation|2|||
160983871|NCT02206685|581330117|FG001|Overall Study|Protocol Violation|2|||
160983872|NCT01195675|581330118|FG000|Overall Study|Adverse Event|1|||
160798973|NCT04756531|580653166|FG006|Overall Study|Adverse Event|0|||
160798974|NCT04756531|580653167|FG007|Overall Study|Adverse Event|0|||
160895454|NCT03161093|581012883|FG001|Overall Study|Physician Decision|1|||
160895455|NCT03161093|581012884|FG002|Overall Study|Physician Decision|0|||
160895456|NCT03161093|581012885|FG003|Overall Study|Physician Decision|2|||
160895457|NCT03161093|581012886|FG004|Overall Study|Physician Decision|17|||
160895458|NCT03161093|581012887|FG005|Overall Study|Physician Decision|15|||
160895459|NCT03161093|581012882|FG000|Overall Study|Withdrawal by Subject|24|||
160895460|NCT03161093|581012883|FG001|Overall Study|Withdrawal by Subject|73|||
160895461|NCT03161093|581012884|FG002|Overall Study|Withdrawal by Subject|44|||
160895462|NCT03161093|581012885|FG003|Overall Study|Withdrawal by Subject|97|||
160895463|NCT03161093|581012886|FG004|Overall Study|Withdrawal by Subject|11|||
160895464|NCT03161093|581012887|FG005|Overall Study|Withdrawal by Subject|10|||
160895465|NCT03161093|581012882|FG000|Overall Study|Lost to Follow-up|3|||
160895466|NCT03161093|581012883|FG001|Overall Study|Lost to Follow-up|12|||
160895467|NCT03161093|581012884|FG002|Overall Study|Lost to Follow-up|4|||
160895468|NCT03161093|581012885|FG003|Overall Study|Lost to Follow-up|7|||
160895469|NCT03161093|581012886|FG004|Overall Study|Lost to Follow-up|8|||
160895470|NCT03161093|581012887|FG005|Overall Study|Lost to Follow-up|13|||
160895471|NCT03161093|581012882|FG000|Overall Study|Death|3|||
160895472|NCT03161093|581012883|FG001|Overall Study|Death|9|||
160895473|NCT03161093|581012884|FG002|Overall Study|Death|7|||
160895474|NCT03161093|581012885|FG003|Overall Study|Death|9|||
160643810|NCT00863057|580078880|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
160643811|NCT00863057|580078881|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
160643812|NCT00863057|580078882|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
160643813|NCT00863057|580078879|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
160643814|NCT00863057|580078880|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
160643815|NCT00863057|580078881|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
160643816|NCT00863057|580078882|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
160643817|NCT00863057|580078879|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
160643818|NCT00863057|580078880|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
160643819|NCT00863057|580078881|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
160643820|NCT00863057|580078882|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
160643821|NCT00863057|580078879|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
160643822|NCT00863057|580078880|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
160643823|NCT00863057|580078881|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
160643824|NCT00863057|580078882|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
160643825|NCT00686920|580078885|FG000|Overall Study|Death|45|||
160643826|NCT00686920|580078886|FG001|Overall Study|Death|14|||
160643827|NCT00686920|580078885|FG000|Overall Study|Liver Transplant|23|||
160643828|NCT00686920|580078886|FG001|Overall Study|Liver Transplant|8|||
160643829|NCT00686920|580078885|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
160643830|NCT00686920|580078886|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
160643831|NCT00686920|580078885|FG000|Overall Study|Withdrawal by Subject|23|||
160643832|NCT00686920|580078886|FG001|Overall Study|Withdrawal by Subject|5|||
160643833|NCT00686920|580078885|FG000|Overall Study|Protocol Violation|2|||
160643834|NCT00686920|580078886|FG001|Overall Study|Protocol Violation|1|||
160643835|NCT00686920|580078885|FG000|Overall Study|Adverse Event|10|||
160643836|NCT00686920|580078886|FG001|Overall Study|Adverse Event|2|||
160643837|NCT00686920|580078885|FG000|Overall Study|Personal Reason|0|||
160643838|NCT00686920|580078886|FG001|Overall Study|Personal Reason|1|||
160643839|NCT00686920|580078885|FG000|Overall Study|Lost to Follow-up|15|||
160643840|NCT00686920|580078886|FG001|Overall Study|Lost to Follow-up|3|||
160643841|NCT00686920|580078885|FG000|Overall Study|Moved to Another State|1|||
160643842|NCT00686920|580078886|FG001|Overall Study|Moved to Another State|0|||
160643843|NCT00686920|580078885|FG000|Overall Study|Transferred to Nursing Home|1|||
160643844|NCT00686920|580078886|FG001|Overall Study|Transferred to Nursing Home|0|||
160643845|NCT00686920|580078885|FG000|Overall Study|Noncompliance|9|||
160643846|NCT00686920|580078886|FG001|Overall Study|Noncompliance|0|||
160643847|NCT00686920|580078885|FG000|Overall Study|Principal Investigator Decision|2|||
160643848|NCT00686920|580078886|FG001|Overall Study|Principal Investigator Decision|0|||
160643849|NCT00814658|580078889|FG000|Overall Study|Lost to Follow-up|0|||
160643850|NCT00814658|580078890|FG001|Overall Study|Lost to Follow-up|1|||
160643851|NCT00814658|580078889|FG000|Overall Study|Physician Decision|1|||
160643852|NCT00814658|580078890|FG001|Overall Study|Physician Decision|0|||
160643853|NCT00814658|580078889|FG000|Overall Study|Adverse Event|3|||
160643854|NCT00814658|580078890|FG001|Overall Study|Adverse Event|3|||
160643855|NCT01141283|580078891|FG000|Overall Study|Adverse Event|56|||
160895475|NCT03161093|581012886|FG004|Overall Study|Death|0|||
160895476|NCT03161093|581012887|FG005|Overall Study|Death|0|||
160895477|NCT03161093|581012882|FG000|Overall Study|Unknown - Not reported|0|||
160895478|NCT03161093|581012883|FG001|Overall Study|Unknown - Not reported|1|||
160643856|NCT01141283|580078891|FG000|Overall Study|Lost to Follow-up|4|||
160643857|NCT01141283|580078891|FG000|Overall Study|Withdrawal by Subject|14|||
160643858|NCT01141283|580078891|FG000|Overall Study|Administrative|4|||
160643859|NCT01141283|580078891|FG000|Overall Study|Lack of Efficacy|10|||
160643860|NCT02974114|580078894|FG000|Overall Study|Other (Not specified)|0|||
160895479|NCT03161093|581012884|FG002|Overall Study|Unknown - Not reported|0|||
160798975|NCT04756531|580653168|FG008|Overall Study|Adverse Event|0|||
160798976|NCT04756531|580653169|FG009|Overall Study|Adverse Event|0|||
160798977|NCT04756531|580653170|FG010|Overall Study|Adverse Event|0|||
160798978|NCT04756531|580653171|FG011|Overall Study|Adverse Event|0|||
160798979|NCT04756531|580653172|FG012|Overall Study|Adverse Event|0|||
160798980|NCT04756531|580653173|FG013|Overall Study|Adverse Event|0|||
160798981|NCT04756531|580653174|FG014|Overall Study|Adverse Event|0|||
160798982|NCT04756531|580653175|FG015|Overall Study|Adverse Event|0|||
160798983|NCT04756531|580653176|FG016|Overall Study|Adverse Event|0|||
160798984|NCT04756531|580653177|FG017|Overall Study|Adverse Event|0|||
160798985|NCT04756531|580653160|FG000|Overall Study|Withdrawal by Subject|0|||
160798986|NCT04756531|580653161|FG001|Overall Study|Withdrawal by Subject|0|||
160798987|NCT04756531|580653162|FG002|Overall Study|Withdrawal by Subject|0|||
160798988|NCT04756531|580653163|FG003|Overall Study|Withdrawal by Subject|0|||
160798989|NCT04756531|580653164|FG004|Overall Study|Withdrawal by Subject|0|||
160798990|NCT04756531|580653165|FG005|Overall Study|Withdrawal by Subject|0|||
160798991|NCT04756531|580653166|FG006|Overall Study|Withdrawal by Subject|1|||
160798992|NCT04756531|580653167|FG007|Overall Study|Withdrawal by Subject|0|||
160798993|NCT04756531|580653168|FG008|Overall Study|Withdrawal by Subject|0|||
160798994|NCT04756531|580653169|FG009|Overall Study|Withdrawal by Subject|0|||
160798995|NCT04756531|580653170|FG010|Overall Study|Withdrawal by Subject|0|||
160798996|NCT04756531|580653171|FG011|Overall Study|Withdrawal by Subject|0|||
160798997|NCT04756531|580653172|FG012|Overall Study|Withdrawal by Subject|0|||
160798998|NCT04756531|580653173|FG013|Overall Study|Withdrawal by Subject|0|||
160798999|NCT04756531|580653174|FG014|Overall Study|Withdrawal by Subject|0|||
160799000|NCT04756531|580653175|FG015|Overall Study|Withdrawal by Subject|0|||
160799001|NCT04756531|580653176|FG016|Overall Study|Withdrawal by Subject|0|||
160799002|NCT04756531|580653177|FG017|Overall Study|Withdrawal by Subject|0|||
160799003|NCT01729039|580653180|FG000|Overall Study|disqualified|2|||
160799004|NCT01729039|580653181|FG001|Overall Study|disqualified|5|||
160799005|NCT01729039|580653180|FG000|Overall Study|Withdrawal by Subject|8|||
160799006|NCT01729039|580653181|FG001|Overall Study|Withdrawal by Subject|7|||
160799007|NCT04237584|580653182|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
160799008|NCT04237584|580653183|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
160799009|NCT04237584|580653184|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
160799010|NCT04237584|580653185|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
160799011|NCT04237584|580653182|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
160799012|NCT04237584|580653183|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
160799013|NCT04237584|580653184|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
160799014|NCT04237584|580653185|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
160799015|NCT04237584|580653182|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
160799016|NCT04237584|580653183|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
160799017|NCT04237584|580653184|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
160799018|NCT04237584|580653185|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
160799019|NCT04237584|580653182|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
160799020|NCT04237584|580653183|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
160799021|NCT04237584|580653184|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
160799022|NCT04237584|580653185|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
160799023|NCT04237584|580653182|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
160799024|NCT04237584|580653183|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
160799025|NCT04237584|580653184|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
160799026|NCT04237584|580653185|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
160799027|NCT01135992|580654508|FG000|Overall Study|Adverse Event|1|||
160799028|NCT01135992|580654508|FG000|Overall Study|Lack of Efficacy|1|||
160799029|NCT01135992|580654508|FG000|Overall Study|Protocol Violation|2|||
160799030|NCT01135992|580654508|FG000|Overall Study|Withdrawal criteria|10|||
160799031|NCT01135992|580654508|FG000|Overall Study|Unclassified|7|||
160799032|NCT00256126|580654509|FG000|Overall Study|Adverse Event|1|||
160799033|NCT00256126|580654510|FG001|Overall Study|Adverse Event|0|||
160799034|NCT00256126|580654509|FG000|Overall Study|Other|1|||
160799035|NCT00256126|580654510|FG001|Overall Study|Other|2|||
160799036|NCT03435380|580654511|FG000|Overall Study|Death|1|||
160799037|NCT03435380|580654512|FG001|Overall Study|Death|2|||
160799038|NCT03435380|580654513|FG002|Overall Study|Death|1|||
160799039|NCT03435380|580654511|FG000|Overall Study|Lost to Follow-up|12|||
160799040|NCT03435380|580654512|FG001|Overall Study|Lost to Follow-up|8|||
160799041|NCT03435380|580654513|FG002|Overall Study|Lost to Follow-up|6|||
160799042|NCT03435380|580654511|FG000|Overall Study|Physician Decision|1|||
160799043|NCT03435380|580654512|FG001|Overall Study|Physician Decision|0|||
160799044|NCT03435380|580654513|FG002|Overall Study|Physician Decision|0|||
160983873|NCT01195675|581330118|FG000|Overall Study|Withdrawal by Subject|2|||
160983874|NCT01174550|581330119|FG000|Overall Study|Death|75|||
160983875|NCT01174550|581330120|FG001|Overall Study|Death|74|||
160983876|NCT01174550|581330119|FG000|Overall Study|Lost to Follow-up|652|||
160983877|NCT01174550|581330120|FG001|Overall Study|Lost to Follow-up|510|||
160983878|NCT01174550|581330119|FG000|Overall Study|Withdrawal by Subject|543|||
160983879|NCT01174550|581330120|FG001|Overall Study|Withdrawal by Subject|289|||
160983880|NCT01536262|581330121|FG000|Overall Study|Adverse Event|6|||
160983881|NCT01536262|581330122|FG001|Overall Study|Adverse Event|1|||
160983882|NCT01536262|581330123|FG002|Overall Study|Adverse Event|2|||
160983883|NCT01536262|581330121|FG000|Overall Study|Withdrawal by Subject|1|||
160983884|NCT01536262|581330122|FG001|Overall Study|Withdrawal by Subject|1|||
160983885|NCT01536262|581330123|FG002|Overall Study|Withdrawal by Subject|0|||
160983886|NCT01536262|581330121|FG000|Overall Study|Other than stated above|1|||
160983887|NCT01536262|581330122|FG001|Overall Study|Other than stated above|0|||
160983888|NCT01536262|581330123|FG002|Overall Study|Other than stated above|0|||
160983889|NCT00839917|581330127|FG000|Overall Study|Lost to Follow-up|1|||
160799045|NCT03435380|580654511|FG000|Overall Study|Withdrawal by Subject|0|||
160983890|NCT00839917|581330128|FG001|Overall Study|Lost to Follow-up|0|||
160983891|NCT00839917|581330127|FG000|Overall Study|Did not receive vaccine|0|||
160983892|NCT00839917|581330128|FG001|Overall Study|Did not receive vaccine|1|||
160983893|NCT04466618|581330133|FG000|Overall Study|Withdrawal by Subject|0|||
160983894|NCT04466618|581330134|FG001|Overall Study|Withdrawal by Subject|1|||
160983895|NCT02800928|581330135|FG000|Overall Study|Withdrawal by Subject|1|||
160799046|NCT03435380|580654512|FG001|Overall Study|Withdrawal by Subject|1|||
160799047|NCT03435380|580654513|FG002|Overall Study|Withdrawal by Subject|1|||
160799048|NCT03435380|580654511|FG000|Overall Study|Ineligible|0|||
160799049|NCT03435380|580654512|FG001|Overall Study|Ineligible|1|||
160799050|NCT03435380|580654513|FG002|Overall Study|Ineligible|1|||
160799051|NCT01170663|580654514|FG000|Overall Study|Lost to Follow-up|3|||
160799052|NCT01170663|580654515|FG001|Overall Study|Lost to Follow-up|9|||
160799053|NCT01170663|580654514|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
160799054|NCT01170663|580654515|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
160799055|NCT02746809|580654516|FG000|Enrollment|Inclusion Exclusion not met|9|||
160799056|NCT02746809|580654516|FG000|Enrollment|Withdrawal by Subject|1|||
160799057|NCT02746809|580654516|FG000|Enrollment|Expected Enrollment Met|2|||
160799058|NCT02746809|580654516|FG000|Procedure|Death|1|||
160799059|NCT02746809|580654516|FG000|1-Month|Death|5|||
160799060|NCT02746809|580654516|FG000|6-Month|Death|2|||
160799061|NCT02746809|580654516|FG000|6-Month|Withdrawal by Subject|1|||
160799062|NCT02746809|580654516|FG000|12-Month|Death|3|||
160799063|NCT02746809|580654516|FG000|12-Month|Withdrawal by Subject|2|||
160799064|NCT02746809|580654516|FG000|24-Month|Death|1|||
160799065|NCT02746809|580654516|FG000|24-Month|Withdrawal by Subject|1|||
160799066|NCT02746809|580654516|FG000|36-Month|Death|8|||
160799067|NCT02746809|580654516|FG000|36-Month|Withdrawal by Subject|1|||
160799068|NCT02746809|580654516|FG000|48-Month|Death|7|||
160799069|NCT02746809|580654516|FG000|48-Month|Withdrawal by Subject|1|||
160799070|NCT02746809|580654516|FG000|60-Month|Death|1|||
160799071|NCT02746809|580654516|FG000|60-Month|Lost to Follow-up|2|||
160799072|NCT00742625|580654517|FG000|Remission Induction|Progression|6|||
160799073|NCT00742625|580654517|FG000|Remission Induction|Failed induction|8|||
160799074|NCT00742625|580654517|FG000|Remission Induction|Adverse Event|3|||
160799075|NCT00742625|580654517|FG000|Remission Induction|Death|10|||
160799076|NCT00742625|580654517|FG000|Remission Induction|Refusal|5|||
160799077|NCT00742625|580654517|FG000|Remission Induction|Non protocol treatment|17|||
160799078|NCT00742625|580654517|FG000|Remission Induction|Other, not specified|5|||
160799079|NCT00742625|580654517|FG000|Consolidation|Progression|5|||
160799080|NCT00742625|580654517|FG000|Consolidation|Adverse Event|1|||
160799081|NCT00742625|580654517|FG000|Consolidation|Death|1|||
160799082|NCT00742625|580654517|FG000|Consolidation|Refused|1|||
160799083|NCT00742625|580654517|FG000|Consolidation|Non protocol therapy|13|||
160799084|NCT00894387|580654521|FG000|Overall Study|Adverse Event|44|||
160799085|NCT00894387|580654522|FG001|Overall Study|Adverse Event|45|||
160799086|NCT00894387|580654521|FG000|Overall Study|Abnormal Laboratory values|2|||
160799087|NCT00894387|580654522|FG001|Overall Study|Abnormal Laboratory values|2|||
160799088|NCT00894387|580654521|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160799089|NCT00894387|580654522|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160799090|NCT00894387|580654521|FG000|Overall Study|Lost to Follow-up|3|||
160799091|NCT00894387|580654522|FG001|Overall Study|Lost to Follow-up|5|||
160799092|NCT00894387|580654521|FG000|Overall Study|Administrative problems|2|||
160799093|NCT00894387|580654522|FG001|Overall Study|Administrative problems|2|||
160799094|NCT00894387|580654521|FG000|Overall Study|Death|77|||
160799095|NCT00894387|580654522|FG001|Overall Study|Death|76|||
160799096|NCT00894387|580654521|FG000|Overall Study|Protocol Deviation|4|||
160799097|NCT00894387|580654522|FG001|Overall Study|Protocol Deviation|0|||
160799098|NCT00894387|580654521|FG000|Overall Study|Patient's request|25|||
160799099|NCT00894387|580654522|FG001|Overall Study|Patient's request|30|||
160799100|NCT00894387|580654521|FG000|Overall Study|Other (Missing)|5|||
160983896|NCT02800928|581330136|FG001|Overall Study|Withdrawal by Subject|1|||
160983897|NCT02800928|581330135|FG000|Overall Study|Protocol Violation|1|||
160983898|NCT02800928|581330136|FG001|Overall Study|Protocol Violation|1|||
160983899|NCT02886728|581330144|FG000|Overall Study|Withdrew Consent|31|||
160983900|NCT02886728|581330145|FG001|Overall Study|Withdrew Consent|13|||
160983901|NCT02886728|581330146|FG002|Overall Study|Withdrew Consent|11|||
160983902|NCT02886728|581330147|FG003|Overall Study|Withdrew Consent|47|||
160983903|NCT02886728|581330144|FG000|Overall Study|Lost to Follow-up|12|||
160983904|NCT02886728|581330145|FG001|Overall Study|Lost to Follow-up|6|||
160983905|NCT02886728|581330146|FG002|Overall Study|Lost to Follow-up|13|||
160983906|NCT02886728|581330147|FG003|Overall Study|Lost to Follow-up|12|||
160983907|NCT02886728|581330144|FG000|Overall Study|Adverse Event|13|||
160983908|NCT02886728|581330145|FG001|Overall Study|Adverse Event|5|||
160983909|NCT02886728|581330146|FG002|Overall Study|Adverse Event|5|||
160983910|NCT02886728|581330147|FG003|Overall Study|Adverse Event|11|||
160983911|NCT02886728|581330144|FG000|Overall Study|Investigator's Discretion|11|||
160983912|NCT02886728|581330145|FG001|Overall Study|Investigator's Discretion|7|||
160983913|NCT02886728|581330146|FG002|Overall Study|Investigator's Discretion|5|||
160983914|NCT02886728|581330147|FG003|Overall Study|Investigator's Discretion|11|||
160983915|NCT02886728|581330144|FG000|Overall Study|Death|3|||
160983916|NCT02886728|581330145|FG001|Overall Study|Death|1|||
160983917|NCT02886728|581330146|FG002|Overall Study|Death|0|||
160983918|NCT02886728|581330147|FG003|Overall Study|Death|0|||
160983919|NCT02886728|581330144|FG000|Overall Study|Protocol Violation|0|||
160983920|NCT02886728|581330145|FG001|Overall Study|Protocol Violation|0|||
160983921|NCT02886728|581330146|FG002|Overall Study|Protocol Violation|0|||
160983922|NCT02886728|581330147|FG003|Overall Study|Protocol Violation|4|||
160983923|NCT02886728|581330144|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160983924|NCT02886728|581330145|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160983925|NCT02886728|581330146|FG002|Overall Study|Non-Compliance with Study Drug|1|||
160983926|NCT02886728|581330147|FG003|Overall Study|Non-Compliance with Study Drug|0|||
160983927|NCT02886728|581330144|FG000|Overall Study|Pregnancy|0|||
160983928|NCT02886728|581330145|FG001|Overall Study|Pregnancy|0|||
160983929|NCT02886728|581330146|FG002|Overall Study|Pregnancy|1|||
160983930|NCT02886728|581330147|FG003|Overall Study|Pregnancy|0|||
160983931|NCT02886728|581330144|FG000|Overall Study|Randomized but Not Dosed|1|||
160983932|NCT02886728|581330145|FG001|Overall Study|Randomized but Not Dosed|0|||
160983933|NCT02886728|581330146|FG002|Overall Study|Randomized but Not Dosed|0|||
160983934|NCT02886728|581330147|FG003|Overall Study|Randomized but Not Dosed|2|||
160983935|NCT00109928|581330148|FG000|Overall Study|Adverse Event|2|||
160983936|NCT00109928|581330148|FG000|Overall Study|Progression|6|||
160983937|NCT00109928|581330148|FG000|Overall Study|Death|2|||
160983938|NCT00109928|581330148|FG000|Overall Study|not protocol specified|2|||
160983939|NCT00109928|581330148|FG000|Overall Study|not eligible|1|||
160983940|NCT01364727|581330151|FG000|Overall Study|Not Eligible|2|||
160983941|NCT01676220|581330152|FG000|Overall Study|Randomized But Not Treated|4|||
160983942|NCT01676220|581330153|FG001|Overall Study|Randomized But Not Treated|1|||
160983943|NCT01676220|581330152|FG000|Overall Study|Adverse Event|10|||
160983944|NCT01676220|581330153|FG001|Overall Study|Adverse Event|8|||
160983945|NCT01676220|581330152|FG000|Overall Study|Lack of Efficacy|2|||
160983946|NCT01676220|581330153|FG001|Overall Study|Lack of Efficacy|5|||
160983947|NCT01676220|581330152|FG000|Overall Study|Protocol Violation|11|||
160983948|NCT01676220|581330153|FG001|Overall Study|Protocol Violation|12|||
160983949|NCT01676220|581330152|FG000|Overall Study|Received Rescue Therapy|14|||
160983950|NCT01676220|581330153|FG001|Overall Study|Received Rescue Therapy|22|||
160983951|NCT01676220|581330152|FG000|Overall Study|Personal Reason|34|||
160983952|NCT01676220|581330153|FG001|Overall Study|Personal Reason|45|||
160983953|NCT01676220|581330152|FG000|Overall Study|Lost to Follow-up|11|||
160983954|NCT01676220|581330153|FG001|Overall Study|Lost to Follow-up|18|||
160983955|NCT01676220|581330152|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
160983956|NCT01676220|581330153|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
160983957|NCT01676220|581330152|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
160983958|NCT01676220|581330153|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
160983959|NCT01676220|581330152|FG000|Overall Study|Perceived Lack of Efficacy|3|||
160983960|NCT01676220|581330153|FG001|Overall Study|Perceived Lack of Efficacy|1|||
160983961|NCT01676220|581330152|FG000|Overall Study|Non Serious Hypoglycemia|2|||
160983962|NCT01676220|581330153|FG001|Overall Study|Non Serious Hypoglycemia|0|||
160983963|NCT01676220|581330152|FG000|Overall Study|No More Need of Insulin|1|||
160983964|NCT01676220|581330153|FG001|Overall Study|No More Need of Insulin|0|||
160983965|NCT02411591|581330154|FG000|Overall Study|Adverse Event|0|||
160983966|NCT02411591|581330155|FG001|Overall Study|Adverse Event|4|||
160983967|NCT02411591|581330156|FG002|Overall Study|Adverse Event|2|||
160983968|NCT02411591|581330154|FG000|Overall Study|Withdrawal by Subject|0|||
160983969|NCT02411591|581330155|FG001|Overall Study|Withdrawal by Subject|3|||
160983970|NCT02411591|581330156|FG002|Overall Study|Withdrawal by Subject|0|||
160983971|NCT02411591|581330154|FG000|Overall Study|Physician Decision|0|||
160983972|NCT02411591|581330155|FG001|Overall Study|Physician Decision|3|||
160983973|NCT02411591|581330156|FG002|Overall Study|Physician Decision|1|||
160983974|NCT00873093|581330158|FG000|Overall Study|Adverse Event|0|||
160983975|NCT00873093|581330159|FG001|Overall Study|Adverse Event|2|||
160983976|NCT00873093|581330160|FG002|Overall Study|Adverse Event|0|||
160983977|NCT00873093|581330161|FG003|Overall Study|Adverse Event|0|||
160983978|NCT00873093|581330162|FG004|Overall Study|Adverse Event|0|||
160983979|NCT00873093|581330158|FG000|Overall Study|Death|0|||
160983980|NCT00873093|581330159|FG001|Overall Study|Death|3|||
160983981|NCT00873093|581330160|FG002|Overall Study|Death|2|||
160983982|NCT00873093|581330161|FG003|Overall Study|Death|0|||
160983983|NCT00873093|581330162|FG004|Overall Study|Death|0|||
160983984|NCT00873093|581330158|FG000|Overall Study|Physician Decision|0|||
160983985|NCT00873093|581330159|FG001|Overall Study|Physician Decision|17|||
160983986|NCT00873093|581330160|FG002|Overall Study|Physician Decision|10|||
160983987|NCT00873093|581330161|FG003|Overall Study|Physician Decision|10|||
160983988|NCT00873093|581330162|FG004|Overall Study|Physician Decision|2|||
160983989|NCT00873093|581330158|FG000|Overall Study|Withdrawal by Subject|1|||
160983990|NCT00873093|581330159|FG001|Overall Study|Withdrawal by Subject|4|||
160983991|NCT00873093|581330160|FG002|Overall Study|Withdrawal by Subject|4|||
160983992|NCT00873093|581330161|FG003|Overall Study|Withdrawal by Subject|0|||
160983993|NCT00873093|581330162|FG004|Overall Study|Withdrawal by Subject|0|||
160983994|NCT00873093|581330158|FG000|Overall Study|Ineligible|0|||
160983995|NCT00873093|581330159|FG001|Overall Study|Ineligible|1|||
160983996|NCT00873093|581330160|FG002|Overall Study|Ineligible|0|||
160983997|NCT00873093|581330161|FG003|Overall Study|Ineligible|1|||
160983998|NCT00873093|581330162|FG004|Overall Study|Ineligible|0|||
160983999|NCT01152554|581330164|FG000|Overall Study|Withdrawal by Subject|73|||
160984000|NCT01152554|581330165|FG001|Overall Study|Withdrawal by Subject|28|||
160984001|NCT01152554|581330164|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
160984002|NCT01152554|581330165|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
160984003|NCT01152554|581330164|FG000|Overall Study|Adverse Event|67|||
160984004|NCT01152554|581330165|FG001|Overall Study|Adverse Event|14|||
160984005|NCT01152554|581330164|FG000|Overall Study|Severe non-compliance to protocol|36|||
160984006|NCT01152554|581330165|FG001|Overall Study|Severe non-compliance to protocol|14|||
160984007|NCT01152554|581330164|FG000|Overall Study|Condition under investigation worsened|5|||
160984008|NCT01152554|581330165|FG001|Overall Study|Condition under investigation worsened|2|||
160984009|NCT01152554|581330164|FG000|Overall Study|Lack of Efficacy|20|||
160984010|NCT01152554|581330165|FG001|Overall Study|Lack of Efficacy|3|||
160984011|NCT01152554|581330164|FG000|Overall Study|Study-specific withdrawal criteria|17|||
160984012|NCT01152554|581330165|FG001|Overall Study|Study-specific withdrawal criteria|8|||
160799101|NCT00894387|580654522|FG001|Overall Study|Other (Missing)|3|||
160799102|NCT00894387|580654521|FG000|Overall Study|Mis-randomized|13|||
160799103|NCT00894387|580654522|FG001|Overall Study|Mis-randomized|9|||
160799104|NCT00894387|580654521|FG000|Overall Study|GCP non-compliance|0|||
160799105|NCT00894387|580654522|FG001|Overall Study|GCP non-compliance|2|||
160799106|NCT01865487|580654523|FG000|Overall Study|Lost to Follow-up|0|||
160799107|NCT01865487|580654524|FG001|Overall Study|Lost to Follow-up|0|||
160799108|NCT01865487|580654525|FG002|Overall Study|Lost to Follow-up|0|||
160799109|NCT01865487|580654526|FG003|Overall Study|Lost to Follow-up|1|||
160799110|NCT01865487|580654527|FG004|Overall Study|Lost to Follow-up|0|||
160799111|NCT01865487|580654528|FG005|Overall Study|Lost to Follow-up|0|||
160799112|NCT01865487|580654529|FG006|Overall Study|Lost to Follow-up|1|||
160799113|NCT01865487|580654530|FG007|Overall Study|Lost to Follow-up|0|||
160799114|NCT01865487|580654531|FG008|Overall Study|Lost to Follow-up|0|||
160799115|NCT01865487|580654532|FG009|Overall Study|Lost to Follow-up|0|||
160799116|NCT01865487|580654523|FG000|Overall Study|Withdrawal by Subject|0|||
160895480|NCT03161093|581012885|FG003|Overall Study|Unknown - Not reported|0|||
160895481|NCT03161093|581012886|FG004|Overall Study|Unknown - Not reported|0|||
160895482|NCT03161093|581012887|FG005|Overall Study|Unknown - Not reported|1|||
160895483|NCT02124161|581012888|FG000|Overall Study|Other unspecified|0|||
160895484|NCT02124161|581012889|FG001|Overall Study|Other unspecified|1|||
160895485|NCT02124161|581012888|FG000|Overall Study|Death|1|||
160895486|NCT02124161|581012889|FG001|Overall Study|Death|0|||
160895487|NCT02124161|581012888|FG000|Overall Study|Protocol Violation|2|||
160895488|NCT02124161|581012889|FG001|Overall Study|Protocol Violation|1|||
160895489|NCT02124161|581012888|FG000|Overall Study|Withdrawal by Subject|1|||
160984013|NCT01152554|581330164|FG000|Overall Study|Lost to Follow-up|87|||
160984014|NCT01152554|581330165|FG001|Overall Study|Lost to Follow-up|32|||
160984015|NCT01152554|581330164|FG000|Overall Study|Other|28|||
160984016|NCT01152554|581330165|FG001|Overall Study|Other|8|||
160984017|NCT01152554|581330164|FG000|Overall Study|Death|1|||
160799117|NCT01865487|580654524|FG001|Overall Study|Withdrawal by Subject|0|||
160799118|NCT01865487|580654525|FG002|Overall Study|Withdrawal by Subject|0|||
160799119|NCT01865487|580654526|FG003|Overall Study|Withdrawal by Subject|0|||
160895490|NCT02124161|581012889|FG001|Overall Study|Withdrawal by Subject|2|||
160895491|NCT02124161|581012888|FG000|Overall Study|Adverse Event|2|||
160895492|NCT02124161|581012889|FG001|Overall Study|Adverse Event|0|||
160799120|NCT01865487|580654527|FG004|Overall Study|Withdrawal by Subject|1|||
160984018|NCT01152554|581330165|FG001|Overall Study|Death|1|||
160984019|NCT00146640|581330168|FG000|Overall Study|Adverse Event|12|||
160984020|NCT00146640|581330169|FG001|Overall Study|Adverse Event|10|||
160984021|NCT00146640|581330168|FG000|Overall Study|Medical Reasons|3|||
160984022|NCT00146640|581330169|FG001|Overall Study|Medical Reasons|0|||
160984023|NCT00146640|581330168|FG000|Overall Study|Non-Medical Reasons|8|||
160984024|NCT00146640|581330169|FG001|Overall Study|Non-Medical Reasons|4|||
160984025|NCT02117544|581330170|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
160984026|NCT02117544|581330171|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
160984027|NCT04172987|581330173|FG000|Lead In Period|Adverse Event|1|||
160984028|NCT04172987|581330173|FG000|Lead In Period|Protocol Violation|1|||
160984029|NCT04172987|581330173|FG000|Period 1|Physician Decision|1|||
160984030|NCT04172987|581330173|FG000|Period 2|Adverse Event|5|||
160984031|NCT04172987|581330173|FG000|Period 2|Dosing Termination by Sponsor|4|||
160984032|NCT01603121|581330174|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
160984033|NCT01603121|581330175|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
160984034|NCT00738530|581330176|FG000|Overall Study|Death|220|||
160984035|NCT00738530|581330177|FG001|Overall Study|Death|224|||
160984036|NCT00738530|581330176|FG000|Overall Study|Lost to Follow-up|8|||
160984037|NCT00738530|581330177|FG001|Overall Study|Lost to Follow-up|6|||
160984038|NCT00738530|581330176|FG000|Overall Study|Withdrawal by Subject|6|||
160984039|NCT00738530|581330177|FG001|Overall Study|Withdrawal by Subject|8|||
160984040|NCT01656759|581330178|FG000|Overall Study|Protocol Violation|2|||
160984041|NCT01656759|581330179|FG001|Overall Study|Protocol Violation|3|||
160984042|NCT01628510|581330180|FG000|Overall Study|Withdrawal by Subject|0|||
160984043|NCT01628510|581330181|FG001|Overall Study|Withdrawal by Subject|4|||
160984044|NCT01628510|581330180|FG000|Overall Study|Death|3|||
160984045|NCT01628510|581330181|FG001|Overall Study|Death|1|||
160984046|NCT04179461|581330182|FG000|Overall Study|Lost to Follow-up|4|||
160984047|NCT03160079|581330188|FG000|Overall Study|Adverse Event|2|||
160984048|NCT03160079|581330189|FG001|Overall Study|Adverse Event|0|||
160984049|NCT03160079|581330188|FG000|Overall Study|Disease Progression|1|||
160984050|NCT03160079|581330189|FG001|Overall Study|Disease Progression|0|||
160984051|NCT03160079|581330188|FG000|Overall Study|Physician Decision|1|||
160984052|NCT03160079|581330189|FG001|Overall Study|Physician Decision|0|||
160984053|NCT03259373|581330201|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
160984054|NCT03259373|581330202|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
160984055|NCT03259373|581330201|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
160984056|NCT03259373|581330202|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
160984057|NCT03259373|581330201|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
160984058|NCT03259373|581330202|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
160984059|NCT03259373|581330201|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
160984060|NCT03259373|581330202|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
160984061|NCT03259373|581330201|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
160984062|NCT03259373|581330202|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
160984063|NCT03259373|581330201|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
160984064|NCT03259373|581330202|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
160984065|NCT01513967|581330206|FG000|Overall Study|Pregnancy|0|||
160984066|NCT01513967|581330207|FG001|Overall Study|Pregnancy|0|||
160984067|NCT01513967|581330208|FG002|Overall Study|Pregnancy|0|||
160984068|NCT01513967|581330209|FG003|Overall Study|Pregnancy|0|||
160984069|NCT01513967|581330210|FG004|Overall Study|Pregnancy|0|||
160984070|NCT01513967|581330211|FG005|Overall Study|Pregnancy|0|||
160984071|NCT01513967|581330212|FG006|Overall Study|Pregnancy|1|||
160984072|NCT01513967|581330213|FG007|Overall Study|Pregnancy|0|||
160984073|NCT01513967|581330206|FG000|Overall Study|missed a study visit|0|||
160984074|NCT01513967|581330207|FG001|Overall Study|missed a study visit|0|||
160984075|NCT01513967|581330208|FG002|Overall Study|missed a study visit|0|||
160984076|NCT01513967|581330209|FG003|Overall Study|missed a study visit|0|||
160984077|NCT01513967|581330210|FG004|Overall Study|missed a study visit|0|||
160984078|NCT01513967|581330211|FG005|Overall Study|missed a study visit|0|||
160984079|NCT01513967|581330212|FG006|Overall Study|missed a study visit|1|||
160984080|NCT01513967|581330213|FG007|Overall Study|missed a study visit|0|||
160984081|NCT01513967|581330206|FG000|Overall Study|excluded due to positive drug screen|0|||
160984082|NCT01513967|581330207|FG001|Overall Study|excluded due to positive drug screen|0|||
160984083|NCT01513967|581330208|FG002|Overall Study|excluded due to positive drug screen|0|||
160984084|NCT01513967|581330209|FG003|Overall Study|excluded due to positive drug screen|0|||
160984085|NCT01513967|581330210|FG004|Overall Study|excluded due to positive drug screen|0|||
160984086|NCT01513967|581330211|FG005|Overall Study|excluded due to positive drug screen|0|||
160984087|NCT01513967|581330212|FG006|Overall Study|excluded due to positive drug screen|0|||
160799121|NCT01865487|580654528|FG005|Overall Study|Withdrawal by Subject|0|||
160799122|NCT01865487|580654529|FG006|Overall Study|Withdrawal by Subject|0|||
160799123|NCT01865487|580654530|FG007|Overall Study|Withdrawal by Subject|0|||
160799124|NCT01865487|580654531|FG008|Overall Study|Withdrawal by Subject|0|||
160799125|NCT01865487|580654532|FG009|Overall Study|Withdrawal by Subject|0|||
160799126|NCT01307449|580654533|FG000|Overall Study|Adverse Event|1|||
160799127|NCT01307449|580654534|FG001|Overall Study|Adverse Event|0|||
160799128|NCT01307449|580654535|FG002|Overall Study|Adverse Event|0|||
160799129|NCT01307449|580654536|FG003|Overall Study|Adverse Event|0|||
160799130|NCT01531998|580654539|FG000|Overall Study|Withdrawal by Subject|3|||
160799131|NCT02581891|580654540|FG000|Overall Study|Adverse Event|4|||
160799132|NCT02581891|580654541|FG001|Overall Study|Adverse Event|6|||
160799133|NCT02581891|580654540|FG000|Overall Study|Death|3|||
160799134|NCT02581891|580654541|FG001|Overall Study|Death|4|||
160799135|NCT02581891|580654540|FG000|Overall Study|Lost to Follow-up|1|||
160799136|NCT02581891|580654541|FG001|Overall Study|Lost to Follow-up|2|||
160799137|NCT02581891|580654540|FG000|Overall Study|Physician Decision|0|||
160799138|NCT02581891|580654541|FG001|Overall Study|Physician Decision|1|||
160984088|NCT01513967|581330213|FG007|Overall Study|excluded due to positive drug screen|2|||
160799139|NCT02581891|580654540|FG000|Overall Study|Withdrawal by Subject|4|||
160799140|NCT02581891|580654541|FG001|Overall Study|Withdrawal by Subject|5|||
160799141|NCT02581891|580654540|FG000|Overall Study|Other Reasons|3|||
160799142|NCT02581891|580654541|FG001|Overall Study|Other Reasons|1|||
160799143|NCT02581891|580654540|FG000|Overall Study|Discontinued during followup|1|||
160799144|NCT02581891|580654541|FG001|Overall Study|Discontinued during followup|0|||
160799145|NCT02927795|580654542|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
160799146|NCT02927795|580654542|FG000|Overall Study|Not Treated|4|||
160799147|NCT01612676|580654543|FG000|Overall Study|Adverse Event|2|||
160799148|NCT01612676|580654544|FG001|Overall Study|Adverse Event|3|||
160799149|NCT01612676|580654545|FG002|Overall Study|Adverse Event|1|||
160799150|NCT01612676|580654546|FG003|Overall Study|Adverse Event|3|||
160799151|NCT01612676|580654543|FG000|Overall Study|Protocol Violation|0|||
160799152|NCT01612676|580654544|FG001|Overall Study|Protocol Violation|1|||
160799153|NCT01612676|580654545|FG002|Overall Study|Protocol Violation|0|||
160799154|NCT01612676|580654546|FG003|Overall Study|Protocol Violation|0|||
160799155|NCT00181844|580654553|FG000|Signed Consent|Withdrawal by Subject|5|||
160799156|NCT00181844|580654553|FG000|Signed Consent|Did not meet entrance criteria|7|||
160799157|NCT00181844|580654553|FG000|Exposed to Study Medication|Adverse Event|10|||
160799158|NCT00181844|580654553|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
160799159|NCT00181844|580654553|FG000|Exposed to Study Medication|Non-compliance|2|||
160799160|NCT00181844|580654553|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
160799161|NCT00181844|580654553|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
160799162|NCT04661033|580654554|FG000|Overall Study|Adverse Event|0|||
160799163|NCT04661033|580654555|FG001|Overall Study|Adverse Event|0|||
160799164|NCT04661033|580654556|FG002|Overall Study|Adverse Event|1|||
160799165|NCT04661033|580654557|FG003|Overall Study|Adverse Event|0|||
160799166|NCT04661033|580654554|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
160799167|NCT04661033|580654555|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
160799168|NCT04661033|580654556|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
160799169|NCT04661033|580654557|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
160799170|NCT04661033|580654554|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
160799171|NCT04661033|580654555|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
160799172|NCT04661033|580654556|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
160799173|NCT04661033|580654557|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
160799174|NCT04661033|580654554|FG000|Overall Study|Early discontinuation as per PI|1|||
160799175|NCT04661033|580654555|FG001|Overall Study|Early discontinuation as per PI|0|||
160799176|NCT04661033|580654556|FG002|Overall Study|Early discontinuation as per PI|0|||
160799177|NCT04661033|580654557|FG003|Overall Study|Early discontinuation as per PI|0|||
160799178|NCT03440008|580654558|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
160799179|NCT03440008|580654559|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
160799180|NCT03440008|580654558|FG000|Overall Study|Withdrawal by Subject|1|||
160799181|NCT03440008|580654559|FG001|Overall Study|Withdrawal by Subject|0|||
160799182|NCT01734902|580654568|FG000|Overall Study|Other than listed|0|||
160799183|NCT01734902|580654569|FG001|Overall Study|Other than listed|2|||
160799184|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
160799185|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
160799186|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
160799187|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Death|0|||
160799188|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Death|0|||
160799189|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Death|1|||
160799190|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
160799191|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
160984089|NCT01513967|581330206|FG000|Overall Study|Physician Decision|0|||
160984090|NCT01513967|581330207|FG001|Overall Study|Physician Decision|0|||
160984091|NCT01513967|581330208|FG002|Overall Study|Physician Decision|0|||
160984092|NCT01513967|581330209|FG003|Overall Study|Physician Decision|0|||
160984093|NCT01513967|581330210|FG004|Overall Study|Physician Decision|0|||
160984094|NCT01513967|581330211|FG005|Overall Study|Physician Decision|1|||
160984095|NCT01513967|581330212|FG006|Overall Study|Physician Decision|0|||
160984096|NCT01513967|581330213|FG007|Overall Study|Physician Decision|0|||
160984097|NCT04131907|581330214|FG000|Overall Study|Adverse Event|2|||
160984098|NCT04131907|581330215|FG001|Overall Study|Adverse Event|0|||
160984099|NCT04131907|581330216|FG002|Overall Study|Adverse Event|0|||
160984100|NCT04131907|581330214|FG000|Overall Study|Physician Decision|4|||
160984101|NCT04131907|581330215|FG001|Overall Study|Physician Decision|22|||
160984102|NCT04131907|581330216|FG002|Overall Study|Physician Decision|0|||
160984103|NCT04131907|581330214|FG000|Overall Study|Withdrawal by Subject|2|||
160984104|NCT04131907|581330215|FG001|Overall Study|Withdrawal by Subject|0|||
160984105|NCT04131907|581330216|FG002|Overall Study|Withdrawal by Subject|1|||
160984106|NCT04131907|581330214|FG000|Overall Study|Treatment failure|2|||
160984107|NCT04131907|581330215|FG001|Overall Study|Treatment failure|0|||
160984108|NCT04131907|581330216|FG002|Overall Study|Treatment failure|1|||
160984109|NCT05294419|581330217|FG000|Overall Study|Protocol Violation|4|||
160984110|NCT05294419|581330218|FG001|Overall Study|Protocol Violation|0|||
160984111|NCT05294419|581330219|FG002|Overall Study|Protocol Violation|0|||
160984112|NCT05294419|581330217|FG000|Overall Study|Lost to Follow-up|6|||
160984113|NCT05294419|581330218|FG001|Overall Study|Lost to Follow-up|0|||
160984114|NCT05294419|581330219|FG002|Overall Study|Lost to Follow-up|0|||
160984115|NCT05294419|581330217|FG000|Overall Study|Results voided after publishing|2|||
160984116|NCT05294419|581330218|FG001|Overall Study|Results voided after publishing|0|||
160984117|NCT05294419|581330219|FG002|Overall Study|Results voided after publishing|0|||
160984118|NCT00847301|581330220|FG000|Overall Study|Adverse Event|35|||
160984119|NCT00847301|581330220|FG000|Overall Study|Switch to other anticoagulants|16|||
160984120|NCT00847301|581330220|FG000|Overall Study|Lost to Follow-up|1|||
160984121|NCT00847301|581330220|FG000|Overall Study|No prescription after hospital discharge|1|||
160984122|NCT00847301|581330220|FG000|Overall Study|Other reason not defined above|1|||
160984123|NCT03317379|581330221|FG000|Overall Study|Lost to Follow-up|0|||
160984124|NCT03317379|581330222|FG001|Overall Study|Lost to Follow-up|3|||
160984125|NCT03317379|581330223|FG002|Overall Study|Lost to Follow-up|2|||
160984126|NCT02846558|581330224|FG000|Overall Study|Adverse Event|1|||
160984127|NCT02846558|581330225|FG001|Overall Study|Adverse Event|0|||
160984128|NCT02846558|581330226|FG002|Overall Study|Adverse Event|0|||
160643861|NCT02974114|580078895|FG001|Overall Study|Other (Not specified)|1|||
160643862|NCT02974114|580078896|FG002|Overall Study|Other (Not specified)|2|||
160643863|NCT00545233|580078900|FG000|Overall Study|Adverse Event|10|||
160643864|NCT00545233|580078901|FG001|Overall Study|Adverse Event|5|||
160643865|NCT00545233|580078900|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
160643866|NCT00545233|580078901|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
160643867|NCT00545233|580078900|FG000|Overall Study|Protocol Violation|2|||
160643868|NCT00545233|580078901|FG001|Overall Study|Protocol Violation|0|||
160643869|NCT00545233|580078900|FG000|Overall Study|Refused Treatment|9|||
160643870|NCT00545233|580078901|FG001|Overall Study|Refused Treatment|7|||
160643871|NCT00545233|580078900|FG000|Overall Study|Failure to Return|4|||
160643872|NCT00545233|580078901|FG001|Overall Study|Failure to Return|6|||
160643873|NCT00545233|580078900|FG000|Overall Study|Insufficient response|14|||
160643874|NCT00545233|580078901|FG001|Overall Study|Insufficient response|15|||
160643875|NCT00545233|580078900|FG000|Overall Study|Physician Decision|2|||
160643876|NCT00545233|580078901|FG001|Overall Study|Physician Decision|1|||
160643877|NCT06371079|580078902|FG000|Overall Study|Missing data|88|||
160643878|NCT06371079|580078903|FG001|Overall Study|Missing data|247|||
160643879|NCT01238211|580078904|FG000|Overall Study|Continues active treatment|31|||
160984129|NCT02846558|581330227|FG003|Overall Study|Adverse Event|0|||
160984130|NCT02846558|581330224|FG000|Overall Study|Withdrawal by Subject|5|||
160984131|NCT02846558|581330225|FG001|Overall Study|Withdrawal by Subject|4|||
160984132|NCT02846558|581330226|FG002|Overall Study|Withdrawal by Subject|2|||
160643880|NCT01238211|580078904|FG000|Overall Study|Adverse Event|7|||
160643881|NCT01238211|580078904|FG000|Overall Study|Death|4|||
160643882|NCT01238211|580078904|FG000|Overall Study|Relapse/Progression|2|||
160643883|NCT01238211|580078904|FG000|Overall Study|Withdrawal by Subject|7|||
160984133|NCT02846558|581330227|FG003|Overall Study|Withdrawal by Subject|2|||
160984134|NCT02846558|581330224|FG000|Overall Study|Lost to Follow-up|2|||
160984135|NCT02846558|581330225|FG001|Overall Study|Lost to Follow-up|0|||
160984136|NCT02846558|581330226|FG002|Overall Study|Lost to Follow-up|0|||
160984137|NCT02846558|581330227|FG003|Overall Study|Lost to Follow-up|0|||
160984138|NCT01388543|581330228|FG000|Day 14|Adverse Event|1|||
160643884|NCT01238211|580078904|FG000|Overall Study|Non-protocol treatment|4|||
160643885|NCT01238211|580078904|FG000|Overall Study|Investigator/Patient Decision|3|||
160643886|NCT00449930|580078905|FG000|Overall Study|Adverse Event|9|||
160643887|NCT00449930|580078906|FG001|Overall Study|Adverse Event|19|||
160643888|NCT00449930|580078905|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
160984139|NCT01388543|581330229|FG001|Day 14|Adverse Event|4|||
160895493|NCT02124161|581012888|FG000|Overall Study|Does not meet entrance criteria|2|||
160895494|NCT02124161|581012889|FG001|Overall Study|Does not meet entrance criteria|3|||
160895495|NCT02124161|581012888|FG000|Overall Study|No longer meets eligibility criteria|5|||
160895496|NCT02124161|581012889|FG001|Overall Study|No longer meets eligibility criteria|4|||
160895497|NCT02124161|581012888|FG000|Overall Study|Lost to Follow-up|3|||
160895498|NCT02124161|581012889|FG001|Overall Study|Lost to Follow-up|4|||
160895499|NCT01954342|581012895|FG000|Overall Study|Missing data from 13-16week study visit|0|||
160895500|NCT01954342|581012896|FG001|Overall Study|Missing data from 13-16week study visit|0|||
160895501|NCT01954342|581012897|FG002|Overall Study|Missing data from 13-16week study visit|0|||
160895502|NCT01954342|581012898|FG003|Overall Study|Missing data from 13-16week study visit|1|||
160895503|NCT01954342|581012895|FG000|Overall Study|Miscarriage|0|||
160895504|NCT01954342|581012896|FG001|Overall Study|Miscarriage|0|||
160895505|NCT01954342|581012897|FG002|Overall Study|Miscarriage|0|||
160895506|NCT01954342|581012898|FG003|Overall Study|Miscarriage|3|||
160895507|NCT01954342|581012895|FG000|Overall Study|Lost to Follow-up|0|||
160895508|NCT01954342|581012896|FG001|Overall Study|Lost to Follow-up|0|||
160895509|NCT01954342|581012897|FG002|Overall Study|Lost to Follow-up|0|||
160895510|NCT01954342|581012898|FG003|Overall Study|Lost to Follow-up|5|||
160895511|NCT01954342|581012895|FG000|Overall Study|Preterm delivery|0|||
160895512|NCT01954342|581012896|FG001|Overall Study|Preterm delivery|0|||
160895513|NCT01954342|581012897|FG002|Overall Study|Preterm delivery|0|||
160895514|NCT01954342|581012898|FG003|Overall Study|Preterm delivery|3|||
160895515|NCT01954342|581012895|FG000|Overall Study|Pre-eclampsia|0|||
160895516|NCT01954342|581012896|FG001|Overall Study|Pre-eclampsia|0|||
160895517|NCT01954342|581012897|FG002|Overall Study|Pre-eclampsia|0|||
160895518|NCT01954342|581012898|FG003|Overall Study|Pre-eclampsia|4|||
160895519|NCT01954342|581012895|FG000|Overall Study|Unreliable Data|0|||
160895520|NCT01954342|581012896|FG001|Overall Study|Unreliable Data|0|||
160895521|NCT01954342|581012897|FG002|Overall Study|Unreliable Data|0|||
160895522|NCT01954342|581012898|FG003|Overall Study|Unreliable Data|2|||
160895523|NCT00984568|581012900|FG000|Overall Study|Withdrawal by Subject|1|||
160895524|NCT00984568|581012901|FG001|Overall Study|Withdrawal by Subject|2|||
160895525|NCT00984568|581012900|FG000|Overall Study|Lack of Efficacy|2|||
160895526|NCT00984568|581012901|FG001|Overall Study|Lack of Efficacy|0|||
160895527|NCT00984568|581012900|FG000|Overall Study|Adverse Event|2|||
160895528|NCT00984568|581012901|FG001|Overall Study|Adverse Event|0|||
160895529|NCT00984568|581012900|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
160895530|NCT00984568|581012901|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
160895531|NCT00984568|581012900|FG000|Overall Study|Lost to Follow-up|0|||
160895532|NCT00984568|581012901|FG001|Overall Study|Lost to Follow-up|1|||
160895533|NCT00984568|581012900|FG000|Overall Study|Opportunistic Infection|1|||
160895534|NCT00984568|581012901|FG001|Overall Study|Opportunistic Infection|0|||
160895535|NCT00984568|581012900|FG000|Overall Study|Unknown Reason|1|||
160895536|NCT00984568|581012901|FG001|Overall Study|Unknown Reason|3|||
160895537|NCT01649804|581012908|FG000|Overall Study|Administrative/Other|8|||
160895538|NCT03845543|581012909|FG000|Overall Study|Death|25|||
160895539|NCT03845543|581012909|FG000|Overall Study|Withdrawal by Subject|2|||
160895540|NCT03845543|581012909|FG000|Overall Study|Lost to Follow-up|12|||
160895541|NCT03845543|581012909|FG000|Overall Study|Adverse Event|17|||
160895542|NCT04010539|581012914|FG000|Overall Study|Withdrawal by Subject|4|||
160895543|NCT04010539|581012915|FG001|Overall Study|Withdrawal by Subject|1|||
160895544|NCT04010539|581012914|FG000|Overall Study|Physician Decision|0|||
160895545|NCT04010539|581012915|FG001|Overall Study|Physician Decision|2|||
160895546|NCT04010539|581012914|FG000|Overall Study|Lost to Follow-up|10|||
160895547|NCT04010539|581012915|FG001|Overall Study|Lost to Follow-up|14|||
160895548|NCT04010539|581012914|FG000|Overall Study|Adverse Event|3|||
160895549|NCT04010539|581012915|FG001|Overall Study|Adverse Event|0|||
160895550|NCT04010539|581012914|FG000|Overall Study|Participant Did Not Receive IP|0|||
160895551|NCT04010539|581012915|FG001|Overall Study|Participant Did Not Receive IP|1|||
160895552|NCT04010539|581012914|FG000|Overall Study|Protocol Deviation|0|||
160895553|NCT04010539|581012915|FG001|Overall Study|Protocol Deviation|1|||
160895554|NCT04010539|581012914|FG000|Overall Study|Randomized in Error/ Mistake|2|||
160895555|NCT04010539|581012915|FG001|Overall Study|Randomized in Error/ Mistake|0|||
160895556|NCT04010539|581012914|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
160895557|NCT04010539|581012915|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
160895558|NCT02028871|581012916|FG000|Overall Study|Positive urine drug screen|1|||
160895559|NCT02028871|581012917|FG001|Overall Study|Positive urine drug screen|1|||
160895560|NCT02028871|581012916|FG000|Overall Study|Withdrawal by Subject|1|||
160895561|NCT02028871|581012917|FG001|Overall Study|Withdrawal by Subject|2|||
160643889|NCT00449930|580078906|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
160895562|NCT02028871|581012916|FG000|Overall Study|IV placement difficulty|1|||
160895563|NCT02028871|581012917|FG001|Overall Study|IV placement difficulty|0|||
160895564|NCT02028871|581012916|FG000|Overall Study|Current Illness|1|||
160895565|NCT02028871|581012917|FG001|Overall Study|Current Illness|0|||
160895566|NCT01912963|581012919|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
160984140|NCT04684914|581330230|FG000|Overall Study|Withdrawal by Subject|1|||
160984141|NCT04684914|581330231|FG001|Overall Study|Withdrawal by Subject|0|||
160984142|NCT04684914|581330230|FG000|Overall Study|Discontinued before receiving study treatment|1|||
160984143|NCT04684914|581330231|FG001|Overall Study|Discontinued before receiving study treatment|2|||
160984144|NCT03363659|581330232|FG000|Overall Study|Adverse Event|1|||
160984145|NCT03363659|581330232|FG000|Overall Study|Screen fail|1|||
160984146|NCT03363659|581330232|FG000|Overall Study|Withdrawal by Subject|1|||
160984147|NCT02353832|581330233|FG000|Overall Study|Ineligible after enrollment|1|||
160984148|NCT02353832|581330233|FG000|Overall Study|Lost to Follow-up|1|||
160984149|NCT00904150|581330234|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
160984150|NCT00904150|581330235|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
160984151|NCT00904150|581330234|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
160984152|NCT00904150|581330235|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
160984153|NCT03872388|581330238|FG000|Overall Study|Disease Progression|0|||
160984154|NCT03872388|581330239|FG001|Overall Study|Disease Progression|0|||
160984155|NCT03872388|581330240|FG002|Overall Study|Disease Progression|0|||
160984156|NCT03872388|581330241|FG003|Overall Study|Disease Progression|0|||
160984157|NCT03872388|581330242|FG004|Overall Study|Disease Progression|0|||
160984158|NCT03872388|581330243|FG005|Overall Study|Disease Progression|0|||
160984159|NCT03872388|581330244|FG006|Overall Study|Disease Progression|1|||
160984160|NCT03872388|581330245|FG007|Overall Study|Disease Progression|1|||
160984161|NCT01460381|581332163|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
160984162|NCT01460381|581332164|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
160984163|NCT01097655|581332165|FG000|Overall Study|Withdrawal by Subject|1|||
160984164|NCT01097655|581332165|FG000|Overall Study|Subject Documented Twice|1|||
160984165|NCT01097655|581332165|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
160984166|NCT01033643|581332166|FG000|Overall Study|Withdrew Consent|0|||
160984167|NCT01033643|581332167|FG001|Overall Study|Withdrew Consent|3|||
160984168|NCT01033643|581332168|FG002|Overall Study|Withdrew Consent|0|||
160984169|NCT01033643|581332169|FG003|Overall Study|Withdrew Consent|0|||
160984170|NCT01033643|581332170|FG004|Overall Study|Withdrew Consent|0|||
160799192|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
160799193|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
160799194|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
160799195|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
160799196|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
160799197|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
160799198|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
160799199|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Graft loss|0|||
160799200|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Graft loss|0|||
160799201|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Graft loss|7|||
160799202|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
160799203|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
160799204|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
160799205|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
160799206|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
160799207|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
160799208|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
160799209|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
160799210|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
160799211|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
160799212|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
160799213|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
160799214|NCT00956293|580654573|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
160799215|NCT00956293|580654574|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
160799216|NCT00956293|580654575|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
160799217|NCT00956293|580654573|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
160799218|NCT00956293|580654574|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
160799219|NCT00956293|580654575|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
160799220|NCT00956293|580654573|FG000|Main Period (Randomization)|Adverse Event|0|||
160799221|NCT00956293|580654574|FG001|Main Period (Randomization)|Adverse Event|15|||
160799222|NCT00956293|580654575|FG002|Main Period (Randomization)|Adverse Event|0|||
160799223|NCT00956293|580654573|FG000|Follow-up Period|Follow-up period was terminated.|20|||
160799224|NCT00956293|580654574|FG001|Follow-up Period|Follow-up period was terminated.|32|||
160984171|NCT01033643|581332171|FG005|Overall Study|Withdrew Consent|1|||
160984172|NCT03527277|581332172|FG000|Overall Study|Withdrawal by Subject|5|||
160984173|NCT03527277|581332173|FG001|Overall Study|Withdrawal by Subject|0|||
160984174|NCT03527277|581332172|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
160984175|NCT03527277|581332173|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
160643890|NCT00449930|580078905|FG000|Overall Study|Lack of Efficacy|10|||
160799225|NCT00956293|580654575|FG002|Follow-up Period|Follow-up period was terminated.|0|||
160799226|NCT02359903|580654576|FG000|Overall Study|Adverse Event|0|||
160799227|NCT02359903|580654577|FG001|Overall Study|Adverse Event|2|||
160799228|NCT03383666|580654578|FG000|Overall Study|Withdrawal by Subject|2|||
160799229|NCT03383666|580654578|FG000|Overall Study|Lost to Follow-up|2|||
160799230|NCT02536664|580654579|FG000|Overall Study|Inadequate completion of documentation|2|||
160799231|NCT02536664|580654580|FG001|Overall Study|Inadequate completion of documentation|4|||
160799232|NCT02536664|580654579|FG000|Overall Study|Progression|13|||
160799233|NCT02536664|580654580|FG001|Overall Study|Progression|18|||
160799234|NCT02536664|580654579|FG000|Overall Study|Death due to lymphoma|2|||
160799235|NCT02536664|580654580|FG001|Overall Study|Death due to lymphoma|1|||
160799236|NCT02536664|580654579|FG000|Overall Study|Death due to other reason|3|||
160799237|NCT02536664|580654580|FG001|Overall Study|Death due to other reason|2|||
160799238|NCT02536664|580654579|FG000|Overall Study|Intolerability|8|||
160799239|NCT02536664|580654580|FG001|Overall Study|Intolerability|6|||
160799240|NCT02536664|580654579|FG000|Overall Study|Withdrawal by Subject|8|||
160799241|NCT02536664|580654580|FG001|Overall Study|Withdrawal by Subject|5|||
160799242|NCT02536664|580654579|FG000|Overall Study|Other|18|||
160799243|NCT02536664|580654580|FG001|Overall Study|Other|24|||
160799244|NCT02536664|580654579|FG000|Overall Study|Missing|53|||
160799245|NCT02536664|580654580|FG001|Overall Study|Missing|20|||
160799246|NCT03507127|580654584|FG000|Overall Study|Withdrawal by Subject|1|||
160799247|NCT03507127|580654585|FG001|Overall Study|Withdrawal by Subject|0|||
160799248|NCT03507127|580654584|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
160799249|NCT03507127|580654585|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
160799250|NCT01240863|580654586|FG000|Open-label Titration Period|Adverse Event|47|||
160799251|NCT01240863|580654587|FG001|Open-label Titration Period|Adverse Event|0|||
160799252|NCT01240863|580654588|FG002|Open-label Titration Period|Adverse Event|0|||
160799253|NCT01240863|580654586|FG000|Open-label Titration Period|Lack of Efficacy|19|||
160799254|NCT01240863|580654587|FG001|Open-label Titration Period|Lack of Efficacy|0|||
160799255|NCT01240863|580654588|FG002|Open-label Titration Period|Lack of Efficacy|0|||
160799256|NCT01240863|580654586|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
160799257|NCT01240863|580654587|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
160799258|NCT01240863|580654588|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
160799259|NCT01240863|580654586|FG000|Open-label Titration Period|Protocol Violation|7|||
160799260|NCT01240863|580654587|FG001|Open-label Titration Period|Protocol Violation|0|||
160799261|NCT01240863|580654588|FG002|Open-label Titration Period|Protocol Violation|0|||
160799262|NCT01240863|580654586|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
160799263|NCT01240863|580654587|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
160799264|NCT01240863|580654588|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
160799265|NCT01240863|580654586|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
160799266|NCT01240863|580654587|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
160799267|NCT01240863|580654588|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
160799268|NCT01240863|580654586|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
160799269|NCT01240863|580654587|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
160799270|NCT01240863|580654588|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
160799271|NCT01240863|580654586|FG000|Open-label Titration Period|Other|7|||
160799272|NCT01240863|580654587|FG001|Open-label Titration Period|Other|0|||
160799273|NCT01240863|580654588|FG002|Open-label Titration Period|Other|0|||
160799274|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
160799275|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
160799276|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
160799277|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
160799278|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
160799279|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
160799280|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160799281|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
160799282|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
160799283|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
160799284|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
160799285|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
160799286|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
160799287|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
160799288|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
160799289|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
160799290|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
160799291|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
160799292|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
160799293|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
160799294|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
160799295|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
160799296|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
160984176|NCT03527277|581332172|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
160984177|NCT03527277|581332173|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
160984178|NCT01781611|581332174|FG000|Overall Study|Adverse Event|4|||
160984179|NCT01781611|581332175|FG001|Overall Study|Adverse Event|0|||
160984180|NCT02652130|581332176|FG000|Overall Study|Death|1|||
160984181|NCT00354029|581332177|FG000|Overall Study|Protocol Violation|4|||
160984182|NCT00354029|581332178|FG001|Overall Study|Protocol Violation|2|||
160984183|NCT01021332|581332179|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
160984184|NCT01021332|581332179|FG000|Overall Study|Adverse Event|43|||
160984185|NCT01021332|581332179|FG000|Overall Study|Lack of Efficacy|19|||
160984186|NCT01021332|581332179|FG000|Overall Study|Withdrawal of Consent|23|||
160984187|NCT01021332|581332179|FG000|Overall Study|Lost to Follow-up|4|||
160984188|NCT01021332|581332179|FG000|Overall Study|Protocol Violation|9|||
160984189|NCT01021332|581332179|FG000|Overall Study|Miscellaneous|3|||
160984190|NCT00826280|581332180|FG000|Overall Study|Randomized but drug not received|1|||
160984191|NCT00826280|581332181|FG001|Overall Study|Randomized but drug not received|0|||
160984192|NCT00826280|581332182|FG002|Overall Study|Randomized but drug not received|1|||
160984193|NCT00826280|581332180|FG000|Overall Study|Adverse Event|1|||
160984194|NCT00826280|581332181|FG001|Overall Study|Adverse Event|3|||
160984195|NCT00826280|581332182|FG002|Overall Study|Adverse Event|0|||
160984196|NCT00826280|581332180|FG000|Overall Study|Lost to Follow-up|0|||
160984197|NCT00826280|581332181|FG001|Overall Study|Lost to Follow-up|1|||
160799297|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
160799298|NCT03961308|580654590|FG000|Overall Study|Withdrawal by Subject|1|||
160799299|NCT03961308|580654591|FG001|Overall Study|Withdrawal by Subject|0|||
160799300|NCT03961308|580654590|FG000|Overall Study|Other|1|||
160799301|NCT03961308|580654591|FG001|Overall Study|Other|0|||
160799302|NCT03961308|580654590|FG000|Overall Study|Lost to Follow-up|0|||
160799303|NCT03961308|580654591|FG001|Overall Study|Lost to Follow-up|1|||
160799304|NCT03961308|580654590|FG000|Overall Study|Adverse Event|0|||
160799305|NCT03961308|580654591|FG001|Overall Study|Adverse Event|1|||
160799306|NCT02081586|580654597|FG000|Overall Study|Lost to Follow-up|0|||
160799307|NCT02081586|580654598|FG001|Overall Study|Lost to Follow-up|1|||
160799308|NCT02081586|580654599|FG002|Overall Study|Lost to Follow-up|0|||
160799309|NCT02081586|580654600|FG003|Overall Study|Lost to Follow-up|1|||
160799310|NCT02081586|580654597|FG000|Overall Study|Head injury not related to study|0|||
160799311|NCT02081586|580654598|FG001|Overall Study|Head injury not related to study|0|||
160799312|NCT02081586|580654599|FG002|Overall Study|Head injury not related to study|1|||
160799313|NCT02081586|580654600|FG003|Overall Study|Head injury not related to study|0|||
160799314|NCT04549454|580654602|FG000|T1 to T2|Lost to Follow-up|22|||
160799315|NCT04549454|580654603|FG001|T1 to T2|Lost to Follow-up|26|||
160799316|NCT04549454|580654602|FG000|T1 to T3|Lost to Follow-up|31|||
160799317|NCT04549454|580654603|FG001|T1 to T3|Lost to Follow-up|36|||
160799318|NCT01355627|580654614|FG000|Overall Study|Request By the Patient to Discontinue|5|||
160799319|NCT01355627|580654615|FG001|Overall Study|Request By the Patient to Discontinue|7|||
160799320|NCT01355627|580654614|FG000|Overall Study|Lost to Follow-up|8|||
160799321|NCT01355627|580654615|FG001|Overall Study|Lost to Follow-up|7|||
160799322|NCT01355627|580654614|FG000|Overall Study|Fatal Adverse Event|19|||
160799323|NCT01355627|580654615|FG001|Overall Study|Fatal Adverse Event|23|||
160799324|NCT01355627|580654614|FG000|Overall Study|Other|1|||
160799325|NCT01355627|580654615|FG001|Overall Study|Other|1|||
160799326|NCT00545779|580654620|FG000|Overall Study|Violation of selection criteria at entry|8|||
160799327|NCT00545779|580654620|FG000|Overall Study|Other protocol violation|1|||
160799328|NCT00545779|580654620|FG000|Overall Study|Did not cooperate|7|||
160799329|NCT00545779|580654620|FG000|Overall Study|Withdrawal by Subject|20|||
160799330|NCT00545779|580654620|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
160799331|NCT00545779|580654620|FG000|Overall Study|Failure to return|3|||
160799332|NCT01405196|580654621|FG000|Overall Study|Study Terminated by Sponsor|0|||
160799333|NCT01405196|580654622|FG001|Overall Study|Study Terminated by Sponsor|0|||
160799334|NCT01405196|580654623|FG002|Overall Study|Study Terminated by Sponsor|9|||
160799335|NCT01405196|580654624|FG003|Overall Study|Study Terminated by Sponsor|0|||
160799336|NCT01405196|580654621|FG000|Overall Study|Other|2|||
160799337|NCT01405196|580654622|FG001|Overall Study|Other|2|||
160984198|NCT00826280|581332182|FG002|Overall Study|Lost to Follow-up|0|||
160799338|NCT01405196|580654623|FG002|Overall Study|Other|5|||
160799339|NCT01405196|580654624|FG003|Overall Study|Other|0|||
160799340|NCT01405196|580654621|FG000|Overall Study|Withdrawal by Subject|4|||
160799341|NCT01405196|580654622|FG001|Overall Study|Withdrawal by Subject|6|||
160799342|NCT01405196|580654623|FG002|Overall Study|Withdrawal by Subject|3|||
160984199|NCT00826280|581332180|FG000|Overall Study|Sponsor discontinued subject or study|1|||
160984200|NCT00826280|581332181|FG001|Overall Study|Sponsor discontinued subject or study|0|||
160984201|NCT00826280|581332182|FG002|Overall Study|Sponsor discontinued subject or study|0|||
160984202|NCT00826280|581332180|FG000|Overall Study|Reversible ischemic defect not present|43|||
160984203|NCT00826280|581332181|FG001|Overall Study|Reversible ischemic defect not present|40|||
160643891|NCT00449930|580078906|FG001|Overall Study|Lack of Efficacy|1|||
160643892|NCT00449930|580078905|FG000|Overall Study|Lost to Follow-up|9|||
160643893|NCT00449930|580078906|FG001|Overall Study|Lost to Follow-up|14|||
160643894|NCT00449930|580078905|FG000|Overall Study|Physician Decision|1|||
160643895|NCT00449930|580078906|FG001|Overall Study|Physician Decision|2|||
160643896|NCT00449930|580078905|FG000|Overall Study|Protocol Violation|14|||
160643897|NCT00449930|580078906|FG001|Overall Study|Protocol Violation|15|||
160643898|NCT00449930|580078905|FG000|Overall Study|Withdrawal by Subject|16|||
160643899|NCT00449930|580078906|FG001|Overall Study|Withdrawal by Subject|23|||
160643900|NCT00449930|580078905|FG000|Overall Study|Glycemic discontinuation criteria|1|||
160643901|NCT00449930|580078906|FG001|Overall Study|Glycemic discontinuation criteria|1|||
160643902|NCT00575328|580078908|FG000|Overall Study|Adverse Event|1|||
160643903|NCT00575328|580078909|FG001|Overall Study|Adverse Event|1|||
160643904|NCT00575328|580078908|FG000|Overall Study|Lost to Follow-up|2|||
160643905|NCT00575328|580078909|FG001|Overall Study|Lost to Follow-up|1|||
160643906|NCT02868281|580078910|FG000|Overall Study|Adverse Event|2|||
160643907|NCT02868281|580078911|FG001|Overall Study|Adverse Event|2|||
160643908|NCT02868281|580078910|FG000|Overall Study|Protocol Violation|13|||
160643909|NCT02868281|580078911|FG001|Overall Study|Protocol Violation|10|||
160643910|NCT02868281|580078910|FG000|Overall Study|Lost to Follow-up|3|||
160643911|NCT02868281|580078911|FG001|Overall Study|Lost to Follow-up|6|||
160643912|NCT02868281|580078910|FG000|Overall Study|Withdrawal by Subject|11|||
160643913|NCT02868281|580078911|FG001|Overall Study|Withdrawal by Subject|15|||
160643914|NCT02868281|580078910|FG000|Overall Study|Physician Decision|2|||
160643915|NCT02868281|580078911|FG001|Overall Study|Physician Decision|0|||
160643916|NCT02868281|580078910|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
160643917|NCT02868281|580078911|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
160643918|NCT02868281|580078910|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
160643919|NCT02868281|580078911|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
160643920|NCT02868281|580078910|FG000|Overall Study|Long journey/moving away|1|||
160643921|NCT02868281|580078911|FG001|Overall Study|Long journey/moving away|1|||
160643922|NCT01722266|580078912|FG000|Overall Study|Withdrawal by Subject|1|||
160643923|NCT01722266|580078913|FG001|Overall Study|Withdrawal by Subject|2|||
160643924|NCT01722266|580078914|FG002|Overall Study|Withdrawal by Subject|0|||
160643925|NCT01722266|580078915|FG003|Overall Study|Withdrawal by Subject|0|||
160643926|NCT01722266|580078912|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
160643927|NCT01722266|580078913|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
160643928|NCT01722266|580078914|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
160643929|NCT01722266|580078915|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
160643930|NCT01722266|580078912|FG000|Overall Study|Dropped out due to Nausea|0|||
160643931|NCT01722266|580078913|FG001|Overall Study|Dropped out due to Nausea|0|||
160643932|NCT01722266|580078914|FG002|Overall Study|Dropped out due to Nausea|2|||
160643933|NCT01722266|580078915|FG003|Overall Study|Dropped out due to Nausea|0|||
160643934|NCT03811249|580078920|FG000|Overall Study|Withdrawal by Subject|44|||
160643935|NCT03811249|580078920|FG000|Overall Study|Missed Visit|24|||
160643936|NCT00124449|580078921|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
160643937|NCT00124449|580078922|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
160643938|NCT00124449|580078921|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
160643939|NCT00124449|580078922|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
160643940|NCT00124449|580078921|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
160643941|NCT00124449|580078922|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
160643942|NCT00124449|580078921|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
160643943|NCT00124449|580078922|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
160643944|NCT00124449|580078921|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
160643945|NCT00124449|580078922|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
160643946|NCT00124449|580078921|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
160643947|NCT00124449|580078922|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
160643948|NCT00124449|580078921|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
160643949|NCT00124449|580078922|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
160643950|NCT00124449|580078921|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
160643951|NCT00124449|580078922|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
160643952|NCT00124449|580078921|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
160643953|NCT00124449|580078922|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
160643954|NCT00124449|580078921|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
160643955|NCT00124449|580078922|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
160643956|NCT00124449|580078921|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
160643957|NCT00124449|580078922|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
160643958|NCT00124449|580078921|FG000|18-Month Untreated Observation Period|Relocated|1|||
160643959|NCT00124449|580078922|FG001|18-Month Untreated Observation Period|Relocated|0|||
160643960|NCT04304950|580078927|FG000|Overall Study|Lost to Follow-up|1|||
160643961|NCT04304950|580078928|FG001|Overall Study|Lost to Follow-up|1|||
160984204|NCT00826280|581332182|FG002|Overall Study|Reversible ischemic defect not present|44|||
160984205|NCT00826280|581332180|FG000|Overall Study|Interpretation Failure|1|||
160984206|NCT00826280|581332181|FG001|Overall Study|Interpretation Failure|0|||
160984207|NCT00826280|581332182|FG002|Overall Study|Interpretation Failure|0|||
160984208|NCT00826280|581332180|FG000|Overall Study|Machine Failure|1|||
160984209|NCT00826280|581332181|FG001|Overall Study|Machine Failure|1|||
160984210|NCT00826280|581332182|FG002|Overall Study|Machine Failure|0|||
160984211|NCT00826280|581332180|FG000|Overall Study|One or more non-interpretable scan|0|||
160984212|NCT00826280|581332181|FG001|Overall Study|One or more non-interpretable scan|1|||
160984213|NCT00826280|581332182|FG002|Overall Study|One or more non-interpretable scan|1|||
160984214|NCT00750893|581332196|FG000|Overall Study|Adverse Event|5|||
160984215|NCT00750893|581332196|FG000|Overall Study|Withdrawal by Subject|10|||
160984216|NCT00750893|581332196|FG000|Overall Study|Lost to Follow-up|510|||
160984217|NCT00750893|581332196|FG000|Overall Study|Other|17|||
160984218|NCT00661258|581332203|FG000|Overall Study|Death|1|||
160984219|NCT00661258|581332204|FG001|Overall Study|Death|0|||
160984220|NCT00661258|581332203|FG000|Overall Study|caught by police and in detox center|2|||
160984221|NCT00661258|581332204|FG001|Overall Study|caught by police and in detox center|1|||
160984222|NCT01628874|581332205|FG000|Overall Study|Physician Decision|1|||
160984223|NCT01628874|581332206|FG001|Overall Study|Physician Decision|1|||
160984224|NCT01628874|581332205|FG000|Overall Study|Age >4 months|4|||
160984225|NCT01628874|581332206|FG001|Overall Study|Age >4 months|2|||
160984226|NCT03486899|581332207|FG000|Overall Study|Lost to Follow-up|4|||
160984227|NCT03486899|581332208|FG001|Overall Study|Lost to Follow-up|1|||
160984228|NCT03486899|581332209|FG002|Overall Study|Lost to Follow-up|4|||
160984229|NCT03486899|581332210|FG003|Overall Study|Lost to Follow-up|3|||
160984230|NCT03486899|581332207|FG000|Overall Study|Death|1|||
160984231|NCT03486899|581332208|FG001|Overall Study|Death|0|||
160984232|NCT03486899|581332209|FG002|Overall Study|Death|0|||
160984233|NCT03486899|581332210|FG003|Overall Study|Death|1|||
160984234|NCT03486899|581332207|FG000|Overall Study|Adverse Event|0|||
160984235|NCT03486899|581332208|FG001|Overall Study|Adverse Event|2|||
160984236|NCT03486899|581332209|FG002|Overall Study|Adverse Event|0|||
160984237|NCT03486899|581332210|FG003|Overall Study|Adverse Event|2|||
160984238|NCT03486899|581332207|FG000|Overall Study|Withdrawal by Subject|3|||
160984239|NCT03486899|581332208|FG001|Overall Study|Withdrawal by Subject|7|||
160984240|NCT03486899|581332209|FG002|Overall Study|Withdrawal by Subject|4|||
160984241|NCT03486899|581332210|FG003|Overall Study|Withdrawal by Subject|3|||
160984242|NCT03486899|581332207|FG000|Overall Study|Other Reasons|0|||
160984243|NCT03486899|581332208|FG001|Overall Study|Other Reasons|1|||
160984244|NCT03486899|581332209|FG002|Overall Study|Other Reasons|0|||
160984245|NCT03486899|581332210|FG003|Overall Study|Other Reasons|1|||
160984246|NCT01439711|581332211|FG000|Overall Study|Ineligible|13|||
160984247|NCT01439711|581332211|FG000|Overall Study|Cancel|3|||
160984248|NCT01439711|581332211|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
160895567|NCT01912963|581012920|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
160895568|NCT01912963|581012921|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
160895569|NCT01912963|581012919|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
160895570|NCT01912963|581012920|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
160895571|NCT01912963|581012921|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
160895572|NCT01912963|581012919|FG000|Overall Study|Adverse Event|0|||
160895573|NCT01912963|581012920|FG001|Overall Study|Adverse Event|1|||
160895574|NCT01912963|581012921|FG002|Overall Study|Adverse Event|1|||
160895575|NCT01912963|581012919|FG000|Overall Study|Withdrawal by Subject|0|||
160895576|NCT01912963|581012920|FG001|Overall Study|Withdrawal by Subject|1|||
160895577|NCT01912963|581012921|FG002|Overall Study|Withdrawal by Subject|0|||
160895578|NCT01912963|581012919|FG000|Overall Study|Sought treatment locally|0|||
160895579|NCT01912963|581012920|FG001|Overall Study|Sought treatment locally|1|||
160895580|NCT01912963|581012921|FG002|Overall Study|Sought treatment locally|0|||
160895581|NCT01336569|581012925|FG000|Overall Study|Lost to Follow-up|4|||
160895582|NCT00406354|581012926|FG000|All Randomized Patients|Protocol Violation|0|||
160895583|NCT00406354|581012927|FG001|All Randomized Patients|Protocol Violation|0|||
160895584|NCT00406354|581012928|FG002|All Randomized Patients|Protocol Violation|1|||
160895585|NCT00406354|581012926|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
160895586|NCT00406354|581012927|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
160895587|NCT00406354|581012928|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
160895588|NCT00406354|581012926|FG000|All Randomized and Treated Patients|Adverse Event|6|||
160984249|NCT01439711|581332211|FG000|Overall Study|Adverse Event|5|||
160895589|NCT00406354|581012927|FG001|All Randomized and Treated Patients|Adverse Event|2|||
160984250|NCT01439711|581332211|FG000|Overall Study|Withdrawal by Subject|3|||
160984251|NCT01439711|581332211|FG000|Overall Study|Progression During Active Tx|3|||
160984252|NCT01439711|581332211|FG000|Overall Study|Noncompliance|3|||
160984253|NCT01439711|581332211|FG000|Overall Study|No MRI|9|||
160984254|NCT04242875|581332212|FG000|Overall Study|Adverse Event|2|||
160984255|NCT02397460|581332213|FG000|Treatment Period 2|Adverse Event|0|||
160984256|NCT02397460|581332214|FG001|Treatment Period 2|Adverse Event|0|||
160984257|NCT02397460|581332215|FG002|Treatment Period 2|Adverse Event|0|||
160895590|NCT00406354|581012928|FG002|All Randomized and Treated Patients|Adverse Event|1|||
160895591|NCT00406354|581012926|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
160895592|NCT00406354|581012927|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
160895593|NCT00406354|581012928|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
160895594|NCT00406354|581012926|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
160895595|NCT00406354|581012927|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
160895596|NCT00406354|581012928|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
160895597|NCT00406354|581012926|FG000|All Randomized and Treated Patients|Physician Decision|0|||
160895598|NCT00406354|581012927|FG001|All Randomized and Treated Patients|Physician Decision|0|||
160895599|NCT00406354|581012928|FG002|All Randomized and Treated Patients|Physician Decision|1|||
160895600|NCT02027376|581012937|FG000|Overall Study|Death|1|||
160895601|NCT02027376|581012938|FG001|Overall Study|Death|0|||
160895602|NCT02027376|581012939|FG002|Overall Study|Death|0|||
160895603|NCT02130024|581012940|FG000|Overall Study|Adverse Event|10|||
160895604|NCT02130024|581012941|FG001|Overall Study|Adverse Event|11|||
160895605|NCT02130024|581012940|FG000|Overall Study|Death|2|||
160895606|NCT02130024|581012941|FG001|Overall Study|Death|2|||
160895607|NCT02130024|581012940|FG000|Overall Study|Lost to Follow-up|1|||
160895608|NCT02130024|581012941|FG001|Overall Study|Lost to Follow-up|1|||
160895609|NCT02130024|581012940|FG000|Overall Study|Physician Decision|1|||
160895610|NCT02130024|581012941|FG001|Overall Study|Physician Decision|3|||
160895611|NCT02130024|581012940|FG000|Overall Study|Protocol Deviation|4|||
160895612|NCT02130024|581012941|FG001|Overall Study|Protocol Deviation|0|||
160895613|NCT02130024|581012940|FG000|Overall Study|Site Administration Problems|1|||
160895614|NCT02130024|581012941|FG001|Overall Study|Site Administration Problems|0|||
160895615|NCT02130024|581012940|FG000|Overall Study|Subject Withdrew Consent|6|||
160895616|NCT02130024|581012941|FG001|Overall Study|Subject Withdrew Consent|14|||
160895617|NCT05597020|581012942|FG000|Washout|Forbidden medication|2|||
160895618|NCT05597020|581012943|FG001|Washout|Forbidden medication|0|||
160895619|NCT05597020|581012942|FG000|Treatment Period II|Advice from primary care physician|1|||
160895620|NCT05597020|581012943|FG001|Treatment Period II|Advice from primary care physician|0|||
160895621|NCT05597020|581012942|FG000|Treatment Period II|Subject lost investigational product|1|||
160895622|NCT05597020|581012943|FG001|Treatment Period II|Subject lost investigational product|0|||
160895623|NCT05597020|581012942|FG000|Treatment Period II|Private reasons|0|||
160895624|NCT05597020|581012943|FG001|Treatment Period II|Private reasons|1|||
160895625|NCT05736224|581012944|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
160895626|NCT01015131|581012945|FG000|Overall Study|Physician Decision|1|||
160895627|NCT01015131|581012945|FG000|Overall Study|Protocol Violation|1|||
160895628|NCT01015131|581012945|FG000|Overall Study|Withdrawal by Subject|2|||
160895629|NCT01015131|581012945|FG000|Overall Study|Other Protocol Specified Criteria|4|||
160895630|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
160895631|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895632|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895633|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895634|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895635|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895636|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895637|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
160895638|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895639|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895640|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895641|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895642|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895643|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895644|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
160895645|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160895646|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160895647|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160895648|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160895649|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160984258|NCT02397460|581332216|FG003|Treatment Period 2|Adverse Event|0|||
160895650|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160895651|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
160895652|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895653|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895654|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895655|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895656|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895657|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895658|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
160895659|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895660|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895661|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895662|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895663|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895664|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895665|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
160895666|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895667|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895668|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895669|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895670|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895671|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895672|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
160895673|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895674|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895675|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895676|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895677|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895678|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895679|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
160895680|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895681|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895682|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895683|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895684|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895685|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895686|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
160895687|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895688|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895689|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895690|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895691|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895692|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895693|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
160895694|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160895695|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160984259|NCT02397460|581332217|FG004|Treatment Period 2|Adverse Event|0|||
160984260|NCT02397460|581332218|FG005|Treatment Period 2|Adverse Event|0|||
160984261|NCT02397460|581332219|FG006|Treatment Period 2|Adverse Event|0|||
160984262|NCT02397460|581332220|FG007|Treatment Period 2|Adverse Event|1|||
160984263|NCT02397460|581332213|FG000|Treatment Period 4|Adverse Event|0|||
160984264|NCT02397460|581332214|FG001|Treatment Period 4|Adverse Event|1|||
160984265|NCT02397460|581332215|FG002|Treatment Period 4|Adverse Event|0|||
160984266|NCT02397460|581332216|FG003|Treatment Period 4|Adverse Event|0|||
160984267|NCT02397460|581332217|FG004|Treatment Period 4|Adverse Event|0|||
160984268|NCT02397460|581332218|FG005|Treatment Period 4|Adverse Event|0|||
160984269|NCT02397460|581332219|FG006|Treatment Period 4|Adverse Event|0|||
160984270|NCT02397460|581332220|FG007|Treatment Period 4|Adverse Event|0|||
160984271|NCT02397460|581332213|FG000|Treatment Period 4|Physician Decision|0|||
160984272|NCT02397460|581332214|FG001|Treatment Period 4|Physician Decision|0|||
160984273|NCT02397460|581332215|FG002|Treatment Period 4|Physician Decision|0|||
160984274|NCT02397460|581332216|FG003|Treatment Period 4|Physician Decision|0|||
160984275|NCT02397460|581332217|FG004|Treatment Period 4|Physician Decision|1|||
160984276|NCT02397460|581332218|FG005|Treatment Period 4|Physician Decision|0|||
160984277|NCT02397460|581332219|FG006|Treatment Period 4|Physician Decision|0|||
160984278|NCT02397460|581332220|FG007|Treatment Period 4|Physician Decision|0|||
160984279|NCT01723826|581332224|FG000|Overall Study|Adverse Event|4|||
160984280|NCT01723826|581332225|FG001|Overall Study|Adverse Event|1|||
160984281|NCT01723826|581332226|FG002|Overall Study|Adverse Event|4|||
160984282|NCT01723826|581332227|FG003|Overall Study|Adverse Event|5|||
160984283|NCT01723826|581332224|FG000|Overall Study|Death according to AE eCRF|2|||
160984284|NCT01723826|581332225|FG001|Overall Study|Death according to AE eCRF|3|||
160984285|NCT01723826|581332226|FG002|Overall Study|Death according to AE eCRF|3|||
160984286|NCT01723826|581332227|FG003|Overall Study|Death according to AE eCRF|7|||
160984287|NCT01723826|581332224|FG000|Overall Study|Lost to Follow-up|1|||
160984288|NCT01723826|581332225|FG001|Overall Study|Lost to Follow-up|3|||
160984289|NCT01723826|581332226|FG002|Overall Study|Lost to Follow-up|1|||
160984290|NCT01723826|581332227|FG003|Overall Study|Lost to Follow-up|1|||
160984291|NCT01723826|581332224|FG000|Overall Study|Non-compliance|0|||
160984292|NCT01723826|581332225|FG001|Overall Study|Non-compliance|1|||
160984293|NCT01723826|581332226|FG002|Overall Study|Non-compliance|3|||
160984294|NCT01723826|581332227|FG003|Overall Study|Non-compliance|3|||
160984295|NCT01723826|581332224|FG000|Overall Study|Non-compliance With Study Drug|0|||
160984296|NCT01723826|581332225|FG001|Overall Study|Non-compliance With Study Drug|1|||
160984297|NCT01723826|581332226|FG002|Overall Study|Non-compliance With Study Drug|0|||
160984298|NCT01723826|581332227|FG003|Overall Study|Non-compliance With Study Drug|0|||
160984299|NCT01723826|581332224|FG000|Overall Study|Other Reason|8|||
160984300|NCT01723826|581332225|FG001|Overall Study|Other Reason|6|||
160984301|NCT01723826|581332226|FG002|Overall Study|Other Reason|12|||
160984302|NCT01723826|581332227|FG003|Overall Study|Other Reason|14|||
160984303|NCT01723826|581332224|FG000|Overall Study|Physician Decision|1|||
160984304|NCT01723826|581332225|FG001|Overall Study|Physician Decision|3|||
160984305|NCT01723826|581332226|FG002|Overall Study|Physician Decision|4|||
160984306|NCT01723826|581332227|FG003|Overall Study|Physician Decision|11|||
160984307|NCT01723826|581332224|FG000|Overall Study|Protocol Violation|1|||
160984308|NCT01723826|581332225|FG001|Overall Study|Protocol Violation|1|||
160984309|NCT01723826|581332226|FG002|Overall Study|Protocol Violation|3|||
160984310|NCT01723826|581332227|FG003|Overall Study|Protocol Violation|1|||
160984311|NCT01723826|581332224|FG000|Overall Study|Withdrawal by Subject|10|||
160984312|NCT01723826|581332225|FG001|Overall Study|Withdrawal by Subject|17|||
160984313|NCT01723826|581332226|FG002|Overall Study|Withdrawal by Subject|27|||
160984314|NCT01723826|581332227|FG003|Overall Study|Withdrawal by Subject|48|||
160984315|NCT01767129|581332228|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
160984316|NCT01767129|581332229|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
160984317|NCT01473420|581332232|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
160984318|NCT01473420|581332233|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
160984319|NCT01473420|581332232|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
160984320|NCT01473420|581332233|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
160984321|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
160984322|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
160984323|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
160984324|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
160984325|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
160984326|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
160984327|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
160984328|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
160984329|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
160984330|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
160984331|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
160984332|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
160984333|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
160984334|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
160895696|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160895697|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160895698|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160895699|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160895700|NCT04526509|581012946|FG000|Enrolled|Study Terminated by Sponsor|0|||
160895701|NCT04526509|581012947|FG001|Enrolled|Study Terminated by Sponsor|0|||
160895702|NCT04526509|581012948|FG002|Enrolled|Study Terminated by Sponsor|0|||
160895703|NCT04526509|581012949|FG003|Enrolled|Study Terminated by Sponsor|0|||
160895704|NCT04526509|581012950|FG004|Enrolled|Study Terminated by Sponsor|0|||
160895705|NCT04526509|581012951|FG005|Enrolled|Study Terminated by Sponsor|0|||
160895706|NCT04526509|581012952|FG006|Enrolled|Study Terminated by Sponsor|1|||
160895707|NCT04526509|581012946|FG000|Enrolled|Death prior to lymphodepletion|0|||
160895708|NCT04526509|581012947|FG001|Enrolled|Death prior to lymphodepletion|0|||
160895709|NCT04526509|581012948|FG002|Enrolled|Death prior to lymphodepletion|0|||
160895710|NCT04526509|581012949|FG003|Enrolled|Death prior to lymphodepletion|1|||
160895711|NCT04526509|581012950|FG004|Enrolled|Death prior to lymphodepletion|0|||
160895712|NCT04526509|581012951|FG005|Enrolled|Death prior to lymphodepletion|0|||
160895713|NCT04526509|581012952|FG006|Enrolled|Death prior to lymphodepletion|0|||
160895714|NCT04526509|581012946|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895715|NCT04526509|581012947|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895716|NCT04526509|581012948|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895717|NCT04526509|581012949|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
160895718|NCT04526509|581012950|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895719|NCT04526509|581012951|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895720|NCT04526509|581012952|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895721|NCT04526509|581012946|FG000|Enrolled|Physician Decision|0|||
160895722|NCT04526509|581012947|FG001|Enrolled|Physician Decision|1|||
160895723|NCT04526509|581012948|FG002|Enrolled|Physician Decision|0|||
160895724|NCT04526509|581012949|FG003|Enrolled|Physician Decision|0|||
160895725|NCT04526509|581012950|FG004|Enrolled|Physician Decision|0|||
160895726|NCT04526509|581012951|FG005|Enrolled|Physician Decision|0|||
160895727|NCT04526509|581012952|FG006|Enrolled|Physician Decision|0|||
160895728|NCT02887859|581012953|FG000|Overall Study|Ongoing|6|||
160895729|NCT02887859|581012953|FG000|Overall Study|Adverse Event|7|||
160895730|NCT02887859|581012953|FG000|Overall Study|Death|1|||
160895731|NCT02887859|581012953|FG000|Overall Study|Physician Decision|1|||
160895732|NCT01554397|581012954|FG000|Overall Study|Withdrawal by Subject|1|||
160895733|NCT01554397|581012955|FG001|Overall Study|Withdrawal by Subject|0|||
160895734|NCT01554397|581012954|FG000|Overall Study|Ineligible|7|||
160895735|NCT01554397|581012955|FG001|Overall Study|Ineligible|0|||
160895736|NCT03817879|581014843|FG000|Overall Study|Drop out|5|||
160895737|NCT03817879|581014844|FG001|Overall Study|Drop out|12|||
160895738|NCT03817879|581014843|FG000|Overall Study|Withdrawal by Subject|0|||
160895739|NCT03817879|581014844|FG001|Overall Study|Withdrawal by Subject|1|||
160895740|NCT04493333|581014845|FG000|Overall Study|Withdrawal by Subject|1|||
160895741|NCT04493333|581014846|FG001|Overall Study|Withdrawal by Subject|1|||
160895742|NCT04493333|581014845|FG000|Overall Study|Ineligible|0|||
160895743|NCT04493333|581014846|FG001|Overall Study|Ineligible|1|||
160895744|NCT04493333|581014845|FG000|Overall Study|Noncompliance|2|||
160895745|NCT04493333|581014846|FG001|Overall Study|Noncompliance|1|||
160895746|NCT02206048|581014852|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
160895747|NCT02925923|581014853|FG000|Overall Study|blood samples hemolyzed|0|||
160895748|NCT02925923|581014854|FG001|Overall Study|blood samples hemolyzed|2|||
160895749|NCT00697073|581014855|FG000|Overall Study|Withdrawal by Subject|2|||
160895750|NCT00697073|581014855|FG000|Overall Study|Pregnancy|1|||
160895751|NCT00697073|581014855|FG000|Overall Study|non compliance and other|6|||
160895752|NCT00426231|581014856|FG000|Overall Study|Withdrawal by Subject|9|||
160895753|NCT00426231|581014857|FG001|Overall Study|Withdrawal by Subject|12|||
160895754|NCT03911713|581014858|FG000|Overall Study|Lost to Follow-up|0|||
160895755|NCT03911713|581014859|FG001|Overall Study|Lost to Follow-up|2|||
160895756|NCT03911713|581014860|FG002|Overall Study|Lost to Follow-up|0|||
160895757|NCT03911713|581014861|FG003|Overall Study|Lost to Follow-up|0|||
160895758|NCT03911713|581014862|FG004|Overall Study|Lost to Follow-up|0|||
160895759|NCT03911713|581014858|FG000|Overall Study|Other|0|||
160895760|NCT03911713|581014859|FG001|Overall Study|Other|0|||
160895761|NCT03911713|581014860|FG002|Overall Study|Other|0|||
160895762|NCT03911713|581014861|FG003|Overall Study|Other|1|||
160895763|NCT03911713|581014862|FG004|Overall Study|Other|0|||
160895764|NCT03911713|581014858|FG000|Overall Study|Randomized, Never Dosed|1|||
160895765|NCT03911713|581014859|FG001|Overall Study|Randomized, Never Dosed|0|||
160895766|NCT03911713|581014860|FG002|Overall Study|Randomized, Never Dosed|0|||
160895767|NCT03911713|581014861|FG003|Overall Study|Randomized, Never Dosed|1|||
160895768|NCT03911713|581014862|FG004|Overall Study|Randomized, Never Dosed|0|||
160895769|NCT00108433|581014865|FG000|Overall Study|Lack of Efficacy|1|||
160799343|NCT01405196|580654624|FG003|Overall Study|Withdrawal by Subject|6|||
160799344|NCT01405196|580654621|FG000|Overall Study|Adverse Event|2|||
160799345|NCT01405196|580654622|FG001|Overall Study|Adverse Event|2|||
160799346|NCT01405196|580654623|FG002|Overall Study|Adverse Event|0|||
160799347|NCT01405196|580654624|FG003|Overall Study|Adverse Event|2|||
160799348|NCT01405196|580654621|FG000|Overall Study|Death|1|||
160799349|NCT01405196|580654622|FG001|Overall Study|Death|0|||
160799350|NCT01405196|580654623|FG002|Overall Study|Death|3|||
160799351|NCT01405196|580654624|FG003|Overall Study|Death|0|||
160799352|NCT01405196|580654621|FG000|Overall Study|Lost to Follow-up|2|||
160799353|NCT01405196|580654622|FG001|Overall Study|Lost to Follow-up|2|||
160799354|NCT01405196|580654623|FG002|Overall Study|Lost to Follow-up|3|||
160799355|NCT01405196|580654624|FG003|Overall Study|Lost to Follow-up|1|||
160799356|NCT01542788|580654625|FG000|Overall Study|Randomized but Not Treated|2|||
160799357|NCT01542788|580654626|FG001|Overall Study|Randomized but Not Treated|0|||
160799358|NCT01542788|580654625|FG000|Overall Study|Lack of Efficacy|41|||
160799359|NCT01542788|580654626|FG001|Overall Study|Lack of Efficacy|71|||
160799360|NCT01542788|580654625|FG000|Overall Study|Lost to Follow-up|5|||
160799361|NCT01542788|580654626|FG001|Overall Study|Lost to Follow-up|0|||
160799362|NCT01542788|580654625|FG000|Overall Study|Death|3|||
160799363|NCT01542788|580654626|FG001|Overall Study|Death|0|||
160799364|NCT01542788|580654625|FG000|Overall Study|Protocol Violation|2|||
160799365|NCT01542788|580654626|FG001|Overall Study|Protocol Violation|0|||
160799366|NCT01542788|580654625|FG000|Overall Study|Physician Decision|1|||
160799367|NCT01542788|580654626|FG001|Overall Study|Physician Decision|0|||
160799368|NCT01542788|580654625|FG000|Overall Study|Withdrawal by Subject|1|||
160799369|NCT01542788|580654626|FG001|Overall Study|Withdrawal by Subject|0|||
160799370|NCT05643495|580654627|FG000|Overall Study|Adverse Event|0|||
160895770|NCT00108433|581014866|FG001|Overall Study|Lack of Efficacy|2|||
160895771|NCT00108433|581014865|FG000|Overall Study|Death|3|||
160895772|NCT00108433|581014866|FG001|Overall Study|Death|0|||
160895773|NCT00108433|581014865|FG000|Overall Study|Adverse Event|3|||
160895774|NCT00108433|581014866|FG001|Overall Study|Adverse Event|1|||
160895775|NCT00108433|581014865|FG000|Overall Study|Other|14|||
160895776|NCT00108433|581014866|FG001|Overall Study|Other|14|||
160895777|NCT02203071|581014867|FG000|Overall Study|Lost to Follow-up|3|||
160895778|NCT02203071|581014868|FG001|Overall Study|Lost to Follow-up|1|||
160895779|NCT01845818|581014869|FG000|Overall Study|Withdrawal by Subject|0|||
160895780|NCT01845818|581014870|FG001|Overall Study|Withdrawal by Subject|1|||
160895781|NCT01845818|581014869|FG000|Overall Study|Lost to Follow-up|7|||
160895782|NCT01845818|581014870|FG001|Overall Study|Lost to Follow-up|5|||
160895783|NCT01845818|581014869|FG000|Overall Study|Administrative Reasons|3|||
160895784|NCT01845818|581014870|FG001|Overall Study|Administrative Reasons|1|||
160895785|NCT01845818|581014869|FG000|Overall Study|Serious Adverse Event|1|||
160895786|NCT01845818|581014870|FG001|Overall Study|Serious Adverse Event|1|||
160895787|NCT01845818|581014869|FG000|Overall Study|Other|25|||
160895788|NCT01845818|581014870|FG001|Overall Study|Other|8|||
160895789|NCT01845818|581014869|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
160895790|NCT01845818|581014870|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
160895791|NCT01845818|581014869|FG000|Overall Study|No Follow-Up Data Available|4|||
160895792|NCT01845818|581014870|FG001|Overall Study|No Follow-Up Data Available|1|||
160895793|NCT02595970|581014871|FG000|Overall Study|Withdrawal by Subject|2|||
160895794|NCT02595970|581014871|FG000|Overall Study|Physician Decision|2|||
160895795|NCT02595970|581014871|FG000|Overall Study|Protocol Violation|4|||
160895796|NCT02595970|581014871|FG000|Overall Study|Adverse Event|5|||
160895797|NCT02595970|581014871|FG000|Overall Study|Lack of Efficacy|7|||
160895798|NCT02572388|581014872|FG000|Overall Study|Withdrawal by Subject|1|||
160895799|NCT02572388|581014873|FG001|Overall Study|Withdrawal by Subject|1|||
160895800|NCT02572388|581014874|FG002|Overall Study|Withdrawal by Subject|2|||
160895801|NCT02572388|581014875|FG003|Overall Study|Withdrawal by Subject|2|||
160895802|NCT02202837|581014877|FG000|Overall Study|Enbrel treatment discontinued|36|||
160895803|NCT02202837|581014878|FG001|Overall Study|Enbrel treatment discontinued|4|||
160895804|NCT02202837|581014877|FG000|Overall Study|Other|10|||
160895805|NCT02202837|581014878|FG001|Overall Study|Other|0|||
160895806|NCT02202837|581014877|FG000|Overall Study|Lost to Follow-up|7|||
160895807|NCT02202837|581014878|FG001|Overall Study|Lost to Follow-up|1|||
160799371|NCT05643495|580654628|FG001|Overall Study|Adverse Event|1|||
160799372|NCT05643495|580654627|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
160799373|NCT05643495|580654628|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
160799374|NCT02257528|580654629|FG000|Overall Study|Never received study treatment|1|||
160799375|NCT00698841|580654630|FG000|Overall Study|Withdrawal by Subject|2|||
160895808|NCT00231842|581014884|FG000|Overall Study|Withdrawal by Subject|3|||
160895809|NCT00231842|581014884|FG000|Overall Study|Did not complete the last 3 cycle|8|||
160895810|NCT02422303|581014885|FG000|Overall Study|Lost to Follow-up|1|||
160895811|NCT02422303|581014886|FG001|Overall Study|Lost to Follow-up|1|||
160895812|NCT00850343|581014887|FG000|Overall Study|Withdrawal by Subject|11|||
160895813|NCT00850343|581014888|FG001|Overall Study|Withdrawal by Subject|0|||
160895814|NCT00850343|581014889|FG002|Overall Study|Withdrawal by Subject|3|||
160895815|NCT00850343|581014890|FG003|Overall Study|Withdrawal by Subject|2|||
160984335|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
160984336|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
160984337|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
160984338|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
160984339|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
160984340|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
160984341|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
160984342|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
160984343|NCT02906202|581332244|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
160984344|NCT03990363|581332246|FG000|Overall Study|Withdrawal by Subject|10|||
160984345|NCT03990363|581332247|FG001|Overall Study|Withdrawal by Subject|9|||
160984346|NCT03990363|581332248|FG002|Overall Study|Withdrawal by Subject|18|||
160984347|NCT03990363|581332249|FG003|Overall Study|Withdrawal by Subject|11|||
160984348|NCT03990363|581332250|FG004|Overall Study|Withdrawal by Subject|9|||
160984349|NCT03990363|581332246|FG000|Overall Study|Physician Decision|1|||
160984350|NCT03990363|581332247|FG001|Overall Study|Physician Decision|0|||
160984351|NCT03990363|581332248|FG002|Overall Study|Physician Decision|0|||
160984352|NCT03990363|581332249|FG003|Overall Study|Physician Decision|0|||
160984353|NCT03990363|581332250|FG004|Overall Study|Physician Decision|0|||
160984354|NCT03990363|581332246|FG000|Overall Study|Adverse Event|1|||
160984355|NCT03990363|581332247|FG001|Overall Study|Adverse Event|3|||
160984356|NCT03990363|581332248|FG002|Overall Study|Adverse Event|2|||
160984357|NCT03990363|581332249|FG003|Overall Study|Adverse Event|2|||
160984358|NCT03990363|581332250|FG004|Overall Study|Adverse Event|0|||
160984359|NCT03990363|581332246|FG000|Overall Study|Death|14|||
160984360|NCT03990363|581332247|FG001|Overall Study|Death|8|||
160984361|NCT03990363|581332248|FG002|Overall Study|Death|14|||
160984362|NCT03990363|581332249|FG003|Overall Study|Death|10|||
160984363|NCT03990363|581332250|FG004|Overall Study|Death|11|||
160984364|NCT03990363|581332246|FG000|Overall Study|Failure to meet randomization criteria|0|||
160984365|NCT03990363|581332247|FG001|Overall Study|Failure to meet randomization criteria|1|||
160643962|NCT01337050|580078933|FG000|Overall Study|Death|0|||
160643963|NCT01337050|580078934|FG001|Overall Study|Death|0|||
160643964|NCT01337050|580078935|FG002|Overall Study|Death|4|||
160643965|NCT01337050|580078933|FG000|Overall Study|Other|4|||
160643966|NCT01337050|580078934|FG001|Overall Study|Other|6|||
160643967|NCT01337050|580078935|FG002|Overall Study|Other|8|||
160643968|NCT01337050|580078933|FG000|Overall Study|Participants refused further follow-up|0|||
160643969|NCT01337050|580078934|FG001|Overall Study|Participants refused further follow-up|7|||
160643970|NCT01337050|580078935|FG002|Overall Study|Participants refused further follow-up|7|||
160895816|NCT00850343|581014887|FG000|Overall Study|Adverse Event|15|||
160895817|NCT00850343|581014888|FG001|Overall Study|Adverse Event|2|||
160895818|NCT00850343|581014889|FG002|Overall Study|Adverse Event|6|||
160895819|NCT00850343|581014890|FG003|Overall Study|Adverse Event|6|||
160895820|NCT00850343|581014887|FG000|Overall Study|Pregnancy|0|||
160895821|NCT00850343|581014888|FG001|Overall Study|Pregnancy|0|||
160895822|NCT00850343|581014889|FG002|Overall Study|Pregnancy|0|||
160895823|NCT00850343|581014890|FG003|Overall Study|Pregnancy|1|||
160895824|NCT00850343|581014887|FG000|Overall Study|Lack of Efficacy|17|||
160895825|NCT00850343|581014888|FG001|Overall Study|Lack of Efficacy|0|||
160895826|NCT00850343|581014889|FG002|Overall Study|Lack of Efficacy|3|||
160895827|NCT00850343|581014890|FG003|Overall Study|Lack of Efficacy|2|||
160895828|NCT00850343|581014887|FG000|Overall Study|Non-compliance with Study Procedures|1|||
160895829|NCT00850343|581014888|FG001|Overall Study|Non-compliance with Study Procedures|0|||
160984366|NCT03990363|581332248|FG002|Overall Study|Failure to meet randomization criteria|1|||
160643971|NCT00003102|580078936|FG000|Overall Study|Physician Decision|1|||
160643972|NCT00003102|580078937|FG001|Overall Study|Physician Decision|1|||
160643973|NCT00003102|580078938|FG002|Overall Study|Physician Decision|0|||
160643974|NCT00003102|580078936|FG000|Overall Study|Progressive Disease|0|||
160643975|NCT00003102|580078937|FG001|Overall Study|Progressive Disease|1|||
160643976|NCT00003102|580078938|FG002|Overall Study|Progressive Disease|0|||
160643977|NCT00003102|580078936|FG000|Overall Study|Adverse Event|0|||
160643978|NCT00003102|580078937|FG001|Overall Study|Adverse Event|1|||
160643979|NCT00003102|580078938|FG002|Overall Study|Adverse Event|1|||
160643980|NCT00003102|580078936|FG000|Overall Study|Death|0|||
160643981|NCT00003102|580078937|FG001|Overall Study|Death|0|||
160643982|NCT00003102|580078938|FG002|Overall Study|Death|1|||
160643983|NCT01559818|580078941|FG000|Overall Study|Physician Decision|1|||
160643984|NCT01559818|580078941|FG000|Overall Study|Pregnancy|1|||
160643985|NCT01559818|580078941|FG000|Overall Study|Study terminated by Sponsor|4|||
160643986|NCT01559818|580078941|FG000|Overall Study|Withdrawal by Subject|1|||
160643987|NCT01512979|580078942|FG000|Overall Study|Adverse Event|2|||
160643988|NCT01512979|580078943|FG001|Overall Study|Adverse Event|2|||
160895830|NCT00850343|581014889|FG002|Overall Study|Non-compliance with Study Procedures|1|||
160984367|NCT03990363|581332249|FG003|Overall Study|Failure to meet randomization criteria|0|||
160984368|NCT03990363|581332250|FG004|Overall Study|Failure to meet randomization criteria|0|||
160984369|NCT03990363|581332246|FG000|Overall Study|Lost to Follow-up|0|||
160984370|NCT03990363|581332247|FG001|Overall Study|Lost to Follow-up|0|||
160984371|NCT03990363|581332248|FG002|Overall Study|Lost to Follow-up|0|||
160984372|NCT03990363|581332249|FG003|Overall Study|Lost to Follow-up|1|||
160984373|NCT03990363|581332250|FG004|Overall Study|Lost to Follow-up|2|||
160984374|NCT03990363|581332246|FG000|Overall Study|Non-compliance with study drug|2|||
160984375|NCT03990363|581332247|FG001|Overall Study|Non-compliance with study drug|1|||
160984376|NCT03990363|581332248|FG002|Overall Study|Non-compliance with study drug|2|||
160984377|NCT03990363|581332249|FG003|Overall Study|Non-compliance with study drug|0|||
160984378|NCT03990363|581332250|FG004|Overall Study|Non-compliance with study drug|0|||
160984379|NCT03990363|581332246|FG000|Overall Study|Study terminated by sponsor|0|||
160984380|NCT03990363|581332247|FG001|Overall Study|Study terminated by sponsor|1|||
160984381|NCT03990363|581332248|FG002|Overall Study|Study terminated by sponsor|0|||
160984382|NCT03990363|581332249|FG003|Overall Study|Study terminated by sponsor|0|||
160984383|NCT03990363|581332250|FG004|Overall Study|Study terminated by sponsor|0|||
160984384|NCT03990363|581332246|FG000|Overall Study|Site terminated by sponsor|2|||
160984385|NCT03990363|581332247|FG001|Overall Study|Site terminated by sponsor|1|||
160984386|NCT03990363|581332248|FG002|Overall Study|Site terminated by sponsor|2|||
160984387|NCT03990363|581332249|FG003|Overall Study|Site terminated by sponsor|0|||
160984388|NCT03990363|581332250|FG004|Overall Study|Site terminated by sponsor|2|||
160984389|NCT03990363|581332246|FG000|Overall Study|Not categorized|5|||
160984390|NCT03990363|581332247|FG001|Overall Study|Not categorized|5|||
160984391|NCT03990363|581332248|FG002|Overall Study|Not categorized|3|||
160984392|NCT03990363|581332249|FG003|Overall Study|Not categorized|2|||
160984393|NCT03990363|581332250|FG004|Overall Study|Not categorized|2|||
160984394|NCT01349660|581332256|FG000|Overall Study|Still Receiving Study Treatment|0|||
160984395|NCT01349660|581332257|FG001|Overall Study|Still Receiving Study Treatment|0|||
160984396|NCT01349660|581332258|FG002|Overall Study|Still Receiving Study Treatment|1|||
160984397|NCT01349660|581332256|FG000|Overall Study|Disease Progression|2|||
160984398|NCT01349660|581332257|FG001|Overall Study|Disease Progression|4|||
160984399|NCT01349660|581332258|FG002|Overall Study|Disease Progression|50|||
160984400|NCT01349660|581332256|FG000|Overall Study|Adverse Event|1|||
160799376|NCT00698841|580654630|FG000|Overall Study|Adverse Event|3|||
160799377|NCT00698841|580654630|FG000|Overall Study|Disease progression|7|||
160799378|NCT00698841|580654630|FG000|Overall Study|Failure to meet eligibility criteria|2|||
160799379|NCT00698841|580654630|FG000|Overall Study|Study drug toxicity|2|||
160799380|NCT00698841|580654630|FG000|Overall Study|Other|2|||
160799381|NCT04646005|580654634|FG000|Overall Study|Adverse Event|1|||
160799382|NCT04646005|580654634|FG000|Overall Study|Progressive Disease|71|||
160799383|NCT04646005|580654634|FG000|Overall Study|Death|20|||
160799384|NCT04646005|580654634|FG000|Overall Study|Withdrawal by Subject|12|||
160799385|NCT04646005|580654634|FG000|Overall Study|Sponsor Request|9|||
160799386|NCT05788991|580654636|FG000|Overall Study|Not treated with study medication|1|||
160799387|NCT05788991|580654637|FG001|Overall Study|Not treated with study medication|3|||
160799388|NCT05788991|580654636|FG000|Overall Study|Withdrawal by Subject|1|||
160799389|NCT05788991|580654637|FG001|Overall Study|Withdrawal by Subject|0|||
160799390|NCT05788991|580654636|FG000|Overall Study|Lack of Efficacy|0|||
160799391|NCT05788991|580654637|FG001|Overall Study|Lack of Efficacy|1|||
160799392|NCT05788991|580654636|FG000|Overall Study|Protocol Violation|1|||
160799393|NCT05788991|580654637|FG001|Overall Study|Protocol Violation|2|||
160799394|NCT04712669|580654638|FG000|Double Blind Phase|Adverse Event|4|||
160799395|NCT04712669|580654639|FG001|Double Blind Phase|Adverse Event|4|||
160799396|NCT04712669|580654640|FG002|Double Blind Phase|Adverse Event|3|||
160799397|NCT04712669|580654641|FG003|Double Blind Phase|Adverse Event|0|||
160799398|NCT04712669|580654642|FG004|Double Blind Phase|Adverse Event|0|||
160799399|NCT04712669|580654643|FG005|Double Blind Phase|Adverse Event|0|||
160799400|NCT04712669|580654644|FG006|Double Blind Phase|Adverse Event|0|||
160984401|NCT01349660|581332257|FG001|Overall Study|Adverse Event|1|||
160984402|NCT01349660|581332258|FG002|Overall Study|Adverse Event|12|||
160984403|NCT01349660|581332256|FG000|Overall Study|Withdrawal by Subject|2|||
160984404|NCT01349660|581332257|FG001|Overall Study|Withdrawal by Subject|0|||
160984405|NCT01349660|581332258|FG002|Overall Study|Withdrawal by Subject|9|||
160549958|NCT03529773|579740177|FG025|Overall Study|Death|0|||
160549959|NCT03529773|579740178|FG026|Overall Study|Death|0|||
160799401|NCT04712669|580654645|FG007|Double Blind Phase|Adverse Event|0|||
160984406|NCT01349660|581332256|FG000|Overall Study|Death|1|||
160984407|NCT01349660|581332257|FG001|Overall Study|Death|1|||
160984408|NCT01349660|581332258|FG002|Overall Study|Death|0|||
160799402|NCT04712669|580654638|FG000|Double Blind Phase|Physician Decision|1|||
160799403|NCT04712669|580654639|FG001|Double Blind Phase|Physician Decision|0|||
160799404|NCT04712669|580654640|FG002|Double Blind Phase|Physician Decision|0|||
160799405|NCT04712669|580654641|FG003|Double Blind Phase|Physician Decision|0|||
160799406|NCT04712669|580654642|FG004|Double Blind Phase|Physician Decision|0|||
160984409|NCT01349660|581332256|FG000|Overall Study|Non-Permitted Interventions|0|||
160984410|NCT01349660|581332257|FG001|Overall Study|Non-Permitted Interventions|0|||
160984411|NCT01349660|581332258|FG002|Overall Study|Non-Permitted Interventions|2|||
160895831|NCT00850343|581014890|FG003|Overall Study|Non-compliance with Study Procedures|1|||
160895832|NCT00850343|581014887|FG000|Overall Study|Physician Decision|2|||
160895833|NCT00850343|581014888|FG001|Overall Study|Physician Decision|1|||
160895834|NCT00850343|581014889|FG002|Overall Study|Physician Decision|1|||
160895835|NCT00850343|581014890|FG003|Overall Study|Physician Decision|1|||
160895836|NCT02436304|581014891|FG000|Overall Study|Lost to Follow-up|0|||
160895837|NCT02436304|581014892|FG001|Overall Study|Lost to Follow-up|1|||
160895838|NCT02436304|581014893|FG002|Overall Study|Lost to Follow-up|0|||
160895839|NCT02436304|581014891|FG000|Overall Study|Withdrawal by Subject|0|||
160895840|NCT02436304|581014892|FG001|Overall Study|Withdrawal by Subject|1|||
160895841|NCT02436304|581014893|FG002|Overall Study|Withdrawal by Subject|0|||
160895842|NCT02436304|581014891|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
160895843|NCT02436304|581014892|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
160895844|NCT02436304|581014893|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
160895845|NCT05274815|581014899|FG000|Overall Study|Adverse Event|1|||
160895846|NCT05274815|581014899|FG000|Overall Study|Death|2|||
160895847|NCT05274815|581014899|FG000|Overall Study|Lost to Follow-up|4|||
160895848|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
160895849|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
160895850|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
160895851|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
160895852|NCT05274815|581014899|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
160895853|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
160895854|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
160895855|NCT05274815|581014899|FG000|Overall Study|Withdrawal by Subject|11|||
160895856|NCT04416633|581014900|FG000|Overall Study|Death|1|||
160895857|NCT04416633|581014900|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
160895858|NCT04416633|581014900|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
160895859|NCT04416633|581014900|FG000|Overall Study|Adverse Event|6|||
160895860|NCT04416633|581014900|FG000|Overall Study|Withdrawal by Subject|6|||
160895861|NCT00785928|581014901|FG000|Treatment Phase|Adverse Event|1|||
160895862|NCT00785928|581014902|FG001|Treatment Phase|Adverse Event|1|||
160895863|NCT00785928|581014903|FG002|Treatment Phase|Adverse Event|2|||
160895864|NCT00785928|581014904|FG003|Treatment Phase|Adverse Event|0|||
160895865|NCT00785928|581014905|FG004|Treatment Phase|Adverse Event|0|||
160895866|NCT00785928|581014906|FG005|Treatment Phase|Adverse Event|0|||
160895867|NCT00785928|581014907|FG006|Treatment Phase|Adverse Event|2|||
160895868|NCT00785928|581014901|FG000|Treatment Phase|Inadequate Response|0|||
160895869|NCT00785928|581014902|FG001|Treatment Phase|Inadequate Response|1|||
160895870|NCT00785928|581014903|FG002|Treatment Phase|Inadequate Response|0|||
160895871|NCT00785928|581014904|FG003|Treatment Phase|Inadequate Response|0|||
160895872|NCT00785928|581014905|FG004|Treatment Phase|Inadequate Response|0|||
160895873|NCT00785928|581014906|FG005|Treatment Phase|Inadequate Response|0|||
160895874|NCT00785928|581014907|FG006|Treatment Phase|Inadequate Response|0|||
160895875|NCT00785928|581014901|FG000|Treatment Phase|Lack of Efficacy|0|||
160895876|NCT00785928|581014902|FG001|Treatment Phase|Lack of Efficacy|1|||
160895877|NCT00785928|581014903|FG002|Treatment Phase|Lack of Efficacy|1|||
160895878|NCT00785928|581014904|FG003|Treatment Phase|Lack of Efficacy|0|||
160895879|NCT00785928|581014905|FG004|Treatment Phase|Lack of Efficacy|0|||
160895880|NCT00785928|581014906|FG005|Treatment Phase|Lack of Efficacy|0|||
160895881|NCT00785928|581014907|FG006|Treatment Phase|Lack of Efficacy|0|||
160895882|NCT00785928|581014901|FG000|Treatment Phase|Physician Decision|0|||
160895883|NCT00785928|581014902|FG001|Treatment Phase|Physician Decision|0|||
160895884|NCT00785928|581014903|FG002|Treatment Phase|Physician Decision|0|||
160895885|NCT00785928|581014904|FG003|Treatment Phase|Physician Decision|0|||
160895886|NCT00785928|581014905|FG004|Treatment Phase|Physician Decision|1|||
160895887|NCT00785928|581014906|FG005|Treatment Phase|Physician Decision|0|||
160895888|NCT00785928|581014907|FG006|Treatment Phase|Physician Decision|0|||
160895889|NCT00785928|581014901|FG000|Treatment Phase|Sponsor Decision|1|||
160895890|NCT00785928|581014902|FG001|Treatment Phase|Sponsor Decision|0|||
160895891|NCT00785928|581014903|FG002|Treatment Phase|Sponsor Decision|0|||
160895892|NCT00785928|581014904|FG003|Treatment Phase|Sponsor Decision|0|||
160895893|NCT00785928|581014905|FG004|Treatment Phase|Sponsor Decision|0|||
160895894|NCT00785928|581014906|FG005|Treatment Phase|Sponsor Decision|0|||
160895895|NCT00785928|581014907|FG006|Treatment Phase|Sponsor Decision|1|||
160895896|NCT00785928|581014901|FG000|Treatment Phase|Withdrawal by Subject|1|||
160895897|NCT00785928|581014902|FG001|Treatment Phase|Withdrawal by Subject|2|||
160895898|NCT00785928|581014903|FG002|Treatment Phase|Withdrawal by Subject|0|||
160895899|NCT00785928|581014904|FG003|Treatment Phase|Withdrawal by Subject|0|||
160895900|NCT00785928|581014905|FG004|Treatment Phase|Withdrawal by Subject|1|||
160895901|NCT00785928|581014906|FG005|Treatment Phase|Withdrawal by Subject|0|||
160799407|NCT04712669|580654643|FG005|Double Blind Phase|Physician Decision|0|||
160799408|NCT04712669|580654644|FG006|Double Blind Phase|Physician Decision|0|||
160799409|NCT04712669|580654645|FG007|Double Blind Phase|Physician Decision|0|||
160799410|NCT04712669|580654638|FG000|Double Blind Phase|Withdrawal by Subject|3|||
160799411|NCT04712669|580654639|FG001|Double Blind Phase|Withdrawal by Subject|6|||
160799412|NCT04712669|580654640|FG002|Double Blind Phase|Withdrawal by Subject|0|||
160799413|NCT04712669|580654641|FG003|Double Blind Phase|Withdrawal by Subject|0|||
160799414|NCT04712669|580654642|FG004|Double Blind Phase|Withdrawal by Subject|0|||
160799415|NCT04712669|580654643|FG005|Double Blind Phase|Withdrawal by Subject|0|||
160799416|NCT04712669|580654644|FG006|Double Blind Phase|Withdrawal by Subject|0|||
160799417|NCT04712669|580654645|FG007|Double Blind Phase|Withdrawal by Subject|0|||
160799418|NCT04712669|580654638|FG000|Double Blind Phase|Termination by Sponsor|0|||
160799419|NCT04712669|580654639|FG001|Double Blind Phase|Termination by Sponsor|0|||
160799420|NCT04712669|580654640|FG002|Double Blind Phase|Termination by Sponsor|1|||
160799421|NCT04712669|580654641|FG003|Double Blind Phase|Termination by Sponsor|0|||
160799422|NCT04712669|580654642|FG004|Double Blind Phase|Termination by Sponsor|0|||
160799423|NCT04712669|580654643|FG005|Double Blind Phase|Termination by Sponsor|0|||
160799424|NCT04712669|580654644|FG006|Double Blind Phase|Termination by Sponsor|0|||
160799425|NCT04712669|580654645|FG007|Double Blind Phase|Termination by Sponsor|0|||
160799426|NCT04712669|580654638|FG000|Open Label Phase|Adverse Event|0|||
160799427|NCT04712669|580654639|FG001|Open Label Phase|Adverse Event|0|||
160799428|NCT04712669|580654640|FG002|Open Label Phase|Adverse Event|0|||
160799429|NCT04712669|580654641|FG003|Open Label Phase|Adverse Event|1|||
160799430|NCT04712669|580654642|FG004|Open Label Phase|Adverse Event|1|||
160799431|NCT04712669|580654643|FG005|Open Label Phase|Adverse Event|3|||
160799432|NCT04712669|580654644|FG006|Open Label Phase|Adverse Event|1|||
160799433|NCT04712669|580654645|FG007|Open Label Phase|Adverse Event|2|||
160799434|NCT04712669|580654638|FG000|Open Label Phase|Death|0|||
160799435|NCT04712669|580654639|FG001|Open Label Phase|Death|0|||
160799436|NCT04712669|580654640|FG002|Open Label Phase|Death|0|||
160895902|NCT00785928|581014907|FG006|Treatment Phase|Withdrawal by Subject|0|||
160895903|NCT01675427|581014914|FG000|Overall Study|Withdrawal by Subject|7|||
160895904|NCT01675427|581014914|FG000|Overall Study|Participant Refused Sample Collection|18|||
160895905|NCT01675427|581014914|FG000|Overall Study|Sample not Collected by Mistake|2|||
160895906|NCT01675427|581014914|FG000|Overall Study|Lost to Follow-up|5|||
160895907|NCT01675427|581014914|FG000|Overall Study|Other|2|||
160895908|NCT05021081|581014918|FG000|Phase 2|Subject enrolled in error|1|||
160895909|NCT05021081|581014919|FG001|Phase 2|Subject enrolled in error|1|||
160895910|NCT05021081|581014920|FG002|Phase 2|Subject enrolled in error|0|||
160895911|NCT01890746|581014925|FG000|Overall Study|Death|39|||
160895912|NCT01890746|581014926|FG001|Overall Study|Death|30|||
160895913|NCT01890746|581014925|FG000|Overall Study|Adverse Event|1|||
160895914|NCT01890746|581014926|FG001|Overall Study|Adverse Event|0|||
160895915|NCT01890746|581014925|FG000|Overall Study|Lost to Follow-up|4|||
160895916|NCT01890746|581014926|FG001|Overall Study|Lost to Follow-up|1|||
160895917|NCT01890746|581014925|FG000|Overall Study|Physician Decision|3|||
160895918|NCT01890746|581014926|FG001|Overall Study|Physician Decision|2|||
160895919|NCT01890746|581014925|FG000|Overall Study|Withdrawal by Subject|5|||
160895920|NCT01890746|581014926|FG001|Overall Study|Withdrawal by Subject|8|||
160895921|NCT03257371|581014931|FG000|Overall Study|Lost to Follow-up|1|||
160895922|NCT02477839|581014932|FG000|Overall Study|Adverse Event|0|||
160895923|NCT02477839|581014933|FG001|Overall Study|Adverse Event|1|||
160895924|NCT02477839|581014932|FG000|Overall Study|Protocol Violation|0|||
160895925|NCT02477839|581014933|FG001|Overall Study|Protocol Violation|2|||
160895926|NCT02477839|581014932|FG000|Overall Study|Withdrawal by Subject|3|||
160895927|NCT02477839|581014933|FG001|Overall Study|Withdrawal by Subject|3|||
160895928|NCT02477839|581014932|FG000|Overall Study|Participant had PGS during V6|0|||
160895929|NCT02477839|581014933|FG001|Overall Study|Participant had PGS during V6|1|||
160895930|NCT02477839|581014932|FG000|Overall Study|Parents decided to stop medication|0|||
160895931|NCT02477839|581014933|FG001|Overall Study|Parents decided to stop medication|1|||
160895932|NCT02477839|581014932|FG000|Overall Study|Lack of tolerability|0|||
160895933|NCT02477839|581014933|FG001|Overall Study|Lack of tolerability|1|||
160895934|NCT02477839|581014932|FG000|Overall Study|Exclusion criterion|0|||
160895935|NCT02477839|581014933|FG001|Overall Study|Exclusion criterion|1|||
160895936|NCT03053271|581014936|FG000|Overall Study|Did not meet randomization criteria|3|||
160895937|NCT03053271|581014936|FG000|Overall Study|Withdrawal by Subject|1|||
160895938|NCT00580970|581014937|FG000|Pre-treatment|Non-compliance|1|||
160895939|NCT00580970|581014937|FG000|Treatment (Lovastatin)|Non-compliance|6|||
160895940|NCT00580970|581014937|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
160799437|NCT04712669|580654641|FG003|Open Label Phase|Death|1|||
160895941|NCT00580970|581014937|FG000|Treatment (Lovastatin)|Physician Decision|4|||
160895942|NCT00580970|581014937|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
160895943|NCT00580970|581014937|FG000|Treatment (Lovastatin)|Death|1|||
160799438|NCT04712669|580654642|FG004|Open Label Phase|Death|0|||
160984412|NCT01349660|581332256|FG000|Overall Study|Study Compliance|0|||
160984413|NCT01349660|581332257|FG001|Overall Study|Study Compliance|0|||
160984414|NCT01349660|581332258|FG002|Overall Study|Study Compliance|1|||
160984415|NCT01349660|581332256|FG000|Overall Study|Declining Performance Status|0|||
160984416|NCT01349660|581332257|FG001|Overall Study|Declining Performance Status|0|||
160984417|NCT01349660|581332258|FG002|Overall Study|Declining Performance Status|1|||
160984418|NCT01563978|581332260|FG000|Overall Study|Physician Decision|1|||
160984419|NCT01563978|581332261|FG001|Overall Study|Physician Decision|0|||
160984420|NCT01563978|581332260|FG000|Overall Study|Lost to Follow-up|1|||
160984421|NCT01563978|581332261|FG001|Overall Study|Lost to Follow-up|0|||
160984422|NCT01563978|581332260|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
160984423|NCT01563978|581332261|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
160984424|NCT01563978|581332260|FG000|Overall Study|Adverse Event|1|||
160984425|NCT01563978|581332261|FG001|Overall Study|Adverse Event|2|||
160984426|NCT04630756|581332262|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
160984427|NCT04630756|581332263|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
160984428|NCT04630756|581332264|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
160984429|NCT05593211|581332266|FG000|Overall Study|Withdrawal by Subject|1|||
160984430|NCT03225846|581332267|FG000|Overall Study|Adverse Event|0|||
160984431|NCT03225846|581332268|FG001|Overall Study|Adverse Event|0|||
160984432|NCT03225846|581332269|FG002|Overall Study|Adverse Event|0|||
160984433|NCT03225846|581332270|FG003|Overall Study|Adverse Event|0|||
160984434|NCT03225846|581332271|FG004|Overall Study|Adverse Event|0|||
160984435|NCT03225846|581332272|FG005|Overall Study|Adverse Event|0|||
160984436|NCT03225846|581332273|FG006|Overall Study|Adverse Event|6|||
160984437|NCT03225846|581332267|FG000|Overall Study|Withdrawal by Subject|0|||
160984438|NCT03225846|581332268|FG001|Overall Study|Withdrawal by Subject|1|||
160984439|NCT03225846|581332269|FG002|Overall Study|Withdrawal by Subject|0|||
160984440|NCT03225846|581332270|FG003|Overall Study|Withdrawal by Subject|0|||
160984441|NCT03225846|581332271|FG004|Overall Study|Withdrawal by Subject|0|||
160984442|NCT03225846|581332272|FG005|Overall Study|Withdrawal by Subject|0|||
160984443|NCT03225846|581332273|FG006|Overall Study|Withdrawal by Subject|0|||
160984444|NCT03225846|581332267|FG000|Overall Study|Death|0|||
160984445|NCT03225846|581332268|FG001|Overall Study|Death|1|||
160984446|NCT03225846|581332269|FG002|Overall Study|Death|0|||
160984447|NCT03225846|581332270|FG003|Overall Study|Death|0|||
160984448|NCT03225846|581332271|FG004|Overall Study|Death|0|||
160984449|NCT03225846|581332272|FG005|Overall Study|Death|0|||
160984450|NCT03225846|581332273|FG006|Overall Study|Death|0|||
160984451|NCT03225846|581332267|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984452|NCT03225846|581332268|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984453|NCT03225846|581332269|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
160984454|NCT03225846|581332270|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984455|NCT03225846|581332271|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984456|NCT03225846|581332272|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984457|NCT03225846|581332273|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984458|NCT03225846|581332267|FG000|Overall Study|Patient decision|0|||
160984459|NCT03225846|581332268|FG001|Overall Study|Patient decision|0|||
160984460|NCT03225846|581332269|FG002|Overall Study|Patient decision|0|||
160984461|NCT03225846|581332270|FG003|Overall Study|Patient decision|0|||
160984462|NCT03225846|581332271|FG004|Overall Study|Patient decision|0|||
160984463|NCT03225846|581332272|FG005|Overall Study|Patient decision|0|||
160984464|NCT03225846|581332273|FG006|Overall Study|Patient decision|1|||
160984465|NCT04248465|581332274|FG000|Randomized-Controlled Period|Death|12|||
160984466|NCT04248465|581332275|FG001|Randomized-Controlled Period|Death|5|||
160984467|NCT04248465|581332274|FG000|Randomized-Controlled Period|Adverse Event|2|||
160984468|NCT04248465|581332275|FG001|Randomized-Controlled Period|Adverse Event|0|||
160984469|NCT04248465|581332274|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
160984470|NCT04248465|581332275|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
160984471|NCT04248465|581332274|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
160984472|NCT04248465|581332275|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
160984473|NCT04248465|581332274|FG000|Randomized-Controlled Period|Physician Decision|1|||
160984474|NCT04248465|581332275|FG001|Randomized-Controlled Period|Physician Decision|1|||
160984475|NCT04248465|581332274|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
160984476|NCT04248465|581332275|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
160984477|NCT04248465|581332274|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
160984478|NCT04248465|581332275|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
160984479|NCT04248465|581332274|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
160984480|NCT04248465|581332275|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
160984481|NCT05708846|581332276|FG000|Overall Study|Death|5|||
160984482|NCT05708846|581332276|FG000|Overall Study|Withdrawal by Subject|20|||
160984483|NCT03621982|581332277|FG000|Overall Study|Withdrawal by Subject|1|||
160895944|NCT00570765|581014938|FG000|DB Phase|Withdrawal by Subject|1|||
160895945|NCT00570765|581014939|FG001|DB Phase|Withdrawal by Subject|0|||
160895946|NCT00570765|581014940|FG002|DB Phase|Withdrawal by Subject|0|||
160895947|NCT00570765|581014941|FG003|DB Phase|Withdrawal by Subject|0|||
160895948|NCT00570765|581014938|FG000|DB Phase|Protocol Violation|0|||
160895949|NCT00570765|581014939|FG001|DB Phase|Protocol Violation|1|||
160895950|NCT00570765|581014940|FG002|DB Phase|Protocol Violation|0|||
160895951|NCT00570765|581014941|FG003|DB Phase|Protocol Violation|0|||
160895952|NCT00570765|581014938|FG000|DB Phase|Adverse Event|3|||
160895953|NCT00570765|581014939|FG001|DB Phase|Adverse Event|6|||
160895954|NCT00570765|581014940|FG002|DB Phase|Adverse Event|0|||
160895955|NCT00570765|581014941|FG003|DB Phase|Adverse Event|0|||
160895956|NCT00570765|581014938|FG000|DB Phase|Did Not Receive Study Drug|0|||
160895957|NCT00570765|581014939|FG001|DB Phase|Did Not Receive Study Drug|0|||
160895958|NCT00570765|581014940|FG002|DB Phase|Did Not Receive Study Drug|1|||
160895959|NCT00570765|581014941|FG003|DB Phase|Did Not Receive Study Drug|0|||
160895960|NCT00570765|581014938|FG000|LTSE Phase|Withdrawal by Subject|0|||
160895961|NCT00570765|581014939|FG001|LTSE Phase|Withdrawal by Subject|0|||
160895962|NCT00570765|581014940|FG002|LTSE Phase|Withdrawal by Subject|0|||
160895963|NCT00570765|581014941|FG003|LTSE Phase|Withdrawal by Subject|1|||
160895964|NCT00570765|581014938|FG000|LTSE Phase|Adverse Event|0|||
160895965|NCT00570765|581014939|FG001|LTSE Phase|Adverse Event|0|||
160895966|NCT00570765|581014940|FG002|LTSE Phase|Adverse Event|0|||
160895967|NCT00570765|581014941|FG003|LTSE Phase|Adverse Event|7|||
160895968|NCT00570765|581014938|FG000|LTSE Phase|Physician Decision|0|||
160895969|NCT00570765|581014939|FG001|LTSE Phase|Physician Decision|0|||
160895970|NCT00570765|581014940|FG002|LTSE Phase|Physician Decision|0|||
160895971|NCT00570765|581014941|FG003|LTSE Phase|Physician Decision|4|||
160895972|NCT01031706|581014942|FG000|Overall Study|Adverse Event|1|||
160895973|NCT01031706|581014943|FG001|Overall Study|Adverse Event|0|||
160895974|NCT01031706|581014942|FG000|Overall Study|Withdrawal by Subject|1|||
160895975|NCT01031706|581014943|FG001|Overall Study|Withdrawal by Subject|1|||
160895976|NCT03114488|581014944|FG000|Time Period 2|Withdrawal by Subject|1|||
160895977|NCT03114488|581014945|FG001|Time Period 2|Withdrawal by Subject|3|||
160895978|NCT03711266|581014947|FG000|Overall Study|Lost to Follow-up|10|||
160895979|NCT03387683|581014948|FG000|Overall Study|In receipt of disallowed medication|1|||
160895980|NCT03387683|581014949|FG001|Overall Study|In receipt of disallowed medication|0|||
160895981|NCT03387683|581014948|FG000|Overall Study|Did not receive treatment|1|||
160895982|NCT03387683|581014949|FG001|Overall Study|Did not receive treatment|0|||
160895983|NCT00566501|581014952|FG000|Overall Study|Adverse Event|68|||
160895984|NCT00566501|581014953|FG001|Overall Study|Adverse Event|59|||
160895985|NCT00566501|581014952|FG000|Overall Study|Medication Non-compliance|5|||
160895986|NCT00566501|581014953|FG001|Overall Study|Medication Non-compliance|0|||
160895987|NCT00566501|581014952|FG000|Overall Study|Protocol Violation|2|||
160895988|NCT00566501|581014953|FG001|Overall Study|Protocol Violation|2|||
160895989|NCT00566501|581014952|FG000|Overall Study|Request of Investigator or Sponsor|6|||
160895990|NCT00566501|581014953|FG001|Overall Study|Request of Investigator or Sponsor|7|||
160895991|NCT00566501|581014952|FG000|Overall Study|Withdrawal by Subject|33|||
160895992|NCT00566501|581014953|FG001|Overall Study|Withdrawal by Subject|30|||
160895993|NCT00566501|581014952|FG000|Overall Study|Lack of Efficacy|8|||
160895994|NCT00566501|581014953|FG001|Overall Study|Lack of Efficacy|3|||
160895995|NCT00566501|581014952|FG000|Overall Study|Other|25|||
160895996|NCT00566501|581014953|FG001|Overall Study|Other|21|||
160895997|NCT05095454|581014956|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
160895998|NCT05095454|581014957|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
160895999|NCT00057876|581014958|FG000|Overall Study|Adverse Event|8|||
160896000|NCT00057876|581014959|FG001|Overall Study|Adverse Event|8|||
160896001|NCT00057876|581014958|FG000|Overall Study|Death|2|||
160896002|NCT00057876|581014959|FG001|Overall Study|Death|1|||
160896003|NCT00057876|581014958|FG000|Overall Study|Withdrawal by Subject|5|||
160896004|NCT00057876|581014959|FG001|Overall Study|Withdrawal by Subject|6|||
160896005|NCT00057876|581014958|FG000|Overall Study|Lack of Efficacy|10|||
160896006|NCT00057876|581014959|FG001|Overall Study|Lack of Efficacy|8|||
160896007|NCT00057876|581014958|FG000|Overall Study|Ineligible|1|||
160896008|NCT00057876|581014959|FG001|Overall Study|Ineligible|2|||
160896009|NCT00057876|581014958|FG000|Overall Study|other reason|2|||
160896010|NCT00057876|581014959|FG001|Overall Study|other reason|2|||
160896011|NCT00057876|581014958|FG000|Overall Study|other complicating disease|1|||
160896012|NCT00057876|581014959|FG001|Overall Study|other complicating disease|0|||
160896013|NCT01368432|581014960|FG000|Overall Study|Lost to Follow-up|0|||
160896014|NCT01368432|581014961|FG001|Overall Study|Lost to Follow-up|1|||
160896015|NCT02758171|581014962|FG000|Wash-out|Withdrawal by Subject|1|||
160896016|NCT02758171|581014963|FG001|Wash-out|Withdrawal by Subject|0|||
160896017|NCT02758171|581014962|FG000|Wash-out|Other reason|1|||
160896018|NCT02758171|581014963|FG001|Wash-out|Other reason|0|||
160896019|NCT00853073|581014964|FG000|Overall Study|Withdrawal by Subject|3|||
160896020|NCT00853073|581014965|FG001|Overall Study|Withdrawal by Subject|2|||
160896021|NCT01999114|581014966|FG000|Overall Study|Adverse Event|8|||
160896022|NCT01999114|581014967|FG001|Overall Study|Adverse Event|7|||
160896023|NCT01999114|581014968|FG002|Overall Study|Adverse Event|2|||
160896024|NCT01999114|581014969|FG003|Overall Study|Adverse Event|2|||
160896025|NCT01999114|581014970|FG004|Overall Study|Adverse Event|1|||
160896026|NCT01999114|581014966|FG000|Overall Study|Withdrawal by Subject|0|||
160896027|NCT01999114|581014967|FG001|Overall Study|Withdrawal by Subject|0|||
160896028|NCT01999114|581014968|FG002|Overall Study|Withdrawal by Subject|1|||
160896029|NCT01999114|581014969|FG003|Overall Study|Withdrawal by Subject|0|||
160896030|NCT01999114|581014970|FG004|Overall Study|Withdrawal by Subject|1|||
160896031|NCT01999114|581014966|FG000|Overall Study|Lost to Follow-up|0|||
160896032|NCT01999114|581014967|FG001|Overall Study|Lost to Follow-up|0|||
160896033|NCT01999114|581014968|FG002|Overall Study|Lost to Follow-up|1|||
160896034|NCT01999114|581014969|FG003|Overall Study|Lost to Follow-up|0|||
160896035|NCT01999114|581014970|FG004|Overall Study|Lost to Follow-up|0|||
160896036|NCT01999114|581014966|FG000|Overall Study|Administrative|0|||
160896037|NCT01999114|581014967|FG001|Overall Study|Administrative|0|||
160896038|NCT01999114|581014968|FG002|Overall Study|Administrative|1|||
160896039|NCT01999114|581014969|FG003|Overall Study|Administrative|1|||
160896040|NCT01999114|581014970|FG004|Overall Study|Administrative|2|||
160896041|NCT03840174|581014971|FG000|Overall Study|Withdrawal by Subject|1|||
160896042|NCT03840174|581014972|FG001|Overall Study|Withdrawal by Subject|0|||
160896043|NCT03840174|581014973|FG002|Overall Study|Withdrawal by Subject|0|||
160896044|NCT03840174|581014974|FG003|Overall Study|Withdrawal by Subject|0|||
160896045|NCT01008150|581014975|FG000|Overall Study|did not receive study drug|1|||
160896046|NCT01008150|581014976|FG001|Overall Study|did not receive study drug|1|||
160896047|NCT01008150|581014977|FG002|Overall Study|did not receive study drug|1|||
160896048|NCT01008150|581014978|FG003|Overall Study|did not receive study drug|0|||
160896049|NCT01497275|581014979|FG000|Overall Study|Death|1|||
160896050|NCT01497275|581014979|FG000|Overall Study|Adverse Event|1|||
160896051|NCT00381381|581014988|FG000|Overall Study|Adverse Event|3|||
160896052|NCT00381381|581014988|FG000|Overall Study|Lost to Follow-up|52|||
160896053|NCT00381381|581014988|FG000|Overall Study|Withdrawal by Subject|9|||
160896054|NCT00568685|581014989|FG000|Overall Study|Adverse Event|2|||
160896055|NCT00568685|581014990|FG001|Overall Study|Adverse Event|3|||
160896056|NCT00568685|581014991|FG002|Overall Study|Adverse Event|3|||
160896057|NCT00568685|581014989|FG000|Overall Study|Withdrawal by Subject|7|||
160896058|NCT00568685|581014990|FG001|Overall Study|Withdrawal by Subject|2|||
160896059|NCT00568685|581014991|FG002|Overall Study|Withdrawal by Subject|2|||
160896060|NCT00568685|581014989|FG000|Overall Study|Protocol Violation|1|||
160896061|NCT00568685|581014990|FG001|Overall Study|Protocol Violation|0|||
160896062|NCT00568685|581014991|FG002|Overall Study|Protocol Violation|0|||
160896063|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Adverse Event|10|||
160896064|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Adverse Event|0|||
160896065|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
160896066|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
160896067|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
160896068|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
160896069|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
160896070|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
160896071|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
160896072|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
160896073|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Other than specified|3|||
160896074|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Other than specified|1|||
160896075|NCT02787551|581014992|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
160896076|NCT02787551|581014993|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
160896077|NCT02787551|581014992|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
160896078|NCT02787551|581014993|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
160896079|NCT02787551|581014992|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
160896080|NCT02787551|581014993|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
160896081|NCT03799211|581014994|FG000|Overall Study|Lost to Follow-up|2|||
160896082|NCT03799211|581014995|FG001|Overall Study|Lost to Follow-up|13|||
160896083|NCT03799211|581014994|FG000|Overall Study|Withdrawal by Subject|2|||
160896084|NCT03799211|581014995|FG001|Overall Study|Withdrawal by Subject|0|||
160896085|NCT00764491|581014996|FG000|Overall Study|Lost to Follow-up|35|||
160896086|NCT00764491|581014997|FG001|Overall Study|Lost to Follow-up|17|||
160896087|NCT03538431|581015000|FG000|Overall Study|Physician Decision|0|||
160896088|NCT03538431|581015001|FG001|Overall Study|Physician Decision|1|||
160896089|NCT03538431|581015000|FG000|Overall Study|Withdrawal by Subject|1|||
160896090|NCT03538431|581015001|FG001|Overall Study|Withdrawal by Subject|0|||
160896091|NCT00620464|581015002|FG000|Overall Study|Adverse Event|15|||
160896092|NCT00620464|581015003|FG001|Overall Study|Adverse Event|17|||
160896093|NCT00620464|581015002|FG000|Overall Study|Lost to Follow-up|1|||
160799439|NCT04712669|580654643|FG005|Open Label Phase|Death|0|||
160799440|NCT04712669|580654644|FG006|Open Label Phase|Death|0|||
160799441|NCT04712669|580654645|FG007|Open Label Phase|Death|0|||
160799442|NCT04712669|580654638|FG000|Open Label Phase|Lack of Efficacy|0|||
160799443|NCT04712669|580654639|FG001|Open Label Phase|Lack of Efficacy|0|||
160799444|NCT04712669|580654640|FG002|Open Label Phase|Lack of Efficacy|0|||
160799445|NCT04712669|580654641|FG003|Open Label Phase|Lack of Efficacy|0|||
160799446|NCT04712669|580654642|FG004|Open Label Phase|Lack of Efficacy|1|||
160799447|NCT04712669|580654643|FG005|Open Label Phase|Lack of Efficacy|0|||
160799448|NCT04712669|580654644|FG006|Open Label Phase|Lack of Efficacy|0|||
160799449|NCT04712669|580654645|FG007|Open Label Phase|Lack of Efficacy|0|||
160799450|NCT04712669|580654638|FG000|Open Label Phase|Lost to Follow-up|0|||
160799451|NCT04712669|580654639|FG001|Open Label Phase|Lost to Follow-up|0|||
160799452|NCT04712669|580654640|FG002|Open Label Phase|Lost to Follow-up|0|||
160799453|NCT04712669|580654641|FG003|Open Label Phase|Lost to Follow-up|0|||
160799454|NCT04712669|580654642|FG004|Open Label Phase|Lost to Follow-up|0|||
160799455|NCT04712669|580654643|FG005|Open Label Phase|Lost to Follow-up|0|||
160799456|NCT04712669|580654644|FG006|Open Label Phase|Lost to Follow-up|1|||
160799457|NCT04712669|580654645|FG007|Open Label Phase|Lost to Follow-up|1|||
160799458|NCT04712669|580654638|FG000|Open Label Phase|Physician Decision|0|||
160799459|NCT04712669|580654639|FG001|Open Label Phase|Physician Decision|0|||
160799460|NCT04712669|580654640|FG002|Open Label Phase|Physician Decision|0|||
160799461|NCT04712669|580654641|FG003|Open Label Phase|Physician Decision|1|||
160799462|NCT04712669|580654642|FG004|Open Label Phase|Physician Decision|0|||
160799463|NCT04712669|580654643|FG005|Open Label Phase|Physician Decision|0|||
160799464|NCT04712669|580654644|FG006|Open Label Phase|Physician Decision|0|||
160799465|NCT04712669|580654645|FG007|Open Label Phase|Physician Decision|0|||
160799466|NCT04712669|580654638|FG000|Open Label Phase|Withdrawal by Subject|0|||
160799467|NCT04712669|580654639|FG001|Open Label Phase|Withdrawal by Subject|0|||
160799468|NCT04712669|580654640|FG002|Open Label Phase|Withdrawal by Subject|0|||
160799469|NCT04712669|580654641|FG003|Open Label Phase|Withdrawal by Subject|1|||
160799470|NCT04712669|580654642|FG004|Open Label Phase|Withdrawal by Subject|5|||
160799471|NCT04712669|580654643|FG005|Open Label Phase|Withdrawal by Subject|5|||
160799472|NCT04712669|580654644|FG006|Open Label Phase|Withdrawal by Subject|0|||
160799473|NCT04712669|580654645|FG007|Open Label Phase|Withdrawal by Subject|4|||
160799474|NCT04712669|580654638|FG000|Open Label Phase|Termination by Sponsor|0|||
160799475|NCT04712669|580654639|FG001|Open Label Phase|Termination by Sponsor|0|||
160799476|NCT04712669|580654640|FG002|Open Label Phase|Termination by Sponsor|0|||
160799477|NCT04712669|580654641|FG003|Open Label Phase|Termination by Sponsor|11|||
160799478|NCT04712669|580654642|FG004|Open Label Phase|Termination by Sponsor|9|||
160799479|NCT04712669|580654643|FG005|Open Label Phase|Termination by Sponsor|14|||
160799480|NCT04712669|580654644|FG006|Open Label Phase|Termination by Sponsor|0|||
160799481|NCT04712669|580654645|FG007|Open Label Phase|Termination by Sponsor|14|||
160799482|NCT03802396|580654646|FG000|Overall Study|Withdrawal by Subject|2|||
160799483|NCT03802396|580654647|FG001|Overall Study|Withdrawal by Subject|0|||
160799484|NCT03802396|580654646|FG000|Overall Study|Surgery Cancelled|1|||
160799485|NCT03802396|580654647|FG001|Overall Study|Surgery Cancelled|0|||
160799486|NCT03549338|580655904|FG000|Overall Study|Progressive Disease|1|||
160799487|NCT03549338|580655905|FG001|Overall Study|Progressive Disease|0|||
160799488|NCT03549338|580655906|FG002|Overall Study|Progressive Disease|0|||
160799489|NCT03549338|580655904|FG000|Overall Study|Clinical Progression|0|||
160799490|NCT03549338|580655905|FG001|Overall Study|Clinical Progression|1|||
160799491|NCT03549338|580655906|FG002|Overall Study|Clinical Progression|0|||
160799492|NCT01492426|580655907|FG000|Treatment|Death|0|||
160799493|NCT01492426|580655908|FG001|Treatment|Death|1|||
160799494|NCT01492426|580655907|FG000|Treatment|Other|1|||
160799495|NCT01492426|580655908|FG001|Treatment|Other|0|||
160799496|NCT01492426|580655907|FG000|Treatment|Adverse Event|25|||
160799497|NCT01492426|580655908|FG001|Treatment|Adverse Event|25|||
160799498|NCT01492426|580655907|FG000|Treatment|Lack of Efficacy|38|||
160799499|NCT01492426|580655908|FG001|Treatment|Lack of Efficacy|5|||
160799500|NCT01492426|580655907|FG000|Treatment|Participant withdrew consent|1|||
160799501|NCT01492426|580655908|FG001|Treatment|Participant withdrew consent|2|||
160799502|NCT01492426|580655907|FG000|Treatment|Poor compliance/noncompliance|1|||
160799503|NCT01492426|580655908|FG001|Treatment|Poor compliance/noncompliance|0|||
160799504|NCT01492426|580655907|FG000|Treatment|Subject requested discontinue study drug|7|||
160799505|NCT01492426|580655908|FG001|Treatment|Subject requested discontinue study drug|3|||
160799506|NCT01492426|580655907|FG000|Treatment|Lost to Follow-up|9|||
160799507|NCT01492426|580655908|FG001|Treatment|Lost to Follow-up|4|||
160799508|NCT01492426|580655907|FG000|Treatment|Participant does not meet study criteria|1|||
160896094|NCT00620464|581015003|FG001|Overall Study|Lost to Follow-up|1|||
160896095|NCT00620464|581015002|FG000|Overall Study|Planning Pregnancy|1|||
160799509|NCT01492426|580655908|FG001|Treatment|Participant does not meet study criteria|0|||
160799510|NCT01492426|580655907|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
160799511|NCT01492426|580655908|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
160799512|NCT01492426|580655907|FG000|Follow-Up|Death|1|||
160799513|NCT01492426|580655908|FG001|Follow-Up|Death|0|||
160799514|NCT01492426|580655907|FG000|Follow-Up|Other|4|||
160643989|NCT01512979|580078942|FG000|Overall Study|Protocol Violation|1|||
160643990|NCT01512979|580078943|FG001|Overall Study|Protocol Violation|4|||
160984484|NCT03621982|581332278|FG001|Overall Study|Withdrawal by Subject|0|||
160643991|NCT01512979|580078942|FG000|Overall Study|Lost to Follow-up|2|||
160643992|NCT01512979|580078943|FG001|Overall Study|Lost to Follow-up|5|||
160643993|NCT01512979|580078942|FG000|Overall Study|Withdrawal by Subject|1|||
160643994|NCT01512979|580078943|FG001|Overall Study|Withdrawal by Subject|2|||
160643995|NCT01512979|580078942|FG000|Overall Study|Reason other than stated above|13|||
160643996|NCT01512979|580078943|FG001|Overall Study|Reason other than stated above|9|||
160643997|NCT00125359|580078944|FG000|Overall Study|Death|4|||
160643998|NCT00125359|580078944|FG000|Overall Study|Adverse Event|5|||
160643999|NCT00125359|580078944|FG000|Overall Study|Physician Decision|14|||
160644000|NCT00529568|580078945|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
160644001|NCT00529568|580078946|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
160644002|NCT00529568|580078947|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
160644003|NCT00529568|580078945|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
160644004|NCT00529568|580078946|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
160644005|NCT00529568|580078947|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
160644006|NCT00529568|580078945|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
160644007|NCT00529568|580078946|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
160644008|NCT00529568|580078947|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
160644009|NCT00529568|580078945|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
160644010|NCT00529568|580078946|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
160644011|NCT00529568|580078947|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
160644012|NCT00529568|580078945|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
160644013|NCT00529568|580078946|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
160644014|NCT00529568|580078947|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
160644015|NCT00529568|580078945|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
160644016|NCT00529568|580078946|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
160644017|NCT00529568|580078947|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
160644018|NCT00529568|580078945|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
160644019|NCT00529568|580078946|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
160644020|NCT00529568|580078947|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
160644021|NCT00529568|580078945|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
160644022|NCT00529568|580078946|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
160644023|NCT00529568|580078947|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
160644024|NCT00529568|580078945|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
160644025|NCT00529568|580078946|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
160644026|NCT00529568|580078947|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
160644027|NCT00529568|580078945|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
160644028|NCT00529568|580078946|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
160644029|NCT00529568|580078947|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
160644030|NCT00529568|580078945|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
160644031|NCT00529568|580078946|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
160644032|NCT00529568|580078947|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
160644033|NCT04049552|580078948|FG000|Overall Study|Lost to Follow-up|1|||
160984485|NCT03621982|581332279|FG002|Overall Study|Withdrawal by Subject|0|||
160984486|NCT03621982|581332280|FG003|Overall Study|Withdrawal by Subject|1|||
160984487|NCT03621982|581332281|FG004|Overall Study|Withdrawal by Subject|0|||
160984488|NCT03621982|581332282|FG005|Overall Study|Withdrawal by Subject|1|||
160984489|NCT03621982|581332283|FG006|Overall Study|Withdrawal by Subject|1|||
160984490|NCT03621982|581332284|FG007|Overall Study|Withdrawal by Subject|0|||
160984491|NCT03621982|581332285|FG008|Overall Study|Withdrawal by Subject|1|||
160984492|NCT03621982|581332286|FG009|Overall Study|Withdrawal by Subject|0|||
160984493|NCT03621982|581332287|FG010|Overall Study|Withdrawal by Subject|2|||
160984494|NCT03621982|581332288|FG011|Overall Study|Withdrawal by Subject|1|||
160984495|NCT03621982|581332289|FG012|Overall Study|Withdrawal by Subject|2|||
160644034|NCT01201356|580078949|FG000|Overall Study|Adverse Event|170|||
160644035|NCT01201356|580078949|FG000|Overall Study|Abnormal laboratory value(s)|51|||
160644036|NCT01201356|580078949|FG000|Overall Study|Abnormal test procedure result(s)|3|||
160644037|NCT01201356|580078949|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
160644038|NCT01201356|580078949|FG000|Overall Study|Condition no longer requires study drug|12|||
160644039|NCT01201356|580078949|FG000|Overall Study|Withdrawal by Subject|144|||
160644040|NCT01201356|580078949|FG000|Overall Study|Lost to Follow-up|50|||
160644041|NCT01201356|580078949|FG000|Overall Study|administrative problems|74|||
160644042|NCT01201356|580078949|FG000|Overall Study|Death|16|||
160984496|NCT03621982|581332290|FG013|Overall Study|Withdrawal by Subject|2|||
160984497|NCT03621982|581332277|FG000|Overall Study|Investigator/Sponsor decision|0|||
160984498|NCT03621982|581332278|FG001|Overall Study|Investigator/Sponsor decision|0|||
160799515|NCT01492426|580655908|FG001|Follow-Up|Other|2|||
160799516|NCT01492426|580655907|FG000|Follow-Up|Participant Withdrew Consent|6|||
160799517|NCT01492426|580655908|FG001|Follow-Up|Participant Withdrew Consent|1|||
160799518|NCT01492426|580655907|FG000|Follow-Up|Lost to Follow-up|12|||
160799519|NCT01492426|580655908|FG001|Follow-Up|Lost to Follow-up|6|||
160799520|NCT00269113|580655909|FG000|Overall Study|Adverse Event|14|||
160799521|NCT00269113|580655910|FG001|Overall Study|Adverse Event|7|||
160799522|NCT00269113|580655909|FG000|Overall Study|Lack of Efficacy|35|||
160799523|NCT00269113|580655910|FG001|Overall Study|Lack of Efficacy|18|||
160799524|NCT00269113|580655909|FG000|Overall Study|Early Improvement|2|||
160799525|NCT00269113|580655910|FG001|Overall Study|Early Improvement|0|||
160799526|NCT00269113|580655909|FG000|Overall Study|Withdrawal by Subject|0|||
160799527|NCT00269113|580655910|FG001|Overall Study|Withdrawal by Subject|2|||
160799528|NCT00269113|580655909|FG000|Overall Study|Death|6|||
160799529|NCT00269113|580655910|FG001|Overall Study|Death|2|||
160799530|NCT00269113|580655909|FG000|Overall Study|Lost to Follow-up|2|||
160799531|NCT00269113|580655910|FG001|Overall Study|Lost to Follow-up|1|||
160799532|NCT00269113|580655909|FG000|Overall Study|Protocol Violation|15|||
160799533|NCT00269113|580655910|FG001|Overall Study|Protocol Violation|5|||
160799534|NCT00269113|580655909|FG000|Overall Study|Other|0|||
160799535|NCT00269113|580655910|FG001|Overall Study|Other|2|||
160799536|NCT00140140|580655911|FG000|Overall Study|Unacceptable toxicity|1|||
160799537|NCT00140140|580655912|FG001|Overall Study|Unacceptable toxicity|1|||
160799538|NCT00140140|580655913|FG002|Overall Study|Unacceptable toxicity|2|||
160799539|NCT00140140|580655911|FG000|Overall Study|Physician Decision|1|||
160799540|NCT00140140|580655912|FG001|Overall Study|Physician Decision|1|||
160799541|NCT00140140|580655913|FG002|Overall Study|Physician Decision|0|||
160799542|NCT00639457|580655914|FG000|Overall Study|Withdrawal by Subject|2|||
160799543|NCT00639457|580655915|FG001|Overall Study|Withdrawal by Subject|3|||
160799544|NCT01126190|580655916|FG000|Double-Blind Phase|Death|0|||
160799545|NCT01126190|580655917|FG001|Double-Blind Phase|Death|1|||
160799546|NCT01126190|580655918|FG002|Double-Blind Phase|Death|0|||
160799547|NCT01126190|580655916|FG000|Double-Blind Phase|Adverse Event|1|||
160799548|NCT01126190|580655917|FG001|Double-Blind Phase|Adverse Event|2|||
160799549|NCT01126190|580655918|FG002|Double-Blind Phase|Adverse Event|0|||
160799550|NCT01126190|580655916|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
160799551|NCT01126190|580655917|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
160799552|NCT01126190|580655918|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160799553|NCT01126190|580655916|FG000|Double-Blind Phase|Request of Investigator|1|||
160799554|NCT01126190|580655917|FG001|Double-Blind Phase|Request of Investigator|0|||
160799555|NCT01126190|580655918|FG002|Double-Blind Phase|Request of Investigator|0|||
160799556|NCT01126190|580655916|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
160799557|NCT01126190|580655917|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
160799558|NCT01126190|580655918|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
160799559|NCT01126190|580655916|FG000|Double-Blind Phase|Non-compliance|1|||
160799560|NCT01126190|580655917|FG001|Double-Blind Phase|Non-compliance|0|||
160799561|NCT01126190|580655918|FG002|Double-Blind Phase|Non-compliance|0|||
160799562|NCT01126190|580655916|FG000|Double-Blind Phase|Lost to Follow-up|1|||
160799563|NCT01126190|580655917|FG001|Double-Blind Phase|Lost to Follow-up|3|||
160799564|NCT01126190|580655918|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160799565|NCT01126190|580655916|FG000|Open-Label Phase|Death|0|||
160799566|NCT01126190|580655917|FG001|Open-Label Phase|Death|0|||
160799567|NCT01126190|580655918|FG002|Open-Label Phase|Death|1|||
160799568|NCT01126190|580655916|FG000|Open-Label Phase|Adverse Event|0|||
160799569|NCT01126190|580655917|FG001|Open-Label Phase|Adverse Event|0|||
160799570|NCT01126190|580655918|FG002|Open-Label Phase|Adverse Event|4|||
160799571|NCT01126190|580655916|FG000|Open-Label Phase|Withdrawal by Subject|0|||
160799572|NCT01126190|580655917|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160799573|NCT01126190|580655918|FG002|Open-Label Phase|Withdrawal by Subject|6|||
160799574|NCT01128569|580655919|FG000|Washout Period 1|Adverse Event|0|||
160799575|NCT01128569|580655920|FG001|Washout Period 1|Adverse Event|0|||
160799576|NCT01128569|580655921|FG002|Washout Period 1|Adverse Event|1|||
160799577|NCT01128569|580655922|FG003|Washout Period 1|Adverse Event|0|||
160799578|NCT01128569|580655923|FG004|Washout Period 1|Adverse Event|0|||
160896096|NCT00620464|581015003|FG001|Overall Study|Planning Pregnancy|4|||
160896097|NCT00620464|581015002|FG000|Overall Study|Personal|2|||
160799579|NCT01128569|580655924|FG005|Washout Period 1|Adverse Event|0|||
160896098|NCT00620464|581015003|FG001|Overall Study|Personal|2|||
160896099|NCT00620464|581015002|FG000|Overall Study|Used prohibited medication|1|||
160896100|NCT00620464|581015003|FG001|Overall Study|Used prohibited medication|0|||
160799580|NCT01128569|580655919|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160799581|NCT01128569|580655920|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160799582|NCT01128569|580655921|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160799583|NCT01128569|580655922|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160799584|NCT01128569|580655923|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160799585|NCT01128569|580655924|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160799586|NCT03338400|580655925|FG000|Overall Study|Lost to Follow-up|1|||
160896101|NCT03139279|581015004|FG000|Overall Study|Physician Decision|2|||
160896102|NCT03139279|581015005|FG001|Overall Study|Physician Decision|0|||
160799587|NCT03338400|580655926|FG001|Overall Study|Lost to Follow-up|2|||
160799588|NCT01627691|580655927|FG000|Overall Study|Death|11|||
160799589|NCT01627691|580655927|FG000|Overall Study|Lost to Follow-up|3|||
160799590|NCT01627691|580655927|FG000|Overall Study|Withdrawal by Subject|1|||
160799591|NCT01627691|580655927|FG000|Overall Study|Missed the visit|3|||
160799592|NCT01156844|580655934|FG000|Overall Study|Adverse Event|0|||
160799593|NCT01156844|580655935|FG001|Overall Study|Adverse Event|0|||
160799594|NCT01156844|580655936|FG002|Overall Study|Adverse Event|1|||
160799595|NCT01156844|580655937|FG003|Overall Study|Adverse Event|1|||
160799596|NCT01156844|580655934|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160799597|NCT01156844|580655935|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160799598|NCT01156844|580655936|FG002|Overall Study|Abnormal test procedure result(s)|2|||
160799599|NCT01156844|580655937|FG003|Overall Study|Abnormal test procedure result(s)|2|||
160799600|NCT01156844|580655934|FG000|Overall Study|Withdrawal by Subject|0|||
160799601|NCT01156844|580655935|FG001|Overall Study|Withdrawal by Subject|0|||
160799602|NCT01156844|580655936|FG002|Overall Study|Withdrawal by Subject|2|||
160799603|NCT01156844|580655937|FG003|Overall Study|Withdrawal by Subject|2|||
160799604|NCT01156844|580655934|FG000|Overall Study|Lost to Follow-up|0|||
160799605|NCT01156844|580655935|FG001|Overall Study|Lost to Follow-up|0|||
160799606|NCT01156844|580655936|FG002|Overall Study|Lost to Follow-up|1|||
160799607|NCT01156844|580655937|FG003|Overall Study|Lost to Follow-up|0|||
160799608|NCT01156844|580655934|FG000|Overall Study|Administrative problems|0|||
160799609|NCT01156844|580655935|FG001|Overall Study|Administrative problems|1|||
160799610|NCT01156844|580655936|FG002|Overall Study|Administrative problems|0|||
160799611|NCT01156844|580655937|FG003|Overall Study|Administrative problems|1|||
160799612|NCT01156844|580655934|FG000|Overall Study|Protocol deviation|2|||
160799613|NCT01156844|580655935|FG001|Overall Study|Protocol deviation|0|||
160799614|NCT01156844|580655936|FG002|Overall Study|Protocol deviation|0|||
160799615|NCT01156844|580655937|FG003|Overall Study|Protocol deviation|0|||
160799616|NCT01130337|580655942|FG000|Overall Study|Withdrawal by Subject|3|||
160799617|NCT01130337|580655942|FG000|Overall Study|Principal investigator decision|1|||
160799618|NCT01130337|580655942|FG000|Overall Study|Death|1|||
160799619|NCT01130337|580655942|FG000|Overall Study|Disease progression|1|||
160799620|NCT01130337|580655942|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
160799621|NCT01130337|580655942|FG000|Overall Study|Surgical resection (R2)|1|||
160799622|NCT05525910|580655943|FG000|Period 4|Per sponsor due to study timelines|0|||
160799623|NCT05525910|580655944|FG001|Period 4|Per sponsor due to study timelines|0|||
160799624|NCT05525910|580655945|FG002|Period 4|Per sponsor due to study timelines|1|||
160799625|NCT05525910|580655946|FG003|Period 4|Per sponsor due to study timelines|1|||
160896103|NCT03139279|581015004|FG000|Overall Study|Protocol Violation|5|||
160896104|NCT03139279|581015005|FG001|Overall Study|Protocol Violation|4|||
160896105|NCT03139279|581015004|FG000|Overall Study|Withdrawal by Subject|0|||
160896106|NCT03139279|581015005|FG001|Overall Study|Withdrawal by Subject|2|||
160896107|NCT05394350|581015006|FG000|Overall Study|Death|2|||
160896108|NCT05394350|581015007|FG001|Overall Study|Death|2|||
160896109|NCT05394350|581015008|FG002|Overall Study|Death|4|||
160896110|NCT05394350|581015009|FG003|Overall Study|Death|0|||
160896111|NCT05394350|581015010|FG004|Overall Study|Death|1|||
160896112|NCT05394350|581015011|FG005|Overall Study|Death|0|||
160896113|NCT05394350|581015006|FG000|Overall Study|Study terminated by sponsor|1|||
160896114|NCT05394350|581015007|FG001|Overall Study|Study terminated by sponsor|1|||
160896115|NCT05394350|581015008|FG002|Overall Study|Study terminated by sponsor|7|||
160896116|NCT05394350|581015009|FG003|Overall Study|Study terminated by sponsor|3|||
160896117|NCT05394350|581015010|FG004|Overall Study|Study terminated by sponsor|2|||
160896118|NCT05394350|581015011|FG005|Overall Study|Study terminated by sponsor|4|||
160896119|NCT02024555|581015016|FG000|Overall Study|Lost to Follow-up|1|||
160896120|NCT02024555|581015017|FG001|Overall Study|Lost to Follow-up|1|||
160896121|NCT02024555|581015016|FG000|Overall Study|Withdrawal by Subject|5|||
160896122|NCT02024555|581015017|FG001|Overall Study|Withdrawal by Subject|1|||
160896123|NCT00492050|581015018|FG000|Overall Study|Adverse Event|1|||
160896124|NCT00492050|581015018|FG000|Overall Study|Lack of Efficacy|1|||
160896125|NCT00492050|581015018|FG000|Overall Study|Withdrawal by Subject|3|||
160799626|NCT05525910|580655947|FG004|Period 4|Per sponsor due to study timelines|1|||
160799627|NCT03886493|580655948|FG000|Overall Study|Adverse Event|1|||
160799628|NCT04067011|580655950|FG000|Overall Study|Not Treated|8|||
160799629|NCT04067011|580655951|FG001|Overall Study|Not Treated|7|||
160799630|NCT04067011|580655952|FG002|Overall Study|Not Treated|5|||
160799631|NCT04067011|580655950|FG000|Overall Study|Adverse Event|2|||
160799632|NCT04067011|580655951|FG001|Overall Study|Adverse Event|1|||
160799633|NCT04067011|580655952|FG002|Overall Study|Adverse Event|0|||
160896126|NCT00492050|581015018|FG000|Overall Study|Unable to collect SCT|2|||
160896127|NCT00492050|581015018|FG000|Overall Study|Progressive Disease|2|||
160896128|NCT04246372|581016837|FG000|Overall Study|Adverse Event|1|||
160896129|NCT04246372|581016837|FG000|Overall Study|Withdrawal by Subject|1|||
160896130|NCT04246372|581016837|FG000|Overall Study|Protocol Violation|2|||
160896131|NCT04246372|581016837|FG000|Overall Study|Physician Decision|1|||
160896132|NCT00392015|581016839|FG000|Overall Study|Lost to Follow-up|2|||
160896133|NCT00392015|581016840|FG001|Overall Study|Lost to Follow-up|0|||
160984499|NCT03621982|581332279|FG002|Overall Study|Investigator/Sponsor decision|0|||
160984500|NCT03621982|581332280|FG003|Overall Study|Investigator/Sponsor decision|0|||
160984501|NCT03621982|581332281|FG004|Overall Study|Investigator/Sponsor decision|0|||
160984502|NCT03621982|581332282|FG005|Overall Study|Investigator/Sponsor decision|0|||
160984503|NCT03621982|581332283|FG006|Overall Study|Investigator/Sponsor decision|0|||
160984504|NCT03621982|581332284|FG007|Overall Study|Investigator/Sponsor decision|0|||
160984505|NCT03621982|581332285|FG008|Overall Study|Investigator/Sponsor decision|0|||
160984506|NCT03621982|581332286|FG009|Overall Study|Investigator/Sponsor decision|0|||
160984507|NCT03621982|581332287|FG010|Overall Study|Investigator/Sponsor decision|0|||
160984508|NCT03621982|581332288|FG011|Overall Study|Investigator/Sponsor decision|4|||
160984509|NCT03621982|581332289|FG012|Overall Study|Investigator/Sponsor decision|0|||
160984510|NCT03621982|581332290|FG013|Overall Study|Investigator/Sponsor decision|2|||
160984511|NCT03621982|581332277|FG000|Overall Study|Death|2|||
160984512|NCT03621982|581332278|FG001|Overall Study|Death|4|||
160984513|NCT03621982|581332279|FG002|Overall Study|Death|4|||
160984514|NCT03621982|581332280|FG003|Overall Study|Death|3|||
160984515|NCT03621982|581332281|FG004|Overall Study|Death|8|||
160984516|NCT03621982|581332282|FG005|Overall Study|Death|4|||
160984517|NCT03621982|581332283|FG006|Overall Study|Death|6|||
160984518|NCT03621982|581332284|FG007|Overall Study|Death|3|||
160984519|NCT03621982|581332285|FG008|Overall Study|Death|0|||
160984520|NCT03621982|581332286|FG009|Overall Study|Death|3|||
160984521|NCT03621982|581332287|FG010|Overall Study|Death|8|||
160984522|NCT03621982|581332288|FG011|Overall Study|Death|4|||
160984523|NCT03621982|581332289|FG012|Overall Study|Death|2|||
160984524|NCT03621982|581332290|FG013|Overall Study|Death|2|||
160984525|NCT03621982|581332277|FG000|Overall Study|Lost to Follow-up|0|||
160984526|NCT03621982|581332278|FG001|Overall Study|Lost to Follow-up|0|||
160984527|NCT03621982|581332279|FG002|Overall Study|Lost to Follow-up|1|||
160984528|NCT03621982|581332280|FG003|Overall Study|Lost to Follow-up|0|||
160984529|NCT03621982|581332281|FG004|Overall Study|Lost to Follow-up|0|||
160984530|NCT03621982|581332282|FG005|Overall Study|Lost to Follow-up|0|||
160984531|NCT03621982|581332283|FG006|Overall Study|Lost to Follow-up|1|||
160984532|NCT03621982|581332284|FG007|Overall Study|Lost to Follow-up|0|||
160984533|NCT03621982|581332285|FG008|Overall Study|Lost to Follow-up|0|||
160984534|NCT03621982|581332286|FG009|Overall Study|Lost to Follow-up|1|||
160984535|NCT03621982|581332287|FG010|Overall Study|Lost to Follow-up|0|||
160984536|NCT03621982|581332288|FG011|Overall Study|Lost to Follow-up|0|||
160984537|NCT03621982|581332289|FG012|Overall Study|Lost to Follow-up|0|||
160984538|NCT03621982|581332290|FG013|Overall Study|Lost to Follow-up|0|||
160984539|NCT00238420|581332291|FG000|Overall Study|Protocol Violation|1|||
160984540|NCT00238420|581332292|FG001|Overall Study|Protocol Violation|1|||
160984541|NCT01254890|581332295|FG000|Overall Study|Ineligible|0|||
160984542|NCT01254890|581332296|FG001|Overall Study|Ineligible|3|||
160984543|NCT01254890|581332295|FG000|Overall Study|Withdrawal by Subject|1|||
160984544|NCT01254890|581332296|FG001|Overall Study|Withdrawal by Subject|2|||
160984545|NCT01254890|581332295|FG000|Overall Study|Disease Progression|0|||
160984546|NCT01254890|581332296|FG001|Overall Study|Disease Progression|5|||
160984547|NCT02419755|581332307|FG000|Overall Study|Death|1|||
160984548|NCT02419755|581332308|FG001|Overall Study|Death|3|||
160984549|NCT02419755|581332307|FG000|Overall Study|Relapse|0|||
160984550|NCT02419755|581332308|FG001|Overall Study|Relapse|1|||
160984551|NCT02419755|581332307|FG000|Overall Study|Ineligible|1|||
160984552|NCT02419755|581332308|FG001|Overall Study|Ineligible|0|||
160984553|NCT02419755|581332307|FG000|Overall Study|Withdrawal by Subject|1|||
160984554|NCT02419755|581332308|FG001|Overall Study|Withdrawal by Subject|0|||
160984555|NCT00810641|581332311|FG000|Overall Study|Withdrawal by Subject|0|||
160984556|NCT00810641|581332312|FG001|Overall Study|Withdrawal by Subject|1|||
160984557|NCT00810641|581332313|FG002|Overall Study|Withdrawal by Subject|2|||
160984558|NCT02325713|581332316|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984559|NCT02325713|581332317|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984560|NCT02325713|581332318|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984561|NCT02325713|581332319|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984562|NCT02325713|581332320|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984563|NCT02325713|581332321|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984564|NCT02325713|581332322|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984565|NCT02325713|581332323|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984566|NCT02325713|581332324|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984567|NCT02325713|581332325|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984568|NCT02325713|581332326|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
160984569|NCT02325713|581332327|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984570|NCT02325713|581332328|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984571|NCT02325713|581332329|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984572|NCT02325713|581332330|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984573|NCT02325713|581332331|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984574|NCT02325713|581332316|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
160799634|NCT04067011|580655950|FG000|Overall Study|Withdrawal by Subject|6|||
160799635|NCT04067011|580655951|FG001|Overall Study|Withdrawal by Subject|2|||
160799636|NCT04067011|580655952|FG002|Overall Study|Withdrawal by Subject|1|||
160799637|NCT04067011|580655950|FG000|Overall Study|Lost to Follow-up|0|||
160799638|NCT04067011|580655951|FG001|Overall Study|Lost to Follow-up|0|||
160799639|NCT04067011|580655952|FG002|Overall Study|Lost to Follow-up|1|||
160799640|NCT04067011|580655950|FG000|Overall Study|Physician Decision|1|||
160799641|NCT04067011|580655951|FG001|Overall Study|Physician Decision|1|||
160799642|NCT04067011|580655952|FG002|Overall Study|Physician Decision|0|||
160799643|NCT04067011|580655950|FG000|Overall Study|Other Reasons|2|||
160799644|NCT04067011|580655951|FG001|Overall Study|Other Reasons|0|||
160799645|NCT04067011|580655952|FG002|Overall Study|Other Reasons|1|||
160799646|NCT04067011|580655950|FG000|Overall Study|Missing|0|||
160799647|NCT04067011|580655951|FG001|Overall Study|Missing|2|||
160799648|NCT04067011|580655952|FG002|Overall Study|Missing|0|||
160799649|NCT05209386|580655953|FG000|Overall Study|Withdrawal by Subject|8|||
160799650|NCT05209386|580655953|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
160799651|NCT03179761|580655954|FG000|Overall Study|Death|2|||
160799652|NCT03179761|580655955|FG001|Overall Study|Death|5|||
160799653|NCT03179761|580655954|FG000|Overall Study|Lost to Follow-up|2|||
160799654|NCT03179761|580655955|FG001|Overall Study|Lost to Follow-up|2|||
160799655|NCT03179761|580655954|FG000|Overall Study|Protocol Violation|1|||
160799656|NCT03179761|580655955|FG001|Overall Study|Protocol Violation|0|||
160799657|NCT03179761|580655954|FG000|Overall Study|Withdrawal by Subject|1|||
160799658|NCT03179761|580655955|FG001|Overall Study|Withdrawal by Subject|4|||
160799659|NCT03179761|580655954|FG000|Overall Study|Investigator Request|0|||
160799660|NCT03179761|580655955|FG001|Overall Study|Investigator Request|2|||
160799661|NCT00565409|580655956|FG000|Period 1 Open Label|Adverse Event|17|||
160799662|NCT00565409|580655957|FG001|Period 1 Open Label|Adverse Event|0|||
160799663|NCT00565409|580655958|FG002|Period 1 Open Label|Adverse Event|0|||
160799664|NCT00565409|580655959|FG003|Period 1 Open Label|Adverse Event|0|||
160799665|NCT00565409|580655956|FG000|Period 1 Open Label|Death|2|||
160799666|NCT00565409|580655957|FG001|Period 1 Open Label|Death|0|||
160799667|NCT00565409|580655958|FG002|Period 1 Open Label|Death|0|||
160799668|NCT00565409|580655959|FG003|Period 1 Open Label|Death|0|||
160799669|NCT00565409|580655956|FG000|Period 1 Open Label|Lost to Follow-up|1|||
160799670|NCT00565409|580655957|FG001|Period 1 Open Label|Lost to Follow-up|0|||
160799671|NCT00565409|580655958|FG002|Period 1 Open Label|Lost to Follow-up|0|||
160799672|NCT00565409|580655959|FG003|Period 1 Open Label|Lost to Follow-up|0|||
160799673|NCT00565409|580655956|FG000|Period 1 Open Label|Other|21|||
160799674|NCT00565409|580655957|FG001|Period 1 Open Label|Other|0|||
160799675|NCT00565409|580655958|FG002|Period 1 Open Label|Other|0|||
160799676|NCT00565409|580655959|FG003|Period 1 Open Label|Other|0|||
160799677|NCT00565409|580655956|FG000|Period 1 Open Label|Protocol Violation|14|||
160799678|NCT00565409|580655957|FG001|Period 1 Open Label|Protocol Violation|0|||
160799679|NCT00565409|580655958|FG002|Period 1 Open Label|Protocol Violation|0|||
160799680|NCT00565409|580655959|FG003|Period 1 Open Label|Protocol Violation|0|||
160799681|NCT00565409|580655956|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
160799682|NCT00565409|580655957|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
160799683|NCT00565409|580655958|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
160799684|NCT00565409|580655959|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
160799685|NCT00565409|580655956|FG000|Period 1 Open Label|no conclusion of participation record|1|||
160799686|NCT00565409|580655957|FG001|Period 1 Open Label|no conclusion of participation record|0|||
160799687|NCT00565409|580655958|FG002|Period 1 Open Label|no conclusion of participation record|0|||
160799688|NCT00565409|580655959|FG003|Period 1 Open Label|no conclusion of participation record|0|||
160799689|NCT00565409|580655956|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
160799690|NCT00565409|580655957|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
160799691|NCT00565409|580655958|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
160799692|NCT00565409|580655959|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
160799693|NCT00565409|580655956|FG000|Period 2 Double-Blind|Adverse Event|0|||
160799694|NCT00565409|580655957|FG001|Period 2 Double-Blind|Adverse Event|7|||
160799695|NCT00565409|580655958|FG002|Period 2 Double-Blind|Adverse Event|4|||
160799696|NCT00565409|580655959|FG003|Period 2 Double-Blind|Adverse Event|5|||
160799697|NCT00565409|580655956|FG000|Period 2 Double-Blind|Death|0|||
160799698|NCT00565409|580655957|FG001|Period 2 Double-Blind|Death|2|||
160799699|NCT00565409|580655958|FG002|Period 2 Double-Blind|Death|0|||
160896134|NCT00392015|581016841|FG002|Overall Study|Lost to Follow-up|2|||
160549960|NCT03529773|579740179|FG027|Overall Study|Death|0|||
160799700|NCT00565409|580655959|FG003|Period 2 Double-Blind|Death|0|||
160799701|NCT00565409|580655956|FG000|Period 2 Double-Blind|Protocol Violation|0|||
160799702|NCT00565409|580655957|FG001|Period 2 Double-Blind|Protocol Violation|4|||
160799703|NCT00565409|580655958|FG002|Period 2 Double-Blind|Protocol Violation|6|||
160799704|NCT00565409|580655959|FG003|Period 2 Double-Blind|Protocol Violation|2|||
160799705|NCT00565409|580655956|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
160799706|NCT00565409|580655957|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
160896135|NCT00392015|581016842|FG003|Overall Study|Lost to Follow-up|1|||
160549961|NCT03529773|579740180|FG028|Overall Study|Death|0|||
160799707|NCT00565409|580655958|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
160799708|NCT00565409|580655959|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
160799709|NCT00565409|580655956|FG000|Period 2 Double-Blind|Other|0|||
160799710|NCT00565409|580655957|FG001|Period 2 Double-Blind|Other|4|||
160799711|NCT00565409|580655958|FG002|Period 2 Double-Blind|Other|5|||
160799712|NCT00565409|580655959|FG003|Period 2 Double-Blind|Other|9|||
160799713|NCT00565409|580655956|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
160799714|NCT00565409|580655957|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
160799715|NCT00565409|580655958|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
160799716|NCT00565409|580655959|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
160799717|NCT03139448|580655965|FG000|Overall Study|Lack of Efficacy|6|||
160799718|NCT03139448|580655966|FG001|Overall Study|Lack of Efficacy|7|||
160799719|NCT03139448|580655965|FG000|Overall Study|Location of procedure changed|2|||
160799720|NCT03139448|580655966|FG001|Overall Study|Location of procedure changed|8|||
160799721|NCT03139448|580655965|FG000|Overall Study|Withdrawal by Subject|3|||
160799722|NCT03139448|580655966|FG001|Overall Study|Withdrawal by Subject|6|||
160799723|NCT03139448|580655965|FG000|Overall Study|Screen fail|1|||
160799724|NCT03139448|580655966|FG001|Overall Study|Screen fail|3|||
160799725|NCT03139448|580655965|FG000|Overall Study|Physician Decision|0|||
160799726|NCT03139448|580655966|FG001|Overall Study|Physician Decision|2|||
160799727|NCT01038323|580655967|FG000|Overall Study|Withdrawal by Subject|3|||
160799728|NCT01038323|580655968|FG001|Overall Study|Withdrawal by Subject|2|||
160799729|NCT01038323|580655969|FG002|Overall Study|Withdrawal by Subject|4|||
160799730|NCT04436744|580655972|FG000|Overall Study|Adverse Event|1|||
160799731|NCT04436744|580655973|FG001|Overall Study|Adverse Event|1|||
160799732|NCT04436744|580655972|FG000|Overall Study|Death|1|||
160799733|NCT04436744|580655973|FG001|Overall Study|Death|0|||
160799734|NCT04436744|580655972|FG000|Overall Study|Lost to Follow-up|0|||
160799735|NCT04436744|580655973|FG001|Overall Study|Lost to Follow-up|2|||
160799736|NCT04436744|580655972|FG000|Overall Study|Physician Decision|0|||
160799737|NCT04436744|580655973|FG001|Overall Study|Physician Decision|1|||
160799738|NCT04436744|580655972|FG000|Overall Study|Progressive Disease|0|||
160799739|NCT04436744|580655973|FG001|Overall Study|Progressive Disease|4|||
160799740|NCT04436744|580655972|FG000|Overall Study|Protocol Deviation|1|||
160799741|NCT04436744|580655973|FG001|Overall Study|Protocol Deviation|1|||
160799742|NCT04436744|580655972|FG000|Overall Study|Withdrawal by Subject|1|||
160799743|NCT04436744|580655973|FG001|Overall Study|Withdrawal by Subject|2|||
160799744|NCT01463033|580655974|FG000|Overall Study|Lost to Follow-up|4|||
160799745|NCT01463033|580655975|FG001|Overall Study|Lost to Follow-up|4|||
160799746|NCT01463033|580655974|FG000|Overall Study|Death|3|||
160799747|NCT01463033|580655975|FG001|Overall Study|Death|2|||
160799748|NCT00746811|580655976|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
160799749|NCT00746811|580655977|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
160799750|NCT01538199|580655978|FG000|Overall Study|Lost to Follow-up|1|||
160799751|NCT01538199|580655979|FG001|Overall Study|Lost to Follow-up|2|||
160799752|NCT01538199|580655980|FG002|Overall Study|Lost to Follow-up|1|||
160799753|NCT01538199|580655981|FG003|Overall Study|Lost to Follow-up|0|||
160799754|NCT01538199|580655978|FG000|Overall Study|participant did not have time|1|||
160799755|NCT01538199|580655979|FG001|Overall Study|participant did not have time|0|||
160799756|NCT01538199|580655980|FG002|Overall Study|participant did not have time|0|||
160799757|NCT01538199|580655981|FG003|Overall Study|participant did not have time|2|||
160799758|NCT01538199|580655978|FG000|Overall Study|Lack of Efficacy|0|||
160799759|NCT01538199|580655979|FG001|Overall Study|Lack of Efficacy|1|||
160799760|NCT01538199|580655980|FG002|Overall Study|Lack of Efficacy|0|||
160799761|NCT01538199|580655981|FG003|Overall Study|Lack of Efficacy|0|||
160799762|NCT03358030|580655982|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
160799763|NCT03358030|580655983|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
160799764|NCT03358030|580655984|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
160799765|NCT03358030|580655985|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
160799766|NCT03358030|580655982|FG000|Overall Study|Ineligibility|0|||
160799767|NCT03358030|580655983|FG001|Overall Study|Ineligibility|0|||
160799768|NCT03358030|580655984|FG002|Overall Study|Ineligibility|0|||
160799769|NCT03358030|580655985|FG003|Overall Study|Ineligibility|2|||
160799770|NCT03358030|580655982|FG000|Overall Study|Voluntary Withdrawal|1|||
160799771|NCT03358030|580655983|FG001|Overall Study|Voluntary Withdrawal|1|||
160799772|NCT03358030|580655984|FG002|Overall Study|Voluntary Withdrawal|3|||
160799773|NCT03358030|580655985|FG003|Overall Study|Voluntary Withdrawal|1|||
160799774|NCT03358030|580655982|FG000|Overall Study|Other|0|||
160799775|NCT03358030|580655983|FG001|Overall Study|Other|0|||
160799776|NCT03358030|580655984|FG002|Overall Study|Other|1|||
160799777|NCT03358030|580655985|FG003|Overall Study|Other|0|||
160799778|NCT03342560|580655986|FG000|Overall Study|Lost to Follow-up|2|||
160799779|NCT02604511|580655987|FG000|Overall Study|Adverse Event|3|||
160799780|NCT02604511|580655987|FG000|Overall Study|Disease Progression|4|||
160799781|NCT02604511|580655987|FG000|Overall Study|Withdrawal by Subject|3|||
160799782|NCT02604511|580655987|FG000|Overall Study|Participant ineligible|1|||
160799783|NCT02604511|580655987|FG000|Overall Study|Intercurrent illness|1|||
160896136|NCT00392015|581016843|FG004|Overall Study|Lost to Follow-up|1|||
160896137|NCT00392015|581016844|FG005|Overall Study|Lost to Follow-up|0|||
160896138|NCT00392015|581016839|FG000|Overall Study|Withdrawal by Subject|0|||
160896139|NCT00392015|581016840|FG001|Overall Study|Withdrawal by Subject|0|||
160644043|NCT01201356|580078949|FG000|Overall Study|Protocol Violation|12|||
160644044|NCT00738920|580078951|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
160644045|NCT00738920|580078952|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
160644046|NCT00738920|580078953|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
160896140|NCT00392015|581016841|FG002|Overall Study|Withdrawal by Subject|2|||
160549962|NCT03529773|579740181|FG029|Overall Study|Death|0|||
160644047|NCT00738920|580078951|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
160644048|NCT00738920|580078952|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
160644049|NCT00738920|580078953|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
160644050|NCT00738920|580078951|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
160644051|NCT00738920|580078952|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
160644052|NCT00738920|580078953|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
160644053|NCT00738920|580078951|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
160644054|NCT00738920|580078952|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
160644055|NCT00738920|580078953|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
160644056|NCT00738920|580078951|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
160644057|NCT00738920|580078952|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
160644058|NCT00738920|580078953|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
160644059|NCT00738920|580078951|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
160644060|NCT00738920|580078952|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
160644061|NCT00738920|580078953|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
160644062|NCT00738920|580078951|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
160644063|NCT00738920|580078952|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
160644064|NCT00738920|580078953|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
160644065|NCT00738920|580078951|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
160644066|NCT00738920|580078952|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
160644067|NCT00738920|580078953|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
160644068|NCT00738920|580078951|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
160644069|NCT00738920|580078952|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
160549963|NCT03529773|579740182|FG030|Overall Study|Death|0|||
160549964|NCT03529773|579740183|FG031|Overall Study|Death|0|||
160549965|NCT03529773|579740184|FG032|Overall Study|Death|0|||
160549966|NCT03529773|579740185|FG033|Overall Study|Death|1|||
160549967|NCT03529773|579740186|FG034|Overall Study|Death|1|||
160549968|NCT03529773|579740187|FG035|Overall Study|Death|0|||
160549969|NCT03529773|579740188|FG036|Overall Study|Death|1|||
160549970|NCT03529773|579740189|FG037|Overall Study|Death|0|||
160549971|NCT03529773|579740190|FG038|Overall Study|Death|0|||
160549972|NCT03529773|579740191|FG039|Overall Study|Death|0|||
160549973|NCT03529773|579740152|FG000|Overall Study|Lost to Follow-up|0|||
160549974|NCT03529773|579740153|FG001|Overall Study|Lost to Follow-up|0|||
160549975|NCT03529773|579740154|FG002|Overall Study|Lost to Follow-up|1|||
160549976|NCT03529773|579740155|FG003|Overall Study|Lost to Follow-up|0|||
160549977|NCT03529773|579740156|FG004|Overall Study|Lost to Follow-up|1|||
160549978|NCT03529773|579740157|FG005|Overall Study|Lost to Follow-up|1|||
160549979|NCT03529773|579740158|FG006|Overall Study|Lost to Follow-up|0|||
160549980|NCT03529773|579740159|FG007|Overall Study|Lost to Follow-up|0|||
160549981|NCT03529773|579740160|FG008|Overall Study|Lost to Follow-up|0|||
160549982|NCT03529773|579740161|FG009|Overall Study|Lost to Follow-up|0|||
160549983|NCT03529773|579740162|FG010|Overall Study|Lost to Follow-up|0|||
160549984|NCT03529773|579740163|FG011|Overall Study|Lost to Follow-up|0|||
160549985|NCT03529773|579740164|FG012|Overall Study|Lost to Follow-up|0|||
160549986|NCT03529773|579740165|FG013|Overall Study|Lost to Follow-up|1|||
160549987|NCT03529773|579740166|FG014|Overall Study|Lost to Follow-up|4|||
160549988|NCT03529773|579740167|FG015|Overall Study|Lost to Follow-up|1|||
160549989|NCT03529773|579740168|FG016|Overall Study|Lost to Follow-up|1|||
160549990|NCT03529773|579740169|FG017|Overall Study|Lost to Follow-up|0|||
160549991|NCT03529773|579740170|FG018|Overall Study|Lost to Follow-up|1|||
160549992|NCT03529773|579740171|FG019|Overall Study|Lost to Follow-up|1|||
160549993|NCT03529773|579740172|FG020|Overall Study|Lost to Follow-up|2|||
160549994|NCT03529773|579740173|FG021|Overall Study|Lost to Follow-up|4|||
160549995|NCT03529773|579740174|FG022|Overall Study|Lost to Follow-up|3|||
160549996|NCT03529773|579740175|FG023|Overall Study|Lost to Follow-up|4|||
160549997|NCT03529773|579740176|FG024|Overall Study|Lost to Follow-up|3|||
160549998|NCT03529773|579740177|FG025|Overall Study|Lost to Follow-up|5|||
160549999|NCT03529773|579740178|FG026|Overall Study|Lost to Follow-up|5|||
160550000|NCT03529773|579740179|FG027|Overall Study|Lost to Follow-up|0|||
160896141|NCT00392015|581016842|FG003|Overall Study|Withdrawal by Subject|0|||
160550001|NCT03529773|579740180|FG028|Overall Study|Lost to Follow-up|0|||
160550002|NCT03529773|579740181|FG029|Overall Study|Lost to Follow-up|0|||
160550003|NCT03529773|579740182|FG030|Overall Study|Lost to Follow-up|1|||
160799784|NCT03770286|580655988|FG000|Overall Study|Lost to Follow-up|6|||
160799785|NCT03770286|580655989|FG001|Overall Study|Lost to Follow-up|4|||
160799786|NCT03770286|580655990|FG002|Overall Study|Lost to Follow-up|3|||
160799787|NCT03770286|580655988|FG000|Overall Study|Protocol Violation|1|||
160799788|NCT03770286|580655989|FG001|Overall Study|Protocol Violation|0|||
160799789|NCT03770286|580655990|FG002|Overall Study|Protocol Violation|2|||
160799790|NCT02505425|580655991|FG000|Overall Study|Lost to Follow-up|41|||
160799791|NCT02505425|580655992|FG001|Overall Study|Lost to Follow-up|61|||
160799792|NCT02505425|580655993|FG002|Overall Study|Lost to Follow-up|31|||
160799793|NCT02505425|580655994|FG003|Overall Study|Lost to Follow-up|19|||
160799794|NCT02505425|580655991|FG000|Overall Study|Withdrawal by Subject|39|||
160799795|NCT02505425|580655992|FG001|Overall Study|Withdrawal by Subject|9|||
160896142|NCT00392015|581016843|FG004|Overall Study|Withdrawal by Subject|0|||
160896143|NCT00392015|581016844|FG005|Overall Study|Withdrawal by Subject|0|||
160896144|NCT00392015|581016839|FG000|Overall Study|Adverse Event|0|||
160896145|NCT00392015|581016840|FG001|Overall Study|Adverse Event|0|||
160896146|NCT00392015|581016841|FG002|Overall Study|Adverse Event|0|||
160896147|NCT00392015|581016842|FG003|Overall Study|Adverse Event|0|||
160896148|NCT00392015|581016843|FG004|Overall Study|Adverse Event|1|||
160896149|NCT00392015|581016844|FG005|Overall Study|Adverse Event|0|||
160799796|NCT02505425|580655993|FG002|Overall Study|Withdrawal by Subject|19|||
160799797|NCT02505425|580655994|FG003|Overall Study|Withdrawal by Subject|7|||
160799798|NCT02505425|580655991|FG000|Overall Study|Death|8|||
160799799|NCT02505425|580655992|FG001|Overall Study|Death|12|||
160799800|NCT02505425|580655993|FG002|Overall Study|Death|0|||
160799801|NCT02505425|580655994|FG003|Overall Study|Death|0|||
160799802|NCT00404248|580656003|FG000|Overall Study|pts declining status|0|||
160799803|NCT00404248|580656004|FG001|Overall Study|pts declining status|1|||
160799804|NCT00404248|580656005|FG002|Overall Study|pts declining status|0|||
160799805|NCT00404248|580656006|FG003|Overall Study|pts declining status|0|||
160799806|NCT00404248|580656007|FG004|Overall Study|pts declining status|0|||
160799807|NCT00404248|580656008|FG005|Overall Study|pts declining status|0|||
160799808|NCT00404248|580656009|FG006|Overall Study|pts declining status|0|||
160799809|NCT00404248|580656010|FG007|Overall Study|pts declining status|0|||
160799810|NCT00404248|580656011|FG008|Overall Study|pts declining status|0|||
160799811|NCT00789555|580656012|FG000|Overall Study|Protocol Amendment|78|||
160799812|NCT00789555|580656013|FG001|Overall Study|Protocol Amendment|76|||
160799813|NCT00789555|580656014|FG002|Overall Study|Protocol Amendment|80|||
160799814|NCT00789555|580656012|FG000|Overall Study|Adverse Event|17|||
160799815|NCT00789555|580656013|FG001|Overall Study|Adverse Event|7|||
160799816|NCT00789555|580656014|FG002|Overall Study|Adverse Event|10|||
160799817|NCT00789555|580656012|FG000|Overall Study|Lost to Follow-up|9|||
160799818|NCT00789555|580656013|FG001|Overall Study|Lost to Follow-up|10|||
160799819|NCT00789555|580656014|FG002|Overall Study|Lost to Follow-up|18|||
160799820|NCT00789555|580656012|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
160896150|NCT00392015|581016839|FG000|Overall Study|Previous trial recipient|0|||
160896151|NCT00392015|581016840|FG001|Overall Study|Previous trial recipient|0|||
160896152|NCT00392015|581016841|FG002|Overall Study|Previous trial recipient|0|||
160896153|NCT00392015|581016842|FG003|Overall Study|Previous trial recipient|0|||
160896154|NCT00392015|581016843|FG004|Overall Study|Previous trial recipient|1|||
160896155|NCT00392015|581016844|FG005|Overall Study|Previous trial recipient|0|||
160896156|NCT02742441|581016846|FG000|Overall Study|Lost to Follow-up|4|||
160896157|NCT02742441|581016847|FG001|Overall Study|Lost to Follow-up|4|||
160896158|NCT02742441|581016846|FG000|Overall Study|Withdrawal by Subject|2|||
160896159|NCT02742441|581016847|FG001|Overall Study|Withdrawal by Subject|2|||
160896160|NCT02742441|581016846|FG000|Overall Study|Adverse Event|0|||
160896161|NCT02742441|581016847|FG001|Overall Study|Adverse Event|2|||
160896162|NCT00537238|581016848|FG000|Overall Study|Death|1|||
160799821|NCT00789555|580656013|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
160799822|NCT00789555|580656014|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
160799823|NCT00789555|580656012|FG000|Overall Study|Treatment failure|11|||
160799824|NCT00789555|580656013|FG001|Overall Study|Treatment failure|8|||
160799825|NCT00789555|580656014|FG002|Overall Study|Treatment failure|12|||
160799826|NCT00789555|580656012|FG000|Overall Study|Protocol Violation|6|||
160896163|NCT00537238|581016849|FG001|Overall Study|Death|2|||
160896164|NCT00537238|581016848|FG000|Overall Study|Adverse Event|31|||
160896165|NCT00537238|581016849|FG001|Overall Study|Adverse Event|22|||
160896166|NCT00537238|581016848|FG000|Overall Study|Lack of Efficacy|20|||
160896167|NCT00537238|581016849|FG001|Overall Study|Lack of Efficacy|21|||
160799827|NCT00789555|580656013|FG001|Overall Study|Protocol Violation|9|||
160799828|NCT00789555|580656014|FG002|Overall Study|Protocol Violation|13|||
160896168|NCT00537238|581016848|FG000|Overall Study|Lost to Follow-up|12|||
160896169|NCT00537238|581016849|FG001|Overall Study|Lost to Follow-up|8|||
160896170|NCT00537238|581016848|FG000|Overall Study|Withdrawal by Subject|51|||
160896171|NCT00537238|581016849|FG001|Overall Study|Withdrawal by Subject|47|||
160896172|NCT00537238|581016848|FG000|Overall Study|Protocol Violation|15|||
160896173|NCT00537238|581016849|FG001|Overall Study|Protocol Violation|19|||
160896174|NCT00537238|581016848|FG000|Overall Study|Does not meet entrance criteria|0|||
160896175|NCT00537238|581016849|FG001|Overall Study|Does not meet entrance criteria|2|||
160896176|NCT00537238|581016848|FG000|Overall Study|Other|44|||
160896177|NCT00537238|581016849|FG001|Overall Study|Other|52|||
160896178|NCT03265665|581016850|FG000|24-week Data Collection|Withdrawal by Subject|2|||
160896179|NCT03265665|581016851|FG001|24-week Data Collection|Withdrawal by Subject|2|||
160896180|NCT03265665|581016850|FG000|24-week Data Collection|Lost to Follow-up|4|||
160896181|NCT03265665|581016851|FG001|24-week Data Collection|Lost to Follow-up|5|||
160644070|NCT00738920|580078953|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
160644071|NCT00738920|580078951|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
160644072|NCT00738920|580078952|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
160644073|NCT00738920|580078953|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
160644074|NCT02173301|580078957|FG000|Overall Study|Adverse Event|7|||
160644075|NCT02173301|580078958|FG001|Overall Study|Adverse Event|8|||
160644076|NCT02173301|580078959|FG002|Overall Study|Adverse Event|13|||
160644077|NCT02173301|580078960|FG003|Overall Study|Adverse Event|5|||
160644078|NCT02173301|580078957|FG000|Overall Study|Withdrawal by Subject|8|||
160644079|NCT02173301|580078958|FG001|Overall Study|Withdrawal by Subject|10|||
160644080|NCT02173301|580078959|FG002|Overall Study|Withdrawal by Subject|4|||
160644081|NCT02173301|580078960|FG003|Overall Study|Withdrawal by Subject|8|||
160644082|NCT02173301|580078957|FG000|Overall Study|Lost to Follow-up|4|||
160644083|NCT02173301|580078958|FG001|Overall Study|Lost to Follow-up|4|||
160644084|NCT02173301|580078959|FG002|Overall Study|Lost to Follow-up|2|||
160644085|NCT02173301|580078960|FG003|Overall Study|Lost to Follow-up|2|||
160644086|NCT02173301|580078957|FG000|Overall Study|Protocol Violation|0|||
160644087|NCT02173301|580078958|FG001|Overall Study|Protocol Violation|1|||
160644088|NCT02173301|580078959|FG002|Overall Study|Protocol Violation|0|||
160644089|NCT02173301|580078960|FG003|Overall Study|Protocol Violation|0|||
160644090|NCT02173301|580078957|FG000|Overall Study|Physician Decision|0|||
160644091|NCT02173301|580078958|FG001|Overall Study|Physician Decision|0|||
160644092|NCT02173301|580078959|FG002|Overall Study|Physician Decision|1|||
160644093|NCT02173301|580078960|FG003|Overall Study|Physician Decision|0|||
160644094|NCT02173301|580078957|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
160644095|NCT02173301|580078958|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
160644096|NCT02173301|580078959|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
160644097|NCT02173301|580078960|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
160644098|NCT04079842|580078963|FG000|Overall Study|Request of subject|2|||
160644099|NCT04079842|580078963|FG000|Overall Study|Unable to draw Arterial samples|1|||
160644100|NCT02904200|580078964|FG000|Overall Study|Withdrawal by Subject|1|||
160644101|NCT02904200|580078965|FG001|Overall Study|Withdrawal by Subject|0|||
160644102|NCT02133352|580078966|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
160644103|NCT00433381|580080672|FG000|Overall Study|Ineligible / no protocol treatment|3|||
160644104|NCT00433381|580080673|FG001|Overall Study|Ineligible / no protocol treatment|3|||
160644105|NCT00458302|580080674|FG000|Overall Study|Adverse Event|4|||
160644106|NCT00458302|580080675|FG001|Overall Study|Adverse Event|14|||
160644107|NCT00458302|580080674|FG000|Overall Study|Pregnancy|2|||
160644108|NCT00458302|580080675|FG001|Overall Study|Pregnancy|1|||
160644109|NCT00458302|580080674|FG000|Overall Study|Protocol Violation|0|||
160644110|NCT00458302|580080675|FG001|Overall Study|Protocol Violation|2|||
160644111|NCT00458302|580080674|FG000|Overall Study|Withdrawal by Subject|6|||
160644112|NCT00458302|580080675|FG001|Overall Study|Withdrawal by Subject|4|||
160644113|NCT00458302|580080674|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
160644114|NCT00458302|580080675|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
160644115|NCT00458302|580080674|FG000|Overall Study|Study Termination By Sponsor|1|||
160644116|NCT00458302|580080675|FG001|Overall Study|Study Termination By Sponsor|0|||
160644117|NCT00458302|580080674|FG000|Overall Study|Lost to Follow-up|2|||
160644118|NCT00458302|580080675|FG001|Overall Study|Lost to Follow-up|0|||
160644119|NCT00458302|580080674|FG000|Overall Study|Other|4|||
160644120|NCT00458302|580080675|FG001|Overall Study|Other|2|||
160644121|NCT00549198|580080676|FG000|Overall Study|Adverse Event|28|||
160644122|NCT00549198|580080677|FG001|Overall Study|Adverse Event|26|||
160644123|NCT00549198|580080676|FG000|Overall Study|Insufficient Viral Load Response|4|||
160644124|NCT00549198|580080677|FG001|Overall Study|Insufficient Viral Load Response|2|||
160644125|NCT00549198|580080676|FG000|Overall Study|Protocol-defined Virological Failure|7|||
160644126|NCT00549198|580080677|FG001|Overall Study|Protocol-defined Virological Failure|0|||
160644127|NCT00549198|580080676|FG000|Overall Study|Non-compliance|2|||
160644128|NCT00549198|580080677|FG001|Overall Study|Non-compliance|4|||
160644129|NCT00549198|580080676|FG000|Overall Study|Lost to Follow-up|7|||
160644130|NCT00549198|580080677|FG001|Overall Study|Lost to Follow-up|8|||
160896182|NCT03265665|581016850|FG000|36-week Data Collection|Lost to Follow-up|6|||
160896183|NCT03265665|581016851|FG001|36-week Data Collection|Lost to Follow-up|8|||
160896184|NCT01858376|581016852|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
160644131|NCT00549198|580080676|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
160644132|NCT00549198|580080677|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160644133|NCT00549198|580080676|FG000|Overall Study|Protocol Violation|7|||
160984575|NCT02325713|581332317|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984576|NCT02325713|581332318|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984577|NCT02325713|581332319|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984578|NCT02325713|581332320|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984579|NCT02325713|581332321|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984580|NCT02325713|581332322|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984581|NCT02325713|581332323|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984582|NCT02325713|581332324|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984583|NCT02325713|581332325|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984584|NCT02325713|581332326|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984585|NCT02325713|581332327|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160896185|NCT01680965|581016856|FG000|Overall Study|Death|0|||
160896186|NCT01680965|581016857|FG001|Overall Study|Death|0|||
160896187|NCT01680965|581016858|FG002|Overall Study|Death|0|||
160896188|NCT01680965|581016859|FG003|Overall Study|Death|6|||
160896189|NCT01871142|581016870|FG000|Overall Study|Adverse Event|1|||
160896190|NCT00734474|581016873|FG000|Overall Study|Entry Criteria Not Met|0|||
160896191|NCT00734474|581016874|FG001|Overall Study|Entry Criteria Not Met|0|||
160896192|NCT00734474|581016875|FG002|Overall Study|Entry Criteria Not Met|5|||
160896193|NCT00734474|581016876|FG003|Overall Study|Entry Criteria Not Met|0|||
160896194|NCT00734474|581016877|FG004|Overall Study|Entry Criteria Not Met|3|||
160896195|NCT00734474|581016878|FG005|Overall Study|Entry Criteria Not Met|1|||
160896196|NCT00734474|581016879|FG006|Overall Study|Entry Criteria Not Met|0|||
160896197|NCT00734474|581016880|FG007|Overall Study|Entry Criteria Not Met|1|||
160896198|NCT00734474|581016881|FG008|Overall Study|Entry Criteria Not Met|1|||
160896199|NCT00734474|581016873|FG000|Overall Study|Lost to Follow-up|1|||
160896200|NCT00734474|581016874|FG001|Overall Study|Lost to Follow-up|0|||
160896201|NCT00734474|581016875|FG002|Overall Study|Lost to Follow-up|13|||
160896202|NCT00734474|581016876|FG003|Overall Study|Lost to Follow-up|0|||
160896203|NCT00734474|581016877|FG004|Overall Study|Lost to Follow-up|11|||
160896204|NCT00734474|581016878|FG005|Overall Study|Lost to Follow-up|1|||
160896205|NCT00734474|581016879|FG006|Overall Study|Lost to Follow-up|0|||
160896206|NCT00734474|581016880|FG007|Overall Study|Lost to Follow-up|9|||
160896207|NCT00734474|581016881|FG008|Overall Study|Lost to Follow-up|4|||
160896208|NCT00734474|581016873|FG000|Overall Study|Withdrawal by Subject|2|||
160896209|NCT00734474|581016874|FG001|Overall Study|Withdrawal by Subject|1|||
160896210|NCT00734474|581016875|FG002|Overall Study|Withdrawal by Subject|18|||
160896211|NCT00734474|581016876|FG003|Overall Study|Withdrawal by Subject|0|||
160896212|NCT00734474|581016877|FG004|Overall Study|Withdrawal by Subject|24|||
160896213|NCT00734474|581016878|FG005|Overall Study|Withdrawal by Subject|2|||
160896214|NCT00734474|581016879|FG006|Overall Study|Withdrawal by Subject|0|||
160896215|NCT00734474|581016880|FG007|Overall Study|Withdrawal by Subject|36|||
160896216|NCT00734474|581016881|FG008|Overall Study|Withdrawal by Subject|21|||
160896217|NCT00734474|581016873|FG000|Overall Study|Physician Decision|0|||
160896218|NCT00734474|581016874|FG001|Overall Study|Physician Decision|0|||
160896219|NCT00734474|581016875|FG002|Overall Study|Physician Decision|4|||
160896220|NCT00734474|581016876|FG003|Overall Study|Physician Decision|1|||
160896221|NCT00734474|581016877|FG004|Overall Study|Physician Decision|11|||
160896222|NCT00734474|581016878|FG005|Overall Study|Physician Decision|0|||
160896223|NCT00734474|581016879|FG006|Overall Study|Physician Decision|0|||
160896224|NCT00734474|581016880|FG007|Overall Study|Physician Decision|9|||
160896225|NCT00734474|581016881|FG008|Overall Study|Physician Decision|9|||
160896226|NCT00734474|581016873|FG000|Overall Study|Adverse Event|4|||
160896227|NCT00734474|581016874|FG001|Overall Study|Adverse Event|4|||
160896228|NCT00734474|581016875|FG002|Overall Study|Adverse Event|63|||
160896229|NCT00734474|581016876|FG003|Overall Study|Adverse Event|1|||
160896230|NCT00734474|581016877|FG004|Overall Study|Adverse Event|64|||
160896231|NCT00734474|581016878|FG005|Overall Study|Adverse Event|0|||
160896232|NCT00734474|581016879|FG006|Overall Study|Adverse Event|1|||
160896233|NCT00734474|581016880|FG007|Overall Study|Adverse Event|65|||
160896234|NCT00734474|581016881|FG008|Overall Study|Adverse Event|39|||
160896235|NCT00734474|581016873|FG000|Overall Study|Protocol Violation|0|||
160896236|NCT00734474|581016874|FG001|Overall Study|Protocol Violation|0|||
160896237|NCT00734474|581016875|FG002|Overall Study|Protocol Violation|4|||
160896238|NCT00734474|581016876|FG003|Overall Study|Protocol Violation|0|||
160896239|NCT00734474|581016877|FG004|Overall Study|Protocol Violation|3|||
160896240|NCT00734474|581016878|FG005|Overall Study|Protocol Violation|0|||
160896241|NCT00734474|581016879|FG006|Overall Study|Protocol Violation|0|||
160896242|NCT00734474|581016880|FG007|Overall Study|Protocol Violation|3|||
160896243|NCT00734474|581016881|FG008|Overall Study|Protocol Violation|1|||
160896244|NCT00734474|581016873|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
160550004|NCT03529773|579740183|FG031|Overall Study|Lost to Follow-up|0|||
160550005|NCT03529773|579740184|FG032|Overall Study|Lost to Follow-up|0|||
160896245|NCT00734474|581016874|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
160896246|NCT00734474|581016875|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
160896247|NCT00734474|581016876|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
160799829|NCT04464473|580656015|FG000|Overall Study|New piercing could not be removed for scanning|0|||
160799830|NCT04464473|580656016|FG001|Overall Study|New piercing could not be removed for scanning|0|||
160799831|NCT04464473|580656017|FG002|Overall Study|New piercing could not be removed for scanning|0|||
160799832|NCT04464473|580656018|FG003|Overall Study|New piercing could not be removed for scanning|1|||
160799833|NCT04464473|580656019|FG004|Overall Study|New piercing could not be removed for scanning|0|||
160799834|NCT04464473|580656020|FG005|Overall Study|New piercing could not be removed for scanning|0|||
160799835|NCT04464473|580656015|FG000|Overall Study|Adverse Event|0|||
160799836|NCT04464473|580656016|FG001|Overall Study|Adverse Event|0|||
160799837|NCT04464473|580656017|FG002|Overall Study|Adverse Event|0|||
160799838|NCT04464473|580656018|FG003|Overall Study|Adverse Event|1|||
160799839|NCT04464473|580656019|FG004|Overall Study|Adverse Event|0|||
160799840|NCT04464473|580656020|FG005|Overall Study|Adverse Event|0|||
160799841|NCT04464473|580656015|FG000|Overall Study|Lost to Follow-up|0|||
160799842|NCT04464473|580656016|FG001|Overall Study|Lost to Follow-up|0|||
160799843|NCT04464473|580656017|FG002|Overall Study|Lost to Follow-up|0|||
160799844|NCT04464473|580656018|FG003|Overall Study|Lost to Follow-up|1|||
160799845|NCT04464473|580656019|FG004|Overall Study|Lost to Follow-up|0|||
160799846|NCT04464473|580656020|FG005|Overall Study|Lost to Follow-up|0|||
160799847|NCT01150357|580656036|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
160799848|NCT01150357|580656037|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
160799849|NCT01150357|580656038|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
160799850|NCT01150357|580656036|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
160799851|NCT01150357|580656037|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
160799852|NCT01150357|580656038|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
160799853|NCT01150357|580656036|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
160799854|NCT01150357|580656037|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
160799855|NCT01150357|580656038|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
160799856|NCT01150357|580656036|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
160799857|NCT01150357|580656037|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
160799858|NCT01150357|580656038|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
160799859|NCT01150357|580656036|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
160799860|NCT01150357|580656037|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
160799861|NCT01150357|580656038|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
160799862|NCT01150357|580656036|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
160799863|NCT01150357|580656037|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
160799864|NCT01150357|580656038|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
160799865|NCT01150357|580656036|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
160799866|NCT01150357|580656037|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
160896248|NCT00734474|581016877|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
160896249|NCT00734474|581016878|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
160896250|NCT00734474|581016879|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
160896251|NCT00734474|581016880|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
160896252|NCT00734474|581016881|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
160896253|NCT00734474|581016873|FG000|Overall Study|Sponsor Decision|0|||
160896254|NCT00734474|581016874|FG001|Overall Study|Sponsor Decision|0|||
160896255|NCT00734474|581016875|FG002|Overall Study|Sponsor Decision|0|||
160896256|NCT00734474|581016876|FG003|Overall Study|Sponsor Decision|0|||
160896257|NCT00734474|581016877|FG004|Overall Study|Sponsor Decision|2|||
160896258|NCT00734474|581016878|FG005|Overall Study|Sponsor Decision|0|||
160896259|NCT00734474|581016879|FG006|Overall Study|Sponsor Decision|0|||
160896260|NCT00734474|581016880|FG007|Overall Study|Sponsor Decision|0|||
160896261|NCT00734474|581016881|FG008|Overall Study|Sponsor Decision|0|||
160896262|NCT00734474|581016873|FG000|Overall Study|Death|0|||
160896263|NCT00734474|581016874|FG001|Overall Study|Death|0|||
160896264|NCT00734474|581016875|FG002|Overall Study|Death|1|||
160896265|NCT00734474|581016876|FG003|Overall Study|Death|0|||
160896266|NCT00734474|581016877|FG004|Overall Study|Death|0|||
160896267|NCT00734474|581016878|FG005|Overall Study|Death|0|||
160896268|NCT00734474|581016879|FG006|Overall Study|Death|0|||
160896269|NCT00734474|581016880|FG007|Overall Study|Death|2|||
160896270|NCT00734474|581016881|FG008|Overall Study|Death|1|||
160896271|NCT00734474|581016873|FG000|Overall Study|Lack of Efficacy|0|||
160896272|NCT00734474|581016874|FG001|Overall Study|Lack of Efficacy|0|||
160896273|NCT00734474|581016875|FG002|Overall Study|Lack of Efficacy|4|||
160896274|NCT00734474|581016876|FG003|Overall Study|Lack of Efficacy|0|||
160799867|NCT01150357|580656038|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
160896275|NCT00734474|581016877|FG004|Overall Study|Lack of Efficacy|0|||
160896276|NCT00734474|581016878|FG005|Overall Study|Lack of Efficacy|0|||
160896277|NCT00734474|581016879|FG006|Overall Study|Lack of Efficacy|0|||
160896278|NCT00734474|581016880|FG007|Overall Study|Lack of Efficacy|4|||
160896279|NCT00734474|581016881|FG008|Overall Study|Lack of Efficacy|6|||
160896280|NCT02104752|581016884|FG000|Overall Study|Withdrawal by Subject|1|||
160896281|NCT02104752|581016885|FG001|Overall Study|Withdrawal by Subject|0|||
160896282|NCT02104752|581016884|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
160799868|NCT02661672|580656039|FG000|Overall Study|Lost to Follow-up|1|||
160799869|NCT02661672|580656039|FG000|Overall Study|Death|4|||
160799870|NCT02735421|580658131|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
160799871|NCT02735421|580658131|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
160799872|NCT02735421|580658131|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
160799873|NCT02735421|580658131|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
160799874|NCT02735421|580658131|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
160799875|NCT02735421|580658131|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
160799876|NCT02735421|580658131|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
160799877|NCT01978145|580658133|FG000|Treatment Period 1|Adverse Event|1|||
160799878|NCT01978145|580658134|FG001|Treatment Period 1|Adverse Event|9|||
160799879|NCT01978145|580658133|FG000|Treatment Period 1|Physician Decision|1|||
160799880|NCT01978145|580658134|FG001|Treatment Period 1|Physician Decision|0|||
160799881|NCT01978145|580658133|FG000|Treatment Period 1|Withdrawal by Subject|5|||
160799882|NCT01978145|580658134|FG001|Treatment Period 1|Withdrawal by Subject|4|||
160799883|NCT01978145|580658133|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
160799884|NCT01978145|580658134|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
160799885|NCT01978145|580658133|FG000|Washout Period 1|Adverse Event|0|||
160799886|NCT01978145|580658134|FG001|Washout Period 1|Adverse Event|1|||
160799887|NCT01978145|580658133|FG000|Washout Period 1|Withdrawal by Subject|1|||
160799888|NCT01978145|580658134|FG001|Washout Period 1|Withdrawal by Subject|1|||
160799889|NCT01978145|580658133|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
160799890|NCT01978145|580658134|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
160799891|NCT01978145|580658133|FG000|Treatment Period 2|Adverse Event|3|||
160799892|NCT01978145|580658134|FG001|Treatment Period 2|Adverse Event|3|||
160799893|NCT01978145|580658133|FG000|Treatment Period 2|Protocol Violation|0|||
160799894|NCT01978145|580658134|FG001|Treatment Period 2|Protocol Violation|1|||
160799895|NCT01978145|580658133|FG000|Treatment Period 2|Lost to Follow-up|1|||
160799896|NCT01978145|580658134|FG001|Treatment Period 2|Lost to Follow-up|1|||
160799897|NCT01978145|580658133|FG000|Treatment Period 2|Withdrawal by Subject|7|||
160799898|NCT01978145|580658134|FG001|Treatment Period 2|Withdrawal by Subject|4|||
160799899|NCT01978145|580658133|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
160799900|NCT01978145|580658134|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
160896283|NCT02104752|581016885|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
160896284|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
160896285|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
160896286|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
160896287|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
160896288|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
160896289|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
160984586|NCT02325713|581332328|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984587|NCT02325713|581332329|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984588|NCT02325713|581332330|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984589|NCT02325713|581332331|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984590|NCT02325713|581332316|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984591|NCT02325713|581332317|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984592|NCT02325713|581332318|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984593|NCT02325713|581332319|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984594|NCT02325713|581332320|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984595|NCT02325713|581332321|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984596|NCT02325713|581332322|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984597|NCT02325713|581332323|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984598|NCT02325713|581332324|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984599|NCT02325713|581332325|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
160984600|NCT02325713|581332326|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984601|NCT02325713|581332327|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984602|NCT02325713|581332328|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984603|NCT02325713|581332329|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160799901|NCT01250054|580658135|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
160799902|NCT01250054|580658136|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
160799903|NCT00652743|580658137|FG000|Months 12-18|Lost to Follow-up|1|||
160799904|NCT00652743|580658138|FG001|Months 12-18|Lost to Follow-up|2|||
160799905|NCT00652743|580658139|FG002|Months 12-18|Lost to Follow-up|7|||
160799906|NCT00652743|580658137|FG000|Months 24-30|Other|5|||
160799907|NCT00652743|580658138|FG001|Months 24-30|Other|1|||
160799908|NCT00652743|580658139|FG002|Months 24-30|Other|11|||
160799909|NCT00652743|580658137|FG000|Months 36-42|Serious Adverse Events|0|||
160799910|NCT00652743|580658138|FG001|Months 36-42|Serious Adverse Events|1|||
160984604|NCT02325713|581332330|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160799911|NCT00652743|580658139|FG002|Months 36-42|Serious Adverse Events|1|||
160799912|NCT00652743|580658137|FG000|Months 36-42|Withdrawal by Subject|1|||
160799913|NCT00652743|580658138|FG001|Months 36-42|Withdrawal by Subject|1|||
160799914|NCT00652743|580658139|FG002|Months 36-42|Withdrawal by Subject|0|||
160799915|NCT00652743|580658137|FG000|Months 36-42|Lost to Follow-up|0|||
160799916|NCT00652743|580658138|FG001|Months 36-42|Lost to Follow-up|1|||
160799917|NCT00652743|580658139|FG002|Months 36-42|Lost to Follow-up|0|||
160799918|NCT00652743|580658137|FG000|Months 36-42|Migrated/moved from study area|1|||
160799919|NCT00652743|580658138|FG001|Months 36-42|Migrated/moved from study area|0|||
160799920|NCT00652743|580658139|FG002|Months 36-42|Migrated/moved from study area|0|||
160896290|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
160896291|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
160896292|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
160896293|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
160896294|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
160896295|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
160896296|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
160896297|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
160896298|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
160896299|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
160896300|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
160896301|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
160896302|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
160896303|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
160896304|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
160896305|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
160896306|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
160896307|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
160896308|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
160896309|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
160896310|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
160896311|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
160896312|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
160896313|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
160896314|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
160896315|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
160896316|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
160896317|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
160896318|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
160896319|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
160896320|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
160896321|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
160896322|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
160896323|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
160896324|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
160896325|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
160896326|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
160896327|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
160896328|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
160896329|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
160896330|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
160896331|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
160896332|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
160896333|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
160896334|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
160896335|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
160896336|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
160896337|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
160896338|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
160896339|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
160896340|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
160896341|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
160896342|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
160896343|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
160896344|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
160896345|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
160799921|NCT00652743|580658137|FG000|Months 36-42|Other|4|||
160799922|NCT00652743|580658138|FG001|Months 36-42|Other|2|||
160799923|NCT00652743|580658139|FG002|Months 36-42|Other|8|||
160799924|NCT01192126|580658141|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
160799925|NCT01192126|580658142|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
160799926|NCT01192126|580658141|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
160799927|NCT01192126|580658142|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
160799928|NCT01248793|580658143|FG000|Overall Study|Lost to Follow-up|0|||
160799929|NCT01248793|580658144|FG001|Overall Study|Lost to Follow-up|1|||
160799930|NCT01248793|580658143|FG000|Overall Study|Adverse Event|1|||
160799931|NCT01248793|580658144|FG001|Overall Study|Adverse Event|1|||
160799932|NCT01248793|580658143|FG000|Overall Study|Protocol Violation|0|||
160799933|NCT01248793|580658144|FG001|Overall Study|Protocol Violation|1|||
160799934|NCT01248793|580658143|FG000|Overall Study|Withdrawal by Subject|3|||
160799935|NCT01248793|580658144|FG001|Overall Study|Withdrawal by Subject|3|||
160799936|NCT00517699|580658145|FG000|Overall Study|Withdrawal by Subject|1|||
160799937|NCT00517699|580658145|FG000|Overall Study|Lack of Efficacy|1|||
160799938|NCT00517699|580658145|FG000|Overall Study|Administrative error|1|||
160799939|NCT00517699|580658145|FG000|Overall Study|Study terminated by Sponsor|2|||
160799940|NCT01114737|580658146|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
160799941|NCT01114737|580658147|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
160799942|NCT01114737|580658146|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
160799943|NCT01114737|580658147|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
160799944|NCT01114737|580658146|FG000|Randomized Treatment Period|Pregnancy|1|||
160799945|NCT01114737|580658147|FG001|Randomized Treatment Period|Pregnancy|0|||
160799946|NCT01114737|580658146|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
160799947|NCT01114737|580658147|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
160799948|NCT01114737|580658146|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
160799949|NCT01114737|580658147|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
160799950|NCT01114737|580658146|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
160799951|NCT01114737|580658147|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
160799952|NCT02580877|580658150|FG000|Overall Study|Withdrawal by Subject|1|||
160799953|NCT02580877|580658151|FG001|Overall Study|Withdrawal by Subject|3|||
160799954|NCT02580877|580658150|FG000|Overall Study|Adverse Event|0|||
160799955|NCT02580877|580658151|FG001|Overall Study|Adverse Event|1|||
160799956|NCT00892008|580658152|FG000|Overall Study|Death|5|||
160799957|NCT00892008|580658152|FG000|Overall Study|Lack of Efficacy|3|||
160984605|NCT02325713|581332331|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984606|NCT01213173|581332333|FG000|Overall Study|Protocol Violation|2|||
160984607|NCT01213173|581332334|FG001|Overall Study|Protocol Violation|0|||
160984608|NCT01213173|581332333|FG000|Overall Study|Adverse Event|4|||
160984609|NCT01213173|581332334|FG001|Overall Study|Adverse Event|8|||
160984610|NCT01213173|581332333|FG000|Overall Study|Withdrawal by Subject|5|||
160984611|NCT01213173|581332334|FG001|Overall Study|Withdrawal by Subject|5|||
160984612|NCT01213173|581332333|FG000|Overall Study|Incorrect Enrollment|1|||
160984613|NCT01213173|581332334|FG001|Overall Study|Incorrect Enrollment|3|||
160984614|NCT02253316|581332335|FG000|Consolidation|Progression|4|||
160984615|NCT02253316|581332336|FG001|Consolidation|Progression|0|||
160984616|NCT02253316|581332337|FG002|Consolidation|Progression|0|||
160984617|NCT02253316|581332335|FG000|Consolidation|Non-Compliance|1|||
160984618|NCT02253316|581332336|FG001|Consolidation|Non-Compliance|0|||
160984619|NCT02253316|581332337|FG002|Consolidation|Non-Compliance|0|||
160984620|NCT02253316|581332335|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
160984621|NCT02253316|581332336|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
160984622|NCT02253316|581332337|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
160984623|NCT02253316|581332335|FG000|Consolidation|Secondary Malignancy|2|||
160984624|NCT02253316|581332336|FG001|Consolidation|Secondary Malignancy|0|||
160984625|NCT02253316|581332337|FG002|Consolidation|Secondary Malignancy|0|||
160984626|NCT02253316|581332335|FG000|Consolidation|Adverse Event|7|||
160984627|NCT02253316|581332336|FG001|Consolidation|Adverse Event|0|||
160984628|NCT02253316|581332337|FG002|Consolidation|Adverse Event|0|||
160984629|NCT02253316|581332335|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
160984630|NCT02253316|581332336|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
160984631|NCT02253316|581332337|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
160984632|NCT02253316|581332335|FG000|Maintenance|Physician Decision|0|||
160984633|NCT02253316|581332336|FG001|Maintenance|Physician Decision|7|||
160799958|NCT00892008|580658152|FG000|Overall Study|Lost to Follow-up|142|||
160799959|NCT00892008|580658152|FG000|Overall Study|Other|378|||
160799960|NCT00892008|580658152|FG000|Overall Study|Adverse Event|37|||
160799961|NCT01466491|580658153|FG000|Overall Study|Protocol Violation|0|||
160799962|NCT01466491|580658154|FG001|Overall Study|Protocol Violation|3|||
160984634|NCT02253316|581332337|FG002|Maintenance|Physician Decision|16|||
160984635|NCT02253316|581332335|FG000|Maintenance|Non-Compliance|0|||
160984636|NCT02253316|581332336|FG001|Maintenance|Non-Compliance|1|||
160799963|NCT01466491|580658155|FG002|Overall Study|Protocol Violation|2|||
160799964|NCT01466491|580658156|FG003|Overall Study|Protocol Violation|0|||
160799965|NCT01466491|580658153|FG000|Overall Study|Missing Data|0|||
160799966|NCT01466491|580658154|FG001|Overall Study|Missing Data|0|||
160799967|NCT01466491|580658155|FG002|Overall Study|Missing Data|1|||
160799968|NCT01466491|580658156|FG003|Overall Study|Missing Data|0|||
160799969|NCT00355030|580658157|FG000|Study Period 1 Treatment|Adverse Event|1|||
160799970|NCT00355030|580658158|FG001|Study Period 1 Treatment|Adverse Event|1|||
160799971|NCT00355030|580658157|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
160799972|NCT00355030|580658158|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
160799973|NCT00355030|580658157|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
160799974|NCT00355030|580658158|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
160799975|NCT00355030|580658157|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
160799976|NCT00355030|580658158|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
160799977|NCT00355030|580658157|FG000|Study Period 1 Treatment|Physician Decision|0|||
160799978|NCT00355030|580658158|FG001|Study Period 1 Treatment|Physician Decision|1|||
160799979|NCT00355030|580658157|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
160799980|NCT00355030|580658158|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
160799981|NCT00355030|580658157|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
160799982|NCT00355030|580658158|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
160799983|NCT00355030|580658157|FG000|Study Period 1 Treatment|Other|2|||
160799984|NCT00355030|580658158|FG001|Study Period 1 Treatment|Other|6|||
160799985|NCT00355030|580658157|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
160799986|NCT00355030|580658158|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
160799987|NCT00355030|580658157|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
160799988|NCT00355030|580658158|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
160799989|NCT01123148|580658159|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
160799990|NCT01123148|580658159|FG000|Overall Study|Didn't meet milestone criteria|1|||
160799991|NCT01693367|580658160|FG000|Overall Study|Withdrawal by Subject|1|||
160799992|NCT01693367|580658161|FG001|Overall Study|Withdrawal by Subject|1|||
160799993|NCT01693367|580658160|FG000|Overall Study|Physician Decision|0|||
160799994|NCT01693367|580658161|FG001|Overall Study|Physician Decision|1|||
160799995|NCT00690794|580658162|FG000|Overall Study|Adverse Event|12|||
160799996|NCT00690794|580658163|FG001|Overall Study|Adverse Event|10|||
160799997|NCT00690794|580658162|FG000|Overall Study|Lost to Follow-up|1|||
160799998|NCT00690794|580658163|FG001|Overall Study|Lost to Follow-up|4|||
160799999|NCT00690794|580658162|FG000|Overall Study|Withdrawal by Subject|0|||
160800000|NCT00690794|580658163|FG001|Overall Study|Withdrawal by Subject|9|||
160800001|NCT00690794|580658162|FG000|Overall Study|Protocol Violation|6|||
160800002|NCT00690794|580658163|FG001|Overall Study|Protocol Violation|7|||
160800003|NCT00690794|580658162|FG000|Overall Study|Noncompliance|1|||
160800004|NCT00690794|580658163|FG001|Overall Study|Noncompliance|2|||
160800005|NCT00690794|580658162|FG000|Overall Study|Other not specified|1|||
160800006|NCT00690794|580658163|FG001|Overall Study|Other not specified|3|||
160800007|NCT00325143|580658164|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
160800008|NCT00325143|580658164|FG000|Overall Study|Migrated/moved from study area|1|||
160800009|NCT00325143|580658164|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
160800010|NCT00325143|580658164|FG000|Overall Study|Withdrawal by Subject|8|||
160800011|NCT02286895|580658165|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
160800012|NCT02286895|580658166|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
160800013|NCT02286895|580658165|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
160800014|NCT02286895|580658166|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
160800015|NCT02286895|580658165|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
160800016|NCT02286895|580658166|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
160800017|NCT00399035|580658168|FG000|Overall Study|Death|289|||
160800018|NCT00399035|580658169|FG001|Overall Study|Death|141|||
160800019|NCT00399035|580658170|FG002|Overall Study|Death|234|||
160800020|NCT00399035|580658168|FG000|Overall Study|Lost to Follow-up|2|||
160800021|NCT00399035|580658169|FG001|Overall Study|Lost to Follow-up|1|||
160896346|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
160896347|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
160896348|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
160896349|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
160896350|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
160896351|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
160896352|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
160896353|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
160800022|NCT00399035|580658170|FG002|Overall Study|Lost to Follow-up|5|||
160800023|NCT00399035|580658168|FG000|Overall Study|Withdrawal by Subject|19|||
160800024|NCT00399035|580658169|FG001|Overall Study|Withdrawal by Subject|15|||
160800025|NCT00399035|580658170|FG002|Overall Study|Withdrawal by Subject|12|||
160800026|NCT00399035|580658168|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
160800027|NCT00399035|580658169|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
160800028|NCT00399035|580658170|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
160800029|NCT00399035|580658168|FG000|Overall Study|Severe non-compliance with protocol|2|||
160800030|NCT00399035|580658169|FG001|Overall Study|Severe non-compliance with protocol|1|||
160800031|NCT00399035|580658170|FG002|Overall Study|Severe non-compliance with protocol|0|||
160800032|NCT02949011|580658173|FG000|Overall Study|Adverse Event|6|||
160800033|NCT02949011|580658174|FG001|Overall Study|Adverse Event|7|||
160800034|NCT02949011|580658175|FG002|Overall Study|Adverse Event|3|||
160800035|NCT02949011|580658173|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
160800036|NCT02949011|580658174|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
160800037|NCT02949011|580658175|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
160800038|NCT02949011|580658173|FG000|Overall Study|Protocol Deviation|5|||
160800039|NCT02949011|580658174|FG001|Overall Study|Protocol Deviation|3|||
160800040|NCT02949011|580658175|FG002|Overall Study|Protocol Deviation|3|||
160550006|NCT03529773|579740185|FG033|Overall Study|Lost to Follow-up|1|||
160800041|NCT02949011|580658173|FG000|Overall Study|Lack of Efficacy|0|||
160800042|NCT02949011|580658174|FG001|Overall Study|Lack of Efficacy|2|||
160800043|NCT02949011|580658175|FG002|Overall Study|Lack of Efficacy|0|||
160896354|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
160896355|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
160896356|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
160896357|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
160896358|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
160896359|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
160896360|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
160896361|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
160896362|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
160896363|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
160896364|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
160896365|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
160896366|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
160896367|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
160896368|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
160896369|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
160896370|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
160896371|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
160896372|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
160896373|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
160896374|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
160896375|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
160896376|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
160896377|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
160896378|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
160896379|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
160896380|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
160896381|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
160896382|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
160896383|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
160896384|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
160896385|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
160896386|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
160896387|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
160896388|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
160896389|NCT00428792|581016892|FG000|Overall Study|Lack of Efficacy|1|||
160896390|NCT00428792|581016893|FG001|Overall Study|Lack of Efficacy|3|||
160896391|NCT00428792|581016892|FG000|Overall Study|Lost to Follow-up|0|||
160896392|NCT00428792|581016893|FG001|Overall Study|Lost to Follow-up|1|||
160896393|NCT02468232|581016896|FG000|Core Part of Study|Adverse Event|0|||
160896394|NCT02468232|581016897|FG001|Core Part of Study|Adverse Event|1|||
160896395|NCT02468232|581016898|FG002|Core Part of Study|Adverse Event|0|||
160896396|NCT02468232|581016899|FG003|Core Part of Study|Adverse Event|0|||
160896397|NCT02468232|581016896|FG000|Core Part of Study|Death|20|||
160896398|NCT02468232|581016897|FG001|Core Part of Study|Death|17|||
160896399|NCT02468232|581016898|FG002|Core Part of Study|Death|0|||
160896400|NCT02468232|581016899|FG003|Core Part of Study|Death|0|||
160896401|NCT02468232|581016896|FG000|Core Part of Study|Technical Problems|1|||
160896402|NCT02468232|581016897|FG001|Core Part of Study|Technical Problems|1|||
160896403|NCT02468232|581016898|FG002|Core Part of Study|Technical Problems|0|||
160800044|NCT02949011|580658173|FG000|Overall Study|Withdrawal by Subject|13|||
160800045|NCT02949011|580658174|FG001|Overall Study|Withdrawal by Subject|13|||
160800046|NCT02949011|580658175|FG002|Overall Study|Withdrawal by Subject|21|||
160800047|NCT02949011|580658173|FG000|Overall Study|Lost to Follow-up|7|||
160800048|NCT02949011|580658174|FG001|Overall Study|Lost to Follow-up|5|||
160984637|NCT02253316|581332337|FG002|Maintenance|Non-Compliance|1|||
160984638|NCT02253316|581332335|FG000|Maintenance|Secondary Malignancy|0|||
160984639|NCT02253316|581332336|FG001|Maintenance|Secondary Malignancy|2|||
160984640|NCT02253316|581332337|FG002|Maintenance|Secondary Malignancy|6|||
160984641|NCT02253316|581332335|FG000|Maintenance|Adverse Event|0|||
160984642|NCT02253316|581332336|FG001|Maintenance|Adverse Event|8|||
160984643|NCT02253316|581332337|FG002|Maintenance|Adverse Event|12|||
160984644|NCT02253316|581332335|FG000|Maintenance|Still receiving active treatment|0|||
160984645|NCT02253316|581332336|FG001|Maintenance|Still receiving active treatment|4|||
160984646|NCT02253316|581332337|FG002|Maintenance|Still receiving active treatment|0|||
160984647|NCT02684903|581332338|FG000|Overall Study|COVID-19 shutdown of lab|4|||
160984648|NCT02684903|581332339|FG001|Overall Study|COVID-19 shutdown of lab|6|||
160984649|NCT02684903|581332338|FG000|Overall Study|Lost to Follow-up|31|||
160984650|NCT02684903|581332339|FG001|Overall Study|Lost to Follow-up|41|||
160984651|NCT06403605|581332344|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
160984652|NCT06403605|581332345|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
160984653|NCT06403605|581332344|FG000|Follow-up|Adverse Event|4|||
160984654|NCT06403605|581332345|FG001|Follow-up|Adverse Event|2|||
160984655|NCT06403605|581332344|FG000|Follow-up|Withdrawal by Subject|2|||
160984656|NCT06403605|581332345|FG001|Follow-up|Withdrawal by Subject|3|||
160984657|NCT06403605|581332344|FG000|Follow-up|Lost to Follow-up|1|||
160984658|NCT06403605|581332345|FG001|Follow-up|Lost to Follow-up|0|||
160984659|NCT06403605|581332344|FG000|Follow-up|Death|1|||
160984660|NCT06403605|581332345|FG001|Follow-up|Death|0|||
160984661|NCT06403605|581332344|FG000|Follow-up|Other reasons|0|||
160984662|NCT06403605|581332345|FG001|Follow-up|Other reasons|4|||
160984663|NCT07083843|581332346|FG000|Intervention period.|Withdrawal by Subject|1|||
160984664|NCT07083843|581332347|FG001|Intervention period.|Withdrawal by Subject|0|||
160984665|NCT07083843|581332346|FG000|Intervention period.|Death|0|||
160984666|NCT07083843|581332347|FG001|Intervention period.|Death|1|||
160984667|NCT04213846|581333736|FG000|Overall Study|Withdrawal by Subject|7|||
160984668|NCT04213846|581333737|FG001|Overall Study|Withdrawal by Subject|6|||
160984669|NCT04213846|581333736|FG000|Overall Study|Lost to Follow-up|15|||
160984670|NCT04213846|581333737|FG001|Overall Study|Lost to Follow-up|21|||
160984671|NCT04096365|581333745|FG000|Overall Study|Adverse Event|1|||
160984672|NCT01939158|581333750|FG000|Overall Study|Adverse Event|1|||
160984673|NCT01939158|581333751|FG001|Overall Study|Adverse Event|0|||
160984674|NCT01939158|581333752|FG002|Overall Study|Adverse Event|0|||
160984675|NCT01939158|581333753|FG003|Overall Study|Adverse Event|0|||
160984676|NCT01939158|581333750|FG000|Overall Study|Withdrawal by Subject|22|||
160984677|NCT01939158|581333751|FG001|Overall Study|Withdrawal by Subject|25|||
160984678|NCT01939158|581333752|FG002|Overall Study|Withdrawal by Subject|15|||
160984679|NCT01939158|581333753|FG003|Overall Study|Withdrawal by Subject|17|||
160984680|NCT01939158|581333750|FG000|Overall Study|Migrated/moved from study area|5|||
160984681|NCT01939158|581333751|FG001|Overall Study|Migrated/moved from study area|7|||
160984682|NCT01939158|581333752|FG002|Overall Study|Migrated/moved from study area|3|||
160984683|NCT01939158|581333753|FG003|Overall Study|Migrated/moved from study area|6|||
160984684|NCT01939158|581333750|FG000|Overall Study|Lost to Follow-up|18|||
160984685|NCT01939158|581333751|FG001|Overall Study|Lost to Follow-up|17|||
160984686|NCT01939158|581333752|FG002|Overall Study|Lost to Follow-up|17|||
160984687|NCT01939158|581333753|FG003|Overall Study|Lost to Follow-up|17|||
160984688|NCT01939158|581333750|FG000|Overall Study|Death|0|||
160984689|NCT01939158|581333751|FG001|Overall Study|Death|0|||
160984690|NCT01939158|581333752|FG002|Overall Study|Death|1|||
160984691|NCT01939158|581333753|FG003|Overall Study|Death|1|||
160984692|NCT01939158|581333750|FG000|Overall Study|No longer meets eligibility criteria|0|||
160984693|NCT01939158|581333751|FG001|Overall Study|No longer meets eligibility criteria|0|||
160800049|NCT02949011|580658175|FG002|Overall Study|Lost to Follow-up|5|||
160800050|NCT02949011|580658173|FG000|Overall Study|Death|0|||
160800051|NCT02949011|580658174|FG001|Overall Study|Death|0|||
160800052|NCT02949011|580658175|FG002|Overall Study|Death|1|||
160800053|NCT02949011|580658173|FG000|Overall Study|Miscellaneous|2|||
160800054|NCT02949011|580658174|FG001|Overall Study|Miscellaneous|4|||
160800055|NCT02949011|580658175|FG002|Overall Study|Miscellaneous|6|||
160800056|NCT00163189|580658176|FG000|Overall Study|Other|6|||
160984694|NCT01939158|581333752|FG002|Overall Study|No longer meets eligibility criteria|1|||
160644134|NCT00549198|580080677|FG001|Overall Study|Protocol Violation|2|||
160800057|NCT00163189|580658176|FG000|Overall Study|Lost to Follow-up|1|||
160800058|NCT00163189|580658176|FG000|Overall Study|Protocol Violation|2|||
160984695|NCT01939158|581333753|FG003|Overall Study|No longer meets eligibility criteria|0|||
160984696|NCT01939158|581333750|FG000|Overall Study|Other|1|||
160984697|NCT01939158|581333751|FG001|Overall Study|Other|3|||
160984698|NCT01939158|581333752|FG002|Overall Study|Other|4|||
160984699|NCT01939158|581333753|FG003|Overall Study|Other|3|||
160984700|NCT05310084|581333754|FG000|Overall Study|Withdrawal by Subject|2|||
160984701|NCT05310084|581333755|FG001|Overall Study|Withdrawal by Subject|3|||
160984702|NCT05310084|581333754|FG000|Overall Study|Participant availability|0|||
160984703|NCT05310084|581333755|FG001|Overall Study|Participant availability|4|||
160984704|NCT05310084|581333754|FG000|Overall Study|Lost to Follow-up|1|||
160800059|NCT00163189|580658176|FG000|Overall Study|Death|3|||
160800060|NCT00163189|580658176|FG000|Overall Study|Adverse Event|6|||
160800061|NCT00163189|580658176|FG000|Overall Study|Lack of Efficacy|7|||
160800062|NCT00163189|580658176|FG000|Overall Study|Study terminated by sponsor|11|||
160800063|NCT00163189|580658176|FG000|Overall Study|Withdrawal by Subject|11|||
160800064|NCT00163189|580658176|FG000|Overall Study|Did not meet continuation criterion|16|||
160800065|NCT00454116|580658177|FG000|Overall Study|Adverse Event|5|||
160800066|NCT00454116|580658178|FG001|Overall Study|Adverse Event|11|||
160800067|NCT00454116|580658179|FG002|Overall Study|Adverse Event|9|||
160800068|NCT00454116|580658177|FG000|Overall Study|Condition under investigation worsened|17|||
160896404|NCT02468232|581016899|FG003|Core Part of Study|Technical Problems|0|||
160896405|NCT02468232|581016896|FG000|OLE Part of Study|Adverse Event|0|||
160896406|NCT02468232|581016897|FG001|OLE Part of Study|Adverse Event|0|||
160896407|NCT02468232|581016898|FG002|OLE Part of Study|Adverse Event|4|||
160896408|NCT02468232|581016899|FG003|OLE Part of Study|Adverse Event|5|||
160896409|NCT02468232|581016896|FG000|OLE Part of Study|Death|0|||
160896410|NCT02468232|581016897|FG001|OLE Part of Study|Death|0|||
160896411|NCT02468232|581016898|FG002|OLE Part of Study|Death|4|||
160896412|NCT02468232|581016899|FG003|OLE Part of Study|Death|2|||
160896413|NCT02468232|581016896|FG000|OLE Part of Study|Physician Decision|0|||
160896414|NCT02468232|581016897|FG001|OLE Part of Study|Physician Decision|0|||
160896415|NCT02468232|581016898|FG002|OLE Part of Study|Physician Decision|4|||
160896416|NCT02468232|581016899|FG003|OLE Part of Study|Physician Decision|0|||
160896417|NCT02468232|581016896|FG000|OLE Part of Study|Subject/Guardian decision|0|||
160896418|NCT02468232|581016897|FG001|OLE Part of Study|Subject/Guardian decision|0|||
160896419|NCT02468232|581016898|FG002|OLE Part of Study|Subject/Guardian decision|2|||
160896420|NCT02468232|581016899|FG003|OLE Part of Study|Subject/Guardian decision|5|||
160896421|NCT04540497|581016902|FG000|Overall Study|Adverse Event|0|||
160896422|NCT04540497|581016903|FG001|Overall Study|Adverse Event|2|||
160896423|NCT04540497|581016902|FG000|Overall Study|Lost to Follow-up|1|||
160896424|NCT04540497|581016903|FG001|Overall Study|Lost to Follow-up|0|||
160896425|NCT04540497|581016902|FG000|Overall Study|Withdrawal by Subject|1|||
160896426|NCT04540497|581016903|FG001|Overall Study|Withdrawal by Subject|1|||
160896427|NCT04540497|581016902|FG000|Overall Study|Miscellaneous|2|||
160896428|NCT04540497|581016903|FG001|Overall Study|Miscellaneous|1|||
160896429|NCT03914326|581016904|FG000|Overall Study|Withdrawal by Subject|27|||
160896430|NCT03914326|581016905|FG001|Overall Study|Withdrawal by Subject|34|||
160896431|NCT03914326|581016904|FG000|Overall Study|Lost to Follow-up|43|||
160896432|NCT03914326|581016905|FG001|Overall Study|Lost to Follow-up|51|||
160896433|NCT03914326|581016904|FG000|Overall Study|Randomised more than once|0|||
160896434|NCT03914326|581016905|FG001|Overall Study|Randomised more than once|1|||
160896435|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Death|1|||
160896436|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Death|1|||
160896437|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Death|0|||
160896438|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Death|0|||
160896439|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
160896440|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
160896441|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
160896442|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
160896443|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
160896444|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
160896445|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
160896446|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
160896447|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
160896448|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
160896449|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
160896450|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
160896451|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
160896452|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
160896453|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
160896454|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
160896455|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Other|1|||
160896456|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Other|0|||
160800069|NCT00454116|580658178|FG001|Overall Study|Condition under investigation worsened|13|||
160896457|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Other|0|||
160896458|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Other|0|||
160800070|NCT00454116|580658179|FG002|Overall Study|Condition under investigation worsened|18|||
160896459|NCT04612790|581016906|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
160896460|NCT04612790|581016907|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
160984705|NCT05310084|581333755|FG001|Overall Study|Lost to Follow-up|1|||
160800071|NCT00454116|580658177|FG000|Overall Study|Withdrawal by Subject|3|||
160896461|NCT04612790|581016908|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
160896462|NCT04612790|581016909|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
160896463|NCT04612790|581016906|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
160984706|NCT05310084|581333754|FG000|Overall Study|Adverse Event|1|||
160984707|NCT05310084|581333755|FG001|Overall Study|Adverse Event|1|||
160800072|NCT00454116|580658178|FG001|Overall Study|Withdrawal by Subject|3|||
160800073|NCT00454116|580658179|FG002|Overall Study|Withdrawal by Subject|1|||
160800074|NCT00454116|580658177|FG000|Overall Study|Other|2|||
160800075|NCT00454116|580658178|FG001|Overall Study|Other|2|||
160800076|NCT00454116|580658179|FG002|Overall Study|Other|0|||
160800077|NCT03500211|580658182|FG000|Overall Study|Withdrawal by Subject|1|||
160800078|NCT03500211|580658183|FG001|Overall Study|Withdrawal by Subject|1|||
160800079|NCT02431325|580658184|FG000|Overall Study|Adverse Event|3|||
160800080|NCT02431325|580658185|FG001|Overall Study|Adverse Event|0|||
160800081|NCT02431325|580658184|FG000|Overall Study|Lost to Follow-up|0|||
160800082|NCT02431325|580658185|FG001|Overall Study|Lost to Follow-up|1|||
160800083|NCT02431325|580658184|FG000|Overall Study|Withdrawal by Subject|1|||
160800084|NCT02431325|580658185|FG001|Overall Study|Withdrawal by Subject|2|||
160800085|NCT02431325|580658184|FG000|Overall Study|Declined to take study medication|1|||
160800086|NCT02431325|580658185|FG001|Overall Study|Declined to take study medication|0|||
160800087|NCT02431325|580658184|FG000|Overall Study|Withdrew before starting study medication|1|||
160800088|NCT02431325|580658185|FG001|Overall Study|Withdrew before starting study medication|0|||
160800089|NCT02431325|580658184|FG000|Overall Study|Placebo shortage|2|||
160800090|NCT02431325|580658185|FG001|Overall Study|Placebo shortage|0|||
160800091|NCT01917318|580658186|FG000|First Treatment|Withdrawal by Subject|0|||
160800092|NCT01917318|580658187|FG001|First Treatment|Withdrawal by Subject|1|||
160800093|NCT01008618|580658188|FG000|Period 1 (Titration Period)|Physician Decision|2|||
160800094|NCT01008618|580658189|FG001|Period 1 (Titration Period)|Physician Decision|0|||
160800095|NCT01008618|580658190|FG002|Period 1 (Titration Period)|Physician Decision|0|||
160800096|NCT01008618|580658188|FG000|Period 1 (Titration Period)|Adverse Event|33|||
160800097|NCT01008618|580658189|FG001|Period 1 (Titration Period)|Adverse Event|0|||
160800098|NCT01008618|580658190|FG002|Period 1 (Titration Period)|Adverse Event|0|||
160800099|NCT01008618|580658188|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
160800100|NCT01008618|580658189|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
160896464|NCT04612790|581016907|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
160896465|NCT04612790|581016908|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
160896466|NCT04612790|581016909|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
160896467|NCT04612790|581016906|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
160896468|NCT04612790|581016907|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
160896469|NCT04612790|581016908|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
160896470|NCT04612790|581016909|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
160896471|NCT04612790|581016906|FG000|OLE Period (Up to 1 Year)|Other|0|||
160896472|NCT04612790|581016907|FG001|OLE Period (Up to 1 Year)|Other|0|||
160896473|NCT04612790|581016908|FG002|OLE Period (Up to 1 Year)|Other|0|||
160896474|NCT04612790|581016909|FG003|OLE Period (Up to 1 Year)|Other|1|||
160896475|NCT03323502|581016913|FG000|Overall Study|Resident could not be linked to CMS data|594|||
160896476|NCT03323502|581016914|FG001|Overall Study|Resident could not be linked to CMS data|435|||
160896477|NCT03323502|581016913|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
160896478|NCT03323502|581016914|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
160896479|NCT03323502|581016913|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
160896480|NCT03323502|581016914|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
160896481|NCT03323502|581016913|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
160896482|NCT03323502|581016914|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
160896483|NCT03323502|581016913|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
160896484|NCT03323502|581016914|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
160896485|NCT00902668|581016922|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
160896486|NCT01914757|581016923|FG000|Overall Study|Severe non-compliance to protocol|3|||
160896487|NCT01914757|581016924|FG001|Overall Study|Severe non-compliance to protocol|1|||
160896488|NCT01914757|581016925|FG002|Overall Study|Severe non-compliance to protocol|2|||
160896489|NCT01914757|581016923|FG000|Overall Study|Lost to Follow-up|5|||
160896490|NCT01914757|581016924|FG001|Overall Study|Lost to Follow-up|8|||
160800101|NCT01008618|580658190|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
160800102|NCT01008618|580658188|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
160800103|NCT01008618|580658189|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
160896491|NCT01914757|581016925|FG002|Overall Study|Lost to Follow-up|6|||
160896492|NCT01914757|581016923|FG000|Overall Study|Withdrawal by Subject|15|||
160800104|NCT01008618|580658190|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
160800105|NCT01008618|580658188|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
160800106|NCT01008618|580658189|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
160800107|NCT01008618|580658190|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
160800108|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
160800109|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
160800110|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
160800111|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
160800112|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
160800113|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
160800114|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
160800115|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
160800116|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
160800117|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
160800118|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
160800119|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
160800120|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
160800121|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
160800122|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
160800123|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
160800124|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
160800125|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
160800126|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
160800127|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
160800128|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
160800129|NCT00487981|580658191|FG000|Overall Study|Hypothyroidism diagnosis|1|||
160800130|NCT01213082|580658197|FG000|Overall Study|Lost to Follow-up|6|||
160800131|NCT01213082|580658198|FG001|Overall Study|Lost to Follow-up|7|||
160800132|NCT01213082|580658199|FG002|Overall Study|Lost to Follow-up|4|||
160800133|NCT01213082|580658197|FG000|Overall Study|Physician Decision|0|||
160800134|NCT01213082|580658198|FG001|Overall Study|Physician Decision|0|||
160800135|NCT01213082|580658199|FG002|Overall Study|Physician Decision|1|||
160800136|NCT00698828|580658205|FG000|Overall Study|Adverse Event|3|||
160800137|NCT00698828|580658206|FG001|Overall Study|Adverse Event|4|||
160800138|NCT00698828|580658207|FG002|Overall Study|Adverse Event|4|||
160800139|NCT00698828|580658205|FG000|Overall Study|Death|0|||
160800140|NCT00698828|580658206|FG001|Overall Study|Death|0|||
160800141|NCT00698828|580658207|FG002|Overall Study|Death|1|||
160800142|NCT00698828|580658205|FG000|Overall Study|Exacerbation of COPD|1|||
160800143|NCT00698828|580658206|FG001|Overall Study|Exacerbation of COPD|3|||
160800144|NCT00698828|580658207|FG002|Overall Study|Exacerbation of COPD|0|||
160800145|NCT00698828|580658205|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
160800146|NCT00698828|580658206|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
160800147|NCT00698828|580658207|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
160800148|NCT00698828|580658205|FG000|Overall Study|Investigator/Sponsor decision|1|||
160800149|NCT00698828|580658206|FG001|Overall Study|Investigator/Sponsor decision|0|||
160800150|NCT00698828|580658207|FG002|Overall Study|Investigator/Sponsor decision|2|||
160800151|NCT00698828|580658205|FG000|Overall Study|Lost to Follow-up|1|||
160800152|NCT00698828|580658206|FG001|Overall Study|Lost to Follow-up|1|||
160800153|NCT00698828|580658207|FG002|Overall Study|Lost to Follow-up|0|||
160800154|NCT00698828|580658205|FG000|Overall Study|Withdrew consent|0|||
160800155|NCT00698828|580658206|FG001|Overall Study|Withdrew consent|7|||
160800156|NCT00698828|580658207|FG002|Overall Study|Withdrew consent|4|||
160800157|NCT00698828|580658205|FG000|Overall Study|Withdrew consent (not treated)|2|||
160800158|NCT00698828|580658206|FG001|Overall Study|Withdrew consent (not treated)|0|||
160800159|NCT00698828|580658207|FG002|Overall Study|Withdrew consent (not treated)|0|||
160800160|NCT02013609|580658210|FG000|Overall Study|Withdrawal by Subject|9|||
160800161|NCT02013609|580658210|FG000|Overall Study|Lost to Follow-up|3|||
160800162|NCT02013609|580658210|FG000|Overall Study|Adverse Event|3|||
160800163|NCT02013609|580658210|FG000|Overall Study|Met Withdrawal Criteria|3|||
160800164|NCT01816295|580658211|FG000|Double Blind Phase|Adverse Event|11|||
160800165|NCT01816295|580658212|FG001|Double Blind Phase|Adverse Event|8|||
160800166|NCT01816295|580658211|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
160800167|NCT01816295|580658212|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
160800168|NCT01816295|580658211|FG000|Double Blind Phase|Lost to Follow-up|3|||
160800169|NCT01816295|580658212|FG001|Double Blind Phase|Lost to Follow-up|5|||
160800170|NCT01816295|580658211|FG000|Double Blind Phase|Physician Decision|2|||
160800171|NCT01816295|580658212|FG001|Double Blind Phase|Physician Decision|2|||
160800172|NCT01816295|580658211|FG000|Double Blind Phase|Protocol Violation|17|||
160896493|NCT01914757|581016924|FG001|Overall Study|Withdrawal by Subject|27|||
160896494|NCT01914757|581016925|FG002|Overall Study|Withdrawal by Subject|19|||
160896495|NCT01914757|581016923|FG000|Overall Study|Death|2|||
160896496|NCT01914757|581016924|FG001|Overall Study|Death|2|||
160896497|NCT01914757|581016925|FG002|Overall Study|Death|1|||
160896498|NCT01914757|581016923|FG000|Overall Study|Adverse Event|4|||
160896499|NCT01914757|581016924|FG001|Overall Study|Adverse Event|3|||
160896500|NCT01914757|581016925|FG002|Overall Study|Adverse Event|4|||
160800173|NCT01816295|580658212|FG001|Double Blind Phase|Protocol Violation|11|||
160800174|NCT01816295|580658211|FG000|Double Blind Phase|Sponsor Decision|8|||
160800175|NCT01816295|580658212|FG001|Double Blind Phase|Sponsor Decision|8|||
160800176|NCT01816295|580658211|FG000|Double Blind Phase|Withdrawal by Subject|22|||
160800177|NCT01816295|580658212|FG001|Double Blind Phase|Withdrawal by Subject|20|||
160800178|NCT01816295|580658211|FG000|OLE Phase|Adverse Event|17|||
160984708|NCT05310084|581333754|FG000|Overall Study|Randomized but not vaccinated|4|||
160984709|NCT05310084|581333755|FG001|Overall Study|Randomized but not vaccinated|2|||
160984710|NCT02065245|581333757|FG000|Infusion 1|Lost to Follow-up|0|||
160984711|NCT02065245|581333758|FG001|Infusion 1|Lost to Follow-up|0|||
160984712|NCT02065245|581333759|FG002|Infusion 1|Lost to Follow-up|0|||
160984713|NCT02065245|581333760|FG003|Infusion 1|Lost to Follow-up|0|||
160800179|NCT01816295|580658212|FG001|OLE Phase|Adverse Event|15|||
160800180|NCT01816295|580658211|FG000|OLE Phase|Death|1|||
160800181|NCT01816295|580658212|FG001|OLE Phase|Death|0|||
160800182|NCT01816295|580658211|FG000|OLE Phase|Entry Criteria Not Met|3|||
160800183|NCT01816295|580658212|FG001|OLE Phase|Entry Criteria Not Met|5|||
160800184|NCT01816295|580658211|FG000|OLE Phase|Lost to Follow-up|5|||
160800185|NCT01816295|580658212|FG001|OLE Phase|Lost to Follow-up|5|||
160800186|NCT01816295|580658211|FG000|OLE Phase|Physician Decision|3|||
160800187|NCT01816295|580658212|FG001|OLE Phase|Physician Decision|1|||
160800188|NCT01816295|580658211|FG000|OLE Phase|Protocol Violation|4|||
160800189|NCT01816295|580658212|FG001|OLE Phase|Protocol Violation|4|||
160800190|NCT01816295|580658211|FG000|OLE Phase|Sponsor Decision|7|||
160800191|NCT01816295|580658212|FG001|OLE Phase|Sponsor Decision|9|||
160800192|NCT01816295|580658211|FG000|OLE Phase|Withdrawal by Subject|10|||
160896501|NCT01914757|581016923|FG000|Overall Study|Study specific withdrawal criteria|0|||
160896502|NCT01914757|581016924|FG001|Overall Study|Study specific withdrawal criteria|1|||
160896503|NCT01914757|581016925|FG002|Overall Study|Study specific withdrawal criteria|0|||
160896504|NCT01914757|581016923|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
160896505|NCT01914757|581016924|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160896506|NCT01914757|581016925|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
160896507|NCT01914757|581016923|FG000|Overall Study|Other reasons|5|||
160896508|NCT01914757|581016924|FG001|Overall Study|Other reasons|9|||
160896509|NCT01914757|581016925|FG002|Overall Study|Other reasons|4|||
160896510|NCT00408629|581016928|FG000|Overall Study|Adverse Event|13|||
160896511|NCT00408629|581016929|FG001|Overall Study|Adverse Event|27|||
160896512|NCT00408629|581016928|FG000|Overall Study|Withdrawal by Subject|8|||
160896513|NCT00408629|581016929|FG001|Overall Study|Withdrawal by Subject|4|||
160896514|NCT00408629|581016928|FG000|Overall Study|Lost to Follow-up|1|||
160896515|NCT00408629|581016929|FG001|Overall Study|Lost to Follow-up|1|||
160896516|NCT00408629|581016928|FG000|Overall Study|Lack of Efficacy|63|||
160896517|NCT00408629|581016929|FG001|Overall Study|Lack of Efficacy|73|||
160896518|NCT00408629|581016928|FG000|Overall Study|Protocol Violation|1|||
160896519|NCT00408629|581016929|FG001|Overall Study|Protocol Violation|5|||
160896520|NCT00408629|581016928|FG000|Overall Study|Miscellaneous|11|||
160896521|NCT00408629|581016929|FG001|Overall Study|Miscellaneous|15|||
160896522|NCT01461980|581016930|FG000|Overall Study|Other|9|||
160896523|NCT01461980|581016931|FG001|Overall Study|Other|8|||
160896524|NCT01461980|581016932|FG002|Overall Study|Other|6|||
160896525|NCT01461980|581016930|FG000|Overall Study|Medication error|7|||
160896526|NCT01461980|581016931|FG001|Overall Study|Medication error|5|||
160896527|NCT01461980|581016932|FG002|Overall Study|Medication error|6|||
160896528|NCT01461980|581016930|FG000|Overall Study|Adverse Event|12|||
160896529|NCT01461980|581016931|FG001|Overall Study|Adverse Event|5|||
160896530|NCT01461980|581016932|FG002|Overall Study|Adverse Event|6|||
160896531|NCT01461980|581016930|FG000|Overall Study|Protocol Violation|12|||
160896532|NCT01461980|581016931|FG001|Overall Study|Protocol Violation|19|||
160896533|NCT01461980|581016932|FG002|Overall Study|Protocol Violation|16|||
160896534|NCT01461980|581016930|FG000|Overall Study|No longer meets eligibility criteria|18|||
160896535|NCT01461980|581016931|FG001|Overall Study|No longer meets eligibility criteria|9|||
160896536|NCT01461980|581016932|FG002|Overall Study|No longer meets eligibility criteria|19|||
160984714|NCT02065245|581333761|FG004|Infusion 1|Lost to Follow-up|0|||
160896537|NCT01461980|581016930|FG000|Overall Study|Lost to Follow-up|52|||
160644135|NCT00549198|580080676|FG000|Overall Study|Investigator Decision|4|||
160896538|NCT01461980|581016931|FG001|Overall Study|Lost to Follow-up|53|||
160896539|NCT01461980|581016932|FG002|Overall Study|Lost to Follow-up|51|||
160896540|NCT01461980|581016930|FG000|Overall Study|No longer willing to participate|52|||
160896541|NCT01461980|581016931|FG001|Overall Study|No longer willing to participate|38|||
160984715|NCT02065245|581333762|FG005|Infusion 1|Lost to Follow-up|0|||
160800193|NCT01816295|580658212|FG001|OLE Phase|Withdrawal by Subject|10|||
160800194|NCT01816295|580658211|FG000|OLE Phase|Lack of Efficacy|3|||
160800195|NCT01816295|580658212|FG001|OLE Phase|Lack of Efficacy|7|||
160800196|NCT00783432|580658213|FG000|Overall Study|Adverse Event|22|||
160800197|NCT00783432|580658214|FG001|Overall Study|Adverse Event|17|||
160896542|NCT01461980|581016932|FG002|Overall Study|No longer willing to participate|54|||
160896543|NCT01461980|581016930|FG000|Overall Study|Randomized but not vaccinated|4|||
160896544|NCT01461980|581016931|FG001|Overall Study|Randomized but not vaccinated|8|||
160800198|NCT00783432|580658213|FG000|Overall Study|Lack of Efficacy|20|||
160896545|NCT01461980|581016932|FG002|Overall Study|Randomized but not vaccinated|7|||
160896546|NCT00122109|581016933|FG000|Overall Study|Did not meet criteria|6|||
160896547|NCT00122109|581016934|FG001|Overall Study|Did not meet criteria|7|||
160896548|NCT00100178|581016935|FG000|Overall Study|Lost to Follow-up|0|||
160896549|NCT00100178|581016936|FG001|Overall Study|Lost to Follow-up|6|||
160896550|NCT00100178|581016937|FG002|Overall Study|Lost to Follow-up|5|||
160896551|NCT00100178|581016935|FG000|Overall Study|Adverse Event|2|||
160896552|NCT00100178|581016936|FG001|Overall Study|Adverse Event|2|||
160896553|NCT00100178|581016937|FG002|Overall Study|Adverse Event|1|||
160896554|NCT00100178|581016935|FG000|Overall Study|Withdrawal by Subject|1|||
160896555|NCT00100178|581016936|FG001|Overall Study|Withdrawal by Subject|1|||
160896556|NCT00100178|581016937|FG002|Overall Study|Withdrawal by Subject|1|||
160896557|NCT00100178|581016935|FG000|Overall Study|Physician Decision|6|||
160896558|NCT00100178|581016936|FG001|Overall Study|Physician Decision|1|||
160896559|NCT00100178|581016937|FG002|Overall Study|Physician Decision|3|||
160896560|NCT00631696|581016938|FG000|Overall Study|Entered, not randomized to treatment|1|||
160896561|NCT00631696|581016939|FG001|Overall Study|Entered, not randomized to treatment|1|||
160896562|NCT00631696|581016938|FG000|Overall Study|Discontinued after database release date|1|||
160896563|NCT00631696|581016939|FG001|Overall Study|Discontinued after database release date|0|||
160896564|NCT00631696|581016938|FG000|Overall Study|Follow up after database release date|1|||
160896565|NCT00631696|581016939|FG001|Overall Study|Follow up after database release date|0|||
160896566|NCT00631696|581016938|FG000|Overall Study|Lost to Follow-up|7|||
160896567|NCT00631696|581016939|FG001|Overall Study|Lost to Follow-up|10|||
160896568|NCT00631696|581016938|FG000|Overall Study|Withdrawal by Subject|2|||
160800199|NCT00783432|580658214|FG001|Overall Study|Lack of Efficacy|21|||
160800200|NCT00783432|580658213|FG000|Overall Study|Lost to Follow-up|11|||
160800201|NCT00783432|580658214|FG001|Overall Study|Lost to Follow-up|6|||
160800202|NCT00783432|580658213|FG000|Overall Study|Withdrawal by Subject|23|||
160800203|NCT00783432|580658214|FG001|Overall Study|Withdrawal by Subject|20|||
160800204|NCT00783432|580658213|FG000|Overall Study|subject moved|3|||
160800205|NCT00783432|580658214|FG001|Overall Study|subject moved|5|||
160800206|NCT00783432|580658213|FG000|Overall Study|Protocol Violation|6|||
160800207|NCT00783432|580658214|FG001|Overall Study|Protocol Violation|9|||
160800208|NCT01119287|580658215|FG000|Overall Study|Patient Decision, not related to AE|0|||
160800209|NCT01119287|580658216|FG001|Overall Study|Patient Decision, not related to AE|0|||
160800210|NCT01119287|580658217|FG002|Overall Study|Patient Decision, not related to AE|2|||
160800211|NCT01119287|580658218|FG003|Overall Study|Patient Decision, not related to AE|2|||
160800212|NCT01119287|580658219|FG004|Overall Study|Patient Decision, not related to AE|1|||
160800213|NCT01119287|580658220|FG005|Overall Study|Patient Decision, not related to AE|0|||
160800214|NCT01331681|580658225|FG000|Overall Study|Adverse Event|10|||
160800215|NCT01331681|580658226|FG001|Overall Study|Adverse Event|13|||
160800216|NCT01331681|580658227|FG002|Overall Study|Adverse Event|10|||
160800217|NCT01331681|580658225|FG000|Overall Study|Death|6|||
160800218|NCT01331681|580658226|FG001|Overall Study|Death|6|||
160800219|NCT01331681|580658227|FG002|Overall Study|Death|2|||
160800220|NCT01331681|580658225|FG000|Overall Study|Lack of Efficacy|0|||
160800221|NCT01331681|580658226|FG001|Overall Study|Lack of Efficacy|1|||
160800222|NCT01331681|580658227|FG002|Overall Study|Lack of Efficacy|0|||
160800223|NCT01331681|580658225|FG000|Overall Study|Withdrawal by Subject|12|||
160800224|NCT01331681|580658226|FG001|Overall Study|Withdrawal by Subject|8|||
160800225|NCT01331681|580658227|FG002|Overall Study|Withdrawal by Subject|15|||
160800226|NCT01331681|580658225|FG000|Overall Study|Protocol Violation|1|||
160800227|NCT01331681|580658226|FG001|Overall Study|Protocol Violation|1|||
160800228|NCT01331681|580658227|FG002|Overall Study|Protocol Violation|0|||
160800229|NCT01331681|580658225|FG000|Overall Study|Lost to Follow-up|2|||
160800230|NCT01331681|580658226|FG001|Overall Study|Lost to Follow-up|4|||
160800231|NCT01331681|580658227|FG002|Overall Study|Lost to Follow-up|1|||
160800232|NCT01331681|580658225|FG000|Overall Study|Physician Decision|2|||
160800233|NCT01331681|580658226|FG001|Overall Study|Physician Decision|0|||
160800234|NCT01331681|580658227|FG002|Overall Study|Physician Decision|4|||
160896569|NCT00631696|581016939|FG001|Overall Study|Withdrawal by Subject|9|||
160800235|NCT01331681|580658225|FG000|Overall Study|Therapeutic procedure required|1|||
160800236|NCT01331681|580658226|FG001|Overall Study|Therapeutic procedure required|0|||
160800237|NCT01331681|580658227|FG002|Overall Study|Therapeutic procedure required|0|||
160800238|NCT01331681|580658225|FG000|Overall Study|Sponsor decision|1|||
160800239|NCT01331681|580658226|FG001|Overall Study|Sponsor decision|1|||
160896570|NCT00631696|581016938|FG000|Overall Study|Other|8|||
160896571|NCT00631696|581016939|FG001|Overall Study|Other|8|||
160896572|NCT00631696|581016938|FG000|Overall Study|Protocol Violation|9|||
160896573|NCT00631696|581016939|FG001|Overall Study|Protocol Violation|9|||
160800240|NCT01331681|580658227|FG002|Overall Study|Sponsor decision|0|||
160800241|NCT01331681|580658225|FG000|Overall Study|Switching to other therapy|0|||
160800242|NCT01331681|580658226|FG001|Overall Study|Switching to other therapy|0|||
160800243|NCT01331681|580658227|FG002|Overall Study|Switching to other therapy|1|||
160800244|NCT01331681|580658225|FG000|Overall Study|Not Received Study Treatment|0|||
160800245|NCT01331681|580658226|FG001|Overall Study|Not Received Study Treatment|0|||
160800246|NCT01331681|580658227|FG002|Overall Study|Not Received Study Treatment|2|||
160800247|NCT01534481|580658228|FG000|Overall Study|Lost to Follow-up|29|||
160800248|NCT01534481|580658229|FG001|Overall Study|Lost to Follow-up|24|||
160800249|NCT01534481|580658228|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
160800250|NCT01534481|580658229|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
160896574|NCT00631696|581016938|FG000|Overall Study|Study terminated by sponsor|3|||
160896575|NCT00631696|581016939|FG001|Overall Study|Study terminated by sponsor|3|||
160896576|NCT00631696|581016938|FG000|Overall Study|Adverse Event|5|||
160800251|NCT00107276|580658230|FG000|Overall Study|Progression|46|||
160800252|NCT00107276|580658230|FG000|Overall Study|Adverse Event|6|||
160800253|NCT00107276|580658230|FG000|Overall Study|M.D. decision|2|||
160800254|NCT00107276|580658230|FG000|Overall Study|Patient refusal|1|||
160800255|NCT00107276|580658230|FG000|Overall Study|Death|1|||
160800256|NCT00107276|580658230|FG000|Overall Study|Ineligible|16|||
160800257|NCT03498716|580658240|FG000|Overall Study|Withdrawal by Subject|88|||
160800258|NCT03498716|580658241|FG001|Overall Study|Withdrawal by Subject|73|||
160800259|NCT03498716|580658240|FG000|Overall Study|Study Terminated By Sponsor|933|||
160800260|NCT03498716|580658241|FG001|Overall Study|Study Terminated By Sponsor|927|||
160800261|NCT03498716|580658240|FG000|Overall Study|Lost to Follow-up|15|||
160800262|NCT03498716|580658241|FG001|Overall Study|Lost to Follow-up|26|||
160800263|NCT03498716|580658240|FG000|Overall Study|Disease Relapse|0|||
160800264|NCT03498716|580658241|FG001|Overall Study|Disease Relapse|1|||
160800265|NCT03498716|580658240|FG000|Overall Study|Death|58|||
160800266|NCT03498716|580658241|FG001|Overall Study|Death|72|||
160800267|NCT03498716|580658240|FG000|Overall Study|Physician Decision|4|||
160800268|NCT03498716|580658241|FG001|Overall Study|Physician Decision|2|||
160800269|NCT02284191|580658242|FG000|Overall Study|Withdrawal by Subject|1|||
160800270|NCT02284191|580658243|FG001|Overall Study|Withdrawal by Subject|3|||
160800271|NCT02284191|580658242|FG000|Overall Study|Lost to Follow-up|1|||
160800272|NCT02284191|580658243|FG001|Overall Study|Lost to Follow-up|0|||
160800273|NCT04064905|580658244|FG000|Overall Study|Lost to Follow-up|0|||
160800274|NCT04064905|580658245|FG001|Overall Study|Lost to Follow-up|3|||
160800275|NCT04064905|580658246|FG002|Overall Study|Lost to Follow-up|1|||
160800276|NCT04064905|580658247|FG003|Overall Study|Lost to Follow-up|4|||
160800277|NCT04064905|580658248|FG004|Overall Study|Lost to Follow-up|2|||
160800278|NCT02257684|580658251|FG000|Overall Study|Adverse Event|2|||
160800279|NCT02257684|580658251|FG000|Overall Study|Lack of Efficacy|1|||
160800280|NCT02257684|580658251|FG000|Overall Study|Sponsor's Decision|1|||
160800281|NCT01987557|580658252|FG000|Overall Study|Protocol Violation|1|||
160800282|NCT01987557|580658253|FG001|Overall Study|Protocol Violation|0|||
160800283|NCT01987557|580658254|FG002|Overall Study|Protocol Violation|1|||
160800284|NCT01987557|580658252|FG000|Overall Study|Withdrawal by Subject|2|||
160800285|NCT01987557|580658253|FG001|Overall Study|Withdrawal by Subject|1|||
160800286|NCT01987557|580658254|FG002|Overall Study|Withdrawal by Subject|2|||
160800287|NCT01987557|580658252|FG000|Overall Study|Adverse Event|0|||
160800288|NCT01987557|580658253|FG001|Overall Study|Adverse Event|2|||
160800289|NCT01987557|580658254|FG002|Overall Study|Adverse Event|0|||
160800290|NCT00760552|580658255|FG000|Overall Study|Death|2|||
160800291|NCT00760552|580658256|FG001|Overall Study|Death|0|||
160800292|NCT00760552|580658255|FG000|Overall Study|Lost to Follow-up|11|||
160800293|NCT00760552|580658256|FG001|Overall Study|Lost to Follow-up|10|||
160800294|NCT01832727|580658260|FG000|Overall Study|Adverse Event|4|||
160800295|NCT01832727|580658261|FG001|Overall Study|Adverse Event|6|||
160800296|NCT01832727|580658262|FG002|Overall Study|Adverse Event|1|||
160800297|NCT01832727|580658263|FG003|Overall Study|Adverse Event|0|||
160800298|NCT01832727|580658264|FG004|Overall Study|Adverse Event|1|||
160800299|NCT01832727|580658265|FG005|Overall Study|Adverse Event|1|||
160800300|NCT01832727|580658266|FG006|Overall Study|Adverse Event|2|||
160800301|NCT01832727|580658267|FG007|Overall Study|Adverse Event|1|||
160800302|NCT01832727|580658268|FG008|Overall Study|Adverse Event|9|||
160800303|NCT01832727|580658260|FG000|Overall Study|Disease progression|3|||
160800304|NCT01832727|580658261|FG001|Overall Study|Disease progression|0|||
160800305|NCT01832727|580658262|FG002|Overall Study|Disease progression|2|||
160800306|NCT01832727|580658263|FG003|Overall Study|Disease progression|1|||
160800307|NCT01832727|580658264|FG004|Overall Study|Disease progression|3|||
160800308|NCT01832727|580658265|FG005|Overall Study|Disease progression|3|||
160800309|NCT01832727|580658266|FG006|Overall Study|Disease progression|6|||
160800310|NCT01832727|580658267|FG007|Overall Study|Disease progression|2|||
160800311|NCT01832727|580658268|FG008|Overall Study|Disease progression|7|||
160800312|NCT01832727|580658260|FG000|Overall Study|Lost to Follow-up|0|||
160800313|NCT01832727|580658261|FG001|Overall Study|Lost to Follow-up|0|||
160800314|NCT01832727|580658262|FG002|Overall Study|Lost to Follow-up|0|||
160800315|NCT01832727|580658263|FG003|Overall Study|Lost to Follow-up|1|||
160800316|NCT01832727|580658264|FG004|Overall Study|Lost to Follow-up|0|||
160800317|NCT01832727|580658265|FG005|Overall Study|Lost to Follow-up|0|||
160800318|NCT01832727|580658266|FG006|Overall Study|Lost to Follow-up|0|||
160800319|NCT01832727|580658267|FG007|Overall Study|Lost to Follow-up|0|||
160800320|NCT01832727|580658268|FG008|Overall Study|Lost to Follow-up|0|||
160896577|NCT00631696|581016939|FG001|Overall Study|Adverse Event|0|||
160800321|NCT01832727|580658260|FG000|Overall Study|Physician Decision|1|||
160896578|NCT01439568|581016941|FG000|Overall Study|Lost to Follow-up|1|||
160896579|NCT01439568|581016942|FG001|Overall Study|Lost to Follow-up|0|||
160896580|NCT01439568|581016941|FG000|Overall Study|Withdrawal by Subject|2|||
160896581|NCT01439568|581016942|FG001|Overall Study|Withdrawal by Subject|2|||
160896582|NCT03198078|581016943|FG000|Overall Study|Adverse Event|0|||
160896583|NCT03198078|581016944|FG001|Overall Study|Adverse Event|1|||
160896584|NCT03198078|581016945|FG002|Overall Study|Adverse Event|2|||
160896585|NCT03198078|581016943|FG000|Overall Study|Lack of Efficacy|0|||
160896586|NCT03198078|581016944|FG001|Overall Study|Lack of Efficacy|0|||
160896587|NCT03198078|581016945|FG002|Overall Study|Lack of Efficacy|3|||
160896588|NCT03198078|581016943|FG000|Overall Study|Lost to Follow-up|1|||
160896589|NCT03198078|581016944|FG001|Overall Study|Lost to Follow-up|0|||
160896590|NCT03198078|581016945|FG002|Overall Study|Lost to Follow-up|0|||
160896591|NCT03198078|581016943|FG000|Overall Study|Pregnancy|0|||
160896592|NCT03198078|581016944|FG001|Overall Study|Pregnancy|1|||
160896593|NCT03198078|581016945|FG002|Overall Study|Pregnancy|0|||
160896594|NCT03198078|581016943|FG000|Overall Study|Withdrawal by Subject|1|||
160896595|NCT03198078|581016944|FG001|Overall Study|Withdrawal by Subject|0|||
160896596|NCT03198078|581016945|FG002|Overall Study|Withdrawal by Subject|2|||
160896597|NCT03198078|581016943|FG000|Overall Study|Withdrawal by Caregiver|1|||
160896598|NCT03198078|581016944|FG001|Overall Study|Withdrawal by Caregiver|3|||
160896599|NCT03198078|581016945|FG002|Overall Study|Withdrawal by Caregiver|5|||
160896600|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
160896601|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
160896602|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
160896603|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
160896604|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
160896605|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
160896606|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
160896607|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
160896608|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
160896609|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
160896610|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
160896611|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
160896612|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
160896613|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
160896614|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
160896615|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
160896616|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
160896617|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
160896618|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
160896619|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
160896620|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
160896621|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
160896622|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
160896623|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
160896624|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Death|2|||
160896625|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Death|1|||
160896626|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Death|0|||
160896627|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Death|0|||
160896628|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
160896629|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
160896630|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
160896631|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
160896632|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
160896633|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
160896634|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
160896635|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
160896636|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
160896637|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
160896638|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
160896639|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
160896640|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
160896641|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
160896642|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
160896643|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
160896644|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
160896645|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
160984716|NCT02065245|581333763|FG006|Infusion 1|Lost to Follow-up|1|||
160984717|NCT02065245|581333757|FG000|Infusion 1|Death|0|||
160644136|NCT00549198|580080677|FG001|Overall Study|Investigator Decision|3|||
160984718|NCT02065245|581333758|FG001|Infusion 1|Death|0|||
160984719|NCT02065245|581333759|FG002|Infusion 1|Death|1|||
160984720|NCT02065245|581333760|FG003|Infusion 1|Death|0|||
160984721|NCT02065245|581333761|FG004|Infusion 1|Death|1|||
160984722|NCT02065245|581333762|FG005|Infusion 1|Death|0|||
160984723|NCT02065245|581333763|FG006|Infusion 1|Death|0|||
160984724|NCT02065245|581333757|FG000|Infusion 2|Death|0|||
160984725|NCT02065245|581333758|FG001|Infusion 2|Death|0|||
160984726|NCT02065245|581333759|FG002|Infusion 2|Death|0|||
160984727|NCT02065245|581333760|FG003|Infusion 2|Death|0|||
160984728|NCT02065245|581333761|FG004|Infusion 2|Death|0|||
160984729|NCT02065245|581333762|FG005|Infusion 2|Death|0|||
160984730|NCT02065245|581333763|FG006|Infusion 2|Death|1|||
160984731|NCT02065245|581333757|FG000|Infusion 3|Lost to Follow-up|1|||
160984732|NCT02065245|581333758|FG001|Infusion 3|Lost to Follow-up|1|||
160984733|NCT02065245|581333759|FG002|Infusion 3|Lost to Follow-up|0|||
160984734|NCT02065245|581333760|FG003|Infusion 3|Lost to Follow-up|0|||
160984735|NCT02065245|581333761|FG004|Infusion 3|Lost to Follow-up|0|||
160984736|NCT02065245|581333762|FG005|Infusion 3|Lost to Follow-up|0|||
160984737|NCT02065245|581333763|FG006|Infusion 3|Lost to Follow-up|0|||
160984738|NCT00924664|581333764|FG000|Overall Study|Adverse Event|23|||
160984739|NCT00924664|581333765|FG001|Overall Study|Adverse Event|39|||
160984740|NCT00924664|581333764|FG000|Overall Study|Lack of Efficacy|10|||
160984741|NCT00924664|581333765|FG001|Overall Study|Lack of Efficacy|15|||
160984742|NCT00924664|581333764|FG000|Overall Study|Lost to Follow-up|10|||
160984743|NCT00924664|581333765|FG001|Overall Study|Lost to Follow-up|12|||
160984744|NCT00924664|581333764|FG000|Overall Study|Withdrawal by Subject|47|||
160984745|NCT00924664|581333765|FG001|Overall Study|Withdrawal by Subject|71|||
160984746|NCT00924664|581333764|FG000|Overall Study|Protocol Violation|2|||
160984747|NCT00924664|581333765|FG001|Overall Study|Protocol Violation|5|||
160984748|NCT00924664|581333764|FG000|Overall Study|Pregnancy|1|||
160984749|NCT00924664|581333765|FG001|Overall Study|Pregnancy|1|||
160984750|NCT00924664|581333764|FG000|Overall Study|Death|0|||
160984751|NCT00924664|581333765|FG001|Overall Study|Death|2|||
160984752|NCT00924664|581333764|FG000|Overall Study|Study terminated by sponsor|199|||
160984753|NCT00924664|581333765|FG001|Overall Study|Study terminated by sponsor|330|||
160984754|NCT00924664|581333764|FG000|Overall Study|Other|29|||
160984755|NCT00924664|581333765|FG001|Overall Study|Other|52|||
160984756|NCT00924664|581333764|FG000|Overall Study|Randomized but not Treated|1|||
160984757|NCT00924664|581333765|FG001|Overall Study|Randomized but not Treated|0|||
160984758|NCT01598987|581333766|FG000|Baseline to Month 12|Administrative problems|2|||
160984759|NCT01598987|581333766|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
160984760|NCT01598987|581333766|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
160984761|NCT01598987|581333766|FG000|Baseline to 24 Month|Administrative problems|2|||
160984762|NCT01598987|581333766|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
160984763|NCT03531905|581333767|FG000|Overall Study|Withdrawal by Subject|3|||
160984764|NCT03531905|581333768|FG001|Overall Study|Withdrawal by Subject|3|||
160984765|NCT03531905|581333769|FG002|Overall Study|Withdrawal by Subject|2|||
160984766|NCT03531905|581333767|FG000|Overall Study|Lost to Follow-up|2|||
160984767|NCT03531905|581333768|FG001|Overall Study|Lost to Follow-up|2|||
160984768|NCT03531905|581333769|FG002|Overall Study|Lost to Follow-up|1|||
160984769|NCT03531905|581333767|FG000|Overall Study|Participant was out of town|1|||
160984770|NCT03531905|581333768|FG001|Overall Study|Participant was out of town|0|||
160984771|NCT03531905|581333769|FG002|Overall Study|Participant was out of town|0|||
160984772|NCT03531905|581333767|FG000|Overall Study|Could not speak with the participant|1|||
160984773|NCT03531905|581333768|FG001|Overall Study|Could not speak with the participant|0|||
160984774|NCT03531905|581333769|FG002|Overall Study|Could not speak with the participant|0|||
160984775|NCT01616563|581333770|FG000|Overall Study|Lost to Follow-up|40|||
160984776|NCT01333943|581333776|FG000|Overall Study|Known neuropathy|1|||
160984777|NCT01333943|581333777|FG001|Overall Study|Known neuropathy|0|||
160984778|NCT02459587|581333784|FG000|3-Month Follow-up Assessment|Death|0|||
160984779|NCT02459587|581333785|FG001|3-Month Follow-up Assessment|Death|2|||
160984780|NCT02459587|581333784|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
160984781|NCT02459587|581333785|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
160984782|NCT02459587|581333784|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
160644137|NCT00549198|580080676|FG000|Overall Study|Withdrawal by Subject|7|||
160984783|NCT02459587|581333785|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
160984784|NCT02459587|581333784|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
160984785|NCT02459587|581333785|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
160984786|NCT02459587|581333784|FG000|6-month Follow-up Assessment|Death|2|||
160984787|NCT02459587|581333785|FG001|6-month Follow-up Assessment|Death|1|||
160984788|NCT02459587|581333784|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
160984789|NCT02459587|581333785|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
160984790|NCT02459587|581333784|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
160984791|NCT02459587|581333785|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
160984792|NCT02459587|581333784|FG000|12-month Follow-up Assessment|Death|2|||
160896646|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
160896647|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
160896648|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
160896649|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
160896650|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
160896651|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
160896652|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
160896653|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
160896654|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
160896655|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
160896656|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
160896657|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
160896658|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
160896659|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
160896660|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
160896661|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
160896662|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
160896663|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
160896664|NCT01676727|581016952|FG000|Overall Study|Death|18|||
160896665|NCT01676727|581016952|FG000|Overall Study|Withdrawal by Subject|6|||
160896666|NCT01676727|581016952|FG000|Overall Study|Screening failure|5|||
160896667|NCT01676727|581016952|FG000|Overall Study|Not willing to attend 1-year visit|2|||
160896668|NCT01676727|581016952|FG000|Overall Study|Valve explanted|1|||
160896669|NCT01578330|581016953|FG000|Overall Study|Adverse Event|2|||
160896670|NCT01578330|581016953|FG000|Overall Study|Protocol Violation|5|||
160896671|NCT01134731|581016954|FG000|Overall Study|Adverse Event|3|||
160896672|NCT01134731|581016955|FG001|Overall Study|Adverse Event|2|||
160896673|NCT01134731|581016956|FG002|Overall Study|Adverse Event|1|||
160896674|NCT01134731|581016954|FG000|Overall Study|Physician Decision|2|||
160896675|NCT01134731|581016955|FG001|Overall Study|Physician Decision|2|||
160896676|NCT01134731|581016956|FG002|Overall Study|Physician Decision|2|||
160896677|NCT01134731|581016954|FG000|Overall Study|Lack of Efficacy|0|||
160896678|NCT01134731|581016955|FG001|Overall Study|Lack of Efficacy|0|||
160896679|NCT01134731|581016956|FG002|Overall Study|Lack of Efficacy|1|||
160896680|NCT01134731|581016954|FG000|Overall Study|Withdrawal by Subject|3|||
160896681|NCT01134731|581016955|FG001|Overall Study|Withdrawal by Subject|3|||
160896682|NCT01134731|581016956|FG002|Overall Study|Withdrawal by Subject|1|||
160896683|NCT01134731|581016954|FG000|Overall Study|Lost to Follow-up|5|||
160896684|NCT01134731|581016955|FG001|Overall Study|Lost to Follow-up|4|||
160896685|NCT01134731|581016956|FG002|Overall Study|Lost to Follow-up|3|||
160896686|NCT01050543|581016957|FG000|Overall Study|Withdrawal by Subject|0|||
160896687|NCT01050543|581016958|FG001|Overall Study|Withdrawal by Subject|2|||
160896688|NCT01050543|581016957|FG000|Overall Study|Protocol Violation|0|||
160896689|NCT01050543|581016958|FG001|Overall Study|Protocol Violation|1|||
160896690|NCT01050543|581016957|FG000|Overall Study|Administrative|4|||
160896691|NCT01050543|581016958|FG001|Overall Study|Administrative|1|||
160896692|NCT02517866|581016962|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
160896693|NCT02517866|581016963|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
160896694|NCT02517866|581016964|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
160896695|NCT02517866|581016962|FG000|Overall Study|Significant Protocol Deviation|4|||
160896696|NCT02517866|581016963|FG001|Overall Study|Significant Protocol Deviation|1|||
160896697|NCT02517866|581016964|FG002|Overall Study|Significant Protocol Deviation|0|||
160896698|NCT02517866|581016962|FG000|Overall Study|Lost to Follow-up|1|||
160896699|NCT02517866|581016963|FG001|Overall Study|Lost to Follow-up|0|||
160896700|NCT02517866|581016964|FG002|Overall Study|Lost to Follow-up|0|||
160896701|NCT02517866|581016962|FG000|Overall Study|Voluntary Withdrawal|2|||
160896702|NCT02517866|581016963|FG001|Overall Study|Voluntary Withdrawal|2|||
160896703|NCT02517866|581016964|FG002|Overall Study|Voluntary Withdrawal|0|||
160896704|NCT02517866|581016962|FG000|Overall Study|Investigator Decision|2|||
160896705|NCT02517866|581016963|FG001|Overall Study|Investigator Decision|1|||
160896706|NCT02517866|581016964|FG002|Overall Study|Investigator Decision|0|||
160896707|NCT02517866|581016962|FG000|Overall Study|Reason not specified|2|||
160896708|NCT02517866|581016963|FG001|Overall Study|Reason not specified|0|||
160896709|NCT02517866|581016964|FG002|Overall Study|Reason not specified|0|||
160896710|NCT01646073|581016965|FG000|Period A (12 Weeks)|Adverse Event|0|||
160896711|NCT01646073|581016966|FG001|Period A (12 Weeks)|Adverse Event|2|||
160896712|NCT01646073|581016965|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
160896713|NCT01646073|581016966|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
160896714|NCT01646073|581016965|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
160896715|NCT01646073|581016966|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
160896716|NCT01646073|581016965|FG000|Period A (12 Weeks)|Protocol Violation|0|||
160896717|NCT01646073|581016966|FG001|Period A (12 Weeks)|Protocol Violation|1|||
160896718|NCT01646073|581016965|FG000|Period A (12 Weeks)|Other|0|||
160896719|NCT01646073|581016966|FG001|Period A (12 Weeks)|Other|1|||
160984793|NCT02459587|581333785|FG001|12-month Follow-up Assessment|Death|0|||
160984794|NCT02459587|581333784|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
160984795|NCT02459587|581333785|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
160984796|NCT02459587|581333784|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
160800322|NCT01832727|580658261|FG001|Overall Study|Physician Decision|0|||
160800323|NCT01832727|580658262|FG002|Overall Study|Physician Decision|0|||
160800324|NCT01832727|580658263|FG003|Overall Study|Physician Decision|1|||
160800325|NCT01832727|580658264|FG004|Overall Study|Physician Decision|0|||
160800326|NCT01832727|580658265|FG005|Overall Study|Physician Decision|1|||
160800327|NCT01832727|580658266|FG006|Overall Study|Physician Decision|0|||
160984797|NCT02459587|581333785|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
160984798|NCT02459587|581333784|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
160800328|NCT01832727|580658267|FG007|Overall Study|Physician Decision|0|||
160800329|NCT01832727|580658268|FG008|Overall Study|Physician Decision|0|||
160800330|NCT01832727|580658260|FG000|Overall Study|Withdrawal by Subject|1|||
160800331|NCT01832727|580658261|FG001|Overall Study|Withdrawal by Subject|1|||
160800332|NCT01832727|580658262|FG002|Overall Study|Withdrawal by Subject|0|||
160800333|NCT01832727|580658263|FG003|Overall Study|Withdrawal by Subject|1|||
160800334|NCT01832727|580658264|FG004|Overall Study|Withdrawal by Subject|0|||
160984799|NCT02459587|581333785|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
160984800|NCT02028884|581333788|FG000|Double-blind Period|Adverse Event|5|||
160984801|NCT02028884|581333789|FG001|Double-blind Period|Adverse Event|3|||
160984802|NCT02028884|581333790|FG002|Double-blind Period|Adverse Event|0|||
160984803|NCT02028884|581333788|FG000|Double-blind Period|Eligibility Violation|1|||
160984804|NCT02028884|581333789|FG001|Double-blind Period|Eligibility Violation|0|||
160984805|NCT02028884|581333790|FG002|Double-blind Period|Eligibility Violation|0|||
160984806|NCT02028884|581333788|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
160984807|NCT02028884|581333789|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
160984808|NCT02028884|581333790|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
160984809|NCT02028884|581333788|FG000|Double-blind Period|Withdrawal by Subject|2|||
160984810|NCT02028884|581333789|FG001|Double-blind Period|Withdrawal by Subject|0|||
160984811|NCT02028884|581333790|FG002|Double-blind Period|Withdrawal by Subject|0|||
160984812|NCT02028884|581333788|FG000|Open-label Extension Period|Adverse Event|3|||
160800335|NCT01832727|580658265|FG005|Overall Study|Withdrawal by Subject|1|||
160800336|NCT01832727|580658266|FG006|Overall Study|Withdrawal by Subject|0|||
160800337|NCT01832727|580658267|FG007|Overall Study|Withdrawal by Subject|2|||
160800338|NCT01832727|580658268|FG008|Overall Study|Withdrawal by Subject|1|||
160800339|NCT01832727|580658260|FG000|Overall Study|Study terminated by sponsor|0|||
160800340|NCT01832727|580658261|FG001|Overall Study|Study terminated by sponsor|0|||
160800341|NCT01832727|580658262|FG002|Overall Study|Study terminated by sponsor|0|||
160800342|NCT01832727|580658263|FG003|Overall Study|Study terminated by sponsor|0|||
160896720|NCT01646073|581016965|FG000|Period B (12 Weeks)|Adverse Event|0|||
160896721|NCT01646073|581016966|FG001|Period B (12 Weeks)|Adverse Event|7|||
160896722|NCT01646073|581016965|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
160896723|NCT01646073|581016966|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
160896724|NCT01646073|581016965|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
160896725|NCT01646073|581016966|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
160896726|NCT00679055|581016967|FG000|Overall Study|Adverse Event|0|||
160896727|NCT00679055|581016968|FG001|Overall Study|Adverse Event|1|||
160896728|NCT00679055|581016967|FG000|Overall Study|Other|0|||
160896729|NCT00679055|581016968|FG001|Overall Study|Other|3|||
160896730|NCT00679055|581016967|FG000|Overall Study|Study Terminated|2|||
160896731|NCT00679055|581016968|FG001|Overall Study|Study Terminated|1|||
160896732|NCT00629772|581016969|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
160896733|NCT00629772|581016970|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
160896734|NCT00629772|581016969|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
160896735|NCT00629772|581016970|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
160896736|NCT01393301|581016973|FG000|Overall Study|Lost to Follow-up|5|||
160896737|NCT01393301|581016974|FG001|Overall Study|Lost to Follow-up|3|||
160896738|NCT01393301|581016973|FG000|Overall Study|Withdrawal by Subject|2|||
160896739|NCT01393301|581016974|FG001|Overall Study|Withdrawal by Subject|0|||
160896740|NCT01393301|581016973|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
160896741|NCT01393301|581016974|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
160896742|NCT03342963|581016977|FG000|Overall Study|Adverse Event|1|||
160896743|NCT03342963|581016978|FG001|Overall Study|Adverse Event|2|||
160896744|NCT03342963|581016979|FG002|Overall Study|Adverse Event|0|||
160896745|NCT03342963|581016980|FG003|Overall Study|Adverse Event|0|||
160896746|NCT03342963|581016977|FG000|Overall Study|Withdrawal by Subject|1|||
160896747|NCT03342963|581016978|FG001|Overall Study|Withdrawal by Subject|0|||
160896748|NCT03342963|581016979|FG002|Overall Study|Withdrawal by Subject|0|||
160896749|NCT03342963|581016980|FG003|Overall Study|Withdrawal by Subject|0|||
160896750|NCT01309165|581016981|FG000|Overall Study|Lost to Follow-up|4|||
160800343|NCT01832727|580658264|FG004|Overall Study|Study terminated by sponsor|0|||
160800344|NCT01832727|580658265|FG005|Overall Study|Study terminated by sponsor|0|||
160800345|NCT01832727|580658266|FG006|Overall Study|Study terminated by sponsor|0|||
160800346|NCT01832727|580658267|FG007|Overall Study|Study terminated by sponsor|1|||
160800347|NCT01832727|580658268|FG008|Overall Study|Study terminated by sponsor|1|||
160800348|NCT02170064|580658269|FG000|Overall Study|Withdrawal by Subject|5|||
160800349|NCT02170064|580658270|FG001|Overall Study|Withdrawal by Subject|1|||
160800350|NCT02170064|580658271|FG002|Overall Study|Withdrawal by Subject|1|||
160800351|NCT02170064|580658269|FG000|Overall Study|Physician Decision|1|||
160800352|NCT02170064|580658270|FG001|Overall Study|Physician Decision|1|||
160800353|NCT02170064|580658271|FG002|Overall Study|Physician Decision|0|||
160800354|NCT04211363|580658272|FG000|Overall Study|Adverse Event|5|||
160800355|NCT04211363|580658273|FG001|Overall Study|Adverse Event|2|||
160800356|NCT04211363|580658272|FG000|Overall Study|Physician Decision|0|||
160800357|NCT04211363|580658273|FG001|Overall Study|Physician Decision|1|||
160800358|NCT04211363|580658272|FG000|Overall Study|Protocol Violation|1|||
160800359|NCT04211363|580658273|FG001|Overall Study|Protocol Violation|0|||
160800360|NCT04211363|580658272|FG000|Overall Study|Pregnancy|1|||
160800361|NCT04211363|580658273|FG001|Overall Study|Pregnancy|0|||
160800362|NCT04211363|580658272|FG000|Overall Study|Lost to Follow-up|12|||
160800363|NCT04211363|580658273|FG001|Overall Study|Lost to Follow-up|4|||
160800364|NCT04211363|580658272|FG000|Overall Study|Withdrawal by Subject|11|||
160800365|NCT04211363|580658273|FG001|Overall Study|Withdrawal by Subject|11|||
160800366|NCT04211363|580658272|FG000|Overall Study|Other|1|||
160800367|NCT04211363|580658273|FG001|Overall Study|Other|2|||
160800368|NCT00461708|580658274|FG000|Overall Study|Adverse Event|17|||
160800369|NCT00461708|580658275|FG001|Overall Study|Adverse Event|7|||
160800370|NCT00461708|580658274|FG000|Overall Study|Lack of Efficacy|68|||
160800371|NCT00461708|580658275|FG001|Overall Study|Lack of Efficacy|20|||
160800372|NCT00461708|580658274|FG000|Overall Study|Physician Decision|10|||
160800373|NCT00461708|580658275|FG001|Overall Study|Physician Decision|4|||
160800374|NCT00461708|580658274|FG000|Overall Study|Withdrawal by Subject|8|||
160800375|NCT00461708|580658275|FG001|Overall Study|Withdrawal by Subject|2|||
160800376|NCT00461708|580658274|FG000|Overall Study|Other|4|||
160800377|NCT00461708|580658275|FG001|Overall Study|Other|4|||
160800378|NCT00461708|580658274|FG000|Overall Study|Death|8|||
160800379|NCT00461708|580658275|FG001|Overall Study|Death|1|||
160800380|NCT01812057|580658276|FG000|Overall Study|Protocol Violation|1|||
160800381|NCT01812057|580658277|FG001|Overall Study|Protocol Violation|0|||
160800382|NCT01812057|580658276|FG000|Overall Study|Physician Decision|1|||
160800383|NCT01812057|580658277|FG001|Overall Study|Physician Decision|0|||
160984813|NCT02028884|581333789|FG001|Open-label Extension Period|Adverse Event|1|||
160984814|NCT02028884|581333790|FG002|Open-label Extension Period|Adverse Event|0|||
160800384|NCT01736917|580658278|FG000|Overall Study|Adverse Event|1|||
160800385|NCT01736917|580658278|FG000|Overall Study|Protocol Violation|10|||
160800386|NCT02961244|580658281|FG000|Overall Study|Protocol Violation|0|||
160800387|NCT02961244|580658282|FG001|Overall Study|Protocol Violation|1|||
160800388|NCT02961244|580658281|FG000|Overall Study|Withdrawal by Subject|1|||
160800389|NCT02961244|580658282|FG001|Overall Study|Withdrawal by Subject|2|||
160800390|NCT02961244|580658281|FG000|Overall Study|Surgery plan change after study approval|0|||
160800391|NCT02961244|580658282|FG001|Overall Study|Surgery plan change after study approval|2|||
160800392|NCT02961244|580658281|FG000|Overall Study|Lost to Follow-up|0|||
160800393|NCT02961244|580658282|FG001|Overall Study|Lost to Follow-up|2|||
160800394|NCT02961244|580658281|FG000|Overall Study|İnadequate data|0|||
160800395|NCT02961244|580658282|FG001|Overall Study|İnadequate data|2|||
160800396|NCT01368614|580658283|FG000|Screening Period|Screen Failure|58|||
160800397|NCT01368614|580658284|FG001|Screening Period|Screen Failure|0|||
160800398|NCT01368614|580658285|FG002|Screening Period|Screen Failure|0|||
160800399|NCT01368614|580658286|FG003|Screening Period|Screen Failure|0|||
160800400|NCT01368614|580658283|FG000|Study Period|Withdrawal by Subject|0|||
160800401|NCT01368614|580658284|FG001|Study Period|Withdrawal by Subject|1|||
160800402|NCT01368614|580658285|FG002|Study Period|Withdrawal by Subject|1|||
160800403|NCT01368614|580658286|FG003|Study Period|Withdrawal by Subject|3|||
160800404|NCT01368614|580658283|FG000|Study Period|Lost to Follow-up|0|||
160800405|NCT01368614|580658284|FG001|Study Period|Lost to Follow-up|0|||
160800406|NCT01368614|580658285|FG002|Study Period|Lost to Follow-up|1|||
160800407|NCT01368614|580658286|FG003|Study Period|Lost to Follow-up|0|||
160800408|NCT00659425|580658295|FG000|Overall Study|Disease progression|1|||
160800409|NCT00659425|580658296|FG001|Overall Study|Disease progression|0|||
160800410|NCT00659425|580658297|FG002|Overall Study|Disease progression|0|||
160800411|NCT00659425|580658298|FG003|Overall Study|Disease progression|1|||
160800412|NCT00659425|580658299|FG004|Overall Study|Disease progression|0|||
160800413|NCT00659425|580658300|FG005|Overall Study|Disease progression|2|||
160800414|NCT00659425|580658301|FG006|Overall Study|Disease progression|4|||
160800415|NCT00659425|580658302|FG007|Overall Study|Disease progression|3|||
160800416|NCT00659425|580658303|FG008|Overall Study|Disease progression|5|||
160800417|NCT00659425|580658304|FG009|Overall Study|Disease progression|3|||
160800418|NCT00659425|580658295|FG000|Overall Study|Death|0|||
160984815|NCT02028884|581333788|FG000|Open-label Extension Period|Lack of Efficacy|3|||
160984816|NCT02028884|581333789|FG001|Open-label Extension Period|Lack of Efficacy|0|||
160984817|NCT02028884|581333790|FG002|Open-label Extension Period|Lack of Efficacy|0|||
160984818|NCT02028884|581333788|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
160984819|NCT02028884|581333789|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
160984820|NCT02028884|581333790|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
160984821|NCT02028884|581333788|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
160984822|NCT02028884|581333789|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
160984823|NCT02028884|581333790|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
160984824|NCT02028884|581333788|FG000|Open-label Extension Period|Switched to another treatment option|3|||
160984825|NCT02028884|581333789|FG001|Open-label Extension Period|Switched to another treatment option|0|||
160984826|NCT02028884|581333790|FG002|Open-label Extension Period|Switched to another treatment option|0|||
160984827|NCT02297503|581333793|FG000|Overall Study|Withdrawal by Subject|1|||
160984828|NCT02297503|581333794|FG001|Overall Study|Withdrawal by Subject|1|||
160984829|NCT02297503|581333793|FG000|Overall Study|Protocol Violation|1|||
160984830|NCT02297503|581333794|FG001|Overall Study|Protocol Violation|0|||
160800419|NCT00659425|580658296|FG001|Overall Study|Death|0|||
160800420|NCT00659425|580658297|FG002|Overall Study|Death|0|||
160800421|NCT00659425|580658298|FG003|Overall Study|Death|1|||
160800422|NCT00659425|580658299|FG004|Overall Study|Death|0|||
160800423|NCT00659425|580658300|FG005|Overall Study|Death|0|||
160800424|NCT00659425|580658301|FG006|Overall Study|Death|1|||
160800425|NCT00659425|580658302|FG007|Overall Study|Death|0|||
160800426|NCT00659425|580658303|FG008|Overall Study|Death|0|||
160800427|NCT00659425|580658304|FG009|Overall Study|Death|0|||
160800428|NCT00659425|580658295|FG000|Overall Study|Adverse Event|0|||
160800429|NCT00659425|580658296|FG001|Overall Study|Adverse Event|0|||
160800430|NCT00659425|580658297|FG002|Overall Study|Adverse Event|0|||
160800431|NCT00659425|580658298|FG003|Overall Study|Adverse Event|0|||
160800432|NCT00659425|580658299|FG004|Overall Study|Adverse Event|0|||
160800433|NCT00659425|580658300|FG005|Overall Study|Adverse Event|1|||
160800434|NCT00659425|580658301|FG006|Overall Study|Adverse Event|0|||
160800435|NCT00659425|580658302|FG007|Overall Study|Adverse Event|3|||
160800436|NCT00659425|580658303|FG008|Overall Study|Adverse Event|1|||
160800437|NCT00659425|580658304|FG009|Overall Study|Adverse Event|4|||
160800438|NCT00659425|580658295|FG000|Overall Study|Investigator Discretion|0|||
160800439|NCT00659425|580658296|FG001|Overall Study|Investigator Discretion|0|||
160800440|NCT00659425|580658297|FG002|Overall Study|Investigator Discretion|0|||
160800441|NCT00659425|580658298|FG003|Overall Study|Investigator Discretion|0|||
160800442|NCT00659425|580658299|FG004|Overall Study|Investigator Discretion|0|||
160800443|NCT00659425|580658300|FG005|Overall Study|Investigator Discretion|1|||
160800444|NCT00659425|580658301|FG006|Overall Study|Investigator Discretion|0|||
160800445|NCT00659425|580658302|FG007|Overall Study|Investigator Discretion|3|||
160800446|NCT00659425|580658303|FG008|Overall Study|Investigator Discretion|0|||
160800447|NCT00659425|580658304|FG009|Overall Study|Investigator Discretion|0|||
160800448|NCT00659425|580658295|FG000|Overall Study|Other|0|||
160800449|NCT00659425|580658296|FG001|Overall Study|Other|1|||
160800450|NCT00659425|580658297|FG002|Overall Study|Other|1|||
160984831|NCT02297503|581333793|FG000|Overall Study|Pregnancy|0|||
160984832|NCT02297503|581333794|FG001|Overall Study|Pregnancy|1|||
160984833|NCT02297503|581333793|FG000|Overall Study|Lost to Follow-up|0|||
160984834|NCT02297503|581333794|FG001|Overall Study|Lost to Follow-up|1|||
160800451|NCT00659425|580658298|FG003|Overall Study|Other|2|||
160800452|NCT00659425|580658299|FG004|Overall Study|Other|4|||
160800453|NCT00659425|580658300|FG005|Overall Study|Other|0|||
160800454|NCT00659425|580658301|FG006|Overall Study|Other|3|||
160800455|NCT00659425|580658302|FG007|Overall Study|Other|2|||
160800456|NCT00659425|580658303|FG008|Overall Study|Other|0|||
160800457|NCT00659425|580658304|FG009|Overall Study|Other|6|||
160800458|NCT00636181|580658308|FG000|Overall Study|Withdrawal by Subject|8|||
160800459|NCT00636181|580658309|FG001|Overall Study|Withdrawal by Subject|6|||
160800460|NCT00636181|580658310|FG002|Overall Study|Withdrawal by Subject|10|||
160984835|NCT02297503|581333793|FG000|Overall Study|Medical reason|0|||
160984836|NCT02297503|581333794|FG001|Overall Study|Medical reason|1|||
160984837|NCT00765362|581333795|FG000|Overall Study|Death|9|||
160800461|NCT02561962|580658312|FG000|Overall Study|Withdrawal by Subject|1|||
160800462|NCT02561962|580658313|FG001|Overall Study|Withdrawal by Subject|0|||
160800463|NCT02561962|580658314|FG002|Overall Study|Withdrawal by Subject|0|||
160800464|NCT02561962|580658315|FG003|Overall Study|Withdrawal by Subject|0|||
160984838|NCT00765362|581333795|FG000|Overall Study|Adverse Event|2|||
160800465|NCT02561962|580658316|FG004|Overall Study|Withdrawal by Subject|1|||
160800466|NCT02561962|580658317|FG005|Overall Study|Withdrawal by Subject|1|||
160800467|NCT02561962|580658318|FG006|Overall Study|Withdrawal by Subject|2|||
160800468|NCT02561962|580658319|FG007|Overall Study|Withdrawal by Subject|1|||
160800469|NCT02561962|580658320|FG008|Overall Study|Withdrawal by Subject|0|||
160984839|NCT00765362|581333795|FG000|Overall Study|Protocol Violation|18|||
160800470|NCT02561962|580658312|FG000|Overall Study|Decision by sponsor|0|||
160800471|NCT02561962|580658313|FG001|Overall Study|Decision by sponsor|0|||
160800472|NCT02561962|580658314|FG002|Overall Study|Decision by sponsor|0|||
160800473|NCT02561962|580658315|FG003|Overall Study|Decision by sponsor|0|||
160800474|NCT02561962|580658316|FG004|Overall Study|Decision by sponsor|1|||
160800475|NCT02561962|580658317|FG005|Overall Study|Decision by sponsor|1|||
160800476|NCT02561962|580658318|FG006|Overall Study|Decision by sponsor|0|||
160800477|NCT02561962|580658319|FG007|Overall Study|Decision by sponsor|3|||
160800478|NCT02561962|580658320|FG008|Overall Study|Decision by sponsor|0|||
160800479|NCT02561962|580658312|FG000|Overall Study|Lost to Follow-up|0|||
160800480|NCT02561962|580658313|FG001|Overall Study|Lost to Follow-up|0|||
160800481|NCT02561962|580658314|FG002|Overall Study|Lost to Follow-up|0|||
160800482|NCT02561962|580658315|FG003|Overall Study|Lost to Follow-up|0|||
160800483|NCT02561962|580658316|FG004|Overall Study|Lost to Follow-up|0|||
160800484|NCT02561962|580658317|FG005|Overall Study|Lost to Follow-up|1|||
160800485|NCT02561962|580658318|FG006|Overall Study|Lost to Follow-up|0|||
160800486|NCT02561962|580658319|FG007|Overall Study|Lost to Follow-up|0|||
160800487|NCT02561962|580658320|FG008|Overall Study|Lost to Follow-up|0|||
160800488|NCT03586973|580658321|FG000|Overall Study|Death|15|||
160800489|NCT03586973|580658322|FG001|Overall Study|Death|8|||
160800490|NCT03586973|580658321|FG000|Overall Study|Site Terminated by Sponsor|3|||
160800491|NCT03586973|580658322|FG001|Overall Study|Site Terminated by Sponsor|6|||
160800492|NCT03586973|580658321|FG000|Overall Study|Withdrawal by Subject|1|||
160800493|NCT03586973|580658322|FG001|Overall Study|Withdrawal by Subject|0|||
160800494|NCT03586973|580658321|FG000|Overall Study|Lost to Follow-up|1|||
160800495|NCT03586973|580658322|FG001|Overall Study|Lost to Follow-up|0|||
160800496|NCT00322049|580659911|FG000|Overall Study|Moved out of area|0|||
160800497|NCT00322049|580659912|FG001|Overall Study|Moved out of area|0|||
160800498|NCT00322049|580659913|FG002|Overall Study|Moved out of area|0|||
160800499|NCT00322049|580659914|FG003|Overall Study|Moved out of area|1|||
160800500|NCT00322049|580659911|FG000|Overall Study|Infected with Dengue during study|0|||
160800501|NCT00322049|580659912|FG001|Overall Study|Infected with Dengue during study|1|||
160800502|NCT00322049|580659913|FG002|Overall Study|Infected with Dengue during study|0|||
160800503|NCT00322049|580659914|FG003|Overall Study|Infected with Dengue during study|0|||
160800504|NCT01770743|580659915|FG000|Overall Study|Adverse Event|1|||
160800505|NCT01770743|580659916|FG001|Overall Study|Adverse Event|0|||
160800506|NCT01770743|580659917|FG002|Overall Study|Adverse Event|0|||
160800507|NCT01770743|580659918|FG003|Overall Study|Adverse Event|0|||
160800508|NCT01770743|580659919|FG004|Overall Study|Adverse Event|0|||
160800509|NCT01770743|580659915|FG000|Overall Study|Withdrawal by Subject|0|||
160800510|NCT01770743|580659916|FG001|Overall Study|Withdrawal by Subject|0|||
160800511|NCT01770743|580659917|FG002|Overall Study|Withdrawal by Subject|1|||
160800512|NCT01770743|580659918|FG003|Overall Study|Withdrawal by Subject|1|||
160800513|NCT01770743|580659919|FG004|Overall Study|Withdrawal by Subject|1|||
160800514|NCT01770743|580659915|FG000|Overall Study|Lost to Follow-up|0|||
160800515|NCT01770743|580659916|FG001|Overall Study|Lost to Follow-up|2|||
160800516|NCT01770743|580659917|FG002|Overall Study|Lost to Follow-up|0|||
160800517|NCT01770743|580659918|FG003|Overall Study|Lost to Follow-up|0|||
160800518|NCT01770743|580659919|FG004|Overall Study|Lost to Follow-up|1|||
160800519|NCT01770743|580659915|FG000|Overall Study|Sponsor Terminated Subject|1|||
160800520|NCT01770743|580659916|FG001|Overall Study|Sponsor Terminated Subject|0|||
160800521|NCT01770743|580659917|FG002|Overall Study|Sponsor Terminated Subject|0|||
160800522|NCT01770743|580659918|FG003|Overall Study|Sponsor Terminated Subject|1|||
160800523|NCT01770743|580659919|FG004|Overall Study|Sponsor Terminated Subject|0|||
160800524|NCT01770743|580659915|FG000|Overall Study|Moving Out of State|0|||
160800525|NCT01770743|580659916|FG001|Overall Study|Moving Out of State|1|||
160800526|NCT01770743|580659917|FG002|Overall Study|Moving Out of State|0|||
160800527|NCT01770743|580659918|FG003|Overall Study|Moving Out of State|0|||
160800528|NCT01770743|580659919|FG004|Overall Study|Moving Out of State|0|||
160800529|NCT00755807|580659922|FG000|Acute Phase|Adverse Event|16|||
160800530|NCT00755807|580659923|FG001|Acute Phase|Adverse Event|5|||
160800531|NCT00755807|580659922|FG000|Acute Phase|Protocol Violation|1|||
160800532|NCT00755807|580659923|FG001|Acute Phase|Protocol Violation|3|||
160800533|NCT00755807|580659922|FG000|Acute Phase|Withdrawal by Subject|1|||
160800534|NCT00755807|580659923|FG001|Acute Phase|Withdrawal by Subject|2|||
160800535|NCT00755807|580659922|FG000|Acute Phase|Lack of Efficacy|0|||
160800536|NCT00755807|580659923|FG001|Acute Phase|Lack of Efficacy|1|||
160800537|NCT00755807|580659922|FG000|Acute Phase|Physician Decision|0|||
160800538|NCT00755807|580659923|FG001|Acute Phase|Physician Decision|1|||
160800539|NCT00755807|580659922|FG000|Open-label Extension Phase|Adverse Event|7|||
160800540|NCT00755807|580659923|FG001|Open-label Extension Phase|Adverse Event|7|||
160800541|NCT00755807|580659922|FG000|Open-label Extension Phase|Protocol Violation|5|||
160800542|NCT00755807|580659923|FG001|Open-label Extension Phase|Protocol Violation|2|||
160800543|NCT00755807|580659922|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
160800544|NCT00755807|580659923|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
160896751|NCT01309165|581016982|FG001|Overall Study|Lost to Follow-up|3|||
160896752|NCT01309165|581016981|FG000|Overall Study|Return to work|1|||
160896753|NCT01309165|581016982|FG001|Overall Study|Return to work|2|||
160896754|NCT01309165|581016981|FG000|Overall Study|Left country|0|||
160896755|NCT01309165|581016982|FG001|Overall Study|Left country|1|||
160800545|NCT00755807|580659922|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
160800546|NCT00755807|580659923|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
160800547|NCT00755807|580659922|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
160800548|NCT00755807|580659923|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
160800549|NCT00755807|580659922|FG000|Open-label Extension Phase|Sponsor Decision|0|||
160800550|NCT00755807|580659923|FG001|Open-label Extension Phase|Sponsor Decision|1|||
160800551|NCT00939107|580659926|FG000|Overall Study|Lost to Follow-up|14|||
160800552|NCT00939107|580659927|FG001|Overall Study|Lost to Follow-up|12|||
160800553|NCT01585025|580659934|FG000|Overall Study|Withdrawal by Subject|0|||
160800554|NCT01585025|580659935|FG001|Overall Study|Withdrawal by Subject|3|||
160800555|NCT01585025|580659936|FG002|Overall Study|Withdrawal by Subject|4|||
160800556|NCT00503984|580659937|FG000|Overall Study|Protocol Violation|0|||
160800557|NCT00503984|580659938|FG001|Overall Study|Protocol Violation|1|||
160800558|NCT00503984|580659939|FG002|Overall Study|Protocol Violation|0|||
160800559|NCT00503984|580659940|FG003|Overall Study|Protocol Violation|0|||
160800560|NCT00503984|580659941|FG004|Overall Study|Protocol Violation|0|||
160800561|NCT00503984|580659942|FG005|Overall Study|Protocol Violation|0|||
160800562|NCT00503984|580659937|FG000|Overall Study|Adverse Event|0|||
160800563|NCT00503984|580659938|FG001|Overall Study|Adverse Event|1|||
160800564|NCT00503984|580659939|FG002|Overall Study|Adverse Event|0|||
160800565|NCT00503984|580659940|FG003|Overall Study|Adverse Event|0|||
160800566|NCT00503984|580659941|FG004|Overall Study|Adverse Event|0|||
160800567|NCT00503984|580659942|FG005|Overall Study|Adverse Event|0|||
160800568|NCT00503984|580659937|FG000|Overall Study|Death|0|||
160800569|NCT00503984|580659938|FG001|Overall Study|Death|0|||
160800570|NCT00503984|580659939|FG002|Overall Study|Death|0|||
160800571|NCT00503984|580659940|FG003|Overall Study|Death|0|||
160800572|NCT00503984|580659941|FG004|Overall Study|Death|1|||
160800573|NCT00503984|580659942|FG005|Overall Study|Death|0|||
160800574|NCT02122380|580659945|FG000|First Intervention (30 Days)|Adverse Event|1|||
160800575|NCT02122380|580659946|FG001|First Intervention (30 Days)|Adverse Event|0|||
160800576|NCT02122380|580659945|FG000|First Intervention (30 Days)|Physician Decision|0|||
160984840|NCT00765362|581333795|FG000|Overall Study|Withdrawal by Subject|13|||
160800577|NCT02122380|580659946|FG001|First Intervention (30 Days)|Physician Decision|1|||
160800578|NCT02122380|580659945|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
160800579|NCT02122380|580659946|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
160800580|NCT02122380|580659945|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
160800581|NCT02122380|580659946|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
160800582|NCT02122380|580659945|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
160800583|NCT02122380|580659946|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
160800584|NCT00427011|580659947|FG000|Overall Study|Adverse Event|10|||
160800585|NCT00427011|580659947|FG000|Overall Study|Withdrawal by Subject|1|||
160800586|NCT00427011|580659947|FG000|Overall Study|Lack of Efficacy|2|||
160800587|NCT00427011|580659947|FG000|Overall Study|Other|12|||
160800588|NCT00952705|580659948|FG000|Overall Study|Lost to Follow-up|24|||
160800589|NCT00952705|580659949|FG001|Overall Study|Lost to Follow-up|8|||
160800590|NCT00952705|580659950|FG002|Overall Study|Lost to Follow-up|9|||
160800591|NCT00952705|580659948|FG000|Overall Study|Withdrawal by Subject|2|||
160800592|NCT00952705|580659949|FG001|Overall Study|Withdrawal by Subject|1|||
160800593|NCT00952705|580659950|FG002|Overall Study|Withdrawal by Subject|1|||
160800594|NCT00952705|580659948|FG000|Overall Study|Death|2|||
160800595|NCT00952705|580659949|FG001|Overall Study|Death|0|||
160800596|NCT00952705|580659950|FG002|Overall Study|Death|0|||
160800597|NCT00952705|580659948|FG000|Overall Study|Incarcerated post dose|5|||
160800598|NCT00952705|580659949|FG001|Overall Study|Incarcerated post dose|0|||
160800599|NCT00952705|580659950|FG002|Overall Study|Incarcerated post dose|0|||
160800600|NCT00952705|580659948|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
160800601|NCT00952705|580659949|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
160800602|NCT00952705|580659950|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
160800603|NCT00387088|580659951|FG000|Overall Study|Adverse Event|143|||
160800604|NCT00387088|580659952|FG001|Overall Study|Adverse Event|156|||
160800605|NCT00387088|580659951|FG000|Overall Study|Protocol Violation|47|||
160800606|NCT00387088|580659952|FG001|Overall Study|Protocol Violation|35|||
160800607|NCT00387088|580659951|FG000|Overall Study|Withdrawal by Subject|20|||
160800608|NCT00387088|580659952|FG001|Overall Study|Withdrawal by Subject|35|||
160800609|NCT00387088|580659951|FG000|Overall Study|Lack of Efficacy|28|||
160800610|NCT00387088|580659952|FG001|Overall Study|Lack of Efficacy|67|||
160800611|NCT00387088|580659951|FG000|Overall Study|Lost to Follow-up|22|||
160800612|NCT00387088|580659952|FG001|Overall Study|Lost to Follow-up|28|||
160800613|NCT00387088|580659951|FG000|Overall Study|Other|58|||
160800614|NCT00387088|580659952|FG001|Overall Study|Other|52|||
160800615|NCT04108273|580659953|FG000|Overall Study|COVID Pandemic|1|||
160800616|NCT04108273|580659954|FG001|Overall Study|COVID Pandemic|0|||
160984841|NCT00765362|581333795|FG000|Overall Study|Lost to Follow-up|95|||
160800617|NCT01541371|580659955|FG000|Overall Study|Withdrawal by Subject|14|||
160800618|NCT01541371|580659955|FG000|Overall Study|Lost to Follow-up|21|||
160800619|NCT01541371|580659955|FG000|Overall Study|Adverse Event|15|||
160800620|NCT01541371|580659955|FG000|Overall Study|Lack of Efficacy|12|||
160800621|NCT01541371|580659955|FG000|Overall Study|Protocol Violation|6|||
160800622|NCT01541371|580659955|FG000|Overall Study|Study medication non-compliance|3|||
160800623|NCT01541371|580659955|FG000|Overall Study|Other|6|||
160800624|NCT02441218|580659956|FG000|Overall Study|Death|503|||
160800625|NCT02441218|580659957|FG001|Overall Study|Death|553|||
160800626|NCT02441218|580659956|FG000|Overall Study|Withdrawal by Subject|73|||
160800627|NCT02441218|580659957|FG001|Overall Study|Withdrawal by Subject|58|||
160800628|NCT02441218|580659956|FG000|Overall Study|Lost to Follow-up|2|||
160800629|NCT02441218|580659957|FG001|Overall Study|Lost to Follow-up|1|||
160800630|NCT04460183|580659961|FG000|Overall Study|Lost to Follow-up|3|||
160800631|NCT04460183|580659962|FG001|Overall Study|Lost to Follow-up|1|||
160800632|NCT04460183|580659961|FG000|Overall Study|Withdrawal by Subject|1|||
160800633|NCT04460183|580659962|FG001|Overall Study|Withdrawal by Subject|0|||
160800634|NCT00856609|580659965|FG000|Overall Study|Adverse Event|1|||
160800635|NCT00856609|580659966|FG001|Overall Study|Adverse Event|0|||
160800636|NCT01788943|580659967|FG000|Overall Study|Withdrawal by Subject|1|||
160800637|NCT01788943|580659968|FG001|Overall Study|Withdrawal by Subject|0|||
160800638|NCT00186628|580659969|FG000|Overall Study|Death|2|||
160800639|NCT00186628|580659969|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
160800640|NCT00945659|580659973|FG000|Overall Study|Lost to Follow-up|7|||
160800641|NCT00945659|580659974|FG001|Overall Study|Lost to Follow-up|20|||
160800642|NCT00945659|580659975|FG002|Overall Study|Lost to Follow-up|17|||
160800643|NCT00658541|580659976|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
160800644|NCT00658541|580659977|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
160800645|NCT00658541|580659976|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
160800646|NCT00658541|580659977|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
160800647|NCT04828707|580659978|FG000|Overall Study|Lost to Follow-up|3|||
160800648|NCT04828707|580659979|FG001|Overall Study|Lost to Follow-up|2|||
160800649|NCT04828707|580659978|FG000|Overall Study|Withdrawal by Subject|2|||
160800650|NCT04828707|580659979|FG001|Overall Study|Withdrawal by Subject|1|||
160800651|NCT01570387|580659986|FG000|Overall Study|Adverse Event|1|||
160800652|NCT01570387|580659987|FG001|Overall Study|Adverse Event|0|||
160800653|NCT01570387|580659988|FG002|Overall Study|Adverse Event|0|||
160800654|NCT01570387|580659989|FG003|Overall Study|Adverse Event|0|||
160800655|NCT01570387|580659986|FG000|Overall Study|Death|0|||
160800656|NCT01570387|580659987|FG001|Overall Study|Death|0|||
160800657|NCT01570387|580659988|FG002|Overall Study|Death|0|||
160800658|NCT01570387|580659989|FG003|Overall Study|Death|1|||
160800659|NCT01570387|580659986|FG000|Overall Study|Withdrawal by Subject|0|||
160800660|NCT01570387|580659987|FG001|Overall Study|Withdrawal by Subject|0|||
160800661|NCT01570387|580659988|FG002|Overall Study|Withdrawal by Subject|0|||
160800662|NCT01570387|580659989|FG003|Overall Study|Withdrawal by Subject|1|||
160800663|NCT01876381|580659990|FG000|Overall Study|Lack of Efficacy|5|||
160800664|NCT01876381|580659990|FG000|Overall Study|Physician Decision|1|||
160800665|NCT01876381|580659990|FG000|Overall Study|Withdrawal by Subject|1|||
160800666|NCT03323164|580659998|FG000|Overall Study|Poor quality imaging/scans|2|||
160800667|NCT03323164|580659999|FG001|Overall Study|Poor quality imaging/scans|2|||
160800668|NCT02394561|580660002|FG000|CORE Phase|Adverse Event|7|||
160800669|NCT02394561|580660003|FG001|CORE Phase|Adverse Event|9|||
160800670|NCT02394561|580660002|FG000|CORE Phase|Death|0|||
160800671|NCT02394561|580660003|FG001|CORE Phase|Death|1|||
160800672|NCT02394561|580660002|FG000|CORE Phase|Pregnancy|1|||
160800673|NCT02394561|580660003|FG001|CORE Phase|Pregnancy|0|||
160800674|NCT02394561|580660002|FG000|CORE Phase|Lost to Follow-up|1|||
160800675|NCT02394561|580660003|FG001|CORE Phase|Lost to Follow-up|0|||
160800676|NCT02394561|580660002|FG000|CORE Phase|Physician Decision|1|||
160800677|NCT02394561|580660003|FG001|CORE Phase|Physician Decision|1|||
160800678|NCT02394561|580660002|FG000|CORE Phase|Withdrawal by Subject|2|||
160800679|NCT02394561|580660003|FG001|CORE Phase|Withdrawal by Subject|2|||
160800680|NCT02394561|580660002|FG000|CORE Phase|Lack of Efficacy|1|||
160800681|NCT02394561|580660003|FG001|CORE Phase|Lack of Efficacy|6|||
160800682|NCT02394561|580660002|FG000|Extension Phase|Adverse Event|6|||
160800683|NCT02394561|580660003|FG001|Extension Phase|Adverse Event|1|||
160800684|NCT02394561|580660002|FG000|Extension Phase|Death|0|||
160800685|NCT02394561|580660003|FG001|Extension Phase|Death|1|||
160800686|NCT02394561|580660002|FG000|Extension Phase|Protocol Violation|1|||
160800687|NCT02394561|580660003|FG001|Extension Phase|Protocol Violation|0|||
160800688|NCT02394561|580660002|FG000|Extension Phase|Lost to Follow-up|1|||
160800689|NCT02394561|580660003|FG001|Extension Phase|Lost to Follow-up|0|||
160800690|NCT02394561|580660002|FG000|Extension Phase|Physician Decision|0|||
160800691|NCT02394561|580660003|FG001|Extension Phase|Physician Decision|2|||
160800692|NCT02394561|580660002|FG000|Extension Phase|Withdrawal by Subject|0|||
160800693|NCT02394561|580660003|FG001|Extension Phase|Withdrawal by Subject|5|||
160800694|NCT02394561|580660002|FG000|Extension Phase|Lack of Efficacy|3|||
160800695|NCT02394561|580660003|FG001|Extension Phase|Lack of Efficacy|3|||
160800696|NCT00501644|580660004|FG000|Overall Study|Adverse Event|4|||
160800697|NCT00501644|580660004|FG000|Overall Study|Withdrawal by Subject|1|||
160800698|NCT02553629|580660005|FG000|Overall Study|Logistic reasons|3|||
160800699|NCT02553629|580660006|FG001|Overall Study|Logistic reasons|6|||
160644138|NCT00549198|580080677|FG001|Overall Study|Withdrawal by Subject|7|||
160644139|NCT00549198|580080676|FG000|Overall Study|Disease Progression|1|||
160644140|NCT00549198|580080677|FG001|Overall Study|Disease Progression|0|||
160644141|NCT00549198|580080676|FG000|Overall Study|Participant Moved|2|||
160644142|NCT00549198|580080677|FG001|Overall Study|Participant Moved|0|||
160644143|NCT00549198|580080676|FG000|Overall Study|Participant not able to perform Week 96|1|||
160644144|NCT00549198|580080677|FG001|Overall Study|Participant not able to perform Week 96|0|||
160644145|NCT00549198|580080676|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
160644146|NCT00549198|580080677|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
160644147|NCT00549198|580080676|FG000|Overall Study|Prohibited Medication|1|||
160644148|NCT00549198|580080677|FG001|Overall Study|Prohibited Medication|2|||
160644149|NCT00549198|580080676|FG000|Overall Study|Participant planning pregnancy|1|||
160644150|NCT00549198|580080677|FG001|Overall Study|Participant planning pregnancy|0|||
160644151|NCT00549198|580080676|FG000|Overall Study|Participant overweight, no scan possible|1|||
160644152|NCT00549198|580080677|FG001|Overall Study|Participant overweight, no scan possible|0|||
160644153|NCT00549198|580080676|FG000|Overall Study|No scan facilities|0|||
160644154|NCT00549198|580080677|FG001|Overall Study|No scan facilities|2|||
160644155|NCT00549198|580080676|FG000|Overall Study|Pregnancy|0|||
160644156|NCT00549198|580080677|FG001|Overall Study|Pregnancy|3|||
160644157|NCT00549198|580080676|FG000|Overall Study|Not Exposed to Study Drug|3|||
160644158|NCT00549198|580080677|FG001|Overall Study|Not Exposed to Study Drug|4|||
160644159|NCT03273387|580080679|FG000|Overall Study|Death|2|||
160644160|NCT03273387|580080680|FG001|Overall Study|Death|2|||
160644161|NCT03273387|580080679|FG000|Overall Study|Withdrawal by Subject|1|||
160644162|NCT03273387|580080680|FG001|Overall Study|Withdrawal by Subject|1|||
160644163|NCT01405950|580080681|FG000|Overall Study|Withdrawal by Subject|1|||
160644164|NCT01405950|580080682|FG001|Overall Study|Withdrawal by Subject|0|||
160644165|NCT01405950|580080683|FG002|Overall Study|Withdrawal by Subject|0|||
160644166|NCT01405950|580080684|FG003|Overall Study|Withdrawal by Subject|0|||
160644167|NCT01381900|580080685|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
160644168|NCT01381900|580080686|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
160644169|NCT01381900|580080687|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
160644170|NCT01381900|580080685|FG000|Overall Study|Adverse Event|4|||
160644171|NCT01381900|580080686|FG001|Overall Study|Adverse Event|6|||
160644172|NCT01381900|580080687|FG002|Overall Study|Adverse Event|7|||
160644173|NCT01381900|580080685|FG000|Overall Study|Noncompliance with study drug|0|||
160644174|NCT01381900|580080686|FG001|Overall Study|Noncompliance with study drug|0|||
160644175|NCT01381900|580080687|FG002|Overall Study|Noncompliance with study drug|1|||
160644176|NCT01381900|580080685|FG000|Overall Study|Physician Decision|0|||
160644177|NCT01381900|580080686|FG001|Overall Study|Physician Decision|1|||
160644178|NCT01381900|580080687|FG002|Overall Study|Physician Decision|1|||
160644179|NCT01381900|580080685|FG000|Overall Study|Protocol Violation|0|||
160644180|NCT01381900|580080686|FG001|Overall Study|Protocol Violation|1|||
160644181|NCT01381900|580080687|FG002|Overall Study|Protocol Violation|1|||
160644182|NCT01381900|580080685|FG000|Overall Study|Withdrawal by Subject|0|||
160644183|NCT01381900|580080686|FG001|Overall Study|Withdrawal by Subject|0|||
160644184|NCT01381900|580080687|FG002|Overall Study|Withdrawal by Subject|1|||
160644185|NCT01381900|580080685|FG000|Overall Study|Early withdraw|3|||
160644186|NCT01381900|580080686|FG001|Overall Study|Early withdraw|1|||
160644187|NCT01381900|580080687|FG002|Overall Study|Early withdraw|1|||
160644188|NCT01772368|580080689|FG000|Overall Study|Adverse Event|1|||
160644189|NCT01772368|580080689|FG000|Overall Study|Withdrawal by Subject|3|||
160644190|NCT01772368|580080689|FG000|Overall Study|Protocol Violation|2|||
160644191|NCT01772368|580080689|FG000|Overall Study|Other|1|||
160644192|NCT02668783|580080693|FG000|Overall Study|Pregnancy|0|||
160644193|NCT02668783|580080694|FG001|Overall Study|Pregnancy|1|||
160644194|NCT02668783|580080693|FG000|Overall Study|Protocol Violation|2|||
160644195|NCT02668783|580080694|FG001|Overall Study|Protocol Violation|1|||
160644196|NCT02668783|580080693|FG000|Overall Study|Study terminated by sponsor|9|||
160644197|NCT02668783|580080694|FG001|Overall Study|Study terminated by sponsor|10|||
160644198|NCT02668783|580080693|FG000|Overall Study|Subject moved|1|||
160644199|NCT02668783|580080694|FG001|Overall Study|Subject moved|0|||
160644200|NCT02668783|580080693|FG000|Overall Study|Withdrawal by Subject|1|||
160800700|NCT03434834|580660007|FG000|Overall Study|unable to swallow OCT probe|16|||
160800701|NCT01823289|580660008|FG000|Overall Study|Lost to Follow-up|5|||
160800702|NCT01823289|580660008|FG000|Overall Study|Adverse Event|5|||
160644201|NCT02668783|580080694|FG001|Overall Study|Withdrawal by Subject|0|||
160644202|NCT00112489|580080695|FG000|Overall Study|Refused further treatment|8|||
160644203|NCT00112489|580080695|FG000|Overall Study|Adverse Event|12|||
160644204|NCT00112489|580080695|FG000|Overall Study|Death|2|||
160644205|NCT00112489|580080695|FG000|Overall Study|Other, Not Specified|9|||
160644206|NCT00112489|580080695|FG000|Overall Study|Patient never treated|2|||
160644207|NCT00112489|580080695|FG000|Overall Study|Ineligible|7|||
160644208|NCT02891200|580080700|FG000|Overall Study|Lost to Follow-up|31|||
160644209|NCT02891200|580080701|FG001|Overall Study|Lost to Follow-up|36|||
160644210|NCT02891200|580080700|FG000|Overall Study|Death|10|||
160644211|NCT02891200|580080701|FG001|Overall Study|Death|9|||
160644212|NCT02891200|580080700|FG000|Overall Study|Withdrawal by Subject|1|||
160644213|NCT02891200|580080701|FG001|Overall Study|Withdrawal by Subject|4|||
160896756|NCT01309165|581016981|FG000|Overall Study|No transportation|0|||
160896757|NCT01309165|581016982|FG001|Overall Study|No transportation|1|||
160896758|NCT01309165|581016981|FG000|Overall Study|Admitted to hospital for second stroke|1|||
160896759|NCT01309165|581016982|FG001|Overall Study|Admitted to hospital for second stroke|0|||
160896760|NCT00437320|581016983|FG000|Overall Study|Participant request|2|||
160896761|NCT00437320|581016984|FG001|Overall Study|Participant request|1|||
160896762|NCT00437320|581016985|FG002|Overall Study|Participant request|4|||
160896763|NCT01950169|581016986|FG000|Overall Study|Withdrawal by Subject|2|||
160896764|NCT01950169|581016987|FG001|Overall Study|Withdrawal by Subject|8|||
160896765|NCT01950169|581016988|FG002|Overall Study|Withdrawal by Subject|1|||
160896766|NCT01950169|581016986|FG000|Overall Study|Death|1|||
160896767|NCT01950169|581016987|FG001|Overall Study|Death|0|||
160896768|NCT01950169|581016988|FG002|Overall Study|Death|0|||
160896769|NCT01938573|581016989|FG000|Overall Study|Lack of Efficacy|1|||
160896770|NCT01938573|581016990|FG001|Overall Study|Lack of Efficacy|0|||
160896771|NCT01938573|581016989|FG000|Overall Study|Operation at other hospital|1|||
160896772|NCT01938573|581016990|FG001|Overall Study|Operation at other hospital|0|||
160896773|NCT00737438|581016991|FG000|Overall Study|Withdrawal by Subject|2|||
160896774|NCT00737438|581016991|FG000|Overall Study|Patient ineligible|1|||
160896775|NCT02410551|581016992|FG000|Overall Study|Adverse Event|1|||
160896776|NCT02410551|581016992|FG000|Overall Study|Withdrawal by Subject|1|||
160896777|NCT02410551|581016992|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
160896778|NCT01739309|581016993|FG000|Overall Study|Adverse Event|1|||
160896779|NCT01739309|581016993|FG000|Overall Study|Withdrawal by Subject|1|||
160896780|NCT05447897|581016994|FG000|Overall Study|Did not participate in survey|2|||
160896781|NCT00178633|581016995|FG000|Overall Study|Lost to Follow-up|6|||
160896782|NCT04810481|581016997|FG000|Overall Study|Disqualified data sets|10|||
160896783|NCT04810481|581016998|FG001|Overall Study|Disqualified data sets|28|||
160896784|NCT01484132|581017004|FG000|Overall Study|Lost to Follow-up|8|||
160896785|NCT01484132|581017004|FG000|Overall Study|Difficulty with time commitment|2|||
160896786|NCT01484132|581017004|FG000|Overall Study|Ineligible|1|||
160896787|NCT01484132|581017004|FG000|Overall Study|No pre-treatment urine sample collected|1|||
160896788|NCT01484132|581017004|FG000|Overall Study|No post-treatment urine sample collected|10|||
160896789|NCT03643159|581017005|FG000|Overall Study|Adverse Event|1|||
160896790|NCT03643159|581017005|FG000|Overall Study|Withdrawal by Subject|1|||
160896791|NCT01631812|581017006|FG000|Overall Study|Adverse Event|25|||
160896792|NCT01631812|581017006|FG000|Overall Study|Lack of Efficacy|5|||
160896793|NCT01631812|581017006|FG000|Overall Study|Withdrawal by Subject|4|||
160896794|NCT01631812|581017006|FG000|Overall Study|Physician Decision|3|||
160644214|NCT04480463|580080702|FG000|Overall Study|Death|0|||
160644215|NCT04480463|580080703|FG001|Overall Study|Death|1|||
160644216|NCT04480463|580080702|FG000|Overall Study|Adverse Event|6|||
160644217|NCT04480463|580080703|FG001|Overall Study|Adverse Event|8|||
160644218|NCT04480463|580080702|FG000|Overall Study|Lost to Follow-up|3|||
160644219|NCT04480463|580080703|FG001|Overall Study|Lost to Follow-up|2|||
160644220|NCT04480463|580080702|FG000|Overall Study|Physician Decision|2|||
160644221|NCT04480463|580080703|FG001|Overall Study|Physician Decision|5|||
160644222|NCT04480463|580080702|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
160644223|NCT04480463|580080703|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
160644224|NCT04480463|580080702|FG000|Overall Study|Protocol Violation|2|||
160644225|NCT04480463|580080703|FG001|Overall Study|Protocol Violation|1|||
160644226|NCT04480463|580080702|FG000|Overall Study|Withdrawal by Subject|6|||
160644227|NCT04480463|580080703|FG001|Overall Study|Withdrawal by Subject|7|||
160644228|NCT04480463|580080702|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
160644229|NCT04480463|580080703|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
160644230|NCT04480463|580080702|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
160644231|NCT04480463|580080703|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
160644232|NCT04480463|580080702|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
160644233|NCT04480463|580080703|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
160644234|NCT04480463|580080702|FG000|Overall Study|Other|6|||
160644235|NCT04480463|580080703|FG001|Overall Study|Other|4|||
160644236|NCT02231710|580080704|FG000|Overall Study|Physician Decision|1|||
160896795|NCT02718300|581017007|FG000|Overall Study|Death|4|||
160896796|NCT02718300|581017008|FG001|Overall Study|Death|5|||
160896797|NCT02718300|581017009|FG002|Overall Study|Death|17|||
160896798|NCT02718300|581017007|FG000|Overall Study|Lost to Follow-up|1|||
160896799|NCT02718300|581017008|FG001|Overall Study|Lost to Follow-up|0|||
160896800|NCT02718300|581017009|FG002|Overall Study|Lost to Follow-up|2|||
160896801|NCT02718300|581017007|FG000|Overall Study|Physician Decision|1|||
160896802|NCT02718300|581017008|FG001|Overall Study|Physician Decision|0|||
160896803|NCT02718300|581017009|FG002|Overall Study|Physician Decision|2|||
160800703|NCT01823289|580660008|FG000|Overall Study|Lack of Efficacy|1|||
160800704|NCT01823289|580660008|FG000|Overall Study|Physician Decision|9|||
160800705|NCT01823289|580660008|FG000|Overall Study|Administered contraindicated medicine|1|||
160800706|NCT01823289|580660008|FG000|Overall Study|Transaminase increased more than 3 times|1|||
160800707|NCT01823289|580660008|FG000|Overall Study|Drug affected efficacy and safety|1|||
160800708|NCT01823289|580660008|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
160800709|NCT00654732|580660016|FG000|Overall Study|Adverse Event|4|||
160800710|NCT00654732|580660017|FG001|Overall Study|Adverse Event|6|||
160800711|NCT01133847|580660024|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
160800712|NCT01133847|580660025|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
160800713|NCT01133847|580660026|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
160800714|NCT01133847|580660024|FG000|Follow-Up Phase|Lost to Follow-up|1|||
160800715|NCT01133847|580660025|FG001|Follow-Up Phase|Lost to Follow-up|3|||
160800716|NCT01133847|580660026|FG002|Follow-Up Phase|Lost to Follow-up|7|||
160800717|NCT01880957|580660027|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
160800718|NCT01880957|580660028|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
160800719|NCT01880957|580660027|FG000|Overall Study|Lost to Follow-up|11|||
160800720|NCT01880957|580660028|FG001|Overall Study|Lost to Follow-up|0|||
160800721|NCT01880957|580660027|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
160800722|NCT01880957|580660028|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
160800723|NCT01378117|580660029|FG000|Overall Study|withdrawal|2|||
160800724|NCT01378117|580660030|FG001|Overall Study|withdrawal|1|||
160800725|NCT01378117|580660031|FG002|Overall Study|withdrawal|2|||
160800726|NCT01378117|580660029|FG000|Overall Study|discharged before med given|2|||
160800727|NCT01378117|580660030|FG001|Overall Study|discharged before med given|0|||
160800728|NCT01378117|580660031|FG002|Overall Study|discharged before med given|1|||
160800729|NCT01854528|580660032|FG000|Overall Study|Adverse Event|0|||
160800730|NCT01854528|580660033|FG001|Overall Study|Adverse Event|4|||
160800731|NCT01854528|580660032|FG000|Overall Study|Withdrawal by Subject|0|||
160800732|NCT01854528|580660033|FG001|Overall Study|Withdrawal by Subject|2|||
160800733|NCT01854528|580660032|FG000|Overall Study|Virologic Failure|0|||
160800734|NCT01854528|580660033|FG001|Overall Study|Virologic Failure|9|||
160800735|NCT01696643|580660034|FG000|Overall Study|Adverse Event|15|||
160800736|NCT01696643|580660035|FG001|Overall Study|Adverse Event|7|||
160800737|NCT01696643|580660034|FG000|Overall Study|Death|1|||
160800738|NCT01696643|580660035|FG001|Overall Study|Death|2|||
160800739|NCT01696643|580660034|FG000|Overall Study|Lack of Efficacy|3|||
160800740|NCT01696643|580660035|FG001|Overall Study|Lack of Efficacy|0|||
160800741|NCT01696643|580660034|FG000|Overall Study|Lost to Follow-up|67|||
160800742|NCT01696643|580660035|FG001|Overall Study|Lost to Follow-up|67|||
160800743|NCT01696643|580660034|FG000|Overall Study|Physician Decision|3|||
160896804|NCT02718300|581017007|FG000|Overall Study|Study Terminated by Sponsor|6|||
160896805|NCT02718300|581017008|FG001|Overall Study|Study Terminated by Sponsor|3|||
160896806|NCT02718300|581017009|FG002|Overall Study|Study Terminated by Sponsor|4|||
160896807|NCT02718300|581017007|FG000|Overall Study|Withdrawal by Subject|0|||
160896808|NCT02718300|581017008|FG001|Overall Study|Withdrawal by Subject|4|||
160896809|NCT02718300|581017009|FG002|Overall Study|Withdrawal by Subject|3|||
160896810|NCT02718300|581017007|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
160896811|NCT02718300|581017008|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
160896812|NCT02718300|581017009|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
160896813|NCT00257608|581018679|FG000|Chemotherapy Phase|Adverse Event|138|||
160896814|NCT00257608|581018680|FG001|Chemotherapy Phase|Adverse Event|0|||
160896815|NCT00257608|581018681|FG002|Chemotherapy Phase|Adverse Event|0|||
160896816|NCT00257608|581018679|FG000|Chemotherapy Phase|Disease progression|139|||
160896817|NCT00257608|581018680|FG001|Chemotherapy Phase|Disease progression|0|||
160896818|NCT00257608|581018681|FG002|Chemotherapy Phase|Disease progression|0|||
160896819|NCT00257608|581018679|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
160896820|NCT00257608|581018680|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
160896821|NCT00257608|581018681|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
160896822|NCT00257608|581018679|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
160550007|NCT03529773|579740186|FG034|Overall Study|Lost to Follow-up|1|||
160800744|NCT01696643|580660035|FG001|Overall Study|Physician Decision|2|||
160800745|NCT01696643|580660034|FG000|Overall Study|Pregnancy|0|||
160800746|NCT01696643|580660035|FG001|Overall Study|Pregnancy|1|||
160800747|NCT01696643|580660034|FG000|Overall Study|Protocol Violation|7|||
160800748|NCT01696643|580660035|FG001|Overall Study|Protocol Violation|7|||
160800749|NCT01696643|580660034|FG000|Overall Study|Study Terminated by Sponsor|286|||
160896823|NCT00257608|581018680|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
160896824|NCT00257608|581018681|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
160896825|NCT00257608|581018679|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
160550008|NCT03529773|579740187|FG035|Overall Study|Lost to Follow-up|0|||
160550009|NCT03529773|579740188|FG036|Overall Study|Lost to Follow-up|0|||
160800750|NCT01696643|580660035|FG001|Overall Study|Study Terminated by Sponsor|294|||
160800751|NCT01696643|580660034|FG000|Overall Study|Withdrawal by Subject|142|||
160800752|NCT01696643|580660035|FG001|Overall Study|Withdrawal by Subject|149|||
160800753|NCT01696643|580660034|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
160800754|NCT01696643|580660035|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
160800755|NCT01696643|580660034|FG000|Overall Study|Site Error|2|||
160800756|NCT01696643|580660035|FG001|Overall Study|Site Error|1|||
160800757|NCT01696643|580660034|FG000|Overall Study|Participant Incarcerated|0|||
160800758|NCT01696643|580660035|FG001|Overall Study|Participant Incarcerated|1|||
160800759|NCT01696643|580660034|FG000|Overall Study|Medical Monitor Decision|0|||
160800760|NCT01696643|580660035|FG001|Overall Study|Medical Monitor Decision|2|||
160800761|NCT01696643|580660034|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
160800762|NCT01696643|580660035|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
160800763|NCT00518180|580660039|FG000|Overall Study|Withdrawal by Subject|29|||
160800764|NCT00518180|580660040|FG001|Overall Study|Withdrawal by Subject|30|||
160800765|NCT00518180|580660041|FG002|Overall Study|Withdrawal by Subject|42|||
160800766|NCT00518180|580660039|FG000|Overall Study|Lost to Follow-up|30|||
160800767|NCT00518180|580660040|FG001|Overall Study|Lost to Follow-up|28|||
160800768|NCT00518180|580660041|FG002|Overall Study|Lost to Follow-up|34|||
160800769|NCT00518180|580660039|FG000|Overall Study|Administrative reason|0|||
160800770|NCT00518180|580660040|FG001|Overall Study|Administrative reason|2|||
160800771|NCT00518180|580660041|FG002|Overall Study|Administrative reason|2|||
160800772|NCT00518180|580660039|FG000|Overall Study|Protocol Violation|5|||
160800773|NCT00518180|580660040|FG001|Overall Study|Protocol Violation|7|||
160800774|NCT00518180|580660041|FG002|Overall Study|Protocol Violation|4|||
160800775|NCT00518180|580660039|FG000|Overall Study|Unable to classify|0|||
160800776|NCT00518180|580660040|FG001|Overall Study|Unable to classify|2|||
160800777|NCT00518180|580660041|FG002|Overall Study|Unable to classify|0|||
160800778|NCT00518180|580660039|FG000|Overall Study|Adverse Event|1|||
160800779|NCT00518180|580660040|FG001|Overall Study|Adverse Event|0|||
160800780|NCT00518180|580660041|FG002|Overall Study|Adverse Event|0|||
160800781|NCT02951780|580660042|FG000|Period 1|Adverse Event|0|||
160800782|NCT02951780|580660043|FG001|Period 1|Adverse Event|0|||
160800783|NCT02951780|580660044|FG002|Period 1|Adverse Event|0|||
160800784|NCT02951780|580660045|FG003|Period 1|Adverse Event|1|||
160800785|NCT02951780|580660046|FG004|Period 1|Adverse Event|0|||
160800786|NCT02951780|580660047|FG005|Period 1|Adverse Event|0|||
160800787|NCT02951780|580660048|FG006|Period 1|Adverse Event|0|||
160800788|NCT02951780|580660049|FG007|Period 1|Adverse Event|0|||
160984842|NCT00519779|581333798|FG000|Overall Study|Withdrawal by Subject|0|||
160800789|NCT02951780|580660050|FG008|Period 1|Adverse Event|0|||
160800790|NCT02951780|580660042|FG000|Period 1|Scheduling Conflicts|0|||
160800791|NCT02951780|580660043|FG001|Period 1|Scheduling Conflicts|0|||
160800792|NCT02951780|580660044|FG002|Period 1|Scheduling Conflicts|0|||
160800793|NCT02951780|580660045|FG003|Period 1|Scheduling Conflicts|0|||
160800794|NCT02951780|580660046|FG004|Period 1|Scheduling Conflicts|0|||
160800795|NCT02951780|580660047|FG005|Period 1|Scheduling Conflicts|0|||
160800796|NCT02951780|580660048|FG006|Period 1|Scheduling Conflicts|0|||
160800797|NCT02951780|580660049|FG007|Period 1|Scheduling Conflicts|1|||
160800798|NCT02951780|580660050|FG008|Period 1|Scheduling Conflicts|0|||
160800799|NCT02951780|580660042|FG000|Period 2|Scheduling Conflicts|0|||
160800800|NCT02951780|580660043|FG001|Period 2|Scheduling Conflicts|0|||
160800801|NCT02951780|580660044|FG002|Period 2|Scheduling Conflicts|0|||
160800802|NCT02951780|580660045|FG003|Period 2|Scheduling Conflicts|0|||
160800803|NCT02951780|580660046|FG004|Period 2|Scheduling Conflicts|0|||
160800804|NCT02951780|580660047|FG005|Period 2|Scheduling Conflicts|0|||
160800805|NCT02951780|580660048|FG006|Period 2|Scheduling Conflicts|0|||
160800806|NCT02951780|580660049|FG007|Period 2|Scheduling Conflicts|1|||
160800807|NCT02951780|580660050|FG008|Period 2|Scheduling Conflicts|0|||
160800808|NCT00508482|580660051|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
160800809|NCT00508482|580660052|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
160800810|NCT00508482|580660053|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
160800811|NCT00508482|580660051|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
160800812|NCT00508482|580660052|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
160800813|NCT00508482|580660053|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
160800814|NCT00508482|580660051|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
160800815|NCT00508482|580660052|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
160800816|NCT00508482|580660053|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
160800817|NCT00244621|580660054|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
160800818|NCT00244621|580660055|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
160800819|NCT00244621|580660056|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
160800820|NCT00244621|580660054|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
160800821|NCT00244621|580660055|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
160800822|NCT00244621|580660056|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160800823|NCT00244621|580660054|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
160800824|NCT00244621|580660055|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
160800825|NCT00244621|580660056|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
160800826|NCT00244621|580660054|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
160800827|NCT00244621|580660055|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
160800828|NCT00244621|580660056|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
160800829|NCT00244621|580660054|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
160800830|NCT00244621|580660055|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
160800831|NCT00244621|580660056|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
160800832|NCT00244621|580660054|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
160800833|NCT00244621|580660055|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
160800834|NCT00244621|580660056|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
160800835|NCT00244621|580660054|FG000|Open-label Treatment Period|Adverse Event|0|||
160800836|NCT00244621|580660055|FG001|Open-label Treatment Period|Adverse Event|0|||
160800837|NCT00244621|580660056|FG002|Open-label Treatment Period|Adverse Event|1|||
160800838|NCT00244621|580660054|FG000|Open-label Treatment Period|Moved abroad|0|||
160800839|NCT00244621|580660055|FG001|Open-label Treatment Period|Moved abroad|0|||
160800840|NCT00244621|580660056|FG002|Open-label Treatment Period|Moved abroad|1|||
160800841|NCT01193101|580660057|FG000|Overall Study|Adverse Event|0|||
160800842|NCT01193101|580660058|FG001|Overall Study|Adverse Event|1|||
160800843|NCT01193101|580660059|FG002|Overall Study|Adverse Event|1|||
160800844|NCT01193101|580660060|FG003|Overall Study|Adverse Event|3|||
160800845|NCT01193101|580660057|FG000|Overall Study|Lack of Efficacy|3|||
160800846|NCT01193101|580660058|FG001|Overall Study|Lack of Efficacy|1|||
160800847|NCT01193101|580660059|FG002|Overall Study|Lack of Efficacy|0|||
160800848|NCT01193101|580660060|FG003|Overall Study|Lack of Efficacy|8|||
160800849|NCT01193101|580660057|FG000|Overall Study|Withdrawal by Subject|2|||
160800850|NCT01193101|580660058|FG001|Overall Study|Withdrawal by Subject|4|||
160800851|NCT01193101|580660059|FG002|Overall Study|Withdrawal by Subject|1|||
160800852|NCT01193101|580660060|FG003|Overall Study|Withdrawal by Subject|1|||
160800853|NCT01193101|580660057|FG000|Overall Study|Administrative problems|0|||
160800854|NCT01193101|580660058|FG001|Overall Study|Administrative problems|0|||
160800855|NCT01193101|580660059|FG002|Overall Study|Administrative problems|1|||
160800856|NCT01193101|580660060|FG003|Overall Study|Administrative problems|0|||
160800857|NCT01193101|580660057|FG000|Overall Study|Abnormal test procedure results|0|||
160800858|NCT01193101|580660058|FG001|Overall Study|Abnormal test procedure results|1|||
160800859|NCT01193101|580660059|FG002|Overall Study|Abnormal test procedure results|0|||
160800860|NCT01193101|580660060|FG003|Overall Study|Abnormal test procedure results|0|||
160800861|NCT02347085|580660061|FG000|Overall Study|Adverse Event|2|||
160800862|NCT02347085|580660061|FG000|Overall Study|Lack of Efficacy|1|||
160800863|NCT02347085|580660061|FG000|Overall Study|Withdrawal by Subject|4|||
160800864|NCT02347085|580660061|FG000|Overall Study|Lost to Follow-up|1|||
160800865|NCT02347085|580660061|FG000|Overall Study|Protocol Criteria|2|||
160800866|NCT01957865|580660062|FG000|Overall Study|Found HIV negative|0|||
160800867|NCT01957865|580660063|FG001|Overall Study|Found HIV negative|0|||
160800868|NCT01957865|580660064|FG002|Overall Study|Found HIV negative|1|||
160800869|NCT01957865|580660062|FG000|Overall Study|Lost to Follow-up|0|||
160800870|NCT01957865|580660063|FG001|Overall Study|Lost to Follow-up|2|||
160800871|NCT01957865|580660064|FG002|Overall Study|Lost to Follow-up|2|||
160800872|NCT00867035|580660066|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
160800873|NCT00867035|580660067|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
160800874|NCT00867035|580660066|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
160800875|NCT00867035|580660067|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
160800876|NCT00542178|580660068|FG000|Overall Study|did not complete year 4 follow-up|75|||
160800877|NCT00542178|580660069|FG001|Overall Study|did not complete year 4 follow-up|80|||
160800878|NCT00542178|580660070|FG002|Overall Study|did not complete year 4 follow-up|74|||
160800879|NCT00542178|580660071|FG003|Overall Study|did not complete year 4 follow-up|62|||
160800880|NCT00542178|580660072|FG004|Overall Study|did not complete year 4 follow-up|64|||
160800881|NCT00542178|580660073|FG005|Overall Study|did not complete year 4 follow-up|89|||
160800882|NCT00542178|580660074|FG006|Overall Study|did not complete year 4 follow-up|87|||
160800883|NCT00542178|580660075|FG007|Overall Study|did not complete year 4 follow-up|85|||
160800884|NCT02026011|580661233|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
160800885|NCT02026011|580661234|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
160800886|NCT02026011|580661233|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
160800887|NCT02026011|580661234|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
160800888|NCT02026011|580661233|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
160800889|NCT02026011|580661234|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
160800890|NCT02026011|580661233|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
160800891|NCT02026011|580661234|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
160800892|NCT05010070|580661235|FG000|Overall Study|Lost to Follow-up|1|||
160800893|NCT05010070|580661235|FG000|Overall Study|Withdrawal by Subject|1|||
160800894|NCT01669902|580661236|FG000|Overall Study|Adverse Event|11|||
160800895|NCT01669902|580661236|FG000|Overall Study|Lack of Efficacy|10|||
160800896|NCT01669902|580661236|FG000|Overall Study|Other|8|||
160800897|NCT00688467|580661245|FG000|Treatment Period 1|Adverse Event|2|||
160800898|NCT00688467|580661246|FG001|Treatment Period 1|Adverse Event|1|||
160800899|NCT00688467|580661245|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
160800900|NCT00688467|580661246|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
160800901|NCT00688467|580661245|FG000|Treatment Period 2|Protocol Violation|0|||
160800902|NCT00688467|580661246|FG001|Treatment Period 2|Protocol Violation|1|||
160800903|NCT00688467|580661245|FG000|Treatment Period 2|Adverse Event|0|||
160800904|NCT00688467|580661246|FG001|Treatment Period 2|Adverse Event|1|||
160800905|NCT02808897|580661247|FG000|Overall Study|Lost to Follow-up|9|||
160800906|NCT02808897|580661248|FG001|Overall Study|Lost to Follow-up|11|||
160800907|NCT00002766|580661249|FG000|Overall Study|Withdrawal by Subject|0|||
160800908|NCT00002766|580661250|FG001|Overall Study|Withdrawal by Subject|1|||
160800909|NCT00002766|580661249|FG000|Overall Study|Patient Not Treated|1|||
160800910|NCT00002766|580661250|FG001|Overall Study|Patient Not Treated|2|||
160800911|NCT00002766|580661249|FG000|Overall Study|Adverse Event|1|||
160800912|NCT00002766|580661250|FG001|Overall Study|Adverse Event|1|||
160800913|NCT00002766|580661249|FG000|Overall Study|Protocol Violation|1|||
160800914|NCT00002766|580661250|FG001|Overall Study|Protocol Violation|0|||
160800915|NCT03848416|580661270|FG000|Overall Study|Withdrawal by Subject|1|||
160800916|NCT03848416|580661271|FG001|Overall Study|Withdrawal by Subject|0|||
160800917|NCT03848416|580661272|FG002|Overall Study|Withdrawal by Subject|0|||
160800918|NCT03848416|580661270|FG000|Overall Study|Death|0|||
160800919|NCT03848416|580661271|FG001|Overall Study|Death|0|||
160800920|NCT03848416|580661272|FG002|Overall Study|Death|1|||
160800921|NCT01847092|580661278|FG000|Overall Study|Adverse Event|12|||
160800922|NCT01847092|580661279|FG001|Overall Study|Adverse Event|3|||
160800923|NCT01847092|580661278|FG000|Overall Study|Withdrawal by Subject|5|||
160800924|NCT01847092|580661279|FG001|Overall Study|Withdrawal by Subject|5|||
160800925|NCT01847092|580661278|FG000|Overall Study|Protocol Specified|8|||
160800926|NCT01847092|580661279|FG001|Overall Study|Protocol Specified|0|||
160800927|NCT01847092|580661278|FG000|Overall Study|Physician Decision|1|||
160800928|NCT01847092|580661279|FG001|Overall Study|Physician Decision|1|||
160800929|NCT01847092|580661278|FG000|Overall Study|Protocol Violation|0|||
160800930|NCT01847092|580661279|FG001|Overall Study|Protocol Violation|2|||
160800931|NCT03604497|580661281|FG000|Overall Study|Protocol Violation|52|||
160800932|NCT00811954|580661282|FG000|Overall Study|Death|10|||
160800933|NCT00811954|580661283|FG001|Overall Study|Death|6|||
160800934|NCT00811954|580661284|FG002|Overall Study|Death|13|||
160800935|NCT00811954|580661282|FG000|Overall Study|Lost to Follow-up|29|||
160800936|NCT00811954|580661283|FG001|Overall Study|Lost to Follow-up|23|||
160800937|NCT00811954|580661284|FG002|Overall Study|Lost to Follow-up|34|||
160800938|NCT00811954|580661282|FG000|Overall Study|Not able to get to clinic|28|||
160800939|NCT00811954|580661283|FG001|Overall Study|Not able to get to clinic|35|||
160800940|NCT00811954|580661284|FG002|Overall Study|Not able to get to clinic|30|||
160800941|NCT00811954|580661282|FG000|Overall Study|Not willing to adhere to requirements|12|||
160800942|NCT00811954|580661283|FG001|Overall Study|Not willing to adhere to requirements|2|||
160800943|NCT00811954|580661284|FG002|Overall Study|Not willing to adhere to requirements|16|||
160800944|NCT00811954|580661282|FG000|Overall Study|Withdraw consent prior study completion|4|||
160800945|NCT00811954|580661283|FG001|Overall Study|Withdraw consent prior study completion|6|||
160800946|NCT00811954|580661284|FG002|Overall Study|Withdraw consent prior study completion|5|||
160644237|NCT01339910|580080705|FG000|Overall Study|Withdrawal by Subject|1|||
160644238|NCT01339910|580080706|FG001|Overall Study|Withdrawal by Subject|0|||
160644239|NCT01339910|580080705|FG000|Overall Study|Physician Decision|1|||
160644240|NCT01339910|580080706|FG001|Overall Study|Physician Decision|0|||
160644241|NCT01339910|580080705|FG000|Overall Study|Disease relapse|1|||
160644242|NCT01339910|580080706|FG001|Overall Study|Disease relapse|4|||
160644243|NCT00673361|580080707|FG000|Overall Study|Screen Failure|2|||
160644244|NCT00124020|580080709|FG000|Overall Study|Death|67|||
160644245|NCT00124020|580080710|FG001|Overall Study|Death|71|||
160644246|NCT00124020|580080709|FG000|Overall Study|Withdrawal by Subject|13|||
160644247|NCT00124020|580080710|FG001|Overall Study|Withdrawal by Subject|11|||
160644248|NCT00124020|580080709|FG000|Overall Study|Lost to Follow-up|5|||
160644249|NCT00124020|580080710|FG001|Overall Study|Lost to Follow-up|8|||
160644250|NCT00124020|580080709|FG000|Overall Study|Other|1|||
160644251|NCT00124020|580080710|FG001|Overall Study|Other|1|||
160644252|NCT00124020|580080709|FG000|Overall Study|Transfer to another hospital|2|||
160644253|NCT00124020|580080710|FG001|Overall Study|Transfer to another hospital|0|||
160644254|NCT01799590|580080711|FG000|Overall Study|Adverse Event|13|||
160644255|NCT01799590|580080712|FG001|Overall Study|Adverse Event|7|||
160800947|NCT00811954|580661282|FG000|Overall Study|Site Closure|4|||
160644256|NCT01799590|580080713|FG002|Overall Study|Adverse Event|5|||
160644257|NCT01799590|580080711|FG000|Overall Study|Pregnancy|2|||
160644258|NCT01799590|580080712|FG001|Overall Study|Pregnancy|0|||
160800948|NCT00811954|580661283|FG001|Overall Study|Site Closure|0|||
160800949|NCT00811954|580661284|FG002|Overall Study|Site Closure|1|||
160800950|NCT00811954|580661282|FG000|Overall Study|Severe Debilitation|2|||
160800951|NCT00811954|580661283|FG001|Overall Study|Severe Debilitation|0|||
160800952|NCT00811954|580661284|FG002|Overall Study|Severe Debilitation|1|||
160800953|NCT00811954|580661282|FG000|Overall Study|Complete Protocol: No follow-up|0|||
160800954|NCT00811954|580661283|FG001|Overall Study|Complete Protocol: No follow-up|0|||
160800955|NCT00811954|580661284|FG002|Overall Study|Complete Protocol: No follow-up|1|||
160800956|NCT01016067|580661285|FG000|Overall Study|Lost to Follow-up|1|||
160800957|NCT01016067|580661286|FG001|Overall Study|Lost to Follow-up|2|||
160800958|NCT01016067|580661285|FG000|Overall Study|Physician Decision|1|||
160800959|NCT01016067|580661286|FG001|Overall Study|Physician Decision|1|||
160800960|NCT01016067|580661285|FG000|Overall Study|Withdrew due to Relocation|0|||
160800961|NCT01016067|580661286|FG001|Overall Study|Withdrew due to Relocation|1|||
160800962|NCT01664247|580661288|FG000|Overall Study|Adverse Event|5|||
160800963|NCT01664247|580661289|FG001|Overall Study|Adverse Event|3|||
160800964|NCT01664247|580661288|FG000|Overall Study|Protocol Violation|3|||
160800965|NCT01664247|580661289|FG001|Overall Study|Protocol Violation|5|||
160800966|NCT01664247|580661288|FG000|Overall Study|Withdrawal Criteria|1|||
160800967|NCT01664247|580661289|FG001|Overall Study|Withdrawal Criteria|4|||
160800968|NCT01664247|580661288|FG000|Overall Study|Unclassified|5|||
160800969|NCT01664247|580661289|FG001|Overall Study|Unclassified|29|||
160800970|NCT01000506|580661290|FG000|Overall Study|Adverse Event|6|||
160800971|NCT01000506|580661291|FG001|Overall Study|Adverse Event|5|||
160800972|NCT01000506|580661292|FG002|Overall Study|Adverse Event|8|||
160800973|NCT01000506|580661293|FG003|Overall Study|Adverse Event|9|||
160800974|NCT01000506|580661290|FG000|Overall Study|Lack of Efficacy|8|||
160800975|NCT01000506|580661291|FG001|Overall Study|Lack of Efficacy|6|||
160800976|NCT01000506|580661292|FG002|Overall Study|Lack of Efficacy|4|||
160800977|NCT01000506|580661293|FG003|Overall Study|Lack of Efficacy|4|||
160800978|NCT01000506|580661290|FG000|Overall Study|Protocol Violation|1|||
160800979|NCT01000506|580661291|FG001|Overall Study|Protocol Violation|1|||
160800980|NCT01000506|580661292|FG002|Overall Study|Protocol Violation|0|||
160800981|NCT01000506|580661293|FG003|Overall Study|Protocol Violation|0|||
160800982|NCT01000506|580661290|FG000|Overall Study|Lost to Follow-up|1|||
160800983|NCT01000506|580661291|FG001|Overall Study|Lost to Follow-up|1|||
160800984|NCT01000506|580661292|FG002|Overall Study|Lost to Follow-up|4|||
160800985|NCT01000506|580661293|FG003|Overall Study|Lost to Follow-up|0|||
160800986|NCT01000506|580661290|FG000|Overall Study|Physician Decision|1|||
160800987|NCT01000506|580661291|FG001|Overall Study|Physician Decision|3|||
160800988|NCT01000506|580661292|FG002|Overall Study|Physician Decision|3|||
160800989|NCT01000506|580661293|FG003|Overall Study|Physician Decision|3|||
160800990|NCT01000506|580661290|FG000|Overall Study|Withdrawal by Subject|11|||
160800991|NCT01000506|580661291|FG001|Overall Study|Withdrawal by Subject|8|||
160800992|NCT01000506|580661292|FG002|Overall Study|Withdrawal by Subject|2|||
160984843|NCT00519779|581333799|FG001|Overall Study|Withdrawal by Subject|1|||
160984844|NCT01123161|581333800|FG000|Overall Study|Lost to Follow-up|1|||
160984845|NCT01123161|581333801|FG001|Overall Study|Lost to Follow-up|0|||
160984846|NCT01123161|581333800|FG000|Overall Study|Withdrawal by Subject|1|||
160984847|NCT01123161|581333801|FG001|Overall Study|Withdrawal by Subject|0|||
160984848|NCT03566680|581333818|FG000|Overall Study|Pregnancy|1|||
160984849|NCT03566680|581333818|FG000|Overall Study|Lost to Follow-up|13|||
160984850|NCT03566680|581333818|FG000|Overall Study|Withdrawal by Subject|3|||
160984851|NCT02724020|581333820|FG000|Overall Study|Death|16|||
160984852|NCT02724020|581333821|FG001|Overall Study|Death|18|||
160800993|NCT01000506|580661293|FG003|Overall Study|Withdrawal by Subject|7|||
160800994|NCT03064074|580661294|FG000|Overall Study|Physician Decision|0|||
160984853|NCT02724020|581333822|FG002|Overall Study|Death|19|||
160984854|NCT02724020|581333820|FG000|Overall Study|Lost to Follow-up|0|||
160984855|NCT02724020|581333821|FG001|Overall Study|Lost to Follow-up|3|||
160984856|NCT02724020|581333822|FG002|Overall Study|Lost to Follow-up|0|||
160984857|NCT02724020|581333820|FG000|Overall Study|Site Terminated by Sponsor|15|||
160984858|NCT02724020|581333821|FG001|Overall Study|Site Terminated by Sponsor|8|||
160800995|NCT03064074|580661295|FG001|Overall Study|Physician Decision|0|||
160800996|NCT03064074|580661296|FG002|Overall Study|Physician Decision|0|||
160800997|NCT03064074|580661297|FG003|Overall Study|Physician Decision|1|||
160800998|NCT00269087|580661298|FG000|Overall Study|Adverse Event|20|||
160800999|NCT00269087|580661298|FG000|Overall Study|Withdrawal by Subject|1|||
160801000|NCT00269087|580661298|FG000|Overall Study|Exacerbation of COPD|13|||
160801001|NCT01188967|580661304|FG000|Overall Study|Withdrawal by Subject|1|||
160984859|NCT02724020|581333822|FG002|Overall Study|Site Terminated by Sponsor|8|||
160984860|NCT02724020|581333820|FG000|Overall Study|Withdrawal by Subject|1|||
160801002|NCT01188967|580661305|FG001|Overall Study|Withdrawal by Subject|1|||
160984861|NCT02724020|581333821|FG001|Overall Study|Withdrawal by Subject|3|||
160801003|NCT01188967|580661304|FG000|Overall Study|Physician Decision|1|||
160801004|NCT01188967|580661305|FG001|Overall Study|Physician Decision|1|||
160801005|NCT01188967|580661304|FG000|Overall Study|Lost to Follow-up|3|||
160801006|NCT01188967|580661305|FG001|Overall Study|Lost to Follow-up|2|||
160801007|NCT01448616|580661306|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
160801008|NCT01448616|580661307|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
160801009|NCT01448616|580661308|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
160801010|NCT01448616|580661309|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
160984862|NCT02724020|581333822|FG002|Overall Study|Withdrawal by Subject|5|||
160984863|NCT02179918|581333823|FG000|Overall Study|Death|0|||
160984864|NCT02179918|581333824|FG001|Overall Study|Death|0|||
160801011|NCT01448616|580661306|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
160801012|NCT01448616|580661307|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
160801013|NCT01448616|580661308|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
160801014|NCT01448616|580661309|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
160801015|NCT01448616|580661306|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
160801016|NCT01448616|580661307|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
160801017|NCT01448616|580661308|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
160801018|NCT01448616|580661309|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
160801019|NCT01448616|580661306|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
160801020|NCT01448616|580661307|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
160984865|NCT02179918|581333825|FG002|Overall Study|Death|0|||
160984866|NCT02179918|581333826|FG003|Overall Study|Death|1|||
160984867|NCT02179918|581333827|FG004|Overall Study|Death|0|||
160984868|NCT02179918|581333823|FG000|Overall Study|Lost to Follow-up|0|||
160984869|NCT02179918|581333824|FG001|Overall Study|Lost to Follow-up|0|||
160984870|NCT02179918|581333825|FG002|Overall Study|Lost to Follow-up|1|||
160984871|NCT02179918|581333826|FG003|Overall Study|Lost to Follow-up|0|||
160984872|NCT02179918|581333827|FG004|Overall Study|Lost to Follow-up|0|||
160984873|NCT02179918|581333823|FG000|Overall Study|Progressive Disease|4|||
160984874|NCT02179918|581333824|FG001|Overall Study|Progressive Disease|1|||
160984875|NCT02179918|581333825|FG002|Overall Study|Progressive Disease|1|||
160984876|NCT02179918|581333826|FG003|Overall Study|Progressive Disease|2|||
160984877|NCT02179918|581333827|FG004|Overall Study|Progressive Disease|6|||
160984878|NCT02179918|581333823|FG000|Overall Study|Other|0|||
160984879|NCT02179918|581333824|FG001|Overall Study|Other|1|||
160984880|NCT02179918|581333825|FG002|Overall Study|Other|0|||
160984881|NCT02179918|581333826|FG003|Overall Study|Other|0|||
160984882|NCT02179918|581333827|FG004|Overall Study|Other|1|||
160984883|NCT02179918|581333823|FG000|Overall Study|Subject refused further follow-up|0|||
160801021|NCT01448616|580661308|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
160801022|NCT01448616|580661309|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
160801023|NCT01448616|580661306|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
160801024|NCT01448616|580661307|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
160801025|NCT01448616|580661308|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
160801026|NCT01448616|580661309|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
160801027|NCT00523978|580661310|FG000|Overall Study|Withdrawal by Subject|3|||
160801028|NCT00523978|580661311|FG001|Overall Study|Withdrawal by Subject|7|||
160801029|NCT00523978|580661310|FG000|Overall Study|Screen Failures|5|||
160801030|NCT00523978|580661311|FG001|Overall Study|Screen Failures|1|||
160801031|NCT00523978|580661310|FG000|Overall Study|Death|1|||
160801032|NCT00523978|580661311|FG001|Overall Study|Death|0|||
160801033|NCT01911260|580661314|FG000|Supplementation Period|transference or evasion of school|7|||
160801034|NCT01911260|580661315|FG001|Supplementation Period|transference or evasion of school|9|||
160801035|NCT01911260|580661316|FG002|Supplementation Period|transference or evasion of school|7|||
160801036|NCT01911260|580661317|FG003|Supplementation Period|transference or evasion of school|6|||
160801037|NCT01911260|580661314|FG000|Supplementation Period|Adverse Event|2|||
160801038|NCT01911260|580661315|FG001|Supplementation Period|Adverse Event|0|||
160801039|NCT01911260|580661316|FG002|Supplementation Period|Adverse Event|1|||
160801040|NCT01911260|580661317|FG003|Supplementation Period|Adverse Event|0|||
160801041|NCT01911260|580661314|FG000|Supplementation Period|refused to receive supplement|1|||
160801042|NCT01911260|580661315|FG001|Supplementation Period|refused to receive supplement|0|||
160801043|NCT01911260|580661316|FG002|Supplementation Period|refused to receive supplement|1|||
160801044|NCT01911260|580661317|FG003|Supplementation Period|refused to receive supplement|0|||
160801045|NCT01911260|580661314|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
160801046|NCT01911260|580661315|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
160801047|NCT01911260|580661316|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
160801048|NCT01911260|580661317|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
160801049|NCT01911260|580661314|FG000|Follow-up Period|transference or evasion of school|13|||
160801050|NCT01911260|580661315|FG001|Follow-up Period|transference or evasion of school|20|||
160801051|NCT01911260|580661316|FG002|Follow-up Period|transference or evasion of school|15|||
160801052|NCT01911260|580661317|FG003|Follow-up Period|transference or evasion of school|12|||
160801053|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
160801054|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
160801055|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
160801056|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
160801057|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
160801058|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
160984884|NCT02179918|581333824|FG001|Overall Study|Subject refused further follow-up|1|||
160984885|NCT02179918|581333825|FG002|Overall Study|Subject refused further follow-up|0|||
160984886|NCT02179918|581333826|FG003|Overall Study|Subject refused further follow-up|0|||
160984887|NCT02179918|581333827|FG004|Overall Study|Subject refused further follow-up|1|||
160801059|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
160801060|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
160801061|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
160801062|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
160801063|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
160801064|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
160801065|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
160801066|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
160801067|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
160801068|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
160801069|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
160801070|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
160801071|NCT00546481|580661323|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
160801072|NCT00546481|580661324|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
160801073|NCT00546481|580661325|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
160801074|NCT00546481|580661323|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
160801075|NCT00546481|580661324|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
160801076|NCT00546481|580661325|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
160801077|NCT00546481|580661323|FG000|Maintenance Phase (CERA)|Other Reason|0|||
160801078|NCT00546481|580661324|FG001|Maintenance Phase (CERA)|Other Reason|0|||
160801079|NCT00546481|580661325|FG002|Maintenance Phase (CERA)|Other Reason|1|||
160801080|NCT02271529|580661331|FG000|Overall Study|Withdrawal by Subject|1|||
160801081|NCT03508050|580661333|FG000|Overall Study|Pleural adhesions|1|||
160801082|NCT03508050|580661334|FG001|Overall Study|Pleural adhesions|0|||
160801083|NCT03508050|580661333|FG000|Overall Study|Mucus plug|1|||
160801084|NCT03508050|580661334|FG001|Overall Study|Mucus plug|0|||
160801085|NCT03508050|580661333|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
160801086|NCT03508050|580661334|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
160801087|NCT03508050|580661333|FG000|Overall Study|Sustained desaturation|0|||
160801088|NCT03508050|580661334|FG001|Overall Study|Sustained desaturation|1|||
160801089|NCT01082614|580661335|FG000|Overall Study|Adverse Event|1|||
160801090|NCT01082614|580661336|FG001|Overall Study|Adverse Event|4|||
160801091|NCT01082614|580661335|FG000|Overall Study|Equipment Malfunction|0|||
160801092|NCT01082614|580661336|FG001|Overall Study|Equipment Malfunction|1|||
160801093|NCT01082614|580661335|FG000|Overall Study|Physician Decision|2|||
160801094|NCT01082614|580661336|FG001|Overall Study|Physician Decision|0|||
160801095|NCT00811720|580661337|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
160801096|NCT00811720|580661338|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
160801097|NCT00811720|580661337|FG000|All Treated Patients|Adverse Event|20|||
160801098|NCT00811720|580661338|FG001|All Treated Patients|Adverse Event|62|||
160801099|NCT00811720|580661337|FG000|All Treated Patients|Lack of Efficacy|22|||
160801100|NCT00811720|580661338|FG001|All Treated Patients|Lack of Efficacy|18|||
160801101|NCT00811720|580661337|FG000|All Treated Patients|Non-compliance|0|||
160801102|NCT00811720|580661338|FG001|All Treated Patients|Non-compliance|14|||
160801103|NCT00811720|580661337|FG000|All Treated Patients|Protocol Violation|9|||
160801104|NCT00811720|580661338|FG001|All Treated Patients|Protocol Violation|16|||
160801105|NCT00811720|580661337|FG000|All Treated Patients|Withdrawal by Subject|28|||
160801106|NCT00811720|580661338|FG001|All Treated Patients|Withdrawal by Subject|34|||
160801107|NCT00811720|580661337|FG000|All Treated Patients|Lost to Follow-up|10|||
160801108|NCT00811720|580661338|FG001|All Treated Patients|Lost to Follow-up|16|||
160801109|NCT00811720|580661337|FG000|All Treated Patients|Other Reason|7|||
160801110|NCT00811720|580661338|FG001|All Treated Patients|Other Reason|4|||
160801111|NCT00950651|580661346|FG000|Overall Study|Adverse Event|17|||
160801112|NCT00950651|580661347|FG001|Overall Study|Adverse Event|20|||
160801113|NCT00950651|580661346|FG000|Overall Study|Death|1|||
160801114|NCT00950651|580661347|FG001|Overall Study|Death|0|||
160801115|NCT00950651|580661346|FG000|Overall Study|Lack of Efficacy|2|||
160801116|NCT00950651|580661347|FG001|Overall Study|Lack of Efficacy|2|||
160801117|NCT00950651|580661346|FG000|Overall Study|Protocol Violation|3|||
160896826|NCT00257608|581018680|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
160896827|NCT00257608|581018681|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
160896828|NCT00257608|581018679|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
160896829|NCT00257608|581018680|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
160801118|NCT00950651|580661347|FG001|Overall Study|Protocol Violation|4|||
160801119|NCT00950651|580661346|FG000|Overall Study|Withdrawal by Subject|8|||
160801120|NCT00950651|580661347|FG001|Overall Study|Withdrawal by Subject|9|||
160801121|NCT03783780|580661348|FG000|Overall Study|Withdrawn prior to completion|1|||
160801122|NCT03768427|580661349|FG000|Overall Study|Death|0|||
160801123|NCT03768427|580661350|FG001|Overall Study|Death|0|||
160801124|NCT03768427|580661351|FG002|Overall Study|Death|1|||
160801125|NCT03768427|580661352|FG003|Overall Study|Death|0|||
160801126|NCT03768427|580661349|FG000|Overall Study|Lost to Follow-up|2|||
160801127|NCT03768427|580661350|FG001|Overall Study|Lost to Follow-up|0|||
160801128|NCT03768427|580661351|FG002|Overall Study|Lost to Follow-up|0|||
160801129|NCT03768427|580661352|FG003|Overall Study|Lost to Follow-up|0|||
160801130|NCT03768427|580661349|FG000|Overall Study|Physician Decision|3|||
160801131|NCT03768427|580661350|FG001|Overall Study|Physician Decision|2|||
160801132|NCT03768427|580661351|FG002|Overall Study|Physician Decision|4|||
160801133|NCT03768427|580661352|FG003|Overall Study|Physician Decision|4|||
160801134|NCT03768427|580661349|FG000|Overall Study|Withdrawal by Subject|7|||
160801135|NCT03768427|580661350|FG001|Overall Study|Withdrawal by Subject|2|||
160801136|NCT03768427|580661351|FG002|Overall Study|Withdrawal by Subject|6|||
160801137|NCT03768427|580661352|FG003|Overall Study|Withdrawal by Subject|7|||
160801138|NCT03710889|580661355|FG000|Overall Study|Adverse Event|2|||
160801139|NCT03710889|580661355|FG000|Overall Study|Protocol Deviation|1|||
160801140|NCT02121509|580661360|FG000|Washout Period (35 Days)|Adverse Event|1|||
160801141|NCT02121509|580661361|FG001|Washout Period (35 Days)|Adverse Event|1|||
160801142|NCT02121509|580661362|FG002|Washout Period (35 Days)|Adverse Event|0|||
160801143|NCT02121509|580661363|FG003|Washout Period (35 Days)|Adverse Event|0|||
160801144|NCT02121509|580661360|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
160801145|NCT02121509|580661361|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
160801146|NCT02121509|580661362|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
160801147|NCT02121509|580661363|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
160801148|NCT02121509|580661360|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
160801149|NCT02121509|580661361|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
160801150|NCT02121509|580661362|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
160801151|NCT02121509|580661363|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
160801152|NCT05076045|580661366|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
160801153|NCT05076045|580661367|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
160801154|NCT02993263|580661369|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
160801155|NCT00829998|580661372|FG000|Washout|Adverse Event|0|||
160801156|NCT00829998|580661373|FG001|Washout|Adverse Event|1|||
160801157|NCT01173679|580663074|FG000|Overall Study|Death|1|||
160801158|NCT00441272|580663075|FG000|Overall Study|Study terminated prior to enrollment|25|||
160801159|NCT00441272|580663076|FG001|Overall Study|Study terminated prior to enrollment|25|||
160801160|NCT02921789|580663077|FG000|Overall Study|Adverse Event|0|||
160801161|NCT02921789|580663078|FG001|Overall Study|Adverse Event|1|||
160801162|NCT02921789|580663077|FG000|Overall Study|Lost to Follow-up|1|||
160896830|NCT00257608|581018681|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
160896831|NCT00257608|581018679|FG000|Chemotherapy Phase|Physician Decision|28|||
160896832|NCT00257608|581018680|FG001|Chemotherapy Phase|Physician Decision|0|||
160801163|NCT02921789|580663078|FG001|Overall Study|Lost to Follow-up|0|||
160801164|NCT02921789|580663077|FG000|Overall Study|Protocol Deviation|2|||
160801165|NCT02921789|580663078|FG001|Overall Study|Protocol Deviation|0|||
160801166|NCT02921789|580663077|FG000|Overall Study|Withdrawal by Subject|2|||
160801167|NCT02921789|580663078|FG001|Overall Study|Withdrawal by Subject|1|||
160801168|NCT02921789|580663077|FG000|Overall Study|Miscellaneous|3|||
160801169|NCT02921789|580663078|FG001|Overall Study|Miscellaneous|2|||
160896833|NCT00257608|581018681|FG002|Chemotherapy Phase|Physician Decision|0|||
160896834|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Adverse Event|0|||
160801170|NCT01944020|580663079|FG000|Overall Study|Withdrawal by Subject|5|||
160801171|NCT01944020|580663080|FG001|Overall Study|Withdrawal by Subject|0|||
160801172|NCT03423602|580663085|FG000|Overall Study|Death|1|||
160801173|NCT03423602|580663085|FG000|Overall Study|Lost to Follow-up|6|||
160801174|NCT03423602|580663085|FG000|Overall Study|Protocol Violation|1|||
160896835|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Adverse Event|34|||
160896836|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Adverse Event|38|||
160896837|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Disease progression|0|||
160896838|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Disease progression|204|||
160896839|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Disease progression|168|||
160896840|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
160896841|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
160896842|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
160896843|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
160896844|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
160896845|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
160896846|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
160801175|NCT03423602|580663085|FG000|Overall Study|Withdrawal by Subject|4|||
160801176|NCT02332187|580663086|FG000|Overall Study|Withdrawal by Subject|2|||
160896847|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
160896848|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
160801177|NCT02332187|580663087|FG001|Overall Study|Withdrawal by Subject|2|||
160801178|NCT02332187|580663086|FG000|Overall Study|Adverse Event|0|||
160801179|NCT02332187|580663087|FG001|Overall Study|Adverse Event|1|||
160801180|NCT02903823|580663088|FG000|Overall Study|Physician Decision|5|||
160801181|NCT02903823|580663088|FG000|Overall Study|Could not advance catheter|1|||
160801182|NCT02903823|580663088|FG000|Overall Study|Catheter dislodgement|1|||
160801183|NCT01462929|580663095|FG000|Overall Study|Adverse Event|3|||
160801184|NCT01462929|580663096|FG001|Overall Study|Adverse Event|3|||
160801185|NCT01462929|580663097|FG002|Overall Study|Adverse Event|4|||
160801186|NCT01462929|580663095|FG000|Overall Study|Withdrawal by Subject|2|||
160801187|NCT01462929|580663096|FG001|Overall Study|Withdrawal by Subject|1|||
160801188|NCT01462929|580663097|FG002|Overall Study|Withdrawal by Subject|0|||
160801189|NCT01462929|580663095|FG000|Overall Study|Lack of Efficacy|0|||
160801190|NCT01462929|580663096|FG001|Overall Study|Lack of Efficacy|0|||
160801191|NCT01462929|580663097|FG002|Overall Study|Lack of Efficacy|1|||
160801192|NCT00887159|580663098|FG000|Overall Study|Disease progression|6|||
160801193|NCT00887159|580663099|FG001|Overall Study|Disease progression|39|||
160801194|NCT00887159|580663100|FG002|Overall Study|Disease progression|33|||
160801195|NCT00887159|580663098|FG000|Overall Study|Adverse Event|3|||
160801196|NCT00887159|580663099|FG001|Overall Study|Adverse Event|4|||
160801197|NCT00887159|580663100|FG002|Overall Study|Adverse Event|17|||
160801198|NCT00887159|580663098|FG000|Overall Study|Death|2|||
160801199|NCT00887159|580663099|FG001|Overall Study|Death|2|||
160801200|NCT00887159|580663100|FG002|Overall Study|Death|0|||
160801201|NCT00887159|580663098|FG000|Overall Study|Withdrawal by Subject|4|||
160801202|NCT00887159|580663099|FG001|Overall Study|Withdrawal by Subject|4|||
160801203|NCT00887159|580663100|FG002|Overall Study|Withdrawal by Subject|2|||
160801204|NCT00887159|580663098|FG000|Overall Study|Alternative therapy|2|||
160801205|NCT00887159|580663099|FG001|Overall Study|Alternative therapy|0|||
160801206|NCT00887159|580663100|FG002|Overall Study|Alternative therapy|0|||
160801207|NCT00887159|580663098|FG000|Overall Study|Physician Decision|1|||
160801208|NCT00887159|580663099|FG001|Overall Study|Physician Decision|1|||
160896849|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
160896850|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
160896851|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
160896852|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
160896853|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
160896854|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
160896855|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Physician Decision|0|||
160896856|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Physician Decision|8|||
160896857|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Physician Decision|11|||
160896858|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
160896859|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
160896860|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
160896861|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Not treated|0|||
160896862|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Not treated|4|||
160896863|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Not treated|7|||
160896864|NCT03673046|581018682|FG000|Overall Study|Adverse Event|1|||
160896865|NCT03673046|581018683|FG001|Overall Study|Adverse Event|1|||
160896866|NCT03673046|581018682|FG000|Overall Study|Withdrawal by Subject|8|||
160896867|NCT03673046|581018683|FG001|Overall Study|Withdrawal by Subject|2|||
160896868|NCT01896050|581018684|FG000|Overall Study|Adverse Event|37|||
160896869|NCT01896050|581018685|FG001|Overall Study|Adverse Event|2|||
160896870|NCT01896050|581018684|FG000|Overall Study|Death|1|||
160896871|NCT01896050|581018685|FG001|Overall Study|Death|0|||
160896872|NCT03693300|581018686|FG000|Overall Study|Withdrawal by Subject|6|||
160896873|NCT03693300|581018687|FG001|Overall Study|Withdrawal by Subject|0|||
160896874|NCT03693300|581018686|FG000|Overall Study|Death|50|||
160896875|NCT03693300|581018687|FG001|Overall Study|Death|2|||
160896876|NCT03693300|581018686|FG000|Overall Study|Lost to Follow-up|2|||
160896877|NCT03693300|581018687|FG001|Overall Study|Lost to Follow-up|0|||
160896878|NCT01824342|581018691|FG000|Overall Study|Withdrawal by Subject|0|||
160896879|NCT01824342|581018692|FG001|Overall Study|Withdrawal by Subject|3|||
160896880|NCT01824342|581018691|FG000|Overall Study|Adverse Event|1|||
160896881|NCT01824342|581018692|FG001|Overall Study|Adverse Event|1|||
160896882|NCT01824342|581018691|FG000|Overall Study|Disease Progression|1|||
160896883|NCT01824342|581018692|FG001|Overall Study|Disease Progression|1|||
160896884|NCT01824342|581018691|FG000|Overall Study|Physician Decision|5|||
160896885|NCT01824342|581018692|FG001|Overall Study|Physician Decision|0|||
160801209|NCT00887159|580663100|FG002|Overall Study|Physician Decision|0|||
160896886|NCT01824342|581018691|FG000|Overall Study|Death|2|||
160896887|NCT01824342|581018692|FG001|Overall Study|Death|0|||
160896888|NCT02486302|581018693|FG000|Overall Study|Discontinued prematurely|410|||
160896889|NCT02486302|581018693|FG000|Overall Study|Documentation not completed|255|||
160896890|NCT02486302|581018693|FG000|Overall Study|Excluded due to legal reasons|8|||
160896891|NCT02486302|581018693|FG000|Overall Study|Not treated|3|||
160984888|NCT04770220|581333830|FG000|Overall Study|Adverse Event|2|||
160984889|NCT04770220|581333831|FG001|Overall Study|Adverse Event|11|||
160984890|NCT04770220|581333830|FG000|Overall Study|Withdrawal by Subject|5|||
160801210|NCT00887159|580663098|FG000|Overall Study|Sympomatic deterioration|1|||
160801211|NCT00887159|580663099|FG001|Overall Study|Sympomatic deterioration|0|||
160801212|NCT00887159|580663100|FG002|Overall Study|Sympomatic deterioration|0|||
160801213|NCT00887159|580663098|FG000|Overall Study|Treatment delayed|1|||
160801214|NCT00887159|580663099|FG001|Overall Study|Treatment delayed|1|||
160801215|NCT00887159|580663100|FG002|Overall Study|Treatment delayed|0|||
160984891|NCT04770220|581333831|FG001|Overall Study|Withdrawal by Subject|11|||
160984892|NCT04770220|581333830|FG000|Overall Study|Lost to Follow-up|4|||
160984893|NCT04770220|581333831|FG001|Overall Study|Lost to Follow-up|3|||
160984894|NCT04770220|581333830|FG000|Overall Study|not otherwise specified|2|||
160984895|NCT04770220|581333831|FG001|Overall Study|not otherwise specified|3|||
160984896|NCT04770220|581333830|FG000|Overall Study|Physician Decision|1|||
160984897|NCT04770220|581333831|FG001|Overall Study|Physician Decision|3|||
160984898|NCT04894903|581333833|FG000|Overall Study|Death|1|||
160984899|NCT04894903|581333834|FG001|Overall Study|Death|0|||
160984900|NCT04894903|581333833|FG000|Overall Study|Pregnancy|1|||
160984901|NCT04894903|581333834|FG001|Overall Study|Pregnancy|0|||
160984902|NCT04894903|581333833|FG000|Overall Study|Withdrawal by Subject|1|||
160801216|NCT00887159|580663098|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
160801217|NCT00887159|580663099|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
160801218|NCT00887159|580663100|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
160801219|NCT00887159|580663098|FG000|Overall Study|Received more tx instead of observation|1|||
160801220|NCT00887159|580663099|FG001|Overall Study|Received more tx instead of observation|0|||
160801221|NCT00887159|580663100|FG002|Overall Study|Received more tx instead of observation|0|||
160801222|NCT00887159|580663098|FG000|Overall Study|Ineligible|5|||
160801223|NCT00887159|580663099|FG001|Overall Study|Ineligible|1|||
160801224|NCT00887159|580663100|FG002|Overall Study|Ineligible|0|||
160801225|NCT00887159|580663098|FG000|Overall Study|Never started assigned therapy|3|||
160801226|NCT00887159|580663099|FG001|Overall Study|Never started assigned therapy|3|||
160801227|NCT00887159|580663100|FG002|Overall Study|Never started assigned therapy|4|||
160801228|NCT06164691|580663102|FG000|Overall Study|Withdrawal by Subject|2|||
160801229|NCT06164691|580663103|FG001|Overall Study|Withdrawal by Subject|0|||
160801230|NCT06164691|580663104|FG002|Overall Study|Withdrawal by Subject|0|||
160801231|NCT02391311|580663105|FG000|Overall Study|Lost to Follow-up|2|||
160801232|NCT02391311|580663106|FG001|Overall Study|Lost to Follow-up|1|||
160801233|NCT02391311|580663105|FG000|Overall Study|deemed ineligible after baseline|1|||
160801234|NCT02391311|580663106|FG001|Overall Study|deemed ineligible after baseline|1|||
160801235|NCT00305448|580663107|FG000|Overall Study|Protocol Violation|0|||
160801236|NCT00305448|580663108|FG001|Overall Study|Protocol Violation|1|||
160801237|NCT00305448|580663109|FG002|Overall Study|Protocol Violation|0|||
160801238|NCT00305448|580663107|FG000|Overall Study|Withdrawal by Subject|2|||
160801239|NCT00305448|580663108|FG001|Overall Study|Withdrawal by Subject|0|||
160984903|NCT04894903|581333834|FG001|Overall Study|Withdrawal by Subject|1|||
160984904|NCT04894903|581333833|FG000|Overall Study|moved or exited health system|1|||
160984905|NCT04894903|581333834|FG001|Overall Study|moved or exited health system|3|||
160801240|NCT00305448|580663109|FG002|Overall Study|Withdrawal by Subject|1|||
160801241|NCT00305448|580663107|FG000|Overall Study|Adverse Event|1|||
160801242|NCT00305448|580663108|FG001|Overall Study|Adverse Event|0|||
160801243|NCT00305448|580663109|FG002|Overall Study|Adverse Event|1|||
160801244|NCT00305448|580663107|FG000|Overall Study|Disease Progression|27|||
160801245|NCT00305448|580663108|FG001|Overall Study|Disease Progression|31|||
160801246|NCT00305448|580663109|FG002|Overall Study|Disease Progression|28|||
160801247|NCT00305448|580663107|FG000|Overall Study|Subjective Disease Progression|1|||
160801248|NCT00305448|580663108|FG001|Overall Study|Subjective Disease Progression|2|||
160801249|NCT00305448|580663109|FG002|Overall Study|Subjective Disease Progression|2|||
160801250|NCT00305448|580663107|FG000|Overall Study|Tumor Marker Elevation|0|||
160801251|NCT00305448|580663108|FG001|Overall Study|Tumor Marker Elevation|0|||
160801252|NCT00305448|580663109|FG002|Overall Study|Tumor Marker Elevation|1|||
160801253|NCT01343888|580663110|FG000|Overall Study|Adverse Event|12|||
160801254|NCT01343888|580663111|FG001|Overall Study|Adverse Event|22|||
160801255|NCT01343888|580663112|FG002|Overall Study|Adverse Event|5|||
160801256|NCT01343888|580663110|FG000|Overall Study|Lack of Efficacy|9|||
160801257|NCT01343888|580663111|FG001|Overall Study|Lack of Efficacy|9|||
160801258|NCT01343888|580663112|FG002|Overall Study|Lack of Efficacy|13|||
160801259|NCT01343888|580663110|FG000|Overall Study|Lost to Follow-up|0|||
160801260|NCT01343888|580663111|FG001|Overall Study|Lost to Follow-up|2|||
160801261|NCT01343888|580663112|FG002|Overall Study|Lost to Follow-up|1|||
160801262|NCT01343888|580663110|FG000|Overall Study|Protocol Violation|0|||
160801263|NCT01343888|580663111|FG001|Overall Study|Protocol Violation|2|||
160801264|NCT01343888|580663112|FG002|Overall Study|Protocol Violation|0|||
160801265|NCT01343888|580663110|FG000|Overall Study|Withdrawal by Subject|4|||
160801266|NCT01343888|580663111|FG001|Overall Study|Withdrawal by Subject|4|||
160801267|NCT01343888|580663112|FG002|Overall Study|Withdrawal by Subject|2|||
160801268|NCT01343888|580663110|FG000|Overall Study|other than stated above|0|||
160984906|NCT01923428|581333836|FG000|Overall Study|Adverse Event|8|||
160801269|NCT01343888|580663111|FG001|Overall Study|other than stated above|0|||
160801270|NCT01343888|580663112|FG002|Overall Study|other than stated above|1|||
160801271|NCT00558636|580663114|FG000|Treatment|Adverse Event|9|||
160801272|NCT00558636|580663115|FG001|Treatment|Adverse Event|2|||
160801273|NCT00558636|580663114|FG000|Treatment|Withdrawal by Subject|2|||
160801274|NCT00558636|580663115|FG001|Treatment|Withdrawal by Subject|0|||
160801275|NCT00558636|580663114|FG000|Treatment|Premature termination of the study|35|||
160984907|NCT01923428|581333837|FG001|Overall Study|Adverse Event|6|||
160896892|NCT02899299|581018696|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
160896893|NCT02899299|581018697|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
160896894|NCT02899299|581018696|FG000|Pre-treatment|Participant withdrew consent|1|||
160896895|NCT02899299|581018697|FG001|Pre-treatment|Participant withdrew consent|11|||
160896896|NCT02899299|581018696|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
160896897|NCT02899299|581018697|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
160896898|NCT02899299|581018696|FG000|Pre-treatment|Not reported|0|||
160896899|NCT02899299|581018697|FG001|Pre-treatment|Not reported|1|||
160896900|NCT02899299|581018696|FG000|Treatment|Disease Progression|182|||
160896901|NCT02899299|581018697|FG001|Treatment|Disease Progression|43|||
160896902|NCT02899299|581018696|FG000|Treatment|Study Drug Toxicity|60|||
160896903|NCT02899299|581018697|FG001|Treatment|Study Drug Toxicity|24|||
160896904|NCT02899299|581018696|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
160896905|NCT02899299|581018697|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
160896906|NCT02899299|581018696|FG000|Treatment|Participant request to discontinue Study treatment|4|||
160896907|NCT02899299|581018697|FG001|Treatment|Participant request to discontinue Study treatment|10|||
160896908|NCT02899299|581018696|FG000|Treatment|Participant withdrew consent|6|||
160896909|NCT02899299|581018697|FG001|Treatment|Participant withdrew consent|3|||
160896910|NCT02899299|581018696|FG000|Treatment|Lost to Follow-up|0|||
160896911|NCT02899299|581018697|FG001|Treatment|Lost to Follow-up|2|||
160896912|NCT02899299|581018696|FG000|Treatment|Maximum Clinical Benefit|11|||
160896913|NCT02899299|581018697|FG001|Treatment|Maximum Clinical Benefit|2|||
160896914|NCT02899299|581018696|FG000|Treatment|Poor/Non-compliance|1|||
160896915|NCT02899299|581018697|FG001|Treatment|Poor/Non-compliance|0|||
160896916|NCT02899299|581018696|FG000|Treatment|Participant no longer meets Study criteria|4|||
160896917|NCT02899299|581018697|FG001|Treatment|Participant no longer meets Study criteria|0|||
160896918|NCT02899299|581018696|FG000|Treatment|Administrative reason by Sponsor|2|||
160896919|NCT02899299|581018697|FG001|Treatment|Administrative reason by Sponsor|0|||
160896920|NCT02899299|581018696|FG000|Treatment|Other reasons|12|||
160896921|NCT02899299|581018697|FG001|Treatment|Other reasons|2|||
160896922|NCT02899299|581018696|FG000|Treatment|Not reported|7|||
160896923|NCT02899299|581018697|FG001|Treatment|Not reported|0|||
160896924|NCT01926015|581018698|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160896925|NCT01926015|581018699|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160896926|NCT01926015|581018698|FG000|Overall Study|Randomized not treated|2|||
160896927|NCT01926015|581018699|FG001|Overall Study|Randomized not treated|0|||
160896928|NCT01364649|581018700|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
160896929|NCT01364649|581018701|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
160896930|NCT01364649|581018700|FG000|Overall Study|Lack of Efficacy|6|||
160896931|NCT01364649|581018701|FG001|Overall Study|Lack of Efficacy|0|||
160896932|NCT01364649|581018700|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
160896933|NCT01364649|581018701|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
160896934|NCT01364649|581018700|FG000|Overall Study|Protocol Deviations|4|||
160896935|NCT01364649|581018701|FG001|Overall Study|Protocol Deviations|8|||
160896936|NCT01364649|581018700|FG000|Overall Study|Withdrawal of Consent|9|||
160896937|NCT01364649|581018701|FG001|Overall Study|Withdrawal of Consent|7|||
160896938|NCT01364649|581018700|FG000|Overall Study|Lost to Follow-up|12|||
160896939|NCT01364649|581018701|FG001|Overall Study|Lost to Follow-up|13|||
160896940|NCT01364649|581018700|FG000|Overall Study|Other|4|||
160896941|NCT01364649|581018701|FG001|Overall Study|Other|1|||
160896942|NCT01826604|581018702|FG000|Overall Study|Lost to Follow-up|8|||
160896943|NCT01826604|581018703|FG001|Overall Study|Lost to Follow-up|9|||
160896944|NCT06132659|581018704|FG000|Overall Study|Lost to Follow-up|0|||
160896945|NCT06132659|581018705|FG001|Overall Study|Lost to Follow-up|1|||
160896946|NCT06132659|581018706|FG002|Overall Study|Lost to Follow-up|0|||
160896947|NCT03615326|581018707|FG000|Overall Study|Death|266|||
160896948|NCT03615326|581018708|FG001|Overall Study|Death|286|||
160896949|NCT03615326|581018709|FG002|Overall Study|Death|14|||
160984908|NCT01923428|581333838|FG002|Overall Study|Adverse Event|3|||
160984909|NCT01923428|581333839|FG003|Overall Study|Adverse Event|3|||
160984910|NCT01923428|581333836|FG000|Overall Study|Withdrawal by Subject|5|||
160896950|NCT03615326|581018710|FG003|Overall Study|Death|17|||
160896951|NCT03615326|581018707|FG000|Overall Study|Lost to Follow-up|0|||
160896952|NCT03615326|581018708|FG001|Overall Study|Lost to Follow-up|1|||
160896953|NCT03615326|581018709|FG002|Overall Study|Lost to Follow-up|0|||
160896954|NCT03615326|581018710|FG003|Overall Study|Lost to Follow-up|0|||
160896955|NCT03615326|581018707|FG000|Overall Study|Withdrawal by Subject|1|||
160896956|NCT03615326|581018708|FG001|Overall Study|Withdrawal by Subject|3|||
160896957|NCT03615326|581018709|FG002|Overall Study|Withdrawal by Subject|0|||
160984911|NCT01923428|581333837|FG001|Overall Study|Withdrawal by Subject|3|||
160896958|NCT03615326|581018710|FG003|Overall Study|Withdrawal by Subject|0|||
160896959|NCT03615326|581018707|FG000|Overall Study|Participants Ongoing|83|||
160896960|NCT03615326|581018708|FG001|Overall Study|Participants Ongoing|58|||
160896961|NCT03615326|581018709|FG002|Overall Study|Participants Ongoing|6|||
160896962|NCT03615326|581018710|FG003|Overall Study|Participants Ongoing|3|||
160896963|NCT03794583|581018711|FG000|Overall Study|Death|8|||
160801276|NCT00558636|580663115|FG001|Treatment|Premature termination of the study|37|||
160801277|NCT00558636|580663114|FG000|Treatment|Disease progression|1|||
160801278|NCT00558636|580663115|FG001|Treatment|Disease progression|5|||
160801279|NCT00558636|580663114|FG000|Follow-up|Premature termination of the study|12|||
160801280|NCT00558636|580663115|FG001|Follow-up|Premature termination of the study|7|||
160801281|NCT01990742|580663116|FG000|Overall Study|Withdrawal by facility|407|||
160801282|NCT01990742|580663117|FG001|Overall Study|Withdrawal by facility|1083|||
160801283|NCT01990742|580663116|FG000|Overall Study|Facility closed|0|||
160801284|NCT01990742|580663117|FG001|Overall Study|Facility closed|270|||
160801285|NCT03443687|580663118|FG000|Overall Study|Lost to Follow-up|3|||
160801286|NCT03443687|580663119|FG001|Overall Study|Lost to Follow-up|5|||
160801287|NCT03443687|580663118|FG000|Overall Study|Withdrawal by Subject|1|||
160801288|NCT03443687|580663119|FG001|Overall Study|Withdrawal by Subject|0|||
160801289|NCT03443687|580663118|FG000|Overall Study|Discontinued intervention|1|||
160801290|NCT03443687|580663119|FG001|Overall Study|Discontinued intervention|1|||
160801291|NCT00800735|580663120|FG000|Overall Study|Administrative/Other|2|||
160801292|NCT00800735|580663120|FG000|Overall Study|Insufficient Therapeutic Response|2|||
160801293|NCT00800735|580663120|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
160801294|NCT00800735|580663120|FG000|Overall Study|Withdrew Consent|3|||
160801295|NCT02805790|580663121|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
160801296|NCT02805790|580663122|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
160801297|NCT00506142|580663123|FG000|Overall Study|Adverse Event|8|||
160801298|NCT00506142|580663124|FG001|Overall Study|Adverse Event|7|||
160801299|NCT00506142|580663123|FG000|Overall Study|Lack of Efficacy|21|||
160801300|NCT00506142|580663124|FG001|Overall Study|Lack of Efficacy|7|||
160801301|NCT00506142|580663123|FG000|Overall Study|Withdrawal by Subject|4|||
160801302|NCT00506142|580663124|FG001|Overall Study|Withdrawal by Subject|5|||
160801303|NCT00506142|580663123|FG000|Overall Study|Physician Decision|1|||
160801304|NCT00506142|580663124|FG001|Overall Study|Physician Decision|0|||
160801305|NCT00506142|580663123|FG000|Overall Study|New health condition|1|||
160801306|NCT00506142|580663124|FG001|Overall Study|New health condition|0|||
160801307|NCT02154061|580663125|FG000|Overall Study|Pregnancy|1|||
160801308|NCT02154061|580663126|FG001|Overall Study|Pregnancy|0|||
160801309|NCT02154061|580663125|FG000|Overall Study|enrolled but not vaccinated|1|||
160801310|NCT02154061|580663126|FG001|Overall Study|enrolled but not vaccinated|0|||
160801311|NCT01936831|580663127|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801312|NCT01936831|580663128|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801313|NCT01936831|580663129|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801314|NCT01936831|580663130|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801315|NCT01936831|580663131|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801316|NCT01936831|580663132|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
160801317|NCT01936831|580663133|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801318|NCT01936831|580663134|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801319|NCT01936831|580663135|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801320|NCT02133573|580663141|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
160801321|NCT02133573|580663142|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
160801322|NCT02133573|580663141|FG000|Overall Study|Child Deaths|3|||
160801323|NCT02133573|580663142|FG001|Overall Study|Child Deaths|5|||
160801324|NCT02133573|580663141|FG000|Overall Study|Child Declined Follow Ups|2|||
160896964|NCT03794583|581018711|FG000|Overall Study|Study Terminated by Sponsor|24|||
160896965|NCT03794583|581018711|FG000|Overall Study|Withdrawal by Subject|9|||
160896966|NCT02497612|581018712|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
160896967|NCT02497612|581018713|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
160896968|NCT02497612|581018714|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
160896969|NCT02497612|581018715|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
160896970|NCT02497612|581018712|FG000|Overall Study|Participant's request|2|||
160896971|NCT02497612|581018713|FG001|Overall Study|Participant's request|3|||
160896972|NCT02497612|581018714|FG002|Overall Study|Participant's request|4|||
160896973|NCT02497612|581018715|FG003|Overall Study|Participant's request|1|||
160896974|NCT02497612|581018712|FG000|Overall Study|Investigator's judgement|1|||
160896975|NCT02497612|581018713|FG001|Overall Study|Investigator's judgement|0|||
160896976|NCT02497612|581018714|FG002|Overall Study|Investigator's judgement|0|||
160896977|NCT02497612|581018715|FG003|Overall Study|Investigator's judgement|2|||
160896978|NCT02497612|581018712|FG000|Overall Study|Adverse Event|3|||
160896979|NCT02497612|581018713|FG001|Overall Study|Adverse Event|1|||
160896980|NCT02497612|581018714|FG002|Overall Study|Adverse Event|4|||
160801325|NCT02133573|580663142|FG001|Overall Study|Child Declined Follow Ups|1|||
160801326|NCT02133573|580663141|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
160801327|NCT02133573|580663142|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
160801328|NCT02808429|580663144|FG000|Overall Study|Lost to Follow-up|1|||
160801329|NCT02808429|580663145|FG001|Overall Study|Lost to Follow-up|0|||
160801330|NCT02808429|580663146|FG002|Overall Study|Lost to Follow-up|0|||
160801331|NCT02808429|580663144|FG000|Overall Study|Protocol Violation|0|||
160801332|NCT02808429|580663145|FG001|Overall Study|Protocol Violation|1|||
160801333|NCT02808429|580663146|FG002|Overall Study|Protocol Violation|0|||
160801334|NCT02808429|580663144|FG000|Overall Study|Premature study termination by sponsor|2|||
160801335|NCT02808429|580663145|FG001|Overall Study|Premature study termination by sponsor|0|||
160801336|NCT02808429|580663146|FG002|Overall Study|Premature study termination by sponsor|1|||
160801337|NCT02808429|580663144|FG000|Overall Study|Relocation|0|||
160801338|NCT02808429|580663145|FG001|Overall Study|Relocation|0|||
160801339|NCT02808429|580663146|FG002|Overall Study|Relocation|1|||
160801340|NCT01436110|580663147|FG000|Overall Study|Lack of Efficacy|23|||
160801341|NCT01436110|580663148|FG001|Overall Study|Lack of Efficacy|14|||
160801342|NCT01436110|580663149|FG002|Overall Study|Lack of Efficacy|9|||
160801343|NCT01436110|580663147|FG000|Overall Study|Withdrawal by Subject|6|||
160801344|NCT01436110|580663148|FG001|Overall Study|Withdrawal by Subject|8|||
160801345|NCT01436110|580663149|FG002|Overall Study|Withdrawal by Subject|4|||
160801346|NCT01436110|580663147|FG000|Overall Study|Adverse Event|2|||
160801347|NCT01436110|580663148|FG001|Overall Study|Adverse Event|1|||
160801348|NCT01436110|580663149|FG002|Overall Study|Adverse Event|2|||
160801349|NCT01436110|580663147|FG000|Overall Study|Physician Decision|3|||
160801350|NCT01436110|580663148|FG001|Overall Study|Physician Decision|1|||
160801351|NCT01436110|580663149|FG002|Overall Study|Physician Decision|1|||
160801352|NCT01436110|580663147|FG000|Overall Study|Lost to Follow-up|1|||
160801353|NCT01436110|580663148|FG001|Overall Study|Lost to Follow-up|1|||
160801354|NCT01436110|580663149|FG002|Overall Study|Lost to Follow-up|3|||
160801355|NCT01436110|580663147|FG000|Overall Study|Protocol Violation|3|||
160801356|NCT01436110|580663148|FG001|Overall Study|Protocol Violation|1|||
160801357|NCT01436110|580663149|FG002|Overall Study|Protocol Violation|1|||
160801358|NCT01436110|580663147|FG000|Overall Study|Did Not Receive Trial Medication|1|||
160801359|NCT01436110|580663148|FG001|Overall Study|Did Not Receive Trial Medication|0|||
160801360|NCT01436110|580663149|FG002|Overall Study|Did Not Receive Trial Medication|3|||
160801361|NCT03273907|580663150|FG000|Overall Study|Death|1|||
160801362|NCT03273907|580663150|FG000|Overall Study|Lost to Follow-up|4|||
160801363|NCT03273907|580663150|FG000|Overall Study|Withdrawal by Subject|2|||
160801364|NCT03273907|580663150|FG000|Overall Study|COVID 19|2|||
160801365|NCT01088503|580663151|FG000|Overall Study|Withdrawal by Subject|118|||
160801366|NCT01088503|580663152|FG001|Overall Study|Withdrawal by Subject|327|||
160801367|NCT01088503|580663153|FG002|Overall Study|Withdrawal by Subject|10|||
160801368|NCT01088503|580663151|FG000|Overall Study|Death|64|||
160801369|NCT01088503|580663152|FG001|Overall Study|Death|358|||
160801370|NCT01088503|580663153|FG002|Overall Study|Death|7|||
160801371|NCT00110214|580663154|FG000|Overall Study|Never started treatment|21|||
160801372|NCT00110214|580663155|FG001|Overall Study|Never started treatment|20|||
160801373|NCT00110214|580663154|FG000|Overall Study|Disease progression or death|260|||
160801374|NCT00110214|580663155|FG001|Overall Study|Disease progression or death|151|||
160801375|NCT00110214|580663154|FG000|Overall Study|Adverse Event|115|||
160801376|NCT00110214|580663155|FG001|Overall Study|Adverse Event|192|||
160801377|NCT00110214|580663154|FG000|Overall Study|Refused further treatment|52|||
160801378|NCT00110214|580663155|FG001|Overall Study|Refused further treatment|65|||
160801379|NCT00110214|580663154|FG000|Overall Study|Other (not specified)|61|||
160801380|NCT00110214|580663155|FG001|Overall Study|Other (not specified)|75|||
160801381|NCT01673646|580663158|FG000|Overall Study|Adverse Event|2|||
160801382|NCT01673646|580663159|FG001|Overall Study|Adverse Event|1|||
160801383|NCT01673646|580663160|FG002|Overall Study|Adverse Event|1|||
160801384|NCT01673646|580663158|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160801385|NCT01673646|580663159|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160801386|NCT01673646|580663160|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160801387|NCT01673646|580663158|FG000|Overall Study|Condition no longer requires study drug|0|||
160801388|NCT01673646|580663159|FG001|Overall Study|Condition no longer requires study drug|1|||
160801389|NCT01673646|580663160|FG002|Overall Study|Condition no longer requires study drug|0|||
160801390|NCT01673646|580663158|FG000|Overall Study|Withdrawal by Subject|0|||
160801391|NCT01673646|580663159|FG001|Overall Study|Withdrawal by Subject|2|||
160801392|NCT01673646|580663160|FG002|Overall Study|Withdrawal by Subject|2|||
160801393|NCT01673646|580663158|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
160801394|NCT01673646|580663159|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
160801395|NCT01673646|580663160|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
160801396|NCT04577781|580663164|FG000|Overall Study|Adverse Event|2|||
160801397|NCT04577781|580663165|FG001|Overall Study|Adverse Event|2|||
160984912|NCT01923428|581333838|FG002|Overall Study|Withdrawal by Subject|0|||
160801398|NCT04577781|580663164|FG000|Overall Study|Physician Decision|1|||
160801399|NCT04577781|580663165|FG001|Overall Study|Physician Decision|0|||
160801400|NCT03894891|580663166|FG000|Overall Study|Withdrawal by Subject|1|||
160801401|NCT03894891|580663166|FG000|Overall Study|Completed protocol treatment per protocol|5|||
160801402|NCT04389866|580663170|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
160801403|NCT04389866|580663171|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
160801404|NCT00776789|580663174|FG000|Overall Study|Consent refusal|2|||
160801405|NCT00776789|580663175|FG001|Overall Study|Consent refusal|2|||
160801406|NCT00776789|580663174|FG000|Overall Study|Poor quality video|1|||
160801407|NCT00776789|580663175|FG001|Overall Study|Poor quality video|1|||
160801408|NCT04940130|580663176|FG000|Overall Study|Travel|1|||
160801409|NCT04940130|580663177|FG001|Overall Study|Travel|0|||
160801410|NCT04940130|580663178|FG002|Overall Study|Travel|2|||
160801411|NCT04940130|580663176|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
160801412|NCT04940130|580663177|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
160801413|NCT04940130|580663178|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
160801414|NCT04940130|580663176|FG000|Overall Study|Adverse Event|0|||
160801415|NCT04940130|580663177|FG001|Overall Study|Adverse Event|0|||
160801416|NCT04940130|580663178|FG002|Overall Study|Adverse Event|2|||
160801417|NCT04940130|580663176|FG000|Overall Study|Disease progression/treatment failure|0|||
160801418|NCT04940130|580663177|FG001|Overall Study|Disease progression/treatment failure|0|||
160801419|NCT04940130|580663178|FG002|Overall Study|Disease progression/treatment failure|1|||
160801420|NCT04940130|580663176|FG000|Overall Study|Participant refusal|0|||
160801421|NCT04940130|580663177|FG001|Overall Study|Participant refusal|0|||
160801422|NCT04940130|580663178|FG002|Overall Study|Participant refusal|1|||
160801423|NCT02850978|580663181|FG000|Overall Study|Uncollectable CRF|27|||
160801424|NCT02850978|580663181|FG000|Overall Study|No visit since the first visit|35|||
160801425|NCT02850978|580663181|FG000|Overall Study|Adverse Event|81|||
160801426|NCT02850978|580663181|FG000|Overall Study|Lack of Efficacy|40|||
160801427|NCT02850978|580663181|FG000|Overall Study|Improvement in condition|34|||
160801428|NCT02850978|580663181|FG000|Overall Study|Lost to Follow-up|121|||
160801429|NCT02850978|580663181|FG000|Overall Study|Reason not listed|88|||
160801430|NCT00114127|580663182|FG000|Overall Study|Adverse Event|2|||
160801431|NCT00114127|580663183|FG001|Overall Study|Adverse Event|1|||
160801432|NCT00114127|580663182|FG000|Overall Study|Lost to Follow-up|1|||
160801433|NCT00114127|580663183|FG001|Overall Study|Lost to Follow-up|0|||
160801434|NCT00114127|580663182|FG000|Overall Study|Withdrawal by Subject|1|||
160801435|NCT00114127|580663183|FG001|Overall Study|Withdrawal by Subject|3|||
160801436|NCT00421148|580663184|FG000|Overall Study|Lost to Follow-up|0|||
160801437|NCT00421148|580663185|FG001|Overall Study|Lost to Follow-up|0|||
160801438|NCT00421148|580663186|FG002|Overall Study|Lost to Follow-up|0|||
160801439|NCT00421148|580663187|FG003|Overall Study|Lost to Follow-up|0|||
160801440|NCT00421148|580663188|FG004|Overall Study|Lost to Follow-up|0|||
160801441|NCT00421148|580663189|FG005|Overall Study|Lost to Follow-up|0|||
160801442|NCT00421148|580663190|FG006|Overall Study|Lost to Follow-up|0|||
160801443|NCT00421148|580663191|FG007|Overall Study|Lost to Follow-up|0|||
160801444|NCT00421148|580663192|FG008|Overall Study|Lost to Follow-up|0|||
160801445|NCT00421148|580663193|FG009|Overall Study|Lost to Follow-up|0|||
160801446|NCT00421148|580663194|FG010|Overall Study|Lost to Follow-up|0|||
160801447|NCT00421148|580663195|FG011|Overall Study|Lost to Follow-up|0|||
160801448|NCT00421148|580663196|FG012|Overall Study|Lost to Follow-up|0|||
160801449|NCT00421148|580663197|FG013|Overall Study|Lost to Follow-up|0|||
160801450|NCT00421148|580663198|FG014|Overall Study|Lost to Follow-up|0|||
160801451|NCT00421148|580663199|FG015|Overall Study|Lost to Follow-up|0|||
160801452|NCT00421148|580663200|FG016|Overall Study|Lost to Follow-up|0|||
160801453|NCT00421148|580663201|FG017|Overall Study|Lost to Follow-up|1|||
160801454|NCT00421148|580663202|FG018|Overall Study|Lost to Follow-up|0|||
160801455|NCT00421148|580663203|FG019|Overall Study|Lost to Follow-up|0|||
160801456|NCT00421148|580663184|FG000|Overall Study|Withdrawal by Subject|0|||
160801457|NCT00421148|580663185|FG001|Overall Study|Withdrawal by Subject|0|||
160801458|NCT00421148|580663186|FG002|Overall Study|Withdrawal by Subject|0|||
160801459|NCT00421148|580663187|FG003|Overall Study|Withdrawal by Subject|0|||
160801460|NCT00421148|580663188|FG004|Overall Study|Withdrawal by Subject|0|||
160801461|NCT00421148|580663189|FG005|Overall Study|Withdrawal by Subject|0|||
160801462|NCT00421148|580663190|FG006|Overall Study|Withdrawal by Subject|0|||
160801463|NCT00421148|580663191|FG007|Overall Study|Withdrawal by Subject|0|||
160801464|NCT00421148|580663192|FG008|Overall Study|Withdrawal by Subject|0|||
160801465|NCT00421148|580663193|FG009|Overall Study|Withdrawal by Subject|0|||
160801466|NCT00421148|580663194|FG010|Overall Study|Withdrawal by Subject|0|||
160801467|NCT00421148|580663195|FG011|Overall Study|Withdrawal by Subject|0|||
160801468|NCT00421148|580663196|FG012|Overall Study|Withdrawal by Subject|0|||
160801469|NCT00421148|580663197|FG013|Overall Study|Withdrawal by Subject|0|||
160801470|NCT00421148|580663198|FG014|Overall Study|Withdrawal by Subject|0|||
160801471|NCT00421148|580663199|FG015|Overall Study|Withdrawal by Subject|0|||
160801472|NCT00421148|580663200|FG016|Overall Study|Withdrawal by Subject|0|||
160801473|NCT00421148|580663201|FG017|Overall Study|Withdrawal by Subject|1|||
160801474|NCT00421148|580663202|FG018|Overall Study|Withdrawal by Subject|0|||
160801475|NCT00421148|580663203|FG019|Overall Study|Withdrawal by Subject|0|||
160801476|NCT00421148|580663184|FG000|Overall Study|Protocol Violation|0|||
160801477|NCT00421148|580663185|FG001|Overall Study|Protocol Violation|0|||
160801478|NCT00421148|580663186|FG002|Overall Study|Protocol Violation|0|||
160801479|NCT00421148|580663187|FG003|Overall Study|Protocol Violation|0|||
160801480|NCT00421148|580663188|FG004|Overall Study|Protocol Violation|0|||
160801481|NCT00421148|580663189|FG005|Overall Study|Protocol Violation|1|||
160801482|NCT00421148|580663190|FG006|Overall Study|Protocol Violation|0|||
160801483|NCT00421148|580663191|FG007|Overall Study|Protocol Violation|0|||
160801484|NCT00421148|580663192|FG008|Overall Study|Protocol Violation|0|||
160801485|NCT00421148|580663193|FG009|Overall Study|Protocol Violation|0|||
160801486|NCT00421148|580663194|FG010|Overall Study|Protocol Violation|0|||
160801487|NCT00421148|580663195|FG011|Overall Study|Protocol Violation|0|||
160801488|NCT00421148|580663196|FG012|Overall Study|Protocol Violation|0|||
160801489|NCT00421148|580663197|FG013|Overall Study|Protocol Violation|0|||
160801490|NCT00421148|580663198|FG014|Overall Study|Protocol Violation|0|||
160801491|NCT00421148|580663199|FG015|Overall Study|Protocol Violation|0|||
160801492|NCT00421148|580663200|FG016|Overall Study|Protocol Violation|0|||
160801493|NCT00421148|580663201|FG017|Overall Study|Protocol Violation|0|||
160801494|NCT00421148|580663202|FG018|Overall Study|Protocol Violation|1|||
160801495|NCT00421148|580663203|FG019|Overall Study|Protocol Violation|0|||
160801496|NCT00570713|580663204|FG000|Overall Study|Adverse Event|16|||
160801497|NCT00570713|580663205|FG001|Overall Study|Adverse Event|9|||
160801498|NCT00570713|580663204|FG000|Overall Study|Death|7|||
160801499|NCT00570713|580663205|FG001|Overall Study|Death|7|||
160801500|NCT00570713|580663204|FG000|Overall Study|Lack of Efficacy|40|||
160801501|NCT00570713|580663205|FG001|Overall Study|Lack of Efficacy|49|||
160801502|NCT00570713|580663204|FG000|Overall Study|Physician Decision|2|||
160801503|NCT00570713|580663205|FG001|Overall Study|Physician Decision|2|||
160801504|NCT00570713|580663204|FG000|Overall Study|Withdrawal by Subject|3|||
160801505|NCT00570713|580663205|FG001|Overall Study|Withdrawal by Subject|3|||
160801506|NCT00570713|580663204|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
160801507|NCT00570713|580663205|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
160801508|NCT00469833|580663206|FG000|Overall Study|No IV access|2|||
160801509|NCT03289533|580663207|FG000|Overall Study|Death|12|||
160801510|NCT03289533|580663207|FG000|Overall Study|Terminated from study by sponsor|10|||
160801511|NCT00539240|580663208|FG000|Overall Study|Withdrawal by Subject|0|||
160801512|NCT00539240|580663209|FG001|Overall Study|Withdrawal by Subject|2|||
160801513|NCT00539240|580663210|FG002|Overall Study|Withdrawal by Subject|0|||
160801514|NCT00539240|580663208|FG000|Overall Study|Protocol Violation|1|||
160801515|NCT00539240|580663209|FG001|Overall Study|Protocol Violation|1|||
160801516|NCT00539240|580663210|FG002|Overall Study|Protocol Violation|4|||
160801517|NCT00539240|580663208|FG000|Overall Study|Lost to Follow-up|2|||
160801518|NCT00539240|580663209|FG001|Overall Study|Lost to Follow-up|3|||
160801519|NCT00539240|580663210|FG002|Overall Study|Lost to Follow-up|1|||
160801520|NCT00539240|580663208|FG000|Overall Study|Adverse Event|3|||
160801521|NCT00539240|580663209|FG001|Overall Study|Adverse Event|1|||
160801522|NCT00539240|580663210|FG002|Overall Study|Adverse Event|10|||
160801523|NCT01284959|580663211|FG000|Overall Study|Withdrawal by Subject|1|||
160801524|NCT01284959|580663212|FG001|Overall Study|Withdrawal by Subject|0|||
160801525|NCT01284959|580663213|FG002|Overall Study|Withdrawal by Subject|0|||
160801526|NCT01284959|580663211|FG000|Overall Study|Adverse Event|0|||
160801527|NCT01284959|580663212|FG001|Overall Study|Adverse Event|0|||
160801528|NCT01284959|580663213|FG002|Overall Study|Adverse Event|1|||
160801529|NCT01055613|580663214|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
160801530|NCT01055613|580663215|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160801531|NCT01055613|580663214|FG000|Overall Study|Unacceptable lens fit|1|||
160801532|NCT01055613|580663215|FG001|Overall Study|Unacceptable lens fit|0|||
160801533|NCT01055613|580663214|FG000|Overall Study|Discomfort|2|||
160801534|NCT01055613|580663215|FG001|Overall Study|Discomfort|1|||
160801535|NCT01055613|580663214|FG000|Overall Study|Lost to Follow-up|1|||
160801536|NCT01055613|580663215|FG001|Overall Study|Lost to Follow-up|1|||
160801537|NCT01055613|580663214|FG000|Overall Study|Protocol Violation|1|||
160801538|NCT01055613|580663215|FG001|Overall Study|Protocol Violation|1|||
160801539|NCT01055613|580663214|FG000|Overall Study|Subject Disinterest|1|||
160801540|NCT01055613|580663215|FG001|Overall Study|Subject Disinterest|1|||
160801541|NCT00363311|580663216|FG000|Overall Study|Adverse Event|6|||
160801542|NCT00363311|580663217|FG001|Overall Study|Adverse Event|4|||
160801543|NCT00363311|580663216|FG000|Overall Study|Lost to Follow-up|3|||
160984913|NCT01923428|581333839|FG003|Overall Study|Withdrawal by Subject|4|||
160984914|NCT01923428|581333836|FG000|Overall Study|Lost to Follow-up|2|||
160801544|NCT00363311|580663217|FG001|Overall Study|Lost to Follow-up|0|||
160801545|NCT00363311|580663216|FG000|Overall Study|Protocol Violation|1|||
160801546|NCT00363311|580663217|FG001|Overall Study|Protocol Violation|2|||
160801547|NCT00363311|580663216|FG000|Overall Study|Withdrawal by Subject|12|||
160801548|NCT00363311|580663217|FG001|Overall Study|Withdrawal by Subject|6|||
160801549|NCT00363311|580663216|FG000|Overall Study|Physician Decision|1|||
160801550|NCT00363311|580663217|FG001|Overall Study|Physician Decision|1|||
160801551|NCT00363311|580663216|FG000|Overall Study|Sponsor Terminated Study|2|||
160801552|NCT00363311|580663217|FG001|Overall Study|Sponsor Terminated Study|2|||
160801553|NCT00363311|580663216|FG000|Overall Study|Disease Progression|46|||
160801554|NCT00363311|580663217|FG001|Overall Study|Disease Progression|26|||
160801555|NCT00363311|580663216|FG000|Overall Study|Non-Compliance|1|||
160801556|NCT00363311|580663217|FG001|Overall Study|Non-Compliance|1|||
160801557|NCT00363311|580663216|FG000|Overall Study|Participant Refused Biopsy|1|||
160801558|NCT00363311|580663217|FG001|Overall Study|Participant Refused Biopsy|0|||
160801559|NCT00363311|580663216|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
160801560|NCT00363311|580663217|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
160984915|NCT01923428|581333837|FG001|Overall Study|Lost to Follow-up|1|||
160984916|NCT01923428|581333838|FG002|Overall Study|Lost to Follow-up|5|||
160984917|NCT01923428|581333839|FG003|Overall Study|Lost to Follow-up|0|||
160984918|NCT01923428|581333836|FG000|Overall Study|Protocol Violation|3|||
160984919|NCT01923428|581333837|FG001|Overall Study|Protocol Violation|0|||
160984920|NCT01923428|581333838|FG002|Overall Study|Protocol Violation|2|||
160984921|NCT01923428|581333839|FG003|Overall Study|Protocol Violation|1|||
160984922|NCT01923428|581333836|FG000|Overall Study|Non Compliance to treatment|1|||
160984923|NCT01923428|581333837|FG001|Overall Study|Non Compliance to treatment|2|||
160984924|NCT01923428|581333838|FG002|Overall Study|Non Compliance to treatment|0|||
160984925|NCT01923428|581333839|FG003|Overall Study|Non Compliance to treatment|1|||
160984926|NCT01923428|581333836|FG000|Overall Study|Lack of Efficacy|0|||
160984927|NCT01923428|581333837|FG001|Overall Study|Lack of Efficacy|0|||
160984928|NCT01923428|581333838|FG002|Overall Study|Lack of Efficacy|1|||
160984929|NCT01923428|581333839|FG003|Overall Study|Lack of Efficacy|1|||
160984930|NCT04320615|581333840|FG000|Overall Study|Withdrawal by Subject|4|||
160984931|NCT04320615|581333841|FG001|Overall Study|Withdrawal by Subject|10|||
160984932|NCT04320615|581333840|FG000|Overall Study|Physician Decision|2|||
160984933|NCT04320615|581333841|FG001|Overall Study|Physician Decision|0|||
160984934|NCT04320615|581333840|FG000|Overall Study|Other|2|||
160984935|NCT04320615|581333841|FG001|Overall Study|Other|0|||
160984936|NCT04320615|581333840|FG000|Overall Study|Lost to Follow-up|5|||
160644259|NCT01799590|580080713|FG002|Overall Study|Pregnancy|0|||
160644260|NCT01799590|580080711|FG000|Overall Study|Lack of Efficacy|3|||
160644261|NCT01799590|580080712|FG001|Overall Study|Lack of Efficacy|1|||
160644262|NCT01799590|580080713|FG002|Overall Study|Lack of Efficacy|3|||
160644263|NCT01799590|580080711|FG000|Overall Study|Participants convenience|4|||
160644264|NCT01799590|580080712|FG001|Overall Study|Participants convenience|4|||
160644265|NCT01799590|580080713|FG002|Overall Study|Participants convenience|2|||
160644266|NCT01799590|580080711|FG000|Overall Study|Aggravation of complications|0|||
160644267|NCT01799590|580080712|FG001|Overall Study|Aggravation of complications|1|||
160644268|NCT01799590|580080713|FG002|Overall Study|Aggravation of complications|1|||
160644269|NCT01799590|580080711|FG000|Overall Study|Using drugs with restricted days of use|0|||
160644270|NCT01799590|580080712|FG001|Overall Study|Using drugs with restricted days of use|3|||
160644271|NCT01799590|580080713|FG002|Overall Study|Using drugs with restricted days of use|2|||
160644272|NCT01799590|580080711|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
160644273|NCT01799590|580080712|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
160644274|NCT01799590|580080713|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
160644275|NCT01799590|580080711|FG000|Overall Study|Other|3|||
160644276|NCT01799590|580080712|FG001|Overall Study|Other|0|||
160644277|NCT01799590|580080713|FG002|Overall Study|Other|1|||
160644278|NCT00752791|580080714|FG000|Overall Study|Adverse Event|7|||
160644279|NCT00752791|580080714|FG000|Overall Study|Withdrawal by Subject|1|||
160644280|NCT00752791|580080714|FG000|Overall Study|Physician Decision|1|||
160644281|NCT00752791|580080714|FG000|Overall Study|Death|1|||
160644282|NCT00752791|580080714|FG000|Overall Study|Renal transplant|3|||
160644283|NCT00752791|580080714|FG000|Overall Study|Switched to hemodialysis|2|||
160644284|NCT00752791|580080714|FG000|Overall Study|Protocol deviation|1|||
160644285|NCT01769378|580080717|FG000|Overall Study|Adverse Event|10|||
160644286|NCT01769378|580080718|FG001|Overall Study|Adverse Event|0|||
160644287|NCT01769378|580080717|FG000|Overall Study|Entry criteria not met|1|||
160644288|NCT01769378|580080718|FG001|Overall Study|Entry criteria not met|0|||
160644289|NCT01769378|580080717|FG000|Overall Study|Protocol Violation|1|||
160644290|NCT01769378|580080718|FG001|Overall Study|Protocol Violation|1|||
160644291|NCT01769378|580080717|FG000|Overall Study|Withdrawal by Subject|10|||
160644292|NCT01769378|580080718|FG001|Overall Study|Withdrawal by Subject|3|||
160644293|NCT01769378|580080717|FG000|Overall Study|Sponsor Decision|1|||
160644294|NCT01769378|580080718|FG001|Overall Study|Sponsor Decision|0|||
160644295|NCT01769378|580080717|FG000|Overall Study|Lost to Follow-up|2|||
160644296|NCT01769378|580080718|FG001|Overall Study|Lost to Follow-up|0|||
160644297|NCT00175019|580080723|FG000|Overall Study|Adverse Event|54|||
160644298|NCT00175019|580080724|FG001|Overall Study|Adverse Event|22|||
160644299|NCT00175019|580080725|FG002|Overall Study|Adverse Event|2|||
160644300|NCT00175019|580080723|FG000|Overall Study|Protocol Violation|6|||
160644301|NCT00175019|580080724|FG001|Overall Study|Protocol Violation|3|||
160644302|NCT00175019|580080725|FG002|Overall Study|Protocol Violation|3|||
160644303|NCT00175019|580080723|FG000|Overall Study|Lost to Follow-up|42|||
160644304|NCT00175019|580080724|FG001|Overall Study|Lost to Follow-up|39|||
160644305|NCT00175019|580080725|FG002|Overall Study|Lost to Follow-up|9|||
160644306|NCT00175019|580080723|FG000|Overall Study|Did not continue under Amendment 4|1|||
160644307|NCT00175019|580080724|FG001|Overall Study|Did not continue under Amendment 4|1|||
160644308|NCT00175019|580080725|FG002|Overall Study|Did not continue under Amendment 4|2|||
160644309|NCT00175019|580080723|FG000|Overall Study|Personal Reason(s)|39|||
160984937|NCT04320615|581333841|FG001|Overall Study|Lost to Follow-up|23|||
160644310|NCT00175019|580080724|FG001|Overall Study|Personal Reason(s)|31|||
160644311|NCT00175019|580080725|FG002|Overall Study|Personal Reason(s)|8|||
160644312|NCT00175019|580080723|FG000|Overall Study|Therapeutic Failure|10|||
160984938|NCT04320615|581333840|FG000|Overall Study|Death|35|||
160984939|NCT04320615|581333841|FG001|Overall Study|Death|71|||
160801561|NCT00363311|580663216|FG000|Overall Study|Participant Opted for Treatment|1|||
160801562|NCT00363311|580663217|FG001|Overall Study|Participant Opted for Treatment|0|||
160801563|NCT00363311|580663216|FG000|Overall Study|Participant Moved to Another Country|1|||
160801564|NCT00363311|580663217|FG001|Overall Study|Participant Moved to Another Country|0|||
160801565|NCT00363311|580663216|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
160801566|NCT00363311|580663217|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
160801567|NCT00363311|580663216|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
160801568|NCT00363311|580663217|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
160801569|NCT00363311|580663216|FG000|Overall Study|Participant Moved to Louisiana|0|||
160801570|NCT00363311|580663217|FG001|Overall Study|Participant Moved to Louisiana|1|||
160801571|NCT00401843|580663218|FG000|Overall Study|Achieved Complete Response|1|||
160801572|NCT00401843|580663219|FG001|Overall Study|Achieved Complete Response|5|||
160801573|NCT00401843|580663220|FG002|Overall Study|Achieved Complete Response|11|||
160801574|NCT00401843|580663218|FG000|Overall Study|Adverse Event|7|||
160801575|NCT00401843|580663219|FG001|Overall Study|Adverse Event|26|||
160801576|NCT00401843|580663220|FG002|Overall Study|Adverse Event|27|||
160801577|NCT00401843|580663218|FG000|Overall Study|Death|0|||
160801578|NCT00401843|580663219|FG001|Overall Study|Death|8|||
160801579|NCT00401843|580663220|FG002|Overall Study|Death|10|||
160801580|NCT00401843|580663218|FG000|Overall Study|Disease progression|10|||
160801581|NCT00401843|580663219|FG001|Overall Study|Disease progression|60|||
160801582|NCT00401843|580663220|FG002|Overall Study|Disease progression|49|||
160801583|NCT00401843|580663218|FG000|Overall Study|End of Study|1|||
160801584|NCT00401843|580663219|FG001|Overall Study|End of Study|1|||
160801585|NCT00401843|580663220|FG002|Overall Study|End of Study|2|||
160801586|NCT00401843|580663218|FG000|Overall Study|Lost to Follow-up|0|||
160801587|NCT00401843|580663219|FG001|Overall Study|Lost to Follow-up|0|||
160801588|NCT00401843|580663220|FG002|Overall Study|Lost to Follow-up|2|||
160801589|NCT00401843|580663218|FG000|Overall Study|Other Unspecified|0|||
160801590|NCT00401843|580663219|FG001|Overall Study|Other Unspecified|3|||
160801591|NCT00401843|580663220|FG002|Overall Study|Other Unspecified|5|||
160801592|NCT00401843|580663218|FG000|Overall Study|Physician Decision|0|||
160801593|NCT00401843|580663219|FG001|Overall Study|Physician Decision|16|||
160801594|NCT00401843|580663220|FG002|Overall Study|Physician Decision|10|||
160801595|NCT00401843|580663218|FG000|Overall Study|Protocol Violation|0|||
160801596|NCT00401843|580663219|FG001|Overall Study|Protocol Violation|0|||
160801597|NCT00401843|580663220|FG002|Overall Study|Protocol Violation|1|||
160801598|NCT00401843|580663218|FG000|Overall Study|Withdrawal by Subject|1|||
160801599|NCT00401843|580663219|FG001|Overall Study|Withdrawal by Subject|5|||
160801600|NCT00401843|580663220|FG002|Overall Study|Withdrawal by Subject|5|||
160801601|NCT00401843|580663218|FG000|Overall Study|Withdrawal of consent to study agent|1|||
160801602|NCT00401843|580663219|FG001|Overall Study|Withdrawal of consent to study agent|15|||
160801603|NCT00401843|580663220|FG002|Overall Study|Withdrawal of consent to study agent|17|||
160801604|NCT00401843|580663218|FG000|Overall Study|Randomized but not Treated|0|||
160801605|NCT00401843|580663219|FG001|Overall Study|Randomized but not Treated|2|||
160801606|NCT00401843|580663220|FG002|Overall Study|Randomized but not Treated|3|||
160801607|NCT00401843|580663218|FG000|Overall Study|Received incorrect treatment|0|||
160801608|NCT00401843|580663219|FG001|Overall Study|Received incorrect treatment|3|||
160801609|NCT00401843|580663220|FG002|Overall Study|Received incorrect treatment|0|||
160801610|NCT04881760|580663223|FG000|Overall Study|Adverse Event|0|||
160896981|NCT02497612|581018715|FG003|Overall Study|Adverse Event|1|||
160896982|NCT02497612|581018712|FG000|Overall Study|Lost to Follow-up|1|||
160896983|NCT02497612|581018713|FG001|Overall Study|Lost to Follow-up|1|||
160896984|NCT02497612|581018714|FG002|Overall Study|Lost to Follow-up|0|||
160896985|NCT02497612|581018715|FG003|Overall Study|Lost to Follow-up|1|||
160801611|NCT04881760|580663224|FG001|Overall Study|Adverse Event|1|||
160801612|NCT04881760|580663225|FG002|Overall Study|Adverse Event|1|||
160801613|NCT04881760|580663226|FG003|Overall Study|Adverse Event|0|||
160801614|NCT04881760|580663227|FG004|Overall Study|Adverse Event|1|||
160896986|NCT02497612|581018712|FG000|Overall Study|Other unspecified|1|||
160896987|NCT02497612|581018713|FG001|Overall Study|Other unspecified|1|||
160896988|NCT02497612|581018714|FG002|Overall Study|Other unspecified|2|||
160984940|NCT03873246|581333843|FG000|Overall Study|Adverse Event|1|||
160801615|NCT04881760|580663228|FG005|Overall Study|Adverse Event|1|||
160801616|NCT04881760|580663229|FG006|Overall Study|Adverse Event|2|||
160801617|NCT04881760|580663223|FG000|Overall Study|Death|0|||
160801618|NCT04881760|580663224|FG001|Overall Study|Death|0|||
160801619|NCT04881760|580663225|FG002|Overall Study|Death|0|||
160801620|NCT04881760|580663226|FG003|Overall Study|Death|1|||
160801621|NCT04881760|580663227|FG004|Overall Study|Death|0|||
160801622|NCT04881760|580663228|FG005|Overall Study|Death|0|||
160801623|NCT04881760|580663229|FG006|Overall Study|Death|0|||
160801624|NCT04881760|580663223|FG000|Overall Study|Lost to Follow-up|5|||
160801625|NCT04881760|580663224|FG001|Overall Study|Lost to Follow-up|7|||
160801626|NCT04881760|580663225|FG002|Overall Study|Lost to Follow-up|5|||
160801627|NCT04881760|580663226|FG003|Overall Study|Lost to Follow-up|1|||
160896989|NCT02497612|581018715|FG003|Overall Study|Other unspecified|0|||
160896990|NCT02497612|581018712|FG000|Overall Study|Not eligible|1|||
160801628|NCT04881760|580663227|FG004|Overall Study|Lost to Follow-up|2|||
160801629|NCT04881760|580663228|FG005|Overall Study|Lost to Follow-up|4|||
160984941|NCT03873246|581333844|FG001|Overall Study|Adverse Event|3|||
160984942|NCT03873246|581333845|FG002|Overall Study|Adverse Event|3|||
160801630|NCT04881760|580663229|FG006|Overall Study|Lost to Follow-up|4|||
160801631|NCT04881760|580663223|FG000|Overall Study|Withdrawal by Subject|13|||
160801632|NCT04881760|580663224|FG001|Overall Study|Withdrawal by Subject|1|||
160984943|NCT03873246|581333843|FG000|Overall Study|Lost to Follow-up|4|||
160984944|NCT03873246|581333844|FG001|Overall Study|Lost to Follow-up|4|||
160984945|NCT03873246|581333845|FG002|Overall Study|Lost to Follow-up|5|||
160984946|NCT03873246|581333843|FG000|Overall Study|Protocol Violation|0|||
160984947|NCT03873246|581333844|FG001|Overall Study|Protocol Violation|1|||
160984948|NCT03873246|581333845|FG002|Overall Study|Protocol Violation|0|||
160984949|NCT03873246|581333843|FG000|Overall Study|Withdrawal by Subject|0|||
160984950|NCT03873246|581333844|FG001|Overall Study|Withdrawal by Subject|4|||
160984951|NCT03873246|581333845|FG002|Overall Study|Withdrawal by Subject|1|||
160984952|NCT00946647|581333846|FG000|Phase 1 Part|Adverse Event|2|||
160984953|NCT00946647|581333847|FG001|Phase 1 Part|Adverse Event|5|||
160984954|NCT00946647|581333848|FG002|Phase 1 Part|Adverse Event|3|||
160801633|NCT04881760|580663225|FG002|Overall Study|Withdrawal by Subject|1|||
160801634|NCT04881760|580663226|FG003|Overall Study|Withdrawal by Subject|4|||
160801635|NCT04881760|580663227|FG004|Overall Study|Withdrawal by Subject|2|||
160801636|NCT04881760|580663228|FG005|Overall Study|Withdrawal by Subject|1|||
160801637|NCT04881760|580663229|FG006|Overall Study|Withdrawal by Subject|2|||
160801638|NCT04881760|580663223|FG000|Overall Study|Randomized but Never Treated|0|||
160801639|NCT04881760|580663224|FG001|Overall Study|Randomized but Never Treated|0|||
160801640|NCT04881760|580663225|FG002|Overall Study|Randomized but Never Treated|0|||
160801641|NCT04881760|580663226|FG003|Overall Study|Randomized but Never Treated|1|||
160801642|NCT04881760|580663227|FG004|Overall Study|Randomized but Never Treated|0|||
160801643|NCT04881760|580663228|FG005|Overall Study|Randomized but Never Treated|0|||
160801644|NCT04881760|580663229|FG006|Overall Study|Randomized but Never Treated|0|||
160801645|NCT04881760|580663223|FG000|Overall Study|Inadvertent Enrollment|2|||
160801646|NCT04881760|580663224|FG001|Overall Study|Inadvertent Enrollment|0|||
160801647|NCT04881760|580663225|FG002|Overall Study|Inadvertent Enrollment|0|||
160984955|NCT00946647|581333849|FG003|Phase 1 Part|Adverse Event|0|||
160984956|NCT00946647|581333850|FG004|Phase 1 Part|Adverse Event|0|||
160984957|NCT00946647|581333846|FG000|Phase 1 Part|Disease progression|3|||
160984958|NCT00946647|581333847|FG001|Phase 1 Part|Disease progression|6|||
160984959|NCT00946647|581333848|FG002|Phase 1 Part|Disease progression|1|||
160984960|NCT00946647|581333849|FG003|Phase 1 Part|Disease progression|0|||
160984961|NCT00946647|581333850|FG004|Phase 1 Part|Disease progression|0|||
160984962|NCT00946647|581333846|FG000|Phase 1 Part|Withdrawal by Subject|1|||
160984963|NCT00946647|581333847|FG001|Phase 1 Part|Withdrawal by Subject|4|||
160984964|NCT00946647|581333848|FG002|Phase 1 Part|Withdrawal by Subject|3|||
160801648|NCT04881760|580663226|FG003|Overall Study|Inadvertent Enrollment|0|||
160801649|NCT04881760|580663227|FG004|Overall Study|Inadvertent Enrollment|0|||
160801650|NCT04881760|580663228|FG005|Overall Study|Inadvertent Enrollment|0|||
160801651|NCT04881760|580663229|FG006|Overall Study|Inadvertent Enrollment|0|||
160801652|NCT04881760|580663223|FG000|Overall Study|Site Closure|0|||
160801653|NCT04881760|580663224|FG001|Overall Study|Site Closure|0|||
160801654|NCT04881760|580663225|FG002|Overall Study|Site Closure|0|||
160801655|NCT04881760|580663226|FG003|Overall Study|Site Closure|1|||
160801656|NCT04881760|580663227|FG004|Overall Study|Site Closure|0|||
160801657|NCT04881760|580663228|FG005|Overall Study|Site Closure|0|||
160801658|NCT04881760|580663229|FG006|Overall Study|Site Closure|0|||
160801659|NCT01182298|580663230|FG000|Overall Study|Lack of Efficacy|4|||
160801660|NCT01182298|580663230|FG000|Overall Study|Withdrawal by Subject|2|||
160801661|NCT01508910|580663231|FG000|Treatment|Death|2|||
160801662|NCT01508910|580663232|FG001|Treatment|Death|3|||
160801663|NCT01508910|580663233|FG002|Treatment|Death|2|||
160801664|NCT01508910|580663234|FG003|Treatment|Death|0|||
160984965|NCT00946647|581333849|FG003|Phase 1 Part|Withdrawal by Subject|0|||
160984966|NCT00946647|581333850|FG004|Phase 1 Part|Withdrawal by Subject|0|||
160984967|NCT00946647|581333846|FG000|Phase 1 Part|Abnormal values|0|||
160984968|NCT00946647|581333847|FG001|Phase 1 Part|Abnormal values|2|||
160984969|NCT00946647|581333848|FG002|Phase 1 Part|Abnormal values|0|||
160801665|NCT01508910|580663231|FG000|Treatment|Lost to Follow-up|0|||
160801666|NCT01508910|580663232|FG001|Treatment|Lost to Follow-up|0|||
160801667|NCT01508910|580663233|FG002|Treatment|Lost to Follow-up|2|||
160984970|NCT00946647|581333849|FG003|Phase 1 Part|Abnormal values|0|||
160984971|NCT00946647|581333850|FG004|Phase 1 Part|Abnormal values|0|||
160984972|NCT00946647|581333846|FG000|Phase 1 Part|Reason missing|0|||
160801668|NCT01508910|580663234|FG003|Treatment|Lost to Follow-up|1|||
160801669|NCT01508910|580663231|FG000|Treatment|Withdrawal by Subject|0|||
160801670|NCT01508910|580663232|FG001|Treatment|Withdrawal by Subject|1|||
160801671|NCT01508910|580663233|FG002|Treatment|Withdrawal by Subject|6|||
160984973|NCT00946647|581333847|FG001|Phase 1 Part|Reason missing|1|||
160644313|NCT00175019|580080724|FG001|Overall Study|Therapeutic Failure|38|||
160644314|NCT00175019|580080725|FG002|Overall Study|Therapeutic Failure|22|||
160644315|NCT00175019|580080723|FG000|Overall Study|Gout Flare|2|||
160644316|NCT00175019|580080724|FG001|Overall Study|Gout Flare|3|||
160644317|NCT00175019|580080725|FG002|Overall Study|Gout Flare|0|||
160644318|NCT00175019|580080723|FG000|Overall Study|Reason Not Specified|40|||
160644319|NCT00175019|580080724|FG001|Overall Study|Reason Not Specified|34|||
160644320|NCT00175019|580080725|FG002|Overall Study|Reason Not Specified|11|||
160644321|NCT01698320|580080732|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
160644322|NCT01698320|580080733|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
160644323|NCT01698320|580080734|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
160644324|NCT01698320|580080732|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
160644325|NCT01698320|580080733|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
160644326|NCT01698320|580080734|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
160644327|NCT01698320|580080732|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
160644328|NCT01698320|580080733|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
160644329|NCT01698320|580080734|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
160644330|NCT01698320|580080732|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
160644331|NCT01698320|580080733|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
160644332|NCT01698320|580080734|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
160644333|NCT01698320|580080732|FG000|12-Week Double-Blind Period|Adverse Event|0|||
160644334|NCT01698320|580080733|FG001|12-Week Double-Blind Period|Adverse Event|1|||
160644335|NCT01698320|580080734|FG002|12-Week Double-Blind Period|Adverse Event|1|||
160644336|NCT01698320|580080732|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
160644337|NCT01698320|580080733|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
160644338|NCT01698320|580080734|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
160644339|NCT01698320|580080732|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
160644340|NCT01698320|580080733|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
160644341|NCT01698320|580080734|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
160644342|NCT01698320|580080732|FG000|12-Week Double-Blind Period|Pregnancy|0|||
160644343|NCT01698320|580080733|FG001|12-Week Double-Blind Period|Pregnancy|1|||
160644344|NCT01698320|580080734|FG002|12-Week Double-Blind Period|Pregnancy|1|||
160644345|NCT01698320|580080732|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
160644346|NCT01698320|580080733|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
160644347|NCT01698320|580080734|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
160644348|NCT01698320|580080732|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
160644349|NCT01698320|580080733|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
160644350|NCT01698320|580080734|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
160644351|NCT01698320|580080732|FG000|40-Week Open-Label Period|Adverse Event|0|||
160644352|NCT01698320|580080733|FG001|40-Week Open-Label Period|Adverse Event|3|||
160644353|NCT01698320|580080734|FG002|40-Week Open-Label Period|Adverse Event|2|||
160644354|NCT01698320|580080732|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
160644355|NCT01698320|580080733|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
160644356|NCT01698320|580080734|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
160644357|NCT01698320|580080732|FG000|40-Week Open-Label Period|Pregnancy|0|||
160644358|NCT01698320|580080733|FG001|40-Week Open-Label Period|Pregnancy|2|||
160644359|NCT01698320|580080734|FG002|40-Week Open-Label Period|Pregnancy|1|||
160644360|NCT01698320|580080732|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
160644361|NCT01698320|580080733|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
160644362|NCT01698320|580080734|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
160644363|NCT01698320|580080732|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
160644364|NCT01698320|580080733|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
160644365|NCT01698320|580080734|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
160644366|NCT01107535|580080738|FG000|Overall Study|Death|5|||
160644367|NCT02444533|580080739|FG000|Overall Study|Not able to complete forms|0|||
160644368|NCT02444533|580080740|FG001|Overall Study|Not able to complete forms|2|||
160644369|NCT02444533|580080739|FG000|Overall Study|Only gave post-procedure complications|2|||
160644370|NCT02444533|580080740|FG001|Overall Study|Only gave post-procedure complications|2|||
160644371|NCT00602030|580080741|FG000|Lead-in Phase|Disease Progression|2|||
160644372|NCT00602030|580080742|FG001|Lead-in Phase|Disease Progression|3|||
160644373|NCT00602030|580080743|FG002|Lead-in Phase|Disease Progression|0|||
160644374|NCT00602030|580080744|FG003|Lead-in Phase|Disease Progression|0|||
160644375|NCT00602030|580080745|FG004|Lead-in Phase|Disease Progression|0|||
160644376|NCT00602030|580080741|FG000|Lead-in Phase|Adverse Event|0|||
160644377|NCT00602030|580080742|FG001|Lead-in Phase|Adverse Event|2|||
160644378|NCT00602030|580080743|FG002|Lead-in Phase|Adverse Event|0|||
160644379|NCT00602030|580080744|FG003|Lead-in Phase|Adverse Event|0|||
160644380|NCT00602030|580080745|FG004|Lead-in Phase|Adverse Event|0|||
160644381|NCT00602030|580080741|FG000|Double-blind Phase|Disease progression|0|||
160644382|NCT00602030|580080742|FG001|Double-blind Phase|Disease progression|0|||
160644383|NCT00602030|580080743|FG002|Double-blind Phase|Disease progression|33|||
160644384|NCT00602030|580080744|FG003|Double-blind Phase|Disease progression|30|||
160801672|NCT01508910|580663234|FG003|Treatment|Withdrawal by Subject|1|||
160801673|NCT01508910|580663231|FG000|Treatment|Sponsor Decision|0|||
160801674|NCT01508910|580663232|FG001|Treatment|Sponsor Decision|0|||
160801675|NCT01508910|580663233|FG002|Treatment|Sponsor Decision|0|||
160801676|NCT01508910|580663234|FG003|Treatment|Sponsor Decision|1|||
160801677|NCT01595529|580663235|FG000|Overall Study|Adverse Event|2|||
160801678|NCT01595529|580663236|FG001|Overall Study|Adverse Event|0|||
160801679|NCT01595529|580663235|FG000|Overall Study|Subject Non-Compliant|2|||
160801680|NCT01595529|580663236|FG001|Overall Study|Subject Non-Compliant|0|||
160801681|NCT01595529|580663235|FG000|Overall Study|Lost to Follow-up|8|||
160801682|NCT01595529|580663236|FG001|Overall Study|Lost to Follow-up|14|||
160801683|NCT01595529|580663235|FG000|Overall Study|Protocol Violation|1|||
160801684|NCT01595529|580663236|FG001|Overall Study|Protocol Violation|2|||
160801685|NCT01595529|580663235|FG000|Overall Study|Physician Decision|1|||
160801686|NCT01595529|580663236|FG001|Overall Study|Physician Decision|0|||
160801687|NCT01595529|580663235|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
160801688|NCT01595529|580663236|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
160801689|NCT01595529|580663235|FG000|Overall Study|Administrative Decision|1|||
160801690|NCT01595529|580663236|FG001|Overall Study|Administrative Decision|0|||
160801691|NCT01595529|580663235|FG000|Overall Study|Entry Failure/Screening Failure|6|||
160801692|NCT01595529|580663236|FG001|Overall Study|Entry Failure/Screening Failure|1|||
160801693|NCT04016714|580663237|FG000|Overall Study|Death|1|||
160896991|NCT02497612|581018713|FG001|Overall Study|Not eligible|0|||
160896992|NCT02497612|581018714|FG002|Overall Study|Not eligible|0|||
160896993|NCT02497612|581018715|FG003|Overall Study|Not eligible|1|||
160896994|NCT02651467|581018716|FG000|Overall Study|Withdrawal by Subject|0|||
160896995|NCT02651467|581018717|FG001|Overall Study|Withdrawal by Subject|0|||
160896996|NCT02651467|581018718|FG002|Overall Study|Withdrawal by Subject|2|||
160896997|NCT02651467|581018716|FG000|Overall Study|Other (Not specified)|1|||
160896998|NCT02651467|581018717|FG001|Overall Study|Other (Not specified)|0|||
160896999|NCT02651467|581018718|FG002|Overall Study|Other (Not specified)|2|||
160897000|NCT05469113|581018719|FG000|Period 2|Adverse Event|0|||
160801694|NCT04016714|580663238|FG001|Overall Study|Death|0|||
160801695|NCT04016714|580663237|FG000|Overall Study|Lost to Follow-up|3|||
160801696|NCT04016714|580663238|FG001|Overall Study|Lost to Follow-up|1|||
160801697|NCT04016714|580663237|FG000|Overall Study|Physician Decision|3|||
160801698|NCT04016714|580663238|FG001|Overall Study|Physician Decision|3|||
160801699|NCT04016714|580663237|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
160801700|NCT04016714|580663238|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
160801701|NCT01677988|580663244|FG000|Overall Study|Lack of Efficacy|2|||
160801702|NCT02629861|580663249|FG000|Overall Study|Adverse Event|7|||
160801703|NCT02629861|580663250|FG001|Overall Study|Adverse Event|5|||
160801704|NCT02629861|580663251|FG002|Overall Study|Adverse Event|4|||
160801705|NCT02629861|580663249|FG000|Overall Study|Withdrawal by Subject|5|||
160801706|NCT02629861|580663250|FG001|Overall Study|Withdrawal by Subject|8|||
160801707|NCT02629861|580663251|FG002|Overall Study|Withdrawal by Subject|13|||
160897001|NCT05469113|581018720|FG001|Period 2|Adverse Event|3|||
160897002|NCT04553679|581018721|FG000|Overall Study|Withdrawal by Subject|2|||
160897003|NCT04553679|581018722|FG001|Overall Study|Withdrawal by Subject|0|||
160897004|NCT04553679|581018721|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
160801708|NCT02629861|580663249|FG000|Overall Study|Protocol Violation|2|||
160801709|NCT02629861|580663250|FG001|Overall Study|Protocol Violation|3|||
160801710|NCT02629861|580663251|FG002|Overall Study|Protocol Violation|7|||
160801711|NCT02629861|580663249|FG000|Overall Study|Lost to Follow-up|12|||
160801712|NCT02629861|580663250|FG001|Overall Study|Lost to Follow-up|9|||
160897005|NCT04553679|581018722|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
160984974|NCT00946647|581333848|FG002|Phase 1 Part|Reason missing|0|||
160984975|NCT00946647|581333849|FG003|Phase 1 Part|Reason missing|0|||
160984976|NCT00946647|581333850|FG004|Phase 1 Part|Reason missing|0|||
160984977|NCT00946647|581333846|FG000|Phase ll Part|Untreated|0|||
160801713|NCT02629861|580663251|FG002|Overall Study|Lost to Follow-up|4|||
160801714|NCT02629861|580663249|FG000|Overall Study|Other|1|||
160801715|NCT02629861|580663250|FG001|Overall Study|Other|1|||
160897006|NCT01230710|581018724|FG000|Overall Study|Disease Progression|41|||
160897007|NCT01230710|581018724|FG000|Overall Study|Lost to Follow-up|3|||
160897008|NCT01230710|581018724|FG000|Overall Study|Death|4|||
160984978|NCT00946647|581333847|FG001|Phase ll Part|Untreated|0|||
160801716|NCT02629861|580663251|FG002|Overall Study|Other|0|||
160801717|NCT02629861|580663249|FG000|Overall Study|Pregnancy|2|||
160801718|NCT02629861|580663250|FG001|Overall Study|Pregnancy|1|||
160801719|NCT02629861|580663251|FG002|Overall Study|Pregnancy|0|||
160801720|NCT01822665|580663252|FG000|Overall Study|Adverse Event|3|||
160801721|NCT01822665|580663252|FG000|Overall Study|Other Reason|5|||
160801722|NCT00165789|580663259|FG000|Overall Study|Adverse Event|0|||
160801723|NCT00165789|580663260|FG001|Overall Study|Adverse Event|3|||
160801724|NCT00165789|580663261|FG002|Overall Study|Adverse Event|0|||
160801725|NCT00165789|580663262|FG003|Overall Study|Adverse Event|12|||
160897009|NCT01230710|581018724|FG000|Overall Study|Withdrawal of Consent|1|||
160984979|NCT00946647|581333848|FG002|Phase ll Part|Untreated|0|||
160801726|NCT00165789|580663259|FG000|Overall Study|Withdrawal by Subject|0|||
160801727|NCT00165789|580663260|FG001|Overall Study|Withdrawal by Subject|1|||
160801728|NCT00165789|580663261|FG002|Overall Study|Withdrawal by Subject|1|||
160801729|NCT00165789|580663262|FG003|Overall Study|Withdrawal by Subject|2|||
160801730|NCT02031302|580663263|FG000|Overall Study|Death|115|||
160801731|NCT02031302|580663264|FG001|Overall Study|Death|0|||
160801732|NCT02031302|580663263|FG000|Overall Study|Not treated with study valve system|18|||
160801733|NCT02031302|580663264|FG001|Overall Study|Not treated with study valve system|0|||
160801734|NCT02031302|580663263|FG000|Overall Study|Missed Follow Up|27|||
160801735|NCT02031302|580663264|FG001|Overall Study|Missed Follow Up|0|||
160801736|NCT02031302|580663263|FG000|Overall Study|Lost to Follow-up|4|||
160801737|NCT02031302|580663264|FG001|Overall Study|Lost to Follow-up|0|||
160801738|NCT01847443|580663265|FG000|Study Period 1|Withdrawal by Subject|0|||
160801739|NCT01847443|580663266|FG001|Study Period 1|Withdrawal by Subject|1|||
160801740|NCT01847443|580663267|FG002|Study Period 1|Withdrawal by Subject|0|||
160801741|NCT01847443|580663268|FG003|Study Period 1|Withdrawal by Subject|0|||
160801742|NCT01847443|580663265|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
160801743|NCT01847443|580663266|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
160801744|NCT01847443|580663267|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
160801745|NCT01847443|580663268|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
160801746|NCT01847443|580663265|FG000|Washout Period Before Study Period 2|Other reason|1|||
160801747|NCT01847443|580663266|FG001|Washout Period Before Study Period 2|Other reason|0|||
160801748|NCT01847443|580663267|FG002|Washout Period Before Study Period 2|Other reason|0|||
160801749|NCT01847443|580663268|FG003|Washout Period Before Study Period 2|Other reason|0|||
160801750|NCT01847443|580663265|FG000|Washout Period Before Study Period 3|Other reason|1|||
160801751|NCT01847443|580663266|FG001|Washout Period Before Study Period 3|Other reason|0|||
160801752|NCT01847443|580663267|FG002|Washout Period Before Study Period 3|Other reason|0|||
160801753|NCT01847443|580663268|FG003|Washout Period Before Study Period 3|Other reason|0|||
160801754|NCT01847443|580663265|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
160801755|NCT01847443|580663266|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
160801756|NCT01847443|580663267|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
160801757|NCT01847443|580663268|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
160801758|NCT01847443|580663265|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
160801759|NCT01847443|580663266|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
160801760|NCT01847443|580663267|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
160801761|NCT01847443|580663268|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
160801762|NCT04422431|580663269|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
160801763|NCT04422431|580663269|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
160801764|NCT04422431|580663269|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
160801765|NCT04422431|580663269|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
160801766|NCT04422431|580663269|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
160801767|NCT04422431|580663269|FG000|Extension Period (48 Weeks)|Other than specified|2|||
160801768|NCT01174563|580663274|FG000|Overall Study|Progressive Disease|45|||
160801769|NCT01174563|580663274|FG000|Overall Study|Death|5|||
160801770|NCT01174563|580663274|FG000|Overall Study|Investigator's Discretion|5|||
160801771|NCT01174563|580663274|FG000|Overall Study|Participant Withdrew Consent|3|||
160801772|NCT01174563|580663274|FG000|Overall Study|Rash Adverse Event|1|||
160801773|NCT01174563|580663274|FG000|Overall Study|Sponsor's decision|1|||
160801774|NCT03402841|580663275|FG000|Overall Study|Withdrawal by Subject|3|||
160801775|NCT03402841|580663275|FG000|Overall Study|Lost to Follow-up|2|||
160801776|NCT03402841|580663275|FG000|Overall Study|Death|146|||
160801777|NCT00444106|580663276|FG000|Overall Study|Lost to Follow-up|2|||
160801778|NCT00444106|580663277|FG001|Overall Study|Lost to Follow-up|1|||
160801779|NCT00444106|580663278|FG002|Overall Study|Lost to Follow-up|0|||
160801780|NCT00444106|580663276|FG000|Overall Study|Abnormal Test Procedure Results|0|||
160801781|NCT00444106|580663277|FG001|Overall Study|Abnormal Test Procedure Results|0|||
160801782|NCT00444106|580663278|FG002|Overall Study|Abnormal Test Procedure Results|1|||
160801783|NCT04704193|580663279|FG000|Overall Study|Withdrawal by Subject|1|||
160801784|NCT05270863|580663280|FG000|Visit 2 First Intervention|Randomization error|0|||
160897010|NCT02905149|581018725|FG000|Overall Study|Lost to Follow-up|2|||
160897011|NCT02905149|581018726|FG001|Overall Study|Lost to Follow-up|0|||
160897012|NCT00747812|581018727|FG000|Overall Study|Research Site Staff Relocation|5|||
160897013|NCT00747812|581018728|FG001|Overall Study|Research Site Staff Relocation|3|||
160897014|NCT01708161|581018729|FG000|Overall Study|Adverse Event|1|||
160801785|NCT05270863|580663281|FG001|Visit 2 First Intervention|Randomization error|0|||
160801786|NCT05270863|580663282|FG002|Visit 2 First Intervention|Randomization error|0|||
160897015|NCT01708161|581018730|FG001|Overall Study|Adverse Event|3|||
160897016|NCT01708161|581018731|FG002|Overall Study|Adverse Event|4|||
160897017|NCT01708161|581018732|FG003|Overall Study|Adverse Event|2|||
160801787|NCT05270863|580663283|FG003|Visit 2 First Intervention|Randomization error|1|||
160897018|NCT01708161|581018733|FG004|Overall Study|Adverse Event|3|||
160644385|NCT00602030|580080745|FG004|Double-blind Phase|Disease progression|0|||
160801788|NCT05270863|580663284|FG004|Visit 2 First Intervention|Randomization error|0|||
160801789|NCT05270863|580663285|FG005|Visit 2 First Intervention|Randomization error|0|||
160801790|NCT05270863|580663280|FG000|First Washout|Withdrawal by Subject|0|||
160801791|NCT05270863|580663281|FG001|First Washout|Withdrawal by Subject|0|||
160801792|NCT05270863|580663282|FG002|First Washout|Withdrawal by Subject|0|||
160801793|NCT05270863|580663283|FG003|First Washout|Withdrawal by Subject|0|||
160801794|NCT05270863|580663284|FG004|First Washout|Withdrawal by Subject|1|||
160801795|NCT05270863|580663285|FG005|First Washout|Withdrawal by Subject|1|||
160801796|NCT05270863|580663280|FG000|First Washout|Lost to Follow-up|0|||
160801797|NCT05270863|580663281|FG001|First Washout|Lost to Follow-up|0|||
160801798|NCT05270863|580663282|FG002|First Washout|Lost to Follow-up|0|||
160801799|NCT05270863|580663283|FG003|First Washout|Lost to Follow-up|0|||
160801800|NCT05270863|580663284|FG004|First Washout|Lost to Follow-up|0|||
160801801|NCT05270863|580663285|FG005|First Washout|Lost to Follow-up|1|||
160801802|NCT05270863|580663280|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
160801803|NCT05270863|580663281|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
160801804|NCT05270863|580663282|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
160801805|NCT05270863|580663283|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
160801806|NCT05270863|580663284|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
160801807|NCT05270863|580663285|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
160801808|NCT05270863|580663280|FG000|Second Washout|Withdrawal by Subject|1|||
160801809|NCT05270863|580663281|FG001|Second Washout|Withdrawal by Subject|1|||
160801810|NCT05270863|580663282|FG002|Second Washout|Withdrawal by Subject|0|||
160801811|NCT05270863|580663283|FG003|Second Washout|Withdrawal by Subject|0|||
160801812|NCT05270863|580663284|FG004|Second Washout|Withdrawal by Subject|0|||
160801813|NCT05270863|580663285|FG005|Second Washout|Withdrawal by Subject|0|||
160801814|NCT05270863|580663280|FG000|Second Washout|Lost to Follow-up|0|||
160801815|NCT05270863|580663281|FG001|Second Washout|Lost to Follow-up|0|||
160801816|NCT05270863|580663282|FG002|Second Washout|Lost to Follow-up|0|||
160801817|NCT05270863|580663283|FG003|Second Washout|Lost to Follow-up|1|||
160801818|NCT05270863|580663284|FG004|Second Washout|Lost to Follow-up|0|||
160801819|NCT05270863|580663285|FG005|Second Washout|Lost to Follow-up|0|||
160801820|NCT03984188|580663286|FG000|Overall Study|Death|2|||
160801821|NCT03984188|580663287|FG001|Overall Study|Death|4|||
160801822|NCT03984188|580663286|FG000|Overall Study|Physician Decision|0|||
160801823|NCT03984188|580663287|FG001|Overall Study|Physician Decision|2|||
160801824|NCT03984188|580663286|FG000|Overall Study|Lost to Follow-up|3|||
160801825|NCT03984188|580663287|FG001|Overall Study|Lost to Follow-up|2|||
160801826|NCT03984188|580663286|FG000|Overall Study|Withdrawal by Subject|6|||
160801827|NCT03984188|580663287|FG001|Overall Study|Withdrawal by Subject|0|||
160801828|NCT03384875|580663288|FG000|Overall Study|Death|1|||
160984980|NCT00946647|581333849|FG003|Phase ll Part|Untreated|0|||
160984981|NCT00946647|581333850|FG004|Phase ll Part|Untreated|2|||
160984982|NCT00946647|581333846|FG000|Phase ll Part|Adverse Event|0|||
160984983|NCT00946647|581333847|FG001|Phase ll Part|Adverse Event|0|||
160984984|NCT00946647|581333848|FG002|Phase ll Part|Adverse Event|0|||
160984985|NCT00946647|581333849|FG003|Phase ll Part|Adverse Event|10|||
160801829|NCT03384875|580663289|FG001|Overall Study|Death|1|||
160801830|NCT03384875|580663290|FG002|Overall Study|Death|0|||
160801831|NCT03384875|580663288|FG000|Overall Study|Reason not provided|1|||
160801832|NCT03384875|580663289|FG001|Overall Study|Reason not provided|0|||
160801833|NCT03384875|580663290|FG002|Overall Study|Reason not provided|0|||
160801834|NCT04592341|580665835|FG000|Overall Study|Physician Decision|5|||
160801835|NCT04592341|580665835|FG000|Overall Study|Study Terminated by Sponsor|5|||
160801836|NCT04592341|580665835|FG000|Overall Study|Withdrawal by Subject|53|||
160801837|NCT04592341|580665835|FG000|Overall Study|Lost to Follow-up|3|||
160801838|NCT04592341|580665835|FG000|Overall Study|Death|1|||
160801839|NCT04592341|580665835|FG000|Overall Study|Adverse Event|5|||
160801840|NCT04592341|580665835|FG000|Overall Study|other|4|||
160801841|NCT02896257|580665836|FG000|Providers|Without eligible patients|21|||
160801842|NCT02896257|580665837|FG001|Providers|Without eligible patients|28|||
160801843|NCT02896257|580665836|FG000|Patients|PFT entry criteria not met|43|||
160801844|NCT02896257|580665837|FG001|Patients|PFT entry criteria not met|50|||
160801845|NCT02896257|580665836|FG000|Patients|No capacity to review|8|||
160801846|NCT02896257|580665837|FG001|Patients|No capacity to review|11|||
160801847|NCT02896257|580665836|FG000|Patients|Appointment rescheduled/cancelled|5|||
160801848|NCT02896257|580665837|FG001|Patients|Appointment rescheduled/cancelled|7|||
160801849|NCT02896257|580665836|FG000|Patients|PCP not assigned a clinic|4|||
160801850|NCT02896257|580665837|FG001|Patients|PCP not assigned a clinic|0|||
160801851|NCT02896257|580665836|FG000|Patients|No history of COPD|0|||
160801852|NCT02896257|580665837|FG001|Patients|No history of COPD|1|||
160801853|NCT02896257|580665836|FG000|Patients|Deceased between review and index date|0|||
160801854|NCT02896257|580665837|FG001|Patients|Deceased between review and index date|1|||
160801855|NCT02896257|580665836|FG000|Patients|No ICS Rx upon review|1|||
160801856|NCT02896257|580665837|FG001|Patients|No ICS Rx upon review|1|||
160801857|NCT02896257|580665836|FG000|Patients|Protocol Violation|2|||
160801858|NCT02896257|580665837|FG001|Patients|Protocol Violation|1|||
160801859|NCT02896257|580665836|FG000|Patients|Hospice care|0|||
160801860|NCT02896257|580665837|FG001|Patients|Hospice care|1|||
160801861|NCT03759600|580665838|FG000|Overall Study|Adverse Event|2|||
160801862|NCT03759600|580665838|FG000|Overall Study|Progressive Disease|15|||
160801863|NCT03759600|580665838|FG000|Overall Study|Site Terminated by Sponsor|3|||
160801864|NCT00692003|580665840|FG000|Overall Study|Sponsor Decision|5|||
160801865|NCT00692003|580665841|FG001|Overall Study|Sponsor Decision|1|||
160801866|NCT03257358|580665842|FG000|Overall Study|Adverse Event|25|||
160801867|NCT03257358|580665843|FG001|Overall Study|Adverse Event|12|||
160801868|NCT03257358|580665842|FG000|Overall Study|Lack of Efficacy|1|||
160801869|NCT03257358|580665843|FG001|Overall Study|Lack of Efficacy|1|||
160801870|NCT03257358|580665842|FG000|Overall Study|Lost to Follow-up|12|||
160801871|NCT03257358|580665843|FG001|Overall Study|Lost to Follow-up|4|||
160801872|NCT03257358|580665842|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
160801873|NCT03257358|580665843|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
160801874|NCT03257358|580665842|FG000|Overall Study|Physician Decision|2|||
160801875|NCT03257358|580665843|FG001|Overall Study|Physician Decision|2|||
160801876|NCT03257358|580665842|FG000|Overall Study|Protocol Violation|5|||
160801877|NCT03257358|580665843|FG001|Overall Study|Protocol Violation|3|||
160801878|NCT03257358|580665842|FG000|Overall Study|Technical problems|4|||
160801879|NCT03257358|580665843|FG001|Overall Study|Technical problems|1|||
160801880|NCT03257358|580665842|FG000|Overall Study|Withdrawal by Subject|8|||
160801881|NCT03257358|580665843|FG001|Overall Study|Withdrawal by Subject|3|||
160801882|NCT03257358|580665842|FG000|Overall Study|Withdrawal of informed consent|9|||
160801883|NCT03257358|580665843|FG001|Overall Study|Withdrawal of informed consent|5|||
160801884|NCT03257358|580665842|FG000|Overall Study|New therapy for study indication|1|||
160801885|NCT03257358|580665843|FG001|Overall Study|New therapy for study indication|0|||
160801886|NCT03257358|580665842|FG000|Overall Study|No longer requires treatment|0|||
160801887|NCT03257358|580665843|FG001|Overall Study|No longer requires treatment|1|||
160801888|NCT02852967|580665844|FG000|Overall Study|Adverse Event|3|||
160801889|NCT02852967|580665845|FG001|Overall Study|Adverse Event|1|||
160801890|NCT02852967|580665846|FG002|Overall Study|Adverse Event|0|||
160801891|NCT02852967|580665847|FG003|Overall Study|Adverse Event|1|||
160801892|NCT02852967|580665848|FG004|Overall Study|Adverse Event|0|||
160801893|NCT02852967|580665844|FG000|Overall Study|Death|1|||
160801894|NCT02852967|580665845|FG001|Overall Study|Death|0|||
160801895|NCT02852967|580665846|FG002|Overall Study|Death|0|||
160801896|NCT02852967|580665847|FG003|Overall Study|Death|0|||
160801897|NCT02852967|580665848|FG004|Overall Study|Death|0|||
160801898|NCT02852967|580665844|FG000|Overall Study|Lost to Follow-up|1|||
160801899|NCT02852967|580665845|FG001|Overall Study|Lost to Follow-up|2|||
160801900|NCT02852967|580665846|FG002|Overall Study|Lost to Follow-up|3|||
160801901|NCT02852967|580665847|FG003|Overall Study|Lost to Follow-up|4|||
160801902|NCT02852967|580665848|FG004|Overall Study|Lost to Follow-up|4|||
160801903|NCT02852967|580665844|FG000|Overall Study|Withdrawal by Subject|6|||
160801904|NCT02852967|580665845|FG001|Overall Study|Withdrawal by Subject|12|||
160801905|NCT02852967|580665846|FG002|Overall Study|Withdrawal by Subject|7|||
160801906|NCT02852967|580665847|FG003|Overall Study|Withdrawal by Subject|10|||
160801907|NCT02852967|580665848|FG004|Overall Study|Withdrawal by Subject|10|||
160801908|NCT02852967|580665844|FG000|Overall Study|SAE|0|||
160801909|NCT02852967|580665845|FG001|Overall Study|SAE|0|||
160801910|NCT02852967|580665846|FG002|Overall Study|SAE|0|||
160801911|NCT02852967|580665847|FG003|Overall Study|SAE|3|||
160801912|NCT02852967|580665848|FG004|Overall Study|SAE|0|||
160801913|NCT02852967|580665844|FG000|Overall Study|Elevated Liver Enzymes|2|||
160801914|NCT02852967|580665845|FG001|Overall Study|Elevated Liver Enzymes|0|||
160801915|NCT02852967|580665846|FG002|Overall Study|Elevated Liver Enzymes|0|||
160801916|NCT02852967|580665847|FG003|Overall Study|Elevated Liver Enzymes|2|||
160801917|NCT02852967|580665848|FG004|Overall Study|Elevated Liver Enzymes|2|||
160801918|NCT02852967|580665844|FG000|Overall Study|Physician Decision|0|||
160897019|NCT01708161|581018734|FG005|Overall Study|Adverse Event|0|||
160897020|NCT01708161|581018729|FG000|Overall Study|Death|0|||
160897021|NCT01708161|581018730|FG001|Overall Study|Death|0|||
160897022|NCT01708161|581018731|FG002|Overall Study|Death|0|||
160897023|NCT01708161|581018732|FG003|Overall Study|Death|1|||
160897024|NCT01708161|581018733|FG004|Overall Study|Death|0|||
160550010|NCT03529773|579740189|FG037|Overall Study|Lost to Follow-up|3|||
160801919|NCT02852967|580665845|FG001|Overall Study|Physician Decision|0|||
160801920|NCT02852967|580665846|FG002|Overall Study|Physician Decision|0|||
160897025|NCT01708161|581018734|FG005|Overall Study|Death|1|||
160897026|NCT01708161|581018729|FG000|Overall Study|Withdrawal by Subject|0|||
160897027|NCT01708161|581018730|FG001|Overall Study|Withdrawal by Subject|1|||
160801921|NCT02852967|580665847|FG003|Overall Study|Physician Decision|1|||
160801922|NCT02852967|580665848|FG004|Overall Study|Physician Decision|0|||
160801923|NCT02852967|580665844|FG000|Overall Study|Lack of Efficacy|0|||
160801924|NCT02852967|580665845|FG001|Overall Study|Lack of Efficacy|1|||
160801925|NCT02852967|580665846|FG002|Overall Study|Lack of Efficacy|0|||
160801926|NCT02852967|580665847|FG003|Overall Study|Lack of Efficacy|0|||
160801927|NCT02852967|580665848|FG004|Overall Study|Lack of Efficacy|0|||
160801928|NCT02852967|580665844|FG000|Overall Study|Non-compliance|0|||
160801929|NCT02852967|580665845|FG001|Overall Study|Non-compliance|0|||
160801930|NCT02852967|580665846|FG002|Overall Study|Non-compliance|1|||
160801931|NCT02852967|580665847|FG003|Overall Study|Non-compliance|1|||
160801932|NCT02852967|580665848|FG004|Overall Study|Non-compliance|0|||
160801933|NCT02852967|580665844|FG000|Overall Study|Dispensing Drug Violation|0|||
160801934|NCT02852967|580665845|FG001|Overall Study|Dispensing Drug Violation|0|||
160801935|NCT02852967|580665846|FG002|Overall Study|Dispensing Drug Violation|1|||
160801936|NCT02852967|580665847|FG003|Overall Study|Dispensing Drug Violation|0|||
160801937|NCT02852967|580665848|FG004|Overall Study|Dispensing Drug Violation|0|||
160801938|NCT02852967|580665844|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
160801939|NCT02852967|580665845|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
160801940|NCT02852967|580665846|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
160801941|NCT02852967|580665847|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
160801942|NCT02852967|580665848|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
160801943|NCT00339040|580665855|FG000|Stage I|Not able to attend clinic|1|||
160801944|NCT00339040|580665856|FG001|Stage I|Not able to attend clinic|0|||
160801945|NCT00339040|580665855|FG000|Stage I|Protocol Violation|1|||
160801946|NCT00339040|580665856|FG001|Stage I|Protocol Violation|1|||
160801947|NCT00339040|580665855|FG000|Stage II|Lost to Follow-up|3|||
160801948|NCT00339040|580665856|FG001|Stage II|Lost to Follow-up|0|||
160801949|NCT00339040|580665855|FG000|Stage II|Withdrawal by Subject|1|||
160801950|NCT00339040|580665856|FG001|Stage II|Withdrawal by Subject|2|||
160801951|NCT00339040|580665855|FG000|Stage II|Protocol Violation|3|||
160801952|NCT00339040|580665856|FG001|Stage II|Protocol Violation|0|||
160801953|NCT00339040|580665855|FG000|Stage II|Not able to attend clinic|1|||
160801954|NCT00339040|580665856|FG001|Stage II|Not able to attend clinic|0|||
160801955|NCT00339040|580665855|FG000|Stage II|Site closing|2|||
160801956|NCT00339040|580665856|FG001|Stage II|Site closing|0|||
160801957|NCT01747915|580665857|FG000|Overall Study|Other|1|||
160801958|NCT01747915|580665858|FG001|Overall Study|Other|1|||
160801959|NCT01747915|580665859|FG002|Overall Study|Other|1|||
160801960|NCT01747915|580665857|FG000|Overall Study|Adverse Event|8|||
160801961|NCT01747915|580665858|FG001|Overall Study|Adverse Event|5|||
160801962|NCT01747915|580665859|FG002|Overall Study|Adverse Event|2|||
160801963|NCT01747915|580665857|FG000|Overall Study|Death|0|||
160801964|NCT01747915|580665858|FG001|Overall Study|Death|0|||
160801965|NCT01747915|580665859|FG002|Overall Study|Death|1|||
160801966|NCT01747915|580665857|FG000|Overall Study|Lack of Efficacy|0|||
160801967|NCT01747915|580665858|FG001|Overall Study|Lack of Efficacy|1|||
160801968|NCT01747915|580665859|FG002|Overall Study|Lack of Efficacy|0|||
160801969|NCT01747915|580665857|FG000|Overall Study|Lost to Follow-up|1|||
160801970|NCT01747915|580665858|FG001|Overall Study|Lost to Follow-up|0|||
160801971|NCT01747915|580665859|FG002|Overall Study|Lost to Follow-up|0|||
160801972|NCT01747915|580665857|FG000|Overall Study|Withdrawal by Subject|4|||
160801973|NCT01747915|580665858|FG001|Overall Study|Withdrawal by Subject|4|||
160801974|NCT01747915|580665859|FG002|Overall Study|Withdrawal by Subject|1|||
160801975|NCT01747915|580665857|FG000|Overall Study|Protocol Violation|1|||
160801976|NCT01747915|580665858|FG001|Overall Study|Protocol Violation|0|||
160801977|NCT01747915|580665859|FG002|Overall Study|Protocol Violation|0|||
160801978|NCT01747915|580665857|FG000|Overall Study|Pregnancy|0|||
160801979|NCT01747915|580665858|FG001|Overall Study|Pregnancy|0|||
160801980|NCT01747915|580665859|FG002|Overall Study|Pregnancy|1|||
160801981|NCT03341637|580665860|FG000|Overall Study|Lost to Follow-up|1|||
160801982|NCT03341637|580665861|FG001|Overall Study|Lost to Follow-up|0|||
160801983|NCT03341637|580665860|FG000|Overall Study|Withdrawal by Subject|3|||
160801984|NCT03341637|580665861|FG001|Overall Study|Withdrawal by Subject|3|||
160801985|NCT03341637|580665860|FG000|Overall Study|Reason not Specified|1|||
160801986|NCT03341637|580665861|FG001|Overall Study|Reason not Specified|1|||
160801987|NCT00812955|580665862|FG000|Overall Study|Adverse Event|7|||
160801988|NCT00812955|580665863|FG001|Overall Study|Adverse Event|6|||
160801989|NCT00812955|580665864|FG002|Overall Study|Adverse Event|3|||
160801990|NCT00812955|580665865|FG003|Overall Study|Adverse Event|4|||
160801991|NCT00812955|580665862|FG000|Overall Study|Lost to Follow-up|2|||
160801992|NCT00812955|580665863|FG001|Overall Study|Lost to Follow-up|1|||
160801993|NCT00812955|580665864|FG002|Overall Study|Lost to Follow-up|1|||
160801994|NCT00812955|580665865|FG003|Overall Study|Lost to Follow-up|2|||
160801995|NCT00812955|580665862|FG000|Overall Study|Withdrawal by Subject|1|||
160801996|NCT00812955|580665863|FG001|Overall Study|Withdrawal by Subject|0|||
160801997|NCT00812955|580665864|FG002|Overall Study|Withdrawal by Subject|1|||
160801998|NCT00812955|580665865|FG003|Overall Study|Withdrawal by Subject|2|||
160801999|NCT00812955|580665862|FG000|Overall Study|randomized in error|0|||
160802000|NCT00812955|580665863|FG001|Overall Study|randomized in error|0|||
160802001|NCT00812955|580665864|FG002|Overall Study|randomized in error|1|||
160802002|NCT00812955|580665865|FG003|Overall Study|randomized in error|0|||
160802003|NCT03046446|580665866|FG000|Overall Study|Lack of Efficacy|7|||
160802004|NCT03046446|580665866|FG000|Overall Study|Adverse Event|6|||
160802005|NCT03046446|580665866|FG000|Overall Study|Lost to Follow-up|3|||
160802006|NCT03046446|580665866|FG000|Overall Study|Withdrawal by Subject|14|||
160984986|NCT00946647|581333850|FG004|Phase ll Part|Adverse Event|6|||
160802007|NCT03046446|580665866|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
160802008|NCT03046446|580665866|FG000|Overall Study|Disease Progression (see caveats)|25|||
160802009|NCT03046446|580665866|FG000|Overall Study|Non OA related knee surgery|1|||
160802010|NCT03183063|580665867|FG000|Overall Study|Withdrawal by Subject|2|||
160802011|NCT03183063|580665868|FG001|Overall Study|Withdrawal by Subject|0|||
160802012|NCT03183063|580665869|FG002|Overall Study|Withdrawal by Subject|0|||
160802013|NCT03183063|580665867|FG000|Overall Study|Physician Decision|3|||
160802014|NCT03183063|580665868|FG001|Overall Study|Physician Decision|4|||
160802015|NCT03183063|580665869|FG002|Overall Study|Physician Decision|4|||
160802016|NCT00399568|580665870|FG000|Overall Study|Adverse Event|1|||
160802017|NCT00399568|580665871|FG001|Overall Study|Adverse Event|2|||
160802018|NCT00399568|580665870|FG000|Overall Study|Withdrawal by Subject|7|||
160802019|NCT00399568|580665871|FG001|Overall Study|Withdrawal by Subject|3|||
160802020|NCT00399568|580665870|FG000|Overall Study|Protocol non-compliance|2|||
160802021|NCT00399568|580665871|FG001|Overall Study|Protocol non-compliance|2|||
160802022|NCT00399568|580665870|FG000|Overall Study|Lost to Follow-up|2|||
160802023|NCT00399568|580665871|FG001|Overall Study|Lost to Follow-up|2|||
160802024|NCT00925002|580665874|FG000|Overall Study|Other|1|||
160802025|NCT00925002|580665875|FG001|Overall Study|Other|4|||
160802026|NCT00925002|580665876|FG002|Overall Study|Other|0|||
160802027|NCT00925002|580665874|FG000|Overall Study|Death|1|||
160802028|NCT00925002|580665875|FG001|Overall Study|Death|1|||
160802029|NCT00925002|580665876|FG002|Overall Study|Death|5|||
160802030|NCT00925002|580665874|FG000|Overall Study|Adverse Event|3|||
160802031|NCT00925002|580665875|FG001|Overall Study|Adverse Event|1|||
160802032|NCT00925002|580665876|FG002|Overall Study|Adverse Event|2|||
160802033|NCT00925002|580665874|FG000|Overall Study|Participant withdrew consent|1|||
160802034|NCT00925002|580665875|FG001|Overall Study|Participant withdrew consent|3|||
160802035|NCT00925002|580665876|FG002|Overall Study|Participant withdrew consent|3|||
160802036|NCT02071771|580665884|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
160802037|NCT02071771|580665885|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
160802038|NCT02071771|580665884|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
160802039|NCT02071771|580665885|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
160802040|NCT02078752|580665886|FG000|Overall Study|Death|0|||
160802041|NCT02078752|580665887|FG001|Overall Study|Death|3|||
160802042|NCT02078752|580665888|FG002|Overall Study|Death|0|||
160802043|NCT02078752|580665889|FG003|Overall Study|Death|0|||
160802044|NCT02078752|580665890|FG004|Overall Study|Death|0|||
160802045|NCT02078752|580665891|FG005|Overall Study|Death|1|||
160802046|NCT02078752|580665892|FG006|Overall Study|Death|0|||
160802047|NCT02078752|580665893|FG007|Overall Study|Death|1|||
160802048|NCT02078752|580665894|FG008|Overall Study|Death|0|||
160802049|NCT02078752|580665895|FG009|Overall Study|Death|4|||
160802050|NCT02078752|580665886|FG000|Overall Study|Lost to Follow-up|1|||
160802051|NCT02078752|580665887|FG001|Overall Study|Lost to Follow-up|0|||
160802052|NCT02078752|580665888|FG002|Overall Study|Lost to Follow-up|0|||
160802053|NCT02078752|580665889|FG003|Overall Study|Lost to Follow-up|1|||
160802054|NCT02078752|580665890|FG004|Overall Study|Lost to Follow-up|0|||
160802055|NCT02078752|580665891|FG005|Overall Study|Lost to Follow-up|0|||
160802056|NCT02078752|580665892|FG006|Overall Study|Lost to Follow-up|0|||
160802057|NCT02078752|580665893|FG007|Overall Study|Lost to Follow-up|0|||
160802058|NCT02078752|580665894|FG008|Overall Study|Lost to Follow-up|0|||
160802059|NCT02078752|580665895|FG009|Overall Study|Lost to Follow-up|0|||
160802060|NCT02078752|580665886|FG000|Overall Study|Withdrawal by Subject|1|||
160802061|NCT02078752|580665887|FG001|Overall Study|Withdrawal by Subject|1|||
160802062|NCT02078752|580665888|FG002|Overall Study|Withdrawal by Subject|1|||
160802063|NCT02078752|580665889|FG003|Overall Study|Withdrawal by Subject|1|||
160802064|NCT02078752|580665890|FG004|Overall Study|Withdrawal by Subject|0|||
160802065|NCT02078752|580665891|FG005|Overall Study|Withdrawal by Subject|3|||
160802066|NCT02078752|580665892|FG006|Overall Study|Withdrawal by Subject|2|||
160802067|NCT02078752|580665893|FG007|Overall Study|Withdrawal by Subject|1|||
160802068|NCT02078752|580665894|FG008|Overall Study|Withdrawal by Subject|0|||
160802069|NCT02078752|580665895|FG009|Overall Study|Withdrawal by Subject|1|||
160802070|NCT02078752|580665886|FG000|Overall Study|Other|0|||
160802071|NCT02078752|580665887|FG001|Overall Study|Other|3|||
160550011|NCT03529773|579740190|FG038|Overall Study|Lost to Follow-up|1|||
160802072|NCT02078752|580665888|FG002|Overall Study|Other|0|||
160802073|NCT02078752|580665889|FG003|Overall Study|Other|0|||
160802074|NCT02078752|580665890|FG004|Overall Study|Other|1|||
160802075|NCT02078752|580665891|FG005|Overall Study|Other|0|||
160802076|NCT02078752|580665892|FG006|Overall Study|Other|0|||
160802077|NCT02078752|580665893|FG007|Overall Study|Other|1|||
160802078|NCT02078752|580665894|FG008|Overall Study|Other|0|||
160802079|NCT02078752|580665895|FG009|Overall Study|Other|0|||
160802080|NCT02078752|580665886|FG000|Overall Study|Study terminated by sponsor|0|||
160802081|NCT02078752|580665887|FG001|Overall Study|Study terminated by sponsor|0|||
160802082|NCT02078752|580665888|FG002|Overall Study|Study terminated by sponsor|0|||
160802083|NCT02078752|580665889|FG003|Overall Study|Study terminated by sponsor|0|||
160802084|NCT02078752|580665890|FG004|Overall Study|Study terminated by sponsor|0|||
160802085|NCT02078752|580665891|FG005|Overall Study|Study terminated by sponsor|0|||
160984987|NCT00946647|581333846|FG000|Phase ll Part|Withdrawal by Subject|0|||
160984988|NCT00946647|581333847|FG001|Phase ll Part|Withdrawal by Subject|0|||
160984989|NCT00946647|581333848|FG002|Phase ll Part|Withdrawal by Subject|0|||
160984990|NCT00946647|581333849|FG003|Phase ll Part|Withdrawal by Subject|8|||
160984991|NCT00946647|581333850|FG004|Phase ll Part|Withdrawal by Subject|6|||
160984992|NCT00946647|581333846|FG000|Phase ll Part|Administrative problems|0|||
160984993|NCT00946647|581333847|FG001|Phase ll Part|Administrative problems|0|||
160984994|NCT00946647|581333848|FG002|Phase ll Part|Administrative problems|0|||
160984995|NCT00946647|581333849|FG003|Phase ll Part|Administrative problems|3|||
160984996|NCT00946647|581333850|FG004|Phase ll Part|Administrative problems|8|||
160984997|NCT00946647|581333846|FG000|Phase ll Part|Death|0|||
160984998|NCT00946647|581333847|FG001|Phase ll Part|Death|0|||
160984999|NCT00946647|581333848|FG002|Phase ll Part|Death|0|||
160985000|NCT00946647|581333849|FG003|Phase ll Part|Death|7|||
160985001|NCT00946647|581333850|FG004|Phase ll Part|Death|4|||
160985002|NCT00946647|581333846|FG000|Phase ll Part|Disease progression|0|||
160985003|NCT00946647|581333847|FG001|Phase ll Part|Disease progression|0|||
160985004|NCT00946647|581333848|FG002|Phase ll Part|Disease progression|0|||
160985005|NCT00946647|581333849|FG003|Phase ll Part|Disease progression|6|||
160985006|NCT00946647|581333850|FG004|Phase ll Part|Disease progression|14|||
160985007|NCT00946647|581333846|FG000|Phase ll Part|Protocol Violation|0|||
160985008|NCT00946647|581333847|FG001|Phase ll Part|Protocol Violation|0|||
160985009|NCT00946647|581333848|FG002|Phase ll Part|Protocol Violation|0|||
160985010|NCT00946647|581333849|FG003|Phase ll Part|Protocol Violation|4|||
160985011|NCT00946647|581333850|FG004|Phase ll Part|Protocol Violation|2|||
160985012|NCT00946647|581333846|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
160985013|NCT00946647|581333847|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
160985014|NCT00946647|581333848|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
160985015|NCT00946647|581333849|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
160985016|NCT00946647|581333850|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
160985017|NCT01368211|581333851|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
160985018|NCT01368211|581333852|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
160985019|NCT04988477|581333859|FG000|Overall Study|Death|1|||
160985020|NCT04988477|581333860|FG001|Overall Study|Death|0|||
160985021|NCT04988477|581333861|FG002|Overall Study|Death|0|||
160985022|NCT04988477|581333859|FG000|Overall Study|Lost to Follow-up|5|||
160985023|NCT04988477|581333860|FG001|Overall Study|Lost to Follow-up|2|||
160985024|NCT04988477|581333861|FG002|Overall Study|Lost to Follow-up|0|||
160985025|NCT04988477|581333859|FG000|Overall Study|Withdrawal by Subject|2|||
160985026|NCT04988477|581333860|FG001|Overall Study|Withdrawal by Subject|0|||
160985027|NCT04988477|581333861|FG002|Overall Study|Withdrawal by Subject|0|||
160985028|NCT00394095|581335302|FG000|Screening|Withdrawal by Subject|1|||
160985029|NCT00394095|581335303|FG001|Screening|Withdrawal by Subject|0|||
160985030|NCT00394095|581335302|FG000|Randomized|Withdrawal by Subject|5|||
160985031|NCT00394095|581335303|FG001|Randomized|Withdrawal by Subject|1|||
160985032|NCT00394095|581335302|FG000|Randomized|Adverse Event|1|||
160985033|NCT00394095|581335303|FG001|Randomized|Adverse Event|1|||
160985034|NCT00394095|581335302|FG000|Randomized|Overdose|1|||
160985035|NCT00394095|581335303|FG001|Randomized|Overdose|0|||
160985036|NCT00394095|581335302|FG000|Randomized|Lost to Follow-up|1|||
160985037|NCT00394095|581335303|FG001|Randomized|Lost to Follow-up|2|||
160985038|NCT02401529|581335315|FG000|Overall Study|Lost to Follow-up|2|||
160985039|NCT02401529|581335316|FG001|Overall Study|Lost to Follow-up|1|||
160985040|NCT02401529|581335315|FG000|Overall Study|Physician Decision|2|||
160985041|NCT02401529|581335316|FG001|Overall Study|Physician Decision|6|||
160985042|NCT02401529|581335315|FG000|Overall Study|Protocol Violation|5|||
160985043|NCT02401529|581335316|FG001|Overall Study|Protocol Violation|0|||
160985044|NCT01036087|581335317|FG000|Overall Study|Adverse Event|2|||
160985045|NCT01036087|581335317|FG000|Overall Study|Lack of Efficacy|1|||
160985046|NCT00072475|581335320|FG000|Overall Study|Adverse Event|44|||
160985047|NCT00072475|581335320|FG000|Overall Study|Death|3|||
160985048|NCT00072475|581335320|FG000|Overall Study|Withdrawal by Subject|46|||
160985049|NCT00072475|581335320|FG000|Overall Study|Patient/Investigator Decision|4|||
160985050|NCT03303105|581335321|FG000|Overall Study|Adverse Event|0|||
160985051|NCT03303105|581335322|FG001|Overall Study|Adverse Event|2|||
160985052|NCT03303105|581335321|FG000|Overall Study|Lack of Efficacy|1|||
160985053|NCT03303105|581335322|FG001|Overall Study|Lack of Efficacy|0|||
160644386|NCT00602030|580080741|FG000|Double-blind Phase|Adverse Event|0|||
160644387|NCT00602030|580080742|FG001|Double-blind Phase|Adverse Event|0|||
160985054|NCT03303105|581335321|FG000|Overall Study|Protocol Violation|1|||
160985055|NCT03303105|581335322|FG001|Overall Study|Protocol Violation|0|||
160985056|NCT03303105|581335321|FG000|Overall Study|Withdrawal by Subject|0|||
160985057|NCT03303105|581335322|FG001|Overall Study|Withdrawal by Subject|2|||
160985058|NCT02954575|581335328|FG000|Overall Study|Withdrawal by Subject|2|||
160985059|NCT02954575|581335328|FG000|Overall Study|Adverse Event|1|||
160985060|NCT04227340|581335329|FG000|Overall Study|Withdrawal by Subject|3|||
160985061|NCT00570661|581335332|FG000|Overall Study|Disease worsening|5|||
160985062|NCT00570661|581335332|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
160802086|NCT02078752|580665892|FG006|Overall Study|Study terminated by sponsor|0|||
160802087|NCT02078752|580665893|FG007|Overall Study|Study terminated by sponsor|0|||
160802088|NCT02078752|580665894|FG008|Overall Study|Study terminated by sponsor|0|||
160802089|NCT02078752|580665895|FG009|Overall Study|Study terminated by sponsor|5|||
160802090|NCT01567722|580665904|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
160802091|NCT01567722|580665905|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
160802092|NCT01567722|580665906|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
160802093|NCT01567722|580665904|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
160802094|NCT01567722|580665905|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
160802095|NCT01567722|580665906|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
160802096|NCT01567722|580665904|FG000|Overall Study|Protocol closure by the OCG|2|||
160802097|NCT01567722|580665905|FG001|Overall Study|Protocol closure by the OCG|0|||
160802098|NCT01567722|580665906|FG002|Overall Study|Protocol closure by the OCG|0|||
160802099|NCT01567722|580665904|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
160802100|NCT01567722|580665905|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
160802101|NCT01567722|580665906|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
160802102|NCT00382174|580665907|FG000|Overall Study|Lost to Follow-up|1|||
160802103|NCT00382174|580665908|FG001|Overall Study|Lost to Follow-up|4|||
160802104|NCT00382174|580665909|FG002|Overall Study|Lost to Follow-up|5|||
160802105|NCT00382174|580665907|FG000|Overall Study|Adverse Event|1|||
160802106|NCT00382174|580665908|FG001|Overall Study|Adverse Event|4|||
160802107|NCT00382174|580665909|FG002|Overall Study|Adverse Event|5|||
160802108|NCT00382174|580665907|FG000|Overall Study|Withdrawal by Subject|1|||
160802109|NCT00382174|580665908|FG001|Overall Study|Withdrawal by Subject|4|||
160802110|NCT00382174|580665909|FG002|Overall Study|Withdrawal by Subject|5|||
160802111|NCT00382174|580665907|FG000|Overall Study|Non compliance|1|||
160802112|NCT00382174|580665908|FG001|Overall Study|Non compliance|0|||
160802113|NCT00382174|580665909|FG002|Overall Study|Non compliance|1|||
160802114|NCT00382174|580665907|FG000|Overall Study|Physician Decision|0|||
160802115|NCT00382174|580665908|FG001|Overall Study|Physician Decision|2|||
160802116|NCT00382174|580665909|FG002|Overall Study|Physician Decision|2|||
160802117|NCT00382174|580665907|FG000|Overall Study|Failed to meet criteria|0|||
160802118|NCT00382174|580665908|FG001|Overall Study|Failed to meet criteria|1|||
160802119|NCT00382174|580665909|FG002|Overall Study|Failed to meet criteria|1|||
160802120|NCT00382174|580665907|FG000|Overall Study|Wounds merged|0|||
160802121|NCT00382174|580665908|FG001|Overall Study|Wounds merged|2|||
160802122|NCT00382174|580665909|FG002|Overall Study|Wounds merged|2|||
160802123|NCT01464879|580665910|FG000|Overall Study|Physician Decision|1|||
160802124|NCT01464879|580665910|FG000|Overall Study|Non-compliance|1|||
160802125|NCT01657305|580665911|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
160802126|NCT01657305|580665911|FG000|Overall Study|Withdrawal by Subject|4|||
160802127|NCT01657305|580665911|FG000|Overall Study|Adverse Event|1|||
160802128|NCT01657305|580665911|FG000|Overall Study|Lost to Follow-up|1|||
160802129|NCT01657305|580665911|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
160802130|NCT02259114|580665914|FG000|Overall Study|Progressive Disease|14|||
160802131|NCT02259114|580665915|FG001|Overall Study|Progressive Disease|2|||
160802132|NCT02259114|580665916|FG002|Overall Study|Progressive Disease|10|||
160802133|NCT02259114|580665917|FG003|Overall Study|Progressive Disease|2|||
160802134|NCT02259114|580665918|FG004|Overall Study|Progressive Disease|5|||
160802135|NCT02259114|580665914|FG000|Overall Study|Adverse Event|2|||
160802136|NCT02259114|580665915|FG001|Overall Study|Adverse Event|1|||
160802137|NCT02259114|580665916|FG002|Overall Study|Adverse Event|0|||
160897028|NCT01708161|581018731|FG002|Overall Study|Withdrawal by Subject|1|||
160897029|NCT01708161|581018732|FG003|Overall Study|Withdrawal by Subject|0|||
160897030|NCT01708161|581018733|FG004|Overall Study|Withdrawal by Subject|0|||
160897031|NCT01708161|581018734|FG005|Overall Study|Withdrawal by Subject|0|||
160897032|NCT01708161|581018729|FG000|Overall Study|Administrative problems|0|||
160897033|NCT01708161|581018730|FG001|Overall Study|Administrative problems|1|||
160897034|NCT01708161|581018731|FG002|Overall Study|Administrative problems|0|||
160802138|NCT02259114|580665917|FG003|Overall Study|Adverse Event|0|||
160897035|NCT01708161|581018732|FG003|Overall Study|Administrative problems|0|||
160897036|NCT01708161|581018733|FG004|Overall Study|Administrative problems|0|||
160897037|NCT01708161|581018734|FG005|Overall Study|Administrative problems|0|||
160897038|NCT01708161|581018729|FG000|Overall Study|Disease progression|3|||
160897039|NCT01708161|581018730|FG001|Overall Study|Disease progression|5|||
160897040|NCT01708161|581018731|FG002|Overall Study|Disease progression|5|||
160897041|NCT01708161|581018732|FG003|Overall Study|Disease progression|13|||
160897042|NCT01708161|581018733|FG004|Overall Study|Disease progression|3|||
160897043|NCT01708161|581018734|FG005|Overall Study|Disease progression|0|||
160802139|NCT02259114|580665918|FG004|Overall Study|Adverse Event|1|||
160802140|NCT02259114|580665914|FG000|Overall Study|Death|3|||
160802141|NCT02259114|580665915|FG001|Overall Study|Death|0|||
160802142|NCT02259114|580665916|FG002|Overall Study|Death|1|||
160897044|NCT02633501|581018736|FG000|Overall Study|Adverse Event|0|||
160802143|NCT02259114|580665917|FG003|Overall Study|Death|0|||
160802144|NCT02259114|580665918|FG004|Overall Study|Death|0|||
160802145|NCT02259114|580665914|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
160802146|NCT02259114|580665915|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
160802147|NCT02259114|580665916|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
160802148|NCT02259114|580665917|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
160802149|NCT02259114|580665918|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
160802150|NCT02259114|580665914|FG000|Overall Study|Withdrawal by Subject|0|||
160802151|NCT02259114|580665915|FG001|Overall Study|Withdrawal by Subject|0|||
160802152|NCT02259114|580665916|FG002|Overall Study|Withdrawal by Subject|1|||
160802153|NCT02259114|580665917|FG003|Overall Study|Withdrawal by Subject|1|||
160802154|NCT02259114|580665918|FG004|Overall Study|Withdrawal by Subject|0|||
160802155|NCT02259114|580665914|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
160802156|NCT02259114|580665915|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
160802157|NCT02259114|580665916|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
160802158|NCT02259114|580665917|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
160802159|NCT02259114|580665918|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
160802160|NCT02259114|580665914|FG000|Overall Study|Not Treated|1|||
160802161|NCT02259114|580665915|FG001|Overall Study|Not Treated|0|||
160802162|NCT02259114|580665916|FG002|Overall Study|Not Treated|0|||
160802163|NCT02259114|580665917|FG003|Overall Study|Not Treated|0|||
160802164|NCT02259114|580665918|FG004|Overall Study|Not Treated|0|||
160802165|NCT03937479|580665919|FG000|Overall Study|Adverse Event|2|||
160802166|NCT03937479|580665920|FG001|Overall Study|Adverse Event|3|||
160802167|NCT03937479|580665921|FG002|Overall Study|Adverse Event|0|||
160802168|NCT03937479|580665922|FG003|Overall Study|Adverse Event|0|||
160802169|NCT03937479|580665923|FG004|Overall Study|Adverse Event|1|||
160802170|NCT03937479|580665919|FG000|Overall Study|Withdrawal by Subject|3|||
160802171|NCT03937479|580665920|FG001|Overall Study|Withdrawal by Subject|5|||
160802172|NCT03937479|580665921|FG002|Overall Study|Withdrawal by Subject|2|||
160802173|NCT03937479|580665922|FG003|Overall Study|Withdrawal by Subject|2|||
160802174|NCT03937479|580665923|FG004|Overall Study|Withdrawal by Subject|1|||
160802175|NCT03937479|580665919|FG000|Overall Study|Protocol Violation|5|||
160802176|NCT03937479|580665920|FG001|Overall Study|Protocol Violation|6|||
160802177|NCT03937479|580665921|FG002|Overall Study|Protocol Violation|4|||
160802178|NCT03937479|580665922|FG003|Overall Study|Protocol Violation|3|||
160802179|NCT03937479|580665923|FG004|Overall Study|Protocol Violation|2|||
160802180|NCT03937479|580665919|FG000|Overall Study|Lost to Follow-up|0|||
160802181|NCT03937479|580665920|FG001|Overall Study|Lost to Follow-up|1|||
160802182|NCT03937479|580665921|FG002|Overall Study|Lost to Follow-up|0|||
160802183|NCT03937479|580665922|FG003|Overall Study|Lost to Follow-up|1|||
160802184|NCT03937479|580665923|FG004|Overall Study|Lost to Follow-up|0|||
160802185|NCT03937479|580665919|FG000|Overall Study|Physician Decision|0|||
160802186|NCT03937479|580665920|FG001|Overall Study|Physician Decision|0|||
160802187|NCT03937479|580665921|FG002|Overall Study|Physician Decision|1|||
160802188|NCT03937479|580665922|FG003|Overall Study|Physician Decision|0|||
160802189|NCT03937479|580665923|FG004|Overall Study|Physician Decision|1|||
160802190|NCT00940602|580665926|FG000|Overall Study|Administrative problems|1|||
160802191|NCT00940602|580665927|FG001|Overall Study|Administrative problems|1|||
160802192|NCT00940602|580665926|FG000|Overall Study|Patient/guardian decision|13|||
160802193|NCT00940602|580665927|FG001|Overall Study|Patient/guardian decision|28|||
160985063|NCT00570661|581335332|FG000|Overall Study|Adverse Event|1|||
160985064|NCT01066156|581335333|FG000|Overall Study|ineligible|2|||
160802194|NCT00940602|580665926|FG000|Overall Study|Physician Decision|8|||
160802195|NCT00940602|580665927|FG001|Overall Study|Physician Decision|5|||
160802196|NCT00940602|580665926|FG000|Overall Study|Pregnancy|1|||
160802197|NCT00940602|580665927|FG001|Overall Study|Pregnancy|0|||
160802198|NCT00940602|580665926|FG000|Overall Study|Protocol Deviation (untreated)|1|||
160802199|NCT00940602|580665927|FG001|Overall Study|Protocol Deviation (untreated)|0|||
160802200|NCT00940602|580665926|FG000|Overall Study|Disease progression|8|||
160802201|NCT00940602|580665927|FG001|Overall Study|Disease progression|2|||
160802202|NCT00940602|580665926|FG000|Overall Study|Death|38|||
160802203|NCT00940602|580665927|FG001|Overall Study|Death|19|||
160802204|NCT00940602|580665926|FG000|Overall Study|Lost to Follow-up|3|||
160802205|NCT00940602|580665927|FG001|Overall Study|Lost to Follow-up|1|||
160802206|NCT00940602|580665926|FG000|Overall Study|Patient withdrew consent|26|||
160802207|NCT00940602|580665927|FG001|Overall Study|Patient withdrew consent|13|||
160802208|NCT00940602|580665926|FG000|Overall Study|Adverse Event|7|||
160802209|NCT00940602|580665927|FG001|Overall Study|Adverse Event|2|||
160802210|NCT00940602|580665926|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
160802211|NCT00940602|580665927|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
160802212|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
160802213|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
160802214|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
160802215|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
160985065|NCT01066156|581335333|FG000|Overall Study|Lost to Follow-up|7|||
160802216|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
160802217|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
160802218|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
160802219|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
160802220|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
160802221|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
160802222|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
160802223|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
160802224|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
160802225|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
160802226|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
160802227|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
160802228|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
160802229|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
160802230|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
160897045|NCT02633501|581018737|FG001|Overall Study|Adverse Event|0|||
160897046|NCT02633501|581018738|FG002|Overall Study|Adverse Event|1|||
160897047|NCT02633501|581018739|FG003|Overall Study|Adverse Event|0|||
160897048|NCT02633501|581018740|FG004|Overall Study|Adverse Event|1|||
160897049|NCT02633501|581018741|FG005|Overall Study|Adverse Event|1|||
160897050|NCT02633501|581018736|FG000|Overall Study|Withdrawal by Subject|2|||
160897051|NCT02633501|581018737|FG001|Overall Study|Withdrawal by Subject|1|||
160897052|NCT02633501|581018738|FG002|Overall Study|Withdrawal by Subject|2|||
160897053|NCT02633501|581018739|FG003|Overall Study|Withdrawal by Subject|2|||
160897054|NCT02633501|581018740|FG004|Overall Study|Withdrawal by Subject|1|||
160897055|NCT02633501|581018741|FG005|Overall Study|Withdrawal by Subject|3|||
160897056|NCT02633501|581018736|FG000|Overall Study|Various other reasons|0|||
160897057|NCT02633501|581018737|FG001|Overall Study|Various other reasons|2|||
160897058|NCT02633501|581018738|FG002|Overall Study|Various other reasons|4|||
160897059|NCT02633501|581018739|FG003|Overall Study|Various other reasons|1|||
160897060|NCT02633501|581018740|FG004|Overall Study|Various other reasons|7|||
160897061|NCT02633501|581018741|FG005|Overall Study|Various other reasons|11|||
160897062|NCT02633501|581018736|FG000|Overall Study|Lost to Follow-up|0|||
160897063|NCT02633501|581018737|FG001|Overall Study|Lost to Follow-up|0|||
160897064|NCT02633501|581018738|FG002|Overall Study|Lost to Follow-up|0|||
160897065|NCT02633501|581018739|FG003|Overall Study|Lost to Follow-up|1|||
160897066|NCT02633501|581018740|FG004|Overall Study|Lost to Follow-up|2|||
160897067|NCT02633501|581018741|FG005|Overall Study|Lost to Follow-up|0|||
160897068|NCT01986140|581018743|FG000|Overall Study|Withdrawal by Subject|31|||
160897069|NCT01986140|581018744|FG001|Overall Study|Withdrawal by Subject|25|||
160897070|NCT01986140|581018743|FG000|Overall Study|alternative treatment|1|||
160897071|NCT01986140|581018744|FG001|Overall Study|alternative treatment|1|||
160897072|NCT01986140|581018743|FG000|Overall Study|found not eligible|3|||
160897073|NCT01986140|581018744|FG001|Overall Study|found not eligible|0|||
160897074|NCT01986140|581018743|FG000|Overall Study|Adverse Event|0|||
160897075|NCT01986140|581018744|FG001|Overall Study|Adverse Event|1|||
160897076|NCT01986140|581018743|FG000|Overall Study|progression disease|0|||
160897077|NCT01986140|581018744|FG001|Overall Study|progression disease|1|||
160897078|NCT01104155|581018749|FG000|Overall Study|Adverse Event|15|||
160897079|NCT01104155|581018750|FG001|Overall Study|Adverse Event|8|||
160897080|NCT01104155|581018749|FG000|Overall Study|Participant choice|6|||
160897081|NCT01104155|581018750|FG001|Overall Study|Participant choice|5|||
160897082|NCT01104155|581018749|FG000|Overall Study|Withdrawal of consent|1|||
160897083|NCT01104155|581018750|FG001|Overall Study|Withdrawal of consent|1|||
160897084|NCT01104155|581018749|FG000|Overall Study|Other|3|||
160897085|NCT01104155|581018750|FG001|Overall Study|Other|4|||
160897086|NCT01069627|581018762|FG000|Overall Study|Disease progression|7|||
160897087|NCT01069627|581018762|FG000|Overall Study|Adverse Event|12|||
160897088|NCT01069627|581018762|FG000|Overall Study|Protocol Violation|1|||
160897089|NCT02963935|581018767|FG000|Overall Study|Adverse Event|12|||
160897090|NCT02963935|581018768|FG001|Overall Study|Adverse Event|6|||
160897091|NCT02963935|581018767|FG000|Overall Study|Protocol Violation|2|||
160897092|NCT02963935|581018768|FG001|Overall Study|Protocol Violation|1|||
160897093|NCT02963935|581018767|FG000|Overall Study|Lack of Efficacy|0|||
160897094|NCT02963935|581018768|FG001|Overall Study|Lack of Efficacy|2|||
160897095|NCT02963935|581018767|FG000|Overall Study|Lost to Follow-up|1|||
160897096|NCT02963935|581018768|FG001|Overall Study|Lost to Follow-up|6|||
160897097|NCT02963935|581018767|FG000|Overall Study|Unclassified|13|||
160897098|NCT02963935|581018768|FG001|Overall Study|Unclassified|22|||
160897099|NCT00464269|581018769|FG000|Overall Study|Lack of Efficacy|1|||
160897100|NCT00464269|581018770|FG001|Overall Study|Lack of Efficacy|0|||
160802231|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
160802232|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
160802233|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
160802234|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
160802235|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
160802236|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
160550012|NCT03529773|579740191|FG039|Overall Study|Lost to Follow-up|1|||
160802237|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
160802238|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
160802239|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
160802240|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
160802241|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
160802242|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
160802243|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
160802244|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
160802245|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
160802246|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
160802247|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
160802248|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
160802249|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
160802250|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
160802251|NCT00575666|580665931|FG000|Overall Study|Withdrawal by Subject|3|||
160802252|NCT00575666|580665932|FG001|Overall Study|Withdrawal by Subject|2|||
160802253|NCT00575666|580665931|FG000|Overall Study|Physician Decision|1|||
160802254|NCT00575666|580665932|FG001|Overall Study|Physician Decision|1|||
160802255|NCT01374425|580665933|FG000|Overall Study|Radiographic Disease Progression|86|||
160802256|NCT01374425|580665934|FG001|Overall Study|Radiographic Disease Progression|81|||
160802257|NCT01374425|580665933|FG000|Overall Study|Clinical Disease Progression|9|||
160802258|NCT01374425|580665934|FG001|Overall Study|Clinical Disease Progression|6|||
160802259|NCT01374425|580665933|FG000|Overall Study|Adverse Event|29|||
160802260|NCT01374425|580665934|FG001|Overall Study|Adverse Event|18|||
160802261|NCT01374425|580665933|FG000|Overall Study|Death (Progression of Disease)|1|||
160802262|NCT01374425|580665934|FG001|Overall Study|Death (Progression of Disease)|0|||
160802263|NCT01374425|580665933|FG000|Overall Study|Death (Adverse Event)|2|||
160802264|NCT01374425|580665934|FG001|Overall Study|Death (Adverse Event)|4|||
160802265|NCT01374425|580665933|FG000|Overall Study|Withdrawal by Subject|6|||
160802266|NCT01374425|580665934|FG001|Overall Study|Withdrawal by Subject|7|||
160802267|NCT01374425|580665933|FG000|Overall Study|Refused Treatment|10|||
160802268|NCT01374425|580665934|FG001|Overall Study|Refused Treatment|24|||
160802269|NCT01374425|580665933|FG000|Overall Study|Protocol Violation|2|||
160802270|NCT01374425|580665934|FG001|Overall Study|Protocol Violation|3|||
160802271|NCT01374425|580665933|FG000|Overall Study|Sponsor Decision|0|||
160802272|NCT01374425|580665934|FG001|Overall Study|Sponsor Decision|1|||
160802273|NCT01374425|580665933|FG000|Overall Study|Lost to Follow-up|2|||
160802274|NCT01374425|580665934|FG001|Overall Study|Lost to Follow-up|1|||
160802275|NCT01374425|580665933|FG000|Overall Study|Other|41|||
160802276|NCT01374425|580665934|FG001|Overall Study|Other|43|||
160802277|NCT02289469|580665935|FG000|Overall Study|Unable to match a control|6|||
160802278|NCT02289469|580665936|FG001|Overall Study|Unable to match a control|0|||
160802279|NCT01904721|580665939|FG000|Overall Study|Other Reasons|0|||
160802280|NCT01904721|580665940|FG001|Overall Study|Other Reasons|0|||
160802281|NCT01904721|580665941|FG002|Overall Study|Other Reasons|1|||
160802282|NCT01904721|580665942|FG003|Overall Study|Other Reasons|1|||
160802283|NCT01904721|580665943|FG004|Overall Study|Other Reasons|2|||
160802284|NCT01904721|580665944|FG005|Overall Study|Other Reasons|2|||
160802285|NCT01904721|580665945|FG006|Overall Study|Other Reasons|2|||
160802286|NCT01904721|580665939|FG000|Overall Study|Personal Reasons|0|||
160897101|NCT00464269|581018771|FG002|Overall Study|Lack of Efficacy|0|||
160897102|NCT00464269|581018772|FG003|Overall Study|Lack of Efficacy|0|||
160897103|NCT00464269|581018769|FG000|Overall Study|Lost to Follow-up|0|||
160897104|NCT00464269|581018770|FG001|Overall Study|Lost to Follow-up|4|||
160897105|NCT00464269|581018771|FG002|Overall Study|Lost to Follow-up|0|||
160897106|NCT00464269|581018772|FG003|Overall Study|Lost to Follow-up|1|||
160897107|NCT00464269|581018769|FG000|Overall Study|Withdrawal by Subject|0|||
160897108|NCT00464269|581018770|FG001|Overall Study|Withdrawal by Subject|2|||
160897109|NCT00464269|581018771|FG002|Overall Study|Withdrawal by Subject|1|||
160550013|NCT03529773|579740152|FG000|Overall Study|No longer meets eligibility criteria|0|||
160802287|NCT01904721|580665940|FG001|Overall Study|Personal Reasons|0|||
160802288|NCT01904721|580665941|FG002|Overall Study|Personal Reasons|0|||
160802289|NCT01904721|580665942|FG003|Overall Study|Personal Reasons|0|||
160897110|NCT00464269|581018772|FG003|Overall Study|Withdrawal by Subject|1|||
160550014|NCT03529773|579740153|FG001|Overall Study|No longer meets eligibility criteria|0|||
160802290|NCT01904721|580665943|FG004|Overall Study|Personal Reasons|2|||
160802291|NCT01904721|580665944|FG005|Overall Study|Personal Reasons|3|||
160802292|NCT01904721|580665945|FG006|Overall Study|Personal Reasons|3|||
160802293|NCT01904721|580665939|FG000|Overall Study|Lost to Follow-up|0|||
160802294|NCT01904721|580665940|FG001|Overall Study|Lost to Follow-up|0|||
160802295|NCT01904721|580665941|FG002|Overall Study|Lost to Follow-up|0|||
160802296|NCT01904721|580665942|FG003|Overall Study|Lost to Follow-up|0|||
160802297|NCT01904721|580665943|FG004|Overall Study|Lost to Follow-up|1|||
160802298|NCT01904721|580665944|FG005|Overall Study|Lost to Follow-up|3|||
160802299|NCT01904721|580665945|FG006|Overall Study|Lost to Follow-up|1|||
160802300|NCT01904721|580665939|FG000|Overall Study|Lack of Efficacy|0|||
160802301|NCT01904721|580665940|FG001|Overall Study|Lack of Efficacy|0|||
160802302|NCT01904721|580665941|FG002|Overall Study|Lack of Efficacy|0|||
160802303|NCT01904721|580665942|FG003|Overall Study|Lack of Efficacy|0|||
160802304|NCT01904721|580665943|FG004|Overall Study|Lack of Efficacy|0|||
160802305|NCT01904721|580665944|FG005|Overall Study|Lack of Efficacy|0|||
160802306|NCT01904721|580665945|FG006|Overall Study|Lack of Efficacy|1|||
160802307|NCT01904721|580665939|FG000|Overall Study|Adverse Event|0|||
160802308|NCT01904721|580665940|FG001|Overall Study|Adverse Event|0|||
160802309|NCT01904721|580665941|FG002|Overall Study|Adverse Event|0|||
160802310|NCT01904721|580665942|FG003|Overall Study|Adverse Event|0|||
160802311|NCT01904721|580665943|FG004|Overall Study|Adverse Event|3|||
160802312|NCT01904721|580665944|FG005|Overall Study|Adverse Event|1|||
160802313|NCT01904721|580665945|FG006|Overall Study|Adverse Event|0|||
160802314|NCT00532844|580665949|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
160802315|NCT00532844|580665950|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
160802316|NCT00532844|580665949|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
160802317|NCT00532844|580665950|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
160802318|NCT00532844|580665949|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
160802319|NCT00532844|580665950|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
160802320|NCT00532844|580665949|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
160802321|NCT00532844|580665950|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
160802322|NCT00532844|580665949|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
160802323|NCT00532844|580665950|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
160802324|NCT01077063|580665952|FG000|Overall Study|Adverse Event|3|||
160802325|NCT01077063|580665953|FG001|Overall Study|Adverse Event|0|||
160802326|NCT01077063|580665952|FG000|Overall Study|Death|1|||
160802327|NCT01077063|580665953|FG001|Overall Study|Death|1|||
160802328|NCT01077063|580665952|FG000|Overall Study|Withdrawal by Subject|0|||
160802329|NCT01077063|580665953|FG001|Overall Study|Withdrawal by Subject|2|||
160802330|NCT02750930|580665954|FG000|Overall Study|Study closed/terminated|8|||
160802331|NCT00553631|580665956|FG000|Overall Study|Withdrawal by Subject|0|||
160802332|NCT00553631|580665957|FG001|Overall Study|Withdrawal by Subject|1|||
160802333|NCT00553631|580665956|FG000|Overall Study|Lost to Follow-up|1|||
160802334|NCT00553631|580665957|FG001|Overall Study|Lost to Follow-up|0|||
160802335|NCT02761642|580665958|FG000|Overall Study|Did not Receive Study Treatment|3|||
160802336|NCT02761642|580665958|FG000|Overall Study|Adverse Event|13|||
160802337|NCT02761642|580665958|FG000|Overall Study|Withdrawal by Subject|2|||
160802338|NCT02761642|580665958|FG000|Overall Study|Non-compliant|7|||
160802339|NCT02761642|580665958|FG000|Overall Study|Death|3|||
160802340|NCT02761642|580665958|FG000|Overall Study|Lack of Efficacy|20|||
160802341|NCT02761642|580665958|FG000|Overall Study|Physician Decision|1|||
160802342|NCT02761642|580665958|FG000|Overall Study|Reason Unspecified|21|||
160802343|NCT01644643|580665961|FG000|Overall Study|Death|1|||
160802344|NCT01644643|580665962|FG001|Overall Study|Death|0|||
160802345|NCT01644643|580665963|FG002|Overall Study|Death|3|||
160802346|NCT01644643|580665964|FG003|Overall Study|Death|3|||
160802347|NCT01644643|580665961|FG000|Overall Study|Lost to Follow-up|0|||
160802348|NCT01644643|580665962|FG001|Overall Study|Lost to Follow-up|0|||
160802349|NCT01644643|580665963|FG002|Overall Study|Lost to Follow-up|0|||
160802350|NCT01644643|580665964|FG003|Overall Study|Lost to Follow-up|4|||
160802351|NCT01644643|580665961|FG000|Overall Study|Withdrawal by Subject|1|||
160802352|NCT01644643|580665962|FG001|Overall Study|Withdrawal by Subject|0|||
160802353|NCT01644643|580665963|FG002|Overall Study|Withdrawal by Subject|2|||
160802354|NCT01644643|580665964|FG003|Overall Study|Withdrawal by Subject|1|||
160802355|NCT01644643|580665961|FG000|Overall Study|Other Eligibility criteria|0|||
160802356|NCT01644643|580665962|FG001|Overall Study|Other Eligibility criteria|0|||
160802357|NCT01644643|580665963|FG002|Overall Study|Other Eligibility criteria|0|||
160802358|NCT01644643|580665964|FG003|Overall Study|Other Eligibility criteria|2|||
160802359|NCT00271544|580665981|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
160802360|NCT00271544|580665981|FG000|Overall Study|Model 4196 lead not attempted|9|||
160802361|NCT00271544|580665981|FG000|Overall Study|Implant not attempted|4|||
160802362|NCT04540367|580665982|FG000|Overall Study|Withdrawal by Subject|0|||
160802363|NCT04540367|580665983|FG001|Overall Study|Withdrawal by Subject|0|||
160802364|NCT04540367|580665984|FG002|Overall Study|Withdrawal by Subject|0|||
160802365|NCT04540367|580665985|FG003|Overall Study|Withdrawal by Subject|2|||
160802366|NCT04540367|580665982|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
160802367|NCT04540367|580665983|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
160802368|NCT04540367|580665984|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
160802369|NCT04540367|580665985|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
160802370|NCT04540367|580665982|FG000|Overall Study|Adverse Event|0|||
160802371|NCT04540367|580665983|FG001|Overall Study|Adverse Event|0|||
160802372|NCT04540367|580665984|FG002|Overall Study|Adverse Event|1|||
160802373|NCT04540367|580665985|FG003|Overall Study|Adverse Event|1|||
160802374|NCT00902330|580665987|FG000|Overall Study|Too overwhelmed by treatment|2|||
160802375|NCT00902330|580665988|FG001|Overall Study|Too overwhelmed by treatment|5|||
160802376|NCT00902330|580665987|FG000|Overall Study|Adverse Event|1|||
160802377|NCT00902330|580665988|FG001|Overall Study|Adverse Event|0|||
160802378|NCT00902330|580665987|FG000|Overall Study|No post baseline data|1|||
160802379|NCT00902330|580665988|FG001|Overall Study|No post baseline data|0|||
160802380|NCT00730886|580665989|FG000|Overall Study|Lost to Follow-up|1|||
160802381|NCT00730886|580665990|FG001|Overall Study|Lost to Follow-up|0|||
160802382|NCT00730886|580665989|FG000|Overall Study|Physician Decision|1|||
160802383|NCT00730886|580665990|FG001|Overall Study|Physician Decision|0|||
160802384|NCT01816048|580665991|FG000|Overall Study|Adverse Event|1|||
160802385|NCT01816048|580665991|FG000|Overall Study|Death|1|||
160802386|NCT01816048|580665991|FG000|Overall Study|Withdrawal by Subject|1|||
160802387|NCT01816048|580665991|FG000|Overall Study|Disease Progression|3|||
160802388|NCT03571971|580665992|FG000|Overall Study|Lost to Follow-up|2|||
160802389|NCT03571971|580665993|FG001|Overall Study|Lost to Follow-up|2|||
160802390|NCT03571971|580665992|FG000|Overall Study|Protocol Violation|2|||
160802391|NCT03571971|580665993|FG001|Overall Study|Protocol Violation|3|||
160802392|NCT03571971|580665992|FG000|Overall Study|Withdrawal by Subject|2|||
160802393|NCT03571971|580665993|FG001|Overall Study|Withdrawal by Subject|0|||
160802394|NCT03571971|580665992|FG000|Overall Study|Incomplete primary outcome data|2|||
160802395|NCT03571971|580665993|FG001|Overall Study|Incomplete primary outcome data|0|||
160802396|NCT04067492|580665994|FG000|Overall Study|Lost to Follow-up|0|||
160802397|NCT04067492|580665995|FG001|Overall Study|Lost to Follow-up|0|||
160802398|NCT04067492|580665996|FG002|Overall Study|Lost to Follow-up|0|||
160802399|NCT04067492|580665997|FG003|Overall Study|Lost to Follow-up|0|||
160802400|NCT04067492|580665998|FG004|Overall Study|Lost to Follow-up|0|||
160802401|NCT04067492|580665999|FG005|Overall Study|Lost to Follow-up|1|||
160802402|NCT04067492|580665994|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
160802403|NCT04067492|580665995|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
160802404|NCT04067492|580665996|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
160802405|NCT04067492|580665997|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
160802406|NCT04067492|580665998|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
160802407|NCT04067492|580665999|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
160802408|NCT04067492|580665994|FG000|Overall Study|COVID-19 epidemiological situation|0|||
160802409|NCT04067492|580665995|FG001|Overall Study|COVID-19 epidemiological situation|0|||
160802410|NCT04067492|580665996|FG002|Overall Study|COVID-19 epidemiological situation|0|||
160802411|NCT04067492|580665997|FG003|Overall Study|COVID-19 epidemiological situation|1|||
160802412|NCT04067492|580665998|FG004|Overall Study|COVID-19 epidemiological situation|0|||
160802413|NCT04067492|580665999|FG005|Overall Study|COVID-19 epidemiological situation|0|||
160802414|NCT03950856|580666007|FG000|Overall Study|Death|1|||
160802415|NCT03950856|580666008|FG001|Overall Study|Death|2|||
160802416|NCT03950856|580666009|FG002|Overall Study|Death|0|||
160802417|NCT03950856|580666010|FG003|Overall Study|Death|0|||
160802418|NCT03950856|580666007|FG000|Overall Study|Lost to Follow-up|5|||
160802419|NCT03950856|580666008|FG001|Overall Study|Lost to Follow-up|6|||
160802420|NCT03950856|580666009|FG002|Overall Study|Lost to Follow-up|8|||
160802421|NCT03950856|580666010|FG003|Overall Study|Lost to Follow-up|2|||
160802422|NCT03950856|580666007|FG000|Overall Study|Protocol Violation|2|||
160802423|NCT03950856|580666008|FG001|Overall Study|Protocol Violation|0|||
160802424|NCT03950856|580666009|FG002|Overall Study|Protocol Violation|0|||
160802425|NCT03950856|580666010|FG003|Overall Study|Protocol Violation|1|||
160802426|NCT03950856|580666007|FG000|Overall Study|Withdrawal by Subject|4|||
160802427|NCT03950856|580666008|FG001|Overall Study|Withdrawal by Subject|1|||
160802428|NCT03950856|580666009|FG002|Overall Study|Withdrawal by Subject|3|||
160802429|NCT03950856|580666010|FG003|Overall Study|Withdrawal by Subject|1|||
160802430|NCT03950856|580666007|FG000|Overall Study|Unable to phone|7|||
160802431|NCT03950856|580666008|FG001|Overall Study|Unable to phone|6|||
160802432|NCT03950856|580666009|FG002|Overall Study|Unable to phone|7|||
160802433|NCT03950856|580666010|FG003|Overall Study|Unable to phone|2|||
160802434|NCT01816984|580666011|FG000|Overall Study|declining health status|1|||
160802435|NCT05899829|580666014|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
160802436|NCT05899829|580666015|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
160802437|NCT05899829|580666014|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
160802438|NCT05899829|580666015|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
160802439|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
160897111|NCT00464269|581018769|FG000|Overall Study|Other reason|3|||
160550015|NCT03529773|579740154|FG002|Overall Study|No longer meets eligibility criteria|0|||
160550016|NCT03529773|579740155|FG003|Overall Study|No longer meets eligibility criteria|0|||
160644388|NCT00602030|580080743|FG002|Double-blind Phase|Adverse Event|9|||
160644389|NCT00602030|580080744|FG003|Double-blind Phase|Adverse Event|18|||
160550017|NCT03529773|579740156|FG004|Overall Study|No longer meets eligibility criteria|0|||
160550018|NCT03529773|579740157|FG005|Overall Study|No longer meets eligibility criteria|0|||
160550019|NCT03529773|579740158|FG006|Overall Study|No longer meets eligibility criteria|0|||
160550020|NCT03529773|579740159|FG007|Overall Study|No longer meets eligibility criteria|0|||
160550021|NCT03529773|579740160|FG008|Overall Study|No longer meets eligibility criteria|0|||
160550022|NCT03529773|579740161|FG009|Overall Study|No longer meets eligibility criteria|0|||
160550023|NCT03529773|579740162|FG010|Overall Study|No longer meets eligibility criteria|0|||
160550024|NCT03529773|579740163|FG011|Overall Study|No longer meets eligibility criteria|0|||
160550025|NCT03529773|579740164|FG012|Overall Study|No longer meets eligibility criteria|0|||
160550026|NCT03529773|579740165|FG013|Overall Study|No longer meets eligibility criteria|0|||
160550027|NCT03529773|579740166|FG014|Overall Study|No longer meets eligibility criteria|0|||
160550028|NCT03529773|579740167|FG015|Overall Study|No longer meets eligibility criteria|0|||
160550029|NCT03529773|579740168|FG016|Overall Study|No longer meets eligibility criteria|0|||
160550030|NCT03529773|579740169|FG017|Overall Study|No longer meets eligibility criteria|0|||
160550031|NCT03529773|579740170|FG018|Overall Study|No longer meets eligibility criteria|0|||
160550032|NCT03529773|579740171|FG019|Overall Study|No longer meets eligibility criteria|0|||
160550033|NCT03529773|579740172|FG020|Overall Study|No longer meets eligibility criteria|0|||
160550034|NCT03529773|579740173|FG021|Overall Study|No longer meets eligibility criteria|0|||
160550035|NCT03529773|579740174|FG022|Overall Study|No longer meets eligibility criteria|1|||
160550036|NCT03529773|579740175|FG023|Overall Study|No longer meets eligibility criteria|0|||
160550037|NCT03529773|579740176|FG024|Overall Study|No longer meets eligibility criteria|0|||
160550038|NCT03529773|579740177|FG025|Overall Study|No longer meets eligibility criteria|0|||
160550039|NCT03529773|579740178|FG026|Overall Study|No longer meets eligibility criteria|0|||
160550040|NCT03529773|579740179|FG027|Overall Study|No longer meets eligibility criteria|0|||
160644390|NCT00602030|580080745|FG004|Double-blind Phase|Adverse Event|0|||
160644391|NCT00602030|580080741|FG000|Double-blind Phase|Consent withdrawal|0|||
160644392|NCT00602030|580080742|FG001|Double-blind Phase|Consent withdrawal|0|||
160644393|NCT00602030|580080743|FG002|Double-blind Phase|Consent withdrawal|4|||
160644394|NCT00602030|580080744|FG003|Double-blind Phase|Consent withdrawal|3|||
160644395|NCT00602030|580080745|FG004|Double-blind Phase|Consent withdrawal|0|||
160644396|NCT00602030|580080741|FG000|Double-blind Phase|Death|0|||
160644397|NCT00602030|580080742|FG001|Double-blind Phase|Death|0|||
160644398|NCT00602030|580080743|FG002|Double-blind Phase|Death|3|||
160644399|NCT00602030|580080744|FG003|Double-blind Phase|Death|3|||
160644400|NCT00602030|580080745|FG004|Double-blind Phase|Death|0|||
160644401|NCT00602030|580080741|FG000|Double-blind Phase|Administrative decision|0|||
160644402|NCT00602030|580080742|FG001|Double-blind Phase|Administrative decision|0|||
160644403|NCT00602030|580080743|FG002|Double-blind Phase|Administrative decision|0|||
160644404|NCT00602030|580080744|FG003|Double-blind Phase|Administrative decision|2|||
160644405|NCT00602030|580080745|FG004|Double-blind Phase|Administrative decision|0|||
160644406|NCT00602030|580080741|FG000|Double-blind Phase|Ineligibility|0|||
160644407|NCT00602030|580080742|FG001|Double-blind Phase|Ineligibility|0|||
160644408|NCT00602030|580080743|FG002|Double-blind Phase|Ineligibility|0|||
160644409|NCT00602030|580080744|FG003|Double-blind Phase|Ineligibility|1|||
160644410|NCT00602030|580080745|FG004|Double-blind Phase|Ineligibility|0|||
160644411|NCT00602030|580080741|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
160644412|NCT00602030|580080742|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
160644413|NCT00602030|580080743|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
160644414|NCT00602030|580080744|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
160644415|NCT00602030|580080745|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
160644416|NCT00602030|580080741|FG000|Double-blind Phase|Reason not specified|0|||
160644417|NCT00602030|580080742|FG001|Double-blind Phase|Reason not specified|0|||
160644418|NCT00602030|580080743|FG002|Double-blind Phase|Reason not specified|4|||
160644419|NCT00602030|580080744|FG003|Double-blind Phase|Reason not specified|2|||
160644420|NCT00602030|580080745|FG004|Double-blind Phase|Reason not specified|0|||
160644421|NCT00602030|580080741|FG000|Crossover Phase|Disease Progression|0|||
160644422|NCT00602030|580080742|FG001|Crossover Phase|Disease Progression|0|||
160644423|NCT00602030|580080743|FG002|Crossover Phase|Disease Progression|0|||
160644424|NCT00602030|580080744|FG003|Crossover Phase|Disease Progression|0|||
160644425|NCT00602030|580080745|FG004|Crossover Phase|Disease Progression|11|||
160644426|NCT00602030|580080741|FG000|Crossover Phase|Adverse Event|0|||
160644427|NCT00602030|580080742|FG001|Crossover Phase|Adverse Event|0|||
160644428|NCT00602030|580080743|FG002|Crossover Phase|Adverse Event|0|||
160644429|NCT00602030|580080744|FG003|Crossover Phase|Adverse Event|0|||
160644430|NCT00602030|580080745|FG004|Crossover Phase|Adverse Event|3|||
160644431|NCT00602030|580080741|FG000|Crossover Phase|Consent withdrawal|0|||
160644432|NCT00602030|580080742|FG001|Crossover Phase|Consent withdrawal|0|||
160802440|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
160802441|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
160802442|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
160802443|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
160802444|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
160802445|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
160802446|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
160802447|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
160802448|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
160802449|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
160802450|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
160802451|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
160802452|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
160802453|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
160802454|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
160802455|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
160802456|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
160802457|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
160802458|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
160802459|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
160802460|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
160802461|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
160802462|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
160802463|NCT04021290|580666016|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
160802464|NCT04021290|580666017|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
160802465|NCT04021290|580666018|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
160802466|NCT04021290|580666016|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
160802467|NCT04021290|580666017|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
160802468|NCT04021290|580666018|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
160802469|NCT04021290|580666016|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
160802470|NCT04021290|580666017|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
160802471|NCT04021290|580666018|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
160802472|NCT04021290|580666016|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
160802473|NCT04021290|580666017|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
160802474|NCT04021290|580666018|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
160802475|NCT03391882|580666019|FG000|Study Overall|Adverse Event|3|||
160802476|NCT03391882|580666020|FG001|Study Overall|Adverse Event|6|||
160802477|NCT03391882|580666021|FG002|Study Overall|Adverse Event|1|||
160802478|NCT03391882|580666022|FG003|Study Overall|Adverse Event|1|||
160802479|NCT03391882|580666023|FG004|Study Overall|Adverse Event|3|||
160802480|NCT03391882|580666024|FG005|Study Overall|Adverse Event|1|||
160802481|NCT03391882|580666019|FG000|Study Overall|Lack of Efficacy|13|||
160802482|NCT03391882|580666020|FG001|Study Overall|Lack of Efficacy|9|||
160802483|NCT03391882|580666021|FG002|Study Overall|Lack of Efficacy|0|||
160802484|NCT03391882|580666022|FG003|Study Overall|Lack of Efficacy|0|||
160802485|NCT03391882|580666023|FG004|Study Overall|Lack of Efficacy|0|||
160802486|NCT03391882|580666024|FG005|Study Overall|Lack of Efficacy|0|||
160802487|NCT03391882|580666019|FG000|Study Overall|Withdrawal by Subject|3|||
160802488|NCT03391882|580666020|FG001|Study Overall|Withdrawal by Subject|3|||
160802489|NCT03391882|580666021|FG002|Study Overall|Withdrawal by Subject|2|||
160802490|NCT03391882|580666022|FG003|Study Overall|Withdrawal by Subject|2|||
160802491|NCT03391882|580666023|FG004|Study Overall|Withdrawal by Subject|1|||
160802492|NCT03391882|580666024|FG005|Study Overall|Withdrawal by Subject|3|||
160802493|NCT03391882|580666019|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
160802494|NCT03391882|580666020|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
160802495|NCT03391882|580666021|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
160802496|NCT03391882|580666022|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
160897112|NCT00464269|581018770|FG001|Overall Study|Other reason|3|||
160897113|NCT00464269|581018771|FG002|Overall Study|Other reason|1|||
160897114|NCT00464269|581018772|FG003|Overall Study|Other reason|1|||
160897115|NCT00464269|581018769|FG000|Overall Study|AE, serious fatal|0|||
160897116|NCT00464269|581018770|FG001|Overall Study|AE, serious fatal|0|||
160897117|NCT00464269|581018771|FG002|Overall Study|AE, serious fatal|1|||
160897118|NCT00464269|581018772|FG003|Overall Study|AE, serious fatal|1|||
160897119|NCT00464269|581018769|FG000|Overall Study|SAE, non-fatal|0|||
160802497|NCT03391882|580666023|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
160802498|NCT03391882|580666024|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
160802499|NCT03391882|580666019|FG000|Study Overall|Protocol Violation|1|||
160802500|NCT03391882|580666020|FG001|Study Overall|Protocol Violation|0|||
160897120|NCT00464269|581018770|FG001|Overall Study|SAE, non-fatal|0|||
160897121|NCT00464269|581018771|FG002|Overall Study|SAE, non-fatal|0|||
160802501|NCT03391882|580666021|FG002|Study Overall|Protocol Violation|0|||
160802502|NCT03391882|580666022|FG003|Study Overall|Protocol Violation|0|||
160802503|NCT03391882|580666023|FG004|Study Overall|Protocol Violation|0|||
160802504|NCT03391882|580666024|FG005|Study Overall|Protocol Violation|0|||
160802505|NCT03391882|580666019|FG000|Part A - Titration Phase|Adverse Event|3|||
160802506|NCT03391882|580666020|FG001|Part A - Titration Phase|Adverse Event|6|||
160802507|NCT03391882|580666021|FG002|Part A - Titration Phase|Adverse Event|0|||
160802508|NCT03391882|580666022|FG003|Part A - Titration Phase|Adverse Event|0|||
160802509|NCT03391882|580666023|FG004|Part A - Titration Phase|Adverse Event|0|||
160802510|NCT03391882|580666024|FG005|Part A - Titration Phase|Adverse Event|0|||
160802511|NCT03391882|580666019|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
160802512|NCT03391882|580666020|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
160802513|NCT03391882|580666021|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
160802514|NCT03391882|580666022|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
160802515|NCT03391882|580666023|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
160802516|NCT03391882|580666024|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
160802517|NCT03391882|580666019|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
160802518|NCT03391882|580666020|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
160802519|NCT03391882|580666021|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
160802520|NCT03391882|580666022|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
160802521|NCT03391882|580666023|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
160802522|NCT03391882|580666024|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
160802523|NCT03391882|580666019|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
160802524|NCT03391882|580666020|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
160802525|NCT03391882|580666021|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
160802526|NCT03391882|580666022|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
160802527|NCT03391882|580666023|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
160802528|NCT03391882|580666024|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
160802529|NCT03391882|580666019|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
160802530|NCT03391882|580666020|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
160802531|NCT03391882|580666021|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
160802532|NCT03391882|580666022|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
160802533|NCT03391882|580666023|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
160802534|NCT03391882|580666024|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
160802535|NCT03391882|580666019|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
160802536|NCT03391882|580666020|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
160802537|NCT03391882|580666021|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
160802538|NCT03391882|580666022|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
160802539|NCT03391882|580666023|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
160802540|NCT03391882|580666024|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
160802541|NCT03391882|580666019|FG000|Part B - Treatment Phase|Adverse Event|0|||
160802542|NCT03391882|580666020|FG001|Part B - Treatment Phase|Adverse Event|0|||
160802543|NCT03391882|580666021|FG002|Part B - Treatment Phase|Adverse Event|1|||
160802544|NCT03391882|580666022|FG003|Part B - Treatment Phase|Adverse Event|1|||
160802545|NCT03391882|580666023|FG004|Part B - Treatment Phase|Adverse Event|3|||
160802546|NCT03391882|580666024|FG005|Part B - Treatment Phase|Adverse Event|1|||
160802547|NCT03391882|580666019|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
160802548|NCT03391882|580666020|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
160802549|NCT03391882|580666021|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
160802550|NCT03391882|580666022|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
160802551|NCT03391882|580666023|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
160802552|NCT03391882|580666024|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
160802553|NCT03092479|580666025|FG000|Overall Study|Lost to Follow-up|3|||
160802554|NCT03092479|580666026|FG001|Overall Study|Lost to Follow-up|2|||
160802555|NCT03092479|580666025|FG000|Overall Study|Withdrawal by Subject|4|||
160802556|NCT03092479|580666026|FG001|Overall Study|Withdrawal by Subject|0|||
160802557|NCT03913130|580666029|FG000|Overall Study|Sponsor Decision|1|||
160802558|NCT04046939|580666034|FG000|Primary Assessment Period|Adverse Event|1|||
160802559|NCT04046939|580666035|FG001|Primary Assessment Period|Adverse Event|0|||
160802560|NCT04046939|580666036|FG002|Primary Assessment Period|Adverse Event|0|||
160802561|NCT04046939|580666037|FG003|Primary Assessment Period|Adverse Event|0|||
160802562|NCT04046939|580666034|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
160802563|NCT04046939|580666035|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
160985066|NCT01066156|581335333|FG000|Overall Study|Withdrawal by Subject|1|||
160802564|NCT04046939|580666036|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
160802565|NCT04046939|580666037|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
160802566|NCT04046939|580666034|FG000|Primary Assessment Period|Physician Decision|0|||
160802567|NCT04046939|580666035|FG001|Primary Assessment Period|Physician Decision|0|||
160802568|NCT04046939|580666036|FG002|Primary Assessment Period|Physician Decision|1|||
160802569|NCT04046939|580666037|FG003|Primary Assessment Period|Physician Decision|0|||
160802570|NCT04046939|580666034|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
160802571|NCT04046939|580666035|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
160985067|NCT01734382|581335337|FG000|Part 1|Adverse Event|2|||
160550041|NCT03529773|579740180|FG028|Overall Study|No longer meets eligibility criteria|0|||
160550042|NCT03529773|579740181|FG029|Overall Study|No longer meets eligibility criteria|0|||
160550043|NCT03529773|579740182|FG030|Overall Study|No longer meets eligibility criteria|0|||
160550044|NCT03529773|579740183|FG031|Overall Study|No longer meets eligibility criteria|0|||
160550045|NCT03529773|579740184|FG032|Overall Study|No longer meets eligibility criteria|0|||
160550046|NCT03529773|579740185|FG033|Overall Study|No longer meets eligibility criteria|0|||
160550047|NCT03529773|579740186|FG034|Overall Study|No longer meets eligibility criteria|0|||
160550048|NCT03529773|579740187|FG035|Overall Study|No longer meets eligibility criteria|0|||
160550049|NCT03529773|579740188|FG036|Overall Study|No longer meets eligibility criteria|0|||
160550050|NCT03529773|579740189|FG037|Overall Study|No longer meets eligibility criteria|0|||
160550051|NCT03529773|579740190|FG038|Overall Study|No longer meets eligibility criteria|1|||
160550052|NCT03529773|579740191|FG039|Overall Study|No longer meets eligibility criteria|0|||
160550053|NCT03529773|579740152|FG000|Overall Study|Other|0|||
160550054|NCT03529773|579740153|FG001|Overall Study|Other|0|||
160550055|NCT03529773|579740154|FG002|Overall Study|Other|0|||
160550056|NCT03529773|579740155|FG003|Overall Study|Other|0|||
160550057|NCT03529773|579740156|FG004|Overall Study|Other|0|||
160550058|NCT03529773|579740157|FG005|Overall Study|Other|0|||
160550059|NCT03529773|579740158|FG006|Overall Study|Other|0|||
160550060|NCT03529773|579740159|FG007|Overall Study|Other|0|||
160550061|NCT03529773|579740160|FG008|Overall Study|Other|0|||
160550062|NCT03529773|579740161|FG009|Overall Study|Other|0|||
160550063|NCT03529773|579740162|FG010|Overall Study|Other|0|||
160644433|NCT00602030|580080743|FG002|Crossover Phase|Consent withdrawal|0|||
160644434|NCT00602030|580080744|FG003|Crossover Phase|Consent withdrawal|0|||
160644435|NCT00602030|580080745|FG004|Crossover Phase|Consent withdrawal|2|||
160644436|NCT01580020|580080746|FG000|Overall Study|Lack of Efficacy|0|||
160644437|NCT01580020|580080747|FG001|Overall Study|Lack of Efficacy|5|||
160644438|NCT01580020|580080748|FG002|Overall Study|Lack of Efficacy|0|||
160644439|NCT01580020|580080749|FG003|Overall Study|Lack of Efficacy|1|||
160644440|NCT01580020|580080746|FG000|Overall Study|Withdrawal by Subject|0|||
160644441|NCT01580020|580080747|FG001|Overall Study|Withdrawal by Subject|1|||
160644442|NCT01580020|580080748|FG002|Overall Study|Withdrawal by Subject|1|||
160644443|NCT01580020|580080749|FG003|Overall Study|Withdrawal by Subject|0|||
160644444|NCT01580020|580080746|FG000|Overall Study|Adverse Event|1|||
160644445|NCT01580020|580080747|FG001|Overall Study|Adverse Event|1|||
160644446|NCT01580020|580080748|FG002|Overall Study|Adverse Event|1|||
160644447|NCT01580020|580080749|FG003|Overall Study|Adverse Event|1|||
160644448|NCT01580020|580080746|FG000|Overall Study|Administrative Problems|0|||
160644449|NCT01580020|580080747|FG001|Overall Study|Administrative Problems|0|||
160644450|NCT01580020|580080748|FG002|Overall Study|Administrative Problems|1|||
160644451|NCT01580020|580080749|FG003|Overall Study|Administrative Problems|0|||
160644452|NCT01580020|580080746|FG000|Overall Study|Lost to Follow-up|0|||
160644453|NCT01580020|580080747|FG001|Overall Study|Lost to Follow-up|0|||
160644454|NCT01580020|580080748|FG002|Overall Study|Lost to Follow-up|1|||
160644455|NCT01580020|580080749|FG003|Overall Study|Lost to Follow-up|0|||
160644456|NCT01208402|580080754|FG000|Overall Study|Withdrawal by Subject|1|||
160644457|NCT01208402|580080755|FG001|Overall Study|Withdrawal by Subject|0|||
160644458|NCT01571635|580080757|FG000|Overall Study|Adverse Event|3|||
160644459|NCT01571635|580080758|FG001|Overall Study|Adverse Event|0|||
160644460|NCT01571635|580080759|FG002|Overall Study|Adverse Event|2|||
160644461|NCT01571635|580080760|FG003|Overall Study|Adverse Event|3|||
160644462|NCT01571635|580080761|FG004|Overall Study|Adverse Event|5|||
160644463|NCT01571635|580080757|FG000|Overall Study|Other reasons|2|||
160644464|NCT01571635|580080758|FG001|Overall Study|Other reasons|1|||
160644465|NCT01571635|580080759|FG002|Overall Study|Other reasons|2|||
160644466|NCT01571635|580080760|FG003|Overall Study|Other reasons|2|||
160644467|NCT01571635|580080761|FG004|Overall Study|Other reasons|1|||
160644468|NCT01571635|580080757|FG000|Overall Study|Study terminated by sponsor|0|||
160644469|NCT01571635|580080758|FG001|Overall Study|Study terminated by sponsor|4|||
160644470|NCT01571635|580080759|FG002|Overall Study|Study terminated by sponsor|1|||
160644471|NCT01571635|580080760|FG003|Overall Study|Study terminated by sponsor|3|||
160644472|NCT01571635|580080761|FG004|Overall Study|Study terminated by sponsor|1|||
160644473|NCT01571635|580080757|FG000|Overall Study|Withdrew consent|1|||
160644474|NCT01571635|580080758|FG001|Overall Study|Withdrew consent|1|||
160644475|NCT01571635|580080759|FG002|Overall Study|Withdrew consent|2|||
160644476|NCT01571635|580080760|FG003|Overall Study|Withdrew consent|3|||
160644477|NCT01571635|580080761|FG004|Overall Study|Withdrew consent|0|||
160644478|NCT01571635|580080757|FG000|Overall Study|Lack of Efficacy|0|||
160644479|NCT01571635|580080758|FG001|Overall Study|Lack of Efficacy|2|||
160644480|NCT01571635|580080759|FG002|Overall Study|Lack of Efficacy|0|||
160644481|NCT01571635|580080760|FG003|Overall Study|Lack of Efficacy|1|||
160644482|NCT01571635|580080761|FG004|Overall Study|Lack of Efficacy|2|||
160644483|NCT01335464|580080762|FG000|Overall Study|Adverse Event|15|||
160644484|NCT01335464|580080763|FG001|Overall Study|Adverse Event|25|||
160644485|NCT01335464|580080762|FG000|Overall Study|Non compliant with protocol|2|||
160644486|NCT01335464|580080763|FG001|Overall Study|Non compliant with protocol|0|||
160897122|NCT00464269|581018772|FG003|Overall Study|SAE, non-fatal|1|||
160897123|NCT00464269|581018769|FG000|Overall Study|AE, non-serious non-fatal|2|||
160897124|NCT00464269|581018770|FG001|Overall Study|AE, non-serious non-fatal|8|||
160897125|NCT00464269|581018771|FG002|Overall Study|AE, non-serious non-fatal|3|||
160897126|NCT00464269|581018772|FG003|Overall Study|AE, non-serious non-fatal|4|||
160897127|NCT00464269|581018769|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
160897128|NCT00464269|581018770|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
160897129|NCT00464269|581018771|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
160897130|NCT00464269|581018772|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
160897131|NCT03911154|581018773|FG000|Overall Study|Withdrawal by Subject|1|||
160897132|NCT05055128|581018774|FG000|Overall Study|Adverse Event|0|||
160897133|NCT05055128|581018775|FG001|Overall Study|Adverse Event|0|||
160897134|NCT05055128|581018776|FG002|Overall Study|Adverse Event|0|||
160897135|NCT05055128|581018777|FG003|Overall Study|Adverse Event|1|||
160897136|NCT05055128|581018778|FG004|Overall Study|Adverse Event|1|||
160897137|NCT05055128|581018774|FG000|Overall Study|Protocol Violation|0|||
160897138|NCT05055128|581018775|FG001|Overall Study|Protocol Violation|0|||
160897139|NCT05055128|581018776|FG002|Overall Study|Protocol Violation|0|||
160897140|NCT05055128|581018777|FG003|Overall Study|Protocol Violation|1|||
160897141|NCT05055128|581018778|FG004|Overall Study|Protocol Violation|0|||
160897142|NCT05055128|581018774|FG000|Overall Study|Withdrawal by Subject|5|||
160897143|NCT05055128|581018775|FG001|Overall Study|Withdrawal by Subject|2|||
160897144|NCT05055128|581018776|FG002|Overall Study|Withdrawal by Subject|2|||
160897145|NCT05055128|581018777|FG003|Overall Study|Withdrawal by Subject|4|||
160897146|NCT05055128|581018778|FG004|Overall Study|Withdrawal by Subject|2|||
160802572|NCT04046939|580666036|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
160802573|NCT04046939|580666037|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
160802574|NCT00038948|580666038|FG000|Overall Study|Adverse Event|131|||
160802575|NCT00038948|580666039|FG001|Overall Study|Adverse Event|43|||
160802576|NCT00038948|580666038|FG000|Overall Study|Lost to Follow-up|4|||
160802577|NCT00038948|580666039|FG001|Overall Study|Lost to Follow-up|4|||
160802578|NCT00038948|580666038|FG000|Overall Study|Nonmedical event|5|||
160802579|NCT00038948|580666039|FG001|Overall Study|Nonmedical event|7|||
160802580|NCT00038948|580666038|FG000|Overall Study|Withdrawal by Subject|23|||
160802581|NCT00038948|580666039|FG001|Overall Study|Withdrawal by Subject|10|||
160802582|NCT00038948|580666038|FG000|Overall Study|Protocol Violation|3|||
160802583|NCT00038948|580666039|FG001|Overall Study|Protocol Violation|7|||
160802584|NCT00038948|580666038|FG000|Overall Study|Lack of Efficacy|3|||
160802585|NCT00038948|580666039|FG001|Overall Study|Lack of Efficacy|6|||
160802586|NCT00810277|580667560|FG000|Overall Study|Adverse Event|1|||
160802587|NCT00529243|580667564|FG000|Overall Study|Adverse Event|1|||
160802588|NCT00529243|580667564|FG000|Overall Study|Death|1|||
160802589|NCT00529243|580667564|FG000|Overall Study|Relocated|1|||
160802590|NCT00678288|580667571|FG000|Overall Study|Adverse Event|0|||
160802591|NCT00678288|580667572|FG001|Overall Study|Adverse Event|2|||
160802592|NCT00678288|580667571|FG000|Overall Study|Withdrawal by Subject|1|||
160802593|NCT00678288|580667572|FG001|Overall Study|Withdrawal by Subject|1|||
160802594|NCT00678288|580667571|FG000|Overall Study|Study terminated by the sponsor|2|||
160802595|NCT00678288|580667572|FG001|Overall Study|Study terminated by the sponsor|0|||
160802596|NCT00678288|580667571|FG000|Overall Study|Not compliant with study medication|0|||
160802597|NCT00678288|580667572|FG001|Overall Study|Not compliant with study medication|1|||
160802598|NCT00678288|580667571|FG000|Overall Study|Switch to commercial drug|0|||
160802599|NCT00678288|580667572|FG001|Overall Study|Switch to commercial drug|1|||
160802600|NCT00678288|580667571|FG000|Overall Study|Reason not reported|1|||
160802601|NCT00678288|580667572|FG001|Overall Study|Reason not reported|0|||
160897147|NCT05055128|581018774|FG000|Overall Study|Randomized By Mistake|0|||
160897148|NCT05055128|581018775|FG001|Overall Study|Randomized By Mistake|1|||
160897149|NCT05055128|581018776|FG002|Overall Study|Randomized By Mistake|0|||
160897150|NCT05055128|581018777|FG003|Overall Study|Randomized By Mistake|0|||
160897151|NCT05055128|581018778|FG004|Overall Study|Randomized By Mistake|0|||
160897152|NCT05055128|581018774|FG000|Overall Study|Other|1|||
160897153|NCT05055128|581018775|FG001|Overall Study|Other|0|||
160550064|NCT03529773|579740163|FG011|Overall Study|Other|0|||
160802602|NCT00678288|580667571|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
160802603|NCT00678288|580667572|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
160802604|NCT04472650|580667583|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
160802605|NCT04472650|580667584|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
160802606|NCT03247829|580667587|FG000|Overall Study|Death|3|||
160802607|NCT03247829|580667588|FG001|Overall Study|Death|4|||
160802608|NCT03247829|580667587|FG000|Overall Study|Enter Hospice Care|1|||
160802609|NCT03247829|580667588|FG001|Overall Study|Enter Hospice Care|0|||
160897154|NCT05055128|581018776|FG002|Overall Study|Other|0|||
160897155|NCT05055128|581018777|FG003|Overall Study|Other|0|||
160897156|NCT05055128|581018778|FG004|Overall Study|Other|0|||
160897157|NCT00292318|581018780|FG000|Overall Study|Study terminated by officials|2|||
160897158|NCT00292318|581018781|FG001|Overall Study|Study terminated by officials|1|||
160897159|NCT01822496|581018782|FG000|Overall Study|Protocol Violation|2|||
160897160|NCT01822496|581018783|FG001|Overall Study|Protocol Violation|2|||
160802610|NCT03247829|580667587|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
160802611|NCT03247829|580667588|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
160802612|NCT03247829|580667587|FG000|Overall Study|LVAD Explant|1|||
160802613|NCT03247829|580667588|FG001|Overall Study|LVAD Explant|1|||
160802614|NCT03247829|580667587|FG000|Overall Study|Transplant|1|||
160802615|NCT03247829|580667588|FG001|Overall Study|Transplant|1|||
160802616|NCT01783444|580667589|FG000|Treatment Phase|Adverse Event|9|||
160802617|NCT01783444|580667590|FG001|Treatment Phase|Adverse Event|20|||
160802618|NCT01783444|580667591|FG002|Treatment Phase|Adverse Event|19|||
160802619|NCT01783444|580667589|FG000|Treatment Phase|Disease Progression|76|||
160802620|NCT01783444|580667590|FG001|Treatment Phase|Disease Progression|66|||
160802621|NCT01783444|580667591|FG002|Treatment Phase|Disease Progression|64|||
160802622|NCT01783444|580667589|FG000|Treatment Phase|Death|2|||
160802623|NCT01783444|580667590|FG001|Treatment Phase|Death|2|||
160802624|NCT01783444|580667591|FG002|Treatment Phase|Death|2|||
160802625|NCT01783444|580667589|FG000|Treatment Phase|Protocol Violation|1|||
160802626|NCT01783444|580667590|FG001|Treatment Phase|Protocol Violation|1|||
160802627|NCT01783444|580667591|FG002|Treatment Phase|Protocol Violation|2|||
160802628|NCT01783444|580667589|FG000|Treatment Phase|Withdrawal by Subject|6|||
160802629|NCT01783444|580667590|FG001|Treatment Phase|Withdrawal by Subject|8|||
160802630|NCT01783444|580667591|FG002|Treatment Phase|Withdrawal by Subject|9|||
160802631|NCT01783444|580667589|FG000|Treatment Phase|Administrative problems|2|||
160802632|NCT01783444|580667590|FG001|Treatment Phase|Administrative problems|0|||
160802633|NCT01783444|580667591|FG002|Treatment Phase|Administrative problems|1|||
160802634|NCT01783444|580667589|FG000|Treatment Phase|Physician Decision|8|||
160802635|NCT01783444|580667590|FG001|Treatment Phase|Physician Decision|6|||
160644487|NCT01335464|580080762|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
160644488|NCT01335464|580080763|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
160644489|NCT01335464|580080762|FG000|Overall Study|Not treated|2|||
160644490|NCT01335464|580080763|FG001|Overall Study|Not treated|0|||
160644491|NCT01335464|580080762|FG000|Overall Study|Reason other than those stated above|1|||
160644492|NCT01335464|580080763|FG001|Overall Study|Reason other than those stated above|1|||
160644493|NCT01783730|580080766|FG000|Overall Study|Failed to meet inclusion criteria|6|||
160644494|NCT02151461|580080767|FG000|Overall Study|Adverse Event|5|||
160644495|NCT02151461|580080768|FG001|Overall Study|Adverse Event|1|||
160644496|NCT02151461|580080769|FG002|Overall Study|Adverse Event|0|||
160644497|NCT02151461|580080770|FG003|Overall Study|Adverse Event|2|||
160644498|NCT02151461|580080767|FG000|Overall Study|Lost to Follow-up|0|||
160644499|NCT02151461|580080768|FG001|Overall Study|Lost to Follow-up|0|||
160644500|NCT02151461|580080769|FG002|Overall Study|Lost to Follow-up|1|||
160644501|NCT02151461|580080770|FG003|Overall Study|Lost to Follow-up|1|||
160644502|NCT02151461|580080767|FG000|Overall Study|Withdrawal by Subject|1|||
160644503|NCT02151461|580080768|FG001|Overall Study|Withdrawal by Subject|0|||
160644504|NCT02151461|580080769|FG002|Overall Study|Withdrawal by Subject|1|||
160644505|NCT02151461|580080770|FG003|Overall Study|Withdrawal by Subject|1|||
160802636|NCT01783444|580667591|FG002|Treatment Phase|Physician Decision|5|||
160802637|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
160802638|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
160802639|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
160802640|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
160802641|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
160802642|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
160802643|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
160802644|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
160897161|NCT01822496|581018784|FG002|Overall Study|Protocol Violation|0|||
160897162|NCT01822496|581018785|FG003|Overall Study|Protocol Violation|1|||
160897163|NCT01822496|581018782|FG000|Overall Study|Withdrawal by Subject|0|||
160897164|NCT01822496|581018783|FG001|Overall Study|Withdrawal by Subject|0|||
160897165|NCT01822496|581018784|FG002|Overall Study|Withdrawal by Subject|0|||
160897166|NCT01822496|581018785|FG003|Overall Study|Withdrawal by Subject|3|||
160897167|NCT02906332|581018786|FG000|Overall Study|Withdrawal by Subject|1|||
160897168|NCT03945266|581018787|FG000|Overall Study|Withdrawal by Subject|1|||
160897169|NCT03945266|581018788|FG001|Overall Study|Withdrawal by Subject|0|||
160644506|NCT02151461|580080767|FG000|Overall Study|Treatment discontinuation|0|||
160644507|NCT02151461|580080768|FG001|Overall Study|Treatment discontinuation|0|||
160644508|NCT02151461|580080769|FG002|Overall Study|Treatment discontinuation|1|||
160644509|NCT02151461|580080770|FG003|Overall Study|Treatment discontinuation|0|||
160644510|NCT00408876|580080771|FG000|Overall Study|Adverse Event|9|||
160802645|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
160802646|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
160897170|NCT03945266|581018787|FG000|Overall Study|Miscarriage|0|||
160897171|NCT03945266|581018788|FG001|Overall Study|Miscarriage|2|||
160644511|NCT00408876|580080772|FG001|Overall Study|Adverse Event|17|||
160897172|NCT03945266|581018787|FG000|Overall Study|Lost to Follow-up|1|||
160802647|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
160802648|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
160802649|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
160802650|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
160802651|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
160802652|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
160802653|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
160802654|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
160802655|NCT00552071|580667593|FG000|Overall Study|Adverse Event|1|||
160802656|NCT00552071|580667594|FG001|Overall Study|Adverse Event|0|||
160802657|NCT00552071|580667593|FG000|Overall Study|Lack of Efficacy|1|||
160802658|NCT00552071|580667594|FG001|Overall Study|Lack of Efficacy|0|||
160802659|NCT00552071|580667593|FG000|Overall Study|Physician Decision|1|||
160802660|NCT00552071|580667594|FG001|Overall Study|Physician Decision|0|||
160802661|NCT00552071|580667593|FG000|Overall Study|Pregnancy|1|||
160802662|NCT00552071|580667594|FG001|Overall Study|Pregnancy|0|||
160802663|NCT00552071|580667593|FG000|Overall Study|Death|0|||
160802664|NCT00552071|580667594|FG001|Overall Study|Death|1|||
160802665|NCT00552071|580667593|FG000|Overall Study|Withdrawal by Subject|0|||
160802666|NCT00552071|580667594|FG001|Overall Study|Withdrawal by Subject|1|||
160802667|NCT00272792|580667595|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
160802668|NCT00272792|580667596|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
160802669|NCT00272792|580667595|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
160802670|NCT00272792|580667596|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
160802671|NCT00272792|580667595|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
160802672|NCT00272792|580667596|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
160802673|NCT00272792|580667595|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
160802674|NCT00272792|580667596|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
160802675|NCT00937495|580667601|FG000|Overall Study|Protocol Violation|2|||
160802676|NCT01856322|580667602|FG000|Overall Study|off study due to lack of accrual|0|||
160802677|NCT01856322|580667603|FG001|Overall Study|off study due to lack of accrual|0|||
160802678|NCT01856322|580667604|FG002|Overall Study|off study due to lack of accrual|3|||
160802679|NCT02628444|580667605|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
160802680|NCT02628444|580667606|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802681|NCT02628444|580667607|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802682|NCT02628444|580667608|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802683|NCT02628444|580667609|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802684|NCT02628444|580667610|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802685|NCT02628444|580667611|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802686|NCT02628444|580667612|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802687|NCT02628444|580667613|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802688|NCT02628444|580667605|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802689|NCT02628444|580667606|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
160802690|NCT02628444|580667607|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
160802691|NCT02628444|580667608|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802692|NCT02628444|580667609|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802693|NCT02628444|580667610|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802694|NCT02628444|580667611|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802695|NCT02628444|580667612|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802696|NCT02628444|580667613|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802697|NCT02628444|580667605|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
160802698|NCT02628444|580667606|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
160802699|NCT02628444|580667607|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
160802700|NCT02628444|580667608|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802701|NCT02628444|580667609|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802702|NCT02628444|580667610|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802703|NCT02628444|580667611|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802704|NCT02628444|580667612|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802705|NCT02628444|580667613|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802706|NCT02628444|580667605|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
160861916|NCT00449696|580887879|FG000|Overall Study|Withdrawal by Subject|5|||
160861917|NCT00449696|580887880|FG001|Overall Study|Withdrawal by Subject|5|||
160861918|NCT00449696|580887879|FG000|Overall Study|Lost to Follow-up|2|||
160802707|NCT02628444|580667606|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
160802708|NCT02628444|580667607|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
160802709|NCT02628444|580667608|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802710|NCT02628444|580667609|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802711|NCT02628444|580667610|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802712|NCT02628444|580667611|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802713|NCT02628444|580667612|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802714|NCT02628444|580667613|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802715|NCT02628444|580667605|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
160802716|NCT02628444|580667606|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
160802717|NCT02628444|580667607|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
160802718|NCT02628444|580667608|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802719|NCT02628444|580667609|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802720|NCT02628444|580667610|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802721|NCT02628444|580667611|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802722|NCT02628444|580667612|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802723|NCT02628444|580667613|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802724|NCT02628444|580667605|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802725|NCT02628444|580667606|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802726|NCT02628444|580667607|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802727|NCT02628444|580667608|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
160802728|NCT02628444|580667609|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802729|NCT02628444|580667610|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802730|NCT02628444|580667611|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802731|NCT02628444|580667612|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802732|NCT02628444|580667613|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802733|NCT02628444|580667605|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
160802734|NCT02628444|580667606|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
160802735|NCT02628444|580667607|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
160802736|NCT02628444|580667608|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
160802737|NCT02628444|580667609|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
160802738|NCT02628444|580667610|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
160802739|NCT02628444|580667611|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
160802740|NCT02628444|580667612|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
160802741|NCT02628444|580667613|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
160802742|NCT02628444|580667605|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802743|NCT02628444|580667606|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802744|NCT02628444|580667607|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802745|NCT02628444|580667608|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
160802746|NCT02628444|580667609|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
160802747|NCT02628444|580667610|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
160802748|NCT02628444|580667611|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
160802749|NCT02628444|580667612|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
160802750|NCT02628444|580667613|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
160802751|NCT02628444|580667605|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160802752|NCT02628444|580667606|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160985068|NCT01734382|581335338|FG001|Part 1|Adverse Event|0|||
160985069|NCT01734382|581335339|FG002|Part 1|Adverse Event|0|||
160985070|NCT01734382|581335337|FG000|Part 2|Adverse Event|0|||
160985071|NCT01734382|581335338|FG001|Part 2|Adverse Event|0|||
160802753|NCT02628444|580667607|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160802754|NCT02628444|580667608|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160802755|NCT02628444|580667609|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
160802756|NCT02628444|580667610|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160802757|NCT02628444|580667611|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160802758|NCT02628444|580667612|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
160802759|NCT02628444|580667613|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
160861919|NCT00449696|580887880|FG001|Overall Study|Lost to Follow-up|3|||
160985072|NCT01734382|581335339|FG002|Part 2|Adverse Event|1|||
160985073|NCT01734382|581335337|FG000|Part 2|Lack of Efficacy|0|||
160985074|NCT01734382|581335338|FG001|Part 2|Lack of Efficacy|1|||
160985075|NCT01734382|581335339|FG002|Part 2|Lack of Efficacy|1|||
160985076|NCT01734382|581335337|FG000|Part 2|Other|0|||
160985077|NCT01734382|581335338|FG001|Part 2|Other|0|||
160985078|NCT01734382|581335339|FG002|Part 2|Other|1|||
160985079|NCT01734382|581335337|FG000|Part 2|Physician Decision|0|||
160802760|NCT02628444|580667605|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
160802761|NCT02628444|580667606|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
160802762|NCT02628444|580667607|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
160802763|NCT02628444|580667608|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
160802764|NCT02628444|580667609|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
160802765|NCT02628444|580667610|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
160802766|NCT02628444|580667611|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
160802767|NCT02628444|580667612|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
160802768|NCT02628444|580667613|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
160802769|NCT00288015|580667614|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
160802770|NCT00288015|580667614|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
160802771|NCT00288015|580667614|FG000|First Response Assessment|Withdrawal by Subject|1|||
160802772|NCT00288015|580667614|FG000|First Response Assessment|Death|1|||
160802773|NCT00288015|580667614|FG000|First Response Assessment|Physician Decision|2|||
160802774|NCT00288015|580667614|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
160802775|NCT00288015|580667614|FG000|Follow up for Survival x 2 Years|Death|13|||
160802776|NCT00288015|580667614|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
160802777|NCT00288015|580667614|FG000|Follow up for Survival x 2 Years|Other|9|||
160802778|NCT00443703|580667617|FG000|Overall Study|Never Treated|3|||
160802779|NCT00443703|580667618|FG001|Overall Study|Never Treated|1|||
160802780|NCT00443703|580667617|FG000|Overall Study|Adverse Event|7|||
160802781|NCT00443703|580667618|FG001|Overall Study|Adverse Event|3|||
160802782|NCT00443703|580667617|FG000|Overall Study|Lack of Efficacy|3|||
160802783|NCT00443703|580667618|FG001|Overall Study|Lack of Efficacy|1|||
160802784|NCT00443703|580667617|FG000|Overall Study|Lost to Follow-up|0|||
160802785|NCT00443703|580667618|FG001|Overall Study|Lost to Follow-up|4|||
160802786|NCT00443703|580667617|FG000|Overall Study|Physician Decision|4|||
160802787|NCT00443703|580667618|FG001|Overall Study|Physician Decision|2|||
160802788|NCT00443703|580667617|FG000|Overall Study|Protocol Violation|1|||
160802789|NCT00443703|580667618|FG001|Overall Study|Protocol Violation|1|||
160802790|NCT00443703|580667617|FG000|Overall Study|Withdrawal by Subject|9|||
160802791|NCT00443703|580667618|FG001|Overall Study|Withdrawal by Subject|6|||
160802792|NCT00443703|580667617|FG000|Overall Study|Progressive Disease|1|||
160802793|NCT00443703|580667618|FG001|Overall Study|Progressive Disease|0|||
160802794|NCT01047007|580667619|FG000|Overall Study|Adverse Event|0|||
160802795|NCT01047007|580667620|FG001|Overall Study|Adverse Event|2|||
160802796|NCT01047007|580667621|FG002|Overall Study|Adverse Event|1|||
160802797|NCT01047007|580667622|FG003|Overall Study|Adverse Event|0|||
160802798|NCT01047007|580667619|FG000|Overall Study|Progressive Disease|2|||
160802799|NCT01047007|580667620|FG001|Overall Study|Progressive Disease|4|||
160802800|NCT01047007|580667621|FG002|Overall Study|Progressive Disease|1|||
160802801|NCT01047007|580667622|FG003|Overall Study|Progressive Disease|0|||
160802802|NCT00592631|580667626|FG000|Overall Study|Lost to Follow-up|0|||
160802803|NCT00592631|580667627|FG001|Overall Study|Lost to Follow-up|2|||
160802804|NCT03389308|580667629|FG000|Overall Study|Withdrawal by Subject|5|||
160802805|NCT03389308|580667629|FG000|Overall Study|Lost to Follow-up|3|||
160802806|NCT03389308|580667629|FG000|Overall Study|Adverse Event|2|||
160802807|NCT03389308|580667629|FG000|Overall Study|Sponsor Request|2|||
160802808|NCT00616642|580667631|FG000|Overall Study|Withdrawal by Subject|0|||
160802809|NCT00616642|580667632|FG001|Overall Study|Withdrawal by Subject|1|||
160802810|NCT00570323|580667633|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
160802811|NCT00570323|580667634|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
160802812|NCT00570323|580667633|FG000|Started Treatment After Randomization|Protocol Violation|1|||
160802813|NCT00570323|580667634|FG001|Started Treatment After Randomization|Protocol Violation|0|||
160802814|NCT00570323|580667633|FG000|Started Treatment After Randomization|Physician Decision|1|||
160802815|NCT00570323|580667634|FG001|Started Treatment After Randomization|Physician Decision|0|||
160802816|NCT00570323|580667633|FG000|Complete Study After Start|Lost to Follow-up|0|||
160802817|NCT00570323|580667634|FG001|Complete Study After Start|Lost to Follow-up|1|||
160802818|NCT00570323|580667633|FG000|Complete Study After Start|Withdrawal by Subject|2|||
160802819|NCT00570323|580667634|FG001|Complete Study After Start|Withdrawal by Subject|0|||
160802820|NCT00570323|580667633|FG000|Complete Study After Start|Physician Decision|1|||
160802821|NCT00570323|580667634|FG001|Complete Study After Start|Physician Decision|0|||
160802822|NCT02266147|580667637|FG000|PART 1: Dose Escalation|Physician Decision|0|||
160802823|NCT02266147|580667638|FG001|PART 1: Dose Escalation|Physician Decision|0|||
160802824|NCT02266147|580667639|FG002|PART 1: Dose Escalation|Physician Decision|1|||
160802825|NCT02266147|580667640|FG003|PART 1: Dose Escalation|Physician Decision|0|||
160802826|NCT02266147|580667637|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
160802827|NCT02266147|580667638|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
160550065|NCT03529773|579740164|FG012|Overall Study|Other|1|||
160802828|NCT02266147|580667639|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
160802829|NCT02266147|580667640|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
160802830|NCT02266147|580667637|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
160802831|NCT02266147|580667638|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
160802832|NCT02266147|580667639|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
160802833|NCT02266147|580667640|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
160802834|NCT02266147|580667637|FG000|PART 1: Dose Escalation|Other|1|||
160802835|NCT02266147|580667638|FG001|PART 1: Dose Escalation|Other|1|||
160802836|NCT02266147|580667639|FG002|PART 1: Dose Escalation|Other|0|||
160802837|NCT02266147|580667640|FG003|PART 1: Dose Escalation|Other|0|||
160802838|NCT02266147|580667637|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
160802839|NCT02266147|580667638|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
160802840|NCT02266147|580667639|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
160802841|NCT02266147|580667640|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
160802842|NCT02266147|580667637|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
160802843|NCT02266147|580667638|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
160802844|NCT02266147|580667639|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
160802845|NCT02266147|580667640|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
160802846|NCT01023217|580667641|FG000|Overall Study|Withdrawal by Subject|1|||
160802847|NCT01023217|580667642|FG001|Overall Study|Withdrawal by Subject|0|||
160802848|NCT00332696|580667643|FG000|Overall Study|Death|24|||
160802849|NCT00332696|580667644|FG001|Overall Study|Death|14|||
160644512|NCT00408876|580080773|FG002|Overall Study|Adverse Event|27|||
160644513|NCT00408876|580080774|FG003|Overall Study|Adverse Event|10|||
160644514|NCT00408876|580080771|FG000|Overall Study|Withdrawal by Subject|3|||
160802850|NCT00332696|580667643|FG000|Overall Study|Insufficient therapeutic effect|4|||
160802851|NCT00332696|580667644|FG001|Overall Study|Insufficient therapeutic effect|11|||
160802852|NCT00332696|580667643|FG000|Overall Study|Adverse Event|1|||
160802853|NCT00332696|580667644|FG001|Overall Study|Adverse Event|2|||
160802854|NCT00332696|580667643|FG000|Overall Study|Condition does not justify treatment|0|||
160802855|NCT00332696|580667644|FG001|Overall Study|Condition does not justify treatment|2|||
160802856|NCT00332696|580667643|FG000|Overall Study|Lost to Follow-up|0|||
160802857|NCT00332696|580667644|FG001|Overall Study|Lost to Follow-up|1|||
160802858|NCT00332696|580667643|FG000|Overall Study|Withdrawal by Subject|1|||
160802859|NCT00332696|580667644|FG001|Overall Study|Withdrawal by Subject|0|||
160802860|NCT02216526|580667645|FG000|Overall Study|Adverse Event|1|||
160802861|NCT02216526|580667646|FG001|Overall Study|Adverse Event|1|||
160802862|NCT02216526|580667647|FG002|Overall Study|Adverse Event|0|||
160802863|NCT02216526|580667645|FG000|Overall Study|Death|0|||
160802864|NCT02216526|580667646|FG001|Overall Study|Death|1|||
160802865|NCT02216526|580667647|FG002|Overall Study|Death|3|||
160802866|NCT02216526|580667645|FG000|Overall Study|Protocol Violation|2|||
160802867|NCT02216526|580667646|FG001|Overall Study|Protocol Violation|0|||
160802868|NCT02216526|580667647|FG002|Overall Study|Protocol Violation|2|||
160802869|NCT02216526|580667645|FG000|Overall Study|Hospitalization|2|||
160802870|NCT02216526|580667646|FG001|Overall Study|Hospitalization|1|||
160802871|NCT02216526|580667647|FG002|Overall Study|Hospitalization|3|||
160802872|NCT04103450|580667652|FG000|Overall Study|Adverse Event|4|||
160802873|NCT04103450|580667653|FG001|Overall Study|Adverse Event|2|||
160802874|NCT04103450|580667652|FG000|Overall Study|Lack of Efficacy|3|||
160802875|NCT04103450|580667653|FG001|Overall Study|Lack of Efficacy|0|||
160802876|NCT04103450|580667652|FG000|Overall Study|Withdrawal by Subject|5|||
160802877|NCT04103450|580667653|FG001|Overall Study|Withdrawal by Subject|3|||
160802878|NCT04103450|580667652|FG000|Overall Study|Lost to Follow-up|1|||
160802879|NCT04103450|580667653|FG001|Overall Study|Lost to Follow-up|2|||
160802880|NCT04103450|580667652|FG000|Overall Study|Physician Decision|1|||
160802881|NCT04103450|580667653|FG001|Overall Study|Physician Decision|2|||
160802882|NCT04103450|580667652|FG000|Overall Study|Protocol Violation|1|||
160802883|NCT04103450|580667653|FG001|Overall Study|Protocol Violation|0|||
160802884|NCT04103450|580667652|FG000|Overall Study|Other|1|||
160802885|NCT04103450|580667653|FG001|Overall Study|Other|1|||
160802886|NCT00696878|580667654|FG000|Overall Study|Adverse Event|8|||
160802887|NCT00696878|580667654|FG000|Overall Study|Withdrawal by Subject|87|||
160802888|NCT00696878|580667654|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
160802889|NCT00696878|580667654|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
160802890|NCT00696878|580667654|FG000|Overall Study|Trial stopped|32|||
160802891|NCT00696878|580667654|FG000|Overall Study|Other reason (not specified)|55|||
160802892|NCT02712788|580667655|FG000|Overall Study|Physician Decision|1|||
160802893|NCT02712788|580667656|FG001|Overall Study|Physician Decision|0|||
160802894|NCT02712788|580667655|FG000|Overall Study|Protocol Violation|1|||
160802895|NCT02712788|580667656|FG001|Overall Study|Protocol Violation|0|||
160802896|NCT00967616|580667663|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
160802897|NCT00967616|580667664|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
160802898|NCT00967616|580667663|FG000|Overall Study|Death|0|||
160802899|NCT00967616|580667664|FG001|Overall Study|Death|3|||
160802900|NCT00967616|580667663|FG000|Overall Study|Withdrawal by Subject|8|||
160985080|NCT01734382|581335338|FG001|Part 2|Physician Decision|0|||
160802901|NCT00967616|580667664|FG001|Overall Study|Withdrawal by Subject|4|||
160802902|NCT00967616|580667663|FG000|Overall Study|Progressive Disease|31|||
160802903|NCT00967616|580667664|FG001|Overall Study|Progressive Disease|18|||
160802904|NCT00967616|580667663|FG000|Overall Study|Other|8|||
160802905|NCT00967616|580667664|FG001|Overall Study|Other|8|||
160802906|NCT00967616|580667663|FG000|Overall Study|Protocol Violation|1|||
160802907|NCT00967616|580667664|FG001|Overall Study|Protocol Violation|0|||
160802908|NCT03188263|580667670|FG000|Overall Study|Withdrawal by Subject|3|||
160802909|NCT03188263|580667671|FG001|Overall Study|Withdrawal by Subject|0|||
160802910|NCT03188263|580667670|FG000|Overall Study|Physician Decision|1|||
160802911|NCT03188263|580667671|FG001|Overall Study|Physician Decision|0|||
160802912|NCT00699413|580667672|FG000|Overall Study|Withdrawal by Subject|0|||
160802913|NCT00699413|580667673|FG001|Overall Study|Withdrawal by Subject|2|||
160802914|NCT00699413|580667672|FG000|Overall Study|Study terminated by sponsor|4|||
160802915|NCT00699413|580667673|FG001|Overall Study|Study terminated by sponsor|2|||
160802916|NCT00251693|580667674|FG000|Overall Study|Adverse Event|17|||
160802917|NCT00251693|580667675|FG001|Overall Study|Adverse Event|9|||
160802918|NCT00251693|580667676|FG002|Overall Study|Adverse Event|9|||
160802919|NCT00251693|580667674|FG000|Overall Study|Protocol Violation|2|||
160802920|NCT00251693|580667675|FG001|Overall Study|Protocol Violation|0|||
160802921|NCT00251693|580667676|FG002|Overall Study|Protocol Violation|2|||
160802922|NCT00251693|580667674|FG000|Overall Study|Lost to Follow-up|12|||
160802923|NCT00251693|580667675|FG001|Overall Study|Lost to Follow-up|7|||
160802924|NCT00251693|580667676|FG002|Overall Study|Lost to Follow-up|8|||
160802925|NCT00251693|580667674|FG000|Overall Study|Withdrawal by Subject|11|||
160802926|NCT00251693|580667675|FG001|Overall Study|Withdrawal by Subject|17|||
160802927|NCT00251693|580667676|FG002|Overall Study|Withdrawal by Subject|14|||
160802928|NCT00251693|580667674|FG000|Overall Study|Lack of Efficacy|0|||
160802929|NCT00251693|580667675|FG001|Overall Study|Lack of Efficacy|1|||
160802930|NCT00251693|580667676|FG002|Overall Study|Lack of Efficacy|0|||
160802931|NCT00251693|580667674|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
160802932|NCT00251693|580667675|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
160802933|NCT00251693|580667676|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
160802934|NCT00251693|580667674|FG000|Overall Study|Noncompliant|0|||
160802935|NCT00251693|580667675|FG001|Overall Study|Noncompliant|0|||
160802936|NCT00251693|580667676|FG002|Overall Study|Noncompliant|2|||
160802937|NCT00251693|580667674|FG000|Overall Study|Possible Barrett's esophagus|3|||
160802938|NCT00251693|580667675|FG001|Overall Study|Possible Barrett's esophagus|5|||
160802939|NCT00251693|580667676|FG002|Overall Study|Possible Barrett's esophagus|2|||
160802940|NCT00251693|580667674|FG000|Overall Study|Subject request/subject unavailable|1|||
160802941|NCT00251693|580667675|FG001|Overall Study|Subject request/subject unavailable|2|||
160802942|NCT00251693|580667676|FG002|Overall Study|Subject request/subject unavailable|0|||
160802943|NCT00251693|580667674|FG000|Overall Study|Abnormal laboratory findings|0|||
160802944|NCT00251693|580667675|FG001|Overall Study|Abnormal laboratory findings|0|||
160802945|NCT00251693|580667676|FG002|Overall Study|Abnormal laboratory findings|1|||
160802946|NCT02779777|580667677|FG000|Overall Study|Disease Progression|1|||
160802947|NCT02779777|580667678|FG001|Overall Study|Disease Progression|0|||
160802948|NCT02779777|580667679|FG002|Overall Study|Disease Progression|0|||
160802949|NCT02779777|580667677|FG000|Overall Study|Adverse Event|3|||
160802950|NCT02779777|580667678|FG001|Overall Study|Adverse Event|1|||
160802951|NCT02779777|580667679|FG002|Overall Study|Adverse Event|0|||
160897173|NCT03945266|581018788|FG001|Overall Study|Lost to Follow-up|0|||
160897174|NCT03698331|581018794|FG000|Overall Study|Adverse Event|2|||
160897175|NCT03698331|581018795|FG001|Overall Study|Adverse Event|3|||
160897176|NCT03698331|581018794|FG000|Overall Study|Withdrawal by Subject|1|||
160897177|NCT03698331|581018795|FG001|Overall Study|Withdrawal by Subject|1|||
160897178|NCT03698331|581018794|FG000|Overall Study|Lost to Follow-up|0|||
160897179|NCT03698331|581018795|FG001|Overall Study|Lost to Follow-up|2|||
160985081|NCT01734382|581335339|FG002|Part 2|Physician Decision|3|||
160985082|NCT01734382|581335337|FG000|Part 2|Protocol Violation|0|||
160985083|NCT01734382|581335338|FG001|Part 2|Protocol Violation|1|||
160802952|NCT02779777|580667677|FG000|Overall Study|Physician Decision|9|||
160802953|NCT02779777|580667678|FG001|Overall Study|Physician Decision|0|||
160802954|NCT02779777|580667679|FG002|Overall Study|Physician Decision|1|||
160802955|NCT02779777|580667677|FG000|Overall Study|Withdrawal by Subject|1|||
160802956|NCT02779777|580667678|FG001|Overall Study|Withdrawal by Subject|0|||
160802957|NCT02779777|580667679|FG002|Overall Study|Withdrawal by Subject|0|||
160802958|NCT01030822|580667681|FG000|Overall Study|Moved/migrated from study area|6|||
160802959|NCT01030822|580667682|FG001|Overall Study|Moved/migrated from study area|7|||
160802960|NCT01030822|580667683|FG002|Overall Study|Moved/migrated from study area|3|||
160897180|NCT03698331|581018794|FG000|Overall Study|Non-compliance with study drug|1|||
160897181|NCT03698331|581018795|FG001|Overall Study|Non-compliance with study drug|0|||
160897182|NCT04916769|581018799|FG000|Period 1|Physician Decision|0|||
160897183|NCT04916769|581018800|FG001|Period 1|Physician Decision|0|||
160897184|NCT04916769|581018801|FG002|Period 1|Physician Decision|0|||
160985084|NCT01734382|581335339|FG002|Part 2|Protocol Violation|0|||
160985085|NCT01734382|581335337|FG000|Part 2|Withdrawal by Subject|0|||
160985086|NCT01734382|581335338|FG001|Part 2|Withdrawal by Subject|0|||
160985087|NCT01734382|581335339|FG002|Part 2|Withdrawal by Subject|1|||
160985088|NCT04537949|581335340|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
160985089|NCT04537949|581335341|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
160985090|NCT04537949|581335342|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
160985091|NCT04537949|581335343|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
160985092|NCT04537949|581335344|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
160985093|NCT04537949|581335345|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
160985094|NCT04537949|581335346|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
160985095|NCT04537949|581335347|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
160985096|NCT04537949|581335340|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
160985097|NCT04537949|581335341|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
160985098|NCT04537949|581335342|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
160985099|NCT04537949|581335343|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
160985100|NCT04537949|581335344|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
160985101|NCT04537949|581335345|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
160985102|NCT04537949|581335346|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
160985103|NCT04537949|581335347|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
160985104|NCT04537949|581335340|FG000|Follow-up Phase|Lost to Follow-up|0|||
160985105|NCT04537949|581335341|FG001|Follow-up Phase|Lost to Follow-up|3|||
160985106|NCT04537949|581335342|FG002|Follow-up Phase|Lost to Follow-up|0|||
160985107|NCT04537949|581335343|FG003|Follow-up Phase|Lost to Follow-up|0|||
160985108|NCT04537949|581335344|FG004|Follow-up Phase|Lost to Follow-up|0|||
160985109|NCT04537949|581335345|FG005|Follow-up Phase|Lost to Follow-up|0|||
160985110|NCT04537949|581335346|FG006|Follow-up Phase|Lost to Follow-up|0|||
160985111|NCT04537949|581335347|FG007|Follow-up Phase|Lost to Follow-up|0|||
160985112|NCT04537949|581335340|FG000|Follow-up Phase|personal reasons|0|||
160985113|NCT04537949|581335341|FG001|Follow-up Phase|personal reasons|0|||
160985114|NCT04537949|581335342|FG002|Follow-up Phase|personal reasons|0|||
160985115|NCT04537949|581335343|FG003|Follow-up Phase|personal reasons|1|||
160985116|NCT04537949|581335344|FG004|Follow-up Phase|personal reasons|1|||
160985117|NCT04537949|581335345|FG005|Follow-up Phase|personal reasons|0|||
160985118|NCT04537949|581335346|FG006|Follow-up Phase|personal reasons|0|||
160985119|NCT04537949|581335347|FG007|Follow-up Phase|personal reasons|0|||
160985120|NCT04537949|581335340|FG000|Follow-up Phase|Withdrawal by Subject|0|||
160985121|NCT04537949|581335341|FG001|Follow-up Phase|Withdrawal by Subject|0|||
160985122|NCT04537949|581335342|FG002|Follow-up Phase|Withdrawal by Subject|0|||
160985123|NCT04537949|581335343|FG003|Follow-up Phase|Withdrawal by Subject|0|||
160985124|NCT04537949|581335344|FG004|Follow-up Phase|Withdrawal by Subject|1|||
160985125|NCT04537949|581335345|FG005|Follow-up Phase|Withdrawal by Subject|0|||
160985126|NCT04537949|581335346|FG006|Follow-up Phase|Withdrawal by Subject|0|||
160985127|NCT04537949|581335347|FG007|Follow-up Phase|Withdrawal by Subject|0|||
160985128|NCT04003974|581335348|FG000|Overall Study|Missing|1|||
160985129|NCT04003974|581335349|FG001|Overall Study|Missing|0|||
160985130|NCT04003974|581335348|FG000|Overall Study|Withdrawal by Subject|0|||
160985131|NCT04003974|581335349|FG001|Overall Study|Withdrawal by Subject|2|||
160985132|NCT02400307|581335350|FG000|Overall Study|Enrolled and Never Dosed|1|||
160985133|NCT02400307|581335351|FG001|Overall Study|Enrolled and Never Dosed|0|||
160985134|NCT02015663|581335355|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
160985135|NCT02015663|581335356|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
160985136|NCT02015663|581335355|FG000|Overall Study|Withdrawal by Subject|1|||
160985137|NCT02015663|581335356|FG001|Overall Study|Withdrawal by Subject|0|||
160985138|NCT02015663|581335355|FG000|Overall Study|Protocol Violation|0|||
160985139|NCT02015663|581335356|FG001|Overall Study|Protocol Violation|1|||
160985140|NCT02015663|581335355|FG000|Overall Study|Adverse Event|3|||
160985141|NCT02015663|581335356|FG001|Overall Study|Adverse Event|0|||
160985142|NCT02015663|581335355|FG000|Overall Study|Administrative problems|10|||
160985143|NCT02015663|581335356|FG001|Overall Study|Administrative problems|11|||
160985144|NCT02059161|581335358|FG000|Overall Study|Pregnancy|0|||
160985145|NCT02059161|581335359|FG001|Overall Study|Pregnancy|2|||
160985146|NCT02059161|581335358|FG000|Overall Study|Adverse Event|2|||
160985147|NCT02059161|581335359|FG001|Overall Study|Adverse Event|6|||
160985148|NCT02059161|581335358|FG000|Overall Study|Lost to Follow-up|20|||
160985149|NCT02059161|581335359|FG001|Overall Study|Lost to Follow-up|12|||
160985150|NCT02059161|581335358|FG000|Overall Study|Physician Decision|4|||
160985151|NCT02059161|581335359|FG001|Overall Study|Physician Decision|4|||
160985152|NCT02059161|581335358|FG000|Overall Study|Protocol Violation|1|||
160985153|NCT02059161|581335359|FG001|Overall Study|Protocol Violation|1|||
160985154|NCT02059161|581335358|FG000|Overall Study|Withdrawal by Subject|16|||
160985155|NCT02059161|581335359|FG001|Overall Study|Withdrawal by Subject|13|||
160802961|NCT01030822|580667681|FG000|Overall Study|Withdrawal by Subject|16|||
160802962|NCT01030822|580667682|FG001|Overall Study|Withdrawal by Subject|13|||
160802963|NCT01030822|580667683|FG002|Overall Study|Withdrawal by Subject|16|||
160802964|NCT01030822|580667681|FG000|Overall Study|Lost to Follow-up|9|||
160802965|NCT01030822|580667682|FG001|Overall Study|Lost to Follow-up|4|||
160802966|NCT01030822|580667683|FG002|Overall Study|Lost to Follow-up|7|||
160897185|NCT04916769|581018802|FG003|Period 1|Physician Decision|0|||
160897186|NCT04916769|581018803|FG004|Period 1|Physician Decision|0|||
160897187|NCT04916769|581018804|FG005|Period 1|Physician Decision|1|||
160897188|NCT04916769|581018799|FG000|Period 2|Physician Decision|0|||
160897189|NCT04916769|581018800|FG001|Period 2|Physician Decision|1|||
160897190|NCT04916769|581018801|FG002|Period 2|Physician Decision|0|||
160897191|NCT04916769|581018802|FG003|Period 2|Physician Decision|0|||
160897192|NCT04916769|581018803|FG004|Period 2|Physician Decision|0|||
160897193|NCT04916769|581018804|FG005|Period 2|Physician Decision|0|||
160550066|NCT03529773|579740165|FG013|Overall Study|Other|0|||
160802967|NCT00120627|580667689|FG000|Overall Study|Withdrawal by Subject|5|||
160802968|NCT00120627|580667690|FG001|Overall Study|Withdrawal by Subject|5|||
160802969|NCT03386435|580667691|FG000|Overall Study|Protocol Violation|5|||
160802970|NCT03386435|580667692|FG001|Overall Study|Protocol Violation|7|||
160802971|NCT00907621|580667694|FG000|Overall Study|Lost to Follow-up|6|||
160802972|NCT00907621|580667695|FG001|Overall Study|Lost to Follow-up|3|||
160802973|NCT00907621|580667694|FG000|Overall Study|intercurrent febrile illness|1|||
160802974|NCT00907621|580667695|FG001|Overall Study|intercurrent febrile illness|1|||
160802975|NCT00959907|580667696|FG000|Overall Study|Protocol Violation|0|||
160802976|NCT00959907|580667697|FG001|Overall Study|Protocol Violation|1|||
160802977|NCT00959907|580667696|FG000|Overall Study|Adverse Event|1|||
160802978|NCT00959907|580667697|FG001|Overall Study|Adverse Event|0|||
160802979|NCT00959907|580667696|FG000|Overall Study|Withdrawal by Subject|2|||
160802980|NCT00959907|580667697|FG001|Overall Study|Withdrawal by Subject|0|||
160802981|NCT04290624|580667698|FG000|Overall Study|Adverse Event|1|||
160897194|NCT05628103|581018822|FG000|Overall Study|Adverse Event|7|||
160897195|NCT05628103|581018822|FG000|Overall Study|Withdrawal by Subject|3|||
160897196|NCT05628103|581018822|FG000|Overall Study|Lost to Follow-up|3|||
160897197|NCT05628103|581018822|FG000|Overall Study|Lack of Efficacy|1|||
160897198|NCT05628103|581018822|FG000|Overall Study|Non-Compliance With Study Drug|4|||
160897199|NCT04840888|581018823|FG000|Period 1|Withdrawal by Subject|0|||
160897200|NCT04840888|581018824|FG001|Period 1|Withdrawal by Subject|0|||
160897201|NCT04840888|581018825|FG002|Period 1|Withdrawal by Subject|0|||
160897202|NCT04840888|581018826|FG003|Period 1|Withdrawal by Subject|0|||
160897203|NCT04840888|581018827|FG004|Period 1|Withdrawal by Subject|1|||
160897204|NCT04840888|581018828|FG005|Period 1|Withdrawal by Subject|0|||
160897205|NCT04840888|581018823|FG000|Period 1|Adverse Event|0|||
160897206|NCT04840888|581018824|FG001|Period 1|Adverse Event|0|||
160897207|NCT04840888|581018825|FG002|Period 1|Adverse Event|1|||
160897208|NCT04840888|581018826|FG003|Period 1|Adverse Event|1|||
160897209|NCT04840888|581018827|FG004|Period 1|Adverse Event|10|||
160897210|NCT04840888|581018828|FG005|Period 1|Adverse Event|1|||
160897211|NCT02719327|581018831|FG000|Overall Study|Withdrawal by Subject|11|||
160897212|NCT02719327|581018832|FG001|Overall Study|Withdrawal by Subject|8|||
160897213|NCT04340193|581018833|FG000|Overall Study|Other reason|0|||
160897214|NCT04340193|581018834|FG001|Overall Study|Other reason|0|||
160897215|NCT04340193|581018835|FG002|Overall Study|Other reason|1|||
160897216|NCT04340193|581018833|FG000|Overall Study|Disease recurrence|0|||
160897217|NCT04340193|581018834|FG001|Overall Study|Disease recurrence|1|||
160897218|NCT04340193|581018835|FG002|Overall Study|Disease recurrence|0|||
160897219|NCT04340193|581018833|FG000|Overall Study|Study drug toxicity|1|||
160897220|NCT04340193|581018834|FG001|Overall Study|Study drug toxicity|0|||
160897221|NCT04340193|581018835|FG002|Overall Study|Study drug toxicity|0|||
160897222|NCT04340193|581018833|FG000|Overall Study|Disease progression|1|||
160897223|NCT04340193|581018834|FG001|Overall Study|Disease progression|2|||
160897224|NCT04340193|581018835|FG002|Overall Study|Disease progression|3|||
160897225|NCT04340193|581018833|FG000|Overall Study|Administrative reasons by sponsor|0|||
160802982|NCT04290624|580667699|FG001|Overall Study|Adverse Event|0|||
160802983|NCT00027560|580667704|FG000|Overall Study|Withdrawal by Subject|1|||
160802984|NCT03559270|580667708|FG000|Overall Study|Adverse Event|6|||
160802985|NCT03559270|580667709|FG001|Overall Study|Adverse Event|5|||
160802986|NCT03559270|580667710|FG002|Overall Study|Adverse Event|3|||
160802987|NCT03559270|580667711|FG003|Overall Study|Adverse Event|0|||
160897226|NCT04340193|581018834|FG001|Overall Study|Administrative reasons by sponsor|1|||
160897227|NCT04340193|581018835|FG002|Overall Study|Administrative reasons by sponsor|0|||
160897228|NCT04340193|581018833|FG000|Overall Study|Adverse Event|1|||
160897229|NCT04340193|581018834|FG001|Overall Study|Adverse Event|1|||
160897230|NCT04340193|581018835|FG002|Overall Study|Adverse Event|0|||
160897231|NCT05741528|581018839|FG000|Overall Study|Withdrawal by Subject|11|||
160897232|NCT05741528|581018839|FG000|Overall Study|Lost to Follow-up|3|||
160897233|NCT05741528|581018839|FG000|Overall Study|Adverse Event|2|||
160897234|NCT05741528|581018839|FG000|Overall Study|Non-Compliance With Study Drug|2|||
160897235|NCT05741528|581018839|FG000|Overall Study|Reason Not Specified|1|||
160897236|NCT03894046|581020031|FG000|Overall Study|Protocol Violation|1|||
160802988|NCT03559270|580667708|FG000|Overall Study|Lack of Efficacy|34|||
160802989|NCT03559270|580667709|FG001|Overall Study|Lack of Efficacy|52|||
160802990|NCT03559270|580667710|FG002|Overall Study|Lack of Efficacy|37|||
160802991|NCT03559270|580667711|FG003|Overall Study|Lack of Efficacy|2|||
160802992|NCT03559270|580667708|FG000|Overall Study|Death|0|||
160802993|NCT03559270|580667709|FG001|Overall Study|Death|2|||
160802994|NCT03559270|580667710|FG002|Overall Study|Death|0|||
160802995|NCT03559270|580667711|FG003|Overall Study|Death|0|||
160802996|NCT03559270|580667708|FG000|Overall Study|Lost to Follow-up|16|||
160802997|NCT03559270|580667709|FG001|Overall Study|Lost to Follow-up|4|||
160802998|NCT03559270|580667710|FG002|Overall Study|Lost to Follow-up|12|||
160802999|NCT03559270|580667711|FG003|Overall Study|Lost to Follow-up|3|||
160803000|NCT03559270|580667708|FG000|Overall Study|Sponsor Decision|38|||
160803001|NCT03559270|580667709|FG001|Overall Study|Sponsor Decision|31|||
160803002|NCT03559270|580667710|FG002|Overall Study|Sponsor Decision|35|||
160803003|NCT03559270|580667711|FG003|Overall Study|Sponsor Decision|18|||
160803004|NCT03559270|580667708|FG000|Overall Study|Withdrawal by Subject|19|||
160803005|NCT03559270|580667709|FG001|Overall Study|Withdrawal by Subject|21|||
160803006|NCT03559270|580667710|FG002|Overall Study|Withdrawal by Subject|18|||
160803007|NCT03559270|580667711|FG003|Overall Study|Withdrawal by Subject|7|||
160803008|NCT03559270|580667708|FG000|Overall Study|Physician Decision|3|||
160803009|NCT03559270|580667709|FG001|Overall Study|Physician Decision|2|||
160803010|NCT03559270|580667710|FG002|Overall Study|Physician Decision|1|||
160803011|NCT03559270|580667711|FG003|Overall Study|Physician Decision|0|||
160803012|NCT03559270|580667708|FG000|Overall Study|Pregnancy|0|||
160803013|NCT03559270|580667709|FG001|Overall Study|Pregnancy|1|||
160803014|NCT03559270|580667710|FG002|Overall Study|Pregnancy|0|||
160803015|NCT03559270|580667711|FG003|Overall Study|Pregnancy|0|||
160803016|NCT03559270|580667708|FG000|Overall Study|Protocol Violation|1|||
160803017|NCT03559270|580667709|FG001|Overall Study|Protocol Violation|0|||
160803018|NCT03559270|580667710|FG002|Overall Study|Protocol Violation|2|||
160803019|NCT03559270|580667711|FG003|Overall Study|Protocol Violation|0|||
160803020|NCT02549989|580669514|FG000|Overall Study|Adverse Event|4|||
160803021|NCT02549989|580669514|FG000|Overall Study|Death|1|||
160803022|NCT02549989|580669514|FG000|Overall Study|Lack of Efficacy|19|||
160803023|NCT02549989|580669514|FG000|Overall Study|Withdrawal by Subject|3|||
160803024|NCT01333722|580669518|FG000|Overall Study|Lack of Efficacy|0|||
160803025|NCT01333722|580669519|FG001|Overall Study|Lack of Efficacy|2|||
160803026|NCT01333722|580669518|FG000|Overall Study|Withdrawal by Subject|0|||
160803027|NCT01333722|580669519|FG001|Overall Study|Withdrawal by Subject|1|||
160803028|NCT00784368|580669520|FG000|Overall Study|Physician Decision|0|||
160803029|NCT00784368|580669521|FG001|Overall Study|Physician Decision|0|||
160803030|NCT00784368|580669522|FG002|Overall Study|Physician Decision|6|||
160803031|NCT00784368|580669520|FG000|Overall Study|Lack of Efficacy|2|||
160803032|NCT00784368|580669521|FG001|Overall Study|Lack of Efficacy|0|||
160803033|NCT00784368|580669522|FG002|Overall Study|Lack of Efficacy|1|||
160803034|NCT00784368|580669520|FG000|Overall Study|Adverse Event|6|||
160803035|NCT00784368|580669521|FG001|Overall Study|Adverse Event|9|||
160803036|NCT00784368|580669522|FG002|Overall Study|Adverse Event|2|||
160803037|NCT00784368|580669520|FG000|Overall Study|Diagnosis of fever|0|||
160803038|NCT00784368|580669521|FG001|Overall Study|Diagnosis of fever|0|||
160803039|NCT00784368|580669522|FG002|Overall Study|Diagnosis of fever|1|||
160803040|NCT00784368|580669520|FG000|Overall Study|Worsening of complications|0|||
160803041|NCT00784368|580669521|FG001|Overall Study|Worsening of complications|0|||
160803042|NCT00784368|580669522|FG002|Overall Study|Worsening of complications|1|||
160803043|NCT00784368|580669520|FG000|Overall Study|Worsening of symptoms|0|||
160803044|NCT00784368|580669521|FG001|Overall Study|Worsening of symptoms|1|||
160803045|NCT00784368|580669522|FG002|Overall Study|Worsening of symptoms|0|||
160803046|NCT00784368|580669520|FG000|Overall Study|Withdrawal of informed consent|0|||
160803047|NCT00784368|580669521|FG001|Overall Study|Withdrawal of informed consent|1|||
160803048|NCT00784368|580669522|FG002|Overall Study|Withdrawal of informed consent|0|||
160803049|NCT02079909|580669523|FG000|Overall Study|Adverse Event|23|||
160803050|NCT02079909|580669524|FG001|Overall Study|Adverse Event|23|||
160897237|NCT03894046|581020032|FG001|Overall Study|Protocol Violation|0|||
160803051|NCT02079909|580669525|FG002|Overall Study|Adverse Event|7|||
160803052|NCT02079909|580669523|FG000|Overall Study|Withdrawal by Subject|9|||
160803053|NCT02079909|580669524|FG001|Overall Study|Withdrawal by Subject|17|||
160803054|NCT02079909|580669525|FG002|Overall Study|Withdrawal by Subject|4|||
160803055|NCT02079909|580669523|FG000|Overall Study|Lost to Follow-up|2|||
160803056|NCT02079909|580669524|FG001|Overall Study|Lost to Follow-up|3|||
160803057|NCT02079909|580669525|FG002|Overall Study|Lost to Follow-up|1|||
160803058|NCT02079909|580669523|FG000|Overall Study|Death|2|||
160803059|NCT02079909|580669524|FG001|Overall Study|Death|2|||
160803060|NCT02079909|580669525|FG002|Overall Study|Death|0|||
160803061|NCT02079909|580669523|FG000|Overall Study|Lack of Efficacy|0|||
160803062|NCT02079909|580669524|FG001|Overall Study|Lack of Efficacy|0|||
160803063|NCT02079909|580669525|FG002|Overall Study|Lack of Efficacy|1|||
160803064|NCT02079909|580669523|FG000|Overall Study|Protocol Violation|0|||
160803065|NCT02079909|580669524|FG001|Overall Study|Protocol Violation|1|||
160803066|NCT02079909|580669525|FG002|Overall Study|Protocol Violation|1|||
160803067|NCT02079909|580669523|FG000|Overall Study|Physician Decision|0|||
160803068|NCT02079909|580669524|FG001|Overall Study|Physician Decision|1|||
160803069|NCT02079909|580669525|FG002|Overall Study|Physician Decision|1|||
160803070|NCT02079909|580669523|FG000|Overall Study|Relocation etc.|2|||
160803071|NCT02079909|580669524|FG001|Overall Study|Relocation etc.|2|||
160803072|NCT02079909|580669525|FG002|Overall Study|Relocation etc.|3|||
160803073|NCT00720356|580669530|FG000|Registration to Study|Determined to have methylated MGMT|67|||
160803074|NCT00720356|580669530|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
160803075|NCT00720356|580669530|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
160803076|NCT00720356|580669530|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
160803077|NCT00720356|580669530|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
160803078|NCT00720356|580669530|FG000|Follow up Until Death|Withdrawal by Subject|1|||
160803079|NCT00720356|580669530|FG000|Follow up Until Death|Alive at last data collection|4|||
160803080|NCT02237001|580669533|FG000|Overall Study|Lost to Follow-up|2|||
160803081|NCT02237001|580669533|FG000|Overall Study|Withdrawal by Subject|1|||
160803082|NCT02237001|580669533|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
160803083|NCT02237001|580669533|FG000|Overall Study|Re-operation|4|||
160803084|NCT02237001|580669533|FG000|Overall Study|Incarceration|1|||
160803085|NCT01713582|580669534|FG000|Overall Study|Disease progression|3|||
160803086|NCT01713582|580669535|FG001|Overall Study|Disease progression|3|||
160803087|NCT01713582|580669536|FG002|Overall Study|Disease progression|3|||
160803088|NCT01713582|580669537|FG003|Overall Study|Disease progression|2|||
160803089|NCT01713582|580669538|FG004|Overall Study|Disease progression|3|||
160803090|NCT01713582|580669539|FG005|Overall Study|Disease progression|3|||
160803091|NCT01713582|580669540|FG006|Overall Study|Disease progression|3|||
160803092|NCT01713582|580669541|FG007|Overall Study|Disease progression|3|||
160803093|NCT01713582|580669542|FG008|Overall Study|Disease progression|3|||
160803094|NCT01713582|580669543|FG009|Overall Study|Disease progression|11|||
160803095|NCT01713582|580669544|FG010|Overall Study|Disease progression|10|||
160803096|NCT01713582|580669545|FG011|Overall Study|Disease progression|5|||
160803097|NCT01713582|580669546|FG012|Overall Study|Disease progression|3|||
160803098|NCT01713582|580669547|FG013|Overall Study|Disease progression|3|||
160803099|NCT01713582|580669548|FG014|Overall Study|Disease progression|6|||
160803100|NCT01713582|580669549|FG015|Overall Study|Disease progression|6|||
160803101|NCT01713582|580669550|FG016|Overall Study|Disease progression|5|||
160803102|NCT01713582|580669551|FG017|Overall Study|Disease progression|2|||
160803103|NCT01713582|580669552|FG018|Overall Study|Disease progression|3|||
160803104|NCT01713582|580669553|FG019|Overall Study|Disease progression|5|||
160803105|NCT01713582|580669554|FG020|Overall Study|Disease progression|15|||
160803106|NCT01713582|580669534|FG000|Overall Study|Death|0|||
160803107|NCT01713582|580669535|FG001|Overall Study|Death|0|||
160803108|NCT01713582|580669536|FG002|Overall Study|Death|0|||
160803109|NCT01713582|580669537|FG003|Overall Study|Death|1|||
160803110|NCT01713582|580669538|FG004|Overall Study|Death|1|||
160803111|NCT01713582|580669539|FG005|Overall Study|Death|3|||
160803112|NCT01713582|580669540|FG006|Overall Study|Death|3|||
160803113|NCT01713582|580669541|FG007|Overall Study|Death|2|||
160803114|NCT01713582|580669542|FG008|Overall Study|Death|3|||
160803115|NCT01713582|580669543|FG009|Overall Study|Death|4|||
160803116|NCT01713582|580669544|FG010|Overall Study|Death|3|||
160803117|NCT01713582|580669545|FG011|Overall Study|Death|0|||
160803118|NCT01713582|580669546|FG012|Overall Study|Death|0|||
160803119|NCT01713582|580669547|FG013|Overall Study|Death|0|||
160803120|NCT01713582|580669548|FG014|Overall Study|Death|0|||
160803121|NCT01713582|580669549|FG015|Overall Study|Death|0|||
160803122|NCT01713582|580669550|FG016|Overall Study|Death|0|||
160803123|NCT01713582|580669551|FG017|Overall Study|Death|0|||
160803124|NCT01713582|580669552|FG018|Overall Study|Death|0|||
160803125|NCT01713582|580669553|FG019|Overall Study|Death|0|||
160803126|NCT01713582|580669554|FG020|Overall Study|Death|0|||
160803127|NCT01713582|580669534|FG000|Overall Study|Adverse event-related|0|||
160803128|NCT01713582|580669535|FG001|Overall Study|Adverse event-related|0|||
160803129|NCT01713582|580669536|FG002|Overall Study|Adverse event-related|0|||
160803130|NCT01713582|580669537|FG003|Overall Study|Adverse event-related|0|||
160803131|NCT01713582|580669538|FG004|Overall Study|Adverse event-related|0|||
160803132|NCT01713582|580669539|FG005|Overall Study|Adverse event-related|0|||
160803133|NCT01713582|580669540|FG006|Overall Study|Adverse event-related|0|||
160803134|NCT01713582|580669541|FG007|Overall Study|Adverse event-related|0|||
160803135|NCT01713582|580669542|FG008|Overall Study|Adverse event-related|0|||
160803136|NCT01713582|580669543|FG009|Overall Study|Adverse event-related|1|||
160803137|NCT01713582|580669544|FG010|Overall Study|Adverse event-related|1|||
160803138|NCT01713582|580669545|FG011|Overall Study|Adverse event-related|0|||
160803139|NCT01713582|580669546|FG012|Overall Study|Adverse event-related|0|||
160803140|NCT01713582|580669547|FG013|Overall Study|Adverse event-related|0|||
160803141|NCT01713582|580669548|FG014|Overall Study|Adverse event-related|0|||
160803142|NCT01713582|580669549|FG015|Overall Study|Adverse event-related|0|||
160803143|NCT01713582|580669550|FG016|Overall Study|Adverse event-related|0|||
160803144|NCT01713582|580669551|FG017|Overall Study|Adverse event-related|0|||
160803145|NCT01713582|580669552|FG018|Overall Study|Adverse event-related|1|||
160803146|NCT01713582|580669553|FG019|Overall Study|Adverse event-related|0|||
160897238|NCT03894046|581020033|FG002|Overall Study|Protocol Violation|0|||
160897239|NCT03894046|581020031|FG000|Overall Study|Adverse Event|0|||
160897240|NCT03894046|581020032|FG001|Overall Study|Adverse Event|1|||
160897241|NCT03894046|581020033|FG002|Overall Study|Adverse Event|0|||
160897242|NCT03894046|581020031|FG000|Overall Study|Withdrawal by Subject|2|||
160897243|NCT03894046|581020032|FG001|Overall Study|Withdrawal by Subject|3|||
160897244|NCT03894046|581020033|FG002|Overall Study|Withdrawal by Subject|1|||
160897245|NCT03894046|581020031|FG000|Overall Study|Death|15|||
160897246|NCT03894046|581020032|FG001|Overall Study|Death|21|||
160897247|NCT03894046|581020033|FG002|Overall Study|Death|4|||
160897248|NCT03894046|581020031|FG000|Overall Study|No growth of ABC|2|||
160897249|NCT03894046|581020032|FG001|Overall Study|No growth of ABC|1|||
160897250|NCT03894046|581020033|FG002|Overall Study|No growth of ABC|0|||
160897251|NCT03894046|581020031|FG000|Overall Study|Physician Decision|1|||
160897252|NCT03894046|581020032|FG001|Overall Study|Physician Decision|1|||
160897253|NCT03894046|581020033|FG002|Overall Study|Physician Decision|1|||
160897254|NCT03894046|581020031|FG000|Overall Study|Prohibited concomitant medication|1|||
160897255|NCT03894046|581020032|FG001|Overall Study|Prohibited concomitant medication|0|||
160897256|NCT03894046|581020033|FG002|Overall Study|Prohibited concomitant medication|0|||
160897257|NCT03894046|581020031|FG000|Overall Study|Transferred to other arm/group|1|||
160897258|NCT03894046|581020032|FG001|Overall Study|Transferred to other arm/group|1|||
160897259|NCT03894046|581020033|FG002|Overall Study|Transferred to other arm/group|0|||
160897260|NCT03270644|581020036|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
160897261|NCT03270644|581020036|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
160897262|NCT00004635|581020037|FG000|Period One|refused|2|||
160897263|NCT00004635|581020038|FG001|Period One|refused|1|||
160897264|NCT00004635|581020037|FG000|Period One|Withdrawal by Subject|1|||
160897265|NCT00004635|581020038|FG001|Period One|Withdrawal by Subject|1|||
160897266|NCT00004635|581020037|FG000|Period One|Protocol Violation|1|||
160897267|NCT00004635|581020038|FG001|Period One|Protocol Violation|0|||
160897268|NCT00004635|581020037|FG000|Period One|PSA did not go <5 ng/mL|1|||
160897269|NCT00004635|581020038|FG001|Period One|PSA did not go <5 ng/mL|0|||
160897270|NCT00004635|581020037|FG000|Period One|second malignancy|1|||
160897271|NCT00004635|581020038|FG001|Period One|second malignancy|0|||
160897272|NCT00004635|581020037|FG000|Period One|progressed|0|||
160897273|NCT00004635|581020038|FG001|Period One|progressed|2|||
160897274|NCT00004635|581020037|FG000|Period One|health problem|0|||
160897275|NCT00004635|581020038|FG001|Period One|health problem|1|||
160897276|NCT00004635|581020037|FG000|Period One|discrepancy in data entry|0|||
160897277|NCT00004635|581020038|FG001|Period One|discrepancy in data entry|1|||
160897278|NCT00004635|581020037|FG000|Period Two|progression|2|||
160897279|NCT00004635|581020038|FG001|Period Two|progression|3|||
160897280|NCT00004635|581020037|FG000|Period Two|Adverse Event|1|||
160897281|NCT00004635|581020038|FG001|Period Two|Adverse Event|0|||
160897282|NCT00004635|581020037|FG000|Period Two|refused|0|||
160897283|NCT00004635|581020038|FG001|Period Two|refused|2|||
160897284|NCT00004635|581020037|FG000|Period Two|health problem|1|||
160897285|NCT00004635|581020038|FG001|Period Two|health problem|1|||
160897286|NCT00004635|581020037|FG000|Period Two|travel issues|0|||
160897287|NCT00004635|581020038|FG001|Period Two|travel issues|1|||
160897288|NCT00004635|581020037|FG000|Period Two|secondary malignancy|1|||
160897289|NCT00004635|581020038|FG001|Period Two|secondary malignancy|1|||
160897290|NCT00004635|581020037|FG000|Period Two|Lost to Follow-up|1|||
160897291|NCT00004635|581020038|FG001|Period Two|Lost to Follow-up|0|||
160897292|NCT00004635|581020037|FG000|Period Two|discrepancy in data entry|0|||
160897293|NCT00004635|581020038|FG001|Period Two|discrepancy in data entry|1|||
160897294|NCT00191906|581020039|FG000|Study Period II|Adverse Event|0|||
160897295|NCT00191906|581020040|FG001|Study Period II|Adverse Event|1|||
160897296|NCT00191906|581020041|FG002|Study Period II|Adverse Event|0|||
160897297|NCT00191906|581020042|FG003|Study Period II|Adverse Event|0|||
160897298|NCT00191906|581020039|FG000|Study Period II|Withdrawal by Subject|0|||
160897299|NCT00191906|581020040|FG001|Study Period II|Withdrawal by Subject|3|||
160897300|NCT00191906|581020041|FG002|Study Period II|Withdrawal by Subject|0|||
160897301|NCT00191906|581020042|FG003|Study Period II|Withdrawal by Subject|0|||
160985156|NCT02059161|581335358|FG000|Overall Study|Randomized in error, no study drug|0|||
160897302|NCT00191906|581020039|FG000|Study Period II|Parent/Caregiver Decision|0|||
160897303|NCT00191906|581020040|FG001|Study Period II|Parent/Caregiver Decision|1|||
160897304|NCT00191906|581020041|FG002|Study Period II|Parent/Caregiver Decision|0|||
160897305|NCT00191906|581020042|FG003|Study Period II|Parent/Caregiver Decision|0|||
160897306|NCT00191906|581020039|FG000|Study Period II|Entry Criteria Exclusion|0|||
160897307|NCT00191906|581020040|FG001|Study Period II|Entry Criteria Exclusion|0|||
160897308|NCT00191906|581020041|FG002|Study Period II|Entry Criteria Exclusion|1|||
160897309|NCT00191906|581020042|FG003|Study Period II|Entry Criteria Exclusion|0|||
160897310|NCT00191906|581020039|FG000|Study Period III|Adverse Event|1|||
160897311|NCT00191906|581020040|FG001|Study Period III|Adverse Event|0|||
160897312|NCT00191906|581020041|FG002|Study Period III|Adverse Event|0|||
160897313|NCT00191906|581020042|FG003|Study Period III|Adverse Event|0|||
160897314|NCT00191906|581020039|FG000|Study Period III|Lost to Follow-up|0|||
160897315|NCT00191906|581020040|FG001|Study Period III|Lost to Follow-up|1|||
160803147|NCT01713582|580669554|FG020|Overall Study|Adverse event-related|0|||
160803148|NCT01713582|580669534|FG000|Overall Study|Adverse event-unrelated|0|||
160803149|NCT01713582|580669535|FG001|Overall Study|Adverse event-unrelated|0|||
160985157|NCT02059161|581335359|FG001|Overall Study|Randomized in error, no study drug|1|||
160985158|NCT02059161|581335358|FG000|Overall Study|Non-compliance with study drug|6|||
160803150|NCT01713582|580669536|FG002|Overall Study|Adverse event-unrelated|0|||
160985159|NCT02059161|581335359|FG001|Overall Study|Non-compliance with study drug|2|||
160803151|NCT01713582|580669537|FG003|Overall Study|Adverse event-unrelated|0|||
160803152|NCT01713582|580669538|FG004|Overall Study|Adverse event-unrelated|0|||
160803153|NCT01713582|580669539|FG005|Overall Study|Adverse event-unrelated|1|||
160803154|NCT01713582|580669540|FG006|Overall Study|Adverse event-unrelated|1|||
160803155|NCT01713582|580669541|FG007|Overall Study|Adverse event-unrelated|1|||
160803156|NCT01713582|580669542|FG008|Overall Study|Adverse event-unrelated|0|||
160897316|NCT00191906|581020041|FG002|Study Period III|Lost to Follow-up|0|||
160897317|NCT00191906|581020042|FG003|Study Period III|Lost to Follow-up|0|||
160897318|NCT00191906|581020039|FG000|Study Period III|Parent/Caregiver Decision|1|||
160897319|NCT00191906|581020040|FG001|Study Period III|Parent/Caregiver Decision|0|||
160897320|NCT00191906|581020041|FG002|Study Period III|Parent/Caregiver Decision|0|||
160897321|NCT00191906|581020042|FG003|Study Period III|Parent/Caregiver Decision|0|||
160897322|NCT00191906|581020039|FG000|Study Period III|Lack of Efficacy|3|||
160897323|NCT00191906|581020040|FG001|Study Period III|Lack of Efficacy|3|||
160897324|NCT00191906|581020041|FG002|Study Period III|Lack of Efficacy|0|||
160897325|NCT00191906|581020042|FG003|Study Period III|Lack of Efficacy|0|||
160897326|NCT00573937|581020043|FG000|Overall Study|Study Terminated|0|||
160897327|NCT00573937|581020044|FG001|Overall Study|Study Terminated|1|||
160897328|NCT00333801|581020045|FG000|Overall Study|Moved to another state|5|||
160897329|NCT00333801|581020046|FG001|Overall Study|Moved to another state|3|||
160897330|NCT00333801|581020045|FG000|Overall Study|Lost to Follow-up|2|||
160897331|NCT00333801|581020046|FG001|Overall Study|Lost to Follow-up|0|||
160897332|NCT00333801|581020045|FG000|Overall Study|Incarcerated|1|||
160897333|NCT00333801|581020046|FG001|Overall Study|Incarcerated|2|||
160897334|NCT00333801|581020045|FG000|Overall Study|Withdrawal by Subject|0|||
160897335|NCT00333801|581020046|FG001|Overall Study|Withdrawal by Subject|1|||
160897336|NCT02476201|581020047|FG000|Overall Study|Unable to program MPP|9|||
160897337|NCT02476201|581020047|FG000|Overall Study|Study echo not performed|5|||
160897338|NCT02476201|581020047|FG000|Overall Study|Adverse Event|4|||
160897339|NCT02476201|581020047|FG000|Overall Study|Death|2|||
160897340|NCT02476201|581020047|FG000|Overall Study|Lost to Follow-up|2|||
160897341|NCT02476201|581020047|FG000|Overall Study|MPP programmed to OFF|2|||
160897342|NCT02476201|581020047|FG000|Overall Study|Withdrawal by Subject|1|||
160897343|NCT02476201|581020047|FG000|Overall Study|Unsuccessful implant|1|||
160897344|NCT00777205|581020048|FG000|Overall Study|Lost to Follow-up|25|||
160897345|NCT00777205|581020049|FG001|Overall Study|Lost to Follow-up|9|||
160897346|NCT00777205|581020048|FG000|Overall Study|Withdrawal by Subject|6|||
160897347|NCT00777205|581020049|FG001|Overall Study|Withdrawal by Subject|4|||
160897348|NCT00777205|581020048|FG000|Overall Study|Death|0|||
160897349|NCT00777205|581020049|FG001|Overall Study|Death|2|||
160897350|NCT00777205|581020048|FG000|Overall Study|Protocol Violation|0|||
160897351|NCT00777205|581020049|FG001|Overall Study|Protocol Violation|56|||
160897352|NCT00722423|581020053|FG000|Overall Study|Protocol Violation|0|||
160985160|NCT03389893|581335360|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
160985161|NCT03389893|581335361|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
160897353|NCT00722423|581020054|FG001|Overall Study|Protocol Violation|1|||
160897354|NCT00747461|581020055|FG000|Overall Study|study terminated by sponsor|5|||
160897355|NCT02149875|581020056|FG000|Overall Study|Lost to Follow-up|3|||
160897356|NCT02149875|581020057|FG001|Overall Study|Lost to Follow-up|4|||
160897357|NCT02149875|581020058|FG002|Overall Study|Lost to Follow-up|5|||
160897358|NCT02149875|581020056|FG000|Overall Study|Withdrawal by Subject|3|||
160897359|NCT02149875|581020057|FG001|Overall Study|Withdrawal by Subject|2|||
160897360|NCT02149875|581020058|FG002|Overall Study|Withdrawal by Subject|2|||
160897361|NCT02149875|581020056|FG000|Overall Study|Physician Decision|1|||
160985162|NCT03389893|581335362|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
160803157|NCT01713582|580669543|FG009|Overall Study|Adverse event-unrelated|0|||
160897362|NCT02149875|581020057|FG001|Overall Study|Physician Decision|2|||
160897363|NCT02149875|581020058|FG002|Overall Study|Physician Decision|2|||
160897364|NCT00299182|581020060|FG000|Overall Study|Withdrawal by Subject|0|||
160897365|NCT00299182|581020061|FG001|Overall Study|Withdrawal by Subject|0|||
160897366|NCT00299182|581020062|FG002|Overall Study|Withdrawal by Subject|1|||
160897367|NCT00299182|581020063|FG003|Overall Study|Withdrawal by Subject|0|||
160897368|NCT00299182|581020064|FG004|Overall Study|Withdrawal by Subject|1|||
160897369|NCT00299182|581020065|FG005|Overall Study|Withdrawal by Subject|2|||
160897370|NCT00299182|581020066|FG006|Overall Study|Withdrawal by Subject|0|||
160897371|NCT00299182|581020060|FG000|Overall Study|Chemotherapy Changed|0|||
160897372|NCT00299182|581020061|FG001|Overall Study|Chemotherapy Changed|0|||
160897373|NCT00299182|581020062|FG002|Overall Study|Chemotherapy Changed|1|||
160897374|NCT00299182|581020063|FG003|Overall Study|Chemotherapy Changed|0|||
160803158|NCT01713582|580669544|FG010|Overall Study|Adverse event-unrelated|0|||
160803159|NCT01713582|580669545|FG011|Overall Study|Adverse event-unrelated|0|||
160803160|NCT01713582|580669546|FG012|Overall Study|Adverse event-unrelated|0|||
160803161|NCT01713582|580669547|FG013|Overall Study|Adverse event-unrelated|1|||
160803162|NCT01713582|580669548|FG014|Overall Study|Adverse event-unrelated|1|||
160803163|NCT01713582|580669549|FG015|Overall Study|Adverse event-unrelated|0|||
160803164|NCT01713582|580669550|FG016|Overall Study|Adverse event-unrelated|0|||
160803165|NCT01713582|580669551|FG017|Overall Study|Adverse event-unrelated|0|||
160803166|NCT01713582|580669552|FG018|Overall Study|Adverse event-unrelated|0|||
160803167|NCT01713582|580669553|FG019|Overall Study|Adverse event-unrelated|0|||
160803168|NCT01713582|580669554|FG020|Overall Study|Adverse event-unrelated|0|||
160803169|NCT01713582|580669534|FG000|Overall Study|Withdrawal of consent|0|||
160803170|NCT01713582|580669535|FG001|Overall Study|Withdrawal of consent|0|||
160803171|NCT01713582|580669536|FG002|Overall Study|Withdrawal of consent|1|||
160803172|NCT01713582|580669537|FG003|Overall Study|Withdrawal of consent|0|||
160803173|NCT01713582|580669538|FG004|Overall Study|Withdrawal of consent|0|||
160803174|NCT01713582|580669539|FG005|Overall Study|Withdrawal of consent|1|||
160803175|NCT01713582|580669540|FG006|Overall Study|Withdrawal of consent|0|||
160803176|NCT01713582|580669541|FG007|Overall Study|Withdrawal of consent|0|||
160803177|NCT01713582|580669542|FG008|Overall Study|Withdrawal of consent|0|||
160803178|NCT01713582|580669543|FG009|Overall Study|Withdrawal of consent|1|||
160803179|NCT01713582|580669544|FG010|Overall Study|Withdrawal of consent|0|||
160803180|NCT01713582|580669545|FG011|Overall Study|Withdrawal of consent|0|||
160803181|NCT01713582|580669546|FG012|Overall Study|Withdrawal of consent|0|||
160803182|NCT01713582|580669547|FG013|Overall Study|Withdrawal of consent|0|||
160803183|NCT01713582|580669548|FG014|Overall Study|Withdrawal of consent|0|||
160803184|NCT01713582|580669549|FG015|Overall Study|Withdrawal of consent|0|||
160803185|NCT01713582|580669550|FG016|Overall Study|Withdrawal of consent|0|||
160803186|NCT01713582|580669551|FG017|Overall Study|Withdrawal of consent|0|||
160803187|NCT01713582|580669552|FG018|Overall Study|Withdrawal of consent|1|||
160803188|NCT01713582|580669553|FG019|Overall Study|Withdrawal of consent|0|||
160803189|NCT01713582|580669554|FG020|Overall Study|Withdrawal of consent|0|||
160803190|NCT01713582|580669534|FG000|Overall Study|Lack of Efficacy|0|||
160803191|NCT01713582|580669535|FG001|Overall Study|Lack of Efficacy|0|||
160803192|NCT01713582|580669536|FG002|Overall Study|Lack of Efficacy|0|||
160803193|NCT01713582|580669537|FG003|Overall Study|Lack of Efficacy|0|||
160803194|NCT01713582|580669538|FG004|Overall Study|Lack of Efficacy|0|||
160803195|NCT01713582|580669539|FG005|Overall Study|Lack of Efficacy|0|||
160803196|NCT01713582|580669540|FG006|Overall Study|Lack of Efficacy|0|||
160803197|NCT01713582|580669541|FG007|Overall Study|Lack of Efficacy|0|||
160803198|NCT01713582|580669542|FG008|Overall Study|Lack of Efficacy|0|||
160803199|NCT01713582|580669543|FG009|Overall Study|Lack of Efficacy|1|||
160803200|NCT01713582|580669544|FG010|Overall Study|Lack of Efficacy|2|||
160803201|NCT01713582|580669545|FG011|Overall Study|Lack of Efficacy|0|||
160803202|NCT01713582|580669546|FG012|Overall Study|Lack of Efficacy|0|||
160803203|NCT01713582|580669547|FG013|Overall Study|Lack of Efficacy|0|||
160803204|NCT01713582|580669548|FG014|Overall Study|Lack of Efficacy|0|||
160803205|NCT01713582|580669549|FG015|Overall Study|Lack of Efficacy|0|||
160803206|NCT01713582|580669550|FG016|Overall Study|Lack of Efficacy|0|||
160803207|NCT01713582|580669551|FG017|Overall Study|Lack of Efficacy|0|||
160803208|NCT01713582|580669552|FG018|Overall Study|Lack of Efficacy|0|||
160803209|NCT01713582|580669553|FG019|Overall Study|Lack of Efficacy|0|||
160803210|NCT01713582|580669554|FG020|Overall Study|Lack of Efficacy|0|||
160803211|NCT01713582|580669534|FG000|Overall Study|Withdrawal by Subject|0|||
160803212|NCT01713582|580669535|FG001|Overall Study|Withdrawal by Subject|0|||
160803213|NCT01713582|580669536|FG002|Overall Study|Withdrawal by Subject|0|||
160803214|NCT01713582|580669537|FG003|Overall Study|Withdrawal by Subject|0|||
160803215|NCT01713582|580669538|FG004|Overall Study|Withdrawal by Subject|0|||
160803216|NCT01713582|580669539|FG005|Overall Study|Withdrawal by Subject|0|||
160803217|NCT01713582|580669540|FG006|Overall Study|Withdrawal by Subject|0|||
160803218|NCT01713582|580669541|FG007|Overall Study|Withdrawal by Subject|0|||
160803219|NCT01713582|580669542|FG008|Overall Study|Withdrawal by Subject|0|||
160803220|NCT01713582|580669543|FG009|Overall Study|Withdrawal by Subject|0|||
160803221|NCT01713582|580669544|FG010|Overall Study|Withdrawal by Subject|0|||
160803222|NCT01713582|580669545|FG011|Overall Study|Withdrawal by Subject|0|||
160803223|NCT01713582|580669546|FG012|Overall Study|Withdrawal by Subject|0|||
160803224|NCT01713582|580669547|FG013|Overall Study|Withdrawal by Subject|0|||
160803225|NCT01713582|580669548|FG014|Overall Study|Withdrawal by Subject|0|||
160803226|NCT01713582|580669549|FG015|Overall Study|Withdrawal by Subject|0|||
160803227|NCT01713582|580669550|FG016|Overall Study|Withdrawal by Subject|0|||
160803228|NCT01713582|580669551|FG017|Overall Study|Withdrawal by Subject|1|||
160803229|NCT01713582|580669552|FG018|Overall Study|Withdrawal by Subject|0|||
160803230|NCT01713582|580669553|FG019|Overall Study|Withdrawal by Subject|0|||
160803231|NCT01713582|580669554|FG020|Overall Study|Withdrawal by Subject|0|||
160803232|NCT01713582|580669534|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
160861920|NCT00449696|580887879|FG000|Overall Study|Others|7|||
160861921|NCT00449696|580887880|FG001|Overall Study|Others|0|||
160985163|NCT03389893|581335363|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
160803233|NCT01713582|580669535|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
160803234|NCT01713582|580669536|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
160803235|NCT01713582|580669537|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
160803236|NCT01713582|580669538|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
160803237|NCT01713582|580669539|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
160803238|NCT01713582|580669540|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
160803239|NCT01713582|580669541|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
160803240|NCT01713582|580669542|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
160803241|NCT01713582|580669543|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
160985164|NCT03389893|581335360|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
160803242|NCT01713582|580669544|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
160803243|NCT01713582|580669545|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
160803244|NCT01713582|580669546|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
160803245|NCT01713582|580669547|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
160803246|NCT01713582|580669548|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
160803247|NCT01713582|580669549|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
160803248|NCT01713582|580669550|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
160803249|NCT01713582|580669551|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
160803250|NCT01713582|580669552|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
160803251|NCT01713582|580669553|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
160803252|NCT01713582|580669554|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
160803253|NCT01713582|580669534|FG000|Overall Study|Disease progression and adverse event|0|||
160803254|NCT01713582|580669535|FG001|Overall Study|Disease progression and adverse event|0|||
160803255|NCT01713582|580669536|FG002|Overall Study|Disease progression and adverse event|0|||
160803256|NCT01713582|580669537|FG003|Overall Study|Disease progression and adverse event|0|||
160803257|NCT01713582|580669538|FG004|Overall Study|Disease progression and adverse event|0|||
160803258|NCT01713582|580669539|FG005|Overall Study|Disease progression and adverse event|0|||
160803259|NCT01713582|580669540|FG006|Overall Study|Disease progression and adverse event|0|||
160803260|NCT01713582|580669541|FG007|Overall Study|Disease progression and adverse event|0|||
160803261|NCT01713582|580669542|FG008|Overall Study|Disease progression and adverse event|0|||
160803262|NCT01713582|580669543|FG009|Overall Study|Disease progression and adverse event|0|||
160803263|NCT01713582|580669544|FG010|Overall Study|Disease progression and adverse event|0|||
160803264|NCT01713582|580669545|FG011|Overall Study|Disease progression and adverse event|0|||
160803265|NCT01713582|580669546|FG012|Overall Study|Disease progression and adverse event|0|||
160803266|NCT01713582|580669547|FG013|Overall Study|Disease progression and adverse event|0|||
160803267|NCT01713582|580669548|FG014|Overall Study|Disease progression and adverse event|0|||
160803268|NCT01713582|580669549|FG015|Overall Study|Disease progression and adverse event|0|||
160803269|NCT01713582|580669550|FG016|Overall Study|Disease progression and adverse event|1|||
160803270|NCT01713582|580669551|FG017|Overall Study|Disease progression and adverse event|0|||
160803271|NCT01713582|580669552|FG018|Overall Study|Disease progression and adverse event|0|||
160803272|NCT01713582|580669553|FG019|Overall Study|Disease progression and adverse event|0|||
160803273|NCT01713582|580669554|FG020|Overall Study|Disease progression and adverse event|0|||
160803274|NCT03427814|580669555|FG000|Overall Study|Withdrawal by Subject|4|||
160803275|NCT03427814|580669556|FG001|Overall Study|Withdrawal by Subject|4|||
160803276|NCT03427814|580669555|FG000|Overall Study|Lost to Follow-up|0|||
160803277|NCT03427814|580669556|FG001|Overall Study|Lost to Follow-up|2|||
160803278|NCT03427814|580669555|FG000|Overall Study|Death|42|||
160803279|NCT03427814|580669556|FG001|Overall Study|Death|31|||
160803280|NCT03427814|580669555|FG000|Overall Study|Sponsor's Decision|1|||
160803281|NCT03427814|580669556|FG001|Overall Study|Sponsor's Decision|0|||
160803282|NCT03427814|580669555|FG000|Overall Study|Investigator's Decision|1|||
160803283|NCT03427814|580669556|FG001|Overall Study|Investigator's Decision|2|||
160897375|NCT00299182|581020064|FG004|Overall Study|Chemotherapy Changed|1|||
160897376|NCT00299182|581020065|FG005|Overall Study|Chemotherapy Changed|0|||
160897377|NCT00299182|581020066|FG006|Overall Study|Chemotherapy Changed|1|||
160897378|NCT00299182|581020060|FG000|Overall Study|Adverse Event|0|||
160897379|NCT00299182|581020061|FG001|Overall Study|Adverse Event|0|||
160897380|NCT00299182|581020062|FG002|Overall Study|Adverse Event|0|||
160897381|NCT00299182|581020063|FG003|Overall Study|Adverse Event|0|||
160897382|NCT00299182|581020064|FG004|Overall Study|Adverse Event|0|||
160897383|NCT00299182|581020065|FG005|Overall Study|Adverse Event|1|||
160897384|NCT00299182|581020066|FG006|Overall Study|Adverse Event|0|||
160897385|NCT00299182|581020060|FG000|Overall Study|Not Eligible|0|||
160897386|NCT00299182|581020061|FG001|Overall Study|Not Eligible|0|||
160897387|NCT00299182|581020062|FG002|Overall Study|Not Eligible|0|||
160897388|NCT00299182|581020063|FG003|Overall Study|Not Eligible|0|||
160803284|NCT03427814|580669555|FG000|Overall Study|Disease progression|1|||
160803285|NCT03427814|580669556|FG001|Overall Study|Disease progression|0|||
160803286|NCT03427814|580669555|FG000|Overall Study|Treatment Completed|0|||
160803287|NCT03427814|580669556|FG001|Overall Study|Treatment Completed|1|||
160803288|NCT03427814|580669555|FG000|Overall Study|Sponsor's Decision to End study|21|||
160803289|NCT03427814|580669556|FG001|Overall Study|Sponsor's Decision to End study|25|||
160803290|NCT03427814|580669555|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
160803291|NCT03427814|580669556|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
160803292|NCT03846427|580669557|FG000|Overall Study|Death|13|||
160803293|NCT03846427|580669557|FG000|Overall Study|Withdrawal by Subject|3|||
160803294|NCT03846427|580669557|FG000|Overall Study|Physician Decision|1|||
160803295|NCT01334554|580669558|FG000|Overall Study|Adverse Event|4|||
160803296|NCT01334554|580669559|FG001|Overall Study|Adverse Event|2|||
160803297|NCT02393859|580669561|FG000|Overall Study|Decision by Sponsor|2|||
160803298|NCT02393859|580669562|FG001|Overall Study|Decision by Sponsor|4|||
160803299|NCT02393859|580669561|FG000|Overall Study|Withdrawal by Subject|11|||
160803300|NCT02393859|580669562|FG001|Overall Study|Withdrawal by Subject|6|||
160803301|NCT02393859|580669561|FG000|Overall Study|Death|27|||
160803302|NCT02393859|580669562|FG001|Overall Study|Death|10|||
160803303|NCT02393859|580669561|FG000|Overall Study|Lost to Follow-up|1|||
160803304|NCT02393859|580669562|FG001|Overall Study|Lost to Follow-up|1|||
160803305|NCT00954447|580669563|FG000|Overall Study|Adverse Event|33|||
160803306|NCT00954447|580669564|FG001|Overall Study|Adverse Event|25|||
160803307|NCT00954447|580669563|FG000|Overall Study|Lack of Efficacy|17|||
160803308|NCT00954447|580669564|FG001|Overall Study|Lack of Efficacy|3|||
160803309|NCT00954447|580669563|FG000|Overall Study|Protocol Violation|5|||
160803310|NCT00954447|580669564|FG001|Overall Study|Protocol Violation|7|||
160803311|NCT00954447|580669563|FG000|Overall Study|Lost to Follow-up|8|||
160803312|NCT00954447|580669564|FG001|Overall Study|Lost to Follow-up|14|||
160803313|NCT00954447|580669563|FG000|Overall Study|Withdrawal by Subject|26|||
160803314|NCT00954447|580669564|FG001|Overall Study|Withdrawal by Subject|21|||
160803315|NCT00954447|580669563|FG000|Overall Study|Other|21|||
160803316|NCT00954447|580669564|FG001|Overall Study|Other|18|||
160803317|NCT00488514|580669565|FG000|Overall Study|Adverse Event|41|||
160803318|NCT00488514|580669565|FG000|Overall Study|Lost to Follow-up|44|||
160803319|NCT00488514|580669565|FG000|Overall Study|Protocol Violation|32|||
160803320|NCT00488514|580669565|FG000|Overall Study|Withdrawal by Subject|106|||
160803321|NCT00488514|580669565|FG000|Overall Study|Lack of Efficacy|28|||
160803322|NCT00488514|580669565|FG000|Overall Study|Did not meet criteria for treatment|30|||
160803323|NCT00488514|580669565|FG000|Overall Study|Postive drug screen|1|||
160803324|NCT00488514|580669565|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
160803325|NCT00488514|580669565|FG000|Overall Study|Investigator decision|1|||
160803326|NCT00488514|580669565|FG000|Overall Study|Participant had too few migraines|5|||
160803327|NCT00488514|580669565|FG000|Overall Study|Increase in number of migraines|2|||
160803328|NCT00488514|580669565|FG000|Overall Study|Increased use of concomitant medication|1|||
160803329|NCT00305877|580669566|FG000|Overall Study|Lack of Efficacy|6|||
160803330|NCT00305877|580669567|FG001|Overall Study|Lack of Efficacy|9|||
160803331|NCT00305877|580669566|FG000|Overall Study|Adverse Event|9|||
160803332|NCT00305877|580669567|FG001|Overall Study|Adverse Event|14|||
160803333|NCT00305877|580669566|FG000|Overall Study|Death|0|||
160803334|NCT00305877|580669567|FG001|Overall Study|Death|1|||
160803335|NCT00305877|580669566|FG000|Overall Study|Withdrawal by Subject|4|||
160803336|NCT00305877|580669567|FG001|Overall Study|Withdrawal by Subject|2|||
160803337|NCT00305877|580669566|FG000|Overall Study|Physician Decision|1|||
160803338|NCT00305877|580669567|FG001|Overall Study|Physician Decision|1|||
160803339|NCT00305877|580669566|FG000|Overall Study|Never start treatment|2|||
160803340|NCT00305877|580669567|FG001|Overall Study|Never start treatment|5|||
160803341|NCT00305877|580669566|FG000|Overall Study|Ineligible|2|||
160803342|NCT00305877|580669567|FG001|Overall Study|Ineligible|1|||
160803343|NCT00305877|580669566|FG000|Overall Study|Transportation issue with daily RT|0|||
160803344|NCT00305877|580669567|FG001|Overall Study|Transportation issue with daily RT|1|||
160803345|NCT00457392|580669568|FG000|Overall Study|Objective Progression or Relapse|229|||
160803346|NCT00457392|580669569|FG001|Overall Study|Objective Progression or Relapse|296|||
160803347|NCT00457392|580669568|FG000|Overall Study|Death|106|||
160803348|NCT00457392|580669569|FG001|Overall Study|Death|106|||
160803349|NCT00457392|580669568|FG000|Overall Study|Adverse Event|84|||
160803350|NCT00457392|580669569|FG001|Overall Study|Adverse Event|41|||
160803351|NCT00457392|580669568|FG000|Overall Study|Global Deterioration of Health Status|22|||
160803352|NCT00457392|580669569|FG001|Overall Study|Global Deterioration of Health Status|8|||
160803353|NCT00457392|580669568|FG000|Overall Study|Withdrawal by Subject|14|||
160803354|NCT00457392|580669569|FG001|Overall Study|Withdrawal by Subject|8|||
160803355|NCT00457392|580669568|FG000|Overall Study|Lost to Follow-up|6|||
160803356|NCT00457392|580669569|FG001|Overall Study|Lost to Follow-up|7|||
160803357|NCT00457392|580669568|FG000|Overall Study|Protocol Violation|4|||
160803358|NCT00457392|580669569|FG001|Overall Study|Protocol Violation|3|||
160803359|NCT00457392|580669568|FG000|Overall Study|Other|7|||
160803360|NCT00457392|580669569|FG001|Overall Study|Other|4|||
160803361|NCT00457392|580669568|FG000|Overall Study|Study Terminated by Sponsor|1|||
160803362|NCT00457392|580669569|FG001|Overall Study|Study Terminated by Sponsor|4|||
160803363|NCT00457392|580669568|FG000|Overall Study|Randomized, Not Treated|7|||
160803364|NCT00457392|580669569|FG001|Overall Study|Randomized, Not Treated|3|||
160803365|NCT00756275|580669570|FG000|Overall Study|Lost to Follow-up|25|||
160803366|NCT00756275|580669571|FG001|Overall Study|Lost to Follow-up|21|||
160803367|NCT00756275|580669570|FG000|Overall Study|Withdrawal by Subject|4|||
160803368|NCT00756275|580669571|FG001|Overall Study|Withdrawal by Subject|7|||
160803369|NCT00980148|580669572|FG000|Overall Study|Discharged from facility|89|||
160803370|NCT00980148|580669573|FG001|Overall Study|Discharged from facility|96|||
160803371|NCT00980148|580669572|FG000|Overall Study|Received other antichlamydia treatment|20|||
160803372|NCT00980148|580669573|FG001|Overall Study|Received other antichlamydia treatment|14|||
160803373|NCT00980148|580669572|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
160803374|NCT00980148|580669573|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
160803375|NCT00980148|580669572|FG000|Overall Study|Various other reasons|8|||
160897389|NCT00299182|581020064|FG004|Overall Study|Not Eligible|1|||
160985165|NCT03389893|581335361|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
160985166|NCT03389893|581335362|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
160897390|NCT00299182|581020065|FG005|Overall Study|Not Eligible|0|||
160897391|NCT00299182|581020066|FG006|Overall Study|Not Eligible|0|||
160897392|NCT00771316|581020076|FG000|Overall Study|Adverse Event|0|||
160897393|NCT00771316|581020077|FG001|Overall Study|Adverse Event|1|||
160550067|NCT03529773|579740166|FG014|Overall Study|Other|2|||
160550068|NCT03529773|579740167|FG015|Overall Study|Other|0|||
160897394|NCT00771316|581020076|FG000|Overall Study|Patient withdrew consent|1|||
160897395|NCT00771316|581020077|FG001|Overall Study|Patient withdrew consent|0|||
160897396|NCT00771316|581020076|FG000|Overall Study|Discontinued due to early termination|1|||
160897397|NCT00771316|581020077|FG001|Overall Study|Discontinued due to early termination|0|||
160897398|NCT04043728|581020081|FG000|Overall Study|Lost to Follow-up|1|||
160897399|NCT04043728|581020082|FG001|Overall Study|Lost to Follow-up|2|||
160897400|NCT04043728|581020083|FG002|Overall Study|Lost to Follow-up|0|||
160897401|NCT00543543|581020084|FG000|Base Study|Adverse Event|1|||
160897402|NCT00543543|581020085|FG001|Base Study|Adverse Event|11|||
160897403|NCT00543543|581020086|FG002|Base Study|Adverse Event|0|||
160897404|NCT00543543|581020087|FG003|Base Study|Adverse Event|5|||
160897405|NCT00543543|581020084|FG000|Base Study|Lost to Follow-up|12|||
160897406|NCT00543543|581020085|FG001|Base Study|Lost to Follow-up|749|||
160897407|NCT00543543|581020086|FG002|Base Study|Lost to Follow-up|9|||
160897408|NCT00543543|581020087|FG003|Base Study|Lost to Follow-up|701|||
160897409|NCT00543543|581020084|FG000|Base Study|Physician Decision|0|||
160897410|NCT00543543|581020085|FG001|Base Study|Physician Decision|4|||
160897411|NCT00543543|581020086|FG002|Base Study|Physician Decision|0|||
160897412|NCT00543543|581020087|FG003|Base Study|Physician Decision|7|||
160897413|NCT00543543|581020084|FG000|Base Study|Protocol Violation|0|||
160897414|NCT00543543|581020085|FG001|Base Study|Protocol Violation|6|||
160897415|NCT00543543|581020086|FG002|Base Study|Protocol Violation|0|||
160897416|NCT00543543|581020087|FG003|Base Study|Protocol Violation|6|||
160897417|NCT00543543|581020084|FG000|Base Study|Withdrawal by Subject|7|||
160897418|NCT00543543|581020085|FG001|Base Study|Withdrawal by Subject|482|||
160897419|NCT00543543|581020086|FG002|Base Study|Withdrawal by Subject|5|||
160897420|NCT00543543|581020087|FG003|Base Study|Withdrawal by Subject|503|||
160897421|NCT00543543|581020084|FG000|Extension Study|Adverse Event|0|||
160897422|NCT00543543|581020085|FG001|Extension Study|Adverse Event|0|||
160897423|NCT00543543|581020086|FG002|Extension Study|Adverse Event|0|||
160897424|NCT00543543|581020087|FG003|Extension Study|Adverse Event|5|||
160897425|NCT00543543|581020084|FG000|Extension Study|Lost to Follow-up|0|||
160897426|NCT00543543|581020085|FG001|Extension Study|Lost to Follow-up|0|||
160897427|NCT00543543|581020086|FG002|Extension Study|Lost to Follow-up|0|||
160897428|NCT00543543|581020087|FG003|Extension Study|Lost to Follow-up|77|||
160897429|NCT00543543|581020084|FG000|Extension Study|Physician Decision|0|||
160897430|NCT00543543|581020085|FG001|Extension Study|Physician Decision|0|||
160897431|NCT00543543|581020086|FG002|Extension Study|Physician Decision|0|||
160897432|NCT00543543|581020087|FG003|Extension Study|Physician Decision|7|||
160897433|NCT00543543|581020084|FG000|Extension Study|Pregnancy|0|||
160897434|NCT00543543|581020085|FG001|Extension Study|Pregnancy|0|||
160897435|NCT00543543|581020086|FG002|Extension Study|Pregnancy|0|||
160897436|NCT00543543|581020087|FG003|Extension Study|Pregnancy|6|||
160897437|NCT00543543|581020084|FG000|Extension Study|Protocol Violation|0|||
160897438|NCT00543543|581020085|FG001|Extension Study|Protocol Violation|0|||
160897439|NCT00543543|581020086|FG002|Extension Study|Protocol Violation|0|||
160897440|NCT00543543|581020087|FG003|Extension Study|Protocol Violation|11|||
160897441|NCT00543543|581020084|FG000|Extension Study|Withdrawal by Subject|0|||
160897442|NCT00543543|581020085|FG001|Extension Study|Withdrawal by Subject|0|||
160550069|NCT03529773|579740168|FG016|Overall Study|Other|0|||
160897443|NCT00543543|581020086|FG002|Extension Study|Withdrawal by Subject|0|||
160897444|NCT00543543|581020087|FG003|Extension Study|Withdrawal by Subject|120|||
160550070|NCT03529773|579740169|FG017|Overall Study|Other|3|||
160550071|NCT03529773|579740170|FG018|Overall Study|Other|0|||
160897445|NCT04308304|581020088|FG000|Overall Study|Withdrawal by Subject|4|||
160897446|NCT04308304|581020089|FG001|Overall Study|Withdrawal by Subject|0|||
160550072|NCT03529773|579740171|FG019|Overall Study|Other|0|||
160897447|NCT04308304|581020088|FG000|Overall Study|Protocol Violation|1|||
160897448|NCT04308304|581020089|FG001|Overall Study|Protocol Violation|0|||
160803376|NCT00980148|580669573|FG001|Overall Study|Various other reasons|9|||
160803377|NCT03012334|580669576|FG000|Period 1|Withdrawal by Subject|0|||
160550073|NCT03529773|579740172|FG020|Overall Study|Other|1|||
160550074|NCT03529773|579740173|FG021|Overall Study|Other|0|||
160550075|NCT03529773|579740174|FG022|Overall Study|Other|1|||
160550076|NCT03529773|579740175|FG023|Overall Study|Other|0|||
160550077|NCT03529773|579740176|FG024|Overall Study|Other|3|||
160550078|NCT03529773|579740177|FG025|Overall Study|Other|2|||
160550079|NCT03529773|579740178|FG026|Overall Study|Other|2|||
160550080|NCT03529773|579740179|FG027|Overall Study|Other|0|||
160550081|NCT03529773|579740180|FG028|Overall Study|Other|0|||
160550082|NCT03529773|579740181|FG029|Overall Study|Other|0|||
160550083|NCT03529773|579740182|FG030|Overall Study|Other|0|||
160550084|NCT03529773|579740183|FG031|Overall Study|Other|0|||
160550085|NCT03529773|579740184|FG032|Overall Study|Other|0|||
160550086|NCT03529773|579740185|FG033|Overall Study|Other|0|||
160550087|NCT03529773|579740186|FG034|Overall Study|Other|1|||
160550088|NCT03529773|579740187|FG035|Overall Study|Other|1|||
160550089|NCT03529773|579740188|FG036|Overall Study|Other|0|||
160550090|NCT03529773|579740189|FG037|Overall Study|Other|0|||
160550091|NCT03529773|579740190|FG038|Overall Study|Other|0|||
160550092|NCT03529773|579740191|FG039|Overall Study|Other|0|||
160550093|NCT03529773|579740152|FG000|Overall Study|Physician Decision|0|||
160550094|NCT03529773|579740153|FG001|Overall Study|Physician Decision|0|||
160550095|NCT03529773|579740154|FG002|Overall Study|Physician Decision|0|||
160550096|NCT03529773|579740155|FG003|Overall Study|Physician Decision|0|||
160550097|NCT03529773|579740156|FG004|Overall Study|Physician Decision|0|||
160550098|NCT03529773|579740157|FG005|Overall Study|Physician Decision|0|||
160550099|NCT03529773|579740158|FG006|Overall Study|Physician Decision|0|||
160550100|NCT03529773|579740159|FG007|Overall Study|Physician Decision|0|||
160550101|NCT03529773|579740160|FG008|Overall Study|Physician Decision|0|||
160550102|NCT03529773|579740161|FG009|Overall Study|Physician Decision|0|||
160550103|NCT03529773|579740162|FG010|Overall Study|Physician Decision|0|||
160550104|NCT03529773|579740163|FG011|Overall Study|Physician Decision|0|||
160550105|NCT03529773|579740164|FG012|Overall Study|Physician Decision|0|||
160550106|NCT03529773|579740165|FG013|Overall Study|Physician Decision|0|||
160550107|NCT03529773|579740166|FG014|Overall Study|Physician Decision|0|||
160550108|NCT03529773|579740167|FG015|Overall Study|Physician Decision|0|||
160550109|NCT03529773|579740168|FG016|Overall Study|Physician Decision|0|||
160550110|NCT03529773|579740169|FG017|Overall Study|Physician Decision|0|||
160550111|NCT03529773|579740170|FG018|Overall Study|Physician Decision|0|||
160550112|NCT03529773|579740171|FG019|Overall Study|Physician Decision|1|||
160550113|NCT03529773|579740172|FG020|Overall Study|Physician Decision|1|||
160550114|NCT03529773|579740173|FG021|Overall Study|Physician Decision|0|||
160550115|NCT03529773|579740174|FG022|Overall Study|Physician Decision|0|||
160550116|NCT03529773|579740175|FG023|Overall Study|Physician Decision|0|||
160550117|NCT03529773|579740176|FG024|Overall Study|Physician Decision|0|||
160550118|NCT03529773|579740177|FG025|Overall Study|Physician Decision|0|||
160550119|NCT03529773|579740178|FG026|Overall Study|Physician Decision|0|||
160550120|NCT03529773|579740179|FG027|Overall Study|Physician Decision|0|||
160550121|NCT03529773|579740180|FG028|Overall Study|Physician Decision|0|||
160550122|NCT03529773|579740181|FG029|Overall Study|Physician Decision|0|||
160550123|NCT03529773|579740182|FG030|Overall Study|Physician Decision|0|||
160550124|NCT03529773|579740183|FG031|Overall Study|Physician Decision|0|||
160550125|NCT03529773|579740184|FG032|Overall Study|Physician Decision|0|||
160550126|NCT03529773|579740185|FG033|Overall Study|Physician Decision|0|||
160550127|NCT03529773|579740186|FG034|Overall Study|Physician Decision|0|||
160550128|NCT03529773|579740187|FG035|Overall Study|Physician Decision|0|||
160550129|NCT03529773|579740188|FG036|Overall Study|Physician Decision|0|||
160550130|NCT03529773|579740189|FG037|Overall Study|Physician Decision|0|||
160550131|NCT03529773|579740190|FG038|Overall Study|Physician Decision|0|||
160550132|NCT03529773|579740191|FG039|Overall Study|Physician Decision|0|||
160550133|NCT03529773|579740152|FG000|Overall Study|Protocol Violation|0|||
160550134|NCT03529773|579740153|FG001|Overall Study|Protocol Violation|0|||
160550135|NCT03529773|579740154|FG002|Overall Study|Protocol Violation|0|||
160550136|NCT03529773|579740155|FG003|Overall Study|Protocol Violation|0|||
160550137|NCT03529773|579740156|FG004|Overall Study|Protocol Violation|0|||
160550138|NCT03529773|579740157|FG005|Overall Study|Protocol Violation|0|||
160550139|NCT03529773|579740158|FG006|Overall Study|Protocol Violation|0|||
160550140|NCT03529773|579740159|FG007|Overall Study|Protocol Violation|0|||
160550141|NCT03529773|579740160|FG008|Overall Study|Protocol Violation|0|||
160550142|NCT03529773|579740161|FG009|Overall Study|Protocol Violation|0|||
160550143|NCT03529773|579740162|FG010|Overall Study|Protocol Violation|0|||
160550144|NCT03529773|579740163|FG011|Overall Study|Protocol Violation|0|||
160550145|NCT03529773|579740164|FG012|Overall Study|Protocol Violation|0|||
160550146|NCT03529773|579740165|FG013|Overall Study|Protocol Violation|0|||
160550147|NCT03529773|579740166|FG014|Overall Study|Protocol Violation|0|||
160550148|NCT03529773|579740167|FG015|Overall Study|Protocol Violation|0|||
160550149|NCT03529773|579740168|FG016|Overall Study|Protocol Violation|0|||
160550150|NCT03529773|579740169|FG017|Overall Study|Protocol Violation|0|||
160985167|NCT03389893|581335363|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
160985168|NCT03389893|581335360|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
160985169|NCT03389893|581335361|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
160803378|NCT03012334|580669577|FG001|Period 1|Withdrawal by Subject|0|||
160803379|NCT03012334|580669578|FG002|Period 1|Withdrawal by Subject|0|||
160803380|NCT03012334|580669579|FG003|Period 1|Withdrawal by Subject|0|||
160803381|NCT03012334|580669580|FG004|Period 1|Withdrawal by Subject|0|||
160803382|NCT03012334|580669581|FG005|Period 1|Withdrawal by Subject|0|||
160803383|NCT03012334|580669582|FG006|Period 1|Withdrawal by Subject|0|||
160803384|NCT03012334|580669583|FG007|Period 1|Withdrawal by Subject|0|||
160803385|NCT03012334|580669584|FG008|Period 1|Withdrawal by Subject|0|||
160803386|NCT03012334|580669585|FG009|Period 1|Withdrawal by Subject|1|||
160803387|NCT03012334|580669576|FG000|Period 2|Withdrawal by Subject|0|||
160803388|NCT03012334|580669577|FG001|Period 2|Withdrawal by Subject|1|||
160803389|NCT03012334|580669578|FG002|Period 2|Withdrawal by Subject|0|||
160803390|NCT03012334|580669579|FG003|Period 2|Withdrawal by Subject|0|||
160803391|NCT03012334|580669580|FG004|Period 2|Withdrawal by Subject|0|||
160803392|NCT03012334|580669581|FG005|Period 2|Withdrawal by Subject|0|||
160803393|NCT03012334|580669582|FG006|Period 2|Withdrawal by Subject|0|||
160803394|NCT03012334|580669583|FG007|Period 2|Withdrawal by Subject|0|||
160803395|NCT03012334|580669584|FG008|Period 2|Withdrawal by Subject|0|||
160803396|NCT03012334|580669585|FG009|Period 2|Withdrawal by Subject|0|||
160803397|NCT03012334|580669576|FG000|Period 2|Protocol Violation|0|||
160803398|NCT03012334|580669577|FG001|Period 2|Protocol Violation|0|||
160803399|NCT03012334|580669578|FG002|Period 2|Protocol Violation|1|||
160803400|NCT03012334|580669579|FG003|Period 2|Protocol Violation|0|||
160803401|NCT03012334|580669580|FG004|Period 2|Protocol Violation|0|||
160897449|NCT00945555|581020090|FG000|Overall Study|Referred to another hospital|5|||
160897450|NCT00945555|581020090|FG000|Overall Study|Worsening condition, intensive care unit|1|||
160897451|NCT00945555|581020090|FG000|Overall Study|Withdrawal by Subject|2|||
160897452|NCT00945555|581020090|FG000|Overall Study|Participant continued treatment at home|1|||
160897453|NCT00945555|581020090|FG000|Overall Study|Death|18|||
160985170|NCT03389893|581335362|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
160985171|NCT03389893|581335363|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
160985172|NCT03389893|581335360|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
160985173|NCT03389893|581335361|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
160985174|NCT03389893|581335362|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
160985175|NCT03389893|581335363|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
160985176|NCT01719861|581335367|FG000|Cycle 1|Death|4|||
160985177|NCT01719861|581335367|FG000|Cycle 2|Death|1|||
160985178|NCT00958009|581335368|FG000|Overall Study|Adverse Event|1|||
160985179|NCT00958009|581335368|FG000|Overall Study|Subject found device difficult to use|1|||
160985180|NCT00087490|581335381|FG000|Overall Study|Death|6|||
160985181|NCT00087490|581335382|FG001|Overall Study|Death|4|||
160985182|NCT00087490|581335381|FG000|Overall Study|Adverse Event|3|||
160985183|NCT00087490|581335382|FG001|Overall Study|Adverse Event|8|||
160985184|NCT00087490|581335381|FG000|Overall Study|Lack of Efficacy|0|||
160985185|NCT00087490|581335382|FG001|Overall Study|Lack of Efficacy|2|||
160985186|NCT00087490|581335381|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
160985187|NCT00087490|581335382|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
160985188|NCT00087490|581335381|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
160985189|NCT00087490|581335382|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
160985190|NCT00087490|581335381|FG000|Overall Study|Randomized but not treated|7|||
160803402|NCT03012334|580669581|FG005|Period 2|Protocol Violation|0|||
160803403|NCT03012334|580669582|FG006|Period 2|Protocol Violation|0|||
160803404|NCT03012334|580669583|FG007|Period 2|Protocol Violation|1|||
160803405|NCT03012334|580669584|FG008|Period 2|Protocol Violation|0|||
160897454|NCT00945555|581020090|FG000|Overall Study|Other|1|||
160897455|NCT04502979|581020091|FG000|Overall Study|Lost to Follow-up|1|||
160897456|NCT04502979|581020092|FG001|Overall Study|Lost to Follow-up|3|||
160897457|NCT04502979|581020091|FG000|Overall Study|Withdrawal by Subject|2|||
160803406|NCT03012334|580669585|FG009|Period 2|Protocol Violation|0|||
160803407|NCT03012334|580669576|FG000|Period 4|Non-Compliance|0|||
160897458|NCT04502979|581020092|FG001|Overall Study|Withdrawal by Subject|1|||
160897459|NCT00586625|581020099|FG000|Overall Study|Adverse Event|6|||
160897460|NCT00586625|581020100|FG001|Overall Study|Adverse Event|6|||
160897461|NCT00586625|581020099|FG000|Overall Study|Protocol Violation|3|||
160897462|NCT00586625|581020100|FG001|Overall Study|Protocol Violation|0|||
160897463|NCT00586625|581020099|FG000|Overall Study|Withdrawal by Subject|32|||
160985191|NCT00087490|581335382|FG001|Overall Study|Randomized but not treated|18|||
160803408|NCT03012334|580669577|FG001|Period 4|Non-Compliance|0|||
160897464|NCT00586625|581020100|FG001|Overall Study|Withdrawal by Subject|10|||
160897465|NCT00586625|581020099|FG000|Overall Study|Subject non-compliance|0|||
160803409|NCT03012334|580669578|FG002|Period 4|Non-Compliance|0|||
160803410|NCT03012334|580669579|FG003|Period 4|Non-Compliance|0|||
160550151|NCT03529773|579740170|FG018|Overall Study|Protocol Violation|0|||
160803411|NCT03012334|580669580|FG004|Period 4|Non-Compliance|0|||
160803412|NCT03012334|580669581|FG005|Period 4|Non-Compliance|0|||
160803413|NCT03012334|580669582|FG006|Period 4|Non-Compliance|1|||
160803414|NCT03012334|580669583|FG007|Period 4|Non-Compliance|0|||
160803415|NCT03012334|580669584|FG008|Period 4|Non-Compliance|0|||
160803416|NCT03012334|580669585|FG009|Period 4|Non-Compliance|0|||
160803417|NCT03012334|580669576|FG000|Period 4|Adverse Event|0|||
160803418|NCT03012334|580669577|FG001|Period 4|Adverse Event|0|||
160803419|NCT03012334|580669578|FG002|Period 4|Adverse Event|0|||
160803420|NCT03012334|580669579|FG003|Period 4|Adverse Event|0|||
160803421|NCT03012334|580669580|FG004|Period 4|Adverse Event|0|||
160803422|NCT03012334|580669581|FG005|Period 4|Adverse Event|0|||
160803423|NCT03012334|580669582|FG006|Period 4|Adverse Event|0|||
160803424|NCT03012334|580669583|FG007|Period 4|Adverse Event|0|||
160803425|NCT03012334|580669584|FG008|Period 4|Adverse Event|1|||
160803426|NCT03012334|580669585|FG009|Period 4|Adverse Event|0|||
160803427|NCT01823107|580669586|FG000|Overall Study|Withdrawal by Subject|1|||
160803428|NCT01073293|580669587|FG000|Overall Study|Lost to Follow-up|0|||
160803429|NCT01073293|580669588|FG001|Overall Study|Lost to Follow-up|1|||
160803430|NCT01073293|580669587|FG000|Overall Study|Withdrawal by Subject|5|||
160803431|NCT01073293|580669588|FG001|Overall Study|Withdrawal by Subject|10|||
160803432|NCT00328172|580669591|FG000|Overall Study|Adverse Event|3|||
160803433|NCT00328172|580669592|FG001|Overall Study|Adverse Event|2|||
160803434|NCT00328172|580669593|FG002|Overall Study|Adverse Event|1|||
160803435|NCT00328172|580669594|FG003|Overall Study|Adverse Event|2|||
160803436|NCT00328172|580669595|FG004|Overall Study|Adverse Event|1|||
160803437|NCT00328172|580669591|FG000|Overall Study|Protocol Violation|0|||
160803438|NCT00328172|580669592|FG001|Overall Study|Protocol Violation|1|||
160803439|NCT00328172|580669593|FG002|Overall Study|Protocol Violation|1|||
160803440|NCT00328172|580669594|FG003|Overall Study|Protocol Violation|0|||
160803441|NCT00328172|580669595|FG004|Overall Study|Protocol Violation|0|||
160803442|NCT00328172|580669591|FG000|Overall Study|Lost to Follow-up|1|||
160803443|NCT00328172|580669592|FG001|Overall Study|Lost to Follow-up|1|||
160803444|NCT00328172|580669593|FG002|Overall Study|Lost to Follow-up|2|||
160803445|NCT00328172|580669594|FG003|Overall Study|Lost to Follow-up|1|||
160803446|NCT00328172|580669595|FG004|Overall Study|Lost to Follow-up|1|||
160803447|NCT00328172|580669591|FG000|Overall Study|Withdrawal by Subject|1|||
160803448|NCT00328172|580669592|FG001|Overall Study|Withdrawal by Subject|1|||
160803449|NCT00328172|580669593|FG002|Overall Study|Withdrawal by Subject|1|||
160803450|NCT00328172|580669594|FG003|Overall Study|Withdrawal by Subject|6|||
160803451|NCT00328172|580669595|FG004|Overall Study|Withdrawal by Subject|0|||
160803452|NCT00328172|580669591|FG000|Overall Study|Lack of Efficacy|14|||
160803453|NCT00328172|580669592|FG001|Overall Study|Lack of Efficacy|9|||
160803454|NCT00328172|580669593|FG002|Overall Study|Lack of Efficacy|4|||
160803455|NCT00328172|580669594|FG003|Overall Study|Lack of Efficacy|4|||
160803456|NCT00328172|580669595|FG004|Overall Study|Lack of Efficacy|3|||
160803457|NCT00328172|580669591|FG000|Overall Study|Other reason (not specified)|3|||
160803458|NCT00328172|580669592|FG001|Overall Study|Other reason (not specified)|0|||
160803459|NCT00328172|580669593|FG002|Overall Study|Other reason (not specified)|1|||
160803460|NCT00328172|580669594|FG003|Overall Study|Other reason (not specified)|0|||
160803461|NCT00328172|580669595|FG004|Overall Study|Other reason (not specified)|0|||
160803462|NCT00077974|580669596|FG000|Overall Study|Adverse Event|22|||
160803463|NCT00077974|580669596|FG000|Overall Study|Protocol Violation|1|||
160803464|NCT00077974|580669596|FG000|Overall Study|Withdrawal by Subject|3|||
160803465|NCT00077974|580669596|FG000|Overall Study|Lack of Efficacy|76|||
160803466|NCT00077974|580669596|FG000|Overall Study|Decision of Sponsor|2|||
160803467|NCT02897115|580669599|FG000|Overall Study|Early termination of study by sponsor|11|||
160803468|NCT02897115|580669600|FG001|Overall Study|Early termination of study by sponsor|8|||
160803469|NCT00420381|580669601|FG000|Overall Study|Protocol Violation|1|||
160803470|NCT01244035|580669613|FG000|Part 1: Period 1|Adverse Event|0|||
160803471|NCT01244035|580669614|FG001|Part 1: Period 1|Adverse Event|0|||
160803472|NCT01244035|580669615|FG002|Part 1: Period 1|Adverse Event|0|||
160803473|NCT01244035|580669616|FG003|Part 1: Period 1|Adverse Event|0|||
160803474|NCT01244035|580669617|FG004|Part 1: Period 1|Adverse Event|0|||
160803475|NCT01244035|580669618|FG005|Part 1: Period 1|Adverse Event|1|||
160803476|NCT01244035|580669613|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
160803477|NCT01244035|580669614|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
160803478|NCT01244035|580669615|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
160803479|NCT01244035|580669616|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
160803480|NCT01244035|580669617|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
160803481|NCT01244035|580669618|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
160803482|NCT01244035|580669613|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
160803483|NCT01244035|580669614|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
160803484|NCT01244035|580669615|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
160803485|NCT01244035|580669616|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
160803486|NCT01244035|580669617|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
160803487|NCT01244035|580669618|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
160803488|NCT01244035|580669613|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
160803489|NCT01244035|580669614|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
160803490|NCT01244035|580669615|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
160803491|NCT01244035|580669616|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
160803492|NCT01244035|580669617|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
160803493|NCT01244035|580669618|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
160803494|NCT01244035|580669613|FG000|Part 1: Period 3|Adverse Event|0|||
160803495|NCT01244035|580669614|FG001|Part 1: Period 3|Adverse Event|0|||
160803496|NCT01244035|580669615|FG002|Part 1: Period 3|Adverse Event|0|||
160897466|NCT00586625|581020100|FG001|Overall Study|Subject non-compliance|1|||
160897467|NCT00586625|581020099|FG000|Overall Study|Subject unable to return for visit|2|||
160897468|NCT00586625|581020100|FG001|Overall Study|Subject unable to return for visit|0|||
160897469|NCT00165984|581020103|FG000|Overall Study|Death|15|||
160897470|NCT01686828|581020107|FG000|Overall Study|Physician Decision|1|||
160897471|NCT01686828|581020108|FG001|Overall Study|Physician Decision|0|||
160897472|NCT01686828|581020109|FG002|Overall Study|Physician Decision|0|||
160897473|NCT01686828|581020110|FG003|Overall Study|Physician Decision|0|||
160897474|NCT01686828|581020107|FG000|Overall Study|New Job|0|||
160897475|NCT01686828|581020108|FG001|Overall Study|New Job|1|||
160897476|NCT01686828|581020109|FG002|Overall Study|New Job|0|||
160897477|NCT01686828|581020110|FG003|Overall Study|New Job|0|||
160897478|NCT01686828|581020107|FG000|Overall Study|Weight Loss|0|||
160897479|NCT01686828|581020108|FG001|Overall Study|Weight Loss|0|||
160897480|NCT01686828|581020109|FG002|Overall Study|Weight Loss|1|||
160897481|NCT01686828|581020110|FG003|Overall Study|Weight Loss|0|||
160897482|NCT04430738|581020111|FG000|Phase 1: Dose Escalation|Death|1|||
160897483|NCT04430738|581020112|FG001|Phase 1: Dose Escalation|Death|4|||
160897484|NCT04430738|581020113|FG002|Phase 1: Dose Escalation|Death|4|||
160897485|NCT04430738|581020114|FG003|Phase 1: Dose Escalation|Death|1|||
160897486|NCT04430738|581020115|FG004|Phase 1: Dose Escalation|Death|6|||
160897487|NCT04430738|581020116|FG005|Phase 1: Dose Escalation|Death|0|||
160897488|NCT04430738|581020111|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
160897489|NCT04430738|581020112|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
160897490|NCT04430738|581020113|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
160897491|NCT04430738|581020114|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
160897492|NCT04430738|581020115|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
160897493|NCT04430738|581020116|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
160897494|NCT04430738|581020111|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
160897495|NCT04430738|581020112|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
160897496|NCT04430738|581020113|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
160897497|NCT04430738|581020114|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
160897498|NCT04430738|581020115|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
160897499|NCT04430738|581020116|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
160897500|NCT04430738|581020111|FG000|Phase 1: Dose Escalation|Other|1|||
160897501|NCT04430738|581020112|FG001|Phase 1: Dose Escalation|Other|0|||
160550152|NCT03529773|579740171|FG019|Overall Study|Protocol Violation|0|||
160550153|NCT03529773|579740172|FG020|Overall Study|Protocol Violation|0|||
160550154|NCT03529773|579740173|FG021|Overall Study|Protocol Violation|0|||
160550155|NCT03529773|579740174|FG022|Overall Study|Protocol Violation|0|||
160550156|NCT03529773|579740175|FG023|Overall Study|Protocol Violation|0|||
160550157|NCT03529773|579740176|FG024|Overall Study|Protocol Violation|0|||
160897502|NCT04430738|581020113|FG002|Phase 1: Dose Escalation|Other|0|||
160550158|NCT03529773|579740177|FG025|Overall Study|Protocol Violation|0|||
160550159|NCT03529773|579740178|FG026|Overall Study|Protocol Violation|0|||
160550160|NCT03529773|579740179|FG027|Overall Study|Protocol Violation|0|||
160897503|NCT04430738|581020114|FG003|Phase 1: Dose Escalation|Other|0|||
160897504|NCT04430738|581020115|FG004|Phase 1: Dose Escalation|Other|0|||
160550161|NCT03529773|579740180|FG028|Overall Study|Protocol Violation|0|||
160550162|NCT03529773|579740181|FG029|Overall Study|Protocol Violation|0|||
160550163|NCT03529773|579740182|FG030|Overall Study|Protocol Violation|1|||
160550164|NCT03529773|579740183|FG031|Overall Study|Protocol Violation|0|||
160803497|NCT01244035|580669616|FG003|Part 1: Period 3|Adverse Event|0|||
160803498|NCT01244035|580669617|FG004|Part 1: Period 3|Adverse Event|0|||
160803499|NCT01244035|580669618|FG005|Part 1: Period 3|Adverse Event|1|||
160803500|NCT01244035|580669613|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
160803501|NCT01244035|580669614|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
160803502|NCT01244035|580669615|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
160803503|NCT01244035|580669616|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
160897505|NCT04430738|581020116|FG005|Phase 1: Dose Escalation|Other|0|||
160897506|NCT04430738|581020111|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
160897507|NCT04430738|581020112|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
160897508|NCT04430738|581020113|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
160897509|NCT04430738|581020114|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
160897510|NCT04430738|581020115|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
160897511|NCT04430738|581020116|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
160803504|NCT01244035|580669617|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
160803505|NCT01244035|580669618|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
160803506|NCT01244035|580669613|FG000|Part 1: Period 3|Protocol Deviation|0|||
160803507|NCT01244035|580669614|FG001|Part 1: Period 3|Protocol Deviation|1|||
160803508|NCT01244035|580669615|FG002|Part 1: Period 3|Protocol Deviation|0|||
160803509|NCT01244035|580669616|FG003|Part 1: Period 3|Protocol Deviation|0|||
160803510|NCT01244035|580669617|FG004|Part 1: Period 3|Protocol Deviation|0|||
160803511|NCT01244035|580669618|FG005|Part 1: Period 3|Protocol Deviation|0|||
160803512|NCT04512001|580669621|FG000|Week 0 to Week 24|Adverse Event|14|||
160803513|NCT04512001|580669622|FG001|Week 0 to Week 24|Adverse Event|10|||
160803514|NCT04512001|580669623|FG002|Week 0 to Week 24|Adverse Event|0|||
160803515|NCT04512001|580669624|FG003|Week 0 to Week 24|Adverse Event|0|||
160803516|NCT04512001|580669625|FG004|Week 0 to Week 24|Adverse Event|0|||
160803517|NCT04512001|580669621|FG000|Week 0 to Week 24|Death|0|||
160803518|NCT04512001|580669622|FG001|Week 0 to Week 24|Death|2|||
160803519|NCT04512001|580669623|FG002|Week 0 to Week 24|Death|0|||
160803520|NCT04512001|580669624|FG003|Week 0 to Week 24|Death|0|||
160803521|NCT04512001|580669625|FG004|Week 0 to Week 24|Death|0|||
160803522|NCT04512001|580669621|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
160803523|NCT04512001|580669622|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
160803524|NCT04512001|580669623|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
160803525|NCT04512001|580669624|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
160803526|NCT04512001|580669625|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
160803527|NCT04512001|580669621|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
160803528|NCT04512001|580669622|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
160803529|NCT04512001|580669623|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
160803530|NCT04512001|580669624|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
160803531|NCT04512001|580669625|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
160803532|NCT04512001|580669621|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
160803533|NCT04512001|580669622|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
160803534|NCT04512001|580669623|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
160803535|NCT04512001|580669624|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
160803536|NCT04512001|580669625|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
160803537|NCT04512001|580669621|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
160803538|NCT04512001|580669622|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
160803539|NCT04512001|580669623|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
160803540|NCT04512001|580669624|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
160803541|NCT04512001|580669625|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
160803542|NCT04512001|580669621|FG000|Week 24 to Week 63|Adverse Event|0|||
160803543|NCT04512001|580669622|FG001|Week 24 to Week 63|Adverse Event|0|||
160803544|NCT04512001|580669623|FG002|Week 24 to Week 63|Adverse Event|13|||
160803545|NCT04512001|580669624|FG003|Week 24 to Week 63|Adverse Event|8|||
160803546|NCT04512001|580669625|FG004|Week 24 to Week 63|Adverse Event|6|||
160803547|NCT04512001|580669621|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
160803548|NCT04512001|580669622|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
160803549|NCT04512001|580669623|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
160803550|NCT04512001|580669624|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
160803551|NCT04512001|580669625|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
160803552|NCT04512001|580669621|FG000|Week 24 to Week 63|Death|0|||
160803553|NCT04512001|580669622|FG001|Week 24 to Week 63|Death|0|||
160803554|NCT04512001|580669623|FG002|Week 24 to Week 63|Death|0|||
160803555|NCT04512001|580669624|FG003|Week 24 to Week 63|Death|1|||
160803556|NCT04512001|580669625|FG004|Week 24 to Week 63|Death|1|||
160803557|NCT04512001|580669621|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
160803558|NCT04512001|580669622|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
160803559|NCT04512001|580669623|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
160803560|NCT04512001|580669624|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
160803561|NCT04512001|580669625|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
160803562|NCT04512001|580669621|FG000|Week 24 to Week 63|Miscellaneous|0|||
160803563|NCT04512001|580669622|FG001|Week 24 to Week 63|Miscellaneous|0|||
160803564|NCT04512001|580669623|FG002|Week 24 to Week 63|Miscellaneous|3|||
160803565|NCT04512001|580669624|FG003|Week 24 to Week 63|Miscellaneous|2|||
160803566|NCT04512001|580669625|FG004|Week 24 to Week 63|Miscellaneous|1|||
160803567|NCT02776683|580669626|FG000|Pre-switch Period|Protocol Violation|1|||
160803568|NCT02776683|580669627|FG001|Pre-switch Period|Protocol Violation|0|||
160803569|NCT02776683|580669626|FG000|Pre-switch Period|Adverse Event|21|||
160803570|NCT02776683|580669627|FG001|Pre-switch Period|Adverse Event|0|||
160803571|NCT02776683|580669626|FG000|Pre-switch Period|Withdrawal by Subject|9|||
160985192|NCT01925170|581335383|FG000|Overall Study|Unverified cancer status|53|||
160985193|NCT01077024|581335386|FG000|Overall Study|Lost to Follow-up|20|||
160803572|NCT02776683|580669627|FG001|Pre-switch Period|Withdrawal by Subject|0|||
160803573|NCT02776683|580669626|FG000|Pre-switch Period|Physician Decision|7|||
160803574|NCT02776683|580669627|FG001|Pre-switch Period|Physician Decision|0|||
160803575|NCT02776683|580669626|FG000|Pre-switch Period|Progressive disease|39|||
160803576|NCT02776683|580669627|FG001|Pre-switch Period|Progressive disease|0|||
160803577|NCT02776683|580669626|FG000|Pre-switch Period|Other than listed|3|||
160803578|NCT02776683|580669627|FG001|Pre-switch Period|Other than listed|0|||
160803579|NCT02776683|580669626|FG000|Post-switch Period|Adverse Event|0|||
160803580|NCT02776683|580669627|FG001|Post-switch Period|Adverse Event|3|||
160803581|NCT02776683|580669626|FG000|Post-switch Period|Withdrawal by Subject|0|||
160803582|NCT02776683|580669627|FG001|Post-switch Period|Withdrawal by Subject|2|||
160803583|NCT02776683|580669626|FG000|Post-switch Period|Physician Decision|0|||
160803584|NCT02776683|580669627|FG001|Post-switch Period|Physician Decision|3|||
160803585|NCT02776683|580669626|FG000|Post-switch Period|Progressive disease|0|||
160803586|NCT02776683|580669627|FG001|Post-switch Period|Progressive disease|20|||
160803587|NCT02776683|580669626|FG000|Post-switch Period|Other than listed|0|||
160803588|NCT02776683|580669627|FG001|Post-switch Period|Other than listed|15|||
160803589|NCT02298868|580669637|FG000|Overall Study|Adverse Event|1|||
160803590|NCT02298868|580669637|FG000|Overall Study|Death|1|||
160803591|NCT02298868|580669637|FG000|Overall Study|Patient underwent transplant|1|||
160803592|NCT01063348|580669638|FG000|Overall Study|Lost to Follow-up|3|||
160803593|NCT01063348|580669639|FG001|Overall Study|Lost to Follow-up|10|||
160803594|NCT03824392|580669640|FG000|Overall Study|Adverse Event|1|||
160803595|NCT03824392|580669641|FG001|Overall Study|Adverse Event|0|||
160803596|NCT03824392|580669642|FG002|Overall Study|Adverse Event|0|||
160803597|NCT03824392|580669643|FG003|Overall Study|Adverse Event|0|||
160803598|NCT03824392|580669640|FG000|Overall Study|Investigator Decision|0|||
160803599|NCT03824392|580669641|FG001|Overall Study|Investigator Decision|1|||
160803600|NCT03824392|580669642|FG002|Overall Study|Investigator Decision|0|||
160803601|NCT03824392|580669643|FG003|Overall Study|Investigator Decision|0|||
160803602|NCT03824392|580669640|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
160803603|NCT03824392|580669641|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
160803604|NCT03824392|580669642|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
160803605|NCT03824392|580669643|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
160803606|NCT02230189|580669644|FG000|Overall Study|Withdrawal by Subject|3|||
160803607|NCT02230189|580669645|FG001|Overall Study|Withdrawal by Subject|0|||
160803608|NCT02230189|580669646|FG002|Overall Study|Withdrawal by Subject|1|||
160803609|NCT02230189|580669644|FG000|Overall Study|Lost to Follow-up|1|||
160803610|NCT02230189|580669645|FG001|Overall Study|Lost to Follow-up|0|||
160803611|NCT02230189|580669646|FG002|Overall Study|Lost to Follow-up|0|||
160803612|NCT02230189|580669644|FG000|Overall Study|Physician Decision|1|||
160803613|NCT02230189|580669645|FG001|Overall Study|Physician Decision|0|||
160803614|NCT02230189|580669646|FG002|Overall Study|Physician Decision|0|||
160803615|NCT01847755|580669647|FG000|Overall Study|Adverse Event|2|||
160803616|NCT01847755|580669647|FG000|Overall Study|Withdrawal by Subject|2|||
160803617|NCT01847755|580669647|FG000|Overall Study|Physician Decision|1|||
160803618|NCT01261975|580669655|FG000|Overall Study|Surgical complication|1|||
160803619|NCT01932788|580669656|FG000|Overall Study|Protocol Violation|18|||
160803620|NCT01932788|580669657|FG001|Overall Study|Protocol Violation|0|||
160803621|NCT01932788|580669656|FG000|Overall Study|Lost to Follow-up|18|||
160803622|NCT01932788|580669657|FG001|Overall Study|Lost to Follow-up|46|||
160803623|NCT01932788|580669656|FG000|Overall Study|Lack of Efficacy|2|||
160803624|NCT01932788|580669657|FG001|Overall Study|Lack of Efficacy|0|||
160803625|NCT01932788|580669656|FG000|Overall Study|Withdrawal by Subject|0|||
160803626|NCT01932788|580669657|FG001|Overall Study|Withdrawal by Subject|5|||
160803627|NCT01171677|580669658|FG000|Overall Study|Withdrawal by Subject|0|||
160803628|NCT01171677|580669659|FG001|Overall Study|Withdrawal by Subject|3|||
160803629|NCT01171677|580669658|FG000|Overall Study|Adverse Event|1|||
160803630|NCT01171677|580669659|FG001|Overall Study|Adverse Event|0|||
160803631|NCT01171677|580669658|FG000|Overall Study|completed <70% IntenSati classes|5|||
160803632|NCT01171677|580669659|FG001|Overall Study|completed <70% IntenSati classes|0|||
160985194|NCT01077024|581335387|FG001|Overall Study|Lost to Follow-up|14|||
160803633|NCT00656370|580669660|FG000|Overall Study|Screen Failures|7|||
160803634|NCT00656370|580669660|FG000|Overall Study|Alternates|3|||
160803635|NCT05653700|580669678|FG000|Overall Study|Non Responders|9|||
160803636|NCT05653700|580669679|FG001|Overall Study|Non Responders|0|||
160803637|NCT01900665|580669686|FG000|Placebo Controlled Period|Death|9|||
160803638|NCT01900665|580669687|FG001|Placebo Controlled Period|Death|16|||
160803639|NCT01900665|580669686|FG000|Placebo Controlled Period|Adverse Event|48|||
160803640|NCT01900665|580669687|FG001|Placebo Controlled Period|Adverse Event|39|||
160803641|NCT01900665|580669686|FG000|Placebo Controlled Period|Protocol Violation|1|||
160803642|NCT01900665|580669687|FG001|Placebo Controlled Period|Protocol Violation|7|||
160803643|NCT01900665|580669686|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
160803644|NCT01900665|580669687|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
160803645|NCT01900665|580669686|FG000|Placebo Controlled Period|Physician Decision|11|||
160803646|NCT01900665|580669687|FG001|Placebo Controlled Period|Physician Decision|7|||
160803647|NCT01900665|580669686|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
160803648|NCT01900665|580669687|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
160803649|NCT01900665|580669686|FG000|Placebo Controlled Period|Caregiver Decision|33|||
160803650|NCT01900665|580669687|FG001|Placebo Controlled Period|Caregiver Decision|41|||
160803651|NCT01900665|580669686|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
160803652|NCT01900665|580669687|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
160803653|NCT01900665|580669686|FG000|Open Label Period|Adverse Event|16|||
160803654|NCT01900665|580669687|FG001|Open Label Period|Adverse Event|20|||
160803655|NCT01900665|580669686|FG000|Open Label Period|Death|5|||
160803656|NCT01900665|580669687|FG001|Open Label Period|Death|6|||
160803657|NCT01900665|580669686|FG000|Open Label Period|Lost to Follow-up|1|||
160803658|NCT01900665|580669687|FG001|Open Label Period|Lost to Follow-up|1|||
160803659|NCT01900665|580669686|FG000|Open Label Period|Parent/Caregiver Decision|33|||
160803660|NCT01900665|580669687|FG001|Open Label Period|Parent/Caregiver Decision|34|||
160803661|NCT01900665|580669686|FG000|Open Label Period|Physician Decision|4|||
160803662|NCT01900665|580669687|FG001|Open Label Period|Physician Decision|4|||
160803663|NCT01900665|580669686|FG000|Open Label Period|Protocol Violation|0|||
160803664|NCT01900665|580669687|FG001|Open Label Period|Protocol Violation|1|||
160803665|NCT01900665|580669686|FG000|Open Label Period|Sponsor Decision|802|||
160803666|NCT01900665|580669687|FG001|Open Label Period|Sponsor Decision|765|||
160803667|NCT01900665|580669686|FG000|Open Label Period|Withdrawal by Subject|20|||
160803668|NCT01900665|580669687|FG001|Open Label Period|Withdrawal by Subject|28|||
160803669|NCT02317627|580669688|FG000|Overall Study|Withdrawal by Subject|0|||
160803670|NCT02317627|580669689|FG001|Overall Study|Withdrawal by Subject|1|||
160803671|NCT02317627|580669690|FG002|Overall Study|Withdrawal by Subject|1|||
160803672|NCT02317627|580669688|FG000|Overall Study|Lost to Follow-up|2|||
160803673|NCT02317627|580669689|FG001|Overall Study|Lost to Follow-up|0|||
160803674|NCT02317627|580669690|FG002|Overall Study|Lost to Follow-up|0|||
160803675|NCT02317627|580669688|FG000|Overall Study|Stopped by Investigator|0|||
160803676|NCT02317627|580669689|FG001|Overall Study|Stopped by Investigator|1|||
160803677|NCT02317627|580669690|FG002|Overall Study|Stopped by Investigator|0|||
160803678|NCT02317627|580669688|FG000|Overall Study|Adverse Event|0|||
160803679|NCT02317627|580669689|FG001|Overall Study|Adverse Event|2|||
160803680|NCT02317627|580669690|FG002|Overall Study|Adverse Event|3|||
160803681|NCT02317627|580669688|FG000|Overall Study|Non-compliance with study drug|0|||
160803682|NCT02317627|580669689|FG001|Overall Study|Non-compliance with study drug|1|||
160803683|NCT02317627|580669690|FG002|Overall Study|Non-compliance with study drug|0|||
160803684|NCT00279214|580669691|FG000|Overall Study|Physician Decision|3|||
160803685|NCT00279214|580669692|FG001|Overall Study|Physician Decision|2|||
160803686|NCT04749914|580669693|FG000|Period 1|Adverse Event|1|||
160803687|NCT04749914|580669694|FG001|Period 1|Adverse Event|0|||
160803688|NCT04749914|580669695|FG002|Period 1|Adverse Event|0|||
160803689|NCT04749914|580669696|FG003|Period 1|Adverse Event|0|||
160803690|NCT04749914|580669693|FG000|Period 1|Withdrawal by Subject|1|||
160803691|NCT04749914|580669694|FG001|Period 1|Withdrawal by Subject|0|||
160803692|NCT04749914|580669695|FG002|Period 1|Withdrawal by Subject|1|||
160803693|NCT04749914|580669696|FG003|Period 1|Withdrawal by Subject|0|||
160803694|NCT01280968|580669697|FG000|Overall Study|Lost to Follow-up|8|||
160803695|NCT01280968|580669698|FG001|Overall Study|Lost to Follow-up|2|||
160803696|NCT01280968|580669697|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
160803697|NCT01280968|580669698|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
160803698|NCT01280968|580669697|FG000|Overall Study|Commuting Problems|2|||
160803699|NCT01280968|580669698|FG001|Overall Study|Commuting Problems|0|||
160897512|NCT04430738|581020111|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
160803700|NCT01280968|580669697|FG000|Overall Study|Anxiety|2|||
160803701|NCT01280968|580669698|FG001|Overall Study|Anxiety|0|||
160897513|NCT04430738|581020112|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
160897514|NCT04430738|581020113|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
160897515|NCT04430738|581020114|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
160897516|NCT04430738|581020115|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
160897517|NCT04430738|581020116|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
160897518|NCT02734433|581020117|FG000|Overall Study|Disease progression|1|||
160897519|NCT02734433|581020118|FG001|Overall Study|Disease progression|5|||
160897520|NCT02734433|581020117|FG000|Overall Study|Clinical progression|0|||
160897521|NCT02734433|581020118|FG001|Overall Study|Clinical progression|1|||
160897522|NCT02734433|581020117|FG000|Overall Study|Withdrawal by Subject|1|||
160897523|NCT02734433|581020118|FG001|Overall Study|Withdrawal by Subject|2|||
160897524|NCT03659916|581020119|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
160897525|NCT03659916|581020120|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
160550165|NCT03529773|579740184|FG032|Overall Study|Protocol Violation|0|||
160550166|NCT03529773|579740185|FG033|Overall Study|Protocol Violation|0|||
160803702|NCT01280968|580669697|FG000|Overall Study|Adverse Event|1|||
160550167|NCT03529773|579740186|FG034|Overall Study|Protocol Violation|0|||
160803703|NCT01280968|580669698|FG001|Overall Study|Adverse Event|0|||
160803704|NCT01280968|580669697|FG000|Overall Study|Scheduling Conflicts|1|||
160803705|NCT01280968|580669698|FG001|Overall Study|Scheduling Conflicts|1|||
160803706|NCT01280968|580669697|FG000|Overall Study|Pre-existing Neurological Condition|1|||
160803707|NCT01280968|580669698|FG001|Overall Study|Pre-existing Neurological Condition|0|||
160803708|NCT01280968|580669697|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
160897526|NCT03659916|581020121|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
160897527|NCT03659916|581020119|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
160897528|NCT03659916|581020120|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
160803709|NCT01280968|580669698|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
160803710|NCT01897532|580669700|FG000|Discontinuation From Treatment|Not Treated|7|||
160803711|NCT01897532|580669701|FG001|Discontinuation From Treatment|Not Treated|5|||
160803712|NCT01897532|580669700|FG000|Discontinuation From Treatment|Other reason than specified|196|||
160803713|NCT01897532|580669701|FG001|Discontinuation From Treatment|Other reason than specified|176|||
160803714|NCT01897532|580669700|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
160803715|NCT01897532|580669701|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
160803716|NCT01897532|580669700|FG000|Discontinuation From Treatment|Non compliance|24|||
160803717|NCT01897532|580669701|FG001|Discontinuation From Treatment|Non compliance|15|||
160803718|NCT01897532|580669700|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
160803719|NCT01897532|580669701|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
160803720|NCT01897532|580669700|FG000|Discontinuation From Trial|Not Treated|7|||
160803721|NCT01897532|580669701|FG001|Discontinuation From Trial|Not Treated|5|||
160803722|NCT01897532|580669700|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
160803723|NCT01897532|580669701|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
160803724|NCT01074931|580669706|FG000|Overall Study|Economic reasons|1|||
160803725|NCT01074931|580669706|FG000|Overall Study|Death|5|||
160803726|NCT00953706|580669709|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
160803727|NCT00953706|580669710|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
160803728|NCT00953706|580669711|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
160803729|NCT00953706|580669712|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
160803730|NCT00953706|580669709|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
160803731|NCT00953706|580669710|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
160803732|NCT00953706|580669711|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
160803733|NCT00953706|580669712|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
160803734|NCT00953706|580669709|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
160803735|NCT00953706|580669710|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
160803736|NCT00953706|580669711|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
160803737|NCT00953706|580669712|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
160803738|NCT00953706|580669709|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
160803739|NCT00953706|580669710|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
160803740|NCT00953706|580669711|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
160803741|NCT00953706|580669712|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
160803742|NCT00953706|580669709|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
160803743|NCT00953706|580669710|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
160803744|NCT00953706|580669711|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
160803745|NCT00953706|580669712|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
160803746|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
160803747|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
160803748|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
160803749|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
160803750|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
160803751|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
160803752|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
160803753|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
160803754|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
160803755|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
160803756|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
160803757|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
160803758|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
160803759|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
160803760|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
160897529|NCT03659916|581020121|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
160897530|NCT03659916|581020119|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
160897531|NCT03659916|581020120|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
160897532|NCT03659916|581020121|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
160897533|NCT03659916|581020119|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
160897534|NCT03659916|581020120|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
160897535|NCT03659916|581020121|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
160897536|NCT03659916|581020119|FG000|Treatment Period (72 Weeks)|Other|1|||
160897537|NCT03659916|581020120|FG001|Treatment Period (72 Weeks)|Other|3|||
160897538|NCT03659916|581020121|FG002|Treatment Period (72 Weeks)|Other|9|||
160985195|NCT01077024|581335386|FG000|Overall Study|Withdrawal by Subject|0|||
160985196|NCT01077024|581335387|FG001|Overall Study|Withdrawal by Subject|2|||
160985197|NCT01077024|581335386|FG000|Overall Study|Incarcerated|7|||
160803761|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
160803762|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
160803763|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
160803764|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
160803765|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
160803766|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
160803767|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
160803768|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
160803769|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
160803770|NCT01404234|580669713|FG000|Overall Study|Withdrawal by Subject|2|||
160803771|NCT01214837|580669714|FG000|Overall Study|Death|0|||
160803772|NCT01214837|580669715|FG001|Overall Study|Death|0|||
160803773|NCT01214837|580669716|FG002|Overall Study|Death|1|||
160803774|NCT01214837|580669714|FG000|Overall Study|Adverse Event|1|||
160803775|NCT01214837|580669715|FG001|Overall Study|Adverse Event|2|||
160803776|NCT01214837|580669716|FG002|Overall Study|Adverse Event|1|||
160803777|NCT01214837|580669714|FG000|Overall Study|Withdrawal by Subject|27|||
160803778|NCT01214837|580669715|FG001|Overall Study|Withdrawal by Subject|36|||
160803779|NCT01214837|580669716|FG002|Overall Study|Withdrawal by Subject|28|||
160803780|NCT01214837|580669714|FG000|Overall Study|Lost to Follow-up|20|||
160803781|NCT01214837|580669715|FG001|Overall Study|Lost to Follow-up|15|||
160803782|NCT01214837|580669716|FG002|Overall Study|Lost to Follow-up|21|||
160803783|NCT01214837|580669714|FG000|Overall Study|Inappropriate Enrolment|0|||
160803784|NCT01214837|580669715|FG001|Overall Study|Inappropriate Enrolment|1|||
160803785|NCT01214837|580669716|FG002|Overall Study|Inappropriate Enrolment|2|||
160803786|NCT01214837|580669714|FG000|Overall Study|Administrative Reason|2|||
160803787|NCT01214837|580669715|FG001|Overall Study|Administrative Reason|6|||
160803788|NCT01214837|580669716|FG002|Overall Study|Administrative Reason|4|||
160803789|NCT01214837|580669714|FG000|Overall Study|Protocol Violation|3|||
160803790|NCT01214837|580669715|FG001|Overall Study|Protocol Violation|1|||
160803791|NCT01214837|580669716|FG002|Overall Study|Protocol Violation|5|||
160803792|NCT01214837|580669714|FG000|Overall Study|Unable to Classify|1|||
160803793|NCT01214837|580669715|FG001|Overall Study|Unable to Classify|3|||
160803794|NCT01214837|580669716|FG002|Overall Study|Unable to Classify|0|||
160803795|NCT04790279|580671761|FG000|Overall Study|Did not meet medication start criteria|27|||
160803796|NCT04790279|580671762|FG001|Overall Study|Did not meet medication start criteria|15|||
160803797|NCT04790279|580671761|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
160803798|NCT04790279|580671762|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
160803799|NCT04790279|580671761|FG000|Overall Study|Protocol Violation|8|||
160803800|NCT04790279|580671762|FG001|Overall Study|Protocol Violation|3|||
160803801|NCT04790279|580671761|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
160803802|NCT04790279|580671762|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
160803803|NCT04776161|580671768|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
160803804|NCT04776161|580671769|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
160803805|NCT04776161|580671770|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
160803806|NCT04776161|580671768|FG000|Overall Study|Withdrawal by Subject|1|||
160803807|NCT04776161|580671769|FG001|Overall Study|Withdrawal by Subject|0|||
160803808|NCT04776161|580671770|FG002|Overall Study|Withdrawal by Subject|1|||
160803809|NCT04776161|580671768|FG000|Overall Study|Adverse Event|0|||
160803810|NCT04776161|580671769|FG001|Overall Study|Adverse Event|1|||
160803811|NCT04776161|580671770|FG002|Overall Study|Adverse Event|1|||
160803812|NCT00342628|580671771|FG000|Overall Study|Withdrawal by Subject|19|||
160803813|NCT00342628|580671772|FG001|Overall Study|Withdrawal by Subject|19|||
160803814|NCT00342628|580671773|FG002|Overall Study|Withdrawal by Subject|18|||
160803815|NCT00342628|580671771|FG000|Overall Study|Death|1|||
160803816|NCT00342628|580671772|FG001|Overall Study|Death|1|||
160803817|NCT00342628|580671773|FG002|Overall Study|Death|0|||
160803818|NCT00342628|580671771|FG000|Overall Study|moved residence|0|||
160803819|NCT00342628|580671772|FG001|Overall Study|moved residence|1|||
160803820|NCT00342628|580671773|FG002|Overall Study|moved residence|1|||
160803821|NCT04551898|580671774|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
160803822|NCT04551898|580671775|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
160803823|NCT04551898|580671776|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
160803824|NCT04551898|580671777|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
160803825|NCT04551898|580671774|FG000|Overall Study|Withdrawal by Subject|5|||
160803826|NCT04551898|580671775|FG001|Overall Study|Withdrawal by Subject|1|||
160803827|NCT04551898|580671776|FG002|Overall Study|Withdrawal by Subject|2|||
160803828|NCT04551898|580671777|FG003|Overall Study|Withdrawal by Subject|2|||
160803829|NCT04551898|580671774|FG000|Overall Study|Lost to Follow-up|2|||
160803830|NCT04551898|580671775|FG001|Overall Study|Lost to Follow-up|1|||
160803831|NCT04551898|580671776|FG002|Overall Study|Lost to Follow-up|2|||
160803832|NCT04551898|580671777|FG003|Overall Study|Lost to Follow-up|2|||
160803833|NCT04551898|580671774|FG000|Overall Study|Death|1|||
160803834|NCT04551898|580671775|FG001|Overall Study|Death|0|||
160803835|NCT04551898|580671776|FG002|Overall Study|Death|0|||
160803836|NCT04551898|580671777|FG003|Overall Study|Death|0|||
160803837|NCT04551898|580671774|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
160803838|NCT04551898|580671775|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
160803839|NCT04551898|580671776|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
160803840|NCT04551898|580671777|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
160803841|NCT01979614|580671778|FG000|Overall Study|Adverse Event|1|||
160803842|NCT01979614|580671779|FG001|Overall Study|Adverse Event|1|||
160803843|NCT01535287|580671780|FG000|Overall Study|drug not prepared in time|5|||
160803844|NCT01535287|580671781|FG001|Overall Study|drug not prepared in time|6|||
160803845|NCT00628446|580671784|FG000|Overall Study|Lost to Follow-up|3|||
160803846|NCT00628446|580671784|FG000|Overall Study|Withdrawal by Subject|1|||
160803847|NCT00628446|580671784|FG000|Overall Study|Protocol Violation|3|||
160803848|NCT04971967|580671785|FG000|Overall Study|Lost to Follow-up|6|||
160803849|NCT04971967|580671786|FG001|Overall Study|Lost to Follow-up|7|||
160803850|NCT00682929|580671789|FG000|Overall Study|Adverse Event|4|||
160803851|NCT00682929|580671790|FG001|Overall Study|Adverse Event|1|||
160803852|NCT00682929|580671791|FG002|Overall Study|Adverse Event|1|||
160803853|NCT00682929|580671789|FG000|Overall Study|Withdrawal by Subject|1|||
160803854|NCT00682929|580671790|FG001|Overall Study|Withdrawal by Subject|2|||
160803855|NCT00682929|580671791|FG002|Overall Study|Withdrawal by Subject|1|||
160803856|NCT00682929|580671789|FG000|Overall Study|dosing compliance < 80%|0|||
160803857|NCT00682929|580671790|FG001|Overall Study|dosing compliance < 80%|2|||
160803858|NCT00682929|580671791|FG002|Overall Study|dosing compliance < 80%|0|||
160803859|NCT00682929|580671789|FG000|Overall Study|lag in DEA renewal|1|||
160803860|NCT00682929|580671790|FG001|Overall Study|lag in DEA renewal|0|||
160803861|NCT00682929|580671791|FG002|Overall Study|lag in DEA renewal|0|||
160803862|NCT00938912|580671792|FG000|Overall Study|Withdrawal by Subject|28|||
160803863|NCT00938912|580671792|FG000|Overall Study|Lost to Follow-up|4|||
160803864|NCT00938912|580671792|FG000|Overall Study|Lack of Efficacy|43|||
160803865|NCT00938912|580671792|FG000|Overall Study|Adverse event, non-fatal|24|||
160803866|NCT00938912|580671792|FG000|Overall Study|Adverse event, fatal|1|||
160803867|NCT00938912|580671792|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
160803868|NCT00938912|580671792|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
160803869|NCT00938912|580671792|FG000|Overall Study|Participant needed prohibit medication|1|||
160803870|NCT00938912|580671792|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
160803871|NCT00938912|580671792|FG000|Overall Study|Did not meet Eligibility criteria|1|||
160803872|NCT00938912|580671792|FG000|Overall Study|Participant relocated not related to AE|1|||
160803873|NCT00938912|580671792|FG000|Overall Study|Participant moved to another city|1|||
160803874|NCT00938912|580671792|FG000|Overall Study|Participant experienced break through seizures|1|||
160803875|NCT00938912|580671792|FG000|Overall Study|No longer wished to participate in the study|1|||
160803876|NCT00938912|580671792|FG000|Overall Study|Protocol Deviation|2|||
160803877|NCT00803738|580671798|FG000|Overall Study|Adverse Event|3|||
160803878|NCT00803738|580671799|FG001|Overall Study|Adverse Event|5|||
160803879|NCT00803738|580671798|FG000|Overall Study|Lost to Follow-up|4|||
160803880|NCT00803738|580671799|FG001|Overall Study|Lost to Follow-up|4|||
160803881|NCT00803738|580671798|FG000|Overall Study|Protocol Violation|18|||
160803882|NCT00803738|580671799|FG001|Overall Study|Protocol Violation|10|||
160803883|NCT00803738|580671798|FG000|Overall Study|Withdrawal by Subject|1|||
160803884|NCT00803738|580671799|FG001|Overall Study|Withdrawal by Subject|4|||
160803885|NCT00803738|580671798|FG000|Overall Study|Lack of Efficacy|10|||
160803886|NCT00803738|580671799|FG001|Overall Study|Lack of Efficacy|16|||
160803887|NCT00803738|580671798|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
160803888|NCT00803738|580671799|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
160803889|NCT00803738|580671798|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
160803890|NCT00803738|580671799|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
160803891|NCT01048242|580671800|FG000|Overall Study|See study flow chart|4|||
160803892|NCT01048242|580671801|FG001|Overall Study|See study flow chart|2|||
160803893|NCT02964273|580671802|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
160803894|NCT02964273|580671803|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
160803895|NCT02964273|580671804|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
160803896|NCT02964273|580671805|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
160803897|NCT02964273|580671802|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
160803898|NCT02964273|580671803|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
160803899|NCT02964273|580671804|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
160803900|NCT02964273|580671805|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
160803901|NCT02964273|580671802|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
160803902|NCT02964273|580671803|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
160803903|NCT02964273|580671804|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
160803904|NCT02964273|580671805|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
160803905|NCT02964273|580671802|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
160803906|NCT02964273|580671803|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
160803907|NCT02964273|580671804|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
160803908|NCT02964273|580671805|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
160803909|NCT02964273|580671802|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
160803910|NCT02964273|580671803|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
160803911|NCT02964273|580671804|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
160803912|NCT02964273|580671805|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
160803913|NCT02964273|580671802|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
160803914|NCT02964273|580671803|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
160803915|NCT02964273|580671804|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
160803916|NCT02964273|580671805|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
160803917|NCT01772550|580671806|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
160803918|NCT01772550|580671807|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
160803919|NCT01772550|580671808|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
160803920|NCT01772550|580671806|FG000|Overall Study|Adverse Event|0|||
160803921|NCT01772550|580671807|FG001|Overall Study|Adverse Event|0|||
160803922|NCT01772550|580671808|FG002|Overall Study|Adverse Event|1|||
160803923|NCT00559104|580671810|FG000|Overall Study|Lack of Efficacy|9|||
160803924|NCT00559104|580671811|FG001|Overall Study|Lack of Efficacy|0|||
160803925|NCT01815424|580671812|FG000|Week 0 to 16|Adverse Event|1|||
160803926|NCT01815424|580671813|FG001|Week 0 to 16|Adverse Event|3|||
160803927|NCT01815424|580671814|FG002|Week 0 to 16|Adverse Event|3|||
160803928|NCT01815424|580671815|FG003|Week 0 to 16|Adverse Event|0|||
160803929|NCT01815424|580671816|FG004|Week 0 to 16|Adverse Event|0|||
160803930|NCT01815424|580671812|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
160803931|NCT01815424|580671813|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
160803932|NCT01815424|580671814|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
160803933|NCT01815424|580671815|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
160803934|NCT01815424|580671816|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
160803935|NCT01815424|580671812|FG000|Week 0 to 16|Lost to Follow-up|0|||
160803936|NCT01815424|580671813|FG001|Week 0 to 16|Lost to Follow-up|1|||
160803937|NCT01815424|580671814|FG002|Week 0 to 16|Lost to Follow-up|0|||
160803938|NCT01815424|580671815|FG003|Week 0 to 16|Lost to Follow-up|0|||
160803939|NCT01815424|580671816|FG004|Week 0 to 16|Lost to Follow-up|0|||
160803940|NCT01815424|580671812|FG000|Week 0 to 16|Withdrawal by Subject|0|||
160803941|NCT01815424|580671813|FG001|Week 0 to 16|Withdrawal by Subject|0|||
160803942|NCT01815424|580671814|FG002|Week 0 to 16|Withdrawal by Subject|1|||
160803943|NCT01815424|580671815|FG003|Week 0 to 16|Withdrawal by Subject|0|||
160803944|NCT01815424|580671816|FG004|Week 0 to 16|Withdrawal by Subject|0|||
160803945|NCT01815424|580671812|FG000|Week 0 to 16|Other|1|||
160803946|NCT01815424|580671813|FG001|Week 0 to 16|Other|0|||
160803947|NCT01815424|580671814|FG002|Week 0 to 16|Other|3|||
160803948|NCT01815424|580671815|FG003|Week 0 to 16|Other|0|||
160803949|NCT01815424|580671816|FG004|Week 0 to 16|Other|0|||
160803950|NCT01815424|580671812|FG000|Week 0 to 16|Protocol Violation|1|||
160803951|NCT01815424|580671813|FG001|Week 0 to 16|Protocol Violation|0|||
160803952|NCT01815424|580671814|FG002|Week 0 to 16|Protocol Violation|0|||
160803953|NCT01815424|580671815|FG003|Week 0 to 16|Protocol Violation|0|||
160897539|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
160897540|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
160803954|NCT01815424|580671816|FG004|Week 0 to 16|Protocol Violation|0|||
160803955|NCT01815424|580671812|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
160803956|NCT01815424|580671813|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
160897541|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
160897542|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
160897543|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
160897544|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
160897545|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
160897546|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
160897547|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
160985198|NCT01077024|581335387|FG001|Overall Study|Incarcerated|8|||
160803957|NCT01815424|580671814|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
160803958|NCT01815424|580671815|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
160803959|NCT01815424|580671816|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
160985199|NCT01077024|581335386|FG000|Overall Study|Other|4|||
160985200|NCT01077024|581335387|FG001|Overall Study|Other|4|||
160985201|NCT02034435|581335388|FG000|Overall Study|Withdrawal by Subject|1|||
160985202|NCT02034435|581335389|FG001|Overall Study|Withdrawal by Subject|0|||
160985203|NCT02034435|581335390|FG002|Overall Study|Withdrawal by Subject|0|||
160985204|NCT02034435|581335391|FG003|Overall Study|Withdrawal by Subject|0|||
160985205|NCT02034435|581335388|FG000|Overall Study|Illness|0|||
160985206|NCT02034435|581335389|FG001|Overall Study|Illness|2|||
160985207|NCT02034435|581335390|FG002|Overall Study|Illness|0|||
160985208|NCT02034435|581335391|FG003|Overall Study|Illness|0|||
160550168|NCT03529773|579740187|FG035|Overall Study|Protocol Violation|0|||
160550169|NCT03529773|579740188|FG036|Overall Study|Protocol Violation|0|||
160550170|NCT03529773|579740189|FG037|Overall Study|Protocol Violation|0|||
160985209|NCT02034435|581335388|FG000|Overall Study|Inadequate IV access|1|||
160550171|NCT03529773|579740190|FG038|Overall Study|Protocol Violation|0|||
160550172|NCT03529773|579740191|FG039|Overall Study|Protocol Violation|0|||
160550173|NCT03529773|579740152|FG000|Overall Study|Withdrawal by Subject|0|||
160550174|NCT03529773|579740153|FG001|Overall Study|Withdrawal by Subject|0|||
160550175|NCT03529773|579740154|FG002|Overall Study|Withdrawal by Subject|0|||
160550176|NCT03529773|579740155|FG003|Overall Study|Withdrawal by Subject|0|||
160550177|NCT03529773|579740156|FG004|Overall Study|Withdrawal by Subject|0|||
160550178|NCT03529773|579740157|FG005|Overall Study|Withdrawal by Subject|0|||
160550179|NCT03529773|579740158|FG006|Overall Study|Withdrawal by Subject|0|||
160550180|NCT03529773|579740159|FG007|Overall Study|Withdrawal by Subject|1|||
160550181|NCT03529773|579740160|FG008|Overall Study|Withdrawal by Subject|0|||
160550182|NCT03529773|579740161|FG009|Overall Study|Withdrawal by Subject|1|||
160550183|NCT03529773|579740162|FG010|Overall Study|Withdrawal by Subject|1|||
160550184|NCT03529773|579740163|FG011|Overall Study|Withdrawal by Subject|0|||
160550185|NCT03529773|579740164|FG012|Overall Study|Withdrawal by Subject|0|||
160550186|NCT03529773|579740165|FG013|Overall Study|Withdrawal by Subject|0|||
160550187|NCT03529773|579740166|FG014|Overall Study|Withdrawal by Subject|0|||
160550188|NCT03529773|579740167|FG015|Overall Study|Withdrawal by Subject|3|||
160550189|NCT03529773|579740168|FG016|Overall Study|Withdrawal by Subject|0|||
160550190|NCT03529773|579740169|FG017|Overall Study|Withdrawal by Subject|2|||
160550191|NCT03529773|579740170|FG018|Overall Study|Withdrawal by Subject|3|||
160550192|NCT03529773|579740171|FG019|Overall Study|Withdrawal by Subject|1|||
160550193|NCT03529773|579740172|FG020|Overall Study|Withdrawal by Subject|3|||
160550194|NCT03529773|579740173|FG021|Overall Study|Withdrawal by Subject|1|||
160550195|NCT03529773|579740174|FG022|Overall Study|Withdrawal by Subject|1|||
160550196|NCT03529773|579740175|FG023|Overall Study|Withdrawal by Subject|2|||
160550197|NCT03529773|579740176|FG024|Overall Study|Withdrawal by Subject|2|||
160550198|NCT03529773|579740177|FG025|Overall Study|Withdrawal by Subject|4|||
160550199|NCT03529773|579740178|FG026|Overall Study|Withdrawal by Subject|2|||
160550200|NCT03529773|579740179|FG027|Overall Study|Withdrawal by Subject|1|||
160550201|NCT03529773|579740180|FG028|Overall Study|Withdrawal by Subject|1|||
160550202|NCT03529773|579740181|FG029|Overall Study|Withdrawal by Subject|0|||
160550203|NCT03529773|579740182|FG030|Overall Study|Withdrawal by Subject|0|||
160550204|NCT03529773|579740183|FG031|Overall Study|Withdrawal by Subject|0|||
160550205|NCT03529773|579740184|FG032|Overall Study|Withdrawal by Subject|0|||
160550206|NCT03529773|579740185|FG033|Overall Study|Withdrawal by Subject|0|||
160550207|NCT03529773|579740186|FG034|Overall Study|Withdrawal by Subject|1|||
160550208|NCT03529773|579740187|FG035|Overall Study|Withdrawal by Subject|2|||
160550209|NCT03529773|579740188|FG036|Overall Study|Withdrawal by Subject|0|||
160550210|NCT03529773|579740189|FG037|Overall Study|Withdrawal by Subject|2|||
160550211|NCT03529773|579740190|FG038|Overall Study|Withdrawal by Subject|1|||
160550212|NCT03529773|579740191|FG039|Overall Study|Withdrawal by Subject|1|||
160550213|NCT03529773|579740152|FG000|Overall Study|Screen Failure|0|||
160550214|NCT03529773|579740153|FG001|Overall Study|Screen Failure|0|||
160550215|NCT03529773|579740154|FG002|Overall Study|Screen Failure|0|||
160550216|NCT03529773|579740155|FG003|Overall Study|Screen Failure|0|||
160550217|NCT03529773|579740156|FG004|Overall Study|Screen Failure|0|||
160550218|NCT03529773|579740157|FG005|Overall Study|Screen Failure|0|||
160550219|NCT03529773|579740158|FG006|Overall Study|Screen Failure|0|||
160550220|NCT03529773|579740159|FG007|Overall Study|Screen Failure|0|||
160550221|NCT03529773|579740160|FG008|Overall Study|Screen Failure|0|||
160550222|NCT03529773|579740161|FG009|Overall Study|Screen Failure|0|||
160550223|NCT03529773|579740162|FG010|Overall Study|Screen Failure|0|||
160550224|NCT03529773|579740163|FG011|Overall Study|Screen Failure|0|||
160550225|NCT03529773|579740164|FG012|Overall Study|Screen Failure|0|||
160550226|NCT03529773|579740165|FG013|Overall Study|Screen Failure|0|||
160550227|NCT03529773|579740166|FG014|Overall Study|Screen Failure|0|||
160985210|NCT02034435|581335389|FG001|Overall Study|Inadequate IV access|0|||
160550228|NCT03529773|579740167|FG015|Overall Study|Screen Failure|0|||
160550229|NCT03529773|579740168|FG016|Overall Study|Screen Failure|0|||
160550230|NCT03529773|579740169|FG017|Overall Study|Screen Failure|0|||
160550231|NCT03529773|579740170|FG018|Overall Study|Screen Failure|0|||
160550232|NCT03529773|579740171|FG019|Overall Study|Screen Failure|0|||
160550233|NCT03529773|579740172|FG020|Overall Study|Screen Failure|0|||
160803960|NCT01815424|580671812|FG000|Week 16 to 52|Other|0|||
160803961|NCT01815424|580671813|FG001|Week 16 to 52|Other|1|||
160803962|NCT01815424|580671814|FG002|Week 16 to 52|Other|0|||
160803963|NCT01815424|580671815|FG003|Week 16 to 52|Other|0|||
160803964|NCT01815424|580671816|FG004|Week 16 to 52|Other|0|||
160803965|NCT01815424|580671812|FG000|Week 16 to 52|Adverse Event|0|||
160803966|NCT01815424|580671813|FG001|Week 16 to 52|Adverse Event|0|||
160803967|NCT01815424|580671814|FG002|Week 16 to 52|Adverse Event|0|||
160803968|NCT01815424|580671815|FG003|Week 16 to 52|Adverse Event|0|||
160803969|NCT01815424|580671816|FG004|Week 16 to 52|Adverse Event|1|||
160803970|NCT01815424|580671812|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
160803971|NCT01815424|580671813|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
160803972|NCT01815424|580671814|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
160803973|NCT01815424|580671815|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
160550234|NCT03529773|579740173|FG021|Overall Study|Screen Failure|0|||
160550235|NCT03529773|579740174|FG022|Overall Study|Screen Failure|0|||
160550236|NCT03529773|579740175|FG023|Overall Study|Screen Failure|0|||
160550237|NCT03529773|579740176|FG024|Overall Study|Screen Failure|0|||
160550238|NCT03529773|579740177|FG025|Overall Study|Screen Failure|0|||
160550239|NCT03529773|579740178|FG026|Overall Study|Screen Failure|0|||
160550240|NCT03529773|579740179|FG027|Overall Study|Screen Failure|0|||
160550241|NCT03529773|579740180|FG028|Overall Study|Screen Failure|0|||
160550242|NCT03529773|579740181|FG029|Overall Study|Screen Failure|0|||
160550243|NCT03529773|579740182|FG030|Overall Study|Screen Failure|0|||
160550244|NCT03529773|579740183|FG031|Overall Study|Screen Failure|0|||
160803974|NCT01815424|580671816|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
160803975|NCT01815424|580671812|FG000|Week 16 to 52|Lost to Follow-up|0|||
160803976|NCT01815424|580671813|FG001|Week 16 to 52|Lost to Follow-up|2|||
160897548|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
160897549|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
160897550|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
160897551|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
160897552|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
160897553|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
160897554|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
160897555|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
160897556|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
160897557|NCT04941456|581020122|FG000|Overall Study|Withdrawal by Subject|1|||
160897558|NCT04941456|581020123|FG001|Overall Study|Withdrawal by Subject|0|||
160897559|NCT04941456|581020122|FG000|Overall Study|Protocol Violation|1|||
160897560|NCT04941456|581020123|FG001|Overall Study|Protocol Violation|0|||
160897561|NCT01555983|581020124|FG000|Overall Study|Withdrawal by Subject|1|||
160897562|NCT01555983|581020125|FG001|Overall Study|Withdrawal by Subject|0|||
160897563|NCT01555983|581020126|FG002|Overall Study|Withdrawal by Subject|0|||
160897564|NCT01555983|581020127|FG003|Overall Study|Withdrawal by Subject|0|||
160897565|NCT01555983|581020128|FG004|Overall Study|Withdrawal by Subject|1|||
160897566|NCT01555983|581020129|FG005|Overall Study|Withdrawal by Subject|1|||
160897567|NCT04026711|581020130|FG000|Overall Study|Withdrawal by Subject|1|||
160897568|NCT04026711|581020131|FG001|Overall Study|Withdrawal by Subject|0|||
160897569|NCT04026711|581020130|FG000|Overall Study|mental health crisis|1|||
160897570|NCT04026711|581020131|FG001|Overall Study|mental health crisis|0|||
160897571|NCT05985395|581020137|FG000|Overall Study|Physician Decision|2|||
160897572|NCT05985395|581020138|FG001|Overall Study|Physician Decision|1|||
160897573|NCT05985395|581020137|FG000|Overall Study|Withdrawal by Subject|1|||
160897574|NCT05985395|581020138|FG001|Overall Study|Withdrawal by Subject|0|||
160897575|NCT04823650|581020139|FG000|Overall Study|Withdrawal by Subject|0|||
160897576|NCT04823650|581020140|FG001|Overall Study|Withdrawal by Subject|0|||
160897577|NCT04823650|581020141|FG002|Overall Study|Withdrawal by Subject|0|||
160897578|NCT04823650|581020142|FG003|Overall Study|Withdrawal by Subject|0|||
160897579|NCT04823650|581020143|FG004|Overall Study|Withdrawal by Subject|1|||
160897580|NCT04823650|581020144|FG005|Overall Study|Withdrawal by Subject|0|||
160897581|NCT04063384|581021370|FG000|Overall Study|placebo manipulation issue|1|||
160550245|NCT03529773|579740184|FG032|Overall Study|Screen Failure|0|||
160550246|NCT03529773|579740185|FG033|Overall Study|Screen Failure|0|||
160803977|NCT01815424|580671814|FG002|Week 16 to 52|Lost to Follow-up|0|||
160803978|NCT01815424|580671815|FG003|Week 16 to 52|Lost to Follow-up|2|||
160803979|NCT01815424|580671816|FG004|Week 16 to 52|Lost to Follow-up|1|||
160897582|NCT04063384|581021371|FG001|Overall Study|placebo manipulation issue|2|||
160897583|NCT04063384|581021372|FG002|Overall Study|placebo manipulation issue|1|||
160897584|NCT04063384|581021373|FG003|Overall Study|placebo manipulation issue|1|||
160897585|NCT01823146|581021380|FG000|Overall Study|Withdrawal by Subject|0|||
160550247|NCT03529773|579740186|FG034|Overall Study|Screen Failure|0|||
160550248|NCT03529773|579740187|FG035|Overall Study|Screen Failure|0|||
160803980|NCT01815424|580671812|FG000|Week 16 to 52|Withdrawal by Subject|1|||
160803981|NCT01815424|580671813|FG001|Week 16 to 52|Withdrawal by Subject|2|||
160803982|NCT01815424|580671814|FG002|Week 16 to 52|Withdrawal by Subject|0|||
160803983|NCT01815424|580671815|FG003|Week 16 to 52|Withdrawal by Subject|0|||
160803984|NCT01815424|580671816|FG004|Week 16 to 52|Withdrawal by Subject|0|||
160803985|NCT01309204|580671817|FG000|Overall Study|Adverse Event|48|||
160803986|NCT01309204|580671818|FG001|Overall Study|Adverse Event|58|||
160803987|NCT01309204|580671817|FG000|Overall Study|Lost to Follow-up|2|||
160803988|NCT01309204|580671818|FG001|Overall Study|Lost to Follow-up|2|||
160803989|NCT01309204|580671817|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
160803990|NCT01309204|580671818|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
160803991|NCT01309204|580671817|FG000|Overall Study|Inadequate control of IOP|4|||
160803992|NCT01309204|580671818|FG001|Overall Study|Inadequate control of IOP|4|||
160803993|NCT01309204|580671817|FG000|Overall Study|Other|4|||
160803994|NCT01309204|580671818|FG001|Overall Study|Other|1|||
160803995|NCT04723355|580671819|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
160803996|NCT04723355|580671819|FG000|Overall Study|Errors in the informed consent form|2|||
160803997|NCT03374358|580671821|FG000|Overall Study|Withdrawal by Subject|0|||
160803998|NCT03374358|580671822|FG001|Overall Study|Withdrawal by Subject|2|||
160803999|NCT01127633|580671823|FG000|Overall Study|Adverse Event|74|||
160804000|NCT01127633|580671824|FG001|Overall Study|Adverse Event|73|||
160804001|NCT01127633|580671823|FG000|Overall Study|Death|40|||
160804002|NCT01127633|580671824|FG001|Overall Study|Death|43|||
160804003|NCT01127633|580671823|FG000|Overall Study|Lost to Follow-up|4|||
160804004|NCT01127633|580671824|FG001|Overall Study|Lost to Follow-up|0|||
160804005|NCT01127633|580671823|FG000|Overall Study|Parent/Caregiver Decision|246|||
160804006|NCT01127633|580671824|FG001|Overall Study|Parent/Caregiver Decision|228|||
160804007|NCT01127633|580671823|FG000|Overall Study|Physician Decision|60|||
160804008|NCT01127633|580671824|FG001|Overall Study|Physician Decision|45|||
160804009|NCT01127633|580671823|FG000|Overall Study|Withdrawal by Subject|57|||
160804010|NCT01127633|580671824|FG001|Overall Study|Withdrawal by Subject|72|||
160804011|NCT01127633|580671823|FG000|Overall Study|Sponsor Decision|163|||
160804012|NCT01127633|580671824|FG001|Overall Study|Sponsor Decision|195|||
160804013|NCT01127633|580671823|FG000|Overall Study|Protocol Violation|8|||
160804014|NCT01127633|580671824|FG001|Overall Study|Protocol Violation|16|||
160804015|NCT01127633|580671823|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
160804016|NCT01127633|580671824|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
160804017|NCT01127633|580671823|FG000|Overall Study|Not treated|1|||
160804018|NCT01127633|580671824|FG001|Overall Study|Not treated|0|||
160804019|NCT03432494|580671826|FG000|Overall Study|Death|1|||
160804020|NCT03432494|580671826|FG000|Overall Study|Noncompliance|1|||
160804021|NCT00775268|580671827|FG000|Baseline|Drug not synthesize dose|1|||
160804022|NCT00775268|580671828|FG001|Baseline|Drug not synthesize dose|0|||
160804023|NCT00775268|580671827|FG000|Baseline|Not treated-ineligible per CT|0|||
160804024|NCT00775268|580671828|FG001|Baseline|Not treated-ineligible per CT|1|||
160804025|NCT00775268|580671827|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
160804026|NCT00775268|580671828|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
160804027|NCT00775268|580671827|FG000|After Completion|Participant missed scan appointment|1|||
160985211|NCT02034435|581335390|FG002|Overall Study|Inadequate IV access|0|||
160985212|NCT02034435|581335391|FG003|Overall Study|Inadequate IV access|1|||
160985213|NCT02839681|581335394|FG000|Overall Study|Death|2|||
160985214|NCT00848211|581335395|FG000|Overall Study|Protocol Violation|0|||
160985215|NCT00848211|581335396|FG001|Overall Study|Protocol Violation|1|||
160985216|NCT00848211|581335397|FG002|Overall Study|Protocol Violation|1|||
160985217|NCT00848211|581335398|FG003|Overall Study|Protocol Violation|0|||
160985218|NCT00848211|581335395|FG000|Overall Study|Adverse Event|0|||
160985219|NCT00848211|581335396|FG001|Overall Study|Adverse Event|0|||
160985220|NCT00848211|581335397|FG002|Overall Study|Adverse Event|0|||
160985221|NCT00848211|581335398|FG003|Overall Study|Adverse Event|0|||
160985222|NCT00772928|581335399|FG000|Overall Study|Lost to Follow-up|9|||
160985223|NCT00772928|581335400|FG001|Overall Study|Lost to Follow-up|6|||
160985224|NCT00772928|581335399|FG000|Overall Study|Protocol Violation|10|||
160804028|NCT00775268|580671828|FG001|After Completion|Participant missed scan appointment|0|||
160804029|NCT04263766|580671829|FG000|Overall Study|Withdrawal by Subject|6|||
160804030|NCT04263766|580671830|FG001|Overall Study|Withdrawal by Subject|4|||
160804031|NCT04263766|580671829|FG000|Overall Study|Lack of Efficacy|1|||
160804032|NCT04263766|580671830|FG001|Overall Study|Lack of Efficacy|3|||
160804033|NCT04232943|580671831|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
160804034|NCT04232943|580671832|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
160985225|NCT00772928|581335400|FG001|Overall Study|Protocol Violation|12|||
160985226|NCT00772928|581335399|FG000|Overall Study|Withdrawal by Subject|25|||
160804035|NCT04232943|580671833|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
160985227|NCT00772928|581335400|FG001|Overall Study|Withdrawal by Subject|22|||
160985228|NCT00772928|581335399|FG000|Overall Study|Did not receive vaccine|0|||
160804036|NCT04232943|580671831|FG000|Overall Study|Withdrawal by Subject|1|||
160804037|NCT04232943|580671832|FG001|Overall Study|Withdrawal by Subject|1|||
160804038|NCT04232943|580671833|FG002|Overall Study|Withdrawal by Subject|0|||
160804039|NCT00573391|580671839|FG000|Overall Study|study stopped|2|||
160985229|NCT00772928|581335400|FG001|Overall Study|Did not receive vaccine|1|||
160804040|NCT00573391|580671840|FG001|Overall Study|study stopped|2|||
160804041|NCT00573391|580671839|FG000|Overall Study|Death|1|||
160804042|NCT00573391|580671840|FG001|Overall Study|Death|0|||
160804043|NCT03896477|580671841|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
160804044|NCT03896477|580671842|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
160804045|NCT03896477|580671843|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
160804046|NCT03896477|580671841|FG000|Overall Study|Parent Requested Withdrawal|8|||
160804047|NCT03896477|580671842|FG001|Overall Study|Parent Requested Withdrawal|12|||
160804048|NCT03896477|580671843|FG002|Overall Study|Parent Requested Withdrawal|9|||
160804049|NCT03896477|580671841|FG000|Overall Study|Adverse Event|0|||
160804050|NCT03896477|580671842|FG001|Overall Study|Adverse Event|0|||
160804051|NCT03896477|580671843|FG002|Overall Study|Adverse Event|1|||
160804052|NCT03896477|580671841|FG000|Overall Study|Death|1|||
160804053|NCT03896477|580671842|FG001|Overall Study|Death|0|||
160804054|NCT03896477|580671843|FG002|Overall Study|Death|0|||
160804055|NCT03896477|580671841|FG000|Overall Study|Other|5|||
160804056|NCT03896477|580671842|FG001|Overall Study|Other|6|||
160804057|NCT03896477|580671843|FG002|Overall Study|Other|7|||
160804058|NCT03896477|580671841|FG000|Overall Study|Lost to Follow-up|2|||
160804059|NCT03896477|580671842|FG001|Overall Study|Lost to Follow-up|1|||
160804060|NCT03896477|580671843|FG002|Overall Study|Lost to Follow-up|1|||
160804061|NCT00400517|580671844|FG000|Overall Study|Withdrawal by Subject|1|||
160804062|NCT00400517|580671844|FG000|Overall Study|Physician Decision|1|||
160804063|NCT01106157|580671845|FG000|Overall Study|Withdrawal by Subject|1|||
160804064|NCT01106157|580671846|FG001|Overall Study|Withdrawal by Subject|0|||
160804065|NCT01118780|580671848|FG000|Overall Study|Adverse Event|15|||
160804066|NCT01118780|580671849|FG001|Overall Study|Adverse Event|15|||
160804067|NCT01118780|580671848|FG000|Overall Study|Death|1|||
160804068|NCT01118780|580671849|FG001|Overall Study|Death|0|||
160804069|NCT01118780|580671848|FG000|Overall Study|Lack of Efficacy|2|||
160804070|NCT01118780|580671849|FG001|Overall Study|Lack of Efficacy|6|||
160804071|NCT01118780|580671848|FG000|Overall Study|Physician Decision|2|||
160804072|NCT01118780|580671849|FG001|Overall Study|Physician Decision|0|||
160804073|NCT01118780|580671848|FG000|Overall Study|Protocol Violation|3|||
160804074|NCT01118780|580671849|FG001|Overall Study|Protocol Violation|6|||
160804075|NCT01118780|580671848|FG000|Overall Study|Withdrawal by Subject|13|||
160804076|NCT01118780|580671849|FG001|Overall Study|Withdrawal by Subject|8|||
160804077|NCT05518461|580671850|FG000|Overall Study|Lost to Follow-up|25|||
160804078|NCT03962855|580671851|FG000|Overall Study|Death|0|||
160804079|NCT03962855|580671852|FG001|Overall Study|Death|1|||
160804080|NCT03962855|580671851|FG000|Overall Study|Lost to Follow-up|0|||
160804081|NCT03962855|580671852|FG001|Overall Study|Lost to Follow-up|1|||
160804082|NCT03962855|580671851|FG000|Overall Study|Adverse Event|0|||
160804083|NCT03962855|580671852|FG001|Overall Study|Adverse Event|1|||
160804084|NCT03962855|580671851|FG000|Overall Study|Physician Decision|0|||
160804085|NCT03962855|580671852|FG001|Overall Study|Physician Decision|2|||
160804086|NCT02750514|580671854|FG000|Track 1|Disease progression|20|||
160804087|NCT02750514|580671855|FG001|Track 1|Disease progression|1|||
160804088|NCT02750514|580671856|FG002|Track 1|Disease progression|0|||
160804089|NCT02750514|580671857|FG003|Track 1|Disease progression|1|||
160804090|NCT02750514|580671858|FG004|Track 1|Disease progression|0|||
160804091|NCT02750514|580671854|FG000|Track 1|Adverse event unrelated to study drug|1|||
160804092|NCT02750514|580671855|FG001|Track 1|Adverse event unrelated to study drug|0|||
160804093|NCT02750514|580671856|FG002|Track 1|Adverse event unrelated to study drug|0|||
160804094|NCT02750514|580671857|FG003|Track 1|Adverse event unrelated to study drug|0|||
160804095|NCT02750514|580671858|FG004|Track 1|Adverse event unrelated to study drug|0|||
160804096|NCT02750514|580671854|FG000|Track 1|Study drug toxicity|4|||
160804097|NCT02750514|580671855|FG001|Track 1|Study drug toxicity|1|||
160804098|NCT02750514|580671856|FG002|Track 1|Study drug toxicity|0|||
160804099|NCT02750514|580671857|FG003|Track 1|Study drug toxicity|1|||
160897586|NCT01823146|581021381|FG001|Overall Study|Withdrawal by Subject|1|||
160897587|NCT01823146|581021380|FG000|Overall Study|Lost to Follow-up|2|||
160897588|NCT01823146|581021381|FG001|Overall Study|Lost to Follow-up|1|||
160897589|NCT01788046|581021382|FG000|Overall Study|Withdrawal by Subject|12|||
160897590|NCT01788046|581021383|FG001|Overall Study|Withdrawal by Subject|12|||
160897591|NCT01788046|581021382|FG000|Overall Study|Lost to Follow-up|12|||
160897592|NCT01788046|581021383|FG001|Overall Study|Lost to Follow-up|19|||
160985230|NCT03100838|581335401|FG000|Overall Study|Adverse Event|1|||
160804100|NCT02750514|580671858|FG004|Track 1|Study drug toxicity|0|||
160804101|NCT02750514|580671854|FG000|Track 1|Participant request to discontinue|1|||
160804102|NCT02750514|580671855|FG001|Track 1|Participant request to discontinue|0|||
160804103|NCT02750514|580671856|FG002|Track 1|Participant request to discontinue|0|||
160804104|NCT02750514|580671857|FG003|Track 1|Participant request to discontinue|0|||
160804105|NCT02750514|580671858|FG004|Track 1|Participant request to discontinue|0|||
160804106|NCT02750514|580671854|FG000|Track 1|Other reasons|1|||
160804107|NCT02750514|580671855|FG001|Track 1|Other reasons|0|||
160804108|NCT02750514|580671856|FG002|Track 1|Other reasons|0|||
160804109|NCT02750514|580671857|FG003|Track 1|Other reasons|0|||
160897593|NCT01788046|581021382|FG000|Overall Study|Death|7|||
160985231|NCT03100838|581335402|FG001|Overall Study|Adverse Event|0|||
160985232|NCT03100838|581335403|FG002|Overall Study|Adverse Event|0|||
160985233|NCT03100838|581335404|FG003|Overall Study|Adverse Event|0|||
160985234|NCT03100838|581335401|FG000|Overall Study|Physician Decision|1|||
160985235|NCT03100838|581335402|FG001|Overall Study|Physician Decision|1|||
160985236|NCT03100838|581335403|FG002|Overall Study|Physician Decision|1|||
160985237|NCT03100838|581335404|FG003|Overall Study|Physician Decision|1|||
160804110|NCT02750514|580671858|FG004|Track 1|Other reasons|0|||
160804111|NCT02750514|580671854|FG000|Track 2|Disease progression|4|||
160804112|NCT02750514|580671855|FG001|Track 2|Disease progression|5|||
160804113|NCT02750514|580671856|FG002|Track 2|Disease progression|2|||
160804114|NCT02750514|580671857|FG003|Track 2|Disease progression|5|||
160804115|NCT02750514|580671858|FG004|Track 2|Disease progression|0|||
160804116|NCT02750514|580671854|FG000|Track 2|Adverse event unrelated to study drug|1|||
160804117|NCT02750514|580671855|FG001|Track 2|Adverse event unrelated to study drug|0|||
160804118|NCT02750514|580671856|FG002|Track 2|Adverse event unrelated to study drug|0|||
160804119|NCT02750514|580671857|FG003|Track 2|Adverse event unrelated to study drug|0|||
160804120|NCT02750514|580671858|FG004|Track 2|Adverse event unrelated to study drug|0|||
160804121|NCT02750514|580671854|FG000|Track 2|Study drug toxicity|1|||
160804122|NCT02750514|580671855|FG001|Track 2|Study drug toxicity|2|||
160804123|NCT02750514|580671856|FG002|Track 2|Study drug toxicity|0|||
160804124|NCT02750514|580671857|FG003|Track 2|Study drug toxicity|2|||
160804125|NCT02750514|580671858|FG004|Track 2|Study drug toxicity|0|||
160804126|NCT02750514|580671854|FG000|Track 2|Participant withdrew consent|0|||
160804127|NCT02750514|580671855|FG001|Track 2|Participant withdrew consent|1|||
160804128|NCT02750514|580671856|FG002|Track 2|Participant withdrew consent|0|||
160804129|NCT02750514|580671857|FG003|Track 2|Participant withdrew consent|0|||
160804130|NCT02750514|580671858|FG004|Track 2|Participant withdrew consent|0|||
160804131|NCT02750514|580671854|FG000|Track 3|Disease progression|0|||
160804132|NCT02750514|580671855|FG001|Track 3|Disease progression|24|||
160804133|NCT02750514|580671856|FG002|Track 3|Disease progression|13|||
160804134|NCT02750514|580671857|FG003|Track 3|Disease progression|14|||
160804135|NCT02750514|580671858|FG004|Track 3|Disease progression|0|||
160804136|NCT02750514|580671854|FG000|Track 3|Adverse event unrelated to study drug|0|||
160804137|NCT02750514|580671855|FG001|Track 3|Adverse event unrelated to study drug|1|||
160804138|NCT02750514|580671856|FG002|Track 3|Adverse event unrelated to study drug|1|||
160804139|NCT02750514|580671857|FG003|Track 3|Adverse event unrelated to study drug|1|||
160804140|NCT02750514|580671858|FG004|Track 3|Adverse event unrelated to study drug|0|||
160985238|NCT03100838|581335401|FG000|Overall Study|Pregnancy|0|||
160985239|NCT03100838|581335402|FG001|Overall Study|Pregnancy|1|||
160985240|NCT03100838|581335403|FG002|Overall Study|Pregnancy|0|||
160985241|NCT03100838|581335404|FG003|Overall Study|Pregnancy|0|||
160985242|NCT03100838|581335401|FG000|Overall Study|Lost to Follow-up|0|||
160985243|NCT03100838|581335402|FG001|Overall Study|Lost to Follow-up|0|||
160985244|NCT03100838|581335403|FG002|Overall Study|Lost to Follow-up|1|||
160985245|NCT03100838|581335404|FG003|Overall Study|Lost to Follow-up|0|||
160985246|NCT00801242|581335408|FG000|Overall Study|Adverse Event|10|||
160985247|NCT00801242|581335408|FG000|Overall Study|Withdrawal by Subject|13|||
160985248|NCT00801242|581335408|FG000|Overall Study|Protocol Violation|5|||
160985249|NCT00801242|581335408|FG000|Overall Study|Physician Decision|3|||
160985250|NCT00801242|581335408|FG000|Overall Study|Lost to Follow-up|1|||
160985251|NCT00801242|581335408|FG000|Overall Study|Miscellaneous reasons|20|||
160985252|NCT01347645|581335409|FG000|Overall Study|Death|1|||
160985253|NCT01347645|581335410|FG001|Overall Study|Death|5|||
160985254|NCT01347645|581335411|FG002|Overall Study|Death|2|||
160985255|NCT01347645|581335412|FG003|Overall Study|Death|7|||
160985256|NCT01347645|581335413|FG004|Overall Study|Death|7|||
160985257|NCT01347645|581335409|FG000|Overall Study|Lost to Follow-up|1|||
160985258|NCT01347645|581335410|FG001|Overall Study|Lost to Follow-up|1|||
160985259|NCT01347645|581335411|FG002|Overall Study|Lost to Follow-up|0|||
160985260|NCT01347645|581335412|FG003|Overall Study|Lost to Follow-up|1|||
160804141|NCT02750514|580671854|FG000|Track 3|Study drug toxicity|0|||
160804142|NCT02750514|580671855|FG001|Track 3|Study drug toxicity|3|||
160804143|NCT02750514|580671856|FG002|Track 3|Study drug toxicity|0|||
160985261|NCT01347645|581335413|FG004|Overall Study|Lost to Follow-up|1|||
160804144|NCT02750514|580671857|FG003|Track 3|Study drug toxicity|1|||
160804145|NCT02750514|580671858|FG004|Track 3|Study drug toxicity|0|||
160804146|NCT02750514|580671854|FG000|Track 3|Participant request to discontinue|0|||
160804147|NCT02750514|580671855|FG001|Track 3|Participant request to discontinue|2|||
160985262|NCT01347645|581335409|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
160985263|NCT01347645|581335410|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
160985264|NCT01347645|581335411|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
160804148|NCT02750514|580671856|FG002|Track 3|Participant request to discontinue|0|||
160985265|NCT01347645|581335412|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
160996828|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
160804149|NCT02750514|580671857|FG003|Track 3|Participant request to discontinue|0|||
160804150|NCT02750514|580671858|FG004|Track 3|Participant request to discontinue|0|||
160804151|NCT02750514|580671854|FG000|Track 3|Participant withdrew consent|0|||
160804152|NCT02750514|580671855|FG001|Track 3|Participant withdrew consent|3|||
160804153|NCT02750514|580671856|FG002|Track 3|Participant withdrew consent|1|||
160804154|NCT02750514|580671857|FG003|Track 3|Participant withdrew consent|0|||
160804155|NCT02750514|580671858|FG004|Track 3|Participant withdrew consent|0|||
160804156|NCT02750514|580671854|FG000|Track 3|Other reasons|0|||
160804157|NCT02750514|580671855|FG001|Track 3|Other reasons|3|||
160804158|NCT02750514|580671856|FG002|Track 3|Other reasons|0|||
160804159|NCT02750514|580671857|FG003|Track 3|Other reasons|0|||
160804160|NCT02750514|580671858|FG004|Track 3|Other reasons|0|||
160804161|NCT02750514|580671854|FG000|Track 4|Study drug toxicity|0|||
160804162|NCT02750514|580671855|FG001|Track 4|Study drug toxicity|6|||
160804163|NCT02750514|580671856|FG002|Track 4|Study drug toxicity|0|||
160804164|NCT02750514|580671857|FG003|Track 4|Study drug toxicity|5|||
160804165|NCT02750514|580671858|FG004|Track 4|Study drug toxicity|0|||
160804166|NCT02750514|580671854|FG000|Track 4|Participant request to discontinue|0|||
160804167|NCT02750514|580671855|FG001|Track 4|Participant request to discontinue|1|||
160804168|NCT02750514|580671856|FG002|Track 4|Participant request to discontinue|0|||
160550249|NCT03529773|579740188|FG036|Overall Study|Screen Failure|1|||
160550250|NCT03529773|579740189|FG037|Overall Study|Screen Failure|1|||
160804169|NCT02750514|580671857|FG003|Track 4|Participant request to discontinue|1|||
160550251|NCT03529773|579740190|FG038|Overall Study|Screen Failure|0|||
160550252|NCT03529773|579740191|FG039|Overall Study|Screen Failure|1|||
160550253|NCT03529773|579740152|FG000|Overall Study|Randomized but not vaccinated|0|||
160550254|NCT03529773|579740153|FG001|Overall Study|Randomized but not vaccinated|0|||
160550255|NCT03529773|579740154|FG002|Overall Study|Randomized but not vaccinated|0|||
160550256|NCT03529773|579740155|FG003|Overall Study|Randomized but not vaccinated|0|||
160550257|NCT03529773|579740156|FG004|Overall Study|Randomized but not vaccinated|0|||
160550258|NCT03529773|579740157|FG005|Overall Study|Randomized but not vaccinated|0|||
160550259|NCT03529773|579740158|FG006|Overall Study|Randomized but not vaccinated|0|||
160550260|NCT03529773|579740159|FG007|Overall Study|Randomized but not vaccinated|0|||
160550261|NCT03529773|579740160|FG008|Overall Study|Randomized but not vaccinated|0|||
160550262|NCT03529773|579740161|FG009|Overall Study|Randomized but not vaccinated|0|||
160550263|NCT03529773|579740162|FG010|Overall Study|Randomized but not vaccinated|0|||
160550264|NCT03529773|579740163|FG011|Overall Study|Randomized but not vaccinated|0|||
160550265|NCT03529773|579740164|FG012|Overall Study|Randomized but not vaccinated|0|||
160550266|NCT03529773|579740165|FG013|Overall Study|Randomized but not vaccinated|0|||
160550267|NCT03529773|579740166|FG014|Overall Study|Randomized but not vaccinated|0|||
160550268|NCT03529773|579740167|FG015|Overall Study|Randomized but not vaccinated|0|||
160550269|NCT03529773|579740168|FG016|Overall Study|Randomized but not vaccinated|0|||
160804170|NCT02750514|580671858|FG004|Track 4|Participant request to discontinue|0|||
160804171|NCT02750514|580671854|FG000|Track 4|Participant withdrew consent|0|||
160550270|NCT03529773|579740169|FG017|Overall Study|Randomized but not vaccinated|1|||
160550271|NCT03529773|579740170|FG018|Overall Study|Randomized but not vaccinated|0|||
160550272|NCT03529773|579740171|FG019|Overall Study|Randomized but not vaccinated|0|||
160804172|NCT02750514|580671855|FG001|Track 4|Participant withdrew consent|1|||
160804173|NCT02750514|580671856|FG002|Track 4|Participant withdrew consent|0|||
160804174|NCT02750514|580671857|FG003|Track 4|Participant withdrew consent|0|||
160804175|NCT02750514|580671858|FG004|Track 4|Participant withdrew consent|0|||
160804176|NCT02750514|580671854|FG000|Track 4|Other reasons|0|||
160804177|NCT02750514|580671855|FG001|Track 4|Other reasons|5|||
160804178|NCT02750514|580671856|FG002|Track 4|Other reasons|0|||
160804179|NCT02750514|580671857|FG003|Track 4|Other reasons|3|||
160804180|NCT02750514|580671858|FG004|Track 4|Other reasons|0|||
160804181|NCT02750514|580671854|FG000|Track 4|Disease progression|0|||
160804182|NCT02750514|580671855|FG001|Track 4|Disease progression|33|||
160804183|NCT02750514|580671856|FG002|Track 4|Disease progression|0|||
160804184|NCT02750514|580671857|FG003|Track 4|Disease progression|32|||
160804185|NCT02750514|580671858|FG004|Track 4|Disease progression|0|||
160804186|NCT02750514|580671854|FG000|Track 4|Adverse event unrelated to study drug|0|||
160804187|NCT02750514|580671855|FG001|Track 4|Adverse event unrelated to study drug|5|||
160804188|NCT02750514|580671856|FG002|Track 4|Adverse event unrelated to study drug|0|||
160804189|NCT02750514|580671857|FG003|Track 4|Adverse event unrelated to study drug|0|||
160804190|NCT02750514|580671858|FG004|Track 4|Adverse event unrelated to study drug|0|||
160804191|NCT02750514|580671854|FG000|Track 4|Death|0|||
160804192|NCT02750514|580671855|FG001|Track 4|Death|0|||
160804193|NCT02750514|580671856|FG002|Track 4|Death|0|||
160804194|NCT02750514|580671857|FG003|Track 4|Death|1|||
160804195|NCT02750514|580671858|FG004|Track 4|Death|0|||
160804196|NCT02750514|580671854|FG000|Track 5|Disease progression|0|||
160804197|NCT02750514|580671855|FG001|Track 5|Disease progression|0|||
160804198|NCT02750514|580671856|FG002|Track 5|Disease progression|0|||
160804199|NCT02750514|580671857|FG003|Track 5|Disease progression|0|||
160804200|NCT02750514|580671858|FG004|Track 5|Disease progression|34|||
160804201|NCT02750514|580671854|FG000|Track 5|Adverse event unrelated to study drug|0|||
160804202|NCT02750514|580671855|FG001|Track 5|Adverse event unrelated to study drug|0|||
160804203|NCT02750514|580671856|FG002|Track 5|Adverse event unrelated to study drug|0|||
160804204|NCT02750514|580671857|FG003|Track 5|Adverse event unrelated to study drug|0|||
160804205|NCT02750514|580671858|FG004|Track 5|Adverse event unrelated to study drug|2|||
160804206|NCT02750514|580671854|FG000|Track 5|Study drug toxicity|0|||
160804207|NCT02750514|580671855|FG001|Track 5|Study drug toxicity|0|||
160804208|NCT02750514|580671856|FG002|Track 5|Study drug toxicity|0|||
160804209|NCT02750514|580671857|FG003|Track 5|Study drug toxicity|0|||
160804210|NCT02750514|580671858|FG004|Track 5|Study drug toxicity|2|||
160804211|NCT02750514|580671854|FG000|Track 5|Participant request to discontinue|0|||
160804212|NCT02750514|580671855|FG001|Track 5|Participant request to discontinue|0|||
160804213|NCT02750514|580671856|FG002|Track 5|Participant request to discontinue|0|||
160804214|NCT02750514|580671857|FG003|Track 5|Participant request to discontinue|0|||
160804215|NCT02750514|580671858|FG004|Track 5|Participant request to discontinue|3|||
160804216|NCT02750514|580671854|FG000|Track 5|Other reasons|0|||
160804217|NCT02750514|580671855|FG001|Track 5|Other reasons|0|||
160804218|NCT02750514|580671856|FG002|Track 5|Other reasons|0|||
160804219|NCT02750514|580671857|FG003|Track 5|Other reasons|0|||
160804220|NCT02750514|580671858|FG004|Track 5|Other reasons|2|||
160804221|NCT01882465|580671859|FG000|Period 1|Lens Discomfort|0|||
160804222|NCT01882465|580671860|FG001|Period 1|Lens Discomfort|0|||
160804223|NCT01882465|580671861|FG002|Period 1|Lens Discomfort|0|||
160804224|NCT01882465|580671862|FG003|Period 1|Lens Discomfort|1|||
160804225|NCT01882465|580671863|FG004|Period 1|Lens Discomfort|0|||
160804226|NCT01882465|580671864|FG005|Period 1|Lens Discomfort|0|||
160804227|NCT01882465|580671865|FG006|Period 1|Lens Discomfort|0|||
160804228|NCT01882465|580671859|FG000|Period 1|Withdrawal by Subject|0|||
160804229|NCT01882465|580671860|FG001|Period 1|Withdrawal by Subject|0|||
160804230|NCT01882465|580671861|FG002|Period 1|Withdrawal by Subject|0|||
160804231|NCT01882465|580671862|FG003|Period 1|Withdrawal by Subject|0|||
160804232|NCT01882465|580671863|FG004|Period 1|Withdrawal by Subject|0|||
160804233|NCT01882465|580671864|FG005|Period 1|Withdrawal by Subject|0|||
160804234|NCT01882465|580671865|FG006|Period 1|Withdrawal by Subject|1|||
160804235|NCT01882465|580671859|FG000|Period 2|Protocol Violation|0|||
160804236|NCT01882465|580671860|FG001|Period 2|Protocol Violation|0|||
160804237|NCT01882465|580671861|FG002|Period 2|Protocol Violation|0|||
160804238|NCT01882465|580671862|FG003|Period 2|Protocol Violation|0|||
160804239|NCT01882465|580671863|FG004|Period 2|Protocol Violation|1|||
160804240|NCT01882465|580671864|FG005|Period 2|Protocol Violation|0|||
160804241|NCT01882465|580671865|FG006|Period 2|Protocol Violation|0|||
160804242|NCT01824290|580671868|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
160804243|NCT01824290|580671869|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
160804244|NCT01824290|580671870|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
160804245|NCT01824290|580671871|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
160804246|NCT01824290|580671868|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
160804247|NCT01824290|580671869|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
160804248|NCT01824290|580671870|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
160804249|NCT01824290|580671871|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
160804250|NCT01824290|580671868|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
160804251|NCT01824290|580671869|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
160804252|NCT01824290|580671870|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
160804253|NCT01824290|580671871|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
160644515|NCT00408876|580080772|FG001|Overall Study|Withdrawal by Subject|6|||
160644516|NCT00408876|580080773|FG002|Overall Study|Withdrawal by Subject|6|||
160644517|NCT00408876|580080774|FG003|Overall Study|Withdrawal by Subject|14|||
160644518|NCT00408876|580080771|FG000|Overall Study|Lack of Efficacy|2|||
160644519|NCT00408876|580080772|FG001|Overall Study|Lack of Efficacy|4|||
160804254|NCT01824290|580671868|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
160804255|NCT01824290|580671869|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
160804256|NCT01824290|580671870|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
160804257|NCT01824290|580671871|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
160804258|NCT01824290|580671868|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
160804259|NCT01824290|580671869|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
160804260|NCT01824290|580671870|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
160804261|NCT01824290|580671871|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
160804262|NCT01824290|580671868|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
160804263|NCT01824290|580671869|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
160804264|NCT01824290|580671870|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
160804265|NCT01824290|580671871|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
160804266|NCT00800982|580671872|FG000|Overall Study|Lost to Follow-up|1|||
160804267|NCT00800982|580671873|FG001|Overall Study|Lost to Follow-up|2|||
160804268|NCT00800982|580671872|FG000|Overall Study|Withdrawal by Subject|0|||
160804269|NCT00800982|580671873|FG001|Overall Study|Withdrawal by Subject|1|||
160804270|NCT00800982|580671872|FG000|Overall Study|Patient moved out of state|1|||
160804271|NCT00800982|580671873|FG001|Overall Study|Patient moved out of state|0|||
160804272|NCT00527618|580671874|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
160804273|NCT00527618|580671875|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
160804274|NCT00527618|580671874|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
160804275|NCT00527618|580671875|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
160804276|NCT00527618|580671874|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
160804277|NCT00527618|580671875|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
160804278|NCT00527618|580671874|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
160804279|NCT00527618|580671875|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
160804280|NCT00527618|580671874|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
160804281|NCT00527618|580671875|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
160804282|NCT00527618|580671874|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
160804283|NCT00527618|580671875|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
160897594|NCT01788046|581021383|FG001|Overall Study|Death|5|||
160897595|NCT01788046|581021382|FG000|Overall Study|Protocol Specified Criteria|25|||
160897596|NCT01788046|581021383|FG001|Overall Study|Protocol Specified Criteria|1|||
160897597|NCT01797731|581021389|FG000|Overall Study|Didn't have proper radiographs required|3|||
160897598|NCT01797731|581021390|FG001|Overall Study|Didn't have proper radiographs required|3|||
160897599|NCT01604408|581021391|FG000|Treatment Period 1|Protocol Violation|0|||
160897600|NCT01604408|581021392|FG001|Treatment Period 1|Protocol Violation|1|||
160897601|NCT01604408|581021391|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160897602|NCT01604408|581021392|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160897603|NCT01604408|581021391|FG000|Treatment Period 2|Protocol Violation|1|||
160897604|NCT01604408|581021392|FG001|Treatment Period 2|Protocol Violation|0|||
160897605|NCT01604408|581021391|FG000|Treatment Period 2|Adverse Event|0|||
160897606|NCT01604408|581021392|FG001|Treatment Period 2|Adverse Event|1|||
160897607|NCT01604408|581021391|FG000|Treatment Period 3|Protocol Violation|1|||
160897608|NCT01604408|581021392|FG001|Treatment Period 3|Protocol Violation|1|||
160897609|NCT01604408|581021391|FG000|Treatment Period 3|Adverse Event|0|||
160897610|NCT01604408|581021392|FG001|Treatment Period 3|Adverse Event|3|||
160897611|NCT01604408|581021391|FG000|Treatment Period 3|Withdrawal by Subject|3|||
160897612|NCT01604408|581021392|FG001|Treatment Period 3|Withdrawal by Subject|1|||
160897613|NCT01604408|581021391|FG000|Treatment Period 3|Sponsor Decision|1|||
160897614|NCT01604408|581021392|FG001|Treatment Period 3|Sponsor Decision|0|||
160897615|NCT01604408|581021391|FG000|Treatment Period 4|Death|1|||
160897616|NCT01604408|581021392|FG001|Treatment Period 4|Death|0|||
160897617|NCT01604408|581021391|FG000|Treatment Period 4|Withdrawal by Subject|2|||
160897618|NCT01604408|581021392|FG001|Treatment Period 4|Withdrawal by Subject|1|||
160897619|NCT01604408|581021391|FG000|Treatment Period 4|Adverse Event|0|||
160897620|NCT01604408|581021392|FG001|Treatment Period 4|Adverse Event|1|||
160897621|NCT01604408|581021391|FG000|Treatment Period 5|Adverse Event|4|||
160897622|NCT01604408|581021392|FG001|Treatment Period 5|Adverse Event|0|||
160897623|NCT01604408|581021391|FG000|Treatment Period 6|Lost to Follow-up|0|||
160897624|NCT01604408|581021392|FG001|Treatment Period 6|Lost to Follow-up|1|||
160897625|NCT01604408|581021391|FG000|Treatment Period 6|Adverse Event|2|||
160644520|NCT00408876|580080773|FG002|Overall Study|Lack of Efficacy|5|||
160897626|NCT01604408|581021392|FG001|Treatment Period 6|Adverse Event|0|||
160897627|NCT01604408|581021391|FG000|Treatment Period 6|Sponsor decision|0|||
160897628|NCT01604408|581021392|FG001|Treatment Period 6|Sponsor decision|1|||
160897629|NCT01604408|581021391|FG000|Observation Period|Adverse Event|1|||
160897630|NCT01604408|581021392|FG001|Observation Period|Adverse Event|1|||
160644521|NCT00408876|580080774|FG003|Overall Study|Lack of Efficacy|6|||
160804284|NCT01490918|580671876|FG000|Overall Study|Lost to Follow-up|2|||
160804285|NCT01490918|580671877|FG001|Overall Study|Lost to Follow-up|1|||
160804286|NCT01490918|580671878|FG002|Overall Study|Lost to Follow-up|0|||
160804287|NCT01490918|580671876|FG000|Overall Study|Withdrawal by Subject|7|||
160804288|NCT01490918|580671877|FG001|Overall Study|Withdrawal by Subject|8|||
160804289|NCT01490918|580671878|FG002|Overall Study|Withdrawal by Subject|3|||
160804290|NCT01490918|580671876|FG000|Overall Study|Adverse Event|0|||
160804291|NCT01490918|580671877|FG001|Overall Study|Adverse Event|0|||
160804292|NCT01490918|580671878|FG002|Overall Study|Adverse Event|1|||
160804293|NCT01490918|580671876|FG000|Overall Study|other cause|4|||
160804294|NCT01490918|580671877|FG001|Overall Study|other cause|5|||
160804295|NCT01490918|580671878|FG002|Overall Study|other cause|8|||
160804296|NCT02240121|580671883|FG000|Overall Study|Protocol Violation|1|||
160804297|NCT02240121|580671884|FG001|Overall Study|Protocol Violation|2|||
160804298|NCT02240121|580671883|FG000|Overall Study|Physician Decision|0|||
160804299|NCT02240121|580671884|FG001|Overall Study|Physician Decision|1|||
160804300|NCT02240121|580671883|FG000|Overall Study|Change in protocol interpretation|1|||
160804301|NCT02240121|580671884|FG001|Overall Study|Change in protocol interpretation|0|||
160897631|NCT01604408|581021391|FG000|Observation Period|Withdrawal by Subject|0|||
160897632|NCT01604408|581021392|FG001|Observation Period|Withdrawal by Subject|2|||
160897633|NCT01189604|581021396|FG000|Overall Study|Impossible to visit|0|||
160804302|NCT02240121|580671883|FG000|Overall Study|Lack of Efficacy|2|||
160804303|NCT02240121|580671884|FG001|Overall Study|Lack of Efficacy|3|||
160804304|NCT02240121|580671883|FG000|Overall Study|Site closed|1|||
160804305|NCT02240121|580671884|FG001|Overall Study|Site closed|1|||
160804306|NCT02240121|580671883|FG000|Overall Study|Pregnancy|1|||
160804307|NCT02240121|580671884|FG001|Overall Study|Pregnancy|0|||
160804308|NCT02240121|580671883|FG000|Overall Study|Adverse Event|2|||
160804309|NCT02240121|580671884|FG001|Overall Study|Adverse Event|4|||
160804310|NCT02240121|580671883|FG000|Overall Study|Withdrawal by Subject|6|||
160804311|NCT02240121|580671884|FG001|Overall Study|Withdrawal by Subject|2|||
160804312|NCT02240121|580671883|FG000|Overall Study|Lost to Follow-up|3|||
160804313|NCT02240121|580671884|FG001|Overall Study|Lost to Follow-up|4|||
160804314|NCT02240121|580671883|FG000|Overall Study|Other than specified|1|||
160804315|NCT02240121|580671884|FG001|Overall Study|Other than specified|3|||
160804316|NCT00648037|580671885|FG000|Overall Study|Not Treated|1|||
160804317|NCT00648037|580671885|FG000|Overall Study|Withdrawal by Subject|1|||
160804318|NCT00648037|580671885|FG000|Overall Study|Adverse Event|11|||
160804319|NCT00648037|580671885|FG000|Overall Study|Relapse|2|||
160804320|NCT00648037|580671885|FG000|Overall Study|Other|1|||
160804321|NCT02765399|580671896|FG000|Overall Study|Nausea|1|||
160804322|NCT02765399|580671897|FG001|Overall Study|Nausea|0|||
160804323|NCT04068922|580671898|FG000|Overall Study|Lost to Follow-up|5|||
160804324|NCT04068922|580671898|FG000|Overall Study|Withdrawal by Subject|7|||
160804325|NCT04068922|580671898|FG000|Overall Study|Adverse Event|1|||
160804326|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
160804327|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
160804328|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
160804329|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
160804330|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
160804331|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
160804332|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
160804333|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
160804334|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
160804335|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
160804336|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
160804337|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
160804338|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
160804339|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
160804340|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
160804341|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
160804342|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
160804343|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
160804344|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
160804345|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
160804346|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
160804347|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
160804348|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
160897634|NCT01189604|581021397|FG001|Overall Study|Impossible to visit|0|||
160897635|NCT01189604|581021398|FG002|Overall Study|Impossible to visit|0|||
160644522|NCT00408876|580080771|FG000|Overall Study|Lost to Follow-up|1|||
160804349|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
160804350|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
160804351|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
160804352|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
160804353|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
160804354|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
160804355|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
160804356|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
160804357|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
160804358|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
160804359|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
160804360|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
160897636|NCT01189604|581021399|FG003|Overall Study|Impossible to visit|0|||
160897637|NCT01189604|581021400|FG004|Overall Study|Impossible to visit|0|||
160897638|NCT01189604|581021401|FG005|Overall Study|Impossible to visit|1|||
160897639|NCT01189604|581021402|FG006|Overall Study|Impossible to visit|0|||
160897640|NCT01189604|581021396|FG000|Overall Study|Adverse Event|0|||
160550273|NCT03529773|579740172|FG020|Overall Study|Randomized but not vaccinated|0|||
160550274|NCT03529773|579740173|FG021|Overall Study|Randomized but not vaccinated|0|||
160550275|NCT03529773|579740174|FG022|Overall Study|Randomized but not vaccinated|0|||
160897641|NCT01189604|581021397|FG001|Overall Study|Adverse Event|1|||
160897642|NCT01189604|581021398|FG002|Overall Study|Adverse Event|0|||
160897643|NCT01189604|581021399|FG003|Overall Study|Adverse Event|0|||
160897644|NCT01189604|581021400|FG004|Overall Study|Adverse Event|2|||
160897645|NCT01189604|581021401|FG005|Overall Study|Adverse Event|0|||
160897646|NCT01189604|581021402|FG006|Overall Study|Adverse Event|1|||
160897647|NCT01189604|581021396|FG000|Overall Study|Withdrawal by Subject|1|||
160897648|NCT01189604|581021397|FG001|Overall Study|Withdrawal by Subject|0|||
160897649|NCT01189604|581021398|FG002|Overall Study|Withdrawal by Subject|0|||
160897650|NCT01189604|581021399|FG003|Overall Study|Withdrawal by Subject|0|||
160897651|NCT01189604|581021400|FG004|Overall Study|Withdrawal by Subject|0|||
160897652|NCT01189604|581021401|FG005|Overall Study|Withdrawal by Subject|0|||
160897653|NCT01189604|581021402|FG006|Overall Study|Withdrawal by Subject|0|||
160897654|NCT03945214|581021403|FG000|Overall Study|Lost to Follow-up|3|||
160897655|NCT03945214|581021404|FG001|Overall Study|Lost to Follow-up|4|||
160897656|NCT03945214|581021405|FG002|Overall Study|Lost to Follow-up|7|||
160897657|NCT03945214|581021406|FG003|Overall Study|Lost to Follow-up|4|||
160897658|NCT04102098|581021421|FG000|Main Study Period|Ongoing in study|302|||
160897659|NCT04102098|581021422|FG001|Main Study Period|Ongoing in study|291|||
160897660|NCT04102098|581021421|FG000|Main Study Period|Death|20|||
160897661|NCT04102098|581021422|FG001|Main Study Period|Death|27|||
160897662|NCT04102098|581021421|FG000|Main Study Period|Lost to Follow-up|1|||
160897663|NCT04102098|581021422|FG001|Main Study Period|Lost to Follow-up|1|||
160897664|NCT04102098|581021421|FG000|Main Study Period|Physician Decision|0|||
160897665|NCT04102098|581021422|FG001|Main Study Period|Physician Decision|1|||
160897666|NCT04102098|581021421|FG000|Main Study Period|Withdrawal by Subject|11|||
160897667|NCT04102098|581021422|FG001|Main Study Period|Withdrawal by Subject|14|||
160897668|NCT04102098|581021421|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
160897669|NCT04102098|581021422|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
160897670|NCT04102098|581021421|FG000|Crossover: AS Who Crossed Over|Death|11|||
160897671|NCT04102098|581021422|FG001|Crossover: AS Who Crossed Over|Death|0|||
160897672|NCT04102098|581021421|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
160897673|NCT04102098|581021422|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
160897674|NCT03755791|581021425|FG000|Overall Study|Did not receive any study treatment|3|||
160897675|NCT03755791|581021426|FG001|Overall Study|Did not receive any study treatment|0|||
160897676|NCT03755791|581021427|FG002|Overall Study|Did not receive any study treatment|10|||
160897677|NCT03755791|581021425|FG000|Overall Study|Radiographic progression|204|||
160897678|NCT03755791|581021426|FG001|Overall Study|Radiographic progression|92|||
160897679|NCT03755791|581021427|FG002|Overall Study|Radiographic progression|115|||
160897680|NCT03755791|581021425|FG000|Overall Study|Adverse Event|140|||
160897681|NCT03755791|581021426|FG001|Overall Study|Adverse Event|60|||
160897682|NCT03755791|581021427|FG002|Overall Study|Adverse Event|51|||
160897683|NCT03755791|581021425|FG000|Overall Study|Lack of Efficacy|12|||
160897684|NCT03755791|581021426|FG001|Overall Study|Lack of Efficacy|6|||
160897685|NCT03755791|581021427|FG002|Overall Study|Lack of Efficacy|6|||
160897686|NCT03755791|581021425|FG000|Overall Study|Withdrawal by Subject|26|||
160897687|NCT03755791|581021426|FG001|Overall Study|Withdrawal by Subject|23|||
160550276|NCT03529773|579740175|FG023|Overall Study|Randomized but not vaccinated|0|||
160550277|NCT03529773|579740176|FG024|Overall Study|Randomized but not vaccinated|0|||
160550278|NCT03529773|579740177|FG025|Overall Study|Randomized but not vaccinated|0|||
160897688|NCT03755791|581021427|FG002|Overall Study|Withdrawal by Subject|24|||
160897689|NCT03755791|581021425|FG000|Overall Study|Sponsor decision,|41|||
160897690|NCT03755791|581021426|FG001|Overall Study|Sponsor decision,|5|||
160897691|NCT03755791|581021427|FG002|Overall Study|Sponsor decision,|7|||
160897692|NCT03755791|581021425|FG000|Overall Study|Lost to Follow-up|1|||
160897693|NCT03755791|581021426|FG001|Overall Study|Lost to Follow-up|0|||
160897694|NCT03755791|581021427|FG002|Overall Study|Lost to Follow-up|2|||
160897695|NCT03755791|581021425|FG000|Overall Study|Protocol Violation|0|||
160897696|NCT03755791|581021426|FG001|Overall Study|Protocol Violation|0|||
160897697|NCT03755791|581021427|FG002|Overall Study|Protocol Violation|2|||
160897698|NCT03755791|581021425|FG000|Overall Study|Other than specified|5|||
160804361|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
160804362|NCT00716274|580671904|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
160804363|NCT00716274|580671905|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
160804364|NCT00716274|580671906|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
160804365|NCT00716274|580671907|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
160804366|NCT00716274|580671908|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
160804367|NCT00716274|580671909|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
160804368|NCT00716274|580671904|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
160804369|NCT00716274|580671905|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
160804370|NCT00716274|580671906|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
160804371|NCT00716274|580671907|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
160804372|NCT00716274|580671908|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
160804373|NCT00716274|580671909|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
160804374|NCT00716274|580671904|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
160804375|NCT00716274|580671905|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
160804376|NCT00716274|580671906|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
160804377|NCT00716274|580671907|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
160804378|NCT00716274|580671908|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
160804379|NCT00716274|580671909|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
160804380|NCT00716274|580671904|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
160804381|NCT00716274|580671905|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
160804382|NCT00716274|580671906|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
160804383|NCT00716274|580671907|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
160804384|NCT00716274|580671908|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
160804385|NCT00716274|580671909|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
160804386|NCT01342094|580671910|FG000|Overall Study|Adverse Event|5|||
160804387|NCT01342094|580671911|FG001|Overall Study|Adverse Event|0|||
160804388|NCT01342094|580671910|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
160804389|NCT01342094|580671911|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
160804390|NCT01342094|580671910|FG000|Overall Study|Withdrawal by Subject|0|||
160804391|NCT01342094|580671911|FG001|Overall Study|Withdrawal by Subject|2|||
160804392|NCT02806414|580671914|FG000|Overall Study|Lost to Follow-up|2|||
160804393|NCT00543985|580671917|FG000|Overall Study|Withdrawal by Subject|4|||
160804394|NCT01634152|580671918|FG000|Overall Study|Adverse Event|2|||
160804395|NCT01634152|580671919|FG001|Overall Study|Adverse Event|0|||
160804396|NCT01634152|580671920|FG002|Overall Study|Adverse Event|2|||
160804397|NCT01634152|580671918|FG000|Overall Study|Consent withdrawn not due to AE|1|||
160804398|NCT01634152|580671919|FG001|Overall Study|Consent withdrawn not due to AE|0|||
160804399|NCT01634152|580671920|FG002|Overall Study|Consent withdrawn not due to AE|1|||
160804400|NCT01634152|580671918|FG000|Overall Study|Not treated|0|||
160804401|NCT01634152|580671919|FG001|Overall Study|Not treated|1|||
160804402|NCT01634152|580671920|FG002|Overall Study|Not treated|0|||
160804403|NCT01634152|580671918|FG000|Overall Study|Other reason not defined above|1|||
160804404|NCT01634152|580671919|FG001|Overall Study|Other reason not defined above|0|||
160804405|NCT01634152|580671920|FG002|Overall Study|Other reason not defined above|1|||
160804406|NCT00403130|580671924|FG000|2 Years From Start of Treatment|Not Eligible|3|||
160804407|NCT00403130|580671924|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
160804408|NCT00403130|580671924|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
160804409|NCT00403130|580671924|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
160804410|NCT00806260|580671925|FG000|Period 1 (1 Day)|Adverse Event|0|||
160804411|NCT00806260|580671926|FG001|Period 1 (1 Day)|Adverse Event|0|||
160804412|NCT00806260|580671927|FG002|Period 1 (1 Day)|Adverse Event|0|||
160804413|NCT00806260|580671928|FG003|Period 1 (1 Day)|Adverse Event|0|||
160804414|NCT00806260|580671929|FG004|Period 1 (1 Day)|Adverse Event|3|||
160804415|NCT00806260|580671930|FG005|Period 1 (1 Day)|Adverse Event|0|||
160804416|NCT00806260|580671925|FG000|Period 2|Adverse Event|0|||
160804417|NCT00806260|580671926|FG001|Period 2|Adverse Event|0|||
160804418|NCT00806260|580671927|FG002|Period 2|Adverse Event|0|||
160804419|NCT00806260|580671928|FG003|Period 2|Adverse Event|1|||
160804420|NCT00806260|580671929|FG004|Period 2|Adverse Event|0|||
160804421|NCT00806260|580671930|FG005|Period 2|Adverse Event|0|||
160804422|NCT00806260|580671925|FG000|Period 2|Protocol Violation|1|||
160804423|NCT00806260|580671926|FG001|Period 2|Protocol Violation|0|||
160804424|NCT00806260|580671927|FG002|Period 2|Protocol Violation|1|||
160804425|NCT00806260|580671928|FG003|Period 2|Protocol Violation|0|||
160804426|NCT00806260|580671929|FG004|Period 2|Protocol Violation|0|||
160804427|NCT00806260|580671930|FG005|Period 2|Protocol Violation|0|||
160804428|NCT00806260|580671925|FG000|Period 2|Need to take concomitant medication|1|||
160804429|NCT00806260|580671926|FG001|Period 2|Need to take concomitant medication|0|||
160804430|NCT00806260|580671927|FG002|Period 2|Need to take concomitant medication|0|||
160804431|NCT00806260|580671928|FG003|Period 2|Need to take concomitant medication|0|||
160804432|NCT00806260|580671929|FG004|Period 2|Need to take concomitant medication|0|||
160804433|NCT00806260|580671930|FG005|Period 2|Need to take concomitant medication|0|||
160804434|NCT00806260|580671925|FG000|Period 2|sponsor request|0|||
160804435|NCT00806260|580671926|FG001|Period 2|sponsor request|0|||
160644523|NCT00408876|580080772|FG001|Overall Study|Lost to Follow-up|6|||
160804436|NCT00806260|580671927|FG002|Period 2|sponsor request|1|||
160644524|NCT00408876|580080773|FG002|Overall Study|Lost to Follow-up|5|||
160804437|NCT00806260|580671928|FG003|Period 2|sponsor request|1|||
160644525|NCT00408876|580080774|FG003|Overall Study|Lost to Follow-up|2|||
160804438|NCT00806260|580671929|FG004|Period 2|sponsor request|0|||
160804439|NCT00806260|580671930|FG005|Period 2|sponsor request|0|||
160804440|NCT00806260|580671925|FG000|Period 3|Protocol Violation|0|||
160804441|NCT00806260|580671926|FG001|Period 3|Protocol Violation|1|||
160804442|NCT00806260|580671927|FG002|Period 3|Protocol Violation|1|||
160804443|NCT00806260|580671928|FG003|Period 3|Protocol Violation|0|||
160804444|NCT00806260|580671929|FG004|Period 3|Protocol Violation|0|||
160804445|NCT00806260|580671930|FG005|Period 3|Protocol Violation|0|||
160804446|NCT00806260|580671925|FG000|Period 3|Pregnancy|1|||
160804447|NCT00806260|580671926|FG001|Period 3|Pregnancy|0|||
160804448|NCT00806260|580671927|FG002|Period 3|Pregnancy|0|||
160985266|NCT01347645|581335413|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
160985267|NCT01347645|581335409|FG000|Overall Study|Other|1|||
160985268|NCT01347645|581335410|FG001|Overall Study|Other|0|||
160985269|NCT01347645|581335411|FG002|Overall Study|Other|0|||
160985270|NCT01347645|581335412|FG003|Overall Study|Other|0|||
160985271|NCT01347645|581335413|FG004|Overall Study|Other|1|||
160804449|NCT00806260|580671928|FG003|Period 3|Pregnancy|0|||
160804450|NCT00806260|580671929|FG004|Period 3|Pregnancy|0|||
160804451|NCT00806260|580671930|FG005|Period 3|Pregnancy|0|||
160804452|NCT02670473|580671931|FG000|Overall Study|Withdrawal by Subject|1|||
160804453|NCT05414175|580671932|FG000|Overall Study|Withdrawal by Subject|1|||
160804454|NCT05414175|580671932|FG000|Overall Study|Other Reasons|1|||
160804455|NCT00456755|580673284|FG000|Overall Study|Lost to Follow-up|2|||
160804456|NCT00456755|580673285|FG001|Overall Study|Lost to Follow-up|1|||
160804457|NCT01475721|580673288|FG000|Overall Study|Death|3|||
160804458|NCT01475721|580673289|FG001|Overall Study|Death|6|||
160804459|NCT01475721|580673288|FG000|Overall Study|Withdrawal by Subject|8|||
160804460|NCT01475721|580673289|FG001|Overall Study|Withdrawal by Subject|8|||
160804461|NCT02364037|580673291|FG000|Overall Study|Withdrawal by Subject|7|||
160804462|NCT02364037|580673292|FG001|Overall Study|Withdrawal by Subject|4|||
160804463|NCT02364037|580673291|FG000|Overall Study|Lost to Follow-up|37|||
160804464|NCT02364037|580673292|FG001|Overall Study|Lost to Follow-up|49|||
160804465|NCT01453036|580673293|FG000|Overall Study|Lost to Follow-up|26|||
160985272|NCT01347645|581335409|FG000|Overall Study|Withdrawal by Subject|0|||
160985273|NCT01347645|581335410|FG001|Overall Study|Withdrawal by Subject|0|||
160985274|NCT01347645|581335411|FG002|Overall Study|Withdrawal by Subject|0|||
160804466|NCT01453036|580673294|FG001|Overall Study|Lost to Follow-up|115|||
160804467|NCT01453036|580673295|FG002|Overall Study|Lost to Follow-up|31|||
160985275|NCT01347645|581335412|FG003|Overall Study|Withdrawal by Subject|3|||
160985276|NCT01347645|581335413|FG004|Overall Study|Withdrawal by Subject|3|||
160804468|NCT04567524|580673296|FG000|Overall Study|Adverse Event|1|||
160804469|NCT04567524|580673297|FG001|Overall Study|Adverse Event|1|||
160804470|NCT04567524|580673298|FG002|Overall Study|Adverse Event|0|||
160804471|NCT04567524|580673299|FG003|Overall Study|Adverse Event|0|||
160804472|NCT04567524|580673296|FG000|Overall Study|Withdrawal by Subject|2|||
160804473|NCT04567524|580673297|FG001|Overall Study|Withdrawal by Subject|0|||
160804474|NCT04567524|580673298|FG002|Overall Study|Withdrawal by Subject|0|||
160804475|NCT04567524|580673299|FG003|Overall Study|Withdrawal by Subject|1|||
160804476|NCT02848092|580673300|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
160804477|NCT02848092|580673301|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
160804478|NCT02848092|580673300|FG000|1-month Post-training Follow-up|Adverse Event|2|||
160804479|NCT02848092|580673301|FG001|1-month Post-training Follow-up|Adverse Event|1|||
160804480|NCT02848092|580673300|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
160804481|NCT02848092|580673301|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
160897699|NCT03755791|581021426|FG001|Overall Study|Other than specified|2|||
160897700|NCT03755791|581021427|FG002|Overall Study|Other than specified|0|||
160897701|NCT02083081|581021431|FG000|Overall Study|Lost to Follow-up|31|||
160897702|NCT02083081|581021432|FG001|Overall Study|Lost to Follow-up|9|||
160897703|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
160897704|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
160897705|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Physician Decision|1|||
160897706|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Physician Decision|0|||
160897707|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
160897708|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
160897709|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
160897710|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
160897711|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Adverse Event|15|||
160897712|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Adverse Event|0|||
160897713|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
160897714|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
160897715|NCT03277690|581021435|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
160897716|NCT03277690|581021436|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
160897717|NCT03109847|581021437|FG000|Overall Study|Withdrawal by Subject|1|||
160897718|NCT03109847|581021438|FG001|Overall Study|Withdrawal by Subject|0|||
160897719|NCT04209348|581021439|FG000|Overall Study|Lost to Follow-up|1|||
160897720|NCT04209348|581021440|FG001|Overall Study|Lost to Follow-up|0|||
160897721|NCT02853344|581021441|FG000|Overall Study|Lost to Follow-up|1|||
160897722|NCT02853344|581021442|FG001|Overall Study|Lost to Follow-up|1|||
160897723|NCT02853344|581021441|FG000|Overall Study|Withdrawal by Subject|2|||
160897724|NCT02853344|581021442|FG001|Overall Study|Withdrawal by Subject|4|||
160897725|NCT02853344|581021441|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
160897726|NCT02853344|581021442|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
160897727|NCT02853344|581021441|FG000|Overall Study|Death|70|||
160897728|NCT02853344|581021442|FG001|Overall Study|Death|112|||
160897729|NCT02955797|581021443|FG000|Overall Study|Protocol Violation|1|||
160897730|NCT02955797|581021444|FG001|Overall Study|Protocol Violation|0|||
160897731|NCT02955797|581021445|FG002|Overall Study|Protocol Violation|0|||
160897732|NCT02955797|581021446|FG003|Overall Study|Protocol Violation|1|||
160897733|NCT02955797|581021443|FG000|Overall Study|Withdrawal by Subject|2|||
160897734|NCT02955797|581021444|FG001|Overall Study|Withdrawal by Subject|2|||
160897735|NCT02955797|581021445|FG002|Overall Study|Withdrawal by Subject|0|||
160897736|NCT02955797|581021446|FG003|Overall Study|Withdrawal by Subject|1|||
160897737|NCT02955797|581021443|FG000|Overall Study|Lost to Follow-up|0|||
160897738|NCT02955797|581021444|FG001|Overall Study|Lost to Follow-up|1|||
160897739|NCT02955797|581021445|FG002|Overall Study|Lost to Follow-up|0|||
160897740|NCT02955797|581021446|FG003|Overall Study|Lost to Follow-up|0|||
160897741|NCT03131453|581021447|FG000|Overall Study|Study terminated by Sponsor|424|||
160897742|NCT03131453|581021448|FG001|Overall Study|Study terminated by Sponsor|222|||
160897743|NCT03131453|581021449|FG002|Overall Study|Study terminated by Sponsor|438|||
160897744|NCT03131453|581021447|FG000|Overall Study|Withdrawal by Subject|18|||
160897745|NCT03131453|581021448|FG001|Overall Study|Withdrawal by Subject|7|||
160897746|NCT03131453|581021449|FG002|Overall Study|Withdrawal by Subject|13|||
160804482|NCT02848092|580673300|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
160804483|NCT02848092|580673301|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
160897747|NCT03131453|581021447|FG000|Overall Study|Adverse Event|10|||
160897748|NCT03131453|581021448|FG001|Overall Study|Adverse Event|3|||
160897749|NCT03131453|581021449|FG002|Overall Study|Adverse Event|3|||
160897750|NCT03131453|581021447|FG000|Overall Study|Lost to Follow-up|1|||
160897751|NCT03131453|581021448|FG001|Overall Study|Lost to Follow-up|0|||
160804484|NCT02848092|580673300|FG000|1-month Post-training Follow-up|fatigue|0|||
160804485|NCT02848092|580673301|FG001|1-month Post-training Follow-up|fatigue|1|||
160804486|NCT02848092|580673300|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
160804487|NCT02848092|580673301|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
160804488|NCT02848092|580673300|FG000|6-month Post-training Follow-up|Adverse Event|1|||
160804489|NCT02848092|580673301|FG001|6-month Post-training Follow-up|Adverse Event|1|||
160804490|NCT02848092|580673300|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
160804491|NCT02848092|580673301|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
160804492|NCT02848092|580673300|FG000|6-month Post-training Follow-up|frustrated with task|1|||
160804493|NCT02848092|580673301|FG001|6-month Post-training Follow-up|frustrated with task|0|||
160804494|NCT02848092|580673300|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
160804495|NCT02848092|580673301|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
160804496|NCT02848092|580673300|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
160804497|NCT02848092|580673301|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
160804498|NCT01147393|580673306|FG000|Dose Level 1|Dose limiting Toxicity|2|||
160804499|NCT01147393|580673306|FG000|Dose Level -1|Dose Limited Toxicity|1|||
160804500|NCT01833494|580673324|FG000|Overall Study|Adverse Event|24|||
160804501|NCT01833494|580673324|FG000|Overall Study|Physician Decision|6|||
160804502|NCT01833494|580673324|FG000|Overall Study|Withdrawal by Subject|6|||
160804503|NCT01833494|580673324|FG000|Overall Study|Decrease in serum phosphorus|4|||
160644526|NCT00408876|580080771|FG000|Overall Study|Protocol Violation|0|||
160804504|NCT01833494|580673324|FG000|Overall Study|Decrease in serum calcium|4|||
160804505|NCT01833494|580673324|FG000|Overall Study|Increase in serum ferritin|1|||
160804506|NCT01694433|580673329|FG000|Overall Study|Adverse Event|7|||
160804507|NCT01694433|580673330|FG001|Overall Study|Adverse Event|0|||
160804508|NCT01694433|580673329|FG000|Overall Study|Physician Decision|1|||
160804509|NCT01694433|580673330|FG001|Overall Study|Physician Decision|0|||
160804510|NCT01694433|580673329|FG000|Overall Study|Withdrawal by Subject|3|||
160804511|NCT01694433|580673330|FG001|Overall Study|Withdrawal by Subject|4|||
160804512|NCT00374595|580673331|FG000|Overall Study|Death|23|||
160804513|NCT00374595|580673331|FG000|Overall Study|Withdrawal by Subject|39|||
160804514|NCT00374595|580673331|FG000|Overall Study|Lost to Follow-up|3|||
160804515|NCT00374595|580673331|FG000|Overall Study|too much time commitment|1|||
160804516|NCT00374595|580673331|FG000|Overall Study|transfer care to other clinical site|1|||
160804517|NCT00374595|580673331|FG000|Overall Study|relocation|3|||
160804518|NCT03745768|580673333|FG000|Overall Study|discontinued study|2|||
160804519|NCT03745768|580673334|FG001|Overall Study|discontinued study|0|||
160804520|NCT00443118|580673335|FG000|Overall Study|unknown primary outcome|3|||
160804521|NCT00443118|580673336|FG001|Overall Study|unknown primary outcome|1|||
160804522|NCT00443118|580673337|FG002|Overall Study|unknown primary outcome|0|||
160804523|NCT00443118|580673335|FG000|Overall Study|Withdrawal by Subject|1|||
160804524|NCT00443118|580673336|FG001|Overall Study|Withdrawal by Subject|0|||
160804525|NCT00443118|580673337|FG002|Overall Study|Withdrawal by Subject|0|||
160804526|NCT00506779|580673340|FG000|Overall Study|Withdrawal by Subject|1|||
160804527|NCT00506779|580673341|FG001|Overall Study|Withdrawal by Subject|0|||
160804528|NCT00506779|580673342|FG002|Overall Study|Withdrawal by Subject|1|||
160804529|NCT00506779|580673343|FG003|Overall Study|Withdrawal by Subject|0|||
160804530|NCT00506779|580673340|FG000|Overall Study|Adverse Event|0|||
160804531|NCT00506779|580673341|FG001|Overall Study|Adverse Event|1|||
160804532|NCT00506779|580673342|FG002|Overall Study|Adverse Event|1|||
160804533|NCT00506779|580673343|FG003|Overall Study|Adverse Event|1|||
160804534|NCT02639247|580673344|FG000|Overall Study|Lost to Follow-up|2|||
160804535|NCT02639247|580673345|FG001|Overall Study|Lost to Follow-up|1|||
160804536|NCT02639247|580673344|FG000|Overall Study|Death|2|||
160804537|NCT02639247|580673345|FG001|Overall Study|Death|0|||
160804538|NCT02639247|580673344|FG000|Overall Study|Withdrew Consent|0|||
160804539|NCT02639247|580673345|FG001|Overall Study|Withdrew Consent|1|||
160804540|NCT02639247|580673344|FG000|Overall Study|Protocol Violation|1|||
160804541|NCT02639247|580673345|FG001|Overall Study|Protocol Violation|0|||
160804542|NCT01891396|580673346|FG000|Overall Study|Withdrawal by Subject|4|||
160804543|NCT01891396|580673347|FG001|Overall Study|Withdrawal by Subject|4|||
160804544|NCT01891396|580673348|FG002|Overall Study|Withdrawal by Subject|3|||
160804545|NCT01891396|580673346|FG000|Overall Study|Lost to Follow-up|0|||
160897752|NCT03131453|581021449|FG002|Overall Study|Lost to Follow-up|1|||
160897753|NCT03131453|581021447|FG000|Overall Study|Physician Decision|1|||
160897754|NCT03131453|581021448|FG001|Overall Study|Physician Decision|0|||
160897755|NCT03131453|581021449|FG002|Overall Study|Physician Decision|1|||
160897756|NCT03131453|581021447|FG000|Overall Study|Non-compliance with study treatment|1|||
160897757|NCT03131453|581021448|FG001|Overall Study|Non-compliance with study treatment|0|||
160804546|NCT01891396|580673347|FG001|Overall Study|Lost to Follow-up|1|||
160644527|NCT00408876|580080772|FG001|Overall Study|Protocol Violation|3|||
160804547|NCT01891396|580673348|FG002|Overall Study|Lost to Follow-up|0|||
160804548|NCT02168101|580673351|FG000|Overall Study|Death|2|||
160804549|NCT02168101|580673352|FG001|Overall Study|Death|2|||
160804550|NCT02168101|580673353|FG002|Overall Study|Death|1|||
160897758|NCT03131453|581021449|FG002|Overall Study|Non-compliance with study treatment|0|||
160804551|NCT01881009|580673354|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
160804552|NCT01881009|580673355|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
160804553|NCT04011735|580673356|FG000|Overall Study|Withdrawal by Subject|1|||
160804554|NCT04011735|580673357|FG001|Overall Study|Withdrawal by Subject|0|||
160804555|NCT04011735|580673358|FG002|Overall Study|Withdrawal by Subject|1|||
160804556|NCT04011735|580673356|FG000|Overall Study|Met exclusion criteria after study entry|0|||
160804557|NCT04011735|580673357|FG001|Overall Study|Met exclusion criteria after study entry|1|||
160804558|NCT04011735|580673358|FG002|Overall Study|Met exclusion criteria after study entry|0|||
160804559|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
160804560|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
160804561|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
160804562|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
160804563|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
160804564|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
160804565|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
160804566|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
160804567|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
160804568|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
160804569|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
160804570|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
160804571|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
160804572|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
160804573|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
160804574|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
160804575|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
160804576|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
160804577|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Other|4|||
160804578|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Other|0|||
160804579|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Other|0|||
160804580|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
160804581|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
160804582|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
160804583|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Death|0|||
160804584|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Death|0|||
160804585|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Death|2|||
160804586|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
160804587|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
160804588|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
160804589|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
160804590|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
160804591|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
160804592|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
160804593|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
160804594|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
160804595|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Other|0|||
160804596|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Other|2|||
160897759|NCT03131453|581021447|FG000|Overall Study|Technical problems|1|||
160897760|NCT03131453|581021448|FG001|Overall Study|Technical problems|0|||
160897761|NCT03131453|581021449|FG002|Overall Study|Technical problems|0|||
160897762|NCT03131453|581021447|FG000|Overall Study|Protocol deviation|0|||
160897763|NCT03131453|581021448|FG001|Overall Study|Protocol deviation|1|||
160897764|NCT03131453|581021449|FG002|Overall Study|Protocol deviation|0|||
160897765|NCT02081183|581021451|FG000|Overall Study|Lost to Follow-up|0|||
160897766|NCT02081183|581021452|FG001|Overall Study|Lost to Follow-up|1|||
160897767|NCT02081183|581021451|FG000|Overall Study|Protocol Violation|1|||
160897768|NCT02081183|581021452|FG001|Overall Study|Protocol Violation|0|||
160897769|NCT02081183|581021451|FG000|Overall Study|Other|3|||
160897770|NCT02081183|581021452|FG001|Overall Study|Other|3|||
160897771|NCT02840721|581021453|FG000|Treatment Period|Adverse Event|1|||
160897772|NCT02840721|581021453|FG000|Follow-Up|Lack of Efficacy|1|||
160897773|NCT02840721|581021453|FG000|Follow-Up|Withdrawal by Subject|4|||
160897774|NCT02840721|581021453|FG000|Follow-Up|Withdrawal of Consent|2|||
160897775|NCT05535972|581021457|FG000|Overall Study|Withdrawal by Subject|31|||
160897776|NCT05535972|581021457|FG000|Overall Study|Lost to Follow-up|5|||
160897777|NCT05535972|581021457|FG000|Overall Study|Adverse Event|6|||
160897778|NCT05535972|581021457|FG000|Overall Study|Protocol Deviation|2|||
160897779|NCT02649894|581021458|FG000|Overall Study|Adverse Event|1|||
160897780|NCT02649894|581021459|FG001|Overall Study|Adverse Event|0|||
160897781|NCT02649894|581021458|FG000|Overall Study|Physician Decision|0|||
160804597|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Other|5|||
160804598|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
160804599|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
160897782|NCT02649894|581021459|FG001|Overall Study|Physician Decision|1|||
160804600|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
160804601|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
160804602|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
160804603|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
160804604|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
160804605|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
160804606|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
160804607|NCT01194245|580673364|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
160804608|NCT01194245|580673365|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
160550279|NCT03529773|579740178|FG026|Overall Study|Randomized but not vaccinated|0|||
160550280|NCT03529773|579740179|FG027|Overall Study|Randomized but not vaccinated|1|||
160550281|NCT03529773|579740180|FG028|Overall Study|Randomized but not vaccinated|0|||
160804609|NCT01194245|580673366|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
160804610|NCT01194245|580673367|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
160804611|NCT01194245|580673368|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
160804612|NCT01194245|580673364|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
160804613|NCT01194245|580673365|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
160804614|NCT01194245|580673366|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
160897783|NCT02649894|581021458|FG000|Overall Study|Withdrawal by Subject|5|||
160897784|NCT02649894|581021459|FG001|Overall Study|Withdrawal by Subject|2|||
160804615|NCT01194245|580673367|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
160897785|NCT02649894|581021458|FG000|Overall Study|Lost to Follow-up|2|||
160897786|NCT02649894|581021459|FG001|Overall Study|Lost to Follow-up|1|||
160897787|NCT02649894|581021458|FG000|Overall Study|Death|30|||
160897788|NCT02649894|581021459|FG001|Overall Study|Death|7|||
160897789|NCT02649894|581021458|FG000|Overall Study|Other, not specified|6|||
160897790|NCT02649894|581021459|FG001|Overall Study|Other, not specified|0|||
160897791|NCT04590963|581021460|FG000|Overall Study|Death|118|||
160897792|NCT04590963|581021461|FG001|Overall Study|Death|59|||
160897793|NCT04590963|581021460|FG000|Overall Study|Lost to Follow-up|1|||
160897794|NCT04590963|581021461|FG001|Overall Study|Lost to Follow-up|1|||
160897795|NCT04590963|581021460|FG000|Overall Study|Progressive disease|0|||
160897796|NCT04590963|581021461|FG001|Overall Study|Progressive disease|1|||
160897797|NCT04590963|581021460|FG000|Overall Study|Study terminated by sponsor|103|||
160897798|NCT04590963|581021461|FG001|Overall Study|Study terminated by sponsor|50|||
160897799|NCT04590963|581021460|FG000|Overall Study|Withdrawal by Subject|15|||
160897800|NCT04590963|581021461|FG001|Overall Study|Withdrawal by Subject|8|||
160897801|NCT04590963|581021460|FG000|Overall Study|Ongoing at data cut-off|9|||
160897802|NCT04590963|581021461|FG001|Overall Study|Ongoing at data cut-off|4|||
160897803|NCT04590963|581021460|FG000|Overall Study|Screen failure|1|||
160897804|NCT04590963|581021461|FG001|Overall Study|Screen failure|0|||
160897805|NCT01736124|581021462|FG000|Post-intervention Assessment|Death|2|||
160897806|NCT01736124|581021463|FG001|Post-intervention Assessment|Death|2|||
160897807|NCT01736124|581021462|FG000|Post-intervention Assessment|lost computer access|1|||
160897808|NCT01736124|581021463|FG001|Post-intervention Assessment|lost computer access|1|||
160897809|NCT01736124|581021462|FG000|Post-intervention Assessment|Moved away|3|||
160897810|NCT01736124|581021463|FG001|Post-intervention Assessment|Moved away|1|||
160897811|NCT01736124|581021462|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
160897812|NCT01736124|581021463|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
160897813|NCT01736124|581021462|FG000|Post-intervention Assessment|Illness|3|||
160897814|NCT01736124|581021463|FG001|Post-intervention Assessment|Illness|2|||
160897815|NCT01736124|581021462|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
160897816|NCT01736124|581021463|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
160897817|NCT01736124|581021462|FG000|Post-intervention Assessment|Temporarily away|3|||
160897818|NCT01736124|581021463|FG001|Post-intervention Assessment|Temporarily away|1|||
160897819|NCT01736124|581021462|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
160897820|NCT01736124|581021463|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
160897821|NCT01736124|581021462|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
160897822|NCT01736124|581021463|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
160804616|NCT01194245|580673368|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
160804617|NCT01194245|580673364|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
160897823|NCT01736124|581021462|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
160897824|NCT01736124|581021463|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
160550282|NCT03529773|579740181|FG029|Overall Study|Randomized but not vaccinated|0|||
160897825|NCT01736124|581021462|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
160897826|NCT01736124|581021463|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
160897827|NCT01736124|581021462|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
160897828|NCT01736124|581021463|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
160897829|NCT01736124|581021462|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
160897830|NCT01736124|581021463|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
160897831|NCT01736124|581021462|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
160897832|NCT01736124|581021463|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
160804618|NCT01194245|580673365|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
160804619|NCT01194245|580673366|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
160804620|NCT01194245|580673367|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
160804621|NCT01194245|580673368|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
160804622|NCT01194245|580673364|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
160804623|NCT01194245|580673365|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
160804624|NCT01194245|580673366|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
160804625|NCT01194245|580673367|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
160804626|NCT01194245|580673368|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
160804627|NCT01194245|580673364|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160804628|NCT01194245|580673365|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160804629|NCT01194245|580673366|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160804630|NCT01194245|580673367|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160804631|NCT01194245|580673368|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
160804632|NCT01194245|580673364|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160804633|NCT01194245|580673365|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160804634|NCT01194245|580673366|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
160804635|NCT01194245|580673367|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
160804636|NCT01194245|580673368|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
160804637|NCT02457247|580673369|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
160804638|NCT02457247|580673370|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
160804639|NCT02457247|580673371|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
160804640|NCT02457247|580673372|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
160804641|NCT02457247|580673369|FG000|Period 1|Significant Protocol Deviation|1|||
160804642|NCT02457247|580673370|FG001|Period 1|Significant Protocol Deviation|1|||
160804643|NCT02457247|580673371|FG002|Period 1|Significant Protocol Deviation|0|||
160804644|NCT02457247|580673372|FG003|Period 1|Significant Protocol Deviation|0|||
160804645|NCT02457247|580673369|FG000|Period 1|Voluntary Withdrawal|1|||
160804646|NCT02457247|580673370|FG001|Period 1|Voluntary Withdrawal|0|||
160804647|NCT02457247|580673371|FG002|Period 1|Voluntary Withdrawal|0|||
160804648|NCT02457247|580673372|FG003|Period 1|Voluntary Withdrawal|0|||
160804649|NCT02457247|580673369|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
160804650|NCT02457247|580673370|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
160804651|NCT02457247|580673371|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
160804652|NCT02457247|580673372|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
160804653|NCT02457247|580673369|FG000|Period 2|Significant Protocol Deviation|1|||
160804654|NCT02457247|580673370|FG001|Period 2|Significant Protocol Deviation|0|||
160804655|NCT02457247|580673371|FG002|Period 2|Significant Protocol Deviation|0|||
160804656|NCT02457247|580673372|FG003|Period 2|Significant Protocol Deviation|0|||
160804657|NCT02457247|580673369|FG000|Period 2|Lost to Follow-up|0|||
160804658|NCT02457247|580673370|FG001|Period 2|Lost to Follow-up|1|||
160804659|NCT02457247|580673371|FG002|Period 2|Lost to Follow-up|0|||
160804660|NCT02457247|580673372|FG003|Period 2|Lost to Follow-up|0|||
160804661|NCT02457247|580673369|FG000|Period 2|Voluntary Withdrawal|1|||
160804662|NCT02457247|580673370|FG001|Period 2|Voluntary Withdrawal|1|||
160804663|NCT02457247|580673371|FG002|Period 2|Voluntary Withdrawal|0|||
160804664|NCT02457247|580673372|FG003|Period 2|Voluntary Withdrawal|0|||
160804665|NCT03326063|580673373|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
160804666|NCT03326063|580673374|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
160804667|NCT00739310|580673375|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
160804668|NCT00739310|580673375|FG000|Overall Study|Withdrawal by Subject|1|||
160804669|NCT00739310|580673375|FG000|Overall Study|Lost to Follow-up|2|||
160804670|NCT02954887|580673376|FG000|Overall Study|Withdrawal by Subject|3|||
160804671|NCT02954887|580673376|FG000|Overall Study|Lack of Efficacy|3|||
160804672|NCT02954887|580673376|FG000|Overall Study|Other|1|||
160804673|NCT01492088|580673379|FG000|Overall Study|Withdrawal by Patient|0|||
160804674|NCT01492088|580673380|FG001|Overall Study|Withdrawal by Patient|2|||
160804675|NCT01492088|580673381|FG002|Overall Study|Withdrawal by Patient|0|||
160804676|NCT01492088|580673379|FG000|Overall Study|Death|1|||
160804677|NCT01492088|580673380|FG001|Overall Study|Death|6|||
160804678|NCT01492088|580673381|FG002|Overall Study|Death|2|||
160804679|NCT01492088|580673379|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
160804680|NCT01492088|580673380|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
160804681|NCT01492088|580673381|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
160804682|NCT01492088|580673379|FG000|Overall Study|Alive at Last Follow-up|0|||
160804683|NCT01492088|580673380|FG001|Overall Study|Alive at Last Follow-up|6|||
160804684|NCT01492088|580673381|FG002|Overall Study|Alive at Last Follow-up|11|||
160804685|NCT00889707|580673382|FG000|Overall Study|Adverse Event|1|||
160804686|NCT00889707|580673383|FG001|Overall Study|Adverse Event|0|||
160804687|NCT00889707|580673382|FG000|Overall Study|Withdrawal by Subject|4|||
160804688|NCT00889707|580673383|FG001|Overall Study|Withdrawal by Subject|3|||
160804689|NCT00889707|580673382|FG000|Overall Study|Lost to Follow-up|0|||
160804690|NCT00889707|580673383|FG001|Overall Study|Lost to Follow-up|2|||
160804691|NCT00889707|580673382|FG000|Overall Study|Lack of Efficacy|2|||
160804692|NCT00889707|580673383|FG001|Overall Study|Lack of Efficacy|5|||
160804693|NCT02756403|580673385|FG000|Overall Study|Unable to swallow medication|0|||
160804694|NCT02756403|580673386|FG001|Overall Study|Unable to swallow medication|1|||
160804695|NCT02756403|580673387|FG002|Overall Study|Unable to swallow medication|1|||
160804696|NCT02756403|580673388|FG003|Overall Study|Unable to swallow medication|1|||
160804697|NCT02756403|580673385|FG000|Overall Study|Did not complete Procedure|0|||
160804698|NCT02756403|580673386|FG001|Overall Study|Did not complete Procedure|1|||
160804699|NCT02756403|580673387|FG002|Overall Study|Did not complete Procedure|0|||
160804700|NCT02756403|580673388|FG003|Overall Study|Did not complete Procedure|0|||
160804701|NCT02756403|580673385|FG000|Overall Study|Changed Mind About Procedure|0|||
160804702|NCT02756403|580673386|FG001|Overall Study|Changed Mind About Procedure|0|||
160804703|NCT02756403|580673387|FG002|Overall Study|Changed Mind About Procedure|1|||
160804704|NCT02756403|580673388|FG003|Overall Study|Changed Mind About Procedure|0|||
160804705|NCT02756403|580673385|FG000|Overall Study|Protocol Violation|0|||
160804706|NCT02756403|580673386|FG001|Overall Study|Protocol Violation|1|||
160804707|NCT02756403|580673387|FG002|Overall Study|Protocol Violation|0|||
160804708|NCT02756403|580673388|FG003|Overall Study|Protocol Violation|1|||
160804709|NCT01151020|580673389|FG000|Overall Study|Death|25|||
160804710|NCT01151020|580673389|FG000|Overall Study|Conversion to open repair|1|||
160804711|NCT01151020|580673389|FG000|Overall Study|Lost to Follow-up|4|||
160804712|NCT01151020|580673389|FG000|Overall Study|Withdrawal by Subject|22|||
160804713|NCT01151020|580673389|FG000|Overall Study|Patients did not receive the device|2|||
160804714|NCT01635998|580673390|FG000|Overall Study|Death|1|||
160804715|NCT01635998|580673391|FG001|Overall Study|Death|1|||
160804716|NCT01635998|580673390|FG000|Overall Study|Lost to Follow-up|2|||
160804717|NCT01635998|580673391|FG001|Overall Study|Lost to Follow-up|1|||
160804718|NCT01635998|580673390|FG000|Overall Study|Withdrawal by Subject|1|||
160804719|NCT01635998|580673391|FG001|Overall Study|Withdrawal by Subject|5|||
160804720|NCT00846846|580673392|FG000|Overall Study|Death|56|||
160804721|NCT00846846|580673392|FG000|Overall Study|Withdrawal by Subject|19|||
160804722|NCT02967679|580673396|FG000|Overall Study|Adverse Event|1|||
160804723|NCT00600067|580673399|FG000|Overall Study|Adverse Event|0|||
160804724|NCT00600067|580673400|FG001|Overall Study|Adverse Event|1|||
160804725|NCT00600067|580673399|FG000|Overall Study|Lost to Follow-up|2|||
160804726|NCT00600067|580673400|FG001|Overall Study|Lost to Follow-up|3|||
160804727|NCT00600067|580673399|FG000|Overall Study|protocol non-compliance|0|||
160804728|NCT00600067|580673400|FG001|Overall Study|protocol non-compliance|3|||
160804729|NCT00600067|580673399|FG000|Overall Study|Lack of Efficacy|1|||
160804730|NCT00600067|580673400|FG001|Overall Study|Lack of Efficacy|0|||
160804731|NCT00003631|580673401|FG000|Overall Study|Patient not treated|1|||
160804732|NCT00003631|580673402|FG001|Overall Study|Patient not treated|0|||
160804733|NCT00003631|580673403|FG002|Overall Study|Patient not treated|1|||
160804734|NCT00003631|580673401|FG000|Overall Study|Protocol Violation|1|||
160804735|NCT00003631|580673402|FG001|Overall Study|Protocol Violation|0|||
160804736|NCT00003631|580673403|FG002|Overall Study|Protocol Violation|0|||
160804737|NCT00003631|580673401|FG000|Overall Study|Adverse Event|1|||
160804738|NCT00003631|580673402|FG001|Overall Study|Adverse Event|1|||
160804739|NCT00003631|580673403|FG002|Overall Study|Adverse Event|5|||
160804740|NCT00003631|580673401|FG000|Overall Study|Death|0|||
160804741|NCT00003631|580673402|FG001|Overall Study|Death|0|||
160804742|NCT00003631|580673403|FG002|Overall Study|Death|1|||
160804743|NCT00003631|580673401|FG000|Overall Study|Evaluable for toxicity only|0|||
160454059|NCT02038777|579394025|FG003|Overall Study|Randomized but not treated|0|||
160804744|NCT00003631|580673402|FG001|Overall Study|Evaluable for toxicity only|0|||
160804745|NCT00003631|580673403|FG002|Overall Study|Evaluable for toxicity only|2|||
160804746|NCT00881894|580673405|FG000|Overall Study|Consent withdrawn|0|||
160804747|NCT00881894|580673406|FG001|Overall Study|Consent withdrawn|1|||
160804748|NCT00881894|580673405|FG000|Overall Study|Other reasons for premature termination|1|||
160804749|NCT00881894|580673406|FG001|Overall Study|Other reasons for premature termination|2|||
160804750|NCT01220401|580673411|FG000|Overall Study|Withdrawal by Subject|2|||
160804751|NCT01220401|580673411|FG000|Overall Study|Protocol Violation|1|||
160804752|NCT01853462|580673412|FG000|Overall Study|Withdrawal by Subject|1|||
160804753|NCT01853462|580673413|FG001|Overall Study|Withdrawal by Subject|1|||
160804754|NCT02103062|580673414|FG000|Overall Study|Adverse Event|1|||
160804755|NCT02103062|580673415|FG001|Overall Study|Adverse Event|2|||
160804756|NCT02103062|580673414|FG000|Overall Study|Progressive Disease|17|||
160804757|NCT02103062|580673415|FG001|Overall Study|Progressive Disease|20|||
160804758|NCT02103062|580673414|FG000|Overall Study|Death|0|||
160804759|NCT02103062|580673415|FG001|Overall Study|Death|1|||
160804760|NCT03958331|580673416|FG000|Overall Study|Withdrawal by Subject|3|||
160804761|NCT03958331|580673417|FG001|Overall Study|Withdrawal by Subject|1|||
160804762|NCT03958331|580673418|FG002|Overall Study|Withdrawal by Subject|5|||
160804763|NCT03958331|580673416|FG000|Overall Study|Weaned from medicine|2|||
160804764|NCT03958331|580673417|FG001|Overall Study|Weaned from medicine|0|||
160804765|NCT03958331|580673418|FG002|Overall Study|Weaned from medicine|0|||
160804766|NCT03958331|580673416|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
160985277|NCT01347645|581335409|FG000|Overall Study|Physician Decision|0|||
160804767|NCT03958331|580673417|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
160804768|NCT03958331|580673418|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
160804769|NCT01991483|580673419|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
160804770|NCT01991483|580673420|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
160804771|NCT01991483|580673421|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
160804772|NCT01991483|580673422|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
160804773|NCT01991483|580673419|FG000|Dose Level 600 mg|Physician Decision|0|||
160804774|NCT01991483|580673420|FG001|Dose Level 600 mg|Physician Decision|0|||
160804775|NCT01991483|580673421|FG002|Dose Level 600 mg|Physician Decision|1|||
160804776|NCT01991483|580673422|FG003|Dose Level 600 mg|Physician Decision|0|||
160804777|NCT01991483|580673419|FG000|Dose Level 1000 mg|Protocol Violation|0|||
160804778|NCT01991483|580673420|FG001|Dose Level 1000 mg|Protocol Violation|0|||
160804779|NCT01991483|580673421|FG002|Dose Level 1000 mg|Protocol Violation|0|||
160804780|NCT01991483|580673422|FG003|Dose Level 1000 mg|Protocol Violation|1|||
160804781|NCT02030821|580673423|FG000|Overall Study|Physician Decision|2|||
160804782|NCT02030821|580673424|FG001|Overall Study|Physician Decision|2|||
160804783|NCT02030821|580673425|FG002|Overall Study|Physician Decision|5|||
160804784|NCT02030821|580673426|FG003|Overall Study|Physician Decision|2|||
160804785|NCT03192137|580673427|FG000|Overall Study|Adverse Event|10|||
160804786|NCT03192137|580673428|FG001|Overall Study|Adverse Event|11|||
160804787|NCT03192137|580673427|FG000|Overall Study|Physician Decision|1|||
160804788|NCT03192137|580673428|FG001|Overall Study|Physician Decision|0|||
160804789|NCT03192137|580673427|FG000|Overall Study|Lack of Efficacy|20|||
160804790|NCT03192137|580673428|FG001|Overall Study|Lack of Efficacy|37|||
160804791|NCT03192137|580673427|FG000|Overall Study|Withdrawal by Subject|3|||
160804792|NCT03192137|580673428|FG001|Overall Study|Withdrawal by Subject|3|||
160804793|NCT03192137|580673427|FG000|Overall Study|Protocol Violation|4|||
160804794|NCT03192137|580673428|FG001|Overall Study|Protocol Violation|3|||
160804795|NCT03192137|580673427|FG000|Overall Study|Surgery Cancelled|4|||
160804796|NCT03192137|580673428|FG001|Overall Study|Surgery Cancelled|1|||
160804797|NCT03192137|580673427|FG000|Overall Study|Other - Various Administrative Reasons|8|||
160804798|NCT03192137|580673428|FG001|Overall Study|Other - Various Administrative Reasons|3|||
160804799|NCT00972023|580674555|FG000|Overall Study|Withdrawal by Subject|1|||
160804800|NCT01428219|580674567|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
160804801|NCT00825994|580674568|FG000|Overall Study|Withdrawal by Subject|2|||
160804802|NCT00825994|580674568|FG000|Overall Study|Lost to Follow-up|1|||
160804803|NCT00825994|580674568|FG000|Overall Study|Protocol Violation|1|||
160804804|NCT00825994|580674568|FG000|Overall Study|Placebo Responder at V2|1|||
160804805|NCT01665911|580674573|FG000|Overall Study|Protocol Violation|4|||
160804806|NCT01665911|580674573|FG000|Overall Study|Withdrawal by Subject|1|||
160804807|NCT01665911|580674573|FG000|Overall Study|Adverse Event|1|||
160804808|NCT01484496|580674574|FG000|Period 1|Protocol Violation|3|||
160804809|NCT01484496|580674575|FG001|Period 1|Protocol Violation|4|||
160804810|NCT01484496|580674576|FG002|Period 1|Protocol Violation|0|||
160804811|NCT01484496|580674577|FG003|Period 1|Protocol Violation|0|||
160804812|NCT01484496|580674574|FG000|Period 1|Physician Decision|5|||
160804813|NCT01484496|580674575|FG001|Period 1|Physician Decision|1|||
160804814|NCT01484496|580674576|FG002|Period 1|Physician Decision|0|||
160804815|NCT01484496|580674577|FG003|Period 1|Physician Decision|0|||
160804816|NCT01484496|580674574|FG000|Period 1|Lack of Efficacy|10|||
160804817|NCT01484496|580674575|FG001|Period 1|Lack of Efficacy|15|||
160804818|NCT01484496|580674576|FG002|Period 1|Lack of Efficacy|0|||
160804819|NCT01484496|580674577|FG003|Period 1|Lack of Efficacy|0|||
160897833|NCT01736124|581021462|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
160897834|NCT01736124|581021463|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
160897835|NCT01736124|581021462|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
160897836|NCT01736124|581021463|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
160897837|NCT04176705|581021465|FG000|Overall Study|Withdrawal by Subject|4|||
160897838|NCT04176705|581021466|FG001|Overall Study|Withdrawal by Subject|4|||
160897839|NCT04176705|581021465|FG000|Overall Study|Death|1|||
160897840|NCT04176705|581021466|FG001|Overall Study|Death|1|||
160897841|NCT04176705|581021465|FG000|Overall Study|Lost to Follow-up|3|||
160804820|NCT01484496|580674574|FG000|Period 1|Adverse Event|25|||
160804821|NCT01484496|580674575|FG001|Period 1|Adverse Event|40|||
160804822|NCT01484496|580674576|FG002|Period 1|Adverse Event|0|||
160804823|NCT01484496|580674577|FG003|Period 1|Adverse Event|0|||
160804824|NCT01484496|580674574|FG000|Period 1|Withdrawal by Subject|15|||
160804825|NCT01484496|580674575|FG001|Period 1|Withdrawal by Subject|12|||
160804826|NCT01484496|580674576|FG002|Period 1|Withdrawal by Subject|0|||
160897842|NCT04176705|581021466|FG001|Overall Study|Lost to Follow-up|3|||
160897843|NCT02628769|581021467|FG000|First Intervention|Adverse Event|1|||
160897844|NCT02628769|581021468|FG001|First Intervention|Adverse Event|0|||
160804827|NCT01484496|580674577|FG003|Period 1|Withdrawal by Subject|0|||
160804828|NCT01484496|580674574|FG000|Period 1|Lost to Follow-up|2|||
160804829|NCT01484496|580674575|FG001|Period 1|Lost to Follow-up|6|||
160804830|NCT01484496|580674576|FG002|Period 1|Lost to Follow-up|0|||
160804831|NCT01484496|580674577|FG003|Period 1|Lost to Follow-up|0|||
160804832|NCT01484496|580674574|FG000|Period 1|Positive Pregnancy|1|||
160804833|NCT01484496|580674575|FG001|Period 1|Positive Pregnancy|6|||
160804834|NCT01484496|580674576|FG002|Period 1|Positive Pregnancy|0|||
160804835|NCT01484496|580674577|FG003|Period 1|Positive Pregnancy|0|||
160804836|NCT01484496|580674574|FG000|Period 1|Treatment Failure|3|||
160804837|NCT01484496|580674575|FG001|Period 1|Treatment Failure|6|||
160804838|NCT01484496|580674576|FG002|Period 1|Treatment Failure|0|||
160804839|NCT01484496|580674577|FG003|Period 1|Treatment Failure|0|||
160804840|NCT01484496|580674574|FG000|Period 1|Lack of Compliance|2|||
160804841|NCT01484496|580674575|FG001|Period 1|Lack of Compliance|1|||
160804842|NCT01484496|580674576|FG002|Period 1|Lack of Compliance|0|||
160804843|NCT01484496|580674577|FG003|Period 1|Lack of Compliance|0|||
160804844|NCT01484496|580674574|FG000|Period 1|Unable to Visit Site|0|||
160804845|NCT01484496|580674575|FG001|Period 1|Unable to Visit Site|2|||
160804846|NCT01484496|580674576|FG002|Period 1|Unable to Visit Site|0|||
160804847|NCT01484496|580674577|FG003|Period 1|Unable to Visit Site|0|||
160804848|NCT01484496|580674574|FG000|Period 2|Lack of Efficacy|0|||
160804849|NCT01484496|580674575|FG001|Period 2|Lack of Efficacy|0|||
160804850|NCT01484496|580674576|FG002|Period 2|Lack of Efficacy|1|||
160804851|NCT01484496|580674577|FG003|Period 2|Lack of Efficacy|3|||
160804852|NCT01484496|580674574|FG000|Period 2|Adverse Event|0|||
160804853|NCT01484496|580674575|FG001|Period 2|Adverse Event|0|||
160804854|NCT01484496|580674576|FG002|Period 2|Adverse Event|5|||
160804855|NCT01484496|580674577|FG003|Period 2|Adverse Event|13|||
160804856|NCT01484496|580674574|FG000|Period 2|Other|0|||
160804857|NCT01484496|580674575|FG001|Period 2|Other|0|||
160804858|NCT01484496|580674576|FG002|Period 2|Other|9|||
160804859|NCT01484496|580674577|FG003|Period 2|Other|6|||
160804860|NCT01645735|580674578|FG000|Overall Study|Physician Decision|2|||
160644528|NCT00408876|580080773|FG002|Overall Study|Protocol Violation|4|||
160644529|NCT00408876|580080774|FG003|Overall Study|Protocol Violation|3|||
160644530|NCT00408876|580080771|FG000|Overall Study|Physician Decision|1|||
160644531|NCT00408876|580080772|FG001|Overall Study|Physician Decision|0|||
160804861|NCT01645735|580674579|FG001|Overall Study|Physician Decision|0|||
160644532|NCT00408876|580080773|FG002|Overall Study|Physician Decision|3|||
160804862|NCT01645735|580674578|FG000|Overall Study|Withdrawal by Subject|1|||
160804863|NCT01645735|580674579|FG001|Overall Study|Withdrawal by Subject|0|||
160804864|NCT01645735|580674578|FG000|Overall Study|Protocol Violation|1|||
160804865|NCT01645735|580674579|FG001|Overall Study|Protocol Violation|0|||
160804866|NCT01645735|580674578|FG000|Overall Study|Adverse Event|0|||
160804867|NCT01645735|580674579|FG001|Overall Study|Adverse Event|1|||
160804868|NCT02010593|580674580|FG000|Overall Study|Lost to Follow-up|1|||
160804869|NCT02010593|580674581|FG001|Overall Study|Lost to Follow-up|0|||
160804870|NCT02010593|580674580|FG000|Overall Study|Physician Decision|1|||
160804871|NCT02010593|580674581|FG001|Overall Study|Physician Decision|0|||
160804872|NCT02010593|580674580|FG000|Overall Study|Unable to adhere to visit schedule|0|||
160804873|NCT02010593|580674581|FG001|Overall Study|Unable to adhere to visit schedule|2|||
160804874|NCT01887717|580674582|FG000|Overall Study|Withdrawal by Subject|1|||
160804875|NCT01887717|580674583|FG001|Overall Study|Withdrawal by Subject|7|||
160804876|NCT01887717|580674582|FG000|Overall Study|Physician Decision|0|||
160804877|NCT01887717|580674583|FG001|Overall Study|Physician Decision|2|||
160804878|NCT01887717|580674582|FG000|Overall Study|Administrative reasons|5|||
160804879|NCT01887717|580674583|FG001|Overall Study|Administrative reasons|2|||
160804880|NCT01299389|580674584|FG000|Double-blind|Adverse Event|45|||
160804881|NCT01299389|580674585|FG001|Double-blind|Adverse Event|27|||
160897845|NCT02628769|581021467|FG000|First Intervention|Withdrawal by Subject|0|||
160897846|NCT02628769|581021468|FG001|First Intervention|Withdrawal by Subject|1|||
160897847|NCT02628769|581021467|FG000|Second Intervention|Adverse Event|2|||
160897848|NCT02628769|581021468|FG001|Second Intervention|Adverse Event|0|||
160897849|NCT02628769|581021467|FG000|Second Intervention|Physician Decision|0|||
160897850|NCT02628769|581021468|FG001|Second Intervention|Physician Decision|1|||
160897851|NCT01467583|581021469|FG000|Overall Study|Death|1|||
160897852|NCT01467583|581021470|FG001|Overall Study|Death|1|||
160897853|NCT01467583|581021471|FG002|Overall Study|Death|0|||
160897854|NCT01467583|581021469|FG000|Overall Study|Withdrawal by Subject|1|||
160897855|NCT01467583|581021470|FG001|Overall Study|Withdrawal by Subject|0|||
160897856|NCT01467583|581021471|FG002|Overall Study|Withdrawal by Subject|0|||
160897857|NCT01467583|581021469|FG000|Overall Study|Protocol Violation|0|||
160897858|NCT01467583|581021470|FG001|Overall Study|Protocol Violation|0|||
160897859|NCT01467583|581021471|FG002|Overall Study|Protocol Violation|2|||
160897860|NCT05274165|581021473|FG000|Overall Study|Withdrawal by Subject|3|||
160897861|NCT05274165|581021474|FG001|Overall Study|Withdrawal by Subject|3|||
160897862|NCT02296684|581021476|FG000|Overall Study|Withdrawal by Subject|0|||
160804882|NCT01299389|580674586|FG002|Double-blind|Adverse Event|0|||
160804883|NCT01299389|580674587|FG003|Double-blind|Adverse Event|0|||
160804884|NCT01299389|580674584|FG000|Double-blind|Lack of Efficacy|45|||
160804885|NCT01299389|580674585|FG001|Double-blind|Lack of Efficacy|21|||
160804886|NCT01299389|580674586|FG002|Double-blind|Lack of Efficacy|0|||
160804887|NCT01299389|580674587|FG003|Double-blind|Lack of Efficacy|0|||
160804888|NCT01299389|580674584|FG000|Double-blind|Lost to Follow-up|2|||
160804889|NCT01299389|580674585|FG001|Double-blind|Lost to Follow-up|1|||
160804890|NCT01299389|580674586|FG002|Double-blind|Lost to Follow-up|0|||
160985278|NCT01347645|581335410|FG001|Overall Study|Physician Decision|0|||
160985279|NCT01347645|581335411|FG002|Overall Study|Physician Decision|0|||
160985280|NCT01347645|581335412|FG003|Overall Study|Physician Decision|0|||
160985281|NCT01347645|581335413|FG004|Overall Study|Physician Decision|1|||
160985282|NCT01347645|581335409|FG000|Overall Study|Adverse Event|0|||
160985283|NCT01347645|581335410|FG001|Overall Study|Adverse Event|0|||
160985284|NCT01347645|581335411|FG002|Overall Study|Adverse Event|0|||
160985285|NCT01347645|581335412|FG003|Overall Study|Adverse Event|1|||
160985286|NCT01347645|581335413|FG004|Overall Study|Adverse Event|1|||
160804891|NCT01299389|580674587|FG003|Double-blind|Lost to Follow-up|0|||
160804892|NCT01299389|580674584|FG000|Double-blind|Withdrawal by Subject|16|||
160804893|NCT01299389|580674585|FG001|Double-blind|Withdrawal by Subject|13|||
160804894|NCT01299389|580674586|FG002|Double-blind|Withdrawal by Subject|0|||
160804895|NCT01299389|580674587|FG003|Double-blind|Withdrawal by Subject|0|||
160804896|NCT01299389|580674584|FG000|Double-blind|Other|1|||
160804897|NCT01299389|580674585|FG001|Double-blind|Other|1|||
160804898|NCT01299389|580674586|FG002|Double-blind|Other|0|||
160804899|NCT01299389|580674587|FG003|Double-blind|Other|0|||
160804900|NCT01299389|580674584|FG000|Double-blind|"fail to meet study population criteria"|0|||
160804901|NCT01299389|580674585|FG001|Double-blind|"fail to meet study population criteria"|1|||
160804902|NCT01299389|580674586|FG002|Double-blind|"fail to meet study population criteria"|0|||
160804903|NCT01299389|580674587|FG003|Double-blind|"fail to meet study population criteria"|0|||
160804904|NCT01299389|580674584|FG000|Post-observational|Other|0|||
160804905|NCT01299389|580674585|FG001|Post-observational|Other|0|||
160804906|NCT01299389|580674586|FG002|Post-observational|Other|12|||
160804907|NCT01299389|580674587|FG003|Post-observational|Other|6|||
160804908|NCT03637491|580674588|FG000|Overall Study|Death|9|||
160804909|NCT03637491|580674589|FG001|Overall Study|Death|9|||
160804910|NCT03637491|580674590|FG002|Overall Study|Death|5|||
160804911|NCT03637491|580674591|FG003|Overall Study|Death|3|||
160804912|NCT03637491|580674588|FG000|Overall Study|Lost to Follow-up|0|||
160804913|NCT03637491|580674589|FG001|Overall Study|Lost to Follow-up|1|||
160804914|NCT03637491|580674590|FG002|Overall Study|Lost to Follow-up|0|||
160804915|NCT03637491|580674591|FG003|Overall Study|Lost to Follow-up|1|||
160804916|NCT03637491|580674588|FG000|Overall Study|Study Terminated By Sponsor|0|||
160804917|NCT03637491|580674589|FG001|Overall Study|Study Terminated By Sponsor|2|||
160804918|NCT03637491|580674590|FG002|Overall Study|Study Terminated By Sponsor|1|||
160804919|NCT03637491|580674591|FG003|Overall Study|Study Terminated By Sponsor|0|||
160804920|NCT03637491|580674588|FG000|Overall Study|Withdrawal by Subject|1|||
160804921|NCT03637491|580674589|FG001|Overall Study|Withdrawal by Subject|0|||
160804922|NCT03637491|580674590|FG002|Overall Study|Withdrawal by Subject|1|||
160804923|NCT03637491|580674591|FG003|Overall Study|Withdrawal by Subject|2|||
160804924|NCT02185534|580674593|FG000|First Period|Withdrawal by Subject|0|||
160804925|NCT02185534|580674594|FG001|First Period|Withdrawal by Subject|0|||
160804926|NCT02185534|580674595|FG002|First Period|Withdrawal by Subject|0|||
160804927|NCT02185534|580674596|FG003|First Period|Withdrawal by Subject|1|||
160804928|NCT02185534|580674597|FG004|First Period|Withdrawal by Subject|0|||
160804929|NCT02185534|580674598|FG005|First Period|Withdrawal by Subject|0|||
160804930|NCT02185534|580674593|FG000|First Washout Period|Withdrawal by Subject|1|||
160804931|NCT02185534|580674594|FG001|First Washout Period|Withdrawal by Subject|0|||
160804932|NCT02185534|580674595|FG002|First Washout Period|Withdrawal by Subject|0|||
160804933|NCT02185534|580674596|FG003|First Washout Period|Withdrawal by Subject|0|||
160804934|NCT02185534|580674597|FG004|First Washout Period|Withdrawal by Subject|1|||
160804935|NCT02185534|580674598|FG005|First Washout Period|Withdrawal by Subject|0|||
160804936|NCT02185534|580674593|FG000|First Washout Period|Protocol Violation|0|||
160804937|NCT02185534|580674594|FG001|First Washout Period|Protocol Violation|0|||
160804938|NCT02185534|580674595|FG002|First Washout Period|Protocol Violation|0|||
160804939|NCT02185534|580674596|FG003|First Washout Period|Protocol Violation|0|||
160804940|NCT02185534|580674597|FG004|First Washout Period|Protocol Violation|0|||
160804941|NCT02185534|580674598|FG005|First Washout Period|Protocol Violation|1|||
160804942|NCT04419467|580674601|FG000|Overall Study|Not treated with IP|0|||
160804943|NCT04419467|580674602|FG001|Overall Study|Not treated with IP|0|||
160804944|NCT04419467|580674603|FG002|Overall Study|Not treated with IP|2|||
160804945|NCT04419467|580674601|FG000|Overall Study|Adverse Event|0|||
160804946|NCT04419467|580674602|FG001|Overall Study|Adverse Event|2|||
160804947|NCT04419467|580674603|FG002|Overall Study|Adverse Event|0|||
160804948|NCT04419467|580674601|FG000|Overall Study|Death|1|||
160985287|NCT00184028|581335414|FG000|Overall Study|Death|1|||
160985288|NCT00184028|581335414|FG000|Overall Study|Lack of Efficacy|4|||
160985289|NCT00184028|581335414|FG000|Overall Study|Adverse Event|2|||
160804949|NCT04419467|580674602|FG001|Overall Study|Death|0|||
160804950|NCT04419467|580674603|FG002|Overall Study|Death|0|||
160804951|NCT04419467|580674601|FG000|Overall Study|Lost to Follow-up|0|||
160804952|NCT04419467|580674602|FG001|Overall Study|Lost to Follow-up|1|||
160804953|NCT04419467|580674603|FG002|Overall Study|Lost to Follow-up|2|||
160804954|NCT04419467|580674601|FG000|Overall Study|Withdrawal by Subject|0|||
160804955|NCT04419467|580674602|FG001|Overall Study|Withdrawal by Subject|0|||
160804956|NCT04419467|580674603|FG002|Overall Study|Withdrawal by Subject|4|||
160804957|NCT04419467|580674601|FG000|Overall Study|Pandemic related|0|||
160804958|NCT04419467|580674602|FG001|Overall Study|Pandemic related|0|||
160804959|NCT04419467|580674603|FG002|Overall Study|Pandemic related|1|||
160804960|NCT04419467|580674601|FG000|Overall Study|Reason not known|1|||
160804961|NCT04419467|580674602|FG001|Overall Study|Reason not known|0|||
160804962|NCT04419467|580674603|FG002|Overall Study|Reason not known|0|||
160804963|NCT04571060|580674609|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
160804964|NCT04571060|580674610|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
160804965|NCT04571060|580674609|FG000|Overall Study|Never treated migraine|47|||
160804966|NCT04571060|580674610|FG001|Overall Study|Never treated migraine|36|||
160804967|NCT04571060|580674609|FG000|Overall Study|Protocol Violation|4|||
160804968|NCT04571060|580674610|FG001|Overall Study|Protocol Violation|2|||
160804969|NCT04571060|580674609|FG000|Overall Study|Withdrawal by Subject|6|||
160804970|NCT04571060|580674610|FG001|Overall Study|Withdrawal by Subject|2|||
160804971|NCT04571060|580674609|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
160804972|NCT04571060|580674610|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
160804973|NCT01253369|580674611|FG000|Overall Study|Adverse Event|4|||
160804974|NCT01253369|580674611|FG000|Overall Study|Withdrawal by Subject|2|||
160804975|NCT01253369|580674611|FG000|Overall Study|Death|1|||
160804976|NCT01253369|580674611|FG000|Overall Study|Progressive disease|23|||
160804977|NCT01253369|580674611|FG000|Overall Study|Not Evaluable|3|||
160804978|NCT03943290|580674614|FG000|Overall Study|Sponsor Terminated Study|6|||
160804979|NCT03943290|580674615|FG001|Overall Study|Sponsor Terminated Study|1|||
160804980|NCT03943290|580674616|FG002|Overall Study|Sponsor Terminated Study|11|||
160804981|NCT03943290|580674617|FG003|Overall Study|Sponsor Terminated Study|6|||
160804982|NCT03943290|580674618|FG004|Overall Study|Sponsor Terminated Study|7|||
160804983|NCT03943290|580674619|FG005|Overall Study|Sponsor Terminated Study|6|||
160804984|NCT03943290|580674620|FG006|Overall Study|Sponsor Terminated Study|6|||
160804985|NCT03943290|580674621|FG007|Overall Study|Sponsor Terminated Study|7|||
160804986|NCT03943290|580674622|FG008|Overall Study|Sponsor Terminated Study|8|||
160804987|NCT03943290|580674614|FG000|Overall Study|Lost to Follow-up|1|||
160804988|NCT03943290|580674615|FG001|Overall Study|Lost to Follow-up|0|||
160804989|NCT03943290|580674616|FG002|Overall Study|Lost to Follow-up|1|||
160804990|NCT03943290|580674617|FG003|Overall Study|Lost to Follow-up|0|||
160804991|NCT03943290|580674618|FG004|Overall Study|Lost to Follow-up|0|||
160804992|NCT03943290|580674619|FG005|Overall Study|Lost to Follow-up|0|||
160804993|NCT03943290|580674620|FG006|Overall Study|Lost to Follow-up|0|||
160804994|NCT03943290|580674621|FG007|Overall Study|Lost to Follow-up|1|||
160804995|NCT03943290|580674622|FG008|Overall Study|Lost to Follow-up|0|||
160804996|NCT03943290|580674614|FG000|Overall Study|Withdrawal by Subject|0|||
160804997|NCT03943290|580674615|FG001|Overall Study|Withdrawal by Subject|0|||
160644533|NCT00408876|580080774|FG003|Overall Study|Physician Decision|0|||
160804998|NCT03943290|580674616|FG002|Overall Study|Withdrawal by Subject|1|||
160804999|NCT03943290|580674617|FG003|Overall Study|Withdrawal by Subject|0|||
160985290|NCT00184028|581335414|FG000|Overall Study|Withdrawal by Subject|1|||
160985291|NCT00184028|581335414|FG000|Overall Study|Non-compliance|2|||
160805000|NCT03943290|580674618|FG004|Overall Study|Withdrawal by Subject|0|||
160805001|NCT03943290|580674619|FG005|Overall Study|Withdrawal by Subject|0|||
160805002|NCT03943290|580674620|FG006|Overall Study|Withdrawal by Subject|0|||
160805003|NCT03943290|580674621|FG007|Overall Study|Withdrawal by Subject|0|||
160805004|NCT03943290|580674622|FG008|Overall Study|Withdrawal by Subject|0|||
160805005|NCT04179305|580674623|FG000|Overall Study|Death|1|||
160805006|NCT04179305|580674624|FG001|Overall Study|Death|1|||
160805007|NCT04179305|580674625|FG002|Overall Study|Death|0|||
160805008|NCT04179305|580674626|FG003|Overall Study|Death|0|||
160550283|NCT03529773|579740182|FG030|Overall Study|Randomized but not vaccinated|0|||
160805009|NCT04179305|580674623|FG000|Overall Study|Lost to Follow-up|1|||
160805010|NCT04179305|580674624|FG001|Overall Study|Lost to Follow-up|1|||
160805011|NCT04179305|580674625|FG002|Overall Study|Lost to Follow-up|0|||
160805012|NCT04179305|580674626|FG003|Overall Study|Lost to Follow-up|0|||
160805013|NCT04179305|580674623|FG000|Overall Study|Withdrawal by Subject|0|||
160805014|NCT04179305|580674624|FG001|Overall Study|Withdrawal by Subject|1|||
160805015|NCT04179305|580674625|FG002|Overall Study|Withdrawal by Subject|0|||
160805016|NCT04179305|580674626|FG003|Overall Study|Withdrawal by Subject|0|||
160805017|NCT04179305|580674623|FG000|Overall Study|Did not have scan|1|||
160805018|NCT04179305|580674624|FG001|Overall Study|Did not have scan|0|||
160805019|NCT04179305|580674625|FG002|Overall Study|Did not have scan|0|||
160805020|NCT04179305|580674626|FG003|Overall Study|Did not have scan|0|||
160805021|NCT04179305|580674623|FG000|Overall Study|In hospice care|3|||
160805022|NCT04179305|580674624|FG001|Overall Study|In hospice care|0|||
160805023|NCT04179305|580674625|FG002|Overall Study|In hospice care|0|||
160805024|NCT04179305|580674626|FG003|Overall Study|In hospice care|0|||
160805025|NCT01737762|580674629|FG000|Overall Study|Adverse Event|2|||
160805026|NCT01737762|580674630|FG001|Overall Study|Adverse Event|2|||
160805027|NCT01737762|580674629|FG000|Overall Study|Lost to Follow-up|1|||
160805028|NCT01737762|580674630|FG001|Overall Study|Lost to Follow-up|0|||
160805029|NCT01737762|580674629|FG000|Overall Study|Withdrawal by Subject|2|||
160805030|NCT01737762|580674630|FG001|Overall Study|Withdrawal by Subject|2|||
160805031|NCT01737762|580674629|FG000|Overall Study|Progressive disease|1|||
160805032|NCT01737762|580674630|FG001|Overall Study|Progressive disease|2|||
160805033|NCT01737762|580674629|FG000|Overall Study|Physician Decision|1|||
160805034|NCT01737762|580674630|FG001|Overall Study|Physician Decision|1|||
160805035|NCT01737762|580674629|FG000|Overall Study|Moved from area|2|||
160805036|NCT01737762|580674630|FG001|Overall Study|Moved from area|1|||
160805037|NCT01737762|580674629|FG000|Overall Study|Trial termination|11|||
160805038|NCT01737762|580674630|FG001|Overall Study|Trial termination|9|||
160805039|NCT00326599|580674631|FG000|Overall Study|Withdrawal by Subject|1|||
160805040|NCT00326599|580674632|FG001|Overall Study|Withdrawal by Subject|0|||
160805041|NCT00326599|580674633|FG002|Overall Study|Withdrawal by Subject|5|||
160805042|NCT00326599|580674634|FG003|Overall Study|Withdrawal by Subject|2|||
160805043|NCT00326599|580674631|FG000|Overall Study|Adverse Event|1|||
160805044|NCT00326599|580674632|FG001|Overall Study|Adverse Event|0|||
160805045|NCT00326599|580674633|FG002|Overall Study|Adverse Event|32|||
160805046|NCT00326599|580674634|FG003|Overall Study|Adverse Event|3|||
160805047|NCT00326599|580674631|FG000|Overall Study|Disease Progression|3|||
160805048|NCT00326599|580674632|FG001|Overall Study|Disease Progression|1|||
160805049|NCT00326599|580674633|FG002|Overall Study|Disease Progression|13|||
160805050|NCT00326599|580674634|FG003|Overall Study|Disease Progression|11|||
160805051|NCT00326599|580674631|FG000|Overall Study|Alternate Treatment|1|||
160805052|NCT00326599|580674632|FG001|Overall Study|Alternate Treatment|0|||
160805053|NCT00326599|580674633|FG002|Overall Study|Alternate Treatment|0|||
160805054|NCT00326599|580674634|FG003|Overall Study|Alternate Treatment|0|||
160805055|NCT00326599|580674631|FG000|Overall Study|Death|0|||
160805056|NCT00326599|580674632|FG001|Overall Study|Death|0|||
160805057|NCT00326599|580674633|FG002|Overall Study|Death|1|||
160805058|NCT00326599|580674634|FG003|Overall Study|Death|2|||
160805059|NCT00326599|580674631|FG000|Overall Study|Other Unspecified Reason|0|||
160805060|NCT00326599|580674632|FG001|Overall Study|Other Unspecified Reason|0|||
160805061|NCT00326599|580674633|FG002|Overall Study|Other Unspecified Reason|2|||
160805062|NCT00326599|580674634|FG003|Overall Study|Other Unspecified Reason|1|||
160805063|NCT00625586|580674635|FG000|Overall Study|Adverse Event|1|||
160805064|NCT00625586|580674635|FG000|Overall Study|Progressive disease|1|||
160805065|NCT00437268|580674639|FG000|Overall Study|Adverse Event|1|||
160805066|NCT00437268|580674640|FG001|Overall Study|Adverse Event|1|||
160805067|NCT00437268|580674639|FG000|Overall Study|Withdrawal by Subject|2|||
160805068|NCT00437268|580674640|FG001|Overall Study|Withdrawal by Subject|2|||
160805069|NCT00437268|580674639|FG000|Overall Study|Progressive disease|9|||
160805070|NCT00437268|580674640|FG001|Overall Study|Progressive disease|9|||
160805071|NCT00437268|580674639|FG000|Overall Study|Physician Decision|1|||
160805072|NCT00437268|580674640|FG001|Overall Study|Physician Decision|0|||
160805073|NCT00437268|580674639|FG000|Overall Study|Death|0|||
160805074|NCT00437268|580674640|FG001|Overall Study|Death|1|||
160805075|NCT01085214|580674643|FG000|Overall Study|Alternate treatment required|1|||
160805076|NCT01985022|580674658|FG000|Overall Study|Lost to Follow-up|0|||
160805077|NCT01985022|580674659|FG001|Overall Study|Lost to Follow-up|1|||
160805078|NCT01985022|580674658|FG000|Overall Study|Protocol Violation|0|||
160805079|NCT01985022|580674659|FG001|Overall Study|Protocol Violation|1|||
160805080|NCT01985022|580674658|FG000|Overall Study|Withdrawal by Subject|4|||
160805081|NCT01985022|580674659|FG001|Overall Study|Withdrawal by Subject|1|||
160805082|NCT01152437|580674660|FG000|Overall Study|Other Adverse Event|8|||
160805083|NCT01152437|580674661|FG001|Overall Study|Other Adverse Event|1|||
160805084|NCT01152437|580674662|FG002|Overall Study|Other Adverse Event|7|||
160805085|NCT01152437|580674660|FG000|Overall Study|Not treated|0|||
160805086|NCT01152437|580674661|FG001|Overall Study|Not treated|1|||
160805087|NCT01152437|580674662|FG002|Overall Study|Not treated|2|||
160805088|NCT01152437|580674660|FG000|Overall Study|Progressive disease|27|||
160805089|NCT01152437|580674661|FG001|Overall Study|Progressive disease|13|||
160805090|NCT01152437|580674662|FG002|Overall Study|Progressive disease|32|||
160805091|NCT01152437|580674660|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
160805092|NCT01152437|580674661|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
160805093|NCT01152437|580674662|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
160805094|NCT02015039|580674663|FG000|Overall Study|Not eligible|0|||
160805095|NCT02015039|580674664|FG001|Overall Study|Not eligible|1|||
160805096|NCT03132467|580674665|FG000|Overall Study|Adverse Event|2|||
160805097|NCT03132467|580674665|FG000|Overall Study|Withdrawal by Subject|2|||
160805098|NCT01088906|580674666|FG000|Overall Study|Inclusion error|1|||
160805099|NCT01088906|580674666|FG000|Overall Study|Did not receive study treatment|3|||
160805100|NCT01088906|580674666|FG000|Overall Study|Missing data|1|||
160805101|NCT00457626|580674669|FG000|Overall Study|Adverse Event|3|||
160805102|NCT00457626|580674669|FG000|Overall Study|Administrative Problems|2|||
160897863|NCT02296684|581021477|FG001|Overall Study|Withdrawal by Subject|1|||
160897864|NCT02296684|581021478|FG002|Overall Study|Withdrawal by Subject|1|||
160897865|NCT02296684|581021476|FG000|Overall Study|Death|2|||
160897866|NCT02296684|581021477|FG001|Overall Study|Death|0|||
160897867|NCT02296684|581021478|FG002|Overall Study|Death|0|||
160897868|NCT03805646|581021479|FG000|Overall Study|Death|40|||
160897869|NCT03805646|581021480|FG001|Overall Study|Death|49|||
160897870|NCT03805646|581021479|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
160897871|NCT03805646|581021480|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
160897872|NCT04452344|581021481|FG000|Overall Study|Withdrawal by Subject|3|||
160897873|NCT04452344|581021482|FG001|Overall Study|Withdrawal by Subject|6|||
160897874|NCT04452344|581021481|FG000|Overall Study|Adverse Event|1|||
160897875|NCT04452344|581021482|FG001|Overall Study|Adverse Event|2|||
160897876|NCT04452344|581021481|FG000|Overall Study|Lost to Follow-up|2|||
160897877|NCT04452344|581021482|FG001|Overall Study|Lost to Follow-up|2|||
160897878|NCT04452344|581021481|FG000|Overall Study|No Post-Op Visit|6|||
160897879|NCT04452344|581021482|FG001|Overall Study|No Post-Op Visit|7|||
160897880|NCT05171777|581021483|FG000|Treatment Crossover Period|Adverse Event|9|||
160897881|NCT05171777|581021484|FG001|Treatment Crossover Period|Adverse Event|6|||
160897882|NCT05171777|581021485|FG002|Treatment Crossover Period|Adverse Event|0|||
160897883|NCT05171777|581021486|FG003|Treatment Crossover Period|Adverse Event|0|||
160897884|NCT05171777|581021483|FG000|Treatment Crossover Period|Death|5|||
160897885|NCT05171777|581021484|FG001|Treatment Crossover Period|Death|5|||
160897886|NCT05171777|581021485|FG002|Treatment Crossover Period|Death|0|||
160897887|NCT05171777|581021486|FG003|Treatment Crossover Period|Death|0|||
160897888|NCT05171777|581021483|FG000|Treatment Crossover Period|Disease Relapse|1|||
160897889|NCT05171777|581021484|FG001|Treatment Crossover Period|Disease Relapse|0|||
160897890|NCT05171777|581021485|FG002|Treatment Crossover Period|Disease Relapse|0|||
160897891|NCT05171777|581021486|FG003|Treatment Crossover Period|Disease Relapse|0|||
160897892|NCT05171777|581021483|FG000|Treatment Crossover Period|Reason not Specified|1|||
160897893|NCT05171777|581021484|FG001|Treatment Crossover Period|Reason not Specified|1|||
160897894|NCT05171777|581021485|FG002|Treatment Crossover Period|Reason not Specified|0|||
160897895|NCT05171777|581021486|FG003|Treatment Crossover Period|Reason not Specified|0|||
160897896|NCT05171777|581021483|FG000|Treatment Crossover Period|Physician Decision|0|||
160897897|NCT05171777|581021484|FG001|Treatment Crossover Period|Physician Decision|1|||
160897898|NCT05171777|581021485|FG002|Treatment Crossover Period|Physician Decision|0|||
160897899|NCT05171777|581021486|FG003|Treatment Crossover Period|Physician Decision|0|||
160897900|NCT05171777|581021483|FG000|Treatment Crossover Period|Progressive Disease|14|||
160897901|NCT05171777|581021484|FG001|Treatment Crossover Period|Progressive Disease|10|||
160897902|NCT05171777|581021485|FG002|Treatment Crossover Period|Progressive Disease|0|||
160897903|NCT05171777|581021486|FG003|Treatment Crossover Period|Progressive Disease|0|||
160897904|NCT05171777|581021483|FG000|Treatment Crossover Period|Protocol Violation|0|||
160897905|NCT05171777|581021484|FG001|Treatment Crossover Period|Protocol Violation|2|||
160897906|NCT05171777|581021485|FG002|Treatment Crossover Period|Protocol Violation|0|||
160897907|NCT05171777|581021486|FG003|Treatment Crossover Period|Protocol Violation|0|||
160897908|NCT05171777|581021483|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
160897909|NCT05171777|581021484|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
160897910|NCT05171777|581021485|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
160805103|NCT00457626|580674669|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
160805104|NCT01365455|580674670|FG000|Induction Period|Adverse Event|5|||
160897911|NCT05171777|581021486|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
160897912|NCT05171777|581021483|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
160897913|NCT05171777|581021484|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
160897914|NCT05171777|581021485|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
160805105|NCT01365455|580674671|FG001|Induction Period|Adverse Event|3|||
160805106|NCT01365455|580674672|FG002|Induction Period|Adverse Event|4|||
160805107|NCT01365455|580674673|FG003|Induction Period|Adverse Event|0|||
160805108|NCT01365455|580674674|FG004|Induction Period|Adverse Event|0|||
160805109|NCT01365455|580674670|FG000|Induction Period|Lack of Efficacy|1|||
160805110|NCT01365455|580674671|FG001|Induction Period|Lack of Efficacy|1|||
160805111|NCT01365455|580674672|FG002|Induction Period|Lack of Efficacy|0|||
160805112|NCT01365455|580674673|FG003|Induction Period|Lack of Efficacy|0|||
160805113|NCT01365455|580674674|FG004|Induction Period|Lack of Efficacy|0|||
160805114|NCT01365455|580674670|FG000|Induction Period|Pregnancy|0|||
160805115|NCT01365455|580674671|FG001|Induction Period|Pregnancy|1|||
160805116|NCT01365455|580674672|FG002|Induction Period|Pregnancy|0|||
160805117|NCT01365455|580674673|FG003|Induction Period|Pregnancy|0|||
160805118|NCT01365455|580674674|FG004|Induction Period|Pregnancy|0|||
160805119|NCT01365455|580674670|FG000|Induction Period|Protocol deviation|0|||
160805120|NCT01365455|580674671|FG001|Induction Period|Protocol deviation|1|||
160805121|NCT01365455|580674672|FG002|Induction Period|Protocol deviation|1|||
160805122|NCT01365455|580674673|FG003|Induction Period|Protocol deviation|0|||
160805123|NCT01365455|580674674|FG004|Induction Period|Protocol deviation|0|||
160805124|NCT01365455|580674670|FG000|Induction Period|Subject/guardian decision|9|||
160805125|NCT01365455|580674671|FG001|Induction Period|Subject/guardian decision|1|||
160985292|NCT00388362|581335415|FG000|Enrolled|Ineligible|1|||
160985293|NCT00388362|581335415|FG000|Enrolled|Adverse Event|9|||
160985294|NCT00388362|581335415|FG000|Enrolled|Death|1|||
160805126|NCT01365455|580674672|FG002|Induction Period|Subject/guardian decision|8|||
160805127|NCT01365455|580674673|FG003|Induction Period|Subject/guardian decision|0|||
160897915|NCT05171777|581021486|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
160897916|NCT05171777|581021483|FG000|Treatment Continuation Period|Adverse Event|0|||
160897917|NCT05171777|581021484|FG001|Treatment Continuation Period|Adverse Event|0|||
160897918|NCT05171777|581021485|FG002|Treatment Continuation Period|Adverse Event|3|||
160897919|NCT05171777|581021486|FG003|Treatment Continuation Period|Adverse Event|6|||
160897920|NCT05171777|581021483|FG000|Treatment Continuation Period|Death|0|||
160897921|NCT05171777|581021484|FG001|Treatment Continuation Period|Death|0|||
160897922|NCT05171777|581021485|FG002|Treatment Continuation Period|Death|1|||
160897923|NCT05171777|581021486|FG003|Treatment Continuation Period|Death|3|||
160897924|NCT05171777|581021483|FG000|Treatment Continuation Period|Disease Relapse|0|||
160897925|NCT05171777|581021484|FG001|Treatment Continuation Period|Disease Relapse|0|||
160897926|NCT05171777|581021485|FG002|Treatment Continuation Period|Disease Relapse|1|||
160897927|NCT05171777|581021486|FG003|Treatment Continuation Period|Disease Relapse|0|||
160897928|NCT05171777|581021483|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
160897929|NCT05171777|581021484|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
160897930|NCT05171777|581021485|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
160897931|NCT05171777|581021486|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
160897932|NCT05171777|581021483|FG000|Treatment Continuation Period|Physician Decision|0|||
160897933|NCT05171777|581021484|FG001|Treatment Continuation Period|Physician Decision|0|||
160897934|NCT05171777|581021485|FG002|Treatment Continuation Period|Physician Decision|0|||
160897935|NCT05171777|581021486|FG003|Treatment Continuation Period|Physician Decision|4|||
160897936|NCT05171777|581021483|FG000|Treatment Continuation Period|Progressive Disease|0|||
160897937|NCT05171777|581021484|FG001|Treatment Continuation Period|Progressive Disease|0|||
160897938|NCT05171777|581021485|FG002|Treatment Continuation Period|Progressive Disease|6|||
160897939|NCT05171777|581021486|FG003|Treatment Continuation Period|Progressive Disease|20|||
160897940|NCT05171777|581021483|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
160897941|NCT05171777|581021484|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
160897942|NCT05171777|581021485|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
160897943|NCT05171777|581021486|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
160897944|NCT05171777|581021483|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
160897945|NCT05171777|581021484|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
160897946|NCT05171777|581021485|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
160897947|NCT05171777|581021486|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
160897948|NCT05171777|581021483|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
160897949|NCT05171777|581021484|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
160897950|NCT05171777|581021485|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
160897951|NCT05171777|581021486|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
160897952|NCT02364713|581021487|FG000|Overall Study|Ineligible|2|||
160805128|NCT01365455|580674674|FG004|Induction Period|Subject/guardian decision|0|||
160805129|NCT01365455|580674670|FG000|Induction Period|Lost to Follow-up|0|||
160805130|NCT01365455|580674671|FG001|Induction Period|Lost to Follow-up|0|||
160897953|NCT02364713|581021488|FG001|Overall Study|Ineligible|2|||
160897954|NCT04686786|581021489|FG000|Overall Study|Adverse Event|9|||
160897955|NCT04686786|581021489|FG000|Overall Study|Death|1|||
160897956|NCT04686786|581021489|FG000|Overall Study|Lack of Efficacy|25|||
160805131|NCT01365455|580674672|FG002|Induction Period|Lost to Follow-up|3|||
160985295|NCT00388362|581335415|FG000|Enrolled|Loss insurance|1|||
160985296|NCT00388362|581335415|FG000|Enrolled|Withdrawal by Subject|1|||
160805132|NCT01365455|580674673|FG003|Induction Period|Lost to Follow-up|0|||
160985297|NCT00388362|581335415|FG000|Remained on Study Median of 514 Days|Death|2|||
160805133|NCT01365455|580674674|FG004|Induction Period|Lost to Follow-up|0|||
160805134|NCT01365455|580674670|FG000|Maintenance Period|Adverse Event|12|||
160805135|NCT01365455|580674671|FG001|Maintenance Period|Adverse Event|5|||
160805136|NCT01365455|580674672|FG002|Maintenance Period|Adverse Event|1|||
160805137|NCT01365455|580674673|FG003|Maintenance Period|Adverse Event|2|||
160805138|NCT01365455|580674674|FG004|Maintenance Period|Adverse Event|4|||
160805139|NCT01365455|580674670|FG000|Maintenance Period|Lack of Efficacy|10|||
160805140|NCT01365455|580674671|FG001|Maintenance Period|Lack of Efficacy|2|||
160805141|NCT01365455|580674672|FG002|Maintenance Period|Lack of Efficacy|0|||
160805142|NCT01365455|580674673|FG003|Maintenance Period|Lack of Efficacy|2|||
160805143|NCT01365455|580674674|FG004|Maintenance Period|Lack of Efficacy|2|||
160805144|NCT01365455|580674670|FG000|Maintenance Period|Lost to Follow-up|2|||
160805145|NCT01365455|580674671|FG001|Maintenance Period|Lost to Follow-up|4|||
160805146|NCT01365455|580674672|FG002|Maintenance Period|Lost to Follow-up|0|||
160805147|NCT01365455|580674673|FG003|Maintenance Period|Lost to Follow-up|0|||
160805148|NCT01365455|580674674|FG004|Maintenance Period|Lost to Follow-up|3|||
160805149|NCT01365455|580674670|FG000|Maintenance Period|Non-compliance with study treatment|0|||
160805150|NCT01365455|580674671|FG001|Maintenance Period|Non-compliance with study treatment|0|||
160805151|NCT01365455|580674672|FG002|Maintenance Period|Non-compliance with study treatment|0|||
160805152|NCT01365455|580674673|FG003|Maintenance Period|Non-compliance with study treatment|1|||
160805153|NCT01365455|580674674|FG004|Maintenance Period|Non-compliance with study treatment|0|||
160897957|NCT04686786|581021489|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
160897958|NCT04686786|581021489|FG000|Overall Study|Study Terminated by Sponsor|14|||
160897959|NCT04686786|581021489|FG000|Overall Study|Withdrawal by Subject|15|||
160897960|NCT04686786|581021489|FG000|Overall Study|Other than specified|1|||
160897961|NCT03924869|581021490|FG000|Overall Study|Death|73|||
160897962|NCT03924869|581021491|FG001|Overall Study|Death|62|||
160897963|NCT03924869|581021490|FG000|Overall Study|Lost to Follow-up|3|||
160897964|NCT03924869|581021491|FG001|Overall Study|Lost to Follow-up|0|||
160897965|NCT03924869|581021490|FG000|Overall Study|Physician Decision|0|||
160897966|NCT03924869|581021491|FG001|Overall Study|Physician Decision|3|||
160897967|NCT03924869|581021490|FG000|Overall Study|Withdrawal by Subject|7|||
160897968|NCT03924869|581021491|FG001|Overall Study|Withdrawal by Subject|3|||
160897969|NCT03924869|581021490|FG000|Overall Study|Study Terminated By Sponsor|144|||
160897970|NCT03924869|581021491|FG001|Overall Study|Study Terminated By Sponsor|153|||
160897971|NCT03001882|581021494|FG000|Overall Study|Death|1|||
160897972|NCT03001882|581021495|FG001|Overall Study|Death|0|||
160897973|NCT03001882|581021496|FG002|Overall Study|Death|0|||
160897974|NCT03001882|581021497|FG003|Overall Study|Death|3|||
160897975|NCT03001882|581021494|FG000|Overall Study|Participant withdrew consent|0|||
160897976|NCT03001882|581021495|FG001|Overall Study|Participant withdrew consent|1|||
160897977|NCT03001882|581021496|FG002|Overall Study|Participant withdrew consent|0|||
160897978|NCT03001882|581021497|FG003|Overall Study|Participant withdrew consent|5|||
160897979|NCT03001882|581021494|FG000|Overall Study|Other reasons|1|||
160897980|NCT03001882|581021495|FG001|Overall Study|Other reasons|2|||
160897981|NCT03001882|581021496|FG002|Overall Study|Other reasons|0|||
160897982|NCT03001882|581021497|FG003|Overall Study|Other reasons|5|||
160897983|NCT03001882|581021494|FG000|Overall Study|Administrative reason by sponsor|0|||
160897984|NCT03001882|581021495|FG001|Overall Study|Administrative reason by sponsor|0|||
160897985|NCT03001882|581021496|FG002|Overall Study|Administrative reason by sponsor|0|||
160897986|NCT03001882|581021497|FG003|Overall Study|Administrative reason by sponsor|1|||
160897987|NCT03001882|581021494|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
160897988|NCT03001882|581021495|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
160805154|NCT01365455|580674670|FG000|Maintenance Period|Physician Decision|0|||
160805155|NCT01365455|580674671|FG001|Maintenance Period|Physician Decision|1|||
160805156|NCT01365455|580674672|FG002|Maintenance Period|Physician Decision|0|||
160805157|NCT01365455|580674673|FG003|Maintenance Period|Physician Decision|0|||
160805158|NCT01365455|580674674|FG004|Maintenance Period|Physician Decision|1|||
160897989|NCT03001882|581021496|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
160897990|NCT03001882|581021497|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
160897991|NCT03001882|581021494|FG000|Overall Study|Not reported|0|||
160897992|NCT03001882|581021495|FG001|Overall Study|Not reported|0|||
160897993|NCT03001882|581021496|FG002|Overall Study|Not reported|0|||
160897994|NCT03001882|581021497|FG003|Overall Study|Not reported|6|||
160805159|NCT01365455|580674670|FG000|Maintenance Period|Pregnancy|0|||
160805160|NCT01365455|580674671|FG001|Maintenance Period|Pregnancy|4|||
160805161|NCT01365455|580674672|FG002|Maintenance Period|Pregnancy|0|||
160805162|NCT01365455|580674673|FG003|Maintenance Period|Pregnancy|0|||
160805163|NCT01365455|580674674|FG004|Maintenance Period|Pregnancy|2|||
160805164|NCT01365455|580674670|FG000|Maintenance Period|Protocol deviation|1|||
160897995|NCT03001882|581021494|FG000|Overall Study|Maximum clinical benefit|2|||
160897996|NCT03001882|581021495|FG001|Overall Study|Maximum clinical benefit|3|||
160897997|NCT03001882|581021496|FG002|Overall Study|Maximum clinical benefit|0|||
160897998|NCT03001882|581021497|FG003|Overall Study|Maximum clinical benefit|10|||
160897999|NCT03001882|581021494|FG000|Overall Study|AE unrelated to study drug|3|||
160805165|NCT01365455|580674671|FG001|Maintenance Period|Protocol deviation|1|||
160805166|NCT01365455|580674672|FG002|Maintenance Period|Protocol deviation|0|||
160805167|NCT01365455|580674673|FG003|Maintenance Period|Protocol deviation|0|||
160805168|NCT01365455|580674674|FG004|Maintenance Period|Protocol deviation|0|||
160805169|NCT01365455|580674670|FG000|Maintenance Period|Subject/guardian decision|4|||
160805170|NCT01365455|580674671|FG001|Maintenance Period|Subject/guardian decision|6|||
160805171|NCT01365455|580674672|FG002|Maintenance Period|Subject/guardian decision|2|||
160805172|NCT01365455|580674673|FG003|Maintenance Period|Subject/guardian decision|4|||
160805173|NCT01365455|580674674|FG004|Maintenance Period|Subject/guardian decision|1|||
160805174|NCT03965403|580674675|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
160805175|NCT00532129|580676513|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
160805176|NCT00532129|580676513|FG000|Treatment Period|Physician Decision|15|||
160805177|NCT00532129|580676513|FG000|Treatment Period|Disease progression|3|||
160805178|NCT00532129|580676513|FG000|Treatment Period|Protocol Violation|1|||
160805179|NCT00532129|580676513|FG000|Treatment Period|Other|5|||
160805180|NCT00532129|580676513|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
160805181|NCT00532129|580676513|FG000|Follow-up Period|Disease progression|57|||
160805182|NCT00532129|580676513|FG000|Follow-up Period|Lost to Follow-up|1|||
160805183|NCT00532129|580676513|FG000|Follow-up Period|Other|6|||
160805184|NCT03052608|580676514|FG000|Treatment Phase|Adverse Event|10|||
160805185|NCT03052608|580676515|FG001|Treatment Phase|Adverse Event|12|||
160985298|NCT01141660|581335416|FG000|Overall Study|Physician Decision|0|||
160805186|NCT03052608|580676514|FG000|Treatment Phase|Death|6|||
160805187|NCT03052608|580676515|FG001|Treatment Phase|Death|4|||
160805188|NCT03052608|580676514|FG000|Treatment Phase|Withdrawal by Subject|4|||
160805189|NCT03052608|580676515|FG001|Treatment Phase|Withdrawal by Subject|12|||
160805190|NCT03052608|580676514|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
160805191|NCT03052608|580676515|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
160805192|NCT03052608|580676514|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
160805193|NCT03052608|580676515|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
160805194|NCT03052608|580676514|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
160805195|NCT03052608|580676515|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
160805196|NCT03052608|580676514|FG000|Treatment Phase|Ongoing|103|||
160805197|NCT03052608|580676515|FG001|Treatment Phase|Ongoing|31|||
160805198|NCT03052608|580676514|FG000|Long-Term Follow-up Phase|Death|23|||
160805199|NCT03052608|580676515|FG001|Long-Term Follow-up Phase|Death|28|||
160805200|NCT03052608|580676514|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
160805201|NCT03052608|580676515|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
160805202|NCT03052608|580676514|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
160805203|NCT03052608|580676515|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
160805204|NCT03052608|580676514|FG000|Long-Term Follow-up Phase|Ongoing|122|||
160805205|NCT03052608|580676515|FG001|Long-Term Follow-up Phase|Ongoing|99|||
160805206|NCT00551031|580676516|FG000|Overall Study|Adverse Event|0|||
160805207|NCT00551031|580676517|FG001|Overall Study|Adverse Event|1|||
160805208|NCT00551031|580676518|FG002|Overall Study|Adverse Event|0|||
160805209|NCT00551031|580676519|FG003|Overall Study|Adverse Event|0|||
160805210|NCT00551031|580676520|FG004|Overall Study|Adverse Event|0|||
160805211|NCT00551031|580676516|FG000|Overall Study|Protocol Violation|1|||
160805212|NCT00551031|580676517|FG001|Overall Study|Protocol Violation|1|||
160805213|NCT00551031|580676518|FG002|Overall Study|Protocol Violation|0|||
160805214|NCT00551031|580676519|FG003|Overall Study|Protocol Violation|0|||
160805215|NCT00551031|580676520|FG004|Overall Study|Protocol Violation|0|||
160805216|NCT00551031|580676516|FG000|Overall Study|Lost to Follow-up|0|||
160805217|NCT00551031|580676517|FG001|Overall Study|Lost to Follow-up|1|||
160805218|NCT00551031|580676518|FG002|Overall Study|Lost to Follow-up|0|||
160805219|NCT00551031|580676519|FG003|Overall Study|Lost to Follow-up|1|||
160805220|NCT00551031|580676520|FG004|Overall Study|Lost to Follow-up|1|||
160805221|NCT00551031|580676516|FG000|Overall Study|Withdrawal by Subject|0|||
160805222|NCT00551031|580676517|FG001|Overall Study|Withdrawal by Subject|4|||
160805223|NCT00551031|580676518|FG002|Overall Study|Withdrawal by Subject|1|||
160805224|NCT00551031|580676519|FG003|Overall Study|Withdrawal by Subject|2|||
160805225|NCT00551031|580676520|FG004|Overall Study|Withdrawal by Subject|0|||
160805226|NCT00551031|580676516|FG000|Overall Study|Serious Adverse Event|0|||
160805227|NCT00551031|580676517|FG001|Overall Study|Serious Adverse Event|2|||
160805228|NCT00551031|580676518|FG002|Overall Study|Serious Adverse Event|1|||
160805229|NCT00551031|580676519|FG003|Overall Study|Serious Adverse Event|0|||
160805230|NCT00551031|580676520|FG004|Overall Study|Serious Adverse Event|0|||
160805231|NCT00551031|580676516|FG000|Overall Study|Did not receive vaccine|1|||
160805232|NCT00551031|580676517|FG001|Overall Study|Did not receive vaccine|2|||
160805233|NCT00551031|580676518|FG002|Overall Study|Did not receive vaccine|0|||
160805234|NCT00551031|580676519|FG003|Overall Study|Did not receive vaccine|0|||
160805235|NCT00551031|580676520|FG004|Overall Study|Did not receive vaccine|0|||
160805236|NCT04072835|580676522|FG000|Overall Study|Overall trial ended|603|||
160805237|NCT04072835|580676522|FG000|Overall Study|Ablation|97|||
160805238|NCT04072835|580676522|FG000|Overall Study|Withdrawal of consent|66|||
160805239|NCT04072835|580676522|FG000|Overall Study|Physician Decision|50|||
160805240|NCT04072835|580676522|FG000|Overall Study|Lost to Follow-up|39|||
160805241|NCT04072835|580676522|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
160805242|NCT04072835|580676522|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
160805243|NCT04072835|580676522|FG000|Overall Study|Adverse Event|25|||
160805244|NCT04072835|580676522|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
160805245|NCT04072835|580676522|FG000|Overall Study|Death|11|||
160805246|NCT04072835|580676522|FG000|Overall Study|Participant felt the drug did not work|8|||
160805247|NCT04072835|580676522|FG000|Overall Study|Participant tolerability|5|||
160805248|NCT04072835|580676522|FG000|Overall Study|Missing|5|||
160805249|NCT04072835|580676522|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
160805250|NCT04072835|580676522|FG000|Overall Study|Pregnancy|3|||
160805251|NCT01336712|580676523|FG000|Overall Study|Death|2|||
160805252|NCT01336712|580676523|FG000|Overall Study|Lack of Efficacy|1|||
160805253|NCT00841776|580676524|FG000|Overall Study|Lack of Efficacy|0|||
160805254|NCT00841776|580676525|FG001|Overall Study|Lack of Efficacy|1|||
160805255|NCT00841776|580676524|FG000|Overall Study|Lost to Follow-up|2|||
160805256|NCT00841776|580676525|FG001|Overall Study|Lost to Follow-up|1|||
160805257|NCT00841776|580676524|FG000|Overall Study|Withdrawal by Subject|0|||
160805258|NCT00841776|580676525|FG001|Overall Study|Withdrawal by Subject|1|||
160805259|NCT03073525|580676528|FG000|Overall Study|Withdrawal by Subject|0|||
160805260|NCT03073525|580676529|FG001|Overall Study|Withdrawal by Subject|0|||
160805261|NCT03073525|580676530|FG002|Overall Study|Withdrawal by Subject|3|||
160805262|NCT01976299|580676531|FG000|Overall Study|Withdrawal by Subject|3|||
160805263|NCT01976299|580676532|FG001|Overall Study|Withdrawal by Subject|1|||
160805264|NCT01976299|580676531|FG000|Overall Study|Death|4|||
160805265|NCT01976299|580676532|FG001|Overall Study|Death|2|||
160805266|NCT01976299|580676531|FG000|Overall Study|Lost to Follow-up|7|||
160805267|NCT01976299|580676532|FG001|Overall Study|Lost to Follow-up|1|||
160805268|NCT01976299|580676531|FG000|Overall Study|See clarification above in comments|9|||
160805269|NCT01976299|580676532|FG001|Overall Study|See clarification above in comments|2|||
160805270|NCT00856323|580676534|FG000|Overall Study|Withdrawal by Subject|2|||
160805271|NCT01639469|580676535|FG000|Overall Study|Death|4|||
160805272|NCT01639469|580676536|FG001|Overall Study|Death|2|||
160805273|NCT01639469|580676535|FG000|Overall Study|Lost to Follow-up|1|||
160805274|NCT01639469|580676536|FG001|Overall Study|Lost to Follow-up|1|||
160805275|NCT01119443|580676537|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
160805276|NCT01119443|580676538|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
160805277|NCT02329743|580676541|FG000|Overall Study|Adverse Event|1|||
160805278|NCT02329743|580676542|FG001|Overall Study|Adverse Event|1|||
160805279|NCT02329743|580676543|FG002|Overall Study|Adverse Event|3|||
160805280|NCT02329743|580676541|FG000|Overall Study|Lost to Follow-up|1|||
160805281|NCT02329743|580676542|FG001|Overall Study|Lost to Follow-up|0|||
160805282|NCT02329743|580676543|FG002|Overall Study|Lost to Follow-up|1|||
160805283|NCT02329743|580676541|FG000|Overall Study|Withdrawal by Subject|4|||
160805284|NCT02329743|580676542|FG001|Overall Study|Withdrawal by Subject|4|||
160805285|NCT02329743|580676543|FG002|Overall Study|Withdrawal by Subject|1|||
160805286|NCT02329743|580676541|FG000|Overall Study|Other|0|||
160805287|NCT02329743|580676542|FG001|Overall Study|Other|2|||
160805288|NCT02329743|580676543|FG002|Overall Study|Other|3|||
160805289|NCT00355368|580676544|FG000|Overall Study|Protocol Violation|8|||
160805290|NCT00355368|580676545|FG001|Overall Study|Protocol Violation|7|||
160805291|NCT00355368|580676544|FG000|Overall Study|cardiac arrest prior to intubation|2|||
160805292|NCT00355368|580676545|FG001|Overall Study|cardiac arrest prior to intubation|2|||
160805293|NCT00347932|580676548|FG000|Overall Study|Adverse Event|4|||
160805294|NCT00347932|580676549|FG001|Overall Study|Adverse Event|5|||
160805295|NCT00347932|580676548|FG000|Overall Study|Lack of Efficacy|3|||
160805296|NCT00347932|580676549|FG001|Overall Study|Lack of Efficacy|14|||
160805297|NCT00347932|580676548|FG000|Overall Study|Lost to Follow-up|10|||
160805298|NCT00347932|580676549|FG001|Overall Study|Lost to Follow-up|9|||
160805299|NCT00347932|580676548|FG000|Overall Study|Withdrawal by Subject|10|||
160805300|NCT00347932|580676549|FG001|Overall Study|Withdrawal by Subject|16|||
160805301|NCT00347932|580676548|FG000|Overall Study|Did not meet inclusion criteria|4|||
160805302|NCT00347932|580676549|FG001|Overall Study|Did not meet inclusion criteria|8|||
160805303|NCT03462758|580676552|FG000|Overall Study|Chose no or other method of contraception|20|||
160805304|NCT03462758|580676553|FG001|Overall Study|Chose no or other method of contraception|23|||
160805305|NCT03462758|580676552|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
160805306|NCT03462758|580676553|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
160805307|NCT03462758|580676552|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
160805308|NCT03462758|580676553|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
160805309|NCT03462758|580676552|FG000|Overall Study|Medical contraindication|2|||
160805310|NCT03462758|580676553|FG001|Overall Study|Medical contraindication|2|||
160805311|NCT03462758|580676552|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
160805312|NCT03462758|580676553|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
160805313|NCT02820844|580676554|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
160805314|NCT02820844|580676555|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
160805315|NCT02820844|580676556|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
160805316|NCT02820844|580676557|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
160805317|NCT02820844|580676558|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
160805318|NCT02820844|580676559|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
160805319|NCT02820844|580676554|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
160805320|NCT02820844|580676555|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
160805321|NCT02820844|580676556|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
160805322|NCT02820844|580676557|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
160805323|NCT02820844|580676558|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
160805324|NCT02820844|580676559|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
160805325|NCT02820844|580676554|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
160805326|NCT02820844|580676555|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
160805327|NCT02820844|580676556|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
160805328|NCT02820844|580676557|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
160805329|NCT02820844|580676558|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
160805330|NCT02820844|580676559|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
160805331|NCT02820844|580676554|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
160805332|NCT02820844|580676555|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
160805333|NCT02820844|580676556|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
160805334|NCT02820844|580676557|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
160805335|NCT02820844|580676558|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
160805336|NCT02820844|580676559|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
160805337|NCT02820844|580676554|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
160805338|NCT02820844|580676555|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
160805339|NCT02820844|580676556|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
160805340|NCT02820844|580676557|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
160805341|NCT02820844|580676558|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
160805342|NCT02820844|580676559|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
160805343|NCT02820844|580676554|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
160805344|NCT02820844|580676555|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
160805345|NCT02820844|580676556|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
160805346|NCT02820844|580676557|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
160805347|NCT02820844|580676558|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
160805348|NCT02820844|580676559|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
160805349|NCT02820844|580676554|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
160805350|NCT02820844|580676555|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
160805351|NCT02820844|580676556|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
160805352|NCT02820844|580676557|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
160805353|NCT02820844|580676558|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
160805354|NCT02820844|580676559|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
160805355|NCT02820844|580676554|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805356|NCT02820844|580676555|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805357|NCT02820844|580676556|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
160805358|NCT02820844|580676557|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
160805359|NCT02820844|580676558|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805360|NCT02820844|580676559|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805361|NCT02820844|580676554|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
160805362|NCT02820844|580676555|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
160805363|NCT02820844|580676556|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
160805364|NCT02820844|580676557|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
160805365|NCT02820844|580676558|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
160805366|NCT02820844|580676559|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
160805367|NCT02820844|580676554|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805368|NCT02820844|580676555|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805369|NCT02820844|580676556|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805370|NCT02820844|580676557|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805371|NCT02820844|580676558|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805372|NCT02820844|580676559|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
160805373|NCT00413660|580676561|FG000|Up To Week 12|Adverse Event|1|||
160805374|NCT00413660|580676562|FG001|Up To Week 12|Adverse Event|3|||
160805375|NCT00413660|580676563|FG002|Up To Week 12|Adverse Event|1|||
160805376|NCT00413660|580676564|FG003|Up To Week 12|Adverse Event|4|||
160805377|NCT00413660|580676565|FG004|Up To Week 12|Adverse Event|6|||
160805378|NCT00413660|580676566|FG005|Up To Week 12|Adverse Event|4|||
160805379|NCT00413660|580676567|FG006|Up To Week 12|Adverse Event|1|||
160805380|NCT00413660|580676568|FG007|Up To Week 12|Adverse Event|0|||
160805381|NCT00413660|580676569|FG008|Up To Week 12|Adverse Event|0|||
160805382|NCT00413660|580676570|FG009|Up To Week 12|Adverse Event|0|||
160805383|NCT00413660|580676571|FG010|Up To Week 12|Adverse Event|0|||
160805384|NCT00413660|580676561|FG000|Up To Week 12|Lack of Efficacy|2|||
160805385|NCT00413660|580676562|FG001|Up To Week 12|Lack of Efficacy|0|||
160898000|NCT03001882|581021495|FG001|Overall Study|AE unrelated to study drug|3|||
160898001|NCT03001882|581021496|FG002|Overall Study|AE unrelated to study drug|0|||
160898002|NCT03001882|581021497|FG003|Overall Study|AE unrelated to study drug|11|||
160898003|NCT03001882|581021494|FG000|Overall Study|Study Drug Toxicity|8|||
160898004|NCT03001882|581021495|FG001|Overall Study|Study Drug Toxicity|5|||
160898005|NCT03001882|581021496|FG002|Overall Study|Study Drug Toxicity|0|||
160898006|NCT03001882|581021497|FG003|Overall Study|Study Drug Toxicity|37|||
160898007|NCT03001882|581021494|FG000|Overall Study|Disease progression|16|||
160898008|NCT03001882|581021495|FG001|Overall Study|Disease progression|14|||
160898009|NCT03001882|581021496|FG002|Overall Study|Disease progression|1|||
160898010|NCT03001882|581021497|FG003|Overall Study|Disease progression|90|||
160898011|NCT05268055|581021499|FG000|Overall Study|Lost to Follow-up|68|||
160898012|NCT05268055|581021500|FG001|Overall Study|Lost to Follow-up|68|||
160898013|NCT05268055|581021499|FG000|Overall Study|Withdrawal by Subject|12|||
160898014|NCT05268055|581021500|FG001|Overall Study|Withdrawal by Subject|8|||
160898015|NCT03507400|581021501|FG000|Overall Study|discontinued|5|||
160898016|NCT03507400|581021502|FG001|Overall Study|discontinued|1|||
160898017|NCT03507400|581021501|FG000|Overall Study|Lost to Follow-up|8|||
160805386|NCT00413660|580676563|FG002|Up To Week 12|Lack of Efficacy|0|||
160805387|NCT00413660|580676564|FG003|Up To Week 12|Lack of Efficacy|0|||
160805388|NCT00413660|580676565|FG004|Up To Week 12|Lack of Efficacy|0|||
160805389|NCT00413660|580676566|FG005|Up To Week 12|Lack of Efficacy|0|||
160898018|NCT03507400|581021502|FG001|Overall Study|Lost to Follow-up|6|||
160898019|NCT03507400|581021501|FG000|Overall Study|Protocol Violation|0|||
160898020|NCT03507400|581021502|FG001|Overall Study|Protocol Violation|1|||
160898021|NCT00717093|581023368|FG000|Overall Study|Adverse Event|19|||
160805390|NCT00413660|580676567|FG006|Up To Week 12|Lack of Efficacy|5|||
160805391|NCT00413660|580676568|FG007|Up To Week 12|Lack of Efficacy|0|||
160805392|NCT00413660|580676569|FG008|Up To Week 12|Lack of Efficacy|0|||
160805393|NCT00413660|580676570|FG009|Up To Week 12|Lack of Efficacy|0|||
160805394|NCT00413660|580676571|FG010|Up To Week 12|Lack of Efficacy|0|||
160805395|NCT00413660|580676561|FG000|Up To Week 12|Lost to Follow-up|0|||
160805396|NCT00413660|580676562|FG001|Up To Week 12|Lost to Follow-up|1|||
160805397|NCT00413660|580676563|FG002|Up To Week 12|Lost to Follow-up|0|||
160805398|NCT00413660|580676564|FG003|Up To Week 12|Lost to Follow-up|0|||
160805399|NCT00413660|580676565|FG004|Up To Week 12|Lost to Follow-up|1|||
160805400|NCT00413660|580676566|FG005|Up To Week 12|Lost to Follow-up|0|||
160805401|NCT00413660|580676567|FG006|Up To Week 12|Lost to Follow-up|0|||
160805402|NCT00413660|580676568|FG007|Up To Week 12|Lost to Follow-up|0|||
160805403|NCT00413660|580676569|FG008|Up To Week 12|Lost to Follow-up|0|||
160805404|NCT00413660|580676570|FG009|Up To Week 12|Lost to Follow-up|0|||
160805405|NCT00413660|580676571|FG010|Up To Week 12|Lost to Follow-up|0|||
160805406|NCT00413660|580676561|FG000|Up To Week 12|Withdrawal by Subject|0|||
160805407|NCT00413660|580676562|FG001|Up To Week 12|Withdrawal by Subject|2|||
160805408|NCT00413660|580676563|FG002|Up To Week 12|Withdrawal by Subject|0|||
160805409|NCT00413660|580676564|FG003|Up To Week 12|Withdrawal by Subject|2|||
160805410|NCT00413660|580676565|FG004|Up To Week 12|Withdrawal by Subject|0|||
160805411|NCT00413660|580676566|FG005|Up To Week 12|Withdrawal by Subject|2|||
160805412|NCT00413660|580676567|FG006|Up To Week 12|Withdrawal by Subject|2|||
160805413|NCT00413660|580676568|FG007|Up To Week 12|Withdrawal by Subject|0|||
160805414|NCT00413660|580676569|FG008|Up To Week 12|Withdrawal by Subject|0|||
160805415|NCT00413660|580676570|FG009|Up To Week 12|Withdrawal by Subject|0|||
160805416|NCT00413660|580676571|FG010|Up To Week 12|Withdrawal by Subject|0|||
160805417|NCT00413660|580676561|FG000|Up To Week 12|Randomized, Not Treated|1|||
160805418|NCT00413660|580676562|FG001|Up To Week 12|Randomized, Not Treated|0|||
160805419|NCT00413660|580676563|FG002|Up To Week 12|Randomized, Not Treated|0|||
160805420|NCT00413660|580676564|FG003|Up To Week 12|Randomized, Not Treated|1|||
160805421|NCT00413660|580676565|FG004|Up To Week 12|Randomized, Not Treated|0|||
160805422|NCT00413660|580676566|FG005|Up To Week 12|Randomized, Not Treated|0|||
160805423|NCT00413660|580676567|FG006|Up To Week 12|Randomized, Not Treated|0|||
160805424|NCT00413660|580676568|FG007|Up To Week 12|Randomized, Not Treated|0|||
160805425|NCT00413660|580676569|FG008|Up To Week 12|Randomized, Not Treated|0|||
160805426|NCT00413660|580676570|FG009|Up To Week 12|Randomized, Not Treated|0|||
160805427|NCT00413660|580676571|FG010|Up To Week 12|Randomized, Not Treated|0|||
160805428|NCT00413660|580676561|FG000|Up To Week 12|Other|3|||
160805429|NCT00413660|580676562|FG001|Up To Week 12|Other|1|||
160805430|NCT00413660|580676563|FG002|Up To Week 12|Other|6|||
160805431|NCT00413660|580676564|FG003|Up To Week 12|Other|1|||
160805432|NCT00413660|580676565|FG004|Up To Week 12|Other|2|||
160805433|NCT00413660|580676566|FG005|Up To Week 12|Other|4|||
160805434|NCT00413660|580676567|FG006|Up To Week 12|Other|3|||
160805435|NCT00413660|580676568|FG007|Up To Week 12|Other|0|||
160805436|NCT00413660|580676569|FG008|Up To Week 12|Other|0|||
160805437|NCT00413660|580676570|FG009|Up To Week 12|Other|0|||
160805438|NCT00413660|580676571|FG010|Up To Week 12|Other|0|||
160805439|NCT00413660|580676561|FG000|Post Week 12|Adverse Event|2|||
160805440|NCT00413660|580676562|FG001|Post Week 12|Adverse Event|0|||
160805441|NCT00413660|580676563|FG002|Post Week 12|Adverse Event|2|||
160805442|NCT00413660|580676564|FG003|Post Week 12|Adverse Event|1|||
160805443|NCT00413660|580676565|FG004|Post Week 12|Adverse Event|4|||
160805444|NCT00413660|580676566|FG005|Post Week 12|Adverse Event|2|||
160805445|NCT00413660|580676567|FG006|Post Week 12|Adverse Event|2|||
160805446|NCT00413660|580676568|FG007|Post Week 12|Adverse Event|0|||
160805447|NCT00413660|580676569|FG008|Post Week 12|Adverse Event|0|||
160805448|NCT00413660|580676570|FG009|Post Week 12|Adverse Event|0|||
160805449|NCT00413660|580676571|FG010|Post Week 12|Adverse Event|0|||
160805450|NCT00413660|580676561|FG000|Post Week 12|Lack of Efficacy|0|||
160805451|NCT00413660|580676562|FG001|Post Week 12|Lack of Efficacy|0|||
160805452|NCT00413660|580676563|FG002|Post Week 12|Lack of Efficacy|1|||
160805453|NCT00413660|580676564|FG003|Post Week 12|Lack of Efficacy|0|||
160805454|NCT00413660|580676565|FG004|Post Week 12|Lack of Efficacy|0|||
160805455|NCT00413660|580676566|FG005|Post Week 12|Lack of Efficacy|0|||
160805456|NCT00413660|580676567|FG006|Post Week 12|Lack of Efficacy|0|||
160805457|NCT00413660|580676568|FG007|Post Week 12|Lack of Efficacy|0|||
160805458|NCT00413660|580676569|FG008|Post Week 12|Lack of Efficacy|0|||
160805459|NCT00413660|580676570|FG009|Post Week 12|Lack of Efficacy|1|||
160805460|NCT00413660|580676571|FG010|Post Week 12|Lack of Efficacy|0|||
160805461|NCT00413660|580676561|FG000|Post Week 12|Lost to Follow-up|0|||
160805462|NCT00413660|580676562|FG001|Post Week 12|Lost to Follow-up|1|||
160805463|NCT00413660|580676563|FG002|Post Week 12|Lost to Follow-up|1|||
160805464|NCT00413660|580676564|FG003|Post Week 12|Lost to Follow-up|0|||
160805465|NCT00413660|580676565|FG004|Post Week 12|Lost to Follow-up|0|||
160805466|NCT00413660|580676566|FG005|Post Week 12|Lost to Follow-up|0|||
160805467|NCT00413660|580676567|FG006|Post Week 12|Lost to Follow-up|0|||
160805468|NCT00413660|580676568|FG007|Post Week 12|Lost to Follow-up|0|||
160805469|NCT00413660|580676569|FG008|Post Week 12|Lost to Follow-up|0|||
160805470|NCT00413660|580676570|FG009|Post Week 12|Lost to Follow-up|0|||
160805471|NCT00413660|580676571|FG010|Post Week 12|Lost to Follow-up|0|||
160805472|NCT00413660|580676561|FG000|Post Week 12|Withdrawal by Subject|0|||
160805473|NCT00413660|580676562|FG001|Post Week 12|Withdrawal by Subject|1|||
160805474|NCT00413660|580676563|FG002|Post Week 12|Withdrawal by Subject|1|||
160805475|NCT00413660|580676564|FG003|Post Week 12|Withdrawal by Subject|0|||
160805476|NCT00413660|580676565|FG004|Post Week 12|Withdrawal by Subject|1|||
160805477|NCT00413660|580676566|FG005|Post Week 12|Withdrawal by Subject|0|||
160805478|NCT00413660|580676567|FG006|Post Week 12|Withdrawal by Subject|0|||
160805479|NCT00413660|580676568|FG007|Post Week 12|Withdrawal by Subject|0|||
160805480|NCT00413660|580676569|FG008|Post Week 12|Withdrawal by Subject|0|||
160805481|NCT00413660|580676570|FG009|Post Week 12|Withdrawal by Subject|0|||
160805482|NCT00413660|580676571|FG010|Post Week 12|Withdrawal by Subject|1|||
160805483|NCT00413660|580676561|FG000|Post Week 12|Other|1|||
160805484|NCT00413660|580676562|FG001|Post Week 12|Other|2|||
160805485|NCT00413660|580676563|FG002|Post Week 12|Other|3|||
160805486|NCT00413660|580676564|FG003|Post Week 12|Other|0|||
160805487|NCT00413660|580676565|FG004|Post Week 12|Other|1|||
160805488|NCT00413660|580676566|FG005|Post Week 12|Other|1|||
160805489|NCT00413660|580676567|FG006|Post Week 12|Other|1|||
160805490|NCT00413660|580676568|FG007|Post Week 12|Other|0|||
160805491|NCT00413660|580676569|FG008|Post Week 12|Other|0|||
160805492|NCT00413660|580676570|FG009|Post Week 12|Other|0|||
160805493|NCT00413660|580676571|FG010|Post Week 12|Other|0|||
160805494|NCT01791517|580676574|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
160805495|NCT01791517|580676575|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
160805496|NCT01791517|580676576|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
160805497|NCT01791517|580676577|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
160805498|NCT01791517|580676578|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
160805499|NCT01791517|580676579|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
160805500|NCT01791517|580676580|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
160805501|NCT01791517|580676581|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
160805502|NCT01791517|580676582|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
160805503|NCT01791517|580676583|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
160805504|NCT01791517|580676584|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
160805505|NCT01791517|580676585|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
160805506|NCT01791517|580676574|FG000|Phase I: Period 1|Adverse Event|0|||
160805507|NCT01791517|580676575|FG001|Phase I: Period 1|Adverse Event|0|||
160805508|NCT01791517|580676576|FG002|Phase I: Period 1|Adverse Event|1|||
160805509|NCT01791517|580676577|FG003|Phase I: Period 1|Adverse Event|1|||
160805510|NCT01791517|580676578|FG004|Phase I: Period 1|Adverse Event|0|||
160805511|NCT01791517|580676579|FG005|Phase I: Period 1|Adverse Event|0|||
160805512|NCT01791517|580676580|FG006|Phase I: Period 1|Adverse Event|0|||
160805513|NCT01791517|580676581|FG007|Phase I: Period 1|Adverse Event|0|||
160805514|NCT01791517|580676582|FG008|Phase I: Period 1|Adverse Event|0|||
160805515|NCT01791517|580676583|FG009|Phase I: Period 1|Adverse Event|0|||
160805516|NCT01791517|580676584|FG010|Phase I: Period 1|Adverse Event|0|||
160805517|NCT01791517|580676585|FG011|Phase I: Period 1|Adverse Event|0|||
160805518|NCT01791517|580676574|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
160805519|NCT01791517|580676575|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805520|NCT01791517|580676576|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805521|NCT01791517|580676577|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805522|NCT01791517|580676578|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805523|NCT01791517|580676579|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805524|NCT01791517|580676580|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160985299|NCT01141660|581335417|FG001|Overall Study|Physician Decision|12|||
160985300|NCT00209027|581335419|FG000|Overall Study|study terminated|10|||
160985301|NCT00209027|581335420|FG001|Overall Study|study terminated|0|||
160985302|NCT02335268|581335421|FG000|Overall Study|Physician Decision|5|||
160805525|NCT01791517|580676581|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805526|NCT01791517|580676582|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805527|NCT01791517|580676583|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805528|NCT01791517|580676584|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805529|NCT01791517|580676585|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805530|NCT01791517|580676574|FG000|Phase I: Period 1|Protocol Violation|0|||
160805531|NCT01791517|580676575|FG001|Phase I: Period 1|Protocol Violation|1|||
160805532|NCT01791517|580676576|FG002|Phase I: Period 1|Protocol Violation|0|||
160805533|NCT01791517|580676577|FG003|Phase I: Period 1|Protocol Violation|0|||
160805534|NCT01791517|580676578|FG004|Phase I: Period 1|Protocol Violation|0|||
160805535|NCT01791517|580676579|FG005|Phase I: Period 1|Protocol Violation|0|||
160985303|NCT02335268|581335422|FG001|Overall Study|Physician Decision|1|||
160805536|NCT01791517|580676580|FG006|Phase I: Period 1|Protocol Violation|0|||
160805537|NCT01791517|580676581|FG007|Phase I: Period 1|Protocol Violation|0|||
160985304|NCT02335268|581335421|FG000|Overall Study|Lack of Efficacy|2|||
160985305|NCT02335268|581335422|FG001|Overall Study|Lack of Efficacy|1|||
160805538|NCT01791517|580676582|FG008|Phase I: Period 1|Protocol Violation|0|||
160805539|NCT01791517|580676583|FG009|Phase I: Period 1|Protocol Violation|0|||
160805540|NCT01791517|580676584|FG010|Phase I: Period 1|Protocol Violation|0|||
160805541|NCT01791517|580676585|FG011|Phase I: Period 1|Protocol Violation|0|||
160805542|NCT01791517|580676574|FG000|Phase I: Period 1|Lost to Follow-up|0|||
160805543|NCT01791517|580676575|FG001|Phase I: Period 1|Lost to Follow-up|0|||
160805544|NCT01791517|580676576|FG002|Phase I: Period 1|Lost to Follow-up|0|||
160805545|NCT01791517|580676577|FG003|Phase I: Period 1|Lost to Follow-up|1|||
160805546|NCT01791517|580676578|FG004|Phase I: Period 1|Lost to Follow-up|0|||
160805547|NCT01791517|580676579|FG005|Phase I: Period 1|Lost to Follow-up|0|||
160805548|NCT01791517|580676580|FG006|Phase I: Period 1|Lost to Follow-up|1|||
160805549|NCT01791517|580676581|FG007|Phase I: Period 1|Lost to Follow-up|0|||
160805550|NCT01791517|580676582|FG008|Phase I: Period 1|Lost to Follow-up|1|||
160805551|NCT01791517|580676583|FG009|Phase I: Period 1|Lost to Follow-up|1|||
160805552|NCT01791517|580676584|FG010|Phase I: Period 1|Lost to Follow-up|0|||
160805553|NCT01791517|580676585|FG011|Phase I: Period 1|Lost to Follow-up|0|||
160805554|NCT01791517|580676574|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805555|NCT01791517|580676575|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805556|NCT01791517|580676576|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805557|NCT01791517|580676577|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805558|NCT01791517|580676578|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805559|NCT01791517|580676579|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805560|NCT01791517|580676580|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805561|NCT01791517|580676581|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805562|NCT01791517|580676582|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805563|NCT01791517|580676583|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805564|NCT01791517|580676584|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805565|NCT01791517|580676585|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
160805566|NCT01791517|580676574|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
160805567|NCT01791517|580676575|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805568|NCT01791517|580676576|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805569|NCT01791517|580676577|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805570|NCT01791517|580676578|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805571|NCT01791517|580676579|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805572|NCT01791517|580676580|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805573|NCT01791517|580676581|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805574|NCT01791517|580676582|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805575|NCT01791517|580676583|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805576|NCT01791517|580676584|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805577|NCT01791517|580676585|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805578|NCT01791517|580676574|FG000|Phase I: Period 2|Protocol Violation|0|||
160805579|NCT01791517|580676575|FG001|Phase I: Period 2|Protocol Violation|0|||
160805580|NCT01791517|580676576|FG002|Phase I: Period 2|Protocol Violation|0|||
160898022|NCT00717093|581023369|FG001|Overall Study|Adverse Event|9|||
160898023|NCT00717093|581023368|FG000|Overall Study|Lack of Efficacy|3|||
160898024|NCT00717093|581023369|FG001|Overall Study|Lack of Efficacy|13|||
160898025|NCT00717093|581023368|FG000|Overall Study|Lost to Follow-up|9|||
160898026|NCT00717093|581023369|FG001|Overall Study|Lost to Follow-up|6|||
160898027|NCT00717093|581023368|FG000|Overall Study|Withdrawal by Subject|12|||
160898028|NCT00717093|581023369|FG001|Overall Study|Withdrawal by Subject|19|||
160898029|NCT00717093|581023368|FG000|Overall Study|Other|0|||
160898030|NCT00717093|581023369|FG001|Overall Study|Other|1|||
160898031|NCT00717093|581023368|FG000|Overall Study|Randomized but not treated|1|||
160898032|NCT00717093|581023369|FG001|Overall Study|Randomized but not treated|0|||
160898033|NCT01543698|581023374|FG000|Phase 1b|Disease progression|2|||
160898034|NCT01543698|581023375|FG001|Phase 1b|Disease progression|4|||
160898035|NCT01543698|581023376|FG002|Phase 1b|Disease progression|3|||
160898036|NCT01543698|581023377|FG003|Phase 1b|Disease progression|2|||
160898037|NCT01543698|581023378|FG004|Phase 1b|Disease progression|10|||
160898038|NCT01543698|581023379|FG005|Phase 1b|Disease progression|6|||
160898039|NCT01543698|581023380|FG006|Phase 1b|Disease progression|5|||
160898040|NCT01543698|581023381|FG007|Phase 1b|Disease progression|3|||
160898041|NCT01543698|581023382|FG008|Phase 1b|Disease progression|4|||
160898042|NCT01543698|581023383|FG009|Phase 1b|Disease progression|5|||
160898043|NCT01543698|581023384|FG010|Phase 1b|Disease progression|1|||
160898044|NCT01543698|581023385|FG011|Phase 1b|Disease progression|0|||
160550284|NCT03529773|579740183|FG031|Overall Study|Randomized but not vaccinated|0|||
160550285|NCT03529773|579740184|FG032|Overall Study|Randomized but not vaccinated|0|||
160805581|NCT01791517|580676577|FG003|Phase I: Period 2|Protocol Violation|1|||
160805582|NCT01791517|580676578|FG004|Phase I: Period 2|Protocol Violation|0|||
160805583|NCT01791517|580676579|FG005|Phase I: Period 2|Protocol Violation|0|||
160805584|NCT01791517|580676580|FG006|Phase I: Period 2|Protocol Violation|0|||
160805585|NCT01791517|580676581|FG007|Phase I: Period 2|Protocol Violation|0|||
160805586|NCT01791517|580676582|FG008|Phase I: Period 2|Protocol Violation|0|||
160805587|NCT01791517|580676583|FG009|Phase I: Period 2|Protocol Violation|0|||
160805588|NCT01791517|580676584|FG010|Phase I: Period 2|Protocol Violation|0|||
160805589|NCT01791517|580676585|FG011|Phase I: Period 2|Protocol Violation|0|||
160805590|NCT01791517|580676574|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
160805591|NCT01791517|580676575|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
160805592|NCT01791517|580676576|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
160805593|NCT01791517|580676577|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
160805594|NCT01791517|580676578|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
160805595|NCT01791517|580676579|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
160805596|NCT01791517|580676580|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
160805597|NCT01791517|580676581|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
160805598|NCT01791517|580676582|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
160805599|NCT01791517|580676583|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
160805600|NCT01791517|580676584|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
160805601|NCT01791517|580676585|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
160805602|NCT01791517|580676574|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805603|NCT01791517|580676575|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805604|NCT01791517|580676576|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805605|NCT01791517|580676577|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805606|NCT01791517|580676578|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805607|NCT01791517|580676579|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805608|NCT01791517|580676580|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805609|NCT01791517|580676581|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805610|NCT01791517|580676582|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805611|NCT01791517|580676583|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805612|NCT01791517|580676584|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
160805613|NCT01791517|580676585|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805614|NCT01791517|580676574|FG000|Phase I: Period 2|Lens Discomfort|0|||
160805615|NCT01791517|580676575|FG001|Phase I: Period 2|Lens Discomfort|0|||
160805616|NCT01791517|580676576|FG002|Phase I: Period 2|Lens Discomfort|0|||
160805617|NCT01791517|580676577|FG003|Phase I: Period 2|Lens Discomfort|0|||
160805618|NCT01791517|580676578|FG004|Phase I: Period 2|Lens Discomfort|0|||
160805619|NCT01791517|580676579|FG005|Phase I: Period 2|Lens Discomfort|1|||
160898045|NCT01543698|581023386|FG012|Phase 1b|Disease progression|0|||
160898046|NCT01543698|581023387|FG013|Phase 1b|Disease progression|0|||
160898047|NCT01543698|581023388|FG014|Phase 1b|Disease progression|0|||
160898048|NCT01543698|581023374|FG000|Phase 1b|Death|0|||
160805620|NCT01791517|580676580|FG006|Phase I: Period 2|Lens Discomfort|0|||
160898049|NCT01543698|581023375|FG001|Phase 1b|Death|0|||
160898050|NCT01543698|581023376|FG002|Phase 1b|Death|1|||
160985306|NCT02335268|581335421|FG000|Overall Study|Adverse Event|5|||
160898051|NCT01543698|581023377|FG003|Phase 1b|Death|1|||
160898052|NCT01543698|581023378|FG004|Phase 1b|Death|0|||
160898053|NCT01543698|581023379|FG005|Phase 1b|Death|0|||
160898054|NCT01543698|581023380|FG006|Phase 1b|Death|0|||
160898055|NCT01543698|581023381|FG007|Phase 1b|Death|0|||
160898056|NCT01543698|581023382|FG008|Phase 1b|Death|0|||
160985307|NCT02335268|581335422|FG001|Overall Study|Adverse Event|2|||
160805621|NCT01791517|580676581|FG007|Phase I: Period 2|Lens Discomfort|0|||
160805622|NCT01791517|580676582|FG008|Phase I: Period 2|Lens Discomfort|0|||
160805623|NCT01791517|580676583|FG009|Phase I: Period 2|Lens Discomfort|0|||
160805624|NCT01791517|580676584|FG010|Phase I: Period 2|Lens Discomfort|0|||
160805625|NCT01791517|580676585|FG011|Phase I: Period 2|Lens Discomfort|0|||
160805626|NCT01791517|580676574|FG000|Phase I: Period 2|Lost to Follow-up|0|||
160805627|NCT01791517|580676575|FG001|Phase I: Period 2|Lost to Follow-up|3|||
160805628|NCT01791517|580676576|FG002|Phase I: Period 2|Lost to Follow-up|2|||
160805629|NCT01791517|580676577|FG003|Phase I: Period 2|Lost to Follow-up|0|||
160805630|NCT01791517|580676578|FG004|Phase I: Period 2|Lost to Follow-up|0|||
160805631|NCT01791517|580676579|FG005|Phase I: Period 2|Lost to Follow-up|0|||
160805632|NCT01791517|580676580|FG006|Phase I: Period 2|Lost to Follow-up|0|||
160805633|NCT01791517|580676581|FG007|Phase I: Period 2|Lost to Follow-up|0|||
160805634|NCT01791517|580676582|FG008|Phase I: Period 2|Lost to Follow-up|0|||
160805635|NCT01791517|580676583|FG009|Phase I: Period 2|Lost to Follow-up|0|||
160805636|NCT01791517|580676584|FG010|Phase I: Period 2|Lost to Follow-up|0|||
160805637|NCT01791517|580676585|FG011|Phase I: Period 2|Lost to Follow-up|0|||
160805638|NCT01791517|580676574|FG000|Phase I: Period 3|Lens Discomfort|0|||
160805639|NCT01791517|580676575|FG001|Phase I: Period 3|Lens Discomfort|0|||
160805640|NCT01791517|580676576|FG002|Phase I: Period 3|Lens Discomfort|0|||
160805641|NCT01791517|580676577|FG003|Phase I: Period 3|Lens Discomfort|0|||
160805642|NCT01791517|580676578|FG004|Phase I: Period 3|Lens Discomfort|0|||
160805643|NCT01791517|580676579|FG005|Phase I: Period 3|Lens Discomfort|0|||
160805644|NCT01791517|580676580|FG006|Phase I: Period 3|Lens Discomfort|0|||
160805645|NCT01791517|580676581|FG007|Phase I: Period 3|Lens Discomfort|0|||
160805646|NCT01791517|580676582|FG008|Phase I: Period 3|Lens Discomfort|0|||
160805647|NCT01791517|580676583|FG009|Phase I: Period 3|Lens Discomfort|0|||
160805648|NCT01791517|580676584|FG010|Phase I: Period 3|Lens Discomfort|0|||
160805649|NCT01791517|580676585|FG011|Phase I: Period 3|Lens Discomfort|1|||
160805650|NCT01791517|580676574|FG000|Phase I: Period 3|Lost to Follow-up|0|||
160805651|NCT01791517|580676575|FG001|Phase I: Period 3|Lost to Follow-up|1|||
160805652|NCT01791517|580676576|FG002|Phase I: Period 3|Lost to Follow-up|0|||
160805653|NCT01791517|580676577|FG003|Phase I: Period 3|Lost to Follow-up|0|||
160805654|NCT01791517|580676578|FG004|Phase I: Period 3|Lost to Follow-up|1|||
160805655|NCT01791517|580676579|FG005|Phase I: Period 3|Lost to Follow-up|0|||
160805656|NCT01791517|580676580|FG006|Phase I: Period 3|Lost to Follow-up|0|||
160805657|NCT01791517|580676581|FG007|Phase I: Period 3|Lost to Follow-up|0|||
160805658|NCT01791517|580676582|FG008|Phase I: Period 3|Lost to Follow-up|0|||
160805659|NCT01791517|580676583|FG009|Phase I: Period 3|Lost to Follow-up|0|||
160805660|NCT01791517|580676584|FG010|Phase I: Period 3|Lost to Follow-up|0|||
160805661|NCT01791517|580676585|FG011|Phase I: Period 3|Lost to Follow-up|0|||
160805662|NCT01791517|580676574|FG000|Phase I: Period 3|Adverse Event|0|||
160805663|NCT01791517|580676575|FG001|Phase I: Period 3|Adverse Event|0|||
160805664|NCT01791517|580676576|FG002|Phase I: Period 3|Adverse Event|0|||
160805665|NCT01791517|580676577|FG003|Phase I: Period 3|Adverse Event|1|||
160805666|NCT01791517|580676578|FG004|Phase I: Period 3|Adverse Event|0|||
160805667|NCT01791517|580676579|FG005|Phase I: Period 3|Adverse Event|0|||
160805668|NCT01791517|580676580|FG006|Phase I: Period 3|Adverse Event|0|||
160805669|NCT01791517|580676581|FG007|Phase I: Period 3|Adverse Event|0|||
160805670|NCT01791517|580676582|FG008|Phase I: Period 3|Adverse Event|0|||
160805671|NCT01791517|580676583|FG009|Phase I: Period 3|Adverse Event|0|||
160805672|NCT01791517|580676584|FG010|Phase I: Period 3|Adverse Event|0|||
160985308|NCT02335268|581335421|FG000|Overall Study|increase blasts|2|||
160985309|NCT02335268|581335422|FG001|Overall Study|increase blasts|0|||
160985310|NCT02335268|581335421|FG000|Overall Study|Withdrawal by Subject|3|||
160985311|NCT02335268|581335422|FG001|Overall Study|Withdrawal by Subject|2|||
160985312|NCT05893797|581335423|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
160985313|NCT05893797|581335423|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
160985314|NCT05893797|581335423|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
160985315|NCT05893797|581335423|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
160985316|NCT01822353|581335424|FG000|Overall Study|Adverse Event|1|||
160985317|NCT01822353|581335425|FG001|Overall Study|Adverse Event|3|||
160985318|NCT01822353|581335426|FG002|Overall Study|Adverse Event|1|||
160805673|NCT01791517|580676585|FG011|Phase I: Period 3|Adverse Event|0|||
160805674|NCT01791517|580676574|FG000|Phase II|Lost to Follow-up|1|||
160805675|NCT01791517|580676575|FG001|Phase II|Lost to Follow-up|0|||
160805676|NCT01791517|580676576|FG002|Phase II|Lost to Follow-up|1|||
160805677|NCT01791517|580676577|FG003|Phase II|Lost to Follow-up|0|||
160805678|NCT01791517|580676578|FG004|Phase II|Lost to Follow-up|1|||
160805679|NCT01791517|580676579|FG005|Phase II|Lost to Follow-up|2|||
160805680|NCT01791517|580676580|FG006|Phase II|Lost to Follow-up|0|||
160805681|NCT01791517|580676581|FG007|Phase II|Lost to Follow-up|1|||
160805682|NCT01791517|580676582|FG008|Phase II|Lost to Follow-up|1|||
160805683|NCT01791517|580676583|FG009|Phase II|Lost to Follow-up|1|||
160985319|NCT01822353|581335424|FG000|Overall Study|Pregnancy|0|||
160985320|NCT01822353|581335425|FG001|Overall Study|Pregnancy|1|||
160805684|NCT01791517|580676584|FG010|Phase II|Lost to Follow-up|0|||
160805685|NCT01791517|580676585|FG011|Phase II|Lost to Follow-up|0|||
160805686|NCT01791517|580676574|FG000|Phase II|Withdrawal by Subject|1|||
160805687|NCT01791517|580676575|FG001|Phase II|Withdrawal by Subject|0|||
160805688|NCT01791517|580676576|FG002|Phase II|Withdrawal by Subject|0|||
160805689|NCT01791517|580676577|FG003|Phase II|Withdrawal by Subject|0|||
160805690|NCT01791517|580676578|FG004|Phase II|Withdrawal by Subject|0|||
160805691|NCT01791517|580676579|FG005|Phase II|Withdrawal by Subject|2|||
160805692|NCT01791517|580676580|FG006|Phase II|Withdrawal by Subject|0|||
160805693|NCT01791517|580676581|FG007|Phase II|Withdrawal by Subject|1|||
160805694|NCT01791517|580676582|FG008|Phase II|Withdrawal by Subject|0|||
160805695|NCT01791517|580676583|FG009|Phase II|Withdrawal by Subject|0|||
160805696|NCT01791517|580676584|FG010|Phase II|Withdrawal by Subject|1|||
160805697|NCT01791517|580676585|FG011|Phase II|Withdrawal by Subject|0|||
160805698|NCT01791517|580676574|FG000|Phase II|Lack of Efficacy|0|||
160805699|NCT01791517|580676575|FG001|Phase II|Lack of Efficacy|0|||
160805700|NCT01791517|580676576|FG002|Phase II|Lack of Efficacy|0|||
160805701|NCT01791517|580676577|FG003|Phase II|Lack of Efficacy|0|||
160805702|NCT01791517|580676578|FG004|Phase II|Lack of Efficacy|1|||
160805703|NCT01791517|580676579|FG005|Phase II|Lack of Efficacy|0|||
160805704|NCT01791517|580676580|FG006|Phase II|Lack of Efficacy|0|||
160805705|NCT01791517|580676581|FG007|Phase II|Lack of Efficacy|0|||
160805706|NCT01791517|580676582|FG008|Phase II|Lack of Efficacy|0|||
160805707|NCT01791517|580676583|FG009|Phase II|Lack of Efficacy|0|||
160805708|NCT01791517|580676584|FG010|Phase II|Lack of Efficacy|0|||
160805709|NCT01791517|580676585|FG011|Phase II|Lack of Efficacy|0|||
160805710|NCT01791517|580676574|FG000|Phase II|Adverse Event|0|||
160805711|NCT01791517|580676575|FG001|Phase II|Adverse Event|0|||
160805712|NCT01791517|580676576|FG002|Phase II|Adverse Event|0|||
160805713|NCT01791517|580676577|FG003|Phase II|Adverse Event|0|||
160805714|NCT01791517|580676578|FG004|Phase II|Adverse Event|0|||
160805715|NCT01791517|580676579|FG005|Phase II|Adverse Event|0|||
160805716|NCT01791517|580676580|FG006|Phase II|Adverse Event|2|||
160805717|NCT01791517|580676581|FG007|Phase II|Adverse Event|1|||
160805718|NCT01791517|580676582|FG008|Phase II|Adverse Event|0|||
160805719|NCT01791517|580676583|FG009|Phase II|Adverse Event|1|||
160805720|NCT01791517|580676584|FG010|Phase II|Adverse Event|0|||
160898057|NCT01543698|581023383|FG009|Phase 1b|Death|0|||
160898058|NCT01543698|581023384|FG010|Phase 1b|Death|1|||
160898059|NCT01543698|581023385|FG011|Phase 1b|Death|0|||
160898060|NCT01543698|581023386|FG012|Phase 1b|Death|0|||
160898061|NCT01543698|581023387|FG013|Phase 1b|Death|0|||
160898062|NCT01543698|581023388|FG014|Phase 1b|Death|0|||
160898063|NCT01543698|581023374|FG000|Phase 1b|Withdrawal by Subject|0|||
160898064|NCT01543698|581023375|FG001|Phase 1b|Withdrawal by Subject|1|||
160898065|NCT01543698|581023376|FG002|Phase 1b|Withdrawal by Subject|0|||
160898066|NCT01543698|581023377|FG003|Phase 1b|Withdrawal by Subject|1|||
160898067|NCT01543698|581023378|FG004|Phase 1b|Withdrawal by Subject|0|||
160898068|NCT01543698|581023379|FG005|Phase 1b|Withdrawal by Subject|0|||
160898069|NCT01543698|581023380|FG006|Phase 1b|Withdrawal by Subject|1|||
160898070|NCT01543698|581023381|FG007|Phase 1b|Withdrawal by Subject|0|||
160898071|NCT01543698|581023382|FG008|Phase 1b|Withdrawal by Subject|0|||
160898072|NCT01543698|581023383|FG009|Phase 1b|Withdrawal by Subject|0|||
160898073|NCT01543698|581023384|FG010|Phase 1b|Withdrawal by Subject|0|||
160898074|NCT01543698|581023385|FG011|Phase 1b|Withdrawal by Subject|0|||
160898075|NCT01543698|581023386|FG012|Phase 1b|Withdrawal by Subject|0|||
160898076|NCT01543698|581023387|FG013|Phase 1b|Withdrawal by Subject|0|||
160985321|NCT01822353|581335426|FG002|Overall Study|Pregnancy|0|||
160985322|NCT01822353|581335424|FG000|Overall Study|Withdrawal by Subject|3|||
160985323|NCT01822353|581335425|FG001|Overall Study|Withdrawal by Subject|1|||
160550286|NCT03529773|579740185|FG033|Overall Study|Randomized but not vaccinated|0|||
160550287|NCT03529773|579740186|FG034|Overall Study|Randomized but not vaccinated|0|||
160805721|NCT01791517|580676585|FG011|Phase II|Adverse Event|0|||
160805722|NCT01791517|580676574|FG000|Phase II|Lens Handling Difficulties|0|||
160805723|NCT01791517|580676575|FG001|Phase II|Lens Handling Difficulties|0|||
160805724|NCT01791517|580676576|FG002|Phase II|Lens Handling Difficulties|0|||
160805725|NCT01791517|580676577|FG003|Phase II|Lens Handling Difficulties|0|||
160805726|NCT01791517|580676578|FG004|Phase II|Lens Handling Difficulties|0|||
160805727|NCT01791517|580676579|FG005|Phase II|Lens Handling Difficulties|0|||
160550288|NCT03529773|579740187|FG035|Overall Study|Randomized but not vaccinated|0|||
160898077|NCT01543698|581023388|FG014|Phase 1b|Withdrawal by Subject|0|||
160898078|NCT01543698|581023374|FG000|Phase 1b|Adverse Event|1|||
160805728|NCT01791517|580676580|FG006|Phase II|Lens Handling Difficulties|0|||
160805729|NCT01791517|580676581|FG007|Phase II|Lens Handling Difficulties|0|||
160805730|NCT01791517|580676582|FG008|Phase II|Lens Handling Difficulties|1|||
160805731|NCT01791517|580676583|FG009|Phase II|Lens Handling Difficulties|0|||
160805732|NCT01791517|580676584|FG010|Phase II|Lens Handling Difficulties|0|||
160805733|NCT01791517|580676585|FG011|Phase II|Lens Handling Difficulties|0|||
160805734|NCT01791517|580676574|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
160898079|NCT01543698|581023375|FG001|Phase 1b|Adverse Event|0|||
160898080|NCT01543698|581023376|FG002|Phase 1b|Adverse Event|0|||
160898081|NCT01543698|581023377|FG003|Phase 1b|Adverse Event|1|||
160985324|NCT01822353|581335426|FG002|Overall Study|Withdrawal by Subject|0|||
160550289|NCT03529773|579740188|FG036|Overall Study|Randomized but not vaccinated|0|||
160550290|NCT03529773|579740189|FG037|Overall Study|Randomized but not vaccinated|0|||
160550291|NCT03529773|579740190|FG038|Overall Study|Randomized but not vaccinated|0|||
160550292|NCT03529773|579740191|FG039|Overall Study|Randomized but not vaccinated|0|||
160550293|NCT01496066|579740193|FG000|Overall Study|Lost to Follow-up|8|||
160550294|NCT01496066|579740194|FG001|Overall Study|Lost to Follow-up|5|||
160550295|NCT01496066|579740193|FG000|Overall Study|Explant|3|||
160550296|NCT01496066|579740194|FG001|Overall Study|Explant|0|||
160550297|NCT01496066|579740193|FG000|Overall Study|Death|1|||
160550298|NCT01496066|579740194|FG001|Overall Study|Death|4|||
160550299|NCT00253630|579740195|FG000|Overall Study|ineligible|2|||
160550300|NCT00209339|579740196|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
160550301|NCT00209339|579740196|FG000|At 12 Months Follow-up|Death|1|||
160550302|NCT00209339|579740196|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
160550303|NCT00209339|579740196|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
160550304|NCT00209339|579740196|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
160550305|NCT00209339|579740196|FG000|At 24 Months Follow-up|Death|1|||
160550306|NCT00209339|579740196|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
160550307|NCT00209339|579740196|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
160550308|NCT00209339|579740196|FG000|At 4 Years Follow-up|Death|1|||
160550309|NCT00209339|579740196|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
160550310|NCT00209339|579740196|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
160550311|NCT00209339|579740196|FG000|At 5 Years Follow-up|Death|1|||
160550312|NCT02062658|579740198|FG000|Overall Study|Withdrawal by Subject|1|||
160550313|NCT02062658|579740198|FG000|Overall Study|Lack of Efficacy|1|||
160550314|NCT02574637|579740199|FG000|Double-blind Period|Adverse Event|1|||
160550315|NCT02574637|579740200|FG001|Double-blind Period|Adverse Event|0|||
160550316|NCT02574637|579740201|FG002|Double-blind Period|Adverse Event|0|||
160550317|NCT02574637|579740202|FG003|Double-blind Period|Adverse Event|0|||
160550318|NCT02574637|579740203|FG004|Double-blind Period|Adverse Event|0|||
160550319|NCT02574637|579740204|FG005|Double-blind Period|Adverse Event|0|||
160550320|NCT02574637|579740205|FG006|Double-blind Period|Adverse Event|0|||
160550321|NCT02574637|579740206|FG007|Double-blind Period|Adverse Event|0|||
160550322|NCT02574637|579740207|FG008|Double-blind Period|Adverse Event|0|||
160550323|NCT02574637|579740208|FG009|Double-blind Period|Adverse Event|0|||
160550324|NCT02574637|579740199|FG000|Double-blind Period|Lack of Efficacy|0|||
160550325|NCT02574637|579740200|FG001|Double-blind Period|Lack of Efficacy|0|||
160550326|NCT02574637|579740201|FG002|Double-blind Period|Lack of Efficacy|2|||
160550327|NCT02574637|579740202|FG003|Double-blind Period|Lack of Efficacy|0|||
160550328|NCT02574637|579740203|FG004|Double-blind Period|Lack of Efficacy|0|||
160550329|NCT02574637|579740204|FG005|Double-blind Period|Lack of Efficacy|0|||
160550330|NCT02574637|579740205|FG006|Double-blind Period|Lack of Efficacy|0|||
160550331|NCT02574637|579740206|FG007|Double-blind Period|Lack of Efficacy|0|||
160550332|NCT02574637|579740207|FG008|Double-blind Period|Lack of Efficacy|0|||
160550333|NCT02574637|579740208|FG009|Double-blind Period|Lack of Efficacy|0|||
160550334|NCT02574637|579740199|FG000|Double-blind Period|Protocol Deviation|1|||
160550335|NCT02574637|579740200|FG001|Double-blind Period|Protocol Deviation|0|||
160550336|NCT02574637|579740201|FG002|Double-blind Period|Protocol Deviation|0|||
160550337|NCT02574637|579740202|FG003|Double-blind Period|Protocol Deviation|0|||
160550338|NCT02574637|579740203|FG004|Double-blind Period|Protocol Deviation|0|||
160550339|NCT02574637|579740204|FG005|Double-blind Period|Protocol Deviation|0|||
160550340|NCT02574637|579740205|FG006|Double-blind Period|Protocol Deviation|0|||
160550341|NCT02574637|579740206|FG007|Double-blind Period|Protocol Deviation|0|||
160644534|NCT00096486|580080780|FG000|Overall Study|Withdrawal by Subject|0|||
160644535|NCT00096486|580080781|FG001|Overall Study|Withdrawal by Subject|0|||
160644536|NCT00096486|580080782|FG002|Overall Study|Withdrawal by Subject|1|||
160644537|NCT00096486|580080783|FG003|Overall Study|Withdrawal by Subject|1|||
160644538|NCT00096486|580080780|FG000|Overall Study|Not Treated|0|||
160644539|NCT00096486|580080781|FG001|Overall Study|Not Treated|0|||
160550342|NCT02574637|579740207|FG008|Double-blind Period|Protocol Deviation|0|||
160550343|NCT02574637|579740208|FG009|Double-blind Period|Protocol Deviation|0|||
160550344|NCT02574637|579740199|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
160550345|NCT02574637|579740200|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
160550346|NCT02574637|579740201|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
160550347|NCT02574637|579740202|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
160550348|NCT02574637|579740203|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
160550349|NCT02574637|579740204|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
160550350|NCT02574637|579740205|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
160550351|NCT02574637|579740206|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
160550352|NCT02574637|579740207|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
160550353|NCT02574637|579740208|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
160550354|NCT02574637|579740199|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
160550355|NCT02574637|579740200|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
160550356|NCT02574637|579740201|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
160644540|NCT00096486|580080782|FG002|Overall Study|Not Treated|1|||
160550357|NCT02574637|579740202|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
160550358|NCT02574637|579740203|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
160550359|NCT02574637|579740204|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
160550360|NCT02574637|579740205|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
160550361|NCT02574637|579740206|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
160550362|NCT02574637|579740207|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
160550363|NCT02574637|579740208|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
160550364|NCT02574637|579740199|FG000|Double-blind Period|Reason Not Specified|0|||
160550365|NCT02574637|579740200|FG001|Double-blind Period|Reason Not Specified|0|||
160550366|NCT02574637|579740201|FG002|Double-blind Period|Reason Not Specified|0|||
160550367|NCT02574637|579740202|FG003|Double-blind Period|Reason Not Specified|1|||
160550368|NCT02574637|579740203|FG004|Double-blind Period|Reason Not Specified|0|||
160550369|NCT02574637|579740204|FG005|Double-blind Period|Reason Not Specified|0|||
160550370|NCT02574637|579740205|FG006|Double-blind Period|Reason Not Specified|0|||
160550371|NCT02574637|579740206|FG007|Double-blind Period|Reason Not Specified|0|||
160550372|NCT02574637|579740207|FG008|Double-blind Period|Reason Not Specified|0|||
160898082|NCT01543698|581023378|FG004|Phase 1b|Adverse Event|2|||
160898083|NCT01543698|581023379|FG005|Phase 1b|Adverse Event|2|||
160898084|NCT01543698|581023380|FG006|Phase 1b|Adverse Event|0|||
160898085|NCT01543698|581023381|FG007|Phase 1b|Adverse Event|0|||
160898086|NCT01543698|581023382|FG008|Phase 1b|Adverse Event|1|||
160898087|NCT01543698|581023383|FG009|Phase 1b|Adverse Event|1|||
160898088|NCT01543698|581023384|FG010|Phase 1b|Adverse Event|2|||
160898089|NCT01543698|581023385|FG011|Phase 1b|Adverse Event|0|||
160898090|NCT01543698|581023386|FG012|Phase 1b|Adverse Event|0|||
160898091|NCT01543698|581023387|FG013|Phase 1b|Adverse Event|0|||
160898092|NCT01543698|581023388|FG014|Phase 1b|Adverse Event|0|||
160898093|NCT01543698|581023374|FG000|Phase 1b|Administrative problems|1|||
160898094|NCT01543698|581023375|FG001|Phase 1b|Administrative problems|0|||
160898095|NCT01543698|581023376|FG002|Phase 1b|Administrative problems|0|||
160898096|NCT01543698|581023377|FG003|Phase 1b|Administrative problems|0|||
160898097|NCT01543698|581023378|FG004|Phase 1b|Administrative problems|1|||
160898098|NCT01543698|581023379|FG005|Phase 1b|Administrative problems|0|||
160898099|NCT01543698|581023380|FG006|Phase 1b|Administrative problems|0|||
160898100|NCT01543698|581023381|FG007|Phase 1b|Administrative problems|1|||
160898101|NCT01543698|581023382|FG008|Phase 1b|Administrative problems|0|||
160898102|NCT01543698|581023383|FG009|Phase 1b|Administrative problems|0|||
160898103|NCT01543698|581023384|FG010|Phase 1b|Administrative problems|2|||
160898104|NCT01543698|581023385|FG011|Phase 1b|Administrative problems|0|||
160898105|NCT01543698|581023386|FG012|Phase 1b|Administrative problems|0|||
160898106|NCT01543698|581023387|FG013|Phase 1b|Administrative problems|0|||
160898107|NCT01543698|581023388|FG014|Phase 1b|Administrative problems|0|||
160898108|NCT01543698|581023374|FG000|Phase 1b|Protocol Violation|2|||
160898109|NCT01543698|581023375|FG001|Phase 1b|Protocol Violation|0|||
160898110|NCT01543698|581023376|FG002|Phase 1b|Protocol Violation|0|||
160898111|NCT01543698|581023377|FG003|Phase 1b|Protocol Violation|0|||
160898112|NCT01543698|581023378|FG004|Phase 1b|Protocol Violation|0|||
160898113|NCT01543698|581023379|FG005|Phase 1b|Protocol Violation|0|||
160898114|NCT01543698|581023380|FG006|Phase 1b|Protocol Violation|0|||
160898115|NCT01543698|581023381|FG007|Phase 1b|Protocol Violation|0|||
160898116|NCT01543698|581023382|FG008|Phase 1b|Protocol Violation|0|||
160898117|NCT01543698|581023383|FG009|Phase 1b|Protocol Violation|0|||
160898118|NCT01543698|581023384|FG010|Phase 1b|Protocol Violation|0|||
160550373|NCT02574637|579740208|FG009|Double-blind Period|Reason Not Specified|0|||
160550374|NCT02574637|579740199|FG000|Open-label (OL) Period|Adverse Event|0|||
160550375|NCT02574637|579740200|FG001|Open-label (OL) Period|Adverse Event|0|||
160550376|NCT02574637|579740201|FG002|Open-label (OL) Period|Adverse Event|0|||
160550377|NCT02574637|579740202|FG003|Open-label (OL) Period|Adverse Event|0|||
160550378|NCT02574637|579740203|FG004|Open-label (OL) Period|Adverse Event|0|||
160550379|NCT02574637|579740204|FG005|Open-label (OL) Period|Adverse Event|0|||
160550380|NCT02574637|579740205|FG006|Open-label (OL) Period|Adverse Event|0|||
160550381|NCT02574637|579740206|FG007|Open-label (OL) Period|Adverse Event|0|||
160550382|NCT02574637|579740207|FG008|Open-label (OL) Period|Adverse Event|1|||
160550383|NCT02574637|579740208|FG009|Open-label (OL) Period|Adverse Event|0|||
160550384|NCT02574637|579740199|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
160550385|NCT02574637|579740200|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
160550386|NCT02574637|579740201|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
160550387|NCT02574637|579740202|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
160550388|NCT02574637|579740203|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
160550389|NCT02574637|579740204|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
160898119|NCT01543698|581023385|FG011|Phase 1b|Protocol Violation|0|||
160898120|NCT01543698|581023386|FG012|Phase 1b|Protocol Violation|0|||
160898121|NCT01543698|581023387|FG013|Phase 1b|Protocol Violation|0|||
160898122|NCT01543698|581023388|FG014|Phase 1b|Protocol Violation|0|||
160898123|NCT01543698|581023374|FG000|Phase 2|Protocol Violation|0|||
160898124|NCT01543698|581023375|FG001|Phase 2|Protocol Violation|0|||
160898125|NCT01543698|581023376|FG002|Phase 2|Protocol Violation|0|||
160898126|NCT01543698|581023377|FG003|Phase 2|Protocol Violation|0|||
160550390|NCT02574637|579740205|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
160550391|NCT02574637|579740206|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
160550392|NCT02574637|579740207|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
160550393|NCT02574637|579740208|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
160550394|NCT02574637|579740199|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
160550395|NCT02574637|579740200|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
160550396|NCT02574637|579740201|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
160550397|NCT02574637|579740202|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
160550398|NCT02574637|579740203|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
160805735|NCT01791517|580676575|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
160805736|NCT01791517|580676576|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
160805737|NCT01791517|580676577|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
160805738|NCT01791517|580676578|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
160805739|NCT01791517|580676579|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
160805740|NCT01791517|580676580|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
160805741|NCT01791517|580676581|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
160805742|NCT01791517|580676582|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
160805743|NCT01791517|580676583|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
160805744|NCT01791517|580676584|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
160805745|NCT01791517|580676585|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
160805746|NCT01791517|580676574|FG000|Phase II|Pre-Existing Ocular Issue|0|||
160805747|NCT01791517|580676575|FG001|Phase II|Pre-Existing Ocular Issue|0|||
160805748|NCT01791517|580676576|FG002|Phase II|Pre-Existing Ocular Issue|0|||
160805749|NCT01791517|580676577|FG003|Phase II|Pre-Existing Ocular Issue|0|||
160898127|NCT01543698|581023378|FG004|Phase 2|Protocol Violation|0|||
160898128|NCT01543698|581023379|FG005|Phase 2|Protocol Violation|0|||
160898129|NCT01543698|581023380|FG006|Phase 2|Protocol Violation|0|||
160898130|NCT01543698|581023381|FG007|Phase 2|Protocol Violation|0|||
160898131|NCT01543698|581023382|FG008|Phase 2|Protocol Violation|0|||
160898132|NCT01543698|581023383|FG009|Phase 2|Protocol Violation|0|||
160898133|NCT01543698|581023384|FG010|Phase 2|Protocol Violation|0|||
160898134|NCT01543698|581023385|FG011|Phase 2|Protocol Violation|0|||
160898135|NCT01543698|581023386|FG012|Phase 2|Protocol Violation|1|||
160898136|NCT01543698|581023387|FG013|Phase 2|Protocol Violation|0|||
160898137|NCT01543698|581023388|FG014|Phase 2|Protocol Violation|0|||
160898138|NCT01543698|581023374|FG000|Phase 2|Disease progression|0|||
160898139|NCT01543698|581023375|FG001|Phase 2|Disease progression|0|||
160898140|NCT01543698|581023376|FG002|Phase 2|Disease progression|0|||
160898141|NCT01543698|581023377|FG003|Phase 2|Disease progression|0|||
160898142|NCT01543698|581023378|FG004|Phase 2|Disease progression|0|||
160898143|NCT01543698|581023379|FG005|Phase 2|Disease progression|0|||
160898144|NCT01543698|581023380|FG006|Phase 2|Disease progression|0|||
160898145|NCT01543698|581023381|FG007|Phase 2|Disease progression|0|||
160898146|NCT01543698|581023382|FG008|Phase 2|Disease progression|0|||
160898147|NCT01543698|581023383|FG009|Phase 2|Disease progression|0|||
160898148|NCT01543698|581023384|FG010|Phase 2|Disease progression|0|||
160898149|NCT01543698|581023385|FG011|Phase 2|Disease progression|10|||
160898150|NCT01543698|581023386|FG012|Phase 2|Disease progression|21|||
160898151|NCT01543698|581023387|FG013|Phase 2|Disease progression|30|||
160550399|NCT02574637|579740204|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
160898152|NCT01543698|581023388|FG014|Phase 2|Disease progression|25|||
160550400|NCT02574637|579740205|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
160550401|NCT02574637|579740206|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
160550402|NCT02574637|579740207|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
160550403|NCT02574637|579740208|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
160550404|NCT04029519|579740209|FG000|Overall Study|Protocol Violation|1|||
160550405|NCT04029519|579740209|FG000|Overall Study|Withdrawal by Subject|3|||
160550406|NCT04029519|579740209|FG000|Overall Study|Lost to Follow-up|1|||
160550407|NCT04823949|579740214|FG000|Overall Study|Withdrawal by Subject|0|||
160550408|NCT04823949|579740215|FG001|Overall Study|Withdrawal by Subject|4|||
160550409|NCT04823949|579740214|FG000|Overall Study|Physician Decision|0|||
160550410|NCT04823949|579740215|FG001|Overall Study|Physician Decision|1|||
160550411|NCT00939692|579740220|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
160550412|NCT00939692|579740221|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
160550413|NCT00939692|579740220|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
160550414|NCT00939692|579740221|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
160550415|NCT02462473|579740222|FG000|Overall Study|Death|1|||
160550416|NCT02462473|579740222|FG000|Overall Study|Other|3|||
160550417|NCT01536860|579740224|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
160550418|NCT01536860|579740225|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
160550419|NCT01536860|579740226|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
160550420|NCT01164722|579740227|FG000|Overall Study|Adverse Event|0|||
160550421|NCT01164722|579740228|FG001|Overall Study|Adverse Event|1|||
160550422|NCT01164722|579740227|FG000|Overall Study|Withdrawal by Subject|3|||
160550423|NCT01164722|579740228|FG001|Overall Study|Withdrawal by Subject|4|||
160550424|NCT01164722|579740227|FG000|Overall Study|Lost to Follow-up|3|||
160550425|NCT01164722|579740228|FG001|Overall Study|Lost to Follow-up|6|||
160550426|NCT01164722|579740227|FG000|Overall Study|met protocol criteria for non-treatment|11|||
160550427|NCT01164722|579740228|FG001|Overall Study|met protocol criteria for non-treatment|1|||
160550428|NCT01164722|579740227|FG000|Overall Study|enrolled on other study, concomitant med|1|||
160550429|NCT01164722|579740228|FG001|Overall Study|enrolled on other study, concomitant med|3|||
160550430|NCT03889639|579740230|FG000|Overall Study|Withdrawal by Subject|0|||
160550431|NCT03889639|579740231|FG001|Overall Study|Withdrawal by Subject|0|||
160550432|NCT03889639|579740232|FG002|Overall Study|Withdrawal by Subject|0|||
160550433|NCT03889639|579740233|FG003|Overall Study|Withdrawal by Subject|0|||
160550434|NCT03889639|579740234|FG004|Overall Study|Withdrawal by Subject|0|||
160550435|NCT03889639|579740235|FG005|Overall Study|Withdrawal by Subject|0|||
160550436|NCT03889639|579740236|FG006|Overall Study|Withdrawal by Subject|0|||
160550437|NCT03889639|579740237|FG007|Overall Study|Withdrawal by Subject|1|||
160550438|NCT01703858|579740238|FG000|Overall Study|Withdrawal by Subject|0|||
160550439|NCT01703858|579740239|FG001|Overall Study|Withdrawal by Subject|1|||
160550440|NCT01703858|579740240|FG002|Overall Study|Withdrawal by Subject|0|||
160550441|NCT02556255|579740241|FG000|Overall Study|Lost to Follow-up|4|||
160550442|NCT00993031|579740242|FG000|Overall Study|Death|0|||
160550443|NCT00993031|579740243|FG001|Overall Study|Death|1|||
160550444|NCT00993031|579740242|FG000|Overall Study|Physician Decision|0|||
160550445|NCT00993031|579740243|FG001|Overall Study|Physician Decision|2|||
160550446|NCT00993031|579740242|FG000|Overall Study|Withdrawal by Subject|3|||
160550447|NCT00993031|579740243|FG001|Overall Study|Withdrawal by Subject|3|||
160550448|NCT00993031|579740242|FG000|Overall Study|Lost to Follow-up|19|||
160550449|NCT00993031|579740243|FG001|Overall Study|Lost to Follow-up|13|||
160550450|NCT03115151|579740244|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
160550451|NCT03115151|579740245|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
160550452|NCT03115151|579740244|FG000|Overall Study|Epidural catheter removal|1|||
160550453|NCT03115151|579740245|FG001|Overall Study|Epidural catheter removal|0|||
160550454|NCT03115151|579740244|FG000|Overall Study|Withdrawal by Subject|0|||
160550455|NCT03115151|579740245|FG001|Overall Study|Withdrawal by Subject|1|||
160550456|NCT03115151|579740244|FG000|Overall Study|Intervention not received according to the protocol.|1|||
160550457|NCT03115151|579740245|FG001|Overall Study|Intervention not received according to the protocol.|1|||
160550458|NCT03115151|579740244|FG000|Overall Study|Physician Decision|1|||
160550459|NCT03115151|579740245|FG001|Overall Study|Physician Decision|0|||
160898153|NCT01543698|581023374|FG000|Phase 2|Death|0|||
160898154|NCT01543698|581023375|FG001|Phase 2|Death|0|||
160898155|NCT01543698|581023376|FG002|Phase 2|Death|0|||
160898156|NCT01543698|581023377|FG003|Phase 2|Death|0|||
160898157|NCT01543698|581023378|FG004|Phase 2|Death|0|||
160898158|NCT01543698|581023379|FG005|Phase 2|Death|0|||
160898159|NCT01543698|581023380|FG006|Phase 2|Death|0|||
160898160|NCT01543698|581023381|FG007|Phase 2|Death|0|||
160898161|NCT01543698|581023382|FG008|Phase 2|Death|0|||
160898162|NCT01543698|581023383|FG009|Phase 2|Death|0|||
160898163|NCT01543698|581023384|FG010|Phase 2|Death|0|||
160898164|NCT01543698|581023385|FG011|Phase 2|Death|0|||
160898165|NCT01543698|581023386|FG012|Phase 2|Death|1|||
160898166|NCT01543698|581023387|FG013|Phase 2|Death|1|||
160898167|NCT01543698|581023388|FG014|Phase 2|Death|1|||
160898168|NCT01543698|581023374|FG000|Phase 2|Administrative problems|0|||
160898169|NCT01543698|581023375|FG001|Phase 2|Administrative problems|0|||
160550460|NCT03115151|579740244|FG000|Overall Study|Randomization not applied|1|||
160550461|NCT03115151|579740245|FG001|Overall Study|Randomization not applied|1|||
160550462|NCT01834729|579740250|FG000|Overall Study|Did not return bowel diaries|0|||
160550463|NCT01834729|579740251|FG001|Overall Study|Did not return bowel diaries|0|||
160550464|NCT01834729|579740252|FG002|Overall Study|Did not return bowel diaries|3|||
160550465|NCT01834729|579740253|FG003|Overall Study|Did not return bowel diaries|0|||
160550466|NCT01834729|579740250|FG000|Overall Study|Withdrawal by Subject|1|||
160550467|NCT01834729|579740251|FG001|Overall Study|Withdrawal by Subject|1|||
160550468|NCT01834729|579740252|FG002|Overall Study|Withdrawal by Subject|0|||
160550469|NCT01834729|579740253|FG003|Overall Study|Withdrawal by Subject|0|||
160550470|NCT01834729|579740250|FG000|Overall Study|Adverse Event|0|||
160550471|NCT01834729|579740251|FG001|Overall Study|Adverse Event|0|||
160550472|NCT01834729|579740252|FG002|Overall Study|Adverse Event|0|||
160550473|NCT01834729|579740253|FG003|Overall Study|Adverse Event|2|||
160550474|NCT01543087|579740254|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
160550475|NCT01543087|579740255|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
160550476|NCT01543087|579740256|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
160550477|NCT01543087|579740257|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
160550478|NCT01543087|579740258|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
160550479|NCT01543087|579740259|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
160550480|NCT01543087|579740254|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
160550481|NCT01543087|579740255|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
160550482|NCT01543087|579740256|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
160550483|NCT01543087|579740257|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
160550484|NCT01543087|579740258|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
160550485|NCT01543087|579740259|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
160550486|NCT01543087|579740254|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
160550487|NCT01543087|579740255|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
160550488|NCT01543087|579740256|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
160550489|NCT01543087|579740257|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
160550490|NCT01543087|579740258|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
160550491|NCT01543087|579740259|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
160550492|NCT01543087|579740254|FG000|Stage 1 (48 Months)|Other than specified|5|||
160550493|NCT01543087|579740255|FG001|Stage 1 (48 Months)|Other than specified|0|||
160550494|NCT01543087|579740256|FG002|Stage 1 (48 Months)|Other than specified|9|||
160550495|NCT01543087|579740257|FG003|Stage 1 (48 Months)|Other than specified|0|||
160550496|NCT01543087|579740258|FG004|Stage 1 (48 Months)|Other than specified|0|||
160550497|NCT01543087|579740259|FG005|Stage 1 (48 Months)|Other than specified|0|||
160550498|NCT01543087|579740254|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
160550499|NCT01543087|579740255|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
160550500|NCT01543087|579740256|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
160550501|NCT01543087|579740257|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
160550502|NCT01543087|579740258|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
160550503|NCT01543087|579740259|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
160550504|NCT01543087|579740254|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
160550505|NCT01543087|579740255|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
160550506|NCT01543087|579740256|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
160550507|NCT01543087|579740257|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
160550508|NCT01543087|579740258|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
160550509|NCT01543087|579740259|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
160550510|NCT01543087|579740254|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
160550511|NCT01543087|579740255|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
160550512|NCT01543087|579740256|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
160550513|NCT01543087|579740257|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
160550514|NCT01543087|579740258|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
160550515|NCT01543087|579740259|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
160550516|NCT03403192|579740260|FG000|Overall Study|Lost to Follow-up|1|||
160898170|NCT01543698|581023376|FG002|Phase 2|Administrative problems|0|||
160898171|NCT01543698|581023377|FG003|Phase 2|Administrative problems|0|||
160898172|NCT01543698|581023378|FG004|Phase 2|Administrative problems|0|||
160898173|NCT01543698|581023379|FG005|Phase 2|Administrative problems|0|||
160898174|NCT01543698|581023380|FG006|Phase 2|Administrative problems|0|||
160550517|NCT03403192|579740261|FG001|Overall Study|Lost to Follow-up|2|||
160550518|NCT03403192|579740262|FG002|Overall Study|Lost to Follow-up|0|||
160550519|NCT03403192|579740263|FG003|Overall Study|Lost to Follow-up|0|||
160550520|NCT03403192|579740260|FG000|Overall Study|Unable to respond|0|||
160550521|NCT03403192|579740261|FG001|Overall Study|Unable to respond|1|||
160898175|NCT01543698|581023381|FG007|Phase 2|Administrative problems|0|||
160898176|NCT01543698|581023382|FG008|Phase 2|Administrative problems|0|||
160550522|NCT03403192|579740262|FG002|Overall Study|Unable to respond|0|||
160550523|NCT03403192|579740263|FG003|Overall Study|Unable to respond|0|||
160550524|NCT03403192|579740260|FG000|Overall Study|Incomplete|3|||
160898177|NCT01543698|581023383|FG009|Phase 2|Administrative problems|0|||
160550525|NCT03403192|579740261|FG001|Overall Study|Incomplete|1|||
160550526|NCT03403192|579740262|FG002|Overall Study|Incomplete|3|||
160550527|NCT03403192|579740263|FG003|Overall Study|Incomplete|6|||
160550528|NCT04673786|579740264|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
160550529|NCT04673786|579740265|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
160550530|NCT04673786|579740266|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
160550531|NCT04673786|579740264|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
160550532|NCT04673786|579740265|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
160550533|NCT04673786|579740266|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
160550534|NCT04673786|579740264|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
160550535|NCT04673786|579740265|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
160550536|NCT04673786|579740266|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
160550537|NCT04673786|579740264|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
160550538|NCT04673786|579740265|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
160550539|NCT04673786|579740266|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
160550540|NCT04673786|579740264|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
160550541|NCT04673786|579740265|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
160550542|NCT04673786|579740266|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
160550543|NCT04673786|579740264|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
160550544|NCT04673786|579740265|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
160550545|NCT04673786|579740266|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
160550546|NCT01298492|579740267|FG000|Overall Study|Death|2|||
160550547|NCT01298492|579740267|FG000|Overall Study|Insufficient Clinical Response|22|||
160550548|NCT01298492|579740267|FG000|Overall Study|Lost to Follow-up|12|||
160550549|NCT01298492|579740267|FG000|Overall Study|Withdrawal by Subject|47|||
160550550|NCT01298492|579740267|FG000|Overall Study|Other (Unspecified)|7|||
160550551|NCT01298492|579740267|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
160550552|NCT01298492|579740267|FG000|Overall Study|Protocol Violation|2|||
160550553|NCT01298492|579740267|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
160550554|NCT01298492|579740267|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
160550555|NCT02902120|579740269|FG000|Overall Study|Lack of Efficacy|1|||
160550556|NCT03298022|579740270|FG000|Overall Study|Lack of Efficacy|4|||
160550557|NCT03298022|579740270|FG000|Overall Study|Withdrawal by Subject|7|||
160550558|NCT03298022|579740270|FG000|Overall Study|Adverse Event|1|||
160550559|NCT03298022|579740270|FG000|Overall Study|disease relapse|1|||
160550560|NCT03694925|579740271|FG000|Overall Study|Inadequate laboratory testing|0|||
160550561|NCT03694925|579740272|FG001|Overall Study|Inadequate laboratory testing|3|||
160550562|NCT03694925|579740273|FG002|Overall Study|Inadequate laboratory testing|0|||
160550563|NCT01422239|579740274|FG000|Overall Study|Lost to Follow-up|4|||
160550564|NCT01422239|579740275|FG001|Overall Study|Lost to Follow-up|3|||
160550565|NCT03033875|579740276|FG000|Overall Study|Withdrawal by Subject|5|||
160550566|NCT03033875|579740277|FG001|Overall Study|Withdrawal by Subject|9|||
160550567|NCT03033875|579740278|FG002|Overall Study|Withdrawal by Subject|4|||
160550568|NCT03033875|579740276|FG000|Overall Study|Other|14|||
160550569|NCT03033875|579740277|FG001|Overall Study|Other|15|||
160550570|NCT03033875|579740278|FG002|Overall Study|Other|8|||
160550571|NCT03595553|579740279|FG000|Overall Study|Withdrawal by Subject|20|||
160550572|NCT03595553|579740280|FG001|Overall Study|Withdrawal by Subject|8|||
160550573|NCT03595553|579740279|FG000|Overall Study|Physician Decision|3|||
160550574|NCT03595553|579740280|FG001|Overall Study|Physician Decision|2|||
160550575|NCT03595553|579740279|FG000|Overall Study|Adverse Event|2|||
160550576|NCT03595553|579740280|FG001|Overall Study|Adverse Event|5|||
160550577|NCT03595553|579740279|FG000|Overall Study|Death|24|||
160550578|NCT03595553|579740280|FG001|Overall Study|Death|22|||
160550579|NCT03595553|579740279|FG000|Overall Study|Lost to Follow-up|6|||
160550580|NCT03595553|579740280|FG001|Overall Study|Lost to Follow-up|7|||
160550581|NCT03595553|579740279|FG000|Overall Study|Other as indicated in CSR|3|||
160550582|NCT03595553|579740280|FG001|Overall Study|Other as indicated in CSR|3|||
160550583|NCT03595553|579740279|FG000|Overall Study|Sponsor Decision|0|||
160898178|NCT01543698|581023384|FG010|Phase 2|Administrative problems|0|||
160550584|NCT03595553|579740280|FG001|Overall Study|Sponsor Decision|1|||
160550585|NCT03467958|579740281|FG000|Overall Study|Adverse Event|20|||
160550586|NCT03467958|579740282|FG001|Overall Study|Adverse Event|32|||
160550587|NCT03467958|579740283|FG002|Overall Study|Adverse Event|5|||
160550588|NCT03467958|579740284|FG003|Overall Study|Adverse Event|3|||
160550589|NCT03467958|579740285|FG004|Overall Study|Adverse Event|3|||
160550590|NCT03467958|579740286|FG005|Overall Study|Adverse Event|3|||
160550591|NCT03467958|579740287|FG006|Overall Study|Adverse Event|6|||
160550592|NCT03467958|579740288|FG007|Overall Study|Adverse Event|5|||
160550593|NCT03467958|579740289|FG008|Overall Study|Adverse Event|0|||
160898179|NCT01543698|581023385|FG011|Phase 2|Administrative problems|0|||
160898180|NCT01543698|581023386|FG012|Phase 2|Administrative problems|0|||
160550594|NCT03467958|579740281|FG000|Overall Study|Lack of Efficacy|59|||
160550595|NCT03467958|579740282|FG001|Overall Study|Lack of Efficacy|120|||
160550596|NCT03467958|579740283|FG002|Overall Study|Lack of Efficacy|6|||
160898181|NCT01543698|581023387|FG013|Phase 2|Administrative problems|3|||
160550597|NCT03467958|579740284|FG003|Overall Study|Lack of Efficacy|9|||
160644541|NCT00096486|580080783|FG003|Overall Study|Not Treated|1|||
160644542|NCT04071626|580080784|FG000|Overall Study|Withdrawal by Subject|1|||
160644543|NCT04071626|580080785|FG001|Overall Study|Withdrawal by Subject|1|||
160644544|NCT04071626|580080784|FG000|Overall Study|Protocol Violation|0|||
160644545|NCT04071626|580080785|FG001|Overall Study|Protocol Violation|1|||
160644546|NCT00580983|580080786|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
160644547|NCT00811070|580080787|FG000|Overall Study|Death|0|||
160644548|NCT00811070|580080788|FG001|Overall Study|Death|0|||
160550598|NCT03467958|579740285|FG004|Overall Study|Lack of Efficacy|8|||
160550599|NCT03467958|579740286|FG005|Overall Study|Lack of Efficacy|9|||
160550600|NCT03467958|579740287|FG006|Overall Study|Lack of Efficacy|11|||
160550601|NCT03467958|579740288|FG007|Overall Study|Lack of Efficacy|9|||
160550602|NCT03467958|579740289|FG008|Overall Study|Lack of Efficacy|3|||
160550603|NCT03467958|579740281|FG000|Overall Study|Lost to Follow-up|1|||
160550604|NCT03467958|579740282|FG001|Overall Study|Lost to Follow-up|2|||
160550605|NCT03467958|579740283|FG002|Overall Study|Lost to Follow-up|1|||
160550606|NCT03467958|579740284|FG003|Overall Study|Lost to Follow-up|0|||
160550607|NCT03467958|579740285|FG004|Overall Study|Lost to Follow-up|4|||
160550608|NCT03467958|579740286|FG005|Overall Study|Lost to Follow-up|0|||
160550609|NCT03467958|579740287|FG006|Overall Study|Lost to Follow-up|0|||
160550610|NCT03467958|579740288|FG007|Overall Study|Lost to Follow-up|0|||
160644549|NCT00811070|580080789|FG002|Overall Study|Death|0|||
160644550|NCT00811070|580080790|FG003|Overall Study|Death|2|||
160550611|NCT03467958|579740289|FG008|Overall Study|Lost to Follow-up|0|||
160550612|NCT03467958|579740281|FG000|Overall Study|Other reasons|8|||
160550613|NCT03467958|579740282|FG001|Overall Study|Other reasons|14|||
160550614|NCT03467958|579740283|FG002|Overall Study|Other reasons|2|||
160550615|NCT03467958|579740284|FG003|Overall Study|Other reasons|1|||
160550616|NCT03467958|579740285|FG004|Overall Study|Other reasons|4|||
160644551|NCT00811070|580080791|FG004|Overall Study|Death|5|||
160644552|NCT00811070|580080792|FG005|Overall Study|Death|0|||
160644553|NCT00811070|580080787|FG000|Overall Study|Other|1|||
160550617|NCT03467958|579740286|FG005|Overall Study|Other reasons|0|||
160644554|NCT00811070|580080788|FG001|Overall Study|Other|0|||
160644555|NCT00811070|580080789|FG002|Overall Study|Other|0|||
160644556|NCT00811070|580080790|FG003|Overall Study|Other|0|||
160644557|NCT00811070|580080791|FG004|Overall Study|Other|0|||
160550618|NCT03467958|579740287|FG006|Overall Study|Other reasons|1|||
160550619|NCT03467958|579740288|FG007|Overall Study|Other reasons|0|||
160550620|NCT03467958|579740289|FG008|Overall Study|Other reasons|1|||
160550621|NCT03467958|579740281|FG000|Overall Study|Pregnancy|1|||
160550622|NCT03467958|579740282|FG001|Overall Study|Pregnancy|0|||
160550623|NCT03467958|579740283|FG002|Overall Study|Pregnancy|0|||
160550624|NCT03467958|579740284|FG003|Overall Study|Pregnancy|0|||
160550625|NCT03467958|579740285|FG004|Overall Study|Pregnancy|0|||
160550626|NCT03467958|579740286|FG005|Overall Study|Pregnancy|1|||
160644558|NCT00811070|580080792|FG005|Overall Study|Other|0|||
160644559|NCT00811070|580080787|FG000|Overall Study|Withdrawal by Subject|0|||
160644560|NCT00811070|580080788|FG001|Overall Study|Withdrawal by Subject|1|||
160644561|NCT00811070|580080789|FG002|Overall Study|Withdrawal by Subject|0|||
160644562|NCT00811070|580080790|FG003|Overall Study|Withdrawal by Subject|0|||
160644563|NCT00811070|580080791|FG004|Overall Study|Withdrawal by Subject|0|||
160644564|NCT00811070|580080792|FG005|Overall Study|Withdrawal by Subject|0|||
160644565|NCT00811070|580080787|FG000|Overall Study|Physician Decision|0|||
160644566|NCT00811070|580080788|FG001|Overall Study|Physician Decision|0|||
160644567|NCT00811070|580080789|FG002|Overall Study|Physician Decision|0|||
160644568|NCT00811070|580080790|FG003|Overall Study|Physician Decision|0|||
160644569|NCT00811070|580080791|FG004|Overall Study|Physician Decision|0|||
160644570|NCT00811070|580080792|FG005|Overall Study|Physician Decision|1|||
160644571|NCT00665626|580080793|FG000|Overall Study|Lack of Efficacy|8|||
160644572|NCT00665626|580080794|FG001|Overall Study|Lack of Efficacy|5|||
160644573|NCT00665626|580080793|FG000|Overall Study|Lost to Follow-up|0|||
160644574|NCT00665626|580080794|FG001|Overall Study|Lost to Follow-up|2|||
160805750|NCT01791517|580676578|FG004|Phase II|Pre-Existing Ocular Issue|0|||
160805751|NCT01791517|580676579|FG005|Phase II|Pre-Existing Ocular Issue|0|||
160805752|NCT01791517|580676580|FG006|Phase II|Pre-Existing Ocular Issue|0|||
160805753|NCT01791517|580676581|FG007|Phase II|Pre-Existing Ocular Issue|0|||
160805754|NCT01791517|580676582|FG008|Phase II|Pre-Existing Ocular Issue|0|||
160550627|NCT03467958|579740287|FG006|Overall Study|Pregnancy|0|||
160805755|NCT01791517|580676583|FG009|Phase II|Pre-Existing Ocular Issue|0|||
160644575|NCT00665626|580080793|FG000|Overall Study|Withdrawal by Subject|0|||
160644576|NCT00665626|580080794|FG001|Overall Study|Withdrawal by Subject|1|||
160644577|NCT00665626|580080793|FG000|Overall Study|Protocol Violation|0|||
160644578|NCT00665626|580080794|FG001|Overall Study|Protocol Violation|2|||
160644579|NCT00665626|580080793|FG000|Overall Study|Adverse Event|1|||
160644580|NCT00665626|580080794|FG001|Overall Study|Adverse Event|9|||
160550628|NCT03467958|579740288|FG007|Overall Study|Pregnancy|0|||
160550629|NCT03467958|579740289|FG008|Overall Study|Pregnancy|0|||
160550630|NCT03467958|579740281|FG000|Overall Study|Study terminated by sponsor|65|||
160644581|NCT00665626|580080793|FG000|Overall Study|Due to exclusion criteria|0|||
160805756|NCT01791517|580676584|FG010|Phase II|Pre-Existing Ocular Issue|0|||
160805757|NCT01791517|580676585|FG011|Phase II|Pre-Existing Ocular Issue|1|||
160805758|NCT00589797|580676586|FG000|Overall Study|Death|1|||
160805759|NCT00589797|580676587|FG001|Overall Study|Death|0|||
160805760|NCT00589797|580676586|FG000|Overall Study|Lost to Follow-up|12|||
160550631|NCT03467958|579740282|FG001|Overall Study|Study terminated by sponsor|117|||
160550632|NCT03467958|579740283|FG002|Overall Study|Study terminated by sponsor|45|||
160550633|NCT03467958|579740284|FG003|Overall Study|Study terminated by sponsor|64|||
160550634|NCT03467958|579740285|FG004|Overall Study|Study terminated by sponsor|66|||
160550635|NCT03467958|579740286|FG005|Overall Study|Study terminated by sponsor|17|||
160550636|NCT03467958|579740287|FG006|Overall Study|Study terminated by sponsor|11|||
160550637|NCT03467958|579740288|FG007|Overall Study|Study terminated by sponsor|5|||
160550638|NCT03467958|579740289|FG008|Overall Study|Study terminated by sponsor|5|||
160550639|NCT03467958|579740281|FG000|Overall Study|Withdrawal by Subject|25|||
160550640|NCT03467958|579740282|FG001|Overall Study|Withdrawal by Subject|44|||
160550641|NCT03467958|579740283|FG002|Overall Study|Withdrawal by Subject|7|||
160550642|NCT03467958|579740284|FG003|Overall Study|Withdrawal by Subject|8|||
160550643|NCT03467958|579740285|FG004|Overall Study|Withdrawal by Subject|6|||
160550644|NCT03467958|579740286|FG005|Overall Study|Withdrawal by Subject|8|||
160550645|NCT03467958|579740287|FG006|Overall Study|Withdrawal by Subject|4|||
160550646|NCT03467958|579740288|FG007|Overall Study|Withdrawal by Subject|1|||
160550647|NCT03467958|579740289|FG008|Overall Study|Withdrawal by Subject|4|||
160550648|NCT00730639|579740290|FG000|Overall Study|Adverse Event|3|||
160550649|NCT00730639|579740291|FG001|Overall Study|Adverse Event|0|||
160550650|NCT00730639|579740292|FG002|Overall Study|Adverse Event|9|||
160550651|NCT00730639|579740293|FG003|Overall Study|Adverse Event|8|||
160550652|NCT00730639|579740294|FG004|Overall Study|Adverse Event|23|||
160550653|NCT00730639|579740290|FG000|Overall Study|Complete Response|0|||
160550654|NCT00730639|579740291|FG001|Overall Study|Complete Response|0|||
160550655|NCT00730639|579740292|FG002|Overall Study|Complete Response|2|||
160550656|NCT00730639|579740293|FG003|Overall Study|Complete Response|2|||
160550657|NCT00730639|579740294|FG004|Overall Study|Complete Response|1|||
160550658|NCT00730639|579740290|FG000|Overall Study|Completed Maximum Cycles|0|||
160550659|NCT00730639|579740291|FG001|Overall Study|Completed Maximum Cycles|0|||
160550660|NCT00730639|579740292|FG002|Overall Study|Completed Maximum Cycles|11|||
160644582|NCT00665626|580080794|FG001|Overall Study|Due to exclusion criteria|1|||
160644583|NCT00665626|580080793|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
160644584|NCT00665626|580080794|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
160805761|NCT00589797|580676587|FG001|Overall Study|Lost to Follow-up|9|||
160805762|NCT00589797|580676586|FG000|Overall Study|Physician Decision|8|||
160805763|NCT00589797|580676587|FG001|Overall Study|Physician Decision|3|||
160805764|NCT00589797|580676586|FG000|Overall Study|Withdrawal by Subject|6|||
160805765|NCT00589797|580676587|FG001|Overall Study|Withdrawal by Subject|5|||
160805766|NCT00589797|580676586|FG000|Overall Study|Non-Randomized Training Subjects|46|||
160805767|NCT00589797|580676587|FG001|Overall Study|Non-Randomized Training Subjects|6|||
160805768|NCT02141672|580676589|FG000|Overall Study|Adverse Event|0|||
160805769|NCT02141672|580676590|FG001|Overall Study|Adverse Event|1|||
160805770|NCT02141672|580676591|FG002|Overall Study|Adverse Event|0|||
160805771|NCT02141672|580676589|FG000|Overall Study|Death|10|||
160805772|NCT02141672|580676590|FG001|Overall Study|Death|2|||
160805773|NCT02141672|580676591|FG002|Overall Study|Death|1|||
160805774|NCT02141672|580676589|FG000|Overall Study|Lack of Efficacy|0|||
160805775|NCT02141672|580676590|FG001|Overall Study|Lack of Efficacy|0|||
160805776|NCT02141672|580676591|FG002|Overall Study|Lack of Efficacy|2|||
160805777|NCT02141672|580676589|FG000|Overall Study|Lost to Follow-up|1|||
160805778|NCT02141672|580676590|FG001|Overall Study|Lost to Follow-up|1|||
160805779|NCT02141672|580676591|FG002|Overall Study|Lost to Follow-up|3|||
160805780|NCT02141672|580676589|FG000|Overall Study|Physician Decision|1|||
160805781|NCT02141672|580676590|FG001|Overall Study|Physician Decision|2|||
160805782|NCT02141672|580676591|FG002|Overall Study|Physician Decision|5|||
160805783|NCT02141672|580676589|FG000|Overall Study|Protocol Violation|0|||
160805784|NCT02141672|580676590|FG001|Overall Study|Protocol Violation|0|||
160805785|NCT02141672|580676591|FG002|Overall Study|Protocol Violation|1|||
160805786|NCT02141672|580676589|FG000|Overall Study|Withdrawal by Subject|3|||
160805787|NCT02141672|580676590|FG001|Overall Study|Withdrawal by Subject|2|||
160805788|NCT02141672|580676591|FG002|Overall Study|Withdrawal by Subject|5|||
160805789|NCT02141672|580676589|FG000|Overall Study|refused to follow-up|1|||
160805790|NCT02141672|580676590|FG001|Overall Study|refused to follow-up|0|||
160805791|NCT02141672|580676591|FG002|Overall Study|refused to follow-up|1|||
160805792|NCT02688192|580676592|FG000|Overall Study|Lost to Follow-up|11|||
160805793|NCT02688192|580676593|FG001|Overall Study|Lost to Follow-up|5|||
160805794|NCT02688192|580676592|FG000|Overall Study|Physician Decision|1|||
160805795|NCT02688192|580676593|FG001|Overall Study|Physician Decision|0|||
160805796|NCT01773967|580676594|FG000|Overall Study|Lost to Follow-up|15|||
160805797|NCT01773967|580676595|FG001|Overall Study|Lost to Follow-up|13|||
160805798|NCT02803203|580676600|FG000|Overall Study|Adverse Event|4|||
160805799|NCT02803203|580676600|FG000|Overall Study|Death|4|||
160805800|NCT02803203|580676600|FG000|Overall Study|Progressive disease|29|||
160898182|NCT01543698|581023388|FG014|Phase 2|Administrative problems|1|||
160550661|NCT00730639|579740293|FG003|Overall Study|Completed Maximum Cycles|3|||
160550662|NCT00730639|579740294|FG004|Overall Study|Completed Maximum Cycles|6|||
160550663|NCT00730639|579740290|FG000|Overall Study|Death|0|||
160550664|NCT00730639|579740291|FG001|Overall Study|Death|0|||
160550665|NCT00730639|579740292|FG002|Overall Study|Death|0|||
160550666|NCT00730639|579740293|FG003|Overall Study|Death|0|||
160550667|NCT00730639|579740294|FG004|Overall Study|Death|2|||
160550668|NCT00730639|579740290|FG000|Overall Study|Disease Progression|12|||
160550669|NCT00730639|579740291|FG001|Overall Study|Disease Progression|13|||
160550670|NCT00730639|579740292|FG002|Overall Study|Disease Progression|48|||
160550671|NCT00730639|579740293|FG003|Overall Study|Disease Progression|32|||
160550672|NCT00730639|579740294|FG004|Overall Study|Disease Progression|88|||
160550673|NCT00730639|579740290|FG000|Overall Study|non-specified|0|||
160550674|NCT00730639|579740291|FG001|Overall Study|non-specified|0|||
160550675|NCT00730639|579740292|FG002|Overall Study|non-specified|4|||
160550676|NCT00730639|579740293|FG003|Overall Study|non-specified|2|||
160550677|NCT00730639|579740294|FG004|Overall Study|non-specified|3|||
160550678|NCT00730639|579740290|FG000|Overall Study|Protocol Violation|0|||
160550679|NCT00730639|579740291|FG001|Overall Study|Protocol Violation|0|||
160550680|NCT00730639|579740292|FG002|Overall Study|Protocol Violation|1|||
160550681|NCT00730639|579740293|FG003|Overall Study|Protocol Violation|0|||
160550682|NCT00730639|579740294|FG004|Overall Study|Protocol Violation|0|||
160550683|NCT00730639|579740290|FG000|Overall Study|Withdrawal by Subject|0|||
160550684|NCT00730639|579740291|FG001|Overall Study|Withdrawal by Subject|0|||
160550685|NCT00730639|579740292|FG002|Overall Study|Withdrawal by Subject|6|||
160550686|NCT00730639|579740293|FG003|Overall Study|Withdrawal by Subject|3|||
160550687|NCT00730639|579740294|FG004|Overall Study|Withdrawal by Subject|4|||
160550688|NCT00730639|579740290|FG000|Overall Study|Treatment on-going|2|||
160550689|NCT00730639|579740291|FG001|Overall Study|Treatment on-going|5|||
160550690|NCT00730639|579740292|FG002|Overall Study|Treatment on-going|5|||
160550691|NCT00730639|579740293|FG003|Overall Study|Treatment on-going|4|||
160550692|NCT00730639|579740294|FG004|Overall Study|Treatment on-going|4|||
160550693|NCT00516737|579740300|FG000|Overall Study|Lost to Follow-up|2|||
160550694|NCT00516737|579740301|FG001|Overall Study|Lost to Follow-up|0|||
160550695|NCT00516737|579740300|FG000|Overall Study|Physician Decision|0|||
160550696|NCT00516737|579740301|FG001|Overall Study|Physician Decision|1|||
160550697|NCT00516737|579740300|FG000|Overall Study|Withdrawal by Subject|0|||
160550698|NCT00516737|579740301|FG001|Overall Study|Withdrawal by Subject|1|||
160550699|NCT00516737|579740300|FG000|Overall Study|Lack of Qualifying Event|9|||
160550700|NCT00516737|579740301|FG001|Overall Study|Lack of Qualifying Event|6|||
160550701|NCT00848354|579740302|FG000|Phase 1|Adverse Event|5|||
160550702|NCT00848354|579740303|FG001|Phase 1|Adverse Event|4|||
160550703|NCT00848354|579740302|FG000|Phase 1|Discontinuation of study by sponsor|2|||
160550704|NCT00848354|579740303|FG001|Phase 1|Discontinuation of study by sponsor|1|||
160550705|NCT00848354|579740302|FG000|Phase 1|Failed to return|0|||
160550706|NCT00848354|579740303|FG001|Phase 1|Failed to return|1|||
160550707|NCT00848354|579740302|FG000|Phase 1|Lost to Follow-up|1|||
160550708|NCT00848354|579740303|FG001|Phase 1|Lost to Follow-up|1|||
160550709|NCT00848354|579740302|FG000|Phase 1|Unspecified Reason|1|||
160550710|NCT00848354|579740303|FG001|Phase 1|Unspecified Reason|1|||
160550711|NCT00848354|579740302|FG000|Phase 1|Protocol Violation|1|||
160550712|NCT00848354|579740303|FG001|Phase 1|Protocol Violation|1|||
160550713|NCT00848354|579740302|FG000|Phase 1|Withdrawal by Subject|2|||
160550714|NCT00848354|579740303|FG001|Phase 1|Withdrawal by Subject|4|||
160550715|NCT00848354|579740302|FG000|Phase 1|Lack of Efficacy|0|||
160550716|NCT00848354|579740303|FG001|Phase 1|Lack of Efficacy|1|||
160550717|NCT00848354|579740302|FG000|Phase 2 Year 1|Adverse Event|7|||
160550718|NCT00848354|579740303|FG001|Phase 2 Year 1|Adverse Event|2|||
160550719|NCT00848354|579740302|FG000|Phase 2 Year 1|Death|1|||
160550720|NCT00848354|579740303|FG001|Phase 2 Year 1|Death|0|||
160550721|NCT00848354|579740302|FG000|Phase 2 Year 1|Failed to Return|1|||
160644585|NCT00665626|580080793|FG000|Overall Study|Unably to comply with dosing regimen|0|||
160805801|NCT02803203|580676600|FG000|Overall Study|Withdrawal by Subject|8|||
160805802|NCT02803203|580676600|FG000|Overall Study|Complete resection of target disease|2|||
160805803|NCT02803203|580676600|FG000|Overall Study|Switched to commercial Osi|1|||
160805804|NCT02803203|580676600|FG000|Overall Study|Participant moved away|1|||
160805805|NCT00590967|580676601|FG000|Overall Study|Withdrawal by Subject|1|||
160550722|NCT00848354|579740303|FG001|Phase 2 Year 1|Failed to Return|1|||
160550723|NCT00848354|579740302|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
160550724|NCT00848354|579740303|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
160550725|NCT00848354|579740302|FG000|Phase 2 Year 1|Unspecified Reason|3|||
160550726|NCT00848354|579740303|FG001|Phase 2 Year 1|Unspecified Reason|0|||
160550727|NCT00848354|579740302|FG000|Phase 2 Year 1|Protocol Violation|4|||
160550728|NCT00848354|579740303|FG001|Phase 2 Year 1|Protocol Violation|1|||
160550729|NCT00848354|579740302|FG000|Phase 2 Year 1|Subject Request|1|||
160550730|NCT00848354|579740303|FG001|Phase 2 Year 1|Subject Request|2|||
160550731|NCT00848354|579740302|FG000|Phase 2 Year 2|Adverse Event|12|||
160550732|NCT00848354|579740303|FG001|Phase 2 Year 2|Adverse Event|2|||
160550733|NCT00848354|579740302|FG000|Phase 2 Year 2|Death|2|||
160550734|NCT00848354|579740303|FG001|Phase 2 Year 2|Death|0|||
160550735|NCT00848354|579740302|FG000|Phase 2 Year 2|Failed to return|3|||
160805806|NCT00590967|580676602|FG001|Overall Study|Withdrawal by Subject|1|||
160805807|NCT00590967|580676601|FG000|Overall Study|Ineligible|1|||
160805808|NCT00590967|580676602|FG001|Overall Study|Ineligible|0|||
160805809|NCT00590967|580676601|FG000|Overall Study|Poor performance status|0|||
160805810|NCT00590967|580676602|FG001|Overall Study|Poor performance status|1|||
160805811|NCT00590967|580676601|FG000|Overall Study|Non-compliant|0|||
160805812|NCT00590967|580676602|FG001|Overall Study|Non-compliant|2|||
160805813|NCT00590967|580676601|FG000|Overall Study|Did not sign consent form|0|||
160805814|NCT00590967|580676602|FG001|Overall Study|Did not sign consent form|1|||
160805815|NCT00590967|580676601|FG000|Overall Study|Did not receive chemo per protocol|1|||
160805816|NCT00590967|580676602|FG001|Overall Study|Did not receive chemo per protocol|0|||
160805817|NCT01881789|580676603|FG000|Overall Study|Withdrawal by Subject|0|||
160898183|NCT01543698|581023374|FG000|Phase 2|Withdrawal by Subject|0|||
160898184|NCT01543698|581023375|FG001|Phase 2|Withdrawal by Subject|0|||
160898185|NCT01543698|581023376|FG002|Phase 2|Withdrawal by Subject|0|||
160898186|NCT01543698|581023377|FG003|Phase 2|Withdrawal by Subject|0|||
160898187|NCT01543698|581023378|FG004|Phase 2|Withdrawal by Subject|0|||
160898188|NCT01543698|581023379|FG005|Phase 2|Withdrawal by Subject|0|||
160898189|NCT01543698|581023380|FG006|Phase 2|Withdrawal by Subject|0|||
160805818|NCT01881789|580676604|FG001|Overall Study|Withdrawal by Subject|2|||
160805819|NCT01881789|580676605|FG002|Overall Study|Withdrawal by Subject|1|||
160805820|NCT01881789|580676606|FG003|Overall Study|Withdrawal by Subject|0|||
160898190|NCT01543698|581023381|FG007|Phase 2|Withdrawal by Subject|0|||
160805821|NCT01881789|580676607|FG004|Overall Study|Withdrawal by Subject|1|||
160805822|NCT01881789|580676608|FG005|Overall Study|Withdrawal by Subject|1|||
160805823|NCT01881789|580676603|FG000|Overall Study|Study Terminated by Sponsor|0|||
160805824|NCT01881789|580676604|FG001|Overall Study|Study Terminated by Sponsor|0|||
160805825|NCT01881789|580676605|FG002|Overall Study|Study Terminated by Sponsor|0|||
160805826|NCT01881789|580676606|FG003|Overall Study|Study Terminated by Sponsor|0|||
160805827|NCT01881789|580676607|FG004|Overall Study|Study Terminated by Sponsor|0|||
160805828|NCT01881789|580676608|FG005|Overall Study|Study Terminated by Sponsor|1|||
160805829|NCT01881789|580676603|FG000|Overall Study|Other|3|||
160805830|NCT01881789|580676604|FG001|Overall Study|Other|5|||
160805831|NCT01881789|580676605|FG002|Overall Study|Other|2|||
160805832|NCT01881789|580676606|FG003|Overall Study|Other|3|||
160805833|NCT01881789|580676607|FG004|Overall Study|Other|1|||
160805834|NCT01881789|580676608|FG005|Overall Study|Other|1|||
160805835|NCT00920556|580676609|FG000|Overall Study|Adverse Event|16|||
160805836|NCT00920556|580676609|FG000|Overall Study|Physician Decision|7|||
160898191|NCT01543698|581023382|FG008|Phase 2|Withdrawal by Subject|0|||
160805837|NCT00920556|580676609|FG000|Overall Study|Withdrawal by Subject|1|||
160805838|NCT02834819|580676610|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
160898192|NCT01543698|581023383|FG009|Phase 2|Withdrawal by Subject|0|||
160985325|NCT02550873|581335427|FG000|Randomized Double Blind|Adverse Event|3|||
160985326|NCT02550873|581335428|FG001|Randomized Double Blind|Adverse Event|1|||
160985327|NCT02550873|581335429|FG002|Randomized Double Blind|Adverse Event|0|||
160985328|NCT02550873|581335427|FG000|Randomized Double Blind|Disease progression|1|||
160985329|NCT02550873|581335428|FG001|Randomized Double Blind|Disease progression|1|||
160550736|NCT00848354|579740303|FG001|Phase 2 Year 2|Failed to return|0|||
160550737|NCT00848354|579740302|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
160550738|NCT00848354|579740303|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
160550739|NCT00848354|579740302|FG000|Phase 2 Year 2|Unspecified Reason|1|||
160550740|NCT00848354|579740303|FG001|Phase 2 Year 2|Unspecified Reason|0|||
160550741|NCT00848354|579740302|FG000|Phase 2 Year 2|Protocol Violation|1|||
160550742|NCT00848354|579740303|FG001|Phase 2 Year 2|Protocol Violation|1|||
160550743|NCT00848354|579740302|FG000|Phase 2 Year 2|Subject Request|1|||
160550744|NCT00848354|579740303|FG001|Phase 2 Year 2|Subject Request|1|||
160550745|NCT00848354|579740302|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
160550746|NCT00848354|579740303|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
160550747|NCT00716976|579742198|FG000|Overall Study|Adverse Event|2|||
160550748|NCT00716976|579742199|FG001|Overall Study|Adverse Event|0|||
160550749|NCT00716976|579742198|FG000|Overall Study|Death|1|||
160550750|NCT00716976|579742199|FG001|Overall Study|Death|0|||
160550751|NCT00716976|579742198|FG000|Overall Study|Physician Decision|2|||
160550752|NCT00716976|579742199|FG001|Overall Study|Physician Decision|2|||
160550753|NCT00716976|579742198|FG000|Overall Study|Withdrawal by Subject|5|||
160550754|NCT00716976|579742199|FG001|Overall Study|Withdrawal by Subject|1|||
160550755|NCT00716976|579742198|FG000|Overall Study|Premature discontinuation cisplatin|5|||
160550756|NCT00716976|579742199|FG001|Overall Study|Premature discontinuation cisplatin|4|||
160550757|NCT00716976|579742198|FG000|Overall Study|Radiation during protocol|1|||
160550758|NCT00716976|579742199|FG001|Overall Study|Radiation during protocol|0|||
160550759|NCT00716976|579742198|FG000|Overall Study|Ineligibles|4|||
160985330|NCT02550873|581335429|FG002|Randomized Double Blind|Disease progression|0|||
160550760|NCT00716976|579742199|FG001|Overall Study|Ineligibles|2|||
160550761|NCT00805740|579742200|FG000|Overall Study|Death|7|||
160550762|NCT00805740|579742201|FG001|Overall Study|Death|4|||
160550763|NCT00805740|579742200|FG000|Overall Study|Withdrawal by Subject|1|||
160550764|NCT00805740|579742201|FG001|Overall Study|Withdrawal by Subject|0|||
160550765|NCT00805740|579742200|FG000|Overall Study|Lost to Follow-up|1|||
160805839|NCT02834819|580676611|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
160805840|NCT00087698|580676618|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
160805841|NCT00087698|580676618|FG000|Overall Study|Death from Other Causes|3|||
160805842|NCT00087698|580676618|FG000|Overall Study|Adverse Event|4|||
160805843|NCT00087698|580676618|FG000|Overall Study|Withdrawal by Subject|4|||
160805844|NCT00087698|580676618|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
160805845|NCT00087698|580676618|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
160805846|NCT00087698|580676618|FG000|Overall Study|Clinical Relapse|1|||
160805847|NCT00087698|580676618|FG000|Overall Study|Death from Study Disease|2|||
160805848|NCT00087698|580676618|FG000|Overall Study|Death from Study Drug Toxicity|2|||
160805849|NCT00087698|580676618|FG000|Overall Study|Protocol Violation|1|||
160805850|NCT00657267|580676625|FG000|Overall Study|Progressive disease|45|||
160805851|NCT00657267|580676625|FG000|Overall Study|Adverse Event|9|||
160805852|NCT02737501|580676626|FG000|Randomized Phase|Died|41|||
160805853|NCT02737501|580676627|FG001|Randomized Phase|Died|29|||
160805854|NCT02737501|580676628|FG002|Randomized Phase|Died|0|||
160805855|NCT02737501|580676626|FG000|Randomized Phase|Withdrawal by Subject|16|||
160805856|NCT02737501|580676627|FG001|Randomized Phase|Withdrawal by Subject|6|||
160805857|NCT02737501|580676628|FG002|Randomized Phase|Withdrawal by Subject|0|||
160805858|NCT02737501|580676626|FG000|Randomized Phase|Lost to Follow-up|0|||
160805859|NCT02737501|580676627|FG001|Randomized Phase|Lost to Follow-up|1|||
160805860|NCT02737501|580676628|FG002|Randomized Phase|Lost to Follow-up|0|||
160805861|NCT02737501|580676626|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
160805862|NCT02737501|580676627|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
160805863|NCT02737501|580676628|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
160805864|NCT02737501|580676626|FG000|Randomized Phase|Reason not Specified|1|||
160805865|NCT02737501|580676627|FG001|Randomized Phase|Reason not Specified|1|||
160805866|NCT02737501|580676628|FG002|Randomized Phase|Reason not Specified|0|||
160805867|NCT02737501|580676626|FG000|Randomized Phase|Never Treated|1|||
160550766|NCT00805740|579742201|FG001|Overall Study|Lost to Follow-up|0|||
160550767|NCT00805740|579742200|FG000|Overall Study|Randomized, but not treated|2|||
160550768|NCT00805740|579742201|FG001|Overall Study|Randomized, but not treated|0|||
160550769|NCT02971202|579742213|FG000|Overall Study|Pregnancy|1|||
160550770|NCT02971202|579742214|FG001|Overall Study|Pregnancy|0|||
160644586|NCT00665626|580080794|FG001|Overall Study|Unably to comply with dosing regimen|1|||
160805868|NCT02737501|580676627|FG001|Randomized Phase|Never Treated|1|||
160805869|NCT02737501|580676628|FG002|Randomized Phase|Never Treated|0|||
160805870|NCT02737501|580676626|FG000|Crossover Phase|Died|0|||
160805871|NCT02737501|580676627|FG001|Crossover Phase|Died|0|||
160985331|NCT02550873|581335427|FG000|Open Label Extension|Study ongoing|0|||
160550771|NCT02971202|579742215|FG002|Overall Study|Pregnancy|0|||
160550772|NCT02971202|579742213|FG000|Overall Study|screen fail after consent|1|||
160550773|NCT02971202|579742214|FG001|Overall Study|screen fail after consent|0|||
160550774|NCT02971202|579742215|FG002|Overall Study|screen fail after consent|1|||
160550775|NCT04033367|579742216|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
160550776|NCT04033367|579742217|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
160550777|NCT04033367|579742216|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
160550778|NCT04033367|579742217|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
160550779|NCT04033367|579742216|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
160550780|NCT04033367|579742217|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
160550781|NCT04033367|579742216|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
160550782|NCT04033367|579742217|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
160550783|NCT02723201|579742218|FG000|Second Intervention Period|Protocol Violation|1|||
160550784|NCT02723201|579742219|FG001|Second Intervention Period|Protocol Violation|0|||
160550785|NCT02723201|579742220|FG002|Second Intervention Period|Protocol Violation|0|||
160550786|NCT02723201|579742218|FG000|Second Intervention Period|Adverse Event|1|||
160550787|NCT02723201|579742219|FG001|Second Intervention Period|Adverse Event|0|||
160550788|NCT02723201|579742220|FG002|Second Intervention Period|Adverse Event|0|||
160550789|NCT01946178|579742221|FG000|Overall Study|Pregnancy|1|||
160550790|NCT01946178|579742221|FG000|Overall Study|Lost to Follow-up|1|||
160550791|NCT01191697|579742227|FG000|Overall Study|Death|1|||
160550792|NCT01191697|579742227|FG000|Overall Study|Physician Decision|2|||
160550793|NCT01191697|579742227|FG000|Overall Study|Pursue chemoradiation|2|||
160550794|NCT01191697|579742227|FG000|Overall Study|Break from chemotherapy|2|||
160550795|NCT01191697|579742227|FG000|Overall Study|Withdrawal by Subject|1|||
160550796|NCT01191697|579742227|FG000|Overall Study|Surveillance|1|||
160550797|NCT01191697|579742227|FG000|Overall Study|Adverse Event|2|||
160550798|NCT01191697|579742227|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
160550799|NCT01191697|579742227|FG000|Overall Study|Not completed but analyzed|25|||
160550800|NCT01534676|579742228|FG000|Overall Study|Study closed due to poor enrollment|2|||
160550801|NCT01534676|579742229|FG001|Overall Study|Study closed due to poor enrollment|1|||
160550802|NCT02634580|579742230|FG000|Double-blind Treatment Period|Subject Request|1|||
160550803|NCT02634580|579742231|FG001|Double-blind Treatment Period|Subject Request|0|||
160550804|NCT02634580|579742232|FG002|Double-blind Treatment Period|Subject Request|1|||
160550805|NCT02634580|579742233|FG003|Double-blind Treatment Period|Subject Request|1|||
160550806|NCT02634580|579742230|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
160550807|NCT02634580|579742231|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
160550808|NCT02634580|579742232|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
160550809|NCT02634580|579742233|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
160550810|NCT00424827|579742234|FG000|Overall Study|Adverse Event|1|||
160550811|NCT00491179|579742237|FG000|Overall Study|Adverse Event|5|||
160550812|NCT00491179|579742238|FG001|Overall Study|Adverse Event|1|||
160550813|NCT00491179|579742237|FG000|Overall Study|Withdrawal by Subject|2|||
160550814|NCT00491179|579742238|FG001|Overall Study|Withdrawal by Subject|1|||
160550815|NCT02009878|579742240|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
160550816|NCT02009878|579742241|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
160550817|NCT02009878|579742242|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
160550818|NCT03178487|579742250|FG000|Period 1|Adverse Event|1|||
160550819|NCT03178487|579742251|FG001|Period 1|Adverse Event|2|||
160550820|NCT03178487|579742250|FG000|Period 1|Withdrawal by Subject|2|||
160550821|NCT03178487|579742251|FG001|Period 1|Withdrawal by Subject|1|||
160550822|NCT03178487|579742250|FG000|Period 1|Lost to Follow-up|1|||
160550823|NCT03178487|579742251|FG001|Period 1|Lost to Follow-up|0|||
160550824|NCT03178487|579742250|FG000|Period 1|Other|0|||
160550825|NCT03178487|579742251|FG001|Period 1|Other|1|||
160550826|NCT03178487|579742250|FG000|Period 2|Adverse Event|4|||
160550827|NCT03178487|579742251|FG001|Period 2|Adverse Event|4|||
160550828|NCT03178487|579742250|FG000|Period 2|Withdrawal by Subject|6|||
160550829|NCT03178487|579742251|FG001|Period 2|Withdrawal by Subject|6|||
160550830|NCT03178487|579742250|FG000|Period 2|Lost to Follow-up|2|||
160550831|NCT03178487|579742251|FG001|Period 2|Lost to Follow-up|2|||
160805872|NCT02737501|580676628|FG002|Crossover Phase|Died|22|||
160805873|NCT02737501|580676626|FG000|Crossover Phase|Withdrew Consent|0|||
160805874|NCT02737501|580676627|FG001|Crossover Phase|Withdrew Consent|0|||
160805875|NCT02737501|580676628|FG002|Crossover Phase|Withdrew Consent|9|||
160805876|NCT02737501|580676626|FG000|Crossover Phase|Physician Decision|0|||
160805877|NCT02737501|580676627|FG001|Crossover Phase|Physician Decision|0|||
160550832|NCT03178487|579742250|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
160550833|NCT03178487|579742251|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
160550834|NCT03178487|579742250|FG000|Period 2|Other|8|||
160550835|NCT03178487|579742251|FG001|Period 2|Other|7|||
160550836|NCT03655756|579742254|FG000|Overall Study|Death|1|||
160550837|NCT03237065|579742255|FG000|Overall Study|Adverse Event|0|||
160550838|NCT03237065|579742256|FG001|Overall Study|Adverse Event|2|||
160550839|NCT03237065|579742255|FG000|Overall Study|Protocol Violation|0|||
160550840|NCT03237065|579742256|FG001|Overall Study|Protocol Violation|1|||
160550841|NCT03237065|579742255|FG000|Overall Study|Withdrawal by Subject|3|||
160898193|NCT01543698|581023384|FG010|Phase 2|Withdrawal by Subject|0|||
160898194|NCT01543698|581023385|FG011|Phase 2|Withdrawal by Subject|0|||
160898195|NCT01543698|581023386|FG012|Phase 2|Withdrawal by Subject|0|||
160898196|NCT01543698|581023387|FG013|Phase 2|Withdrawal by Subject|3|||
160898197|NCT01543698|581023388|FG014|Phase 2|Withdrawal by Subject|1|||
160898198|NCT01543698|581023374|FG000|Phase 2|Adverse Event|0|||
160898199|NCT01543698|581023375|FG001|Phase 2|Adverse Event|0|||
160898200|NCT01543698|581023376|FG002|Phase 2|Adverse Event|0|||
160898201|NCT01543698|581023377|FG003|Phase 2|Adverse Event|0|||
160550842|NCT03237065|579742256|FG001|Overall Study|Withdrawal by Subject|0|||
160550843|NCT03237065|579742255|FG000|Overall Study|Lost to Follow-up|1|||
160550844|NCT03237065|579742256|FG001|Overall Study|Lost to Follow-up|0|||
160644587|NCT00665626|580080793|FG000|Overall Study|Death|1|||
160805878|NCT02737501|580676628|FG002|Crossover Phase|Physician Decision|1|||
160805879|NCT02737501|580676626|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
160805880|NCT02737501|580676627|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
160805881|NCT02737501|580676628|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
160805882|NCT02012218|580676631|FG000|Overall Study|Withdrawal by Subject|1|||
160805883|NCT02012218|580676632|FG001|Overall Study|Withdrawal by Subject|0|||
160805884|NCT02012218|580676633|FG002|Overall Study|Withdrawal by Subject|1|||
160805885|NCT02012218|580676634|FG003|Overall Study|Withdrawal by Subject|1|||
160805886|NCT02012218|580676635|FG004|Overall Study|Withdrawal by Subject|1|||
160805887|NCT02012218|580676631|FG000|Overall Study|Adverse Event|1|||
160805888|NCT02012218|580676632|FG001|Overall Study|Adverse Event|0|||
160805889|NCT02012218|580676633|FG002|Overall Study|Adverse Event|0|||
160805890|NCT02012218|580676634|FG003|Overall Study|Adverse Event|1|||
160805891|NCT02012218|580676635|FG004|Overall Study|Adverse Event|0|||
160805892|NCT02012218|580676631|FG000|Overall Study|Lost to Follow-up|0|||
160805893|NCT02012218|580676632|FG001|Overall Study|Lost to Follow-up|1|||
160805894|NCT02012218|580676633|FG002|Overall Study|Lost to Follow-up|1|||
160805895|NCT02012218|580676634|FG003|Overall Study|Lost to Follow-up|0|||
160805896|NCT02012218|580676635|FG004|Overall Study|Lost to Follow-up|0|||
160805897|NCT02012218|580676631|FG000|Overall Study|Protocol Specified|1|||
160805898|NCT02012218|580676632|FG001|Overall Study|Protocol Specified|0|||
160805899|NCT02012218|580676633|FG002|Overall Study|Protocol Specified|0|||
160805900|NCT02012218|580676634|FG003|Overall Study|Protocol Specified|0|||
160805901|NCT02012218|580676635|FG004|Overall Study|Protocol Specified|0|||
160805902|NCT02012218|580676631|FG000|Overall Study|Protocol Deviation|1|||
160805903|NCT02012218|580676632|FG001|Overall Study|Protocol Deviation|0|||
160805904|NCT02012218|580676633|FG002|Overall Study|Protocol Deviation|0|||
160805905|NCT02012218|580676634|FG003|Overall Study|Protocol Deviation|0|||
160644588|NCT00665626|580080794|FG001|Overall Study|Death|0|||
160644589|NCT00585039|580080795|FG000|Overall Study|medication spilled|2|||
160805906|NCT02012218|580676635|FG004|Overall Study|Protocol Deviation|0|||
160805907|NCT01070979|580676636|FG000|Overall Study|Adverse Event|2|||
160805908|NCT01070979|580676637|FG001|Overall Study|Adverse Event|3|||
160805909|NCT01070979|580676638|FG002|Overall Study|Adverse Event|3|||
160805910|NCT01070979|580676636|FG000|Overall Study|Lost to Follow-up|2|||
160805911|NCT01070979|580676637|FG001|Overall Study|Lost to Follow-up|1|||
160805912|NCT01070979|580676638|FG002|Overall Study|Lost to Follow-up|1|||
160805913|NCT01070979|580676636|FG000|Overall Study|Protocol Violation|0|||
160805914|NCT01070979|580676637|FG001|Overall Study|Protocol Violation|2|||
160805915|NCT01070979|580676638|FG002|Overall Study|Protocol Violation|6|||
160805916|NCT01070979|580676636|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
160805917|NCT01070979|580676637|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
160898202|NCT01543698|581023378|FG004|Phase 2|Adverse Event|0|||
160898203|NCT01543698|581023379|FG005|Phase 2|Adverse Event|0|||
160985332|NCT02550873|581335428|FG001|Open Label Extension|Study ongoing|0|||
160985333|NCT02550873|581335429|FG002|Open Label Extension|Study ongoing|111|||
160985334|NCT01857323|581335430|FG000|Overall Study|Adverse Event|1|||
160985335|NCT01857323|581335430|FG000|Overall Study|Withdrawal by Subject|3|||
160985336|NCT01857323|581335430|FG000|Overall Study|Non-compliance|1|||
160805918|NCT01070979|580676638|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
160805919|NCT01070979|580676636|FG000|Overall Study|Withdrawal by Subject|3|||
160805920|NCT01070979|580676637|FG001|Overall Study|Withdrawal by Subject|1|||
160805921|NCT01070979|580676638|FG002|Overall Study|Withdrawal by Subject|1|||
160805922|NCT01070979|580676636|FG000|Overall Study|No study drug taken|0|||
160805923|NCT01070979|580676637|FG001|Overall Study|No study drug taken|1|||
160985337|NCT01857323|581335430|FG000|Overall Study|Protocol Violation|6|||
160805924|NCT01070979|580676638|FG002|Overall Study|No study drug taken|0|||
160805925|NCT00142792|580676639|FG000|Overall Study|Death|0|||
160805926|NCT00142792|580676640|FG001|Overall Study|Death|0|||
160805927|NCT00142792|580676641|FG002|Overall Study|Death|1|||
160805928|NCT00142792|580676639|FG000|Overall Study|Withdrawal by Subject|3|||
160805929|NCT00142792|580676640|FG001|Overall Study|Withdrawal by Subject|2|||
160805930|NCT00142792|580676641|FG002|Overall Study|Withdrawal by Subject|3|||
160805931|NCT00142792|580676639|FG000|Overall Study|Lost to Follow-up|8|||
160805932|NCT00142792|580676640|FG001|Overall Study|Lost to Follow-up|11|||
160898204|NCT01543698|581023380|FG006|Phase 2|Adverse Event|0|||
160898205|NCT01543698|581023381|FG007|Phase 2|Adverse Event|0|||
160898206|NCT01543698|581023382|FG008|Phase 2|Adverse Event|0|||
160898207|NCT01543698|581023383|FG009|Phase 2|Adverse Event|0|||
160898208|NCT01543698|581023384|FG010|Phase 2|Adverse Event|0|||
160898209|NCT01543698|581023385|FG011|Phase 2|Adverse Event|1|||
160898210|NCT01543698|581023386|FG012|Phase 2|Adverse Event|3|||
160898211|NCT01543698|581023387|FG013|Phase 2|Adverse Event|5|||
160898212|NCT01543698|581023388|FG014|Phase 2|Adverse Event|14|||
160898213|NCT04195906|581023394|FG000|Part 1|Adverse Event|3|||
160985338|NCT01857323|581335430|FG000|Overall Study|Lost to Follow-up|1|||
160985339|NCT01857323|581335430|FG000|Overall Study|Other|4|||
160985340|NCT01857323|581335430|FG000|Overall Study|Did not complete 180 doses|48|||
160985341|NCT02107443|581335431|FG000|Overall Study|Death|42|||
160985342|NCT02107443|581335432|FG001|Overall Study|Death|30|||
160985343|NCT02107443|581335431|FG000|Overall Study|Study Protocol Violation|3|||
160985344|NCT02107443|581335432|FG001|Overall Study|Study Protocol Violation|1|||
160985345|NCT02107443|581335431|FG000|Overall Study|Registered but Not Eligible|0|||
160985346|NCT02107443|581335432|FG001|Overall Study|Registered but Not Eligible|1|||
160985347|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
160985348|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
160985349|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
160985350|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
160985351|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Changed Mind|2|||
160985352|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Changed Mind|0|||
160805933|NCT00142792|580676641|FG002|Overall Study|Lost to Follow-up|7|||
160805934|NCT00142792|580676639|FG000|Overall Study|No category|1|||
160898214|NCT04195906|581023395|FG001|Part 1|Adverse Event|7|||
160898215|NCT04195906|581023394|FG000|Part 1|Withdrawal by Subject|0|||
160898216|NCT04195906|581023395|FG001|Part 1|Withdrawal by Subject|1|||
160644590|NCT00585039|580080796|FG001|Overall Study|medication spilled|0|||
160805935|NCT00142792|580676640|FG001|Overall Study|No category|2|||
160898217|NCT04195906|581023394|FG000|Part 2|Adverse Event|1|||
160898218|NCT04195906|581023395|FG001|Part 2|Adverse Event|1|||
160805936|NCT00142792|580676641|FG002|Overall Study|No category|1|||
160805937|NCT04819113|580676642|FG000|Overall Study|Withdrawal by parent/guardian|3|||
160805938|NCT04819113|580676642|FG000|Overall Study|Lost to Follow-up|1|||
160898219|NCT04195906|581023394|FG000|Part 2|Withdrawal by Subject|0|||
160898220|NCT04195906|581023395|FG001|Part 2|Withdrawal by Subject|3|||
160985353|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
160985354|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
160985355|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
160985356|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
160985357|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
160985358|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
160985359|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
160550845|NCT03237065|579742255|FG000|Overall Study|Unable to obtain venous access|0|||
160550846|NCT03237065|579742256|FG001|Overall Study|Unable to obtain venous access|1|||
160550847|NCT02475655|579742257|FG000|Overall Study|Lost to Follow-up|0|||
160550848|NCT02475655|579742258|FG001|Overall Study|Lost to Follow-up|1|||
160550849|NCT00257010|579742263|FG000|Overall Study|Lack of Efficacy|11|||
160550850|NCT00257010|579742263|FG000|Overall Study|Lost to Follow-up|53|||
160550851|NCT00257010|579742263|FG000|Overall Study|Withdrawal by Subject|34|||
160550852|NCT00257010|579742263|FG000|Overall Study|Adverse Event|10|||
160550853|NCT00257010|579742263|FG000|Overall Study|various|11|||
160550854|NCT00257010|579742263|FG000|Overall Study|no headache reported|9|||
160550855|NCT00662792|579742264|FG000|Period 1|Personal Reasons|0|||
160550856|NCT00662792|579742265|FG001|Period 1|Personal Reasons|0|||
160550857|NCT00662792|579742266|FG002|Period 1|Personal Reasons|1|||
160550858|NCT00662792|579742267|FG003|Period 1|Personal Reasons|0|||
160550859|NCT00662792|579742264|FG000|Period 1|Refused continuing medication|0|||
160550860|NCT00662792|579742265|FG001|Period 1|Refused continuing medication|1|||
160550861|NCT00662792|579742266|FG002|Period 1|Refused continuing medication|1|||
160550862|NCT00662792|579742267|FG003|Period 1|Refused continuing medication|0|||
160550863|NCT00662792|579742264|FG000|Period 1|Lost to Follow-up|1|||
160550864|NCT00662792|579742265|FG001|Period 1|Lost to Follow-up|0|||
160550865|NCT00662792|579742266|FG002|Period 1|Lost to Follow-up|0|||
160550866|NCT00662792|579742267|FG003|Period 1|Lost to Follow-up|0|||
160550867|NCT00662792|579742264|FG000|Period 1|Other adverse event (AE)|0|||
160550868|NCT00662792|579742265|FG001|Period 1|Other adverse event (AE)|2|||
160550869|NCT00662792|579742266|FG002|Period 1|Other adverse event (AE)|0|||
160550870|NCT00662792|579742267|FG003|Period 1|Other adverse event (AE)|0|||
160550871|NCT00662792|579742264|FG000|Period 1|Worsening of disease under study (AE)|1|||
160550872|NCT00662792|579742265|FG001|Period 1|Worsening of disease under study (AE)|3|||
160550873|NCT00662792|579742266|FG002|Period 1|Worsening of disease under study (AE)|2|||
160550874|NCT00662792|579742267|FG003|Period 1|Worsening of disease under study (AE)|0|||
160550875|NCT00662792|579742264|FG000|Period 1|Not treated|0|||
160550876|NCT00662792|579742265|FG001|Period 1|Not treated|1|||
160550877|NCT00662792|579742266|FG002|Period 1|Not treated|0|||
160550878|NCT00662792|579742267|FG003|Period 1|Not treated|0|||
160550879|NCT00662792|579742264|FG000|Period 2|Worsening of disease under study|1|||
160550880|NCT00662792|579742265|FG001|Period 2|Worsening of disease under study|0|||
160550881|NCT00662792|579742266|FG002|Period 2|Worsening of disease under study|0|||
160550882|NCT00662792|579742267|FG003|Period 2|Worsening of disease under study|3|||
160550883|NCT00662792|579742264|FG000|Period 3|Refused continuing medication|1|||
160550884|NCT00662792|579742265|FG001|Period 3|Refused continuing medication|0|||
160550885|NCT00662792|579742266|FG002|Period 3|Refused continuing medication|1|||
160550886|NCT00662792|579742267|FG003|Period 3|Refused continuing medication|0|||
160550887|NCT00662792|579742264|FG000|Period 3|Other adverse event (AE)|0|||
160550888|NCT00662792|579742265|FG001|Period 3|Other adverse event (AE)|0|||
160550889|NCT00662792|579742266|FG002|Period 3|Other adverse event (AE)|1|||
160550890|NCT00662792|579742267|FG003|Period 3|Other adverse event (AE)|1|||
160550891|NCT00662792|579742264|FG000|Period 4|Refused continuing medication|0|||
160550892|NCT00662792|579742265|FG001|Period 4|Refused continuing medication|1|||
160550893|NCT00662792|579742266|FG002|Period 4|Refused continuing medication|0|||
160550894|NCT00662792|579742267|FG003|Period 4|Refused continuing medication|0|||
160550895|NCT00662792|579742264|FG000|Period 4|Other adverse event (AE)|1|||
160550896|NCT00662792|579742265|FG001|Period 4|Other adverse event (AE)|0|||
160550897|NCT00662792|579742266|FG002|Period 4|Other adverse event (AE)|0|||
160550898|NCT00662792|579742267|FG003|Period 4|Other adverse event (AE)|0|||
160550899|NCT00662792|579742264|FG000|Period 4|Worsening of disease under study (AE)|0|||
160550900|NCT00662792|579742265|FG001|Period 4|Worsening of disease under study (AE)|0|||
160550901|NCT00662792|579742266|FG002|Period 4|Worsening of disease under study (AE)|0|||
160550902|NCT00662792|579742267|FG003|Period 4|Worsening of disease under study (AE)|1|||
160550903|NCT02347176|579742268|FG000|Overall Study|Lost to Follow-up|2|||
160550904|NCT02347176|579742269|FG001|Overall Study|Lost to Follow-up|3|||
160550905|NCT02347176|579742270|FG002|Overall Study|Lost to Follow-up|1|||
160550906|NCT02347176|579742271|FG003|Overall Study|Lost to Follow-up|1|||
160550907|NCT02347176|579742268|FG000|Overall Study|Withdrawal by Subject|9|||
160550908|NCT02347176|579742269|FG001|Overall Study|Withdrawal by Subject|5|||
160550909|NCT02347176|579742270|FG002|Overall Study|Withdrawal by Subject|5|||
160550910|NCT02347176|579742271|FG003|Overall Study|Withdrawal by Subject|3|||
160985360|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
160550911|NCT02347176|579742268|FG000|Overall Study|Other|1|||
160550912|NCT02347176|579742269|FG001|Overall Study|Other|2|||
160550913|NCT02347176|579742270|FG002|Overall Study|Other|2|||
160550914|NCT02347176|579742271|FG003|Overall Study|Other|0|||
160550915|NCT00699907|579742276|FG000|Overall Study|Withdrawal by Subject|2|||
160805939|NCT04819113|580676642|FG000|Overall Study|Withdrawn before vaccination|2|||
160805940|NCT00833027|580676647|FG000|Overall Study|Adverse Event|33|||
160805941|NCT00833027|580676647|FG000|Overall Study|Death|1|||
160805942|NCT00833027|580676647|FG000|Overall Study|Lack of Efficacy|12|||
160805943|NCT00833027|580676647|FG000|Overall Study|Lost to Follow-up|24|||
160805944|NCT00833027|580676647|FG000|Overall Study|Protocol Violation|115|||
160805945|NCT00833027|580676647|FG000|Overall Study|Withdrawal by Subject|16|||
160805946|NCT00833027|580676647|FG000|Overall Study|Missing|10|||
160805947|NCT00444925|580676648|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
160805948|NCT00444925|580676649|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
160805949|NCT00444925|580676650|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
160805950|NCT00444925|580676648|FG000|Double-blind Treatment Period|Death|2|||
160805951|NCT00444925|580676649|FG001|Double-blind Treatment Period|Death|0|||
160805952|NCT00444925|580676650|FG002|Double-blind Treatment Period|Death|0|||
160805953|NCT00444925|580676648|FG000|Double-blind Treatment Period|Adverse Event|6|||
160805954|NCT00444925|580676649|FG001|Double-blind Treatment Period|Adverse Event|28|||
160805955|NCT00444925|580676650|FG002|Double-blind Treatment Period|Adverse Event|44|||
160805956|NCT00444925|580676648|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
160805957|NCT00444925|580676649|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
160805958|NCT00444925|580676650|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
160805959|NCT00444925|580676648|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
160805960|NCT00444925|580676649|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
160805961|NCT00444925|580676650|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
160805962|NCT00444925|580676648|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
160805963|NCT00444925|580676649|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
160805964|NCT00444925|580676650|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
160805965|NCT00444925|580676648|FG000|Double-blind Treatment Period|Other|7|||
160805966|NCT00444925|580676649|FG001|Double-blind Treatment Period|Other|7|||
160805967|NCT00444925|580676650|FG002|Double-blind Treatment Period|Other|12|||
160805968|NCT04417257|580676651|FG000|Pilot Phase 2|Adverse Event|2|||
160805969|NCT04417257|580676652|FG001|Pilot Phase 2|Adverse Event|0|||
160805970|NCT04417257|580676651|FG000|Pilot Phase 2|Death|14|||
160805971|NCT04417257|580676652|FG001|Pilot Phase 2|Death|11|||
160805972|NCT04417257|580676651|FG000|Pilot Phase 2|Lost to Follow-up|3|||
160805973|NCT04417257|580676652|FG001|Pilot Phase 2|Lost to Follow-up|5|||
160805974|NCT04417257|580676651|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
160805975|NCT04417257|580676652|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
160805976|NCT04417257|580676651|FG000|Pilot Phase 2|Hepatic impairment|1|||
160805977|NCT04417257|580676652|FG001|Pilot Phase 2|Hepatic impairment|0|||
160805978|NCT04417257|580676651|FG000|Pilot Phase 2|Unblinding|1|||
160805979|NCT04417257|580676652|FG001|Pilot Phase 2|Unblinding|0|||
160805980|NCT04417257|580676651|FG000|Pilot Phase 2|All other|0|||
160805981|NCT04417257|580676652|FG001|Pilot Phase 2|All other|2|||
160805982|NCT04417257|580676651|FG000|Phase 3 Extension|Death|3|||
160805983|NCT04417257|580676652|FG001|Phase 3 Extension|Death|1|||
160805984|NCT04417257|580676651|FG000|Phase 3 Extension|Lost to Follow-up|4|||
160805985|NCT04417257|580676652|FG001|Phase 3 Extension|Lost to Follow-up|2|||
160805986|NCT04417257|580676651|FG000|Phase 3 Extension|Patient withdrawal|2|||
160805987|NCT04417257|580676652|FG001|Phase 3 Extension|Patient withdrawal|2|||
160805988|NCT04417257|580676651|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
160805989|NCT04417257|580676652|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
160805990|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Death|2|||
160805991|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
160805992|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
160805993|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Physician Decision|1|||
160805994|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
160805995|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
160805996|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Adverse Event|2|||
160805997|NCT00786422|580676654|FG000|Follow-up Period|Death|1|||
160805998|NCT00786422|580676654|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
160805999|NCT03484429|580676655|FG000|Overall Study|Withdrawal by Subject|1|||
160806000|NCT03484429|580676656|FG001|Overall Study|Withdrawal by Subject|0|||
160806001|NCT03484429|580676655|FG000|Overall Study|Adverse Event|2|||
160898221|NCT04195906|581023394|FG000|Part 2|Other|1|||
160898222|NCT04195906|581023395|FG001|Part 2|Other|3|||
160898223|NCT02699697|581023397|FG000|Overall Study|Death|18|||
160806002|NCT03484429|580676656|FG001|Overall Study|Adverse Event|0|||
160806003|NCT04466384|580676657|FG000|First Phase|Protocol Violation|1|||
160806004|NCT04466384|580676658|FG001|First Phase|Protocol Violation|0|||
160806005|NCT04466384|580676657|FG000|First Phase|Missing data|1|||
160806006|NCT04466384|580676658|FG001|First Phase|Missing data|0|||
160806007|NCT04466384|580676657|FG000|Cross Over Phase|Physician Decision|1|||
160806008|NCT04466384|580676658|FG001|Cross Over Phase|Physician Decision|0|||
160806009|NCT04466384|580676657|FG000|Cross Over Phase|Withdrawal by Subject|0|||
160806010|NCT04466384|580676658|FG001|Cross Over Phase|Withdrawal by Subject|1|||
160898224|NCT02699697|581023398|FG001|Overall Study|Death|15|||
160806011|NCT03761056|580676659|FG000|Overall Study|Death|8|||
160806012|NCT03761056|580676659|FG000|Overall Study|Enrolled but never treated|2|||
160806013|NCT03761056|580676659|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
160806014|NCT03761056|580676659|FG000|Overall Study|Investigator decision|1|||
160806015|NCT04267926|580678127|FG000|Overall Study|abnormal labs. No longer eligible|0|||
160806016|NCT04267926|580678128|FG001|Overall Study|abnormal labs. No longer eligible|0|||
160806017|NCT04267926|580678129|FG002|Overall Study|abnormal labs. No longer eligible|1|||
160806018|NCT04267926|580678127|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
160806019|NCT04267926|580678128|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
160806020|NCT04267926|580678129|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
160806021|NCT02595879|580678130|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
160806022|NCT02595879|580678131|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
160806023|NCT03145064|580678132|FG000|Overall Study|Death|24|||
160806024|NCT03145064|580678132|FG000|Overall Study|Lost to Follow-up|3|||
160806025|NCT03145064|580678132|FG000|Overall Study|Withdrawal by Subject|6|||
160806026|NCT03145064|580678132|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
160806027|NCT03145064|580678132|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
160806028|NCT00661830|580678133|FG000|Overall Study|Death|37|||
160806029|NCT00661830|580678134|FG001|Overall Study|Death|33|||
160806030|NCT00661830|580678133|FG000|Overall Study|Lost to Follow-up|1|||
160806031|NCT00661830|580678134|FG001|Overall Study|Lost to Follow-up|3|||
160806032|NCT00661830|580678133|FG000|Overall Study|Withdrawal by Subject|1|||
160806033|NCT00661830|580678134|FG001|Overall Study|Withdrawal by Subject|1|||
160806034|NCT00661830|580678133|FG000|Overall Study|Other reason|1|||
160806035|NCT00661830|580678134|FG001|Overall Study|Other reason|5|||
160806036|NCT01396187|580678135|FG000|Overall Study|Adverse Event|0|||
160806037|NCT01396187|580678136|FG001|Overall Study|Adverse Event|1|||
160806038|NCT01396187|580678137|FG002|Overall Study|Adverse Event|0|||
160806039|NCT01396187|580678138|FG003|Overall Study|Adverse Event|0|||
160806040|NCT01396187|580678139|FG004|Overall Study|Adverse Event|0|||
160806041|NCT01396187|580678135|FG000|Overall Study|Withdrawal by Subject|0|||
160806042|NCT01396187|580678136|FG001|Overall Study|Withdrawal by Subject|1|||
160806043|NCT01396187|580678137|FG002|Overall Study|Withdrawal by Subject|1|||
160806044|NCT01396187|580678138|FG003|Overall Study|Withdrawal by Subject|0|||
160806045|NCT01396187|580678139|FG004|Overall Study|Withdrawal by Subject|0|||
160806046|NCT01396187|580678135|FG000|Overall Study|Other|1|||
160806047|NCT01396187|580678136|FG001|Overall Study|Other|1|||
160806048|NCT01396187|580678137|FG002|Overall Study|Other|0|||
160806049|NCT01396187|580678138|FG003|Overall Study|Other|0|||
160806050|NCT01396187|580678139|FG004|Overall Study|Other|1|||
160806051|NCT01898286|580678140|FG000|Overall Study|Withdrawal by Subject|1|||
160806052|NCT01898286|580678140|FG000|Overall Study|Protocol Violation|1|||
160806053|NCT01898286|580678140|FG000|Overall Study|Lost to Follow-up|1|||
160898225|NCT02699697|581023397|FG000|Overall Study|Physician Decision|0|||
160898226|NCT02699697|581023398|FG001|Overall Study|Physician Decision|1|||
160898227|NCT02699697|581023397|FG000|Overall Study|Lost to Follow-up|2|||
160898228|NCT02699697|581023398|FG001|Overall Study|Lost to Follow-up|3|||
160898229|NCT02699697|581023397|FG000|Overall Study|Refused to follow up|1|||
160898230|NCT02699697|581023398|FG001|Overall Study|Refused to follow up|1|||
160898231|NCT02699697|581023397|FG000|Overall Study|Entered hospice care|5|||
160898232|NCT02699697|581023398|FG001|Overall Study|Entered hospice care|2|||
160898233|NCT02699697|581023397|FG000|Overall Study|Missing reason for discontinuation|6|||
160898234|NCT02699697|581023398|FG001|Overall Study|Missing reason for discontinuation|5|||
160898235|NCT02362035|581023399|FG000|Overall Study|Death|67|||
160898236|NCT02362035|581023399|FG000|Overall Study|Lost to Follow-up|3|||
160898237|NCT02362035|581023399|FG000|Overall Study|Adverse Event|1|||
160898238|NCT02362035|581023399|FG000|Overall Study|Physician Decision|1|||
160985361|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Other Medical|9|||
160550916|NCT00699907|579742277|FG001|Overall Study|Withdrawal by Subject|1|||
160550917|NCT00699907|579742278|FG002|Overall Study|Withdrawal by Subject|0|||
160550918|NCT00699907|579742276|FG000|Overall Study|No usable sample|0|||
160550919|NCT00699907|579742277|FG001|Overall Study|No usable sample|9|||
160550920|NCT00699907|579742278|FG002|Overall Study|No usable sample|8|||
160550921|NCT02161211|579742279|FG000|Overall Study|Lost to Follow-up|21|||
160806054|NCT01650831|580678141|FG000|Overall Study|Screen failure|1|||
160806055|NCT05554146|580678144|FG000|Overall Study|Adverse Event|0|||
160806056|NCT05554146|580678145|FG001|Overall Study|Adverse Event|1|||
160806057|NCT05554146|580678146|FG002|Overall Study|Adverse Event|0|||
160898239|NCT02362035|581023399|FG000|Overall Study|Subject started another cancer therapy|10|||
160985362|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Other Medical|5|||
160806058|NCT05554146|580678147|FG003|Overall Study|Adverse Event|0|||
160985363|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Disease Progression|4|||
160550922|NCT02161211|579742280|FG001|Overall Study|Lost to Follow-up|27|||
160806059|NCT05554146|580678144|FG000|Overall Study|Protocol Violation|0|||
160806060|NCT05554146|580678145|FG001|Overall Study|Protocol Violation|1|||
160806061|NCT05554146|580678146|FG002|Overall Study|Protocol Violation|0|||
160806062|NCT05554146|580678147|FG003|Overall Study|Protocol Violation|0|||
160806063|NCT05554146|580678144|FG000|Overall Study|No longer interested in participating|0|||
160806064|NCT05554146|580678145|FG001|Overall Study|No longer interested in participating|0|||
160806065|NCT05554146|580678146|FG002|Overall Study|No longer interested in participating|1|||
160806066|NCT05554146|580678147|FG003|Overall Study|No longer interested in participating|0|||
160806067|NCT05554146|580678144|FG000|Overall Study|Lost to Follow-up|1|||
160806068|NCT05554146|580678145|FG001|Overall Study|Lost to Follow-up|0|||
160806069|NCT05554146|580678146|FG002|Overall Study|Lost to Follow-up|0|||
160806070|NCT05554146|580678147|FG003|Overall Study|Lost to Follow-up|0|||
160806071|NCT02477527|580678148|FG000|Overall Study|Lost to Follow-up|2|||
160806072|NCT02477527|580678148|FG000|Overall Study|Withdrawal by Subject|1|||
160806073|NCT02477527|580678148|FG000|Overall Study|Screen Failure|3|||
160806074|NCT03692403|580678149|FG000|Overall Study|Withdrawal by Subject|1|||
160806075|NCT03692403|580678150|FG001|Overall Study|Withdrawal by Subject|0|||
160806076|NCT03692403|580678151|FG002|Overall Study|Withdrawal by Subject|1|||
160806077|NCT03692403|580678152|FG003|Overall Study|Withdrawal by Subject|0|||
160806078|NCT03692403|580678149|FG000|Overall Study|Adverse Event|0|||
160806079|NCT03692403|580678150|FG001|Overall Study|Adverse Event|0|||
160806080|NCT03692403|580678151|FG002|Overall Study|Adverse Event|0|||
160806081|NCT03692403|580678152|FG003|Overall Study|Adverse Event|1|||
160806082|NCT03692403|580678149|FG000|Overall Study|Pregnancy|0|||
160806083|NCT03692403|580678150|FG001|Overall Study|Pregnancy|1|||
160806084|NCT03692403|580678151|FG002|Overall Study|Pregnancy|0|||
160806085|NCT03692403|580678152|FG003|Overall Study|Pregnancy|0|||
160806086|NCT03692403|580678149|FG000|Overall Study|Other|0|||
160806087|NCT03692403|580678150|FG001|Overall Study|Other|0|||
160806088|NCT03692403|580678151|FG002|Overall Study|Other|1|||
160806089|NCT03692403|580678152|FG003|Overall Study|Other|0|||
160806090|NCT00856635|580678153|FG000|Overall Study|Lost to Follow-up|2|||
160806091|NCT00856635|580678154|FG001|Overall Study|Lost to Follow-up|5|||
160806092|NCT00856635|580678153|FG000|Overall Study|Pregnancy|1|||
160806093|NCT00856635|580678154|FG001|Overall Study|Pregnancy|0|||
160806094|NCT00856635|580678153|FG000|Overall Study|Withdrawal by Subject|3|||
160806095|NCT00856635|580678154|FG001|Overall Study|Withdrawal by Subject|1|||
160806096|NCT00856635|580678153|FG000|Overall Study|Serious Adverse Event|1|||
160806097|NCT00856635|580678154|FG001|Overall Study|Serious Adverse Event|0|||
160806098|NCT00856635|580678153|FG000|Overall Study|Other|1|||
160806099|NCT00856635|580678154|FG001|Overall Study|Other|0|||
160806100|NCT00856635|580678153|FG000|Overall Study|Discontinued at Randomization|2|||
160806101|NCT00856635|580678154|FG001|Overall Study|Discontinued at Randomization|2|||
160806102|NCT01349673|580678155|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
160806103|NCT01349673|580678155|FG000|Overall Study|No Longer Qualified For Study|1|||
160806104|NCT01349673|580678155|FG000|Overall Study|Site Closure|10|||
160806105|NCT01349673|580678155|FG000|Overall Study|Withdrawal by Subject|21|||
160806106|NCT01349673|580678155|FG000|Overall Study|Lost to Follow-up|6|||
160806107|NCT01349673|580678155|FG000|Overall Study|Adverse Event|17|||
160806108|NCT01349673|580678155|FG000|Overall Study|Study Terminated By Sponsor|50|||
160806109|NCT01349673|580678155|FG000|Overall Study|Lack of Efficacy|8|||
160806110|NCT02383862|580678156|FG000|3 Month Follow up|Lost to Follow-up|23|||
160806111|NCT02383862|580678157|FG001|3 Month Follow up|Lost to Follow-up|21|||
160550923|NCT02161211|579742281|FG002|Overall Study|Lost to Follow-up|21|||
160550924|NCT02161211|579742279|FG000|Overall Study|Dropped|12|||
160806112|NCT01724216|580678158|FG000|Overall Study|Scan was not completed|1|||
160806113|NCT00564733|580678159|FG000|Overall Study|Withdrawal by Subject|4|||
160550925|NCT02161211|579742280|FG001|Overall Study|Dropped|5|||
160806114|NCT00564733|580678159|FG000|Overall Study|Ineligible|5|||
160806115|NCT03198767|580678164|FG000|Overall Study|Protocol Violation|0|||
160806116|NCT03198767|580678165|FG001|Overall Study|Protocol Violation|0|||
160806117|NCT03198767|580678166|FG002|Overall Study|Protocol Violation|0|||
160806118|NCT03198767|580678167|FG003|Overall Study|Protocol Violation|6|||
160806119|NCT03198767|580678168|FG004|Overall Study|Protocol Violation|0|||
160806120|NCT03198767|580678169|FG005|Overall Study|Protocol Violation|0|||
160806121|NCT03198767|580678170|FG006|Overall Study|Protocol Violation|0|||
160806122|NCT00579553|580678174|FG000|Overall Study|Lost to Follow-up|16|||
160806123|NCT00579553|580678175|FG001|Overall Study|Lost to Follow-up|13|||
160806124|NCT04860869|580678180|FG000|Overall Study|Withdrawal by Subject|1|||
160806125|NCT04860869|580678181|FG001|Overall Study|Withdrawal by Subject|0|||
160806126|NCT02651116|580678182|FG000|Overall Study|Adverse Event|0|||
160806127|NCT02651116|580678183|FG001|Overall Study|Adverse Event|1|||
160806128|NCT02651116|580678182|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
160806129|NCT02651116|580678183|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
160806130|NCT01775553|580678184|FG000|Overall Study|Adverse Event|1|||
160806131|NCT01775553|580678184|FG000|Overall Study|Disease Progression|12|||
160806132|NCT02041299|580678195|FG000|Overall Study|Adverse Event|9|||
160806133|NCT02041299|580678196|FG001|Overall Study|Adverse Event|3|||
160806134|NCT02041299|580678195|FG000|Overall Study|Lost to Follow-up|4|||
160806135|NCT02041299|580678196|FG001|Overall Study|Lost to Follow-up|1|||
160806136|NCT02041299|580678195|FG000|Overall Study|Physician Decision|1|||
160806137|NCT02041299|580678196|FG001|Overall Study|Physician Decision|1|||
160806138|NCT02041299|580678195|FG000|Overall Study|Withdrawal by Subject|13|||
160806139|NCT02041299|580678196|FG001|Overall Study|Withdrawal by Subject|7|||
160806140|NCT02041299|580678195|FG000|Overall Study|Protocol Violation|11|||
160806141|NCT02041299|580678196|FG001|Overall Study|Protocol Violation|4|||
160806142|NCT02041299|580678195|FG000|Overall Study|Termination of the study|7|||
160806143|NCT02041299|580678196|FG001|Overall Study|Termination of the study|3|||
160806144|NCT02041299|580678195|FG000|Overall Study|Required bone marrow transplant|0|||
160806145|NCT02041299|580678196|FG001|Overall Study|Required bone marrow transplant|1|||
160806146|NCT02041299|580678195|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
160806147|NCT02041299|580678196|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
160806148|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
160806149|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160806150|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
160806151|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
160806152|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
160806153|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
160806154|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
160806155|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
160985364|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Disease Progression|2|||
160806156|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
160806157|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
160806158|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
160806159|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
160806160|NCT01925768|580678197|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
160806161|NCT01925768|580678198|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
160806162|NCT01925768|580678197|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
160806163|NCT01925768|580678198|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
160806164|NCT01925768|580678197|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
160806165|NCT01925768|580678198|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
160806166|NCT01925768|580678197|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
160806167|NCT01925768|580678198|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
160806168|NCT01925768|580678197|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
160806169|NCT01925768|580678198|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
160806170|NCT04339413|580678199|FG000|Overall Study|Reason Not Specified|2|||
160806171|NCT04339413|580678200|FG001|Overall Study|Reason Not Specified|7|||
160550926|NCT02161211|579742281|FG002|Overall Study|Dropped|9|||
160550927|NCT02971670|579742282|FG000|Overall Study|Withdrawal by Subject|4|||
160550928|NCT02971670|579742283|FG001|Overall Study|Withdrawal by Subject|1|||
160550929|NCT02971670|579742284|FG002|Overall Study|Withdrawal by Subject|1|||
160550930|NCT02971670|579742285|FG003|Overall Study|Withdrawal by Subject|2|||
160550931|NCT01325428|579742288|FG000|Part A|Progressive disease according to RECIST|9|||
160550932|NCT01325428|579742288|FG000|Part A|Clinical signs, symptoms of progression|2|||
160550933|NCT01325428|579742288|FG000|Part A|Other adverse event|1|||
160550934|NCT01325428|579742288|FG000|Part A|Refused continue taking trial medication|2|||
160550935|NCT01325428|579742288|FG000|Part A|Other reason not defined above|2|||
160550936|NCT01325428|579742288|FG000|Part B|Refused continue taking trial medication|2|||
160550937|NCT01325428|579742288|FG000|Part B|Other reason not defined above|1|||
160550938|NCT04849780|579742289|FG000|Period 1|Covid-19 Related|1|||
160550939|NCT04849780|579742290|FG001|Period 1|Covid-19 Related|0|||
160550940|NCT04849780|579742289|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
160550941|NCT04849780|579742290|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
160550942|NCT04849780|579742289|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
160550943|NCT04849780|579742290|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
160550944|NCT00725075|579742291|FG000|Overall Study|Use of Excluded Medication|0|||
160550945|NCT00725075|579742292|FG001|Overall Study|Use of Excluded Medication|1|||
160550946|NCT00725075|579742293|FG002|Overall Study|Use of Excluded Medication|0|||
160550947|NCT00725075|579742291|FG000|Overall Study|Protocol Violation|0|||
160550948|NCT00725075|579742292|FG001|Overall Study|Protocol Violation|0|||
160550949|NCT00725075|579742293|FG002|Overall Study|Protocol Violation|1|||
160550950|NCT00725075|579742291|FG000|Overall Study|Lost to Follow-up|1|||
160550951|NCT00725075|579742292|FG001|Overall Study|Lost to Follow-up|0|||
160550952|NCT00725075|579742293|FG002|Overall Study|Lost to Follow-up|0|||
160550953|NCT00725075|579742291|FG000|Overall Study|Withdrawal by Subject|4|||
160550954|NCT00725075|579742292|FG001|Overall Study|Withdrawal by Subject|5|||
160550955|NCT00725075|579742293|FG002|Overall Study|Withdrawal by Subject|4|||
160550956|NCT00725075|579742291|FG000|Overall Study|Adverse Event|2|||
160550957|NCT00725075|579742292|FG001|Overall Study|Adverse Event|1|||
160550958|NCT00725075|579742293|FG002|Overall Study|Adverse Event|1|||
160550959|NCT00725075|579742291|FG000|Overall Study|Worsening of Disease|2|||
160550960|NCT00725075|579742292|FG001|Overall Study|Worsening of Disease|1|||
160550961|NCT00725075|579742293|FG002|Overall Study|Worsening of Disease|2|||
160550962|NCT00725075|579742291|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
160550963|NCT00725075|579742292|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
160550964|NCT00725075|579742293|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
160550965|NCT00725075|579742291|FG000|Overall Study|Other|1|||
160550966|NCT00725075|579742292|FG001|Overall Study|Other|0|||
160550967|NCT00725075|579742293|FG002|Overall Study|Other|0|||
160550968|NCT02340663|579742294|FG000|Overall Study|Lost to Follow-up|1|||
160550969|NCT02340663|579742295|FG001|Overall Study|Lost to Follow-up|0|||
160550970|NCT02340663|579742294|FG000|Overall Study|Protocol Violation|1|||
160806172|NCT04339413|580678199|FG000|Overall Study|Study Terminated by Sponsor|30|||
160806173|NCT04339413|580678200|FG001|Overall Study|Study Terminated by Sponsor|33|||
160806174|NCT04339413|580678199|FG000|Overall Study|Progressive Disease|9|||
160806175|NCT04339413|580678200|FG001|Overall Study|Progressive Disease|6|||
160806176|NCT04339413|580678199|FG000|Overall Study|Withdrawal by Subject|9|||
160550971|NCT02340663|579742295|FG001|Overall Study|Protocol Violation|0|||
160550972|NCT02340663|579742294|FG000|Overall Study|Withdrawal by Subject|3|||
160550973|NCT02340663|579742295|FG001|Overall Study|Withdrawal by Subject|1|||
160550974|NCT01353703|579742296|FG000|Overall Study|Migrated/moved from study area|1|||
160550975|NCT01353703|579742297|FG001|Overall Study|Migrated/moved from study area|0|||
160550976|NCT02286947|579742304|FG000|Overall Study|Withdrawal by Subject|2|||
160550977|NCT01687712|579742305|FG000|Cycle 1|Not Biochemically Pregnant|386|||
160550978|NCT01687712|579742306|FG001|Cycle 1|Not Biochemically Pregnant|348|||
160806177|NCT04339413|580678200|FG001|Overall Study|Withdrawal by Subject|10|||
160550979|NCT01687712|579742305|FG000|Cycle 1|Early Pregnancy Loss|43|||
160550980|NCT01687712|579742306|FG001|Cycle 1|Early Pregnancy Loss|60|||
160550981|NCT01687712|579742305|FG000|Cycle 1|Ectopic Pregnancy|5|||
160550982|NCT01687712|579742306|FG001|Cycle 1|Ectopic Pregnancy|5|||
160550983|NCT01687712|579742305|FG000|Cycle 1|Heterotropic Pregnancy|1|||
160550984|NCT01687712|579742306|FG001|Cycle 1|Heterotropic Pregnancy|0|||
160550985|NCT01687712|579742305|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
160550986|NCT01687712|579742306|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
160644591|NCT01629693|580080797|FG000|Overall Study|Lost to Follow-up|2|||
160806178|NCT04339413|580678199|FG000|Overall Study|Physician Decision|3|||
160806179|NCT04339413|580678200|FG001|Overall Study|Physician Decision|1|||
160806180|NCT04339413|580678199|FG000|Overall Study|Death|2|||
160806181|NCT04339413|580678200|FG001|Overall Study|Death|0|||
160806182|NCT04339413|580678199|FG000|Overall Study|Adverse Event|3|||
160806183|NCT04339413|580678200|FG001|Overall Study|Adverse Event|0|||
160806184|NCT01964378|580678205|FG000|Overall Study|Disc. due to death before first dosing|0|||
160806185|NCT01964378|580678206|FG001|Overall Study|Disc. due to death before first dosing|1|||
160806186|NCT01964378|580678205|FG000|Overall Study|Disc. due to AE before first dosing|1|||
160806187|NCT01964378|580678206|FG001|Overall Study|Disc. due to AE before first dosing|0|||
160806188|NCT01964378|580678205|FG000|Overall Study|Death|3|||
160806189|NCT01964378|580678206|FG001|Overall Study|Death|2|||
160806190|NCT01964378|580678205|FG000|Overall Study|Adverse Event|12|||
160806191|NCT01964378|580678206|FG001|Overall Study|Adverse Event|5|||
160806192|NCT01964378|580678205|FG000|Overall Study|Lack of Efficacy|0|||
160806193|NCT01964378|580678206|FG001|Overall Study|Lack of Efficacy|1|||
160806194|NCT01964378|580678205|FG000|Overall Study|Protocol Violation|0|||
160806195|NCT01964378|580678206|FG001|Overall Study|Protocol Violation|1|||
160806196|NCT01964378|580678205|FG000|Overall Study|Lost to Follow-up|0|||
160806197|NCT01964378|580678206|FG001|Overall Study|Lost to Follow-up|1|||
160806198|NCT01964378|580678205|FG000|Overall Study|Withdrawal by Subject|7|||
160806199|NCT01964378|580678206|FG001|Overall Study|Withdrawal by Subject|5|||
160806200|NCT01964378|580678205|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
160806201|NCT01964378|580678206|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
160806202|NCT01964378|580678205|FG000|Overall Study|Other|1|||
160806203|NCT01964378|580678206|FG001|Overall Study|Other|2|||
160806204|NCT03542266|580678207|FG000|Treatment Phase|Withdrawal by Subject|1|||
160806205|NCT03542266|580678207|FG000|Treatment Phase|Adverse Event|1|||
160806206|NCT03542266|580678207|FG000|Treatment Phase|PD|1|||
160806207|NCT03069716|580678224|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
160806208|NCT03069716|580678225|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
160898240|NCT02362035|581023399|FG000|Overall Study|Study terminated by sponsor|45|||
160898241|NCT02362035|581023399|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
160898242|NCT02362035|581023399|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
160806209|NCT03069716|580678226|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
160806210|NCT03069716|580678224|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
160806211|NCT03069716|580678225|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
160806212|NCT03069716|580678226|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
160806213|NCT03069716|580678224|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
160806214|NCT03069716|580678225|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
160806215|NCT03069716|580678226|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
160806216|NCT03069716|580678224|FG000|Randomized Treatment|Withdrawal by Subject|0|||
160550987|NCT01687712|579742305|FG000|Cycle 1|Abortion|3|||
160550988|NCT01687712|579742306|FG001|Cycle 1|Abortion|0|||
160806217|NCT03069716|580678225|FG001|Randomized Treatment|Withdrawal by Subject|2|||
160806218|NCT03069716|580678226|FG002|Randomized Treatment|Withdrawal by Subject|0|||
160806219|NCT00714948|580678227|FG000|Overall Study|Adverse Event|2|||
160806220|NCT01673126|580678228|FG000|Overall Study|change of diagnosis|4|||
160806221|NCT01673126|580678229|FG001|Overall Study|change of diagnosis|3|||
160806222|NCT00237042|580678232|FG000|Treatment|Became ineligible post-randomization|0|||
160806223|NCT00237042|580678233|FG001|Treatment|Became ineligible post-randomization|1|||
160806224|NCT00237042|580678234|FG002|Treatment|Became ineligible post-randomization|16|||
160806225|NCT00237042|580678232|FG000|Treatment|Moved out of state|1|||
160806226|NCT00237042|580678233|FG001|Treatment|Moved out of state|1|||
160806227|NCT00237042|580678234|FG002|Treatment|Moved out of state|1|||
160806228|NCT00237042|580678232|FG000|Treatment|Completed no treatment|5|||
160806229|NCT00237042|580678233|FG001|Treatment|Completed no treatment|5|||
160806230|NCT00237042|580678234|FG002|Treatment|Completed no treatment|21|||
160806231|NCT00237042|580678232|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
160806232|NCT00237042|580678233|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
160806233|NCT00237042|580678234|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
160806234|NCT00237042|580678232|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
160806235|NCT00237042|580678233|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
160806236|NCT00237042|580678234|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
160806237|NCT01913327|580678241|FG000|Overall Study|Withdrawal by Subject|0|||
160806238|NCT01913327|580678242|FG001|Overall Study|Withdrawal by Subject|1|||
160806239|NCT02454530|580678245|FG000|Overall Study|Other|8|||
160806240|NCT02454530|580678246|FG001|Overall Study|Other|13|||
160806241|NCT02454530|580678245|FG000|Overall Study|Missing information|56|||
160806242|NCT02454530|580678246|FG001|Overall Study|Missing information|69|||
160806243|NCT02454530|580678245|FG000|Overall Study|Death|2|||
160806244|NCT02454530|580678246|FG001|Overall Study|Death|41|||
160806245|NCT02454530|580678245|FG000|Overall Study|Lost to Follow-up|4|||
160806246|NCT02454530|580678246|FG001|Overall Study|Lost to Follow-up|4|||
160806247|NCT00326001|580678247|FG000|Overall Study|Adverse Event|4|||
160806248|NCT00326001|580678248|FG001|Overall Study|Adverse Event|5|||
160806249|NCT00326001|580678247|FG000|Overall Study|Physician Decision|3|||
160806250|NCT00326001|580678248|FG001|Overall Study|Physician Decision|3|||
160806251|NCT05223673|580678250|FG000|Overall Study|Protocol Violation|1|||
160806252|NCT05223673|580678250|FG000|Overall Study|Study termination|6|||
160806253|NCT02112656|580678254|FG000|Overall Study|Death|78|||
160806254|NCT02112656|580678255|FG001|Overall Study|Death|82|||
160806255|NCT02112656|580678254|FG000|Overall Study|Withdrawal by Subject|9|||
160806256|NCT02112656|580678255|FG001|Overall Study|Withdrawal by Subject|11|||
160806257|NCT02112656|580678254|FG000|Overall Study|Lost to Follow-up|2|||
160806258|NCT02112656|580678255|FG001|Overall Study|Lost to Follow-up|4|||
160806259|NCT02112656|580678254|FG000|Overall Study|Noncompliance|1|||
160806260|NCT02112656|580678255|FG001|Overall Study|Noncompliance|2|||
160806261|NCT00996658|580678256|FG000|Overall Study|Adverse Event|2|||
160806262|NCT00996658|580678257|FG001|Overall Study|Adverse Event|5|||
160806263|NCT00996658|580678256|FG000|Overall Study|Protocol Violation|0|||
160806264|NCT00996658|580678257|FG001|Overall Study|Protocol Violation|1|||
160806265|NCT00996658|580678256|FG000|Overall Study|Lost to Follow-up|2|||
160644592|NCT01629693|580080798|FG001|Overall Study|Lost to Follow-up|4|||
160644593|NCT01629693|580080797|FG000|Overall Study|Withdrawal by Subject|2|||
160806266|NCT00996658|580678257|FG001|Overall Study|Lost to Follow-up|5|||
160806267|NCT00996658|580678256|FG000|Overall Study|Non-compliance issues|3|||
160806268|NCT00996658|580678257|FG001|Overall Study|Non-compliance issues|3|||
160806269|NCT00996658|580678256|FG000|Overall Study|Other|9|||
160806270|NCT00996658|580678257|FG001|Overall Study|Other|7|||
160806271|NCT04749745|580678258|FG000|Overall Study|Withdrawal by Subject|1|||
160806272|NCT04749745|580678259|FG001|Overall Study|Withdrawal by Subject|0|||
160806273|NCT01234480|580679725|FG000|Overall Study|Pregnancy|88|||
160806274|NCT01234480|580679725|FG000|Overall Study|>36/Normal History|50|||
160806275|NCT01234480|580679725|FG000|Overall Study|Age|3|||
160806276|NCT01234480|580679725|FG000|Overall Study|HPV Vaccine History|28|||
160806277|NCT01234480|580679725|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
160806278|NCT01234480|580679725|FG000|Overall Study|Hysterectomy|2|||
160806279|NCT01234480|580679725|FG000|Overall Study|Hysterectomy post enrollment|1|||
160806280|NCT01234480|580679725|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
160806281|NCT01234480|580679725|FG000|Overall Study|Informed Consent Form Violation|30|||
160806282|NCT01234480|580679725|FG000|Overall Study|Incorrect Visit|3|||
160806283|NCT01234480|580679725|FG000|Overall Study|No Florida Lab License|20|||
160806284|NCT01234480|580679725|FG000|Overall Study|Out of Window|42|||
160806285|NCT01234480|580679725|FG000|Overall Study|Sample Processing/Storage|92|||
160806286|NCT01234480|580679725|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
160806287|NCT01234480|580679725|FG000|Overall Study|Site/Subject non-compliance|44|||
160806288|NCT01234480|580679725|FG000|Overall Study|Missing Sample|9|||
160806289|NCT03370419|580679726|FG000|Overall Study|Lost to Follow-up|16|||
160806290|NCT00620373|580679733|FG000|Overall Study|Unverified cancer status|33|||
160806291|NCT01897727|580679734|FG000|Overall Study|Exclusion: central sleep apnea|0|||
160806292|NCT01897727|580679735|FG001|Overall Study|Exclusion: central sleep apnea|1|||
160806293|NCT04245449|580679736|FG000|Overall Study|COVID shutdown|7|||
160806294|NCT01273038|580679739|FG000|Second Intervention (14 Days)|Adverse Event|0|||
160806295|NCT01273038|580679740|FG001|Second Intervention (14 Days)|Adverse Event|1|||
160806296|NCT01273038|580679739|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
160806297|NCT01273038|580679740|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
160806298|NCT02197572|580679741|FG000|Overall Study|Progressive Disease|28|||
160806299|NCT02197572|580679741|FG000|Overall Study|Withdrawal by Subject|9|||
160550989|NCT01687712|579742305|FG000|Cycle 1|Intrauterine Fetal Death|0|||
160550990|NCT01687712|579742306|FG001|Cycle 1|Intrauterine Fetal Death|1|||
160550991|NCT01687712|579742305|FG000|Cycle 1|Lost to Follow-up|1|||
160550992|NCT01687712|579742306|FG001|Cycle 1|Lost to Follow-up|1|||
160550993|NCT01687712|579742305|FG000|Cycle 2|Not Biochemically Pregnant|74|||
160550994|NCT01687712|579742306|FG001|Cycle 2|Not Biochemically Pregnant|77|||
160550995|NCT01687712|579742305|FG000|Cycle 2|Early Pregnancy Loss|18|||
160550996|NCT01687712|579742306|FG001|Cycle 2|Early Pregnancy Loss|16|||
160550997|NCT01687712|579742305|FG000|Cycle 2|Ectopic Pregnancy|0|||
160550998|NCT01687712|579742306|FG001|Cycle 2|Ectopic Pregnancy|1|||
160550999|NCT01687712|579742305|FG000|Cycle 2|Still Birth|1|||
160551000|NCT01687712|579742306|FG001|Cycle 2|Still Birth|0|||
160551001|NCT01687712|579742305|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
160551002|NCT01687712|579742306|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
160551003|NCT01687712|579742305|FG000|Cycle 3|Not Biochemically Pregnant|21|||
160551004|NCT01687712|579742306|FG001|Cycle 3|Not Biochemically Pregnant|22|||
160551005|NCT01687712|579742305|FG000|Cycle 3|Early Pregnancy Loss|1|||
160551006|NCT01687712|579742306|FG001|Cycle 3|Early Pregnancy Loss|2|||
160551007|NCT01687712|579742305|FG000|Cycle 3|Ectopic Pregnancy|1|||
160551008|NCT01687712|579742306|FG001|Cycle 3|Ectopic Pregnancy|0|||
160551009|NCT01687712|579742305|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
160551010|NCT01687712|579742306|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
160551011|NCT00915343|579742307|FG000|Part B - Open Label Period|Treatment switch|0|||
160551012|NCT00915343|579742308|FG001|Part B - Open Label Period|Treatment switch|0|||
160551013|NCT00915343|579742309|FG002|Part B - Open Label Period|Treatment switch|1|||
160551014|NCT00915343|579742307|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
160551015|NCT00915343|579742308|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
160551016|NCT00915343|579742309|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
160551017|NCT00512798|579742310|FG000|Overall Study|Death|0|||
160551018|NCT00512798|579742311|FG001|Overall Study|Death|3|||
160551019|NCT00512798|579742310|FG000|Overall Study|Adverse Event|2|||
160551020|NCT00512798|579742311|FG001|Overall Study|Adverse Event|4|||
160551021|NCT00512798|579742310|FG000|Overall Study|Progression of disease|14|||
160551022|NCT00512798|579742311|FG001|Overall Study|Progression of disease|20|||
160551023|NCT00512798|579742310|FG000|Overall Study|Withdrawal by Subject|3|||
160551024|NCT00512798|579742311|FG001|Overall Study|Withdrawal by Subject|0|||
160551025|NCT03551743|579742312|FG000|Overall Study|Adverse Event|1|||
160551026|NCT03551743|579742313|FG001|Overall Study|Adverse Event|0|||
160551027|NCT03551743|579742314|FG002|Overall Study|Adverse Event|0|||
160806300|NCT02197572|580679741|FG000|Overall Study|Adverse Event|3|||
160806301|NCT02197572|580679741|FG000|Overall Study|Reason Not Specified|4|||
160806302|NCT01465386|580679742|FG000|Overall Study|Lack of Efficacy|3|||
160806303|NCT01465386|580679742|FG000|Overall Study|Adverse Event|1|||
160806304|NCT02479880|580679743|FG000|Overall Study|Study Terminated by Sponsor|13|||
160806305|NCT02479880|580679744|FG001|Overall Study|Study Terminated by Sponsor|12|||
160806306|NCT02479880|580679743|FG000|Overall Study|Pregnancy|0|||
160806307|NCT02479880|580679744|FG001|Overall Study|Pregnancy|1|||
160806308|NCT02840253|580679745|FG000|Overall Study|Unsuccessful block|4|||
160806309|NCT03801928|580679746|FG000|Overall Study|Adverse Event|1|||
160806310|NCT03801928|580679747|FG001|Overall Study|Adverse Event|0|||
160806311|NCT03801928|580679748|FG002|Overall Study|Adverse Event|1|||
160806312|NCT03801928|580679749|FG003|Overall Study|Adverse Event|2|||
160806313|NCT03801928|580679750|FG004|Overall Study|Adverse Event|0|||
160806314|NCT03801928|580679751|FG005|Overall Study|Adverse Event|2|||
160806315|NCT03801928|580679746|FG000|Overall Study|Lack of Efficacy|0|||
160806316|NCT03801928|580679747|FG001|Overall Study|Lack of Efficacy|0|||
160806317|NCT03801928|580679748|FG002|Overall Study|Lack of Efficacy|1|||
160806318|NCT03801928|580679749|FG003|Overall Study|Lack of Efficacy|0|||
160806319|NCT03801928|580679750|FG004|Overall Study|Lack of Efficacy|0|||
160806320|NCT03801928|580679751|FG005|Overall Study|Lack of Efficacy|0|||
160806321|NCT03801928|580679746|FG000|Overall Study|Lost to Follow-up|5|||
160806322|NCT03801928|580679747|FG001|Overall Study|Lost to Follow-up|1|||
160806323|NCT03801928|580679748|FG002|Overall Study|Lost to Follow-up|1|||
160806324|NCT03801928|580679749|FG003|Overall Study|Lost to Follow-up|4|||
160806325|NCT03801928|580679750|FG004|Overall Study|Lost to Follow-up|4|||
160806326|NCT03801928|580679751|FG005|Overall Study|Lost to Follow-up|2|||
160806327|NCT03801928|580679746|FG000|Overall Study|Withdrawal by Subject|0|||
160806328|NCT03801928|580679747|FG001|Overall Study|Withdrawal by Subject|0|||
160898243|NCT02362035|581023399|FG000|Overall Study|Disease progression|11|||
160551028|NCT03551743|579742315|FG003|Overall Study|Adverse Event|0|||
160551029|NCT03551743|579742312|FG000|Overall Study|Withdrawal by Subject|1|||
160551030|NCT03551743|579742313|FG001|Overall Study|Withdrawal by Subject|0|||
160551031|NCT03551743|579742314|FG002|Overall Study|Withdrawal by Subject|0|||
160551032|NCT03551743|579742315|FG003|Overall Study|Withdrawal by Subject|0|||
160551033|NCT02317562|579742316|FG000|Overall Study|Physician Decision|1|||
160551034|NCT02317562|579742316|FG000|Overall Study|early termination of the study|8|||
160551035|NCT02317562|579742316|FG000|Overall Study|Lack of Efficacy|4|||
160551036|NCT02317562|579742316|FG000|Overall Study|Withdrawal by Subject|1|||
160551037|NCT00911989|579742317|FG000|Overall Study|Adverse Event|1|||
160551038|NCT03064841|579742318|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
160551039|NCT03064841|579742318|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
160551040|NCT03064841|579742318|FG000|Overall Study|Screen failure|2|||
160551041|NCT03434977|579742319|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
160551042|NCT03434977|579742320|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
160551043|NCT01145066|579742321|FG000|Overall Study|To resume NSAIDs|2|||
160551044|NCT01145066|579742322|FG001|Overall Study|To resume NSAIDs|2|||
160551045|NCT01145066|579742323|FG002|Overall Study|To resume NSAIDs|1|||
160551046|NCT01145066|579742321|FG000|Overall Study|Non-related surgery|0|||
160551047|NCT01145066|579742322|FG001|Overall Study|Non-related surgery|0|||
160551048|NCT01145066|579742323|FG002|Overall Study|Non-related surgery|1|||
160551049|NCT01145066|579742321|FG000|Overall Study|Withdrawal by Subject|0|||
160551050|NCT01145066|579742322|FG001|Overall Study|Withdrawal by Subject|0|||
160551051|NCT01145066|579742323|FG002|Overall Study|Withdrawal by Subject|2|||
160551052|NCT01145066|579742321|FG000|Overall Study|To start new med|1|||
160551053|NCT01145066|579742322|FG001|Overall Study|To start new med|0|||
160551054|NCT01145066|579742323|FG002|Overall Study|To start new med|0|||
160551055|NCT01145066|579742321|FG000|Overall Study|problems swallowing capsule|1|||
160551056|NCT01145066|579742322|FG001|Overall Study|problems swallowing capsule|0|||
160551057|NCT01145066|579742323|FG002|Overall Study|problems swallowing capsule|0|||
160551058|NCT01145066|579742321|FG000|Overall Study|Abdominal discomfort|0|||
160551059|NCT01145066|579742322|FG001|Overall Study|Abdominal discomfort|1|||
160551060|NCT01145066|579742323|FG002|Overall Study|Abdominal discomfort|0|||
160551061|NCT01145066|579742321|FG000|Overall Study|Low platelet count|0|||
160551062|NCT01145066|579742322|FG001|Overall Study|Low platelet count|1|||
160551063|NCT01145066|579742323|FG002|Overall Study|Low platelet count|0|||
160551064|NCT03920670|579742324|FG000|Overall Study|Protocol Violation|2|||
160551065|NCT03920670|579742325|FG001|Overall Study|Protocol Violation|2|||
160551066|NCT03920670|579742324|FG000|Overall Study|Adverse Event|1|||
160551067|NCT03920670|579742325|FG001|Overall Study|Adverse Event|0|||
160551068|NCT01250379|579742332|FG000|Overall Study|Death|141|||
160551069|NCT01250379|579742333|FG001|Overall Study|Death|148|||
160551070|NCT01250379|579742332|FG000|Overall Study|Withdrawal by Subject|32|||
160551071|NCT01250379|579742333|FG001|Overall Study|Withdrawal by Subject|20|||
160898244|NCT02362035|581023399|FG000|Overall Study|Withdrawal by Subject|20|||
160985365|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Personal Issues|0|||
160985366|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Personal Issues|3|||
160985367|NCT00885495|581335433|FG000|Overall Study|Adverse Event|1|||
160985368|NCT00885495|581335434|FG001|Overall Study|Adverse Event|2|||
160985369|NCT00885495|581335433|FG000|Overall Study|Protocol Violation|0|||
160985370|NCT00885495|581335434|FG001|Overall Study|Protocol Violation|1|||
160985371|NCT00885495|581335433|FG000|Overall Study|Withdrawal by Subject|1|||
160985372|NCT00885495|581335434|FG001|Overall Study|Withdrawal by Subject|0|||
160985373|NCT01400893|581335435|FG000|Overall Study|Death|27|||
160985374|NCT01400893|581335436|FG001|Overall Study|Death|21|||
160985375|NCT01400893|581335435|FG000|Overall Study|Lost to Follow-up|0|||
160898245|NCT02024529|581023400|FG000|Overall Study|Withdrawal by Subject|11|||
160898246|NCT02024529|581023401|FG001|Overall Study|Withdrawal by Subject|21|||
160898247|NCT02024529|581023400|FG000|Overall Study|Lost to Follow-up|2|||
160898248|NCT02024529|581023401|FG001|Overall Study|Lost to Follow-up|4|||
160898249|NCT00354614|581023402|FG000|Overall Study|Lack of Efficacy|28|||
160898250|NCT00691301|581023403|FG000|Overall Study|Adverse Event|10|||
160898251|NCT00691301|581023403|FG000|Overall Study|Death|2|||
160898252|NCT00691301|581023403|FG000|Overall Study|Lack of Efficacy|32|||
160898253|NCT00691301|581023403|FG000|Overall Study|Withdrawal by Subject|4|||
160898254|NCT00691301|581023403|FG000|Overall Study|Concurrent illness|2|||
160898255|NCT00691301|581023403|FG000|Overall Study|other reason|3|||
160898256|NCT00691301|581023403|FG000|Overall Study|Did not initiate study treatment|1|||
160898257|NCT02642029|581023404|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
160898258|NCT02642029|581023405|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
160898259|NCT02642029|581023406|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
160898260|NCT02642029|581023407|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
160898261|NCT02642029|581023408|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
160898262|NCT02642029|581023409|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
160985376|NCT01400893|581335436|FG001|Overall Study|Lost to Follow-up|6|||
160985377|NCT00519636|581335437|FG000|Treatment Period 1|Adverse Event|1|||
160985378|NCT00519636|581335438|FG001|Treatment Period 1|Adverse Event|0|||
160551072|NCT01250379|579742332|FG000|Overall Study|Physician Decision|11|||
160551073|NCT01250379|579742333|FG001|Overall Study|Physician Decision|3|||
160551074|NCT01250379|579742332|FG000|Overall Study|Protocol Violation|2|||
160898263|NCT02642029|581023404|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
160985379|NCT00519636|581335439|FG002|Treatment Period 1|Adverse Event|1|||
160985380|NCT00519636|581335440|FG003|Treatment Period 1|Adverse Event|0|||
160985381|NCT00519636|581335437|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
160551075|NCT01250379|579742333|FG001|Overall Study|Protocol Violation|8|||
160806329|NCT03801928|580679748|FG002|Overall Study|Withdrawal by Subject|2|||
160806330|NCT03801928|580679749|FG003|Overall Study|Withdrawal by Subject|1|||
160806331|NCT03801928|580679750|FG004|Overall Study|Withdrawal by Subject|0|||
160806332|NCT03801928|580679751|FG005|Overall Study|Withdrawal by Subject|0|||
160806333|NCT03801928|580679746|FG000|Overall Study|Other|0|||
160806334|NCT03801928|580679747|FG001|Overall Study|Other|2|||
160806335|NCT03801928|580679748|FG002|Overall Study|Other|0|||
160806336|NCT03801928|580679749|FG003|Overall Study|Other|1|||
160806337|NCT03801928|580679750|FG004|Overall Study|Other|0|||
160806338|NCT03801928|580679751|FG005|Overall Study|Other|1|||
160806339|NCT03688919|580679752|FG000|Overall Study|Lost to Follow-up|2|||
160806340|NCT03688919|580679753|FG001|Overall Study|Lost to Follow-up|1|||
160806341|NCT03688919|580679752|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
160898264|NCT02642029|581023405|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
160898265|NCT02642029|581023406|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
160898266|NCT02642029|581023407|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
160898267|NCT02642029|581023408|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
160898268|NCT02642029|581023409|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
160898269|NCT02642029|581023404|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
160898270|NCT02642029|581023405|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
160898271|NCT02642029|581023406|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
160898272|NCT02642029|581023407|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
160898273|NCT02642029|581023408|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
160898274|NCT02642029|581023409|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
160898275|NCT02642029|581023404|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
160898276|NCT02642029|581023405|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
160898277|NCT02642029|581023406|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
160898278|NCT02642029|581023407|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
160898279|NCT02642029|581023408|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
160898280|NCT02642029|581023409|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
160898281|NCT02642029|581023404|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
160898282|NCT02642029|581023405|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
160898283|NCT02642029|581023406|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
160898284|NCT02642029|581023407|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
160898285|NCT02642029|581023408|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
160898286|NCT02642029|581023409|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
160898287|NCT02642029|581023404|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
160898288|NCT02642029|581023405|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
160898289|NCT02642029|581023406|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
160898290|NCT02642029|581023407|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
160898291|NCT02642029|581023408|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
160898292|NCT02642029|581023409|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
160898293|NCT00463580|581023412|FG000|Overall Study|Lost to Follow-up|1|||
160898294|NCT00463580|581023413|FG001|Overall Study|Lost to Follow-up|0|||
160898295|NCT00463580|581023412|FG000|Overall Study|Schedule conflict|2|||
160898296|NCT00463580|581023413|FG001|Overall Study|Schedule conflict|0|||
160898297|NCT00463580|581023412|FG000|Overall Study|Medical/psychiatric complications|0|||
160898298|NCT00463580|581023413|FG001|Overall Study|Medical/psychiatric complications|2|||
160898299|NCT01426438|581023414|FG000|Overall Study|Lost to Follow-up|1|||
160898300|NCT01426438|581023415|FG001|Overall Study|Lost to Follow-up|3|||
160898301|NCT01426438|581023414|FG000|Overall Study|Off study Treatment|9|||
160898302|NCT01426438|581023415|FG001|Overall Study|Off study Treatment|3|||
160898303|NCT01426438|581023414|FG000|Overall Study|Poor scan quality|3|||
160898304|NCT01426438|581023415|FG001|Overall Study|Poor scan quality|2|||
160898305|NCT01426438|581023414|FG000|Overall Study|Missed Scan|2|||
160898306|NCT01426438|581023415|FG001|Overall Study|Missed Scan|2|||
160898307|NCT01495975|581023418|FG000|Overall Study|Lost to Follow-up|1|||
160898308|NCT01495975|581023419|FG001|Overall Study|Lost to Follow-up|0|||
160898309|NCT00808483|581023422|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
160898310|NCT00808483|581023423|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
160898311|NCT00808483|581023422|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
160898312|NCT00808483|581023423|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
160898313|NCT00808483|581023422|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
160898314|NCT00808483|581023423|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
160898315|NCT02038881|581023424|FG000|Overall Study|Withdrawal by Subject|0|||
160898316|NCT02038881|581023425|FG001|Overall Study|Withdrawal by Subject|0|||
160898317|NCT02038881|581023426|FG002|Overall Study|Withdrawal by Subject|1|||
160898318|NCT02038881|581023424|FG000|Overall Study|Lost to Follow-up|2|||
160806342|NCT03688919|580679753|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
160806343|NCT04423939|580679758|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
160985382|NCT00519636|581335438|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
160985383|NCT00519636|581335439|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
160985384|NCT00519636|581335440|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
160985385|NCT00519636|581335437|FG000|Washout Period|Adverse Event|2|||
160985386|NCT00519636|581335438|FG001|Washout Period|Adverse Event|1|||
160985387|NCT00519636|581335439|FG002|Washout Period|Adverse Event|1|||
160985388|NCT00519636|581335440|FG003|Washout Period|Adverse Event|0|||
160985389|NCT00519636|581335437|FG000|Washout Period|Lost to Follow-up|1|||
160985390|NCT00519636|581335438|FG001|Washout Period|Lost to Follow-up|0|||
160985391|NCT00519636|581335439|FG002|Washout Period|Lost to Follow-up|0|||
160985392|NCT00519636|581335440|FG003|Washout Period|Lost to Follow-up|0|||
160551076|NCT01250379|579742332|FG000|Overall Study|Lost to Follow-up|9|||
160551077|NCT01250379|579742333|FG001|Overall Study|Lost to Follow-up|6|||
160551078|NCT01250379|579742332|FG000|Overall Study|Adverse Event|5|||
160551079|NCT01250379|579742333|FG001|Overall Study|Adverse Event|4|||
160551080|NCT01250379|579742332|FG000|Overall Study|Other|0|||
160551081|NCT01250379|579742333|FG001|Overall Study|Other|4|||
160551082|NCT01250379|579742332|FG000|Overall Study|Participant noncompliance|2|||
160551083|NCT01250379|579742333|FG001|Overall Study|Participant noncompliance|0|||
160551084|NCT01984268|579742334|FG000|Overall Study|Study Terminated|15|||
160551085|NCT01314716|579742335|FG000|Double-Blind Phase|Randomized but not treated|1|||
160551086|NCT01314716|579742336|FG001|Double-Blind Phase|Randomized but not treated|1|||
160551087|NCT01314716|579742335|FG000|Double-Blind Phase|Adverse Event|10|||
160551088|NCT01314716|579742336|FG001|Double-Blind Phase|Adverse Event|4|||
160551089|NCT01314716|579742335|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
160551090|NCT01314716|579742336|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
160551091|NCT01314716|579742335|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160551092|NCT01314716|579742336|FG001|Double-Blind Phase|Lost to Follow-up|1|||
160551093|NCT01314716|579742335|FG000|Double-Blind Phase|Sponsor request|1|||
160551094|NCT01314716|579742336|FG001|Double-Blind Phase|Sponsor request|2|||
160551095|NCT01314716|579742335|FG000|Double-Blind Phase|Physician Decision|0|||
160551096|NCT01314716|579742336|FG001|Double-Blind Phase|Physician Decision|1|||
160551097|NCT01314716|579742335|FG000|Open-Label Phase|Adverse Event|4|||
160551098|NCT01314716|579742336|FG001|Open-Label Phase|Adverse Event|6|||
160551099|NCT01314716|579742335|FG000|Open-Label Phase|Withdrawal by Subject|1|||
160551100|NCT01314716|579742336|FG001|Open-Label Phase|Withdrawal by Subject|2|||
160551101|NCT01314716|579742335|FG000|Open-Label Phase|Physician Decision|5|||
160551102|NCT01314716|579742336|FG001|Open-Label Phase|Physician Decision|4|||
160551103|NCT01928381|579742340|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
160551104|NCT01928381|579742341|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
160551105|NCT01928381|579742342|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
160551106|NCT01928381|579742343|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
160551107|NCT01928381|579742344|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
160551108|NCT01928381|579742345|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
160551109|NCT01928381|579742346|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
160551110|NCT01928381|579742340|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
160551111|NCT01928381|579742341|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
160551112|NCT01928381|579742342|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
160551113|NCT01928381|579742343|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
160551114|NCT01928381|579742344|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
160551115|NCT01928381|579742345|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
160551116|NCT01928381|579742346|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
160551117|NCT01928381|579742340|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
160551118|NCT01928381|579742341|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
160551119|NCT01928381|579742342|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
160551120|NCT01928381|579742343|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
160551121|NCT01928381|579742344|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
160551122|NCT01928381|579742345|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
160551123|NCT01928381|579742346|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
160551124|NCT01928381|579742340|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
160551125|NCT01928381|579742341|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
160551126|NCT01928381|579742342|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
160644594|NCT01629693|580080798|FG001|Overall Study|Withdrawal by Subject|2|||
160985393|NCT00519636|581335437|FG000|Washout Period|Protocol Violation|0|||
160985394|NCT00519636|581335438|FG001|Washout Period|Protocol Violation|0|||
160985395|NCT00519636|581335439|FG002|Washout Period|Protocol Violation|1|||
160985396|NCT00519636|581335440|FG003|Washout Period|Protocol Violation|2|||
160551127|NCT01928381|579742343|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
160551128|NCT01928381|579742344|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
160551129|NCT01928381|579742345|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
160551130|NCT01928381|579742346|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
160985397|NCT00519636|581335437|FG000|Washout Period|Withdrawal by Subject|1|||
160985398|NCT00519636|581335438|FG001|Washout Period|Withdrawal by Subject|0|||
160985399|NCT00519636|581335439|FG002|Washout Period|Withdrawal by Subject|1|||
160985400|NCT00519636|581335440|FG003|Washout Period|Withdrawal by Subject|0|||
160985401|NCT00519636|581335437|FG000|Washout Period|Failed to meet continuation criteria|14|||
160985402|NCT00519636|581335438|FG001|Washout Period|Failed to meet continuation criteria|11|||
160985403|NCT00519636|581335439|FG002|Washout Period|Failed to meet continuation criteria|9|||
160985404|NCT00519636|581335440|FG003|Washout Period|Failed to meet continuation criteria|3|||
160985405|NCT00519636|581335437|FG000|Washout Period|Out of pollen area > 48 hours|1|||
160985406|NCT00519636|581335438|FG001|Washout Period|Out of pollen area > 48 hours|0|||
160985407|NCT00519636|581335439|FG002|Washout Period|Out of pollen area > 48 hours|0|||
160985408|NCT00519636|581335440|FG003|Washout Period|Out of pollen area > 48 hours|0|||
160985409|NCT00519636|581335437|FG000|Washout Period|Participating in study at another site|1|||
160985410|NCT00519636|581335438|FG001|Washout Period|Participating in study at another site|0|||
160985411|NCT00519636|581335439|FG002|Washout Period|Participating in study at another site|0|||
160985412|NCT00519636|581335440|FG003|Washout Period|Participating in study at another site|0|||
160985413|NCT00519636|581335437|FG000|Washout Period|Non-compliant|0|||
160985414|NCT00519636|581335438|FG001|Washout Period|Non-compliant|1|||
160985415|NCT00519636|581335439|FG002|Washout Period|Non-compliant|0|||
160985416|NCT00519636|581335440|FG003|Washout Period|Non-compliant|0|||
160985417|NCT00519636|581335437|FG000|Washout Period|Per doctors request|0|||
160985418|NCT00519636|581335438|FG001|Washout Period|Per doctors request|1|||
160985419|NCT00519636|581335439|FG002|Washout Period|Per doctors request|0|||
160985420|NCT00519636|581335440|FG003|Washout Period|Per doctors request|0|||
160985421|NCT00519636|581335437|FG000|Washout Period|Subject randomized in error|0|||
160985422|NCT00519636|581335438|FG001|Washout Period|Subject randomized in error|0|||
160985423|NCT00519636|581335439|FG002|Washout Period|Subject randomized in error|1|||
160985424|NCT00519636|581335440|FG003|Washout Period|Subject randomized in error|0|||
160985425|NCT00519636|581335437|FG000|Washout Period|Prohibited medications|0|||
160985426|NCT00519636|581335438|FG001|Washout Period|Prohibited medications|0|||
160985427|NCT00519636|581335439|FG002|Washout Period|Prohibited medications|1|||
160985428|NCT00519636|581335440|FG003|Washout Period|Prohibited medications|0|||
160985429|NCT00519636|581335437|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
160985430|NCT00519636|581335438|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
160985431|NCT00519636|581335439|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
160985432|NCT00519636|581335440|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
160985433|NCT00519636|581335437|FG000|Treatment Period 2|Subject randomized in error|0|||
160985434|NCT00519636|581335438|FG001|Treatment Period 2|Subject randomized in error|1|||
160985435|NCT00519636|581335439|FG002|Treatment Period 2|Subject randomized in error|0|||
160985436|NCT00519636|581335440|FG003|Treatment Period 2|Subject randomized in error|0|||
160985437|NCT00519636|581335437|FG000|Treatment Period 2|Per doctors request|0|||
160985438|NCT00519636|581335438|FG001|Treatment Period 2|Per doctors request|0|||
160985439|NCT00519636|581335439|FG002|Treatment Period 2|Per doctors request|1|||
160985440|NCT00519636|581335440|FG003|Treatment Period 2|Per doctors request|0|||
160985441|NCT00519636|581335437|FG000|Treatment Period 2|Subject misrandomized|0|||
160985442|NCT00519636|581335438|FG001|Treatment Period 2|Subject misrandomized|0|||
160985443|NCT00519636|581335439|FG002|Treatment Period 2|Subject misrandomized|0|||
160985444|NCT00519636|581335440|FG003|Treatment Period 2|Subject misrandomized|1|||
160985445|NCT00519636|581335437|FG000|Post Study Period|Subject randomized in error|0|||
160985446|NCT00519636|581335438|FG001|Post Study Period|Subject randomized in error|0|||
160985447|NCT00519636|581335439|FG002|Post Study Period|Subject randomized in error|0|||
160985448|NCT00519636|581335440|FG003|Post Study Period|Subject randomized in error|1|||
160985449|NCT04504916|581335441|FG000|Overall Study|Study terminated|7|||
160985450|NCT04504916|581335442|FG001|Overall Study|Study terminated|8|||
160985451|NCT04504916|581335441|FG000|Overall Study|Death|54|||
160806344|NCT04423939|580679759|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
160806345|NCT04423939|580679758|FG000|Overall Study|Death|3|||
160806346|NCT04423939|580679759|FG001|Overall Study|Death|0|||
160806347|NCT04423939|580679758|FG000|Overall Study|Withdrawal by Subject|3|||
160806348|NCT04423939|580679759|FG001|Overall Study|Withdrawal by Subject|0|||
160806349|NCT04423939|580679758|FG000|Overall Study|Caregiver to patient who died|0|||
160806350|NCT04423939|580679759|FG001|Overall Study|Caregiver to patient who died|3|||
160806351|NCT04423939|580679758|FG000|Overall Study|Caregiver to patient who withdrew|0|||
160806352|NCT04423939|580679759|FG001|Overall Study|Caregiver to patient who withdrew|3|||
160806353|NCT01456130|580679761|FG000|Overall Study|Adverse Event|4|||
160806354|NCT01456130|580679761|FG000|Overall Study|Voluntary Withdrawal|1|||
160806355|NCT01456130|580679761|FG000|Overall Study|Lack of Efficacy|4|||
160806356|NCT01456130|580679761|FG000|Overall Study|Other|1|||
160985452|NCT04504916|581335442|FG001|Overall Study|Death|18|||
160985453|NCT04504916|581335441|FG000|Overall Study|Lost to Follow-up|1|||
160985454|NCT04504916|581335442|FG001|Overall Study|Lost to Follow-up|1|||
160985455|NCT04504916|581335441|FG000|Overall Study|Withdrawal by Subject|8|||
160985456|NCT04504916|581335442|FG001|Overall Study|Withdrawal by Subject|4|||
160985457|NCT04504916|581335441|FG000|Overall Study|Did not agree to follow-up|0|||
160985458|NCT04504916|581335442|FG001|Overall Study|Did not agree to follow-up|1|||
160985459|NCT03057834|581335443|FG000|Overall Study|Withdrawal by Subject|25|||
160985460|NCT03057834|581335444|FG001|Overall Study|Withdrawal by Subject|29|||
160985461|NCT00003509|581335445|FG000|Overall Study|Not evaluable|5|||
160985462|NCT03077620|581335450|FG000|Overall Study|Unable to place lumbar catheter|1|||
160985463|NCT03077620|581335451|FG001|Overall Study|Unable to place lumbar catheter|0|||
160985464|NCT03077620|581335452|FG002|Overall Study|Unable to place lumbar catheter|1|||
160985465|NCT03077620|581335453|FG003|Overall Study|Unable to place lumbar catheter|0|||
160985466|NCT03077620|581335450|FG000|Overall Study|Withdrawal by Subject|0|||
160985467|NCT03077620|581335451|FG001|Overall Study|Withdrawal by Subject|1|||
160985468|NCT03077620|581335452|FG002|Overall Study|Withdrawal by Subject|0|||
160985469|NCT03077620|581335453|FG003|Overall Study|Withdrawal by Subject|0|||
160985470|NCT03077620|581335450|FG000|Overall Study|Physician Decision|0|||
160985471|NCT03077620|581335451|FG001|Overall Study|Physician Decision|0|||
160985472|NCT03077620|581335452|FG002|Overall Study|Physician Decision|1|||
160985473|NCT03077620|581335453|FG003|Overall Study|Physician Decision|0|||
160985474|NCT00245011|581335455|FG000|Overall Study|Lack of Efficacy|1|||
160985475|NCT00550173|581335456|FG000|Overall Study|Death|45|||
160985476|NCT00550173|581335457|FG001|Overall Study|Death|38|||
160985477|NCT00550173|581335458|FG002|Overall Study|Death|50|||
160985478|NCT00550173|581335456|FG000|Overall Study|Physician Decision|1|||
160985479|NCT00550173|581335457|FG001|Overall Study|Physician Decision|2|||
160985480|NCT00550173|581335458|FG002|Overall Study|Physician Decision|2|||
160985481|NCT00550173|581335456|FG000|Overall Study|Withdrawal by Subject|9|||
160985482|NCT00550173|581335457|FG001|Overall Study|Withdrawal by Subject|12|||
160985483|NCT00550173|581335458|FG002|Overall Study|Withdrawal by Subject|17|||
160985484|NCT00550173|581335456|FG000|Overall Study|Sponsor Decision|13|||
160985485|NCT00550173|581335457|FG001|Overall Study|Sponsor Decision|7|||
160985486|NCT00550173|581335458|FG002|Overall Study|Sponsor Decision|1|||
160985487|NCT00550173|581335456|FG000|Overall Study|Lost to Follow-up|4|||
160985488|NCT00550173|581335457|FG001|Overall Study|Lost to Follow-up|4|||
160985489|NCT00550173|581335458|FG002|Overall Study|Lost to Follow-up|3|||
160985490|NCT04034238|581336930|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
160985491|NCT04034238|581336931|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
160985492|NCT04034238|581336932|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
160985493|NCT04034238|581336933|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160985494|NCT04034238|581336930|FG000|Dose Escalation Phase|Screen failures|0|||
160985495|NCT04034238|581336931|FG001|Dose Escalation Phase|Screen failures|0|||
160985496|NCT04034238|581336932|FG002|Dose Escalation Phase|Screen failures|0|||
160985497|NCT04034238|581336933|FG003|Dose Escalation Phase|Screen failures|2|||
160985498|NCT04034238|581336930|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
160985499|NCT04034238|581336931|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
160985500|NCT04034238|581336932|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
160985501|NCT04034238|581336933|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
160985502|NCT04034238|581336930|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
160985503|NCT04034238|581336931|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
160985504|NCT04034238|581336932|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
160985505|NCT04034238|581336933|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
160985506|NCT02153788|581336936|FG000|Overall Study|Physician Decision|2|||
160985507|NCT02153788|581336937|FG001|Overall Study|Physician Decision|1|||
160985508|NCT01106287|581336938|FG000|Overall Study|Adverse Event|1|||
160985509|NCT01106287|581336939|FG001|Overall Study|Adverse Event|0|||
160985510|NCT01106287|581336940|FG002|Overall Study|Adverse Event|0|||
160985511|NCT01106287|581336941|FG003|Overall Study|Adverse Event|0|||
160985512|NCT01450943|581336944|FG000|Overall Study|Screen failure, loss to follow-up|2|||
160985513|NCT01450943|581336945|FG001|Overall Study|Screen failure, loss to follow-up|7|||
160985514|NCT01450943|581336946|FG002|Overall Study|Screen failure, loss to follow-up|6|||
160985515|NCT01345292|581336947|FG000|Overall Study|Withdrawal by Subject|2|||
160985516|NCT01345292|581336948|FG001|Overall Study|Withdrawal by Subject|0|||
160985517|NCT01345292|581336949|FG002|Overall Study|Withdrawal by Subject|1|||
160985518|NCT04822298|581336953|FG000|Overall Study|Death|3|||
160985519|NCT00465361|581336956|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
160985520|NCT05406791|581336957|FG000|Overall Study|Lost to Follow-up|13|||
160985521|NCT05406791|581336958|FG001|Overall Study|Lost to Follow-up|10|||
160985522|NCT01625338|581336959|FG000|Overall Study|Enrolled but not Treated|0|||
160985523|NCT01625338|581336960|FG001|Overall Study|Enrolled but not Treated|0|||
160985524|NCT01625338|581336961|FG002|Overall Study|Enrolled but not Treated|1|||
160985525|NCT01625338|581336959|FG000|Overall Study|Efficacy Failure|27|||
160985526|NCT01625338|581336960|FG001|Overall Study|Efficacy Failure|39|||
160985527|NCT01625338|581336961|FG002|Overall Study|Efficacy Failure|31|||
160985528|NCT01625338|581336959|FG000|Overall Study|Lost to Follow-up|3|||
160985529|NCT01625338|581336960|FG001|Overall Study|Lost to Follow-up|3|||
160985530|NCT01625338|581336961|FG002|Overall Study|Lost to Follow-up|2|||
160985531|NCT01625338|581336959|FG000|Overall Study|Investigator Decision|0|||
160985532|NCT01625338|581336960|FG001|Overall Study|Investigator Decision|2|||
160985533|NCT01625338|581336961|FG002|Overall Study|Investigator Decision|1|||
160806357|NCT03369665|580679766|FG000|Overall Study|Adverse Event|3|||
160806358|NCT03369665|580679766|FG000|Overall Study|Lost to Follow-up|7|||
160806359|NCT03369665|580679766|FG000|Overall Study|Withdrawal by Subject|15|||
160806360|NCT03369665|580679766|FG000|Overall Study|Progression Disease|2|||
160806361|NCT03369665|580679766|FG000|Overall Study|Not classified|3|||
160806362|NCT03230318|580679770|FG000|Overall Study|Radiographic disease progression|72|||
160806363|NCT03230318|580679771|FG001|Overall Study|Radiographic disease progression|19|||
160806364|NCT03230318|580679770|FG000|Overall Study|Clinical progression|17|||
160806365|NCT03230318|580679771|FG001|Overall Study|Clinical progression|7|||
160806366|NCT03230318|580679770|FG000|Overall Study|Adverse Event|5|||
160806367|NCT03230318|580679771|FG001|Overall Study|Adverse Event|3|||
160806368|NCT03230318|580679770|FG000|Overall Study|Physician Decision|2|||
160806369|NCT03230318|580679771|FG001|Overall Study|Physician Decision|3|||
160806370|NCT03230318|580679770|FG000|Overall Study|Death|3|||
160806371|NCT03230318|580679771|FG001|Overall Study|Death|2|||
160806372|NCT03230318|580679770|FG000|Overall Study|Lost to Follow-up|1|||
160806373|NCT03230318|580679771|FG001|Overall Study|Lost to Follow-up|0|||
160806374|NCT03230318|580679770|FG000|Overall Study|Withdrawal by Subject|1|||
160806375|NCT03230318|580679771|FG001|Overall Study|Withdrawal by Subject|3|||
160898319|NCT02038881|581023425|FG001|Overall Study|Lost to Follow-up|0|||
160898320|NCT02038881|581023426|FG002|Overall Study|Lost to Follow-up|0|||
160898321|NCT02038881|581023424|FG000|Overall Study|incarcerated|1|||
160898322|NCT02038881|581023425|FG001|Overall Study|incarcerated|0|||
160898323|NCT02038881|581023426|FG002|Overall Study|incarcerated|0|||
160898324|NCT00333840|581023427|FG000|First-line Treatment Period|Adverse Event|38|||
160898325|NCT00333840|581023428|FG001|First-line Treatment Period|Adverse Event|37|||
160898326|NCT00333840|581023429|FG002|First-line Treatment Period|Adverse Event|0|||
160898327|NCT00333840|581023430|FG003|First-line Treatment Period|Adverse Event|0|||
160898328|NCT00333840|581023427|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
160898329|NCT00333840|581023428|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
160898330|NCT00333840|581023429|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
160898331|NCT00333840|581023430|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
160898332|NCT00333840|581023427|FG000|First-line Treatment Period|Abnormal procedure|2|||
160898333|NCT00333840|581023428|FG001|First-line Treatment Period|Abnormal procedure|0|||
160898334|NCT00333840|581023429|FG002|First-line Treatment Period|Abnormal procedure|0|||
160898335|NCT00333840|581023430|FG003|First-line Treatment Period|Abnormal procedure|0|||
160898336|NCT00333840|581023427|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
160898337|NCT00333840|581023428|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
160898338|NCT00333840|581023429|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
160898339|NCT00333840|581023430|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
160898340|NCT00333840|581023427|FG000|First-line Treatment Period|No longer required study drug|21|||
160898341|NCT00333840|581023428|FG001|First-line Treatment Period|No longer required study drug|8|||
160898342|NCT00333840|581023429|FG002|First-line Treatment Period|No longer required study drug|0|||
160898343|NCT00333840|581023430|FG003|First-line Treatment Period|No longer required study drug|0|||
160898344|NCT00333840|581023427|FG000|First-line Treatment Period|Protocol Violation|17|||
160898345|NCT00333840|581023428|FG001|First-line Treatment Period|Protocol Violation|17|||
160898346|NCT00333840|581023429|FG002|First-line Treatment Period|Protocol Violation|0|||
160898347|NCT00333840|581023430|FG003|First-line Treatment Period|Protocol Violation|0|||
160898348|NCT00333840|581023427|FG000|First-line Treatment Period|Subject withdrew consent|57|||
160898349|NCT00333840|581023428|FG001|First-line Treatment Period|Subject withdrew consent|77|||
160898350|NCT00333840|581023429|FG002|First-line Treatment Period|Subject withdrew consent|0|||
160898351|NCT00333840|581023430|FG003|First-line Treatment Period|Subject withdrew consent|0|||
160898352|NCT00333840|581023427|FG000|First-line Treatment Period|Lost to Follow-up|15|||
160898353|NCT00333840|581023428|FG001|First-line Treatment Period|Lost to Follow-up|6|||
160898354|NCT00333840|581023429|FG002|First-line Treatment Period|Lost to Follow-up|0|||
160898355|NCT00333840|581023430|FG003|First-line Treatment Period|Lost to Follow-up|0|||
160898356|NCT00333840|581023427|FG000|First-line Treatment Period|Administrative problems|12|||
160898357|NCT00333840|581023428|FG001|First-line Treatment Period|Administrative problems|6|||
160898358|NCT00333840|581023429|FG002|First-line Treatment Period|Administrative problems|0|||
160898359|NCT00333840|581023430|FG003|First-line Treatment Period|Administrative problems|0|||
160898360|NCT00333840|581023427|FG000|First-line Treatment Period|Death|19|||
160898361|NCT00333840|581023428|FG001|First-line Treatment Period|Death|2|||
160898362|NCT00333840|581023429|FG002|First-line Treatment Period|Death|0|||
160898363|NCT00333840|581023430|FG003|First-line Treatment Period|Death|0|||
160898364|NCT00333840|581023427|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
160898365|NCT00333840|581023428|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
160898366|NCT00333840|581023429|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
160898367|NCT00333840|581023430|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
160898368|NCT00333840|581023427|FG000|Second-line Treatment Period|Adverse Event|0|||
160898369|NCT00333840|581023428|FG001|Second-line Treatment Period|Adverse Event|0|||
160806376|NCT03230318|580679770|FG000|Overall Study|Other|3|||
160806377|NCT03230318|580679771|FG001|Overall Study|Other|7|||
160806378|NCT01722994|580679772|FG000|Overall Study|Missing data|25|||
160806379|NCT01722994|580679773|FG001|Overall Study|Missing data|17|||
160806380|NCT01206140|580679777|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
160806381|NCT01206140|580679778|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
160806382|NCT00075764|580679779|FG000|Overall Study|Adverse Event|5|||
160806383|NCT00075764|580679780|FG001|Overall Study|Adverse Event|12|||
160806384|NCT00075764|580679779|FG000|Overall Study|Death|4|||
160806385|NCT00075764|580679780|FG001|Overall Study|Death|8|||
160806386|NCT00075764|580679779|FG000|Overall Study|Withdrawal by Subject|28|||
160806387|NCT00075764|580679780|FG001|Overall Study|Withdrawal by Subject|18|||
160806388|NCT00075764|580679779|FG000|Overall Study|Progression|269|||
160806389|NCT00075764|580679780|FG001|Overall Study|Progression|274|||
160806390|NCT00075764|580679779|FG000|Overall Study|Still on treatment|8|||
160806391|NCT00075764|580679780|FG001|Overall Study|Still on treatment|15|||
160985534|NCT01625338|581336959|FG000|Overall Study|Subject Withdrew Consent|1|||
160985535|NCT01625338|581336960|FG001|Overall Study|Subject Withdrew Consent|0|||
160985536|NCT01625338|581336961|FG002|Overall Study|Subject Withdrew Consent|2|||
160985537|NCT01625338|581336959|FG000|Overall Study|Adverse Event|1|||
160985538|NCT01625338|581336960|FG001|Overall Study|Adverse Event|0|||
160985539|NCT01625338|581336961|FG002|Overall Study|Adverse Event|1|||
160985540|NCT01625338|581336959|FG000|Overall Study|Study Discontinued by Sponsor|0|||
160985541|NCT01625338|581336960|FG001|Overall Study|Study Discontinued by Sponsor|0|||
160985542|NCT01625338|581336961|FG002|Overall Study|Study Discontinued by Sponsor|1|||
160985543|NCT01789203|581336962|FG000|Overall Study|Adverse Event|2|||
160985544|NCT01789203|581336963|FG001|Overall Study|Adverse Event|2|||
160985545|NCT01789203|581336962|FG000|Overall Study|Withdrawal by Subject|1|||
160985546|NCT01789203|581336963|FG001|Overall Study|Withdrawal by Subject|0|||
160985547|NCT01789203|581336962|FG000|Overall Study|Death|1|||
160985548|NCT01789203|581336963|FG001|Overall Study|Death|0|||
160985549|NCT01789203|581336962|FG000|Overall Study|Protocol Violation|2|||
160985550|NCT01789203|581336963|FG001|Overall Study|Protocol Violation|1|||
160806392|NCT00075764|580679779|FG000|Overall Study|Delinquent|4|||
160806393|NCT00075764|580679780|FG001|Overall Study|Delinquent|2|||
160806394|NCT00075764|580679779|FG000|Overall Study|Not protocol specified|27|||
160985551|NCT01789203|581336962|FG000|Overall Study|Other|1|||
160806395|NCT00075764|580679780|FG001|Overall Study|Not protocol specified|19|||
160644595|NCT01629693|580080797|FG000|Overall Study|Adverse Event|1|||
160806396|NCT00075764|580679779|FG000|Overall Study|Under review|0|||
160806397|NCT00075764|580679780|FG001|Overall Study|Under review|1|||
160806398|NCT02817594|580679784|FG000|Overall Study|Withdrawal by Subject|1|||
160806399|NCT02817594|580679784|FG000|Overall Study|Other|1|||
160806400|NCT02817594|580679784|FG000|Overall Study|Did Not Receive Treatment|1|||
160806401|NCT01135459|580679785|FG000|Overall Study|Adverse Event|8|||
160806402|NCT01135459|580679786|FG001|Overall Study|Adverse Event|10|||
160806403|NCT01135459|580679785|FG000|Overall Study|Lack of Efficacy|3|||
160806404|NCT01135459|580679786|FG001|Overall Study|Lack of Efficacy|1|||
160806405|NCT01135459|580679785|FG000|Overall Study|Withdrawal by Subject|2|||
160806406|NCT01135459|580679786|FG001|Overall Study|Withdrawal by Subject|3|||
160806407|NCT01135459|580679785|FG000|Overall Study|Protocol Violation|5|||
160806408|NCT01135459|580679786|FG001|Overall Study|Protocol Violation|3|||
160806409|NCT01135459|580679785|FG000|Overall Study|Lost to Follow-up|2|||
160806410|NCT01135459|580679786|FG001|Overall Study|Lost to Follow-up|1|||
160806411|NCT01135459|580679785|FG000|Overall Study|Non-compliance to study procedures|0|||
160806412|NCT01135459|580679786|FG001|Overall Study|Non-compliance to study procedures|1|||
160806413|NCT01135459|580679785|FG000|Overall Study|Other than specified|1|||
160806414|NCT01135459|580679786|FG001|Overall Study|Other than specified|1|||
160806415|NCT01803880|580679787|FG000|Overall Study|Adverse Event|1|||
160806416|NCT01803880|580679788|FG001|Overall Study|Adverse Event|0|||
160806417|NCT01803880|580679789|FG002|Overall Study|Adverse Event|0|||
160806418|NCT01803880|580679787|FG000|Overall Study|Withdrawal by Subject|1|||
160806419|NCT01803880|580679788|FG001|Overall Study|Withdrawal by Subject|1|||
160806420|NCT01803880|580679789|FG002|Overall Study|Withdrawal by Subject|4|||
160806421|NCT01803880|580679787|FG000|Overall Study|Physician Decision|0|||
160806422|NCT01803880|580679788|FG001|Overall Study|Physician Decision|0|||
160806423|NCT01803880|580679789|FG002|Overall Study|Physician Decision|1|||
160806424|NCT01803880|580679787|FG000|Overall Study|Unable to return for follow-up visits|0|||
160806425|NCT01803880|580679788|FG001|Overall Study|Unable to return for follow-up visits|1|||
160806426|NCT01803880|580679789|FG002|Overall Study|Unable to return for follow-up visits|2|||
160806427|NCT01803880|580679787|FG000|Overall Study|Lost to Follow-up|1|||
160806428|NCT01803880|580679788|FG001|Overall Study|Lost to Follow-up|2|||
160806429|NCT01803880|580679789|FG002|Overall Study|Lost to Follow-up|3|||
160806430|NCT01803880|580679787|FG000|Overall Study|Protocol Violation|1|||
160806431|NCT01803880|580679788|FG001|Overall Study|Protocol Violation|0|||
160806432|NCT01803880|580679789|FG002|Overall Study|Protocol Violation|0|||
160806433|NCT01803880|580679787|FG000|Overall Study|Early study termination|0|||
160806434|NCT01803880|580679788|FG001|Overall Study|Early study termination|6|||
160985552|NCT01789203|581336963|FG001|Overall Study|Other|1|||
160985553|NCT01789203|581336962|FG000|Overall Study|patient non-adherent|2|||
160898370|NCT00333840|581023429|FG002|Second-line Treatment Period|Adverse Event|3|||
160898371|NCT00333840|581023430|FG003|Second-line Treatment Period|Adverse Event|34|||
160898372|NCT00333840|581023427|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
160898373|NCT00333840|581023428|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
160898374|NCT00333840|581023429|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
160898375|NCT00333840|581023430|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
160898376|NCT00333840|581023427|FG000|Second-line Treatment Period|Abnormal procedure|0|||
160898377|NCT00333840|581023428|FG001|Second-line Treatment Period|Abnormal procedure|0|||
160898378|NCT00333840|581023429|FG002|Second-line Treatment Period|Abnormal procedure|0|||
160898379|NCT00333840|581023430|FG003|Second-line Treatment Period|Abnormal procedure|1|||
160898380|NCT00333840|581023427|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
160898381|NCT00333840|581023428|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
160898382|NCT00333840|581023429|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
160898383|NCT00333840|581023430|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
160898384|NCT00333840|581023427|FG000|Second-line Treatment Period|No longer required study drug|0|||
160898385|NCT00333840|581023428|FG001|Second-line Treatment Period|No longer required study drug|0|||
160985554|NCT01789203|581336963|FG001|Overall Study|patient non-adherent|0|||
160985555|NCT00515086|581336970|FG000|Overall Study|Adverse Event|1|||
160985556|NCT00515086|581336971|FG001|Overall Study|Adverse Event|1|||
160985557|NCT00515086|581336972|FG002|Overall Study|Adverse Event|2|||
160985558|NCT00515086|581336973|FG003|Overall Study|Adverse Event|3|||
160985559|NCT00515086|581336970|FG000|Overall Study|Administrative|1|||
160985560|NCT00515086|581336971|FG001|Overall Study|Administrative|1|||
160985561|NCT00515086|581336972|FG002|Overall Study|Administrative|0|||
160985562|NCT00515086|581336973|FG003|Overall Study|Administrative|0|||
160985563|NCT00515086|581336970|FG000|Overall Study|Withdrawal by Subject|1|||
160985564|NCT00515086|581336971|FG001|Overall Study|Withdrawal by Subject|0|||
160985565|NCT00515086|581336972|FG002|Overall Study|Withdrawal by Subject|0|||
160985566|NCT00515086|581336973|FG003|Overall Study|Withdrawal by Subject|1|||
160985567|NCT00515086|581336970|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
160985568|NCT00515086|581336971|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160985569|NCT00515086|581336972|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
160985570|NCT00515086|581336973|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
160985571|NCT00515086|581336970|FG000|Overall Study|Lost to Follow-up|1|||
160985572|NCT00515086|581336971|FG001|Overall Study|Lost to Follow-up|0|||
160985573|NCT00515086|581336972|FG002|Overall Study|Lost to Follow-up|0|||
160985574|NCT00515086|581336973|FG003|Overall Study|Lost to Follow-up|0|||
160985575|NCT00515086|581336970|FG000|Overall Study|Study drug no longer required|0|||
160985576|NCT00515086|581336971|FG001|Overall Study|Study drug no longer required|1|||
160985577|NCT00515086|581336972|FG002|Overall Study|Study drug no longer required|0|||
160985578|NCT00515086|581336973|FG003|Overall Study|Study drug no longer required|0|||
160985579|NCT00515086|581336970|FG000|Overall Study|Death|2|||
160985580|NCT00515086|581336971|FG001|Overall Study|Death|0|||
160985581|NCT00515086|581336972|FG002|Overall Study|Death|0|||
160985582|NCT00515086|581336973|FG003|Overall Study|Death|0|||
160985583|NCT02403674|581336976|FG000|Base Study|Death|1|||
160985584|NCT02403674|581336977|FG001|Base Study|Death|4|||
160985585|NCT02403674|581336976|FG000|Base Study|Adverse Event|11|||
160985586|NCT02403674|581336977|FG001|Base Study|Adverse Event|26|||
160985587|NCT02403674|581336976|FG000|Base Study|Lack of Efficacy|31|||
160985588|NCT02403674|581336977|FG001|Base Study|Lack of Efficacy|23|||
160985589|NCT02403674|581336976|FG000|Base Study|Lost to Follow-up|6|||
160985590|NCT02403674|581336977|FG001|Base Study|Lost to Follow-up|8|||
160985591|NCT02403674|581336976|FG000|Base Study|Withdrawal by Subject|10|||
160985592|NCT02403674|581336977|FG001|Base Study|Withdrawal by Subject|17|||
160985593|NCT02403674|581336976|FG000|Base Study|Physician Decision|2|||
160985594|NCT02403674|581336977|FG001|Base Study|Physician Decision|2|||
160985595|NCT02403674|581336976|FG000|Base Study|Pregnancy|2|||
160985596|NCT02403674|581336977|FG001|Base Study|Pregnancy|2|||
160985597|NCT02403674|581336976|FG000|Base Study|Protocol Violation|8|||
160985598|NCT02403674|581336977|FG001|Base Study|Protocol Violation|4|||
160806435|NCT01803880|580679789|FG002|Overall Study|Early study termination|5|||
160806436|NCT01803880|580679787|FG000|Overall Study|Incomplete data entry by sites|2|||
160806437|NCT01803880|580679788|FG001|Overall Study|Incomplete data entry by sites|0|||
160806438|NCT01803880|580679789|FG002|Overall Study|Incomplete data entry by sites|0|||
160806439|NCT04158375|580679796|FG000|Overall Study|Withdrawal by Subject|0|||
160806440|NCT04158375|580679797|FG001|Overall Study|Withdrawal by Subject|3|||
160806441|NCT04158375|580679798|FG002|Overall Study|Withdrawal by Subject|0|||
160806442|NCT04847843|580679799|FG000|Overall Study|Scheduling Conflicts|6|||
160806443|NCT04847843|580679800|FG001|Overall Study|Scheduling Conflicts|9|||
160806444|NCT04847843|580679799|FG000|Overall Study|Withdrawal by Subject|1|||
160806445|NCT04847843|580679800|FG001|Overall Study|Withdrawal by Subject|0|||
160806446|NCT04847843|580679799|FG000|Overall Study|Lost to Follow-up|1|||
160806447|NCT04847843|580679800|FG001|Overall Study|Lost to Follow-up|1|||
160806448|NCT04847843|580679799|FG000|Overall Study|Pregnancy|0|||
160806449|NCT04847843|580679800|FG001|Overall Study|Pregnancy|2|||
160806450|NCT04847843|580679799|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
160806451|NCT04847843|580679800|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
160806452|NCT02734004|580679801|FG000|Overall Study|Death|36|||
160985599|NCT02403674|581336976|FG000|Base Study|Non-Compliance with study drug|1|||
160985600|NCT02403674|581336977|FG001|Base Study|Non-Compliance with study drug|4|||
160985601|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
160985602|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
160985603|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
160806453|NCT02734004|580679802|FG001|Overall Study|Death|24|||
160806454|NCT02734004|580679803|FG002|Overall Study|Death|26|||
160985604|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
160985605|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
160985606|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
160985607|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
160806455|NCT02734004|580679804|FG003|Overall Study|Death|35|||
160806456|NCT02734004|580679805|FG004|Overall Study|Death|13|||
160985608|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
160985609|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
160806457|NCT02734004|580679806|FG005|Overall Study|Death|17|||
160806458|NCT02734004|580679807|FG006|Overall Study|Death|20|||
160806459|NCT02734004|580679801|FG000|Overall Study|Lost to Follow-up|1|||
160806460|NCT02734004|580679802|FG001|Overall Study|Lost to Follow-up|1|||
160806461|NCT02734004|580679803|FG002|Overall Study|Lost to Follow-up|0|||
160806462|NCT02734004|580679804|FG003|Overall Study|Lost to Follow-up|0|||
160806463|NCT02734004|580679805|FG004|Overall Study|Lost to Follow-up|1|||
160806464|NCT02734004|580679806|FG005|Overall Study|Lost to Follow-up|0|||
160806465|NCT02734004|580679807|FG006|Overall Study|Lost to Follow-up|0|||
160806466|NCT02734004|580679801|FG000|Overall Study|Withdrawal by Subject|3|||
160806467|NCT02734004|580679802|FG001|Overall Study|Withdrawal by Subject|1|||
160806468|NCT02734004|580679803|FG002|Overall Study|Withdrawal by Subject|1|||
160985610|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
160985611|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
160985612|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
160985613|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Death|1|||
160985614|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Death|0|||
160985615|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
160985616|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
160985617|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
160985618|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
160985619|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
160985620|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
160985621|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
160985622|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
160985623|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
160985624|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
160985625|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
160985626|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
160985627|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
160985628|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
160985629|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Death|2|||
160985630|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Death|2|||
160985631|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
160985632|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
160985633|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
160985634|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
160985635|NCT02403674|581336976|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
160985636|NCT02403674|581336977|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
160985637|NCT02403674|581336976|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
160985638|NCT02403674|581336977|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
160985639|NCT02403674|581336976|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
160985640|NCT02403674|581336977|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
160985641|NCT02403674|581336976|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
160806469|NCT02734004|580679804|FG003|Overall Study|Withdrawal by Subject|1|||
160806470|NCT02734004|580679805|FG004|Overall Study|Withdrawal by Subject|3|||
160806471|NCT02734004|580679806|FG005|Overall Study|Withdrawal by Subject|0|||
160806472|NCT02734004|580679807|FG006|Overall Study|Withdrawal by Subject|2|||
160806473|NCT02734004|580679801|FG000|Overall Study|Other|0|||
160985642|NCT02403674|581336977|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
160985643|NCT02403674|581336976|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
160985644|NCT02403674|581336977|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
160985645|NCT03487666|581336980|FG000|Overall Study|Disease progression|4|||
160985646|NCT03487666|581336981|FG001|Overall Study|Disease progression|2|||
160985647|NCT03487666|581336982|FG002|Overall Study|Disease progression|0|||
160985648|NCT03487666|581336980|FG000|Overall Study|Adverse Event|0|||
160985649|NCT03487666|581336981|FG001|Overall Study|Adverse Event|0|||
160985650|NCT03487666|581336982|FG002|Overall Study|Adverse Event|1|||
160985651|NCT03201757|581336983|FG000|Overall Study|Withdrawal by Subject|133|||
160985652|NCT03201757|581336983|FG000|Overall Study|Adverse Event|44|||
160985653|NCT03201757|581336983|FG000|Overall Study|Lost to Follow-up|37|||
160985654|NCT03201757|581336983|FG000|Overall Study|Pregnancy|2|||
160644596|NCT01629693|580080798|FG001|Overall Study|Adverse Event|0|||
160644597|NCT01629693|580080797|FG000|Overall Study|Investigator decision|0|||
160806474|NCT02734004|580679802|FG001|Overall Study|Other|8|||
160806475|NCT02734004|580679803|FG002|Overall Study|Other|7|||
160806476|NCT02734004|580679804|FG003|Overall Study|Other|4|||
160806477|NCT02734004|580679805|FG004|Overall Study|Other|34|||
160985655|NCT03201757|581336983|FG000|Overall Study|Lack of Efficacy|1|||
160985656|NCT03201757|581336983|FG000|Overall Study|Protocol Violation|20|||
160985657|NCT03201757|581336983|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
160985658|NCT03201757|581336983|FG000|Overall Study|Not Yet Determined|5|||
160806478|NCT02734004|580679806|FG005|Overall Study|Other|14|||
160806479|NCT02734004|580679807|FG006|Overall Study|Other|10|||
160644598|NCT01629693|580080798|FG001|Overall Study|Investigator decision|1|||
160806480|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
160806481|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
160806482|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
160806483|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
160806484|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
160806485|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
160806486|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
160806487|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
160806488|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
160806489|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
160806490|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
160806491|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
160806492|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
160806493|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
160806494|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
160806495|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
160806496|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
160806497|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
160806498|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
160806499|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
160806500|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
160806501|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
160806502|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
160806503|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
160806504|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Other|6|||
160806505|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Other|0|||
160806506|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Other|0|||
160806507|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
160806508|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
160806509|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
160806510|NCT05615220|580679808|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
160806511|NCT05615220|580679809|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
160806512|NCT05615220|580679810|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
160806513|NCT05615220|580679808|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
160806514|NCT05615220|580679809|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
160806515|NCT05615220|580679810|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
160806516|NCT05615220|580679808|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
160806517|NCT05615220|580679809|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
160806518|NCT05615220|580679810|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
160806519|NCT05615220|580679808|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
160806520|NCT05615220|580679809|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
160806521|NCT05615220|580679810|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
160806522|NCT05615220|580679808|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
160806523|NCT05615220|580679809|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
160806524|NCT05615220|580679810|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
160806525|NCT01459666|580679811|FG000|Overall Study|PI left institution|5|||
160806526|NCT01459666|580679812|FG001|Overall Study|PI left institution|4|||
160806527|NCT01061385|580679813|FG000|Overall Study|Lost to Follow-up|1|||
160985659|NCT03201757|581336983|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
160985660|NCT03201757|581336983|FG000|Overall Study|Other|20|||
160985661|NCT01254305|581336987|FG000|Overall Study|Adverse Event|6|||
160985662|NCT01254305|581336988|FG001|Overall Study|Adverse Event|3|||
160985663|NCT01254305|581336989|FG002|Overall Study|Adverse Event|2|||
160985664|NCT01254305|581336987|FG000|Overall Study|Lack of Efficacy|1|||
160985665|NCT01254305|581336988|FG001|Overall Study|Lack of Efficacy|0|||
160985666|NCT01254305|581336989|FG002|Overall Study|Lack of Efficacy|1|||
160985667|NCT01254305|581336987|FG000|Overall Study|Protocol Violation|1|||
160985668|NCT01254305|581336988|FG001|Overall Study|Protocol Violation|7|||
160985669|NCT01254305|581336989|FG002|Overall Study|Protocol Violation|3|||
160985670|NCT01254305|581336987|FG000|Overall Study|Withdrawal by Subject|4|||
160985671|NCT01254305|581336988|FG001|Overall Study|Withdrawal by Subject|2|||
160985672|NCT01254305|581336989|FG002|Overall Study|Withdrawal by Subject|4|||
160985673|NCT01254305|581336987|FG000|Overall Study|Lost to Follow-up|10|||
160985674|NCT01254305|581336988|FG001|Overall Study|Lost to Follow-up|6|||
160985675|NCT01254305|581336989|FG002|Overall Study|Lost to Follow-up|5|||
160985676|NCT01254305|581336987|FG000|Overall Study|Other Reasons|0|||
160985677|NCT01254305|581336988|FG001|Overall Study|Other Reasons|0|||
160985678|NCT01254305|581336989|FG002|Overall Study|Other Reasons|2|||
160985679|NCT03930186|581336990|FG000|Weeks 0 to 16|Adverse Event|6|||
160985680|NCT03930186|581336990|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
160985681|NCT03930186|581336990|FG000|Weeks 16 to 32|Adverse Event|1|||
160985682|NCT03930186|581336990|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
160985683|NCT00557505|581336993|FG000|Overall Study|Death|0|||
160985684|NCT00557505|581336994|FG001|Overall Study|Death|0|||
160985685|NCT00557505|581336995|FG002|Overall Study|Death|0|||
160985686|NCT00557505|581336996|FG003|Overall Study|Death|0|||
160985687|NCT00557505|581336997|FG004|Overall Study|Death|0|||
160985688|NCT00557505|581336998|FG005|Overall Study|Death|0|||
160985689|NCT00557505|581336999|FG006|Overall Study|Death|0|||
160985690|NCT00557505|581337000|FG007|Overall Study|Death|0|||
160985691|NCT00557505|581337001|FG008|Overall Study|Death|1|||
160985692|NCT00557505|581336993|FG000|Overall Study|Adverse Event|0|||
160985693|NCT00557505|581336994|FG001|Overall Study|Adverse Event|0|||
160985694|NCT00557505|581336995|FG002|Overall Study|Adverse Event|1|||
160985695|NCT00557505|581336996|FG003|Overall Study|Adverse Event|0|||
160985696|NCT00557505|581336997|FG004|Overall Study|Adverse Event|0|||
160985697|NCT00557505|581336998|FG005|Overall Study|Adverse Event|0|||
160985698|NCT00557505|581336999|FG006|Overall Study|Adverse Event|1|||
160985699|NCT00557505|581337000|FG007|Overall Study|Adverse Event|0|||
160985700|NCT00557505|581337001|FG008|Overall Study|Adverse Event|0|||
160985701|NCT00557505|581336993|FG000|Overall Study|Global deterioration of health|1|||
160985702|NCT00557505|581336994|FG001|Overall Study|Global deterioration of health|0|||
160985703|NCT00557505|581336995|FG002|Overall Study|Global deterioration of health|0|||
160985704|NCT00557505|581336996|FG003|Overall Study|Global deterioration of health|0|||
160806528|NCT01061385|580679814|FG001|Overall Study|Lost to Follow-up|0|||
160806529|NCT01061385|580679813|FG000|Overall Study|subject decision not related to AE|0|||
160806530|NCT01061385|580679814|FG001|Overall Study|subject decision not related to AE|1|||
160806531|NCT00533429|580679816|FG000|Overall Study|Adverse Event|3|||
160806532|NCT00533429|580679817|FG001|Overall Study|Adverse Event|1|||
160806533|NCT00533429|580679816|FG000|Overall Study|Death|1|||
160806534|NCT00533429|580679817|FG001|Overall Study|Death|0|||
160806535|NCT00533429|580679816|FG000|Overall Study|Withdrawal by Subject|2|||
160806536|NCT00533429|580679817|FG001|Overall Study|Withdrawal by Subject|0|||
160806537|NCT00533429|580679816|FG000|Overall Study|Progressive Disease|12|||
160806538|NCT00533429|580679817|FG001|Overall Study|Progressive Disease|13|||
160806539|NCT00533429|580679816|FG000|Overall Study|Symptomatic deterioration|1|||
160806540|NCT00533429|580679817|FG001|Overall Study|Symptomatic deterioration|2|||
160806541|NCT02655887|580679818|FG000|Overall Study|Lost to Follow-up|3|||
160806542|NCT02655887|580679818|FG000|Overall Study|Death|4|||
160806543|NCT02655887|580679818|FG000|Overall Study|Withdrawal by Subject|3|||
160806544|NCT02655887|580679818|FG000|Overall Study|Missed 12-month follow-up visit|4|||
160806545|NCT04245709|580679821|FG000|Overall Study|Adverse Event|13|||
160806546|NCT04245709|580679821|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
160806547|NCT02389465|580679825|FG000|Overall Study|Lost to Follow-up|1|||
160806548|NCT02389465|580679826|FG001|Overall Study|Lost to Follow-up|3|||
160806549|NCT02389465|580679827|FG002|Overall Study|Lost to Follow-up|3|||
160806550|NCT02389465|580679828|FG003|Overall Study|Lost to Follow-up|0|||
160806551|NCT02389465|580679825|FG000|Overall Study|Physician Decision|0|||
160806552|NCT02389465|580679826|FG001|Overall Study|Physician Decision|0|||
160806553|NCT02389465|580679827|FG002|Overall Study|Physician Decision|0|||
160806554|NCT02389465|580679828|FG003|Overall Study|Physician Decision|1|||
160806555|NCT02389465|580679825|FG000|Overall Study|Withdrawal by Subject|0|||
160806556|NCT02389465|580679826|FG001|Overall Study|Withdrawal by Subject|1|||
160806557|NCT02389465|580679827|FG002|Overall Study|Withdrawal by Subject|2|||
160806558|NCT02389465|580679828|FG003|Overall Study|Withdrawal by Subject|2|||
160806559|NCT04721158|580679833|FG000|Overall Study|Lost to Follow-up|4|||
160806560|NCT04721158|580679833|FG000|Overall Study|Device did not connect|1|||
160806561|NCT02382991|580679839|FG000|Overall Study|Adverse Event|1|||
160806562|NCT02382991|580679840|FG001|Overall Study|Adverse Event|2|||
160806563|NCT02382991|580679839|FG000|Overall Study|Lost to Follow-up|1|||
160806564|NCT02382991|580679840|FG001|Overall Study|Lost to Follow-up|0|||
160806565|NCT02382991|580679839|FG000|Overall Study|Withdrawal by Subject|0|||
160806566|NCT02382991|580679840|FG001|Overall Study|Withdrawal by Subject|1|||
160806567|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
160806568|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
160806569|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
160806570|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806571|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806572|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806573|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806574|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806575|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806576|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806577|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806578|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806579|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806580|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806581|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806582|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806583|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
160806584|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
160806585|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160898386|NCT00333840|581023429|FG002|Second-line Treatment Period|No longer required study drug|1|||
160898387|NCT00333840|581023430|FG003|Second-line Treatment Period|No longer required study drug|14|||
160898388|NCT00333840|581023427|FG000|Second-line Treatment Period|Protocol Violation|0|||
160898389|NCT00333840|581023428|FG001|Second-line Treatment Period|Protocol Violation|0|||
160898390|NCT00333840|581023429|FG002|Second-line Treatment Period|Protocol Violation|1|||
160898391|NCT00333840|581023430|FG003|Second-line Treatment Period|Protocol Violation|10|||
160898392|NCT00333840|581023427|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
160898393|NCT00333840|581023428|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
160898394|NCT00333840|581023429|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
160806586|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806587|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806588|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806589|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806590|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806591|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806592|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806593|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806594|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806595|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806596|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806597|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806598|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806599|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806600|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806601|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806602|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
160806603|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806604|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806605|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806606|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806607|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806608|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806609|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806610|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806611|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806612|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806613|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806614|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806615|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806616|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806617|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
160806618|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806619|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806620|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160985705|NCT00557505|581336997|FG004|Overall Study|Global deterioration of health|0|||
160806621|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806622|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806623|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806624|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806625|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806626|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806627|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806628|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806629|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806630|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806631|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806632|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806633|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806634|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
160806635|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806636|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806637|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806638|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806639|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806640|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806641|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806642|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160898395|NCT00333840|581023430|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
160898396|NCT00333840|581023427|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
160898397|NCT00333840|581023428|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
160898398|NCT00333840|581023429|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
160898399|NCT00333840|581023430|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
160898400|NCT00333840|581023427|FG000|Second-line Treatment Period|Administrative problems|0|||
160898401|NCT00333840|581023428|FG001|Second-line Treatment Period|Administrative problems|0|||
160898402|NCT00333840|581023429|FG002|Second-line Treatment Period|Administrative problems|0|||
160898403|NCT00333840|581023430|FG003|Second-line Treatment Period|Administrative problems|7|||
160898404|NCT00333840|581023427|FG000|Second-line Treatment Period|Death|0|||
160898405|NCT00333840|581023428|FG001|Second-line Treatment Period|Death|0|||
160898406|NCT00333840|581023429|FG002|Second-line Treatment Period|Death|0|||
160898407|NCT00333840|581023430|FG003|Second-line Treatment Period|Death|9|||
160898408|NCT02357979|581023431|FG000|Overall Study|Lost to Follow-up|5|||
160806643|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806644|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806645|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806646|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806647|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806648|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160898409|NCT02357979|581023432|FG001|Overall Study|Lost to Follow-up|5|||
160985706|NCT00557505|581336998|FG005|Overall Study|Global deterioration of health|0|||
160985707|NCT00557505|581336999|FG006|Overall Study|Global deterioration of health|0|||
160985708|NCT00557505|581337000|FG007|Overall Study|Global deterioration of health|0|||
160985709|NCT00557505|581337001|FG008|Overall Study|Global deterioration of health|0|||
160985710|NCT00557505|581336993|FG000|Overall Study|Objective progression or relapse|2|||
160985711|NCT00557505|581336994|FG001|Overall Study|Objective progression or relapse|3|||
160985712|NCT00557505|581336995|FG002|Overall Study|Objective progression or relapse|3|||
160985713|NCT00557505|581336996|FG003|Overall Study|Objective progression or relapse|2|||
160985714|NCT00557505|581336997|FG004|Overall Study|Objective progression or relapse|2|||
160985715|NCT00557505|581336998|FG005|Overall Study|Objective progression or relapse|3|||
160985716|NCT00557505|581336999|FG006|Overall Study|Objective progression or relapse|2|||
160985717|NCT00557505|581337000|FG007|Overall Study|Objective progression or relapse|5|||
160985718|NCT00557505|581337001|FG008|Overall Study|Objective progression or relapse|15|||
160985719|NCT00557505|581336993|FG000|Overall Study|Withdrawal by Subject|0|||
160985720|NCT00557505|581336994|FG001|Overall Study|Withdrawal by Subject|0|||
160985721|NCT00557505|581336995|FG002|Overall Study|Withdrawal by Subject|0|||
160985722|NCT00557505|581336996|FG003|Overall Study|Withdrawal by Subject|1|||
160985723|NCT00557505|581336997|FG004|Overall Study|Withdrawal by Subject|0|||
160985724|NCT00557505|581336998|FG005|Overall Study|Withdrawal by Subject|0|||
160985725|NCT00557505|581336999|FG006|Overall Study|Withdrawal by Subject|0|||
160985726|NCT00557505|581337000|FG007|Overall Study|Withdrawal by Subject|0|||
160644599|NCT01629693|580080797|FG000|Overall Study|Poor comfort of study lenses|0|||
160644600|NCT01629693|580080798|FG001|Overall Study|Poor comfort of study lenses|2|||
160644601|NCT01629693|580080797|FG000|Overall Study|Subject decision unrelated to AE|0|||
160644602|NCT01629693|580080798|FG001|Overall Study|Subject decision unrelated to AE|1|||
160644603|NCT01025193|580080800|FG000|Overall Study|Protocol Violation|1|||
160644604|NCT01025193|580080800|FG000|Overall Study|Adverse Event|3|||
160985727|NCT00557505|581337001|FG008|Overall Study|Withdrawal by Subject|1|||
160985728|NCT03019458|581337002|FG000|Overall Study|Death|0|||
160985729|NCT03019458|581337003|FG001|Overall Study|Death|1|||
160985730|NCT00031447|581337004|FG000|Overall Study|Lost to Follow-up|0|||
160985731|NCT00031447|581337005|FG001|Overall Study|Lost to Follow-up|1|||
160985732|NCT00031447|581337004|FG000|Overall Study|Non-compliant|1|||
160985733|NCT00031447|581337005|FG001|Overall Study|Non-compliant|1|||
160985734|NCT00031447|581337004|FG000|Overall Study|Re-activation of Disease|2|||
160985735|NCT00031447|581337005|FG001|Overall Study|Re-activation of Disease|1|||
160985736|NCT00031447|581337004|FG000|Overall Study|Disruption of blinded study drug supply|7|||
160985737|NCT00031447|581337005|FG001|Overall Study|Disruption of blinded study drug supply|4|||
160985738|NCT01636362|581337009|FG000|Overall Study|Physician Decision|6|||
160985739|NCT01636362|581337009|FG000|Overall Study|Subject healed, not returning|1|||
160985740|NCT01636362|581337009|FG000|Overall Study|Withdrawal by Subject|1|||
160985741|NCT01244763|581337010|FG000|Overall Study|Adverse Event|1|||
160985742|NCT01244763|581337011|FG001|Overall Study|Adverse Event|0|||
160985743|NCT01244763|581337012|FG002|Overall Study|Adverse Event|0|||
160985744|NCT01244763|581337013|FG003|Overall Study|Adverse Event|0|||
160985745|NCT01244763|581337014|FG004|Overall Study|Adverse Event|0|||
160985746|NCT01244763|581337015|FG005|Overall Study|Adverse Event|1|||
160985747|NCT01244763|581337010|FG000|Overall Study|Death|1|||
160985748|NCT01244763|581337011|FG001|Overall Study|Death|0|||
160985749|NCT01244763|581337012|FG002|Overall Study|Death|1|||
160551131|NCT01928381|579742340|FG000|Part 1 - Pain Training|Protocol Violation|1|||
160551132|NCT01928381|579742341|FG001|Part 1 - Pain Training|Protocol Violation|0|||
160551133|NCT01928381|579742342|FG002|Part 1 - Pain Training|Protocol Violation|0|||
160551134|NCT01928381|579742343|FG003|Part 1 - Pain Training|Protocol Violation|0|||
160551135|NCT01928381|579742344|FG004|Part 1 - Pain Training|Protocol Violation|0|||
160551136|NCT01928381|579742345|FG005|Part 1 - Pain Training|Protocol Violation|0|||
160551137|NCT01928381|579742346|FG006|Part 1 - Pain Training|Protocol Violation|0|||
160551138|NCT01928381|579742340|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
160551139|NCT01928381|579742341|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
160551140|NCT01928381|579742342|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
160551141|NCT01928381|579742343|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
160551142|NCT01928381|579742344|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
160551143|NCT01928381|579742345|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
160551144|NCT01928381|579742346|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
160551145|NCT01928381|579742340|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
160551146|NCT01928381|579742341|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
160551147|NCT01928381|579742342|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
160551148|NCT01928381|579742343|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
160985750|NCT01244763|581337013|FG003|Overall Study|Death|0|||
160985751|NCT01244763|581337014|FG004|Overall Study|Death|2|||
160985752|NCT01244763|581337015|FG005|Overall Study|Death|0|||
160985753|NCT01244763|581337010|FG000|Overall Study|Physician Decision|0|||
160985754|NCT01244763|581337011|FG001|Overall Study|Physician Decision|0|||
160985755|NCT01244763|581337012|FG002|Overall Study|Physician Decision|1|||
160985756|NCT01244763|581337013|FG003|Overall Study|Physician Decision|0|||
160551149|NCT01928381|579742344|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
160551150|NCT01928381|579742345|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
160551151|NCT01928381|579742346|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
160551152|NCT01928381|579742340|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
160985757|NCT01244763|581337014|FG004|Overall Study|Physician Decision|0|||
160985758|NCT01244763|581337015|FG005|Overall Study|Physician Decision|0|||
160985759|NCT01244763|581337010|FG000|Overall Study|Withdrawal by Subject|1|||
160985760|NCT01244763|581337011|FG001|Overall Study|Withdrawal by Subject|2|||
160985761|NCT01244763|581337012|FG002|Overall Study|Withdrawal by Subject|0|||
160551153|NCT01928381|579742341|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
160551154|NCT01928381|579742342|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
160551155|NCT01928381|579742343|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
160551156|NCT01928381|579742344|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
160551157|NCT01928381|579742345|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
160551158|NCT01928381|579742346|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
160551159|NCT01928381|579742340|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
160551160|NCT01928381|579742341|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
160551161|NCT01928381|579742342|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
160551162|NCT01928381|579742343|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
160551163|NCT01928381|579742344|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
160551164|NCT01928381|579742345|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
160551165|NCT01928381|579742346|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
160551166|NCT01928381|579742340|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
160551167|NCT01928381|579742341|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
160551168|NCT01928381|579742342|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
160551169|NCT01928381|579742343|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
160551170|NCT01928381|579742344|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
160551171|NCT01928381|579742345|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
160551172|NCT01928381|579742346|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
160551173|NCT01928381|579742340|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
160551174|NCT01928381|579742341|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
160551175|NCT01928381|579742342|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
160551176|NCT01928381|579742343|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
160551177|NCT01928381|579742344|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
160551178|NCT01928381|579742345|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
160551179|NCT01928381|579742346|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
160551180|NCT01928381|579742340|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
160551181|NCT01928381|579742341|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
160551182|NCT01928381|579742342|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
160551183|NCT01928381|579742343|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
160551184|NCT01928381|579742344|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
160551185|NCT01928381|579742345|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
160551186|NCT01928381|579742346|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
160551187|NCT01928381|579742340|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
160551188|NCT01928381|579742341|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
160551189|NCT01928381|579742342|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
160551190|NCT01928381|579742343|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
160551191|NCT01928381|579742344|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
160551192|NCT01928381|579742345|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
160551193|NCT01928381|579742346|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
160551194|NCT01928381|579742340|FG000|Washout First Intervention|Protocol Violation|0|||
160551195|NCT01928381|579742341|FG001|Washout First Intervention|Protocol Violation|0|||
160551196|NCT01928381|579742342|FG002|Washout First Intervention|Protocol Violation|0|||
160551197|NCT01928381|579742343|FG003|Washout First Intervention|Protocol Violation|0|||
160551198|NCT01928381|579742344|FG004|Washout First Intervention|Protocol Violation|1|||
160551199|NCT01928381|579742345|FG005|Washout First Intervention|Protocol Violation|0|||
160551200|NCT01928381|579742346|FG006|Washout First Intervention|Protocol Violation|0|||
160551201|NCT01928381|579742340|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
160551202|NCT01928381|579742341|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
160551203|NCT01928381|579742342|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
160551204|NCT01928381|579742343|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
160551205|NCT01928381|579742344|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
160551206|NCT01928381|579742345|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
160551207|NCT01928381|579742346|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
160551208|NCT01928381|579742340|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
160551209|NCT01928381|579742341|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
160985762|NCT01244763|581337013|FG003|Overall Study|Withdrawal by Subject|1|||
160806649|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806650|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
160806651|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806652|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806653|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806654|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806655|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806656|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806657|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806658|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806659|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806660|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806661|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806662|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806663|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806664|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806665|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806666|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806667|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806668|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806669|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
160806670|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
160806671|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
160806672|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
160806673|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806674|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806675|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806676|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806677|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806678|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806679|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806680|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806681|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806682|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806683|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806684|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
160806685|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806686|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806687|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806688|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
160806689|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806690|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806691|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806692|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806693|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806694|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806695|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806696|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806697|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806698|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806699|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806700|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806701|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
160806702|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
160806703|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
160806704|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
160806705|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806706|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806707|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806708|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806709|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806710|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806711|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806712|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806713|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806714|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806715|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
160806716|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806717|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806718|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160985763|NCT01244763|581337014|FG004|Overall Study|Withdrawal by Subject|1|||
160806719|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806720|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806721|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806722|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806723|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806724|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806725|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806726|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806727|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806728|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806729|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806730|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806731|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806732|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806733|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
160806734|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806735|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806736|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806737|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806738|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806739|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806740|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806741|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806742|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806743|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806744|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806745|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806746|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806747|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806748|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806749|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806750|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
160806751|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
160806752|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
160806753|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806754|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160985764|NCT01244763|581337015|FG005|Overall Study|Withdrawal by Subject|2|||
160806755|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806756|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806757|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806758|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806759|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806760|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806761|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806762|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806763|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806764|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806765|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806766|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
160806767|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806768|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806769|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806770|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806771|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806772|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806773|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806774|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806775|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806776|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806777|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806778|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806779|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806780|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806781|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806782|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806783|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
160806784|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806785|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806786|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806787|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806788|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806789|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806790|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806791|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806792|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806793|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806794|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806795|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806796|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806797|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806798|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806799|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806800|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
160806801|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806802|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806803|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806804|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806805|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806806|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806807|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806808|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806809|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806810|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806811|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806812|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806813|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806814|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806815|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806816|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
160806817|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806818|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806819|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806820|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806821|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806822|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806823|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806824|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806825|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806826|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806827|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806828|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806829|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806830|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806831|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806832|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160644605|NCT00185211|580080803|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
160806833|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
160806834|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806835|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806836|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160898410|NCT01453725|581023433|FG000|Overall Study|Adverse Event|3|||
160898411|NCT01453725|581023434|FG001|Overall Study|Adverse Event|3|||
160898412|NCT01453725|581023433|FG000|Overall Study|Lost to Follow-up|4|||
160898413|NCT01453725|581023434|FG001|Overall Study|Lost to Follow-up|0|||
160806837|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806838|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806839|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806840|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806841|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806842|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806843|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806844|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806845|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806846|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806847|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806848|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806849|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
160806850|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806851|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806852|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806853|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806854|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806855|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806856|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806857|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806858|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806859|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806860|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806861|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806862|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806863|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806864|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806865|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
160806866|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806867|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806868|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806869|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806870|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806871|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806872|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806873|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806874|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806875|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806876|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806877|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806878|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160898414|NCT01453725|581023433|FG000|Overall Study|Non-compliance With Protocol|1|||
160898415|NCT01453725|581023434|FG001|Overall Study|Non-compliance With Protocol|2|||
160806879|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160898416|NCT01453725|581023433|FG000|Overall Study|Protocol Violation|1|||
160898417|NCT01453725|581023434|FG001|Overall Study|Protocol Violation|0|||
160898418|NCT01453725|581023433|FG000|Overall Study|Withdrawal by Subject|2|||
160898419|NCT01453725|581023434|FG001|Overall Study|Withdrawal by Subject|3|||
160898420|NCT01453725|581023433|FG000|Overall Study|Pregnancy Wish|0|||
160898421|NCT01453725|581023434|FG001|Overall Study|Pregnancy Wish|2|||
160898422|NCT01453725|581023433|FG000|Overall Study|Pregnancy|1|||
160898423|NCT01453725|581023434|FG001|Overall Study|Pregnancy|0|||
160898424|NCT01453725|581023433|FG000|Overall Study|Physician Decision|1|||
160898425|NCT01453725|581023434|FG001|Overall Study|Physician Decision|1|||
160898426|NCT03449901|581023438|FG000|Overall Study|Progression|57|||
160898427|NCT03449901|581023439|FG001|Overall Study|Progression|12|||
160898428|NCT03449901|581023438|FG000|Overall Study|Adverse Event|3|||
160644606|NCT00185211|580080804|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
160806880|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806881|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
160806882|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806883|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160898429|NCT03449901|581023439|FG001|Overall Study|Adverse Event|0|||
160898430|NCT03449901|581023438|FG000|Overall Study|Death|6|||
160898431|NCT03449901|581023439|FG001|Overall Study|Death|2|||
160806884|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806885|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806886|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806887|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806888|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806889|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806890|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806891|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806892|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806893|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806894|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806895|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806896|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160898432|NCT03449901|581023438|FG000|Overall Study|Withdrawal by Subject|12|||
160898433|NCT03449901|581023439|FG001|Overall Study|Withdrawal by Subject|1|||
160898434|NCT03449901|581023438|FG000|Overall Study|Physician Decision|1|||
160898435|NCT03449901|581023439|FG001|Overall Study|Physician Decision|0|||
160898436|NCT03449901|581023438|FG000|Overall Study|Patient elected for surgical intervention|1|||
160898437|NCT03449901|581023439|FG001|Overall Study|Patient elected for surgical intervention|0|||
160898438|NCT03449901|581023438|FG000|Overall Study|Patient off for other complicating disease|1|||
160898439|NCT03449901|581023439|FG001|Overall Study|Patient off for other complicating disease|0|||
160898440|NCT03150173|581023440|FG000|Overall Study|Lost to Follow-up|13|||
160898441|NCT03150173|581023441|FG001|Overall Study|Lost to Follow-up|5|||
160898442|NCT03605212|581023447|FG000|Treatment Period|Adverse Event|1|||
160898443|NCT03605212|581023448|FG001|Treatment Period|Adverse Event|0|||
160898444|NCT03605212|581023449|FG002|Treatment Period|Adverse Event|0|||
160898445|NCT03605212|581023450|FG003|Treatment Period|Adverse Event|0|||
160898446|NCT03605212|581023451|FG004|Treatment Period|Adverse Event|0|||
160898447|NCT03605212|581023447|FG000|Treatment Period|Physician Decision|0|||
160898448|NCT03605212|581023448|FG001|Treatment Period|Physician Decision|0|||
160898449|NCT03605212|581023449|FG002|Treatment Period|Physician Decision|0|||
160898450|NCT03605212|581023450|FG003|Treatment Period|Physician Decision|0|||
160898451|NCT03605212|581023451|FG004|Treatment Period|Physician Decision|1|||
160898452|NCT01756053|581023452|FG000|Period 1 (10 Days)|Protocol Violation|1|||
160898453|NCT01756053|581023453|FG001|Period 1 (10 Days)|Protocol Violation|1|||
160898454|NCT01756053|581023452|FG000|Period 2 (10 Days)|Protocol Violation|0|||
160898455|NCT01756053|581023453|FG001|Period 2 (10 Days)|Protocol Violation|2|||
160898456|NCT01254292|581023454|FG000|Comparative Phase|Adverse Event|25|||
160898457|NCT01254292|581023455|FG001|Comparative Phase|Adverse Event|25|||
160898458|NCT01254292|581023454|FG000|Comparative Phase|Lost to Follow-up|3|||
160898459|NCT01254292|581023455|FG001|Comparative Phase|Lost to Follow-up|21|||
160898460|NCT01254292|581023454|FG000|Comparative Phase|Pregnancy|2|||
160898461|NCT01254292|581023455|FG001|Comparative Phase|Pregnancy|6|||
160898462|NCT01254292|581023454|FG000|Comparative Phase|Withdrawal by Subject|20|||
160898463|NCT01254292|581023455|FG001|Comparative Phase|Withdrawal by Subject|21|||
160898464|NCT01254292|581023454|FG000|Comparative Phase|Protocol Violation|1|||
160898465|NCT01254292|581023455|FG001|Comparative Phase|Protocol Violation|2|||
160898466|NCT01254292|581023454|FG000|Comparative Phase|Wish for pregnancy|4|||
160898467|NCT01254292|581023455|FG001|Comparative Phase|Wish for pregnancy|6|||
160898468|NCT01254292|581023454|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
160898469|NCT01254292|581023455|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
160898470|NCT01254292|581023454|FG000|LCS12 Extension Phase|Adverse Event|9|||
160898471|NCT01254292|581023455|FG001|LCS12 Extension Phase|Adverse Event|0|||
160898472|NCT01254292|581023454|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
160898473|NCT01254292|581023455|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
160985765|NCT01244763|581337010|FG000|Overall Study|Lost to Follow-up|0|||
160985766|NCT01244763|581337011|FG001|Overall Study|Lost to Follow-up|1|||
160985767|NCT01244763|581337012|FG002|Overall Study|Lost to Follow-up|0|||
160985768|NCT01244763|581337013|FG003|Overall Study|Lost to Follow-up|0|||
160898474|NCT01254292|581023454|FG000|LCS12 Extension Phase|Other unknown|4|||
160898475|NCT01254292|581023455|FG001|LCS12 Extension Phase|Other unknown|0|||
160898476|NCT01254292|581023454|FG000|LCS12 Extension Phase|Pregnancy|2|||
160898477|NCT01254292|581023455|FG001|LCS12 Extension Phase|Pregnancy|0|||
160898478|NCT01254292|581023454|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
160898479|NCT01254292|581023455|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
160898480|NCT00285818|581023456|FG000|Overall Study|Withdrawal by Subject|3|||
160898481|NCT00285818|581023457|FG001|Overall Study|Withdrawal by Subject|2|||
160898482|NCT00285818|581023456|FG000|Overall Study|Lost to Follow-up|1|||
160898483|NCT00285818|581023457|FG001|Overall Study|Lost to Follow-up|0|||
160898484|NCT01268150|581023463|FG000|Treatment Phase|Progression of disease|18|||
160806897|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
160806898|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806899|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806900|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806901|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806902|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806903|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806904|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806905|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806906|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806907|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806908|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806909|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806910|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806911|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806912|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806913|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
160806914|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806915|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806916|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806917|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806918|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806919|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806920|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806921|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806922|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806923|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806924|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806925|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806926|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806927|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806928|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806929|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
160806930|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806931|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806932|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806933|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806934|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806935|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806936|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806937|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806938|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806939|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806940|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806941|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806942|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806943|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806944|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806945|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
160806946|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160898485|NCT01268150|581023463|FG000|Treatment Phase|Adverse Event|3|||
160898486|NCT01268150|581023463|FG000|Treatment Phase|Withdrawal by Subject|3|||
160898487|NCT01268150|581023463|FG000|Treatment Phase|Other|4|||
160898488|NCT01268150|581023463|FG000|Extension Phase|Adverse Event|3|||
160898489|NCT01268150|581023463|FG000|Extension Phase|Disease progression|18|||
160898490|NCT01268150|581023463|FG000|Extension Phase|Other|6|||
160898491|NCT01672736|581023465|FG000|Overall Study|Available drug expired on 31 May 16|3|||
160898492|NCT02913612|581023466|FG000|Overall Study|Lost to Follow-up|6|||
160898493|NCT02913612|581023467|FG001|Overall Study|Lost to Follow-up|5|||
160898494|NCT02913612|581023468|FG002|Overall Study|Lost to Follow-up|2|||
160898495|NCT02913612|581023469|FG003|Overall Study|Lost to Follow-up|0|||
160898496|NCT02913612|581023466|FG000|Overall Study|Physician Decision|1|||
160898497|NCT02913612|581023467|FG001|Overall Study|Physician Decision|4|||
160644607|NCT00185211|580080803|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
160644608|NCT00185211|580080804|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
160806947|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806948|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806949|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806950|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806951|NCT02891226|580679844|FG000|Follow-up Period|Withdrawal by Subject|0|||
160806952|NCT02891226|580679845|FG001|Follow-up Period|Withdrawal by Subject|0|||
160806953|NCT02891226|580679846|FG002|Follow-up Period|Withdrawal by Subject|0|||
160806954|NCT02891226|580679847|FG003|Follow-up Period|Withdrawal by Subject|0|||
160806955|NCT02891226|580679848|FG004|Follow-up Period|Withdrawal by Subject|0|||
160806956|NCT02891226|580679849|FG005|Follow-up Period|Withdrawal by Subject|0|||
160806957|NCT02891226|580679850|FG006|Follow-up Period|Withdrawal by Subject|0|||
160806958|NCT02891226|580679851|FG007|Follow-up Period|Withdrawal by Subject|0|||
160806959|NCT02891226|580679852|FG008|Follow-up Period|Withdrawal by Subject|0|||
160806960|NCT02891226|580679853|FG009|Follow-up Period|Withdrawal by Subject|0|||
160806961|NCT02891226|580679854|FG010|Follow-up Period|Withdrawal by Subject|0|||
160806962|NCT02891226|580679855|FG011|Follow-up Period|Withdrawal by Subject|1|||
160806963|NCT02891226|580679856|FG012|Follow-up Period|Withdrawal by Subject|0|||
160806964|NCT02891226|580679857|FG013|Follow-up Period|Withdrawal by Subject|0|||
160806965|NCT02891226|580679858|FG014|Follow-up Period|Withdrawal by Subject|1|||
160806966|NCT02891226|580679859|FG015|Follow-up Period|Withdrawal by Subject|1|||
160806967|NCT01445847|580679862|FG000|Overall Study|Protocol Violation|13|||
160806968|NCT01445847|580679863|FG001|Overall Study|Protocol Violation|14|||
160806969|NCT01445847|580679862|FG000|Overall Study|Missed Data|1|||
160806970|NCT01445847|580679863|FG001|Overall Study|Missed Data|0|||
160806971|NCT03654274|580679866|FG000|Overall Study|Adverse Event|19|||
160806972|NCT03654274|580679867|FG001|Overall Study|Adverse Event|23|||
160806973|NCT03654274|580679868|FG002|Overall Study|Adverse Event|24|||
160806974|NCT03654274|580679866|FG000|Overall Study|Protocol Deviation|0|||
160806975|NCT03654274|580679867|FG001|Overall Study|Protocol Deviation|2|||
160806976|NCT03654274|580679868|FG002|Overall Study|Protocol Deviation|0|||
160806977|NCT03654274|580679866|FG000|Overall Study|Lost to Follow-up|8|||
160806978|NCT03654274|580679867|FG001|Overall Study|Lost to Follow-up|6|||
160806979|NCT03654274|580679868|FG002|Overall Study|Lost to Follow-up|5|||
160806980|NCT03654274|580679866|FG000|Overall Study|Withdrawal by Subject|46|||
160806981|NCT03654274|580679867|FG001|Overall Study|Withdrawal by Subject|25|||
160806982|NCT03654274|580679868|FG002|Overall Study|Withdrawal by Subject|33|||
160806983|NCT03654274|580679866|FG000|Overall Study|Lack of Efficacy|4|||
160806984|NCT03654274|580679867|FG001|Overall Study|Lack of Efficacy|5|||
160806985|NCT03654274|580679868|FG002|Overall Study|Lack of Efficacy|7|||
160806986|NCT03654274|580679866|FG000|Overall Study|Pregnancy|2|||
160806987|NCT03654274|580679867|FG001|Overall Study|Pregnancy|2|||
160898498|NCT02913612|581023468|FG002|Overall Study|Physician Decision|1|||
160898499|NCT02913612|581023469|FG003|Overall Study|Physician Decision|0|||
160898500|NCT02913612|581023466|FG000|Overall Study|Withdrawal by Subject|2|||
160898501|NCT02913612|581023467|FG001|Overall Study|Withdrawal by Subject|4|||
160898502|NCT02913612|581023468|FG002|Overall Study|Withdrawal by Subject|0|||
160806988|NCT03654274|580679868|FG002|Overall Study|Pregnancy|1|||
160806989|NCT03654274|580679866|FG000|Overall Study|Other|27|||
160806990|NCT03654274|580679867|FG001|Overall Study|Other|29|||
160806991|NCT03654274|580679868|FG002|Overall Study|Other|32|||
160806992|NCT03654274|580679866|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
160806993|NCT03654274|580679867|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
160806994|NCT03654274|580679868|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
160806995|NCT01102491|580679869|FG000|Overall Study|Protocol Violation|11|||
160806996|NCT01102491|580679870|FG001|Overall Study|Protocol Violation|12|||
160806997|NCT01265992|580679871|FG000|Overall Study|Lost to Follow-up|1|||
160806998|NCT01265992|580679871|FG000|Overall Study|Withdrawal by Subject|1|||
160806999|NCT01265992|580679871|FG000|Overall Study|Adverse Event|1|||
160807000|NCT01265992|580679871|FG000|Overall Study|Administrative reasons|2|||
160807001|NCT01265992|580679871|FG000|Overall Study|Stopped treatment|3|||
160807002|NCT01265992|580679871|FG000|Overall Study|Did not receive treatment|1|||
160807003|NCT02137070|580679889|FG000|Overall Study|Adverse Event|12|||
160807004|NCT02137070|580679890|FG001|Overall Study|Adverse Event|3|||
160807005|NCT02137070|580679889|FG000|Overall Study|Death|2|||
160807006|NCT02137070|580679890|FG001|Overall Study|Death|0|||
160807007|NCT02137070|580679889|FG000|Overall Study|Lost to Follow-up|24|||
160807008|NCT02137070|580679890|FG001|Overall Study|Lost to Follow-up|9|||
160807009|NCT02137070|580679889|FG000|Overall Study|Physician Decision|0|||
160807010|NCT02137070|580679890|FG001|Overall Study|Physician Decision|1|||
160807011|NCT02137070|580679889|FG000|Overall Study|Protocol Violation|18|||
160807012|NCT02137070|580679890|FG001|Overall Study|Protocol Violation|4|||
160807013|NCT02137070|580679889|FG000|Overall Study|Withdrawal by Subject|18|||
160807014|NCT02137070|580679890|FG001|Overall Study|Withdrawal by Subject|1|||
160807015|NCT02151786|580679891|FG000|Overall Study|Unavailability of Case Report Form|26|||
160807016|NCT02151786|580679891|FG000|Overall Study|Outside the Contract Period|1|||
160807017|NCT02151786|580679891|FG000|Overall Study|Randomized, not Treated|1|||
160807018|NCT02151786|580679891|FG000|Overall Study|Unavailability of Information|8|||
160861922|NCT01033019|580887883|FG000|Overall Study|Withdrawal by Subject|1|||
160861923|NCT01033019|580887884|FG001|Overall Study|Withdrawal by Subject|0|||
160861924|NCT01339832|580887885|FG000|Overall Study|Lost to Follow-up|3|||
160861925|NCT01339832|580887885|FG000|Overall Study|Death|11|||
160861926|NCT01052493|580887886|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
160861927|NCT01052493|580887887|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
160861928|NCT01052493|580887888|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
160861929|NCT01075243|580887894|FG000|Overall Study|Lost to Follow-up|5|||
160861930|NCT01075243|580887895|FG001|Overall Study|Lost to Follow-up|2|||
160861931|NCT01075243|580887896|FG002|Overall Study|Lost to Follow-up|0|||
160861932|NCT01075243|580887894|FG000|Overall Study|Withdrawal by Subject|1|||
160861933|NCT01075243|580887895|FG001|Overall Study|Withdrawal by Subject|1|||
160861934|NCT01075243|580887896|FG002|Overall Study|Withdrawal by Subject|0|||
160861935|NCT00551642|580887897|FG000|Treatment Period|Protocol Deviation|6|||
160861936|NCT00551642|580887898|FG001|Treatment Period|Protocol Deviation|11|||
160861937|NCT00551642|580887897|FG000|Treatment Period|Delivery device failure|1|||
160861938|NCT00551642|580887898|FG001|Treatment Period|Delivery device failure|3|||
160861939|NCT00551642|580887897|FG000|Treatment Period|Physician Decision|0|||
160861940|NCT00551642|580887898|FG001|Treatment Period|Physician Decision|1|||
160861941|NCT00551642|580887897|FG000|Treatment Period|Death|33|||
160861942|NCT00551642|580887898|FG001|Treatment Period|Death|31|||
160861943|NCT00551642|580887897|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
160861944|NCT00551642|580887898|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
160861945|NCT00551642|580887897|FG000|Treatment Period|Adverse Event|15|||
160861946|NCT00551642|580887898|FG001|Treatment Period|Adverse Event|12|||
160861947|NCT00551642|580887897|FG000|Treatment Period|Withdrawal by Subject|2|||
160861948|NCT00551642|580887898|FG001|Treatment Period|Withdrawal by Subject|1|||
160861949|NCT05386329|580887899|FG000|Overall Study|Lost to Follow-up|3|||
160861950|NCT00888134|580887900|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
160861951|NCT00888134|580887900|FG000|Follow-up|being followed for long-term survival|1|||
160861952|NCT04973449|580887905|FG000|Overall Study|Withdrawal by Subject|3|||
160861953|NCT04973449|580887906|FG001|Overall Study|Withdrawal by Subject|3|||
160861954|NCT04973449|580887907|FG002|Overall Study|Withdrawal by Subject|2|||
160861955|NCT04973449|580887908|FG003|Overall Study|Withdrawal by Subject|5|||
160861956|NCT04973449|580887909|FG004|Overall Study|Withdrawal by Subject|5|||
160861957|NCT04973449|580887910|FG005|Overall Study|Withdrawal by Subject|4|||
160861958|NCT04973449|580887911|FG006|Overall Study|Withdrawal by Subject|7|||
160861959|NCT04973449|580887912|FG007|Overall Study|Withdrawal by Subject|5|||
160861960|NCT04973449|580887905|FG000|Overall Study|Lost to Follow-up|15|||
160861961|NCT04973449|580887906|FG001|Overall Study|Lost to Follow-up|16|||
160861962|NCT04973449|580887907|FG002|Overall Study|Lost to Follow-up|16|||
160861963|NCT04973449|580887908|FG003|Overall Study|Lost to Follow-up|13|||
160861964|NCT04973449|580887909|FG004|Overall Study|Lost to Follow-up|5|||
160861965|NCT04973449|580887910|FG005|Overall Study|Lost to Follow-up|6|||
160861966|NCT04973449|580887911|FG006|Overall Study|Lost to Follow-up|10|||
160861967|NCT04973449|580887912|FG007|Overall Study|Lost to Follow-up|6|||
160861968|NCT04973449|580887905|FG000|Overall Study|Death|1|||
160861969|NCT04973449|580887906|FG001|Overall Study|Death|0|||
160861970|NCT04973449|580887907|FG002|Overall Study|Death|0|||
160985769|NCT01244763|581337014|FG004|Overall Study|Lost to Follow-up|0|||
160861971|NCT04973449|580887908|FG003|Overall Study|Death|0|||
160861972|NCT04973449|580887909|FG004|Overall Study|Death|0|||
160861973|NCT04973449|580887910|FG005|Overall Study|Death|1|||
160861974|NCT04973449|580887911|FG006|Overall Study|Death|0|||
160861975|NCT04973449|580887912|FG007|Overall Study|Death|0|||
160861976|NCT04973449|580887905|FG000|Overall Study|Other|1|||
160861977|NCT04973449|580887906|FG001|Overall Study|Other|1|||
160807019|NCT03718325|580681280|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
160807020|NCT03718325|580681281|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
160807021|NCT03718325|580681282|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
160807022|NCT03718325|580681280|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
160807023|NCT03718325|580681281|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
160807024|NCT03718325|580681282|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
160807025|NCT01147965|580681287|FG000|Overall Study|Progressive Disease|3|||
160807026|NCT01147965|580681288|FG001|Overall Study|Progressive Disease|3|||
160807027|NCT01147965|580681289|FG002|Overall Study|Progressive Disease|5|||
160807028|NCT01147965|580681290|FG003|Overall Study|Progressive Disease|9|||
160807029|NCT01147965|580681291|FG004|Overall Study|Progressive Disease|5|||
160807030|NCT01147965|580681292|FG005|Overall Study|Progressive Disease|5|||
160807031|NCT01147965|580681287|FG000|Overall Study|Death|0|||
160807032|NCT01147965|580681288|FG001|Overall Study|Death|0|||
160807033|NCT01147965|580681289|FG002|Overall Study|Death|1|||
160807034|NCT01147965|580681290|FG003|Overall Study|Death|1|||
160644609|NCT00185211|580080803|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
160644610|NCT00185211|580080804|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
160644611|NCT00185211|580080803|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
160644612|NCT00185211|580080804|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
160644613|NCT00185211|580080803|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
160644614|NCT00185211|580080804|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
160644615|NCT00185211|580080803|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
160807035|NCT01147965|580681291|FG004|Overall Study|Death|0|||
160807036|NCT01147965|580681292|FG005|Overall Study|Death|2|||
160807037|NCT01147965|580681287|FG000|Overall Study|Withdrawal by Subject|0|||
160807038|NCT01147965|580681288|FG001|Overall Study|Withdrawal by Subject|0|||
160807039|NCT01147965|580681289|FG002|Overall Study|Withdrawal by Subject|1|||
160807040|NCT01147965|580681290|FG003|Overall Study|Withdrawal by Subject|1|||
160807041|NCT01147965|580681291|FG004|Overall Study|Withdrawal by Subject|0|||
160807042|NCT01147965|580681292|FG005|Overall Study|Withdrawal by Subject|0|||
160807043|NCT01147965|580681287|FG000|Overall Study|Administration Of Alternative Therapy|0|||
160807044|NCT01147965|580681288|FG001|Overall Study|Administration Of Alternative Therapy|0|||
160807045|NCT01147965|580681289|FG002|Overall Study|Administration Of Alternative Therapy|0|||
160807046|NCT01147965|580681290|FG003|Overall Study|Administration Of Alternative Therapy|0|||
160807047|NCT01147965|580681291|FG004|Overall Study|Administration Of Alternative Therapy|0|||
160807048|NCT01147965|580681292|FG005|Overall Study|Administration Of Alternative Therapy|1|||
160807049|NCT01147965|580681287|FG000|Overall Study|Other|0|||
160807050|NCT01147965|580681288|FG001|Overall Study|Other|0|||
160807051|NCT01147965|580681289|FG002|Overall Study|Other|0|||
160807052|NCT01147965|580681290|FG003|Overall Study|Other|3|||
160807053|NCT01147965|580681291|FG004|Overall Study|Other|1|||
160807054|NCT01147965|580681292|FG005|Overall Study|Other|0|||
160807055|NCT01279044|580681295|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
160807056|NCT01279044|580681296|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
160807057|NCT01279044|580681297|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
160807058|NCT01279044|580681295|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
160551210|NCT01928381|579742342|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
160551211|NCT01928381|579742343|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
160551212|NCT01928381|579742344|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
160551213|NCT01928381|579742345|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
160551214|NCT01928381|579742346|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
160551215|NCT02406781|579742350|FG000|Overall Study|Protocol Violation|2|||
160551216|NCT02406781|579742351|FG001|Overall Study|Protocol Violation|2|||
160807059|NCT01279044|580681296|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
160807060|NCT01279044|580681297|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
160807061|NCT01279044|580681295|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
160807062|NCT01279044|580681296|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
160807063|NCT01279044|580681297|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
160807064|NCT01408277|580681300|FG000|Overall Study|Adverse Event|3|||
160807065|NCT01408277|580681301|FG001|Overall Study|Adverse Event|4|||
160807066|NCT01408277|580681300|FG000|Overall Study|Lost to Follow-up|1|||
160807067|NCT01408277|580681301|FG001|Overall Study|Lost to Follow-up|0|||
160807068|NCT01408277|580681300|FG000|Overall Study|Withdrawal by Subject|2|||
160807069|NCT01408277|580681301|FG001|Overall Study|Withdrawal by Subject|0|||
160807070|NCT01408277|580681300|FG000|Overall Study|Protocol Violation|2|||
160807071|NCT01408277|580681301|FG001|Overall Study|Protocol Violation|0|||
160807072|NCT02630693|580681308|FG000|Overall Study|No receive treatment|0|||
160807073|NCT02630693|580681309|FG001|Overall Study|No receive treatment|1|||
160807074|NCT02763059|580681310|FG000|Overall Study|Lost to Follow-up|4|||
160807075|NCT02763059|580681311|FG001|Overall Study|Lost to Follow-up|1|||
160807076|NCT02763059|580681312|FG002|Overall Study|Lost to Follow-up|6|||
160807077|NCT02763059|580681310|FG000|Overall Study|Withdrawal by Subject|1|||
160807078|NCT02763059|580681311|FG001|Overall Study|Withdrawal by Subject|0|||
160807079|NCT02763059|580681312|FG002|Overall Study|Withdrawal by Subject|3|||
160807080|NCT02370368|580681313|FG000|Overall Study|Adverse Event|1|||
160807081|NCT02370368|580681314|FG001|Overall Study|Adverse Event|2|||
160807082|NCT02370368|580681313|FG000|Overall Study|Withdrawal by Subject|5|||
160807083|NCT02370368|580681314|FG001|Overall Study|Withdrawal by Subject|4|||
160807084|NCT00175916|580681315|FG000|Overall Study|Death|19|||
160807085|NCT00175916|580681315|FG000|Overall Study|Adverse Event|81|||
160807086|NCT00175916|580681315|FG000|Overall Study|Lack of Efficacy|354|||
160807087|NCT00175916|580681315|FG000|Overall Study|Lost to Follow-up|17|||
160807088|NCT00175916|580681315|FG000|Overall Study|Subject Choice|98|||
160807089|NCT00175916|580681315|FG000|Overall Study|Lack of compliance|8|||
160807090|NCT00175916|580681315|FG000|Overall Study|Patient cannot record seizures|1|||
160807091|NCT00175916|580681315|FG000|Overall Study|Sponsor decision|17|||
160807092|NCT00175916|580681315|FG000|Overall Study|Vigabatrin intake|1|||
160807093|NCT00175916|580681315|FG000|Overall Study|Suicidal behaviour|1|||
160898503|NCT02913612|581023469|FG003|Overall Study|Withdrawal by Subject|0|||
160898504|NCT02913612|581023466|FG000|Overall Study|Hemangioma resolved|1|||
160898505|NCT02913612|581023467|FG001|Overall Study|Hemangioma resolved|0|||
160807094|NCT00175916|580681315|FG000|Overall Study|Withdrawal by Subject|1|||
160898506|NCT02913612|581023468|FG002|Overall Study|Hemangioma resolved|0|||
160807095|NCT00175916|580681315|FG000|Overall Study|Seizure - free|4|||
160807096|NCT00175916|580681315|FG000|Overall Study|Administrative reason|1|||
160898507|NCT02913612|581023469|FG003|Overall Study|Hemangioma resolved|0|||
160807097|NCT00175916|580681315|FG000|Overall Study|Pregnancy|1|||
160807098|NCT00175916|580681315|FG000|Overall Study|Patient's request|2|||
160807099|NCT00175916|580681315|FG000|Overall Study|Treating physiciant's choice|1|||
160807100|NCT00175916|580681315|FG000|Overall Study|Moved overseas|1|||
160807101|NCT00175916|580681315|FG000|Overall Study|Loss of job and economic burden|1|||
160807102|NCT00175916|580681315|FG000|Overall Study|Site was closed|9|||
160807103|NCT00175916|580681315|FG000|Overall Study|Patient went to prison|1|||
160807104|NCT02236572|580681316|FG000|Overall Study|Withdrawal by Subject|1|||
160807105|NCT02236572|580681316|FG000|Overall Study|Protocol Violation|1|||
160807106|NCT02236572|580681316|FG000|Overall Study|Lost to Follow-up|1|||
160807107|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
160807108|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
160807109|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
160807110|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
160807111|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
160807112|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
160807113|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
160807114|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
160807115|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
160807116|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
160807117|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
160807118|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
160807119|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
160807120|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
160807121|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
160807122|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
160807123|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
160807124|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
160807125|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
160807126|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
160807127|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
160807128|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
160807129|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
160807130|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
160807131|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
160807132|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
160807133|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
160807134|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
160807135|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
160807136|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
160807137|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
160807138|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
160807139|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
160807140|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Other|6|||
160807141|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Other|0|||
160807142|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Other|0|||
160807143|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
160807144|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
160807145|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
160807146|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
160807147|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
160807148|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
160807149|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
160807150|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
160807151|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
160807152|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
160807153|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
160807154|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
160807155|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
160807156|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
160807157|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
160807158|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
160807159|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
160807160|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
160807161|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
160807162|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
160807163|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
160985770|NCT01244763|581337015|FG005|Overall Study|Lost to Follow-up|0|||
160985771|NCT01244763|581337010|FG000|Overall Study|Enrolled into the Extension Study|0|||
160807164|NCT02959463|580681320|FG000|Overall Study|Adverse Event|1|||
160807165|NCT02959463|580681321|FG001|Overall Study|Adverse Event|1|||
160807166|NCT02959463|580681320|FG000|Overall Study|Death|1|||
160807167|NCT02959463|580681321|FG001|Overall Study|Death|0|||
160807168|NCT02959463|580681320|FG000|Overall Study|Withdrawal by Subject|1|||
160807169|NCT02959463|580681321|FG001|Overall Study|Withdrawal by Subject|0|||
160807170|NCT02413996|580681322|FG000|Overall Study|not comfortable with the intervention|9|||
160807171|NCT02413996|580681323|FG001|Overall Study|not comfortable with the intervention|2|||
160807172|NCT00709319|580681324|FG000|Overall Study|Death|4|||
160807173|NCT00709319|580681324|FG000|Overall Study|Withdrawal by Subject|2|||
160807174|NCT00090779|580681325|FG000|Step 1|Withdrawal by Subject|4|||
160807175|NCT00090779|580681326|FG001|Step 1|Withdrawal by Subject|2|||
160807176|NCT00090779|580681325|FG000|Step 1|Lost to Follow-up|3|||
160807177|NCT00090779|580681326|FG001|Step 1|Lost to Follow-up|2|||
160807178|NCT00090779|580681325|FG000|Step 1|Death|0|||
160807179|NCT00090779|580681326|FG001|Step 1|Death|2|||
160807180|NCT00090779|580681325|FG000|Step 1|Physician Decision|1|||
160807181|NCT00090779|580681326|FG001|Step 1|Physician Decision|0|||
160807182|NCT00090779|580681325|FG000|Step 1|Pregnancy|1|||
160807183|NCT00090779|580681326|FG001|Step 1|Pregnancy|0|||
160807184|NCT00090779|580681325|FG000|Step 1|Non-compliance to study requirements|0|||
160807185|NCT00090779|580681326|FG001|Step 1|Non-compliance to study requirements|1|||
160807186|NCT00090779|580681325|FG000|Step 1|Subject relocated|2|||
160807187|NCT00090779|580681326|FG001|Step 1|Subject relocated|8|||
160807188|NCT00090779|580681325|FG000|Step 2|Off study per study closure|6|||
160807189|NCT00090779|580681326|FG001|Step 2|Off study per study closure|16|||
160807190|NCT00090779|580681325|FG000|Step 2|Subject relocated|0|||
160807191|NCT00090779|580681326|FG001|Step 2|Subject relocated|1|||
160807192|NCT00090779|580681325|FG000|Step 2|Non-compliance to study requirements|0|||
160807193|NCT00090779|580681326|FG001|Step 2|Non-compliance to study requirements|1|||
160807194|NCT00090779|580681325|FG000|Step 3|Initiation of ART and off extended study|3|||
160807195|NCT00090779|580681326|FG001|Step 3|Initiation of ART and off extended study|2|||
160807196|NCT00090779|580681325|FG000|Step 3|Off extended study due to study closure|4|||
160807197|NCT00090779|580681326|FG001|Step 3|Off extended study due to study closure|3|||
160807198|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
160807199|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
160807200|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
160807201|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
160807202|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
160807203|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
160807204|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
160807205|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
160807206|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
160807207|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
160807208|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
160807209|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
160807210|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
160807211|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
160807212|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
160807213|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
160807214|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
160807215|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
160807216|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
160807217|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
160807218|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
160551217|NCT02406781|579742352|FG002|Overall Study|Protocol Violation|2|||
160551218|NCT02406781|579742353|FG003|Overall Study|Protocol Violation|2|||
160807219|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
160807220|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
160807221|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
160807222|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
160807223|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
160807224|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
160807225|NCT01672879|580681329|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
160807226|NCT01672879|580681330|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
160807227|NCT01672879|580681331|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
160807228|NCT01672879|580681329|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
160807229|NCT01672879|580681330|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
160807230|NCT01672879|580681331|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
160807231|NCT01672879|580681329|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
160807232|NCT01672879|580681330|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
160807233|NCT01672879|580681331|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
160807234|NCT01672879|580681329|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
160807235|NCT01672879|580681330|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
160551219|NCT02406781|579742354|FG004|Overall Study|Protocol Violation|1|||
160551220|NCT02406781|579742355|FG005|Overall Study|Protocol Violation|5|||
160551221|NCT02406781|579742356|FG006|Overall Study|Protocol Violation|3|||
160551222|NCT04484285|579744107|FG000|Overall Study|Unable to operate stimulator|3|||
160551223|NCT04484285|579744108|FG001|Overall Study|Unable to operate stimulator|0|||
160551224|NCT02527707|579744109|FG000|Overall Study|Adverse Event|1|||
160551225|NCT02527707|579744109|FG000|Overall Study|Adverse Event|1|||
160551226|NCT04002310|579744110|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
160551227|NCT04002310|579744111|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
160551228|NCT04002310|579744112|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
160551229|NCT04002310|579744113|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
160644616|NCT00185211|580080804|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
160807236|NCT01672879|580681331|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
160807237|NCT03951766|580681340|FG000|Treatment Phase|Lost to Follow-up|1|||
160898508|NCT02913612|581023466|FG000|Overall Study|Local IRB decision|1|||
160898509|NCT02913612|581023467|FG001|Overall Study|Local IRB decision|0|||
160898510|NCT02913612|581023468|FG002|Overall Study|Local IRB decision|0|||
160898511|NCT02913612|581023469|FG003|Overall Study|Local IRB decision|0|||
160898512|NCT02913612|581023466|FG000|Overall Study|Study drug non-compliance|1|||
160898513|NCT02913612|581023467|FG001|Overall Study|Study drug non-compliance|1|||
160898514|NCT02913612|581023468|FG002|Overall Study|Study drug non-compliance|0|||
160898515|NCT02913612|581023469|FG003|Overall Study|Study drug non-compliance|0|||
160898516|NCT02913612|581023466|FG000|Overall Study|Insurance issues|0|||
160898517|NCT02913612|581023467|FG001|Overall Study|Insurance issues|1|||
160898518|NCT02913612|581023468|FG002|Overall Study|Insurance issues|0|||
160898519|NCT02913612|581023469|FG003|Overall Study|Insurance issues|0|||
160898520|NCT02913612|581023466|FG000|Overall Study|Needed to treat second hemangioma|0|||
160898521|NCT02913612|581023467|FG001|Overall Study|Needed to treat second hemangioma|1|||
160898522|NCT02913612|581023468|FG002|Overall Study|Needed to treat second hemangioma|0|||
160898523|NCT02913612|581023469|FG003|Overall Study|Needed to treat second hemangioma|0|||
160898524|NCT02913612|581023466|FG000|Overall Study|Study completion criteria not met|0|||
160898525|NCT02913612|581023467|FG001|Overall Study|Study completion criteria not met|1|||
160898526|NCT02913612|581023468|FG002|Overall Study|Study completion criteria not met|0|||
160898527|NCT02913612|581023469|FG003|Overall Study|Study completion criteria not met|0|||
160898528|NCT02913612|581023466|FG000|Overall Study|Ineligible|0|||
160898529|NCT02913612|581023467|FG001|Overall Study|Ineligible|1|||
160898530|NCT02913612|581023468|FG002|Overall Study|Ineligible|0|||
160898531|NCT02913612|581023469|FG003|Overall Study|Ineligible|0|||
160898532|NCT04251273|581023470|FG000|Overall Study|Lost to Follow-up|331|||
160898533|NCT04251273|581023471|FG001|Overall Study|Lost to Follow-up|290|||
160898534|NCT04402060|581023472|FG000|Overall Study|Death|1|||
160898535|NCT04402060|581023473|FG001|Overall Study|Death|12|||
160898536|NCT04402060|581023474|FG002|Overall Study|Death|7|||
160898537|NCT04402060|581023472|FG000|Overall Study|Adverse Event|0|||
160898538|NCT04402060|581023473|FG001|Overall Study|Adverse Event|0|||
160551230|NCT04002310|579744114|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
160807238|NCT03951766|580681340|FG000|Follow-up Phase|Lost to Follow-up|10|||
160807239|NCT00041470|580681341|FG000|Overall Study|Loss of Funding|38|||
160807240|NCT02379052|580681357|FG000|Overall Study|Protocol Violation|0|||
160807241|NCT02379052|580681358|FG001|Overall Study|Protocol Violation|1|||
160807242|NCT02379052|580681357|FG000|Overall Study|Adverse Event|0|||
160807243|NCT02379052|580681358|FG001|Overall Study|Adverse Event|1|||
160807244|NCT02379052|580681357|FG000|Overall Study|Physician Decision|1|||
160807245|NCT02379052|580681358|FG001|Overall Study|Physician Decision|1|||
160807246|NCT02379052|580681357|FG000|Overall Study|Withdrawal by Subject|2|||
160807247|NCT02379052|580681358|FG001|Overall Study|Withdrawal by Subject|0|||
160807248|NCT02379052|580681357|FG000|Overall Study|Lost to Follow-up|2|||
160807249|NCT02379052|580681358|FG001|Overall Study|Lost to Follow-up|1|||
160807250|NCT02379052|580681357|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
160807251|NCT02379052|580681358|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
160807252|NCT02379052|580681357|FG000|Overall Study|Subject was Incarcerated|0|||
160807253|NCT02379052|580681358|FG001|Overall Study|Subject was Incarcerated|1|||
160807254|NCT00127855|580681359|FG000|Primary Vaccination Course|Adverse Event|0|||
160807255|NCT00127855|580681360|FG001|Primary Vaccination Course|Adverse Event|0|||
160807256|NCT00127855|580681361|FG002|Primary Vaccination Course|Adverse Event|1|||
160807257|NCT00127855|580681362|FG003|Primary Vaccination Course|Adverse Event|0|||
160807258|NCT00127855|580681363|FG004|Primary Vaccination Course|Adverse Event|0|||
160807259|NCT00127855|580681359|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
160807260|NCT00127855|580681360|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
160807261|NCT00127855|580681361|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
160807262|NCT00127855|580681362|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
160807263|NCT00127855|580681363|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
160807264|NCT00127855|580681359|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
160807265|NCT00127855|580681360|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
160807266|NCT00127855|580681361|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
160807267|NCT00127855|580681362|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
160807268|NCT00127855|580681363|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
160807269|NCT00127855|580681359|FG000|Primary Vaccination Course|Other|0|||
160807270|NCT00127855|580681360|FG001|Primary Vaccination Course|Other|0|||
160807271|NCT00127855|580681361|FG002|Primary Vaccination Course|Other|0|||
160807272|NCT00127855|580681362|FG003|Primary Vaccination Course|Other|0|||
160807273|NCT00127855|580681363|FG004|Primary Vaccination Course|Other|1|||
160807274|NCT02343302|580681364|FG000|Overall Study|Physician Decision|1|||
160807275|NCT02343302|580681365|FG001|Overall Study|Physician Decision|1|||
160807276|NCT00003869|580681373|FG000|Overall Study|Adverse Event|14|||
160807277|NCT00003869|580681374|FG001|Overall Study|Adverse Event|3|||
160807278|NCT00003869|580681373|FG000|Overall Study|Withdrawal by Subject|21|||
160807279|NCT00003869|580681374|FG001|Overall Study|Withdrawal by Subject|3|||
160807280|NCT00003869|580681373|FG000|Overall Study|Death|1|||
160807281|NCT00003869|580681374|FG001|Overall Study|Death|2|||
160807282|NCT00003869|580681373|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
160807283|NCT00003869|580681374|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
160807284|NCT01272037|580681379|FG000|Overall Study|Death|25|||
160807285|NCT01272037|580681380|FG001|Overall Study|Death|28|||
160807286|NCT01272037|580681379|FG000|Overall Study|Adverse Event|12|||
160807287|NCT01272037|580681380|FG001|Overall Study|Adverse Event|7|||
160807288|NCT01272037|580681379|FG000|Overall Study|Withdrawal by Subject|175|||
160807289|NCT01272037|580681380|FG001|Overall Study|Withdrawal by Subject|93|||
160807290|NCT01272037|580681379|FG000|Overall Study|Disease progression|70|||
160807291|NCT01272037|580681380|FG001|Overall Study|Disease progression|111|||
160807292|NCT01272037|580681379|FG000|Overall Study|Other reason|42|||
160807293|NCT01272037|580681380|FG001|Overall Study|Other reason|41|||
160807294|NCT01272037|580681379|FG000|Overall Study|Delinquent data|24|||
160807295|NCT01272037|580681380|FG001|Overall Study|Delinquent data|19|||
160807296|NCT01272037|580681379|FG000|Overall Study|Reason under review|33|||
160807297|NCT01272037|580681380|FG001|Overall Study|Reason under review|29|||
160807298|NCT01272037|580681379|FG000|Overall Study|On treatment|626|||
160898539|NCT04402060|581023474|FG002|Overall Study|Adverse Event|1|||
160898540|NCT04402060|581023472|FG000|Overall Study|Withdrawal by Subject|0|||
160807299|NCT01272037|580681380|FG001|Overall Study|On treatment|632|||
160898541|NCT04402060|581023473|FG001|Overall Study|Withdrawal by Subject|1|||
160898542|NCT04402060|581023474|FG002|Overall Study|Withdrawal by Subject|2|||
160807300|NCT02534883|580681381|FG000|Overall Study|Early Termination|8|||
160807301|NCT02534883|580681382|FG001|Overall Study|Early Termination|3|||
160807302|NCT03328832|580681383|FG000|Overall Study|Lost to Follow-up|0|||
160807303|NCT03328832|580681384|FG001|Overall Study|Lost to Follow-up|1|||
160807304|NCT00886769|580681385|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
160807305|NCT00886769|580681386|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
160807306|NCT00049257|580681387|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
160807307|NCT00049257|580681387|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
160807308|NCT00049257|580681387|FG000|Carboplatin, Paclitaxel|Death|2|||
160807309|NCT00049257|580681387|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
160807310|NCT04872569|580681390|FG000|Overall Study|Withdrawal by Subject|2|||
160807311|NCT01890265|580681391|FG000|Overall Study|Other (Unspecified reason)|0|||
160807312|NCT01890265|580681392|FG001|Overall Study|Other (Unspecified reason)|1|||
160807313|NCT01890265|580681393|FG002|Overall Study|Other (Unspecified reason)|0|||
160807314|NCT01890265|580681394|FG003|Overall Study|Other (Unspecified reason)|0|||
160807315|NCT01890265|580681395|FG004|Overall Study|Other (Unspecified reason)|0|||
160807316|NCT01890265|580681396|FG005|Overall Study|Other (Unspecified reason)|0|||
160807317|NCT01890265|580681391|FG000|Overall Study|Progressive disease|6|||
160807318|NCT01890265|580681392|FG001|Overall Study|Progressive disease|6|||
160807319|NCT01890265|580681393|FG002|Overall Study|Progressive disease|0|||
160807320|NCT01890265|580681394|FG003|Overall Study|Progressive disease|0|||
160807321|NCT01890265|580681395|FG004|Overall Study|Progressive disease|0|||
160807322|NCT01890265|580681396|FG005|Overall Study|Progressive disease|0|||
160807323|NCT01890265|580681391|FG000|Overall Study|Adverse Event|2|||
160807324|NCT01890265|580681392|FG001|Overall Study|Adverse Event|1|||
160807325|NCT01890265|580681393|FG002|Overall Study|Adverse Event|0|||
160807326|NCT01890265|580681394|FG003|Overall Study|Adverse Event|0|||
160807327|NCT01890265|580681395|FG004|Overall Study|Adverse Event|0|||
160807328|NCT01890265|580681396|FG005|Overall Study|Adverse Event|0|||
160807329|NCT01890265|580681391|FG000|Overall Study|Death|2|||
160807330|NCT01890265|580681392|FG001|Overall Study|Death|3|||
160807331|NCT01890265|580681393|FG002|Overall Study|Death|1|||
160807332|NCT01890265|580681394|FG003|Overall Study|Death|0|||
160807333|NCT01890265|580681395|FG004|Overall Study|Death|0|||
160807334|NCT01890265|580681396|FG005|Overall Study|Death|0|||
160807335|NCT01890265|580681391|FG000|Overall Study|Withdrawal by Subject|0|||
160807336|NCT01890265|580681392|FG001|Overall Study|Withdrawal by Subject|2|||
160807337|NCT01890265|580681393|FG002|Overall Study|Withdrawal by Subject|3|||
160807338|NCT01890265|580681394|FG003|Overall Study|Withdrawal by Subject|0|||
160807339|NCT01890265|580681395|FG004|Overall Study|Withdrawal by Subject|2|||
160807340|NCT01890265|580681396|FG005|Overall Study|Withdrawal by Subject|0|||
160807341|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
160807342|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
160807343|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
160807344|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
160807345|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
160807346|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
160807347|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
160807348|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
160807349|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
160807350|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
160807351|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
160807352|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
160807353|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
160807354|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
160807355|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
160807356|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
160807357|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
160807358|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
160807359|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
160807360|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
160807361|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
160807362|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
160807363|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
160807364|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
160807365|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
160807366|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
160807367|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
160807368|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
160807369|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
160807370|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
160807371|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
160807372|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
160807373|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
160807374|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
160807375|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
160807376|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
160807377|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
160807378|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
160807379|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
160807380|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
160807381|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
160861978|NCT04973449|580887907|FG002|Overall Study|Other|2|||
160551231|NCT00352534|579744115|FG000|Initial Staging|Ineligible|8|||
160551232|NCT00352534|579744116|FG001|Initial Staging|Ineligible|9|||
160551233|NCT00352534|579744117|FG002|Initial Staging|Ineligible|0|||
160551234|NCT00352534|579744118|FG003|Initial Staging|Ineligible|0|||
160551235|NCT00352534|579744119|FG004|Initial Staging|Ineligible|0|||
160551236|NCT00352534|579744120|FG005|Initial Staging|Ineligible|0|||
160551237|NCT00352534|579744121|FG006|Initial Staging|Ineligible|0|||
160551238|NCT00352534|579744115|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
160807382|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
160807383|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
160807384|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
160807385|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
160807386|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
160807387|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
160807388|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
160807389|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
160807390|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
160807391|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
160807392|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
160807393|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
160807394|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
160807395|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
160807396|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
160807397|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
160807398|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
160807399|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
160807400|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
160807401|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
160807402|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
160807403|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
160807404|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
160807405|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
160807406|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
160807407|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
160807408|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
160807409|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
160807410|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
160807411|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
160807412|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
160807413|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
160807414|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
160807415|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
160861979|NCT04973449|580887908|FG003|Overall Study|Other|1|||
160861980|NCT04973449|580887909|FG004|Overall Study|Other|4|||
160861981|NCT04973449|580887910|FG005|Overall Study|Other|0|||
160551239|NCT00352534|579744116|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
160551240|NCT00352534|579744117|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
160861982|NCT04973449|580887911|FG006|Overall Study|Other|2|||
160861983|NCT04973449|580887912|FG007|Overall Study|Other|2|||
160861984|NCT01488890|580887913|FG000|Overall Study|Serious adverse event|2|||
160861985|NCT01488890|580887914|FG001|Overall Study|Serious adverse event|0|||
160861986|NCT01488890|580887915|FG002|Overall Study|Serious adverse event|0|||
160861987|NCT01488890|580887916|FG003|Overall Study|Serious adverse event|0|||
160861988|NCT01488890|580887913|FG000|Overall Study|Protocol Violation|3|||
160861989|NCT01488890|580887914|FG001|Overall Study|Protocol Violation|0|||
160861990|NCT01488890|580887915|FG002|Overall Study|Protocol Violation|4|||
160861991|NCT01488890|580887916|FG003|Overall Study|Protocol Violation|0|||
160861992|NCT01488890|580887913|FG000|Overall Study|Lost to Follow-up|13|||
160861993|NCT01488890|580887914|FG001|Overall Study|Lost to Follow-up|10|||
160861994|NCT01488890|580887915|FG002|Overall Study|Lost to Follow-up|20|||
160861995|NCT01488890|580887916|FG003|Overall Study|Lost to Follow-up|3|||
160861996|NCT01488890|580887913|FG000|Overall Study|Withdrawal by Subject|14|||
160861997|NCT01488890|580887914|FG001|Overall Study|Withdrawal by Subject|10|||
160861998|NCT01488890|580887915|FG002|Overall Study|Withdrawal by Subject|11|||
160861999|NCT01488890|580887916|FG003|Overall Study|Withdrawal by Subject|2|||
160862000|NCT02532517|580887917|FG000|Overall Study|Did not complete 24-Month visit|4|||
160862001|NCT02532517|580887917|FG000|Overall Study|Failed Angiographic eligibility|1|||
160862002|NCT02532517|580887917|FG000|Overall Study|Lost to Follow-up|4|||
160862003|NCT02532517|580887917|FG000|Overall Study|Withdrawal by Subject|4|||
160862004|NCT02532517|580887917|FG000|Overall Study|Death|4|||
160807416|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
160807417|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
160807418|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
160807419|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
160807420|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
160807421|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
160807422|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
160807423|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
160807424|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
160807425|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
160807426|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
160807427|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
160807428|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
160807429|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
160807430|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
160807431|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
160807432|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
160807433|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
160807434|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
160807435|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
160807436|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
160807437|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
160807438|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
160807439|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
160807440|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
160807441|NCT04570384|580681407|FG000|Overall Study|Adverse Event|2|||
160807442|NCT04570384|580681408|FG001|Overall Study|Adverse Event|1|||
160807443|NCT04570384|580681407|FG000|Overall Study|Death|2|||
160807444|NCT04570384|580681408|FG001|Overall Study|Death|5|||
160807445|NCT04570384|580681407|FG000|Overall Study|Lost to Follow-up|1|||
160807446|NCT04570384|580681408|FG001|Overall Study|Lost to Follow-up|0|||
160807447|NCT04570384|580681407|FG000|Overall Study|Other|1|||
160807448|NCT04570384|580681408|FG001|Overall Study|Other|0|||
160807449|NCT04570384|580681407|FG000|Overall Study|Protocol Violation|0|||
160807450|NCT04570384|580681408|FG001|Overall Study|Protocol Violation|1|||
160807451|NCT04570384|580681407|FG000|Overall Study|Sponsor Decision|1|||
160807452|NCT04570384|580681408|FG001|Overall Study|Sponsor Decision|0|||
160807453|NCT04570384|580681407|FG000|Overall Study|Withdrawal by Subject|4|||
160807454|NCT04570384|580681408|FG001|Overall Study|Withdrawal by Subject|2|||
160807455|NCT02573948|580681409|FG000|Longitudinal Cohort|Death|9|||
160807456|NCT02573948|580681409|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
160807457|NCT02573948|580681409|FG000|Longitudinal Cohort|Incarcerated|25|||
160807458|NCT00707993|580681410|FG000|Overall Study|Adverse Event|16|||
160807459|NCT00707993|580681411|FG001|Overall Study|Adverse Event|20|||
160807460|NCT00707993|580681410|FG000|Overall Study|Protocol Violation|4|||
160807461|NCT00707993|580681411|FG001|Overall Study|Protocol Violation|7|||
160807462|NCT00707993|580681410|FG000|Overall Study|Lost to Follow-up|0|||
160807463|NCT00707993|580681411|FG001|Overall Study|Lost to Follow-up|4|||
160807464|NCT00707993|580681410|FG000|Overall Study|Withdrawal by Subject|12|||
160807465|NCT00707993|580681411|FG001|Overall Study|Withdrawal by Subject|16|||
160807466|NCT00707993|580681410|FG000|Overall Study|Hyperglycemic Rescue|55|||
160807467|NCT00707993|580681411|FG001|Overall Study|Hyperglycemic Rescue|47|||
160807468|NCT00707993|580681410|FG000|Overall Study|Other|2|||
160807469|NCT00707993|580681411|FG001|Overall Study|Other|0|||
160807470|NCT00436436|580681414|FG000|Overall Study|Progression|4|||
160807471|NCT00436436|580681414|FG000|Overall Study|Adverse Event|2|||
160807472|NCT00436436|580681414|FG000|Overall Study|Death|6|||
160807473|NCT03265145|580681415|FG000|Overall Study|Protocol Violation|2|||
160807474|NCT03265145|580681416|FG001|Overall Study|Protocol Violation|0|||
160807475|NCT03265145|580681415|FG000|Overall Study|Adverse Event|1|||
160807476|NCT03265145|580681416|FG001|Overall Study|Adverse Event|0|||
160807477|NCT03265145|580681415|FG000|Overall Study|Withdrawal by Subject|23|||
160807478|NCT03265145|580681416|FG001|Overall Study|Withdrawal by Subject|19|||
160807479|NCT03265145|580681415|FG000|Overall Study|Death|12|||
160807480|NCT03265145|580681416|FG001|Overall Study|Death|12|||
160807481|NCT03265145|580681415|FG000|Overall Study|Lost to Follow-up|13|||
160807482|NCT03265145|580681416|FG001|Overall Study|Lost to Follow-up|9|||
160807483|NCT03265145|580681415|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
160807484|NCT03265145|580681416|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
160807485|NCT03265145|580681415|FG000|Overall Study|Switched back to previous medication|1|||
160807486|NCT03265145|580681416|FG001|Overall Study|Switched back to previous medication|0|||
160807487|NCT03265145|580681415|FG000|Overall Study|Did not want to take medication|1|||
160807488|NCT03265145|580681416|FG001|Overall Study|Did not want to take medication|0|||
160807489|NCT03265145|580681415|FG000|Overall Study|Subject could not afford medication|0|||
160807490|NCT03265145|580681416|FG001|Overall Study|Subject could not afford medication|1|||
160807491|NCT03265145|580681415|FG000|Overall Study|Site closed|2|||
160807492|NCT03265145|580681416|FG001|Overall Study|Site closed|3|||
160807493|NCT03265145|580681415|FG000|Overall Study|Incorrectly randomized|16|||
160807494|NCT03265145|580681416|FG001|Overall Study|Incorrectly randomized|6|||
160807495|NCT03265145|580681415|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
160807496|NCT03265145|580681416|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
160807497|NCT03265145|580681415|FG000|Overall Study|Physician Decision|0|||
160807498|NCT03265145|580681416|FG001|Overall Study|Physician Decision|3|||
160807499|NCT03265145|580681415|FG000|Overall Study|Subject transferred to another facility|0|||
160807500|NCT03265145|580681416|FG001|Overall Study|Subject transferred to another facility|1|||
160807501|NCT03941483|580681417|FG000|Overall Study|Miscellaneous|2|||
160807502|NCT03941483|580681418|FG001|Overall Study|Miscellaneous|3|||
160807503|NCT03941483|580681419|FG002|Overall Study|Miscellaneous|0|||
160807504|NCT03941483|580681417|FG000|Overall Study|Study Terminated by Sponsor|1|||
160807505|NCT03941483|580681418|FG001|Overall Study|Study Terminated by Sponsor|0|||
160807506|NCT03941483|580681419|FG002|Overall Study|Study Terminated by Sponsor|0|||
160807507|NCT03941483|580681417|FG000|Overall Study|Withdrawal by Subject|1|||
160807508|NCT03941483|580681418|FG001|Overall Study|Withdrawal by Subject|4|||
160807509|NCT03941483|580681419|FG002|Overall Study|Withdrawal by Subject|1|||
160807510|NCT03941483|580681417|FG000|Overall Study|Lost to Follow-up|2|||
160807511|NCT03941483|580681418|FG001|Overall Study|Lost to Follow-up|1|||
160807512|NCT03941483|580681419|FG002|Overall Study|Lost to Follow-up|8|||
160807513|NCT03941483|580681417|FG000|Overall Study|Death|3|||
160807514|NCT03941483|580681418|FG001|Overall Study|Death|2|||
160807515|NCT03941483|580681419|FG002|Overall Study|Death|6|||
160807516|NCT02685826|580681424|FG000|Overall Study|Adverse Event|2|||
160807517|NCT02685826|580681425|FG001|Overall Study|Adverse Event|0|||
160807518|NCT02685826|580681426|FG002|Overall Study|Adverse Event|1|||
160807519|NCT02685826|580681424|FG000|Overall Study|Progressive Disease|2|||
160807520|NCT02685826|580681425|FG001|Overall Study|Progressive Disease|1|||
160807521|NCT02685826|580681426|FG002|Overall Study|Progressive Disease|0|||
160807522|NCT02685826|580681424|FG000|Overall Study|Withdrawal by Subject|2|||
160807523|NCT02685826|580681425|FG001|Overall Study|Withdrawal by Subject|0|||
160807524|NCT02685826|580681426|FG002|Overall Study|Withdrawal by Subject|0|||
160807525|NCT02685826|580681424|FG000|Overall Study|Full Clinical Hold by FDA|19|||
160807526|NCT02685826|580681425|FG001|Overall Study|Full Clinical Hold by FDA|9|||
160807527|NCT02685826|580681426|FG002|Overall Study|Full Clinical Hold by FDA|20|||
160807528|NCT03154476|580681427|FG000|Overall Study|Lost to Follow-up|4|||
160807529|NCT03154476|580681428|FG001|Overall Study|Lost to Follow-up|4|||
160807530|NCT01444430|580681430|FG000|Overall Study|Withdrawal by Subject|53|||
160807531|NCT01444430|580681431|FG001|Overall Study|Withdrawal by Subject|72|||
160807532|NCT01444430|580681430|FG000|Overall Study|Death|6|||
160807533|NCT01444430|580681431|FG001|Overall Study|Death|8|||
160807534|NCT01444430|580681430|FG000|Overall Study|Lost to Follow-up|2|||
160807535|NCT01444430|580681431|FG001|Overall Study|Lost to Follow-up|0|||
160807536|NCT01444430|580681430|FG000|Overall Study|CRF termination module not completed.|0|||
160807537|NCT01444430|580681431|FG001|Overall Study|CRF termination module not completed.|1|||
160644617|NCT00185211|580080803|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
160644618|NCT00185211|580080804|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
160644619|NCT00185211|580080803|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
160644620|NCT00185211|580080804|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
160644621|NCT00185211|580080803|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
160644622|NCT00185211|580080804|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
160644623|NCT00185211|580080803|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
160644624|NCT00185211|580080804|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
160644625|NCT00185211|580080803|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
160644626|NCT00185211|580080804|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
160644627|NCT00185211|580080803|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
160644628|NCT00185211|580080804|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
160644629|NCT01759537|580080805|FG000|Overall Study|Death|1|||
160644630|NCT01759537|580080806|FG001|Overall Study|Death|1|||
160644631|NCT01759537|580080805|FG000|Overall Study|Pregnancy|1|||
160644632|NCT01759537|580080806|FG001|Overall Study|Pregnancy|1|||
160644633|NCT01759537|580080805|FG000|Overall Study|Lost to Follow-up|9|||
160644634|NCT01759537|580080806|FG001|Overall Study|Lost to Follow-up|9|||
160644635|NCT01759537|580080805|FG000|Overall Study|Accident involving jaw fracture|1|||
160807538|NCT01142388|580682825|FG000|Overall Study|Lack of Efficacy|21|||
160807539|NCT01142388|580682826|FG001|Overall Study|Lack of Efficacy|31|||
160807540|NCT01142388|580682825|FG000|Overall Study|Adverse Event|9|||
160807541|NCT01142388|580682826|FG001|Overall Study|Adverse Event|5|||
160807542|NCT01142388|580682825|FG000|Overall Study|Death|3|||
160807543|NCT01142388|580682826|FG001|Overall Study|Death|2|||
160807544|NCT01142388|580682825|FG000|Overall Study|Withdrawal by Subject|5|||
160807545|NCT01142388|580682826|FG001|Overall Study|Withdrawal by Subject|3|||
160807546|NCT01142388|580682825|FG000|Overall Study|Alternative therapy|1|||
160807547|NCT01142388|580682826|FG001|Overall Study|Alternative therapy|0|||
160807548|NCT01142388|580682825|FG000|Overall Study|Other complications|0|||
160807549|NCT01142388|580682826|FG001|Overall Study|Other complications|2|||
160807550|NCT01142388|580682825|FG000|Overall Study|Other|1|||
160807551|NCT01142388|580682826|FG001|Overall Study|Other|1|||
160807552|NCT01142388|580682825|FG000|Overall Study|Never started therapy|7|||
160807553|NCT01142388|580682826|FG001|Overall Study|Never started therapy|3|||
160898543|NCT04402060|581023472|FG000|Overall Study|Sponsor Request|0|||
160898544|NCT04402060|581023473|FG001|Overall Study|Sponsor Request|2|||
160898545|NCT04402060|581023474|FG002|Overall Study|Sponsor Request|0|||
160898546|NCT04402060|581023472|FG000|Overall Study|Physician Decision|0|||
160898547|NCT04402060|581023473|FG001|Overall Study|Physician Decision|0|||
160898548|NCT04402060|581023474|FG002|Overall Study|Physician Decision|1|||
160898549|NCT04402060|581023472|FG000|Overall Study|Other|0|||
160898550|NCT04402060|581023473|FG001|Overall Study|Other|1|||
160898551|NCT04402060|581023474|FG002|Overall Study|Other|0|||
160898552|NCT00936611|581023475|FG000|Overall Study|Progressive Disease|3|||
160898553|NCT00936611|581023475|FG000|Overall Study|New Systemic Therapy|22|||
160898554|NCT00936611|581023475|FG000|Overall Study|Lost to Follow-up|1|||
160898555|NCT00936611|581023475|FG000|Overall Study|Withdrawal by Subject|2|||
160898556|NCT00936611|581023475|FG000|Overall Study|Still on Follow-up|1|||
160898557|NCT00936611|581023475|FG000|Overall Study|Still on Active Therapy|7|||
160898558|NCT00936611|581023475|FG000|Overall Study|Ineligible for Study Drug|3|||
160898559|NCT02282358|581023484|FG000|Overall Study|Nonevaluable|1|||
160898560|NCT01898208|581023485|FG000|Overall Study|Positive blood culture|17|||
160898561|NCT01898208|581023486|FG001|Overall Study|Positive blood culture|23|||
160898562|NCT01898208|581023487|FG002|Overall Study|Positive blood culture|15|||
160898563|NCT01898208|581023485|FG000|Overall Study|Death/comfort care within 24 hours|10|||
160898564|NCT01898208|581023486|FG001|Overall Study|Death/comfort care within 24 hours|9|||
160898565|NCT01898208|581023487|FG002|Overall Study|Death/comfort care within 24 hours|8|||
160898566|NCT01898208|581023485|FG000|Overall Study|Negative Gram Stain|6|||
160898567|NCT01898208|581023486|FG001|Overall Study|Negative Gram Stain|9|||
160898568|NCT01898208|581023487|FG002|Overall Study|Negative Gram Stain|6|||
160898569|NCT01898208|581023485|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
160898570|NCT01898208|581023486|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
160898571|NCT01898208|581023487|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
160898572|NCT01898208|581023485|FG000|Overall Study|System/Technical Error|1|||
160898573|NCT01898208|581023486|FG001|Overall Study|System/Technical Error|2|||
160898574|NCT01898208|581023487|FG002|Overall Study|System/Technical Error|3|||
160898575|NCT01898208|581023485|FG000|Overall Study|Lost to Follow-up|3|||
160898576|NCT01898208|581023486|FG001|Overall Study|Lost to Follow-up|1|||
160898577|NCT01898208|581023487|FG002|Overall Study|Lost to Follow-up|1|||
160898578|NCT00961649|581023488|FG000|Overall Study|Adverse Event|4|||
160898579|NCT00961649|581023489|FG001|Overall Study|Adverse Event|0|||
160898580|NCT00961649|581023490|FG002|Overall Study|Adverse Event|0|||
160898581|NCT00961649|581023491|FG003|Overall Study|Adverse Event|2|||
160898582|NCT00961649|581023488|FG000|Overall Study|Inadequate control of IOP|0|||
160898583|NCT00961649|581023489|FG001|Overall Study|Inadequate control of IOP|0|||
160898584|NCT00961649|581023490|FG002|Overall Study|Inadequate control of IOP|0|||
160898585|NCT00961649|581023491|FG003|Overall Study|Inadequate control of IOP|1|||
160898586|NCT00961649|581023488|FG000|Overall Study|Patient has travel plans during holidays|0|||
160898587|NCT00961649|581023489|FG001|Overall Study|Patient has travel plans during holidays|0|||
160898588|NCT00961649|581023490|FG002|Overall Study|Patient has travel plans during holidays|1|||
160898589|NCT00961649|581023491|FG003|Overall Study|Patient has travel plans during holidays|0|||
160898590|NCT00961649|581023488|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
160898591|NCT00961649|581023489|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
160898592|NCT00961649|581023490|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
160898593|NCT00961649|581023491|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
160898594|NCT00961649|581023488|FG000|Overall Study|Study terminated by sponsor|4|||
160898595|NCT00961649|581023489|FG001|Overall Study|Study terminated by sponsor|4|||
160898596|NCT00961649|581023490|FG002|Overall Study|Study terminated by sponsor|4|||
160898597|NCT00961649|581023491|FG003|Overall Study|Study terminated by sponsor|1|||
160898598|NCT02155881|581023492|FG000|Overall Study|Withdrawal by Subject|0|||
160898599|NCT02155881|581023493|FG001|Overall Study|Withdrawal by Subject|2|||
160898600|NCT02155881|581023492|FG000|Overall Study|Inappropriately randomized|2|||
160807554|NCT03640325|580682832|FG000|Overall Study|Withdrawal by Subject|4|||
160807555|NCT03640325|580682833|FG001|Overall Study|Withdrawal by Subject|1|||
160807556|NCT03640325|580682834|FG002|Overall Study|Withdrawal by Subject|0|||
160807557|NCT03640325|580682832|FG000|Overall Study|Lost to Follow-up|4|||
160807558|NCT03640325|580682833|FG001|Overall Study|Lost to Follow-up|5|||
160807559|NCT03640325|580682834|FG002|Overall Study|Lost to Follow-up|21|||
160807560|NCT03640325|580682832|FG000|Overall Study|Death|5|||
160898601|NCT02155881|581023493|FG001|Overall Study|Inappropriately randomized|2|||
160898602|NCT02711345|581023494|FG000|Overall Study|Adverse Event|0|||
160898603|NCT02711345|581023495|FG001|Overall Study|Adverse Event|0|||
160898604|NCT02711345|581023496|FG002|Overall Study|Adverse Event|0|||
160898605|NCT02711345|581023497|FG003|Overall Study|Adverse Event|1|||
160898606|NCT02711345|581023498|FG004|Overall Study|Adverse Event|1|||
160898607|NCT02711345|581023499|FG005|Overall Study|Adverse Event|2|||
160898608|NCT02711345|581023500|FG006|Overall Study|Adverse Event|1|||
160898609|NCT02711345|581023501|FG007|Overall Study|Adverse Event|0|||
160898610|NCT02711345|581023502|FG008|Overall Study|Adverse Event|0|||
160898611|NCT02711345|581023503|FG009|Overall Study|Adverse Event|2|||
160898612|NCT02711345|581023494|FG000|Overall Study|Physician Decision|0|||
160898613|NCT02711345|581023495|FG001|Overall Study|Physician Decision|0|||
160898614|NCT02711345|581023496|FG002|Overall Study|Physician Decision|1|||
160898615|NCT02711345|581023497|FG003|Overall Study|Physician Decision|0|||
160898616|NCT02711345|581023498|FG004|Overall Study|Physician Decision|0|||
160898617|NCT02711345|581023499|FG005|Overall Study|Physician Decision|0|||
160898618|NCT02711345|581023500|FG006|Overall Study|Physician Decision|0|||
160898619|NCT02711345|581023501|FG007|Overall Study|Physician Decision|0|||
160898620|NCT02711345|581023502|FG008|Overall Study|Physician Decision|1|||
160898621|NCT02711345|581023503|FG009|Overall Study|Physician Decision|0|||
160898622|NCT02711345|581023494|FG000|Overall Study|Progressive disease|1|||
160898623|NCT02711345|581023495|FG001|Overall Study|Progressive disease|3|||
160898624|NCT02711345|581023496|FG002|Overall Study|Progressive disease|5|||
160898625|NCT02711345|581023497|FG003|Overall Study|Progressive disease|3|||
160898626|NCT02711345|581023498|FG004|Overall Study|Progressive disease|7|||
160898627|NCT02711345|581023499|FG005|Overall Study|Progressive disease|2|||
160898628|NCT02711345|581023500|FG006|Overall Study|Progressive disease|8|||
160898629|NCT02711345|581023501|FG007|Overall Study|Progressive disease|4|||
160898630|NCT02711345|581023502|FG008|Overall Study|Progressive disease|5|||
160898631|NCT02711345|581023503|FG009|Overall Study|Progressive disease|6|||
160898632|NCT02711345|581023494|FG000|Overall Study|Subject/guardian decision|0|||
160898633|NCT02711345|581023495|FG001|Overall Study|Subject/guardian decision|0|||
160898634|NCT02711345|581023496|FG002|Overall Study|Subject/guardian decision|0|||
160898635|NCT02711345|581023497|FG003|Overall Study|Subject/guardian decision|0|||
160898636|NCT02711345|581023498|FG004|Overall Study|Subject/guardian decision|0|||
160898637|NCT02711345|581023499|FG005|Overall Study|Subject/guardian decision|2|||
160898638|NCT02711345|581023500|FG006|Overall Study|Subject/guardian decision|3|||
160898639|NCT02711345|581023501|FG007|Overall Study|Subject/guardian decision|1|||
160898640|NCT02711345|581023502|FG008|Overall Study|Subject/guardian decision|0|||
160898641|NCT02711345|581023503|FG009|Overall Study|Subject/guardian decision|4|||
160898642|NCT02711345|581023494|FG000|Overall Study|Death|1|||
160898643|NCT02711345|581023495|FG001|Overall Study|Death|0|||
160898644|NCT02711345|581023496|FG002|Overall Study|Death|0|||
160898645|NCT02711345|581023497|FG003|Overall Study|Death|0|||
160898646|NCT02711345|581023498|FG004|Overall Study|Death|0|||
160898647|NCT02711345|581023499|FG005|Overall Study|Death|0|||
160898648|NCT02711345|581023500|FG006|Overall Study|Death|0|||
160898649|NCT02711345|581023501|FG007|Overall Study|Death|1|||
160898650|NCT02711345|581023502|FG008|Overall Study|Death|0|||
160898651|NCT02711345|581023503|FG009|Overall Study|Death|0|||
160898652|NCT04357782|581023504|FG000|Overall Study|Discharged from hospital|1|||
160898653|NCT04357782|581023505|FG001|Overall Study|Discharged from hospital|0|||
160898654|NCT04357782|581023504|FG000|Overall Study|Death|0|||
160898655|NCT04357782|581023505|FG001|Overall Study|Death|2|||
160898656|NCT01786148|581023506|FG000|Overall Study|Lost to Follow-up|21|||
160898657|NCT01786148|581023507|FG001|Overall Study|Lost to Follow-up|13|||
160898658|NCT01786148|581023506|FG000|Overall Study|Death|0|||
160898659|NCT01786148|581023507|FG001|Overall Study|Death|1|||
160898660|NCT01786148|581023506|FG000|Overall Study|Withdrawal by Subject|0|||
160898661|NCT01786148|581023507|FG001|Overall Study|Withdrawal by Subject|7|||
160898662|NCT01786148|581023506|FG000|Overall Study|Incarceration|1|||
160898663|NCT01786148|581023507|FG001|Overall Study|Incarceration|1|||
160898664|NCT03780543|581023509|FG000|Overall Study|Adverse Event|1|||
160898665|NCT03780543|581023510|FG001|Overall Study|Adverse Event|0|||
160898666|NCT03780543|581023511|FG002|Overall Study|Adverse Event|2|||
160898667|NCT03780543|581023509|FG000|Overall Study|Lost to Follow-up|2|||
160898668|NCT03780543|581023510|FG001|Overall Study|Lost to Follow-up|0|||
160898669|NCT03780543|581023511|FG002|Overall Study|Lost to Follow-up|1|||
160898670|NCT03780543|581023509|FG000|Overall Study|Study terminated by Sponsor|8|||
160898671|NCT03780543|581023510|FG001|Overall Study|Study terminated by Sponsor|7|||
160898672|NCT03780543|581023511|FG002|Overall Study|Study terminated by Sponsor|13|||
160898673|NCT03780543|581023509|FG000|Overall Study|Withdrawal by Subject|1|||
160898674|NCT03780543|581023510|FG001|Overall Study|Withdrawal by Subject|8|||
160898675|NCT03780543|581023511|FG002|Overall Study|Withdrawal by Subject|1|||
160985772|NCT01244763|581337011|FG001|Overall Study|Enrolled into the Extension Study|0|||
160985773|NCT01244763|581337012|FG002|Overall Study|Enrolled into the Extension Study|0|||
160985774|NCT01244763|581337013|FG003|Overall Study|Enrolled into the Extension Study|0|||
160985775|NCT01244763|581337014|FG004|Overall Study|Enrolled into the Extension Study|0|||
160985776|NCT01244763|581337015|FG005|Overall Study|Enrolled into the Extension Study|1|||
160985777|NCT02271594|581337016|FG000|Overall Study|Study closed; recruiting failure|19|||
160985778|NCT02271594|581337017|FG001|Overall Study|Study closed; recruiting failure|12|||
160985779|NCT03330119|581337020|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
160985780|NCT03330119|581337021|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
160985781|NCT01561079|581337022|FG000|Overall Study|Physician Decision|17|||
160985782|NCT01561079|581337022|FG000|Overall Study|Withdrawal by Subject|59|||
160985783|NCT01561079|581337022|FG000|Overall Study|Protocol Violation|2|||
160985784|NCT00550732|581337033|FG000|Overall Study|Death|4|||
160985785|NCT00550732|581337033|FG000|Overall Study|Withdrawal by Subject|2|||
160985786|NCT00550732|581337033|FG000|Overall Study|Physician Decision|2|||
160985787|NCT00550732|581337033|FG000|Overall Study|Lost to Follow-up|1|||
160985788|NCT00550732|581337033|FG000|Overall Study|Palliative care|1|||
160985789|NCT00550732|581337033|FG000|Overall Study|Adverse Event|1|||
160985790|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
160985791|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
160985792|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
160985793|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
160985794|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
160985795|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
160985796|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
160985797|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
160985798|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
160985799|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
160985800|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
160985801|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
160985802|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
160985803|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
160985804|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
160985805|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
160985806|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
160985807|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
160985808|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160985809|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160985810|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160985811|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160985812|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
160985813|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160985814|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160985815|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160985816|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160985817|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160985818|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160985819|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160985820|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
160985821|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160985822|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
160985823|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
160985824|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
160985825|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160985826|NCT01323660|581337035|FG000|Washout Period (14 Days)|Adverse Event|0|||
160985827|NCT01323660|581337036|FG001|Washout Period (14 Days)|Adverse Event|0|||
160985828|NCT01323660|581337037|FG002|Washout Period (14 Days)|Adverse Event|0|||
160985829|NCT01323660|581337038|FG003|Washout Period (14 Days)|Adverse Event|0|||
160985830|NCT01323660|581337039|FG004|Washout Period (14 Days)|Adverse Event|1|||
160985831|NCT01323660|581337040|FG005|Washout Period (14 Days)|Adverse Event|0|||
160985832|NCT01323660|581337035|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
160985833|NCT01323660|581337036|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
160985834|NCT01323660|581337037|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
160985835|NCT01323660|581337038|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
160985836|NCT01323660|581337039|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
160985837|NCT01323660|581337040|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
160985838|NCT01323660|581337035|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160985839|NCT01323660|581337036|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
160985840|NCT01323660|581337037|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
160898676|NCT03780543|581023509|FG000|Overall Study|Noncompliance with study drug|1|||
160898677|NCT03780543|581023510|FG001|Overall Study|Noncompliance with study drug|0|||
160898678|NCT03780543|581023511|FG002|Overall Study|Noncompliance with study drug|0|||
160898679|NCT01033851|581023512|FG000|Overall Study|Withdrawal by Subject|3|||
160898680|NCT01033851|581023513|FG001|Overall Study|Withdrawal by Subject|7|||
160898681|NCT00338104|581023514|FG000|Overall Study|Protocol Violation|2|||
160898682|NCT00338104|581023515|FG001|Overall Study|Protocol Violation|1|||
160898683|NCT00338104|581023516|FG002|Overall Study|Protocol Violation|3|||
160898684|NCT02362269|581023519|FG000|Overall Study|Moved|1|||
160898685|NCT02362269|581023520|FG001|Overall Study|Moved|0|||
160898686|NCT02362269|581023519|FG000|Overall Study|Lost to Follow-up|0|||
160898687|NCT02362269|581023520|FG001|Overall Study|Lost to Follow-up|6|||
160898688|NCT03841448|581023521|FG000|Double-blind Treatment (DBT) Period|Death|1|||
160898689|NCT03841448|581023522|FG001|Double-blind Treatment (DBT) Period|Death|1|||
160898690|NCT03841448|581023523|FG002|Double-blind Treatment (DBT) Period|Death|0|||
160898691|NCT03841448|581023524|FG003|Double-blind Treatment (DBT) Period|Death|0|||
160898692|NCT03841448|581023521|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
160898693|NCT03841448|581023522|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
160898694|NCT03841448|581023523|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
160898695|NCT03841448|581023524|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
160898696|NCT03841448|581023521|FG000|Open-Label Extension (OLE) Period|Death|0|||
160898697|NCT03841448|581023522|FG001|Open-Label Extension (OLE) Period|Death|0|||
160898698|NCT03841448|581023523|FG002|Open-Label Extension (OLE) Period|Death|0|||
160898699|NCT03841448|581023524|FG003|Open-Label Extension (OLE) Period|Death|1|||
160898700|NCT03841448|581023521|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
160898701|NCT03841448|581023522|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
160898702|NCT03841448|581023523|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
160898703|NCT03841448|581023524|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
160898704|NCT03841448|581023521|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
160898705|NCT03841448|581023522|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
160898706|NCT03841448|581023523|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
160898707|NCT03841448|581023524|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
160898708|NCT03841448|581023521|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
160898709|NCT03841448|581023522|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
160898710|NCT03841448|581023523|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
160898711|NCT03841448|581023524|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
160898712|NCT04068610|581023525|FG000|Overall Study|Death|4|||
160898713|NCT04068610|581023526|FG001|Overall Study|Death|8|||
160898714|NCT04068610|581023527|FG002|Overall Study|Death|13|||
160898715|NCT04068610|581023525|FG000|Overall Study|Lost to Follow-up|0|||
160898716|NCT04068610|581023526|FG001|Overall Study|Lost to Follow-up|2|||
160898717|NCT04068610|581023527|FG002|Overall Study|Lost to Follow-up|0|||
160898718|NCT04068610|581023525|FG000|Overall Study|Withdrawal by Subject|0|||
160898719|NCT04068610|581023526|FG001|Overall Study|Withdrawal by Subject|4|||
160898720|NCT04068610|581023527|FG002|Overall Study|Withdrawal by Subject|2|||
160898721|NCT04068610|581023525|FG000|Overall Study|Other|3|||
160898722|NCT04068610|581023526|FG001|Overall Study|Other|12|||
160898723|NCT04068610|581023527|FG002|Overall Study|Other|11|||
160898724|NCT00072176|581023528|FG000|Overall Study|Withdrawal by Subject|1|||
160898725|NCT00072176|581023529|FG001|Overall Study|Withdrawal by Subject|0|||
160898726|NCT00072176|581023528|FG000|Overall Study|Protocol Violation|0|||
160898727|NCT00072176|581023529|FG001|Overall Study|Protocol Violation|1|||
160898728|NCT02586064|581023530|FG000|Overall Study|Other Obligations|6|||
160898729|NCT02586064|581023531|FG001|Overall Study|Other Obligations|6|||
160898730|NCT02586064|581023530|FG000|Overall Study|Other|3|||
160898731|NCT02586064|581023531|FG001|Overall Study|Other|7|||
160898732|NCT02586064|581023530|FG000|Overall Study|Never Started|3|||
160898733|NCT02586064|581023531|FG001|Overall Study|Never Started|3|||
160985841|NCT01323660|581337038|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160985842|NCT01323660|581337039|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160985843|NCT01323660|581337040|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
160985844|NCT01323660|581337035|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
160985845|NCT01323660|581337036|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
160985846|NCT01323660|581337037|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
160985847|NCT01323660|581337038|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
160985848|NCT01323660|581337039|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
160985849|NCT01323660|581337040|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
160898734|NCT02586064|581023530|FG000|Overall Study|Lost Interest|1|||
160898735|NCT02586064|581023531|FG001|Overall Study|Lost Interest|4|||
160898736|NCT02586064|581023530|FG000|Overall Study|Miscellaneous Life Issues|0|||
160898737|NCT02586064|581023531|FG001|Overall Study|Miscellaneous Life Issues|5|||
160985850|NCT01323660|581337035|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
160985851|NCT01323660|581337036|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
160898738|NCT02586064|581023530|FG000|Overall Study|Infrequent Attendance|2|||
160551241|NCT00352534|579744118|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
160551242|NCT00352534|579744119|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
160551243|NCT00352534|579744120|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
160551244|NCT00352534|579744121|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
160551245|NCT00352534|579744115|FG000|Final Risk Group Assignment|Physician Decision|0|||
160551246|NCT00352534|579744116|FG001|Final Risk Group Assignment|Physician Decision|0|||
160807561|NCT03640325|580682833|FG001|Overall Study|Death|5|||
160807562|NCT03640325|580682834|FG002|Overall Study|Death|0|||
160807563|NCT05265728|580682835|FG000|Overall Study|Adverse Event|1|||
160807564|NCT05265728|580682835|FG000|Overall Study|Study Terminated by Sponsor|5|||
160807565|NCT05265728|580682835|FG000|Overall Study|Withdrawal by Subject|2|||
160807566|NCT03493451|580682836|FG000|Overall Study|Death|11|||
160807567|NCT03493451|580682837|FG001|Overall Study|Death|26|||
160807568|NCT03493451|580682838|FG002|Overall Study|Death|3|||
160807569|NCT03493451|580682836|FG000|Overall Study|Lost to Follow-up|1|||
160807570|NCT03493451|580682837|FG001|Overall Study|Lost to Follow-up|4|||
160807571|NCT03493451|580682838|FG002|Overall Study|Lost to Follow-up|1|||
160807572|NCT03493451|580682836|FG000|Overall Study|Withdrawal by Subject|1|||
160807573|NCT03493451|580682837|FG001|Overall Study|Withdrawal by Subject|1|||
160807574|NCT03493451|580682838|FG002|Overall Study|Withdrawal by Subject|2|||
160807575|NCT03493451|580682836|FG000|Overall Study|Progressive Disease|1|||
160807576|NCT03493451|580682837|FG001|Overall Study|Progressive Disease|0|||
160807577|NCT03493451|580682838|FG002|Overall Study|Progressive Disease|0|||
160807578|NCT03493451|580682836|FG000|Overall Study|Transferred to long term extension study|8|||
160807579|NCT03493451|580682837|FG001|Overall Study|Transferred to long term extension study|13|||
160807580|NCT03493451|580682838|FG002|Overall Study|Transferred to long term extension study|5|||
160807581|NCT01566149|580682841|FG000|Overall Study|Adverse Event|0|||
160898739|NCT02586064|581023531|FG001|Overall Study|Infrequent Attendance|1|||
160898740|NCT02586064|581023530|FG000|Overall Study|Timed Out|2|||
160898741|NCT02586064|581023531|FG001|Overall Study|Timed Out|0|||
160898742|NCT02586064|581023530|FG000|Overall Study|AUD relapse|0|||
160898743|NCT02586064|581023531|FG001|Overall Study|AUD relapse|2|||
160898744|NCT02586064|581023530|FG000|Overall Study|Legal Issue|1|||
160898745|NCT02586064|581023531|FG001|Overall Study|Legal Issue|0|||
160898746|NCT02158975|581023532|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
160898747|NCT00484094|581023533|FG000|Overall Study|Discontinued|39|||
160898748|NCT00484094|581023533|FG000|Overall Study|Other|3|||
160898749|NCT02728596|581023534|FG000|Overall Study|Refusal unrelated to adverse event|3|||
160898750|NCT02728596|581023535|FG001|Overall Study|Refusal unrelated to adverse event|6|||
160898751|NCT02728596|581023536|FG002|Overall Study|Refusal unrelated to adverse event|7|||
160898752|NCT02728596|581023537|FG003|Overall Study|Refusal unrelated to adverse event|7|||
160898753|NCT02728596|581023534|FG000|Overall Study|Death|44|||
160898754|NCT02728596|581023535|FG001|Overall Study|Death|42|||
160898755|NCT02728596|581023536|FG002|Overall Study|Death|123|||
160898756|NCT02728596|581023537|FG003|Overall Study|Death|68|||
160898757|NCT00309985|581023538|FG000|Overall Study|Disease progression|12|||
160898758|NCT00309985|581023539|FG001|Overall Study|Disease progression|0|||
160898759|NCT00309985|581023538|FG000|Overall Study|Adverse Event|30|||
160898760|NCT00309985|581023539|FG001|Overall Study|Adverse Event|0|||
160985852|NCT01323660|581337037|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
160807582|NCT01566149|580682842|FG001|Overall Study|Adverse Event|1|||
160807583|NCT01566149|580682841|FG000|Overall Study|Non-compliance with study medication|2|||
160807584|NCT01566149|580682842|FG001|Overall Study|Non-compliance with study medication|0|||
160807585|NCT01566149|580682841|FG000|Overall Study|Protocol Violation|0|||
160807586|NCT01566149|580682842|FG001|Overall Study|Protocol Violation|1|||
160807587|NCT01566149|580682841|FG000|Overall Study|Withdrawal by Subject|1|||
160807588|NCT01566149|580682842|FG001|Overall Study|Withdrawal by Subject|0|||
160807589|NCT03687957|580682847|FG000|Overall Study|Withdrawal by Subject|0|||
160807590|NCT03687957|580682848|FG001|Overall Study|Withdrawal by Subject|0|||
160807591|NCT03687957|580682849|FG002|Overall Study|Withdrawal by Subject|0|||
160807592|NCT03687957|580682850|FG003|Overall Study|Withdrawal by Subject|2|||
160807593|NCT03687957|580682851|FG004|Overall Study|Withdrawal by Subject|0|||
160807594|NCT03687957|580682852|FG005|Overall Study|Withdrawal by Subject|0|||
160898761|NCT00309985|581023538|FG000|Overall Study|Death|2|||
160898762|NCT00309985|581023539|FG001|Overall Study|Death|0|||
160985853|NCT01323660|581337038|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
160807595|NCT03687957|580682853|FG006|Overall Study|Withdrawal by Subject|3|||
160807596|NCT03687957|580682854|FG007|Overall Study|Withdrawal by Subject|1|||
160807597|NCT03687957|580682855|FG008|Overall Study|Withdrawal by Subject|1|||
160898763|NCT00309985|581023538|FG000|Overall Study|Withdrawal by Subject|5|||
160551247|NCT00352534|579744117|FG002|Final Risk Group Assignment|Physician Decision|0|||
160898764|NCT00309985|581023539|FG001|Overall Study|Withdrawal by Subject|1|||
160898765|NCT00309985|581023538|FG000|Overall Study|Physician Decision|3|||
160898766|NCT00309985|581023539|FG001|Overall Study|Physician Decision|0|||
160898767|NCT00309985|581023538|FG000|Overall Study|Never started treatment|7|||
160898768|NCT00309985|581023539|FG001|Overall Study|Never started treatment|0|||
160898769|NCT00309985|581023538|FG000|Overall Study|Complicating disease|1|||
160985854|NCT01323660|581337039|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
160985855|NCT01323660|581337040|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
160644636|NCT01759537|580080806|FG001|Overall Study|Accident involving jaw fracture|1|||
160644637|NCT01759537|580080805|FG000|Overall Study|Subcrestal implant too coronal|1|||
160644638|NCT01759537|580080806|FG001|Overall Study|Subcrestal implant too coronal|1|||
160644639|NCT00420290|580080807|FG000|Overall Study|Adverse Event|3|||
160644640|NCT00420290|580080808|FG001|Overall Study|Adverse Event|1|||
160644641|NCT00420290|580080807|FG000|Overall Study|Withdrawal by Subject|0|||
160644642|NCT00420290|580080808|FG001|Overall Study|Withdrawal by Subject|2|||
160644643|NCT00420290|580080807|FG000|Overall Study|did not meet inclusion/exclusion|1|||
160644644|NCT00420290|580080808|FG001|Overall Study|did not meet inclusion/exclusion|1|||
160807598|NCT03687957|580682856|FG009|Overall Study|Withdrawal by Subject|0|||
160807599|NCT03687957|580682847|FG000|Overall Study|Disease progression|0|||
160807600|NCT03687957|580682848|FG001|Overall Study|Disease progression|1|||
160807601|NCT03687957|580682849|FG002|Overall Study|Disease progression|1|||
160807602|NCT03687957|580682850|FG003|Overall Study|Disease progression|2|||
160807603|NCT03687957|580682851|FG004|Overall Study|Disease progression|2|||
160807604|NCT03687957|580682852|FG005|Overall Study|Disease progression|0|||
160807605|NCT03687957|580682853|FG006|Overall Study|Disease progression|2|||
160807606|NCT03687957|580682854|FG007|Overall Study|Disease progression|1|||
160807607|NCT03687957|580682855|FG008|Overall Study|Disease progression|0|||
160807608|NCT03687957|580682856|FG009|Overall Study|Disease progression|0|||
160807609|NCT03687957|580682847|FG000|Overall Study|Physician Decision|0|||
160807610|NCT03687957|580682848|FG001|Overall Study|Physician Decision|0|||
160807611|NCT03687957|580682849|FG002|Overall Study|Physician Decision|0|||
160807612|NCT03687957|580682850|FG003|Overall Study|Physician Decision|2|||
160807613|NCT03687957|580682851|FG004|Overall Study|Physician Decision|1|||
160807614|NCT03687957|580682852|FG005|Overall Study|Physician Decision|0|||
160807615|NCT03687957|580682853|FG006|Overall Study|Physician Decision|1|||
160807616|NCT03687957|580682854|FG007|Overall Study|Physician Decision|0|||
160807617|NCT03687957|580682855|FG008|Overall Study|Physician Decision|0|||
160807618|NCT03687957|580682856|FG009|Overall Study|Physician Decision|0|||
160807619|NCT03687957|580682847|FG000|Overall Study|New malignancy|0|||
160807620|NCT03687957|580682848|FG001|Overall Study|New malignancy|0|||
160807621|NCT03687957|580682849|FG002|Overall Study|New malignancy|0|||
160807622|NCT03687957|580682850|FG003|Overall Study|New malignancy|0|||
160807623|NCT03687957|580682851|FG004|Overall Study|New malignancy|1|||
160807624|NCT03687957|580682852|FG005|Overall Study|New malignancy|0|||
160807625|NCT03687957|580682853|FG006|Overall Study|New malignancy|0|||
160807626|NCT03687957|580682854|FG007|Overall Study|New malignancy|0|||
160807627|NCT03687957|580682855|FG008|Overall Study|New malignancy|0|||
160807628|NCT03687957|580682856|FG009|Overall Study|New malignancy|0|||
160807629|NCT03687957|580682847|FG000|Overall Study|Adverse Event|0|||
160807630|NCT03687957|580682848|FG001|Overall Study|Adverse Event|0|||
160807631|NCT03687957|580682849|FG002|Overall Study|Adverse Event|0|||
160807632|NCT03687957|580682850|FG003|Overall Study|Adverse Event|0|||
160807633|NCT03687957|580682851|FG004|Overall Study|Adverse Event|0|||
160807634|NCT03687957|580682852|FG005|Overall Study|Adverse Event|2|||
160807635|NCT03687957|580682853|FG006|Overall Study|Adverse Event|0|||
160807636|NCT03687957|580682854|FG007|Overall Study|Adverse Event|3|||
160807637|NCT03687957|580682855|FG008|Overall Study|Adverse Event|0|||
160807638|NCT03687957|580682856|FG009|Overall Study|Adverse Event|0|||
160807639|NCT03687957|580682847|FG000|Overall Study|Patient went on hospice|0|||
160807640|NCT03687957|580682848|FG001|Overall Study|Patient went on hospice|0|||
160807641|NCT03687957|580682849|FG002|Overall Study|Patient went on hospice|0|||
160807642|NCT03687957|580682850|FG003|Overall Study|Patient went on hospice|0|||
160807643|NCT03687957|580682851|FG004|Overall Study|Patient went on hospice|0|||
160807644|NCT03687957|580682852|FG005|Overall Study|Patient went on hospice|0|||
160807645|NCT03687957|580682853|FG006|Overall Study|Patient went on hospice|1|||
160807646|NCT03687957|580682854|FG007|Overall Study|Patient went on hospice|0|||
160807647|NCT03687957|580682855|FG008|Overall Study|Patient went on hospice|0|||
160807648|NCT03687957|580682856|FG009|Overall Study|Patient went on hospice|0|||
160807649|NCT03687957|580682847|FG000|Overall Study|Death|0|||
160807650|NCT03687957|580682848|FG001|Overall Study|Death|0|||
160807651|NCT03687957|580682849|FG002|Overall Study|Death|0|||
160807652|NCT03687957|580682850|FG003|Overall Study|Death|0|||
160807653|NCT03687957|580682851|FG004|Overall Study|Death|0|||
160807654|NCT03687957|580682852|FG005|Overall Study|Death|0|||
160807655|NCT03687957|580682853|FG006|Overall Study|Death|0|||
160807656|NCT03687957|580682854|FG007|Overall Study|Death|1|||
160807657|NCT03687957|580682855|FG008|Overall Study|Death|0|||
160807658|NCT03687957|580682856|FG009|Overall Study|Death|0|||
160807659|NCT00617084|580682857|FG000|Overall Study|Withdrawal by Subject|5|||
160807660|NCT00617084|580682858|FG001|Overall Study|Withdrawal by Subject|7|||
160985856|NCT01323660|581337035|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
160807661|NCT00617084|580682857|FG000|Overall Study|Missed 12 Months visit|16|||
160807662|NCT00617084|580682858|FG001|Overall Study|Missed 12 Months visit|19|||
160807663|NCT01693250|580682859|FG000|Overall Study|Lost to Follow-up|2|||
160898770|NCT00309985|581023539|FG001|Overall Study|Complicating disease|0|||
160898771|NCT00309985|581023538|FG000|Overall Study|Non-compliance|1|||
160898772|NCT00309985|581023539|FG001|Overall Study|Non-compliance|0|||
160898773|NCT00309985|581023538|FG000|Overall Study|Chemotherapy discontinued only|1|||
160898774|NCT00309985|581023539|FG001|Overall Study|Chemotherapy discontinued only|0|||
160898775|NCT03672643|581023540|FG000|Overall Study|Adverse Event|3|||
160898776|NCT03672643|581023540|FG000|Overall Study|Death|2|||
160898777|NCT03672643|581023540|FG000|Overall Study|Withdrawal by Subject|1|||
160898778|NCT03672643|581023540|FG000|Overall Study|Progressive disease|11|||
160898779|NCT03672643|581023540|FG000|Overall Study|Global deterioration of health status|1|||
160898780|NCT03672643|581023540|FG000|Overall Study|Refused further treatment|7|||
160898781|NCT03672643|581023540|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
160898782|NCT04102189|581023541|FG000|Overall Study|Withdrawal by Subject|1|||
160898783|NCT04102189|581023542|FG001|Overall Study|Withdrawal by Subject|2|||
160898784|NCT04102189|581023541|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160898785|NCT04102189|581023542|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160898786|NCT04102189|581023541|FG000|Overall Study|Lost to Follow-up|1|||
160898787|NCT04102189|581023542|FG001|Overall Study|Lost to Follow-up|0|||
160898788|NCT00217620|581024702|FG000|Overall Study|Adverse Event|2|||
160898789|NCT00217620|581024702|FG000|Overall Study|Progression|31|||
160898790|NCT00217620|581024702|FG000|Overall Study|Not Protocol Specified|4|||
160898791|NCT00217620|581024702|FG000|Overall Study|Ineligible|13|||
160898792|NCT00217620|581024702|FG000|Overall Study|Never received treatment|1|||
160898793|NCT01314703|581024712|FG000|Overall Study|screen failure and closed enrollment|8|||
160898794|NCT01863953|581024713|FG000|Overall Study|Adverse Event|0|||
160898795|NCT01863953|581024714|FG001|Overall Study|Adverse Event|0|||
160898796|NCT01863953|581024715|FG002|Overall Study|Adverse Event|1|||
160898797|NCT02008318|581024721|FG000|Overall Study|Adverse Event|4|||
160898798|NCT02008318|581024722|FG001|Overall Study|Adverse Event|0|||
160898799|NCT02008318|581024721|FG000|Overall Study|Physician Decision|2|||
160898800|NCT02008318|581024722|FG001|Overall Study|Physician Decision|0|||
160898801|NCT02008318|581024721|FG000|Overall Study|Progressive Disease|2|||
160898802|NCT02008318|581024722|FG001|Overall Study|Progressive Disease|0|||
160898803|NCT02008318|581024721|FG000|Overall Study|Protocol Violation|1|||
160898804|NCT02008318|581024722|FG001|Overall Study|Protocol Violation|1|||
160898805|NCT02008318|581024721|FG000|Overall Study|Withdrawal by Subject|3|||
160898806|NCT02008318|581024722|FG001|Overall Study|Withdrawal by Subject|0|||
160898807|NCT02281773|581024723|FG000|Overall Study|Adverse Event|6|||
160898808|NCT02281773|581024724|FG001|Overall Study|Adverse Event|1|||
160898809|NCT02281773|581024725|FG002|Overall Study|Adverse Event|4|||
160898810|NCT02281773|581024726|FG003|Overall Study|Adverse Event|8|||
160898811|NCT02281773|581024727|FG004|Overall Study|Adverse Event|9|||
160898812|NCT02281773|581024723|FG000|Overall Study|Protocol Violation|1|||
160898813|NCT02281773|581024724|FG001|Overall Study|Protocol Violation|0|||
160898814|NCT02281773|581024725|FG002|Overall Study|Protocol Violation|0|||
160898815|NCT02281773|581024726|FG003|Overall Study|Protocol Violation|2|||
160898816|NCT02281773|581024727|FG004|Overall Study|Protocol Violation|2|||
160898817|NCT02281773|581024723|FG000|Overall Study|Lost to Follow-up|2|||
160898818|NCT02281773|581024724|FG001|Overall Study|Lost to Follow-up|2|||
160898819|NCT02281773|581024725|FG002|Overall Study|Lost to Follow-up|6|||
160898820|NCT02281773|581024726|FG003|Overall Study|Lost to Follow-up|2|||
160898821|NCT02281773|581024727|FG004|Overall Study|Lost to Follow-up|10|||
160898822|NCT02281773|581024723|FG000|Overall Study|Withdrawal by Subject|2|||
160898823|NCT02281773|581024724|FG001|Overall Study|Withdrawal by Subject|8|||
160898824|NCT02281773|581024725|FG002|Overall Study|Withdrawal by Subject|6|||
160898825|NCT02281773|581024726|FG003|Overall Study|Withdrawal by Subject|6|||
160898826|NCT02281773|581024727|FG004|Overall Study|Withdrawal by Subject|8|||
160898827|NCT02281773|581024723|FG000|Overall Study|Other Reason|0|||
160898828|NCT02281773|581024724|FG001|Overall Study|Other Reason|4|||
160898829|NCT02281773|581024725|FG002|Overall Study|Other Reason|2|||
160898830|NCT02281773|581024726|FG003|Overall Study|Other Reason|3|||
160898831|NCT02281773|581024727|FG004|Overall Study|Other Reason|1|||
160898832|NCT00385762|581024728|FG000|Overall Study|Adverse Event|1|||
160985857|NCT01323660|581337036|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
160898833|NCT00385762|581024728|FG000|Overall Study|Lost to Follow-up|1|||
160898834|NCT05439941|581024729|FG000|Overall Study|Lack of Efficacy|8|||
160898835|NCT05439941|581024730|FG001|Overall Study|Lack of Efficacy|5|||
160898836|NCT05439941|581024731|FG002|Overall Study|Lack of Efficacy|3|||
160898837|NCT05439941|581024729|FG000|Overall Study|Treatment Failure|0|||
160898838|NCT05439941|581024730|FG001|Overall Study|Treatment Failure|1|||
160898839|NCT05439941|581024731|FG002|Overall Study|Treatment Failure|0|||
160898840|NCT05439941|581024729|FG000|Overall Study|Adverse Event|1|||
160898841|NCT05439941|581024730|FG001|Overall Study|Adverse Event|3|||
160898842|NCT05439941|581024731|FG002|Overall Study|Adverse Event|0|||
160898843|NCT05439941|581024729|FG000|Overall Study|Adverse Event - Parent Study|1|||
160898844|NCT05439941|581024730|FG001|Overall Study|Adverse Event - Parent Study|0|||
160898845|NCT05439941|581024731|FG002|Overall Study|Adverse Event - Parent Study|0|||
160898846|NCT05439941|581024729|FG000|Overall Study|Pregnancy|1|||
160898847|NCT05439941|581024730|FG001|Overall Study|Pregnancy|0|||
160898848|NCT05439941|581024731|FG002|Overall Study|Pregnancy|0|||
160898849|NCT05439941|581024729|FG000|Overall Study|Withdrawal by Subject|9|||
160898850|NCT05439941|581024730|FG001|Overall Study|Withdrawal by Subject|6|||
160898851|NCT05439941|581024731|FG002|Overall Study|Withdrawal by Subject|10|||
160898852|NCT05439941|581024729|FG000|Overall Study|Non-Compliance|1|||
160898853|NCT05439941|581024730|FG001|Overall Study|Non-Compliance|1|||
160898854|NCT05439941|581024731|FG002|Overall Study|Non-Compliance|1|||
160898855|NCT05439941|581024729|FG000|Overall Study|Lost to Follow-up|2|||
160898856|NCT05439941|581024730|FG001|Overall Study|Lost to Follow-up|2|||
160898857|NCT05439941|581024731|FG002|Overall Study|Lost to Follow-up|0|||
160898858|NCT05439941|581024729|FG000|Overall Study|Physician Decision|1|||
160898859|NCT05439941|581024730|FG001|Overall Study|Physician Decision|0|||
160898860|NCT05439941|581024731|FG002|Overall Study|Physician Decision|0|||
160898861|NCT05439941|581024729|FG000|Overall Study|Trial Termination by Sponsor|78|||
160898862|NCT05439941|581024730|FG001|Overall Study|Trial Termination by Sponsor|83|||
160898863|NCT05439941|581024731|FG002|Overall Study|Trial Termination by Sponsor|65|||
160898864|NCT05439941|581024729|FG000|Overall Study|Other than Reasons Listed|2|||
160898865|NCT05439941|581024730|FG001|Overall Study|Other than Reasons Listed|1|||
160898866|NCT05439941|581024731|FG002|Overall Study|Other than Reasons Listed|0|||
160898867|NCT00573183|581024732|FG000|Overall Study|Lost to Follow-up|52|||
160898868|NCT00573183|581024733|FG001|Overall Study|Lost to Follow-up|50|||
160898869|NCT00573183|581024732|FG000|Overall Study|Withdrawal by Subject|8|||
160898870|NCT00573183|581024733|FG001|Overall Study|Withdrawal by Subject|2|||
160898871|NCT00573183|581024732|FG000|Overall Study|Death|0|||
160898872|NCT00573183|581024733|FG001|Overall Study|Death|1|||
160898873|NCT00573183|581024732|FG000|Overall Study|Adverse Event|2|||
160898874|NCT00573183|581024733|FG001|Overall Study|Adverse Event|0|||
160898875|NCT00573183|581024732|FG000|Overall Study|Incarceration|5|||
160898876|NCT00573183|581024733|FG001|Overall Study|Incarceration|8|||
160898877|NCT00573183|581024732|FG000|Overall Study|Other|5|||
160898878|NCT00573183|581024733|FG001|Overall Study|Other|2|||
160898879|NCT02336373|581024736|FG000|Overall Study|Protocol closed early|4|||
160898880|NCT02336373|581024736|FG000|Overall Study|Physician Decision|14|||
160898881|NCT04798781|581024741|FG000|Overall Study|Withdrawal by Subject|1|||
160898882|NCT00615108|581024744|FG000|Overall Study|Adverse Event|122|||
160898883|NCT00615108|581024744|FG000|Overall Study|Other|370|||
160898884|NCT00615108|581024744|FG000|Overall Study|Lost to Follow-up|15|||
160898885|NCT00875979|581024745|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
160898886|NCT00875979|581024746|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
160898887|NCT00875979|581024745|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
160898888|NCT00875979|581024746|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
160898889|NCT00875979|581024745|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
160898890|NCT00875979|581024746|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
160898891|NCT00875979|581024745|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
160898892|NCT00875979|581024746|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
160898893|NCT00875979|581024745|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
160898894|NCT00875979|581024746|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
160898895|NCT00875979|581024745|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
160898896|NCT00875979|581024746|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
160898897|NCT00875979|581024745|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
160898898|NCT00875979|581024746|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
160898899|NCT00875979|581024745|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
160898900|NCT00875979|581024746|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
160898901|NCT00875979|581024745|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
160898902|NCT00875979|581024746|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
160898903|NCT04041375|581024747|FG000|Intervention Phase|Withdrawal by Subject|2|||
160898904|NCT04041375|581024748|FG001|Intervention Phase|Withdrawal by Subject|2|||
160898905|NCT04041375|581024747|FG000|Follow-up Phase|Death|2|||
160898906|NCT04041375|581024748|FG001|Follow-up Phase|Death|0|||
160898907|NCT04041375|581024747|FG000|Follow-up Phase|Lost to Follow-up|2|||
160898908|NCT04041375|581024748|FG001|Follow-up Phase|Lost to Follow-up|1|||
160898909|NCT04041375|581024747|FG000|Follow-up Phase|Too ill|3|||
160898910|NCT04041375|581024748|FG001|Follow-up Phase|Too ill|0|||
160898911|NCT02404220|581024754|FG000|Overall Study|Adverse Event|0|||
160898912|NCT02404220|581024755|FG001|Overall Study|Adverse Event|0|||
160898913|NCT02404220|581024756|FG002|Overall Study|Adverse Event|1|||
160898914|NCT02404220|581024757|FG003|Overall Study|Adverse Event|0|||
160898915|NCT02404220|581024754|FG000|Overall Study|Death|5|||
160898916|NCT02404220|581024755|FG001|Overall Study|Death|5|||
160898917|NCT02404220|581024756|FG002|Overall Study|Death|3|||
160898918|NCT02404220|581024757|FG003|Overall Study|Death|8|||
160898919|NCT02404220|581024754|FG000|Overall Study|Progressive Disease|0|||
160898920|NCT02404220|581024755|FG001|Overall Study|Progressive Disease|0|||
160898921|NCT02404220|581024756|FG002|Overall Study|Progressive Disease|1|||
160898922|NCT02404220|581024757|FG003|Overall Study|Progressive Disease|1|||
160898923|NCT02404220|581024754|FG000|Overall Study|Study Terminated by Sponsor|0|||
160898924|NCT02404220|581024755|FG001|Overall Study|Study Terminated by Sponsor|0|||
160898925|NCT02404220|581024756|FG002|Overall Study|Study Terminated by Sponsor|2|||
160898926|NCT02404220|581024757|FG003|Overall Study|Study Terminated by Sponsor|1|||
160898927|NCT02404220|581024754|FG000|Overall Study|Withdrawal by Subject|0|||
160898928|NCT02404220|581024755|FG001|Overall Study|Withdrawal by Subject|1|||
160898929|NCT02404220|581024756|FG002|Overall Study|Withdrawal by Subject|0|||
160898930|NCT02404220|581024757|FG003|Overall Study|Withdrawal by Subject|0|||
160898931|NCT02404220|581024754|FG000|Overall Study|Enrolled but Never Treated|0|||
160898932|NCT02404220|581024755|FG001|Overall Study|Enrolled but Never Treated|2|||
160898933|NCT02404220|581024756|FG002|Overall Study|Enrolled but Never Treated|0|||
160898934|NCT02404220|581024757|FG003|Overall Study|Enrolled but Never Treated|0|||
160898935|NCT00395733|581024758|FG000|Period 2|Withdrawal by Subject|1|||
160898936|NCT00395733|581024759|FG001|Period 2|Withdrawal by Subject|2|||
160898937|NCT00395733|581024758|FG000|Period 2|Protocol Violation|0|||
160898938|NCT00395733|581024759|FG001|Period 2|Protocol Violation|1|||
160898939|NCT00395733|581024758|FG000|Period 2|Adverse Event|0|||
160898940|NCT00395733|581024759|FG001|Period 2|Adverse Event|2|||
160898941|NCT00395733|581024758|FG000|Period 2|Technical problems|1|||
160898942|NCT00395733|581024759|FG001|Period 2|Technical problems|0|||
160898943|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
160898944|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
160898945|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Death|1|||
160898946|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Death|0|||
160898947|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
160898948|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
160898949|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
160898950|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
160898951|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
160898952|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
160898953|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
160898954|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
160898955|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
160898956|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
160898957|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
160898958|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
160898959|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
160898960|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
160898961|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
160898962|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
160898963|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
160898964|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
160898965|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
160898966|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
160898967|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
160898968|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
160898969|NCT02927262|581024762|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
160898970|NCT02927262|581024763|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
160898971|NCT02927262|581024762|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
160898972|NCT02927262|581024763|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
160898973|NCT02927262|581024762|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
160898974|NCT02927262|581024763|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
160898975|NCT02345226|581024768|FG000|Double-Blind Phase|Adverse Event|5|||
160898976|NCT02345226|581024769|FG001|Double-Blind Phase|Adverse Event|6|||
160898977|NCT02345226|581024768|FG000|Double-Blind Phase|Death|3|||
160898978|NCT02345226|581024769|FG001|Double-Blind Phase|Death|0|||
160898979|NCT02345226|581024768|FG000|Double-Blind Phase|Pregnancy|0|||
160898980|NCT02345226|581024769|FG001|Double-Blind Phase|Pregnancy|1|||
160898981|NCT02345226|581024768|FG000|Double-Blind Phase|Lack of Efficacy|1|||
160898982|NCT02345226|581024769|FG001|Double-Blind Phase|Lack of Efficacy|0|||
160898983|NCT02345226|581024768|FG000|Double-Blind Phase|Investigator's Discretion|4|||
160898984|NCT02345226|581024769|FG001|Double-Blind Phase|Investigator's Discretion|3|||
160898985|NCT02345226|581024768|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
160985858|NCT01323660|581337037|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
160898986|NCT02345226|581024769|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
160898987|NCT02345226|581024768|FG000|Double-Blind Phase|Withdrew Consent|41|||
160985859|NCT01323660|581337038|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
160898988|NCT02345226|581024769|FG001|Double-Blind Phase|Withdrew Consent|39|||
160898989|NCT02345226|581024768|FG000|Double-Blind Phase|Lost to Follow-up|12|||
160898990|NCT02345226|581024769|FG001|Double-Blind Phase|Lost to Follow-up|16|||
160898991|NCT02345226|581024768|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
160898992|NCT02345226|581024769|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
160898993|NCT02345226|581024768|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
160898994|NCT02345226|581024769|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
160898995|NCT03386474|581024770|FG000|Overall Study|Death|1|||
160898996|NCT03386474|581024771|FG001|Overall Study|Death|0|||
160898997|NCT03386474|581024770|FG000|Overall Study|Adverse Event|0|||
160898998|NCT03386474|581024771|FG001|Overall Study|Adverse Event|1|||
160898999|NCT03896165|581024774|FG000|Overall Study|Withdrawal by Subject|2|||
160899000|NCT01163266|581024775|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
160899001|NCT01163266|581024776|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
160899002|NCT01163266|581024777|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
160899003|NCT01163266|581024775|FG000|Overall Study|Lack of Efficacy|1|||
160899004|NCT01163266|581024776|FG001|Overall Study|Lack of Efficacy|3|||
160899005|NCT01163266|581024777|FG002|Overall Study|Lack of Efficacy|1|||
160899006|NCT01163266|581024775|FG000|Overall Study|Noncompliance with Study Drug|0|||
160899007|NCT01163266|581024776|FG001|Overall Study|Noncompliance with Study Drug|2|||
160899008|NCT01163266|581024777|FG002|Overall Study|Noncompliance with Study Drug|0|||
160899009|NCT01163266|581024775|FG000|Overall Study|Protocol Deviations|2|||
160899010|NCT01163266|581024776|FG001|Overall Study|Protocol Deviations|2|||
160899011|NCT01163266|581024777|FG002|Overall Study|Protocol Deviations|5|||
160899012|NCT01163266|581024775|FG000|Overall Study|Withdrawal of Consent|5|||
160899013|NCT01163266|581024776|FG001|Overall Study|Withdrawal of Consent|7|||
160899014|NCT01163266|581024777|FG002|Overall Study|Withdrawal of Consent|3|||
160899015|NCT01163266|581024775|FG000|Overall Study|Lost to Follow-up|7|||
160899016|NCT01163266|581024776|FG001|Overall Study|Lost to Follow-up|7|||
160899017|NCT01163266|581024777|FG002|Overall Study|Lost to Follow-up|10|||
160899018|NCT01163266|581024775|FG000|Overall Study|Other|1|||
160899019|NCT01163266|581024776|FG001|Overall Study|Other|1|||
160899020|NCT01163266|581024777|FG002|Overall Study|Other|2|||
160899021|NCT02919696|581024778|FG000|Overall Study|Adverse Event|1|||
160899022|NCT02919696|581024779|FG001|Overall Study|Adverse Event|2|||
160899023|NCT02919696|581024778|FG000|Overall Study|Withdrawal by Subject|2|||
160899024|NCT02919696|581024779|FG001|Overall Study|Withdrawal by Subject|1|||
160899025|NCT02919696|581024778|FG000|Overall Study|Sponsor Decision|1|||
160899026|NCT02919696|581024779|FG001|Overall Study|Sponsor Decision|1|||
160899027|NCT02919696|581024778|FG000|Overall Study|Never Treated|0|||
160899028|NCT02919696|581024779|FG001|Overall Study|Never Treated|1|||
160899029|NCT03181893|581024780|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899030|NCT03181893|581024781|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
160899031|NCT03181893|581024782|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899032|NCT03181893|581024783|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899033|NCT03181893|581024784|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899034|NCT03181893|581024785|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899035|NCT03181893|581024786|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899036|NCT03181893|581024787|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899037|NCT03181893|581024788|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899038|NCT03181893|581024789|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899039|NCT03181893|581024790|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899040|NCT03181893|581024780|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
160899041|NCT03181893|581024781|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
160899042|NCT03181893|581024782|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899043|NCT03181893|581024783|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899044|NCT03181893|581024784|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899045|NCT03181893|581024785|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899046|NCT03181893|581024786|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899047|NCT03181893|581024787|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899048|NCT03181893|581024788|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899049|NCT03181893|581024789|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899050|NCT03181893|581024790|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899051|NCT03181893|581024780|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899052|NCT03181893|581024781|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899053|NCT03181893|581024782|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899054|NCT03181893|581024783|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899055|NCT03181893|581024784|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899056|NCT03181893|581024785|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899057|NCT03181893|581024786|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899058|NCT03181893|581024787|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
160899059|NCT03181893|581024788|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
160899060|NCT03181893|581024789|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899061|NCT03181893|581024790|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899062|NCT03181893|581024780|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899063|NCT03181893|581024781|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899064|NCT03181893|581024782|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899065|NCT03181893|581024783|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899066|NCT03181893|581024784|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899067|NCT03181893|581024785|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899068|NCT03181893|581024786|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899069|NCT03181893|581024787|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899070|NCT03181893|581024788|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899071|NCT03181893|581024789|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
160899072|NCT03181893|581024790|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899073|NCT03181893|581024780|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899074|NCT03181893|581024781|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160807664|NCT01693250|580682860|FG001|Overall Study|Lost to Follow-up|2|||
160807665|NCT03783962|580682863|FG000|Overall Study|Lost to Follow-up|3|||
160807666|NCT03783962|580682864|FG001|Overall Study|Lost to Follow-up|6|||
160807667|NCT03783962|580682863|FG000|Overall Study|Protocol Violation|0|||
160807668|NCT03783962|580682864|FG001|Overall Study|Protocol Violation|1|||
160807669|NCT03458325|580682865|FG000|Overall Study|Withdrawal by Subject|1|||
160807670|NCT01766037|580682866|FG000|Overall Study|Adverse Event|1|||
160807671|NCT01766037|580682867|FG001|Overall Study|Adverse Event|0|||
160807672|NCT01766037|580682866|FG000|Overall Study|Lack of Efficacy|1|||
160807673|NCT01766037|580682867|FG001|Overall Study|Lack of Efficacy|0|||
160807674|NCT01766037|580682866|FG000|Overall Study|Lost to Follow-up|0|||
160807675|NCT01766037|580682867|FG001|Overall Study|Lost to Follow-up|10|||
160899075|NCT03181893|581024782|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899076|NCT03181893|581024783|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899077|NCT03181893|581024784|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899078|NCT03181893|581024785|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899079|NCT03181893|581024786|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899080|NCT03181893|581024787|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899081|NCT03181893|581024788|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899082|NCT03181893|581024789|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899083|NCT03181893|581024790|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
160807676|NCT01766037|580682866|FG000|Overall Study|Physician Decision|0|||
160807677|NCT01766037|580682867|FG001|Overall Study|Physician Decision|1|||
160807678|NCT01766037|580682866|FG000|Overall Study|Withdrawal by Subject|18|||
160899084|NCT03021304|581024794|FG000|Overall Study|Lack of Efficacy|1|||
160899085|NCT04815031|581024795|FG000|Overall Study|No adverse event information (missing information)|33|||
160899086|NCT03594994|581024798|FG000|Overall Study|Adverse Event|1|||
160899087|NCT03594994|581024799|FG001|Overall Study|Adverse Event|0|||
160899088|NCT03594994|581024798|FG000|Overall Study|Withdrawal by Subject|0|||
160899089|NCT03594994|581024799|FG001|Overall Study|Withdrawal by Subject|1|||
160899090|NCT03774082|581024805|FG000|Overall Study|Death|6|||
160899091|NCT03774082|581024806|FG001|Overall Study|Death|3|||
160899092|NCT03774082|581024807|FG002|Overall Study|Death|2|||
160899093|NCT03774082|581024805|FG000|Overall Study|Subject decision|0|||
160899094|NCT03774082|581024806|FG001|Overall Study|Subject decision|3|||
160899095|NCT03774082|581024807|FG002|Overall Study|Subject decision|0|||
160899096|NCT03774082|581024805|FG000|Overall Study|Lost to Follow-up|2|||
160899097|NCT03774082|581024806|FG001|Overall Study|Lost to Follow-up|0|||
160899098|NCT03774082|581024807|FG002|Overall Study|Lost to Follow-up|0|||
160807679|NCT01766037|580682867|FG001|Overall Study|Withdrawal by Subject|16|||
160899099|NCT03774082|581024805|FG000|Overall Study|Guardian decision|0|||
160899100|NCT03774082|581024806|FG001|Overall Study|Guardian decision|0|||
160899101|NCT03774082|581024807|FG002|Overall Study|Guardian decision|1|||
160807680|NCT01766037|580682866|FG000|Overall Study|Moved from area|5|||
160807681|NCT01766037|580682867|FG001|Overall Study|Moved from area|0|||
160807682|NCT01766037|580682866|FG000|Overall Study|medical - unrelated|1|||
160807683|NCT01766037|580682867|FG001|Overall Study|medical - unrelated|2|||
160807684|NCT01766037|580682866|FG000|Overall Study|nausea / discomfort|3|||
160807685|NCT01766037|580682867|FG001|Overall Study|nausea / discomfort|0|||
160807686|NCT05226598|580682868|FG000|Overall Study|Death|186|||
160807687|NCT05226598|580682869|FG001|Overall Study|Death|191|||
160807688|NCT05226598|580682868|FG000|Overall Study|Withdrawal by Subject|6|||
160807689|NCT05226598|580682869|FG001|Overall Study|Withdrawal by Subject|6|||
160807690|NCT05226598|580682868|FG000|Overall Study|Ongoing|174|||
160807691|NCT05226598|580682869|FG001|Overall Study|Ongoing|176|||
160807692|NCT01282866|580682871|FG000|Overall Study|Adverse Event|1|||
160807693|NCT04834726|580682872|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
160807694|NCT04834726|580682873|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
160807695|NCT04834726|580682874|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
160807696|NCT04834726|580682875|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
160807697|NCT04834726|580682876|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
160807698|NCT04834726|580682877|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
160807699|NCT04834726|580682878|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
160807700|NCT04834726|580682879|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
160807701|NCT04834726|580682880|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
160807702|NCT03465722|580682882|FG000|Overall Study|Withdrawal by Subject|21|||
160807703|NCT03465722|580682883|FG001|Overall Study|Withdrawal by Subject|14|||
160807704|NCT03465722|580682882|FG000|Overall Study|Death|89|||
160807705|NCT03465722|580682883|FG001|Overall Study|Death|87|||
160807706|NCT03465722|580682882|FG000|Overall Study|Lost to Follow-up|5|||
160807707|NCT03465722|580682883|FG001|Overall Study|Lost to Follow-up|3|||
160807708|NCT03465722|580682882|FG000|Overall Study|Administrative/Other|33|||
160807709|NCT03465722|580682883|FG001|Overall Study|Administrative/Other|32|||
160807710|NCT03465722|580682882|FG000|Overall Study|Not treated|1|||
160807711|NCT03465722|580682883|FG001|Overall Study|Not treated|2|||
160807712|NCT03465722|580682882|FG000|Overall Study|Sponsor decision|91|||
160807713|NCT03465722|580682883|FG001|Overall Study|Sponsor decision|98|||
160807714|NCT02948582|580682886|FG000|Washout Period 1|Adverse Event|0|||
160807715|NCT02948582|580682887|FG001|Washout Period 1|Adverse Event|2|||
160807716|NCT02948582|580682888|FG002|Washout Period 1|Adverse Event|0|||
160807717|NCT02948582|580682889|FG003|Washout Period 1|Adverse Event|0|||
160807718|NCT02948582|580682890|FG004|Washout Period 1|Adverse Event|0|||
160807719|NCT02948582|580682891|FG005|Washout Period 1|Adverse Event|0|||
160807720|NCT02948582|580682886|FG000|Washout Period 1|Protocol Violation|0|||
160807721|NCT02948582|580682887|FG001|Washout Period 1|Protocol Violation|0|||
160807722|NCT02948582|580682888|FG002|Washout Period 1|Protocol Violation|0|||
160807723|NCT02948582|580682889|FG003|Washout Period 1|Protocol Violation|0|||
160807724|NCT02948582|580682890|FG004|Washout Period 1|Protocol Violation|0|||
160807725|NCT02948582|580682891|FG005|Washout Period 1|Protocol Violation|1|||
160807726|NCT02948582|580682886|FG000|Washout Period 2|Adverse Event|0|||
160807727|NCT02948582|580682887|FG001|Washout Period 2|Adverse Event|1|||
160807728|NCT02948582|580682888|FG002|Washout Period 2|Adverse Event|0|||
160807729|NCT02948582|580682889|FG003|Washout Period 2|Adverse Event|0|||
160807730|NCT02948582|580682890|FG004|Washout Period 2|Adverse Event|0|||
160807731|NCT02948582|580682891|FG005|Washout Period 2|Adverse Event|0|||
160807732|NCT02948582|580682886|FG000|Washout Period 2|personal reasons|0|||
160899102|NCT03774082|581024805|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
160899103|NCT03774082|581024806|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
160899104|NCT03774082|581024807|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
160899105|NCT01950390|581024808|FG000|Overall Study|Never started treatment|3|||
160807733|NCT02948582|580682887|FG001|Washout Period 2|personal reasons|0|||
160807734|NCT02948582|580682888|FG002|Washout Period 2|personal reasons|0|||
160807735|NCT02948582|580682889|FG003|Washout Period 2|personal reasons|1|||
160807736|NCT02948582|580682890|FG004|Washout Period 2|personal reasons|0|||
160807737|NCT02948582|580682891|FG005|Washout Period 2|personal reasons|0|||
160807738|NCT02948582|580682886|FG000|Washout Period 4|Adverse Event|1|||
160807739|NCT02948582|580682887|FG001|Washout Period 4|Adverse Event|0|||
160807740|NCT02948582|580682888|FG002|Washout Period 4|Adverse Event|1|||
160807741|NCT02948582|580682889|FG003|Washout Period 4|Adverse Event|0|||
160807742|NCT02948582|580682890|FG004|Washout Period 4|Adverse Event|0|||
160807743|NCT02948582|580682891|FG005|Washout Period 4|Adverse Event|0|||
160807744|NCT03810014|580682892|FG000|Overall Study|Pregnancy|2|||
160807745|NCT03810014|580682893|FG001|Overall Study|Pregnancy|2|||
160807746|NCT03810014|580682894|FG002|Overall Study|Pregnancy|0|||
160807747|NCT03810014|580682895|FG003|Overall Study|Pregnancy|2|||
160807748|NCT03606486|580682901|FG000|Overall Study|Unable to collect sample|5|||
160807749|NCT00442416|580682908|FG000|Overall Study|Adverse Event|4|||
160807750|NCT00442416|580682909|FG001|Overall Study|Adverse Event|1|||
160807751|NCT00442416|580682908|FG000|Overall Study|Death|1|||
160807752|NCT00442416|580682909|FG001|Overall Study|Death|0|||
160807753|NCT00442416|580682908|FG000|Overall Study|Lack of Efficacy|2|||
160807754|NCT00442416|580682909|FG001|Overall Study|Lack of Efficacy|0|||
160807755|NCT00442416|580682908|FG000|Overall Study|Protocol Violation|2|||
160807756|NCT00442416|580682909|FG001|Overall Study|Protocol Violation|3|||
160807757|NCT00442416|580682908|FG000|Overall Study|Withdrew consent|1|||
160807758|NCT00442416|580682909|FG001|Overall Study|Withdrew consent|2|||
160807759|NCT00442416|580682908|FG000|Overall Study|Administrative/Other|27|||
160807760|NCT00442416|580682909|FG001|Overall Study|Administrative/Other|33|||
160807761|NCT00955474|580682921|FG000|Overall Study|Physician Decision|7|||
160807762|NCT00955474|580682922|FG001|Overall Study|Physician Decision|5|||
160807763|NCT00132301|580682925|FG000|Overall Study|Death|7|||
160807764|NCT00132301|580682926|FG001|Overall Study|Death|6|||
160807765|NCT00132301|580682925|FG000|Overall Study|Withdrawal by Subject|5|||
160807766|NCT00132301|580682926|FG001|Overall Study|Withdrawal by Subject|2|||
160807767|NCT00132301|580682925|FG000|Overall Study|Physician Decision|1|||
160807768|NCT00132301|580682926|FG001|Overall Study|Physician Decision|1|||
160807769|NCT00132301|580682925|FG000|Overall Study|Lost to Follow-up|5|||
160807770|NCT00132301|580682926|FG001|Overall Study|Lost to Follow-up|3|||
160807771|NCT00132301|580682925|FG000|Overall Study|Other|1|||
160807772|NCT00132301|580682926|FG001|Overall Study|Other|1|||
160807773|NCT00132301|580682925|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
160807774|NCT00132301|580682926|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
160807775|NCT03517436|580682928|FG000|Overall Study|Death|3|||
160807776|NCT03517436|580682928|FG000|Overall Study|Withdrawal by Subject|4|||
160807777|NCT03517436|580682928|FG000|Overall Study|Did not receive study valve.|1|||
160807778|NCT04271540|580682929|FG000|Overall Study|Lost to Follow-up|1|||
160807779|NCT04271540|580682929|FG000|Overall Study|Screen Fail|5|||
160807780|NCT04587869|580682932|FG000|Overall Study|Death|1|||
160807781|NCT04587869|580682933|FG001|Overall Study|Death|0|||
160807782|NCT04587869|580682932|FG000|Overall Study|Lost to Follow-up|27|||
160807783|NCT04587869|580682933|FG001|Overall Study|Lost to Follow-up|34|||
160807784|NCT04587869|580682932|FG000|Overall Study|Grant Termination|13|||
160807785|NCT04587869|580682933|FG001|Overall Study|Grant Termination|25|||
160807786|NCT04587869|580682932|FG000|Overall Study|too busy|2|||
160807787|NCT04587869|580682933|FG001|Overall Study|too busy|0|||
160807788|NCT04587869|580682932|FG000|Overall Study|Withdrawal by Subject|2|||
160807789|NCT04587869|580682933|FG001|Overall Study|Withdrawal by Subject|2|||
160807790|NCT04587869|580682932|FG000|Overall Study|Other|1|||
160807791|NCT04587869|580682933|FG001|Overall Study|Other|0|||
160807792|NCT02268383|580682934|FG000|Overall Study|Death|12|||
160807793|NCT02268383|580682934|FG000|Overall Study|Lost to Follow-up|2|||
160807794|NCT02268383|580682934|FG000|Overall Study|Withdrawal by Subject|9|||
160807795|NCT02268383|580682934|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
160807796|NCT02268383|580682934|FG000|Overall Study|Protocol deviation|3|||
160807797|NCT02268383|580682934|FG000|Overall Study|Sponsor decision|22|||
160807798|NCT02268383|580682934|FG000|Overall Study|Not reported|12|||
160807799|NCT00943761|580682935|FG000|Overall Study|Lost to Follow-up|2|||
160899106|NCT01950390|581024809|FG001|Overall Study|Never started treatment|2|||
160807800|NCT00943761|580682936|FG001|Overall Study|Lost to Follow-up|0|||
160807801|NCT00943761|580682935|FG000|Overall Study|Withdrawal by Subject|2|||
160807802|NCT00943761|580682936|FG001|Overall Study|Withdrawal by Subject|1|||
160899107|NCT01950390|581024808|FG000|Overall Study|Disease progression|45|||
160551248|NCT00352534|579744118|FG003|Final Risk Group Assignment|Physician Decision|0|||
160551249|NCT00352534|579744119|FG004|Final Risk Group Assignment|Physician Decision|0|||
160807803|NCT03382912|580682937|FG000|Overall Study|Physician Decision|0|||
160807804|NCT03382912|580682938|FG001|Overall Study|Physician Decision|1|||
160807805|NCT03382912|580682937|FG000|Overall Study|Sponsor Decision|6|||
160807806|NCT03382912|580682938|FG001|Overall Study|Sponsor Decision|6|||
160807807|NCT03382912|580682937|FG000|Overall Study|Withdrawal by Subject|0|||
160807808|NCT03382912|580682938|FG001|Overall Study|Withdrawal by Subject|5|||
160807809|NCT05526521|580682943|FG000|Overall Study|Withdrawal by Subject|0|||
160807810|NCT05526521|580682944|FG001|Overall Study|Withdrawal by Subject|1|||
160899108|NCT01950390|581024809|FG001|Overall Study|Disease progression|52|||
160551250|NCT00352534|579744120|FG005|Final Risk Group Assignment|Physician Decision|8|||
160807811|NCT05526521|580682945|FG002|Overall Study|Withdrawal by Subject|0|||
160807812|NCT05526521|580682946|FG003|Overall Study|Withdrawal by Subject|0|||
160807813|NCT03929913|580682947|FG000|Overall Study|Death|4|||
160807814|NCT03929913|580682947|FG000|Overall Study|Lost to Follow-up|1|||
160807815|NCT03929913|580682947|FG000|Overall Study|Failed Procedure|2|||
160807816|NCT03919929|580682950|FG000|Overall Study|Withdrawal by Subject|0|||
160807817|NCT03919929|580682951|FG001|Overall Study|Withdrawal by Subject|4|||
160807818|NCT03919929|580682950|FG000|Overall Study|Screen Failure|0|||
160807819|NCT03919929|580682951|FG001|Overall Study|Screen Failure|5|||
160807820|NCT01402869|580682952|FG000|Overall Study|Required Tooth Extraction|0|||
160807821|NCT01402869|580682953|FG001|Overall Study|Required Tooth Extraction|0|||
160807822|NCT01402869|580682954|FG002|Overall Study|Required Tooth Extraction|1|||
160807823|NCT01544348|580682955|FG000|Overall Study|Lost to Follow-up|1|||
160807824|NCT01544348|580682956|FG001|Overall Study|Lost to Follow-up|0|||
160807825|NCT01544348|580682957|FG002|Overall Study|Lost to Follow-up|0|||
160807826|NCT01544348|580682958|FG003|Overall Study|Lost to Follow-up|0|||
160807827|NCT01544348|580682959|FG004|Overall Study|Lost to Follow-up|0|||
160807828|NCT01544348|580682960|FG005|Overall Study|Lost to Follow-up|0|||
160807829|NCT01544348|580682961|FG006|Overall Study|Lost to Follow-up|1|||
160807830|NCT01544348|580682962|FG007|Overall Study|Lost to Follow-up|0|||
160807831|NCT01544348|580682955|FG000|Overall Study|Withdrawal by Subject|1|||
160807832|NCT01544348|580682956|FG001|Overall Study|Withdrawal by Subject|0|||
160807833|NCT01544348|580682957|FG002|Overall Study|Withdrawal by Subject|0|||
160807834|NCT01544348|580682958|FG003|Overall Study|Withdrawal by Subject|0|||
160807835|NCT01544348|580682959|FG004|Overall Study|Withdrawal by Subject|1|||
160807836|NCT01544348|580682960|FG005|Overall Study|Withdrawal by Subject|2|||
160807837|NCT01544348|580682961|FG006|Overall Study|Withdrawal by Subject|1|||
160807838|NCT01544348|580682962|FG007|Overall Study|Withdrawal by Subject|0|||
160807839|NCT01544348|580682955|FG000|Overall Study|Physician Decision|0|||
160807840|NCT01544348|580682956|FG001|Overall Study|Physician Decision|0|||
160807841|NCT01544348|580682957|FG002|Overall Study|Physician Decision|0|||
160807842|NCT01544348|580682958|FG003|Overall Study|Physician Decision|0|||
160807843|NCT01544348|580682959|FG004|Overall Study|Physician Decision|0|||
160807844|NCT01544348|580682960|FG005|Overall Study|Physician Decision|1|||
160807845|NCT01544348|580682961|FG006|Overall Study|Physician Decision|0|||
160807846|NCT01544348|580682962|FG007|Overall Study|Physician Decision|0|||
160807847|NCT00642707|580682963|FG000|Overall Study|Adverse Event|0|||
160807848|NCT00642707|580682964|FG001|Overall Study|Adverse Event|0|||
160807849|NCT00642707|580682965|FG002|Overall Study|Adverse Event|0|||
160807850|NCT00642707|580682966|FG003|Overall Study|Adverse Event|2|||
160807851|NCT00642707|580682963|FG000|Overall Study|Withdrawal by Subject|1|||
160807852|NCT00642707|580682964|FG001|Overall Study|Withdrawal by Subject|0|||
160807853|NCT00642707|580682965|FG002|Overall Study|Withdrawal by Subject|0|||
160807854|NCT00642707|580682966|FG003|Overall Study|Withdrawal by Subject|0|||
160807855|NCT01837680|580682972|FG000|Overall Study|Lost to Follow-up|2|||
160807856|NCT01837680|580682973|FG001|Overall Study|Lost to Follow-up|2|||
160807857|NCT01837680|580682972|FG000|Overall Study|lack of insurance|0|||
160807858|NCT01837680|580682973|FG001|Overall Study|lack of insurance|2|||
160807859|NCT01837680|580682972|FG000|Overall Study|allergic reaction|6|||
160807860|NCT01837680|580682973|FG001|Overall Study|allergic reaction|0|||
160807861|NCT01837680|580682972|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
160807862|NCT01837680|580682973|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
160807863|NCT03008070|580682974|FG000|Overall Study|Adverse Event|3|||
160807864|NCT03008070|580682975|FG001|Overall Study|Adverse Event|3|||
160807865|NCT03008070|580682976|FG002|Overall Study|Adverse Event|3|||
160807866|NCT03008070|580682974|FG000|Overall Study|Lost to Follow-up|1|||
160807867|NCT03008070|580682975|FG001|Overall Study|Lost to Follow-up|1|||
160807868|NCT03008070|580682976|FG002|Overall Study|Lost to Follow-up|0|||
160807869|NCT03008070|580682974|FG000|Overall Study|Non compliance|0|||
160807870|NCT03008070|580682975|FG001|Overall Study|Non compliance|1|||
160807871|NCT03008070|580682976|FG002|Overall Study|Non compliance|1|||
160899109|NCT01950390|581024808|FG000|Overall Study|Adverse Event|22|||
160899110|NCT01950390|581024809|FG001|Overall Study|Adverse Event|16|||
160807872|NCT03008070|580682974|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
160807873|NCT03008070|580682975|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
160807874|NCT03008070|580682976|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
160807875|NCT03008070|580682974|FG000|Overall Study|Withdrawal by Subject|2|||
160807876|NCT03008070|580682975|FG001|Overall Study|Withdrawal by Subject|0|||
160807877|NCT03008070|580682976|FG002|Overall Study|Withdrawal by Subject|1|||
160807878|NCT03008070|580682974|FG000|Overall Study|Use of prohibited drug|0|||
160807879|NCT03008070|580682975|FG001|Overall Study|Use of prohibited drug|0|||
160899111|NCT01950390|581024808|FG000|Overall Study|Death|5|||
160807880|NCT03008070|580682976|FG002|Overall Study|Use of prohibited drug|2|||
160807881|NCT05005273|580682977|FG000|Overall Study|Study Terminated|1|||
160807882|NCT05005273|580682978|FG001|Overall Study|Study Terminated|0|||
160807883|NCT04409834|580682979|FG000|Overall Study|Death|55|||
160807884|NCT04409834|580682980|FG001|Overall Study|Death|62|||
160899112|NCT01950390|581024809|FG001|Overall Study|Death|3|||
160807885|NCT03960684|580682982|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
160807886|NCT03533660|580682983|FG000|Overall Study|Withdrawal by Subject|2|||
160807887|NCT03533660|580682984|FG001|Overall Study|Withdrawal by Subject|2|||
160807888|NCT03533660|580682983|FG000|Overall Study|Death|2|||
160807889|NCT03533660|580682984|FG001|Overall Study|Death|4|||
160551251|NCT00352534|579744121|FG006|Final Risk Group Assignment|Physician Decision|0|||
160551252|NCT00352534|579744115|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
160551253|NCT00352534|579744116|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
160551254|NCT00352534|579744117|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
160551255|NCT00352534|579744118|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
160551256|NCT00352534|579744119|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
160551257|NCT00352534|579744120|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
160551258|NCT00352534|579744121|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
160551259|NCT00352534|579744115|FG000|Final Risk Group Assignment|Ineligible|0|||
160551260|NCT00352534|579744116|FG001|Final Risk Group Assignment|Ineligible|0|||
160551261|NCT00352534|579744117|FG002|Final Risk Group Assignment|Ineligible|3|||
160551262|NCT00352534|579744118|FG003|Final Risk Group Assignment|Ineligible|1|||
160551263|NCT00352534|579744119|FG004|Final Risk Group Assignment|Ineligible|0|||
160551264|NCT00352534|579744120|FG005|Final Risk Group Assignment|Ineligible|13|||
160551265|NCT00352534|579744121|FG006|Final Risk Group Assignment|Ineligible|0|||
160551266|NCT00352534|579744115|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
160551267|NCT00352534|579744116|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
160551268|NCT00352534|579744117|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
160551269|NCT00352534|579744118|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
160551270|NCT00352534|579744119|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
160551271|NCT00352534|579744120|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
160551272|NCT00352534|579744121|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
160551273|NCT00352534|579744115|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
160551274|NCT00352534|579744116|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
160551275|NCT00352534|579744117|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
160551276|NCT00352534|579744118|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
160551277|NCT00352534|579744119|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
160551278|NCT00352534|579744120|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
160551279|NCT00352534|579744121|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
160551280|NCT00352534|579744115|FG000|Final Risk Group Assignment|Death|0|||
160551281|NCT00352534|579744116|FG001|Final Risk Group Assignment|Death|0|||
160551282|NCT00352534|579744117|FG002|Final Risk Group Assignment|Death|0|||
160551283|NCT00352534|579744118|FG003|Final Risk Group Assignment|Death|0|||
160551284|NCT00352534|579744119|FG004|Final Risk Group Assignment|Death|0|||
160551285|NCT00352534|579744120|FG005|Final Risk Group Assignment|Death|2|||
160551286|NCT00352534|579744121|FG006|Final Risk Group Assignment|Death|0|||
160551287|NCT02090855|579744122|FG000|Overall Study|no evaluable Standard of Truth results|2|||
160551288|NCT00544869|579744126|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
160551289|NCT00544869|579744127|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
160551290|NCT00544869|579744128|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
160551291|NCT00544869|579744126|FG000|Overall Study|Adverse Event|6|||
160551292|NCT00544869|579744127|FG001|Overall Study|Adverse Event|1|||
160551293|NCT00544869|579744128|FG002|Overall Study|Adverse Event|0|||
160551294|NCT00544869|579744126|FG000|Overall Study|Lack of Efficacy|1|||
160551295|NCT00544869|579744127|FG001|Overall Study|Lack of Efficacy|1|||
160551296|NCT00544869|579744128|FG002|Overall Study|Lack of Efficacy|0|||
160551297|NCT00544869|579744126|FG000|Overall Study|Physician Decision|2|||
160551298|NCT00544869|579744127|FG001|Overall Study|Physician Decision|0|||
160551299|NCT00544869|579744128|FG002|Overall Study|Physician Decision|0|||
160551300|NCT00619502|579744129|FG000|Overall Study|Lost to Follow-up|8|||
160551301|NCT00619502|579744130|FG001|Overall Study|Lost to Follow-up|10|||
160551302|NCT01354028|579744131|FG000|Overall Study|Physician Decision|0|||
160551303|NCT01354028|579744132|FG001|Overall Study|Physician Decision|2|||
160551304|NCT01354028|579744131|FG000|Overall Study|Discharged before study start|2|||
160551305|NCT01354028|579744132|FG001|Overall Study|Discharged before study start|2|||
160551306|NCT01354028|579744131|FG000|Overall Study|No quiet alert state|0|||
160551307|NCT01354028|579744132|FG001|Overall Study|No quiet alert state|1|||
160551308|NCT03968419|579744133|FG000|Treatment Period|Adverse Event|0|||
160551309|NCT03968419|579744134|FG001|Treatment Period|Adverse Event|0|||
160551310|NCT03968419|579744135|FG002|Treatment Period|Adverse Event|1|||
160551311|NCT03968419|579744133|FG000|Safety Follow-up Period|Death|3|||
160551312|NCT03968419|579744134|FG001|Safety Follow-up Period|Death|2|||
160551313|NCT03968419|579744135|FG002|Safety Follow-up Period|Death|1|||
160551314|NCT03968419|579744133|FG000|Safety Follow-up Period|Subject Decision|2|||
160551315|NCT03968419|579744134|FG001|Safety Follow-up Period|Subject Decision|1|||
160551316|NCT03968419|579744135|FG002|Safety Follow-up Period|Subject Decision|0|||
160551317|NCT00935883|579744138|FG000|Treatment Period|Physician Decision|1|||
160807890|NCT03533660|580682983|FG000|Overall Study|Adverse Event|0|||
160807891|NCT03533660|580682984|FG001|Overall Study|Adverse Event|2|||
160807892|NCT03941873|580684497|FG000|Overall Study|Death|0|||
160807893|NCT03941873|580684498|FG001|Overall Study|Death|12|||
160807894|NCT03941873|580684499|FG002|Overall Study|Death|2|||
160807895|NCT03941873|580684500|FG003|Overall Study|Death|53|||
160807896|NCT03941873|580684497|FG000|Overall Study|Withdrawal by Subject|1|||
160807897|NCT03941873|580684498|FG001|Overall Study|Withdrawal by Subject|1|||
160807898|NCT03941873|580684499|FG002|Overall Study|Withdrawal by Subject|0|||
160807899|NCT03941873|580684500|FG003|Overall Study|Withdrawal by Subject|5|||
160807900|NCT03941873|580684497|FG000|Overall Study|Lost to Follow-up|1|||
160807901|NCT03941873|580684498|FG001|Overall Study|Lost to Follow-up|2|||
160807902|NCT03941873|580684499|FG002|Overall Study|Lost to Follow-up|0|||
160807903|NCT03941873|580684500|FG003|Overall Study|Lost to Follow-up|0|||
160807904|NCT03941873|580684497|FG000|Overall Study|Sponsor Decision|0|||
160807905|NCT03941873|580684498|FG001|Overall Study|Sponsor Decision|6|||
160807906|NCT03941873|580684499|FG002|Overall Study|Sponsor Decision|0|||
160807907|NCT03941873|580684500|FG003|Overall Study|Sponsor Decision|15|||
160807908|NCT03276728|580684503|FG000|Overall Study|Lost to Follow-up|0|||
160807909|NCT03276728|580684504|FG001|Overall Study|Lost to Follow-up|0|||
160807910|NCT03276728|580684505|FG002|Overall Study|Lost to Follow-up|2|||
160807911|NCT03276728|580684506|FG003|Overall Study|Lost to Follow-up|2|||
160807912|NCT03276728|580684507|FG004|Overall Study|Lost to Follow-up|0|||
160807913|NCT03276728|580684508|FG005|Overall Study|Lost to Follow-up|0|||
160807914|NCT03276728|580684509|FG006|Overall Study|Lost to Follow-up|0|||
160807915|NCT03276728|580684510|FG007|Overall Study|Lost to Follow-up|0|||
160807916|NCT03276728|580684503|FG000|Overall Study|Withdrawal by Subject|0|||
160807917|NCT03276728|580684504|FG001|Overall Study|Withdrawal by Subject|0|||
160899113|NCT01950390|581024808|FG000|Overall Study|Withdrawal by Subject|5|||
160899114|NCT01950390|581024809|FG001|Overall Study|Withdrawal by Subject|1|||
160899115|NCT01950390|581024808|FG000|Overall Study|Alternative therapy|0|||
160985860|NCT01323660|581337039|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
160985861|NCT01323660|581337040|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
160985862|NCT01323660|581337035|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160985863|NCT01323660|581337036|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160985864|NCT01323660|581337037|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160985865|NCT01323660|581337038|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160985866|NCT01323660|581337039|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
160985867|NCT01323660|581337040|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160985868|NCT00926393|581337043|FG000|Overall Study|Withdrawal by Subject|1|||
160985869|NCT00926393|581337044|FG001|Overall Study|Withdrawal by Subject|2|||
160899116|NCT01950390|581024809|FG001|Overall Study|Alternative therapy|3|||
160899117|NCT01950390|581024808|FG000|Overall Study|Complicating disease|1|||
160899118|NCT01950390|581024809|FG001|Overall Study|Complicating disease|0|||
160899119|NCT01950390|581024808|FG000|Overall Study|On treatment|1|||
160899120|NCT01950390|581024809|FG001|Overall Study|On treatment|0|||
160899121|NCT01950390|581024808|FG000|Overall Study|Symptomatic deterioration|2|||
160899122|NCT01950390|581024809|FG001|Overall Study|Symptomatic deterioration|1|||
160899123|NCT01950390|581024808|FG000|Overall Study|Physician Decision|0|||
160899124|NCT01950390|581024809|FG001|Overall Study|Physician Decision|4|||
160899125|NCT01950390|581024808|FG000|Overall Study|Lack of clinical benefit|0|||
160899126|NCT01950390|581024809|FG001|Overall Study|Lack of clinical benefit|1|||
160899127|NCT01950390|581024808|FG000|Overall Study|Maintained PR and moved to observation only|0|||
160899128|NCT01950390|581024809|FG001|Overall Study|Maintained PR and moved to observation only|1|||
160899129|NCT05938920|581024810|FG000|Overall Study|Adverse Event|1|||
160899130|NCT05938920|581024811|FG001|Overall Study|Adverse Event|3|||
160899131|NCT05938920|581024812|FG002|Overall Study|Adverse Event|2|||
160899132|NCT05938920|581024813|FG003|Overall Study|Adverse Event|1|||
160899133|NCT05938920|581024810|FG000|Overall Study|Death|0|||
160899134|NCT05938920|581024811|FG001|Overall Study|Death|1|||
160899135|NCT05938920|581024812|FG002|Overall Study|Death|0|||
160899136|NCT05938920|581024813|FG003|Overall Study|Death|0|||
160899137|NCT05938920|581024810|FG000|Overall Study|Lost to Follow-up|0|||
160899138|NCT05938920|581024811|FG001|Overall Study|Lost to Follow-up|0|||
160644645|NCT04582266|580082311|FG000|Overall Study|Lost to Follow-up|7|||
160807918|NCT03276728|580684505|FG002|Overall Study|Withdrawal by Subject|0|||
160807919|NCT03276728|580684506|FG003|Overall Study|Withdrawal by Subject|3|||
160899139|NCT05938920|581024812|FG002|Overall Study|Lost to Follow-up|1|||
160899140|NCT05938920|581024813|FG003|Overall Study|Lost to Follow-up|0|||
160899141|NCT05938920|581024810|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
160899142|NCT05938920|581024811|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
160899143|NCT05938920|581024812|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
160807920|NCT03276728|580684507|FG004|Overall Study|Withdrawal by Subject|0|||
160899144|NCT05938920|581024813|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
160985870|NCT00926393|581337043|FG000|Overall Study|Adverse Event|1|||
160985871|NCT00926393|581337044|FG001|Overall Study|Adverse Event|1|||
160985872|NCT01403987|581337046|FG000|Overall Study|Residents forgot their secret PIN|18|||
160985873|NCT01403987|581337047|FG001|Overall Study|Residents forgot their secret PIN|17|||
160985874|NCT01403987|581337048|FG002|Overall Study|Residents forgot their secret PIN|18|||
160985875|NCT00751790|581337053|FG000|Overall Study|Lost to Follow-up|1|||
160985876|NCT00751790|581337053|FG000|Overall Study|Death|3|||
160985877|NCT00751790|581337053|FG000|Overall Study|Withdrawal by Subject|1|||
160985878|NCT00180674|581337055|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
160985879|NCT00180674|581337055|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
160985880|NCT03302910|581337056|FG000|Overall Study|Protocol Violation|1|||
160985881|NCT03302910|581337057|FG001|Overall Study|Protocol Violation|0|||
160985882|NCT01106976|581337058|FG000|Overall Study|Lost to Follow-up|8|||
160985883|NCT01477749|581337059|FG000|Overall Study|Physician Decision|4|||
160985884|NCT04004208|581337062|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160985885|NCT04004208|581337063|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160985886|NCT04004208|581337062|FG000|Overall Study|Death|3|||
160985887|NCT04004208|581337063|FG001|Overall Study|Death|0|||
160985888|NCT04004208|581337062|FG000|Overall Study|COVID-19 pandemic|1|||
160985889|NCT04004208|581337063|FG001|Overall Study|COVID-19 pandemic|0|||
160985890|NCT04004208|581337062|FG000|Overall Study|Physician Decision|1|||
160985891|NCT04004208|581337063|FG001|Overall Study|Physician Decision|0|||
160985892|NCT04004208|581337062|FG000|Overall Study|Adverse Event|1|||
160985893|NCT04004208|581337063|FG001|Overall Study|Adverse Event|1|||
160985894|NCT04990440|581337064|FG000|Overall Study|Sponsor's Decision|0|||
160985895|NCT04990440|581337065|FG001|Overall Study|Sponsor's Decision|0|||
160985896|NCT04990440|581337066|FG002|Overall Study|Sponsor's Decision|1|||
160985897|NCT02118714|581337067|FG000|Overall Study|Lost to Follow-up|2|||
160985898|NCT02118714|581337067|FG000|Overall Study|Protocol Violation|1|||
160985899|NCT02300311|581337073|FG000|Overall Study|Other than the reason specified|1|||
160985900|NCT02300311|581337074|FG001|Overall Study|Other than the reason specified|0|||
160985901|NCT02300311|581337073|FG000|Overall Study|Refused to continue taking medication|18|||
160985902|NCT02300311|581337074|FG001|Overall Study|Refused to continue taking medication|0|||
160985903|NCT02687919|581337075|FG000|Overall Study|Withdrawal by Subject|6|||
160985904|NCT02687919|581337076|FG001|Overall Study|Withdrawal by Subject|6|||
160985905|NCT02687919|581337075|FG000|Overall Study|Protocol Violation|2|||
160985906|NCT02687919|581337076|FG001|Overall Study|Protocol Violation|0|||
160985907|NCT00419003|581337077|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
160985908|NCT00419003|581337078|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
160985909|NCT00419003|581337077|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
160985910|NCT00419003|581337078|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
160899145|NCT05938920|581024810|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
160899146|NCT05938920|581024811|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
160899147|NCT05938920|581024812|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
160899148|NCT05938920|581024813|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
160899149|NCT05938920|581024810|FG000|Overall Study|Participant Refused to Come In|0|||
160899150|NCT05938920|581024811|FG001|Overall Study|Participant Refused to Come In|0|||
160899151|NCT05938920|581024812|FG002|Overall Study|Participant Refused to Come In|1|||
160899152|NCT05938920|581024813|FG003|Overall Study|Participant Refused to Come In|0|||
160899153|NCT01251861|581024814|FG000|Overall Study|Disease progression|6|||
160899154|NCT01251861|581024815|FG001|Overall Study|Disease progression|6|||
160899155|NCT01251861|581024814|FG000|Overall Study|Adverse Event|2|||
160899156|NCT01251861|581024815|FG001|Overall Study|Adverse Event|17|||
160899157|NCT01251861|581024814|FG000|Overall Study|Withdrawal by Subject|2|||
160899158|NCT01251861|581024815|FG001|Overall Study|Withdrawal by Subject|2|||
160899159|NCT01251861|581024814|FG000|Overall Study|Alternative therapy|1|||
160899160|NCT01251861|581024815|FG001|Overall Study|Alternative therapy|0|||
160899161|NCT01251861|581024814|FG000|Overall Study|Other complicating disease|0|||
160985911|NCT01653847|581337079|FG000|Overall Study|Withdrawal by Subject|1|||
160985912|NCT01653847|581337080|FG001|Overall Study|Withdrawal by Subject|0|||
160985913|NCT02554513|581337082|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
160551318|NCT00935883|579744139|FG001|Treatment Period|Physician Decision|0|||
160551319|NCT00935883|579744138|FG000|Treatment Period|Withdrawal by Subject|0|||
160551320|NCT00935883|579744139|FG001|Treatment Period|Withdrawal by Subject|2|||
160551321|NCT01641939|579744142|FG000|Overall Study|Death|90|||
160985914|NCT02554513|581337083|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
160985915|NCT01094743|581338519|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
160985916|NCT02851511|581338520|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
160985917|NCT02851511|581338521|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
160985918|NCT02851511|581338522|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
160551322|NCT01641939|579744143|FG001|Overall Study|Death|187|||
160551323|NCT01641939|579744144|FG002|Overall Study|Death|61|||
160807921|NCT03276728|580684508|FG005|Overall Study|Withdrawal by Subject|0|||
160807922|NCT03276728|580684509|FG006|Overall Study|Withdrawal by Subject|0|||
160807923|NCT03276728|580684510|FG007|Overall Study|Withdrawal by Subject|0|||
160807924|NCT03276728|580684503|FG000|Overall Study|Decision by sponsor|0|||
160807925|NCT03276728|580684504|FG001|Overall Study|Decision by sponsor|0|||
160807926|NCT03276728|580684505|FG002|Overall Study|Decision by sponsor|0|||
160807927|NCT03276728|580684506|FG003|Overall Study|Decision by sponsor|0|||
160807928|NCT03276728|580684507|FG004|Overall Study|Decision by sponsor|1|||
160807929|NCT03276728|580684508|FG005|Overall Study|Decision by sponsor|0|||
160807930|NCT03276728|580684509|FG006|Overall Study|Decision by sponsor|2|||
160807931|NCT03276728|580684510|FG007|Overall Study|Decision by sponsor|1|||
160807932|NCT02257242|580684511|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
160807933|NCT02257242|580684512|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807934|NCT02257242|580684513|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807935|NCT02257242|580684514|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807936|NCT02257242|580684515|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807937|NCT02257242|580684516|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807938|NCT02257242|580684517|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807939|NCT02257242|580684518|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807940|NCT02257242|580684519|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807941|NCT00600106|580684520|FG000|Overall Study|Withdrawal by Subject|1|||
160807942|NCT00600106|580684521|FG001|Overall Study|Withdrawal by Subject|1|||
160807951|NCT02213926|580684526|FG000|Overall Study|Death|59|||
160807952|NCT02213926|580684526|FG000|Overall Study|Withdrawal by Subject|10|||
160807953|NCT02213926|580684526|FG000|Overall Study|study terminated by sponsor|51|||
160807954|NCT02213926|580684526|FG000|Overall Study|Lost to Follow-up|3|||
160807955|NCT02213926|580684526|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
160807956|NCT01188551|580684527|FG000|Overall Study|Pharmacy issues|1|||
160807957|NCT01188551|580684528|FG001|Overall Study|Pharmacy issues|0|||
160807958|NCT01188551|580684529|FG002|Overall Study|Pharmacy issues|0|||
160807959|NCT01188551|580684530|FG003|Overall Study|Pharmacy issues|0|||
160807960|NCT01306643|580684535|FG000|Overall Study|Adverse Event|5|||
160807961|NCT01306643|580684535|FG000|Overall Study|Disease Progression|7|||
160807962|NCT01306643|580684535|FG000|Overall Study|Other: Change in Eligibility Status|1|||
160807963|NCT04024436|580684537|FG000|Overall Study|Death|10|||
160807964|NCT04024436|580684538|FG001|Overall Study|Death|14|||
160807965|NCT04024436|580684539|FG002|Overall Study|Death|2|||
160807966|NCT04024436|580684540|FG003|Overall Study|Death|7|||
160807967|NCT04024436|580684537|FG000|Overall Study|Loss to follow up|1|||
160807968|NCT04024436|580684538|FG001|Overall Study|Loss to follow up|0|||
160807969|NCT04024436|580684539|FG002|Overall Study|Loss to follow up|0|||
160807970|NCT04024436|580684540|FG003|Overall Study|Loss to follow up|1|||
160807971|NCT04024436|580684537|FG000|Overall Study|Withdrawal of consent|2|||
160807972|NCT04024436|580684538|FG001|Overall Study|Withdrawal of consent|0|||
160807973|NCT04024436|580684539|FG002|Overall Study|Withdrawal of consent|0|||
160807974|NCT04024436|580684540|FG003|Overall Study|Withdrawal of consent|1|||
160807975|NCT04024436|580684537|FG000|Overall Study|Study termination by sponsor|4|||
160807976|NCT04024436|580684538|FG001|Overall Study|Study termination by sponsor|6|||
160807977|NCT04024436|580684539|FG002|Overall Study|Study termination by sponsor|2|||
160807978|NCT04024436|580684540|FG003|Overall Study|Study termination by sponsor|11|||
160807979|NCT04024436|580684537|FG000|Overall Study|Reason Not Specified|0|||
160807980|NCT04024436|580684538|FG001|Overall Study|Reason Not Specified|1|||
160807981|NCT04024436|580684539|FG002|Overall Study|Reason Not Specified|0|||
160807982|NCT04024436|580684540|FG003|Overall Study|Reason Not Specified|2|||
160807983|NCT01169337|580684541|FG000|Overall Study|Lack of Efficacy|5|||
160807984|NCT01169337|580684542|FG001|Overall Study|Lack of Efficacy|7|||
160807985|NCT01169337|580684543|FG002|Overall Study|Lack of Efficacy|0|||
160807986|NCT01169337|580684541|FG000|Overall Study|Adverse Event|12|||
160807987|NCT01169337|580684542|FG001|Overall Study|Adverse Event|18|||
160807988|NCT01169337|580684543|FG002|Overall Study|Adverse Event|0|||
160807989|NCT01169337|580684541|FG000|Overall Study|Death|2|||
160807990|NCT01169337|580684542|FG001|Overall Study|Death|0|||
160807991|NCT01169337|580684543|FG002|Overall Study|Death|0|||
160807992|NCT01169337|580684541|FG000|Overall Study|Withdrawal by Subject|11|||
160807993|NCT01169337|580684542|FG001|Overall Study|Withdrawal by Subject|11|||
160807994|NCT01169337|580684543|FG002|Overall Study|Withdrawal by Subject|6|||
160807995|NCT01169337|580684541|FG000|Overall Study|Noncompliance|2|||
160807996|NCT01169337|580684542|FG001|Overall Study|Noncompliance|0|||
160807997|NCT01169337|580684543|FG002|Overall Study|Noncompliance|0|||
160807998|NCT01169337|580684541|FG000|Overall Study|Other complicating disease|1|||
160807999|NCT01169337|580684542|FG001|Overall Study|Other complicating disease|1|||
160808000|NCT01169337|580684543|FG002|Overall Study|Other complicating disease|0|||
160808001|NCT01169337|580684541|FG000|Overall Study|Physician Decision|1|||
160808002|NCT01169337|580684542|FG001|Overall Study|Physician Decision|5|||
160808003|NCT01169337|580684543|FG002|Overall Study|Physician Decision|0|||
160808004|NCT01169337|580684541|FG000|Overall Study|Alternative therapy|0|||
160808005|NCT01169337|580684542|FG001|Overall Study|Alternative therapy|2|||
160808006|NCT01169337|580684543|FG002|Overall Study|Alternative therapy|0|||
160808007|NCT01169337|580684541|FG000|Overall Study|Changed hospital|0|||
160808008|NCT01169337|580684542|FG001|Overall Study|Changed hospital|1|||
160808009|NCT01169337|580684543|FG002|Overall Study|Changed hospital|0|||
160808010|NCT01169337|580684541|FG000|Overall Study|Never started treatment|0|||
160808011|NCT01169337|580684542|FG001|Overall Study|Never started treatment|2|||
160808012|NCT01169337|580684543|FG002|Overall Study|Never started treatment|0|||
160808013|NCT01169337|580684541|FG000|Overall Study|Reason not reported|1|||
160808014|NCT01169337|580684542|FG001|Overall Study|Reason not reported|0|||
160808015|NCT01169337|580684543|FG002|Overall Study|Reason not reported|0|||
160808016|NCT01169337|580684541|FG000|Overall Study|Continuing lenalidomide|9|||
160808017|NCT01169337|580684542|FG001|Overall Study|Continuing lenalidomide|43|||
160808018|NCT01169337|580684543|FG002|Overall Study|Continuing lenalidomide|0|||
160808019|NCT05507567|580684545|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
160808020|NCT05507567|580684546|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
160808021|NCT05507567|580684547|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
160808022|NCT05507567|580684545|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
160808023|NCT05507567|580684546|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
160808024|NCT05507567|580684547|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
160808025|NCT05507567|580684545|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
160899162|NCT01251861|581024815|FG001|Overall Study|Other complicating disease|1|||
160899163|NCT01251861|581024814|FG000|Overall Study|Physician Decision|1|||
160899164|NCT01251861|581024815|FG001|Overall Study|Physician Decision|0|||
160899165|NCT01251861|581024814|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
160899166|NCT01251861|581024815|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
160899167|NCT01251861|581024814|FG000|Overall Study|Other|1|||
160899168|NCT01251861|581024815|FG001|Overall Study|Other|0|||
160899169|NCT01251861|581024814|FG000|Overall Study|Never started therapy|4|||
160899170|NCT01251861|581024815|FG001|Overall Study|Never started therapy|1|||
160899171|NCT01251861|581024814|FG000|Overall Study|Potential interaction of drugs|0|||
160899172|NCT01251861|581024815|FG001|Overall Study|Potential interaction of drugs|1|||
160899173|NCT00316719|581026261|FG000|Overall Study|Adverse Event|0|||
160899174|NCT00316719|581026262|FG001|Overall Study|Adverse Event|6|||
160899175|NCT00316719|581026261|FG000|Overall Study|Consent withdrawn|2|||
160899176|NCT00316719|581026262|FG001|Overall Study|Consent withdrawn|0|||
160899177|NCT00676338|581026263|FG000|Overall Study|Adverse Event|6|||
160899178|NCT00676338|581026264|FG001|Overall Study|Adverse Event|6|||
160899179|NCT00676338|581026265|FG002|Overall Study|Adverse Event|5|||
160899180|NCT00676338|581026266|FG003|Overall Study|Adverse Event|1|||
160899181|NCT00676338|581026263|FG000|Overall Study|Lost to Follow-up|4|||
160899182|NCT00676338|581026264|FG001|Overall Study|Lost to Follow-up|1|||
160899183|NCT00676338|581026265|FG002|Overall Study|Lost to Follow-up|3|||
160899184|NCT00676338|581026266|FG003|Overall Study|Lost to Follow-up|4|||
160899185|NCT00676338|581026263|FG000|Overall Study|Physician Decision|3|||
160899186|NCT00676338|581026264|FG001|Overall Study|Physician Decision|3|||
160899187|NCT00676338|581026265|FG002|Overall Study|Physician Decision|2|||
160899188|NCT00676338|581026266|FG003|Overall Study|Physician Decision|3|||
160899189|NCT00676338|581026263|FG000|Overall Study|Protocol Violation|5|||
160899190|NCT00676338|581026264|FG001|Overall Study|Protocol Violation|9|||
160899191|NCT00676338|581026265|FG002|Overall Study|Protocol Violation|2|||
160899192|NCT00676338|581026266|FG003|Overall Study|Protocol Violation|5|||
160899193|NCT00676338|581026263|FG000|Overall Study|Withdrawal by Subject|17|||
160899194|NCT00676338|581026264|FG001|Overall Study|Withdrawal by Subject|9|||
160899195|NCT00676338|581026265|FG002|Overall Study|Withdrawal by Subject|12|||
160899196|NCT00676338|581026266|FG003|Overall Study|Withdrawal by Subject|6|||
160899197|NCT00676338|581026263|FG000|Overall Study|Entry Criteria Not Met|0|||
160551324|NCT01641939|579744142|FG000|Overall Study|Lost to Follow-up|3|||
160808026|NCT05507567|580684546|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
160808027|NCT05507567|580684547|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
160808028|NCT05507567|580684545|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
160808029|NCT05507567|580684546|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
160808030|NCT05507567|580684547|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
160808031|NCT01485796|580684548|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
160808032|NCT01485796|580684548|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
160808033|NCT01485796|580684548|FG000|Period 2: Epoch 2|Adverse Event|3|||
160808034|NCT01485796|580684548|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
160808035|NCT01485796|580684548|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
160808036|NCT01485796|580684548|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
160808037|NCT01485796|580684548|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
160808038|NCT01485796|580684548|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
160808039|NCT04830215|580684549|FG000|Overall Study|Adverse Event|6|||
160808040|NCT04830215|580684549|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
160808041|NCT04830215|580684549|FG000|Overall Study|Withdrawal by Subject|3|||
160808042|NCT04830215|580684549|FG000|Overall Study|Protocol Deviation|1|||
160808043|NCT01643408|580684551|FG000|Overall Study|Adverse Event|12|||
160808044|NCT01643408|580684551|FG000|Overall Study|Other|2|||
160808045|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
160808046|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
160808047|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808048|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808049|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808050|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808051|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808052|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808053|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808054|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808055|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
160808056|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
160808057|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808058|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808059|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808060|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808061|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808062|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808063|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808064|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808065|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
160808066|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808067|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808068|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808069|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808070|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808071|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808072|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808073|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808074|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808075|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
160808076|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
160808077|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808078|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808079|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808080|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808081|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808082|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160551325|NCT01641939|579744143|FG001|Overall Study|Lost to Follow-up|2|||
160551326|NCT01641939|579744144|FG002|Overall Study|Lost to Follow-up|1|||
160551327|NCT01641939|579744142|FG000|Overall Study|Withdrawal by Subject|14|||
160551328|NCT01641939|579744143|FG001|Overall Study|Withdrawal by Subject|11|||
160551329|NCT01641939|579744144|FG002|Overall Study|Withdrawal by Subject|5|||
160551330|NCT01641939|579744142|FG000|Overall Study|Study Terminated by Sponsor|10|||
160551331|NCT01641939|579744143|FG001|Overall Study|Study Terminated by Sponsor|28|||
160551332|NCT01641939|579744144|FG002|Overall Study|Study Terminated by Sponsor|3|||
160551333|NCT02894840|579744145|FG000|Overall Study|Lost to Follow-up|1|||
160808083|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808084|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808085|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808086|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
160808087|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808088|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808089|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808090|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808091|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808092|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808093|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808094|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808095|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
160808096|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
160808097|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808098|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808099|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808100|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808101|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808102|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808103|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808104|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808105|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
160808106|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
160808107|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808108|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808109|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808110|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808111|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808112|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808113|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808114|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808115|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
160808116|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
160808117|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808118|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808119|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808120|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808121|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808122|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808123|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808124|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808125|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808126|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808127|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
160808128|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
160808129|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808130|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808131|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808132|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808133|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808134|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808135|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808136|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808137|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
160808138|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
160808139|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808140|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808141|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808142|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160551334|NCT02894840|579744146|FG001|Overall Study|Lost to Follow-up|0|||
160551335|NCT02894840|579744147|FG002|Overall Study|Lost to Follow-up|3|||
160551336|NCT02894840|579744148|FG003|Overall Study|Lost to Follow-up|0|||
160551337|NCT01072344|579744153|FG000|Overall Study|Relasped-reached end point|7|||
160551338|NCT01072344|579744154|FG001|Overall Study|Relasped-reached end point|12|||
160551339|NCT01072344|579744153|FG000|Overall Study|Protocol Violation|1|||
160551340|NCT01072344|579744154|FG001|Overall Study|Protocol Violation|2|||
160551341|NCT01072344|579744153|FG000|Overall Study|Lost to Follow-up|3|||
160644646|NCT04582266|580082312|FG001|Overall Study|Lost to Follow-up|5|||
160644647|NCT04582266|580082311|FG000|Overall Study|Withdrawal by Subject|1|||
160644648|NCT04582266|580082312|FG001|Overall Study|Withdrawal by Subject|0|||
160644649|NCT04582266|580082311|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
160644650|NCT04582266|580082312|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
160644651|NCT01466686|580082319|FG000|Overall Study|Withdrawal by Subject|1|||
160644652|NCT02049359|580082320|FG000|Overall Study|Lost to Follow-up|26|||
160644653|NCT02049359|580082321|FG001|Overall Study|Lost to Follow-up|19|||
160644654|NCT00387712|580082324|FG000|Overall Study|Physician Decision|6|||
160644655|NCT00387712|580082325|FG001|Overall Study|Physician Decision|4|||
160644656|NCT00387712|580082324|FG000|Overall Study|Lost to Follow-up|17|||
160644657|NCT00387712|580082325|FG001|Overall Study|Lost to Follow-up|20|||
160644658|NCT00387712|580082324|FG000|Overall Study|Withdrawal by Subject|6|||
160644659|NCT00387712|580082325|FG001|Overall Study|Withdrawal by Subject|12|||
160644660|NCT03347695|580082342|FG000|Overall Study|Death|0|||
160644661|NCT03347695|580082343|FG001|Overall Study|Death|4|||
160644662|NCT03347695|580082342|FG000|Overall Study|Lost to Follow-up|0|||
160644663|NCT03347695|580082343|FG001|Overall Study|Lost to Follow-up|1|||
160644664|NCT04633837|580082344|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
160644665|NCT04633837|580082345|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
160644666|NCT04467697|580082347|FG000|Overall Study|Adverse Event|2|||
160644667|NCT04467697|580082347|FG000|Overall Study|Lost to Follow-up|6|||
160644668|NCT04467697|580082347|FG000|Overall Study|Withdrawal by Subject|9|||
160644669|NCT04467697|580082347|FG000|Overall Study|Protocol Violation|3|||
160644670|NCT03907280|580082348|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
160644671|NCT03907280|580082349|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
160644672|NCT03907280|580082350|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
160644673|NCT02322879|580082353|FG000|First Intervention|Physician Decision|1|||
160644674|NCT02322879|580082354|FG001|First Intervention|Physician Decision|0|||
160644675|NCT02711956|580082355|FG000|Overall Study|Adverse Event|0|||
160644676|NCT02711956|580082356|FG001|Overall Study|Adverse Event|0|||
160644677|NCT02711956|580082357|FG002|Overall Study|Adverse Event|0|||
160644678|NCT02711956|580082358|FG003|Overall Study|Adverse Event|1|||
160644679|NCT02711956|580082359|FG004|Overall Study|Adverse Event|2|||
160644680|NCT02711956|580082360|FG005|Overall Study|Adverse Event|0|||
160644681|NCT02711956|580082361|FG006|Overall Study|Adverse Event|0|||
160644682|NCT02711956|580082362|FG007|Overall Study|Adverse Event|1|||
160644683|NCT02711956|580082363|FG008|Overall Study|Adverse Event|1|||
160644684|NCT02711956|580082364|FG009|Overall Study|Adverse Event|1|||
160644685|NCT02711956|580082365|FG010|Overall Study|Adverse Event|1|||
160644686|NCT02711956|580082366|FG011|Overall Study|Adverse Event|0|||
160644687|NCT02711956|580082367|FG012|Overall Study|Adverse Event|0|||
160644688|NCT02711956|580082368|FG013|Overall Study|Adverse Event|0|||
160551342|NCT01072344|579744154|FG001|Overall Study|Lost to Follow-up|4|||
160551343|NCT00804687|579744155|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
160551344|NCT00804687|579744156|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
160551345|NCT00804687|579744157|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
160551346|NCT00804687|579744158|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
160551347|NCT00804687|579744159|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
160551348|NCT00804687|579744160|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
160551349|NCT00804687|579744155|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
160551350|NCT00804687|579744156|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
160551351|NCT00804687|579744157|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
160551352|NCT00804687|579744158|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
160551353|NCT00804687|579744159|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
160644689|NCT02711956|580082369|FG014|Overall Study|Adverse Event|2|||
160644690|NCT02711956|580082355|FG000|Overall Study|Physician Decision|0|||
160808143|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808144|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808145|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808146|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808147|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
160808148|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
160808149|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808150|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808151|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808152|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808153|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808154|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808155|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808156|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808157|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
160808158|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
160808159|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808160|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808161|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808162|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808163|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808164|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808165|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808166|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808167|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
160808168|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808169|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808170|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808171|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808172|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808173|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808174|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808175|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808176|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808177|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808178|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
160808179|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808180|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808181|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808182|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808183|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808184|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808185|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Other|0|||
160808186|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Other|0|||
160808187|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Other|2|||
160808188|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Other|1|||
160808189|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Other|0|||
160808190|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Other|0|||
160808191|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Other|0|||
160808192|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Other|0|||
160551354|NCT00804687|579744160|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
160551355|NCT00804687|579744155|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
160551356|NCT00804687|579744156|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
160551357|NCT00804687|579744157|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
160551358|NCT00804687|579744158|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
160551359|NCT00804687|579744159|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
160808193|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Other|0|||
160808194|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Other|0|||
160808195|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808196|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160985919|NCT02851511|581338523|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
160551360|NCT00804687|579744160|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
160551361|NCT00804687|579744155|FG000|Period 5: Treatment Period|Positive drug test|1|||
160808197|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808198|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808199|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808200|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
160985920|NCT02851511|581338520|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
160644691|NCT02711956|580082356|FG001|Overall Study|Physician Decision|0|||
160644692|NCT02711956|580082357|FG002|Overall Study|Physician Decision|0|||
160644693|NCT02711956|580082358|FG003|Overall Study|Physician Decision|2|||
160644694|NCT02711956|580082359|FG004|Overall Study|Physician Decision|0|||
160644695|NCT02711956|580082360|FG005|Overall Study|Physician Decision|0|||
160644696|NCT02711956|580082361|FG006|Overall Study|Physician Decision|0|||
160644697|NCT02711956|580082362|FG007|Overall Study|Physician Decision|0|||
160644698|NCT02711956|580082363|FG008|Overall Study|Physician Decision|0|||
160644699|NCT02711956|580082364|FG009|Overall Study|Physician Decision|0|||
160644700|NCT02711956|580082365|FG010|Overall Study|Physician Decision|0|||
160644701|NCT02711956|580082366|FG011|Overall Study|Physician Decision|0|||
160644702|NCT02711956|580082367|FG012|Overall Study|Physician Decision|0|||
160644703|NCT02711956|580082368|FG013|Overall Study|Physician Decision|0|||
160644704|NCT02711956|580082369|FG014|Overall Study|Physician Decision|0|||
160644705|NCT02711956|580082355|FG000|Overall Study|Withdrawal by Subject|0|||
160644706|NCT02711956|580082356|FG001|Overall Study|Withdrawal by Subject|0|||
160644707|NCT02711956|580082357|FG002|Overall Study|Withdrawal by Subject|0|||
160644708|NCT02711956|580082358|FG003|Overall Study|Withdrawal by Subject|0|||
160644709|NCT02711956|580082359|FG004|Overall Study|Withdrawal by Subject|0|||
160644710|NCT02711956|580082360|FG005|Overall Study|Withdrawal by Subject|0|||
160644711|NCT02711956|580082361|FG006|Overall Study|Withdrawal by Subject|1|||
160644712|NCT02711956|580082362|FG007|Overall Study|Withdrawal by Subject|0|||
160644713|NCT02711956|580082363|FG008|Overall Study|Withdrawal by Subject|0|||
160644714|NCT02711956|580082364|FG009|Overall Study|Withdrawal by Subject|0|||
160644715|NCT02711956|580082365|FG010|Overall Study|Withdrawal by Subject|0|||
160644716|NCT02711956|580082366|FG011|Overall Study|Withdrawal by Subject|1|||
160644717|NCT02711956|580082367|FG012|Overall Study|Withdrawal by Subject|6|||
160644718|NCT02711956|580082368|FG013|Overall Study|Withdrawal by Subject|0|||
160644719|NCT02711956|580082369|FG014|Overall Study|Withdrawal by Subject|1|||
160644720|NCT02711956|580082355|FG000|Overall Study|Clinical progression|1|||
160644721|NCT02711956|580082356|FG001|Overall Study|Clinical progression|0|||
160644722|NCT02711956|580082357|FG002|Overall Study|Clinical progression|0|||
160644723|NCT02711956|580082358|FG003|Overall Study|Clinical progression|0|||
160644724|NCT02711956|580082359|FG004|Overall Study|Clinical progression|0|||
160644725|NCT02711956|580082360|FG005|Overall Study|Clinical progression|0|||
160644726|NCT02711956|580082361|FG006|Overall Study|Clinical progression|1|||
160644727|NCT02711956|580082362|FG007|Overall Study|Clinical progression|0|||
160644728|NCT02711956|580082363|FG008|Overall Study|Clinical progression|1|||
160644729|NCT02711956|580082364|FG009|Overall Study|Clinical progression|0|||
160644730|NCT02711956|580082365|FG010|Overall Study|Clinical progression|0|||
160644731|NCT02711956|580082366|FG011|Overall Study|Clinical progression|2|||
160644732|NCT02711956|580082367|FG012|Overall Study|Clinical progression|4|||
160644733|NCT02711956|580082368|FG013|Overall Study|Clinical progression|1|||
160644734|NCT02711956|580082369|FG014|Overall Study|Clinical progression|1|||
160644735|NCT02711956|580082355|FG000|Overall Study|Radiographic progression|1|||
160644736|NCT02711956|580082356|FG001|Overall Study|Radiographic progression|1|||
160644737|NCT02711956|580082357|FG002|Overall Study|Radiographic progression|2|||
160644738|NCT02711956|580082358|FG003|Overall Study|Radiographic progression|0|||
160644739|NCT02711956|580082359|FG004|Overall Study|Radiographic progression|1|||
160644740|NCT02711956|580082360|FG005|Overall Study|Radiographic progression|0|||
160644741|NCT02711956|580082361|FG006|Overall Study|Radiographic progression|0|||
160644742|NCT02711956|580082362|FG007|Overall Study|Radiographic progression|0|||
160644743|NCT02711956|580082363|FG008|Overall Study|Radiographic progression|2|||
160644744|NCT02711956|580082364|FG009|Overall Study|Radiographic progression|1|||
160644745|NCT02711956|580082365|FG010|Overall Study|Radiographic progression|0|||
160644746|NCT02711956|580082366|FG011|Overall Study|Radiographic progression|5|||
160644747|NCT02711956|580082367|FG012|Overall Study|Radiographic progression|3|||
160644748|NCT02711956|580082368|FG013|Overall Study|Radiographic progression|0|||
160644749|NCT02711956|580082369|FG014|Overall Study|Radiographic progression|1|||
160644750|NCT02711956|580082355|FG000|Overall Study|PSA progression with clinical progression|0|||
160644751|NCT02711956|580082356|FG001|Overall Study|PSA progression with clinical progression|0|||
160644752|NCT02711956|580082357|FG002|Overall Study|PSA progression with clinical progression|0|||
160644753|NCT02711956|580082358|FG003|Overall Study|PSA progression with clinical progression|0|||
160644754|NCT02711956|580082359|FG004|Overall Study|PSA progression with clinical progression|1|||
160644755|NCT02711956|580082360|FG005|Overall Study|PSA progression with clinical progression|0|||
160644756|NCT02711956|580082361|FG006|Overall Study|PSA progression with clinical progression|0|||
160644757|NCT02711956|580082362|FG007|Overall Study|PSA progression with clinical progression|0|||
160644758|NCT02711956|580082363|FG008|Overall Study|PSA progression with clinical progression|0|||
160899198|NCT00676338|581026264|FG001|Overall Study|Entry Criteria Not Met|2|||
160899199|NCT00676338|581026265|FG002|Overall Study|Entry Criteria Not Met|1|||
160644759|NCT02711956|580082364|FG009|Overall Study|PSA progression with clinical progression|0|||
160644760|NCT02711956|580082365|FG010|Overall Study|PSA progression with clinical progression|0|||
160644761|NCT02711956|580082366|FG011|Overall Study|PSA progression with clinical progression|0|||
160899200|NCT00676338|581026266|FG003|Overall Study|Entry Criteria Not Met|1|||
160808201|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
160808202|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
160808203|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808204|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808205|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808206|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808207|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808208|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808209|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
160808210|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
160808211|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
160808212|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
160808213|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808214|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808215|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808216|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808217|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808218|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808219|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
160808220|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808221|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
160808222|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808223|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808224|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808225|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808226|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808227|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808228|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808229|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
160808230|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808231|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
160808232|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
160808233|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808234|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808235|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808236|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808237|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808238|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808239|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
160808240|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
160808241|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
160808242|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808243|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808244|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808245|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808246|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808247|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808248|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808249|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808250|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808251|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808252|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
160808253|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808254|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808255|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808256|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808257|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808258|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808259|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160551362|NCT00804687|579744156|FG001|Period 5: Treatment Period|Positive drug test|0|||
160551363|NCT00804687|579744157|FG002|Period 5: Treatment Period|Positive drug test|0|||
160551364|NCT00804687|579744158|FG003|Period 5: Treatment Period|Positive drug test|0|||
160551365|NCT00804687|579744159|FG004|Period 5: Treatment Period|Positive drug test|0|||
160551366|NCT00804687|579744160|FG005|Period 5: Treatment Period|Positive drug test|0|||
160551367|NCT05227690|579744164|FG000|Overall Study|Adverse Event|5|||
160551368|NCT05227690|579744165|FG001|Overall Study|Adverse Event|6|||
160551369|NCT05227690|579744166|FG002|Overall Study|Adverse Event|10|||
160551370|NCT05227690|579744164|FG000|Overall Study|Lack of Efficacy|2|||
160551371|NCT05227690|579744165|FG001|Overall Study|Lack of Efficacy|4|||
160551372|NCT05227690|579744166|FG002|Overall Study|Lack of Efficacy|1|||
160551373|NCT05227690|579744164|FG000|Overall Study|Physician Decision|6|||
160551374|NCT05227690|579744165|FG001|Overall Study|Physician Decision|0|||
160551375|NCT05227690|579744166|FG002|Overall Study|Physician Decision|4|||
160551376|NCT05227690|579744164|FG000|Overall Study|Withdrawal of consent|28|||
160551377|NCT05227690|579744165|FG001|Overall Study|Withdrawal of consent|27|||
160551378|NCT05227690|579744166|FG002|Overall Study|Withdrawal of consent|21|||
160551379|NCT05227690|579744164|FG000|Overall Study|Other, not specified|2|||
160551380|NCT05227690|579744165|FG001|Overall Study|Other, not specified|2|||
160551381|NCT05227690|579744166|FG002|Overall Study|Other, not specified|1|||
160551382|NCT00975156|579744167|FG000|Overall Study|Protocol Violation|0|||
160551383|NCT00975156|579744168|FG001|Overall Study|Protocol Violation|1|||
160551384|NCT05499559|579744169|FG000|Overall Study|Lost to Follow-up|467|||
160551385|NCT03472560|579744170|FG000|Overall Study|Subject transfer to continuation protocol|0|||
160551386|NCT03472560|579744171|FG001|Overall Study|Subject transfer to continuation protocol|1|||
160551387|NCT03472560|579744170|FG000|Overall Study|Withdrawal by Subject|4|||
160551388|NCT03472560|579744171|FG001|Overall Study|Withdrawal by Subject|0|||
160551389|NCT03472560|579744170|FG000|Overall Study|Progressive disease|24|||
160551390|NCT03472560|579744171|FG001|Overall Study|Progressive disease|8|||
160551391|NCT03472560|579744170|FG000|Overall Study|Physician Decision|1|||
160551392|NCT03472560|579744171|FG001|Overall Study|Physician Decision|0|||
160808260|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808261|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
160808262|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808263|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160985921|NCT02851511|581338521|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
160985922|NCT02851511|581338522|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
160551393|NCT03472560|579744170|FG000|Overall Study|Death|7|||
160808264|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808265|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808266|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808267|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808268|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808269|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808270|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160899201|NCT00676338|581026263|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
160899202|NCT00676338|581026264|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
160899203|NCT00676338|581026265|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
160899204|NCT00676338|581026266|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
160899205|NCT02122458|581026267|FG000|Overall Study|Withdrawal by Subject|0|||
160899206|NCT02122458|581026268|FG001|Overall Study|Withdrawal by Subject|0|||
160899207|NCT02122458|581026269|FG002|Overall Study|Withdrawal by Subject|0|||
160899208|NCT02122458|581026270|FG003|Overall Study|Withdrawal by Subject|4|||
160899209|NCT02122458|581026271|FG004|Overall Study|Withdrawal by Subject|4|||
160899210|NCT02122458|581026272|FG005|Overall Study|Withdrawal by Subject|4|||
160899211|NCT02122458|581026273|FG006|Overall Study|Withdrawal by Subject|0|||
160899212|NCT02122458|581026267|FG000|Overall Study|Lost to Follow-up|1|||
160899213|NCT02122458|581026268|FG001|Overall Study|Lost to Follow-up|3|||
160899214|NCT02122458|581026269|FG002|Overall Study|Lost to Follow-up|0|||
160899215|NCT02122458|581026270|FG003|Overall Study|Lost to Follow-up|7|||
160899216|NCT02122458|581026271|FG004|Overall Study|Lost to Follow-up|5|||
160899217|NCT02122458|581026272|FG005|Overall Study|Lost to Follow-up|15|||
160899218|NCT02122458|581026273|FG006|Overall Study|Lost to Follow-up|1|||
160899219|NCT02122458|581026267|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
160899220|NCT02122458|581026268|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
160899221|NCT02122458|581026269|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
160899222|NCT02122458|581026270|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
160899223|NCT02122458|581026271|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
160899224|NCT02122458|581026272|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
160899225|NCT02122458|581026273|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
160551394|NCT03472560|579744171|FG001|Overall Study|Death|4|||
160551395|NCT03472560|579744170|FG000|Overall Study|Adverse Event|5|||
160551396|NCT03472560|579744171|FG001|Overall Study|Adverse Event|3|||
160551397|NCT03472560|579744170|FG000|Overall Study|Global deterioration of health status|0|||
160551398|NCT03472560|579744171|FG001|Overall Study|Global deterioration of health status|4|||
160808271|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160985923|NCT02851511|581338523|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
160808272|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808273|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
160808274|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
160808275|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808276|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808277|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808278|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808279|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808280|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808281|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808282|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808283|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
160808284|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
160808285|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808286|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808287|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808288|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808289|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808290|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808291|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808292|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808293|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
160808294|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
160808295|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808296|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808297|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808298|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808299|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808300|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808301|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808302|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808303|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
160808304|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
160808305|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
160808306|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
160808307|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
160808308|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
160808309|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
160808310|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
160808311|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
160808312|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
160808313|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
160808314|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
160808315|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808316|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808317|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808318|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808319|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808320|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808321|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808322|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808323|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
160808324|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
160808325|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808326|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808327|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808328|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808329|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808330|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808331|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808332|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160551399|NCT02908880|579744173|FG000|Overall Study|Lost to Follow-up|4|||
160808333|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
160808334|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808335|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808336|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808337|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160644762|NCT02711956|580082367|FG012|Overall Study|PSA progression with clinical progression|1|||
160644763|NCT02711956|580082368|FG013|Overall Study|PSA progression with clinical progression|1|||
160644764|NCT02711956|580082369|FG014|Overall Study|PSA progression with clinical progression|0|||
160644765|NCT02711956|580082355|FG000|Overall Study|PSA progression with radiographic progression|0|||
160644766|NCT02711956|580082356|FG001|Overall Study|PSA progression with radiographic progression|1|||
160644767|NCT02711956|580082357|FG002|Overall Study|PSA progression with radiographic progression|0|||
160644768|NCT02711956|580082358|FG003|Overall Study|PSA progression with radiographic progression|0|||
160644769|NCT02711956|580082359|FG004|Overall Study|PSA progression with radiographic progression|0|||
160644770|NCT02711956|580082360|FG005|Overall Study|PSA progression with radiographic progression|2|||
160644771|NCT02711956|580082361|FG006|Overall Study|PSA progression with radiographic progression|2|||
160644772|NCT02711956|580082362|FG007|Overall Study|PSA progression with radiographic progression|1|||
160644773|NCT02711956|580082363|FG008|Overall Study|PSA progression with radiographic progression|0|||
160644774|NCT02711956|580082364|FG009|Overall Study|PSA progression with radiographic progression|1|||
160644775|NCT02711956|580082365|FG010|Overall Study|PSA progression with radiographic progression|0|||
160644776|NCT02711956|580082366|FG011|Overall Study|PSA progression with radiographic progression|1|||
160644777|NCT02711956|580082367|FG012|Overall Study|PSA progression with radiographic progression|2|||
160644778|NCT02711956|580082368|FG013|Overall Study|PSA progression with radiographic progression|3|||
160644779|NCT02711956|580082369|FG014|Overall Study|PSA progression with radiographic progression|3|||
160644780|NCT05487456|580082370|FG000|Overall Study|Withdrawal by Subject|0|||
160644781|NCT05487456|580082371|FG001|Overall Study|Withdrawal by Subject|0|||
160644782|NCT05487456|580082372|FG002|Overall Study|Withdrawal by Subject|1|||
160644783|NCT05487456|580082373|FG003|Overall Study|Withdrawal by Subject|0|||
160644784|NCT02043366|580082376|FG000|Overall Study|Lost to Follow-up|2|||
160644785|NCT02043366|580082377|FG001|Overall Study|Lost to Follow-up|2|||
160644786|NCT02043366|580082378|FG002|Overall Study|Lost to Follow-up|2|||
160644787|NCT02043366|580082379|FG003|Overall Study|Lost to Follow-up|2|||
160644788|NCT02043366|580082380|FG004|Overall Study|Lost to Follow-up|2|||
160808338|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808339|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808340|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808341|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808342|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808343|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
160808344|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
160808345|NCT03726658|580684562|FG000|Overall Study|Lost to Follow-up|0|||
160808346|NCT03726658|580684563|FG001|Overall Study|Lost to Follow-up|0|||
160808347|NCT03726658|580684564|FG002|Overall Study|Lost to Follow-up|2|||
160808348|NCT03726658|580684565|FG003|Overall Study|Lost to Follow-up|0|||
160808349|NCT03726658|580684566|FG004|Overall Study|Lost to Follow-up|0|||
160808350|NCT03726658|580684567|FG005|Overall Study|Lost to Follow-up|1|||
160808351|NCT03726658|580684568|FG006|Overall Study|Lost to Follow-up|1|||
160808352|NCT03726658|580684562|FG000|Overall Study|Withdrawal by Subject|1|||
160808353|NCT03726658|580684563|FG001|Overall Study|Withdrawal by Subject|0|||
160808354|NCT03726658|580684564|FG002|Overall Study|Withdrawal by Subject|0|||
160808355|NCT03726658|580684565|FG003|Overall Study|Withdrawal by Subject|0|||
160808356|NCT03726658|580684566|FG004|Overall Study|Withdrawal by Subject|6|||
160808357|NCT03726658|580684567|FG005|Overall Study|Withdrawal by Subject|4|||
160808358|NCT03726658|580684568|FG006|Overall Study|Withdrawal by Subject|2|||
160808359|NCT03726658|580684562|FG000|Overall Study|Pregnancy|0|||
160808360|NCT03726658|580684563|FG001|Overall Study|Pregnancy|0|||
160808361|NCT03726658|580684564|FG002|Overall Study|Pregnancy|0|||
160808362|NCT03726658|580684565|FG003|Overall Study|Pregnancy|0|||
160808363|NCT03726658|580684566|FG004|Overall Study|Pregnancy|0|||
160808364|NCT03726658|580684567|FG005|Overall Study|Pregnancy|0|||
160808365|NCT03726658|580684568|FG006|Overall Study|Pregnancy|1|||
160808366|NCT03726658|580684562|FG000|Overall Study|Not Reported|0|||
160808367|NCT03726658|580684563|FG001|Overall Study|Not Reported|0|||
160899226|NCT02122458|581026267|FG000|Overall Study|Adverse Event|1|||
160899227|NCT02122458|581026268|FG001|Overall Study|Adverse Event|0|||
160899228|NCT02122458|581026269|FG002|Overall Study|Adverse Event|0|||
160899229|NCT02122458|581026270|FG003|Overall Study|Adverse Event|0|||
160644789|NCT02043366|580082381|FG005|Overall Study|Lost to Follow-up|2|||
160644790|NCT03294538|580082384|FG000|Overall Study|Adverse Event|0|||
160644791|NCT03294538|580082385|FG001|Overall Study|Adverse Event|1|||
160644792|NCT03294538|580082386|FG002|Overall Study|Adverse Event|1|||
160808368|NCT03726658|580684564|FG002|Overall Study|Not Reported|0|||
160808369|NCT03726658|580684565|FG003|Overall Study|Not Reported|0|||
160899230|NCT02122458|581026271|FG004|Overall Study|Adverse Event|0|||
160808370|NCT03726658|580684566|FG004|Overall Study|Not Reported|0|||
160808371|NCT03726658|580684567|FG005|Overall Study|Not Reported|0|||
160808372|NCT03726658|580684568|FG006|Overall Study|Not Reported|1|||
160808373|NCT05710640|580684569|FG000|Overall Study|Physician Decision|0|||
160808374|NCT05710640|580684570|FG001|Overall Study|Physician Decision|1|||
160808375|NCT05710640|580684569|FG000|Overall Study|Withdrawal by Subject|1|||
160985924|NCT02851511|581338520|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
160985925|NCT02851511|581338521|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
160985926|NCT02851511|581338522|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
160985927|NCT02851511|581338523|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
160985928|NCT02851511|581338520|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
160985929|NCT02851511|581338521|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
160985930|NCT02851511|581338522|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
160985931|NCT02851511|581338523|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
160985932|NCT02851511|581338520|FG000|Phase I|Physician Decision|0|||
160985933|NCT02851511|581338521|FG001|Phase I|Physician Decision|0|||
160985934|NCT02851511|581338522|FG002|Phase I|Physician Decision|0|||
160985935|NCT02851511|581338523|FG003|Phase I|Physician Decision|1|||
160985936|NCT02851511|581338520|FG000|Phase I|Withdrawal by Subject|2|||
160985937|NCT02851511|581338521|FG001|Phase I|Withdrawal by Subject|1|||
160985938|NCT02851511|581338522|FG002|Phase I|Withdrawal by Subject|0|||
160985939|NCT02851511|581338523|FG003|Phase I|Withdrawal by Subject|3|||
160985940|NCT02851511|581338520|FG000|Phase II|Physician Decision|18|||
160985941|NCT02851511|581338521|FG001|Phase II|Physician Decision|16|||
160985942|NCT02851511|581338522|FG002|Phase II|Physician Decision|0|||
160985943|NCT02851511|581338523|FG003|Phase II|Physician Decision|0|||
160985944|NCT02851511|581338520|FG000|Phase II|Withdrawal by Subject|18|||
160985945|NCT02851511|581338521|FG001|Phase II|Withdrawal by Subject|16|||
160985946|NCT02851511|581338522|FG002|Phase II|Withdrawal by Subject|0|||
160985947|NCT02851511|581338523|FG003|Phase II|Withdrawal by Subject|0|||
160985948|NCT02851511|581338520|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
160985949|NCT02851511|581338521|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
160985950|NCT02851511|581338522|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
160985951|NCT02851511|581338523|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
160985952|NCT02851511|581338520|FG000|Phase II|Lost to Follow-up|0|||
160985953|NCT02851511|581338521|FG001|Phase II|Lost to Follow-up|1|||
160985954|NCT02851511|581338522|FG002|Phase II|Lost to Follow-up|0|||
160985955|NCT02851511|581338523|FG003|Phase II|Lost to Follow-up|0|||
160985956|NCT00051311|581338526|FG000|Overall Study|Starting new study|0|||
160985957|NCT00051311|581338527|FG001|Overall Study|Starting new study|1|||
160985958|NCT00051311|581338526|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
160985959|NCT00051311|581338527|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
160985960|NCT00051311|581338526|FG000|Overall Study|Death of recipient|8|||
160985961|NCT00051311|581338527|FG001|Overall Study|Death of recipient|8|||
160985962|NCT00051311|581338526|FG000|Overall Study|Recipient taken off study|4|||
160985963|NCT00051311|581338527|FG001|Overall Study|Recipient taken off study|4|||
160985964|NCT04170023|581338528|FG000|LTE Period|Withdrawal by Subject|1|||
160985965|NCT04170023|581338529|FG001|LTE Period|Withdrawal by Subject|0|||
160985966|NCT04170023|581338530|FG002|LTE Period|Withdrawal by Subject|0|||
160985967|NCT04170023|581338528|FG000|LTE Period|Study Termination|11|||
160808376|NCT05710640|580684570|FG001|Overall Study|Withdrawal by Subject|0|||
160808377|NCT05710640|580684569|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
160808378|NCT05710640|580684570|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
160808379|NCT04188509|580684571|FG000|Overall Study|Adverse Event|2|||
160985968|NCT04170023|581338529|FG001|LTE Period|Study Termination|11|||
160985969|NCT04170023|581338530|FG002|LTE Period|Study Termination|5|||
160985970|NCT03712098|581338531|FG000|Overall Study|Lost to Follow-up|3|||
160985971|NCT03712098|581338532|FG001|Overall Study|Lost to Follow-up|7|||
160985972|NCT03712098|581338531|FG000|Overall Study|Withdrawal by Subject|9|||
160985973|NCT03712098|581338532|FG001|Overall Study|Withdrawal by Subject|4|||
160985974|NCT03712098|581338531|FG000|Overall Study|Protocol Violation|2|||
160985975|NCT03712098|581338532|FG001|Overall Study|Protocol Violation|1|||
160808380|NCT04188509|580684571|FG000|Overall Study|Lost to Follow-up|1|||
160985976|NCT02256969|581338533|FG000|Overall Study|Screenfailed or withdrew|2|||
160985977|NCT02256969|581338534|FG001|Overall Study|Screenfailed or withdrew|1|||
160985978|NCT02256969|581338535|FG002|Overall Study|Screenfailed or withdrew|1|||
160985979|NCT00372567|581338536|FG000|Phase 3 Study|Adverse Event|5|||
160985980|NCT00372567|581338537|FG001|Phase 3 Study|Adverse Event|1|||
160985981|NCT00372567|581338538|FG002|Phase 3 Study|Adverse Event|1|||
160985982|NCT00372567|581338536|FG000|Phase 3 Study|Death|1|||
160985983|NCT00372567|581338537|FG001|Phase 3 Study|Death|1|||
160985984|NCT00372567|581338538|FG002|Phase 3 Study|Death|0|||
160985985|NCT00372567|581338536|FG000|Phase 3 Study|Protocol Violation|0|||
160985986|NCT00372567|581338537|FG001|Phase 3 Study|Protocol Violation|0|||
160985987|NCT00372567|581338538|FG002|Phase 3 Study|Protocol Violation|1|||
160985988|NCT00372567|581338536|FG000|Phase 3 Study|Objective progression or relapse|10|||
160808381|NCT04188509|580684571|FG000|Overall Study|Withdrawal of Consent|1|||
160808382|NCT04188509|580684571|FG000|Overall Study|Discretion of Investigator|1|||
160808383|NCT04188509|580684571|FG000|Overall Study|Noncompliance|3|||
160808384|NCT04188509|580684571|FG000|Overall Study|Sponsor Decision|127|||
160808385|NCT04188509|580684571|FG000|Overall Study|Other|2|||
160808386|NCT00049322|580684581|FG000|Overall Study|disease burden|0|||
160808387|NCT00049322|580684582|FG001|Overall Study|disease burden|3|||
160808388|NCT00049322|580684581|FG000|Overall Study|Adverse Event|1|||
160808389|NCT00049322|580684582|FG001|Overall Study|Adverse Event|0|||
160808390|NCT00049322|580684581|FG000|Overall Study|refused angio|0|||
160808391|NCT00049322|580684582|FG001|Overall Study|refused angio|3|||
160808392|NCT00703963|580684583|FG000|Overall Study|Withdrawal by Subject|7|||
160808393|NCT00703963|580684584|FG001|Overall Study|Withdrawal by Subject|13|||
160808394|NCT00703963|580684583|FG000|Overall Study|Physician Decision|0|||
160808395|NCT00703963|580684584|FG001|Overall Study|Physician Decision|1|||
160808396|NCT03994211|580684585|FG000|Core Phase|Adverse Event|0|||
160808397|NCT03994211|580684586|FG001|Core Phase|Adverse Event|1|||
160808398|NCT03994211|580684587|FG002|Core Phase|Adverse Event|0|||
160808399|NCT03994211|580684585|FG000|Extension Phase|Adverse Event|0|||
160808400|NCT03994211|580684586|FG001|Extension Phase|Adverse Event|0|||
160808401|NCT03994211|580684587|FG002|Extension Phase|Adverse Event|1|||
160808402|NCT03994211|580684585|FG000|Extension Phase|Physician Decision|0|||
160808403|NCT03994211|580684586|FG001|Extension Phase|Physician Decision|0|||
160808404|NCT03994211|580684587|FG002|Extension Phase|Physician Decision|1|||
160808405|NCT03994211|580684585|FG000|Extension Phase|Progressive Disease|0|||
160808406|NCT03994211|580684586|FG001|Extension Phase|Progressive Disease|0|||
160808407|NCT03994211|580684587|FG002|Extension Phase|Progressive Disease|20|||
160808408|NCT03994211|580684585|FG000|Extension Phase|Withdrawal by Subject|0|||
160808409|NCT03994211|580684586|FG001|Extension Phase|Withdrawal by Subject|0|||
160808410|NCT03994211|580684587|FG002|Extension Phase|Withdrawal by Subject|2|||
160808411|NCT00503425|580684588|FG000|Overall Study|Participant files lost|6|||
160808412|NCT00503425|580684588|FG000|Overall Study|Adverse Event|5|||
160808413|NCT00503425|580684588|FG000|Overall Study|Lack of Efficacy|25|||
160808414|NCT00503425|580684588|FG000|Overall Study|Withdrawal by Subject|8|||
160808415|NCT00503425|580684588|FG000|Overall Study|Lost to Follow-up|3|||
160808416|NCT00503425|580684588|FG000|Overall Study|Death|3|||
160808417|NCT00503425|580684588|FG000|Overall Study|Missing Data/Unknown|4|||
160808418|NCT02148263|580684589|FG000|Overall Study|Withdrawal by Subject|3|||
160808419|NCT02148263|580684590|FG001|Overall Study|Withdrawal by Subject|2|||
160808420|NCT03900728|580684591|FG000|Overall Study|No text responses|0|||
160808421|NCT03900728|580684592|FG001|Overall Study|No text responses|0|||
160808422|NCT03900728|580684593|FG002|Overall Study|No text responses|4|||
160808423|NCT00763256|580684595|FG000|Overall Study|Didn't return for appointments|7|||
160808424|NCT00763256|580684596|FG001|Overall Study|Didn't return for appointments|10|||
160808425|NCT03364231|580684597|FG000|Overall Study|Adverse Event|1|||
160808426|NCT03364231|580684598|FG001|Overall Study|Adverse Event|4|||
160808427|NCT03364231|580684597|FG000|Overall Study|Death|1|||
160808428|NCT03364231|580684598|FG001|Overall Study|Death|0|||
160808429|NCT03364231|580684597|FG000|Overall Study|Investigator Decision|2|||
160808430|NCT03364231|580684598|FG001|Overall Study|Investigator Decision|2|||
160808431|NCT03364231|580684597|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
160808432|NCT03364231|580684598|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
160808433|NCT03364231|580684597|FG000|Overall Study|Withdrawal of Subject Consent|1|||
160808434|NCT03364231|580684598|FG001|Overall Study|Withdrawal of Subject Consent|0|||
160808435|NCT03364231|580684597|FG000|Overall Study|Reason Not Specified|1|||
160808436|NCT03364231|580684598|FG001|Overall Study|Reason Not Specified|0|||
160808437|NCT03364231|580684597|FG000|Overall Study|Disease Progression|0|||
160808438|NCT03364231|580684598|FG001|Overall Study|Disease Progression|6|||
160808439|NCT01393899|580684605|FG000|Overall Study|Study terminated by sponsor|1|||
160808440|NCT01393899|580684606|FG001|Overall Study|Study terminated by sponsor|0|||
160808441|NCT01393899|580684607|FG002|Overall Study|Study terminated by sponsor|1|||
160808442|NCT01393899|580684605|FG000|Overall Study|Other|1|||
160808443|NCT01393899|580684606|FG001|Overall Study|Other|0|||
160808444|NCT01393899|580684607|FG002|Overall Study|Other|0|||
160808445|NCT01393899|580684605|FG000|Overall Study|Withdrawal by Subject|2|||
160808446|NCT01393899|580684606|FG001|Overall Study|Withdrawal by Subject|2|||
160808447|NCT01393899|580684607|FG002|Overall Study|Withdrawal by Subject|1|||
160808448|NCT01393899|580684605|FG000|Overall Study|Lost to Follow-up|0|||
160808449|NCT01393899|580684606|FG001|Overall Study|Lost to Follow-up|0|||
160808450|NCT01393899|580684607|FG002|Overall Study|Lost to Follow-up|1|||
160808451|NCT01393899|580684605|FG000|Overall Study|Does not meet entrance criteria|1|||
160808452|NCT01393899|580684606|FG001|Overall Study|Does not meet entrance criteria|0|||
160808453|NCT01393899|580684607|FG002|Overall Study|Does not meet entrance criteria|1|||
160808454|NCT01393899|580684605|FG000|Overall Study|Lack of Efficacy|26|||
160808455|NCT01393899|580684606|FG001|Overall Study|Lack of Efficacy|21|||
160808456|NCT01393899|580684607|FG002|Overall Study|Lack of Efficacy|16|||
160808457|NCT01393899|580684605|FG000|Overall Study|Adverse Event|1|||
160808458|NCT01393899|580684606|FG001|Overall Study|Adverse Event|5|||
160808459|NCT01393899|580684607|FG002|Overall Study|Adverse Event|3|||
160808460|NCT02503085|580684608|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
160808461|NCT02503085|580684609|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
160808462|NCT02503085|580684610|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
160808463|NCT02503085|580684611|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
160808464|NCT01162473|580684615|FG000|Overall Study|Adverse Event|2|||
160808465|NCT01162473|580684616|FG001|Overall Study|Adverse Event|1|||
160808466|NCT01162473|580684615|FG000|Overall Study|Withdrawal by Subject|0|||
160808467|NCT01162473|580684616|FG001|Overall Study|Withdrawal by Subject|4|||
160808468|NCT01144416|580684617|FG000|Intervention Period|Adverse Event|5|||
160808469|NCT01144416|580684618|FG001|Intervention Period|Adverse Event|6|||
160808470|NCT01144416|580684617|FG000|Intervention Period|Insufficient ovarian response|11|||
160808471|NCT01144416|580684618|FG001|Intervention Period|Insufficient ovarian response|17|||
160808472|NCT01144416|580684617|FG000|Intervention Period|Risk of OHSS|0|||
160808473|NCT01144416|580684618|FG001|Intervention Period|Risk of OHSS|1|||
160808474|NCT01144416|580684617|FG000|Intervention Period|Too high ovarian response|4|||
160808475|NCT01144416|580684618|FG001|Intervention Period|Too high ovarian response|2|||
160808476|NCT01144416|580684617|FG000|Intervention Period|No/too few/bad oocytes|7|||
160808477|NCT01144416|580684618|FG001|Intervention Period|No/too few/bad oocytes|5|||
160808478|NCT01144416|580684617|FG000|Intervention Period|No or abnormal fertilization|25|||
160808479|NCT01144416|580684618|FG001|Intervention Period|No or abnormal fertilization|10|||
160808480|NCT01144416|580684617|FG000|Intervention Period|No/too few/bad quality embryos|3|||
160808481|NCT01144416|580684618|FG001|Intervention Period|No/too few/bad quality embryos|3|||
160808482|NCT01144416|580684617|FG000|Intervention Period|Other|7|||
160808483|NCT01144416|580684618|FG001|Intervention Period|Other|5|||
160808484|NCT00124072|580684619|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
160808485|NCT00124072|580684620|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
160985989|NCT00372567|581338537|FG001|Phase 3 Study|Objective progression or relapse|13|||
160985990|NCT00372567|581338538|FG002|Phase 3 Study|Objective progression or relapse|4|||
160985991|NCT00372567|581338536|FG000|Phase 3 Study|Global deterioration of health status|0|||
160985992|NCT00372567|581338537|FG001|Phase 3 Study|Global deterioration of health status|1|||
160985993|NCT00372567|581338538|FG002|Phase 3 Study|Global deterioration of health status|0|||
160985994|NCT00372567|581338536|FG000|Phase 3 Study|Other|2|||
160985995|NCT00372567|581338537|FG001|Phase 3 Study|Other|2|||
160985996|NCT00372567|581338538|FG002|Phase 3 Study|Other|1|||
160985997|NCT00372567|581338536|FG000|Phase 3 Study|study terminated by sponsor|13|||
160985998|NCT00372567|581338537|FG001|Phase 3 Study|study terminated by sponsor|8|||
160985999|NCT00372567|581338538|FG002|Phase 3 Study|study terminated by sponsor|5|||
160986000|NCT00953160|581338543|FG000|Overall Study|Lost to Follow-up|23|||
160986001|NCT00953160|581338543|FG000|Overall Study|Withdrawal by Subject|4|||
160986002|NCT03836664|581338556|FG000|Overall Study|Didn't complete forms and lost drug|3|||
160986003|NCT03836664|581338557|FG001|Overall Study|Didn't complete forms and lost drug|3|||
160986004|NCT01427907|581338558|FG000|Overall Study|Withdrawal by Subject|3|||
160986005|NCT01427907|581338559|FG001|Overall Study|Withdrawal by Subject|4|||
160986006|NCT00425503|581338562|FG000|Overall Study|Adverse Event|2|||
160986007|NCT00425503|581338562|FG000|Overall Study|Protocol Violation|1|||
160986008|NCT03278028|581338564|FG000|Overall Study|Lost to Follow-up|1|||
160986009|NCT03278028|581338565|FG001|Overall Study|Lost to Follow-up|0|||
160986010|NCT03278028|581338564|FG000|Overall Study|Withdrawal by Subject|3|||
160986011|NCT03278028|581338565|FG001|Overall Study|Withdrawal by Subject|1|||
160986012|NCT03278028|581338564|FG000|Overall Study|Pregnancy|0|||
160986013|NCT03278028|581338565|FG001|Overall Study|Pregnancy|1|||
160986014|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
160808486|NCT00124072|580684621|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
160551400|NCT02908880|579744173|FG000|Overall Study|Explantation of the device|1|||
160551401|NCT02908880|579744173|FG000|Overall Study|Withdrawal by Subject|17|||
160551402|NCT02908880|579744173|FG000|Overall Study|Death|5|||
160551403|NCT05425563|579744178|FG000|Overall Study|Withdrawal by Subject|17|||
160551404|NCT01001702|579744179|FG000|Overall Study|Lost to Follow-up|7|||
160551405|NCT01001702|579744179|FG000|Overall Study|Adverse Event|7|||
160551406|NCT01001702|579744179|FG000|Overall Study|Sponsor Discontinued Study|4|||
160551407|NCT01001702|579744179|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
160808487|NCT00124072|580684622|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
160808488|NCT00124072|580684619|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
160808489|NCT00124072|580684620|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
160808490|NCT00124072|580684621|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
160986015|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
160986016|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
160986017|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
160986018|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
160986019|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
160986020|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
160644793|NCT03294538|580082384|FG000|Overall Study|Lost to Follow-up|1|||
160644794|NCT03294538|580082385|FG001|Overall Study|Lost to Follow-up|0|||
160644795|NCT03294538|580082386|FG002|Overall Study|Lost to Follow-up|0|||
160644796|NCT03294538|580082384|FG000|Overall Study|Outside of Visit Window|4|||
160644797|NCT03294538|580082385|FG001|Overall Study|Outside of Visit Window|4|||
160644798|NCT03294538|580082386|FG002|Overall Study|Outside of Visit Window|1|||
160644799|NCT01489956|580082388|FG000|Overall Study|Lost to Follow-up|1|||
160644800|NCT01489956|580082389|FG001|Overall Study|Lost to Follow-up|0|||
160644801|NCT01489956|580082390|FG002|Overall Study|Lost to Follow-up|0|||
160644802|NCT01489956|580082388|FG000|Overall Study|Withdrawal by Subject|0|||
160644803|NCT01489956|580082389|FG001|Overall Study|Withdrawal by Subject|0|||
160644804|NCT01489956|580082390|FG002|Overall Study|Withdrawal by Subject|1|||
160644805|NCT00723554|580082392|FG000|Overall Study|Adverse Event|12|||
160644806|NCT00723554|580082392|FG000|Overall Study|Investigator's judgement|5|||
160644807|NCT00723554|580082392|FG000|Overall Study|Inhaled medication other than iloprost|4|||
160644808|NCT00723554|580082392|FG000|Overall Study|Withdrawal of consent|3|||
160644809|NCT00723554|580082392|FG000|Overall Study|Other|3|||
160644810|NCT00723554|580082392|FG000|Overall Study|Lost to Follow-up|1|||
160644811|NCT00723554|580082392|FG000|Overall Study|Non-compliance|1|||
160644812|NCT01405820|580082393|FG000|Randomized Treatment Period|Adverse Event|3|||
160644813|NCT01405820|580082394|FG001|Randomized Treatment Period|Adverse Event|3|||
160644814|NCT01405820|580082395|FG002|Randomized Treatment Period|Adverse Event|3|||
160644815|NCT01405820|580082396|FG003|Randomized Treatment Period|Adverse Event|0|||
160644816|NCT01405820|580082397|FG004|Randomized Treatment Period|Adverse Event|2|||
160644817|NCT01405820|580082398|FG005|Randomized Treatment Period|Adverse Event|1|||
160644818|NCT01405820|580082393|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
160644819|NCT01405820|580082394|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
160644820|NCT01405820|580082395|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
160644821|NCT01405820|580082396|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
160644822|NCT01405820|580082397|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
160644823|NCT01405820|580082398|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
160644824|NCT01405820|580082393|FG000|Randomized Treatment Period|Other|2|||
160644825|NCT01405820|580082394|FG001|Randomized Treatment Period|Other|2|||
160644826|NCT01405820|580082395|FG002|Randomized Treatment Period|Other|1|||
160644827|NCT01405820|580082396|FG003|Randomized Treatment Period|Other|1|||
160644828|NCT01405820|580082397|FG004|Randomized Treatment Period|Other|0|||
160644829|NCT01405820|580082398|FG005|Randomized Treatment Period|Other|0|||
160644830|NCT01405820|580082393|FG000|Randomized Treatment Period|Physician Decision|0|||
160644831|NCT01405820|580082394|FG001|Randomized Treatment Period|Physician Decision|2|||
160644832|NCT01405820|580082395|FG002|Randomized Treatment Period|Physician Decision|1|||
160644833|NCT01405820|580082396|FG003|Randomized Treatment Period|Physician Decision|0|||
160644834|NCT01405820|580082397|FG004|Randomized Treatment Period|Physician Decision|0|||
160644835|NCT01405820|580082398|FG005|Randomized Treatment Period|Physician Decision|0|||
160644836|NCT01405820|580082393|FG000|Randomized Treatment Period|Rescue|0|||
160644837|NCT01405820|580082394|FG001|Randomized Treatment Period|Rescue|1|||
160644838|NCT01405820|580082395|FG002|Randomized Treatment Period|Rescue|13|||
160644839|NCT01405820|580082396|FG003|Randomized Treatment Period|Rescue|10|||
160644840|NCT01405820|580082397|FG004|Randomized Treatment Period|Rescue|8|||
160808491|NCT00124072|580684622|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
160808492|NCT00124072|580684619|FG000|Overall Study|Death|499|||
160808493|NCT00124072|580684620|FG001|Overall Study|Death|484|||
160808494|NCT00124072|580684621|FG002|Overall Study|Death|471|||
160808495|NCT00124072|580684622|FG003|Overall Study|Death|480|||
160808496|NCT00414076|580684623|FG000|Overall Study|Progression|1|||
160808497|NCT00414076|580684624|FG001|Overall Study|Progression|2|||
160808498|NCT00414076|580684623|FG000|Overall Study|Withdrawal by Subject|1|||
160808499|NCT00414076|580684624|FG001|Overall Study|Withdrawal by Subject|3|||
160808500|NCT00414076|580684623|FG000|Overall Study|Adverse Event|1|||
160808501|NCT00414076|580684624|FG001|Overall Study|Adverse Event|0|||
160808502|NCT03670355|580684632|FG000|Overall Study|Adverse Event|1|||
160808503|NCT03670355|580684633|FG001|Overall Study|Adverse Event|0|||
160808504|NCT03670355|580684632|FG000|Overall Study|Unable to comply with study procedures|0|||
160808505|NCT03670355|580684633|FG001|Overall Study|Unable to comply with study procedures|1|||
160808506|NCT03670355|580684632|FG000|Overall Study|Participant refused|0|||
160808507|NCT03670355|580684633|FG001|Overall Study|Participant refused|1|||
160808508|NCT02708680|580684638|FG000|Overall Study|Withdrawal by Subject|4|||
160808509|NCT02708680|580684639|FG001|Overall Study|Withdrawal by Subject|12|||
160808510|NCT02708680|580684640|FG002|Overall Study|Withdrawal by Subject|12|||
160808511|NCT02708680|580684638|FG000|Overall Study|Death|4|||
160808512|NCT02708680|580684639|FG001|Overall Study|Death|19|||
160808513|NCT02708680|580684640|FG002|Overall Study|Death|21|||
160808514|NCT02708680|580684638|FG000|Overall Study|Lost to Follow-up|0|||
160808515|NCT02708680|580684639|FG001|Overall Study|Lost to Follow-up|3|||
160808516|NCT02708680|580684640|FG002|Overall Study|Lost to Follow-up|3|||
160808517|NCT02708680|580684638|FG000|Overall Study|Study Terminated By Sponsor|0|||
160808518|NCT02708680|580684639|FG001|Overall Study|Study Terminated By Sponsor|5|||
160808519|NCT02708680|580684640|FG002|Overall Study|Study Terminated By Sponsor|4|||
160808520|NCT02708680|580684638|FG000|Overall Study|Other than Specified|0|||
160808521|NCT02708680|580684639|FG001|Overall Study|Other than Specified|0|||
160808522|NCT02708680|580684640|FG002|Overall Study|Other than Specified|1|||
160808523|NCT02708680|580684638|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
160808524|NCT02708680|580684639|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
160808525|NCT02708680|580684640|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
160808526|NCT01342926|580684641|FG000|Overall Study|Adverse Event|5|||
160808527|NCT01342926|580684642|FG001|Overall Study|Adverse Event|8|||
160808528|NCT01342926|580684643|FG002|Overall Study|Adverse Event|10|||
160808529|NCT01342926|580684644|FG003|Overall Study|Adverse Event|7|||
160808530|NCT01342926|580684641|FG000|Overall Study|Lost to Follow-up|0|||
160808531|NCT01342926|580684642|FG001|Overall Study|Lost to Follow-up|1|||
160808532|NCT01342926|580684643|FG002|Overall Study|Lost to Follow-up|1|||
160808533|NCT01342926|580684644|FG003|Overall Study|Lost to Follow-up|0|||
160808534|NCT01342926|580684641|FG000|Overall Study|Investigator Discretion|2|||
160551408|NCT01001702|579744179|FG000|Overall Study|Investigator withdrew Subject|10|||
160551409|NCT01001702|579744179|FG000|Overall Study|Withdrawal by Subject|19|||
160551410|NCT01001702|579744179|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
160551411|NCT00584233|579744182|FG000|Overall Study|Withdrawal by Subject|5|||
160551412|NCT00584233|579744182|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
160551413|NCT02494596|579744183|FG000|Overall Study|Insufficient Therapeutic Response|3|||
160551414|NCT02494596|579744184|FG001|Overall Study|Insufficient Therapeutic Response|3|||
160551415|NCT02494596|579744185|FG002|Overall Study|Insufficient Therapeutic Response|1|||
160551416|NCT02494596|579744183|FG000|Overall Study|Adverse Event|0|||
160551417|NCT02494596|579744184|FG001|Overall Study|Adverse Event|1|||
160551418|NCT02494596|579744185|FG002|Overall Study|Adverse Event|0|||
160551419|NCT02494596|579744183|FG000|Overall Study|Refused Treatment|0|||
160551420|NCT02494596|579744184|FG001|Overall Study|Refused Treatment|1|||
160551421|NCT02494596|579744185|FG002|Overall Study|Refused Treatment|0|||
160551422|NCT02222714|579744186|FG000|Overall Study|Death|0|||
160808535|NCT01342926|580684642|FG001|Overall Study|Investigator Discretion|2|||
160808536|NCT01342926|580684643|FG002|Overall Study|Investigator Discretion|0|||
160808537|NCT01342926|580684644|FG003|Overall Study|Investigator Discretion|0|||
160808538|NCT01342926|580684641|FG000|Overall Study|Withdrawal by Subject|2|||
160808539|NCT01342926|580684642|FG001|Overall Study|Withdrawal by Subject|4|||
160551423|NCT02222714|579744187|FG001|Overall Study|Death|2|||
160808540|NCT01342926|580684643|FG002|Overall Study|Withdrawal by Subject|3|||
160808541|NCT01342926|580684644|FG003|Overall Study|Withdrawal by Subject|5|||
160808542|NCT04162470|580684645|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
160808543|NCT01671956|580684646|FG000|Overall Study|Disease progression|0|||
160808544|NCT01671956|580684647|FG001|Overall Study|Disease progression|1|||
160808545|NCT01671956|580684646|FG000|Overall Study|Withdrawal by Subject|1|||
160551424|NCT02222714|579744188|FG002|Overall Study|Death|3|||
160551425|NCT02222714|579744189|FG003|Overall Study|Death|4|||
160551426|NCT02222714|579744190|FG004|Overall Study|Death|6|||
160551427|NCT02222714|579744186|FG000|Overall Study|Withdrawal by Subject|0|||
160808546|NCT01671956|580684647|FG001|Overall Study|Withdrawal by Subject|1|||
160808547|NCT01671956|580684646|FG000|Overall Study|Adverse Event|1|||
160899231|NCT02122458|581026272|FG005|Overall Study|Adverse Event|0|||
160899232|NCT02122458|581026273|FG006|Overall Study|Adverse Event|0|||
160899233|NCT02122458|581026267|FG000|Overall Study|Experimental Error|0|||
160899234|NCT02122458|581026268|FG001|Overall Study|Experimental Error|0|||
160899235|NCT02122458|581026269|FG002|Overall Study|Experimental Error|0|||
160899236|NCT02122458|581026270|FG003|Overall Study|Experimental Error|0|||
160899237|NCT02122458|581026271|FG004|Overall Study|Experimental Error|3|||
160899238|NCT02122458|581026272|FG005|Overall Study|Experimental Error|0|||
160899239|NCT02122458|581026273|FG006|Overall Study|Experimental Error|0|||
160644841|NCT01405820|580082398|FG005|Randomized Treatment Period|Rescue|8|||
160644842|NCT01405820|580082393|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
160644843|NCT01405820|580082394|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
160644844|NCT01405820|580082395|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
160644845|NCT01405820|580082396|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
160644846|NCT01405820|580082397|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
160644847|NCT01405820|580082398|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
160644848|NCT01405820|580082393|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
160644849|NCT01405820|580082394|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
160644850|NCT01405820|580082395|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
160644851|NCT01405820|580082396|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
160644852|NCT01405820|580082397|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
160644853|NCT01405820|580082398|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
160644854|NCT01405820|580082393|FG000|Randomized Treatment Period|Death|0|||
160644855|NCT01405820|580082394|FG001|Randomized Treatment Period|Death|0|||
160644856|NCT01405820|580082395|FG002|Randomized Treatment Period|Death|0|||
160644857|NCT01405820|580082396|FG003|Randomized Treatment Period|Death|1|||
160644858|NCT01405820|580082397|FG004|Randomized Treatment Period|Death|0|||
160644859|NCT01405820|580082398|FG005|Randomized Treatment Period|Death|0|||
160644860|NCT01405820|580082393|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
160644861|NCT01405820|580082394|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
160644862|NCT01405820|580082395|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
160644863|NCT01405820|580082396|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
160644864|NCT01405820|580082397|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
160644865|NCT01405820|580082398|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
160644866|NCT01405820|580082393|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
160644867|NCT01405820|580082394|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
160644868|NCT01405820|580082395|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
160644869|NCT01405820|580082396|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
160644870|NCT01405820|580082397|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
160644871|NCT01405820|580082398|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
160644872|NCT01405820|580082393|FG000|Open-Label Treatment Period|Other|1|||
160644873|NCT01405820|580082394|FG001|Open-Label Treatment Period|Other|1|||
160644874|NCT01405820|580082395|FG002|Open-Label Treatment Period|Other|1|||
160644875|NCT01405820|580082396|FG003|Open-Label Treatment Period|Other|1|||
160644876|NCT01405820|580082397|FG004|Open-Label Treatment Period|Other|1|||
160644877|NCT01405820|580082398|FG005|Open-Label Treatment Period|Other|1|||
160644878|NCT01405820|580082393|FG000|Open-Label Treatment Period|Physician Decision|0|||
160644879|NCT01405820|580082394|FG001|Open-Label Treatment Period|Physician Decision|0|||
160644880|NCT01405820|580082395|FG002|Open-Label Treatment Period|Physician Decision|1|||
160644881|NCT01405820|580082396|FG003|Open-Label Treatment Period|Physician Decision|2|||
160644882|NCT01405820|580082397|FG004|Open-Label Treatment Period|Physician Decision|1|||
160644883|NCT01405820|580082398|FG005|Open-Label Treatment Period|Physician Decision|0|||
160644884|NCT01405820|580082393|FG000|Open-Label Treatment Period|Adverse Event|0|||
160644885|NCT01405820|580082394|FG001|Open-Label Treatment Period|Adverse Event|0|||
160644886|NCT01405820|580082395|FG002|Open-Label Treatment Period|Adverse Event|0|||
160644887|NCT01405820|580082396|FG003|Open-Label Treatment Period|Adverse Event|1|||
160644888|NCT01405820|580082397|FG004|Open-Label Treatment Period|Adverse Event|0|||
160644889|NCT01405820|580082398|FG005|Open-Label Treatment Period|Adverse Event|0|||
160644890|NCT01894984|580082404|FG000|Overall Study|Other|314|||
160644891|NCT01894984|580082405|FG001|Overall Study|Other|175|||
160644892|NCT00827359|580082406|FG000|Overall Study|Progressive Diseas|19|||
160644893|NCT00827359|580082406|FG000|Overall Study|Unacceptable Toxicity|5|||
160644894|NCT00827359|580082406|FG000|Overall Study|Ineligible|1|||
160644895|NCT02436135|580082407|FG000|Overall Study|Progressive Disease|3|||
160644896|NCT02436135|580082408|FG001|Overall Study|Progressive Disease|1|||
160644897|NCT02436135|580082407|FG000|Overall Study|Investigator Discretion|1|||
160644898|NCT02436135|580082408|FG001|Overall Study|Investigator Discretion|2|||
160644899|NCT02436135|580082407|FG000|Overall Study|Adverse Event|1|||
160644900|NCT02436135|580082408|FG001|Overall Study|Adverse Event|0|||
160644901|NCT02436135|580082407|FG000|Overall Study|Withdrawal by Participant|1|||
160644902|NCT02436135|580082408|FG001|Overall Study|Withdrawal by Participant|0|||
160644903|NCT02436135|580082407|FG000|Overall Study|Study Terminated By Sponsor|0|||
160899240|NCT02122458|581026267|FG000|Overall Study|Deployed or Moved|0|||
160808548|NCT01671956|580684647|FG001|Overall Study|Adverse Event|0|||
160808549|NCT04266912|580684651|FG000|Overall Study|Withdrawal by Subject|1|||
160808550|NCT04266912|580684652|FG001|Overall Study|Withdrawal by Subject|0|||
160808551|NCT04266912|580684653|FG002|Overall Study|Withdrawal by Subject|0|||
160808552|NCT04266912|580684654|FG003|Overall Study|Withdrawal by Subject|0|||
160808553|NCT04266912|580684651|FG000|Overall Study|Progression|6|||
160808554|NCT04266912|580684652|FG001|Overall Study|Progression|6|||
160808555|NCT04266912|580684653|FG002|Overall Study|Progression|0|||
160808556|NCT04266912|580684654|FG003|Overall Study|Progression|10|||
160808557|NCT03816176|580684661|FG000|Overall Study|Miscellaneous|5|||
160808558|NCT03816176|580684661|FG000|Overall Study|Lack of Efficacy|4|||
160808559|NCT03816176|580684661|FG000|Overall Study|Adverse Event|3|||
160808560|NCT05200572|580684662|FG000|Overall Study|Withdrawal by Subject|14|||
160808561|NCT07214935|580684663|FG000|Overall Study|Adverse Event|1|||
160808562|NCT07214935|580684664|FG001|Overall Study|Adverse Event|1|||
160808563|NCT07214935|580684665|FG002|Overall Study|Adverse Event|1|||
160808564|NCT07214935|580684666|FG003|Overall Study|Adverse Event|0|||
160808565|NCT07214935|580684663|FG000|Overall Study|Lost to Follow-up|0|||
160808566|NCT07214935|580684664|FG001|Overall Study|Lost to Follow-up|1|||
160808567|NCT07214935|580684665|FG002|Overall Study|Lost to Follow-up|0|||
160808568|NCT07214935|580684666|FG003|Overall Study|Lost to Follow-up|0|||
160808569|NCT07214935|580684663|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
160808570|NCT07214935|580684664|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
160808571|NCT07214935|580684665|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
160808572|NCT07214935|580684666|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
160986021|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
160986022|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
160986023|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
160986024|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
160808573|NCT07214935|580684663|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
160808574|NCT07214935|580684664|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
160808575|NCT07214935|580684665|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
160808576|NCT07214935|580684666|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
160808577|NCT05823974|580686475|FG000|Overall Study|Lost to Follow-up|0|||
160808578|NCT05823974|580686476|FG001|Overall Study|Lost to Follow-up|3|||
160808579|NCT05823974|580686477|FG002|Overall Study|Lost to Follow-up|1|||
160808580|NCT05823974|580686478|FG003|Overall Study|Lost to Follow-up|0|||
160808581|NCT05823974|580686479|FG004|Overall Study|Lost to Follow-up|1|||
160808582|NCT05823974|580686480|FG005|Overall Study|Lost to Follow-up|0|||
160808583|NCT05823974|580686481|FG006|Overall Study|Lost to Follow-up|1|||
160808584|NCT05823974|580686482|FG007|Overall Study|Lost to Follow-up|0|||
160808585|NCT05823974|580686483|FG008|Overall Study|Lost to Follow-up|0|||
160808586|NCT05823974|580686484|FG009|Overall Study|Lost to Follow-up|1|||
160808587|NCT05823974|580686485|FG010|Overall Study|Lost to Follow-up|1|||
160808588|NCT05823974|580686486|FG011|Overall Study|Lost to Follow-up|0|||
160808589|NCT05823974|580686487|FG012|Overall Study|Lost to Follow-up|1|||
160808590|NCT05823974|580686488|FG013|Overall Study|Lost to Follow-up|2|||
160808591|NCT05823974|580686489|FG014|Overall Study|Lost to Follow-up|1|||
160808592|NCT05823974|580686490|FG015|Overall Study|Lost to Follow-up|1|||
160808593|NCT05823974|580686491|FG016|Overall Study|Lost to Follow-up|1|||
160808594|NCT05823974|580686492|FG017|Overall Study|Lost to Follow-up|0|||
160808595|NCT05823974|580686493|FG018|Overall Study|Lost to Follow-up|0|||
160808596|NCT05823974|580686494|FG019|Overall Study|Lost to Follow-up|2|||
160808597|NCT05823974|580686495|FG020|Overall Study|Lost to Follow-up|0|||
160808598|NCT05823974|580686475|FG000|Overall Study|Physician Decision|0|||
160808599|NCT05823974|580686476|FG001|Overall Study|Physician Decision|0|||
160808600|NCT05823974|580686477|FG002|Overall Study|Physician Decision|0|||
160808601|NCT05823974|580686478|FG003|Overall Study|Physician Decision|0|||
160808602|NCT05823974|580686479|FG004|Overall Study|Physician Decision|0|||
160986025|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
160986026|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
160986027|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
160986028|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
160986029|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
160986030|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
160986031|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
160551428|NCT02222714|579744187|FG001|Overall Study|Withdrawal by Subject|0|||
160551429|NCT02222714|579744188|FG002|Overall Study|Withdrawal by Subject|1|||
160551430|NCT02222714|579744189|FG003|Overall Study|Withdrawal by Subject|0|||
160551431|NCT02222714|579744190|FG004|Overall Study|Withdrawal by Subject|1|||
160551432|NCT00159432|579744191|FG000|Overall Study|Adverse Event|1|||
160551433|NCT00159432|579744191|FG000|Overall Study|Death|1|||
160551434|NCT00159432|579744191|FG000|Overall Study|Lack of Efficacy|8|||
160551435|NCT04537208|579744192|FG000|Overall Study|Adverse Event|0|||
160644904|NCT02436135|580082408|FG001|Overall Study|Study Terminated By Sponsor|1|||
160644905|NCT02087046|580082413|FG000|Overall Study|Adverse Event|4|||
160644906|NCT02087046|580082413|FG000|Overall Study|Death|1|||
160644907|NCT02087046|580082413|FG000|Overall Study|Lost to Follow-up|3|||
160644908|NCT02087046|580082413|FG000|Overall Study|Withdrawal by Subject|2|||
160644909|NCT02087046|580082413|FG000|Overall Study|Physician Decision|1|||
160644910|NCT03567057|580082414|FG000|Overall Study|Adverse Event|56|||
160644911|NCT03567057|580082415|FG001|Overall Study|Adverse Event|53|||
160644912|NCT03567057|580082416|FG002|Overall Study|Adverse Event|28|||
160644913|NCT03567057|580082414|FG000|Overall Study|Withdrawal by Subject|22|||
160644914|NCT03567057|580082415|FG001|Overall Study|Withdrawal by Subject|24|||
160644915|NCT03567057|580082416|FG002|Overall Study|Withdrawal by Subject|13|||
160644916|NCT03567057|580082414|FG000|Overall Study|Lost to Follow-up|3|||
160644917|NCT03567057|580082415|FG001|Overall Study|Lost to Follow-up|5|||
160644918|NCT03567057|580082416|FG002|Overall Study|Lost to Follow-up|2|||
160644919|NCT03567057|580082414|FG000|Overall Study|COVID-19 pandemic|4|||
160644920|NCT03567057|580082415|FG001|Overall Study|COVID-19 pandemic|3|||
160644921|NCT03567057|580082416|FG002|Overall Study|COVID-19 pandemic|0|||
160644922|NCT03567057|580082414|FG000|Overall Study|Non-compliance with study drug|4|||
160644923|NCT03567057|580082415|FG001|Overall Study|Non-compliance with study drug|2|||
160644924|NCT03567057|580082416|FG002|Overall Study|Non-compliance with study drug|0|||
160644925|NCT03567057|580082414|FG000|Overall Study|Lack of Efficacy|3|||
160644926|NCT03567057|580082415|FG001|Overall Study|Lack of Efficacy|0|||
160644927|NCT03567057|580082416|FG002|Overall Study|Lack of Efficacy|1|||
160644928|NCT03567057|580082414|FG000|Overall Study|Death|1|||
160644929|NCT03567057|580082415|FG001|Overall Study|Death|0|||
160644930|NCT03567057|580082416|FG002|Overall Study|Death|0|||
160644931|NCT03567057|580082414|FG000|Overall Study|Physician Decision|1|||
160644932|NCT03567057|580082415|FG001|Overall Study|Physician Decision|0|||
160644933|NCT03567057|580082416|FG002|Overall Study|Physician Decision|0|||
160644934|NCT03567057|580082414|FG000|Overall Study|Unstable medical condition|1|||
160644935|NCT03567057|580082415|FG001|Overall Study|Unstable medical condition|0|||
160644936|NCT03567057|580082416|FG002|Overall Study|Unstable medical condition|0|||
160644937|NCT03567057|580082414|FG000|Overall Study|Medical history event|0|||
160644938|NCT03567057|580082415|FG001|Overall Study|Medical history event|0|||
160644939|NCT03567057|580082416|FG002|Overall Study|Medical history event|1|||
160644940|NCT03567057|580082414|FG000|Overall Study|Other|0|||
160644941|NCT03567057|580082415|FG001|Overall Study|Other|0|||
160644942|NCT03567057|580082416|FG002|Overall Study|Other|1|||
160644943|NCT01155583|580082417|FG000|Phase I|Screen failure - did not start treatment|0|||
160644944|NCT01155583|580082418|FG001|Phase I|Screen failure - did not start treatment|0|||
160644945|NCT01155583|580082419|FG002|Phase I|Screen failure - did not start treatment|0|||
160644946|NCT01155583|580082420|FG003|Phase I|Screen failure - did not start treatment|0|||
160644947|NCT01155583|580082421|FG004|Phase I|Screen failure - did not start treatment|1|||
160644948|NCT01155583|580082422|FG005|Phase I|Screen failure - did not start treatment|0|||
160986032|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
160986033|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
160986034|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
160986035|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
160986036|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
160986037|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
160644949|NCT01155583|580082423|FG006|Phase I|Screen failure - did not start treatment|0|||
160644950|NCT01155583|580082424|FG007|Phase I|Screen failure - did not start treatment|2|||
160644951|NCT01155583|580082425|FG008|Phase I|Screen failure - did not start treatment|0|||
160644952|NCT01155583|580082417|FG000|Phase I|Withdrawal by Subject|0|||
160644953|NCT01155583|580082418|FG001|Phase I|Withdrawal by Subject|0|||
160644954|NCT01155583|580082419|FG002|Phase I|Withdrawal by Subject|0|||
160644955|NCT01155583|580082420|FG003|Phase I|Withdrawal by Subject|0|||
160644956|NCT01155583|580082421|FG004|Phase I|Withdrawal by Subject|0|||
160644957|NCT01155583|580082422|FG005|Phase I|Withdrawal by Subject|0|||
160644958|NCT01155583|580082423|FG006|Phase I|Withdrawal by Subject|0|||
160644959|NCT01155583|580082424|FG007|Phase I|Withdrawal by Subject|1|||
160644960|NCT01155583|580082425|FG008|Phase I|Withdrawal by Subject|0|||
160644961|NCT02040766|580082430|FG000|Overall Study|Adverse Event|1|||
160644962|NCT02040766|580082431|FG001|Overall Study|Adverse Event|1|||
160644963|NCT02040766|580082432|FG002|Overall Study|Adverse Event|1|||
160644964|NCT02040766|580082433|FG003|Overall Study|Adverse Event|0|||
160644965|NCT02040766|580082434|FG004|Overall Study|Adverse Event|2|||
160644966|NCT02040766|580082430|FG000|Overall Study|Withdrawal by Subject|4|||
160644967|NCT02040766|580082431|FG001|Overall Study|Withdrawal by Subject|3|||
160644968|NCT02040766|580082432|FG002|Overall Study|Withdrawal by Subject|2|||
160644969|NCT02040766|580082433|FG003|Overall Study|Withdrawal by Subject|3|||
160644970|NCT02040766|580082434|FG004|Overall Study|Withdrawal by Subject|2|||
160644971|NCT02040766|580082430|FG000|Overall Study|Non-compliance|0|||
160644972|NCT02040766|580082431|FG001|Overall Study|Non-compliance|1|||
160644973|NCT02040766|580082432|FG002|Overall Study|Non-compliance|0|||
160644974|NCT02040766|580082433|FG003|Overall Study|Non-compliance|0|||
160644975|NCT02040766|580082434|FG004|Overall Study|Non-compliance|0|||
160644976|NCT02040766|580082430|FG000|Overall Study|Protocol Violation|2|||
160644977|NCT02040766|580082431|FG001|Overall Study|Protocol Violation|1|||
160644978|NCT02040766|580082432|FG002|Overall Study|Protocol Violation|2|||
160644979|NCT02040766|580082433|FG003|Overall Study|Protocol Violation|3|||
160644980|NCT02040766|580082434|FG004|Overall Study|Protocol Violation|0|||
160644981|NCT02040766|580082430|FG000|Overall Study|Lost to Follow-up|4|||
160644982|NCT02040766|580082431|FG001|Overall Study|Lost to Follow-up|1|||
160644983|NCT02040766|580082432|FG002|Overall Study|Lost to Follow-up|3|||
160644984|NCT02040766|580082433|FG003|Overall Study|Lost to Follow-up|1|||
160644985|NCT02040766|580082434|FG004|Overall Study|Lost to Follow-up|4|||
160644986|NCT02040766|580082430|FG000|Overall Study|Not reported|1|||
160644987|NCT02040766|580082431|FG001|Overall Study|Not reported|0|||
160644988|NCT02040766|580082432|FG002|Overall Study|Not reported|0|||
160644989|NCT02040766|580082433|FG003|Overall Study|Not reported|0|||
160644990|NCT02040766|580082434|FG004|Overall Study|Not reported|0|||
160644991|NCT02040766|580082430|FG000|Overall Study|Lack of Efficacy|6|||
160644992|NCT02040766|580082431|FG001|Overall Study|Lack of Efficacy|3|||
160644993|NCT02040766|580082432|FG002|Overall Study|Lack of Efficacy|4|||
160644994|NCT02040766|580082433|FG003|Overall Study|Lack of Efficacy|6|||
160644995|NCT02040766|580082434|FG004|Overall Study|Lack of Efficacy|5|||
160644996|NCT01841359|580082438|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
160644997|NCT01841359|580082438|FG000|Overall Study|Concommitant medical issues|2|||
160644998|NCT01841359|580082438|FG000|Overall Study|Adverse Event|3|||
160644999|NCT01841359|580082438|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
160645000|NCT02168270|580082439|FG000|Overall Study|Lack of Efficacy|4|||
160645001|NCT01738581|580082440|FG000|Overall Study|Lost to Follow-up|1|||
160645002|NCT01738581|580082441|FG001|Overall Study|Lost to Follow-up|0|||
160645003|NCT00947856|580082448|FG000|Treatment Period|Progressive Disease|33|||
160645004|NCT00947856|580082449|FG001|Treatment Period|Progressive Disease|12|||
160645005|NCT00947856|580082448|FG000|Treatment Period|Adverse Event|15|||
160645006|NCT00947856|580082449|FG001|Treatment Period|Adverse Event|9|||
160645007|NCT00947856|580082448|FG000|Treatment Period|Physician Decision|14|||
160645008|NCT00947856|580082449|FG001|Treatment Period|Physician Decision|6|||
160645009|NCT00947856|580082448|FG000|Treatment Period|Study Stopped by Sponsor|4|||
160645010|NCT00947856|580082449|FG001|Treatment Period|Study Stopped by Sponsor|4|||
160645011|NCT00947856|580082448|FG000|Treatment Period|Withdrawal by Subject|12|||
160645012|NCT00947856|580082449|FG001|Treatment Period|Withdrawal by Subject|1|||
160645013|NCT00947856|580082448|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
160645014|NCT00947856|580082449|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
160645015|NCT00947856|580082448|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
160645016|NCT00947856|580082449|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
160645017|NCT00947856|580082448|FG000|Follow-up Period|Lost to Follow-up|7|||
160645018|NCT00947856|580082449|FG001|Follow-up Period|Lost to Follow-up|0|||
160808603|NCT05823974|580686480|FG005|Overall Study|Physician Decision|0|||
160808604|NCT05823974|580686481|FG006|Overall Study|Physician Decision|0|||
160808605|NCT05823974|580686482|FG007|Overall Study|Physician Decision|0|||
160808606|NCT05823974|580686483|FG008|Overall Study|Physician Decision|0|||
160808607|NCT05823974|580686484|FG009|Overall Study|Physician Decision|0|||
160808608|NCT05823974|580686485|FG010|Overall Study|Physician Decision|0|||
160808609|NCT05823974|580686486|FG011|Overall Study|Physician Decision|0|||
160808610|NCT05823974|580686487|FG012|Overall Study|Physician Decision|0|||
160808611|NCT05823974|580686488|FG013|Overall Study|Physician Decision|0|||
160808612|NCT05823974|580686489|FG014|Overall Study|Physician Decision|0|||
160808613|NCT05823974|580686490|FG015|Overall Study|Physician Decision|1|||
160808614|NCT05823974|580686491|FG016|Overall Study|Physician Decision|0|||
160808615|NCT05823974|580686492|FG017|Overall Study|Physician Decision|1|||
160808616|NCT05823974|580686493|FG018|Overall Study|Physician Decision|1|||
160808617|NCT05823974|580686494|FG019|Overall Study|Physician Decision|0|||
160808618|NCT05823974|580686495|FG020|Overall Study|Physician Decision|0|||
160808619|NCT05823974|580686475|FG000|Overall Study|Withdrawal by Subject|1|||
160808620|NCT05823974|580686476|FG001|Overall Study|Withdrawal by Subject|1|||
160808621|NCT05823974|580686477|FG002|Overall Study|Withdrawal by Subject|2|||
160808622|NCT05823974|580686478|FG003|Overall Study|Withdrawal by Subject|0|||
160808623|NCT05823974|580686479|FG004|Overall Study|Withdrawal by Subject|2|||
160808624|NCT05823974|580686480|FG005|Overall Study|Withdrawal by Subject|3|||
160808625|NCT05823974|580686481|FG006|Overall Study|Withdrawal by Subject|1|||
160808626|NCT05823974|580686482|FG007|Overall Study|Withdrawal by Subject|1|||
160808627|NCT05823974|580686483|FG008|Overall Study|Withdrawal by Subject|2|||
160808628|NCT05823974|580686484|FG009|Overall Study|Withdrawal by Subject|1|||
160808629|NCT05823974|580686485|FG010|Overall Study|Withdrawal by Subject|1|||
160808630|NCT05823974|580686486|FG011|Overall Study|Withdrawal by Subject|0|||
160808631|NCT05823974|580686487|FG012|Overall Study|Withdrawal by Subject|0|||
160808632|NCT05823974|580686488|FG013|Overall Study|Withdrawal by Subject|1|||
160808633|NCT05823974|580686489|FG014|Overall Study|Withdrawal by Subject|1|||
160808634|NCT05823974|580686490|FG015|Overall Study|Withdrawal by Subject|3|||
160808635|NCT05823974|580686491|FG016|Overall Study|Withdrawal by Subject|0|||
160808636|NCT05823974|580686492|FG017|Overall Study|Withdrawal by Subject|2|||
160808637|NCT05823974|580686493|FG018|Overall Study|Withdrawal by Subject|2|||
160808638|NCT05823974|580686494|FG019|Overall Study|Withdrawal by Subject|0|||
160808639|NCT05823974|580686495|FG020|Overall Study|Withdrawal by Subject|1|||
160808640|NCT05823974|580686475|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808641|NCT05823974|580686476|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808642|NCT05823974|580686477|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160808643|NCT05823974|580686478|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808644|NCT05823974|580686479|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808645|NCT05823974|580686480|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808646|NCT05823974|580686481|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808647|NCT05823974|580686482|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808648|NCT05823974|580686483|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808649|NCT05823974|580686484|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808650|NCT05823974|580686485|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808651|NCT05823974|580686486|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808652|NCT05823974|580686487|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808653|NCT05823974|580686488|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808654|NCT05823974|580686489|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160808655|NCT05823974|580686490|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808656|NCT05823974|580686491|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808657|NCT05823974|580686492|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808658|NCT05823974|580686493|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808659|NCT05823974|580686494|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808660|NCT05823974|580686495|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808661|NCT05823974|580686475|FG000|Overall Study|Other|0|||
160808662|NCT05823974|580686476|FG001|Overall Study|Other|1|||
160808663|NCT05823974|580686477|FG002|Overall Study|Other|1|||
160808664|NCT05823974|580686478|FG003|Overall Study|Other|1|||
160551436|NCT04537208|579744193|FG001|Overall Study|Adverse Event|0|||
160808665|NCT05823974|580686479|FG004|Overall Study|Other|0|||
160808666|NCT05823974|580686480|FG005|Overall Study|Other|1|||
160808667|NCT05823974|580686481|FG006|Overall Study|Other|1|||
160551437|NCT04537208|579744194|FG002|Overall Study|Adverse Event|0|||
160808668|NCT05823974|580686482|FG007|Overall Study|Other|1|||
160808669|NCT05823974|580686483|FG008|Overall Study|Other|1|||
160808670|NCT05823974|580686484|FG009|Overall Study|Other|0|||
160808671|NCT05823974|580686485|FG010|Overall Study|Other|0|||
160808672|NCT05823974|580686486|FG011|Overall Study|Other|0|||
160808673|NCT05823974|580686487|FG012|Overall Study|Other|2|||
160808674|NCT05823974|580686488|FG013|Overall Study|Other|1|||
160808675|NCT05823974|580686489|FG014|Overall Study|Other|0|||
160808676|NCT05823974|580686490|FG015|Overall Study|Other|1|||
160808677|NCT05823974|580686491|FG016|Overall Study|Other|0|||
160808678|NCT05823974|580686492|FG017|Overall Study|Other|0|||
160808679|NCT05823974|580686493|FG018|Overall Study|Other|0|||
160808680|NCT05823974|580686494|FG019|Overall Study|Other|0|||
160808681|NCT05823974|580686495|FG020|Overall Study|Other|0|||
160808682|NCT02744612|580686496|FG000|Overall Study|Withdrawal by Subject|0|||
160808683|NCT02744612|580686497|FG001|Overall Study|Withdrawal by Subject|2|||
160808684|NCT00316706|580686498|FG000|Overall Study|Lost to Follow-up|38|||
160808685|NCT00316706|580686499|FG001|Overall Study|Lost to Follow-up|48|||
160808686|NCT01133756|580686502|FG000|Overall Study|Adverse Event|1|||
160808687|NCT01133756|580686503|FG001|Overall Study|Adverse Event|2|||
160808688|NCT01133756|580686504|FG002|Overall Study|Adverse Event|1|||
160808689|NCT01133756|580686502|FG000|Overall Study|Investigator Decision|1|||
160808690|NCT01133756|580686503|FG001|Overall Study|Investigator Decision|0|||
160808691|NCT01133756|580686504|FG002|Overall Study|Investigator Decision|0|||
160808692|NCT01133756|580686502|FG000|Overall Study|Withdrawal by Subject|0|||
160808693|NCT01133756|580686503|FG001|Overall Study|Withdrawal by Subject|1|||
160808694|NCT01133756|580686504|FG002|Overall Study|Withdrawal by Subject|0|||
160808695|NCT01133756|580686502|FG000|Overall Study|Progression of Disease|0|||
160808696|NCT01133756|580686503|FG001|Overall Study|Progression of Disease|0|||
160808697|NCT01133756|580686504|FG002|Overall Study|Progression of Disease|1|||
160808698|NCT02574078|580686516|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808699|NCT02574078|580686517|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808700|NCT02574078|580686518|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808701|NCT02574078|580686519|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808702|NCT02574078|580686520|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808703|NCT02574078|580686521|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
160808704|NCT02574078|580686522|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
160808705|NCT02574078|580686523|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808706|NCT02574078|580686524|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
160808707|NCT02574078|580686525|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808708|NCT02574078|580686526|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808709|NCT02574078|580686527|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808710|NCT02574078|580686528|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808711|NCT02574078|580686516|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
160808712|NCT02574078|580686517|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
160808713|NCT02574078|580686518|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
160808714|NCT02574078|580686519|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
160808715|NCT02574078|580686520|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
160808716|NCT02574078|580686521|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
160899241|NCT02122458|581026268|FG001|Overall Study|Deployed or Moved|0|||
160899242|NCT02122458|581026269|FG002|Overall Study|Deployed or Moved|0|||
160899243|NCT02122458|581026270|FG003|Overall Study|Deployed or Moved|0|||
160899244|NCT02122458|581026271|FG004|Overall Study|Deployed or Moved|1|||
160899245|NCT02122458|581026272|FG005|Overall Study|Deployed or Moved|0|||
160899246|NCT02122458|581026273|FG006|Overall Study|Deployed or Moved|0|||
160899247|NCT02122458|581026267|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
160899248|NCT02122458|581026268|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
160899249|NCT02122458|581026269|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
160899250|NCT02122458|581026270|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
160899251|NCT02122458|581026271|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
160899252|NCT02122458|581026272|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
160899253|NCT02122458|581026273|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
160899254|NCT02122458|581026267|FG000|Overall Study|Noncompliance|0|||
160899255|NCT02122458|581026268|FG001|Overall Study|Noncompliance|1|||
160899256|NCT02122458|581026269|FG002|Overall Study|Noncompliance|0|||
160899257|NCT02122458|581026270|FG003|Overall Study|Noncompliance|0|||
160899258|NCT02122458|581026271|FG004|Overall Study|Noncompliance|0|||
160899259|NCT02122458|581026272|FG005|Overall Study|Noncompliance|0|||
160899260|NCT02122458|581026273|FG006|Overall Study|Noncompliance|0|||
160899261|NCT00412542|581026274|FG000|Overall Study|Withdrawal by Subject|0|||
160899262|NCT00412542|581026275|FG001|Overall Study|Withdrawal by Subject|2|||
160899263|NCT00412542|581026274|FG000|Overall Study|Not Eligible|0|||
160899264|NCT00412542|581026275|FG001|Overall Study|Not Eligible|1|||
160899265|NCT02833350|581026276|FG000|Overall Study|Adverse Event|0|||
160899266|NCT02833350|581026277|FG001|Overall Study|Adverse Event|3|||
160899267|NCT02833350|581026278|FG002|Overall Study|Adverse Event|4|||
160899268|NCT02833350|581026279|FG003|Overall Study|Adverse Event|4|||
160808717|NCT02574078|580686522|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
160808718|NCT02574078|580686523|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
160808719|NCT02574078|580686524|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
160808720|NCT02574078|580686525|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
160808721|NCT02574078|580686526|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
160808722|NCT02574078|580686527|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
160808723|NCT02574078|580686528|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
160808724|NCT02574078|580686516|FG000|Pre-Treatment Period|Other reasons|0|||
160808725|NCT02574078|580686517|FG001|Pre-Treatment Period|Other reasons|0|||
160808726|NCT02574078|580686518|FG002|Pre-Treatment Period|Other reasons|0|||
160808727|NCT02574078|580686519|FG003|Pre-Treatment Period|Other reasons|0|||
160551438|NCT04537208|579744195|FG003|Overall Study|Adverse Event|0|||
160551439|NCT04537208|579744196|FG004|Overall Study|Adverse Event|0|||
160551440|NCT04537208|579744197|FG005|Overall Study|Adverse Event|0|||
160551441|NCT04537208|579744198|FG006|Overall Study|Adverse Event|0|||
160551442|NCT04537208|579744199|FG007|Overall Study|Adverse Event|0|||
160808728|NCT02574078|580686520|FG004|Pre-Treatment Period|Other reasons|0|||
160808729|NCT02574078|580686521|FG005|Pre-Treatment Period|Other reasons|0|||
160808730|NCT02574078|580686522|FG006|Pre-Treatment Period|Other reasons|2|||
160808731|NCT02574078|580686523|FG007|Pre-Treatment Period|Other reasons|0|||
160808732|NCT02574078|580686524|FG008|Pre-Treatment Period|Other reasons|0|||
160808733|NCT02574078|580686525|FG009|Pre-Treatment Period|Other reasons|0|||
160808734|NCT02574078|580686526|FG010|Pre-Treatment Period|Other reasons|2|||
160808735|NCT02574078|580686527|FG011|Pre-Treatment Period|Other reasons|0|||
160551443|NCT04537208|579744200|FG008|Overall Study|Adverse Event|1|||
160551444|NCT04537208|579744201|FG009|Overall Study|Adverse Event|0|||
160551445|NCT04537208|579744202|FG010|Overall Study|Adverse Event|0|||
160551446|NCT04537208|579744192|FG000|Overall Study|Protocol deviation|0|||
160551447|NCT04537208|579744193|FG001|Overall Study|Protocol deviation|0|||
160551448|NCT04537208|579744194|FG002|Overall Study|Protocol deviation|2|||
160551449|NCT04537208|579744195|FG003|Overall Study|Protocol deviation|0|||
160551450|NCT04537208|579744196|FG004|Overall Study|Protocol deviation|0|||
160551451|NCT04537208|579744197|FG005|Overall Study|Protocol deviation|2|||
160551452|NCT04537208|579744198|FG006|Overall Study|Protocol deviation|4|||
160808736|NCT02574078|580686528|FG012|Pre-Treatment Period|Other reasons|0|||
160808737|NCT02574078|580686516|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
160808738|NCT02574078|580686517|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
160808739|NCT02574078|580686518|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
160808740|NCT02574078|580686519|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
160808741|NCT02574078|580686520|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
160808742|NCT02574078|580686521|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
160808743|NCT02574078|580686522|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
160808744|NCT02574078|580686523|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
160808745|NCT02574078|580686524|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
160808746|NCT02574078|580686525|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
160808747|NCT02574078|580686526|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
160808748|NCT02574078|580686527|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
160808749|NCT02574078|580686528|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
160808750|NCT02574078|580686516|FG000|Treatment Period|Disease progression|6|||
160808751|NCT02574078|580686517|FG001|Treatment Period|Disease progression|4|||
160808752|NCT02574078|580686518|FG002|Treatment Period|Disease progression|7|||
160808753|NCT02574078|580686519|FG003|Treatment Period|Disease progression|18|||
160808754|NCT02574078|580686520|FG004|Treatment Period|Disease progression|16|||
160808755|NCT02574078|580686521|FG005|Treatment Period|Disease progression|26|||
160808756|NCT02574078|580686522|FG006|Treatment Period|Disease progression|5|||
160808757|NCT02574078|580686523|FG007|Treatment Period|Disease progression|9|||
160808758|NCT02574078|580686524|FG008|Treatment Period|Disease progression|8|||
160808759|NCT02574078|580686525|FG009|Treatment Period|Disease progression|5|||
160808760|NCT02574078|580686526|FG010|Treatment Period|Disease progression|20|||
160808761|NCT02574078|580686527|FG011|Treatment Period|Disease progression|29|||
160808762|NCT02574078|580686528|FG012|Treatment Period|Disease progression|2|||
160808763|NCT02574078|580686516|FG000|Treatment Period|Study drug toxicity|1|||
160808764|NCT02574078|580686517|FG001|Treatment Period|Study drug toxicity|1|||
160808765|NCT02574078|580686518|FG002|Treatment Period|Study drug toxicity|0|||
160808766|NCT02574078|580686519|FG003|Treatment Period|Study drug toxicity|5|||
160808767|NCT02574078|580686520|FG004|Treatment Period|Study drug toxicity|3|||
160808768|NCT02574078|580686521|FG005|Treatment Period|Study drug toxicity|1|||
160808769|NCT02574078|580686522|FG006|Treatment Period|Study drug toxicity|2|||
160808770|NCT02574078|580686523|FG007|Treatment Period|Study drug toxicity|0|||
160808771|NCT02574078|580686524|FG008|Treatment Period|Study drug toxicity|2|||
160808772|NCT02574078|580686525|FG009|Treatment Period|Study drug toxicity|1|||
160808773|NCT02574078|580686526|FG010|Treatment Period|Study drug toxicity|16|||
160808774|NCT02574078|580686527|FG011|Treatment Period|Study drug toxicity|2|||
160808775|NCT02574078|580686528|FG012|Treatment Period|Study drug toxicity|4|||
160808776|NCT02574078|580686516|FG000|Treatment Period|Death|2|||
160808777|NCT02574078|580686517|FG001|Treatment Period|Death|0|||
160808778|NCT02574078|580686518|FG002|Treatment Period|Death|0|||
160808779|NCT02574078|580686519|FG003|Treatment Period|Death|0|||
160808780|NCT02574078|580686520|FG004|Treatment Period|Death|1|||
160808781|NCT02574078|580686521|FG005|Treatment Period|Death|1|||
160808782|NCT02574078|580686522|FG006|Treatment Period|Death|1|||
160808783|NCT02574078|580686523|FG007|Treatment Period|Death|1|||
160808784|NCT02574078|580686524|FG008|Treatment Period|Death|7|||
160808785|NCT02574078|580686525|FG009|Treatment Period|Death|1|||
160808786|NCT02574078|580686526|FG010|Treatment Period|Death|0|||
160808787|NCT02574078|580686527|FG011|Treatment Period|Death|2|||
160808788|NCT02574078|580686528|FG012|Treatment Period|Death|1|||
160808789|NCT02574078|580686516|FG000|Treatment Period|Adverse event unrelated to drug|0|||
160808790|NCT02574078|580686517|FG001|Treatment Period|Adverse event unrelated to drug|0|||
160808791|NCT02574078|580686518|FG002|Treatment Period|Adverse event unrelated to drug|1|||
160808792|NCT02574078|580686519|FG003|Treatment Period|Adverse event unrelated to drug|0|||
160808793|NCT02574078|580686520|FG004|Treatment Period|Adverse event unrelated to drug|2|||
160808794|NCT02574078|580686521|FG005|Treatment Period|Adverse event unrelated to drug|3|||
160808795|NCT02574078|580686522|FG006|Treatment Period|Adverse event unrelated to drug|0|||
160808796|NCT02574078|580686523|FG007|Treatment Period|Adverse event unrelated to drug|0|||
160808797|NCT02574078|580686524|FG008|Treatment Period|Adverse event unrelated to drug|1|||
160808798|NCT02574078|580686525|FG009|Treatment Period|Adverse event unrelated to drug|2|||
160808799|NCT02574078|580686526|FG010|Treatment Period|Adverse event unrelated to drug|4|||
160808800|NCT02574078|580686527|FG011|Treatment Period|Adverse event unrelated to drug|1|||
160808801|NCT02574078|580686528|FG012|Treatment Period|Adverse event unrelated to drug|0|||
160808802|NCT02574078|580686516|FG000|Treatment Period|Administrative reason by Sponsor|0|||
160808803|NCT02574078|580686517|FG001|Treatment Period|Administrative reason by Sponsor|1|||
160808804|NCT02574078|580686518|FG002|Treatment Period|Administrative reason by Sponsor|0|||
160808805|NCT02574078|580686519|FG003|Treatment Period|Administrative reason by Sponsor|0|||
160808806|NCT02574078|580686520|FG004|Treatment Period|Administrative reason by Sponsor|0|||
160808807|NCT02574078|580686521|FG005|Treatment Period|Administrative reason by Sponsor|0|||
160808808|NCT02574078|580686522|FG006|Treatment Period|Administrative reason by Sponsor|1|||
160808809|NCT02574078|580686523|FG007|Treatment Period|Administrative reason by Sponsor|0|||
160808810|NCT02574078|580686524|FG008|Treatment Period|Administrative reason by Sponsor|0|||
160899269|NCT02833350|581026280|FG004|Overall Study|Adverse Event|1|||
160808811|NCT02574078|580686525|FG009|Treatment Period|Administrative reason by Sponsor|0|||
160808812|NCT02574078|580686526|FG010|Treatment Period|Administrative reason by Sponsor|0|||
160808813|NCT02574078|580686527|FG011|Treatment Period|Administrative reason by Sponsor|0|||
160808814|NCT02574078|580686528|FG012|Treatment Period|Administrative reason by Sponsor|3|||
160808815|NCT02574078|580686516|FG000|Treatment Period|Other reasons|1|||
160808816|NCT02574078|580686517|FG001|Treatment Period|Other reasons|0|||
160808817|NCT02574078|580686518|FG002|Treatment Period|Other reasons|1|||
160808818|NCT02574078|580686519|FG003|Treatment Period|Other reasons|3|||
160808819|NCT02574078|580686520|FG004|Treatment Period|Other reasons|3|||
160808820|NCT02574078|580686521|FG005|Treatment Period|Other reasons|1|||
160808821|NCT02574078|580686522|FG006|Treatment Period|Other reasons|2|||
160808822|NCT02574078|580686523|FG007|Treatment Period|Other reasons|1|||
160808823|NCT02574078|580686524|FG008|Treatment Period|Other reasons|3|||
160808824|NCT02574078|580686525|FG009|Treatment Period|Other reasons|1|||
160808825|NCT02574078|580686526|FG010|Treatment Period|Other reasons|1|||
160808826|NCT02574078|580686527|FG011|Treatment Period|Other reasons|3|||
160808827|NCT02574078|580686528|FG012|Treatment Period|Other reasons|1|||
160808828|NCT02574078|580686516|FG000|Treatment Period|Participant request to stop drug|0|||
160808829|NCT02574078|580686517|FG001|Treatment Period|Participant request to stop drug|0|||
160808830|NCT02574078|580686518|FG002|Treatment Period|Participant request to stop drug|0|||
160808831|NCT02574078|580686519|FG003|Treatment Period|Participant request to stop drug|2|||
160808832|NCT02574078|580686520|FG004|Treatment Period|Participant request to stop drug|4|||
160808833|NCT02574078|580686521|FG005|Treatment Period|Participant request to stop drug|0|||
160808834|NCT02574078|580686522|FG006|Treatment Period|Participant request to stop drug|1|||
160808835|NCT02574078|580686523|FG007|Treatment Period|Participant request to stop drug|0|||
160808836|NCT02574078|580686524|FG008|Treatment Period|Participant request to stop drug|3|||
160808837|NCT02574078|580686525|FG009|Treatment Period|Participant request to stop drug|2|||
160808838|NCT02574078|580686526|FG010|Treatment Period|Participant request to stop drug|2|||
160808839|NCT02574078|580686527|FG011|Treatment Period|Participant request to stop drug|4|||
160808840|NCT02574078|580686528|FG012|Treatment Period|Participant request to stop drug|1|||
160808841|NCT02574078|580686516|FG000|Treatment Period|Participant withdrew consent|0|||
160808842|NCT02574078|580686517|FG001|Treatment Period|Participant withdrew consent|0|||
160899270|NCT02833350|581026281|FG005|Overall Study|Adverse Event|0|||
160645019|NCT00947856|580082448|FG000|Follow-up Period|Patient unavailable for site visits|1|||
160645020|NCT00947856|580082449|FG001|Follow-up Period|Patient unavailable for site visits|0|||
160645021|NCT00947856|580082448|FG000|Follow-up Period|Withdrawal by Subject|1|||
160645022|NCT00947856|580082449|FG001|Follow-up Period|Withdrawal by Subject|0|||
160645023|NCT02191579|580082450|FG000|Treatment 1|Multiple Reasons Specified|27|||
160645024|NCT02191579|580082451|FG001|Treatment 1|Multiple Reasons Specified|58|||
160645025|NCT02191579|580082450|FG000|Treatment 2|Multiple Reasons Specified|0|||
160645026|NCT02191579|580082451|FG001|Treatment 2|Multiple Reasons Specified|25|||
160645027|NCT02280356|580082454|FG000|Overall Study|Not Treated|2|||
160645028|NCT02280356|580082454|FG000|Overall Study|Withdrawal by Subject|1|||
160645029|NCT02280356|580082454|FG000|Overall Study|Not evaluable|2|||
160645030|NCT01086215|580082455|FG000|Overall Study|Death|14|||
160645031|NCT01086215|580082456|FG001|Overall Study|Death|8|||
160645032|NCT01086215|580082457|FG002|Overall Study|Death|8|||
160645033|NCT01086215|580082458|FG003|Overall Study|Death|1|||
160645034|NCT01086215|580082455|FG000|Overall Study|Lost to Follow-up|22|||
160645035|NCT01086215|580082456|FG001|Overall Study|Lost to Follow-up|39|||
160645036|NCT01086215|580082457|FG002|Overall Study|Lost to Follow-up|18|||
160645037|NCT01086215|580082458|FG003|Overall Study|Lost to Follow-up|2|||
160645038|NCT01965652|580082459|FG000|Overall Study|Adverse Event|40|||
160645039|NCT01965652|580082460|FG001|Overall Study|Adverse Event|37|||
160645040|NCT01965652|580082459|FG000|Overall Study|Withdrawal by Subject|62|||
160645041|NCT01965652|580082460|FG001|Overall Study|Withdrawal by Subject|69|||
160645042|NCT01965652|580082459|FG000|Overall Study|Lost to Follow-up|53|||
160645043|NCT01965652|580082460|FG001|Overall Study|Lost to Follow-up|40|||
160645044|NCT01965652|580082459|FG000|Overall Study|Protocol Violation|34|||
160645045|NCT01965652|580082460|FG001|Overall Study|Protocol Violation|38|||
160645046|NCT01965652|580082459|FG000|Overall Study|Death|3|||
160645047|NCT01965652|580082460|FG001|Overall Study|Death|4|||
160645048|NCT01965652|580082459|FG000|Overall Study|Other - Miscellaneous|18|||
160645049|NCT01965652|580082460|FG001|Overall Study|Other - Miscellaneous|21|||
160645050|NCT01965652|580082459|FG000|Overall Study|Pregnancy|0|||
160645051|NCT01965652|580082460|FG001|Overall Study|Pregnancy|1|||
160645052|NCT01121900|580082465|FG000|First Intervention Period|Adverse Event|1|||
160645053|NCT01121900|580082466|FG001|First Intervention Period|Adverse Event|1|||
160645054|NCT01121900|580082465|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
160645055|NCT01121900|580082466|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
160808843|NCT02574078|580686518|FG002|Treatment Period|Participant withdrew consent|0|||
160808844|NCT02574078|580686519|FG003|Treatment Period|Participant withdrew consent|0|||
160808845|NCT02574078|580686520|FG004|Treatment Period|Participant withdrew consent|1|||
160808846|NCT02574078|580686521|FG005|Treatment Period|Participant withdrew consent|1|||
160808847|NCT02574078|580686522|FG006|Treatment Period|Participant withdrew consent|0|||
160808848|NCT02574078|580686523|FG007|Treatment Period|Participant withdrew consent|1|||
160808849|NCT02574078|580686524|FG008|Treatment Period|Participant withdrew consent|0|||
160808850|NCT02574078|580686525|FG009|Treatment Period|Participant withdrew consent|2|||
160808851|NCT02574078|580686526|FG010|Treatment Period|Participant withdrew consent|1|||
160808852|NCT02574078|580686527|FG011|Treatment Period|Participant withdrew consent|4|||
160808853|NCT02574078|580686528|FG012|Treatment Period|Participant withdrew consent|1|||
160808854|NCT02574078|580686516|FG000|Treatment Period|Participant no longer meets criteria|0|||
160808855|NCT02574078|580686517|FG001|Treatment Period|Participant no longer meets criteria|0|||
160808856|NCT02574078|580686518|FG002|Treatment Period|Participant no longer meets criteria|0|||
160808857|NCT02574078|580686519|FG003|Treatment Period|Participant no longer meets criteria|0|||
160808858|NCT02574078|580686520|FG004|Treatment Period|Participant no longer meets criteria|1|||
160808859|NCT02574078|580686521|FG005|Treatment Period|Participant no longer meets criteria|0|||
160808860|NCT02574078|580686522|FG006|Treatment Period|Participant no longer meets criteria|0|||
160808861|NCT02574078|580686523|FG007|Treatment Period|Participant no longer meets criteria|0|||
160808862|NCT02574078|580686524|FG008|Treatment Period|Participant no longer meets criteria|0|||
160808863|NCT02574078|580686525|FG009|Treatment Period|Participant no longer meets criteria|1|||
160808864|NCT02574078|580686526|FG010|Treatment Period|Participant no longer meets criteria|1|||
160808865|NCT02574078|580686527|FG011|Treatment Period|Participant no longer meets criteria|1|||
160808866|NCT02574078|580686528|FG012|Treatment Period|Participant no longer meets criteria|0|||
160808867|NCT02574078|580686516|FG000|Treatment Period|Lost to Follow-up|0|||
160808868|NCT02574078|580686517|FG001|Treatment Period|Lost to Follow-up|0|||
160808869|NCT02574078|580686518|FG002|Treatment Period|Lost to Follow-up|0|||
160808870|NCT02574078|580686519|FG003|Treatment Period|Lost to Follow-up|0|||
160808871|NCT02574078|580686520|FG004|Treatment Period|Lost to Follow-up|0|||
160808872|NCT02574078|580686521|FG005|Treatment Period|Lost to Follow-up|0|||
160808873|NCT02574078|580686522|FG006|Treatment Period|Lost to Follow-up|0|||
160808874|NCT02574078|580686523|FG007|Treatment Period|Lost to Follow-up|0|||
160808875|NCT02574078|580686524|FG008|Treatment Period|Lost to Follow-up|0|||
160808876|NCT02574078|580686525|FG009|Treatment Period|Lost to Follow-up|1|||
160808877|NCT02574078|580686526|FG010|Treatment Period|Lost to Follow-up|0|||
160808878|NCT02574078|580686527|FG011|Treatment Period|Lost to Follow-up|1|||
160808879|NCT02574078|580686528|FG012|Treatment Period|Lost to Follow-up|0|||
160808880|NCT02574078|580686516|FG000|Treatment Period|Maximum clinical benefit|0|||
160808881|NCT02574078|580686517|FG001|Treatment Period|Maximum clinical benefit|0|||
160808882|NCT02574078|580686518|FG002|Treatment Period|Maximum clinical benefit|0|||
160808883|NCT02574078|580686519|FG003|Treatment Period|Maximum clinical benefit|0|||
160808884|NCT02574078|580686520|FG004|Treatment Period|Maximum clinical benefit|0|||
160808885|NCT02574078|580686521|FG005|Treatment Period|Maximum clinical benefit|0|||
160808886|NCT02574078|580686522|FG006|Treatment Period|Maximum clinical benefit|0|||
160808887|NCT02574078|580686523|FG007|Treatment Period|Maximum clinical benefit|0|||
160899271|NCT02833350|581026282|FG006|Overall Study|Adverse Event|1|||
160899272|NCT02833350|581026276|FG000|Overall Study|Death|0|||
160899273|NCT02833350|581026277|FG001|Overall Study|Death|0|||
160899274|NCT02833350|581026278|FG002|Overall Study|Death|1|||
160454060|NCT02038777|579394026|FG004|Overall Study|Randomized but not treated|0|||
160808888|NCT02574078|580686524|FG008|Treatment Period|Maximum clinical benefit|0|||
160808889|NCT02574078|580686525|FG009|Treatment Period|Maximum clinical benefit|1|||
160808890|NCT02574078|580686526|FG010|Treatment Period|Maximum clinical benefit|0|||
160808891|NCT02574078|580686527|FG011|Treatment Period|Maximum clinical benefit|0|||
160808892|NCT02574078|580686528|FG012|Treatment Period|Maximum clinical benefit|0|||
160808893|NCT02222688|580686529|FG000|Overall Study|Withdrawal by Subject|0|||
160808894|NCT02222688|580686530|FG001|Overall Study|Withdrawal by Subject|0|||
160808895|NCT02222688|580686531|FG002|Overall Study|Withdrawal by Subject|0|||
160808896|NCT02222688|580686532|FG003|Overall Study|Withdrawal by Subject|2|||
160808897|NCT02222688|580686533|FG004|Overall Study|Withdrawal by Subject|1|||
160899275|NCT02833350|581026279|FG003|Overall Study|Death|0|||
160899276|NCT02833350|581026280|FG004|Overall Study|Death|0|||
160808898|NCT02222688|580686534|FG005|Overall Study|Withdrawal by Subject|0|||
160808899|NCT02222688|580686535|FG006|Overall Study|Withdrawal by Subject|1|||
160808900|NCT02222688|580686529|FG000|Overall Study|Disease progression|1|||
160808901|NCT02222688|580686530|FG001|Overall Study|Disease progression|0|||
160808902|NCT02222688|580686531|FG002|Overall Study|Disease progression|0|||
160808903|NCT02222688|580686532|FG003|Overall Study|Disease progression|0|||
160808904|NCT02222688|580686533|FG004|Overall Study|Disease progression|0|||
160808905|NCT02222688|580686534|FG005|Overall Study|Disease progression|0|||
160808906|NCT02222688|580686535|FG006|Overall Study|Disease progression|0|||
160808907|NCT05935878|580686536|FG000|Overall Study|Death|1|||
160808908|NCT05935878|580686537|FG001|Overall Study|Death|2|||
160808909|NCT05935878|580686536|FG000|Overall Study|Withdrawal by Subject|5|||
160808910|NCT05935878|580686537|FG001|Overall Study|Withdrawal by Subject|5|||
160808911|NCT05935878|580686536|FG000|Overall Study|Revision of implant|1|||
160808912|NCT05935878|580686537|FG001|Overall Study|Revision of implant|1|||
160808913|NCT05935878|580686536|FG000|Overall Study|Mobile bearing dislocation|0|||
160808914|NCT05935878|580686537|FG001|Overall Study|Mobile bearing dislocation|1|||
160808915|NCT01734785|580686546|FG000|Open-Label Period|Adverse Event|0|||
160808916|NCT01734785|580686547|FG001|Open-Label Period|Adverse Event|0|||
160808917|NCT01734785|580686548|FG002|Open-Label Period|Adverse Event|0|||
160808918|NCT01734785|580686549|FG003|Open-Label Period|Adverse Event|9|||
160808919|NCT01734785|580686546|FG000|Open-Label Period|Lack of Efficacy|0|||
160808920|NCT01734785|580686547|FG001|Open-Label Period|Lack of Efficacy|0|||
160808921|NCT01734785|580686548|FG002|Open-Label Period|Lack of Efficacy|0|||
160808922|NCT01734785|580686549|FG003|Open-Label Period|Lack of Efficacy|1|||
160808923|NCT01734785|580686546|FG000|Open-Label Period|Protocol Violation|0|||
160808924|NCT01734785|580686547|FG001|Open-Label Period|Protocol Violation|0|||
160808925|NCT01734785|580686548|FG002|Open-Label Period|Protocol Violation|0|||
160808926|NCT01734785|580686549|FG003|Open-Label Period|Protocol Violation|13|||
160808927|NCT01734785|580686546|FG000|Open-Label Period|Lost to Follow-up|0|||
160808928|NCT01734785|580686547|FG001|Open-Label Period|Lost to Follow-up|0|||
160808929|NCT01734785|580686548|FG002|Open-Label Period|Lost to Follow-up|0|||
160645056|NCT03493698|580082467|FG000|Treatment Period C|Adverse Event|1|||
160645057|NCT03493698|580082467|FG000|Treatment Period C|Withdrawal by Subject|1|||
160645058|NCT00291330|580082468|FG000|Overall Study|Adverse Event|47|||
160645059|NCT00291330|580082469|FG001|Overall Study|Adverse Event|40|||
160645060|NCT00291330|580082468|FG000|Overall Study|Protocol Violation|13|||
160645061|NCT00291330|580082469|FG001|Overall Study|Protocol Violation|20|||
160645062|NCT00291330|580082468|FG000|Overall Study|Lost to Follow-up|16|||
160645063|NCT00291330|580082469|FG001|Overall Study|Lost to Follow-up|11|||
160645064|NCT00291330|580082468|FG000|Overall Study|Withdrawal by Subject|22|||
160645065|NCT00291330|580082469|FG001|Overall Study|Withdrawal by Subject|25|||
160645066|NCT00291330|580082468|FG000|Overall Study|Other|3|||
160645067|NCT00291330|580082469|FG001|Overall Study|Other|1|||
160645068|NCT00931385|580082470|FG000|Overall Study|Adverse Event|2|||
160645069|NCT00931385|580082471|FG001|Overall Study|Adverse Event|1|||
160645070|NCT00931385|580082472|FG002|Overall Study|Adverse Event|0|||
160645071|NCT00931385|580082473|FG003|Overall Study|Adverse Event|3|||
160645072|NCT00931385|580082470|FG000|Overall Study|Protocol Violation|0|||
160645073|NCT00931385|580082471|FG001|Overall Study|Protocol Violation|0|||
160645074|NCT00931385|580082472|FG002|Overall Study|Protocol Violation|1|||
160645075|NCT00931385|580082473|FG003|Overall Study|Protocol Violation|0|||
160645076|NCT00931385|580082470|FG000|Overall Study|Withdrawal by Subject|0|||
160645077|NCT00931385|580082471|FG001|Overall Study|Withdrawal by Subject|1|||
160645078|NCT00931385|580082472|FG002|Overall Study|Withdrawal by Subject|0|||
160808930|NCT01734785|580686549|FG003|Open-Label Period|Lost to Follow-up|14|||
160808931|NCT01734785|580686546|FG000|Open-Label Period|Withdrawal by Subject|0|||
160808932|NCT01734785|580686547|FG001|Open-Label Period|Withdrawal by Subject|0|||
160808933|NCT01734785|580686548|FG002|Open-Label Period|Withdrawal by Subject|0|||
160808934|NCT01734785|580686549|FG003|Open-Label Period|Withdrawal by Subject|12|||
160808935|NCT01734785|580686546|FG000|Open-Label Period|Other Reasons|0|||
160645079|NCT00931385|580082473|FG003|Overall Study|Withdrawal by Subject|1|||
160808936|NCT01734785|580686547|FG001|Open-Label Period|Other Reasons|0|||
160808937|NCT01734785|580686548|FG002|Open-Label Period|Other Reasons|0|||
160808938|NCT01734785|580686549|FG003|Open-Label Period|Other Reasons|224|||
160808939|NCT01734785|580686546|FG000|Double-Blind Period|Adverse Event|0|||
160899277|NCT02833350|581026281|FG005|Overall Study|Death|0|||
160645080|NCT00931385|580082470|FG000|Overall Study|Lost to Follow-up|0|||
160645081|NCT00931385|580082471|FG001|Overall Study|Lost to Follow-up|0|||
160645082|NCT00931385|580082472|FG002|Overall Study|Lost to Follow-up|0|||
160645083|NCT00931385|580082473|FG003|Overall Study|Lost to Follow-up|1|||
160645084|NCT02230085|580082476|FG000|Overall Study|Physician Decision|1|||
160645085|NCT02230085|580082476|FG000|Overall Study|Withdrawal by Subject|3|||
160645086|NCT03740100|580082479|FG000|Overall Study|Adverse Event|1|||
160808940|NCT01734785|580686547|FG001|Double-Blind Period|Adverse Event|3|||
160808941|NCT01734785|580686548|FG002|Double-Blind Period|Adverse Event|2|||
160808942|NCT01734785|580686549|FG003|Double-Blind Period|Adverse Event|0|||
160808943|NCT01734785|580686546|FG000|Double-Blind Period|Lack of Efficacy|0|||
160808944|NCT01734785|580686547|FG001|Double-Blind Period|Lack of Efficacy|1|||
160808945|NCT01734785|580686548|FG002|Double-Blind Period|Lack of Efficacy|0|||
160808946|NCT01734785|580686549|FG003|Double-Blind Period|Lack of Efficacy|0|||
160808947|NCT01734785|580686546|FG000|Double-Blind Period|Protocol Violation|0|||
160808948|NCT01734785|580686547|FG001|Double-Blind Period|Protocol Violation|1|||
160808949|NCT01734785|580686548|FG002|Double-Blind Period|Protocol Violation|1|||
160808950|NCT01734785|580686549|FG003|Double-Blind Period|Protocol Violation|0|||
160808951|NCT01734785|580686546|FG000|Double-Blind Period|Lost to Follow-up|2|||
160808952|NCT01734785|580686547|FG001|Double-Blind Period|Lost to Follow-up|4|||
160808953|NCT01734785|580686548|FG002|Double-Blind Period|Lost to Follow-up|2|||
160808954|NCT01734785|580686549|FG003|Double-Blind Period|Lost to Follow-up|0|||
160808955|NCT01734785|580686546|FG000|Double-Blind Period|Withdrawal by Subject|2|||
160808956|NCT01734785|580686547|FG001|Double-Blind Period|Withdrawal by Subject|0|||
160808957|NCT01734785|580686548|FG002|Double-Blind Period|Withdrawal by Subject|0|||
160808958|NCT01734785|580686549|FG003|Double-Blind Period|Withdrawal by Subject|0|||
160899278|NCT02833350|581026282|FG006|Overall Study|Death|0|||
160899279|NCT02833350|581026276|FG000|Overall Study|Lack of Efficacy|0|||
160899280|NCT02833350|581026277|FG001|Overall Study|Lack of Efficacy|2|||
160899281|NCT02833350|581026278|FG002|Overall Study|Lack of Efficacy|1|||
160899282|NCT02833350|581026279|FG003|Overall Study|Lack of Efficacy|4|||
160899283|NCT02833350|581026280|FG004|Overall Study|Lack of Efficacy|0|||
160899284|NCT02833350|581026281|FG005|Overall Study|Lack of Efficacy|1|||
160899285|NCT02833350|581026282|FG006|Overall Study|Lack of Efficacy|1|||
160899286|NCT02833350|581026276|FG000|Overall Study|Lost to Follow-up|0|||
160899287|NCT02833350|581026277|FG001|Overall Study|Lost to Follow-up|1|||
160899288|NCT02833350|581026278|FG002|Overall Study|Lost to Follow-up|0|||
160899289|NCT02833350|581026279|FG003|Overall Study|Lost to Follow-up|0|||
160899290|NCT02833350|581026280|FG004|Overall Study|Lost to Follow-up|0|||
160899291|NCT02833350|581026281|FG005|Overall Study|Lost to Follow-up|0|||
160899292|NCT02833350|581026282|FG006|Overall Study|Lost to Follow-up|1|||
160899293|NCT02833350|581026276|FG000|Overall Study|Withdrawal by Subject|3|||
160899294|NCT02833350|581026277|FG001|Overall Study|Withdrawal by Subject|3|||
160899295|NCT02833350|581026278|FG002|Overall Study|Withdrawal by Subject|2|||
160899296|NCT02833350|581026279|FG003|Overall Study|Withdrawal by Subject|0|||
160899297|NCT02833350|581026280|FG004|Overall Study|Withdrawal by Subject|2|||
160899298|NCT02833350|581026281|FG005|Overall Study|Withdrawal by Subject|0|||
160899299|NCT02833350|581026282|FG006|Overall Study|Withdrawal by Subject|2|||
160899300|NCT01500031|581026285|FG000|Overall Study|Death|1|||
160899301|NCT01500031|581026285|FG000|Overall Study|Withdrawal by Subject|4|||
160899302|NCT01147640|581026286|FG000|Overall Study|Adverse Event|2|||
160899303|NCT01147640|581026287|FG001|Overall Study|Adverse Event|0|||
160899304|NCT01147640|581026286|FG000|Overall Study|Physician Decision|1|||
160899305|NCT01147640|581026287|FG001|Overall Study|Physician Decision|0|||
160899306|NCT01147640|581026286|FG000|Overall Study|Withdrawal by Subject|1|||
160899307|NCT01147640|581026287|FG001|Overall Study|Withdrawal by Subject|0|||
160899308|NCT01147640|581026286|FG000|Overall Study|Lost to Follow-up|0|||
160899309|NCT01147640|581026287|FG001|Overall Study|Lost to Follow-up|1|||
160899310|NCT01147640|581026286|FG000|Overall Study|Didn't meet eligibility criteria|1|||
160899311|NCT01147640|581026287|FG001|Overall Study|Didn't meet eligibility criteria|0|||
160899312|NCT01856907|581026290|FG000|Overall Study|Pregnancy|0|||
160899313|NCT01856907|581026291|FG001|Overall Study|Pregnancy|1|||
160899314|NCT01856907|581026292|FG002|Overall Study|Pregnancy|0|||
160899315|NCT01856907|581026290|FG000|Overall Study|Pregnancy|0|||
160899316|NCT01856907|581026291|FG001|Overall Study|Pregnancy|1|||
160899317|NCT01856907|581026292|FG002|Overall Study|Pregnancy|0|||
160899318|NCT01856907|581026290|FG000|Overall Study|Withdrawal by Subject|0|||
160899319|NCT01856907|581026291|FG001|Overall Study|Withdrawal by Subject|1|||
160899320|NCT01856907|581026292|FG002|Overall Study|Withdrawal by Subject|0|||
160899321|NCT00091442|581026293|FG000|Overall Study|Progressive Disease|220|||
160899322|NCT00091442|581026294|FG001|Overall Study|Progressive Disease|189|||
160899323|NCT00091442|581026293|FG000|Overall Study|Physician Decision|61|||
160899324|NCT00091442|581026294|FG001|Overall Study|Physician Decision|58|||
160899325|NCT00091442|581026293|FG000|Overall Study|Withdrawal by Subject|38|||
160899326|NCT00091442|581026294|FG001|Overall Study|Withdrawal by Subject|46|||
160899327|NCT00091442|581026293|FG000|Overall Study|Adverse Event|29|||
160899328|NCT00091442|581026294|FG001|Overall Study|Adverse Event|48|||
160899329|NCT00091442|581026293|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
160808959|NCT01734785|580686546|FG000|Double-Blind Period|Not treated|1|||
160808960|NCT01734785|580686547|FG001|Double-Blind Period|Not treated|0|||
160899330|NCT00091442|581026294|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
160899331|NCT00091442|581026293|FG000|Overall Study|Death|9|||
160899332|NCT00091442|581026294|FG001|Overall Study|Death|7|||
160899333|NCT00091442|581026293|FG000|Overall Study|Lost to Follow-up|1|||
160899334|NCT00091442|581026294|FG001|Overall Study|Lost to Follow-up|3|||
160899335|NCT00091442|581026293|FG000|Overall Study|Other|2|||
160899336|NCT00091442|581026294|FG001|Overall Study|Other|6|||
160899337|NCT00917501|581026295|FG000|Overall Study|Lost to Follow-up|4|||
160899338|NCT00917501|581026296|FG001|Overall Study|Lost to Follow-up|1|||
160899339|NCT00917501|581026295|FG000|Overall Study|Withdrawal by Subject|3|||
160899340|NCT00917501|581026296|FG001|Overall Study|Withdrawal by Subject|1|||
160808961|NCT01734785|580686548|FG002|Double-Blind Period|Not treated|0|||
160808962|NCT01734785|580686549|FG003|Double-Blind Period|Not treated|0|||
160808963|NCT02397915|580686550|FG000|Period 1|Protocol Violation|0|||
160808964|NCT02397915|580686551|FG001|Period 1|Protocol Violation|1|||
160808965|NCT02397915|580686552|FG002|Period 1|Protocol Violation|0|||
160808966|NCT02397915|580686553|FG003|Period 1|Protocol Violation|0|||
160808967|NCT02397915|580686550|FG000|Period 1|Physician Decision|1|||
160808968|NCT02397915|580686551|FG001|Period 1|Physician Decision|0|||
160808969|NCT02397915|580686552|FG002|Period 1|Physician Decision|0|||
160808970|NCT02397915|580686553|FG003|Period 1|Physician Decision|0|||
160808971|NCT00368745|580686554|FG000|Double-blind Treatment Period|Adverse Event|6|||
160808972|NCT00368745|580686555|FG001|Double-blind Treatment Period|Adverse Event|6|||
160808973|NCT00368745|580686554|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
160808974|NCT00368745|580686555|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
160808975|NCT00368745|580686554|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
160808976|NCT00368745|580686555|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
160808977|NCT00368745|580686554|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
160808978|NCT00368745|580686555|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
160808979|NCT00368745|580686554|FG000|Double-blind Treatment Period|Other|7|||
160808980|NCT00368745|580686555|FG001|Double-blind Treatment Period|Other|6|||
160808981|NCT00293813|580686559|FG000|Overall Study|Physician Decision|0|||
160808982|NCT00293813|580686560|FG001|Overall Study|Physician Decision|1|||
160808983|NCT00293813|580686561|FG002|Overall Study|Physician Decision|0|||
160808984|NCT00293813|580686559|FG000|Overall Study|Adverse Event|3|||
160808985|NCT00293813|580686560|FG001|Overall Study|Adverse Event|1|||
160808986|NCT00293813|580686561|FG002|Overall Study|Adverse Event|1|||
160808987|NCT00293813|580686559|FG000|Overall Study|Withdrawal by Subject|7|||
160808988|NCT00293813|580686560|FG001|Overall Study|Withdrawal by Subject|4|||
160808989|NCT00293813|580686561|FG002|Overall Study|Withdrawal by Subject|4|||
160808990|NCT00293813|580686559|FG000|Overall Study|Lost to Follow-up|3|||
160808991|NCT00293813|580686560|FG001|Overall Study|Lost to Follow-up|2|||
160808992|NCT00293813|580686561|FG002|Overall Study|Lost to Follow-up|3|||
160808993|NCT00293813|580686559|FG000|Overall Study|Noncompliance|0|||
160645087|NCT03740100|580082479|FG000|Overall Study|Death|1|||
160645088|NCT02046369|580082480|FG000|Overall Study|Adverse Event|3|||
160645089|NCT02046369|580082481|FG001|Overall Study|Adverse Event|3|||
160645090|NCT02046369|580082480|FG000|Overall Study|Lack of Efficacy|3|||
160645091|NCT02046369|580082481|FG001|Overall Study|Lack of Efficacy|3|||
160645092|NCT02046369|580082480|FG000|Overall Study|Lost to Follow-up|3|||
160645093|NCT02046369|580082481|FG001|Overall Study|Lost to Follow-up|3|||
160645094|NCT02046369|580082480|FG000|Overall Study|Protocol Violation|1|||
160645095|NCT02046369|580082481|FG001|Overall Study|Protocol Violation|2|||
160645096|NCT02046369|580082480|FG000|Overall Study|Withdrawal by Subject|3|||
160645097|NCT02046369|580082481|FG001|Overall Study|Withdrawal by Subject|6|||
160645098|NCT02046369|580082480|FG000|Overall Study|never received study drug|0|||
160645099|NCT02046369|580082481|FG001|Overall Study|never received study drug|1|||
160645100|NCT02046369|580082480|FG000|Overall Study|non compliance|1|||
160645101|NCT02046369|580082481|FG001|Overall Study|non compliance|0|||
160645102|NCT03120520|580082482|FG000|Overall Study|Lost to Follow-up|1|||
160645103|NCT03120520|580082483|FG001|Overall Study|Lost to Follow-up|1|||
160645104|NCT03120520|580082484|FG002|Overall Study|Lost to Follow-up|1|||
160645105|NCT03120520|580082485|FG003|Overall Study|Lost to Follow-up|1|||
160645106|NCT03120520|580082482|FG000|Overall Study|Withdrawal by Subject|3|||
160645107|NCT03120520|580082483|FG001|Overall Study|Withdrawal by Subject|2|||
160808994|NCT00293813|580686560|FG001|Overall Study|Noncompliance|1|||
160808995|NCT00293813|580686561|FG002|Overall Study|Noncompliance|0|||
160808996|NCT01582009|580686564|FG000|Overall Study|Withdrawal by Subject|1|||
160808997|NCT01582009|580686564|FG000|Overall Study|Physician Decision|1|||
160808998|NCT00310375|580686565|FG000|Primary Reporting Phase|Adverse Event|28|||
160808999|NCT00310375|580686566|FG001|Primary Reporting Phase|Adverse Event|22|||
160809000|NCT00310375|580686567|FG002|Primary Reporting Phase|Adverse Event|0|||
160809001|NCT00310375|580686565|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
160809002|NCT00310375|580686566|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
160809003|NCT00310375|580686567|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
160809004|NCT00310375|580686565|FG000|Primary Reporting Phase|Pregnancy|2|||
160809005|NCT00310375|580686566|FG001|Primary Reporting Phase|Pregnancy|2|||
160645108|NCT03120520|580082484|FG002|Overall Study|Withdrawal by Subject|3|||
160645109|NCT03120520|580082485|FG003|Overall Study|Withdrawal by Subject|2|||
160645110|NCT03120520|580082482|FG000|Overall Study|Other|0|||
160645111|NCT03120520|580082483|FG001|Overall Study|Other|1|||
160809006|NCT00310375|580686567|FG002|Primary Reporting Phase|Pregnancy|0|||
160809007|NCT00310375|580686565|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
160809008|NCT00310375|580686566|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
160809009|NCT00310375|580686567|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
160809010|NCT00310375|580686565|FG000|Primary Reporting Phase|Protocol Violation|8|||
160645112|NCT03120520|580082484|FG002|Overall Study|Other|0|||
160809011|NCT00310375|580686566|FG001|Primary Reporting Phase|Protocol Violation|5|||
160809012|NCT00310375|580686567|FG002|Primary Reporting Phase|Protocol Violation|0|||
160809013|NCT00310375|580686565|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
160809014|NCT00310375|580686566|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
160809015|NCT00310375|580686567|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
160809016|NCT00310375|580686565|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
160809017|NCT00310375|580686566|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
160809018|NCT00310375|580686567|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
160809019|NCT00310375|580686565|FG000|Primary Reporting Phase|Physician Decision|5|||
160809020|NCT00310375|580686566|FG001|Primary Reporting Phase|Physician Decision|3|||
160809021|NCT00310375|580686567|FG002|Primary Reporting Phase|Physician Decision|0|||
160809022|NCT00310375|580686565|FG000|Primary Reporting Phase|Request of the sponsor|2|||
160809023|NCT00310375|580686566|FG001|Primary Reporting Phase|Request of the sponsor|2|||
160809024|NCT00310375|580686567|FG002|Primary Reporting Phase|Request of the sponsor|0|||
160809025|NCT00310375|580686565|FG000|Primary Reporting Phase|Failed to return|1|||
160809026|NCT00310375|580686566|FG001|Primary Reporting Phase|Failed to return|3|||
160809027|NCT00310375|580686567|FG002|Primary Reporting Phase|Failed to return|0|||
160809028|NCT00310375|580686565|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
160809029|NCT00310375|580686566|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
160809030|NCT00310375|580686567|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
160809031|NCT00310375|580686565|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
160809032|NCT00310375|580686566|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
160809033|NCT00310375|580686567|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
160809034|NCT00310375|580686565|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
160809035|NCT00310375|580686566|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
160809036|NCT00310375|580686567|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
160809037|NCT00310375|580686565|FG000|Primary Reporting Phase|Site closure|3|||
160809038|NCT00310375|580686566|FG001|Primary Reporting Phase|Site closure|0|||
160809039|NCT00310375|580686567|FG002|Primary Reporting Phase|Site closure|0|||
160809040|NCT00310375|580686565|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
160809041|NCT00310375|580686566|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
160809042|NCT00310375|580686567|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
160809043|NCT00310375|580686565|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
160809044|NCT00310375|580686566|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
160809045|NCT00310375|580686567|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
160809046|NCT00310375|580686565|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
160809047|NCT00310375|580686566|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
160809048|NCT00310375|580686567|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
160809049|NCT00310375|580686565|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
160809050|NCT00310375|580686566|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
160809051|NCT00310375|580686567|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
160809052|NCT01134614|580686568|FG000|Overall Study|Still on treatment as of March 2013|21|||
160809053|NCT01134614|580686569|FG001|Overall Study|Still on treatment as of March 2013|13|||
160809054|NCT01134614|580686568|FG000|Overall Study|Progressive disease|60|||
160809055|NCT01134614|580686569|FG001|Overall Study|Progressive disease|54|||
160809056|NCT01134614|580686568|FG000|Overall Study|Adverse Event|26|||
160809057|NCT01134614|580686569|FG001|Overall Study|Adverse Event|39|||
160809058|NCT01134614|580686568|FG000|Overall Study|Death|5|||
160809059|NCT01134614|580686569|FG001|Overall Study|Death|8|||
160809060|NCT01134614|580686568|FG000|Overall Study|Withdrawal by Subject|3|||
160809061|NCT01134614|580686569|FG001|Overall Study|Withdrawal by Subject|2|||
160809062|NCT01134614|580686568|FG000|Overall Study|Alternative therapy|2|||
160809063|NCT01134614|580686569|FG001|Overall Study|Alternative therapy|0|||
160809064|NCT01134614|580686568|FG000|Overall Study|Complicating disease|2|||
160809065|NCT01134614|580686569|FG001|Overall Study|Complicating disease|1|||
160809066|NCT01134614|580686568|FG000|Overall Study|Physician's decision|0|||
160809067|NCT01134614|580686569|FG001|Overall Study|Physician's decision|1|||
160809068|NCT01134614|580686568|FG000|Overall Study|Never started treatment|4|||
160899341|NCT00917501|581026295|FG000|Overall Study|Lack of Efficacy|1|||
160899342|NCT00917501|581026296|FG001|Overall Study|Lack of Efficacy|2|||
160899343|NCT00917501|581026295|FG000|Overall Study|trouble swollowing capsules|0|||
160899344|NCT00917501|581026296|FG001|Overall Study|trouble swollowing capsules|1|||
160809069|NCT01134614|580686569|FG001|Overall Study|Never started treatment|1|||
160809070|NCT01134614|580686568|FG000|Overall Study|Pt received tx not allowed on study|0|||
160809071|NCT01134614|580686569|FG001|Overall Study|Pt received tx not allowed on study|1|||
160809072|NCT01134614|580686568|FG000|Overall Study|Symptomatic deterioration|0|||
160809073|NCT01134614|580686569|FG001|Overall Study|Symptomatic deterioration|1|||
160809074|NCT01134614|580686568|FG000|Overall Study|Patient in hospice care|0|||
160809075|NCT01134614|580686569|FG001|Overall Study|Patient in hospice care|1|||
160899345|NCT00075218|581026297|FG000|Double-Blind Treatment|Adverse Event|23|||
160899346|NCT00075218|581026298|FG001|Double-Blind Treatment|Adverse Event|4|||
160809076|NCT02553928|580686570|FG000|Overall Study|Adverse Event|2|||
160809077|NCT02553928|580686571|FG001|Overall Study|Adverse Event|1|||
160809078|NCT02553928|580686570|FG000|Overall Study|Lost to Follow-up|0|||
160809079|NCT02553928|580686571|FG001|Overall Study|Lost to Follow-up|1|||
160809080|NCT02553928|580686570|FG000|Overall Study|Administrative reason(s)|0|||
160809081|NCT02553928|580686571|FG001|Overall Study|Administrative reason(s)|1|||
160809082|NCT00770562|580686576|FG000|Overall Study|Did not take treatment|1|||
160809083|NCT00770562|580686577|FG001|Overall Study|Did not take treatment|1|||
160809084|NCT05338710|580686581|FG000|Overall Study|Withdrawal by Subject|3|||
160809085|NCT01081951|580686582|FG000|Overall Study|Death|54|||
160809086|NCT01081951|580686583|FG001|Overall Study|Death|47|||
160809087|NCT01081951|580686582|FG000|Overall Study|Withdrawal by Subject|2|||
160809088|NCT01081951|580686583|FG001|Overall Study|Withdrawal by Subject|6|||
160809089|NCT01081951|580686582|FG000|Overall Study|Allocated treatment but did not take it|0|||
160809090|NCT01081951|580686583|FG001|Overall Study|Allocated treatment but did not take it|1|||
160809091|NCT01081951|580686582|FG000|Overall Study|Lost to Follow-up|0|||
160809092|NCT01081951|580686583|FG001|Overall Study|Lost to Follow-up|1|||
160809093|NCT00292045|580686586|FG000|Core Study (Through Week 13)|Adverse Event|1|||
160809094|NCT00292045|580686586|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
160809095|NCT00606411|580686587|FG000|Overall Study|Adverse Event|1|||
160809096|NCT00606411|580686588|FG001|Overall Study|Adverse Event|2|||
160809097|NCT00606411|580686587|FG000|Overall Study|Lack of Adherence|1|||
160809098|NCT00606411|580686588|FG001|Overall Study|Lack of Adherence|1|||
160809099|NCT00606411|580686587|FG000|Overall Study|Lack of Efficacy|1|||
160809100|NCT00606411|580686588|FG001|Overall Study|Lack of Efficacy|1|||
160809101|NCT00606411|580686587|FG000|Overall Study|Withdrawal by Subject|2|||
160809102|NCT00606411|580686588|FG001|Overall Study|Withdrawal by Subject|0|||
160809103|NCT00606411|580686587|FG000|Overall Study|Lost to Follow-up|1|||
160809104|NCT00606411|580686588|FG001|Overall Study|Lost to Follow-up|2|||
160809105|NCT00606411|580686587|FG000|Overall Study|Move out of state|0|||
160809106|NCT00606411|580686588|FG001|Overall Study|Move out of state|1|||
160809107|NCT04503551|580686589|FG000|Overall Study|Withdrawal by Subject|5|||
160809108|NCT04503551|580686590|FG001|Overall Study|Withdrawal by Subject|3|||
160809109|NCT04503551|580686589|FG000|Overall Study|Physician Decision|1|||
160809110|NCT04503551|580686590|FG001|Overall Study|Physician Decision|0|||
160809111|NCT04503551|580686589|FG000|Overall Study|Death|0|||
160809112|NCT04503551|580686590|FG001|Overall Study|Death|1|||
160809113|NCT04503551|580686589|FG000|Overall Study|Lost to Follow-up|1|||
160809114|NCT04503551|580686590|FG001|Overall Study|Lost to Follow-up|2|||
160809115|NCT04503551|580686589|FG000|Overall Study|Ongoing at Week 52|99|||
160809116|NCT04503551|580686590|FG001|Overall Study|Ongoing at Week 52|62|||
160809117|NCT00412958|580686591|FG000|Overall Study|Withdrawal by Subject|3|||
160809118|NCT00412958|580686592|FG001|Overall Study|Withdrawal by Subject|0|||
160809119|NCT00412958|580686593|FG002|Overall Study|Withdrawal by Subject|0|||
160809120|NCT00412958|580686594|FG003|Overall Study|Withdrawal by Subject|1|||
160809121|NCT00412958|580686591|FG000|Overall Study|Adverse Event|0|||
160809122|NCT00412958|580686592|FG001|Overall Study|Adverse Event|1|||
160809123|NCT00412958|580686593|FG002|Overall Study|Adverse Event|0|||
160809124|NCT00412958|580686594|FG003|Overall Study|Adverse Event|0|||
160809125|NCT00412958|580686591|FG000|Overall Study|Lost to Follow-up|0|||
160809126|NCT00412958|580686592|FG001|Overall Study|Lost to Follow-up|1|||
160809127|NCT00412958|580686593|FG002|Overall Study|Lost to Follow-up|0|||
160809128|NCT00412958|580686594|FG003|Overall Study|Lost to Follow-up|0|||
160809129|NCT00412958|580686591|FG000|Overall Study|Death|0|||
160809130|NCT00412958|580686592|FG001|Overall Study|Death|1|||
160809131|NCT00412958|580686593|FG002|Overall Study|Death|0|||
160809132|NCT00412958|580686594|FG003|Overall Study|Death|0|||
160809133|NCT00412958|580686591|FG000|Overall Study|Transport issue|0|||
160809134|NCT00412958|580686592|FG001|Overall Study|Transport issue|1|||
160809135|NCT00412958|580686593|FG002|Overall Study|Transport issue|0|||
160809136|NCT00412958|580686594|FG003|Overall Study|Transport issue|0|||
160809137|NCT01318135|580686595|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
160809138|NCT01318135|580686596|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809139|NCT01318135|580686597|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809140|NCT01318135|580686598|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809141|NCT01318135|580686599|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809142|NCT01318135|580686600|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809143|NCT01318135|580686601|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809144|NCT01318135|580686602|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809145|NCT01318135|580686595|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
160809146|NCT01318135|580686596|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809147|NCT01318135|580686597|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809148|NCT01318135|580686598|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809149|NCT01318135|580686599|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809150|NCT01318135|580686600|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809151|NCT01318135|580686601|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809152|NCT01318135|580686602|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809153|NCT01318135|580686595|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
160809154|NCT01318135|580686596|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
160809155|NCT01318135|580686597|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
160809156|NCT01318135|580686598|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
160809157|NCT01318135|580686599|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
160809158|NCT01318135|580686600|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
160809159|NCT01318135|580686601|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
160809160|NCT01318135|580686602|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
160809161|NCT01318135|580686595|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
160809162|NCT01318135|580686596|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
160809163|NCT01318135|580686597|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
160809164|NCT01318135|580686598|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
160809165|NCT01318135|580686599|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
160809166|NCT01318135|580686600|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
160809167|NCT01318135|580686601|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
160809168|NCT01318135|580686602|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
160809169|NCT01318135|580686595|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160809170|NCT01318135|580686596|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160809171|NCT01318135|580686597|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160809172|NCT01318135|580686598|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
160809173|NCT01318135|580686599|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160809174|NCT01318135|580686600|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
160809175|NCT01318135|580686601|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
160809176|NCT01318135|580686602|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
160809177|NCT01318135|580686595|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
160809178|NCT01318135|580686596|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
160809179|NCT01318135|580686597|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
160809180|NCT01318135|580686598|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
160809181|NCT01318135|580686599|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
160809182|NCT01318135|580686600|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
160809183|NCT01318135|580686601|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
160809184|NCT01318135|580686602|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
160809185|NCT01318135|580686595|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809186|NCT01318135|580686596|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809187|NCT01318135|580686597|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809188|NCT01318135|580686598|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809189|NCT01318135|580686599|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809190|NCT01318135|580686600|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809191|NCT01318135|580686601|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809192|NCT01318135|580686602|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
160809193|NCT05384834|580686606|FG000|Overall Study|Lost to Follow-up|43|||
160809194|NCT05384834|580686606|FG000|Overall Study|Withdrawal by Subject|5|||
160809195|NCT01871545|580686607|FG000|Overall Study|Death|2|||
160809196|NCT01871545|580686608|FG001|Overall Study|Death|0|||
160809197|NCT01871545|580686607|FG000|Overall Study|Lack of Efficacy|11|||
160809198|NCT01871545|580686608|FG001|Overall Study|Lack of Efficacy|2|||
160809199|NCT01871545|580686607|FG000|Overall Study|Physician Decision|4|||
160809200|NCT01871545|580686608|FG001|Overall Study|Physician Decision|0|||
160809201|NCT01871545|580686607|FG000|Overall Study|Withdrawal by Subject|0|||
160809202|NCT01871545|580686608|FG001|Overall Study|Withdrawal by Subject|1|||
160809203|NCT02569476|580686609|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
160809204|NCT02569476|580686609|FG000|Overall Study|Death|33|||
160809205|NCT02569476|580686609|FG000|Overall Study|Withdrawal by Subject|9|||
160809206|NCT02569476|580686609|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
160809207|NCT02569476|580686609|FG000|Overall Study|Palliative care|1|||
160986038|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
160986039|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
160986040|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
160986041|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
160986042|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
160986043|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
160986044|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
160986045|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
160986046|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
160809208|NCT02569476|580686609|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
160809209|NCT02569476|580686609|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
160809210|NCT01152788|580686610|FG000|Overall Study|Withdrawal by Subject|0|||
160809211|NCT01152788|580686611|FG001|Overall Study|Withdrawal by Subject|3|||
160809212|NCT01152788|580686610|FG000|Overall Study|No treatment|0|||
160809213|NCT01152788|580686611|FG001|Overall Study|No treatment|1|||
160809214|NCT01541865|580686612|FG000|Overall Study|Lost to Follow-up|11|||
160809215|NCT01541865|580686612|FG000|Overall Study|Withdrawal by Subject|9|||
160809216|NCT01541865|580686612|FG000|Overall Study|Adverse Event|1|||
160809217|NCT01541865|580686612|FG000|Overall Study|Protocol Violation|1|||
160809218|NCT01140867|580686613|FG000|Overall Study|Adverse Event|22|||
160809219|NCT01140867|580686613|FG000|Overall Study|Lack of Efficacy|3|||
160809220|NCT01140867|580686613|FG000|Overall Study|Lost to Follow-up|2|||
160809221|NCT01140867|580686613|FG000|Overall Study|Withdrawal by Subject|1|||
160809222|NCT01140867|580686613|FG000|Overall Study|Protocol Violation|1|||
160809223|NCT01140867|580686613|FG000|Overall Study|Uncooperative patient|2|||
160809224|NCT01140867|580686613|FG000|Overall Study|Medication Noncompliance|2|||
160809225|NCT00881530|580686614|FG000|Overall Study|Adverse Event|5|||
160809226|NCT00881530|580686615|FG001|Overall Study|Adverse Event|1|||
160809227|NCT00881530|580686616|FG002|Overall Study|Adverse Event|1|||
160809228|NCT00881530|580686617|FG003|Overall Study|Adverse Event|4|||
160809229|NCT00881530|580686618|FG004|Overall Study|Adverse Event|10|||
160809230|NCT00881530|580686619|FG005|Overall Study|Adverse Event|2|||
160809231|NCT00881530|580686614|FG000|Overall Study|Lack of Efficacy|1|||
160809232|NCT00881530|580686615|FG001|Overall Study|Lack of Efficacy|0|||
160809233|NCT00881530|580686616|FG002|Overall Study|Lack of Efficacy|0|||
160809234|NCT00881530|580686617|FG003|Overall Study|Lack of Efficacy|0|||
160809235|NCT00881530|580686618|FG004|Overall Study|Lack of Efficacy|1|||
160809236|NCT00881530|580686619|FG005|Overall Study|Lack of Efficacy|1|||
160809237|NCT00881530|580686614|FG000|Overall Study|Not compliant with the protocol|0|||
160809238|NCT00881530|580686615|FG001|Overall Study|Not compliant with the protocol|0|||
160809239|NCT00881530|580686616|FG002|Overall Study|Not compliant with the protocol|0|||
160809240|NCT00881530|580686617|FG003|Overall Study|Not compliant with the protocol|0|||
160809241|NCT00881530|580686618|FG004|Overall Study|Not compliant with the protocol|2|||
160809242|NCT00881530|580686619|FG005|Overall Study|Not compliant with the protocol|0|||
160809243|NCT00881530|580686614|FG000|Overall Study|Lost to Follow-up|0|||
160809244|NCT00881530|580686615|FG001|Overall Study|Lost to Follow-up|1|||
160809245|NCT00881530|580686616|FG002|Overall Study|Lost to Follow-up|1|||
160809246|NCT00881530|580686617|FG003|Overall Study|Lost to Follow-up|3|||
160809247|NCT00881530|580686618|FG004|Overall Study|Lost to Follow-up|1|||
160809248|NCT00881530|580686619|FG005|Overall Study|Lost to Follow-up|0|||
160809249|NCT00881530|580686614|FG000|Overall Study|Refused to continue medication|7|||
160809250|NCT00881530|580686615|FG001|Overall Study|Refused to continue medication|2|||
160809251|NCT00881530|580686616|FG002|Overall Study|Refused to continue medication|1|||
160809252|NCT00881530|580686617|FG003|Overall Study|Refused to continue medication|2|||
160809253|NCT00881530|580686618|FG004|Overall Study|Refused to continue medication|0|||
160809254|NCT00881530|580686619|FG005|Overall Study|Refused to continue medication|0|||
160809255|NCT00881530|580686614|FG000|Overall Study|Other reason not defined above|1|||
160809256|NCT00881530|580686615|FG001|Overall Study|Other reason not defined above|1|||
160809257|NCT00881530|580686616|FG002|Overall Study|Other reason not defined above|2|||
160809258|NCT00881530|580686617|FG003|Overall Study|Other reason not defined above|0|||
160809259|NCT00881530|580686618|FG004|Overall Study|Other reason not defined above|0|||
160809260|NCT00881530|580686619|FG005|Overall Study|Other reason not defined above|2|||
160809261|NCT00778336|580686620|FG000|Index Procedure-Discharge|Death|6|||
160809262|NCT00778336|580686621|FG001|Index Procedure-Discharge|Death|3|||
160809263|NCT00778336|580686622|FG002|Index Procedure-Discharge|Death|2|||
160809264|NCT00778336|580686623|FG003|Index Procedure-Discharge|Death|0|||
160809265|NCT00778336|580686620|FG000|3 Month Follow Up|Lost to Follow-up|15|||
160809266|NCT00778336|580686621|FG001|3 Month Follow Up|Lost to Follow-up|20|||
160809267|NCT00778336|580686622|FG002|3 Month Follow Up|Lost to Follow-up|3|||
160809268|NCT00778336|580686623|FG003|3 Month Follow Up|Lost to Follow-up|0|||
160809269|NCT00778336|580686620|FG000|3 Month Follow Up|Death|8|||
160809270|NCT00778336|580686621|FG001|3 Month Follow Up|Death|3|||
160809271|NCT00778336|580686622|FG002|3 Month Follow Up|Death|2|||
160809272|NCT00778336|580686623|FG003|3 Month Follow Up|Death|0|||
160809273|NCT02720523|580686624|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
160809274|NCT02720523|580686625|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
160809275|NCT02720523|580686626|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
160809276|NCT02720523|580686627|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
160809277|NCT02720523|580686628|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
160809278|NCT02720523|580686629|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
160809279|NCT02720523|580686630|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
160809280|NCT02720523|580686624|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
160809281|NCT02720523|580686625|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809282|NCT02720523|580686626|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809283|NCT02720523|580686627|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809284|NCT02720523|580686628|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809285|NCT02720523|580686629|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809286|NCT02720523|580686630|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809287|NCT02720523|580686624|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
160809288|NCT02720523|580686625|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809289|NCT02720523|580686626|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809290|NCT02720523|580686627|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809291|NCT02720523|580686628|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809292|NCT02720523|580686629|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809293|NCT02720523|580686630|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809294|NCT02720523|580686624|FG000|Period 1: Placebo-controlled Period|Other|0|||
160809295|NCT02720523|580686625|FG001|Period 1: Placebo-controlled Period|Other|0|||
160809296|NCT02720523|580686626|FG002|Period 1: Placebo-controlled Period|Other|1|||
160809297|NCT02720523|580686627|FG003|Period 1: Placebo-controlled Period|Other|1|||
160809298|NCT02720523|580686628|FG004|Period 1: Placebo-controlled Period|Other|0|||
160809299|NCT02720523|580686629|FG005|Period 1: Placebo-controlled Period|Other|0|||
160809300|NCT02720523|580686630|FG006|Period 1: Placebo-controlled Period|Other|0|||
160809301|NCT02720523|580686624|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
160809302|NCT02720523|580686625|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
160809303|NCT02720523|580686626|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
160809304|NCT02720523|580686627|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
160809305|NCT02720523|580686628|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
160809306|NCT02720523|580686629|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
160809307|NCT02720523|580686630|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
160809308|NCT02720523|580686624|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
160809309|NCT02720523|580686625|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
160809310|NCT02720523|580686626|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
160809311|NCT02720523|580686627|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
160809312|NCT02720523|580686628|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
160809313|NCT02720523|580686629|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
160809314|NCT02720523|580686630|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
160809315|NCT02720523|580686624|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
160809316|NCT02720523|580686625|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
160809317|NCT02720523|580686626|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
160809318|NCT02720523|580686627|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
160809319|NCT02720523|580686628|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
160809320|NCT02720523|580686629|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
160809321|NCT02720523|580686630|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
160809322|NCT02720523|580686624|FG000|Period 2: Long-term Extension Period|Other|0|||
160809323|NCT02720523|580686625|FG001|Period 2: Long-term Extension Period|Other|0|||
160551453|NCT04537208|579744199|FG007|Overall Study|Protocol deviation|0|||
160551454|NCT04537208|579744200|FG008|Overall Study|Protocol deviation|1|||
160551455|NCT04537208|579744201|FG009|Overall Study|Protocol deviation|0|||
160551456|NCT04537208|579744202|FG010|Overall Study|Protocol deviation|2|||
160809324|NCT02720523|580686626|FG002|Period 2: Long-term Extension Period|Other|0|||
160809325|NCT02720523|580686627|FG003|Period 2: Long-term Extension Period|Other|0|||
160809326|NCT02720523|580686628|FG004|Period 2: Long-term Extension Period|Other|2|||
160809327|NCT02720523|580686629|FG005|Period 2: Long-term Extension Period|Other|0|||
160809328|NCT02720523|580686630|FG006|Period 2: Long-term Extension Period|Other|3|||
160809329|NCT03146663|580686631|FG000|Overall Study|Did not receive study treatment|1|||
160809330|NCT03146663|580686632|FG001|Overall Study|Did not receive study treatment|1|||
160809331|NCT03581292|580686633|FG000|Overall Study|Physician Decision|9|||
160809332|NCT03581292|580686634|FG001|Overall Study|Physician Decision|5|||
160809333|NCT03581292|580686633|FG000|Overall Study|Withdrawal by Subject|3|||
160809334|NCT03581292|580686634|FG001|Overall Study|Withdrawal by Subject|0|||
160809335|NCT03581292|580686633|FG000|Overall Study|Withdrawal before Therapy Start|1|||
160809336|NCT03581292|580686634|FG001|Overall Study|Withdrawal before Therapy Start|0|||
160809337|NCT02524145|580686638|FG000|Overall Study|Withdrawal by Subject|2|||
160809338|NCT02524145|580686639|FG001|Overall Study|Withdrawal by Subject|2|||
160809339|NCT02524145|580686640|FG002|Overall Study|Withdrawal by Subject|3|||
160809340|NCT00283803|580689263|FG000|Overall Study|Physician Decision|9|||
160809341|NCT00283803|580689263|FG000|Overall Study|Withdrawal by Subject|4|||
160809342|NCT01127607|580689264|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
160809343|NCT01127607|580689265|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
160809344|NCT01127607|580689264|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
160809345|NCT01127607|580689265|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
160809346|NCT02220855|580689266|FG000|Overall Study|Adverse Event|8|||
160809347|NCT02220855|580689266|FG000|Overall Study|Disease Progression|5|||
160809348|NCT02220855|580689266|FG000|Overall Study|Withdrawal by Subject|1|||
160809349|NCT03419897|580689267|FG000|Overall Study|Death|180|||
160809350|NCT03419897|580689267|FG000|Overall Study|Lost to Follow-up|1|||
160809351|NCT03419897|580689267|FG000|Overall Study|Withdrawal by Subject|6|||
160809352|NCT03419897|580689267|FG000|Overall Study|Sponsor Decision|61|||
160809353|NCT03419897|580689267|FG000|Overall Study|Physician Decision|1|||
160809354|NCT05730725|580689270|FG000|Overall Study|Withdrawal by Subject|3|||
160809355|NCT05730725|580689271|FG001|Overall Study|Withdrawal by Subject|0|||
160809356|NCT05730725|580689272|FG002|Overall Study|Withdrawal by Subject|0|||
160809357|NCT05730725|580689273|FG003|Overall Study|Withdrawal by Subject|1|||
160809358|NCT05730725|580689270|FG000|Overall Study|Not Reported|1|||
160809359|NCT05730725|580689271|FG001|Overall Study|Not Reported|1|||
160809360|NCT05730725|580689272|FG002|Overall Study|Not Reported|1|||
160809361|NCT05730725|580689273|FG003|Overall Study|Not Reported|1|||
160809362|NCT01945216|580689276|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
160809363|NCT01945216|580689276|FG000|Overall Study|Protocol Violation|42|||
160809364|NCT01945216|580689276|FG000|Overall Study|CRF not assured by investigators|5|||
160809365|NCT02982772|580689278|FG000|Intervention|Lost to Follow-up|19|||
160809366|NCT02982772|580689279|FG001|Intervention|Lost to Follow-up|13|||
160809367|NCT02982772|580689278|FG000|1M Follow-Up|Lost to Follow-up|21|||
160809368|NCT02982772|580689279|FG001|1M Follow-Up|Lost to Follow-up|18|||
160809369|NCT02982772|580689278|FG000|3M Follow-Up|Lost to Follow-up|17|||
160809370|NCT02982772|580689279|FG001|3M Follow-Up|Lost to Follow-up|11|||
160809371|NCT02982772|580689278|FG000|6M Follow-Up|Lost to Follow-up|11|||
160551457|NCT04537208|579744192|FG000|Overall Study|Withdrawal by Subject|4|||
160551458|NCT04537208|579744193|FG001|Overall Study|Withdrawal by Subject|2|||
160551459|NCT04537208|579744194|FG002|Overall Study|Withdrawal by Subject|1|||
160551460|NCT04537208|579744195|FG003|Overall Study|Withdrawal by Subject|3|||
160809372|NCT02982772|580689279|FG001|6M Follow-Up|Lost to Follow-up|9|||
160809373|NCT02982772|580689278|FG000|12M Follow-Up|Lost to Follow-up|11|||
160809374|NCT02982772|580689279|FG001|12M Follow-Up|Lost to Follow-up|5|||
160809375|NCT01905943|580689280|FG000|Overall Study|Withdrawal of consent|90|||
160809376|NCT01905943|580689280|FG000|Overall Study|Lost to Follow-up|16|||
160809377|NCT01905943|580689280|FG000|Overall Study|Investigator discretion|7|||
160809378|NCT01905943|580689280|FG000|Overall Study|Death|186|||
160809379|NCT01905943|580689280|FG000|Overall Study|Adverse Event|3|||
160809380|NCT01905943|580689280|FG000|Overall Study|Other|12|||
160809381|NCT02974140|580689281|FG000|Overall Study|Adverse Event|2|||
160809382|NCT02974140|580689281|FG000|Overall Study|Lost to Follow-up|1|||
160809383|NCT02974140|580689281|FG000|Overall Study|Study Terminated by Sponsor|36|||
160809384|NCT01238991|580689284|FG000|Overall Study|Adverse Event|1|||
160809385|NCT01238991|580689285|FG001|Overall Study|Adverse Event|0|||
160809386|NCT01238991|580689286|FG002|Overall Study|Adverse Event|3|||
160809387|NCT01238991|580689287|FG003|Overall Study|Adverse Event|1|||
160809388|NCT01238991|580689288|FG004|Overall Study|Adverse Event|1|||
160809389|NCT01238991|580689289|FG005|Overall Study|Adverse Event|0|||
160809390|NCT01238991|580689290|FG006|Overall Study|Adverse Event|1|||
160809391|NCT01238991|580689291|FG007|Overall Study|Adverse Event|1|||
160809392|NCT01238991|580689292|FG008|Overall Study|Adverse Event|0|||
160809393|NCT01238991|580689293|FG009|Overall Study|Adverse Event|0|||
160809394|NCT01238991|580689284|FG000|Overall Study|Death|0|||
160809395|NCT01238991|580689285|FG001|Overall Study|Death|0|||
160809396|NCT01238991|580689286|FG002|Overall Study|Death|0|||
160809397|NCT01238991|580689287|FG003|Overall Study|Death|1|||
160809398|NCT01238991|580689288|FG004|Overall Study|Death|0|||
160809399|NCT01238991|580689289|FG005|Overall Study|Death|0|||
160809400|NCT01238991|580689290|FG006|Overall Study|Death|0|||
160809401|NCT01238991|580689291|FG007|Overall Study|Death|0|||
160809402|NCT01238991|580689292|FG008|Overall Study|Death|0|||
160809403|NCT01238991|580689293|FG009|Overall Study|Death|0|||
160809404|NCT01238991|580689284|FG000|Overall Study|Lack of Efficacy|0|||
160809405|NCT01238991|580689285|FG001|Overall Study|Lack of Efficacy|0|||
160809406|NCT01238991|580689286|FG002|Overall Study|Lack of Efficacy|1|||
160809407|NCT01238991|580689287|FG003|Overall Study|Lack of Efficacy|0|||
160809408|NCT01238991|580689288|FG004|Overall Study|Lack of Efficacy|0|||
160809409|NCT01238991|580689289|FG005|Overall Study|Lack of Efficacy|0|||
160809410|NCT01238991|580689290|FG006|Overall Study|Lack of Efficacy|0|||
160809411|NCT01238991|580689291|FG007|Overall Study|Lack of Efficacy|0|||
160809412|NCT01238991|580689292|FG008|Overall Study|Lack of Efficacy|1|||
160809413|NCT01238991|580689293|FG009|Overall Study|Lack of Efficacy|0|||
160809414|NCT01238991|580689284|FG000|Overall Study|Withdrawal by Subject|0|||
160809415|NCT01238991|580689285|FG001|Overall Study|Withdrawal by Subject|0|||
160809416|NCT01238991|580689286|FG002|Overall Study|Withdrawal by Subject|1|||
160809417|NCT01238991|580689287|FG003|Overall Study|Withdrawal by Subject|0|||
160551461|NCT04537208|579744196|FG004|Overall Study|Withdrawal by Subject|5|||
160551462|NCT04537208|579744197|FG005|Overall Study|Withdrawal by Subject|1|||
160551463|NCT04537208|579744198|FG006|Overall Study|Withdrawal by Subject|6|||
160551464|NCT04537208|579744199|FG007|Overall Study|Withdrawal by Subject|1|||
160809418|NCT01238991|580689288|FG004|Overall Study|Withdrawal by Subject|0|||
160809419|NCT01238991|580689289|FG005|Overall Study|Withdrawal by Subject|0|||
160809420|NCT01238991|580689290|FG006|Overall Study|Withdrawal by Subject|0|||
160809421|NCT01238991|580689291|FG007|Overall Study|Withdrawal by Subject|0|||
160809422|NCT01238991|580689292|FG008|Overall Study|Withdrawal by Subject|0|||
160809423|NCT01238991|580689293|FG009|Overall Study|Withdrawal by Subject|0|||
160809424|NCT01238991|580689284|FG000|Overall Study|Study Terminated by Sponsor|0|||
160809425|NCT01238991|580689285|FG001|Overall Study|Study Terminated by Sponsor|0|||
160809426|NCT01238991|580689286|FG002|Overall Study|Study Terminated by Sponsor|0|||
160809427|NCT01238991|580689287|FG003|Overall Study|Study Terminated by Sponsor|0|||
160809428|NCT01238991|580689288|FG004|Overall Study|Study Terminated by Sponsor|1|||
160809429|NCT01238991|580689289|FG005|Overall Study|Study Terminated by Sponsor|0|||
160551465|NCT04537208|579744200|FG008|Overall Study|Withdrawal by Subject|7|||
160809430|NCT01238991|580689290|FG006|Overall Study|Study Terminated by Sponsor|7|||
160809431|NCT01238991|580689291|FG007|Overall Study|Study Terminated by Sponsor|4|||
160809432|NCT01238991|580689292|FG008|Overall Study|Study Terminated by Sponsor|2|||
160809433|NCT01238991|580689293|FG009|Overall Study|Study Terminated by Sponsor|2|||
160809434|NCT01238991|580689284|FG000|Overall Study|Caregiver's request|0|||
160809435|NCT01238991|580689285|FG001|Overall Study|Caregiver's request|0|||
160809436|NCT01238991|580689286|FG002|Overall Study|Caregiver's request|0|||
160809437|NCT01238991|580689287|FG003|Overall Study|Caregiver's request|0|||
160809438|NCT01238991|580689288|FG004|Overall Study|Caregiver's request|0|||
160809439|NCT01238991|580689289|FG005|Overall Study|Caregiver's request|0|||
160809440|NCT01238991|580689290|FG006|Overall Study|Caregiver's request|0|||
160809441|NCT01238991|580689291|FG007|Overall Study|Caregiver's request|0|||
160809442|NCT01238991|580689292|FG008|Overall Study|Caregiver's request|1|||
160809443|NCT01238991|580689293|FG009|Overall Study|Caregiver's request|0|||
160809444|NCT01238991|580689284|FG000|Overall Study|Admission to a nursing home|1|||
160809445|NCT01238991|580689285|FG001|Overall Study|Admission to a nursing home|0|||
160809446|NCT01238991|580689286|FG002|Overall Study|Admission to a nursing home|1|||
160809447|NCT01238991|580689287|FG003|Overall Study|Admission to a nursing home|0|||
160809448|NCT01238991|580689288|FG004|Overall Study|Admission to a nursing home|0|||
160809449|NCT01238991|580689289|FG005|Overall Study|Admission to a nursing home|0|||
160809450|NCT01238991|580689290|FG006|Overall Study|Admission to a nursing home|0|||
160809451|NCT01238991|580689291|FG007|Overall Study|Admission to a nursing home|0|||
160809452|NCT01238991|580689292|FG008|Overall Study|Admission to a nursing home|0|||
160809453|NCT01238991|580689293|FG009|Overall Study|Admission to a nursing home|0|||
160809454|NCT02297815|580689314|FG000|Overall Study|Lost to Follow-up|236|||
160809455|NCT02297815|580689315|FG001|Overall Study|Lost to Follow-up|140|||
160809456|NCT00662831|580689316|FG000|Overall Study|Death|4|||
160809457|NCT00662831|580689317|FG001|Overall Study|Death|1|||
160809458|NCT00662831|580689316|FG000|Overall Study|Lack of Efficacy|6|||
160809459|NCT00662831|580689317|FG001|Overall Study|Lack of Efficacy|6|||
160809460|NCT00662831|580689316|FG000|Overall Study|Lost to Follow-up|1|||
160809461|NCT00662831|580689317|FG001|Overall Study|Lost to Follow-up|0|||
160551466|NCT04537208|579744201|FG009|Overall Study|Withdrawal by Subject|2|||
160551467|NCT04537208|579744202|FG010|Overall Study|Withdrawal by Subject|4|||
160551468|NCT04537208|579744192|FG000|Overall Study|Lost to Follow-up|4|||
160551469|NCT04537208|579744193|FG001|Overall Study|Lost to Follow-up|1|||
160551470|NCT04537208|579744194|FG002|Overall Study|Lost to Follow-up|3|||
160551471|NCT04537208|579744195|FG003|Overall Study|Lost to Follow-up|4|||
160551472|NCT04537208|579744196|FG004|Overall Study|Lost to Follow-up|3|||
160551473|NCT04537208|579744197|FG005|Overall Study|Lost to Follow-up|2|||
160551474|NCT04537208|579744198|FG006|Overall Study|Lost to Follow-up|3|||
160551475|NCT04537208|579744199|FG007|Overall Study|Lost to Follow-up|2|||
160551476|NCT04537208|579744200|FG008|Overall Study|Lost to Follow-up|7|||
160551477|NCT04537208|579744201|FG009|Overall Study|Lost to Follow-up|2|||
160809462|NCT00662831|580689316|FG000|Overall Study|Withdrawal by Subject|2|||
160809463|NCT00662831|580689317|FG001|Overall Study|Withdrawal by Subject|1|||
160809464|NCT00662831|580689316|FG000|Overall Study|Other|62|||
160809465|NCT00662831|580689317|FG001|Overall Study|Other|31|||
160809466|NCT00662831|580689316|FG000|Overall Study|Protocol Violation|8|||
160809467|NCT00662831|580689317|FG001|Overall Study|Protocol Violation|4|||
160809468|NCT00662831|580689316|FG000|Overall Study|Adverse Event|23|||
160809469|NCT00662831|580689317|FG001|Overall Study|Adverse Event|16|||
160809470|NCT02522429|580689318|FG000|Overall Study|Lost to Follow-up|8|||
160809471|NCT02522429|580689318|FG000|Overall Study|Adverse Event|2|||
160809472|NCT02522429|580689318|FG000|Overall Study|Death|1|||
160809473|NCT02522429|580689318|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
160809474|NCT00294671|580689319|FG000|Overall Study|Lack of Efficacy|11|||
160809475|NCT00294671|580689320|FG001|Overall Study|Lack of Efficacy|23|||
160809476|NCT00294671|580689319|FG000|Overall Study|Liver transplant|7|||
160809477|NCT00294671|580689320|FG001|Overall Study|Liver transplant|9|||
160551478|NCT04537208|579744202|FG010|Overall Study|Lost to Follow-up|2|||
160551479|NCT01537211|579744207|FG000|Overall Study|Lost to Follow-up|0|||
160551480|NCT01537211|579744208|FG001|Overall Study|Lost to Follow-up|1|||
160551481|NCT00704964|579744209|FG000|Overall Study|Not completed on time|328|||
160645113|NCT03120520|580082485|FG003|Overall Study|Other|0|||
160809478|NCT00294671|580689319|FG000|Overall Study|Drug related adverse event (AE)|4|||
160809479|NCT00294671|580689320|FG001|Overall Study|Drug related adverse event (AE)|2|||
160809480|NCT00294671|580689319|FG000|Overall Study|Non-drug related AE|3|||
160809481|NCT00294671|580689320|FG001|Overall Study|Non-drug related AE|2|||
160809482|NCT00294671|580689319|FG000|Overall Study|Lost to Follow-up|1|||
160809483|NCT00294671|580689320|FG001|Overall Study|Lost to Follow-up|3|||
160809484|NCT00294671|580689319|FG000|Overall Study|Non-compliance|1|||
160809485|NCT00294671|580689320|FG001|Overall Study|Non-compliance|0|||
160809486|NCT00294671|580689319|FG000|Overall Study|Death|0|||
160809487|NCT00294671|580689320|FG001|Overall Study|Death|1|||
160809488|NCT03015363|580689325|FG000|Overall Study|Physician Decision|14|||
160809489|NCT03015363|580689325|FG000|Overall Study|Withdrawal by Subject|3|||
160809490|NCT00958360|580689326|FG000|Overall Study|Withdrawal by Subject|3|||
160809491|NCT00958360|580689327|FG001|Overall Study|Withdrawal by Subject|1|||
160809492|NCT00958360|580689326|FG000|Overall Study|Death|6|||
160809493|NCT00958360|580689327|FG001|Overall Study|Death|7|||
160809494|NCT00958360|580689326|FG000|Overall Study|Physician Decision|2|||
160809495|NCT00958360|580689327|FG001|Overall Study|Physician Decision|1|||
160809496|NCT00958360|580689326|FG000|Overall Study|Lost to Follow-up|0|||
160809497|NCT00958360|580689327|FG001|Overall Study|Lost to Follow-up|1|||
160809498|NCT03107052|580689328|FG000|Overall Study|Adverse Event|6|||
160809499|NCT03107052|580689329|FG001|Overall Study|Adverse Event|1|||
160986047|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
160551482|NCT02161562|579744210|FG000|Overall Study|Withdrawal by Subject|5|||
160551483|NCT02161562|579744211|FG001|Overall Study|Withdrawal by Subject|8|||
160551484|NCT02161562|579744210|FG000|Overall Study|Protocol Violation|9|||
160551485|NCT02161562|579744211|FG001|Overall Study|Protocol Violation|4|||
160551486|NCT02161562|579744210|FG000|Overall Study|Pregnancy|1|||
160551487|NCT02161562|579744211|FG001|Overall Study|Pregnancy|2|||
160551488|NCT02161562|579744210|FG000|Overall Study|Lost to Follow-up|3|||
160551489|NCT02161562|579744211|FG001|Overall Study|Lost to Follow-up|1|||
160551490|NCT02161562|579744210|FG000|Overall Study|Lack of Efficacy|4|||
160551491|NCT02161562|579744211|FG001|Overall Study|Lack of Efficacy|1|||
160551492|NCT02161562|579744210|FG000|Overall Study|Adverse Event|1|||
160551493|NCT02161562|579744211|FG001|Overall Study|Adverse Event|1|||
160551494|NCT02161562|579744210|FG000|Overall Study|Participant moved back to home country|1|||
160986048|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
160986049|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
160986050|NCT03890120|581338569|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
160986051|NCT03890120|581338570|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
160986052|NCT03890120|581338571|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
160986053|NCT03890120|581338572|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
160986054|NCT03890120|581338569|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
160986055|NCT03890120|581338570|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
160986056|NCT03890120|581338571|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
160986057|NCT03890120|581338572|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
160986058|NCT03890120|581338569|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
160986059|NCT03890120|581338570|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
160986060|NCT03890120|581338571|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
160986061|NCT03890120|581338572|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
160986062|NCT03890120|581338569|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
160986063|NCT03890120|581338570|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
160986064|NCT03890120|581338571|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
160986065|NCT03890120|581338572|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
160986066|NCT01052662|581338573|FG000|Overall Study|Lost to Follow-up|15|||
160986067|NCT01052662|581338574|FG001|Overall Study|Lost to Follow-up|13|||
160986068|NCT01052662|581338575|FG002|Overall Study|Lost to Follow-up|18|||
160986069|NCT01052662|581338573|FG000|Overall Study|Withdrawal by Subject|3|||
160986070|NCT01052662|581338574|FG001|Overall Study|Withdrawal by Subject|2|||
160986071|NCT01052662|581338575|FG002|Overall Study|Withdrawal by Subject|1|||
160986072|NCT01052662|581338573|FG000|Overall Study|Pharmacy issue|1|||
160551495|NCT02161562|579744211|FG001|Overall Study|Participant moved back to home country|0|||
160551496|NCT02161562|579744210|FG000|Overall Study|Withdrew due to being out of the country|1|||
160551497|NCT02161562|579744211|FG001|Overall Study|Withdrew due to being out of the country|0|||
160809500|NCT03107052|580689330|FG002|Overall Study|Adverse Event|2|||
160809501|NCT03107052|580689328|FG000|Overall Study|Withdrawal by Subject|9|||
160809502|NCT03107052|580689329|FG001|Overall Study|Withdrawal by Subject|5|||
160809503|NCT03107052|580689330|FG002|Overall Study|Withdrawal by Subject|8|||
160809504|NCT03107052|580689328|FG000|Overall Study|Protocol Violation|6|||
160809505|NCT03107052|580689329|FG001|Overall Study|Protocol Violation|0|||
160809506|NCT03107052|580689330|FG002|Overall Study|Protocol Violation|3|||
160809507|NCT03107052|580689328|FG000|Overall Study|Lost to Follow-up|4|||
160809508|NCT03107052|580689329|FG001|Overall Study|Lost to Follow-up|0|||
160809509|NCT03107052|580689330|FG002|Overall Study|Lost to Follow-up|1|||
160986073|NCT01052662|581338574|FG001|Overall Study|Pharmacy issue|3|||
160899347|NCT00075218|581026299|FG002|Double-Blind Treatment|Adverse Event|0|||
160899348|NCT00075218|581026297|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
160899349|NCT00075218|581026298|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
160899350|NCT00075218|581026299|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
160899351|NCT00075218|581026297|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
160899352|NCT00075218|581026298|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
160899353|NCT00075218|581026299|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
160899354|NCT00075218|581026297|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
160899355|NCT00075218|581026298|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
160899356|NCT00075218|581026299|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
160899357|NCT00075218|581026297|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
160899358|NCT00075218|581026298|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
160899359|NCT00075218|581026299|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
160899360|NCT00075218|581026297|FG000|Double-Blind Treatment|No study medication taken|2|||
160899361|NCT00075218|581026298|FG001|Double-Blind Treatment|No study medication taken|0|||
160899362|NCT00075218|581026299|FG002|Double-Blind Treatment|No study medication taken|0|||
160551498|NCT02161562|579744210|FG000|Overall Study|Participant moved out of province|1|||
160551499|NCT02161562|579744211|FG001|Overall Study|Participant moved out of province|0|||
160551500|NCT03021642|579744216|FG000|Washout Period (21 Days)|Adverse Event|1|||
160551501|NCT03021642|579744217|FG001|Washout Period (21 Days)|Adverse Event|1|||
160551502|NCT01192347|579744218|FG000|Overall Study|Death|3|||
160551503|NCT01192347|579744218|FG000|Overall Study|Lost to Follow-up|3|||
160551504|NCT01192347|579744218|FG000|Overall Study|Withdrawal by Subject|1|||
160551505|NCT01192347|579744218|FG000|Overall Study|Adverse Event|1|||
160551506|NCT01192347|579744218|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
160551507|NCT01192347|579744218|FG000|Overall Study|Patient seen in different hospital|1|||
160551508|NCT01192347|579744218|FG000|Overall Study|Patient not visiting hospital regularly|1|||
160551509|NCT01192347|579744218|FG000|Overall Study|Patient did not show up for visits|1|||
160551510|NCT02623335|579744219|FG000|Overall Study|Death|8|||
160551511|NCT02623335|579744220|FG001|Overall Study|Death|7|||
160551512|NCT02623335|579744219|FG000|Overall Study|Lost to Follow-up|15|||
160551513|NCT02623335|579744220|FG001|Overall Study|Lost to Follow-up|23|||
160551514|NCT02623335|579744219|FG000|Overall Study|Withdrawal by Subject|2|||
160551515|NCT02623335|579744220|FG001|Overall Study|Withdrawal by Subject|5|||
160551516|NCT02623335|579744219|FG000|Overall Study|Protocol Violation|2|||
160551517|NCT02623335|579744220|FG001|Overall Study|Protocol Violation|1|||
160551518|NCT02474082|579744221|FG000|Overall Study|Adverse Event|2|||
160551519|NCT02474082|579744222|FG001|Overall Study|Adverse Event|32|||
160645114|NCT04345471|580082487|FG000|Overall Study|Adverse Event|8|||
160899363|NCT00075218|581026297|FG000|Open-Label Treatment|Lack of Efficacy|0|||
160899364|NCT00075218|581026298|FG001|Open-Label Treatment|Lack of Efficacy|0|||
160899365|NCT00075218|581026299|FG002|Open-Label Treatment|Lack of Efficacy|174|||
160986074|NCT01052662|581338575|FG002|Overall Study|Pharmacy issue|3|||
160986075|NCT01052662|581338573|FG000|Overall Study|Adverse Event|1|||
160986076|NCT01052662|581338574|FG001|Overall Study|Adverse Event|1|||
160986077|NCT01052662|581338575|FG002|Overall Study|Adverse Event|0|||
160986078|NCT01052662|581338573|FG000|Overall Study|Legal Problem|2|||
160986079|NCT01052662|581338574|FG001|Overall Study|Legal Problem|0|||
160986080|NCT01052662|581338575|FG002|Overall Study|Legal Problem|0|||
160986081|NCT01052662|581338573|FG000|Overall Study|Administrative|0|||
160986082|NCT01052662|581338574|FG001|Overall Study|Administrative|3|||
160899366|NCT00075218|581026297|FG000|Open-Label Treatment|Adverse Event|0|||
160899367|NCT00075218|581026298|FG001|Open-Label Treatment|Adverse Event|0|||
160899368|NCT00075218|581026299|FG002|Open-Label Treatment|Adverse Event|51|||
160899369|NCT00075218|581026297|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
160899370|NCT00075218|581026298|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
160986083|NCT01052662|581338575|FG002|Overall Study|Administrative|0|||
160986084|NCT00479674|581338576|FG000|Overall Study|Adverse Event|18|||
160986085|NCT00479674|581338576|FG000|Overall Study|Withdrawal by Subject|6|||
160986086|NCT00479674|581338576|FG000|Overall Study|Physician Decision|14|||
160986087|NCT00479674|581338576|FG000|Overall Study|none provided|3|||
160986088|NCT02478359|581338578|FG000|Overall Study|Disenrolled from health plan|106|||
160986089|NCT02478359|581338579|FG001|Overall Study|Disenrolled from health plan|65|||
160551520|NCT02474082|579744221|FG000|Overall Study|Withdrawal of informed consent|1|||
160551521|NCT02474082|579744222|FG001|Overall Study|Withdrawal of informed consent|11|||
160899371|NCT00075218|581026299|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
160899372|NCT00075218|581026297|FG000|Open-Label Treatment|Decision of Sponsor|0|||
160899373|NCT00075218|581026298|FG001|Open-Label Treatment|Decision of Sponsor|0|||
160899374|NCT00075218|581026299|FG002|Open-Label Treatment|Decision of Sponsor|8|||
160899375|NCT00075218|581026297|FG000|Open-Label Treatment|Protocol Violation|0|||
160986090|NCT03293485|581338583|FG000|Overall Study|Death|1|||
160986091|NCT03293485|581338583|FG000|Overall Study|Screen Failure|2|||
160986092|NCT03293485|581338583|FG000|Overall Study|Withdrawal by Subject|2|||
160986093|NCT03023332|581338584|FG000|Overall Study|Withdrawal by Subject|10|||
160551522|NCT02474082|579744221|FG000|Overall Study|Lost to Follow-up|2|||
160551523|NCT02474082|579744222|FG001|Overall Study|Lost to Follow-up|2|||
160809510|NCT03107052|580689328|FG000|Overall Study|Lack of Efficacy|23|||
160809511|NCT03107052|580689329|FG001|Overall Study|Lack of Efficacy|7|||
160809512|NCT03107052|580689330|FG002|Overall Study|Lack of Efficacy|4|||
160809513|NCT03107052|580689328|FG000|Overall Study|Other than specified|4|||
160809514|NCT03107052|580689329|FG001|Overall Study|Other than specified|2|||
160809515|NCT03107052|580689330|FG002|Overall Study|Other than specified|0|||
160809516|NCT03107052|580689328|FG000|Overall Study|Study terminated due to futility|67|||
160809517|NCT03107052|580689329|FG001|Overall Study|Study terminated due to futility|31|||
160809518|NCT03107052|580689330|FG002|Overall Study|Study terminated due to futility|23|||
160809519|NCT00500357|580689331|FG000|Overall Study|Death|1|||
160809520|NCT02263326|580689332|FG000|Overall Study|Lost to Follow-up|1|||
160809521|NCT02263326|580689333|FG001|Overall Study|Lost to Follow-up|1|||
160809522|NCT01061723|580689334|FG000|Overall Study|Adverse Event|0|||
160809523|NCT01061723|580689335|FG001|Overall Study|Adverse Event|2|||
160809524|NCT01061723|580689336|FG002|Overall Study|Adverse Event|5|||
160809525|NCT01061723|580689337|FG003|Overall Study|Adverse Event|5|||
160809526|NCT01061723|580689338|FG004|Overall Study|Adverse Event|2|||
160809527|NCT01061723|580689339|FG005|Overall Study|Adverse Event|6|||
160809528|NCT01061723|580689334|FG000|Overall Study|Lack of Efficacy|2|||
160809529|NCT01061723|580689335|FG001|Overall Study|Lack of Efficacy|3|||
160809530|NCT01061723|580689336|FG002|Overall Study|Lack of Efficacy|4|||
160809531|NCT01061723|580689337|FG003|Overall Study|Lack of Efficacy|2|||
160809532|NCT01061723|580689338|FG004|Overall Study|Lack of Efficacy|1|||
160809533|NCT01061723|580689339|FG005|Overall Study|Lack of Efficacy|1|||
160809534|NCT01061723|580689334|FG000|Overall Study|Randomized but not treated|0|||
160809535|NCT01061723|580689335|FG001|Overall Study|Randomized but not treated|0|||
160809536|NCT01061723|580689336|FG002|Overall Study|Randomized but not treated|0|||
160809537|NCT01061723|580689337|FG003|Overall Study|Randomized but not treated|0|||
160809538|NCT01061723|580689338|FG004|Overall Study|Randomized but not treated|0|||
160809539|NCT01061723|580689339|FG005|Overall Study|Randomized but not treated|1|||
160809540|NCT01061723|580689334|FG000|Overall Study|Other than specified above|2|||
160809541|NCT01061723|580689335|FG001|Overall Study|Other than specified above|1|||
160809542|NCT01061723|580689336|FG002|Overall Study|Other than specified above|1|||
160809543|NCT01061723|580689337|FG003|Overall Study|Other than specified above|1|||
160809544|NCT01061723|580689338|FG004|Overall Study|Other than specified above|0|||
160809545|NCT01061723|580689339|FG005|Overall Study|Other than specified above|1|||
160809546|NCT03292874|580689340|FG000|Overall Study|Due to pandemic|5|||
160809547|NCT01961297|580689343|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
160809548|NCT01961297|580689344|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
160809549|NCT02482298|580689345|FG000|Overall Study|Withdrawal by Subject|2|||
160809550|NCT02482298|580689346|FG001|Overall Study|Withdrawal by Subject|1|||
160809551|NCT02482298|580689347|FG002|Overall Study|Withdrawal by Subject|2|||
160809552|NCT02482298|580689345|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
160809553|NCT02482298|580689346|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
160809554|NCT02482298|580689347|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
160809555|NCT02482298|580689345|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
160809556|NCT02482298|580689346|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
160809557|NCT02482298|580689347|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
160809558|NCT02482298|580689345|FG000|Overall Study|Lost to Follow-up|0|||
160809559|NCT02482298|580689346|FG001|Overall Study|Lost to Follow-up|1|||
160809560|NCT02482298|580689347|FG002|Overall Study|Lost to Follow-up|0|||
160809561|NCT00540592|580689355|FG000|Overall Study|Adverse Event|0|||
160809562|NCT00540592|580689356|FG001|Overall Study|Adverse Event|1|||
160809563|NCT00540592|580689357|FG002|Overall Study|Adverse Event|0|||
160551524|NCT02474082|579744221|FG000|Overall Study|Dose tapering not achieved|0|||
160551525|NCT02474082|579744222|FG001|Overall Study|Dose tapering not achieved|4|||
160551526|NCT02474082|579744221|FG000|Overall Study|Participant/guardian decision|1|||
160551527|NCT02474082|579744222|FG001|Overall Study|Participant/guardian decision|2|||
160551528|NCT02474082|579744221|FG000|Overall Study|Non-compliance with study treatment|0|||
160551529|NCT02474082|579744222|FG001|Overall Study|Non-compliance with study treatment|2|||
160551530|NCT02474082|579744221|FG000|Overall Study|Protocol deviation|0|||
160551531|NCT02474082|579744222|FG001|Overall Study|Protocol deviation|1|||
160551532|NCT04317274|579744223|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
160551533|NCT04317274|579744224|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
160551534|NCT04317274|579744225|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
160551535|NCT04317274|579744226|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
160551536|NCT00430508|579744227|FG000|Overall Study|Adverse Event|2|||
160551537|NCT00430508|579744228|FG001|Overall Study|Adverse Event|3|||
160551538|NCT00430508|579744229|FG002|Overall Study|Adverse Event|5|||
160551539|NCT00430508|579744230|FG003|Overall Study|Adverse Event|3|||
160551540|NCT00430508|579744227|FG000|Overall Study|Withdrawal by Subject|0|||
160551541|NCT00430508|579744228|FG001|Overall Study|Withdrawal by Subject|1|||
160551542|NCT00430508|579744229|FG002|Overall Study|Withdrawal by Subject|1|||
160551543|NCT00430508|579744230|FG003|Overall Study|Withdrawal by Subject|1|||
160551544|NCT00430508|579744227|FG000|Overall Study|responder at visit 4|0|||
160551545|NCT00430508|579744228|FG001|Overall Study|responder at visit 4|0|||
160551546|NCT00430508|579744229|FG002|Overall Study|responder at visit 4|2|||
160551547|NCT00430508|579744230|FG003|Overall Study|responder at visit 4|0|||
160551548|NCT00430508|579744227|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
160551549|NCT00430508|579744228|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
160551550|NCT00430508|579744229|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
160551551|NCT00430508|579744230|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
160551552|NCT00430508|579744227|FG000|Overall Study|Other|1|||
160551553|NCT00430508|579744228|FG001|Overall Study|Other|1|||
160551554|NCT00430508|579744229|FG002|Overall Study|Other|3|||
160551555|NCT00430508|579744230|FG003|Overall Study|Other|0|||
160551556|NCT00288080|579744237|FG000|Overall Study|Withdrawal by Subject|1|||
160551557|NCT00288080|579744238|FG001|Overall Study|Withdrawal by Subject|3|||
160551558|NCT00288080|579744237|FG000|Overall Study|Protocol Violation|25|||
160551559|NCT00288080|579744238|FG001|Overall Study|Protocol Violation|20|||
160551560|NCT00379795|579744239|FG000|Overall Study|Death|31|||
160551561|NCT00379795|579744240|FG001|Overall Study|Death|8|||
160551562|NCT00379795|579744241|FG002|Overall Study|Death|6|||
160551563|NCT00379795|579744242|FG003|Overall Study|Death|4|||
160551564|NCT00379795|579744243|FG004|Overall Study|Death|7|||
160551565|NCT00379795|579744239|FG000|Overall Study|Adverse Event|17|||
160551566|NCT00379795|579744240|FG001|Overall Study|Adverse Event|3|||
160551567|NCT00379795|579744241|FG002|Overall Study|Adverse Event|3|||
160551568|NCT00379795|579744242|FG003|Overall Study|Adverse Event|1|||
160551569|NCT00379795|579744243|FG004|Overall Study|Adverse Event|4|||
160551570|NCT00379795|579744239|FG000|Overall Study|Lost to Follow-up|8|||
160551571|NCT00379795|579744240|FG001|Overall Study|Lost to Follow-up|1|||
160551572|NCT00379795|579744241|FG002|Overall Study|Lost to Follow-up|2|||
160551573|NCT00379795|579744242|FG003|Overall Study|Lost to Follow-up|1|||
160551574|NCT00379795|579744243|FG004|Overall Study|Lost to Follow-up|4|||
160551575|NCT00379795|579744239|FG000|Overall Study|Physician Decision|25|||
160551576|NCT00379795|579744240|FG001|Overall Study|Physician Decision|0|||
160551577|NCT00379795|579744241|FG002|Overall Study|Physician Decision|2|||
160551578|NCT00379795|579744242|FG003|Overall Study|Physician Decision|2|||
160551579|NCT00379795|579744243|FG004|Overall Study|Physician Decision|2|||
160551580|NCT00379795|579744239|FG000|Overall Study|Withdrawal by Subject|94|||
160551581|NCT00379795|579744240|FG001|Overall Study|Withdrawal by Subject|11|||
160551582|NCT00379795|579744241|FG002|Overall Study|Withdrawal by Subject|19|||
160551583|NCT00379795|579744242|FG003|Overall Study|Withdrawal by Subject|7|||
160551584|NCT00379795|579744243|FG004|Overall Study|Withdrawal by Subject|14|||
160551585|NCT00379795|579744239|FG000|Overall Study|Subject non-compliance|7|||
160551586|NCT00379795|579744240|FG001|Overall Study|Subject non-compliance|2|||
160551587|NCT00379795|579744241|FG002|Overall Study|Subject non-compliance|0|||
160551588|NCT00379795|579744242|FG003|Overall Study|Subject non-compliance|0|||
160551589|NCT00379795|579744243|FG004|Overall Study|Subject non-compliance|1|||
160551590|NCT00379795|579744239|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
160551591|NCT00379795|579744240|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
160551592|NCT00379795|579744241|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
160551593|NCT00379795|579744242|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
160551594|NCT00379795|579744243|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
160551595|NCT00379795|579744239|FG000|Overall Study|Subjects condition mandated intervention|34|||
160551596|NCT00379795|579744240|FG001|Overall Study|Subjects condition mandated intervention|9|||
160645115|NCT04345471|580082488|FG001|Overall Study|Adverse Event|5|||
160809564|NCT00540592|580689358|FG003|Overall Study|Adverse Event|0|||
160809565|NCT00540592|580689359|FG004|Overall Study|Adverse Event|1|||
160809566|NCT00540592|580689360|FG005|Overall Study|Adverse Event|0|||
160809567|NCT00540592|580689361|FG006|Overall Study|Adverse Event|0|||
160809568|NCT00540592|580689362|FG007|Overall Study|Adverse Event|1|||
160809569|NCT00540592|580689363|FG008|Overall Study|Adverse Event|1|||
160551597|NCT00379795|579744241|FG002|Overall Study|Subjects condition mandated intervention|7|||
160809570|NCT00540592|580689364|FG009|Overall Study|Adverse Event|2|||
160809571|NCT00540592|580689355|FG000|Overall Study|Lost to Follow-up|2|||
160809572|NCT00540592|580689356|FG001|Overall Study|Lost to Follow-up|0|||
160809573|NCT00540592|580689357|FG002|Overall Study|Lost to Follow-up|0|||
160809574|NCT00540592|580689358|FG003|Overall Study|Lost to Follow-up|0|||
160809575|NCT00540592|580689359|FG004|Overall Study|Lost to Follow-up|0|||
160809576|NCT00540592|580689360|FG005|Overall Study|Lost to Follow-up|0|||
160809577|NCT00540592|580689361|FG006|Overall Study|Lost to Follow-up|0|||
160809578|NCT00540592|580689362|FG007|Overall Study|Lost to Follow-up|0|||
160809579|NCT00540592|580689363|FG008|Overall Study|Lost to Follow-up|0|||
160809580|NCT00540592|580689364|FG009|Overall Study|Lost to Follow-up|0|||
160809581|NCT00540592|580689355|FG000|Overall Study|Withdrawal by Subject|0|||
160809582|NCT00540592|580689356|FG001|Overall Study|Withdrawal by Subject|0|||
160809583|NCT00540592|580689357|FG002|Overall Study|Withdrawal by Subject|1|||
160809584|NCT00540592|580689358|FG003|Overall Study|Withdrawal by Subject|1|||
160809585|NCT00540592|580689359|FG004|Overall Study|Withdrawal by Subject|0|||
160809586|NCT00540592|580689360|FG005|Overall Study|Withdrawal by Subject|0|||
160809587|NCT00540592|580689361|FG006|Overall Study|Withdrawal by Subject|0|||
160809588|NCT00540592|580689362|FG007|Overall Study|Withdrawal by Subject|0|||
160809589|NCT00540592|580689363|FG008|Overall Study|Withdrawal by Subject|0|||
160809590|NCT00540592|580689364|FG009|Overall Study|Withdrawal by Subject|0|||
160809591|NCT04908683|580689365|FG000|Overall Study|Failure to meet continuation criteria|34|||
160809592|NCT04908683|580689366|FG001|Overall Study|Failure to meet continuation criteria|22|||
160809593|NCT04908683|580689365|FG000|Overall Study|Initiated prohibited medication|3|||
160809594|NCT04908683|580689366|FG001|Overall Study|Initiated prohibited medication|0|||
160809595|NCT04908683|580689365|FG000|Overall Study|Randomized by mistake|1|||
160809596|NCT04908683|580689366|FG001|Overall Study|Randomized by mistake|0|||
160809597|NCT04908683|580689365|FG000|Overall Study|Lost to Follow-up|679|||
160809598|NCT04908683|580689366|FG001|Overall Study|Lost to Follow-up|341|||
160809599|NCT04908683|580689365|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
160809600|NCT04908683|580689366|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
160809601|NCT04908683|580689365|FG000|Overall Study|Physician Decision|44|||
160809602|NCT04908683|580689366|FG001|Overall Study|Physician Decision|35|||
160809603|NCT04908683|580689365|FG000|Overall Study|Technical problems|12|||
160809604|NCT04908683|580689366|FG001|Overall Study|Technical problems|9|||
160809605|NCT04908683|580689365|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
160809606|NCT04908683|580689366|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
160809607|NCT04908683|580689365|FG000|Overall Study|Protocol Violation|2|||
160809608|NCT04908683|580689366|FG001|Overall Study|Protocol Violation|0|||
160809609|NCT04908683|580689365|FG000|Overall Study|Withdrawal by Subject|1188|||
160809610|NCT04908683|580689366|FG001|Overall Study|Withdrawal by Subject|570|||
160809611|NCT04908683|580689365|FG000|Overall Study|Site Closure by Sponsor|6|||
160809612|NCT04908683|580689366|FG001|Overall Study|Site Closure by Sponsor|3|||
160809613|NCT04908683|580689365|FG000|Overall Study|Adverse Event|21|||
160809614|NCT04908683|580689366|FG001|Overall Study|Adverse Event|11|||
160809615|NCT04908683|580689365|FG000|Overall Study|Death|101|||
160809616|NCT04908683|580689366|FG001|Overall Study|Death|61|||
160809617|NCT04908683|580689365|FG000|Overall Study|Sponsor's decision|14398|||
160809618|NCT04908683|580689366|FG001|Overall Study|Sponsor's decision|7205|||
160809619|NCT04908683|580689365|FG000|Overall Study|Other|92|||
160809620|NCT04908683|580689366|FG001|Overall Study|Other|50|||
160809621|NCT04908683|580689365|FG000|Overall Study|Randomized not vaccinated|108|||
160809622|NCT04908683|580689366|FG001|Overall Study|Randomized not vaccinated|52|||
160809623|NCT00910910|580689367|FG000|Overall Study|Adverse Event|63|||
160809624|NCT00910910|580689368|FG001|Overall Study|Adverse Event|35|||
160809625|NCT00910910|580689367|FG000|Overall Study|PD without histologic change|27|||
160809626|NCT00910910|580689368|FG001|Overall Study|PD without histologic change|23|||
160809627|NCT00910910|580689367|FG000|Overall Study|PD with histologic change|0|||
160809628|NCT00910910|580689368|FG001|Overall Study|PD with histologic change|2|||
160809629|NCT00910910|580689367|FG000|Overall Study|Withdrawal by Subject|7|||
160809630|NCT00910910|580689368|FG001|Overall Study|Withdrawal by Subject|5|||
160809631|NCT00910910|580689367|FG000|Overall Study|Lost to Follow-up|2|||
160809632|NCT00910910|580689368|FG001|Overall Study|Lost to Follow-up|2|||
160809633|NCT00910910|580689367|FG000|Overall Study|Death|9|||
160809634|NCT00910910|580689368|FG001|Overall Study|Death|3|||
160809635|NCT00910910|580689367|FG000|Overall Study|Protocol Violation|2|||
160809636|NCT00910910|580689368|FG001|Overall Study|Protocol Violation|2|||
160809637|NCT00910910|580689367|FG000|Overall Study|Completed 13 cycles of treatment|0|||
160809638|NCT00910910|580689368|FG001|Overall Study|Completed 13 cycles of treatment|118|||
160809639|NCT00910910|580689367|FG000|Overall Study|Other|114|||
160809640|NCT00910910|580689368|FG001|Overall Study|Other|32|||
160809641|NCT00910910|580689367|FG000|Overall Study|Untreated before cycle 1|1|||
160809642|NCT00910910|580689368|FG001|Overall Study|Untreated before cycle 1|2|||
160809643|NCT01973231|580689369|FG000|Overall Study|Protocol Violation|1|||
160809644|NCT01973231|580689370|FG001|Overall Study|Protocol Violation|1|||
160809645|NCT01973231|580689369|FG000|Overall Study|Lost to Follow-up|1|||
160809646|NCT01973231|580689370|FG001|Overall Study|Lost to Follow-up|1|||
160809647|NCT01973231|580689369|FG000|Overall Study|unclassified|2|||
160551598|NCT00379795|579744242|FG003|Overall Study|Subjects condition mandated intervention|5|||
160551599|NCT00379795|579744243|FG004|Overall Study|Subjects condition mandated intervention|7|||
160551600|NCT00379795|579744239|FG000|Overall Study|Sponsor's decision|257|||
160551601|NCT00379795|579744240|FG001|Overall Study|Sponsor's decision|17|||
160551602|NCT00379795|579744241|FG002|Overall Study|Sponsor's decision|54|||
160551603|NCT00379795|579744242|FG003|Overall Study|Sponsor's decision|47|||
160551604|NCT00379795|579744243|FG004|Overall Study|Sponsor's decision|10|||
160551605|NCT00763321|579744244|FG000|Open-label Period|Adverse Event|24|||
160551606|NCT00763321|579744245|FG001|Open-label Period|Adverse Event|0|||
160551607|NCT00763321|579744246|FG002|Open-label Period|Adverse Event|0|||
160551608|NCT00763321|579744244|FG000|Open-label Period|Lost to Follow-up|14|||
160551609|NCT00763321|579744245|FG001|Open-label Period|Lost to Follow-up|0|||
160551610|NCT00763321|579744246|FG002|Open-label Period|Lost to Follow-up|0|||
160551611|NCT00763321|579744244|FG000|Open-label Period|Withdrawal by Subject|7|||
160551612|NCT00763321|579744245|FG001|Open-label Period|Withdrawal by Subject|0|||
160551613|NCT00763321|579744246|FG002|Open-label Period|Withdrawal by Subject|0|||
160551614|NCT00763321|579744244|FG000|Open-label Period|Subject noncompliant|7|||
160551615|NCT00763321|579744245|FG001|Open-label Period|Subject noncompliant|0|||
160551616|NCT00763321|579744246|FG002|Open-label Period|Subject noncompliant|0|||
160551617|NCT00763321|579744244|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
160551618|NCT00763321|579744245|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
160551619|NCT00763321|579744246|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
160551620|NCT00763321|579744244|FG000|Open-label Period|Lack of Efficacy|2|||
160551621|NCT00763321|579744245|FG001|Open-label Period|Lack of Efficacy|0|||
160551622|NCT00763321|579744246|FG002|Open-label Period|Lack of Efficacy|0|||
160551623|NCT00763321|579744244|FG000|Open-label Period|Other|4|||
160551624|NCT00763321|579744245|FG001|Open-label Period|Other|0|||
160551625|NCT00763321|579744246|FG002|Open-label Period|Other|0|||
160551626|NCT00763321|579744244|FG000|Double-blind Period|Lack of Efficacy|0|||
160551627|NCT00763321|579744245|FG001|Double-blind Period|Lack of Efficacy|9|||
160551628|NCT00763321|579744246|FG002|Double-blind Period|Lack of Efficacy|17|||
160551629|NCT00763321|579744244|FG000|Double-blind Period|Adverse Event|0|||
160551630|NCT00763321|579744245|FG001|Double-blind Period|Adverse Event|4|||
160551631|NCT00763321|579744246|FG002|Double-blind Period|Adverse Event|4|||
160551632|NCT00763321|579744244|FG000|Double-blind Period|Lost to Follow-up|0|||
160551633|NCT00763321|579744245|FG001|Double-blind Period|Lost to Follow-up|4|||
160551634|NCT00763321|579744246|FG002|Double-blind Period|Lost to Follow-up|2|||
160551635|NCT00763321|579744244|FG000|Double-blind Period|Withdrawal by Subject|0|||
160551636|NCT00763321|579744245|FG001|Double-blind Period|Withdrawal by Subject|2|||
160551637|NCT00763321|579744246|FG002|Double-blind Period|Withdrawal by Subject|3|||
160551638|NCT00763321|579744244|FG000|Double-blind Period|Other|0|||
160551639|NCT00763321|579744245|FG001|Double-blind Period|Other|2|||
160551640|NCT00763321|579744246|FG002|Double-blind Period|Other|3|||
160551641|NCT02793232|579744247|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
160551642|NCT02793232|579744248|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
160551643|NCT02793232|579744249|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
160551644|NCT02793232|579744250|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
160551645|NCT02793232|579744251|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
160551646|NCT02793232|579744252|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
160551647|NCT02793232|579744253|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
160551648|NCT02793232|579744254|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
160551649|NCT02793232|579744255|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
160551650|NCT02387580|579744258|FG000|Overall Study|Withdrawal by Subject|0|||
160551651|NCT02387580|579744259|FG001|Overall Study|Withdrawal by Subject|0|||
160551652|NCT02387580|579744260|FG002|Overall Study|Withdrawal by Subject|0|||
160809648|NCT01973231|580689370|FG001|Overall Study|unclassified|1|||
160809649|NCT01973231|580689369|FG000|Overall Study|Withdrawal by Subject|7|||
160809650|NCT01973231|580689370|FG001|Overall Study|Withdrawal by Subject|9|||
160809651|NCT01071954|580689375|FG000|Overall Study|Noncompliance|4|||
160551653|NCT02387580|579744261|FG003|Overall Study|Withdrawal by Subject|1|||
160551654|NCT02387580|579744262|FG004|Overall Study|Withdrawal by Subject|0|||
160551655|NCT02387580|579744263|FG005|Overall Study|Withdrawal by Subject|0|||
160551656|NCT01060059|579744269|FG000|Overall Study|Adverse Event|1|||
160551657|NCT01060059|579744270|FG001|Overall Study|Adverse Event|1|||
160809652|NCT01071954|580689375|FG000|Overall Study|Adverse Event|1|||
160809653|NCT01071954|580689375|FG000|Overall Study|Withdrawal by Subject|11|||
160809654|NCT01071954|580689375|FG000|Overall Study|Requirement for Alternative Therapy|5|||
160809655|NCT01071954|580689375|FG000|Overall Study|Administrative Decision|5|||
160809656|NCT01071954|580689375|FG000|Overall Study|Protocol Specified Criteria|1|||
160809657|NCT01434654|580689376|FG000|Overall Study|Withdrawal by Subject|1|||
160809658|NCT01434654|580689377|FG001|Overall Study|Withdrawal by Subject|0|||
160809659|NCT01434654|580689376|FG000|Overall Study|Lost to Follow-up|1|||
160809660|NCT01434654|580689377|FG001|Overall Study|Lost to Follow-up|0|||
160809661|NCT01823198|580689378|FG000|Overall Study|Physician Decision|0|||
160809662|NCT01823198|580689379|FG001|Overall Study|Physician Decision|1|||
160809663|NCT01823198|580689380|FG002|Overall Study|Physician Decision|0|||
160809664|NCT01823198|580689381|FG003|Overall Study|Physician Decision|0|||
160809665|NCT01823198|580689382|FG004|Overall Study|Physician Decision|0|||
160809666|NCT01823198|580689383|FG005|Overall Study|Physician Decision|3|||
160809667|NCT01823198|580689384|FG006|Overall Study|Physician Decision|3|||
160809668|NCT01926444|580689385|FG000|Overall Study|Colonoscopy not performed|0|||
160809669|NCT01926444|580689386|FG001|Overall Study|Colonoscopy not performed|0|||
160809670|NCT01926444|580689387|FG002|Overall Study|Colonoscopy not performed|4|||
160809671|NCT01926444|580689388|FG003|Overall Study|Colonoscopy not performed|2|||
160809672|NCT02243371|580689398|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
160809673|NCT02243371|580689399|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
160809674|NCT02243371|580689398|FG000|Overall Study|Death (unrelated)|2|||
160809675|NCT02243371|580689399|FG001|Overall Study|Death (unrelated)|4|||
160809676|NCT02243371|580689398|FG000|Overall Study|Adverse Event (unrelated)|0|||
160809677|NCT02243371|580689399|FG001|Overall Study|Adverse Event (unrelated)|1|||
160809678|NCT02243371|580689398|FG000|Overall Study|Lack of Clinical Benefit|0|||
160809679|NCT02243371|580689399|FG001|Overall Study|Lack of Clinical Benefit|1|||
160809680|NCT02243371|580689398|FG000|Overall Study|Withdrawal by Subject|0|||
160809681|NCT02243371|580689399|FG001|Overall Study|Withdrawal by Subject|2|||
160809682|NCT04585269|580689402|FG000|Intervention|Withdrawal by Subject|9|||
160809683|NCT04585269|580689403|FG001|Intervention|Withdrawal by Subject|0|||
160809684|NCT04585269|580689402|FG000|Intervention|Unable to schedule|15|||
160809685|NCT04585269|580689403|FG001|Intervention|Unable to schedule|0|||
160809686|NCT04585269|580689402|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
160809687|NCT04585269|580689403|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
160809688|NCT04585269|580689402|FG000|FU Time 2 (3 months)|Death|2|||
160809689|NCT04585269|580689403|FG001|FU Time 2 (3 months)|Death|2|||
160809690|NCT04585269|580689402|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
160809691|NCT04585269|580689403|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
160809692|NCT04585269|580689402|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
160809693|NCT04585269|580689403|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
160809694|NCT04585269|580689402|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
160809695|NCT04585269|580689403|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
160809696|NCT04585269|580689402|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
160809697|NCT04585269|580689403|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
160809698|NCT04585269|580689402|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
160809699|NCT04585269|580689403|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
160809700|NCT03307785|580689406|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
160809701|NCT03307785|580689407|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809702|NCT03307785|580689408|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809703|NCT03307785|580689409|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809704|NCT03307785|580689410|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809705|NCT03307785|580689411|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809706|NCT03307785|580689412|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809707|NCT03307785|580689413|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809708|NCT03307785|580689414|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809709|NCT03307785|580689415|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809710|NCT03307785|580689416|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809711|NCT03307785|580689417|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809712|NCT03307785|580689418|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809713|NCT03307785|580689406|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
160809714|NCT03307785|580689407|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
160809715|NCT03307785|580689408|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809716|NCT03307785|580689409|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809717|NCT03307785|580689410|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809718|NCT03307785|580689411|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809719|NCT03307785|580689412|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809720|NCT03307785|580689413|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809721|NCT03307785|580689414|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809722|NCT03307785|580689415|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809723|NCT03307785|580689416|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809724|NCT03307785|580689417|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809725|NCT03307785|580689418|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809726|NCT03307785|580689406|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
160551658|NCT01060059|579744269|FG000|Overall Study|Death|2|||
160551659|NCT01060059|579744270|FG001|Overall Study|Death|3|||
160551660|NCT01060059|579744269|FG000|Overall Study|Lost to Follow-up|18|||
160551661|NCT01060059|579744270|FG001|Overall Study|Lost to Follow-up|34|||
160551662|NCT01060059|579744269|FG000|Overall Study|entry criteria not met|4|||
160551663|NCT01060059|579744270|FG001|Overall Study|entry criteria not met|3|||
160551664|NCT01060059|579744269|FG000|Overall Study|Withdrawal by Subject|35|||
160551665|NCT01060059|579744270|FG001|Overall Study|Withdrawal by Subject|23|||
160551666|NCT01060059|579744269|FG000|Overall Study|lack of glycemic control|2|||
160551667|NCT01060059|579744270|FG001|Overall Study|lack of glycemic control|1|||
160551668|NCT01060059|579744269|FG000|Overall Study|lack of compliance|5|||
160551669|NCT01060059|579744270|FG001|Overall Study|lack of compliance|2|||
160551670|NCT04202679|579744279|FG000|Overall Study|Adverse Event|2|||
160551671|NCT04202679|579744280|FG001|Overall Study|Adverse Event|0|||
160551672|NCT04202679|579744279|FG000|Overall Study|Poor compliance to protocol|1|||
160645116|NCT04345471|580082489|FG002|Overall Study|Adverse Event|6|||
160645117|NCT04345471|580082487|FG000|Overall Study|Lack of Efficacy|1|||
160645118|NCT04345471|580082488|FG001|Overall Study|Lack of Efficacy|1|||
160645119|NCT04345471|580082489|FG002|Overall Study|Lack of Efficacy|0|||
160645120|NCT04345471|580082487|FG000|Overall Study|Protocol Violation|0|||
160645121|NCT04345471|580082488|FG001|Overall Study|Protocol Violation|1|||
160645122|NCT04345471|580082489|FG002|Overall Study|Protocol Violation|2|||
160809727|NCT03307785|580689407|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
160551673|NCT04202679|579744280|FG001|Overall Study|Poor compliance to protocol|0|||
160551674|NCT04202679|579744279|FG000|Overall Study|Withdrawal by Subject|23|||
160551675|NCT04202679|579744280|FG001|Overall Study|Withdrawal by Subject|6|||
160551676|NCT02270242|579744281|FG000|Overall Study|Withdrawal by Subject|18|||
160645123|NCT04345471|580082487|FG000|Overall Study|Withdrawal by Subject|10|||
160809728|NCT03307785|580689408|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
160899376|NCT00075218|581026298|FG001|Open-Label Treatment|Protocol Violation|0|||
160899377|NCT00075218|581026299|FG002|Open-Label Treatment|Protocol Violation|1|||
160899378|NCT00075218|581026297|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
160899379|NCT00075218|581026298|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
160899380|NCT00075218|581026299|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
160899381|NCT03643575|581026300|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
160899382|NCT03643575|581026301|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
160899383|NCT03643575|581026302|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
160899384|NCT03643575|581026303|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
160899385|NCT03643575|581026304|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
160899386|NCT03643575|581026305|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
160899387|NCT03643575|581026300|FG000|Washout: 7 Days|Adverse Event|1|||
160899388|NCT03643575|581026301|FG001|Washout: 7 Days|Adverse Event|0|||
160899389|NCT03643575|581026302|FG002|Washout: 7 Days|Adverse Event|0|||
160899390|NCT03643575|581026303|FG003|Washout: 7 Days|Adverse Event|0|||
160899391|NCT03643575|581026304|FG004|Washout: 7 Days|Adverse Event|0|||
160899392|NCT03643575|581026305|FG005|Washout: 7 Days|Adverse Event|0|||
160899393|NCT03643575|581026300|FG000|Washout: 7 Days|Non compliance check in|0|||
160899394|NCT03643575|581026301|FG001|Washout: 7 Days|Non compliance check in|1|||
160899395|NCT03643575|581026302|FG002|Washout: 7 Days|Non compliance check in|0|||
160899396|NCT03643575|581026303|FG003|Washout: 7 Days|Non compliance check in|0|||
160899397|NCT03643575|581026304|FG004|Washout: 7 Days|Non compliance check in|0|||
160899398|NCT03643575|581026305|FG005|Washout: 7 Days|Non compliance check in|0|||
160899399|NCT00131508|581026306|FG000|Overall Study|Disease progression|0|||
160899400|NCT00131508|581026307|FG001|Overall Study|Disease progression|2|||
160899401|NCT00131508|581026306|FG000|Overall Study|Non-Compliance|2|||
160899402|NCT00131508|581026307|FG001|Overall Study|Non-Compliance|4|||
160899403|NCT00131508|581026306|FG000|Overall Study|Withdrawal by Subject|1|||
160899404|NCT00131508|581026307|FG001|Overall Study|Withdrawal by Subject|2|||
160899405|NCT00986830|581026308|FG000|Overall Study|Death|1|||
160899406|NCT00986830|581026308|FG000|Overall Study|Lost to Follow-up|1|||
160899407|NCT00986830|581026308|FG000|Overall Study|Lack of Efficacy|1|||
160551677|NCT02270242|579744282|FG001|Overall Study|Withdrawal by Subject|25|||
160551678|NCT02270242|579744281|FG000|Overall Study|Lost to Follow-up|41|||
160551679|NCT02270242|579744282|FG001|Overall Study|Lost to Follow-up|27|||
160551680|NCT02270242|579744281|FG000|Overall Study|Physician Decision|0|||
160645124|NCT04345471|580082488|FG001|Overall Study|Withdrawal by Subject|5|||
160899408|NCT00986830|581026308|FG000|Overall Study|Unable to access sinus with device|5|||
160899409|NCT00845858|581026309|FG000|Overall Study|Withdrawal by Subject|5|||
160899410|NCT00845858|581026310|FG001|Overall Study|Withdrawal by Subject|1|||
160899411|NCT00845858|581026311|FG002|Overall Study|Withdrawal by Subject|1|||
160899412|NCT00845858|581026309|FG000|Overall Study|Adverse Event|3|||
160899413|NCT00845858|581026310|FG001|Overall Study|Adverse Event|8|||
160899414|NCT00845858|581026311|FG002|Overall Study|Adverse Event|4|||
160899415|NCT00845858|581026309|FG000|Overall Study|Protocol Violation|0|||
160899416|NCT00845858|581026310|FG001|Overall Study|Protocol Violation|0|||
160899417|NCT00845858|581026311|FG002|Overall Study|Protocol Violation|1|||
160899418|NCT00845858|581026309|FG000|Overall Study|not eligible|0|||
160899419|NCT00845858|581026310|FG001|Overall Study|not eligible|3|||
160899420|NCT00845858|581026311|FG002|Overall Study|not eligible|2|||
160899421|NCT01436396|581026312|FG000|Overall Study|Protocol Violation|7|||
160899422|NCT01436396|581026313|FG001|Overall Study|Protocol Violation|5|||
160899423|NCT01436396|581026312|FG000|Overall Study|Adverse Event|1|||
160899424|NCT01436396|581026313|FG001|Overall Study|Adverse Event|2|||
160899425|NCT01436396|581026312|FG000|Overall Study|Withdrawal by Subject|19|||
160899426|NCT01436396|581026313|FG001|Overall Study|Withdrawal by Subject|29|||
160899427|NCT01436396|581026312|FG000|Overall Study|Serious adverse event|2|||
160899428|NCT01436396|581026313|FG001|Overall Study|Serious adverse event|3|||
160899429|NCT01436396|581026312|FG000|Overall Study|Lost to Follow-up|3|||
160899430|NCT01436396|581026313|FG001|Overall Study|Lost to Follow-up|3|||
160899431|NCT00216476|581026315|FG000|Overall Study|Withdrawal by Subject|59|||
160899432|NCT00216476|581026316|FG001|Overall Study|Withdrawal by Subject|72|||
160899433|NCT00216476|581026317|FG002|Overall Study|Withdrawal by Subject|9|||
160899434|NCT00216476|581026315|FG000|Overall Study|Lost to Follow-up|10|||
160899435|NCT00216476|581026316|FG001|Overall Study|Lost to Follow-up|9|||
160899436|NCT00216476|581026317|FG002|Overall Study|Lost to Follow-up|1|||
160899437|NCT00216476|581026315|FG000|Overall Study|Adverse Event|6|||
160899438|NCT00216476|581026316|FG001|Overall Study|Adverse Event|10|||
160899439|NCT00216476|581026317|FG002|Overall Study|Adverse Event|1|||
160899440|NCT00216476|581026315|FG000|Overall Study|Lack of Efficacy|4|||
160899441|NCT00216476|581026316|FG001|Overall Study|Lack of Efficacy|3|||
160899442|NCT00216476|581026317|FG002|Overall Study|Lack of Efficacy|0|||
160899443|NCT00216476|581026315|FG000|Overall Study|Death|2|||
160899444|NCT00216476|581026316|FG001|Overall Study|Death|0|||
160899445|NCT00216476|581026317|FG002|Overall Study|Death|0|||
160899446|NCT00216476|581026315|FG000|Overall Study|Pregnancy|0|||
160899447|NCT00216476|581026316|FG001|Overall Study|Pregnancy|1|||
160899448|NCT00216476|581026317|FG002|Overall Study|Pregnancy|1|||
160899449|NCT00216476|581026315|FG000|Overall Study|Other|0|||
160899450|NCT00216476|581026316|FG001|Overall Study|Other|0|||
160899451|NCT00216476|581026317|FG002|Overall Study|Other|1|||
160899452|NCT00216476|581026315|FG000|Overall Study|Refuses Injection|11|||
160899453|NCT00216476|581026316|FG001|Overall Study|Refuses Injection|0|||
160899454|NCT00216476|581026317|FG002|Overall Study|Refuses Injection|0|||
160899455|NCT00216476|581026315|FG000|Overall Study|No Further Need for Treatment|3|||
160899456|NCT00216476|581026316|FG001|Overall Study|No Further Need for Treatment|4|||
160899457|NCT00216476|581026317|FG002|Overall Study|No Further Need for Treatment|1|||
160899458|NCT00216476|581026315|FG000|Overall Study|Non-compliance|0|||
160899459|NCT00216476|581026316|FG001|Overall Study|Non-compliance|4|||
160899460|NCT00216476|581026317|FG002|Overall Study|Non-compliance|1|||
160899461|NCT00216476|581026315|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
160899462|NCT00216476|581026316|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
160899463|NCT00216476|581026317|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
160899464|NCT00216476|581026315|FG000|Overall Study|Administrative Reasons|1|||
160899465|NCT00216476|581026316|FG001|Overall Study|Administrative Reasons|1|||
160899466|NCT00216476|581026317|FG002|Overall Study|Administrative Reasons|0|||
160899467|NCT00216476|581026315|FG000|Overall Study|Protocol Deviation|5|||
160899468|NCT00216476|581026316|FG001|Overall Study|Protocol Deviation|1|||
160899469|NCT00216476|581026317|FG002|Overall Study|Protocol Deviation|0|||
160899470|NCT00216476|581026315|FG000|Overall Study|Patient Moved|2|||
160899471|NCT00216476|581026316|FG001|Overall Study|Patient Moved|2|||
160899472|NCT00216476|581026317|FG002|Overall Study|Patient Moved|0|||
160899473|NCT02191137|581026320|FG000|Treatment|Death|4|||
160899474|NCT02191137|581026320|FG000|Treatment|Withdrawal by Subject|3|||
160899475|NCT02191137|581026320|FG000|Treatment|Adverse Event|2|||
160899476|NCT02191137|581026320|FG000|Treatment|Other|1|||
160899477|NCT02191137|581026320|FG000|Follow-up|Lost to Follow-up|2|||
160899478|NCT02191137|581026320|FG000|Follow-up|Ongoing/unknown|2|||
160899479|NCT02191137|581026320|FG000|Follow-up|Adverse Event|1|||
160899480|NCT00538291|581026321|FG000|Overall Study|Adverse Event|2|||
160899481|NCT00538291|581026321|FG000|Overall Study|Withdrawal by Subject|1|||
160899482|NCT00694707|581026322|FG000|Overall Study|Did Not Receive Treatment|0|||
160899483|NCT00694707|581026323|FG001|Overall Study|Did Not Receive Treatment|0|||
160899484|NCT00694707|581026324|FG002|Overall Study|Did Not Receive Treatment|1|||
160899485|NCT00694707|581026325|FG003|Overall Study|Did Not Receive Treatment|1|||
160551681|NCT02270242|579744282|FG001|Overall Study|Physician Decision|1|||
160899486|NCT00694707|581026326|FG004|Overall Study|Did Not Receive Treatment|1|||
160899487|NCT00694707|581026322|FG000|Overall Study|Adverse Event|22|||
160809729|NCT03307785|580689409|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809730|NCT03307785|580689410|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809731|NCT03307785|580689411|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809732|NCT03307785|580689412|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809733|NCT03307785|580689413|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809734|NCT03307785|580689414|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809735|NCT03307785|580689415|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809736|NCT03307785|580689416|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809737|NCT03307785|580689417|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809738|NCT03307785|580689418|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809739|NCT03307785|580689406|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
160809740|NCT03307785|580689407|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
160809741|NCT03307785|580689408|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809742|NCT03307785|580689409|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809743|NCT03307785|580689410|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809744|NCT03307785|580689411|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809745|NCT03307785|580689412|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809746|NCT03307785|580689413|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809747|NCT03307785|580689414|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809748|NCT03307785|580689415|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809749|NCT03307785|580689416|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809750|NCT03307785|580689417|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809751|NCT03307785|580689418|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809752|NCT03307785|580689406|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809753|NCT03307785|580689407|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809754|NCT03307785|580689408|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
160809755|NCT03307785|580689409|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809756|NCT03307785|580689410|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809757|NCT03307785|580689411|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809758|NCT03307785|580689412|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809759|NCT03307785|580689413|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809760|NCT03307785|580689414|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809761|NCT03307785|580689415|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809762|NCT03307785|580689416|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809763|NCT03307785|580689417|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809764|NCT03307785|580689418|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809765|NCT03307785|580689406|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809766|NCT03307785|580689407|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809767|NCT03307785|580689408|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
160809768|NCT03307785|580689409|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809769|NCT03307785|580689410|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809770|NCT03307785|580689411|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809771|NCT03307785|580689412|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809772|NCT03307785|580689413|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809773|NCT03307785|580689414|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809774|NCT03307785|580689415|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809775|NCT03307785|580689416|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809776|NCT03307785|580689417|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809777|NCT03307785|580689418|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809778|NCT03307785|580689406|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809779|NCT03307785|580689407|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809780|NCT03307785|580689408|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
160809781|NCT03307785|580689409|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809782|NCT03307785|580689410|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809783|NCT03307785|580689411|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809784|NCT03307785|580689412|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809785|NCT03307785|580689413|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809786|NCT03307785|580689414|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809787|NCT03307785|580689415|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809788|NCT03307785|580689416|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809789|NCT03307785|580689417|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809790|NCT03307785|580689418|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809791|NCT03307785|580689406|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809792|NCT03307785|580689407|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809793|NCT03307785|580689408|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
160986094|NCT03023332|581338585|FG001|Overall Study|Withdrawal by Subject|5|||
160986095|NCT03023332|581338586|FG002|Overall Study|Withdrawal by Subject|4|||
160986096|NCT03023332|581338587|FG003|Overall Study|Withdrawal by Subject|7|||
160986097|NCT03023332|581338584|FG000|Overall Study|Lost to Follow-up|13|||
160986098|NCT03023332|581338585|FG001|Overall Study|Lost to Follow-up|16|||
160986099|NCT03023332|581338586|FG002|Overall Study|Lost to Follow-up|8|||
160986100|NCT03023332|581338587|FG003|Overall Study|Lost to Follow-up|13|||
160986101|NCT03023332|581338584|FG000|Overall Study|Death|1|||
160986102|NCT03023332|581338585|FG001|Overall Study|Death|0|||
160986103|NCT03023332|581338586|FG002|Overall Study|Death|0|||
160986104|NCT03023332|581338587|FG003|Overall Study|Death|0|||
160986105|NCT02412761|581338588|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160986106|NCT02412761|581338589|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160809794|NCT03307785|580689409|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809795|NCT03307785|580689410|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809796|NCT03307785|580689411|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809797|NCT03307785|580689412|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809798|NCT03307785|580689413|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809799|NCT03307785|580689414|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809800|NCT03307785|580689415|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809801|NCT03307785|580689416|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809802|NCT03307785|580689417|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809803|NCT03307785|580689418|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809804|NCT03307785|580689406|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809805|NCT03307785|580689407|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809806|NCT03307785|580689408|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
160809807|NCT03307785|580689409|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809808|NCT03307785|580689410|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809809|NCT03307785|580689411|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809810|NCT03307785|580689412|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809811|NCT03307785|580689413|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809812|NCT03307785|580689414|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809813|NCT03307785|580689415|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809814|NCT03307785|580689416|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809815|NCT03307785|580689417|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809816|NCT03307785|580689418|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809817|NCT03307785|580689406|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809818|NCT03307785|580689407|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809819|NCT03307785|580689408|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809820|NCT03307785|580689409|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
160809821|NCT03307785|580689410|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
160809822|NCT03307785|580689411|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809823|NCT03307785|580689412|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809824|NCT03307785|580689413|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160899488|NCT00694707|581026323|FG001|Overall Study|Adverse Event|14|||
160899489|NCT00694707|581026324|FG002|Overall Study|Adverse Event|8|||
160899490|NCT00694707|581026325|FG003|Overall Study|Adverse Event|12|||
160899491|NCT00694707|581026326|FG004|Overall Study|Adverse Event|13|||
160899492|NCT00694707|581026322|FG000|Overall Study|Insufficient Therapeutic Response|33|||
160899493|NCT00694707|581026323|FG001|Overall Study|Insufficient Therapeutic Response|18|||
160899494|NCT00694707|581026324|FG002|Overall Study|Insufficient Therapeutic Response|17|||
160899495|NCT00694707|581026325|FG003|Overall Study|Insufficient Therapeutic Response|15|||
160899496|NCT00694707|581026326|FG004|Overall Study|Insufficient Therapeutic Response|10|||
160899497|NCT00694707|581026322|FG000|Overall Study|Protocol Violation|1|||
160899498|NCT00694707|581026323|FG001|Overall Study|Protocol Violation|2|||
160899499|NCT00694707|581026324|FG002|Overall Study|Protocol Violation|1|||
160899500|NCT00694707|581026325|FG003|Overall Study|Protocol Violation|3|||
160986107|NCT02412761|581338590|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160986108|NCT02412761|581338591|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160986109|NCT02412761|581338592|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160986110|NCT02412761|581338593|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160986111|NCT01818700|581338594|FG000|Overall Study|Adverse Event|67|||
160899501|NCT00694707|581026326|FG004|Overall Study|Protocol Violation|1|||
160899502|NCT00694707|581026322|FG000|Overall Study|Withdrawal of Consent|14|||
160899503|NCT00694707|581026323|FG001|Overall Study|Withdrawal of Consent|18|||
160986112|NCT01818700|581338594|FG000|Overall Study|Lack of Efficacy|2|||
160986113|NCT01818700|581338594|FG000|Overall Study|Lost to Follow-up|5|||
160986114|NCT01818700|581338594|FG000|Overall Study|Withdrawal by Subject|27|||
160986115|NCT01818700|581338594|FG000|Overall Study|Protocol Violation|2|||
160809825|NCT03307785|580689414|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809826|NCT03307785|580689415|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809827|NCT03307785|580689416|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809828|NCT03307785|580689417|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809829|NCT03307785|580689418|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809830|NCT03307785|580689406|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809831|NCT03307785|580689407|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809832|NCT03307785|580689408|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809833|NCT03307785|580689409|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
160809834|NCT03307785|580689410|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
160809835|NCT03307785|580689411|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809836|NCT03307785|580689412|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809837|NCT03307785|580689413|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809838|NCT03307785|580689414|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809839|NCT03307785|580689415|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809840|NCT03307785|580689416|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809841|NCT03307785|580689417|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809842|NCT03307785|580689418|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809843|NCT03307785|580689406|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809844|NCT03307785|580689407|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809845|NCT03307785|580689408|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809846|NCT03307785|580689409|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
160809847|NCT03307785|580689410|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809848|NCT03307785|580689411|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809849|NCT03307785|580689412|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809850|NCT03307785|580689413|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809851|NCT03307785|580689414|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809852|NCT03307785|580689415|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809853|NCT03307785|580689416|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809854|NCT03307785|580689417|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809855|NCT03307785|580689418|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809856|NCT03307785|580689406|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809857|NCT03307785|580689407|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809858|NCT03307785|580689408|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809859|NCT03307785|580689409|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809860|NCT03307785|580689410|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
160809861|NCT03307785|580689411|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809862|NCT03307785|580689412|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809863|NCT03307785|580689413|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809864|NCT03307785|580689414|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809865|NCT03307785|580689415|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809866|NCT03307785|580689416|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809867|NCT03307785|580689417|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809868|NCT03307785|580689418|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809869|NCT03307785|580689406|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809870|NCT03307785|580689407|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160551682|NCT03864653|579744283|FG000|Overall Study|Withdrawal by Subject|1|||
160551683|NCT06272370|579746772|FG000|Overall Study|Lost to Follow-up|0|||
160551684|NCT06272370|579746773|FG001|Overall Study|Lost to Follow-up|3|||
160986116|NCT01818700|581338594|FG000|Overall Study|Other|1|||
160986117|NCT02013687|581338597|FG000|Overall Study|Lost to Follow-up|0|||
160986118|NCT02013687|581338598|FG001|Overall Study|Lost to Follow-up|0|||
160986119|NCT02013687|581338599|FG002|Overall Study|Lost to Follow-up|1|||
160986120|NCT02013687|581338600|FG003|Overall Study|Lost to Follow-up|0|||
160986121|NCT02013687|581338597|FG000|Overall Study|Protocol Violation|0|||
160986122|NCT02013687|581338598|FG001|Overall Study|Protocol Violation|0|||
160986123|NCT02013687|581338599|FG002|Overall Study|Protocol Violation|0|||
160986124|NCT02013687|581338600|FG003|Overall Study|Protocol Violation|1|||
160809871|NCT03307785|580689408|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160986125|NCT02013687|581338597|FG000|Overall Study|Withdrawal by Subject|0|||
160986126|NCT02013687|581338598|FG001|Overall Study|Withdrawal by Subject|0|||
160986127|NCT02013687|581338599|FG002|Overall Study|Withdrawal by Subject|0|||
160986128|NCT02013687|581338600|FG003|Overall Study|Withdrawal by Subject|1|||
160986129|NCT02013687|581338597|FG000|Overall Study|Missed visits due to patient travel|0|||
160986130|NCT02013687|581338598|FG001|Overall Study|Missed visits due to patient travel|0|||
160986131|NCT02013687|581338599|FG002|Overall Study|Missed visits due to patient travel|1|||
160986132|NCT02013687|581338600|FG003|Overall Study|Missed visits due to patient travel|0|||
160986133|NCT01272011|581338601|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
160986134|NCT01272011|581338602|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
160986135|NCT01272011|581338603|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
160986136|NCT01627340|581338604|FG000|Overall Study|Adverse Event|1|||
160986137|NCT01627340|581338605|FG001|Overall Study|Adverse Event|0|||
160986138|NCT01627340|581338604|FG000|Overall Study|Lost to Follow-up|8|||
160986139|NCT01627340|581338605|FG001|Overall Study|Lost to Follow-up|4|||
160986140|NCT01627340|581338604|FG000|Overall Study|Pregnancy|1|||
160986141|NCT01627340|581338605|FG001|Overall Study|Pregnancy|0|||
160986142|NCT01627340|581338604|FG000|Overall Study|Withdrawal by Subject|2|||
160986143|NCT01627340|581338605|FG001|Overall Study|Withdrawal by Subject|0|||
160986144|NCT02240680|581338608|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
160986145|NCT02240680|581338609|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
160986146|NCT02240680|581338610|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
160986147|NCT02240680|581338611|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
160986148|NCT02240680|581338608|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
160986149|NCT02240680|581338609|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
160986150|NCT02240680|581338610|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
160986151|NCT02240680|581338611|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
160986152|NCT02240680|581338608|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
160986153|NCT02240680|581338609|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
160986154|NCT02240680|581338610|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
160986155|NCT02240680|581338611|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
160986156|NCT02240680|581338608|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
160986157|NCT02240680|581338609|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
160986158|NCT02240680|581338610|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
160986159|NCT02240680|581338611|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
160986160|NCT02240680|581338608|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
160809872|NCT03307785|580689409|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809873|NCT03307785|580689410|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809874|NCT03307785|580689411|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
160809875|NCT03307785|580689412|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809876|NCT03307785|580689413|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809877|NCT03307785|580689414|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809878|NCT03307785|580689415|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809879|NCT03307785|580689416|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809880|NCT03307785|580689417|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809881|NCT03307785|580689418|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160986161|NCT02240680|581338609|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
160809882|NCT03307785|580689406|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160986162|NCT02240680|581338610|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
160986163|NCT02240680|581338611|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
160986164|NCT02240680|581338608|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
160986165|NCT02240680|581338609|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
160986166|NCT02240680|581338610|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
160986167|NCT02240680|581338611|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
160645125|NCT04345471|580082489|FG002|Overall Study|Withdrawal by Subject|10|||
160986168|NCT02240680|581338608|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
160986169|NCT02240680|581338609|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
160986170|NCT02240680|581338610|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
160986171|NCT02240680|581338611|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
160986172|NCT02240680|581338608|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
160986173|NCT02240680|581338609|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
160986174|NCT02240680|581338610|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
160986175|NCT02240680|581338611|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
160986176|NCT01657032|581338612|FG000|Overall Study|Lost to Follow-up|0|||
160986177|NCT01657032|581338613|FG001|Overall Study|Lost to Follow-up|7|||
160986178|NCT01782326|581338614|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
160986179|NCT01782326|581338615|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
160986180|NCT01782326|581338614|FG000|Planned Treatment Epoch|Death|29|||
160986181|NCT01782326|581338615|FG001|Planned Treatment Epoch|Death|30|||
160986182|NCT01782326|581338614|FG000|Planned Treatment Epoch|Physician Decision|18|||
160986183|NCT01782326|581338615|FG001|Planned Treatment Epoch|Physician Decision|16|||
160986184|NCT01782326|581338614|FG000|Planned Treatment Epoch|Protocol deviation|2|||
160986185|NCT01782326|581338615|FG001|Planned Treatment Epoch|Protocol deviation|3|||
160986186|NCT01782326|581338614|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
160986187|NCT01782326|581338615|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
160986188|NCT01782326|581338614|FG000|Planned Treatment Epoch|Technical problems|0|||
160986189|NCT01782326|581338615|FG001|Planned Treatment Epoch|Technical problems|4|||
160986190|NCT01782326|581338614|FG000|Double-blind Treatment|Adverse Event|129|||
160986191|NCT01782326|581338615|FG001|Double-blind Treatment|Adverse Event|145|||
160986192|NCT01782326|581338614|FG000|Double-blind Treatment|Subject/guardian decision|111|||
160986193|NCT01782326|581338615|FG001|Double-blind Treatment|Subject/guardian decision|125|||
160986194|NCT01782326|581338614|FG000|Double-blind Treatment|Lack of Efficacy|17|||
160986195|NCT01782326|581338615|FG001|Double-blind Treatment|Lack of Efficacy|22|||
160986196|NCT01782326|581338614|FG000|Double-blind Treatment|Physician Decision|13|||
160986197|NCT01782326|581338615|FG001|Double-blind Treatment|Physician Decision|16|||
160986198|NCT01782326|581338614|FG000|Double-blind Treatment|Protocol deviation|8|||
160986199|NCT01782326|581338615|FG001|Double-blind Treatment|Protocol deviation|7|||
160986200|NCT01782326|581338614|FG000|Double-blind Treatment|Technical problems|0|||
160986201|NCT01782326|581338615|FG001|Double-blind Treatment|Technical problems|5|||
160809883|NCT03307785|580689407|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809884|NCT03307785|580689408|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809885|NCT03307785|580689409|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809886|NCT03307785|580689410|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809887|NCT03307785|580689411|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
160809888|NCT03307785|580689412|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809889|NCT03307785|580689413|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809890|NCT03307785|580689414|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809891|NCT03307785|580689415|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809892|NCT03307785|580689416|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809893|NCT03307785|580689417|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809894|NCT03307785|580689418|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809895|NCT03307785|580689406|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809896|NCT03307785|580689407|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809897|NCT03307785|580689408|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809898|NCT03307785|580689409|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809899|NCT03307785|580689410|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160986202|NCT03633903|581338616|FG000|Overall Study|Withdrawal by Subject|1|||
160986203|NCT03633903|581338617|FG001|Overall Study|Withdrawal by Subject|2|||
160986204|NCT03633903|581338616|FG000|Overall Study|Lost to Follow-up|5|||
160986205|NCT03633903|581338617|FG001|Overall Study|Lost to Follow-up|5|||
160986206|NCT05968482|581338618|FG000|First Crossover Period|Withdrawal by Subject|0|||
160986207|NCT05968482|581338619|FG001|First Crossover Period|Withdrawal by Subject|0|||
160986208|NCT05968482|581338620|FG002|First Crossover Period|Withdrawal by Subject|1|||
160986209|NCT05968482|581338621|FG003|First Crossover Period|Withdrawal by Subject|0|||
160986210|NCT05968482|581338622|FG004|First Crossover Period|Withdrawal by Subject|0|||
160986211|NCT05968482|581338623|FG005|First Crossover Period|Withdrawal by Subject|0|||
160986212|NCT05968482|581338618|FG000|First Crossover Period|Adverse Event|0|||
160645126|NCT02378506|580082492|FG000|Overall Study|Lack of Efficacy|3|||
160809900|NCT03307785|580689411|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
160809901|NCT03307785|580689412|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809902|NCT03307785|580689413|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160986213|NCT05968482|581338619|FG001|First Crossover Period|Adverse Event|0|||
160986214|NCT05968482|581338620|FG002|First Crossover Period|Adverse Event|0|||
160986215|NCT05968482|581338621|FG003|First Crossover Period|Adverse Event|0|||
160986216|NCT05968482|581338622|FG004|First Crossover Period|Adverse Event|0|||
160986217|NCT05968482|581338623|FG005|First Crossover Period|Adverse Event|1|||
160986218|NCT05968482|581338618|FG000|Second Crossover Period|Withdrawal by Subject|0|||
160986219|NCT05968482|581338619|FG001|Second Crossover Period|Withdrawal by Subject|0|||
160986220|NCT05968482|581338620|FG002|Second Crossover Period|Withdrawal by Subject|0|||
160986221|NCT05968482|581338621|FG003|Second Crossover Period|Withdrawal by Subject|0|||
160809903|NCT03307785|580689414|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809904|NCT03307785|580689415|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809905|NCT03307785|580689416|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809906|NCT03307785|580689417|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809907|NCT03307785|580689418|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809908|NCT03307785|580689406|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809909|NCT03307785|580689407|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809910|NCT03307785|580689408|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809911|NCT03307785|580689409|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809912|NCT03307785|580689410|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809913|NCT03307785|580689411|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
160809914|NCT03307785|580689412|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809915|NCT03307785|580689413|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809916|NCT03307785|580689414|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809917|NCT03307785|580689415|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809918|NCT03307785|580689416|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809919|NCT03307785|580689417|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809920|NCT03307785|580689418|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809921|NCT03307785|580689406|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809922|NCT03307785|580689407|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809923|NCT03307785|580689408|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809924|NCT03307785|580689409|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809925|NCT03307785|580689410|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809926|NCT03307785|580689411|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
160809927|NCT03307785|580689412|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809928|NCT03307785|580689413|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809929|NCT03307785|580689414|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809930|NCT03307785|580689415|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809931|NCT03307785|580689416|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809932|NCT03307785|580689417|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809933|NCT03307785|580689418|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809934|NCT03307785|580689406|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809935|NCT03307785|580689407|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809936|NCT03307785|580689408|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809937|NCT03307785|580689409|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809938|NCT03307785|580689410|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809939|NCT03307785|580689411|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809940|NCT03307785|580689412|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
160809941|NCT03307785|580689413|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809942|NCT03307785|580689414|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809943|NCT03307785|580689415|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809944|NCT03307785|580689416|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809945|NCT03307785|580689417|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809946|NCT03307785|580689418|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809947|NCT03307785|580689406|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809948|NCT03307785|580689407|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809949|NCT03307785|580689408|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809950|NCT03307785|580689409|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809951|NCT03307785|580689410|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809952|NCT03307785|580689411|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809953|NCT03307785|580689412|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
160809954|NCT03307785|580689413|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809955|NCT03307785|580689414|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809956|NCT03307785|580689415|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809957|NCT03307785|580689416|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160899504|NCT00694707|581026324|FG002|Overall Study|Withdrawal of Consent|22|||
160899505|NCT00694707|581026325|FG003|Overall Study|Withdrawal of Consent|16|||
160899506|NCT00694707|581026326|FG004|Overall Study|Withdrawal of Consent|15|||
160899507|NCT00694707|581026322|FG000|Overall Study|Lost to Follow-up|0|||
160899508|NCT00694707|581026323|FG001|Overall Study|Lost to Follow-up|1|||
160899509|NCT00694707|581026324|FG002|Overall Study|Lost to Follow-up|2|||
160899510|NCT00694707|581026325|FG003|Overall Study|Lost to Follow-up|0|||
160899511|NCT00694707|581026326|FG004|Overall Study|Lost to Follow-up|0|||
160899512|NCT00694707|581026322|FG000|Overall Study|Jeopardizing Parole Status|1|||
160809958|NCT03307785|580689417|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809959|NCT03307785|580689418|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809960|NCT03307785|580689406|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809961|NCT03307785|580689407|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160986222|NCT05968482|581338622|FG004|Second Crossover Period|Withdrawal by Subject|1|||
160986223|NCT05968482|581338623|FG005|Second Crossover Period|Withdrawal by Subject|0|||
160986224|NCT05968482|581338618|FG000|Third Crossover Period|Adverse Event|0|||
160986225|NCT05968482|581338619|FG001|Third Crossover Period|Adverse Event|0|||
160986226|NCT05968482|581338620|FG002|Third Crossover Period|Adverse Event|0|||
160986227|NCT05968482|581338621|FG003|Third Crossover Period|Adverse Event|0|||
160986228|NCT05968482|581338622|FG004|Third Crossover Period|Adverse Event|1|||
160986229|NCT05968482|581338623|FG005|Third Crossover Period|Adverse Event|0|||
160809962|NCT03307785|580689408|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809963|NCT03307785|580689409|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809964|NCT03307785|580689410|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809965|NCT03307785|580689411|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809966|NCT03307785|580689412|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809967|NCT03307785|580689413|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
160809968|NCT03307785|580689414|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809969|NCT03307785|580689415|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809970|NCT03307785|580689416|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809971|NCT03307785|580689417|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809972|NCT03307785|580689418|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809973|NCT03307785|580689406|FG000|PACT Phase: Up to 19 Months|Death|0|||
160809974|NCT03307785|580689407|FG001|PACT Phase: Up to 19 Months|Death|0|||
160809975|NCT03307785|580689408|FG002|PACT Phase: Up to 19 Months|Death|0|||
160809976|NCT03307785|580689409|FG003|PACT Phase: Up to 19 Months|Death|0|||
160809977|NCT03307785|580689410|FG004|PACT Phase: Up to 19 Months|Death|0|||
160809978|NCT03307785|580689411|FG005|PACT Phase: Up to 19 Months|Death|0|||
160809979|NCT03307785|580689412|FG006|PACT Phase: Up to 19 Months|Death|0|||
160809980|NCT03307785|580689413|FG007|PACT Phase: Up to 19 Months|Death|0|||
160809981|NCT03307785|580689414|FG008|PACT Phase: Up to 19 Months|Death|0|||
160809982|NCT03307785|580689415|FG009|PACT Phase: Up to 19 Months|Death|0|||
160809983|NCT03307785|580689416|FG010|PACT Phase: Up to 19 Months|Death|0|||
160809984|NCT03307785|580689417|FG011|PACT Phase: Up to 19 Months|Death|0|||
160809985|NCT03307785|580689418|FG012|PACT Phase: Up to 19 Months|Death|1|||
160809986|NCT03666988|580689419|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
160809987|NCT03666988|580689420|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
160809988|NCT03666988|580689421|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
160809989|NCT03666988|580689422|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
160809990|NCT03666988|580689423|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
160809991|NCT03666988|580689424|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
160809992|NCT03666988|580689419|FG000|Part 1 (Up to 28 Months)|Other|0|||
160809993|NCT03666988|580689420|FG001|Part 1 (Up to 28 Months)|Other|1|||
160809994|NCT03666988|580689421|FG002|Part 1 (Up to 28 Months)|Other|1|||
160809995|NCT03666988|580689422|FG003|Part 1 (Up to 28 Months)|Other|0|||
160899513|NCT00694707|581026323|FG001|Overall Study|Jeopardizing Parole Status|0|||
160899514|NCT00694707|581026324|FG002|Overall Study|Jeopardizing Parole Status|0|||
160899515|NCT00694707|581026325|FG003|Overall Study|Jeopardizing Parole Status|0|||
160899516|NCT00694707|581026326|FG004|Overall Study|Jeopardizing Parole Status|0|||
160899517|NCT00694707|581026322|FG000|Overall Study|Death in the Family|1|||
160899518|NCT00694707|581026323|FG001|Overall Study|Death in the Family|0|||
160899519|NCT00694707|581026324|FG002|Overall Study|Death in the Family|0|||
160899520|NCT00694707|581026325|FG003|Overall Study|Death in the Family|0|||
160899521|NCT00694707|581026326|FG004|Overall Study|Death in the Family|0|||
160986230|NCT05968482|581338618|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
160986231|NCT05968482|581338619|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
160986232|NCT05968482|581338620|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
160986233|NCT05968482|581338621|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
160986234|NCT05968482|581338622|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
160986235|NCT05968482|581338623|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
160809996|NCT03666988|580689423|FG004|Part 1 (Up to 28 Months)|Other|0|||
160809997|NCT03666988|580689424|FG005|Part 1 (Up to 28 Months)|Other|0|||
160809998|NCT03666988|580689419|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
160809999|NCT03666988|580689420|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
160810000|NCT03666988|580689421|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
160899522|NCT00694707|581026322|FG000|Overall Study|Arrest by Police|0|||
160899523|NCT00694707|581026323|FG001|Overall Study|Arrest by Police|1|||
160986236|NCT02559817|581338630|FG000|Treatment Period|Adverse Event|1|||
160810001|NCT03666988|580689422|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
160810002|NCT03666988|580689423|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
160810003|NCT03666988|580689424|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
160899524|NCT00694707|581026324|FG002|Overall Study|Arrest by Police|0|||
160986237|NCT02559817|581338631|FG001|Treatment Period|Adverse Event|0|||
160986238|NCT02559817|581338632|FG002|Treatment Period|Adverse Event|1|||
160986239|NCT02559817|581338633|FG003|Treatment Period|Adverse Event|0|||
160810004|NCT03666988|580689419|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
160986240|NCT02559817|581338634|FG004|Treatment Period|Adverse Event|0|||
160986241|NCT02559817|581338630|FG000|Treatment Period|Lack of Efficacy|0|||
160986242|NCT02559817|581338631|FG001|Treatment Period|Lack of Efficacy|1|||
160986243|NCT02559817|581338632|FG002|Treatment Period|Lack of Efficacy|0|||
160986244|NCT02559817|581338633|FG003|Treatment Period|Lack of Efficacy|0|||
160986245|NCT02559817|581338634|FG004|Treatment Period|Lack of Efficacy|0|||
160986246|NCT02559817|581338630|FG000|Treatment Period|Lost to Follow-up|0|||
160986247|NCT02559817|581338631|FG001|Treatment Period|Lost to Follow-up|1|||
160986248|NCT02559817|581338632|FG002|Treatment Period|Lost to Follow-up|0|||
160986249|NCT02559817|581338633|FG003|Treatment Period|Lost to Follow-up|1|||
160986250|NCT02559817|581338634|FG004|Treatment Period|Lost to Follow-up|0|||
160986251|NCT02559817|581338630|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
160986252|NCT02559817|581338631|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
160986253|NCT02559817|581338632|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
160986254|NCT02559817|581338633|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
160986255|NCT02559817|581338634|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
160986256|NCT02559817|581338630|FG000|Treatment Period|Protocol Violation|0|||
160986257|NCT02559817|581338631|FG001|Treatment Period|Protocol Violation|0|||
160986258|NCT02559817|581338632|FG002|Treatment Period|Protocol Violation|0|||
160986259|NCT02559817|581338633|FG003|Treatment Period|Protocol Violation|1|||
160986260|NCT02559817|581338634|FG004|Treatment Period|Protocol Violation|0|||
160986261|NCT02303574|581338639|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986262|NCT02303574|581338640|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986263|NCT02303574|581338641|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
160986264|NCT02303574|581338642|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986265|NCT02303574|581338643|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986266|NCT02303574|581338644|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986267|NCT02303574|581338645|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986268|NCT02303574|581338646|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986269|NCT02303574|581338647|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986270|NCT02303574|581338648|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986271|NCT02303574|581338639|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986272|NCT02303574|581338640|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986273|NCT02303574|581338641|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160810005|NCT03666988|580689420|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
160986274|NCT02303574|581338642|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986275|NCT02303574|581338643|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986276|NCT02303574|581338644|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986277|NCT02303574|581338645|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986278|NCT02303574|581338646|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
160986279|NCT02303574|581338647|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986280|NCT02303574|581338648|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160810006|NCT03666988|580689421|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
160810007|NCT03666988|580689422|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
160810008|NCT03666988|580689423|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
160810009|NCT03666988|580689424|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
160810010|NCT03666988|580689419|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
160810011|NCT03666988|580689420|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
160810012|NCT03666988|580689421|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
160810013|NCT03666988|580689422|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
160810014|NCT03666988|580689423|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
160810015|NCT03666988|580689424|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
160810016|NCT02517398|580689425|FG000|Overall Study|Death|2|||
160810017|NCT02517398|580689426|FG001|Overall Study|Death|3|||
160810018|NCT02517398|580689427|FG002|Overall Study|Death|4|||
160810019|NCT02517398|580689428|FG003|Overall Study|Death|2|||
160810020|NCT02517398|580689429|FG004|Overall Study|Death|3|||
160810021|NCT02517398|580689430|FG005|Overall Study|Death|8|||
160810022|NCT02517398|580689431|FG006|Overall Study|Death|3|||
160810023|NCT02517398|580689432|FG007|Overall Study|Death|2|||
160810024|NCT02517398|580689433|FG008|Overall Study|Death|6|||
160810025|NCT02517398|580689434|FG009|Overall Study|Death|24|||
160810026|NCT02517398|580689435|FG010|Overall Study|Death|53|||
160810027|NCT02517398|580689436|FG011|Overall Study|Death|25|||
160810028|NCT02517398|580689437|FG012|Overall Study|Death|73|||
160810029|NCT02517398|580689438|FG013|Overall Study|Death|29|||
160810030|NCT02517398|580689439|FG014|Overall Study|Death|26|||
160810031|NCT02517398|580689440|FG015|Overall Study|Death|23|||
160810032|NCT02517398|580689441|FG016|Overall Study|Death|26|||
160810033|NCT02517398|580689442|FG017|Overall Study|Death|25|||
160810034|NCT02517398|580689443|FG018|Overall Study|Death|22|||
160810035|NCT02517398|580689444|FG019|Overall Study|Death|7|||
160899525|NCT00694707|581026325|FG003|Overall Study|Arrest by Police|0|||
160899526|NCT00694707|581026326|FG004|Overall Study|Arrest by Police|0|||
160899527|NCT00694707|581026322|FG000|Overall Study|Administrative Reasons|0|||
160899528|NCT00694707|581026323|FG001|Overall Study|Administrative Reasons|1|||
160899529|NCT00694707|581026324|FG002|Overall Study|Administrative Reasons|0|||
160899530|NCT00694707|581026325|FG003|Overall Study|Administrative Reasons|2|||
160899531|NCT00694707|581026326|FG004|Overall Study|Administrative Reasons|0|||
160899532|NCT00694707|581026322|FG000|Overall Study|Notification of Past Head Injury|0|||
160899533|NCT00694707|581026323|FG001|Overall Study|Notification of Past Head Injury|0|||
160899534|NCT00694707|581026324|FG002|Overall Study|Notification of Past Head Injury|0|||
160899535|NCT00694707|581026325|FG003|Overall Study|Notification of Past Head Injury|1|||
160899536|NCT00694707|581026326|FG004|Overall Study|Notification of Past Head Injury|0|||
160899537|NCT01696695|581026327|FG000|Overall Study|Disease progression|373|||
160899538|NCT01696695|581026327|FG000|Overall Study|Death|29|||
160899539|NCT01696695|581026327|FG000|Overall Study|Adverse Event|74|||
160899540|NCT01696695|581026327|FG000|Overall Study|Withdrawal by Subject|92|||
160899541|NCT01696695|581026327|FG000|Overall Study|Lost to Follow-up|48|||
160899542|NCT01696695|581026327|FG000|Overall Study|Other|74|||
160899543|NCT01696695|581026327|FG000|Overall Study|Major Protocol Violation|192|||
160899544|NCT01904058|581026334|FG000|Overall Study|Adverse Event|2|||
160899545|NCT01904058|581026335|FG001|Overall Study|Adverse Event|0|||
160899546|NCT01904058|581026336|FG002|Overall Study|Adverse Event|0|||
160899547|NCT01904058|581026337|FG003|Overall Study|Adverse Event|0|||
160899548|NCT01904058|581026334|FG000|Overall Study|Withdrawal by Subject|1|||
160899549|NCT01904058|581026335|FG001|Overall Study|Withdrawal by Subject|0|||
160899550|NCT01904058|581026336|FG002|Overall Study|Withdrawal by Subject|1|||
160899551|NCT01904058|581026337|FG003|Overall Study|Withdrawal by Subject|0|||
160899552|NCT01904058|581026334|FG000|Overall Study|Pregnancy|0|||
160899553|NCT01904058|581026335|FG001|Overall Study|Pregnancy|0|||
160899554|NCT01904058|581026336|FG002|Overall Study|Pregnancy|0|||
160899555|NCT01904058|581026337|FG003|Overall Study|Pregnancy|1|||
160899556|NCT03096483|581026341|FG000|Overall Study|Withdrawal by site|1|||
160899557|NCT00369707|581026342|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
160899558|NCT00369707|581026342|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
160810036|NCT02517398|580689445|FG020|Overall Study|Death|26|||
160810037|NCT02517398|580689446|FG021|Overall Study|Death|30|||
160810038|NCT02517398|580689447|FG022|Overall Study|Death|20|||
160810039|NCT02517398|580689425|FG000|Overall Study|Other|0|||
160810040|NCT02517398|580689426|FG001|Overall Study|Other|0|||
160810041|NCT02517398|580689427|FG002|Overall Study|Other|0|||
160810042|NCT02517398|580689428|FG003|Overall Study|Other|1|||
160810043|NCT02517398|580689429|FG004|Overall Study|Other|0|||
160810044|NCT02517398|580689430|FG005|Overall Study|Other|0|||
160810045|NCT02517398|580689431|FG006|Overall Study|Other|0|||
160810046|NCT02517398|580689432|FG007|Overall Study|Other|0|||
160810047|NCT02517398|580689433|FG008|Overall Study|Other|0|||
160899559|NCT00369707|581026342|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
160899560|NCT00369707|581026342|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
160899561|NCT00369707|581026342|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
160551685|NCT06272370|579746774|FG002|Overall Study|Lost to Follow-up|1|||
160551686|NCT06272370|579746775|FG003|Overall Study|Lost to Follow-up|1|||
160551687|NCT01227902|579746777|FG000|Overall Study|Adverse Event|12|||
160551688|NCT01227902|579746778|FG001|Overall Study|Adverse Event|8|||
160551689|NCT01227902|579746779|FG002|Overall Study|Adverse Event|11|||
160551690|NCT01227902|579746780|FG003|Overall Study|Adverse Event|4|||
160551691|NCT01227902|579746777|FG000|Overall Study|Lack of Efficacy|1|||
160551692|NCT01227902|579746778|FG001|Overall Study|Lack of Efficacy|2|||
160551693|NCT01227902|579746779|FG002|Overall Study|Lack of Efficacy|2|||
160551694|NCT01227902|579746780|FG003|Overall Study|Lack of Efficacy|1|||
160551695|NCT01227902|579746777|FG000|Overall Study|Protocol Violation|1|||
160551696|NCT01227902|579746778|FG001|Overall Study|Protocol Violation|0|||
160551697|NCT01227902|579746779|FG002|Overall Study|Protocol Violation|0|||
160551698|NCT01227902|579746780|FG003|Overall Study|Protocol Violation|0|||
160551699|NCT01227902|579746777|FG000|Overall Study|Lost to Follow-up|0|||
160551700|NCT01227902|579746778|FG001|Overall Study|Lost to Follow-up|0|||
160551701|NCT01227902|579746779|FG002|Overall Study|Lost to Follow-up|1|||
160551702|NCT01227902|579746780|FG003|Overall Study|Lost to Follow-up|2|||
160551703|NCT01227902|579746777|FG000|Overall Study|Physician Decision|0|||
160551704|NCT01227902|579746778|FG001|Overall Study|Physician Decision|1|||
160551705|NCT01227902|579746779|FG002|Overall Study|Physician Decision|1|||
160551706|NCT01227902|579746780|FG003|Overall Study|Physician Decision|0|||
160551707|NCT01227902|579746777|FG000|Overall Study|Withdrawal by Subject|4|||
160551708|NCT01227902|579746778|FG001|Overall Study|Withdrawal by Subject|2|||
160551709|NCT01227902|579746779|FG002|Overall Study|Withdrawal by Subject|4|||
160551710|NCT01227902|579746780|FG003|Overall Study|Withdrawal by Subject|3|||
160551711|NCT02363478|579746786|FG000|Overall Study|Lost to Follow-up|4|||
160551712|NCT02363478|579746786|FG000|Overall Study|Adverse Event|4|||
160551713|NCT00930059|579746787|FG000|Overall Study|Death|1|||
160551714|NCT00930059|579746788|FG001|Overall Study|Death|0|||
160551715|NCT00930059|579746787|FG000|Overall Study|Did not meet entrance criteria|1|||
160551716|NCT00930059|579746788|FG001|Overall Study|Did not meet entrance criteria|1|||
160551717|NCT00930059|579746787|FG000|Overall Study|Withdrawal by Subject|3|||
160551718|NCT00930059|579746788|FG001|Overall Study|Withdrawal by Subject|4|||
160551719|NCT00930059|579746787|FG000|Overall Study|Other|1|||
160551720|NCT00930059|579746788|FG001|Overall Study|Other|0|||
160551721|NCT00930059|579746787|FG000|Overall Study|1 site terminated by sponsor|1|||
160551722|NCT00930059|579746788|FG001|Overall Study|1 site terminated by sponsor|1|||
160551723|NCT00930059|579746787|FG000|Overall Study|Adverse Event|1|||
160551724|NCT00930059|579746788|FG001|Overall Study|Adverse Event|6|||
160551725|NCT01299766|579746790|FG000|Overall Study|Death|5|||
160551726|NCT01299766|579746791|FG001|Overall Study|Death|4|||
160551727|NCT01299766|579746790|FG000|Overall Study|Withdrawal by Subject|29|||
160551728|NCT01299766|579746791|FG001|Overall Study|Withdrawal by Subject|19|||
160551729|NCT02624492|579746809|FG000|Overall Study|Adverse Event|2|||
160551730|NCT02624492|579746810|FG001|Overall Study|Adverse Event|2|||
160551731|NCT02624492|579746811|FG002|Overall Study|Adverse Event|2|||
160551732|NCT02624492|579746809|FG000|Overall Study|Progressive disease|0|||
160551733|NCT02624492|579746810|FG001|Overall Study|Progressive disease|2|||
160986281|NCT00994279|581338653|FG000|Overall Study|Withdrawal by Subject|2|||
160986282|NCT00994279|581338654|FG001|Overall Study|Withdrawal by Subject|2|||
160986283|NCT00994279|581338653|FG000|Overall Study|Toxicity|1|||
160986284|NCT00994279|581338654|FG001|Overall Study|Toxicity|0|||
160986285|NCT00994279|581338653|FG000|Overall Study|Multiple reasons|1|||
160986286|NCT00994279|581338654|FG001|Overall Study|Multiple reasons|3|||
160986287|NCT01606189|581338655|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
160986288|NCT01606189|581338656|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
160986289|NCT01606189|581338657|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
160986290|NCT01606189|581338658|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
160986291|NCT01606189|581338659|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
160551734|NCT02624492|579746811|FG002|Overall Study|Progressive disease|3|||
160551735|NCT00343512|579746817|FG000|Overall Study|Withdrawal by Subject|2|||
160551736|NCT00323557|579746818|FG000|Overall Study|Physician Decision|1|||
160551737|NCT00323557|579746819|FG001|Overall Study|Physician Decision|0|||
160551738|NCT00197054|579746820|FG000|Overall Study|Withdrawal by Subject|9|||
160551739|NCT00197054|579746821|FG001|Overall Study|Withdrawal by Subject|3|||
160551740|NCT00197054|579746822|FG002|Overall Study|Withdrawal by Subject|3|||
160551741|NCT00197054|579746820|FG000|Overall Study|Moved from area|7|||
160551742|NCT00197054|579746821|FG001|Overall Study|Moved from area|14|||
160551743|NCT00197054|579746822|FG002|Overall Study|Moved from area|9|||
160551744|NCT00197054|579746820|FG000|Overall Study|Lost to Follow-up|1|||
160551745|NCT00197054|579746821|FG001|Overall Study|Lost to Follow-up|4|||
160810048|NCT02517398|580689434|FG009|Overall Study|Other|1|||
160810049|NCT02517398|580689435|FG010|Overall Study|Other|0|||
160810050|NCT02517398|580689436|FG011|Overall Study|Other|0|||
160810051|NCT02517398|580689437|FG012|Overall Study|Other|0|||
160810052|NCT02517398|580689438|FG013|Overall Study|Other|1|||
160810053|NCT02517398|580689439|FG014|Overall Study|Other|0|||
160810054|NCT02517398|580689440|FG015|Overall Study|Other|1|||
160810055|NCT02517398|580689441|FG016|Overall Study|Other|1|||
160810056|NCT02517398|580689442|FG017|Overall Study|Other|0|||
160810057|NCT02517398|580689443|FG018|Overall Study|Other|0|||
160810058|NCT02517398|580689444|FG019|Overall Study|Other|1|||
160810059|NCT02517398|580689445|FG020|Overall Study|Other|0|||
160810060|NCT02517398|580689446|FG021|Overall Study|Other|0|||
160810061|NCT02517398|580689447|FG022|Overall Study|Other|0|||
160810062|NCT02517398|580689425|FG000|Overall Study|Lost to Follow-up|0|||
160810063|NCT02517398|580689426|FG001|Overall Study|Lost to Follow-up|0|||
160810064|NCT02517398|580689427|FG002|Overall Study|Lost to Follow-up|0|||
160810065|NCT02517398|580689428|FG003|Overall Study|Lost to Follow-up|0|||
160810066|NCT02517398|580689429|FG004|Overall Study|Lost to Follow-up|0|||
160810067|NCT02517398|580689430|FG005|Overall Study|Lost to Follow-up|0|||
160810068|NCT02517398|580689431|FG006|Overall Study|Lost to Follow-up|0|||
160810069|NCT02517398|580689432|FG007|Overall Study|Lost to Follow-up|0|||
160810070|NCT02517398|580689433|FG008|Overall Study|Lost to Follow-up|0|||
160899562|NCT00369707|581026342|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
160899563|NCT00369707|581026342|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
160899564|NCT00369707|581026342|FG000|Follow up for 2 Years After Treatment|Death|1|||
160899565|NCT00369707|581026342|FG000|Follow up for 2 Years After Treatment|Other|2|||
160899566|NCT02046733|581026343|FG000|Overall Study|never initiated 'treatment visits'|6|||
160899567|NCT02046733|581026344|FG001|Overall Study|never initiated 'treatment visits'|0|||
160899568|NCT04515394|581026346|FG000|Overall Study|Participant did not receive treatment|1|||
160899569|NCT00199875|581026347|FG000|Overall Study|Withdrawal by Subject|0|||
160899570|NCT00199875|581026348|FG001|Overall Study|Withdrawal by Subject|0|||
160899571|NCT00199875|581026349|FG002|Overall Study|Withdrawal by Subject|0|||
160899572|NCT00199875|581026350|FG003|Overall Study|Withdrawal by Subject|0|||
160899573|NCT00199875|581026351|FG004|Overall Study|Withdrawal by Subject|1|||
160899574|NCT01024231|581026353|FG000|Overall Study|Other Reasons|1|||
160899575|NCT01024231|581026354|FG001|Overall Study|Other Reasons|2|||
160899576|NCT01024231|581026355|FG002|Overall Study|Other Reasons|0|||
160899577|NCT01024231|581026356|FG003|Overall Study|Other Reasons|0|||
160899578|NCT01024231|581026357|FG004|Overall Study|Other Reasons|2|||
160899579|NCT01024231|581026358|FG005|Overall Study|Other Reasons|0|||
160899580|NCT01024231|581026359|FG006|Overall Study|Other Reasons|1|||
160899581|NCT01024231|581026353|FG000|Overall Study|Maximum Clinical Benefit|1|||
160899582|NCT01024231|581026354|FG001|Overall Study|Maximum Clinical Benefit|2|||
160899583|NCT01024231|581026355|FG002|Overall Study|Maximum Clinical Benefit|0|||
160899584|NCT01024231|581026356|FG003|Overall Study|Maximum Clinical Benefit|1|||
160899585|NCT01024231|581026357|FG004|Overall Study|Maximum Clinical Benefit|1|||
160899586|NCT01024231|581026358|FG005|Overall Study|Maximum Clinical Benefit|0|||
160986292|NCT01606189|581338660|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
160551746|NCT00197054|579746822|FG002|Overall Study|Lost to Follow-up|0|||
160810071|NCT02517398|580689434|FG009|Overall Study|Lost to Follow-up|1|||
160810072|NCT02517398|580689435|FG010|Overall Study|Lost to Follow-up|0|||
160810073|NCT02517398|580689436|FG011|Overall Study|Lost to Follow-up|2|||
160810074|NCT02517398|580689437|FG012|Overall Study|Lost to Follow-up|2|||
160810075|NCT02517398|580689438|FG013|Overall Study|Lost to Follow-up|0|||
160810076|NCT02517398|580689439|FG014|Overall Study|Lost to Follow-up|1|||
160810077|NCT02517398|580689440|FG015|Overall Study|Lost to Follow-up|1|||
160810078|NCT02517398|580689441|FG016|Overall Study|Lost to Follow-up|0|||
160810079|NCT02517398|580689442|FG017|Overall Study|Lost to Follow-up|3|||
160810080|NCT02517398|580689443|FG018|Overall Study|Lost to Follow-up|1|||
160810081|NCT02517398|580689444|FG019|Overall Study|Lost to Follow-up|0|||
160810082|NCT02517398|580689445|FG020|Overall Study|Lost to Follow-up|1|||
160899587|NCT01024231|581026359|FG006|Overall Study|Maximum Clinical Benefit|0|||
160899588|NCT01024231|581026353|FG000|Overall Study|Disease Progression|3|||
160899589|NCT01024231|581026354|FG001|Overall Study|Disease Progression|1|||
160899590|NCT01024231|581026355|FG002|Overall Study|Disease Progression|3|||
160810083|NCT02517398|580689446|FG021|Overall Study|Lost to Follow-up|0|||
160899591|NCT01024231|581026356|FG003|Overall Study|Disease Progression|0|||
160899592|NCT01024231|581026357|FG004|Overall Study|Disease Progression|4|||
160899593|NCT01024231|581026358|FG005|Overall Study|Disease Progression|11|||
160810084|NCT02517398|580689447|FG022|Overall Study|Lost to Follow-up|2|||
160810085|NCT02517398|580689425|FG000|Overall Study|Withdrew Consent|0|||
160810086|NCT02517398|580689426|FG001|Overall Study|Withdrew Consent|0|||
160810087|NCT02517398|580689427|FG002|Overall Study|Withdrew Consent|0|||
160810088|NCT02517398|580689428|FG003|Overall Study|Withdrew Consent|0|||
160810089|NCT02517398|580689429|FG004|Overall Study|Withdrew Consent|0|||
160810090|NCT02517398|580689430|FG005|Overall Study|Withdrew Consent|0|||
160810091|NCT02517398|580689431|FG006|Overall Study|Withdrew Consent|1|||
160810092|NCT02517398|580689432|FG007|Overall Study|Withdrew Consent|0|||
160810093|NCT02517398|580689433|FG008|Overall Study|Withdrew Consent|0|||
160810094|NCT02517398|580689434|FG009|Overall Study|Withdrew Consent|2|||
160810095|NCT02517398|580689435|FG010|Overall Study|Withdrew Consent|7|||
160810096|NCT02517398|580689436|FG011|Overall Study|Withdrew Consent|1|||
160810097|NCT02517398|580689437|FG012|Overall Study|Withdrew Consent|5|||
160810098|NCT02517398|580689438|FG013|Overall Study|Withdrew Consent|4|||
160810099|NCT02517398|580689439|FG014|Overall Study|Withdrew Consent|2|||
160810100|NCT02517398|580689440|FG015|Overall Study|Withdrew Consent|5|||
160986293|NCT01606189|581338655|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
160986294|NCT01606189|581338656|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
160986295|NCT01606189|581338657|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
160986296|NCT01606189|581338658|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
160986297|NCT01606189|581338659|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
160986298|NCT01606189|581338660|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
160986299|NCT00859014|581338661|FG000|Overall Study|Death|4|||
160986300|NCT00859014|581338661|FG000|Overall Study|Lost to Follow-up|1|||
160986301|NCT04796935|581338662|FG000|Overall Study|Withdrawal by Subject|0|||
160986302|NCT04796935|581338663|FG001|Overall Study|Withdrawal by Subject|1|||
160986303|NCT04796935|581338662|FG000|Overall Study|Physician Decision|0|||
160986304|NCT04796935|581338663|FG001|Overall Study|Physician Decision|1|||
160986305|NCT04796935|581338662|FG000|Overall Study|Device not available|1|||
160986306|NCT04796935|581338663|FG001|Overall Study|Device not available|0|||
160986307|NCT04796935|581338662|FG000|Overall Study|Trained provider not available|1|||
160986308|NCT04796935|581338663|FG001|Overall Study|Trained provider not available|0|||
160986309|NCT04640571|581338664|FG000|Overall Study|Withdrawal by Subject|0|||
160986310|NCT04640571|581338665|FG001|Overall Study|Withdrawal by Subject|0|||
160986311|NCT04640571|581338666|FG002|Overall Study|Withdrawal by Subject|0|||
160986312|NCT04640571|581338667|FG003|Overall Study|Withdrawal by Subject|0|||
160986313|NCT04640571|581338668|FG004|Overall Study|Withdrawal by Subject|0|||
160986314|NCT04640571|581338669|FG005|Overall Study|Withdrawal by Subject|2|||
160986315|NCT03658811|581338672|FG000|Overall Study|Lost to Follow-up|3|||
160551747|NCT00684515|579746823|FG000|Overall Study|Adverse Event|3|||
160899594|NCT01024231|581026359|FG006|Overall Study|Disease Progression|6|||
160899595|NCT01024231|581026353|FG000|Overall Study|AE unrelated to Study Drug|0|||
160899596|NCT01024231|581026354|FG001|Overall Study|AE unrelated to Study Drug|1|||
160899597|NCT01024231|581026355|FG002|Overall Study|AE unrelated to Study Drug|0|||
160899598|NCT01024231|581026356|FG003|Overall Study|AE unrelated to Study Drug|0|||
160899599|NCT01024231|581026357|FG004|Overall Study|AE unrelated to Study Drug|0|||
160899600|NCT01024231|581026358|FG005|Overall Study|AE unrelated to Study Drug|0|||
160899601|NCT01024231|581026359|FG006|Overall Study|AE unrelated to Study Drug|0|||
160899602|NCT01024231|581026353|FG000|Overall Study|No longer meets criteria|0|||
160899603|NCT01024231|581026354|FG001|Overall Study|No longer meets criteria|0|||
160899604|NCT01024231|581026355|FG002|Overall Study|No longer meets criteria|0|||
160899605|NCT01024231|581026356|FG003|Overall Study|No longer meets criteria|0|||
160899606|NCT01024231|581026357|FG004|Overall Study|No longer meets criteria|1|||
160899607|NCT01024231|581026358|FG005|Overall Study|No longer meets criteria|0|||
160986316|NCT04060680|581338674|FG000|Overall Study|Unsuccessful implant|17|||
160810101|NCT02517398|580689441|FG016|Overall Study|Withdrew Consent|4|||
160810102|NCT02517398|580689442|FG017|Overall Study|Withdrew Consent|2|||
160810103|NCT02517398|580689443|FG018|Overall Study|Withdrew Consent|3|||
160810104|NCT02517398|580689444|FG019|Overall Study|Withdrew Consent|2|||
160810105|NCT02517398|580689445|FG020|Overall Study|Withdrew Consent|9|||
160810106|NCT02517398|580689446|FG021|Overall Study|Withdrew Consent|3|||
160810107|NCT02517398|580689447|FG022|Overall Study|Withdrew Consent|1|||
160810108|NCT05588440|580689458|FG000|Overall Study|Sponsor Decision|2|||
160810109|NCT05588440|580689459|FG001|Overall Study|Sponsor Decision|0|||
160810110|NCT05588440|580689460|FG002|Overall Study|Sponsor Decision|1|||
160810111|NCT05588440|580689458|FG000|Overall Study|Death|1|||
160810112|NCT05588440|580689459|FG001|Overall Study|Death|1|||
160810113|NCT05588440|580689460|FG002|Overall Study|Death|1|||
160810114|NCT05588440|580689458|FG000|Overall Study|Screen Fail|0|||
160810115|NCT05588440|580689459|FG001|Overall Study|Screen Fail|1|||
160810116|NCT05588440|580689460|FG002|Overall Study|Screen Fail|1|||
160810117|NCT05588440|580689458|FG000|Overall Study|Withdrawal by Subject|0|||
160810118|NCT05588440|580689459|FG001|Overall Study|Withdrawal by Subject|0|||
160810119|NCT05588440|580689460|FG002|Overall Study|Withdrawal by Subject|1|||
160810120|NCT01154452|580689461|FG000|Phase Ib|Not Treated|1|||
160810121|NCT01154452|580689462|FG001|Phase Ib|Not Treated|0|||
160810122|NCT01154452|580689463|FG002|Phase Ib|Not Treated|0|||
160810123|NCT01154452|580689464|FG003|Phase Ib|Not Treated|0|||
160810124|NCT01154452|580689461|FG000|Phase Ib|Adverse Event|2|||
160810125|NCT01154452|580689462|FG001|Phase Ib|Adverse Event|1|||
160810126|NCT01154452|580689463|FG002|Phase Ib|Adverse Event|0|||
160810127|NCT01154452|580689464|FG003|Phase Ib|Adverse Event|0|||
160810128|NCT01154452|580689461|FG000|Phase II|Withdrawal by Subject|0|||
160810129|NCT01154452|580689462|FG001|Phase II|Withdrawal by Subject|0|||
160810130|NCT01154452|580689463|FG002|Phase II|Withdrawal by Subject|1|||
160810131|NCT01154452|580689464|FG003|Phase II|Withdrawal by Subject|2|||
160810132|NCT01154452|580689461|FG000|Phase II|Adverse Event|0|||
160810133|NCT01154452|580689462|FG001|Phase II|Adverse Event|0|||
160810134|NCT01154452|580689463|FG002|Phase II|Adverse Event|4|||
160810135|NCT01154452|580689464|FG003|Phase II|Adverse Event|4|||
160810136|NCT00590122|580690837|FG000|Overall Study|swallowed oral dissolving dose|1|||
160810137|NCT00590122|580690838|FG001|Overall Study|swallowed oral dissolving dose|0|||
160810138|NCT03050450|580690839|FG000|Overall Study|Physician Decision|1|||
160810139|NCT03050450|580690840|FG001|Overall Study|Physician Decision|0|||
160810140|NCT03050450|580690841|FG002|Overall Study|Physician Decision|0|||
160810141|NCT03050450|580690842|FG003|Overall Study|Physician Decision|0|||
160810142|NCT03050450|580690843|FG004|Overall Study|Physician Decision|0|||
160810143|NCT03592771|580690847|FG000|Overall Study|Adverse Event|2|||
160810144|NCT03592771|580690848|FG001|Overall Study|Adverse Event|0|||
160810145|NCT03592771|580690849|FG002|Overall Study|Adverse Event|1|||
160810146|NCT03592771|580690847|FG000|Overall Study|Death|0|||
160810147|NCT03592771|580690848|FG001|Overall Study|Death|1|||
160810148|NCT03592771|580690849|FG002|Overall Study|Death|1|||
160810149|NCT03592771|580690847|FG000|Overall Study|Lost to Follow-up|5|||
160810150|NCT03592771|580690848|FG001|Overall Study|Lost to Follow-up|11|||
160810151|NCT03592771|580690849|FG002|Overall Study|Lost to Follow-up|15|||
160810152|NCT03592771|580690847|FG000|Overall Study|Withdrawal by Subject|0|||
160810153|NCT03592771|580690848|FG001|Overall Study|Withdrawal by Subject|2|||
160810154|NCT03592771|580690849|FG002|Overall Study|Withdrawal by Subject|0|||
160810155|NCT01642901|580690850|FG000|12-month Follow-up|Withdrawal by Subject|1|||
160810156|NCT01642901|580690851|FG001|12-month Follow-up|Withdrawal by Subject|0|||
160810157|NCT05069597|580690852|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
160810158|NCT05069597|580690853|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
160810159|NCT00735553|580690854|FG000|Overall Study|Study prematurely terminated|77|||
160810160|NCT02705105|580690855|FG000|Treatment|Objective Disease Progression|1|||
160810161|NCT02705105|580690856|FG001|Treatment|Objective Disease Progression|50|||
160810162|NCT02705105|580690855|FG000|Treatment|Withdrawal by Subject|3|||
160810163|NCT02705105|580690856|FG001|Treatment|Withdrawal by Subject|5|||
160810164|NCT02705105|580690855|FG000|Treatment|Adverse Event|0|||
160810165|NCT02705105|580690856|FG001|Treatment|Adverse Event|17|||
160810166|NCT02705105|580690855|FG000|Treatment|Clinical Disease Progression|0|||
160810167|NCT02705105|580690856|FG001|Treatment|Clinical Disease Progression|32|||
160810168|NCT02705105|580690855|FG000|Treatment|Physician Decision|0|||
160810169|NCT02705105|580690856|FG001|Treatment|Physician Decision|3|||
160810170|NCT02705105|580690855|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
160810171|NCT02705105|580690856|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
160810172|NCT02705105|580690855|FG000|Follow-Up|Death|3|||
160810173|NCT02705105|580690856|FG001|Follow-Up|Death|68|||
160810174|NCT02705105|580690855|FG000|Follow-Up|Withdrawal by Subject|1|||
160810175|NCT02705105|580690856|FG001|Follow-Up|Withdrawal by Subject|14|||
160810176|NCT02705105|580690855|FG000|Follow-Up|Study Terminated|0|||
160810177|NCT02705105|580690856|FG001|Follow-Up|Study Terminated|26|||
160810178|NCT02705105|580690855|FG000|Follow-Up|Discontinued per Amendment 3|0|||
160810179|NCT02705105|580690856|FG001|Follow-Up|Discontinued per Amendment 3|2|||
160810180|NCT02707965|580690857|FG000|Overall Study|Withdrawal by Subject|0|||
160810181|NCT02707965|580690858|FG001|Overall Study|Withdrawal by Subject|0|||
160810182|NCT02707965|580690859|FG002|Overall Study|Withdrawal by Subject|1|||
160810183|NCT02707965|580690860|FG003|Overall Study|Withdrawal by Subject|0|||
160810184|NCT02707965|580690861|FG004|Overall Study|Withdrawal by Subject|0|||
160810185|NCT02707965|580690862|FG005|Overall Study|Withdrawal by Subject|0|||
160810186|NCT02707965|580690863|FG006|Overall Study|Withdrawal by Subject|0|||
160810187|NCT02707965|580690864|FG007|Overall Study|Withdrawal by Subject|2|||
160810188|NCT02707965|580690865|FG008|Overall Study|Withdrawal by Subject|0|||
160810189|NCT02707965|580690866|FG009|Overall Study|Withdrawal by Subject|0|||
160810190|NCT02707965|580690867|FG010|Overall Study|Withdrawal by Subject|0|||
160810191|NCT02707965|580690868|FG011|Overall Study|Withdrawal by Subject|0|||
160810192|NCT02707965|580690869|FG012|Overall Study|Withdrawal by Subject|0|||
160810193|NCT02707965|580690870|FG013|Overall Study|Withdrawal by Subject|0|||
160810194|NCT02707965|580690871|FG014|Overall Study|Withdrawal by Subject|0|||
160810195|NCT02707965|580690872|FG015|Overall Study|Withdrawal by Subject|0|||
160810196|NCT02707965|580690857|FG000|Overall Study|PI decisions|0|||
160810197|NCT02707965|580690858|FG001|Overall Study|PI decisions|0|||
160810198|NCT02707965|580690859|FG002|Overall Study|PI decisions|0|||
160810199|NCT02707965|580690860|FG003|Overall Study|PI decisions|0|||
160810200|NCT02707965|580690861|FG004|Overall Study|PI decisions|0|||
160810201|NCT02707965|580690862|FG005|Overall Study|PI decisions|0|||
160810202|NCT02707965|580690863|FG006|Overall Study|PI decisions|0|||
160810203|NCT02707965|580690864|FG007|Overall Study|PI decisions|0|||
160810204|NCT02707965|580690865|FG008|Overall Study|PI decisions|0|||
160810205|NCT02707965|580690866|FG009|Overall Study|PI decisions|0|||
160810206|NCT02707965|580690867|FG010|Overall Study|PI decisions|0|||
160810207|NCT02707965|580690868|FG011|Overall Study|PI decisions|0|||
160810208|NCT02707965|580690869|FG012|Overall Study|PI decisions|0|||
160810209|NCT02707965|580690870|FG013|Overall Study|PI decisions|0|||
160810210|NCT02707965|580690871|FG014|Overall Study|PI decisions|2|||
160810211|NCT02707965|580690872|FG015|Overall Study|PI decisions|0|||
160810212|NCT02707965|580690857|FG000|Overall Study|Protocol deviation|1|||
160810213|NCT02707965|580690858|FG001|Overall Study|Protocol deviation|1|||
160810214|NCT02707965|580690859|FG002|Overall Study|Protocol deviation|0|||
160810215|NCT02707965|580690860|FG003|Overall Study|Protocol deviation|0|||
160810216|NCT02707965|580690861|FG004|Overall Study|Protocol deviation|0|||
160810217|NCT02707965|580690862|FG005|Overall Study|Protocol deviation|0|||
160810218|NCT02707965|580690863|FG006|Overall Study|Protocol deviation|0|||
160810219|NCT02707965|580690864|FG007|Overall Study|Protocol deviation|1|||
160810220|NCT02707965|580690865|FG008|Overall Study|Protocol deviation|0|||
160810221|NCT02707965|580690866|FG009|Overall Study|Protocol deviation|0|||
160810222|NCT02707965|580690867|FG010|Overall Study|Protocol deviation|0|||
160810223|NCT02707965|580690868|FG011|Overall Study|Protocol deviation|0|||
160810224|NCT02707965|580690869|FG012|Overall Study|Protocol deviation|0|||
160810225|NCT02707965|580690870|FG013|Overall Study|Protocol deviation|0|||
160810226|NCT02707965|580690871|FG014|Overall Study|Protocol deviation|0|||
160810227|NCT02707965|580690872|FG015|Overall Study|Protocol deviation|0|||
160810228|NCT03650413|580690873|FG000|Overall Study|Adverse Event|1|||
160810229|NCT03650413|580690873|FG000|Overall Study|Lack of Efficacy|17|||
160810230|NCT03650413|580690873|FG000|Overall Study|Other|9|||
160810231|NCT03650413|580690873|FG000|Overall Study|Physician Decision|2|||
160810232|NCT03650413|580690873|FG000|Overall Study|Study Terminated By Sponsor|16|||
160810233|NCT03650413|580690873|FG000|Overall Study|Withdrawal by Subject|16|||
160810234|NCT00485758|580690878|FG000|Overall Study|Adverse Event|102|||
160810235|NCT00485758|580690879|FG001|Overall Study|Adverse Event|31|||
160810236|NCT00485758|580690878|FG000|Overall Study|Death|0|||
160810237|NCT00485758|580690879|FG001|Overall Study|Death|1|||
160810238|NCT00485758|580690878|FG000|Overall Study|Lost to Follow-up|5|||
160810239|NCT00485758|580690879|FG001|Overall Study|Lost to Follow-up|1|||
160810240|NCT00485758|580690878|FG000|Overall Study|Physician Decision|3|||
160810241|NCT00485758|580690879|FG001|Overall Study|Physician Decision|3|||
160810242|NCT00485758|580690878|FG000|Overall Study|Protocol Violation|11|||
160810243|NCT00485758|580690879|FG001|Overall Study|Protocol Violation|2|||
160810244|NCT00485758|580690878|FG000|Overall Study|Withdrawal by Subject|32|||
160810245|NCT00485758|580690879|FG001|Overall Study|Withdrawal by Subject|27|||
160810246|NCT00485758|580690878|FG000|Overall Study|Study Terminated by Sponsor|3|||
160810247|NCT00485758|580690879|FG001|Overall Study|Study Terminated by Sponsor|0|||
160810248|NCT03332173|580690880|FG000|Overall Study|Death|7|||
160810249|NCT03332173|580690880|FG000|Overall Study|Withdrawal by Subject|6|||
160810250|NCT03332173|580690880|FG000|Overall Study|Lost to Follow-up|2|||
160810251|NCT03332173|580690880|FG000|Overall Study|Transferred to long-term extension study|29|||
160810252|NCT00131352|580690881|FG000|Initial Treatment Period|Adverse Event|1|||
160810253|NCT00131352|580690882|FG001|Initial Treatment Period|Adverse Event|3|||
160810254|NCT00131352|580690881|FG000|Initial Treatment Period|Non-compliant|1|||
160810255|NCT00131352|580690882|FG001|Initial Treatment Period|Non-compliant|2|||
160810256|NCT00131352|580690881|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
160810257|NCT00131352|580690882|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
160810258|NCT00131352|580690881|FG000|Initial Treatment Period|Lack of Efficacy|6|||
160810259|NCT00131352|580690882|FG001|Initial Treatment Period|Lack of Efficacy|4|||
160810260|NCT00131352|580690881|FG000|Initial Treatment Period|Other|0|||
160810261|NCT00131352|580690882|FG001|Initial Treatment Period|Other|2|||
160810262|NCT00131352|580690881|FG000|Repeat Treatment Period|Adverse Event|1|||
160810263|NCT00131352|580690882|FG001|Repeat Treatment Period|Adverse Event|0|||
160810264|NCT00131352|580690881|FG000|Repeat Treatment Period|Other|1|||
160810265|NCT00131352|580690882|FG001|Repeat Treatment Period|Other|0|||
160810266|NCT00383331|580690883|FG000|Overall Study|Protocol Violation|0|||
160810267|NCT00383331|580690884|FG001|Overall Study|Protocol Violation|1|||
160810268|NCT00211172|580690886|FG000|Overall Study|Died or lost health plan eligibility|39|||
160810269|NCT00211172|580690887|FG001|Overall Study|Died or lost health plan eligibility|32|||
160810270|NCT02253433|580690888|FG000|Overall Study|Unable to Contact|9|||
160810271|NCT02253433|580690889|FG001|Overall Study|Unable to Contact|16|||
160810272|NCT02253433|580690888|FG000|Overall Study|Death|1|||
160810273|NCT02253433|580690889|FG001|Overall Study|Death|1|||
160810274|NCT02253433|580690888|FG000|Overall Study|No Longer Interested|3|||
160899608|NCT01024231|581026359|FG006|Overall Study|No longer meets criteria|1|||
160899609|NCT01024231|581026353|FG000|Overall Study|Study Drug Toxicity|1|||
160899610|NCT01024231|581026354|FG001|Overall Study|Study Drug Toxicity|6|||
160899611|NCT01024231|581026355|FG002|Overall Study|Study Drug Toxicity|6|||
160899612|NCT01024231|581026356|FG003|Overall Study|Study Drug Toxicity|4|||
160899613|NCT01024231|581026357|FG004|Overall Study|Study Drug Toxicity|2|||
160899614|NCT01024231|581026358|FG005|Overall Study|Study Drug Toxicity|0|||
160899615|NCT01024231|581026359|FG006|Overall Study|Study Drug Toxicity|7|||
160899616|NCT01024231|581026353|FG000|Overall Study|Death|6|||
160899617|NCT01024231|581026354|FG001|Overall Study|Death|2|||
160899618|NCT01024231|581026355|FG002|Overall Study|Death|1|||
160899619|NCT01024231|581026356|FG003|Overall Study|Death|0|||
160899620|NCT01024231|581026357|FG004|Overall Study|Death|4|||
160899621|NCT01024231|581026358|FG005|Overall Study|Death|3|||
160899622|NCT01024231|581026359|FG006|Overall Study|Death|5|||
160899623|NCT01024231|581026353|FG000|Overall Study|Lost to Follow-up|0|||
160899624|NCT01024231|581026354|FG001|Overall Study|Lost to Follow-up|0|||
160899625|NCT01024231|581026355|FG002|Overall Study|Lost to Follow-up|0|||
160899626|NCT01024231|581026356|FG003|Overall Study|Lost to Follow-up|0|||
160899627|NCT01024231|581026357|FG004|Overall Study|Lost to Follow-up|0|||
160899628|NCT01024231|581026358|FG005|Overall Study|Lost to Follow-up|0|||
160899629|NCT01024231|581026359|FG006|Overall Study|Lost to Follow-up|1|||
160899630|NCT01024231|581026353|FG000|Overall Study|Withdrew Consent|0|||
160899631|NCT01024231|581026354|FG001|Overall Study|Withdrew Consent|1|||
160899632|NCT01024231|581026355|FG002|Overall Study|Withdrew Consent|0|||
160899633|NCT01024231|581026356|FG003|Overall Study|Withdrew Consent|0|||
160899634|NCT01024231|581026357|FG004|Overall Study|Withdrew Consent|0|||
160899635|NCT01024231|581026358|FG005|Overall Study|Withdrew Consent|0|||
160899636|NCT01024231|581026359|FG006|Overall Study|Withdrew Consent|0|||
160899637|NCT01024231|581026353|FG000|Overall Study|Continuing on Treatment|0|||
160899638|NCT01024231|581026354|FG001|Overall Study|Continuing on Treatment|0|||
160899639|NCT01024231|581026355|FG002|Overall Study|Continuing on Treatment|0|||
160899640|NCT01024231|581026356|FG003|Overall Study|Continuing on Treatment|0|||
160899641|NCT01024231|581026357|FG004|Overall Study|Continuing on Treatment|3|||
160899642|NCT01024231|581026358|FG005|Overall Study|Continuing on Treatment|2|||
160899643|NCT01024231|581026359|FG006|Overall Study|Continuing on Treatment|0|||
160986317|NCT04060680|581338675|FG001|Overall Study|Unsuccessful implant|2|||
160986318|NCT04060680|581338674|FG000|Overall Study|Adverse Event|3|||
160986319|NCT04060680|581338675|FG001|Overall Study|Adverse Event|0|||
160986320|NCT04060680|581338674|FG000|Overall Study|Death|2|||
160986321|NCT04060680|581338675|FG001|Overall Study|Death|0|||
160986322|NCT04060680|581338674|FG000|Overall Study|Study product no longer in use|1|||
160986323|NCT04060680|581338675|FG001|Overall Study|Study product no longer in use|0|||
160986324|NCT04060680|581338674|FG000|Overall Study|Withdrawal by Subject|1|||
160986325|NCT04060680|581338675|FG001|Overall Study|Withdrawal by Subject|0|||
160986326|NCT03803774|581338676|FG000|Dose Escalation|Withdrawal by Subject|0|||
160986327|NCT03803774|581338677|FG001|Dose Escalation|Withdrawal by Subject|0|||
160986328|NCT03803774|581338678|FG002|Dose Escalation|Withdrawal by Subject|0|||
160899644|NCT01147172|581026362|FG000|Overall Study|Withdrawal by Subject|2|||
160986329|NCT03803774|581338679|FG003|Dose Escalation|Withdrawal by Subject|1|||
160986330|NCT03803774|581338680|FG004|Dose Escalation|Withdrawal by Subject|0|||
160986331|NCT05194735|581340969|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
160986332|NCT05194735|581340970|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
160899645|NCT01147172|581026362|FG000|Overall Study|Lost to Follow-up|2|||
160810275|NCT02253433|580690889|FG001|Overall Study|No Longer Interested|15|||
160810276|NCT02253433|580690888|FG000|Overall Study|Out of Study Area|2|||
160810277|NCT02253433|580690889|FG001|Overall Study|Out of Study Area|7|||
160810278|NCT02253433|580690888|FG000|Overall Study|Uncomfortable with home visitors|0|||
160810279|NCT02253433|580690889|FG001|Overall Study|Uncomfortable with home visitors|3|||
160810280|NCT02253433|580690888|FG000|Overall Study|Unstable Housing/Homeless|0|||
160810281|NCT02253433|580690889|FG001|Overall Study|Unstable Housing/Homeless|7|||
160810282|NCT02253433|580690888|FG000|Overall Study|Too Busy|0|||
160810283|NCT02253433|580690889|FG001|Overall Study|Too Busy|4|||
160810284|NCT02253433|580690888|FG000|Overall Study|Medical or Other Concerns|1|||
160810285|NCT02253433|580690889|FG001|Overall Study|Medical or Other Concerns|2|||
160810286|NCT02229825|580690890|FG000|Overall Study|Personal Reasons|0|||
160810287|NCT02229825|580690891|FG001|Overall Study|Personal Reasons|1|||
160810288|NCT02229825|580690890|FG000|Overall Study|Refused continuing medication|7|||
160810289|NCT02229825|580690891|FG001|Overall Study|Refused continuing medication|6|||
160810290|NCT02229825|580690890|FG000|Overall Study|Lost to Follow-up|1|||
160810291|NCT02229825|580690891|FG001|Overall Study|Lost to Follow-up|2|||
160810292|NCT02229825|580690890|FG000|Overall Study|Protocol Violation|1|||
160810293|NCT02229825|580690891|FG001|Overall Study|Protocol Violation|1|||
160810294|NCT02229825|580690890|FG000|Overall Study|Lack of Efficacy|4|||
160810295|NCT02229825|580690891|FG001|Overall Study|Lack of Efficacy|10|||
160810296|NCT02229825|580690890|FG000|Overall Study|Adverse Event|11|||
160810297|NCT02229825|580690891|FG001|Overall Study|Adverse Event|9|||
160810298|NCT02229825|580690890|FG000|Overall Study|Not treated|0|||
160810299|NCT02229825|580690891|FG001|Overall Study|Not treated|1|||
160810300|NCT02443337|580690892|FG000|Overall Study|Adverse Event|0|||
160810301|NCT02443337|580690893|FG001|Overall Study|Adverse Event|1|||
160810302|NCT02443337|580690892|FG000|Overall Study|Clinical Progressive Disease|3|||
160810303|NCT02443337|580690893|FG001|Overall Study|Clinical Progressive Disease|0|||
160810304|NCT02443337|580690892|FG000|Overall Study|Withdrawal by Subject|2|||
160810305|NCT02443337|580690893|FG001|Overall Study|Withdrawal by Subject|1|||
160810306|NCT00372619|580690894|FG000|Overall Study|Ineligible|0|||
160810307|NCT00372619|580690895|FG001|Overall Study|Ineligible|0|||
160810308|NCT00372619|580690896|FG002|Overall Study|Ineligible|0|||
160810309|NCT00372619|580690897|FG003|Overall Study|Ineligible|0|||
160810310|NCT00372619|580690898|FG004|Overall Study|Ineligible|0|||
160810311|NCT00372619|580690899|FG005|Overall Study|Ineligible|2|||
160810312|NCT00372619|580690900|FG006|Overall Study|Ineligible|0|||
160810313|NCT00372619|580690894|FG000|Overall Study|Inevaluable|0|||
160810314|NCT00372619|580690895|FG001|Overall Study|Inevaluable|0|||
160810315|NCT00372619|580690896|FG002|Overall Study|Inevaluable|0|||
160810316|NCT00372619|580690897|FG003|Overall Study|Inevaluable|0|||
160810317|NCT00372619|580690898|FG004|Overall Study|Inevaluable|0|||
160810318|NCT00372619|580690899|FG005|Overall Study|Inevaluable|1|||
160810319|NCT00372619|580690900|FG006|Overall Study|Inevaluable|0|||
160810320|NCT01523743|580690901|FG000|Period 1|Adverse Event|1|||
160986333|NCT05194735|581340971|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
160986334|NCT05194735|581340969|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
160986335|NCT05194735|581340970|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
160986336|NCT05194735|581340971|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
160986337|NCT05194735|581340969|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
160986338|NCT05194735|581340970|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
160986339|NCT05194735|581340971|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
160986340|NCT05194735|581340969|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
160986341|NCT05194735|581340970|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
160986342|NCT05194735|581340971|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
160986343|NCT00731042|581340972|FG000|Second Intervention|Did not meet inclusion criteria|0|||
160986344|NCT00731042|581340973|FG001|Second Intervention|Did not meet inclusion criteria|2|||
160986345|NCT01256476|581340974|FG000|Overall Study|Adverse Event|2|||
160986346|NCT01256476|581340975|FG001|Overall Study|Adverse Event|1|||
160986347|NCT01256476|581340974|FG000|Overall Study|Withdrawal by Subject|2|||
160986348|NCT01256476|581340975|FG001|Overall Study|Withdrawal by Subject|1|||
160810321|NCT01523743|580690902|FG001|Period 1|Adverse Event|0|||
160810322|NCT01523743|580690901|FG000|Period 1|Withdrawal by Subject|6|||
160810323|NCT01523743|580690902|FG001|Period 1|Withdrawal by Subject|2|||
160810324|NCT01523743|580690901|FG000|Period 1|Lost to Follow-up|1|||
160810325|NCT01523743|580690902|FG001|Period 1|Lost to Follow-up|0|||
160810326|NCT01523743|580690901|FG000|Period 1|Lack of Efficacy|1|||
160810327|NCT01523743|580690902|FG001|Period 1|Lack of Efficacy|0|||
160810328|NCT01523743|580690901|FG000|Period 1|Felt unable to empty bladder|1|||
160810329|NCT01523743|580690902|FG001|Period 1|Felt unable to empty bladder|0|||
160810330|NCT01523743|580690901|FG000|Period 2|Withdrawal by Subject|0|||
160810331|NCT01523743|580690902|FG001|Period 2|Withdrawal by Subject|2|||
160810332|NCT01523743|580690901|FG000|Period 2|Adverse Event|1|||
160810333|NCT01523743|580690902|FG001|Period 2|Adverse Event|0|||
160810334|NCT03782064|580690903|FG000|Overall Study|Lack of Efficacy|2|||
160810335|NCT03782064|580690903|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
160810336|NCT00363142|580690904|FG000|Overall Study|Adverse Event|2|||
160810337|NCT00363142|580690905|FG001|Overall Study|Adverse Event|0|||
160810338|NCT00363142|580690904|FG000|Overall Study|Lack of Efficacy|0|||
160810339|NCT00363142|580690905|FG001|Overall Study|Lack of Efficacy|1|||
160810340|NCT00363142|580690904|FG000|Overall Study|Lost to Follow-up|1|||
160810341|NCT00363142|580690905|FG001|Overall Study|Lost to Follow-up|0|||
160810342|NCT00363142|580690904|FG000|Overall Study|Non-compliance|1|||
160810343|NCT00363142|580690905|FG001|Overall Study|Non-compliance|1|||
160810344|NCT00363142|580690904|FG000|Overall Study|Withdrawal by Subject|3|||
160810345|NCT00363142|580690905|FG001|Overall Study|Withdrawal by Subject|1|||
160810346|NCT02446769|580690908|FG000|Screening Period|Screen Failure|11|||
160810347|NCT02446769|580690909|FG001|Screening Period|Screen Failure|0|||
160810348|NCT02446769|580690910|FG002|Screening Period|Screen Failure|0|||
160810349|NCT02446769|580690908|FG000|Study Period|Randomized in Error|0|||
160810350|NCT02446769|580690909|FG001|Study Period|Randomized in Error|2|||
160810351|NCT02446769|580690910|FG002|Study Period|Randomized in Error|0|||
160810352|NCT01340664|580690913|FG000|Overall Study|Adverse Event|0|||
160810353|NCT01340664|580690914|FG001|Overall Study|Adverse Event|1|||
160810354|NCT01340664|580690915|FG002|Overall Study|Adverse Event|7|||
160810355|NCT01340664|580690913|FG000|Overall Study|Lost to Follow-up|2|||
160810356|NCT01340664|580690914|FG001|Overall Study|Lost to Follow-up|0|||
160810357|NCT01340664|580690915|FG002|Overall Study|Lost to Follow-up|2|||
160810358|NCT01340664|580690913|FG000|Overall Study|Withdrawal by Subject|2|||
160810359|NCT01340664|580690914|FG001|Overall Study|Withdrawal by Subject|4|||
160810360|NCT01340664|580690915|FG002|Overall Study|Withdrawal by Subject|0|||
160810361|NCT01340664|580690913|FG000|Overall Study|Glycemic withdrawal criteria|2|||
160810362|NCT01340664|580690914|FG001|Overall Study|Glycemic withdrawal criteria|0|||
160810363|NCT01340664|580690915|FG002|Overall Study|Glycemic withdrawal criteria|0|||
160810364|NCT01340664|580690913|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
160810365|NCT01340664|580690914|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
160810366|NCT01340664|580690915|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
160810367|NCT01340664|580690913|FG000|Overall Study|Other|1|||
160810368|NCT01340664|580690914|FG001|Overall Study|Other|2|||
160810369|NCT01340664|580690915|FG002|Overall Study|Other|2|||
160810370|NCT02441101|580690917|FG000|Overall Study|Withdrawal by Subject|1|||
160810371|NCT02441101|580690918|FG001|Overall Study|Withdrawal by Subject|0|||
160810372|NCT02441101|580690917|FG000|Overall Study|Lost to Follow-up|1|||
160810373|NCT02441101|580690918|FG001|Overall Study|Lost to Follow-up|0|||
160810374|NCT02441101|580690917|FG000|Overall Study|PI relocated and study terminated|1|||
160986349|NCT01256476|581340974|FG000|Overall Study|Lost to Follow-up|1|||
160986350|NCT01256476|581340975|FG001|Overall Study|Lost to Follow-up|2|||
160986351|NCT01256476|581340974|FG000|Overall Study|Persistent ALT or AST elevation|1|||
160986352|NCT01256476|581340975|FG001|Overall Study|Persistent ALT or AST elevation|0|||
160986353|NCT01256476|581340974|FG000|Overall Study|Physician Decision|0|||
160986354|NCT01256476|581340975|FG001|Overall Study|Physician Decision|1|||
160986355|NCT01256476|581340974|FG000|Overall Study|Subject non-compliance|0|||
160986356|NCT01256476|581340975|FG001|Overall Study|Subject non-compliance|1|||
160986357|NCT01256476|581340974|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
160986358|NCT01256476|581340975|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
160986359|NCT02491411|581340978|FG000|Overall Study|Physician Decision|4|||
160986360|NCT00852475|581340980|FG000|Overall Study|Lost to Follow-up|3|||
160986361|NCT00852475|581340981|FG001|Overall Study|Lost to Follow-up|4|||
160986362|NCT00495469|581340982|FG000|Overall Study|Adverse Event|0|||
160986363|NCT00495469|581340983|FG001|Overall Study|Adverse Event|1|||
160986364|NCT00495469|581340984|FG002|Overall Study|Adverse Event|3|||
160986365|NCT00495469|581340985|FG003|Overall Study|Adverse Event|0|||
160986366|NCT00495469|581340986|FG004|Overall Study|Adverse Event|1|||
160986367|NCT00495469|581340987|FG005|Overall Study|Adverse Event|1|||
160986368|NCT00495469|581340988|FG006|Overall Study|Adverse Event|1|||
160986369|NCT00495469|581340982|FG000|Overall Study|Lost to Follow-up|1|||
160986370|NCT00495469|581340983|FG001|Overall Study|Lost to Follow-up|1|||
160810375|NCT02441101|580690918|FG001|Overall Study|PI relocated and study terminated|0|||
160810376|NCT02528942|580690921|FG000|Overall Study|Did not meet imaging criteria|9|||
160810377|NCT02528942|580690921|FG000|Overall Study|Lost to Follow-up|25|||
160810378|NCT00271856|580690922|FG000|Overall Study|Withdrawal by Subject|1|||
160810379|NCT00271856|580690923|FG001|Overall Study|Withdrawal by Subject|7|||
160810380|NCT00271856|580690922|FG000|Overall Study|Lost to Follow-up|10|||
160810381|NCT00271856|580690923|FG001|Overall Study|Lost to Follow-up|11|||
160810382|NCT04599803|580690924|FG000|Overall Study|Withdrawal by Subject|5|||
160810383|NCT04599803|580690924|FG000|Overall Study|Lost to Follow-up|26|||
160810384|NCT02544750|580690925|FG000|Overall Study|Physician Decision|3|||
160986371|NCT00495469|581340984|FG002|Overall Study|Lost to Follow-up|3|||
160986372|NCT00495469|581340985|FG003|Overall Study|Lost to Follow-up|1|||
160986373|NCT00495469|581340986|FG004|Overall Study|Lost to Follow-up|0|||
160986374|NCT00495469|581340987|FG005|Overall Study|Lost to Follow-up|0|||
160810385|NCT02544750|580690926|FG001|Overall Study|Physician Decision|1|||
160810386|NCT02544750|580690925|FG000|Overall Study|Other reasons|69|||
160810387|NCT02544750|580690926|FG001|Overall Study|Other reasons|39|||
160810388|NCT02544750|580690925|FG000|Overall Study|Met withdrawal criteria|2|||
160810389|NCT02544750|580690926|FG001|Overall Study|Met withdrawal criteria|2|||
160810390|NCT02544750|580690925|FG000|Overall Study|Transition To Commercial Product|1|||
160810391|NCT02544750|580690926|FG001|Overall Study|Transition To Commercial Product|0|||
160810392|NCT02544750|580690925|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
160810393|NCT02544750|580690926|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
160810394|NCT02544750|580690925|FG000|Overall Study|Adverse Event|8|||
160810395|NCT02544750|580690926|FG001|Overall Study|Adverse Event|10|||
160810396|NCT02544750|580690925|FG000|Overall Study|Withdrawal by Subject|10|||
160810397|NCT02544750|580690926|FG001|Overall Study|Withdrawal by Subject|4|||
160810398|NCT02544750|580690925|FG000|Overall Study|Lost to Follow-up|1|||
160810399|NCT02544750|580690926|FG001|Overall Study|Lost to Follow-up|0|||
160810400|NCT01392573|580690927|FG000|Overall Study|Adverse Event|1|||
160810401|NCT01392573|580690928|FG001|Overall Study|Adverse Event|3|||
160810402|NCT01392573|580690927|FG000|Overall Study|Lack of Efficacy|1|||
160810403|NCT01392573|580690928|FG001|Overall Study|Lack of Efficacy|2|||
160810404|NCT01392573|580690927|FG000|Overall Study|Protocol Violation|0|||
160810405|NCT01392573|580690928|FG001|Overall Study|Protocol Violation|2|||
160810406|NCT01392573|580690927|FG000|Overall Study|Withdrawal Criteria|13|||
160810407|NCT01392573|580690928|FG001|Overall Study|Withdrawal Criteria|15|||
160810408|NCT01392573|580690927|FG000|Overall Study|Site closure|8|||
160810409|NCT01392573|580690928|FG001|Overall Study|Site closure|7|||
160810410|NCT01392573|580690927|FG000|Overall Study|Unclassified|9|||
160810411|NCT01392573|580690928|FG001|Overall Study|Unclassified|6|||
160810412|NCT03381287|580690930|FG000|Overall Study|Withdrawal by Subject|0|||
160810413|NCT03381287|580690931|FG001|Overall Study|Withdrawal by Subject|1|||
160899646|NCT01697358|581026364|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
160899647|NCT01697358|581026365|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
160899648|NCT01697358|581026364|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
160899649|NCT01697358|581026365|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
160899650|NCT01697358|581026364|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
160899651|NCT01697358|581026365|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
160899652|NCT01697358|581026364|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
160899653|NCT01697358|581026365|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
160899654|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
160899655|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
160899656|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
160899657|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
160899658|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
160899659|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
160899660|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
160899661|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
160899662|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
160899663|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
160899664|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
160899665|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
160899666|NCT00669396|581026366|FG000|Overall Study|Lost to Follow-up|10|||
160899667|NCT00669396|581026367|FG001|Overall Study|Lost to Follow-up|12|||
160899668|NCT01262573|581026368|FG000|Overall Study|Withdrawal by Subject|0|||
160899669|NCT01262573|581026369|FG001|Overall Study|Withdrawal by Subject|1|||
160899670|NCT00810693|581026370|FG000|Treatment Period|Adverse Event|8|||
160899671|NCT00810693|581026371|FG001|Treatment Period|Adverse Event|1|||
160899672|NCT00810693|581026372|FG002|Treatment Period|Adverse Event|7|||
160899673|NCT00810693|581026370|FG000|Treatment Period|Death|0|||
160899674|NCT00810693|581026371|FG001|Treatment Period|Death|1|||
160899675|NCT00810693|581026372|FG002|Treatment Period|Death|2|||
160899676|NCT00810693|581026370|FG000|Treatment Period|Lack of Efficacy|0|||
160899677|NCT00810693|581026371|FG001|Treatment Period|Lack of Efficacy|0|||
160899678|NCT00810693|581026372|FG002|Treatment Period|Lack of Efficacy|1|||
160899679|NCT00810693|581026370|FG000|Treatment Period|Lost to Follow-up|1|||
160899680|NCT00810693|581026371|FG001|Treatment Period|Lost to Follow-up|0|||
160810414|NCT03381287|580690932|FG002|Overall Study|Withdrawal by Subject|0|||
160810415|NCT03381287|580690933|FG003|Overall Study|Withdrawal by Subject|0|||
160810416|NCT03381287|580690930|FG000|Overall Study|Adverse Event|0|||
160810417|NCT03381287|580690931|FG001|Overall Study|Adverse Event|0|||
160810418|NCT03381287|580690932|FG002|Overall Study|Adverse Event|0|||
160899681|NCT00810693|581026372|FG002|Treatment Period|Lost to Follow-up|0|||
160810419|NCT03381287|580690933|FG003|Overall Study|Adverse Event|1|||
160810420|NCT03381287|580690930|FG000|Overall Study|Physician Decision|0|||
160810421|NCT03381287|580690931|FG001|Overall Study|Physician Decision|0|||
160810422|NCT03381287|580690932|FG002|Overall Study|Physician Decision|0|||
160810423|NCT03381287|580690933|FG003|Overall Study|Physician Decision|1|||
160810424|NCT00325130|580690973|FG000|Overall Study|Lost to Follow-up|6|||
160810425|NCT00325130|580690974|FG001|Overall Study|Lost to Follow-up|14|||
160810426|NCT00325130|580690973|FG000|Overall Study|Withdrawal by Subject|12|||
160810427|NCT00325130|580690974|FG001|Overall Study|Withdrawal by Subject|14|||
160810428|NCT00325130|580690973|FG000|Overall Study|Protocol Deviation|0|||
160810429|NCT00325130|580690974|FG001|Overall Study|Protocol Deviation|1|||
160810430|NCT00325130|580690973|FG000|Overall Study|Moved|0|||
160810431|NCT00325130|580690974|FG001|Overall Study|Moved|1|||
160899682|NCT00810693|581026370|FG000|Treatment Period|Non-compliance|1|||
160810432|NCT00325130|580690973|FG000|Overall Study|Patient Discontinued for Other|1|||
160899683|NCT00810693|581026371|FG001|Treatment Period|Non-compliance|0|||
160899684|NCT00810693|581026372|FG002|Treatment Period|Non-compliance|0|||
160899685|NCT00810693|581026370|FG000|Treatment Period|Protocol Violation|1|||
160899686|NCT00810693|581026371|FG001|Treatment Period|Protocol Violation|2|||
160899687|NCT00810693|581026372|FG002|Treatment Period|Protocol Violation|2|||
160899688|NCT00810693|581026370|FG000|Treatment Period|Withdrawal by Subject|6|||
160899689|NCT00810693|581026371|FG001|Treatment Period|Withdrawal by Subject|2|||
160899690|NCT00810693|581026372|FG002|Treatment Period|Withdrawal by Subject|3|||
160899691|NCT00810693|581026370|FG000|Treatment Period|Not treated|0|||
160899692|NCT00810693|581026371|FG001|Treatment Period|Not treated|1|||
160899693|NCT00810693|581026372|FG002|Treatment Period|Not treated|1|||
160899694|NCT00810693|581026370|FG000|Follow-up Period (FUP)|Adverse Event|3|||
160899695|NCT00810693|581026371|FG001|Follow-up Period (FUP)|Adverse Event|1|||
160899696|NCT00810693|581026372|FG002|Follow-up Period (FUP)|Adverse Event|1|||
160899697|NCT00810693|581026370|FG000|Follow-up Period (FUP)|Death|2|||
160899698|NCT00810693|581026371|FG001|Follow-up Period (FUP)|Death|0|||
160899699|NCT00810693|581026372|FG002|Follow-up Period (FUP)|Death|1|||
160899700|NCT00810693|581026370|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
160899701|NCT00810693|581026371|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
160899702|NCT00810693|581026372|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
160899703|NCT00810693|581026370|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
160899704|NCT00810693|581026371|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
160899705|NCT00810693|581026372|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
160899706|NCT00810693|581026370|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
160899707|NCT00810693|581026371|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
160899708|NCT00810693|581026372|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
160899709|NCT02507973|581026373|FG000|Overall Study|Adverse Event|1|||
160899710|NCT04295772|581026374|FG000|Overall Study|Protocol Violation|1|||
160899711|NCT04295772|581026375|FG001|Overall Study|Protocol Violation|0|||
160899712|NCT04295772|581026374|FG000|Overall Study|Ongoing for safety monitoring|14|||
160899713|NCT04295772|581026375|FG001|Overall Study|Ongoing for safety monitoring|1|||
160899714|NCT04295772|581026374|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
160899715|NCT04295772|581026375|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
160899716|NCT00331422|581026376|FG000|Overall Study|Did not receive entire study regimen|5|||
160899717|NCT00066729|581026385|FG000|Overall Study|Lost to Follow-up|1|||
160899718|NCT00066729|581026385|FG000|Overall Study|Disease progression|1|||
160899719|NCT02349542|581026388|FG000|Overall Study|Withdrawal by Subject|5|||
160899720|NCT04128371|581026389|FG000|Overall Study|Lack of Efficacy|1|||
160899721|NCT01361568|581026390|FG000|Overall Study|Adverse Event|0|||
160899722|NCT01361568|581026391|FG001|Overall Study|Adverse Event|0|||
160899723|NCT01361568|581026392|FG002|Overall Study|Adverse Event|0|||
160899724|NCT01361568|581026393|FG003|Overall Study|Adverse Event|0|||
160899725|NCT01361568|581026394|FG004|Overall Study|Adverse Event|1|||
160899726|NCT01361568|581026395|FG005|Overall Study|Adverse Event|0|||
160899727|NCT01361568|581026390|FG000|Overall Study|Physician Decision|0|||
160899728|NCT01361568|581026391|FG001|Overall Study|Physician Decision|0|||
160899729|NCT01361568|581026392|FG002|Overall Study|Physician Decision|0|||
160899730|NCT01361568|581026393|FG003|Overall Study|Physician Decision|0|||
160899731|NCT01361568|581026394|FG004|Overall Study|Physician Decision|0|||
160899732|NCT01361568|581026395|FG005|Overall Study|Physician Decision|1|||
160810433|NCT00325130|580690974|FG001|Overall Study|Patient Discontinued for Other|0|||
160810434|NCT00980460|580690981|FG000|Overall Study|Death|0|||
160810435|NCT00980460|580690982|FG001|Overall Study|Death|0|||
160810436|NCT00980460|580690983|FG002|Overall Study|Death|1|||
160810437|NCT00980460|580690984|FG003|Overall Study|Death|2|||
160899733|NCT01361568|581026390|FG000|Overall Study|Withdrawal by Subject|2|||
160899734|NCT01361568|581026391|FG001|Overall Study|Withdrawal by Subject|1|||
160899735|NCT01361568|581026392|FG002|Overall Study|Withdrawal by Subject|0|||
160899736|NCT01361568|581026393|FG003|Overall Study|Withdrawal by Subject|0|||
160899737|NCT01361568|581026394|FG004|Overall Study|Withdrawal by Subject|0|||
160899738|NCT01361568|581026395|FG005|Overall Study|Withdrawal by Subject|1|||
160899739|NCT03308786|581026396|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
160899740|NCT01999868|581026397|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
160899741|NCT01999868|581026398|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
160899742|NCT01999868|581026399|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
160899743|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
160810438|NCT00980460|580690985|FG004|Overall Study|Death|1|||
160810439|NCT00980460|580690981|FG000|Overall Study|Lack of Efficacy|0|||
160810440|NCT00980460|580690982|FG001|Overall Study|Lack of Efficacy|0|||
160810441|NCT00980460|580690983|FG002|Overall Study|Lack of Efficacy|10|||
160810442|NCT00980460|580690984|FG003|Overall Study|Lack of Efficacy|6|||
160810443|NCT00980460|580690985|FG004|Overall Study|Lack of Efficacy|8|||
160810444|NCT00980460|580690981|FG000|Overall Study|Lost to Follow-up|0|||
160810445|NCT00980460|580690982|FG001|Overall Study|Lost to Follow-up|0|||
160810446|NCT00980460|580690983|FG002|Overall Study|Lost to Follow-up|0|||
160810447|NCT00980460|580690984|FG003|Overall Study|Lost to Follow-up|1|||
160810448|NCT00980460|580690985|FG004|Overall Study|Lost to Follow-up|0|||
160810449|NCT00980460|580690981|FG000|Overall Study|Physician Decision|0|||
160810450|NCT00980460|580690982|FG001|Overall Study|Physician Decision|0|||
160810451|NCT00980460|580690983|FG002|Overall Study|Physician Decision|11|||
160810452|NCT00980460|580690984|FG003|Overall Study|Physician Decision|5|||
160810453|NCT00980460|580690985|FG004|Overall Study|Physician Decision|3|||
160810454|NCT00980460|580690981|FG000|Overall Study|Withdrawal by Subject|0|||
160810455|NCT00980460|580690982|FG001|Overall Study|Withdrawal by Subject|0|||
160810456|NCT00980460|580690983|FG002|Overall Study|Withdrawal by Subject|1|||
160810457|NCT00980460|580690984|FG003|Overall Study|Withdrawal by Subject|0|||
160810458|NCT00980460|580690985|FG004|Overall Study|Withdrawal by Subject|0|||
160810459|NCT00980460|580690981|FG000|Overall Study|Ineligible|0|||
160810460|NCT00980460|580690982|FG001|Overall Study|Ineligible|2|||
160810461|NCT00980460|580690983|FG002|Overall Study|Ineligible|3|||
160899744|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
160899745|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
160899746|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
160899747|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
160810462|NCT00980460|580690984|FG003|Overall Study|Ineligible|1|||
160810463|NCT00980460|580690985|FG004|Overall Study|Ineligible|4|||
160810464|NCT00980460|580690981|FG000|Overall Study|Refusal of further therapy|0|||
160810465|NCT00980460|580690982|FG001|Overall Study|Refusal of further therapy|2|||
160810466|NCT00980460|580690983|FG002|Overall Study|Refusal of further therapy|3|||
160810467|NCT00980460|580690984|FG003|Overall Study|Refusal of further therapy|2|||
160810468|NCT00980460|580690985|FG004|Overall Study|Refusal of further therapy|0|||
160899748|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
160899749|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
160986375|NCT00495469|581340988|FG006|Overall Study|Lost to Follow-up|0|||
160810469|NCT00980460|580690981|FG000|Overall Study|No therapy within 42 days of resection|0|||
160810470|NCT00980460|580690982|FG001|Overall Study|No therapy within 42 days of resection|0|||
160810471|NCT00980460|580690983|FG002|Overall Study|No therapy within 42 days of resection|3|||
160810472|NCT00980460|580690984|FG003|Overall Study|No therapy within 42 days of resection|1|||
160810473|NCT00980460|580690985|FG004|Overall Study|No therapy within 42 days of resection|0|||
160810474|NCT00980460|580690981|FG000|Overall Study|No transplant by protocol timepoints|0|||
160810475|NCT00980460|580690982|FG001|Overall Study|No transplant by protocol timepoints|0|||
160810476|NCT00980460|580690983|FG002|Overall Study|No transplant by protocol timepoints|3|||
160810477|NCT00980460|580690984|FG003|Overall Study|No transplant by protocol timepoints|0|||
160810478|NCT00980460|580690985|FG004|Overall Study|No transplant by protocol timepoints|0|||
160810479|NCT02842086|580690986|FG000|Overall Study|Randomized but Never Treated|6|||
160810480|NCT02842086|580690987|FG001|Overall Study|Randomized but Never Treated|6|||
160810481|NCT02842086|580690986|FG000|Overall Study|Still in Double-Blind Phase|7|||
160810482|NCT02842086|580690987|FG001|Overall Study|Still in Double-Blind Phase|3|||
160810483|NCT02842086|580690986|FG000|Overall Study|Adverse Event|18|||
160810484|NCT02842086|580690987|FG001|Overall Study|Adverse Event|20|||
160810485|NCT02842086|580690986|FG000|Overall Study|Death|3|||
160810486|NCT02842086|580690987|FG001|Overall Study|Death|3|||
160810487|NCT02842086|580690986|FG000|Overall Study|Investigator's Discretion|9|||
160810488|NCT02842086|580690987|FG001|Overall Study|Investigator's Discretion|13|||
160810489|NCT02842086|580690986|FG000|Overall Study|Non-Compliance with Study Drug|9|||
160810490|NCT02842086|580690987|FG001|Overall Study|Non-Compliance with Study Drug|8|||
160810491|NCT02842086|580690986|FG000|Overall Study|Protocol Violation|8|||
160810492|NCT02842086|580690987|FG001|Overall Study|Protocol Violation|4|||
160810493|NCT02842086|580690986|FG000|Overall Study|Withdrew Consent|205|||
160810494|NCT02842086|580690987|FG001|Overall Study|Withdrew Consent|194|||
160810495|NCT02842086|580690986|FG000|Overall Study|Lost to Follow-up|274|||
160810496|NCT02842086|580690987|FG001|Overall Study|Lost to Follow-up|236|||
160810497|NCT02842086|580690986|FG000|Overall Study|HIV-1 Infection|5|||
160810498|NCT02842086|580690987|FG001|Overall Study|HIV-1 Infection|6|||
160810499|NCT00928187|580690988|FG000|Overall Study|Death|1|||
160810500|NCT00928187|580690989|FG001|Overall Study|Death|2|||
160810501|NCT00928187|580690990|FG002|Overall Study|Death|3|||
160810502|NCT00928187|580690988|FG000|Overall Study|Lost to Follow-up|1|||
160810503|NCT00928187|580690989|FG001|Overall Study|Lost to Follow-up|2|||
160810504|NCT00928187|580690990|FG002|Overall Study|Lost to Follow-up|1|||
160810505|NCT00928187|580690988|FG000|Overall Study|Withdrawal by Subject|0|||
160810506|NCT00928187|580690989|FG001|Overall Study|Withdrawal by Subject|1|||
160810507|NCT00928187|580690990|FG002|Overall Study|Withdrawal by Subject|1|||
160810508|NCT00928187|580690988|FG000|Overall Study|Protocol Violation|0|||
160810509|NCT00928187|580690989|FG001|Overall Study|Protocol Violation|1|||
160986376|NCT00495469|581340982|FG000|Overall Study|Protocol Violation|0|||
160986377|NCT00495469|581340983|FG001|Overall Study|Protocol Violation|0|||
160986378|NCT00495469|581340984|FG002|Overall Study|Protocol Violation|0|||
160986379|NCT00495469|581340985|FG003|Overall Study|Protocol Violation|0|||
160986380|NCT00495469|581340986|FG004|Overall Study|Protocol Violation|1|||
160986381|NCT00495469|581340987|FG005|Overall Study|Protocol Violation|2|||
160986382|NCT00495469|581340988|FG006|Overall Study|Protocol Violation|0|||
160986383|NCT00495469|581340982|FG000|Overall Study|Withdrawal by Subject|5|||
160810510|NCT00928187|580690990|FG002|Overall Study|Protocol Violation|0|||
160810511|NCT05696444|580690991|FG000|Treatment|Physician Decision|0|||
160810512|NCT05696444|580690992|FG001|Treatment|Physician Decision|1|||
160810513|NCT05696444|580690993|FG002|Treatment|Physician Decision|0|||
160810514|NCT05696444|580690991|FG000|30 Days|Death|1|||
160810515|NCT05696444|580690992|FG001|30 Days|Death|1|||
160810516|NCT05696444|580690993|FG002|30 Days|Death|0|||
160810517|NCT05696444|580690991|FG000|30 Days|Missed Visit|1|||
160810518|NCT05696444|580690992|FG001|30 Days|Missed Visit|1|||
160810519|NCT05696444|580690993|FG002|30 Days|Missed Visit|1|||
160810520|NCT05959447|580692237|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
160810521|NCT05959447|580692238|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
160810522|NCT05959447|580692237|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
160810523|NCT05959447|580692238|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
160810524|NCT05959447|580692237|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
160986384|NCT00495469|581340983|FG001|Overall Study|Withdrawal by Subject|3|||
160810525|NCT05959447|580692238|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
160810526|NCT05959447|580692237|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
160810527|NCT05959447|580692238|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
160810528|NCT01893411|580692243|FG000|Overall Study|Protocol Violation|1|||
160810529|NCT01893411|580692244|FG001|Overall Study|Protocol Violation|0|||
160986385|NCT00495469|581340984|FG002|Overall Study|Withdrawal by Subject|1|||
160810530|NCT01893411|580692245|FG002|Overall Study|Protocol Violation|0|||
160810531|NCT01893411|580692243|FG000|Overall Study|Physician Decision|1|||
160810532|NCT01893411|580692244|FG001|Overall Study|Physician Decision|1|||
160810533|NCT01893411|580692245|FG002|Overall Study|Physician Decision|2|||
160986386|NCT00495469|581340985|FG003|Overall Study|Withdrawal by Subject|3|||
160645127|NCT02378506|580082492|FG000|Overall Study|Withdrawal by Subject|4|||
160810534|NCT01893411|580692243|FG000|Overall Study|Lack of Efficacy|2|||
160810535|NCT01893411|580692244|FG001|Overall Study|Lack of Efficacy|1|||
160810536|NCT01893411|580692245|FG002|Overall Study|Lack of Efficacy|0|||
160810537|NCT01893411|580692243|FG000|Overall Study|Other|3|||
160810538|NCT01893411|580692244|FG001|Overall Study|Other|1|||
160810539|NCT01893411|580692245|FG002|Overall Study|Other|3|||
160810540|NCT01893411|580692243|FG000|Overall Study|Adverse Event|1|||
160810541|NCT01893411|580692244|FG001|Overall Study|Adverse Event|0|||
160810542|NCT01893411|580692245|FG002|Overall Study|Adverse Event|0|||
160810543|NCT01893411|580692243|FG000|Overall Study|Withdrawal by Subject|7|||
160810544|NCT01893411|580692244|FG001|Overall Study|Withdrawal by Subject|4|||
160645128|NCT02378506|580082492|FG000|Overall Study|Protocol Violation|2|||
160810545|NCT01893411|580692245|FG002|Overall Study|Withdrawal by Subject|3|||
160810546|NCT01893411|580692243|FG000|Overall Study|Lost to Follow-up|2|||
160810547|NCT01893411|580692244|FG001|Overall Study|Lost to Follow-up|0|||
160810548|NCT01893411|580692245|FG002|Overall Study|Lost to Follow-up|1|||
160810549|NCT00566982|580692246|FG000|Overall Study|Adverse Event|6|||
160810550|NCT00566982|580692247|FG001|Overall Study|Adverse Event|48|||
160810551|NCT00566982|580692246|FG000|Overall Study|Withdrawal by Subject|1|||
160810552|NCT00566982|580692247|FG001|Overall Study|Withdrawal by Subject|14|||
160810553|NCT00566982|580692246|FG000|Overall Study|Protocol Violation|1|||
160810554|NCT00566982|580692247|FG001|Overall Study|Protocol Violation|4|||
160810555|NCT00566982|580692246|FG000|Overall Study|Lost to Follow-up|0|||
160810556|NCT00566982|580692247|FG001|Overall Study|Lost to Follow-up|1|||
160810557|NCT00566982|580692246|FG000|Overall Study|Other-family problems & doctor's request|0|||
160810558|NCT00566982|580692247|FG001|Overall Study|Other-family problems & doctor's request|2|||
160810559|NCT03053440|580692250|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
160810560|NCT03053440|580692251|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
160810561|NCT03053440|580692250|FG000|Overall Study|Death|18|||
160810562|NCT03053440|580692251|FG001|Overall Study|Death|14|||
160810563|NCT03053440|580692250|FG000|Overall Study|Withdrawal by Subject|9|||
160810564|NCT03053440|580692251|FG001|Overall Study|Withdrawal by Subject|8|||
160810565|NCT03053440|580692250|FG000|Overall Study|Lost to Follow-up|1|||
160810566|NCT03053440|580692251|FG001|Overall Study|Lost to Follow-up|0|||
160810567|NCT03053440|580692250|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
160810568|NCT03053440|580692251|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
160810569|NCT03053440|580692250|FG000|Overall Study|Physician Decision|2|||
160810570|NCT03053440|580692251|FG001|Overall Study|Physician Decision|1|||
160810571|NCT03053440|580692250|FG000|Overall Study|Participant Randomized but died before dosing|1|||
160810572|NCT03053440|580692251|FG001|Overall Study|Participant Randomized but died before dosing|0|||
160899750|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
160899751|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
160899752|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
160899753|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
160899754|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
160899755|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
160899756|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
160899757|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
160899758|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
160899759|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
160899760|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
160899761|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
160899762|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
160899763|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
160810573|NCT00391053|580692257|FG000|Overall Study|Serious Adverse Events|1|||
160810574|NCT00391053|580692258|FG001|Overall Study|Serious Adverse Events|0|||
160810575|NCT00391053|580692259|FG002|Overall Study|Serious Adverse Events|1|||
160810576|NCT00391053|580692260|FG003|Overall Study|Serious Adverse Events|4|||
160810577|NCT00391053|580692257|FG000|Overall Study|Protocol Violation|2|||
160810578|NCT00391053|580692258|FG001|Overall Study|Protocol Violation|0|||
160810579|NCT00391053|580692259|FG002|Overall Study|Protocol Violation|0|||
160810580|NCT00391053|580692260|FG003|Overall Study|Protocol Violation|0|||
160810581|NCT00391053|580692257|FG000|Overall Study|Lost to Follow-up|1|||
160810582|NCT00391053|580692258|FG001|Overall Study|Lost to Follow-up|0|||
160810583|NCT00391053|580692259|FG002|Overall Study|Lost to Follow-up|0|||
160810584|NCT00391053|580692260|FG003|Overall Study|Lost to Follow-up|5|||
160810585|NCT00391053|580692257|FG000|Overall Study|Withdrawal by Subject|5|||
160810586|NCT00391053|580692258|FG001|Overall Study|Withdrawal by Subject|1|||
160810587|NCT00391053|580692259|FG002|Overall Study|Withdrawal by Subject|1|||
160810588|NCT00391053|580692260|FG003|Overall Study|Withdrawal by Subject|1|||
160810589|NCT00473889|580692262|FG000|Overall Study|Did not receive study medication|1|||
160810590|NCT00473889|580692263|FG001|Overall Study|Did not receive study medication|4|||
160810591|NCT00473889|580692262|FG000|Overall Study|Adverse Event|30|||
160810592|NCT00473889|580692263|FG001|Overall Study|Adverse Event|17|||
160810593|NCT00473889|580692262|FG000|Overall Study|Protocol Violation|4|||
160810594|NCT00473889|580692263|FG001|Overall Study|Protocol Violation|2|||
160810595|NCT00473889|580692262|FG000|Overall Study|Lack of Efficacy|28|||
160810596|NCT00473889|580692263|FG001|Overall Study|Lack of Efficacy|29|||
160810597|NCT00473889|580692262|FG000|Overall Study|Lost to Follow-up|2|||
160810598|NCT00473889|580692263|FG001|Overall Study|Lost to Follow-up|1|||
160810599|NCT00473889|580692262|FG000|Overall Study|Physician Decision|10|||
160810600|NCT00473889|580692263|FG001|Overall Study|Physician Decision|5|||
160810601|NCT00473889|580692262|FG000|Overall Study|Trial Terminated|3|||
160810602|NCT00473889|580692263|FG001|Overall Study|Trial Terminated|6|||
160810603|NCT00473889|580692262|FG000|Overall Study|Withdrawal by Subject|5|||
160810604|NCT00473889|580692263|FG001|Overall Study|Withdrawal by Subject|0|||
160810605|NCT02140970|580692264|FG000|Overall Study|Lost to Follow-up|1|||
160810606|NCT02140970|580692265|FG001|Overall Study|Lost to Follow-up|2|||
160810607|NCT02140970|580692264|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
160810608|NCT02140970|580692265|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
160810609|NCT02140970|580692264|FG000|Overall Study|Did not meet inclusion criteria|0|||
160810610|NCT02140970|580692265|FG001|Overall Study|Did not meet inclusion criteria|1|||
160810611|NCT01498692|580692269|FG000|Overall Study|Death|4|||
160810612|NCT01498692|580692269|FG000|Overall Study|Withdrawal by Subject|1|||
160810613|NCT01498692|580692269|FG000|Overall Study|Missed 12-month visit|3|||
160810614|NCT01947283|580692270|FG000|Overall Study|Death|1|||
160810615|NCT01947283|580692271|FG001|Overall Study|Death|1|||
160810616|NCT01947283|580692272|FG002|Overall Study|Death|1|||
160810617|NCT01947283|580692273|FG003|Overall Study|Death|0|||
160810618|NCT01947283|580692274|FG004|Overall Study|Death|0|||
160810619|NCT01947283|580692275|FG005|Overall Study|Death|0|||
160810620|NCT01947283|580692276|FG006|Overall Study|Death|0|||
160810621|NCT01947283|580692270|FG000|Overall Study|Lost to Follow-up|4|||
160810622|NCT01947283|580692271|FG001|Overall Study|Lost to Follow-up|6|||
160810623|NCT01947283|580692272|FG002|Overall Study|Lost to Follow-up|5|||
160810624|NCT01947283|580692273|FG003|Overall Study|Lost to Follow-up|5|||
160810625|NCT01947283|580692274|FG004|Overall Study|Lost to Follow-up|0|||
160810626|NCT01947283|580692275|FG005|Overall Study|Lost to Follow-up|2|||
160810627|NCT01947283|580692276|FG006|Overall Study|Lost to Follow-up|5|||
160810628|NCT01947283|580692270|FG000|Overall Study|Withdrawal by Subject|10|||
160810629|NCT01947283|580692271|FG001|Overall Study|Withdrawal by Subject|8|||
160810630|NCT01947283|580692272|FG002|Overall Study|Withdrawal by Subject|4|||
160810631|NCT01947283|580692273|FG003|Overall Study|Withdrawal by Subject|1|||
160810632|NCT01947283|580692274|FG004|Overall Study|Withdrawal by Subject|0|||
160810633|NCT01947283|580692275|FG005|Overall Study|Withdrawal by Subject|0|||
160810634|NCT01947283|580692276|FG006|Overall Study|Withdrawal by Subject|2|||
160810635|NCT01947283|580692270|FG000|Overall Study|No Clinical Recording|12|||
160645129|NCT02378506|580082492|FG000|Overall Study|Death|1|||
160810636|NCT01947283|580692271|FG001|Overall Study|No Clinical Recording|6|||
160810637|NCT01947283|580692272|FG002|Overall Study|No Clinical Recording|8|||
160810638|NCT01947283|580692273|FG003|Overall Study|No Clinical Recording|10|||
160810639|NCT01947283|580692274|FG004|Overall Study|No Clinical Recording|0|||
160810640|NCT01947283|580692275|FG005|Overall Study|No Clinical Recording|0|||
160810641|NCT01947283|580692276|FG006|Overall Study|No Clinical Recording|0|||
160810642|NCT01947283|580692270|FG000|Overall Study|Non-coding Clinical Recording language|0|||
160810643|NCT01947283|580692271|FG001|Overall Study|Non-coding Clinical Recording language|0|||
160810644|NCT01947283|580692272|FG002|Overall Study|Non-coding Clinical Recording language|0|||
160810645|NCT01947283|580692273|FG003|Overall Study|Non-coding Clinical Recording language|1|||
160810646|NCT01947283|580692274|FG004|Overall Study|Non-coding Clinical Recording language|0|||
160810647|NCT01947283|580692275|FG005|Overall Study|Non-coding Clinical Recording language|0|||
160810648|NCT01947283|580692276|FG006|Overall Study|Non-coding Clinical Recording language|0|||
160810649|NCT01947283|580692270|FG000|Overall Study|Missing Follow-up Assessment|2|||
160810650|NCT01947283|580692271|FG001|Overall Study|Missing Follow-up Assessment|2|||
160810651|NCT01947283|580692272|FG002|Overall Study|Missing Follow-up Assessment|3|||
160810652|NCT01947283|580692273|FG003|Overall Study|Missing Follow-up Assessment|0|||
160810653|NCT01947283|580692274|FG004|Overall Study|Missing Follow-up Assessment|0|||
160810654|NCT01947283|580692275|FG005|Overall Study|Missing Follow-up Assessment|2|||
160810655|NCT01947283|580692276|FG006|Overall Study|Missing Follow-up Assessment|0|||
160810656|NCT01947283|580692270|FG000|Overall Study|No patients were enrolled in study|0|||
160810657|NCT01947283|580692271|FG001|Overall Study|No patients were enrolled in study|0|||
160810658|NCT01947283|580692272|FG002|Overall Study|No patients were enrolled in study|0|||
160810659|NCT01947283|580692273|FG003|Overall Study|No patients were enrolled in study|0|||
160810660|NCT01947283|580692274|FG004|Overall Study|No patients were enrolled in study|0|||
160810661|NCT01947283|580692275|FG005|Overall Study|No patients were enrolled in study|3|||
160810662|NCT01947283|580692276|FG006|Overall Study|No patients were enrolled in study|1|||
160810663|NCT04729972|580692277|FG000|Overall Study|Adverse Event|1|||
160810664|NCT00430989|580692278|FG000|Overall Study|Lost to Follow-up|2|||
160810665|NCT00430989|580692279|FG001|Overall Study|Lost to Follow-up|3|||
160810666|NCT00430989|580692278|FG000|Overall Study|Withdrawal by Subject|15|||
160810667|NCT00430989|580692279|FG001|Overall Study|Withdrawal by Subject|14|||
160810668|NCT00430989|580692278|FG000|Overall Study|Protocol Violation|30|||
160810669|NCT00430989|580692279|FG001|Overall Study|Protocol Violation|37|||
160810670|NCT00430989|580692278|FG000|Overall Study|Not eligible|13|||
160810671|NCT00430989|580692279|FG001|Overall Study|Not eligible|6|||
160810672|NCT05002985|580692280|FG000|Overall Study|Withdrawal by Subject|1|||
160810673|NCT00460655|580692281|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
160810674|NCT00460655|580692282|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160810675|NCT00460655|580692283|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160810676|NCT00460655|580692284|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160810677|NCT00460655|580692281|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
160810678|NCT00460655|580692282|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160810679|NCT00460655|580692283|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160810680|NCT00460655|580692284|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160810681|NCT00460655|580692281|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
160810682|NCT00460655|580692282|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
160810683|NCT00460655|580692283|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
160810684|NCT00460655|580692284|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
160810685|NCT00460655|580692281|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
160810686|NCT00460655|580692282|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
160810687|NCT00460655|580692283|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
160810688|NCT00460655|580692284|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
160986387|NCT00495469|581340986|FG004|Overall Study|Withdrawal by Subject|3|||
160986388|NCT00495469|581340987|FG005|Overall Study|Withdrawal by Subject|2|||
160986389|NCT00495469|581340988|FG006|Overall Study|Withdrawal by Subject|3|||
160986390|NCT00495469|581340982|FG000|Overall Study|Lack of Efficacy|0|||
160986391|NCT00495469|581340983|FG001|Overall Study|Lack of Efficacy|0|||
160551748|NCT00684515|579746824|FG001|Overall Study|Adverse Event|3|||
160551749|NCT00684515|579746825|FG002|Overall Study|Adverse Event|1|||
160551750|NCT00684515|579746823|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
160551751|NCT00684515|579746824|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
160810689|NCT00460655|580692281|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
160810690|NCT00460655|580692282|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
160810691|NCT00460655|580692283|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
160810692|NCT00460655|580692284|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
160810693|NCT00460655|580692281|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
160810694|NCT00460655|580692282|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
160810695|NCT00460655|580692283|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
160810696|NCT00460655|580692284|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
160810697|NCT03782259|580692285|FG000|Overall Study|Lost to Follow-up|1|||
160810698|NCT03782259|580692286|FG001|Overall Study|Lost to Follow-up|1|||
160810699|NCT03782259|580692285|FG000|Overall Study|Moved out of state|0|||
160810700|NCT03782259|580692286|FG001|Overall Study|Moved out of state|2|||
160551752|NCT00684515|579746825|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
160810701|NCT03782259|580692285|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
160810702|NCT03782259|580692286|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
160810703|NCT03782259|580692285|FG000|Overall Study|Subject discontinued intervention|1|||
160986392|NCT00495469|581340984|FG002|Overall Study|Lack of Efficacy|0|||
160551753|NCT02450578|579746826|FG000|Overall Study|ECG abnormality so not treated|1|||
160551754|NCT02450578|579746827|FG001|Overall Study|ECG abnormality so not treated|0|||
160810704|NCT03782259|580692286|FG001|Overall Study|Subject discontinued intervention|0|||
160810705|NCT00603941|580692287|FG000|Overall Study|Disease progression|6|||
160810706|NCT00603941|580692288|FG001|Overall Study|Disease progression|7|||
160810707|NCT00603941|580692289|FG002|Overall Study|Disease progression|1|||
160810708|NCT00603941|580692287|FG000|Overall Study|Adverse Event|1|||
160810709|NCT00603941|580692288|FG001|Overall Study|Adverse Event|0|||
160551755|NCT02450578|579746828|FG002|Overall Study|ECG abnormality so not treated|0|||
160645130|NCT02378506|580082492|FG000|Overall Study|Adverse Event|14|||
160810710|NCT00603941|580692289|FG002|Overall Study|Adverse Event|1|||
160810711|NCT00603941|580692287|FG000|Overall Study|Physician Decision|0|||
160810712|NCT00603941|580692288|FG001|Overall Study|Physician Decision|1|||
160810713|NCT00603941|580692289|FG002|Overall Study|Physician Decision|0|||
160810714|NCT00603941|580692287|FG000|Overall Study|Withdrawal by Subject|0|||
160810715|NCT00603941|580692288|FG001|Overall Study|Withdrawal by Subject|2|||
160986393|NCT00495469|581340985|FG003|Overall Study|Lack of Efficacy|0|||
160986394|NCT00495469|581340986|FG004|Overall Study|Lack of Efficacy|0|||
160551756|NCT02450578|579746829|FG003|Overall Study|ECG abnormality so not treated|0|||
160551757|NCT01163786|579746830|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
160551758|NCT01163786|579746830|FG000|Treatment With Bortezomib|Adverse Event|2|||
160551759|NCT01163786|579746830|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
160551760|NCT01699087|579746832|FG000|Overall Study|Lost to Follow-up|7|||
160551761|NCT01699087|579746832|FG000|Overall Study|Screen failure (prior to treatment)|15|||
160551762|NCT01699087|579746832|FG000|Overall Study|Unable to make future visits|2|||
160551763|NCT02167945|579746836|FG000|Overall Study|Adverse Event|16|||
160551764|NCT02167945|579746836|FG000|Overall Study|Withdrew Consent|42|||
160551765|NCT02167945|579746836|FG000|Overall Study|Lost to Follow-up|122|||
160551766|NCT02167945|579746836|FG000|Overall Study|COVID-19 logistical restrictions|6|||
160551767|NCT02167945|579746836|FG000|Overall Study|Other, not specified|63|||
160986395|NCT00495469|581340987|FG005|Overall Study|Lack of Efficacy|0|||
160986396|NCT00495469|581340988|FG006|Overall Study|Lack of Efficacy|1|||
160986397|NCT00495469|581340982|FG000|Overall Study|Liver function test abnormality|0|||
160986398|NCT00495469|581340983|FG001|Overall Study|Liver function test abnormality|1|||
160986399|NCT00495469|581340984|FG002|Overall Study|Liver function test abnormality|0|||
160986400|NCT00495469|581340985|FG003|Overall Study|Liver function test abnormality|0|||
160986401|NCT00495469|581340986|FG004|Overall Study|Liver function test abnormality|0|||
160986402|NCT00495469|581340987|FG005|Overall Study|Liver function test abnormality|0|||
160986403|NCT00495469|581340988|FG006|Overall Study|Liver function test abnormality|0|||
160986404|NCT00495469|581340982|FG000|Overall Study|ST depression at randomisation in ECG|0|||
160986405|NCT00495469|581340983|FG001|Overall Study|ST depression at randomisation in ECG|1|||
160986406|NCT00495469|581340984|FG002|Overall Study|ST depression at randomisation in ECG|0|||
160986407|NCT00495469|581340985|FG003|Overall Study|ST depression at randomisation in ECG|0|||
160986408|NCT00495469|581340986|FG004|Overall Study|ST depression at randomisation in ECG|0|||
160986409|NCT00495469|581340987|FG005|Overall Study|ST depression at randomisation in ECG|0|||
160986410|NCT00495469|581340988|FG006|Overall Study|ST depression at randomisation in ECG|0|||
160986411|NCT00664521|581340992|FG000|Overall Study|Adverse Event|4|||
160986412|NCT00664521|581340993|FG001|Overall Study|Adverse Event|1|||
160551768|NCT00132730|579746837|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
160551769|NCT00132730|579746838|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
160986413|NCT00664521|581340992|FG000|Overall Study|Lost to Follow-up|1|||
160986414|NCT00664521|581340993|FG001|Overall Study|Lost to Follow-up|0|||
160551770|NCT00132730|579746839|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
160551771|NCT00132730|579746840|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
160551772|NCT00132730|579746841|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
160551773|NCT00132730|579746842|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
160551774|NCT00132730|579746837|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
160551775|NCT00132730|579746838|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
160551776|NCT00132730|579746839|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
160551777|NCT00132730|579746840|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
160551778|NCT00132730|579746841|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
160551779|NCT00132730|579746842|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
160551780|NCT00132730|579746837|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
160551781|NCT00132730|579746838|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
160810716|NCT00603941|580692289|FG002|Overall Study|Withdrawal by Subject|0|||
160986415|NCT00664521|581340992|FG000|Overall Study|Other|1|||
160986416|NCT00664521|581340993|FG001|Overall Study|Other|0|||
160986417|NCT01657682|581340994|FG000|Overall Study|Lost to Follow-up|1|||
160986418|NCT01657682|581340995|FG001|Overall Study|Lost to Follow-up|0|||
160986419|NCT01657682|581340996|FG002|Overall Study|Lost to Follow-up|0|||
160986420|NCT01657682|581340994|FG000|Overall Study|Withdrawal by Subject|0|||
160986421|NCT01657682|581340995|FG001|Overall Study|Withdrawal by Subject|1|||
160986422|NCT01657682|581340996|FG002|Overall Study|Withdrawal by Subject|1|||
160986423|NCT01657682|581340994|FG000|Overall Study|Adverse Event|0|||
160986424|NCT01657682|581340995|FG001|Overall Study|Adverse Event|1|||
160551782|NCT00132730|579746839|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
160810717|NCT00249808|580692291|FG000|Overall Study|Other|27|||
160810718|NCT00249808|580692291|FG000|Overall Study|Protocol Violation|3|||
160986425|NCT01657682|581340996|FG002|Overall Study|Adverse Event|0|||
160986426|NCT03379233|581341003|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
160986427|NCT03379233|581341004|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
160986428|NCT02531438|581341005|FG000|Overall Study|Adverse Event|7|||
160986429|NCT02531438|581341006|FG001|Overall Study|Adverse Event|9|||
160899764|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
160899765|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
160899766|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
160899767|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
160899768|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
160899769|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
160899770|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
160899771|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
160899772|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
160899773|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
160899774|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
160899775|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
160899776|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
160899777|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
160899778|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
160899779|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
160899780|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
160899781|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
160899782|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
160899783|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
160899784|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
160899785|NCT00289016|581026400|FG000|Overall Study|Disease Progression|29|||
160899786|NCT00289016|581026400|FG000|Overall Study|Death|2|||
160899787|NCT00289016|581026400|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
160899788|NCT00289016|581026400|FG000|Overall Study|Withdrawal by Subject|2|||
160899789|NCT00289016|581026400|FG000|Overall Study|Adverse Event|1|||
160551783|NCT00132730|579746840|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
160551784|NCT00132730|579746841|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
160551785|NCT00132730|579746842|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
160551786|NCT00132730|579746837|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
160551787|NCT00132730|579746838|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
160551788|NCT00132730|579746839|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
160551789|NCT00132730|579746840|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
160551790|NCT00132730|579746841|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
160551791|NCT00132730|579746842|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
160645131|NCT02378506|580082492|FG000|Overall Study|Randomized But Not Treated|1|||
160645132|NCT01715415|580082497|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
160645133|NCT01715415|580082498|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
160645134|NCT01715415|580082497|FG000|Double-blind Treatment|Adverse Event|3|||
160645135|NCT01715415|580082498|FG001|Double-blind Treatment|Adverse Event|0|||
160645136|NCT01715415|580082497|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
160645137|NCT01715415|580082498|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
160645138|NCT01715415|580082497|FG000|Double-blind Treatment|Other|1|||
160645139|NCT01715415|580082498|FG001|Double-blind Treatment|Other|0|||
160645140|NCT01715415|580082497|FG000|Open-label Treatment|Adverse Event|0|||
160645141|NCT01715415|580082498|FG001|Open-label Treatment|Adverse Event|1|||
160645142|NCT01715415|580082497|FG000|Open-label Treatment|Subject Noncompliant|0|||
160645143|NCT01715415|580082498|FG001|Open-label Treatment|Subject Noncompliant|1|||
160645144|NCT01015612|580082499|FG000|Overall Study|Death|113|||
160645145|NCT01015612|580082499|FG000|Overall Study|Withdrawal by Subject|40|||
160645146|NCT00972153|580082502|FG000|Overall Study|Equipment malfunction during case|0|||
160645147|NCT00972153|580082503|FG001|Overall Study|Equipment malfunction during case|1|||
160645148|NCT00972153|580082504|FG002|Overall Study|Equipment malfunction during case|0|||
160645149|NCT01077713|580082505|FG000|Overall Study|Withdrawal by Subject|1|||
160645150|NCT01077713|580082506|FG001|Overall Study|Withdrawal by Subject|2|||
160645151|NCT01077713|580082505|FG000|Overall Study|Progressive Disease (PD)|0|||
160645152|NCT01077713|580082506|FG001|Overall Study|Progressive Disease (PD)|1|||
160899790|NCT00289016|581026400|FG000|Overall Study|Other|1|||
160810719|NCT00249808|580692291|FG000|Overall Study|Lost to Follow-up|8|||
160810720|NCT00249808|580692291|FG000|Overall Study|Adverse Event|81|||
160810721|NCT00249808|580692291|FG000|Overall Study|Lack of Efficacy|52|||
160810722|NCT00249808|580692291|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
160810723|NCT00711594|580692292|FG000|Overall Study|Progressive disease|2|||
160810724|NCT00711594|580692293|FG001|Overall Study|Progressive disease|2|||
160810725|NCT00711594|580692294|FG002|Overall Study|Progressive disease|6|||
160810726|NCT00711594|580692295|FG003|Overall Study|Progressive disease|44|||
160986430|NCT02531438|581341005|FG000|Overall Study|Lost to Follow-up|0|||
160986431|NCT02531438|581341006|FG001|Overall Study|Lost to Follow-up|3|||
160986432|NCT02531438|581341005|FG000|Overall Study|Withdrawal by Subject|7|||
160986433|NCT02531438|581341006|FG001|Overall Study|Withdrawal by Subject|8|||
160986434|NCT02531438|581341005|FG000|Overall Study|Physician Decision|0|||
160986435|NCT02531438|581341006|FG001|Overall Study|Physician Decision|1|||
160986436|NCT02531438|581341005|FG000|Overall Study|Death|6|||
160986437|NCT02531438|581341006|FG001|Overall Study|Death|3|||
160986438|NCT02531438|581341005|FG000|Overall Study|Randomized, but Not Treated|4|||
160986439|NCT02531438|581341006|FG001|Overall Study|Randomized, but Not Treated|0|||
160986440|NCT02531438|581341005|FG000|Overall Study|Missed EOT/PTE Visit|5|||
160986441|NCT02531438|581341006|FG001|Overall Study|Missed EOT/PTE Visit|2|||
160986442|NCT02531438|581341005|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
160986443|NCT02531438|581341006|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
160986444|NCT01813422|581341008|FG000|Overall Study|Withdrawal by Subject|14|||
160986445|NCT01813422|581341009|FG001|Overall Study|Withdrawal by Subject|8|||
160986446|NCT01813422|581341008|FG000|Overall Study|Death|2|||
160986447|NCT01813422|581341009|FG001|Overall Study|Death|3|||
160986448|NCT01813422|581341008|FG000|Overall Study|Sponsor Decision|2|||
160986449|NCT01813422|581341009|FG001|Overall Study|Sponsor Decision|1|||
160986450|NCT01813422|581341008|FG000|Overall Study|Lost to Follow-up|2|||
160986451|NCT01813422|581341009|FG001|Overall Study|Lost to Follow-up|4|||
160986452|NCT01653743|581341012|FG000|Overall Study|Withdrawal by Subject|1|||
160986453|NCT01653743|581341013|FG001|Overall Study|Withdrawal by Subject|0|||
160986454|NCT01653743|581341012|FG000|Overall Study|Investigator discretion|3|||
160986455|NCT01653743|581341013|FG001|Overall Study|Investigator discretion|0|||
160986456|NCT02015195|581341016|FG000|Overall Study|Adverse Event|0|||
160810727|NCT00711594|580692292|FG000|Overall Study|Other Adverse Event|1|||
160986457|NCT02015195|581341017|FG001|Overall Study|Adverse Event|0|||
160986458|NCT02015195|581341018|FG002|Overall Study|Adverse Event|0|||
160986459|NCT02015195|581341019|FG003|Overall Study|Adverse Event|1|||
160986460|NCT02015195|581341020|FG004|Overall Study|Adverse Event|0|||
160986461|NCT02015195|581341021|FG005|Overall Study|Adverse Event|0|||
160986462|NCT02015195|581341022|FG006|Overall Study|Adverse Event|0|||
160986463|NCT01318811|581341023|FG000|Overall Study|Physician Decision|1|||
160986464|NCT01318811|581341024|FG001|Overall Study|Physician Decision|1|||
160810728|NCT00711594|580692293|FG001|Overall Study|Other Adverse Event|0|||
160810729|NCT00711594|580692294|FG002|Overall Study|Other Adverse Event|0|||
160810730|NCT00711594|580692295|FG003|Overall Study|Other Adverse Event|16|||
160810731|NCT00711594|580692292|FG000|Overall Study|Withdrawal by Subject|0|||
160810732|NCT00711594|580692293|FG001|Overall Study|Withdrawal by Subject|1|||
160810733|NCT00711594|580692294|FG002|Overall Study|Withdrawal by Subject|0|||
160810734|NCT00711594|580692295|FG003|Overall Study|Withdrawal by Subject|2|||
160810735|NCT04556591|580692300|FG000|Overall Study|Lost to Follow-up|1|||
160810736|NCT04556591|580692301|FG001|Overall Study|Lost to Follow-up|0|||
160810737|NCT04556591|580692300|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
160810738|NCT04556591|580692301|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
160986465|NCT01318811|581341023|FG000|Overall Study|CRRT stopped for head CT|0|||
160986466|NCT01318811|581341024|FG001|Overall Study|CRRT stopped for head CT|1|||
160986467|NCT01318811|581341023|FG000|Overall Study|Death|0|||
160986468|NCT01318811|581341024|FG001|Overall Study|Death|1|||
160986469|NCT01318811|581341023|FG000|Overall Study|CRRT stopped for head MRI|0|||
160986470|NCT01318811|581341024|FG001|Overall Study|CRRT stopped for head MRI|1|||
160986471|NCT00811187|581341025|FG000|Overall Study|Unable to place device / procedure abort|3|||
160986472|NCT00811187|581341026|FG001|Overall Study|Unable to place device / procedure abort|3|||
160986473|NCT00131911|581341027|FG000|Overall Study|Withdrawal by Subject|1|||
160986474|NCT00131911|581341028|FG001|Overall Study|Withdrawal by Subject|0|||
160986475|NCT02825043|581341029|FG000|Overall Study|Lost to Follow-up|4|||
160986476|NCT00329303|581341030|FG000|Overall Study|Lack of Efficacy|1|||
160986477|NCT00329303|581341031|FG001|Overall Study|Lack of Efficacy|0|||
160986478|NCT00329303|581341030|FG000|Overall Study|Decision of the sponsor|0|||
160986479|NCT00329303|581341031|FG001|Overall Study|Decision of the sponsor|1|||
160986480|NCT00329303|581341030|FG000|Overall Study|Patient no longer available|1|||
160986481|NCT00329303|581341031|FG001|Overall Study|Patient no longer available|0|||
160986482|NCT00329303|581341030|FG000|Overall Study|Patient relocated|0|||
160810739|NCT00135330|580692303|FG000|Overall Study|Adverse Event|2|||
160810740|NCT00135330|580692304|FG001|Overall Study|Adverse Event|5|||
160810741|NCT00135330|580692305|FG002|Overall Study|Adverse Event|1|||
160810742|NCT00135330|580692303|FG000|Overall Study|Lost to Follow-up|0|||
160810743|NCT00135330|580692304|FG001|Overall Study|Lost to Follow-up|2|||
160810744|NCT00135330|580692305|FG002|Overall Study|Lost to Follow-up|3|||
160810745|NCT00135330|580692303|FG000|Overall Study|Physician Decision|1|||
160810746|NCT00135330|580692304|FG001|Overall Study|Physician Decision|1|||
160810747|NCT00135330|580692305|FG002|Overall Study|Physician Decision|0|||
160810748|NCT00135330|580692303|FG000|Overall Study|Protocol Violation|4|||
160810749|NCT00135330|580692304|FG001|Overall Study|Protocol Violation|3|||
160810750|NCT00135330|580692305|FG002|Overall Study|Protocol Violation|3|||
160810751|NCT00135330|580692303|FG000|Overall Study|Patient Decision|5|||
160810752|NCT00135330|580692304|FG001|Overall Study|Patient Decision|1|||
160810753|NCT00135330|580692305|FG002|Overall Study|Patient Decision|4|||
160810754|NCT00135330|580692303|FG000|Overall Study|Sponsor Decision|0|||
160810755|NCT00135330|580692304|FG001|Overall Study|Sponsor Decision|1|||
160810756|NCT00135330|580692305|FG002|Overall Study|Sponsor Decision|0|||
160810757|NCT02526212|580692315|FG000|Overall Study|Incarceration|1|||
160810758|NCT02526212|580692316|FG001|Overall Study|Incarceration|0|||
160810759|NCT02526212|580692315|FG000|Overall Study|Lost to Follow-up|1|||
160810760|NCT02526212|580692316|FG001|Overall Study|Lost to Follow-up|0|||
160810761|NCT02526212|580692315|FG000|Overall Study|Death|0|||
160810762|NCT02526212|580692316|FG001|Overall Study|Death|1|||
160810763|NCT02096952|580692318|FG000|Overall Study|Adverse Event|1|||
160810764|NCT00040742|580692319|FG000|Overall Study|Death|0|||
160810765|NCT00040742|580692320|FG001|Overall Study|Death|0|||
160810766|NCT00040742|580692321|FG002|Overall Study|Death|1|||
160810767|NCT00040742|580692322|FG003|Overall Study|Death|0|||
160810768|NCT00040742|580692319|FG000|Overall Study|Adverse Event|15|||
160810769|NCT00040742|580692320|FG001|Overall Study|Adverse Event|16|||
160810770|NCT00040742|580692321|FG002|Overall Study|Adverse Event|21|||
160810771|NCT00040742|580692322|FG003|Overall Study|Adverse Event|9|||
160810772|NCT00040742|580692319|FG000|Overall Study|Withdrawal by Subject|7|||
160810773|NCT00040742|580692320|FG001|Overall Study|Withdrawal by Subject|15|||
160810774|NCT00040742|580692321|FG002|Overall Study|Withdrawal by Subject|10|||
160810775|NCT00040742|580692322|FG003|Overall Study|Withdrawal by Subject|13|||
160810776|NCT00040742|580692319|FG000|Overall Study|Chemotoxicity|4|||
160986483|NCT00329303|581341031|FG001|Overall Study|Patient relocated|1|||
160986484|NCT03582137|581341037|FG000|Overall Study|Adverse Event|1|||
160986485|NCT03582137|581341038|FG001|Overall Study|Adverse Event|0|||
160986486|NCT03704298|581341043|FG000|Overall Study|Death|3|||
160986487|NCT03704298|581341044|FG001|Overall Study|Death|1|||
160986488|NCT03704298|581341045|FG002|Overall Study|Death|1|||
160986489|NCT03704298|581341046|FG003|Overall Study|Death|0|||
160986490|NCT03704298|581341043|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
160986491|NCT03704298|581341044|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
160986492|NCT03704298|581341045|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
160986493|NCT03704298|581341046|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
160986494|NCT03704298|581341043|FG000|Overall Study|Withdrawal by Subject|1|||
160986495|NCT03704298|581341044|FG001|Overall Study|Withdrawal by Subject|0|||
160986496|NCT03704298|581341045|FG002|Overall Study|Withdrawal by Subject|0|||
160986497|NCT03704298|581341046|FG003|Overall Study|Withdrawal by Subject|0|||
160986498|NCT03704298|581341043|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
160986499|NCT03704298|581341044|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
160986500|NCT03704298|581341045|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
160986501|NCT03704298|581341046|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
160986502|NCT00558753|581341047|FG000|Overall Study|Lost to Follow-up|5|||
160986503|NCT00558753|581341048|FG001|Overall Study|Lost to Follow-up|7|||
160986504|NCT00783718|581341053|FG000|Induction Phase|Adverse Event|4|||
160986505|NCT00783718|581341054|FG001|Induction Phase|Adverse Event|0|||
160986506|NCT00783718|581341055|FG002|Induction Phase|Adverse Event|7|||
160986507|NCT00783718|581341056|FG003|Induction Phase|Adverse Event|0|||
160986508|NCT00783718|581341057|FG004|Induction Phase|Adverse Event|0|||
160986509|NCT00783718|581341058|FG005|Induction Phase|Adverse Event|0|||
160986510|NCT00783718|581341059|FG006|Induction Phase|Adverse Event|0|||
160810777|NCT00040742|580692320|FG001|Overall Study|Chemotoxicity|3|||
160810778|NCT00040742|580692321|FG002|Overall Study|Chemotoxicity|5|||
160810779|NCT00040742|580692322|FG003|Overall Study|Chemotoxicity|2|||
160810780|NCT00040742|580692319|FG000|Overall Study|Incomplete Forms|6|||
160810781|NCT00040742|580692320|FG001|Overall Study|Incomplete Forms|10|||
160810782|NCT00040742|580692321|FG002|Overall Study|Incomplete Forms|4|||
160810783|NCT00040742|580692322|FG003|Overall Study|Incomplete Forms|5|||
160810784|NCT00040742|580692319|FG000|Overall Study|Other medical|7|||
160810785|NCT00040742|580692320|FG001|Overall Study|Other medical|5|||
160810786|NCT00040742|580692321|FG002|Overall Study|Other medical|5|||
160810787|NCT00040742|580692322|FG003|Overall Study|Other medical|5|||
160810788|NCT00624468|580692323|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
160810789|NCT00624468|580692324|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
160810790|NCT00624468|580692325|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
160810791|NCT00624468|580692326|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
160810792|NCT00624468|580692323|FG000|Double-blind Period|Withdrew Prematurely|1|||
160810793|NCT00624468|580692324|FG001|Double-blind Period|Withdrew Prematurely|1|||
160810794|NCT00624468|580692325|FG002|Double-blind Period|Withdrew Prematurely|0|||
160810795|NCT00624468|580692326|FG003|Double-blind Period|Withdrew Prematurely|0|||
160810796|NCT00624468|580692323|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
160810797|NCT00624468|580692324|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
160810798|NCT00624468|580692325|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
160899791|NCT03553927|581026401|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
160899792|NCT03553927|581026402|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
160899793|NCT03553927|581026401|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
160899794|NCT03553927|581026402|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
160899795|NCT03350620|581026404|FG000|Stage 2|Adverse Event|0|||
160899796|NCT03350620|581026405|FG001|Stage 2|Adverse Event|1|||
160986511|NCT00783718|581341053|FG000|Induction Phase|Protocol Violation|1|||
160986512|NCT00783718|581341054|FG001|Induction Phase|Protocol Violation|1|||
160551792|NCT00132730|579746837|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
160551793|NCT00132730|579746838|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
160899797|NCT03350620|581026406|FG002|Stage 2|Adverse Event|1|||
160899798|NCT03350620|581026404|FG000|Stage 2|Lack of Efficacy|0|||
160899799|NCT03350620|581026405|FG001|Stage 2|Lack of Efficacy|2|||
160899800|NCT03350620|581026406|FG002|Stage 2|Lack of Efficacy|0|||
160899801|NCT03350620|581026404|FG000|Stage 2|Lost to Follow-up|1|||
160810799|NCT00624468|580692326|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
160810800|NCT00624468|580692323|FG000|Safety Follow-up (SFU) Period|Other|0|||
160810801|NCT00624468|580692324|FG001|Safety Follow-up (SFU) Period|Other|0|||
160899802|NCT03350620|581026405|FG001|Stage 2|Lost to Follow-up|2|||
160810802|NCT00624468|580692325|FG002|Safety Follow-up (SFU) Period|Other|1|||
160899803|NCT03350620|581026406|FG002|Stage 2|Lost to Follow-up|2|||
160986513|NCT00783718|581341055|FG002|Induction Phase|Protocol Violation|6|||
160986514|NCT00783718|581341056|FG003|Induction Phase|Protocol Violation|0|||
160986515|NCT00783718|581341057|FG004|Induction Phase|Protocol Violation|0|||
160986516|NCT00783718|581341058|FG005|Induction Phase|Protocol Violation|0|||
160986517|NCT00783718|581341059|FG006|Induction Phase|Protocol Violation|0|||
160986518|NCT00783718|581341053|FG000|Induction Phase|Lack of Efficacy|5|||
160986519|NCT00783718|581341054|FG001|Induction Phase|Lack of Efficacy|2|||
160986520|NCT00783718|581341055|FG002|Induction Phase|Lack of Efficacy|14|||
160986521|NCT00783718|581341056|FG003|Induction Phase|Lack of Efficacy|0|||
160986522|NCT00783718|581341057|FG004|Induction Phase|Lack of Efficacy|0|||
160986523|NCT00783718|581341058|FG005|Induction Phase|Lack of Efficacy|0|||
160986524|NCT00783718|581341059|FG006|Induction Phase|Lack of Efficacy|0|||
160986525|NCT00783718|581341053|FG000|Induction Phase|Withdrawal by Subject|3|||
160986526|NCT00783718|581341054|FG001|Induction Phase|Withdrawal by Subject|4|||
160986527|NCT00783718|581341055|FG002|Induction Phase|Withdrawal by Subject|8|||
160986528|NCT00783718|581341056|FG003|Induction Phase|Withdrawal by Subject|0|||
160986529|NCT00783718|581341057|FG004|Induction Phase|Withdrawal by Subject|0|||
160986530|NCT00783718|581341058|FG005|Induction Phase|Withdrawal by Subject|0|||
160986531|NCT00783718|581341059|FG006|Induction Phase|Withdrawal by Subject|0|||
160986532|NCT00783718|581341053|FG000|Induction Phase|Lost to Follow-up|1|||
160986533|NCT00783718|581341054|FG001|Induction Phase|Lost to Follow-up|0|||
160986534|NCT00783718|581341055|FG002|Induction Phase|Lost to Follow-up|1|||
160986535|NCT00783718|581341056|FG003|Induction Phase|Lost to Follow-up|0|||
160986536|NCT00783718|581341057|FG004|Induction Phase|Lost to Follow-up|0|||
160986537|NCT00783718|581341058|FG005|Induction Phase|Lost to Follow-up|0|||
160986538|NCT00783718|581341059|FG006|Induction Phase|Lost to Follow-up|0|||
160986539|NCT00783718|581341053|FG000|Maintenance Phase|Adverse Event|12|||
160986540|NCT00783718|581341054|FG001|Maintenance Phase|Adverse Event|0|||
160986541|NCT00783718|581341055|FG002|Maintenance Phase|Adverse Event|0|||
160986542|NCT00783718|581341056|FG003|Maintenance Phase|Adverse Event|15|||
160986543|NCT00783718|581341057|FG004|Maintenance Phase|Adverse Event|7|||
160986544|NCT00783718|581341058|FG005|Maintenance Phase|Adverse Event|6|||
160986545|NCT00783718|581341059|FG006|Maintenance Phase|Adverse Event|16|||
160986546|NCT00783718|581341053|FG000|Maintenance Phase|Protocol Violation|1|||
160986547|NCT00783718|581341054|FG001|Maintenance Phase|Protocol Violation|0|||
160986548|NCT00783718|581341055|FG002|Maintenance Phase|Protocol Violation|0|||
160986549|NCT00783718|581341056|FG003|Maintenance Phase|Protocol Violation|0|||
160986550|NCT00783718|581341057|FG004|Maintenance Phase|Protocol Violation|0|||
160986551|NCT00783718|581341058|FG005|Maintenance Phase|Protocol Violation|0|||
160986552|NCT00783718|581341059|FG006|Maintenance Phase|Protocol Violation|2|||
160986553|NCT00783718|581341053|FG000|Maintenance Phase|Lack of Efficacy|83|||
160986554|NCT00783718|581341054|FG001|Maintenance Phase|Lack of Efficacy|0|||
160986555|NCT00783718|581341055|FG002|Maintenance Phase|Lack of Efficacy|0|||
160986556|NCT00783718|581341056|FG003|Maintenance Phase|Lack of Efficacy|61|||
160986557|NCT00783718|581341057|FG004|Maintenance Phase|Lack of Efficacy|31|||
160986558|NCT00783718|581341058|FG005|Maintenance Phase|Lack of Efficacy|33|||
160986559|NCT00783718|581341059|FG006|Maintenance Phase|Lack of Efficacy|155|||
160986560|NCT00783718|581341053|FG000|Maintenance Phase|Withdrawal by Subject|6|||
160986561|NCT00783718|581341054|FG001|Maintenance Phase|Withdrawal by Subject|0|||
160986562|NCT00783718|581341055|FG002|Maintenance Phase|Withdrawal by Subject|0|||
160986563|NCT00783718|581341056|FG003|Maintenance Phase|Withdrawal by Subject|2|||
160986564|NCT00783718|581341057|FG004|Maintenance Phase|Withdrawal by Subject|5|||
160986565|NCT00783718|581341058|FG005|Maintenance Phase|Withdrawal by Subject|2|||
160986566|NCT00783718|581341059|FG006|Maintenance Phase|Withdrawal by Subject|20|||
160986567|NCT00783718|581341053|FG000|Maintenance Phase|Lost to Follow-up|3|||
160986568|NCT00783718|581341054|FG001|Maintenance Phase|Lost to Follow-up|0|||
160986569|NCT00783718|581341055|FG002|Maintenance Phase|Lost to Follow-up|0|||
160986570|NCT00783718|581341056|FG003|Maintenance Phase|Lost to Follow-up|0|||
160986571|NCT00783718|581341057|FG004|Maintenance Phase|Lost to Follow-up|2|||
160986572|NCT00783718|581341058|FG005|Maintenance Phase|Lost to Follow-up|0|||
160645153|NCT01077713|580082505|FG000|Overall Study|Death|28|||
160899804|NCT03350620|581026404|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
160899805|NCT03350620|581026405|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
160899806|NCT03350620|581026406|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
160899807|NCT00566111|581026407|FG000|Overall Study|Adverse Event|0|||
160899808|NCT00566111|581026408|FG001|Overall Study|Adverse Event|2|||
160899809|NCT00531934|581028564|FG000|Overall Study|Adverse Event|4|||
160899810|NCT00531934|581028565|FG001|Overall Study|Adverse Event|8|||
160899811|NCT00531934|581028564|FG000|Overall Study|Progression|52|||
160899812|NCT00531934|581028565|FG001|Overall Study|Progression|42|||
160899813|NCT00531934|581028564|FG000|Overall Study|Death|7|||
160899814|NCT00531934|581028565|FG001|Overall Study|Death|10|||
160899815|NCT00531934|581028564|FG000|Overall Study|Withdrawal by Subject|1|||
160899816|NCT00531934|581028565|FG001|Overall Study|Withdrawal by Subject|1|||
160899817|NCT00531934|581028564|FG000|Overall Study|Other|2|||
160986573|NCT00783718|581341059|FG006|Maintenance Phase|Lost to Follow-up|2|||
160986574|NCT00577629|581341060|FG000|Treatment Period|Death|1|||
160986575|NCT00577629|581341060|FG000|Long Term Follow-Up|Death|15|||
160986576|NCT00577629|581341060|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
160986577|NCT00577629|581341060|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
160986578|NCT00577629|581341060|FG000|Long Term Follow-Up|Physician Decision|1|||
160986579|NCT02929108|581341063|FG000|Overall Study|Hospice patient death|100|||
160986580|NCT02929108|581341064|FG001|Overall Study|Hospice patient death|64|||
160810803|NCT00624468|580692326|FG003|Safety Follow-up (SFU) Period|Other|1|||
160810804|NCT03520920|580692327|FG000|Overall Study|Death|13|||
160810805|NCT03520920|580692328|FG001|Overall Study|Death|1|||
160810806|NCT03520920|580692329|FG002|Overall Study|Death|0|||
160810807|NCT03520920|580692327|FG000|Overall Study|Withdrawal by Subject|2|||
160810808|NCT03520920|580692328|FG001|Overall Study|Withdrawal by Subject|1|||
160551794|NCT00132730|579746839|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
160810809|NCT03520920|580692329|FG002|Overall Study|Withdrawal by Subject|0|||
160810810|NCT03520920|580692327|FG000|Overall Study|Study Terminated by the Sponsor|5|||
160810811|NCT03520920|580692328|FG001|Overall Study|Study Terminated by the Sponsor|14|||
160810812|NCT03520920|580692329|FG002|Overall Study|Study Terminated by the Sponsor|5|||
160810813|NCT04677543|580692330|FG000|Overall Study|Withdrawal by Subject|4|||
160810814|NCT04677543|580692331|FG001|Overall Study|Withdrawal by Subject|1|||
160810815|NCT04677543|580692330|FG000|Overall Study|Physician Decision|0|||
160810816|NCT04677543|580692331|FG001|Overall Study|Physician Decision|1|||
160810817|NCT04677543|580692330|FG000|Overall Study|Adverse Event|0|||
160899818|NCT00531934|581028565|FG001|Overall Study|Other|2|||
160899819|NCT00150709|581028566|FG000|Overall Study|Protocol Violation|7|||
160899820|NCT00150709|581028567|FG001|Overall Study|Protocol Violation|8|||
160899821|NCT00150709|581028568|FG002|Overall Study|Protocol Violation|3|||
160899822|NCT00150709|581028569|FG003|Overall Study|Protocol Violation|1|||
160899823|NCT00150709|581028566|FG000|Overall Study|Adverse Event|8|||
160899824|NCT00150709|581028567|FG001|Overall Study|Adverse Event|2|||
160899825|NCT00150709|581028568|FG002|Overall Study|Adverse Event|2|||
160899826|NCT00150709|581028569|FG003|Overall Study|Adverse Event|3|||
160899827|NCT00150709|581028566|FG000|Overall Study|Lack of Efficacy|6|||
160899828|NCT00150709|581028567|FG001|Overall Study|Lack of Efficacy|11|||
160899829|NCT00150709|581028568|FG002|Overall Study|Lack of Efficacy|9|||
160899830|NCT00150709|581028569|FG003|Overall Study|Lack of Efficacy|0|||
160899831|NCT00150709|581028566|FG000|Overall Study|Withdrawal by Subject|7|||
160899832|NCT00150709|581028567|FG001|Overall Study|Withdrawal by Subject|10|||
160899833|NCT00150709|581028568|FG002|Overall Study|Withdrawal by Subject|5|||
160899834|NCT00150709|581028569|FG003|Overall Study|Withdrawal by Subject|0|||
160899835|NCT00150709|581028566|FG000|Overall Study|Lost to Follow-up|3|||
160899836|NCT00150709|581028567|FG001|Overall Study|Lost to Follow-up|2|||
160899837|NCT00150709|581028568|FG002|Overall Study|Lost to Follow-up|0|||
160899838|NCT00150709|581028569|FG003|Overall Study|Lost to Follow-up|0|||
160899839|NCT00150709|581028566|FG000|Overall Study|Sponsor decision|0|||
160899840|NCT00150709|581028567|FG001|Overall Study|Sponsor decision|0|||
160899841|NCT00150709|581028568|FG002|Overall Study|Sponsor decision|0|||
160899842|NCT00150709|581028569|FG003|Overall Study|Sponsor decision|1|||
160899843|NCT00150709|581028566|FG000|Overall Study|Site/Investigator discontinued the study|5|||
160899844|NCT00150709|581028567|FG001|Overall Study|Site/Investigator discontinued the study|5|||
160899845|NCT00150709|581028568|FG002|Overall Study|Site/Investigator discontinued the study|2|||
160899846|NCT00150709|581028569|FG003|Overall Study|Site/Investigator discontinued the study|0|||
160899847|NCT00150709|581028566|FG000|Overall Study|Decision of parent(s)|1|||
160899848|NCT00150709|581028567|FG001|Overall Study|Decision of parent(s)|2|||
160899849|NCT00150709|581028568|FG002|Overall Study|Decision of parent(s)|0|||
160899850|NCT00150709|581028569|FG003|Overall Study|Decision of parent(s)|0|||
160899851|NCT00150709|581028566|FG000|Overall Study|Decision of parent(s) and investigator|3|||
160899852|NCT00150709|581028567|FG001|Overall Study|Decision of parent(s) and investigator|0|||
160899853|NCT00150709|581028568|FG002|Overall Study|Decision of parent(s) and investigator|0|||
160899854|NCT00150709|581028569|FG003|Overall Study|Decision of parent(s) and investigator|0|||
160899855|NCT00150709|581028566|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
160899856|NCT00150709|581028567|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
160899857|NCT00150709|581028568|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
160899858|NCT00150709|581028569|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
160899859|NCT00150709|581028566|FG000|Overall Study|Investigator decision|1|||
160899860|NCT00150709|581028567|FG001|Overall Study|Investigator decision|0|||
160899861|NCT00150709|581028568|FG002|Overall Study|Investigator decision|0|||
160899862|NCT00150709|581028569|FG003|Overall Study|Investigator decision|1|||
160899863|NCT00150709|581028566|FG000|Overall Study|Subject relocated|2|||
160899864|NCT00150709|581028567|FG001|Overall Study|Subject relocated|2|||
160899865|NCT00150709|581028568|FG002|Overall Study|Subject relocated|1|||
160899866|NCT00150709|581028569|FG003|Overall Study|Subject relocated|0|||
160899867|NCT00150709|581028566|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
160899868|NCT00150709|581028567|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
160899869|NCT00150709|581028568|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
160899870|NCT00150709|581028569|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
160899871|NCT00150709|581028566|FG000|Overall Study|Convenience|0|||
160899872|NCT00150709|581028567|FG001|Overall Study|Convenience|1|||
160899873|NCT00150709|581028568|FG002|Overall Study|Convenience|0|||
160899874|NCT00150709|581028569|FG003|Overall Study|Convenience|0|||
160899875|NCT00150709|581028566|FG000|Overall Study|Subject entered new drug study|0|||
160899876|NCT00150709|581028567|FG001|Overall Study|Subject entered new drug study|1|||
160810818|NCT04677543|580692331|FG001|Overall Study|Adverse Event|1|||
160810819|NCT00995436|580692332|FG000|Overall Study|Withdrawal by Subject|2|||
160810820|NCT00995436|580692333|FG001|Overall Study|Withdrawal by Subject|5|||
160810821|NCT00995436|580692334|FG002|Overall Study|Withdrawal by Subject|0|||
160810822|NCT03035864|580692336|FG000|Treatment Period|Adverse Event|1|||
160810823|NCT03035864|580692337|FG001|Treatment Period|Adverse Event|0|||
160810824|NCT03035864|580692336|FG000|Treatment Period|Other|3|||
160810825|NCT03035864|580692337|FG001|Treatment Period|Other|1|||
160810826|NCT03035864|580692336|FG000|Follow-up Period|Adverse Event|1|||
160810827|NCT03035864|580692337|FG001|Follow-up Period|Adverse Event|0|||
160810828|NCT03035864|580692336|FG000|Follow-up Period|Lost to Follow-up|6|||
160986581|NCT02929108|581341065|FG002|Overall Study|Hospice patient death|28|||
160986582|NCT02929108|581341066|FG003|Overall Study|Hospice patient death|46|||
160986583|NCT02929108|581341067|FG004|Overall Study|Hospice patient death|55|||
160986584|NCT02929108|581341068|FG005|Overall Study|Hospice patient death|28|||
160986585|NCT02929108|581341069|FG006|Overall Study|Hospice patient death|78|||
160986586|NCT01027871|581341070|FG000|Overall Study|Physician Decision|1|||
160986587|NCT01027871|581341071|FG001|Overall Study|Physician Decision|5|||
160986588|NCT01027871|581341072|FG002|Overall Study|Physician Decision|0|||
160986589|NCT01027871|581341070|FG000|Overall Study|Protocol Violation|0|||
160986590|NCT01027871|581341071|FG001|Overall Study|Protocol Violation|2|||
160986591|NCT01027871|581341072|FG002|Overall Study|Protocol Violation|2|||
160986592|NCT01027871|581341070|FG000|Overall Study|Withdrawal by Subject|1|||
160986593|NCT01027871|581341071|FG001|Overall Study|Withdrawal by Subject|2|||
160986594|NCT01027871|581341072|FG002|Overall Study|Withdrawal by Subject|2|||
160986595|NCT01027871|581341070|FG000|Overall Study|Adverse Event|0|||
160986596|NCT01027871|581341071|FG001|Overall Study|Adverse Event|2|||
160645154|NCT01077713|580082506|FG001|Overall Study|Death|29|||
160810829|NCT03035864|580692337|FG001|Follow-up Period|Lost to Follow-up|2|||
160810830|NCT03035864|580692336|FG000|Follow-up Period|Physician Decision|1|||
160810831|NCT03035864|580692337|FG001|Follow-up Period|Physician Decision|0|||
160810832|NCT03035864|580692336|FG000|Follow-up Period|Other|3|||
160810833|NCT03035864|580692337|FG001|Follow-up Period|Other|2|||
160810834|NCT00407602|580692340|FG000|Overall Study|Death - unrelated to device|1|||
160810835|NCT00407602|580692340|FG000|Overall Study|Device explanted|5|||
160810836|NCT00407602|580692340|FG000|Overall Study|Withdrawal by Subject|1|||
160810837|NCT00553436|580692341|FG000|Overall Study|Conversion to another procedure|1|||
160810838|NCT04188834|580692342|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
160810839|NCT00577707|580692345|FG000|Overall Study|Withdrawal by Subject|3|||
160810840|NCT03706430|580692353|FG000|Overall Study|No A-Line placed|5|||
160810841|NCT03706430|580692353|FG000|Overall Study|Subject had gel nail polish|1|||
160810842|NCT03706430|580692353|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
160810843|NCT03706430|580692353|FG000|Overall Study|Cancelled Case|6|||
160810844|NCT03706430|580692353|FG000|Overall Study|Physician Decision|2|||
160810845|NCT01928433|580692354|FG000|Overall Study|Adverse Event|5|||
160810846|NCT01928433|580692355|FG001|Overall Study|Adverse Event|2|||
160810847|NCT01928433|580692356|FG002|Overall Study|Adverse Event|5|||
160810848|NCT01928433|580692354|FG000|Overall Study|Protocol Violation|0|||
160810849|NCT01928433|580692355|FG001|Overall Study|Protocol Violation|0|||
160810850|NCT01928433|580692356|FG002|Overall Study|Protocol Violation|2|||
160810851|NCT01928433|580692354|FG000|Overall Study|Lack of Efficacy|5|||
160810852|NCT01928433|580692355|FG001|Overall Study|Lack of Efficacy|4|||
160810853|NCT01928433|580692356|FG002|Overall Study|Lack of Efficacy|4|||
160810854|NCT01928433|580692354|FG000|Overall Study|Withdrawal by Subject|0|||
160810855|NCT01928433|580692355|FG001|Overall Study|Withdrawal by Subject|4|||
160810856|NCT01928433|580692356|FG002|Overall Study|Withdrawal by Subject|0|||
160810857|NCT01928433|580692354|FG000|Overall Study|Negative screening urine culture|7|||
160810858|NCT01928433|580692355|FG001|Overall Study|Negative screening urine culture|6|||
160810859|NCT01928433|580692356|FG002|Overall Study|Negative screening urine culture|10|||
160810860|NCT01928433|580692354|FG000|Overall Study|Lost to Follow-up|0|||
160810861|NCT01928433|580692355|FG001|Overall Study|Lost to Follow-up|2|||
160810862|NCT01928433|580692356|FG002|Overall Study|Lost to Follow-up|3|||
160810863|NCT01928433|580692354|FG000|Overall Study|Other reasons|3|||
160810864|NCT01928433|580692355|FG001|Overall Study|Other reasons|3|||
160986597|NCT01027871|581341072|FG002|Overall Study|Adverse Event|2|||
160810865|NCT01928433|580692356|FG002|Overall Study|Other reasons|4|||
160810866|NCT00145626|580692357|FG000|Overall Study|Did not have NK infusions|2|||
160810867|NCT00145626|580692357|FG000|Overall Study|Turned 2 years old before treatment|1|||
160986598|NCT01027871|581341070|FG000|Overall Study|Sponsor Decision|0|||
160986599|NCT01027871|581341071|FG001|Overall Study|Sponsor Decision|2|||
160986600|NCT01027871|581341072|FG002|Overall Study|Sponsor Decision|0|||
160645155|NCT01077713|580082505|FG000|Overall Study|Lost to Follow-up|1|||
160810868|NCT00145626|580692357|FG000|Overall Study|Death|1|||
160810869|NCT00145626|580692357|FG000|Overall Study|Withdrawal by Subject|1|||
160810870|NCT00100802|580692358|FG000|Overall Study|Adverse Event|9|||
160810871|NCT00100802|580692358|FG000|Overall Study|Death|1|||
160810872|NCT00100802|580692358|FG000|Overall Study|Lack of Efficacy|47|||
160810873|NCT00100802|580692358|FG000|Overall Study|Physician Decision|5|||
160810874|NCT00100802|580692358|FG000|Overall Study|Protocol Violation|1|||
160810875|NCT00100802|580692358|FG000|Overall Study|Withdrawal by Subject|5|||
160810876|NCT00100802|580692358|FG000|Overall Study|Ineligible|12|||
160810877|NCT02709720|580692359|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
160810878|NCT02709720|580692359|FG000|Overall Study|Protocol Violation|1|||
160810879|NCT02709720|580692359|FG000|Overall Study|Not take study medication|1|||
160810880|NCT01198574|580692361|FG000|Overall Study|Resigned from schools|4|||
160810881|NCT01198574|580692362|FG001|Overall Study|Resigned from schools|1|||
160810882|NCT01198574|580692363|FG002|Overall Study|Resigned from schools|1|||
160810883|NCT01198574|580692364|FG003|Overall Study|Resigned from schools|4|||
160810884|NCT00200967|580692367|FG000|First Treatment Period|Withdrawal by Subject|5|||
160810885|NCT00200967|580692368|FG001|First Treatment Period|Withdrawal by Subject|1|||
160810886|NCT00200967|580692367|FG000|First Treatment Period|Pregnancy|1|||
160810887|NCT00200967|580692368|FG001|First Treatment Period|Pregnancy|0|||
160810888|NCT00200967|580692367|FG000|Wash-out Period|Lost to Follow-up|0|||
160810889|NCT00200967|580692368|FG001|Wash-out Period|Lost to Follow-up|1|||
160810890|NCT00200967|580692367|FG000|Second Treatment Period|Withdrawal by Subject|1|||
160810891|NCT00200967|580692368|FG001|Second Treatment Period|Withdrawal by Subject|2|||
160810892|NCT00200967|580692367|FG000|Run-out Period|Lost to Follow-up|1|||
160810893|NCT00200967|580692368|FG001|Run-out Period|Lost to Follow-up|0|||
160810894|NCT03744910|580694477|FG000|Overall Study|Withdrew Consent|1|||
160810895|NCT03744910|580694478|FG001|Overall Study|Withdrew Consent|8|||
160810896|NCT03744910|580694477|FG000|Overall Study|Physician Decision|5|||
160810897|NCT03744910|580694478|FG001|Overall Study|Physician Decision|4|||
160810898|NCT03744910|580694477|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
160810899|NCT03744910|580694478|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
160810900|NCT03744910|580694477|FG000|Overall Study|Lost to Follow-up|0|||
160810901|NCT03744910|580694478|FG001|Overall Study|Lost to Follow-up|1|||
160810902|NCT03744910|580694477|FG000|Overall Study|Other-unspecified|4|||
160810903|NCT03744910|580694478|FG001|Overall Study|Other-unspecified|1|||
160810904|NCT02712983|580694479|FG000|Treatment Phase|Adverse Event|3|||
160810905|NCT02712983|580694480|FG001|Treatment Phase|Adverse Event|1|||
160810906|NCT02712983|580694481|FG002|Treatment Phase|Adverse Event|1|||
160810907|NCT02712983|580694482|FG003|Treatment Phase|Adverse Event|4|||
160810908|NCT02712983|580694483|FG004|Treatment Phase|Adverse Event|3|||
160810909|NCT02712983|580694484|FG005|Treatment Phase|Adverse Event|0|||
160810910|NCT02712983|580694485|FG006|Treatment Phase|Adverse Event|6|||
160810911|NCT02712983|580694486|FG007|Treatment Phase|Adverse Event|6|||
160810912|NCT02712983|580694487|FG008|Treatment Phase|Adverse Event|1|||
160810913|NCT02712983|580694479|FG000|Treatment Phase|Protocol Deviation|0|||
160810914|NCT02712983|580694480|FG001|Treatment Phase|Protocol Deviation|0|||
160810915|NCT02712983|580694481|FG002|Treatment Phase|Protocol Deviation|0|||
160810916|NCT02712983|580694482|FG003|Treatment Phase|Protocol Deviation|2|||
160810917|NCT02712983|580694483|FG004|Treatment Phase|Protocol Deviation|0|||
160810918|NCT02712983|580694484|FG005|Treatment Phase|Protocol Deviation|0|||
160810919|NCT02712983|580694485|FG006|Treatment Phase|Protocol Deviation|1|||
160810920|NCT02712983|580694486|FG007|Treatment Phase|Protocol Deviation|0|||
160810921|NCT02712983|580694487|FG008|Treatment Phase|Protocol Deviation|0|||
160810922|NCT02712983|580694479|FG000|Treatment Phase|Technical Problems|0|||
160810923|NCT02712983|580694480|FG001|Treatment Phase|Technical Problems|0|||
160810924|NCT02712983|580694481|FG002|Treatment Phase|Technical Problems|0|||
160810925|NCT02712983|580694482|FG003|Treatment Phase|Technical Problems|0|||
160810926|NCT02712983|580694483|FG004|Treatment Phase|Technical Problems|0|||
160810927|NCT02712983|580694484|FG005|Treatment Phase|Technical Problems|0|||
160810928|NCT02712983|580694485|FG006|Treatment Phase|Technical Problems|1|||
160810929|NCT02712983|580694486|FG007|Treatment Phase|Technical Problems|0|||
160810930|NCT02712983|580694487|FG008|Treatment Phase|Technical Problems|0|||
160810931|NCT02712983|580694479|FG000|Treatment Phase|Physician Decision|0|||
160810932|NCT02712983|580694480|FG001|Treatment Phase|Physician Decision|0|||
160810933|NCT02712983|580694481|FG002|Treatment Phase|Physician Decision|0|||
160810934|NCT02712983|580694482|FG003|Treatment Phase|Physician Decision|0|||
160810935|NCT02712983|580694483|FG004|Treatment Phase|Physician Decision|0|||
160810936|NCT02712983|580694484|FG005|Treatment Phase|Physician Decision|0|||
160810937|NCT02712983|580694485|FG006|Treatment Phase|Physician Decision|0|||
160810938|NCT02712983|580694486|FG007|Treatment Phase|Physician Decision|1|||
160810939|NCT02712983|580694487|FG008|Treatment Phase|Physician Decision|1|||
160810940|NCT02712983|580694479|FG000|Treatment Phase|Subject Decision|2|||
160810941|NCT02712983|580694480|FG001|Treatment Phase|Subject Decision|0|||
160810942|NCT02712983|580694481|FG002|Treatment Phase|Subject Decision|0|||
160810943|NCT02712983|580694482|FG003|Treatment Phase|Subject Decision|2|||
160810944|NCT02712983|580694483|FG004|Treatment Phase|Subject Decision|1|||
160986601|NCT01027871|581341070|FG000|Overall Study|Discontinued Prior to Treatment|0|||
160986602|NCT01027871|581341071|FG001|Overall Study|Discontinued Prior to Treatment|0|||
160986603|NCT01027871|581341072|FG002|Overall Study|Discontinued Prior to Treatment|1|||
160986604|NCT00052962|581341073|FG000|Overall Study|Not evaluable|0|||
160986605|NCT00052962|581341074|FG001|Overall Study|Not evaluable|2|||
160986606|NCT00052962|581341073|FG000|Overall Study|Not randomized/not evaluable|1|||
160986607|NCT00052962|581341074|FG001|Overall Study|Not randomized/not evaluable|0|||
160986608|NCT01414166|581341075|FG000|Overall Study|Adverse Event|10|||
160986609|NCT01414166|581341076|FG001|Overall Study|Adverse Event|2|||
160986610|NCT01414166|581341075|FG000|Overall Study|Lost to Follow-up|4|||
160986611|NCT01414166|581341076|FG001|Overall Study|Lost to Follow-up|1|||
160645156|NCT01077713|580082506|FG001|Overall Study|Lost to Follow-up|1|||
160645157|NCT01077713|580082505|FG000|Overall Study|Adverse Event|2|||
160645158|NCT01077713|580082506|FG001|Overall Study|Adverse Event|1|||
160645159|NCT01077713|580082505|FG000|Overall Study|Other|4|||
160645160|NCT01077713|580082506|FG001|Overall Study|Other|2|||
160645161|NCT04136626|580082507|FG000|Treatment Phase|Withdrawal by Subject|1|||
160810945|NCT02712983|580694484|FG005|Treatment Phase|Subject Decision|0|||
160810946|NCT02712983|580694485|FG006|Treatment Phase|Subject Decision|1|||
160810947|NCT02712983|580694486|FG007|Treatment Phase|Subject Decision|2|||
160810948|NCT02712983|580694487|FG008|Treatment Phase|Subject Decision|0|||
160810949|NCT02712983|580694479|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810950|NCT02712983|580694480|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
160810951|NCT02712983|580694481|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810952|NCT02712983|580694482|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810953|NCT02712983|580694483|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810954|NCT02712983|580694484|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810955|NCT02712983|580694485|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
160810956|NCT02712983|580694486|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
160810957|NCT02712983|580694487|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810958|NCT02712983|580694479|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810959|NCT02712983|580694480|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810960|NCT02712983|580694481|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810961|NCT02712983|580694482|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
160810962|NCT02712983|580694483|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810963|NCT02712983|580694484|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810964|NCT02712983|580694485|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810965|NCT02712983|580694486|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810966|NCT02712983|580694487|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810967|NCT02712983|580694479|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
160899877|NCT00150709|581028568|FG002|Overall Study|Subject entered new drug study|0|||
160899878|NCT00150709|581028569|FG003|Overall Study|Subject entered new drug study|0|||
160899879|NCT00150709|581028566|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
160899880|NCT00150709|581028567|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
160899881|NCT00150709|581028568|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
160899882|NCT00150709|581028569|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
160899883|NCT00150709|581028566|FG000|Overall Study|Lack of ease of swallowing|0|||
160899884|NCT00150709|581028567|FG001|Overall Study|Lack of ease of swallowing|1|||
160899885|NCT00150709|581028568|FG002|Overall Study|Lack of ease of swallowing|0|||
160899886|NCT00150709|581028569|FG003|Overall Study|Lack of ease of swallowing|0|||
160899887|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Adverse Event|16|||
160899888|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Adverse Event|17|||
160899889|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Adverse Event|13|||
160899890|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Adverse Event|18|||
160899891|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Adverse Event|0|||
160899892|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Adverse Event|0|||
160899893|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Adverse Event|0|||
160899894|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Adverse Event|0|||
160899895|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
160899896|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
160899897|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
160899898|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
160899899|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
160899900|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
160899901|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
160899902|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
160899903|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
160986612|NCT01414166|581341075|FG000|Overall Study|Non-compliance with study drug|2|||
160810968|NCT02712983|580694480|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
160810969|NCT02712983|580694481|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
160899904|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
160986613|NCT01414166|581341076|FG001|Overall Study|Non-compliance with study drug|0|||
160986614|NCT01414166|581341075|FG000|Overall Study|Physician Decision|2|||
160986615|NCT01414166|581341076|FG001|Overall Study|Physician Decision|0|||
160986616|NCT01414166|581341075|FG000|Overall Study|Protocol Violation|2|||
160810970|NCT02712983|580694482|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
160810971|NCT02712983|580694483|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
160810972|NCT02712983|580694484|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
160810973|NCT02712983|580694485|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
160810974|NCT02712983|580694486|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
160810975|NCT02712983|580694487|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
160810976|NCT03280303|580694488|FG000|Overall Study|Death|505|||
160810977|NCT03280303|580694488|FG000|Overall Study|Study terminated by sponsor|383|||
160810978|NCT03280303|580694488|FG000|Overall Study|Other|148|||
160810979|NCT03280303|580694488|FG000|Overall Study|No longer willing to participate in study|101|||
160810980|NCT03280303|580694488|FG000|Overall Study|Lost to follow up|39|||
160810981|NCT03280303|580694488|FG000|Overall Study|Adverse Event|20|||
160810982|NCT00064259|580694489|FG000|Overall Study|Adverse Event|1|||
160810983|NCT00064259|580694490|FG001|Overall Study|Adverse Event|0|||
160810984|NCT00064259|580694491|FG002|Overall Study|Adverse Event|0|||
160986617|NCT01414166|581341076|FG001|Overall Study|Protocol Violation|0|||
160810985|NCT00064259|580694492|FG003|Overall Study|Adverse Event|1|||
160810986|NCT01132651|580694495|FG000|Overall Study|Lost to Follow-up|1|||
160810987|NCT01132651|580694496|FG001|Overall Study|Lost to Follow-up|1|||
160810988|NCT00948857|580694497|FG000|Overall Study|Lost to Follow-up|1|||
160810989|NCT00948857|580694498|FG001|Overall Study|Lost to Follow-up|0|||
160810990|NCT03430843|580694500|FG000|Overall Study|Death|233|||
160810991|NCT03430843|580694501|FG001|Overall Study|Death|233|||
160810992|NCT03430843|580694500|FG000|Overall Study|Sponsor Decision|17|||
160810993|NCT03430843|580694501|FG001|Overall Study|Sponsor Decision|6|||
160810994|NCT03430843|580694500|FG000|Overall Study|Withdrawal by Subject|5|||
160810995|NCT03430843|580694501|FG001|Overall Study|Withdrawal by Subject|14|||
160810996|NCT03430843|580694500|FG000|Overall Study|Lost to Follow-up|1|||
160810997|NCT03430843|580694501|FG001|Overall Study|Lost to Follow-up|3|||
160810998|NCT05360966|580694508|FG000|Overall Study|Adverse Event|5|||
160810999|NCT05360966|580694509|FG001|Overall Study|Adverse Event|5|||
160811000|NCT05360966|580694508|FG000|Overall Study|Withdrawal of Consent|5|||
160811001|NCT05360966|580694509|FG001|Overall Study|Withdrawal of Consent|3|||
160811002|NCT05360966|580694508|FG000|Overall Study|Noncompliance|2|||
160811003|NCT05360966|580694509|FG001|Overall Study|Noncompliance|1|||
160811004|NCT05360966|580694508|FG000|Overall Study|Lost to Follow-up|2|||
160811005|NCT05360966|580694509|FG001|Overall Study|Lost to Follow-up|3|||
160811006|NCT05360966|580694508|FG000|Overall Study|Protocol Deviation|2|||
160811007|NCT05360966|580694509|FG001|Overall Study|Protocol Deviation|1|||
160986618|NCT01414166|581341075|FG000|Overall Study|Study terminated by Sponsor|68|||
160986619|NCT01414166|581341076|FG001|Overall Study|Study terminated by Sponsor|75|||
160986620|NCT01414166|581341075|FG000|Overall Study|Withdrawal by Subject|3|||
160986621|NCT01414166|581341076|FG001|Overall Study|Withdrawal by Subject|5|||
160986622|NCT03782727|581341077|FG000|Overall Study|Lost to Follow-up|32|||
160986623|NCT05489224|581341080|FG000|Treatment Period I|Withdrawal by Subject|6|||
160986624|NCT05489224|581341081|FG001|Treatment Period I|Withdrawal by Subject|5|||
160986625|NCT05489224|581341082|FG002|Treatment Period I|Withdrawal by Subject|0|||
160986626|NCT05489224|581341080|FG000|Treatment Period I|Adverse Event|3|||
160986627|NCT05489224|581341081|FG001|Treatment Period I|Adverse Event|11|||
160986628|NCT05489224|581341082|FG002|Treatment Period I|Adverse Event|0|||
160986629|NCT05489224|581341080|FG000|Treatment Period I|Lost to Follow-up|0|||
160986630|NCT05489224|581341081|FG001|Treatment Period I|Lost to Follow-up|1|||
160986631|NCT05489224|581341082|FG002|Treatment Period I|Lost to Follow-up|0|||
160986632|NCT05489224|581341080|FG000|Treatment Period I|Physician Decision|0|||
160811008|NCT05360966|580694508|FG000|Overall Study|As specified in the Clinical Study Report|1|||
160986633|NCT05489224|581341081|FG001|Treatment Period I|Physician Decision|1|||
160986634|NCT05489224|581341082|FG002|Treatment Period I|Physician Decision|0|||
160986635|NCT05489224|581341080|FG000|Treatment Period II up to Week 32|Ongoing|222|||
160986636|NCT05489224|581341081|FG001|Treatment Period II up to Week 32|Ongoing|107|||
160986637|NCT05489224|581341082|FG002|Treatment Period II up to Week 32|Ongoing|107|||
160811009|NCT05360966|580694509|FG001|Overall Study|As specified in the Clinical Study Report|3|||
160986638|NCT05489224|581341080|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
160986639|NCT05489224|581341081|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
160986640|NCT05489224|581341082|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
160986641|NCT05489224|581341080|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
160986642|NCT05489224|581341081|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
160811010|NCT05396014|580694510|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
160811011|NCT05396014|580694511|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811012|NCT05396014|580694512|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811013|NCT05396014|580694513|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811014|NCT05396014|580694514|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811015|NCT05396014|580694515|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160986643|NCT05489224|581341082|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
160986644|NCT04887285|581341084|FG000|Overall Study|Lost to Follow-up|0|||
160986645|NCT04887285|581341085|FG001|Overall Study|Lost to Follow-up|2|||
160986646|NCT04887285|581341086|FG002|Overall Study|Lost to Follow-up|3|||
160986647|NCT02820051|581341090|FG000|Overall Study|Lost to Follow-up|7|||
160986648|NCT02820051|581341091|FG001|Overall Study|Lost to Follow-up|4|||
160986649|NCT00832780|581341095|FG000|Overall Study|Death|16|||
160986650|NCT00832780|581341095|FG000|Overall Study|Lost to Follow-up|4|||
160986651|NCT00832780|581341095|FG000|Overall Study|no reason given|2|||
160986652|NCT00832780|581341095|FG000|Overall Study|other complicating condition|2|||
160811016|NCT05396014|580694516|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811017|NCT05396014|580694517|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811018|NCT05396014|580694518|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811019|NCT05396014|580694519|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811020|NCT05396014|580694520|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811021|NCT05396014|580694521|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811022|NCT05396014|580694522|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811023|NCT05396014|580694523|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
160811024|NCT05396014|580694524|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811025|NCT05396014|580694525|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811026|NCT05396014|580694526|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811027|NCT05396014|580694527|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811028|NCT05396014|580694528|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811029|NCT05396014|580694529|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811030|NCT05396014|580694530|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811031|NCT05396014|580694531|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811032|NCT05396014|580694532|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811033|NCT05396014|580694533|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811034|NCT05396014|580694534|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811035|NCT05396014|580694535|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811036|NCT05396014|580694536|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
160811037|NCT05396014|580694537|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811038|NCT05396014|580694538|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811039|NCT05396014|580694539|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811040|NCT05396014|580694540|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811041|NCT05396014|580694541|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811042|NCT05396014|580694542|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811043|NCT05396014|580694543|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811044|NCT05396014|580694544|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811045|NCT05396014|580694545|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811046|NCT05396014|580694546|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811047|NCT05396014|580694547|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811048|NCT05396014|580694548|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811049|NCT05396014|580694549|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
160811050|NCT05396014|580694550|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160986653|NCT00832780|581341095|FG000|Overall Study|Physician Decision|1|||
160645162|NCT04136626|580082508|FG001|Treatment Phase|Withdrawal by Subject|9|||
160811051|NCT05396014|580694551|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811052|NCT05396014|580694552|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811053|NCT05396014|580694510|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
160811054|NCT05396014|580694511|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811055|NCT05396014|580694512|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811056|NCT05396014|580694513|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811057|NCT05396014|580694514|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811058|NCT05396014|580694515|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811059|NCT05396014|580694516|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811060|NCT05396014|580694517|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811061|NCT05396014|580694518|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811062|NCT05396014|580694519|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811063|NCT05396014|580694520|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811064|NCT05396014|580694521|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811065|NCT05396014|580694522|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811066|NCT05396014|580694523|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
160986654|NCT05705167|581341096|FG000|Overall Study|Randomised but not Treated|0|||
160986655|NCT05705167|581341097|FG001|Overall Study|Randomised but not Treated|2|||
160986656|NCT05705167|581341098|FG002|Overall Study|Randomised but not Treated|0|||
160986657|NCT05705167|581341099|FG003|Overall Study|Randomised but not Treated|7|||
160811067|NCT05396014|580694524|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811068|NCT05396014|580694525|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811069|NCT05396014|580694526|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811070|NCT05396014|580694527|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811071|NCT05396014|580694528|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811072|NCT05396014|580694529|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811073|NCT05396014|580694530|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811074|NCT05396014|580694531|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811075|NCT05396014|580694532|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811076|NCT05396014|580694533|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811077|NCT05396014|580694534|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811078|NCT05396014|580694535|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811079|NCT05396014|580694536|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
160811080|NCT05396014|580694537|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811081|NCT05396014|580694538|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811082|NCT05396014|580694539|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811083|NCT05396014|580694540|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811084|NCT05396014|580694541|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811085|NCT05396014|580694542|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811086|NCT05396014|580694543|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811087|NCT05396014|580694544|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811088|NCT05396014|580694545|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811089|NCT05396014|580694546|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811090|NCT05396014|580694547|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811091|NCT05396014|580694548|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811092|NCT05396014|580694549|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
160811093|NCT05396014|580694550|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811094|NCT05396014|580694551|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811095|NCT05396014|580694552|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811096|NCT05396014|580694510|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
160811097|NCT05396014|580694511|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811098|NCT05396014|580694512|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811099|NCT05396014|580694513|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811100|NCT05396014|580694514|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811101|NCT05396014|580694515|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811102|NCT05396014|580694516|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811103|NCT05396014|580694517|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811104|NCT05396014|580694518|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811105|NCT05396014|580694519|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811106|NCT05396014|580694520|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811107|NCT05396014|580694521|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811108|NCT05396014|580694522|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811109|NCT05396014|580694523|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
160811110|NCT05396014|580694524|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811111|NCT05396014|580694525|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811112|NCT05396014|580694526|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811113|NCT05396014|580694527|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811114|NCT05396014|580694528|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811115|NCT05396014|580694529|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811116|NCT05396014|580694530|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811117|NCT05396014|580694531|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811118|NCT05396014|580694532|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811119|NCT05396014|580694533|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811120|NCT05396014|580694534|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811121|NCT05396014|580694535|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811122|NCT05396014|580694536|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
160811123|NCT05396014|580694537|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811124|NCT05396014|580694538|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811125|NCT05396014|580694539|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811126|NCT05396014|580694540|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811127|NCT05396014|580694541|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811128|NCT05396014|580694542|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811129|NCT05396014|580694543|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811130|NCT05396014|580694544|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811131|NCT05396014|580694545|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811132|NCT05396014|580694546|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811133|NCT05396014|580694547|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160899905|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
160986658|NCT05705167|581341100|FG004|Overall Study|Randomised but not Treated|0|||
160811134|NCT05396014|580694548|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811135|NCT05396014|580694549|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
160986659|NCT05705167|581341101|FG005|Overall Study|Randomised but not Treated|0|||
160986660|NCT05705167|581341102|FG006|Overall Study|Randomised but not Treated|0|||
160986661|NCT05705167|581341096|FG000|Overall Study|Death|0|||
160986662|NCT05705167|581341097|FG001|Overall Study|Death|0|||
160986663|NCT05705167|581341098|FG002|Overall Study|Death|3|||
160986664|NCT05705167|581341099|FG003|Overall Study|Death|0|||
160986665|NCT05705167|581341100|FG004|Overall Study|Death|1|||
160986666|NCT05705167|581341101|FG005|Overall Study|Death|1|||
160986667|NCT05705167|581341102|FG006|Overall Study|Death|1|||
160986668|NCT05705167|581341096|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
160986669|NCT05705167|581341097|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
160986670|NCT05705167|581341098|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
160986671|NCT05705167|581341099|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
160986672|NCT05705167|581341100|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
160986673|NCT05705167|581341101|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
160986674|NCT05705167|581341102|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
160811136|NCT05396014|580694550|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811137|NCT05396014|580694551|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811138|NCT05396014|580694552|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811139|NCT05396014|580694510|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811140|NCT05396014|580694511|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811141|NCT05396014|580694512|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811142|NCT05396014|580694513|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811143|NCT05396014|580694514|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811144|NCT05396014|580694515|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811145|NCT05396014|580694516|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811146|NCT05396014|580694517|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811147|NCT05396014|580694518|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811148|NCT05396014|580694519|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811149|NCT05396014|580694520|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811150|NCT05396014|580694521|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811151|NCT05396014|580694522|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811152|NCT05396014|580694523|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811153|NCT05396014|580694524|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811154|NCT05396014|580694525|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811155|NCT05396014|580694526|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811156|NCT05396014|580694527|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811157|NCT05396014|580694528|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811158|NCT05396014|580694529|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811159|NCT05396014|580694530|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811160|NCT05396014|580694531|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811161|NCT05396014|580694532|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811162|NCT05396014|580694533|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811163|NCT05396014|580694534|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811164|NCT05396014|580694535|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811165|NCT05396014|580694536|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
160811166|NCT05396014|580694537|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811167|NCT05396014|580694538|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160986675|NCT01670500|581341103|FG000|Overall Study|Withdrawal by Subject|1|||
160986676|NCT01670500|581341104|FG001|Overall Study|Withdrawal by Subject|0|||
160986677|NCT04955626|581341105|FG000|Blinded Period|Lost to Follow-up|28|||
160986678|NCT04955626|581341106|FG001|Blinded Period|Lost to Follow-up|28|||
160811168|NCT05396014|580694539|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811169|NCT05396014|580694540|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811170|NCT05396014|580694541|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811171|NCT05396014|580694542|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811172|NCT05396014|580694543|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160986679|NCT04955626|581341107|FG002|Blinded Period|Lost to Follow-up|7|||
160986680|NCT04955626|581341108|FG003|Blinded Period|Lost to Follow-up|14|||
160986681|NCT04955626|581341109|FG004|Blinded Period|Lost to Follow-up|3|||
160986682|NCT04955626|581341110|FG005|Blinded Period|Lost to Follow-up|2|||
160986683|NCT04955626|581341111|FG006|Blinded Period|Lost to Follow-up|6|||
160986684|NCT04955626|581341112|FG007|Blinded Period|Lost to Follow-up|4|||
160986685|NCT04955626|581341113|FG008|Blinded Period|Lost to Follow-up|5|||
160811173|NCT05396014|580694544|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811174|NCT05396014|580694545|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811175|NCT05396014|580694546|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811176|NCT05396014|580694547|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811177|NCT05396014|580694548|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811178|NCT05396014|580694549|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
160811179|NCT05396014|580694550|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811180|NCT05396014|580694551|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811181|NCT05396014|580694552|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811182|NCT05396014|580694510|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811183|NCT05396014|580694511|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811184|NCT05396014|580694512|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811185|NCT05396014|580694513|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811186|NCT05396014|580694514|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811187|NCT05396014|580694515|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811188|NCT05396014|580694516|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811189|NCT05396014|580694517|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811190|NCT05396014|580694518|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811191|NCT05396014|580694519|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811192|NCT05396014|580694520|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811193|NCT05396014|580694521|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811194|NCT05396014|580694522|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811195|NCT05396014|580694523|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811196|NCT05396014|580694524|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811197|NCT05396014|580694525|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811198|NCT05396014|580694526|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811199|NCT05396014|580694527|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811200|NCT05396014|580694528|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811201|NCT05396014|580694529|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811202|NCT05396014|580694530|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811203|NCT05396014|580694531|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811204|NCT05396014|580694532|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811205|NCT05396014|580694533|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811206|NCT05396014|580694534|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811207|NCT05396014|580694535|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811208|NCT05396014|580694536|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
160811209|NCT05396014|580694537|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811210|NCT05396014|580694538|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811211|NCT05396014|580694539|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160986686|NCT04955626|581341114|FG009|Blinded Period|Lost to Follow-up|8|||
160986687|NCT04955626|581341115|FG010|Blinded Period|Lost to Follow-up|10|||
160811212|NCT05396014|580694540|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811213|NCT05396014|580694541|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811214|NCT05396014|580694542|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811215|NCT05396014|580694543|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811216|NCT05396014|580694544|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811217|NCT05396014|580694545|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811218|NCT05396014|580694546|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811219|NCT05396014|580694547|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811220|NCT05396014|580694548|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811221|NCT05396014|580694549|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811222|NCT05396014|580694550|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811223|NCT05396014|580694551|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811224|NCT05396014|580694552|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811225|NCT05396014|580694510|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811226|NCT05396014|580694511|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811227|NCT05396014|580694512|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811228|NCT05396014|580694513|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811229|NCT05396014|580694514|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160986688|NCT04955626|581341116|FG011|Blinded Period|Lost to Follow-up|32|||
160986689|NCT04955626|581341117|FG012|Blinded Period|Lost to Follow-up|0|||
160986690|NCT04955626|581341118|FG013|Blinded Period|Lost to Follow-up|0|||
160811230|NCT05396014|580694515|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811231|NCT05396014|580694516|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811232|NCT05396014|580694517|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811233|NCT05396014|580694518|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811234|NCT05396014|580694519|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811235|NCT05396014|580694520|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811236|NCT05396014|580694521|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811237|NCT05396014|580694522|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811238|NCT05396014|580694523|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
160811239|NCT05396014|580694524|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811240|NCT05396014|580694525|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811241|NCT05396014|580694526|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811242|NCT05396014|580694527|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811243|NCT05396014|580694528|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811244|NCT05396014|580694529|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811245|NCT05396014|580694530|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811246|NCT05396014|580694531|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811247|NCT05396014|580694532|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811248|NCT05396014|580694533|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811249|NCT05396014|580694534|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811250|NCT05396014|580694535|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811251|NCT05396014|580694536|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811252|NCT05396014|580694537|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811253|NCT05396014|580694538|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811254|NCT05396014|580694539|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811255|NCT05396014|580694540|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811256|NCT05396014|580694541|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811257|NCT05396014|580694542|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811258|NCT05396014|580694543|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811259|NCT05396014|580694544|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811260|NCT05396014|580694545|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811261|NCT05396014|580694546|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811262|NCT05396014|580694547|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811263|NCT05396014|580694548|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811264|NCT05396014|580694549|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811265|NCT05396014|580694550|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811266|NCT05396014|580694551|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811267|NCT05396014|580694552|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811268|NCT05396014|580694510|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
160811269|NCT05396014|580694511|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811270|NCT05396014|580694512|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811271|NCT05396014|580694513|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811272|NCT05396014|580694514|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811273|NCT05396014|580694515|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811274|NCT05396014|580694516|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811275|NCT05396014|580694517|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811276|NCT05396014|580694518|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811277|NCT05396014|580694519|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811278|NCT05396014|580694520|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811279|NCT05396014|580694521|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811280|NCT05396014|580694522|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811281|NCT05396014|580694523|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
160811282|NCT05396014|580694524|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811283|NCT05396014|580694525|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811284|NCT05396014|580694526|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811285|NCT05396014|580694527|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811286|NCT05396014|580694528|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811287|NCT05396014|580694529|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811288|NCT05396014|580694530|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811289|NCT05396014|580694531|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811290|NCT05396014|580694532|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811291|NCT05396014|580694533|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160986691|NCT04955626|581341119|FG014|Blinded Period|Lost to Follow-up|0|||
160811292|NCT05396014|580694534|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811293|NCT05396014|580694535|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811294|NCT05396014|580694536|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811295|NCT05396014|580694537|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811296|NCT05396014|580694538|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811297|NCT05396014|580694539|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811298|NCT05396014|580694540|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811299|NCT05396014|580694541|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811300|NCT05396014|580694542|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811301|NCT05396014|580694543|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811302|NCT05396014|580694544|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811303|NCT05396014|580694545|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811304|NCT05396014|580694546|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811305|NCT05396014|580694547|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811306|NCT05396014|580694548|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811307|NCT05396014|580694549|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
160811308|NCT05396014|580694550|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811309|NCT05396014|580694551|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811310|NCT05396014|580694552|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811311|NCT05396014|580694510|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
160811312|NCT05396014|580694511|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811313|NCT05396014|580694512|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811314|NCT05396014|580694513|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811315|NCT05396014|580694514|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811316|NCT05396014|580694515|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811317|NCT05396014|580694516|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811318|NCT05396014|580694517|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811319|NCT05396014|580694518|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811320|NCT05396014|580694519|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811321|NCT05396014|580694520|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811322|NCT05396014|580694521|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811323|NCT05396014|580694522|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811324|NCT05396014|580694523|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811325|NCT05396014|580694524|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811326|NCT05396014|580694525|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811327|NCT05396014|580694526|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811328|NCT05396014|580694527|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811329|NCT05396014|580694528|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811330|NCT05396014|580694529|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811331|NCT05396014|580694530|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811332|NCT05396014|580694531|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811333|NCT05396014|580694532|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811334|NCT05396014|580694533|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811335|NCT05396014|580694534|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811336|NCT05396014|580694535|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811337|NCT05396014|580694536|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
160811338|NCT05396014|580694537|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811339|NCT05396014|580694538|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811340|NCT05396014|580694539|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811341|NCT05396014|580694540|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811342|NCT05396014|580694541|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811343|NCT05396014|580694542|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811344|NCT05396014|580694543|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811345|NCT05396014|580694544|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811346|NCT05396014|580694545|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811347|NCT05396014|580694546|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811348|NCT05396014|580694547|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160986692|NCT04955626|581341120|FG015|Blinded Period|Lost to Follow-up|12|||
160986693|NCT04955626|581341121|FG016|Blinded Period|Lost to Follow-up|2|||
160986694|NCT04955626|581341122|FG017|Blinded Period|Lost to Follow-up|5|||
160986695|NCT04955626|581341123|FG018|Blinded Period|Lost to Follow-up|0|||
160986696|NCT04955626|581341124|FG019|Blinded Period|Lost to Follow-up|0|||
160811349|NCT05396014|580694548|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160986697|NCT04955626|581341125|FG020|Blinded Period|Lost to Follow-up|0|||
160986698|NCT04955626|581341126|FG021|Blinded Period|Lost to Follow-up|0|||
160986699|NCT04955626|581341127|FG022|Blinded Period|Lost to Follow-up|0|||
160551795|NCT00132730|579746840|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
160551796|NCT00132730|579746841|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
160551797|NCT00132730|579746842|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
160551798|NCT00132730|579746837|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
160551799|NCT00132730|579746838|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
160551800|NCT00132730|579746839|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
160551801|NCT00132730|579746840|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
160551802|NCT00132730|579746841|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
160551803|NCT00132730|579746842|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
160551804|NCT00132730|579746837|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
160551805|NCT00132730|579746838|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
160645163|NCT04136626|580082507|FG000|Treatment Phase|Adverse Event|1|||
160645164|NCT04136626|580082508|FG001|Treatment Phase|Adverse Event|0|||
160645165|NCT04136626|580082507|FG000|Treatment Phase|Lost to Follow-up|1|||
160645166|NCT04136626|580082508|FG001|Treatment Phase|Lost to Follow-up|5|||
160645167|NCT04136626|580082507|FG000|12-month Follow-up|Lost to Follow-up|8|||
160811350|NCT05396014|580694549|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811351|NCT05396014|580694550|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811352|NCT05396014|580694551|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811353|NCT05396014|580694552|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811354|NCT05396014|580694510|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811355|NCT05396014|580694511|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811356|NCT05396014|580694512|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811357|NCT05396014|580694513|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811358|NCT05396014|580694514|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811359|NCT05396014|580694515|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811360|NCT05396014|580694516|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811361|NCT05396014|580694517|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811362|NCT05396014|580694518|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811363|NCT05396014|580694519|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811364|NCT05396014|580694520|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811365|NCT05396014|580694521|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811366|NCT05396014|580694522|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811367|NCT05396014|580694523|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
160811368|NCT05396014|580694524|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811369|NCT05396014|580694525|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811370|NCT05396014|580694526|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811371|NCT05396014|580694527|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811372|NCT05396014|580694528|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811373|NCT05396014|580694529|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811374|NCT05396014|580694530|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811375|NCT05396014|580694531|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811376|NCT05396014|580694532|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811377|NCT05396014|580694533|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160986700|NCT04955626|581341128|FG023|Blinded Period|Lost to Follow-up|0|||
160645168|NCT04136626|580082508|FG001|12-month Follow-up|Lost to Follow-up|7|||
160645169|NCT02247479|580084159|FG000|Overall Study|Adverse Event|8|||
160645170|NCT02247479|580084160|FG001|Overall Study|Adverse Event|9|||
160645171|NCT02247479|580084161|FG002|Overall Study|Adverse Event|8|||
160645172|NCT02247479|580084159|FG000|Overall Study|Death|5|||
160645173|NCT02247479|580084160|FG001|Overall Study|Death|4|||
160645174|NCT02247479|580084161|FG002|Overall Study|Death|6|||
160645175|NCT02247479|580084159|FG000|Overall Study|Lost to Follow-up|3|||
160645176|NCT02247479|580084160|FG001|Overall Study|Lost to Follow-up|3|||
160645177|NCT02247479|580084161|FG002|Overall Study|Lost to Follow-up|1|||
160645178|NCT02247479|580084159|FG000|Overall Study|Non-compliance|0|||
160645179|NCT02247479|580084160|FG001|Overall Study|Non-compliance|0|||
160645180|NCT02247479|580084161|FG002|Overall Study|Non-compliance|1|||
160645181|NCT02247479|580084159|FG000|Overall Study|Withdrawal by Subject|25|||
160645182|NCT02247479|580084160|FG001|Overall Study|Withdrawal by Subject|29|||
160645183|NCT02247479|580084161|FG002|Overall Study|Withdrawal by Subject|24|||
160645184|NCT02247479|580084159|FG000|Overall Study|Study Terminated by Sponsor|98|||
160645185|NCT02247479|580084160|FG001|Overall Study|Study Terminated by Sponsor|88|||
160645186|NCT02247479|580084161|FG002|Overall Study|Study Terminated by Sponsor|94|||
160645187|NCT02247479|580084159|FG000|Overall Study|Physician Decision|1|||
160645188|NCT02247479|580084160|FG001|Overall Study|Physician Decision|0|||
160551806|NCT00132730|579746839|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
160551807|NCT00132730|579746840|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
160645189|NCT02247479|580084161|FG002|Overall Study|Physician Decision|2|||
160899906|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
160899907|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
160899908|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
160899909|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
160899910|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
160899911|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
160899912|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
160899913|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
160899914|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
160899915|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
160899916|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
160986701|NCT04955626|581341129|FG024|Blinded Period|Lost to Follow-up|3|||
160899917|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
160899918|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
160899919|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
160899920|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
160899921|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
160899922|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
160899923|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
160899924|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
160899925|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
160899926|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
160899927|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
160899928|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
160899929|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
160899930|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
160899931|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
160899932|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
160899933|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
160899934|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
160899935|NCT02975336|581028570|FG000|LTE (104 Weeks)|Adverse Event|0|||
160899936|NCT02975336|581028571|FG001|LTE (104 Weeks)|Adverse Event|0|||
160899937|NCT02975336|581028572|FG002|LTE (104 Weeks)|Adverse Event|0|||
160899938|NCT02975336|581028573|FG003|LTE (104 Weeks)|Adverse Event|0|||
160899939|NCT02975336|581028574|FG004|LTE (104 Weeks)|Adverse Event|7|||
160899940|NCT02975336|581028575|FG005|LTE (104 Weeks)|Adverse Event|4|||
160899941|NCT02975336|581028576|FG006|LTE (104 Weeks)|Adverse Event|2|||
160899942|NCT02975336|581028577|FG007|LTE (104 Weeks)|Adverse Event|0|||
160899943|NCT02975336|581028570|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
160899944|NCT02975336|581028571|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
160899945|NCT02975336|581028572|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
160899946|NCT02975336|581028573|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
160899947|NCT02975336|581028574|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
160899948|NCT02975336|581028575|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
160899949|NCT02975336|581028576|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
160899950|NCT02975336|581028577|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
160899951|NCT02975336|581028570|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
160899952|NCT02975336|581028571|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
160899953|NCT02975336|581028572|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
160899954|NCT02975336|581028573|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
160899955|NCT02975336|581028574|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
160899956|NCT02975336|581028575|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
160899957|NCT02975336|581028576|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
160899958|NCT02975336|581028577|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
160899959|NCT02975336|581028570|FG000|LTE (104 Weeks)|Other|0|||
160899960|NCT02975336|581028571|FG001|LTE (104 Weeks)|Other|0|||
160899961|NCT02975336|581028572|FG002|LTE (104 Weeks)|Other|0|||
160899962|NCT02975336|581028573|FG003|LTE (104 Weeks)|Other|0|||
160899963|NCT02975336|581028574|FG004|LTE (104 Weeks)|Other|55|||
160899964|NCT02975336|581028575|FG005|LTE (104 Weeks)|Other|63|||
160899965|NCT02975336|581028576|FG006|LTE (104 Weeks)|Other|76|||
160986702|NCT04955626|581341130|FG025|Blinded Period|Lost to Follow-up|1|||
160986703|NCT04955626|581341131|FG026|Blinded Period|Lost to Follow-up|2|||
160986704|NCT04955626|581341132|FG027|Blinded Period|Lost to Follow-up|2|||
160986705|NCT04955626|581341133|FG028|Blinded Period|Lost to Follow-up|2|||
160986706|NCT04955626|581341134|FG029|Blinded Period|Lost to Follow-up|0|||
160986707|NCT04955626|581341135|FG030|Blinded Period|Lost to Follow-up|0|||
160986708|NCT04955626|581341136|FG031|Blinded Period|Lost to Follow-up|0|||
160986709|NCT04955626|581341137|FG032|Blinded Period|Lost to Follow-up|0|||
160986710|NCT04955626|581341138|FG033|Blinded Period|Lost to Follow-up|0|||
160551808|NCT00132730|579746841|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
160551809|NCT00132730|579746842|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
160551810|NCT00132730|579746837|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
160551811|NCT00132730|579746838|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
160551812|NCT00132730|579746839|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
160551813|NCT00132730|579746840|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
160551814|NCT00132730|579746841|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
160551815|NCT00132730|579746842|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
160551816|NCT00132730|579746837|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
160551817|NCT00132730|579746838|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
160551818|NCT00132730|579746839|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
160899966|NCT02975336|581028577|FG007|LTE (104 Weeks)|Other|72|||
160899967|NCT01816074|581028581|FG000|Phase 1|Time commitment issues|0|||
160899968|NCT01816074|581028582|FG001|Phase 1|Time commitment issues|0|||
160899969|NCT01816074|581028583|FG002|Phase 1|Time commitment issues|1|||
160986711|NCT04955626|581341139|FG034|Blinded Period|Lost to Follow-up|0|||
160551819|NCT00132730|579746840|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
160551820|NCT00132730|579746841|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
160986712|NCT04955626|581341140|FG035|Blinded Period|Lost to Follow-up|0|||
160551821|NCT00132730|579746842|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
160551822|NCT00132730|579746837|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
160551823|NCT00132730|579746838|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
160551824|NCT00132730|579746839|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
160551825|NCT00132730|579746840|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
160551826|NCT00132730|579746841|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
160645190|NCT02247479|580084159|FG000|Overall Study|Unspecified Reason|2|||
160811378|NCT05396014|580694534|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160986713|NCT04955626|581341105|FG000|Blinded Period|Protocol Violation|5|||
160811379|NCT05396014|580694535|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811380|NCT05396014|580694536|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160986714|NCT04955626|581341106|FG001|Blinded Period|Protocol Violation|14|||
160986715|NCT04955626|581341107|FG002|Blinded Period|Protocol Violation|0|||
160986716|NCT04955626|581341108|FG003|Blinded Period|Protocol Violation|1|||
160811381|NCT05396014|580694537|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811382|NCT05396014|580694538|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811383|NCT05396014|580694539|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811384|NCT05396014|580694540|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811385|NCT05396014|580694541|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811386|NCT05396014|580694542|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811387|NCT05396014|580694543|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811388|NCT05396014|580694544|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811389|NCT05396014|580694545|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160645191|NCT02247479|580084160|FG001|Overall Study|Unspecified Reason|5|||
160811390|NCT05396014|580694546|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811391|NCT05396014|580694547|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811392|NCT05396014|580694548|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160986717|NCT04955626|581341109|FG004|Blinded Period|Protocol Violation|2|||
160986718|NCT04955626|581341110|FG005|Blinded Period|Protocol Violation|2|||
160811393|NCT05396014|580694549|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160986719|NCT04955626|581341111|FG006|Blinded Period|Protocol Violation|0|||
160986720|NCT04955626|581341112|FG007|Blinded Period|Protocol Violation|0|||
160986721|NCT04955626|581341113|FG008|Blinded Period|Protocol Violation|0|||
160986722|NCT04955626|581341114|FG009|Blinded Period|Protocol Violation|4|||
160986723|NCT04955626|581341115|FG010|Blinded Period|Protocol Violation|6|||
160551827|NCT00132730|579746842|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
160811394|NCT05396014|580694550|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811395|NCT05396014|580694551|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811396|NCT05396014|580694552|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811397|NCT05396014|580694510|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811398|NCT05396014|580694511|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811399|NCT05396014|580694512|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811400|NCT05396014|580694513|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
160811401|NCT05396014|580694514|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811402|NCT05396014|580694515|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811403|NCT05396014|580694516|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811404|NCT05396014|580694517|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811405|NCT05396014|580694518|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
160811406|NCT05396014|580694519|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811407|NCT05396014|580694520|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811408|NCT05396014|580694521|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811409|NCT05396014|580694522|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811410|NCT05396014|580694523|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811411|NCT05396014|580694524|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811412|NCT05396014|580694525|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811413|NCT05396014|580694526|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160986724|NCT04955626|581341116|FG011|Blinded Period|Protocol Violation|1|||
160986725|NCT04955626|581341117|FG012|Blinded Period|Protocol Violation|0|||
160986726|NCT04955626|581341118|FG013|Blinded Period|Protocol Violation|0|||
160986727|NCT04955626|581341119|FG014|Blinded Period|Protocol Violation|2|||
160986728|NCT04955626|581341120|FG015|Blinded Period|Protocol Violation|6|||
160986729|NCT04955626|581341121|FG016|Blinded Period|Protocol Violation|4|||
160986730|NCT04955626|581341122|FG017|Blinded Period|Protocol Violation|6|||
160986731|NCT04955626|581341123|FG018|Blinded Period|Protocol Violation|0|||
160986732|NCT04955626|581341124|FG019|Blinded Period|Protocol Violation|1|||
160986733|NCT04955626|581341125|FG020|Blinded Period|Protocol Violation|0|||
160986734|NCT04955626|581341126|FG021|Blinded Period|Protocol Violation|1|||
160986735|NCT04955626|581341127|FG022|Blinded Period|Protocol Violation|0|||
160986736|NCT04955626|581341128|FG023|Blinded Period|Protocol Violation|0|||
160986737|NCT04955626|581341129|FG024|Blinded Period|Protocol Violation|4|||
160986738|NCT04955626|581341130|FG025|Blinded Period|Protocol Violation|6|||
160986739|NCT04955626|581341131|FG026|Blinded Period|Protocol Violation|5|||
160986740|NCT04955626|581341132|FG027|Blinded Period|Protocol Violation|3|||
160986741|NCT04955626|581341133|FG028|Blinded Period|Protocol Violation|4|||
160986742|NCT04955626|581341134|FG029|Blinded Period|Protocol Violation|3|||
160986743|NCT04955626|581341135|FG030|Blinded Period|Protocol Violation|0|||
160986744|NCT04955626|581341136|FG031|Blinded Period|Protocol Violation|0|||
160986745|NCT04955626|581341137|FG032|Blinded Period|Protocol Violation|0|||
160986746|NCT04955626|581341138|FG033|Blinded Period|Protocol Violation|0|||
160811414|NCT05396014|580694527|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811415|NCT05396014|580694528|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811416|NCT05396014|580694529|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811417|NCT05396014|580694530|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811418|NCT05396014|580694531|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811419|NCT05396014|580694532|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811420|NCT05396014|580694533|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811421|NCT05396014|580694534|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811422|NCT05396014|580694535|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
160811423|NCT05396014|580694536|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811424|NCT05396014|580694537|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811425|NCT05396014|580694538|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811426|NCT05396014|580694539|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811427|NCT05396014|580694540|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811428|NCT05396014|580694541|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811429|NCT05396014|580694542|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811430|NCT05396014|580694543|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811431|NCT05396014|580694544|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811432|NCT05396014|580694545|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811433|NCT05396014|580694546|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160986747|NCT04955626|581341139|FG034|Blinded Period|Protocol Violation|0|||
160986748|NCT04955626|581341140|FG035|Blinded Period|Protocol Violation|0|||
160986749|NCT04955626|581341105|FG000|Blinded Period|Death|0|||
160986750|NCT04955626|581341106|FG001|Blinded Period|Death|2|||
160986751|NCT04955626|581341107|FG002|Blinded Period|Death|0|||
160986752|NCT04955626|581341108|FG003|Blinded Period|Death|0|||
160986753|NCT04955626|581341109|FG004|Blinded Period|Death|0|||
160986754|NCT04955626|581341110|FG005|Blinded Period|Death|0|||
160811434|NCT05396014|580694547|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811435|NCT05396014|580694548|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811436|NCT05396014|580694549|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811437|NCT05396014|580694550|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
160811438|NCT05396014|580694551|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
160811439|NCT05396014|580694552|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811440|NCT05396014|580694510|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811441|NCT05396014|580694511|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811442|NCT05396014|580694512|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811443|NCT05396014|580694513|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811444|NCT05396014|580694514|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811445|NCT05396014|580694515|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811446|NCT05396014|580694516|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811447|NCT05396014|580694517|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811448|NCT05396014|580694518|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
160811449|NCT05396014|580694519|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811450|NCT05396014|580694520|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811451|NCT05396014|580694521|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811452|NCT05396014|580694522|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811453|NCT05396014|580694523|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811454|NCT05396014|580694524|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811455|NCT05396014|580694525|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811456|NCT05396014|580694526|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811457|NCT05396014|580694527|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811458|NCT05396014|580694528|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811459|NCT05396014|580694529|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811460|NCT05396014|580694530|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811461|NCT05396014|580694531|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811462|NCT05396014|580694532|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
160811463|NCT05396014|580694533|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811464|NCT05396014|580694534|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811465|NCT05396014|580694535|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811466|NCT05396014|580694536|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811467|NCT05396014|580694537|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811468|NCT05396014|580694538|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811469|NCT05396014|580694539|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811470|NCT05396014|580694540|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811471|NCT05396014|580694541|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811472|NCT05396014|580694542|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811473|NCT05396014|580694543|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811474|NCT05396014|580694544|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811475|NCT05396014|580694545|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
160811476|NCT05396014|580694546|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811477|NCT05396014|580694547|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811478|NCT05396014|580694548|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811479|NCT05396014|580694549|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811480|NCT05396014|580694550|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811481|NCT05396014|580694551|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
160811482|NCT05396014|580694552|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811483|NCT05396014|580694510|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811484|NCT05396014|580694511|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811485|NCT05396014|580694512|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811486|NCT05396014|580694513|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811487|NCT05396014|580694514|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811488|NCT05396014|580694515|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811489|NCT05396014|580694516|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811490|NCT05396014|580694517|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811491|NCT05396014|580694518|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811492|NCT05396014|580694519|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811493|NCT05396014|580694520|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811494|NCT05396014|580694521|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811495|NCT05396014|580694522|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811496|NCT05396014|580694523|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
160811497|NCT05396014|580694524|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811498|NCT05396014|580694525|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811499|NCT05396014|580694526|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811500|NCT05396014|580694527|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811501|NCT05396014|580694528|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811502|NCT05396014|580694529|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811503|NCT05396014|580694530|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811504|NCT05396014|580694531|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811505|NCT05396014|580694532|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811506|NCT05396014|580694533|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811507|NCT05396014|580694534|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811508|NCT05396014|580694535|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811509|NCT05396014|580694536|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
160811510|NCT05396014|580694537|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811511|NCT05396014|580694538|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811512|NCT05396014|580694539|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811513|NCT05396014|580694540|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811514|NCT05396014|580694541|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811515|NCT05396014|580694542|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811516|NCT05396014|580694543|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811517|NCT05396014|580694544|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
160811518|NCT05396014|580694545|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811519|NCT05396014|580694546|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811520|NCT05396014|580694547|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811521|NCT05396014|580694548|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811522|NCT05396014|580694549|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811523|NCT05396014|580694550|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811524|NCT05396014|580694551|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811525|NCT05396014|580694552|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
160811526|NCT05396014|580694510|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811527|NCT05396014|580694511|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811528|NCT05396014|580694512|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811529|NCT05396014|580694513|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811530|NCT05396014|580694514|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811531|NCT05396014|580694515|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811532|NCT05396014|580694516|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811533|NCT05396014|580694517|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811534|NCT05396014|580694518|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811535|NCT05396014|580694519|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811536|NCT05396014|580694520|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811537|NCT05396014|580694521|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811538|NCT05396014|580694522|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811539|NCT05396014|580694523|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811540|NCT05396014|580694524|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811541|NCT05396014|580694525|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811542|NCT05396014|580694526|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811543|NCT05396014|580694527|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811544|NCT05396014|580694528|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811545|NCT05396014|580694529|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811546|NCT05396014|580694530|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811547|NCT05396014|580694531|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811548|NCT05396014|580694532|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160899970|NCT01816074|581028584|FG003|Phase 1|Time commitment issues|0|||
160899971|NCT01816074|581028581|FG000|Phase 2|Time commitment Issues|0|||
160899972|NCT01816074|581028582|FG001|Phase 2|Time commitment Issues|2|||
160899973|NCT01816074|581028583|FG002|Phase 2|Time commitment Issues|0|||
160899974|NCT01816074|581028584|FG003|Phase 2|Time commitment Issues|0|||
160899975|NCT01816074|581028581|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
160899976|NCT01816074|581028582|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
160899977|NCT01816074|581028583|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
160899978|NCT01816074|581028584|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
160899979|NCT01816074|581028581|FG000|Phase 2|Physician Decision|0|||
160899980|NCT01816074|581028582|FG001|Phase 2|Physician Decision|0|||
160899981|NCT01816074|581028583|FG002|Phase 2|Physician Decision|0|||
160899982|NCT01816074|581028584|FG003|Phase 2|Physician Decision|1|||
160899983|NCT01816074|581028581|FG000|Phase 2|Withdrawal by Subject|1|||
160899984|NCT01816074|581028582|FG001|Phase 2|Withdrawal by Subject|0|||
160811549|NCT05396014|580694533|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811550|NCT05396014|580694534|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811551|NCT05396014|580694535|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160899985|NCT01816074|581028583|FG002|Phase 2|Withdrawal by Subject|0|||
160899986|NCT01816074|581028584|FG003|Phase 2|Withdrawal by Subject|0|||
160899987|NCT03355365|581028585|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
160899988|NCT03355365|581028586|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
160811552|NCT05396014|580694536|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
160811553|NCT05396014|580694537|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160551828|NCT00132730|579746837|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
160551829|NCT00132730|579746838|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
160551830|NCT00132730|579746839|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
160551831|NCT00132730|579746840|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
160551832|NCT00132730|579746841|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
160811554|NCT05396014|580694538|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811555|NCT05396014|580694539|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811556|NCT05396014|580694540|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811557|NCT05396014|580694541|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811558|NCT05396014|580694542|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811559|NCT05396014|580694543|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811560|NCT05396014|580694544|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811561|NCT05396014|580694545|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811562|NCT05396014|580694546|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811563|NCT05396014|580694547|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811564|NCT05396014|580694548|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811565|NCT05396014|580694549|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811566|NCT05396014|580694550|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811567|NCT05396014|580694551|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811568|NCT05396014|580694552|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811569|NCT04439539|580694553|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
160811570|NCT04439539|580694554|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
160811571|NCT04439539|580694555|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
160811572|NCT04439539|580694553|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
160811573|NCT04439539|580694554|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
160811574|NCT04439539|580694555|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
160811575|NCT04439539|580694553|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
160811576|NCT04439539|580694554|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
160811577|NCT04439539|580694555|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
160811578|NCT05258890|580694557|FG000|Overall Study|Patient withdrawal|6|||
160811579|NCT05258890|580694558|FG001|Overall Study|Patient withdrawal|7|||
160811580|NCT05258890|580694557|FG000|Overall Study|Patient lost to follow-up|10|||
160811581|NCT05258890|580694558|FG001|Overall Study|Patient lost to follow-up|3|||
160811582|NCT05258890|580694557|FG000|Overall Study|Social network member withdrawal|1|||
160811583|NCT05258890|580694558|FG001|Overall Study|Social network member withdrawal|0|||
160811584|NCT05258890|580694557|FG000|Overall Study|Social network member lost to follow-up|5|||
160811585|NCT05258890|580694558|FG001|Overall Study|Social network member lost to follow-up|0|||
160811586|NCT02013778|580694563|FG000|Overall Study|Death|4|||
160811587|NCT02013778|580694563|FG000|Overall Study|Withdrawal by Subject|1|||
160811588|NCT02013778|580694563|FG000|Overall Study|Physician Decision|1|||
160811589|NCT02013778|580694563|FG000|Overall Study|Adverse Event|1|||
160811590|NCT02719691|580694564|FG000|Overall Study|Physician Decision|0|||
160811591|NCT02719691|580694565|FG001|Overall Study|Physician Decision|0|||
160811592|NCT02719691|580694566|FG002|Overall Study|Physician Decision|1|||
160811593|NCT02719691|580694567|FG003|Overall Study|Physician Decision|0|||
160811594|NCT02719691|580694568|FG004|Overall Study|Physician Decision|0|||
160811595|NCT02719691|580694569|FG005|Overall Study|Physician Decision|0|||
160811596|NCT02719691|580694570|FG006|Overall Study|Physician Decision|0|||
160811597|NCT02719691|580694564|FG000|Overall Study|Withdrawal by Subject|0|||
160811598|NCT02719691|580694565|FG001|Overall Study|Withdrawal by Subject|0|||
160811599|NCT02719691|580694566|FG002|Overall Study|Withdrawal by Subject|0|||
160811600|NCT02719691|580694567|FG003|Overall Study|Withdrawal by Subject|0|||
160811601|NCT02719691|580694568|FG004|Overall Study|Withdrawal by Subject|0|||
160811602|NCT02719691|580694569|FG005|Overall Study|Withdrawal by Subject|1|||
160811603|NCT02719691|580694570|FG006|Overall Study|Withdrawal by Subject|0|||
160811604|NCT00861757|580694573|FG000|Overall Study|Adverse Event|1|||
160899989|NCT03355365|581028585|FG000|Year 1, First Intervention|Protocol Violation|1|||
160899990|NCT03355365|581028586|FG001|Year 1, First Intervention|Protocol Violation|0|||
160899991|NCT03355365|581028585|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
160899992|NCT03355365|581028586|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
160899993|NCT03355365|581028585|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
160899994|NCT03355365|581028586|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
160899995|NCT03355365|581028585|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
160551833|NCT00132730|579746842|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
160551834|NCT00132730|579746837|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
160551835|NCT00132730|579746838|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
160551836|NCT00132730|579746839|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
160811605|NCT00861757|580694574|FG001|Overall Study|Adverse Event|5|||
160811606|NCT00861757|580694575|FG002|Overall Study|Adverse Event|7|||
160811607|NCT00861757|580694576|FG003|Overall Study|Adverse Event|2|||
160811608|NCT00861757|580694573|FG000|Overall Study|Entry Criteria Not Met|1|||
160811609|NCT00861757|580694574|FG001|Overall Study|Entry Criteria Not Met|2|||
160811610|NCT00861757|580694575|FG002|Overall Study|Entry Criteria Not Met|1|||
160811611|NCT00861757|580694576|FG003|Overall Study|Entry Criteria Not Met|1|||
160986755|NCT04955626|581341111|FG006|Blinded Period|Death|0|||
160551837|NCT00132730|579746840|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
160551838|NCT00132730|579746841|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
160551839|NCT00132730|579746842|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
160551840|NCT00094757|579746843|FG000|Overall Study|Adverse Event|11|||
160551841|NCT00094757|579746844|FG001|Overall Study|Adverse Event|9|||
160551842|NCT00094757|579746845|FG002|Overall Study|Adverse Event|6|||
160551843|NCT00094757|579746843|FG000|Overall Study|Lack of Efficacy|11|||
160551844|NCT00094757|579746844|FG001|Overall Study|Lack of Efficacy|15|||
160551845|NCT00094757|579746845|FG002|Overall Study|Lack of Efficacy|8|||
160551846|NCT00094757|579746843|FG000|Overall Study|Lost to Follow-up|3|||
160986756|NCT04955626|581341112|FG007|Blinded Period|Death|2|||
160986757|NCT04955626|581341113|FG008|Blinded Period|Death|1|||
160986758|NCT04955626|581341114|FG009|Blinded Period|Death|1|||
160986759|NCT04955626|581341115|FG010|Blinded Period|Death|0|||
160986760|NCT04955626|581341116|FG011|Blinded Period|Death|2|||
160986761|NCT04955626|581341117|FG012|Blinded Period|Death|0|||
160986762|NCT04955626|581341118|FG013|Blinded Period|Death|0|||
160986763|NCT04955626|581341119|FG014|Blinded Period|Death|0|||
160986764|NCT04955626|581341120|FG015|Blinded Period|Death|0|||
160986765|NCT04955626|581341121|FG016|Blinded Period|Death|0|||
160986766|NCT04955626|581341122|FG017|Blinded Period|Death|0|||
160986767|NCT04955626|581341123|FG018|Blinded Period|Death|0|||
160986768|NCT04955626|581341124|FG019|Blinded Period|Death|0|||
160986769|NCT04955626|581341125|FG020|Blinded Period|Death|0|||
160986770|NCT04955626|581341126|FG021|Blinded Period|Death|0|||
160811612|NCT00861757|580694573|FG000|Overall Study|Lack of Efficacy|3|||
160811613|NCT00861757|580694574|FG001|Overall Study|Lack of Efficacy|1|||
160811614|NCT00861757|580694575|FG002|Overall Study|Lack of Efficacy|0|||
160811615|NCT00861757|580694576|FG003|Overall Study|Lack of Efficacy|1|||
160811616|NCT00861757|580694573|FG000|Overall Study|Lost to Follow-up|1|||
160811617|NCT00861757|580694574|FG001|Overall Study|Lost to Follow-up|0|||
160811618|NCT00861757|580694575|FG002|Overall Study|Lost to Follow-up|1|||
160811619|NCT00861757|580694576|FG003|Overall Study|Lost to Follow-up|1|||
160811620|NCT00861757|580694573|FG000|Overall Study|Physician Decision|0|||
160811621|NCT00861757|580694574|FG001|Overall Study|Physician Decision|0|||
160811622|NCT00861757|580694575|FG002|Overall Study|Physician Decision|0|||
160811623|NCT00861757|580694576|FG003|Overall Study|Physician Decision|1|||
160811624|NCT00861757|580694573|FG000|Overall Study|Protocol Violation|2|||
160811625|NCT00861757|580694574|FG001|Overall Study|Protocol Violation|2|||
160811626|NCT00861757|580694575|FG002|Overall Study|Protocol Violation|4|||
160811627|NCT00861757|580694576|FG003|Overall Study|Protocol Violation|1|||
160811628|NCT00861757|580694573|FG000|Overall Study|Withdrawal by Subject|1|||
160811629|NCT00861757|580694574|FG001|Overall Study|Withdrawal by Subject|5|||
160811630|NCT00861757|580694575|FG002|Overall Study|Withdrawal by Subject|5|||
160811631|NCT00861757|580694576|FG003|Overall Study|Withdrawal by Subject|2|||
160811632|NCT03037476|580694579|FG000|Overall Study|Lost to Follow-up|63|||
160811633|NCT03037476|580694580|FG001|Overall Study|Lost to Follow-up|46|||
160986771|NCT04955626|581341127|FG022|Blinded Period|Death|0|||
160986772|NCT04955626|581341128|FG023|Blinded Period|Death|1|||
160986773|NCT04955626|581341129|FG024|Blinded Period|Death|0|||
160551847|NCT00094757|579746844|FG001|Overall Study|Lost to Follow-up|5|||
160551848|NCT00094757|579746845|FG002|Overall Study|Lost to Follow-up|6|||
160811634|NCT02403817|580694581|FG000|Overall Study|Withdrawal by Subject|5|||
160811635|NCT02403817|580694582|FG001|Overall Study|Withdrawal by Subject|0|||
160811636|NCT04908384|580694586|FG000|Overall Study|Lost to Follow-up|4|||
160811637|NCT04908384|580694587|FG001|Overall Study|Lost to Follow-up|4|||
160986774|NCT04955626|581341130|FG025|Blinded Period|Death|0|||
160551849|NCT00094757|579746843|FG000|Overall Study|Patient Moved|2|||
160811638|NCT04908384|580694588|FG002|Overall Study|Lost to Follow-up|0|||
160986775|NCT04955626|581341131|FG026|Blinded Period|Death|1|||
160986776|NCT04955626|581341132|FG027|Blinded Period|Death|1|||
160986777|NCT04955626|581341133|FG028|Blinded Period|Death|0|||
160986778|NCT04955626|581341134|FG029|Blinded Period|Death|1|||
160986779|NCT04955626|581341135|FG030|Blinded Period|Death|0|||
160551850|NCT00094757|579746844|FG001|Overall Study|Patient Moved|1|||
160551851|NCT00094757|579746845|FG002|Overall Study|Patient Moved|1|||
160551852|NCT00094757|579746843|FG000|Overall Study|Protocol Violation|8|||
160551853|NCT00094757|579746844|FG001|Overall Study|Protocol Violation|5|||
160811639|NCT04908384|580694589|FG003|Overall Study|Lost to Follow-up|0|||
160811640|NCT00833469|580694590|FG000|Overall Study|Withdrawal by Subject|1|||
160986780|NCT04955626|581341136|FG031|Blinded Period|Death|0|||
160986781|NCT04955626|581341137|FG032|Blinded Period|Death|0|||
160986782|NCT04955626|581341138|FG033|Blinded Period|Death|0|||
160986783|NCT04955626|581341139|FG034|Blinded Period|Death|0|||
160811641|NCT00833469|580694590|FG000|Overall Study|Lost to Follow-up|1|||
160811642|NCT01208324|580694591|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
160811643|NCT01208324|580694592|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
160811644|NCT01208324|580694593|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
160811645|NCT01208324|580694594|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
160811646|NCT00984165|580694595|FG000|Overall Study|Death on study|2|||
160811647|NCT00984165|580694596|FG001|Overall Study|Death on study|0|||
160811648|NCT00984165|580694597|FG002|Overall Study|Death on study|0|||
160811649|NCT00984165|580694598|FG003|Overall Study|Death on study|0|||
160811650|NCT00984165|580694595|FG000|Overall Study|Disease progression on study|5|||
160811651|NCT00984165|580694596|FG001|Overall Study|Disease progression on study|1|||
160811652|NCT00984165|580694597|FG002|Overall Study|Disease progression on study|0|||
160811653|NCT00984165|580694598|FG003|Overall Study|Disease progression on study|0|||
160811654|NCT00984165|580694595|FG000|Overall Study|Death of recipient|0|||
160811655|NCT00984165|580694596|FG001|Overall Study|Death of recipient|0|||
160811656|NCT00984165|580694597|FG002|Overall Study|Death of recipient|0|||
160811657|NCT00984165|580694598|FG003|Overall Study|Death of recipient|1|||
160811658|NCT00984165|580694595|FG000|Overall Study|New protocol|0|||
160811659|NCT00984165|580694596|FG001|Overall Study|New protocol|0|||
160811660|NCT00984165|580694597|FG002|Overall Study|New protocol|0|||
160811661|NCT00984165|580694598|FG003|Overall Study|New protocol|1|||
160811662|NCT00984165|580694595|FG000|Overall Study|P+/donor pair removed from protocol|0|||
160811663|NCT00984165|580694596|FG001|Overall Study|P+/donor pair removed from protocol|0|||
160811664|NCT00984165|580694597|FG002|Overall Study|P+/donor pair removed from protocol|0|||
160811665|NCT00984165|580694598|FG003|Overall Study|P+/donor pair removed from protocol|1|||
160811666|NCT00984165|580694595|FG000|Overall Study|removed with a pair recipient|0|||
160811667|NCT00984165|580694596|FG001|Overall Study|removed with a pair recipient|0|||
160811668|NCT00984165|580694597|FG002|Overall Study|removed with a pair recipient|0|||
160811669|NCT00984165|580694598|FG003|Overall Study|removed with a pair recipient|1|||
160811670|NCT00700622|580694599|FG000|Overall Study|Adverse Event|4|||
160811671|NCT00700622|580694600|FG001|Overall Study|Adverse Event|0|||
160811672|NCT00700622|580694599|FG000|Overall Study|Lost to Follow-up|0|||
160811673|NCT00700622|580694600|FG001|Overall Study|Lost to Follow-up|1|||
160811674|NCT00700622|580694599|FG000|Overall Study|Physician Decision|2|||
160811675|NCT00700622|580694600|FG001|Overall Study|Physician Decision|1|||
160811676|NCT00700622|580694599|FG000|Overall Study|Protocol Violation|0|||
160811677|NCT00700622|580694600|FG001|Overall Study|Protocol Violation|1|||
160811678|NCT00700622|580694599|FG000|Overall Study|Withdrawal by Subject|4|||
160811679|NCT00700622|580694600|FG001|Overall Study|Withdrawal by Subject|1|||
160811680|NCT00700622|580694599|FG000|Overall Study|Other|3|||
160811681|NCT00700622|580694600|FG001|Overall Study|Other|1|||
160811682|NCT01309997|580694601|FG000|Overall Study|Adverse Event|1|||
160811683|NCT01309997|580694602|FG001|Overall Study|Adverse Event|0|||
160811684|NCT01309997|580694601|FG000|Overall Study|Death|1|||
160811685|NCT01309997|580694602|FG001|Overall Study|Death|3|||
160811686|NCT01309997|580694601|FG000|Overall Study|Lack of Efficacy|2|||
160811687|NCT01309997|580694602|FG001|Overall Study|Lack of Efficacy|2|||
160811688|NCT01309997|580694601|FG000|Overall Study|Withdrawal by Subject|1|||
160899996|NCT03355365|581028586|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
160551854|NCT00094757|579746845|FG002|Overall Study|Protocol Violation|3|||
160551855|NCT00094757|579746843|FG000|Overall Study|Withdrawal by Subject|14|||
160551856|NCT00094757|579746844|FG001|Overall Study|Withdrawal by Subject|21|||
160551857|NCT00094757|579746845|FG002|Overall Study|Withdrawal by Subject|5|||
160551858|NCT00094757|579746843|FG000|Overall Study|Other|3|||
160551859|NCT00094757|579746844|FG001|Overall Study|Other|3|||
160811689|NCT01309997|580694602|FG001|Overall Study|Withdrawal by Subject|1|||
160811690|NCT04474197|580694603|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
160811691|NCT04474197|580694604|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
160811692|NCT04474197|580694605|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
160811693|NCT04474197|580694606|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
160811694|NCT01532921|580694607|FG000|Overall Study|Death|3|||
160811695|NCT01532921|580694607|FG000|Overall Study|Withdrawal by Subject|2|||
160811696|NCT01532921|580694607|FG000|Overall Study|Lost to Follow-up|3|||
160811697|NCT01532921|580694607|FG000|Overall Study|Physician Decision|7|||
160899997|NCT03355365|581028585|FG000|Year 2, Crossover Intervention|severe COVID|0|||
160811698|NCT01532921|580694607|FG000|Overall Study|Device was explanted during procedure|1|||
160811699|NCT01390298|580694608|FG000|Overall Study|Death|1|||
160811700|NCT01390298|580694608|FG000|Overall Study|long term ICU admission|1|||
160811701|NCT01390298|580694608|FG000|Overall Study|Withdrawal by Subject|14|||
160811702|NCT01390298|580694608|FG000|Overall Study|Lost to Follow-up|7|||
160811703|NCT01390298|580694608|FG000|Overall Study|Surgery cancelled|1|||
160811704|NCT00066222|580694617|FG000|Overall Study|No protocol treatment received|1|||
160811705|NCT00635349|580694618|FG000|Overall Study|Other|8|||
160811706|NCT00635349|580694619|FG001|Overall Study|Other|6|||
160811707|NCT00635349|580694618|FG000|Overall Study|Protocol Violation|18|||
160811708|NCT00635349|580694619|FG001|Overall Study|Protocol Violation|22|||
160811709|NCT00635349|580694618|FG000|Overall Study|Withdrawal by Subject|3|||
160811710|NCT00635349|580694619|FG001|Overall Study|Withdrawal by Subject|8|||
160811711|NCT00635349|580694618|FG000|Overall Study|Lost to Follow-up|4|||
160811712|NCT00635349|580694619|FG001|Overall Study|Lost to Follow-up|3|||
160811713|NCT00635349|580694618|FG000|Overall Study|Adverse Event|11|||
160811714|NCT00635349|580694619|FG001|Overall Study|Adverse Event|9|||
160811715|NCT05420961|580694630|FG000|Overall Study|Withdrawal by Subject|2|||
160811716|NCT05420961|580694631|FG001|Overall Study|Withdrawal by Subject|1|||
160811717|NCT05420961|580694632|FG002|Overall Study|Withdrawal by Subject|1|||
160811718|NCT05420961|580694633|FG003|Overall Study|Withdrawal by Subject|0|||
160811719|NCT05420961|580694634|FG004|Overall Study|Withdrawal by Subject|0|||
160811720|NCT05420961|580694630|FG000|Overall Study|Lost to Follow-up|0|||
160811721|NCT05420961|580694631|FG001|Overall Study|Lost to Follow-up|0|||
160811722|NCT05420961|580694632|FG002|Overall Study|Lost to Follow-up|1|||
160811723|NCT05420961|580694633|FG003|Overall Study|Lost to Follow-up|0|||
160811724|NCT05420961|580694634|FG004|Overall Study|Lost to Follow-up|0|||
160811725|NCT05420961|580694630|FG000|Overall Study|Randomized by mistake without study treatment|0|||
160811726|NCT05420961|580694631|FG001|Overall Study|Randomized by mistake without study treatment|0|||
160811727|NCT05420961|580694632|FG002|Overall Study|Randomized by mistake without study treatment|1|||
160811728|NCT05420961|580694633|FG003|Overall Study|Randomized by mistake without study treatment|0|||
160811729|NCT05420961|580694634|FG004|Overall Study|Randomized by mistake without study treatment|1|||
160811730|NCT04283656|580694635|FG000|Overall Study|Adverse Event|1|||
160811731|NCT04283656|580694636|FG001|Overall Study|Adverse Event|0|||
160811732|NCT04283656|580694635|FG000|Overall Study|Lost to Follow-up|0|||
160811733|NCT04283656|580694636|FG001|Overall Study|Lost to Follow-up|1|||
160811734|NCT00803361|580694637|FG000|Overall Study|Adverse Event|13|||
160811735|NCT00803361|580694638|FG001|Overall Study|Adverse Event|3|||
160811736|NCT00803361|580694637|FG000|Overall Study|Lack of Efficacy|4|||
160811737|NCT00803361|580694638|FG001|Overall Study|Lack of Efficacy|13|||
160811738|NCT00803361|580694637|FG000|Overall Study|Lost to Follow-up|1|||
160811739|NCT00803361|580694638|FG001|Overall Study|Lost to Follow-up|2|||
160811740|NCT00803361|580694637|FG000|Overall Study|Physician Decision|1|||
160811741|NCT00803361|580694638|FG001|Overall Study|Physician Decision|0|||
160811742|NCT00803361|580694637|FG000|Overall Study|Protocol Violation|2|||
160811743|NCT00803361|580694638|FG001|Overall Study|Protocol Violation|4|||
160811744|NCT00803361|580694637|FG000|Overall Study|Withdrawal by Subject|5|||
160811745|NCT00803361|580694638|FG001|Overall Study|Withdrawal by Subject|6|||
160811746|NCT04445519|580694639|FG000|Overall Study|Due to adaptive design|3|||
160811747|NCT04445519|580694640|FG001|Overall Study|Due to adaptive design|0|||
160811748|NCT04445519|580694641|FG002|Overall Study|Due to adaptive design|0|||
160811749|NCT04445519|580694639|FG000|Overall Study|Lost to Follow-up|0|||
160811750|NCT04445519|580694640|FG001|Overall Study|Lost to Follow-up|1|||
160811751|NCT04445519|580694641|FG002|Overall Study|Lost to Follow-up|4|||
160811752|NCT04445519|580694639|FG000|Overall Study|Sponsor or IRB Decision|0|||
160811753|NCT04445519|580694640|FG001|Overall Study|Sponsor or IRB Decision|1|||
160811754|NCT04445519|580694641|FG002|Overall Study|Sponsor or IRB Decision|2|||
160811755|NCT04445519|580694639|FG000|Overall Study|Withdrawal by Subject|0|||
160811756|NCT04445519|580694640|FG001|Overall Study|Withdrawal by Subject|3|||
160811757|NCT04445519|580694641|FG002|Overall Study|Withdrawal by Subject|3|||
160811758|NCT04445519|580694639|FG000|Overall Study|Adverse Event|0|||
160811759|NCT04445519|580694640|FG001|Overall Study|Adverse Event|8|||
160811760|NCT04445519|580694641|FG002|Overall Study|Adverse Event|6|||
160811761|NCT04445519|580694639|FG000|Overall Study|Other Reason|0|||
160811762|NCT04445519|580694640|FG001|Overall Study|Other Reason|1|||
160811763|NCT04445519|580694641|FG002|Overall Study|Other Reason|1|||
160811764|NCT04445519|580694639|FG000|Overall Study|Protocol Violation|0|||
160811765|NCT04445519|580694640|FG001|Overall Study|Protocol Violation|0|||
160899998|NCT03355365|581028586|FG001|Year 2, Crossover Intervention|severe COVID|1|||
160811766|NCT04445519|580694641|FG002|Overall Study|Protocol Violation|1|||
160811767|NCT04482439|580694646|FG000|Overall Study|Lost to Follow-up|1|||
160811768|NCT04482439|580694646|FG000|Overall Study|Unrelated illness|1|||
160811769|NCT03072043|580694647|FG000|Overall Study|Death|0|||
160811770|NCT03072043|580694648|FG001|Overall Study|Death|0|||
160811771|NCT03072043|580694649|FG002|Overall Study|Death|3|||
160811772|NCT03072043|580694647|FG000|Overall Study|Adverse Event|0|||
160811773|NCT03072043|580694648|FG001|Overall Study|Adverse Event|0|||
160811774|NCT03072043|580694649|FG002|Overall Study|Adverse Event|2|||
160811775|NCT03072043|580694647|FG000|Overall Study|Withdrawal by Subject|0|||
160811776|NCT03072043|580694648|FG001|Overall Study|Withdrawal by Subject|0|||
160811777|NCT03072043|580694649|FG002|Overall Study|Withdrawal by Subject|4|||
160811778|NCT00645840|580694650|FG000|Overall Study|Protocol Violation|3|||
160811779|NCT02625220|580694651|FG000|Overall Study|Adverse Event|2|||
160811780|NCT02625220|580694651|FG000|Overall Study|Lost to Follow-up|2|||
160811781|NCT02625220|580694651|FG000|Overall Study|Protocol Violation|1|||
160811782|NCT02625220|580694651|FG000|Overall Study|Study discontinued at site|2|||
160811783|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
160811784|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
160811785|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
160811786|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
160811787|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
160811788|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
160811789|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
160811790|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
160811791|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
160811792|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
160811793|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
160811794|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
160811795|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
160811796|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
160811797|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
160811798|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
160811799|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
160811800|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
160811801|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
160811802|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
160811803|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
160811804|NCT03162796|580694654|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
160811805|NCT03162796|580694655|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
160811806|NCT03162796|580694656|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
160811807|NCT03162796|580694654|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
160811808|NCT03162796|580694655|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
160811809|NCT03162796|580694656|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
160811810|NCT03162796|580694654|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
160811811|NCT03162796|580694655|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
160811812|NCT03162796|580694656|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
160811813|NCT03162796|580694654|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
160811814|NCT03162796|580694655|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
160811815|NCT03162796|580694656|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
160811816|NCT02342288|580694657|FG000|Overall Study|no protocol anesthesiologist available|3|||
160811817|NCT02342288|580694658|FG001|Overall Study|no protocol anesthesiologist available|2|||
160811818|NCT02342288|580694657|FG000|Overall Study|anesthesia leak in system|1|||
160811819|NCT02342288|580694658|FG001|Overall Study|anesthesia leak in system|0|||
160811820|NCT02342288|580694657|FG000|Overall Study|Withdrawal by Subject|1|||
160811821|NCT02342288|580694658|FG001|Overall Study|Withdrawal by Subject|0|||
160811822|NCT02342288|580694657|FG000|Overall Study|coordinator contaminated with blood|0|||
160811823|NCT02342288|580694658|FG001|Overall Study|coordinator contaminated with blood|1|||
160811824|NCT02342288|580694657|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
160811825|NCT02342288|580694658|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
160811826|NCT02342288|580694657|FG000|Overall Study|coordinator not available|0|||
160811827|NCT02342288|580694658|FG001|Overall Study|coordinator not available|2|||
160811828|NCT02375373|580694660|FG000|Overall Study|Withdrawal by Subject|11|||
160811829|NCT02725476|580694661|FG000|Overall Study|Physician Decision|2|||
160811830|NCT02725476|580694662|FG001|Overall Study|Physician Decision|0|||
160811831|NCT02725476|580694661|FG000|Overall Study|Adverse Event|1|||
160811832|NCT02725476|580694662|FG001|Overall Study|Adverse Event|1|||
160811833|NCT00289289|580694664|FG000|Overall Study|Withdrawal by Subject|5|||
160811834|NCT00289289|580694665|FG001|Overall Study|Withdrawal by Subject|3|||
160811835|NCT00289289|580694666|FG002|Overall Study|Withdrawal by Subject|15|||
160986784|NCT04955626|581341140|FG035|Blinded Period|Death|0|||
160986785|NCT04955626|581341105|FG000|Blinded Period|Adverse Event|0|||
160986786|NCT04955626|581341106|FG001|Blinded Period|Adverse Event|1|||
160811836|NCT00289289|580694664|FG000|Overall Study|Lost to Follow-up|1|||
160811837|NCT00289289|580694665|FG001|Overall Study|Lost to Follow-up|0|||
160811838|NCT00289289|580694666|FG002|Overall Study|Lost to Follow-up|1|||
160811839|NCT00289289|580694664|FG000|Overall Study|Death|4|||
160986787|NCT04955626|581341107|FG002|Blinded Period|Adverse Event|1|||
160811840|NCT00289289|580694665|FG001|Overall Study|Death|2|||
160811841|NCT00289289|580694666|FG002|Overall Study|Death|5|||
160811842|NCT00289289|580694664|FG000|Overall Study|No implant attempted|0|||
160811843|NCT00289289|580694665|FG001|Overall Study|No implant attempted|0|||
160811844|NCT00289289|580694666|FG002|Overall Study|No implant attempted|1|||
160811845|NCT00289289|580694664|FG000|Overall Study|Physician Decision|1|||
160811846|NCT00289289|580694665|FG001|Overall Study|Physician Decision|0|||
160811847|NCT00289289|580694666|FG002|Overall Study|Physician Decision|6|||
160986788|NCT04955626|581341108|FG003|Blinded Period|Adverse Event|1|||
160986789|NCT04955626|581341109|FG004|Blinded Period|Adverse Event|0|||
160986790|NCT04955626|581341110|FG005|Blinded Period|Adverse Event|0|||
160986791|NCT04955626|581341111|FG006|Blinded Period|Adverse Event|0|||
160986792|NCT04955626|581341112|FG007|Blinded Period|Adverse Event|0|||
160986793|NCT04955626|581341113|FG008|Blinded Period|Adverse Event|0|||
160986794|NCT04955626|581341114|FG009|Blinded Period|Adverse Event|1|||
160986795|NCT04955626|581341115|FG010|Blinded Period|Adverse Event|1|||
160986796|NCT04955626|581341116|FG011|Blinded Period|Adverse Event|0|||
160986797|NCT04955626|581341117|FG012|Blinded Period|Adverse Event|0|||
160986798|NCT04955626|581341118|FG013|Blinded Period|Adverse Event|0|||
160986799|NCT04955626|581341119|FG014|Blinded Period|Adverse Event|0|||
160986800|NCT04955626|581341120|FG015|Blinded Period|Adverse Event|0|||
160986801|NCT04955626|581341121|FG016|Blinded Period|Adverse Event|0|||
160986802|NCT04955626|581341122|FG017|Blinded Period|Adverse Event|0|||
160986803|NCT04955626|581341123|FG018|Blinded Period|Adverse Event|1|||
160986804|NCT04955626|581341124|FG019|Blinded Period|Adverse Event|0|||
160986805|NCT04955626|581341125|FG020|Blinded Period|Adverse Event|0|||
160986806|NCT04955626|581341126|FG021|Blinded Period|Adverse Event|0|||
160986807|NCT04955626|581341127|FG022|Blinded Period|Adverse Event|0|||
160986808|NCT04955626|581341128|FG023|Blinded Period|Adverse Event|0|||
160986809|NCT04955626|581341129|FG024|Blinded Period|Adverse Event|0|||
160986810|NCT04955626|581341130|FG025|Blinded Period|Adverse Event|0|||
160986811|NCT04955626|581341131|FG026|Blinded Period|Adverse Event|1|||
160986812|NCT04955626|581341132|FG027|Blinded Period|Adverse Event|0|||
160986813|NCT04955626|581341133|FG028|Blinded Period|Adverse Event|0|||
160986814|NCT04955626|581341134|FG029|Blinded Period|Adverse Event|0|||
160986815|NCT04955626|581341135|FG030|Blinded Period|Adverse Event|0|||
160986816|NCT04955626|581341136|FG031|Blinded Period|Adverse Event|0|||
160986817|NCT04955626|581341137|FG032|Blinded Period|Adverse Event|0|||
160551860|NCT00094757|579746845|FG002|Overall Study|Other|1|||
160551861|NCT00094757|579746843|FG000|Overall Study|Protocol specified discontinuation|1|||
160551862|NCT00094757|579746844|FG001|Overall Study|Protocol specified discontinuation|3|||
160551863|NCT00094757|579746845|FG002|Overall Study|Protocol specified discontinuation|0|||
160551864|NCT00090545|579746849|FG000|Overall Study|Disease progression on study|21|||
160551865|NCT00090545|579746850|FG001|Overall Study|Disease progression on study|17|||
160551866|NCT00090545|579746849|FG000|Overall Study|Refused further treatment|1|||
160551867|NCT00090545|579746850|FG001|Overall Study|Refused further treatment|4|||
160551868|NCT00090545|579746849|FG000|Overall Study|Death|0|||
160551869|NCT00090545|579746850|FG001|Overall Study|Death|1|||
160551870|NCT00090545|579746849|FG000|Overall Study|Adverse Event|0|||
160551871|NCT00090545|579746850|FG001|Overall Study|Adverse Event|2|||
160551872|NCT01463098|579746854|FG000|Part A (11 Days)|Participant Choice|2|||
160551873|NCT01463098|579746855|FG001|Part A (11 Days)|Participant Choice|0|||
160551874|NCT01463098|579746856|FG002|Part A (11 Days)|Participant Choice|0|||
160551875|NCT01463098|579746857|FG003|Part A (11 Days)|Participant Choice|0|||
160551876|NCT01463098|579746858|FG004|Part A (11 Days)|Participant Choice|0|||
160551877|NCT01463098|579746859|FG005|Part A (11 Days)|Participant Choice|0|||
160551878|NCT01463098|579746860|FG006|Part A (11 Days)|Participant Choice|0|||
160551879|NCT01463098|579746861|FG007|Part A (11 Days)|Participant Choice|0|||
160551880|NCT01463098|579746862|FG008|Part A (11 Days)|Participant Choice|1|||
160551881|NCT01463098|579746863|FG009|Part A (11 Days)|Participant Choice|0|||
160811848|NCT00289289|580694664|FG000|Overall Study|Non-study device implanted|2|||
160811849|NCT00289289|580694665|FG001|Overall Study|Non-study device implanted|1|||
160811850|NCT00289289|580694666|FG002|Overall Study|Non-study device implanted|3|||
160811851|NCT00289289|580694664|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
160986818|NCT04955626|581341138|FG033|Blinded Period|Adverse Event|0|||
160986819|NCT04955626|581341139|FG034|Blinded Period|Adverse Event|0|||
160986820|NCT04955626|581341140|FG035|Blinded Period|Adverse Event|0|||
160986821|NCT04955626|581341105|FG000|Blinded Period|No longer meets eligibility criteria|1|||
160551882|NCT01463098|579746864|FG010|Part A (11 Days)|Participant Choice|0|||
160551883|NCT01463098|579746865|FG011|Part A (11 Days)|Participant Choice|0|||
160551884|NCT01463098|579746866|FG012|Part A (11 Days)|Participant Choice|0|||
160551885|NCT01463098|579746867|FG013|Part A (11 Days)|Participant Choice|0|||
160811852|NCT00289289|580694665|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
160811853|NCT00289289|580694666|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
160811854|NCT00289289|580694664|FG000|Overall Study|Other Exit Reason|6|||
160986822|NCT04955626|581341106|FG001|Blinded Period|No longer meets eligibility criteria|2|||
160986823|NCT04955626|581341107|FG002|Blinded Period|No longer meets eligibility criteria|0|||
160986824|NCT04955626|581341108|FG003|Blinded Period|No longer meets eligibility criteria|1|||
160551886|NCT01463098|579746854|FG000|Part A (11 Days)|Lost to Follow-up|0|||
160551887|NCT01463098|579746855|FG001|Part A (11 Days)|Lost to Follow-up|0|||
160551888|NCT01463098|579746856|FG002|Part A (11 Days)|Lost to Follow-up|0|||
160551889|NCT01463098|579746857|FG003|Part A (11 Days)|Lost to Follow-up|0|||
160551890|NCT01463098|579746858|FG004|Part A (11 Days)|Lost to Follow-up|1|||
160811855|NCT00289289|580694665|FG001|Overall Study|Other Exit Reason|4|||
160811856|NCT00289289|580694666|FG002|Overall Study|Other Exit Reason|12|||
160811857|NCT01445613|580694667|FG000|30-day Follow-up|Withdrawal by Subject|6|||
160811858|NCT01445613|580694667|FG000|30-day Follow-up|Physician Decision|3|||
160811859|NCT01445613|580694667|FG000|30-day Follow-up|Missed visit|23|||
160811860|NCT01445613|580694667|FG000|30-day Follow-up|Death|3|||
160811861|NCT01445613|580694667|FG000|1-year Follow-up|Withdrawal by Subject|12|||
160811862|NCT01445613|580694667|FG000|1-year Follow-up|Missed visit|29|||
160811863|NCT01445613|580694667|FG000|1-year Follow-up|Lost to Follow-up|2|||
160811864|NCT01445613|580694667|FG000|1-year Follow-up|Death|30|||
160811865|NCT01445613|580694667|FG000|1-year Follow-up|Physician Decision|2|||
160811866|NCT01445613|580694667|FG000|1-year Follow-up|Received a non-study stent|2|||
160645192|NCT02247479|580084161|FG002|Overall Study|Unspecified Reason|2|||
160811867|NCT01169701|580694668|FG000|Overall Study|Lost to Follow-up|1|||
160811868|NCT01169701|580694669|FG001|Overall Study|Lost to Follow-up|1|||
160811869|NCT01169701|580694668|FG000|Overall Study|Withdrawal by Subject|1|||
160811870|NCT01169701|580694669|FG001|Overall Study|Withdrawal by Subject|3|||
160811871|NCT01169701|580694668|FG000|Overall Study|Adverse Event|1|||
160811872|NCT01169701|580694669|FG001|Overall Study|Adverse Event|2|||
160811873|NCT01169701|580694668|FG000|Overall Study|Exclusion criteria|2|||
160811874|NCT01169701|580694669|FG001|Overall Study|Exclusion criteria|0|||
160811875|NCT01169701|580694668|FG000|Overall Study|Death|0|||
160811876|NCT01169701|580694669|FG001|Overall Study|Death|1|||
160811877|NCT01169701|580694668|FG000|Overall Study|Administrative problems|0|||
160811878|NCT01169701|580694669|FG001|Overall Study|Administrative problems|1|||
160811879|NCT01169701|580694668|FG000|Overall Study|Serious adverse event|0|||
160811880|NCT01169701|580694669|FG001|Overall Study|Serious adverse event|1|||
160811881|NCT01169701|580694668|FG000|Overall Study|Sponsor decision|0|||
160811882|NCT01169701|580694669|FG001|Overall Study|Sponsor decision|1|||
160811883|NCT02455336|580694672|FG000|Overall Study|Withdrawal by Subject|0|||
160811884|NCT02455336|580694673|FG001|Overall Study|Withdrawal by Subject|2|||
160811885|NCT02455336|580694672|FG000|Overall Study|Adverse Event|3|||
160811886|NCT02455336|580694673|FG001|Overall Study|Adverse Event|0|||
160811887|NCT02455336|580694672|FG000|Overall Study|Non-responder to treatment|2|||
160811888|NCT02455336|580694673|FG001|Overall Study|Non-responder to treatment|0|||
160811889|NCT00391430|580694674|FG000|Overall Study|Withdrawal by Subject|3|||
160811890|NCT00391430|580694675|FG001|Overall Study|Withdrawal by Subject|0|||
160811891|NCT00391430|580694676|FG002|Overall Study|Withdrawal by Subject|12|||
160811892|NCT03299244|580694677|FG000|Overall Study|Withdrawal by Subject|34|||
160811893|NCT03299244|580694678|FG001|Overall Study|Withdrawal by Subject|29|||
160811894|NCT03299244|580694677|FG000|Overall Study|Decision by Sponsor|4|||
160811895|NCT03299244|580694678|FG001|Overall Study|Decision by Sponsor|5|||
160551891|NCT01463098|579746859|FG005|Part A (11 Days)|Lost to Follow-up|0|||
160551892|NCT01463098|579746860|FG006|Part A (11 Days)|Lost to Follow-up|0|||
160551893|NCT01463098|579746861|FG007|Part A (11 Days)|Lost to Follow-up|0|||
160551894|NCT01463098|579746862|FG008|Part A (11 Days)|Lost to Follow-up|0|||
160551895|NCT01463098|579746863|FG009|Part A (11 Days)|Lost to Follow-up|0|||
160551896|NCT01463098|579746864|FG010|Part A (11 Days)|Lost to Follow-up|0|||
160645193|NCT03433001|580084170|FG000|Overall Study|Lack of Efficacy|109|||
160811896|NCT03299244|580694677|FG000|Overall Study|Death|9|||
160811897|NCT03299244|580694678|FG001|Overall Study|Death|4|||
160811898|NCT00130039|580694683|FG000|Overall Study|Withdrawal by Subject|15|||
160899999|NCT03355365|581028585|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
160900000|NCT03355365|581028586|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
160900001|NCT03650556|581028596|FG000|Overall Study|Death|2|||
160900002|NCT03650556|581028596|FG000|Overall Study|Withdrawal by Subject|20|||
160900003|NCT03650556|581028596|FG000|Overall Study|Physician Decision|2|||
160900004|NCT03650556|581028596|FG000|Overall Study|Lost to Follow-up|8|||
160551897|NCT01463098|579746865|FG011|Part A (11 Days)|Lost to Follow-up|0|||
160551898|NCT01463098|579746866|FG012|Part A (11 Days)|Lost to Follow-up|0|||
160551899|NCT01463098|579746867|FG013|Part A (11 Days)|Lost to Follow-up|0|||
160551900|NCT01463098|579746854|FG000|Part B (11 Days)|Participant Choice|0|||
160811899|NCT00130039|580694684|FG001|Overall Study|Withdrawal by Subject|11|||
160811900|NCT00130039|580694683|FG000|Overall Study|Lost to Follow-up|3|||
160811901|NCT00130039|580694684|FG001|Overall Study|Lost to Follow-up|1|||
160811902|NCT00130039|580694683|FG000|Overall Study|Adverse Event|4|||
160811903|NCT00130039|580694684|FG001|Overall Study|Adverse Event|2|||
160811904|NCT00130039|580694683|FG000|Overall Study|Physician Decision|3|||
160811905|NCT00130039|580694684|FG001|Overall Study|Physician Decision|0|||
160811906|NCT00130039|580694683|FG000|Overall Study|clinical events without follow up MRI|5|||
160811907|NCT00130039|580694684|FG001|Overall Study|clinical events without follow up MRI|4|||
160900005|NCT03650556|581028596|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
160551901|NCT01463098|579746855|FG001|Part B (11 Days)|Participant Choice|0|||
160551902|NCT01463098|579746856|FG002|Part B (11 Days)|Participant Choice|0|||
160551903|NCT01463098|579746857|FG003|Part B (11 Days)|Participant Choice|0|||
160551904|NCT01463098|579746858|FG004|Part B (11 Days)|Participant Choice|0|||
160551905|NCT01463098|579746859|FG005|Part B (11 Days)|Participant Choice|0|||
160551906|NCT01463098|579746860|FG006|Part B (11 Days)|Participant Choice|0|||
160551907|NCT01463098|579746861|FG007|Part B (11 Days)|Participant Choice|0|||
160551908|NCT01463098|579746862|FG008|Part B (11 Days)|Participant Choice|0|||
160551909|NCT01463098|579746863|FG009|Part B (11 Days)|Participant Choice|0|||
160551910|NCT01463098|579746864|FG010|Part B (11 Days)|Participant Choice|0|||
160551911|NCT01463098|579746865|FG011|Part B (11 Days)|Participant Choice|1|||
160551912|NCT01463098|579746866|FG012|Part B (11 Days)|Participant Choice|0|||
160551913|NCT01463098|579746867|FG013|Part B (11 Days)|Participant Choice|0|||
160551914|NCT00395967|579746868|FG000|Treatment Period|Failed Mobilization|1|||
160811908|NCT01740687|580694685|FG000|Overall Study|Lost to Follow-up|11|||
160811909|NCT01740687|580694685|FG000|Overall Study|Withdrawal by Subject|2|||
160811910|NCT01740687|580694685|FG000|Overall Study|other reason|22|||
160811911|NCT01740687|580694685|FG000|Overall Study|treatment not received|2|||
160811912|NCT00078806|580696404|FG000|Part 1A|Adverse Event|2|||
160811913|NCT00078806|580696405|FG001|Part 1A|Adverse Event|0|||
160811914|NCT00078806|580696406|FG002|Part 1A|Adverse Event|0|||
160811915|NCT00078806|580696407|FG003|Part 1A|Adverse Event|0|||
160811916|NCT00078806|580696404|FG000|Part 1A|Lack of Efficacy|7|||
160811917|NCT00078806|580696405|FG001|Part 1A|Lack of Efficacy|0|||
160811918|NCT00078806|580696406|FG002|Part 1A|Lack of Efficacy|0|||
160811919|NCT00078806|580696407|FG003|Part 1A|Lack of Efficacy|0|||
160811920|NCT00078806|580696404|FG000|Part 1A|Other|1|||
160811921|NCT00078806|580696405|FG001|Part 1A|Other|0|||
160811922|NCT00078806|580696406|FG002|Part 1A|Other|0|||
160811923|NCT00078806|580696407|FG003|Part 1A|Other|0|||
160551915|NCT00395967|579746868|FG000|Follow-up Period|Death|1|||
160551916|NCT00395967|579746868|FG000|Follow-up Period|Lost to Follow-up|1|||
160811924|NCT00078806|580696404|FG000|Part 1B|Adverse Event|1|||
160811925|NCT00078806|580696405|FG001|Part 1B|Adverse Event|0|||
160811926|NCT00078806|580696406|FG002|Part 1B|Adverse Event|0|||
160811927|NCT00078806|580696407|FG003|Part 1B|Adverse Event|0|||
160811928|NCT00078806|580696404|FG000|Part 1B|Lack of Efficacy|7|||
160811929|NCT00078806|580696405|FG001|Part 1B|Lack of Efficacy|0|||
160811930|NCT00078806|580696406|FG002|Part 1B|Lack of Efficacy|0|||
160811931|NCT00078806|580696407|FG003|Part 1B|Lack of Efficacy|0|||
160811932|NCT00078806|580696404|FG000|Part 2|Adverse Event|0|||
160811933|NCT00078806|580696405|FG001|Part 2|Adverse Event|1|||
160811934|NCT00078806|580696406|FG002|Part 2|Adverse Event|0|||
160811935|NCT00078806|580696407|FG003|Part 2|Adverse Event|0|||
160811936|NCT00161616|580696408|FG000|Overall Study|Withdrawal by Subject|6|||
160811937|NCT00161616|580696409|FG001|Overall Study|Withdrawal by Subject|5|||
160811938|NCT00161616|580696408|FG000|Overall Study|Physician Decision|1|||
160811939|NCT00161616|580696409|FG001|Overall Study|Physician Decision|0|||
160811940|NCT00161616|580696408|FG000|Overall Study|Death|1|||
160811941|NCT00161616|580696409|FG001|Overall Study|Death|1|||
160811942|NCT00161616|580696408|FG000|Overall Study|Lost to Follow-up|17|||
160811943|NCT00161616|580696409|FG001|Overall Study|Lost to Follow-up|13|||
160811944|NCT00161616|580696408|FG000|Overall Study|Protocol deviation|1|||
160811945|NCT00161616|580696409|FG001|Overall Study|Protocol deviation|0|||
160811946|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
160551917|NCT01262976|579746869|FG000|Up to Month 2|Serious Adverse Event|0|||
160551918|NCT01262976|579746870|FG001|Up to Month 2|Serious Adverse Event|0|||
160551919|NCT01262976|579746871|FG002|Up to Month 2|Serious Adverse Event|1|||
160551920|NCT01262976|579746872|FG003|Up to Month 2|Serious Adverse Event|0|||
160551921|NCT01262976|579746873|FG004|Up to Month 2|Serious Adverse Event|0|||
160551922|NCT01262976|579746874|FG005|Up to Month 2|Serious Adverse Event|0|||
160811947|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
160811948|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
160811949|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
160811950|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
160811951|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
160551923|NCT01262976|579746869|FG000|Up to Month 2|Withdrawal by Subject|1|||
160551924|NCT01262976|579746870|FG001|Up to Month 2|Withdrawal by Subject|0|||
160551925|NCT01262976|579746871|FG002|Up to Month 2|Withdrawal by Subject|0|||
160811952|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
160811953|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
160811954|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
160811955|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
160811956|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
160811957|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
160811958|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
160551926|NCT01262976|579746872|FG003|Up to Month 2|Withdrawal by Subject|0|||
160811959|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
160811960|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
160811961|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
160811962|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
160811963|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
160811964|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
160811965|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
160811966|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
160811967|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
160811968|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
160811969|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
160811970|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
160811971|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
160811972|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
160811973|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
160811974|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
160811975|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
160811976|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
160811977|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
160811978|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
160811979|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
160811980|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
160811981|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
160811982|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
160811983|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
160811984|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
160811985|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
160811986|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
160811987|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
160811988|NCT01521923|580696416|FG000|Overall Study|AE, serious fatal|1|||
160811989|NCT01521923|580696417|FG001|Overall Study|AE, serious fatal|0|||
160811990|NCT01521923|580696418|FG002|Overall Study|AE, serious fatal|0|||
160811991|NCT01521923|580696419|FG003|Overall Study|AE, serious fatal|0|||
160811992|NCT01521923|580696416|FG000|Overall Study|SAE, non-fatal|0|||
160811993|NCT01521923|580696417|FG001|Overall Study|SAE, non-fatal|2|||
160811994|NCT01521923|580696418|FG002|Overall Study|SAE, non-fatal|2|||
160811995|NCT01521923|580696419|FG003|Overall Study|SAE, non-fatal|0|||
160811996|NCT01521923|580696416|FG000|Overall Study|AE, non-serious, non-fatal|1|||
160811997|NCT01521923|580696417|FG001|Overall Study|AE, non-serious, non-fatal|3|||
160811998|NCT01521923|580696418|FG002|Overall Study|AE, non-serious, non-fatal|6|||
160811999|NCT01521923|580696419|FG003|Overall Study|AE, non-serious, non-fatal|2|||
160812000|NCT01521923|580696416|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
160812001|NCT01521923|580696417|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
160812002|NCT01521923|580696418|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
160812003|NCT01521923|580696419|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
160812004|NCT01521923|580696416|FG000|Overall Study|Lack of Efficacy|1|||
160812005|NCT01521923|580696417|FG001|Overall Study|Lack of Efficacy|1|||
160812006|NCT01521923|580696418|FG002|Overall Study|Lack of Efficacy|0|||
160812007|NCT01521923|580696419|FG003|Overall Study|Lack of Efficacy|0|||
160812008|NCT01521923|580696416|FG000|Overall Study|Protocol Violation|0|||
160812009|NCT01521923|580696417|FG001|Overall Study|Protocol Violation|0|||
160812010|NCT01521923|580696418|FG002|Overall Study|Protocol Violation|1|||
160812011|NCT01521923|580696419|FG003|Overall Study|Protocol Violation|0|||
160812012|NCT01521923|580696416|FG000|Overall Study|Lost to Follow-up|1|||
160812013|NCT01521923|580696417|FG001|Overall Study|Lost to Follow-up|0|||
160812014|NCT01521923|580696418|FG002|Overall Study|Lost to Follow-up|2|||
160812015|NCT01521923|580696419|FG003|Overall Study|Lost to Follow-up|1|||
160812016|NCT01521923|580696416|FG000|Overall Study|Withdrawal by Subject|1|||
160900006|NCT03650556|581028596|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
160812017|NCT01521923|580696417|FG001|Overall Study|Withdrawal by Subject|1|||
160812018|NCT01521923|580696418|FG002|Overall Study|Withdrawal by Subject|1|||
160812019|NCT01521923|580696419|FG003|Overall Study|Withdrawal by Subject|2|||
160812020|NCT01521923|580696416|FG000|Overall Study|Other|2|||
160812021|NCT01521923|580696417|FG001|Overall Study|Other|1|||
160812022|NCT01521923|580696418|FG002|Overall Study|Other|3|||
160812023|NCT01521923|580696419|FG003|Overall Study|Other|6|||
160812024|NCT01521923|580696416|FG000|Overall Study|AE, captured in Period 1|0|||
160812025|NCT01521923|580696417|FG001|Overall Study|AE, captured in Period 1|1|||
160812026|NCT01521923|580696418|FG002|Overall Study|AE, captured in Period 1|0|||
160812027|NCT01521923|580696419|FG003|Overall Study|AE, captured in Period 1|1|||
160812028|NCT02141633|580696420|FG000|Overall Study|Physician Decision|1|||
160551927|NCT01262976|579746873|FG004|Up to Month 2|Withdrawal by Subject|0|||
160812029|NCT02141633|580696421|FG001|Overall Study|Physician Decision|0|||
160812030|NCT02943070|580696424|FG000|Overall Study|Physician Decision|1|||
160812031|NCT02943070|580696424|FG000|Overall Study|Adverse Event|2|||
160812032|NCT02943070|580696424|FG000|Overall Study|Death|2|||
160812033|NCT02943070|580696424|FG000|Overall Study|Withdrawal by Subject|3|||
160812034|NCT02943070|580696424|FG000|Overall Study|Lost to Follow-up|4|||
160812035|NCT02943070|580696424|FG000|Overall Study|Retreatment or TURP|13|||
160812036|NCT02943070|580696424|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
160812037|NCT01701362|580696425|FG000|Overall Study|Adverse events not related to study drug|1|||
160551928|NCT01262976|579746874|FG005|Up to Month 2|Withdrawal by Subject|0|||
160551929|NCT01262976|579746869|FG000|Up to Month 2|Migrated/moved from study area|0|||
160645194|NCT03433001|580084170|FG000|Overall Study|Adverse Event|69|||
160645195|NCT03433001|580084170|FG000|Overall Study|Withdrawal by Subject|10|||
160645196|NCT03433001|580084170|FG000|Overall Study|Death|12|||
160645197|NCT03433001|580084170|FG000|Overall Study|Lost to Follow-up|4|||
160645198|NCT03433001|580084170|FG000|Overall Study|Other|25|||
160645199|NCT01007916|580084174|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
160645200|NCT01007916|580084175|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
160645201|NCT01007916|580084174|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
160645202|NCT01007916|580084175|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
160645203|NCT01299038|580084176|FG000|Overall Study|Withdrawal by Subject|1|||
160645204|NCT01299038|580084177|FG001|Overall Study|Withdrawal by Subject|0|||
160645205|NCT01162499|580084182|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
160645206|NCT01162499|580084183|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
160645207|NCT02884206|580084188|FG000|Valsartan Run-in Period|Death|1|||
160551930|NCT01262976|579746870|FG001|Up to Month 2|Migrated/moved from study area|1|||
160551931|NCT01262976|579746871|FG002|Up to Month 2|Migrated/moved from study area|0|||
160551932|NCT01262976|579746872|FG003|Up to Month 2|Migrated/moved from study area|0|||
160551933|NCT01262976|579746873|FG004|Up to Month 2|Migrated/moved from study area|1|||
160551934|NCT01262976|579746874|FG005|Up to Month 2|Migrated/moved from study area|1|||
160551935|NCT01262976|579746869|FG000|Up to Month 2|Lost to Follow-up|1|||
160551936|NCT01262976|579746870|FG001|Up to Month 2|Lost to Follow-up|0|||
160551937|NCT01262976|579746871|FG002|Up to Month 2|Lost to Follow-up|0|||
160551938|NCT01262976|579746872|FG003|Up to Month 2|Lost to Follow-up|1|||
160551939|NCT01262976|579746873|FG004|Up to Month 2|Lost to Follow-up|1|||
160551940|NCT01262976|579746874|FG005|Up to Month 2|Lost to Follow-up|1|||
160551941|NCT01262976|579746869|FG000|Up to Month 2|Other|1|||
160551942|NCT01262976|579746870|FG001|Up to Month 2|Other|0|||
160551943|NCT01262976|579746871|FG002|Up to Month 2|Other|0|||
160551944|NCT01262976|579746872|FG003|Up to Month 2|Other|1|||
160551945|NCT01262976|579746873|FG004|Up to Month 2|Other|0|||
160551946|NCT01262976|579746874|FG005|Up to Month 2|Other|2|||
160645208|NCT02884206|580084189|FG001|Valsartan Run-in Period|Death|0|||
160812038|NCT01701362|580696426|FG001|Overall Study|Adverse events not related to study drug|6|||
160551947|NCT01262976|579746869|FG000|Up to Month 7|Serious Adverse Event|0|||
160551948|NCT01262976|579746870|FG001|Up to Month 7|Serious Adverse Event|0|||
160645209|NCT02884206|580084190|FG002|Valsartan Run-in Period|Death|0|||
160645210|NCT02884206|580084188|FG000|Valsartan Run-in Period|Adverse Event|31|||
160812039|NCT01701362|580696425|FG000|Overall Study|Adverse events related to study drug|12|||
160812040|NCT01701362|580696426|FG001|Overall Study|Adverse events related to study drug|10|||
160551949|NCT01262976|579746871|FG002|Up to Month 7|Serious Adverse Event|2|||
160551950|NCT01262976|579746872|FG003|Up to Month 7|Serious Adverse Event|0|||
160551951|NCT01262976|579746873|FG004|Up to Month 7|Serious Adverse Event|0|||
160645211|NCT02884206|580084189|FG001|Valsartan Run-in Period|Adverse Event|0|||
160645212|NCT02884206|580084190|FG002|Valsartan Run-in Period|Adverse Event|0|||
160812041|NCT01701362|580696425|FG000|Overall Study|Protocol Violation|5|||
160645213|NCT02884206|580084188|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
160645214|NCT02884206|580084189|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
160645215|NCT02884206|580084190|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
160645216|NCT02884206|580084188|FG000|Valsartan Run-in Period|Protocol deviation|4|||
160645217|NCT02884206|580084189|FG001|Valsartan Run-in Period|Protocol deviation|0|||
160645218|NCT02884206|580084190|FG002|Valsartan Run-in Period|Protocol deviation|0|||
160645219|NCT02884206|580084188|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
160645220|NCT02884206|580084189|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
160645221|NCT02884206|580084190|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
160645222|NCT02884206|580084188|FG000|Valsartan Run-in Period|Physician Decision|1|||
160645223|NCT02884206|580084189|FG001|Valsartan Run-in Period|Physician Decision|0|||
160645224|NCT02884206|580084190|FG002|Valsartan Run-in Period|Physician Decision|0|||
160645225|NCT02884206|580084188|FG000|LCZ696 Run-in Period|Adverse Event|38|||
160645226|NCT02884206|580084189|FG001|LCZ696 Run-in Period|Adverse Event|0|||
160645227|NCT02884206|580084190|FG002|LCZ696 Run-in Period|Adverse Event|0|||
160645228|NCT02884206|580084188|FG000|LCZ696 Run-in Period|Death|2|||
160645229|NCT02884206|580084189|FG001|LCZ696 Run-in Period|Death|0|||
160645230|NCT02884206|580084190|FG002|LCZ696 Run-in Period|Death|0|||
160645231|NCT02884206|580084188|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
160645232|NCT02884206|580084189|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
160645233|NCT02884206|580084190|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
160645234|NCT02884206|580084188|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
160645235|NCT02884206|580084189|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
160645236|NCT02884206|580084190|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
160645237|NCT02884206|580084188|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
160645238|NCT02884206|580084189|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
160645239|NCT02884206|580084190|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
160645240|NCT02884206|580084188|FG000|LCZ696 Run-in Period|Physician Decision|1|||
160645241|NCT02884206|580084189|FG001|LCZ696 Run-in Period|Physician Decision|0|||
160645242|NCT02884206|580084190|FG002|LCZ696 Run-in Period|Physician Decision|0|||
160645243|NCT02884206|580084188|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
160645244|NCT02884206|580084189|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
160645245|NCT02884206|580084190|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
160645246|NCT02884206|580084188|FG000|Double-Blind Period|Death|0|||
160645247|NCT02884206|580084189|FG001|Double-Blind Period|Death|28|||
160645248|NCT02884206|580084190|FG002|Double-Blind Period|Death|39|||
160645249|NCT02884206|580084188|FG000|Double-Blind Period|Patient/guardian decision|0|||
160645250|NCT02884206|580084189|FG001|Double-Blind Period|Patient/guardian decision|10|||
160645251|NCT02884206|580084190|FG002|Double-Blind Period|Patient/guardian decision|13|||
160645252|NCT02884206|580084188|FG000|Double-Blind Period|Lost to Follow-up|0|||
160645253|NCT02884206|580084189|FG001|Double-Blind Period|Lost to Follow-up|4|||
160645254|NCT02884206|580084190|FG002|Double-Blind Period|Lost to Follow-up|4|||
160645255|NCT02884206|580084188|FG000|Double-Blind Period|Physician Decision|0|||
160645256|NCT02884206|580084189|FG001|Double-Blind Period|Physician Decision|2|||
160645257|NCT02884206|580084190|FG002|Double-Blind Period|Physician Decision|0|||
160645258|NCT02884206|580084188|FG000|Double-Blind Period|Adverse Event|0|||
160645259|NCT02884206|580084189|FG001|Double-Blind Period|Adverse Event|0|||
160645260|NCT02884206|580084190|FG002|Double-Blind Period|Adverse Event|3|||
160645261|NCT02884206|580084188|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
160645262|NCT02884206|580084189|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
160645263|NCT02884206|580084190|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
160645264|NCT00678392|580084192|FG000|Overall Study|Adverse Event|0|||
160645265|NCT00678392|580084193|FG001|Overall Study|Adverse Event|6|||
160645266|NCT00678392|580084192|FG000|Overall Study|Death|280|||
160645267|NCT00678392|580084193|FG001|Overall Study|Death|269|||
160645268|NCT00678392|580084192|FG000|Overall Study|Lost to Follow-up|15|||
160645269|NCT00678392|580084193|FG001|Overall Study|Lost to Follow-up|13|||
160645270|NCT00678392|580084192|FG000|Overall Study|Objective Progression or Relapse|3|||
160645271|NCT00678392|580084193|FG001|Overall Study|Objective Progression or Relapse|8|||
160645272|NCT00678392|580084192|FG000|Overall Study|Sponsor's Decision|1|||
160645273|NCT00678392|580084193|FG001|Overall Study|Sponsor's Decision|2|||
160645274|NCT00678392|580084192|FG000|Overall Study|Withdrawal by Subject|4|||
160645275|NCT00678392|580084193|FG001|Overall Study|Withdrawal by Subject|4|||
160645276|NCT00678392|580084192|FG000|Overall Study|Randomized But Not Treated|2|||
160900007|NCT03917459|581028597|FG000|Overall Study|Adverse Event|1|||
160645277|NCT00678392|580084193|FG001|Overall Study|Randomized But Not Treated|7|||
160645278|NCT00678392|580084192|FG000|Overall Study|Other|56|||
160645279|NCT00678392|580084193|FG001|Overall Study|Other|53|||
160645280|NCT03341507|580084194|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
160645281|NCT00718159|580084200|FG000|Overall Study|Progressive Disease|3|||
160645282|NCT00718159|580084201|FG001|Overall Study|Progressive Disease|3|||
160645283|NCT00718159|580084202|FG002|Overall Study|Progressive Disease|2|||
160645284|NCT00718159|580084203|FG003|Overall Study|Progressive Disease|0|||
160645285|NCT00718159|580084204|FG004|Overall Study|Progressive Disease|6|||
160551952|NCT01262976|579746874|FG005|Up to Month 7|Serious Adverse Event|0|||
160551953|NCT01262976|579746869|FG000|Up to Month 7|Withdrawal by Subject|1|||
160551954|NCT01262976|579746870|FG001|Up to Month 7|Withdrawal by Subject|0|||
160551955|NCT01262976|579746871|FG002|Up to Month 7|Withdrawal by Subject|0|||
160551956|NCT01262976|579746872|FG003|Up to Month 7|Withdrawal by Subject|0|||
160551957|NCT01262976|579746873|FG004|Up to Month 7|Withdrawal by Subject|0|||
160551958|NCT01262976|579746874|FG005|Up to Month 7|Withdrawal by Subject|0|||
160551959|NCT01262976|579746869|FG000|Up to Month 7|Migrated/moved from study area|0|||
160551960|NCT01262976|579746870|FG001|Up to Month 7|Migrated/moved from study area|0|||
160551961|NCT01262976|579746871|FG002|Up to Month 7|Migrated/moved from study area|1|||
160551962|NCT01262976|579746872|FG003|Up to Month 7|Migrated/moved from study area|3|||
160551963|NCT01262976|579746873|FG004|Up to Month 7|Migrated/moved from study area|1|||
160551964|NCT01262976|579746874|FG005|Up to Month 7|Migrated/moved from study area|1|||
160551965|NCT01262976|579746869|FG000|Up to Month 7|Lost to Follow-up|1|||
160551966|NCT01262976|579746870|FG001|Up to Month 7|Lost to Follow-up|0|||
160551967|NCT01262976|579746871|FG002|Up to Month 7|Lost to Follow-up|1|||
160551968|NCT01262976|579746872|FG003|Up to Month 7|Lost to Follow-up|3|||
160551969|NCT01262976|579746873|FG004|Up to Month 7|Lost to Follow-up|1|||
160551970|NCT01262976|579746874|FG005|Up to Month 7|Lost to Follow-up|3|||
160551971|NCT01262976|579746869|FG000|Up to Month 7|Other|3|||
160551972|NCT01262976|579746870|FG001|Up to Month 7|Other|0|||
160551973|NCT01262976|579746871|FG002|Up to Month 7|Other|2|||
160551974|NCT01262976|579746872|FG003|Up to Month 7|Other|0|||
160551975|NCT01262976|579746873|FG004|Up to Month 7|Other|0|||
160551976|NCT01262976|579746874|FG005|Up to Month 7|Other|0|||
160551977|NCT01262976|579746869|FG000|Up to Year 1|Serious Adverse Event|0|||
160551978|NCT01262976|579746870|FG001|Up to Year 1|Serious Adverse Event|0|||
160551979|NCT01262976|579746871|FG002|Up to Year 1|Serious Adverse Event|2|||
160551980|NCT01262976|579746872|FG003|Up to Year 1|Serious Adverse Event|0|||
160551981|NCT01262976|579746873|FG004|Up to Year 1|Serious Adverse Event|0|||
160551982|NCT01262976|579746874|FG005|Up to Year 1|Serious Adverse Event|0|||
160551983|NCT01262976|579746869|FG000|Up to Year 1|Withdrawal by Subject|1|||
160551984|NCT01262976|579746870|FG001|Up to Year 1|Withdrawal by Subject|0|||
160551985|NCT01262976|579746871|FG002|Up to Year 1|Withdrawal by Subject|0|||
160551986|NCT01262976|579746872|FG003|Up to Year 1|Withdrawal by Subject|0|||
160551987|NCT01262976|579746873|FG004|Up to Year 1|Withdrawal by Subject|0|||
160551988|NCT01262976|579746874|FG005|Up to Year 1|Withdrawal by Subject|0|||
160551989|NCT01262976|579746869|FG000|Up to Year 1|Migrated/moved from study area|1|||
160551990|NCT01262976|579746870|FG001|Up to Year 1|Migrated/moved from study area|0|||
160551991|NCT01262976|579746871|FG002|Up to Year 1|Migrated/moved from study area|0|||
160551992|NCT01262976|579746872|FG003|Up to Year 1|Migrated/moved from study area|3|||
160551993|NCT01262976|579746873|FG004|Up to Year 1|Migrated/moved from study area|3|||
160551994|NCT01262976|579746874|FG005|Up to Year 1|Migrated/moved from study area|2|||
160551995|NCT01262976|579746869|FG000|Up to Year 1|Lost to Follow-up|4|||
160551996|NCT01262976|579746870|FG001|Up to Year 1|Lost to Follow-up|0|||
160551997|NCT01262976|579746871|FG002|Up to Year 1|Lost to Follow-up|0|||
160551998|NCT01262976|579746872|FG003|Up to Year 1|Lost to Follow-up|1|||
160551999|NCT01262976|579746873|FG004|Up to Year 1|Lost to Follow-up|6|||
160552000|NCT01262976|579746874|FG005|Up to Year 1|Lost to Follow-up|5|||
160552001|NCT01262976|579746869|FG000|Up to Year 1|Other|3|||
160552002|NCT01262976|579746870|FG001|Up to Year 1|Other|1|||
160552003|NCT01262976|579746871|FG002|Up to Year 1|Other|0|||
160552004|NCT01262976|579746872|FG003|Up to Year 1|Other|0|||
160552005|NCT01262976|579746873|FG004|Up to Year 1|Other|2|||
160552006|NCT01262976|579746874|FG005|Up to Year 1|Other|1|||
160552007|NCT01262976|579746869|FG000|Up to Year 1|Subjects with unknown completion status|0|||
160552008|NCT01262976|579746870|FG001|Up to Year 1|Subjects with unknown completion status|0|||
160552009|NCT01262976|579746871|FG002|Up to Year 1|Subjects with unknown completion status|1|||
160552010|NCT01262976|579746872|FG003|Up to Year 1|Subjects with unknown completion status|0|||
160552011|NCT01262976|579746873|FG004|Up to Year 1|Subjects with unknown completion status|0|||
160552012|NCT01262976|579746874|FG005|Up to Year 1|Subjects with unknown completion status|1|||
160552013|NCT01262976|579746869|FG000|Up to Year 2|Serious Adverse Event|0|||
160552014|NCT01262976|579746870|FG001|Up to Year 2|Serious Adverse Event|0|||
160552015|NCT01262976|579746871|FG002|Up to Year 2|Serious Adverse Event|2|||
160552016|NCT01262976|579746872|FG003|Up to Year 2|Serious Adverse Event|0|||
160552017|NCT01262976|579746873|FG004|Up to Year 2|Serious Adverse Event|0|||
160552018|NCT01262976|579746874|FG005|Up to Year 2|Serious Adverse Event|0|||
160552019|NCT01262976|579746869|FG000|Up to Year 2|Withdrawal by Subject|1|||
160552020|NCT01262976|579746870|FG001|Up to Year 2|Withdrawal by Subject|0|||
160552021|NCT01262976|579746871|FG002|Up to Year 2|Withdrawal by Subject|0|||
160552022|NCT01262976|579746872|FG003|Up to Year 2|Withdrawal by Subject|0|||
160645286|NCT00718159|580084205|FG005|Overall Study|Progressive Disease|0|||
160552023|NCT01262976|579746873|FG004|Up to Year 2|Withdrawal by Subject|0|||
160552024|NCT01262976|579746874|FG005|Up to Year 2|Withdrawal by Subject|0|||
160552025|NCT01262976|579746869|FG000|Up to Year 2|Migrated/moved from study area|0|||
160552026|NCT01262976|579746870|FG001|Up to Year 2|Migrated/moved from study area|0|||
160552027|NCT01262976|579746871|FG002|Up to Year 2|Migrated/moved from study area|0|||
160552028|NCT01262976|579746872|FG003|Up to Year 2|Migrated/moved from study area|2|||
160552029|NCT01262976|579746873|FG004|Up to Year 2|Migrated/moved from study area|1|||
160552030|NCT01262976|579746874|FG005|Up to Year 2|Migrated/moved from study area|2|||
160552031|NCT01262976|579746869|FG000|Up to Year 2|Lost to Follow-up|1|||
160552032|NCT01262976|579746870|FG001|Up to Year 2|Lost to Follow-up|1|||
160552033|NCT01262976|579746871|FG002|Up to Year 2|Lost to Follow-up|2|||
160552034|NCT01262976|579746872|FG003|Up to Year 2|Lost to Follow-up|2|||
160552035|NCT01262976|579746873|FG004|Up to Year 2|Lost to Follow-up|3|||
160552036|NCT01262976|579746874|FG005|Up to Year 2|Lost to Follow-up|3|||
160552037|NCT01262976|579746869|FG000|Up to Year 2|Subjects with unknown completion status|0|||
160552038|NCT01262976|579746870|FG001|Up to Year 2|Subjects with unknown completion status|0|||
160552039|NCT01262976|579746871|FG002|Up to Year 2|Subjects with unknown completion status|1|||
160552040|NCT01262976|579746872|FG003|Up to Year 2|Subjects with unknown completion status|0|||
160552041|NCT01262976|579746873|FG004|Up to Year 2|Subjects with unknown completion status|0|||
160552042|NCT01262976|579746874|FG005|Up to Year 2|Subjects with unknown completion status|0|||
160552043|NCT01262976|579746869|FG000|Up to Year 2|Other|3|||
160552044|NCT01262976|579746870|FG001|Up to Year 2|Other|0|||
160552045|NCT01262976|579746871|FG002|Up to Year 2|Other|0|||
160552046|NCT01262976|579746872|FG003|Up to Year 2|Other|0|||
160552047|NCT01262976|579746873|FG004|Up to Year 2|Other|0|||
160552048|NCT01262976|579746874|FG005|Up to Year 2|Other|0|||
160552049|NCT01262976|579746869|FG000|Up to Year 3|Serious Adverse Event|0|||
160552050|NCT01262976|579746870|FG001|Up to Year 3|Serious Adverse Event|0|||
160552051|NCT01262976|579746871|FG002|Up to Year 3|Serious Adverse Event|2|||
160552052|NCT01262976|579746872|FG003|Up to Year 3|Serious Adverse Event|0|||
160552053|NCT01262976|579746873|FG004|Up to Year 3|Serious Adverse Event|0|||
160552054|NCT01262976|579746874|FG005|Up to Year 3|Serious Adverse Event|0|||
160552055|NCT01262976|579746869|FG000|Up to Year 3|Withdrawal by Subject|1|||
160552056|NCT01262976|579746870|FG001|Up to Year 3|Withdrawal by Subject|0|||
160552057|NCT01262976|579746871|FG002|Up to Year 3|Withdrawal by Subject|0|||
160552058|NCT01262976|579746872|FG003|Up to Year 3|Withdrawal by Subject|0|||
160552059|NCT01262976|579746873|FG004|Up to Year 3|Withdrawal by Subject|0|||
160552060|NCT01262976|579746874|FG005|Up to Year 3|Withdrawal by Subject|0|||
160552061|NCT01262976|579746869|FG000|Up to Year 3|Migrated/moved from study area|0|||
160552062|NCT01262976|579746870|FG001|Up to Year 3|Migrated/moved from study area|0|||
160552063|NCT01262976|579746871|FG002|Up to Year 3|Migrated/moved from study area|0|||
160552064|NCT01262976|579746872|FG003|Up to Year 3|Migrated/moved from study area|2|||
160552065|NCT01262976|579746873|FG004|Up to Year 3|Migrated/moved from study area|1|||
160552066|NCT01262976|579746874|FG005|Up to Year 3|Migrated/moved from study area|1|||
160552067|NCT01262976|579746869|FG000|Up to Year 3|Lost to Follow-up|2|||
160552068|NCT01262976|579746870|FG001|Up to Year 3|Lost to Follow-up|2|||
160552069|NCT01262976|579746871|FG002|Up to Year 3|Lost to Follow-up|4|||
160552070|NCT01262976|579746872|FG003|Up to Year 3|Lost to Follow-up|3|||
160552071|NCT01262976|579746873|FG004|Up to Year 3|Lost to Follow-up|1|||
160552072|NCT01262976|579746874|FG005|Up to Year 3|Lost to Follow-up|3|||
160552073|NCT01262976|579746869|FG000|Up to Year 3|Subjects with unknown completion status|0|||
160552074|NCT01262976|579746870|FG001|Up to Year 3|Subjects with unknown completion status|0|||
160552075|NCT01262976|579746871|FG002|Up to Year 3|Subjects with unknown completion status|1|||
160552076|NCT01262976|579746872|FG003|Up to Year 3|Subjects with unknown completion status|0|||
160552077|NCT01262976|579746873|FG004|Up to Year 3|Subjects with unknown completion status|0|||
160552078|NCT01262976|579746874|FG005|Up to Year 3|Subjects with unknown completion status|0|||
160552079|NCT01262976|579746869|FG000|Up to Year 3|Other|3|||
160552080|NCT01262976|579746870|FG001|Up to Year 3|Other|0|||
160552081|NCT01262976|579746871|FG002|Up to Year 3|Other|0|||
160552082|NCT01262976|579746872|FG003|Up to Year 3|Other|0|||
160552083|NCT01262976|579746873|FG004|Up to Year 3|Other|0|||
160552084|NCT01262976|579746874|FG005|Up to Year 3|Other|0|||
160552085|NCT01528787|579746875|FG000|Overall Study|Withdrawal by Subject|0|||
160552086|NCT01528787|579746876|FG001|Overall Study|Withdrawal by Subject|0|||
160552087|NCT01528787|579746877|FG002|Overall Study|Withdrawal by Subject|0|||
160812042|NCT01701362|580696426|FG001|Overall Study|Protocol Violation|3|||
160986825|NCT04955626|581341109|FG004|Blinded Period|No longer meets eligibility criteria|0|||
160552088|NCT01528787|579746878|FG003|Overall Study|Withdrawal by Subject|1|||
160552089|NCT01528787|579746875|FG000|Overall Study|Family Emergency|0|||
160552090|NCT01528787|579746876|FG001|Overall Study|Family Emergency|0|||
160552091|NCT01528787|579746877|FG002|Overall Study|Family Emergency|1|||
160552092|NCT01528787|579746878|FG003|Overall Study|Family Emergency|0|||
160552093|NCT02568046|579746886|FG000|Overall Study|Adverse Event|0|||
160552094|NCT02568046|579746887|FG001|Overall Study|Adverse Event|1|||
160645287|NCT00718159|580084206|FG006|Overall Study|Progressive Disease|0|||
160552095|NCT02568046|579746886|FG000|Overall Study|Death|2|||
160552096|NCT02568046|579746887|FG001|Overall Study|Death|0|||
160552097|NCT02568046|579746886|FG000|Overall Study|Progressive Disease|1|||
160552098|NCT02568046|579746887|FG001|Overall Study|Progressive Disease|0|||
160552099|NCT02568046|579746886|FG000|Overall Study|Withdrawal by Subject|2|||
160552100|NCT02568046|579746887|FG001|Overall Study|Withdrawal by Subject|1|||
160812043|NCT01701362|580696425|FG000|Overall Study|No longer willing to participate|8|||
160812044|NCT01701362|580696426|FG001|Overall Study|No longer willing to participate|14|||
160812045|NCT01701362|580696425|FG000|Overall Study|Lost to Follow-up|6|||
160812046|NCT01701362|580696426|FG001|Overall Study|Lost to Follow-up|9|||
160812047|NCT01701362|580696425|FG000|Overall Study|Insufficient clinical response|6|||
160812048|NCT01701362|580696426|FG001|Overall Study|Insufficient clinical response|6|||
160812049|NCT01701362|580696425|FG000|Overall Study|Death|0|||
160812050|NCT01701362|580696426|FG001|Overall Study|Death|1|||
160812051|NCT01701362|580696425|FG000|Overall Study|Randomized but not treated|1|||
160812052|NCT01701362|580696426|FG001|Overall Study|Randomized but not treated|2|||
160812053|NCT01701362|580696425|FG000|Overall Study|Reasons other than those mentioned above|3|||
160812054|NCT01701362|580696426|FG001|Overall Study|Reasons other than those mentioned above|5|||
160812055|NCT00570778|580696427|FG000|Overall Study|Protocol deviation|2|||
160812056|NCT00570778|580696428|FG001|Overall Study|Protocol deviation|1|||
160812057|NCT00570778|580696429|FG002|Overall Study|Protocol deviation|2|||
160812058|NCT00570778|580696430|FG003|Overall Study|Protocol deviation|2|||
160812059|NCT00570778|580696427|FG000|Overall Study|Adverse Event|0|||
160812060|NCT00570778|580696428|FG001|Overall Study|Adverse Event|1|||
160812061|NCT00570778|580696429|FG002|Overall Study|Adverse Event|4|||
160812062|NCT00570778|580696430|FG003|Overall Study|Adverse Event|1|||
160812063|NCT00570778|580696427|FG000|Overall Study|Subject withdrew consent|0|||
160812064|NCT00570778|580696428|FG001|Overall Study|Subject withdrew consent|1|||
160812065|NCT00570778|580696429|FG002|Overall Study|Subject withdrew consent|0|||
160812066|NCT00570778|580696430|FG003|Overall Study|Subject withdrew consent|1|||
160812067|NCT00570778|580696427|FG000|Overall Study|Abnormal test procedure|1|||
160812068|NCT00570778|580696428|FG001|Overall Study|Abnormal test procedure|0|||
160812069|NCT00570778|580696429|FG002|Overall Study|Abnormal test procedure|0|||
160812070|NCT00570778|580696430|FG003|Overall Study|Abnormal test procedure|0|||
160812071|NCT00570778|580696427|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160812072|NCT00570778|580696428|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160812073|NCT00570778|580696429|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160812074|NCT00570778|580696430|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
160812075|NCT00570778|580696427|FG000|Overall Study|Lost to Follow-up|0|||
160812076|NCT00570778|580696428|FG001|Overall Study|Lost to Follow-up|0|||
160812077|NCT00570778|580696429|FG002|Overall Study|Lost to Follow-up|1|||
160812078|NCT00570778|580696430|FG003|Overall Study|Lost to Follow-up|0|||
160812079|NCT00570778|580696427|FG000|Overall Study|Subject no longer requires study drug|0|||
160812080|NCT00570778|580696428|FG001|Overall Study|Subject no longer requires study drug|1|||
160812081|NCT00570778|580696429|FG002|Overall Study|Subject no longer requires study drug|0|||
160552101|NCT02568046|579746886|FG000|Overall Study|Other Events|0|||
160552102|NCT02568046|579746887|FG001|Overall Study|Other Events|1|||
160552103|NCT02809833|579746888|FG000|Overall Study|Death|3|||
160552104|NCT02809833|579746888|FG000|Overall Study|Intolerance|54|||
160552105|NCT02809833|579746888|FG000|Overall Study|Lack of Efficacy|89|||
160552106|NCT02809833|579746888|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
160552107|NCT02809833|579746888|FG000|Overall Study|Noncompliance|1|||
160552108|NCT02809833|579746888|FG000|Overall Study|Withdrawal by Subject|34|||
160552109|NCT02809833|579746888|FG000|Overall Study|Lost to Follow-up|35|||
160552110|NCT02809833|579746888|FG000|Overall Study|Adverse Event (AE)|24|||
160552111|NCT02809833|579746888|FG000|Overall Study|Other|5|||
160552112|NCT02809833|579746888|FG000|Overall Study|Missing Information|52|||
160552113|NCT00408694|579746889|FG000|Overall Study|Ineligible|1|||
160552114|NCT00408694|579746889|FG000|Overall Study|No protocol treatment|1|||
160552115|NCT00523991|579746892|FG000|Overall Study|Adverse Event|6|||
160552116|NCT00523991|579746893|FG001|Overall Study|Adverse Event|5|||
160552117|NCT00523991|579746892|FG000|Overall Study|Protocol Violation|1|||
160552118|NCT00523991|579746893|FG001|Overall Study|Protocol Violation|4|||
160552119|NCT00523991|579746892|FG000|Overall Study|Lost to Follow-up|4|||
160552120|NCT00523991|579746893|FG001|Overall Study|Lost to Follow-up|1|||
160552121|NCT00523991|579746892|FG000|Overall Study|Withdrawal by Subject|7|||
160552122|NCT00523991|579746893|FG001|Overall Study|Withdrawal by Subject|17|||
160552123|NCT00523991|579746892|FG000|Overall Study|Other reason (not specified)|3|||
160812082|NCT00570778|580696430|FG003|Overall Study|Subject no longer requires study drug|0|||
160552124|NCT00523991|579746893|FG001|Overall Study|Other reason (not specified)|0|||
160812083|NCT00443872|580696433|FG000|Overall Study|Protocol Violation|7|||
160812084|NCT00443872|580696433|FG000|Overall Study|Lost to Follow-up|2|||
160812085|NCT00443872|580696433|FG000|Overall Study|Adverse Event|8|||
160812086|NCT01014767|580696434|FG000|Overall Study|PI left institution, data unavailable|12|||
160552125|NCT00193063|579746895|FG000|Overall Study|Lack of Efficacy|3|||
160552126|NCT00193063|579746895|FG000|Overall Study|Adverse Event|1|||
160552127|NCT00744874|579746897|FG000|Overall Study|Lost to Follow-up|1|||
160812087|NCT01014767|580696435|FG001|Overall Study|PI left institution, data unavailable|1|||
160812088|NCT01014767|580696436|FG002|Overall Study|PI left institution, data unavailable|4|||
160812089|NCT01014767|580696437|FG003|Overall Study|PI left institution, data unavailable|1|||
160812090|NCT00282087|580696438|FG000|Overall Study|Death|1|||
160552128|NCT00744874|579746897|FG000|Overall Study|Withdrawal by Subject|1|||
160552129|NCT00744874|579746897|FG000|Overall Study|Study Device not available at procedure|1|||
160552130|NCT00744874|579746897|FG000|Overall Study|Unable to accomodate schedule|1|||
160552131|NCT03175549|579746900|FG000|Overall Study|Lost to Follow-up|2|||
160552132|NCT03175549|579746901|FG001|Overall Study|Lost to Follow-up|2|||
160552133|NCT03175549|579746900|FG000|Overall Study|Medication non-compliance|2|||
160552134|NCT03175549|579746901|FG001|Overall Study|Medication non-compliance|2|||
160552135|NCT02486757|579746902|FG000|Overall Study|Lost to Follow-up|1|||
160552136|NCT00087646|579746903|FG000|Overall Study|Adverse Event|37|||
160552137|NCT00087646|579746904|FG001|Overall Study|Adverse Event|6|||
160552138|NCT00087646|579746905|FG002|Overall Study|Adverse Event|18|||
160552139|NCT00087646|579746906|FG003|Overall Study|Adverse Event|20|||
160552140|NCT00087646|579746903|FG000|Overall Study|Death|0|||
160552141|NCT00087646|579746904|FG001|Overall Study|Death|1|||
160552142|NCT00087646|579746905|FG002|Overall Study|Death|0|||
160552143|NCT00087646|579746906|FG003|Overall Study|Death|0|||
160552144|NCT00087646|579746903|FG000|Overall Study|Withdrawal by Subject|6|||
160552145|NCT00087646|579746904|FG001|Overall Study|Withdrawal by Subject|1|||
160552146|NCT00087646|579746905|FG002|Overall Study|Withdrawal by Subject|2|||
160552147|NCT00087646|579746906|FG003|Overall Study|Withdrawal by Subject|2|||
160552148|NCT00087646|579746903|FG000|Overall Study|Insufficient therapeutic response|64|||
160552149|NCT00087646|579746904|FG001|Overall Study|Insufficient therapeutic response|24|||
160552150|NCT00087646|579746905|FG002|Overall Study|Insufficient therapeutic response|38|||
160552151|NCT00087646|579746906|FG003|Overall Study|Insufficient therapeutic response|51|||
160552152|NCT00087646|579746903|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
160552153|NCT00087646|579746904|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
160552154|NCT00087646|579746905|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
160552155|NCT00087646|579746906|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
160552156|NCT00087646|579746903|FG000|Overall Study|Failure to Return|5|||
160552157|NCT00087646|579746904|FG001|Overall Study|Failure to Return|2|||
160645288|NCT00718159|580084200|FG000|Overall Study|Death due to Adverse Event|0|||
160812091|NCT00588237|580696441|FG000|Overall Study|Evaluable for toxicity only|3|||
160812092|NCT00588237|580696441|FG000|Overall Study|Patien not treated|1|||
160812093|NCT00405392|580696449|FG000|Overall Study|Adverse Event|15|||
160812094|NCT00405392|580696450|FG001|Overall Study|Adverse Event|14|||
160812095|NCT00405392|580696449|FG000|Overall Study|Did not meet Eligibility criteria|7|||
160812096|NCT00405392|580696450|FG001|Overall Study|Did not meet Eligibility criteria|2|||
160812097|NCT00405392|580696449|FG000|Overall Study|Withdrawal by Subject|4|||
160812098|NCT00405392|580696450|FG001|Overall Study|Withdrawal by Subject|3|||
160812099|NCT00405392|580696449|FG000|Overall Study|Lost to Follow-up|1|||
160812100|NCT00405392|580696450|FG001|Overall Study|Lost to Follow-up|2|||
160812101|NCT00405392|580696449|FG000|Overall Study|Data missing|2|||
160812102|NCT00405392|580696450|FG001|Overall Study|Data missing|0|||
160812103|NCT00405392|580696449|FG000|Overall Study|Non-compliance|0|||
160812104|NCT00405392|580696450|FG001|Overall Study|Non-compliance|1|||
160812105|NCT00405392|580696449|FG000|Overall Study|Other|1|||
160812106|NCT00405392|580696450|FG001|Overall Study|Other|5|||
160812107|NCT00441142|580696471|FG000|Overall Study|Adverse Event|2|||
160812108|NCT00441142|580696472|FG001|Overall Study|Adverse Event|3|||
160552158|NCT00087646|579746905|FG002|Overall Study|Failure to Return|2|||
160552159|NCT00087646|579746906|FG003|Overall Study|Failure to Return|3|||
160552160|NCT00087646|579746903|FG000|Overall Study|Administrative/Other|6|||
160552161|NCT00087646|579746904|FG001|Overall Study|Administrative/Other|1|||
160552162|NCT00087646|579746905|FG002|Overall Study|Administrative/Other|1|||
160552163|NCT00087646|579746906|FG003|Overall Study|Administrative/Other|2|||
160552164|NCT00087646|579746903|FG000|Overall Study|Other Protocol Violation|3|||
160552165|NCT00087646|579746904|FG001|Overall Study|Other Protocol Violation|1|||
160552166|NCT00087646|579746905|FG002|Overall Study|Other Protocol Violation|0|||
160552167|NCT00087646|579746906|FG003|Overall Study|Other Protocol Violation|0|||
160552168|NCT00087646|579746903|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
160552169|NCT00087646|579746904|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
160552170|NCT00087646|579746905|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
160552171|NCT00087646|579746906|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
160552172|NCT03979274|579746920|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160552173|NCT03979274|579746921|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160552174|NCT02301403|579746922|FG000|Overall Study|Withdrawal by Subject|28|||
160552175|NCT02301403|579746923|FG001|Overall Study|Withdrawal by Subject|41|||
160552176|NCT02302963|579746926|FG000|Overall Study|Withdrawal by Subject|2|||
160552177|NCT02302963|579746927|FG001|Overall Study|Withdrawal by Subject|1|||
160812109|NCT00441142|580696473|FG002|Overall Study|Adverse Event|3|||
160552178|NCT02302963|579746926|FG000|Overall Study|Steroid injection|0|||
160552179|NCT02302963|579746927|FG001|Overall Study|Steroid injection|1|||
160552180|NCT02302963|579746926|FG000|Overall Study|Physician Decision|1|||
160552181|NCT02302963|579746927|FG001|Overall Study|Physician Decision|0|||
160645289|NCT00718159|580084201|FG001|Overall Study|Death due to Adverse Event|0|||
160812110|NCT00441142|580696474|FG003|Overall Study|Adverse Event|22|||
160812111|NCT00441142|580696471|FG000|Overall Study|Lack of Efficacy|3|||
160812112|NCT00441142|580696472|FG001|Overall Study|Lack of Efficacy|3|||
160812113|NCT00441142|580696473|FG002|Overall Study|Lack of Efficacy|17|||
160812114|NCT00441142|580696474|FG003|Overall Study|Lack of Efficacy|32|||
160812115|NCT00441142|580696471|FG000|Overall Study|Withdrawal by Subject|0|||
160812116|NCT00441142|580696472|FG001|Overall Study|Withdrawal by Subject|0|||
160812117|NCT00441142|580696473|FG002|Overall Study|Withdrawal by Subject|2|||
160812118|NCT00441142|580696474|FG003|Overall Study|Withdrawal by Subject|10|||
160812119|NCT00441142|580696471|FG000|Overall Study|Patient still receiving active study tx|1|||
160812120|NCT00441142|580696472|FG001|Overall Study|Patient still receiving active study tx|0|||
160812121|NCT00441142|580696473|FG002|Overall Study|Patient still receiving active study tx|0|||
160812122|NCT00441142|580696474|FG003|Overall Study|Patient still receiving active study tx|2|||
160812123|NCT00441142|580696471|FG000|Overall Study|Physician Decision|0|||
160812124|NCT00441142|580696472|FG001|Overall Study|Physician Decision|1|||
160812125|NCT00441142|580696473|FG002|Overall Study|Physician Decision|0|||
160812126|NCT00441142|580696474|FG003|Overall Study|Physician Decision|1|||
160812127|NCT00441142|580696471|FG000|Overall Study|Death|0|||
160812128|NCT00441142|580696472|FG001|Overall Study|Death|0|||
160812129|NCT00441142|580696473|FG002|Overall Study|Death|0|||
160812130|NCT00441142|580696474|FG003|Overall Study|Death|1|||
160812131|NCT01703091|580696475|FG000|Overall Study|Adverse Event|5|||
160812132|NCT01703091|580696476|FG001|Overall Study|Adverse Event|3|||
160812133|NCT01703091|580696475|FG000|Overall Study|Physician Decision|2|||
160812134|NCT01703091|580696476|FG001|Overall Study|Physician Decision|1|||
160812135|NCT01703091|580696475|FG000|Overall Study|Withdrawal by Subject|1|||
160812136|NCT01703091|580696476|FG001|Overall Study|Withdrawal by Subject|0|||
160812137|NCT01703091|580696475|FG000|Overall Study|Sponsor Decision|1|||
160812138|NCT01703091|580696476|FG001|Overall Study|Sponsor Decision|0|||
160812139|NCT02550288|580696477|FG000|Overall Study|Adverse Event|0|||
160812140|NCT02550288|580696478|FG001|Overall Study|Adverse Event|1|||
160812141|NCT02550288|580696479|FG002|Overall Study|Adverse Event|0|||
160812142|NCT02550288|580696480|FG003|Overall Study|Adverse Event|0|||
160812143|NCT02550288|580696481|FG004|Overall Study|Adverse Event|0|||
160812144|NCT02550288|580696477|FG000|Overall Study|Physician Decision|0|||
160812145|NCT02550288|580696478|FG001|Overall Study|Physician Decision|0|||
160812146|NCT02550288|580696479|FG002|Overall Study|Physician Decision|0|||
160812147|NCT02550288|580696480|FG003|Overall Study|Physician Decision|1|||
160812148|NCT02550288|580696481|FG004|Overall Study|Physician Decision|0|||
160812149|NCT02550288|580696477|FG000|Overall Study|Protocol Violation|2|||
160812150|NCT02550288|580696478|FG001|Overall Study|Protocol Violation|2|||
160812151|NCT02550288|580696479|FG002|Overall Study|Protocol Violation|1|||
160812152|NCT02550288|580696480|FG003|Overall Study|Protocol Violation|0|||
160812153|NCT02550288|580696481|FG004|Overall Study|Protocol Violation|3|||
160812154|NCT02550288|580696477|FG000|Overall Study|Participant moved|0|||
160812155|NCT02550288|580696478|FG001|Overall Study|Participant moved|0|||
160812156|NCT02550288|580696479|FG002|Overall Study|Participant moved|0|||
160812157|NCT02550288|580696480|FG003|Overall Study|Participant moved|1|||
160812158|NCT02550288|580696481|FG004|Overall Study|Participant moved|0|||
160812159|NCT02550288|580696477|FG000|Overall Study|Withdrawal by Subject|0|||
160812160|NCT02550288|580696478|FG001|Overall Study|Withdrawal by Subject|0|||
160812161|NCT02550288|580696479|FG002|Overall Study|Withdrawal by Subject|0|||
160812162|NCT02550288|580696480|FG003|Overall Study|Withdrawal by Subject|1|||
160812163|NCT02550288|580696481|FG004|Overall Study|Withdrawal by Subject|0|||
160812164|NCT01524224|580696484|FG000|Overall Study|Progressive Disease|1|||
160812165|NCT01524224|580696485|FG001|Overall Study|Progressive Disease|0|||
160812166|NCT01524224|580696486|FG002|Overall Study|Progressive Disease|2|||
160812167|NCT01524224|580696487|FG003|Overall Study|Progressive Disease|1|||
160812168|NCT01524224|580696488|FG004|Overall Study|Progressive Disease|2|||
160812169|NCT01524224|580696489|FG005|Overall Study|Progressive Disease|1|||
160812170|NCT01524224|580696490|FG006|Overall Study|Progressive Disease|1|||
160812171|NCT01524224|580696491|FG007|Overall Study|Progressive Disease|5|||
160812172|NCT01524224|580696484|FG000|Overall Study|Withdrawal by Subject|2|||
160812173|NCT01524224|580696485|FG001|Overall Study|Withdrawal by Subject|0|||
160812174|NCT01524224|580696486|FG002|Overall Study|Withdrawal by Subject|0|||
160812175|NCT01524224|580696487|FG003|Overall Study|Withdrawal by Subject|0|||
160812176|NCT01524224|580696488|FG004|Overall Study|Withdrawal by Subject|0|||
160812177|NCT01524224|580696489|FG005|Overall Study|Withdrawal by Subject|0|||
160812178|NCT01524224|580696490|FG006|Overall Study|Withdrawal by Subject|2|||
160812179|NCT01524224|580696491|FG007|Overall Study|Withdrawal by Subject|0|||
160812180|NCT01524224|580696484|FG000|Overall Study|Adverse Event|0|||
160812181|NCT01524224|580696485|FG001|Overall Study|Adverse Event|1|||
160812182|NCT01524224|580696486|FG002|Overall Study|Adverse Event|0|||
160812183|NCT01524224|580696487|FG003|Overall Study|Adverse Event|0|||
160812184|NCT01524224|580696488|FG004|Overall Study|Adverse Event|0|||
160812185|NCT01524224|580696489|FG005|Overall Study|Adverse Event|1|||
160812186|NCT01524224|580696490|FG006|Overall Study|Adverse Event|0|||
160812187|NCT01524224|580696491|FG007|Overall Study|Adverse Event|0|||
160812188|NCT01524224|580696484|FG000|Overall Study|Physician Decision|0|||
160812189|NCT01524224|580696485|FG001|Overall Study|Physician Decision|0|||
160812190|NCT01524224|580696486|FG002|Overall Study|Physician Decision|0|||
160812191|NCT01524224|580696487|FG003|Overall Study|Physician Decision|1|||
160812192|NCT01524224|580696488|FG004|Overall Study|Physician Decision|1|||
160812193|NCT01524224|580696489|FG005|Overall Study|Physician Decision|0|||
160812194|NCT01524224|580696490|FG006|Overall Study|Physician Decision|0|||
160812195|NCT01524224|580696491|FG007|Overall Study|Physician Decision|1|||
160812196|NCT01524224|580696484|FG000|Overall Study|Sponsor Decision|0|||
160812197|NCT01524224|580696485|FG001|Overall Study|Sponsor Decision|0|||
160812198|NCT01524224|580696486|FG002|Overall Study|Sponsor Decision|0|||
160812199|NCT01524224|580696487|FG003|Overall Study|Sponsor Decision|0|||
160812200|NCT01524224|580696488|FG004|Overall Study|Sponsor Decision|1|||
160812201|NCT01524224|580696489|FG005|Overall Study|Sponsor Decision|0|||
160812202|NCT01524224|580696490|FG006|Overall Study|Sponsor Decision|0|||
160812203|NCT01524224|580696491|FG007|Overall Study|Sponsor Decision|0|||
160812204|NCT00988052|580696498|FG000|Overall Study|Missing|1|||
160812205|NCT00988052|580696499|FG001|Overall Study|Missing|0|||
160812206|NCT00988052|580696498|FG000|Overall Study|Teva requested subject withdrawal|3|||
160812207|NCT00988052|580696499|FG001|Overall Study|Teva requested subject withdrawal|1|||
160812208|NCT00988052|580696498|FG000|Overall Study|Death|1|||
160812209|NCT00988052|580696499|FG001|Overall Study|Death|3|||
160812210|NCT00988052|580696498|FG000|Overall Study|Protocol Violation|6|||
160812211|NCT00988052|580696499|FG001|Overall Study|Protocol Violation|5|||
160812212|NCT00988052|580696498|FG000|Overall Study|Pregnancy|6|||
160812213|NCT00988052|580696499|FG001|Overall Study|Pregnancy|6|||
160812214|NCT00988052|580696498|FG000|Overall Study|Lack of Efficacy|8|||
160812215|NCT00988052|580696499|FG001|Overall Study|Lack of Efficacy|7|||
160812216|NCT00988052|580696498|FG000|Overall Study|Lost to Follow-up|6|||
160812217|NCT00988052|580696499|FG001|Overall Study|Lost to Follow-up|11|||
160900008|NCT03917459|581028598|FG001|Overall Study|Adverse Event|0|||
160900009|NCT03917459|581028597|FG000|Overall Study|Withdrawal by Subject|0|||
160900010|NCT03917459|581028598|FG001|Overall Study|Withdrawal by Subject|1|||
160900011|NCT00736944|581028599|FG000|Induction|Death|1|||
160900012|NCT00736944|581028599|FG000|Definitive Treatment|Physician Decision|1|||
160900013|NCT00894166|581028600|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
160900014|NCT00894166|581028601|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
160900015|NCT00894166|581028602|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
160900016|NCT00894166|581028603|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
160900017|NCT00894166|581028604|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
160900018|NCT00894166|581028605|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
160900019|NCT00894166|581028606|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
160900020|NCT00894166|581028607|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
160900021|NCT00894166|581028600|FG000|Overall Study|Death|0|||
160900022|NCT00894166|581028601|FG001|Overall Study|Death|0|||
160900023|NCT00894166|581028602|FG002|Overall Study|Death|0|||
160900024|NCT00894166|581028603|FG003|Overall Study|Death|1|||
160900025|NCT00894166|581028604|FG004|Overall Study|Death|0|||
160900026|NCT00894166|581028605|FG005|Overall Study|Death|0|||
160900027|NCT00894166|581028606|FG006|Overall Study|Death|0|||
160900028|NCT00894166|581028607|FG007|Overall Study|Death|0|||
160900029|NCT01601132|581028609|FG000|Overall Study|Patient withdrew consent|1|||
160900030|NCT01601132|581028609|FG000|Overall Study|Protocol deviation|1|||
160552182|NCT01614093|579746930|FG000|Overall Study|Withdrawal by Subject|1|||
160552183|NCT01816243|579746931|FG000|Overall Study|Adverse Event|6|||
160900031|NCT00850070|581028614|FG000|Overall Study|Lack of Efficacy|1|||
160900032|NCT00850070|581028615|FG001|Overall Study|Lack of Efficacy|1|||
160900033|NCT00850070|581028614|FG000|Overall Study|Adverse Event|2|||
160552184|NCT01816243|579746931|FG000|Overall Study|Lost to Follow-up|1|||
160552185|NCT01816243|579746931|FG000|Overall Study|Lack of Efficacy|1|||
160552186|NCT01816243|579746931|FG000|Overall Study|Not eligible for the study|1|||
160552187|NCT01816243|579746931|FG000|Overall Study|Amputation|3|||
160812218|NCT00988052|580696498|FG000|Overall Study|Physician Decision|27|||
160812219|NCT00988052|580696499|FG001|Overall Study|Physician Decision|28|||
160812220|NCT00988052|580696498|FG000|Overall Study|Adverse Event|35|||
160812221|NCT00988052|580696499|FG001|Overall Study|Adverse Event|28|||
160812222|NCT00988052|580696498|FG000|Overall Study|Withdrawal by Subject|90|||
160812223|NCT00988052|580696499|FG001|Overall Study|Withdrawal by Subject|91|||
160812224|NCT00988052|580696498|FG000|Overall Study|Study terminated by sponsor|240|||
160812225|NCT00988052|580696499|FG001|Overall Study|Study terminated by sponsor|236|||
160812226|NCT05312697|580696500|FG000|Overall Study|Sponsor Terminated Trial|2|||
160812227|NCT02858440|580696501|FG000|Overall Study|Lost to Follow-up|3|||
160812228|NCT02858440|580696501|FG000|Overall Study|Protocol Violation|2|||
160812229|NCT02858440|580696501|FG000|Overall Study|Consent withdrawal|3|||
160900034|NCT00850070|581028615|FG001|Overall Study|Adverse Event|0|||
160986826|NCT04955626|581341110|FG005|Blinded Period|No longer meets eligibility criteria|0|||
160986827|NCT04955626|581341111|FG006|Blinded Period|No longer meets eligibility criteria|0|||
160645290|NCT00718159|580084202|FG002|Overall Study|Death due to Adverse Event|0|||
160645291|NCT00718159|580084203|FG003|Overall Study|Death due to Adverse Event|2|||
160645292|NCT00718159|580084204|FG004|Overall Study|Death due to Adverse Event|2|||
160812230|NCT02858440|580696501|FG000|Overall Study|Migrated/moved from study area|4|||
160812231|NCT00402324|580696502|FG000|Overall Study|Lost to Follow-up|11|||
160812232|NCT00402324|580696503|FG001|Overall Study|Lost to Follow-up|11|||
160812233|NCT00402324|580696502|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
160812234|NCT00402324|580696503|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
160812235|NCT00402324|580696502|FG000|Overall Study|Protocol Violation|8|||
160812236|NCT00402324|580696503|FG001|Overall Study|Protocol Violation|7|||
160812237|NCT00402324|580696502|FG000|Overall Study|Withdrawal by Subject|5|||
160812238|NCT00402324|580696503|FG001|Overall Study|Withdrawal by Subject|2|||
160812239|NCT00402324|580696502|FG000|Overall Study|Physician Decision|2|||
160812240|NCT00402324|580696503|FG001|Overall Study|Physician Decision|4|||
160812241|NCT00402324|580696502|FG000|Overall Study|Sponsor Decision|4|||
160812242|NCT00402324|580696503|FG001|Overall Study|Sponsor Decision|5|||
160812243|NCT00402324|580696502|FG000|Overall Study|Lack of Efficacy|1|||
160812244|NCT00402324|580696503|FG001|Overall Study|Lack of Efficacy|4|||
160812245|NCT00402324|580696502|FG000|Overall Study|Adverse Event|6|||
160812246|NCT00402324|580696503|FG001|Overall Study|Adverse Event|4|||
160812247|NCT00402324|580696502|FG000|Overall Study|Death|1|||
160812248|NCT00402324|580696503|FG001|Overall Study|Death|0|||
160812249|NCT01277822|580696504|FG000|Overall Study|Adverse Event|2|||
160812250|NCT01277822|580696505|FG001|Overall Study|Adverse Event|1|||
160812251|NCT01277822|580696504|FG000|Overall Study|Withdrawal by Subject|6|||
160812252|NCT01277822|580696505|FG001|Overall Study|Withdrawal by Subject|7|||
160812253|NCT01277822|580696504|FG000|Overall Study|Physician Decision|1|||
160812254|NCT01277822|580696505|FG001|Overall Study|Physician Decision|1|||
160812255|NCT01277822|580696504|FG000|Overall Study|Protocol Violation|1|||
160812256|NCT01277822|580696505|FG001|Overall Study|Protocol Violation|0|||
160812257|NCT01277822|580696504|FG000|Overall Study|Lost to Follow-up|2|||
160812258|NCT01277822|580696505|FG001|Overall Study|Lost to Follow-up|1|||
160812259|NCT01277822|580696504|FG000|Overall Study|Contraindicated medication used|2|||
160812260|NCT01277822|580696505|FG001|Overall Study|Contraindicated medication used|1|||
160812261|NCT01277822|580696504|FG000|Overall Study|Participant moved|1|||
160812262|NCT01277822|580696505|FG001|Overall Study|Participant moved|0|||
160812263|NCT02923531|580696506|FG000|Overall Study|Adverse Event|4|||
160812264|NCT02923531|580696506|FG000|Overall Study|Clinical Deterioration|1|||
160812265|NCT02923531|580696506|FG000|Overall Study|Disease Progression|3|||
160812266|NCT02923531|580696506|FG000|Overall Study|Study Termination|1|||
160812267|NCT00997984|580696507|FG000|Overall Study|Adverse Event|1|||
160812268|NCT00997984|580696508|FG001|Overall Study|Adverse Event|8|||
160645293|NCT00718159|580084205|FG005|Overall Study|Death due to Adverse Event|0|||
160645294|NCT00718159|580084206|FG006|Overall Study|Death due to Adverse Event|0|||
160645295|NCT00718159|580084200|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
160812269|NCT00997984|580696509|FG002|Overall Study|Adverse Event|8|||
160812270|NCT00997984|580696507|FG000|Overall Study|Protocol Violation|1|||
160812271|NCT00997984|580696508|FG001|Overall Study|Protocol Violation|3|||
160812272|NCT00997984|580696509|FG002|Overall Study|Protocol Violation|0|||
160812273|NCT00997984|580696507|FG000|Overall Study|Withdrawal by Subject|6|||
160812274|NCT00997984|580696508|FG001|Overall Study|Withdrawal by Subject|9|||
160812275|NCT00997984|580696509|FG002|Overall Study|Withdrawal by Subject|5|||
160812276|NCT00997984|580696507|FG000|Overall Study|Lost to Follow-up|8|||
160812277|NCT00997984|580696508|FG001|Overall Study|Lost to Follow-up|5|||
160812278|NCT00997984|580696509|FG002|Overall Study|Lost to Follow-up|4|||
160812279|NCT00997984|580696507|FG000|Overall Study|Lack of Efficacy|20|||
160812280|NCT00997984|580696508|FG001|Overall Study|Lack of Efficacy|6|||
160812281|NCT00997984|580696509|FG002|Overall Study|Lack of Efficacy|3|||
160812282|NCT00997984|580696507|FG000|Overall Study|Met exclusion criteria|1|||
160812283|NCT00997984|580696508|FG001|Overall Study|Met exclusion criteria|0|||
160812284|NCT00997984|580696509|FG002|Overall Study|Met exclusion criteria|0|||
160812285|NCT00997984|580696507|FG000|Overall Study|non-compliance|0|||
160812286|NCT00997984|580696508|FG001|Overall Study|non-compliance|2|||
160812287|NCT00997984|580696509|FG002|Overall Study|non-compliance|3|||
160812288|NCT00997984|580696507|FG000|Overall Study|Wrong medication dispensed|0|||
160812289|NCT00997984|580696508|FG001|Overall Study|Wrong medication dispensed|1|||
160812290|NCT00997984|580696509|FG002|Overall Study|Wrong medication dispensed|0|||
160812291|NCT00997984|580696507|FG000|Overall Study|Suicidal ideation|0|||
160812292|NCT00997984|580696508|FG001|Overall Study|Suicidal ideation|0|||
160812293|NCT00997984|580696509|FG002|Overall Study|Suicidal ideation|1|||
160812294|NCT00997984|580696507|FG000|Overall Study|Work schedule|0|||
160812295|NCT00997984|580696508|FG001|Overall Study|Work schedule|0|||
160812296|NCT00997984|580696509|FG002|Overall Study|Work schedule|2|||
160812297|NCT02997865|580696511|FG000|Overall Study|Death|2|||
160812298|NCT02997865|580696512|FG001|Overall Study|Death|1|||
160812299|NCT02997865|580696511|FG000|Overall Study|Lost to Follow-up|6|||
160812300|NCT02997865|580696512|FG001|Overall Study|Lost to Follow-up|3|||
160812301|NCT02997865|580696511|FG000|Overall Study|Withdrawal by Subject|5|||
160812302|NCT02997865|580696512|FG001|Overall Study|Withdrawal by Subject|0|||
160812303|NCT01119066|580696513|FG000|Overall Study|Withdrawal by Subject|4|||
160812304|NCT01119066|580696514|FG001|Overall Study|Withdrawal by Subject|6|||
160812305|NCT01119066|580696515|FG002|Overall Study|Withdrawal by Subject|0|||
160812306|NCT01119066|580696516|FG003|Overall Study|Withdrawal by Subject|0|||
160812307|NCT01119066|580696513|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
160812308|NCT01119066|580696514|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
160812309|NCT01119066|580696515|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
160812310|NCT01119066|580696516|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
160812311|NCT01119066|580696513|FG000|Overall Study|Relapse identified before transplant|1|||
160812312|NCT01119066|580696514|FG001|Overall Study|Relapse identified before transplant|0|||
160812313|NCT01119066|580696515|FG002|Overall Study|Relapse identified before transplant|0|||
160812314|NCT01119066|580696516|FG003|Overall Study|Relapse identified before transplant|0|||
160812315|NCT01119066|580696513|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
160812316|NCT01119066|580696514|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
160812317|NCT01119066|580696515|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
160812318|NCT01119066|580696516|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
160812319|NCT01119066|580696513|FG000|Overall Study|Relapse identified before transplant|0|||
160812320|NCT01119066|580696514|FG001|Overall Study|Relapse identified before transplant|4|||
160812321|NCT01119066|580696515|FG002|Overall Study|Relapse identified before transplant|0|||
160812322|NCT01119066|580696516|FG003|Overall Study|Relapse identified before transplant|0|||
160812323|NCT00783835|580696517|FG000|Overall Study|Adverse Event|3|||
160812324|NCT00783835|580696517|FG000|Overall Study|Medical Criteria|1|||
160812325|NCT00783835|580696517|FG000|Overall Study|Withdrawal by Subject|2|||
160812326|NCT00783835|580696517|FG000|Overall Study|Lost to Follow-up|1|||
160812327|NCT00783835|580696517|FG000|Overall Study|Participant not Adherent|3|||
160812328|NCT00295646|580696518|FG000|Overall Study|Protocol Violation|18|||
160812329|NCT00295646|580696519|FG001|Overall Study|Protocol Violation|20|||
160812330|NCT00295646|580696520|FG002|Overall Study|Protocol Violation|20|||
160812331|NCT00295646|580696521|FG003|Overall Study|Protocol Violation|18|||
160812332|NCT00295646|580696518|FG000|Overall Study|Withdrawal by Subject|8|||
160812333|NCT00295646|580696519|FG001|Overall Study|Withdrawal by Subject|9|||
160812334|NCT00295646|580696520|FG002|Overall Study|Withdrawal by Subject|11|||
160552188|NCT01920711|579746932|FG000|Overall Study|Death|347|||
160812335|NCT00295646|580696521|FG003|Overall Study|Withdrawal by Subject|14|||
160812336|NCT00295646|580696518|FG000|Overall Study|Lost to Follow-up|0|||
160812337|NCT00295646|580696519|FG001|Overall Study|Lost to Follow-up|5|||
160812338|NCT00295646|580696520|FG002|Overall Study|Lost to Follow-up|1|||
160812339|NCT00295646|580696521|FG003|Overall Study|Lost to Follow-up|5|||
160812340|NCT00295646|580696518|FG000|Overall Study|Death|9|||
160812341|NCT00295646|580696519|FG001|Overall Study|Death|7|||
160812342|NCT00295646|580696520|FG002|Overall Study|Death|18|||
160812343|NCT00295646|580696521|FG003|Overall Study|Death|8|||
160812344|NCT01945996|580696522|FG000|Overall Study|Lost to Follow-up|3|||
160812345|NCT01945996|580696523|FG001|Overall Study|Lost to Follow-up|5|||
160812346|NCT04660552|580696525|FG000|Overall Study|Withdrawal by Subject|3|||
160812347|NCT04660552|580696526|FG001|Overall Study|Withdrawal by Subject|1|||
160812348|NCT03012828|580696527|FG000|Overall Study|Lost to Follow-up|1|||
160812349|NCT03012828|580696528|FG001|Overall Study|Lost to Follow-up|0|||
160812350|NCT03012828|580696529|FG002|Overall Study|Lost to Follow-up|1|||
160812351|NCT03012828|580696530|FG003|Overall Study|Lost to Follow-up|0|||
160812352|NCT03012828|580696531|FG004|Overall Study|Lost to Follow-up|1|||
160552189|NCT01920711|579746933|FG001|Overall Study|Death|356|||
160812353|NCT03012828|580696532|FG005|Overall Study|Lost to Follow-up|0|||
160812354|NCT03012828|580696527|FG000|Overall Study|Withdrawal by Subject|0|||
160812355|NCT03012828|580696528|FG001|Overall Study|Withdrawal by Subject|0|||
160812356|NCT03012828|580696529|FG002|Overall Study|Withdrawal by Subject|1|||
160812357|NCT03012828|580696530|FG003|Overall Study|Withdrawal by Subject|0|||
160812358|NCT03012828|580696531|FG004|Overall Study|Withdrawal by Subject|0|||
160812359|NCT03012828|580696532|FG005|Overall Study|Withdrawal by Subject|1|||
160812360|NCT03012828|580696527|FG000|Overall Study|Non-compliance with protocol|0|||
160812361|NCT03012828|580696528|FG001|Overall Study|Non-compliance with protocol|0|||
160812362|NCT03012828|580696529|FG002|Overall Study|Non-compliance with protocol|0|||
160812363|NCT03012828|580696530|FG003|Overall Study|Non-compliance with protocol|0|||
160812364|NCT03012828|580696531|FG004|Overall Study|Non-compliance with protocol|1|||
160812365|NCT03012828|580696532|FG005|Overall Study|Non-compliance with protocol|0|||
160812366|NCT03012828|580696527|FG000|Overall Study|Delay to last visit would delay DBL|0|||
160812367|NCT03012828|580696528|FG001|Overall Study|Delay to last visit would delay DBL|0|||
160812368|NCT03012828|580696529|FG002|Overall Study|Delay to last visit would delay DBL|0|||
160812369|NCT03012828|580696530|FG003|Overall Study|Delay to last visit would delay DBL|0|||
160812370|NCT03012828|580696531|FG004|Overall Study|Delay to last visit would delay DBL|0|||
160812371|NCT03012828|580696532|FG005|Overall Study|Delay to last visit would delay DBL|1|||
160812372|NCT01970241|580696533|FG000|Overall Study|Withdrawal by Subject|2|||
160812373|NCT01970241|580696534|FG001|Overall Study|Withdrawal by Subject|0|||
160812374|NCT01970241|580696533|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
160552190|NCT01920711|579746932|FG000|Overall Study|Lost to Follow-up|13|||
160552191|NCT01920711|579746933|FG001|Overall Study|Lost to Follow-up|14|||
160552192|NCT01920711|579746932|FG000|Overall Study|Withdrawal by Subject|4|||
160552193|NCT01920711|579746933|FG001|Overall Study|Withdrawal by Subject|3|||
160552194|NCT00603915|579746934|FG000|Overall Study|Physician Decision|1|||
160812375|NCT01970241|580696534|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
160812376|NCT01107392|580696535|FG000|Overall Study|Adverse Event|2|||
160812377|NCT01107392|580696536|FG001|Overall Study|Adverse Event|0|||
160812378|NCT01107392|580696535|FG000|Overall Study|Personal Reasons|2|||
160812379|NCT01107392|580696536|FG001|Overall Study|Personal Reasons|3|||
160812380|NCT01107392|580696535|FG000|Overall Study|Administrative decision|1|||
160812381|NCT01107392|580696536|FG001|Overall Study|Administrative decision|0|||
160812382|NCT02689206|580696540|FG000|Overall Study|Adverse Event|0|||
160812383|NCT02689206|580696541|FG001|Overall Study|Adverse Event|0|||
160812384|NCT02689206|580696542|FG002|Overall Study|Adverse Event|1|||
160812385|NCT02689206|580696543|FG003|Overall Study|Adverse Event|0|||
160812386|NCT02689206|580696544|FG004|Overall Study|Adverse Event|2|||
160812387|NCT02689206|580696540|FG000|Overall Study|Protocol Violation|1|||
160812388|NCT02689206|580696541|FG001|Overall Study|Protocol Violation|0|||
160812389|NCT02689206|580696542|FG002|Overall Study|Protocol Violation|0|||
160812390|NCT02689206|580696543|FG003|Overall Study|Protocol Violation|1|||
160812391|NCT02689206|580696544|FG004|Overall Study|Protocol Violation|2|||
160812392|NCT02689206|580696540|FG000|Overall Study|Other: Reached stopping criteria|0|||
160812393|NCT02689206|580696541|FG001|Overall Study|Other: Reached stopping criteria|1|||
160812394|NCT02689206|580696542|FG002|Overall Study|Other: Reached stopping criteria|2|||
160812395|NCT02689206|580696543|FG003|Overall Study|Other: Reached stopping criteria|3|||
160812396|NCT02689206|580696544|FG004|Overall Study|Other: Reached stopping criteria|4|||
160812397|NCT02689206|580696540|FG000|Overall Study|Physician Decision|1|||
160812398|NCT02689206|580696541|FG001|Overall Study|Physician Decision|0|||
160812399|NCT02689206|580696542|FG002|Overall Study|Physician Decision|0|||
160812400|NCT02689206|580696543|FG003|Overall Study|Physician Decision|0|||
160812401|NCT02689206|580696544|FG004|Overall Study|Physician Decision|0|||
160812402|NCT02689206|580696540|FG000|Overall Study|Withdrawal by Subject|1|||
160812403|NCT02689206|580696541|FG001|Overall Study|Withdrawal by Subject|0|||
160812404|NCT02689206|580696542|FG002|Overall Study|Withdrawal by Subject|1|||
160812405|NCT02689206|580696543|FG003|Overall Study|Withdrawal by Subject|0|||
160812406|NCT02689206|580696544|FG004|Overall Study|Withdrawal by Subject|0|||
160900035|NCT01522248|581028620|FG000|Overall Study|Lost to Follow-up|1|||
160900036|NCT01522248|581028621|FG001|Overall Study|Lost to Follow-up|0|||
160900037|NCT01332331|581028623|FG000|Overall Study|Lost to Follow-up|0|||
160900038|NCT01332331|581028624|FG001|Overall Study|Lost to Follow-up|1|||
160900039|NCT01332331|581028623|FG000|Overall Study|Adverse Event|1|||
160900040|NCT01332331|581028624|FG001|Overall Study|Adverse Event|1|||
160900041|NCT01332331|581028623|FG000|Overall Study|Physician Decision|1|||
160900042|NCT01332331|581028624|FG001|Overall Study|Physician Decision|0|||
160552195|NCT03891901|579746935|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
160812407|NCT02520388|580696545|FG000|Overall Study|Physician Decision|1|||
160812408|NCT02520388|580696546|FG001|Overall Study|Physician Decision|0|||
160812409|NCT02520388|580696545|FG000|Overall Study|Subject or parent/guardian request|0|||
160812410|NCT02520388|580696546|FG001|Overall Study|Subject or parent/guardian request|6|||
160900043|NCT04674644|581028633|FG000|Overall Study|with missing data|37|||
160900044|NCT03469934|581028635|FG000|Overall Study|Withdrawal by Subject|0|||
160900045|NCT03469934|581028636|FG001|Overall Study|Withdrawal by Subject|1|||
160900046|NCT01691898|581028637|FG000|Overall Study|Death|34|||
160900047|NCT01691898|581028638|FG001|Overall Study|Death|32|||
160812411|NCT02520388|580696545|FG000|Overall Study|Adverse Event|1|||
160812412|NCT02520388|580696546|FG001|Overall Study|Adverse Event|4|||
160812413|NCT02520388|580696545|FG000|Overall Study|Lost to Follow-up|3|||
160812414|NCT02520388|580696546|FG001|Overall Study|Lost to Follow-up|2|||
160900048|NCT01691898|581028639|FG002|Overall Study|Death|6|||
160900049|NCT01691898|581028640|FG003|Overall Study|Death|3|||
160812415|NCT02520388|580696545|FG000|Overall Study|Other (reason not defined)|4|||
160812416|NCT02520388|580696546|FG001|Overall Study|Other (reason not defined)|4|||
160812417|NCT01437111|580696547|FG000|Overall Study|Adverse Event|2|||
160812418|NCT01437111|580696547|FG000|Overall Study|Withdrawal by Subject|4|||
160812419|NCT01437111|580696547|FG000|Overall Study|Not reported|5|||
160812420|NCT01437111|580696547|FG000|Overall Study|Physician Decision|1|||
160812421|NCT01437111|580696547|FG000|Overall Study|Lost to Follow-up|5|||
160812422|NCT01437111|580696547|FG000|Overall Study|Protocol Violation|1|||
160812423|NCT01232127|580696548|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
160812424|NCT01232127|580696549|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
160812425|NCT01232127|580696550|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
160812426|NCT02623205|580696553|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
160812427|NCT02623205|580696554|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
160812428|NCT03062280|580697916|FG000|Overall Study|Adverse Event|1|||
160812429|NCT03062280|580697916|FG000|Overall Study|Death|1|||
160812430|NCT03062280|580697916|FG000|Overall Study|Fertility Treatment|2|||
160645296|NCT00718159|580084201|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
160645297|NCT00718159|580084202|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
160645298|NCT00718159|580084203|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
160812431|NCT03062280|580697916|FG000|Overall Study|Physician Decision|2|||
160812432|NCT03062280|580697916|FG000|Overall Study|Pregnancy|5|||
160812433|NCT03062280|580697916|FG000|Overall Study|Withdrawal by Subject|11|||
160812434|NCT00022763|580697917|FG000|Overall Study|Adverse Event|1|||
160812435|NCT00022763|580697918|FG001|Overall Study|Adverse Event|2|||
160812436|NCT00022763|580697917|FG000|Overall Study|Injection Site Reactions|0|||
160812437|NCT00022763|580697918|FG001|Overall Study|Injection Site Reactions|2|||
160812438|NCT00022763|580697917|FG000|Overall Study|Death|0|||
160812439|NCT00022763|580697918|FG001|Overall Study|Death|1|||
160812440|NCT00022763|580697917|FG000|Overall Study|Lost to Follow-up|0|||
160812441|NCT00022763|580697918|FG001|Overall Study|Lost to Follow-up|3|||
160812442|NCT00022763|580697917|FG000|Overall Study|Withdrawal by Subject|4|||
160812443|NCT00022763|580697918|FG001|Overall Study|Withdrawal by Subject|7|||
160812444|NCT00022763|580697917|FG000|Overall Study|Insufficient Therapy|1|||
160812445|NCT00022763|580697918|FG001|Overall Study|Insufficient Therapy|0|||
160812446|NCT00022763|580697917|FG000|Overall Study|Admin|3|||
160812447|NCT00022763|580697918|FG001|Overall Study|Admin|2|||
160812448|NCT03248531|580697919|FG000|Overall Study|Adverse Event|0|||
160812449|NCT03248531|580697920|FG001|Overall Study|Adverse Event|0|||
160812450|NCT03248531|580697921|FG002|Overall Study|Adverse Event|1|||
160812451|NCT03248531|580697919|FG000|Overall Study|Lost to Follow-up|1|||
160812452|NCT03248531|580697920|FG001|Overall Study|Lost to Follow-up|0|||
160812453|NCT03248531|580697921|FG002|Overall Study|Lost to Follow-up|5|||
160812454|NCT03248531|580697919|FG000|Overall Study|Withdrawal by Subject|3|||
160812455|NCT03248531|580697920|FG001|Overall Study|Withdrawal by Subject|3|||
160812456|NCT03248531|580697921|FG002|Overall Study|Withdrawal by Subject|2|||
160812457|NCT03248531|580697919|FG000|Overall Study|Sponsor Request|0|||
160812458|NCT03248531|580697920|FG001|Overall Study|Sponsor Request|2|||
160812459|NCT03248531|580697921|FG002|Overall Study|Sponsor Request|0|||
160812460|NCT04908865|580697922|FG000|Overall Study|Adverse Event|2|||
160812461|NCT04908865|580697922|FG000|Overall Study|Lack of Efficacy|5|||
160812462|NCT04908865|580697922|FG000|Overall Study|Lost to Follow-up|1|||
160812463|NCT05286658|580697923|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
160812464|NCT05286658|580697923|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
160812465|NCT00842153|580697926|FG000|Overall Study|Adverse Event|0|||
160812466|NCT00842153|580697927|FG001|Overall Study|Adverse Event|1|||
160812467|NCT00842153|580697926|FG000|Overall Study|Lost to Follow-up|1|||
160812468|NCT00842153|580697927|FG001|Overall Study|Lost to Follow-up|2|||
160812469|NCT02201329|580697929|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
160812470|NCT02201329|580697929|FG000|Overall Study|Withdrawal by Subject|2|||
160812471|NCT00470262|580697930|FG000|Overall Study|Withdrawal by Subject|2|||
160812472|NCT00470262|580697931|FG001|Overall Study|Withdrawal by Subject|0|||
160812473|NCT01509846|580697932|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
160812474|NCT01509846|580697933|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
160812475|NCT01509846|580697934|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
160812476|NCT01509846|580697935|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
160812477|NCT01509846|580697936|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
160812478|NCT01509846|580697932|FG000|Received Vaccination 2|Illness|0|||
160812479|NCT01509846|580697933|FG001|Received Vaccination 2|Illness|0|||
160812480|NCT01509846|580697934|FG002|Received Vaccination 2|Illness|0|||
160812481|NCT01509846|580697935|FG003|Received Vaccination 2|Illness|0|||
160812482|NCT01509846|580697936|FG004|Received Vaccination 2|Illness|1|||
160812483|NCT01509846|580697932|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
160812484|NCT01509846|580697933|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
160812485|NCT01509846|580697934|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
160812486|NCT01509846|580697935|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
160900050|NCT01691898|581028641|FG004|Overall Study|Death|8|||
160900051|NCT01691898|581028642|FG005|Overall Study|Death|31|||
160900052|NCT01691898|581028637|FG000|Overall Study|Adverse Event|0|||
160900053|NCT01691898|581028638|FG001|Overall Study|Adverse Event|1|||
160986828|NCT04955626|581341112|FG007|Blinded Period|No longer meets eligibility criteria|0|||
160986829|NCT04955626|581341113|FG008|Blinded Period|No longer meets eligibility criteria|1|||
160986830|NCT04955626|581341114|FG009|Blinded Period|No longer meets eligibility criteria|0|||
160986831|NCT04955626|581341115|FG010|Blinded Period|No longer meets eligibility criteria|1|||
160986832|NCT04955626|581341116|FG011|Blinded Period|No longer meets eligibility criteria|1|||
160986833|NCT04955626|581341117|FG012|Blinded Period|No longer meets eligibility criteria|0|||
160986834|NCT04955626|581341118|FG013|Blinded Period|No longer meets eligibility criteria|0|||
160986835|NCT04955626|581341119|FG014|Blinded Period|No longer meets eligibility criteria|0|||
160986836|NCT04955626|581341120|FG015|Blinded Period|No longer meets eligibility criteria|3|||
160900054|NCT01691898|581028639|FG002|Overall Study|Adverse Event|0|||
160900055|NCT01691898|581028640|FG003|Overall Study|Adverse Event|1|||
160986837|NCT04955626|581341121|FG016|Blinded Period|No longer meets eligibility criteria|0|||
160986838|NCT04955626|581341122|FG017|Blinded Period|No longer meets eligibility criteria|2|||
160986839|NCT04955626|581341123|FG018|Blinded Period|No longer meets eligibility criteria|0|||
160986840|NCT04955626|581341124|FG019|Blinded Period|No longer meets eligibility criteria|0|||
160986841|NCT04955626|581341125|FG020|Blinded Period|No longer meets eligibility criteria|0|||
160986842|NCT04955626|581341126|FG021|Blinded Period|No longer meets eligibility criteria|0|||
160986843|NCT04955626|581341127|FG022|Blinded Period|No longer meets eligibility criteria|0|||
160986844|NCT04955626|581341128|FG023|Blinded Period|No longer meets eligibility criteria|0|||
160986845|NCT04955626|581341129|FG024|Blinded Period|No longer meets eligibility criteria|1|||
160986846|NCT04955626|581341130|FG025|Blinded Period|No longer meets eligibility criteria|0|||
160900056|NCT01691898|581028641|FG004|Overall Study|Adverse Event|1|||
160900057|NCT01691898|581028642|FG005|Overall Study|Adverse Event|0|||
160900058|NCT01691898|581028637|FG000|Overall Study|Progression of Disease|1|||
160900059|NCT01691898|581028638|FG001|Overall Study|Progression of Disease|2|||
160900060|NCT01691898|581028639|FG002|Overall Study|Progression of Disease|1|||
160900061|NCT01691898|581028640|FG003|Overall Study|Progression of Disease|0|||
160900062|NCT01691898|581028641|FG004|Overall Study|Progression of Disease|0|||
160900063|NCT01691898|581028642|FG005|Overall Study|Progression of Disease|1|||
160900064|NCT01691898|581028637|FG000|Overall Study|Lost to Follow-up|3|||
160900065|NCT01691898|581028638|FG001|Overall Study|Lost to Follow-up|1|||
160900066|NCT01691898|581028639|FG002|Overall Study|Lost to Follow-up|0|||
160900067|NCT01691898|581028640|FG003|Overall Study|Lost to Follow-up|0|||
160900068|NCT01691898|581028641|FG004|Overall Study|Lost to Follow-up|1|||
160900069|NCT01691898|581028642|FG005|Overall Study|Lost to Follow-up|0|||
160900070|NCT01691898|581028637|FG000|Overall Study|Withdrawal by Subject|9|||
160900071|NCT01691898|581028638|FG001|Overall Study|Withdrawal by Subject|8|||
160900072|NCT01691898|581028639|FG002|Overall Study|Withdrawal by Subject|2|||
160900073|NCT01691898|581028640|FG003|Overall Study|Withdrawal by Subject|1|||
160900074|NCT01691898|581028641|FG004|Overall Study|Withdrawal by Subject|3|||
160900075|NCT01691898|581028642|FG005|Overall Study|Withdrawal by Subject|3|||
160900076|NCT01691898|581028637|FG000|Overall Study|Non-Compliance|0|||
160900077|NCT01691898|581028638|FG001|Overall Study|Non-Compliance|0|||
160900078|NCT01691898|581028639|FG002|Overall Study|Non-Compliance|0|||
160900079|NCT01691898|581028640|FG003|Overall Study|Non-Compliance|0|||
160900080|NCT01691898|581028641|FG004|Overall Study|Non-Compliance|1|||
160900081|NCT01691898|581028642|FG005|Overall Study|Non-Compliance|0|||
160900082|NCT01013350|581028643|FG000|Overall Study|Lost to Follow-up|15|||
160900083|NCT01013350|581028644|FG001|Overall Study|Lost to Follow-up|95|||
160900084|NCT01013350|581028643|FG000|Overall Study|Adverse Event|0|||
160900085|NCT01013350|581028644|FG001|Overall Study|Adverse Event|1|||
160900086|NCT01013350|581028643|FG000|Overall Study|Physician Decision|4|||
160900087|NCT01013350|581028644|FG001|Overall Study|Physician Decision|20|||
160900088|NCT01013350|581028643|FG000|Overall Study|Withdrawal by Subject|15|||
160900089|NCT01013350|581028644|FG001|Overall Study|Withdrawal by Subject|38|||
160900090|NCT01013350|581028643|FG000|Overall Study|Death|3|||
160900091|NCT01013350|581028644|FG001|Overall Study|Death|5|||
160900092|NCT01013350|581028643|FG000|Overall Study|Participant entered interventional study|0|||
160986847|NCT04955626|581341131|FG026|Blinded Period|No longer meets eligibility criteria|0|||
160986848|NCT04955626|581341132|FG027|Blinded Period|No longer meets eligibility criteria|1|||
160986849|NCT04955626|581341133|FG028|Blinded Period|No longer meets eligibility criteria|0|||
160986850|NCT04955626|581341134|FG029|Blinded Period|No longer meets eligibility criteria|0|||
160986851|NCT04955626|581341135|FG030|Blinded Period|No longer meets eligibility criteria|0|||
160986852|NCT04955626|581341136|FG031|Blinded Period|No longer meets eligibility criteria|0|||
160986853|NCT04955626|581341137|FG032|Blinded Period|No longer meets eligibility criteria|0|||
160986854|NCT04955626|581341138|FG033|Blinded Period|No longer meets eligibility criteria|0|||
160986855|NCT04955626|581341139|FG034|Blinded Period|No longer meets eligibility criteria|0|||
160986856|NCT04955626|581341140|FG035|Blinded Period|No longer meets eligibility criteria|0|||
160986857|NCT04955626|581341105|FG000|Blinded Period|Other|54|||
160986858|NCT04955626|581341106|FG001|Blinded Period|Other|3|||
160986859|NCT04955626|581341107|FG002|Blinded Period|Other|4|||
160986860|NCT04955626|581341108|FG003|Blinded Period|Other|2|||
160986861|NCT04955626|581341109|FG004|Blinded Period|Other|0|||
160986862|NCT04955626|581341110|FG005|Blinded Period|Other|0|||
160986863|NCT04955626|581341111|FG006|Blinded Period|Other|2|||
160986864|NCT04955626|581341112|FG007|Blinded Period|Other|2|||
160986865|NCT04955626|581341113|FG008|Blinded Period|Other|1|||
160986866|NCT04955626|581341114|FG009|Blinded Period|Other|0|||
160986867|NCT04955626|581341115|FG010|Blinded Period|Other|1|||
160986868|NCT04955626|581341116|FG011|Blinded Period|Other|1|||
160986869|NCT04955626|581341117|FG012|Blinded Period|Other|0|||
160986870|NCT04955626|581341118|FG013|Blinded Period|Other|0|||
160986871|NCT04955626|581341119|FG014|Blinded Period|Other|0|||
160986872|NCT04955626|581341120|FG015|Blinded Period|Other|0|||
160986873|NCT04955626|581341121|FG016|Blinded Period|Other|0|||
160986874|NCT04955626|581341122|FG017|Blinded Period|Other|1|||
160986875|NCT04955626|581341123|FG018|Blinded Period|Other|0|||
160986876|NCT04955626|581341124|FG019|Blinded Period|Other|0|||
160986877|NCT04955626|581341125|FG020|Blinded Period|Other|0|||
160986878|NCT04955626|581341126|FG021|Blinded Period|Other|0|||
160986879|NCT04955626|581341127|FG022|Blinded Period|Other|0|||
160986880|NCT04955626|581341128|FG023|Blinded Period|Other|0|||
160986881|NCT04955626|581341129|FG024|Blinded Period|Other|0|||
160986882|NCT04955626|581341130|FG025|Blinded Period|Other|0|||
160986883|NCT04955626|581341131|FG026|Blinded Period|Other|2|||
160986884|NCT04955626|581341132|FG027|Blinded Period|Other|0|||
160986885|NCT04955626|581341133|FG028|Blinded Period|Other|0|||
160986886|NCT04955626|581341134|FG029|Blinded Period|Other|0|||
160986887|NCT04955626|581341135|FG030|Blinded Period|Other|0|||
160986888|NCT04955626|581341136|FG031|Blinded Period|Other|0|||
160986889|NCT04955626|581341137|FG032|Blinded Period|Other|0|||
160986890|NCT04955626|581341138|FG033|Blinded Period|Other|0|||
160986891|NCT04955626|581341139|FG034|Blinded Period|Other|0|||
160986892|NCT04955626|581341140|FG035|Blinded Period|Other|0|||
160986893|NCT04955626|581341105|FG000|Blinded Period|Physician Decision|1|||
160986894|NCT04955626|581341106|FG001|Blinded Period|Physician Decision|1|||
160986895|NCT04955626|581341107|FG002|Blinded Period|Physician Decision|0|||
160986896|NCT04955626|581341108|FG003|Blinded Period|Physician Decision|3|||
160986897|NCT04955626|581341109|FG004|Blinded Period|Physician Decision|0|||
160986898|NCT04955626|581341110|FG005|Blinded Period|Physician Decision|0|||
160986899|NCT04955626|581341111|FG006|Blinded Period|Physician Decision|1|||
160986900|NCT04955626|581341112|FG007|Blinded Period|Physician Decision|1|||
160986901|NCT04955626|581341113|FG008|Blinded Period|Physician Decision|0|||
160986902|NCT04955626|581341114|FG009|Blinded Period|Physician Decision|0|||
160986903|NCT04955626|581341115|FG010|Blinded Period|Physician Decision|0|||
160986904|NCT04955626|581341116|FG011|Blinded Period|Physician Decision|5|||
160986905|NCT04955626|581341117|FG012|Blinded Period|Physician Decision|0|||
160986906|NCT04955626|581341118|FG013|Blinded Period|Physician Decision|0|||
160986907|NCT04955626|581341119|FG014|Blinded Period|Physician Decision|0|||
160986908|NCT04955626|581341120|FG015|Blinded Period|Physician Decision|0|||
160986909|NCT04955626|581341121|FG016|Blinded Period|Physician Decision|0|||
160986910|NCT04955626|581341122|FG017|Blinded Period|Physician Decision|0|||
160986911|NCT04955626|581341123|FG018|Blinded Period|Physician Decision|0|||
160986912|NCT04955626|581341124|FG019|Blinded Period|Physician Decision|0|||
160986913|NCT04955626|581341125|FG020|Blinded Period|Physician Decision|0|||
160986914|NCT04955626|581341126|FG021|Blinded Period|Physician Decision|0|||
160986915|NCT04955626|581341127|FG022|Blinded Period|Physician Decision|0|||
160986916|NCT04955626|581341128|FG023|Blinded Period|Physician Decision|0|||
160986917|NCT04955626|581341129|FG024|Blinded Period|Physician Decision|0|||
160986918|NCT04955626|581341130|FG025|Blinded Period|Physician Decision|0|||
160986919|NCT04955626|581341131|FG026|Blinded Period|Physician Decision|0|||
160812487|NCT01509846|580697936|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
160812488|NCT01509846|580697932|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
160812489|NCT01509846|580697933|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
160812490|NCT01509846|580697934|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
160812491|NCT01509846|580697935|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
160812492|NCT01509846|580697936|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
160812493|NCT01509846|580697932|FG000|Received Vaccination 3|Pregnancy|0|||
160812494|NCT01509846|580697933|FG001|Received Vaccination 3|Pregnancy|0|||
160812495|NCT01509846|580697934|FG002|Received Vaccination 3|Pregnancy|0|||
160812496|NCT01509846|580697935|FG003|Received Vaccination 3|Pregnancy|1|||
160812497|NCT01509846|580697936|FG004|Received Vaccination 3|Pregnancy|0|||
160812498|NCT01509846|580697932|FG000|Received Vaccination 3|Lost to Follow-up|0|||
160812499|NCT01509846|580697933|FG001|Received Vaccination 3|Lost to Follow-up|0|||
160812500|NCT01509846|580697934|FG002|Received Vaccination 3|Lost to Follow-up|1|||
160812501|NCT01509846|580697935|FG003|Received Vaccination 3|Lost to Follow-up|0|||
160812502|NCT01509846|580697936|FG004|Received Vaccination 3|Lost to Follow-up|0|||
160812503|NCT01637584|580697938|FG000|Overall Study|Withdrawal by Subject|1|||
160812504|NCT01637584|580697939|FG001|Overall Study|Withdrawal by Subject|3|||
160812505|NCT04396795|580697940|FG000|Month 1|Lost to Follow-up|2|||
160812506|NCT04396795|580697941|FG001|Month 1|Lost to Follow-up|3|||
160812507|NCT04396795|580697940|FG000|Month 3|Lost to Follow-up|1|||
160812508|NCT04396795|580697941|FG001|Month 3|Lost to Follow-up|3|||
160812509|NCT04396795|580697940|FG000|Month 6|Lost to Follow-up|3|||
160812510|NCT04396795|580697941|FG001|Month 6|Lost to Follow-up|3|||
160812511|NCT02366923|580697942|FG000|Overall Study|Withdrawal by Subject|1|||
160812512|NCT02366923|580697942|FG000|Overall Study|Positive Slit Lamp Findings|2|||
160812513|NCT02366923|580697942|FG000|Overall Study|High Astigmatism|3|||
160812514|NCT02484443|580697943|FG000|Overall Study|Lack of Efficacy|28|||
160812515|NCT02484443|580697943|FG000|Overall Study|Physician Decision|2|||
160812516|NCT02484443|580697943|FG000|Overall Study|Ineligible|2|||
160812517|NCT02122146|580697944|FG000|Part 1: Dose Escalation|Death|0|||
160812518|NCT02122146|580697945|FG001|Part 1: Dose Escalation|Death|1|||
160812519|NCT02122146|580697946|FG002|Part 1: Dose Escalation|Death|1|||
160812520|NCT02122146|580697947|FG003|Part 1: Dose Escalation|Death|0|||
160812521|NCT02122146|580697948|FG004|Part 1: Dose Escalation|Death|0|||
160812522|NCT02122146|580697949|FG005|Part 1: Dose Escalation|Death|0|||
160812523|NCT02122146|580697950|FG006|Part 1: Dose Escalation|Death|0|||
160812524|NCT02122146|580697951|FG007|Part 1: Dose Escalation|Death|0|||
160812525|NCT02122146|580697944|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812526|NCT02122146|580697945|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812527|NCT02122146|580697946|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
160812528|NCT02122146|580697947|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812529|NCT02122146|580697948|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
160812530|NCT02122146|580697949|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812531|NCT02122146|580697950|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812532|NCT02122146|580697951|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812533|NCT02122146|580697944|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812534|NCT02122146|580697945|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812535|NCT02122146|580697946|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812536|NCT02122146|580697947|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
160812537|NCT02122146|580697948|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812538|NCT02122146|580697949|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812539|NCT02122146|580697950|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812540|NCT02122146|580697951|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812541|NCT02122146|580697944|FG000|Part 1: Dose Escalation|Other|1|||
160812542|NCT02122146|580697945|FG001|Part 1: Dose Escalation|Other|0|||
160812543|NCT02122146|580697946|FG002|Part 1: Dose Escalation|Other|0|||
160812544|NCT02122146|580697947|FG003|Part 1: Dose Escalation|Other|0|||
160812545|NCT02122146|580697948|FG004|Part 1: Dose Escalation|Other|0|||
160812546|NCT02122146|580697949|FG005|Part 1: Dose Escalation|Other|1|||
160812547|NCT02122146|580697950|FG006|Part 1: Dose Escalation|Other|1|||
160812548|NCT02122146|580697951|FG007|Part 1: Dose Escalation|Other|2|||
160812549|NCT03472495|580697952|FG000|Overall Study|Treatment no longer indicated|1|||
160812550|NCT03472495|580697953|FG001|Overall Study|Treatment no longer indicated|2|||
160812551|NCT03472495|580697952|FG000|Overall Study|Physician Decision|0|||
160812552|NCT03472495|580697953|FG001|Overall Study|Physician Decision|2|||
160812553|NCT00992056|580697956|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
160812554|NCT00992056|580697957|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
160812555|NCT00992056|580697956|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
160812556|NCT00992056|580697957|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
160812557|NCT02595866|580697958|FG000|Overall Study|Adverse Event|2|||
160812558|NCT02595866|580697959|FG001|Overall Study|Adverse Event|5|||
160812559|NCT02595866|580697958|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
160812560|NCT02595866|580697959|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
160812561|NCT02595866|580697958|FG000|Overall Study|Death|0|||
160812562|NCT02595866|580697959|FG001|Overall Study|Death|1|||
160812563|NCT02595866|580697958|FG000|Overall Study|Incarceration|1|||
160812564|NCT02595866|580697959|FG001|Overall Study|Incarceration|0|||
160812565|NCT02595866|580697958|FG000|Overall Study|Lack of Efficacy|17|||
160812566|NCT02595866|580697959|FG001|Overall Study|Lack of Efficacy|7|||
160812567|NCT02595866|580697958|FG000|Overall Study|Physician Decision|4|||
160812568|NCT02595866|580697959|FG001|Overall Study|Physician Decision|3|||
160812569|NCT02595866|580697958|FG000|Overall Study|Switched to Alternative Treatment|1|||
160812570|NCT02595866|580697959|FG001|Overall Study|Switched to Alternative Treatment|0|||
160812571|NCT02595866|580697958|FG000|Overall Study|Study Terminated|0|||
160812572|NCT02595866|580697959|FG001|Overall Study|Study Terminated|4|||
160812573|NCT02595866|580697958|FG000|Overall Study|Withdrawal by Subject|6|||
160812574|NCT02595866|580697959|FG001|Overall Study|Withdrawal by Subject|1|||
160812575|NCT01001767|580697962|FG000|Overall Study|no baseline study performed|1|||
160812576|NCT01001767|580697963|FG001|Overall Study|no baseline study performed|0|||
160812577|NCT01001767|580697962|FG000|Overall Study|Protocol Violation|1|||
160812578|NCT01001767|580697963|FG001|Overall Study|Protocol Violation|0|||
160812579|NCT01001767|580697962|FG000|Overall Study|Lost to Follow-up|1|||
160812580|NCT01001767|580697963|FG001|Overall Study|Lost to Follow-up|0|||
160812581|NCT01001767|580697962|FG000|Overall Study|Physician Decision|1|||
160812582|NCT01001767|580697963|FG001|Overall Study|Physician Decision|0|||
160812583|NCT02584452|580697964|FG000|Overall Study|Physician Decision|1|||
160812584|NCT02584452|580697965|FG001|Overall Study|Physician Decision|1|||
160812585|NCT02584452|580697964|FG000|Overall Study|Lost to Follow-up|1|||
160812586|NCT02584452|580697965|FG001|Overall Study|Lost to Follow-up|1|||
160812587|NCT00851552|580697966|FG000|Overall Study|Death|2|||
160812588|NCT00851552|580697966|FG000|Overall Study|Adverse Event|1|||
160812589|NCT00851552|580697966|FG000|Overall Study|Disease Progression|4|||
160812590|NCT00177294|580697967|FG000|Overall Study|Withdrawal by Subject|7|||
160812591|NCT00177294|580697968|FG001|Overall Study|Withdrawal by Subject|5|||
160812592|NCT02998671|580697969|FG000|Period 1|Study Terminated By Sponsor|2|||
160812593|NCT02998671|580697970|FG001|Period 1|Study Terminated By Sponsor|1|||
160812594|NCT02998671|580697971|FG002|Period 1|Study Terminated By Sponsor|0|||
160812595|NCT02998671|580697972|FG003|Period 1|Study Terminated By Sponsor|0|||
160812596|NCT02998671|580697973|FG004|Period 1|Study Terminated By Sponsor|1|||
160812597|NCT02998671|580697969|FG000|Period 1|Withdrawal by Subject|1|||
160812598|NCT02998671|580697970|FG001|Period 1|Withdrawal by Subject|2|||
160812599|NCT02998671|580697971|FG002|Period 1|Withdrawal by Subject|0|||
160812600|NCT02998671|580697972|FG003|Period 1|Withdrawal by Subject|0|||
160812601|NCT02998671|580697973|FG004|Period 1|Withdrawal by Subject|2|||
160552196|NCT03891901|579746936|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
160812602|NCT02998671|580697969|FG000|Period 1|Pregnancy|1|||
160812603|NCT02998671|580697970|FG001|Period 1|Pregnancy|0|||
160812604|NCT02998671|580697971|FG002|Period 1|Pregnancy|0|||
160812605|NCT02998671|580697972|FG003|Period 1|Pregnancy|0|||
160812606|NCT02998671|580697973|FG004|Period 1|Pregnancy|0|||
160812607|NCT02998671|580697969|FG000|Period 1|Adverse Event|0|||
160812608|NCT02998671|580697970|FG001|Period 1|Adverse Event|0|||
160812609|NCT02998671|580697971|FG002|Period 1|Adverse Event|0|||
160812610|NCT02998671|580697972|FG003|Period 1|Adverse Event|0|||
160812611|NCT02998671|580697973|FG004|Period 1|Adverse Event|1|||
160812612|NCT02998671|580697969|FG000|Period 2|Adverse Event|0|||
160812613|NCT02998671|580697970|FG001|Period 2|Adverse Event|1|||
160812614|NCT02998671|580697971|FG002|Period 2|Adverse Event|0|||
160552197|NCT03891901|579746937|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
160552198|NCT03891901|579746938|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
160552199|NCT03891901|579746939|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
160552200|NCT03891901|579746940|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
160812615|NCT02998671|580697972|FG003|Period 2|Adverse Event|0|||
160812616|NCT02998671|580697973|FG004|Period 2|Adverse Event|0|||
160812617|NCT02998671|580697969|FG000|Period 2|Study Terminated By Sponsor|3|||
160812618|NCT02998671|580697970|FG001|Period 2|Study Terminated By Sponsor|5|||
160812619|NCT02998671|580697971|FG002|Period 2|Study Terminated By Sponsor|1|||
160812620|NCT02998671|580697972|FG003|Period 2|Study Terminated By Sponsor|3|||
160812621|NCT02998671|580697973|FG004|Period 2|Study Terminated By Sponsor|0|||
160812622|NCT02998671|580697969|FG000|Period 2|Withdrawal by Subject|0|||
160812623|NCT02998671|580697970|FG001|Period 2|Withdrawal by Subject|1|||
160812624|NCT02998671|580697971|FG002|Period 2|Withdrawal by Subject|0|||
160812625|NCT02998671|580697972|FG003|Period 2|Withdrawal by Subject|0|||
160812626|NCT02998671|580697973|FG004|Period 2|Withdrawal by Subject|0|||
160812627|NCT02998671|580697969|FG000|Period 2|Lost to Follow-up|0|||
160812628|NCT02998671|580697970|FG001|Period 2|Lost to Follow-up|0|||
160812629|NCT02998671|580697971|FG002|Period 2|Lost to Follow-up|0|||
160812630|NCT02998671|580697972|FG003|Period 2|Lost to Follow-up|1|||
160812631|NCT02998671|580697973|FG004|Period 2|Lost to Follow-up|0|||
160812632|NCT02038946|580697974|FG000|Overall Study|Death|5|||
160812633|NCT02038946|580697974|FG000|Overall Study|Withdrawal by Subject|3|||
160812634|NCT02038946|580697974|FG000|Overall Study|Lost to Follow-up|2|||
160812635|NCT02038946|580697974|FG000|Overall Study|Other reasons|2|||
160812636|NCT02131311|580697978|FG000|Overall Study|Adverse Event|2|||
160812637|NCT02131311|580697978|FG000|Overall Study|Protocol Violation|1|||
160812638|NCT02131311|580697978|FG000|Overall Study|Lost to Follow-up|1|||
160812639|NCT01479764|580697979|FG000|Randomized|Adverse Event|1|||
160812640|NCT01479764|580697980|FG001|Randomized|Adverse Event|1|||
160812641|NCT01479764|580697979|FG000|Randomized|Withdrawal by Subject|1|||
160812642|NCT01479764|580697980|FG001|Randomized|Withdrawal by Subject|0|||
160812643|NCT01479764|580697979|FG000|Treated|Lost to Follow-up|0|||
160812644|NCT01479764|580697980|FG001|Treated|Lost to Follow-up|2|||
160812645|NCT02473471|580697981|FG000|Overall Study|poor oral hygiene|2|||
160812646|NCT02473471|580697981|FG000|Overall Study|Lost to Follow-up|1|||
160812647|NCT03082677|580697982|FG000|Overall Study|Not Treated|2|||
160812648|NCT00255723|580697988|FG000|Overall Study|Adverse Event|1|||
160812649|NCT00255723|580697989|FG001|Overall Study|Adverse Event|1|||
160812650|NCT00255723|580697988|FG000|Overall Study|Death|0|||
160812651|NCT00255723|580697989|FG001|Overall Study|Death|1|||
160812652|NCT00255723|580697988|FG000|Overall Study|Response Data Not Available|1|||
160812653|NCT00255723|580697989|FG001|Overall Study|Response Data Not Available|0|||
160812654|NCT00191945|580697990|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
160812655|NCT00191945|580697991|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
160812656|NCT00191945|580697990|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
160812657|NCT00191945|580697991|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
160812658|NCT00191945|580697990|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
160812659|NCT00191945|580697991|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
160812660|NCT00191945|580697990|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
160812661|NCT00191945|580697991|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
160812662|NCT03711370|580697993|FG000|Overall Study|Lost to Follow-up|16|||
160812663|NCT03711370|580697994|FG001|Overall Study|Lost to Follow-up|10|||
160812664|NCT03711370|580697993|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
160812665|NCT03711370|580697994|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
160812666|NCT02063984|580697995|FG000|Overall Study|Lost to Follow-up|6|||
160812667|NCT02063984|580697996|FG001|Overall Study|Lost to Follow-up|5|||
160812668|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
160812669|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
160812670|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
160812671|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
160812672|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
160812673|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
160812674|NCT01030952|580698006|FG000|Overall Study|Protocol Violation|0|||
160812675|NCT01030952|580698007|FG001|Overall Study|Protocol Violation|1|||
160812676|NCT01030952|580698006|FG000|Overall Study|Informed consent withdrawal|1|||
160812677|NCT01030952|580698007|FG001|Overall Study|Informed consent withdrawal|0|||
160812678|NCT01030952|580698006|FG000|Overall Study|Lost to Follow-up|0|||
160812679|NCT01030952|580698007|FG001|Overall Study|Lost to Follow-up|1|||
160812680|NCT01030952|580698006|FG000|Overall Study|Unexplained|1|||
160812681|NCT01030952|580698007|FG001|Overall Study|Unexplained|1|||
160812682|NCT00431444|580698010|FG000|Overall Study|Protocol Violation|1|||
160812683|NCT00431444|580698011|FG001|Overall Study|Protocol Violation|4|||
160812684|NCT00431444|580698010|FG000|Overall Study|Adverse Event|2|||
160812685|NCT00431444|580698011|FG001|Overall Study|Adverse Event|1|||
160812686|NCT00431444|580698010|FG000|Overall Study|Withdrawal by Subject|1|||
160812687|NCT00431444|580698011|FG001|Overall Study|Withdrawal by Subject|1|||
160812688|NCT00431444|580698010|FG000|Overall Study|Lost to Follow-up|1|||
160812689|NCT00431444|580698011|FG001|Overall Study|Lost to Follow-up|0|||
160812690|NCT00431444|580698010|FG000|Overall Study|Administrative Problems|0|||
160812691|NCT00431444|580698011|FG001|Overall Study|Administrative Problems|1|||
160812692|NCT03583359|580698015|FG000|Overall Study|Withdrawal by Subject|15|||
160812693|NCT03583359|580698016|FG001|Overall Study|Withdrawal by Subject|6|||
160812694|NCT03583359|580698015|FG000|Overall Study|Lost to Follow-up|12|||
160812695|NCT03583359|580698016|FG001|Overall Study|Lost to Follow-up|3|||
160812696|NCT03583359|580698015|FG000|Overall Study|Adverse Event|0|||
160812697|NCT03583359|580698016|FG001|Overall Study|Adverse Event|1|||
160812698|NCT03583359|580698015|FG000|Overall Study|Protocol Violation|0|||
160812699|NCT03583359|580698016|FG001|Overall Study|Protocol Violation|1|||
160812700|NCT03583359|580698015|FG000|Overall Study|Other|2|||
160812701|NCT03583359|580698016|FG001|Overall Study|Other|1|||
160454061|NCT02038777|579394027|FG005|Overall Study|Randomized but not treated|0|||
160645299|NCT00718159|580084204|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
160812702|NCT03497039|580698017|FG000|Overall Study|Withdrawal by Subject|1|||
160812703|NCT03497039|580698018|FG001|Overall Study|Withdrawal by Subject|0|||
160812704|NCT03497039|580698017|FG000|Overall Study|Protocol Violation|0|||
160812705|NCT03497039|580698018|FG001|Overall Study|Protocol Violation|1|||
160812706|NCT02131662|580698020|FG000|Overall Study|Protocol Violation|1|||
160812707|NCT02131662|580698021|FG001|Overall Study|Protocol Violation|0|||
160812708|NCT02131662|580698022|FG002|Overall Study|Protocol Violation|0|||
160812709|NCT02131662|580698023|FG003|Overall Study|Protocol Violation|0|||
160812710|NCT02131662|580698024|FG004|Overall Study|Protocol Violation|0|||
160812711|NCT02131662|580698020|FG000|Overall Study|Other|2|||
160812712|NCT02131662|580698021|FG001|Overall Study|Other|4|||
160812713|NCT02131662|580698022|FG002|Overall Study|Other|3|||
160812714|NCT02131662|580698023|FG003|Overall Study|Other|3|||
160812715|NCT02131662|580698024|FG004|Overall Study|Other|4|||
160812716|NCT02131662|580698020|FG000|Overall Study|Adverse Event|0|||
160812717|NCT02131662|580698021|FG001|Overall Study|Adverse Event|1|||
160812718|NCT02131662|580698022|FG002|Overall Study|Adverse Event|1|||
160812719|NCT02131662|580698023|FG003|Overall Study|Adverse Event|1|||
160812720|NCT02131662|580698024|FG004|Overall Study|Adverse Event|3|||
160812721|NCT02131662|580698020|FG000|Overall Study|Pregnancy|0|||
160812722|NCT02131662|580698021|FG001|Overall Study|Pregnancy|1|||
160812723|NCT02131662|580698022|FG002|Overall Study|Pregnancy|0|||
160812724|NCT02131662|580698023|FG003|Overall Study|Pregnancy|1|||
160812725|NCT02131662|580698024|FG004|Overall Study|Pregnancy|0|||
160812726|NCT02131662|580698020|FG000|Overall Study|Wish for pregnancy|0|||
160812727|NCT02131662|580698021|FG001|Overall Study|Wish for pregnancy|0|||
160812728|NCT02131662|580698022|FG002|Overall Study|Wish for pregnancy|0|||
160812729|NCT02131662|580698023|FG003|Overall Study|Wish for pregnancy|0|||
160812730|NCT02131662|580698024|FG004|Overall Study|Wish for pregnancy|1|||
160812731|NCT02131662|580698020|FG000|Overall Study|Lack of Efficacy|1|||
160812732|NCT02131662|580698021|FG001|Overall Study|Lack of Efficacy|0|||
160812733|NCT02131662|580698022|FG002|Overall Study|Lack of Efficacy|0|||
160812734|NCT02131662|580698023|FG003|Overall Study|Lack of Efficacy|0|||
160812735|NCT02131662|580698024|FG004|Overall Study|Lack of Efficacy|1|||
160812736|NCT02131662|580698020|FG000|Overall Study|Withdrawal by Subject|1|||
160812737|NCT02131662|580698021|FG001|Overall Study|Withdrawal by Subject|5|||
160812738|NCT02131662|580698022|FG002|Overall Study|Withdrawal by Subject|1|||
160812739|NCT02131662|580698023|FG003|Overall Study|Withdrawal by Subject|5|||
160812740|NCT02131662|580698024|FG004|Overall Study|Withdrawal by Subject|6|||
160812741|NCT02131662|580698020|FG000|Overall Study|Lost to Follow-up|1|||
160812742|NCT02131662|580698021|FG001|Overall Study|Lost to Follow-up|3|||
160812743|NCT02131662|580698022|FG002|Overall Study|Lost to Follow-up|0|||
160812744|NCT02131662|580698023|FG003|Overall Study|Lost to Follow-up|9|||
160812745|NCT02131662|580698024|FG004|Overall Study|Lost to Follow-up|0|||
160812746|NCT02131662|580698020|FG000|Overall Study|Not treated|2|||
160812747|NCT02131662|580698021|FG001|Overall Study|Not treated|0|||
160812748|NCT02131662|580698022|FG002|Overall Study|Not treated|2|||
160812749|NCT02131662|580698023|FG003|Overall Study|Not treated|2|||
160812750|NCT02131662|580698024|FG004|Overall Study|Not treated|3|||
160812751|NCT03554018|580698025|FG000|Overall Study|Lost to Follow-up|3|||
160812752|NCT03554018|580698026|FG001|Overall Study|Lost to Follow-up|7|||
160812753|NCT01016132|580698030|FG000|Overall Study|Discomfort|1|||
160812754|NCT02949024|580698031|FG000|Overall Study|Withdrawal by Subject|0|||
160812755|NCT02949024|580698032|FG001|Overall Study|Withdrawal by Subject|1|||
160812756|NCT00854724|580699987|FG000|First Intervention|Withdrawal by Subject|1|||
160812757|NCT00854724|580699988|FG001|First Intervention|Withdrawal by Subject|1|||
160812758|NCT00854724|580699987|FG000|Washout|Protocol Violation|1|||
160812759|NCT00854724|580699988|FG001|Washout|Protocol Violation|0|||
160812760|NCT00854724|580699987|FG000|Washout|Withdrawal by Subject|0|||
160812761|NCT00854724|580699988|FG001|Washout|Withdrawal by Subject|1|||
160812762|NCT00854724|580699987|FG000|Second Intervention|Protocol Violation|1|||
160812763|NCT00854724|580699988|FG001|Second Intervention|Protocol Violation|0|||
160812764|NCT00854724|580699987|FG000|Second Intervention|Physician Decision|0|||
160812765|NCT00854724|580699988|FG001|Second Intervention|Physician Decision|1|||
160812766|NCT00933608|580699990|FG000|Overall Study|Adverse Event|4|||
160812767|NCT00933608|580699991|FG001|Overall Study|Adverse Event|2|||
160812768|NCT00933608|580699990|FG000|Overall Study|Physician Decision|1|||
160812769|NCT00933608|580699991|FG001|Overall Study|Physician Decision|0|||
160812770|NCT00336284|580699996|FG000|Overall Study|Death|52|||
160812771|NCT00336284|580699997|FG001|Overall Study|Death|26|||
160812772|NCT00336284|580699996|FG000|Overall Study|Lost to Follow-up|82|||
160812773|NCT00336284|580699997|FG001|Overall Study|Lost to Follow-up|61|||
160812774|NCT00336284|580699996|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
160812775|NCT00336284|580699997|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
160812776|NCT02789345|580700000|FG000|Overall Study|Adverse Event|0|||
160812777|NCT02789345|580700001|FG001|Overall Study|Adverse Event|0|||
160812778|NCT02789345|580700002|FG002|Overall Study|Adverse Event|1|||
160812779|NCT02789345|580700000|FG000|Overall Study|Death|0|||
160812780|NCT02789345|580700001|FG001|Overall Study|Death|0|||
160812781|NCT02789345|580700002|FG002|Overall Study|Death|1|||
160812782|NCT02789345|580700000|FG000|Overall Study|Physician Decision|2|||
160812783|NCT02789345|580700001|FG001|Overall Study|Physician Decision|0|||
160812784|NCT02789345|580700002|FG002|Overall Study|Physician Decision|1|||
160812785|NCT02789345|580700000|FG000|Overall Study|Progressive Disease|1|||
160812786|NCT02789345|580700001|FG001|Overall Study|Progressive Disease|3|||
160812787|NCT02789345|580700002|FG002|Overall Study|Progressive Disease|14|||
160812788|NCT01709110|580700003|FG000|Overall Study|Adverse Event|56|||
160812789|NCT01709110|580700004|FG001|Overall Study|Adverse Event|48|||
160812790|NCT01709110|580700003|FG000|Overall Study|Death|14|||
160812791|NCT01709110|580700004|FG001|Overall Study|Death|6|||
160812792|NCT01709110|580700003|FG000|Overall Study|Lost to Follow-up|7|||
160812793|NCT01709110|580700004|FG001|Overall Study|Lost to Follow-up|5|||
160812794|NCT01709110|580700003|FG000|Overall Study|Protocol Violation|4|||
160812795|NCT01709110|580700004|FG001|Overall Study|Protocol Violation|6|||
160812796|NCT01709110|580700003|FG000|Overall Study|Withdrawal by Subject|96|||
160812797|NCT01709110|580700004|FG001|Overall Study|Withdrawal by Subject|89|||
160812798|NCT01709110|580700003|FG000|Overall Study|Physician Decision|4|||
160812799|NCT01709110|580700004|FG001|Overall Study|Physician Decision|10|||
160812800|NCT01709110|580700003|FG000|Overall Study|Sponsor Decision|2|||
160812801|NCT01709110|580700004|FG001|Overall Study|Sponsor Decision|2|||
160812802|NCT01709110|580700003|FG000|Overall Study|Lack of Efficacy|1|||
160812803|NCT01709110|580700004|FG001|Overall Study|Lack of Efficacy|1|||
160812804|NCT01709110|580700003|FG000|Overall Study|Caregiver Decision|1|||
160812805|NCT01709110|580700004|FG001|Overall Study|Caregiver Decision|1|||
160812806|NCT03645421|580700013|FG000|Overall Study|Adverse Event|0|||
160812807|NCT03645421|580700014|FG001|Overall Study|Adverse Event|0|||
160812808|NCT03645421|580700015|FG002|Overall Study|Adverse Event|4|||
160812809|NCT03645421|580700016|FG003|Overall Study|Adverse Event|1|||
160812810|NCT03645421|580700013|FG000|Overall Study|Withdrawal by patient|0|||
160812811|NCT03645421|580700014|FG001|Overall Study|Withdrawal by patient|0|||
160812812|NCT03645421|580700015|FG002|Overall Study|Withdrawal by patient|0|||
160812813|NCT03645421|580700016|FG003|Overall Study|Withdrawal by patient|3|||
160812814|NCT03645421|580700013|FG000|Overall Study|Study specific withdrawal criteria|0|||
160812815|NCT03645421|580700014|FG001|Overall Study|Study specific withdrawal criteria|0|||
160812816|NCT03645421|580700015|FG002|Overall Study|Study specific withdrawal criteria|1|||
160812817|NCT03645421|580700016|FG003|Overall Study|Study specific withdrawal criteria|0|||
160812818|NCT02120781|580700017|FG000|Overall Study|Physician Decision|2|||
160812819|NCT02120781|580700018|FG001|Overall Study|Physician Decision|0|||
160812820|NCT02120781|580700017|FG000|Overall Study|Completion not documented|2|||
160812821|NCT02120781|580700018|FG001|Overall Study|Completion not documented|1|||
160812822|NCT04123093|580700024|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
160812823|NCT04123093|580700025|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
160812824|NCT04123093|580700024|FG000|Phase 2|Physician Decision|0|||
160812825|NCT04123093|580700025|FG001|Phase 2|Physician Decision|1|||
160812826|NCT04123093|580700024|FG000|Phase 2|Withdrawal by Subject|0|||
160812827|NCT04123093|580700025|FG001|Phase 2|Withdrawal by Subject|1|||
160812828|NCT03286543|580700026|FG000|Consented|Screen failure before randomization|2|||
160812829|NCT03286543|580700027|FG001|Consented|Screen failure before randomization|0|||
160812830|NCT03286543|580700028|FG002|Consented|Screen failure before randomization|0|||
160812831|NCT03286543|580700026|FG000|Consented|Screen failure before enrollment|4|||
160812832|NCT03286543|580700027|FG001|Consented|Screen failure before enrollment|0|||
160812833|NCT03286543|580700028|FG002|Consented|Screen failure before enrollment|0|||
160812834|NCT03286543|580700026|FG000|Consented|TKA cancelled after enrollment|1|||
160812835|NCT03286543|580700027|FG001|Consented|TKA cancelled after enrollment|0|||
160812836|NCT03286543|580700028|FG002|Consented|TKA cancelled after enrollment|0|||
160812837|NCT03286543|580700026|FG000|Consented|Withdrawn from study|12|||
160812838|NCT03286543|580700027|FG001|Consented|Withdrawn from study|0|||
160812839|NCT03286543|580700028|FG002|Consented|Withdrawn from study|0|||
160812840|NCT03286543|580700026|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
160812841|NCT03286543|580700027|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
160812842|NCT03286543|580700028|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
160812843|NCT03286543|580700026|FG000|Study Enrollment|Withdrawn from study|0|||
160812844|NCT03286543|580700027|FG001|Study Enrollment|Withdrawn from study|6|||
160900093|NCT01013350|581028644|FG001|Overall Study|Participant entered interventional study|8|||
160900094|NCT01013350|581028643|FG000|Overall Study|Other|1|||
160812845|NCT03286543|580700028|FG002|Study Enrollment|Withdrawn from study|6|||
160812846|NCT03850093|580700032|FG000|Overall Study|Withdrawal by Subject|1|||
160812847|NCT03850093|580700033|FG001|Overall Study|Withdrawal by Subject|0|||
160812848|NCT03850093|580700034|FG002|Overall Study|Withdrawal by Subject|2|||
160812849|NCT02836717|580700037|FG000|Test Phase|Lack of Efficacy|14|||
160812850|NCT02836717|580700038|FG001|Test Phase|Lack of Efficacy|8|||
160812851|NCT02836717|580700039|FG002|Test Phase|Lack of Efficacy|0|||
160812852|NCT02836717|580700037|FG000|Study Phase|Adverse Event|2|||
160812853|NCT02836717|580700038|FG001|Study Phase|Adverse Event|0|||
160812854|NCT02836717|580700039|FG002|Study Phase|Adverse Event|0|||
160812855|NCT02836717|580700037|FG000|Study Phase|Lack of Efficacy|8|||
160812856|NCT02836717|580700038|FG001|Study Phase|Lack of Efficacy|6|||
160812857|NCT02836717|580700039|FG002|Study Phase|Lack of Efficacy|1|||
160812858|NCT02836717|580700037|FG000|Study Phase|Withdrawal by Subject|1|||
160812859|NCT02836717|580700038|FG001|Study Phase|Withdrawal by Subject|0|||
160812860|NCT02836717|580700039|FG002|Study Phase|Withdrawal by Subject|0|||
160900095|NCT01013350|581028644|FG001|Overall Study|Other|25|||
160812861|NCT02836717|580700037|FG000|Study Phase|Death|1|||
160812862|NCT02836717|580700038|FG001|Study Phase|Death|0|||
160812863|NCT02836717|580700039|FG002|Study Phase|Death|0|||
160812864|NCT02836717|580700037|FG000|Study Phase|abdominal surgeries|2|||
160812865|NCT02836717|580700038|FG001|Study Phase|abdominal surgeries|1|||
160812866|NCT02836717|580700039|FG002|Study Phase|abdominal surgeries|0|||
160812867|NCT03226249|580700041|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
160812868|NCT03226249|580700041|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
160812869|NCT03226249|580700041|FG000|Survival Follow-up|Patients still in follow-up.|30|||
160812870|NCT03462641|580700042|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
160812871|NCT03462641|580700043|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
160812872|NCT03462641|580700042|FG000|Visit 2|Withdrawal by Subject|0|||
160812873|NCT03462641|580700043|FG001|Visit 2|Withdrawal by Subject|1|||
160812874|NCT01804049|580700044|FG000|Overall Study|Adverse Event|2|||
160812875|NCT01804049|580700045|FG001|Overall Study|Adverse Event|10|||
160812876|NCT01804049|580700044|FG000|Overall Study|Lost to Follow-up|2|||
160812877|NCT01804049|580700045|FG001|Overall Study|Lost to Follow-up|1|||
160812878|NCT01804049|580700044|FG000|Overall Study|Decreased interest/personal|4|||
160812879|NCT01804049|580700045|FG001|Overall Study|Decreased interest/personal|5|||
160812880|NCT01804049|580700044|FG000|Overall Study|Other health concerns|2|||
160812881|NCT01804049|580700045|FG001|Overall Study|Other health concerns|7|||
160812882|NCT01804049|580700044|FG000|Overall Study|Moved out of area|0|||
160812883|NCT01804049|580700045|FG001|Overall Study|Moved out of area|7|||
160812884|NCT01804049|580700044|FG000|Overall Study|other MD recommended|1|||
160812885|NCT01804049|580700045|FG001|Overall Study|other MD recommended|1|||
160812886|NCT01804049|580700044|FG000|Overall Study|Enrollment in dual studies|0|||
160812887|NCT01804049|580700045|FG001|Overall Study|Enrollment in dual studies|1|||
160812888|NCT00070109|580700046|FG000|Overall Study|Death|1|||
160812889|NCT00070109|580700047|FG001|Overall Study|Death|1|||
160812890|NCT00070109|580700048|FG002|Overall Study|Death|0|||
160812891|NCT00070109|580700049|FG003|Overall Study|Death|0|||
160812892|NCT00070109|580700050|FG004|Overall Study|Death|1|||
160812893|NCT00070109|580700046|FG000|Overall Study|Lack of Efficacy|6|||
160812894|NCT00070109|580700047|FG001|Overall Study|Lack of Efficacy|4|||
160812895|NCT00070109|580700048|FG002|Overall Study|Lack of Efficacy|5|||
160812896|NCT00070109|580700049|FG003|Overall Study|Lack of Efficacy|15|||
160812897|NCT00070109|580700050|FG004|Overall Study|Lack of Efficacy|5|||
160812898|NCT00070109|580700046|FG000|Overall Study|Physician Decision|1|||
160812899|NCT00070109|580700047|FG001|Overall Study|Physician Decision|0|||
160812900|NCT00070109|580700048|FG002|Overall Study|Physician Decision|0|||
160812901|NCT00070109|580700049|FG003|Overall Study|Physician Decision|0|||
160812902|NCT00070109|580700050|FG004|Overall Study|Physician Decision|0|||
160812903|NCT00070109|580700046|FG000|Overall Study|Withdrawal by Subject|0|||
160812904|NCT00070109|580700047|FG001|Overall Study|Withdrawal by Subject|1|||
160812905|NCT00070109|580700048|FG002|Overall Study|Withdrawal by Subject|1|||
160812906|NCT00070109|580700049|FG003|Overall Study|Withdrawal by Subject|0|||
160812907|NCT00070109|580700050|FG004|Overall Study|Withdrawal by Subject|0|||
160812908|NCT00070109|580700046|FG000|Overall Study|Adverse Event|0|||
160812909|NCT00070109|580700047|FG001|Overall Study|Adverse Event|0|||
160812910|NCT00070109|580700048|FG002|Overall Study|Adverse Event|2|||
160812911|NCT00070109|580700049|FG003|Overall Study|Adverse Event|4|||
160812912|NCT00070109|580700050|FG004|Overall Study|Adverse Event|2|||
160812913|NCT00070109|580700046|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
160812914|NCT00070109|580700047|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
160812915|NCT00070109|580700048|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
160812916|NCT00070109|580700049|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
160812917|NCT00070109|580700050|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
160812918|NCT01164891|580700051|FG000|Overall Study|Disease Progression|5|||
160812919|NCT01164891|580700051|FG000|Overall Study|Adverse Event|1|||
160812920|NCT00338286|580700052|FG000|Overall Study|Withdrawal by Subject|50|||
160812921|NCT00338286|580700053|FG001|Overall Study|Withdrawal by Subject|54|||
160812922|NCT00338286|580700052|FG000|Overall Study|Lost to Follow-up|80|||
160812923|NCT00338286|580700053|FG001|Overall Study|Lost to Follow-up|66|||
160812924|NCT00338286|580700052|FG000|Overall Study|Other|103|||
160812925|NCT00338286|580700053|FG001|Overall Study|Other|93|||
160812926|NCT01265563|580700054|FG000|Overall Study|Withdrawal by Subject|0|||
160812927|NCT01265563|580700055|FG001|Overall Study|Withdrawal by Subject|1|||
160812928|NCT01265563|580700056|FG002|Overall Study|Withdrawal by Subject|1|||
160986920|NCT04955626|581341132|FG027|Blinded Period|Physician Decision|0|||
160645300|NCT00718159|580084205|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
160812929|NCT01265563|580700057|FG003|Overall Study|Withdrawal by Subject|0|||
160812930|NCT01265563|580700058|FG004|Overall Study|Withdrawal by Subject|2|||
160812931|NCT01667133|580700062|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
160812932|NCT01667133|580700063|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
160812933|NCT01667133|580700064|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
160812934|NCT01667133|580700065|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
160812935|NCT01667133|580700066|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
160812936|NCT01667133|580700067|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
160812937|NCT01667133|580700068|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
160812938|NCT01667133|580700069|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
160812939|NCT01667133|580700070|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
160812940|NCT01667133|580700071|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
160812941|NCT01667133|580700072|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
160812942|NCT01667133|580700073|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
160812943|NCT01667133|580700062|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812944|NCT01667133|580700063|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812945|NCT01667133|580700064|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
160812946|NCT01667133|580700065|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812947|NCT01667133|580700066|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812948|NCT01667133|580700067|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812949|NCT01667133|580700068|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812950|NCT01667133|580700069|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812951|NCT01667133|580700070|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812952|NCT01667133|580700071|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812953|NCT01667133|580700072|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812954|NCT01667133|580700073|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812955|NCT01667133|580700062|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
160812956|NCT01667133|580700063|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
160812957|NCT01667133|580700064|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
160812958|NCT01667133|580700065|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
160812959|NCT01667133|580700066|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
160812960|NCT01667133|580700067|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
160812961|NCT01667133|580700068|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
160812962|NCT01667133|580700069|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
160812963|NCT01667133|580700070|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
160812964|NCT01667133|580700071|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
160812965|NCT01667133|580700072|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
160812966|NCT01667133|580700073|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
160812967|NCT01667133|580700062|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812968|NCT01667133|580700063|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812969|NCT01667133|580700064|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812970|NCT01667133|580700065|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
160812971|NCT01667133|580700066|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812972|NCT01667133|580700067|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812973|NCT01667133|580700068|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160552201|NCT03891901|579746941|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
160812974|NCT01667133|580700069|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812975|NCT01667133|580700070|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812976|NCT01667133|580700071|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812977|NCT01667133|580700072|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812978|NCT01667133|580700073|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812979|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
160812980|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
160812981|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
160812982|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
160812983|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
160812984|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
160812985|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
160812986|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
160812987|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
160812988|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
160812989|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
160812990|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
160812991|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812992|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160900096|NCT02019277|581028645|FG000|Overall Study|Withdrawal by Subject|3|||
160900097|NCT02019277|581028645|FG000|Overall Study|Death|7|||
160552202|NCT03891901|579746942|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
160552203|NCT03891901|579746943|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
160552204|NCT03891901|579746935|FG000|Overall Study|Adverse Event|2|||
160552205|NCT03891901|579746936|FG001|Overall Study|Adverse Event|2|||
160812993|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812994|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812995|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812996|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160552206|NCT03891901|579746937|FG002|Overall Study|Adverse Event|0|||
160552207|NCT03891901|579746938|FG003|Overall Study|Adverse Event|0|||
160812997|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812998|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812999|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160900098|NCT02019277|581028645|FG000|Overall Study|Did no Cooperate|1|||
160813000|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
160813001|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160813002|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160813003|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
160813004|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
160813005|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
160813006|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
160813007|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
160813008|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
160813009|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
160813010|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
160813011|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
160813012|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
160813013|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
160813014|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
160813015|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813016|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813017|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813018|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813019|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813020|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813021|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813022|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813023|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813024|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
160813025|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813026|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813027|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Death|0|||
160813028|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Death|0|||
160813029|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Death|0|||
160813030|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Death|0|||
160813031|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Death|0|||
160813032|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Death|0|||
160813033|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Death|0|||
160813034|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Death|0|||
160813035|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Death|0|||
160813036|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Death|1|||
160813037|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Death|0|||
160813038|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Death|0|||
160813039|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Other|0|||
160813040|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Other|0|||
160813041|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Other|0|||
160813042|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Other|0|||
160813043|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Other|0|||
160813044|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Other|0|||
160813045|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Other|0|||
160813046|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Other|0|||
160813047|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Other|0|||
160813048|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Other|0|||
160813049|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Other|0|||
160986921|NCT04955626|581341133|FG028|Blinded Period|Physician Decision|0|||
160986922|NCT04955626|581341134|FG029|Blinded Period|Physician Decision|0|||
160986923|NCT04955626|581341135|FG030|Blinded Period|Physician Decision|0|||
160552208|NCT03891901|579746939|FG004|Overall Study|Adverse Event|0|||
160552209|NCT03891901|579746940|FG005|Overall Study|Adverse Event|0|||
160552210|NCT03891901|579746941|FG006|Overall Study|Adverse Event|0|||
160986924|NCT04955626|581341136|FG031|Blinded Period|Physician Decision|0|||
160986925|NCT04955626|581341137|FG032|Blinded Period|Physician Decision|0|||
160986926|NCT04955626|581341138|FG033|Blinded Period|Physician Decision|0|||
160986927|NCT04955626|581341139|FG034|Blinded Period|Physician Decision|0|||
160552211|NCT03891901|579746942|FG007|Overall Study|Adverse Event|0|||
160552212|NCT03891901|579746943|FG008|Overall Study|Adverse Event|0|||
160552213|NCT03891901|579746935|FG000|Overall Study|Poor venous access|1|||
160552214|NCT03891901|579746936|FG001|Overall Study|Poor venous access|0|||
160813050|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Other|1|||
160813051|NCT01916824|580700074|FG000|Overall Study|Lost to Follow-up|3|||
160813052|NCT01916824|580700075|FG001|Overall Study|Lost to Follow-up|6|||
160813053|NCT01916824|580700074|FG000|Overall Study|Physician Decision|2|||
160813054|NCT01916824|580700075|FG001|Overall Study|Physician Decision|0|||
160813055|NCT01916824|580700074|FG000|Overall Study|Withdrawal by Subject|2|||
160813056|NCT01916824|580700075|FG001|Overall Study|Withdrawal by Subject|3|||
160552215|NCT03891901|579746937|FG002|Overall Study|Poor venous access|0|||
160813057|NCT03835481|580700080|FG000|Double-blind Period|Other not stated below|0|||
160813058|NCT03835481|580700081|FG001|Double-blind Period|Other not stated below|0|||
160552216|NCT03891901|579746938|FG003|Overall Study|Poor venous access|0|||
160552217|NCT03891901|579746939|FG004|Overall Study|Poor venous access|0|||
160986928|NCT04955626|581341140|FG035|Blinded Period|Physician Decision|0|||
160645301|NCT00718159|580084206|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
160645302|NCT00718159|580084200|FG000|Overall Study|Investigator Decision|0|||
160645303|NCT00718159|580084201|FG001|Overall Study|Investigator Decision|0|||
160645304|NCT00718159|580084202|FG002|Overall Study|Investigator Decision|0|||
160645305|NCT00718159|580084203|FG003|Overall Study|Investigator Decision|0|||
160645306|NCT00718159|580084204|FG004|Overall Study|Investigator Decision|0|||
160645307|NCT00718159|580084205|FG005|Overall Study|Investigator Decision|1|||
160645308|NCT00718159|580084206|FG006|Overall Study|Investigator Decision|1|||
160645309|NCT01238848|580084208|FG000|Overall Study|Physician Decision|13|||
160645310|NCT01238848|580084209|FG001|Overall Study|Physician Decision|5|||
160645311|NCT03222141|580084219|FG000|Overall Study|Death|15|||
160645312|NCT03222141|580084219|FG000|Overall Study|Lost to Follow-up|3|||
160645313|NCT01401478|580084221|FG000|Overall Study|Study drug not available|6|||
160645314|NCT01401478|580084221|FG000|Overall Study|Adverse Event|5|||
160645315|NCT01401478|580084221|FG000|Overall Study|Hyperphosphatemia|5|||
160645316|NCT01401478|580084221|FG000|Overall Study|Lost to Follow-up|5|||
160900099|NCT02019277|581028645|FG000|Overall Study|Adverse Event|1|||
160900100|NCT03725852|581028646|FG000|Overall Study|Death|1|||
160645317|NCT01401478|580084221|FG000|Overall Study|Kidney transplantation|3|||
160900101|NCT03725852|581028647|FG001|Overall Study|Death|0|||
160813059|NCT03835481|580700082|FG002|Double-blind Period|Other not stated below|0|||
160813060|NCT03835481|580700083|FG003|Double-blind Period|Other not stated below|1|||
160552218|NCT03891901|579746940|FG005|Overall Study|Poor venous access|0|||
160813061|NCT03835481|580700084|FG004|Double-blind Period|Other not stated below|1|||
160813062|NCT03835481|580700080|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
160813063|NCT03835481|580700081|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
160813064|NCT03835481|580700082|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
160813065|NCT03835481|580700083|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
160813066|NCT03835481|580700084|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
160813067|NCT03835481|580700080|FG000|Double-blind Period|Withdrawal by Subject|0|||
160813068|NCT03835481|580700081|FG001|Double-blind Period|Withdrawal by Subject|0|||
160813069|NCT03835481|580700082|FG002|Double-blind Period|Withdrawal by Subject|1|||
160813070|NCT03835481|580700083|FG003|Double-blind Period|Withdrawal by Subject|0|||
160813071|NCT03835481|580700084|FG004|Double-blind Period|Withdrawal by Subject|5|||
160813072|NCT03835481|580700080|FG000|Double-blind Period|Lost to Follow-up|0|||
160813073|NCT03835481|580700081|FG001|Double-blind Period|Lost to Follow-up|0|||
160813074|NCT03835481|580700082|FG002|Double-blind Period|Lost to Follow-up|0|||
160813075|NCT03835481|580700083|FG003|Double-blind Period|Lost to Follow-up|1|||
160813076|NCT03835481|580700084|FG004|Double-blind Period|Lost to Follow-up|0|||
160813077|NCT03835481|580700080|FG000|Double-blind Period|Protocol Violation|0|||
160813078|NCT03835481|580700081|FG001|Double-blind Period|Protocol Violation|2|||
160813079|NCT03835481|580700082|FG002|Double-blind Period|Protocol Violation|0|||
160813080|NCT03835481|580700083|FG003|Double-blind Period|Protocol Violation|1|||
160813081|NCT03835481|580700084|FG004|Double-blind Period|Protocol Violation|0|||
160813082|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
160552219|NCT03891901|579746941|FG006|Overall Study|Poor venous access|0|||
160552220|NCT03891901|579746942|FG007|Overall Study|Poor venous access|0|||
160552221|NCT03891901|579746943|FG008|Overall Study|Poor venous access|0|||
160813083|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
160813084|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
160813085|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
160813086|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
160813087|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
160813088|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
160813089|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
160813090|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
160813091|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
160813092|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
160813093|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
160813094|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
160813095|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
160813096|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
160813097|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
160813098|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
160813099|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
160552222|NCT03891901|579746935|FG000|Overall Study|Withdrawal by Subject|0|||
160552223|NCT03891901|579746936|FG001|Overall Study|Withdrawal by Subject|2|||
160552224|NCT03891901|579746937|FG002|Overall Study|Withdrawal by Subject|0|||
160552225|NCT03891901|579746938|FG003|Overall Study|Withdrawal by Subject|0|||
160552226|NCT03891901|579746939|FG004|Overall Study|Withdrawal by Subject|0|||
160552227|NCT03891901|579746940|FG005|Overall Study|Withdrawal by Subject|0|||
160552228|NCT03891901|579746941|FG006|Overall Study|Withdrawal by Subject|0|||
160552229|NCT03891901|579746942|FG007|Overall Study|Withdrawal by Subject|0|||
160552230|NCT03891901|579746943|FG008|Overall Study|Withdrawal by Subject|0|||
160552231|NCT00573794|579746944|FG000|Overall Study|Adverse Event|81|||
160552232|NCT00573794|579746944|FG000|Overall Study|Withdrew Consent|90|||
160552233|NCT00573794|579746944|FG000|Overall Study|Lost to Follow-up|13|||
160552234|NCT00573794|579746944|FG000|Overall Study|Protocol Violation|6|||
160645318|NCT01401478|580084221|FG000|Overall Study|Withdrawal by Subject|3|||
160645319|NCT01401478|580084221|FG000|Overall Study|Blood samples not available|1|||
160645320|NCT01401478|580084221|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
160645321|NCT01401478|580084221|FG000|Overall Study|Low intact parathyroid hormone|1|||
160813100|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
160813101|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
160813102|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
160552235|NCT00573794|579746944|FG000|Overall Study|Lack of Efficacy|94|||
160552236|NCT00573794|579746944|FG000|Overall Study|Other|46|||
160552237|NCT04556617|579746952|FG000|Overall Study|progressive disease|0|||
160552238|NCT04556617|579746953|FG001|Overall Study|progressive disease|2|||
160552239|NCT04556617|579746954|FG002|Overall Study|progressive disease|2|||
160552240|NCT04556617|579746955|FG003|Overall Study|progressive disease|1|||
160552241|NCT04556617|579746956|FG004|Overall Study|progressive disease|1|||
160552242|NCT04556617|579746952|FG000|Overall Study|Physician Decision|0|||
160552243|NCT04556617|579746953|FG001|Overall Study|Physician Decision|0|||
160552244|NCT04556617|579746954|FG002|Overall Study|Physician Decision|2|||
160552245|NCT04556617|579746955|FG003|Overall Study|Physician Decision|0|||
160552246|NCT04556617|579746956|FG004|Overall Study|Physician Decision|0|||
160552247|NCT04556617|579746952|FG000|Overall Study|Adverse Event|0|||
160552248|NCT04556617|579746953|FG001|Overall Study|Adverse Event|0|||
160552249|NCT04556617|579746954|FG002|Overall Study|Adverse Event|2|||
160552250|NCT04556617|579746955|FG003|Overall Study|Adverse Event|3|||
160552251|NCT04556617|579746956|FG004|Overall Study|Adverse Event|0|||
160552252|NCT04556617|579746952|FG000|Overall Study|Withdrawal by Subject|0|||
160552253|NCT04556617|579746953|FG001|Overall Study|Withdrawal by Subject|2|||
160552254|NCT04556617|579746954|FG002|Overall Study|Withdrawal by Subject|1|||
160552255|NCT04556617|579746955|FG003|Overall Study|Withdrawal by Subject|1|||
160552256|NCT04556617|579746956|FG004|Overall Study|Withdrawal by Subject|0|||
160552257|NCT04556617|579746952|FG000|Overall Study|PSA increase|0|||
160552258|NCT04556617|579746953|FG001|Overall Study|PSA increase|1|||
160552259|NCT04556617|579746954|FG002|Overall Study|PSA increase|0|||
160552260|NCT04556617|579746955|FG003|Overall Study|PSA increase|0|||
160813103|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
160813104|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
160813105|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
160813106|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
160813107|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
160813108|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
160813109|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
160813110|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
160813111|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
160813112|NCT00375505|580700093|FG000|Overall Study|Adverse Event|1|||
160813113|NCT00375505|580700094|FG001|Overall Study|Adverse Event|2|||
160813114|NCT01831466|580700095|FG000|Overall Study|Protocol Violation|1|||
160813115|NCT01831466|580700096|FG001|Overall Study|Protocol Violation|1|||
160813116|NCT01831466|580700097|FG002|Overall Study|Protocol Violation|2|||
160813117|NCT01831466|580700098|FG003|Overall Study|Protocol Violation|0|||
160813118|NCT01831466|580700099|FG004|Overall Study|Protocol Violation|0|||
160813119|NCT01831466|580700100|FG005|Overall Study|Protocol Violation|1|||
160813120|NCT01831466|580700101|FG006|Overall Study|Protocol Violation|0|||
160813121|NCT01831466|580700102|FG007|Overall Study|Protocol Violation|0|||
160813122|NCT01831466|580700103|FG008|Overall Study|Protocol Violation|0|||
160813123|NCT01831466|580700104|FG009|Overall Study|Protocol Violation|0|||
160813124|NCT01831466|580700105|FG010|Overall Study|Protocol Violation|0|||
160813125|NCT01831466|580700106|FG011|Overall Study|Protocol Violation|0|||
160813126|NCT01831466|580700095|FG000|Overall Study|Other|2|||
160813127|NCT01831466|580700096|FG001|Overall Study|Other|3|||
160813128|NCT01831466|580700097|FG002|Overall Study|Other|2|||
160813129|NCT01831466|580700098|FG003|Overall Study|Other|2|||
160813130|NCT01831466|580700099|FG004|Overall Study|Other|2|||
160813131|NCT01831466|580700100|FG005|Overall Study|Other|1|||
160813132|NCT01831466|580700101|FG006|Overall Study|Other|0|||
160813133|NCT01831466|580700102|FG007|Overall Study|Other|0|||
160552261|NCT04556617|579746956|FG004|Overall Study|PSA increase|0|||
160552262|NCT04556617|579746952|FG000|Overall Study|Sponsor study termination|1|||
160552263|NCT04556617|579746953|FG001|Overall Study|Sponsor study termination|0|||
160552264|NCT04556617|579746954|FG002|Overall Study|Sponsor study termination|0|||
160813134|NCT01831466|580700103|FG008|Overall Study|Other|0|||
160813135|NCT01831466|580700104|FG009|Overall Study|Other|0|||
160813136|NCT01831466|580700105|FG010|Overall Study|Other|0|||
160552265|NCT04556617|579746955|FG003|Overall Study|Sponsor study termination|0|||
160552266|NCT04556617|579746956|FG004|Overall Study|Sponsor study termination|0|||
160552267|NCT04820309|579746957|FG000|Overall Study|Adverse Event|96|||
160813137|NCT01831466|580700106|FG011|Overall Study|Other|0|||
160813138|NCT01831466|580700095|FG000|Overall Study|Non-compliance with study treatment|2|||
160813139|NCT01831466|580700096|FG001|Overall Study|Non-compliance with study treatment|1|||
160813140|NCT01831466|580700097|FG002|Overall Study|Non-compliance with study treatment|1|||
160813141|NCT01831466|580700098|FG003|Overall Study|Non-compliance with study treatment|0|||
160813142|NCT01831466|580700099|FG004|Overall Study|Non-compliance with study treatment|0|||
160813143|NCT01831466|580700100|FG005|Overall Study|Non-compliance with study treatment|1|||
160813144|NCT01831466|580700101|FG006|Overall Study|Non-compliance with study treatment|0|||
160813145|NCT01831466|580700102|FG007|Overall Study|Non-compliance with study treatment|0|||
160813146|NCT01831466|580700103|FG008|Overall Study|Non-compliance with study treatment|0|||
160813147|NCT01831466|580700104|FG009|Overall Study|Non-compliance with study treatment|0|||
160813148|NCT01831466|580700105|FG010|Overall Study|Non-compliance with study treatment|0|||
160813149|NCT01831466|580700106|FG011|Overall Study|Non-compliance with study treatment|0|||
160813150|NCT01831466|580700095|FG000|Overall Study|Death|0|||
160813151|NCT01831466|580700096|FG001|Overall Study|Death|1|||
160900102|NCT03725852|581028646|FG000|Overall Study|Withdrawal by Subject|1|||
160900103|NCT03725852|581028647|FG001|Overall Study|Withdrawal by Subject|0|||
160900104|NCT03725852|581028646|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
160900105|NCT03725852|581028647|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
160900106|NCT04738734|581028649|FG000|Overall Study|Withdrawal by Subject|2|||
160900107|NCT04738734|581028650|FG001|Overall Study|Withdrawal by Subject|4|||
160900108|NCT04738734|581028649|FG000|Overall Study|Lost to Follow-up|5|||
160900109|NCT04738734|581028650|FG001|Overall Study|Lost to Follow-up|2|||
160900110|NCT04738734|581028649|FG000|Overall Study|Physician Decision|0|||
160900111|NCT04738734|581028650|FG001|Overall Study|Physician Decision|1|||
160900112|NCT04738734|581028649|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
160900113|NCT04738734|581028650|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
160900114|NCT04093414|581028653|FG000|3 Month Follow up|Physician Decision|0|||
160900115|NCT04093414|581028654|FG001|3 Month Follow up|Physician Decision|1|||
160900116|NCT04093414|581028653|FG000|6month Follow up|Physician Decision|1|||
160900117|NCT04093414|581028654|FG001|6month Follow up|Physician Decision|3|||
160900118|NCT03452228|581028655|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
160900119|NCT03452228|581028656|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
160900120|NCT03452228|581028657|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
160900121|NCT03452228|581028655|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
160986929|NCT04955626|581341105|FG000|Blinded Period|Withdrawal by Subject|26|||
160986930|NCT04955626|581341106|FG001|Blinded Period|Withdrawal by Subject|62|||
160552268|NCT04820309|579746957|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
160552269|NCT04820309|579746957|FG000|Overall Study|Consent Withdrawn|93|||
160813152|NCT01831466|580700097|FG002|Overall Study|Death|0|||
160813153|NCT01831466|580700098|FG003|Overall Study|Death|0|||
160813154|NCT01831466|580700099|FG004|Overall Study|Death|0|||
160813155|NCT01831466|580700100|FG005|Overall Study|Death|0|||
160813156|NCT01831466|580700101|FG006|Overall Study|Death|0|||
160813157|NCT01831466|580700102|FG007|Overall Study|Death|0|||
160813158|NCT01831466|580700103|FG008|Overall Study|Death|0|||
160813159|NCT01831466|580700104|FG009|Overall Study|Death|0|||
160813160|NCT01831466|580700105|FG010|Overall Study|Death|0|||
160813161|NCT01831466|580700106|FG011|Overall Study|Death|0|||
160813162|NCT01831466|580700095|FG000|Overall Study|Withdrawal by Subject|6|||
160813163|NCT01831466|580700096|FG001|Overall Study|Withdrawal by Subject|3|||
160813164|NCT01831466|580700097|FG002|Overall Study|Withdrawal by Subject|3|||
160813165|NCT01831466|580700098|FG003|Overall Study|Withdrawal by Subject|3|||
160813166|NCT01831466|580700099|FG004|Overall Study|Withdrawal by Subject|3|||
160813167|NCT01831466|580700100|FG005|Overall Study|Withdrawal by Subject|5|||
160645322|NCT01401478|580084221|FG000|Overall Study|Serious adverse event|1|||
160813168|NCT01831466|580700101|FG006|Overall Study|Withdrawal by Subject|0|||
160813169|NCT01831466|580700102|FG007|Overall Study|Withdrawal by Subject|0|||
160813170|NCT01831466|580700103|FG008|Overall Study|Withdrawal by Subject|0|||
160813171|NCT01831466|580700104|FG009|Overall Study|Withdrawal by Subject|1|||
160813172|NCT01831466|580700105|FG010|Overall Study|Withdrawal by Subject|0|||
160813173|NCT01831466|580700106|FG011|Overall Study|Withdrawal by Subject|1|||
160813174|NCT01831466|580700095|FG000|Overall Study|Lost to Follow-up|0|||
160813175|NCT01831466|580700096|FG001|Overall Study|Lost to Follow-up|1|||
160813176|NCT01831466|580700097|FG002|Overall Study|Lost to Follow-up|4|||
160813177|NCT01831466|580700098|FG003|Overall Study|Lost to Follow-up|2|||
160813178|NCT01831466|580700099|FG004|Overall Study|Lost to Follow-up|0|||
160813179|NCT01831466|580700100|FG005|Overall Study|Lost to Follow-up|3|||
160813180|NCT01831466|580700101|FG006|Overall Study|Lost to Follow-up|0|||
160813181|NCT01831466|580700102|FG007|Overall Study|Lost to Follow-up|0|||
160813182|NCT01831466|580700103|FG008|Overall Study|Lost to Follow-up|0|||
160813183|NCT01831466|580700104|FG009|Overall Study|Lost to Follow-up|1|||
160813184|NCT01831466|580700105|FG010|Overall Study|Lost to Follow-up|0|||
160813185|NCT01831466|580700106|FG011|Overall Study|Lost to Follow-up|1|||
160813186|NCT01831466|580700095|FG000|Overall Study|Lack of Efficacy|5|||
160813187|NCT01831466|580700096|FG001|Overall Study|Lack of Efficacy|8|||
160813188|NCT01831466|580700097|FG002|Overall Study|Lack of Efficacy|7|||
160813189|NCT01831466|580700098|FG003|Overall Study|Lack of Efficacy|6|||
160813190|NCT01831466|580700099|FG004|Overall Study|Lack of Efficacy|9|||
160813191|NCT01831466|580700100|FG005|Overall Study|Lack of Efficacy|8|||
160813192|NCT01831466|580700101|FG006|Overall Study|Lack of Efficacy|1|||
160813193|NCT01831466|580700102|FG007|Overall Study|Lack of Efficacy|1|||
160813194|NCT01831466|580700103|FG008|Overall Study|Lack of Efficacy|2|||
160813195|NCT01831466|580700104|FG009|Overall Study|Lack of Efficacy|2|||
160813196|NCT01831466|580700105|FG010|Overall Study|Lack of Efficacy|2|||
160813197|NCT01831466|580700106|FG011|Overall Study|Lack of Efficacy|0|||
160813198|NCT01831466|580700095|FG000|Overall Study|Adverse Event|0|||
160813199|NCT01831466|580700096|FG001|Overall Study|Adverse Event|0|||
160813200|NCT01831466|580700097|FG002|Overall Study|Adverse Event|4|||
160813201|NCT01831466|580700098|FG003|Overall Study|Adverse Event|6|||
160813202|NCT01831466|580700099|FG004|Overall Study|Adverse Event|3|||
160813203|NCT01831466|580700100|FG005|Overall Study|Adverse Event|7|||
160813204|NCT01831466|580700101|FG006|Overall Study|Adverse Event|0|||
160813205|NCT01831466|580700102|FG007|Overall Study|Adverse Event|1|||
160813206|NCT01831466|580700103|FG008|Overall Study|Adverse Event|1|||
160813207|NCT01831466|580700104|FG009|Overall Study|Adverse Event|1|||
160813208|NCT01831466|580700105|FG010|Overall Study|Adverse Event|0|||
160813209|NCT01831466|580700106|FG011|Overall Study|Adverse Event|2|||
160813210|NCT00429182|580700108|FG000|Overall Study|Not evaluable, Disease Progression|2|||
160813211|NCT00429182|580700108|FG000|Overall Study|Not eligible|5|||
160813212|NCT02146131|580700109|FG000|Overall Study|Physician Decision|61|||
160813213|NCT02146131|580700110|FG001|Overall Study|Physician Decision|56|||
160813214|NCT02567799|580700111|FG000|Concurrent Chemoradiotherapy|Death|1|||
160813215|NCT02567799|580700112|FG001|Concurrent Chemoradiotherapy|Death|0|||
160813216|NCT02567799|580700113|FG002|Concurrent Chemoradiotherapy|Death|0|||
160813217|NCT02567799|580700111|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
160813218|NCT02567799|580700112|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
160813219|NCT02567799|580700113|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
160813220|NCT02567799|580700111|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
160813221|NCT02567799|580700112|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
160813222|NCT02567799|580700113|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
160813223|NCT02567799|580700111|FG000|Follow-up|Death|1|||
160813224|NCT02567799|580700112|FG001|Follow-up|Death|0|||
160813225|NCT02567799|580700113|FG002|Follow-up|Death|1|||
160813226|NCT02567799|580700111|FG000|Follow-up|Progressive Disease|1|||
160813227|NCT02567799|580700112|FG001|Follow-up|Progressive Disease|1|||
160813228|NCT02567799|580700113|FG002|Follow-up|Progressive Disease|3|||
160813229|NCT02142803|580700120|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
160813230|NCT02142803|580700121|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
160813231|NCT02142803|580700122|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
160813232|NCT02142803|580700123|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
160813233|NCT05111002|580700124|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
160813234|NCT05111002|580700125|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
160813235|NCT05111002|580700124|FG000|Secondary Outcome|Lost to Follow-up|1|||
160813236|NCT05111002|580700125|FG001|Secondary Outcome|Lost to Follow-up|0|||
160813237|NCT04776720|580700139|FG000|Overall Study|COVID Related|4|||
160813238|NCT04776720|580700140|FG001|Overall Study|COVID Related|2|||
160813239|NCT04776720|580700139|FG000|Overall Study|Adverse Event|2|||
160813240|NCT04776720|580700140|FG001|Overall Study|Adverse Event|0|||
160813241|NCT04776720|580700139|FG000|Overall Study|Serious Adverse Event|0|||
160813242|NCT04776720|580700140|FG001|Overall Study|Serious Adverse Event|1|||
160813243|NCT04776720|580700139|FG000|Overall Study|Too Busy|3|||
160813244|NCT04776720|580700140|FG001|Overall Study|Too Busy|1|||
160813245|NCT04776720|580700139|FG000|Overall Study|Lost to Follow-up|1|||
160813246|NCT04776720|580700140|FG001|Overall Study|Lost to Follow-up|2|||
160813247|NCT04776720|580700139|FG000|Overall Study|Family|2|||
160813248|NCT04776720|580700140|FG001|Overall Study|Family|2|||
160813249|NCT04776720|580700139|FG000|Overall Study|No remote technology access|0|||
160813250|NCT04776720|580700140|FG001|Overall Study|No remote technology access|1|||
160813251|NCT04776720|580700139|FG000|Overall Study|Withdrawal by Subject|1|||
160813252|NCT04776720|580700140|FG001|Overall Study|Withdrawal by Subject|0|||
160813253|NCT04776720|580700139|FG000|Overall Study|Cannot tolerate intervention|1|||
160813254|NCT04776720|580700140|FG001|Overall Study|Cannot tolerate intervention|0|||
160813255|NCT04776720|580700139|FG000|Overall Study|Incomplete outcome data|6|||
160813256|NCT04776720|580700140|FG001|Overall Study|Incomplete outcome data|1|||
160813257|NCT05356910|580700143|FG000|Overall Study|Lost to Follow-up|10|||
160813258|NCT05356910|580700144|FG001|Overall Study|Lost to Follow-up|19|||
160813259|NCT05356910|580700145|FG002|Overall Study|Lost to Follow-up|0|||
160813260|NCT05356910|580700146|FG003|Overall Study|Lost to Follow-up|0|||
160813261|NCT05356910|580700143|FG000|Overall Study|Withdrawal by Subject|4|||
160813262|NCT05356910|580700144|FG001|Overall Study|Withdrawal by Subject|2|||
160813263|NCT05356910|580700145|FG002|Overall Study|Withdrawal by Subject|0|||
160813264|NCT05356910|580700146|FG003|Overall Study|Withdrawal by Subject|0|||
160813265|NCT02712996|580700150|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
160813266|NCT02712996|580700151|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
160813267|NCT01451749|580700155|FG000|Overall Study|Protocol Violation|14|||
160986931|NCT04955626|581341107|FG002|Blinded Period|Withdrawal by Subject|14|||
160986932|NCT04955626|581341108|FG003|Blinded Period|Withdrawal by Subject|16|||
160986933|NCT04955626|581341109|FG004|Blinded Period|Withdrawal by Subject|1|||
160986934|NCT04955626|581341110|FG005|Blinded Period|Withdrawal by Subject|2|||
160813268|NCT01451749|580700156|FG001|Overall Study|Protocol Violation|7|||
160813269|NCT01451749|580700155|FG000|Overall Study|Lost to Follow-up|15|||
160813270|NCT01451749|580700156|FG001|Overall Study|Lost to Follow-up|5|||
160813271|NCT01451749|580700155|FG000|Overall Study|Meet the exclusion criteria,and|1|||
160813272|NCT01451749|580700156|FG001|Overall Study|Meet the exclusion criteria,and|1|||
160813273|NCT01451749|580700155|FG000|Overall Study|Adverse Event|2|||
160813274|NCT01451749|580700156|FG001|Overall Study|Adverse Event|0|||
160813275|NCT01451749|580700155|FG000|Overall Study|Withdrawal by Subject|0|||
160813276|NCT01451749|580700156|FG001|Overall Study|Withdrawal by Subject|1|||
160813277|NCT00972517|580700159|FG000|Overall Study|Adverse Event|0|||
160813278|NCT00972517|580700160|FG001|Overall Study|Adverse Event|0|||
160813279|NCT00972517|580700161|FG002|Overall Study|Adverse Event|0|||
160813280|NCT00972517|580700162|FG003|Overall Study|Adverse Event|1|||
160813281|NCT00972517|580700163|FG004|Overall Study|Adverse Event|0|||
160813282|NCT00972517|580700164|FG005|Overall Study|Adverse Event|0|||
160813283|NCT00972517|580700159|FG000|Overall Study|Withdrawal by Subject|0|||
160813284|NCT00972517|580700160|FG001|Overall Study|Withdrawal by Subject|1|||
160813285|NCT00972517|580700161|FG002|Overall Study|Withdrawal by Subject|0|||
160986935|NCT04955626|581341111|FG006|Blinded Period|Withdrawal by Subject|9|||
160813286|NCT00972517|580700162|FG003|Overall Study|Withdrawal by Subject|2|||
160813287|NCT00972517|580700163|FG004|Overall Study|Withdrawal by Subject|1|||
160813288|NCT00972517|580700164|FG005|Overall Study|Withdrawal by Subject|0|||
160813289|NCT02311881|580700165|FG000|Overall Study|Did not meet the study criteria|2|||
160813290|NCT02311881|580700166|FG001|Overall Study|Did not meet the study criteria|2|||
160813291|NCT02311881|580700167|FG002|Overall Study|Did not meet the study criteria|0|||
160813292|NCT02311881|580700165|FG000|Overall Study|Adverse Event|7|||
160813293|NCT02311881|580700166|FG001|Overall Study|Adverse Event|15|||
160813294|NCT02311881|580700167|FG002|Overall Study|Adverse Event|8|||
160813295|NCT02311881|580700165|FG000|Overall Study|Lost to Follow-up|3|||
160813296|NCT02311881|580700166|FG001|Overall Study|Lost to Follow-up|3|||
160813297|NCT02311881|580700167|FG002|Overall Study|Lost to Follow-up|2|||
160813298|NCT02311881|580700165|FG000|Overall Study|Protocol Violation|1|||
160813299|NCT02311881|580700166|FG001|Overall Study|Protocol Violation|2|||
160813300|NCT02311881|580700167|FG002|Overall Study|Protocol Violation|3|||
160813301|NCT02311881|580700165|FG000|Overall Study|Withdrawal of consent|14|||
160813302|NCT02311881|580700166|FG001|Overall Study|Withdrawal of consent|16|||
160813303|NCT02311881|580700167|FG002|Overall Study|Withdrawal of consent|17|||
160813304|NCT02311881|580700165|FG000|Overall Study|Other|0|||
160813305|NCT02311881|580700166|FG001|Overall Study|Other|0|||
160813306|NCT02311881|580700167|FG002|Overall Study|Other|1|||
160813307|NCT02311881|580700165|FG000|Overall Study|Lack of Efficacy|1|||
160813308|NCT02311881|580700166|FG001|Overall Study|Lack of Efficacy|2|||
160813309|NCT02311881|580700167|FG002|Overall Study|Lack of Efficacy|0|||
160813310|NCT02311881|580700165|FG000|Overall Study|Subject has border line pregnancy test|1|||
160813311|NCT02311881|580700166|FG001|Overall Study|Subject has border line pregnancy test|0|||
160813312|NCT02311881|580700167|FG002|Overall Study|Subject has border line pregnancy test|0|||
160813313|NCT02311881|580700165|FG000|Overall Study|Withdrawal by Subject|3|||
160813314|NCT02311881|580700166|FG001|Overall Study|Withdrawal by Subject|1|||
160813315|NCT02311881|580700167|FG002|Overall Study|Withdrawal by Subject|4|||
160813316|NCT02311881|580700165|FG000|Overall Study|Sponsor Decision|1|||
160813317|NCT02311881|580700166|FG001|Overall Study|Sponsor Decision|1|||
160813318|NCT02311881|580700167|FG002|Overall Study|Sponsor Decision|1|||
160813319|NCT02311881|580700165|FG000|Overall Study|Protocol Deviation|1|||
160813320|NCT02311881|580700166|FG001|Overall Study|Protocol Deviation|0|||
160813321|NCT02311881|580700167|FG002|Overall Study|Protocol Deviation|0|||
160813322|NCT02311881|580700165|FG000|Overall Study|Non-Compliance|1|||
160813323|NCT02311881|580700166|FG001|Overall Study|Non-Compliance|0|||
160813324|NCT02311881|580700167|FG002|Overall Study|Non-Compliance|2|||
160813325|NCT02311881|580700165|FG000|Overall Study|Physician Decision|0|||
160813326|NCT02311881|580700166|FG001|Overall Study|Physician Decision|0|||
160813327|NCT02311881|580700167|FG002|Overall Study|Physician Decision|1|||
160813328|NCT02311881|580700165|FG000|Overall Study|Medical Monitor Discretion|0|||
160813329|NCT02311881|580700166|FG001|Overall Study|Medical Monitor Discretion|0|||
160813330|NCT02311881|580700167|FG002|Overall Study|Medical Monitor Discretion|1|||
160813331|NCT02311881|580700165|FG000|Overall Study|Participant taking another medication|0|||
160813332|NCT02311881|580700166|FG001|Overall Study|Participant taking another medication|0|||
160813333|NCT02311881|580700167|FG002|Overall Study|Participant taking another medication|1|||
160813334|NCT02311881|580700165|FG000|Overall Study|Serious Adverse Event|0|||
160813335|NCT02311881|580700166|FG001|Overall Study|Serious Adverse Event|1|||
160813336|NCT02311881|580700167|FG002|Overall Study|Serious Adverse Event|0|||
160813337|NCT03306433|580700170|FG000|Overall Study|Lost to Follow-up|3|||
160813338|NCT03306433|580700170|FG000|Overall Study|Patient did not have teeth extracted|1|||
160813339|NCT03306433|580700170|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
160813340|NCT00819156|580700171|FG000|Overall Study|Adverse Event|1|||
160813341|NCT00819156|580700172|FG001|Overall Study|Adverse Event|4|||
160813342|NCT00819156|580700173|FG002|Overall Study|Adverse Event|2|||
160813343|NCT00819156|580700174|FG003|Overall Study|Adverse Event|1|||
160813344|NCT00819156|580700175|FG004|Overall Study|Adverse Event|2|||
160813345|NCT00819156|580700176|FG005|Overall Study|Adverse Event|3|||
160813346|NCT00819156|580700171|FG000|Overall Study|Withdrawal by Subject|0|||
160813347|NCT00819156|580700172|FG001|Overall Study|Withdrawal by Subject|3|||
160813348|NCT00819156|580700173|FG002|Overall Study|Withdrawal by Subject|2|||
160813349|NCT00819156|580700174|FG003|Overall Study|Withdrawal by Subject|0|||
160813350|NCT00819156|580700175|FG004|Overall Study|Withdrawal by Subject|1|||
160813351|NCT00819156|580700176|FG005|Overall Study|Withdrawal by Subject|0|||
160813352|NCT00819156|580700171|FG000|Overall Study|Protocol Violation|1|||
160813353|NCT00819156|580700172|FG001|Overall Study|Protocol Violation|0|||
160813354|NCT00819156|580700173|FG002|Overall Study|Protocol Violation|1|||
160813355|NCT00819156|580700174|FG003|Overall Study|Protocol Violation|0|||
160813356|NCT00819156|580700175|FG004|Overall Study|Protocol Violation|0|||
160813357|NCT00819156|580700176|FG005|Overall Study|Protocol Violation|1|||
160813358|NCT00819156|580700171|FG000|Overall Study|Lost to Follow-up|0|||
160813359|NCT00819156|580700172|FG001|Overall Study|Lost to Follow-up|1|||
160813360|NCT00819156|580700173|FG002|Overall Study|Lost to Follow-up|0|||
160813361|NCT00819156|580700174|FG003|Overall Study|Lost to Follow-up|0|||
160813362|NCT00819156|580700175|FG004|Overall Study|Lost to Follow-up|0|||
160813363|NCT00819156|580700176|FG005|Overall Study|Lost to Follow-up|2|||
160813364|NCT00819156|580700171|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
160813365|NCT00819156|580700172|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
160813366|NCT00819156|580700173|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
160813367|NCT00819156|580700174|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
160813368|NCT00819156|580700175|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
160813369|NCT00819156|580700176|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
160813370|NCT00819156|580700171|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
160813371|NCT00819156|580700172|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
160813372|NCT00819156|580700173|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
160813373|NCT00819156|580700174|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
160813374|NCT00819156|580700175|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
160813375|NCT00819156|580700176|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
160813376|NCT00819156|580700171|FG000|Overall Study|Prostate-specific antigen progression|0|||
160813377|NCT00819156|580700172|FG001|Overall Study|Prostate-specific antigen progression|0|||
160813378|NCT00819156|580700173|FG002|Overall Study|Prostate-specific antigen progression|0|||
160813379|NCT00819156|580700174|FG003|Overall Study|Prostate-specific antigen progression|0|||
160813380|NCT00819156|580700175|FG004|Overall Study|Prostate-specific antigen progression|1|||
160813381|NCT00819156|580700176|FG005|Overall Study|Prostate-specific antigen progression|0|||
160813382|NCT00790582|580700177|FG000|Overall Study|Death|14|||
160813383|NCT00790582|580700178|FG001|Overall Study|Death|32|||
160813384|NCT00790582|580700177|FG000|Overall Study|Physician Decision|7|||
160813385|NCT00790582|580700178|FG001|Overall Study|Physician Decision|1|||
160813386|NCT00790582|580700177|FG000|Overall Study|Lost to Follow-up|3|||
160813387|NCT00790582|580700178|FG001|Overall Study|Lost to Follow-up|3|||
160813388|NCT00790582|580700177|FG000|Overall Study|Withdrawal by Subject|7|||
160813389|NCT00790582|580700178|FG001|Overall Study|Withdrawal by Subject|51|||
160813390|NCT00803595|580700179|FG000|Overall Study|Adverse Event|3|||
160813391|NCT00803595|580700180|FG001|Overall Study|Adverse Event|4|||
160813392|NCT00803595|580700181|FG002|Overall Study|Adverse Event|1|||
160813393|NCT00803595|580700179|FG000|Overall Study|Protocol Violation|7|||
160813394|NCT00803595|580700180|FG001|Overall Study|Protocol Violation|2|||
160813395|NCT00803595|580700181|FG002|Overall Study|Protocol Violation|12|||
160813396|NCT00803595|580700179|FG000|Overall Study|Withdrawal by Subject|5|||
160813397|NCT00803595|580700180|FG001|Overall Study|Withdrawal by Subject|2|||
160813398|NCT00803595|580700181|FG002|Overall Study|Withdrawal by Subject|3|||
160813399|NCT00556439|580700185|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
160813400|NCT00556439|580700186|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
160813401|NCT00556439|580700187|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
160813402|NCT00556439|580700188|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
160813403|NCT00556439|580700185|FG000|Study Entry to Week 12|Physician Decision|1|||
160813404|NCT00556439|580700186|FG001|Study Entry to Week 12|Physician Decision|0|||
160813405|NCT00556439|580700187|FG002|Study Entry to Week 12|Physician Decision|0|||
160813406|NCT00556439|580700188|FG003|Study Entry to Week 12|Physician Decision|0|||
160813407|NCT00556439|580700185|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
160813408|NCT00556439|580700186|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
160813409|NCT00556439|580700187|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
160813410|NCT00556439|580700188|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
160813411|NCT00556439|580700185|FG000|Study Entry to Week 12|Recurrent infection|1|||
160813412|NCT00556439|580700186|FG001|Study Entry to Week 12|Recurrent infection|0|||
160813413|NCT00556439|580700187|FG002|Study Entry to Week 12|Recurrent infection|0|||
160813414|NCT00556439|580700188|FG003|Study Entry to Week 12|Recurrent infection|0|||
160813415|NCT00556439|580700185|FG000|Study Entry to Week 12|Malignancy|0|||
160813416|NCT00556439|580700186|FG001|Study Entry to Week 12|Malignancy|0|||
160813417|NCT00556439|580700187|FG002|Study Entry to Week 12|Malignancy|1|||
160813418|NCT00556439|580700188|FG003|Study Entry to Week 12|Malignancy|0|||
160813419|NCT00556439|580700185|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
160813420|NCT00556439|580700186|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
160813421|NCT00556439|580700187|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
160813422|NCT00556439|580700188|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
160813423|NCT00556439|580700185|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
160813424|NCT00556439|580700186|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
160813425|NCT00556439|580700187|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
160813426|NCT00556439|580700188|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
160813427|NCT00556439|580700185|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
160813428|NCT00556439|580700186|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
160813429|NCT00556439|580700187|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
160900122|NCT03452228|581028656|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
160813430|NCT00556439|580700188|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
160813431|NCT00556439|580700185|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
160813432|NCT00556439|580700186|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
160813433|NCT00556439|580700187|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
160813434|NCT00556439|580700188|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
160813435|NCT02100423|580700189|FG000|Overall Study|Death|1|||
160813436|NCT02100423|580700189|FG000|Overall Study|Withdrawal by Subject|3|||
160552270|NCT04820309|579746957|FG000|Overall Study|failure to adhere to protocol|32|||
160552271|NCT04820309|579746957|FG000|Overall Study|alcohol or drug use|6|||
160552272|NCT04820309|579746957|FG000|Overall Study|Lost to Follow-up|46|||
160552273|NCT04820309|579746957|FG000|Overall Study|Death|2|||
160552274|NCT04820309|579746957|FG000|Overall Study|Pregnancy|1|||
160552275|NCT04820309|579746957|FG000|Overall Study|Other reasons|12|||
160552276|NCT05902364|579746962|FG000|Overall Study|Adverse Event|1|||
160552277|NCT05902364|579746963|FG001|Overall Study|Adverse Event|0|||
160552278|NCT00429585|579746964|FG000|Overall Study|Death|1|||
160552279|NCT00429585|579746965|FG001|Overall Study|Death|0|||
160552280|NCT00429585|579746964|FG000|Overall Study|Lost to Follow-up|27|||
160552281|NCT00429585|579746965|FG001|Overall Study|Lost to Follow-up|20|||
160552282|NCT00429585|579746964|FG000|Overall Study|Physician Decision|2|||
160552283|NCT00429585|579746965|FG001|Overall Study|Physician Decision|0|||
160552284|NCT00684957|579746969|FG000|Overall Study|Withdrawal by Subject|1|||
160552285|NCT00684957|579746970|FG001|Overall Study|Withdrawal by Subject|1|||
160552286|NCT00684957|579746969|FG000|Overall Study|Lost to Follow-up|1|||
160552287|NCT00684957|579746970|FG001|Overall Study|Lost to Follow-up|0|||
160552288|NCT04341948|579746971|FG000|Overall Study|Adverse Event|0|||
160552289|NCT04341948|579746972|FG001|Overall Study|Adverse Event|1|||
160552290|NCT04341948|579746971|FG000|Overall Study|Lost to Follow-up|6|||
160552291|NCT04341948|579746972|FG001|Overall Study|Lost to Follow-up|1|||
160552292|NCT04341948|579746971|FG000|Overall Study|Physician Decision|1|||
160552293|NCT04341948|579746972|FG001|Overall Study|Physician Decision|2|||
160552294|NCT04341948|579746971|FG000|Overall Study|Withdrawal by Participant|6|||
160552295|NCT04341948|579746972|FG001|Overall Study|Withdrawal by Participant|3|||
160552296|NCT04341948|579746971|FG000|Overall Study|Lack of compliance by Participant|1|||
160552297|NCT04341948|579746972|FG001|Overall Study|Lack of compliance by Participant|0|||
160552298|NCT03406897|579746973|FG000|Overall Study|Lost to Follow-up|1|||
160552299|NCT03406897|579746974|FG001|Overall Study|Lost to Follow-up|2|||
160552300|NCT03406897|579746973|FG000|Overall Study|Withdrawal by Subject|4|||
160552301|NCT03406897|579746974|FG001|Overall Study|Withdrawal by Subject|4|||
160552302|NCT03406897|579746973|FG000|Overall Study|Physician Decision|0|||
160552303|NCT03406897|579746974|FG001|Overall Study|Physician Decision|1|||
160552304|NCT01916980|579748388|FG000|Overall Study|Adverse Event|4|||
160552305|NCT01916980|579748389|FG001|Overall Study|Adverse Event|2|||
160552306|NCT01916980|579748388|FG000|Overall Study|Lack of Efficacy|2|||
160552307|NCT01916980|579748389|FG001|Overall Study|Lack of Efficacy|2|||
160552308|NCT01916980|579748388|FG000|Overall Study|Withdrawal by Subject|1|||
160552309|NCT01916980|579748389|FG001|Overall Study|Withdrawal by Subject|0|||
160552310|NCT00546364|579748390|FG000|Overall Study|Disease progression|5|||
160552311|NCT00546364|579748391|FG001|Overall Study|Disease progression|11|||
160552312|NCT00546364|579748392|FG002|Overall Study|Disease progression|8|||
160552313|NCT00546364|579748390|FG000|Overall Study|Completed and off treatment|1|||
160552314|NCT00546364|579748391|FG001|Overall Study|Completed and off treatment|0|||
160552315|NCT00546364|579748392|FG002|Overall Study|Completed and off treatment|2|||
160552316|NCT00546364|579748390|FG000|Overall Study|Administrative reason by sponsor|1|||
160552317|NCT00546364|579748391|FG001|Overall Study|Administrative reason by sponsor|0|||
160552318|NCT00546364|579748392|FG002|Overall Study|Administrative reason by sponsor|0|||
160552319|NCT00546364|579748390|FG000|Overall Study|Poor compliance/noncompliance|0|||
160552320|NCT00546364|579748391|FG001|Overall Study|Poor compliance/noncompliance|0|||
160552321|NCT00546364|579748392|FG002|Overall Study|Poor compliance/noncompliance|1|||
160552322|NCT00546364|579748390|FG000|Overall Study|No longer meets study criteria|1|||
160552323|NCT00546364|579748391|FG001|Overall Study|No longer meets study criteria|1|||
160552324|NCT00546364|579748392|FG002|Overall Study|No longer meets study criteria|0|||
160552325|NCT00546364|579748390|FG000|Overall Study|Withdrawal by Subject|5|||
160552326|NCT00546364|579748391|FG001|Overall Study|Withdrawal by Subject|6|||
160552327|NCT00546364|579748392|FG002|Overall Study|Withdrawal by Subject|3|||
160552328|NCT00546364|579748390|FG000|Overall Study|Prior taxotere|1|||
160552329|NCT00546364|579748391|FG001|Overall Study|Prior taxotere|0|||
160552330|NCT00546364|579748392|FG002|Overall Study|Prior taxotere|0|||
160552331|NCT00546364|579748390|FG000|Overall Study|Mixed response|1|||
160552332|NCT00546364|579748391|FG001|Overall Study|Mixed response|0|||
160552333|NCT00546364|579748392|FG002|Overall Study|Mixed response|0|||
160552334|NCT00546364|579748390|FG000|Overall Study|Palliative treatment|1|||
160552335|NCT00546364|579748391|FG001|Overall Study|Palliative treatment|0|||
160645323|NCT01427803|580084222|FG000|Overall Study|Lost to Follow-up|32|||
160552336|NCT00546364|579748392|FG002|Overall Study|Palliative treatment|1|||
160552337|NCT00546364|579748390|FG000|Overall Study|Target lesions resected|1|||
160552338|NCT00546364|579748391|FG001|Overall Study|Target lesions resected|0|||
160552339|NCT00546364|579748392|FG002|Overall Study|Target lesions resected|0|||
160552340|NCT00546364|579748390|FG000|Overall Study|Physician Decision|0|||
160552341|NCT00546364|579748391|FG001|Overall Study|Physician Decision|0|||
160552342|NCT00546364|579748392|FG002|Overall Study|Physician Decision|1|||
160552343|NCT00546364|579748390|FG000|Overall Study|Sponsor decision|0|||
160552344|NCT00546364|579748391|FG001|Overall Study|Sponsor decision|0|||
160552345|NCT00546364|579748392|FG002|Overall Study|Sponsor decision|1|||
160552346|NCT03064763|579748393|FG000|Overall Study|Lost to Follow-up|1|||
160813437|NCT02100423|580700189|FG000|Overall Study|Adverse Event|1|||
160813438|NCT02100423|580700189|FG000|Overall Study|Physician Decision|1|||
160813439|NCT00703846|580700190|FG000|Overall Study|Adverse Event|8|||
160813440|NCT00703846|580700190|FG000|Overall Study|Lost to Follow-up|55|||
160813441|NCT00703846|580700190|FG000|Overall Study|Lack of Efficacy|15|||
160813442|NCT00703846|580700190|FG000|Overall Study|Noncompliance with Study Treatment|2|||
160813443|NCT00703846|580700190|FG000|Overall Study|Withdrawal by Subject|40|||
160813444|NCT00703846|580700190|FG000|Overall Study|Death|1|||
160813445|NCT00703846|580700190|FG000|Overall Study|Other|14|||
160813446|NCT00703846|580700190|FG000|Overall Study|Did Not Receive Study Drug|2|||
160813447|NCT04601532|580700191|FG000|Overall Study|Lost to Follow-up|1|||
160813448|NCT04601532|580700192|FG001|Overall Study|Lost to Follow-up|2|||
160813449|NCT04601532|580700191|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
160813450|NCT04601532|580700192|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
160813451|NCT02195700|580700193|FG000|Overall Study|Protocol Violation|0|||
160813452|NCT02195700|580700194|FG001|Overall Study|Protocol Violation|2|||
160813453|NCT02195700|580700193|FG000|Overall Study|Noncompliance|1|||
160813454|NCT02195700|580700194|FG001|Overall Study|Noncompliance|0|||
160813455|NCT02195700|580700193|FG000|Overall Study|Adverse Event|1|||
160813456|NCT02195700|580700194|FG001|Overall Study|Adverse Event|2|||
160813457|NCT02195700|580700193|FG000|Overall Study|Withdrawal by Subject|3|||
160813458|NCT02195700|580700194|FG001|Overall Study|Withdrawal by Subject|2|||
160813459|NCT02195700|580700193|FG000|Overall Study|Lost to Follow-up|1|||
160813460|NCT02195700|580700194|FG001|Overall Study|Lost to Follow-up|1|||
160813461|NCT01352221|580700195|FG000|Double-blind Phase|Adverse Event|6|||
160813462|NCT01352221|580700196|FG001|Double-blind Phase|Adverse Event|4|||
160813463|NCT01352221|580700197|FG002|Double-blind Phase|Adverse Event|0|||
160813464|NCT01352221|580700198|FG003|Double-blind Phase|Adverse Event|0|||
160813465|NCT01352221|580700195|FG000|Double-blind Phase|Withdrawal by Subject|3|||
160813466|NCT01352221|580700196|FG001|Double-blind Phase|Withdrawal by Subject|5|||
160813467|NCT01352221|580700197|FG002|Double-blind Phase|Withdrawal by Subject|0|||
160813468|NCT01352221|580700198|FG003|Double-blind Phase|Withdrawal by Subject|0|||
160813469|NCT01352221|580700195|FG000|Double-blind Phase|Lost to Follow-up|0|||
160813470|NCT01352221|580700196|FG001|Double-blind Phase|Lost to Follow-up|1|||
160813471|NCT01352221|580700197|FG002|Double-blind Phase|Lost to Follow-up|0|||
160813472|NCT01352221|580700198|FG003|Double-blind Phase|Lost to Follow-up|0|||
160813473|NCT01352221|580700195|FG000|Double-blind Phase|Protocol Violation|0|||
160813474|NCT01352221|580700196|FG001|Double-blind Phase|Protocol Violation|1|||
160813475|NCT01352221|580700197|FG002|Double-blind Phase|Protocol Violation|0|||
160813476|NCT01352221|580700198|FG003|Double-blind Phase|Protocol Violation|0|||
160813477|NCT01352221|580700195|FG000|Open-label Phase|Physician Decision|0|||
160813478|NCT01352221|580700196|FG001|Open-label Phase|Physician Decision|0|||
160813479|NCT01352221|580700197|FG002|Open-label Phase|Physician Decision|2|||
160813480|NCT01352221|580700198|FG003|Open-label Phase|Physician Decision|1|||
160813481|NCT01352221|580700195|FG000|Open-label Phase|Pregnancy|0|||
160813482|NCT01352221|580700196|FG001|Open-label Phase|Pregnancy|0|||
160813483|NCT01352221|580700197|FG002|Open-label Phase|Pregnancy|1|||
160813484|NCT01352221|580700198|FG003|Open-label Phase|Pregnancy|0|||
160813485|NCT01352221|580700195|FG000|Open-label Phase|Adverse Event|0|||
160813486|NCT01352221|580700196|FG001|Open-label Phase|Adverse Event|0|||
160813487|NCT01352221|580700197|FG002|Open-label Phase|Adverse Event|8|||
160813488|NCT01352221|580700198|FG003|Open-label Phase|Adverse Event|4|||
160813489|NCT01352221|580700195|FG000|Open-label Phase|Withdrawal by Subject|0|||
160813490|NCT01352221|580700196|FG001|Open-label Phase|Withdrawal by Subject|0|||
160813491|NCT01352221|580700197|FG002|Open-label Phase|Withdrawal by Subject|1|||
160813492|NCT01352221|580700198|FG003|Open-label Phase|Withdrawal by Subject|6|||
160813493|NCT01352221|580700195|FG000|Open-label Phase|Worsening of IBD|0|||
160813494|NCT01352221|580700196|FG001|Open-label Phase|Worsening of IBD|0|||
160813495|NCT01352221|580700197|FG002|Open-label Phase|Worsening of IBD|1|||
160813496|NCT01352221|580700198|FG003|Open-label Phase|Worsening of IBD|0|||
160813497|NCT02566785|580700199|FG000|Overall Study|Lost to Follow-up|0|||
160813498|NCT02566785|580700200|FG001|Overall Study|Lost to Follow-up|2|||
160813499|NCT02566785|580700199|FG000|Overall Study|Worsening condition|1|||
160813500|NCT02566785|580700200|FG001|Overall Study|Worsening condition|1|||
160813501|NCT01597908|580700201|FG000|Randomized Phase|Death|217|||
160813502|NCT01597908|580700202|FG001|Randomized Phase|Death|238|||
160813503|NCT01597908|580700203|FG002|Randomized Phase|Death|0|||
160813504|NCT01597908|580700201|FG000|Randomized Phase|Sponsor Decision|93|||
160813505|NCT01597908|580700202|FG001|Randomized Phase|Sponsor Decision|39|||
160813506|NCT01597908|580700203|FG002|Randomized Phase|Sponsor Decision|0|||
160813507|NCT01597908|580700201|FG000|Randomized Phase|Lost to Follow-up|9|||
160813508|NCT01597908|580700202|FG001|Randomized Phase|Lost to Follow-up|16|||
160813509|NCT01597908|580700203|FG002|Randomized Phase|Lost to Follow-up|0|||
160813510|NCT01597908|580700201|FG000|Randomized Phase|Physician Decision|6|||
160813511|NCT01597908|580700202|FG001|Randomized Phase|Physician Decision|3|||
160813512|NCT01597908|580700203|FG002|Randomized Phase|Physician Decision|0|||
160813513|NCT01597908|580700201|FG000|Randomized Phase|Withdrawal by Subject|26|||
160813514|NCT01597908|580700202|FG001|Randomized Phase|Withdrawal by Subject|22|||
160813515|NCT01597908|580700203|FG002|Randomized Phase|Withdrawal by Subject|0|||
160813516|NCT01597908|580700201|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
160813517|NCT01597908|580700202|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
160813518|NCT01597908|580700203|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
160813519|NCT01597908|580700201|FG000|Crossover Phase|Death|0|||
160813520|NCT01597908|580700202|FG001|Crossover Phase|Death|0|||
160813521|NCT01597908|580700203|FG002|Crossover Phase|Death|11|||
160552347|NCT03064763|579748393|FG000|Overall Study|Death|8|||
160813522|NCT01597908|580700201|FG000|Crossover Phase|Withdrawal by Subject|0|||
160813523|NCT01597908|580700202|FG001|Crossover Phase|Withdrawal by Subject|0|||
160813524|NCT01597908|580700203|FG002|Crossover Phase|Withdrawal by Subject|3|||
160813525|NCT01597908|580700201|FG000|Crossover Phase|Sponsor Decision|0|||
160813526|NCT01597908|580700202|FG001|Crossover Phase|Sponsor Decision|0|||
160813527|NCT01597908|580700203|FG002|Crossover Phase|Sponsor Decision|20|||
160813528|NCT02547038|580701760|FG000|Overall Study|Lost to Follow-up|3|||
160813529|NCT02547038|580701761|FG001|Overall Study|Lost to Follow-up|2|||
160813530|NCT01340625|580701764|FG000|First Intervention|Adverse Event|1|||
160813531|NCT01340625|580701765|FG001|First Intervention|Adverse Event|0|||
160813532|NCT01340625|580701764|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
160813533|NCT01340625|580701765|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
160813534|NCT05160415|580701766|FG000|Overall Study|Withdrawal by Subject|3|||
160813535|NCT00623233|580701767|FG000|Overall Study|Adverse Event|10|||
160813536|NCT00623233|580701767|FG000|Overall Study|Physician Decision|10|||
160813537|NCT00623233|580701767|FG000|Overall Study|Lost to Follow-up|1|||
160813538|NCT00623233|580701767|FG000|Overall Study|Withdrawal by Subject|3|||
160813539|NCT00459875|580701768|FG000|Overall Study|Ineligible participant|1|||
160813540|NCT00459875|580701768|FG000|Overall Study|Adverse Event|2|||
160813541|NCT00576628|580701771|FG000|Overall Study|Adverse Event|11|||
160813542|NCT00576628|580701771|FG000|Overall Study|Death|2|||
160813543|NCT00576628|580701771|FG000|Overall Study|Failure to return|1|||
160813544|NCT00576628|580701771|FG000|Overall Study|Refused Treatment|8|||
160813545|NCT00576628|580701771|FG000|Overall Study|Pregnancy|1|||
160813546|NCT00576628|580701771|FG000|Overall Study|RBC transfusion|1|||
160813547|NCT00576628|580701771|FG000|Overall Study|Progression of Kidney Disease|1|||
160813548|NCT00576628|580701771|FG000|Overall Study|Progression of Renal Failure|1|||
160813549|NCT00576628|580701771|FG000|Overall Study|The patient move into other town|1|||
160813550|NCT00576628|580701771|FG000|Overall Study|Transplantation|1|||
160813551|NCT00576628|580701771|FG000|Overall Study|Dialysis|15|||
160813552|NCT03206970|580701772|FG000|Overall Study|Death|21|||
160813553|NCT03206970|580701772|FG000|Overall Study|Withdrawal by Subject|13|||
160813554|NCT03206970|580701772|FG000|Overall Study|Lost to Follow-up|3|||
160813555|NCT03206970|580701772|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
160813556|NCT03654040|580701779|FG000|Overall Study|Death|1|||
160813557|NCT03654040|580701780|FG001|Overall Study|Death|0|||
160813558|NCT03654040|580701779|FG000|Overall Study|Withdrawal by Subject|1|||
160813559|NCT03654040|580701780|FG001|Overall Study|Withdrawal by Subject|0|||
160813560|NCT03654040|580701779|FG000|Overall Study|Study terminated by sponsor|8|||
160813561|NCT03654040|580701780|FG001|Overall Study|Study terminated by sponsor|2|||
160813562|NCT03654040|580701779|FG000|Overall Study|Failure to initiate study therapy|2|||
160813563|NCT03654040|580701780|FG001|Overall Study|Failure to initiate study therapy|0|||
160813564|NCT03654040|580701779|FG000|Overall Study|Transplanted at another center|2|||
160813565|NCT03654040|580701780|FG001|Overall Study|Transplanted at another center|0|||
160813566|NCT03654040|580701779|FG000|Overall Study|Failure to meet eligibility criteria|14|||
160813567|NCT03654040|580701780|FG001|Overall Study|Failure to meet eligibility criteria|2|||
160813568|NCT03654040|580701779|FG000|Overall Study|No longer transplant candidate|1|||
160813569|NCT03654040|580701780|FG001|Overall Study|No longer transplant candidate|0|||
160813570|NCT03654040|580701779|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
160813571|NCT03654040|580701780|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
160813572|NCT03654040|580701779|FG000|Overall Study|Recipient ineligible|0|||
160813573|NCT03654040|580701780|FG001|Overall Study|Recipient ineligible|2|||
160813574|NCT03654040|580701779|FG000|Overall Study|Received deceased liver|0|||
160813575|NCT03654040|580701780|FG001|Overall Study|Received deceased liver|1|||
160813576|NCT01951586|580701785|FG000|Overall Study|Death|61|||
160813577|NCT01951586|580701786|FG001|Overall Study|Death|120|||
160813578|NCT01951586|580701785|FG000|Overall Study|Withdrawal by Subject|8|||
160813579|NCT01951586|580701786|FG001|Overall Study|Withdrawal by Subject|17|||
160813580|NCT01951586|580701785|FG000|Overall Study|Lost to Follow-up|0|||
160813581|NCT01951586|580701786|FG001|Overall Study|Lost to Follow-up|1|||
160813582|NCT01951586|580701785|FG000|Overall Study|Sponsor Decision|9|||
160813583|NCT01951586|580701786|FG001|Overall Study|Sponsor Decision|10|||
160813584|NCT05332392|580701787|FG000|Overall Study|Did not meet inclusion criteria|25|||
160813585|NCT05332392|580701787|FG000|Overall Study|Principal Investigator's decision|17|||
160813586|NCT05332392|580701787|FG000|Overall Study|Adverse Event|1|||
160813587|NCT05332392|580701787|FG000|Overall Study|Subject's decision|1|||
160813588|NCT00224120|580701788|FG000|Overall Study|Adverse Event|10|||
160813589|NCT00224120|580701789|FG001|Overall Study|Adverse Event|4|||
160813590|NCT00224120|580701788|FG000|Overall Study|Protocol Violation|1|||
160813591|NCT00224120|580701789|FG001|Overall Study|Protocol Violation|0|||
160813592|NCT00224120|580701788|FG000|Overall Study|Withdrawal by Subject|5|||
160552348|NCT00388947|579748395|FG000|Overall Study|Protocol Violation|47|||
160552349|NCT04187092|579748396|FG000|Overall Study|Lost to Follow-up|1|||
160552350|NCT04187092|579748397|FG001|Overall Study|Lost to Follow-up|1|||
160813593|NCT00224120|580701789|FG001|Overall Study|Withdrawal by Subject|10|||
160813594|NCT00224120|580701788|FG000|Overall Study|Lack of Efficacy|0|||
160813595|NCT00224120|580701789|FG001|Overall Study|Lack of Efficacy|2|||
160813596|NCT00224120|580701788|FG000|Overall Study|Lost to Follow-up|2|||
160813597|NCT00224120|580701789|FG001|Overall Study|Lost to Follow-up|3|||
160813598|NCT00224120|580701788|FG000|Overall Study|Other|4|||
160813599|NCT00224120|580701789|FG001|Overall Study|Other|5|||
160552351|NCT04187092|579748396|FG000|Overall Study|Withdrawal by Subject|1|||
160813600|NCT00104416|580701792|FG000|Double-Blind Phase|Adverse Event|2|||
160813601|NCT00104416|580701793|FG001|Double-Blind Phase|Adverse Event|1|||
160813602|NCT00104416|580701794|FG002|Double-Blind Phase|Adverse Event|0|||
160813603|NCT00104416|580701795|FG003|Double-Blind Phase|Adverse Event|0|||
160813604|NCT00104416|580701796|FG004|Double-Blind Phase|Adverse Event|0|||
160813605|NCT00104416|580701792|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160813606|NCT00104416|580701793|FG001|Double-Blind Phase|Lost to Follow-up|1|||
160813607|NCT00104416|580701794|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160813608|NCT00104416|580701795|FG003|Double-Blind Phase|Lost to Follow-up|0|||
160813609|NCT00104416|580701796|FG004|Double-Blind Phase|Lost to Follow-up|0|||
160813610|NCT00104416|580701792|FG000|Double-Blind Phase|Protocol Violation|0|||
160813611|NCT00104416|580701793|FG001|Double-Blind Phase|Protocol Violation|1|||
160813612|NCT00104416|580701794|FG002|Double-Blind Phase|Protocol Violation|0|||
160813613|NCT00104416|580701795|FG003|Double-Blind Phase|Protocol Violation|0|||
160813614|NCT00104416|580701796|FG004|Double-Blind Phase|Protocol Violation|0|||
160813615|NCT00104416|580701792|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
160813616|NCT00104416|580701793|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
160813617|NCT00104416|580701794|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160813618|NCT00104416|580701795|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160813619|NCT00104416|580701796|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
160813620|NCT00104416|580701792|FG000|Double-Blind Phase|Pregnancy|1|||
160813621|NCT00104416|580701793|FG001|Double-Blind Phase|Pregnancy|0|||
160813622|NCT00104416|580701794|FG002|Double-Blind Phase|Pregnancy|0|||
160813623|NCT00104416|580701795|FG003|Double-Blind Phase|Pregnancy|0|||
160813624|NCT00104416|580701796|FG004|Double-Blind Phase|Pregnancy|0|||
160813625|NCT00104416|580701792|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
160813626|NCT00104416|580701793|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
160813627|NCT00104416|580701794|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
160813628|NCT00104416|580701795|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
160813629|NCT00104416|580701796|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
160813630|NCT00104416|580701792|FG000|Continuation Phase|Adverse Event|0|||
160813631|NCT00104416|580701793|FG001|Continuation Phase|Adverse Event|0|||
160813632|NCT00104416|580701794|FG002|Continuation Phase|Adverse Event|2|||
160813633|NCT00104416|580701795|FG003|Continuation Phase|Adverse Event|0|||
160813634|NCT00104416|580701796|FG004|Continuation Phase|Adverse Event|2|||
160813635|NCT00104416|580701792|FG000|Continuation Phase|Lost to Follow-up|0|||
160813636|NCT00104416|580701793|FG001|Continuation Phase|Lost to Follow-up|0|||
160813637|NCT00104416|580701794|FG002|Continuation Phase|Lost to Follow-up|1|||
160813638|NCT00104416|580701795|FG003|Continuation Phase|Lost to Follow-up|0|||
160813639|NCT00104416|580701796|FG004|Continuation Phase|Lost to Follow-up|1|||
160813640|NCT00104416|580701792|FG000|Continuation Phase|Withdrawal by Subject|0|||
160813641|NCT00104416|580701793|FG001|Continuation Phase|Withdrawal by Subject|0|||
160813642|NCT00104416|580701794|FG002|Continuation Phase|Withdrawal by Subject|2|||
160813643|NCT00104416|580701795|FG003|Continuation Phase|Withdrawal by Subject|1|||
160813644|NCT00104416|580701796|FG004|Continuation Phase|Withdrawal by Subject|1|||
160813645|NCT00104416|580701792|FG000|Continuation Phase|Pregnancy|0|||
160813646|NCT00104416|580701793|FG001|Continuation Phase|Pregnancy|0|||
160813647|NCT00104416|580701794|FG002|Continuation Phase|Pregnancy|1|||
160813648|NCT00104416|580701795|FG003|Continuation Phase|Pregnancy|1|||
160813649|NCT00104416|580701796|FG004|Continuation Phase|Pregnancy|0|||
160813650|NCT00104416|580701792|FG000|Continuation Phase|Non-compliance|0|||
160813651|NCT00104416|580701793|FG001|Continuation Phase|Non-compliance|0|||
160813652|NCT00104416|580701794|FG002|Continuation Phase|Non-compliance|0|||
160813653|NCT00104416|580701795|FG003|Continuation Phase|Non-compliance|0|||
160813654|NCT00104416|580701796|FG004|Continuation Phase|Non-compliance|1|||
160813655|NCT00438360|580701797|FG000|Overall Study|Adverse Event|6|||
160813656|NCT00438360|580701798|FG001|Overall Study|Adverse Event|1|||
160813657|NCT00438360|580701797|FG000|Overall Study|Lack of Efficacy|42|||
160813658|NCT00438360|580701798|FG001|Overall Study|Lack of Efficacy|27|||
160813659|NCT00438360|580701797|FG000|Overall Study|Other|24|||
160813660|NCT00438360|580701798|FG001|Overall Study|Other|15|||
160813661|NCT03629223|580701799|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
160813662|NCT03629223|580701800|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
160813663|NCT03629223|580701801|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
160813664|NCT03629223|580701802|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
160813665|NCT03629223|580701803|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
160813666|NCT03629223|580701804|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
160813667|NCT03629223|580701799|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
160813668|NCT03629223|580701800|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
160813669|NCT03629223|580701801|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
160813670|NCT03629223|580701802|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
160813671|NCT03629223|580701803|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
160813672|NCT03629223|580701804|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
160813673|NCT03629223|580701799|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
160813674|NCT03629223|580701800|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
160813675|NCT03629223|580701801|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
160813676|NCT03629223|580701802|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
160813677|NCT03629223|580701803|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
160813678|NCT03629223|580701804|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
160813679|NCT03629223|580701799|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
160813680|NCT03629223|580701800|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
160813681|NCT03629223|580701801|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
160813682|NCT03629223|580701802|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
160813683|NCT03629223|580701803|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
160813684|NCT03629223|580701804|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
160813685|NCT03629223|580701799|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
160813686|NCT03629223|580701800|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
160813687|NCT03629223|580701801|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
160813688|NCT03629223|580701802|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
160813689|NCT03629223|580701803|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
160813690|NCT03629223|580701804|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
160813691|NCT01534351|580701805|FG000|Overall Study|Study Terminated Early|1|||
160813692|NCT01534351|580701806|FG001|Overall Study|Study Terminated Early|0|||
160813693|NCT01534351|580701807|FG002|Overall Study|Study Terminated Early|0|||
160813694|NCT02702609|580701808|FG000|Overall Study|Lost to Follow-up|8|||
160813695|NCT02702609|580701809|FG001|Overall Study|Lost to Follow-up|4|||
160813696|NCT02702609|580701808|FG000|Overall Study|Physician Decision|1|||
160813697|NCT02702609|580701809|FG001|Overall Study|Physician Decision|0|||
160813698|NCT02674464|580701810|FG000|Overall Study|Death|10|||
160813699|NCT02674464|580701811|FG001|Overall Study|Death|21|||
160813700|NCT02674464|580701810|FG000|Overall Study|Withdrawal by Subject|24|||
160813701|NCT02674464|580701811|FG001|Overall Study|Withdrawal by Subject|44|||
160813702|NCT02674464|580701810|FG000|Overall Study|Lost to Follow-up|97|||
160813703|NCT02674464|580701811|FG001|Overall Study|Lost to Follow-up|92|||
160813704|NCT02674464|580701810|FG000|Overall Study|Outside survey window|6|||
160813705|NCT02674464|580701811|FG001|Overall Study|Outside survey window|3|||
160813706|NCT04153981|580701812|FG000|Overall Study|Death|1|||
160813707|NCT04153981|580701812|FG000|Overall Study|Withdrawal by Subject|24|||
160813708|NCT04153981|580701812|FG000|Overall Study|Lost to Follow-up|1|||
160813709|NCT04153981|580701812|FG000|Overall Study|Physician Decision|1|||
160645324|NCT01427803|580084223|FG001|Overall Study|Lost to Follow-up|26|||
160645325|NCT01427803|580084222|FG000|Overall Study|Withdrawal by Subject|20|||
160813710|NCT04153981|580701812|FG000|Overall Study|Due to Unavailable Glucometer|1|||
160813711|NCT04153981|580701812|FG000|Overall Study|Covid 19|52|||
160813712|NCT04153981|580701812|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
160813713|NCT04153981|580701812|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
160813714|NCT01262638|580701813|FG000|Overall Study|Adverse Event|3|||
160813715|NCT01262638|580701814|FG001|Overall Study|Adverse Event|4|||
160813716|NCT01262638|580701815|FG002|Overall Study|Adverse Event|3|||
160813717|NCT01262638|580701816|FG003|Overall Study|Adverse Event|4|||
160813718|NCT01262638|580701813|FG000|Overall Study|Protocol Violation|1|||
160813719|NCT01262638|580701814|FG001|Overall Study|Protocol Violation|0|||
160813720|NCT01262638|580701815|FG002|Overall Study|Protocol Violation|0|||
160813721|NCT01262638|580701816|FG003|Overall Study|Protocol Violation|1|||
160813722|NCT01262638|580701813|FG000|Overall Study|Withdrawal by Subject|2|||
160813723|NCT01262638|580701814|FG001|Overall Study|Withdrawal by Subject|1|||
160813724|NCT01262638|580701815|FG002|Overall Study|Withdrawal by Subject|0|||
160813725|NCT01262638|580701816|FG003|Overall Study|Withdrawal by Subject|1|||
160813726|NCT01262638|580701813|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
160813727|NCT01262638|580701814|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
160813728|NCT01262638|580701815|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
160813729|NCT01262638|580701816|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
160813730|NCT01262638|580701813|FG000|Overall Study|Lost to Follow-up|1|||
160813731|NCT01262638|580701814|FG001|Overall Study|Lost to Follow-up|1|||
160813732|NCT01262638|580701815|FG002|Overall Study|Lost to Follow-up|1|||
160813733|NCT01262638|580701816|FG003|Overall Study|Lost to Follow-up|1|||
160813734|NCT01262638|580701813|FG000|Overall Study|Participant Went Out of Town|0|||
160813735|NCT01262638|580701814|FG001|Overall Study|Participant Went Out of Town|0|||
160813736|NCT01262638|580701815|FG002|Overall Study|Participant Went Out of Town|1|||
160813737|NCT01262638|580701816|FG003|Overall Study|Participant Went Out of Town|0|||
160813738|NCT01369199|580701819|FG000|Overall Study|Withdrawal by Subject|1|||
160813739|NCT01369199|580701819|FG000|Overall Study|Lost to Follow-up|2|||
160813740|NCT01071252|580701820|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
160813741|NCT01071252|580701821|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
160813742|NCT01071252|580701822|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
160813743|NCT01071252|580701823|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
160813744|NCT01071252|580701824|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
160813745|NCT01071252|580701820|FG000|Overall Study|Withdrawal by Subject|8|||
160813746|NCT01071252|580701821|FG001|Overall Study|Withdrawal by Subject|2|||
160813747|NCT01071252|580701822|FG002|Overall Study|Withdrawal by Subject|1|||
160813748|NCT01071252|580701823|FG003|Overall Study|Withdrawal by Subject|2|||
160813749|NCT01071252|580701824|FG004|Overall Study|Withdrawal by Subject|3|||
160813750|NCT01071252|580701820|FG000|Overall Study|administrative problems|1|||
160552352|NCT04187092|579748397|FG001|Overall Study|Withdrawal by Subject|1|||
160552353|NCT04187092|579748396|FG000|Overall Study|Adverse Event|0|||
160552354|NCT04187092|579748397|FG001|Overall Study|Adverse Event|1|||
160552355|NCT04660643|579748398|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
160552356|NCT04660643|579748399|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
160813751|NCT01071252|580701821|FG001|Overall Study|administrative problems|1|||
160813752|NCT01071252|580701822|FG002|Overall Study|administrative problems|0|||
160813753|NCT01071252|580701823|FG003|Overall Study|administrative problems|2|||
160813754|NCT01071252|580701824|FG004|Overall Study|administrative problems|1|||
160813755|NCT01071252|580701820|FG000|Overall Study|Lost to Follow-up|1|||
160813756|NCT01071252|580701821|FG001|Overall Study|Lost to Follow-up|0|||
160813757|NCT01071252|580701822|FG002|Overall Study|Lost to Follow-up|1|||
160813758|NCT01071252|580701823|FG003|Overall Study|Lost to Follow-up|2|||
160813759|NCT01071252|580701824|FG004|Overall Study|Lost to Follow-up|0|||
160813760|NCT01071252|580701820|FG000|Overall Study|Adverse Event|1|||
160813761|NCT01071252|580701821|FG001|Overall Study|Adverse Event|1|||
160813762|NCT01071252|580701822|FG002|Overall Study|Adverse Event|0|||
160813763|NCT01071252|580701823|FG003|Overall Study|Adverse Event|1|||
160645326|NCT01427803|580084223|FG001|Overall Study|Withdrawal by Subject|0|||
160645327|NCT01427803|580084222|FG000|Overall Study|Unable to complete full treatment period|6|||
160645328|NCT01427803|580084223|FG001|Overall Study|Unable to complete full treatment period|0|||
160645329|NCT01427803|580084222|FG000|Overall Study|Protocol Violation|1|||
160645330|NCT01427803|580084223|FG001|Overall Study|Protocol Violation|0|||
160645331|NCT01427803|580084222|FG000|Overall Study|Physician Decision|3|||
160645332|NCT01427803|580084223|FG001|Overall Study|Physician Decision|0|||
160645333|NCT01427803|580084222|FG000|Overall Study|did not take product|1|||
160645334|NCT01427803|580084223|FG001|Overall Study|did not take product|0|||
160645335|NCT03412019|580084224|FG000|Overall Study|Withdrawal by Subject|1|||
160645336|NCT03412019|580084225|FG001|Overall Study|Withdrawal by Subject|1|||
160645337|NCT00886483|580084228|FG000|Overall Study|Lost to Follow-up|0|||
160645338|NCT00886483|580084229|FG001|Overall Study|Lost to Follow-up|1|||
160645339|NCT00886483|580084228|FG000|Overall Study|Pursue medications|1|||
160645340|NCT00886483|580084229|FG001|Overall Study|Pursue medications|2|||
160645341|NCT00886483|580084228|FG000|Overall Study|Distance to center, poor grades|1|||
160645342|NCT00886483|580084229|FG001|Overall Study|Distance to center, poor grades|0|||
160645343|NCT01001169|580084230|FG000|Overall Study|Withdrawal by Subject|2|||
160645344|NCT01001169|580084231|FG001|Overall Study|Withdrawal by Subject|1|||
160645345|NCT01271933|580084232|FG000|Single-Blind Phase|Lack of Efficacy|37|||
160645346|NCT01271933|580084233|FG001|Single-Blind Phase|Lack of Efficacy|0|||
160645347|NCT01271933|580084234|FG002|Single-Blind Phase|Lack of Efficacy|0|||
160645348|NCT01271933|580084232|FG000|Single-Blind Phase|Lost to Follow-up|10|||
160645349|NCT01271933|580084233|FG001|Single-Blind Phase|Lost to Follow-up|0|||
160645350|NCT01271933|580084234|FG002|Single-Blind Phase|Lost to Follow-up|0|||
160645351|NCT01271933|580084232|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
160645352|NCT01271933|580084233|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
160645353|NCT01271933|580084234|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
160645354|NCT01271933|580084232|FG000|Single-Blind Phase|Protocol Violation|3|||
160645355|NCT01271933|580084233|FG001|Single-Blind Phase|Protocol Violation|0|||
160645356|NCT01271933|580084234|FG002|Single-Blind Phase|Protocol Violation|0|||
160645357|NCT01271933|580084232|FG000|Single-Blind Phase|Adverse Event|52|||
160645358|NCT01271933|580084233|FG001|Single-Blind Phase|Adverse Event|0|||
160645359|NCT01271933|580084234|FG002|Single-Blind Phase|Adverse Event|0|||
160645360|NCT01271933|580084232|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
160645361|NCT01271933|580084233|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
160645362|NCT01271933|580084234|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
160645363|NCT01271933|580084232|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
160645364|NCT01271933|580084233|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
160645365|NCT01271933|580084234|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
160645366|NCT01271933|580084232|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
160645367|NCT01271933|580084233|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
160645368|NCT01271933|580084234|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
160645369|NCT01271933|580084232|FG000|Double-Blind Phase|Randomized but not treated|0|||
160645370|NCT01271933|580084233|FG001|Double-Blind Phase|Randomized but not treated|0|||
160813764|NCT01071252|580701824|FG004|Overall Study|Adverse Event|0|||
160813765|NCT01071252|580701820|FG000|Overall Study|Death|0|||
160813766|NCT01071252|580701821|FG001|Overall Study|Death|0|||
160813767|NCT01071252|580701822|FG002|Overall Study|Death|0|||
160813768|NCT01071252|580701823|FG003|Overall Study|Death|0|||
160813769|NCT01071252|580701824|FG004|Overall Study|Death|1|||
160813770|NCT01066104|580701825|FG000|Overall Study|Adverse Event|1|||
160813771|NCT01066104|580701826|FG001|Overall Study|Adverse Event|1|||
160813772|NCT01066104|580701825|FG000|Overall Study|Protocol Violation|1|||
160813773|NCT01066104|580701826|FG001|Overall Study|Protocol Violation|0|||
160813774|NCT03902392|580701829|FG000|Overall Study|Lost to Follow-up|7|||
160813775|NCT03902392|580701830|FG001|Overall Study|Lost to Follow-up|7|||
160813776|NCT03248167|580701833|FG000|Overall Study|Withdrawal by Subject|2|||
160813777|NCT03248167|580701834|FG001|Overall Study|Withdrawal by Subject|2|||
160813778|NCT03248167|580701833|FG000|Overall Study|Physician Decision|0|||
160813779|NCT03248167|580701834|FG001|Overall Study|Physician Decision|1|||
160813780|NCT03248167|580701833|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
160813781|NCT03248167|580701834|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
160813782|NCT03248167|580701833|FG000|Overall Study|Lost to Follow-up|1|||
160813783|NCT03248167|580701834|FG001|Overall Study|Lost to Follow-up|0|||
160813784|NCT01558596|580701838|FG000|Overall Study|Withdrawal by Subject|1|||
160813785|NCT01558596|580701839|FG001|Overall Study|Withdrawal by Subject|0|||
160813786|NCT01558596|580701838|FG000|Overall Study|surgery elsewhere or cancelled|1|||
160813787|NCT01558596|580701839|FG001|Overall Study|surgery elsewhere or cancelled|1|||
160813788|NCT01558596|580701838|FG000|Overall Study|Protocol Violation|1|||
160813789|NCT01558596|580701839|FG001|Overall Study|Protocol Violation|0|||
160813790|NCT00260832|580701840|FG000|Overall Study|Adverse Event|26|||
160813791|NCT00260832|580701841|FG001|Overall Study|Adverse Event|19|||
160813792|NCT00260832|580701840|FG000|Overall Study|Progression|116|||
160813793|NCT00260832|580701841|FG001|Overall Study|Progression|96|||
160813794|NCT00260832|580701840|FG000|Overall Study|Withdrawal by Subject|15|||
160813795|NCT00260832|580701841|FG001|Overall Study|Withdrawal by Subject|17|||
160813796|NCT00260832|580701840|FG000|Overall Study|Physician Decision|15|||
160813797|NCT00260832|580701841|FG001|Overall Study|Physician Decision|9|||
160813798|NCT00260832|580701840|FG000|Overall Study|Death|43|||
160813799|NCT00260832|580701841|FG001|Overall Study|Death|62|||
160813800|NCT00260832|580701840|FG000|Overall Study|Other|10|||
160813801|NCT00260832|580701841|FG001|Overall Study|Other|7|||
160813802|NCT00260832|580701840|FG000|Overall Study|Protocol Violation|3|||
160813803|NCT00260832|580701841|FG001|Overall Study|Protocol Violation|1|||
160813804|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
160813805|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
160813806|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
160813807|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160813808|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160813809|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160813810|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160813811|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
160813812|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160552357|NCT04660643|579748400|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
160552358|NCT04660643|579748398|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
160552359|NCT04660643|579748399|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
160552360|NCT04660643|579748400|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
160552361|NCT04660643|579748398|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
160552362|NCT04660643|579748399|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
160552363|NCT04660643|579748400|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
160552364|NCT04660643|579748398|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
160552365|NCT04660643|579748399|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
160552366|NCT04660643|579748400|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
160552367|NCT04660643|579748398|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
160552368|NCT04660643|579748399|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
160552369|NCT04660643|579748400|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
160552370|NCT04660643|579748398|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
160552371|NCT04660643|579748399|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
160552372|NCT04660643|579748400|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
160552373|NCT04660643|579748398|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
160552374|NCT04660643|579748399|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
160552375|NCT04660643|579748400|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
160552376|NCT04660643|579748398|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
160552377|NCT04660643|579748399|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
160552378|NCT04660643|579748400|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
160552379|NCT04660643|579748398|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
160552380|NCT04660643|579748399|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
160552381|NCT04660643|579748400|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
160552382|NCT04660643|579748398|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
160552383|NCT04660643|579748399|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
160552384|NCT04660643|579748400|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
160552385|NCT04660643|579748398|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
160552386|NCT04660643|579748399|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
160552387|NCT04660643|579748400|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
160552388|NCT04660643|579748398|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
160552389|NCT04660643|579748399|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
160552390|NCT04660643|579748400|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
160552391|NCT04660643|579748398|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
160552392|NCT04660643|579748399|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
160552393|NCT04660643|579748400|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
160552394|NCT04660643|579748398|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
160552395|NCT04660643|579748399|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
160552396|NCT04660643|579748400|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
160552397|NCT04660643|579748398|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
160552398|NCT04660643|579748399|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
160813813|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160813814|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160813815|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160813816|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160813817|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160645371|NCT01271933|580084234|FG002|Double-Blind Phase|Randomized but not treated|1|||
160645372|NCT01271933|580084232|FG000|Double-Blind Phase|Lack of Efficacy|0|||
160645373|NCT01271933|580084233|FG001|Double-Blind Phase|Lack of Efficacy|6|||
160645374|NCT01271933|580084234|FG002|Double-Blind Phase|Lack of Efficacy|9|||
160645375|NCT01271933|580084232|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160645376|NCT01271933|580084233|FG001|Double-Blind Phase|Lost to Follow-up|1|||
160645377|NCT01271933|580084234|FG002|Double-Blind Phase|Lost to Follow-up|1|||
160645378|NCT01271933|580084232|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
160645379|NCT01271933|580084233|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
160645380|NCT01271933|580084234|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
160645381|NCT01271933|580084232|FG000|Double-Blind Phase|Adverse Event|0|||
160645382|NCT01271933|580084233|FG001|Double-Blind Phase|Adverse Event|3|||
160645383|NCT01271933|580084234|FG002|Double-Blind Phase|Adverse Event|0|||
160645384|NCT01271933|580084232|FG000|Double-Blind Phase|Participant request-personal reason|0|||
160645385|NCT01271933|580084233|FG001|Double-Blind Phase|Participant request-personal reason|1|||
160645386|NCT01271933|580084234|FG002|Double-Blind Phase|Participant request-personal reason|0|||
160645387|NCT01138150|580084235|FG000|Overall Study|blood unable to be processed|0|||
160645388|NCT01138150|580084236|FG001|Overall Study|blood unable to be processed|1|||
160645389|NCT01138150|580084235|FG000|Overall Study|Physician Decision|1|||
160645390|NCT01138150|580084236|FG001|Overall Study|Physician Decision|0|||
160645391|NCT01620983|580084237|FG000|Overall Study|Lost to Follow-up|8|||
160645392|NCT01620983|580084238|FG001|Overall Study|Lost to Follow-up|4|||
160645393|NCT01620983|580084239|FG002|Overall Study|Lost to Follow-up|9|||
160645394|NCT01620983|580084237|FG000|Overall Study|Withdrawal by Subject|6|||
160645395|NCT01620983|580084238|FG001|Overall Study|Withdrawal by Subject|8|||
160645396|NCT01620983|580084239|FG002|Overall Study|Withdrawal by Subject|1|||
160645397|NCT01620983|580084237|FG000|Overall Study|Death|2|||
160645398|NCT01620983|580084238|FG001|Overall Study|Death|0|||
160645399|NCT01620983|580084239|FG002|Overall Study|Death|0|||
160645400|NCT01620983|580084237|FG000|Overall Study|Physician Decision|3|||
160645401|NCT01620983|580084238|FG001|Overall Study|Physician Decision|10|||
160645402|NCT01620983|580084239|FG002|Overall Study|Physician Decision|5|||
160645403|NCT00798889|580084241|FG000|Overall Study|Adverse Event|53|||
160645404|NCT00798889|580084241|FG000|Overall Study|Protocol Violation|2|||
160645405|NCT00798889|580084241|FG000|Overall Study|Withdrawal by Subject|31|||
160645406|NCT00798889|580084241|FG000|Overall Study|Lost to Follow-up|1|||
160645407|NCT00798889|580084241|FG000|Overall Study|Lack of Efficacy|213|||
160645408|NCT00798889|580084241|FG000|Overall Study|Decision of Sponsor|11|||
160645409|NCT00798889|580084241|FG000|Overall Study|Enrolled, Not treated|3|||
160645410|NCT00617461|580084242|FG000|First Treatment Intervention Period|Adverse Event|2|||
160645411|NCT00617461|580084243|FG001|First Treatment Intervention Period|Adverse Event|0|||
160645412|NCT00617461|580084242|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
160813818|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
160813819|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
160813820|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
160813821|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160813822|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160813823|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160813824|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160813825|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
160813826|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
160813827|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160813828|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160813829|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160813830|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160813831|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160813832|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
160813833|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160813834|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160813835|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160813836|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160900123|NCT03452228|581028657|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160645413|NCT00617461|580084243|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
160645414|NCT00617461|580084242|FG000|First Treatment Intervention Period|Protocol Violation|2|||
160645415|NCT00617461|580084243|FG001|First Treatment Intervention Period|Protocol Violation|1|||
160645416|NCT00617461|580084242|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
160645417|NCT00617461|580084243|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
160645418|NCT00617461|580084242|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
160645419|NCT00617461|580084243|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
160645420|NCT00617461|580084242|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
160813837|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160813838|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160813839|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813840|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
160813841|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813842|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813843|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813844|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813845|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813846|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
160813847|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
160813848|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
160813849|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160813850|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160813851|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160813852|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160813853|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
160813854|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
160813855|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
160813856|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
160900124|NCT03452228|581028655|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
160900125|NCT03452228|581028656|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
160813857|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
160813858|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
160813859|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
160813860|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160813861|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160813862|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160813863|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160813864|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160552399|NCT04660643|579748400|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
160552400|NCT04660643|579748398|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
160552401|NCT04660643|579748399|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
160552402|NCT04660643|579748400|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
160552403|NCT05162066|579748404|FG000|Overall Study|Adverse Event|1|||
160552404|NCT05162066|579748405|FG001|Overall Study|Adverse Event|0|||
160552405|NCT05162066|579748406|FG002|Overall Study|Adverse Event|0|||
160552406|NCT05162066|579748404|FG000|Overall Study|Perceived lack of efficacy|1|||
160552407|NCT05162066|579748405|FG001|Overall Study|Perceived lack of efficacy|0|||
160552408|NCT05162066|579748406|FG002|Overall Study|Perceived lack of efficacy|0|||
160552409|NCT01220414|579748407|FG000|Overall Study|Withdrawal by Subject|1|||
160552410|NCT01220414|579748408|FG001|Overall Study|Withdrawal by Subject|0|||
160552411|NCT01220414|579748409|FG002|Overall Study|Withdrawal by Subject|0|||
160552412|NCT01220414|579748410|FG003|Overall Study|Withdrawal by Subject|1|||
160552413|NCT00669617|579748411|FG000|Period 1|Withdrawal by Subject|0|||
160552414|NCT00669617|579748412|FG001|Period 1|Withdrawal by Subject|0|||
160552415|NCT00669617|579748413|FG002|Period 1|Withdrawal by Subject|1|||
160552416|NCT00669617|579748414|FG003|Period 1|Withdrawal by Subject|0|||
160552417|NCT00669617|579748415|FG004|Period 1|Withdrawal by Subject|0|||
160552418|NCT00669617|579748411|FG000|Period 1|Protocol Deviation|0|||
160552419|NCT00669617|579748412|FG001|Period 1|Protocol Deviation|0|||
160552420|NCT00669617|579748413|FG002|Period 1|Protocol Deviation|0|||
160552421|NCT00669617|579748414|FG003|Period 1|Protocol Deviation|0|||
160552422|NCT00669617|579748415|FG004|Period 1|Protocol Deviation|1|||
160813865|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
160813866|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
160813867|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160813868|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160813869|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160813870|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
160813871|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160813872|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
160813873|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
160813874|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160813875|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160813876|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160813877|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
160813878|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
160813879|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
160813880|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
160813881|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160813882|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160813883|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160813884|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160813885|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
160813886|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
160813887|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160813888|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160813889|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160552423|NCT00669617|579748411|FG000|Period 3|Lost to Follow-up|1|||
160552424|NCT00669617|579748412|FG001|Period 3|Lost to Follow-up|0|||
160552425|NCT00669617|579748413|FG002|Period 3|Lost to Follow-up|0|||
160813890|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160552426|NCT00669617|579748414|FG003|Period 3|Lost to Follow-up|0|||
160552427|NCT00669617|579748415|FG004|Period 3|Lost to Follow-up|0|||
160552428|NCT00623831|579748416|FG000|Overall Study|Withdrawal by Subject|1|||
160552429|NCT00623831|579748417|FG001|Overall Study|Withdrawal by Subject|0|||
160552430|NCT00623831|579748416|FG000|Overall Study|Progressive Disease|0|||
160552431|NCT00623831|579748417|FG001|Overall Study|Progressive Disease|1|||
160552432|NCT01276821|579748418|FG000|Overall Study|Protocol Violation|0|||
160645421|NCT00617461|580084243|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
160813891|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160813892|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160813893|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
160813894|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160813895|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160813896|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160813897|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160813898|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
160813899|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
160813900|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
160813901|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
160813902|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
160813903|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
160813904|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
160813905|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
160813906|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
160813907|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
160813908|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
160813909|NCT00771927|580701851|FG000|Overall Study|Adverse Event|100|||
160813910|NCT00771927|580701852|FG001|Overall Study|Adverse Event|105|||
160813911|NCT00771927|580701851|FG000|Overall Study|Lack of Efficacy|70|||
160813912|NCT00771927|580701852|FG001|Overall Study|Lack of Efficacy|42|||
160813913|NCT00771927|580701851|FG000|Overall Study|Lost to Follow-up|46|||
160813914|NCT00771927|580701852|FG001|Overall Study|Lost to Follow-up|46|||
160813915|NCT00771927|580701851|FG000|Overall Study|Withdrawal by Subject|16|||
160813916|NCT00771927|580701852|FG001|Overall Study|Withdrawal by Subject|17|||
160813917|NCT00771927|580701851|FG000|Overall Study|Other reason|23|||
160813918|NCT00771927|580701852|FG001|Overall Study|Other reason|27|||
160813919|NCT04222699|580701858|FG000|Overall Study|Lost to Follow-up|2|||
160813920|NCT02467192|580701862|FG000|Overall Study|Death|1|||
160813921|NCT02467192|580701862|FG000|Overall Study|revealed to have pneumonia before|2|||
160813922|NCT03213938|580701863|FG000|Overall Study|Lost to Follow-up|4|||
160813923|NCT03213938|580701864|FG001|Overall Study|Lost to Follow-up|3|||
160813924|NCT03213938|580701863|FG000|Overall Study|Lack of Efficacy|1|||
160813925|NCT03213938|580701864|FG001|Overall Study|Lack of Efficacy|0|||
160813926|NCT03213938|580701863|FG000|Overall Study|Decline to participate|5|||
160813927|NCT03213938|580701864|FG001|Overall Study|Decline to participate|4|||
160813928|NCT03213938|580701863|FG000|Overall Study|Without reason|4|||
160813929|NCT03213938|580701864|FG001|Overall Study|Without reason|5|||
160813930|NCT00005947|580701879|FG000|Overall Study|Death|54|||
160813931|NCT00005947|580701880|FG001|Overall Study|Death|40|||
160813932|NCT00005947|580701879|FG000|Overall Study|Patient Refused to Continue|2|||
160813933|NCT00005947|580701880|FG001|Overall Study|Patient Refused to Continue|1|||
160813934|NCT00005947|580701879|FG000|Overall Study|Site Closure|1|||
160813935|NCT00005947|580701880|FG001|Overall Study|Site Closure|0|||
160813936|NCT03335150|580701883|FG000|Overall Study|Withdrawal by Subject|10|||
160813937|NCT03335150|580701884|FG001|Overall Study|Withdrawal by Subject|4|||
160813938|NCT03335150|580701883|FG000|Overall Study|Adverse Event|0|||
160813939|NCT03335150|580701884|FG001|Overall Study|Adverse Event|1|||
160813940|NCT02218697|580701885|FG000|Overall Study|Adverse Event|0|||
160813941|NCT02218697|580701886|FG001|Overall Study|Adverse Event|2|||
160813942|NCT02218697|580701885|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
160813943|NCT02218697|580701886|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
160813944|NCT02218697|580701885|FG000|Overall Study|Withdrawal by Subject|2|||
160900126|NCT03452228|581028657|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
160900127|NCT03452228|581028655|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160552433|NCT01276821|579748419|FG001|Overall Study|Protocol Violation|1|||
160552434|NCT01748071|579748420|FG000|Overall Study|Adverse Event|2|||
160813945|NCT02218697|580701886|FG001|Overall Study|Withdrawal by Subject|3|||
160813946|NCT04380753|580701891|FG000|Overall Study|Participants continuing study|4|||
160813947|NCT04380753|580701891|FG000|Overall Study|Death|2|||
160813948|NCT00809926|580701892|FG000|Overall Study|Adverse Event|18|||
160813949|NCT00809926|580701893|FG001|Overall Study|Adverse Event|10|||
160813950|NCT00809926|580701892|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
160813951|NCT00809926|580701893|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160813952|NCT00809926|580701892|FG000|Overall Study|Patient withdrew consent|8|||
160645422|NCT00617461|580084242|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
160813953|NCT00809926|580701893|FG001|Overall Study|Patient withdrew consent|6|||
160813954|NCT00809926|580701892|FG000|Overall Study|Lost to Follow-up|2|||
160813955|NCT00809926|580701893|FG001|Overall Study|Lost to Follow-up|1|||
160813956|NCT00809926|580701892|FG000|Overall Study|Administrative Problems|0|||
160813957|NCT00809926|580701893|FG001|Overall Study|Administrative Problems|1|||
160813958|NCT00809926|580701892|FG000|Overall Study|Protocol deviation|0|||
160813959|NCT00809926|580701893|FG001|Overall Study|Protocol deviation|2|||
160813960|NCT00837161|580701900|FG000|Overall Study|refused hysterectomy|2|||
160813961|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Adverse Event|21|||
160813962|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Adverse Event|34|||
160813963|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Adverse Event|14|||
160813964|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Adverse Event|17|||
160813965|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Adverse Event|0|||
160813966|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
160813967|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
160813968|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
160813969|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
160813970|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
160813971|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
160813972|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
160813973|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
160813974|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
160813975|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
160813976|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Physician Decision|2|||
160813977|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Physician Decision|4|||
160813978|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Physician Decision|4|||
160813979|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Physician Decision|4|||
160813980|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Physician Decision|0|||
160813981|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
160813982|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
160813983|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
160813984|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
160813985|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
160813986|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
160813987|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
160813988|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
160813989|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
160813990|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
160813991|NCT01027650|580701908|FG000|Overall Study|Personal Reasons|0|||
160813992|NCT01027650|580701909|FG001|Overall Study|Personal Reasons|0|||
160645423|NCT00617461|580084243|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
160813993|NCT01027650|580701910|FG002|Overall Study|Personal Reasons|0|||
160454062|NCT02038777|579394028|FG006|Overall Study|Randomized but not treated|0|||
160813994|NCT01027650|580701911|FG003|Overall Study|Personal Reasons|0|||
160813995|NCT01027650|580701912|FG004|Overall Study|Personal Reasons|2|||
160813996|NCT01027650|580701913|FG005|Overall Study|Personal Reasons|1|||
160813997|NCT01027650|580701914|FG006|Overall Study|Personal Reasons|0|||
160813998|NCT01027650|580701915|FG007|Overall Study|Personal Reasons|0|||
160813999|NCT01027650|580701908|FG000|Overall Study|Lost to Follow-up|0|||
160814000|NCT01027650|580701909|FG001|Overall Study|Lost to Follow-up|0|||
160814001|NCT01027650|580701910|FG002|Overall Study|Lost to Follow-up|0|||
160814002|NCT01027650|580701911|FG003|Overall Study|Lost to Follow-up|0|||
160814003|NCT01027650|580701912|FG004|Overall Study|Lost to Follow-up|0|||
160814004|NCT01027650|580701913|FG005|Overall Study|Lost to Follow-up|0|||
160814005|NCT01027650|580701914|FG006|Overall Study|Lost to Follow-up|1|||
160814006|NCT01027650|580701915|FG007|Overall Study|Lost to Follow-up|0|||
160814007|NCT01027650|580701908|FG000|Overall Study|Lack of Efficacy|0|||
160814008|NCT01027650|580701909|FG001|Overall Study|Lack of Efficacy|0|||
160645424|NCT00617461|580084242|FG000|Second Treatment Intervention Period|Adverse Event|0|||
160645425|NCT00617461|580084243|FG001|Second Treatment Intervention Period|Adverse Event|1|||
160645426|NCT00617461|580084242|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
160645427|NCT00617461|580084243|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
160645428|NCT00617461|580084242|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
160645429|NCT00617461|580084243|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
160645430|NCT00617461|580084242|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
160645431|NCT00617461|580084243|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
160645432|NCT01724359|580084244|FG000|Overall Study|Adverse Event|10|||
160645433|NCT01724359|580084244|FG000|Overall Study|Death|1|||
160645434|NCT01724359|580084244|FG000|Overall Study|Other|20|||
160645435|NCT05085964|580084245|FG000|Overall Study|Premature termination of study|21|||
160645436|NCT05085964|580084246|FG001|Overall Study|Premature termination of study|0|||
160645437|NCT03156270|580084251|FG000|Overall Study|Failed pre-treatment screening|1|||
160645438|NCT03156270|580084251|FG000|Overall Study|Lost to Follow-up|1|||
160645439|NCT00591253|580084252|FG000|Overall Study|Adverse Event|3|||
160645440|NCT00591253|580084253|FG001|Overall Study|Adverse Event|3|||
160645441|NCT00591253|580084254|FG002|Overall Study|Adverse Event|1|||
160645442|NCT00591253|580084252|FG000|Overall Study|Protocol Violation|2|||
160645443|NCT00591253|580084253|FG001|Overall Study|Protocol Violation|2|||
160645444|NCT00591253|580084254|FG002|Overall Study|Protocol Violation|2|||
160645445|NCT00591253|580084252|FG000|Overall Study|Lost to Follow-up|2|||
160645446|NCT00591253|580084253|FG001|Overall Study|Lost to Follow-up|4|||
160814009|NCT01027650|580701910|FG002|Overall Study|Lack of Efficacy|0|||
160814010|NCT01027650|580701911|FG003|Overall Study|Lack of Efficacy|0|||
160814011|NCT01027650|580701912|FG004|Overall Study|Lack of Efficacy|0|||
160814012|NCT01027650|580701913|FG005|Overall Study|Lack of Efficacy|1|||
160552435|NCT01748071|579748421|FG001|Overall Study|Adverse Event|2|||
160552436|NCT01748071|579748422|FG002|Overall Study|Adverse Event|0|||
160552437|NCT03068325|579748423|FG000|Overall Study|Lost to Follow-up|5|||
160552438|NCT00066690|579748426|FG000|Overall Study|Adverse Event|145|||
160552439|NCT00066690|579748427|FG001|Overall Study|Adverse Event|58|||
160552440|NCT00066690|579748428|FG002|Overall Study|Adverse Event|126|||
160552441|NCT00066690|579748426|FG000|Overall Study|Death|3|||
160552442|NCT00066690|579748427|FG001|Overall Study|Death|0|||
160552443|NCT00066690|579748428|FG002|Overall Study|Death|2|||
160552444|NCT00066690|579748426|FG000|Overall Study|Lack of Efficacy|114|||
160552445|NCT00066690|579748427|FG001|Overall Study|Lack of Efficacy|110|||
160552446|NCT00066690|579748428|FG002|Overall Study|Lack of Efficacy|76|||
160552447|NCT00066690|579748426|FG000|Overall Study|Lost to Follow-up|40|||
160552448|NCT00066690|579748427|FG001|Overall Study|Lost to Follow-up|21|||
160552449|NCT00066690|579748428|FG002|Overall Study|Lost to Follow-up|29|||
160552450|NCT00066690|579748426|FG000|Overall Study|Withdrawal by Subject|50|||
160552451|NCT00066690|579748427|FG001|Overall Study|Withdrawal by Subject|55|||
160552452|NCT00066690|579748428|FG002|Overall Study|Withdrawal by Subject|49|||
160552453|NCT00066690|579748426|FG000|Overall Study|Treatment Ongoing|246|||
160552454|NCT00066690|579748427|FG001|Overall Study|Treatment Ongoing|278|||
160552455|NCT00066690|579748428|FG002|Overall Study|Treatment Ongoing|282|||
160552456|NCT00223496|579748429|FG000|Overall Study|screen failure|9|||
160552457|NCT00223496|579748429|FG000|Overall Study|Lost to Follow-up|4|||
160552458|NCT00223496|579748429|FG000|Overall Study|Lack of Efficacy|6|||
160552459|NCT00223496|579748429|FG000|Overall Study|Withdrawal by Subject|1|||
160552460|NCT00223496|579748429|FG000|Overall Study|Physician Decision|2|||
160552461|NCT02939131|579748432|FG000|Overall Study|Unable to get to clinic|6|||
160552462|NCT02939131|579748433|FG001|Overall Study|Unable to get to clinic|4|||
160552463|NCT02939131|579748432|FG000|Overall Study|Lost to Follow-up|2|||
160552464|NCT02939131|579748433|FG001|Overall Study|Lost to Follow-up|4|||
160552465|NCT02939131|579748432|FG000|Overall Study|severe debilitation|1|||
160552466|NCT02939131|579748433|FG001|Overall Study|severe debilitation|0|||
160645447|NCT00591253|580084254|FG002|Overall Study|Lost to Follow-up|0|||
160645448|NCT00591253|580084252|FG000|Overall Study|Withdrawal by Subject|1|||
160645449|NCT00591253|580084253|FG001|Overall Study|Withdrawal by Subject|7|||
160814013|NCT01027650|580701914|FG006|Overall Study|Lack of Efficacy|0|||
160814014|NCT01027650|580701915|FG007|Overall Study|Lack of Efficacy|0|||
160814015|NCT02175277|580701916|FG000|Overall Study|Protocol-specified Criteria|1|||
160814016|NCT00670930|580701917|FG000|Overall Study|Adminstrative Problem|0|||
160814017|NCT00670930|580701918|FG001|Overall Study|Adminstrative Problem|1|||
160552467|NCT02939131|579748432|FG000|Overall Study|Other|0|||
160552468|NCT02939131|579748433|FG001|Overall Study|Other|1|||
160552469|NCT02939131|579748432|FG000|Overall Study|not willing to adhere to protocol|2|||
160552470|NCT02939131|579748433|FG001|Overall Study|not willing to adhere to protocol|0|||
160552471|NCT03569202|579748437|FG000|Part 3|Physician Decision|1|||
160814018|NCT00670930|580701917|FG000|Overall Study|Lost to Follow-up|1|||
160814019|NCT00670930|580701918|FG001|Overall Study|Lost to Follow-up|0|||
160814020|NCT01042158|580701919|FG000|Overall Study|Physician Decision|1|||
160814021|NCT00875485|580703718|FG000|Challenge Dose Epoch|Pregnancy|1|||
160814022|NCT00875485|580703719|FG001|Challenge Dose Epoch|Pregnancy|0|||
160814023|NCT01271010|580703720|FG000|Overall Study|Reason not specified|11|||
160814024|NCT01271010|580703720|FG000|Overall Study|Start of new CLL therapy|1|||
160552472|NCT03569202|579748438|FG001|Part 3|Physician Decision|0|||
160552473|NCT03569202|579748437|FG000|Part 3|Other|1|||
160552474|NCT03569202|579748438|FG001|Part 3|Other|1|||
160552475|NCT00420511|579748439|FG000|Overall Study|Adverse Event|1|||
160552476|NCT00420511|579748440|FG001|Overall Study|Adverse Event|1|||
160552477|NCT00420511|579748439|FG000|Overall Study|Lost to Follow-up|1|||
160552478|NCT00420511|579748440|FG001|Overall Study|Lost to Follow-up|0|||
160552479|NCT02415712|579748441|FG000|Overall Study|Protocol Violation|16|||
160552480|NCT04428411|579748445|FG000|Overall Study|Lost to Follow-up|114|||
160552481|NCT00634569|579748446|FG000|Overall Study|Withdrawal by Subject|0|||
160552482|NCT00634569|579748447|FG001|Overall Study|Withdrawal by Subject|4|||
160552483|NCT00634569|579748446|FG000|Overall Study|Physician Decision|0|||
160552484|NCT00634569|579748447|FG001|Overall Study|Physician Decision|1|||
160552485|NCT02918019|579748449|FG000|Overall Study|Death|0|||
160552486|NCT02918019|579748450|FG001|Overall Study|Death|0|||
160552487|NCT02918019|579748451|FG002|Overall Study|Death|1|||
160552488|NCT02918019|579748452|FG003|Overall Study|Death|0|||
160552489|NCT02918019|579748449|FG000|Overall Study|Lost to Follow-up|1|||
160552490|NCT02918019|579748450|FG001|Overall Study|Lost to Follow-up|1|||
160552491|NCT02918019|579748451|FG002|Overall Study|Lost to Follow-up|0|||
160552492|NCT02918019|579748452|FG003|Overall Study|Lost to Follow-up|1|||
160552493|NCT02918019|579748449|FG000|Overall Study|Principal investigator request|0|||
160814025|NCT01271010|580703720|FG000|Overall Study|Protocol Violation|1|||
160814026|NCT01271010|580703720|FG000|Overall Study|Death|2|||
160552494|NCT02918019|579748450|FG001|Overall Study|Principal investigator request|0|||
160552495|NCT02918019|579748451|FG002|Overall Study|Principal investigator request|0|||
160552496|NCT02918019|579748452|FG003|Overall Study|Principal investigator request|1|||
160552497|NCT02918019|579748449|FG000|Overall Study|Physician Decision|1|||
160552498|NCT02918019|579748450|FG001|Overall Study|Physician Decision|3|||
160552499|NCT02918019|579748451|FG002|Overall Study|Physician Decision|2|||
160552500|NCT02918019|579748452|FG003|Overall Study|Physician Decision|0|||
160552501|NCT02918019|579748449|FG000|Overall Study|Protocol deviation|1|||
160552502|NCT02918019|579748450|FG001|Overall Study|Protocol deviation|1|||
160552503|NCT02918019|579748451|FG002|Overall Study|Protocol deviation|0|||
160814027|NCT01271010|580703720|FG000|Overall Study|Progression and relapse of disease|1|||
160814028|NCT01271010|580703720|FG000|Overall Study|Withdrawal by Subject|18|||
160814029|NCT01271010|580703720|FG000|Overall Study|Disease progression|27|||
160814030|NCT01631747|580703721|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
160814031|NCT01631747|580703722|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
160814032|NCT01631747|580703721|FG000|Live Birth|Pregnancy Termination|1|||
160814033|NCT01631747|580703722|FG001|Live Birth|Pregnancy Termination|0|||
160814034|NCT01631747|580703721|FG000|Live Birth|MIscarriage|2|||
160814035|NCT01631747|580703722|FG001|Live Birth|MIscarriage|0|||
160814036|NCT01631747|580703721|FG000|Live Birth|Stillbirth|1|||
160814037|NCT01631747|580703722|FG001|Live Birth|Stillbirth|1|||
160814038|NCT01631747|580703721|FG000|One Year Infant Outcomes|Patient Refused|13|||
160814039|NCT01631747|580703722|FG001|One Year Infant Outcomes|Patient Refused|9|||
160814040|NCT02908685|580703723|FG000|Part 1 OLE|Withdrawal by Subject|0|||
160814041|NCT02908685|580703724|FG001|Part 1 OLE|Withdrawal by Subject|0|||
160814042|NCT02908685|580703725|FG002|Part 1 OLE|Withdrawal by Subject|0|||
160814043|NCT02908685|580703726|FG003|Part 1 OLE|Withdrawal by Subject|0|||
160814044|NCT02908685|580703727|FG004|Part 1 OLE|Withdrawal by Subject|0|||
160814045|NCT02908685|580703728|FG005|Part 1 OLE|Withdrawal by Subject|0|||
160814046|NCT02908685|580703729|FG006|Part 1 OLE|Withdrawal by Subject|0|||
160814047|NCT02908685|580703730|FG007|Part 1 OLE|Withdrawal by Subject|0|||
160814048|NCT02908685|580703731|FG008|Part 1 OLE|Withdrawal by Subject|0|||
160814049|NCT02908685|580703732|FG009|Part 1 OLE|Withdrawal by Subject|0|||
160814050|NCT02908685|580703733|FG010|Part 1 OLE|Withdrawal by Subject|2|||
160645450|NCT00591253|580084254|FG002|Overall Study|Withdrawal by Subject|6|||
160552504|NCT02918019|579748452|FG003|Overall Study|Protocol deviation|2|||
160814051|NCT02908685|580703734|FG011|Part 1 OLE|Withdrawal by Subject|1|||
160814052|NCT02908685|580703735|FG012|Part 1 OLE|Withdrawal by Subject|0|||
160814053|NCT02908685|580703736|FG013|Part 1 OLE|Withdrawal by Subject|0|||
160814054|NCT02908685|580703723|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814055|NCT02908685|580703724|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160552505|NCT02918019|579748449|FG000|Overall Study|Withdrawal by Subject|3|||
160552506|NCT02918019|579748450|FG001|Overall Study|Withdrawal by Subject|4|||
160552507|NCT02918019|579748451|FG002|Overall Study|Withdrawal by Subject|6|||
160552508|NCT02918019|579748452|FG003|Overall Study|Withdrawal by Subject|4|||
160552509|NCT02918019|579748449|FG000|Overall Study|Adverse Event|0|||
160552510|NCT02918019|579748450|FG001|Overall Study|Adverse Event|1|||
160814056|NCT02908685|580703725|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160552511|NCT02918019|579748451|FG002|Overall Study|Adverse Event|0|||
160552512|NCT02918019|579748452|FG003|Overall Study|Adverse Event|1|||
160552513|NCT01212185|579748453|FG000|Overall Study|Protocol Violation|2|||
160552514|NCT01212185|579748454|FG001|Overall Study|Protocol Violation|1|||
160552515|NCT03370770|579748455|FG000|Overall Study|Patient was followed in another hospital center|1|||
160552516|NCT03370770|579748455|FG000|Overall Study|Progressive Disease|98|||
160552517|NCT03370770|579748455|FG000|Overall Study|Adverse Event|2|||
160552518|NCT03370770|579748455|FG000|Overall Study|Death|5|||
160552519|NCT03433781|579748456|FG000|Overall Study|Progression of Disease|1|||
160552520|NCT03433781|579748457|FG001|Overall Study|Progression of Disease|0|||
160552521|NCT03433781|579748458|FG002|Overall Study|Progression of Disease|0|||
160552522|NCT03433781|579748456|FG000|Overall Study|Physician Decision|0|||
160814057|NCT02908685|580703726|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814058|NCT02908685|580703727|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814059|NCT02908685|580703728|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814060|NCT02908685|580703729|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814061|NCT02908685|580703730|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814062|NCT02908685|580703731|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814063|NCT02908685|580703732|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814064|NCT02908685|580703733|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814065|NCT02908685|580703734|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814066|NCT02908685|580703735|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
160814067|NCT02908685|580703736|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
160814068|NCT02908685|580703723|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814069|NCT02908685|580703724|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814070|NCT02908685|580703725|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814071|NCT02908685|580703726|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814072|NCT02908685|580703727|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814073|NCT02908685|580703728|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814074|NCT02908685|580703729|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814075|NCT02908685|580703730|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814076|NCT02908685|580703731|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814077|NCT02908685|580703732|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814078|NCT02908685|580703733|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814079|NCT02908685|580703734|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814080|NCT02908685|580703735|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
160552523|NCT03433781|579748457|FG001|Overall Study|Physician Decision|1|||
160552524|NCT03433781|579748458|FG002|Overall Study|Physician Decision|0|||
160552525|NCT02400255|579748459|FG000|Overall Study|Relapse|4|||
160552526|NCT02400255|579748460|FG001|Overall Study|Relapse|1|||
160552527|NCT02400255|579748461|FG002|Overall Study|Relapse|1|||
160552528|NCT02400255|579748462|FG003|Overall Study|Relapse|2|||
160552529|NCT02400255|579748459|FG000|Overall Study|Adverse Event|6|||
160552530|NCT02400255|579748460|FG001|Overall Study|Adverse Event|3|||
160552531|NCT02400255|579748461|FG002|Overall Study|Adverse Event|0|||
160552532|NCT02400255|579748462|FG003|Overall Study|Adverse Event|0|||
160552533|NCT02400255|579748459|FG000|Overall Study|Physician Decision|6|||
160552534|NCT02400255|579748460|FG001|Overall Study|Physician Decision|0|||
160552535|NCT02400255|579748461|FG002|Overall Study|Physician Decision|0|||
160552536|NCT02400255|579748462|FG003|Overall Study|Physician Decision|0|||
160552537|NCT02400255|579748459|FG000|Overall Study|Loss of insurance|1|||
160645451|NCT00591253|580084252|FG000|Overall Study|Lack of Efficacy|1|||
160645452|NCT00591253|580084253|FG001|Overall Study|Lack of Efficacy|0|||
160645453|NCT00591253|580084254|FG002|Overall Study|Lack of Efficacy|3|||
160645454|NCT00591253|580084252|FG000|Overall Study|Other|5|||
160645455|NCT00591253|580084253|FG001|Overall Study|Other|5|||
160645456|NCT00591253|580084254|FG002|Overall Study|Other|3|||
160645457|NCT00252187|580084255|FG000|Overall Study|Adverse Event|3|||
160645458|NCT00252187|580084256|FG001|Overall Study|Adverse Event|1|||
160645459|NCT00252187|580084255|FG000|Overall Study|Withdrawal by Subject|1|||
160645460|NCT00252187|580084256|FG001|Overall Study|Withdrawal by Subject|0|||
160645461|NCT01752920|580084259|FG000|Overall Study|Adverse Event|1|||
160645462|NCT01752920|580084260|FG001|Overall Study|Adverse Event|0|||
160645463|NCT01752920|580084261|FG002|Overall Study|Adverse Event|5|||
160645464|NCT01752920|580084262|FG003|Overall Study|Adverse Event|10|||
160645465|NCT01752920|580084259|FG000|Overall Study|Clinical Disease Progression|6|||
160645466|NCT01752920|580084260|FG001|Overall Study|Clinical Disease Progression|4|||
160645467|NCT01752920|580084261|FG002|Overall Study|Clinical Disease Progression|1|||
160552538|NCT02400255|579748460|FG001|Overall Study|Loss of insurance|0|||
160552539|NCT02400255|579748461|FG002|Overall Study|Loss of insurance|0|||
160552540|NCT02400255|579748462|FG003|Overall Study|Loss of insurance|0|||
160552541|NCT03261531|579748463|FG000|Overall Study|Withdrawal by Subject|4|||
160552542|NCT01127165|579748464|FG000|Overall Study|Adverse Event|2|||
160552543|NCT01127165|579748465|FG001|Overall Study|Adverse Event|2|||
160814081|NCT02908685|580703736|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814082|NCT02908685|580703723|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814083|NCT02908685|580703724|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814084|NCT02908685|580703725|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814085|NCT02908685|580703726|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814086|NCT02908685|580703727|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814087|NCT02908685|580703728|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160552544|NCT01127165|579748464|FG000|Overall Study|Lack of Efficacy|10|||
160814088|NCT02908685|580703729|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814089|NCT02908685|580703730|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814090|NCT02908685|580703731|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814091|NCT02908685|580703732|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814092|NCT02908685|580703733|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814093|NCT02908685|580703734|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814094|NCT02908685|580703735|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
160814095|NCT02908685|580703736|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814096|NCT02908685|580703723|FG000|Part 2 OLE: > Month 24|Death|0|||
160814097|NCT02908685|580703724|FG001|Part 2 OLE: > Month 24|Death|0|||
160814098|NCT02908685|580703725|FG002|Part 2 OLE: > Month 24|Death|0|||
160900128|NCT03452228|581028656|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160900129|NCT03452228|581028657|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
160552545|NCT01127165|579748465|FG001|Overall Study|Lack of Efficacy|8|||
160552546|NCT01127165|579748464|FG000|Overall Study|Lost to Follow-up|3|||
160552547|NCT01127165|579748465|FG001|Overall Study|Lost to Follow-up|5|||
160552548|NCT01127165|579748464|FG000|Overall Study|Withdrawal by Subject|1|||
160552549|NCT01127165|579748465|FG001|Overall Study|Withdrawal by Subject|3|||
160552550|NCT01127165|579748464|FG000|Overall Study|Protocol Violation|0|||
160552551|NCT01127165|579748465|FG001|Overall Study|Protocol Violation|1|||
160900130|NCT02761733|581028658|FG000|Overall Study|Death|3|||
160900131|NCT02761733|581028659|FG001|Overall Study|Death|5|||
160900132|NCT02761733|581028660|FG002|Overall Study|Death|1|||
160900133|NCT02761733|581028661|FG003|Overall Study|Death|1|||
160900134|NCT02761733|581028658|FG000|Overall Study|Lost to Follow-up|6|||
160900135|NCT02761733|581028659|FG001|Overall Study|Lost to Follow-up|7|||
160552552|NCT02435849|579748466|FG000|Overall Study|Death|23|||
160552553|NCT02435849|579748467|FG001|Overall Study|Death|0|||
160814099|NCT02908685|580703726|FG003|Part 2 OLE: > Month 24|Death|0|||
160814100|NCT02908685|580703727|FG004|Part 2 OLE: > Month 24|Death|0|||
160900136|NCT02761733|581028660|FG002|Overall Study|Lost to Follow-up|0|||
160900137|NCT02761733|581028661|FG003|Overall Study|Lost to Follow-up|3|||
160814101|NCT02908685|580703728|FG005|Part 2 OLE: > Month 24|Death|0|||
160814102|NCT02908685|580703729|FG006|Part 2 OLE: > Month 24|Death|0|||
160814103|NCT02908685|580703730|FG007|Part 2 OLE: > Month 24|Death|0|||
160814104|NCT02908685|580703731|FG008|Part 2 OLE: > Month 24|Death|0|||
160814105|NCT02908685|580703732|FG009|Part 2 OLE: > Month 24|Death|0|||
160814106|NCT02908685|580703733|FG010|Part 2 OLE: > Month 24|Death|0|||
160814107|NCT02908685|580703734|FG011|Part 2 OLE: > Month 24|Death|0|||
160814108|NCT02908685|580703735|FG012|Part 2 OLE: > Month 24|Death|1|||
160814109|NCT02908685|580703736|FG013|Part 2 OLE: > Month 24|Death|0|||
160814110|NCT02908685|580703723|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
160814111|NCT02908685|580703724|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
160814112|NCT02908685|580703725|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
160814113|NCT02908685|580703726|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
160814114|NCT02908685|580703727|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
160814115|NCT02908685|580703728|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
160814116|NCT02908685|580703729|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
160814117|NCT02908685|580703730|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
160814118|NCT02908685|580703731|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
160814119|NCT02908685|580703732|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
160814120|NCT02908685|580703733|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
160814121|NCT02908685|580703734|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
160814122|NCT02908685|580703735|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
160814123|NCT02908685|580703736|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
160814124|NCT02908685|580703723|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814125|NCT02908685|580703724|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814126|NCT02908685|580703725|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814127|NCT02908685|580703726|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814128|NCT02908685|580703727|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814129|NCT02908685|580703728|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814130|NCT02908685|580703729|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160552554|NCT02435849|579748466|FG000|Overall Study|Lack of Efficacy|10|||
160552555|NCT02435849|579748467|FG001|Overall Study|Lack of Efficacy|0|||
160552556|NCT02435849|579748466|FG000|Overall Study|New therapy for study indication|8|||
160552557|NCT02435849|579748467|FG001|Overall Study|New therapy for study indication|0|||
160552558|NCT02435849|579748466|FG000|Overall Study|Subject/guardian decision|5|||
160552559|NCT02435849|579748467|FG001|Overall Study|Subject/guardian decision|1|||
160552560|NCT02435849|579748466|FG000|Overall Study|Lost to Follow-up|1|||
160552561|NCT02435849|579748467|FG001|Overall Study|Lost to Follow-up|0|||
160552562|NCT02435849|579748466|FG000|Overall Study|Physician Decision|1|||
160552563|NCT02435849|579748467|FG001|Overall Study|Physician Decision|0|||
160552564|NCT01017952|579748468|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
160552565|NCT01017952|579748469|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
160552566|NCT01017952|579748470|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
160552567|NCT01017952|579748471|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
160552568|NCT01017952|579748472|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
160552569|NCT01017952|579748468|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
160552570|NCT01017952|579748469|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
160552571|NCT01017952|579748470|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
160552572|NCT01017952|579748471|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
160552573|NCT01017952|579748472|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
160552574|NCT01017952|579748468|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
160552575|NCT01017952|579748469|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
160814131|NCT02908685|580703730|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814132|NCT02908685|580703731|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814133|NCT02908685|580703732|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160900138|NCT02761733|581028658|FG000|Overall Study|Physician Decision|4|||
160552576|NCT01017952|579748470|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
160552577|NCT01017952|579748471|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
160552578|NCT01017952|579748472|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
160552579|NCT01017952|579748468|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
160552580|NCT01017952|579748469|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160552581|NCT01017952|579748470|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160645468|NCT01752920|580084262|FG003|Overall Study|Clinical Disease Progression|13|||
160814134|NCT02908685|580703733|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160552582|NCT01017952|579748471|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160552583|NCT01017952|579748472|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160814135|NCT02908685|580703734|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814136|NCT02908685|580703735|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
160814137|NCT02908685|580703736|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
160814138|NCT02954406|580703737|FG000|Overall Study|Adverse Event|0|||
160814139|NCT02954406|580703738|FG001|Overall Study|Adverse Event|1|||
160814140|NCT02954406|580703739|FG002|Overall Study|Adverse Event|0|||
160814141|NCT02954406|580703740|FG003|Overall Study|Adverse Event|0|||
160814142|NCT02954406|580703741|FG004|Overall Study|Adverse Event|1|||
160814143|NCT02954406|580703742|FG005|Overall Study|Adverse Event|0|||
160814144|NCT02954406|580703743|FG006|Overall Study|Adverse Event|0|||
160814145|NCT02954406|580703744|FG007|Overall Study|Adverse Event|0|||
160814146|NCT02954406|580703745|FG008|Overall Study|Adverse Event|1|||
160814147|NCT02954406|580703746|FG009|Overall Study|Adverse Event|1|||
160814148|NCT02954406|580703747|FG010|Overall Study|Adverse Event|0|||
160814149|NCT02954406|580703737|FG000|Overall Study|Progressive Disease|3|||
160814150|NCT02954406|580703738|FG001|Overall Study|Progressive Disease|4|||
160814151|NCT02954406|580703739|FG002|Overall Study|Progressive Disease|3|||
160814152|NCT02954406|580703740|FG003|Overall Study|Progressive Disease|4|||
160814153|NCT02954406|580703741|FG004|Overall Study|Progressive Disease|3|||
160814154|NCT02954406|580703742|FG005|Overall Study|Progressive Disease|3|||
160814155|NCT02954406|580703743|FG006|Overall Study|Progressive Disease|2|||
160814156|NCT02954406|580703744|FG007|Overall Study|Progressive Disease|2|||
160814157|NCT02954406|580703745|FG008|Overall Study|Progressive Disease|1|||
160814158|NCT02954406|580703746|FG009|Overall Study|Progressive Disease|1|||
160814159|NCT02954406|580703747|FG010|Overall Study|Progressive Disease|0|||
160814160|NCT02954406|580703737|FG000|Overall Study|Symptomatic Deterioration|0|||
160814161|NCT02954406|580703738|FG001|Overall Study|Symptomatic Deterioration|1|||
160814162|NCT02954406|580703739|FG002|Overall Study|Symptomatic Deterioration|0|||
160814163|NCT02954406|580703740|FG003|Overall Study|Symptomatic Deterioration|0|||
160814164|NCT02954406|580703741|FG004|Overall Study|Symptomatic Deterioration|0|||
160814165|NCT02954406|580703742|FG005|Overall Study|Symptomatic Deterioration|0|||
160814166|NCT02954406|580703743|FG006|Overall Study|Symptomatic Deterioration|0|||
160814167|NCT02954406|580703744|FG007|Overall Study|Symptomatic Deterioration|0|||
160814168|NCT02954406|580703745|FG008|Overall Study|Symptomatic Deterioration|0|||
160814169|NCT02954406|580703746|FG009|Overall Study|Symptomatic Deterioration|0|||
160814170|NCT02954406|580703747|FG010|Overall Study|Symptomatic Deterioration|0|||
160814171|NCT02954406|580703737|FG000|Overall Study|Death|0|||
160814172|NCT02954406|580703738|FG001|Overall Study|Death|0|||
160814173|NCT02954406|580703739|FG002|Overall Study|Death|0|||
160814174|NCT02954406|580703740|FG003|Overall Study|Death|0|||
160814175|NCT02954406|580703741|FG004|Overall Study|Death|1|||
160814176|NCT02954406|580703742|FG005|Overall Study|Death|0|||
160814177|NCT02954406|580703743|FG006|Overall Study|Death|0|||
160814178|NCT02954406|580703744|FG007|Overall Study|Death|0|||
160814179|NCT02954406|580703745|FG008|Overall Study|Death|1|||
160814180|NCT02954406|580703746|FG009|Overall Study|Death|1|||
160814181|NCT02954406|580703747|FG010|Overall Study|Death|0|||
160814182|NCT02954406|580703737|FG000|Overall Study|Reason Not Specified|0|||
160814183|NCT02954406|580703738|FG001|Overall Study|Reason Not Specified|0|||
160814184|NCT02954406|580703739|FG002|Overall Study|Reason Not Specified|3|||
160814185|NCT02954406|580703740|FG003|Overall Study|Reason Not Specified|2|||
160814186|NCT02954406|580703741|FG004|Overall Study|Reason Not Specified|2|||
160814187|NCT02954406|580703742|FG005|Overall Study|Reason Not Specified|0|||
160814188|NCT02954406|580703743|FG006|Overall Study|Reason Not Specified|1|||
160814189|NCT02954406|580703744|FG007|Overall Study|Reason Not Specified|0|||
160814190|NCT02954406|580703745|FG008|Overall Study|Reason Not Specified|1|||
160814191|NCT02954406|580703746|FG009|Overall Study|Reason Not Specified|0|||
160814192|NCT02954406|580703747|FG010|Overall Study|Reason Not Specified|0|||
160814193|NCT00782171|580703748|FG000|Overall Study|Lost to Follow-up|2|||
160814194|NCT00782171|580703749|FG001|Overall Study|Lost to Follow-up|2|||
160814195|NCT00782171|580703748|FG000|Overall Study|Withdrawal by Subject|2|||
160814196|NCT00782171|580703749|FG001|Overall Study|Withdrawal by Subject|1|||
160814197|NCT00782171|580703748|FG000|Overall Study|complications|3|||
160814198|NCT00782171|580703749|FG001|Overall Study|complications|1|||
160814199|NCT00782171|580703748|FG000|Overall Study|others|7|||
160814200|NCT00782171|580703749|FG001|Overall Study|others|9|||
160814201|NCT00782171|580703748|FG000|Overall Study|not eligible|8|||
160814202|NCT00782171|580703749|FG001|Overall Study|not eligible|6|||
160814203|NCT01691014|580703750|FG000|Overall Study|Premature Termination|1|||
160814204|NCT01691014|580703751|FG001|Overall Study|Premature Termination|6|||
160814205|NCT01691014|580703752|FG002|Overall Study|Premature Termination|0|||
160814206|NCT01691014|580703753|FG003|Overall Study|Premature Termination|3|||
160814207|NCT01691014|580703750|FG000|Overall Study|Other|0|||
160814208|NCT01691014|580703751|FG001|Overall Study|Other|0|||
160814209|NCT01691014|580703752|FG002|Overall Study|Other|2|||
160814210|NCT01691014|580703753|FG003|Overall Study|Other|0|||
160814211|NCT01691014|580703750|FG000|Overall Study|Withdrawal by Subject|0|||
160814212|NCT01691014|580703751|FG001|Overall Study|Withdrawal by Subject|1|||
160814213|NCT01691014|580703752|FG002|Overall Study|Withdrawal by Subject|1|||
160814214|NCT01691014|580703753|FG003|Overall Study|Withdrawal by Subject|1|||
160814215|NCT01691014|580703750|FG000|Overall Study|Adverse Event|0|||
160814216|NCT01691014|580703751|FG001|Overall Study|Adverse Event|5|||
160814217|NCT01691014|580703752|FG002|Overall Study|Adverse Event|1|||
160814218|NCT01691014|580703753|FG003|Overall Study|Adverse Event|1|||
160814219|NCT01691014|580703750|FG000|Overall Study|Lack of Efficacy|2|||
160814220|NCT01691014|580703751|FG001|Overall Study|Lack of Efficacy|3|||
160814221|NCT01691014|580703752|FG002|Overall Study|Lack of Efficacy|7|||
160814222|NCT01691014|580703753|FG003|Overall Study|Lack of Efficacy|0|||
160814223|NCT05897242|580703756|FG000|Overall Study|Lost to Follow-up|6|||
160814224|NCT05897242|580703757|FG001|Overall Study|Lost to Follow-up|1|||
160814225|NCT05897242|580703756|FG000|Overall Study|Incomplete|1|||
160814226|NCT05897242|580703757|FG001|Overall Study|Incomplete|0|||
160814227|NCT05897242|580703756|FG000|Overall Study|Withdrawal by Subject|1|||
160814228|NCT05897242|580703757|FG001|Overall Study|Withdrawal by Subject|0|||
160814229|NCT03522246|580703758|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
160814230|NCT03522246|580703759|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
160814231|NCT03522246|580703760|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
160814232|NCT03522246|580703761|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
160814233|NCT03522246|580703762|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
160552584|NCT01017952|579748468|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
160552585|NCT01017952|579748469|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
160552586|NCT01017952|579748470|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
160552587|NCT01017952|579748471|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
160552588|NCT01017952|579748472|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
160552589|NCT01017952|579748468|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
160552590|NCT01017952|579748469|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
160552591|NCT01017952|579748470|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
160552592|NCT01017952|579748471|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
160552593|NCT01017952|579748472|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
160552594|NCT01017952|579748468|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
160552595|NCT01017952|579748469|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
160552596|NCT01017952|579748470|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
160552597|NCT01017952|579748471|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
160552598|NCT01017952|579748472|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
160552599|NCT01017952|579748468|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
160552600|NCT01017952|579748469|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
160552601|NCT01017952|579748470|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
160552602|NCT01017952|579748471|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
160552603|NCT01017952|579748472|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
160552604|NCT01017952|579748468|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
160552605|NCT01017952|579748469|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
160645469|NCT01752920|580084259|FG000|Overall Study|Physician Decision|1|||
160645470|NCT01752920|580084260|FG001|Overall Study|Physician Decision|0|||
160814234|NCT00814580|580703763|FG000|Overall Study|Adverse Event|6|||
160814235|NCT00814580|580703764|FG001|Overall Study|Adverse Event|15|||
160814236|NCT00814580|580703763|FG000|Overall Study|Lack of Efficacy|18|||
160814237|NCT00814580|580703764|FG001|Overall Study|Lack of Efficacy|25|||
160814238|NCT00814580|580703763|FG000|Overall Study|Protocol Violation|2|||
160814239|NCT00814580|580703764|FG001|Overall Study|Protocol Violation|0|||
160814240|NCT00814580|580703763|FG000|Overall Study|Withdrawal by Subject|2|||
160814241|NCT00814580|580703764|FG001|Overall Study|Withdrawal by Subject|2|||
160814242|NCT00814580|580703763|FG000|Overall Study|Other|1|||
160814243|NCT00814580|580703764|FG001|Overall Study|Other|3|||
160814244|NCT00814580|580703763|FG000|Overall Study|Did Not Take Drug|2|||
160814245|NCT00814580|580703764|FG001|Overall Study|Did Not Take Drug|2|||
160814246|NCT02482428|580703765|FG000|Overall Study|Lost to Follow-up|4|||
160814247|NCT02482428|580703766|FG001|Overall Study|Lost to Follow-up|9|||
160814248|NCT02482428|580703767|FG002|Overall Study|Lost to Follow-up|1|||
160814249|NCT02482428|580703768|FG003|Overall Study|Lost to Follow-up|2|||
160814250|NCT02482428|580703769|FG004|Overall Study|Lost to Follow-up|4|||
160814251|NCT02482428|580703765|FG000|Overall Study|Physician Decision|0|||
160814252|NCT02482428|580703766|FG001|Overall Study|Physician Decision|0|||
160814253|NCT02482428|580703767|FG002|Overall Study|Physician Decision|0|||
160814254|NCT02482428|580703768|FG003|Overall Study|Physician Decision|0|||
160814255|NCT02482428|580703769|FG004|Overall Study|Physician Decision|1|||
160814256|NCT02482428|580703765|FG000|Overall Study|protocol deviation|1|||
160645471|NCT01752920|580084261|FG002|Overall Study|Physician Decision|0|||
160645472|NCT01752920|580084262|FG003|Overall Study|Physician Decision|3|||
160814257|NCT02482428|580703766|FG001|Overall Study|protocol deviation|1|||
160814258|NCT02482428|580703767|FG002|Overall Study|protocol deviation|0|||
160814259|NCT02482428|580703768|FG003|Overall Study|protocol deviation|0|||
160814260|NCT02482428|580703769|FG004|Overall Study|protocol deviation|0|||
160814261|NCT02482428|580703765|FG000|Overall Study|subject/guardian decision|4|||
160814262|NCT02482428|580703766|FG001|Overall Study|subject/guardian decision|2|||
160814263|NCT02482428|580703767|FG002|Overall Study|subject/guardian decision|0|||
160814264|NCT02482428|580703768|FG003|Overall Study|subject/guardian decision|0|||
160552606|NCT01017952|579748470|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
160552607|NCT01017952|579748471|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
160900139|NCT02761733|581028659|FG001|Overall Study|Physician Decision|0|||
160814265|NCT02482428|580703769|FG004|Overall Study|subject/guardian decision|2|||
160814266|NCT00809835|580703772|FG000|Overall Study|Lost to Follow-up|7|||
160814267|NCT00809835|580703773|FG001|Overall Study|Lost to Follow-up|6|||
160814268|NCT00809835|580703774|FG002|Overall Study|Lost to Follow-up|10|||
160814269|NCT00809835|580703775|FG003|Overall Study|Lost to Follow-up|2|||
160814270|NCT00809835|580703772|FG000|Overall Study|Withdrawal by Subject|1|||
160814271|NCT00809835|580703773|FG001|Overall Study|Withdrawal by Subject|1|||
160814272|NCT00809835|580703774|FG002|Overall Study|Withdrawal by Subject|1|||
160814273|NCT00809835|580703775|FG003|Overall Study|Withdrawal by Subject|0|||
160814274|NCT00516893|580703776|FG000|Overall Study|Lost to Follow-up|4|||
160814275|NCT00516893|580703776|FG000|Overall Study|Adverse Event|3|||
160814276|NCT00516893|580703776|FG000|Overall Study|Withdrawal by Subject|2|||
160814277|NCT00516893|580703776|FG000|Overall Study|Noncompliance|2|||
160814278|NCT00516893|580703776|FG000|Overall Study|Death|1|||
160814279|NCT00516893|580703776|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
160900140|NCT02761733|581028660|FG002|Overall Study|Physician Decision|0|||
160900141|NCT02761733|581028661|FG003|Overall Study|Physician Decision|0|||
160900142|NCT02761733|581028658|FG000|Overall Study|Withdrawal by Subject|2|||
160900143|NCT02761733|581028659|FG001|Overall Study|Withdrawal by Subject|0|||
160900144|NCT02761733|581028660|FG002|Overall Study|Withdrawal by Subject|0|||
160900145|NCT02761733|581028661|FG003|Overall Study|Withdrawal by Subject|0|||
160900146|NCT02761733|581028658|FG000|Overall Study|Discharged from Study Site|10|||
160900147|NCT02761733|581028659|FG001|Overall Study|Discharged from Study Site|9|||
160900148|NCT02761733|581028660|FG002|Overall Study|Discharged from Study Site|25|||
160900149|NCT02761733|581028661|FG003|Overall Study|Discharged from Study Site|11|||
160900150|NCT02761733|581028658|FG000|Overall Study|Cognitive Impairment|5|||
160900151|NCT02761733|581028659|FG001|Overall Study|Cognitive Impairment|0|||
160900152|NCT02761733|581028660|FG002|Overall Study|Cognitive Impairment|1|||
160900153|NCT02761733|581028661|FG003|Overall Study|Cognitive Impairment|0|||
160900154|NCT01297920|581028664|FG000|Overall Study|Adverse Event|42|||
160900155|NCT01297920|581028665|FG001|Overall Study|Adverse Event|10|||
160900156|NCT01297920|581028666|FG002|Overall Study|Adverse Event|38|||
160552608|NCT01017952|579748472|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
160814280|NCT00516893|580703776|FG000|Overall Study|Relocated|1|||
160814281|NCT00516893|580703776|FG000|Overall Study|Pregnancy|1|||
160814282|NCT00516893|580703776|FG000|Overall Study|Received Medication From Another Study|1|||
160814283|NCT01519791|580703778|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
160900157|NCT01297920|581028664|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
160900158|NCT01297920|581028665|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
160900159|NCT01297920|581028666|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
160900160|NCT01297920|581028664|FG000|Overall Study|Noncompliance|1|||
160814284|NCT01519791|580703779|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
160814285|NCT01519791|580703778|FG000|Overall Study|Protocol Violation|6|||
160814286|NCT01519791|580703779|FG001|Overall Study|Protocol Violation|19|||
160814287|NCT01519791|580703778|FG000|Overall Study|Other Reason|87|||
160814288|NCT01519791|580703779|FG001|Overall Study|Other Reason|222|||
160814289|NCT01519791|580703778|FG000|Overall Study|subjects randomized in error|2|||
160552609|NCT01017952|579748468|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
160552610|NCT01017952|579748469|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
160814290|NCT01519791|580703779|FG001|Overall Study|subjects randomized in error|0|||
160814291|NCT01519791|580703778|FG000|Overall Study|Lack of Efficacy|16|||
160814292|NCT01519791|580703779|FG001|Overall Study|Lack of Efficacy|20|||
160814293|NCT01519791|580703778|FG000|Overall Study|SAE, non-fatal|6|||
160814294|NCT01519791|580703779|FG001|Overall Study|SAE, non-fatal|22|||
160814295|NCT01519791|580703778|FG000|Overall Study|AE, serious fatal|0|||
160814296|NCT01519791|580703779|FG001|Overall Study|AE, serious fatal|1|||
160814297|NCT01519791|580703778|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
160814298|NCT01519791|580703779|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
160814299|NCT01519791|580703778|FG000|Overall Study|AE, non-serious non-fatal|12|||
160814300|NCT01519791|580703779|FG001|Overall Study|AE, non-serious non-fatal|31|||
160814301|NCT01519791|580703778|FG000|Overall Study|Withdrawal by Subject|15|||
160814302|NCT01519791|580703779|FG001|Overall Study|Withdrawal by Subject|37|||
160814303|NCT01519791|580703778|FG000|Overall Study|Lost to Follow-up|6|||
160814304|NCT01519791|580703779|FG001|Overall Study|Lost to Follow-up|14|||
160552611|NCT01017952|579748470|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
160552612|NCT01017952|579748471|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
160552613|NCT01017952|579748472|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
160552614|NCT01017952|579748468|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
160552615|NCT01017952|579748469|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
160814305|NCT00559845|580703780|FG000|Overall Study|Withdrew Consent|1|||
160814306|NCT00559845|580703780|FG000|Overall Study|Disease Progression|1|||
160814307|NCT00559845|580703780|FG000|Overall Study|Adverse Event|3|||
160814308|NCT00559845|580703780|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
160814309|NCT00559845|580703780|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
160814310|NCT05791565|580703781|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
160814311|NCT05791565|580703782|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
160814312|NCT00880269|580703783|FG000|Overall Study|Protocol Violation|1|||
160814313|NCT00880269|580703784|FG001|Overall Study|Protocol Violation|0|||
160814314|NCT00880269|580703783|FG000|Overall Study|Disease Progression|13|||
160814315|NCT00880269|580703784|FG001|Overall Study|Disease Progression|11|||
160814316|NCT00880269|580703783|FG000|Overall Study|New Cancer Therapy|1|||
160814317|NCT00880269|580703784|FG001|Overall Study|New Cancer Therapy|0|||
160814318|NCT00880269|580703783|FG000|Overall Study|Death|4|||
160552616|NCT01017952|579748470|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
160814319|NCT00880269|580703784|FG001|Overall Study|Death|2|||
160814320|NCT00880269|580703783|FG000|Overall Study|Lost to Follow-up|0|||
160814321|NCT00880269|580703784|FG001|Overall Study|Lost to Follow-up|1|||
160986936|NCT04955626|581341112|FG007|Blinded Period|Withdrawal by Subject|5|||
160552617|NCT01017952|579748471|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
160814322|NCT00880269|580703783|FG000|Overall Study|Withdrawal by Subject|3|||
160814323|NCT00880269|580703784|FG001|Overall Study|Withdrawal by Subject|4|||
160814324|NCT00880269|580703783|FG000|Overall Study|Adverse Event|10|||
160814325|NCT00880269|580703784|FG001|Overall Study|Adverse Event|9|||
160814326|NCT02516982|580703785|FG000|Overall Study|Called in to antenatal appointment|32|||
160814327|NCT02516982|580703786|FG001|Overall Study|Called in to antenatal appointment|35|||
160814328|NCT02516982|580703787|FG002|Overall Study|Called in to antenatal appointment|0|||
160814329|NCT02516982|580703788|FG003|Overall Study|Called in to antenatal appointment|0|||
160814330|NCT02516982|580703785|FG000|Overall Study|Withdrawal by Subject|0|||
160814331|NCT02516982|580703786|FG001|Overall Study|Withdrawal by Subject|0|||
160814332|NCT02516982|580703787|FG002|Overall Study|Withdrawal by Subject|1|||
160814333|NCT02516982|580703788|FG003|Overall Study|Withdrawal by Subject|2|||
160814334|NCT02516982|580703785|FG000|Overall Study|Protocol Violation|0|||
160814335|NCT02516982|580703786|FG001|Overall Study|Protocol Violation|0|||
160814336|NCT02516982|580703787|FG002|Overall Study|Protocol Violation|1|||
160814337|NCT02516982|580703788|FG003|Overall Study|Protocol Violation|1|||
160814338|NCT02516982|580703785|FG000|Overall Study|Did not install the app|0|||
160814339|NCT02516982|580703786|FG001|Overall Study|Did not install the app|0|||
160814340|NCT02516982|580703787|FG002|Overall Study|Did not install the app|46|||
160814341|NCT02516982|580703788|FG003|Overall Study|Did not install the app|47|||
160814342|NCT03379259|580703790|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
160814343|NCT03379259|580703791|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
160814344|NCT03379259|580703792|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
160814345|NCT03379259|580703793|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
160814346|NCT03379259|580703794|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
160814347|NCT03379259|580703795|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
160814348|NCT03379259|580703790|FG000|Overall Study|Death|0|||
160814349|NCT03379259|580703791|FG001|Overall Study|Death|1|||
160814350|NCT03379259|580703792|FG002|Overall Study|Death|2|||
160814351|NCT03379259|580703793|FG003|Overall Study|Death|1|||
160814352|NCT03379259|580703794|FG004|Overall Study|Death|4|||
160814353|NCT03379259|580703795|FG005|Overall Study|Death|2|||
160814354|NCT03379259|580703790|FG000|Overall Study|Withdrawal by Subject|0|||
160814355|NCT03379259|580703791|FG001|Overall Study|Withdrawal by Subject|0|||
160814356|NCT03379259|580703792|FG002|Overall Study|Withdrawal by Subject|1|||
160814357|NCT03379259|580703793|FG003|Overall Study|Withdrawal by Subject|0|||
160814358|NCT03379259|580703794|FG004|Overall Study|Withdrawal by Subject|2|||
160814359|NCT03379259|580703795|FG005|Overall Study|Withdrawal by Subject|0|||
160814360|NCT03379259|580703790|FG000|Overall Study|Study terminated by sponsor|0|||
160814361|NCT03379259|580703791|FG001|Overall Study|Study terminated by sponsor|0|||
160814362|NCT03379259|580703792|FG002|Overall Study|Study terminated by sponsor|0|||
160814363|NCT03379259|580703793|FG003|Overall Study|Study terminated by sponsor|1|||
160814364|NCT03379259|580703794|FG004|Overall Study|Study terminated by sponsor|1|||
160814365|NCT03379259|580703795|FG005|Overall Study|Study terminated by sponsor|4|||
160814366|NCT03379259|580703790|FG000|Overall Study|Disease progression|0|||
160814367|NCT03379259|580703791|FG001|Overall Study|Disease progression|0|||
160814368|NCT03379259|580703792|FG002|Overall Study|Disease progression|0|||
160814369|NCT03379259|580703793|FG003|Overall Study|Disease progression|1|||
160814370|NCT03379259|580703794|FG004|Overall Study|Disease progression|0|||
160814371|NCT03379259|580703795|FG005|Overall Study|Disease progression|1|||
160814372|NCT03379259|580703790|FG000|Overall Study|Lost to Follow-up|0|||
160814373|NCT03379259|580703791|FG001|Overall Study|Lost to Follow-up|0|||
160814374|NCT03379259|580703792|FG002|Overall Study|Lost to Follow-up|0|||
160814375|NCT03379259|580703793|FG003|Overall Study|Lost to Follow-up|0|||
160814376|NCT03379259|580703794|FG004|Overall Study|Lost to Follow-up|1|||
160814377|NCT03379259|580703795|FG005|Overall Study|Lost to Follow-up|0|||
160814378|NCT03379259|580703790|FG000|Overall Study|Deteriorating condition|0|||
160814379|NCT03379259|580703791|FG001|Overall Study|Deteriorating condition|0|||
160814380|NCT03379259|580703792|FG002|Overall Study|Deteriorating condition|0|||
160814381|NCT03379259|580703793|FG003|Overall Study|Deteriorating condition|0|||
160900161|NCT01297920|581028665|FG001|Overall Study|Noncompliance|0|||
160900162|NCT01297920|581028666|FG002|Overall Study|Noncompliance|0|||
160900163|NCT01297920|581028664|FG000|Overall Study|Protocol Violation|1|||
160552618|NCT01017952|579748472|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
160552619|NCT01017952|579748468|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
160552620|NCT01017952|579748469|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
160552621|NCT01017952|579748470|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
160552622|NCT01017952|579748471|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
160552623|NCT01017952|579748472|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
160552624|NCT01017952|579748468|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160814382|NCT03379259|580703794|FG004|Overall Study|Deteriorating condition|1|||
160814383|NCT03379259|580703795|FG005|Overall Study|Deteriorating condition|0|||
160814384|NCT03195660|580703796|FG000|Overall Study|The study was terminated|2|||
160814385|NCT00375427|580703797|FG000|Overall Study|Adverse Event|21|||
160814386|NCT00375427|580703798|FG001|Overall Study|Adverse Event|27|||
160814387|NCT00375427|580703797|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160814388|NCT00375427|580703798|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160814389|NCT00375427|580703797|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160900164|NCT01297920|581028665|FG001|Overall Study|Protocol Violation|3|||
160552625|NCT01017952|579748469|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
160552626|NCT01017952|579748470|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
160552627|NCT01017952|579748471|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
160552628|NCT01017952|579748472|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
160552629|NCT01017952|579748468|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
160552630|NCT01017952|579748469|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
160552631|NCT01017952|579748470|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
160552632|NCT01017952|579748471|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
160552633|NCT01017952|579748472|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
160552634|NCT01064167|579748473|FG000|Overall Study|Protocol Violation|14|||
160552635|NCT01064167|579748474|FG001|Overall Study|Protocol Violation|15|||
160552636|NCT03984305|579748477|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
160552637|NCT03984305|579748478|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
160552638|NCT03984305|579748477|FG000|Overall Study|Withdrawal by Subject|3|||
160552639|NCT03984305|579748478|FG001|Overall Study|Withdrawal by Subject|3|||
160552640|NCT03984305|579748477|FG000|Overall Study|Lost to Follow-up|1|||
160552641|NCT03984305|579748478|FG001|Overall Study|Lost to Follow-up|0|||
160552642|NCT00352105|579748479|FG000|Overall Study|Death|5|||
160552643|NCT00352105|579748479|FG000|Overall Study|Withdrawal by Subject|5|||
160552644|NCT00352105|579748479|FG000|Overall Study|Lack of Efficacy|9|||
160552645|NCT00352105|579748479|FG000|Overall Study|Adverse Event|19|||
160552646|NCT00352105|579748479|FG000|Overall Study|Protocol Violation|2|||
160552647|NCT02979431|579748482|FG000|Overall Study|Parent/guardian withdrew consent|2|||
160552648|NCT02979431|579748483|FG001|Overall Study|Parent/guardian withdrew consent|1|||
160552649|NCT02979431|579748484|FG002|Overall Study|Parent/guardian withdrew consent|1|||
160552650|NCT02979431|579748485|FG003|Overall Study|Parent/guardian withdrew consent|1|||
160552651|NCT02979431|579748482|FG000|Overall Study|Randomized but received no study drug|1|||
160552652|NCT02979431|579748483|FG001|Overall Study|Randomized but received no study drug|1|||
160552653|NCT02979431|579748484|FG002|Overall Study|Randomized but received no study drug|0|||
160552654|NCT02979431|579748485|FG003|Overall Study|Randomized but received no study drug|0|||
160552655|NCT02979431|579748482|FG000|Overall Study|Adverse Event|0|||
160552656|NCT02979431|579748483|FG001|Overall Study|Adverse Event|0|||
160552657|NCT02979431|579748484|FG002|Overall Study|Adverse Event|1|||
160552658|NCT02979431|579748485|FG003|Overall Study|Adverse Event|0|||
160814390|NCT00375427|580703798|FG001|Overall Study|Abnormal laboratory value(s)|2|||
160814391|NCT00375427|580703797|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160814392|NCT00375427|580703798|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
160814393|NCT00375427|580703797|FG000|Overall Study|Patient no longer requires study drug|3|||
160814394|NCT00375427|580703798|FG001|Overall Study|Patient no longer requires study drug|7|||
160814395|NCT00375427|580703797|FG000|Overall Study|Protocol Violation|10|||
160814396|NCT00375427|580703798|FG001|Overall Study|Protocol Violation|8|||
160814397|NCT00375427|580703797|FG000|Overall Study|Withdrawal by Subject|9|||
160814398|NCT00375427|580703798|FG001|Overall Study|Withdrawal by Subject|13|||
160814399|NCT00375427|580703797|FG000|Overall Study|Lost to Follow-up|1|||
160814400|NCT00375427|580703798|FG001|Overall Study|Lost to Follow-up|1|||
160814401|NCT00375427|580703797|FG000|Overall Study|Administrative reasons|0|||
160814402|NCT00375427|580703798|FG001|Overall Study|Administrative reasons|1|||
160814403|NCT00375427|580703797|FG000|Overall Study|Death|11|||
160814404|NCT00375427|580703798|FG001|Overall Study|Death|10|||
160814405|NCT01977729|580703804|FG000|Overall Study|Study terminated|1|||
160814406|NCT01268046|580703805|FG000|Overall Study|Withdrawal by Subject|1|||
160814407|NCT01268046|580703806|FG001|Overall Study|Withdrawal by Subject|0|||
160814408|NCT01268046|580703807|FG002|Overall Study|Withdrawal by Subject|0|||
160814409|NCT01268046|580703808|FG003|Overall Study|Withdrawal by Subject|1|||
160814410|NCT01268046|580703805|FG000|Overall Study|Lost to Follow-up|0|||
160814411|NCT01268046|580703806|FG001|Overall Study|Lost to Follow-up|0|||
160814412|NCT01268046|580703807|FG002|Overall Study|Lost to Follow-up|1|||
160814413|NCT01268046|580703808|FG003|Overall Study|Lost to Follow-up|0|||
160814414|NCT03636893|580703809|FG000|Overall Study|Death|0|||
160814415|NCT03636893|580703810|FG001|Overall Study|Death|1|||
160814416|NCT03636893|580703809|FG000|Overall Study|Protocol Violation|0|||
160814417|NCT03636893|580703810|FG001|Overall Study|Protocol Violation|3|||
160814418|NCT03636893|580703809|FG000|Overall Study|Withdrawal by Subject|1|||
160986937|NCT04955626|581341113|FG008|Blinded Period|Withdrawal by Subject|3|||
160814419|NCT03636893|580703810|FG001|Overall Study|Withdrawal by Subject|2|||
160814420|NCT03636893|580703809|FG000|Overall Study|Refusal to surgery|4|||
160814421|NCT03636893|580703810|FG001|Overall Study|Refusal to surgery|3|||
160814422|NCT03636893|580703809|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
160986938|NCT04955626|581341114|FG009|Blinded Period|Withdrawal by Subject|15|||
160986939|NCT04955626|581341115|FG010|Blinded Period|Withdrawal by Subject|11|||
160986940|NCT04955626|581341116|FG011|Blinded Period|Withdrawal by Subject|7|||
160986941|NCT04955626|581341117|FG012|Blinded Period|Withdrawal by Subject|2|||
160986942|NCT04955626|581341118|FG013|Blinded Period|Withdrawal by Subject|0|||
160986943|NCT04955626|581341119|FG014|Blinded Period|Withdrawal by Subject|1|||
160814423|NCT03636893|580703810|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
160814424|NCT03636893|580703809|FG000|Overall Study|Adverse Event|1|||
160814425|NCT03636893|580703810|FG001|Overall Study|Adverse Event|1|||
160814426|NCT02314156|580703811|FG000|Overall Study|Adverse Event|1|||
160814427|NCT02314156|580703812|FG001|Overall Study|Adverse Event|0|||
160814428|NCT02314156|580703811|FG000|Overall Study|Withdrawal by Subject|1|||
160814429|NCT02314156|580703812|FG001|Overall Study|Withdrawal by Subject|0|||
160814430|NCT00758069|580703815|FG000|Overall Study|Lack of Efficacy|0|||
160814431|NCT00758069|580703816|FG001|Overall Study|Lack of Efficacy|0|||
160814432|NCT00758069|580703817|FG002|Overall Study|Lack of Efficacy|1|||
160814433|NCT00758069|580703815|FG000|Overall Study|Incorrect Study Drug|1|||
160814434|NCT00758069|580703816|FG001|Overall Study|Incorrect Study Drug|0|||
160814435|NCT00758069|580703817|FG002|Overall Study|Incorrect Study Drug|0|||
160814436|NCT04560816|580703818|FG000|Overall Study|Withdrawal by Subject|1|||
160814437|NCT04560816|580703819|FG001|Overall Study|Withdrawal by Subject|1|||
160814438|NCT04560816|580703820|FG002|Overall Study|Withdrawal by Subject|1|||
160814439|NCT04560816|580703821|FG003|Overall Study|Withdrawal by Subject|0|||
160814440|NCT04560816|580703822|FG004|Overall Study|Withdrawal by Subject|3|||
160814441|NCT04560816|580703823|FG005|Overall Study|Withdrawal by Subject|0|||
160814442|NCT04560816|580703818|FG000|Overall Study|Lost to Follow-up|1|||
160814443|NCT04560816|580703819|FG001|Overall Study|Lost to Follow-up|0|||
160814444|NCT04560816|580703820|FG002|Overall Study|Lost to Follow-up|0|||
160814445|NCT04560816|580703821|FG003|Overall Study|Lost to Follow-up|0|||
160814446|NCT04560816|580703822|FG004|Overall Study|Lost to Follow-up|0|||
160814447|NCT04560816|580703823|FG005|Overall Study|Lost to Follow-up|0|||
160814448|NCT04560816|580703818|FG000|Overall Study|Protocol Violation|1|||
160814449|NCT04560816|580703819|FG001|Overall Study|Protocol Violation|0|||
160814450|NCT04560816|580703820|FG002|Overall Study|Protocol Violation|0|||
160814451|NCT04560816|580703821|FG003|Overall Study|Protocol Violation|0|||
160814452|NCT04560816|580703822|FG004|Overall Study|Protocol Violation|0|||
160814453|NCT04560816|580703823|FG005|Overall Study|Protocol Violation|0|||
160814454|NCT02277691|580703824|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
160814455|NCT02277691|580703824|FG000|Overall Study|Voluntary Withdrawal|7|||
160814456|NCT02277691|580703824|FG000|Overall Study|Lack of Efficacy|5|||
160814457|NCT02277691|580703824|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
160814458|NCT02846389|580703827|FG000|Overall Study|Withdrawal by Subject|1|||
160814459|NCT02846389|580703828|FG001|Overall Study|Withdrawal by Subject|1|||
160814460|NCT03818607|580703831|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
160814461|NCT03818607|580703832|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
160814462|NCT03818607|580703831|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
160814463|NCT03818607|580703832|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
160814464|NCT03818607|580703831|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
160814465|NCT03818607|580703832|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
160814466|NCT01147250|580703836|FG000|Overall Study|Lost to Follow-up|14|||
160814467|NCT01147250|580703837|FG001|Overall Study|Lost to Follow-up|11|||
160814468|NCT01147250|580703836|FG000|Overall Study|Withdrawal by Subject|83|||
160814469|NCT01147250|580703837|FG001|Overall Study|Withdrawal by Subject|88|||
160814470|NCT01147250|580703836|FG000|Overall Study|Site termination by sponsor|13|||
160814471|NCT01147250|580703837|FG001|Overall Study|Site termination by sponsor|5|||
160814472|NCT01147250|580703836|FG000|Overall Study|Other than specified|0|||
160814473|NCT01147250|580703837|FG001|Overall Study|Other than specified|1|||
160814474|NCT02249091|580703839|FG000|Overall Study|Lack of Efficacy|8|||
160814475|NCT02249091|580703840|FG001|Overall Study|Lack of Efficacy|3|||
160814476|NCT02249091|580703839|FG000|Overall Study|Physician Decision|4|||
160814477|NCT02249091|580703840|FG001|Overall Study|Physician Decision|1|||
160814478|NCT02249091|580703839|FG000|Overall Study|Withdrawal by Subject|2|||
160814479|NCT02249091|580703840|FG001|Overall Study|Withdrawal by Subject|2|||
160814480|NCT02249091|580703839|FG000|Overall Study|Death|3|||
160814481|NCT02249091|580703840|FG001|Overall Study|Death|4|||
160814482|NCT02249091|580703839|FG000|Overall Study|Adverse Event|1|||
160814483|NCT02249091|580703840|FG001|Overall Study|Adverse Event|0|||
160814484|NCT02249091|580703839|FG000|Overall Study|Stable disease with following SCT|0|||
160814485|NCT02249091|580703840|FG001|Overall Study|Stable disease with following SCT|1|||
160814486|NCT02249091|580703839|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
160814487|NCT02249091|580703840|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
160814488|NCT02249091|580703839|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
160814489|NCT02249091|580703840|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
160814490|NCT02249091|580703839|FG000|Overall Study|Refractory AML|1|||
160814491|NCT02249091|580703840|FG001|Overall Study|Refractory AML|1|||
160814492|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
160814493|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
160814494|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
160814495|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
160814496|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
160814497|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
160814498|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
160814499|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
160814500|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160814501|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160814502|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160814503|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160814504|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
160814505|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
160814506|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160814507|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160814508|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160814509|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160814510|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
160814511|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
160814512|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
160814513|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
160814514|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
160814515|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
160814516|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160814517|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
160814518|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160814519|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160814520|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160814521|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160814522|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
160814523|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
160814524|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
160814525|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
160814526|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
160814527|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
160814528|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
160814529|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
160814530|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
160814531|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
160814532|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
160814533|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
160814534|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
160814535|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
160900165|NCT01297920|581028666|FG002|Overall Study|Protocol Violation|0|||
160900166|NCT01297920|581028664|FG000|Overall Study|Inadequate Control of IOP|7|||
160900167|NCT01297920|581028665|FG001|Overall Study|Inadequate Control of IOP|9|||
160900168|NCT01297920|581028666|FG002|Overall Study|Inadequate Control of IOP|17|||
160900169|NCT01297920|581028664|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
160900170|NCT01297920|581028665|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
160900171|NCT01297920|581028666|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
160900172|NCT01710046|581028667|FG000|Overall Study|Lost to Follow-up|1|||
160900173|NCT01710046|581028668|FG001|Overall Study|Lost to Follow-up|0|||
160900174|NCT02215096|581028669|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
160900175|NCT02215096|581028670|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
160900176|NCT02215096|581028671|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
160900177|NCT02215096|581028672|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
160900178|NCT02215096|581028673|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
160900179|NCT02215096|581028669|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
160900180|NCT02215096|581028670|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
160900181|NCT02215096|581028671|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
160900182|NCT02215096|581028672|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
160900183|NCT02215096|581028673|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
160986944|NCT04955626|581341120|FG015|Blinded Period|Withdrawal by Subject|11|||
160986945|NCT04955626|581341121|FG016|Blinded Period|Withdrawal by Subject|2|||
160645473|NCT01752920|580084259|FG000|Overall Study|Radiographic Disease Progression|20|||
160814536|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
160814537|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
160814538|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
160814539|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
160814540|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160814541|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160814542|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
160814543|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
160814544|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
160814545|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
160814546|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160814547|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160814548|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
160986946|NCT04955626|581341122|FG017|Blinded Period|Withdrawal by Subject|5|||
160986947|NCT04955626|581341123|FG018|Blinded Period|Withdrawal by Subject|0|||
160986948|NCT04955626|581341124|FG019|Blinded Period|Withdrawal by Subject|0|||
160986949|NCT04955626|581341125|FG020|Blinded Period|Withdrawal by Subject|1|||
160814549|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
160814550|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
160814551|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
160814552|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
160814553|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
160814554|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
160814555|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
160814556|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
160814557|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
160814558|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160986950|NCT04955626|581341126|FG021|Blinded Period|Withdrawal by Subject|0|||
160986951|NCT04955626|581341127|FG022|Blinded Period|Withdrawal by Subject|0|||
160986952|NCT04955626|581341128|FG023|Blinded Period|Withdrawal by Subject|0|||
160986953|NCT04955626|581341129|FG024|Blinded Period|Withdrawal by Subject|5|||
160986954|NCT04955626|581341130|FG025|Blinded Period|Withdrawal by Subject|1|||
160986955|NCT04955626|581341131|FG026|Blinded Period|Withdrawal by Subject|5|||
160814559|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160814560|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160986956|NCT04955626|581341132|FG027|Blinded Period|Withdrawal by Subject|1|||
160986957|NCT04955626|581341133|FG028|Blinded Period|Withdrawal by Subject|4|||
160986958|NCT04955626|581341134|FG029|Blinded Period|Withdrawal by Subject|2|||
160986959|NCT04955626|581341135|FG030|Blinded Period|Withdrawal by Subject|0|||
160986960|NCT04955626|581341136|FG031|Blinded Period|Withdrawal by Subject|0|||
160986961|NCT04955626|581341137|FG032|Blinded Period|Withdrawal by Subject|0|||
160986962|NCT04955626|581341138|FG033|Blinded Period|Withdrawal by Subject|0|||
160986963|NCT04955626|581341139|FG034|Blinded Period|Withdrawal by Subject|0|||
160986964|NCT04955626|581341140|FG035|Blinded Period|Withdrawal by Subject|0|||
160986965|NCT04955626|581341105|FG000|Blinded Period|Refused further study procedures|0|||
160986966|NCT04955626|581341106|FG001|Blinded Period|Refused further study procedures|0|||
160986967|NCT04955626|581341107|FG002|Blinded Period|Refused further study procedures|0|||
160986968|NCT04955626|581341108|FG003|Blinded Period|Refused further study procedures|0|||
160986969|NCT04955626|581341109|FG004|Blinded Period|Refused further study procedures|0|||
160986970|NCT04955626|581341110|FG005|Blinded Period|Refused further study procedures|0|||
160986971|NCT04955626|581341111|FG006|Blinded Period|Refused further study procedures|1|||
160986972|NCT04955626|581341112|FG007|Blinded Period|Refused further study procedures|0|||
160986973|NCT04955626|581341113|FG008|Blinded Period|Refused further study procedures|0|||
160986974|NCT04955626|581341114|FG009|Blinded Period|Refused further study procedures|0|||
160986975|NCT04955626|581341115|FG010|Blinded Period|Refused further study procedures|0|||
160986976|NCT04955626|581341116|FG011|Blinded Period|Refused further study procedures|2|||
160814561|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
160814562|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
160814563|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
160814564|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
160986977|NCT04955626|581341117|FG012|Blinded Period|Refused further study procedures|0|||
160986978|NCT04955626|581341118|FG013|Blinded Period|Refused further study procedures|0|||
160986979|NCT04955626|581341119|FG014|Blinded Period|Refused further study procedures|0|||
160986980|NCT04955626|581341120|FG015|Blinded Period|Refused further study procedures|0|||
160986981|NCT04955626|581341121|FG016|Blinded Period|Refused further study procedures|0|||
160986982|NCT04955626|581341122|FG017|Blinded Period|Refused further study procedures|0|||
160986983|NCT04955626|581341123|FG018|Blinded Period|Refused further study procedures|0|||
160986984|NCT04955626|581341124|FG019|Blinded Period|Refused further study procedures|0|||
160986985|NCT04955626|581341125|FG020|Blinded Period|Refused further study procedures|0|||
160814565|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
160814566|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
160814567|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
160814568|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
160814569|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
160814570|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
160814571|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
160814572|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
160814573|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
160814574|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
160814575|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
160814576|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
160814577|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
160814578|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
160814579|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
160814580|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
160814581|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
160814582|NCT00716482|580703850|FG000|Overall Study|Lost to Follow-up|6|||
160814583|NCT00716482|580703850|FG000|Overall Study|Inadequate acquisition or analysis|50|||
160814584|NCT00716482|580703850|FG000|Overall Study|no pathology obtained|10|||
160814585|NCT00716482|580703850|FG000|Overall Study|technical/machine error|28|||
160814586|NCT00716482|580703850|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
160814587|NCT04075513|580703853|FG000|Overall Study|Withdrawal by Subject|2|||
160814588|NCT04075513|580703854|FG001|Overall Study|Withdrawal by Subject|2|||
160814589|NCT04075513|580703853|FG000|Overall Study|Lack of Efficacy|1|||
160814590|NCT04075513|580703854|FG001|Overall Study|Lack of Efficacy|0|||
160814591|NCT04075513|580703853|FG000|Overall Study|Lost to Follow-up|4|||
160814592|NCT04075513|580703854|FG001|Overall Study|Lost to Follow-up|2|||
160814593|NCT04075513|580703853|FG000|Overall Study|Switch to insulin pump|1|||
160814594|NCT04075513|580703854|FG001|Overall Study|Switch to insulin pump|0|||
160814595|NCT05730335|580703855|FG000|Overall Study|Lost to Follow-up|8|||
160814596|NCT05730335|580703855|FG000|Overall Study|Withdrawal by Subject|6|||
160814597|NCT03249909|580703856|FG000|Overall Study|Withdrawal by Subject|3|||
160814598|NCT03249909|580703857|FG001|Overall Study|Withdrawal by Subject|0|||
160814599|NCT03249909|580703858|FG002|Overall Study|Withdrawal by Subject|0|||
160814600|NCT03249909|580703856|FG000|Overall Study|Adverse Event|3|||
160814601|NCT03249909|580703857|FG001|Overall Study|Adverse Event|0|||
160814602|NCT03249909|580703858|FG002|Overall Study|Adverse Event|0|||
160814603|NCT03249909|580703856|FG000|Overall Study|Lost to Follow-up|0|||
160814604|NCT03249909|580703857|FG001|Overall Study|Lost to Follow-up|1|||
160814605|NCT03249909|580703858|FG002|Overall Study|Lost to Follow-up|0|||
160814606|NCT03517371|580703859|FG000|Overall Study|Adverse Event|8|||
160814607|NCT03517371|580703860|FG001|Overall Study|Adverse Event|9|||
160814608|NCT03517371|580703859|FG000|Overall Study|Lost to Follow-up|1|||
160814609|NCT03517371|580703860|FG001|Overall Study|Lost to Follow-up|2|||
160814610|NCT03517371|580703859|FG000|Overall Study|Withdrawal by Subject|4|||
160814611|NCT03517371|580703860|FG001|Overall Study|Withdrawal by Subject|4|||
160814612|NCT03517371|580703859|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
160814613|NCT03517371|580703860|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
160814614|NCT03517371|580703859|FG000|Overall Study|COVID restrictions|2|||
160814615|NCT03517371|580703860|FG001|Overall Study|COVID restrictions|0|||
160814616|NCT03517371|580703859|FG000|Overall Study|Receiving DBS Surgery|0|||
160814617|NCT03517371|580703860|FG001|Overall Study|Receiving DBS Surgery|1|||
160814618|NCT05411822|580703861|FG000|Overall Study|Withdrawal by Subject|2|||
160814619|NCT05411822|580703862|FG001|Overall Study|Withdrawal by Subject|1|||
160814620|NCT01345929|580703863|FG000|Overall Study|Withdrawal by Subject|9|||
160814621|NCT01345929|580703864|FG001|Overall Study|Withdrawal by Subject|8|||
160814622|NCT01345929|580703863|FG000|Overall Study|Lost to Follow-up|9|||
160814623|NCT01345929|580703864|FG001|Overall Study|Lost to Follow-up|9|||
160814624|NCT01345929|580703863|FG000|Overall Study|Adverse Event|0|||
160814625|NCT01345929|580703864|FG001|Overall Study|Adverse Event|1|||
160814626|NCT01345929|580703863|FG000|Overall Study|Didn't meet eligibility criteria|2|||
160814627|NCT01345929|580703864|FG001|Overall Study|Didn't meet eligibility criteria|0|||
160814628|NCT01345929|580703863|FG000|Overall Study|40,000 CFU/ML|1|||
160814629|NCT01345929|580703864|FG001|Overall Study|40,000 CFU/ML|0|||
160814630|NCT01345929|580703863|FG000|Overall Study|Patient withdrawal|0|||
160814631|NCT01345929|580703864|FG001|Overall Study|Patient withdrawal|1|||
160814632|NCT02819297|580703865|FG000|Overall Study|Withdrawal by Subject|25|||
160900184|NCT02215096|581028669|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
160814633|NCT02819297|580703866|FG001|Overall Study|Withdrawal by Subject|13|||
160814634|NCT02819297|580703865|FG000|Overall Study|Lost to Follow-up|12|||
160814635|NCT02819297|580703866|FG001|Overall Study|Lost to Follow-up|14|||
160814636|NCT02819297|580703865|FG000|Overall Study|Adverse Event|12|||
160900185|NCT02215096|581028670|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
160814637|NCT02819297|580703866|FG001|Overall Study|Adverse Event|10|||
160814638|NCT02819297|580703865|FG000|Overall Study|Physician Decision|5|||
160814639|NCT02819297|580703866|FG001|Overall Study|Physician Decision|5|||
160814640|NCT02819297|580703865|FG000|Overall Study|Lack of Efficacy|5|||
160814641|NCT02819297|580703866|FG001|Overall Study|Lack of Efficacy|8|||
160814642|NCT02819297|580703865|FG000|Overall Study|Protocol Violation|1|||
160814643|NCT02819297|580703866|FG001|Overall Study|Protocol Violation|2|||
160814644|NCT02318368|580703867|FG000|Overall Study|Withdrawal by Subject|2|||
160814645|NCT02318368|580703868|FG001|Overall Study|Withdrawal by Subject|0|||
160814646|NCT02318368|580703867|FG000|Overall Study|Study terminated by the sponsor|5|||
160814647|NCT02318368|580703868|FG001|Overall Study|Study terminated by the sponsor|2|||
160814648|NCT02318368|580703867|FG000|Overall Study|Death|0|||
160814649|NCT02318368|580703868|FG001|Overall Study|Death|1|||
160814650|NCT01901614|580703869|FG000|Overall Study|Adverse Event|0|||
160814651|NCT01901614|580703870|FG001|Overall Study|Adverse Event|1|||
160814652|NCT01901614|580703869|FG000|Overall Study|Lost to Follow-up|1|||
160814653|NCT01901614|580703870|FG001|Overall Study|Lost to Follow-up|0|||
160814654|NCT01901614|580703869|FG000|Overall Study|Screen Fail|1|||
160814655|NCT01901614|580703870|FG001|Overall Study|Screen Fail|0|||
160814656|NCT01814046|580703876|FG000|Drug Administration|Death due to complications of RSV|1|||
160814657|NCT01814046|580703877|FG001|Drug Administration|Death due to complications of RSV|0|||
160814658|NCT01814046|580703878|FG002|Drug Administration|Death due to complications of RSV|0|||
160814659|NCT00564902|580703879|FG000|Overall Study|Withdrawal by Subject|0|||
160814660|NCT00564902|580703880|FG001|Overall Study|Withdrawal by Subject|3|||
160814661|NCT00564902|580703881|FG002|Overall Study|Withdrawal by Subject|4|||
160814662|NCT00564902|580703879|FG000|Overall Study|Death|1|||
160814663|NCT00564902|580703880|FG001|Overall Study|Death|1|||
160814664|NCT00564902|580703881|FG002|Overall Study|Death|0|||
160814665|NCT00958347|580703882|FG000|Overall Study|Death|43|||
160814666|NCT00958347|580703882|FG000|Overall Study|Withdrawal by Subject|23|||
160814667|NCT00958347|580703882|FG000|Overall Study|Lost to Follow-up|15|||
160814668|NCT00958347|580703882|FG000|Overall Study|revision/removal|10|||
160814669|NCT00958347|580703882|FG000|Overall Study|study termination|135|||
160814670|NCT04552288|580703885|FG000|Overall Study|Death|3|||
160814671|NCT04552288|580703885|FG000|Overall Study|Lost to Follow-up|6|||
160814672|NCT04552288|580703885|FG000|Overall Study|Physician Decision|3|||
160814673|NCT04552288|580703885|FG000|Overall Study|Protocol Violation|9|||
160814674|NCT04552288|580703885|FG000|Overall Study|Withdrawal by Subject|6|||
160814675|NCT04552288|580703885|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
160814676|NCT01603043|580703886|FG000|Overall Study|Study Futility|7|||
160814677|NCT01603043|580703887|FG001|Overall Study|Study Futility|3|||
160814678|NCT01917929|580703888|FG000|Overall Study|Death|8|||
160814679|NCT01917929|580703888|FG000|Overall Study|Lost to Follow-up|19|||
160814680|NCT01917929|580703888|FG000|Overall Study|Withdrawal by Subject|33|||
160814681|NCT01917929|580703888|FG000|Overall Study|Adverse Event|6|||
160814682|NCT01917929|580703888|FG000|Overall Study|Investigative Site Terminated|35|||
160814683|NCT01917929|580703888|FG000|Overall Study|Censored because study device not implanted|6|||
160814684|NCT01917929|580703888|FG000|Overall Study|Censored because surgery not performed|3|||
160814685|NCT01917929|580703888|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
160814686|NCT01917929|580703888|FG000|Overall Study|Sponsor terminated study|175|||
160814687|NCT04532294|580703889|FG000|Overall Study|Withdrawal by Subject|0|||
160814688|NCT04532294|580703890|FG001|Overall Study|Withdrawal by Subject|0|||
160814689|NCT04532294|580703891|FG002|Overall Study|Withdrawal by Subject|1|||
160814690|NCT04532294|580703889|FG000|Overall Study|Participants Not Dosed|0|||
160814691|NCT04532294|580703890|FG001|Overall Study|Participants Not Dosed|0|||
160814692|NCT04532294|580703891|FG002|Overall Study|Participants Not Dosed|2|||
160814693|NCT03089047|580703892|FG000|Overall Study|Lost to Follow-up|1|||
160814694|NCT03089047|580703893|FG001|Overall Study|Lost to Follow-up|0|||
160814695|NCT03599518|580703894|FG000|Overall Study|Clinical progression|0|||
160814696|NCT03599518|580703895|FG001|Overall Study|Clinical progression|0|||
160814697|NCT03599518|580703896|FG002|Overall Study|Clinical progression|0|||
160814698|NCT03599518|580703897|FG003|Overall Study|Clinical progression|0|||
160814699|NCT03599518|580703898|FG004|Overall Study|Clinical progression|1|||
160814700|NCT03599518|580703894|FG000|Overall Study|Adverse Event|0|||
160814701|NCT03599518|580703895|FG001|Overall Study|Adverse Event|0|||
160814702|NCT03599518|580703896|FG002|Overall Study|Adverse Event|0|||
160814703|NCT03599518|580703897|FG003|Overall Study|Adverse Event|0|||
160814704|NCT03599518|580703898|FG004|Overall Study|Adverse Event|1|||
160814705|NCT03599518|580703894|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
160814706|NCT03599518|580703895|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
160814707|NCT03599518|580703896|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
160814708|NCT03599518|580703897|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
160814709|NCT03599518|580703898|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
160814710|NCT03599518|580703894|FG000|Overall Study|Participant withdrawal from study treatment|0|||
160900186|NCT02215096|581028671|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
160900187|NCT02215096|581028672|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
160814711|NCT03599518|580703895|FG001|Overall Study|Participant withdrawal from study treatment|0|||
160814712|NCT03599518|580703896|FG002|Overall Study|Participant withdrawal from study treatment|1|||
160814713|NCT03599518|580703897|FG003|Overall Study|Participant withdrawal from study treatment|0|||
160814714|NCT03599518|580703898|FG004|Overall Study|Participant withdrawal from study treatment|0|||
160814715|NCT06899737|580703899|FG000|Overall Study|Lost to Follow-up|19|||
160814716|NCT06899737|580703900|FG001|Overall Study|Lost to Follow-up|7|||
160814717|NCT01082081|580703901|FG000|Overall Study|Lost to Follow-up|0|||
160814718|NCT01082081|580703902|FG001|Overall Study|Lost to Follow-up|0|||
160814719|NCT01082081|580703903|FG002|Overall Study|Lost to Follow-up|1|||
160814720|NCT01082081|580703901|FG000|Overall Study|Withdrawal by Subject|0|||
160814721|NCT01082081|580703902|FG001|Overall Study|Withdrawal by Subject|0|||
160814722|NCT01082081|580703903|FG002|Overall Study|Withdrawal by Subject|1|||
160814723|NCT01082081|580703901|FG000|Overall Study|Other Reason|0|||
160814724|NCT01082081|580703902|FG001|Overall Study|Other Reason|1|||
160814725|NCT01082081|580703903|FG002|Overall Study|Other Reason|0|||
160814726|NCT01575808|580703904|FG000|Overall Study|Death|2|||
160814727|NCT01575808|580703905|FG001|Overall Study|Death|0|||
160814728|NCT01575808|580703904|FG000|Overall Study|Withdrawal by Subject|1|||
160814729|NCT01575808|580703905|FG001|Overall Study|Withdrawal by Subject|0|||
160814730|NCT03159468|580703906|FG000|Overall Study|Withdrawal by Subject|0|||
160814731|NCT03159468|580703907|FG001|Overall Study|Withdrawal by Subject|0|||
160814732|NCT03159468|580703908|FG002|Overall Study|Withdrawal by Subject|3|||
160814733|NCT03159468|580703909|FG003|Overall Study|Withdrawal by Subject|0|||
160814734|NCT03159468|580703910|FG004|Overall Study|Withdrawal by Subject|0|||
160814735|NCT03159468|580703911|FG005|Overall Study|Withdrawal by Subject|0|||
160814736|NCT04308239|580705493|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
160814737|NCT04308239|580705494|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
160814738|NCT04308239|580705493|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
160814739|NCT04308239|580705494|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
160814740|NCT04308239|580705493|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
160814741|NCT04308239|580705494|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
160814742|NCT04308239|580705493|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
160814743|NCT04308239|580705494|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
160814744|NCT01670279|580705497|FG000|Overall Study|Adverse Event|0|||
160814745|NCT01670279|580705498|FG001|Overall Study|Adverse Event|1|||
160814746|NCT01670279|580705499|FG002|Overall Study|Adverse Event|0|||
160814747|NCT01670279|580705500|FG003|Overall Study|Adverse Event|0|||
160814748|NCT01670279|580705497|FG000|Overall Study|Physician Decision|0|||
160814749|NCT01670279|580705498|FG001|Overall Study|Physician Decision|1|||
160814750|NCT01670279|580705499|FG002|Overall Study|Physician Decision|0|||
160814751|NCT01670279|580705500|FG003|Overall Study|Physician Decision|0|||
160814752|NCT01670279|580705497|FG000|Overall Study|Participant met withdrawal criteria|0|||
160814753|NCT01670279|580705498|FG001|Overall Study|Participant met withdrawal criteria|0|||
160814754|NCT01670279|580705499|FG002|Overall Study|Participant met withdrawal criteria|0|||
160814755|NCT01670279|580705500|FG003|Overall Study|Participant met withdrawal criteria|1|||
160814756|NCT01555073|580705501|FG000|Overall Study|Lost to Follow-up|1|||
160814757|NCT01555073|580705502|FG001|Overall Study|Lost to Follow-up|2|||
160814758|NCT01555073|580705503|FG002|Overall Study|Lost to Follow-up|0|||
160814759|NCT01555073|580705504|FG003|Overall Study|Lost to Follow-up|5|||
160814760|NCT02125838|580705505|FG000|Overall Study|Lost to Follow-up|4|||
160814761|NCT02125838|580705506|FG001|Overall Study|Lost to Follow-up|4|||
160814762|NCT02565147|580705507|FG000|Overall Study|Withdrawal by Subject|5|||
160814763|NCT02565147|580705508|FG001|Overall Study|Withdrawal by Subject|1|||
160814764|NCT02565147|580705507|FG000|Overall Study|Lost to Follow-up|0|||
160814765|NCT02565147|580705508|FG001|Overall Study|Lost to Follow-up|1|||
160814766|NCT02565147|580705507|FG000|Overall Study|Death|1|||
160814767|NCT02565147|580705508|FG001|Overall Study|Death|1|||
160814768|NCT00787839|580705509|FG000|Overall Study|Failure to have the OGTT was most common|404|||
160814769|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
160814770|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
160814771|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
160814772|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
160814773|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Death|58|||
160814774|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Death|65|||
160900188|NCT02215096|581028673|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
160814775|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Adverse Event|28|||
160814776|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Adverse Event|40|||
160814777|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Disease Progression|22|||
160814778|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Disease Progression|35|||
160814779|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Other|25|||
160814780|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Other|33|||
160814781|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
160900189|NCT02215096|581028669|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
160814782|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
160814783|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Noncompliance|8|||
160814784|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Noncompliance|8|||
160814785|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
160814786|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
160814787|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
160814788|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
160814789|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
160814790|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
160814791|NCT00286091|580705517|FG000|Open-label Treatment Phase|Physician Decision|24|||
160814792|NCT00286091|580705518|FG001|Open-label Treatment Phase|Physician Decision|21|||
160814793|NCT00286091|580705517|FG000|Open-label Treatment Phase|Adverse Event|5|||
160814794|NCT00286091|580705518|FG001|Open-label Treatment Phase|Adverse Event|16|||
160814795|NCT00286091|580705517|FG000|Open-label Treatment Phase|Other|11|||
160814796|NCT00286091|580705518|FG001|Open-label Treatment Phase|Other|11|||
160814797|NCT00286091|580705517|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
160814798|NCT00286091|580705518|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
160814799|NCT00286091|580705517|FG000|Open-label Treatment Phase|Death|10|||
160814800|NCT00286091|580705518|FG001|Open-label Treatment Phase|Death|7|||
160814801|NCT00286091|580705517|FG000|Open-label Treatment Phase|Disease Progression|9|||
160814802|NCT00286091|580705518|FG001|Open-label Treatment Phase|Disease Progression|3|||
160814803|NCT00286091|580705517|FG000|Open-label Treatment Phase|Noncompliance|3|||
160814804|NCT00286091|580705518|FG001|Open-label Treatment Phase|Noncompliance|1|||
160814805|NCT00286091|580705517|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
160814806|NCT00286091|580705518|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
160814807|NCT00286091|580705517|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
160814808|NCT00286091|580705518|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
160814809|NCT00286091|580705517|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
160814810|NCT00286091|580705518|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
160814811|NCT00244725|580705521|FG000|Overall Study|Lost to Follow-up|3|||
160814812|NCT00244725|580705522|FG001|Overall Study|Lost to Follow-up|4|||
160814813|NCT00244725|580705523|FG002|Overall Study|Lost to Follow-up|9|||
160814814|NCT00244725|580705524|FG003|Overall Study|Lost to Follow-up|2|||
160814815|NCT00244725|580705521|FG000|Overall Study|Withdrawal by Subject|9|||
160814816|NCT00244725|580705522|FG001|Overall Study|Withdrawal by Subject|7|||
160814817|NCT00244725|580705523|FG002|Overall Study|Withdrawal by Subject|7|||
160814818|NCT00244725|580705524|FG003|Overall Study|Withdrawal by Subject|8|||
160814819|NCT00244725|580705521|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
160814820|NCT00244725|580705522|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
160986986|NCT04955626|581341126|FG021|Blinded Period|Refused further study procedures|0|||
160986987|NCT04955626|581341127|FG022|Blinded Period|Refused further study procedures|0|||
160986988|NCT04955626|581341128|FG023|Blinded Period|Refused further study procedures|0|||
160986989|NCT04955626|581341129|FG024|Blinded Period|Refused further study procedures|0|||
160986990|NCT04955626|581341130|FG025|Blinded Period|Refused further study procedures|0|||
160986991|NCT04955626|581341131|FG026|Blinded Period|Refused further study procedures|0|||
160986992|NCT04955626|581341132|FG027|Blinded Period|Refused further study procedures|0|||
160986993|NCT04955626|581341133|FG028|Blinded Period|Refused further study procedures|0|||
160986994|NCT04955626|581341134|FG029|Blinded Period|Refused further study procedures|0|||
160986995|NCT04955626|581341135|FG030|Blinded Period|Refused further study procedures|0|||
160986996|NCT04955626|581341136|FG031|Blinded Period|Refused further study procedures|0|||
160986997|NCT04955626|581341137|FG032|Blinded Period|Refused further study procedures|0|||
160986998|NCT04955626|581341138|FG033|Blinded Period|Refused further study procedures|0|||
160986999|NCT04955626|581341139|FG034|Blinded Period|Refused further study procedures|0|||
160987000|NCT04955626|581341140|FG035|Blinded Period|Refused further study procedures|0|||
160987001|NCT04955626|581341105|FG000|Blinded Period|Participants entered open label period|4544|||
160987002|NCT04955626|581341106|FG001|Blinded Period|Participants entered open label period|4906|||
160987003|NCT04955626|581341107|FG002|Blinded Period|Participants entered open label period|0|||
160987004|NCT04955626|581341108|FG003|Blinded Period|Participants entered open label period|0|||
160814821|NCT00244725|580705523|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
160814822|NCT00244725|580705524|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
160814823|NCT00244725|580705521|FG000|Overall Study|Physician Decision|3|||
160814824|NCT00244725|580705522|FG001|Overall Study|Physician Decision|0|||
160814825|NCT00244725|580705523|FG002|Overall Study|Physician Decision|1|||
160814826|NCT00244725|580705524|FG003|Overall Study|Physician Decision|2|||
160814827|NCT00244725|580705521|FG000|Overall Study|Adverse Events|3|||
160987005|NCT04955626|581341109|FG004|Blinded Period|Participants entered open label period|0|||
160814828|NCT00244725|580705522|FG001|Overall Study|Adverse Events|1|||
160814829|NCT00244725|580705523|FG002|Overall Study|Adverse Events|4|||
160814830|NCT00244725|580705524|FG003|Overall Study|Adverse Events|4|||
160814831|NCT00244725|580705521|FG000|Overall Study|Withdrwal by participant|1|||
160814832|NCT00244725|580705522|FG001|Overall Study|Withdrwal by participant|0|||
160814833|NCT00244725|580705523|FG002|Overall Study|Withdrwal by participant|0|||
160814834|NCT00244725|580705524|FG003|Overall Study|Withdrwal by participant|1|||
160814835|NCT00244725|580705521|FG000|Overall Study|Liver function test abnormality|2|||
160814836|NCT00244725|580705522|FG001|Overall Study|Liver function test abnormality|0|||
160814837|NCT00244725|580705523|FG002|Overall Study|Liver function test abnormality|0|||
160814838|NCT00244725|580705524|FG003|Overall Study|Liver function test abnormality|1|||
160814839|NCT00244725|580705521|FG000|Overall Study|Sponsor withdrew the participant|1|||
160814840|NCT00244725|580705522|FG001|Overall Study|Sponsor withdrew the participant|0|||
160987006|NCT04955626|581341110|FG005|Blinded Period|Participants entered open label period|0|||
160987007|NCT04955626|581341111|FG006|Blinded Period|Participants entered open label period|0|||
160987008|NCT04955626|581341112|FG007|Blinded Period|Participants entered open label period|0|||
160987009|NCT04955626|581341113|FG008|Blinded Period|Participants entered open label period|0|||
160987010|NCT04955626|581341114|FG009|Blinded Period|Participants entered open label period|0|||
160987011|NCT04955626|581341115|FG010|Blinded Period|Participants entered open label period|0|||
160987012|NCT04955626|581341116|FG011|Blinded Period|Participants entered open label period|0|||
160987013|NCT04955626|581341117|FG012|Blinded Period|Participants entered open label period|0|||
160987014|NCT04955626|581341118|FG013|Blinded Period|Participants entered open label period|0|||
160987015|NCT04955626|581341119|FG014|Blinded Period|Participants entered open label period|0|||
160987016|NCT04955626|581341120|FG015|Blinded Period|Participants entered open label period|0|||
160987017|NCT04955626|581341121|FG016|Blinded Period|Participants entered open label period|0|||
160987018|NCT04955626|581341122|FG017|Blinded Period|Participants entered open label period|0|||
160987019|NCT04955626|581341123|FG018|Blinded Period|Participants entered open label period|0|||
160987020|NCT04955626|581341124|FG019|Blinded Period|Participants entered open label period|0|||
160987021|NCT04955626|581341125|FG020|Blinded Period|Participants entered open label period|0|||
160987022|NCT04955626|581341126|FG021|Blinded Period|Participants entered open label period|0|||
160987023|NCT04955626|581341127|FG022|Blinded Period|Participants entered open label period|0|||
160987024|NCT04955626|581341128|FG023|Blinded Period|Participants entered open label period|0|||
160987025|NCT04955626|581341129|FG024|Blinded Period|Participants entered open label period|0|||
160987026|NCT04955626|581341130|FG025|Blinded Period|Participants entered open label period|0|||
160987027|NCT04955626|581341131|FG026|Blinded Period|Participants entered open label period|0|||
160987028|NCT04955626|581341132|FG027|Blinded Period|Participants entered open label period|0|||
160987029|NCT04955626|581341133|FG028|Blinded Period|Participants entered open label period|0|||
160987030|NCT04955626|581341134|FG029|Blinded Period|Participants entered open label period|0|||
160987031|NCT04955626|581341135|FG030|Blinded Period|Participants entered open label period|0|||
160987032|NCT04955626|581341136|FG031|Blinded Period|Participants entered open label period|0|||
160987033|NCT04955626|581341137|FG032|Blinded Period|Participants entered open label period|0|||
160987034|NCT04955626|581341138|FG033|Blinded Period|Participants entered open label period|0|||
160987035|NCT04955626|581341139|FG034|Blinded Period|Participants entered open label period|0|||
160987036|NCT04955626|581341140|FG035|Blinded Period|Participants entered open label period|0|||
160552659|NCT02979431|579748482|FG000|Overall Study|Subject left country after Day14|1|||
160552660|NCT02979431|579748483|FG001|Overall Study|Subject left country after Day14|0|||
160552661|NCT02979431|579748484|FG002|Overall Study|Subject left country after Day14|0|||
160552662|NCT02979431|579748485|FG003|Overall Study|Subject left country after Day14|0|||
160552663|NCT02883244|579748486|FG000|Overall Study|Lost to Follow-up|0|||
160552664|NCT02883244|579748487|FG001|Overall Study|Lost to Follow-up|1|||
160552665|NCT01727258|579748488|FG000|Overall Study|Adverse Event|0|||
160552666|NCT01727258|579748489|FG001|Overall Study|Adverse Event|2|||
160552667|NCT01727258|579748490|FG002|Overall Study|Adverse Event|0|||
160552668|NCT01727258|579748488|FG000|Overall Study|Noncompliance with Study Drug|0|||
160552669|NCT01727258|579748489|FG001|Overall Study|Noncompliance with Study Drug|0|||
160552670|NCT01727258|579748490|FG002|Overall Study|Noncompliance with Study Drug|1|||
160552671|NCT01727258|579748488|FG000|Overall Study|Withdrawal by Subject|1|||
160552672|NCT01727258|579748489|FG001|Overall Study|Withdrawal by Subject|1|||
160552673|NCT01727258|579748490|FG002|Overall Study|Withdrawal by Subject|0|||
160552674|NCT01727258|579748488|FG000|Overall Study|Lost to Follow-up|1|||
160552675|NCT01727258|579748489|FG001|Overall Study|Lost to Follow-up|0|||
160987037|NCT04955626|581341105|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
160987038|NCT04955626|581341106|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
160987039|NCT04955626|581341107|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
160987040|NCT04955626|581341108|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
160987041|NCT04955626|581341109|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
160987042|NCT04955626|581341110|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
160987043|NCT04955626|581341111|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
160987044|NCT04955626|581341112|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
160987045|NCT04955626|581341113|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
160987046|NCT04955626|581341114|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
160987047|NCT04955626|581341115|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
160987048|NCT04955626|581341116|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
160987049|NCT04955626|581341117|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
160814841|NCT00244725|580705523|FG002|Overall Study|Sponsor withdrew the participant|0|||
160814842|NCT00244725|580705524|FG003|Overall Study|Sponsor withdrew the participant|1|||
160814843|NCT00244725|580705521|FG000|Overall Study|Mediciation Error|0|||
160814844|NCT00244725|580705522|FG001|Overall Study|Mediciation Error|1|||
160987050|NCT04955626|581341118|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
160814845|NCT00244725|580705523|FG002|Overall Study|Mediciation Error|0|||
160814846|NCT00244725|580705524|FG003|Overall Study|Mediciation Error|0|||
160987051|NCT04955626|581341119|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
160814847|NCT00244725|580705521|FG000|Overall Study|Rehab Refused to allow participantion|0|||
160814848|NCT00244725|580705522|FG001|Overall Study|Rehab Refused to allow participantion|1|||
160814849|NCT00244725|580705523|FG002|Overall Study|Rehab Refused to allow participantion|0|||
160814850|NCT00244725|580705524|FG003|Overall Study|Rehab Refused to allow participantion|0|||
160814851|NCT00244725|580705521|FG000|Overall Study|Headache|0|||
160814852|NCT00244725|580705522|FG001|Overall Study|Headache|1|||
160814853|NCT00244725|580705523|FG002|Overall Study|Headache|0|||
160814854|NCT00244725|580705524|FG003|Overall Study|Headache|0|||
160814855|NCT00244725|580705521|FG000|Overall Study|Received prohibited medication|0|||
160814856|NCT00244725|580705522|FG001|Overall Study|Received prohibited medication|1|||
160814857|NCT00244725|580705523|FG002|Overall Study|Received prohibited medication|0|||
160987052|NCT04955626|581341120|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
160987053|NCT04955626|581341121|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
160987054|NCT04955626|581341122|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
160987055|NCT04955626|581341123|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
160814858|NCT00244725|580705524|FG003|Overall Study|Received prohibited medication|1|||
160814859|NCT00244725|580705521|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
160814860|NCT00244725|580705522|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
160814861|NCT00244725|580705523|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
160814862|NCT00244725|580705524|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
160814863|NCT00244725|580705521|FG000|Overall Study|Administrative reason|0|||
160814864|NCT00244725|580705522|FG001|Overall Study|Administrative reason|0|||
160814865|NCT00244725|580705523|FG002|Overall Study|Administrative reason|1|||
160900190|NCT02215096|581028670|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
160900191|NCT02215096|581028671|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
160900192|NCT02215096|581028672|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
160900193|NCT02215096|581028673|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
160900194|NCT03439657|581028674|FG000|Overall Study|Adverse Event|2|||
160987056|NCT04955626|581341124|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
160987057|NCT04955626|581341125|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
160987058|NCT04955626|581341126|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
160987059|NCT04955626|581341127|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
160987060|NCT04955626|581341128|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
160987061|NCT04955626|581341129|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
160987062|NCT04955626|581341130|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
160987063|NCT04955626|581341131|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
160987064|NCT04955626|581341132|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
160987065|NCT04955626|581341133|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
160987066|NCT04955626|581341134|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
160987067|NCT04955626|581341135|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
160987068|NCT04955626|581341136|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
160987069|NCT04955626|581341137|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
160987070|NCT04955626|581341138|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
160987071|NCT04955626|581341139|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
160987072|NCT04955626|581341140|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
160987073|NCT04955626|581341105|FG000|Blinded Period|Medication error|0|||
160987074|NCT04955626|581341106|FG001|Blinded Period|Medication error|0|||
160987075|NCT04955626|581341107|FG002|Blinded Period|Medication error|0|||
160987076|NCT04955626|581341108|FG003|Blinded Period|Medication error|0|||
160987077|NCT04955626|581341109|FG004|Blinded Period|Medication error|0|||
160987078|NCT04955626|581341110|FG005|Blinded Period|Medication error|0|||
160987079|NCT04955626|581341111|FG006|Blinded Period|Medication error|0|||
160987080|NCT04955626|581341112|FG007|Blinded Period|Medication error|0|||
160987081|NCT04955626|581341113|FG008|Blinded Period|Medication error|0|||
160987082|NCT04955626|581341114|FG009|Blinded Period|Medication error|0|||
160987083|NCT04955626|581341115|FG010|Blinded Period|Medication error|2|||
160987084|NCT04955626|581341116|FG011|Blinded Period|Medication error|0|||
160987085|NCT04955626|581341117|FG012|Blinded Period|Medication error|0|||
160987086|NCT04955626|581341118|FG013|Blinded Period|Medication error|0|||
160987087|NCT04955626|581341119|FG014|Blinded Period|Medication error|0|||
160987088|NCT04955626|581341120|FG015|Blinded Period|Medication error|0|||
160987089|NCT04955626|581341121|FG016|Blinded Period|Medication error|0|||
160987090|NCT04955626|581341122|FG017|Blinded Period|Medication error|0|||
160814866|NCT00244725|580705524|FG003|Overall Study|Administrative reason|0|||
160814867|NCT00244725|580705521|FG000|Overall Study|Vomit|0|||
160814868|NCT00244725|580705522|FG001|Overall Study|Vomit|0|||
160987091|NCT04955626|581341123|FG018|Blinded Period|Medication error|0|||
160987092|NCT04955626|581341124|FG019|Blinded Period|Medication error|0|||
160987093|NCT04955626|581341125|FG020|Blinded Period|Medication error|0|||
160552676|NCT01727258|579748490|FG002|Overall Study|Lost to Follow-up|0|||
160552677|NCT00357500|579748497|FG000|Overall Study|Adverse Event|3|||
160900195|NCT03439657|581028675|FG001|Overall Study|Adverse Event|3|||
160900196|NCT03439657|581028674|FG000|Overall Study|Lost to Follow-up|1|||
160900197|NCT03439657|581028675|FG001|Overall Study|Lost to Follow-up|0|||
160814869|NCT00244725|580705523|FG002|Overall Study|Vomit|1|||
160814870|NCT00244725|580705524|FG003|Overall Study|Vomit|0|||
160814871|NCT00244725|580705521|FG000|Overall Study|Failed to follow-up|0|||
160814872|NCT00244725|580705522|FG001|Overall Study|Failed to follow-up|0|||
160814873|NCT00244725|580705523|FG002|Overall Study|Failed to follow-up|1|||
160814874|NCT00244725|580705524|FG003|Overall Study|Failed to follow-up|1|||
160814875|NCT02936869|580705525|FG000|Overall Study|Lost to Follow-up|1|||
160814876|NCT02936869|580705526|FG001|Overall Study|Lost to Follow-up|3|||
160814877|NCT02936869|580705525|FG000|Overall Study|Death|0|||
160814878|NCT02936869|580705526|FG001|Overall Study|Death|1|||
160814879|NCT02936869|580705525|FG000|Overall Study|Legal Case|0|||
160814880|NCT02936869|580705526|FG001|Overall Study|Legal Case|1|||
160645474|NCT01752920|580084260|FG001|Overall Study|Radiographic Disease Progression|7|||
160645475|NCT01752920|580084261|FG002|Overall Study|Radiographic Disease Progression|12|||
160645476|NCT01752920|580084262|FG003|Overall Study|Radiographic Disease Progression|29|||
160645477|NCT01752920|580084259|FG000|Overall Study|Study Terminated by Sponsor|0|||
160645478|NCT01752920|580084260|FG001|Overall Study|Study Terminated by Sponsor|0|||
160645479|NCT01752920|580084261|FG002|Overall Study|Study Terminated by Sponsor|0|||
160645480|NCT01752920|580084262|FG003|Overall Study|Study Terminated by Sponsor|1|||
160645481|NCT01752920|580084259|FG000|Overall Study|Withdrawal by Subject|0|||
160645482|NCT01752920|580084260|FG001|Overall Study|Withdrawal by Subject|1|||
160645483|NCT01752920|580084261|FG002|Overall Study|Withdrawal by Subject|0|||
160645484|NCT01752920|580084262|FG003|Overall Study|Withdrawal by Subject|1|||
160645485|NCT01752920|580084259|FG000|Overall Study|Lack of clinical benefit|1|||
160645486|NCT01752920|580084260|FG001|Overall Study|Lack of clinical benefit|1|||
160645487|NCT01752920|580084261|FG002|Overall Study|Lack of clinical benefit|1|||
160645488|NCT01752920|580084262|FG003|Overall Study|Lack of clinical benefit|1|||
160645489|NCT00771901|580084263|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
160645490|NCT00771901|580084264|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
160645491|NCT00771901|580084265|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
160645492|NCT02862535|580084266|FG000|Overall Study|Death|7|||
160645493|NCT02862535|580084267|FG001|Overall Study|Death|3|||
160814881|NCT02936869|580705525|FG000|Overall Study|Protocol Violation|1|||
160814882|NCT02936869|580705526|FG001|Overall Study|Protocol Violation|0|||
160814883|NCT03799952|580705527|FG000|Overall Study|Program was too easy, discontinued|1|||
160814884|NCT03799952|580705528|FG001|Overall Study|Program was too easy, discontinued|0|||
160814885|NCT03799952|580705527|FG000|Overall Study|Lost to Follow-up|0|||
160814886|NCT03799952|580705528|FG001|Overall Study|Lost to Follow-up|2|||
160814887|NCT00335738|580705529|FG000|Overall Study|Physician Decision|6|||
160814888|NCT00335738|580705530|FG001|Overall Study|Physician Decision|0|||
160814889|NCT00335738|580705529|FG000|Overall Study|Withdrawal by Subject|2|||
160814890|NCT00335738|580705530|FG001|Overall Study|Withdrawal by Subject|0|||
160814891|NCT00335738|580705529|FG000|Overall Study|Ineligible|3|||
160814892|NCT00335738|580705530|FG001|Overall Study|Ineligible|4|||
160814893|NCT04004221|580705535|FG000|Overall Study|Death|89|||
160814894|NCT04004221|580705535|FG000|Overall Study|Withdrawal by Subject|5|||
160814895|NCT04004221|580705535|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
160814896|NCT04004221|580705535|FG000|Overall Study|Sponsor Decision|9|||
160814897|NCT04004221|580705535|FG000|Overall Study|Participant refused to enter LTE|1|||
160814898|NCT03423238|580705536|FG000|Overall Study|Lost to Follow-up|1|||
160814899|NCT03423238|580705537|FG001|Overall Study|Lost to Follow-up|0|||
160814900|NCT03423238|580705536|FG000|Overall Study|Withdrawal by Subject|1|||
160814901|NCT03423238|580705537|FG001|Overall Study|Withdrawal by Subject|0|||
160814902|NCT02036580|580705539|FG000|Overall Study|Withdrawal by Subject|0|||
160814903|NCT02036580|580705540|FG001|Overall Study|Withdrawal by Subject|1|||
160814904|NCT02036580|580705541|FG002|Overall Study|Withdrawal by Subject|0|||
160814905|NCT02036580|580705539|FG000|Overall Study|Adverse Event|1|||
160814906|NCT02036580|580705540|FG001|Overall Study|Adverse Event|0|||
160814907|NCT02036580|580705541|FG002|Overall Study|Adverse Event|0|||
160814908|NCT00506454|580705542|FG000|Overall Study|Withdrawal by Subject|1|||
160814909|NCT00506454|580705543|FG001|Overall Study|Withdrawal by Subject|1|||
160814910|NCT01104545|580705544|FG000|Overall Study|Adverse Event|0|||
160645494|NCT02862535|580084268|FG002|Overall Study|Death|2|||
160814911|NCT01104545|580705545|FG001|Overall Study|Adverse Event|1|||
160814912|NCT01104545|580705546|FG002|Overall Study|Adverse Event|2|||
160814913|NCT00976716|580705547|FG000|Overall Study|Adverse Event|1|||
160814914|NCT02993822|580705555|FG000|Overall Study|Lack of Efficacy|1|||
160814915|NCT02993822|580705556|FG001|Overall Study|Lack of Efficacy|1|||
160814916|NCT02993822|580705557|FG002|Overall Study|Lack of Efficacy|0|||
160645495|NCT02862535|580084269|FG003|Overall Study|Death|5|||
160645496|NCT02862535|580084266|FG000|Overall Study|Study Terminated by Sponsor|1|||
160814917|NCT02993822|580705558|FG003|Overall Study|Lack of Efficacy|0|||
160814918|NCT02993822|580705555|FG000|Overall Study|Protocol Violation|1|||
160814919|NCT02993822|580705556|FG001|Overall Study|Protocol Violation|0|||
160814920|NCT02993822|580705557|FG002|Overall Study|Protocol Violation|0|||
160814921|NCT02993822|580705558|FG003|Overall Study|Protocol Violation|0|||
160814922|NCT02993822|580705555|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
160814923|NCT02993822|580705556|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
160987094|NCT04955626|581341126|FG021|Blinded Period|Medication error|0|||
160987095|NCT04955626|581341127|FG022|Blinded Period|Medication error|0|||
160987096|NCT04955626|581341128|FG023|Blinded Period|Medication error|0|||
160987097|NCT04955626|581341129|FG024|Blinded Period|Medication error|0|||
160987098|NCT04955626|581341130|FG025|Blinded Period|Medication error|0|||
160987099|NCT04955626|581341131|FG026|Blinded Period|Medication error|0|||
160987100|NCT04955626|581341132|FG027|Blinded Period|Medication error|0|||
160987101|NCT04955626|581341133|FG028|Blinded Period|Medication error|4|||
160987102|NCT04955626|581341134|FG029|Blinded Period|Medication error|0|||
160987103|NCT04955626|581341135|FG030|Blinded Period|Medication error|0|||
160987104|NCT04955626|581341136|FG031|Blinded Period|Medication error|0|||
160987105|NCT04955626|581341137|FG032|Blinded Period|Medication error|0|||
160987106|NCT04955626|581341138|FG033|Blinded Period|Medication error|0|||
160987107|NCT04955626|581341139|FG034|Blinded Period|Medication error|0|||
160987108|NCT04955626|581341140|FG035|Blinded Period|Medication error|0|||
160987109|NCT04955626|581341105|FG000|Open-Label Period|Lost to Follow-up|109|||
160987110|NCT04955626|581341106|FG001|Open-Label Period|Lost to Follow-up|41|||
160987111|NCT04955626|581341107|FG002|Open-Label Period|Lost to Follow-up|0|||
160987112|NCT04955626|581341108|FG003|Open-Label Period|Lost to Follow-up|0|||
160987113|NCT04955626|581341109|FG004|Open-Label Period|Lost to Follow-up|0|||
160987114|NCT04955626|581341110|FG005|Open-Label Period|Lost to Follow-up|0|||
160987115|NCT04955626|581341111|FG006|Open-Label Period|Lost to Follow-up|0|||
160987116|NCT04955626|581341112|FG007|Open-Label Period|Lost to Follow-up|0|||
160552678|NCT00357500|579748497|FG000|Overall Study|Withdrawal by Subject|5|||
160552679|NCT00357500|579748497|FG000|Overall Study|Progressive Disease|65|||
160814924|NCT02993822|580705557|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
160814925|NCT02993822|580705558|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
160814926|NCT02993822|580705555|FG000|Overall Study|Adverse Event|3|||
160814927|NCT02993822|580705556|FG001|Overall Study|Adverse Event|1|||
160814928|NCT02993822|580705557|FG002|Overall Study|Adverse Event|7|||
160814929|NCT02993822|580705558|FG003|Overall Study|Adverse Event|0|||
160814930|NCT02993822|580705555|FG000|Overall Study|Withdrawal by Subject|4|||
160814931|NCT02993822|580705556|FG001|Overall Study|Withdrawal by Subject|2|||
160814932|NCT02993822|580705557|FG002|Overall Study|Withdrawal by Subject|2|||
160814933|NCT02993822|580705558|FG003|Overall Study|Withdrawal by Subject|3|||
160552680|NCT00357500|579748497|FG000|Overall Study|Not Started Protocol Therapy|4|||
160814934|NCT02993822|580705555|FG000|Overall Study|Lost to Follow-up|1|||
160814935|NCT02993822|580705556|FG001|Overall Study|Lost to Follow-up|0|||
160814936|NCT02993822|580705557|FG002|Overall Study|Lost to Follow-up|1|||
160814937|NCT02993822|580705558|FG003|Overall Study|Lost to Follow-up|0|||
160814938|NCT01221753|580705562|FG000|Overall Study|Adverse Event|1|||
160814939|NCT01939977|580705563|FG000|Overall Study|Adverse Event|4|||
160814940|NCT01939977|580705564|FG001|Overall Study|Adverse Event|3|||
160814941|NCT01939977|580705563|FG000|Overall Study|Lack of Efficacy|3|||
160814942|NCT01939977|580705564|FG001|Overall Study|Lack of Efficacy|0|||
160814943|NCT01939977|580705563|FG000|Overall Study|Physician Decision|1|||
160814944|NCT01939977|580705564|FG001|Overall Study|Physician Decision|1|||
160814945|NCT01939977|580705563|FG000|Overall Study|Withdrawal by Subject|0|||
160814946|NCT01939977|580705564|FG001|Overall Study|Withdrawal by Subject|2|||
160814947|NCT01939977|580705563|FG000|Overall Study|Did not meet inclusion criteria|1|||
160814948|NCT01939977|580705564|FG001|Overall Study|Did not meet inclusion criteria|0|||
160552681|NCT01724528|579748499|FG000|Overall Study|Death|3|||
160814949|NCT01939977|580705563|FG000|Overall Study|Did not receive study medication|0|||
160814950|NCT01939977|580705564|FG001|Overall Study|Did not receive study medication|1|||
160814951|NCT01696981|580705568|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
160814952|NCT01696981|580705569|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
160814953|NCT01696981|580705568|FG000|Overall Study|Died Before Randomization|3|||
160814954|NCT01696981|580705569|FG001|Overall Study|Died Before Randomization|8|||
160814955|NCT01696981|580705568|FG000|Overall Study|Died Before ASU (Control)|278|||
160987117|NCT04955626|581341113|FG008|Open-Label Period|Lost to Follow-up|0|||
160987118|NCT04955626|581341114|FG009|Open-Label Period|Lost to Follow-up|0|||
160987119|NCT04955626|581341115|FG010|Open-Label Period|Lost to Follow-up|0|||
160987120|NCT04955626|581341116|FG011|Open-Label Period|Lost to Follow-up|0|||
160987121|NCT04955626|581341117|FG012|Open-Label Period|Lost to Follow-up|0|||
160987122|NCT04955626|581341118|FG013|Open-Label Period|Lost to Follow-up|0|||
160987123|NCT04955626|581341119|FG014|Open-Label Period|Lost to Follow-up|0|||
160987124|NCT04955626|581341120|FG015|Open-Label Period|Lost to Follow-up|0|||
160987125|NCT04955626|581341121|FG016|Open-Label Period|Lost to Follow-up|0|||
160987126|NCT04955626|581341122|FG017|Open-Label Period|Lost to Follow-up|0|||
160987127|NCT04955626|581341123|FG018|Open-Label Period|Lost to Follow-up|0|||
160987128|NCT04955626|581341124|FG019|Open-Label Period|Lost to Follow-up|0|||
160987129|NCT04955626|581341125|FG020|Open-Label Period|Lost to Follow-up|0|||
160987130|NCT04955626|581341126|FG021|Open-Label Period|Lost to Follow-up|0|||
160987131|NCT04955626|581341127|FG022|Open-Label Period|Lost to Follow-up|0|||
160987132|NCT04955626|581341128|FG023|Open-Label Period|Lost to Follow-up|0|||
160987133|NCT04955626|581341129|FG024|Open-Label Period|Lost to Follow-up|0|||
160987134|NCT04955626|581341130|FG025|Open-Label Period|Lost to Follow-up|0|||
160814956|NCT01696981|580705569|FG001|Overall Study|Died Before ASU (Control)|0|||
160814957|NCT01696981|580705568|FG000|Overall Study|Refused ASU (Control)|920|||
160814958|NCT01696981|580705569|FG001|Overall Study|Refused ASU (Control)|0|||
160814959|NCT01696981|580705568|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
160814960|NCT01696981|580705569|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
160814961|NCT02798315|580705572|FG000|Overall Study|Failure to return|1|||
160814962|NCT00465972|580705573|FG000|Overall Study|Withdrawal by Subject|2|||
160814963|NCT00465972|580705574|FG001|Overall Study|Withdrawal by Subject|1|||
160814964|NCT02097719|580705575|FG000|Overall Study|Subject Withdrew Consent|1|||
160814965|NCT02097719|580705576|FG001|Overall Study|Subject Withdrew Consent|0|||
160814966|NCT02097719|580705575|FG000|Overall Study|Lost to Follow-up|0|||
160814967|NCT02097719|580705576|FG001|Overall Study|Lost to Follow-up|1|||
160814968|NCT02097719|580705575|FG000|Overall Study|Adverse Event|2|||
160814969|NCT02097719|580705576|FG001|Overall Study|Adverse Event|0|||
160814970|NCT03292640|580705577|FG000|Overall Study|Withdrawal by Subject|17|||
160814971|NCT03292640|580705578|FG001|Overall Study|Withdrawal by Subject|16|||
160814972|NCT03292640|580705577|FG000|Overall Study|Adverse Event|20|||
160814973|NCT03292640|580705578|FG001|Overall Study|Adverse Event|2|||
160814974|NCT03292640|580705577|FG000|Overall Study|Lost to Follow-up|24|||
160814975|NCT03292640|580705578|FG001|Overall Study|Lost to Follow-up|24|||
160814976|NCT01108731|580705586|FG000|Overall Study|Withdrawal by Subject|1|||
160814977|NCT01108731|580705587|FG001|Overall Study|Withdrawal by Subject|1|||
160814978|NCT01108731|580705586|FG000|Overall Study|Adverse Event|3|||
160814979|NCT01108731|580705587|FG001|Overall Study|Adverse Event|3|||
160814980|NCT00984594|580705588|FG000|Overall Study|Lost to Follow-up|1|||
160814981|NCT00984594|580705589|FG001|Overall Study|Lost to Follow-up|0|||
160814982|NCT00984594|580705588|FG000|Overall Study|Withdrawal by Subject|0|||
160814983|NCT00984594|580705589|FG001|Overall Study|Withdrawal by Subject|1|||
160814984|NCT00851890|580705590|FG000|Overall Study|Lost to Follow-up|0|||
160814985|NCT00851890|580705591|FG001|Overall Study|Lost to Follow-up|1|||
160814986|NCT00851890|580705592|FG002|Overall Study|Lost to Follow-up|0|||
160814987|NCT00851890|580705593|FG003|Overall Study|Lost to Follow-up|1|||
160814988|NCT03135431|580705594|FG000|Overall Study|Study Surgeon not available|2|||
160814989|NCT03135431|580705595|FG001|Overall Study|Study Surgeon not available|0|||
160814990|NCT01063062|580705596|FG000|Overall Study|Patient withdrew consent|0|||
160814991|NCT01063062|580705597|FG001|Overall Study|Patient withdrew consent|1|||
160814992|NCT01063062|580705596|FG000|Overall Study|Adverse Event|2|||
160814993|NCT01063062|580705597|FG001|Overall Study|Adverse Event|4|||
160814994|NCT01063062|580705596|FG000|Overall Study|Protocol Violation|5|||
160814995|NCT01063062|580705597|FG001|Overall Study|Protocol Violation|4|||
160987135|NCT04955626|581341131|FG026|Open-Label Period|Lost to Follow-up|0|||
160814996|NCT01063062|580705596|FG000|Overall Study|Investigator's request|1|||
160814997|NCT01063062|580705597|FG001|Overall Study|Investigator's request|0|||
160814998|NCT01063062|580705596|FG000|Overall Study|Lost to Follow-up|0|||
160814999|NCT01063062|580705597|FG001|Overall Study|Lost to Follow-up|2|||
160815000|NCT01063062|580705596|FG000|Overall Study|Miscellaneous reason|0|||
160815001|NCT01063062|580705597|FG001|Overall Study|Miscellaneous reason|1|||
160987136|NCT04955626|581341132|FG027|Open-Label Period|Lost to Follow-up|0|||
160987137|NCT04955626|581341133|FG028|Open-Label Period|Lost to Follow-up|0|||
160815002|NCT02015481|580705598|FG000|Overall Study|Death|1|||
160815003|NCT02597452|580705600|FG000|Overall Study|testing incomplete|30|||
160815004|NCT03122145|580705603|FG000|Overall Study|Concurrent respiratory disease|3|||
160815005|NCT03122145|580705604|FG001|Overall Study|Concurrent respiratory disease|0|||
160987138|NCT04955626|581341134|FG029|Open-Label Period|Lost to Follow-up|0|||
160815006|NCT02016716|580705609|FG000|Overall Study|Withdrawal by Subject|5|||
160987139|NCT04955626|581341135|FG030|Open-Label Period|Lost to Follow-up|0|||
160987140|NCT04955626|581341136|FG031|Open-Label Period|Lost to Follow-up|0|||
160987141|NCT04955626|581341137|FG032|Open-Label Period|Lost to Follow-up|0|||
160987142|NCT04955626|581341138|FG033|Open-Label Period|Lost to Follow-up|0|||
160987143|NCT04955626|581341139|FG034|Open-Label Period|Lost to Follow-up|0|||
160987144|NCT04955626|581341140|FG035|Open-Label Period|Lost to Follow-up|0|||
160987145|NCT04955626|581341105|FG000|Open-Label Period|Protocol Violation|377|||
160987146|NCT04955626|581341106|FG001|Open-Label Period|Protocol Violation|48|||
160987147|NCT04955626|581341107|FG002|Open-Label Period|Protocol Violation|0|||
160987148|NCT04955626|581341108|FG003|Open-Label Period|Protocol Violation|0|||
160552682|NCT01724528|579748500|FG001|Overall Study|Death|0|||
160552683|NCT01724528|579748499|FG000|Overall Study|Withdrawal by Subject|0|||
160552684|NCT01724528|579748500|FG001|Overall Study|Withdrawal by Subject|2|||
160552685|NCT01724528|579748499|FG000|Overall Study|Protocol Violation|0|||
160552686|NCT01724528|579748500|FG001|Overall Study|Protocol Violation|1|||
160815007|NCT02016716|580705610|FG001|Overall Study|Withdrawal by Subject|5|||
160987149|NCT04955626|581341109|FG004|Open-Label Period|Protocol Violation|0|||
160987150|NCT04955626|581341110|FG005|Open-Label Period|Protocol Violation|0|||
160987151|NCT04955626|581341111|FG006|Open-Label Period|Protocol Violation|0|||
160987152|NCT04955626|581341112|FG007|Open-Label Period|Protocol Violation|0|||
160987153|NCT04955626|581341113|FG008|Open-Label Period|Protocol Violation|0|||
160987154|NCT04955626|581341114|FG009|Open-Label Period|Protocol Violation|0|||
160987155|NCT04955626|581341115|FG010|Open-Label Period|Protocol Violation|0|||
160987156|NCT04955626|581341116|FG011|Open-Label Period|Protocol Violation|0|||
160987157|NCT04955626|581341117|FG012|Open-Label Period|Protocol Violation|0|||
160987158|NCT04955626|581341118|FG013|Open-Label Period|Protocol Violation|0|||
160987159|NCT04955626|581341119|FG014|Open-Label Period|Protocol Violation|0|||
160987160|NCT04955626|581341120|FG015|Open-Label Period|Protocol Violation|0|||
160987161|NCT04955626|581341121|FG016|Open-Label Period|Protocol Violation|0|||
160987162|NCT04955626|581341122|FG017|Open-Label Period|Protocol Violation|0|||
160987163|NCT04955626|581341123|FG018|Open-Label Period|Protocol Violation|0|||
160815008|NCT02016716|580705611|FG002|Overall Study|Withdrawal by Subject|5|||
160815009|NCT02016716|580705609|FG000|Overall Study|Protocol-specified Criteria|0|||
160815010|NCT02016716|580705610|FG001|Overall Study|Protocol-specified Criteria|1|||
160815011|NCT02016716|580705611|FG002|Overall Study|Protocol-specified Criteria|0|||
160815012|NCT02016716|580705609|FG000|Overall Study|Lost to Follow-up|1|||
160815013|NCT02016716|580705610|FG001|Overall Study|Lost to Follow-up|2|||
160815014|NCT02016716|580705611|FG002|Overall Study|Lost to Follow-up|1|||
160815015|NCT00079391|580705612|FG000|Overall Study|Withdrawal by Subject|1|||
160815016|NCT00281099|580705613|FG000|Overall Study|Death|46|||
160815017|NCT00281099|580705614|FG001|Overall Study|Death|57|||
160815018|NCT00281099|580705613|FG000|Overall Study|Lost to Follow-up|10|||
160987164|NCT04955626|581341124|FG019|Open-Label Period|Protocol Violation|0|||
160987165|NCT04955626|581341125|FG020|Open-Label Period|Protocol Violation|0|||
160987166|NCT04955626|581341126|FG021|Open-Label Period|Protocol Violation|0|||
160987167|NCT04955626|581341127|FG022|Open-Label Period|Protocol Violation|0|||
160987168|NCT04955626|581341128|FG023|Open-Label Period|Protocol Violation|0|||
160987169|NCT04955626|581341129|FG024|Open-Label Period|Protocol Violation|0|||
160987170|NCT04955626|581341130|FG025|Open-Label Period|Protocol Violation|0|||
160987171|NCT04955626|581341131|FG026|Open-Label Period|Protocol Violation|0|||
160987172|NCT04955626|581341132|FG027|Open-Label Period|Protocol Violation|0|||
160987173|NCT04955626|581341133|FG028|Open-Label Period|Protocol Violation|0|||
160987174|NCT04955626|581341134|FG029|Open-Label Period|Protocol Violation|0|||
160987175|NCT04955626|581341135|FG030|Open-Label Period|Protocol Violation|0|||
160987176|NCT04955626|581341136|FG031|Open-Label Period|Protocol Violation|0|||
160987177|NCT04955626|581341137|FG032|Open-Label Period|Protocol Violation|0|||
160815019|NCT00281099|580705614|FG001|Overall Study|Lost to Follow-up|19|||
160815020|NCT00281099|580705613|FG000|Overall Study|Withdrawal by Subject|65|||
160815021|NCT00281099|580705614|FG001|Overall Study|Withdrawal by Subject|70|||
160815022|NCT00281099|580705613|FG000|Overall Study|Physician Decision|79|||
160987178|NCT04955626|581341138|FG033|Open-Label Period|Protocol Violation|0|||
160987179|NCT04955626|581341139|FG034|Open-Label Period|Protocol Violation|0|||
160987180|NCT04955626|581341140|FG035|Open-Label Period|Protocol Violation|0|||
160987181|NCT04955626|581341105|FG000|Open-Label Period|Death|5|||
160987182|NCT04955626|581341106|FG001|Open-Label Period|Death|5|||
160987183|NCT04955626|581341107|FG002|Open-Label Period|Death|0|||
160987184|NCT04955626|581341108|FG003|Open-Label Period|Death|0|||
160987185|NCT04955626|581341109|FG004|Open-Label Period|Death|0|||
160987186|NCT04955626|581341110|FG005|Open-Label Period|Death|0|||
160987187|NCT04955626|581341111|FG006|Open-Label Period|Death|0|||
160987188|NCT04955626|581341112|FG007|Open-Label Period|Death|0|||
160987189|NCT04955626|581341113|FG008|Open-Label Period|Death|0|||
160987190|NCT04955626|581341114|FG009|Open-Label Period|Death|0|||
160987191|NCT04955626|581341115|FG010|Open-Label Period|Death|0|||
160987192|NCT04955626|581341116|FG011|Open-Label Period|Death|0|||
160552687|NCT01724528|579748499|FG000|Overall Study|Patient refused to attend last visit|1|||
160552688|NCT01724528|579748500|FG001|Overall Study|Patient refused to attend last visit|0|||
160552689|NCT02183519|579748504|FG000|Overall Study|computer error|3|||
160552690|NCT02183519|579748505|FG001|Overall Study|computer error|0|||
160552691|NCT02183519|579748504|FG000|Overall Study|Did not respond to cough inducter|0|||
160552692|NCT02183519|579748505|FG001|Overall Study|Did not respond to cough inducter|3|||
160815023|NCT00281099|580705614|FG001|Overall Study|Physician Decision|72|||
160815024|NCT00281099|580705613|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
160815025|NCT00281099|580705614|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
160815026|NCT02931838|580705615|FG000|Overall Study|Reason not provided by investigator|1|||
160815027|NCT02931838|580705616|FG001|Overall Study|Reason not provided by investigator|0|||
160815028|NCT02931838|580705617|FG002|Overall Study|Reason not provided by investigator|1|||
160815029|NCT02931838|580705618|FG003|Overall Study|Reason not provided by investigator|0|||
160815030|NCT02931838|580705619|FG004|Overall Study|Reason not provided by investigator|0|||
160815031|NCT02931838|580705620|FG005|Overall Study|Reason not provided by investigator|0|||
160815032|NCT02931838|580705615|FG000|Overall Study|Poor/non-compliance|0|||
160815033|NCT02931838|580705616|FG001|Overall Study|Poor/non-compliance|0|||
160815034|NCT02931838|580705617|FG002|Overall Study|Poor/non-compliance|1|||
160815035|NCT02931838|580705618|FG003|Overall Study|Poor/non-compliance|0|||
160815036|NCT02931838|580705619|FG004|Overall Study|Poor/non-compliance|0|||
160815037|NCT02931838|580705620|FG005|Overall Study|Poor/non-compliance|0|||
160815038|NCT02931838|580705615|FG000|Overall Study|Lack of Efficacy|5|||
160815039|NCT02931838|580705616|FG001|Overall Study|Lack of Efficacy|4|||
160815040|NCT02931838|580705617|FG002|Overall Study|Lack of Efficacy|0|||
160815041|NCT02931838|580705618|FG003|Overall Study|Lack of Efficacy|0|||
160815042|NCT02931838|580705619|FG004|Overall Study|Lack of Efficacy|0|||
160815043|NCT02931838|580705620|FG005|Overall Study|Lack of Efficacy|1|||
160815044|NCT02931838|580705615|FG000|Overall Study|Lost to Follow-up|1|||
160815045|NCT02931838|580705616|FG001|Overall Study|Lost to Follow-up|0|||
160815046|NCT02931838|580705617|FG002|Overall Study|Lost to Follow-up|1|||
160815047|NCT02931838|580705618|FG003|Overall Study|Lost to Follow-up|1|||
160815048|NCT02931838|580705619|FG004|Overall Study|Lost to Follow-up|2|||
160815049|NCT02931838|580705620|FG005|Overall Study|Lost to Follow-up|0|||
160815050|NCT02931838|580705615|FG000|Overall Study|Subject request to discontinue treatment|4|||
160815051|NCT02931838|580705616|FG001|Overall Study|Subject request to discontinue treatment|3|||
160815052|NCT02931838|580705617|FG002|Overall Study|Subject request to discontinue treatment|3|||
160815053|NCT02931838|580705618|FG003|Overall Study|Subject request to discontinue treatment|0|||
160815054|NCT02931838|580705619|FG004|Overall Study|Subject request to discontinue treatment|1|||
160815055|NCT02931838|580705620|FG005|Overall Study|Subject request to discontinue treatment|0|||
160815056|NCT02931838|580705615|FG000|Overall Study|Withdrawal by Subject|1|||
160815057|NCT02931838|580705616|FG001|Overall Study|Withdrawal by Subject|2|||
160815058|NCT02931838|580705617|FG002|Overall Study|Withdrawal by Subject|0|||
160815059|NCT02931838|580705618|FG003|Overall Study|Withdrawal by Subject|1|||
160815060|NCT02931838|580705619|FG004|Overall Study|Withdrawal by Subject|0|||
160815061|NCT02931838|580705620|FG005|Overall Study|Withdrawal by Subject|0|||
160552693|NCT05574062|579748506|FG000|Pre Run-In|Screening failure|3|||
160815062|NCT02931838|580705615|FG000|Overall Study|Adverse Event|2|||
160815063|NCT02931838|580705616|FG001|Overall Study|Adverse Event|1|||
160815064|NCT02931838|580705617|FG002|Overall Study|Adverse Event|2|||
160815065|NCT02931838|580705618|FG003|Overall Study|Adverse Event|1|||
160815066|NCT02931838|580705619|FG004|Overall Study|Adverse Event|3|||
160815067|NCT02931838|580705620|FG005|Overall Study|Adverse Event|1|||
160815068|NCT00104728|580705621|FG000|Overall Study|screen failures|19|||
160815069|NCT01963767|580705622|FG000|Overall Study|Withdrawal by Subject|4|||
160815070|NCT01963767|580705623|FG001|Overall Study|Withdrawal by Subject|2|||
160987193|NCT04955626|581341117|FG012|Open-Label Period|Death|0|||
160987194|NCT04955626|581341118|FG013|Open-Label Period|Death|0|||
160987195|NCT04955626|581341119|FG014|Open-Label Period|Death|0|||
160987196|NCT04955626|581341120|FG015|Open-Label Period|Death|0|||
160987197|NCT04955626|581341121|FG016|Open-Label Period|Death|0|||
160987198|NCT04955626|581341122|FG017|Open-Label Period|Death|0|||
160987199|NCT04955626|581341123|FG018|Open-Label Period|Death|0|||
160987200|NCT04955626|581341124|FG019|Open-Label Period|Death|0|||
160815071|NCT01963767|580705622|FG000|Overall Study|Adverse Event|2|||
160815072|NCT01963767|580705623|FG001|Overall Study|Adverse Event|0|||
160815073|NCT01659996|580705624|FG000|Overall Study|Protocol Violation|3|||
160815074|NCT01659996|580705625|FG001|Overall Study|Protocol Violation|3|||
160815075|NCT01659996|580705626|FG002|Overall Study|Protocol Violation|3|||
160815076|NCT01659996|580705624|FG000|Overall Study|Lost to Follow-up|1|||
160815077|NCT01659996|580705625|FG001|Overall Study|Lost to Follow-up|3|||
160815078|NCT01659996|580705626|FG002|Overall Study|Lost to Follow-up|2|||
160815079|NCT01659996|580705624|FG000|Overall Study|Adverse Event|0|||
160815080|NCT01659996|580705625|FG001|Overall Study|Adverse Event|0|||
160815081|NCT01659996|580705626|FG002|Overall Study|Adverse Event|1|||
160815082|NCT01659996|580705624|FG000|Overall Study|Withdrawal by Subject|4|||
160815083|NCT01659996|580705625|FG001|Overall Study|Withdrawal by Subject|1|||
160815084|NCT01659996|580705626|FG002|Overall Study|Withdrawal by Subject|5|||
160815085|NCT03206918|580705627|FG000|Overall Study|Death|11|||
160815086|NCT03206918|580705627|FG000|Overall Study|Withdrawal by Subject|5|||
160815087|NCT03206918|580705627|FG000|Overall Study|Study terminated by sponsor|12|||
160815088|NCT03206918|580705627|FG000|Overall Study|Lost to Follow-up|3|||
160815089|NCT03206918|580705627|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
160815090|NCT02709577|580705628|FG000|Overall Study|non-accommodating anatomy|0|||
160815091|NCT02709577|580705629|FG001|Overall Study|non-accommodating anatomy|1|||
160815092|NCT02709577|580705630|FG002|Overall Study|non-accommodating anatomy|0|||
160815093|NCT02709577|580705631|FG003|Overall Study|non-accommodating anatomy|0|||
160815094|NCT02709577|580705628|FG000|Overall Study|procedural complication|0|||
160815095|NCT02709577|580705629|FG001|Overall Study|procedural complication|1|||
160815096|NCT02709577|580705630|FG002|Overall Study|procedural complication|0|||
160815097|NCT02709577|580705631|FG003|Overall Study|procedural complication|0|||
160815098|NCT02709577|580705628|FG000|Overall Study|Withdrawal by Subject|2|||
160815099|NCT02709577|580705629|FG001|Overall Study|Withdrawal by Subject|3|||
160815100|NCT02709577|580705630|FG002|Overall Study|Withdrawal by Subject|2|||
160815101|NCT02709577|580705631|FG003|Overall Study|Withdrawal by Subject|0|||
160815102|NCT02701764|580705632|FG000|Overall Study|Lost to Follow-up|0|||
160815103|NCT02701764|580705633|FG001|Overall Study|Lost to Follow-up|1|||
160815104|NCT00375674|580705638|FG000|Overall Study|Other|26|||
160815105|NCT00375674|580705639|FG001|Overall Study|Other|18|||
160815106|NCT00375674|580705638|FG000|Overall Study|Death|67|||
160815107|NCT00375674|580705639|FG001|Overall Study|Death|76|||
160815108|NCT00375674|580705638|FG000|Overall Study|Participants refused further follow-up|31|||
160815109|NCT00375674|580705639|FG001|Overall Study|Participants refused further follow-up|30|||
160815110|NCT00375674|580705638|FG000|Overall Study|Lost to Follow-up|17|||
160815111|NCT00375674|580705639|FG001|Overall Study|Lost to Follow-up|15|||
160815112|NCT00375674|580705638|FG000|Overall Study|Enrolled but not treated|3|||
160815113|NCT00375674|580705639|FG001|Overall Study|Enrolled but not treated|2|||
160815114|NCT00912782|580705640|FG000|Overall Study|Death|2|||
160815115|NCT00912782|580705641|FG001|Overall Study|Death|1|||
160815116|NCT00912782|580705640|FG000|Overall Study|Lost to Follow-up|0|||
160815117|NCT00912782|580705641|FG001|Overall Study|Lost to Follow-up|1|||
160815118|NCT00912782|580705640|FG000|Overall Study|Did not receive vascular access type|1|||
160815119|NCT00912782|580705641|FG001|Overall Study|Did not receive vascular access type|2|||
160815120|NCT00912782|580705640|FG000|Overall Study|Relocated before study completion|0|||
160815121|NCT00912782|580705641|FG001|Overall Study|Relocated before study completion|1|||
160815122|NCT05924165|580707286|FG000|Overall Study|Physician Decision|2|||
160815123|NCT05924165|580707287|FG001|Overall Study|Physician Decision|3|||
160815124|NCT01681186|580707288|FG000|Washout Period From Second Intervention|Adverse Event|0|||
160815125|NCT01681186|580707289|FG001|Washout Period From Second Intervention|Adverse Event|0|||
160815126|NCT01681186|580707290|FG002|Washout Period From Second Intervention|Adverse Event|0|||
160815127|NCT01681186|580707291|FG003|Washout Period From Second Intervention|Adverse Event|0|||
160815128|NCT01681186|580707292|FG004|Washout Period From Second Intervention|Adverse Event|0|||
160815129|NCT01681186|580707293|FG005|Washout Period From Second Intervention|Adverse Event|0|||
160815130|NCT01681186|580707294|FG006|Washout Period From Second Intervention|Adverse Event|1|||
160900198|NCT03439657|581028674|FG000|Overall Study|Protocol Violation|1|||
160900199|NCT03439657|581028675|FG001|Overall Study|Protocol Violation|1|||
160900200|NCT03439657|581028674|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
160900201|NCT03439657|581028675|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
160900202|NCT00761631|581028676|FG000|Overall Study|Parent/legal guardian request|8|||
160900203|NCT00761631|581028677|FG001|Overall Study|Parent/legal guardian request|3|||
160900204|NCT00761631|581028678|FG002|Overall Study|Parent/legal guardian request|8|||
160900205|NCT00761631|581028679|FG003|Overall Study|Parent/legal guardian request|0|||
160900206|NCT00761631|581028680|FG004|Overall Study|Parent/legal guardian request|5|||
160900207|NCT00761631|581028681|FG005|Overall Study|Parent/legal guardian request|0|||
160900208|NCT00761631|581028676|FG000|Overall Study|Lost to Follow-up|2|||
160900209|NCT00761631|581028677|FG001|Overall Study|Lost to Follow-up|4|||
160900210|NCT00761631|581028678|FG002|Overall Study|Lost to Follow-up|7|||
160900211|NCT00761631|581028679|FG003|Overall Study|Lost to Follow-up|1|||
160900212|NCT00761631|581028680|FG004|Overall Study|Lost to Follow-up|6|||
160815131|NCT01681186|580707295|FG007|Washout Period From Second Intervention|Adverse Event|0|||
160815132|NCT01681186|580707288|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
160815133|NCT01681186|580707289|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
160815134|NCT01681186|580707290|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
160815135|NCT01681186|580707291|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
160645497|NCT02862535|580084267|FG001|Overall Study|Study Terminated by Sponsor|3|||
160645498|NCT02862535|580084268|FG002|Overall Study|Study Terminated by Sponsor|8|||
160645499|NCT02862535|580084269|FG003|Overall Study|Study Terminated by Sponsor|5|||
160645500|NCT02862535|580084266|FG000|Overall Study|Enrolled, not Treated|1|||
160645501|NCT02862535|580084267|FG001|Overall Study|Enrolled, not Treated|0|||
160645502|NCT02862535|580084268|FG002|Overall Study|Enrolled, not Treated|0|||
160645503|NCT02862535|580084269|FG003|Overall Study|Enrolled, not Treated|1|||
160645504|NCT00566709|580084275|FG000|Overall Study|Protocol Violation|5|||
160645505|NCT00566709|580084276|FG001|Overall Study|Protocol Violation|0|||
160645506|NCT01829295|580084277|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
160645507|NCT01829295|580084278|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
160645508|NCT01829295|580084279|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
160645509|NCT01829295|580084280|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
160645510|NCT01829295|580084277|FG000|6-12 Months|Adverse Event|0|||
160645511|NCT01829295|580084278|FG001|6-12 Months|Adverse Event|0|||
160645512|NCT01829295|580084279|FG002|6-12 Months|Adverse Event|3|||
160645513|NCT01829295|580084280|FG003|6-12 Months|Adverse Event|2|||
160645514|NCT01829295|580084277|FG000|6-12 Months|Lost to Follow-up|2|||
160645515|NCT01829295|580084278|FG001|6-12 Months|Lost to Follow-up|0|||
160645516|NCT01829295|580084279|FG002|6-12 Months|Lost to Follow-up|0|||
160645517|NCT01829295|580084280|FG003|6-12 Months|Lost to Follow-up|0|||
160645518|NCT01829295|580084277|FG000|6-12 Months|Withdrawal by Subject|2|||
160645519|NCT01829295|580084278|FG001|6-12 Months|Withdrawal by Subject|2|||
160645520|NCT01829295|580084279|FG002|6-12 Months|Withdrawal by Subject|0|||
160645521|NCT01829295|580084280|FG003|6-12 Months|Withdrawal by Subject|0|||
160645522|NCT02629965|580084283|FG000|Period 1|Adverse Event|1|||
160645523|NCT02629965|580084284|FG001|Period 1|Adverse Event|0|||
160645524|NCT02629965|580084283|FG000|Period 1|Unexpected worsening of disease|2|||
160645525|NCT02629965|580084284|FG001|Period 1|Unexpected worsening of disease|0|||
160645526|NCT02629965|580084283|FG000|Period 1|Other than listed above|1|||
160645527|NCT02629965|580084284|FG001|Period 1|Other than listed above|2|||
160645528|NCT02629965|580084283|FG000|Period 2|Adverse Event|1|||
160645529|NCT02629965|580084284|FG001|Period 2|Adverse Event|0|||
160645530|NCT03443869|580084285|FG000|Overall Study|Death|3|||
160645531|NCT03443869|580084286|FG001|Overall Study|Death|3|||
160645532|NCT03443869|580084285|FG000|Overall Study|Withdrawal by Subject|34|||
160645533|NCT03443869|580084286|FG001|Overall Study|Withdrawal by Subject|22|||
160645534|NCT03443869|580084285|FG000|Overall Study|Lost to Follow-up|1|||
160645535|NCT03443869|580084286|FG001|Overall Study|Lost to Follow-up|2|||
160645536|NCT03443869|580084285|FG000|Overall Study|Physician Decision|3|||
160645537|NCT03443869|580084286|FG001|Overall Study|Physician Decision|3|||
160645538|NCT03443869|580084285|FG000|Overall Study|Other|4|||
160645539|NCT03443869|580084286|FG001|Overall Study|Other|4|||
160645540|NCT02390219|580084287|FG000|Overall Study|Death|1|||
160645541|NCT02390219|580084287|FG000|Overall Study|Physician Decision|1|||
160645542|NCT02390219|580084287|FG000|Overall Study|Adverse Event|6|||
160645543|NCT02390219|580084287|FG000|Overall Study|Withdrawal by Subject|1|||
160645544|NCT02390219|580084287|FG000|Overall Study|Lost to Follow-up|2|||
160645545|NCT02390219|580084287|FG000|Overall Study|Other|2|||
160645546|NCT00299728|580084288|FG000|Overall Study|Lost to Follow-up|0|||
160645547|NCT00299728|580084289|FG001|Overall Study|Lost to Follow-up|1|||
160645548|NCT00299728|580084288|FG000|Overall Study|Withdrawal by Subject|0|||
160645549|NCT00299728|580084289|FG001|Overall Study|Withdrawal by Subject|1|||
160645550|NCT00299728|580084288|FG000|Overall Study|Progressive disease|0|||
160645551|NCT00299728|580084289|FG001|Overall Study|Progressive disease|1|||
160645552|NCT01855126|580084292|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
160645553|NCT01855126|580084293|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
160645554|NCT01855126|580084292|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
160645555|NCT01855126|580084293|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
160645556|NCT01360632|580084296|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
160645557|NCT01360632|580084297|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
160815136|NCT01681186|580707292|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
160645558|NCT01360632|580084298|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
160645559|NCT01360632|580084299|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
160645560|NCT01360632|580084300|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
160645561|NCT01360632|580084296|FG000|Phase A (8 Weeks)|Adverse Event|60|||
160645562|NCT01360632|580084297|FG001|Phase A (8 Weeks)|Adverse Event|0|||
160645563|NCT01360632|580084298|FG002|Phase A (8 Weeks)|Adverse Event|0|||
160645564|NCT01360632|580084299|FG003|Phase A (8 Weeks)|Adverse Event|0|||
160900213|NCT00761631|581028681|FG005|Overall Study|Lost to Follow-up|1|||
160900214|NCT00761631|581028676|FG000|Overall Study|Protocol Violation|2|||
160900215|NCT00761631|581028677|FG001|Overall Study|Protocol Violation|0|||
160900216|NCT00761631|581028678|FG002|Overall Study|Protocol Violation|0|||
160900217|NCT00761631|581028679|FG003|Overall Study|Protocol Violation|1|||
160900218|NCT00761631|581028680|FG004|Overall Study|Protocol Violation|5|||
160900219|NCT00761631|581028681|FG005|Overall Study|Protocol Violation|1|||
160900220|NCT00761631|581028676|FG000|Overall Study|Randomized, not treated|1|||
160900221|NCT00761631|581028677|FG001|Overall Study|Randomized, not treated|0|||
160900222|NCT00761631|581028678|FG002|Overall Study|Randomized, not treated|0|||
160900223|NCT00761631|581028679|FG003|Overall Study|Randomized, not treated|0|||
160900224|NCT00761631|581028680|FG004|Overall Study|Randomized, not treated|0|||
160900225|NCT00761631|581028681|FG005|Overall Study|Randomized, not treated|0|||
160900226|NCT00761631|581028676|FG000|Overall Study|Failed to return|1|||
160900227|NCT00761631|581028677|FG001|Overall Study|Failed to return|0|||
160900228|NCT00761631|581028678|FG002|Overall Study|Failed to return|1|||
160900229|NCT00761631|581028679|FG003|Overall Study|Failed to return|1|||
160900230|NCT00761631|581028680|FG004|Overall Study|Failed to return|5|||
160900231|NCT00761631|581028681|FG005|Overall Study|Failed to return|2|||
160900232|NCT00761631|581028676|FG000|Overall Study|Physician Decision|1|||
160900233|NCT00761631|581028677|FG001|Overall Study|Physician Decision|0|||
160900234|NCT00761631|581028678|FG002|Overall Study|Physician Decision|0|||
160900235|NCT00761631|581028679|FG003|Overall Study|Physician Decision|0|||
160987201|NCT04955626|581341125|FG020|Open-Label Period|Death|0|||
160987202|NCT04955626|581341126|FG021|Open-Label Period|Death|0|||
160987203|NCT04955626|581341127|FG022|Open-Label Period|Death|0|||
160987204|NCT04955626|581341128|FG023|Open-Label Period|Death|0|||
160987205|NCT04955626|581341129|FG024|Open-Label Period|Death|0|||
160987206|NCT04955626|581341130|FG025|Open-Label Period|Death|0|||
160454063|NCT02038777|579394029|FG007|Overall Study|Randomized but not treated|0|||
160900236|NCT00761631|581028680|FG004|Overall Study|Physician Decision|0|||
160900237|NCT00761631|581028681|FG005|Overall Study|Physician Decision|0|||
160900238|NCT00761631|581028676|FG000|Overall Study|Other|0|||
160900239|NCT00761631|581028677|FG001|Overall Study|Other|0|||
160987207|NCT04955626|581341131|FG026|Open-Label Period|Death|0|||
160987208|NCT04955626|581341132|FG027|Open-Label Period|Death|0|||
160987209|NCT04955626|581341133|FG028|Open-Label Period|Death|0|||
160987210|NCT04955626|581341134|FG029|Open-Label Period|Death|0|||
160987211|NCT04955626|581341135|FG030|Open-Label Period|Death|0|||
160987212|NCT04955626|581341136|FG031|Open-Label Period|Death|0|||
160987213|NCT04955626|581341137|FG032|Open-Label Period|Death|0|||
160987214|NCT04955626|581341138|FG033|Open-Label Period|Death|0|||
160987215|NCT04955626|581341139|FG034|Open-Label Period|Death|0|||
160815137|NCT01681186|580707293|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
160815138|NCT01681186|580707294|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
160815139|NCT01681186|580707295|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
160815140|NCT01681186|580707288|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
160987216|NCT04955626|581341140|FG035|Open-Label Period|Death|0|||
160987217|NCT04955626|581341105|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
160987218|NCT04955626|581341106|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
160987219|NCT04955626|581341107|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
160987220|NCT04955626|581341108|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
160987221|NCT04955626|581341109|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
160987222|NCT04955626|581341110|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
160987223|NCT04955626|581341111|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
160987224|NCT04955626|581341112|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
160987225|NCT04955626|581341113|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
160987226|NCT04955626|581341114|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
160987227|NCT04955626|581341115|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
160987228|NCT04955626|581341116|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
160987229|NCT04955626|581341117|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
160987230|NCT04955626|581341118|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
160987231|NCT04955626|581341119|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
160987232|NCT04955626|581341120|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
160987233|NCT04955626|581341121|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
160987234|NCT04955626|581341122|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
160987235|NCT04955626|581341123|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
160987236|NCT04955626|581341124|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
160987237|NCT04955626|581341125|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
160987238|NCT04955626|581341126|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
160987239|NCT04955626|581341127|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
160987240|NCT04955626|581341128|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
160987241|NCT04955626|581341129|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
160987242|NCT04955626|581341130|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
160987243|NCT04955626|581341131|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
160987244|NCT04955626|581341132|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
160987245|NCT04955626|581341133|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
160987246|NCT04955626|581341134|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
160987247|NCT04955626|581341135|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
160987248|NCT04955626|581341136|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
160987249|NCT04955626|581341137|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
160987250|NCT04955626|581341138|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
160987251|NCT04955626|581341139|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
160987252|NCT04955626|581341140|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
160987253|NCT04955626|581341105|FG000|Open-Label Period|Other|621|||
160552694|NCT05574062|579748507|FG001|Pre Run-In|Screening failure|0|||
160552695|NCT05574062|579748508|FG002|Pre Run-In|Screening failure|0|||
160552696|NCT05574062|579748509|FG003|Pre Run-In|Screening failure|0|||
160552697|NCT05574062|579748510|FG004|Pre Run-In|Screening failure|0|||
160552698|NCT05574062|579748506|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
160552699|NCT05574062|579748507|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
160552700|NCT05574062|579748508|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
160552701|NCT05574062|579748509|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
160552702|NCT05574062|579748510|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
160552703|NCT05574062|579748506|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
160552704|NCT05574062|579748507|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
160552705|NCT05574062|579748508|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
160552706|NCT05574062|579748509|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
160552707|NCT05574062|579748510|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
160552708|NCT05574062|579748506|FG000|Continuation Phase Period 1|Physician Decision|1|||
160552709|NCT05574062|579748507|FG001|Continuation Phase Period 1|Physician Decision|0|||
160552710|NCT05574062|579748508|FG002|Continuation Phase Period 1|Physician Decision|0|||
160987254|NCT04955626|581341106|FG001|Open-Label Period|Other|429|||
160987255|NCT04955626|581341107|FG002|Open-Label Period|Other|0|||
160987256|NCT04955626|581341108|FG003|Open-Label Period|Other|0|||
160987257|NCT04955626|581341109|FG004|Open-Label Period|Other|0|||
160987258|NCT04955626|581341110|FG005|Open-Label Period|Other|0|||
160645565|NCT01360632|580084300|FG004|Phase A (8 Weeks)|Adverse Event|0|||
160645566|NCT01360632|580084296|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
160645567|NCT01360632|580084297|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
160645568|NCT01360632|580084298|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
160645569|NCT01360632|580084299|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
160645570|NCT01360632|580084300|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
160645571|NCT01360632|580084296|FG000|Phase A (8 Weeks)|Physician Decision|10|||
160645572|NCT01360632|580084297|FG001|Phase A (8 Weeks)|Physician Decision|0|||
160645573|NCT01360632|580084298|FG002|Phase A (8 Weeks)|Physician Decision|0|||
160645574|NCT01360632|580084299|FG003|Phase A (8 Weeks)|Physician Decision|0|||
160645575|NCT01360632|580084300|FG004|Phase A (8 Weeks)|Physician Decision|0|||
160645576|NCT01360632|580084296|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
160645577|NCT01360632|580084297|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
160645578|NCT01360632|580084298|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
160645579|NCT01360632|580084299|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
160645580|NCT01360632|580084300|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
160645581|NCT01360632|580084296|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
160645582|NCT01360632|580084297|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
160645583|NCT01360632|580084298|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
160645584|NCT01360632|580084299|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
160645585|NCT01360632|580084300|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
160645586|NCT01360632|580084296|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
160645587|NCT01360632|580084297|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
160645588|NCT01360632|580084298|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
160645589|NCT01360632|580084299|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
160645590|NCT01360632|580084300|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
160645591|NCT01360632|580084296|FG000|Phase B (6 Weeks)|Adverse Event|0|||
160645592|NCT01360632|580084297|FG001|Phase B (6 Weeks)|Adverse Event|3|||
160645593|NCT01360632|580084298|FG002|Phase B (6 Weeks)|Adverse Event|9|||
160645594|NCT01360632|580084299|FG003|Phase B (6 Weeks)|Adverse Event|3|||
160645595|NCT01360632|580084300|FG004|Phase B (6 Weeks)|Adverse Event|0|||
160815141|NCT01681186|580707289|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815142|NCT01681186|580707290|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815143|NCT01681186|580707291|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815144|NCT01681186|580707292|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815145|NCT01681186|580707293|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815146|NCT01681186|580707294|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
160815147|NCT01681186|580707295|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815148|NCT01681186|580707288|FG000|Fourth Intervention|Protocol Violation|0|||
160815149|NCT01681186|580707289|FG001|Fourth Intervention|Protocol Violation|0|||
160815150|NCT01681186|580707290|FG002|Fourth Intervention|Protocol Violation|0|||
160815151|NCT01681186|580707291|FG003|Fourth Intervention|Protocol Violation|0|||
160815152|NCT01681186|580707292|FG004|Fourth Intervention|Protocol Violation|0|||
160815153|NCT01681186|580707293|FG005|Fourth Intervention|Protocol Violation|0|||
160815154|NCT01681186|580707294|FG006|Fourth Intervention|Protocol Violation|0|||
160815155|NCT01681186|580707295|FG007|Fourth Intervention|Protocol Violation|1|||
160815156|NCT00301262|580707302|FG000|Double Blind Phase (DB)|Adverse Event|1|||
160815157|NCT00301262|580707303|FG001|Double Blind Phase (DB)|Adverse Event|0|||
160815158|NCT00301262|580707302|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
160815159|NCT00301262|580707303|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
160815160|NCT00301262|580707302|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
160815161|NCT00301262|580707303|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
160815162|NCT00301262|580707302|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
160815163|NCT00301262|580707303|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
160815164|NCT00301262|580707302|FG000|Double Blind Phase (DB)|Other|1|||
160815165|NCT00301262|580707303|FG001|Double Blind Phase (DB)|Other|4|||
160815166|NCT00301262|580707302|FG000|Open Label Phase (OL)|Adverse Event|1|||
160815167|NCT00301262|580707303|FG001|Open Label Phase (OL)|Adverse Event|0|||
160815168|NCT00301262|580707302|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
160815169|NCT00301262|580707303|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
160645596|NCT01360632|580084296|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
160645597|NCT01360632|580084297|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
160815170|NCT00301262|580707302|FG000|Open Label Phase (OL)|Other|2|||
160815171|NCT00301262|580707303|FG001|Open Label Phase (OL)|Other|0|||
160645598|NCT01360632|580084298|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
160645599|NCT01360632|580084299|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
160645600|NCT01360632|580084300|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
160645601|NCT01360632|580084296|FG000|Phase B (6 Weeks)|Physician Decision|0|||
160645602|NCT01360632|580084297|FG001|Phase B (6 Weeks)|Physician Decision|0|||
160645603|NCT01360632|580084298|FG002|Phase B (6 Weeks)|Physician Decision|0|||
160815172|NCT03530995|580707304|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
160815173|NCT03530995|580707305|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
160900240|NCT00761631|581028678|FG002|Overall Study|Other|0|||
160900241|NCT00761631|581028679|FG003|Overall Study|Other|0|||
160645604|NCT01360632|580084299|FG003|Phase B (6 Weeks)|Physician Decision|1|||
160815174|NCT03530995|580707304|FG000|Part 1 Period 3|Protocol Violation|1|||
160815175|NCT03530995|580707305|FG001|Part 1 Period 3|Protocol Violation|0|||
160815176|NCT03530995|580707304|FG000|Part 1 Period 4|Physician Decision|1|||
160815177|NCT03530995|580707305|FG001|Part 1 Period 4|Physician Decision|0|||
160815178|NCT03530995|580707304|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
160815179|NCT03530995|580707305|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
160815180|NCT01443364|580707313|FG000|Overall Study|Lack of Efficacy|14|||
160815181|NCT01443364|580707313|FG000|Overall Study|Lost to Follow-up|3|||
160815182|NCT01443364|580707313|FG000|Overall Study|Withdrawal by Subject|5|||
160815183|NCT01443364|580707313|FG000|Overall Study|Other Reason|4|||
160815184|NCT01443364|580707313|FG000|Overall Study|SAE, non-fatal|6|||
160815185|NCT01443364|580707313|FG000|Overall Study|AE, non-serious non-fatal|8|||
160815186|NCT01443364|580707313|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160815187|NCT02650804|580707314|FG000|Overall Study|Adverse Event|3|||
160815188|NCT02650804|580707315|FG001|Overall Study|Adverse Event|2|||
160815189|NCT02650804|580707314|FG000|Overall Study|Death|1|||
160815190|NCT02650804|580707315|FG001|Overall Study|Death|2|||
160815191|NCT02650804|580707314|FG000|Overall Study|Progressive Disease|7|||
160815192|NCT02650804|580707315|FG001|Overall Study|Progressive Disease|10|||
160815193|NCT02650804|580707314|FG000|Overall Study|Physician Decision|0|||
160815194|NCT02650804|580707315|FG001|Overall Study|Physician Decision|2|||
160815195|NCT02650804|580707314|FG000|Overall Study|Withdrawal by Subject|1|||
160815196|NCT02650804|580707315|FG001|Overall Study|Withdrawal by Subject|4|||
160815197|NCT02650804|580707314|FG000|Overall Study|Symptomatic deterioration|5|||
160815198|NCT02650804|580707315|FG001|Overall Study|Symptomatic deterioration|7|||
160815199|NCT02650804|580707314|FG000|Overall Study|Protocol Violation|0|||
160815200|NCT02650804|580707315|FG001|Overall Study|Protocol Violation|1|||
160815201|NCT01986231|580707320|FG000|Overall Study|Adverse Event|1|||
160815202|NCT04848220|580707321|FG000|Overall Study|Unable to proceed to study procedure|0|||
160815203|NCT04848220|580707322|FG001|Overall Study|Unable to proceed to study procedure|1|||
160815204|NCT04848220|580707323|FG002|Overall Study|Unable to proceed to study procedure|0|||
160815205|NCT04848220|580707321|FG000|Overall Study|Fractional flow not significant|0|||
160815206|NCT04848220|580707322|FG001|Overall Study|Fractional flow not significant|1|||
160815207|NCT04848220|580707323|FG002|Overall Study|Fractional flow not significant|0|||
160815208|NCT02150057|580707326|FG000|Overall Study|Lost to Follow-up|6|||
160815209|NCT02150057|580707327|FG001|Overall Study|Lost to Follow-up|4|||
160815210|NCT02388165|580707330|FG000|Overall Study|Study terminated by sponsor|5|||
160815211|NCT02388165|580707331|FG001|Overall Study|Study terminated by sponsor|5|||
160815212|NCT02388165|580707330|FG000|Overall Study|Other|11|||
160815213|NCT02388165|580707331|FG001|Overall Study|Other|13|||
160815214|NCT02388165|580707330|FG000|Overall Study|No longer meet eligibility criteria|40|||
160815215|NCT02388165|580707331|FG001|Overall Study|No longer meet eligibility criteria|43|||
160815216|NCT02388165|580707330|FG000|Overall Study|Withdrawal of consent|31|||
160815217|NCT02388165|580707331|FG001|Overall Study|Withdrawal of consent|32|||
160815218|NCT02388165|580707330|FG000|Overall Study|Lost to Follow-up|19|||
160815219|NCT02388165|580707331|FG001|Overall Study|Lost to Follow-up|20|||
160815220|NCT02388165|580707330|FG000|Overall Study|Death|13|||
160815221|NCT02388165|580707331|FG001|Overall Study|Death|10|||
160815222|NCT02388165|580707330|FG000|Overall Study|Adverse Event|3|||
160815223|NCT02388165|580707331|FG001|Overall Study|Adverse Event|5|||
160987259|NCT04955626|581341111|FG006|Open-Label Period|Other|0|||
160987260|NCT04955626|581341112|FG007|Open-Label Period|Other|0|||
160987261|NCT04955626|581341113|FG008|Open-Label Period|Other|0|||
160987262|NCT04955626|581341114|FG009|Open-Label Period|Other|0|||
160987263|NCT04955626|581341115|FG010|Open-Label Period|Other|0|||
160987264|NCT04955626|581341116|FG011|Open-Label Period|Other|0|||
160987265|NCT04955626|581341117|FG012|Open-Label Period|Other|0|||
160987266|NCT04955626|581341118|FG013|Open-Label Period|Other|0|||
160987267|NCT04955626|581341119|FG014|Open-Label Period|Other|0|||
160552711|NCT05574062|579748509|FG003|Continuation Phase Period 1|Physician Decision|0|||
160552712|NCT05574062|579748510|FG004|Continuation Phase Period 1|Physician Decision|0|||
160987268|NCT04955626|581341120|FG015|Open-Label Period|Other|0|||
160987269|NCT04955626|581341121|FG016|Open-Label Period|Other|0|||
160987270|NCT04955626|581341122|FG017|Open-Label Period|Other|0|||
160987271|NCT04955626|581341123|FG018|Open-Label Period|Other|0|||
160987272|NCT04955626|581341124|FG019|Open-Label Period|Other|0|||
160987273|NCT04955626|581341125|FG020|Open-Label Period|Other|0|||
160987274|NCT04955626|581341126|FG021|Open-Label Period|Other|0|||
160987275|NCT04955626|581341127|FG022|Open-Label Period|Other|0|||
160987276|NCT04955626|581341128|FG023|Open-Label Period|Other|0|||
160987277|NCT04955626|581341129|FG024|Open-Label Period|Other|0|||
160987278|NCT04955626|581341130|FG025|Open-Label Period|Other|0|||
160552713|NCT05574062|579748506|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
160552714|NCT05574062|579748507|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
160815224|NCT02388165|580707330|FG000|Overall Study|Did not meet entrance criteria|5|||
160815225|NCT02388165|580707331|FG001|Overall Study|Did not meet entrance criteria|2|||
160815226|NCT01406938|580707332|FG000|Induction Period|Subject/guardian decision|6|||
160815227|NCT01406938|580707333|FG001|Induction Period|Subject/guardian decision|8|||
160987279|NCT04955626|581341131|FG026|Open-Label Period|Other|0|||
160552715|NCT05574062|579748508|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
160552716|NCT05574062|579748509|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
160552717|NCT05574062|579748510|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
160552718|NCT05574062|579748506|FG000|Continuation Phase Period 1|Adverse Event|1|||
160552719|NCT05574062|579748507|FG001|Continuation Phase Period 1|Adverse Event|0|||
160552720|NCT05574062|579748508|FG002|Continuation Phase Period 1|Adverse Event|0|||
160552721|NCT05574062|579748509|FG003|Continuation Phase Period 1|Adverse Event|0|||
160552722|NCT05574062|579748510|FG004|Continuation Phase Period 1|Adverse Event|0|||
160552723|NCT05574062|579748506|FG000|Continuation Phase Period 1|Death|1|||
160552724|NCT05574062|579748507|FG001|Continuation Phase Period 1|Death|0|||
160552725|NCT05574062|579748508|FG002|Continuation Phase Period 1|Death|0|||
160815228|NCT01406938|580707334|FG002|Induction Period|Subject/guardian decision|0|||
160815229|NCT01406938|580707335|FG003|Induction Period|Subject/guardian decision|0|||
160815230|NCT01406938|580707336|FG004|Induction Period|Subject/guardian decision|0|||
160815231|NCT01406938|580707337|FG005|Induction Period|Subject/guardian decision|0|||
160815232|NCT01406938|580707332|FG000|Induction Period|Protocol deviation|1|||
160815233|NCT01406938|580707333|FG001|Induction Period|Protocol deviation|0|||
160815234|NCT01406938|580707334|FG002|Induction Period|Protocol deviation|0|||
160815235|NCT01406938|580707335|FG003|Induction Period|Protocol deviation|0|||
160815236|NCT01406938|580707336|FG004|Induction Period|Protocol deviation|0|||
160815237|NCT01406938|580707337|FG005|Induction Period|Protocol deviation|0|||
160815238|NCT01406938|580707332|FG000|Induction Period|Adverse Event|8|||
160815239|NCT01406938|580707333|FG001|Induction Period|Adverse Event|9|||
160815240|NCT01406938|580707334|FG002|Induction Period|Adverse Event|0|||
160552726|NCT05574062|579748509|FG003|Continuation Phase Period 1|Death|0|||
160815241|NCT01406938|580707335|FG003|Induction Period|Adverse Event|0|||
160815242|NCT01406938|580707336|FG004|Induction Period|Adverse Event|0|||
160815243|NCT01406938|580707337|FG005|Induction Period|Adverse Event|0|||
160815244|NCT01406938|580707332|FG000|Induction Period|Lack of Efficacy|1|||
160815245|NCT01406938|580707333|FG001|Induction Period|Lack of Efficacy|0|||
160815246|NCT01406938|580707334|FG002|Induction Period|Lack of Efficacy|0|||
160815247|NCT01406938|580707335|FG003|Induction Period|Lack of Efficacy|0|||
160815248|NCT01406938|580707336|FG004|Induction Period|Lack of Efficacy|0|||
160815249|NCT01406938|580707337|FG005|Induction Period|Lack of Efficacy|0|||
160815250|NCT01406938|580707332|FG000|Induction Period|Lost to Follow-up|2|||
160815251|NCT01406938|580707333|FG001|Induction Period|Lost to Follow-up|3|||
160815252|NCT01406938|580707334|FG002|Induction Period|Lost to Follow-up|0|||
160815253|NCT01406938|580707335|FG003|Induction Period|Lost to Follow-up|0|||
160815254|NCT01406938|580707336|FG004|Induction Period|Lost to Follow-up|0|||
160815255|NCT01406938|580707337|FG005|Induction Period|Lost to Follow-up|0|||
160815256|NCT01406938|580707332|FG000|Maintenance Period|Adverse Event|0|||
160815257|NCT01406938|580707333|FG001|Maintenance Period|Adverse Event|0|||
160815258|NCT01406938|580707334|FG002|Maintenance Period|Adverse Event|2|||
160815259|NCT01406938|580707335|FG003|Maintenance Period|Adverse Event|8|||
160815260|NCT01406938|580707336|FG004|Maintenance Period|Adverse Event|4|||
160815261|NCT01406938|580707337|FG005|Maintenance Period|Adverse Event|2|||
160815262|NCT01406938|580707332|FG000|Maintenance Period|Death|0|||
160815263|NCT01406938|580707333|FG001|Maintenance Period|Death|0|||
160815264|NCT01406938|580707334|FG002|Maintenance Period|Death|0|||
160815265|NCT01406938|580707335|FG003|Maintenance Period|Death|0|||
160815266|NCT01406938|580707336|FG004|Maintenance Period|Death|1|||
160815267|NCT01406938|580707337|FG005|Maintenance Period|Death|0|||
160815268|NCT01406938|580707332|FG000|Maintenance Period|Subject/guardian decision|0|||
160815269|NCT01406938|580707333|FG001|Maintenance Period|Subject/guardian decision|0|||
160815270|NCT01406938|580707334|FG002|Maintenance Period|Subject/guardian decision|11|||
160815271|NCT01406938|580707335|FG003|Maintenance Period|Subject/guardian decision|7|||
160815272|NCT01406938|580707336|FG004|Maintenance Period|Subject/guardian decision|10|||
160815273|NCT01406938|580707337|FG005|Maintenance Period|Subject/guardian decision|7|||
160815274|NCT01406938|580707332|FG000|Maintenance Period|Protocol Violation|0|||
160900242|NCT00761631|581028680|FG004|Overall Study|Other|1|||
160900243|NCT00761631|581028681|FG005|Overall Study|Other|1|||
160900244|NCT00319501|581028686|FG000|Double-blind Period|Withdrawal by Subject|0|||
160552727|NCT05574062|579748510|FG004|Continuation Phase Period 1|Death|0|||
160552728|NCT05574062|579748506|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
160552729|NCT05574062|579748507|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
160552730|NCT05574062|579748508|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
160645605|NCT01360632|580084300|FG004|Phase B (6 Weeks)|Physician Decision|0|||
160815275|NCT01406938|580707333|FG001|Maintenance Period|Protocol Violation|0|||
160815276|NCT01406938|580707334|FG002|Maintenance Period|Protocol Violation|2|||
160815277|NCT01406938|580707335|FG003|Maintenance Period|Protocol Violation|2|||
160900245|NCT00319501|581028687|FG001|Double-blind Period|Withdrawal by Subject|3|||
160815278|NCT01406938|580707336|FG004|Maintenance Period|Protocol Violation|2|||
160815279|NCT01406938|580707337|FG005|Maintenance Period|Protocol Violation|2|||
160815280|NCT01406938|580707332|FG000|Maintenance Period|Pregnancy|0|||
160815281|NCT01406938|580707333|FG001|Maintenance Period|Pregnancy|0|||
160815282|NCT01406938|580707334|FG002|Maintenance Period|Pregnancy|0|||
160815283|NCT01406938|580707335|FG003|Maintenance Period|Pregnancy|0|||
160815284|NCT01406938|580707336|FG004|Maintenance Period|Pregnancy|1|||
160815285|NCT01406938|580707337|FG005|Maintenance Period|Pregnancy|0|||
160815286|NCT01406938|580707332|FG000|Maintenance Period|Lost to Follow-up|0|||
160815287|NCT01406938|580707333|FG001|Maintenance Period|Lost to Follow-up|0|||
160815288|NCT01406938|580707334|FG002|Maintenance Period|Lost to Follow-up|0|||
160815289|NCT01406938|580707335|FG003|Maintenance Period|Lost to Follow-up|0|||
160815290|NCT01406938|580707336|FG004|Maintenance Period|Lost to Follow-up|4|||
160815291|NCT01406938|580707337|FG005|Maintenance Period|Lost to Follow-up|0|||
160815292|NCT01406938|580707332|FG000|Maintenance Period|Lack of Efficacy|0|||
160815293|NCT01406938|580707333|FG001|Maintenance Period|Lack of Efficacy|0|||
160815294|NCT01406938|580707334|FG002|Maintenance Period|Lack of Efficacy|2|||
160815295|NCT01406938|580707335|FG003|Maintenance Period|Lack of Efficacy|1|||
160815296|NCT01406938|580707336|FG004|Maintenance Period|Lack of Efficacy|3|||
160815297|NCT01406938|580707337|FG005|Maintenance Period|Lack of Efficacy|5|||
160815298|NCT01406938|580707332|FG000|Follow up|Lack of Efficacy|3|||
160815299|NCT01406938|580707333|FG001|Follow up|Lack of Efficacy|2|||
160815300|NCT01406938|580707334|FG002|Follow up|Lack of Efficacy|1|||
160815301|NCT01406938|580707335|FG003|Follow up|Lack of Efficacy|0|||
160815302|NCT01406938|580707336|FG004|Follow up|Lack of Efficacy|0|||
160815303|NCT01406938|580707337|FG005|Follow up|Lack of Efficacy|0|||
160815304|NCT01406938|580707332|FG000|Follow up|Patient/guardian decision|4|||
160815305|NCT01406938|580707333|FG001|Follow up|Patient/guardian decision|2|||
160815306|NCT01406938|580707334|FG002|Follow up|Patient/guardian decision|4|||
160815307|NCT01406938|580707335|FG003|Follow up|Patient/guardian decision|2|||
160815308|NCT01406938|580707336|FG004|Follow up|Patient/guardian decision|4|||
160815309|NCT01406938|580707337|FG005|Follow up|Patient/guardian decision|1|||
160815310|NCT01406938|580707332|FG000|Follow up|Protocol Violation|0|||
160815311|NCT01406938|580707333|FG001|Follow up|Protocol Violation|0|||
160815312|NCT01406938|580707334|FG002|Follow up|Protocol Violation|1|||
160815313|NCT01406938|580707335|FG003|Follow up|Protocol Violation|0|||
160815314|NCT01406938|580707336|FG004|Follow up|Protocol Violation|0|||
160815315|NCT01406938|580707337|FG005|Follow up|Protocol Violation|0|||
160815316|NCT01406938|580707332|FG000|Follow up|Physician Decision|0|||
160815317|NCT01406938|580707333|FG001|Follow up|Physician Decision|0|||
160815318|NCT01406938|580707334|FG002|Follow up|Physician Decision|2|||
160815319|NCT01406938|580707335|FG003|Follow up|Physician Decision|0|||
160815320|NCT01406938|580707336|FG004|Follow up|Physician Decision|3|||
160815321|NCT01406938|580707337|FG005|Follow up|Physician Decision|1|||
160815322|NCT01406938|580707332|FG000|Follow up|Lost to Follow-up|1|||
160815323|NCT01406938|580707333|FG001|Follow up|Lost to Follow-up|1|||
160815324|NCT01406938|580707334|FG002|Follow up|Lost to Follow-up|0|||
160815325|NCT01406938|580707335|FG003|Follow up|Lost to Follow-up|1|||
160815326|NCT01406938|580707336|FG004|Follow up|Lost to Follow-up|2|||
160815327|NCT01406938|580707337|FG005|Follow up|Lost to Follow-up|1|||
160815328|NCT00962741|580707342|FG000|Overall Study|Failed to return|3|||
160900246|NCT00319501|581028686|FG000|Double-blind Period|Sponsor Request|1|||
160900247|NCT00319501|581028687|FG001|Double-blind Period|Sponsor Request|0|||
160552731|NCT05574062|579748509|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
160552732|NCT05574062|579748510|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
160552733|NCT04949841|579748513|FG000|Overall Study|Adverse Event|7|||
160552734|NCT04949841|579748513|FG000|Overall Study|Death|1|||
160552735|NCT04949841|579748513|FG000|Overall Study|Withdrawal by Subject|52|||
160552736|NCT04949841|579748513|FG000|Overall Study|Pregnancy|4|||
160552737|NCT04949841|579748513|FG000|Overall Study|Lost to Follow-up|9|||
160552738|NCT04949841|579748513|FG000|Overall Study|Lack of Efficacy|55|||
160815329|NCT00962741|580707342|FG000|Overall Study|Lost to Follow-up|2|||
160815330|NCT00962741|580707342|FG000|Overall Study|Withdrawal by Subject|1|||
160815331|NCT00962741|580707342|FG000|Overall Study|Lack of Efficacy|1|||
160815332|NCT00962741|580707342|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
160815333|NCT02141399|580707346|FG000|Overall Study|Adverse Event|158|||
160815334|NCT02141399|580707346|FG000|Overall Study|Lack of Efficacy|62|||
160815335|NCT02141399|580707346|FG000|Overall Study|Lost to Follow-up|151|||
160815336|NCT02141399|580707346|FG000|Overall Study|Non-compliance with study drug|18|||
160815337|NCT02141399|580707346|FG000|Overall Study|Other|45|||
160815338|NCT02141399|580707346|FG000|Overall Study|Physician Decision|17|||
160815339|NCT02141399|580707346|FG000|Overall Study|Pregnancy|3|||
160815340|NCT02141399|580707346|FG000|Overall Study|Protocol Violation|38|||
160815341|NCT02141399|580707346|FG000|Overall Study|Withdrawal by Subject|238|||
160815342|NCT02141399|580707346|FG000|Overall Study|Failure to meet eligibility criteria|14|||
160815343|NCT00606034|580707353|FG000|Overall Study|incarceration|1|||
160815344|NCT02516098|580707357|FG000|Period 1|Protocol Violation|1|||
160815345|NCT02516098|580707358|FG001|Period 1|Protocol Violation|0|||
160900248|NCT00319501|581028686|FG000|Double-blind Period|Did not receive treatment|42|||
160900249|NCT00319501|581028687|FG001|Double-blind Period|Did not receive treatment|29|||
160900250|NCT00319501|581028686|FG000|Open-label Period|Adverse Event|5|||
160900251|NCT00319501|581028687|FG001|Open-label Period|Adverse Event|0|||
160900252|NCT00319501|581028686|FG000|Open-label Period|Protocol Violation|6|||
160900253|NCT00319501|581028687|FG001|Open-label Period|Protocol Violation|0|||
160900254|NCT00319501|581028686|FG000|Open-label Period|Withdrawal by Subject|38|||
160900255|NCT00319501|581028687|FG001|Open-label Period|Withdrawal by Subject|0|||
160900256|NCT00319501|581028686|FG000|Open-label Period|Principal Investigator decision|6|||
160900257|NCT00319501|581028687|FG001|Open-label Period|Principal Investigator decision|0|||
160645606|NCT01360632|580084296|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
160645607|NCT01360632|580084297|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
160645608|NCT01360632|580084298|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
160645609|NCT01360632|580084299|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
160645610|NCT01360632|580084300|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
160645611|NCT01360632|580084296|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
160645612|NCT01360632|580084297|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
160645613|NCT01360632|580084298|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
160645614|NCT01360632|580084299|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
160645615|NCT01360632|580084300|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
160645616|NCT01360632|580084296|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
160645617|NCT01360632|580084297|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
160645618|NCT01360632|580084298|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
160645619|NCT01360632|580084299|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
160645620|NCT01360632|580084300|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
160645621|NCT01360632|580084296|FG000|Phase A+|Lost to Follow-up|0|||
160645622|NCT01360632|580084297|FG001|Phase A+|Lost to Follow-up|0|||
160645623|NCT01360632|580084298|FG002|Phase A+|Lost to Follow-up|0|||
160645624|NCT01360632|580084299|FG003|Phase A+|Lost to Follow-up|0|||
160645625|NCT01360632|580084300|FG004|Phase A+|Lost to Follow-up|2|||
160645626|NCT01360632|580084296|FG000|Phase A+|Adverse Event|0|||
160645627|NCT01360632|580084297|FG001|Phase A+|Adverse Event|0|||
160645628|NCT01360632|580084298|FG002|Phase A+|Adverse Event|0|||
160645629|NCT01360632|580084299|FG003|Phase A+|Adverse Event|0|||
160900258|NCT00319501|581028686|FG000|Open-label Period|Sponsor request|12|||
160645630|NCT01360632|580084300|FG004|Phase A+|Adverse Event|2|||
160900259|NCT00319501|581028687|FG001|Open-label Period|Sponsor request|0|||
160900260|NCT00319501|581028686|FG000|Open-label Period|Lost to Follow-up|5|||
160645631|NCT01360632|580084296|FG000|Phase A+|Met Withdrawal Criteria|0|||
160645632|NCT01360632|580084297|FG001|Phase A+|Met Withdrawal Criteria|0|||
160900261|NCT00319501|581028687|FG001|Open-label Period|Lost to Follow-up|0|||
160900262|NCT00319501|581028686|FG000|Open-label Period|Did not receive treatment|33|||
160900263|NCT00319501|581028687|FG001|Open-label Period|Did not receive treatment|0|||
160900264|NCT00319501|581028686|FG000|Open-label Period|Other|11|||
160900265|NCT00319501|581028687|FG001|Open-label Period|Other|0|||
160900266|NCT00319501|581028686|FG000|Open-label Extension Period|Adverse Event|2|||
160900267|NCT00319501|581028687|FG001|Open-label Extension Period|Adverse Event|0|||
160900268|NCT00319501|581028686|FG000|Open-label Extension Period|Did not receive treatment|18|||
160900269|NCT00319501|581028687|FG001|Open-label Extension Period|Did not receive treatment|0|||
160900270|NCT00319501|581028686|FG000|Open-label Extension Period|Other|1|||
160900271|NCT00319501|581028687|FG001|Open-label Extension Period|Other|0|||
160900272|NCT00319501|581028686|FG000|Open-label Extension Period|Principal investigator decision|2|||
160900273|NCT00319501|581028687|FG001|Open-label Extension Period|Principal investigator decision|0|||
160900274|NCT00319501|581028686|FG000|Open-label Extension Period|Sponsor request|26|||
160900275|NCT00319501|581028687|FG001|Open-label Extension Period|Sponsor request|0|||
160900276|NCT00319501|581028686|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
160900277|NCT00319501|581028687|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
160900278|NCT00667875|581028688|FG000|Overall Study|Adverse Event|0|||
160900279|NCT00667875|581028689|FG001|Overall Study|Adverse Event|2|||
160900280|NCT00667875|581028690|FG002|Overall Study|Adverse Event|6|||
160900281|NCT00667875|581028688|FG000|Overall Study|Withdrawal by Subject|10|||
160900282|NCT00667875|581028689|FG001|Overall Study|Withdrawal by Subject|9|||
160900283|NCT00667875|581028690|FG002|Overall Study|Withdrawal by Subject|7|||
160900284|NCT00450255|581028691|FG000|Overall Study|Prior RFA ablation of liver|1|||
160900285|NCT02764697|581028692|FG000|Overall Study|Lack of Efficacy|3|||
160900286|NCT02612129|581028695|FG000|Single Dose Treatment Period|Screening Failure|1|||
160900287|NCT02612129|581028696|FG001|Single Dose Treatment Period|Screening Failure|0|||
160900288|NCT02612129|581028697|FG002|Single Dose Treatment Period|Screening Failure|0|||
160900289|NCT02612129|581028695|FG000|Continuous Treatment Period|Early Escape|0|||
160900290|NCT02612129|581028696|FG001|Continuous Treatment Period|Early Escape|2|||
160900291|NCT02612129|581028697|FG002|Continuous Treatment Period|Early Escape|0|||
160900292|NCT02612129|581028695|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
160900293|NCT02612129|581028696|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
160900294|NCT02612129|581028697|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
160900295|NCT02612129|581028695|FG000|Continuous Treatment Period|Safety Reasons|0|||
160900296|NCT02612129|581028696|FG001|Continuous Treatment Period|Safety Reasons|3|||
160900297|NCT02612129|581028697|FG002|Continuous Treatment Period|Safety Reasons|0|||
160900298|NCT02612129|581028695|FG000|Continuous Treatment Period|Death|0|||
160815346|NCT02516098|580707357|FG000|Washout After Period 1|Adverse Event|0|||
160815347|NCT02516098|580707358|FG001|Washout After Period 1|Adverse Event|1|||
160815348|NCT02516098|580707357|FG000|Period 2|Withdrawal by Subject|0|||
160815349|NCT02516098|580707358|FG001|Period 2|Withdrawal by Subject|1|||
160815350|NCT01734395|580707359|FG000|Overall Study|Other|65|||
160815351|NCT01734395|580707359|FG000|Overall Study|Lost to Follow-up|287|||
160815352|NCT01734395|580707359|FG000|Overall Study|Lack of Efficacy|5|||
160815353|NCT01734395|580707359|FG000|Overall Study|Adverse Event|40|||
160815354|NCT01734395|580707359|FG000|Overall Study|Withdrawal by Subject|10|||
160815355|NCT01734395|580707359|FG000|Overall Study|Missing the reasons for not completed|3|||
160815356|NCT01092780|580707360|FG000|Washout Period 1|Adverse Event|0|||
160815357|NCT01092780|580707361|FG001|Washout Period 1|Adverse Event|1|||
160815358|NCT01092780|580707362|FG002|Washout Period 1|Adverse Event|0|||
160815359|NCT01092780|580707363|FG003|Washout Period 1|Adverse Event|0|||
160815360|NCT01092780|580707360|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
160815361|NCT01092780|580707361|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
160815362|NCT01092780|580707362|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
160815363|NCT01092780|580707363|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
160815364|NCT01092780|580707360|FG000|Washout Period 2|Adverse Event|0|||
160815365|NCT01092780|580707361|FG001|Washout Period 2|Adverse Event|1|||
160815366|NCT01092780|580707362|FG002|Washout Period 2|Adverse Event|1|||
160815367|NCT01092780|580707363|FG003|Washout Period 2|Adverse Event|0|||
160815368|NCT01257230|580707364|FG000|Overall Study|Not Treated|0|||
160815369|NCT01257230|580707365|FG001|Overall Study|Not Treated|0|||
160815370|NCT01257230|580707366|FG002|Overall Study|Not Treated|1|||
160815371|NCT01257230|580707364|FG000|Overall Study|Adverse Event|2|||
160815372|NCT01257230|580707365|FG001|Overall Study|Adverse Event|0|||
160815373|NCT01257230|580707366|FG002|Overall Study|Adverse Event|0|||
160815374|NCT01257230|580707364|FG000|Overall Study|Lack of Efficacy|0|||
160815375|NCT01257230|580707365|FG001|Overall Study|Lack of Efficacy|1|||
160815376|NCT01257230|580707366|FG002|Overall Study|Lack of Efficacy|0|||
160815377|NCT01257230|580707364|FG000|Overall Study|Protocol Violation|3|||
160815378|NCT01257230|580707365|FG001|Overall Study|Protocol Violation|0|||
160815379|NCT01257230|580707366|FG002|Overall Study|Protocol Violation|1|||
160987280|NCT04955626|581341132|FG027|Open-Label Period|Other|0|||
160987281|NCT04955626|581341133|FG028|Open-Label Period|Other|0|||
160987282|NCT04955626|581341134|FG029|Open-Label Period|Other|0|||
160987283|NCT04955626|581341135|FG030|Open-Label Period|Other|0|||
160552739|NCT04949841|579748513|FG000|Overall Study|Various reasons|9|||
160815380|NCT01257230|580707364|FG000|Overall Study|Withdrawal by Subject|0|||
160815381|NCT01257230|580707365|FG001|Overall Study|Withdrawal by Subject|4|||
160815382|NCT01257230|580707366|FG002|Overall Study|Withdrawal by Subject|1|||
160815383|NCT01257230|580707364|FG000|Overall Study|Other reason not defined above|1|||
160815384|NCT01257230|580707365|FG001|Overall Study|Other reason not defined above|5|||
160815385|NCT01257230|580707366|FG002|Overall Study|Other reason not defined above|3|||
160815386|NCT00765037|580707372|FG000|Overall Study|Lost to Follow-up|5|||
160815387|NCT00765037|580707372|FG000|Overall Study|Adverse Event|1|||
160815388|NCT00615719|580707373|FG000|Overall Study|Physician Decision|5|||
160815389|NCT02300558|580707374|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
160815390|NCT02300558|580707374|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
160815391|NCT02300558|580707374|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
160815392|NCT02300558|580707374|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
160815393|NCT01471028|580707375|FG000|VTI-208|Adverse Event|39|||
160815394|NCT01471028|580707376|FG001|VTI-208|Adverse Event|41|||
160900299|NCT02612129|581028696|FG001|Continuous Treatment Period|Death|1|||
160900300|NCT02612129|581028697|FG002|Continuous Treatment Period|Death|0|||
160900301|NCT02612129|581028695|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
160900302|NCT02612129|581028696|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
160900303|NCT02612129|581028697|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
160900304|NCT02557295|581028698|FG000|Overall Study|Withdrawal by Subject|9|||
160900305|NCT02557295|581028699|FG001|Overall Study|Withdrawal by Subject|2|||
160900306|NCT02557295|581028700|FG002|Overall Study|Withdrawal by Subject|4|||
160900307|NCT02557295|581028701|FG003|Overall Study|Withdrawal by Subject|0|||
160900308|NCT02557295|581028702|FG004|Overall Study|Withdrawal by Subject|0|||
160900309|NCT02557295|581028703|FG005|Overall Study|Withdrawal by Subject|0|||
160987284|NCT04955626|581341136|FG031|Open-Label Period|Other|0|||
160815395|NCT01471028|580707375|FG000|VTI-208|Withdrawal by Subject|0|||
160815396|NCT01471028|580707376|FG001|VTI-208|Withdrawal by Subject|2|||
160815397|NCT01471028|580707375|FG000|VTI-208|Lost to Follow-up|1|||
160815398|NCT01471028|580707376|FG001|VTI-208|Lost to Follow-up|1|||
160815399|NCT01471028|580707375|FG000|VTI-208E|Death|7|||
160815400|NCT01471028|580707376|FG001|VTI-208E|Death|10|||
160815401|NCT01471028|580707375|FG000|VTI-208E|Withdrawal by Subject|1|||
160815402|NCT01471028|580707376|FG001|VTI-208E|Withdrawal by Subject|0|||
160815403|NCT01471028|580707375|FG000|VTI-208E|Lost to Follow-up|0|||
160815404|NCT01471028|580707376|FG001|VTI-208E|Lost to Follow-up|2|||
160815405|NCT00935493|580707379|FG000|Overall Study|Lost to Follow-up|1|||
160900310|NCT02557295|581028704|FG006|Overall Study|Withdrawal by Subject|15|||
160900311|NCT02557295|581028705|FG007|Overall Study|Withdrawal by Subject|1|||
160645633|NCT01360632|580084298|FG002|Phase A+|Met Withdrawal Criteria|0|||
160645634|NCT01360632|580084299|FG003|Phase A+|Met Withdrawal Criteria|0|||
160645635|NCT01360632|580084300|FG004|Phase A+|Met Withdrawal Criteria|7|||
160645636|NCT01360632|580084296|FG000|Phase A+|Physician Decision|0|||
160645637|NCT01360632|580084297|FG001|Phase A+|Physician Decision|0|||
160645638|NCT01360632|580084298|FG002|Phase A+|Physician Decision|0|||
160645639|NCT01360632|580084299|FG003|Phase A+|Physician Decision|0|||
160645640|NCT01360632|580084300|FG004|Phase A+|Physician Decision|3|||
160645641|NCT01360632|580084296|FG000|Phase A+|Withdrawal by Subject|0|||
160645642|NCT01360632|580084297|FG001|Phase A+|Withdrawal by Subject|0|||
160645643|NCT01360632|580084298|FG002|Phase A+|Withdrawal by Subject|0|||
160645644|NCT01360632|580084299|FG003|Phase A+|Withdrawal by Subject|0|||
160645645|NCT01360632|580084300|FG004|Phase A+|Withdrawal by Subject|8|||
160645646|NCT01360632|580084296|FG000|Phase A+|Protocol Deviation|0|||
160645647|NCT01360632|580084297|FG001|Phase A+|Protocol Deviation|0|||
160645648|NCT01360632|580084298|FG002|Phase A+|Protocol Deviation|0|||
160645649|NCT01360632|580084299|FG003|Phase A+|Protocol Deviation|0|||
160645650|NCT01360632|580084300|FG004|Phase A+|Protocol Deviation|3|||
160645651|NCT01298596|580084301|FG000|Overall Study|Withdrawal by Subject|1|||
160645652|NCT01298596|580084302|FG001|Overall Study|Withdrawal by Subject|1|||
160645653|NCT01298596|580084301|FG000|Overall Study|Death|5|||
160645654|NCT01298596|580084302|FG001|Overall Study|Death|3|||
160645655|NCT01298596|580084301|FG000|Overall Study|Lost to Follow-up|6|||
160645656|NCT01298596|580084302|FG001|Overall Study|Lost to Follow-up|14|||
160645657|NCT01298596|580084301|FG000|Overall Study|Referred for further management|16|||
160645658|NCT01298596|580084302|FG001|Overall Study|Referred for further management|15|||
160645659|NCT03387059|580084308|FG000|Overall Study|Study termination|5|||
160645660|NCT03387059|580084309|FG001|Overall Study|Study termination|4|||
160645661|NCT01606137|580084310|FG000|Overall Study|Adverse Event|85|||
160645662|NCT01606137|580084310|FG000|Overall Study|Withdrawal by Subject|74|||
160645663|NCT01606137|580084310|FG000|Overall Study|Lack of Efficacy|56|||
160645664|NCT01606137|580084310|FG000|Overall Study|Lost to Follow-up|15|||
160645665|NCT01606137|580084310|FG000|Overall Study|Protocol Violation|1|||
160645666|NCT01606137|580084310|FG000|Overall Study|Patient non-compliance|9|||
160645667|NCT01606137|580084310|FG000|Overall Study|Death|1|||
160645668|NCT01606137|580084310|FG000|Overall Study|Decreased/no pain|4|||
160645669|NCT01606137|580084310|FG000|Overall Study|Issues with driving|4|||
160645670|NCT01606137|580084310|FG000|Overall Study|multiple sclerosis less stable|1|||
160645671|NCT01606137|580084310|FG000|Overall Study|Increased bilirubin|1|||
160645672|NCT01606137|580084310|FG000|Overall Study|Spray causes nausea|1|||
160645673|NCT01606137|580084310|FG000|Overall Study|Not enough improvement|4|||
160645674|NCT01606137|580084310|FG000|Overall Study|Wanted to try another treatment|1|||
160645675|NCT01606137|580084310|FG000|Overall Study|Patient leaving country|1|||
160645676|NCT01606137|580084310|FG000|Overall Study|Personal reasons|1|||
160645677|NCT01606137|580084310|FG000|Overall Study|Unable to tolerate study med. taste|1|||
160645678|NCT01606137|580084310|FG000|Overall Study|Patient moving|1|||
160645679|NCT01606137|580084310|FG000|Overall Study|Unable to collect consistent data|1|||
160645680|NCT04578548|580084312|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
160645681|NCT04578548|580084313|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
160645682|NCT04578548|580084312|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
160645683|NCT04578548|580084313|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
160645684|NCT04578548|580084312|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
160645685|NCT04578548|580084313|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
160645686|NCT04578548|580084312|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
160645687|NCT04578548|580084313|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
160645688|NCT04578548|580084312|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
160645689|NCT04578548|580084313|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
160645690|NCT04578548|580084312|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
160645691|NCT04578548|580084313|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
160645692|NCT00982410|580085843|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
160645693|NCT00982410|580085844|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
160645694|NCT00982410|580085843|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
160645695|NCT00982410|580085844|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
160645696|NCT00982410|580085843|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
160645697|NCT00982410|580085844|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
160645698|NCT00982410|580085843|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
160645699|NCT00982410|580085844|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
160645700|NCT00982410|580085843|FG000|6-month Follow-up Assessment|participant no transportation|1|||
160645701|NCT00982410|580085844|FG001|6-month Follow-up Assessment|participant no transportation|0|||
160645702|NCT00982410|580085843|FG000|6-month Follow-up Assessment|incarceration|0|||
160900312|NCT02557295|581028706|FG008|Overall Study|Withdrawal by Subject|3|||
160815406|NCT00935493|580707380|FG001|Overall Study|Lost to Follow-up|1|||
160815407|NCT00935493|580707381|FG002|Overall Study|Lost to Follow-up|1|||
160815408|NCT00935493|580707379|FG000|Overall Study|Treatment Discontinued|0|||
160815409|NCT00935493|580707380|FG001|Overall Study|Treatment Discontinued|1|||
160815410|NCT00935493|580707381|FG002|Overall Study|Treatment Discontinued|0|||
160815411|NCT03823287|580707382|FG000|Overall Study|Withdrawal by Subject|25|||
160815412|NCT03823287|580707383|FG001|Overall Study|Withdrawal by Subject|17|||
160815413|NCT03823287|580707382|FG000|Overall Study|Death|13|||
160815414|NCT03823287|580707383|FG001|Overall Study|Death|7|||
160815415|NCT03823287|580707382|FG000|Overall Study|Lost to Follow-up|7|||
160815416|NCT03823287|580707383|FG001|Overall Study|Lost to Follow-up|8|||
160815417|NCT03823287|580707382|FG000|Overall Study|Adverse Event|6|||
160815418|NCT03823287|580707383|FG001|Overall Study|Adverse Event|8|||
160815419|NCT03823287|580707382|FG000|Overall Study|Physician Decision|5|||
160815420|NCT03823287|580707383|FG001|Overall Study|Physician Decision|2|||
160815421|NCT03823287|580707382|FG000|Overall Study|Lack of Efficacy|2|||
160815422|NCT03823287|580707383|FG001|Overall Study|Lack of Efficacy|0|||
160815423|NCT03823287|580707382|FG000|Overall Study|Other|2|||
160815424|NCT03823287|580707383|FG001|Overall Study|Other|4|||
160815425|NCT01059864|580707386|FG000|Open-Label Run-In Phase|Adverse Event|7|||
160815426|NCT01059864|580707387|FG001|Open-Label Run-In Phase|Adverse Event|0|||
160815427|NCT01059864|580707388|FG002|Open-Label Run-In Phase|Adverse Event|0|||
160815428|NCT01059864|580707386|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
160815429|NCT01059864|580707387|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
160815430|NCT01059864|580707388|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
160815431|NCT01059864|580707386|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
160815432|NCT01059864|580707387|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
160815433|NCT01059864|580707388|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
160815434|NCT01059864|580707386|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
160815435|NCT01059864|580707387|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
160815436|NCT01059864|580707388|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
160815437|NCT01059864|580707386|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
160815438|NCT01059864|580707387|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
160815439|NCT01059864|580707388|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
160815440|NCT01059864|580707386|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
160815441|NCT01059864|580707387|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
160815442|NCT01059864|580707388|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
160815443|NCT03108521|580707389|FG000|Overall Study|Lost to Follow-up|3|||
160815444|NCT03108521|580707390|FG001|Overall Study|Lost to Follow-up|0|||
160815445|NCT03108521|580707389|FG000|Overall Study|Lack of Efficacy|2|||
160815446|NCT03108521|580707390|FG001|Overall Study|Lack of Efficacy|0|||
160815447|NCT03108521|580707389|FG000|Overall Study|Physician Decision|4|||
160815448|NCT03108521|580707390|FG001|Overall Study|Physician Decision|0|||
160815449|NCT03108521|580707389|FG000|Overall Study|Adverse Event|3|||
160815450|NCT03108521|580707390|FG001|Overall Study|Adverse Event|0|||
160815451|NCT03281629|580707397|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
160815452|NCT03281629|580707398|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
160815453|NCT03281629|580707397|FG000|Overall Study|Death|0|||
160815454|NCT03281629|580707398|FG001|Overall Study|Death|1|||
160815455|NCT03281629|580707397|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
160815456|NCT03281629|580707398|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
160815457|NCT01170273|580707404|FG000|Overall Study|Lost to Follow-up|6|||
160815458|NCT01170273|580707405|FG001|Overall Study|Lost to Follow-up|8|||
160815459|NCT01170273|580707404|FG000|Overall Study|Protocol Violation|1|||
160815460|NCT01170273|580707405|FG001|Overall Study|Protocol Violation|0|||
160815461|NCT01170273|580707404|FG000|Overall Study|Death|1|||
160815462|NCT01170273|580707405|FG001|Overall Study|Death|0|||
160815463|NCT01170273|580707404|FG000|Overall Study|Adverse Event|0|||
160815464|NCT01170273|580707405|FG001|Overall Study|Adverse Event|1|||
160815465|NCT01456195|580709260|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
160815466|NCT01456195|580709261|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
160815467|NCT01456195|580709262|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
160815468|NCT01456195|580709260|FG000|Overall Study|Lost to Follow-up|3|||
160815469|NCT01456195|580709261|FG001|Overall Study|Lost to Follow-up|1|||
160815470|NCT01456195|580709262|FG002|Overall Study|Lost to Follow-up|3|||
160815471|NCT01456195|580709260|FG000|Overall Study|Voluntary Withdrawal|5|||
160815472|NCT01456195|580709261|FG001|Overall Study|Voluntary Withdrawal|3|||
160815473|NCT01456195|580709262|FG002|Overall Study|Voluntary Withdrawal|7|||
160815474|NCT01456195|580709260|FG000|Overall Study|Lack of Efficacy|0|||
160815475|NCT01456195|580709261|FG001|Overall Study|Lack of Efficacy|1|||
160815476|NCT01456195|580709262|FG002|Overall Study|Lack of Efficacy|0|||
160815477|NCT01456195|580709260|FG000|Overall Study|Other Reasons|2|||
160815478|NCT01456195|580709261|FG001|Overall Study|Other Reasons|1|||
160815479|NCT01456195|580709262|FG002|Overall Study|Other Reasons|3|||
160815480|NCT02109432|580709263|FG000|Overall Study|Withdrawal by Subject|1|||
160815481|NCT03372551|580709270|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
160815482|NCT03372551|580709271|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
160815483|NCT04683029|580709284|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
160815484|NCT04683029|580709285|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
160815485|NCT04683029|580709286|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
160815486|NCT04683029|580709287|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
160815487|NCT04683029|580709284|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
160815488|NCT04683029|580709285|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
160815489|NCT04683029|580709286|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
160815490|NCT04683029|580709287|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
160815491|NCT04683029|580709284|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
160815492|NCT04683029|580709285|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
160815493|NCT04683029|580709286|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
160815494|NCT04683029|580709287|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
160815495|NCT04299308|580709288|FG000|Overall Study|Withdrawal by Subject|1|||
160815496|NCT04299308|580709289|FG001|Overall Study|Withdrawal by Subject|0|||
160815497|NCT04299308|580709288|FG000|Overall Study|issue with PET image (1)|1|||
160815498|NCT04299308|580709289|FG001|Overall Study|issue with PET image (1)|0|||
160815499|NCT02920528|580709292|FG000|Overall Study|Incomplete Data|1|||
160815500|NCT02920528|580709293|FG001|Overall Study|Incomplete Data|1|||
160815501|NCT02920528|580709294|FG002|Overall Study|Incomplete Data|1|||
160815502|NCT02920528|580709292|FG000|Overall Study|Adverse Event|0|||
160815503|NCT02920528|580709293|FG001|Overall Study|Adverse Event|0|||
160815504|NCT02920528|580709294|FG002|Overall Study|Adverse Event|3|||
160815505|NCT02920528|580709292|FG000|Overall Study|Did not meet inclusion criteria|2|||
160815506|NCT02920528|580709293|FG001|Overall Study|Did not meet inclusion criteria|0|||
160815507|NCT02920528|580709294|FG002|Overall Study|Did not meet inclusion criteria|1|||
160815508|NCT03596047|580709296|FG000|Overall Study|Withdrawal by Subject|7|||
160815509|NCT03596047|580709297|FG001|Overall Study|Withdrawal by Subject|4|||
160815510|NCT03596047|580709296|FG000|Overall Study|Lost to Follow-up|0|||
160815511|NCT03596047|580709297|FG001|Overall Study|Lost to Follow-up|2|||
160815512|NCT00066703|580709298|FG000|Overall Study|Adverse Event|80|||
160815513|NCT00066703|580709299|FG001|Overall Study|Adverse Event|111|||
160815514|NCT00066703|580709298|FG000|Overall Study|Death|3|||
160815515|NCT00066703|580709299|FG001|Overall Study|Death|0|||
160815516|NCT00066703|580709298|FG000|Overall Study|Lack of Efficacy|114|||
160815517|NCT00066703|580709299|FG001|Overall Study|Lack of Efficacy|69|||
160815518|NCT00066703|580709298|FG000|Overall Study|Lost to Follow-up|31|||
160815519|NCT00066703|580709299|FG001|Overall Study|Lost to Follow-up|28|||
160815520|NCT00066703|580709298|FG000|Overall Study|Withdrawal by Subject|38|||
160815521|NCT00066703|580709299|FG001|Overall Study|Withdrawal by Subject|63|||
160815522|NCT00066703|580709298|FG000|Overall Study|Treatment ongoing|346|||
160815523|NCT00066703|580709299|FG001|Overall Study|Treatment ongoing|311|||
160815524|NCT01696968|580709300|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
160900313|NCT02557295|581028698|FG000|Overall Study|Disease Progression|0|||
160900314|NCT02557295|581028699|FG001|Overall Study|Disease Progression|0|||
160900315|NCT02557295|581028700|FG002|Overall Study|Disease Progression|0|||
160900316|NCT02557295|581028701|FG003|Overall Study|Disease Progression|0|||
160900317|NCT02557295|581028702|FG004|Overall Study|Disease Progression|0|||
160900318|NCT02557295|581028703|FG005|Overall Study|Disease Progression|0|||
160900319|NCT02557295|581028704|FG006|Overall Study|Disease Progression|1|||
160900320|NCT02557295|581028705|FG007|Overall Study|Disease Progression|0|||
160815525|NCT01696968|580709301|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
160815526|NCT01696968|580709300|FG000|Overall Study|Died Before Randomization|3|||
160815527|NCT01696968|580709301|FG001|Overall Study|Died Before Randomization|8|||
160815528|NCT01696968|580709300|FG000|Overall Study|Died Before ASU (Control)|278|||
160815529|NCT01696968|580709301|FG001|Overall Study|Died Before ASU (Control)|0|||
160815530|NCT01696968|580709300|FG000|Overall Study|Refused ASU (Control)|920|||
160815531|NCT01696968|580709301|FG001|Overall Study|Refused ASU (Control)|0|||
160815532|NCT01696968|580709300|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
160900321|NCT02557295|581028706|FG008|Overall Study|Disease Progression|0|||
160645703|NCT00982410|580085844|FG001|6-month Follow-up Assessment|incarceration|2|||
160645704|NCT00982410|580085843|FG000|6-month Follow-up Assessment|patent surgery|0|||
160645705|NCT00982410|580085844|FG001|6-month Follow-up Assessment|patent surgery|1|||
160645706|NCT00982410|580085843|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
160645707|NCT00982410|580085844|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
160645708|NCT00982410|580085843|FG000|12-month Follow-up Assessment|Death|0|||
160645709|NCT00982410|580085844|FG001|12-month Follow-up Assessment|Death|2|||
160645710|NCT00982410|580085843|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
160645711|NCT00982410|580085844|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
160645712|NCT00982410|580085843|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
160645713|NCT00982410|580085844|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
160645714|NCT00982410|580085843|FG000|12-month Follow-up Assessment|incarceration|2|||
160645715|NCT00982410|580085844|FG001|12-month Follow-up Assessment|incarceration|1|||
160645716|NCT00982410|580085843|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
160645717|NCT00982410|580085844|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
160645718|NCT02034799|580085847|FG000|Overall Study|Withdrawal by Subject|0|||
160645719|NCT02034799|580085848|FG001|Overall Study|Withdrawal by Subject|2|||
160645720|NCT02034799|580085847|FG000|Overall Study|Lost to Follow-up|0|||
160645721|NCT02034799|580085848|FG001|Overall Study|Lost to Follow-up|1|||
160645722|NCT02034799|580085847|FG000|Overall Study|Death|2|||
160645723|NCT02034799|580085848|FG001|Overall Study|Death|1|||
160645724|NCT03381248|580085853|FG000|0-6 Months|Withdrawal by Subject|4|||
160645725|NCT03381248|580085854|FG001|0-6 Months|Withdrawal by Subject|1|||
160645726|NCT03381248|580085853|FG000|0-6 Months|Lost to Follow-up|3|||
160645727|NCT03381248|580085854|FG001|0-6 Months|Lost to Follow-up|2|||
160645728|NCT03381248|580085853|FG000|0-6 Months|Lack of Efficacy|1|||
160645729|NCT03381248|580085854|FG001|0-6 Months|Lack of Efficacy|0|||
160645730|NCT03381248|580085853|FG000|0-6 Months|Adverse Event|1|||
160645731|NCT03381248|580085854|FG001|0-6 Months|Adverse Event|0|||
160645732|NCT03381248|580085853|FG000|0-6 Months|Protocol Violation|2|||
160645733|NCT03381248|580085854|FG001|0-6 Months|Protocol Violation|1|||
160645734|NCT03381248|580085853|FG000|0-6 Months|Physician Decision|1|||
160645735|NCT03381248|580085854|FG001|0-6 Months|Physician Decision|0|||
160645736|NCT03381248|580085853|FG000|0-6 Months|Planning another procedure|1|||
160645737|NCT03381248|580085854|FG001|0-6 Months|Planning another procedure|2|||
160645738|NCT03381248|580085853|FG000|6-12 Months|Withdrawal by Subject|1|||
160645739|NCT03381248|580085854|FG001|6-12 Months|Withdrawal by Subject|3|||
160645740|NCT03381248|580085853|FG000|6-12 Months|Lost to Follow-up|0|||
160645741|NCT03381248|580085854|FG001|6-12 Months|Lost to Follow-up|2|||
160645742|NCT03381248|580085853|FG000|6-12 Months|Protocol Violation|3|||
160645743|NCT03381248|580085854|FG001|6-12 Months|Protocol Violation|2|||
160645744|NCT03381248|580085853|FG000|6-12 Months|Planning another procedure|6|||
160645745|NCT03381248|580085854|FG001|6-12 Months|Planning another procedure|2|||
160645746|NCT03381248|580085853|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
160645747|NCT03381248|580085854|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
160645748|NCT03381248|580085853|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
160645749|NCT03381248|580085854|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
160645750|NCT03381248|580085853|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
160815533|NCT01696968|580709301|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
160645751|NCT03381248|580085854|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
160645752|NCT05188521|580085855|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
160645753|NCT05188521|580085856|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
160645754|NCT01341639|580085857|FG000|Infant Series|Protocol Violation|1|||
160645755|NCT01341639|580085858|FG001|Infant Series|Protocol Violation|0|||
160645756|NCT01341639|580085857|FG000|Infant Series|Not Vaccinated|0|||
160645757|NCT01341639|580085858|FG001|Infant Series|Not Vaccinated|1|||
160815534|NCT03350035|580709302|FG000|Overall Study|Lack of Efficacy|2|||
160815535|NCT03350035|580709303|FG001|Overall Study|Lack of Efficacy|0|||
160815536|NCT03350035|580709304|FG002|Overall Study|Lack of Efficacy|0|||
160815537|NCT03350035|580709302|FG000|Overall Study|Subject discharged to hospice|0|||
160815538|NCT03350035|580709303|FG001|Overall Study|Subject discharged to hospice|0|||
160815539|NCT03350035|580709304|FG002|Overall Study|Subject discharged to hospice|1|||
160815540|NCT01811485|580709305|FG000|Overall Study|Adverse Event|1|||
160815541|NCT01811485|580709306|FG001|Overall Study|Adverse Event|3|||
160815542|NCT01811485|580709307|FG002|Overall Study|Adverse Event|2|||
160815543|NCT01811485|580709305|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160815544|NCT01811485|580709306|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160815545|NCT01811485|580709307|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
160815546|NCT01811485|580709305|FG000|Overall Study|Administrative problems|1|||
160815547|NCT01811485|580709306|FG001|Overall Study|Administrative problems|0|||
160815548|NCT01811485|580709307|FG002|Overall Study|Administrative problems|0|||
160815549|NCT01811485|580709305|FG000|Overall Study|Protocol Deviation|0|||
160815550|NCT01811485|580709306|FG001|Overall Study|Protocol Deviation|1|||
160815551|NCT01811485|580709307|FG002|Overall Study|Protocol Deviation|0|||
160815552|NCT03654404|580709308|FG000|Overall Study|Death|1|||
160815553|NCT03654404|580709308|FG000|Overall Study|Lost to Follow-up|2|||
160815554|NCT03654404|580709308|FG000|Overall Study|Withdrawal by Subject|5|||
160815555|NCT00654745|580709309|FG000|Overall Study|Adverse Event|12|||
160815556|NCT00654745|580709309|FG000|Overall Study|Lost to Follow-up|7|||
160815557|NCT00654745|580709309|FG000|Overall Study|Protocol Violation|11|||
160815558|NCT00654745|580709309|FG000|Overall Study|Withdrawal by Subject|10|||
160815559|NCT00654745|580709309|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
160815560|NCT04551963|580709310|FG000|Overall Study|Physician Decision|1|||
160815561|NCT04551963|580709311|FG001|Overall Study|Physician Decision|1|||
160815562|NCT04551963|580709310|FG000|Overall Study|Death|1|||
160815563|NCT04551963|580709311|FG001|Overall Study|Death|0|||
160815564|NCT02974855|580709312|FG000|Overall Study|Adverse Event|0|||
160815565|NCT02974855|580709313|FG001|Overall Study|Adverse Event|1|||
160815566|NCT02974855|580709314|FG002|Overall Study|Adverse Event|0|||
160815567|NCT02974855|580709315|FG003|Overall Study|Adverse Event|1|||
160815568|NCT01474772|580709316|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
160815569|NCT01474772|580709317|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
160815570|NCT01474772|580709316|FG000|Period 1|AE not Related to Study Drug|1|||
160815571|NCT01474772|580709317|FG001|Period 1|AE not Related to Study Drug|0|||
160815572|NCT01474772|580709316|FG000|Period 1|Withdrawal by Subject|3|||
160815573|NCT01474772|580709317|FG001|Period 1|Withdrawal by Subject|1|||
160815574|NCT01474772|580709316|FG000|Period 1|Lost to Follow-up|1|||
160815575|NCT01474772|580709317|FG001|Period 1|Lost to Follow-up|0|||
160815576|NCT01474772|580709316|FG000|Period 1|Reason not Specified|1|||
160815577|NCT01474772|580709317|FG001|Period 1|Reason not Specified|1|||
160815578|NCT01474772|580709316|FG000|Washout|AE not Related to Study Drug|2|||
160815579|NCT01474772|580709317|FG001|Washout|AE not Related to Study Drug|0|||
160815580|NCT01474772|580709316|FG000|Washout|Withdrawal by Subject|1|||
160815581|NCT01474772|580709317|FG001|Washout|Withdrawal by Subject|0|||
160815582|NCT01474772|580709316|FG000|Washout|Lost to Follow-up|0|||
160815583|NCT01474772|580709317|FG001|Washout|Lost to Follow-up|1|||
160815584|NCT01474772|580709316|FG000|Washout|Reason not Specified|0|||
160815585|NCT01474772|580709317|FG001|Washout|Reason not Specified|1|||
160815586|NCT01474772|580709316|FG000|Period 2|Death|0|||
160815587|NCT01474772|580709317|FG001|Period 2|Death|1|||
160815588|NCT01474772|580709316|FG000|Period 2|AE Related to Study Drug|0|||
160552740|NCT02482129|579748516|FG000|Overall Study|Adverse Event-prior to treatment|0|||
160987285|NCT04955626|581341137|FG032|Open-Label Period|Other|0|||
160987286|NCT04955626|581341138|FG033|Open-Label Period|Other|0|||
160987287|NCT04955626|581341139|FG034|Open-Label Period|Other|0|||
160987288|NCT04955626|581341140|FG035|Open-Label Period|Other|0|||
160815589|NCT01474772|580709317|FG001|Period 2|AE Related to Study Drug|1|||
160815590|NCT01474772|580709316|FG000|Period 2|AE not Related to Study Drug|4|||
160987289|NCT04955626|581341105|FG000|Open-Label Period|Physician Decision|2|||
160987290|NCT04955626|581341106|FG001|Open-Label Period|Physician Decision|0|||
160815591|NCT01474772|580709317|FG001|Period 2|AE not Related to Study Drug|1|||
160815592|NCT01474772|580709316|FG000|Period 2|Lack of Efficacy|1|||
160815593|NCT01474772|580709317|FG001|Period 2|Lack of Efficacy|0|||
160815594|NCT01474772|580709316|FG000|Period 2|Withdrawal by Subject|3|||
160815595|NCT01474772|580709317|FG001|Period 2|Withdrawal by Subject|4|||
160815596|NCT01474772|580709316|FG000|Period 2|Lost to Follow-up|1|||
160815597|NCT01474772|580709317|FG001|Period 2|Lost to Follow-up|1|||
160815598|NCT01474772|580709316|FG000|Period 2|Reason not Specified|0|||
160815599|NCT01474772|580709317|FG001|Period 2|Reason not Specified|2|||
160815600|NCT01474772|580709316|FG000|Follow-up|AE not Related to Study Drug|0|||
160815601|NCT01474772|580709317|FG001|Follow-up|AE not Related to Study Drug|1|||
160815602|NCT00633074|580709318|FG000|Overall Study|Adverse Event|1|||
160815603|NCT00633074|580709319|FG001|Overall Study|Adverse Event|0|||
160815604|NCT00365105|580709320|FG000|Overall Study|Protocol Violation|5|||
160815605|NCT00365105|580709321|FG001|Overall Study|Protocol Violation|8|||
160987291|NCT04955626|581341107|FG002|Open-Label Period|Physician Decision|0|||
160815606|NCT00748618|580709322|FG000|Overall Study|Adverse Event|1|||
160815607|NCT00748618|580709323|FG001|Overall Study|Adverse Event|0|||
160815608|NCT06004895|580709324|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
160815609|NCT06004895|580709324|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
160815610|NCT00466947|580709325|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
160815611|NCT00466947|580709326|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
160815612|NCT00466947|580709325|FG000|Study End Analysis Period|Adverse Event|35|||
160815613|NCT00466947|580709326|FG001|Study End Analysis Period|Adverse Event|43|||
160815614|NCT00466947|580709325|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
160815615|NCT00466947|580709326|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
160815616|NCT00466947|580709325|FG000|Study End Analysis Period|Physician Decision|29|||
160815617|NCT00466947|580709326|FG001|Study End Analysis Period|Physician Decision|29|||
160815618|NCT00466947|580709325|FG000|Study End Analysis Period|Protocol Violation|9|||
160815619|NCT00466947|580709326|FG001|Study End Analysis Period|Protocol Violation|17|||
160815620|NCT00466947|580709325|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
160815621|NCT00466947|580709326|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
160815622|NCT00466947|580709325|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
160815623|NCT00466947|580709326|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
160815624|NCT00466947|580709325|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
160815625|NCT00466947|580709326|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
160815626|NCT00466947|580709325|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
160815627|NCT00466947|580709326|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
160815628|NCT00878254|580709327|FG000|Overall Study|Physician Decision|1|||
160815629|NCT00878254|580709327|FG000|Overall Study|Death|1|||
160815630|NCT00878254|580709327|FG000|Overall Study|Withdrawal by Subject|1|||
160815631|NCT01995526|580709328|FG000|Overall Study|Physician Decision|1|||
160815632|NCT03367403|580709334|FG000|Overall Study|Adverse Event|20|||
160815633|NCT03367403|580709335|FG001|Overall Study|Adverse Event|6|||
160815634|NCT03367403|580709336|FG002|Overall Study|Adverse Event|2|||
160815635|NCT03367403|580709334|FG000|Overall Study|Withdrawal by Subject|12|||
160815636|NCT03367403|580709335|FG001|Overall Study|Withdrawal by Subject|13|||
160815637|NCT03367403|580709336|FG002|Overall Study|Withdrawal by Subject|1|||
160815638|NCT03367403|580709334|FG000|Overall Study|Death|1|||
160815639|NCT03367403|580709335|FG001|Overall Study|Death|2|||
160815640|NCT03367403|580709336|FG002|Overall Study|Death|0|||
160815641|NCT03367403|580709334|FG000|Overall Study|Physician Decision|0|||
160815642|NCT03367403|580709335|FG001|Overall Study|Physician Decision|1|||
160815643|NCT03367403|580709336|FG002|Overall Study|Physician Decision|0|||
160815644|NCT03367403|580709334|FG000|Overall Study|Protocol Violation|1|||
160815645|NCT03367403|580709335|FG001|Overall Study|Protocol Violation|1|||
160815646|NCT03367403|580709336|FG002|Overall Study|Protocol Violation|0|||
160815647|NCT03367403|580709334|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
160815648|NCT03367403|580709335|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
160815649|NCT03367403|580709336|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
160987292|NCT04955626|581341108|FG003|Open-Label Period|Physician Decision|0|||
160987293|NCT04955626|581341109|FG004|Open-Label Period|Physician Decision|0|||
160987294|NCT04955626|581341110|FG005|Open-Label Period|Physician Decision|0|||
160987295|NCT04955626|581341111|FG006|Open-Label Period|Physician Decision|0|||
160987296|NCT04955626|581341112|FG007|Open-Label Period|Physician Decision|0|||
160987297|NCT04955626|581341113|FG008|Open-Label Period|Physician Decision|0|||
160815650|NCT03367403|580709334|FG000|Overall Study|COVID-19|3|||
160815651|NCT03367403|580709335|FG001|Overall Study|COVID-19|6|||
160815652|NCT03367403|580709336|FG002|Overall Study|COVID-19|0|||
160815653|NCT03367403|580709334|FG000|Overall Study|Abuse of Alcohol Intake|0|||
160815654|NCT03367403|580709335|FG001|Overall Study|Abuse of Alcohol Intake|1|||
160815655|NCT03367403|580709336|FG002|Overall Study|Abuse of Alcohol Intake|0|||
160815656|NCT03367403|580709334|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
160815657|NCT03367403|580709335|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
160815658|NCT03367403|580709336|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
160987298|NCT04955626|581341114|FG009|Open-Label Period|Physician Decision|0|||
160987299|NCT04955626|581341115|FG010|Open-Label Period|Physician Decision|0|||
160987300|NCT04955626|581341116|FG011|Open-Label Period|Physician Decision|0|||
160815659|NCT00194077|580709337|FG000|Overall Study|Lack of Efficacy|22|||
160815660|NCT00194077|580709338|FG001|Overall Study|Lack of Efficacy|29|||
160815661|NCT00194077|580709337|FG000|Overall Study|Study nonadherence|1|||
160815662|NCT00194077|580709338|FG001|Overall Study|Study nonadherence|0|||
160815663|NCT00194077|580709337|FG000|Overall Study|Withdrawal by Subject|1|||
160815664|NCT00194077|580709338|FG001|Overall Study|Withdrawal by Subject|1|||
160987301|NCT04955626|581341117|FG012|Open-Label Period|Physician Decision|0|||
160987302|NCT04955626|581341118|FG013|Open-Label Period|Physician Decision|0|||
160987303|NCT04955626|581341119|FG014|Open-Label Period|Physician Decision|0|||
160815665|NCT03470194|580709341|FG000|Overall Study|Lost to Follow-up|11|||
160815666|NCT03470194|580709342|FG001|Overall Study|Lost to Follow-up|17|||
160815667|NCT01822899|580709343|FG000|Overall Study|Adverse Event|6|||
160815668|NCT01822899|580709344|FG001|Overall Study|Adverse Event|5|||
160815669|NCT01822899|580709343|FG000|Overall Study|Lack of Efficacy|6|||
160815670|NCT01822899|580709344|FG001|Overall Study|Lack of Efficacy|3|||
160815671|NCT01822899|580709343|FG000|Overall Study|Protocol Violation|6|||
160815672|NCT01822899|580709344|FG001|Overall Study|Protocol Violation|3|||
160815673|NCT01822899|580709343|FG000|Overall Study|Lost to Follow-up|1|||
160815674|NCT01822899|580709344|FG001|Overall Study|Lost to Follow-up|0|||
160815675|NCT01822899|580709343|FG000|Overall Study|Withdrawal by Subject|5|||
160815676|NCT01822899|580709344|FG001|Overall Study|Withdrawal by Subject|7|||
160815677|NCT00759876|580709346|FG000|Overall Study|Sponsor terminated study early|36|||
160815678|NCT01450696|580709348|FG000|Overall Study|Never Treated|1|||
160815679|NCT01450696|580709349|FG001|Overall Study|Never Treated|1|||
160815680|NCT01450696|580709348|FG000|Overall Study|Death|77|||
160815681|NCT01450696|580709349|FG001|Overall Study|Death|84|||
160815682|NCT01450696|580709348|FG000|Overall Study|Lost to Follow-up|3|||
160815683|NCT01450696|580709349|FG001|Overall Study|Lost to Follow-up|3|||
160815684|NCT01450696|580709348|FG000|Overall Study|Non-Compliance|1|||
160815685|NCT01450696|580709349|FG001|Overall Study|Non-Compliance|0|||
160815686|NCT01450696|580709348|FG000|Overall Study|Withdrawal by Subject|13|||
160815687|NCT01450696|580709349|FG001|Overall Study|Withdrawal by Subject|2|||
160815688|NCT01450696|580709348|FG000|Overall Study|Study Terminated by Sponsor|53|||
160815689|NCT01450696|580709349|FG001|Overall Study|Study Terminated by Sponsor|58|||
160815690|NCT02321319|580709351|FG000|Overall Study|Product discontinued|5|||
160815691|NCT02570152|580709354|FG000|Overall Study|Protocol Violation|2|||
160815692|NCT02570152|580709354|FG000|Overall Study|Migrated/moved from study area|13|||
160815693|NCT02684617|580709355|FG000|Overall Study|Adverse Event|1|||
160815694|NCT02684617|580709356|FG001|Overall Study|Adverse Event|0|||
160815695|NCT02684617|580709357|FG002|Overall Study|Adverse Event|1|||
160815696|NCT02684617|580709355|FG000|Overall Study|Death|8|||
160815697|NCT02684617|580709356|FG001|Overall Study|Death|16|||
160815698|NCT02684617|580709357|FG002|Overall Study|Death|28|||
160815699|NCT02684617|580709355|FG000|Overall Study|Withdrawal by Subject|2|||
160815700|NCT02684617|580709356|FG001|Overall Study|Withdrawal by Subject|0|||
160815701|NCT02684617|580709357|FG002|Overall Study|Withdrawal by Subject|4|||
160815702|NCT02684617|580709355|FG000|Overall Study|Screen Failure|1|||
160815703|NCT02684617|580709356|FG001|Overall Study|Screen Failure|0|||
160815704|NCT02684617|580709357|FG002|Overall Study|Screen Failure|2|||
160815705|NCT02684617|580709355|FG000|Overall Study|Study Terminated by Sponsor|6|||
160815706|NCT02684617|580709356|FG001|Overall Study|Study Terminated by Sponsor|1|||
160815707|NCT02684617|580709357|FG002|Overall Study|Study Terminated by Sponsor|5|||
160815708|NCT00853242|580709358|FG000|Overall Study|Adverse Event|0|||
160815709|NCT00853242|580709359|FG001|Overall Study|Adverse Event|1|||
160815710|NCT00853242|580709360|FG002|Overall Study|Adverse Event|1|||
160815711|NCT00853242|580709361|FG003|Overall Study|Adverse Event|0|||
160815712|NCT00853242|580709362|FG004|Overall Study|Adverse Event|3|||
160815713|NCT00853242|580709363|FG005|Overall Study|Adverse Event|1|||
160815714|NCT00853242|580709364|FG006|Overall Study|Adverse Event|1|||
160815715|NCT00853242|580709358|FG000|Overall Study|Noncompliant|0|||
160815716|NCT00853242|580709359|FG001|Overall Study|Noncompliant|0|||
160815717|NCT00853242|580709360|FG002|Overall Study|Noncompliant|0|||
160815718|NCT00853242|580709361|FG003|Overall Study|Noncompliant|0|||
160815719|NCT00853242|580709362|FG004|Overall Study|Noncompliant|1|||
160815720|NCT00853242|580709363|FG005|Overall Study|Noncompliant|0|||
160900322|NCT02557295|581028698|FG000|Overall Study|Lack of Efficacy|24|||
160900323|NCT02557295|581028699|FG001|Overall Study|Lack of Efficacy|1|||
160900324|NCT02557295|581028700|FG002|Overall Study|Lack of Efficacy|3|||
160900325|NCT02557295|581028701|FG003|Overall Study|Lack of Efficacy|0|||
160900326|NCT02557295|581028702|FG004|Overall Study|Lack of Efficacy|0|||
160815721|NCT00853242|580709364|FG006|Overall Study|Noncompliant|0|||
160815722|NCT00853242|580709358|FG000|Overall Study|Withdrawal by Subject|1|||
160815723|NCT00853242|580709359|FG001|Overall Study|Withdrawal by Subject|2|||
160815724|NCT00853242|580709360|FG002|Overall Study|Withdrawal by Subject|0|||
160815725|NCT00853242|580709361|FG003|Overall Study|Withdrawal by Subject|4|||
160815726|NCT00853242|580709362|FG004|Overall Study|Withdrawal by Subject|0|||
160815727|NCT00853242|580709363|FG005|Overall Study|Withdrawal by Subject|0|||
160815728|NCT00853242|580709364|FG006|Overall Study|Withdrawal by Subject|2|||
160815729|NCT00853242|580709358|FG000|Overall Study|Other|2|||
160815730|NCT00853242|580709359|FG001|Overall Study|Other|0|||
160815731|NCT00853242|580709360|FG002|Overall Study|Other|2|||
160815732|NCT00853242|580709361|FG003|Overall Study|Other|0|||
160815733|NCT00853242|580709362|FG004|Overall Study|Other|0|||
160815734|NCT00853242|580709363|FG005|Overall Study|Other|1|||
160815735|NCT00853242|580709364|FG006|Overall Study|Other|2|||
160815736|NCT03497975|580709365|FG000|Overall Study|Withdrew Consent|34|||
160815737|NCT03497975|580709366|FG001|Overall Study|Withdrew Consent|35|||
160987304|NCT04955626|581341120|FG015|Open-Label Period|Physician Decision|0|||
160987305|NCT04955626|581341121|FG016|Open-Label Period|Physician Decision|0|||
160987306|NCT04955626|581341122|FG017|Open-Label Period|Physician Decision|0|||
160987307|NCT04955626|581341123|FG018|Open-Label Period|Physician Decision|0|||
160987308|NCT04955626|581341124|FG019|Open-Label Period|Physician Decision|0|||
160552741|NCT02482129|579748517|FG001|Overall Study|Adverse Event-prior to treatment|1|||
160552742|NCT02482129|579748516|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
160552743|NCT02482129|579748517|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
160552744|NCT02482129|579748516|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
160552745|NCT02482129|579748517|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
160552746|NCT02482129|579748516|FG000|Overall Study|Criteria not met-prior to treatment|1|||
160552747|NCT02482129|579748517|FG001|Overall Study|Criteria not met-prior to treatment|0|||
160552748|NCT02482129|579748516|FG000|Overall Study|Adverse Event|1|||
160645758|NCT01341639|580085857|FG000|Infant Series|Adverse Event|0|||
160645759|NCT01341639|580085858|FG001|Infant Series|Adverse Event|5|||
160987309|NCT04955626|581341125|FG020|Open-Label Period|Physician Decision|0|||
160987310|NCT04955626|581341126|FG021|Open-Label Period|Physician Decision|0|||
160987311|NCT04955626|581341127|FG022|Open-Label Period|Physician Decision|0|||
160987312|NCT04955626|581341128|FG023|Open-Label Period|Physician Decision|0|||
160987313|NCT04955626|581341129|FG024|Open-Label Period|Physician Decision|0|||
160987314|NCT04955626|581341130|FG025|Open-Label Period|Physician Decision|0|||
160987315|NCT04955626|581341131|FG026|Open-Label Period|Physician Decision|0|||
160987316|NCT04955626|581341132|FG027|Open-Label Period|Physician Decision|0|||
160987317|NCT04955626|581341133|FG028|Open-Label Period|Physician Decision|0|||
160987318|NCT04955626|581341134|FG029|Open-Label Period|Physician Decision|0|||
160987319|NCT04955626|581341135|FG030|Open-Label Period|Physician Decision|0|||
160987320|NCT04955626|581341136|FG031|Open-Label Period|Physician Decision|0|||
160987321|NCT04955626|581341137|FG032|Open-Label Period|Physician Decision|0|||
160987322|NCT04955626|581341138|FG033|Open-Label Period|Physician Decision|0|||
160987323|NCT04955626|581341139|FG034|Open-Label Period|Physician Decision|0|||
160987324|NCT04955626|581341140|FG035|Open-Label Period|Physician Decision|0|||
160645760|NCT01341639|580085857|FG000|Infant Series|Withdrawal by Subject|11|||
160645761|NCT01341639|580085858|FG001|Infant Series|Withdrawal by Subject|8|||
160645762|NCT01341639|580085857|FG000|Infant Series|Lost to Follow-up|0|||
160645763|NCT01341639|580085858|FG001|Infant Series|Lost to Follow-up|2|||
160645764|NCT01341639|580085857|FG000|Infant Series|Site 0048 Participants|17|||
160645765|NCT01341639|580085858|FG001|Infant Series|Site 0048 Participants|16|||
160645766|NCT01341639|580085857|FG000|Interim Period|Withdrawal by Subject|6|||
160645767|NCT01341639|580085858|FG001|Interim Period|Withdrawal by Subject|7|||
160645768|NCT01341639|580085857|FG000|Interim Period|Lost to Follow-up|2|||
160645769|NCT01341639|580085858|FG001|Interim Period|Lost to Follow-up|0|||
160645770|NCT01341639|580085857|FG000|Interim Period|Physician Decision|0|||
160645771|NCT01341639|580085858|FG001|Interim Period|Physician Decision|1|||
160645772|NCT01341639|580085857|FG000|Interim Period|Protocol Violation|0|||
160645773|NCT01341639|580085858|FG001|Interim Period|Protocol Violation|1|||
160645774|NCT01341639|580085857|FG000|Post-Treatment|Withdrawal by Subject|0|||
160645775|NCT01341639|580085858|FG001|Post-Treatment|Withdrawal by Subject|1|||
160645776|NCT01341639|580085857|FG000|Post-Treatment|Adverse Event|0|||
160645777|NCT01341639|580085858|FG001|Post-Treatment|Adverse Event|2|||
160645778|NCT02224456|580085859|FG000|Overall Study|Lack of Efficacy|1|||
160645779|NCT02224456|580085859|FG000|Overall Study|Lost to Follow-up|15|||
160645780|NCT02224456|580085859|FG000|Overall Study|Withdrawal by Subject|9|||
160645781|NCT02224456|580085859|FG000|Overall Study|Physician Decision|3|||
160645782|NCT02224456|580085859|FG000|Overall Study|Death|2|||
160645783|NCT02224456|580085859|FG000|Overall Study|Pregnancy|4|||
160645784|NCT02224456|580085859|FG000|Overall Study|Protocol Violation|1|||
160645785|NCT02224456|580085859|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
160645786|NCT01241461|580085860|FG000|Overall Study|Progressive Disease|3|||
160645787|NCT01241461|580085861|FG001|Overall Study|Progressive Disease|6|||
160645788|NCT01379781|580085862|FG000|Overall Study|Lost to Follow-up|11|||
160645789|NCT01379781|580085863|FG001|Overall Study|Lost to Follow-up|8|||
160645790|NCT03740698|580085864|FG000|Overall Study|Physician Decision|0|||
160645791|NCT03740698|580085865|FG001|Overall Study|Physician Decision|1|||
160645792|NCT03740698|580085866|FG002|Overall Study|Physician Decision|1|||
160645793|NCT05216978|580085875|FG000|Overall Study|Withdrawal by Subject|3|||
160645794|NCT05216978|580085875|FG000|Overall Study|Lost to Follow-up|5|||
160645795|NCT00658320|580085877|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
160645796|NCT00658320|580085878|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
160645797|NCT00658320|580085877|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
160645798|NCT00658320|580085878|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
160645799|NCT00658320|580085877|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
160987325|NCT04955626|581341105|FG000|Open-Label Period|Withdrawal by Subject|135|||
160987326|NCT04955626|581341106|FG001|Open-Label Period|Withdrawal by Subject|25|||
160645800|NCT00658320|580085878|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
160645801|NCT00658320|580085877|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
160645802|NCT00658320|580085878|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
160645803|NCT02410252|580085886|FG000|Overall Study|Withdrawal by Subject|4|||
160645804|NCT02410252|580085886|FG000|Overall Study|Physician Decision|2|||
160645805|NCT03487796|580085891|FG000|Overall Study|Lost to Follow-up|18|||
160645806|NCT03487796|580085892|FG001|Overall Study|Lost to Follow-up|6|||
160645807|NCT00613574|580085896|FG000|Overall Study|Adverse Event|3|||
160645808|NCT00613574|580085896|FG000|Overall Study|Lost to Follow-up|2|||
160645809|NCT00613574|580085896|FG000|Overall Study|Other|1|||
160645810|NCT04604184|580085900|FG000|Overall Study|Adverse Event|5|||
160645811|NCT04604184|580085901|FG001|Overall Study|Adverse Event|5|||
160645812|NCT04604184|580085900|FG000|Overall Study|Death|2|||
160645813|NCT04604184|580085901|FG001|Overall Study|Death|1|||
160645814|NCT04604184|580085900|FG000|Overall Study|Withdrawal by Subject|1|||
160645815|NCT04604184|580085901|FG001|Overall Study|Withdrawal by Subject|3|||
160645816|NCT04604184|580085900|FG000|Overall Study|Not treated|2|||
160645817|NCT04604184|580085901|FG001|Overall Study|Not treated|2|||
160645818|NCT04604184|580085900|FG000|Overall Study|Due to sponsor decision|9|||
160645819|NCT04604184|580085901|FG001|Overall Study|Due to sponsor decision|7|||
160645820|NCT04604184|580085900|FG000|Overall Study|Physician Decision|0|||
160645821|NCT04604184|580085901|FG001|Overall Study|Physician Decision|1|||
160645822|NCT04604184|580085900|FG000|Overall Study|Transfer to healthcare|1|||
160987327|NCT04955626|581341107|FG002|Open-Label Period|Withdrawal by Subject|0|||
160987328|NCT04955626|581341108|FG003|Open-Label Period|Withdrawal by Subject|0|||
160987329|NCT04955626|581341109|FG004|Open-Label Period|Withdrawal by Subject|0|||
160987330|NCT04955626|581341110|FG005|Open-Label Period|Withdrawal by Subject|0|||
160987331|NCT04955626|581341111|FG006|Open-Label Period|Withdrawal by Subject|0|||
160987332|NCT04955626|581341112|FG007|Open-Label Period|Withdrawal by Subject|0|||
160987333|NCT04955626|581341113|FG008|Open-Label Period|Withdrawal by Subject|0|||
160987334|NCT04955626|581341114|FG009|Open-Label Period|Withdrawal by Subject|0|||
160987335|NCT04955626|581341115|FG010|Open-Label Period|Withdrawal by Subject|0|||
160987336|NCT04955626|581341116|FG011|Open-Label Period|Withdrawal by Subject|0|||
160987337|NCT04955626|581341117|FG012|Open-Label Period|Withdrawal by Subject|0|||
160987338|NCT04955626|581341118|FG013|Open-Label Period|Withdrawal by Subject|0|||
160987339|NCT04955626|581341119|FG014|Open-Label Period|Withdrawal by Subject|0|||
160987340|NCT04955626|581341120|FG015|Open-Label Period|Withdrawal by Subject|0|||
160987341|NCT04955626|581341121|FG016|Open-Label Period|Withdrawal by Subject|0|||
160987342|NCT04955626|581341122|FG017|Open-Label Period|Withdrawal by Subject|0|||
160987343|NCT04955626|581341123|FG018|Open-Label Period|Withdrawal by Subject|0|||
160987344|NCT04955626|581341124|FG019|Open-Label Period|Withdrawal by Subject|0|||
160987345|NCT04955626|581341125|FG020|Open-Label Period|Withdrawal by Subject|0|||
160987346|NCT04955626|581341126|FG021|Open-Label Period|Withdrawal by Subject|0|||
160987347|NCT04955626|581341127|FG022|Open-Label Period|Withdrawal by Subject|0|||
160987348|NCT04955626|581341128|FG023|Open-Label Period|Withdrawal by Subject|0|||
160987349|NCT04955626|581341129|FG024|Open-Label Period|Withdrawal by Subject|0|||
160987350|NCT04955626|581341130|FG025|Open-Label Period|Withdrawal by Subject|0|||
160987351|NCT04955626|581341131|FG026|Open-Label Period|Withdrawal by Subject|0|||
160987352|NCT04955626|581341132|FG027|Open-Label Period|Withdrawal by Subject|0|||
160987353|NCT04955626|581341133|FG028|Open-Label Period|Withdrawal by Subject|0|||
160987354|NCT04955626|581341134|FG029|Open-Label Period|Withdrawal by Subject|0|||
160987355|NCT04955626|581341135|FG030|Open-Label Period|Withdrawal by Subject|0|||
160987356|NCT04955626|581341136|FG031|Open-Label Period|Withdrawal by Subject|0|||
160987357|NCT04955626|581341137|FG032|Open-Label Period|Withdrawal by Subject|0|||
160987358|NCT04955626|581341138|FG033|Open-Label Period|Withdrawal by Subject|0|||
160987359|NCT04955626|581341139|FG034|Open-Label Period|Withdrawal by Subject|0|||
160987360|NCT04955626|581341140|FG035|Open-Label Period|Withdrawal by Subject|0|||
160645823|NCT04604184|580085901|FG001|Overall Study|Transfer to healthcare|0|||
160645824|NCT00582036|580085902|FG000|Overall Study|Withdrawal by Subject|0|||
160815738|NCT03497975|580709365|FG000|Overall Study|Lost to Follow-up|7|||
160815739|NCT03497975|580709366|FG001|Overall Study|Lost to Follow-up|7|||
160815740|NCT03497975|580709365|FG000|Overall Study|Physician Decision|4|||
160815741|NCT03497975|580709366|FG001|Overall Study|Physician Decision|5|||
160987361|NCT04955626|581341105|FG000|Open-Label Period|Refused further study procedures|1|||
160987362|NCT04955626|581341106|FG001|Open-Label Period|Refused further study procedures|0|||
160987363|NCT04955626|581341107|FG002|Open-Label Period|Refused further study procedures|0|||
160987364|NCT04955626|581341108|FG003|Open-Label Period|Refused further study procedures|0|||
160987365|NCT04955626|581341109|FG004|Open-Label Period|Refused further study procedures|0|||
160987366|NCT04955626|581341110|FG005|Open-Label Period|Refused further study procedures|0|||
160987367|NCT04955626|581341111|FG006|Open-Label Period|Refused further study procedures|0|||
160987368|NCT04955626|581341112|FG007|Open-Label Period|Refused further study procedures|0|||
160987369|NCT04955626|581341113|FG008|Open-Label Period|Refused further study procedures|0|||
160645825|NCT00582036|580085903|FG001|Overall Study|Withdrawal by Subject|1|||
160645826|NCT01625377|580085904|FG000|Overall Study|Death|1|||
160645827|NCT01625377|580085905|FG001|Overall Study|Death|1|||
160815742|NCT03497975|580709365|FG000|Overall Study|Discontinued|42|||
160815743|NCT03497975|580709366|FG001|Overall Study|Discontinued|39|||
160987370|NCT04955626|581341114|FG009|Open-Label Period|Refused further study procedures|0|||
160987371|NCT04955626|581341115|FG010|Open-Label Period|Refused further study procedures|0|||
160987372|NCT04955626|581341116|FG011|Open-Label Period|Refused further study procedures|0|||
160987373|NCT04955626|581341117|FG012|Open-Label Period|Refused further study procedures|0|||
160987374|NCT04955626|581341118|FG013|Open-Label Period|Refused further study procedures|0|||
160987375|NCT04955626|581341119|FG014|Open-Label Period|Refused further study procedures|0|||
160987376|NCT04955626|581341120|FG015|Open-Label Period|Refused further study procedures|0|||
160987377|NCT04955626|581341121|FG016|Open-Label Period|Refused further study procedures|0|||
160987378|NCT04955626|581341122|FG017|Open-Label Period|Refused further study procedures|0|||
160987379|NCT04955626|581341123|FG018|Open-Label Period|Refused further study procedures|0|||
160987380|NCT04955626|581341124|FG019|Open-Label Period|Refused further study procedures|0|||
160987381|NCT04955626|581341125|FG020|Open-Label Period|Refused further study procedures|0|||
160987382|NCT04955626|581341126|FG021|Open-Label Period|Refused further study procedures|0|||
160987383|NCT04955626|581341127|FG022|Open-Label Period|Refused further study procedures|0|||
160987384|NCT04955626|581341128|FG023|Open-Label Period|Refused further study procedures|0|||
160987385|NCT04955626|581341129|FG024|Open-Label Period|Refused further study procedures|0|||
160987386|NCT04955626|581341130|FG025|Open-Label Period|Refused further study procedures|0|||
160987387|NCT04955626|581341131|FG026|Open-Label Period|Refused further study procedures|0|||
160987388|NCT04955626|581341132|FG027|Open-Label Period|Refused further study procedures|0|||
160987389|NCT04955626|581341133|FG028|Open-Label Period|Refused further study procedures|0|||
160987390|NCT04955626|581341134|FG029|Open-Label Period|Refused further study procedures|0|||
160987391|NCT04955626|581341135|FG030|Open-Label Period|Refused further study procedures|0|||
160987392|NCT04955626|581341136|FG031|Open-Label Period|Refused further study procedures|0|||
160987393|NCT04955626|581341137|FG032|Open-Label Period|Refused further study procedures|0|||
160552749|NCT02482129|579748517|FG001|Overall Study|Adverse Event|0|||
160552750|NCT02482129|579748516|FG000|Overall Study|Withdrawal by Subject|2|||
160552751|NCT02482129|579748517|FG001|Overall Study|Withdrawal by Subject|0|||
160552752|NCT02482129|579748516|FG000|Overall Study|Criteria not met|1|||
160552753|NCT02482129|579748517|FG001|Overall Study|Criteria not met|0|||
160552754|NCT01031446|579748518|FG000|Overall Study|Disease Progression|38|||
160552755|NCT01031446|579748518|FG000|Overall Study|Adverse Event|9|||
160987394|NCT04955626|581341138|FG033|Open-Label Period|Refused further study procedures|0|||
160987395|NCT04955626|581341139|FG034|Open-Label Period|Refused further study procedures|0|||
160987396|NCT04955626|581341140|FG035|Open-Label Period|Refused further study procedures|0|||
160987397|NCT04955626|581341105|FG000|Open-Label Period|Adverse Event|1|||
160987398|NCT04955626|581341106|FG001|Open-Label Period|Adverse Event|0|||
160987399|NCT04955626|581341107|FG002|Open-Label Period|Adverse Event|0|||
160987400|NCT04955626|581341108|FG003|Open-Label Period|Adverse Event|0|||
160987401|NCT04955626|581341109|FG004|Open-Label Period|Adverse Event|0|||
160987402|NCT04955626|581341110|FG005|Open-Label Period|Adverse Event|0|||
160987403|NCT04955626|581341111|FG006|Open-Label Period|Adverse Event|0|||
160987404|NCT04955626|581341112|FG007|Open-Label Period|Adverse Event|0|||
160987405|NCT04955626|581341113|FG008|Open-Label Period|Adverse Event|0|||
160987406|NCT04955626|581341114|FG009|Open-Label Period|Adverse Event|0|||
160552756|NCT01031446|579748518|FG000|Overall Study|Physician Decision|4|||
160552757|NCT01031446|579748518|FG000|Overall Study|Withdrawal by Subject|3|||
160552758|NCT01031446|579748518|FG000|Overall Study|Still on treatment|1|||
160552759|NCT01877083|579748519|FG000|Treatment Phase|Disease Progression|10|||
160552760|NCT01877083|579748519|FG000|Treatment Phase|Clinical Progression|1|||
160552761|NCT01877083|579748519|FG000|Treatment Phase|Adverse Event|6|||
160552762|NCT01877083|579748519|FG000|Treatment Phase|Withdrawal by Subject|2|||
160552763|NCT01877083|579748519|FG000|Treatment Phase|Lost to Follow-up|1|||
160552764|NCT01877083|579748519|FG000|Extension Phase|Disease Progression|3|||
160552765|NCT01877083|579748519|FG000|Extension Phase|Adverse Event|2|||
160552766|NCT02531646|579748522|FG000|Overall Study|equip. image processing issue|5|||
160552767|NCT02531646|579748523|FG001|Overall Study|equip. image processing issue|1|||
160552768|NCT02531646|579748524|FG002|Overall Study|equip. image processing issue|0|||
160552769|NCT01582308|579748525|FG000|Period 1|Withdrawal by Subject|0|||
160552770|NCT01582308|579748526|FG001|Period 1|Withdrawal by Subject|0|||
160552771|NCT01582308|579748527|FG002|Period 1|Withdrawal by Subject|0|||
160552772|NCT01582308|579748528|FG003|Period 1|Withdrawal by Subject|0|||
160552773|NCT01582308|579748529|FG004|Period 1|Withdrawal by Subject|0|||
160552774|NCT01582308|579748530|FG005|Period 1|Withdrawal by Subject|0|||
160552775|NCT01582308|579748531|FG006|Period 1|Withdrawal by Subject|1|||
160552776|NCT01582308|579748532|FG007|Period 1|Withdrawal by Subject|0|||
160552777|NCT01582308|579748533|FG008|Period 1|Withdrawal by Subject|0|||
160552778|NCT01582308|579748534|FG009|Period 1|Withdrawal by Subject|0|||
160552779|NCT01582308|579748525|FG000|10-day Washout Following Period 1|Physician Decision|0|||
160552780|NCT01582308|579748526|FG001|10-day Washout Following Period 1|Physician Decision|0|||
160552781|NCT01582308|579748527|FG002|10-day Washout Following Period 1|Physician Decision|0|||
160552782|NCT01582308|579748528|FG003|10-day Washout Following Period 1|Physician Decision|0|||
160987407|NCT04955626|581341115|FG010|Open-Label Period|Adverse Event|0|||
160987408|NCT04955626|581341116|FG011|Open-Label Period|Adverse Event|0|||
160987409|NCT04955626|581341117|FG012|Open-Label Period|Adverse Event|0|||
160987410|NCT04955626|581341118|FG013|Open-Label Period|Adverse Event|0|||
160987411|NCT04955626|581341119|FG014|Open-Label Period|Adverse Event|0|||
160987412|NCT04955626|581341120|FG015|Open-Label Period|Adverse Event|0|||
160987413|NCT04955626|581341121|FG016|Open-Label Period|Adverse Event|0|||
160645828|NCT01625377|580085904|FG000|Overall Study|Administrative Problem|1|||
160645829|NCT01625377|580085905|FG001|Overall Study|Administrative Problem|1|||
160645830|NCT01625377|580085904|FG000|Overall Study|Protocol Violation|0|||
160645831|NCT01625377|580085905|FG001|Overall Study|Protocol Violation|3|||
160645832|NCT01625377|580085904|FG000|Overall Study|Adverse Event|3|||
160645833|NCT01625377|580085905|FG001|Overall Study|Adverse Event|16|||
160645834|NCT01625377|580085904|FG000|Overall Study|Graft loss|1|||
160645835|NCT01625377|580085905|FG001|Overall Study|Graft loss|0|||
160645836|NCT01625377|580085904|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160645837|NCT01625377|580085905|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160645838|NCT01625377|580085904|FG000|Overall Study|Abnormal laboratory values|1|||
160645839|NCT01625377|580085905|FG001|Overall Study|Abnormal laboratory values|0|||
160645840|NCT01090765|580085908|FG000|Overall Study|Patient withdrew consent|0|||
160645841|NCT01090765|580085909|FG001|Overall Study|Patient withdrew consent|0|||
160645842|NCT01090765|580085910|FG002|Overall Study|Patient withdrew consent|0|||
160645843|NCT01090765|580085911|FG003|Overall Study|Patient withdrew consent|0|||
160645844|NCT01090765|580085912|FG004|Overall Study|Patient withdrew consent|1|||
160645845|NCT01090765|580085913|FG005|Overall Study|Patient withdrew consent|1|||
160645846|NCT01090765|580085908|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
160645847|NCT01090765|580085909|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
160645848|NCT01090765|580085910|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
160645849|NCT01090765|580085911|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
160645850|NCT01090765|580085912|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
160645851|NCT01090765|580085913|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
160645852|NCT01090765|580085908|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
160645853|NCT01090765|580085909|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
160645854|NCT01090765|580085910|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
160645855|NCT01090765|580085911|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
160645856|NCT01090765|580085912|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
160645857|NCT01090765|580085913|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
160645858|NCT01787825|580085914|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
160645859|NCT01787825|580085915|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
160645860|NCT01787825|580085914|FG000|Overall Study|Data Not Analyzable|5|||
160645861|NCT01787825|580085915|FG001|Overall Study|Data Not Analyzable|1|||
160645862|NCT01814137|580085917|FG000|Overall Study|Adverse Event|0|||
160645863|NCT01814137|580085918|FG001|Overall Study|Adverse Event|1|||
160645864|NCT01814137|580085917|FG000|Overall Study|Withdrawal by Subject|2|||
160645865|NCT01814137|580085918|FG001|Overall Study|Withdrawal by Subject|2|||
160645866|NCT01814137|580085917|FG000|Overall Study|Physician Decision|1|||
160645867|NCT01814137|580085918|FG001|Overall Study|Physician Decision|1|||
160645868|NCT01814137|580085917|FG000|Overall Study|Unclassified|2|||
160645869|NCT01814137|580085918|FG001|Overall Study|Unclassified|1|||
160645870|NCT00415532|580085919|FG000|Treatment Period|Adverse Event|2|||
160645871|NCT00415532|580085920|FG001|Treatment Period|Adverse Event|3|||
160645872|NCT00415532|580085919|FG000|Treatment Period|Death|2|||
160645873|NCT00415532|580085920|FG001|Treatment Period|Death|1|||
160645874|NCT00415532|580085919|FG000|Treatment Period|Lost to Follow-up|1|||
160645875|NCT00415532|580085920|FG001|Treatment Period|Lost to Follow-up|1|||
160645876|NCT00415532|580085919|FG000|Treatment Period|Protocol Violation|1|||
160645877|NCT00415532|580085920|FG001|Treatment Period|Protocol Violation|0|||
160645878|NCT00415532|580085919|FG000|Treatment Period|Withdrawal by Subject|6|||
160645879|NCT00415532|580085920|FG001|Treatment Period|Withdrawal by Subject|6|||
160645880|NCT00415532|580085919|FG000|Treatment Period|Other|2|||
160645881|NCT00415532|580085920|FG001|Treatment Period|Other|2|||
160645882|NCT00415532|580085919|FG000|Treatment Period|Ineligibility determined|1|||
160645883|NCT00415532|580085920|FG001|Treatment Period|Ineligibility determined|1|||
160645884|NCT00415532|580085919|FG000|Treatment Period|Noncompliance|1|||
160645885|NCT00415532|580085920|FG001|Treatment Period|Noncompliance|1|||
160645886|NCT00415532|580085919|FG000|Treatment Period|Requirement for alternative therapy|1|||
160645887|NCT00415532|580085920|FG001|Treatment Period|Requirement for alternative therapy|0|||
160645888|NCT00415532|580085919|FG000|Safety Follow Up Period|Adverse Event|1|||
160645889|NCT00415532|580085920|FG001|Safety Follow Up Period|Adverse Event|3|||
160645890|NCT00415532|580085919|FG000|Safety Follow Up Period|Death|3|||
160987414|NCT04955626|581341122|FG017|Open-Label Period|Adverse Event|0|||
160987415|NCT04955626|581341123|FG018|Open-Label Period|Adverse Event|0|||
160645891|NCT00415532|580085920|FG001|Safety Follow Up Period|Death|0|||
160987416|NCT04955626|581341124|FG019|Open-Label Period|Adverse Event|0|||
160645892|NCT00415532|580085919|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
160645893|NCT00415532|580085920|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
160815744|NCT03497975|580709365|FG000|Overall Study|Reason Not Specified|15|||
160815745|NCT03497975|580709366|FG001|Overall Study|Reason Not Specified|14|||
160815746|NCT02957747|580709367|FG000|Overall Study|Withdrawal by Subject|0|||
160815747|NCT02957747|580709368|FG001|Overall Study|Withdrawal by Subject|3|||
160815748|NCT02957747|580709367|FG000|Overall Study|Lost to Follow-up|10|||
160815749|NCT02957747|580709368|FG001|Overall Study|Lost to Follow-up|5|||
160815750|NCT00888329|580709369|FG000|Overall Study|Physician Decision|6|||
160815751|NCT00888329|580709370|FG001|Overall Study|Physician Decision|9|||
160815752|NCT01355679|580709374|FG000|Overall Study|benign tumor types found at biopsy|2|||
160815753|NCT02027311|580709375|FG000|Overall Study|Protocol Violation|3|||
160815754|NCT02027311|580709376|FG001|Overall Study|Protocol Violation|2|||
160815755|NCT03928418|580709377|FG000|Overall Study|Lost to Follow-up|5|||
160815756|NCT03928418|580709378|FG001|Overall Study|Lost to Follow-up|3|||
160815757|NCT03928418|580709379|FG002|Overall Study|Lost to Follow-up|5|||
160815758|NCT03928418|580709377|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
160815759|NCT03928418|580709378|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
160815760|NCT03928418|580709379|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
160815761|NCT00964002|580709381|FG000|Overall Study|Protocol Violation|8|||
160815762|NCT03768089|580709389|FG000|Part A|Lost to Follow-up|0|||
160815763|NCT03768089|580709390|FG001|Part A|Lost to Follow-up|0|||
160815764|NCT03768089|580709391|FG002|Part A|Lost to Follow-up|0|||
160815765|NCT03768089|580709392|FG003|Part A|Lost to Follow-up|0|||
160815766|NCT03768089|580709393|FG004|Part A|Lost to Follow-up|1|||
160815767|NCT03768089|580709394|FG005|Part A|Lost to Follow-up|0|||
160815768|NCT03768089|580709395|FG006|Part A|Lost to Follow-up|0|||
160815769|NCT03768089|580709396|FG007|Part A|Lost to Follow-up|0|||
160815770|NCT03768089|580709397|FG008|Part A|Lost to Follow-up|0|||
160815771|NCT03768089|580709398|FG009|Part A|Lost to Follow-up|0|||
160815772|NCT03768089|580709399|FG010|Part A|Lost to Follow-up|0|||
160815773|NCT03768089|580709400|FG011|Part A|Lost to Follow-up|0|||
160815774|NCT03768089|580709401|FG012|Part A|Lost to Follow-up|0|||
160815775|NCT03768089|580709402|FG013|Part A|Lost to Follow-up|0|||
160815776|NCT03768089|580709403|FG014|Part A|Lost to Follow-up|0|||
160815777|NCT03768089|580709404|FG015|Part A|Lost to Follow-up|0|||
160815778|NCT03768089|580709405|FG016|Part A|Lost to Follow-up|0|||
160815779|NCT03768089|580709406|FG017|Part A|Lost to Follow-up|0|||
160815780|NCT03768089|580709389|FG000|Part C|Randomized, Never Dosed|0|||
160815781|NCT03768089|580709390|FG001|Part C|Randomized, Never Dosed|0|||
160815782|NCT03768089|580709391|FG002|Part C|Randomized, Never Dosed|0|||
160815783|NCT03768089|580709392|FG003|Part C|Randomized, Never Dosed|0|||
160815784|NCT03768089|580709393|FG004|Part C|Randomized, Never Dosed|0|||
160815785|NCT03768089|580709394|FG005|Part C|Randomized, Never Dosed|0|||
160815786|NCT03768089|580709395|FG006|Part C|Randomized, Never Dosed|0|||
160815787|NCT03768089|580709396|FG007|Part C|Randomized, Never Dosed|0|||
160815788|NCT03768089|580709397|FG008|Part C|Randomized, Never Dosed|0|||
160815789|NCT03768089|580709398|FG009|Part C|Randomized, Never Dosed|0|||
160552783|NCT01582308|579748529|FG004|10-day Washout Following Period 1|Physician Decision|1|||
160552784|NCT01582308|579748530|FG005|10-day Washout Following Period 1|Physician Decision|0|||
160552785|NCT01582308|579748531|FG006|10-day Washout Following Period 1|Physician Decision|0|||
160552786|NCT01582308|579748532|FG007|10-day Washout Following Period 1|Physician Decision|0|||
160552787|NCT01582308|579748533|FG008|10-day Washout Following Period 1|Physician Decision|0|||
160987417|NCT04955626|581341125|FG020|Open-Label Period|Adverse Event|0|||
160987418|NCT04955626|581341126|FG021|Open-Label Period|Adverse Event|0|||
160987419|NCT04955626|581341127|FG022|Open-Label Period|Adverse Event|0|||
160552788|NCT01582308|579748534|FG009|10-day Washout Following Period 1|Physician Decision|0|||
160552789|NCT01582308|579748525|FG000|Period 4|Physician Decision|1|||
160552790|NCT01582308|579748526|FG001|Period 4|Physician Decision|0|||
160552791|NCT01582308|579748527|FG002|Period 4|Physician Decision|0|||
160552792|NCT01582308|579748528|FG003|Period 4|Physician Decision|0|||
160552793|NCT01582308|579748529|FG004|Period 4|Physician Decision|0|||
160815790|NCT03768089|580709399|FG010|Part C|Randomized, Never Dosed|0|||
160815791|NCT03768089|580709400|FG011|Part C|Randomized, Never Dosed|0|||
160815792|NCT03768089|580709401|FG012|Part C|Randomized, Never Dosed|0|||
160815793|NCT03768089|580709402|FG013|Part C|Randomized, Never Dosed|0|||
160815794|NCT03768089|580709403|FG014|Part C|Randomized, Never Dosed|1|||
160815795|NCT03768089|580709404|FG015|Part C|Randomized, Never Dosed|0|||
160552794|NCT01582308|579748530|FG005|Period 4|Physician Decision|1|||
160552795|NCT01582308|579748531|FG006|Period 4|Physician Decision|0|||
160815796|NCT03768089|580709405|FG016|Part C|Randomized, Never Dosed|0|||
160815797|NCT03768089|580709406|FG017|Part C|Randomized, Never Dosed|0|||
160815798|NCT02091362|580709411|FG000|Period 1|Protocol Violation|1|||
160815799|NCT02091362|580709412|FG001|Period 1|Protocol Violation|0|||
160815800|NCT02091362|580709411|FG000|Period 1|Withdrawal by Subject|2|||
160815801|NCT02091362|580709412|FG001|Period 1|Withdrawal by Subject|3|||
160815802|NCT02091362|580709411|FG000|Period 1|Lost to Follow-up|0|||
160815803|NCT02091362|580709412|FG001|Period 1|Lost to Follow-up|1|||
160815804|NCT02091362|580709411|FG000|Period 1|Adverse Event|2|||
160815805|NCT02091362|580709412|FG001|Period 1|Adverse Event|0|||
160815806|NCT02091362|580709411|FG000|Wash-out|Lost to Follow-up|1|||
160815807|NCT02091362|580709412|FG001|Wash-out|Lost to Follow-up|1|||
160815808|NCT02091362|580709411|FG000|Wash-out|Withdrawal by Subject|0|||
160815809|NCT02091362|580709412|FG001|Wash-out|Withdrawal by Subject|2|||
160815810|NCT02091362|580709411|FG000|Period 2|Adverse Event|1|||
160815811|NCT02091362|580709412|FG001|Period 2|Adverse Event|0|||
160815812|NCT02091362|580709411|FG000|Period 2|Lost to Follow-up|0|||
160815813|NCT02091362|580709412|FG001|Period 2|Lost to Follow-up|1|||
160815814|NCT02091362|580709411|FG000|Period 2|Withdrawal by Subject|1|||
160815815|NCT02091362|580709412|FG001|Period 2|Withdrawal by Subject|1|||
160815816|NCT02466425|580709413|FG000|Overall Study|Adverse Event|3|||
160815817|NCT02466425|580709414|FG001|Overall Study|Adverse Event|11|||
160815818|NCT02466425|580709413|FG000|Overall Study|Lack of Efficacy|4|||
160815819|NCT02466425|580709414|FG001|Overall Study|Lack of Efficacy|1|||
160815820|NCT02466425|580709413|FG000|Overall Study|Lost to Follow-up|3|||
160815821|NCT02466425|580709414|FG001|Overall Study|Lost to Follow-up|0|||
160815822|NCT02466425|580709413|FG000|Overall Study|Protocol Violation|1|||
160815823|NCT02466425|580709414|FG001|Overall Study|Protocol Violation|0|||
160815824|NCT02466425|580709413|FG000|Overall Study|Withdrawal by Subject|0|||
160815825|NCT02466425|580709414|FG001|Overall Study|Withdrawal by Subject|1|||
160815826|NCT02466425|580709413|FG000|Overall Study|Other|1|||
160815827|NCT02466425|580709414|FG001|Overall Study|Other|3|||
160815828|NCT02466425|580709413|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160815829|NCT02466425|580709414|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160815830|NCT05141175|580709423|FG000|Overall Study|Withdrawal by Subject|1|||
160815831|NCT00902850|580709426|FG000|Overall Study|Physician Decision|2|||
160815832|NCT00902850|580709427|FG001|Overall Study|Physician Decision|2|||
160815833|NCT04470050|580709432|FG000|Double-blind Treatment Phase|Adverse Event|0|||
160815834|NCT04470050|580709433|FG001|Double-blind Treatment Phase|Adverse Event|0|||
160815835|NCT04470050|580709434|FG002|Double-blind Treatment Phase|Adverse Event|0|||
160815836|NCT04470050|580709435|FG003|Double-blind Treatment Phase|Adverse Event|1|||
160815837|NCT04470050|580709436|FG004|Double-blind Treatment Phase|Adverse Event|0|||
160815838|NCT04470050|580709437|FG005|Double-blind Treatment Phase|Adverse Event|0|||
160815839|NCT04470050|580709438|FG006|Double-blind Treatment Phase|Adverse Event|0|||
160815840|NCT04470050|580709432|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815841|NCT04470050|580709433|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815842|NCT04470050|580709434|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815843|NCT04470050|580709435|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815844|NCT04470050|580709436|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
160815845|NCT04470050|580709437|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815846|NCT04470050|580709438|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815847|NCT04470050|580709432|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
160815848|NCT04470050|580709433|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
160815849|NCT04470050|580709434|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
160815850|NCT04470050|580709435|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
160815851|NCT04470050|580709436|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
160815852|NCT04470050|580709437|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
160815853|NCT04470050|580709438|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
160815854|NCT03098433|580709439|FG000|Overall Study|Withdrawal by Subject|10|||
160815855|NCT01813058|580709440|FG000|Overall Study|Withdrawal by Subject|5|||
160815856|NCT01813058|580709441|FG001|Overall Study|Withdrawal by Subject|4|||
160815857|NCT03585764|580709442|FG000|Overall Study|Death|3|||
160815858|NCT03585764|580709443|FG001|Overall Study|Death|2|||
160815859|NCT03585764|580709444|FG002|Overall Study|Death|3|||
160815860|NCT03585764|580709445|FG003|Overall Study|Death|0|||
160815861|NCT03585764|580709442|FG000|Overall Study|Lost to Follow-up|0|||
160815862|NCT03585764|580709443|FG001|Overall Study|Lost to Follow-up|1|||
160815863|NCT03585764|580709444|FG002|Overall Study|Lost to Follow-up|0|||
160815864|NCT03585764|580709445|FG003|Overall Study|Lost to Follow-up|0|||
160815865|NCT03585764|580709442|FG000|Overall Study|Physician Decision|0|||
160815866|NCT03585764|580709443|FG001|Overall Study|Physician Decision|0|||
160815867|NCT03585764|580709444|FG002|Overall Study|Physician Decision|2|||
160815868|NCT03585764|580709445|FG003|Overall Study|Physician Decision|0|||
160815869|NCT01581021|580709447|FG000|Overall Study|Lost to Follow-up|4|||
160815870|NCT01581021|580709448|FG001|Overall Study|Lost to Follow-up|6|||
160815871|NCT01581021|580709447|FG000|Overall Study|More than 2 hooks in thoracic|3|||
160815872|NCT01581021|580709448|FG001|Overall Study|More than 2 hooks in thoracic|0|||
160815873|NCT01581021|580709447|FG000|Overall Study|Neuromuscular|2|||
160815874|NCT01581021|580709448|FG001|Overall Study|Neuromuscular|1|||
160815875|NCT01581021|580709447|FG000|Overall Study|Not Randomized|1|||
160815876|NCT01581021|580709448|FG001|Overall Study|Not Randomized|2|||
160815877|NCT01581021|580709447|FG000|Overall Study|Lenke 6 Classification|0|||
160815878|NCT01581021|580709448|FG001|Overall Study|Lenke 6 Classification|1|||
160815879|NCT01581021|580709447|FG000|Overall Study|Lack of Efficacy|0|||
160815880|NCT01581021|580709448|FG001|Overall Study|Lack of Efficacy|1|||
160815881|NCT03604172|580709451|FG000|Overall Study|Lost to Follow-up|1|||
160815882|NCT03604172|580709452|FG001|Overall Study|Lost to Follow-up|2|||
160815883|NCT00054327|580709453|FG000|Overall Study|Engraftment failure|1|||
160815884|NCT00054327|580709454|FG001|Overall Study|Engraftment failure|0|||
160815885|NCT00054327|580709455|FG002|Overall Study|Engraftment failure|0|||
160815886|NCT00054327|580709456|FG003|Overall Study|Engraftment failure|0|||
160815887|NCT00054327|580709457|FG004|Overall Study|Engraftment failure|0|||
160815888|NCT00054327|580709458|FG005|Overall Study|Engraftment failure|0|||
160815889|NCT03028129|580709461|FG000|Overall Study|Adverse Event|13|||
160815890|NCT03028129|580709462|FG001|Overall Study|Adverse Event|2|||
160815891|NCT03028129|580709461|FG000|Overall Study|Lost to Follow-up|50|||
160815892|NCT03028129|580709462|FG001|Overall Study|Lost to Follow-up|38|||
160815893|NCT03028129|580709461|FG000|Overall Study|Physician Decision|0|||
160815894|NCT03028129|580709462|FG001|Overall Study|Physician Decision|1|||
160815895|NCT03028129|580709461|FG000|Overall Study|Protocol Violation|1|||
160815896|NCT03028129|580709462|FG001|Overall Study|Protocol Violation|1|||
160815897|NCT03028129|580709461|FG000|Overall Study|Withdrawal by Subject|62|||
160815898|NCT03028129|580709462|FG001|Overall Study|Withdrawal by Subject|45|||
160815899|NCT00923351|580709463|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
160815900|NCT00923351|580709464|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
160815901|NCT00923351|580709465|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
160815902|NCT00395486|580709470|FG000|Overall Study|Adverse Event|1|||
160815903|NCT00395486|580709471|FG001|Overall Study|Adverse Event|2|||
160815904|NCT00395486|580709470|FG000|Overall Study|Withdrawal by Subject|5|||
160815905|NCT00395486|580709471|FG001|Overall Study|Withdrawal by Subject|2|||
160815906|NCT00395486|580709470|FG000|Overall Study|Lost to Follow-up|0|||
160815907|NCT00395486|580709471|FG001|Overall Study|Lost to Follow-up|1|||
160815908|NCT00734604|580711906|FG000|Overall Study|Adverse Event|0|||
160815909|NCT00734604|580711907|FG001|Overall Study|Adverse Event|2|||
160815910|NCT00734604|580711908|FG002|Overall Study|Adverse Event|0|||
160815911|NCT00734604|580711909|FG003|Overall Study|Adverse Event|2|||
160815912|NCT00734604|580711910|FG004|Overall Study|Adverse Event|1|||
160815913|NCT00734604|580711911|FG005|Overall Study|Adverse Event|1|||
160815914|NCT00734604|580711906|FG000|Overall Study|Serious Adverse Event|1|||
160815915|NCT00734604|580711907|FG001|Overall Study|Serious Adverse Event|0|||
160815916|NCT00734604|580711908|FG002|Overall Study|Serious Adverse Event|1|||
160815917|NCT00734604|580711909|FG003|Overall Study|Serious Adverse Event|2|||
160815918|NCT00734604|580711910|FG004|Overall Study|Serious Adverse Event|0|||
160815919|NCT00734604|580711911|FG005|Overall Study|Serious Adverse Event|1|||
160815920|NCT00734604|580711906|FG000|Overall Study|Lost to Follow-up|1|||
160815921|NCT00734604|580711907|FG001|Overall Study|Lost to Follow-up|2|||
160815922|NCT00734604|580711908|FG002|Overall Study|Lost to Follow-up|2|||
160815923|NCT00734604|580711909|FG003|Overall Study|Lost to Follow-up|4|||
160815924|NCT00734604|580711910|FG004|Overall Study|Lost to Follow-up|2|||
160815925|NCT00734604|580711911|FG005|Overall Study|Lost to Follow-up|3|||
160815926|NCT00734604|580711906|FG000|Overall Study|Physician Decision|0|||
160815927|NCT00734604|580711907|FG001|Overall Study|Physician Decision|1|||
160815928|NCT00734604|580711908|FG002|Overall Study|Physician Decision|1|||
160815929|NCT00734604|580711909|FG003|Overall Study|Physician Decision|0|||
160815930|NCT00734604|580711910|FG004|Overall Study|Physician Decision|0|||
160815931|NCT00734604|580711911|FG005|Overall Study|Physician Decision|0|||
160815932|NCT00734604|580711906|FG000|Overall Study|Protocol Violation|0|||
160815933|NCT00734604|580711907|FG001|Overall Study|Protocol Violation|2|||
160815934|NCT00734604|580711908|FG002|Overall Study|Protocol Violation|0|||
160815935|NCT00734604|580711909|FG003|Overall Study|Protocol Violation|0|||
160815936|NCT00734604|580711910|FG004|Overall Study|Protocol Violation|1|||
160815937|NCT00734604|580711911|FG005|Overall Study|Protocol Violation|0|||
160815938|NCT00734604|580711906|FG000|Overall Study|Sponsor Decision|1|||
160815939|NCT00734604|580711907|FG001|Overall Study|Sponsor Decision|2|||
160815940|NCT00734604|580711908|FG002|Overall Study|Sponsor Decision|1|||
160815941|NCT00734604|580711909|FG003|Overall Study|Sponsor Decision|0|||
160815942|NCT00734604|580711910|FG004|Overall Study|Sponsor Decision|2|||
160815943|NCT00734604|580711911|FG005|Overall Study|Sponsor Decision|0|||
160815944|NCT00734604|580711906|FG000|Overall Study|Withdrawal by Subject|0|||
160815945|NCT00734604|580711907|FG001|Overall Study|Withdrawal by Subject|2|||
160815946|NCT00734604|580711908|FG002|Overall Study|Withdrawal by Subject|0|||
160815947|NCT00734604|580711909|FG003|Overall Study|Withdrawal by Subject|1|||
160815948|NCT00734604|580711910|FG004|Overall Study|Withdrawal by Subject|2|||
160815949|NCT00734604|580711911|FG005|Overall Study|Withdrawal by Subject|1|||
160815950|NCT00734604|580711906|FG000|Overall Study|Lack of Efficacy|0|||
160815951|NCT00734604|580711907|FG001|Overall Study|Lack of Efficacy|1|||
160815952|NCT00734604|580711908|FG002|Overall Study|Lack of Efficacy|1|||
160815953|NCT00734604|580711909|FG003|Overall Study|Lack of Efficacy|0|||
160815954|NCT00734604|580711910|FG004|Overall Study|Lack of Efficacy|0|||
160815955|NCT00734604|580711911|FG005|Overall Study|Lack of Efficacy|0|||
160815956|NCT02199314|580711912|FG000|Overall Study|Withdrawal by Subject|6|||
160815957|NCT02199314|580711912|FG000|Overall Study|Physician Decision|10|||
160815958|NCT02242435|580711915|FG000|Overall Study|Lost to Follow-up|3|||
160815959|NCT02242435|580711916|FG001|Overall Study|Lost to Follow-up|4|||
160815960|NCT02242435|580711915|FG000|Overall Study|Adverse Event|3|||
160815961|NCT02242435|580711916|FG001|Overall Study|Adverse Event|2|||
160815962|NCT02242435|580711915|FG000|Overall Study|Withdrawal by Subject|13|||
160815963|NCT02242435|580711916|FG001|Overall Study|Withdrawal by Subject|8|||
160815964|NCT02242435|580711915|FG000|Overall Study|Death|0|||
160815965|NCT02242435|580711916|FG001|Overall Study|Death|1|||
160815966|NCT02242435|580711915|FG000|Overall Study|Protocol Violation|1|||
160815967|NCT02242435|580711916|FG001|Overall Study|Protocol Violation|0|||
160815968|NCT02242435|580711915|FG000|Overall Study|Physician Decision|0|||
160815969|NCT02242435|580711916|FG001|Overall Study|Physician Decision|1|||
160900327|NCT02557295|581028703|FG005|Overall Study|Lack of Efficacy|0|||
160900328|NCT02557295|581028704|FG006|Overall Study|Lack of Efficacy|12|||
160900329|NCT02557295|581028705|FG007|Overall Study|Lack of Efficacy|1|||
160900330|NCT02557295|581028706|FG008|Overall Study|Lack of Efficacy|0|||
160900331|NCT02557295|581028698|FG000|Overall Study|Adverse Event|16|||
160900332|NCT02557295|581028699|FG001|Overall Study|Adverse Event|2|||
160900333|NCT02557295|581028700|FG002|Overall Study|Adverse Event|3|||
160900334|NCT02557295|581028701|FG003|Overall Study|Adverse Event|0|||
160900335|NCT02557295|581028702|FG004|Overall Study|Adverse Event|0|||
160900336|NCT02557295|581028703|FG005|Overall Study|Adverse Event|0|||
160900337|NCT02557295|581028704|FG006|Overall Study|Adverse Event|2|||
160900338|NCT02557295|581028705|FG007|Overall Study|Adverse Event|1|||
160900339|NCT02557295|581028706|FG008|Overall Study|Adverse Event|1|||
160900340|NCT02557295|581028698|FG000|Overall Study|Lost to Follow-up|4|||
160900341|NCT02557295|581028699|FG001|Overall Study|Lost to Follow-up|0|||
160900342|NCT02557295|581028700|FG002|Overall Study|Lost to Follow-up|0|||
160900343|NCT02557295|581028701|FG003|Overall Study|Lost to Follow-up|0|||
160645894|NCT00415532|580085919|FG000|Safety Follow Up Period|Other|1|||
160645895|NCT00415532|580085920|FG001|Safety Follow Up Period|Other|4|||
160645896|NCT00415532|580085919|FG000|Safety Follow Up Period|Ineligibility determined|1|||
160645897|NCT00415532|580085920|FG001|Safety Follow Up Period|Ineligibility determined|1|||
160645898|NCT00415532|580085919|FG000|Safety Follow Up Period|Noncompliance|1|||
160645899|NCT00415532|580085920|FG001|Safety Follow Up Period|Noncompliance|0|||
160645900|NCT00415532|580085919|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
160645901|NCT00415532|580085920|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
160645902|NCT01798485|580085921|FG000|Overall Study|Adverse Event|32|||
160645903|NCT01798485|580085922|FG001|Overall Study|Adverse Event|40|||
160645904|NCT01798485|580085921|FG000|Overall Study|Withdrawal by Subject|27|||
160645905|NCT01798485|580085922|FG001|Overall Study|Withdrawal by Subject|31|||
160645906|NCT01798485|580085921|FG000|Overall Study|Lost to Follow-up|0|||
160645907|NCT01798485|580085922|FG001|Overall Study|Lost to Follow-up|3|||
160645908|NCT01798485|580085921|FG000|Overall Study|Physician Decision|14|||
160645909|NCT01798485|580085922|FG001|Overall Study|Physician Decision|10|||
160645910|NCT01798485|580085921|FG000|Overall Study|Objective Disease Progression|152|||
160645911|NCT01798485|580085922|FG001|Overall Study|Objective Disease Progression|106|||
160645912|NCT01798485|580085921|FG000|Overall Study|Death|25|||
160645913|NCT01798485|580085922|FG001|Overall Study|Death|22|||
160645914|NCT01798485|580085921|FG000|Overall Study|Sponsor Decision|61|||
160645915|NCT01798485|580085922|FG001|Overall Study|Sponsor Decision|54|||
160645916|NCT01798485|580085921|FG000|Overall Study|Clinical Progression|35|||
160645917|NCT01798485|580085922|FG001|Overall Study|Clinical Progression|24|||
160815970|NCT02557100|580711927|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
160815971|NCT02557100|580711928|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
160815972|NCT02557100|580711929|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
160900344|NCT02557295|581028702|FG004|Overall Study|Lost to Follow-up|0|||
160900345|NCT02557295|581028703|FG005|Overall Study|Lost to Follow-up|0|||
160900346|NCT02557295|581028704|FG006|Overall Study|Lost to Follow-up|9|||
160900347|NCT02557295|581028705|FG007|Overall Study|Lost to Follow-up|0|||
160987420|NCT04955626|581341128|FG023|Open-Label Period|Adverse Event|0|||
160987421|NCT04955626|581341129|FG024|Open-Label Period|Adverse Event|0|||
160987422|NCT04955626|581341130|FG025|Open-Label Period|Adverse Event|0|||
160987423|NCT04955626|581341131|FG026|Open-Label Period|Adverse Event|0|||
160987424|NCT04955626|581341132|FG027|Open-Label Period|Adverse Event|0|||
160987425|NCT04955626|581341133|FG028|Open-Label Period|Adverse Event|0|||
160987426|NCT04955626|581341134|FG029|Open-Label Period|Adverse Event|0|||
160987427|NCT04955626|581341135|FG030|Open-Label Period|Adverse Event|0|||
160987428|NCT04955626|581341136|FG031|Open-Label Period|Adverse Event|0|||
160987429|NCT04955626|581341137|FG032|Open-Label Period|Adverse Event|0|||
160987430|NCT04955626|581341138|FG033|Open-Label Period|Adverse Event|0|||
160815973|NCT02557100|580711927|FG000|Single Blind Treatment Period|Death|0|||
160815974|NCT02557100|580711928|FG001|Single Blind Treatment Period|Death|1|||
160815975|NCT02557100|580711929|FG002|Single Blind Treatment Period|Death|0|||
160815976|NCT02557100|580711927|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
160815977|NCT02557100|580711928|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
160815978|NCT02557100|580711929|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
160815979|NCT02557100|580711927|FG000|Single Blind Treatment Period|Adverse Event|0|||
160815980|NCT02557100|580711928|FG001|Single Blind Treatment Period|Adverse Event|1|||
160815981|NCT02557100|580711929|FG002|Single Blind Treatment Period|Adverse Event|0|||
160815982|NCT02557100|580711927|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
160815983|NCT02557100|580711928|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
160815984|NCT02557100|580711929|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
160815985|NCT02557100|580711927|FG000|Cumulative Abatacept Period|Other Reasons|0|||
160815986|NCT02557100|580711928|FG001|Cumulative Abatacept Period|Other Reasons|0|||
160815987|NCT02557100|580711929|FG002|Cumulative Abatacept Period|Other Reasons|1|||
160815988|NCT02557100|580711927|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
160815989|NCT02557100|580711928|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
160815990|NCT02557100|580711929|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
160815991|NCT02557100|580711927|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
160815992|NCT02557100|580711928|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
160815993|NCT02557100|580711929|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
160815994|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
160815995|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
160815996|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
160815997|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
160815998|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
160815999|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
160816000|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
160816001|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
160816002|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
160816003|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
160816004|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
160816005|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
160816006|NCT02513485|580711935|FG000|Overall Study|Adverse Event|1|||
160816007|NCT02513485|580711936|FG001|Overall Study|Adverse Event|0|||
160816008|NCT00489424|580711950|FG000|Overall Study|Adverse Event|3|||
160816009|NCT00489424|580711951|FG001|Overall Study|Adverse Event|3|||
160816010|NCT00489424|580711952|FG002|Overall Study|Adverse Event|4|||
160816011|NCT00489424|580711950|FG000|Overall Study|Lack of Efficacy|1|||
160816012|NCT00489424|580711951|FG001|Overall Study|Lack of Efficacy|0|||
160816013|NCT00489424|580711952|FG002|Overall Study|Lack of Efficacy|0|||
160816014|NCT00489424|580711950|FG000|Overall Study|Administrative problems|0|||
160816015|NCT00489424|580711951|FG001|Overall Study|Administrative problems|2|||
160816016|NCT00489424|580711952|FG002|Overall Study|Administrative problems|1|||
160816017|NCT00394251|580711953|FG000|Overall Study|Adverse Event|7|||
160816018|NCT00394251|580711954|FG001|Overall Study|Adverse Event|5|||
160816019|NCT00394251|580711953|FG000|Overall Study|Unacceptable Toxicity|20|||
160987431|NCT04955626|581341139|FG034|Open-Label Period|Adverse Event|0|||
160987432|NCT04955626|581341140|FG035|Open-Label Period|Adverse Event|0|||
160987433|NCT04955626|581341105|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
160816020|NCT00394251|580711954|FG001|Overall Study|Unacceptable Toxicity|18|||
160816021|NCT00394251|580711953|FG000|Overall Study|Physician Decision|1|||
160816022|NCT00394251|580711954|FG001|Overall Study|Physician Decision|1|||
160816023|NCT00394251|580711953|FG000|Overall Study|Protocol Violation|0|||
160816024|NCT00394251|580711954|FG001|Overall Study|Protocol Violation|1|||
160816025|NCT00394251|580711953|FG000|Overall Study|Withdrawal by Subject|7|||
160816026|NCT00394251|580711954|FG001|Overall Study|Withdrawal by Subject|11|||
160816027|NCT00394251|580711953|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
160816028|NCT00394251|580711954|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
160987434|NCT04955626|581341106|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
160816029|NCT01558115|580711955|FG000|Overall Study|Withdrawal by Subject|3|||
160816030|NCT01558115|580711955|FG000|Overall Study|Study closed due to poor enrollment|4|||
160816031|NCT01436656|580711956|FG000|Dose Escalation|Death|1|||
160816032|NCT01436656|580711957|FG001|Dose Escalation|Death|3|||
160816033|NCT01436656|580711958|FG002|Dose Escalation|Death|1|||
160816034|NCT01436656|580711959|FG003|Dose Escalation|Death|0|||
160816035|NCT01436656|580711960|FG004|Dose Escalation|Death|2|||
160816036|NCT01436656|580711961|FG005|Dose Escalation|Death|1|||
160816037|NCT01436656|580711962|FG006|Dose Escalation|Death|1|||
160816038|NCT01436656|580711963|FG007|Dose Escalation|Death|1|||
160816039|NCT01436656|580711964|FG008|Dose Escalation|Death|1|||
160816040|NCT01436656|580711965|FG009|Dose Escalation|Death|0|||
160816041|NCT01436656|580711966|FG010|Dose Escalation|Death|0|||
160816042|NCT01436656|580711967|FG011|Dose Escalation|Death|0|||
160816043|NCT01436656|580711968|FG012|Dose Escalation|Death|0|||
160816044|NCT01436656|580711969|FG013|Dose Escalation|Death|0|||
160816045|NCT01436656|580711970|FG014|Dose Escalation|Death|0|||
160816046|NCT01436656|580711971|FG015|Dose Escalation|Death|0|||
160816047|NCT01436656|580711972|FG016|Dose Escalation|Death|0|||
160816048|NCT01436656|580711973|FG017|Dose Escalation|Death|0|||
160816049|NCT01436656|580711956|FG000|Dose Escalation|Protocol Violation|0|||
160816050|NCT01436656|580711957|FG001|Dose Escalation|Protocol Violation|0|||
160816051|NCT01436656|580711958|FG002|Dose Escalation|Protocol Violation|0|||
160816052|NCT01436656|580711959|FG003|Dose Escalation|Protocol Violation|0|||
160816053|NCT01436656|580711960|FG004|Dose Escalation|Protocol Violation|0|||
160816054|NCT01436656|580711961|FG005|Dose Escalation|Protocol Violation|1|||
160816055|NCT01436656|580711962|FG006|Dose Escalation|Protocol Violation|0|||
160816056|NCT01436656|580711963|FG007|Dose Escalation|Protocol Violation|0|||
160816057|NCT01436656|580711964|FG008|Dose Escalation|Protocol Violation|0|||
160816058|NCT01436656|580711965|FG009|Dose Escalation|Protocol Violation|0|||
160816059|NCT01436656|580711966|FG010|Dose Escalation|Protocol Violation|0|||
160816060|NCT01436656|580711967|FG011|Dose Escalation|Protocol Violation|0|||
160816061|NCT01436656|580711968|FG012|Dose Escalation|Protocol Violation|0|||
160816062|NCT01436656|580711969|FG013|Dose Escalation|Protocol Violation|0|||
160816063|NCT01436656|580711970|FG014|Dose Escalation|Protocol Violation|0|||
160816064|NCT01436656|580711971|FG015|Dose Escalation|Protocol Violation|0|||
160816065|NCT01436656|580711972|FG016|Dose Escalation|Protocol Violation|0|||
160816066|NCT01436656|580711973|FG017|Dose Escalation|Protocol Violation|0|||
160816067|NCT01436656|580711956|FG000|Dose Escalation|Withdrawal by Subject|0|||
160816068|NCT01436656|580711957|FG001|Dose Escalation|Withdrawal by Subject|0|||
160816069|NCT01436656|580711958|FG002|Dose Escalation|Withdrawal by Subject|0|||
160816070|NCT01436656|580711959|FG003|Dose Escalation|Withdrawal by Subject|0|||
160816071|NCT01436656|580711960|FG004|Dose Escalation|Withdrawal by Subject|1|||
160816072|NCT01436656|580711961|FG005|Dose Escalation|Withdrawal by Subject|0|||
160816073|NCT01436656|580711962|FG006|Dose Escalation|Withdrawal by Subject|0|||
160816074|NCT01436656|580711963|FG007|Dose Escalation|Withdrawal by Subject|2|||
160816075|NCT01436656|580711964|FG008|Dose Escalation|Withdrawal by Subject|0|||
160816076|NCT01436656|580711965|FG009|Dose Escalation|Withdrawal by Subject|1|||
160816077|NCT01436656|580711966|FG010|Dose Escalation|Withdrawal by Subject|1|||
160816078|NCT01436656|580711967|FG011|Dose Escalation|Withdrawal by Subject|0|||
160816079|NCT01436656|580711968|FG012|Dose Escalation|Withdrawal by Subject|0|||
160816080|NCT01436656|580711969|FG013|Dose Escalation|Withdrawal by Subject|0|||
160645918|NCT01952574|580085923|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
160816081|NCT01436656|580711970|FG014|Dose Escalation|Withdrawal by Subject|0|||
160816082|NCT01436656|580711971|FG015|Dose Escalation|Withdrawal by Subject|0|||
160816083|NCT01436656|580711972|FG016|Dose Escalation|Withdrawal by Subject|0|||
160816084|NCT01436656|580711973|FG017|Dose Escalation|Withdrawal by Subject|0|||
160816085|NCT01436656|580711956|FG000|Dose Escalation|Administrative problems|0|||
160816086|NCT01436656|580711957|FG001|Dose Escalation|Administrative problems|1|||
160816087|NCT01436656|580711958|FG002|Dose Escalation|Administrative problems|0|||
160816088|NCT01436656|580711959|FG003|Dose Escalation|Administrative problems|0|||
160816089|NCT01436656|580711960|FG004|Dose Escalation|Administrative problems|0|||
160816090|NCT01436656|580711961|FG005|Dose Escalation|Administrative problems|0|||
160816091|NCT01436656|580711962|FG006|Dose Escalation|Administrative problems|0|||
160816092|NCT01436656|580711963|FG007|Dose Escalation|Administrative problems|0|||
160816093|NCT01436656|580711964|FG008|Dose Escalation|Administrative problems|0|||
160816094|NCT01436656|580711965|FG009|Dose Escalation|Administrative problems|0|||
160900348|NCT02557295|581028706|FG008|Overall Study|Lost to Follow-up|0|||
160900349|NCT02557295|581028698|FG000|Overall Study|Study Close|54|||
160900350|NCT02557295|581028699|FG001|Overall Study|Study Close|3|||
160900351|NCT02557295|581028700|FG002|Overall Study|Study Close|5|||
160816095|NCT01436656|580711966|FG010|Dose Escalation|Administrative problems|0|||
160816096|NCT01436656|580711967|FG011|Dose Escalation|Administrative problems|0|||
160816097|NCT01436656|580711968|FG012|Dose Escalation|Administrative problems|0|||
160816098|NCT01436656|580711969|FG013|Dose Escalation|Administrative problems|0|||
160816099|NCT01436656|580711970|FG014|Dose Escalation|Administrative problems|0|||
160816100|NCT01436656|580711971|FG015|Dose Escalation|Administrative problems|0|||
160816101|NCT01436656|580711972|FG016|Dose Escalation|Administrative problems|0|||
160816102|NCT01436656|580711973|FG017|Dose Escalation|Administrative problems|0|||
160816103|NCT01436656|580711956|FG000|Dose Escalation|Lost to Follow-up|1|||
160816104|NCT01436656|580711957|FG001|Dose Escalation|Lost to Follow-up|0|||
160816105|NCT01436656|580711958|FG002|Dose Escalation|Lost to Follow-up|0|||
160816106|NCT01436656|580711959|FG003|Dose Escalation|Lost to Follow-up|0|||
160816107|NCT01436656|580711960|FG004|Dose Escalation|Lost to Follow-up|1|||
160816108|NCT01436656|580711961|FG005|Dose Escalation|Lost to Follow-up|0|||
160816109|NCT01436656|580711962|FG006|Dose Escalation|Lost to Follow-up|0|||
160816110|NCT01436656|580711963|FG007|Dose Escalation|Lost to Follow-up|0|||
160816111|NCT01436656|580711964|FG008|Dose Escalation|Lost to Follow-up|0|||
160816112|NCT01436656|580711965|FG009|Dose Escalation|Lost to Follow-up|0|||
160816113|NCT01436656|580711966|FG010|Dose Escalation|Lost to Follow-up|0|||
160816114|NCT01436656|580711967|FG011|Dose Escalation|Lost to Follow-up|0|||
160816115|NCT01436656|580711968|FG012|Dose Escalation|Lost to Follow-up|0|||
160816116|NCT01436656|580711969|FG013|Dose Escalation|Lost to Follow-up|0|||
160552796|NCT01582308|579748532|FG007|Period 4|Physician Decision|0|||
160552797|NCT01582308|579748533|FG008|Period 4|Physician Decision|0|||
160552798|NCT01582308|579748534|FG009|Period 4|Physician Decision|1|||
160552799|NCT00772668|579748537|FG000|Overall Study|Physician Decision|3|||
160552800|NCT01182428|579748538|FG000|Overall Study|Physician Decision|1|||
160552801|NCT01182428|579748539|FG001|Overall Study|Physician Decision|0|||
160552802|NCT01182428|579748538|FG000|Overall Study|Lost to Follow-up|9|||
160552803|NCT01182428|579748539|FG001|Overall Study|Lost to Follow-up|1|||
160552804|NCT01182428|579748538|FG000|Overall Study|Withdrawal by Subject|1|||
160552805|NCT01182428|579748539|FG001|Overall Study|Withdrawal by Subject|0|||
160552806|NCT03631706|579748541|FG000|Overall Study|Randomized, not treated|1|||
160552807|NCT03631706|579748542|FG001|Overall Study|Randomized, not treated|0|||
160552808|NCT02554929|579749850|FG000|Overall Study|Lost to Follow-up|4|||
160552809|NCT02554929|579749851|FG001|Overall Study|Lost to Follow-up|4|||
160552810|NCT02554929|579749850|FG000|Overall Study|Withdrawal by Subject|2|||
160552811|NCT02554929|579749851|FG001|Overall Study|Withdrawal by Subject|8|||
160552812|NCT03786432|579749852|FG000|Overall Study|Screen Failure after consent|1|||
160552813|NCT03786432|579749852|FG000|Overall Study|Lost to Follow-up|4|||
160552814|NCT03786432|579749852|FG000|Overall Study|did not complete 12 month CT scan|1|||
160552815|NCT03988907|579749854|FG000|Overall Study|Unable to complete visit|0|||
160816117|NCT01436656|580711970|FG014|Dose Escalation|Lost to Follow-up|0|||
160816118|NCT01436656|580711971|FG015|Dose Escalation|Lost to Follow-up|0|||
160816119|NCT01436656|580711972|FG016|Dose Escalation|Lost to Follow-up|0|||
160816120|NCT01436656|580711973|FG017|Dose Escalation|Lost to Follow-up|0|||
160816121|NCT01436656|580711956|FG000|Dose Escalation|New anti-cancer therapy|1|||
160816122|NCT01436656|580711957|FG001|Dose Escalation|New anti-cancer therapy|0|||
160816123|NCT01436656|580711958|FG002|Dose Escalation|New anti-cancer therapy|0|||
160816124|NCT01436656|580711959|FG003|Dose Escalation|New anti-cancer therapy|0|||
160900352|NCT02557295|581028701|FG003|Overall Study|Study Close|3|||
160552816|NCT03988907|579749855|FG001|Overall Study|Unable to complete visit|1|||
160816125|NCT01436656|580711960|FG004|Dose Escalation|New anti-cancer therapy|0|||
160816126|NCT01436656|580711961|FG005|Dose Escalation|New anti-cancer therapy|0|||
160816127|NCT01436656|580711962|FG006|Dose Escalation|New anti-cancer therapy|0|||
160816128|NCT01436656|580711963|FG007|Dose Escalation|New anti-cancer therapy|0|||
160816129|NCT01436656|580711964|FG008|Dose Escalation|New anti-cancer therapy|1|||
160816130|NCT01436656|580711965|FG009|Dose Escalation|New anti-cancer therapy|1|||
160816131|NCT01436656|580711966|FG010|Dose Escalation|New anti-cancer therapy|0|||
160816132|NCT01436656|580711967|FG011|Dose Escalation|New anti-cancer therapy|0|||
160816133|NCT01436656|580711968|FG012|Dose Escalation|New anti-cancer therapy|0|||
160900353|NCT02557295|581028702|FG004|Overall Study|Study Close|0|||
160900354|NCT02557295|581028703|FG005|Overall Study|Study Close|0|||
160900355|NCT02557295|581028704|FG006|Overall Study|Study Close|37|||
160900356|NCT02557295|581028705|FG007|Overall Study|Study Close|3|||
160900357|NCT02557295|581028706|FG008|Overall Study|Study Close|19|||
160900358|NCT02557295|581028698|FG000|Overall Study|except for study close|4|||
160900359|NCT02557295|581028699|FG001|Overall Study|except for study close|0|||
160900360|NCT02557295|581028700|FG002|Overall Study|except for study close|0|||
160900361|NCT02557295|581028701|FG003|Overall Study|except for study close|0|||
160900362|NCT02557295|581028702|FG004|Overall Study|except for study close|0|||
160900363|NCT02557295|581028703|FG005|Overall Study|except for study close|0|||
160900364|NCT02557295|581028704|FG006|Overall Study|except for study close|5|||
160900365|NCT02557295|581028705|FG007|Overall Study|except for study close|1|||
160900366|NCT02557295|581028706|FG008|Overall Study|except for study close|0|||
160900367|NCT01066000|581028707|FG000|Overall Study|Protocol Violation|4|||
160900368|NCT01066000|581028707|FG000|Overall Study|Death|3|||
160900369|NCT01066000|581028707|FG000|Overall Study|Withdrawal by Subject|1|||
160987435|NCT04955626|581341107|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
160987436|NCT04955626|581341108|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
160987437|NCT04955626|581341109|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
160987438|NCT04955626|581341110|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
160987439|NCT04955626|581341111|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
160987440|NCT04955626|581341112|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
160987441|NCT04955626|581341113|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
160987442|NCT04955626|581341114|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
160987443|NCT04955626|581341115|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
160987444|NCT04955626|581341116|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
160987445|NCT04955626|581341117|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
160987446|NCT04955626|581341118|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
160645919|NCT01952574|580085924|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
160645920|NCT01952574|580085925|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
160645921|NCT01952574|580085926|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
160645922|NCT01952574|580085927|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160645923|NCT01952574|580085928|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160645924|NCT01952574|580085929|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160645925|NCT01952574|580085923|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
160645926|NCT01952574|580085924|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
160645927|NCT01952574|580085925|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
160645928|NCT01952574|580085926|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
160645929|NCT01952574|580085927|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
160645930|NCT01952574|580085928|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
160645931|NCT01952574|580085929|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
160645932|NCT01952574|580085923|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
160645933|NCT01952574|580085924|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
160645934|NCT01952574|580085925|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
160645935|NCT01952574|580085926|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
160645936|NCT01952574|580085927|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
160645937|NCT01952574|580085928|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
160645938|NCT01952574|580085929|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
160645939|NCT01952574|580085923|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
160645940|NCT01952574|580085924|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
160645941|NCT01952574|580085925|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
160645942|NCT01952574|580085926|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
160645943|NCT01952574|580085927|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
160645944|NCT01952574|580085928|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
160645945|NCT01952574|580085929|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
160645946|NCT01952574|580085923|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
160645947|NCT01952574|580085924|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
160645948|NCT01952574|580085925|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
160645949|NCT01952574|580085926|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
160645950|NCT01952574|580085927|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
160645951|NCT01952574|580085928|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
160816134|NCT01436656|580711969|FG013|Dose Escalation|New anti-cancer therapy|0|||
160816135|NCT01436656|580711970|FG014|Dose Escalation|New anti-cancer therapy|0|||
160816136|NCT01436656|580711971|FG015|Dose Escalation|New anti-cancer therapy|0|||
160816137|NCT01436656|580711972|FG016|Dose Escalation|New anti-cancer therapy|0|||
160816138|NCT01436656|580711973|FG017|Dose Escalation|New anti-cancer therapy|0|||
160816139|NCT01436656|580711956|FG000|Dose Expansion|Adverse Event|0|||
160816140|NCT01436656|580711957|FG001|Dose Expansion|Adverse Event|0|||
160816141|NCT01436656|580711958|FG002|Dose Expansion|Adverse Event|0|||
160816142|NCT01436656|580711959|FG003|Dose Expansion|Adverse Event|0|||
160816143|NCT01436656|580711960|FG004|Dose Expansion|Adverse Event|0|||
160816144|NCT01436656|580711961|FG005|Dose Expansion|Adverse Event|0|||
160816145|NCT01436656|580711962|FG006|Dose Expansion|Adverse Event|0|||
160816146|NCT01436656|580711963|FG007|Dose Expansion|Adverse Event|0|||
160816147|NCT01436656|580711964|FG008|Dose Expansion|Adverse Event|0|||
160816148|NCT01436656|580711965|FG009|Dose Expansion|Adverse Event|0|||
160816149|NCT01436656|580711966|FG010|Dose Expansion|Adverse Event|0|||
160816150|NCT01436656|580711967|FG011|Dose Expansion|Adverse Event|1|||
160816151|NCT01436656|580711968|FG012|Dose Expansion|Adverse Event|0|||
160816152|NCT01436656|580711969|FG013|Dose Expansion|Adverse Event|0|||
160816153|NCT01436656|580711970|FG014|Dose Expansion|Adverse Event|0|||
160816154|NCT01436656|580711971|FG015|Dose Expansion|Adverse Event|0|||
160816155|NCT01436656|580711972|FG016|Dose Expansion|Adverse Event|0|||
160816156|NCT01436656|580711973|FG017|Dose Expansion|Adverse Event|0|||
160816157|NCT01436656|580711956|FG000|Dose Expansion|Withdrawal by Subject|0|||
160816158|NCT01436656|580711957|FG001|Dose Expansion|Withdrawal by Subject|0|||
160816159|NCT01436656|580711958|FG002|Dose Expansion|Withdrawal by Subject|0|||
160816160|NCT01436656|580711959|FG003|Dose Expansion|Withdrawal by Subject|0|||
160816161|NCT01436656|580711960|FG004|Dose Expansion|Withdrawal by Subject|0|||
160816162|NCT01436656|580711961|FG005|Dose Expansion|Withdrawal by Subject|0|||
160816163|NCT01436656|580711962|FG006|Dose Expansion|Withdrawal by Subject|0|||
160816164|NCT01436656|580711963|FG007|Dose Expansion|Withdrawal by Subject|0|||
160816165|NCT01436656|580711964|FG008|Dose Expansion|Withdrawal by Subject|0|||
160816166|NCT01436656|580711965|FG009|Dose Expansion|Withdrawal by Subject|0|||
160816167|NCT01436656|580711966|FG010|Dose Expansion|Withdrawal by Subject|0|||
160816168|NCT01436656|580711967|FG011|Dose Expansion|Withdrawal by Subject|1|||
160816169|NCT01436656|580711968|FG012|Dose Expansion|Withdrawal by Subject|3|||
160816170|NCT01436656|580711969|FG013|Dose Expansion|Withdrawal by Subject|1|||
160816171|NCT01436656|580711970|FG014|Dose Expansion|Withdrawal by Subject|2|||
160816172|NCT01436656|580711971|FG015|Dose Expansion|Withdrawal by Subject|0|||
160816173|NCT01436656|580711972|FG016|Dose Expansion|Withdrawal by Subject|1|||
160816174|NCT01436656|580711973|FG017|Dose Expansion|Withdrawal by Subject|1|||
160816175|NCT01436656|580711956|FG000|Dose Expansion|Death|0|||
160816176|NCT01436656|580711957|FG001|Dose Expansion|Death|0|||
160816177|NCT01436656|580711958|FG002|Dose Expansion|Death|0|||
160816178|NCT01436656|580711959|FG003|Dose Expansion|Death|0|||
160987447|NCT04955626|581341119|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
160816179|NCT01436656|580711960|FG004|Dose Expansion|Death|0|||
160816180|NCT01436656|580711961|FG005|Dose Expansion|Death|0|||
160816181|NCT01436656|580711962|FG006|Dose Expansion|Death|0|||
160816182|NCT01436656|580711963|FG007|Dose Expansion|Death|0|||
160816183|NCT01436656|580711964|FG008|Dose Expansion|Death|0|||
160816184|NCT01436656|580711965|FG009|Dose Expansion|Death|0|||
160816185|NCT01436656|580711966|FG010|Dose Expansion|Death|0|||
160816186|NCT01436656|580711967|FG011|Dose Expansion|Death|0|||
160816187|NCT01436656|580711968|FG012|Dose Expansion|Death|1|||
160816188|NCT01436656|580711969|FG013|Dose Expansion|Death|0|||
160816189|NCT01436656|580711970|FG014|Dose Expansion|Death|3|||
160816190|NCT01436656|580711971|FG015|Dose Expansion|Death|0|||
160816191|NCT01436656|580711972|FG016|Dose Expansion|Death|3|||
160816192|NCT01436656|580711973|FG017|Dose Expansion|Death|3|||
160816193|NCT01436656|580711956|FG000|Dose Expansion|Lost to Follow-up|0|||
160816194|NCT01436656|580711957|FG001|Dose Expansion|Lost to Follow-up|0|||
160816195|NCT01436656|580711958|FG002|Dose Expansion|Lost to Follow-up|0|||
160816196|NCT01436656|580711959|FG003|Dose Expansion|Lost to Follow-up|0|||
160816197|NCT01436656|580711960|FG004|Dose Expansion|Lost to Follow-up|0|||
160816198|NCT01436656|580711961|FG005|Dose Expansion|Lost to Follow-up|0|||
160816199|NCT01436656|580711962|FG006|Dose Expansion|Lost to Follow-up|0|||
160816200|NCT01436656|580711963|FG007|Dose Expansion|Lost to Follow-up|0|||
160816201|NCT01436656|580711964|FG008|Dose Expansion|Lost to Follow-up|0|||
160816202|NCT01436656|580711965|FG009|Dose Expansion|Lost to Follow-up|0|||
160816203|NCT01436656|580711966|FG010|Dose Expansion|Lost to Follow-up|0|||
160816204|NCT01436656|580711967|FG011|Dose Expansion|Lost to Follow-up|0|||
160816205|NCT01436656|580711968|FG012|Dose Expansion|Lost to Follow-up|0|||
160816206|NCT01436656|580711969|FG013|Dose Expansion|Lost to Follow-up|0|||
160816207|NCT01436656|580711970|FG014|Dose Expansion|Lost to Follow-up|0|||
160816208|NCT01436656|580711971|FG015|Dose Expansion|Lost to Follow-up|0|||
160816209|NCT01436656|580711972|FG016|Dose Expansion|Lost to Follow-up|0|||
160816210|NCT01436656|580711973|FG017|Dose Expansion|Lost to Follow-up|3|||
160816211|NCT01436656|580711956|FG000|Dose Expansion|Disease progression|0|||
160816212|NCT01436656|580711957|FG001|Dose Expansion|Disease progression|0|||
160816213|NCT01436656|580711958|FG002|Dose Expansion|Disease progression|0|||
160816214|NCT01436656|580711959|FG003|Dose Expansion|Disease progression|0|||
160816215|NCT01436656|580711960|FG004|Dose Expansion|Disease progression|0|||
160816216|NCT01436656|580711961|FG005|Dose Expansion|Disease progression|0|||
160816217|NCT01436656|580711962|FG006|Dose Expansion|Disease progression|0|||
160816218|NCT01436656|580711963|FG007|Dose Expansion|Disease progression|0|||
160816219|NCT01436656|580711964|FG008|Dose Expansion|Disease progression|0|||
160816220|NCT01436656|580711965|FG009|Dose Expansion|Disease progression|0|||
160816221|NCT01436656|580711966|FG010|Dose Expansion|Disease progression|0|||
160816222|NCT01436656|580711967|FG011|Dose Expansion|Disease progression|3|||
160816223|NCT01436656|580711968|FG012|Dose Expansion|Disease progression|1|||
160816224|NCT01436656|580711969|FG013|Dose Expansion|Disease progression|0|||
160816225|NCT01436656|580711970|FG014|Dose Expansion|Disease progression|1|||
160816226|NCT01436656|580711971|FG015|Dose Expansion|Disease progression|0|||
160987448|NCT04955626|581341120|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
160987449|NCT04955626|581341121|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
160816227|NCT01436656|580711972|FG016|Dose Expansion|Disease progression|0|||
160816228|NCT01436656|580711973|FG017|Dose Expansion|Disease progression|1|||
160816229|NCT01436656|580711956|FG000|Dose Expansion|New cancer therapy|0|||
160816230|NCT01436656|580711957|FG001|Dose Expansion|New cancer therapy|0|||
160816231|NCT01436656|580711958|FG002|Dose Expansion|New cancer therapy|0|||
160816232|NCT01436656|580711959|FG003|Dose Expansion|New cancer therapy|0|||
160816233|NCT01436656|580711960|FG004|Dose Expansion|New cancer therapy|0|||
160816234|NCT01436656|580711961|FG005|Dose Expansion|New cancer therapy|0|||
160816235|NCT01436656|580711962|FG006|Dose Expansion|New cancer therapy|0|||
160816236|NCT01436656|580711963|FG007|Dose Expansion|New cancer therapy|0|||
160816237|NCT01436656|580711964|FG008|Dose Expansion|New cancer therapy|0|||
160816238|NCT01436656|580711965|FG009|Dose Expansion|New cancer therapy|0|||
160987450|NCT04955626|581341122|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
160987451|NCT04955626|581341123|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
160987452|NCT04955626|581341124|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
160987453|NCT04955626|581341125|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
160987454|NCT04955626|581341126|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
160987455|NCT04955626|581341127|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
160987456|NCT04955626|581341128|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
160987457|NCT04955626|581341129|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
160987458|NCT04955626|581341130|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
160987459|NCT04955626|581341131|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
160987460|NCT04955626|581341132|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
160987461|NCT04955626|581341133|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
160987462|NCT04955626|581341134|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
160987463|NCT04955626|581341135|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
160987464|NCT04955626|581341136|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
160987465|NCT04955626|581341137|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
160987466|NCT04955626|581341138|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
160987467|NCT04955626|581341139|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
160552817|NCT03609619|579749859|FG000|Overall Study|Adverse Event|1|||
160552818|NCT03609619|579749860|FG001|Overall Study|Adverse Event|0|||
160552819|NCT03609619|579749859|FG000|Overall Study|Lack of Efficacy|1|||
160552820|NCT03609619|579749860|FG001|Overall Study|Lack of Efficacy|2|||
160552821|NCT03609619|579749859|FG000|Overall Study|Protocol Violation|5|||
160552822|NCT03609619|579749860|FG001|Overall Study|Protocol Violation|0|||
160552823|NCT03609619|579749859|FG000|Overall Study|Withdrawal by Subject|2|||
160987468|NCT04955626|581341140|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
160987469|NCT04955626|581341105|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987470|NCT04955626|581341106|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
160987471|NCT04955626|581341107|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987472|NCT04955626|581341108|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987473|NCT04955626|581341109|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160645952|NCT01952574|580085929|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
160645953|NCT01952574|580085923|FG000|Open-label Treatment Phase|Missing|0|||
160645954|NCT01952574|580085924|FG001|Open-label Treatment Phase|Missing|0|||
160645955|NCT01952574|580085925|FG002|Open-label Treatment Phase|Missing|0|||
160645956|NCT01952574|580085926|FG003|Open-label Treatment Phase|Missing|0|||
160645957|NCT01952574|580085927|FG004|Open-label Treatment Phase|Missing|4|||
160645958|NCT01952574|580085928|FG005|Open-label Treatment Phase|Missing|0|||
160645959|NCT01952574|580085929|FG006|Open-label Treatment Phase|Missing|0|||
160816239|NCT01436656|580711966|FG010|Dose Expansion|New cancer therapy|0|||
160816240|NCT01436656|580711967|FG011|Dose Expansion|New cancer therapy|1|||
160987474|NCT04955626|581341110|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160552824|NCT03609619|579749860|FG001|Overall Study|Withdrawal by Subject|3|||
160552825|NCT03609619|579749859|FG000|Overall Study|Lost to Follow-up|1|||
160552826|NCT03609619|579749860|FG001|Overall Study|Lost to Follow-up|1|||
160552827|NCT00568555|579749861|FG000|Overall Study|Withdrawal by Subject|1|||
160552828|NCT00568555|579749862|FG001|Overall Study|Withdrawal by Subject|1|||
160552829|NCT01231555|579749863|FG000|Overall Study|Study terminated|8|||
160552830|NCT01231555|579749864|FG001|Overall Study|Study terminated|5|||
160552831|NCT01231555|579749865|FG002|Overall Study|Study terminated|8|||
160552832|NCT01231555|579749863|FG000|Overall Study|Withdrawal by Subject|0|||
160552833|NCT01231555|579749864|FG001|Overall Study|Withdrawal by Subject|2|||
160552834|NCT01231555|579749865|FG002|Overall Study|Withdrawal by Subject|0|||
160552835|NCT00688909|579749866|FG000|Overall Study|Adverse Event|28|||
160552836|NCT00688909|579749866|FG000|Overall Study|Patient withdrew consent|2|||
160552837|NCT00688909|579749866|FG000|Overall Study|Administrative problems|1|||
160552838|NCT00688909|579749866|FG000|Overall Study|Protocol Violation|2|||
160552839|NCT01668654|579749869|FG000|Overall Study|Study Closed/Terminated|3|||
160552840|NCT01668654|579749869|FG000|Overall Study|Withdrawal by Subject|1|||
160552841|NCT03634800|579749870|FG000|Overall Study|Adverse Event|1|||
160552842|NCT03634800|579749870|FG000|Overall Study|Disease Progression|4|||
160552843|NCT03634800|579749870|FG000|Overall Study|Withdrawal by Subject|1|||
160552844|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
160552845|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
160552846|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
160552847|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
160552848|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
160552849|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
160552850|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
160552851|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
160816241|NCT01436656|580711968|FG012|Dose Expansion|New cancer therapy|1|||
160816242|NCT01436656|580711969|FG013|Dose Expansion|New cancer therapy|0|||
160816243|NCT01436656|580711970|FG014|Dose Expansion|New cancer therapy|2|||
160816244|NCT01436656|580711971|FG015|Dose Expansion|New cancer therapy|0|||
160816245|NCT01436656|580711972|FG016|Dose Expansion|New cancer therapy|0|||
160816246|NCT01436656|580711973|FG017|Dose Expansion|New cancer therapy|0|||
160816247|NCT01696994|580711974|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
160816248|NCT01696994|580711975|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
160816249|NCT01696994|580711974|FG000|Overall Study|Died Before Randomization|1|||
160816250|NCT01696994|580711975|FG001|Overall Study|Died Before Randomization|2|||
160816251|NCT01696994|580711974|FG000|Overall Study|Died Before ASU (Control)|73|||
160816252|NCT01696994|580711975|FG001|Overall Study|Died Before ASU (Control)|0|||
160816253|NCT01696994|580711974|FG000|Overall Study|No Ovaries at Baseline|4807|||
160816254|NCT01696994|580711975|FG001|Overall Study|No Ovaries at Baseline|4851|||
160816255|NCT01696994|580711974|FG000|Overall Study|Refused ASU (Control)|311|||
160816256|NCT01696994|580711975|FG001|Overall Study|Refused ASU (Control)|0|||
160816257|NCT01696994|580711974|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
160816258|NCT01696994|580711975|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
160816259|NCT04644276|580711976|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
160816260|NCT04644276|580711977|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
160816261|NCT04644276|580711978|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
160816262|NCT00705250|580711979|FG000|Overall Study|Withdrawal by Subject|1|||
160816263|NCT00705250|580711979|FG000|Overall Study|Patient died in car accident|1|||
160816264|NCT01576146|580711982|FG000|Extension Period 1|Adverse Event|2|||
160816265|NCT01576146|580711982|FG000|Extension Period 1|Death|2|||
160816266|NCT01576146|580711982|FG000|Extension Period 1|Physician Decision|2|||
160816267|NCT01576146|580711982|FG000|Extension Period 1|Withdrawal by Subject|1|||
160816268|NCT01576146|580711982|FG000|Extension Period 1|Lost to Follow-up|1|||
160816269|NCT01576146|580711982|FG000|Extension Period 1|Parathyroidectomy|1|||
160816270|NCT01576146|580711982|FG000|Extension Period 1|Renal Transplant|1|||
160816271|NCT01576146|580711982|FG000|Extension Period 2|Sponsor Decision|13|||
160816272|NCT01576146|580711982|FG000|Extension Period 2|Death|1|||
160816273|NCT01576146|580711982|FG000|Extension Period 2|Adverse Event|1|||
160816274|NCT01576146|580711982|FG000|Extension Period 2|Renal Transplant|1|||
160816275|NCT01576146|580711982|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
160816276|NCT01667224|580711984|FG000|Overall Study|Withdrawal by Subject|3|||
160816277|NCT01667224|580711985|FG001|Overall Study|Withdrawal by Subject|1|||
160816278|NCT01667224|580711984|FG000|Overall Study|Protocol Violation|1|||
160816279|NCT01667224|580711985|FG001|Overall Study|Protocol Violation|1|||
160816280|NCT00316225|580711986|FG000|Overall Study|Adverse Event|2|||
160816281|NCT00316225|580711986|FG000|Overall Study|Physician Decision|3|||
160816282|NCT00316225|580711986|FG000|Overall Study|Progressive Disease|15|||
160816283|NCT00316225|580711986|FG000|Overall Study|Withdrawal by Subject|3|||
160816284|NCT00316225|580711986|FG000|Overall Study|Death|2|||
160816285|NCT01814878|580711987|FG000|Overall Study|Adverse Event|16|||
160816286|NCT01814878|580711988|FG001|Overall Study|Adverse Event|5|||
160816287|NCT01814878|580711987|FG000|Overall Study|Withdrawal by Subject|20|||
160816288|NCT01814878|580711988|FG001|Overall Study|Withdrawal by Subject|16|||
160816289|NCT01814878|580711987|FG000|Overall Study|Protocol Violation|5|||
160816290|NCT01814878|580711988|FG001|Overall Study|Protocol Violation|5|||
160816291|NCT01814878|580711987|FG000|Overall Study|Physician Decision|3|||
160816292|NCT01814878|580711988|FG001|Overall Study|Physician Decision|1|||
160816293|NCT01814878|580711987|FG000|Overall Study|Screening failure (drop-out)|0|||
160816294|NCT01814878|580711988|FG001|Overall Study|Screening failure (drop-out)|3|||
160816295|NCT01814878|580711987|FG000|Overall Study|Other|2|||
160816296|NCT01814878|580711988|FG001|Overall Study|Other|0|||
160816297|NCT01545934|580711989|FG000|Overall Study|Withdrawal by Subject|4|||
160816298|NCT01545934|580711990|FG001|Overall Study|Withdrawal by Subject|3|||
160816299|NCT01545934|580711989|FG000|Overall Study|Lost to Follow-up|1|||
160816300|NCT01545934|580711990|FG001|Overall Study|Lost to Follow-up|0|||
160816301|NCT01843673|580711991|FG000|Overall Study|Lack of Efficacy|2|||
160816302|NCT01843673|580711991|FG000|Overall Study|Withdrawal by Subject|4|||
160816303|NCT00425698|580711992|FG000|Overall Study|Adverse Event|3|||
160816304|NCT00425698|580711993|FG001|Overall Study|Adverse Event|1|||
160816305|NCT00425698|580711992|FG000|Overall Study|Withdrawal by Subject|0|||
160816306|NCT00425698|580711993|FG001|Overall Study|Withdrawal by Subject|1|||
160816307|NCT01205061|580711994|FG000|Overall Study|Adverse Event|4|||
160816308|NCT01205061|580711994|FG000|Overall Study|Withdrawal by Subject|11|||
160816309|NCT01205061|580711994|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
160816310|NCT01205061|580711994|FG000|Overall Study|Lost to Follow-up|9|||
160816311|NCT01205061|580711994|FG000|Overall Study|Other|1|||
160816312|NCT04026009|580711999|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160816313|NCT04026009|580712000|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160816314|NCT04026009|580712001|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
160816315|NCT04026009|580712002|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
160816316|NCT04026009|580712003|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
160816317|NCT04026009|580711999|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
160816318|NCT04026009|580712000|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
160816319|NCT04026009|580712001|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
160816320|NCT04026009|580712002|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
160816321|NCT04026009|580712003|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
160816322|NCT01988662|580712004|FG000|Overall Study|Subject/guardian decision|1|||
160816323|NCT01988662|580712005|FG001|Overall Study|Subject/guardian decision|1|||
160816324|NCT01988662|580712004|FG000|Overall Study|Adverse Event|3|||
160816325|NCT01988662|580712005|FG001|Overall Study|Adverse Event|1|||
160816326|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
160816327|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
160816328|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
160816329|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
160816330|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
160816331|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
160816332|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
160816333|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
160816334|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
160816335|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
160816336|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
160816337|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
160816338|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
160816339|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
160816340|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
160816341|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
160816342|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
160816343|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816344|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816345|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816346|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816347|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816348|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816349|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816350|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816351|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816352|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816353|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816354|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816355|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816356|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
160816357|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
160816358|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
160816359|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
160816360|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
160816361|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
160816362|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
160816363|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
160816364|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
160816365|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
160816366|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
160816367|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
160816368|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
160816369|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
160816370|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
160816371|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
160816372|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
160816373|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
160987475|NCT04955626|581341111|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987476|NCT04955626|581341112|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987477|NCT04955626|581341113|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987478|NCT04955626|581341114|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816374|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
160816375|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
160816376|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
160816377|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
160987479|NCT04955626|581341115|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987480|NCT04955626|581341116|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816378|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
160816379|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
160816380|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
160816381|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
160816382|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
160816383|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
160816384|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
160816385|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
160816386|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
160816387|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
160816388|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
160816389|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
160816390|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816391|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816392|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816393|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816394|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816395|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816396|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816397|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816398|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816399|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816400|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816401|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
160816402|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
160816403|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
160816404|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
160816405|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816406|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816407|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816408|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816409|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816410|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816411|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816412|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816413|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816414|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816415|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816416|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816417|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816418|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816419|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
160816420|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816421|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816422|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816423|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816424|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816425|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816426|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816427|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816428|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816429|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816430|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816431|NCT03831191|580712008|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
160816432|NCT03831191|580712009|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
160987481|NCT04955626|581341117|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987482|NCT04955626|581341118|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987483|NCT04955626|581341119|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987484|NCT04955626|581341120|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987485|NCT04955626|581341121|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987486|NCT04955626|581341122|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987487|NCT04955626|581341123|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987488|NCT04955626|581341124|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816433|NCT03831191|580712010|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
160816434|NCT03831191|580712011|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
160816435|NCT03831191|580712012|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
160816436|NCT03831191|580712013|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
160987489|NCT04955626|581341125|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816437|NCT03831191|580712014|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
160816438|NCT03831191|580712015|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
160816439|NCT03831191|580712016|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
160816440|NCT03831191|580712017|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
160816441|NCT03831191|580712018|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
160816442|NCT03831191|580712019|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
160816443|NCT03831191|580712020|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
160816444|NCT03831191|580712021|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
160816445|NCT03831191|580712022|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
160816446|NCT03831191|580712008|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816447|NCT03831191|580712009|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816448|NCT03831191|580712010|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816449|NCT03831191|580712011|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816450|NCT03831191|580712012|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816451|NCT03831191|580712013|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816452|NCT03831191|580712014|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816453|NCT03831191|580712015|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816454|NCT03831191|580712016|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816455|NCT03831191|580712017|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816456|NCT03831191|580712018|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816457|NCT03831191|580712019|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816458|NCT03831191|580712020|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816459|NCT03831191|580712021|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816460|NCT03831191|580712022|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
160816461|NCT03831191|580712008|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816462|NCT03831191|580712009|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816463|NCT03831191|580712010|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816464|NCT03831191|580712011|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816465|NCT03831191|580712012|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816466|NCT03831191|580712013|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816467|NCT03831191|580712014|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816468|NCT03831191|580712015|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816469|NCT03831191|580712016|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816470|NCT03831191|580712017|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816471|NCT03831191|580712018|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816472|NCT03831191|580712019|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816473|NCT03831191|580712020|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816474|NCT03831191|580712021|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816475|NCT03831191|580712022|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
160816476|NCT00695955|580712023|FG000|Cohort 1|Adverse Event|26|||
160816477|NCT00695955|580712023|FG000|Cohort 1|Protocol Violation|2|||
160816478|NCT00695955|580712023|FG000|Cohort 1|Lost to Follow-up|30|||
160816479|NCT00695955|580712023|FG000|Cohort 1|Withdrawal by Subject|25|||
160816480|NCT00695955|580712023|FG000|Cohort 1|Lack of Efficacy|3|||
160816481|NCT00695955|580712023|FG000|Cohort 1|Other|16|||
160816482|NCT00695955|580712023|FG000|Cohort 2|Adverse Event|24|||
160816483|NCT00695955|580712023|FG000|Cohort 2|Protocol Violation|5|||
160816484|NCT00695955|580712023|FG000|Cohort 2|Lost to Follow-up|38|||
160816485|NCT00695955|580712023|FG000|Cohort 2|Withdrawal by Subject|28|||
160816486|NCT00695955|580712023|FG000|Cohort 2|Lack of Efficacy|4|||
160816487|NCT00695955|580712023|FG000|Cohort 2|Other|5|||
160816488|NCT01177553|580712024|FG000|Overall Study|babies not yet 6 months of age|1|||
160816489|NCT01177553|580712025|FG001|Overall Study|babies not yet 6 months of age|0|||
160816490|NCT04826094|580712027|FG000|Overall Study|Lost to Follow-up|2|||
160816491|NCT04826094|580712028|FG001|Overall Study|Lost to Follow-up|1|||
160816492|NCT04826094|580712029|FG002|Overall Study|Lost to Follow-up|0|||
160816493|NCT04826094|580712030|FG003|Overall Study|Lost to Follow-up|0|||
160816494|NCT04826094|580712031|FG004|Overall Study|Lost to Follow-up|1|||
160816495|NCT04826094|580712032|FG005|Overall Study|Lost to Follow-up|3|||
160816496|NCT04826094|580712033|FG006|Overall Study|Lost to Follow-up|1|||
160816497|NCT04826094|580712034|FG007|Overall Study|Lost to Follow-up|1|||
160816498|NCT04826094|580712027|FG000|Overall Study|Participant withdrew consent|1|||
160816499|NCT04826094|580712028|FG001|Overall Study|Participant withdrew consent|0|||
160816500|NCT04826094|580712029|FG002|Overall Study|Participant withdrew consent|0|||
160816501|NCT04826094|580712030|FG003|Overall Study|Participant withdrew consent|1|||
160816502|NCT04826094|580712031|FG004|Overall Study|Participant withdrew consent|1|||
160900370|NCT01066000|581028707|FG000|Overall Study|Adverse Event|1|||
160816503|NCT04826094|580712032|FG005|Overall Study|Participant withdrew consent|1|||
160816504|NCT04826094|580712033|FG006|Overall Study|Participant withdrew consent|0|||
160816505|NCT04826094|580712034|FG007|Overall Study|Participant withdrew consent|1|||
160816506|NCT04826094|580712027|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
160816507|NCT04826094|580712028|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
160816508|NCT04826094|580712029|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
160816509|NCT04826094|580712030|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
160816510|NCT04826094|580712031|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
160816511|NCT04826094|580712032|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
160816512|NCT04826094|580712033|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
160816513|NCT04826094|580712034|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
160816514|NCT04826094|580712027|FG000|Overall Study|Withdrawn by Investigator|0|||
160816515|NCT04826094|580712028|FG001|Overall Study|Withdrawn by Investigator|0|||
160816516|NCT04826094|580712029|FG002|Overall Study|Withdrawn by Investigator|0|||
160816517|NCT04826094|580712030|FG003|Overall Study|Withdrawn by Investigator|0|||
160816518|NCT04826094|580712031|FG004|Overall Study|Withdrawn by Investigator|0|||
160816519|NCT04826094|580712032|FG005|Overall Study|Withdrawn by Investigator|1|||
160816520|NCT04826094|580712033|FG006|Overall Study|Withdrawn by Investigator|0|||
160816521|NCT04826094|580712034|FG007|Overall Study|Withdrawn by Investigator|1|||
160816522|NCT04826094|580712027|FG000|Overall Study|Other: Moved from area|1|||
160816523|NCT04826094|580712028|FG001|Overall Study|Other: Moved from area|1|||
160816524|NCT04826094|580712029|FG002|Overall Study|Other: Moved from area|1|||
160816525|NCT04826094|580712030|FG003|Overall Study|Other: Moved from area|0|||
160816526|NCT04826094|580712031|FG004|Overall Study|Other: Moved from area|0|||
160816527|NCT04826094|580712032|FG005|Overall Study|Other: Moved from area|0|||
160816528|NCT04826094|580712033|FG006|Overall Study|Other: Moved from area|0|||
160816529|NCT04826094|580712034|FG007|Overall Study|Other: Moved from area|0|||
160816530|NCT04826094|580712027|FG000|Overall Study|Other: Declined|0|||
160816531|NCT04826094|580712028|FG001|Overall Study|Other: Declined|0|||
160816532|NCT04826094|580712029|FG002|Overall Study|Other: Declined|0|||
160816533|NCT04826094|580712030|FG003|Overall Study|Other: Declined|0|||
160816534|NCT04826094|580712031|FG004|Overall Study|Other: Declined|1|||
160816535|NCT04826094|580712032|FG005|Overall Study|Other: Declined|0|||
160816536|NCT04826094|580712033|FG006|Overall Study|Other: Declined|0|||
160816537|NCT04826094|580712034|FG007|Overall Study|Other: Declined|0|||
160816538|NCT04826094|580712027|FG000|Overall Study|Other: Vaccine not administered|0|||
160816539|NCT04826094|580712028|FG001|Overall Study|Other: Vaccine not administered|0|||
160816540|NCT04826094|580712029|FG002|Overall Study|Other: Vaccine not administered|1|||
160816541|NCT04826094|580712030|FG003|Overall Study|Other: Vaccine not administered|0|||
160816542|NCT04826094|580712031|FG004|Overall Study|Other: Vaccine not administered|0|||
160816543|NCT04826094|580712032|FG005|Overall Study|Other: Vaccine not administered|1|||
160816544|NCT04826094|580712033|FG006|Overall Study|Other: Vaccine not administered|1|||
160816545|NCT04826094|580712034|FG007|Overall Study|Other: Vaccine not administered|3|||
160816546|NCT01864148|580712037|FG000|Overall Study|Other|2|||
160816547|NCT01864148|580712038|FG001|Overall Study|Other|1|||
160816548|NCT01864148|580712039|FG002|Overall Study|Other|1|||
160816549|NCT01864148|580712040|FG003|Overall Study|Other|3|||
160816550|NCT01864148|580712041|FG004|Overall Study|Other|1|||
160816551|NCT01864148|580712037|FG000|Overall Study|Death|0|||
160816552|NCT01864148|580712038|FG001|Overall Study|Death|0|||
160816553|NCT01864148|580712039|FG002|Overall Study|Death|0|||
160816554|NCT01864148|580712040|FG003|Overall Study|Death|1|||
160816555|NCT01864148|580712041|FG004|Overall Study|Death|0|||
160816556|NCT01864148|580712037|FG000|Overall Study|Investigator Decision|5|||
160816557|NCT01864148|580712038|FG001|Overall Study|Investigator Decision|0|||
160816558|NCT01864148|580712039|FG002|Overall Study|Investigator Decision|0|||
160900371|NCT01386008|581028708|FG000|Overall Study|exited w/o incident /study discontinued|17|||
160900372|NCT01386008|581028708|FG000|Overall Study|Adverse Event|3|||
160900373|NCT01067976|581028709|FG000|Overall Study|Study drug never administered|20|||
160900374|NCT01067976|581028709|FG000|Overall Study|Study prematurely discontinued|2|||
160816559|NCT01864148|580712040|FG003|Overall Study|Investigator Decision|4|||
160816560|NCT01864148|580712041|FG004|Overall Study|Investigator Decision|6|||
160816561|NCT01864148|580712037|FG000|Overall Study|Withdrawal by Subject|9|||
160816562|NCT01864148|580712038|FG001|Overall Study|Withdrawal by Subject|2|||
160816563|NCT01864148|580712039|FG002|Overall Study|Withdrawal by Subject|6|||
160816564|NCT01864148|580712040|FG003|Overall Study|Withdrawal by Subject|8|||
160900375|NCT04449861|581028710|FG000|Overall Study|Withdrawal by Subject|4|||
160816565|NCT01864148|580712041|FG004|Overall Study|Withdrawal by Subject|8|||
160816566|NCT01864148|580712037|FG000|Overall Study|Lost to Follow-up|0|||
160816567|NCT01864148|580712038|FG001|Overall Study|Lost to Follow-up|0|||
160816568|NCT01864148|580712039|FG002|Overall Study|Lost to Follow-up|0|||
160816569|NCT01864148|580712040|FG003|Overall Study|Lost to Follow-up|2|||
160816570|NCT01864148|580712041|FG004|Overall Study|Lost to Follow-up|1|||
160816571|NCT01864148|580712037|FG000|Overall Study|Adverse Event|4|||
160816572|NCT01864148|580712038|FG001|Overall Study|Adverse Event|2|||
160816573|NCT01864148|580712039|FG002|Overall Study|Adverse Event|4|||
160900376|NCT04449861|581028710|FG000|Overall Study|Lost to Follow-up|5|||
160900377|NCT04449861|581028710|FG000|Overall Study|Death|112|||
160900378|NCT00976677|581028711|FG000|Overall Study|Adverse Event|1|||
160900379|NCT00976677|581028712|FG001|Overall Study|Adverse Event|0|||
160900380|NCT00976677|581028711|FG000|Overall Study|Withdrawal by Subject|0|||
160900381|NCT00976677|581028712|FG001|Overall Study|Withdrawal by Subject|2|||
160816574|NCT01864148|580712040|FG003|Overall Study|Adverse Event|7|||
160816575|NCT01864148|580712041|FG004|Overall Study|Adverse Event|7|||
160816576|NCT01864148|580712037|FG000|Overall Study|Not Dosed|0|||
160816577|NCT01864148|580712038|FG001|Overall Study|Not Dosed|0|||
160816578|NCT01864148|580712039|FG002|Overall Study|Not Dosed|0|||
160816579|NCT01864148|580712040|FG003|Overall Study|Not Dosed|1|||
160816580|NCT01864148|580712041|FG004|Overall Study|Not Dosed|0|||
160816581|NCT01421303|580712044|FG000|Overall Study|Lost to Follow-up|13|||
160816582|NCT01421303|580712044|FG000|Overall Study|Non compliance with study procedure|1|||
160816583|NCT01421303|580712044|FG000|Overall Study|Other|7|||
160816584|NCT01421303|580712044|FG000|Overall Study|Withdrawal by Subject|1|||
160816585|NCT05319600|580712045|FG000|Overall Study|Withdrawal by Subject|1|||
160816586|NCT05319600|580712046|FG001|Overall Study|Withdrawal by Subject|0|||
160816587|NCT05319600|580712045|FG000|Overall Study|Lost to Follow-up|0|||
160816588|NCT05319600|580712046|FG001|Overall Study|Lost to Follow-up|4|||
160816589|NCT00690430|580712047|FG000|Core Phase|Abnormal Laboratory value|0|||
160816590|NCT00690430|580712048|FG001|Core Phase|Abnormal Laboratory value|1|||
160816591|NCT00690430|580712049|FG002|Core Phase|Abnormal Laboratory value|0|||
160816592|NCT00690430|580712047|FG000|Core Phase|Adverse Event|5|||
160816593|NCT00690430|580712048|FG001|Core Phase|Adverse Event|1|||
160816594|NCT00690430|580712049|FG002|Core Phase|Adverse Event|0|||
160816595|NCT00690430|580712047|FG000|Core Phase|Death|0|||
160816596|NCT00690430|580712048|FG001|Core Phase|Death|2|||
160816597|NCT00690430|580712049|FG002|Core Phase|Death|0|||
160816598|NCT00690430|580712047|FG000|Core Phase|Protocol Violation|1|||
160816599|NCT00690430|580712048|FG001|Core Phase|Protocol Violation|0|||
160987490|NCT04955626|581341126|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816600|NCT00690430|580712049|FG002|Core Phase|Protocol Violation|0|||
160816601|NCT00690430|580712047|FG000|Core Phase|Withdrawal by Subject|3|||
160816602|NCT00690430|580712048|FG001|Core Phase|Withdrawal by Subject|3|||
160816603|NCT00690430|580712049|FG002|Core Phase|Withdrawal by Subject|0|||
160816604|NCT00690430|580712047|FG000|Core Phase|Subject no longer requires study drug|1|||
160816605|NCT00690430|580712048|FG001|Core Phase|Subject no longer requires study drug|0|||
160816606|NCT00690430|580712049|FG002|Core Phase|Subject no longer requires study drug|0|||
160816607|NCT00690430|580712047|FG000|Core Phase|Lack of Efficacy|8|||
160816608|NCT00690430|580712048|FG001|Core Phase|Lack of Efficacy|10|||
160987491|NCT04955626|581341127|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987492|NCT04955626|581341128|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987493|NCT04955626|581341129|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987494|NCT04955626|581341130|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987495|NCT04955626|581341131|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987496|NCT04955626|581341132|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987497|NCT04955626|581341133|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987498|NCT04955626|581341134|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987499|NCT04955626|581341135|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987500|NCT04955626|581341136|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987501|NCT04955626|581341137|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987502|NCT04955626|581341138|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987503|NCT04955626|581341139|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987504|NCT04955626|581341140|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816609|NCT00690430|580712049|FG002|Core Phase|Lack of Efficacy|0|||
160816610|NCT00690430|580712047|FG000|Core Phase|Administrative Problems|0|||
160816611|NCT00690430|580712048|FG001|Core Phase|Administrative Problems|1|||
160816612|NCT00690430|580712049|FG002|Core Phase|Administrative Problems|0|||
160816613|NCT00690430|580712047|FG000|Core Phase|Early Termination|0|||
160987505|NCT04951479|581341143|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
160987506|NCT04209790|581341144|FG000|Overall Study|Physician Decision|1|||
160987507|NCT03706690|581341145|FG000|Overall Study|Withdrawal by Subject|8|||
160816614|NCT00690430|580712048|FG001|Core Phase|Early Termination|5|||
160816615|NCT00690430|580712049|FG002|Core Phase|Early Termination|0|||
160816616|NCT00690430|580712047|FG000|Extension Phase|Lack of Efficacy|3|||
160816617|NCT00690430|580712048|FG001|Extension Phase|Lack of Efficacy|1|||
160816618|NCT00690430|580712049|FG002|Extension Phase|Lack of Efficacy|4|||
160816619|NCT00690430|580712047|FG000|Extension Phase|Abnormal Lab Values|1|||
160816620|NCT00690430|580712048|FG001|Extension Phase|Abnormal Lab Values|0|||
160987508|NCT03706690|581341146|FG001|Overall Study|Withdrawal by Subject|8|||
160987509|NCT03706690|581341145|FG000|Overall Study|Death|143|||
160816621|NCT00690430|580712049|FG002|Extension Phase|Abnormal Lab Values|0|||
160816622|NCT00690430|580712047|FG000|Extension Phase|Abnormal test procedure results|1|||
160816623|NCT00690430|580712048|FG001|Extension Phase|Abnormal test procedure results|0|||
160816624|NCT00690430|580712049|FG002|Extension Phase|Abnormal test procedure results|0|||
160816625|NCT00690430|580712047|FG000|Extension Phase|Administrative Problems|0|||
160816626|NCT00690430|580712048|FG001|Extension Phase|Administrative Problems|1|||
160816627|NCT00690430|580712049|FG002|Extension Phase|Administrative Problems|1|||
160816628|NCT00690430|580712047|FG000|Extension Phase|Adverse Event|2|||
160987510|NCT03706690|581341146|FG001|Overall Study|Death|75|||
160987511|NCT03706690|581341145|FG000|Overall Study|Ongoing at DCO|121|||
160987512|NCT03706690|581341146|FG001|Overall Study|Ongoing at DCO|52|||
160987513|NCT05617040|581341147|FG000|Overall Study|Adverse Event|0|||
160987514|NCT05617040|581341148|FG001|Overall Study|Adverse Event|1|||
160816629|NCT00690430|580712048|FG001|Extension Phase|Adverse Event|1|||
160816630|NCT00690430|580712049|FG002|Extension Phase|Adverse Event|2|||
160987515|NCT05617040|581341149|FG002|Overall Study|Adverse Event|0|||
160987516|NCT05617040|581341147|FG000|Overall Study|Death|0|||
160987517|NCT05617040|581341148|FG001|Overall Study|Death|0|||
160987518|NCT05617040|581341149|FG002|Overall Study|Death|1|||
160987519|NCT02711826|581341150|FG000|Overall Study|Physician Decision|0|||
160987520|NCT02711826|581341151|FG001|Overall Study|Physician Decision|0|||
160987521|NCT02711826|581341152|FG002|Overall Study|Physician Decision|0|||
160987522|NCT02711826|581341153|FG003|Overall Study|Physician Decision|1|||
160645960|NCT01952574|580085923|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
160645961|NCT01952574|580085924|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
160816631|NCT00690430|580712047|FG000|Extension Phase|Death|1|||
160816632|NCT00690430|580712048|FG001|Extension Phase|Death|1|||
160816633|NCT00690430|580712049|FG002|Extension Phase|Death|1|||
160816634|NCT00690430|580712047|FG000|Extension Phase|Withdrawal by Subject|0|||
160816635|NCT00690430|580712048|FG001|Extension Phase|Withdrawal by Subject|0|||
160816636|NCT00690430|580712049|FG002|Extension Phase|Withdrawal by Subject|2|||
160816637|NCT00690430|580712047|FG000|Extension Phase|Early Termination|10|||
160816638|NCT00690430|580712048|FG001|Extension Phase|Early Termination|1|||
160816639|NCT00690430|580712049|FG002|Extension Phase|Early Termination|3|||
160816640|NCT02120300|580712054|FG000|Overall Study|Enrolled but Never Treated|2|||
160816641|NCT02120300|580712055|FG001|Overall Study|Enrolled but Never Treated|0|||
160816642|NCT02120300|580712056|FG002|Overall Study|Enrolled but Never Treated|0|||
160816643|NCT02120300|580712057|FG003|Overall Study|Enrolled but Never Treated|0|||
160816644|NCT02120300|580712054|FG000|Overall Study|Lack of Efficacy|0|||
160816645|NCT02120300|580712055|FG001|Overall Study|Lack of Efficacy|0|||
160816646|NCT02120300|580712056|FG002|Overall Study|Lack of Efficacy|0|||
160816647|NCT02120300|580712057|FG003|Overall Study|Lack of Efficacy|1|||
160816648|NCT02120300|580712054|FG000|Overall Study|Lost to Follow-up|1|||
160816649|NCT02120300|580712055|FG001|Overall Study|Lost to Follow-up|0|||
160816650|NCT02120300|580712056|FG002|Overall Study|Lost to Follow-up|0|||
160816651|NCT02120300|580712057|FG003|Overall Study|Lost to Follow-up|0|||
160816652|NCT01721486|580712066|FG000|Overall Study|Protocol Violation|1|||
160816653|NCT01721486|580712067|FG001|Overall Study|Protocol Violation|0|||
160816654|NCT01721486|580712066|FG000|Overall Study|Physician Decision|0|||
160816655|NCT01721486|580712067|FG001|Overall Study|Physician Decision|1|||
160645962|NCT01952574|580085925|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
160645963|NCT01952574|580085926|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
160645964|NCT01952574|580085927|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
160816656|NCT00582712|580712068|FG000|Overall Study|Adverse Event|1|||
160816657|NCT00582712|580712068|FG000|Overall Study|Lack of Efficacy|1|||
160816658|NCT00582712|580712068|FG000|Overall Study|Withdrawal by Subject|1|||
160645965|NCT01952574|580085928|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
160645966|NCT01952574|580085929|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
160816659|NCT00582712|580712068|FG000|Overall Study|Complicating disease requiring treatment|1|||
160816660|NCT02676895|580712072|FG000|Overall Study|Administrative reason|1|||
160816661|NCT02676895|580712073|FG001|Overall Study|Administrative reason|0|||
160816662|NCT02676895|580712074|FG002|Overall Study|Administrative reason|0|||
160816663|NCT02676895|580712072|FG000|Overall Study|Protocol Violation|1|||
160816664|NCT02676895|580712073|FG001|Overall Study|Protocol Violation|0|||
160816665|NCT02676895|580712074|FG002|Overall Study|Protocol Violation|0|||
160816666|NCT02676895|580712072|FG000|Overall Study|Adverse Event|0|||
160816667|NCT02676895|580712073|FG001|Overall Study|Adverse Event|3|||
160987523|NCT02711826|581341154|FG004|Overall Study|Physician Decision|0|||
160816668|NCT02676895|580712074|FG002|Overall Study|Adverse Event|1|||
160987524|NCT02711826|581341150|FG000|Overall Study|Withdrawal by Subject|0|||
160987525|NCT02711826|581341151|FG001|Overall Study|Withdrawal by Subject|1|||
160987526|NCT02711826|581341152|FG002|Overall Study|Withdrawal by Subject|0|||
160816669|NCT02676895|580712072|FG000|Overall Study|Lost to Follow-up|0|||
160816670|NCT02676895|580712073|FG001|Overall Study|Lost to Follow-up|0|||
160816671|NCT02676895|580712074|FG002|Overall Study|Lost to Follow-up|1|||
160816672|NCT02676895|580712072|FG000|Overall Study|Withdrawal by Subject|0|||
160816673|NCT02676895|580712073|FG001|Overall Study|Withdrawal by Subject|0|||
160816674|NCT02676895|580712074|FG002|Overall Study|Withdrawal by Subject|1|||
160816675|NCT01270880|580712075|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
160816676|NCT00344318|580712076|FG000|Overall Study|Adverse Event|0|||
160816677|NCT00344318|580712077|FG001|Overall Study|Adverse Event|3|||
160816678|NCT00344318|580712078|FG002|Overall Study|Adverse Event|0|||
160816679|NCT00344318|580712079|FG003|Overall Study|Adverse Event|1|||
160816680|NCT00344318|580712076|FG000|Overall Study|Withdrawal by Subject|2|||
160987527|NCT02711826|581341153|FG003|Overall Study|Withdrawal by Subject|4|||
160987528|NCT02711826|581341154|FG004|Overall Study|Withdrawal by Subject|0|||
160816681|NCT00344318|580712077|FG001|Overall Study|Withdrawal by Subject|2|||
160987529|NCT02711826|581341150|FG000|Overall Study|Failure to manufacture cellular product|0|||
160816682|NCT00344318|580712078|FG002|Overall Study|Withdrawal by Subject|0|||
160816683|NCT00344318|580712079|FG003|Overall Study|Withdrawal by Subject|2|||
160816684|NCT00344318|580712076|FG000|Overall Study|Lost to Follow-up|2|||
160816685|NCT00344318|580712077|FG001|Overall Study|Lost to Follow-up|0|||
160816686|NCT00344318|580712078|FG002|Overall Study|Lost to Follow-up|1|||
160816687|NCT00344318|580712079|FG003|Overall Study|Lost to Follow-up|0|||
160816688|NCT00182078|580712080|FG000|Overall Study|Withdrawal by Subject|1|||
160816689|NCT00182078|580712081|FG001|Overall Study|Withdrawal by Subject|0|||
160816690|NCT01076205|580712082|FG000|Overall Study|Adverse Drug Reaction|299|||
160816691|NCT01076205|580712082|FG000|Overall Study|Lack of Effectiveness|1423|||
160816692|NCT01076205|580712082|FG000|Overall Study|Other Reason|1075|||
160816693|NCT01076205|580712082|FG000|Overall Study|Unknown Reason|71|||
160816694|NCT01076205|580712082|FG000|Overall Study|Lost to Follow-up|3151|||
160816695|NCT00361231|580712083|FG000|Overall Study|Physician Decision|3|||
160816696|NCT00361231|580712083|FG000|Overall Study|Symptomatic deterioration|5|||
160816697|NCT00361231|580712083|FG000|Overall Study|Radiographic disease progression|16|||
160816698|NCT00361231|580712083|FG000|Overall Study|Withdrawal by Subject|4|||
160816699|NCT00361231|580712083|FG000|Overall Study|Adverse Event|6|||
160816700|NCT01732510|580712084|FG000|Overall Study|Adverse Event|0|||
160816701|NCT01732510|580712085|FG001|Overall Study|Adverse Event|1|||
160816702|NCT01732510|580712086|FG002|Overall Study|Adverse Event|1|||
160816703|NCT01732510|580712087|FG003|Overall Study|Adverse Event|0|||
160816704|NCT01732510|580712088|FG004|Overall Study|Adverse Event|0|||
160816705|NCT01732510|580712089|FG005|Overall Study|Adverse Event|0|||
160987530|NCT02711826|581341151|FG001|Overall Study|Failure to manufacture cellular product|0|||
160987531|NCT02711826|581341152|FG002|Overall Study|Failure to manufacture cellular product|5|||
160987532|NCT02711826|581341153|FG003|Overall Study|Failure to manufacture cellular product|0|||
160816706|NCT01732510|580712090|FG006|Overall Study|Adverse Event|1|||
160816707|NCT01732510|580712084|FG000|Overall Study|Protocol Violation|0|||
160816708|NCT01732510|580712085|FG001|Overall Study|Protocol Violation|0|||
160816709|NCT01732510|580712086|FG002|Overall Study|Protocol Violation|0|||
160816710|NCT01732510|580712087|FG003|Overall Study|Protocol Violation|1|||
160816711|NCT01732510|580712088|FG004|Overall Study|Protocol Violation|0|||
160816712|NCT01732510|580712089|FG005|Overall Study|Protocol Violation|0|||
160816713|NCT01732510|580712090|FG006|Overall Study|Protocol Violation|0|||
160816714|NCT01732510|580712084|FG000|Overall Study|Withdrawal by Subject|1|||
160816715|NCT01732510|580712085|FG001|Overall Study|Withdrawal by Subject|3|||
160816716|NCT01732510|580712086|FG002|Overall Study|Withdrawal by Subject|2|||
160816717|NCT01732510|580712087|FG003|Overall Study|Withdrawal by Subject|1|||
160816718|NCT01732510|580712088|FG004|Overall Study|Withdrawal by Subject|5|||
160816719|NCT01732510|580712089|FG005|Overall Study|Withdrawal by Subject|0|||
160816720|NCT01732510|580712090|FG006|Overall Study|Withdrawal by Subject|1|||
160816721|NCT01732510|580712084|FG000|Overall Study|Lost to Follow-up|0|||
160816722|NCT01732510|580712085|FG001|Overall Study|Lost to Follow-up|0|||
160816723|NCT01732510|580712086|FG002|Overall Study|Lost to Follow-up|1|||
160816724|NCT01732510|580712087|FG003|Overall Study|Lost to Follow-up|1|||
160816725|NCT01732510|580712088|FG004|Overall Study|Lost to Follow-up|0|||
160816726|NCT01732510|580712089|FG005|Overall Study|Lost to Follow-up|1|||
160816727|NCT01732510|580712090|FG006|Overall Study|Lost to Follow-up|0|||
160816728|NCT01732510|580712084|FG000|Overall Study|Physician Decision|0|||
160816729|NCT01732510|580712085|FG001|Overall Study|Physician Decision|1|||
160816730|NCT01732510|580712086|FG002|Overall Study|Physician Decision|0|||
160816731|NCT01732510|580712087|FG003|Overall Study|Physician Decision|0|||
160816732|NCT01732510|580712088|FG004|Overall Study|Physician Decision|0|||
160987533|NCT02711826|581341154|FG004|Overall Study|Failure to manufacture cellular product|0|||
160816733|NCT01732510|580712089|FG005|Overall Study|Physician Decision|0|||
160816734|NCT01732510|580712090|FG006|Overall Study|Physician Decision|0|||
160816735|NCT01732510|580712084|FG000|Overall Study|Pregnancy|0|||
160816736|NCT01732510|580712085|FG001|Overall Study|Pregnancy|0|||
160816737|NCT01732510|580712086|FG002|Overall Study|Pregnancy|0|||
160816738|NCT01732510|580712087|FG003|Overall Study|Pregnancy|1|||
160816739|NCT01732510|580712088|FG004|Overall Study|Pregnancy|0|||
160816740|NCT01732510|580712089|FG005|Overall Study|Pregnancy|0|||
160987534|NCT02711826|581341150|FG000|Overall Study|Infusion canceled for active infection|0|||
160987535|NCT02711826|581341151|FG001|Overall Study|Infusion canceled for active infection|1|||
160816741|NCT01732510|580712090|FG006|Overall Study|Pregnancy|0|||
160816742|NCT01732510|580712084|FG000|Overall Study|Study Terminated By Sponsor|0|||
160816743|NCT01732510|580712085|FG001|Overall Study|Study Terminated By Sponsor|0|||
160816744|NCT01732510|580712086|FG002|Overall Study|Study Terminated By Sponsor|0|||
160816745|NCT01732510|580712087|FG003|Overall Study|Study Terminated By Sponsor|1|||
160816746|NCT01732510|580712088|FG004|Overall Study|Study Terminated By Sponsor|0|||
160816747|NCT01732510|580712089|FG005|Overall Study|Study Terminated By Sponsor|12|||
160816748|NCT01732510|580712090|FG006|Overall Study|Study Terminated By Sponsor|6|||
160816749|NCT03403361|580712091|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
160816750|NCT02487654|580712093|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
160816751|NCT02487654|580712094|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
160816752|NCT02487654|580712093|FG000|Overall Study|Withdrawal by Subject|3|||
160816753|NCT02487654|580712094|FG001|Overall Study|Withdrawal by Subject|7|||
160816754|NCT02443116|580712097|FG000|Part 1|Adverse Event|2|||
160816755|NCT02443116|580712098|FG001|Part 1|Adverse Event|3|||
160816756|NCT02443116|580712099|FG002|Part 1|Adverse Event|0|||
160816757|NCT02443116|580712100|FG003|Part 1|Adverse Event|0|||
160816758|NCT02443116|580712101|FG004|Part 1|Adverse Event|0|||
160816759|NCT02443116|580712102|FG005|Part 1|Adverse Event|0|||
160816760|NCT02443116|580712103|FG006|Part 1|Adverse Event|0|||
160816761|NCT02443116|580712104|FG007|Part 1|Adverse Event|0|||
160816762|NCT02443116|580712105|FG008|Part 1|Adverse Event|0|||
160816763|NCT02443116|580712097|FG000|Part 1|Withdrew informed consent|0|||
160816764|NCT02443116|580712098|FG001|Part 1|Withdrew informed consent|1|||
160816765|NCT02443116|580712099|FG002|Part 1|Withdrew informed consent|0|||
160816766|NCT02443116|580712100|FG003|Part 1|Withdrew informed consent|0|||
160816767|NCT02443116|580712101|FG004|Part 1|Withdrew informed consent|0|||
160816768|NCT02443116|580712102|FG005|Part 1|Withdrew informed consent|0|||
160816769|NCT02443116|580712103|FG006|Part 1|Withdrew informed consent|0|||
160816770|NCT02443116|580712104|FG007|Part 1|Withdrew informed consent|0|||
160816771|NCT02443116|580712105|FG008|Part 1|Withdrew informed consent|0|||
160816772|NCT02443116|580712097|FG000|Part 1|Lost to Follow-up|0|||
160816773|NCT02443116|580712098|FG001|Part 1|Lost to Follow-up|0|||
160816774|NCT02443116|580712099|FG002|Part 1|Lost to Follow-up|2|||
160816775|NCT02443116|580712100|FG003|Part 1|Lost to Follow-up|0|||
160816776|NCT02443116|580712101|FG004|Part 1|Lost to Follow-up|0|||
160816777|NCT02443116|580712102|FG005|Part 1|Lost to Follow-up|0|||
160816778|NCT02443116|580712103|FG006|Part 1|Lost to Follow-up|0|||
160816779|NCT02443116|580712104|FG007|Part 1|Lost to Follow-up|0|||
160816780|NCT02443116|580712105|FG008|Part 1|Lost to Follow-up|0|||
160816781|NCT02443116|580712097|FG000|Part 1|Participant moved out of state|0|||
160816782|NCT02443116|580712098|FG001|Part 1|Participant moved out of state|0|||
160816783|NCT02443116|580712099|FG002|Part 1|Participant moved out of state|1|||
160816784|NCT02443116|580712100|FG003|Part 1|Participant moved out of state|0|||
160816785|NCT02443116|580712101|FG004|Part 1|Participant moved out of state|0|||
160816786|NCT02443116|580712102|FG005|Part 1|Participant moved out of state|0|||
160816787|NCT02443116|580712103|FG006|Part 1|Participant moved out of state|0|||
160816788|NCT02443116|580712104|FG007|Part 1|Participant moved out of state|0|||
160816789|NCT02443116|580712105|FG008|Part 1|Participant moved out of state|0|||
160816790|NCT02443116|580712097|FG000|Part 1|Participant enrolled in another clinical trial|0|||
160816791|NCT02443116|580712098|FG001|Part 1|Participant enrolled in another clinical trial|0|||
160816792|NCT02443116|580712099|FG002|Part 1|Participant enrolled in another clinical trial|1|||
160816793|NCT02443116|580712100|FG003|Part 1|Participant enrolled in another clinical trial|0|||
160816794|NCT02443116|580712101|FG004|Part 1|Participant enrolled in another clinical trial|0|||
160816795|NCT02443116|580712102|FG005|Part 1|Participant enrolled in another clinical trial|0|||
160816796|NCT02443116|580712103|FG006|Part 1|Participant enrolled in another clinical trial|0|||
160816797|NCT02443116|580712104|FG007|Part 1|Participant enrolled in another clinical trial|0|||
160816798|NCT02443116|580712105|FG008|Part 1|Participant enrolled in another clinical trial|0|||
160816799|NCT02443116|580712097|FG000|Part 2|Adverse Event|0|||
160816800|NCT02443116|580712098|FG001|Part 2|Adverse Event|0|||
160816801|NCT02443116|580712099|FG002|Part 2|Adverse Event|0|||
160816802|NCT02443116|580712100|FG003|Part 2|Adverse Event|0|||
160816803|NCT02443116|580712101|FG004|Part 2|Adverse Event|1|||
160816804|NCT02443116|580712102|FG005|Part 2|Adverse Event|1|||
160816805|NCT02443116|580712103|FG006|Part 2|Adverse Event|2|||
160816806|NCT02443116|580712104|FG007|Part 2|Adverse Event|0|||
160816807|NCT02443116|580712105|FG008|Part 2|Adverse Event|0|||
160816808|NCT02443116|580712097|FG000|Part 2|Withdrew informed consent|0|||
160816809|NCT02443116|580712098|FG001|Part 2|Withdrew informed consent|0|||
160816810|NCT02443116|580712099|FG002|Part 2|Withdrew informed consent|0|||
160816811|NCT02443116|580712100|FG003|Part 2|Withdrew informed consent|0|||
160816812|NCT02443116|580712101|FG004|Part 2|Withdrew informed consent|0|||
160816813|NCT02443116|580712102|FG005|Part 2|Withdrew informed consent|1|||
160816814|NCT02443116|580712103|FG006|Part 2|Withdrew informed consent|1|||
160816815|NCT02443116|580712104|FG007|Part 2|Withdrew informed consent|0|||
160816816|NCT02443116|580712105|FG008|Part 2|Withdrew informed consent|0|||
160816817|NCT02443116|580712097|FG000|Part 2|Inability to comply with protocol|0|||
160816818|NCT02443116|580712098|FG001|Part 2|Inability to comply with protocol|0|||
160816819|NCT02443116|580712099|FG002|Part 2|Inability to comply with protocol|0|||
160816820|NCT02443116|580712100|FG003|Part 2|Inability to comply with protocol|1|||
160816821|NCT02443116|580712101|FG004|Part 2|Inability to comply with protocol|0|||
160816822|NCT02443116|580712102|FG005|Part 2|Inability to comply with protocol|0|||
160816823|NCT02443116|580712103|FG006|Part 2|Inability to comply with protocol|0|||
160816824|NCT02443116|580712104|FG007|Part 2|Inability to comply with protocol|0|||
160816825|NCT02443116|580712105|FG008|Part 2|Inability to comply with protocol|0|||
160816826|NCT02443116|580712097|FG000|Part 2|Lost to Follow-up|0|||
160816827|NCT02443116|580712098|FG001|Part 2|Lost to Follow-up|0|||
160816828|NCT02443116|580712099|FG002|Part 2|Lost to Follow-up|0|||
160816829|NCT02443116|580712100|FG003|Part 2|Lost to Follow-up|1|||
160816830|NCT02443116|580712101|FG004|Part 2|Lost to Follow-up|0|||
160816831|NCT02443116|580712102|FG005|Part 2|Lost to Follow-up|0|||
160816832|NCT02443116|580712103|FG006|Part 2|Lost to Follow-up|0|||
160816833|NCT02443116|580712104|FG007|Part 2|Lost to Follow-up|0|||
160816834|NCT02443116|580712105|FG008|Part 2|Lost to Follow-up|0|||
160816835|NCT02443116|580712097|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816836|NCT02443116|580712098|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816837|NCT02443116|580712099|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816838|NCT02443116|580712100|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816839|NCT02443116|580712101|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816840|NCT02443116|580712102|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
160816841|NCT02443116|580712103|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816842|NCT02443116|580712104|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816843|NCT02443116|580712105|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816844|NCT02443116|580712097|FG000|Part 3|Adverse Event|0|||
160816845|NCT02443116|580712098|FG001|Part 3|Adverse Event|0|||
160816846|NCT02443116|580712099|FG002|Part 3|Adverse Event|0|||
160816847|NCT02443116|580712100|FG003|Part 3|Adverse Event|0|||
160816848|NCT02443116|580712101|FG004|Part 3|Adverse Event|0|||
160816849|NCT02443116|580712102|FG005|Part 3|Adverse Event|0|||
160816850|NCT02443116|580712103|FG006|Part 3|Adverse Event|0|||
160816851|NCT02443116|580712104|FG007|Part 3|Adverse Event|0|||
160816852|NCT02443116|580712105|FG008|Part 3|Adverse Event|1|||
160816853|NCT02443116|580712097|FG000|Part 3|Withdrew informed consent|0|||
160816854|NCT02443116|580712098|FG001|Part 3|Withdrew informed consent|0|||
160816855|NCT02443116|580712099|FG002|Part 3|Withdrew informed consent|0|||
160816856|NCT02443116|580712100|FG003|Part 3|Withdrew informed consent|0|||
160816857|NCT02443116|580712101|FG004|Part 3|Withdrew informed consent|0|||
160816858|NCT02443116|580712102|FG005|Part 3|Withdrew informed consent|0|||
160816859|NCT02443116|580712103|FG006|Part 3|Withdrew informed consent|0|||
160816860|NCT02443116|580712104|FG007|Part 3|Withdrew informed consent|3|||
160816861|NCT02443116|580712105|FG008|Part 3|Withdrew informed consent|2|||
160816862|NCT02443116|580712097|FG000|Part 3|Lost to Follow-up|0|||
160816863|NCT02443116|580712098|FG001|Part 3|Lost to Follow-up|0|||
160816864|NCT02443116|580712099|FG002|Part 3|Lost to Follow-up|0|||
160816865|NCT02443116|580712100|FG003|Part 3|Lost to Follow-up|0|||
160816866|NCT02443116|580712101|FG004|Part 3|Lost to Follow-up|0|||
160816867|NCT02443116|580712102|FG005|Part 3|Lost to Follow-up|0|||
160816868|NCT02443116|580712103|FG006|Part 3|Lost to Follow-up|0|||
160816869|NCT02443116|580712104|FG007|Part 3|Lost to Follow-up|1|||
160816870|NCT02443116|580712105|FG008|Part 3|Lost to Follow-up|2|||
160816871|NCT00349349|580712113|FG000|Overall Study|Adverse Event|5|||
160816872|NCT00349349|580712114|FG001|Overall Study|Adverse Event|6|||
160816873|NCT00349349|580712115|FG002|Overall Study|Adverse Event|2|||
160816874|NCT00349349|580712113|FG000|Overall Study|Withdrawal by Subject|5|||
160816875|NCT00349349|580712114|FG001|Overall Study|Withdrawal by Subject|2|||
160816876|NCT00349349|580712115|FG002|Overall Study|Withdrawal by Subject|1|||
160816877|NCT00349349|580712113|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
160816878|NCT00349349|580712114|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
160816879|NCT00349349|580712115|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
160816880|NCT00349349|580712113|FG000|Overall Study|Death|13|||
160816881|NCT00349349|580712114|FG001|Overall Study|Death|10|||
160816882|NCT00349349|580712115|FG002|Overall Study|Death|1|||
160816883|NCT00349349|580712113|FG000|Overall Study|Other Treatment Selected|2|||
160816884|NCT00349349|580712114|FG001|Overall Study|Other Treatment Selected|0|||
160816885|NCT00349349|580712115|FG002|Overall Study|Other Treatment Selected|0|||
160816886|NCT00349349|580712113|FG000|Overall Study|Participant Reduced General Condition|0|||
160816887|NCT00349349|580712114|FG001|Overall Study|Participant Reduced General Condition|1|||
160816888|NCT00349349|580712115|FG002|Overall Study|Participant Reduced General Condition|0|||
160816889|NCT00349349|580712113|FG000|Overall Study|Physician Decision|1|||
160816890|NCT00349349|580712114|FG001|Overall Study|Physician Decision|2|||
160816891|NCT00349349|580712115|FG002|Overall Study|Physician Decision|1|||
160816892|NCT00349349|580712113|FG000|Overall Study|No Response|0|||
160816893|NCT00349349|580712114|FG001|Overall Study|No Response|3|||
160816894|NCT00349349|580712115|FG002|Overall Study|No Response|0|||
160816895|NCT00349349|580712113|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
160816896|NCT00349349|580712114|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
160816897|NCT00349349|580712115|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
160816898|NCT03763656|580712116|FG000|Overall Study|Physician Decision|1|||
160816899|NCT03763656|580712116|FG000|Overall Study|Protocol Violation|1|||
160816900|NCT03763656|580712116|FG000|Overall Study|Withdrawal by Subject|7|||
160816901|NCT03479541|580712117|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
160816902|NCT03479541|580712118|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
160816903|NCT03479541|580712119|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
160816904|NCT03479541|580712120|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
160816905|NCT03479541|580712117|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
160816906|NCT03479541|580712118|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
160816907|NCT03479541|580712119|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
160816908|NCT03479541|580712120|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
160816909|NCT03479541|580712117|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
160816910|NCT03479541|580712118|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
160816911|NCT03479541|580712119|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
160816912|NCT03479541|580712120|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
160816913|NCT03479541|580712117|FG000|Home Monitoring|Lost to Follow-up|0|||
160816914|NCT03479541|580712118|FG001|Home Monitoring|Lost to Follow-up|0|||
160987536|NCT02711826|581341152|FG002|Overall Study|Infusion canceled for active infection|0|||
160816915|NCT03479541|580712119|FG002|Home Monitoring|Lost to Follow-up|8|||
160816916|NCT03479541|580712120|FG003|Home Monitoring|Lost to Follow-up|12|||
160816917|NCT03479541|580712117|FG000|Home Monitoring|Withdrawal by Subject|0|||
160816918|NCT03479541|580712118|FG001|Home Monitoring|Withdrawal by Subject|0|||
160816919|NCT03479541|580712119|FG002|Home Monitoring|Withdrawal by Subject|17|||
160816920|NCT03479541|580712120|FG003|Home Monitoring|Withdrawal by Subject|30|||
160816921|NCT03479541|580712117|FG000|Home Monitoring|Early Termination - PI Decision|0|||
160816922|NCT03479541|580712118|FG001|Home Monitoring|Early Termination - PI Decision|0|||
160816923|NCT03479541|580712119|FG002|Home Monitoring|Early Termination - PI Decision|4|||
160816924|NCT03479541|580712120|FG003|Home Monitoring|Early Termination - PI Decision|6|||
160987537|NCT02711826|581341153|FG003|Overall Study|Infusion canceled for active infection|0|||
160987538|NCT02711826|581341154|FG004|Overall Study|Infusion canceled for active infection|0|||
160987539|NCT02711826|581341150|FG000|Overall Study|Screen failures|0|||
160987540|NCT02711826|581341151|FG001|Overall Study|Screen failures|0|||
160987541|NCT02711826|581341152|FG002|Overall Study|Screen failures|0|||
160987542|NCT02711826|581341153|FG003|Overall Study|Screen failures|4|||
160816925|NCT03110029|580712124|FG000|Overall Study|Withdrawal by Subject|1|||
160816926|NCT03110029|580712125|FG001|Overall Study|Withdrawal by Subject|1|||
160816927|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
160816928|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
160816929|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
160816930|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
160987543|NCT02711826|581341154|FG004|Overall Study|Screen failures|0|||
160816931|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
160816932|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
160816933|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
160816934|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
160816935|NCT01673854|580712127|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
160816936|NCT01673854|580712127|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
160816937|NCT01673854|580712127|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
160816938|NCT01673854|580712127|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
160816939|NCT00334737|580712128|FG000|Hospital Phase|Death|1|||
160816940|NCT00334737|580712129|FG001|Hospital Phase|Death|2|||
160816941|NCT00334737|580712130|FG002|Hospital Phase|Death|3|||
160816942|NCT00334737|580712128|FG000|Hospital Phase|Withdrawal by Subject|0|||
160816943|NCT00334737|580712129|FG001|Hospital Phase|Withdrawal by Subject|0|||
160816944|NCT00334737|580712130|FG002|Hospital Phase|Withdrawal by Subject|1|||
160816945|NCT00334737|580712128|FG000|Hospital Phase|Did not receive study drug|1|||
160816946|NCT00334737|580712129|FG001|Hospital Phase|Did not receive study drug|0|||
160816947|NCT00334737|580712130|FG002|Hospital Phase|Did not receive study drug|0|||
160816948|NCT00334737|580712128|FG000|Follow up Phase|Lost to Follow-up|5|||
160816949|NCT00334737|580712129|FG001|Follow up Phase|Lost to Follow-up|3|||
160816950|NCT00334737|580712130|FG002|Follow up Phase|Lost to Follow-up|6|||
160816951|NCT02316353|580712131|FG000|Overall Study|Pregnancy|1|||
160816952|NCT02316353|580712132|FG001|Overall Study|Pregnancy|3|||
160816953|NCT02316353|580712131|FG000|Overall Study|Adverse Event|1|||
160816954|NCT02316353|580712132|FG001|Overall Study|Adverse Event|3|||
160816955|NCT02316353|580712131|FG000|Overall Study|Withdrawal by Subject|6|||
160816956|NCT02316353|580712132|FG001|Overall Study|Withdrawal by Subject|2|||
160816957|NCT01380535|580714956|FG000|Overall Study|Adverse Event|3|||
160816958|NCT01380535|580714957|FG001|Overall Study|Adverse Event|3|||
160816959|NCT01380535|580714956|FG000|Overall Study|Death|3|||
160816960|NCT01380535|580714957|FG001|Overall Study|Death|0|||
160816961|NCT01380535|580714956|FG000|Overall Study|Study site closed|0|||
160816962|NCT01380535|580714957|FG001|Overall Study|Study site closed|5|||
160816963|NCT01380535|580714956|FG000|Overall Study|Withdrawal by Subject|1|||
160816964|NCT01380535|580714957|FG001|Overall Study|Withdrawal by Subject|2|||
160816965|NCT01380535|580714956|FG000|Overall Study|Protocol Violation|0|||
160816966|NCT01380535|580714957|FG001|Overall Study|Protocol Violation|2|||
160816967|NCT01380535|580714956|FG000|Overall Study|Lack of Efficacy|0|||
160816968|NCT01380535|580714957|FG001|Overall Study|Lack of Efficacy|3|||
160816969|NCT01579565|580714958|FG000|Randomized|Adverse Event|1|||
160816970|NCT01579565|580714959|FG001|Randomized|Adverse Event|3|||
160816971|NCT01579565|580714958|FG000|Randomized|Withdrawal by Subject|3|||
160816972|NCT01579565|580714959|FG001|Randomized|Withdrawal by Subject|0|||
160816973|NCT01579565|580714958|FG000|Randomized|inadequate preoperative pupil dilation|0|||
160816974|NCT01579565|580714959|FG001|Randomized|inadequate preoperative pupil dilation|1|||
160816975|NCT01579565|580714958|FG000|Randomized|prohibited preoperative eating|1|||
160816976|NCT01579565|580714959|FG001|Randomized|prohibited preoperative eating|0|||
160816977|NCT01579565|580714958|FG000|Randomized|prohibited preoperative medication|0|||
160816978|NCT01579565|580714959|FG001|Randomized|prohibited preoperative medication|1|||
160816979|NCT01579565|580714958|FG000|Treated|Physician Decision|0|||
160816980|NCT01579565|580714959|FG001|Treated|Physician Decision|1|||
160816981|NCT01579565|580714958|FG000|Treated|Lost to Follow-up|2|||
160816982|NCT01579565|580714959|FG001|Treated|Lost to Follow-up|1|||
160816983|NCT01579565|580714958|FG000|Treated|declined to return for final visit|0|||
160816984|NCT01579565|580714959|FG001|Treated|declined to return for final visit|1|||
160816985|NCT05425732|580714965|FG000|Overall Study|Death|4|||
160816986|NCT05425732|580714966|FG001|Overall Study|Death|2|||
160816987|NCT05425732|580714967|FG002|Overall Study|Death|0|||
160816988|NCT05425732|580714968|FG003|Overall Study|Death|0|||
160816989|NCT05425732|580714965|FG000|Overall Study|Lost to Follow-up|10|||
160816990|NCT05425732|580714966|FG001|Overall Study|Lost to Follow-up|15|||
160816991|NCT05425732|580714967|FG002|Overall Study|Lost to Follow-up|5|||
160816992|NCT05425732|580714968|FG003|Overall Study|Lost to Follow-up|3|||
160816993|NCT05425732|580714965|FG000|Overall Study|Physician Decision|0|||
160816994|NCT05425732|580714966|FG001|Overall Study|Physician Decision|2|||
160816995|NCT05425732|580714967|FG002|Overall Study|Physician Decision|0|||
160816996|NCT05425732|580714968|FG003|Overall Study|Physician Decision|0|||
160816997|NCT05425732|580714965|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160816998|NCT05425732|580714966|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
160816999|NCT05425732|580714967|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160817000|NCT05425732|580714968|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160817001|NCT05425732|580714965|FG000|Overall Study|Withdrawal by Subject|4|||
160817002|NCT05425732|580714966|FG001|Overall Study|Withdrawal by Subject|8|||
160817003|NCT05425732|580714967|FG002|Overall Study|Withdrawal by Subject|1|||
160817004|NCT05425732|580714968|FG003|Overall Study|Withdrawal by Subject|1|||
160817005|NCT05425732|580714965|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
160817006|NCT05425732|580714966|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
160817007|NCT05425732|580714967|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
160817008|NCT05425732|580714968|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
160817009|NCT02582814|580714969|FG000|Overall Study|Study-specific withdrawal criteria|1|||
160817010|NCT02582814|580714970|FG001|Overall Study|Study-specific withdrawal criteria|0|||
160817011|NCT02582814|580714969|FG000|Overall Study|Withdrawal by Subject|4|||
160817012|NCT02582814|580714970|FG001|Overall Study|Withdrawal by Subject|3|||
160817013|NCT02582814|580714969|FG000|Overall Study|Adverse Event|4|||
160817014|NCT02582814|580714970|FG001|Overall Study|Adverse Event|4|||
160817015|NCT00306293|580714971|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
160817016|NCT00306293|580714972|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
160817017|NCT00306293|580714971|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
160817018|NCT00306293|580714972|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
160817019|NCT00306293|580714971|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
160817020|NCT00306293|580714972|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
160817021|NCT00306293|580714971|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
160817022|NCT00306293|580714972|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
160817023|NCT00306293|580714971|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
160817024|NCT00306293|580714972|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
160817025|NCT00306293|580714971|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
160817026|NCT00306293|580714972|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
160817027|NCT00306293|580714971|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
160817028|NCT00306293|580714972|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
160817029|NCT00306293|580714971|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
160817030|NCT00306293|580714972|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
160817031|NCT01089413|580714978|FG000|Overall Study|Lost to Follow-up|1|||
160817032|NCT01089413|580714978|FG000|Overall Study|Progressive Disease|93|||
160987544|NCT00729690|581341155|FG000|Overall Study|IT Catheter Malfunction|0|||
160987545|NCT00729690|581341156|FG001|Overall Study|IT Catheter Malfunction|2|||
160817033|NCT01089413|580714978|FG000|Overall Study|Participant Withdrew Consent|1|||
160817034|NCT01089413|580714978|FG000|Overall Study|Unacceptable Toxicity|12|||
160817035|NCT01089413|580714978|FG000|Overall Study|Death|10|||
160817036|NCT01089413|580714978|FG000|Overall Study|Metastasectomy|13|||
160817037|NCT01089413|580714978|FG000|Overall Study|Other|71|||
160987546|NCT00729690|581341157|FG002|Overall Study|IT Catheter Malfunction|2|||
160817038|NCT01610557|580714985|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
160817039|NCT01610557|580714986|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
160987547|NCT02169219|581341158|FG000|Overall Study|Lack of Efficacy|6|||
160645967|NCT01952574|580085923|FG000|Open-label Treatment Phase|Death|0|||
160817040|NCT01610557|580714987|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
160987548|NCT04482855|581341159|FG000|Overall Study|Lost to Follow-up|1|||
160817041|NCT01610557|580714988|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
160817042|NCT01610557|580714989|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
160817043|NCT01610557|580714985|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
160817044|NCT01610557|580714986|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
160817045|NCT01610557|580714987|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
160817046|NCT01610557|580714988|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
160817047|NCT01610557|580714989|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
160817060|NCT02003638|580714996|FG000|Overall Study|Withdrawal by Subject|1|||
160817061|NCT02003638|580714997|FG001|Overall Study|Withdrawal by Subject|0|||
160817062|NCT04115748|580715003|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
160817063|NCT04115748|580715004|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
160817064|NCT04115748|580715005|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
160817065|NCT04115748|580715006|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
160817066|NCT04115748|580715007|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817067|NCT04115748|580715008|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817068|NCT04115748|580715009|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817069|NCT04115748|580715010|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817070|NCT04115748|580715011|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817071|NCT04115748|580715012|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817072|NCT04115748|580715003|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817073|NCT04115748|580715004|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817074|NCT04115748|580715005|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817075|NCT04115748|580715006|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
160817076|NCT04115748|580715007|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817077|NCT04115748|580715008|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817078|NCT04115748|580715009|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817079|NCT04115748|580715010|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817080|NCT04115748|580715011|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817081|NCT04115748|580715012|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817082|NCT04115748|580715003|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
160817083|NCT04115748|580715004|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
160817084|NCT04115748|580715005|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
160817085|NCT04115748|580715006|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
160817086|NCT04115748|580715007|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
160817087|NCT04115748|580715008|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
160817088|NCT04115748|580715009|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
160817089|NCT04115748|580715010|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
160817090|NCT04115748|580715011|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
160817091|NCT04115748|580715012|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
160817092|NCT04115748|580715003|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817093|NCT04115748|580715004|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817094|NCT04115748|580715005|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817095|NCT04115748|580715006|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817096|NCT04115748|580715007|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817097|NCT04115748|580715008|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160987549|NCT04482855|581341160|FG001|Overall Study|Lost to Follow-up|0|||
160817098|NCT04115748|580715009|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817099|NCT04115748|580715010|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817100|NCT04115748|580715011|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
160987550|NCT04482855|581341159|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
160817101|NCT04115748|580715012|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817102|NCT01200407|580715013|FG000|Overall Study|Lost to Follow-up|56|||
160817103|NCT01200407|580715013|FG000|Overall Study|Adverse Event|3|||
160817104|NCT01200407|580715013|FG000|Overall Study|Withdrawal by Subject|4|||
160817105|NCT01200407|580715013|FG000|Overall Study|Other|19|||
160817106|NCT03299881|580715014|FG000|Overall Study|Study Termination|17|||
160817107|NCT03299881|580715015|FG001|Overall Study|Study Termination|13|||
160817108|NCT02752633|580715016|FG000|Overall Study|Withdrawal by Subject|1|||
160817109|NCT03425006|580715021|FG000|Overall Study|Withdrawal by Subject|1|||
160817110|NCT03425006|580715021|FG000|Overall Study|Physician Decision|1|||
160817111|NCT03425006|580715021|FG000|Overall Study|Death|1|||
160817112|NCT00610857|580715024|FG000|Overall Study|Not evaluable for response|2|||
160817113|NCT03931382|580715025|FG000|Overall Study|Equipment malfunction|2|||
160817114|NCT03931382|580715026|FG001|Overall Study|Equipment malfunction|0|||
160817115|NCT03931382|580715027|FG002|Overall Study|Equipment malfunction|2|||
160817116|NCT03931382|580715025|FG000|Overall Study|Withdrawal by Subject|0|||
160817117|NCT03931382|580715026|FG001|Overall Study|Withdrawal by Subject|1|||
160817118|NCT03931382|580715027|FG002|Overall Study|Withdrawal by Subject|0|||
160817119|NCT02151903|580715028|FG000|Overall Study|Withdrawal by Subject|1|||
160817120|NCT02151903|580715029|FG001|Overall Study|Withdrawal by Subject|0|||
160817121|NCT02151903|580715028|FG000|Overall Study|Progressive disease|2|||
160817122|NCT02151903|580715029|FG001|Overall Study|Progressive disease|1|||
160817123|NCT01500252|580715030|FG000|Overall Study|Death|4|||
160817124|NCT01500252|580715031|FG001|Overall Study|Death|2|||
160817125|NCT01500252|580715030|FG000|Overall Study|Lost to Follow-up|5|||
160817126|NCT01500252|580715031|FG001|Overall Study|Lost to Follow-up|4|||
160817127|NCT03490292|580715032|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
160817128|NCT03490292|580715033|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
160817129|NCT03490292|580715032|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
160817130|NCT03490292|580715033|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
160817131|NCT03490292|580715032|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
160817132|NCT03490292|580715033|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
160817133|NCT03490292|580715032|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
160817134|NCT03490292|580715033|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
160817135|NCT03490292|580715032|FG000|1 Year Follow Up Post Last Dose|Death|1|||
160817136|NCT03490292|580715033|FG001|1 Year Follow Up Post Last Dose|Death|1|||
160817137|NCT06003777|580715034|FG000|Period 1|Adverse Event|0|||
160817138|NCT06003777|580715035|FG001|Period 1|Adverse Event|0|||
160817139|NCT06003777|580715036|FG002|Period 1|Adverse Event|1|||
160817140|NCT06003777|580715037|FG003|Period 1|Adverse Event|0|||
160817141|NCT06003777|580715038|FG004|Period 1|Adverse Event|0|||
160817142|NCT06003777|580715039|FG005|Period 1|Adverse Event|0|||
160817143|NCT06003777|580715040|FG006|Period 1|Adverse Event|0|||
160817144|NCT06003777|580715041|FG007|Period 1|Adverse Event|0|||
160817145|NCT06003777|580715042|FG008|Period 1|Adverse Event|0|||
160987551|NCT04482855|581341160|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
160987552|NCT04482855|581341159|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
160987553|NCT04482855|581341160|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
160987554|NCT02886936|581341164|FG000|Overall Study|Lost to Follow-up|4|||
160987555|NCT02886936|581341165|FG001|Overall Study|Lost to Follow-up|3|||
160987556|NCT02886936|581341166|FG002|Overall Study|Lost to Follow-up|0|||
160987557|NCT02507219|581341167|FG000|Overall Study|Physician Decision|1|||
160987558|NCT02507219|581341168|FG001|Overall Study|Physician Decision|0|||
160987559|NCT02507219|581341169|FG002|Overall Study|Physician Decision|0|||
160987560|NCT02507219|581341170|FG003|Overall Study|Physician Decision|0|||
160987561|NCT02507219|581341171|FG004|Overall Study|Physician Decision|0|||
160817146|NCT06003777|580715043|FG009|Period 1|Adverse Event|0|||
160817147|NCT06003777|580715044|FG010|Period 1|Adverse Event|0|||
160817148|NCT06003777|580715045|FG011|Period 1|Adverse Event|0|||
160817149|NCT06003777|580715034|FG000|Period 1|Withdrawal by Subject|0|||
160817150|NCT06003777|580715035|FG001|Period 1|Withdrawal by Subject|0|||
160817151|NCT06003777|580715036|FG002|Period 1|Withdrawal by Subject|0|||
160817152|NCT06003777|580715037|FG003|Period 1|Withdrawal by Subject|0|||
160817153|NCT06003777|580715038|FG004|Period 1|Withdrawal by Subject|1|||
160817154|NCT06003777|580715039|FG005|Period 1|Withdrawal by Subject|0|||
160817155|NCT06003777|580715040|FG006|Period 1|Withdrawal by Subject|0|||
160817156|NCT06003777|580715041|FG007|Period 1|Withdrawal by Subject|0|||
160817157|NCT06003777|580715042|FG008|Period 1|Withdrawal by Subject|0|||
160817158|NCT06003777|580715043|FG009|Period 1|Withdrawal by Subject|0|||
160817159|NCT06003777|580715044|FG010|Period 1|Withdrawal by Subject|0|||
160817160|NCT06003777|580715045|FG011|Period 1|Withdrawal by Subject|0|||
160817161|NCT06003777|580715034|FG000|Period 2|Withdrawal by Subject|0|||
160817162|NCT06003777|580715035|FG001|Period 2|Withdrawal by Subject|0|||
160817163|NCT06003777|580715036|FG002|Period 2|Withdrawal by Subject|0|||
160817164|NCT06003777|580715037|FG003|Period 2|Withdrawal by Subject|0|||
160817165|NCT06003777|580715038|FG004|Period 2|Withdrawal by Subject|0|||
160817166|NCT06003777|580715039|FG005|Period 2|Withdrawal by Subject|0|||
160817167|NCT06003777|580715040|FG006|Period 2|Withdrawal by Subject|0|||
160817168|NCT06003777|580715041|FG007|Period 2|Withdrawal by Subject|0|||
160817169|NCT06003777|580715042|FG008|Period 2|Withdrawal by Subject|1|||
160817170|NCT06003777|580715043|FG009|Period 2|Withdrawal by Subject|0|||
160817171|NCT06003777|580715044|FG010|Period 2|Withdrawal by Subject|0|||
160817172|NCT06003777|580715045|FG011|Period 2|Withdrawal by Subject|0|||
160817173|NCT06003777|580715034|FG000|Period 3|Adverse Event|0|||
160817174|NCT06003777|580715035|FG001|Period 3|Adverse Event|0|||
160817175|NCT06003777|580715036|FG002|Period 3|Adverse Event|0|||
160817176|NCT06003777|580715037|FG003|Period 3|Adverse Event|0|||
160817177|NCT06003777|580715038|FG004|Period 3|Adverse Event|0|||
160817178|NCT06003777|580715039|FG005|Period 3|Adverse Event|0|||
160817179|NCT06003777|580715040|FG006|Period 3|Adverse Event|1|||
160817180|NCT06003777|580715041|FG007|Period 3|Adverse Event|0|||
160817181|NCT06003777|580715042|FG008|Period 3|Adverse Event|0|||
160817182|NCT06003777|580715043|FG009|Period 3|Adverse Event|0|||
160817183|NCT06003777|580715044|FG010|Period 3|Adverse Event|0|||
160817184|NCT06003777|580715045|FG011|Period 3|Adverse Event|0|||
160817185|NCT06003777|580715034|FG000|Period 4|No longer met eligibility criteria|0|||
160817186|NCT06003777|580715035|FG001|Period 4|No longer met eligibility criteria|0|||
160817187|NCT06003777|580715036|FG002|Period 4|No longer met eligibility criteria|1|||
160817188|NCT06003777|580715037|FG003|Period 4|No longer met eligibility criteria|0|||
160817189|NCT06003777|580715038|FG004|Period 4|No longer met eligibility criteria|0|||
160817190|NCT06003777|580715039|FG005|Period 4|No longer met eligibility criteria|0|||
160817191|NCT06003777|580715040|FG006|Period 4|No longer met eligibility criteria|0|||
160817192|NCT06003777|580715041|FG007|Period 4|No longer met eligibility criteria|0|||
160817193|NCT06003777|580715042|FG008|Period 4|No longer met eligibility criteria|0|||
160817194|NCT06003777|580715043|FG009|Period 4|No longer met eligibility criteria|0|||
160817195|NCT06003777|580715044|FG010|Period 4|No longer met eligibility criteria|0|||
160817196|NCT06003777|580715045|FG011|Period 4|No longer met eligibility criteria|0|||
160817197|NCT06003777|580715034|FG000|Period 4|Withdrawal by Subject|0|||
160817198|NCT06003777|580715035|FG001|Period 4|Withdrawal by Subject|1|||
160817199|NCT06003777|580715036|FG002|Period 4|Withdrawal by Subject|0|||
160817200|NCT06003777|580715037|FG003|Period 4|Withdrawal by Subject|0|||
160817201|NCT06003777|580715038|FG004|Period 4|Withdrawal by Subject|0|||
160817202|NCT06003777|580715039|FG005|Period 4|Withdrawal by Subject|0|||
160817203|NCT06003777|580715040|FG006|Period 4|Withdrawal by Subject|0|||
160817204|NCT06003777|580715041|FG007|Period 4|Withdrawal by Subject|0|||
160817205|NCT06003777|580715042|FG008|Period 4|Withdrawal by Subject|0|||
160817206|NCT06003777|580715043|FG009|Period 4|Withdrawal by Subject|0|||
160817207|NCT06003777|580715044|FG010|Period 4|Withdrawal by Subject|0|||
160817208|NCT06003777|580715045|FG011|Period 4|Withdrawal by Subject|0|||
160817209|NCT01106651|580715046|FG000|Overall Study|Adverse Event|17|||
160817210|NCT01106651|580715047|FG001|Overall Study|Adverse Event|9|||
160817211|NCT01106651|580715048|FG002|Overall Study|Adverse Event|23|||
160817212|NCT01106651|580715046|FG000|Overall Study|Lost to Follow-up|8|||
160817213|NCT01106651|580715047|FG001|Overall Study|Lost to Follow-up|2|||
160817214|NCT01106651|580715048|FG002|Overall Study|Lost to Follow-up|6|||
160817215|NCT01106651|580715046|FG000|Overall Study|Physician Decision|4|||
160817216|NCT01106651|580715047|FG001|Overall Study|Physician Decision|3|||
160900382|NCT00976677|581028711|FG000|Overall Study|Disease progression|1|||
160900383|NCT00976677|581028712|FG001|Overall Study|Disease progression|1|||
160900384|NCT00976677|581028711|FG000|Overall Study|Trial unblinded|2|||
160900385|NCT00976677|581028712|FG001|Overall Study|Trial unblinded|2|||
160817217|NCT01106651|580715048|FG002|Overall Study|Physician Decision|1|||
160817218|NCT01106651|580715046|FG000|Overall Study|Protocol Violation|1|||
160817219|NCT01106651|580715047|FG001|Overall Study|Protocol Violation|2|||
160817220|NCT01106651|580715048|FG002|Overall Study|Protocol Violation|1|||
160817221|NCT01106651|580715046|FG000|Overall Study|Withdrawal by Subject|14|||
160817222|NCT01106651|580715047|FG001|Overall Study|Withdrawal by Subject|7|||
160817223|NCT01106651|580715048|FG002|Overall Study|Withdrawal by Subject|4|||
160817224|NCT01106651|580715046|FG000|Overall Study|Noncompliance with study drug|1|||
160817225|NCT01106651|580715047|FG001|Overall Study|Noncompliance with study drug|0|||
160817226|NCT01106651|580715048|FG002|Overall Study|Noncompliance with study drug|2|||
160817227|NCT01106651|580715046|FG000|Overall Study|Other|34|||
160817228|NCT01106651|580715047|FG001|Overall Study|Other|31|||
160817229|NCT01106651|580715048|FG002|Overall Study|Other|21|||
160817230|NCT01106651|580715046|FG000|Overall Study|Death|0|||
160817231|NCT01106651|580715047|FG001|Overall Study|Death|3|||
160817232|NCT01106651|580715048|FG002|Overall Study|Death|0|||
160817233|NCT00904670|580715049|FG000|Open Label Phase|Withdrawal by Subject|2|||
160817234|NCT00904670|580715050|FG001|Open Label Phase|Withdrawal by Subject|0|||
160817235|NCT00904670|580715049|FG000|Open Label Phase|Adverse Event|2|||
160817236|NCT00904670|580715050|FG001|Open Label Phase|Adverse Event|0|||
160817237|NCT00904670|580715049|FG000|Open Label Phase|Lack of Efficacy|1|||
160817238|NCT00904670|580715050|FG001|Open Label Phase|Lack of Efficacy|0|||
160817239|NCT00904670|580715049|FG000|Open Label Phase|Lost to Follow-up|1|||
160817240|NCT00904670|580715050|FG001|Open Label Phase|Lost to Follow-up|0|||
160817241|NCT00889603|580715051|FG000|Overall Study|Adverse Event|7|||
160817242|NCT00889603|580715051|FG000|Overall Study|Death|3|||
160817243|NCT00889603|580715051|FG000|Overall Study|Lost to Follow-up|19|||
160817244|NCT00889603|580715051|FG000|Overall Study|No longer willing to participant in stud|4|||
160817245|NCT00889603|580715051|FG000|Overall Study|Other|4|||
160817246|NCT03640507|580715052|FG000|Overall Study|Withdrawal by Subject|0|||
160817247|NCT03640507|580715053|FG001|Overall Study|Withdrawal by Subject|0|||
160817248|NCT03640507|580715054|FG002|Overall Study|Withdrawal by Subject|1|||
160817249|NCT03525600|580715055|FG000|Overall Study|Adverse Event|9|||
160817250|NCT03525600|580715056|FG001|Overall Study|Adverse Event|6|||
160817251|NCT03525600|580715057|FG002|Overall Study|Adverse Event|5|||
160817252|NCT03525600|580715058|FG003|Overall Study|Adverse Event|3|||
160817253|NCT03525600|580715055|FG000|Overall Study|Lost to Follow-up|2|||
160817254|NCT03525600|580715056|FG001|Overall Study|Lost to Follow-up|4|||
160817255|NCT03525600|580715057|FG002|Overall Study|Lost to Follow-up|4|||
160817256|NCT03525600|580715058|FG003|Overall Study|Lost to Follow-up|0|||
160817257|NCT03525600|580715055|FG000|Overall Study|Physician Decision|1|||
160817258|NCT03525600|580715056|FG001|Overall Study|Physician Decision|0|||
160817259|NCT03525600|580715057|FG002|Overall Study|Physician Decision|2|||
160817260|NCT03525600|580715058|FG003|Overall Study|Physician Decision|0|||
160817261|NCT03525600|580715055|FG000|Overall Study|Consent withdrawal|36|||
160817262|NCT03525600|580715056|FG001|Overall Study|Consent withdrawal|20|||
160817263|NCT03525600|580715057|FG002|Overall Study|Consent withdrawal|6|||
160817264|NCT03525600|580715058|FG003|Overall Study|Consent withdrawal|13|||
160817265|NCT03525600|580715055|FG000|Overall Study|Death|7|||
160817266|NCT03525600|580715056|FG001|Overall Study|Death|6|||
160817267|NCT03525600|580715057|FG002|Overall Study|Death|4|||
160817268|NCT03525600|580715058|FG003|Overall Study|Death|3|||
160817269|NCT03525600|580715055|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
160817270|NCT03525600|580715056|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
160817271|NCT03525600|580715057|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
160817272|NCT03525600|580715058|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
160817273|NCT03525600|580715055|FG000|Overall Study|Other|0|||
160817274|NCT03525600|580715056|FG001|Overall Study|Other|1|||
160817275|NCT03525600|580715057|FG002|Overall Study|Other|0|||
160817276|NCT03525600|580715058|FG003|Overall Study|Other|0|||
160817277|NCT00613327|580715062|FG000|Overall Study|Adverse Event|38|||
160817278|NCT00613327|580715062|FG000|Overall Study|Lost to Follow-up|8|||
160817279|NCT00613327|580715062|FG000|Overall Study|Withdrawal by Subject|6|||
160817280|NCT00613327|580715062|FG000|Overall Study|Protocol Violation|2|||
160817281|NCT00613327|580715062|FG000|Overall Study|Other|47|||
160817282|NCT01832493|580715065|FG000|Overall Study|Physician Decision|2|||
160817283|NCT01832493|580715065|FG000|Overall Study|Protocol Violation|4|||
160817284|NCT01832493|580715065|FG000|Overall Study|Unable to place LV lead|2|||
160817285|NCT00313144|580715068|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
160817286|NCT00313144|580715068|FG000|Overall Study|Death|7|||
160817287|NCT00313144|580715068|FG000|Overall Study|Lost to Follow-up|5|||
160817288|NCT00313144|580715068|FG000|Overall Study|Withdrawal by Subject|4|||
160817289|NCT00313144|580715068|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
160817290|NCT00313144|580715068|FG000|Overall Study|Physician Decision|4|||
160817291|NCT00313144|580715068|FG000|Overall Study|Adverse event - transient|5|||
160817292|NCT00313144|580715068|FG000|Overall Study|Liver transplant|1|||
160817293|NCT00313144|580715068|FG000|Overall Study|Insurance (homecare provider) change|1|||
160817294|NCT00313144|580715068|FG000|Overall Study|Change to different product|1|||
160817295|NCT00313144|580715068|FG000|Overall Study|Due to termination of the study|66|||
160817296|NCT04731298|580715069|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
160817297|NCT04731298|580715070|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
160817298|NCT01208961|580715071|FG000|High-Fat Period III|Protocol Violation|1|||
160817299|NCT01208961|580715072|FG001|High-Fat Period III|Protocol Violation|0|||
160817300|NCT01262560|580715073|FG000|Overall Study|Protocol Violation|0|||
160817301|NCT01262560|580715074|FG001|Overall Study|Protocol Violation|1|||
160817302|NCT01262560|580715075|FG002|Overall Study|Protocol Violation|2|||
160817303|NCT00350870|580715078|FG000|Overall Study|Withdrawal by Subject|21|||
160817304|NCT00350870|580715079|FG001|Overall Study|Withdrawal by Subject|17|||
160817305|NCT00350870|580715080|FG002|Overall Study|Withdrawal by Subject|15|||
160817306|NCT00350870|580715081|FG003|Overall Study|Withdrawal by Subject|14|||
160817307|NCT00350870|580715078|FG000|Overall Study|Physician Decision|1|||
160817308|NCT00350870|580715079|FG001|Overall Study|Physician Decision|0|||
160817309|NCT00350870|580715080|FG002|Overall Study|Physician Decision|1|||
160817310|NCT00350870|580715081|FG003|Overall Study|Physician Decision|1|||
160817311|NCT01932372|580715082|FG000|Overall Study|Not meeting eligibility criteria|33|||
160817312|NCT01932372|580715083|FG001|Overall Study|Not meeting eligibility criteria|179|||
160817313|NCT04382586|580715088|FG000|Overall Study|Death|3|||
160817314|NCT04382586|580715089|FG001|Overall Study|Death|4|||
160817315|NCT04382586|580715088|FG000|Overall Study|Lost to Follow-up|11|||
160817316|NCT04382586|580715089|FG001|Overall Study|Lost to Follow-up|8|||
160817317|NCT04382586|580715088|FG000|Overall Study|Withdrawal by Subject|3|||
160817318|NCT04382586|580715089|FG001|Overall Study|Withdrawal by Subject|1|||
160817319|NCT04382586|580715088|FG000|Overall Study|Physician Decision|0|||
160817320|NCT04382586|580715089|FG001|Overall Study|Physician Decision|3|||
160817321|NCT03594747|580715090|FG000|Overall Study|Death|78|||
160817322|NCT03594747|580715091|FG001|Overall Study|Death|86|||
160817323|NCT03594747|580715092|FG002|Overall Study|Death|87|||
160817324|NCT03594747|580715090|FG000|Overall Study|Withdrawal by Subject|5|||
160817325|NCT03594747|580715091|FG001|Overall Study|Withdrawal by Subject|2|||
160817326|NCT03594747|580715092|FG002|Overall Study|Withdrawal by Subject|11|||
160817327|NCT03594747|580715090|FG000|Overall Study|Lost to Follow-up|4|||
160817328|NCT03594747|580715091|FG001|Overall Study|Lost to Follow-up|1|||
160817329|NCT03594747|580715092|FG002|Overall Study|Lost to Follow-up|1|||
160817330|NCT03594747|580715090|FG000|Overall Study|Physician Decision|0|||
160817331|NCT03594747|580715091|FG001|Overall Study|Physician Decision|1|||
160817332|NCT03594747|580715092|FG002|Overall Study|Physician Decision|0|||
160817333|NCT03594747|580715090|FG000|Overall Study|Sponsor decision|23|||
160817334|NCT03594747|580715091|FG001|Overall Study|Sponsor decision|17|||
160817335|NCT03594747|580715092|FG002|Overall Study|Sponsor decision|16|||
160817336|NCT03594747|580715090|FG000|Overall Study|Did not meet inclusion criteria|0|||
160817337|NCT03594747|580715091|FG001|Overall Study|Did not meet inclusion criteria|0|||
160817338|NCT03594747|580715092|FG002|Overall Study|Did not meet inclusion criteria|1|||
160817339|NCT03594747|580715090|FG000|Overall Study|Transfer to long term extension study|10|||
160817340|NCT03594747|580715091|FG001|Overall Study|Transfer to long term extension study|12|||
160817341|NCT03594747|580715092|FG002|Overall Study|Transfer to long term extension study|5|||
160817342|NCT02265536|580715093|FG000|Overall Study|Adverse Event|1|||
160817343|NCT02265536|580715094|FG001|Overall Study|Adverse Event|0|||
160817344|NCT02265536|580715095|FG002|Overall Study|Adverse Event|0|||
160817345|NCT02265536|580715096|FG003|Overall Study|Adverse Event|0|||
160817346|NCT02265536|580715097|FG004|Overall Study|Adverse Event|1|||
160817347|NCT02265536|580715098|FG005|Overall Study|Adverse Event|0|||
160817348|NCT02265536|580715093|FG000|Overall Study|Physician Decision|0|||
160817349|NCT02265536|580715094|FG001|Overall Study|Physician Decision|0|||
160817350|NCT02265536|580715095|FG002|Overall Study|Physician Decision|0|||
160817351|NCT02265536|580715096|FG003|Overall Study|Physician Decision|0|||
160817352|NCT02265536|580715097|FG004|Overall Study|Physician Decision|2|||
160817353|NCT02265536|580715098|FG005|Overall Study|Physician Decision|0|||
160817354|NCT02265536|580715093|FG000|Overall Study|Withdrawal by Subject|0|||
160817355|NCT02265536|580715094|FG001|Overall Study|Withdrawal by Subject|3|||
160817356|NCT02265536|580715095|FG002|Overall Study|Withdrawal by Subject|0|||
160817357|NCT02265536|580715096|FG003|Overall Study|Withdrawal by Subject|0|||
160817358|NCT02265536|580715097|FG004|Overall Study|Withdrawal by Subject|0|||
160817359|NCT02265536|580715098|FG005|Overall Study|Withdrawal by Subject|0|||
160817360|NCT02907216|580715101|FG000|Overall Study|No benefit to be obtained by continuing|0|||
160817361|NCT02907216|580715102|FG001|Overall Study|No benefit to be obtained by continuing|1|||
160817362|NCT02907216|580715101|FG000|Overall Study|Withdrawal by Subject|1|||
160817363|NCT02907216|580715102|FG001|Overall Study|Withdrawal by Subject|0|||
160817364|NCT02095873|580715104|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
160817365|NCT02095873|580715105|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
160817366|NCT02095873|580715104|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
160817367|NCT02095873|580715105|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
160817368|NCT02095873|580715104|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
160817369|NCT02095873|580715105|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
160817370|NCT00792740|580715109|FG000|Overall Study|Disease Worsening|3|||
160817371|NCT00792740|580715110|FG001|Overall Study|Disease Worsening|2|||
160817372|NCT00792740|580715109|FG000|Overall Study|Personal Reason|1|||
160817373|NCT00792740|580715110|FG001|Overall Study|Personal Reason|0|||
160817374|NCT00792740|580715109|FG000|Overall Study|Adverse Event|1|||
160817375|NCT00792740|580715110|FG001|Overall Study|Adverse Event|3|||
160817376|NCT00792740|580715109|FG000|Overall Study|Patient's withdrawal of consent|0|||
160817377|NCT00792740|580715110|FG001|Overall Study|Patient's withdrawal of consent|1|||
160817378|NCT00792740|580715109|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
160817379|NCT00792740|580715110|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
160817380|NCT00792740|580715109|FG000|Overall Study|Other reasons|0|||
160817381|NCT00792740|580715110|FG001|Overall Study|Other reasons|1|||
160817382|NCT02485639|580715115|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
160817383|NCT02485639|580715115|FG000|Overall Study|Early termination|4|||
160817384|NCT02485639|580715115|FG000|Overall Study|Withdrawal by Subject|4|||
160817385|NCT02640625|580716852|FG000|Overall Study|Adverse Event|1|||
160817386|NCT00197145|580716853|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
160817387|NCT00197145|580716854|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
160817388|NCT00197145|580716853|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
160817389|NCT00197145|580716854|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
160817390|NCT00197145|580716853|FG000|Period 1: Randomized Treatment Phase|Other|2|||
160817391|NCT00197145|580716854|FG001|Period 1: Randomized Treatment Phase|Other|2|||
160817392|NCT00197145|580716853|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
160817393|NCT00197145|580716854|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
160817394|NCT00197145|580716853|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
160817395|NCT00197145|580716854|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
160817396|NCT00197145|580716853|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
160817397|NCT00197145|580716854|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
160817398|NCT00197145|580716853|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
160817399|NCT00197145|580716854|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
160817400|NCT00197145|580716853|FG000|Period 2 : Open Label Phase|Other|1|||
160817401|NCT00197145|580716854|FG001|Period 2 : Open Label Phase|Other|0|||
160817402|NCT00790868|580716855|FG000|Overall Study|Withdrawal by Subject|4|||
160817403|NCT00790868|580716856|FG001|Overall Study|Withdrawal by Subject|5|||
160817404|NCT00790868|580716855|FG000|Overall Study|Lost to Follow-up|2|||
160817405|NCT00790868|580716856|FG001|Overall Study|Lost to Follow-up|12|||
160817406|NCT02867813|580716860|FG000|Overall Study|Withdrawal by Subject|57|||
160817407|NCT02867813|580716861|FG001|Overall Study|Withdrawal by Subject|56|||
160817408|NCT02867813|580716860|FG000|Overall Study|Decision by Sponsor|7|||
160817409|NCT02867813|580716861|FG001|Overall Study|Decision by Sponsor|7|||
160817410|NCT02867813|580716860|FG000|Overall Study|Lost to Follow-up|91|||
160817411|NCT02867813|580716861|FG001|Overall Study|Lost to Follow-up|78|||
160817412|NCT02867813|580716860|FG000|Overall Study|Missing|2|||
160817413|NCT02867813|580716861|FG001|Overall Study|Missing|1|||
160817414|NCT02867813|580716860|FG000|Overall Study|Death|294|||
160817415|NCT02867813|580716861|FG001|Overall Study|Death|268|||
160817416|NCT02013206|580716862|FG000|Overall Study|Progressive disease (PD)|14|||
160817417|NCT02013206|580716863|FG001|Overall Study|Progressive disease (PD)|17|||
160817418|NCT02013206|580716862|FG000|Overall Study|Symptomatic deterioration|3|||
160817419|NCT02013206|580716863|FG001|Overall Study|Symptomatic deterioration|1|||
160817420|NCT02013206|580716862|FG000|Overall Study|Adverse Event|1|||
160817421|NCT02013206|580716863|FG001|Overall Study|Adverse Event|0|||
160817422|NCT02013206|580716862|FG000|Overall Study|Patient refusal|2|||
160817423|NCT02013206|580716863|FG001|Overall Study|Patient refusal|0|||
160817424|NCT02013206|580716862|FG000|Overall Study|Patient non-compliance|1|||
160817425|NCT02013206|580716863|FG001|Overall Study|Patient non-compliance|0|||
160817426|NCT02013206|580716862|FG000|Overall Study|Death|1|||
160817427|NCT02013206|580716863|FG001|Overall Study|Death|2|||
160817428|NCT02013206|580716862|FG000|Overall Study|Other reasons off treatment|5|||
160817429|NCT02013206|580716863|FG001|Overall Study|Other reasons off treatment|2|||
160817430|NCT02370537|580716864|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
160817431|NCT02370537|580716865|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
160817432|NCT02370537|580716866|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
160817433|NCT02370537|580716864|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
160817434|NCT02370537|580716865|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
160817435|NCT02370537|580716866|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
160817436|NCT02370537|580716864|FG000|Part B|Not randomised to receive treatment|1|||
160817437|NCT02370537|580716865|FG001|Part B|Not randomised to receive treatment|2|||
160817438|NCT02370537|580716866|FG002|Part B|Not randomised to receive treatment|259|||
160817439|NCT02370537|580716864|FG000|Part B|Withdrawal by Subject|0|||
160817440|NCT02370537|580716865|FG001|Part B|Withdrawal by Subject|1|||
160817441|NCT02370537|580716866|FG002|Part B|Withdrawal by Subject|0|||
160817442|NCT02578680|580716869|FG000|Overall Study|Death|329|||
160817443|NCT02578680|580716870|FG001|Overall Study|Death|181|||
160817444|NCT02578680|580716869|FG000|Overall Study|Lost to Follow-up|3|||
160817445|NCT02578680|580716870|FG001|Overall Study|Lost to Follow-up|1|||
160817446|NCT02578680|580716869|FG000|Overall Study|Physician Decision|0|||
160817447|NCT02578680|580716870|FG001|Overall Study|Physician Decision|1|||
160817448|NCT02578680|580716869|FG000|Overall Study|Protocol Violation|1|||
160817449|NCT02578680|580716870|FG001|Overall Study|Protocol Violation|1|||
160817450|NCT02578680|580716869|FG000|Overall Study|Sponsor Decision|64|||
160987562|NCT02507219|581341172|FG005|Overall Study|Physician Decision|0|||
160987563|NCT02507219|581341167|FG000|Overall Study|Withdrawal by Subject|0|||
160987564|NCT02507219|581341168|FG001|Overall Study|Withdrawal by Subject|0|||
160817451|NCT02578680|580716870|FG001|Overall Study|Sponsor Decision|13|||
160817452|NCT02578680|580716869|FG000|Overall Study|Withdrawal by Subject|13|||
160817453|NCT02578680|580716870|FG001|Overall Study|Withdrawal by Subject|9|||
160817454|NCT02596958|580716872|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
160817455|NCT02596958|580716872|FG000|Overall Study|Cancer Progression|441|||
160987565|NCT02507219|581341169|FG002|Overall Study|Withdrawal by Subject|0|||
160817456|NCT02596958|580716872|FG000|Overall Study|Death From Cancer|112|||
160817457|NCT02596958|580716872|FG000|Overall Study|Death From Other Cause|33|||
160817458|NCT02596958|580716872|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
160817459|NCT02596958|580716872|FG000|Overall Study|Administrative Reasons/Other|231|||
160817460|NCT02596958|580716872|FG000|Overall Study|Lost to Follow-up|33|||
160817461|NCT02596958|580716872|FG000|Overall Study|Missing|32|||
160817462|NCT02596958|580716872|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
160817463|NCT01559259|580716873|FG000|Overall Study|Withdrawal by Subject|0|||
160817464|NCT01559259|580716874|FG001|Overall Study|Withdrawal by Subject|0|||
160817465|NCT01559259|580716875|FG002|Overall Study|Withdrawal by Subject|0|||
160817466|NCT01559259|580716876|FG003|Overall Study|Withdrawal by Subject|1|||
160817467|NCT01559259|580716877|FG004|Overall Study|Withdrawal by Subject|0|||
160817468|NCT01559259|580716873|FG000|Overall Study|Adverse Event|0|||
160817469|NCT01559259|580716874|FG001|Overall Study|Adverse Event|1|||
160817470|NCT01559259|580716875|FG002|Overall Study|Adverse Event|1|||
160817471|NCT01559259|580716876|FG003|Overall Study|Adverse Event|0|||
160817472|NCT01559259|580716877|FG004|Overall Study|Adverse Event|0|||
160817473|NCT01995669|580716878|FG000|Overall Study|Progression|2|||
160817474|NCT01995669|580716879|FG001|Overall Study|Progression|1|||
160817475|NCT01995669|580716880|FG002|Overall Study|Progression|1|||
160817476|NCT01995669|580716881|FG003|Overall Study|Progression|13|||
160817477|NCT01995669|580716878|FG000|Overall Study|Adverse Event|0|||
160817478|NCT01995669|580716879|FG001|Overall Study|Adverse Event|0|||
160817479|NCT01995669|580716880|FG002|Overall Study|Adverse Event|0|||
160817480|NCT01995669|580716881|FG003|Overall Study|Adverse Event|3|||
160817481|NCT01995669|580716878|FG000|Overall Study|Death|0|||
160817482|NCT01995669|580716879|FG001|Overall Study|Death|0|||
160817483|NCT01995669|580716880|FG002|Overall Study|Death|0|||
160817484|NCT01995669|580716881|FG003|Overall Study|Death|6|||
160817485|NCT01995669|580716878|FG000|Overall Study|Withdrawal by Subject|0|||
160817486|NCT01995669|580716879|FG001|Overall Study|Withdrawal by Subject|0|||
160817487|NCT01995669|580716880|FG002|Overall Study|Withdrawal by Subject|0|||
160817488|NCT01995669|580716881|FG003|Overall Study|Withdrawal by Subject|6|||
160817489|NCT01995669|580716878|FG000|Overall Study|Insurance Expired|0|||
160817490|NCT01995669|580716879|FG001|Overall Study|Insurance Expired|0|||
160817491|NCT01995669|580716880|FG002|Overall Study|Insurance Expired|0|||
160817492|NCT01995669|580716881|FG003|Overall Study|Insurance Expired|1|||
160817493|NCT03727646|580716882|FG000|Overall Study|Adverse Event|1|||
160817494|NCT03727646|580716883|FG001|Overall Study|Adverse Event|0|||
160817495|NCT04753658|580716884|FG000|Overall Study|Progressive disease|7|||
160817496|NCT04753658|580716884|FG000|Overall Study|Other|7|||
160817497|NCT04753658|580716884|FG000|Overall Study|Adverse Event|1|||
160817498|NCT05659719|580716885|FG000|Overall Study|At sponsor's request|0|||
160817499|NCT05659719|580716886|FG001|Overall Study|At sponsor's request|0|||
160817500|NCT05659719|580716887|FG002|Overall Study|At sponsor's request|0|||
160817501|NCT05659719|580716888|FG003|Overall Study|At sponsor's request|95|||
160817502|NCT05659719|580716885|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
160817503|NCT05659719|580716886|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
160817504|NCT05659719|580716887|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
160817505|NCT05659719|580716888|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
160817506|NCT05659719|580716885|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
160817507|NCT05659719|580716886|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
160817508|NCT05659719|580716887|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
160817509|NCT05659719|580716888|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
160817510|NCT05659719|580716885|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
160817511|NCT05659719|580716886|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
160817512|NCT05659719|580716887|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
160817513|NCT05659719|580716888|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
160817514|NCT05659719|580716885|FG000|Overall Study|Lost to Follow-up|0|||
160817515|NCT05659719|580716886|FG001|Overall Study|Lost to Follow-up|0|||
160817516|NCT05659719|580716887|FG002|Overall Study|Lost to Follow-up|0|||
160817517|NCT05659719|580716888|FG003|Overall Study|Lost to Follow-up|2|||
160817518|NCT05659719|580716885|FG000|Overall Study|Moved to another observational study|0|||
160817519|NCT05659719|580716886|FG001|Overall Study|Moved to another observational study|0|||
160817520|NCT05659719|580716887|FG002|Overall Study|Moved to another observational study|0|||
160817521|NCT05659719|580716888|FG003|Overall Study|Moved to another observational study|1|||
160817522|NCT05659719|580716885|FG000|Overall Study|The child was enrolled in an interventional study|0|||
160817523|NCT05659719|580716886|FG001|Overall Study|The child was enrolled in an interventional study|0|||
160817524|NCT05659719|580716887|FG002|Overall Study|The child was enrolled in an interventional study|0|||
160817525|NCT05659719|580716888|FG003|Overall Study|The child was enrolled in an interventional study|55|||
160817526|NCT05659719|580716885|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
160817527|NCT05659719|580716886|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
160817528|NCT05659719|580716887|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
160817529|NCT05659719|580716888|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
160817530|NCT05659719|580716885|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
160645968|NCT01952574|580085924|FG001|Open-label Treatment Phase|Death|0|||
160645969|NCT01952574|580085925|FG002|Open-label Treatment Phase|Death|0|||
160817531|NCT05659719|580716886|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
160817532|NCT05659719|580716887|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
160817533|NCT05659719|580716888|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
160817534|NCT02290691|580716892|FG000|Overall Study|Noncompliance|0|||
160817535|NCT02290691|580716893|FG001|Overall Study|Noncompliance|1|||
160817536|NCT02290691|580716892|FG000|Overall Study|Withdrawal by Subject|1|||
160817537|NCT02290691|580716893|FG001|Overall Study|Withdrawal by Subject|1|||
160817538|NCT02290691|580716892|FG000|Overall Study|Lost to Follow-up|7|||
160817539|NCT02290691|580716893|FG001|Overall Study|Lost to Follow-up|7|||
160817540|NCT00218634|580716894|FG000|Overall Study|Lost to Follow-up|8|||
160817541|NCT00218634|580716895|FG001|Overall Study|Lost to Follow-up|15|||
160817542|NCT00978380|580716898|FG000|Overall Study|Protocol Violation|2|||
160817543|NCT00978380|580716898|FG000|Overall Study|Withdrawal criteria|9|||
160817544|NCT00978380|580716898|FG000|Overall Study|Unclassified|8|||
160817545|NCT00176488|580716899|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
160817546|NCT05059301|580716900|FG000|Overall Study|Adverse Event|0|||
160817547|NCT05059301|580716901|FG001|Overall Study|Adverse Event|2|||
160817548|NCT05059301|580716902|FG002|Overall Study|Adverse Event|2|||
160817549|NCT05059301|580716900|FG000|Overall Study|Lost to Follow-up|2|||
160817550|NCT05059301|580716901|FG001|Overall Study|Lost to Follow-up|3|||
160817551|NCT05059301|580716902|FG002|Overall Study|Lost to Follow-up|3|||
160817552|NCT04952597|580716903|FG000|Overall Study|Death|12|||
160817553|NCT04952597|580716904|FG001|Overall Study|Death|13|||
160817554|NCT04952597|580716905|FG002|Overall Study|Death|14|||
160817555|NCT04952597|580716903|FG000|Overall Study|Withdrawal by Subject|1|||
160817556|NCT04952597|580716904|FG001|Overall Study|Withdrawal by Subject|0|||
160817557|NCT04952597|580716905|FG002|Overall Study|Withdrawal by Subject|3|||
160817558|NCT04952597|580716903|FG000|Overall Study|Lost to Follow-up|0|||
160817559|NCT04952597|580716904|FG001|Overall Study|Lost to Follow-up|1|||
160817560|NCT04952597|580716905|FG002|Overall Study|Lost to Follow-up|1|||
160817561|NCT01296711|580716906|FG000|Overall Study|Adverse Event|3|||
160817562|NCT01296711|580716907|FG001|Overall Study|Adverse Event|1|||
160817563|NCT01296711|580716908|FG002|Overall Study|Adverse Event|4|||
160817564|NCT01296711|580716909|FG003|Overall Study|Adverse Event|3|||
160817565|NCT01296711|580716910|FG004|Overall Study|Adverse Event|1|||
160817566|NCT01296711|580716911|FG005|Overall Study|Adverse Event|6|||
160817567|NCT01296711|580716912|FG006|Overall Study|Adverse Event|11|||
160817568|NCT01296711|580716913|FG007|Overall Study|Adverse Event|3|||
160817569|NCT01296711|580716906|FG000|Overall Study|Lack of Efficacy|1|||
160817570|NCT01296711|580716907|FG001|Overall Study|Lack of Efficacy|4|||
160817571|NCT01296711|580716908|FG002|Overall Study|Lack of Efficacy|1|||
160817572|NCT01296711|580716909|FG003|Overall Study|Lack of Efficacy|1|||
160817573|NCT01296711|580716910|FG004|Overall Study|Lack of Efficacy|1|||
160817574|NCT01296711|580716911|FG005|Overall Study|Lack of Efficacy|0|||
160817575|NCT01296711|580716912|FG006|Overall Study|Lack of Efficacy|2|||
160817576|NCT01296711|580716913|FG007|Overall Study|Lack of Efficacy|3|||
160817577|NCT01296711|580716906|FG000|Overall Study|Lost to Follow-up|0|||
160817578|NCT01296711|580716907|FG001|Overall Study|Lost to Follow-up|0|||
160817579|NCT01296711|580716908|FG002|Overall Study|Lost to Follow-up|1|||
160817580|NCT01296711|580716909|FG003|Overall Study|Lost to Follow-up|1|||
160817581|NCT01296711|580716910|FG004|Overall Study|Lost to Follow-up|2|||
160817582|NCT01296711|580716911|FG005|Overall Study|Lost to Follow-up|0|||
160645970|NCT01952574|580085926|FG003|Open-label Treatment Phase|Death|0|||
160817583|NCT01296711|580716912|FG006|Overall Study|Lost to Follow-up|4|||
160817584|NCT01296711|580716913|FG007|Overall Study|Lost to Follow-up|2|||
160817585|NCT01296711|580716906|FG000|Overall Study|Protocol Violation|0|||
160817586|NCT01296711|580716907|FG001|Overall Study|Protocol Violation|0|||
160817587|NCT01296711|580716908|FG002|Overall Study|Protocol Violation|0|||
160817588|NCT01296711|580716909|FG003|Overall Study|Protocol Violation|1|||
160645971|NCT01952574|580085927|FG004|Open-label Treatment Phase|Death|1|||
160645972|NCT01952574|580085928|FG005|Open-label Treatment Phase|Death|0|||
160645973|NCT01952574|580085929|FG006|Open-label Treatment Phase|Death|0|||
160645974|NCT01952574|580085923|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
160645975|NCT01952574|580085924|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
160645976|NCT01952574|580085925|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
160645977|NCT01952574|580085926|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
160645978|NCT01952574|580085927|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
160645979|NCT01952574|580085928|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
160645980|NCT01952574|580085929|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
160645981|NCT01952574|580085923|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
160645982|NCT01952574|580085924|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
160645983|NCT01952574|580085925|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
160645984|NCT01952574|580085926|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
160645985|NCT01952574|580085927|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
160645986|NCT01952574|580085928|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
160645987|NCT01952574|580085929|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
160645988|NCT00770991|580085933|FG000|Overall Study|Physician Decision|2|||
160645989|NCT00770991|580085934|FG001|Overall Study|Physician Decision|0|||
160645990|NCT00770991|580085933|FG000|Overall Study|Withdrawal by Subject|1|||
160645991|NCT00770991|580085934|FG001|Overall Study|Withdrawal by Subject|0|||
160645992|NCT00770991|580085933|FG000|Overall Study|Adverse Event|1|||
160645993|NCT00770991|580085934|FG001|Overall Study|Adverse Event|5|||
160645994|NCT00770991|580085933|FG000|Overall Study|Pregnancy|1|||
160645995|NCT00770991|580085934|FG001|Overall Study|Pregnancy|0|||
160645996|NCT03687125|580085935|FG000|Overall Study|Progressive Disease|2|||
160645997|NCT03687125|580085936|FG001|Overall Study|Progressive Disease|1|||
160645998|NCT03687125|580085935|FG000|Overall Study|Protocol Violation|1|||
160645999|NCT03687125|580085936|FG001|Overall Study|Protocol Violation|0|||
160646000|NCT01992107|580085937|FG000|Overall Study|Administrative reasons|2|||
160646001|NCT01992107|580085938|FG001|Overall Study|Administrative reasons|0|||
160646002|NCT01992107|580085939|FG002|Overall Study|Administrative reasons|0|||
160646003|NCT01992107|580085937|FG000|Overall Study|Adverse Event|0|||
160646004|NCT01992107|580085938|FG001|Overall Study|Adverse Event|1|||
160646005|NCT01992107|580085939|FG002|Overall Study|Adverse Event|0|||
160646006|NCT01992107|580085937|FG000|Overall Study|Lost to Follow-up|46|||
160646007|NCT01992107|580085938|FG001|Overall Study|Lost to Follow-up|22|||
160646008|NCT01992107|580085939|FG002|Overall Study|Lost to Follow-up|26|||
160646009|NCT01992107|580085937|FG000|Overall Study|noncompliance and were unavailable|7|||
160646010|NCT01992107|580085938|FG001|Overall Study|noncompliance and were unavailable|3|||
160646011|NCT01992107|580085939|FG002|Overall Study|noncompliance and were unavailable|2|||
160817589|NCT01296711|580716910|FG004|Overall Study|Protocol Violation|1|||
160817590|NCT01296711|580716911|FG005|Overall Study|Protocol Violation|0|||
160817591|NCT01296711|580716912|FG006|Overall Study|Protocol Violation|0|||
160817592|NCT01296711|580716913|FG007|Overall Study|Protocol Violation|0|||
160817593|NCT01296711|580716906|FG000|Overall Study|Withdrawal by Subject|4|||
160817594|NCT01296711|580716907|FG001|Overall Study|Withdrawal by Subject|2|||
160817595|NCT01296711|580716908|FG002|Overall Study|Withdrawal by Subject|2|||
160817596|NCT01296711|580716909|FG003|Overall Study|Withdrawal by Subject|1|||
160817597|NCT01296711|580716910|FG004|Overall Study|Withdrawal by Subject|1|||
160817598|NCT01296711|580716911|FG005|Overall Study|Withdrawal by Subject|1|||
160817599|NCT01296711|580716912|FG006|Overall Study|Withdrawal by Subject|2|||
160817600|NCT01296711|580716913|FG007|Overall Study|Withdrawal by Subject|1|||
160817601|NCT01296711|580716906|FG000|Overall Study|Study termination|8|||
160817602|NCT01296711|580716907|FG001|Overall Study|Study termination|1|||
160900386|NCT00976677|581028711|FG000|Overall Study|Unknown/Missing|1|||
160900387|NCT00976677|581028712|FG001|Overall Study|Unknown/Missing|0|||
160900388|NCT03487549|581028717|FG000|Overall Study|Protocol Violation|0|||
160900389|NCT03487549|581028718|FG001|Overall Study|Protocol Violation|1|||
160900390|NCT03487549|581028717|FG000|Overall Study|Lost to Follow-up|2|||
160646012|NCT01992107|580085937|FG000|Overall Study|Withdrawal by Subject|13|||
160646013|NCT01992107|580085938|FG001|Overall Study|Withdrawal by Subject|7|||
160646014|NCT01992107|580085939|FG002|Overall Study|Withdrawal by Subject|8|||
160646015|NCT02022007|580085940|FG000|Overall Study|Withdrawal by Subject|1|||
160646016|NCT02022007|580085941|FG001|Overall Study|Withdrawal by Subject|1|||
160646017|NCT02022007|580085942|FG002|Overall Study|Withdrawal by Subject|1|||
160646018|NCT02022007|580085940|FG000|Overall Study|Noncompliant|0|||
160646019|NCT02022007|580085941|FG001|Overall Study|Noncompliant|0|||
160646020|NCT02022007|580085942|FG002|Overall Study|Noncompliant|1|||
160900391|NCT03487549|581028718|FG001|Overall Study|Lost to Follow-up|1|||
160646021|NCT01214603|580085944|FG000|Overall Study|Adverse Event|0|||
160817603|NCT01296711|580716908|FG002|Overall Study|Study termination|5|||
160817604|NCT01296711|580716909|FG003|Overall Study|Study termination|4|||
160817605|NCT01296711|580716910|FG004|Overall Study|Study termination|4|||
160900392|NCT03487549|581028717|FG000|Overall Study|Withdrawal by Subject|2|||
160817606|NCT01296711|580716911|FG005|Overall Study|Study termination|4|||
160817607|NCT01296711|580716912|FG006|Overall Study|Study termination|8|||
160817608|NCT01296711|580716913|FG007|Overall Study|Study termination|10|||
160817609|NCT01296711|580716906|FG000|Overall Study|Continued elevated liver enzymes|0|||
160817610|NCT01296711|580716907|FG001|Overall Study|Continued elevated liver enzymes|0|||
160817611|NCT01296711|580716908|FG002|Overall Study|Continued elevated liver enzymes|0|||
160817612|NCT01296711|580716909|FG003|Overall Study|Continued elevated liver enzymes|1|||
160817613|NCT01296711|580716910|FG004|Overall Study|Continued elevated liver enzymes|0|||
160817614|NCT01296711|580716911|FG005|Overall Study|Continued elevated liver enzymes|0|||
160817615|NCT01296711|580716912|FG006|Overall Study|Continued elevated liver enzymes|0|||
160987566|NCT02507219|581341170|FG003|Overall Study|Withdrawal by Subject|0|||
160987567|NCT02507219|581341171|FG004|Overall Study|Withdrawal by Subject|1|||
160987568|NCT02507219|581341172|FG005|Overall Study|Withdrawal by Subject|0|||
160987569|NCT04562779|581341173|FG000|Overall Study|Lost to Follow-up|7|||
160987570|NCT04562779|581341174|FG001|Overall Study|Lost to Follow-up|5|||
160987571|NCT04562779|581341175|FG002|Overall Study|Lost to Follow-up|10|||
160987572|NCT04562779|581341173|FG000|Overall Study|Protocol Violation|2|||
160987573|NCT04562779|581341174|FG001|Overall Study|Protocol Violation|2|||
160987574|NCT04562779|581341175|FG002|Overall Study|Protocol Violation|0|||
160817616|NCT01296711|580716913|FG007|Overall Study|Continued elevated liver enzymes|0|||
160817617|NCT01296711|580716906|FG000|Overall Study|Methotrexate discontinued|0|||
160817618|NCT01296711|580716907|FG001|Overall Study|Methotrexate discontinued|0|||
160817619|NCT01296711|580716908|FG002|Overall Study|Methotrexate discontinued|0|||
160817620|NCT01296711|580716909|FG003|Overall Study|Methotrexate discontinued|1|||
160817621|NCT01296711|580716910|FG004|Overall Study|Methotrexate discontinued|0|||
160817622|NCT01296711|580716911|FG005|Overall Study|Methotrexate discontinued|0|||
160817623|NCT01296711|580716912|FG006|Overall Study|Methotrexate discontinued|0|||
160817624|NCT01296711|580716913|FG007|Overall Study|Methotrexate discontinued|0|||
160817625|NCT01296711|580716906|FG000|Overall Study|Investigator discretion|0|||
160817626|NCT01296711|580716907|FG001|Overall Study|Investigator discretion|0|||
160817627|NCT01296711|580716908|FG002|Overall Study|Investigator discretion|0|||
160817628|NCT01296711|580716909|FG003|Overall Study|Investigator discretion|0|||
160817629|NCT01296711|580716910|FG004|Overall Study|Investigator discretion|0|||
160817630|NCT01296711|580716911|FG005|Overall Study|Investigator discretion|0|||
160817631|NCT01296711|580716912|FG006|Overall Study|Investigator discretion|1|||
160817632|NCT01296711|580716913|FG007|Overall Study|Investigator discretion|0|||
160817633|NCT01296711|580716906|FG000|Overall Study|Other|0|||
160817634|NCT01296711|580716907|FG001|Overall Study|Other|0|||
160817635|NCT01296711|580716908|FG002|Overall Study|Other|0|||
160817636|NCT01296711|580716909|FG003|Overall Study|Other|0|||
160817637|NCT01296711|580716910|FG004|Overall Study|Other|0|||
160817638|NCT01296711|580716911|FG005|Overall Study|Other|0|||
160817639|NCT01296711|580716912|FG006|Overall Study|Other|1|||
160817640|NCT01296711|580716913|FG007|Overall Study|Other|0|||
160817641|NCT01296711|580716906|FG000|Overall Study|Required restricted steroid injections|0|||
160817642|NCT01296711|580716907|FG001|Overall Study|Required restricted steroid injections|0|||
160817643|NCT01296711|580716908|FG002|Overall Study|Required restricted steroid injections|0|||
160817644|NCT01296711|580716909|FG003|Overall Study|Required restricted steroid injections|0|||
160817645|NCT01296711|580716910|FG004|Overall Study|Required restricted steroid injections|0|||
160817646|NCT01296711|580716911|FG005|Overall Study|Required restricted steroid injections|0|||
160817647|NCT01296711|580716912|FG006|Overall Study|Required restricted steroid injections|1|||
160817648|NCT01296711|580716913|FG007|Overall Study|Required restricted steroid injections|0|||
160817649|NCT01296711|580716906|FG000|Overall Study|Ongoing missed appointments|0|||
160817650|NCT01296711|580716907|FG001|Overall Study|Ongoing missed appointments|0|||
160817651|NCT01296711|580716908|FG002|Overall Study|Ongoing missed appointments|0|||
160817652|NCT01296711|580716909|FG003|Overall Study|Ongoing missed appointments|0|||
160817653|NCT01296711|580716910|FG004|Overall Study|Ongoing missed appointments|0|||
160817654|NCT01296711|580716911|FG005|Overall Study|Ongoing missed appointments|0|||
160817655|NCT01296711|580716912|FG006|Overall Study|Ongoing missed appointments|1|||
160817656|NCT01296711|580716913|FG007|Overall Study|Ongoing missed appointments|0|||
160817657|NCT01296711|580716906|FG000|Overall Study|Failure to comply with visits|0|||
160817658|NCT01296711|580716907|FG001|Overall Study|Failure to comply with visits|0|||
160817659|NCT01296711|580716908|FG002|Overall Study|Failure to comply with visits|0|||
160817660|NCT01296711|580716909|FG003|Overall Study|Failure to comply with visits|0|||
160817661|NCT01296711|580716910|FG004|Overall Study|Failure to comply with visits|0|||
160817662|NCT01296711|580716911|FG005|Overall Study|Failure to comply with visits|0|||
160817663|NCT01296711|580716912|FG006|Overall Study|Failure to comply with visits|0|||
160987575|NCT02320721|581341176|FG000|Overall Study|Adverse Event|6|||
160987576|NCT02320721|581341177|FG001|Overall Study|Adverse Event|6|||
160817664|NCT01296711|580716913|FG007|Overall Study|Failure to comply with visits|1|||
160817665|NCT01296711|580716906|FG000|Overall Study|Patient decision due to transport|0|||
160817666|NCT01296711|580716907|FG001|Overall Study|Patient decision due to transport|0|||
160817667|NCT01296711|580716908|FG002|Overall Study|Patient decision due to transport|0|||
160817668|NCT01296711|580716909|FG003|Overall Study|Patient decision due to transport|0|||
160817669|NCT01296711|580716910|FG004|Overall Study|Patient decision due to transport|0|||
160817670|NCT01296711|580716911|FG005|Overall Study|Patient decision due to transport|0|||
160817671|NCT01296711|580716912|FG006|Overall Study|Patient decision due to transport|0|||
160817672|NCT01296711|580716913|FG007|Overall Study|Patient decision due to transport|1|||
160817673|NCT00923975|580716919|FG000|Overall Study|Did not meet inclusion criteria|1|||
160817674|NCT01328535|580716920|FG000|Overall Study|Ineligible|1|||
160817675|NCT01005316|580716921|FG000|Overall Study|Adverse Event|0|||
160817676|NCT01005316|580716922|FG001|Overall Study|Adverse Event|0|||
160817677|NCT01005316|580716923|FG002|Overall Study|Adverse Event|0|||
160817678|NCT01005316|580716924|FG003|Overall Study|Adverse Event|1|||
160817679|NCT01005316|580716921|FG000|Overall Study|Death|20|||
160817680|NCT01005316|580716922|FG001|Overall Study|Death|5|||
160817681|NCT01005316|580716923|FG002|Overall Study|Death|1|||
160817682|NCT01005316|580716924|FG003|Overall Study|Death|15|||
160817683|NCT01005316|580716921|FG000|Overall Study|Study Termination|5|||
160817684|NCT01005316|580716922|FG001|Overall Study|Study Termination|63|||
160817685|NCT01005316|580716923|FG002|Overall Study|Study Termination|9|||
160817686|NCT01005316|580716924|FG003|Overall Study|Study Termination|85|||
160817687|NCT01005316|580716921|FG000|Overall Study|Lost to Follow-up|1|||
160817688|NCT01005316|580716922|FG001|Overall Study|Lost to Follow-up|3|||
160817689|NCT01005316|580716923|FG002|Overall Study|Lost to Follow-up|0|||
160817690|NCT01005316|580716924|FG003|Overall Study|Lost to Follow-up|2|||
160817691|NCT01005316|580716921|FG000|Overall Study|Physician Decision|6|||
160817692|NCT01005316|580716922|FG001|Overall Study|Physician Decision|0|||
160817693|NCT01005316|580716923|FG002|Overall Study|Physician Decision|0|||
160817694|NCT01005316|580716924|FG003|Overall Study|Physician Decision|0|||
160817695|NCT01005316|580716921|FG000|Overall Study|Sponsor Decision|6|||
160817696|NCT01005316|580716922|FG001|Overall Study|Sponsor Decision|3|||
160817697|NCT01005316|580716923|FG002|Overall Study|Sponsor Decision|0|||
160817698|NCT01005316|580716924|FG003|Overall Study|Sponsor Decision|0|||
160817699|NCT01005316|580716921|FG000|Overall Study|Withdrawal by Subject|1|||
160817700|NCT01005316|580716922|FG001|Overall Study|Withdrawal by Subject|1|||
160817701|NCT01005316|580716923|FG002|Overall Study|Withdrawal by Subject|0|||
160817702|NCT01005316|580716924|FG003|Overall Study|Withdrawal by Subject|2|||
160817703|NCT01005316|580716921|FG000|Overall Study|Consented to Another Study|2|||
160817704|NCT01005316|580716922|FG001|Overall Study|Consented to Another Study|0|||
160817705|NCT01005316|580716923|FG002|Overall Study|Consented to Another Study|0|||
160817706|NCT01005316|580716924|FG003|Overall Study|Consented to Another Study|0|||
160817707|NCT01005316|580716921|FG000|Overall Study|Delisted|8|||
160817708|NCT01005316|580716922|FG001|Overall Study|Delisted|0|||
160817709|NCT01005316|580716923|FG002|Overall Study|Delisted|0|||
160817710|NCT01005316|580716924|FG003|Overall Study|Delisted|0|||
160817711|NCT01005316|580716921|FG000|Overall Study|Transferred Care|1|||
160817712|NCT01005316|580716922|FG001|Overall Study|Transferred Care|0|||
160900393|NCT03487549|581028718|FG001|Overall Study|Withdrawal by Subject|0|||
160900394|NCT04092582|581030069|FG000|Overall Study|Death|1|||
160900395|NCT04092582|581030070|FG001|Overall Study|Death|1|||
160900396|NCT04092582|581030069|FG000|Overall Study|Withdrawal by Subject|4|||
160900397|NCT04092582|581030070|FG001|Overall Study|Withdrawal by Subject|1|||
160900398|NCT04092582|581030069|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
160900399|NCT04092582|581030070|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
160900400|NCT03019185|581030079|FG000|Overall Study|Lost to Follow-up|3|||
160900401|NCT03019185|581030080|FG001|Overall Study|Lost to Follow-up|0|||
160900402|NCT03019185|581030081|FG002|Overall Study|Lost to Follow-up|2|||
160987577|NCT02320721|581341176|FG000|Overall Study|Lack of Efficacy|2|||
160987578|NCT02320721|581341177|FG001|Overall Study|Lack of Efficacy|0|||
160817713|NCT01005316|580716923|FG002|Overall Study|Transferred Care|1|||
160817714|NCT01005316|580716924|FG003|Overall Study|Transferred Care|3|||
160817715|NCT01005316|580716921|FG000|Overall Study|Retransplanted|0|||
160817716|NCT01005316|580716922|FG001|Overall Study|Retransplanted|1|||
160817717|NCT01005316|580716923|FG002|Overall Study|Retransplanted|0|||
160817718|NCT01005316|580716924|FG003|Overall Study|Retransplanted|0|||
160817719|NCT00632827|580716925|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
160817720|NCT00632827|580716925|FG000|Overall Study|Death|2|||
160817721|NCT00632827|580716925|FG000|Overall Study|Adverse Event|5|||
160817722|NCT00632827|580716925|FG000|Overall Study|Lost to Follow-up|1|||
160817723|NCT01035463|580716926|FG000|Overall Study|Adverse Event|0|||
160817724|NCT01035463|580716927|FG001|Overall Study|Adverse Event|0|||
160817725|NCT01035463|580716928|FG002|Overall Study|Adverse Event|4|||
160900403|NCT03019185|581030079|FG000|Overall Study|Withdrawal by Subject|1|||
160817726|NCT01035463|580716929|FG003|Overall Study|Adverse Event|1|||
160817727|NCT01035463|580716930|FG004|Overall Study|Adverse Event|5|||
160817728|NCT01035463|580716931|FG005|Overall Study|Adverse Event|7|||
160817729|NCT01035463|580716926|FG000|Overall Study|Withdrawal by Subject|0|||
160817730|NCT01035463|580716927|FG001|Overall Study|Withdrawal by Subject|2|||
160817731|NCT01035463|580716928|FG002|Overall Study|Withdrawal by Subject|1|||
160817732|NCT01035463|580716929|FG003|Overall Study|Withdrawal by Subject|0|||
160817733|NCT01035463|580716930|FG004|Overall Study|Withdrawal by Subject|1|||
160817734|NCT01035463|580716931|FG005|Overall Study|Withdrawal by Subject|4|||
160817735|NCT01035463|580716926|FG000|Overall Study|Disease progression|0|||
160817736|NCT01035463|580716927|FG001|Overall Study|Disease progression|0|||
160817737|NCT01035463|580716928|FG002|Overall Study|Disease progression|0|||
160817738|NCT01035463|580716929|FG003|Overall Study|Disease progression|0|||
160817739|NCT01035463|580716930|FG004|Overall Study|Disease progression|0|||
160817740|NCT01035463|580716931|FG005|Overall Study|Disease progression|3|||
160817741|NCT01035463|580716926|FG000|Overall Study|Other Malignancy|0|||
160817742|NCT01035463|580716927|FG001|Overall Study|Other Malignancy|0|||
160817743|NCT01035463|580716928|FG002|Overall Study|Other Malignancy|0|||
160817744|NCT01035463|580716929|FG003|Overall Study|Other Malignancy|0|||
160817745|NCT01035463|580716930|FG004|Overall Study|Other Malignancy|0|||
160817746|NCT01035463|580716931|FG005|Overall Study|Other Malignancy|2|||
160817747|NCT01035463|580716926|FG000|Overall Study|Other|0|||
160817748|NCT01035463|580716927|FG001|Overall Study|Other|0|||
160817749|NCT01035463|580716928|FG002|Overall Study|Other|0|||
160817750|NCT01035463|580716929|FG003|Overall Study|Other|1|||
160817751|NCT01035463|580716930|FG004|Overall Study|Other|0|||
160817752|NCT01035463|580716931|FG005|Overall Study|Other|2|||
160817753|NCT01126268|580716936|FG000|Overall Study|Adverse Event|1|||
160817754|NCT03070171|580716943|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
160817755|NCT03070171|580716944|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
160817756|NCT03070171|580716943|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
160817757|NCT03070171|580716944|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
160817758|NCT03655054|580716950|FG000|Overall Study|Lost to Follow-up|1|||
160817759|NCT01626118|580716951|FG000|Overall Study|Lack of Efficacy|1|||
160817760|NCT01626118|580716952|FG001|Overall Study|Lack of Efficacy|0|||
160817761|NCT01626118|580716953|FG002|Overall Study|Lack of Efficacy|1|||
160817762|NCT01626118|580716954|FG003|Overall Study|Lack of Efficacy|3|||
160817763|NCT01626118|580716951|FG000|Overall Study|Lost to Follow-up|1|||
160817764|NCT01626118|580716952|FG001|Overall Study|Lost to Follow-up|0|||
160817765|NCT01626118|580716953|FG002|Overall Study|Lost to Follow-up|0|||
160817766|NCT01626118|580716954|FG003|Overall Study|Lost to Follow-up|0|||
160817767|NCT01626118|580716951|FG000|Overall Study|Adverse Event|0|||
160817768|NCT01626118|580716952|FG001|Overall Study|Adverse Event|1|||
160817769|NCT01626118|580716953|FG002|Overall Study|Adverse Event|1|||
160817770|NCT01626118|580716954|FG003|Overall Study|Adverse Event|0|||
160817771|NCT01626118|580716951|FG000|Overall Study|Investigator Decision|0|||
160817772|NCT01626118|580716952|FG001|Overall Study|Investigator Decision|1|||
160817773|NCT01626118|580716953|FG002|Overall Study|Investigator Decision|0|||
160817774|NCT01626118|580716954|FG003|Overall Study|Investigator Decision|0|||
160817775|NCT00002540|580716955|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
160817776|NCT00002540|580716956|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
160817777|NCT00002540|580716955|FG000|Overall Study|Died Before Randomization|2|||
160817778|NCT00002540|580716956|FG001|Overall Study|Died Before Randomization|6|||
160817779|NCT00002540|580716955|FG000|Overall Study|Died Before ASU (Control)|202|||
160817780|NCT00002540|580716956|FG001|Overall Study|Died Before ASU (Control)|0|||
160817781|NCT00002540|580716955|FG000|Overall Study|Refused ASU (Control)|597|||
160817782|NCT00002540|580716956|FG001|Overall Study|Refused ASU (Control)|0|||
160817783|NCT00002540|580716955|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
160817784|NCT00002540|580716956|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
160817785|NCT00778375|580716959|FG000|Overall Study|Ineligible|3|||
160817786|NCT00712725|580716963|FG000|Overall Study|Adverse Event|1|||
160817787|NCT00712725|580716964|FG001|Overall Study|Adverse Event|0|||
160817788|NCT00712725|580716965|FG002|Overall Study|Adverse Event|0|||
160817789|NCT00712725|580716966|FG003|Overall Study|Adverse Event|1|||
160817790|NCT00712725|580716967|FG004|Overall Study|Adverse Event|0|||
160817791|NCT00712725|580716968|FG005|Overall Study|Adverse Event|0|||
160817792|NCT00712725|580716969|FG006|Overall Study|Adverse Event|0|||
160817793|NCT00712725|580716970|FG007|Overall Study|Adverse Event|0|||
160817794|NCT00712725|580716963|FG000|Overall Study|Lost to Follow-up|3|||
160817795|NCT00712725|580716964|FG001|Overall Study|Lost to Follow-up|2|||
160900404|NCT03019185|581030080|FG001|Overall Study|Withdrawal by Subject|1|||
160817796|NCT00712725|580716965|FG002|Overall Study|Lost to Follow-up|1|||
160817797|NCT00712725|580716966|FG003|Overall Study|Lost to Follow-up|1|||
160817798|NCT00712725|580716967|FG004|Overall Study|Lost to Follow-up|2|||
160817799|NCT00712725|580716968|FG005|Overall Study|Lost to Follow-up|2|||
160817800|NCT00712725|580716969|FG006|Overall Study|Lost to Follow-up|3|||
160817801|NCT00712725|580716970|FG007|Overall Study|Lost to Follow-up|1|||
160817802|NCT00712725|580716963|FG000|Overall Study|Physician Decision|2|||
160817803|NCT00712725|580716964|FG001|Overall Study|Physician Decision|0|||
160817804|NCT00712725|580716965|FG002|Overall Study|Physician Decision|0|||
160817805|NCT00712725|580716966|FG003|Overall Study|Physician Decision|0|||
160817806|NCT00712725|580716967|FG004|Overall Study|Physician Decision|1|||
160817807|NCT00712725|580716968|FG005|Overall Study|Physician Decision|0|||
160817808|NCT00712725|580716969|FG006|Overall Study|Physician Decision|2|||
160900405|NCT03019185|581030081|FG002|Overall Study|Withdrawal by Subject|0|||
160817809|NCT00712725|580716970|FG007|Overall Study|Physician Decision|0|||
160817810|NCT00712725|580716963|FG000|Overall Study|Pregnancy|0|||
160817811|NCT00712725|580716964|FG001|Overall Study|Pregnancy|1|||
160817812|NCT00712725|580716965|FG002|Overall Study|Pregnancy|0|||
160817813|NCT00712725|580716966|FG003|Overall Study|Pregnancy|0|||
160817814|NCT00712725|580716967|FG004|Overall Study|Pregnancy|1|||
160817815|NCT00712725|580716968|FG005|Overall Study|Pregnancy|0|||
160817816|NCT00712725|580716969|FG006|Overall Study|Pregnancy|2|||
160817817|NCT00712725|580716970|FG007|Overall Study|Pregnancy|0|||
160817818|NCT00712725|580716963|FG000|Overall Study|Protocol Violation|2|||
160817819|NCT00712725|580716964|FG001|Overall Study|Protocol Violation|0|||
160817820|NCT00712725|580716965|FG002|Overall Study|Protocol Violation|1|||
160817821|NCT00712725|580716966|FG003|Overall Study|Protocol Violation|3|||
160817822|NCT00712725|580716967|FG004|Overall Study|Protocol Violation|2|||
160817823|NCT00712725|580716968|FG005|Overall Study|Protocol Violation|0|||
160817824|NCT00712725|580716969|FG006|Overall Study|Protocol Violation|1|||
160817825|NCT00712725|580716970|FG007|Overall Study|Protocol Violation|1|||
160817826|NCT00712725|580716963|FG000|Overall Study|Withdrawal by Subject|2|||
160817827|NCT00712725|580716964|FG001|Overall Study|Withdrawal by Subject|1|||
160817828|NCT00712725|580716965|FG002|Overall Study|Withdrawal by Subject|1|||
160817829|NCT00712725|580716966|FG003|Overall Study|Withdrawal by Subject|2|||
160817830|NCT00712725|580716967|FG004|Overall Study|Withdrawal by Subject|1|||
160817831|NCT00712725|580716968|FG005|Overall Study|Withdrawal by Subject|1|||
160817832|NCT00712725|580716969|FG006|Overall Study|Withdrawal by Subject|1|||
160817833|NCT00712725|580716970|FG007|Overall Study|Withdrawal by Subject|2|||
160817834|NCT00712725|580716963|FG000|Overall Study|Lack of Qualifying Event|16|||
160817835|NCT00712725|580716964|FG001|Overall Study|Lack of Qualifying Event|2|||
160817836|NCT00712725|580716965|FG002|Overall Study|Lack of Qualifying Event|6|||
160817837|NCT00712725|580716966|FG003|Overall Study|Lack of Qualifying Event|8|||
160817838|NCT00712725|580716967|FG004|Overall Study|Lack of Qualifying Event|11|||
160817839|NCT00712725|580716968|FG005|Overall Study|Lack of Qualifying Event|13|||
160817840|NCT00712725|580716969|FG006|Overall Study|Lack of Qualifying Event|11|||
160817841|NCT00712725|580716970|FG007|Overall Study|Lack of Qualifying Event|6|||
160817842|NCT00712725|580716963|FG000|Overall Study|Protocol Specified Criteria|3|||
160817843|NCT00712725|580716964|FG001|Overall Study|Protocol Specified Criteria|0|||
160817844|NCT00712725|580716965|FG002|Overall Study|Protocol Specified Criteria|1|||
160817845|NCT00712725|580716966|FG003|Overall Study|Protocol Specified Criteria|2|||
160817846|NCT00712725|580716967|FG004|Overall Study|Protocol Specified Criteria|1|||
160817847|NCT00712725|580716968|FG005|Overall Study|Protocol Specified Criteria|0|||
160817848|NCT00712725|580716969|FG006|Overall Study|Protocol Specified Criteria|2|||
160817849|NCT00712725|580716970|FG007|Overall Study|Protocol Specified Criteria|1|||
160817850|NCT01901289|580716971|FG000|Overall Study|Death|32|||
160817851|NCT01901289|580716971|FG000|Overall Study|Lost to Follow-up|16|||
160817852|NCT01901289|580716971|FG000|Overall Study|Withdrawal by Subject|35|||
160817853|NCT01901289|580716971|FG000|Overall Study|Other type of endpoint met|2|||
160817854|NCT00700882|580716972|FG000|Overall Study|Never received treatment|6|||
160987579|NCT02320721|581341176|FG000|Overall Study|Poor compliance to protocol|3|||
160817855|NCT00700882|580716972|FG000|Overall Study|Ineligible|2|||
160817856|NCT00700882|580716972|FG000|Overall Study|No KIT mutation|51|||
160817857|NCT01814397|580716982|FG000|Overall Study|Adverse Event|7|||
160817858|NCT01814397|580716982|FG000|Overall Study|Withdrawal by Subject|7|||
160817859|NCT00290771|580716983|FG000|Overall Study|Disease progression|95|||
160817860|NCT00290771|580716984|FG001|Overall Study|Disease progression|73|||
160817861|NCT00290771|580716983|FG000|Overall Study|Death|11|||
160817862|NCT00290771|580716984|FG001|Overall Study|Death|10|||
160817863|NCT00290771|580716983|FG000|Overall Study|Adverse Event|12|||
160817864|NCT00290771|580716984|FG001|Overall Study|Adverse Event|6|||
160987580|NCT02320721|581341177|FG001|Overall Study|Poor compliance to protocol|7|||
160987581|NCT02320721|581341176|FG000|Overall Study|Randomized but not treated|0|||
160987582|NCT02320721|581341177|FG001|Overall Study|Randomized but not treated|1|||
160987583|NCT02320721|581341176|FG000|Overall Study|Hypoglycemia|1|||
160987584|NCT02320721|581341177|FG001|Overall Study|Hypoglycemia|0|||
160987585|NCT02320721|581341176|FG000|Overall Study|Other than specified above|15|||
160646022|NCT01214603|580085945|FG001|Overall Study|Adverse Event|0|||
160817865|NCT00290771|580716983|FG000|Overall Study|Withdrawal by Subject|5|||
160817866|NCT00290771|580716984|FG001|Overall Study|Withdrawal by Subject|6|||
160817867|NCT00290771|580716983|FG000|Overall Study|Administrative problems|2|||
160817868|NCT00290771|580716984|FG001|Overall Study|Administrative problems|1|||
160817869|NCT00290771|580716983|FG000|Overall Study|Protocol Violation|2|||
160817870|NCT00290771|580716984|FG001|Overall Study|Protocol Violation|0|||
160817871|NCT00290771|580716983|FG000|Overall Study|Lost to Follow-up|0|||
160817872|NCT00290771|580716984|FG001|Overall Study|Lost to Follow-up|1|||
160817873|NCT04154293|580716987|FG000|Overall Study|Withdrawal by Subject|2|||
160817874|NCT04154293|580716988|FG001|Overall Study|Withdrawal by Subject|3|||
160817875|NCT04154293|580716989|FG002|Overall Study|Withdrawal by Subject|1|||
160817876|NCT04154293|580716987|FG000|Overall Study|Physician Decision|0|||
160817877|NCT04154293|580716988|FG001|Overall Study|Physician Decision|0|||
160987586|NCT02320721|581341177|FG001|Overall Study|Other than specified above|20|||
160817878|NCT04154293|580716989|FG002|Overall Study|Physician Decision|1|||
160817879|NCT03703817|580716990|FG000|Overall Study|Not meeting eligibility criteria|7|||
160817880|NCT03703817|580716991|FG001|Overall Study|Not meeting eligibility criteria|4|||
160817881|NCT02791516|580716992|FG000|Overall Study|Withdrawal by Subject|1|||
160817882|NCT02791516|580716993|FG001|Overall Study|Withdrawal by Subject|1|||
160817883|NCT02524275|580716994|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
160817884|NCT01439971|580716995|FG000|Overall Study|Required number in cohort dosed|0|||
160817885|NCT01439971|580716996|FG001|Overall Study|Required number in cohort dosed|1|||
160817886|NCT01439971|580716997|FG002|Overall Study|Required number in cohort dosed|2|||
160817887|NCT01439971|580716998|FG003|Overall Study|Required number in cohort dosed|0|||
160817888|NCT01439971|580716999|FG004|Overall Study|Required number in cohort dosed|1|||
160817889|NCT02628600|580717002|FG000|Overall Study|Death|2|||
160817890|NCT02628600|580717003|FG001|Overall Study|Death|1|||
160817891|NCT02628600|580717002|FG000|Overall Study|Adverse Event|3|||
160817892|NCT02628600|580717003|FG001|Overall Study|Adverse Event|20|||
160817893|NCT02628600|580717002|FG000|Overall Study|Protocol Violation|0|||
160817894|NCT02628600|580717003|FG001|Overall Study|Protocol Violation|1|||
160817895|NCT02628600|580717002|FG000|Overall Study|Lack of Efficacy|2|||
160817896|NCT02628600|580717003|FG001|Overall Study|Lack of Efficacy|0|||
160817897|NCT02628600|580717002|FG000|Overall Study|Withdrawal by Subject|13|||
160817898|NCT02628600|580717003|FG001|Overall Study|Withdrawal by Subject|8|||
160817899|NCT02628600|580717002|FG000|Overall Study|Lost to Follow-up|1|||
160817900|NCT02628600|580717003|FG001|Overall Study|Lost to Follow-up|0|||
160817901|NCT02628600|580717002|FG000|Overall Study|Physician Decision|2|||
160817902|NCT02628600|580717003|FG001|Overall Study|Physician Decision|2|||
160817903|NCT02628600|580717002|FG000|Overall Study|Other not specified|1|||
160817904|NCT02628600|580717003|FG001|Overall Study|Other not specified|0|||
160817905|NCT00107900|580717008|FG000|Overall Study|Adverse Event|3|||
160817906|NCT00107900|580717009|FG001|Overall Study|Adverse Event|2|||
160817907|NCT00107900|580717010|FG002|Overall Study|Adverse Event|10|||
160817908|NCT00107900|580717011|FG003|Overall Study|Adverse Event|3|||
160817909|NCT00107900|580717012|FG004|Overall Study|Adverse Event|5|||
160817910|NCT00107900|580717013|FG005|Overall Study|Adverse Event|3|||
160817911|NCT00107900|580717008|FG000|Overall Study|Death|0|||
160817912|NCT00107900|580717009|FG001|Overall Study|Death|0|||
160817913|NCT00107900|580717010|FG002|Overall Study|Death|0|||
160817914|NCT00107900|580717011|FG003|Overall Study|Death|0|||
160817915|NCT00107900|580717012|FG004|Overall Study|Death|1|||
160817916|NCT00107900|580717013|FG005|Overall Study|Death|0|||
160817917|NCT00107900|580717008|FG000|Overall Study|Lost to Follow-up|4|||
160817918|NCT00107900|580717009|FG001|Overall Study|Lost to Follow-up|1|||
160817919|NCT00107900|580717010|FG002|Overall Study|Lost to Follow-up|3|||
160817920|NCT00107900|580717011|FG003|Overall Study|Lost to Follow-up|2|||
160817921|NCT00107900|580717012|FG004|Overall Study|Lost to Follow-up|5|||
160817922|NCT00107900|580717013|FG005|Overall Study|Lost to Follow-up|5|||
160817923|NCT00107900|580717008|FG000|Overall Study|Protocol Violation|1|||
160817924|NCT00107900|580717009|FG001|Overall Study|Protocol Violation|0|||
160817925|NCT00107900|580717010|FG002|Overall Study|Protocol Violation|5|||
160817926|NCT00107900|580717011|FG003|Overall Study|Protocol Violation|5|||
160817927|NCT00107900|580717012|FG004|Overall Study|Protocol Violation|7|||
160817928|NCT00107900|580717013|FG005|Overall Study|Protocol Violation|0|||
160817929|NCT00107900|580717008|FG000|Overall Study|Withdrawal by Subject|1|||
160817930|NCT00107900|580717009|FG001|Overall Study|Withdrawal by Subject|0|||
160817931|NCT00107900|580717010|FG002|Overall Study|Withdrawal by Subject|5|||
160817932|NCT00107900|580717011|FG003|Overall Study|Withdrawal by Subject|0|||
160817933|NCT00107900|580717012|FG004|Overall Study|Withdrawal by Subject|1|||
160817934|NCT00107900|580717013|FG005|Overall Study|Withdrawal by Subject|1|||
160817935|NCT00107900|580717008|FG000|Overall Study|Administrative Reasons|1|||
160817936|NCT00107900|580717009|FG001|Overall Study|Administrative Reasons|0|||
160900406|NCT03019185|581030079|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
160646023|NCT01214603|580085946|FG002|Overall Study|Adverse Event|1|||
160817937|NCT00107900|580717010|FG002|Overall Study|Administrative Reasons|2|||
160817938|NCT00107900|580717011|FG003|Overall Study|Administrative Reasons|2|||
160817939|NCT00107900|580717012|FG004|Overall Study|Administrative Reasons|2|||
160817940|NCT00107900|580717013|FG005|Overall Study|Administrative Reasons|0|||
160817941|NCT03724981|580719442|FG000|First Device|Protocol Violation|1|||
160900407|NCT03019185|581030080|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
160817942|NCT03724981|580719443|FG001|First Device|Protocol Violation|1|||
160817943|NCT00511433|580719444|FG000|Overall Study|Adverse Event|5|||
160817944|NCT00511433|580719445|FG001|Overall Study|Adverse Event|0|||
160817945|NCT00511433|580719444|FG000|Overall Study|Other Reason|1|||
160817946|NCT00511433|580719445|FG001|Overall Study|Other Reason|1|||
160817947|NCT02791191|580719446|FG000|Overall Study|Adverse Event|2|||
160817948|NCT02791191|580719447|FG001|Overall Study|Adverse Event|4|||
160817949|NCT02791191|580719448|FG002|Overall Study|Adverse Event|5|||
160817950|NCT02791191|580719446|FG000|Overall Study|Lack of Efficacy|0|||
160817951|NCT02791191|580719447|FG001|Overall Study|Lack of Efficacy|1|||
160817952|NCT02791191|580719448|FG002|Overall Study|Lack of Efficacy|0|||
160817953|NCT02791191|580719446|FG000|Overall Study|Study Drug Non-Compliance|0|||
160817954|NCT02791191|580719447|FG001|Overall Study|Study Drug Non-Compliance|2|||
160817955|NCT02791191|580719448|FG002|Overall Study|Study Drug Non-Compliance|0|||
160817956|NCT02791191|580719446|FG000|Overall Study|Site Closed by Sponsor|1|||
160817957|NCT02791191|580719447|FG001|Overall Study|Site Closed by Sponsor|1|||
160817958|NCT02791191|580719448|FG002|Overall Study|Site Closed by Sponsor|3|||
160817959|NCT02791191|580719446|FG000|Overall Study|Progressive Disease|1|||
160817960|NCT02791191|580719447|FG001|Overall Study|Progressive Disease|0|||
160817961|NCT02791191|580719448|FG002|Overall Study|Progressive Disease|0|||
160817962|NCT02791191|580719446|FG000|Overall Study|Study Terminated by Sponsor|29|||
160817963|NCT02791191|580719447|FG001|Overall Study|Study Terminated by Sponsor|101|||
160817964|NCT02791191|580719448|FG002|Overall Study|Study Terminated by Sponsor|109|||
160817965|NCT02791191|580719446|FG000|Overall Study|Withdrawal by Subject|3|||
160817966|NCT02791191|580719447|FG001|Overall Study|Withdrawal by Subject|1|||
160817967|NCT02791191|580719448|FG002|Overall Study|Withdrawal by Subject|3|||
160817968|NCT02791191|580719446|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
160817969|NCT02791191|580719447|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
160817970|NCT02791191|580719448|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
160817971|NCT01952665|580719450|FG000|Overall Study|Physician Decision|3|||
160817972|NCT01952665|580719451|FG001|Overall Study|Physician Decision|2|||
160817973|NCT01952665|580719450|FG000|Overall Study|Lost to Follow-up|1|||
160817974|NCT01952665|580719451|FG001|Overall Study|Lost to Follow-up|2|||
160817975|NCT01952665|580719450|FG000|Overall Study|Adverse Event|2|||
160817976|NCT01952665|580719451|FG001|Overall Study|Adverse Event|1|||
160817977|NCT01952665|580719450|FG000|Overall Study|Protocol Violation|0|||
160817978|NCT01952665|580719451|FG001|Overall Study|Protocol Violation|1|||
160817979|NCT00185380|580719468|FG000|Overall Study|Adverse Event|41|||
160817980|NCT00185380|580719469|FG001|Overall Study|Adverse Event|43|||
160817981|NCT00185380|580719470|FG002|Overall Study|Adverse Event|48|||
160817982|NCT00185380|580719468|FG000|Overall Study|Lost to Follow-up|0|||
160817983|NCT00185380|580719469|FG001|Overall Study|Lost to Follow-up|4|||
160817984|NCT00185380|580719470|FG002|Overall Study|Lost to Follow-up|3|||
160817985|NCT00185380|580719468|FG000|Overall Study|Pregnancy|1|||
160817986|NCT00185380|580719469|FG001|Overall Study|Pregnancy|4|||
160817987|NCT00185380|580719470|FG002|Overall Study|Pregnancy|0|||
160817988|NCT00185380|580719468|FG000|Overall Study|Protocol Violation|2|||
160817989|NCT00185380|580719469|FG001|Overall Study|Protocol Violation|2|||
160817990|NCT00185380|580719470|FG002|Overall Study|Protocol Violation|1|||
160817991|NCT00185380|580719468|FG000|Overall Study|Withdrawal by Subject|1|||
160817992|NCT00185380|580719469|FG001|Overall Study|Withdrawal by Subject|2|||
160817993|NCT00185380|580719470|FG002|Overall Study|Withdrawal by Subject|0|||
160817994|NCT00185380|580719468|FG000|Overall Study|Failed insertion|1|||
160817995|NCT00185380|580719469|FG001|Overall Study|Failed insertion|1|||
160817996|NCT00185380|580719470|FG002|Overall Study|Failed insertion|2|||
160817997|NCT00185380|580719468|FG000|Overall Study|Planned pregnancy|9|||
160817998|NCT00185380|580719469|FG001|Overall Study|Planned pregnancy|12|||
160817999|NCT00185380|580719470|FG002|Overall Study|Planned pregnancy|12|||
160818000|NCT00185380|580719468|FG000|Overall Study|No need for contraception|3|||
160818001|NCT00185380|580719469|FG001|Overall Study|No need for contraception|3|||
160818002|NCT00185380|580719470|FG002|Overall Study|No need for contraception|3|||
160818003|NCT00185380|580719468|FG000|Overall Study|Could not attend visits|2|||
160818004|NCT00185380|580719469|FG001|Overall Study|Could not attend visits|0|||
160818005|NCT00185380|580719470|FG002|Overall Study|Could not attend visits|4|||
160818006|NCT00185380|580719468|FG000|Overall Study|personal reason|6|||
160818007|NCT00185380|580719469|FG001|Overall Study|personal reason|1|||
160818008|NCT00185380|580719470|FG002|Overall Study|personal reason|1|||
160818009|NCT02589665|580719471|FG000|Induction Period|Did not receive drug|0|||
160818010|NCT02589665|580719472|FG001|Induction Period|Did not receive drug|0|||
160818011|NCT02589665|580719473|FG002|Induction Period|Did not receive drug|0|||
160818012|NCT02589665|580719474|FG003|Induction Period|Did not receive drug|1|||
160818013|NCT02589665|580719475|FG004|Induction Period|Did not receive drug|0|||
160818014|NCT02589665|580719476|FG005|Induction Period|Did not receive drug|0|||
160818015|NCT02589665|580719477|FG006|Induction Period|Did not receive drug|0|||
160818016|NCT02589665|580719478|FG007|Induction Period|Did not receive drug|0|||
160818017|NCT02589665|580719479|FG008|Induction Period|Did not receive drug|0|||
160818018|NCT02589665|580719480|FG009|Induction Period|Did not receive drug|0|||
160818019|NCT02589665|580719471|FG000|Induction Period|Adverse Event|3|||
160818020|NCT02589665|580719472|FG001|Induction Period|Adverse Event|0|||
160818021|NCT02589665|580719473|FG002|Induction Period|Adverse Event|2|||
160818022|NCT02589665|580719474|FG003|Induction Period|Adverse Event|2|||
160818023|NCT02589665|580719475|FG004|Induction Period|Adverse Event|0|||
160818024|NCT02589665|580719476|FG005|Induction Period|Adverse Event|0|||
160818025|NCT02589665|580719477|FG006|Induction Period|Adverse Event|0|||
160818026|NCT02589665|580719478|FG007|Induction Period|Adverse Event|0|||
160818027|NCT02589665|580719479|FG008|Induction Period|Adverse Event|0|||
160818028|NCT02589665|580719480|FG009|Induction Period|Adverse Event|0|||
160818029|NCT02589665|580719471|FG000|Induction Period|Withdrawal by Subject|0|||
160818030|NCT02589665|580719472|FG001|Induction Period|Withdrawal by Subject|1|||
160818031|NCT02589665|580719473|FG002|Induction Period|Withdrawal by Subject|0|||
160818032|NCT02589665|580719474|FG003|Induction Period|Withdrawal by Subject|1|||
160818033|NCT02589665|580719475|FG004|Induction Period|Withdrawal by Subject|0|||
160818034|NCT02589665|580719476|FG005|Induction Period|Withdrawal by Subject|0|||
160818035|NCT02589665|580719477|FG006|Induction Period|Withdrawal by Subject|0|||
160818036|NCT02589665|580719478|FG007|Induction Period|Withdrawal by Subject|0|||
160818037|NCT02589665|580719479|FG008|Induction Period|Withdrawal by Subject|0|||
160818038|NCT02589665|580719480|FG009|Induction Period|Withdrawal by Subject|0|||
160818039|NCT02589665|580719471|FG000|Induction Period|Protocol Violation|0|||
160818040|NCT02589665|580719472|FG001|Induction Period|Protocol Violation|1|||
160818041|NCT02589665|580719473|FG002|Induction Period|Protocol Violation|0|||
160818042|NCT02589665|580719474|FG003|Induction Period|Protocol Violation|0|||
160818043|NCT02589665|580719475|FG004|Induction Period|Protocol Violation|0|||
160818044|NCT02589665|580719476|FG005|Induction Period|Protocol Violation|0|||
160818045|NCT02589665|580719477|FG006|Induction Period|Protocol Violation|0|||
160818046|NCT02589665|580719478|FG007|Induction Period|Protocol Violation|0|||
160818047|NCT02589665|580719479|FG008|Induction Period|Protocol Violation|0|||
160818048|NCT02589665|580719480|FG009|Induction Period|Protocol Violation|0|||
160818049|NCT02589665|580719471|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818050|NCT02589665|580719472|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818051|NCT02589665|580719473|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818052|NCT02589665|580719474|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818053|NCT02589665|580719475|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
160818054|NCT02589665|580719476|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
160818055|NCT02589665|580719477|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
160818056|NCT02589665|580719478|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818057|NCT02589665|580719479|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818058|NCT02589665|580719480|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818059|NCT02589665|580719471|FG000|Maintenance Period|Withdrawal by Subject|0|||
160818060|NCT02589665|580719472|FG001|Maintenance Period|Withdrawal by Subject|0|||
160818061|NCT02589665|580719473|FG002|Maintenance Period|Withdrawal by Subject|0|||
160818062|NCT02589665|580719474|FG003|Maintenance Period|Withdrawal by Subject|0|||
160818063|NCT02589665|580719475|FG004|Maintenance Period|Withdrawal by Subject|4|||
160818064|NCT02589665|580719476|FG005|Maintenance Period|Withdrawal by Subject|2|||
160818065|NCT02589665|580719477|FG006|Maintenance Period|Withdrawal by Subject|4|||
160818066|NCT02589665|580719478|FG007|Maintenance Period|Withdrawal by Subject|0|||
160818067|NCT02589665|580719479|FG008|Maintenance Period|Withdrawal by Subject|0|||
160818068|NCT02589665|580719480|FG009|Maintenance Period|Withdrawal by Subject|0|||
160818069|NCT02589665|580719471|FG000|Maintenance Period|Lack of Efficacy|0|||
160818070|NCT02589665|580719472|FG001|Maintenance Period|Lack of Efficacy|0|||
160818071|NCT02589665|580719473|FG002|Maintenance Period|Lack of Efficacy|0|||
160818072|NCT02589665|580719474|FG003|Maintenance Period|Lack of Efficacy|0|||
160818073|NCT02589665|580719475|FG004|Maintenance Period|Lack of Efficacy|2|||
160818074|NCT02589665|580719476|FG005|Maintenance Period|Lack of Efficacy|1|||
160818075|NCT02589665|580719477|FG006|Maintenance Period|Lack of Efficacy|0|||
160818076|NCT02589665|580719478|FG007|Maintenance Period|Lack of Efficacy|0|||
160818077|NCT02589665|580719479|FG008|Maintenance Period|Lack of Efficacy|0|||
160818078|NCT02589665|580719480|FG009|Maintenance Period|Lack of Efficacy|0|||
160818079|NCT02589665|580719471|FG000|Maintenance Period|Adverse Event|0|||
160818080|NCT02589665|580719472|FG001|Maintenance Period|Adverse Event|0|||
160818081|NCT02589665|580719473|FG002|Maintenance Period|Adverse Event|0|||
160818082|NCT02589665|580719474|FG003|Maintenance Period|Adverse Event|0|||
160818083|NCT02589665|580719475|FG004|Maintenance Period|Adverse Event|0|||
160818084|NCT02589665|580719476|FG005|Maintenance Period|Adverse Event|0|||
160818085|NCT02589665|580719477|FG006|Maintenance Period|Adverse Event|2|||
160900408|NCT03019185|581030081|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
160900409|NCT03019185|581030079|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
160900410|NCT03019185|581030080|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
160900411|NCT03019185|581030081|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
160900412|NCT01303861|581030089|FG000|Overall Study|Lost to Follow-up|34|||
160900413|NCT01303861|581030090|FG001|Overall Study|Lost to Follow-up|14|||
160900414|NCT01303861|581030091|FG002|Overall Study|Lost to Follow-up|27|||
160987587|NCT03173248|581341178|FG000|Overall Study|Death|28|||
160987588|NCT03173248|581341179|FG001|Overall Study|Death|46|||
160987589|NCT03173248|581341178|FG000|Overall Study|Lost to Follow-up|0|||
160987590|NCT03173248|581341179|FG001|Overall Study|Lost to Follow-up|1|||
160818086|NCT02589665|580719478|FG007|Maintenance Period|Adverse Event|0|||
160818087|NCT02589665|580719479|FG008|Maintenance Period|Adverse Event|0|||
160818088|NCT02589665|580719480|FG009|Maintenance Period|Adverse Event|0|||
160818089|NCT02589665|580719471|FG000|Maintenance Period|Lost to Follow-up|0|||
160818090|NCT02589665|580719472|FG001|Maintenance Period|Lost to Follow-up|0|||
160818091|NCT02589665|580719473|FG002|Maintenance Period|Lost to Follow-up|0|||
160818092|NCT02589665|580719474|FG003|Maintenance Period|Lost to Follow-up|0|||
160818093|NCT02589665|580719475|FG004|Maintenance Period|Lost to Follow-up|0|||
160818094|NCT02589665|580719476|FG005|Maintenance Period|Lost to Follow-up|1|||
160818095|NCT02589665|580719477|FG006|Maintenance Period|Lost to Follow-up|0|||
160818096|NCT02589665|580719478|FG007|Maintenance Period|Lost to Follow-up|0|||
160818097|NCT02589665|580719479|FG008|Maintenance Period|Lost to Follow-up|0|||
160818098|NCT02589665|580719480|FG009|Maintenance Period|Lost to Follow-up|0|||
160818099|NCT02589665|580719471|FG000|Maintenance Period|Physician Decision|0|||
160818100|NCT02589665|580719472|FG001|Maintenance Period|Physician Decision|0|||
160818101|NCT02589665|580719473|FG002|Maintenance Period|Physician Decision|0|||
160818102|NCT02589665|580719474|FG003|Maintenance Period|Physician Decision|0|||
160818103|NCT02589665|580719475|FG004|Maintenance Period|Physician Decision|0|||
160818104|NCT02589665|580719476|FG005|Maintenance Period|Physician Decision|1|||
160818105|NCT02589665|580719477|FG006|Maintenance Period|Physician Decision|0|||
160818106|NCT02589665|580719478|FG007|Maintenance Period|Physician Decision|0|||
160818107|NCT02589665|580719479|FG008|Maintenance Period|Physician Decision|0|||
160818108|NCT02589665|580719480|FG009|Maintenance Period|Physician Decision|0|||
160818109|NCT02589665|580719471|FG000|Maintenance Period|Reason Not Collected|0|||
160818110|NCT02589665|580719472|FG001|Maintenance Period|Reason Not Collected|0|||
160818111|NCT02589665|580719473|FG002|Maintenance Period|Reason Not Collected|0|||
160818112|NCT02589665|580719474|FG003|Maintenance Period|Reason Not Collected|0|||
160818113|NCT02589665|580719475|FG004|Maintenance Period|Reason Not Collected|0|||
160818114|NCT02589665|580719476|FG005|Maintenance Period|Reason Not Collected|1|||
160818115|NCT02589665|580719477|FG006|Maintenance Period|Reason Not Collected|1|||
160818116|NCT02589665|580719478|FG007|Maintenance Period|Reason Not Collected|0|||
160818117|NCT02589665|580719479|FG008|Maintenance Period|Reason Not Collected|0|||
160900415|NCT01303861|581030092|FG003|Overall Study|Lost to Follow-up|31|||
160900416|NCT01303861|581030089|FG000|Overall Study|Lack of Efficacy|3|||
160900417|NCT01303861|581030090|FG001|Overall Study|Lack of Efficacy|2|||
160900418|NCT01303861|581030091|FG002|Overall Study|Lack of Efficacy|1|||
160900419|NCT01303861|581030092|FG003|Overall Study|Lack of Efficacy|0|||
160900420|NCT01303861|581030089|FG000|Overall Study|Withdrawal by Subject|16|||
160900421|NCT01303861|581030090|FG001|Overall Study|Withdrawal by Subject|8|||
160900422|NCT01303861|581030091|FG002|Overall Study|Withdrawal by Subject|8|||
160900423|NCT01303861|581030092|FG003|Overall Study|Withdrawal by Subject|23|||
160818118|NCT02589665|580719480|FG009|Maintenance Period|Reason Not Collected|0|||
160818119|NCT02589665|580719471|FG000|Induction Extension Period|Adverse Event|0|||
160900424|NCT01303861|581030089|FG000|Overall Study|Adverse Event|4|||
160900425|NCT01303861|581030090|FG001|Overall Study|Adverse Event|1|||
160900426|NCT01303861|581030091|FG002|Overall Study|Adverse Event|0|||
160900427|NCT01303861|581030092|FG003|Overall Study|Adverse Event|5|||
160900428|NCT01303861|581030089|FG000|Overall Study|Pregnancy|1|||
160900429|NCT01303861|581030090|FG001|Overall Study|Pregnancy|0|||
160900430|NCT01303861|581030091|FG002|Overall Study|Pregnancy|0|||
160818120|NCT02589665|580719472|FG001|Induction Extension Period|Adverse Event|0|||
160818121|NCT02589665|580719473|FG002|Induction Extension Period|Adverse Event|0|||
160900431|NCT01303861|581030092|FG003|Overall Study|Pregnancy|0|||
160900432|NCT01868503|581030104|FG000|Overall Study|Withdrawal by Subject|1|||
160900433|NCT01868503|581030104|FG000|Overall Study|Protocol Violation|1|||
160900434|NCT05224141|581030106|FG000|Overall Study|Ongoing|75|||
160900435|NCT05224141|581030107|FG001|Overall Study|Ongoing|88|||
160900436|NCT05224141|581030106|FG000|Overall Study|Withdrawal by Subject|2|||
160818122|NCT02589665|580719474|FG003|Induction Extension Period|Adverse Event|0|||
160818123|NCT02589665|580719475|FG004|Induction Extension Period|Adverse Event|0|||
160818124|NCT02589665|580719476|FG005|Induction Extension Period|Adverse Event|0|||
160818125|NCT02589665|580719477|FG006|Induction Extension Period|Adverse Event|0|||
160818126|NCT02589665|580719478|FG007|Induction Extension Period|Adverse Event|0|||
160818127|NCT02589665|580719479|FG008|Induction Extension Period|Adverse Event|4|||
160818128|NCT02589665|580719480|FG009|Induction Extension Period|Adverse Event|0|||
160818129|NCT02589665|580719471|FG000|Induction Extension Period|Lack of Efficacy|0|||
160818130|NCT02589665|580719472|FG001|Induction Extension Period|Lack of Efficacy|0|||
160818131|NCT02589665|580719473|FG002|Induction Extension Period|Lack of Efficacy|0|||
160818132|NCT02589665|580719474|FG003|Induction Extension Period|Lack of Efficacy|0|||
160818133|NCT02589665|580719475|FG004|Induction Extension Period|Lack of Efficacy|0|||
160818134|NCT02589665|580719476|FG005|Induction Extension Period|Lack of Efficacy|0|||
160818135|NCT02589665|580719477|FG006|Induction Extension Period|Lack of Efficacy|0|||
160818136|NCT02589665|580719478|FG007|Induction Extension Period|Lack of Efficacy|0|||
160818137|NCT02589665|580719479|FG008|Induction Extension Period|Lack of Efficacy|3|||
160818138|NCT02589665|580719480|FG009|Induction Extension Period|Lack of Efficacy|0|||
160818139|NCT02589665|580719471|FG000|Induction Extension Period|Withdrawal by Subject|0|||
160818140|NCT02589665|580719472|FG001|Induction Extension Period|Withdrawal by Subject|0|||
160818141|NCT02589665|580719473|FG002|Induction Extension Period|Withdrawal by Subject|0|||
160818142|NCT02589665|580719474|FG003|Induction Extension Period|Withdrawal by Subject|0|||
160818143|NCT02589665|580719475|FG004|Induction Extension Period|Withdrawal by Subject|0|||
160818144|NCT02589665|580719476|FG005|Induction Extension Period|Withdrawal by Subject|0|||
160818145|NCT02589665|580719477|FG006|Induction Extension Period|Withdrawal by Subject|0|||
160818146|NCT02589665|580719478|FG007|Induction Extension Period|Withdrawal by Subject|2|||
160818147|NCT02589665|580719479|FG008|Induction Extension Period|Withdrawal by Subject|3|||
160818148|NCT02589665|580719480|FG009|Induction Extension Period|Withdrawal by Subject|0|||
160818149|NCT02589665|580719471|FG000|Induction Extension Period|Physician Decision|0|||
160818150|NCT02589665|580719472|FG001|Induction Extension Period|Physician Decision|0|||
160818151|NCT02589665|580719473|FG002|Induction Extension Period|Physician Decision|0|||
160818152|NCT02589665|580719474|FG003|Induction Extension Period|Physician Decision|0|||
160818153|NCT02589665|580719475|FG004|Induction Extension Period|Physician Decision|0|||
160818154|NCT02589665|580719476|FG005|Induction Extension Period|Physician Decision|0|||
160818155|NCT02589665|580719477|FG006|Induction Extension Period|Physician Decision|0|||
160818156|NCT02589665|580719478|FG007|Induction Extension Period|Physician Decision|0|||
160818157|NCT02589665|580719479|FG008|Induction Extension Period|Physician Decision|1|||
160818158|NCT02589665|580719480|FG009|Induction Extension Period|Physician Decision|0|||
160818159|NCT02589665|580719471|FG000|Induction Extension Period|Reason Not Collected|0|||
160818160|NCT02589665|580719472|FG001|Induction Extension Period|Reason Not Collected|0|||
160818161|NCT02589665|580719473|FG002|Induction Extension Period|Reason Not Collected|0|||
160818162|NCT02589665|580719474|FG003|Induction Extension Period|Reason Not Collected|0|||
160818163|NCT02589665|580719475|FG004|Induction Extension Period|Reason Not Collected|0|||
160818164|NCT02589665|580719476|FG005|Induction Extension Period|Reason Not Collected|0|||
160818165|NCT02589665|580719477|FG006|Induction Extension Period|Reason Not Collected|0|||
160818166|NCT02589665|580719478|FG007|Induction Extension Period|Reason Not Collected|0|||
160818167|NCT02589665|580719479|FG008|Induction Extension Period|Reason Not Collected|1|||
160818168|NCT02589665|580719480|FG009|Induction Extension Period|Reason Not Collected|0|||
160818169|NCT02589665|580719471|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818170|NCT02589665|580719472|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818171|NCT02589665|580719473|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818172|NCT02589665|580719474|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818173|NCT02589665|580719475|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818174|NCT02589665|580719476|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818175|NCT02589665|580719477|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818176|NCT02589665|580719478|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818177|NCT02589665|580719479|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818178|NCT02589665|580719480|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
160818179|NCT02589665|580719471|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
160818180|NCT02589665|580719472|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
160818181|NCT02589665|580719473|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
160818182|NCT02589665|580719474|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
160818183|NCT02589665|580719475|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
160818184|NCT02589665|580719476|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
160818185|NCT02589665|580719477|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
160818186|NCT02589665|580719478|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
160987591|NCT03173248|581341178|FG000|Overall Study|Withdrawal by Subject|6|||
160987592|NCT03173248|581341179|FG001|Overall Study|Withdrawal by Subject|4|||
160646024|NCT01214603|580085944|FG000|Overall Study|Death|1|||
160818187|NCT02589665|580719479|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
160818188|NCT02589665|580719480|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
160818189|NCT02589665|580719471|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
160818190|NCT02589665|580719472|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
160818191|NCT02589665|580719473|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
160818192|NCT02589665|580719474|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
160818193|NCT02589665|580719475|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
160818194|NCT02589665|580719476|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
160818195|NCT02589665|580719477|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
160818196|NCT02589665|580719478|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
160818197|NCT02589665|580719479|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
160818198|NCT02589665|580719480|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
160818199|NCT02589665|580719471|FG000|Maintenance Extension Period|Adverse Event|0|||
160818200|NCT02589665|580719472|FG001|Maintenance Extension Period|Adverse Event|0|||
160818201|NCT02589665|580719473|FG002|Maintenance Extension Period|Adverse Event|0|||
160818202|NCT02589665|580719474|FG003|Maintenance Extension Period|Adverse Event|0|||
160818203|NCT02589665|580719475|FG004|Maintenance Extension Period|Adverse Event|0|||
160818204|NCT02589665|580719476|FG005|Maintenance Extension Period|Adverse Event|0|||
160818205|NCT02589665|580719477|FG006|Maintenance Extension Period|Adverse Event|0|||
160818206|NCT02589665|580719478|FG007|Maintenance Extension Period|Adverse Event|0|||
160818207|NCT02589665|580719479|FG008|Maintenance Extension Period|Adverse Event|0|||
160818208|NCT02589665|580719480|FG009|Maintenance Extension Period|Adverse Event|2|||
160818209|NCT02589665|580719471|FG000|Maintenance Extension Period|Non-responder|0|||
160818210|NCT02589665|580719472|FG001|Maintenance Extension Period|Non-responder|0|||
160818211|NCT02589665|580719473|FG002|Maintenance Extension Period|Non-responder|0|||
160818212|NCT02589665|580719474|FG003|Maintenance Extension Period|Non-responder|0|||
160818213|NCT02589665|580719475|FG004|Maintenance Extension Period|Non-responder|0|||
160818214|NCT02589665|580719476|FG005|Maintenance Extension Period|Non-responder|0|||
160818215|NCT02589665|580719477|FG006|Maintenance Extension Period|Non-responder|0|||
160818216|NCT02589665|580719478|FG007|Maintenance Extension Period|Non-responder|0|||
160818217|NCT02589665|580719479|FG008|Maintenance Extension Period|Non-responder|0|||
160818218|NCT02589665|580719480|FG009|Maintenance Extension Period|Non-responder|1|||
160818219|NCT00327015|580719481|FG000|Overall Study|Lack of Efficacy|18|||
160818220|NCT00327015|580719482|FG001|Overall Study|Lack of Efficacy|18|||
160818221|NCT00327015|580719483|FG002|Overall Study|Lack of Efficacy|35|||
160818222|NCT00327015|580719484|FG003|Overall Study|Lack of Efficacy|29|||
160818223|NCT00327015|580719481|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
160818224|NCT00327015|580719482|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
160818225|NCT00327015|580719483|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
160818226|NCT00327015|580719484|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
160818227|NCT00327015|580719481|FG000|Overall Study|Lost to Follow-up|22|||
160818228|NCT00327015|580719482|FG001|Overall Study|Lost to Follow-up|23|||
160818229|NCT00327015|580719483|FG002|Overall Study|Lost to Follow-up|29|||
160818230|NCT00327015|580719484|FG003|Overall Study|Lost to Follow-up|22|||
160818231|NCT00327015|580719481|FG000|Overall Study|Adverse Event|14|||
160818232|NCT00327015|580719482|FG001|Overall Study|Adverse Event|10|||
160818233|NCT00327015|580719483|FG002|Overall Study|Adverse Event|14|||
160818234|NCT00327015|580719484|FG003|Overall Study|Adverse Event|14|||
160818235|NCT00327015|580719481|FG000|Overall Study|Subject no longer meets study criteria|4|||
160818236|NCT00327015|580719482|FG001|Overall Study|Subject no longer meets study criteria|2|||
160818237|NCT00327015|580719483|FG002|Overall Study|Subject no longer meets study criteria|8|||
160818238|NCT00327015|580719484|FG003|Overall Study|Subject no longer meets study criteria|7|||
160818239|NCT00327015|580719481|FG000|Overall Study|Poor/Noncompliance|11|||
160818240|NCT00327015|580719482|FG001|Overall Study|Poor/Noncompliance|8|||
160818241|NCT00327015|580719483|FG002|Overall Study|Poor/Noncompliance|4|||
160818242|NCT00327015|580719484|FG003|Overall Study|Poor/Noncompliance|5|||
160818243|NCT00327015|580719481|FG000|Overall Study|Physician Decision|0|||
160818244|NCT00327015|580719482|FG001|Overall Study|Physician Decision|1|||
160818245|NCT00327015|580719483|FG002|Overall Study|Physician Decision|3|||
160818246|NCT00327015|580719484|FG003|Overall Study|Physician Decision|2|||
160818247|NCT00327015|580719481|FG000|Overall Study|Death|1|||
160818248|NCT00327015|580719482|FG001|Overall Study|Death|2|||
160818249|NCT00327015|580719483|FG002|Overall Study|Death|2|||
160818250|NCT00327015|580719484|FG003|Overall Study|Death|3|||
160818251|NCT00327015|580719481|FG000|Overall Study|Pregnancy|0|||
160818252|NCT00327015|580719482|FG001|Overall Study|Pregnancy|2|||
160818253|NCT00327015|580719483|FG002|Overall Study|Pregnancy|1|||
160818254|NCT00327015|580719484|FG003|Overall Study|Pregnancy|1|||
160818255|NCT00327015|580719481|FG000|Overall Study|Administrative Reason by Sponsor|1|||
160818256|NCT00327015|580719482|FG001|Overall Study|Administrative Reason by Sponsor|2|||
160818257|NCT00327015|580719483|FG002|Overall Study|Administrative Reason by Sponsor|2|||
160818258|NCT00327015|580719484|FG003|Overall Study|Administrative Reason by Sponsor|1|||
160818259|NCT02923830|580719488|FG000|Overall Study|Physician Decision|13|||
160818260|NCT02923830|580719489|FG001|Overall Study|Physician Decision|15|||
160646025|NCT01214603|580085945|FG001|Overall Study|Death|0|||
160646026|NCT01214603|580085946|FG002|Overall Study|Death|0|||
160646027|NCT01214603|580085944|FG000|Overall Study|Progressive Disease|4|||
160646028|NCT01214603|580085945|FG001|Overall Study|Progressive Disease|1|||
160646029|NCT01214603|580085946|FG002|Overall Study|Progressive Disease|3|||
160646030|NCT02536378|580085949|FG000|Overall Study|Physician Decision|0|||
160646031|NCT02536378|580085950|FG001|Overall Study|Physician Decision|2|||
160900437|NCT05224141|581030107|FG001|Overall Study|Withdrawal by Subject|4|||
160900438|NCT05224141|581030106|FG000|Overall Study|Death|153|||
160900439|NCT05224141|581030107|FG001|Overall Study|Death|138|||
160646032|NCT02536378|580085949|FG000|Overall Study|Withdrawal by Subject|0|||
160646033|NCT02536378|580085950|FG001|Overall Study|Withdrawal by Subject|1|||
160646034|NCT02536378|580085949|FG000|Overall Study|Death|1|||
160646035|NCT02536378|580085950|FG001|Overall Study|Death|2|||
160646036|NCT02536378|580085949|FG000|Overall Study|Patient refused further follow up|6|||
160646037|NCT02536378|580085950|FG001|Overall Study|Patient refused further follow up|2|||
160646038|NCT01821625|580085955|FG000|Overall Study|Withdrawal by Subject|2|||
160646039|NCT01821625|580085955|FG000|Overall Study|Lack of Efficacy|2|||
160818261|NCT00837265|580719490|FG000|Pilot Phase|Withdrawal by Subject|0|||
160818262|NCT00837265|580719491|FG001|Pilot Phase|Withdrawal by Subject|2|||
160818263|NCT00837265|580719492|FG002|Pilot Phase|Withdrawal by Subject|3|||
160818264|NCT00837265|580719493|FG003|Pilot Phase|Withdrawal by Subject|2|||
160818265|NCT00837265|580719494|FG004|Pilot Phase|Withdrawal by Subject|0|||
160818266|NCT00837265|580719495|FG005|Pilot Phase|Withdrawal by Subject|0|||
160818267|NCT00837265|580719496|FG006|Pilot Phase|Withdrawal by Subject|0|||
160818268|NCT00837265|580719490|FG000|Pilot Phase|Decision of the investigator|2|||
160818269|NCT00837265|580719491|FG001|Pilot Phase|Decision of the investigator|1|||
160818270|NCT00837265|580719492|FG002|Pilot Phase|Decision of the investigator|0|||
160818271|NCT00837265|580719493|FG003|Pilot Phase|Decision of the investigator|0|||
160818272|NCT00837265|580719494|FG004|Pilot Phase|Decision of the investigator|0|||
160818273|NCT00837265|580719495|FG005|Pilot Phase|Decision of the investigator|0|||
160818274|NCT00837265|580719496|FG006|Pilot Phase|Decision of the investigator|0|||
160818275|NCT00837265|580719490|FG000|Pilot Phase|Adverse Event|1|||
160818276|NCT00837265|580719491|FG001|Pilot Phase|Adverse Event|0|||
160818277|NCT00837265|580719492|FG002|Pilot Phase|Adverse Event|0|||
160818278|NCT00837265|580719493|FG003|Pilot Phase|Adverse Event|0|||
160818279|NCT00837265|580719494|FG004|Pilot Phase|Adverse Event|0|||
160818280|NCT00837265|580719495|FG005|Pilot Phase|Adverse Event|0|||
160818281|NCT00837265|580719496|FG006|Pilot Phase|Adverse Event|0|||
160818282|NCT00837265|580719490|FG000|Pilot Phase|Disease progression|0|||
160818283|NCT00837265|580719491|FG001|Pilot Phase|Disease progression|0|||
160818284|NCT00837265|580719492|FG002|Pilot Phase|Disease progression|0|||
160818285|NCT00837265|580719493|FG003|Pilot Phase|Disease progression|1|||
160818286|NCT00837265|580719494|FG004|Pilot Phase|Disease progression|0|||
160818287|NCT00837265|580719495|FG005|Pilot Phase|Disease progression|0|||
160646040|NCT01821625|580085955|FG000|Overall Study|Adverse Event|1|||
160646041|NCT01821625|580085955|FG000|Overall Study|Medical contraindication|1|||
160818288|NCT00837265|580719496|FG006|Pilot Phase|Disease progression|0|||
160818289|NCT00837265|580719490|FG000|Pilot Phase|Participant left the city|0|||
160818290|NCT00837265|580719491|FG001|Pilot Phase|Participant left the city|0|||
160818291|NCT00837265|580719492|FG002|Pilot Phase|Participant left the city|0|||
160818292|NCT00837265|580719493|FG003|Pilot Phase|Participant left the city|1|||
160818293|NCT00837265|580719494|FG004|Pilot Phase|Participant left the city|0|||
160818294|NCT00837265|580719495|FG005|Pilot Phase|Participant left the city|0|||
160818295|NCT00837265|580719496|FG006|Pilot Phase|Participant left the city|0|||
160818296|NCT00837265|580719490|FG000|Main Phase|Withdrawal by Subject|0|||
160818297|NCT00837265|580719491|FG001|Main Phase|Withdrawal by Subject|0|||
160818298|NCT00837265|580719492|FG002|Main Phase|Withdrawal by Subject|0|||
160900440|NCT03212690|581030119|FG000|Overall Study|Protocol Violation|1|||
160900441|NCT03208127|581030121|FG000|Overall Study|Death|1|||
160646042|NCT00457665|580085959|FG000|12 Months|Drug allergy|1|||
160646043|NCT00457665|580085960|FG001|12 Months|Drug allergy|1|||
160900442|NCT01254331|581030126|FG000|Initial Phase|Adverse Event|3|||
160646044|NCT00457665|580085959|FG000|12 Months|High HIV viral load|5|||
160900443|NCT01254331|581030126|FG000|Initial Phase|Withdrawal by Subject|1|||
160646045|NCT00457665|580085960|FG001|12 Months|High HIV viral load|1|||
160818299|NCT00837265|580719493|FG003|Main Phase|Withdrawal by Subject|0|||
160900444|NCT01254331|581030126|FG000|Initial Phase|Pregnancy|1|||
160646046|NCT00457665|580085959|FG000|12 Months|Lipodystrophy|2|||
160646047|NCT00457665|580085960|FG001|12 Months|Lipodystrophy|0|||
160646048|NCT00457665|580085959|FG000|12 Months|Withdrawal by Subject|0|||
160646049|NCT00457665|580085960|FG001|12 Months|Withdrawal by Subject|2|||
160818300|NCT00837265|580719494|FG004|Main Phase|Withdrawal by Subject|4|||
160818301|NCT00837265|580719495|FG005|Main Phase|Withdrawal by Subject|2|||
160818302|NCT00837265|580719496|FG006|Main Phase|Withdrawal by Subject|1|||
160818303|NCT00837265|580719490|FG000|Main Phase|Decision of the investigator|0|||
160818304|NCT00837265|580719491|FG001|Main Phase|Decision of the investigator|0|||
160818305|NCT00837265|580719492|FG002|Main Phase|Decision of the investigator|0|||
160646050|NCT00457665|580085959|FG000|12 Months|Abnormal Liver function tests|0|||
160818306|NCT00837265|580719493|FG003|Main Phase|Decision of the investigator|0|||
160818307|NCT00837265|580719494|FG004|Main Phase|Decision of the investigator|0|||
160818308|NCT00837265|580719495|FG005|Main Phase|Decision of the investigator|2|||
160818309|NCT00837265|580719496|FG006|Main Phase|Decision of the investigator|1|||
160818310|NCT00837265|580719490|FG000|Main Phase|Adverse Event|0|||
160818311|NCT00837265|580719491|FG001|Main Phase|Adverse Event|0|||
160818312|NCT00837265|580719492|FG002|Main Phase|Adverse Event|0|||
160818313|NCT00837265|580719493|FG003|Main Phase|Adverse Event|0|||
160818314|NCT00837265|580719494|FG004|Main Phase|Adverse Event|0|||
160818315|NCT00837265|580719495|FG005|Main Phase|Adverse Event|1|||
160818316|NCT00837265|580719496|FG006|Main Phase|Adverse Event|0|||
160818317|NCT00837265|580719490|FG000|Main Phase|Death|0|||
160818318|NCT00837265|580719491|FG001|Main Phase|Death|0|||
160818319|NCT00837265|580719492|FG002|Main Phase|Death|0|||
160818320|NCT00837265|580719493|FG003|Main Phase|Death|0|||
160818321|NCT00837265|580719494|FG004|Main Phase|Death|2|||
160818322|NCT00837265|580719495|FG005|Main Phase|Death|0|||
160818323|NCT00837265|580719496|FG006|Main Phase|Death|1|||
160818324|NCT00837265|580719490|FG000|Main Phase|Lost to Follow-up|0|||
160818325|NCT00837265|580719491|FG001|Main Phase|Lost to Follow-up|0|||
160818326|NCT00837265|580719492|FG002|Main Phase|Lost to Follow-up|0|||
160818327|NCT00837265|580719493|FG003|Main Phase|Lost to Follow-up|0|||
160818328|NCT00837265|580719494|FG004|Main Phase|Lost to Follow-up|1|||
160818329|NCT00837265|580719495|FG005|Main Phase|Lost to Follow-up|0|||
160818330|NCT00837265|580719496|FG006|Main Phase|Lost to Follow-up|0|||
160552852|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
160552853|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
160552854|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
160552855|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
160552856|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
160818331|NCT00837265|580719490|FG000|Main Phase|Principal investigator resignation|0|||
160818332|NCT00837265|580719491|FG001|Main Phase|Principal investigator resignation|0|||
160818333|NCT00837265|580719492|FG002|Main Phase|Principal investigator resignation|0|||
160818334|NCT00837265|580719493|FG003|Main Phase|Principal investigator resignation|0|||
160818335|NCT00837265|580719494|FG004|Main Phase|Principal investigator resignation|2|||
160818336|NCT00837265|580719495|FG005|Main Phase|Principal investigator resignation|0|||
160552857|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
160552858|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
160646051|NCT00457665|580085960|FG001|12 Months|Abnormal Liver function tests|5|||
160646052|NCT00457665|580085959|FG000|24 Months|Withdrawal by Subject|3|||
160818337|NCT00837265|580719496|FG006|Main Phase|Principal investigator resignation|0|||
160818338|NCT00837265|580719490|FG000|Main Phase|Participant's personal reason|0|||
160818339|NCT00837265|580719491|FG001|Main Phase|Participant's personal reason|0|||
160818340|NCT00837265|580719492|FG002|Main Phase|Participant's personal reason|0|||
160818341|NCT00837265|580719493|FG003|Main Phase|Participant's personal reason|0|||
160818342|NCT00837265|580719494|FG004|Main Phase|Participant's personal reason|1|||
160552859|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
160818343|NCT00837265|580719495|FG005|Main Phase|Participant's personal reason|0|||
160818344|NCT00837265|580719496|FG006|Main Phase|Participant's personal reason|0|||
160900445|NCT01254331|581030126|FG000|Extension Phase|Lack of Efficacy|1|||
160900446|NCT01254331|581030126|FG000|Extension Phase|Lost to Follow-up|3|||
160900447|NCT01011738|581030127|FG000|Overall Study|Death|12|||
160900448|NCT01011738|581030128|FG001|Overall Study|Death|3|||
160900449|NCT01011738|581030129|FG002|Overall Study|Death|0|||
160900450|NCT01011738|581030127|FG000|Overall Study|Unknown reasons|312|||
160900451|NCT01011738|581030128|FG001|Overall Study|Unknown reasons|291|||
160900452|NCT01011738|581030129|FG002|Overall Study|Unknown reasons|17|||
160900453|NCT00287365|581030130|FG000|Overall Study|sample not acquired|13|||
160900454|NCT00968864|581030131|FG000|Overall Study|Protocol exception/ not evaluable|1|||
160900455|NCT01967173|581030132|FG000|Overall Study|Lost to Follow-up|5|||
160900456|NCT01967173|581030133|FG001|Overall Study|Lost to Follow-up|3|||
160900457|NCT01967173|581030134|FG002|Overall Study|Lost to Follow-up|2|||
160900458|NCT01967173|581030135|FG003|Overall Study|Lost to Follow-up|4|||
160900459|NCT01967173|581030136|FG004|Overall Study|Lost to Follow-up|8|||
160900460|NCT01967173|581030137|FG005|Overall Study|Lost to Follow-up|12|||
160900461|NCT01967173|581030138|FG006|Overall Study|Lost to Follow-up|6|||
160900462|NCT01967173|581030139|FG007|Overall Study|Lost to Follow-up|8|||
160900463|NCT01967173|581030132|FG000|Overall Study|Physician Decision|2|||
160900464|NCT01967173|581030133|FG001|Overall Study|Physician Decision|0|||
160900465|NCT01967173|581030134|FG002|Overall Study|Physician Decision|2|||
160900466|NCT01967173|581030135|FG003|Overall Study|Physician Decision|1|||
160900467|NCT01967173|581030136|FG004|Overall Study|Physician Decision|1|||
160900468|NCT01967173|581030137|FG005|Overall Study|Physician Decision|1|||
160900469|NCT01967173|581030138|FG006|Overall Study|Physician Decision|1|||
160900470|NCT01967173|581030139|FG007|Overall Study|Physician Decision|0|||
160900471|NCT01967173|581030132|FG000|Overall Study|Lack of Efficacy|2|||
160900472|NCT01967173|581030133|FG001|Overall Study|Lack of Efficacy|0|||
160818345|NCT00733291|580719498|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
160552860|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
160552861|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
160552862|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
160552863|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
160552864|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
160552865|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
160552866|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
160552867|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
160552868|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Death|2|||
160818346|NCT00733291|580719499|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
160900473|NCT01967173|581030134|FG002|Overall Study|Lack of Efficacy|2|||
160552869|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Death|1|||
160900474|NCT01967173|581030135|FG003|Overall Study|Lack of Efficacy|2|||
160900475|NCT01967173|581030136|FG004|Overall Study|Lack of Efficacy|0|||
160900476|NCT01967173|581030137|FG005|Overall Study|Lack of Efficacy|1|||
160900477|NCT01967173|581030138|FG006|Overall Study|Lack of Efficacy|0|||
160900478|NCT01967173|581030139|FG007|Overall Study|Lack of Efficacy|2|||
160900479|NCT01967173|581030132|FG000|Overall Study|Pregnancy|0|||
160900480|NCT01967173|581030133|FG001|Overall Study|Pregnancy|0|||
160900481|NCT01967173|581030134|FG002|Overall Study|Pregnancy|0|||
160900482|NCT01967173|581030135|FG003|Overall Study|Pregnancy|0|||
160900483|NCT01967173|581030136|FG004|Overall Study|Pregnancy|0|||
160900484|NCT01967173|581030137|FG005|Overall Study|Pregnancy|0|||
160900485|NCT01967173|581030138|FG006|Overall Study|Pregnancy|1|||
160900486|NCT01967173|581030139|FG007|Overall Study|Pregnancy|1|||
160900487|NCT01967173|581030132|FG000|Overall Study|Adverse Event|0|||
160900488|NCT01967173|581030133|FG001|Overall Study|Adverse Event|0|||
160900489|NCT01967173|581030134|FG002|Overall Study|Adverse Event|0|||
160900490|NCT01967173|581030135|FG003|Overall Study|Adverse Event|0|||
160818347|NCT00733291|580719500|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
160818348|NCT00733291|580719501|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
160818349|NCT01751906|580719508|FG000|Overall Study|Lost to Follow-up|151|||
160818350|NCT01751906|580719509|FG001|Overall Study|Lost to Follow-up|68|||
160818351|NCT01751906|580719508|FG000|Overall Study|Withdrawal by Subject|22|||
160818352|NCT01751906|580719509|FG001|Overall Study|Withdrawal by Subject|18|||
160818353|NCT01751906|580719508|FG000|Overall Study|Physician Decision|5|||
160818354|NCT01751906|580719509|FG001|Overall Study|Physician Decision|2|||
160818355|NCT01751906|580719508|FG000|Overall Study|Death|84|||
160818356|NCT01751906|580719509|FG001|Overall Study|Death|43|||
160818357|NCT01751906|580719508|FG000|Overall Study|Denied on premises for follow-up by law|1|||
160818358|NCT01751906|580719509|FG001|Overall Study|Denied on premises for follow-up by law|0|||
160818359|NCT01110330|580719514|FG000|Overall Study|Adverse Event|0|||
160818360|NCT01110330|580719515|FG001|Overall Study|Adverse Event|4|||
160818361|NCT01110330|580719516|FG002|Overall Study|Adverse Event|3|||
160818362|NCT01110330|580719514|FG000|Overall Study|Lack of Efficacy|3|||
160818363|NCT01110330|580719515|FG001|Overall Study|Lack of Efficacy|1|||
160818364|NCT01110330|580719516|FG002|Overall Study|Lack of Efficacy|1|||
160818365|NCT01110330|580719514|FG000|Overall Study|Lost to Follow-up|9|||
160818366|NCT01110330|580719515|FG001|Overall Study|Lost to Follow-up|10|||
160818367|NCT01110330|580719516|FG002|Overall Study|Lost to Follow-up|15|||
160818368|NCT01110330|580719514|FG000|Overall Study|Physician Decision|0|||
160818369|NCT01110330|580719515|FG001|Overall Study|Physician Decision|1|||
160818370|NCT01110330|580719516|FG002|Overall Study|Physician Decision|0|||
160818371|NCT01110330|580719514|FG000|Overall Study|Protocol Violation|2|||
160818372|NCT01110330|580719515|FG001|Overall Study|Protocol Violation|0|||
160818373|NCT01110330|580719516|FG002|Overall Study|Protocol Violation|4|||
160818374|NCT01110330|580719514|FG000|Overall Study|Withdrawal by Subject|0|||
160818375|NCT01110330|580719515|FG001|Overall Study|Withdrawal by Subject|6|||
160818376|NCT01110330|580719516|FG002|Overall Study|Withdrawal by Subject|2|||
160818377|NCT01110330|580719514|FG000|Overall Study|Other|1|||
160818378|NCT01110330|580719515|FG001|Overall Study|Other|1|||
160818379|NCT01110330|580719516|FG002|Overall Study|Other|1|||
160818380|NCT02759107|580719517|FG000|Overall Study|Adverse Event|0|||
160818381|NCT02759107|580719518|FG001|Overall Study|Adverse Event|0|||
160818382|NCT02759107|580719519|FG002|Overall Study|Adverse Event|0|||
160818383|NCT02759107|580719520|FG003|Overall Study|Adverse Event|0|||
160818384|NCT02759107|580719521|FG004|Overall Study|Adverse Event|0|||
160818385|NCT02759107|580719522|FG005|Overall Study|Adverse Event|0|||
160818386|NCT02759107|580719523|FG006|Overall Study|Adverse Event|0|||
160818387|NCT02759107|580719524|FG007|Overall Study|Adverse Event|0|||
160818388|NCT02759107|580719525|FG008|Overall Study|Adverse Event|0|||
160818389|NCT02759107|580719526|FG009|Overall Study|Adverse Event|0|||
160818390|NCT02759107|580719527|FG010|Overall Study|Adverse Event|0|||
160818391|NCT02759107|580719528|FG011|Overall Study|Adverse Event|0|||
160818392|NCT02759107|580719529|FG012|Overall Study|Adverse Event|2|||
160818393|NCT02759107|580719530|FG013|Overall Study|Adverse Event|0|||
160818394|NCT02759107|580719531|FG014|Overall Study|Adverse Event|0|||
160818395|NCT02759107|580719532|FG015|Overall Study|Adverse Event|1|||
160818396|NCT02759107|580719533|FG016|Overall Study|Adverse Event|0|||
160818397|NCT02759107|580719534|FG017|Overall Study|Adverse Event|2|||
160818398|NCT02759107|580719517|FG000|Overall Study|Scheduling Conflict|0|||
160818399|NCT02759107|580719518|FG001|Overall Study|Scheduling Conflict|0|||
160818400|NCT02759107|580719519|FG002|Overall Study|Scheduling Conflict|0|||
160900491|NCT01967173|581030136|FG004|Overall Study|Adverse Event|0|||
160900492|NCT01967173|581030137|FG005|Overall Study|Adverse Event|0|||
160900493|NCT01967173|581030138|FG006|Overall Study|Adverse Event|0|||
160900494|NCT01967173|581030139|FG007|Overall Study|Adverse Event|1|||
160900495|NCT01967173|581030132|FG000|Overall Study|Withdrawal by Subject|15|||
160900496|NCT01967173|581030133|FG001|Overall Study|Withdrawal by Subject|14|||
160900497|NCT01967173|581030134|FG002|Overall Study|Withdrawal by Subject|10|||
160900498|NCT01967173|581030135|FG003|Overall Study|Withdrawal by Subject|7|||
160900499|NCT01967173|581030136|FG004|Overall Study|Withdrawal by Subject|8|||
160900500|NCT01967173|581030137|FG005|Overall Study|Withdrawal by Subject|9|||
160900501|NCT01967173|581030138|FG006|Overall Study|Withdrawal by Subject|10|||
160900502|NCT01967173|581030139|FG007|Overall Study|Withdrawal by Subject|12|||
160900503|NCT01346969|581030140|FG000|Overall Study|Withdrawal by Subject|0|||
160900504|NCT01346969|581030141|FG001|Overall Study|Withdrawal by Subject|0|||
160818401|NCT02759107|580719520|FG003|Overall Study|Scheduling Conflict|0|||
160818402|NCT02759107|580719521|FG004|Overall Study|Scheduling Conflict|0|||
160818403|NCT02759107|580719522|FG005|Overall Study|Scheduling Conflict|0|||
160818404|NCT02759107|580719523|FG006|Overall Study|Scheduling Conflict|0|||
160818405|NCT02759107|580719524|FG007|Overall Study|Scheduling Conflict|0|||
160818406|NCT02759107|580719525|FG008|Overall Study|Scheduling Conflict|0|||
160818407|NCT02759107|580719526|FG009|Overall Study|Scheduling Conflict|1|||
160818408|NCT02759107|580719527|FG010|Overall Study|Scheduling Conflict|0|||
160818409|NCT02759107|580719528|FG011|Overall Study|Scheduling Conflict|0|||
160900505|NCT01346969|581030142|FG002|Overall Study|Withdrawal by Subject|1|||
160987593|NCT03173248|581341178|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
160987594|NCT03173248|581341179|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
160987595|NCT01544582|581341180|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
160987596|NCT01544582|581341181|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
160987597|NCT01544582|581341182|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
160818410|NCT02759107|580719529|FG012|Overall Study|Scheduling Conflict|0|||
160818411|NCT02759107|580719530|FG013|Overall Study|Scheduling Conflict|0|||
160818412|NCT02759107|580719531|FG014|Overall Study|Scheduling Conflict|0|||
160818413|NCT02759107|580719532|FG015|Overall Study|Scheduling Conflict|0|||
160818414|NCT02759107|580719533|FG016|Overall Study|Scheduling Conflict|0|||
160818415|NCT02759107|580719534|FG017|Overall Study|Scheduling Conflict|0|||
160818416|NCT00420004|580719541|FG000|Overall Study|Adverse Event|4|||
160818417|NCT00420004|580719542|FG001|Overall Study|Adverse Event|1|||
160818418|NCT00420004|580719543|FG002|Overall Study|Adverse Event|1|||
160818419|NCT00420004|580719541|FG000|Overall Study|Lack of Efficacy|5|||
160818420|NCT00420004|580719542|FG001|Overall Study|Lack of Efficacy|4|||
160818421|NCT00420004|580719543|FG002|Overall Study|Lack of Efficacy|1|||
160818422|NCT00420004|580719541|FG000|Overall Study|Lost to Follow-up|31|||
160818423|NCT00420004|580719542|FG001|Overall Study|Lost to Follow-up|12|||
160818424|NCT00420004|580719543|FG002|Overall Study|Lost to Follow-up|10|||
160818425|NCT00420004|580719541|FG000|Overall Study|Entry Criteria Not Met|0|||
160818426|NCT00420004|580719542|FG001|Overall Study|Entry Criteria Not Met|1|||
160818427|NCT00420004|580719543|FG002|Overall Study|Entry Criteria Not Met|0|||
160818428|NCT00420004|580719541|FG000|Overall Study|Physician Decision|14|||
160818429|NCT00420004|580719542|FG001|Overall Study|Physician Decision|4|||
160818430|NCT00420004|580719543|FG002|Overall Study|Physician Decision|2|||
160818431|NCT00420004|580719541|FG000|Overall Study|Protocol Violation|5|||
160818432|NCT00420004|580719542|FG001|Overall Study|Protocol Violation|4|||
160818433|NCT00420004|580719543|FG002|Overall Study|Protocol Violation|3|||
160818434|NCT00420004|580719541|FG000|Overall Study|Withdrawal by Subject|67|||
160818435|NCT00420004|580719542|FG001|Overall Study|Withdrawal by Subject|42|||
160818436|NCT00420004|580719543|FG002|Overall Study|Withdrawal by Subject|14|||
160818437|NCT00420004|580719541|FG000|Overall Study|Sponsor Decision|3|||
160818438|NCT00420004|580719542|FG001|Overall Study|Sponsor Decision|3|||
160818439|NCT00420004|580719543|FG002|Overall Study|Sponsor Decision|1|||
160818440|NCT00591149|580719544|FG000|Overall Study|Adverse Event|4|||
160818441|NCT00591149|580719544|FG000|Overall Study|Withdrawal by Subject|1|||
160818442|NCT03002818|580719545|FG000|Overall Study|Decision of the investigator|1|||
160818443|NCT01549886|580719546|FG000|Overall Study|Sponsor's decision|2|||
160818444|NCT01549886|580719547|FG001|Overall Study|Sponsor's decision|3|||
160818445|NCT00608023|580719548|FG000|Overall Study|Withdrawal by Subject|8|||
160818446|NCT00608023|580719549|FG001|Overall Study|Withdrawal by Subject|10|||
160818447|NCT00608023|580719550|FG002|Overall Study|Withdrawal by Subject|7|||
160818448|NCT00608023|580719548|FG000|Overall Study|Adverse Event|1|||
160818449|NCT00608023|580719549|FG001|Overall Study|Adverse Event|4|||
160818450|NCT00608023|580719550|FG002|Overall Study|Adverse Event|5|||
160818451|NCT00608023|580719548|FG000|Overall Study|Lost to Follow-up|2|||
160818452|NCT00608023|580719549|FG001|Overall Study|Lost to Follow-up|2|||
160818453|NCT00608023|580719550|FG002|Overall Study|Lost to Follow-up|1|||
160818454|NCT00608023|580719548|FG000|Overall Study|Protocol Violation|1|||
160818455|NCT00608023|580719549|FG001|Overall Study|Protocol Violation|3|||
160818456|NCT00608023|580719550|FG002|Overall Study|Protocol Violation|1|||
160818457|NCT00608023|580719548|FG000|Overall Study|Unknown reason|0|||
160818458|NCT00608023|580719549|FG001|Overall Study|Unknown reason|3|||
160818459|NCT00608023|580719550|FG002|Overall Study|Unknown reason|0|||
160818460|NCT01231321|580719553|FG000|Overall Study|Adverse Event|3|||
160818461|NCT01231321|580719553|FG000|Overall Study|Lack of Efficacy|2|||
160818462|NCT00489736|580719554|FG000|Overall Study|Lack of Efficacy|53|||
160818463|NCT00489736|580719555|FG001|Overall Study|Lack of Efficacy|14|||
160987598|NCT01544582|581341183|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
160987599|NCT01544582|581341180|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
160987600|NCT01544582|581341181|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
160987601|NCT01544582|581341182|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
160987602|NCT01544582|581341183|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
160987603|NCT01544582|581341180|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
160818464|NCT00489736|580719554|FG000|Overall Study|Adverse Event|32|||
160818465|NCT00489736|580719555|FG001|Overall Study|Adverse Event|45|||
160818466|NCT00489736|580719554|FG000|Overall Study|Poor compliance|6|||
160818467|NCT00489736|580719555|FG001|Overall Study|Poor compliance|2|||
160818468|NCT00489736|580719554|FG000|Overall Study|Not coded/ Not pre-specified|5|||
160818469|NCT00489736|580719555|FG001|Overall Study|Not coded/ Not pre-specified|8|||
160818470|NCT04021524|580719556|FG000|Overall Study|Change in surgical intervention|0|||
160818471|NCT04021524|580719557|FG001|Overall Study|Change in surgical intervention|1|||
160818472|NCT06422364|580719558|FG000|Overall Study|Withdrawn due to study closure|0|||
160818473|NCT06422364|580719559|FG001|Overall Study|Withdrawn due to study closure|2|||
160818474|NCT00245050|580719566|FG000|Overall Study|Adverse Event|3|||
160818475|NCT00245050|580719567|FG001|Overall Study|Adverse Event|2|||
160818476|NCT00152477|580719570|FG000|Chemotherapy Period|Adverse Event|9|||
160818477|NCT00152477|580719571|FG001|Chemotherapy Period|Adverse Event|4|||
160818478|NCT00152477|580719572|FG002|Chemotherapy Period|Adverse Event|5|||
160818479|NCT00152477|580719570|FG000|Chemotherapy Period|Death|1|||
160818480|NCT00152477|580719571|FG001|Chemotherapy Period|Death|3|||
160818481|NCT00152477|580719572|FG002|Chemotherapy Period|Death|3|||
160818482|NCT00152477|580719570|FG000|Chemotherapy Period|Lack of Efficacy|4|||
160818483|NCT00152477|580719571|FG001|Chemotherapy Period|Lack of Efficacy|5|||
160818484|NCT00152477|580719572|FG002|Chemotherapy Period|Lack of Efficacy|6|||
160818485|NCT00152477|580719570|FG000|Chemotherapy Period|Lost to Follow-up|1|||
160818486|NCT00152477|580719571|FG001|Chemotherapy Period|Lost to Follow-up|0|||
160818487|NCT00152477|580719572|FG002|Chemotherapy Period|Lost to Follow-up|1|||
160818488|NCT00152477|580719570|FG000|Chemotherapy Period|Protocol Violation|1|||
160818489|NCT00152477|580719571|FG001|Chemotherapy Period|Protocol Violation|1|||
160818490|NCT00152477|580719572|FG002|Chemotherapy Period|Protocol Violation|0|||
160818491|NCT00152477|580719570|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
160818492|NCT00152477|580719571|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
160818493|NCT00152477|580719572|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
160818494|NCT00152477|580719570|FG000|Chemotherapy Period|Progression of Disease|6|||
160818495|NCT00152477|580719571|FG001|Chemotherapy Period|Progression of Disease|8|||
160818496|NCT00152477|580719572|FG002|Chemotherapy Period|Progression of Disease|4|||
160818497|NCT00152477|580719570|FG000|Chemotherapy Period|Investigator decision|0|||
160818498|NCT00152477|580719571|FG001|Chemotherapy Period|Investigator decision|0|||
160818499|NCT00152477|580719572|FG002|Chemotherapy Period|Investigator decision|1|||
160818500|NCT00152477|580719570|FG000|Chemotherapy Period|Patient condition worsened|1|||
160818501|NCT00152477|580719571|FG001|Chemotherapy Period|Patient condition worsened|0|||
160818502|NCT00152477|580719572|FG002|Chemotherapy Period|Patient condition worsened|0|||
160818503|NCT00152477|580719570|FG000|Monotherapy Period|Adverse Event|1|||
160818504|NCT00152477|580719571|FG001|Monotherapy Period|Adverse Event|0|||
160818505|NCT00152477|580719572|FG002|Monotherapy Period|Adverse Event|5|||
160818506|NCT00152477|580719570|FG000|Monotherapy Period|Death|2|||
160818507|NCT00152477|580719571|FG001|Monotherapy Period|Death|0|||
160818508|NCT00152477|580719572|FG002|Monotherapy Period|Death|1|||
160818509|NCT00152477|580719570|FG000|Monotherapy Period|Lack of Efficacy|7|||
160818510|NCT00152477|580719571|FG001|Monotherapy Period|Lack of Efficacy|16|||
160818511|NCT00152477|580719572|FG002|Monotherapy Period|Lack of Efficacy|10|||
160818512|NCT00152477|580719570|FG000|Monotherapy Period|Protocol Violation|0|||
160818513|NCT00152477|580719571|FG001|Monotherapy Period|Protocol Violation|1|||
160818514|NCT00152477|580719572|FG002|Monotherapy Period|Protocol Violation|0|||
160818515|NCT00152477|580719570|FG000|Monotherapy Period|Withdrawal by Subject|0|||
160818516|NCT00152477|580719571|FG001|Monotherapy Period|Withdrawal by Subject|0|||
160818517|NCT00152477|580719572|FG002|Monotherapy Period|Withdrawal by Subject|4|||
160818518|NCT00152477|580719570|FG000|Monotherapy Period|Progression of Disease|5|||
160818519|NCT00152477|580719571|FG001|Monotherapy Period|Progression of Disease|11|||
160818520|NCT00152477|580719572|FG002|Monotherapy Period|Progression of Disease|12|||
160818521|NCT00152477|580719570|FG000|Monotherapy Period|Patient decision|0|||
160818522|NCT00152477|580719571|FG001|Monotherapy Period|Patient decision|1|||
160818523|NCT00152477|580719572|FG002|Monotherapy Period|Patient decision|1|||
160818524|NCT00152477|580719570|FG000|Monotherapy Period|Study personel decision|0|||
160818525|NCT00152477|580719571|FG001|Monotherapy Period|Study personel decision|0|||
160818526|NCT00152477|580719572|FG002|Monotherapy Period|Study personel decision|1|||
160818527|NCT03275246|580719575|FG000|Overall Study|Protocol Violation|5|||
160818528|NCT03275246|580719575|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
160818529|NCT00730041|580719576|FG000|Overall Study|Lost to Follow-up|0|||
160818530|NCT00730041|580719577|FG001|Overall Study|Lost to Follow-up|2|||
160818531|NCT02301546|580719578|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
160818532|NCT02301546|580719579|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
160818533|NCT02301546|580719578|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
160818534|NCT02301546|580719579|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
160818535|NCT02301546|580719578|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
160818536|NCT02301546|580719579|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
160818537|NCT02301546|580719578|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
160818538|NCT02301546|580719579|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
160818539|NCT02301546|580719578|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
160818540|NCT02301546|580719579|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
160818541|NCT02301546|580719578|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
160818542|NCT02301546|580719579|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
160818543|NCT02301546|580719578|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
160818544|NCT02301546|580719579|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
160818545|NCT00433966|580719580|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
160987604|NCT01544582|581341181|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
160818546|NCT00433966|580719581|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
160818547|NCT00433966|580719582|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
160818548|NCT00433966|580719583|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
160818549|NCT00433966|580719580|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
160818550|NCT00433966|580719581|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
160818551|NCT00433966|580719582|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
160818552|NCT00433966|580719583|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
160818553|NCT00433966|580719580|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
160818554|NCT00433966|580719581|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
160818555|NCT00433966|580719582|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
160818556|NCT00433966|580719583|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
160818557|NCT00433966|580719580|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
160818558|NCT00433966|580719581|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
160818559|NCT00433966|580719582|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
160818560|NCT00433966|580719583|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
160818561|NCT00433966|580719580|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
160818562|NCT00433966|580719581|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
160818563|NCT00433966|580719582|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
160818564|NCT00433966|580719583|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
160818565|NCT03748706|580719587|FG000|Overall Study|Lost to Follow-up|1|||
160818566|NCT01606176|580719594|FG000|Overall Study|Adverse Event|2|||
160818567|NCT01606176|580719595|FG001|Overall Study|Adverse Event|3|||
160818568|NCT01606176|580719594|FG000|Overall Study|Disease progression|1|||
160818569|NCT01606176|580719595|FG001|Overall Study|Disease progression|0|||
160818570|NCT01606176|580719594|FG000|Overall Study|Withdrawal by Subject|1|||
160818571|NCT01606176|580719595|FG001|Overall Study|Withdrawal by Subject|0|||
160818572|NCT05129449|580719608|FG000|Overall Study|Protocol Violation|1|||
160818573|NCT04238481|580719609|FG000|Overall Study|Miscellaneous|0|||
160818574|NCT04238481|580719610|FG001|Overall Study|Miscellaneous|1|||
160818575|NCT04238481|580719611|FG002|Overall Study|Miscellaneous|0|||
160818576|NCT04238481|580719612|FG003|Overall Study|Miscellaneous|0|||
160818577|NCT02247011|580719613|FG000|Overall Study|Poor quality of radiological results|125|||
160818578|NCT02152371|580719614|FG000|Overall Study|Adverse Event|6|||
160818579|NCT02152371|580719615|FG001|Overall Study|Adverse Event|2|||
160818580|NCT02152371|580719614|FG000|Overall Study|Withdrawal by Subject|3|||
160818581|NCT02152371|580719615|FG001|Overall Study|Withdrawal by Subject|7|||
160818582|NCT02152371|580719614|FG000|Overall Study|Protocol Violation|2|||
160818583|NCT02152371|580719615|FG001|Overall Study|Protocol Violation|3|||
160818584|NCT02152371|580719614|FG000|Overall Study|Lost to Follow-up|1|||
160818585|NCT02152371|580719615|FG001|Overall Study|Lost to Follow-up|0|||
160818586|NCT02152371|580719614|FG000|Overall Study|Lack of Efficacy|0|||
160818587|NCT02152371|580719615|FG001|Overall Study|Lack of Efficacy|1|||
160818588|NCT02152371|580719614|FG000|Overall Study|Physician Decision|0|||
160818589|NCT02152371|580719615|FG001|Overall Study|Physician Decision|2|||
160818590|NCT02152371|580719614|FG000|Overall Study|Reason Not Given|0|||
160818591|NCT02152371|580719615|FG001|Overall Study|Reason Not Given|1|||
160818592|NCT00656058|580719617|FG000|Overall Study|Withdrawal by Subject|2|||
160818593|NCT00656058|580719617|FG000|Overall Study|Withdrawal by Subject|4|||
160818594|NCT00616018|580719618|FG000|Overall Study|Protocol Violation|3|||
160818595|NCT01818258|580719620|FG000|Overall Study|Death|3|||
160818596|NCT01818258|580719621|FG001|Overall Study|Death|0|||
160818597|NCT01818258|580719620|FG000|Overall Study|Withdrawal by Subject|0|||
160818598|NCT01818258|580719621|FG001|Overall Study|Withdrawal by Subject|1|||
160900506|NCT01346969|581030143|FG003|Overall Study|Withdrawal by Subject|0|||
160900507|NCT01346969|581030140|FG000|Overall Study|Lost to Follow-up|1|||
160900508|NCT01346969|581030141|FG001|Overall Study|Lost to Follow-up|0|||
160900509|NCT01346969|581030142|FG002|Overall Study|Lost to Follow-up|2|||
160900510|NCT01346969|581030143|FG003|Overall Study|Lost to Follow-up|0|||
160987605|NCT01544582|581341182|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
160900511|NCT01346969|581030140|FG000|Overall Study|Physician Decision|0|||
160987606|NCT01544582|581341183|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
160987607|NCT01544582|581341180|FG000|Analysis Population|Physician Decision|0|||
160987608|NCT01544582|581341181|FG001|Analysis Population|Physician Decision|13|||
160987609|NCT01544582|581341182|FG002|Analysis Population|Physician Decision|10|||
160987610|NCT01544582|581341183|FG003|Analysis Population|Physician Decision|9|||
160987611|NCT01544582|581341180|FG000|Analysis Population|Safety Reason|0|||
160818599|NCT01818258|580719620|FG000|Overall Study|Lost to Follow-up|0|||
160818600|NCT01818258|580719621|FG001|Overall Study|Lost to Follow-up|1|||
160818601|NCT01818258|580719620|FG000|Overall Study|Unable to Travel to Clinic|0|||
160818602|NCT01818258|580719621|FG001|Overall Study|Unable to Travel to Clinic|1|||
160818603|NCT02839720|580719622|FG000|Overall Study|Adverse Event|2|||
160818604|NCT02839720|580719622|FG000|Overall Study|Non-compliance|2|||
160818605|NCT02839720|580719622|FG000|Overall Study|Intercurrent Illness|1|||
160900512|NCT01346969|581030141|FG001|Overall Study|Physician Decision|0|||
160900513|NCT01346969|581030142|FG002|Overall Study|Physician Decision|0|||
160900514|NCT01346969|581030143|FG003|Overall Study|Physician Decision|1|||
160987612|NCT01544582|581341181|FG001|Analysis Population|Safety Reason|33|||
160818606|NCT02839720|580719622|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
160818607|NCT00349921|580719623|FG000|First Spinal Injection|Physician Decision|1|||
160818608|NCT00349921|580719624|FG001|First Spinal Injection|Physician Decision|0|||
160818609|NCT00349921|580719625|FG002|First Spinal Injection|Physician Decision|0|||
160818610|NCT00349921|580719626|FG003|First Spinal Injection|Physician Decision|0|||
160818611|NCT00349921|580719623|FG000|First Spinal Injection|Adverse Event|0|||
160818612|NCT00349921|580719624|FG001|First Spinal Injection|Adverse Event|0|||
160818613|NCT00349921|580719625|FG002|First Spinal Injection|Adverse Event|1|||
160818614|NCT00349921|580719626|FG003|First Spinal Injection|Adverse Event|0|||
160818615|NCT05145322|580719627|FG000|Overall Study|Lost to Follow-up|4|||
160818616|NCT05145322|580719628|FG001|Overall Study|Lost to Follow-up|5|||
160987613|NCT01544582|581341182|FG002|Analysis Population|Safety Reason|31|||
160987614|NCT01544582|581341183|FG003|Analysis Population|Safety Reason|8|||
160987615|NCT01544582|581341180|FG000|Analysis Population|Effectiveness Reason|0|||
160987616|NCT01544582|581341181|FG001|Analysis Population|Effectiveness Reason|48|||
160987617|NCT01544582|581341182|FG002|Analysis Population|Effectiveness Reason|29|||
160987618|NCT01544582|581341183|FG003|Analysis Population|Effectiveness Reason|12|||
160987619|NCT01544582|581341180|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
160987620|NCT01544582|581341181|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
160987621|NCT01544582|581341182|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
160987622|NCT01544582|581341183|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
160818617|NCT04700540|580719629|FG000|Overall Study|Withdrawal by Subject|12|||
160818618|NCT04700540|580719630|FG001|Overall Study|Withdrawal by Subject|8|||
160818619|NCT04700540|580719629|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
160818620|NCT04700540|580719630|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
160818621|NCT03194568|580719631|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
160818622|NCT05285644|580719634|FG000|Overall Study|Adverse Event|3|||
160818623|NCT05285644|580719635|FG001|Overall Study|Adverse Event|3|||
160818624|NCT05285644|580719634|FG000|Overall Study|Withdrawal of Consent|2|||
160818625|NCT05285644|580719635|FG001|Overall Study|Withdrawal of Consent|5|||
160818626|NCT05285644|580719634|FG000|Overall Study|Noncompliance|0|||
160818627|NCT05285644|580719635|FG001|Overall Study|Noncompliance|4|||
160818628|NCT05285644|580719634|FG000|Overall Study|Lost to Follow-up|4|||
160818629|NCT05285644|580719635|FG001|Overall Study|Lost to Follow-up|6|||
160818630|NCT05285644|580719634|FG000|Overall Study|Disallowed Concurrent Medication|1|||
160818631|NCT05285644|580719635|FG001|Overall Study|Disallowed Concurrent Medication|1|||
160818632|NCT05285644|580719634|FG000|Overall Study|Investigator Decision|2|||
160818633|NCT05285644|580719635|FG001|Overall Study|Investigator Decision|0|||
160818634|NCT05285644|580719634|FG000|Overall Study|Protocol Deviation|1|||
160818635|NCT05285644|580719635|FG001|Overall Study|Protocol Deviation|0|||
160818636|NCT05285644|580719634|FG000|Overall Study|As specified in the Clinical Study Report|7|||
160818637|NCT05285644|580719635|FG001|Overall Study|As specified in the Clinical Study Report|3|||
160818638|NCT05248997|580719638|FG000|Overall Study|Lost to Follow-up|1|||
160818639|NCT05248997|580719639|FG001|Overall Study|Lost to Follow-up|1|||
160987623|NCT01544582|581341180|FG000|Analysis Population|Lost to Follow-up|0|||
160987624|NCT01544582|581341181|FG001|Analysis Population|Lost to Follow-up|6|||
160987625|NCT01544582|581341182|FG002|Analysis Population|Lost to Follow-up|6|||
160987626|NCT01544582|581341183|FG003|Analysis Population|Lost to Follow-up|5|||
160987627|NCT01544582|581341180|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
160987628|NCT01544582|581341181|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
160987629|NCT01544582|581341182|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
160987630|NCT01544582|581341183|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
160818640|NCT05248997|580719638|FG000|Overall Study|Randomized but not treated|32|||
160818641|NCT05248997|580719639|FG001|Overall Study|Randomized but not treated|25|||
160818642|NCT03515551|580719640|FG000|Overall Study|Death|4|||
160818643|NCT03515551|580719641|FG001|Overall Study|Death|1|||
160818644|NCT03515551|580719642|FG002|Overall Study|Death|2|||
160818645|NCT03515551|580719643|FG003|Overall Study|Death|2|||
160818646|NCT03515551|580719644|FG004|Overall Study|Death|2|||
160818647|NCT03515551|580719645|FG005|Overall Study|Death|4|||
160818648|NCT03515551|580719646|FG006|Overall Study|Death|1|||
160818649|NCT03515551|580719640|FG000|Overall Study|Lost to Follow-up|0|||
160818650|NCT03515551|580719641|FG001|Overall Study|Lost to Follow-up|0|||
160818651|NCT03515551|580719642|FG002|Overall Study|Lost to Follow-up|1|||
160818652|NCT03515551|580719643|FG003|Overall Study|Lost to Follow-up|0|||
160818653|NCT03515551|580719644|FG004|Overall Study|Lost to Follow-up|0|||
160818654|NCT03515551|580719645|FG005|Overall Study|Lost to Follow-up|0|||
160987631|NCT01544582|581341180|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
160987632|NCT01544582|581341181|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
160987633|NCT01544582|581341182|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
160987634|NCT01544582|581341183|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
160646053|NCT00457665|580085960|FG001|24 Months|Withdrawal by Subject|2|||
160987635|NCT01544582|581341180|FG000|Analysis Population|Intolerance|0|||
160646054|NCT00457665|580085959|FG000|24 Months|Lipodystrophy|1|||
160646055|NCT00457665|580085960|FG001|24 Months|Lipodystrophy|1|||
160818655|NCT03515551|580719646|FG006|Overall Study|Lost to Follow-up|0|||
160818656|NCT03515551|580719640|FG000|Overall Study|Withdrawal by Subject|0|||
160818657|NCT03515551|580719641|FG001|Overall Study|Withdrawal by Subject|1|||
160818658|NCT03515551|580719642|FG002|Overall Study|Withdrawal by Subject|0|||
160818659|NCT03515551|580719643|FG003|Overall Study|Withdrawal by Subject|0|||
160818660|NCT03515551|580719644|FG004|Overall Study|Withdrawal by Subject|0|||
160818661|NCT03515551|580719645|FG005|Overall Study|Withdrawal by Subject|0|||
160818662|NCT03515551|580719646|FG006|Overall Study|Withdrawal by Subject|1|||
160818663|NCT03515551|580719640|FG000|Overall Study|Study ended by sponsor|0|||
160818664|NCT03515551|580719641|FG001|Overall Study|Study ended by sponsor|0|||
160818665|NCT03515551|580719642|FG002|Overall Study|Study ended by sponsor|2|||
160818666|NCT03515551|580719643|FG003|Overall Study|Study ended by sponsor|1|||
160818667|NCT03515551|580719644|FG004|Overall Study|Study ended by sponsor|3|||
160818668|NCT03515551|580719645|FG005|Overall Study|Study ended by sponsor|0|||
160818669|NCT03515551|580719646|FG006|Overall Study|Study ended by sponsor|3|||
160818670|NCT03515551|580719640|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818671|NCT03515551|580719641|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
160818672|NCT03515551|580719642|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818673|NCT03515551|580719643|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818674|NCT03515551|580719644|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818675|NCT03515551|580719645|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818676|NCT03515551|580719646|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818677|NCT03028415|580719650|FG000|Overall Study|Lost to Follow-up|6|||
160818678|NCT03028415|580719651|FG001|Overall Study|Lost to Follow-up|3|||
160818679|NCT03028415|580719650|FG000|Overall Study|Withdrawal by Subject|1|||
160818680|NCT03028415|580719651|FG001|Overall Study|Withdrawal by Subject|0|||
160818681|NCT03028415|580719650|FG000|Overall Study|Discontinued due to COVID-19|1|||
160818682|NCT03028415|580719651|FG001|Overall Study|Discontinued due to COVID-19|0|||
160818683|NCT01740089|580721598|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
160818684|NCT01740089|580721599|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
160818685|NCT01740089|580721600|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
160818686|NCT01740089|580721598|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
160818687|NCT01740089|580721599|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
160818688|NCT01740089|580721600|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
160818689|NCT01740089|580721598|FG000|After 12 Weeks|Lack of Efficacy|3|||
160818690|NCT01740089|580721599|FG001|After 12 Weeks|Lack of Efficacy|1|||
160818691|NCT01740089|580721600|FG002|After 12 Weeks|Lack of Efficacy|4|||
160818692|NCT01740089|580721598|FG000|After 12 Weeks|Adverse Event|2|||
160818693|NCT01740089|580721599|FG001|After 12 Weeks|Adverse Event|0|||
160818694|NCT01740089|580721600|FG002|After 12 Weeks|Adverse Event|5|||
160818695|NCT01740089|580721598|FG000|After 12 Weeks|Protocol Violation|1|||
160818696|NCT01740089|580721599|FG001|After 12 Weeks|Protocol Violation|1|||
160818697|NCT01740089|580721600|FG002|After 12 Weeks|Protocol Violation|1|||
160818698|NCT01740089|580721598|FG000|After 12 Weeks|Withdrawal by Subject|1|||
160818699|NCT01740089|580721599|FG001|After 12 Weeks|Withdrawal by Subject|1|||
160818700|NCT01740089|580721600|FG002|After 12 Weeks|Withdrawal by Subject|1|||
160818701|NCT01448824|580721605|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818702|NCT01448824|580721606|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818703|NCT01448824|580721607|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818704|NCT01448824|580721608|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818705|NCT01448824|580721609|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818706|NCT01448824|580721610|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818707|NCT01448824|580721611|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
160818708|NCT01448824|580721612|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818709|NCT01448824|580721605|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
160818710|NCT01448824|580721606|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
160818711|NCT01448824|580721607|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
160818712|NCT01448824|580721608|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
160818713|NCT01448824|580721609|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
160818714|NCT01448824|580721610|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
160818715|NCT01448824|580721611|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
160818716|NCT01448824|580721612|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
160818717|NCT01448824|580721605|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818718|NCT01448824|580721606|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818719|NCT01448824|580721607|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818720|NCT01448824|580721608|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818721|NCT01448824|580721609|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818722|NCT01448824|580721610|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
160818723|NCT01448824|580721611|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818724|NCT01448824|580721612|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818725|NCT01448824|580721605|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
160818726|NCT01448824|580721606|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
160818727|NCT01448824|580721607|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
160818728|NCT01448824|580721608|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
160818729|NCT01448824|580721609|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
160818730|NCT01448824|580721610|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
160818731|NCT01448824|580721611|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
160818732|NCT01448824|580721612|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
160818733|NCT01448824|580721605|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818734|NCT01448824|580721606|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818735|NCT01448824|580721607|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818736|NCT01448824|580721608|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818737|NCT01448824|580721609|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818738|NCT01448824|580721610|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818739|NCT01448824|580721611|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818740|NCT01448824|580721612|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
160818741|NCT01448824|580721605|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818742|NCT01448824|580721606|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818743|NCT01448824|580721607|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818744|NCT01448824|580721608|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818745|NCT01448824|580721609|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818746|NCT01448824|580721610|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818747|NCT01448824|580721611|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818748|NCT01448824|580721612|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
160646056|NCT00457665|580085959|FG000|24 Months|Abnormal liver function tests|1|||
160818749|NCT01448824|580721605|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818750|NCT01448824|580721606|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818751|NCT01448824|580721607|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818752|NCT01448824|580721608|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818753|NCT01448824|580721609|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818754|NCT01448824|580721610|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818755|NCT01448824|580721611|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818756|NCT01448824|580721612|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
160818757|NCT01448824|580721605|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818758|NCT01448824|580721606|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818759|NCT01448824|580721607|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818760|NCT01448824|580721608|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818761|NCT01448824|580721609|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818762|NCT01448824|580721610|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818763|NCT01448824|580721611|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818764|NCT01448824|580721612|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
160818765|NCT01537081|580721614|FG000|Overall Study|Adverse Event|5|||
160818766|NCT01537081|580721615|FG001|Overall Study|Adverse Event|2|||
160818767|NCT01537081|580721616|FG002|Overall Study|Adverse Event|2|||
160818768|NCT01537081|580721614|FG000|Overall Study|Lack of Efficacy|2|||
160818769|NCT01537081|580721615|FG001|Overall Study|Lack of Efficacy|1|||
160818770|NCT01537081|580721616|FG002|Overall Study|Lack of Efficacy|0|||
160818771|NCT01537081|580721614|FG000|Overall Study|Lost to Follow-up|17|||
160818772|NCT01537081|580721615|FG001|Overall Study|Lost to Follow-up|15|||
160818773|NCT01537081|580721616|FG002|Overall Study|Lost to Follow-up|9|||
160818774|NCT01537081|580721614|FG000|Overall Study|Protocol Violation|3|||
160818775|NCT01537081|580721615|FG001|Overall Study|Protocol Violation|2|||
160818776|NCT01537081|580721616|FG002|Overall Study|Protocol Violation|2|||
160818777|NCT01537081|580721614|FG000|Overall Study|Withdrawal by Subject|6|||
160818778|NCT01537081|580721615|FG001|Overall Study|Withdrawal by Subject|11|||
160818779|NCT01537081|580721616|FG002|Overall Study|Withdrawal by Subject|3|||
160818780|NCT01537081|580721614|FG000|Overall Study|Physician Decision|5|||
160818781|NCT01537081|580721615|FG001|Overall Study|Physician Decision|6|||
160818782|NCT01537081|580721616|FG002|Overall Study|Physician Decision|0|||
160818783|NCT01537081|580721614|FG000|Overall Study|Sponsor decision|0|||
160818784|NCT01537081|580721615|FG001|Overall Study|Sponsor decision|1|||
160818785|NCT01537081|580721616|FG002|Overall Study|Sponsor decision|0|||
160818786|NCT01537081|580721614|FG000|Overall Study|Assigned but never dosed|1|||
160818787|NCT01537081|580721615|FG001|Overall Study|Assigned but never dosed|0|||
160818788|NCT01537081|580721616|FG002|Overall Study|Assigned but never dosed|0|||
160818789|NCT01463111|580721617|FG000|Overall Study|Withdrawal by Subject|2|||
160818790|NCT01463111|580721617|FG000|Overall Study|Lost to Follow-up|5|||
160818791|NCT01463111|580721617|FG000|Overall Study|Physician Decision|2|||
160818792|NCT03100539|580721618|FG000|Overall Study|Lost to Follow-up|60|||
160818793|NCT03100539|580721619|FG001|Overall Study|Lost to Follow-up|54|||
160818794|NCT03100539|580721620|FG002|Overall Study|Lost to Follow-up|17|||
160818795|NCT03100539|580721618|FG000|Overall Study|Uncollected|8|||
160818796|NCT03100539|580721619|FG001|Overall Study|Uncollected|8|||
160818797|NCT03100539|580721620|FG002|Overall Study|Uncollected|0|||
160818798|NCT03100539|580721618|FG000|Overall Study|Ally Health|0|||
160818799|NCT03100539|580721619|FG001|Overall Study|Ally Health|0|||
160818800|NCT03100539|580721620|FG002|Overall Study|Ally Health|3|||
160818801|NCT03100539|580721618|FG000|Overall Study|Disinterest|0|||
160818802|NCT03100539|580721619|FG001|Overall Study|Disinterest|0|||
160818803|NCT03100539|580721620|FG002|Overall Study|Disinterest|22|||
160987636|NCT01544582|581341181|FG001|Analysis Population|Intolerance|1|||
160987637|NCT01544582|581341182|FG002|Analysis Population|Intolerance|0|||
160818804|NCT03100539|580721618|FG000|Overall Study|Veteran Health|0|||
160818805|NCT03100539|580721619|FG001|Overall Study|Veteran Health|0|||
160987638|NCT01544582|581341183|FG003|Analysis Population|Intolerance|0|||
160818806|NCT03100539|580721620|FG002|Overall Study|Veteran Health|8|||
160818807|NCT03100539|580721618|FG000|Overall Study|Moved|0|||
160818808|NCT03100539|580721619|FG001|Overall Study|Moved|0|||
160987639|NCT01544582|581341180|FG000|Analysis Population|Liver Transplantation|0|||
160818809|NCT03100539|580721620|FG002|Overall Study|Moved|1|||
160818810|NCT03100539|580721618|FG000|Overall Study|Scheduling Conflicts|0|||
160818811|NCT03100539|580721619|FG001|Overall Study|Scheduling Conflicts|0|||
160818812|NCT03100539|580721620|FG002|Overall Study|Scheduling Conflicts|12|||
160987640|NCT01544582|581341181|FG001|Analysis Population|Liver Transplantation|0|||
160818813|NCT00882583|580721621|FG000|Overall Study|Physician Decision|1|||
160818814|NCT00882583|580721622|FG001|Overall Study|Physician Decision|0|||
160818815|NCT00882583|580721621|FG000|Overall Study|Adverse Event|0|||
160818816|NCT00882583|580721622|FG001|Overall Study|Adverse Event|1|||
160818817|NCT01892436|580721625|FG000|Overall Study|Withdrawal by Subject|8|||
160818818|NCT01892436|580721626|FG001|Overall Study|Withdrawal by Subject|15|||
160818819|NCT01892436|580721627|FG002|Overall Study|Withdrawal by Subject|4|||
160818820|NCT01892436|580721628|FG003|Overall Study|Withdrawal by Subject|4|||
160818821|NCT01892436|580721625|FG000|Overall Study|Death|1|||
160818822|NCT01892436|580721626|FG001|Overall Study|Death|1|||
160818823|NCT01892436|580721627|FG002|Overall Study|Death|0|||
160818824|NCT01892436|580721628|FG003|Overall Study|Death|0|||
160818825|NCT01892436|580721625|FG000|Overall Study|Physician Decision|2|||
160818826|NCT01892436|580721626|FG001|Overall Study|Physician Decision|1|||
160818827|NCT01892436|580721627|FG002|Overall Study|Physician Decision|0|||
160818828|NCT01892436|580721628|FG003|Overall Study|Physician Decision|1|||
160818829|NCT01892436|580721625|FG000|Overall Study|Pregnancy|0|||
160818830|NCT01892436|580721626|FG001|Overall Study|Pregnancy|2|||
160818831|NCT01892436|580721627|FG002|Overall Study|Pregnancy|1|||
160818832|NCT01892436|580721628|FG003|Overall Study|Pregnancy|0|||
160818833|NCT01892436|580721625|FG000|Overall Study|Technical problems|2|||
160818834|NCT01892436|580721626|FG001|Overall Study|Technical problems|1|||
160818835|NCT01892436|580721627|FG002|Overall Study|Technical problems|1|||
160818836|NCT01892436|580721628|FG003|Overall Study|Technical problems|1|||
160818837|NCT01892436|580721625|FG000|Overall Study|Lack of Efficacy|1|||
160818838|NCT01892436|580721626|FG001|Overall Study|Lack of Efficacy|2|||
160818839|NCT01892436|580721627|FG002|Overall Study|Lack of Efficacy|2|||
160818840|NCT01892436|580721628|FG003|Overall Study|Lack of Efficacy|2|||
160818841|NCT01892436|580721625|FG000|Overall Study|Lost to Follow-up|1|||
160818842|NCT01892436|580721626|FG001|Overall Study|Lost to Follow-up|1|||
160818843|NCT01892436|580721627|FG002|Overall Study|Lost to Follow-up|1|||
160818844|NCT01892436|580721628|FG003|Overall Study|Lost to Follow-up|3|||
160818845|NCT01892436|580721625|FG000|Overall Study|non-compliance with treatment|1|||
160818846|NCT01892436|580721626|FG001|Overall Study|non-compliance with treatment|0|||
160818847|NCT01892436|580721627|FG002|Overall Study|non-compliance with treatment|0|||
160818848|NCT01892436|580721628|FG003|Overall Study|non-compliance with treatment|0|||
160818849|NCT01892436|580721625|FG000|Overall Study|Adverse Event|7|||
160818850|NCT01892436|580721626|FG001|Overall Study|Adverse Event|6|||
160818851|NCT01892436|580721627|FG002|Overall Study|Adverse Event|2|||
160818852|NCT01892436|580721628|FG003|Overall Study|Adverse Event|3|||
160818853|NCT02526524|580721629|FG000|Overall Study|Withdrawal by Subject|3|||
160818854|NCT02526524|580721630|FG001|Overall Study|Withdrawal by Subject|3|||
160818855|NCT02526524|580721631|FG002|Overall Study|Withdrawal by Subject|6|||
160818856|NCT02526524|580721632|FG003|Overall Study|Withdrawal by Subject|1|||
160818857|NCT02526524|580721633|FG004|Overall Study|Withdrawal by Subject|9|||
160818858|NCT02526524|580721634|FG005|Overall Study|Withdrawal by Subject|5|||
160818859|NCT02526524|580721629|FG000|Overall Study|Adverse Event|3|||
160818860|NCT02526524|580721630|FG001|Overall Study|Adverse Event|2|||
160818861|NCT02526524|580721631|FG002|Overall Study|Adverse Event|4|||
160818862|NCT02526524|580721632|FG003|Overall Study|Adverse Event|2|||
160818863|NCT02526524|580721633|FG004|Overall Study|Adverse Event|6|||
160818864|NCT02526524|580721634|FG005|Overall Study|Adverse Event|8|||
160818865|NCT02526524|580721629|FG000|Overall Study|Lost to Follow-up|2|||
160818866|NCT02526524|580721630|FG001|Overall Study|Lost to Follow-up|3|||
160818867|NCT02526524|580721631|FG002|Overall Study|Lost to Follow-up|8|||
160818868|NCT02526524|580721632|FG003|Overall Study|Lost to Follow-up|1|||
160818869|NCT02526524|580721633|FG004|Overall Study|Lost to Follow-up|2|||
160818870|NCT02526524|580721634|FG005|Overall Study|Lost to Follow-up|5|||
160818871|NCT02526524|580721629|FG000|Overall Study|Protocol Violation|3|||
160818872|NCT02526524|580721630|FG001|Overall Study|Protocol Violation|1|||
160818873|NCT02526524|580721631|FG002|Overall Study|Protocol Violation|5|||
160818874|NCT02526524|580721632|FG003|Overall Study|Protocol Violation|3|||
160818875|NCT02526524|580721633|FG004|Overall Study|Protocol Violation|4|||
160818876|NCT02526524|580721634|FG005|Overall Study|Protocol Violation|3|||
160818877|NCT02526524|580721629|FG000|Overall Study|Loss of Glucose Control|0|||
160900515|NCT01346969|581030140|FG000|Overall Study|Randomized but not treated|1|||
160818878|NCT02526524|580721630|FG001|Overall Study|Loss of Glucose Control|0|||
160818879|NCT02526524|580721631|FG002|Overall Study|Loss of Glucose Control|3|||
160818880|NCT02526524|580721632|FG003|Overall Study|Loss of Glucose Control|0|||
160818881|NCT02526524|580721633|FG004|Overall Study|Loss of Glucose Control|2|||
160818882|NCT02526524|580721634|FG005|Overall Study|Loss of Glucose Control|0|||
160818883|NCT02526524|580721629|FG000|Overall Study|Physician Decision|0|||
160818884|NCT02526524|580721630|FG001|Overall Study|Physician Decision|0|||
160818885|NCT02526524|580721631|FG002|Overall Study|Physician Decision|0|||
160818886|NCT02526524|580721632|FG003|Overall Study|Physician Decision|0|||
160818887|NCT02526524|580721633|FG004|Overall Study|Physician Decision|1|||
160818888|NCT02526524|580721634|FG005|Overall Study|Physician Decision|0|||
160818889|NCT02526524|580721629|FG000|Overall Study|Sponsor Decision|1|||
160818890|NCT02526524|580721630|FG001|Overall Study|Sponsor Decision|0|||
160818891|NCT02526524|580721631|FG002|Overall Study|Sponsor Decision|0|||
160818892|NCT02526524|580721632|FG003|Overall Study|Sponsor Decision|0|||
160818893|NCT02526524|580721633|FG004|Overall Study|Sponsor Decision|0|||
160900516|NCT01346969|581030141|FG001|Overall Study|Randomized but not treated|0|||
160900517|NCT01346969|581030142|FG002|Overall Study|Randomized but not treated|0|||
160900518|NCT01346969|581030143|FG003|Overall Study|Randomized but not treated|0|||
160900519|NCT03666624|581030145|FG000|Overall Study|participant grieving over recent death of parent|1|||
160646057|NCT00457665|580085960|FG001|24 Months|Abnormal liver function tests|5|||
160646058|NCT02535000|580085961|FG000|Overall Study|Cancellation of surgery.|1|||
160646059|NCT02535000|580085962|FG001|Overall Study|Cancellation of surgery.|2|||
160646060|NCT01620489|580085966|FG000|Overall Study|Adverse Event|17|||
160646061|NCT01620489|580085967|FG001|Overall Study|Adverse Event|4|||
160646062|NCT01620489|580085966|FG000|Overall Study|Protocol Violation|0|||
160646063|NCT01620489|580085967|FG001|Overall Study|Protocol Violation|3|||
160646064|NCT01620489|580085966|FG000|Overall Study|Withdrawal Criteria|17|||
160818894|NCT02526524|580721634|FG005|Overall Study|Sponsor Decision|0|||
160818895|NCT01606787|580721641|FG000|Overall Study|Withdrawal by Subject|4|||
160818896|NCT01606787|580721642|FG001|Overall Study|Withdrawal by Subject|5|||
160646065|NCT01620489|580085967|FG001|Overall Study|Withdrawal Criteria|25|||
160818897|NCT01606787|580721641|FG000|Overall Study|Surgery canceled|0|||
160818898|NCT01606787|580721642|FG001|Overall Study|Surgery canceled|2|||
160818899|NCT00713349|580721644|FG000|Overall Study|Protocol Violation|1|||
160818900|NCT03764631|580721645|FG000|Overall Study|Personal Reasons|3|||
160818901|NCT03764631|580721646|FG001|Overall Study|Personal Reasons|2|||
160818902|NCT03764631|580721645|FG000|Overall Study|Switching Therapy|3|||
160818903|NCT03764631|580721646|FG001|Overall Study|Switching Therapy|3|||
160818904|NCT03764631|580721645|FG000|Overall Study|Adverse Event|0|||
160818905|NCT03764631|580721646|FG001|Overall Study|Adverse Event|1|||
160818906|NCT03764631|580721645|FG000|Overall Study|Lost to Follow-up|33|||
160818907|NCT03764631|580721646|FG001|Overall Study|Lost to Follow-up|41|||
160818908|NCT03764631|580721645|FG000|Overall Study|No data as study site was closed|2|||
160818909|NCT03764631|580721646|FG001|Overall Study|No data as study site was closed|6|||
160818910|NCT01289353|580721647|FG000|Overall Study|Lost to Follow-up|2|||
160818911|NCT00473668|580721650|FG000|Overall Study|Withdrawal by Subject|0|||
160818912|NCT00473668|580721651|FG001|Overall Study|Withdrawal by Subject|2|||
160818913|NCT00473668|580721652|FG002|Overall Study|Withdrawal by Subject|0|||
160818914|NCT00473668|580721650|FG000|Overall Study|Migrated/moved from study area|3|||
160818915|NCT00473668|580721651|FG001|Overall Study|Migrated/moved from study area|2|||
160818916|NCT00473668|580721652|FG002|Overall Study|Migrated/moved from study area|0|||
160818917|NCT00473668|580721650|FG000|Overall Study|Lost to Follow-up|0|||
160818918|NCT00473668|580721651|FG001|Overall Study|Lost to Follow-up|4|||
160818919|NCT00473668|580721652|FG002|Overall Study|Lost to Follow-up|6|||
160818920|NCT00473668|580721650|FG000|Overall Study|Other|2|||
160818921|NCT00473668|580721651|FG001|Overall Study|Other|3|||
160818922|NCT00473668|580721652|FG002|Overall Study|Other|4|||
160818923|NCT02039219|580721653|FG000|Treatment|Withdrawal by Subject|1|||
160818924|NCT02039219|580721654|FG001|Treatment|Withdrawal by Subject|0|||
160818925|NCT02039219|580721653|FG000|Treatment|Adverse Event|0|||
160818926|NCT02039219|580721654|FG001|Treatment|Adverse Event|1|||
160818927|NCT02039219|580721653|FG000|Treatment|Physician Decision|1|||
160818928|NCT02039219|580721654|FG001|Treatment|Physician Decision|0|||
160818929|NCT02039219|580721653|FG000|Treatment|Lost to Follow-up|0|||
160818930|NCT02039219|580721654|FG001|Treatment|Lost to Follow-up|1|||
160818931|NCT02039219|580721653|FG000|Treatment|Protocol Violation|1|||
160818932|NCT02039219|580721654|FG001|Treatment|Protocol Violation|0|||
160818933|NCT02039219|580721653|FG000|Treatment|Death|1|||
160818934|NCT02039219|580721654|FG001|Treatment|Death|0|||
160818935|NCT02039219|580721653|FG000|Follow up|Adverse Event|0|||
160818936|NCT02039219|580721654|FG001|Follow up|Adverse Event|1|||
160818937|NCT02226562|580721655|FG000|Overall Study|Lost to Follow-up|0|||
160818938|NCT02226562|580721656|FG001|Overall Study|Lost to Follow-up|1|||
160818939|NCT04569136|580721662|FG000|Overall Study|Lost to Follow-up|2|||
160818940|NCT04569136|580721663|FG001|Overall Study|Lost to Follow-up|0|||
160818941|NCT04569136|580721664|FG002|Overall Study|Lost to Follow-up|1|||
160646066|NCT01620489|580085966|FG000|Overall Study|Unclassified|1|||
160646067|NCT01620489|580085967|FG001|Overall Study|Unclassified|2|||
160818942|NCT01466660|580721670|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
160818943|NCT01466660|580721671|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
160818944|NCT01466660|580721670|FG000|Overall Study|Worsening of underlying cancer disease|5|||
160818945|NCT01466660|580721671|FG001|Overall Study|Worsening of underlying cancer disease|2|||
160818946|NCT01466660|580721670|FG000|Overall Study|Other adverse event|19|||
160818947|NCT01466660|580721671|FG001|Overall Study|Other adverse event|18|||
160818948|NCT01466660|580721670|FG000|Overall Study|Protocol Violation|2|||
160818949|NCT01466660|580721671|FG001|Overall Study|Protocol Violation|1|||
160818950|NCT01466660|580721670|FG000|Overall Study|Refused continuation of trial medication|4|||
160818951|NCT01466660|580721671|FG001|Overall Study|Refused continuation of trial medication|3|||
160646068|NCT00871169|580085968|FG000|Overall Study|Protocol Violation|1|||
160818952|NCT01466660|580721670|FG000|Overall Study|Other reason not defined above|10|||
160818953|NCT01466660|580721671|FG001|Overall Study|Other reason not defined above|8|||
160818954|NCT03576066|580721672|FG000|Overall Study|Noncompliance with study drug|0|||
160818955|NCT03576066|580721673|FG001|Overall Study|Noncompliance with study drug|1|||
160818956|NCT00129701|580721674|FG000|Overall Study|Withdrawal by Subject|33|||
160818957|NCT00006164|580721675|FG000|Overall Study|Withdrew or lost to follow-up|70|||
160818958|NCT00006164|580721676|FG001|Overall Study|Withdrew or lost to follow-up|81|||
160818959|NCT02750345|580721677|FG000|Intervention 1|Adverse Event|0|||
160900520|NCT03666624|581030146|FG001|Overall Study|participant grieving over recent death of parent|0|||
160818960|NCT02750345|580721678|FG001|Intervention 1|Adverse Event|0|||
160818961|NCT02750345|580721679|FG002|Intervention 1|Adverse Event|0|||
160818962|NCT02750345|580721680|FG003|Intervention 1|Adverse Event|0|||
160818963|NCT02750345|580721681|FG004|Intervention 1|Adverse Event|1|||
160818964|NCT02750345|580721682|FG005|Intervention 1|Adverse Event|0|||
160818965|NCT00223808|580721683|FG000|Overall Study|<5 hrs therapy before discharge|3|||
160818966|NCT00223808|580721684|FG001|Overall Study|<5 hrs therapy before discharge|5|||
160818967|NCT00223808|580721685|FG002|Overall Study|<5 hrs therapy before discharge|5|||
160818968|NCT00191724|580721688|FG000|Overall Study|Adverse Event|0|||
160818969|NCT00191724|580721689|FG001|Overall Study|Adverse Event|0|||
160818970|NCT00191724|580721690|FG002|Overall Study|Adverse Event|1|||
160818971|NCT00191724|580721691|FG003|Overall Study|Adverse Event|0|||
160818972|NCT00191724|580721692|FG004|Overall Study|Adverse Event|0|||
160818973|NCT00191724|580721688|FG000|Overall Study|Lost to Follow-up|1|||
160818974|NCT00191724|580721689|FG001|Overall Study|Lost to Follow-up|1|||
160818975|NCT00191724|580721690|FG002|Overall Study|Lost to Follow-up|0|||
160818976|NCT00191724|580721691|FG003|Overall Study|Lost to Follow-up|2|||
160818977|NCT00191724|580721692|FG004|Overall Study|Lost to Follow-up|3|||
160818978|NCT00191724|580721688|FG000|Overall Study|Withdrawal by Subject|0|||
160818979|NCT00191724|580721689|FG001|Overall Study|Withdrawal by Subject|0|||
160818980|NCT00191724|580721690|FG002|Overall Study|Withdrawal by Subject|0|||
160818981|NCT00191724|580721691|FG003|Overall Study|Withdrawal by Subject|1|||
160818982|NCT00191724|580721692|FG004|Overall Study|Withdrawal by Subject|0|||
160818983|NCT05260073|580721693|FG000|Overall Study|Physician Decision|1|||
160818984|NCT05260073|580721693|FG000|Overall Study|Withdrawal by Subject|6|||
160818985|NCT05260073|580721693|FG000|Overall Study|Lost to Follow-up|14|||
160818986|NCT03458910|580721694|FG000|Overall Study|Withdrawal by Subject|7|||
160818987|NCT03458910|580721695|FG001|Overall Study|Withdrawal by Subject|8|||
160818988|NCT03458910|580721696|FG002|Overall Study|Withdrawal by Subject|6|||
160818989|NCT03458910|580721697|FG003|Overall Study|Withdrawal by Subject|4|||
160818990|NCT03458910|580721694|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
160818991|NCT03458910|580721695|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
160818992|NCT03458910|580721696|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
160818993|NCT03458910|580721697|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
160818994|NCT05275010|580721698|FG000|Overall Study|Reason Not Specified|4|||
160818995|NCT05275010|580721699|FG001|Overall Study|Reason Not Specified|1|||
160818996|NCT05275010|580721698|FG000|Overall Study|Withdrawal by Subject|1|||
160818997|NCT05275010|580721699|FG001|Overall Study|Withdrawal by Subject|0|||
160818998|NCT05275010|580721698|FG000|Overall Study|Lost to Follow-up|0|||
160818999|NCT05275010|580721699|FG001|Overall Study|Lost to Follow-up|1|||
160819000|NCT04484649|580721702|FG000|Overall Study|Lost to Follow-up|2|||
160819001|NCT04484649|580721703|FG001|Overall Study|Lost to Follow-up|1|||
160819002|NCT04484649|580721702|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
160819003|NCT04484649|580721703|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
160819004|NCT01681069|580721704|FG000|Overall Study|Withdrawal by Subject|4|||
160819005|NCT01681069|580721705|FG001|Overall Study|Withdrawal by Subject|5|||
160819006|NCT01681069|580721704|FG000|Overall Study|Protocol Violation|1|||
160819007|NCT01681069|580721705|FG001|Overall Study|Protocol Violation|1|||
160819008|NCT01681069|580721704|FG000|Overall Study|Adverse Event|0|||
160819009|NCT01681069|580721705|FG001|Overall Study|Adverse Event|1|||
160819010|NCT03883165|580721706|FG000|Overall Study|Withdrawal by Subject|4|||
160819011|NCT03883165|580721707|FG001|Overall Study|Withdrawal by Subject|3|||
160819012|NCT00967694|580721708|FG000|Overall Study|Withdrawal by Subject|6|||
160819013|NCT03905265|580721709|FG000|Overall Study|Withdrawal by Subject|1|||
160819014|NCT03905265|580721710|FG001|Overall Study|Withdrawal by Subject|1|||
160819015|NCT03905265|580721711|FG002|Overall Study|Withdrawal by Subject|0|||
160819016|NCT03905265|580721712|FG003|Overall Study|Withdrawal by Subject|0|||
160819017|NCT04085458|580721715|FG000|Overall Study|Other|1|||
160819018|NCT04085458|580721715|FG000|Overall Study|Withdrawal by Subject|2|||
160900521|NCT05213481|581030148|FG000|Overall Study|Adverse Event|3|||
160900522|NCT05213481|581030148|FG000|Overall Study|Lost to Follow-up|1|||
160819019|NCT04085458|580721715|FG000|Overall Study|Adverse Event|2|||
160819020|NCT03632993|580721716|FG000|Overall Study|Withdrawal by Subject|1|||
160819021|NCT03632993|580721717|FG001|Overall Study|Withdrawal by Subject|0|||
160819022|NCT03632993|580721718|FG002|Overall Study|Withdrawal by Subject|0|||
160819023|NCT03632993|580721719|FG003|Overall Study|Withdrawal by Subject|0|||
160819024|NCT03632993|580721720|FG004|Overall Study|Withdrawal by Subject|0|||
160900523|NCT00447005|581030150|FG000|Overall Study|Adverse Event|1|||
160819025|NCT03632993|580721721|FG005|Overall Study|Withdrawal by Subject|0|||
160819026|NCT03632993|580721722|FG006|Overall Study|Withdrawal by Subject|0|||
160819027|NCT03632993|580721723|FG007|Overall Study|Withdrawal by Subject|0|||
160819028|NCT03632993|580721724|FG008|Overall Study|Withdrawal by Subject|0|||
160819029|NCT03632993|580721725|FG009|Overall Study|Withdrawal by Subject|1|||
160819030|NCT03632993|580721716|FG000|Overall Study|Protocol Non-compliance|0|||
160819031|NCT03632993|580721717|FG001|Overall Study|Protocol Non-compliance|1|||
160819032|NCT03632993|580721718|FG002|Overall Study|Protocol Non-compliance|0|||
160819033|NCT03632993|580721719|FG003|Overall Study|Protocol Non-compliance|0|||
160819034|NCT03632993|580721720|FG004|Overall Study|Protocol Non-compliance|0|||
160819035|NCT03632993|580721721|FG005|Overall Study|Protocol Non-compliance|0|||
160819036|NCT03632993|580721722|FG006|Overall Study|Protocol Non-compliance|0|||
160819037|NCT03632993|580721723|FG007|Overall Study|Protocol Non-compliance|0|||
160819038|NCT03632993|580721724|FG008|Overall Study|Protocol Non-compliance|0|||
160819039|NCT03632993|580721725|FG009|Overall Study|Protocol Non-compliance|0|||
160819040|NCT03632993|580721716|FG000|Overall Study|Lost to Follow-up|0|||
160819041|NCT03632993|580721717|FG001|Overall Study|Lost to Follow-up|0|||
160819042|NCT03632993|580721718|FG002|Overall Study|Lost to Follow-up|0|||
160819043|NCT03632993|580721719|FG003|Overall Study|Lost to Follow-up|0|||
160819044|NCT03632993|580721720|FG004|Overall Study|Lost to Follow-up|0|||
160819045|NCT03632993|580721721|FG005|Overall Study|Lost to Follow-up|1|||
160819046|NCT03632993|580721722|FG006|Overall Study|Lost to Follow-up|0|||
160819047|NCT03632993|580721723|FG007|Overall Study|Lost to Follow-up|1|||
160819048|NCT03632993|580721724|FG008|Overall Study|Lost to Follow-up|0|||
160819049|NCT03632993|580721725|FG009|Overall Study|Lost to Follow-up|0|||
160819050|NCT03632993|580721716|FG000|Overall Study|Adverse Event|0|||
160819051|NCT03632993|580721717|FG001|Overall Study|Adverse Event|0|||
160819052|NCT03632993|580721718|FG002|Overall Study|Adverse Event|0|||
160819053|NCT03632993|580721719|FG003|Overall Study|Adverse Event|0|||
160819054|NCT03632993|580721720|FG004|Overall Study|Adverse Event|0|||
160819055|NCT03632993|580721721|FG005|Overall Study|Adverse Event|1|||
160819056|NCT03632993|580721722|FG006|Overall Study|Adverse Event|0|||
160819057|NCT03632993|580721723|FG007|Overall Study|Adverse Event|1|||
160819058|NCT03632993|580721724|FG008|Overall Study|Adverse Event|0|||
160819059|NCT03632993|580721725|FG009|Overall Study|Adverse Event|0|||
160819060|NCT00758264|580721726|FG000|Active Phase|Withdrawal by Subject|0|||
160819061|NCT00758264|580721727|FG001|Active Phase|Withdrawal by Subject|0|||
160819062|NCT00758264|580721728|FG002|Active Phase|Withdrawal by Subject|1|||
160819063|NCT00758264|580721726|FG000|Active Phase|Lost to Follow-up|1|||
160819064|NCT00758264|580721727|FG001|Active Phase|Lost to Follow-up|0|||
160819065|NCT00758264|580721728|FG002|Active Phase|Lost to Follow-up|0|||
160819066|NCT00758264|580721726|FG000|Active Phase|Other|0|||
160819067|NCT00758264|580721727|FG001|Active Phase|Other|0|||
160819068|NCT00758264|580721728|FG002|Active Phase|Other|4|||
160819069|NCT00368836|580721730|FG000|Phase II|Screen Failure|1|||
160819070|NCT00368836|580721730|FG000|Phase II|Withdrawal by Subject|1|||
160819071|NCT00368836|580721730|FG000|Phase II|unable to collect blood and/or breath|17|||
160819072|NCT00368836|580721730|FG000|Phase II|Protocol Violation|2|||
160819073|NCT00244933|580721738|FG000|Overall Study|Not response evaluable|2|||
160819074|NCT02901054|580721744|FG000|Overall Study|Physician Decision|1|||
160819075|NCT02901054|580721744|FG000|Overall Study|Withdrawal by Subject|3|||
160819076|NCT06359028|580721748|FG000|Overall Study|Adverse Event|1|||
160819077|NCT06359028|580721749|FG001|Overall Study|Adverse Event|0|||
160819078|NCT06359028|580721748|FG000|Overall Study|Withdrawal by Subject|1|||
160819079|NCT06359028|580721749|FG001|Overall Study|Withdrawal by Subject|0|||
160819080|NCT00673231|580721750|FG000|Overall Study|Withdrawal by Subject|14|||
160819081|NCT00673231|580721751|FG001|Overall Study|Withdrawal by Subject|10|||
160819082|NCT00673231|580721752|FG002|Overall Study|Withdrawal by Subject|8|||
160987641|NCT01544582|581341182|FG002|Analysis Population|Liver Transplantation|1|||
160987642|NCT01544582|581341183|FG003|Analysis Population|Liver Transplantation|0|||
160987643|NCT01544582|581341180|FG000|Analysis Population|No Social Insurance|0|||
160987644|NCT01544582|581341181|FG001|Analysis Population|No Social Insurance|0|||
160987645|NCT01544582|581341182|FG002|Analysis Population|No Social Insurance|1|||
160819083|NCT00673231|580721753|FG003|Overall Study|Withdrawal by Subject|6|||
160819084|NCT00673231|580721750|FG000|Overall Study|Adverse Event|6|||
160819085|NCT00673231|580721751|FG001|Overall Study|Adverse Event|5|||
160819086|NCT00673231|580721752|FG002|Overall Study|Adverse Event|9|||
160819087|NCT00673231|580721753|FG003|Overall Study|Adverse Event|6|||
160819088|NCT00673231|580721750|FG000|Overall Study|Lost to Follow-up|1|||
160819089|NCT00673231|580721751|FG001|Overall Study|Lost to Follow-up|2|||
160819090|NCT00673231|580721752|FG002|Overall Study|Lost to Follow-up|1|||
160987646|NCT01544582|581341183|FG003|Analysis Population|No Social Insurance|0|||
160987647|NCT01544582|581341180|FG000|Analysis Population|Poor Adherence|0|||
160819091|NCT00673231|580721753|FG003|Overall Study|Lost to Follow-up|2|||
160987648|NCT01544582|581341181|FG001|Analysis Population|Poor Adherence|0|||
160819092|NCT00673231|580721750|FG000|Overall Study|Death|0|||
160819093|NCT00673231|580721751|FG001|Overall Study|Death|0|||
160819094|NCT00673231|580721752|FG002|Overall Study|Death|1|||
160819095|NCT00673231|580721753|FG003|Overall Study|Death|0|||
160819096|NCT00673231|580721750|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
160819097|NCT00673231|580721751|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
160819098|NCT00673231|580721752|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
160819099|NCT00673231|580721753|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
160819100|NCT02952313|580721754|FG000|Primary Endpoint|Lost to Follow-up|4|||
160819101|NCT02952313|580721754|FG000|Primary Endpoint|Withdrawal by Subject|1|||
160819102|NCT02952313|580721754|FG000|Primary Endpoint|Lack of Efficacy|1|||
160819103|NCT02952313|580721754|FG000|Primary Endpoint|Missed visit|1|||
160819104|NCT02952313|580721754|FG000|Long-term Follow-up|Lost to Follow-up|12|||
160819105|NCT02952313|580721754|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
160819106|NCT02952313|580721754|FG000|Long-term Follow-up|Lack of Efficacy|6|||
160819107|NCT02952313|580721754|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
160819108|NCT02952313|580721754|FG000|Long-term Follow-up|Physician Decision|1|||
160819109|NCT02952313|580721754|FG000|Long-term Follow-up|Death|1|||
160819110|NCT02470585|580721765|FG000|Overall Study|Death|224|||
160819111|NCT02470585|580721766|FG001|Overall Study|Death|227|||
160819112|NCT02470585|580721767|FG002|Overall Study|Death|199|||
160819113|NCT02470585|580721765|FG000|Overall Study|Withdrew consent|21|||
160819114|NCT02470585|580721766|FG001|Overall Study|Withdrew consent|22|||
160819115|NCT02470585|580721767|FG002|Overall Study|Withdrew consent|31|||
160819116|NCT02470585|580721765|FG000|Overall Study|Lost to Follow-up|8|||
160819117|NCT02470585|580721766|FG001|Overall Study|Lost to Follow-up|15|||
160819118|NCT02470585|580721767|FG002|Overall Study|Lost to Follow-up|13|||
160819119|NCT02470585|580721765|FG000|Overall Study|Sponsor discontinued study|117|||
160819120|NCT02470585|580721766|FG001|Overall Study|Sponsor discontinued study|110|||
160819121|NCT02470585|580721767|FG002|Overall Study|Sponsor discontinued study|122|||
160819122|NCT02470585|580721765|FG000|Overall Study|Other, not specified|5|||
160819123|NCT02470585|580721766|FG001|Overall Study|Other, not specified|7|||
160819124|NCT02470585|580721767|FG002|Overall Study|Other, not specified|14|||
160819125|NCT02470585|580721765|FG000|Overall Study|Missing due to site non-compliance|0|||
160819126|NCT02470585|580721766|FG001|Overall Study|Missing due to site non-compliance|2|||
160819127|NCT02470585|580721767|FG002|Overall Study|Missing due to site non-compliance|3|||
160819128|NCT02602275|580721768|FG000|Day 1|Physician Decision|0|||
160819129|NCT02602275|580721769|FG001|Day 1|Physician Decision|1|||
160819130|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
160819131|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
160819132|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
160819133|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
160819134|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
160819135|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
160819136|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
160819137|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
160819138|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
160819139|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
160819140|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
160819141|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
160819142|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
160819143|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
160819144|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
160819145|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
160819146|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
160819147|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
160819148|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
160819149|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
160819150|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
160819151|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
160819152|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
160819153|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
160987649|NCT01544582|581341182|FG002|Analysis Population|Poor Adherence|1|||
160987650|NCT01544582|581341183|FG003|Analysis Population|Poor Adherence|0|||
160987651|NCT01544582|581341180|FG000|Analysis Population|Poor Participant Compliance|0|||
160819154|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
160819155|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
160819156|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
160819157|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
160819158|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
160819159|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
160819160|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
160819161|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
160819162|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
160819163|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
160819164|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
160819165|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
160819166|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
160987652|NCT01544582|581341181|FG001|Analysis Population|Poor Participant Compliance|1|||
160987653|NCT01544582|581341182|FG002|Analysis Population|Poor Participant Compliance|0|||
160987654|NCT01544582|581341183|FG003|Analysis Population|Poor Participant Compliance|0|||
160819167|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
160819168|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
160819169|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
160819170|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
160819171|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
160819172|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
160819173|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
160819174|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Death|1|||
160819175|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Death|1|||
160819176|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Death|3|||
160819177|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Death|2|||
160819178|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
160819179|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
160819180|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
160819181|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
160819182|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
160819183|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
160819184|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
160819185|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
160819186|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
160819187|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
160819188|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
160819189|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
160819190|NCT04113018|580721776|FG000|Overall Study|Death|2|||
160819191|NCT04113018|580721776|FG000|Overall Study|Lost to Follow-up|1|||
160819192|NCT04113018|580721776|FG000|Overall Study|Still On Study (on study treatment)|24|||
160819193|NCT04113018|580721776|FG000|Overall Study|Still On Study (in follow up)|12|||
160819194|NCT05005013|580721777|FG000|Overall Study|Withdrawal by Subject|5|||
160819195|NCT05005013|580721778|FG001|Overall Study|Withdrawal by Subject|1|||
160819196|NCT05005013|580721777|FG000|Overall Study|Lost to Follow-up|3|||
160819197|NCT05005013|580721778|FG001|Overall Study|Lost to Follow-up|1|||
160819198|NCT05005013|580721777|FG000|Overall Study|Ineligibility|1|||
160819199|NCT05005013|580721778|FG001|Overall Study|Ineligibility|1|||
160819200|NCT04283994|580721779|FG000|Overall Study|Death|11|||
160819201|NCT04283994|580721780|FG001|Overall Study|Death|20|||
160819202|NCT04283994|580721781|FG002|Overall Study|Death|11|||
160819203|NCT04283994|580721782|FG003|Overall Study|Death|0|||
160819204|NCT04283994|580721783|FG004|Overall Study|Death|0|||
160819205|NCT04283994|580721784|FG005|Overall Study|Death|0|||
160819206|NCT04283994|580721785|FG006|Overall Study|Death|0|||
160819207|NCT04283994|580721779|FG000|Overall Study|Withdrawal by Subject|16|||
160819208|NCT04283994|580721780|FG001|Overall Study|Withdrawal by Subject|4|||
160819209|NCT04283994|580721781|FG002|Overall Study|Withdrawal by Subject|6|||
160987655|NCT01544582|581341180|FG000|Analysis Population|Programmed Surgery|0|||
160987656|NCT01544582|581341181|FG001|Analysis Population|Programmed Surgery|1|||
160819210|NCT04283994|580721782|FG003|Overall Study|Withdrawal by Subject|1|||
160819211|NCT04283994|580721783|FG004|Overall Study|Withdrawal by Subject|0|||
160819212|NCT04283994|580721784|FG005|Overall Study|Withdrawal by Subject|1|||
160819213|NCT04283994|580721785|FG006|Overall Study|Withdrawal by Subject|0|||
160819214|NCT00583752|580721786|FG000|Overall Study|Lost to Follow-up|5|||
160819215|NCT00583752|580721787|FG001|Overall Study|Lost to Follow-up|5|||
160819216|NCT03315793|580721788|FG000|Overall Study|Adverse Event|4|||
160819217|NCT03315793|580721789|FG001|Overall Study|Adverse Event|2|||
160819218|NCT03315793|580721788|FG000|Overall Study|Protocol Deviation|1|||
160819219|NCT03315793|580721789|FG001|Overall Study|Protocol Deviation|0|||
160819220|NCT03315793|580721788|FG000|Overall Study|Difficult for regular visit|0|||
160819221|NCT03315793|580721789|FG001|Overall Study|Difficult for regular visit|1|||
160819222|NCT00983515|580723212|FG000|Ritonavir Alone|liver panel out of range|6|||
160819223|NCT00983515|580723212|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
160819224|NCT01463696|580723217|FG000|Overall Study|Adverse Event|0|||
160819225|NCT01463696|580723218|FG001|Overall Study|Adverse Event|1|||
160819226|NCT01463696|580723219|FG002|Overall Study|Adverse Event|0|||
160819227|NCT01463696|580723220|FG003|Overall Study|Adverse Event|2|||
160819228|NCT01463696|580723221|FG004|Overall Study|Adverse Event|0|||
160987657|NCT01544582|581341182|FG002|Analysis Population|Programmed Surgery|0|||
160987658|NCT01544582|581341183|FG003|Analysis Population|Programmed Surgery|0|||
160819229|NCT01463696|580723222|FG005|Overall Study|Adverse Event|1|||
160819230|NCT01463696|580723223|FG006|Overall Study|Adverse Event|3|||
160819231|NCT01463696|580723224|FG007|Overall Study|Adverse Event|2|||
160819232|NCT01463696|580723217|FG000|Overall Study|Lost to Follow-up|0|||
160819233|NCT01463696|580723218|FG001|Overall Study|Lost to Follow-up|0|||
160819234|NCT01463696|580723219|FG002|Overall Study|Lost to Follow-up|1|||
160819235|NCT01463696|580723220|FG003|Overall Study|Lost to Follow-up|0|||
160819236|NCT01463696|580723221|FG004|Overall Study|Lost to Follow-up|0|||
160819237|NCT01463696|580723222|FG005|Overall Study|Lost to Follow-up|0|||
160819238|NCT01463696|580723223|FG006|Overall Study|Lost to Follow-up|0|||
160819239|NCT01463696|580723224|FG007|Overall Study|Lost to Follow-up|0|||
160819240|NCT01463696|580723217|FG000|Overall Study|Progressive Disease|0|||
160819241|NCT01463696|580723218|FG001|Overall Study|Progressive Disease|1|||
160819242|NCT01463696|580723219|FG002|Overall Study|Progressive Disease|0|||
160819243|NCT01463696|580723220|FG003|Overall Study|Progressive Disease|1|||
160819244|NCT01463696|580723221|FG004|Overall Study|Progressive Disease|0|||
160819245|NCT01463696|580723222|FG005|Overall Study|Progressive Disease|1|||
160819246|NCT01463696|580723223|FG006|Overall Study|Progressive Disease|4|||
160819247|NCT01463696|580723224|FG007|Overall Study|Progressive Disease|2|||
160819248|NCT01463696|580723217|FG000|Overall Study|Withdrawal by Subject|0|||
160819249|NCT01463696|580723218|FG001|Overall Study|Withdrawal by Subject|0|||
160819250|NCT01463696|580723219|FG002|Overall Study|Withdrawal by Subject|0|||
160819251|NCT01463696|580723220|FG003|Overall Study|Withdrawal by Subject|1|||
160819252|NCT01463696|580723221|FG004|Overall Study|Withdrawal by Subject|1|||
160819253|NCT01463696|580723222|FG005|Overall Study|Withdrawal by Subject|1|||
160819254|NCT01463696|580723223|FG006|Overall Study|Withdrawal by Subject|2|||
160819255|NCT01463696|580723224|FG007|Overall Study|Withdrawal by Subject|0|||
160819256|NCT01463696|580723217|FG000|Overall Study|Not Treated|0|||
160819257|NCT01463696|580723218|FG001|Overall Study|Not Treated|0|||
160819258|NCT01463696|580723219|FG002|Overall Study|Not Treated|0|||
160819259|NCT01463696|580723220|FG003|Overall Study|Not Treated|0|||
160819260|NCT01463696|580723221|FG004|Overall Study|Not Treated|0|||
160819261|NCT01463696|580723222|FG005|Overall Study|Not Treated|0|||
160819262|NCT01463696|580723223|FG006|Overall Study|Not Treated|1|||
160819263|NCT01463696|580723224|FG007|Overall Study|Not Treated|0|||
160819264|NCT05526781|580723237|FG000|Overall Study|Lost to Follow-up|1|||
160819265|NCT01801436|580723238|FG000|Overall Study|Withdrawal by Subject|3|||
160819266|NCT01801436|580723238|FG000|Overall Study|Adverse Event|2|||
160819267|NCT01801436|580723238|FG000|Overall Study|Progressive disease|4|||
160819268|NCT02447250|580723241|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
160819269|NCT02447250|580723241|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
160819270|NCT02447250|580723241|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
160819271|NCT02743949|580723242|FG000|Overall Study|Adverse Event|0|||
160819272|NCT02743949|580723243|FG001|Overall Study|Adverse Event|0|||
160819273|NCT02743949|580723244|FG002|Overall Study|Adverse Event|2|||
160819274|NCT02743949|580723242|FG000|Overall Study|Significant Protocol Deviation|2|||
160819275|NCT02743949|580723243|FG001|Overall Study|Significant Protocol Deviation|0|||
160819276|NCT02743949|580723244|FG002|Overall Study|Significant Protocol Deviation|1|||
160819277|NCT02743949|580723242|FG000|Overall Study|Voluntary Withdrawal|2|||
160819278|NCT02743949|580723243|FG001|Overall Study|Voluntary Withdrawal|1|||
160819279|NCT02743949|580723244|FG002|Overall Study|Voluntary Withdrawal|0|||
160819280|NCT01921218|580723245|FG000|Overall Study|Death|2|||
160819281|NCT01921218|580723246|FG001|Overall Study|Death|1|||
160819282|NCT01921218|580723245|FG000|Overall Study|Withdrawal by Subject|0|||
160819283|NCT01921218|580723246|FG001|Overall Study|Withdrawal by Subject|2|||
160819284|NCT01921218|580723245|FG000|Overall Study|Kidney transplant|1|||
160819285|NCT01921218|580723246|FG001|Overall Study|Kidney transplant|1|||
160819286|NCT03389555|580723247|FG000|Overall Study|Protocol Violation|1|||
160819287|NCT03389555|580723248|FG001|Overall Study|Protocol Violation|3|||
160819288|NCT03389555|580723247|FG000|Overall Study|Death|1|||
160819289|NCT03389555|580723248|FG001|Overall Study|Death|0|||
160819290|NCT01885208|580723249|FG000|Overall Study|Unclassified|32|||
160819291|NCT01885208|580723250|FG001|Overall Study|Unclassified|38|||
160819292|NCT00920218|580723251|FG000|Overall Study|Serious Adverse Event|2|||
160819293|NCT00920218|580723252|FG001|Overall Study|Serious Adverse Event|0|||
160819294|NCT00920218|580723253|FG002|Overall Study|Serious Adverse Event|2|||
160819295|NCT00920218|580723254|FG003|Overall Study|Serious Adverse Event|1|||
160819296|NCT00920218|580723251|FG000|Overall Study|Withdrawal by Subject|0|||
160819297|NCT00920218|580723252|FG001|Overall Study|Withdrawal by Subject|3|||
160819298|NCT00920218|580723253|FG002|Overall Study|Withdrawal by Subject|2|||
160819299|NCT00920218|580723254|FG003|Overall Study|Withdrawal by Subject|0|||
160819300|NCT00920218|580723251|FG000|Overall Study|Migrated/moved from study area|0|||
160819301|NCT00920218|580723252|FG001|Overall Study|Migrated/moved from study area|0|||
160819302|NCT00920218|580723253|FG002|Overall Study|Migrated/moved from study area|1|||
160819303|NCT00920218|580723254|FG003|Overall Study|Migrated/moved from study area|0|||
160819304|NCT00920218|580723251|FG000|Overall Study|Lost to Follow-up|0|||
160819305|NCT00920218|580723252|FG001|Overall Study|Lost to Follow-up|1|||
160987659|NCT01544582|581341180|FG000|Analysis Population|Participant in Jail|0|||
160987660|NCT01544582|581341181|FG001|Analysis Population|Participant in Jail|0|||
160819306|NCT00920218|580723253|FG002|Overall Study|Lost to Follow-up|0|||
160819307|NCT00920218|580723254|FG003|Overall Study|Lost to Follow-up|3|||
160819308|NCT00920218|580723251|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
160819309|NCT00920218|580723252|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
160819310|NCT00920218|580723253|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
160819311|NCT00920218|580723254|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
160819312|NCT00920218|580723251|FG000|Overall Study|Other|0|||
160819313|NCT00920218|580723252|FG001|Overall Study|Other|0|||
160819314|NCT00920218|580723253|FG002|Overall Study|Other|1|||
160819315|NCT00920218|580723254|FG003|Overall Study|Other|0|||
160819316|NCT00960011|580723255|FG000|Overall Study|Death|5|||
160819317|NCT00960011|580723256|FG001|Overall Study|Death|0|||
160819318|NCT00960011|580723255|FG000|Overall Study|Lost to Follow-up|6|||
160819319|NCT00960011|580723256|FG001|Overall Study|Lost to Follow-up|2|||
160819320|NCT04417218|580723260|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
160819321|NCT04417218|580723261|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
160819322|NCT00873041|580723262|FG000|Core Study|Adverse Event|2|||
160819323|NCT00873041|580723263|FG001|Core Study|Adverse Event|3|||
160819324|NCT00873041|580723264|FG002|Core Study|Adverse Event|1|||
160819325|NCT00873041|580723262|FG000|Core Study|Withdrawal by Subject|1|||
160819326|NCT00873041|580723263|FG001|Core Study|Withdrawal by Subject|2|||
160819327|NCT00873041|580723264|FG002|Core Study|Withdrawal by Subject|2|||
160819328|NCT00873041|580723262|FG000|Core Study|Lost to Follow-up|3|||
160819329|NCT00873041|580723263|FG001|Core Study|Lost to Follow-up|1|||
160819330|NCT00873041|580723264|FG002|Core Study|Lost to Follow-up|0|||
160819331|NCT00873041|580723262|FG000|Core Study|Abnormal laboratory value|0|||
160819332|NCT00873041|580723263|FG001|Core Study|Abnormal laboratory value|0|||
160819333|NCT00873041|580723264|FG002|Core Study|Abnormal laboratory value|1|||
160819334|NCT00873041|580723262|FG000|Core Study|Protocol deviation|1|||
160819335|NCT00873041|580723263|FG001|Core Study|Protocol deviation|0|||
160819336|NCT00873041|580723264|FG002|Core Study|Protocol deviation|1|||
160819337|NCT00873041|580723262|FG000|Extension Study|Adverse Event|1|||
160819338|NCT00873041|580723263|FG001|Extension Study|Adverse Event|0|||
160819339|NCT00873041|580723264|FG002|Extension Study|Adverse Event|1|||
160819340|NCT00873041|580723262|FG000|Extension Study|Administrative reasons|0|||
160819341|NCT00873041|580723263|FG001|Extension Study|Administrative reasons|0|||
160819342|NCT00873041|580723264|FG002|Extension Study|Administrative reasons|1|||
160819343|NCT02449889|580723267|FG000|Overall Study|Adverse Event|1|||
160819344|NCT02449889|580723268|FG001|Overall Study|Adverse Event|2|||
160819345|NCT02449889|580723269|FG002|Overall Study|Adverse Event|0|||
160819346|NCT02449889|580723267|FG000|Overall Study|Protocol Violation|0|||
160819347|NCT02449889|580723268|FG001|Overall Study|Protocol Violation|4|||
160819348|NCT02449889|580723269|FG002|Overall Study|Protocol Violation|1|||
160819349|NCT01082874|580723274|FG000|Overall Study|Lost to Follow-up|10|||
160819350|NCT01082874|580723275|FG001|Overall Study|Lost to Follow-up|10|||
160819351|NCT01082874|580723276|FG002|Overall Study|Lost to Follow-up|6|||
160819352|NCT01082874|580723277|FG003|Overall Study|Lost to Follow-up|10|||
160819353|NCT01082874|580723274|FG000|Overall Study|Withdrawal by Subject|1|||
160819354|NCT01082874|580723275|FG001|Overall Study|Withdrawal by Subject|2|||
160819355|NCT01082874|580723276|FG002|Overall Study|Withdrawal by Subject|5|||
160819356|NCT01082874|580723277|FG003|Overall Study|Withdrawal by Subject|3|||
160819357|NCT03176472|580723286|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
160819358|NCT03176472|580723287|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
160819359|NCT03176472|580723286|FG000|Double Blind Treatment Period|Adverse Event|0|||
160819360|NCT03176472|580723287|FG001|Double Blind Treatment Period|Adverse Event|5|||
160819361|NCT03176472|580723286|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
160819362|NCT03176472|580723287|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
160819363|NCT03176472|580723286|FG000|Double Blind Treatment Period|Physician Decision|0|||
160819364|NCT03176472|580723287|FG001|Double Blind Treatment Period|Physician Decision|1|||
160819365|NCT03176472|580723286|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160819366|NCT03176472|580723287|FG001|Double Blind Treatment Period|Protocol Violation|0|||
160819367|NCT03176472|580723286|FG000|Double Blind Treatment Period|Not Provided|1|||
160819368|NCT03176472|580723287|FG001|Double Blind Treatment Period|Not Provided|0|||
160819369|NCT03176472|580723286|FG000|Open Label Extension|Withdrawal by Subject|3|||
160819370|NCT03176472|580723287|FG001|Open Label Extension|Withdrawal by Subject|4|||
160819371|NCT03176472|580723286|FG000|Open Label Extension|Adverse Event|2|||
160819372|NCT03176472|580723287|FG001|Open Label Extension|Adverse Event|4|||
160819373|NCT03176472|580723286|FG000|Open Label Extension|Lost to Follow-up|1|||
160987661|NCT01544582|581341182|FG002|Analysis Population|Participant in Jail|1|||
160819374|NCT03176472|580723287|FG001|Open Label Extension|Lost to Follow-up|2|||
160819375|NCT03176472|580723286|FG000|Open Label Extension|Protocol Violation|0|||
160819376|NCT03176472|580723287|FG001|Open Label Extension|Protocol Violation|1|||
160819377|NCT03176472|580723286|FG000|Open Label Extension|Not Provided|2|||
160819378|NCT03176472|580723287|FG001|Open Label Extension|Not Provided|1|||
160819379|NCT03272828|580723288|FG000|Overall Study|Lost to Follow-up|7|||
160987662|NCT01544582|581341183|FG003|Analysis Population|Participant in Jail|0|||
160819380|NCT03272828|580723289|FG001|Overall Study|Lost to Follow-up|7|||
160819381|NCT03272828|580723288|FG000|Overall Study|Withdrawal by Subject|2|||
160819382|NCT03272828|580723289|FG001|Overall Study|Withdrawal by Subject|0|||
160819383|NCT03272828|580723288|FG000|Overall Study|Deceased|1|||
160819384|NCT03272828|580723289|FG001|Overall Study|Deceased|1|||
160819385|NCT03272828|580723288|FG000|Overall Study|Failed implant|1|||
160819386|NCT03272828|580723289|FG001|Overall Study|Failed implant|2|||
160819387|NCT01846663|580723290|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
160819388|NCT01846663|580723291|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
160819389|NCT01846663|580723290|FG000|Overall Study|Withdrawal by Subject|1|||
160819390|NCT01846663|580723291|FG001|Overall Study|Withdrawal by Subject|0|||
160819391|NCT01846663|580723290|FG000|Overall Study|Adverse Event|1|||
160819392|NCT01846663|580723291|FG001|Overall Study|Adverse Event|2|||
160819393|NCT03888235|580723297|FG000|Overall Study|Lost to Follow-up|1|||
160819394|NCT03888235|580723298|FG001|Overall Study|Lost to Follow-up|1|||
160819395|NCT03888235|580723299|FG002|Overall Study|Lost to Follow-up|0|||
160819396|NCT01054560|580723300|FG000|Overall Study|Death|10|||
160819397|NCT01054560|580723301|FG001|Overall Study|Death|21|||
160819398|NCT01054560|580723300|FG000|Overall Study|Lost to Follow-up|2|||
160819399|NCT01054560|580723301|FG001|Overall Study|Lost to Follow-up|5|||
160819400|NCT01054560|580723300|FG000|Overall Study|Withdrawal by Subject|0|||
160819401|NCT01054560|580723301|FG001|Overall Study|Withdrawal by Subject|2|||
160819402|NCT01054560|580723300|FG000|Overall Study|Physician Decision|1|||
160819403|NCT01054560|580723301|FG001|Overall Study|Physician Decision|0|||
160819404|NCT00675441|580723302|FG000|Overall Study|Withdrawal by Subject|2|||
160819405|NCT00675441|580723302|FG000|Overall Study|Death|1|||
160819406|NCT01923363|580723303|FG000|Overall Study|Protocol Violation|1|||
160819407|NCT03718884|580723306|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
160819408|NCT03718884|580723307|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
160819409|NCT03718884|580723306|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
160819410|NCT03718884|580723307|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
160819411|NCT00920387|580723312|FG000|Stage 1|Adverse Event|1|||
160819412|NCT00920387|580723313|FG001|Stage 1|Adverse Event|0|||
160819413|NCT00920387|580723314|FG002|Stage 1|Adverse Event|0|||
160819414|NCT04470908|580723315|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
160819415|NCT02241733|580723318|FG000|Overall Study|Lost to Follow-up|9|||
160819416|NCT02241733|580723319|FG001|Overall Study|Lost to Follow-up|4|||
160819417|NCT02241733|580723318|FG000|Overall Study|Physician Decision|6|||
160819418|NCT02241733|580723319|FG001|Overall Study|Physician Decision|2|||
160819419|NCT02241733|580723318|FG000|Overall Study|Withdrawal by Subject|0|||
160819420|NCT02241733|580723319|FG001|Overall Study|Withdrawal by Subject|2|||
160819421|NCT02241733|580723318|FG000|Overall Study|Death|0|||
160819422|NCT02241733|580723319|FG001|Overall Study|Death|2|||
160819423|NCT00157196|580723322|FG000|Overall Study|Ongoing at data cut-off|9|||
160819424|NCT06099223|580723323|FG000|Overall Study|Preoperative surveys missed|0|||
160819425|NCT06099223|580723324|FG001|Overall Study|Preoperative surveys missed|1|||
160819426|NCT01221623|580723325|FG000|Overall Study|Withdrawal by Subject|19|||
160819427|NCT01221623|580723326|FG001|Overall Study|Withdrawal by Subject|8|||
160819428|NCT01221623|580723325|FG000|Overall Study|Lost to Follow-up|7|||
160819429|NCT01221623|580723326|FG001|Overall Study|Lost to Follow-up|1|||
160819430|NCT01221623|580723325|FG000|Overall Study|Adverse Event|6|||
160819431|NCT01221623|580723326|FG001|Overall Study|Adverse Event|3|||
160819432|NCT01221623|580723325|FG000|Overall Study|Death|1|||
160819433|NCT01221623|580723326|FG001|Overall Study|Death|0|||
160819434|NCT01221623|580723325|FG000|Overall Study|Other|5|||
160819435|NCT01221623|580723326|FG001|Overall Study|Other|2|||
160819436|NCT00661726|580723327|FG000|Overall Study|Adverse Event|1|||
160819437|NCT02147197|580723328|FG000|Overall Study|Adverse Event|1|||
160819438|NCT02147197|580723329|FG001|Overall Study|Adverse Event|0|||
160819439|NCT02147197|580723330|FG002|Overall Study|Adverse Event|0|||
160819440|NCT02147197|580723328|FG000|Overall Study|Withdrawal of Consent|4|||
160819441|NCT02147197|580723329|FG001|Overall Study|Withdrawal of Consent|3|||
160819442|NCT02147197|580723330|FG002|Overall Study|Withdrawal of Consent|2|||
160819443|NCT02147197|580723328|FG000|Overall Study|Lost to Follow-up|2|||
160819444|NCT02147197|580723329|FG001|Overall Study|Lost to Follow-up|3|||
160819445|NCT02147197|580723330|FG002|Overall Study|Lost to Follow-up|1|||
160819446|NCT02147197|580723328|FG000|Overall Study|Protocol Violation|1|||
160819447|NCT02147197|580723329|FG001|Overall Study|Protocol Violation|0|||
160987663|NCT03015740|581341186|FG000|Overall Study|Adverse Event|1|||
160819448|NCT02147197|580723330|FG002|Overall Study|Protocol Violation|3|||
160819449|NCT02147197|580723328|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160819450|NCT02147197|580723329|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160819451|NCT02147197|580723330|FG002|Overall Study|Other Miscellaneous Reasons|3|||
160819452|NCT02644096|580723331|FG000|Overall Study|Withdrawal by Subject|28|||
160819453|NCT02644096|580723332|FG001|Overall Study|Withdrawal by Subject|25|||
160819454|NCT00830375|580723333|FG000|Overall Study|Lost to Follow-up|1|||
160819455|NCT01700959|580723334|FG000|Overall Study|Adverse Event|0|||
160819456|NCT01700959|580723335|FG001|Overall Study|Adverse Event|1|||
160819457|NCT01700959|580723336|FG002|Overall Study|Adverse Event|1|||
160819458|NCT01700959|580723337|FG003|Overall Study|Adverse Event|2|||
160819459|NCT01700959|580723338|FG004|Overall Study|Adverse Event|0|||
160819460|NCT01700959|580723339|FG005|Overall Study|Adverse Event|2|||
160819461|NCT01700959|580723334|FG000|Overall Study|Withdrawal by Subject|15|||
160819462|NCT01700959|580723335|FG001|Overall Study|Withdrawal by Subject|9|||
160819463|NCT01700959|580723336|FG002|Overall Study|Withdrawal by Subject|12|||
160819464|NCT01700959|580723337|FG003|Overall Study|Withdrawal by Subject|11|||
160819465|NCT01700959|580723338|FG004|Overall Study|Withdrawal by Subject|8|||
160819466|NCT01700959|580723339|FG005|Overall Study|Withdrawal by Subject|12|||
160819467|NCT01700959|580723334|FG000|Overall Study|Ineligible|2|||
160819468|NCT01700959|580723335|FG001|Overall Study|Ineligible|1|||
160819469|NCT01700959|580723336|FG002|Overall Study|Ineligible|2|||
160819470|NCT01700959|580723337|FG003|Overall Study|Ineligible|0|||
160819471|NCT01700959|580723338|FG004|Overall Study|Ineligible|0|||
160819472|NCT01700959|580723339|FG005|Overall Study|Ineligible|1|||
160819473|NCT01700959|580723334|FG000|Overall Study|Noncompliant|9|||
160819474|NCT01700959|580723335|FG001|Overall Study|Noncompliant|9|||
160819475|NCT01700959|580723336|FG002|Overall Study|Noncompliant|17|||
160819476|NCT01700959|580723337|FG003|Overall Study|Noncompliant|18|||
160819477|NCT01700959|580723338|FG004|Overall Study|Noncompliant|15|||
160819478|NCT01700959|580723339|FG005|Overall Study|Noncompliant|9|||
160819479|NCT01700959|580723334|FG000|Overall Study|Side effects|1|||
160819480|NCT01700959|580723335|FG001|Overall Study|Side effects|4|||
160819481|NCT01700959|580723336|FG002|Overall Study|Side effects|8|||
160819482|NCT01700959|580723337|FG003|Overall Study|Side effects|4|||
160819483|NCT01700959|580723338|FG004|Overall Study|Side effects|4|||
160819484|NCT01700959|580723339|FG005|Overall Study|Side effects|1|||
160819485|NCT00322452|580723340|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160819486|NCT00322452|580723341|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160819487|NCT00322452|580723340|FG000|Overall Study|Lost to Follow-up|5|||
160819488|NCT00322452|580723341|FG001|Overall Study|Lost to Follow-up|2|||
160819489|NCT00322452|580723340|FG000|Overall Study|Withdrawal by Subject|19|||
160819490|NCT00322452|580723341|FG001|Overall Study|Withdrawal by Subject|46|||
160819491|NCT00322452|580723340|FG000|Overall Study|Death|223|||
160819492|NCT00322452|580723341|FG001|Overall Study|Death|227|||
160819493|NCT00526656|580723342|FG000|Overall Study|Death|1|||
160819494|NCT00526656|580723342|FG000|Overall Study|Refused surgery|1|||
160819495|NCT04091581|580723343|FG000|Overall Study|Lost to Follow-up|0|||
160819496|NCT04091581|580723344|FG001|Overall Study|Lost to Follow-up|1|||
160819497|NCT01795495|580723345|FG000|Overall Study|Protocol Violation|1|||
160819498|NCT01795495|580723346|FG001|Overall Study|Protocol Violation|0|||
160819499|NCT01795495|580723347|FG002|Overall Study|Protocol Violation|1|||
160819500|NCT01795495|580723345|FG000|Overall Study|Physician Decision|0|||
160819501|NCT01795495|580723346|FG001|Overall Study|Physician Decision|0|||
160819502|NCT01795495|580723347|FG002|Overall Study|Physician Decision|1|||
160819503|NCT01331837|580723348|FG000|Overall Study|Death|30|||
160819504|NCT01331837|580723349|FG001|Overall Study|Death|34|||
160819505|NCT01331837|580723348|FG000|Overall Study|Lost to Follow-up|3|||
160819506|NCT01331837|580723349|FG001|Overall Study|Lost to Follow-up|1|||
160819507|NCT01331837|580723348|FG000|Overall Study|Info not recorded|10|||
160819508|NCT01331837|580723349|FG001|Overall Study|Info not recorded|16|||
160819509|NCT01331837|580723348|FG000|Overall Study|Withdrawal by Subject|13|||
160819510|NCT01331837|580723349|FG001|Overall Study|Withdrawal by Subject|16|||
160819511|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Adverse Event|76|||
160819512|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Adverse Event|0|||
160819513|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Adverse Event|0|||
160819514|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Death|3|||
160819515|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Death|0|||
160819516|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Death|0|||
160819517|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
160819518|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
160819519|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
160819520|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Physician Decision|9|||
160819521|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Physician Decision|0|||
160819522|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Physician Decision|0|||
160819523|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
160819524|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
160819525|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
160819526|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Disease progression|45|||
160819527|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Disease progression|0|||
160819528|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Disease progression|0|||
160819529|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
160819530|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
160819531|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
160987664|NCT03015740|581341187|FG001|Overall Study|Adverse Event|0|||
160987665|NCT03015740|581341188|FG002|Overall Study|Adverse Event|0|||
160987666|NCT03015740|581341186|FG000|Overall Study|Death|3|||
160987667|NCT03015740|581341187|FG001|Overall Study|Death|5|||
160987668|NCT03015740|581341188|FG002|Overall Study|Death|0|||
160987669|NCT03015740|581341186|FG000|Overall Study|Withdrawal by Subject|2|||
160987670|NCT03015740|581341187|FG001|Overall Study|Withdrawal by Subject|0|||
160987671|NCT03015740|581341188|FG002|Overall Study|Withdrawal by Subject|0|||
160987672|NCT00231179|581343145|FG000|Overall Study|Lost to Follow-up|21|||
160987673|NCT00231179|581343146|FG001|Overall Study|Lost to Follow-up|21|||
160987674|NCT00231179|581343145|FG000|Overall Study|Withdrawal by Subject|3|||
160987675|NCT00231179|581343146|FG001|Overall Study|Withdrawal by Subject|3|||
160987676|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
160987677|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
160987678|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
160987679|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
160987680|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
160987681|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
160987682|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
160987683|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
160987684|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
160987685|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
160987686|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
160987687|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
160987688|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
160987689|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
160987690|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
160987691|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
160987692|NCT04672460|581343147|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
160987693|NCT04672460|581343148|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
160987694|NCT04672460|581343147|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
160987695|NCT04672460|581343148|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
160987696|NCT04672460|581343147|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
160552870|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Death|2|||
160552871|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Graft loss|0|||
160552872|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Graft loss|2|||
160552873|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Graft loss|0|||
160552874|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
160552875|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
160552876|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
160552877|NCT01114529|579749871|FG000|Completed Study Medication at Month 24|Missing|2|||
160552878|NCT01114529|579749872|FG001|Completed Study Medication at Month 24|Missing|0|||
160552879|NCT01114529|579749873|FG002|Completed Study Medication at Month 24|Missing|0|||
160552880|NCT01114529|579749871|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
160552881|NCT01114529|579749872|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
160552882|NCT01114529|579749873|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
160552883|NCT01114529|579749871|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
160552884|NCT01114529|579749872|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
160552885|NCT01114529|579749873|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
160987697|NCT04672460|581343148|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
160987698|NCT04672460|581343147|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
160987699|NCT04672460|581343148|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
160987700|NCT04672460|581343147|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
160987701|NCT04672460|581343148|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
160987702|NCT04672460|581343147|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
160987703|NCT04672460|581343148|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
160987704|NCT04672460|581343147|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
160987705|NCT04672460|581343148|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
160987706|NCT04672460|581343147|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
160987707|NCT04672460|581343148|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
160987708|NCT04672460|581343147|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
160987709|NCT04672460|581343148|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
160987710|NCT00940017|581343151|FG000|Overall Study|did not meet entrance criteria|3|||
160987711|NCT00940017|581343151|FG000|Overall Study|Adverse Event|1|||
160987712|NCT00569946|581343152|FG000|Overall Study|Adverse Event|16|||
160987713|NCT00569946|581343152|FG000|Overall Study|Objective Progression or Relapse|42|||
160987714|NCT00569946|581343152|FG000|Overall Study|Global Deterioration of Health Status|1|||
160987715|NCT02949271|581343155|FG000|Overall Study|Lack of Efficacy|5|||
160819532|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
160819533|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
160819534|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
160819535|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
160819536|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
160819537|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
160819538|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
160819539|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
160819540|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
160819541|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
160819542|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
160819543|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
160819544|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
160819545|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
160819546|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
160819547|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
160819548|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
160819549|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
160819550|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
160819551|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
160819552|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
160819553|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
160819554|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
160819555|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
160819556|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Promotor request|1|||
160819557|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Promotor request|0|||
160819558|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Promotor request|0|||
160819559|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
160819560|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
160819561|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
160819562|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
160819563|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
160819564|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
160819565|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Death|3|||
160819566|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Death|0|||
160819567|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Death|0|||
160819568|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
160819569|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
160819570|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
160819571|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
160819572|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
160819573|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
160819574|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Diseases progression|91|||
160819575|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Diseases progression|0|||
160819576|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Diseases progression|0|||
160819577|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Adverse Event|70|||
160819578|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Adverse Event|0|||
160819579|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Adverse Event|0|||
160819580|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Physician Decision|9|||
160819581|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Physician Decision|0|||
160819582|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Physician Decision|0|||
160819583|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
160819584|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
160819585|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
160819586|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
160900524|NCT00447005|581030150|FG000|Overall Study|Lack of Efficacy|11|||
160900525|NCT00397215|581030151|FG000|Month 0 (Day 0)|Adverse Event|0|||
160900526|NCT00397215|581030152|FG001|Month 0 (Day 0)|Adverse Event|1|||
160900527|NCT00397215|581030153|FG002|Month 0 (Day 0)|Adverse Event|0|||
160900528|NCT00397215|581030154|FG003|Month 0 (Day 0)|Adverse Event|0|||
160900529|NCT00397215|581030151|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
160900530|NCT00397215|581030152|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
160900531|NCT00397215|581030153|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
160900532|NCT00397215|581030154|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
160900533|NCT00397215|581030151|FG000|Month 0 (Day 0)|Other|4|||
160900534|NCT00397215|581030152|FG001|Month 0 (Day 0)|Other|1|||
160987716|NCT02949271|581343156|FG001|Overall Study|Lack of Efficacy|4|||
160646069|NCT00871169|580085968|FG000|Overall Study|Patient did not receive study treatment|2|||
160819587|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
160819588|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
160819589|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
160819590|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
160819591|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
160819592|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Not compliant|1|||
160819593|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Not compliant|0|||
160819594|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Not compliant|0|||
160819595|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
160819596|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
160819597|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
160819598|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Adverse Event|0|||
160819599|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Adverse Event|2|||
160819600|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Adverse Event|0|||
160819601|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Death|0|||
160819602|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Death|10|||
160819603|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Death|8|||
160819604|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Physician Decision|0|||
160819605|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Physician Decision|0|||
160819606|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Physician Decision|4|||
160819607|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
160819608|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
160819609|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
160819610|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Moved to another town|0|||
160819611|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Moved to another town|1|||
160819612|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Moved to another town|0|||
160819613|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Disease progression|0|||
160819614|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Disease progression|0|||
160819615|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Disease progression|3|||
160819616|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
160819617|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
160819618|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
160819619|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
160819620|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
160819621|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
160819622|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
160819623|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
160819624|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
160819625|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
160819626|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
160819627|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
160819628|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
160819629|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
160819630|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
160819631|NCT01159171|580724847|FG000|Overall Study|Adverse Event|11|||
160819632|NCT01159171|580724847|FG000|Overall Study|Progression of Disease|28|||
160819633|NCT01159171|580724847|FG000|Overall Study|Protocol Violation|1|||
160819634|NCT01159171|580724847|FG000|Overall Study|Need for Surgery|5|||
160819635|NCT01159171|580724847|FG000|Overall Study|Medical Decision|4|||
160819636|NCT01159171|580724847|FG000|Overall Study|Death|1|||
160819637|NCT00470093|580724855|FG000|Overall Study|Adverse Event|2|||
160819638|NCT00539513|580724856|FG000|Overall Study|Withdrawal by Subject|2|||
160819639|NCT00539513|580724857|FG001|Overall Study|Withdrawal by Subject|1|||
160819640|NCT00539513|580724856|FG000|Overall Study|Lost to Follow-up|0|||
160819641|NCT00539513|580724857|FG001|Overall Study|Lost to Follow-up|1|||
160819642|NCT00664560|580724858|FG000|Overall Study|Adverse Event|19|||
160819643|NCT00664560|580724859|FG001|Overall Study|Adverse Event|16|||
160819644|NCT00664560|580724860|FG002|Overall Study|Adverse Event|7|||
160819645|NCT00664560|580724858|FG000|Overall Study|Withdrawal by Subject|9|||
160819646|NCT00664560|580724859|FG001|Overall Study|Withdrawal by Subject|13|||
160819647|NCT00664560|580724860|FG002|Overall Study|Withdrawal by Subject|7|||
160819648|NCT00664560|580724858|FG000|Overall Study|Lost to Follow-up|0|||
160819649|NCT00664560|580724859|FG001|Overall Study|Lost to Follow-up|2|||
160900535|NCT00397215|581030153|FG002|Month 0 (Day 0)|Other|3|||
160819650|NCT00664560|580724860|FG002|Overall Study|Lost to Follow-up|0|||
160819651|NCT00664560|580724858|FG000|Overall Study|Other|11|||
160819652|NCT00664560|580724859|FG001|Overall Study|Other|4|||
160819653|NCT00664560|580724860|FG002|Overall Study|Other|5|||
160819654|NCT01328041|580724861|FG000|Overall Study|Adverse Event|7|||
160900536|NCT00397215|581030154|FG003|Month 0 (Day 0)|Other|3|||
160819655|NCT01328041|580724861|FG000|Overall Study|Lack of Efficacy|27|||
160819656|NCT01328041|580724861|FG000|Overall Study|Protocol Violation|7|||
160900537|NCT00397215|581030151|FG000|Month 6 (Day 180)|Adverse Event|0|||
160819657|NCT01328041|580724861|FG000|Overall Study|Lost to Follow-up|7|||
160819658|NCT01328041|580724861|FG000|Overall Study|Physician Decision|2|||
160819659|NCT01328041|580724861|FG000|Overall Study|Withdrawal by Subject|7|||
160819660|NCT00711113|580724862|FG000|Overall Study|Lost to Follow-up|9|||
160819661|NCT00711113|580724862|FG000|Overall Study|Implant lost|2|||
160819662|NCT02456636|580724863|FG000|Overall Study|Death|0|||
160819663|NCT02456636|580724864|FG001|Overall Study|Death|3|||
160819664|NCT02456636|580724865|FG002|Overall Study|Death|0|||
160819665|NCT02456636|580724863|FG000|Overall Study|Pregnancy|1|||
160819666|NCT02456636|580724864|FG001|Overall Study|Pregnancy|3|||
160819667|NCT02456636|580724865|FG002|Overall Study|Pregnancy|5|||
160819668|NCT02456636|580724863|FG000|Overall Study|Physician Decision|4|||
160819669|NCT02456636|580724864|FG001|Overall Study|Physician Decision|5|||
160819670|NCT02456636|580724865|FG002|Overall Study|Physician Decision|4|||
160819671|NCT02456636|580724863|FG000|Overall Study|Withdrawal by Subject|13|||
160819672|NCT02456636|580724864|FG001|Overall Study|Withdrawal by Subject|14|||
160819673|NCT02456636|580724865|FG002|Overall Study|Withdrawal by Subject|16|||
160819674|NCT02456636|580724863|FG000|Overall Study|Lost to Follow-up|50|||
160819675|NCT02456636|580724864|FG001|Overall Study|Lost to Follow-up|44|||
160819676|NCT02456636|580724865|FG002|Overall Study|Lost to Follow-up|50|||
160819677|NCT02688088|580724868|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
160819678|NCT02688088|580724869|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
160819679|NCT02688088|580724870|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
160819680|NCT02688088|580724871|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
160819681|NCT02688088|580724872|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
160819682|NCT02688088|580724868|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
160819683|NCT02688088|580724869|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
160819684|NCT02688088|580724870|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
160819685|NCT02688088|580724871|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
160819686|NCT02688088|580724872|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
160819687|NCT02688088|580724868|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
160819688|NCT02688088|580724869|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
160819689|NCT02688088|580724870|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
160819690|NCT02688088|580724871|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
160819691|NCT02688088|580724872|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
160819692|NCT02688088|580724868|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
160819693|NCT02688088|580724869|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
160819694|NCT02688088|580724870|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
160819695|NCT02688088|580724871|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
160819696|NCT02688088|580724872|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
160819697|NCT02688088|580724868|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
160819698|NCT02688088|580724869|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
160819699|NCT02688088|580724870|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
160819700|NCT02688088|580724871|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
160819701|NCT02688088|580724872|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
160819702|NCT02688088|580724868|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
160819703|NCT02688088|580724869|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
160819704|NCT02688088|580724870|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
160819705|NCT02688088|580724871|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
160987717|NCT02949271|581343155|FG000|Overall Study|Lost to Follow-up|3|||
160987718|NCT02949271|581343156|FG001|Overall Study|Lost to Follow-up|6|||
160900538|NCT00397215|581030152|FG001|Month 6 (Day 180)|Adverse Event|3|||
160900539|NCT00397215|581030153|FG002|Month 6 (Day 180)|Adverse Event|2|||
160900540|NCT00397215|581030154|FG003|Month 6 (Day 180)|Adverse Event|0|||
160900541|NCT00397215|581030151|FG000|Month 6 (Day 180)|Other|2|||
160900542|NCT00397215|581030152|FG001|Month 6 (Day 180)|Other|0|||
160900543|NCT00397215|581030153|FG002|Month 6 (Day 180)|Other|3|||
160900544|NCT00397215|581030154|FG003|Month 6 (Day 180)|Other|0|||
160900545|NCT00423514|581030155|FG000|Overall Study|Ineligible|1|||
160900546|NCT00423514|581030156|FG001|Overall Study|Ineligible|0|||
160900547|NCT02128932|581030157|FG000|Overall Study|Withdrawal by Subject|11|||
160900548|NCT02128932|581030158|FG001|Overall Study|Withdrawal by Subject|7|||
160900549|NCT02128932|581030159|FG002|Overall Study|Withdrawal by Subject|8|||
160900550|NCT02128932|581030157|FG000|Overall Study|Death|2|||
160819706|NCT02688088|580724872|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
160819707|NCT02688088|580724868|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
160819708|NCT02688088|580724869|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
160819709|NCT02688088|580724870|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
160900551|NCT02128932|581030158|FG001|Overall Study|Death|0|||
160900552|NCT02128932|581030159|FG002|Overall Study|Death|2|||
160900553|NCT02128932|581030157|FG000|Overall Study|Lost to Follow-up|2|||
160900554|NCT02128932|581030158|FG001|Overall Study|Lost to Follow-up|1|||
160900555|NCT02128932|581030159|FG002|Overall Study|Lost to Follow-up|1|||
160987719|NCT02949271|581343155|FG000|Overall Study|Physician Decision|5|||
160646070|NCT01102777|580085969|FG000|Overall Study|Death|2|||
160646071|NCT01102777|580085970|FG001|Overall Study|Death|6|||
160646072|NCT01102777|580085969|FG000|Overall Study|Lost to Follow-up|7|||
160646073|NCT01102777|580085970|FG001|Overall Study|Lost to Follow-up|10|||
160646074|NCT00706706|580085971|FG000|Overall Study|Death|53|||
160646075|NCT00706706|580085971|FG000|Overall Study|Lost to Follow-up|7|||
160646076|NCT00706706|580085971|FG000|Overall Study|Study endpoint had reached|45|||
160646077|NCT00593333|580085976|FG000|Overall Study|Lost to Follow-up|10|||
160646078|NCT00593333|580085977|FG001|Overall Study|Lost to Follow-up|11|||
160646079|NCT02175966|580085978|FG000|Follow-up Period|Lack of Efficacy|10|||
160646080|NCT02175966|580085979|FG001|Follow-up Period|Lack of Efficacy|6|||
160646081|NCT00210626|580085980|FG000|Overall Study|Adverse Event|1|||
160646082|NCT00210626|580085981|FG001|Overall Study|Adverse Event|2|||
160646083|NCT00210626|580085980|FG000|Overall Study|Protocol Violation|1|||
160646084|NCT00210626|580085981|FG001|Overall Study|Protocol Violation|5|||
160646085|NCT00210626|580085980|FG000|Overall Study|Lost to Follow-up|11|||
160646086|NCT00210626|580085981|FG001|Overall Study|Lost to Follow-up|11|||
160646087|NCT00210626|580085980|FG000|Overall Study|Death|1|||
160646088|NCT00210626|580085981|FG001|Overall Study|Death|0|||
160646089|NCT00210626|580085980|FG000|Overall Study|Withdrawal by Subject|29|||
160646090|NCT00210626|580085981|FG001|Overall Study|Withdrawal by Subject|20|||
160646091|NCT00210626|580085980|FG000|Overall Study|Physician Decision|0|||
160646092|NCT00210626|580085981|FG001|Overall Study|Physician Decision|2|||
160646093|NCT00210626|580085980|FG000|Overall Study|Sponser Request|1|||
160646094|NCT00210626|580085981|FG001|Overall Study|Sponser Request|0|||
160646095|NCT00210626|580085980|FG000|Overall Study|Other|4|||
160987720|NCT02949271|581343156|FG001|Overall Study|Physician Decision|5|||
160987721|NCT02949271|581343155|FG000|Overall Study|Protocol Violation|6|||
160987722|NCT02949271|581343156|FG001|Overall Study|Protocol Violation|3|||
160987723|NCT02949271|581343155|FG000|Overall Study|Withdrawal by Subject|1|||
160987724|NCT02949271|581343156|FG001|Overall Study|Withdrawal by Subject|0|||
160987725|NCT02949271|581343155|FG000|Overall Study|Delivered prior to intervention|7|||
160987726|NCT02949271|581343156|FG001|Overall Study|Delivered prior to intervention|9|||
160987727|NCT02949271|581343155|FG000|Overall Study|Outside the window for cervical dilation|2|||
160987728|NCT02949271|581343156|FG001|Overall Study|Outside the window for cervical dilation|3|||
160987729|NCT05458102|581343157|FG000|Overall Study|Withdrew consent|2|||
160987730|NCT05458102|581343158|FG001|Overall Study|Withdrew consent|0|||
160987731|NCT05458102|581343157|FG000|Overall Study|Adverse Event|1|||
160987732|NCT05458102|581343158|FG001|Overall Study|Adverse Event|0|||
160987733|NCT05458102|581343157|FG000|Overall Study|Enrolled but never treated|1|||
160987734|NCT05458102|581343158|FG001|Overall Study|Enrolled but never treated|0|||
160987735|NCT05458102|581343157|FG000|Overall Study|Protocol Violation|1|||
160987736|NCT05458102|581343158|FG001|Overall Study|Protocol Violation|0|||
160987737|NCT02373813|581343164|FG000|Run-In Period|Other, Not Specified|5|||
160987738|NCT02373813|581343165|FG001|Run-In Period|Other, Not Specified|0|||
160987739|NCT02373813|581343166|FG002|Run-In Period|Other, Not Specified|0|||
160987740|NCT02373813|581343167|FG003|Run-In Period|Other, Not Specified|0|||
160646096|NCT00210626|580085981|FG001|Overall Study|Other|5|||
160646097|NCT03469271|580085982|FG000|Overall Study|Withdrawal by Subject|2|||
160987741|NCT02373813|581343164|FG000|Run-In Period|Withdrawal by Subject|16|||
160987742|NCT02373813|581343165|FG001|Run-In Period|Withdrawal by Subject|0|||
160987743|NCT02373813|581343166|FG002|Run-In Period|Withdrawal by Subject|0|||
160646098|NCT03469271|580085983|FG001|Overall Study|Withdrawal by Subject|0|||
160987744|NCT02373813|581343167|FG003|Run-In Period|Withdrawal by Subject|0|||
160987745|NCT02373813|581343164|FG000|Run-In Period|Decision by Sponsor|11|||
160900556|NCT02128932|581030157|FG000|Overall Study|No reason for withdrawal|12|||
160900557|NCT02128932|581030158|FG001|Overall Study|No reason for withdrawal|11|||
160900558|NCT02128932|581030159|FG002|Overall Study|No reason for withdrawal|7|||
160900559|NCT03685123|581030164|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
160900560|NCT03685123|581030165|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
160900561|NCT03685123|581030166|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
160987746|NCT02373813|581343165|FG001|Run-In Period|Decision by Sponsor|0|||
160987747|NCT02373813|581343166|FG002|Run-In Period|Decision by Sponsor|0|||
160987748|NCT02373813|581343167|FG003|Run-In Period|Decision by Sponsor|0|||
160646099|NCT03469271|580085984|FG002|Overall Study|Withdrawal by Subject|0|||
160646100|NCT03469271|580085985|FG003|Overall Study|Withdrawal by Subject|1|||
160646101|NCT01328054|580085986|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
160646102|NCT01328054|580085987|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
160646103|NCT01328054|580085986|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
160646104|NCT01328054|580085987|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
160646105|NCT01328054|580085986|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
160646106|NCT01328054|580085987|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
160646107|NCT02123459|580085988|FG000|Washout Period (1 Day)|Adverse Event|1|||
160646108|NCT02123459|580085989|FG001|Washout Period (1 Day)|Adverse Event|0|||
160987749|NCT02373813|581343164|FG000|Run-In Period|Protocol Violation|75|||
160987750|NCT02373813|581343165|FG001|Run-In Period|Protocol Violation|0|||
160987751|NCT02373813|581343166|FG002|Run-In Period|Protocol Violation|0|||
160987752|NCT02373813|581343167|FG003|Run-In Period|Protocol Violation|0|||
160987753|NCT02373813|581343164|FG000|Run-In Period|Lost to Follow-up|2|||
160987754|NCT02373813|581343165|FG001|Run-In Period|Lost to Follow-up|0|||
160987755|NCT02373813|581343166|FG002|Run-In Period|Lost to Follow-up|0|||
160987756|NCT02373813|581343167|FG003|Run-In Period|Lost to Follow-up|0|||
160987757|NCT02373813|581343164|FG000|Run-In Period|Adverse Event|3|||
160987758|NCT02373813|581343165|FG001|Run-In Period|Adverse Event|0|||
160987759|NCT02373813|581343166|FG002|Run-In Period|Adverse Event|0|||
160987760|NCT02373813|581343167|FG003|Run-In Period|Adverse Event|0|||
160987761|NCT02373813|581343164|FG000|Run-In Period|Noncompliance|1|||
160987762|NCT02373813|581343165|FG001|Run-In Period|Noncompliance|0|||
160646109|NCT02196506|580085990|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
160900562|NCT03685123|581030164|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
160900563|NCT03685123|581030165|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
160900564|NCT03685123|581030166|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
160900565|NCT03685123|581030164|FG000|Weight Loss Phase|Lost to Follow-up|1|||
160900566|NCT03685123|581030165|FG001|Weight Loss Phase|Lost to Follow-up|0|||
160900567|NCT03685123|581030166|FG002|Weight Loss Phase|Lost to Follow-up|0|||
160900568|NCT03685123|581030164|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
160900569|NCT03685123|581030165|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
160900570|NCT03685123|581030166|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
160900571|NCT03685123|581030164|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
160900572|NCT03685123|581030165|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
160900573|NCT03685123|581030166|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
160987763|NCT02373813|581343166|FG002|Run-In Period|Noncompliance|0|||
160987764|NCT02373813|581343167|FG003|Run-In Period|Noncompliance|0|||
160987765|NCT02373813|581343164|FG000|Run-In Period|Ineligibility Determined|3|||
160987766|NCT02373813|581343165|FG001|Run-In Period|Ineligibility Determined|0|||
160987767|NCT02373813|581343166|FG002|Run-In Period|Ineligibility Determined|0|||
160552886|NCT01114529|579749871|FG000|Completed Study Phase at Month 24|Death|8|||
160819710|NCT02688088|580724871|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
160819711|NCT02688088|580724872|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
160819712|NCT02688088|580724868|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
160819713|NCT02688088|580724869|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
160819714|NCT02688088|580724870|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
160819715|NCT02688088|580724871|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
160819716|NCT02688088|580724872|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
160819717|NCT02688088|580724868|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
160819718|NCT02688088|580724869|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
160819719|NCT02688088|580724870|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
160819720|NCT02688088|580724871|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
160819721|NCT02688088|580724872|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
160819722|NCT03812185|580724874|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
160819723|NCT00313313|580724877|FG000|Overall Study|Lack of Efficacy|14|||
160819724|NCT00313313|580724878|FG001|Overall Study|Lack of Efficacy|9|||
160819725|NCT00313313|580724879|FG002|Overall Study|Lack of Efficacy|20|||
160819726|NCT00313313|580724877|FG000|Overall Study|Withdrawal of consent by subject|18|||
160819727|NCT00313313|580724878|FG001|Overall Study|Withdrawal of consent by subject|17|||
160819728|NCT00313313|580724879|FG002|Overall Study|Withdrawal of consent by subject|31|||
160819729|NCT00313313|580724877|FG000|Overall Study|Lost to Follow-up|10|||
160819730|NCT00313313|580724878|FG001|Overall Study|Lost to Follow-up|7|||
160819731|NCT00313313|580724879|FG002|Overall Study|Lost to Follow-up|9|||
160819732|NCT00313313|580724877|FG000|Overall Study|Adverse Event|15|||
160819733|NCT00313313|580724878|FG001|Overall Study|Adverse Event|16|||
160819734|NCT00313313|580724879|FG002|Overall Study|Adverse Event|12|||
160819735|NCT00313313|580724877|FG000|Overall Study|Physician Decision|2|||
160819736|NCT00313313|580724878|FG001|Overall Study|Physician Decision|6|||
160819737|NCT00313313|580724879|FG002|Overall Study|Physician Decision|4|||
160819738|NCT00313313|580724877|FG000|Overall Study|Poor/Noncompliance|3|||
160819739|NCT00313313|580724878|FG001|Overall Study|Poor/Noncompliance|6|||
160819740|NCT00313313|580724879|FG002|Overall Study|Poor/Noncompliance|2|||
160819741|NCT00313313|580724877|FG000|Overall Study|Pregnancy|1|||
160819742|NCT00313313|580724878|FG001|Overall Study|Pregnancy|2|||
160819743|NCT00313313|580724879|FG002|Overall Study|Pregnancy|0|||
160819744|NCT00313313|580724877|FG000|Overall Study|Death|0|||
160819745|NCT00313313|580724878|FG001|Overall Study|Death|0|||
160819746|NCT00313313|580724879|FG002|Overall Study|Death|2|||
160819747|NCT00313313|580724877|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
160819748|NCT00313313|580724878|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
160819749|NCT00313313|580724879|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
160819750|NCT00090142|580724880|FG000|Treatment Period I|Lost to Follow-up|1|||
160819751|NCT00090142|580724881|FG001|Treatment Period I|Lost to Follow-up|2|||
160819752|NCT00090142|580724880|FG000|Treatment Period I|Protocol Violation|2|||
160819753|NCT00090142|580724881|FG001|Treatment Period I|Protocol Violation|0|||
160819754|NCT00090142|580724880|FG000|Treatment Period I|Withdrawal by Subject|2|||
160819755|NCT00090142|580724881|FG001|Treatment Period I|Withdrawal by Subject|0|||
160819756|NCT00090142|580724880|FG000|Treatment Period I|Other|0|||
160819757|NCT00090142|580724881|FG001|Treatment Period I|Other|1|||
160819758|NCT00090142|580724880|FG000|Treatment Period II|Other|1|||
160819759|NCT00090142|580724881|FG001|Treatment Period II|Other|0|||
160819760|NCT00006046|580724887|FG000|Overall Study|Adverse Event|3|||
160819761|NCT00006046|580724888|FG001|Overall Study|Adverse Event|0|||
160819762|NCT00006046|580724889|FG002|Overall Study|Adverse Event|0|||
160819763|NCT00006046|580724890|FG003|Overall Study|Adverse Event|0|||
160552887|NCT01114529|579749872|FG001|Completed Study Phase at Month 24|Death|5|||
160819764|NCT00006046|580724891|FG004|Overall Study|Adverse Event|0|||
160819765|NCT00006046|580724887|FG000|Overall Study|Disease Progression|2|||
160819766|NCT00006046|580724888|FG001|Overall Study|Disease Progression|0|||
160819767|NCT00006046|580724889|FG002|Overall Study|Disease Progression|0|||
160819768|NCT00006046|580724890|FG003|Overall Study|Disease Progression|0|||
160819769|NCT00006046|580724891|FG004|Overall Study|Disease Progression|0|||
160819770|NCT04295681|580724908|FG000|Overall Study|Eligibility error|1|||
160987768|NCT02373813|581343167|FG003|Run-In Period|Ineligibility Determined|0|||
160987769|NCT02373813|581343164|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
160987770|NCT02373813|581343165|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
160819771|NCT04295681|580724909|FG001|Overall Study|Eligibility error|3|||
160819772|NCT02210689|580724916|FG000|Overall Study|Withdrawal by Subject|7|||
160819773|NCT02210689|580724917|FG001|Overall Study|Withdrawal by Subject|4|||
160819774|NCT02210689|580724918|FG002|Overall Study|Withdrawal by Subject|2|||
160819775|NCT02210689|580724916|FG000|Overall Study|Adverse Event|0|||
160819776|NCT02210689|580724917|FG001|Overall Study|Adverse Event|1|||
160819777|NCT02210689|580724918|FG002|Overall Study|Adverse Event|0|||
160819778|NCT02210689|580724916|FG000|Overall Study|Protocol Violation|1|||
160819779|NCT02210689|580724917|FG001|Overall Study|Protocol Violation|0|||
160819780|NCT02210689|580724918|FG002|Overall Study|Protocol Violation|0|||
160819781|NCT02210689|580724916|FG000|Overall Study|Lost to Follow-up|11|||
160819782|NCT02210689|580724917|FG001|Overall Study|Lost to Follow-up|9|||
160819783|NCT02210689|580724918|FG002|Overall Study|Lost to Follow-up|5|||
160819784|NCT02210689|580724916|FG000|Overall Study|Pregnancy|0|||
160819785|NCT02210689|580724917|FG001|Overall Study|Pregnancy|1|||
160819786|NCT02210689|580724918|FG002|Overall Study|Pregnancy|0|||
160819787|NCT02210689|580724916|FG000|Overall Study|Lack of Efficacy|0|||
160819788|NCT02210689|580724917|FG001|Overall Study|Lack of Efficacy|1|||
160819789|NCT02210689|580724918|FG002|Overall Study|Lack of Efficacy|5|||
160819790|NCT02210689|580724916|FG000|Overall Study|Prohibited medication|2|||
160819791|NCT02210689|580724917|FG001|Overall Study|Prohibited medication|8|||
160819792|NCT02210689|580724918|FG002|Overall Study|Prohibited medication|1|||
160819793|NCT02210689|580724916|FG000|Overall Study|Negative Nugent score at baseline|6|||
160819794|NCT02210689|580724917|FG001|Overall Study|Negative Nugent score at baseline|2|||
160819795|NCT02210689|580724918|FG002|Overall Study|Negative Nugent score at baseline|2|||
160819796|NCT02210689|580724916|FG000|Overall Study|Other|25|||
160819797|NCT02210689|580724917|FG001|Overall Study|Other|21|||
160819798|NCT02210689|580724918|FG002|Overall Study|Other|8|||
160819799|NCT00866047|580724919|FG000|Treatment Period|Progressive disease|13|||
160819800|NCT00866047|580724919|FG000|Treatment Period|Adverse Event|16|||
160819801|NCT00866047|580724919|FG000|Treatment Period|Physician Decision|14|||
160819802|NCT00866047|580724919|FG000|Treatment Period|Withdrawal by Subject|5|||
160819803|NCT00866047|580724919|FG000|Follow-up Period|Lost to Follow-up|5|||
160819804|NCT02928029|580724920|FG000|Overall Study|Withdrawal by Subject|0|||
160819805|NCT02928029|580724921|FG001|Overall Study|Withdrawal by Subject|1|||
160819806|NCT02928029|580724920|FG000|Overall Study|Radiological progression|1|||
160819807|NCT02928029|580724921|FG001|Overall Study|Radiological progression|0|||
160819808|NCT02928029|580724920|FG000|Overall Study|Clinical progression|1|||
160819809|NCT02928029|580724921|FG001|Overall Study|Clinical progression|2|||
160819810|NCT02928029|580724920|FG000|Overall Study|AE not related to clinical progression|1|||
160819811|NCT02928029|580724921|FG001|Overall Study|AE not related to clinical progression|1|||
160819812|NCT05427539|580724922|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
160819813|NCT05427539|580724923|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
160819814|NCT05427539|580724922|FG000|Period 1|Withdrawal by Subject|1|||
160819815|NCT05427539|580724923|FG001|Period 1|Withdrawal by Subject|0|||
160819816|NCT02099344|580724924|FG000|Overall Study|Physician Decision|1|||
160819817|NCT02099344|580724925|FG001|Overall Study|Physician Decision|0|||
160819818|NCT00404755|580724928|FG000|Phase I (Bupropion)|Adverse Event|3|||
160819819|NCT00404755|580724928|FG000|Phase I (Bupropion)|Other|1|||
160819820|NCT00404755|580724928|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
160819821|NCT01453205|580724931|FG000|Overall Study|Lost to Follow-up|3|||
160819822|NCT01453205|580724932|FG001|Overall Study|Lost to Follow-up|0|||
160819823|NCT01453205|580724933|FG002|Overall Study|Lost to Follow-up|1|||
160819824|NCT01453205|580724931|FG000|Overall Study|Withdrawal by Subject|8|||
160819825|NCT01453205|580724932|FG001|Overall Study|Withdrawal by Subject|3|||
160819826|NCT01453205|580724933|FG002|Overall Study|Withdrawal by Subject|0|||
160819827|NCT01453205|580724931|FG000|Overall Study|Death|24|||
160819828|NCT01453205|580724932|FG001|Overall Study|Death|22|||
160819829|NCT01453205|580724933|FG002|Overall Study|Death|18|||
160819830|NCT01453205|580724931|FG000|Overall Study|Other|45|||
160819831|NCT01453205|580724932|FG001|Overall Study|Other|27|||
160819832|NCT01453205|580724933|FG002|Overall Study|Other|35|||
160819833|NCT05593913|580724936|FG000|Overall Study|Insufficient image quality|39|||
160819834|NCT04376684|580724937|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
160819835|NCT04376684|580724938|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
160819836|NCT04376684|580724939|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
160819837|NCT04376684|580724940|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
160819838|NCT04376684|580724937|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
160819839|NCT04376684|580724938|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
160819840|NCT04376684|580724939|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
160819841|NCT04376684|580724940|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
160819842|NCT04376684|580724937|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
160819843|NCT04376684|580724938|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
160819844|NCT04376684|580724939|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
160819845|NCT04376684|580724940|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
160819846|NCT04376684|580724937|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
160819847|NCT04376684|580724938|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
160819848|NCT04376684|580724939|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
160819849|NCT04376684|580724940|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
160819850|NCT04376684|580724937|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
160819851|NCT04376684|580724938|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
160819852|NCT04376684|580724939|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
160819853|NCT04376684|580724940|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
160819854|NCT04376684|580724937|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
160819855|NCT04376684|580724938|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
160819856|NCT04376684|580724939|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
160819857|NCT04376684|580724940|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
160819858|NCT04376684|580724937|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
160819859|NCT04376684|580724938|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
160819860|NCT04376684|580724939|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
160819861|NCT04376684|580724940|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
160819862|NCT01666119|580724941|FG000|Overall Study|Adverse Event|6|||
160819863|NCT01666119|580724941|FG000|Overall Study|Withdrawal by Subject|16|||
160819864|NCT01666119|580724941|FG000|Overall Study|Lost to Follow-up|7|||
160819865|NCT01666119|580724941|FG000|Overall Study|non compliance with study medication, pa|18|||
160819866|NCT01666119|580724941|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
160819867|NCT00516906|580724952|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
160819868|NCT00516906|580724953|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
160819869|NCT01974206|580724954|FG000|Overall Study|Did Not Take Study Drug|0|||
160819870|NCT01974206|580724955|FG001|Overall Study|Did Not Take Study Drug|1|||
160819871|NCT01974206|580724954|FG000|Overall Study|Physician Decision|1|||
160819872|NCT01974206|580724955|FG001|Overall Study|Physician Decision|0|||
160819873|NCT01974206|580724954|FG000|Overall Study|Withdrawal by Subject|3|||
160819874|NCT01974206|580724955|FG001|Overall Study|Withdrawal by Subject|0|||
160819875|NCT01974206|580724954|FG000|Overall Study|Lost to Follow-up|1|||
160819876|NCT01974206|580724955|FG001|Overall Study|Lost to Follow-up|0|||
160819877|NCT01974206|580724954|FG000|Overall Study|Death|1|||
160819878|NCT01974206|580724955|FG001|Overall Study|Death|0|||
160819879|NCT03802630|580724956|FG000|Overall Study|Study terminated by sponsor|130|||
160819880|NCT03802630|580724957|FG001|Overall Study|Study terminated by sponsor|134|||
160819881|NCT03802630|580724956|FG000|Overall Study|Subject decision|16|||
160819882|NCT03802630|580724957|FG001|Overall Study|Subject decision|9|||
160819883|NCT03802630|580724956|FG000|Overall Study|Adverse Event|3|||
160819884|NCT03802630|580724957|FG001|Overall Study|Adverse Event|1|||
160819885|NCT03802630|580724956|FG000|Overall Study|Lost to Follow-up|2|||
160819886|NCT03802630|580724957|FG001|Overall Study|Lost to Follow-up|2|||
160819887|NCT03802630|580724956|FG000|Overall Study|Physician Decision|2|||
160819888|NCT03802630|580724957|FG001|Overall Study|Physician Decision|0|||
160819889|NCT03802630|580724956|FG000|Overall Study|Death|0|||
160819890|NCT03802630|580724957|FG001|Overall Study|Death|2|||
160819891|NCT02684058|580724962|FG000|Treatment Period|Progressive disease|4|||
160819892|NCT02684058|580724963|FG001|Treatment Period|Progressive disease|10|||
160819893|NCT02684058|580724964|FG002|Treatment Period|Progressive disease|19|||
160819894|NCT02684058|580724962|FG000|Treatment Period|Adverse Event|3|||
160819895|NCT02684058|580724963|FG001|Treatment Period|Adverse Event|8|||
160819896|NCT02684058|580724964|FG002|Treatment Period|Adverse Event|1|||
160819897|NCT02684058|580724962|FG000|Treatment Period|Physician Decision|5|||
160819898|NCT02684058|580724963|FG001|Treatment Period|Physician Decision|1|||
160819899|NCT02684058|580724964|FG002|Treatment Period|Physician Decision|2|||
160987771|NCT02373813|581343166|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
160646110|NCT02196506|580085991|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
160646111|NCT02196506|580085992|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
160646112|NCT02196506|580085993|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
160646113|NCT02196506|580085990|FG000|Phase A|Withdrawal by Subject|34|||
160646114|NCT02196506|580085991|FG001|Phase A|Withdrawal by Subject|0|||
160646115|NCT02196506|580085992|FG002|Phase A|Withdrawal by Subject|0|||
160646116|NCT02196506|580085993|FG003|Phase A|Withdrawal by Subject|0|||
160646117|NCT02196506|580085990|FG000|Phase A|Adverse Event|22|||
160646118|NCT02196506|580085991|FG001|Phase A|Adverse Event|0|||
160646119|NCT02196506|580085992|FG002|Phase A|Adverse Event|0|||
160646120|NCT02196506|580085993|FG003|Phase A|Adverse Event|0|||
160646121|NCT02196506|580085990|FG000|Phase A|Lost to Follow-up|9|||
160646122|NCT02196506|580085991|FG001|Phase A|Lost to Follow-up|0|||
160646123|NCT02196506|580085992|FG002|Phase A|Lost to Follow-up|0|||
160819900|NCT02684058|580724962|FG000|Treatment Period|New therapy for study indication|1|||
160819901|NCT02684058|580724963|FG001|Treatment Period|New therapy for study indication|0|||
160819902|NCT02684058|580724964|FG002|Treatment Period|New therapy for study indication|0|||
160819903|NCT02684058|580724962|FG000|Treatment Period|Protocol deviation|0|||
160819904|NCT02684058|580724963|FG001|Treatment Period|Protocol deviation|1|||
160819905|NCT02684058|580724964|FG002|Treatment Period|Protocol deviation|0|||
160819906|NCT02684058|580724962|FG000|Treatment Period|Subject/guardian decision|4|||
160819907|NCT02684058|580724963|FG001|Treatment Period|Subject/guardian decision|3|||
160819908|NCT02684058|580724964|FG002|Treatment Period|Subject/guardian decision|0|||
160819909|NCT02684058|580724962|FG000|Treatment Period|Death|0|||
160819910|NCT02684058|580724963|FG001|Treatment Period|Death|0|||
160819911|NCT02684058|580724964|FG002|Treatment Period|Death|2|||
160819912|NCT02684058|580724962|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160819913|NCT02684058|580724963|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
160819914|NCT02684058|580724964|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
160819915|NCT02684058|580724962|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
160819916|NCT02684058|580724963|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
160819917|NCT02684058|580724964|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
160900574|NCT03685123|581030164|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
160900575|NCT03685123|581030165|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
160900576|NCT03685123|581030166|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
160646124|NCT02196506|580085993|FG003|Phase A|Lost to Follow-up|0|||
160819918|NCT02684058|580724962|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
160900577|NCT02959983|581030167|FG000|Overall Study|Protocol Violation|0|||
160900578|NCT02959983|581030168|FG001|Overall Study|Protocol Violation|1|||
160900579|NCT02959983|581030167|FG000|Overall Study|Lack of Efficacy|0|||
160900580|NCT02959983|581030168|FG001|Overall Study|Lack of Efficacy|1|||
160900581|NCT02959983|581030167|FG000|Overall Study|Lost to Follow-up|12|||
160900582|NCT02959983|581030168|FG001|Overall Study|Lost to Follow-up|9|||
160900583|NCT02959983|581030167|FG000|Overall Study|Other|1|||
160900584|NCT02959983|581030168|FG001|Overall Study|Other|1|||
160900585|NCT02959983|581030167|FG000|Overall Study|Physician Decision|1|||
160900586|NCT02959983|581030168|FG001|Overall Study|Physician Decision|0|||
160900587|NCT02959983|581030167|FG000|Overall Study|Adverse Event|5|||
160900588|NCT02959983|581030168|FG001|Overall Study|Adverse Event|1|||
160900589|NCT02959983|581030167|FG000|Overall Study|Withdrawal by Subject|7|||
160900590|NCT02959983|581030168|FG001|Overall Study|Withdrawal by Subject|12|||
160900591|NCT01254630|581030169|FG000|Overall Study|Adverse Event|36|||
160900592|NCT01254630|581030170|FG001|Overall Study|Adverse Event|15|||
160900593|NCT01254630|581030171|FG002|Overall Study|Adverse Event|40|||
160900594|NCT01254630|581030172|FG003|Overall Study|Adverse Event|8|||
160900595|NCT01254630|581030169|FG000|Overall Study|Death|461|||
160900596|NCT01254630|581030170|FG001|Overall Study|Death|151|||
160900597|NCT01254630|581030171|FG002|Overall Study|Death|478|||
160900598|NCT01254630|581030172|FG003|Overall Study|Death|139|||
160900599|NCT01254630|581030169|FG000|Overall Study|Lost to Follow-up|80|||
160900600|NCT01254630|581030170|FG001|Overall Study|Lost to Follow-up|26|||
160900601|NCT01254630|581030171|FG002|Overall Study|Lost to Follow-up|89|||
160900602|NCT01254630|581030172|FG003|Overall Study|Lost to Follow-up|32|||
160900603|NCT01254630|581030169|FG000|Overall Study|Physician Decision|24|||
160900604|NCT01254630|581030170|FG001|Overall Study|Physician Decision|8|||
160900605|NCT01254630|581030171|FG002|Overall Study|Physician Decision|16|||
160900606|NCT01254630|581030172|FG003|Overall Study|Physician Decision|7|||
160900607|NCT01254630|581030169|FG000|Overall Study|Withdrawal by Subject|201|||
160900608|NCT01254630|581030170|FG001|Overall Study|Withdrawal by Subject|94|||
160900609|NCT01254630|581030171|FG002|Overall Study|Withdrawal by Subject|188|||
160900610|NCT01254630|581030172|FG003|Overall Study|Withdrawal by Subject|89|||
160900611|NCT01254630|581030169|FG000|Overall Study|Study terminated by sponsor|0|||
160900612|NCT01254630|581030170|FG001|Overall Study|Study terminated by sponsor|994|||
160900613|NCT01254630|581030171|FG002|Overall Study|Study terminated by sponsor|0|||
160900614|NCT01254630|581030172|FG003|Overall Study|Study terminated by sponsor|1010|||
160900615|NCT01254630|581030169|FG000|Overall Study|Status not recorded|0|||
160900616|NCT01254630|581030170|FG001|Overall Study|Status not recorded|0|||
160900617|NCT01254630|581030171|FG002|Overall Study|Status not recorded|1|||
160900618|NCT01254630|581030172|FG003|Overall Study|Status not recorded|0|||
160900619|NCT02925117|581030178|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
160900620|NCT02925117|581030179|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
160900621|NCT02925117|581030180|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
160900622|NCT02925117|581030181|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
160900623|NCT02925117|581030182|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900624|NCT02925117|581030183|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900625|NCT02925117|581030184|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900626|NCT02925117|581030185|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900627|NCT02925117|581030186|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900628|NCT02925117|581030187|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900629|NCT02925117|581030188|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900630|NCT02925117|581030189|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900631|NCT02925117|581030178|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
160900632|NCT02925117|581030179|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
160900633|NCT02925117|581030180|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
160900634|NCT02925117|581030181|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900635|NCT02925117|581030182|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900636|NCT02925117|581030183|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160646125|NCT02196506|580085990|FG000|Phase A|Protocol deviation|12|||
160819919|NCT02684058|580724963|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
160819920|NCT02684058|580724964|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
160819921|NCT02684058|580724962|FG000|Post-treatment Efficacy Follow-up|Death|0|||
160819922|NCT02684058|580724963|FG001|Post-treatment Efficacy Follow-up|Death|0|||
160819923|NCT02684058|580724964|FG002|Post-treatment Efficacy Follow-up|Death|3|||
160819924|NCT02684058|580724962|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
160819925|NCT02684058|580724963|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
160819926|NCT02684058|580724964|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
160819927|NCT02684058|580724962|FG000|Post-treatment Survival Follow-up|Death|0|||
160819928|NCT02684058|580724963|FG001|Post-treatment Survival Follow-up|Death|0|||
160819929|NCT02684058|580724964|FG002|Post-treatment Survival Follow-up|Death|7|||
160819930|NCT02684058|580724962|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
160819931|NCT02684058|580724963|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
160819932|NCT02684058|580724964|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
160819933|NCT02684058|580724962|FG000|Crossover Treatment Period|Progressive disease|0|||
160819934|NCT02684058|580724963|FG001|Crossover Treatment Period|Progressive disease|1|||
160819935|NCT02684058|580724964|FG002|Crossover Treatment Period|Progressive disease|0|||
160819936|NCT01252186|580724965|FG000|Overall Study|Adverse Event|9|||
160819937|NCT01252186|580724966|FG001|Overall Study|Adverse Event|6|||
160819938|NCT01252186|580724967|FG002|Overall Study|Adverse Event|8|||
160819939|NCT01252186|580724965|FG000|Overall Study|Withdrawal by Subject|2|||
160819940|NCT01252186|580724966|FG001|Overall Study|Withdrawal by Subject|5|||
160819941|NCT01252186|580724967|FG002|Overall Study|Withdrawal by Subject|2|||
160819942|NCT01252186|580724965|FG000|Overall Study|Physician Decision|0|||
160819943|NCT01252186|580724966|FG001|Overall Study|Physician Decision|0|||
160819944|NCT01252186|580724967|FG002|Overall Study|Physician Decision|1|||
160819945|NCT01252186|580724965|FG000|Overall Study|Non-compliance|0|||
160819946|NCT01252186|580724966|FG001|Overall Study|Non-compliance|3|||
160819947|NCT01252186|580724967|FG002|Overall Study|Non-compliance|4|||
160819948|NCT01252186|580724965|FG000|Overall Study|Protocol Violation|0|||
160819949|NCT01252186|580724966|FG001|Overall Study|Protocol Violation|0|||
160819950|NCT01252186|580724967|FG002|Overall Study|Protocol Violation|1|||
160819951|NCT01252186|580724965|FG000|Overall Study|Pregnancy|2|||
160819952|NCT01252186|580724966|FG001|Overall Study|Pregnancy|2|||
160819953|NCT01252186|580724967|FG002|Overall Study|Pregnancy|0|||
160819954|NCT01252186|580724965|FG000|Overall Study|Sponsor Request|2|||
160819955|NCT01252186|580724966|FG001|Overall Study|Sponsor Request|1|||
160819956|NCT01252186|580724967|FG002|Overall Study|Sponsor Request|0|||
160819957|NCT01252186|580724965|FG000|Overall Study|Lost to Follow-up|10|||
160819958|NCT01252186|580724966|FG001|Overall Study|Lost to Follow-up|10|||
160819959|NCT01252186|580724967|FG002|Overall Study|Lost to Follow-up|11|||
160819960|NCT01252186|580724965|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
160819961|NCT01252186|580724966|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
160819962|NCT01252186|580724967|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
160819963|NCT00780143|580724968|FG000|Overall Study|Progressive disease|1|||
160819964|NCT00780143|580724968|FG000|Overall Study|Toxicity|1|||
160819965|NCT00780143|580724968|FG000|Overall Study|Adverse Event|1|||
160819966|NCT01457014|580724973|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
160819967|NCT01457014|580724974|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
160819968|NCT01457014|580724975|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
160819969|NCT01457014|580724976|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
160819970|NCT01457014|580724973|FG000|First Night|Withdrawal by Subject|3|||
160819971|NCT01457014|580724974|FG001|First Night|Withdrawal by Subject|0|||
160819972|NCT01457014|580724975|FG002|First Night|Withdrawal by Subject|0|||
160819973|NCT01457014|580724976|FG003|First Night|Withdrawal by Subject|0|||
160819974|NCT02461290|580724977|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
160819975|NCT02461290|580724977|FG000|Overall Study|Lost to Follow-up|3|||
160819976|NCT03319953|580724982|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
160900637|NCT02925117|581030184|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160819977|NCT03319953|580724983|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
160819978|NCT03319953|580724984|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
160819979|NCT03319953|580724985|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
160819980|NCT03319953|580724982|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
160819981|NCT03319953|580724983|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
160900638|NCT02925117|581030185|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160987772|NCT02373813|581343167|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
160987773|NCT02373813|581343164|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
160987774|NCT02373813|581343165|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
160987775|NCT02373813|581343166|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
160819982|NCT03319953|580724984|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
160819983|NCT03319953|580724985|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
160819984|NCT02438384|580724986|FG000|Overall Study|Lost to Follow-up|8|||
160819985|NCT02438384|580724987|FG001|Overall Study|Lost to Follow-up|6|||
160819986|NCT02438384|580724988|FG002|Overall Study|Lost to Follow-up|4|||
160819987|NCT04027049|580724992|FG000|Overall Study|Withdrawn by family|1|||
160819988|NCT04027049|580724993|FG001|Overall Study|Withdrawn by family|0|||
160819989|NCT04027049|580724992|FG000|Overall Study|Participant safety|1|||
160819990|NCT04027049|580724993|FG001|Overall Study|Participant safety|0|||
160987776|NCT02373813|581343167|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
160987777|NCT02373813|581343164|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160987778|NCT02373813|581343165|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
160987779|NCT02373813|581343166|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
160819991|NCT02650128|580724994|FG000|Overall Study|Death|2|||
160819992|NCT02264665|580726989|FG000|Overall Study|Other|0|||
160819993|NCT02264665|580726990|FG001|Overall Study|Other|0|||
160819994|NCT02264665|580726991|FG002|Overall Study|Other|3|||
160819995|NCT02264665|580726992|FG003|Overall Study|Other|0|||
160819996|NCT02264665|580726993|FG004|Overall Study|Other|0|||
160819997|NCT02264665|580726994|FG005|Overall Study|Other|0|||
160819998|NCT02264665|580726995|FG006|Overall Study|Other|0|||
160819999|NCT02264665|580726989|FG000|Overall Study|Death|9|||
160820000|NCT02264665|580726990|FG001|Overall Study|Death|8|||
160820001|NCT02264665|580726991|FG002|Overall Study|Death|13|||
160820002|NCT02264665|580726992|FG003|Overall Study|Death|5|||
160820003|NCT02264665|580726993|FG004|Overall Study|Death|0|||
160820004|NCT02264665|580726994|FG005|Overall Study|Death|0|||
160820005|NCT02264665|580726995|FG006|Overall Study|Death|1|||
160820006|NCT02264665|580726989|FG000|Overall Study|Lost to Follow-up|1|||
160820007|NCT02264665|580726990|FG001|Overall Study|Lost to Follow-up|0|||
160820008|NCT02264665|580726991|FG002|Overall Study|Lost to Follow-up|2|||
160820009|NCT02264665|580726992|FG003|Overall Study|Lost to Follow-up|1|||
160820010|NCT02264665|580726993|FG004|Overall Study|Lost to Follow-up|0|||
160820011|NCT02264665|580726994|FG005|Overall Study|Lost to Follow-up|0|||
160820012|NCT02264665|580726995|FG006|Overall Study|Lost to Follow-up|0|||
160820013|NCT02264665|580726989|FG000|Overall Study|Participant decision|0|||
160820014|NCT02264665|580726990|FG001|Overall Study|Participant decision|0|||
160820015|NCT02264665|580726991|FG002|Overall Study|Participant decision|0|||
160820016|NCT02264665|580726992|FG003|Overall Study|Participant decision|1|||
160820017|NCT02264665|580726993|FG004|Overall Study|Participant decision|0|||
160820018|NCT02264665|580726994|FG005|Overall Study|Participant decision|0|||
160820019|NCT02264665|580726995|FG006|Overall Study|Participant decision|0|||
160820020|NCT02264665|580726989|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
160820021|NCT02264665|580726990|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
160820022|NCT02264665|580726991|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
160820023|NCT02264665|580726992|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
160820024|NCT02264665|580726993|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
160820025|NCT02264665|580726994|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
160820026|NCT02264665|580726995|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
160820027|NCT02264665|580726989|FG000|Overall Study|Data Missing|0|||
160820028|NCT02264665|580726990|FG001|Overall Study|Data Missing|0|||
160820029|NCT02264665|580726991|FG002|Overall Study|Data Missing|1|||
160820030|NCT02264665|580726992|FG003|Overall Study|Data Missing|0|||
160820031|NCT02264665|580726993|FG004|Overall Study|Data Missing|0|||
160820032|NCT02264665|580726994|FG005|Overall Study|Data Missing|0|||
160820033|NCT02264665|580726995|FG006|Overall Study|Data Missing|0|||
160820034|NCT00789581|580726996|FG000|AC Therapy|Adverse Event|2|||
160820035|NCT00789581|580726997|FG001|AC Therapy|Adverse Event|3|||
160820036|NCT00789581|580726996|FG000|AC Therapy|Withdrawal by Subject|4|||
160820037|NCT00789581|580726997|FG001|AC Therapy|Withdrawal by Subject|7|||
160820038|NCT00789581|580726996|FG000|AC Therapy|Disease recurrence|3|||
160820039|NCT00789581|580726997|FG001|AC Therapy|Disease recurrence|1|||
160820040|NCT00789581|580726996|FG000|AC Therapy|Intercurrent Illness|1|||
160820041|NCT00789581|580726997|FG001|AC Therapy|Intercurrent Illness|0|||
160820042|NCT00789581|580726996|FG000|AC Therapy|Never Treated|1|||
160820043|NCT00789581|580726997|FG001|AC Therapy|Never Treated|4|||
160820044|NCT00789581|580726996|FG000|AC Therapy|Other|0|||
160820045|NCT00789581|580726997|FG001|AC Therapy|Other|2|||
160820046|NCT00789581|580726996|FG000|Adjuvant Therapy|Never treated|2|||
160820047|NCT00789581|580726997|FG001|Adjuvant Therapy|Never treated|2|||
160820048|NCT00789581|580726996|FG000|Adjuvant Therapy|Adverse Event|20|||
160820049|NCT00789581|580726997|FG001|Adjuvant Therapy|Adverse Event|44|||
160820050|NCT00789581|580726996|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
160820051|NCT00789581|580726997|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
160900639|NCT02925117|581030186|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900640|NCT02925117|581030187|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900641|NCT02925117|581030188|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900642|NCT02925117|581030189|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900643|NCT02925117|581030178|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
160987780|NCT02373813|581343167|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
160987781|NCT02373813|581343164|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160987782|NCT02373813|581343165|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
160987783|NCT02373813|581343166|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
160987784|NCT02373813|581343167|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
160987785|NCT01511536|581343168|FG000|Phase 1|Other|0|||
160987786|NCT01511536|581343169|FG001|Phase 1|Other|1|||
160987787|NCT01511536|581343170|FG002|Phase 1|Other|0|||
160987788|NCT01511536|581343168|FG000|Phase 2|Other|0|||
160987789|NCT01511536|581343169|FG001|Phase 2|Other|0|||
160987790|NCT01511536|581343170|FG002|Phase 2|Other|9|||
160987791|NCT01764386|581343174|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
160820052|NCT00789581|580726996|FG000|Adjuvant Therapy|Disease recurrence|2|||
160820053|NCT00789581|580726997|FG001|Adjuvant Therapy|Disease recurrence|1|||
160820054|NCT00789581|580726996|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
160820055|NCT00789581|580726997|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
160820056|NCT00789581|580726996|FG000|Adjuvant Therapy|Protocol Violation|1|||
160820057|NCT00789581|580726997|FG001|Adjuvant Therapy|Protocol Violation|1|||
160820058|NCT00789581|580726996|FG000|Adjuvant Therapy|Other|0|||
160820059|NCT00789581|580726997|FG001|Adjuvant Therapy|Other|1|||
160820060|NCT05312632|580726998|FG000|Overall Study|Adverse Event|12|||
160820061|NCT05312632|580726998|FG000|Overall Study|Withdrawal by Subject|10|||
160987792|NCT01764386|581343175|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
160987793|NCT01764386|581343174|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
160987794|NCT01764386|581343175|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
160987795|NCT01764386|581343174|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
160820062|NCT05312632|580726998|FG000|Overall Study|Lack of Efficacy|4|||
160820063|NCT05312632|580726998|FG000|Overall Study|Non-compliance with study procedures|9|||
160820064|NCT05312632|580726998|FG000|Overall Study|Other|4|||
160820065|NCT02379221|580726999|FG000|Overall Study|Lost to Follow-up|1|||
160820066|NCT00519376|580727000|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820067|NCT00519376|580727001|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820068|NCT00519376|580727002|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820069|NCT00519376|580727003|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820070|NCT00519376|580727004|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820071|NCT00519376|580727005|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820072|NCT00519376|580727006|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820073|NCT00519376|580727007|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820074|NCT00519376|580727008|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820075|NCT00519376|580727009|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820076|NCT00519376|580727010|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820077|NCT00519376|580727011|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820078|NCT00519376|580727012|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
160820079|NCT00519376|580727013|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820080|NCT00519376|580727014|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160987796|NCT01764386|581343175|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
160987797|NCT01764386|581343174|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
160987798|NCT01764386|581343175|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
160987799|NCT01764386|581343174|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
160987800|NCT01764386|581343175|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
160987801|NCT01764386|581343174|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
160987802|NCT01764386|581343175|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
160987803|NCT01764386|581343174|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
160987804|NCT01764386|581343175|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
160900644|NCT02925117|581030179|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
160900645|NCT02925117|581030180|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900646|NCT02925117|581030181|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900647|NCT02925117|581030182|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900648|NCT02925117|581030183|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900649|NCT02925117|581030184|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160820081|NCT00519376|580727015|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820082|NCT00519376|580727000|FG000|Treatment Period 4|Lost to Follow-up|0|||
160820083|NCT00519376|580727001|FG001|Treatment Period 4|Lost to Follow-up|0|||
160900650|NCT02925117|581030185|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900651|NCT02925117|581030186|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160820084|NCT00519376|580727002|FG002|Treatment Period 4|Lost to Follow-up|1|||
160820085|NCT00519376|580727003|FG003|Treatment Period 4|Lost to Follow-up|0|||
160820086|NCT00519376|580727004|FG004|Treatment Period 4|Lost to Follow-up|0|||
160820087|NCT00519376|580727005|FG005|Treatment Period 4|Lost to Follow-up|0|||
160820088|NCT00519376|580727006|FG006|Treatment Period 4|Lost to Follow-up|0|||
160820089|NCT00519376|580727007|FG007|Treatment Period 4|Lost to Follow-up|0|||
160820090|NCT00519376|580727008|FG008|Treatment Period 4|Lost to Follow-up|0|||
160820091|NCT00519376|580727009|FG009|Treatment Period 4|Lost to Follow-up|0|||
160820092|NCT00519376|580727010|FG010|Treatment Period 4|Lost to Follow-up|0|||
160820093|NCT00519376|580727011|FG011|Treatment Period 4|Lost to Follow-up|0|||
160820094|NCT00519376|580727012|FG012|Treatment Period 4|Lost to Follow-up|0|||
160820095|NCT00519376|580727013|FG013|Treatment Period 4|Lost to Follow-up|0|||
160820096|NCT00519376|580727014|FG014|Treatment Period 4|Lost to Follow-up|0|||
160820097|NCT00519376|580727015|FG015|Treatment Period 4|Lost to Follow-up|0|||
160820098|NCT00908115|580727023|FG000|Overall Study|Other|14|||
160820099|NCT01973387|580727031|FG000|Overall Study|Adverse Event|14|||
160820100|NCT01973387|580727032|FG001|Overall Study|Adverse Event|4|||
160820101|NCT01973387|580727031|FG000|Overall Study|Withdrawal by Subject|7|||
160820102|NCT01973387|580727032|FG001|Overall Study|Withdrawal by Subject|4|||
160820103|NCT01973387|580727031|FG000|Overall Study|Study terminated by sponsor|63|||
160820104|NCT01973387|580727032|FG001|Overall Study|Study terminated by sponsor|0|||
160820105|NCT01973387|580727031|FG000|Overall Study|Progressive disease or relapse|16|||
160820106|NCT01973387|580727032|FG001|Overall Study|Progressive disease or relapse|5|||
160820107|NCT01973387|580727031|FG000|Overall Study|Death|4|||
160820108|NCT01973387|580727032|FG001|Overall Study|Death|3|||
160820109|NCT01973387|580727031|FG000|Overall Study|Randomized, not treated|2|||
160820110|NCT01973387|580727032|FG001|Overall Study|Randomized, not treated|2|||
160820111|NCT01498575|580727033|FG000|Overall Sample|Withdrawal by Subject|60|||
160820112|NCT01498575|580727034|FG001|Overall Sample|Withdrawal by Subject|14|||
160820113|NCT01498575|580727033|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
160820114|NCT01498575|580727034|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
160820115|NCT01498575|580727033|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
160820116|NCT01498575|580727034|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
160820117|NCT01345591|580727038|FG000|Overall Study|Lost to Follow-up|1|||
160820118|NCT01126437|580727039|FG000|Overall Study|Not treated|11|||
160820119|NCT01126437|580727040|FG001|Overall Study|Not treated|18|||
160820120|NCT01126437|580727041|FG002|Overall Study|Not treated|19|||
160820121|NCT01126437|580727039|FG000|Overall Study|Sites with data irregularities/fraud|6|||
160820122|NCT01126437|580727040|FG001|Overall Study|Sites with data irregularities/fraud|6|||
160820123|NCT01126437|580727041|FG002|Overall Study|Sites with data irregularities/fraud|7|||
160820124|NCT01126437|580727039|FG000|Overall Study|Adverse Event|602|||
160820125|NCT01126437|580727040|FG001|Overall Study|Adverse Event|606|||
160820126|NCT01126437|580727041|FG002|Overall Study|Adverse Event|635|||
160820127|NCT01126437|580727039|FG000|Overall Study|Lack of Efficacy|65|||
160820128|NCT01126437|580727040|FG001|Overall Study|Lack of Efficacy|60|||
160820129|NCT01126437|580727041|FG002|Overall Study|Lack of Efficacy|59|||
160820130|NCT01126437|580727039|FG000|Overall Study|Protocol Violation|64|||
160820131|NCT01126437|580727040|FG001|Overall Study|Protocol Violation|66|||
160820132|NCT01126437|580727041|FG002|Overall Study|Protocol Violation|41|||
160820133|NCT01126437|580727039|FG000|Overall Study|Lost to Follow-up|52|||
160820134|NCT01126437|580727040|FG001|Overall Study|Lost to Follow-up|63|||
160820135|NCT01126437|580727041|FG002|Overall Study|Lost to Follow-up|55|||
160820136|NCT01126437|580727039|FG000|Overall Study|Withdrawal by Subject|331|||
160820137|NCT01126437|580727040|FG001|Overall Study|Withdrawal by Subject|335|||
160820138|NCT01126437|580727041|FG002|Overall Study|Withdrawal by Subject|319|||
160820139|NCT01126437|580727039|FG000|Overall Study|Other reason not specified|210|||
160820140|NCT01126437|580727040|FG001|Overall Study|Other reason not specified|176|||
160820141|NCT01126437|580727041|FG002|Overall Study|Other reason not specified|178|||
160820142|NCT00596154|580727042|FG000|Overall Study|Not Evaluable|2|||
160820143|NCT00642369|580727047|FG000|Overall Study|Adverse Event|2|||
160820144|NCT00642369|580727048|FG001|Overall Study|Adverse Event|3|||
160820145|NCT00642369|580727047|FG000|Overall Study|Withdrawal by Subject|1|||
160820146|NCT00642369|580727048|FG001|Overall Study|Withdrawal by Subject|0|||
160820147|NCT00642369|580727047|FG000|Overall Study|misdiagnosis|0|||
160820148|NCT00642369|580727048|FG001|Overall Study|misdiagnosis|1|||
160820149|NCT00642369|580727047|FG000|Overall Study|Lack of Efficacy|2|||
160820150|NCT00642369|580727048|FG001|Overall Study|Lack of Efficacy|2|||
160820151|NCT00996281|580727056|FG000|Overall Study|Adverse Event|75|||
160820152|NCT00996281|580727057|FG001|Overall Study|Adverse Event|37|||
160820153|NCT00996281|580727056|FG000|Overall Study|Major Protocol Deviation|6|||
160820154|NCT00996281|580727057|FG001|Overall Study|Major Protocol Deviation|7|||
160820155|NCT00996281|580727056|FG000|Overall Study|Lost to Follow-up|14|||
160820156|NCT00996281|580727057|FG001|Overall Study|Lost to Follow-up|16|||
160820157|NCT00996281|580727056|FG000|Overall Study|Withdrawal by Subject|31|||
160900652|NCT02925117|581030187|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900653|NCT02925117|581030188|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900654|NCT02925117|581030189|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900655|NCT02925117|581030178|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
160900656|NCT02925117|581030179|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
160900657|NCT02925117|581030180|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
160900658|NCT02925117|581030181|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
160900659|NCT02925117|581030182|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
160900660|NCT02925117|581030183|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
160900661|NCT02925117|581030184|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
160900662|NCT02925117|581030185|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
160900663|NCT02925117|581030186|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
160900664|NCT02925117|581030187|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
160900665|NCT02925117|581030188|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
160900666|NCT02925117|581030189|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
160900667|NCT02925117|581030178|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900668|NCT02925117|581030179|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900669|NCT02925117|581030180|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900670|NCT02925117|581030181|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900671|NCT02925117|581030182|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900672|NCT02925117|581030183|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
160900673|NCT02925117|581030184|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900674|NCT02925117|581030185|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900675|NCT02925117|581030186|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900676|NCT02925117|581030187|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900677|NCT02925117|581030188|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
160900678|NCT02925117|581030189|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
160900679|NCT02925117|581030178|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
160900680|NCT02925117|581030179|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
160900681|NCT02925117|581030180|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
160987805|NCT01764386|581343174|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
160820158|NCT00996281|580727057|FG001|Overall Study|Withdrawal by Subject|20|||
160820159|NCT00996281|580727056|FG000|Overall Study|Lack of Efficacy|0|||
160820160|NCT00996281|580727057|FG001|Overall Study|Lack of Efficacy|2|||
160820161|NCT00996281|580727056|FG000|Overall Study|Other|5|||
160820162|NCT00996281|580727057|FG001|Overall Study|Other|7|||
160820163|NCT03466099|580727060|FG000|Overall Study|Adverse Event|1|||
160820164|NCT03466099|580727061|FG001|Overall Study|Adverse Event|1|||
160900682|NCT02925117|581030181|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
160900683|NCT02925117|581030182|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
160900684|NCT02925117|581030183|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
160987806|NCT01764386|581343175|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
160900685|NCT02925117|581030184|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
160900686|NCT02925117|581030185|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
160900687|NCT02925117|581030186|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
160820165|NCT03466099|580727062|FG002|Overall Study|Adverse Event|1|||
160820166|NCT03466099|580727060|FG000|Overall Study|Withdrawal by Subject|2|||
160820167|NCT03466099|580727061|FG001|Overall Study|Withdrawal by Subject|3|||
160820168|NCT03466099|580727062|FG002|Overall Study|Withdrawal by Subject|1|||
160820169|NCT03466099|580727060|FG000|Overall Study|Use of rescue medication|8|||
160820170|NCT03466099|580727061|FG001|Overall Study|Use of rescue medication|9|||
160820171|NCT03466099|580727062|FG002|Overall Study|Use of rescue medication|13|||
160820172|NCT03466099|580727060|FG000|Overall Study|Rescued without meeting criteria|4|||
160820173|NCT03466099|580727061|FG001|Overall Study|Rescued without meeting criteria|1|||
160820174|NCT03466099|580727062|FG002|Overall Study|Rescued without meeting criteria|1|||
160820175|NCT03466099|580727060|FG000|Overall Study|Subject compliance|2|||
160820176|NCT03466099|580727061|FG001|Overall Study|Subject compliance|0|||
160820177|NCT03466099|580727062|FG002|Overall Study|Subject compliance|0|||
160820178|NCT03466099|580727060|FG000|Overall Study|Worsening disease|0|||
160820179|NCT03466099|580727061|FG001|Overall Study|Worsening disease|0|||
160820180|NCT03466099|580727062|FG002|Overall Study|Worsening disease|1|||
160820181|NCT03622112|580727063|FG000|Overall Study|Withdrawal by Subject|6|||
160820182|NCT03622112|580727064|FG001|Overall Study|Withdrawal by Subject|2|||
160820183|NCT03622112|580727065|FG002|Overall Study|Withdrawal by Subject|4|||
160820184|NCT03622112|580727066|FG003|Overall Study|Withdrawal by Subject|2|||
160820185|NCT03622112|580727067|FG004|Overall Study|Withdrawal by Subject|1|||
160820186|NCT03622112|580727068|FG005|Overall Study|Withdrawal by Subject|2|||
160820187|NCT03622112|580727069|FG006|Overall Study|Withdrawal by Subject|2|||
160820188|NCT03622112|580727063|FG000|Overall Study|Death|0|||
160820189|NCT03622112|580727064|FG001|Overall Study|Death|0|||
160820190|NCT03622112|580727065|FG002|Overall Study|Death|0|||
160820191|NCT03622112|580727066|FG003|Overall Study|Death|1|||
160820192|NCT03622112|580727067|FG004|Overall Study|Death|0|||
160820193|NCT03622112|580727068|FG005|Overall Study|Death|0|||
160820194|NCT03622112|580727069|FG006|Overall Study|Death|0|||
160820195|NCT03622112|580727063|FG000|Overall Study|Lost to Follow-up|1|||
160820196|NCT03622112|580727064|FG001|Overall Study|Lost to Follow-up|1|||
160820197|NCT03622112|580727065|FG002|Overall Study|Lost to Follow-up|0|||
160820198|NCT03622112|580727066|FG003|Overall Study|Lost to Follow-up|0|||
160820199|NCT03622112|580727067|FG004|Overall Study|Lost to Follow-up|0|||
160820200|NCT03622112|580727068|FG005|Overall Study|Lost to Follow-up|0|||
160820201|NCT03622112|580727069|FG006|Overall Study|Lost to Follow-up|0|||
160820202|NCT03622112|580727063|FG000|Overall Study|Study-specific withdrawal criteria|10|||
160820203|NCT03622112|580727064|FG001|Overall Study|Study-specific withdrawal criteria|8|||
160820204|NCT03622112|580727065|FG002|Overall Study|Study-specific withdrawal criteria|7|||
160820205|NCT03622112|580727066|FG003|Overall Study|Study-specific withdrawal criteria|6|||
160820206|NCT03622112|580727067|FG004|Overall Study|Study-specific withdrawal criteria|4|||
160820207|NCT03622112|580727068|FG005|Overall Study|Study-specific withdrawal criteria|18|||
160820208|NCT03622112|580727069|FG006|Overall Study|Study-specific withdrawal criteria|4|||
160820209|NCT03622112|580727063|FG000|Overall Study|Protocol Violation|2|||
160820210|NCT03622112|580727064|FG001|Overall Study|Protocol Violation|0|||
160820211|NCT03622112|580727065|FG002|Overall Study|Protocol Violation|1|||
160820212|NCT03622112|580727066|FG003|Overall Study|Protocol Violation|1|||
160820213|NCT03622112|580727067|FG004|Overall Study|Protocol Violation|0|||
160820214|NCT03622112|580727068|FG005|Overall Study|Protocol Violation|0|||
160820215|NCT03622112|580727069|FG006|Overall Study|Protocol Violation|0|||
160820216|NCT03622112|580727063|FG000|Overall Study|Adverse Event|6|||
160820217|NCT03622112|580727064|FG001|Overall Study|Adverse Event|8|||
160820218|NCT03622112|580727065|FG002|Overall Study|Adverse Event|4|||
160820219|NCT03622112|580727066|FG003|Overall Study|Adverse Event|11|||
160820220|NCT03622112|580727067|FG004|Overall Study|Adverse Event|4|||
160820221|NCT03622112|580727068|FG005|Overall Study|Adverse Event|20|||
160820222|NCT03622112|580727069|FG006|Overall Study|Adverse Event|2|||
160820223|NCT03622112|580727063|FG000|Overall Study|Reason not specified|0|||
160820224|NCT03622112|580727064|FG001|Overall Study|Reason not specified|1|||
160820225|NCT03622112|580727065|FG002|Overall Study|Reason not specified|0|||
160820226|NCT03622112|580727066|FG003|Overall Study|Reason not specified|1|||
160820227|NCT03622112|580727067|FG004|Overall Study|Reason not specified|1|||
160820228|NCT03622112|580727068|FG005|Overall Study|Reason not specified|2|||
160820229|NCT03622112|580727069|FG006|Overall Study|Reason not specified|1|||
160987807|NCT02703532|581343177|FG000|Overall Study|Withdrawal by Subject|0|||
160820230|NCT01165320|580727070|FG000|Overall Study|Clinical adverse experience|2|||
160820231|NCT01165320|580727071|FG001|Overall Study|Clinical adverse experience|1|||
160820232|NCT01165320|580727072|FG002|Overall Study|Clinical adverse experience|0|||
160820233|NCT01165320|580727070|FG000|Overall Study|Laboratory adverse experience|1|||
160820234|NCT01165320|580727071|FG001|Overall Study|Laboratory adverse experience|0|||
160820235|NCT01165320|580727072|FG002|Overall Study|Laboratory adverse experience|0|||
160987808|NCT02703532|581343178|FG001|Overall Study|Withdrawal by Subject|1|||
160987809|NCT02703532|581343179|FG002|Overall Study|Withdrawal by Subject|0|||
160820236|NCT01165320|580727070|FG000|Overall Study|Lack of Efficacy|0|||
160820237|NCT01165320|580727071|FG001|Overall Study|Lack of Efficacy|2|||
160820238|NCT01165320|580727072|FG002|Overall Study|Lack of Efficacy|0|||
160820239|NCT01165320|580727070|FG000|Overall Study|Reason unknown|0|||
160820240|NCT01165320|580727071|FG001|Overall Study|Reason unknown|1|||
160820241|NCT01165320|580727072|FG002|Overall Study|Reason unknown|0|||
160820242|NCT01155466|580727078|FG000|Overall Study|Adverse Event|13|||
160820243|NCT01155466|580727079|FG001|Overall Study|Adverse Event|15|||
160820244|NCT01155466|580727080|FG002|Overall Study|Adverse Event|6|||
160820245|NCT01155466|580727081|FG003|Overall Study|Adverse Event|17|||
160820246|NCT01155466|580727082|FG004|Overall Study|Adverse Event|18|||
160820247|NCT01155466|580727078|FG000|Overall Study|Lost to Follow-up|0|||
160820248|NCT01155466|580727079|FG001|Overall Study|Lost to Follow-up|0|||
160820249|NCT01155466|580727080|FG002|Overall Study|Lost to Follow-up|0|||
160820250|NCT01155466|580727081|FG003|Overall Study|Lost to Follow-up|0|||
160820251|NCT01155466|580727082|FG004|Overall Study|Lost to Follow-up|2|||
160820252|NCT01155466|580727078|FG000|Overall Study|Withdrawal by Subject|7|||
160820253|NCT01155466|580727079|FG001|Overall Study|Withdrawal by Subject|5|||
160820254|NCT01155466|580727080|FG002|Overall Study|Withdrawal by Subject|9|||
160987810|NCT02703532|581343180|FG003|Overall Study|Withdrawal by Subject|1|||
160820255|NCT01155466|580727081|FG003|Overall Study|Withdrawal by Subject|4|||
160820256|NCT01155466|580727082|FG004|Overall Study|Withdrawal by Subject|4|||
160820257|NCT01155466|580727078|FG000|Overall Study|Protocol Violation|0|||
160820258|NCT01155466|580727079|FG001|Overall Study|Protocol Violation|0|||
160820259|NCT01155466|580727080|FG002|Overall Study|Protocol Violation|2|||
160987811|NCT02703532|581343177|FG000|Overall Study|Lost to Follow-up|2|||
160987812|NCT02703532|581343178|FG001|Overall Study|Lost to Follow-up|0|||
160987813|NCT02703532|581343179|FG002|Overall Study|Lost to Follow-up|2|||
160987814|NCT02703532|581343180|FG003|Overall Study|Lost to Follow-up|0|||
160820260|NCT01155466|580727081|FG003|Overall Study|Protocol Violation|0|||
160820261|NCT01155466|580727082|FG004|Overall Study|Protocol Violation|1|||
160820262|NCT01155466|580727078|FG000|Overall Study|Administrative|0|||
160820263|NCT01155466|580727079|FG001|Overall Study|Administrative|3|||
160820264|NCT01155466|580727080|FG002|Overall Study|Administrative|0|||
160820265|NCT01155466|580727081|FG003|Overall Study|Administrative|0|||
160820266|NCT01155466|580727082|FG004|Overall Study|Administrative|0|||
160820267|NCT01155466|580727078|FG000|Overall Study|Randomized not treated|2|||
160900688|NCT02925117|581030187|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
160900689|NCT02925117|581030188|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
160900690|NCT02925117|581030189|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
160900691|NCT02925117|581030178|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160900692|NCT02925117|581030179|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160900693|NCT02925117|581030180|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160820268|NCT01155466|580727079|FG001|Overall Study|Randomized not treated|2|||
160820269|NCT01155466|580727080|FG002|Overall Study|Randomized not treated|3|||
160820270|NCT01155466|580727081|FG003|Overall Study|Randomized not treated|0|||
160820271|NCT01155466|580727082|FG004|Overall Study|Randomized not treated|2|||
160820272|NCT03305419|580727083|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820273|NCT03305419|580727084|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
160820274|NCT03305419|580727085|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820275|NCT03305419|580727086|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820276|NCT03305419|580727087|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820277|NCT03305419|580727088|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160900694|NCT02925117|581030181|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160900695|NCT02925117|581030182|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
160900696|NCT02925117|581030183|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
160900697|NCT02925117|581030184|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
160900698|NCT02925117|581030185|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
160900699|NCT02925117|581030186|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
160900700|NCT02925117|581030187|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160900701|NCT02925117|581030188|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160900702|NCT02925117|581030189|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
160900703|NCT02925117|581030178|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
160900704|NCT02925117|581030179|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
160900705|NCT02925117|581030180|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
160900706|NCT02925117|581030181|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
160900707|NCT02925117|581030182|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
160900708|NCT02925117|581030183|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
160900709|NCT02925117|581030184|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
160987815|NCT03738241|581343181|FG000|Overall Study|Withdrawal by Subject|0|||
160987816|NCT03738241|581343182|FG001|Overall Study|Withdrawal by Subject|0|||
160820278|NCT03305419|580727089|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820279|NCT03305419|580727090|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820280|NCT03305419|580727083|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
160820281|NCT03305419|580727084|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820282|NCT03305419|580727085|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820283|NCT03305419|580727086|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160900710|NCT02925117|581030185|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
160987817|NCT03738241|581343183|FG002|Overall Study|Withdrawal by Subject|0|||
160820284|NCT03305419|580727087|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820285|NCT03305419|580727088|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820286|NCT03305419|580727089|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820287|NCT03305419|580727090|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820288|NCT03305419|580727083|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
160820289|NCT03305419|580727084|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820290|NCT03305419|580727085|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820291|NCT03305419|580727086|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820292|NCT03305419|580727087|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820293|NCT03305419|580727088|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820294|NCT03305419|580727089|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820295|NCT03305419|580727090|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820296|NCT03305419|580727083|FG000|Part B (14 Days)|Adverse Event|0|||
160820297|NCT03305419|580727084|FG001|Part B (14 Days)|Adverse Event|0|||
160820298|NCT03305419|580727085|FG002|Part B (14 Days)|Adverse Event|0|||
160820299|NCT03305419|580727086|FG003|Part B (14 Days)|Adverse Event|0|||
160820300|NCT03305419|580727087|FG004|Part B (14 Days)|Adverse Event|1|||
160820301|NCT03305419|580727088|FG005|Part B (14 Days)|Adverse Event|2|||
160820302|NCT03305419|580727089|FG006|Part B (14 Days)|Adverse Event|4|||
160820303|NCT03305419|580727090|FG007|Part B (14 Days)|Adverse Event|0|||
160820304|NCT03305419|580727083|FG000|Part B (14 Days)|Physician Decision|0|||
160820305|NCT03305419|580727084|FG001|Part B (14 Days)|Physician Decision|0|||
160820306|NCT03305419|580727085|FG002|Part B (14 Days)|Physician Decision|0|||
160820307|NCT03305419|580727086|FG003|Part B (14 Days)|Physician Decision|0|||
160820308|NCT03305419|580727087|FG004|Part B (14 Days)|Physician Decision|2|||
160820309|NCT03305419|580727088|FG005|Part B (14 Days)|Physician Decision|8|||
160820310|NCT03305419|580727089|FG006|Part B (14 Days)|Physician Decision|1|||
160820311|NCT03305419|580727090|FG007|Part B (14 Days)|Physician Decision|0|||
160820312|NCT04154605|580727095|FG000|Overall Study|Procedure Canceled|1|||
160820313|NCT04154605|580727096|FG001|Overall Study|Procedure Canceled|1|||
160820314|NCT04154605|580727095|FG000|Overall Study|Missed follow up|1|||
160820315|NCT04154605|580727096|FG001|Overall Study|Missed follow up|1|||
160820316|NCT04154605|580727095|FG000|Overall Study|Withdrawal by Subject|1|||
160820317|NCT04154605|580727096|FG001|Overall Study|Withdrawal by Subject|0|||
160820318|NCT01229254|580727099|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
160820319|NCT01229254|580727100|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
160820320|NCT01229254|580727101|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
160820321|NCT01229254|580727099|FG000|Overall Study|Adverse Event|4|||
160820322|NCT01229254|580727100|FG001|Overall Study|Adverse Event|5|||
160820323|NCT01229254|580727101|FG002|Overall Study|Adverse Event|3|||
160820324|NCT01229254|580727099|FG000|Overall Study|Lost to Follow-up|3|||
160820325|NCT01229254|580727100|FG001|Overall Study|Lost to Follow-up|0|||
160820326|NCT01229254|580727101|FG002|Overall Study|Lost to Follow-up|1|||
160820327|NCT01229254|580727099|FG000|Overall Study|Physician Decision|0|||
160820328|NCT01229254|580727100|FG001|Overall Study|Physician Decision|3|||
160820329|NCT01229254|580727101|FG002|Overall Study|Physician Decision|0|||
160820330|NCT01229254|580727099|FG000|Overall Study|Protocol Violation|4|||
160820331|NCT01229254|580727100|FG001|Overall Study|Protocol Violation|6|||
160820332|NCT01229254|580727101|FG002|Overall Study|Protocol Violation|5|||
160820333|NCT01229254|580727099|FG000|Overall Study|Withdrawal by Subject|1|||
160820334|NCT01229254|580727100|FG001|Overall Study|Withdrawal by Subject|0|||
160820335|NCT01229254|580727101|FG002|Overall Study|Withdrawal by Subject|1|||
160820336|NCT01229254|580727099|FG000|Overall Study|Non-compliance with Study Drug|0|||
160820337|NCT01229254|580727100|FG001|Overall Study|Non-compliance with Study Drug|1|||
160820338|NCT01229254|580727101|FG002|Overall Study|Non-compliance with Study Drug|1|||
160820339|NCT04934800|580727102|FG000|Overall Study|Other|1|||
160820340|NCT04934800|580727102|FG000|Overall Study|Withdrawal by Subject|5|||
160820341|NCT04934800|580727102|FG000|Overall Study|Lack of Efficacy|1|||
160820342|NCT04934800|580727102|FG000|Overall Study|Adverse Event|9|||
160820343|NCT04934800|580727102|FG000|Overall Study|Lost to Follow-up|5|||
160820344|NCT04934800|580727102|FG000|Overall Study|Enrolled but not treated|1|||
160820345|NCT05596734|580727103|FG000|Substudy A|Withdrawal by Subject|1|||
160820346|NCT05596734|580727104|FG001|Substudy A|Withdrawal by Subject|0|||
160820347|NCT05596734|580727105|FG002|Substudy A|Withdrawal by Subject|0|||
160820348|NCT05596734|580727106|FG003|Substudy A|Withdrawal by Subject|0|||
160820349|NCT05596734|580727107|FG004|Substudy A|Withdrawal by Subject|0|||
160820350|NCT05596734|580727108|FG005|Substudy A|Withdrawal by Subject|0|||
160820351|NCT05596734|580727109|FG006|Substudy A|Withdrawal by Subject|1|||
160820352|NCT05596734|580727110|FG007|Substudy A|Withdrawal by Subject|0|||
160820353|NCT05596734|580727111|FG008|Substudy A|Withdrawal by Subject|0|||
160820354|NCT05596734|580727112|FG009|Substudy A|Withdrawal by Subject|0|||
160820355|NCT05596734|580727113|FG010|Substudy A|Withdrawal by Subject|0|||
160820356|NCT05596734|580727114|FG011|Substudy A|Withdrawal by Subject|0|||
160820357|NCT05596734|580727115|FG012|Substudy A|Withdrawal by Subject|0|||
160820358|NCT05596734|580727116|FG013|Substudy A|Withdrawal by Subject|0|||
160987818|NCT03738241|581343184|FG003|Overall Study|Withdrawal by Subject|0|||
160987819|NCT03738241|581343185|FG004|Overall Study|Withdrawal by Subject|0|||
160987820|NCT03738241|581343186|FG005|Overall Study|Withdrawal by Subject|0|||
160987821|NCT03738241|581343187|FG006|Overall Study|Withdrawal by Subject|0|||
160987822|NCT03738241|581343188|FG007|Overall Study|Withdrawal by Subject|0|||
160987823|NCT03738241|581343189|FG008|Overall Study|Withdrawal by Subject|0|||
160987824|NCT03738241|581343190|FG009|Overall Study|Withdrawal by Subject|1|||
160987825|NCT03738241|581343181|FG000|Overall Study|Physician Decision|0|||
160987826|NCT03738241|581343182|FG001|Overall Study|Physician Decision|0|||
160987827|NCT03738241|581343183|FG002|Overall Study|Physician Decision|0|||
160987828|NCT03738241|581343184|FG003|Overall Study|Physician Decision|0|||
160987829|NCT03738241|581343185|FG004|Overall Study|Physician Decision|0|||
160987830|NCT03738241|581343186|FG005|Overall Study|Physician Decision|0|||
160987831|NCT03738241|581343187|FG006|Overall Study|Physician Decision|0|||
160987832|NCT03738241|581343188|FG007|Overall Study|Physician Decision|0|||
160987833|NCT03738241|581343189|FG008|Overall Study|Physician Decision|1|||
160987834|NCT03738241|581343190|FG009|Overall Study|Physician Decision|0|||
160987835|NCT03738241|581343181|FG000|Overall Study|Adverse Event|1|||
160987836|NCT03738241|581343182|FG001|Overall Study|Adverse Event|0|||
160987837|NCT03738241|581343183|FG002|Overall Study|Adverse Event|0|||
160987838|NCT03738241|581343184|FG003|Overall Study|Adverse Event|0|||
160987839|NCT03738241|581343185|FG004|Overall Study|Adverse Event|0|||
160987840|NCT03738241|581343186|FG005|Overall Study|Adverse Event|0|||
160987841|NCT03738241|581343187|FG006|Overall Study|Adverse Event|0|||
160987842|NCT03738241|581343188|FG007|Overall Study|Adverse Event|0|||
160987843|NCT03738241|581343189|FG008|Overall Study|Adverse Event|0|||
160987844|NCT03738241|581343190|FG009|Overall Study|Adverse Event|0|||
160820359|NCT05596734|580727117|FG014|Substudy A|Withdrawal by Subject|0|||
160820360|NCT05596734|580727118|FG015|Substudy A|Withdrawal by Subject|0|||
160820361|NCT05596734|580727119|FG016|Substudy A|Withdrawal by Subject|0|||
160820362|NCT05596734|580727120|FG017|Substudy A|Withdrawal by Subject|0|||
160820363|NCT05596734|580727121|FG018|Substudy A|Withdrawal by Subject|0|||
160820364|NCT05596734|580727122|FG019|Substudy A|Withdrawal by Subject|0|||
160820365|NCT05596734|580727123|FG020|Substudy A|Withdrawal by Subject|0|||
160820366|NCT05596734|580727124|FG021|Substudy A|Withdrawal by Subject|0|||
160820367|NCT05596734|580727125|FG022|Substudy A|Withdrawal by Subject|0|||
160820368|NCT05596734|580727126|FG023|Substudy A|Withdrawal by Subject|0|||
160820369|NCT05596734|580727103|FG000|Substudy A|Lost to Follow-up|1|||
160820370|NCT05596734|580727104|FG001|Substudy A|Lost to Follow-up|0|||
160820371|NCT05596734|580727105|FG002|Substudy A|Lost to Follow-up|1|||
160820372|NCT05596734|580727106|FG003|Substudy A|Lost to Follow-up|0|||
160820373|NCT05596734|580727107|FG004|Substudy A|Lost to Follow-up|0|||
160820374|NCT05596734|580727108|FG005|Substudy A|Lost to Follow-up|0|||
160820375|NCT05596734|580727109|FG006|Substudy A|Lost to Follow-up|0|||
160820376|NCT05596734|580727110|FG007|Substudy A|Lost to Follow-up|0|||
160820377|NCT05596734|580727111|FG008|Substudy A|Lost to Follow-up|0|||
160820378|NCT05596734|580727112|FG009|Substudy A|Lost to Follow-up|0|||
160820379|NCT05596734|580727113|FG010|Substudy A|Lost to Follow-up|0|||
160820380|NCT05596734|580727114|FG011|Substudy A|Lost to Follow-up|0|||
160820381|NCT05596734|580727115|FG012|Substudy A|Lost to Follow-up|0|||
160820382|NCT05596734|580727116|FG013|Substudy A|Lost to Follow-up|0|||
160820383|NCT05596734|580727117|FG014|Substudy A|Lost to Follow-up|0|||
160820384|NCT05596734|580727118|FG015|Substudy A|Lost to Follow-up|0|||
160820385|NCT05596734|580727119|FG016|Substudy A|Lost to Follow-up|0|||
160820386|NCT05596734|580727120|FG017|Substudy A|Lost to Follow-up|0|||
160820387|NCT05596734|580727121|FG018|Substudy A|Lost to Follow-up|0|||
160820388|NCT05596734|580727122|FG019|Substudy A|Lost to Follow-up|0|||
160820389|NCT05596734|580727123|FG020|Substudy A|Lost to Follow-up|0|||
160820390|NCT05596734|580727124|FG021|Substudy A|Lost to Follow-up|0|||
160820391|NCT05596734|580727125|FG022|Substudy A|Lost to Follow-up|0|||
160820392|NCT05596734|580727126|FG023|Substudy A|Lost to Follow-up|0|||
160820393|NCT05596734|580727103|FG000|Substudy B|Withdrawal by Subject|0|||
160820394|NCT05596734|580727104|FG001|Substudy B|Withdrawal by Subject|0|||
160820395|NCT05596734|580727105|FG002|Substudy B|Withdrawal by Subject|0|||
160820396|NCT05596734|580727106|FG003|Substudy B|Withdrawal by Subject|0|||
160820397|NCT05596734|580727107|FG004|Substudy B|Withdrawal by Subject|0|||
160820398|NCT05596734|580727108|FG005|Substudy B|Withdrawal by Subject|0|||
160820399|NCT05596734|580727109|FG006|Substudy B|Withdrawal by Subject|0|||
160820400|NCT05596734|580727110|FG007|Substudy B|Withdrawal by Subject|0|||
160987845|NCT03169361|581343191|FG000|Overall Study|Protocol Violation|32|||
160987846|NCT02788656|581343192|FG000|Overall Study|Withdrawal by Subject|1|||
160820401|NCT05596734|580727111|FG008|Substudy B|Withdrawal by Subject|0|||
160820402|NCT05596734|580727112|FG009|Substudy B|Withdrawal by Subject|0|||
160820403|NCT05596734|580727113|FG010|Substudy B|Withdrawal by Subject|0|||
160820404|NCT05596734|580727114|FG011|Substudy B|Withdrawal by Subject|0|||
160820405|NCT05596734|580727115|FG012|Substudy B|Withdrawal by Subject|1|||
160987847|NCT02788656|581343193|FG001|Overall Study|Withdrawal by Subject|0|||
160987848|NCT02263885|581343194|FG000|Overall Study|Withdrawal by Subject|7|||
160987849|NCT02263885|581343194|FG000|Overall Study|Alternative Treatment|3|||
160987850|NCT02459964|581343203|FG000|Overall Study|Withdrawal by Subject|0|||
160820406|NCT05596734|580727116|FG013|Substudy B|Withdrawal by Subject|0|||
160820407|NCT05596734|580727117|FG014|Substudy B|Withdrawal by Subject|1|||
160820408|NCT05596734|580727118|FG015|Substudy B|Withdrawal by Subject|2|||
160820409|NCT05596734|580727119|FG016|Substudy B|Withdrawal by Subject|2|||
160820410|NCT05596734|580727120|FG017|Substudy B|Withdrawal by Subject|1|||
160820411|NCT05596734|580727121|FG018|Substudy B|Withdrawal by Subject|2|||
160820412|NCT05596734|580727122|FG019|Substudy B|Withdrawal by Subject|0|||
160820413|NCT05596734|580727123|FG020|Substudy B|Withdrawal by Subject|0|||
160820414|NCT05596734|580727124|FG021|Substudy B|Withdrawal by Subject|0|||
160820415|NCT05596734|580727125|FG022|Substudy B|Withdrawal by Subject|0|||
160820416|NCT05596734|580727126|FG023|Substudy B|Withdrawal by Subject|1|||
160820417|NCT05596734|580727103|FG000|Substudy B|Physician Decision|0|||
160820418|NCT05596734|580727104|FG001|Substudy B|Physician Decision|0|||
160820419|NCT05596734|580727105|FG002|Substudy B|Physician Decision|0|||
160820420|NCT05596734|580727106|FG003|Substudy B|Physician Decision|0|||
160820421|NCT05596734|580727107|FG004|Substudy B|Physician Decision|0|||
160820422|NCT05596734|580727108|FG005|Substudy B|Physician Decision|0|||
160820423|NCT05596734|580727109|FG006|Substudy B|Physician Decision|0|||
160820424|NCT05596734|580727110|FG007|Substudy B|Physician Decision|0|||
160820425|NCT05596734|580727111|FG008|Substudy B|Physician Decision|0|||
160820426|NCT05596734|580727112|FG009|Substudy B|Physician Decision|0|||
160820427|NCT05596734|580727113|FG010|Substudy B|Physician Decision|0|||
160820428|NCT05596734|580727114|FG011|Substudy B|Physician Decision|0|||
160820429|NCT05596734|580727115|FG012|Substudy B|Physician Decision|0|||
160820430|NCT05596734|580727116|FG013|Substudy B|Physician Decision|0|||
160820431|NCT05596734|580727117|FG014|Substudy B|Physician Decision|0|||
160820432|NCT05596734|580727118|FG015|Substudy B|Physician Decision|1|||
160820433|NCT05596734|580727119|FG016|Substudy B|Physician Decision|0|||
160820434|NCT05596734|580727120|FG017|Substudy B|Physician Decision|0|||
160820435|NCT05596734|580727121|FG018|Substudy B|Physician Decision|0|||
160820436|NCT05596734|580727122|FG019|Substudy B|Physician Decision|0|||
160820437|NCT05596734|580727123|FG020|Substudy B|Physician Decision|0|||
160820438|NCT05596734|580727124|FG021|Substudy B|Physician Decision|0|||
160820439|NCT05596734|580727125|FG022|Substudy B|Physician Decision|0|||
160820440|NCT05596734|580727126|FG023|Substudy B|Physician Decision|0|||
160820441|NCT05596734|580727103|FG000|Substudy B|Lost to Follow-up|0|||
160820442|NCT05596734|580727104|FG001|Substudy B|Lost to Follow-up|0|||
160820443|NCT05596734|580727105|FG002|Substudy B|Lost to Follow-up|0|||
160820444|NCT05596734|580727106|FG003|Substudy B|Lost to Follow-up|0|||
160820445|NCT05596734|580727107|FG004|Substudy B|Lost to Follow-up|0|||
160820446|NCT05596734|580727108|FG005|Substudy B|Lost to Follow-up|0|||
160820447|NCT05596734|580727109|FG006|Substudy B|Lost to Follow-up|0|||
160820448|NCT05596734|580727110|FG007|Substudy B|Lost to Follow-up|0|||
160820449|NCT05596734|580727111|FG008|Substudy B|Lost to Follow-up|0|||
160820450|NCT05596734|580727112|FG009|Substudy B|Lost to Follow-up|0|||
160820451|NCT05596734|580727113|FG010|Substudy B|Lost to Follow-up|0|||
160820452|NCT05596734|580727114|FG011|Substudy B|Lost to Follow-up|0|||
160820453|NCT05596734|580727115|FG012|Substudy B|Lost to Follow-up|1|||
160820454|NCT05596734|580727116|FG013|Substudy B|Lost to Follow-up|0|||
160820455|NCT05596734|580727117|FG014|Substudy B|Lost to Follow-up|1|||
160820456|NCT05596734|580727118|FG015|Substudy B|Lost to Follow-up|1|||
160820457|NCT05596734|580727119|FG016|Substudy B|Lost to Follow-up|0|||
160820458|NCT05596734|580727120|FG017|Substudy B|Lost to Follow-up|0|||
160820459|NCT05596734|580727121|FG018|Substudy B|Lost to Follow-up|0|||
160820460|NCT05596734|580727122|FG019|Substudy B|Lost to Follow-up|0|||
160820461|NCT05596734|580727123|FG020|Substudy B|Lost to Follow-up|0|||
160820462|NCT05596734|580727124|FG021|Substudy B|Lost to Follow-up|0|||
160820463|NCT05596734|580727125|FG022|Substudy B|Lost to Follow-up|0|||
160820464|NCT05596734|580727126|FG023|Substudy B|Lost to Follow-up|0|||
160820465|NCT02118766|580727131|FG000|Overall Study|Adverse Event|7|||
160820466|NCT02118766|580727132|FG001|Overall Study|Adverse Event|2|||
160820467|NCT02118766|580727131|FG000|Overall Study|Withdrawal by Subject|3|||
160820468|NCT02118766|580727132|FG001|Overall Study|Withdrawal by Subject|6|||
160820469|NCT02118766|580727131|FG000|Overall Study|Lost to Follow-up|5|||
160820470|NCT02118766|580727132|FG001|Overall Study|Lost to Follow-up|4|||
160820471|NCT02118766|580727131|FG000|Overall Study|Withdrawal by parent/guardian|12|||
160820472|NCT02118766|580727132|FG001|Overall Study|Withdrawal by parent/guardian|18|||
160820473|NCT02118766|580727131|FG000|Overall Study|Other|3|||
160820474|NCT02118766|580727132|FG001|Overall Study|Other|1|||
160820475|NCT02059499|580727134|FG000|Upto Week 20|Lost to Follow-up|2|||
160820476|NCT02059499|580727135|FG001|Upto Week 20|Lost to Follow-up|6|||
160820477|NCT02059499|580727136|FG002|Upto Week 20|Lost to Follow-up|0|||
160820478|NCT02059499|580727134|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
160820479|NCT02059499|580727135|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
160900711|NCT02925117|581030186|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
160820480|NCT02059499|580727136|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
160820481|NCT02059499|580727134|FG000|Upto Week 20|Withdrawal by Subject|1|||
160820482|NCT02059499|580727135|FG001|Upto Week 20|Withdrawal by Subject|1|||
160820483|NCT02059499|580727136|FG002|Upto Week 20|Withdrawal by Subject|0|||
160820484|NCT02059499|580727134|FG000|Upto Week 20|No treatment per protocol criteria|0|||
160820485|NCT02059499|580727135|FG001|Upto Week 20|No treatment per protocol criteria|0|||
160820486|NCT02059499|580727136|FG002|Upto Week 20|No treatment per protocol criteria|5|||
160820487|NCT02059499|580727134|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
160820488|NCT02059499|580727135|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
160820489|NCT02059499|580727136|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
160820490|NCT02059499|580727134|FG000|Post-week 20|Lost to Follow-up|0|||
160820491|NCT02059499|580727135|FG001|Post-week 20|Lost to Follow-up|2|||
160820492|NCT02059499|580727136|FG002|Post-week 20|Lost to Follow-up|0|||
160820493|NCT02059499|580727134|FG000|Post-week 20|Withdrawal by Subject|0|||
160820494|NCT02059499|580727135|FG001|Post-week 20|Withdrawal by Subject|1|||
160820495|NCT02059499|580727136|FG002|Post-week 20|Withdrawal by Subject|0|||
160820496|NCT02059499|580727134|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
160820497|NCT02059499|580727135|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
160820498|NCT02059499|580727136|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
160820499|NCT04210245|580727137|FG000|Overall Study|Adverse Event|0|||
160820500|NCT04210245|580727138|FG001|Overall Study|Adverse Event|3|||
160820501|NCT04210245|580727139|FG002|Overall Study|Adverse Event|6|||
160820502|NCT04210245|580727140|FG003|Overall Study|Adverse Event|0|||
160820503|NCT04210245|580727137|FG000|Overall Study|Withdrawal by Subject|0|||
160820504|NCT04210245|580727138|FG001|Overall Study|Withdrawal by Subject|1|||
160820505|NCT04210245|580727139|FG002|Overall Study|Withdrawal by Subject|4|||
160820506|NCT04210245|580727140|FG003|Overall Study|Withdrawal by Subject|4|||
160820507|NCT04210245|580727137|FG000|Overall Study|Lost to Follow-up|0|||
160820508|NCT04210245|580727138|FG001|Overall Study|Lost to Follow-up|1|||
160820509|NCT04210245|580727139|FG002|Overall Study|Lost to Follow-up|1|||
160820510|NCT04210245|580727140|FG003|Overall Study|Lost to Follow-up|1|||
160820511|NCT04210245|580727137|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
160820512|NCT04210245|580727138|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
160820513|NCT04210245|580727139|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
160820514|NCT04210245|580727140|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
160820515|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
160820516|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160820517|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160820518|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160820519|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160820520|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160820521|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
160820522|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
160820523|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160820524|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160820525|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160820526|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160820527|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
160820528|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
160820529|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
160820530|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
160820531|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
160820532|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
160820533|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
160820534|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
160820535|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160820536|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160820537|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160820538|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160987851|NCT02459964|581343204|FG001|Overall Study|Withdrawal by Subject|0|||
160820539|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
160820540|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
160820541|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
160820542|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
160987852|NCT02459964|581343205|FG002|Overall Study|Withdrawal by Subject|1|||
160987853|NCT02459964|581343203|FG000|Overall Study|Abnormal EKG changes|0|||
160987854|NCT02459964|581343204|FG001|Overall Study|Abnormal EKG changes|0|||
160987855|NCT02459964|581343205|FG002|Overall Study|Abnormal EKG changes|1|||
160987856|NCT04531540|581343210|FG000|Overall Study|Adverse Event|1|||
160987857|NCT04531540|581343210|FG000|Overall Study|Protocol Violation|3|||
160987858|NCT04531540|581343210|FG000|Overall Study|Withdrawal by Subject|4|||
160987859|NCT04531540|581343210|FG000|Overall Study|Found to be Ineligible|1|||
160987860|NCT03239210|581343211|FG000|Overall Study|Lost to Follow-up|2|||
160987861|NCT03239210|581343212|FG001|Overall Study|Lost to Follow-up|2|||
160987862|NCT03239210|581343211|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
160987863|NCT03239210|581343212|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
160987864|NCT03239210|581343211|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
160987865|NCT03239210|581343212|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
160987866|NCT01575860|581343213|FG000|Overall Study|Withdrawal by Subject|1|||
160987867|NCT01575860|581343213|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
160987868|NCT02223793|581343215|FG000|Overall Study|Lost to Follow-up|10|||
160552888|NCT01114529|579749873|FG002|Completed Study Phase at Month 24|Death|4|||
160552889|NCT01114529|579749871|FG000|Completed Study Phase at Month 24|Other|2|||
160552890|NCT01114529|579749872|FG001|Completed Study Phase at Month 24|Other|0|||
160820543|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
160820544|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
160820545|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
160820546|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
160820547|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
160820548|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
160552891|NCT01114529|579749873|FG002|Completed Study Phase at Month 24|Other|0|||
160552892|NCT01114529|579749871|FG000|Completed Study Phase at Month 24|Missing|2|||
160552893|NCT01114529|579749872|FG001|Completed Study Phase at Month 24|Missing|0|||
160552894|NCT01114529|579749873|FG002|Completed Study Phase at Month 24|Missing|0|||
160552895|NCT03555266|579749874|FG000|Overall Study|Protocol Violation|6|||
160552896|NCT03555266|579749875|FG001|Overall Study|Protocol Violation|4|||
160552897|NCT00797823|579749876|FG000|First Period (Initial Randomization)|Physician Decision|1|||
160820549|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
160552898|NCT00797823|579749877|FG001|First Period (Initial Randomization)|Physician Decision|0|||
160900712|NCT02925117|581030187|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
160552899|NCT00797823|579749878|FG002|First Period (Initial Randomization)|Physician Decision|0|||
160900713|NCT02925117|581030188|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
160900714|NCT02925117|581030189|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
160900715|NCT04032652|581030190|FG000|Overall Study|The study was terminated and the PI has|1|||
160900716|NCT04032652|581030191|FG001|Overall Study|The study was terminated and the PI has|1|||
160900717|NCT02663908|581030192|FG000|Overall Study|Withdrawal by Subject|8|||
160900718|NCT02663908|581030193|FG001|Overall Study|Withdrawal by Subject|5|||
160900719|NCT02663908|581030192|FG000|Overall Study|Lost to Follow-up|1|||
160900720|NCT02663908|581030193|FG001|Overall Study|Lost to Follow-up|5|||
160900721|NCT02663908|581030192|FG000|Overall Study|Adverse Event|13|||
160900722|NCT02663908|581030193|FG001|Overall Study|Adverse Event|11|||
160900723|NCT02663908|581030192|FG000|Overall Study|Protocol Violation|1|||
160900724|NCT02663908|581030193|FG001|Overall Study|Protocol Violation|2|||
160900725|NCT02663908|581030192|FG000|Overall Study|Lack of therapeutic response|2|||
160900726|NCT02663908|581030193|FG001|Overall Study|Lack of therapeutic response|0|||
160900727|NCT02663908|581030192|FG000|Overall Study|COVID-19|1|||
160900728|NCT02663908|581030193|FG001|Overall Study|COVID-19|0|||
160900729|NCT02663908|581030192|FG000|Overall Study|Site closed|1|||
160900730|NCT02663908|581030193|FG001|Overall Study|Site closed|0|||
160900731|NCT02663908|581030192|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
160900732|NCT02663908|581030193|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
160900733|NCT02663908|581030192|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
160900734|NCT02663908|581030193|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
160900735|NCT02663908|581030192|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
160900736|NCT02663908|581030193|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
160900737|NCT02663908|581030192|FG000|Overall Study|Death|1|||
160900738|NCT02663908|581030193|FG001|Overall Study|Death|0|||
160900739|NCT02663908|581030192|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
160900740|NCT02663908|581030193|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
160900741|NCT02663908|581030192|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
160900742|NCT02663908|581030193|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
160900743|NCT00370071|581030194|FG000|Overall Study|Withdrawal by Subject|2|||
160900744|NCT02004522|581030195|FG000|Overall Study|Adverse Event|55|||
160900745|NCT02004522|581030196|FG001|Overall Study|Adverse Event|6|||
160900746|NCT02004522|581030195|FG000|Overall Study|Withdrawal by Subject|13|||
160987869|NCT02223793|581343216|FG001|Overall Study|Lost to Follow-up|1|||
160987870|NCT02223793|581343217|FG002|Overall Study|Lost to Follow-up|2|||
160552900|NCT01700192|579749879|FG000|Overall Study|Adverse Event|73|||
160552901|NCT01700192|579749880|FG001|Overall Study|Adverse Event|18|||
160552902|NCT01700192|579749879|FG000|Overall Study|Lack of Efficacy|1|||
160552903|NCT01700192|579749880|FG001|Overall Study|Lack of Efficacy|0|||
160552904|NCT01700192|579749879|FG000|Overall Study|Lost to Follow-up|42|||
160552905|NCT01700192|579749880|FG001|Overall Study|Lost to Follow-up|29|||
160820550|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
160820551|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
160820552|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
160820553|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
160820554|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
160820555|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
160820556|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
160820557|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160820558|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160820559|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
160820560|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
160900747|NCT02004522|581030196|FG001|Overall Study|Withdrawal by Subject|7|||
160900748|NCT02004522|581030195|FG000|Overall Study|Death|12|||
160900749|NCT02004522|581030196|FG001|Overall Study|Death|3|||
160900750|NCT02004522|581030195|FG000|Overall Study|Physician Decision|3|||
160900751|NCT02004522|581030196|FG001|Overall Study|Physician Decision|4|||
160900752|NCT02004522|581030195|FG000|Overall Study|Protocol Violation|1|||
160900753|NCT02004522|581030196|FG001|Overall Study|Protocol Violation|0|||
160900754|NCT02004522|581030195|FG000|Overall Study|Other is reason listed by PI|4|||
160900755|NCT02004522|581030196|FG001|Overall Study|Other is reason listed by PI|1|||
160900756|NCT02004522|581030195|FG000|Overall Study|Never Dosed|2|||
160900757|NCT02004522|581030196|FG001|Overall Study|Never Dosed|4|||
160900758|NCT02004522|581030195|FG000|Overall Study|Disease Progression|35|||
160900759|NCT02004522|581030196|FG001|Overall Study|Disease Progression|31|||
160900760|NCT02004522|581030195|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
160900761|NCT02004522|581030196|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
160900762|NCT01787331|581030197|FG000|Overall Study|Physician Decision|1|||
160900763|NCT01787331|581030197|FG000|Overall Study|Withdrawal by Subject|1|||
160900764|NCT00302107|581030201|FG000|Overall Study|Lost to Follow-up|6|||
160900765|NCT00302107|581030202|FG001|Overall Study|Lost to Follow-up|5|||
160900766|NCT00302107|581030201|FG000|Overall Study|Protocol Violation|1|||
160900767|NCT00302107|581030202|FG001|Overall Study|Protocol Violation|0|||
160900768|NCT00302107|581030201|FG000|Overall Study|Relocation|0|||
160900769|NCT00302107|581030202|FG001|Overall Study|Relocation|1|||
160900770|NCT00302107|581030201|FG000|Overall Study|Withdrawal by Subject|0|||
160900771|NCT00302107|581030202|FG001|Overall Study|Withdrawal by Subject|3|||
160900772|NCT00302107|581030201|FG000|Overall Study|Adverse Event|1|||
160900773|NCT00302107|581030202|FG001|Overall Study|Adverse Event|0|||
160900774|NCT01790932|581030203|FG000|Overall Study|Disease Progression|41|||
160900775|NCT01790932|581030203|FG000|Overall Study|Adverse Event|7|||
160900776|NCT01790932|581030203|FG000|Overall Study|Physician Decision|1|||
160900777|NCT01790932|581030203|FG000|Overall Study|Withdrawal by Subject|1|||
160900778|NCT01441180|581030209|FG000|Overall Study|Lost to Follow-up|1|||
160900779|NCT01441180|581030210|FG001|Overall Study|Lost to Follow-up|1|||
160900780|NCT01441180|581030211|FG002|Overall Study|Lost to Follow-up|1|||
160900781|NCT01441180|581030209|FG000|Overall Study|Discontinued|0|||
160900782|NCT01441180|581030210|FG001|Overall Study|Discontinued|0|||
160900783|NCT01441180|581030211|FG002|Overall Study|Discontinued|2|||
160900784|NCT06238362|581030212|FG000|Overall Study|Insufficient total sleep time|1|||
160900785|NCT06238362|581030213|FG001|Overall Study|Insufficient total sleep time|0|||
160900786|NCT06238362|581030212|FG000|Overall Study|Inadequate signal quality|1|||
160900787|NCT06238362|581030213|FG001|Overall Study|Inadequate signal quality|0|||
160900788|NCT01798004|581031822|FG000|Overall Study|Death|2|||
160900789|NCT01798004|581031822|FG000|Overall Study|Lack of Efficacy|8|||
160900790|NCT01798004|581031822|FG000|Overall Study|Physician Decision|25|||
160900791|NCT01798004|581031822|FG000|Overall Study|Withdrawal by Subject|4|||
160900792|NCT01798004|581031822|FG000|Overall Study|Ineligible|4|||
160900793|NCT01798004|581031822|FG000|Overall Study|Patient/parent refusal|7|||
160900794|NCT01798004|581031822|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
160900795|NCT01798004|581031822|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
160900796|NCT03320057|581031823|FG000|Overall Study|Lost to Follow-up|4|||
160900797|NCT03320057|581031824|FG001|Overall Study|Lost to Follow-up|17|||
160900798|NCT03320057|581031823|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
160987871|NCT02223793|581343215|FG000|Overall Study|Withdrawal by Subject|3|||
160552906|NCT01700192|579749879|FG000|Overall Study|Noncompliance with study drug|0|||
160552907|NCT01700192|579749880|FG001|Overall Study|Noncompliance with study drug|5|||
160552908|NCT01700192|579749879|FG000|Overall Study|Physician Decision|2|||
160552909|NCT01700192|579749880|FG001|Overall Study|Physician Decision|3|||
160552910|NCT01700192|579749879|FG000|Overall Study|Pregnancy|1|||
160820561|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
160820562|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
160820563|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160820564|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160820565|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
160820566|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
160820567|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
160820568|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
160820569|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
160820570|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
160820571|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
160820572|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
160820573|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
160820574|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
160820575|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160820576|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160820577|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
160820578|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160820579|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
160820580|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160820581|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
160820582|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
160820583|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
160820584|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
160552911|NCT01700192|579749880|FG001|Overall Study|Pregnancy|4|||
160820585|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
160820586|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
160820587|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
160820588|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
160820589|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
160820590|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
160820591|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
160820592|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
160820593|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
160820594|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
160820595|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
160820596|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
160820597|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
160820598|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
160820599|NCT02248649|580727147|FG000|Overall Study|Death|7|||
160820600|NCT02248649|580727148|FG001|Overall Study|Death|11|||
160820601|NCT02248649|580727147|FG000|Overall Study|Lost to Follow-up|14|||
160820602|NCT02248649|580727148|FG001|Overall Study|Lost to Follow-up|10|||
160820603|NCT03219034|580727151|FG000|Overall Study|Lost to Follow-up|9|||
160820604|NCT03219034|580727152|FG001|Overall Study|Lost to Follow-up|13|||
160820605|NCT03219034|580727151|FG000|Overall Study|Additional dental work needed|1|||
160820606|NCT03219034|580727152|FG001|Overall Study|Additional dental work needed|0|||
160820607|NCT03219034|580727151|FG000|Overall Study|UPPP Surgery|1|||
160820608|NCT03219034|580727152|FG001|Overall Study|UPPP Surgery|0|||
160820609|NCT03219034|580727151|FG000|Overall Study|Dental sensitivity|0|||
160820610|NCT03219034|580727152|FG001|Overall Study|Dental sensitivity|1|||
160820611|NCT03219034|580727151|FG000|Overall Study|Death in family|0|||
160820612|NCT03219034|580727152|FG001|Overall Study|Death in family|1|||
160820613|NCT01802580|580727153|FG000|Overall Study|Physician Decision|1|||
160820614|NCT01802580|580727154|FG001|Overall Study|Physician Decision|0|||
160820615|NCT01802580|580727153|FG000|Overall Study|Protocol Violation|2|||
160820616|NCT01802580|580727154|FG001|Overall Study|Protocol Violation|0|||
160820617|NCT01802580|580727153|FG000|Overall Study|Withdrawal by Subject|5|||
160820618|NCT01802580|580727154|FG001|Overall Study|Withdrawal by Subject|6|||
160820619|NCT01802580|580727153|FG000|Overall Study|Other|1|||
160820620|NCT01802580|580727154|FG001|Overall Study|Other|3|||
160552912|NCT01700192|579749879|FG000|Overall Study|Progressive disease|1|||
160987872|NCT02223793|581343216|FG001|Overall Study|Withdrawal by Subject|2|||
160987873|NCT02223793|581343217|FG002|Overall Study|Withdrawal by Subject|3|||
160552913|NCT01700192|579749880|FG001|Overall Study|Progressive disease|0|||
160820621|NCT01802580|580727153|FG000|Overall Study|Lack of Efficacy|0|||
160820622|NCT01802580|580727154|FG001|Overall Study|Lack of Efficacy|2|||
160987874|NCT02223793|581343215|FG000|Overall Study|Moved/studycenter unable to participate|4|||
160987875|NCT02223793|581343216|FG001|Overall Study|Moved/studycenter unable to participate|6|||
160987876|NCT02223793|581343217|FG002|Overall Study|Moved/studycenter unable to participate|8|||
160820623|NCT03255967|580727155|FG000|Overall Study|Adverse Event|26|||
160820624|NCT03255967|580727156|FG001|Overall Study|Adverse Event|30|||
160820625|NCT03255967|580727155|FG000|Overall Study|Withdrawal by Subject|6|||
160820626|NCT03255967|580727156|FG001|Overall Study|Withdrawal by Subject|6|||
160820627|NCT03255967|580727155|FG000|Overall Study|Schedule conflict|6|||
160820628|NCT03255967|580727156|FG001|Overall Study|Schedule conflict|4|||
160820629|NCT03255967|580727155|FG000|Overall Study|POA did not sign consent form|2|||
160820630|NCT03255967|580727156|FG001|Overall Study|POA did not sign consent form|0|||
160820631|NCT01327053|580727165|FG000|Overall Study|Adverse Event|23|||
160987877|NCT00278564|581343219|FG000|Overall Study|Lack of Efficacy|4|||
160987878|NCT02321540|581343220|FG000|Overall Study|Death|0|||
160987879|NCT02321540|581343221|FG001|Overall Study|Death|1|||
160987880|NCT02321540|581343220|FG000|Overall Study|Progression|3|||
160987881|NCT02321540|581343221|FG001|Overall Study|Progression|9|||
160987882|NCT00003377|581343222|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
160987883|NCT00003377|581343223|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
160987884|NCT00003377|581343224|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
160987885|NCT00003377|581343225|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
160987886|NCT00003377|581343226|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
160987887|NCT00003377|581343222|FG000|Period II|Ureteral stent complications|0|||
160987888|NCT00003377|581343223|FG001|Period II|Ureteral stent complications|0|||
160987889|NCT00003377|581343224|FG002|Period II|Ureteral stent complications|0|||
160987890|NCT00003377|581343225|FG003|Period II|Ureteral stent complications|0|||
160987891|NCT00003377|581343226|FG004|Period II|Ureteral stent complications|1|||
160987892|NCT00480441|581343230|FG000|Screening|Not Eligible|37|||
160987893|NCT00480441|581343231|FG001|Screening|Not Eligible|0|||
160552914|NCT01700192|579749879|FG000|Overall Study|Protocol Violation|3|||
160552915|NCT01700192|579749880|FG001|Overall Study|Protocol Violation|4|||
160552916|NCT01700192|579749879|FG000|Overall Study|Technical problems|0|||
160552917|NCT01700192|579749880|FG001|Overall Study|Technical problems|1|||
160552918|NCT01700192|579749879|FG000|Overall Study|Withdrawal by Subject|56|||
160552919|NCT01700192|579749880|FG001|Overall Study|Withdrawal by Subject|64|||
160987894|NCT00480441|581343232|FG002|Screening|Not Eligible|0|||
160987895|NCT00480441|581343230|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
160987896|NCT00480441|581343231|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
160987897|NCT00480441|581343232|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
160987898|NCT00480441|581343230|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
160987899|NCT00480441|581343231|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
160987900|NCT00480441|581343232|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
160987901|NCT00480441|581343230|FG000|Baseline Functional MRI|physical contraindication|4|||
160987902|NCT00480441|581343231|FG001|Baseline Functional MRI|physical contraindication|0|||
160987903|NCT00480441|581343232|FG002|Baseline Functional MRI|physical contraindication|0|||
160987904|NCT00480441|581343230|FG000|Randomization|Lost to Follow-up|0|||
160987905|NCT00480441|581343231|FG001|Randomization|Lost to Follow-up|7|||
160987906|NCT00480441|581343232|FG002|Randomization|Lost to Follow-up|2|||
160987907|NCT03532178|581343233|FG000|First Period|Withdrawal by Subject|1|||
160987908|NCT03532178|581343234|FG001|First Period|Withdrawal by Subject|3|||
160987909|NCT03532178|581343233|FG000|First Period|technical issues in data collection Technical issues|0|||
160987910|NCT03532178|581343234|FG001|First Period|technical issues in data collection Technical issues|1|||
160987911|NCT03532178|581343233|FG000|Second Period|Withdrawal by Subject|1|||
160987912|NCT03532178|581343234|FG001|Second Period|Withdrawal by Subject|1|||
160987913|NCT03532178|581343233|FG000|Second Period|Technical issues|0|||
160987914|NCT03532178|581343234|FG001|Second Period|Technical issues|1|||
160987915|NCT01113463|581343238|FG000|Overall Study|Physician Decision|5|||
160987916|NCT00372528|581343239|FG000|Overall Study|Lack of Efficacy|1|||
160987917|NCT00372528|581343239|FG000|Overall Study|Adverse Event|1|||
160987918|NCT00372528|581343239|FG000|Overall Study|Study Terminated by Sponsor|18|||
160987919|NCT00372528|581343239|FG000|Overall Study|Other|1|||
160987920|NCT01417000|581343240|FG000|Overall Study|Death|59|||
160820632|NCT01327053|580727166|FG001|Overall Study|Adverse Event|57|||
160820633|NCT01327053|580727165|FG000|Overall Study|Patient/guardian decision|11|||
160987921|NCT01417000|581343241|FG001|Overall Study|Death|28|||
160987922|NCT01417000|581343240|FG000|Overall Study|Lost to Follow-up|1|||
160987923|NCT01417000|581343241|FG001|Overall Study|Lost to Follow-up|0|||
160987924|NCT01417000|581343240|FG000|Overall Study|Study Terminated by Sponsor|1|||
160987925|NCT01417000|581343241|FG001|Overall Study|Study Terminated by Sponsor|1|||
160987926|NCT00965484|581343242|FG000|Overall Study|Protocol Violation|1|||
160987927|NCT00965484|581343242|FG000|Overall Study|Withdrawal by Subject|1|||
160987928|NCT00162942|581343243|FG000|Overall Study|Adverse Event|10|||
160987929|NCT00162942|581343244|FG001|Overall Study|Adverse Event|6|||
160987930|NCT00162942|581343243|FG000|Overall Study|Death|1|||
160987931|NCT00162942|581343244|FG001|Overall Study|Death|0|||
160987932|NCT00162942|581343243|FG000|Overall Study|Withdrawal by Subject|3|||
160987933|NCT00162942|581343244|FG001|Overall Study|Withdrawal by Subject|6|||
160987934|NCT00162942|581343243|FG000|Overall Study|Physician Decision|1|||
160900799|NCT03320057|581031824|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
160900800|NCT06956170|581031825|FG000|Overall Study|Death|2|||
160900801|NCT06956170|581031826|FG001|Overall Study|Death|1|||
160900802|NCT06956170|581031825|FG000|Overall Study|Withdrawal by Subject|1|||
160900803|NCT06956170|581031826|FG001|Overall Study|Withdrawal by Subject|0|||
160900804|NCT06956170|581031825|FG000|Overall Study|Ongoing|7|||
160900805|NCT06956170|581031826|FG001|Overall Study|Ongoing|10|||
160900806|NCT02323113|581031827|FG000|Overall Study|Adverse Event|3|||
160900807|NCT02323113|581031828|FG001|Overall Study|Adverse Event|3|||
160900808|NCT02323113|581031829|FG002|Overall Study|Adverse Event|2|||
160900809|NCT02323113|581031830|FG003|Overall Study|Adverse Event|5|||
160900810|NCT02323113|581031831|FG004|Overall Study|Adverse Event|8|||
160900811|NCT02323113|581031832|FG005|Overall Study|Adverse Event|3|||
160900812|NCT02323113|581031833|FG006|Overall Study|Adverse Event|6|||
160900813|NCT02323113|581031834|FG007|Overall Study|Adverse Event|0|||
160900814|NCT02323113|581031827|FG000|Overall Study|Progressive Disease|0|||
160900815|NCT02323113|581031828|FG001|Overall Study|Progressive Disease|1|||
160900816|NCT02323113|581031829|FG002|Overall Study|Progressive Disease|1|||
160900817|NCT02323113|581031830|FG003|Overall Study|Progressive Disease|0|||
160900818|NCT02323113|581031831|FG004|Overall Study|Progressive Disease|0|||
160900819|NCT02323113|581031832|FG005|Overall Study|Progressive Disease|3|||
160900820|NCT02323113|581031833|FG006|Overall Study|Progressive Disease|0|||
160900821|NCT02323113|581031834|FG007|Overall Study|Progressive Disease|0|||
160900822|NCT02323113|581031827|FG000|Overall Study|Symptomatic Deterioration|0|||
160900823|NCT02323113|581031828|FG001|Overall Study|Symptomatic Deterioration|0|||
160900824|NCT02323113|581031829|FG002|Overall Study|Symptomatic Deterioration|1|||
160900825|NCT02323113|581031830|FG003|Overall Study|Symptomatic Deterioration|0|||
160900826|NCT02323113|581031831|FG004|Overall Study|Symptomatic Deterioration|1|||
160900827|NCT02323113|581031832|FG005|Overall Study|Symptomatic Deterioration|0|||
160900828|NCT02323113|581031833|FG006|Overall Study|Symptomatic Deterioration|0|||
160900829|NCT02323113|581031834|FG007|Overall Study|Symptomatic Deterioration|0|||
160900830|NCT02323113|581031827|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
160900831|NCT02323113|581031828|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
160900832|NCT02323113|581031829|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
160900833|NCT02323113|581031830|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
160900834|NCT02323113|581031831|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
160900835|NCT02323113|581031832|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
160900836|NCT02323113|581031833|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
160900837|NCT02323113|581031834|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
160900838|NCT02323113|581031827|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900839|NCT02323113|581031828|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
160900840|NCT02323113|581031829|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900841|NCT02323113|581031830|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160987935|NCT00162942|581343244|FG001|Overall Study|Physician Decision|0|||
160987936|NCT00162942|581343243|FG000|Overall Study|Enter Open-Label Study|76|||
160987937|NCT00162942|581343244|FG001|Overall Study|Enter Open-Label Study|35|||
160987938|NCT00162942|581343243|FG000|Overall Study|Alternate Therapy|6|||
160987939|NCT00162942|581343244|FG001|Overall Study|Alternate Therapy|2|||
160900842|NCT02323113|581031831|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900843|NCT02323113|581031832|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900844|NCT02323113|581031833|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900845|NCT02323113|581031834|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900846|NCT02280304|581031839|FG000|Overall Study|Lost to Follow-up|7|||
160900847|NCT02280304|581031840|FG001|Overall Study|Lost to Follow-up|8|||
160900848|NCT04805541|581031841|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
160900849|NCT00713323|581031852|FG000|Overall Study|Adverse Event|75|||
160900850|NCT00713323|581031852|FG000|Overall Study|Withdrawal by Subject|15|||
160900851|NCT00713323|581031852|FG000|Overall Study|Lost to Follow-up|11|||
160900852|NCT00713323|581031852|FG000|Overall Study|Lack of Efficacy|36|||
160900853|NCT00713323|581031852|FG000|Overall Study|Low creatine clearance at screening|1|||
160900854|NCT00713323|581031852|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
160900855|NCT00713323|581031852|FG000|Overall Study|Surgery cured allodynic pain|1|||
160900856|NCT00713323|581031852|FG000|Overall Study|Pain free|1|||
160900857|NCT00713323|581031852|FG000|Overall Study|Non-compliance|1|||
160900858|NCT00713323|581031852|FG000|Overall Study|Pain resolved|1|||
160900859|NCT00713323|581031852|FG000|Overall Study|Subject travelling to USA|1|||
160900860|NCT00713323|581031852|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
160900861|NCT00713323|581031852|FG000|Overall Study|Treatment that may interact with Sativex|1|||
160900862|NCT05154578|581031853|FG000|Overall Study|Withdrawal by Subject|2|||
160900863|NCT05154578|581031854|FG001|Overall Study|Withdrawal by Subject|3|||
160987940|NCT00162942|581343243|FG000|Overall Study|Lack of Efficacy|1|||
160900864|NCT05154578|581031855|FG002|Overall Study|Withdrawal by Subject|2|||
160900865|NCT05154578|581031856|FG003|Overall Study|Withdrawal by Subject|4|||
160900866|NCT05154578|581031857|FG004|Overall Study|Withdrawal by Subject|0|||
160900867|NCT05154578|581031853|FG000|Overall Study|Lost to Follow-up|0|||
160900868|NCT05154578|581031854|FG001|Overall Study|Lost to Follow-up|1|||
160900869|NCT05154578|581031855|FG002|Overall Study|Lost to Follow-up|0|||
160900870|NCT05154578|581031856|FG003|Overall Study|Lost to Follow-up|3|||
160900871|NCT05154578|581031857|FG004|Overall Study|Lost to Follow-up|0|||
160900872|NCT05154578|581031853|FG000|Overall Study|Adverse Event|0|||
160900873|NCT05154578|581031854|FG001|Overall Study|Adverse Event|0|||
160900874|NCT05154578|581031855|FG002|Overall Study|Adverse Event|0|||
160900875|NCT05154578|581031856|FG003|Overall Study|Adverse Event|1|||
160900876|NCT05154578|581031857|FG004|Overall Study|Adverse Event|0|||
160900877|NCT05154578|581031853|FG000|Overall Study|Relocated to another province|0|||
160900878|NCT05154578|581031854|FG001|Overall Study|Relocated to another province|0|||
160900879|NCT05154578|581031855|FG002|Overall Study|Relocated to another province|1|||
160900880|NCT05154578|581031856|FG003|Overall Study|Relocated to another province|0|||
160900881|NCT05154578|581031857|FG004|Overall Study|Relocated to another province|1|||
160900882|NCT05154578|581031853|FG000|Overall Study|Baby loss|0|||
160900883|NCT05154578|581031854|FG001|Overall Study|Baby loss|1|||
160900884|NCT05154578|581031855|FG002|Overall Study|Baby loss|0|||
160900885|NCT05154578|581031856|FG003|Overall Study|Baby loss|0|||
160900886|NCT05154578|581031857|FG004|Overall Study|Baby loss|0|||
160900887|NCT02764333|581031858|FG000|Overall Study|Ineligible|1|||
160900888|NCT01200524|581031859|FG000|Overall Study|Withdrawal by Subject|1|||
160900889|NCT01200524|581031860|FG001|Overall Study|Withdrawal by Subject|1|||
160900890|NCT01200524|581031861|FG002|Overall Study|Withdrawal by Subject|3|||
160900891|NCT01200524|581031859|FG000|Overall Study|Adverse Event|1|||
160900892|NCT01200524|581031860|FG001|Overall Study|Adverse Event|0|||
160900893|NCT01200524|581031861|FG002|Overall Study|Adverse Event|0|||
160900894|NCT01200524|581031859|FG000|Overall Study|Non availability of study nurse|0|||
160900895|NCT01200524|581031860|FG001|Overall Study|Non availability of study nurse|0|||
160900896|NCT01200524|581031861|FG002|Overall Study|Non availability of study nurse|1|||
160900897|NCT00491764|581031863|FG000|Overall Study|Adverse Event|1|||
160900898|NCT00491764|581031864|FG001|Overall Study|Adverse Event|2|||
160900899|NCT00491764|581031865|FG002|Overall Study|Adverse Event|4|||
160900900|NCT00491764|581031866|FG003|Overall Study|Adverse Event|4|||
160900901|NCT00491764|581031867|FG004|Overall Study|Adverse Event|0|||
160900902|NCT00491764|581031868|FG005|Overall Study|Adverse Event|1|||
160900903|NCT00491764|581031863|FG000|Overall Study|Lost to Follow-up|0|||
160900904|NCT00491764|581031864|FG001|Overall Study|Lost to Follow-up|1|||
160900905|NCT00491764|581031865|FG002|Overall Study|Lost to Follow-up|0|||
160900906|NCT00491764|581031866|FG003|Overall Study|Lost to Follow-up|1|||
160900907|NCT00491764|581031867|FG004|Overall Study|Lost to Follow-up|0|||
160900908|NCT00491764|581031868|FG005|Overall Study|Lost to Follow-up|3|||
160900909|NCT00491764|581031863|FG000|Overall Study|Withdrawal by Subject|2|||
160900910|NCT00491764|581031864|FG001|Overall Study|Withdrawal by Subject|3|||
160900911|NCT00491764|581031865|FG002|Overall Study|Withdrawal by Subject|1|||
160900912|NCT00491764|581031866|FG003|Overall Study|Withdrawal by Subject|2|||
160900913|NCT00491764|581031867|FG004|Overall Study|Withdrawal by Subject|2|||
160900914|NCT00491764|581031868|FG005|Overall Study|Withdrawal by Subject|4|||
160900915|NCT00491764|581031863|FG000|Overall Study|Non Compliance with the Protocol|1|||
160900916|NCT00491764|581031864|FG001|Overall Study|Non Compliance with the Protocol|0|||
160900917|NCT00491764|581031865|FG002|Overall Study|Non Compliance with the Protocol|0|||
160900918|NCT00491764|581031866|FG003|Overall Study|Non Compliance with the Protocol|0|||
160987941|NCT00162942|581343244|FG001|Overall Study|Lack of Efficacy|0|||
160987942|NCT00162942|581343243|FG000|Overall Study|Flare During Active Treatment|7|||
160987943|NCT00162942|581343244|FG001|Overall Study|Flare During Active Treatment|3|||
160987944|NCT00162942|581343243|FG000|Overall Study|2 or more consecutive treatments missed|1|||
160987945|NCT00162942|581343244|FG001|Overall Study|2 or more consecutive treatments missed|0|||
160987946|NCT01354938|581343245|FG000|Overall Study|Lost to Follow-up|1|||
160987947|NCT00410384|581343246|FG000|Overall Study|Withdrawal by Subject|28|||
160987948|NCT00410384|581343247|FG001|Overall Study|Withdrawal by Subject|17|||
160987949|NCT00410384|581343248|FG002|Overall Study|Withdrawal by Subject|20|||
160987950|NCT00410384|581343246|FG000|Overall Study|Adverse Event|23|||
160987951|NCT00410384|581343247|FG001|Overall Study|Adverse Event|18|||
160987952|NCT00410384|581343248|FG002|Overall Study|Adverse Event|23|||
160646126|NCT02196506|580085991|FG001|Phase A|Protocol deviation|0|||
160646127|NCT02196506|580085992|FG002|Phase A|Protocol deviation|0|||
160900919|NCT00491764|581031867|FG004|Overall Study|Non Compliance with the Protocol|0|||
160900920|NCT00491764|581031868|FG005|Overall Study|Non Compliance with the Protocol|0|||
160900921|NCT00491764|581031863|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
160900922|NCT00491764|581031864|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
160900923|NCT00491764|581031865|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
160900924|NCT00491764|581031866|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
160987953|NCT00410384|581343246|FG000|Overall Study|Lack of Efficacy|20|||
160987954|NCT00410384|581343247|FG001|Overall Study|Lack of Efficacy|12|||
160820634|NCT01327053|580727166|FG001|Overall Study|Patient/guardian decision|35|||
160820635|NCT01327053|580727165|FG000|Overall Study|Physician Decision|10|||
160820636|NCT01327053|580727166|FG001|Overall Study|Physician Decision|14|||
160820637|NCT01327053|580727165|FG000|Overall Study|Death|1|||
160820638|NCT01327053|580727166|FG001|Overall Study|Death|5|||
160820639|NCT01327053|580727165|FG000|Overall Study|Lost to Follow-up|2|||
160820640|NCT01327053|580727166|FG001|Overall Study|Lost to Follow-up|4|||
160820641|NCT01327053|580727165|FG000|Overall Study|Non-compliance with study treatment|0|||
160820642|NCT01327053|580727166|FG001|Overall Study|Non-compliance with study treatment|5|||
160820643|NCT01327053|580727165|FG000|Overall Study|Study terminated by Sponsor|1|||
160900925|NCT00491764|581031867|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
160900926|NCT00491764|581031868|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
160646128|NCT02196506|580085993|FG003|Phase A|Protocol deviation|0|||
160987955|NCT00410384|581343248|FG002|Overall Study|Lack of Efficacy|17|||
160987956|NCT00410384|581343246|FG000|Overall Study|Lack of Compliance|2|||
160987957|NCT00410384|581343247|FG001|Overall Study|Lack of Compliance|2|||
160987958|NCT00410384|581343248|FG002|Overall Study|Lack of Compliance|2|||
160820644|NCT01327053|580727166|FG001|Overall Study|Study terminated by Sponsor|3|||
160820645|NCT01327053|580727165|FG000|Overall Study|Progressive disease|31|||
160820646|NCT01327053|580727166|FG001|Overall Study|Progressive disease|26|||
160820647|NCT01327053|580727165|FG000|Overall Study|Protocol Violation|0|||
160820648|NCT01327053|580727166|FG001|Overall Study|Protocol Violation|1|||
160820649|NCT01327053|580727165|FG000|Overall Study|Untreated|0|||
160820650|NCT01327053|580727166|FG001|Overall Study|Untreated|1|||
160820651|NCT00778258|580727170|FG000|Overall Study|Adverse Event|1|||
160820652|NCT00778258|580727171|FG001|Overall Study|Adverse Event|0|||
160820653|NCT00778258|580727172|FG002|Overall Study|Adverse Event|0|||
160820654|NCT00778258|580727173|FG003|Overall Study|Adverse Event|0|||
160820655|NCT00778258|580727174|FG004|Overall Study|Adverse Event|0|||
160820656|NCT00778258|580727175|FG005|Overall Study|Adverse Event|1|||
160820657|NCT00778258|580727176|FG006|Overall Study|Adverse Event|0|||
160820658|NCT00778258|580727177|FG007|Overall Study|Adverse Event|0|||
160820659|NCT00778258|580727178|FG008|Overall Study|Adverse Event|0|||
160820660|NCT00778258|580727170|FG000|Overall Study|Lost to Follow-up|0|||
160820661|NCT00778258|580727171|FG001|Overall Study|Lost to Follow-up|0|||
160820662|NCT00778258|580727172|FG002|Overall Study|Lost to Follow-up|2|||
160820663|NCT00778258|580727173|FG003|Overall Study|Lost to Follow-up|0|||
160820664|NCT00778258|580727174|FG004|Overall Study|Lost to Follow-up|0|||
160820665|NCT00778258|580727175|FG005|Overall Study|Lost to Follow-up|3|||
160820666|NCT00778258|580727176|FG006|Overall Study|Lost to Follow-up|2|||
160820667|NCT00778258|580727177|FG007|Overall Study|Lost to Follow-up|2|||
160820668|NCT00778258|580727178|FG008|Overall Study|Lost to Follow-up|0|||
160820669|NCT00778258|580727170|FG000|Overall Study|Withdrawal by Subject|6|||
160820670|NCT00778258|580727171|FG001|Overall Study|Withdrawal by Subject|2|||
160820671|NCT00778258|580727172|FG002|Overall Study|Withdrawal by Subject|8|||
160820672|NCT00778258|580727173|FG003|Overall Study|Withdrawal by Subject|2|||
160820673|NCT00778258|580727174|FG004|Overall Study|Withdrawal by Subject|0|||
160820674|NCT00778258|580727175|FG005|Overall Study|Withdrawal by Subject|6|||
160820675|NCT00778258|580727176|FG006|Overall Study|Withdrawal by Subject|12|||
160820676|NCT00778258|580727177|FG007|Overall Study|Withdrawal by Subject|12|||
160820677|NCT00778258|580727178|FG008|Overall Study|Withdrawal by Subject|4|||
160820678|NCT00778258|580727170|FG000|Overall Study|New Contraindication|0|||
160820679|NCT00778258|580727171|FG001|Overall Study|New Contraindication|0|||
160820680|NCT00778258|580727172|FG002|Overall Study|New Contraindication|0|||
160820681|NCT00778258|580727173|FG003|Overall Study|New Contraindication|0|||
160820682|NCT00778258|580727174|FG004|Overall Study|New Contraindication|0|||
160820683|NCT00778258|580727175|FG005|Overall Study|New Contraindication|0|||
160820684|NCT00778258|580727176|FG006|Overall Study|New Contraindication|0|||
160820685|NCT00778258|580727177|FG007|Overall Study|New Contraindication|1|||
160820686|NCT00778258|580727178|FG008|Overall Study|New Contraindication|0|||
160820687|NCT00778258|580727170|FG000|Overall Study|Non-compliance|0|||
160820688|NCT00778258|580727171|FG001|Overall Study|Non-compliance|0|||
160820689|NCT00778258|580727172|FG002|Overall Study|Non-compliance|0|||
160820690|NCT00778258|580727173|FG003|Overall Study|Non-compliance|1|||
160820691|NCT00778258|580727174|FG004|Overall Study|Non-compliance|0|||
160820692|NCT00778258|580727175|FG005|Overall Study|Non-compliance|0|||
160820693|NCT00778258|580727176|FG006|Overall Study|Non-compliance|0|||
160820694|NCT00778258|580727177|FG007|Overall Study|Non-compliance|0|||
160820695|NCT00778258|580727178|FG008|Overall Study|Non-compliance|0|||
160820696|NCT00778258|580727170|FG000|Overall Study|Other|0|||
160820697|NCT00778258|580727171|FG001|Overall Study|Other|0|||
160820698|NCT00778258|580727172|FG002|Overall Study|Other|0|||
160820699|NCT00778258|580727173|FG003|Overall Study|Other|0|||
160820700|NCT00778258|580727174|FG004|Overall Study|Other|0|||
160820701|NCT00778258|580727175|FG005|Overall Study|Other|0|||
160987959|NCT00410384|581343246|FG000|Overall Study|Lost to Follow-up|4|||
160820702|NCT00778258|580727176|FG006|Overall Study|Other|1|||
160820703|NCT00778258|580727177|FG007|Overall Study|Other|0|||
160987960|NCT00410384|581343247|FG001|Overall Study|Lost to Follow-up|6|||
160820704|NCT00778258|580727178|FG008|Overall Study|Other|0|||
160820705|NCT04621240|580727180|FG000|Overall Study|Withdrawal by Subject|36|||
160820706|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
160820707|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
160820708|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
160820709|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
160820710|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
160820711|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
160820712|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
160820713|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
160820714|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
160987961|NCT00410384|581343248|FG002|Overall Study|Lost to Follow-up|6|||
160820715|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
160820716|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
160820717|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
160820718|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
160820719|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
160820720|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
160820721|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
160820722|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
160820723|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
160820724|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
160820725|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
160820726|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
160820727|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
160820728|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
160820729|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
160820730|NCT05599451|580729044|FG000|Overall Study|Not randomized|11|||
160820731|NCT05599451|580729045|FG001|Overall Study|Not randomized|0|||
160820732|NCT05599451|580729046|FG002|Overall Study|Not randomized|0|||
160820733|NCT05599451|580729047|FG003|Overall Study|Not randomized|0|||
160820734|NCT05599451|580729048|FG004|Overall Study|Not randomized|0|||
160820735|NCT05599451|580729044|FG000|Overall Study|Physician Decision|0|||
160820736|NCT05599451|580729045|FG001|Overall Study|Physician Decision|0|||
160820737|NCT05599451|580729046|FG002|Overall Study|Physician Decision|0|||
160820738|NCT05599451|580729047|FG003|Overall Study|Physician Decision|1|||
160820739|NCT05599451|580729048|FG004|Overall Study|Physician Decision|0|||
160820740|NCT02723006|580729049|FG000|Overall Study|Withdrawal by Subject|0|||
160820741|NCT02723006|580729050|FG001|Overall Study|Withdrawal by Subject|1|||
160900927|NCT00491764|581031863|FG000|Overall Study|Administrative|1|||
160900928|NCT00491764|581031864|FG001|Overall Study|Administrative|0|||
160900929|NCT00491764|581031865|FG002|Overall Study|Administrative|2|||
160900930|NCT00491764|581031866|FG003|Overall Study|Administrative|1|||
160900931|NCT00491764|581031867|FG004|Overall Study|Administrative|0|||
160900932|NCT00491764|581031868|FG005|Overall Study|Administrative|0|||
160900933|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Adverse Event|3|||
160900934|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Adverse Event|0|||
160900935|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
160900936|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
160900937|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
160900938|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
160900939|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Physician Decision|0|||
160900940|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Physician Decision|2|||
160900941|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
160900942|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
160900943|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
160900944|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
160900945|NCT02110238|581031869|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
160900946|NCT02110238|581031870|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
160900947|NCT02110238|581031869|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
160900948|NCT02110238|581031870|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
160900949|NCT02110238|581031869|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
160900950|NCT02110238|581031870|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
160900951|NCT02110238|581031869|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
160900952|NCT02110238|581031870|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
160900953|NCT02110238|581031869|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
160900954|NCT02110238|581031870|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
160900955|NCT03228433|581031875|FG000|Overall Study|Lost to Follow-up|1|||
160900956|NCT03228433|581031876|FG001|Overall Study|Lost to Follow-up|0|||
160900957|NCT03228433|581031877|FG002|Overall Study|Lost to Follow-up|0|||
160900958|NCT03228433|581031878|FG003|Overall Study|Lost to Follow-up|0|||
160900959|NCT03228433|581031879|FG004|Overall Study|Lost to Follow-up|0|||
160900960|NCT03228433|581031880|FG005|Overall Study|Lost to Follow-up|0|||
160900961|NCT03228433|581031875|FG000|Overall Study|Positive alcohol test|0|||
160900962|NCT03228433|581031876|FG001|Overall Study|Positive alcohol test|0|||
160900963|NCT03228433|581031877|FG002|Overall Study|Positive alcohol test|0|||
160900964|NCT03228433|581031878|FG003|Overall Study|Positive alcohol test|1|||
160900965|NCT03228433|581031879|FG004|Overall Study|Positive alcohol test|0|||
160820742|NCT02723006|580729051|FG002|Overall Study|Withdrawal by Subject|1|||
160820743|NCT02723006|580729049|FG000|Overall Study|Study Terminated by Sponsor|1|||
160900966|NCT03228433|581031880|FG005|Overall Study|Positive alcohol test|0|||
160900967|NCT03626168|581031883|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160900968|NCT03626168|581031884|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
160820744|NCT02723006|580729050|FG001|Overall Study|Study Terminated by Sponsor|6|||
160820745|NCT02723006|580729051|FG002|Overall Study|Study Terminated by Sponsor|6|||
160820746|NCT00303446|580729052|FG000|Overall Study|Withdrawal by Subject|2|||
160820747|NCT00303446|580729053|FG001|Overall Study|Withdrawal by Subject|2|||
160820748|NCT00303446|580729052|FG000|Overall Study|Death|0|||
160820749|NCT00303446|580729053|FG001|Overall Study|Death|1|||
160820750|NCT00303446|580729052|FG000|Overall Study|Physician Decision|0|||
160820751|NCT00303446|580729053|FG001|Overall Study|Physician Decision|1|||
160820752|NCT03285958|580729054|FG000|Overall Study|Lost to Follow-up|1|||
160820753|NCT03285958|580729055|FG001|Overall Study|Lost to Follow-up|1|||
160820754|NCT03285958|580729054|FG000|Overall Study|Withdrawal by Subject|1|||
160820755|NCT03285958|580729055|FG001|Overall Study|Withdrawal by Subject|0|||
160820756|NCT03285958|580729054|FG000|Overall Study|Not able to attend required orientation|3|||
160820757|NCT03285958|580729055|FG001|Overall Study|Not able to attend required orientation|0|||
160820758|NCT03116828|580729057|FG000|Overall Study|Adverse Event|1|||
160820759|NCT03116828|580729058|FG001|Overall Study|Adverse Event|10|||
160820760|NCT03116828|580729057|FG000|Overall Study|Withdrawal by Subject|4|||
160820761|NCT03116828|580729058|FG001|Overall Study|Withdrawal by Subject|8|||
160820762|NCT03116828|580729057|FG000|Overall Study|OTHER|3|||
160820763|NCT03116828|580729058|FG001|Overall Study|OTHER|3|||
160820764|NCT05243745|580729061|FG000|Overall Study|Withdrawal by Subject|0|||
160820765|NCT05243745|580729062|FG001|Overall Study|Withdrawal by Subject|0|||
160820766|NCT05243745|580729063|FG002|Overall Study|Withdrawal by Subject|0|||
160820767|NCT05243745|580729064|FG003|Overall Study|Withdrawal by Subject|1|||
160820768|NCT05243745|580729061|FG000|Overall Study|Unable to Attend Visit 6|0|||
160820769|NCT05243745|580729062|FG001|Overall Study|Unable to Attend Visit 6|0|||
160820770|NCT05243745|580729063|FG002|Overall Study|Unable to Attend Visit 6|1|||
160820771|NCT05243745|580729064|FG003|Overall Study|Unable to Attend Visit 6|0|||
160820772|NCT02998203|580729065|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
160820773|NCT02998203|580729066|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
160820774|NCT02998203|580729065|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
160820775|NCT02998203|580729066|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
160820776|NCT04187144|580729079|FG000|Overall Study|Lost to Follow-up|12|||
160820777|NCT04187144|580729080|FG001|Overall Study|Lost to Follow-up|11|||
160820778|NCT04187144|580729079|FG000|Overall Study|Withdrawal by Subject|20|||
160820779|NCT04187144|580729080|FG001|Overall Study|Withdrawal by Subject|18|||
160820780|NCT04187144|580729079|FG000|Overall Study|Adverse Event|19|||
160820781|NCT04187144|580729080|FG001|Overall Study|Adverse Event|4|||
160987962|NCT00410384|581343246|FG000|Overall Study|Protocol Violation|6|||
160987963|NCT00410384|581343247|FG001|Overall Study|Protocol Violation|6|||
160987964|NCT00410384|581343248|FG002|Overall Study|Protocol Violation|6|||
160987965|NCT00410384|581343246|FG000|Overall Study|Physician Decision|3|||
160987966|NCT00410384|581343247|FG001|Overall Study|Physician Decision|3|||
160987967|NCT00410384|581343248|FG002|Overall Study|Physician Decision|4|||
160987968|NCT00410384|581343246|FG000|Overall Study|Other|3|||
160987969|NCT00410384|581343247|FG001|Overall Study|Other|8|||
160987970|NCT00410384|581343248|FG002|Overall Study|Other|4|||
160987971|NCT01167023|581343249|FG000|Overall Study|Lost to Follow-up|0|||
160987972|NCT01167023|581343250|FG001|Overall Study|Lost to Follow-up|1|||
160987973|NCT01167023|581343251|FG002|Overall Study|Lost to Follow-up|1|||
160987974|NCT01167023|581343249|FG000|Overall Study|Screen Failure|0|||
160987975|NCT01167023|581343250|FG001|Overall Study|Screen Failure|1|||
160987976|NCT01167023|581343251|FG002|Overall Study|Screen Failure|0|||
160987977|NCT01167023|581343249|FG000|Overall Study|Sponsor Decision|0|||
160987978|NCT01167023|581343250|FG001|Overall Study|Sponsor Decision|1|||
160987979|NCT01167023|581343251|FG002|Overall Study|Sponsor Decision|0|||
160987980|NCT01167023|581343249|FG000|Overall Study|Withdrawal by Subject|0|||
160987981|NCT01167023|581343250|FG001|Overall Study|Withdrawal by Subject|0|||
160987982|NCT01167023|581343251|FG002|Overall Study|Withdrawal by Subject|1|||
160987983|NCT01253200|581343252|FG000|Overall Study|Death|1|||
160987984|NCT01253200|581343253|FG001|Overall Study|Death|0|||
160987985|NCT01253200|581343254|FG002|Overall Study|Death|0|||
160987986|NCT01253200|581343255|FG003|Overall Study|Death|0|||
160987987|NCT01253200|581343256|FG004|Overall Study|Death|0|||
160820782|NCT04187144|580729079|FG000|Overall Study|Physician Decision|5|||
160820783|NCT04187144|580729080|FG001|Overall Study|Physician Decision|3|||
160820784|NCT04187144|580729079|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
160820785|NCT04187144|580729080|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
160820786|NCT04187144|580729079|FG000|Overall Study|Protocol Deviation|1|||
160820787|NCT04187144|580729080|FG001|Overall Study|Protocol Deviation|4|||
160987988|NCT01253200|581343252|FG000|Overall Study|Lost to Follow-up|1|||
160987989|NCT01253200|581343253|FG001|Overall Study|Lost to Follow-up|1|||
160987990|NCT01253200|581343254|FG002|Overall Study|Lost to Follow-up|0|||
160987991|NCT01253200|581343255|FG003|Overall Study|Lost to Follow-up|0|||
160987992|NCT01253200|581343256|FG004|Overall Study|Lost to Follow-up|0|||
160987993|NCT01253200|581343252|FG000|Overall Study|Withdrawal by Subject|2|||
160987994|NCT01253200|581343253|FG001|Overall Study|Withdrawal by Subject|0|||
160987995|NCT01253200|581343254|FG002|Overall Study|Withdrawal by Subject|0|||
160900969|NCT03626168|581031883|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
160900970|NCT03626168|581031884|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
160900971|NCT03626168|581031883|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
160900972|NCT03626168|581031884|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
160900973|NCT01419626|581031885|FG000|Overall Study|Protocol Violation|3|||
160900974|NCT01419626|581031886|FG001|Overall Study|Protocol Violation|2|||
160900975|NCT01419626|581031887|FG002|Overall Study|Protocol Violation|2|||
160900976|NCT01419626|581031885|FG000|Overall Study|Withdrawal by Subject|1|||
160900977|NCT01419626|581031886|FG001|Overall Study|Withdrawal by Subject|0|||
160900978|NCT01419626|581031887|FG002|Overall Study|Withdrawal by Subject|0|||
160900979|NCT01419626|581031885|FG000|Overall Study|Lost to Follow-up|0|||
160900980|NCT01419626|581031886|FG001|Overall Study|Lost to Follow-up|1|||
160900981|NCT01419626|581031887|FG002|Overall Study|Lost to Follow-up|1|||
160900982|NCT01146912|581031888|FG000|Overall Study|Already received influenza vaccination|817|||
160900983|NCT01146912|581031889|FG001|Overall Study|Already received influenza vaccination|822|||
160900984|NCT01146912|581031890|FG002|Overall Study|Already received influenza vaccination|13|||
160900985|NCT01146912|581031891|FG003|Overall Study|Already received influenza vaccination|15|||
160900986|NCT01146912|581031892|FG004|Overall Study|Already received influenza vaccination|41|||
160900987|NCT01146912|581031893|FG005|Overall Study|Already received influenza vaccination|61|||
160900988|NCT01146912|581031894|FG006|Overall Study|Already received influenza vaccination|56|||
160900989|NCT01146912|581031895|FG007|Overall Study|Already received influenza vaccination|0|||
160900990|NCT01146912|581031888|FG000|Overall Study|< 14 weeks gestational age|0|||
160900991|NCT01146912|581031889|FG001|Overall Study|< 14 weeks gestational age|0|||
160900992|NCT01146912|581031890|FG002|Overall Study|< 14 weeks gestational age|3|||
160987996|NCT01253200|581343255|FG003|Overall Study|Withdrawal by Subject|0|||
160987997|NCT01253200|581343256|FG004|Overall Study|Withdrawal by Subject|0|||
160987998|NCT01253200|581343252|FG000|Overall Study|Protocol Violation|1|||
160987999|NCT01253200|581343253|FG001|Overall Study|Protocol Violation|4|||
160988000|NCT01253200|581343254|FG002|Overall Study|Protocol Violation|0|||
160988001|NCT01253200|581343255|FG003|Overall Study|Protocol Violation|0|||
160988002|NCT01253200|581343256|FG004|Overall Study|Protocol Violation|5|||
160988003|NCT01253200|581343252|FG000|Overall Study|intents|10|||
160988004|NCT01253200|581343253|FG001|Overall Study|intents|10|||
160988005|NCT01253200|581343254|FG002|Overall Study|intents|1|||
160988006|NCT01253200|581343255|FG003|Overall Study|intents|3|||
160988007|NCT01253200|581343256|FG004|Overall Study|intents|0|||
160988008|NCT01253200|581343252|FG000|Overall Study|Attempts|6|||
160988009|NCT01253200|581343253|FG001|Overall Study|Attempts|4|||
160988010|NCT01253200|581343254|FG002|Overall Study|Attempts|1|||
160988011|NCT01253200|581343255|FG003|Overall Study|Attempts|2|||
160988012|NCT01253200|581343256|FG004|Overall Study|Attempts|0|||
160988013|NCT02049437|581343257|FG000|Period 1|Adverse Event|1|||
160988014|NCT02049437|581343258|FG001|Period 1|Adverse Event|1|||
160988015|NCT02049437|581343257|FG000|Period 1|Adverse Event|1|||
160988016|NCT02049437|581343258|FG001|Period 1|Adverse Event|0|||
160988017|NCT01192295|581343259|FG000|Overall Study|Adverse Event|3|||
160988018|NCT01192295|581343260|FG001|Overall Study|Adverse Event|7|||
160988019|NCT01192295|581343259|FG000|Overall Study|Withdrawal by Subject|3|||
160988020|NCT01192295|581343260|FG001|Overall Study|Withdrawal by Subject|4|||
160988021|NCT01192295|581343259|FG000|Overall Study|Lost to Follow-up|0|||
160988022|NCT01192295|581343260|FG001|Overall Study|Lost to Follow-up|1|||
160988023|NCT01192295|581343259|FG000|Overall Study|Lack of Efficacy|0|||
160988024|NCT01192295|581343260|FG001|Overall Study|Lack of Efficacy|5|||
160988025|NCT01192295|581343259|FG000|Overall Study|Administrative|4|||
160988026|NCT01192295|581343260|FG001|Overall Study|Administrative|6|||
160988027|NCT00630539|581343261|FG000|Overall Study|Adverse Event|1|||
160988028|NCT00630539|581343262|FG001|Overall Study|Adverse Event|3|||
160988029|NCT00630539|581343263|FG002|Overall Study|Adverse Event|1|||
160988030|NCT00630539|581343264|FG003|Overall Study|Adverse Event|2|||
160988031|NCT00630539|581343261|FG000|Overall Study|Withdrawal by Subject|0|||
160988032|NCT00630539|581343262|FG001|Overall Study|Withdrawal by Subject|1|||
160988033|NCT00630539|581343263|FG002|Overall Study|Withdrawal by Subject|0|||
160900993|NCT01146912|581031891|FG003|Overall Study|< 14 weeks gestational age|2|||
160988034|NCT00630539|581343264|FG003|Overall Study|Withdrawal by Subject|1|||
160900994|NCT01146912|581031892|FG004|Overall Study|< 14 weeks gestational age|0|||
160900995|NCT01146912|581031893|FG005|Overall Study|< 14 weeks gestational age|0|||
160900996|NCT01146912|581031894|FG006|Overall Study|< 14 weeks gestational age|0|||
160988035|NCT00578227|581343270|FG000|Overall Study|Lost to Follow-up|0|||
160988036|NCT00578227|581343271|FG001|Overall Study|Lost to Follow-up|1|||
160988037|NCT00578227|581343272|FG002|Overall Study|Lost to Follow-up|1|||
160988038|NCT00578227|581343270|FG000|Overall Study|Withdrawal by Subject|5|||
160988039|NCT00578227|581343271|FG001|Overall Study|Withdrawal by Subject|1|||
160988040|NCT00578227|581343272|FG002|Overall Study|Withdrawal by Subject|3|||
160988041|NCT04736056|581343285|FG000|Overall Study|Death|0|||
160988042|NCT04736056|581343286|FG001|Overall Study|Death|0|||
160988043|NCT04736056|581343287|FG002|Overall Study|Death|0|||
160988044|NCT04736056|581343288|FG003|Overall Study|Death|1|||
160988045|NCT04736056|581343285|FG000|Overall Study|Lost to Follow-up|1|||
160988046|NCT04736056|581343286|FG001|Overall Study|Lost to Follow-up|0|||
160988047|NCT04736056|581343287|FG002|Overall Study|Lost to Follow-up|1|||
160988048|NCT04736056|581343288|FG003|Overall Study|Lost to Follow-up|1|||
160988049|NCT04736056|581343285|FG000|Overall Study|Withdrawal by Subject|2|||
160988050|NCT04736056|581343286|FG001|Overall Study|Withdrawal by Subject|0|||
160820788|NCT03842969|580729081|FG000|Overall Study|Participant declined follow-up visit|0|||
160820789|NCT03842969|580729082|FG001|Overall Study|Participant declined follow-up visit|1|||
160820790|NCT03842969|580729083|FG002|Overall Study|Participant declined follow-up visit|0|||
160820791|NCT03842969|580729081|FG000|Overall Study|Sponsor's decision|12|||
160820792|NCT03842969|580729082|FG001|Overall Study|Sponsor's decision|99|||
160820793|NCT03842969|580729083|FG002|Overall Study|Sponsor's decision|61|||
160988051|NCT04736056|581343287|FG002|Overall Study|Withdrawal by Subject|0|||
160988052|NCT04736056|581343288|FG003|Overall Study|Withdrawal by Subject|0|||
160988053|NCT04736056|581343285|FG000|Overall Study|Physician Decision|1|||
160988054|NCT04736056|581343286|FG001|Overall Study|Physician Decision|0|||
160988055|NCT04736056|581343287|FG002|Overall Study|Physician Decision|1|||
160988056|NCT04736056|581343288|FG003|Overall Study|Physician Decision|0|||
160988057|NCT04529538|581343289|FG000|Overall Study|Lost to Follow-up|3|||
160988058|NCT04529538|581343290|FG001|Overall Study|Lost to Follow-up|2|||
160988059|NCT04529538|581343291|FG002|Overall Study|Lost to Follow-up|1|||
160988060|NCT04529538|581343292|FG003|Overall Study|Lost to Follow-up|0|||
160988061|NCT04529538|581343293|FG004|Overall Study|Lost to Follow-up|1|||
160988062|NCT04529538|581343294|FG005|Overall Study|Lost to Follow-up|1|||
160988063|NCT04529538|581343295|FG006|Overall Study|Lost to Follow-up|2|||
160988064|NCT04529538|581343296|FG007|Overall Study|Lost to Follow-up|0|||
160988065|NCT04529538|581343289|FG000|Overall Study|Not eligible at enrollment|0|||
160988066|NCT04529538|581343290|FG001|Overall Study|Not eligible at enrollment|1|||
160988067|NCT04529538|581343291|FG002|Overall Study|Not eligible at enrollment|2|||
160988068|NCT04529538|581343292|FG003|Overall Study|Not eligible at enrollment|1|||
160988069|NCT04529538|581343293|FG004|Overall Study|Not eligible at enrollment|0|||
160988070|NCT04529538|581343294|FG005|Overall Study|Not eligible at enrollment|0|||
160988071|NCT04529538|581343295|FG006|Overall Study|Not eligible at enrollment|0|||
160988072|NCT04529538|581343296|FG007|Overall Study|Not eligible at enrollment|1|||
160820794|NCT03842969|580729081|FG000|Overall Study|Pregnancy|0|||
160820795|NCT03842969|580729082|FG001|Overall Study|Pregnancy|0|||
160820796|NCT03842969|580729083|FG002|Overall Study|Pregnancy|1|||
160820797|NCT03842969|580729081|FG000|Overall Study|Death|1|||
160988073|NCT04529538|581343289|FG000|Overall Study|Withdrawal by Subject|0|||
160988074|NCT04529538|581343290|FG001|Overall Study|Withdrawal by Subject|1|||
160988075|NCT04529538|581343291|FG002|Overall Study|Withdrawal by Subject|1|||
160988076|NCT04529538|581343292|FG003|Overall Study|Withdrawal by Subject|2|||
160988077|NCT04529538|581343293|FG004|Overall Study|Withdrawal by Subject|0|||
160988078|NCT04529538|581343294|FG005|Overall Study|Withdrawal by Subject|2|||
160988079|NCT04529538|581343295|FG006|Overall Study|Withdrawal by Subject|3|||
160988080|NCT04529538|581343296|FG007|Overall Study|Withdrawal by Subject|0|||
160988081|NCT04529538|581343289|FG000|Overall Study|Other|0|||
160988082|NCT04529538|581343290|FG001|Overall Study|Other|1|||
160988083|NCT04529538|581343291|FG002|Overall Study|Other|0|||
160988084|NCT04529538|581343292|FG003|Overall Study|Other|0|||
160988085|NCT04529538|581343293|FG004|Overall Study|Other|0|||
160988086|NCT04529538|581343294|FG005|Overall Study|Other|0|||
160988087|NCT04529538|581343295|FG006|Overall Study|Other|0|||
160988088|NCT04529538|581343296|FG007|Overall Study|Other|0|||
160988089|NCT04529538|581343289|FG000|Overall Study|Adverse Event|0|||
160988090|NCT04529538|581343290|FG001|Overall Study|Adverse Event|0|||
160988091|NCT04529538|581343291|FG002|Overall Study|Adverse Event|0|||
160988092|NCT04529538|581343292|FG003|Overall Study|Adverse Event|1|||
160988093|NCT04529538|581343293|FG004|Overall Study|Adverse Event|0|||
160988094|NCT04529538|581343294|FG005|Overall Study|Adverse Event|0|||
160988095|NCT04529538|581343295|FG006|Overall Study|Adverse Event|0|||
160988096|NCT04529538|581343296|FG007|Overall Study|Adverse Event|0|||
160988097|NCT04529538|581343289|FG000|Overall Study|Protocol Deviation|0|||
160988098|NCT04529538|581343290|FG001|Overall Study|Protocol Deviation|0|||
160988099|NCT04529538|581343291|FG002|Overall Study|Protocol Deviation|0|||
160988100|NCT04529538|581343292|FG003|Overall Study|Protocol Deviation|1|||
160988101|NCT04529538|581343293|FG004|Overall Study|Protocol Deviation|0|||
160988102|NCT04529538|581343294|FG005|Overall Study|Protocol Deviation|0|||
160988103|NCT04529538|581343295|FG006|Overall Study|Protocol Deviation|0|||
160988104|NCT04529538|581343296|FG007|Overall Study|Protocol Deviation|0|||
160988105|NCT04529538|581343289|FG000|Overall Study|Physician Decision|0|||
160988106|NCT04529538|581343290|FG001|Overall Study|Physician Decision|0|||
160988107|NCT04529538|581343291|FG002|Overall Study|Physician Decision|0|||
160988108|NCT04529538|581343292|FG003|Overall Study|Physician Decision|0|||
160988109|NCT04529538|581343293|FG004|Overall Study|Physician Decision|0|||
160988110|NCT04529538|581343294|FG005|Overall Study|Physician Decision|1|||
160988111|NCT04529538|581343295|FG006|Overall Study|Physician Decision|0|||
160988112|NCT04529538|581343296|FG007|Overall Study|Physician Decision|1|||
160988113|NCT02223182|581343298|FG000|Double-Blind Period|Adverse Event|0|||
160988114|NCT02223182|581343299|FG001|Double-Blind Period|Adverse Event|2|||
160988115|NCT02223182|581343300|FG002|Double-Blind Period|Adverse Event|1|||
160988116|NCT02223182|581343301|FG003|Double-Blind Period|Adverse Event|0|||
160988117|NCT02223182|581343298|FG000|Double-Blind Period|Withdrawal by Subject|1|||
160820798|NCT03842969|580729082|FG001|Overall Study|Death|0|||
160988118|NCT02223182|581343299|FG001|Double-Blind Period|Withdrawal by Subject|1|||
160988119|NCT02223182|581343300|FG002|Double-Blind Period|Withdrawal by Subject|1|||
160988120|NCT02223182|581343301|FG003|Double-Blind Period|Withdrawal by Subject|0|||
160988121|NCT02223182|581343298|FG000|Double-Blind Period|Lost to Follow-up|0|||
160988122|NCT02223182|581343299|FG001|Double-Blind Period|Lost to Follow-up|1|||
160988123|NCT02223182|581343300|FG002|Double-Blind Period|Lost to Follow-up|0|||
160988124|NCT02223182|581343301|FG003|Double-Blind Period|Lost to Follow-up|0|||
160988125|NCT02223182|581343298|FG000|Double-Blind Period|Non Compliance|0|||
160988126|NCT02223182|581343299|FG001|Double-Blind Period|Non Compliance|0|||
160988127|NCT02223182|581343300|FG002|Double-Blind Period|Non Compliance|0|||
160988128|NCT02223182|581343301|FG003|Double-Blind Period|Non Compliance|1|||
160988129|NCT02223182|581343298|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
160988130|NCT02223182|581343299|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
160988131|NCT02223182|581343300|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
160988132|NCT02223182|581343301|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
160988133|NCT02223182|581343298|FG000|Open-Label 500 Period|Adverse Event|1|||
160988134|NCT02223182|581343299|FG001|Open-Label 500 Period|Adverse Event|0|||
160988135|NCT02223182|581343300|FG002|Open-Label 500 Period|Adverse Event|2|||
160988136|NCT02223182|581343301|FG003|Open-Label 500 Period|Adverse Event|1|||
160820799|NCT03842969|580729083|FG002|Overall Study|Death|1|||
160820800|NCT03842969|580729081|FG000|Overall Study|Withdrawal by Subject|3|||
160820801|NCT03842969|580729082|FG001|Overall Study|Withdrawal by Subject|30|||
160820802|NCT03842969|580729083|FG002|Overall Study|Withdrawal by Subject|18|||
160820803|NCT03842969|580729081|FG000|Overall Study|Protocol Violation|1|||
160820804|NCT03842969|580729082|FG001|Overall Study|Protocol Violation|1|||
160820805|NCT03842969|580729083|FG002|Overall Study|Protocol Violation|0|||
160820806|NCT03842969|580729081|FG000|Overall Study|Physician Decision|0|||
160820807|NCT03842969|580729082|FG001|Overall Study|Physician Decision|3|||
160820808|NCT03842969|580729083|FG002|Overall Study|Physician Decision|0|||
160820809|NCT03842969|580729081|FG000|Overall Study|Lost to Follow-up|0|||
160820810|NCT03842969|580729082|FG001|Overall Study|Lost to Follow-up|2|||
160820811|NCT03842969|580729083|FG002|Overall Study|Lost to Follow-up|0|||
160820812|NCT03842969|580729081|FG000|Overall Study|Adverse Event|0|||
160820813|NCT03842969|580729082|FG001|Overall Study|Adverse Event|2|||
160820814|NCT03842969|580729083|FG002|Overall Study|Adverse Event|0|||
160820815|NCT01044745|580729084|FG000|Overall Study|Ineiligible|2|||
160820816|NCT01962987|580729087|FG000|Overall Study|Adverse Event|4|||
160820817|NCT01962987|580729088|FG001|Overall Study|Adverse Event|4|||
160820818|NCT01962987|580729089|FG002|Overall Study|Adverse Event|0|||
160820819|NCT01962987|580729087|FG000|Overall Study|Lost to Follow-up|0|||
160820820|NCT01962987|580729088|FG001|Overall Study|Lost to Follow-up|0|||
160820821|NCT01962987|580729089|FG002|Overall Study|Lost to Follow-up|1|||
160820822|NCT01962987|580729087|FG000|Overall Study|Non compliance with dosing requirements|4|||
160820823|NCT01962987|580729088|FG001|Overall Study|Non compliance with dosing requirements|2|||
160820824|NCT01962987|580729089|FG002|Overall Study|Non compliance with dosing requirements|0|||
160820825|NCT01962987|580729087|FG000|Overall Study|Miscellaneous|1|||
160820826|NCT01962987|580729088|FG001|Overall Study|Miscellaneous|9|||
160820827|NCT01962987|580729089|FG002|Overall Study|Miscellaneous|2|||
160820828|NCT01962987|580729087|FG000|Overall Study|Restricted medication|5|||
160820829|NCT01962987|580729088|FG001|Overall Study|Restricted medication|1|||
160820830|NCT01962987|580729089|FG002|Overall Study|Restricted medication|1|||
160820831|NCT01962987|580729087|FG000|Overall Study|Serious Adverse Event|1|||
160820832|NCT01962987|580729088|FG001|Overall Study|Serious Adverse Event|0|||
160820833|NCT01962987|580729089|FG002|Overall Study|Serious Adverse Event|0|||
160820834|NCT01962987|580729087|FG000|Overall Study|Withdrawal by Subject|11|||
160820835|NCT01962987|580729088|FG001|Overall Study|Withdrawal by Subject|10|||
160820836|NCT01962987|580729089|FG002|Overall Study|Withdrawal by Subject|6|||
160820837|NCT01962987|580729087|FG000|Overall Study|Randomized in Error|4|||
160820838|NCT01962987|580729088|FG001|Overall Study|Randomized in Error|2|||
160820839|NCT01962987|580729089|FG002|Overall Study|Randomized in Error|2|||
160820840|NCT01468207|580729090|FG000|Treatment Period 1|Adverse Event|1|||
160820841|NCT01468207|580729091|FG001|Treatment Period 1|Adverse Event|0|||
160820842|NCT01468207|580729092|FG002|Treatment Period 1|Adverse Event|0|||
160988137|NCT02223182|581343298|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
160820843|NCT01468207|580729093|FG003|Treatment Period 1|Adverse Event|0|||
160820844|NCT01468207|580729094|FG004|Treatment Period 1|Adverse Event|0|||
160820845|NCT01468207|580729095|FG005|Treatment Period 1|Adverse Event|0|||
160820846|NCT01468207|580729090|FG000|Treatment Period 1|Protocol Violation|1|||
160820847|NCT01468207|580729091|FG001|Treatment Period 1|Protocol Violation|1|||
160988138|NCT02223182|581343299|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
160820848|NCT01468207|580729092|FG002|Treatment Period 1|Protocol Violation|0|||
160820849|NCT01468207|580729093|FG003|Treatment Period 1|Protocol Violation|0|||
160820850|NCT01468207|580729094|FG004|Treatment Period 1|Protocol Violation|0|||
160820851|NCT01468207|580729095|FG005|Treatment Period 1|Protocol Violation|0|||
160820852|NCT01468207|580729090|FG000|Treatment Period 1|Withdrawal by Subject|5|||
160820853|NCT01468207|580729091|FG001|Treatment Period 1|Withdrawal by Subject|4|||
160820854|NCT01468207|580729092|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160820855|NCT01468207|580729093|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160820856|NCT01468207|580729094|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160820857|NCT01468207|580729095|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160820858|NCT01468207|580729090|FG000|Treatment Period 1|Lost to Follow-up|2|||
160820859|NCT01468207|580729091|FG001|Treatment Period 1|Lost to Follow-up|1|||
160820860|NCT01468207|580729092|FG002|Treatment Period 1|Lost to Follow-up|0|||
160820861|NCT01468207|580729093|FG003|Treatment Period 1|Lost to Follow-up|0|||
160820862|NCT01468207|580729094|FG004|Treatment Period 1|Lost to Follow-up|0|||
160820863|NCT01468207|580729095|FG005|Treatment Period 1|Lost to Follow-up|0|||
160820864|NCT01468207|580729090|FG000|Treatment Period 1|Other|0|||
160820865|NCT01468207|580729091|FG001|Treatment Period 1|Other|2|||
160820866|NCT01468207|580729092|FG002|Treatment Period 1|Other|0|||
160820867|NCT01468207|580729093|FG003|Treatment Period 1|Other|0|||
160820868|NCT01468207|580729094|FG004|Treatment Period 1|Other|0|||
160820869|NCT01468207|580729095|FG005|Treatment Period 1|Other|0|||
160820870|NCT01468207|580729090|FG000|Treatment Period 2|Adverse Event|0|||
160820871|NCT01468207|580729091|FG001|Treatment Period 2|Adverse Event|0|||
160820872|NCT01468207|580729092|FG002|Treatment Period 2|Adverse Event|6|||
160820873|NCT01468207|580729093|FG003|Treatment Period 2|Adverse Event|1|||
160820874|NCT01468207|580729094|FG004|Treatment Period 2|Adverse Event|2|||
160820875|NCT01468207|580729095|FG005|Treatment Period 2|Adverse Event|1|||
160820876|NCT01468207|580729090|FG000|Treatment Period 2|Lack of Efficacy|0|||
160820877|NCT01468207|580729091|FG001|Treatment Period 2|Lack of Efficacy|0|||
160820878|NCT01468207|580729092|FG002|Treatment Period 2|Lack of Efficacy|1|||
160820879|NCT01468207|580729093|FG003|Treatment Period 2|Lack of Efficacy|1|||
160820880|NCT01468207|580729094|FG004|Treatment Period 2|Lack of Efficacy|0|||
160820881|NCT01468207|580729095|FG005|Treatment Period 2|Lack of Efficacy|2|||
160820882|NCT01468207|580729090|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160820883|NCT01468207|580729091|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160820884|NCT01468207|580729092|FG002|Treatment Period 2|Withdrawal by Subject|5|||
160820885|NCT01468207|580729093|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160820886|NCT01468207|580729094|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160820887|NCT01468207|580729095|FG005|Treatment Period 2|Withdrawal by Subject|2|||
160820888|NCT01468207|580729090|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
160820889|NCT01468207|580729091|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
160820890|NCT01468207|580729092|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
160820891|NCT01468207|580729093|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
160820892|NCT01468207|580729094|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
160820893|NCT01468207|580729095|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
160820894|NCT01468207|580729090|FG000|Treatment Period 2|Lost to Follow-up|0|||
160820895|NCT01468207|580729091|FG001|Treatment Period 2|Lost to Follow-up|0|||
160820896|NCT01468207|580729092|FG002|Treatment Period 2|Lost to Follow-up|5|||
160820897|NCT01468207|580729093|FG003|Treatment Period 2|Lost to Follow-up|1|||
160820898|NCT01468207|580729094|FG004|Treatment Period 2|Lost to Follow-up|0|||
160820899|NCT01468207|580729095|FG005|Treatment Period 2|Lost to Follow-up|0|||
160820900|NCT01468207|580729090|FG000|Treatment Period 2|Other|0|||
160820901|NCT01468207|580729091|FG001|Treatment Period 2|Other|0|||
160820902|NCT01468207|580729092|FG002|Treatment Period 2|Other|5|||
160820903|NCT01468207|580729093|FG003|Treatment Period 2|Other|1|||
160820904|NCT01468207|580729094|FG004|Treatment Period 2|Other|1|||
160820905|NCT01468207|580729095|FG005|Treatment Period 2|Other|2|||
160820906|NCT01967823|580729098|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
160820907|NCT00316693|580729099|FG000|Overall Study|Adverse Event|6|||
160820908|NCT00316693|580729100|FG001|Overall Study|Adverse Event|1|||
160820909|NCT00316693|580729099|FG000|Overall Study|Protocol Violation|1|||
160820910|NCT00316693|580729100|FG001|Overall Study|Protocol Violation|0|||
160820911|NCT00316693|580729099|FG000|Overall Study|Withdrawal by Subject|6|||
160820912|NCT00316693|580729100|FG001|Overall Study|Withdrawal by Subject|6|||
160820913|NCT00316693|580729099|FG000|Overall Study|Lost to Follow-up|26|||
160820914|NCT00316693|580729100|FG001|Overall Study|Lost to Follow-up|34|||
160820915|NCT00316693|580729099|FG000|Overall Study|Other|38|||
160820916|NCT00316693|580729100|FG001|Overall Study|Other|44|||
160820917|NCT00413894|580729107|FG000|Overall Study|Withdrawal by Subject|10|||
160820918|NCT00413894|580729107|FG000|Overall Study|Administrative Reasons|1|||
160820919|NCT00413894|580729107|FG000|Overall Study|Hb <10 grams/deciliter|12|||
160820920|NCT00413894|580729107|FG000|Overall Study|Adverse Event|28|||
160820921|NCT00413894|580729107|FG000|Overall Study|Protocol Violation|11|||
160820922|NCT00413894|580729107|FG000|Overall Study|Other|18|||
160820923|NCT04225676|580729108|FG000|Overall Study|Physician Decision|1|||
160820924|NCT04225676|580729108|FG000|Overall Study|Lack of Efficacy|1|||
160820925|NCT04225676|580729108|FG000|Overall Study|Study terminated by sponsor|3|||
160820926|NCT05289271|580729111|FG000|Overall Study|Mistakenly allocated, untreated|1|||
160820927|NCT05289271|580729112|FG001|Overall Study|Mistakenly allocated, untreated|0|||
160820928|NCT02019108|580729113|FG000|Overall Study|Lost to Follow-up|5|||
160820929|NCT02019108|580729114|FG001|Overall Study|Lost to Follow-up|7|||
160900997|NCT01146912|581031895|FG007|Overall Study|< 14 weeks gestational age|0|||
160900998|NCT01146912|581031888|FG000|Overall Study|Duplicate patient|0|||
160988139|NCT02223182|581343300|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
160988140|NCT02223182|581343301|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
160988141|NCT02223182|581343298|FG000|Open-Label 500 Period|Physician Decision|0|||
160988142|NCT02223182|581343299|FG001|Open-Label 500 Period|Physician Decision|0|||
160988143|NCT02223182|581343300|FG002|Open-Label 500 Period|Physician Decision|0|||
160988144|NCT02223182|581343301|FG003|Open-Label 500 Period|Physician Decision|1|||
160988145|NCT02223182|581343298|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
160988146|NCT02223182|581343299|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
160988147|NCT02223182|581343300|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
160988148|NCT02223182|581343301|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
160988149|NCT02223182|581343298|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
160988150|NCT02223182|581343299|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
160988151|NCT02223182|581343300|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
160988152|NCT02223182|581343301|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
160988153|NCT02223182|581343298|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
160988154|NCT02223182|581343299|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
160988155|NCT02223182|581343300|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
160988156|NCT02223182|581343301|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
160988157|NCT02223182|581343298|FG000|Open-Label 300 Period|Non Compliance|0|||
160988158|NCT02223182|581343299|FG001|Open-Label 300 Period|Non Compliance|2|||
160988159|NCT02223182|581343300|FG002|Open-Label 300 Period|Non Compliance|1|||
160988160|NCT02223182|581343301|FG003|Open-Label 300 Period|Non Compliance|0|||
160988161|NCT04956692|581343308|FG000|Overall Study|Death|115|||
160988162|NCT04956692|581343309|FG001|Overall Study|Death|47|||
160988163|NCT04956692|581343308|FG000|Overall Study|Lost to Follow-up|0|||
160988164|NCT04956692|581343309|FG001|Overall Study|Lost to Follow-up|1|||
160988165|NCT04956692|581343308|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160988166|NCT04956692|581343309|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160988167|NCT04956692|581343308|FG000|Overall Study|Withdrawal by Subject|5|||
160988168|NCT04956692|581343309|FG001|Overall Study|Withdrawal by Subject|2|||
160988169|NCT04956692|581343308|FG000|Overall Study|Ongoing in Study|236|||
160988170|NCT04956692|581343309|FG001|Overall Study|Ongoing in Study|123|||
160988171|NCT02099539|581343314|FG000|Overall Study|Progressive Disease|3|||
160988172|NCT02099539|581343315|FG001|Overall Study|Progressive Disease|2|||
160988173|NCT02099539|581343316|FG002|Overall Study|Progressive Disease|2|||
160988174|NCT02099539|581343317|FG003|Overall Study|Progressive Disease|1|||
160988175|NCT02099539|581343318|FG004|Overall Study|Progressive Disease|4|||
160988176|NCT02099539|581343319|FG005|Overall Study|Progressive Disease|2|||
160988177|NCT02099539|581343320|FG006|Overall Study|Progressive Disease|0|||
160988178|NCT02099539|581343314|FG000|Overall Study|Adverse Event|0|||
160988179|NCT02099539|581343315|FG001|Overall Study|Adverse Event|0|||
160988180|NCT02099539|581343316|FG002|Overall Study|Adverse Event|1|||
160988181|NCT02099539|581343317|FG003|Overall Study|Adverse Event|1|||
160988182|NCT02099539|581343318|FG004|Overall Study|Adverse Event|0|||
160988183|NCT02099539|581343319|FG005|Overall Study|Adverse Event|0|||
160988184|NCT02099539|581343320|FG006|Overall Study|Adverse Event|0|||
160988185|NCT02099539|581343314|FG000|Overall Study|Physician Decision|0|||
160988186|NCT02099539|581343315|FG001|Overall Study|Physician Decision|0|||
160988187|NCT02099539|581343316|FG002|Overall Study|Physician Decision|0|||
160988188|NCT02099539|581343317|FG003|Overall Study|Physician Decision|0|||
160988189|NCT02099539|581343318|FG004|Overall Study|Physician Decision|0|||
160988190|NCT02099539|581343319|FG005|Overall Study|Physician Decision|1|||
160988191|NCT02099539|581343320|FG006|Overall Study|Physician Decision|0|||
160988192|NCT03473756|581343322|FG000|Overall Study|Withdrawal by Subject|1|||
160988193|NCT03473756|581343323|FG001|Overall Study|Withdrawal by Subject|4|||
160988194|NCT03473756|581343322|FG000|Overall Study|Adverse Event|6|||
160988195|NCT03473756|581343323|FG001|Overall Study|Adverse Event|7|||
160988196|NCT03473756|581343322|FG000|Overall Study|Lack of Efficacy|3|||
160988197|NCT03473756|581343323|FG001|Overall Study|Lack of Efficacy|10|||
160988198|NCT03473756|581343322|FG000|Overall Study|Physician Decision|0|||
160988199|NCT03473756|581343323|FG001|Overall Study|Physician Decision|2|||
160988200|NCT03473756|581343322|FG000|Overall Study|End of study treatment|0|||
160988201|NCT03473756|581343323|FG001|Overall Study|End of study treatment|2|||
160988202|NCT03473756|581343322|FG000|Overall Study|Lost to Follow-up|0|||
160988203|NCT03473756|581343323|FG001|Overall Study|Lost to Follow-up|1|||
160820930|NCT03392883|580729119|FG000|Overall Study|Lost to Follow-up|122|||
160988204|NCT03714022|581343324|FG000|Overall Study|Adverse Event|1|||
160988205|NCT03714022|581343325|FG001|Overall Study|Adverse Event|0|||
160988206|NCT03714022|581343324|FG000|Overall Study|Consent withdrawal|0|||
160988207|NCT03714022|581343325|FG001|Overall Study|Consent withdrawal|1|||
160988208|NCT03714022|581343324|FG000|Overall Study|Lost to Follow-up|3|||
160988209|NCT03714022|581343325|FG001|Overall Study|Lost to Follow-up|2|||
160988210|NCT02487446|581343329|FG000|Period 1|Physician Decision|0|||
160988211|NCT02487446|581343330|FG001|Period 1|Physician Decision|1|||
160988212|NCT02487446|581343329|FG000|Period 1|Lack of Efficacy|1|||
160988213|NCT02487446|581343330|FG001|Period 1|Lack of Efficacy|0|||
160988214|NCT02487446|581343329|FG000|Period 1|Protocol deviation|3|||
160988215|NCT02487446|581343330|FG001|Period 1|Protocol deviation|2|||
160988216|NCT02487446|581343329|FG000|Period 1|Lost to Follow-up|2|||
160988217|NCT02487446|581343330|FG001|Period 1|Lost to Follow-up|0|||
160988218|NCT02487446|581343329|FG000|Period 1|Withdrawal by Subject|2|||
160988219|NCT02487446|581343330|FG001|Period 1|Withdrawal by Subject|0|||
160988220|NCT02487446|581343329|FG000|Period 1|Adverse Event|5|||
160988221|NCT02487446|581343330|FG001|Period 1|Adverse Event|5|||
160988222|NCT02487446|581343329|FG000|Washout|Lost to Follow-up|0|||
160988223|NCT02487446|581343330|FG001|Washout|Lost to Follow-up|2|||
160988224|NCT02487446|581343329|FG000|Washout|Withdrawal by Subject|1|||
160988225|NCT02487446|581343330|FG001|Washout|Withdrawal by Subject|4|||
160988226|NCT02487446|581343329|FG000|Washout|Adverse Event|2|||
160988227|NCT02487446|581343330|FG001|Washout|Adverse Event|2|||
160988228|NCT02487446|581343329|FG000|Period 2|Protocol deviation|0|||
160988229|NCT02487446|581343330|FG001|Period 2|Protocol deviation|1|||
160988230|NCT02487446|581343329|FG000|Period 2|Lost to Follow-up|1|||
160988231|NCT02487446|581343330|FG001|Period 2|Lost to Follow-up|1|||
160988232|NCT02487446|581343329|FG000|Period 2|Withdrawal by Subject|1|||
160988233|NCT02487446|581343330|FG001|Period 2|Withdrawal by Subject|1|||
160988234|NCT02487446|581343329|FG000|Period 2|Adverse Event|6|||
160988235|NCT02487446|581343330|FG001|Period 2|Adverse Event|2|||
160988236|NCT02234310|581343331|FG000|Overall Study|Physician Decision|1|||
160988237|NCT02234310|581343331|FG000|Overall Study|Adverse Event|1|||
160988238|NCT02234310|581343331|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
160988239|NCT02234310|581343331|FG000|Overall Study|Withdrawal by Subject|2|||
160988240|NCT03289455|581343332|FG000|Overall Study|Death|1|||
160988241|NCT03289455|581343333|FG001|Overall Study|Death|0|||
160988242|NCT03289455|581343334|FG002|Overall Study|Death|0|||
160988243|NCT03289455|581343332|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
160988244|NCT03289455|581343333|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
160988245|NCT03289455|581343334|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
160988246|NCT03289455|581343332|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
160988247|NCT03289455|581343333|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
160988248|NCT03289455|581343334|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
160988249|NCT03289455|581343332|FG000|Overall Study|Progressive disease|3|||
160988250|NCT03289455|581343333|FG001|Overall Study|Progressive disease|4|||
160988251|NCT03289455|581343334|FG002|Overall Study|Progressive disease|5|||
160988252|NCT02624778|581345227|FG000|Overall Study|Lost to Follow-up|0|||
160988253|NCT02624778|581345228|FG001|Overall Study|Lost to Follow-up|0|||
160988254|NCT02624778|581345229|FG002|Overall Study|Lost to Follow-up|1|||
160820931|NCT03392883|580729120|FG001|Overall Study|Lost to Follow-up|13|||
160820932|NCT03392883|580729121|FG002|Overall Study|Lost to Follow-up|9|||
160820933|NCT03392883|580729119|FG000|Overall Study|Death|4|||
160820934|NCT03392883|580729120|FG001|Overall Study|Death|0|||
160820935|NCT03392883|580729121|FG002|Overall Study|Death|0|||
160820936|NCT03392883|580729119|FG000|Overall Study|Lack of Efficacy|29|||
160820937|NCT03392883|580729120|FG001|Overall Study|Lack of Efficacy|0|||
160820938|NCT03392883|580729121|FG002|Overall Study|Lack of Efficacy|0|||
160820939|NCT03392883|580729119|FG000|Overall Study|Withdrawal by Subject|180|||
160820940|NCT03392883|580729120|FG001|Overall Study|Withdrawal by Subject|0|||
160820941|NCT03392883|580729121|FG002|Overall Study|Withdrawal by Subject|0|||
160820942|NCT03392883|580729119|FG000|Overall Study|Adverse Event|1|||
160820943|NCT03392883|580729120|FG001|Overall Study|Adverse Event|0|||
160820944|NCT03392883|580729121|FG002|Overall Study|Adverse Event|0|||
160820945|NCT03356977|580729124|FG000|Overall Study|Lost to Follow-up|3|||
160820946|NCT03356977|580729124|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160988255|NCT02624778|581345230|FG003|Overall Study|Lost to Follow-up|0|||
160988256|NCT02624778|581345231|FG004|Overall Study|Lost to Follow-up|0|||
160988257|NCT02624778|581345232|FG005|Overall Study|Lost to Follow-up|0|||
160988258|NCT02624778|581345233|FG006|Overall Study|Lost to Follow-up|0|||
160988259|NCT02624778|581345234|FG007|Overall Study|Lost to Follow-up|0|||
160820947|NCT01728077|580729127|FG000|Overall Study|Lack of Efficacy|3|||
160988260|NCT02624778|581345235|FG008|Overall Study|Lost to Follow-up|0|||
160988261|NCT02624778|581345227|FG000|Overall Study|Withdrawal by Subject|0|||
160988262|NCT02624778|581345228|FG001|Overall Study|Withdrawal by Subject|1|||
160988263|NCT02624778|581345229|FG002|Overall Study|Withdrawal by Subject|0|||
160988264|NCT02624778|581345230|FG003|Overall Study|Withdrawal by Subject|0|||
160988265|NCT02624778|581345231|FG004|Overall Study|Withdrawal by Subject|0|||
160552920|NCT01700192|579749879|FG000|Overall Study|Never received study drug|1|||
160552921|NCT01700192|579749880|FG001|Overall Study|Never received study drug|0|||
160552922|NCT01656434|579749885|FG000|Overall Study|Adverse Event|199|||
160552923|NCT01656434|579749886|FG001|Overall Study|Adverse Event|63|||
160552924|NCT01656434|579749885|FG000|Overall Study|Enrollment terminated at trial site|2|||
160552925|NCT01656434|579749886|FG001|Overall Study|Enrollment terminated at trial site|0|||
160552926|NCT01656434|579749885|FG000|Overall Study|Lost to Follow-up|309|||
160552927|NCT01656434|579749886|FG001|Overall Study|Lost to Follow-up|76|||
160552928|NCT01656434|579749885|FG000|Overall Study|Site discontinued study participation|24|||
160552929|NCT01656434|579749886|FG001|Overall Study|Site discontinued study participation|9|||
160552930|NCT01656434|579749885|FG000|Overall Study|Screen failure|2|||
160552931|NCT01656434|579749886|FG001|Overall Study|Screen failure|0|||
160552932|NCT01656434|579749885|FG000|Overall Study|Protocol Violation|7|||
160552933|NCT01656434|579749886|FG001|Overall Study|Protocol Violation|0|||
160552934|NCT01656434|579749885|FG000|Overall Study|Pregnancy wish|18|||
160552935|NCT01656434|579749886|FG001|Overall Study|Pregnancy wish|6|||
160552936|NCT01656434|579749885|FG000|Overall Study|Pregnancy|45|||
160552937|NCT01656434|579749886|FG001|Overall Study|Pregnancy|10|||
160552938|NCT01656434|579749885|FG000|Overall Study|Physician Decision|7|||
160552939|NCT01656434|579749886|FG001|Overall Study|Physician Decision|2|||
160552940|NCT01656434|579749885|FG000|Overall Study|Non-compliance with study drug|48|||
160552941|NCT01656434|579749886|FG001|Overall Study|Non-compliance with study drug|9|||
160552942|NCT01656434|579749885|FG000|Overall Study|Study terminated by sponsor|1501|||
160552943|NCT01656434|579749886|FG001|Overall Study|Study terminated by sponsor|348|||
160552944|NCT01656434|579749885|FG000|Overall Study|Participant discontinued; drug related|13|||
160552945|NCT01656434|579749886|FG001|Overall Study|Participant discontinued; drug related|4|||
160552946|NCT01656434|579749885|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
160552947|NCT01656434|579749886|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
160552948|NCT01656434|579749885|FG000|Overall Study|Non-compliance with protocol|39|||
160552949|NCT01656434|579749886|FG001|Overall Study|Non-compliance with protocol|15|||
160552950|NCT01656434|579749885|FG000|Overall Study|Participant moved|40|||
160552951|NCT01656434|579749886|FG001|Overall Study|Participant moved|12|||
160552952|NCT01656434|579749885|FG000|Overall Study|Participant withdrew consent|28|||
160552953|NCT01656434|579749886|FG001|Overall Study|Participant withdrew consent|9|||
160552954|NCT01656434|579749885|FG000|Overall Study|Withdrawal by Subject|64|||
160552955|NCT01656434|579749886|FG001|Overall Study|Withdrawal by Subject|7|||
160552956|NCT01235962|579749887|FG000|Overall Study|Withdrawal by Subject|20|||
160552957|NCT01235962|579749888|FG001|Overall Study|Withdrawal by Subject|19|||
160552958|NCT01235962|579749889|FG002|Overall Study|Withdrawal by Subject|62|||
160552959|NCT01235962|579749890|FG003|Overall Study|Withdrawal by Subject|49|||
160552960|NCT01235962|579749887|FG000|Overall Study|Lost to Follow-up|21|||
160552961|NCT01235962|579749888|FG001|Overall Study|Lost to Follow-up|16|||
160552962|NCT01235962|579749889|FG002|Overall Study|Lost to Follow-up|47|||
160552963|NCT01235962|579749890|FG003|Overall Study|Lost to Follow-up|32|||
160552964|NCT01235962|579749887|FG000|Overall Study|Physician Decision|5|||
160552965|NCT01235962|579749888|FG001|Overall Study|Physician Decision|0|||
160552966|NCT01235962|579749889|FG002|Overall Study|Physician Decision|9|||
160552967|NCT01235962|579749890|FG003|Overall Study|Physician Decision|5|||
160552968|NCT01580397|579749891|FG000|Overall Study|Lack of Efficacy|14|||
160552969|NCT02435914|579749892|FG000|Overall Study|Ocular Adverse Event|1|||
160552970|NCT02435914|579749893|FG001|Overall Study|Ocular Adverse Event|0|||
160552971|NCT02435914|579749894|FG002|Overall Study|Ocular Adverse Event|0|||
160552972|NCT02435914|579749895|FG003|Overall Study|Ocular Adverse Event|0|||
160552973|NCT02435914|579749892|FG000|Overall Study|Withdrawal by Subject|0|||
160552974|NCT02435914|579749893|FG001|Overall Study|Withdrawal by Subject|1|||
160552975|NCT02435914|579749894|FG002|Overall Study|Withdrawal by Subject|0|||
160646129|NCT02196506|580085990|FG000|Phase A|Participant withdrawn by investigator|10|||
160552976|NCT02435914|579749895|FG003|Overall Study|Withdrawal by Subject|0|||
160552977|NCT02435914|579749892|FG000|Overall Study|Other Miscellaneous Reason|0|||
160552978|NCT02435914|579749893|FG001|Overall Study|Other Miscellaneous Reason|0|||
160646130|NCT02196506|580085991|FG001|Phase A|Participant withdrawn by investigator|0|||
160646131|NCT02196506|580085992|FG002|Phase A|Participant withdrawn by investigator|0|||
160552979|NCT02435914|579749894|FG002|Overall Study|Other Miscellaneous Reason|1|||
160988266|NCT02624778|581345232|FG005|Overall Study|Withdrawal by Subject|1|||
160988267|NCT02624778|581345233|FG006|Overall Study|Withdrawal by Subject|1|||
160552980|NCT02435914|579749895|FG003|Overall Study|Other Miscellaneous Reason|0|||
160646132|NCT02196506|580085993|FG003|Phase A|Participant withdrawn by investigator|0|||
160646133|NCT02196506|580085990|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
160552981|NCT01405053|579749901|FG000|Overall Study|Adverse Event|3|||
160988268|NCT02624778|581345234|FG007|Overall Study|Withdrawal by Subject|1|||
160988269|NCT02624778|581345235|FG008|Overall Study|Withdrawal by Subject|1|||
160988270|NCT02624778|581345227|FG000|Overall Study|Adverse Event|0|||
160988271|NCT02624778|581345228|FG001|Overall Study|Adverse Event|0|||
160988272|NCT02624778|581345229|FG002|Overall Study|Adverse Event|0|||
160988273|NCT02624778|581345230|FG003|Overall Study|Adverse Event|0|||
160988274|NCT02624778|581345231|FG004|Overall Study|Adverse Event|0|||
160988275|NCT02624778|581345232|FG005|Overall Study|Adverse Event|0|||
160988276|NCT02624778|581345233|FG006|Overall Study|Adverse Event|0|||
160988277|NCT02624778|581345234|FG007|Overall Study|Adverse Event|0|||
160988278|NCT02624778|581345235|FG008|Overall Study|Adverse Event|2|||
160988279|NCT02624778|581345227|FG000|Overall Study|Death|0|||
160988280|NCT02624778|581345228|FG001|Overall Study|Death|0|||
160988281|NCT02624778|581345229|FG002|Overall Study|Death|0|||
160988282|NCT02624778|581345230|FG003|Overall Study|Death|0|||
160988283|NCT02624778|581345231|FG004|Overall Study|Death|0|||
160988284|NCT02624778|581345232|FG005|Overall Study|Death|0|||
160988285|NCT02624778|581345233|FG006|Overall Study|Death|1|||
160988286|NCT02624778|581345234|FG007|Overall Study|Death|0|||
160988287|NCT02624778|581345235|FG008|Overall Study|Death|0|||
160988288|NCT02624778|581345227|FG000|Overall Study|Physician Decision|0|||
160988289|NCT02624778|581345228|FG001|Overall Study|Physician Decision|0|||
160988290|NCT02624778|581345229|FG002|Overall Study|Physician Decision|0|||
160988291|NCT02624778|581345230|FG003|Overall Study|Physician Decision|0|||
160988292|NCT02624778|581345231|FG004|Overall Study|Physician Decision|0|||
160988293|NCT02624778|581345232|FG005|Overall Study|Physician Decision|0|||
160988294|NCT02624778|581345233|FG006|Overall Study|Physician Decision|0|||
160988295|NCT02624778|581345234|FG007|Overall Study|Physician Decision|3|||
160988296|NCT02624778|581345235|FG008|Overall Study|Physician Decision|3|||
160988297|NCT04091672|581345238|FG000|Overall Study|Death|6|||
160988298|NCT04091672|581345239|FG001|Overall Study|Death|6|||
160988299|NCT04091672|581345238|FG000|Overall Study|Lost to Follow-up|7|||
160988300|NCT04091672|581345239|FG001|Overall Study|Lost to Follow-up|7|||
160988301|NCT04091672|581345238|FG000|Overall Study|Withdrawal by Subject|3|||
160988302|NCT04091672|581345239|FG001|Overall Study|Withdrawal by Subject|3|||
160988303|NCT04091672|581345238|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
160988304|NCT04091672|581345239|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
160988305|NCT05296629|581345240|FG000|Overall Study|Withdrawal by Subject|3|||
160988306|NCT05296629|581345241|FG001|Overall Study|Withdrawal by Subject|10|||
160988307|NCT05296629|581345242|FG002|Overall Study|Withdrawal by Subject|4|||
160988308|NCT05296629|581345240|FG000|Overall Study|Lost to Follow-up|2|||
160988309|NCT05296629|581345241|FG001|Overall Study|Lost to Follow-up|7|||
160988310|NCT05296629|581345242|FG002|Overall Study|Lost to Follow-up|1|||
160988311|NCT05296629|581345240|FG000|Overall Study|Adverse Event|0|||
160988312|NCT05296629|581345241|FG001|Overall Study|Adverse Event|4|||
160988313|NCT05296629|581345242|FG002|Overall Study|Adverse Event|2|||
160988314|NCT05296629|581345240|FG000|Overall Study|Protocol Violation|0|||
160988315|NCT05296629|581345241|FG001|Overall Study|Protocol Violation|2|||
160988316|NCT05296629|581345242|FG002|Overall Study|Protocol Violation|0|||
160988317|NCT04610684|581345248|FG000|Study Treatment|Withdrawal by Subject|1|||
160988318|NCT04610684|581345248|FG000|Study Treatment|Disease Progression|2|||
160988319|NCT04610684|581345248|FG000|Follow up|Death|2|||
160988320|NCT04610684|581345248|FG000|Follow up|Withdrawal by Subject|1|||
160988321|NCT00359619|581345249|FG000|Overall Study|Adverse Event|0|||
160988322|NCT00359619|581345250|FG001|Overall Study|Adverse Event|0|||
160988323|NCT00359619|581345251|FG002|Overall Study|Adverse Event|1|||
160988324|NCT00359619|581345252|FG003|Overall Study|Adverse Event|0|||
160988325|NCT00359619|581345253|FG004|Overall Study|Adverse Event|0|||
160988326|NCT00359619|581345254|FG005|Overall Study|Adverse Event|0|||
160820948|NCT01728077|580729128|FG001|Overall Study|Lack of Efficacy|1|||
160820949|NCT01728077|580729127|FG000|Overall Study|Lost to Follow-up|1|||
160820950|NCT01728077|580729128|FG001|Overall Study|Lost to Follow-up|0|||
160820951|NCT01728077|580729127|FG000|Overall Study|Subject choice|2|||
160820952|NCT01728077|580729128|FG001|Overall Study|Subject choice|3|||
160988327|NCT00359619|581345255|FG006|Overall Study|Adverse Event|1|||
160988328|NCT00359619|581345249|FG000|Overall Study|Withdrawal by Subject|3|||
160988329|NCT00359619|581345250|FG001|Overall Study|Withdrawal by Subject|1|||
160988330|NCT00359619|581345251|FG002|Overall Study|Withdrawal by Subject|4|||
160988331|NCT00359619|581345252|FG003|Overall Study|Withdrawal by Subject|2|||
160988332|NCT00359619|581345253|FG004|Overall Study|Withdrawal by Subject|2|||
160988333|NCT00359619|581345254|FG005|Overall Study|Withdrawal by Subject|0|||
160988334|NCT00359619|581345255|FG006|Overall Study|Withdrawal by Subject|3|||
160988335|NCT00359619|581345249|FG000|Overall Study|Other|1|||
160988336|NCT00359619|581345250|FG001|Overall Study|Other|0|||
160988337|NCT00359619|581345251|FG002|Overall Study|Other|0|||
160988338|NCT00359619|581345252|FG003|Overall Study|Other|0|||
160988339|NCT00359619|581345253|FG004|Overall Study|Other|0|||
160988340|NCT00359619|581345254|FG005|Overall Study|Other|0|||
160988341|NCT00359619|581345255|FG006|Overall Study|Other|0|||
160820953|NCT01728077|580729127|FG000|Overall Study|Death|0|||
160820954|NCT01728077|580729128|FG001|Overall Study|Death|1|||
160820955|NCT01728077|580729127|FG000|Overall Study|Patient moving|1|||
160820956|NCT01728077|580729128|FG001|Overall Study|Patient moving|0|||
160820957|NCT01728077|580729127|FG000|Overall Study|Non compliance|1|||
160820958|NCT01728077|580729128|FG001|Overall Study|Non compliance|0|||
160820959|NCT00378599|580729129|FG000|Overall Study|Adverse Event|38|||
160820960|NCT00378599|580729129|FG000|Overall Study|Protocol Violation|2|||
160820961|NCT00378599|580729129|FG000|Overall Study|Treatment failure|7|||
160820962|NCT00378599|580729129|FG000|Overall Study|Withdrawal by Subject|5|||
160820963|NCT03224507|580729132|FG000|Overall Study|Death|3|||
160820964|NCT03224507|580729133|FG001|Overall Study|Death|0|||
160820965|NCT03224507|580729132|FG000|Overall Study|Lack of Efficacy|6|||
160820966|NCT03224507|580729133|FG001|Overall Study|Lack of Efficacy|0|||
160820967|NCT03224507|580729132|FG000|Overall Study|Withdrawal by Subject|6|||
160820968|NCT03224507|580729133|FG001|Overall Study|Withdrawal by Subject|0|||
160820969|NCT02442310|580729137|FG000|Overall Study|Adverse Event|2|||
160820970|NCT02442310|580729137|FG000|Overall Study|Withdrawal by Subject|1|||
160820971|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
160820972|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
160820973|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
160820974|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
160820975|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
160820976|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
160820977|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
160900999|NCT01146912|581031889|FG001|Overall Study|Duplicate patient|0|||
160901000|NCT01146912|581031890|FG002|Overall Study|Duplicate patient|1|||
160901001|NCT01146912|581031891|FG003|Overall Study|Duplicate patient|0|||
160901002|NCT01146912|581031892|FG004|Overall Study|Duplicate patient|0|||
160901003|NCT01146912|581031893|FG005|Overall Study|Duplicate patient|0|||
160901004|NCT01146912|581031894|FG006|Overall Study|Duplicate patient|0|||
160901005|NCT01146912|581031895|FG007|Overall Study|Duplicate patient|0|||
160901006|NCT02980783|581031896|FG000|Overall Study|Lost to Follow-up|1|||
160901007|NCT00880542|581031897|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
160901008|NCT00880542|581031897|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
160901009|NCT00880542|581031897|FG000|REP: Surgical Resection|progressive disease|1|||
160901010|NCT05047770|581031898|FG000|Overall Study|Withdrawal by Subject|15|||
160901011|NCT05047770|581031899|FG001|Overall Study|Withdrawal by Subject|10|||
160901012|NCT05047770|581031900|FG002|Overall Study|Withdrawal by Subject|6|||
160901013|NCT05047770|581031901|FG003|Overall Study|Withdrawal by Subject|12|||
160901014|NCT05047770|581031898|FG000|Overall Study|Lost to Follow-up|7|||
160901015|NCT05047770|581031899|FG001|Overall Study|Lost to Follow-up|5|||
160901016|NCT05047770|581031900|FG002|Overall Study|Lost to Follow-up|12|||
160901017|NCT05047770|581031901|FG003|Overall Study|Lost to Follow-up|13|||
160901018|NCT05047770|581031898|FG000|Overall Study|Other|1|||
160901019|NCT05047770|581031899|FG001|Overall Study|Other|0|||
160901020|NCT05047770|581031900|FG002|Overall Study|Other|1|||
160901021|NCT05047770|581031901|FG003|Overall Study|Other|0|||
160901022|NCT01772160|581031902|FG000|Overall Study|Death|3|||
160901023|NCT01772160|581031902|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
160901024|NCT01772160|581031902|FG000|Overall Study|Consent withdrawal|3|||
160901025|NCT01772160|581031902|FG000|Overall Study|Migrated / moved from the study area|4|||
160901026|NCT01772160|581031902|FG000|Overall Study|Lost to Follow-up|30|||
160901027|NCT01772160|581031902|FG000|Overall Study|Other|5|||
160901028|NCT02202980|581031903|FG000|Overall Study|Lack of Efficacy|1|||
160901029|NCT02202980|581031904|FG001|Overall Study|Lack of Efficacy|0|||
160901030|NCT02202980|581031905|FG002|Overall Study|Lack of Efficacy|7|||
160988342|NCT00359619|581345249|FG000|Overall Study|Lost to Follow-up|4|||
160988343|NCT00359619|581345250|FG001|Overall Study|Lost to Follow-up|4|||
160988344|NCT00359619|581345251|FG002|Overall Study|Lost to Follow-up|2|||
160988345|NCT00359619|581345252|FG003|Overall Study|Lost to Follow-up|1|||
160988346|NCT00359619|581345253|FG004|Overall Study|Lost to Follow-up|1|||
160901031|NCT02202980|581031906|FG003|Overall Study|Lack of Efficacy|0|||
160901032|NCT02202980|581031907|FG004|Overall Study|Lack of Efficacy|3|||
160901033|NCT02202980|581031908|FG005|Overall Study|Lack of Efficacy|1|||
160820978|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
160820979|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
160820980|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
160901034|NCT02202980|581031909|FG006|Overall Study|Lack of Efficacy|11|||
160901035|NCT02202980|581031910|FG007|Overall Study|Lack of Efficacy|2|||
160901036|NCT02202980|581031911|FG008|Overall Study|Lack of Efficacy|2|||
160901037|NCT02202980|581031912|FG009|Overall Study|Lack of Efficacy|0|||
160820981|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Other|1|||
160820982|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Other|1|||
160901038|NCT02202980|581031913|FG010|Overall Study|Lack of Efficacy|0|||
160901039|NCT02202980|581031914|FG011|Overall Study|Lack of Efficacy|3|||
160901040|NCT02202980|581031915|FG012|Overall Study|Lack of Efficacy|10|||
160988347|NCT00359619|581345254|FG005|Overall Study|Lost to Follow-up|5|||
160988348|NCT00359619|581345255|FG006|Overall Study|Lost to Follow-up|0|||
160988349|NCT00049517|581345256|FG000|Induction|Disease progression|0|||
160988350|NCT00049517|581345257|FG001|Induction|Disease progression|0|||
160988351|NCT00049517|581345258|FG002|Induction|Disease progression|0|||
160988352|NCT00049517|581345259|FG003|Induction|Disease progression|0|||
160988353|NCT00049517|581345260|FG004|Induction|Disease progression|18|||
160988354|NCT00049517|581345261|FG005|Induction|Disease progression|11|||
160988355|NCT00049517|581345256|FG000|Induction|Adverse Event|0|||
160988356|NCT00049517|581345257|FG001|Induction|Adverse Event|0|||
160988357|NCT00049517|581345258|FG002|Induction|Adverse Event|0|||
160988358|NCT00049517|581345259|FG003|Induction|Adverse Event|0|||
160988359|NCT00049517|581345260|FG004|Induction|Adverse Event|5|||
160988360|NCT00049517|581345261|FG005|Induction|Adverse Event|7|||
160988361|NCT00049517|581345256|FG000|Induction|Death|0|||
160988362|NCT00049517|581345257|FG001|Induction|Death|0|||
160988363|NCT00049517|581345258|FG002|Induction|Death|0|||
160988364|NCT00049517|581345259|FG003|Induction|Death|0|||
160552982|NCT01405053|579749902|FG001|Overall Study|Adverse Event|0|||
160552983|NCT01405053|579749901|FG000|Overall Study|Lost to Follow-up|0|||
160988365|NCT00049517|581345260|FG004|Induction|Death|9|||
160988366|NCT00049517|581345261|FG005|Induction|Death|6|||
160988367|NCT00049517|581345256|FG000|Induction|Withdrawal by Subject|0|||
160988368|NCT00049517|581345257|FG001|Induction|Withdrawal by Subject|0|||
160988369|NCT00049517|581345258|FG002|Induction|Withdrawal by Subject|0|||
160988370|NCT00049517|581345259|FG003|Induction|Withdrawal by Subject|0|||
160988371|NCT00049517|581345260|FG004|Induction|Withdrawal by Subject|1|||
160988372|NCT00049517|581345261|FG005|Induction|Withdrawal by Subject|3|||
160988373|NCT00049517|581345256|FG000|Induction|Alternative therapy|0|||
160988374|NCT00049517|581345257|FG001|Induction|Alternative therapy|0|||
160988375|NCT00049517|581345258|FG002|Induction|Alternative therapy|0|||
160988376|NCT00049517|581345259|FG003|Induction|Alternative therapy|0|||
160988377|NCT00049517|581345260|FG004|Induction|Alternative therapy|2|||
160988378|NCT00049517|581345261|FG005|Induction|Alternative therapy|2|||
160988379|NCT00049517|581345256|FG000|Induction|Other complicating disease|0|||
160988380|NCT00049517|581345257|FG001|Induction|Other complicating disease|0|||
160988381|NCT00049517|581345258|FG002|Induction|Other complicating disease|0|||
160988382|NCT00049517|581345259|FG003|Induction|Other complicating disease|0|||
160988383|NCT00049517|581345260|FG004|Induction|Other complicating disease|3|||
160988384|NCT00049517|581345261|FG005|Induction|Other complicating disease|0|||
160988385|NCT00049517|581345256|FG000|Induction|Reasons not reported|0|||
160988386|NCT00049517|581345257|FG001|Induction|Reasons not reported|0|||
160988387|NCT00049517|581345258|FG002|Induction|Reasons not reported|0|||
160988388|NCT00049517|581345259|FG003|Induction|Reasons not reported|0|||
160988389|NCT00049517|581345260|FG004|Induction|Reasons not reported|22|||
160988390|NCT00049517|581345261|FG005|Induction|Reasons not reported|25|||
160988391|NCT00049517|581345256|FG000|Conditioning/Transplant|Disease progression|14|||
160988392|NCT00049517|581345257|FG001|Conditioning/Transplant|Disease progression|6|||
160988393|NCT00049517|581345258|FG002|Conditioning/Transplant|Disease progression|10|||
160988394|NCT00049517|581345259|FG003|Conditioning/Transplant|Disease progression|6|||
160988395|NCT00049517|581345260|FG004|Conditioning/Transplant|Disease progression|0|||
160988396|NCT00049517|581345261|FG005|Conditioning/Transplant|Disease progression|0|||
160988397|NCT00049517|581345256|FG000|Conditioning/Transplant|Adverse Event|2|||
160901041|NCT02202980|581031916|FG013|Overall Study|Lack of Efficacy|0|||
160901042|NCT02202980|581031903|FG000|Overall Study|Protocol Violation|0|||
160901043|NCT02202980|581031904|FG001|Overall Study|Protocol Violation|0|||
160901044|NCT02202980|581031905|FG002|Overall Study|Protocol Violation|0|||
160901045|NCT02202980|581031906|FG003|Overall Study|Protocol Violation|3|||
160901046|NCT02202980|581031907|FG004|Overall Study|Protocol Violation|3|||
160901047|NCT02202980|581031908|FG005|Overall Study|Protocol Violation|0|||
160901048|NCT02202980|581031909|FG006|Overall Study|Protocol Violation|0|||
160901049|NCT02202980|581031910|FG007|Overall Study|Protocol Violation|0|||
160901050|NCT02202980|581031911|FG008|Overall Study|Protocol Violation|0|||
160901051|NCT02202980|581031912|FG009|Overall Study|Protocol Violation|0|||
160901052|NCT02202980|581031913|FG010|Overall Study|Protocol Violation|0|||
160988398|NCT00049517|581345257|FG001|Conditioning/Transplant|Adverse Event|1|||
160988399|NCT00049517|581345258|FG002|Conditioning/Transplant|Adverse Event|4|||
160988400|NCT00049517|581345259|FG003|Conditioning/Transplant|Adverse Event|8|||
160988401|NCT00049517|581345260|FG004|Conditioning/Transplant|Adverse Event|0|||
160988402|NCT00049517|581345261|FG005|Conditioning/Transplant|Adverse Event|0|||
160988403|NCT00049517|581345256|FG000|Conditioning/Transplant|Death|1|||
160988404|NCT00049517|581345257|FG001|Conditioning/Transplant|Death|0|||
160988405|NCT00049517|581345258|FG002|Conditioning/Transplant|Death|0|||
160988406|NCT00049517|581345259|FG003|Conditioning/Transplant|Death|2|||
160552984|NCT01405053|579749902|FG001|Overall Study|Lost to Follow-up|1|||
160552985|NCT01405053|579749901|FG000|Overall Study|Participant choice|2|||
160552986|NCT01405053|579749902|FG001|Overall Study|Participant choice|1|||
160988407|NCT00049517|581345260|FG004|Conditioning/Transplant|Death|0|||
160988408|NCT00049517|581345261|FG005|Conditioning/Transplant|Death|0|||
160988409|NCT00049517|581345256|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
160988410|NCT00049517|581345257|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
160988411|NCT00049517|581345258|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
160988412|NCT00049517|581345259|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
160988413|NCT00049517|581345260|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
160988414|NCT00049517|581345261|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
160988415|NCT00049517|581345256|FG000|Conditioning/Transplant|Alternative therapy|4|||
160988416|NCT00049517|581345257|FG001|Conditioning/Transplant|Alternative therapy|4|||
160988417|NCT00049517|581345258|FG002|Conditioning/Transplant|Alternative therapy|2|||
160988418|NCT00049517|581345259|FG003|Conditioning/Transplant|Alternative therapy|1|||
160988419|NCT00049517|581345260|FG004|Conditioning/Transplant|Alternative therapy|1|||
160988420|NCT00049517|581345261|FG005|Conditioning/Transplant|Alternative therapy|0|||
160646134|NCT02196506|580085991|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
160646135|NCT02196506|580085992|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
160820983|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
160820984|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
160820985|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
160820986|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
160820987|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
160820988|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
160820989|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
160820990|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
160820991|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
160820992|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
160820993|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
160820994|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
160820995|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Other|1|||
160820996|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Other|2|||
160820997|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
160820998|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
160820999|NCT00075946|580729140|FG000|Overall Study|Path ineligible: undetermined histology|0|||
160821000|NCT00075946|580729141|FG001|Overall Study|Path ineligible: undetermined histology|0|||
160821001|NCT00075946|580729142|FG002|Overall Study|Path ineligible: undetermined histology|0|||
160821002|NCT00075946|580729143|FG003|Overall Study|Path ineligible: undetermined histology|0|||
160821003|NCT00075946|580729144|FG004|Overall Study|Path ineligible: undetermined histology|6|||
160821004|NCT00075946|580729140|FG000|Overall Study|Did not achieve response after induction|0|||
160821005|NCT00075946|580729141|FG001|Overall Study|Did not achieve response after induction|0|||
160821006|NCT00075946|580729142|FG002|Overall Study|Did not achieve response after induction|0|||
160821007|NCT00075946|580729143|FG003|Overall Study|Did not achieve response after induction|0|||
160821008|NCT00075946|580729144|FG004|Overall Study|Did not achieve response after induction|182|||
160821009|NCT00075946|580729140|FG000|Overall Study|Incorrectly randomized (no response)|5|||
160821010|NCT00075946|580729141|FG001|Overall Study|Incorrectly randomized (no response)|5|||
160821011|NCT00075946|580729142|FG002|Overall Study|Incorrectly randomized (no response)|5|||
160988421|NCT00049517|581345256|FG000|Conditioning/Transplant|Other complicating disease|2|||
160988422|NCT00049517|581345257|FG001|Conditioning/Transplant|Other complicating disease|0|||
160988423|NCT00049517|581345258|FG002|Conditioning/Transplant|Other complicating disease|0|||
160988424|NCT00049517|581345259|FG003|Conditioning/Transplant|Other complicating disease|4|||
160988425|NCT00049517|581345260|FG004|Conditioning/Transplant|Other complicating disease|0|||
160988426|NCT00049517|581345261|FG005|Conditioning/Transplant|Other complicating disease|1|||
160988427|NCT00049517|581345256|FG000|Conditioning/Transplant|Reasons not reported|25|||
160988428|NCT00049517|581345257|FG001|Conditioning/Transplant|Reasons not reported|31|||
160988429|NCT00049517|581345258|FG002|Conditioning/Transplant|Reasons not reported|18|||
160988430|NCT00049517|581345259|FG003|Conditioning/Transplant|Reasons not reported|15|||
160988431|NCT00049517|581345260|FG004|Conditioning/Transplant|Reasons not reported|5|||
160988432|NCT00049517|581345261|FG005|Conditioning/Transplant|Reasons not reported|5|||
160988433|NCT03929302|581345262|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
160988434|NCT03929302|581345263|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
160988435|NCT03929302|581345264|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
160988436|NCT03929302|581345262|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
160988437|NCT03929302|581345263|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
160988438|NCT03929302|581345264|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
160988439|NCT03929302|581345262|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
160821012|NCT00075946|580729143|FG003|Overall Study|Incorrectly randomized (no response)|1|||
160821013|NCT00075946|580729144|FG004|Overall Study|Incorrectly randomized (no response)|0|||
160821014|NCT00075946|580729140|FG000|Overall Study|Adverse Event|2|||
160988440|NCT03929302|581345263|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
160988441|NCT03929302|581345264|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
160988442|NCT04454567|581345265|FG000|Overall Study|Study Terminated by Sponsor|1|||
160988443|NCT04454567|581345266|FG001|Overall Study|Study Terminated by Sponsor|1|||
160821015|NCT00075946|580729141|FG001|Overall Study|Adverse Event|10|||
160821016|NCT00075946|580729142|FG002|Overall Study|Adverse Event|0|||
160821017|NCT00075946|580729143|FG003|Overall Study|Adverse Event|2|||
160821018|NCT00075946|580729144|FG004|Overall Study|Adverse Event|0|||
160821019|NCT00075946|580729140|FG000|Overall Study|Death|0|||
160821020|NCT00075946|580729141|FG001|Overall Study|Death|1|||
160821021|NCT00075946|580729142|FG002|Overall Study|Death|0|||
160821022|NCT00075946|580729143|FG003|Overall Study|Death|0|||
160821023|NCT00075946|580729144|FG004|Overall Study|Death|0|||
160821024|NCT00075946|580729140|FG000|Overall Study|Withdrawal by Subject|23|||
160821025|NCT00075946|580729141|FG001|Overall Study|Withdrawal by Subject|58|||
160821026|NCT00075946|580729142|FG002|Overall Study|Withdrawal by Subject|4|||
160821027|NCT00075946|580729143|FG003|Overall Study|Withdrawal by Subject|9|||
160821028|NCT00075946|580729144|FG004|Overall Study|Withdrawal by Subject|0|||
160821029|NCT00075946|580729140|FG000|Overall Study|Alternative therapy|16|||
160821030|NCT00075946|580729141|FG001|Overall Study|Alternative therapy|2|||
160821031|NCT00075946|580729142|FG002|Overall Study|Alternative therapy|5|||
160821032|NCT00075946|580729143|FG003|Overall Study|Alternative therapy|0|||
160821033|NCT00075946|580729144|FG004|Overall Study|Alternative therapy|0|||
160821034|NCT00075946|580729140|FG000|Overall Study|Other complicating disease|7|||
160821035|NCT00075946|580729141|FG001|Overall Study|Other complicating disease|13|||
160821036|NCT00075946|580729142|FG002|Overall Study|Other complicating disease|1|||
160821037|NCT00075946|580729143|FG003|Overall Study|Other complicating disease|4|||
160821038|NCT00075946|580729144|FG004|Overall Study|Other complicating disease|0|||
160821039|NCT00075946|580729140|FG000|Overall Study|No response to retreatment|23|||
160821040|NCT00075946|580729141|FG001|Overall Study|No response to retreatment|0|||
160821041|NCT00075946|580729142|FG002|Overall Study|No response to retreatment|2|||
160821042|NCT00075946|580729143|FG003|Overall Study|No response to retreatment|0|||
160821043|NCT00075946|580729144|FG004|Overall Study|No response to retreatment|0|||
160821044|NCT00075946|580729140|FG000|Overall Study|Time to progression less than 6 months|15|||
160821045|NCT00075946|580729141|FG001|Overall Study|Time to progression less than 6 months|30|||
160821046|NCT00075946|580729142|FG002|Overall Study|Time to progression less than 6 months|8|||
160821047|NCT00075946|580729143|FG003|Overall Study|Time to progression less than 6 months|3|||
160821048|NCT00075946|580729144|FG004|Overall Study|Time to progression less than 6 months|0|||
160821049|NCT00075946|580729140|FG000|Overall Study|Other|57|||
160821050|NCT00075946|580729141|FG001|Overall Study|Other|32|||
160821051|NCT00075946|580729142|FG002|Overall Study|Other|3|||
160821052|NCT00075946|580729143|FG003|Overall Study|Other|11|||
160901053|NCT02202980|581031914|FG011|Overall Study|Protocol Violation|0|||
160901054|NCT02202980|581031915|FG012|Overall Study|Protocol Violation|0|||
160901055|NCT02202980|581031916|FG013|Overall Study|Protocol Violation|0|||
160901056|NCT02202980|581031903|FG000|Overall Study|Lost to Follow-up|0|||
160901057|NCT02202980|581031904|FG001|Overall Study|Lost to Follow-up|1|||
160901058|NCT02202980|581031905|FG002|Overall Study|Lost to Follow-up|1|||
160901059|NCT02202980|581031906|FG003|Overall Study|Lost to Follow-up|1|||
160901060|NCT02202980|581031907|FG004|Overall Study|Lost to Follow-up|0|||
160901061|NCT02202980|581031908|FG005|Overall Study|Lost to Follow-up|0|||
160901062|NCT02202980|581031909|FG006|Overall Study|Lost to Follow-up|0|||
160901063|NCT02202980|581031910|FG007|Overall Study|Lost to Follow-up|1|||
160901064|NCT02202980|581031911|FG008|Overall Study|Lost to Follow-up|1|||
160901065|NCT02202980|581031912|FG009|Overall Study|Lost to Follow-up|0|||
160901066|NCT02202980|581031913|FG010|Overall Study|Lost to Follow-up|0|||
160901067|NCT02202980|581031914|FG011|Overall Study|Lost to Follow-up|0|||
160901068|NCT02202980|581031915|FG012|Overall Study|Lost to Follow-up|1|||
160901069|NCT02202980|581031916|FG013|Overall Study|Lost to Follow-up|0|||
160901070|NCT02202980|581031903|FG000|Overall Study|Withdrew Consent|0|||
160901071|NCT02202980|581031904|FG001|Overall Study|Withdrew Consent|1|||
160901072|NCT02202980|581031905|FG002|Overall Study|Withdrew Consent|2|||
160901073|NCT02202980|581031906|FG003|Overall Study|Withdrew Consent|0|||
160901074|NCT02202980|581031907|FG004|Overall Study|Withdrew Consent|0|||
160901075|NCT02202980|581031908|FG005|Overall Study|Withdrew Consent|0|||
160901076|NCT02202980|581031909|FG006|Overall Study|Withdrew Consent|0|||
160901077|NCT02202980|581031910|FG007|Overall Study|Withdrew Consent|0|||
160901078|NCT02202980|581031911|FG008|Overall Study|Withdrew Consent|1|||
160901079|NCT02202980|581031912|FG009|Overall Study|Withdrew Consent|0|||
160821053|NCT00075946|580729144|FG004|Overall Study|Other|0|||
160821054|NCT02231892|580729145|FG000|Overall Study|Lost to Follow-up|1|||
160901080|NCT02202980|581031913|FG010|Overall Study|Withdrew Consent|0|||
160901081|NCT02202980|581031914|FG011|Overall Study|Withdrew Consent|0|||
160901082|NCT02202980|581031915|FG012|Overall Study|Withdrew Consent|0|||
160901083|NCT02202980|581031916|FG013|Overall Study|Withdrew Consent|0|||
160901084|NCT01952145|581031917|FG000|Overall Study|Protocol Violation|2|||
160821055|NCT02231892|580729146|FG001|Overall Study|Lost to Follow-up|0|||
160821056|NCT02231892|580729147|FG002|Overall Study|Lost to Follow-up|3|||
160821057|NCT02231892|580729145|FG000|Overall Study|Withdrawal by Subject|4|||
160821058|NCT02231892|580729146|FG001|Overall Study|Withdrawal by Subject|3|||
160821059|NCT02231892|580729147|FG002|Overall Study|Withdrawal by Subject|15|||
160821060|NCT02231892|580729145|FG000|Overall Study|Physician Decision|0|||
160821061|NCT02231892|580729146|FG001|Overall Study|Physician Decision|2|||
160821062|NCT02231892|580729147|FG002|Overall Study|Physician Decision|4|||
160821063|NCT02231892|580729145|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
160821064|NCT02231892|580729146|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
160821065|NCT02231892|580729147|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
160821066|NCT02231892|580729145|FG000|Overall Study|Participant motor threshold was >83%|0|||
160821067|NCT02231892|580729146|FG001|Overall Study|Participant motor threshold was >83%|0|||
160821068|NCT02231892|580729147|FG002|Overall Study|Participant motor threshold was >83%|9|||
160821069|NCT02231892|580729145|FG000|Overall Study|Could not find motor threshold|2|||
160821070|NCT02231892|580729146|FG001|Overall Study|Could not find motor threshold|0|||
160821071|NCT02231892|580729147|FG002|Overall Study|Could not find motor threshold|1|||
160821072|NCT02231892|580729145|FG000|Overall Study|Could not find reliable motor hotspot|0|||
160821073|NCT02231892|580729146|FG001|Overall Study|Could not find reliable motor hotspot|0|||
160821074|NCT02231892|580729147|FG002|Overall Study|Could not find reliable motor hotspot|1|||
160821075|NCT00223977|580729156|FG000|Overall Study|Adverse Event|7|||
160821076|NCT00223977|580729157|FG001|Overall Study|Adverse Event|10|||
160821077|NCT00223977|580729158|FG002|Overall Study|Adverse Event|0|||
160821078|NCT00223977|580729156|FG000|Overall Study|Protocol Violation|0|||
160821079|NCT00223977|580729157|FG001|Overall Study|Protocol Violation|0|||
160821080|NCT00223977|580729158|FG002|Overall Study|Protocol Violation|1|||
160821081|NCT00223977|580729156|FG000|Overall Study|Withdrawal by Subject|1|||
160821082|NCT00223977|580729157|FG001|Overall Study|Withdrawal by Subject|1|||
160821083|NCT00223977|580729158|FG002|Overall Study|Withdrawal by Subject|2|||
160821084|NCT00223977|580729156|FG000|Overall Study|Other|1|||
160821085|NCT00223977|580729157|FG001|Overall Study|Other|0|||
160821086|NCT00223977|580729158|FG002|Overall Study|Other|0|||
160821087|NCT02359045|580729159|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
160821088|NCT02359045|580729160|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160821089|NCT02359045|580729159|FG000|Overall Study|Lost to Follow-up|1|||
160821090|NCT02359045|580729160|FG001|Overall Study|Lost to Follow-up|1|||
160821091|NCT02359045|580729159|FG000|Overall Study|Adverse Event|0|||
160821092|NCT02359045|580729160|FG001|Overall Study|Adverse Event|1|||
160821093|NCT00503581|580729169|FG000|Overall Study|Study closed|3|||
160821094|NCT00503581|580729170|FG001|Overall Study|Study closed|4|||
160821095|NCT00503581|580729171|FG002|Overall Study|Study closed|2|||
160821096|NCT03099174|580729183|FG000|Overall Study|Withdrawal by Subject|0|||
160821097|NCT03099174|580729184|FG001|Overall Study|Withdrawal by Subject|0|||
160821098|NCT03099174|580729185|FG002|Overall Study|Withdrawal by Subject|1|||
160821099|NCT03099174|580729186|FG003|Overall Study|Withdrawal by Subject|0|||
160821100|NCT03099174|580729187|FG004|Overall Study|Withdrawal by Subject|2|||
160821101|NCT03099174|580729188|FG005|Overall Study|Withdrawal by Subject|2|||
160821102|NCT03099174|580729189|FG006|Overall Study|Withdrawal by Subject|1|||
160901085|NCT01952145|581031918|FG001|Overall Study|Protocol Violation|1|||
160901086|NCT01952145|581031917|FG000|Overall Study|Death|0|||
160901087|NCT01952145|581031918|FG001|Overall Study|Death|1|||
160901088|NCT01952145|581031917|FG000|Overall Study|Adverse Event|9|||
160901089|NCT01952145|581031918|FG001|Overall Study|Adverse Event|0|||
160901090|NCT01952145|581031917|FG000|Overall Study|Withdrawal Criteria|16|||
160901091|NCT01952145|581031918|FG001|Overall Study|Withdrawal Criteria|11|||
160901092|NCT01952145|581031917|FG000|Overall Study|Unclassified|1|||
160901093|NCT01952145|581031918|FG001|Overall Study|Unclassified|1|||
160901094|NCT01540838|581031922|FG000|Overall Study|Open nasogastric tube|9|||
160901095|NCT01540838|581031923|FG001|Overall Study|Open nasogastric tube|7|||
160901096|NCT01540838|581031922|FG000|Overall Study|Treatment doses missing|8|||
160901097|NCT01540838|581031923|FG001|Overall Study|Treatment doses missing|12|||
160901098|NCT01540838|581031922|FG000|Overall Study|Additional antibiotic treatment|1|||
160901099|NCT01540838|581031923|FG001|Overall Study|Additional antibiotic treatment|2|||
160901100|NCT01540838|581031922|FG000|Overall Study|Died before treatment initiation|1|||
160901101|NCT01540838|581031923|FG001|Overall Study|Died before treatment initiation|1|||
160901102|NCT01540838|581031922|FG000|Overall Study|Not BM. Other treatment|3|||
160901103|NCT01540838|581031923|FG001|Overall Study|Not BM. Other treatment|1|||
160901104|NCT02130570|581031924|FG000|Overall Study|Death|3|||
160901105|NCT02130570|581031925|FG001|Overall Study|Death|5|||
160901106|NCT02130570|581031924|FG000|Overall Study|Withdrawal by Subject|6|||
160901107|NCT02130570|581031925|FG001|Overall Study|Withdrawal by Subject|3|||
160901108|NCT02130570|581031924|FG000|Overall Study|Part of practice that discontinued study|0|||
160901109|NCT02130570|581031925|FG001|Overall Study|Part of practice that discontinued study|5|||
160901110|NCT02808650|581031935|FG000|Overall Study|Death|0|||
160901111|NCT02808650|581031936|FG001|Overall Study|Death|0|||
160901112|NCT02808650|581031937|FG002|Overall Study|Death|0|||
160901113|NCT02808650|581031938|FG003|Overall Study|Death|0|||
160901114|NCT02808650|581031939|FG004|Overall Study|Death|1|||
160901115|NCT02808650|581031935|FG000|Overall Study|Lack of Efficacy|5|||
160901116|NCT02808650|581031936|FG001|Overall Study|Lack of Efficacy|5|||
160901117|NCT02808650|581031937|FG002|Overall Study|Lack of Efficacy|6|||
160901118|NCT02808650|581031938|FG003|Overall Study|Lack of Efficacy|5|||
160901119|NCT02808650|581031939|FG004|Overall Study|Lack of Efficacy|4|||
160901120|NCT02808650|581031935|FG000|Overall Study|Physician Decision|1|||
160901121|NCT02808650|581031936|FG001|Overall Study|Physician Decision|1|||
160901122|NCT02808650|581031937|FG002|Overall Study|Physician Decision|0|||
160901123|NCT02808650|581031938|FG003|Overall Study|Physician Decision|0|||
160901124|NCT02808650|581031939|FG004|Overall Study|Physician Decision|0|||
160901125|NCT02808650|581031935|FG000|Overall Study|Withdrawal by Subject|0|||
160901126|NCT02808650|581031936|FG001|Overall Study|Withdrawal by Subject|0|||
160901127|NCT02808650|581031937|FG002|Overall Study|Withdrawal by Subject|0|||
160901128|NCT02808650|581031938|FG003|Overall Study|Withdrawal by Subject|1|||
160901129|NCT02808650|581031939|FG004|Overall Study|Withdrawal by Subject|1|||
160901130|NCT00071396|581031947|FG000|Overall Study|Withdrawal by Subject|1|||
160901131|NCT00071396|581031947|FG000|Overall Study|Physician Decision|2|||
160901132|NCT00113087|581031948|FG000|Overall Study|Death or Transplant|14|||
160901133|NCT00113087|581031949|FG001|Overall Study|Death or Transplant|16|||
160901134|NCT00113087|581031948|FG000|Overall Study|Family or MD withdrew subject|10|||
160901135|NCT00113087|581031949|FG001|Overall Study|Family or MD withdrew subject|5|||
160901136|NCT00633750|581031951|FG000|Overall Study|Adverse Event|2|||
160901137|NCT00633750|581031951|FG000|Overall Study|Withdrawal by Subject|3|||
160901138|NCT01903031|581031952|FG000|Overall Study|Not Able to Attend Clinic|1|||
160901139|NCT01903031|581031953|FG001|Overall Study|Not Able to Attend Clinic|1|||
160901140|NCT01903031|581031954|FG002|Overall Study|Not Able to Attend Clinic|0|||
160901141|NCT01903031|581031952|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
160901142|NCT01903031|581031953|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
160901143|NCT01903031|581031954|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
160901144|NCT01903031|581031952|FG000|Overall Study|Adverse Event|0|||
160901145|NCT01903031|581031953|FG001|Overall Study|Adverse Event|1|||
160901146|NCT01903031|581031954|FG002|Overall Study|Adverse Event|0|||
160901147|NCT01903031|581031952|FG000|Overall Study|Withdrawal by Subject|0|||
160901148|NCT01903031|581031953|FG001|Overall Study|Withdrawal by Subject|1|||
160901149|NCT01903031|581031954|FG002|Overall Study|Withdrawal by Subject|1|||
160901150|NCT01903031|581031952|FG000|Overall Study|Protocol Violation|0|||
160901151|NCT01903031|581031953|FG001|Overall Study|Protocol Violation|0|||
160901152|NCT01903031|581031954|FG002|Overall Study|Protocol Violation|2|||
160901153|NCT01903031|581031952|FG000|Overall Study|Lost to Follow-up|0|||
160901154|NCT01903031|581031953|FG001|Overall Study|Lost to Follow-up|0|||
160901155|NCT01903031|581031954|FG002|Overall Study|Lost to Follow-up|1|||
160901156|NCT01903031|581031952|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
160901157|NCT01903031|581031953|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
160901158|NCT01903031|581031954|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
160901159|NCT01811225|581031955|FG000|Treatment Period 1|Adverse Event|2|||
160901160|NCT01811225|581031956|FG001|Treatment Period 1|Adverse Event|3|||
160901161|NCT01811225|581031955|FG000|Treatment Period 1|Lost to Follow-up|12|||
160821103|NCT03099174|580729190|FG007|Overall Study|Withdrawal by Subject|4|||
160821104|NCT03099174|580729183|FG000|Overall Study|Adverse Event|0|||
160821105|NCT03099174|580729184|FG001|Overall Study|Adverse Event|1|||
160821106|NCT03099174|580729185|FG002|Overall Study|Adverse Event|1|||
160821107|NCT03099174|580729186|FG003|Overall Study|Adverse Event|2|||
160821108|NCT03099174|580729187|FG004|Overall Study|Adverse Event|5|||
160821109|NCT03099174|580729188|FG005|Overall Study|Adverse Event|3|||
160821110|NCT03099174|580729189|FG006|Overall Study|Adverse Event|6|||
160821111|NCT03099174|580729190|FG007|Overall Study|Adverse Event|4|||
160821112|NCT03099174|580729183|FG000|Overall Study|Other than listed|6|||
160821113|NCT03099174|580729184|FG001|Overall Study|Other than listed|6|||
160821114|NCT03099174|580729185|FG002|Overall Study|Other than listed|5|||
160821115|NCT03099174|580729186|FG003|Overall Study|Other than listed|6|||
160821116|NCT03099174|580729187|FG004|Overall Study|Other than listed|19|||
160821117|NCT03099174|580729188|FG005|Overall Study|Other than listed|10|||
160821118|NCT03099174|580729189|FG006|Overall Study|Other than listed|26|||
160821119|NCT03099174|580729190|FG007|Overall Study|Other than listed|23|||
160821120|NCT02438683|580729191|FG000|Overall Study|Adverse Event|1|||
160821121|NCT02438683|580729192|FG001|Overall Study|Adverse Event|0|||
160821122|NCT02438683|580729193|FG002|Overall Study|Adverse Event|0|||
160821123|NCT02438683|580729194|FG003|Overall Study|Adverse Event|0|||
160821124|NCT02438683|580729195|FG004|Overall Study|Adverse Event|0|||
160821125|NCT02438683|580729196|FG005|Overall Study|Adverse Event|0|||
160821126|NCT00721578|580729197|FG000|Overall Study|Death|1|||
160821127|NCT00721578|580729198|FG001|Overall Study|Death|1|||
160821128|NCT00721578|580729197|FG000|Overall Study|Withdrawal by Subject|1|||
160821129|NCT00721578|580729198|FG001|Overall Study|Withdrawal by Subject|1|||
160821130|NCT00211757|580729212|FG000|Overall Study|Withdrawal by Subject|1|||
160821131|NCT00211757|580729213|FG001|Overall Study|Withdrawal by Subject|1|||
160552987|NCT01405053|579749901|FG000|Overall Study|Inadequate therapeutic effect|2|||
160552988|NCT01405053|579749902|FG001|Overall Study|Inadequate therapeutic effect|1|||
160552989|NCT01405053|579749901|FG000|Overall Study|Withdrawal by Subject|3|||
160552990|NCT01405053|579749902|FG001|Overall Study|Withdrawal by Subject|4|||
160552991|NCT01405053|579749901|FG000|Overall Study|Other|0|||
160552992|NCT01405053|579749902|FG001|Overall Study|Other|1|||
160552993|NCT00130286|579749903|FG000|Overall Study|Withdrawal by Subject|0|||
160552994|NCT00130286|579749904|FG001|Overall Study|Withdrawal by Subject|1|||
160552995|NCT00130286|579749905|FG002|Overall Study|Withdrawal by Subject|2|||
160552996|NCT00130286|579749906|FG003|Overall Study|Withdrawal by Subject|2|||
160552997|NCT00130286|579749903|FG000|Overall Study|Adverse Event|0|||
160552998|NCT00130286|579749904|FG001|Overall Study|Adverse Event|0|||
160552999|NCT00130286|579749905|FG002|Overall Study|Adverse Event|2|||
160553000|NCT00130286|579749906|FG003|Overall Study|Adverse Event|0|||
160553001|NCT00130286|579749903|FG000|Overall Study|Missing lab specimens|0|||
160553002|NCT00130286|579749904|FG001|Overall Study|Missing lab specimens|2|||
160553003|NCT00130286|579749905|FG002|Overall Study|Missing lab specimens|0|||
160553004|NCT00130286|579749906|FG003|Overall Study|Missing lab specimens|0|||
160553005|NCT01818726|579749910|FG000|Overall Study|Administrative reasons|5|||
160553006|NCT01818726|579749911|FG001|Overall Study|Administrative reasons|1|||
160553007|NCT01818726|579749910|FG000|Overall Study|Withdrawal by Subject|0|||
160553008|NCT01818726|579749911|FG001|Overall Study|Withdrawal by Subject|1|||
160553009|NCT01818726|579749910|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
160553010|NCT01818726|579749911|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
160553011|NCT06098729|579749912|FG000|Overall Study|Withdrawal by Subject|1|||
160821132|NCT00211757|580729212|FG000|Overall Study|Lack of Efficacy|0|||
160901162|NCT01811225|581031956|FG001|Treatment Period 1|Lost to Follow-up|8|||
160901163|NCT01811225|581031955|FG000|Treatment Period 1|transporation|1|||
160901164|NCT01811225|581031956|FG001|Treatment Period 1|transporation|0|||
160901165|NCT01811225|581031955|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
160901166|NCT01811225|581031956|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
160553012|NCT01890421|579749913|FG000|Overall Study|Adverse Event|1|||
160553013|NCT01890421|579749913|FG000|Overall Study|Other reason|10|||
160821133|NCT00211757|580729213|FG001|Overall Study|Lack of Efficacy|1|||
160553014|NCT00993928|579749914|FG000|Overall Study|Withdrawal by Subject|4|||
160553015|NCT00993928|579749915|FG001|Overall Study|Withdrawal by Subject|7|||
160553016|NCT00993928|579749914|FG000|Overall Study|ineligible|1|||
160553017|NCT00993928|579749915|FG001|Overall Study|ineligible|0|||
160821134|NCT02825420|580729215|FG000|Overall Study|Death|30|||
160821135|NCT02825420|580729216|FG001|Overall Study|Death|12|||
160821136|NCT02825420|580729215|FG000|Overall Study|Progressive disease|6|||
160821137|NCT02825420|580729216|FG001|Overall Study|Progressive disease|1|||
160901167|NCT01811225|581031955|FG000|Treatment Period 2|Lost to Follow-up|1|||
160901168|NCT01811225|581031956|FG001|Treatment Period 2|Lost to Follow-up|2|||
160901169|NCT01811225|581031955|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
160901170|NCT01811225|581031956|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
160901171|NCT03000569|581031957|FG000|Overall Study|Withdrawal by Subject|1|||
160901172|NCT03000569|581031958|FG001|Overall Study|Withdrawal by Subject|0|||
160901173|NCT02298023|581031959|FG000|Overall Study|Withdrawal by Subject|1|||
160553018|NCT04871711|579749916|FG000|Overall Study|Withdrawal by Subject|11|||
160553019|NCT04871711|579749917|FG001|Overall Study|Withdrawal by Subject|5|||
160553020|NCT04871711|579749916|FG000|Overall Study|Lack of Efficacy|5|||
160553021|NCT04871711|579749917|FG001|Overall Study|Lack of Efficacy|7|||
160821138|NCT02825420|580729215|FG000|Overall Study|Lost to Follow-up|2|||
160821139|NCT02825420|580729216|FG001|Overall Study|Lost to Follow-up|2|||
160821140|NCT02825420|580729215|FG000|Overall Study|Withdrawal by Subject|1|||
160821141|NCT02825420|580729216|FG001|Overall Study|Withdrawal by Subject|1|||
160821142|NCT02825420|580729215|FG000|Overall Study|Protocol amendment not signed|1|||
160821143|NCT02825420|580729216|FG001|Overall Study|Protocol amendment not signed|1|||
160821144|NCT02825420|580729215|FG000|Overall Study|Physician Decision|1|||
160821145|NCT02825420|580729216|FG001|Overall Study|Physician Decision|0|||
160821146|NCT02825420|580729215|FG000|Overall Study|Did not receive PLD|2|||
160821147|NCT02825420|580729216|FG001|Overall Study|Did not receive PLD|0|||
160821148|NCT02226198|580731171|FG000|Lead-in Phase|Protocol Violation|1|||
160821149|NCT02226198|580731172|FG001|Lead-in Phase|Protocol Violation|0|||
160821150|NCT02226198|580731173|FG002|Lead-in Phase|Protocol Violation|0|||
160821151|NCT02226198|580731171|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
160821152|NCT02226198|580731172|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
160821153|NCT02226198|580731173|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
160821154|NCT01440517|580731177|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
160821155|NCT01288612|580731178|FG000|Overall Study|Unable to contact|11|||
160821156|NCT01288612|580731179|FG001|Overall Study|Unable to contact|16|||
160821157|NCT01288612|580731180|FG002|Overall Study|Unable to contact|20|||
160821158|NCT01288612|580731178|FG000|Overall Study|Declined|78|||
160821159|NCT01288612|580731179|FG001|Overall Study|Declined|63|||
160821160|NCT01288612|580731180|FG002|Overall Study|Declined|62|||
160821161|NCT01288612|580731178|FG000|Overall Study|Unable to intubate|0|||
160821162|NCT01288612|580731179|FG001|Overall Study|Unable to intubate|3|||
160821163|NCT01288612|580731180|FG002|Overall Study|Unable to intubate|0|||
160821164|NCT00871923|580731181|FG000|Overall Study|Death|1|||
160821165|NCT00871923|580731181|FG000|Overall Study|Withdrawal by Subject|1|||
160821166|NCT00496483|580731187|FG000|Overall Study|Not dosed|9|||
160821167|NCT00496483|580731187|FG000|Overall Study|Adverse Event|2|||
160821168|NCT00496483|580731187|FG000|Overall Study|Lack of Efficacy|1|||
160821169|NCT04258995|580731189|FG000|Overall Study|Lost to Follow-up|1|||
160821170|NCT04258995|580731190|FG001|Overall Study|Lost to Follow-up|1|||
160821171|NCT01145352|580731194|FG000|Overall Study|Found to have been registered twice|6|||
160821172|NCT01145352|580731194|FG000|Overall Study|Treated before marketing approval|4|||
160821173|NCT01145352|580731194|FG000|Overall Study|Syringe formulation was used|1|||
160821174|NCT00847665|580731195|FG000|Overall Study|Withdrawal by Subject|1|||
160988444|NCT02757885|581345268|FG000|Overall Study|Screen Failures|4|||
160988445|NCT01175707|581345269|FG000|Overall Study|Adverse Event|4|||
160988446|NCT01175707|581345270|FG001|Overall Study|Adverse Event|6|||
160988447|NCT01456780|581345271|FG000|Overall Study|Lost to Follow-up|3|||
160988448|NCT01456780|581345272|FG001|Overall Study|Lost to Follow-up|3|||
160988449|NCT01456780|581345273|FG002|Overall Study|Lost to Follow-up|0|||
160988450|NCT02688621|581345280|FG000|Overall Study|Pregnancy|1|||
160988451|NCT02688621|581345281|FG001|Overall Study|Pregnancy|3|||
160821175|NCT00847665|580731196|FG001|Overall Study|Withdrawal by Subject|0|||
160821176|NCT00585546|580731197|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
160553022|NCT04871711|579749916|FG000|Overall Study|Adverse Event|2|||
160553023|NCT04871711|579749917|FG001|Overall Study|Adverse Event|6|||
160821177|NCT00585546|580731197|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
160821178|NCT02851797|580731198|FG000|Overall Study|Withdrawal by Subject|4|||
160821179|NCT02851797|580731199|FG001|Overall Study|Withdrawal by Subject|2|||
160821180|NCT02851797|580731198|FG000|Overall Study|Adverse Event|3|||
160821181|NCT02851797|580731199|FG001|Overall Study|Adverse Event|0|||
160821182|NCT03077438|580731200|FG000|Overall Study|Protocol Violation|3|||
160988452|NCT02688621|581345280|FG000|Overall Study|Lost to Follow-up|38|||
160988453|NCT02688621|581345281|FG001|Overall Study|Lost to Follow-up|15|||
160988454|NCT02688621|581345280|FG000|Overall Study|Withdrawal by Subject|1|||
160988455|NCT02688621|581345281|FG001|Overall Study|Withdrawal by Subject|0|||
160821183|NCT03077438|580731201|FG001|Overall Study|Protocol Violation|5|||
160821184|NCT03077438|580731200|FG000|Overall Study|Withdrawal by Subject|3|||
160821185|NCT03077438|580731201|FG001|Overall Study|Withdrawal by Subject|6|||
160988456|NCT05349864|581345288|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
160821186|NCT03077438|580731200|FG000|Overall Study|Lost to Follow-up|6|||
160821187|NCT03077438|580731201|FG001|Overall Study|Lost to Follow-up|3|||
160821188|NCT00813865|580731202|FG000|Overall Study|Failure to Respond|3|||
160821189|NCT00813865|580731202|FG000|Overall Study|Lost to Follow-up|3|||
160821190|NCT00813865|580731202|FG000|Overall Study|Withdrawal by Subject|1|||
160821191|NCT00624585|580731204|FG000|Overall Study|Death|3|||
160553024|NCT04871711|579749916|FG000|Overall Study|Various reasons|2|||
160553025|NCT04871711|579749917|FG001|Overall Study|Various reasons|1|||
160988457|NCT05349864|581345289|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
160988458|NCT00984282|581345290|FG000|Double Blind Treatment|Adverse Event|40|||
160988459|NCT00984282|581345291|FG001|Double Blind Treatment|Adverse Event|6|||
160821192|NCT00624585|580731204|FG000|Overall Study|Disease Progression|6|||
160821193|NCT00624585|580731204|FG000|Overall Study|Adverse Event|3|||
160821194|NCT04686084|580731213|FG000|Overall Study|Lost to Follow-up|1|||
160821195|NCT00676520|580731214|FG000|Overall Study|Withdrawal by Subject|163|||
160821196|NCT00676520|580731214|FG000|Overall Study|Lost to Follow-up|162|||
160821197|NCT00676520|580731214|FG000|Overall Study|Death|159|||
160821198|NCT00676520|580731214|FG000|Overall Study|Physician Decision|20|||
160821199|NCT00676520|580731214|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
160821200|NCT00676520|580731214|FG000|Overall Study|Other Reason|18|||
160821201|NCT01425359|580731215|FG000|Overall Study|Randomized but Not Treated|2|||
160821202|NCT01425359|580731216|FG001|Overall Study|Randomized but Not Treated|3|||
160821203|NCT01425359|580731215|FG000|Overall Study|Adverse Event|9|||
160821204|NCT01425359|580731216|FG001|Overall Study|Adverse Event|8|||
160821205|NCT01425359|580731215|FG000|Overall Study|Revascularization|0|||
160821206|NCT01425359|580731216|FG001|Overall Study|Revascularization|1|||
160821207|NCT01425359|580731215|FG000|Overall Study|Death|0|||
160821208|NCT01425359|580731216|FG001|Overall Study|Death|1|||
160821209|NCT01425359|580731215|FG000|Overall Study|Unsatisfactory Response|1|||
160821210|NCT01425359|580731216|FG001|Overall Study|Unsatisfactory Response|0|||
160821211|NCT01425359|580731215|FG000|Overall Study|Protocol Violation|1|||
160821212|NCT01425359|580731216|FG001|Overall Study|Protocol Violation|2|||
160821213|NCT01425359|580731215|FG000|Overall Study|Subject Withdrew Consent|1|||
160821214|NCT01425359|580731216|FG001|Overall Study|Subject Withdrew Consent|2|||
160821215|NCT01425359|580731215|FG000|Overall Study|Investigator's Discretion|2|||
160821216|NCT01425359|580731216|FG001|Overall Study|Investigator's Discretion|0|||
160821217|NCT01425359|580731215|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
160821218|NCT01425359|580731216|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
160821219|NCT02135029|580731220|FG000|Overall Study|Adverse Event|2|||
160821220|NCT02135029|580731221|FG001|Overall Study|Adverse Event|2|||
160821221|NCT02135029|580731222|FG002|Overall Study|Adverse Event|2|||
160821222|NCT02135029|580731220|FG000|Overall Study|Lost to Follow-up|0|||
160821223|NCT02135029|580731221|FG001|Overall Study|Lost to Follow-up|1|||
160821224|NCT02135029|580731222|FG002|Overall Study|Lost to Follow-up|0|||
160821225|NCT02135029|580731220|FG000|Overall Study|Withdrawal by Subject|2|||
160821226|NCT02135029|580731221|FG001|Overall Study|Withdrawal by Subject|0|||
160821227|NCT02135029|580731222|FG002|Overall Study|Withdrawal by Subject|1|||
160821228|NCT02135029|580731220|FG000|Overall Study|Other|0|||
160821229|NCT02135029|580731221|FG001|Overall Study|Other|1|||
160821230|NCT02135029|580731222|FG002|Overall Study|Other|0|||
160821231|NCT02135029|580731220|FG000|Overall Study|Death|0|||
160821232|NCT02135029|580731221|FG001|Overall Study|Death|1|||
160821233|NCT02135029|580731222|FG002|Overall Study|Death|0|||
160821234|NCT04043234|580731223|FG000|Overall Study|Lost to Follow-up|1|||
160821235|NCT04043234|580731223|FG000|Overall Study|Withdrawal by Subject|1|||
160821236|NCT00744978|580731239|FG000|Period 1|Lost to Follow-up|1|||
160821237|NCT00744978|580731240|FG001|Period 1|Lost to Follow-up|0|||
160821238|NCT00744978|580731239|FG000|Period 1|Withdrawal by Subject|0|||
160821239|NCT00744978|580731240|FG001|Period 1|Withdrawal by Subject|2|||
160821240|NCT00744978|580731239|FG000|Period 1|Other|0|||
160821241|NCT00744978|580731240|FG001|Period 1|Other|2|||
160821242|NCT00744978|580731239|FG000|Period 1|Adverse Event|4|||
160821243|NCT00744978|580731240|FG001|Period 1|Adverse Event|0|||
160821244|NCT00744978|580731239|FG000|Period 1|Randomized but not Treated|1|||
160821245|NCT00744978|580731240|FG001|Period 1|Randomized but not Treated|1|||
160821246|NCT00744978|580731239|FG000|Period 2|Adverse Event|0|||
160988460|NCT00984282|581345290|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
160988461|NCT00984282|581345291|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
160646136|NCT02196506|580085993|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
160646137|NCT02196506|580085990|FG000|Phase B|Lack of Efficacy|0|||
160646138|NCT02196506|580085991|FG001|Phase B|Lack of Efficacy|1|||
160646139|NCT02196506|580085992|FG002|Phase B|Lack of Efficacy|2|||
160821247|NCT00744978|580731240|FG001|Period 2|Adverse Event|1|||
160821248|NCT03773133|580731241|FG000|Overall Study|Screen Failure|8|||
160821249|NCT00515294|580731242|FG000|Overall Study|Lost to Follow-up|3|||
160821250|NCT00515294|580731243|FG001|Overall Study|Lost to Follow-up|2|||
160821251|NCT00515294|580731244|FG002|Overall Study|Lost to Follow-up|3|||
160821252|NCT00515294|580731245|FG003|Overall Study|Lost to Follow-up|1|||
160821253|NCT00515294|580731242|FG000|Overall Study|Driver simulator problems|1|||
160821254|NCT00515294|580731243|FG001|Overall Study|Driver simulator problems|1|||
160821255|NCT00515294|580731244|FG002|Overall Study|Driver simulator problems|1|||
160821256|NCT00515294|580731245|FG003|Overall Study|Driver simulator problems|3|||
160821257|NCT00515294|580731242|FG000|Overall Study|Caffeine amount inaccurate|5|||
160821258|NCT00515294|580731243|FG001|Overall Study|Caffeine amount inaccurate|0|||
160821259|NCT00515294|580731244|FG002|Overall Study|Caffeine amount inaccurate|7|||
160821260|NCT00515294|580731245|FG003|Overall Study|Caffeine amount inaccurate|0|||
160821261|NCT02778555|580731248|FG000|Overall Study|Withdrawal by Subject|55|||
160646140|NCT02196506|580085993|FG003|Phase B|Lack of Efficacy|0|||
160821262|NCT02778555|580731249|FG001|Overall Study|Withdrawal by Subject|32|||
160821263|NCT02778555|580731250|FG002|Overall Study|Withdrawal by Subject|107|||
160821264|NCT03276026|580731253|FG000|Overall Study|Protocol Violation|1|||
160821265|NCT03276026|580731254|FG001|Overall Study|Protocol Violation|0|||
160821266|NCT01534260|580731255|FG000|Overall Study|Adverse Event|1|||
160821267|NCT01534260|580731256|FG001|Overall Study|Adverse Event|8|||
160821268|NCT01534260|580731255|FG000|Overall Study|Death|2|||
160821269|NCT01534260|580731256|FG001|Overall Study|Death|0|||
160821270|NCT01534260|580731255|FG000|Overall Study|Lack of Efficacy|1|||
160821271|NCT01534260|580731256|FG001|Overall Study|Lack of Efficacy|1|||
160821272|NCT01534260|580731255|FG000|Overall Study|Withdrawal by Subject|1|||
160821273|NCT01534260|580731256|FG001|Overall Study|Withdrawal by Subject|3|||
160821274|NCT01534260|580731255|FG000|Overall Study|Disease Progression|8|||
160821275|NCT01534260|580731256|FG001|Overall Study|Disease Progression|6|||
160821276|NCT01534260|580731255|FG000|Overall Study|Physician Decision|3|||
160821277|NCT01534260|580731256|FG001|Overall Study|Physician Decision|1|||
160821278|NCT01534260|580731255|FG000|Overall Study|No treatment, per protocol|0|||
160821279|NCT01534260|580731256|FG001|Overall Study|No treatment, per protocol|1|||
160821280|NCT00367744|580731257|FG000|Overall Study|Lost to Follow-up|4|||
160821281|NCT00367744|580731258|FG001|Overall Study|Lost to Follow-up|5|||
160821282|NCT03664674|580731259|FG000|Overall Study|Adverse Event|1|||
160821283|NCT03664674|580731260|FG001|Overall Study|Adverse Event|1|||
160821284|NCT03664674|580731259|FG000|Overall Study|Physician Decision|0|||
160821285|NCT03664674|580731260|FG001|Overall Study|Physician Decision|1|||
160821286|NCT03664674|580731259|FG000|Overall Study|Withdrawal by Subject|2|||
160821287|NCT03664674|580731260|FG001|Overall Study|Withdrawal by Subject|0|||
160821288|NCT01342965|580731264|FG000|Overall Study|Death|58|||
160821289|NCT01342965|580731265|FG001|Overall Study|Death|57|||
160821290|NCT01342965|580731264|FG000|Overall Study|Lost to Follow-up|5|||
160821291|NCT01342965|580731265|FG001|Overall Study|Lost to Follow-up|3|||
160821292|NCT01342965|580731264|FG000|Overall Study|Other Reasons- Unspecified|44|||
160821293|NCT01342965|580731265|FG001|Overall Study|Other Reasons- Unspecified|38|||
160821294|NCT01342965|580731264|FG000|Overall Study|Withdrawal by Subject|2|||
160821295|NCT01342965|580731265|FG001|Overall Study|Withdrawal by Subject|9|||
160821296|NCT00856206|580731268|FG000|Overall Study|Protocol Violation|6|||
160821297|NCT00856206|580731269|FG001|Overall Study|Protocol Violation|18|||
160821298|NCT00856206|580731268|FG000|Overall Study|Adverse Event|10|||
160821299|NCT00856206|580731269|FG001|Overall Study|Adverse Event|46|||
160821300|NCT00856206|580731268|FG000|Overall Study|Lack of Efficacy|1|||
160821301|NCT00856206|580731269|FG001|Overall Study|Lack of Efficacy|2|||
160821302|NCT00856206|580731268|FG000|Overall Study|Withdrawal by Subject|15|||
160821303|NCT00856206|580731269|FG001|Overall Study|Withdrawal by Subject|36|||
160821304|NCT00856206|580731268|FG000|Overall Study|Lost to Follow-up|13|||
160821305|NCT00856206|580731269|FG001|Overall Study|Lost to Follow-up|39|||
160821306|NCT00856206|580731268|FG000|Overall Study|Death|2|||
160821307|NCT00856206|580731269|FG001|Overall Study|Death|2|||
160821308|NCT00856206|580731268|FG000|Overall Study|Decision by the Sponsor|4|||
160821309|NCT00856206|580731269|FG001|Overall Study|Decision by the Sponsor|8|||
160821310|NCT00856206|580731268|FG000|Overall Study|Other than specified above|3|||
160821311|NCT00856206|580731269|FG001|Overall Study|Other than specified above|10|||
160821312|NCT04584346|580731275|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
160821313|NCT04584346|580731276|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
160821314|NCT02780856|580731279|FG000|Overall Study|Lost to Follow-up|1|||
160821315|NCT04262882|580731280|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
160821316|NCT04262882|580731281|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
160821317|NCT04262882|580731280|FG000|Overall Study|Lost to Follow-up|1|||
160821318|NCT04262882|580731281|FG001|Overall Study|Lost to Follow-up|0|||
160821319|NCT01301066|580731282|FG000|Overall Study|Lost to Follow-up|5|||
160821320|NCT01301066|580731283|FG001|Overall Study|Lost to Follow-up|11|||
160821321|NCT01301066|580731282|FG000|Overall Study|Protocol Violation|8|||
160821322|NCT01301066|580731283|FG001|Overall Study|Protocol Violation|7|||
160821323|NCT01301066|580731282|FG000|Overall Study|Withdrawal by Subject|4|||
160821324|NCT01301066|580731283|FG001|Overall Study|Withdrawal by Subject|9|||
160821325|NCT01301066|580731282|FG000|Overall Study|Adverse Event|6|||
160821326|NCT01301066|580731283|FG001|Overall Study|Adverse Event|6|||
160821327|NCT01301066|580731282|FG000|Overall Study|Sponsor Decision|2|||
160821328|NCT01301066|580731283|FG001|Overall Study|Sponsor Decision|1|||
160821329|NCT01301066|580731282|FG000|Overall Study|Physician Decision|0|||
160821330|NCT01301066|580731283|FG001|Overall Study|Physician Decision|1|||
160821331|NCT01301066|580731282|FG000|Overall Study|Other|2|||
160821332|NCT01301066|580731283|FG001|Overall Study|Other|0|||
160901174|NCT02298023|581031960|FG001|Overall Study|Withdrawal by Subject|0|||
160646141|NCT02196506|580085990|FG000|Phase B|Withdrawal by Participant|0|||
160901175|NCT02298023|581031961|FG002|Overall Study|Withdrawal by Subject|0|||
160901176|NCT00492531|581031967|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
160821333|NCT04003207|580731284|FG000|Overall Study|Protocol Violation|1|||
160821334|NCT03894969|580731286|FG000|Overall Study|Adverse Event|0|||
160821335|NCT03894969|580731287|FG001|Overall Study|Adverse Event|2|||
160821336|NCT03894969|580731288|FG002|Overall Study|Adverse Event|0|||
160821337|NCT03894969|580731289|FG003|Overall Study|Adverse Event|1|||
160821338|NCT03894969|580731290|FG004|Overall Study|Adverse Event|2|||
160553026|NCT04871711|579749916|FG000|Overall Study|Lost to Follow-up|0|||
160553027|NCT04871711|579749917|FG001|Overall Study|Lost to Follow-up|2|||
160553028|NCT01665144|579749918|FG000|Core Part|Withdrawal by Subject|96|||
160553029|NCT01665144|579749919|FG001|Core Part|Withdrawal by Subject|77|||
160553030|NCT01665144|579749920|FG002|Core Part|Withdrawal by Subject|0|||
160553031|NCT01665144|579749918|FG000|Core Part|Adverse Event|45|||
160553032|NCT01665144|579749919|FG001|Core Part|Adverse Event|18|||
160553033|NCT01665144|579749920|FG002|Core Part|Adverse Event|0|||
160553034|NCT01665144|579749918|FG000|Core Part|Lack of Efficacy|16|||
160553035|NCT01665144|579749919|FG001|Core Part|Lack of Efficacy|11|||
160553036|NCT01665144|579749920|FG002|Core Part|Lack of Efficacy|0|||
160553037|NCT01665144|579749918|FG000|Core Part|Lost to Follow-up|9|||
160821339|NCT03894969|580731286|FG000|Overall Study|Lost to Follow-up|3|||
160821340|NCT03894969|580731287|FG001|Overall Study|Lost to Follow-up|1|||
160821341|NCT03894969|580731288|FG002|Overall Study|Lost to Follow-up|1|||
160821342|NCT03894969|580731289|FG003|Overall Study|Lost to Follow-up|0|||
160821343|NCT03894969|580731290|FG004|Overall Study|Lost to Follow-up|0|||
160821344|NCT03894969|580731286|FG000|Overall Study|Withdrawal by Subject|2|||
160821345|NCT03894969|580731287|FG001|Overall Study|Withdrawal by Subject|1|||
160821346|NCT03894969|580731288|FG002|Overall Study|Withdrawal by Subject|3|||
160821347|NCT03894969|580731289|FG003|Overall Study|Withdrawal by Subject|4|||
160821348|NCT03894969|580731290|FG004|Overall Study|Withdrawal by Subject|8|||
160821349|NCT03894969|580731286|FG000|Overall Study|Other|0|||
160821350|NCT03894969|580731287|FG001|Overall Study|Other|0|||
160821351|NCT03894969|580731288|FG002|Overall Study|Other|0|||
160821352|NCT03894969|580731289|FG003|Overall Study|Other|0|||
160821353|NCT03894969|580731290|FG004|Overall Study|Other|3|||
160821354|NCT03894969|580731286|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
160821355|NCT03894969|580731287|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
160821356|NCT03894969|580731288|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
160821357|NCT03894969|580731289|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
160821358|NCT03894969|580731290|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
160821359|NCT03894969|580731286|FG000|Overall Study|Solicited Adverse Event|0|||
160821360|NCT03894969|580731287|FG001|Overall Study|Solicited Adverse Event|1|||
160821361|NCT03894969|580731288|FG002|Overall Study|Solicited Adverse Event|0|||
160821362|NCT03894969|580731289|FG003|Overall Study|Solicited Adverse Event|0|||
160821363|NCT03894969|580731290|FG004|Overall Study|Solicited Adverse Event|0|||
160821364|NCT00468676|580731291|FG000|Overall Study|Lost to Follow-up|14|||
160821365|NCT00468676|580731292|FG001|Overall Study|Lost to Follow-up|11|||
160901177|NCT00492531|581031968|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
160901178|NCT04122534|581031977|FG000|Overall Study|Lost to Follow-up|4|||
160901179|NCT00437983|581031985|FG000|Overall Study|Adverse Event|6|||
160901180|NCT00437983|581031986|FG001|Overall Study|Adverse Event|6|||
160901181|NCT00437983|581031985|FG000|Overall Study|Protocol Violation|2|||
160901182|NCT00437983|581031986|FG001|Overall Study|Protocol Violation|1|||
160901183|NCT00437983|581031985|FG000|Overall Study|Withdrawal by Subject|5|||
160901184|NCT00437983|581031986|FG001|Overall Study|Withdrawal by Subject|6|||
160901185|NCT01558739|581031989|FG000|Overall Study|Adverse Event|7|||
160901186|NCT01558739|581031989|FG000|Overall Study|Withdrawal by Subject|2|||
160901187|NCT01558739|581031989|FG000|Overall Study|Death|3|||
160901188|NCT01558739|581031989|FG000|Overall Study|Disease Progression|4|||
160901189|NCT01558739|581031989|FG000|Overall Study|Protocol Violation|1|||
160901190|NCT01402011|581031994|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
160901191|NCT01402011|581031995|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
160901192|NCT01402011|581031996|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
160901193|NCT01402011|581031994|FG000|Active Treatment Period|Withdrawal by Subject|1|||
160901194|NCT01402011|581031995|FG001|Active Treatment Period|Withdrawal by Subject|3|||
160901195|NCT01402011|581031996|FG002|Active Treatment Period|Withdrawal by Subject|0|||
160901196|NCT01402011|581031994|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
160901197|NCT01402011|581031995|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
160901198|NCT01402011|581031996|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
160901199|NCT00594659|581031997|FG000|Overall Study|Lost to Follow-up|13|||
160901200|NCT00594659|581031998|FG001|Overall Study|Lost to Follow-up|9|||
160901201|NCT00594659|581031999|FG002|Overall Study|Lost to Follow-up|7|||
160901202|NCT00142298|581032001|FG000|Overall Study|Adverse Event|10|||
160901203|NCT00142298|581032002|FG001|Overall Study|Adverse Event|10|||
160901204|NCT00142298|581032003|FG002|Overall Study|Adverse Event|1|||
160901205|NCT00142298|581032004|FG003|Overall Study|Adverse Event|5|||
160901206|NCT00142298|581032005|FG004|Overall Study|Adverse Event|2|||
160901207|NCT00142298|581032006|FG005|Overall Study|Adverse Event|2|||
160901208|NCT00142298|581032007|FG006|Overall Study|Adverse Event|0|||
160901209|NCT00142298|581032008|FG007|Overall Study|Adverse Event|0|||
160901210|NCT00142298|581032009|FG008|Overall Study|Adverse Event|0|||
160901211|NCT00142298|581032010|FG009|Overall Study|Adverse Event|0|||
160901212|NCT00142298|581032001|FG000|Overall Study|Clinical disease progression|1|||
160553038|NCT01665144|579749919|FG001|Core Part|Lost to Follow-up|8|||
160901213|NCT00142298|581032002|FG001|Overall Study|Clinical disease progression|0|||
160821366|NCT00468676|580731291|FG000|Overall Study|Death|2|||
160821367|NCT00468676|580731292|FG001|Overall Study|Death|1|||
160821368|NCT02979093|580731293|FG000|First Scan Session|Scanning data problems|1|||
160821369|NCT02979093|580731294|FG001|First Scan Session|Scanning data problems|2|||
160821370|NCT02979093|580731295|FG002|First Scan Session|Scanning data problems|2|||
160821371|NCT02979093|580731296|FG003|First Scan Session|Scanning data problems|0|||
160821372|NCT02979093|580731293|FG000|Second Scan Session|Scanning data problems|3|||
160988462|NCT00984282|581345290|FG000|Double Blind Treatment|Physician Decision|1|||
160988463|NCT00984282|581345291|FG001|Double Blind Treatment|Physician Decision|2|||
160988464|NCT00984282|581345290|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
160988465|NCT00984282|581345291|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
160988466|NCT00984282|581345290|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
160988467|NCT00984282|581345291|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
160988468|NCT00984282|581345290|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
160988469|NCT00984282|581345291|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
160988470|NCT00984282|581345290|FG000|Double Blind Treatment|Lost to Follow-up|3|||
160988471|NCT00984282|581345291|FG001|Double Blind Treatment|Lost to Follow-up|0|||
160988472|NCT00984282|581345290|FG000|Double Blind Treatment|Death|8|||
160988473|NCT00984282|581345291|FG001|Double Blind Treatment|Death|4|||
160988474|NCT00984282|581345290|FG000|Double Blind Treatment|Not treated|0|||
160988475|NCT00984282|581345291|FG001|Double Blind Treatment|Not treated|1|||
160988476|NCT00984282|581345290|FG000|Double Blind Treatment|Switched to commercial drug|6|||
160988477|NCT00984282|581345291|FG001|Double Blind Treatment|Switched to commercial drug|1|||
160988478|NCT00984282|581345290|FG000|Double Blind Treatment|protocol driven decision point|1|||
160988479|NCT00984282|581345291|FG001|Double Blind Treatment|protocol driven decision point|1|||
160988480|NCT00984282|581345290|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
160988481|NCT00984282|581345291|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
160988482|NCT00984282|581345290|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
160988483|NCT00984282|581345291|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
160988484|NCT00984282|581345290|FG000|Open-label Treatment|Adverse Event|20|||
160988485|NCT00984282|581345291|FG001|Open-label Treatment|Adverse Event|30|||
160988486|NCT00984282|581345290|FG000|Open-label Treatment|Withdrawal by Subject|6|||
160988487|NCT00984282|581345291|FG001|Open-label Treatment|Withdrawal by Subject|21|||
160988488|NCT00984282|581345290|FG000|Open-label Treatment|Death|7|||
160988489|NCT00984282|581345291|FG001|Open-label Treatment|Death|15|||
160988490|NCT00984282|581345290|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
160988491|NCT00984282|581345291|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
160988492|NCT00984282|581345290|FG000|Open-label Treatment|Lost to Follow-up|1|||
160988493|NCT00984282|581345291|FG001|Open-label Treatment|Lost to Follow-up|1|||
160988494|NCT00984282|581345290|FG000|Open-label Treatment|Patient convenience|1|||
160988495|NCT00984282|581345291|FG001|Open-label Treatment|Patient convenience|0|||
160988496|NCT00984282|581345290|FG000|Open-label Treatment|Non-compliant with study medication|1|||
160988497|NCT00984282|581345291|FG001|Open-label Treatment|Non-compliant with study medication|0|||
160988498|NCT00984282|581345290|FG000|Open-label Treatment|Target lesion removed|0|||
160988499|NCT00984282|581345291|FG001|Open-label Treatment|Target lesion removed|1|||
160988500|NCT00984282|581345290|FG000|Open-label Treatment|Protocol driven decision point|1|||
160988501|NCT00984282|581345291|FG001|Open-label Treatment|Protocol driven decision point|1|||
160988502|NCT00984282|581345290|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
160988503|NCT00984282|581345291|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
160988504|NCT00984282|581345290|FG000|Open-label Treatment|Switched to commercial drug|6|||
160988505|NCT00984282|581345291|FG001|Open-label Treatment|Switched to commercial drug|7|||
160988506|NCT00984282|581345290|FG000|Open-label Treatment|Physician Decision|1|||
160988507|NCT00984282|581345291|FG001|Open-label Treatment|Physician Decision|0|||
160988508|NCT00984282|581345290|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
160988509|NCT00984282|581345291|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
160988510|NCT00984282|581345290|FG000|Long Term Follow-up|Death|27|||
160988511|NCT00984282|581345291|FG001|Long Term Follow-up|Death|68|||
160988512|NCT00984282|581345290|FG000|Long Term Follow-up|Lost to Follow-up|3|||
160821373|NCT02979093|580731294|FG001|Second Scan Session|Scanning data problems|0|||
160988513|NCT00984282|581345291|FG001|Long Term Follow-up|Lost to Follow-up|6|||
160988514|NCT00984282|581345290|FG000|Long Term Follow-up|Protocol driven decision point|25|||
160988515|NCT00984282|581345291|FG001|Long Term Follow-up|Protocol driven decision point|26|||
160988516|NCT00984282|581345290|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
160988517|NCT00984282|581345291|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
160988518|NCT00984282|581345290|FG000|Long Term Follow-up|Switched to commercial drug|4|||
160988519|NCT00984282|581345291|FG001|Long Term Follow-up|Switched to commercial drug|2|||
160988520|NCT00984282|581345290|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
160988521|NCT00984282|581345291|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
160988522|NCT03606460|581345293|FG000|Overall Study|Lost to Follow-up|1|||
160988523|NCT03606460|581345294|FG001|Overall Study|Lost to Follow-up|8|||
160988524|NCT04541186|581345298|FG000|Main Study|Adverse Event|0|||
160988525|NCT04541186|581345299|FG001|Main Study|Adverse Event|0|||
160988526|NCT04541186|581345300|FG002|Main Study|Adverse Event|4|||
160988527|NCT04541186|581345301|FG003|Main Study|Adverse Event|0|||
160988528|NCT04541186|581345302|FG004|Main Study|Adverse Event|0|||
160988529|NCT04541186|581345298|FG000|Main Study|Investigator Decision|0|||
160988530|NCT04541186|581345299|FG001|Main Study|Investigator Decision|0|||
160988531|NCT04541186|581345300|FG002|Main Study|Investigator Decision|1|||
160988532|NCT04541186|581345301|FG003|Main Study|Investigator Decision|1|||
160988533|NCT04541186|581345302|FG004|Main Study|Investigator Decision|0|||
160988534|NCT04541186|581345298|FG000|Main Study|Withdrawal by Subject|1|||
160988535|NCT04541186|581345299|FG001|Main Study|Withdrawal by Subject|1|||
160988536|NCT04541186|581345300|FG002|Main Study|Withdrawal by Subject|0|||
160988537|NCT04541186|581345301|FG003|Main Study|Withdrawal by Subject|0|||
160988538|NCT04541186|581345302|FG004|Main Study|Withdrawal by Subject|0|||
160988539|NCT04541186|581345298|FG000|Main Study|COVID-19-related Dose Interruption|0|||
160988540|NCT04541186|581345299|FG001|Main Study|COVID-19-related Dose Interruption|0|||
160988541|NCT04541186|581345300|FG002|Main Study|COVID-19-related Dose Interruption|0|||
160988542|NCT04541186|581345301|FG003|Main Study|COVID-19-related Dose Interruption|0|||
160988543|NCT04541186|581345302|FG004|Main Study|COVID-19-related Dose Interruption|1|||
160988544|NCT04541186|581345298|FG000|Main Study|Randomized in Error Not Treated|0|||
160988545|NCT04541186|581345299|FG001|Main Study|Randomized in Error Not Treated|0|||
160988546|NCT04541186|581345300|FG002|Main Study|Randomized in Error Not Treated|1|||
160988547|NCT04541186|581345301|FG003|Main Study|Randomized in Error Not Treated|0|||
160988548|NCT04541186|581345302|FG004|Main Study|Randomized in Error Not Treated|0|||
160553039|NCT01665144|579749920|FG002|Core Part|Lost to Follow-up|0|||
160553040|NCT01665144|579749918|FG000|Core Part|Physician Decision|13|||
160988549|NCT04541186|581345298|FG000|Fibrate Expansion Study|Other than Specified|0|||
160988550|NCT04541186|581345299|FG001|Fibrate Expansion Study|Other than Specified|0|||
160988551|NCT04541186|581345300|FG002|Fibrate Expansion Study|Other than Specified|0|||
160988552|NCT04541186|581345301|FG003|Fibrate Expansion Study|Other than Specified|0|||
160553041|NCT01665144|579749919|FG001|Core Part|Physician Decision|1|||
160553042|NCT01665144|579749920|FG002|Core Part|Physician Decision|0|||
160988553|NCT04541186|581345302|FG004|Fibrate Expansion Study|Other than Specified|1|||
160988554|NCT00303303|581345303|FG000|Overall Study|Withdrawal by Subject|0|||
160988555|NCT00303303|581345304|FG001|Overall Study|Withdrawal by Subject|0|||
160988556|NCT00303303|581345305|FG002|Overall Study|Withdrawal by Subject|1|||
160988557|NCT03085017|581345306|FG000|Overall Study|Death|0|||
160988558|NCT03085017|581345307|FG001|Overall Study|Death|3|||
160988559|NCT00058058|581345308|FG000|Overall Study|Withdrawal by Subject|4|||
160988560|NCT00058058|581345308|FG000|Overall Study|Ineligible|20|||
160988561|NCT00058058|581345308|FG000|Overall Study|Claustrophobic|5|||
160988562|NCT00058058|581345308|FG000|Overall Study|technical issues|6|||
160988563|NCT00058058|581345308|FG000|Overall Study|Poor positioning, illness,pain|3|||
160988564|NCT00582790|581345309|FG000|Overall Study|Rapid progression of disease|1|||
160988565|NCT02680756|581345313|FG000|Overall Study|Adverse Event|10|||
160988566|NCT02680756|581345314|FG001|Overall Study|Adverse Event|2|||
160553043|NCT01665144|579749918|FG000|Core Part|Progressive disease|8|||
160553044|NCT01665144|579749919|FG001|Core Part|Progressive disease|4|||
160553045|NCT01665144|579749920|FG002|Core Part|Progressive disease|0|||
160553046|NCT01665144|579749918|FG000|Core Part|Non-compliance with study treatment|5|||
160553047|NCT01665144|579749919|FG001|Core Part|Non-compliance with study treatment|0|||
160553048|NCT01665144|579749920|FG002|Core Part|Non-compliance with study treatment|0|||
160988567|NCT02680756|581345313|FG000|Overall Study|Lost to Follow-up|7|||
160988568|NCT02680756|581345314|FG001|Overall Study|Lost to Follow-up|6|||
160988569|NCT02680756|581345313|FG000|Overall Study|Withdrawal by Subject|5|||
160988570|NCT02680756|581345314|FG001|Overall Study|Withdrawal by Subject|5|||
160988571|NCT02680756|581345313|FG000|Overall Study|Physician Decision|4|||
160553049|NCT01665144|579749918|FG000|Core Part|Death|3|||
160553050|NCT01665144|579749919|FG001|Core Part|Death|1|||
160553051|NCT01665144|579749920|FG002|Core Part|Death|0|||
160553052|NCT01665144|579749918|FG000|Core Part|Protocol deviation|3|||
160553053|NCT01665144|579749919|FG001|Core Part|Protocol deviation|1|||
160553054|NCT01665144|579749920|FG002|Core Part|Protocol deviation|0|||
160553055|NCT01665144|579749918|FG000|Core Part|New therapy for study indication|2|||
160821374|NCT02979093|580731295|FG002|Second Scan Session|Scanning data problems|1|||
160821375|NCT02979093|580731296|FG003|Second Scan Session|Scanning data problems|3|||
160821376|NCT00443053|580731297|FG000|Overall Study|Adverse Event|2|||
160821377|NCT00443053|580731298|FG001|Overall Study|Adverse Event|1|||
160553056|NCT01665144|579749919|FG001|Core Part|New therapy for study indication|1|||
160553057|NCT01665144|579749920|FG002|Core Part|New therapy for study indication|0|||
160553058|NCT01665144|579749918|FG000|Core Part|Technical problems|2|||
160553059|NCT01665144|579749919|FG001|Core Part|Technical problems|0|||
160553060|NCT01665144|579749920|FG002|Core Part|Technical problems|0|||
160553061|NCT01665144|579749918|FG000|Extension Part|Patient/guardian decision|180|||
160553062|NCT01665144|579749919|FG001|Extension Part|Patient/guardian decision|0|||
160553063|NCT01665144|579749920|FG002|Extension Part|Patient/guardian decision|98|||
160553064|NCT01665144|579749918|FG000|Extension Part|Adverse Event|104|||
160553065|NCT01665144|579749919|FG001|Extension Part|Adverse Event|0|||
160553066|NCT01665144|579749920|FG002|Extension Part|Adverse Event|59|||
160553067|NCT01665144|579749918|FG000|Extension Part|Study closed early|42|||
160553068|NCT01665144|579749919|FG001|Extension Part|Study closed early|0|||
160553069|NCT01665144|579749920|FG002|Extension Part|Study closed early|19|||
160553070|NCT01665144|579749918|FG000|Extension Part|Progressive disease|36|||
160553071|NCT01665144|579749919|FG001|Extension Part|Progressive disease|0|||
160553072|NCT01665144|579749920|FG002|Extension Part|Progressive disease|14|||
160553073|NCT01665144|579749918|FG000|Extension Part|Lack of Efficacy|37|||
160553074|NCT01665144|579749919|FG001|Extension Part|Lack of Efficacy|0|||
160553075|NCT01665144|579749920|FG002|Extension Part|Lack of Efficacy|12|||
160553076|NCT01665144|579749918|FG000|Extension Part|Physician Decision|29|||
160553077|NCT01665144|579749919|FG001|Extension Part|Physician Decision|0|||
160553078|NCT01665144|579749920|FG002|Extension Part|Physician Decision|13|||
160553079|NCT01665144|579749918|FG000|Extension Part|Technical problems|20|||
160553080|NCT01665144|579749919|FG001|Extension Part|Technical problems|0|||
160553081|NCT01665144|579749920|FG002|Extension Part|Technical problems|8|||
160553082|NCT01665144|579749918|FG000|Extension Part|Death|20|||
160553083|NCT01665144|579749919|FG001|Extension Part|Death|0|||
160553084|NCT01665144|579749920|FG002|Extension Part|Death|4|||
160553085|NCT01665144|579749918|FG000|Extension Part|Missing|12|||
160553086|NCT01665144|579749919|FG001|Extension Part|Missing|0|||
160553087|NCT01665144|579749920|FG002|Extension Part|Missing|6|||
160553088|NCT01665144|579749918|FG000|Extension Part|Lost to Follow-up|9|||
160553089|NCT01665144|579749919|FG001|Extension Part|Lost to Follow-up|0|||
160553090|NCT01665144|579749920|FG002|Extension Part|Lost to Follow-up|5|||
160553091|NCT01665144|579749918|FG000|Extension Part|New therapy for study indication|3|||
160553092|NCT01665144|579749919|FG001|Extension Part|New therapy for study indication|0|||
160553093|NCT01665144|579749920|FG002|Extension Part|New therapy for study indication|2|||
160553094|NCT01665144|579749918|FG000|Extension Part|Protocol deviation|3|||
160553095|NCT01665144|579749919|FG001|Extension Part|Protocol deviation|0|||
160553096|NCT01665144|579749920|FG002|Extension Part|Protocol deviation|0|||
160553097|NCT02319044|579749928|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
160553098|NCT02319044|579749929|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
160553099|NCT02319044|579749930|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
160553100|NCT02319044|579749928|FG000|Overall Study|Withdrawal by Subject|3|||
160553101|NCT02319044|579749929|FG001|Overall Study|Withdrawal by Subject|3|||
160553102|NCT02319044|579749930|FG002|Overall Study|Withdrawal by Subject|6|||
160553103|NCT02319044|579749928|FG000|Overall Study|Condition under investigation worsened|100|||
160553104|NCT02319044|579749929|FG001|Overall Study|Condition under investigation worsened|50|||
160553105|NCT02319044|579749930|FG002|Overall Study|Condition under investigation worsened|46|||
160553106|NCT02319044|579749928|FG000|Overall Study|Adverse Event|17|||
160553107|NCT02319044|579749929|FG001|Overall Study|Adverse Event|2|||
160553108|NCT02319044|579749930|FG002|Overall Study|Adverse Event|8|||
160553109|NCT02319044|579749928|FG000|Overall Study|Study specific discontinuation criteria|2|||
160553110|NCT02319044|579749929|FG001|Overall Study|Study specific discontinuation criteria|2|||
160553111|NCT02319044|579749930|FG002|Overall Study|Study specific discontinuation criteria|1|||
160553112|NCT02319044|579749928|FG000|Overall Study|Not treated|0|||
160553113|NCT02319044|579749929|FG001|Overall Study|Not treated|2|||
160553114|NCT02319044|579749930|FG002|Overall Study|Not treated|2|||
160553115|NCT02026063|579749939|FG000|Overall Study|Physician Decision|0|||
160553116|NCT02026063|579749940|FG001|Overall Study|Physician Decision|10|||
160553117|NCT02026063|579749939|FG000|Overall Study|Noncompliance with Study Drug|1|||
160553118|NCT02026063|579749940|FG001|Overall Study|Noncompliance with Study Drug|1|||
160553119|NCT02026063|579749939|FG000|Overall Study|Withdrawal of Consent|1|||
160553120|NCT02026063|579749940|FG001|Overall Study|Withdrawal of Consent|6|||
160821378|NCT00443053|580731297|FG000|Overall Study|Withdrawal by Subject|9|||
160553121|NCT02026063|579749939|FG000|Overall Study|Adverse Event|5|||
160553122|NCT02026063|579749940|FG001|Overall Study|Adverse Event|20|||
160553123|NCT02026063|579749939|FG000|Overall Study|Lack of Efficacy|0|||
160553124|NCT02026063|579749940|FG001|Overall Study|Lack of Efficacy|4|||
160553125|NCT02026063|579749939|FG000|Overall Study|Lost to Follow-up|0|||
160553126|NCT02026063|579749940|FG001|Overall Study|Lost to Follow-up|1|||
160821379|NCT00443053|580731298|FG001|Overall Study|Withdrawal by Subject|18|||
160988572|NCT02680756|581345314|FG001|Overall Study|Physician Decision|1|||
160553127|NCT02026063|579749939|FG000|Overall Study|Reason not Specified|2|||
160553128|NCT02026063|579749940|FG001|Overall Study|Reason not Specified|7|||
160553129|NCT02154087|579749942|FG000|Overall Study|Study Termination|1|||
160553130|NCT03687502|579749943|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
160553131|NCT03687502|579749943|FG000|Overall Study|Lumason not available|1|||
160553132|NCT00486278|579749945|FG000|Overall Study|Adverse Event|5|||
160553133|NCT00486278|579749945|FG000|Overall Study|Withdrawal by Subject|2|||
160553134|NCT00486278|579749945|FG000|Overall Study|Physician Decision|2|||
160553135|NCT01777581|579749952|FG000|Overall Study|Lost to Follow-up|1|||
160553136|NCT01777581|579749953|FG001|Overall Study|Lost to Follow-up|1|||
160988573|NCT02680756|581345313|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
160988574|NCT02680756|581345314|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
160988575|NCT02680756|581345313|FG000|Overall Study|Blood transfusion for any reason|0|||
160553137|NCT01777581|579749952|FG000|Overall Study|Adverse Event|2|||
160553138|NCT01777581|579749953|FG001|Overall Study|Adverse Event|0|||
160553139|NCT01777581|579749952|FG000|Overall Study|Lack of Efficacy|0|||
160553140|NCT01777581|579749953|FG001|Overall Study|Lack of Efficacy|1|||
160553141|NCT05702736|579749956|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
160553142|NCT05702736|579749957|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
160553143|NCT05702736|579749956|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
160553144|NCT05702736|579749957|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
160553145|NCT03048422|579749972|FG000|Overall Study|Death|1|||
160553146|NCT03048422|579749973|FG001|Overall Study|Death|0|||
160553147|NCT03048422|579749974|FG002|Overall Study|Death|0|||
160988576|NCT02680756|581345314|FG001|Overall Study|Blood transfusion for any reason|1|||
160988577|NCT02680756|581345313|FG000|Overall Study|Death|1|||
160988578|NCT02680756|581345314|FG001|Overall Study|Death|0|||
160988579|NCT02680756|581345313|FG000|Overall Study|Protocol Violation|1|||
160988580|NCT02680756|581345314|FG001|Overall Study|Protocol Violation|0|||
160988581|NCT02680756|581345313|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
160988582|NCT02680756|581345314|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
160988583|NCT02680756|581345313|FG000|Overall Study|None of above or not recorded|3|||
160988584|NCT02680756|581345314|FG001|Overall Study|None of above or not recorded|2|||
160988585|NCT02374957|581345315|FG000|Overall Study|Patient did not complete forms correctly|1|||
160988586|NCT02374957|581345316|FG001|Overall Study|Patient did not complete forms correctly|0|||
160988587|NCT00748969|581345317|FG000|Overall Study|Withdrawal by Subject|1|||
160988588|NCT00748969|581345318|FG001|Overall Study|Withdrawal by Subject|0|||
160988589|NCT00748969|581345317|FG000|Overall Study|Withdrawal by Subject|0|||
160988590|NCT00748969|581345318|FG001|Overall Study|Withdrawal by Subject|1|||
160821380|NCT00443053|580731297|FG000|Overall Study|Lost to Follow-up|4|||
160821381|NCT00443053|580731298|FG001|Overall Study|Lost to Follow-up|5|||
160821382|NCT00443053|580731297|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
160821383|NCT00443053|580731298|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
160821384|NCT00443053|580731297|FG000|Overall Study|Noncompliance|2|||
160821385|NCT00443053|580731298|FG001|Overall Study|Noncompliance|1|||
160821386|NCT00443053|580731297|FG000|Overall Study|Other|3|||
160821387|NCT00443053|580731298|FG001|Overall Study|Other|4|||
160821388|NCT00443053|580731297|FG000|Overall Study|Physician Decision|0|||
160821389|NCT00443053|580731298|FG001|Overall Study|Physician Decision|4|||
160988591|NCT00562965|581345319|FG000|Overall Study|Withdrawal by Subject|0|||
160988592|NCT00562965|581345320|FG001|Overall Study|Withdrawal by Subject|1|||
160988593|NCT00562965|581345319|FG000|Overall Study|Death|2|||
160988594|NCT00562965|581345320|FG001|Overall Study|Death|4|||
160988595|NCT00562965|581345319|FG000|Overall Study|Lost to Follow-up|1|||
160988596|NCT00562965|581345320|FG001|Overall Study|Lost to Follow-up|0|||
160988597|NCT00562965|581345319|FG000|Overall Study|Other|0|||
160988598|NCT00562965|581345320|FG001|Overall Study|Other|1|||
160988599|NCT00761774|581345321|FG000|Overall Study|Adverse Event|17|||
160988600|NCT00761774|581345321|FG000|Overall Study|Lack of Efficacy|37|||
160988601|NCT00761774|581345321|FG000|Overall Study|Lost to Follow-up|2|||
160988602|NCT00761774|581345321|FG000|Overall Study|Withdrawal by Subject|9|||
160988603|NCT00761774|581345321|FG000|Overall Study|Non-compliance|4|||
160988604|NCT00761774|581345321|FG000|Overall Study|End of study|2|||
160988605|NCT00761774|581345321|FG000|Overall Study|Reclassification of seizures|1|||
160988606|NCT00761774|581345321|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
160988607|NCT00761774|581345321|FG000|Overall Study|Sponsor decision|1|||
160988608|NCT00761774|581345321|FG000|Overall Study|Investigator clinical judgement|1|||
160988609|NCT00761774|581345321|FG000|Overall Study|Patient moved out of study area|1|||
160988610|NCT00761774|581345321|FG000|Overall Study|Coordinator leaving site|1|||
160988611|NCT00761774|581345321|FG000|Overall Study|Subject IP non-compliance|1|||
160988612|NCT00761774|581345321|FG000|Overall Study|IP stopped by hospital physician|1|||
160988613|NCT01124617|581345322|FG000|Overall Study|Adverse Event|5|||
160553148|NCT03048422|579749972|FG000|Overall Study|Lost to Follow-up|5|||
160553149|NCT03048422|579749973|FG001|Overall Study|Lost to Follow-up|0|||
160821390|NCT02256384|580731303|FG000|Overall Study|Withdrawal by Subject|12|||
160646142|NCT02196506|580085991|FG001|Phase B|Withdrawal by Participant|8|||
160646143|NCT02196506|580085992|FG002|Phase B|Withdrawal by Participant|1|||
160646144|NCT02196506|580085993|FG003|Phase B|Withdrawal by Participant|0|||
160646145|NCT02196506|580085990|FG000|Phase B|Adverse Event|0|||
160646146|NCT02196506|580085991|FG001|Phase B|Adverse Event|4|||
160646147|NCT02196506|580085992|FG002|Phase B|Adverse Event|1|||
160646148|NCT02196506|580085993|FG003|Phase B|Adverse Event|0|||
160646149|NCT02196506|580085990|FG000|Phase B|Lost to Follow-up|0|||
160646150|NCT02196506|580085991|FG001|Phase B|Lost to Follow-up|2|||
160646151|NCT02196506|580085992|FG002|Phase B|Lost to Follow-up|1|||
160821391|NCT02256384|580731303|FG000|Overall Study|Equipment not capturing data|2|||
160821392|NCT05032690|580731304|FG000|Period 1|Adverse Event|0|||
160821393|NCT05032690|580731305|FG001|Period 1|Adverse Event|1|||
160821394|NCT05032690|580731306|FG002|Period 1|Adverse Event|0|||
160821395|NCT05032690|580731307|FG003|Period 1|Adverse Event|0|||
160821396|NCT05032690|580731304|FG000|Period 1|Withdrawal by Subject|1|||
160821397|NCT05032690|580731305|FG001|Period 1|Withdrawal by Subject|0|||
160988614|NCT01124617|581345323|FG001|Overall Study|Adverse Event|2|||
160988615|NCT01124617|581345322|FG000|Overall Study|Lack of Efficacy|2|||
160988616|NCT01124617|581345323|FG001|Overall Study|Lack of Efficacy|1|||
160988617|NCT01124617|581345322|FG000|Overall Study|Protocol Violation|1|||
160988618|NCT01124617|581345323|FG001|Overall Study|Protocol Violation|1|||
160988619|NCT01124617|581345322|FG000|Overall Study|Withdrawal by Subject|9|||
160988620|NCT01124617|581345323|FG001|Overall Study|Withdrawal by Subject|1|||
160988621|NCT01124617|581345322|FG000|Overall Study|Other|2|||
160988622|NCT01124617|581345323|FG001|Overall Study|Other|1|||
160988623|NCT01163149|581345330|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
160988624|NCT01163149|581345331|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
160988625|NCT01163149|581345332|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
160646152|NCT02196506|580085993|FG003|Phase B|Lost to Follow-up|0|||
160646153|NCT02196506|580085990|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
160646154|NCT02196506|580085991|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
160646155|NCT02196506|580085992|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
160646156|NCT02196506|580085993|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
160646157|NCT02196506|580085990|FG000|Phase A+|Withdrawal by Participant|0|||
160646158|NCT02196506|580085991|FG001|Phase A+|Withdrawal by Participant|0|||
160646159|NCT02196506|580085992|FG002|Phase A+|Withdrawal by Participant|0|||
160821398|NCT05032690|580731306|FG002|Period 1|Withdrawal by Subject|0|||
160646160|NCT02196506|580085993|FG003|Phase A+|Withdrawal by Participant|5|||
160646161|NCT02196506|580085990|FG000|Phase A+|Adverse Event|0|||
160646162|NCT02196506|580085991|FG001|Phase A+|Adverse Event|0|||
160646163|NCT02196506|580085992|FG002|Phase A+|Adverse Event|0|||
160646164|NCT02196506|580085993|FG003|Phase A+|Adverse Event|1|||
160646165|NCT02196506|580085990|FG000|Phase A+|Lost to Follow-up|0|||
160646166|NCT02196506|580085991|FG001|Phase A+|Lost to Follow-up|0|||
160646167|NCT02196506|580085992|FG002|Phase A+|Lost to Follow-up|0|||
160821399|NCT05032690|580731307|FG003|Period 1|Withdrawal by Subject|0|||
160821400|NCT05032690|580731304|FG000|Period 1|No longer meets eligibility criteria|0|||
160988626|NCT01163149|581345330|FG000|Extension Treatment Period|Adverse Event|0|||
160646168|NCT02196506|580085993|FG003|Phase A+|Lost to Follow-up|6|||
160646169|NCT02196506|580085990|FG000|Phase A+|Participant withdrawn by investigator|0|||
160646170|NCT02196506|580085991|FG001|Phase A+|Participant withdrawn by investigator|0|||
160646171|NCT02196506|580085992|FG002|Phase A+|Participant withdrawn by investigator|0|||
160646172|NCT02196506|580085993|FG003|Phase A+|Participant withdrawn by investigator|1|||
160646173|NCT00254397|580085994|FG000|Overall Study|Disease Progression|4|||
160646174|NCT00254397|580085995|FG001|Overall Study|Disease Progression|1|||
160646175|NCT00254397|580085996|FG002|Overall Study|Disease Progression|16|||
160646176|NCT00254397|580085997|FG003|Overall Study|Disease Progression|23|||
160646177|NCT00254397|580085994|FG000|Overall Study|Non-Compliant|0|||
160646178|NCT00254397|580085995|FG001|Overall Study|Non-Compliant|0|||
160646179|NCT00254397|580085996|FG002|Overall Study|Non-Compliant|0|||
160646180|NCT00254397|580085997|FG003|Overall Study|Non-Compliant|1|||
160646181|NCT00254397|580085994|FG000|Overall Study|Adverse Event|2|||
160646182|NCT00254397|580085995|FG001|Overall Study|Adverse Event|0|||
160646183|NCT00254397|580085996|FG002|Overall Study|Adverse Event|3|||
160646184|NCT00254397|580085997|FG003|Overall Study|Adverse Event|1|||
160988627|NCT01163149|581345331|FG001|Extension Treatment Period|Adverse Event|1|||
160988628|NCT01163149|581345332|FG002|Extension Treatment Period|Adverse Event|0|||
160646185|NCT01070394|580085998|FG000|Overall Study|Adverse Event|6|||
160646186|NCT01070394|580085998|FG000|Overall Study|Withdrawal by Subject|1|||
160646187|NCT00066807|580086006|FG000|Overall Study|Study was terminated early|14|||
160646188|NCT00066807|580086007|FG001|Overall Study|Study was terminated early|15|||
160988629|NCT01163149|581345330|FG000|Extension Treatment Period|Noncompliance|0|||
160646189|NCT05028751|580086008|FG000|Overall Study|Study Terminated by Sponsor|3|||
160646190|NCT05028751|580086009|FG001|Overall Study|Study Terminated by Sponsor|0|||
160646191|NCT05028751|580086010|FG002|Overall Study|Study Terminated by Sponsor|0|||
160646192|NCT05028751|580086011|FG003|Overall Study|Study Terminated by Sponsor|0|||
160646193|NCT05028751|580086008|FG000|Overall Study|Death|9|||
160821401|NCT05032690|580731305|FG001|Period 1|No longer meets eligibility criteria|1|||
160821402|NCT05032690|580731306|FG002|Period 1|No longer meets eligibility criteria|0|||
160821403|NCT05032690|580731307|FG003|Period 1|No longer meets eligibility criteria|0|||
160821404|NCT05032690|580731304|FG000|Period 2|Adverse Event|1|||
160821405|NCT05032690|580731305|FG001|Period 2|Adverse Event|0|||
160821406|NCT05032690|580731306|FG002|Period 2|Adverse Event|0|||
160821407|NCT05032690|580731307|FG003|Period 2|Adverse Event|0|||
160821408|NCT05032690|580731304|FG000|Period 2|Withdrawal by Subject|0|||
160821409|NCT05032690|580731305|FG001|Period 2|Withdrawal by Subject|1|||
160821410|NCT05032690|580731306|FG002|Period 2|Withdrawal by Subject|0|||
160821411|NCT05032690|580731307|FG003|Period 2|Withdrawal by Subject|0|||
160821412|NCT05032690|580731304|FG000|Period 2|No longer meets eligibility criteria|0|||
160821413|NCT05032690|580731305|FG001|Period 2|No longer meets eligibility criteria|1|||
160821414|NCT05032690|580731306|FG002|Period 2|No longer meets eligibility criteria|0|||
160821415|NCT05032690|580731307|FG003|Period 2|No longer meets eligibility criteria|0|||
160821416|NCT05032690|580731304|FG000|Period 3|Adverse Event|0|||
160821417|NCT05032690|580731305|FG001|Period 3|Adverse Event|1|||
160821418|NCT05032690|580731306|FG002|Period 3|Adverse Event|0|||
160821419|NCT05032690|580731307|FG003|Period 3|Adverse Event|0|||
160821420|NCT00487942|580731308|FG000|Overall Study|Adverse Event|1|||
160821421|NCT00487942|580731309|FG001|Overall Study|Adverse Event|1|||
160821422|NCT00487942|580731310|FG002|Overall Study|Adverse Event|1|||
160901214|NCT00142298|581032003|FG002|Overall Study|Clinical disease progression|0|||
160901215|NCT00142298|581032004|FG003|Overall Study|Clinical disease progression|0|||
160901216|NCT00142298|581032005|FG004|Overall Study|Clinical disease progression|0|||
160553150|NCT03048422|579749974|FG002|Overall Study|Lost to Follow-up|1|||
160553151|NCT03048422|579749972|FG000|Overall Study|Withdrawal by Subject|5|||
160553152|NCT03048422|579749973|FG001|Overall Study|Withdrawal by Subject|7|||
160646194|NCT05028751|580086009|FG001|Overall Study|Death|3|||
160821423|NCT00487942|580731311|FG003|Overall Study|Adverse Event|1|||
160821424|NCT00487942|580731308|FG000|Overall Study|Lost to Follow-up|1|||
160821425|NCT00487942|580731309|FG001|Overall Study|Lost to Follow-up|0|||
160821426|NCT00487942|580731310|FG002|Overall Study|Lost to Follow-up|0|||
160901217|NCT00142298|581032006|FG005|Overall Study|Clinical disease progression|0|||
160901218|NCT00142298|581032007|FG006|Overall Study|Clinical disease progression|0|||
160901219|NCT00142298|581032008|FG007|Overall Study|Clinical disease progression|0|||
160901220|NCT00142298|581032009|FG008|Overall Study|Clinical disease progression|0|||
160901221|NCT00142298|581032010|FG009|Overall Study|Clinical disease progression|0|||
160901222|NCT00142298|581032001|FG000|Overall Study|Death|1|||
160901223|NCT00142298|581032002|FG001|Overall Study|Death|1|||
160901224|NCT00142298|581032003|FG002|Overall Study|Death|1|||
160901225|NCT00142298|581032004|FG003|Overall Study|Death|0|||
160901226|NCT00142298|581032005|FG004|Overall Study|Death|0|||
160901227|NCT00142298|581032006|FG005|Overall Study|Death|6|||
160901228|NCT00142298|581032007|FG006|Overall Study|Death|0|||
160901229|NCT00142298|581032008|FG007|Overall Study|Death|0|||
160901230|NCT00142298|581032009|FG008|Overall Study|Death|0|||
160901231|NCT00142298|581032010|FG009|Overall Study|Death|0|||
160901232|NCT00142298|581032001|FG000|Overall Study|Lack of Efficacy|44|||
160901233|NCT00142298|581032002|FG001|Overall Study|Lack of Efficacy|62|||
160901234|NCT00142298|581032003|FG002|Overall Study|Lack of Efficacy|9|||
160901235|NCT00142298|581032004|FG003|Overall Study|Lack of Efficacy|12|||
160901236|NCT00142298|581032005|FG004|Overall Study|Lack of Efficacy|1|||
160901237|NCT00142298|581032006|FG005|Overall Study|Lack of Efficacy|0|||
160901238|NCT00142298|581032007|FG006|Overall Study|Lack of Efficacy|0|||
160901239|NCT00142298|581032008|FG007|Overall Study|Lack of Efficacy|1|||
160901240|NCT00142298|581032009|FG008|Overall Study|Lack of Efficacy|0|||
160901241|NCT00142298|581032010|FG009|Overall Study|Lack of Efficacy|0|||
160901242|NCT00142298|581032001|FG000|Overall Study|Non-compliance|15|||
160901243|NCT00142298|581032002|FG001|Overall Study|Non-compliance|13|||
160901244|NCT00142298|581032003|FG002|Overall Study|Non-compliance|0|||
160901245|NCT00142298|581032004|FG003|Overall Study|Non-compliance|6|||
160901246|NCT00142298|581032005|FG004|Overall Study|Non-compliance|1|||
160901247|NCT00142298|581032006|FG005|Overall Study|Non-compliance|0|||
160901248|NCT00142298|581032007|FG006|Overall Study|Non-compliance|0|||
160901249|NCT00142298|581032008|FG007|Overall Study|Non-compliance|3|||
160901250|NCT00142298|581032009|FG008|Overall Study|Non-compliance|3|||
160901251|NCT00142298|581032010|FG009|Overall Study|Non-compliance|0|||
160901252|NCT00142298|581032001|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
160901253|NCT00142298|581032002|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
160901254|NCT00142298|581032003|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
160901255|NCT00142298|581032004|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
160901256|NCT00142298|581032005|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
160901257|NCT00142298|581032006|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
160901258|NCT00142298|581032007|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
160901259|NCT00142298|581032008|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
160901260|NCT00142298|581032009|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
160988630|NCT01163149|581345331|FG001|Extension Treatment Period|Noncompliance|0|||
160988631|NCT01163149|581345332|FG002|Extension Treatment Period|Noncompliance|1|||
160988632|NCT01700530|581345333|FG000|Overall Study|Withdrawal by Subject|0|||
160988633|NCT01700530|581345334|FG001|Overall Study|Withdrawal by Subject|3|||
160988634|NCT01700530|581345335|FG002|Overall Study|Withdrawal by Subject|1|||
160988635|NCT00916006|581345336|FG000|Overall Study|Adverse Event|1|||
160988636|NCT00916006|581345337|FG001|Overall Study|Adverse Event|1|||
160988637|NCT00916006|581345336|FG000|Overall Study|Withdrawal by Subject|2|||
160988638|NCT00916006|581345337|FG001|Overall Study|Withdrawal by Subject|5|||
160988639|NCT00916006|581345336|FG000|Overall Study|Protocol Violation|0|||
160646195|NCT05028751|580086010|FG002|Overall Study|Death|2|||
160988640|NCT00916006|581345337|FG001|Overall Study|Protocol Violation|1|||
160988641|NCT01605136|581345340|FG000|Study Period|Withdrawal by Subject|2|||
160821427|NCT00487942|580731311|FG003|Overall Study|Lost to Follow-up|1|||
160821428|NCT00487942|580731308|FG000|Overall Study|Protocol Violation|1|||
160821429|NCT00487942|580731309|FG001|Overall Study|Protocol Violation|1|||
160821430|NCT00487942|580731310|FG002|Overall Study|Protocol Violation|0|||
160821431|NCT00487942|580731311|FG003|Overall Study|Protocol Violation|0|||
160821432|NCT00487942|580731308|FG000|Overall Study|Withdrawal by Subject|0|||
160821433|NCT00487942|580731309|FG001|Overall Study|Withdrawal by Subject|1|||
160821434|NCT00487942|580731310|FG002|Overall Study|Withdrawal by Subject|2|||
160821435|NCT00487942|580731311|FG003|Overall Study|Withdrawal by Subject|0|||
160988642|NCT01605136|581345341|FG001|Study Period|Withdrawal by Subject|0|||
160646196|NCT05028751|580086011|FG003|Overall Study|Death|4|||
160821436|NCT05151445|580731312|FG000|Overall Study|Withdrawal by Subject|3|||
160821437|NCT02298179|580731313|FG000|Overall Study|Lost to Follow-up|0|||
160821438|NCT02298179|580731314|FG001|Overall Study|Lost to Follow-up|0|||
160821439|NCT02298179|580731315|FG002|Overall Study|Lost to Follow-up|1|||
160821440|NCT02298179|580731316|FG003|Overall Study|Lost to Follow-up|0|||
160821441|NCT02298179|580731317|FG004|Overall Study|Lost to Follow-up|0|||
160821442|NCT02298179|580731318|FG005|Overall Study|Lost to Follow-up|0|||
160821443|NCT02298179|580731319|FG006|Overall Study|Lost to Follow-up|0|||
160821444|NCT02298179|580731320|FG007|Overall Study|Lost to Follow-up|1|||
160821445|NCT02298179|580731321|FG008|Overall Study|Lost to Follow-up|0|||
160821446|NCT02298179|580731322|FG009|Overall Study|Lost to Follow-up|0|||
160821447|NCT02298179|580731323|FG010|Overall Study|Lost to Follow-up|0|||
160821448|NCT02298179|580731324|FG011|Overall Study|Lost to Follow-up|0|||
160821449|NCT00082368|580731325|FG000|Overall Study|Not treated-pt had poor IV access|1|||
160988643|NCT01605136|581345340|FG000|Study Period|Physician Decision|1|||
160988644|NCT01605136|581345341|FG001|Study Period|Physician Decision|1|||
160988645|NCT01605136|581345340|FG000|Study Period|Lost to Follow-up|0|||
160646197|NCT05028751|580086008|FG000|Overall Study|Withdrawal by Subject|0|||
160821450|NCT01739933|580733608|FG000|Overall Study|Death|89|||
160821451|NCT01739933|580733609|FG001|Overall Study|Death|86|||
160821452|NCT01739933|580733608|FG000|Overall Study|Withdrawal by Subject|10|||
160821453|NCT01739933|580733609|FG001|Overall Study|Withdrawal by Subject|8|||
160821454|NCT01739933|580733608|FG000|Overall Study|Lost to Follow-up|3|||
160821455|NCT01739933|580733609|FG001|Overall Study|Lost to Follow-up|10|||
160821456|NCT01739933|580733608|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
160821457|NCT01739933|580733609|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
160821458|NCT01007435|580733622|FG000|Overall Study|Adverse Event|16|||
160821459|NCT01007435|580733623|FG001|Overall Study|Adverse Event|25|||
160821460|NCT01007435|580733624|FG002|Overall Study|Adverse Event|47|||
160821461|NCT01007435|580733625|FG003|Overall Study|Adverse Event|31|||
160821462|NCT01007435|580733622|FG000|Overall Study|Death|2|||
160821463|NCT01007435|580733623|FG001|Overall Study|Death|4|||
160821464|NCT01007435|580733624|FG002|Overall Study|Death|2|||
160821465|NCT01007435|580733625|FG003|Overall Study|Death|1|||
160821466|NCT01007435|580733622|FG000|Overall Study|Insufficient Therapeutic Response|21|||
160821467|NCT01007435|580733623|FG001|Overall Study|Insufficient Therapeutic Response|7|||
160821468|NCT01007435|580733624|FG002|Overall Study|Insufficient Therapeutic Response|2|||
160821469|NCT01007435|580733625|FG003|Overall Study|Insufficient Therapeutic Response|9|||
160821470|NCT01007435|580733622|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
160988646|NCT01605136|581345341|FG001|Study Period|Lost to Follow-up|2|||
160988647|NCT01605136|581345340|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
160988648|NCT01605136|581345341|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
160988649|NCT02806336|581345342|FG000|Overall Study|Physician Decision|1|||
160988650|NCT02806336|581345343|FG001|Overall Study|Physician Decision|0|||
160988651|NCT02806336|581345342|FG000|Overall Study|Withdrawal by Subject|2|||
160553153|NCT03048422|579749974|FG002|Overall Study|Withdrawal by Subject|4|||
160553154|NCT03048422|579749972|FG000|Overall Study|Moved|3|||
160553155|NCT03048422|579749973|FG001|Overall Study|Moved|2|||
160553156|NCT03048422|579749974|FG002|Overall Study|Moved|2|||
160553157|NCT03048422|579749972|FG000|Overall Study|Noncompliant with Study Requirements|2|||
160553158|NCT03048422|579749973|FG001|Overall Study|Noncompliant with Study Requirements|1|||
160553159|NCT03048422|579749974|FG002|Overall Study|Noncompliant with Study Requirements|2|||
160553160|NCT03048422|579749972|FG000|Overall Study|Not Able to Get to Clinic|1|||
160553161|NCT03048422|579749973|FG001|Overall Study|Not Able to Get to Clinic|0|||
160553162|NCT03048422|579749974|FG002|Overall Study|Not Able to Get to Clinic|0|||
160553163|NCT03344003|579749977|FG000|Overall Study|Switched to alternative treatment|1|||
160553164|NCT03344003|579749978|FG001|Overall Study|Switched to alternative treatment|0|||
160553165|NCT03344003|579749977|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
160553166|NCT03344003|579749978|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
160988652|NCT02806336|581345343|FG001|Overall Study|Withdrawal by Subject|4|||
160988653|NCT02806336|581345342|FG000|Overall Study|COVID-19 research shut down|3|||
160988654|NCT02806336|581345343|FG001|Overall Study|COVID-19 research shut down|4|||
160988655|NCT02806336|581345342|FG000|Overall Study|Lack of Efficacy|0|||
160988656|NCT02806336|581345343|FG001|Overall Study|Lack of Efficacy|1|||
160988657|NCT03682536|581345344|FG000|Randomization|Withdrawal by Subject|0|||
160988658|NCT03682536|581345345|FG001|Randomization|Withdrawal by Subject|2|||
160988659|NCT03682536|581345344|FG000|Treatment|Other Reasons|8|||
160988660|NCT03682536|581345345|FG001|Treatment|Other Reasons|7|||
160988661|NCT03682536|581345344|FG000|Treatment|Physician Decision|5|||
160988662|NCT03682536|581345345|FG001|Treatment|Physician Decision|5|||
160988663|NCT03682536|581345344|FG000|Treatment|Protocol Violation|1|||
160988664|NCT03682536|581345345|FG001|Treatment|Protocol Violation|0|||
160988665|NCT03682536|581345344|FG000|Treatment|Study Terminated by Sponsor|1|||
160988666|NCT03682536|581345345|FG001|Treatment|Study Terminated by Sponsor|2|||
160821471|NCT01007435|580733623|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
160821472|NCT01007435|580733624|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
160821473|NCT01007435|580733625|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
160988667|NCT03682536|581345344|FG000|Treatment|Lost to Follow-up|0|||
160988668|NCT03682536|581345345|FG001|Treatment|Lost to Follow-up|1|||
160988669|NCT03682536|581345344|FG000|Treatment|Withdrawal by Subject|16|||
160553169|NCT05900115|579751098|FG000|Overall Study|Lost to Follow-up|129|||
160553170|NCT05900115|579751099|FG001|Overall Study|Lost to Follow-up|98|||
160553171|NCT02152345|579751100|FG000|Overall Study|Case Cancellations|2|||
160553172|NCT02152345|579751101|FG001|Overall Study|Case Cancellations|4|||
160553173|NCT02152345|579751100|FG000|Overall Study|Withdrawal by Subject|2|||
160553174|NCT02152345|579751101|FG001|Overall Study|Withdrawal by Subject|1|||
160553175|NCT02324270|579751103|FG000|Overall Study|Withdrawal by Subject|0|||
160553176|NCT02324270|579751104|FG001|Overall Study|Withdrawal by Subject|1|||
160553177|NCT02324270|579751105|FG002|Overall Study|Withdrawal by Subject|0|||
160553178|NCT02324270|579751103|FG000|Overall Study|Lost to Follow-up|4|||
160553179|NCT02324270|579751104|FG001|Overall Study|Lost to Follow-up|3|||
160553180|NCT02324270|579751105|FG002|Overall Study|Lost to Follow-up|4|||
160553181|NCT02324270|579751103|FG000|Overall Study|Protocol Violation|0|||
160553182|NCT02324270|579751104|FG001|Overall Study|Protocol Violation|1|||
160553183|NCT02324270|579751105|FG002|Overall Study|Protocol Violation|1|||
160821474|NCT01007435|580733622|FG000|Overall Study|Other Protocol Violation|2|||
160821475|NCT01007435|580733623|FG001|Overall Study|Other Protocol Violation|0|||
160821476|NCT01007435|580733624|FG002|Overall Study|Other Protocol Violation|1|||
160821477|NCT01007435|580733625|FG003|Overall Study|Other Protocol Violation|0|||
160821478|NCT01007435|580733622|FG000|Overall Study|Refused Treatment|13|||
160821479|NCT01007435|580733623|FG001|Overall Study|Refused Treatment|13|||
160821480|NCT01007435|580733624|FG002|Overall Study|Refused Treatment|5|||
160821481|NCT01007435|580733625|FG003|Overall Study|Refused Treatment|8|||
160821482|NCT01007435|580733622|FG000|Overall Study|Failure to Return|5|||
160821483|NCT01007435|580733623|FG001|Overall Study|Failure to Return|4|||
160821484|NCT01007435|580733624|FG002|Overall Study|Failure to Return|3|||
160988670|NCT03682536|581345345|FG001|Treatment|Withdrawal by Subject|18|||
160988671|NCT03682536|581345344|FG000|Treatment|Lack of Efficacy|41|||
160988672|NCT03682536|581345345|FG001|Treatment|Lack of Efficacy|68|||
160988673|NCT03682536|581345344|FG000|Treatment|Disease Progression|9|||
160988674|NCT03682536|581345345|FG001|Treatment|Disease Progression|7|||
160988675|NCT03682536|581345344|FG000|Treatment|Adverse Event|9|||
160988676|NCT03682536|581345345|FG001|Treatment|Adverse Event|5|||
160988677|NCT03682536|581345344|FG000|Treatment|Death|14|||
160988678|NCT03682536|581345345|FG001|Treatment|Death|13|||
160988679|NCT04824131|581345346|FG000|CAB LA Oral Phase|Adverse Event|1|||
160988680|NCT04824131|581345346|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
160988681|NCT04824131|581345346|FG000|Step 3|Withdrawal by Subject|2|||
160988682|NCT03008122|581345352|FG000|Overall Study|Physician Decision|3|||
160988683|NCT03008122|581345353|FG001|Overall Study|Physician Decision|2|||
160988684|NCT03008122|581345354|FG002|Overall Study|Physician Decision|0|||
160988685|NCT03008122|581345352|FG000|Overall Study|Withdrawal by Subject|1|||
160988686|NCT03008122|581345353|FG001|Overall Study|Withdrawal by Subject|3|||
160988687|NCT03008122|581345354|FG002|Overall Study|Withdrawal by Subject|0|||
160988688|NCT03008122|581345352|FG000|Overall Study|Lost to Follow-up|4|||
160553184|NCT02324270|579751103|FG000|Overall Study|Non Compliance with Study Drug|1|||
160553185|NCT02324270|579751104|FG001|Overall Study|Non Compliance with Study Drug|2|||
160553186|NCT02324270|579751105|FG002|Overall Study|Non Compliance with Study Drug|0|||
160553187|NCT03521791|579751106|FG000|Overall Study|Protocol Violation|7|||
160553188|NCT03521791|579751107|FG001|Overall Study|Protocol Violation|17|||
160553189|NCT00680836|579751108|FG000|Overall Study|Withdrawal by Subject|3|||
160553190|NCT00680836|579751109|FG001|Overall Study|Withdrawal by Subject|0|||
160553191|NCT00680836|579751108|FG000|Overall Study|Lost to Follow-up|3|||
160553192|NCT00680836|579751109|FG001|Overall Study|Lost to Follow-up|1|||
160553193|NCT00680836|579751108|FG000|Overall Study|Physician Decision|2|||
160553194|NCT00680836|579751109|FG001|Overall Study|Physician Decision|1|||
160553195|NCT03038308|579751110|FG000|Overall Study|Surgical resection|1|||
160553196|NCT03038308|579751110|FG000|Overall Study|Withdrawal by Subject|2|||
160553197|NCT03038308|579751110|FG000|Overall Study|Lost to Follow-up|1|||
160553198|NCT01475734|579751113|FG000|Overall Study|Withdrawal by Subject|1|||
160553199|NCT01475734|579751114|FG001|Overall Study|Withdrawal by Subject|0|||
160553200|NCT01475734|579751113|FG000|Overall Study|Protocol Violation|1|||
160553201|NCT01475734|579751114|FG001|Overall Study|Protocol Violation|0|||
160553202|NCT01475734|579751113|FG000|Overall Study|Physician Decision|0|||
160553203|NCT01475734|579751114|FG001|Overall Study|Physician Decision|1|||
160553204|NCT00771472|579751115|FG000|Overall Study|Physician Decision|2|||
160553205|NCT00771472|579751116|FG001|Overall Study|Physician Decision|3|||
160553206|NCT00771472|579751115|FG000|Overall Study|Progressive Disease|3|||
160553207|NCT00771472|579751116|FG001|Overall Study|Progressive Disease|1|||
160553208|NCT00771472|579751115|FG000|Overall Study|Protocol Violation|1|||
160553209|NCT00771472|579751116|FG001|Overall Study|Protocol Violation|0|||
160553210|NCT00880750|579751122|FG000|First Intervention|Adverse Event|1|||
160988689|NCT03008122|581345353|FG001|Overall Study|Lost to Follow-up|8|||
160553211|NCT00880750|579751123|FG001|First Intervention|Adverse Event|0|||
160553212|NCT00880750|579751122|FG000|First Intervention|Unable to collect urine|4|||
160646198|NCT05028751|580086009|FG001|Overall Study|Withdrawal by Subject|0|||
160646199|NCT05028751|580086010|FG002|Overall Study|Withdrawal by Subject|1|||
160646200|NCT05028751|580086011|FG003|Overall Study|Withdrawal by Subject|0|||
160646201|NCT05028751|580086008|FG000|Overall Study|Miscellaneous|2|||
160988690|NCT03008122|581345354|FG002|Overall Study|Lost to Follow-up|3|||
160988691|NCT03008122|581345352|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
160988692|NCT03008122|581345353|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
160988693|NCT03008122|581345354|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
160988694|NCT03008122|581345352|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
160988695|NCT03008122|581345353|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
160988696|NCT03008122|581345354|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
160988697|NCT03008122|581345352|FG000|Overall Study|Death|0|||
160646202|NCT05028751|580086009|FG001|Overall Study|Miscellaneous|0|||
160988698|NCT03008122|581345353|FG001|Overall Study|Death|0|||
160988699|NCT03008122|581345354|FG002|Overall Study|Death|1|||
160988700|NCT04159896|581345355|FG000|Overall Study|Lack of Efficacy|7|||
160988701|NCT04159896|581345355|FG000|Overall Study|Withdrawal by Subject|1|||
160988702|NCT04159896|581345355|FG000|Overall Study|Adverse Event|1|||
160646203|NCT05028751|580086010|FG002|Overall Study|Miscellaneous|0|||
160646204|NCT05028751|580086011|FG003|Overall Study|Miscellaneous|0|||
160646205|NCT03586830|580086013|FG000|Overall Study|Site terminated by Sponsor|1|||
160646206|NCT03586830|580086014|FG001|Overall Study|Site terminated by Sponsor|4|||
160646207|NCT03586830|580086015|FG002|Overall Study|Site terminated by Sponsor|3|||
160646208|NCT03586830|580086016|FG003|Overall Study|Site terminated by Sponsor|3|||
160901261|NCT00142298|581032010|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
160901262|NCT00142298|581032001|FG000|Overall Study|Pregnancy|4|||
160901263|NCT00142298|581032002|FG001|Overall Study|Pregnancy|4|||
160901264|NCT00142298|581032003|FG002|Overall Study|Pregnancy|2|||
160901265|NCT00142298|581032004|FG003|Overall Study|Pregnancy|3|||
160901266|NCT00142298|581032005|FG004|Overall Study|Pregnancy|0|||
160901267|NCT00142298|581032006|FG005|Overall Study|Pregnancy|0|||
160901268|NCT00142298|581032007|FG006|Overall Study|Pregnancy|0|||
160901269|NCT00142298|581032008|FG007|Overall Study|Pregnancy|0|||
160901270|NCT00142298|581032009|FG008|Overall Study|Pregnancy|1|||
160901271|NCT00142298|581032010|FG009|Overall Study|Pregnancy|0|||
160901272|NCT00142298|581032001|FG000|Overall Study|Virologic breakthrough|19|||
160901273|NCT00142298|581032002|FG001|Overall Study|Virologic breakthrough|23|||
160901274|NCT00142298|581032003|FG002|Overall Study|Virologic breakthrough|9|||
160901275|NCT00142298|581032004|FG003|Overall Study|Virologic breakthrough|7|||
160901276|NCT00142298|581032005|FG004|Overall Study|Virologic breakthrough|2|||
160901277|NCT00142298|581032006|FG005|Overall Study|Virologic breakthrough|3|||
160901278|NCT00142298|581032007|FG006|Overall Study|Virologic breakthrough|3|||
160901279|NCT00142298|581032008|FG007|Overall Study|Virologic breakthrough|0|||
160901280|NCT00142298|581032009|FG008|Overall Study|Virologic breakthrough|0|||
160901281|NCT00142298|581032010|FG009|Overall Study|Virologic breakthrough|0|||
160901282|NCT00142298|581032001|FG000|Overall Study|Other- not specified|0|||
160901283|NCT00142298|581032002|FG001|Overall Study|Other- not specified|3|||
160901284|NCT00142298|581032003|FG002|Overall Study|Other- not specified|0|||
160901285|NCT00142298|581032004|FG003|Overall Study|Other- not specified|1|||
160901286|NCT00142298|581032005|FG004|Overall Study|Other- not specified|0|||
160901287|NCT00142298|581032006|FG005|Overall Study|Other- not specified|0|||
160901288|NCT00142298|581032007|FG006|Overall Study|Other- not specified|0|||
160901289|NCT00142298|581032008|FG007|Overall Study|Other- not specified|0|||
160901290|NCT00142298|581032009|FG008|Overall Study|Other- not specified|0|||
160901291|NCT00142298|581032010|FG009|Overall Study|Other- not specified|0|||
160901292|NCT00142298|581032001|FG000|Overall Study|Lost to Follow-up|0|||
160901293|NCT00142298|581032002|FG001|Overall Study|Lost to Follow-up|0|||
160901294|NCT00142298|581032003|FG002|Overall Study|Lost to Follow-up|0|||
160901295|NCT00142298|581032004|FG003|Overall Study|Lost to Follow-up|0|||
160901296|NCT00142298|581032005|FG004|Overall Study|Lost to Follow-up|0|||
160901297|NCT00142298|581032006|FG005|Overall Study|Lost to Follow-up|0|||
160901298|NCT00142298|581032007|FG006|Overall Study|Lost to Follow-up|2|||
160901299|NCT00142298|581032008|FG007|Overall Study|Lost to Follow-up|0|||
160901300|NCT00142298|581032009|FG008|Overall Study|Lost to Follow-up|0|||
160901301|NCT00142298|581032010|FG009|Overall Study|Lost to Follow-up|0|||
160901302|NCT00142298|581032001|FG000|Overall Study|Treatment Failure|0|||
160901303|NCT00142298|581032002|FG001|Overall Study|Treatment Failure|0|||
160901304|NCT00142298|581032003|FG002|Overall Study|Treatment Failure|0|||
160901305|NCT00142298|581032004|FG003|Overall Study|Treatment Failure|0|||
160901306|NCT00142298|581032005|FG004|Overall Study|Treatment Failure|0|||
160901307|NCT00142298|581032006|FG005|Overall Study|Treatment Failure|2|||
160901308|NCT00142298|581032007|FG006|Overall Study|Treatment Failure|2|||
160901309|NCT00142298|581032008|FG007|Overall Study|Treatment Failure|0|||
160901310|NCT00142298|581032009|FG008|Overall Study|Treatment Failure|0|||
160646209|NCT03586830|580086013|FG000|Overall Study|Lost to Follow-up|0|||
160901311|NCT00142298|581032010|FG009|Overall Study|Treatment Failure|0|||
160901312|NCT02423772|581032013|FG000|Overall Study|Lost to Follow-up|3|||
160901313|NCT02423772|581032014|FG001|Overall Study|Lost to Follow-up|3|||
160901314|NCT02423772|581032013|FG000|Overall Study|Did not begin intervention|2|||
160901315|NCT02423772|581032014|FG001|Overall Study|Did not begin intervention|5|||
160901316|NCT01193842|581032015|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
160901317|NCT01193842|581032016|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
160901318|NCT01193842|581032017|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
160901319|NCT01193842|581032018|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
160901320|NCT01193842|581032019|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
160901321|NCT01193842|581032015|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
160901322|NCT01193842|581032016|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
160821485|NCT01007435|580733625|FG003|Overall Study|Failure to Return|6|||
160821486|NCT01007435|580733622|FG000|Overall Study|Reason not Specified|1|||
160821487|NCT01007435|580733623|FG001|Overall Study|Reason not Specified|1|||
160821488|NCT01007435|580733624|FG002|Overall Study|Reason not Specified|2|||
160821489|NCT01007435|580733625|FG003|Overall Study|Reason not Specified|1|||
160821490|NCT01032291|580733626|FG000|Safety Lead-in|Adverse Event|1|||
160821491|NCT01032291|580733627|FG001|Safety Lead-in|Adverse Event|0|||
160821492|NCT01032291|580733628|FG002|Safety Lead-in|Adverse Event|0|||
160821493|NCT01032291|580733626|FG000|Safety Lead-in|Death|1|||
160821494|NCT01032291|580733627|FG001|Safety Lead-in|Death|0|||
160821495|NCT01032291|580733628|FG002|Safety Lead-in|Death|0|||
160821496|NCT01032291|580733626|FG000|Proof of Concept|Adverse Event|0|||
160821497|NCT01032291|580733627|FG001|Proof of Concept|Adverse Event|5|||
160821498|NCT01032291|580733628|FG002|Proof of Concept|Adverse Event|1|||
160821499|NCT01032291|580733626|FG000|Proof of Concept|Death|0|||
160821500|NCT01032291|580733627|FG001|Proof of Concept|Death|1|||
160821501|NCT01032291|580733628|FG002|Proof of Concept|Death|2|||
160821502|NCT01032291|580733626|FG000|Proof of Concept|Lack of Efficacy|0|||
160821503|NCT01032291|580733627|FG001|Proof of Concept|Lack of Efficacy|1|||
160821504|NCT01032291|580733628|FG002|Proof of Concept|Lack of Efficacy|0|||
160901323|NCT01193842|581032017|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
160901324|NCT01193842|581032018|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
160901325|NCT01193842|581032019|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
160901326|NCT01193842|581032015|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
160901327|NCT01193842|581032016|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
160901328|NCT01193842|581032017|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
160901329|NCT01193842|581032018|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
160901330|NCT01193842|581032019|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
160901331|NCT01193842|581032015|FG000|Phase II: Randomized Groups|Death|0|||
160901332|NCT01193842|581032016|FG001|Phase II: Randomized Groups|Death|0|||
160901333|NCT01193842|581032017|FG002|Phase II: Randomized Groups|Death|0|||
160901334|NCT01193842|581032018|FG003|Phase II: Randomized Groups|Death|1|||
160901335|NCT01193842|581032019|FG004|Phase II: Randomized Groups|Death|1|||
160901336|NCT01193842|581032015|FG000|Phase II: Randomized Groups|Adverse Event|0|||
160901337|NCT01193842|581032016|FG001|Phase II: Randomized Groups|Adverse Event|0|||
160901338|NCT01193842|581032017|FG002|Phase II: Randomized Groups|Adverse Event|0|||
160901339|NCT01193842|581032018|FG003|Phase II: Randomized Groups|Adverse Event|5|||
160901340|NCT01193842|581032019|FG004|Phase II: Randomized Groups|Adverse Event|3|||
160901341|NCT01193842|581032015|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
160901342|NCT01193842|581032016|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
160901343|NCT01193842|581032017|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
160901344|NCT01193842|581032018|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
160901345|NCT01193842|581032019|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
160901346|NCT01193842|581032015|FG000|Phase II: Randomized Groups|Ineligible|0|||
160901347|NCT01193842|581032016|FG001|Phase II: Randomized Groups|Ineligible|0|||
160901348|NCT01193842|581032017|FG002|Phase II: Randomized Groups|Ineligible|0|||
160901349|NCT01193842|581032018|FG003|Phase II: Randomized Groups|Ineligible|0|||
160901350|NCT01193842|581032019|FG004|Phase II: Randomized Groups|Ineligible|1|||
160901351|NCT01193842|581032015|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
160901352|NCT01193842|581032016|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
160901353|NCT01193842|581032017|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
160901354|NCT01193842|581032018|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
160901355|NCT01193842|581032019|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
160901356|NCT01313858|581033988|FG000|Overall Study|Premature Treatment Termination|251|||
160821505|NCT01032291|580733626|FG000|Proof of Concept|Never Received Study Drug|0|||
160821506|NCT01032291|580733627|FG001|Proof of Concept|Never Received Study Drug|1|||
160821507|NCT01032291|580733628|FG002|Proof of Concept|Never Received Study Drug|0|||
160821508|NCT02576535|580733629|FG000|Overall Study|Withdrawal by Subject|2|||
160821509|NCT00347438|580733630|FG000|Overall Study|Withdrawal by Subject|1|||
160901357|NCT01313858|581033989|FG001|Overall Study|Premature Treatment Termination|219|||
160988703|NCT04159896|581345355|FG000|Overall Study|A transient ischaemic attack|1|||
160988704|NCT01222247|581345356|FG000|Overall Study|Lost to Follow-up|2|||
160988705|NCT01222247|581345357|FG001|Overall Study|Lost to Follow-up|2|||
160988706|NCT02338609|581345358|FG000|Overall Study|Physician Decision|1|||
160988707|NCT02338609|581345358|FG000|Overall Study|Death|1|||
160988708|NCT02084082|581345359|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
160988709|NCT02084082|581345360|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
160988710|NCT02084082|581345361|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
160988711|NCT02084082|581345362|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
160988712|NCT02084082|581345359|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
160988713|NCT02084082|581345360|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
160988714|NCT02084082|581345361|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
160988715|NCT02084082|581345362|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
160988716|NCT01449721|581345367|FG000|Overall Study|Physician Decision|0|||
160988717|NCT01449721|581345368|FG001|Overall Study|Physician Decision|1|||
160988718|NCT01449721|581345367|FG000|Overall Study|Physician Decision|0|||
160988719|NCT01449721|581345368|FG001|Overall Study|Physician Decision|1|||
160988720|NCT02148718|581345369|FG000|Overall Study|Protocol Violation|26|||
160988721|NCT02148718|581345369|FG000|Overall Study|Discontinued Study Prematurely|5|||
160988722|NCT01822821|581345374|FG000|Overall Study|Eligible surgery cancelled|1|||
160988723|NCT01822821|581345375|FG001|Overall Study|Eligible surgery cancelled|1|||
160988724|NCT01822821|581345374|FG000|Overall Study|Other reasons|1|||
160988725|NCT01822821|581345375|FG001|Overall Study|Other reasons|0|||
160988726|NCT00333788|581345378|FG000|Overall Study|Adverse Event|44|||
160988727|NCT00333788|581345378|FG000|Overall Study|Lack of Efficacy|80|||
160988728|NCT00333788|581345378|FG000|Overall Study|Lost to Follow-up|2|||
160988729|NCT00333788|581345378|FG000|Overall Study|Withdrawal by Subject|24|||
160988730|NCT00333788|581345378|FG000|Overall Study|Other: Non-compliance|2|||
160553213|NCT00880750|579751123|FG001|First Intervention|Unable to collect urine|0|||
160553214|NCT00880750|579751122|FG000|First Intervention|Non-compliance with meals|0|||
160553215|NCT00880750|579751123|FG001|First Intervention|Non-compliance with meals|1|||
160553216|NCT00880750|579751122|FG000|First Intervention|Withdrawal by Subject|2|||
160553217|NCT00880750|579751123|FG001|First Intervention|Withdrawal by Subject|0|||
160553218|NCT00880750|579751122|FG000|First Intervention|Lost to Follow-up|2|||
160553219|NCT00880750|579751123|FG001|First Intervention|Lost to Follow-up|0|||
160553220|NCT00880750|579751122|FG000|Second Intervention|Withdrawal by Subject|2|||
160553221|NCT00880750|579751123|FG001|Second Intervention|Withdrawal by Subject|2|||
160553222|NCT00880750|579751122|FG000|Second Intervention|Protocol Violation|1|||
160553223|NCT00880750|579751123|FG001|Second Intervention|Protocol Violation|0|||
160553224|NCT00880750|579751122|FG000|Second Intervention|Unable to collect urine|1|||
160553225|NCT00880750|579751123|FG001|Second Intervention|Unable to collect urine|0|||
160553226|NCT00667576|579751124|FG000|Overall Study|Withdrawal by Subject|1|||
160553227|NCT00667576|579751125|FG001|Overall Study|Withdrawal by Subject|0|||
160553228|NCT00667576|579751126|FG002|Overall Study|Withdrawal by Subject|1|||
160553229|NCT00667576|579751127|FG003|Overall Study|Withdrawal by Subject|1|||
160553230|NCT00667576|579751128|FG004|Overall Study|Withdrawal by Subject|1|||
160553231|NCT00667576|579751124|FG000|Overall Study|Adverse Event|1|||
160553232|NCT00667576|579751125|FG001|Overall Study|Adverse Event|1|||
160553233|NCT00667576|579751126|FG002|Overall Study|Adverse Event|0|||
160553234|NCT00667576|579751127|FG003|Overall Study|Adverse Event|0|||
160553235|NCT00667576|579751128|FG004|Overall Study|Adverse Event|0|||
160553236|NCT00667576|579751124|FG000|Overall Study|Lost to Follow-up|0|||
160553237|NCT00667576|579751125|FG001|Overall Study|Lost to Follow-up|0|||
160988731|NCT00333788|581345378|FG000|Overall Study|Other: Moved|2|||
160988732|NCT00333788|581345378|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
160553238|NCT00667576|579751126|FG002|Overall Study|Lost to Follow-up|1|||
160553239|NCT00667576|579751127|FG003|Overall Study|Lost to Follow-up|0|||
160553240|NCT00667576|579751128|FG004|Overall Study|Lost to Follow-up|0|||
160553241|NCT00667576|579751124|FG000|Overall Study|Protocol Violation|0|||
160553242|NCT00667576|579751125|FG001|Overall Study|Protocol Violation|0|||
160553243|NCT00667576|579751126|FG002|Overall Study|Protocol Violation|0|||
160553244|NCT00667576|579751127|FG003|Overall Study|Protocol Violation|1|||
160553245|NCT00667576|579751128|FG004|Overall Study|Protocol Violation|0|||
160553246|NCT00667576|579751124|FG000|Overall Study|Physician Decision|0|||
160553247|NCT00667576|579751125|FG001|Overall Study|Physician Decision|0|||
160646210|NCT03586830|580086014|FG001|Overall Study|Lost to Follow-up|2|||
160646211|NCT03586830|580086015|FG002|Overall Study|Lost to Follow-up|2|||
160646212|NCT03586830|580086016|FG003|Overall Study|Lost to Follow-up|1|||
160646213|NCT03586830|580086013|FG000|Overall Study|Withdrawal by Subject|1|||
160646214|NCT03586830|580086014|FG001|Overall Study|Withdrawal by Subject|0|||
160646215|NCT03586830|580086015|FG002|Overall Study|Withdrawal by Subject|3|||
160646216|NCT03586830|580086016|FG003|Overall Study|Withdrawal by Subject|1|||
160646217|NCT00395083|580086017|FG000|Overall Study|Withdrawal by Subject|6|||
160646218|NCT00395083|580086018|FG001|Overall Study|Withdrawal by Subject|5|||
160646219|NCT00395083|580086017|FG000|Overall Study|Developed another disease|4|||
160646220|NCT00395083|580086018|FG001|Overall Study|Developed another disease|3|||
160646221|NCT00628745|580086023|FG000|Overall Study|Withdrawal by Subject|63|||
160646222|NCT00628745|580086024|FG001|Overall Study|Withdrawal by Subject|3|||
160646223|NCT00628745|580086025|FG002|Overall Study|Withdrawal by Subject|9|||
160646224|NCT00628745|580086026|FG003|Overall Study|Withdrawal by Subject|2|||
160646225|NCT00628745|580086027|FG004|Overall Study|Withdrawal by Subject|69|||
160646226|NCT00628745|580086023|FG000|Overall Study|Does not meet inclusion criteria|0|||
160646227|NCT00628745|580086024|FG001|Overall Study|Does not meet inclusion criteria|12|||
160646228|NCT00628745|580086025|FG002|Overall Study|Does not meet inclusion criteria|0|||
160646229|NCT00628745|580086026|FG003|Overall Study|Does not meet inclusion criteria|0|||
160646230|NCT00628745|580086027|FG004|Overall Study|Does not meet inclusion criteria|18|||
160646231|NCT00628745|580086023|FG000|Overall Study|Participation in an interventional clinical trial|81|||
160646232|NCT00628745|580086024|FG001|Overall Study|Participation in an interventional clinical trial|4|||
160646233|NCT00628745|580086025|FG002|Overall Study|Participation in an interventional clinical trial|7|||
160646234|NCT00628745|580086026|FG003|Overall Study|Participation in an interventional clinical trial|0|||
160646235|NCT00628745|580086027|FG004|Overall Study|Participation in an interventional clinical trial|63|||
160646236|NCT00628745|580086023|FG000|Overall Study|Physician Decision|8|||
160646237|NCT00628745|580086024|FG001|Overall Study|Physician Decision|4|||
160646238|NCT00628745|580086025|FG002|Overall Study|Physician Decision|3|||
160646239|NCT00628745|580086026|FG003|Overall Study|Physician Decision|0|||
160646240|NCT00628745|580086027|FG004|Overall Study|Physician Decision|30|||
160646241|NCT00628745|580086023|FG000|Overall Study|Lost to Follow-up|109|||
160646242|NCT00628745|580086024|FG001|Overall Study|Lost to Follow-up|7|||
160646243|NCT00628745|580086025|FG002|Overall Study|Lost to Follow-up|7|||
160646244|NCT00628745|580086026|FG003|Overall Study|Lost to Follow-up|0|||
160901358|NCT01313858|581033990|FG002|Overall Study|Premature Treatment Termination|191|||
160901359|NCT01313858|581033988|FG000|Overall Study|Lost to Follow-up|35|||
160901360|NCT01313858|581033989|FG001|Overall Study|Lost to Follow-up|51|||
160901361|NCT01313858|581033990|FG002|Overall Study|Lost to Follow-up|47|||
160901362|NCT03689530|581033994|FG000|Overall Study|Withdrawal by Subject|53|||
160901363|NCT03689530|581033995|FG001|Overall Study|Withdrawal by Subject|16|||
160901364|NCT01392443|581033996|FG000|Overall Study|Disease progression|30|||
160901365|NCT01392443|581033996|FG000|Overall Study|Adverse Event|24|||
160901366|NCT01392443|581033996|FG000|Overall Study|Death|7|||
160901367|NCT01392443|581033996|FG000|Overall Study|Withdrawal by Subject|5|||
160901368|NCT01392443|581033996|FG000|Overall Study|Lost to Follow-up|1|||
160901369|NCT01392443|581033996|FG000|Overall Study|Protocol Violation|1|||
160901370|NCT01977794|581033997|FG000|Overall Study|Adverse Event|2|||
160901371|NCT01977794|581033998|FG001|Overall Study|Adverse Event|2|||
160901372|NCT01977794|581033997|FG000|Overall Study|Lost to Follow-up|2|||
160901373|NCT01977794|581033998|FG001|Overall Study|Lost to Follow-up|1|||
160901374|NCT01977794|581033997|FG000|Overall Study|Protocol Violation|1|||
160646245|NCT00628745|580086027|FG004|Overall Study|Lost to Follow-up|498|||
160646246|NCT00628745|580086023|FG000|Overall Study|Death|197|||
160646247|NCT00628745|580086024|FG001|Overall Study|Death|81|||
160646248|NCT00628745|580086025|FG002|Overall Study|Death|12|||
160646249|NCT00628745|580086026|FG003|Overall Study|Death|4|||
160901375|NCT01977794|581033998|FG001|Overall Study|Protocol Violation|0|||
160901376|NCT01977794|581033997|FG000|Overall Study|Death|1|||
160901377|NCT01977794|581033998|FG001|Overall Study|Death|1|||
160553248|NCT00667576|579751126|FG002|Overall Study|Physician Decision|0|||
160553249|NCT00667576|579751127|FG003|Overall Study|Physician Decision|1|||
160646250|NCT00628745|580086027|FG004|Overall Study|Death|939|||
160901378|NCT01977794|581033997|FG000|Overall Study|Withdrew consent|2|||
160901379|NCT01977794|581033998|FG001|Overall Study|Withdrew consent|1|||
160553250|NCT00667576|579751128|FG004|Overall Study|Physician Decision|0|||
160901380|NCT01977794|581033997|FG000|Overall Study|Other|0|||
160901381|NCT01977794|581033998|FG001|Overall Study|Other|1|||
160988733|NCT00333788|581345378|FG000|Overall Study|Other: Investigator decision|1|||
160988734|NCT00333788|581345378|FG000|Overall Study|Other: Quality of life concern|1|||
160988735|NCT00333788|581345378|FG000|Overall Study|Other: Sponsor decision|1|||
160988736|NCT00333788|581345378|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
160988737|NCT00333788|581345378|FG000|Overall Study|Other: Medical monitor decision|1|||
160988738|NCT00333788|581345378|FG000|Overall Study|Other: Physician decision|1|||
160988739|NCT00333788|581345378|FG000|Overall Study|Other: Signed consent for another study|1|||
160988740|NCT00114959|581345379|FG000|Overall Study|Lack of Efficacy|6|||
160988741|NCT00114959|581345379|FG000|Overall Study|Physician Decision|1|||
160988742|NCT00114959|581345379|FG000|Overall Study|Death|1|||
160988743|NCT03253653|581345393|FG000|Overall Study|Withdrawal by Subject|4|||
160988744|NCT03253653|581345394|FG001|Overall Study|Withdrawal by Subject|1|||
160988745|NCT03253653|581345393|FG000|Overall Study|Protocol Violation|0|||
160988746|NCT03253653|581345394|FG001|Overall Study|Protocol Violation|5|||
160988747|NCT04978363|581347257|FG000|Overall Study|Other medical issues unrelated to the study|0|||
160988748|NCT04978363|581347258|FG001|Overall Study|Other medical issues unrelated to the study|0|||
160988749|NCT04978363|581347259|FG002|Overall Study|Other medical issues unrelated to the study|0|||
160988750|NCT04978363|581347260|FG003|Overall Study|Other medical issues unrelated to the study|0|||
160988751|NCT04978363|581347261|FG004|Overall Study|Other medical issues unrelated to the study|1|||
160988752|NCT04978363|581347262|FG005|Overall Study|Other medical issues unrelated to the study|0|||
160988753|NCT04978363|581347263|FG006|Overall Study|Other medical issues unrelated to the study|0|||
160988754|NCT04978363|581347264|FG007|Overall Study|Other medical issues unrelated to the study|0|||
160988755|NCT04978363|581347265|FG008|Overall Study|Other medical issues unrelated to the study|0|||
160988756|NCT04978363|581347266|FG009|Overall Study|Other medical issues unrelated to the study|0|||
160988757|NCT04978363|581347267|FG010|Overall Study|Other medical issues unrelated to the study|0|||
160988758|NCT04978363|581347257|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
160988759|NCT04978363|581347258|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
160988760|NCT04978363|581347259|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
160988761|NCT04978363|581347260|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
160988762|NCT04978363|581347261|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
160988763|NCT04978363|581347262|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
160988764|NCT04978363|581347263|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
160988765|NCT04978363|581347264|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
160988766|NCT04978363|581347265|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
160988767|NCT04978363|581347266|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
160988768|NCT04978363|581347267|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
160988769|NCT04978363|581347257|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988770|NCT04978363|581347258|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
160988771|NCT04978363|581347259|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988772|NCT04978363|581347260|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988773|NCT04978363|581347261|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988774|NCT04978363|581347262|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988775|NCT04978363|581347263|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988776|NCT04978363|581347264|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988777|NCT04978363|581347265|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988778|NCT04978363|581347266|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988779|NCT04978363|581347267|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988780|NCT01251614|581347268|FG000|Overall Study|Adverse Event|1|||
160988781|NCT01251614|581347269|FG001|Overall Study|Adverse Event|0|||
160988782|NCT01251614|581347270|FG002|Overall Study|Adverse Event|1|||
160988783|NCT01251614|581347268|FG000|Overall Study|Lack of Efficacy|1|||
160988784|NCT01251614|581347269|FG001|Overall Study|Lack of Efficacy|9|||
160988785|NCT01251614|581347270|FG002|Overall Study|Lack of Efficacy|4|||
160988786|NCT01251614|581347268|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
160988787|NCT01251614|581347269|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
160988788|NCT01251614|581347270|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
160988789|NCT01251614|581347268|FG000|Overall Study|Pregnancy|0|||
160988790|NCT01251614|581347269|FG001|Overall Study|Pregnancy|0|||
160988791|NCT01251614|581347270|FG002|Overall Study|Pregnancy|2|||
160553251|NCT00667576|579751124|FG000|Overall Study|Missed Visit|0|||
160553252|NCT00667576|579751125|FG001|Overall Study|Missed Visit|0|||
160553253|NCT00667576|579751126|FG002|Overall Study|Missed Visit|0|||
160553254|NCT00667576|579751127|FG003|Overall Study|Missed Visit|1|||
160553255|NCT00667576|579751128|FG004|Overall Study|Missed Visit|0|||
160821510|NCT00347438|580733630|FG000|Overall Study|Physician Decision|1|||
160988792|NCT01251614|581347268|FG000|Overall Study|Loss of Disease Control|0|||
160821511|NCT02545517|580733631|FG000|Overall Study|Death|2|||
160553256|NCT01390389|579751132|FG000|Overall Study|Withdrawal by Subject|2|||
160553257|NCT01390389|579751133|FG001|Overall Study|Withdrawal by Subject|0|||
160553258|NCT01390389|579751132|FG000|Overall Study|Screen Fail|2|||
160553259|NCT01390389|579751133|FG001|Overall Study|Screen Fail|1|||
160646251|NCT00628745|580086023|FG000|Overall Study|Participant transferred to another THAOS site|6|||
160646252|NCT00628745|580086024|FG001|Overall Study|Participant transferred to another THAOS site|0|||
160646253|NCT00628745|580086025|FG002|Overall Study|Participant transferred to another THAOS site|0|||
160553260|NCT03593915|579751134|FG000|Overall Study|Adverse Event|0|||
160553261|NCT03593915|579751135|FG001|Overall Study|Adverse Event|0|||
160553262|NCT03593915|579751136|FG002|Overall Study|Adverse Event|0|||
160553263|NCT03593915|579751137|FG003|Overall Study|Adverse Event|1|||
160553264|NCT03593915|579751138|FG004|Overall Study|Adverse Event|0|||
160553265|NCT03593915|579751139|FG005|Overall Study|Adverse Event|0|||
160553266|NCT03593915|579751134|FG000|Overall Study|Physician Decision|0|||
160553267|NCT03593915|579751135|FG001|Overall Study|Physician Decision|0|||
160553268|NCT03593915|579751136|FG002|Overall Study|Physician Decision|0|||
160553269|NCT03593915|579751137|FG003|Overall Study|Physician Decision|0|||
160553270|NCT03593915|579751138|FG004|Overall Study|Physician Decision|0|||
160553271|NCT03593915|579751139|FG005|Overall Study|Physician Decision|1|||
160553272|NCT01583179|579751140|FG000|Overall Study|Screen failure|1|||
160553273|NCT01583179|579751141|FG001|Overall Study|Screen failure|2|||
160553274|NCT01246206|579751142|FG000|Overall Study|Patient did not receive study regiments.|1|||
160553275|NCT02002975|579751143|FG000|Overall Study|Case Report Forms Uncollected|135|||
160553276|NCT02002975|579751143|FG000|Overall Study|Protocol Deviation|437|||
160553277|NCT02810964|579751144|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
160553278|NCT02810964|579751145|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
160553279|NCT02810964|579751144|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
160553280|NCT02810964|579751145|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
160553281|NCT02810964|579751144|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
160553282|NCT02810964|579751145|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
160553283|NCT02810964|579751144|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
160553284|NCT02810964|579751145|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
160646254|NCT00628745|580086026|FG003|Overall Study|Participant transferred to another THAOS site|0|||
160646255|NCT00628745|580086027|FG004|Overall Study|Participant transferred to another THAOS site|7|||
160646256|NCT00628745|580086023|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
160901382|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
160901383|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
160901384|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
160901385|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
160901386|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
160901387|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
160901388|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
160901389|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
160901390|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
160901391|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901392|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901393|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901394|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901395|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901396|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901397|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901398|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
160901399|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901400|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901401|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901402|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901403|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901404|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901405|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901406|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
160553285|NCT03523351|579751148|FG000|Overall Study|Death|13|||
160553286|NCT03523351|579751149|FG001|Overall Study|Death|11|||
160646257|NCT00628745|580086024|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
160901407|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160646258|NCT00628745|580086025|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
160901408|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160901409|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160553287|NCT03523351|579751148|FG000|Overall Study|Lost to Follow-up|2|||
160553288|NCT03523351|579751149|FG001|Overall Study|Lost to Follow-up|3|||
160553289|NCT03523351|579751148|FG000|Overall Study|Withdrawal by Subject|4|||
160553290|NCT03523351|579751149|FG001|Overall Study|Withdrawal by Subject|0|||
160553291|NCT03523351|579751148|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
160553292|NCT03523351|579751149|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
160553293|NCT00700180|579751156|FG000|Overall Study|Death|99|||
160553294|NCT00700180|579751157|FG001|Overall Study|Death|114|||
160553295|NCT00700180|579751156|FG000|Overall Study|Alive on treatment|5|||
160553296|NCT00700180|579751157|FG001|Overall Study|Alive on treatment|3|||
160553297|NCT00700180|579751156|FG000|Overall Study|Alive in follow-up|46|||
160553298|NCT00700180|579751157|FG001|Overall Study|Alive in follow-up|27|||
160553299|NCT00700180|579751156|FG000|Overall Study|Lost to Follow-up|4|||
160553300|NCT00700180|579751157|FG001|Overall Study|Lost to Follow-up|5|||
160553301|NCT03588741|579751158|FG000|Overall Study|Withdrawal by Subject|1|||
160553302|NCT01445535|579751159|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
160553303|NCT01445535|579751160|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
160553304|NCT01445535|579751161|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
160553305|NCT01445535|579751162|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
160553306|NCT01445535|579751159|FG000|Overall Study|Disease progression|1|||
160553307|NCT01445535|579751160|FG001|Overall Study|Disease progression|0|||
160553308|NCT01445535|579751161|FG002|Overall Study|Disease progression|1|||
160553309|NCT01445535|579751162|FG003|Overall Study|Disease progression|0|||
160553310|NCT01445535|579751159|FG000|Overall Study|PI discretion|0|||
160553311|NCT01445535|579751160|FG001|Overall Study|PI discretion|0|||
160553312|NCT01445535|579751161|FG002|Overall Study|PI discretion|0|||
160553313|NCT01445535|579751162|FG003|Overall Study|PI discretion|1|||
160553314|NCT00454779|579751167|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
160553315|NCT00454779|579751168|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
160553316|NCT00454779|579751167|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
160553317|NCT00454779|579751168|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
160553318|NCT00454779|579751167|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
160553319|NCT00454779|579751168|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
160553320|NCT00454779|579751167|FG000|First-line Treatment Phase|Protocol Violation|0|||
160553321|NCT00454779|579751168|FG001|First-line Treatment Phase|Protocol Violation|1|||
160553322|NCT00454779|579751167|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
160553323|NCT00454779|579751168|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
160553324|NCT00454779|579751167|FG000|First-line Treatment Phase|Ongoing|1|||
160553325|NCT00454779|579751168|FG001|First-line Treatment Phase|Ongoing|0|||
160553326|NCT00454779|579751167|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
160553327|NCT00454779|579751168|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
160553328|NCT00454779|579751167|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
160553329|NCT00454779|579751168|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
160553330|NCT00454779|579751167|FG000|Second-line Treatment Phase|Ongoing|0|||
160553331|NCT00454779|579751168|FG001|Second-line Treatment Phase|Ongoing|1|||
160553332|NCT01337973|579751170|FG000|Overall Study|Lost to Follow-up|2|||
160553333|NCT01337973|579751171|FG001|Overall Study|Lost to Follow-up|4|||
160553334|NCT01337973|579751172|FG002|Overall Study|Lost to Follow-up|3|||
160553335|NCT01337973|579751170|FG000|Overall Study|Death|1|||
160553336|NCT01337973|579751171|FG001|Overall Study|Death|2|||
160553337|NCT01337973|579751172|FG002|Overall Study|Death|1|||
160553338|NCT01337973|579751170|FG000|Overall Study|Withdrawal by Subject|10|||
160553339|NCT01337973|579751171|FG001|Overall Study|Withdrawal by Subject|8|||
160553340|NCT01337973|579751172|FG002|Overall Study|Withdrawal by Subject|4|||
160553341|NCT01337973|579751170|FG000|Overall Study|missing data on primary outcome|3|||
160553342|NCT01337973|579751171|FG001|Overall Study|missing data on primary outcome|1|||
160553343|NCT01337973|579751172|FG002|Overall Study|missing data on primary outcome|3|||
160553344|NCT02817087|579751173|FG000|Overall Study|Withdrawal by Subject|2|||
160553345|NCT02817087|579751174|FG001|Overall Study|Withdrawal by Subject|0|||
160553346|NCT01972074|579751177|FG000|Overall Study|Adverse Event|4|||
160553347|NCT01972074|579751178|FG001|Overall Study|Adverse Event|1|||
160553348|NCT01972074|579751179|FG002|Overall Study|Adverse Event|0|||
160553349|NCT01972074|579751177|FG000|Overall Study|Lack of Efficacy|1|||
160646259|NCT00628745|580086026|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
160821512|NCT02545517|580733632|FG001|Overall Study|Death|2|||
160821513|NCT02545517|580733633|FG002|Overall Study|Death|1|||
160821514|NCT02545517|580733631|FG000|Overall Study|Lost to Follow-up|14|||
160821515|NCT02545517|580733632|FG001|Overall Study|Lost to Follow-up|13|||
160821516|NCT02545517|580733633|FG002|Overall Study|Lost to Follow-up|17|||
160821517|NCT02545517|580733631|FG000|Overall Study|Protocol Violation|0|||
160821518|NCT02545517|580733632|FG001|Overall Study|Protocol Violation|1|||
160821519|NCT02545517|580733633|FG002|Overall Study|Protocol Violation|1|||
160821520|NCT02545517|580733631|FG000|Overall Study|Withdrawal by Subject|5|||
160821521|NCT02545517|580733632|FG001|Overall Study|Withdrawal by Subject|8|||
160553350|NCT01972074|579751178|FG001|Overall Study|Lack of Efficacy|1|||
160553351|NCT01972074|579751179|FG002|Overall Study|Lack of Efficacy|0|||
160553352|NCT01972074|579751177|FG000|Overall Study|Lost to Follow-up|0|||
160653392|NCT05665595|580112377|FG000|Overall Study|Withdrawal by Subject|2|||
160821522|NCT02545517|580733633|FG002|Overall Study|Withdrawal by Subject|9|||
160821523|NCT02545517|580733631|FG000|Overall Study|Administrative reason|5|||
160646260|NCT00628745|580086027|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
160646261|NCT00628745|580086023|FG000|Overall Study|Site closure|152|||
160821524|NCT02545517|580733632|FG001|Overall Study|Administrative reason|6|||
160821525|NCT02545517|580733633|FG002|Overall Study|Administrative reason|10|||
160821526|NCT02545517|580733631|FG000|Overall Study|Other|2|||
160821527|NCT02545517|580733632|FG001|Overall Study|Other|4|||
160821528|NCT02545517|580733633|FG002|Overall Study|Other|3|||
160821529|NCT01529515|580733634|FG000|TRANSITION PHASE|Adverse Event|16|||
160821530|NCT01529515|580733635|FG001|TRANSITION PHASE|Adverse Event|0|||
160821531|NCT01529515|580733636|FG002|TRANSITION PHASE|Adverse Event|0|||
160821532|NCT01529515|580733637|FG003|TRANSITION PHASE|Adverse Event|0|||
160821533|NCT01529515|580733634|FG000|TRANSITION PHASE|Death|1|||
160821534|NCT01529515|580733635|FG001|TRANSITION PHASE|Death|0|||
160821535|NCT01529515|580733636|FG002|TRANSITION PHASE|Death|0|||
160821536|NCT01529515|580733637|FG003|TRANSITION PHASE|Death|0|||
160821537|NCT01529515|580733634|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
160821538|NCT01529515|580733635|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
160821539|NCT01529515|580733636|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
160821540|NCT01529515|580733637|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
160821541|NCT01529515|580733634|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
160821542|NCT01529515|580733635|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
160821543|NCT01529515|580733636|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
160821544|NCT01529515|580733637|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
160821545|NCT01529515|580733634|FG000|TRANSITION PHASE|Protocol Violation|4|||
160821546|NCT01529515|580733635|FG001|TRANSITION PHASE|Protocol Violation|0|||
160821547|NCT01529515|580733636|FG002|TRANSITION PHASE|Protocol Violation|0|||
160821548|NCT01529515|580733637|FG003|TRANSITION PHASE|Protocol Violation|0|||
160821549|NCT01529515|580733634|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
160821550|NCT01529515|580733635|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
160821551|NCT01529515|580733636|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
160821552|NCT01529515|580733637|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
160901410|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160901411|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160901412|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160901413|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160901414|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
160901415|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901416|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901417|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901418|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901419|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901420|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901421|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901422|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
160901423|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901424|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901425|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901426|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901427|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901428|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901429|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901430|NCT00533897|581034001|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160821553|NCT01529515|580733634|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
160821554|NCT01529515|580733635|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
160821555|NCT01529515|580733636|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
160821556|NCT01529515|580733637|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
160821557|NCT01529515|580733634|FG000|TRANSITION PHASE|Other|9|||
160553353|NCT01972074|579751178|FG001|Overall Study|Lost to Follow-up|1|||
160553354|NCT01972074|579751179|FG002|Overall Study|Lost to Follow-up|1|||
160553355|NCT01972074|579751177|FG000|Overall Study|Withdrawal by Subject|1|||
160553356|NCT01972074|579751178|FG001|Overall Study|Withdrawal by Subject|1|||
160821558|NCT01529515|580733635|FG001|TRANSITION PHASE|Other|0|||
160821559|NCT01529515|580733636|FG002|TRANSITION PHASE|Other|0|||
160821560|NCT01529515|580733637|FG003|TRANSITION PHASE|Other|0|||
160821561|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Adverse Event|0|||
160821562|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Adverse Event|10|||
160821563|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Adverse Event|0|||
160821564|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Adverse Event|0|||
160821565|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
160553357|NCT01972074|579751179|FG002|Overall Study|Withdrawal by Subject|1|||
160553358|NCT01972074|579751177|FG000|Overall Study|Scanner Unavailable|0|||
160553359|NCT01972074|579751178|FG001|Overall Study|Scanner Unavailable|0|||
160553360|NCT01972074|579751179|FG002|Overall Study|Scanner Unavailable|1|||
160553361|NCT02887521|579751183|FG000|Overall Study|Withdrawal by Subject|0|||
160553362|NCT02887521|579751184|FG001|Overall Study|Withdrawal by Subject|3|||
160553363|NCT00695565|579751185|FG000|Overall Study|Lost to Follow-up|4|||
160553364|NCT00695565|579751186|FG001|Overall Study|Lost to Follow-up|4|||
160553365|NCT00695565|579751185|FG000|Overall Study|Adverse Event|3|||
160553366|NCT00695565|579751186|FG001|Overall Study|Adverse Event|1|||
160553367|NCT00695565|579751185|FG000|Overall Study|Protocol Violation|3|||
160553368|NCT00695565|579751186|FG001|Overall Study|Protocol Violation|1|||
160553369|NCT00695565|579751185|FG000|Overall Study|Withdrawal by Subject|1|||
160553370|NCT00695565|579751186|FG001|Overall Study|Withdrawal by Subject|1|||
160553371|NCT00695565|579751185|FG000|Overall Study|Lack of Efficacy|1|||
160553372|NCT00695565|579751186|FG001|Overall Study|Lack of Efficacy|1|||
160553373|NCT00695565|579751185|FG000|Overall Study|Subject did not follow instructions|1|||
160553374|NCT00695565|579751186|FG001|Overall Study|Subject did not follow instructions|1|||
160553375|NCT02937350|579751187|FG000|Overall Study|Withdrawal by Subject|0|||
160646262|NCT00628745|580086024|FG001|Overall Study|Site closure|146|||
160821566|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
160821567|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
160901431|NCT00533897|581034002|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
160901432|NCT00533897|581034003|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
160901433|NCT00533897|581034004|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160901434|NCT00533897|581034005|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160901435|NCT00533897|581034006|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160901436|NCT00533897|581034007|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160901437|NCT00533897|581034008|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160901438|NCT00533897|581034001|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901439|NCT00533897|581034002|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901440|NCT00533897|581034003|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
160901441|NCT00533897|581034004|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901442|NCT00533897|581034005|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901443|NCT00533897|581034006|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901444|NCT00533897|581034007|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901445|NCT00533897|581034008|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901446|NCT00533897|581034001|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901447|NCT00533897|581034002|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901448|NCT00533897|581034003|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901449|NCT00533897|581034004|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901450|NCT00533897|581034005|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901451|NCT00533897|581034006|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
160901452|NCT00533897|581034007|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901453|NCT00533897|581034008|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901454|NCT00533897|581034001|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901455|NCT00533897|581034002|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901456|NCT00533897|581034003|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901457|NCT00533897|581034004|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901458|NCT00533897|581034005|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901459|NCT00533897|581034006|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
160901460|NCT00533897|581034007|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160553376|NCT02937350|579751188|FG001|Overall Study|Withdrawal by Subject|1|||
160553377|NCT02937350|579751189|FG002|Overall Study|Withdrawal by Subject|0|||
160553378|NCT01462266|579751190|FG000|Overall Study|Adverse Event|7|||
160553379|NCT01462266|579751191|FG001|Overall Study|Adverse Event|6|||
160553380|NCT01462266|579751190|FG000|Overall Study|Death|2|||
160988793|NCT01251614|581347269|FG001|Overall Study|Loss of Disease Control|1|||
160988794|NCT01251614|581347270|FG002|Overall Study|Loss of Disease Control|0|||
160988795|NCT01251614|581347268|FG000|Overall Study|Withdrawal by Subject|0|||
160988796|NCT01251614|581347269|FG001|Overall Study|Withdrawal by Subject|2|||
160988797|NCT01251614|581347270|FG002|Overall Study|Withdrawal by Subject|1|||
160988798|NCT01251614|581347268|FG000|Overall Study|Lost to Follow-up|0|||
160988799|NCT01251614|581347269|FG001|Overall Study|Lost to Follow-up|1|||
160988800|NCT01251614|581347270|FG002|Overall Study|Lost to Follow-up|0|||
160988801|NCT01876043|581347272|FG000|Overall Study|Death|1|||
160988802|NCT01876043|581347272|FG000|Overall Study|Withdrawal by Subject|1|||
160988803|NCT00079937|581347273|FG000|Overall Study|Adverse Event|2|||
160988804|NCT00079937|581347274|FG001|Overall Study|Adverse Event|1|||
160988805|NCT00079937|581347273|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160988806|NCT00079937|581347274|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160988807|NCT00079937|581347273|FG000|Overall Study|Subject no longer requires study drug|3|||
160988808|NCT00079937|581347274|FG001|Overall Study|Subject no longer requires study drug|0|||
160988809|NCT00079937|581347273|FG000|Overall Study|Protocol Violation|8|||
160988810|NCT00079937|581347274|FG001|Overall Study|Protocol Violation|6|||
160988811|NCT00079937|581347273|FG000|Overall Study|Withdrawal by Subject|21|||
160988812|NCT00079937|581347274|FG001|Overall Study|Withdrawal by Subject|7|||
160988813|NCT00079937|581347273|FG000|Overall Study|Lost to Follow-up|12|||
160988814|NCT00079937|581347274|FG001|Overall Study|Lost to Follow-up|5|||
160988815|NCT00079937|581347273|FG000|Overall Study|Administrative problems|22|||
160988816|NCT00079937|581347274|FG001|Overall Study|Administrative problems|11|||
160988817|NCT02857283|581347275|FG000|First Exposure|Withdrawal by Subject|1|||
160988818|NCT02857283|581347276|FG001|First Exposure|Withdrawal by Subject|0|||
160988819|NCT00093795|581347277|FG000|Overall Study|No follow up data|20|||
160988820|NCT00093795|581347278|FG001|Overall Study|No follow up data|16|||
160988821|NCT00093795|581347279|FG002|Overall Study|No follow up data|17|||
160988822|NCT00613301|581347280|FG000|Overall Study|Adverse Event|49|||
160988823|NCT00613301|581347280|FG000|Overall Study|Lost to Follow-up|88|||
160988824|NCT00613301|581347280|FG000|Overall Study|Withdrawal by Subject|5|||
160988825|NCT00613301|581347280|FG000|Overall Study|Death|6|||
160988826|NCT00613301|581347280|FG000|Overall Study|Lack of Efficacy|13|||
160988827|NCT00613301|581347280|FG000|Overall Study|Physician Decision|2|||
160988828|NCT00613301|581347280|FG000|Overall Study|No data was collected|53|||
160988829|NCT00613301|581347280|FG000|Overall Study|Irregularly enrolled patients|12|||
160988830|NCT01684046|581347283|FG000|Period 1, First 30 Days|Adverse Event|0|||
160988831|NCT01684046|581347284|FG001|Period 1, First 30 Days|Adverse Event|2|||
160988832|NCT00797862|581347285|FG000|Overall Study|Adverse Event|86|||
160988833|NCT00797862|581347286|FG001|Overall Study|Adverse Event|44|||
160988834|NCT00797862|581347287|FG002|Overall Study|Adverse Event|58|||
160988835|NCT00797862|581347285|FG000|Overall Study|Abnormal Test Procedure Result|0|||
160988836|NCT00797862|581347286|FG001|Overall Study|Abnormal Test Procedure Result|1|||
160988837|NCT00797862|581347287|FG002|Overall Study|Abnormal Test Procedure Result|1|||
160988838|NCT00797862|581347285|FG000|Overall Study|Lack of Efficacy|1|||
160988839|NCT00797862|581347286|FG001|Overall Study|Lack of Efficacy|7|||
160988840|NCT00797862|581347287|FG002|Overall Study|Lack of Efficacy|6|||
160988841|NCT00797862|581347285|FG000|Overall Study|No longer required study medication|1|||
160988842|NCT00797862|581347286|FG001|Overall Study|No longer required study medication|0|||
160988843|NCT00797862|581347287|FG002|Overall Study|No longer required study medication|0|||
160988844|NCT00797862|581347285|FG000|Overall Study|Withdrawal by Subject|14|||
160988845|NCT00797862|581347286|FG001|Overall Study|Withdrawal by Subject|7|||
160988846|NCT00797862|581347287|FG002|Overall Study|Withdrawal by Subject|7|||
160988847|NCT00797862|581347285|FG000|Overall Study|Lost to Follow-up|11|||
160988848|NCT00797862|581347286|FG001|Overall Study|Lost to Follow-up|0|||
160988849|NCT00797862|581347287|FG002|Overall Study|Lost to Follow-up|5|||
160988850|NCT00797862|581347285|FG000|Overall Study|Administrative Problem|4|||
160988851|NCT00797862|581347286|FG001|Overall Study|Administrative Problem|0|||
160988852|NCT00797862|581347287|FG002|Overall Study|Administrative Problem|0|||
160988853|NCT00797862|581347285|FG000|Overall Study|Protocol Violation|4|||
160988854|NCT00797862|581347286|FG001|Overall Study|Protocol Violation|6|||
160988855|NCT00797862|581347287|FG002|Overall Study|Protocol Violation|8|||
160988856|NCT00797862|581347285|FG000|Overall Study|Mis-randomized|3|||
160988857|NCT00797862|581347286|FG001|Overall Study|Mis-randomized|3|||
160988858|NCT00797862|581347287|FG002|Overall Study|Mis-randomized|1|||
160988859|NCT01306331|581347291|FG000|Overall Study|Adverse Event|28|||
160988860|NCT01306331|581347292|FG001|Overall Study|Adverse Event|25|||
160988861|NCT01306331|581347291|FG000|Overall Study|Lost to Follow-up|321|||
160646263|NCT00628745|580086025|FG002|Overall Study|Site closure|6|||
160988862|NCT01306331|581347292|FG001|Overall Study|Lost to Follow-up|323|||
160646264|NCT00628745|580086026|FG003|Overall Study|Site closure|8|||
160988863|NCT01306331|581347291|FG000|Overall Study|Physician Decision|26|||
160988864|NCT01306331|581347292|FG001|Overall Study|Physician Decision|22|||
160646265|NCT00628745|580086027|FG004|Overall Study|Site closure|691|||
160646266|NCT00628745|580086023|FG000|Overall Study|Duplicate participant|0|||
160646267|NCT00628745|580086024|FG001|Overall Study|Duplicate participant|0|||
160646268|NCT00628745|580086025|FG002|Overall Study|Duplicate participant|0|||
160646269|NCT00628745|580086026|FG003|Overall Study|Duplicate participant|0|||
160646270|NCT00628745|580086027|FG004|Overall Study|Duplicate participant|1|||
160646271|NCT00628745|580086023|FG000|Overall Study|Missing|4|||
160646272|NCT00628745|580086024|FG001|Overall Study|Missing|3|||
160646273|NCT00628745|580086025|FG002|Overall Study|Missing|0|||
160646274|NCT00628745|580086026|FG003|Overall Study|Missing|0|||
160646275|NCT00628745|580086027|FG004|Overall Study|Missing|10|||
160646276|NCT00628745|580086023|FG000|Overall Study|Othe reasons|987|||
160646277|NCT00628745|580086024|FG001|Overall Study|Othe reasons|373|||
160646278|NCT00628745|580086025|FG002|Overall Study|Othe reasons|105|||
160646279|NCT00628745|580086026|FG003|Overall Study|Othe reasons|1|||
160646280|NCT00628745|580086027|FG004|Overall Study|Othe reasons|1772|||
160646281|NCT01590433|580088176|FG000|Overall Study|Lost to Follow-up|20|||
160646282|NCT01590433|580088177|FG001|Overall Study|Lost to Follow-up|8|||
160646283|NCT01590433|580088176|FG000|Overall Study|Withdrawal by Subject|21|||
160646284|NCT01590433|580088177|FG001|Overall Study|Withdrawal by Subject|11|||
160646285|NCT01590433|580088176|FG000|Overall Study|Adverse Event|11|||
160646286|NCT01590433|580088177|FG001|Overall Study|Adverse Event|3|||
160646287|NCT00322556|580088178|FG000|Overall Study|Adverse Event|1|||
160646288|NCT00322556|580088178|FG000|Overall Study|Withdrawal by Subject|1|||
160988865|NCT01306331|581347291|FG000|Overall Study|Pregnancy|136|||
160988866|NCT01306331|581347292|FG001|Overall Study|Pregnancy|151|||
160988867|NCT01306331|581347291|FG000|Overall Study|Protocol Violation|154|||
160988868|NCT01306331|581347292|FG001|Overall Study|Protocol Violation|124|||
160988869|NCT01306331|581347291|FG000|Overall Study|Withdrawal by Subject|163|||
160988870|NCT01306331|581347292|FG001|Overall Study|Withdrawal by Subject|152|||
160988871|NCT01306331|581347291|FG000|Overall Study|Not sexually active|29|||
160988872|NCT01306331|581347292|FG001|Overall Study|Not sexually active|28|||
160988873|NCT01306331|581347291|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
160988874|NCT01306331|581347292|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
160988875|NCT01306331|581347291|FG000|Overall Study|Other|34|||
160988876|NCT01306331|581347292|FG001|Overall Study|Other|32|||
160988877|NCT00172185|581347297|FG000|Overall Study|Adverse Event|0|||
160988878|NCT00172185|581347298|FG001|Overall Study|Adverse Event|1|||
160988879|NCT00172185|581347299|FG002|Overall Study|Adverse Event|3|||
160988880|NCT00172185|581347300|FG003|Overall Study|Adverse Event|4|||
160988881|NCT00172185|581347297|FG000|Overall Study|Physician Decision|0|||
160988882|NCT00172185|581347298|FG001|Overall Study|Physician Decision|0|||
160988883|NCT00172185|581347299|FG002|Overall Study|Physician Decision|1|||
160988884|NCT00172185|581347300|FG003|Overall Study|Physician Decision|0|||
160988885|NCT00172185|581347297|FG000|Overall Study|SPONSOR Decision|0|||
160988886|NCT00172185|581347298|FG001|Overall Study|SPONSOR Decision|1|||
160988887|NCT00172185|581347299|FG002|Overall Study|SPONSOR Decision|0|||
160988888|NCT00172185|581347300|FG003|Overall Study|SPONSOR Decision|0|||
160988889|NCT00172185|581347297|FG000|Overall Study|Withdrawal by Subject|0|||
160988890|NCT00172185|581347298|FG001|Overall Study|Withdrawal by Subject|0|||
160988891|NCT00172185|581347299|FG002|Overall Study|Withdrawal by Subject|1|||
160988892|NCT00172185|581347300|FG003|Overall Study|Withdrawal by Subject|0|||
160988893|NCT02790606|581347303|FG000|Overall Study|Death|27|||
160988894|NCT02790606|581347303|FG000|Overall Study|Lost to Follow-up|4|||
160988895|NCT02790606|581347303|FG000|Overall Study|Physician Decision|3|||
160988896|NCT02790606|581347303|FG000|Overall Study|Withdrawal by Subject|1|||
160988897|NCT02735915|581347304|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
160988898|NCT02735915|581347304|FG000|Overall Study|Withdrawal following SAE|2|||
160646289|NCT00322556|580088178|FG000|Overall Study|Lost to Follow-up|3|||
160646290|NCT00322556|580088178|FG000|Overall Study|Other Reason|7|||
160646291|NCT00555009|580088179|FG000|Overall Study|Withdrawal by Subject|0|||
160646292|NCT00555009|580088180|FG001|Overall Study|Withdrawal by Subject|1|||
160646293|NCT00555009|580088179|FG000|Overall Study|Terminated by Sponsor|2|||
160988899|NCT02735915|581347304|FG000|Overall Study|Withdrawal by Subject|1|||
160988900|NCT05328973|581347305|FG000|Overall Study|Withdrawal by Subject|0|||
160988901|NCT05328973|581347306|FG001|Overall Study|Withdrawal by Subject|1|||
160988902|NCT00409708|581347312|FG000|Treatment|Abnormal test procedure result(s)|1|||
160646294|NCT00555009|580088180|FG001|Overall Study|Terminated by Sponsor|5|||
160646295|NCT02040428|580088181|FG000|Overall Study|Death|4|||
160646296|NCT02040428|580088182|FG001|Overall Study|Death|3|||
160988903|NCT00409708|581347313|FG001|Treatment|Abnormal test procedure result(s)|0|||
160988904|NCT00409708|581347312|FG000|Treatment|Lack of Efficacy|0|||
160988905|NCT00409708|581347313|FG001|Treatment|Lack of Efficacy|1|||
160988906|NCT00409708|581347312|FG000|Treatment|Protocol Violation|6|||
160646297|NCT02040428|580088181|FG000|Overall Study|Withdrawal by Subject|1|||
160646298|NCT02040428|580088182|FG001|Overall Study|Withdrawal by Subject|1|||
160646299|NCT00832078|580088183|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
160646300|NCT00832078|580088184|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
160988907|NCT00409708|581347313|FG001|Treatment|Protocol Violation|2|||
160646301|NCT00832078|580088183|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
160646302|NCT00832078|580088184|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
160646303|NCT02058628|580088185|FG000|Overall Study|Adverse Event|1|||
160646304|NCT02058628|580088186|FG001|Overall Study|Adverse Event|0|||
160646305|NCT02058628|580088185|FG000|Overall Study|Withdrawal by Subject|2|||
160646306|NCT02058628|580088186|FG001|Overall Study|Withdrawal by Subject|2|||
160646307|NCT02058628|580088185|FG000|Overall Study|Lost to Follow-up|2|||
160646308|NCT02058628|580088186|FG001|Overall Study|Lost to Follow-up|4|||
160646309|NCT02058628|580088185|FG000|Overall Study|Not in time schedule|0|||
160646310|NCT02058628|580088186|FG001|Overall Study|Not in time schedule|1|||
160646311|NCT02058628|580088185|FG000|Overall Study|The visit date was not in timeline|0|||
160646312|NCT02058628|580088186|FG001|Overall Study|The visit date was not in timeline|1|||
160646313|NCT02058628|580088185|FG000|Overall Study|A lot of time for study for participant|1|||
160646314|NCT02058628|580088186|FG001|Overall Study|A lot of time for study for participant|0|||
160646315|NCT02058628|580088185|FG000|Overall Study|Non compliance|1|||
160646316|NCT02058628|580088186|FG001|Overall Study|Non compliance|0|||
160646317|NCT02961920|580088189|FG000|Overall Study|did not achive stydy protocol schedule|1|||
160646318|NCT02961920|580088190|FG001|Overall Study|did not achive stydy protocol schedule|1|||
160646319|NCT01452529|580088191|FG000|Run-in Period|Adverse Event|96|||
160646320|NCT01452529|580088192|FG001|Run-in Period|Adverse Event|0|||
160646321|NCT01452529|580088193|FG002|Run-in Period|Adverse Event|0|||
160646322|NCT01452529|580088191|FG000|Run-in Period|Withdrawal by Subject|49|||
160646323|NCT01452529|580088192|FG001|Run-in Period|Withdrawal by Subject|0|||
160646324|NCT01452529|580088193|FG002|Run-in Period|Withdrawal by Subject|0|||
160646325|NCT01452529|580088191|FG000|Run-in Period|Lost to Follow-up|19|||
160646326|NCT01452529|580088192|FG001|Run-in Period|Lost to Follow-up|0|||
160646327|NCT01452529|580088193|FG002|Run-in Period|Lost to Follow-up|0|||
160646328|NCT01452529|580088191|FG000|Run-in Period|Lack of Efficacy|46|||
160646329|NCT01452529|580088192|FG001|Run-in Period|Lack of Efficacy|0|||
160646330|NCT01452529|580088193|FG002|Run-in Period|Lack of Efficacy|0|||
160646331|NCT01452529|580088191|FG000|Run-in Period|Confirmed or suspected diversion|23|||
160646332|NCT01452529|580088192|FG001|Run-in Period|Confirmed or suspected diversion|0|||
160646333|NCT01452529|580088193|FG002|Run-in Period|Confirmed or suspected diversion|0|||
160646334|NCT01452529|580088191|FG000|Run-in Period|Administrative|21|||
160646335|NCT01452529|580088192|FG001|Run-in Period|Administrative|0|||
160646336|NCT01452529|580088193|FG002|Run-in Period|Administrative|0|||
160646337|NCT01452529|580088191|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
160646338|NCT01452529|580088192|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
160646339|NCT01452529|580088193|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
160646340|NCT01452529|580088191|FG000|Double-blind (DB) Period|Adverse Event|0|||
160646341|NCT01452529|580088192|FG001|Double-blind (DB) Period|Adverse Event|18|||
160646342|NCT01452529|580088193|FG002|Double-blind (DB) Period|Adverse Event|11|||
160646343|NCT01452529|580088191|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
160646344|NCT01452529|580088192|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
160646345|NCT01452529|580088193|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
160646346|NCT01452529|580088191|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
160646347|NCT01452529|580088192|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
160646348|NCT01452529|580088193|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
160646349|NCT01452529|580088191|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
160646350|NCT01452529|580088192|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
160646351|NCT01452529|580088193|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
160646352|NCT01452529|580088191|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
160646353|NCT01452529|580088192|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
160646354|NCT01452529|580088193|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
160646355|NCT01452529|580088191|FG000|Double-blind (DB) Period|Administrative|0|||
160646356|NCT01452529|580088192|FG001|Double-blind (DB) Period|Administrative|11|||
160646357|NCT01452529|580088193|FG002|Double-blind (DB) Period|Administrative|7|||
160646358|NCT03551730|580088194|FG000|Overall Study|Adverse Event|1|||
160821568|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
160821569|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
160821570|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
160646359|NCT03551730|580088195|FG001|Overall Study|Adverse Event|0|||
160646360|NCT03551730|580088196|FG002|Overall Study|Adverse Event|0|||
160646361|NCT03551730|580088197|FG003|Overall Study|Adverse Event|0|||
160646362|NCT00671879|580088198|FG000|Overall Study|Withdrawal by Subject|0|||
160646363|NCT00671879|580088199|FG001|Overall Study|Withdrawal by Subject|4|||
160646364|NCT00671879|580088200|FG002|Overall Study|Withdrawal by Subject|6|||
160646365|NCT04527471|580088203|FG000|Overall Study|Adverse Event|1|||
160646366|NCT04527471|580088204|FG001|Overall Study|Adverse Event|0|||
160821571|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
160821572|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
160988908|NCT00409708|581347312|FG000|Treatment|Withdrawal by Subject|3|||
160821573|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
160646367|NCT04527471|580088203|FG000|Overall Study|Lost to Follow-up|1|||
160646368|NCT04527471|580088204|FG001|Overall Study|Lost to Follow-up|0|||
160821574|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
160821575|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
160821576|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
160821577|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
160821578|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
160821579|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
160821580|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
160821581|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
160821582|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
160821583|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
160821584|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
160821585|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Other|0|||
160821586|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Other|10|||
160821587|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Other|0|||
160821588|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Other|0|||
160821589|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
160821590|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
160821591|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
160821592|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
160821593|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
160901461|NCT00533897|581034008|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901462|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901463|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901464|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901465|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901466|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901467|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901468|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
160901469|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
160901470|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Death|0|||
160901471|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Death|0|||
160988909|NCT00409708|581347313|FG001|Treatment|Withdrawal by Subject|8|||
160988910|NCT00409708|581347312|FG000|Treatment|Lost to Follow-up|0|||
160988911|NCT00409708|581347313|FG001|Treatment|Lost to Follow-up|6|||
160988912|NCT00409708|581347312|FG000|Treatment|Administrative problems|5|||
160988913|NCT00409708|581347313|FG001|Treatment|Administrative problems|0|||
160988914|NCT00409708|581347312|FG000|Washout|Lack of Efficacy|9|||
160988915|NCT00409708|581347313|FG001|Washout|Lack of Efficacy|1|||
160553381|NCT01462266|579751191|FG001|Overall Study|Death|1|||
160553382|NCT01462266|579751190|FG000|Overall Study|Lack of Efficacy|0|||
160553383|NCT01462266|579751191|FG001|Overall Study|Lack of Efficacy|2|||
160553384|NCT01462266|579751190|FG000|Overall Study|Lost to Follow-up|4|||
160553385|NCT01462266|579751191|FG001|Overall Study|Lost to Follow-up|3|||
160553386|NCT01462266|579751190|FG000|Overall Study|Non-compliance with study drug|3|||
160553387|NCT01462266|579751191|FG001|Overall Study|Non-compliance with study drug|0|||
160553388|NCT01462266|579751190|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
160553389|NCT01462266|579751191|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
160553390|NCT01462266|579751190|FG000|Overall Study|Physician Decision|2|||
160553391|NCT01462266|579751191|FG001|Overall Study|Physician Decision|5|||
160553392|NCT01462266|579751190|FG000|Overall Study|Protocol Violation|1|||
160553393|NCT01462266|579751191|FG001|Overall Study|Protocol Violation|3|||
160553394|NCT01462266|579751190|FG000|Overall Study|Withdrawal by Subject|7|||
160553395|NCT01462266|579751191|FG001|Overall Study|Withdrawal by Subject|2|||
160553396|NCT01462266|579751190|FG000|Overall Study|Screen failure|1|||
160553397|NCT01462266|579751191|FG001|Overall Study|Screen failure|1|||
160553398|NCT01106846|579751192|FG000|Overall Study|Change in surgical procedure|0|||
160553399|NCT01106846|579751193|FG001|Overall Study|Change in surgical procedure|1|||
160553400|NCT04811716|579751195|FG000|Overall Study|Withdrawal by Subject|2|||
160553401|NCT04811716|579751196|FG001|Overall Study|Withdrawal by Subject|0|||
160553402|NCT03110900|579751197|FG000|Overall Study|Sponsor withdrew|1|||
160553403|NCT03110900|579751198|FG001|Overall Study|Sponsor withdrew|1|||
160553404|NCT02321436|579751199|FG000|Overall Study|Withdrawal by Subject|1|||
160553405|NCT02321436|579751200|FG001|Overall Study|Withdrawal by Subject|0|||
160553406|NCT02321436|579751199|FG000|Overall Study|Lost to Follow-up|0|||
160553407|NCT02321436|579751200|FG001|Overall Study|Lost to Follow-up|1|||
160553408|NCT00644787|579751201|FG000|Period 1: Titration Phase|Adverse Event|11|||
160553409|NCT00644787|579751202|FG001|Period 1: Titration Phase|Adverse Event|0|||
160553410|NCT00644787|579751203|FG002|Period 1: Titration Phase|Adverse Event|0|||
160553411|NCT00644787|579751201|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
160553412|NCT00644787|579751202|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
160821594|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
160821595|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
160553413|NCT00644787|579751203|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
160553414|NCT00644787|579751201|FG000|Period 1: Titration Phase|Physician Decision|1|||
160553415|NCT00644787|579751202|FG001|Period 1: Titration Phase|Physician Decision|0|||
160988916|NCT00409708|581347312|FG000|Washout|Protocol Violation|0|||
160988917|NCT00409708|581347313|FG001|Washout|Protocol Violation|1|||
160988918|NCT00409708|581347312|FG000|Washout|Withdrawal by Subject|11|||
160988919|NCT00409708|581347313|FG001|Washout|Withdrawal by Subject|5|||
160988920|NCT00409708|581347312|FG000|Washout|Lost to Follow-up|1|||
160988921|NCT00409708|581347313|FG001|Washout|Lost to Follow-up|3|||
160988922|NCT00946114|581347314|FG000|Overall Study|Death|5|||
160988923|NCT00946114|581347315|FG001|Overall Study|Death|2|||
160988924|NCT00946114|581347314|FG000|Overall Study|Other|1|||
160988925|NCT00946114|581347315|FG001|Overall Study|Other|0|||
160988926|NCT00946114|581347314|FG000|Overall Study|Withdrawal by Subject|2|||
160988927|NCT00946114|581347315|FG001|Overall Study|Withdrawal by Subject|0|||
160988928|NCT00723294|581347316|FG000|Overall Study|Lobular histology|2|||
160988929|NCT00723294|581347316|FG000|Overall Study|>25% intraductal component|1|||
160988930|NCT00723294|581347316|FG000|Overall Study|No MRI tumor enhancement|1|||
160988931|NCT00723294|581347316|FG000|Overall Study|1.0-Tesla MRI|1|||
160988932|NCT00723294|581347316|FG000|Overall Study|No cryoabalation|2|||
160988933|NCT00723294|581347316|FG000|Overall Study|Did not undergo surgery|1|||
160988934|NCT00723294|581347316|FG000|Overall Study|Treated prior to registration|1|||
160988935|NCT00723294|581347316|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
160988936|NCT00723294|581347316|FG000|Overall Study|Benign lesion|1|||
160988937|NCT00723294|581347316|FG000|Overall Study|Withdrawal by Subject|1|||
160988938|NCT00723294|581347316|FG000|Overall Study|No treatment due to probe failure|1|||
160988939|NCT01211665|581347317|FG000|Overall Study|Withdrawal by Subject|1|||
160988940|NCT01211665|581347318|FG001|Overall Study|Withdrawal by Subject|0|||
160988941|NCT01211665|581347317|FG000|Overall Study|Death|1|||
160988942|NCT01211665|581347318|FG001|Overall Study|Death|0|||
160988943|NCT00498186|581347321|FG000|Overall Study|Protocol Violation|10|||
160988944|NCT00498186|581347321|FG000|Overall Study|Lack of Efficacy|31|||
160988945|NCT00498186|581347321|FG000|Overall Study|Adverse Event|89|||
160988946|NCT00498186|581347321|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
160988947|NCT00498186|581347321|FG000|Overall Study|Withdrawal by Subject|18|||
160988948|NCT00498186|581347321|FG000|Overall Study|Lost to Follow-up|3|||
160988949|NCT00498186|581347321|FG000|Overall Study|Other|10|||
160988950|NCT03302156|581347322|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
160988951|NCT03302156|581347323|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
160988952|NCT03302156|581347324|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
160988953|NCT02390557|581347325|FG000|Wave 2|Survey non-respondent|72|||
160988954|NCT02390557|581347326|FG001|Wave 2|Survey non-respondent|41|||
160988955|NCT02390557|581347327|FG002|Wave 2|Survey non-respondent|23|||
160988956|NCT03635112|581347329|FG000|Overall Study|Adverse Event|5|||
160988957|NCT03635112|581347330|FG001|Overall Study|Adverse Event|9|||
160988958|NCT03635112|581347331|FG002|Overall Study|Adverse Event|14|||
160988959|NCT03635112|581347329|FG000|Overall Study|Lost to Follow-up|1|||
160988960|NCT03635112|581347330|FG001|Overall Study|Lost to Follow-up|0|||
160988961|NCT03635112|581347331|FG002|Overall Study|Lost to Follow-up|1|||
160988962|NCT03635112|581347329|FG000|Overall Study|Physician Decision|5|||
160988963|NCT03635112|581347330|FG001|Overall Study|Physician Decision|7|||
160988964|NCT03635112|581347331|FG002|Overall Study|Physician Decision|5|||
160988965|NCT03635112|581347329|FG000|Overall Study|Protocol Violation|0|||
160988966|NCT03635112|581347330|FG001|Overall Study|Protocol Violation|0|||
160988967|NCT03635112|581347331|FG002|Overall Study|Protocol Violation|1|||
160988968|NCT03635112|581347329|FG000|Overall Study|Study Terminated by Sponsor|11|||
160988969|NCT03635112|581347330|FG001|Overall Study|Study Terminated by Sponsor|17|||
160988970|NCT03635112|581347331|FG002|Overall Study|Study Terminated by Sponsor|21|||
160988971|NCT03635112|581347329|FG000|Overall Study|Withdrawal by Subject|4|||
160988972|NCT03635112|581347330|FG001|Overall Study|Withdrawal by Subject|9|||
160646369|NCT01628120|580088215|FG000|Overall Study|Withdrawal by Subject|7|||
160821596|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
160821597|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
160821598|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
160821599|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
160821600|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
160821601|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
160988973|NCT03635112|581347331|FG002|Overall Study|Withdrawal by Subject|7|||
160988974|NCT03635112|581347329|FG000|Overall Study|Miscellaneous|0|||
160988975|NCT03635112|581347330|FG001|Overall Study|Miscellaneous|0|||
160821602|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
160821603|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
160988976|NCT03635112|581347331|FG002|Overall Study|Miscellaneous|1|||
160988977|NCT03283553|581347336|FG000|Patient Participant Flow|Death|5|||
160988978|NCT03283553|581347337|FG001|Patient Participant Flow|Death|10|||
160988979|NCT03283553|581347336|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
160821604|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
160821605|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
160988980|NCT03283553|581347337|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
160988981|NCT03283553|581347336|FG000|Patient Participant Flow|Lost to Follow-up|1|||
160988982|NCT03283553|581347337|FG001|Patient Participant Flow|Lost to Follow-up|1|||
160988983|NCT03283553|581347336|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
160988984|NCT03283553|581347337|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
160988985|NCT03283553|581347336|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
160988986|NCT03283553|581347337|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
160988987|NCT03283553|581347336|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
160988988|NCT03283553|581347337|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
160988989|NCT03686683|581347338|FG000|Overall Study|Withdrawal by Subject|52|||
160988990|NCT03686683|581347339|FG001|Overall Study|Withdrawal by Subject|32|||
160988991|NCT03686683|581347338|FG000|Overall Study|Lost to Follow-up|23|||
160988992|NCT03686683|581347339|FG001|Overall Study|Lost to Follow-up|19|||
160988993|NCT03686683|581347338|FG000|Overall Study|Adverse Event|1|||
160988994|NCT03686683|581347339|FG001|Overall Study|Adverse Event|0|||
160988995|NCT03686683|581347338|FG000|Overall Study|Death|10|||
160988996|NCT03686683|581347339|FG001|Overall Study|Death|5|||
160988997|NCT03686683|581347338|FG000|Overall Study|Progressive Disease|1|||
160988998|NCT03686683|581347339|FG001|Overall Study|Progressive Disease|1|||
160988999|NCT03686683|581347338|FG000|Overall Study|Noncompliance|1|||
160989000|NCT03686683|581347339|FG001|Overall Study|Noncompliance|0|||
160989001|NCT03686683|581347338|FG000|Overall Study|Physician Decision|1|||
160989002|NCT03686683|581347339|FG001|Overall Study|Physician Decision|1|||
160989003|NCT03686683|581347338|FG000|Overall Study|Screen fail post-randomization|1|||
160989004|NCT03686683|581347339|FG001|Overall Study|Screen fail post-randomization|0|||
160989005|NCT03686683|581347338|FG000|Overall Study|Protocol Violation|3|||
160989006|NCT03686683|581347339|FG001|Overall Study|Protocol Violation|0|||
160989007|NCT03686683|581347338|FG000|Overall Study|No data available|1|||
160989008|NCT03686683|581347339|FG001|Overall Study|No data available|0|||
160989009|NCT01770860|581347340|FG000|Overall Study|Withdrawal by Subject|4|||
160989010|NCT01770860|581347340|FG000|Overall Study|Lost to Follow-up|1|||
160989011|NCT01770860|581347340|FG000|Overall Study|Administrative decision made by the PI|1|||
160989012|NCT05124899|581347341|FG000|Overall Study|Lost to Follow-up|3|||
160989013|NCT03432533|581347346|FG000|Overall Study|Lost to Follow-up|1|||
160989014|NCT03432533|581347347|FG001|Overall Study|Lost to Follow-up|2|||
160989015|NCT03432533|581347346|FG000|Overall Study|Withdrawal by Subject|14|||
160989016|NCT03432533|581347347|FG001|Overall Study|Withdrawal by Subject|9|||
160553416|NCT00644787|579751203|FG002|Period 1: Titration Phase|Physician Decision|0|||
160553417|NCT00644787|579751201|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
160553418|NCT00644787|579751202|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
160553419|NCT00644787|579751203|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
160553420|NCT00644787|579751201|FG000|Period 1: Titration Phase|Worsening of complications|1|||
160553421|NCT00644787|579751202|FG001|Period 1: Titration Phase|Worsening of complications|0|||
160553422|NCT00644787|579751203|FG002|Period 1: Titration Phase|Worsening of complications|0|||
160553423|NCT00644787|579751201|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
160553424|NCT00644787|579751202|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
160553425|NCT00644787|579751203|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
160553426|NCT00644787|579751201|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
160553427|NCT00644787|579751202|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
160553428|NCT00644787|579751203|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
160553429|NCT00644787|579751201|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
160553430|NCT00644787|579751202|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
160553431|NCT00644787|579751203|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
160553432|NCT00644787|579751201|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
160553433|NCT00644787|579751202|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
160553434|NCT00644787|579751203|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
160553435|NCT00644787|579751201|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
160553436|NCT00644787|579751202|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
160553437|NCT00644787|579751203|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
160553438|NCT00644787|579751201|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
160821606|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
160821607|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
160821608|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
160821609|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Other|0|||
160821610|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Other|0|||
160821611|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Other|9|||
160821612|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Other|2|||
160821613|NCT00322023|580733641|FG000|Overall Study|various|0|||
160821614|NCT00322023|580733642|FG001|Overall Study|various|2|||
160989017|NCT01648283|581347348|FG000|Overall Study|Withdrawal by Subject|14|||
160821615|NCT00322023|580733643|FG002|Overall Study|various|6|||
160821616|NCT03334851|580733644|FG000|Overall Study|Other|0|||
160821617|NCT03334851|580733645|FG001|Overall Study|Other|0|||
160989018|NCT00945477|581347349|FG000|Overall Study|Adverse Event|3|||
160989019|NCT00945477|581347349|FG000|Overall Study|Lack of Efficacy|2|||
160989020|NCT00945477|581347349|FG000|Overall Study|Withdrawal by Subject|1|||
160989021|NCT00797225|581347356|FG000|Weeks 1 to 12|Adverse Event|0|||
160821618|NCT03334851|580733646|FG002|Overall Study|Other|0|||
160821619|NCT03334851|580733647|FG003|Overall Study|Other|0|||
160821620|NCT03334851|580733648|FG004|Overall Study|Other|0|||
160821621|NCT03334851|580733649|FG005|Overall Study|Other|0|||
160821622|NCT03334851|580733650|FG006|Overall Study|Other|0|||
160821623|NCT03334851|580733651|FG007|Overall Study|Other|1|||
160821624|NCT03334851|580733652|FG008|Overall Study|Other|0|||
160821625|NCT03334851|580733653|FG009|Overall Study|Other|0|||
160821626|NCT03334851|580733654|FG010|Overall Study|Other|0|||
160821627|NCT03334851|580733655|FG011|Overall Study|Other|0|||
160821628|NCT03334851|580733656|FG012|Overall Study|Other|0|||
160821629|NCT03334851|580733644|FG000|Overall Study|Adverse Event|0|||
160821630|NCT03334851|580733645|FG001|Overall Study|Adverse Event|0|||
160821631|NCT03334851|580733646|FG002|Overall Study|Adverse Event|0|||
160821632|NCT03334851|580733647|FG003|Overall Study|Adverse Event|0|||
160821633|NCT03334851|580733648|FG004|Overall Study|Adverse Event|0|||
160821634|NCT03334851|580733649|FG005|Overall Study|Adverse Event|0|||
160646370|NCT01628120|580088215|FG000|Overall Study|Adverse Event|12|||
160646371|NCT01628120|580088215|FG000|Overall Study|Lost to Follow-up|1|||
160646372|NCT01628120|580088215|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
160646373|NCT01628120|580088215|FG000|Overall Study|Non-compliant with Study Procedures|1|||
160646374|NCT01628120|580088215|FG000|Overall Study|Not Treated|3|||
160646375|NCT01628120|580088215|FG000|Overall Study|Sponsor Decision|5|||
160646376|NCT01628120|580088215|FG000|Overall Study|Switched Dialysis Method|2|||
160646377|NCT01628120|580088215|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
160646378|NCT01628120|580088215|FG000|Overall Study|Moved or Relocated|5|||
160646379|NCT01628120|580088215|FG000|Overall Study|Kidney Transplant|2|||
160646380|NCT01628120|580088215|FG000|Overall Study|Use of Standard of Care|1|||
160646381|NCT01165996|580088216|FG000|Overall Study|Death|1|||
160646382|NCT01165996|580088216|FG000|Overall Study|Physician Decision|1|||
160646383|NCT00096265|580088217|FG000|Overall Study|Ineligible|1|||
160646384|NCT00096265|580088218|FG001|Overall Study|Ineligible|0|||
160646385|NCT00096265|580088219|FG002|Overall Study|Ineligible|0|||
160646386|NCT01506323|580088220|FG000|Overall Study|Lost to Follow-up|5|||
160646387|NCT01506323|580088221|FG001|Overall Study|Lost to Follow-up|4|||
160646388|NCT01506323|580088220|FG000|Overall Study|Withdrawal by Subject|4|||
160646389|NCT01506323|580088221|FG001|Overall Study|Withdrawal by Subject|4|||
160646390|NCT01506323|580088220|FG000|Overall Study|Lack of Efficacy|1|||
160646391|NCT01506323|580088221|FG001|Overall Study|Lack of Efficacy|3|||
160646392|NCT01506323|580088220|FG000|Overall Study|Moved out of area|5|||
160646393|NCT01506323|580088221|FG001|Overall Study|Moved out of area|2|||
160646394|NCT01506323|580088220|FG000|Overall Study|Schedule or Transportation conflict|8|||
160646395|NCT01506323|580088221|FG001|Overall Study|Schedule or Transportation conflict|0|||
160646396|NCT01506323|580088220|FG000|Overall Study|Started another treatment|1|||
160646397|NCT01506323|580088221|FG001|Overall Study|Started another treatment|0|||
160646398|NCT02232074|580088224|FG000|Overall Study|Withdrawal by Subject|5|||
160646399|NCT02232074|580088225|FG001|Overall Study|Withdrawal by Subject|3|||
160646400|NCT02232074|580088224|FG000|Overall Study|No legal concerns at baseline|36|||
160646401|NCT02232074|580088225|FG001|Overall Study|No legal concerns at baseline|41|||
160646402|NCT02232074|580088224|FG000|Overall Study|deemed ineligible|0|||
160646403|NCT02232074|580088225|FG001|Overall Study|deemed ineligible|1|||
160646404|NCT01927757|580088226|FG000|Overall Study|Withdrawal by Subject|14|||
160646405|NCT01927757|580088226|FG000|Overall Study|Lost to Follow-up|2|||
160646406|NCT01927757|580088226|FG000|Overall Study|Decision by Sponsor|2|||
160646407|NCT01927757|580088226|FG000|Overall Study|Other|1|||
160646408|NCT01927757|580088226|FG000|Overall Study|Ethical Reasons|4|||
160821635|NCT03334851|580733650|FG006|Overall Study|Adverse Event|0|||
160821636|NCT03334851|580733651|FG007|Overall Study|Adverse Event|1|||
160821637|NCT03334851|580733652|FG008|Overall Study|Adverse Event|0|||
160821638|NCT03334851|580733653|FG009|Overall Study|Adverse Event|0|||
160646409|NCT00444795|580088228|FG000|Overall Study|Not Treated|1|||
160646410|NCT00444795|580088228|FG000|Overall Study|Treated Prior to the Contract Date|2|||
160646411|NCT00988169|580088229|FG000|Overall Study|Withdrawal by Subject|1|||
160646412|NCT00704418|580088230|FG000|Overall Study|Withdrawal by Subject|2|||
160646413|NCT00704418|580088231|FG001|Overall Study|Withdrawal by Subject|0|||
160646414|NCT00704418|580088230|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
160646415|NCT00704418|580088231|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
160646416|NCT02637076|580088232|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
160821639|NCT03334851|580733654|FG010|Overall Study|Adverse Event|0|||
160821640|NCT03334851|580733655|FG011|Overall Study|Adverse Event|0|||
160821641|NCT03334851|580733656|FG012|Overall Study|Adverse Event|0|||
160821642|NCT03334851|580733644|FG000|Overall Study|Withdrawal by Subject|0|||
160653393|NCT05665595|580112378|FG001|Overall Study|Withdrawal by Subject|2|||
160821643|NCT03334851|580733645|FG001|Overall Study|Withdrawal by Subject|0|||
160821644|NCT03334851|580733646|FG002|Overall Study|Withdrawal by Subject|0|||
160821645|NCT03334851|580733647|FG003|Overall Study|Withdrawal by Subject|0|||
160821646|NCT03334851|580733648|FG004|Overall Study|Withdrawal by Subject|0|||
160821647|NCT03334851|580733649|FG005|Overall Study|Withdrawal by Subject|0|||
160821648|NCT03334851|580733650|FG006|Overall Study|Withdrawal by Subject|0|||
160821649|NCT03334851|580733651|FG007|Overall Study|Withdrawal by Subject|0|||
160821650|NCT03334851|580733652|FG008|Overall Study|Withdrawal by Subject|0|||
160821651|NCT03334851|580733653|FG009|Overall Study|Withdrawal by Subject|0|||
160821652|NCT03334851|580733654|FG010|Overall Study|Withdrawal by Subject|1|||
160821653|NCT03334851|580733655|FG011|Overall Study|Withdrawal by Subject|0|||
160821654|NCT03334851|580733656|FG012|Overall Study|Withdrawal by Subject|1|||
160821655|NCT03334851|580733644|FG000|Overall Study|Lost to Follow-up|0|||
160821656|NCT03334851|580733645|FG001|Overall Study|Lost to Follow-up|0|||
160821657|NCT03334851|580733646|FG002|Overall Study|Lost to Follow-up|0|||
160821658|NCT03334851|580733647|FG003|Overall Study|Lost to Follow-up|0|||
160821659|NCT03334851|580733648|FG004|Overall Study|Lost to Follow-up|0|||
160821660|NCT03334851|580733649|FG005|Overall Study|Lost to Follow-up|0|||
160821661|NCT03334851|580733650|FG006|Overall Study|Lost to Follow-up|0|||
160821662|NCT03334851|580733651|FG007|Overall Study|Lost to Follow-up|0|||
160821663|NCT03334851|580733652|FG008|Overall Study|Lost to Follow-up|0|||
160821664|NCT03334851|580733653|FG009|Overall Study|Lost to Follow-up|0|||
160821665|NCT03334851|580733654|FG010|Overall Study|Lost to Follow-up|2|||
160821666|NCT03334851|580733655|FG011|Overall Study|Lost to Follow-up|1|||
160821667|NCT03334851|580733656|FG012|Overall Study|Lost to Follow-up|0|||
160821668|NCT03327220|580733657|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
160821669|NCT03327220|580733658|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
160821670|NCT03327220|580733657|FG000|Overall Study|Investigator Decision|2|||
160821671|NCT03327220|580733658|FG001|Overall Study|Investigator Decision|0|||
160821672|NCT03327220|580733657|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
160821673|NCT03327220|580733658|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
160821674|NCT03327220|580733657|FG000|Overall Study|Fungal infection|1|||
160821675|NCT03327220|580733658|FG001|Overall Study|Fungal infection|0|||
160821676|NCT03327220|580733657|FG000|Overall Study|Discharged to Rehabilitation|0|||
160821677|NCT03327220|580733658|FG001|Overall Study|Discharged to Rehabilitation|1|||
160821678|NCT03327220|580733657|FG000|Overall Study|Missing|1|||
160821679|NCT03327220|580733658|FG001|Overall Study|Missing|0|||
160821680|NCT03920293|580733659|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
160821681|NCT03920293|580733660|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
160821682|NCT03920293|580733659|FG000|Randomized-Controlled Period|Physician Decision|1|||
160821683|NCT03920293|580733660|FG001|Randomized-Controlled Period|Physician Decision|2|||
160821684|NCT03920293|580733659|FG000|Randomized-Controlled Period|Adverse Event|0|||
160821685|NCT03920293|580733660|FG001|Randomized-Controlled Period|Adverse Event|2|||
160821686|NCT03920293|580733659|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
160821687|NCT03920293|580733660|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
160821688|NCT03920293|580733659|FG000|Randomized-Controlled Period|Death|2|||
160821689|NCT03920293|580733660|FG001|Randomized-Controlled Period|Death|0|||
160821690|NCT03920293|580733659|FG000|Randomized-Controlled Period|Protocol Violation|1|||
160821691|NCT03920293|580733660|FG001|Randomized-Controlled Period|Protocol Violation|0|||
160821692|NCT03920293|580733659|FG000|Randomized-Controlled Period|Noncompliance|1|||
160821693|NCT03920293|580733660|FG001|Randomized-Controlled Period|Noncompliance|0|||
160553439|NCT00644787|579751202|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
160553440|NCT00644787|579751203|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
160553441|NCT00644787|579751201|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
160553442|NCT00644787|579751202|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
160553443|NCT00644787|579751203|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
160553444|NCT03355300|579751204|FG000|Overall Study|Physician Decision|0|||
160553445|NCT03355300|579751205|FG001|Overall Study|Physician Decision|1|||
160553446|NCT03355300|579751204|FG000|Overall Study|Lack of Efficacy|2|||
160553447|NCT03355300|579751205|FG001|Overall Study|Lack of Efficacy|1|||
160553448|NCT03355300|579751204|FG000|Overall Study|Other reason|1|||
160553449|NCT03355300|579751205|FG001|Overall Study|Other reason|0|||
160553450|NCT00546052|579751208|FG000|Overall Study|Adverse Event|47|||
160553451|NCT00546052|579751208|FG000|Overall Study|Lost to Follow-up|144|||
160553452|NCT00546052|579751208|FG000|Overall Study|Protocol Violation|9|||
160553453|NCT00546052|579751208|FG000|Overall Study|Withdrawal by Subject|20|||
160553454|NCT00546052|579751208|FG000|Overall Study|Non Compliance|7|||
160553455|NCT01602341|579753415|FG000|Overall Study|Adverse Event|0|||
160553456|NCT01602341|579753416|FG001|Overall Study|Adverse Event|1|||
160553457|NCT00483327|579753417|FG000|Overall Study|Adverse Event|1|||
160553458|NCT00483327|579753417|FG000|Overall Study|Withdrawal by Subject|3|||
160553459|NCT00483327|579753417|FG000|Overall Study|Lost to Follow-up|4|||
160553460|NCT00483327|579753417|FG000|Overall Study|Patient Non Compliance|2|||
160553461|NCT00925600|579753418|FG000|Overall Study|Withdrawal by Subject|16|||
160553462|NCT00925600|579753419|FG001|Overall Study|Withdrawal by Subject|14|||
160553463|NCT00925600|579753418|FG000|Overall Study|Death|4|||
160553464|NCT00925600|579753419|FG001|Overall Study|Death|3|||
160553465|NCT00925600|579753418|FG000|Overall Study|Lost to Follow-up|2|||
160553466|NCT00925600|579753419|FG001|Overall Study|Lost to Follow-up|2|||
160553467|NCT00925600|579753418|FG000|Overall Study|Disease Progression|1|||
160553468|NCT00925600|579753419|FG001|Overall Study|Disease Progression|3|||
160553469|NCT00925600|579753418|FG000|Overall Study|Administrative Decision|1|||
160553470|NCT00925600|579753419|FG001|Overall Study|Administrative Decision|1|||
160553471|NCT00925600|579753418|FG000|Overall Study|Noncompliance|2|||
160553472|NCT00925600|579753419|FG001|Overall Study|Noncompliance|0|||
160553473|NCT00925600|579753418|FG000|Overall Study|Ineligibility Determined|2|||
160553474|NCT00925600|579753419|FG001|Overall Study|Ineligibility Determined|0|||
160553475|NCT00925600|579753418|FG000|Overall Study|Protocol Deviation|0|||
160553476|NCT00925600|579753419|FG001|Overall Study|Protocol Deviation|1|||
160553477|NCT00925600|579753418|FG000|Overall Study|Requirement for Alternative Therapy|0|||
160553478|NCT00925600|579753419|FG001|Overall Study|Requirement for Alternative Therapy|1|||
160553479|NCT00925600|579753418|FG000|Overall Study|Other|3|||
160553480|NCT00925600|579753419|FG001|Overall Study|Other|1|||
160653394|NCT05665595|580112377|FG000|Overall Study|Lost to Follow-up|1|||
160821694|NCT03920293|580733659|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
160821695|NCT03920293|580733660|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
160901472|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Death|0|||
160901473|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Death|0|||
160901474|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Death|0|||
160901475|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Death|0|||
160901476|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Death|1|||
160901477|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Death|3|||
160901478|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901479|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901480|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901481|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901482|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901483|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901484|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
160901485|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
160901486|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160553481|NCT00925600|579753418|FG000|Overall Study|Adverse Event|1|||
160553482|NCT00925600|579753419|FG001|Overall Study|Adverse Event|2|||
160901487|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160901488|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160553483|NCT01430442|579753422|FG000|Overall Study|Subject Withdrew Consent|3|||
160553484|NCT01430442|579753423|FG001|Overall Study|Subject Withdrew Consent|0|||
160989022|NCT00797225|581347357|FG001|Weeks 1 to 12|Adverse Event|0|||
160989023|NCT00797225|581347358|FG002|Weeks 1 to 12|Adverse Event|1|||
160989024|NCT00797225|581347359|FG003|Weeks 1 to 12|Adverse Event|0|||
160989025|NCT00797225|581347360|FG004|Weeks 1 to 12|Adverse Event|0|||
160989026|NCT00797225|581347361|FG005|Weeks 1 to 12|Adverse Event|0|||
160989027|NCT00797225|581347362|FG006|Weeks 1 to 12|Adverse Event|0|||
160989028|NCT00797225|581347363|FG007|Weeks 1 to 12|Adverse Event|0|||
160989029|NCT00797225|581347356|FG000|Weeks 1 to 12|Non-compliance|0|||
160989030|NCT00797225|581347357|FG001|Weeks 1 to 12|Non-compliance|1|||
160989031|NCT00797225|581347358|FG002|Weeks 1 to 12|Non-compliance|0|||
160989032|NCT00797225|581347359|FG003|Weeks 1 to 12|Non-compliance|0|||
160989033|NCT00797225|581347360|FG004|Weeks 1 to 12|Non-compliance|0|||
160989034|NCT00797225|581347361|FG005|Weeks 1 to 12|Non-compliance|0|||
160989035|NCT00797225|581347362|FG006|Weeks 1 to 12|Non-compliance|0|||
160989036|NCT00797225|581347363|FG007|Weeks 1 to 12|Non-compliance|0|||
160989037|NCT00797225|581347356|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
160989038|NCT00797225|581347357|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
160989039|NCT00797225|581347358|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
160989040|NCT00797225|581347359|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
160989041|NCT00797225|581347360|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
160989042|NCT00797225|581347361|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
160989043|NCT00797225|581347362|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
160989044|NCT00797225|581347363|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
160989045|NCT00797225|581347356|FG000|Weeks 1 to 12|Sponsor Decision|1|||
160989046|NCT00797225|581347357|FG001|Weeks 1 to 12|Sponsor Decision|0|||
160989047|NCT00797225|581347358|FG002|Weeks 1 to 12|Sponsor Decision|0|||
160989048|NCT00797225|581347359|FG003|Weeks 1 to 12|Sponsor Decision|0|||
160989049|NCT00797225|581347360|FG004|Weeks 1 to 12|Sponsor Decision|0|||
160989050|NCT00797225|581347361|FG005|Weeks 1 to 12|Sponsor Decision|0|||
160989051|NCT00797225|581347362|FG006|Weeks 1 to 12|Sponsor Decision|0|||
160989052|NCT00797225|581347363|FG007|Weeks 1 to 12|Sponsor Decision|0|||
160989053|NCT00797225|581347356|FG000|Weeks 13 to 24|Non-compliance|0|||
160989054|NCT00797225|581347357|FG001|Weeks 13 to 24|Non-compliance|2|||
160989055|NCT00797225|581347358|FG002|Weeks 13 to 24|Non-compliance|0|||
160989056|NCT00797225|581347359|FG003|Weeks 13 to 24|Non-compliance|0|||
160989057|NCT00797225|581347360|FG004|Weeks 13 to 24|Non-compliance|0|||
160989058|NCT00797225|581347361|FG005|Weeks 13 to 24|Non-compliance|0|||
160989059|NCT00797225|581347362|FG006|Weeks 13 to 24|Non-compliance|0|||
160989060|NCT00797225|581347363|FG007|Weeks 13 to 24|Non-compliance|0|||
160989061|NCT00797225|581347356|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
160989062|NCT00797225|581347357|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
160989063|NCT00797225|581347358|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
160989064|NCT00797225|581347359|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
160989065|NCT00797225|581347360|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
160989066|NCT00797225|581347361|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
160989067|NCT00797225|581347362|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
160989068|NCT00797225|581347363|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
160989069|NCT00797225|581347356|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
160989070|NCT00797225|581347357|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
160989071|NCT00797225|581347358|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
160989072|NCT00797225|581347359|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
160989073|NCT00797225|581347360|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
160989074|NCT00797225|581347361|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
160989075|NCT00797225|581347362|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
160989076|NCT00797225|581347363|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
160989077|NCT00797225|581347356|FG000|Weeks 13 to 24|Adverse Event|0|||
160989078|NCT00797225|581347357|FG001|Weeks 13 to 24|Adverse Event|1|||
160989079|NCT00797225|581347358|FG002|Weeks 13 to 24|Adverse Event|0|||
160989080|NCT00797225|581347359|FG003|Weeks 13 to 24|Adverse Event|0|||
160989081|NCT00797225|581347360|FG004|Weeks 13 to 24|Adverse Event|0|||
160989082|NCT00797225|581347361|FG005|Weeks 13 to 24|Adverse Event|0|||
160989083|NCT00797225|581347362|FG006|Weeks 13 to 24|Adverse Event|1|||
160989084|NCT00797225|581347363|FG007|Weeks 13 to 24|Adverse Event|0|||
160989085|NCT00797225|581347356|FG000|Weeks 13 to 24|Sponsor Decision|0|||
160989086|NCT00797225|581347357|FG001|Weeks 13 to 24|Sponsor Decision|0|||
160989087|NCT00797225|581347358|FG002|Weeks 13 to 24|Sponsor Decision|0|||
160989088|NCT00797225|581347359|FG003|Weeks 13 to 24|Sponsor Decision|0|||
160989089|NCT00797225|581347360|FG004|Weeks 13 to 24|Sponsor Decision|0|||
160989090|NCT00797225|581347361|FG005|Weeks 13 to 24|Sponsor Decision|0|||
160989091|NCT00797225|581347362|FG006|Weeks 13 to 24|Sponsor Decision|1|||
160989092|NCT00797225|581347363|FG007|Weeks 13 to 24|Sponsor Decision|0|||
160989093|NCT01072929|581347369|FG000|Overall Study|Adverse Event|8|||
160989094|NCT01072929|581347370|FG001|Overall Study|Adverse Event|11|||
160989095|NCT01072929|581347371|FG002|Overall Study|Adverse Event|2|||
160989096|NCT01072929|581347369|FG000|Overall Study|Lack of Efficacy|7|||
160989097|NCT01072929|581347370|FG001|Overall Study|Lack of Efficacy|4|||
160989098|NCT01072929|581347371|FG002|Overall Study|Lack of Efficacy|0|||
160989099|NCT01072929|581347369|FG000|Overall Study|Withdrawal by Subject|7|||
160989100|NCT01072929|581347370|FG001|Overall Study|Withdrawal by Subject|15|||
160989101|NCT01072929|581347371|FG002|Overall Study|Withdrawal by Subject|3|||
160989102|NCT01072929|581347369|FG000|Overall Study|Protocol Violation|13|||
160989103|NCT01072929|581347370|FG001|Overall Study|Protocol Violation|11|||
160989104|NCT01072929|581347371|FG002|Overall Study|Protocol Violation|2|||
160989105|NCT01072929|581347369|FG000|Overall Study|Lost to Follow-up|8|||
160989106|NCT01072929|581347370|FG001|Overall Study|Lost to Follow-up|4|||
160989107|NCT01072929|581347371|FG002|Overall Study|Lost to Follow-up|1|||
160989108|NCT01072929|581347369|FG000|Overall Study|Noncompliance with study medication|0|||
160646417|NCT02637076|580088233|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
160989109|NCT01072929|581347370|FG001|Overall Study|Noncompliance with study medication|3|||
160989110|NCT01072929|581347371|FG002|Overall Study|Noncompliance with study medication|0|||
160989111|NCT01072929|581347369|FG000|Overall Study|Noncompliance with study procedures|1|||
160989112|NCT01072929|581347370|FG001|Overall Study|Noncompliance with study procedures|0|||
160989113|NCT01072929|581347371|FG002|Overall Study|Noncompliance with study procedures|1|||
160989114|NCT01072929|581347369|FG000|Overall Study|Other|0|||
160989115|NCT01072929|581347370|FG001|Overall Study|Other|3|||
160989116|NCT01072929|581347371|FG002|Overall Study|Other|0|||
160989117|NCT04833855|581347372|FG000|Overall Study|Decision by sponsor|0|||
160989118|NCT04833855|581347373|FG001|Overall Study|Decision by sponsor|1|||
160989119|NCT04833855|581347374|FG002|Overall Study|Decision by sponsor|0|||
160989120|NCT04833855|581347375|FG003|Overall Study|Decision by sponsor|0|||
160989121|NCT04833855|581347372|FG000|Overall Study|Withdrawal by Subject|4|||
160989122|NCT04833855|581347373|FG001|Overall Study|Withdrawal by Subject|1|||
160989123|NCT04833855|581347374|FG002|Overall Study|Withdrawal by Subject|3|||
160989124|NCT04833855|581347375|FG003|Overall Study|Withdrawal by Subject|1|||
160989125|NCT04833855|581347372|FG000|Overall Study|Lost to Follow-up|1|||
160989126|NCT04833855|581347373|FG001|Overall Study|Lost to Follow-up|0|||
160989127|NCT04833855|581347374|FG002|Overall Study|Lost to Follow-up|2|||
160989128|NCT04833855|581347375|FG003|Overall Study|Lost to Follow-up|2|||
160989129|NCT04833855|581347372|FG000|Overall Study|Protocol specified criteria|0|||
160989130|NCT04833855|581347373|FG001|Overall Study|Protocol specified criteria|0|||
160989131|NCT04833855|581347374|FG002|Overall Study|Protocol specified criteria|2|||
160989132|NCT04833855|581347375|FG003|Overall Study|Protocol specified criteria|1|||
160989133|NCT02322775|581347378|FG000|Overall Study|Adverse Event|1|||
160989134|NCT02322775|581347379|FG001|Overall Study|Adverse Event|0|||
160989135|NCT02322775|581347378|FG000|Overall Study|Lost to Follow-up|0|||
160989136|NCT02322775|581347379|FG001|Overall Study|Lost to Follow-up|1|||
160989137|NCT02322775|581347378|FG000|Overall Study|Protocol Violation|1|||
160989138|NCT02322775|581347379|FG001|Overall Study|Protocol Violation|0|||
160989139|NCT02322775|581347378|FG000|Overall Study|Withdrawal by Subject|3|||
160989140|NCT02322775|581347379|FG001|Overall Study|Withdrawal by Subject|4|||
160989141|NCT02322775|581347378|FG000|Overall Study|Not willing to perform all FU visits|0|||
160989142|NCT02322775|581347379|FG001|Overall Study|Not willing to perform all FU visits|1|||
160989143|NCT04739423|581347380|FG000|Overall Study|Protocol Violation|0|||
160989144|NCT04739423|581347381|FG001|Overall Study|Protocol Violation|1|||
160989145|NCT04739423|581347382|FG002|Overall Study|Protocol Violation|0|||
160989146|NCT04739423|581347383|FG003|Overall Study|Protocol Violation|0|||
160989147|NCT04739423|581347384|FG004|Overall Study|Protocol Violation|0|||
160989148|NCT04739423|581347385|FG005|Overall Study|Protocol Violation|0|||
160989149|NCT04739423|581347380|FG000|Overall Study|Adverse Event|0|||
160989150|NCT04739423|581347381|FG001|Overall Study|Adverse Event|0|||
160989151|NCT04739423|581347382|FG002|Overall Study|Adverse Event|1|||
160989152|NCT04739423|581347383|FG003|Overall Study|Adverse Event|0|||
160454064|NCT02038777|579394022|FG000|Overall Study|Started Chemotherapy|1|||
160989153|NCT04739423|581347384|FG004|Overall Study|Adverse Event|1|||
160989154|NCT04739423|581347385|FG005|Overall Study|Adverse Event|0|||
160989155|NCT04739423|581347380|FG000|Overall Study|Withdrawal by Subject|0|||
160989156|NCT04739423|581347381|FG001|Overall Study|Withdrawal by Subject|0|||
160989157|NCT04739423|581347382|FG002|Overall Study|Withdrawal by Subject|0|||
160989158|NCT04739423|581347383|FG003|Overall Study|Withdrawal by Subject|0|||
160989159|NCT04739423|581347384|FG004|Overall Study|Withdrawal by Subject|0|||
160989160|NCT04739423|581347385|FG005|Overall Study|Withdrawal by Subject|1|||
160989161|NCT01007552|581347386|FG000|Overall Study|Withdrawal by Subject|1|||
160989162|NCT03212365|581347396|FG000|Overall Study|Discharged prior to Xa level|12|||
160989163|NCT03212365|581347397|FG001|Overall Study|Discharged prior to Xa level|8|||
160989164|NCT03212365|581347396|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
160989165|NCT03212365|581347397|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
160901489|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160989166|NCT03212365|581347396|FG000|Overall Study|Refused study medication|3|||
160989167|NCT03212365|581347397|FG001|Overall Study|Refused study medication|0|||
160989168|NCT03212365|581347396|FG000|Overall Study|Initiated heparin infusion on floor|1|||
160989169|NCT03212365|581347397|FG001|Overall Study|Initiated heparin infusion on floor|1|||
160989170|NCT03212365|581347396|FG000|Overall Study|Unexpected return to OR|1|||
160989171|NCT03212365|581347397|FG001|Overall Study|Unexpected return to OR|1|||
160989172|NCT03212365|581347396|FG000|Overall Study|Medication distribution error|1|||
160989173|NCT03212365|581347397|FG001|Overall Study|Medication distribution error|0|||
160989174|NCT03212365|581347396|FG000|Overall Study|Required epidural placement|1|||
160989175|NCT03212365|581347397|FG001|Overall Study|Required epidural placement|0|||
160989176|NCT03212365|581347396|FG000|Overall Study|Withdrawal by Subject|0|||
160989177|NCT03212365|581347397|FG001|Overall Study|Withdrawal by Subject|1|||
160989178|NCT03212365|581347396|FG000|Overall Study|developed acute renal failure|0|||
160989179|NCT03212365|581347397|FG001|Overall Study|developed acute renal failure|1|||
160989180|NCT00333138|581347398|FG000|Core Study (6 Months)|Adverse Event|4|||
160989181|NCT00333138|581347399|FG001|Core Study (6 Months)|Adverse Event|5|||
160989182|NCT00333138|581347400|FG002|Core Study (6 Months)|Adverse Event|8|||
160989183|NCT00333138|581347398|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
160989184|NCT00333138|581347399|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
160989185|NCT00333138|581347400|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
160989186|NCT00333138|581347398|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
160989187|NCT00333138|581347399|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
160989188|NCT00333138|581347400|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
160989189|NCT00333138|581347398|FG000|Core Study (6 Months)|Protocol Violation|1|||
160901490|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160901491|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160901492|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
160901493|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160901494|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Adverse Event|0|||
160989190|NCT00333138|581347399|FG001|Core Study (6 Months)|Protocol Violation|0|||
160989191|NCT00333138|581347400|FG002|Core Study (6 Months)|Protocol Violation|1|||
160989192|NCT00333138|581347398|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
160989193|NCT00333138|581347399|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
160989194|NCT00333138|581347400|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
160989195|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
160989196|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
160989197|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
160901495|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Adverse Event|0|||
160901496|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Adverse Event|0|||
160901497|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Adverse Event|0|||
160901498|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Adverse Event|0|||
160901499|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Adverse Event|0|||
160901500|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Adverse Event|2|||
160901501|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Adverse Event|5|||
160901502|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Pregnancy|0|||
160901503|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Pregnancy|0|||
160901504|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Pregnancy|0|||
160901505|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Pregnancy|0|||
160901506|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Pregnancy|0|||
160901507|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Pregnancy|0|||
160901508|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Pregnancy|0|||
160901509|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Pregnancy|2|||
160901510|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
160901511|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
160901512|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
160989198|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
160989199|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
160989200|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
160989201|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
160989202|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
160901513|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
160901514|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
160901515|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
160901516|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
160989203|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
160553485|NCT01430442|579753424|FG002|Overall Study|Subject Withdrew Consent|1|||
160553486|NCT01430442|579753425|FG003|Overall Study|Subject Withdrew Consent|0|||
160553487|NCT01430442|579753426|FG004|Overall Study|Subject Withdrew Consent|2|||
160553488|NCT01430442|579753427|FG005|Overall Study|Subject Withdrew Consent|1|||
160553489|NCT01430442|579753428|FG006|Overall Study|Subject Withdrew Consent|5|||
160553490|NCT01430442|579753429|FG007|Overall Study|Subject Withdrew Consent|2|||
160553491|NCT01430442|579753422|FG000|Overall Study|Lost to Follow-up|2|||
160553492|NCT01430442|579753423|FG001|Overall Study|Lost to Follow-up|0|||
160553493|NCT01430442|579753424|FG002|Overall Study|Lost to Follow-up|1|||
160553494|NCT01430442|579753425|FG003|Overall Study|Lost to Follow-up|2|||
160553495|NCT01430442|579753426|FG004|Overall Study|Lost to Follow-up|2|||
160553496|NCT01430442|579753427|FG005|Overall Study|Lost to Follow-up|1|||
160553497|NCT01430442|579753428|FG006|Overall Study|Lost to Follow-up|5|||
160553498|NCT01430442|579753429|FG007|Overall Study|Lost to Follow-up|1|||
160553499|NCT01430442|579753422|FG000|Overall Study|Pregnancy|1|||
160553500|NCT01430442|579753423|FG001|Overall Study|Pregnancy|0|||
160821696|NCT03920293|580733659|FG000|Open- Label Extension Period|Death|3|||
160821697|NCT03920293|580733660|FG001|Open- Label Extension Period|Death|3|||
160821698|NCT03920293|580733659|FG000|Open- Label Extension Period|Physician Decision|5|||
160821699|NCT03920293|580733660|FG001|Open- Label Extension Period|Physician Decision|3|||
160821700|NCT03920293|580733659|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
160821701|NCT03920293|580733660|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
160821702|NCT00523705|580733661|FG000|Overall Study|No time for study.|0|||
160821703|NCT00523705|580733662|FG001|Overall Study|No time for study.|1|||
160821704|NCT00693017|580733663|FG000|Overall Study|Sponsor Decision|2|||
160821705|NCT00693017|580733664|FG001|Overall Study|Sponsor Decision|1|||
160821706|NCT00693017|580733663|FG000|Overall Study|Death|0|||
160821707|NCT00693017|580733664|FG001|Overall Study|Death|1|||
160553501|NCT01430442|579753424|FG002|Overall Study|Pregnancy|0|||
160553502|NCT01430442|579753425|FG003|Overall Study|Pregnancy|0|||
160553503|NCT01430442|579753426|FG004|Overall Study|Pregnancy|0|||
160553504|NCT01430442|579753427|FG005|Overall Study|Pregnancy|1|||
160553505|NCT01430442|579753428|FG006|Overall Study|Pregnancy|0|||
160553506|NCT01430442|579753429|FG007|Overall Study|Pregnancy|0|||
160553507|NCT01430442|579753422|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
160553508|NCT01430442|579753423|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
160553509|NCT01430442|579753424|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
160553510|NCT01430442|579753425|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
160553511|NCT01430442|579753426|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
160553512|NCT01430442|579753427|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
160553513|NCT01430442|579753428|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
160553514|NCT01430442|579753429|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
160553515|NCT03502330|579753431|FG000|Overall Study|Adverse Event|2|||
160553516|NCT03502330|579753432|FG001|Overall Study|Adverse Event|1|||
160553517|NCT03502330|579753433|FG002|Overall Study|Adverse Event|0|||
160553518|NCT03502330|579753434|FG003|Overall Study|Adverse Event|0|||
160553519|NCT03502330|579753435|FG004|Overall Study|Adverse Event|1|||
160553520|NCT03502330|579753436|FG005|Overall Study|Adverse Event|0|||
160553521|NCT03502330|579753437|FG006|Overall Study|Adverse Event|1|||
160821708|NCT01691885|580733668|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
160901517|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
160901518|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Other|0|||
160901519|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Other|0|||
160901520|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Other|0|||
160901521|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Other|0|||
160901522|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Other|0|||
160901523|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Other|0|||
160901524|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Other|1|||
160901525|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Other|6|||
160901526|NCT01546207|581034011|FG000|Overall Study|Death|1|||
160901527|NCT01626456|581034012|FG000|Overall Study|Withdrawal by Subject|21|||
160901528|NCT01626456|581034013|FG001|Overall Study|Withdrawal by Subject|46|||
160901529|NCT01626456|581034012|FG000|Overall Study|Adverse Event|2|||
160901530|NCT01626456|581034013|FG001|Overall Study|Adverse Event|27|||
160901531|NCT01626456|581034012|FG000|Overall Study|Lost to Follow-up|2|||
160901532|NCT01626456|581034013|FG001|Overall Study|Lost to Follow-up|27|||
160901533|NCT01626456|581034012|FG000|Overall Study|Lack of Efficacy|6|||
160821709|NCT01691885|580733669|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
160821710|NCT01691885|580733668|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
160901534|NCT01626456|581034013|FG001|Overall Study|Lack of Efficacy|7|||
160821711|NCT01691885|580733669|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
160553522|NCT03502330|579753438|FG007|Overall Study|Adverse Event|1|||
160553523|NCT03502330|579753439|FG008|Overall Study|Adverse Event|0|||
160901535|NCT01626456|581034012|FG000|Overall Study|Physician Decision|1|||
160901536|NCT01626456|581034013|FG001|Overall Study|Physician Decision|4|||
160901537|NCT01626456|581034012|FG000|Overall Study|Protocol Violation|1|||
160553524|NCT03502330|579753431|FG000|Overall Study|Lack of Efficacy|1|||
160553525|NCT03502330|579753432|FG001|Overall Study|Lack of Efficacy|5|||
160553526|NCT03502330|579753433|FG002|Overall Study|Lack of Efficacy|3|||
160553527|NCT03502330|579753434|FG003|Overall Study|Lack of Efficacy|5|||
160553528|NCT03502330|579753435|FG004|Overall Study|Lack of Efficacy|1|||
160553529|NCT03502330|579753436|FG005|Overall Study|Lack of Efficacy|5|||
160553530|NCT03502330|579753437|FG006|Overall Study|Lack of Efficacy|5|||
160553531|NCT03502330|579753438|FG007|Overall Study|Lack of Efficacy|6|||
160553532|NCT03502330|579753439|FG008|Overall Study|Lack of Efficacy|0|||
160553533|NCT03502330|579753431|FG000|Overall Study|Physician Decision|0|||
160553534|NCT03502330|579753432|FG001|Overall Study|Physician Decision|0|||
160553535|NCT03502330|579753433|FG002|Overall Study|Physician Decision|0|||
160553536|NCT03502330|579753434|FG003|Overall Study|Physician Decision|0|||
160553537|NCT03502330|579753435|FG004|Overall Study|Physician Decision|1|||
160553538|NCT03502330|579753436|FG005|Overall Study|Physician Decision|0|||
160646418|NCT02637076|580088232|FG000|Overall Study|Withdrawal by Subject|0|||
160821712|NCT03555981|580733670|FG000|Overall Study|Lost to Follow-up|0|||
160821713|NCT03555981|580733671|FG001|Overall Study|Lost to Follow-up|2|||
160821714|NCT00688324|580733673|FG000|Overall Study|Withdrawal by Subject|2|||
160821715|NCT00688324|580733673|FG000|Overall Study|Physician Decision|5|||
160821716|NCT00688324|580733673|FG000|Overall Study|Lost to Follow-up|1|||
160821717|NCT01972308|580733676|FG000|Overall Study|Withdrawal by Subject|0|||
160821718|NCT01972308|580733677|FG001|Overall Study|Withdrawal by Subject|1|||
160821719|NCT01972308|580733676|FG000|Overall Study|Lost to Follow-up|4|||
160821720|NCT01972308|580733677|FG001|Overall Study|Lost to Follow-up|6|||
160821721|NCT01972308|580733676|FG000|Overall Study|Death|4|||
160821722|NCT01972308|580733677|FG001|Overall Study|Death|1|||
160821723|NCT04035564|580733679|FG000|Overall Study|Protocol Violation|1|||
160821724|NCT04035564|580733680|FG001|Overall Study|Protocol Violation|2|||
160821725|NCT04035564|580733679|FG000|Overall Study|No laboratory available|2|||
160821726|NCT04035564|580733680|FG001|Overall Study|No laboratory available|2|||
160821727|NCT04035564|580733679|FG000|Overall Study|Guardian declined consent|1|||
160821728|NCT04035564|580733680|FG001|Overall Study|Guardian declined consent|2|||
160821729|NCT01562314|580733681|FG000|Overall Study|Adverse Event|10|||
160821730|NCT01562314|580733682|FG001|Overall Study|Adverse Event|5|||
160821731|NCT01562314|580733681|FG000|Overall Study|Met Withdrawal Criteria|3|||
160821732|NCT01562314|580733682|FG001|Overall Study|Met Withdrawal Criteria|2|||
160821733|NCT01562314|580733681|FG000|Overall Study|Withdrawal by Subject|0|||
160821734|NCT01562314|580733682|FG001|Overall Study|Withdrawal by Subject|1|||
160821735|NCT01190475|580733689|FG000|Overall Study|Withdrawal by Subject|0|||
160821736|NCT01190475|580733690|FG001|Overall Study|Withdrawal by Subject|0|||
160821737|NCT01190475|580733691|FG002|Overall Study|Withdrawal by Subject|1|||
160821738|NCT00543803|580733692|FG000|Overall Study|Adverse Event|14|||
160821739|NCT00543803|580733692|FG000|Overall Study|Lack of Efficacy|22|||
160821740|NCT00543803|580733692|FG000|Overall Study|Lost to Follow-up|20|||
160821741|NCT00543803|580733692|FG000|Overall Study|Other|86|||
160821742|NCT04154345|580733695|FG000|Overall Study|Covid-19 pandemic|4|||
160821743|NCT03505788|580733696|FG000|Overall Study|Lost to Follow-up|2|||
160821744|NCT03505788|580733697|FG001|Overall Study|Lost to Follow-up|1|||
160821745|NCT03505788|580733696|FG000|Overall Study|Withdrawal by Subject|1|||
160821746|NCT03505788|580733697|FG001|Overall Study|Withdrawal by Subject|3|||
160821747|NCT03505788|580733696|FG000|Overall Study|Physician Decision|0|||
160901538|NCT01626456|581034013|FG001|Overall Study|Protocol Violation|1|||
160821748|NCT03505788|580733697|FG001|Overall Study|Physician Decision|1|||
160821749|NCT03575065|580733698|FG000|Overall Study|Death|31|||
160821750|NCT03575065|580733699|FG001|Overall Study|Death|12|||
160821751|NCT03575065|580733698|FG000|Overall Study|Sponsor's Decision|28|||
160821752|NCT03575065|580733699|FG001|Overall Study|Sponsor's Decision|13|||
160821753|NCT03575065|580733698|FG000|Overall Study|Withdrawal by Subject|2|||
160821754|NCT03575065|580733699|FG001|Overall Study|Withdrawal by Subject|1|||
160901539|NCT01626456|581034012|FG000|Overall Study|Site Closure|2|||
160901540|NCT01626456|581034013|FG001|Overall Study|Site Closure|3|||
160901541|NCT01626456|581034012|FG000|Overall Study|Incarceration|0|||
160901542|NCT01626456|581034013|FG001|Overall Study|Incarceration|2|||
160901543|NCT00506662|581034015|FG000|Overall Study|Adverse Event|0|||
160901544|NCT00506662|581034016|FG001|Overall Study|Adverse Event|2|||
160901545|NCT00506662|581034015|FG000|Overall Study|Lack of Efficacy|1|||
160901546|NCT00506662|581034016|FG001|Overall Study|Lack of Efficacy|0|||
160901547|NCT00506662|581034015|FG000|Overall Study|Protocol Violation|2|||
160901548|NCT00506662|581034016|FG001|Overall Study|Protocol Violation|4|||
160901549|NCT00506662|581034015|FG000|Overall Study|Trial terminated|10|||
160901550|NCT00506662|581034016|FG001|Overall Study|Trial terminated|16|||
160901551|NCT00506662|581034015|FG000|Overall Study|Not recorded|4|||
160901552|NCT00506662|581034016|FG001|Overall Study|Not recorded|6|||
160901553|NCT04015336|581034017|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
160901554|NCT00491075|581034018|FG000|Overall Study|Withdrawal by Subject|1|||
160901555|NCT00491075|581034018|FG000|Overall Study|Physician Decision|1|||
160901556|NCT01603355|581034019|FG000|Overall Study|Lack of Efficacy|2|||
160646419|NCT02637076|580088233|FG001|Overall Study|Withdrawal by Subject|4|||
160901557|NCT00246753|581034020|FG000|Overall Study|Withdrawal by Subject|2|||
160901558|NCT00246753|581034020|FG000|Overall Study|Physician Decision|2|||
160901559|NCT00246753|581034020|FG000|Overall Study|Adverse Event|2|||
160901560|NCT00246753|581034020|FG000|Overall Study|Unacceptable toxicity|2|||
160901561|NCT01030536|581034023|FG000|Overall Study|Withdrawal by Subject|0|||
160901562|NCT01030536|581034024|FG001|Overall Study|Withdrawal by Subject|0|||
160646420|NCT00130520|580088234|FG000|Overall Study|Adverse Event|11|||
160821755|NCT03575065|580733698|FG000|Overall Study|Lost to Follow-up|1|||
160821756|NCT03575065|580733699|FG001|Overall Study|Lost to Follow-up|0|||
160821757|NCT02323126|580733704|FG000|Overall Study|Patient / guardian decision|0|||
160821758|NCT02323126|580733705|FG001|Overall Study|Patient / guardian decision|1|||
160821759|NCT02323126|580733706|FG002|Overall Study|Patient / guardian decision|2|||
160821760|NCT02323126|580733704|FG000|Overall Study|Progressive disease|14|||
160821761|NCT02323126|580733705|FG001|Overall Study|Progressive disease|8|||
160821762|NCT02323126|580733706|FG002|Overall Study|Progressive disease|14|||
160821763|NCT02323126|580733704|FG000|Overall Study|Physician Decision|0|||
160821764|NCT02323126|580733705|FG001|Overall Study|Physician Decision|1|||
160821765|NCT02323126|580733706|FG002|Overall Study|Physician Decision|3|||
160821766|NCT02323126|580733704|FG000|Overall Study|Death|1|||
160821767|NCT02323126|580733705|FG001|Overall Study|Death|1|||
160821768|NCT02323126|580733706|FG002|Overall Study|Death|4|||
160821769|NCT02323126|580733704|FG000|Overall Study|Adverse Event|3|||
160821770|NCT02323126|580733705|FG001|Overall Study|Adverse Event|5|||
160821771|NCT02323126|580733706|FG002|Overall Study|Adverse Event|7|||
160821772|NCT03333252|580733707|FG000|Overall Study|Adverse Event|10|||
160821773|NCT03333252|580733708|FG001|Overall Study|Adverse Event|6|||
160821774|NCT03333252|580733709|FG002|Overall Study|Adverse Event|5|||
160821775|NCT03333252|580733710|FG003|Overall Study|Adverse Event|2|||
160821776|NCT03333252|580733707|FG000|Overall Study|Death|1|||
160821777|NCT03333252|580733708|FG001|Overall Study|Death|3|||
160821778|NCT03333252|580733709|FG002|Overall Study|Death|0|||
160821779|NCT03333252|580733710|FG003|Overall Study|Death|0|||
160821780|NCT03333252|580733707|FG000|Overall Study|Lack of Efficacy|8|||
160821781|NCT03333252|580733708|FG001|Overall Study|Lack of Efficacy|4|||
160821782|NCT03333252|580733709|FG002|Overall Study|Lack of Efficacy|0|||
160821783|NCT03333252|580733710|FG003|Overall Study|Lack of Efficacy|7|||
160821784|NCT03333252|580733707|FG000|Overall Study|Lost to Follow-up|0|||
160821785|NCT03333252|580733708|FG001|Overall Study|Lost to Follow-up|5|||
160821786|NCT03333252|580733709|FG002|Overall Study|Lost to Follow-up|9|||
160821787|NCT03333252|580733710|FG003|Overall Study|Lost to Follow-up|3|||
160821788|NCT03333252|580733707|FG000|Overall Study|Withdrawal by Subject|14|||
160821789|NCT03333252|580733708|FG001|Overall Study|Withdrawal by Subject|24|||
160821790|NCT03333252|580733709|FG002|Overall Study|Withdrawal by Subject|11|||
160821791|NCT03333252|580733710|FG003|Overall Study|Withdrawal by Subject|17|||
160821792|NCT00939029|580733711|FG000|Overall Study|Withdrawal by Subject|3|||
160821793|NCT00939029|580733712|FG001|Overall Study|Withdrawal by Subject|7|||
160821794|NCT00939029|580733711|FG000|Overall Study|Lost to Follow-up|3|||
160821795|NCT00939029|580733712|FG001|Overall Study|Lost to Follow-up|4|||
160821796|NCT00939029|580733711|FG000|Overall Study|Adverse Event|0|||
160821797|NCT00939029|580733712|FG001|Overall Study|Adverse Event|1|||
160821798|NCT00396136|580733713|FG000|Overall Study|Death|43|||
160821799|NCT00396136|580733713|FG000|Overall Study|Withdrawal by Subject|59|||
160821800|NCT00396136|580733713|FG000|Overall Study|Lost to Follow-up|15|||
160821801|NCT00396136|580733713|FG000|Overall Study|Study device explanted|8|||
160821802|NCT01779856|580733714|FG000|Overall Study|Withdrawal by Subject|15|||
160821803|NCT01779856|580733714|FG000|Overall Study|Death|3|||
160821804|NCT01779856|580733714|FG000|Overall Study|Physician Decision|1|||
160821805|NCT01779856|580733714|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
160821806|NCT01779856|580733714|FG000|Overall Study|Delays in scheduling implant|1|||
160821807|NCT01779856|580733714|FG000|Overall Study|Subject ineligible for Implant|2|||
160821808|NCT01535599|580733716|FG000|Overall Study|Adverse Event|6|||
160821809|NCT01535599|580733717|FG001|Overall Study|Adverse Event|15|||
160821810|NCT01535599|580733716|FG000|Overall Study|Lost to Follow-up|3|||
160821811|NCT01535599|580733717|FG001|Overall Study|Lost to Follow-up|4|||
160901563|NCT01030536|581034025|FG002|Overall Study|Withdrawal by Subject|1|||
160901564|NCT01030536|581034026|FG003|Overall Study|Withdrawal by Subject|0|||
160821812|NCT01535599|580733716|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
160821813|NCT01535599|580733717|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
160821814|NCT01535599|580733716|FG000|Overall Study|Treatment Failure|33|||
160821815|NCT01535599|580733717|FG001|Overall Study|Treatment Failure|66|||
160901565|NCT01030536|581034027|FG004|Overall Study|Withdrawal by Subject|0|||
160821816|NCT01535599|580733716|FG000|Overall Study|BL Culture + for Group A Strep|0|||
160821817|NCT01535599|580733717|FG001|Overall Study|BL Culture + for Group A Strep|1|||
160821818|NCT01535599|580733716|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
160821819|NCT01535599|580733717|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
160821820|NCT01535599|580733716|FG000|Overall Study|Randomized in Error|2|||
160821821|NCT01535599|580733717|FG001|Overall Study|Randomized in Error|4|||
160821822|NCT01535599|580733716|FG000|Overall Study|Did not use product|1|||
160646421|NCT00130520|580088234|FG000|Overall Study|Death|1|||
160646422|NCT00130520|580088234|FG000|Overall Study|Physician Decision|1|||
160646423|NCT00130520|580088234|FG000|Overall Study|Withdrawal by Subject|1|||
160646424|NCT00130520|580088234|FG000|Overall Study|Disease Progression|23|||
160646425|NCT00130520|580088234|FG000|Overall Study|Protocol non-compliance|1|||
160646426|NCT00130520|580088234|FG000|Overall Study|Did not meet re-treatment criteria|1|||
160646427|NCT01464827|580088235|FG000|Overall Study|Adverse Event|0|||
160646428|NCT01464827|580088236|FG001|Overall Study|Adverse Event|0|||
160646429|NCT01464827|580088237|FG002|Overall Study|Adverse Event|0|||
160821823|NCT01535599|580733717|FG001|Overall Study|Did not use product|0|||
160821824|NCT01535599|580733716|FG000|Overall Study|Other|1|||
160821825|NCT01535599|580733717|FG001|Overall Study|Other|0|||
160821826|NCT01535599|580733716|FG000|Overall Study|Stopped medication|0|||
160821827|NCT01535599|580733717|FG001|Overall Study|Stopped medication|1|||
160821828|NCT01535599|580733716|FG000|Overall Study|Noncompliance|0|||
160821829|NCT01535599|580733717|FG001|Overall Study|Noncompliance|1|||
160821830|NCT03960580|580733721|FG000|Overall Study|Adverse Event|2|||
160821831|NCT03960580|580733722|FG001|Overall Study|Adverse Event|1|||
160821832|NCT03960580|580733723|FG002|Overall Study|Adverse Event|1|||
160821833|NCT03960580|580733721|FG000|Overall Study|Lost to Follow-up|1|||
160821834|NCT03960580|580733722|FG001|Overall Study|Lost to Follow-up|0|||
160821835|NCT03960580|580733723|FG002|Overall Study|Lost to Follow-up|0|||
160821836|NCT03960580|580733721|FG000|Overall Study|Lack of Efficacy|2|||
160821837|NCT03960580|580733722|FG001|Overall Study|Lack of Efficacy|1|||
160821838|NCT03960580|580733723|FG002|Overall Study|Lack of Efficacy|0|||
160821839|NCT03960580|580733721|FG000|Overall Study|Protocol Violation|0|||
160821840|NCT03960580|580733722|FG001|Overall Study|Protocol Violation|0|||
160821841|NCT03960580|580733723|FG002|Overall Study|Protocol Violation|1|||
160821842|NCT03960580|580733721|FG000|Overall Study|Withdrawal by Subject|1|||
160821843|NCT03960580|580733722|FG001|Overall Study|Withdrawal by Subject|1|||
160821844|NCT03960580|580733723|FG002|Overall Study|Withdrawal by Subject|1|||
160821845|NCT03960580|580733721|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
160821846|NCT03960580|580733722|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
160821847|NCT03960580|580733723|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
160821848|NCT03172325|580733728|FG000|Overall Study|Adverse Event|2|||
160646430|NCT01464827|580088238|FG003|Overall Study|Adverse Event|0|||
160646431|NCT01464827|580088239|FG004|Overall Study|Adverse Event|0|||
160646432|NCT01464827|580088240|FG005|Overall Study|Adverse Event|0|||
160821849|NCT03172325|580733729|FG001|Overall Study|Adverse Event|3|||
160821850|NCT03172325|580733728|FG000|Overall Study|Positive PPD|1|||
160821851|NCT03172325|580733729|FG001|Overall Study|Positive PPD|0|||
160821852|NCT03172325|580733728|FG000|Overall Study|Poor Compliance|1|||
160821853|NCT03172325|580733729|FG001|Overall Study|Poor Compliance|1|||
160821854|NCT00385944|580733733|FG000|1st Maintenance Dose Period|Physician Decision|1|||
160821855|NCT00385944|580733734|FG001|1st Maintenance Dose Period|Physician Decision|0|||
160821856|NCT00385944|580733735|FG002|1st Maintenance Dose Period|Physician Decision|0|||
160821857|NCT00385944|580733733|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
160821858|NCT00385944|580733734|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
160821859|NCT00385944|580733735|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
160821860|NCT00385944|580733733|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
160821861|NCT00385944|580733734|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
160821862|NCT00385944|580733735|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
160821863|NCT00385944|580733733|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
160821864|NCT00385944|580733734|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
160821865|NCT00385944|580733735|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
160821866|NCT00590824|580733736|FG000|Overall Study|Disease could not be resected|0|||
160821867|NCT00590824|580733737|FG001|Overall Study|Disease could not be resected|2|||
160821868|NCT00590824|580733738|FG002|Overall Study|Disease could not be resected|1|||
160989204|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
160989205|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
160989206|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
160989207|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
160989208|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
160989209|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
160989210|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
160989211|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
160989212|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
160989213|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
160989214|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
160989215|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
160989216|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
160989217|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
160989218|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
160989219|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Death|0|||
160989220|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Death|1|||
160989221|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Death|0|||
160989222|NCT03005288|581347401|FG000|Overall Study|Withdrawal by Subject|7|||
160989223|NCT03005288|581347402|FG001|Overall Study|Withdrawal by Subject|5|||
160989224|NCT03005288|581347401|FG000|Overall Study|Lost to Follow-up|0|||
160989225|NCT03005288|581347402|FG001|Overall Study|Lost to Follow-up|1|||
160989226|NCT03005288|581347401|FG000|Overall Study|Adverse Event|5|||
160989227|NCT03005288|581347402|FG001|Overall Study|Adverse Event|0|||
160989228|NCT03005288|581347401|FG000|Overall Study|Protocol deviation|0|||
160989229|NCT03005288|581347402|FG001|Overall Study|Protocol deviation|1|||
160989230|NCT03005288|581347401|FG000|Overall Study|Physician Decision|0|||
160989231|NCT03005288|581347402|FG001|Overall Study|Physician Decision|1|||
160989232|NCT04011033|581347403|FG000|Overall Study|Physician Decision|2|||
160989233|NCT04011033|581347404|FG001|Overall Study|Physician Decision|3|||
160989234|NCT04011033|581347403|FG000|Overall Study|Withdrawal by Subject|1|||
160989235|NCT04011033|581347404|FG001|Overall Study|Withdrawal by Subject|0|||
160989236|NCT01823341|581347405|FG000|Overall Study|Failed run-in|7|||
160989237|NCT01823341|581347405|FG000|Overall Study|Withdrawal by Subject|7|||
160989238|NCT01823341|581347405|FG000|Overall Study|Adverse Event|1|||
160989239|NCT01342887|581347406|FG000|Overall Study|Death|2|||
160989240|NCT00663962|581347407|FG000|Overall Study|somnolence|1|||
160989241|NCT00663962|581347408|FG001|Overall Study|somnolence|0|||
160989242|NCT02698436|581347420|FG000|Overall Study|Adverse Event|1|||
160989243|NCT02698436|581347421|FG001|Overall Study|Adverse Event|0|||
160989244|NCT02698436|581347420|FG000|Overall Study|Withdrawal by Subject|3|||
160989245|NCT02698436|581347421|FG001|Overall Study|Withdrawal by Subject|3|||
160989246|NCT02698436|581347420|FG000|Overall Study|Lost to Follow-up|2|||
160989247|NCT02698436|581347421|FG001|Overall Study|Lost to Follow-up|4|||
160989248|NCT02698436|581347420|FG000|Overall Study|Non-compliance with study regimen|1|||
160821869|NCT00590824|580733739|FG003|Overall Study|Disease could not be resected|0|||
160821870|NCT00590824|580733736|FG000|Overall Study|Adverse Event|0|||
160821871|NCT00590824|580733737|FG001|Overall Study|Adverse Event|0|||
160821872|NCT00590824|580733738|FG002|Overall Study|Adverse Event|0|||
160821873|NCT00590824|580733739|FG003|Overall Study|Adverse Event|1|||
160821874|NCT03832322|580733741|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
160821875|NCT03832322|580733742|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
160821876|NCT01694121|580733744|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
160821877|NCT01694121|580733745|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
160821878|NCT01778049|580733749|FG000|Open Label Treatment Period|Adverse Event|5|||
160821879|NCT01778049|580733750|FG001|Open Label Treatment Period|Adverse Event|15|||
160821880|NCT01778049|580733751|FG002|Open Label Treatment Period|Adverse Event|0|||
160821881|NCT01778049|580733752|FG003|Open Label Treatment Period|Adverse Event|0|||
160821882|NCT01778049|580733753|FG004|Open Label Treatment Period|Adverse Event|0|||
160821883|NCT01778049|580733754|FG005|Open Label Treatment Period|Adverse Event|0|||
160989249|NCT02698436|581347421|FG001|Overall Study|Non-compliance with study regimen|0|||
160821884|NCT01778049|580733749|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
160821885|NCT01778049|580733750|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
160821886|NCT01778049|580733751|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
160989250|NCT00665561|581347426|FG000|Overall Study|Death recorded on subject summary pages|75|||
160989251|NCT00665561|581347427|FG001|Overall Study|Death recorded on subject summary pages|75|||
160989252|NCT00665561|581347426|FG000|Overall Study|Does not meet entrance criteria|19|||
160989253|NCT00665561|581347427|FG001|Overall Study|Does not meet entrance criteria|21|||
160989254|NCT00665561|581347426|FG000|Overall Study|Lost to Follow-up|203|||
160989255|NCT00665561|581347427|FG001|Overall Study|Lost to Follow-up|264|||
160989256|NCT00665561|581347426|FG000|Overall Study|Withdrawal by Subject|74|||
160989257|NCT00665561|581347427|FG001|Overall Study|Withdrawal by Subject|65|||
160989258|NCT00665561|581347426|FG000|Overall Study|Other|123|||
160989259|NCT00665561|581347427|FG001|Overall Study|Other|108|||
160989260|NCT00665561|581347426|FG000|Overall Study|Site closed|8|||
160989261|NCT00665561|581347427|FG001|Overall Study|Site closed|0|||
160989262|NCT00665561|581347426|FG000|Overall Study|Withdrawn due to pregnancy|0|||
160989263|NCT00665561|581347427|FG001|Overall Study|Withdrawn due to pregnancy|1|||
160989264|NCT00097370|581347428|FG000|Stage 1|Adverse Event|3|||
160989265|NCT00097370|581347428|FG000|Stage 1|Withdrawal by Subject|1|||
160989266|NCT00097370|581347428|FG000|Stage 1|Lack of Efficacy|2|||
160989267|NCT00097370|581347428|FG000|Stage 2|Adverse Event|5|||
160989268|NCT00097370|581347428|FG000|Stage 2|Withdrawal by Subject|1|||
160989269|NCT00097370|581347428|FG000|Stage 2|Lack of Efficacy|3|||
160989270|NCT00097370|581347428|FG000|Stage 2|Pregnancy|1|||
160989271|NCT00097370|581347428|FG000|Stage 2|Sponsor Terminated Study|2|||
160989272|NCT00097370|581347428|FG000|Stage 2|Lost to Follow-up|1|||
160989273|NCT00097370|581347428|FG000|Stage 3|Adverse Event|2|||
160989274|NCT00097370|581347428|FG000|Stage 3|Withdrawal by Subject|3|||
160989275|NCT00097370|581347428|FG000|Stage 3|Lack of Efficacy|1|||
160989276|NCT00097370|581347428|FG000|Stage 3|Sponsor Terminated Study|52|||
160989277|NCT00097370|581347428|FG000|Stage 3|Lost to Follow-up|1|||
160989278|NCT00762463|581349491|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
160989279|NCT00762463|581349492|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
160989280|NCT00762463|581349493|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
160989281|NCT00762463|581349494|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
160989282|NCT00762463|581349491|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
160989283|NCT00762463|581349492|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
160989284|NCT00762463|581349493|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
160989285|NCT00762463|581349494|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
160989286|NCT00762463|581349491|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
160989287|NCT00762463|581349492|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
160989288|NCT00762463|581349493|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
160989289|NCT00762463|581349494|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
160989290|NCT00762463|581349491|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
160989291|NCT00762463|581349492|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
160989292|NCT00762463|581349493|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
160989293|NCT00762463|581349494|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
160989294|NCT00762463|581349491|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
160989295|NCT00762463|581349492|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
160989296|NCT00762463|581349493|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
160989297|NCT00762463|581349494|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
160989298|NCT00762463|581349491|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
160989299|NCT00762463|581349492|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
160989300|NCT00762463|581349493|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
160989301|NCT00762463|581349494|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
160989302|NCT00762463|581349491|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
160989303|NCT00762463|581349492|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
160989304|NCT00762463|581349493|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
160989305|NCT00762463|581349494|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
160989306|NCT00762463|581349491|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
160989307|NCT00762463|581349492|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
160989308|NCT00762463|581349493|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
160821887|NCT01778049|580733752|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
160821888|NCT01778049|580733753|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
160821889|NCT01778049|580733754|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
160989309|NCT00762463|581349494|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
160989310|NCT00531479|581349495|FG000|Overall Study|Death|68|||
160821890|NCT01778049|580733749|FG000|Open Label Treatment Period|Protocol Violation|5|||
160821891|NCT01778049|580733750|FG001|Open Label Treatment Period|Protocol Violation|5|||
160821892|NCT01778049|580733751|FG002|Open Label Treatment Period|Protocol Violation|0|||
160989311|NCT00531479|581349496|FG001|Overall Study|Death|71|||
160821893|NCT01778049|580733752|FG003|Open Label Treatment Period|Protocol Violation|0|||
160821894|NCT01778049|580733753|FG004|Open Label Treatment Period|Protocol Violation|0|||
160821895|NCT01778049|580733754|FG005|Open Label Treatment Period|Protocol Violation|0|||
160821896|NCT01778049|580733749|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
160821897|NCT01778049|580733750|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
160821898|NCT01778049|580733751|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
160821899|NCT01778049|580733752|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
160821900|NCT01778049|580733753|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
160821901|NCT01778049|580733754|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
160821902|NCT01778049|580733749|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
160821903|NCT01778049|580733750|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
160821904|NCT01778049|580733751|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
160821905|NCT01778049|580733752|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
160821906|NCT01778049|580733753|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
160821907|NCT01778049|580733754|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
160821908|NCT01778049|580733749|FG000|Open Label Treatment Period|Not treated|2|||
160821909|NCT01778049|580733750|FG001|Open Label Treatment Period|Not treated|1|||
160821910|NCT01778049|580733751|FG002|Open Label Treatment Period|Not treated|0|||
160821911|NCT01778049|580733752|FG003|Open Label Treatment Period|Not treated|0|||
160821912|NCT01778049|580733753|FG004|Open Label Treatment Period|Not treated|0|||
160821913|NCT01778049|580733754|FG005|Open Label Treatment Period|Not treated|0|||
160821914|NCT01778049|580733749|FG000|Open Label Treatment Period|Other reason not defined above|77|||
160821915|NCT01778049|580733750|FG001|Open Label Treatment Period|Other reason not defined above|94|||
160821916|NCT01778049|580733751|FG002|Open Label Treatment Period|Other reason not defined above|0|||
160821917|NCT01778049|580733752|FG003|Open Label Treatment Period|Other reason not defined above|0|||
160821918|NCT01778049|580733753|FG004|Open Label Treatment Period|Other reason not defined above|0|||
160821919|NCT01778049|580733754|FG005|Open Label Treatment Period|Other reason not defined above|0|||
160821920|NCT01778049|580733749|FG000|Double Blind Treatment Period|Adverse Event|0|||
160821921|NCT01778049|580733750|FG001|Double Blind Treatment Period|Adverse Event|0|||
160821922|NCT01778049|580733751|FG002|Double Blind Treatment Period|Adverse Event|4|||
160821923|NCT01778049|580733752|FG003|Double Blind Treatment Period|Adverse Event|5|||
160821924|NCT01778049|580733753|FG004|Double Blind Treatment Period|Adverse Event|3|||
160821925|NCT01778049|580733754|FG005|Double Blind Treatment Period|Adverse Event|2|||
160821926|NCT01778049|580733749|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
160821927|NCT01778049|580733750|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
160821928|NCT01778049|580733751|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
160821929|NCT01778049|580733752|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
160821930|NCT01778049|580733753|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
160821931|NCT01778049|580733754|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
160821932|NCT01778049|580733749|FG000|Double Blind Treatment Period|Protocol Violation|0|||
160821933|NCT01778049|580733750|FG001|Double Blind Treatment Period|Protocol Violation|0|||
160821934|NCT01778049|580733751|FG002|Double Blind Treatment Period|Protocol Violation|2|||
160821935|NCT01778049|580733752|FG003|Double Blind Treatment Period|Protocol Violation|0|||
160821936|NCT01778049|580733753|FG004|Double Blind Treatment Period|Protocol Violation|0|||
160821937|NCT01778049|580733754|FG005|Double Blind Treatment Period|Protocol Violation|0|||
160821938|NCT01778049|580733749|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
160821939|NCT01778049|580733750|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
160821940|NCT01778049|580733751|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
160821941|NCT01778049|580733752|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
160821942|NCT01778049|580733753|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
160821943|NCT01778049|580733754|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
160821944|NCT01778049|580733749|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
160821945|NCT01778049|580733750|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
160821946|NCT01778049|580733751|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
160821947|NCT01778049|580733752|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
160821948|NCT01778049|580733753|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
160821949|NCT01778049|580733754|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
160821950|NCT01778049|580733749|FG000|Double Blind Treatment Period|Not treated|0|||
160821951|NCT01778049|580733750|FG001|Double Blind Treatment Period|Not treated|0|||
160821952|NCT01778049|580733751|FG002|Double Blind Treatment Period|Not treated|0|||
160821953|NCT01778049|580733752|FG003|Double Blind Treatment Period|Not treated|2|||
160821954|NCT01778049|580733753|FG004|Double Blind Treatment Period|Not treated|2|||
160821955|NCT01778049|580733754|FG005|Double Blind Treatment Period|Not treated|0|||
160821956|NCT01778049|580733749|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
160821957|NCT01778049|580733750|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
160821958|NCT01778049|580733751|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
160821959|NCT01778049|580733752|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
160821960|NCT01778049|580733753|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
160821961|NCT01778049|580733754|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
160821962|NCT02186652|580733755|FG000|Overall Study|Lost to Follow-up|2|||
160821963|NCT02186652|580733756|FG001|Overall Study|Lost to Follow-up|0|||
160821964|NCT03770728|580733761|FG000|Overall Study|Adverse Event|1|||
160821965|NCT03770728|580733762|FG001|Overall Study|Adverse Event|0|||
160821966|NCT03770728|580733763|FG002|Overall Study|Adverse Event|1|||
160821967|NCT03770728|580733764|FG003|Overall Study|Adverse Event|0|||
160821968|NCT03770728|580733761|FG000|Overall Study|Poor compliance to protocol|0|||
160821969|NCT03770728|580733762|FG001|Overall Study|Poor compliance to protocol|0|||
160821970|NCT03770728|580733763|FG002|Overall Study|Poor compliance to protocol|1|||
160821971|NCT03770728|580733764|FG003|Overall Study|Poor compliance to protocol|0|||
160821972|NCT03770728|580733761|FG000|Overall Study|Withdrawal by Subject|13|||
160821973|NCT03770728|580733762|FG001|Overall Study|Withdrawal by Subject|8|||
160821974|NCT03770728|580733763|FG002|Overall Study|Withdrawal by Subject|9|||
160821975|NCT03770728|580733764|FG003|Overall Study|Withdrawal by Subject|13|||
160821976|NCT03770728|580733761|FG000|Overall Study|Other than specified|24|||
160821977|NCT03770728|580733762|FG001|Overall Study|Other than specified|23|||
160821978|NCT03770728|580733763|FG002|Overall Study|Other than specified|21|||
160821979|NCT03770728|580733764|FG003|Overall Study|Other than specified|22|||
160821980|NCT00503776|580733765|FG000|Overall Study|Withdrawal by Subject|1|||
160821981|NCT00503776|580733766|FG001|Overall Study|Withdrawal by Subject|0|||
160821982|NCT00503776|580733767|FG002|Overall Study|Withdrawal by Subject|1|||
160821983|NCT00503776|580733768|FG003|Overall Study|Withdrawal by Subject|1|||
160821984|NCT00503776|580733765|FG000|Overall Study|Physician Decision|0|||
160821985|NCT00503776|580733766|FG001|Overall Study|Physician Decision|0|||
160821986|NCT00503776|580733767|FG002|Overall Study|Physician Decision|1|||
160821987|NCT00503776|580733768|FG003|Overall Study|Physician Decision|1|||
160821988|NCT02379988|580733769|FG000|Overall Study|Not eligible|1|||
160821989|NCT00107315|580733770|FG000|Overall Study|Disease Progression|9|||
160821990|NCT00107315|580733770|FG000|Overall Study|Adverse Event|4|||
160821991|NCT00107315|580733770|FG000|Overall Study|Withdrawal by Subject|2|||
160821992|NCT02509039|580733777|FG000|Overall Study|Adverse Event|0|||
160821993|NCT02509039|580733778|FG001|Overall Study|Adverse Event|1|||
160821994|NCT02509039|580733779|FG002|Overall Study|Adverse Event|1|||
160821995|NCT02509039|580733780|FG003|Overall Study|Adverse Event|1|||
160821996|NCT02509039|580733777|FG000|Overall Study|Withdrawal by Subject|0|||
160821997|NCT02509039|580733778|FG001|Overall Study|Withdrawal by Subject|0|||
160821998|NCT02509039|580733779|FG002|Overall Study|Withdrawal by Subject|1|||
160821999|NCT02509039|580733780|FG003|Overall Study|Withdrawal by Subject|0|||
160822000|NCT02509039|580733777|FG000|Overall Study|Progressive disease|2|||
160822001|NCT02509039|580733778|FG001|Overall Study|Progressive disease|2|||
160822002|NCT02509039|580733779|FG002|Overall Study|Progressive disease|1|||
160822003|NCT02509039|580733780|FG003|Overall Study|Progressive disease|5|||
160822004|NCT02509039|580733777|FG000|Overall Study|Study terminated by Sponsor|1|||
160822005|NCT02509039|580733778|FG001|Overall Study|Study terminated by Sponsor|0|||
160901566|NCT01030536|581034023|FG000|Overall Study|undefined|1|||
160901567|NCT01030536|581034024|FG001|Overall Study|undefined|0|||
160901568|NCT01030536|581034025|FG002|Overall Study|undefined|1|||
160901569|NCT01030536|581034026|FG003|Overall Study|undefined|1|||
160901570|NCT01030536|581034027|FG004|Overall Study|undefined|0|||
160901571|NCT01030536|581034023|FG000|Overall Study|Adverse Event|0|||
160901572|NCT01030536|581034024|FG001|Overall Study|Adverse Event|3|||
160901573|NCT01030536|581034025|FG002|Overall Study|Adverse Event|1|||
160901574|NCT01030536|581034026|FG003|Overall Study|Adverse Event|0|||
160901575|NCT01030536|581034027|FG004|Overall Study|Adverse Event|1|||
160901576|NCT01030536|581034023|FG000|Overall Study|Progressive disease|6|||
160901577|NCT01030536|581034024|FG001|Overall Study|Progressive disease|2|||
160901578|NCT01030536|581034025|FG002|Overall Study|Progressive disease|3|||
160901579|NCT01030536|581034026|FG003|Overall Study|Progressive disease|2|||
160901580|NCT01030536|581034027|FG004|Overall Study|Progressive disease|0|||
160901581|NCT01030536|581034023|FG000|Overall Study|Death|0|||
160901582|NCT01030536|581034024|FG001|Overall Study|Death|1|||
160901583|NCT01030536|581034025|FG002|Overall Study|Death|0|||
160901584|NCT01030536|581034026|FG003|Overall Study|Death|0|||
160901585|NCT01030536|581034027|FG004|Overall Study|Death|0|||
160901586|NCT01065597|581034028|FG000|Overall Study|Adverse Event|1|||
160901587|NCT01781975|581034029|FG000|Overall Study|Death|1|||
160901588|NCT01781975|581034030|FG001|Overall Study|Death|0|||
160901589|NCT01781975|581034029|FG000|Overall Study|Withdrawal by Subject|1|||
160901590|NCT01781975|581034030|FG001|Overall Study|Withdrawal by Subject|1|||
160901591|NCT01622231|581034031|FG000|Overall Study|Physician Decision|1|||
160901592|NCT01622231|581034031|FG000|Overall Study|Withdrawal by Subject|1|||
160901593|NCT04889222|581034033|FG000|Overall Study|Did not meet eligibility criteria|8|||
160901594|NCT04889222|581034033|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
160901595|NCT04889222|581034033|FG000|Overall Study|Did not proceed due to time constraints|5|||
160901596|NCT01180647|581034034|FG000|Overall Study|Lost to Follow-up|5|||
160901597|NCT01180647|581034035|FG001|Overall Study|Lost to Follow-up|6|||
160901598|NCT04545554|581034044|FG000|Overall Study|Withdrawal by Subject|0|||
160901599|NCT04545554|581034045|FG001|Overall Study|Withdrawal by Subject|0|||
160901600|NCT04545554|581034046|FG002|Overall Study|Withdrawal by Subject|0|||
160901601|NCT04545554|581034047|FG003|Overall Study|Withdrawal by Subject|1|||
160822006|NCT02509039|580733779|FG002|Overall Study|Study terminated by Sponsor|0|||
160822007|NCT02509039|580733780|FG003|Overall Study|Study terminated by Sponsor|0|||
160822008|NCT03943550|580733783|FG000|Overall Study|Adverse Event|0|||
160822009|NCT03943550|580733784|FG001|Overall Study|Adverse Event|0|||
160822010|NCT03943550|580733785|FG002|Overall Study|Adverse Event|1|||
160822011|NCT03943550|580733783|FG000|Overall Study|Lost to Follow-up|0|||
160822012|NCT03943550|580733784|FG001|Overall Study|Lost to Follow-up|0|||
160822013|NCT03943550|580733785|FG002|Overall Study|Lost to Follow-up|1|||
160822014|NCT03943550|580733783|FG000|Overall Study|Progressive Disease|0|||
160822015|NCT03943550|580733784|FG001|Overall Study|Progressive Disease|0|||
160822016|NCT03943550|580733785|FG002|Overall Study|Progressive Disease|2|||
160822017|NCT03943550|580733783|FG000|Overall Study|Participant Moved Out of the Country|0|||
160822018|NCT03943550|580733784|FG001|Overall Study|Participant Moved Out of the Country|1|||
160822019|NCT03943550|580733785|FG002|Overall Study|Participant Moved Out of the Country|0|||
160822020|NCT03359785|580733786|FG000|Overall Study|Protocol Violation|0|||
160822021|NCT03359785|580733787|FG001|Overall Study|Protocol Violation|1|||
160822022|NCT03359785|580733788|FG002|Overall Study|Protocol Violation|0|||
160822023|NCT03359785|580733789|FG003|Overall Study|Protocol Violation|0|||
160822024|NCT03359785|580733786|FG000|Overall Study|Early study termination due to study pause|0|||
160822025|NCT03359785|580733787|FG001|Overall Study|Early study termination due to study pause|0|||
160822026|NCT03359785|580733788|FG002|Overall Study|Early study termination due to study pause|2|||
160822027|NCT03359785|580733789|FG003|Overall Study|Early study termination due to study pause|0|||
160822028|NCT03359785|580733786|FG000|Overall Study|Withdrawal by Subject|2|||
160822029|NCT03359785|580733787|FG001|Overall Study|Withdrawal by Subject|2|||
160822030|NCT03359785|580733788|FG002|Overall Study|Withdrawal by Subject|0|||
160822031|NCT03359785|580733789|FG003|Overall Study|Withdrawal by Subject|0|||
160822032|NCT01895543|580733790|FG000|Overall Study|Withdrawal by Subject|43|||
160822033|NCT01895543|580733790|FG000|Overall Study|Lost to Follow-up|25|||
160822034|NCT01895543|580733790|FG000|Overall Study|Adverse Event|28|||
160822035|NCT01895543|580733790|FG000|Overall Study|Subject's substantial non-compliance|6|||
160822036|NCT01895543|580733790|FG000|Overall Study|Protocol Violation|1|||
160822037|NCT01895543|580733790|FG000|Overall Study|Physician Decision|2|||
160822038|NCT01895543|580733790|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
160822039|NCT06107803|580733791|FG000|Overall Study|Adverse Event|1|||
160822040|NCT06107803|580733791|FG000|Overall Study|Withdrawal by Subject|2|||
160822041|NCT06107803|580733791|FG000|Overall Study|Protocol Violation|1|||
160822042|NCT04730635|580733792|FG000|Overall Study|Lost to Follow-up|1|||
160822043|NCT04730635|580733793|FG001|Overall Study|Lost to Follow-up|0|||
160822044|NCT04730635|580733792|FG000|Overall Study|Withdrawal by Subject|0|||
160822045|NCT04730635|580733793|FG001|Overall Study|Withdrawal by Subject|1|||
160822046|NCT03070223|580733794|FG000|Overall Study|Lost to Follow-up|34|||
160822047|NCT03070223|580733795|FG001|Overall Study|Lost to Follow-up|27|||
160822048|NCT03070223|580733794|FG000|Overall Study|Withdrawal by Subject|12|||
160822049|NCT03070223|580733795|FG001|Overall Study|Withdrawal by Subject|22|||
160822050|NCT03070223|580733794|FG000|Overall Study|Protocol Violation|0|||
160822051|NCT03070223|580733795|FG001|Overall Study|Protocol Violation|1|||
160822052|NCT00541866|580733797|FG000|Overall Study|Adverse Event|3|||
160822053|NCT00541866|580733798|FG001|Overall Study|Adverse Event|0|||
160822054|NCT00541866|580733799|FG002|Overall Study|Adverse Event|0|||
160822055|NCT00541866|580733800|FG003|Overall Study|Adverse Event|0|||
160822056|NCT00541866|580733801|FG004|Overall Study|Adverse Event|0|||
160822057|NCT00541866|580733797|FG000|Overall Study|Death|1|||
160822058|NCT00541866|580733798|FG001|Overall Study|Death|0|||
160822059|NCT00541866|580733799|FG002|Overall Study|Death|0|||
160822060|NCT00541866|580733800|FG003|Overall Study|Death|0|||
160822061|NCT00541866|580733801|FG004|Overall Study|Death|0|||
160822062|NCT00541866|580733797|FG000|Overall Study|Lack of Efficacy|19|||
160822063|NCT00541866|580733798|FG001|Overall Study|Lack of Efficacy|15|||
160822064|NCT00541866|580733799|FG002|Overall Study|Lack of Efficacy|10|||
160822065|NCT00541866|580733800|FG003|Overall Study|Lack of Efficacy|12|||
160822066|NCT00541866|580733801|FG004|Overall Study|Lack of Efficacy|14|||
160822067|NCT00541866|580733797|FG000|Overall Study|Not Reported or Other|11|||
160822068|NCT00541866|580733798|FG001|Overall Study|Not Reported or Other|3|||
160822069|NCT00541866|580733799|FG002|Overall Study|Not Reported or Other|3|||
160901602|NCT04545554|581034048|FG004|Overall Study|Withdrawal by Subject|0|||
160822070|NCT00541866|580733800|FG003|Overall Study|Not Reported or Other|3|||
160822071|NCT00541866|580733801|FG004|Overall Study|Not Reported or Other|1|||
160822072|NCT00541866|580733797|FG000|Overall Study|Physician Decision|0|||
160553539|NCT03502330|579753437|FG006|Overall Study|Physician Decision|0|||
160822073|NCT00541866|580733798|FG001|Overall Study|Physician Decision|0|||
160822074|NCT00541866|580733799|FG002|Overall Study|Physician Decision|2|||
160822075|NCT00541866|580733800|FG003|Overall Study|Physician Decision|1|||
160822076|NCT00541866|580733801|FG004|Overall Study|Physician Decision|0|||
160822077|NCT00522418|580733802|FG000|Overall Study|Local IRB Consent Violation|5|||
160822078|NCT00522418|580733803|FG001|Overall Study|Local IRB Consent Violation|5|||
160822079|NCT00522418|580733802|FG000|Overall Study|Early Study Termination|46|||
160822080|NCT00522418|580733803|FG001|Overall Study|Early Study Termination|47|||
160901603|NCT04545554|581034049|FG005|Overall Study|Withdrawal by Subject|0|||
160822081|NCT00522418|580733802|FG000|Overall Study|Noncompliance|2|||
160822082|NCT00522418|580733803|FG001|Overall Study|Noncompliance|2|||
160822083|NCT00522418|580733802|FG000|Overall Study|Reason Not Specified|3|||
160822084|NCT00522418|580733803|FG001|Overall Study|Reason Not Specified|1|||
160822085|NCT00522418|580733802|FG000|Overall Study|Consent Withdraw|1|||
160822086|NCT00522418|580733803|FG001|Overall Study|Consent Withdraw|2|||
160822087|NCT00522418|580733802|FG000|Overall Study|Lack of Efficacy|0|||
160822088|NCT00522418|580733803|FG001|Overall Study|Lack of Efficacy|1|||
160822089|NCT00578877|580733804|FG000|Overall Study|Lost to Follow-up|8|||
160822090|NCT00578877|580733805|FG001|Overall Study|Lost to Follow-up|10|||
160822091|NCT00578877|580733804|FG000|Overall Study|early discontinue|61|||
160822092|NCT00578877|580733805|FG001|Overall Study|early discontinue|101|||
160822093|NCT00578877|580733804|FG000|Overall Study|did not provide follow-up data|12|||
160822094|NCT00578877|580733805|FG001|Overall Study|did not provide follow-up data|17|||
160822095|NCT01202188|580733807|FG000|Overall Study|Protocol deviation|14|||
160822096|NCT01202188|580733808|FG001|Overall Study|Protocol deviation|8|||
160822097|NCT01202188|580733809|FG002|Overall Study|Protocol deviation|12|||
160822098|NCT01202188|580733810|FG003|Overall Study|Protocol deviation|10|||
160822099|NCT01202188|580733811|FG004|Overall Study|Protocol deviation|11|||
160822100|NCT01202188|580733807|FG000|Overall Study|Subject withdrew consent|12|||
160822101|NCT01202188|580733808|FG001|Overall Study|Subject withdrew consent|13|||
160822102|NCT01202188|580733809|FG002|Overall Study|Subject withdrew consent|22|||
160822103|NCT01202188|580733810|FG003|Overall Study|Subject withdrew consent|11|||
160822104|NCT01202188|580733811|FG004|Overall Study|Subject withdrew consent|13|||
160822105|NCT01202188|580733807|FG000|Overall Study|Adverse Event|5|||
160822106|NCT01202188|580733808|FG001|Overall Study|Adverse Event|23|||
160822107|NCT01202188|580733809|FG002|Overall Study|Adverse Event|13|||
160822108|NCT01202188|580733810|FG003|Overall Study|Adverse Event|10|||
160822109|NCT01202188|580733811|FG004|Overall Study|Adverse Event|10|||
160822110|NCT01202188|580733807|FG000|Overall Study|Administrative problems|3|||
160822111|NCT01202188|580733808|FG001|Overall Study|Administrative problems|2|||
160822112|NCT01202188|580733809|FG002|Overall Study|Administrative problems|1|||
160822113|NCT01202188|580733810|FG003|Overall Study|Administrative problems|1|||
160822114|NCT01202188|580733811|FG004|Overall Study|Administrative problems|2|||
160822115|NCT01202188|580733807|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160822116|NCT01202188|580733808|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
160822117|NCT01202188|580733809|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
160822118|NCT01202188|580733810|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
160822119|NCT01202188|580733811|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
160822120|NCT01202188|580733807|FG000|Overall Study|Lost to Follow-up|1|||
160822121|NCT01202188|580733808|FG001|Overall Study|Lost to Follow-up|1|||
160822122|NCT01202188|580733809|FG002|Overall Study|Lost to Follow-up|0|||
160822123|NCT01202188|580733810|FG003|Overall Study|Lost to Follow-up|4|||
160822124|NCT01202188|580733811|FG004|Overall Study|Lost to Follow-up|1|||
160822125|NCT01202188|580733807|FG000|Overall Study|Death|1|||
160822126|NCT01202188|580733808|FG001|Overall Study|Death|1|||
160822127|NCT01202188|580733809|FG002|Overall Study|Death|1|||
160822128|NCT01202188|580733810|FG003|Overall Study|Death|1|||
160822129|NCT01202188|580733811|FG004|Overall Study|Death|0|||
160822130|NCT01202188|580733807|FG000|Overall Study|Abnormal test procedure result (s)|0|||
160822131|NCT01202188|580733808|FG001|Overall Study|Abnormal test procedure result (s)|0|||
160822132|NCT01202188|580733809|FG002|Overall Study|Abnormal test procedure result (s)|2|||
160822133|NCT01202188|580733810|FG003|Overall Study|Abnormal test procedure result (s)|0|||
160822134|NCT01202188|580733811|FG004|Overall Study|Abnormal test procedure result (s)|0|||
160822135|NCT00642174|580735774|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
160822136|NCT00642174|580735775|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
160822137|NCT01730339|580735776|FG000|Overall Study|Withdrawal by Subject|3|||
160553540|NCT03502330|579753438|FG007|Overall Study|Physician Decision|0|||
160822138|NCT01730339|580735777|FG001|Overall Study|Withdrawal by Subject|2|||
160822139|NCT01730339|580735776|FG000|Overall Study|Lost to Follow-up|1|||
160822140|NCT01730339|580735777|FG001|Overall Study|Lost to Follow-up|1|||
160822141|NCT01730339|580735776|FG000|Overall Study|Un-specified|1|||
160822142|NCT01730339|580735777|FG001|Overall Study|Un-specified|0|||
160822143|NCT00896363|580735778|FG000|Overall Study|Adverse Event|3|||
160822144|NCT00896363|580735779|FG001|Overall Study|Adverse Event|4|||
160822145|NCT00896363|580735780|FG002|Overall Study|Adverse Event|2|||
160822146|NCT00896363|580735778|FG000|Overall Study|Lack of Efficacy|0|||
160822147|NCT00896363|580735779|FG001|Overall Study|Lack of Efficacy|2|||
160822148|NCT00896363|580735780|FG002|Overall Study|Lack of Efficacy|1|||
160822149|NCT00896363|580735778|FG000|Overall Study|Withdrawal by Subject|3|||
160822150|NCT00896363|580735779|FG001|Overall Study|Withdrawal by Subject|5|||
160822151|NCT00896363|580735780|FG002|Overall Study|Withdrawal by Subject|5|||
160822152|NCT03245736|580735781|FG000|Overall Study|Adverse Event|1|||
160822153|NCT03245736|580735781|FG000|Overall Study|Progressive Disease|4|||
160822154|NCT01942161|580735782|FG000|Overall Study|Adverse Event|1|||
160822155|NCT01942161|580735783|FG001|Overall Study|Adverse Event|2|||
160822156|NCT01942161|580735784|FG002|Overall Study|Adverse Event|5|||
160822157|NCT01942161|580735782|FG000|Overall Study|Physician Decision|3|||
160822158|NCT01942161|580735783|FG001|Overall Study|Physician Decision|1|||
160822159|NCT01942161|580735784|FG002|Overall Study|Physician Decision|0|||
160822160|NCT01942161|580735782|FG000|Overall Study|Protocol Violation|1|||
160822161|NCT01942161|580735783|FG001|Overall Study|Protocol Violation|0|||
160822162|NCT01942161|580735784|FG002|Overall Study|Protocol Violation|0|||
160822163|NCT01942161|580735782|FG000|Overall Study|Withdrawal by Subject|3|||
160822164|NCT01942161|580735783|FG001|Overall Study|Withdrawal by Subject|3|||
160822165|NCT01942161|580735784|FG002|Overall Study|Withdrawal by Subject|1|||
160822166|NCT01257568|580735788|FG000|Overall Study|Lost to Follow-up|2|||
160822167|NCT01257568|580735788|FG000|Overall Study|Withdrawal by Subject|6|||
160822168|NCT01257568|580735788|FG000|Overall Study|Terminated|1|||
160822169|NCT01257568|580735788|FG000|Overall Study|Component Revision|24|||
160822170|NCT00132691|580735790|FG000|Overall Study|Lost to Follow-up|5|||
160822171|NCT00132691|580735791|FG001|Overall Study|Lost to Follow-up|8|||
160901604|NCT02639546|581034050|FG000|Overall Study|Death|2|||
160901605|NCT02639546|581034051|FG001|Overall Study|Death|2|||
160901606|NCT02639546|581034052|FG002|Overall Study|Death|1|||
160901607|NCT02639546|581034053|FG003|Overall Study|Death|2|||
160901608|NCT02639546|581034054|FG004|Overall Study|Death|2|||
160901609|NCT02639546|581034055|FG005|Overall Study|Death|2|||
160901610|NCT02639546|581034056|FG006|Overall Study|Death|0|||
160901611|NCT02639546|581034057|FG007|Overall Study|Death|0|||
160901612|NCT02639546|581034050|FG000|Overall Study|Lost to Follow-up|0|||
160901613|NCT02639546|581034051|FG001|Overall Study|Lost to Follow-up|0|||
160901614|NCT02639546|581034052|FG002|Overall Study|Lost to Follow-up|1|||
160901615|NCT02639546|581034053|FG003|Overall Study|Lost to Follow-up|0|||
160901616|NCT02639546|581034054|FG004|Overall Study|Lost to Follow-up|1|||
160901617|NCT02639546|581034055|FG005|Overall Study|Lost to Follow-up|1|||
160901618|NCT02639546|581034056|FG006|Overall Study|Lost to Follow-up|0|||
160901619|NCT02639546|581034057|FG007|Overall Study|Lost to Follow-up|1|||
160901620|NCT02639546|581034050|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
160901621|NCT02639546|581034051|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
160901622|NCT02639546|581034052|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
160901623|NCT02639546|581034053|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
160901624|NCT02639546|581034054|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
160901625|NCT02639546|581034055|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
160901626|NCT02639546|581034056|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
160901627|NCT02639546|581034057|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
160901628|NCT02639546|581034050|FG000|Overall Study|Study Terminated By Sponsor|0|||
160901629|NCT02639546|581034051|FG001|Overall Study|Study Terminated By Sponsor|2|||
160901630|NCT02639546|581034052|FG002|Overall Study|Study Terminated By Sponsor|3|||
160901631|NCT02639546|581034053|FG003|Overall Study|Study Terminated By Sponsor|4|||
160901632|NCT02639546|581034054|FG004|Overall Study|Study Terminated By Sponsor|4|||
160901633|NCT02639546|581034055|FG005|Overall Study|Study Terminated By Sponsor|3|||
160901634|NCT02639546|581034056|FG006|Overall Study|Study Terminated By Sponsor|3|||
160901635|NCT02639546|581034057|FG007|Overall Study|Study Terminated By Sponsor|9|||
160901636|NCT02639546|581034050|FG000|Overall Study|Withdrawal by Subject|2|||
160901637|NCT02639546|581034051|FG001|Overall Study|Withdrawal by Subject|2|||
160901638|NCT02639546|581034052|FG002|Overall Study|Withdrawal by Subject|1|||
160901639|NCT02639546|581034053|FG003|Overall Study|Withdrawal by Subject|0|||
160989312|NCT00531479|581349495|FG000|Overall Study|Lost to Follow-up|0|||
160989313|NCT00531479|581349496|FG001|Overall Study|Lost to Follow-up|2|||
160822172|NCT00132691|580735790|FG000|Overall Study|Missed 2-year visit|4|||
160822173|NCT00132691|580735791|FG001|Overall Study|Missed 2-year visit|4|||
160822174|NCT00132691|580735790|FG000|Overall Study|Death|2|||
160822175|NCT00132691|580735791|FG001|Overall Study|Death|0|||
160822176|NCT02251717|580735798|FG000|Overall Study|Adverse Event|0|||
160822177|NCT02251717|580735799|FG001|Overall Study|Adverse Event|1|||
160901640|NCT02639546|581034054|FG004|Overall Study|Withdrawal by Subject|0|||
160901641|NCT02639546|581034055|FG005|Overall Study|Withdrawal by Subject|1|||
160901642|NCT02639546|581034056|FG006|Overall Study|Withdrawal by Subject|2|||
160901643|NCT02639546|581034057|FG007|Overall Study|Withdrawal by Subject|1|||
160901644|NCT02478372|581034058|FG000|Overall Study|Protocol Violation|12|||
160901645|NCT02478372|581034059|FG001|Overall Study|Protocol Violation|8|||
160901646|NCT02478372|581034058|FG000|Overall Study|Lost to Follow-up|1|||
160901647|NCT02478372|581034059|FG001|Overall Study|Lost to Follow-up|4|||
160901648|NCT02478372|581034058|FG000|Overall Study|Death|0|||
160901649|NCT02478372|581034059|FG001|Overall Study|Death|2|||
160901650|NCT00116428|581034060|FG000|Overall Study|Withdrawal by Subject|2|||
160822178|NCT02251717|580735798|FG000|Overall Study|Withdrew Consent|1|||
160822179|NCT02251717|580735799|FG001|Overall Study|Withdrew Consent|0|||
160822180|NCT04098367|580735800|FG000|Overall Study|Adverse Event|0|||
160822181|NCT04098367|580735801|FG001|Overall Study|Adverse Event|0|||
160822182|NCT04098367|580735802|FG002|Overall Study|Adverse Event|1|||
160822183|NCT04098367|580735800|FG000|Overall Study|Lost to Follow-up|1|||
160822184|NCT04098367|580735801|FG001|Overall Study|Lost to Follow-up|5|||
160822185|NCT04098367|580735802|FG002|Overall Study|Lost to Follow-up|2|||
160822186|NCT04098367|580735800|FG000|Overall Study|Withdrawal by Subject|0|||
160822187|NCT04098367|580735801|FG001|Overall Study|Withdrawal by Subject|0|||
160822188|NCT04098367|580735802|FG002|Overall Study|Withdrawal by Subject|1|||
160822189|NCT04098367|580735800|FG000|Overall Study|Sick . Could not attend visit|1|||
160822190|NCT04098367|580735801|FG001|Overall Study|Sick . Could not attend visit|0|||
160822191|NCT04098367|580735802|FG002|Overall Study|Sick . Could not attend visit|0|||
160822192|NCT00445939|580735805|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
160901651|NCT00116428|581034061|FG001|Overall Study|Withdrawal by Subject|5|||
160901652|NCT00116428|581034060|FG000|Overall Study|Did not meet inclusion criteria|1|||
160901653|NCT00116428|581034061|FG001|Overall Study|Did not meet inclusion criteria|0|||
160901654|NCT01032174|581034062|FG000|Overall Study|Adverse Event|0|||
160901655|NCT01032174|581034063|FG001|Overall Study|Adverse Event|1|||
160901656|NCT00386607|581034064|FG000|Core|Adverse Event|40|||
160901657|NCT00386607|581034065|FG001|Core|Adverse Event|0|||
160901658|NCT00386607|581034064|FG000|Core|Abnormal laboratory value(s)|3|||
160901659|NCT00386607|581034065|FG001|Core|Abnormal laboratory value(s)|0|||
160901660|NCT00386607|581034064|FG000|Core|Unsatisfactory therapeutic effect|23|||
160901661|NCT00386607|581034065|FG001|Core|Unsatisfactory therapeutic effect|0|||
160901662|NCT00386607|581034064|FG000|Core|Condition no longer requires study drug|4|||
160901663|NCT00386607|581034065|FG001|Core|Condition no longer requires study drug|0|||
160901664|NCT00386607|581034064|FG000|Core|Patient withdrew consent|15|||
160901665|NCT00386607|581034065|FG001|Core|Patient withdrew consent|0|||
160901666|NCT00386607|581034064|FG000|Core|Lost to Follow-up|23|||
160901667|NCT00386607|581034065|FG001|Core|Lost to Follow-up|0|||
160901668|NCT00386607|581034064|FG000|Core|Administrative problems|1|||
160901669|NCT00386607|581034065|FG001|Core|Administrative problems|0|||
160901670|NCT00386607|581034064|FG000|Core|Protocol Deviation|6|||
160901671|NCT00386607|581034065|FG001|Core|Protocol Deviation|0|||
160901672|NCT00386607|581034064|FG000|Extension|Adverse Event|0|||
160901673|NCT00386607|581034065|FG001|Extension|Adverse Event|6|||
160901674|NCT00386607|581034064|FG000|Extension|Abnormal laboratory value(s)|0|||
160901675|NCT00386607|581034065|FG001|Extension|Abnormal laboratory value(s)|1|||
160901676|NCT00386607|581034064|FG000|Extension|Administrative problems|0|||
160901677|NCT00386607|581034065|FG001|Extension|Administrative problems|1|||
160901678|NCT00386607|581034064|FG000|Extension|Lost to Follow-up|0|||
160901679|NCT00386607|581034065|FG001|Extension|Lost to Follow-up|3|||
160901680|NCT00386607|581034064|FG000|Extension|Patient withdrew consent|0|||
160901681|NCT00386607|581034065|FG001|Extension|Patient withdrew consent|5|||
160901682|NCT00386607|581034064|FG000|Extension|Unsatisfactory therapeutic effect|0|||
160901683|NCT00386607|581034065|FG001|Extension|Unsatisfactory therapeutic effect|1|||
160901684|NCT02713204|581034066|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
160901685|NCT02713204|581034067|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901686|NCT02713204|581034068|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
160901687|NCT02713204|581034069|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901688|NCT02713204|581034070|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901689|NCT02713204|581034071|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901690|NCT02713204|581034072|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901691|NCT02713204|581034073|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901692|NCT02713204|581034066|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901693|NCT02713204|581034067|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901694|NCT02713204|581034068|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
160901695|NCT02713204|581034069|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901696|NCT02713204|581034070|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901697|NCT02713204|581034071|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901698|NCT02713204|581034072|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901699|NCT02713204|581034073|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901700|NCT02713204|581034066|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160553541|NCT03502330|579753439|FG008|Overall Study|Physician Decision|0|||
160822193|NCT00445939|580735806|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
160901701|NCT02713204|581034067|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
160822194|NCT00445939|580735807|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
160822195|NCT00445939|580735808|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
160822196|NCT00445939|580735805|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
160822197|NCT00445939|580735806|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
160901702|NCT02713204|581034068|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160901703|NCT02713204|581034069|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160901704|NCT02713204|581034070|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160822198|NCT00445939|580735807|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
160822199|NCT00445939|580735808|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
160822200|NCT00416715|580735809|FG000|Overall Study|Not evaluable for joint aches|7|||
160822201|NCT00416715|580735809|FG000|Overall Study|Vitamin D levels not evaluable|8|||
160822202|NCT00521599|580735811|FG000|Overall Study|Adverse Event|5|||
160822203|NCT00521599|580735812|FG001|Overall Study|Adverse Event|7|||
160822204|NCT00521599|580735813|FG002|Overall Study|Adverse Event|6|||
160822205|NCT00521599|580735811|FG000|Overall Study|Treatment Failure|8|||
160822206|NCT00521599|580735812|FG001|Overall Study|Treatment Failure|9|||
160822207|NCT00521599|580735813|FG002|Overall Study|Treatment Failure|22|||
160822208|NCT00521599|580735811|FG000|Overall Study|Lost to Follow-up|2|||
160822209|NCT00521599|580735812|FG001|Overall Study|Lost to Follow-up|1|||
160822210|NCT00521599|580735813|FG002|Overall Study|Lost to Follow-up|2|||
160822211|NCT00521599|580735811|FG000|Overall Study|Withdrawal by Subject|3|||
160822212|NCT00521599|580735812|FG001|Overall Study|Withdrawal by Subject|5|||
160822213|NCT00521599|580735813|FG002|Overall Study|Withdrawal by Subject|1|||
160822214|NCT00521599|580735811|FG000|Overall Study|Withdrawal by subject treatment related|3|||
160822215|NCT00521599|580735812|FG001|Overall Study|Withdrawal by subject treatment related|1|||
160822216|NCT00521599|580735813|FG002|Overall Study|Withdrawal by subject treatment related|2|||
160822217|NCT00521599|580735811|FG000|Overall Study|Protocol Violation|2|||
160822218|NCT00521599|580735812|FG001|Overall Study|Protocol Violation|4|||
160822219|NCT00521599|580735813|FG002|Overall Study|Protocol Violation|2|||
160822220|NCT00521599|580735811|FG000|Overall Study|Did not meet protocol eligibility|2|||
160822221|NCT00521599|580735812|FG001|Overall Study|Did not meet protocol eligibility|2|||
160822222|NCT00521599|580735813|FG002|Overall Study|Did not meet protocol eligibility|1|||
160822223|NCT00791479|580735814|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
160822224|NCT00791479|580735815|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
160822225|NCT00791479|580735816|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
160822226|NCT00791479|580735817|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
160822227|NCT00791479|580735818|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
160822228|NCT00791479|580735819|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
160822229|NCT00791479|580735814|FG000|Overall Study|Adverse Event|0|||
160822230|NCT00791479|580735815|FG001|Overall Study|Adverse Event|1|||
160822231|NCT00791479|580735816|FG002|Overall Study|Adverse Event|0|||
160822232|NCT00791479|580735817|FG003|Overall Study|Adverse Event|2|||
160822233|NCT00791479|580735818|FG004|Overall Study|Adverse Event|0|||
160822234|NCT00791479|580735819|FG005|Overall Study|Adverse Event|1|||
160822235|NCT00791479|580735814|FG000|Overall Study|Lost to Follow-up|0|||
160822236|NCT00791479|580735815|FG001|Overall Study|Lost to Follow-up|1|||
160822237|NCT00791479|580735816|FG002|Overall Study|Lost to Follow-up|0|||
160822238|NCT00791479|580735817|FG003|Overall Study|Lost to Follow-up|0|||
160822239|NCT00791479|580735818|FG004|Overall Study|Lost to Follow-up|0|||
160822240|NCT00791479|580735819|FG005|Overall Study|Lost to Follow-up|1|||
160822241|NCT00791479|580735814|FG000|Overall Study|Protocol Violation|2|||
160822242|NCT00791479|580735815|FG001|Overall Study|Protocol Violation|1|||
160822243|NCT00791479|580735816|FG002|Overall Study|Protocol Violation|0|||
160822244|NCT00791479|580735817|FG003|Overall Study|Protocol Violation|1|||
160822245|NCT00791479|580735818|FG004|Overall Study|Protocol Violation|0|||
160822246|NCT00791479|580735819|FG005|Overall Study|Protocol Violation|0|||
160822247|NCT00791479|580735814|FG000|Overall Study|Withdrawal by Subject|0|||
160822248|NCT00791479|580735815|FG001|Overall Study|Withdrawal by Subject|0|||
160822249|NCT00791479|580735816|FG002|Overall Study|Withdrawal by Subject|0|||
160822250|NCT00791479|580735817|FG003|Overall Study|Withdrawal by Subject|1|||
160822251|NCT00791479|580735818|FG004|Overall Study|Withdrawal by Subject|0|||
160822252|NCT00791479|580735819|FG005|Overall Study|Withdrawal by Subject|1|||
160822253|NCT00496197|580735820|FG000|Overall Study|Discontinued study due to death|43|||
160822254|NCT00496197|580735820|FG000|Overall Study|Adverse Event|13|||
160822255|NCT00496197|580735820|FG000|Overall Study|Does not meet entrance criteria|5|||
160822256|NCT00496197|580735820|FG000|Overall Study|Insufficient clinical response|3|||
160822257|NCT00496197|580735820|FG000|Overall Study|Insufficient bacteriological response|10|||
160822258|NCT00496197|580735820|FG000|Overall Study|Lost to Follow-up|11|||
160822259|NCT00496197|580735820|FG000|Overall Study|Withdrawal by Subject|11|||
160822260|NCT00496197|580735820|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
160822261|NCT00496197|580735820|FG000|Overall Study|Other|14|||
160822262|NCT00496197|580735820|FG000|Overall Study|Protocol Violation|8|||
160822263|NCT00149994|580735821|FG000|Overall Study|Administrative problems:|1|||
160822264|NCT00149994|580735822|FG001|Overall Study|Administrative problems:|0|||
160822265|NCT00149994|580735821|FG000|Overall Study|Protocol Violation|0|||
160822266|NCT00149994|580735822|FG001|Overall Study|Protocol Violation|1|||
160822267|NCT01610713|580735823|FG000|Overall Study|Adverse Event|3|||
160822268|NCT01610713|580735824|FG001|Overall Study|Adverse Event|0|||
160822269|NCT01610713|580735823|FG000|Overall Study|Lack of Efficacy|1|||
160822270|NCT01610713|580735824|FG001|Overall Study|Lack of Efficacy|0|||
160822271|NCT01610713|580735823|FG000|Overall Study|low mood and poor motivation|1|||
160822272|NCT01610713|580735824|FG001|Overall Study|low mood and poor motivation|0|||
160822273|NCT01610713|580735823|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
160822274|NCT01610713|580735824|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
160822275|NCT01610713|580735823|FG000|Overall Study|Lost to Follow-up|0|||
160822276|NCT01610713|580735824|FG001|Overall Study|Lost to Follow-up|1|||
160822277|NCT04659174|580735834|FG000|Overall Study|Sponsor decision to discontinue study|0|||
160822278|NCT04659174|580735835|FG001|Overall Study|Sponsor decision to discontinue study|2|||
160822279|NCT04659174|580735834|FG000|Overall Study|Lost to Follow-up|9|||
160989314|NCT00531479|581349495|FG000|Overall Study|Other|0|||
160989315|NCT00531479|581349496|FG001|Overall Study|Other|1|||
160989316|NCT00531479|581349495|FG000|Overall Study|Withdrawal by Subject|6|||
160989317|NCT00531479|581349496|FG001|Overall Study|Withdrawal by Subject|6|||
160822280|NCT04659174|580735835|FG001|Overall Study|Lost to Follow-up|11|||
160822281|NCT04659174|580735834|FG000|Overall Study|Adverse Event|8|||
160822282|NCT04659174|580735835|FG001|Overall Study|Adverse Event|5|||
160822283|NCT04659174|580735834|FG000|Overall Study|Withdrawal by Subject|17|||
160822284|NCT04659174|580735835|FG001|Overall Study|Withdrawal by Subject|33|||
160822285|NCT04659174|580735834|FG000|Overall Study|Progressive disease|0|||
160822286|NCT04659174|580735835|FG001|Overall Study|Progressive disease|2|||
160822287|NCT04659174|580735834|FG000|Overall Study|Other reasons|0|||
160822288|NCT04659174|580735835|FG001|Overall Study|Other reasons|2|||
160822289|NCT04659174|580735834|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
160822290|NCT04659174|580735835|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
160822291|NCT04659174|580735834|FG000|Overall Study|Alcohol or illegal drug use|0|||
160822292|NCT04659174|580735835|FG001|Overall Study|Alcohol or illegal drug use|3|||
160822293|NCT04659174|580735834|FG000|Overall Study|Violation of entry criteria|1|||
160822294|NCT04659174|580735835|FG001|Overall Study|Violation of entry criteria|0|||
160822295|NCT04659174|580735834|FG000|Overall Study|Death|0|||
160822296|NCT04659174|580735835|FG001|Overall Study|Death|1|||
160822297|NCT03650803|580735839|FG000|Overall Study|Lost to Follow-up|6|||
160822298|NCT00096226|580735840|FG000|Overall Study|Ineligible|2|||
160822299|NCT00096226|580735840|FG000|Overall Study|Protocol treatment not started|1|||
160822300|NCT04173260|580735846|FG000|Overall Study|Early termination|4|||
160822301|NCT02308163|580735849|FG000|Overall Study|Not fulfill eligible criteria|1|||
160822302|NCT02308163|580735850|FG001|Overall Study|Not fulfill eligible criteria|2|||
160822303|NCT02308163|580735851|FG002|Overall Study|Not fulfill eligible criteria|0|||
160822304|NCT02308163|580735852|FG003|Overall Study|Not fulfill eligible criteria|1|||
160822305|NCT02308163|580735853|FG004|Overall Study|Not fulfill eligible criteria|1|||
160822306|NCT02308163|580735849|FG000|Overall Study|Adverse Event|9|||
160822307|NCT02308163|580735850|FG001|Overall Study|Adverse Event|5|||
160822308|NCT02308163|580735851|FG002|Overall Study|Adverse Event|2|||
160822309|NCT02308163|580735852|FG003|Overall Study|Adverse Event|2|||
160822310|NCT02308163|580735853|FG004|Overall Study|Adverse Event|11|||
160822311|NCT02308163|580735849|FG000|Overall Study|Lack of Efficacy|11|||
160822312|NCT02308163|580735850|FG001|Overall Study|Lack of Efficacy|3|||
160822313|NCT02308163|580735851|FG002|Overall Study|Lack of Efficacy|8|||
160822314|NCT02308163|580735852|FG003|Overall Study|Lack of Efficacy|4|||
160822315|NCT02308163|580735853|FG004|Overall Study|Lack of Efficacy|6|||
160822316|NCT02308163|580735849|FG000|Overall Study|Withdrawal of consent|2|||
160822317|NCT02308163|580735850|FG001|Overall Study|Withdrawal of consent|3|||
160822318|NCT02308163|580735851|FG002|Overall Study|Withdrawal of consent|0|||
160822319|NCT02308163|580735852|FG003|Overall Study|Withdrawal of consent|2|||
160822320|NCT02308163|580735853|FG004|Overall Study|Withdrawal of consent|6|||
160822321|NCT02308163|580735849|FG000|Overall Study|Protocol Violation|3|||
160822322|NCT02308163|580735850|FG001|Overall Study|Protocol Violation|3|||
160822323|NCT02308163|580735851|FG002|Overall Study|Protocol Violation|3|||
160822324|NCT02308163|580735852|FG003|Overall Study|Protocol Violation|2|||
160822325|NCT02308163|580735853|FG004|Overall Study|Protocol Violation|5|||
160822326|NCT02308163|580735849|FG000|Overall Study|Lab data met discontinuation criteria|3|||
160822327|NCT02308163|580735850|FG001|Overall Study|Lab data met discontinuation criteria|0|||
160822328|NCT02308163|580735851|FG002|Overall Study|Lab data met discontinuation criteria|0|||
160822329|NCT02308163|580735852|FG003|Overall Study|Lab data met discontinuation criteria|2|||
160822330|NCT02308163|580735853|FG004|Overall Study|Lab data met discontinuation criteria|0|||
160822331|NCT02308163|580735849|FG000|Overall Study|Miscellaneous|2|||
160822332|NCT02308163|580735850|FG001|Overall Study|Miscellaneous|2|||
160822333|NCT02308163|580735851|FG002|Overall Study|Miscellaneous|1|||
160822334|NCT02308163|580735852|FG003|Overall Study|Miscellaneous|0|||
160822335|NCT02308163|580735853|FG004|Overall Study|Miscellaneous|5|||
160822336|NCT03006458|580735858|FG000|First Intervention|Unsatisfied Vision|0|||
160822337|NCT03006458|580735859|FG001|First Intervention|Unsatisfied Vision|3|||
160989318|NCT00531479|581349495|FG000|Overall Study|Did not receive treatment|2|||
160822338|NCT00118846|580735861|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
160822339|NCT00118846|580735862|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
160822340|NCT00118846|580735861|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
160822341|NCT00118846|580735862|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
160822342|NCT00118846|580735861|FG000|Overall Study|Physician Decision|1|||
160822343|NCT00118846|580735862|FG001|Overall Study|Physician Decision|0|||
160822344|NCT00118846|580735861|FG000|Overall Study|Medical condition|2|||
160989319|NCT00531479|581349496|FG001|Overall Study|Did not receive treatment|3|||
160989320|NCT05074498|581349499|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
160989321|NCT05074498|581349500|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
160989322|NCT05074498|581349501|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
160989323|NCT05074498|581349502|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
160989324|NCT05074498|581349503|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
160989325|NCT05074498|581349504|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
160989326|NCT05074498|581349499|FG000|Part 1 (Upto Day 104)|Other|1|||
160989327|NCT05074498|581349500|FG001|Part 1 (Upto Day 104)|Other|0|||
160989328|NCT05074498|581349501|FG002|Part 1 (Upto Day 104)|Other|0|||
160989329|NCT05074498|581349502|FG003|Part 1 (Upto Day 104)|Other|0|||
160989330|NCT05074498|581349503|FG004|Part 1 (Upto Day 104)|Other|0|||
160822345|NCT00118846|580735862|FG001|Overall Study|Medical condition|2|||
160822346|NCT00118846|580735861|FG000|Overall Study|Lost to Follow-up|0|||
160822347|NCT00118846|580735862|FG001|Overall Study|Lost to Follow-up|2|||
160822348|NCT00118846|580735861|FG000|Overall Study|Personal reason|4|||
160822349|NCT00118846|580735862|FG001|Overall Study|Personal reason|5|||
160822350|NCT01468233|580735865|FG000|Treatment Period 1|Adverse Event|5|||
160822351|NCT01468233|580735866|FG001|Treatment Period 1|Adverse Event|3|||
160822352|NCT01468233|580735867|FG002|Treatment Period 1|Adverse Event|0|||
160822353|NCT01468233|580735868|FG003|Treatment Period 1|Adverse Event|0|||
160822354|NCT01468233|580735869|FG004|Treatment Period 1|Adverse Event|0|||
160822355|NCT01468233|580735870|FG005|Treatment Period 1|Adverse Event|0|||
160822356|NCT01468233|580735865|FG000|Treatment Period 1|Withdrawal by Subject|3|||
160822357|NCT01468233|580735866|FG001|Treatment Period 1|Withdrawal by Subject|4|||
160822358|NCT01468233|580735867|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160822359|NCT01468233|580735868|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160822360|NCT01468233|580735869|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160822361|NCT01468233|580735870|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160822362|NCT01468233|580735865|FG000|Treatment Period 1|Lost to Follow-up|3|||
160822363|NCT01468233|580735866|FG001|Treatment Period 1|Lost to Follow-up|0|||
160822364|NCT01468233|580735867|FG002|Treatment Period 1|Lost to Follow-up|0|||
160822365|NCT01468233|580735868|FG003|Treatment Period 1|Lost to Follow-up|0|||
160822366|NCT01468233|580735869|FG004|Treatment Period 1|Lost to Follow-up|0|||
160822367|NCT01468233|580735870|FG005|Treatment Period 1|Lost to Follow-up|0|||
160822368|NCT01468233|580735865|FG000|Treatment Period 1|Other|1|||
160822369|NCT01468233|580735866|FG001|Treatment Period 1|Other|1|||
160822370|NCT01468233|580735867|FG002|Treatment Period 1|Other|0|||
160822371|NCT01468233|580735868|FG003|Treatment Period 1|Other|0|||
160822372|NCT01468233|580735869|FG004|Treatment Period 1|Other|0|||
160822373|NCT01468233|580735870|FG005|Treatment Period 1|Other|0|||
160822374|NCT01468233|580735865|FG000|Treatment Period 2|Adverse Event|0|||
160822375|NCT01468233|580735866|FG001|Treatment Period 2|Adverse Event|0|||
160822376|NCT01468233|580735867|FG002|Treatment Period 2|Adverse Event|3|||
160822377|NCT01468233|580735868|FG003|Treatment Period 2|Adverse Event|0|||
160822378|NCT01468233|580735869|FG004|Treatment Period 2|Adverse Event|2|||
160822379|NCT01468233|580735870|FG005|Treatment Period 2|Adverse Event|1|||
160822380|NCT01468233|580735865|FG000|Treatment Period 2|Lack of Efficacy|0|||
160822381|NCT01468233|580735866|FG001|Treatment Period 2|Lack of Efficacy|0|||
160822382|NCT01468233|580735867|FG002|Treatment Period 2|Lack of Efficacy|9|||
160822383|NCT01468233|580735868|FG003|Treatment Period 2|Lack of Efficacy|2|||
160822384|NCT01468233|580735869|FG004|Treatment Period 2|Lack of Efficacy|0|||
160822385|NCT01468233|580735870|FG005|Treatment Period 2|Lack of Efficacy|1|||
160822386|NCT01468233|580735865|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160822387|NCT01468233|580735866|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160822388|NCT01468233|580735867|FG002|Treatment Period 2|Withdrawal by Subject|9|||
160822389|NCT01468233|580735868|FG003|Treatment Period 2|Withdrawal by Subject|1|||
160822390|NCT01468233|580735869|FG004|Treatment Period 2|Withdrawal by Subject|1|||
160822391|NCT01468233|580735870|FG005|Treatment Period 2|Withdrawal by Subject|1|||
160822392|NCT01468233|580735865|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
160822393|NCT01468233|580735866|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
160822394|NCT01468233|580735867|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
160822395|NCT01468233|580735868|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
160822396|NCT01468233|580735869|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
160989331|NCT05074498|581349504|FG005|Part 1 (Upto Day 104)|Other|0|||
160822397|NCT01468233|580735870|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
160822398|NCT01468233|580735865|FG000|Treatment Period 2|Lost to Follow-up|0|||
160822399|NCT01468233|580735866|FG001|Treatment Period 2|Lost to Follow-up|0|||
160989332|NCT05074498|581349499|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
160989333|NCT05074498|581349500|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
160822400|NCT01468233|580735867|FG002|Treatment Period 2|Lost to Follow-up|3|||
160822401|NCT01468233|580735868|FG003|Treatment Period 2|Lost to Follow-up|0|||
160822402|NCT01468233|580735869|FG004|Treatment Period 2|Lost to Follow-up|2|||
160822403|NCT01468233|580735870|FG005|Treatment Period 2|Lost to Follow-up|0|||
160822404|NCT01468233|580735865|FG000|Treatment Period 2|Other|0|||
160822405|NCT01468233|580735866|FG001|Treatment Period 2|Other|0|||
160822406|NCT01468233|580735867|FG002|Treatment Period 2|Other|3|||
160822407|NCT01468233|580735868|FG003|Treatment Period 2|Other|0|||
160822408|NCT01468233|580735869|FG004|Treatment Period 2|Other|1|||
160822409|NCT01468233|580735870|FG005|Treatment Period 2|Other|0|||
160822410|NCT01574157|580735874|FG000|Overall Study|Withdrawal by Subject|4|||
160822411|NCT01574157|580735875|FG001|Overall Study|Withdrawal by Subject|5|||
160822412|NCT01574157|580735874|FG000|Overall Study|Lost to Follow-up|0|||
160822413|NCT01574157|580735875|FG001|Overall Study|Lost to Follow-up|3|||
160822414|NCT01944098|580735876|FG000|Overall Study|Physician Decision|1|||
160822415|NCT01944098|580735877|FG001|Overall Study|Physician Decision|0|||
160822416|NCT02136680|580735878|FG000|Overall Study|No Longer Interested|1|||
160822417|NCT02136680|580735879|FG001|Overall Study|No Longer Interested|1|||
160822418|NCT02136680|580735878|FG000|Overall Study|No longer receiving care at clinic|3|||
160822419|NCT02136680|580735879|FG001|Overall Study|No longer receiving care at clinic|5|||
160822420|NCT02136680|580735878|FG000|Overall Study|Moved away|5|||
160822421|NCT02136680|580735879|FG001|Overall Study|Moved away|4|||
160822422|NCT02136680|580735878|FG000|Overall Study|Unable to schedule|17|||
160822423|NCT02136680|580735879|FG001|Overall Study|Unable to schedule|16|||
160822424|NCT02136680|580735878|FG000|Overall Study|Study ended before interview due|6|||
160822425|NCT02136680|580735879|FG001|Overall Study|Study ended before interview due|3|||
160822426|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
160822427|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
160822428|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
160822429|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
160822430|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
160822431|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
160822432|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
160822433|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
160822434|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
160822435|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
160822436|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
160822437|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
160822438|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
160822439|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
160822440|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
160822441|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
160822442|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
160822443|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
160822444|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
160822445|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
160822446|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
160822447|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
160822448|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
160822449|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
160822450|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
160822451|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
160822452|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
160822453|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
160822454|NCT01846299|580735887|FG000|Overall Study|Physician Decision|4|||
160822455|NCT01846299|580735888|FG001|Overall Study|Physician Decision|2|||
160822456|NCT01846299|580735887|FG000|Overall Study|Protocol deviation|1|||
160822457|NCT01846299|580735888|FG001|Overall Study|Protocol deviation|0|||
160822458|NCT01846299|580735887|FG000|Overall Study|Death|1|||
160822459|NCT01846299|580735888|FG001|Overall Study|Death|2|||
160822460|NCT01846299|580735887|FG000|Overall Study|Lost to Follow-up|3|||
160822461|NCT01846299|580735888|FG001|Overall Study|Lost to Follow-up|0|||
160822462|NCT01846299|580735887|FG000|Overall Study|Withdrawal by Subject|1|||
160822463|NCT01846299|580735888|FG001|Overall Study|Withdrawal by Subject|6|||
160901705|NCT02713204|581034071|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160901706|NCT02713204|581034072|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160901707|NCT02713204|581034073|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160646433|NCT01464827|580088241|FG006|Overall Study|Adverse Event|0|||
160822464|NCT01846299|580735887|FG000|Overall Study|Adverse Event|2|||
160822465|NCT01846299|580735888|FG001|Overall Study|Adverse Event|0|||
160822466|NCT03559517|580735889|FG000|Overall Study|Withdrawal by Subject|1|||
160822467|NCT03559517|580735890|FG001|Overall Study|Withdrawal by Subject|0|||
160901708|NCT02713204|581034066|FG000|From Week 12 up to Week 36|Adverse Event|1|||
160822468|NCT03559517|580735891|FG002|Overall Study|Withdrawal by Subject|0|||
160901709|NCT02713204|581034067|FG001|From Week 12 up to Week 36|Adverse Event|0|||
160822469|NCT01330628|580735892|FG000|Overall Study|Death|2|||
160822470|NCT01330628|580735893|FG001|Overall Study|Death|3|||
160822471|NCT01330628|580735892|FG000|Overall Study|Lost to Follow-up|5|||
160822472|NCT01330628|580735893|FG001|Overall Study|Lost to Follow-up|6|||
160822473|NCT01330628|580735892|FG000|Overall Study|Adverse Event|44|||
160822474|NCT01330628|580735893|FG001|Overall Study|Adverse Event|25|||
160822475|NCT01330628|580735892|FG000|Overall Study|Withdrawn|18|||
160822476|NCT01330628|580735893|FG001|Overall Study|Withdrawn|6|||
160822477|NCT01330628|580735892|FG000|Overall Study|Didn't receive study treatment|1|||
160822478|NCT01330628|580735893|FG001|Overall Study|Didn't receive study treatment|0|||
160822479|NCT03761394|580735894|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
160822480|NCT03761394|580735895|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
160822481|NCT03761394|580735896|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
160822482|NCT03761394|580735897|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
160822483|NCT03761394|580735894|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
160822484|NCT03761394|580735895|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
160822485|NCT03761394|580735896|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
160822486|NCT03761394|580735897|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
160822487|NCT03761394|580735894|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
160822488|NCT03761394|580735895|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
160822489|NCT03761394|580735896|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
160822490|NCT03761394|580735897|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
160822491|NCT03761394|580735894|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
160822492|NCT03761394|580735895|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
160822493|NCT03761394|580735896|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
160822494|NCT03761394|580735897|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
160822495|NCT01080768|580735907|FG000|Overall Study|Protocol Deviation|2|||
160822496|NCT01080768|580735908|FG001|Overall Study|Protocol Deviation|1|||
160822497|NCT00580034|580735919|FG000|Overall Study|Toxicity|10|||
160822498|NCT00580034|580735920|FG001|Overall Study|Toxicity|0|||
160822499|NCT01939002|580735921|FG000|Overall Study|Adverse Event|13|||
160822500|NCT01939002|580735922|FG001|Overall Study|Adverse Event|13|||
160822501|NCT01939002|580735921|FG000|Overall Study|Withdrawal by Subject|5|||
160822502|NCT01939002|580735922|FG001|Overall Study|Withdrawal by Subject|3|||
160822503|NCT01939002|580735921|FG000|Overall Study|Other|1|||
160822504|NCT01939002|580735922|FG001|Overall Study|Other|2|||
160822505|NCT00098748|580735926|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
160822506|NCT00098748|580735927|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
160822507|NCT00098748|580735928|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
160822508|NCT00098748|580735926|FG000|Received Study Treatment|Death|2|||
160822509|NCT00098748|580735927|FG001|Received Study Treatment|Death|1|||
160822510|NCT00098748|580735928|FG002|Received Study Treatment|Death|2|||
160822511|NCT00098748|580735926|FG000|Received Study Treatment|Adverse Event|1|||
160822512|NCT00098748|580735927|FG001|Received Study Treatment|Adverse Event|2|||
160822513|NCT00098748|580735928|FG002|Received Study Treatment|Adverse Event|5|||
160822514|NCT00098748|580735926|FG000|Received Study Treatment|Lack of Efficacy|40|||
160822515|NCT00098748|580735927|FG001|Received Study Treatment|Lack of Efficacy|27|||
160822516|NCT00098748|580735928|FG002|Received Study Treatment|Lack of Efficacy|27|||
160822517|NCT00098748|580735926|FG000|Received Study Treatment|Other|2|||
160822518|NCT00098748|580735927|FG001|Received Study Treatment|Other|2|||
160822519|NCT00098748|580735928|FG002|Received Study Treatment|Other|6|||
160646434|NCT01464827|580088242|FG007|Overall Study|Adverse Event|0|||
160822520|NCT00098748|580735926|FG000|Received Study Treatment|Subject defaulted|3|||
160822521|NCT00098748|580735927|FG001|Received Study Treatment|Subject defaulted|4|||
160822522|NCT00098748|580735928|FG002|Received Study Treatment|Subject defaulted|4|||
160822523|NCT00098748|580735926|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
160822524|NCT00098748|580735927|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
160822525|NCT00098748|580735928|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
160822526|NCT00098748|580735926|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
160822527|NCT00098748|580735927|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
160822528|NCT00098748|580735928|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
160822529|NCT00098748|580735926|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
160822530|NCT00098748|580735927|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
160822531|NCT00098748|580735928|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
160822532|NCT00098748|580735926|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
160822533|NCT00098748|580735927|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
160822534|NCT00098748|580735928|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
160822535|NCT00098748|580735926|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
160822536|NCT00098748|580735927|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
160989334|NCT05074498|581349501|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
160989335|NCT05074498|581349502|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
160989336|NCT05074498|581349503|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
160989337|NCT05074498|581349504|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
160989338|NCT05074498|581349499|FG000|Part 2 (Upto Day 104)|Death|0|||
160989339|NCT05074498|581349500|FG001|Part 2 (Upto Day 104)|Death|0|||
160989340|NCT05074498|581349501|FG002|Part 2 (Upto Day 104)|Death|0|||
160989341|NCT05074498|581349502|FG003|Part 2 (Upto Day 104)|Death|0|||
160989342|NCT05074498|581349503|FG004|Part 2 (Upto Day 104)|Death|1|||
160989343|NCT05074498|581349504|FG005|Part 2 (Upto Day 104)|Death|0|||
160989344|NCT05074498|581349499|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
160989345|NCT05074498|581349500|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
160989346|NCT05074498|581349501|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
160989347|NCT05074498|581349502|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
160989348|NCT05074498|581349503|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
160989349|NCT05074498|581349504|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
160989350|NCT05074498|581349499|FG000|Part 2 (Upto Day 104)|Other|0|||
160989351|NCT05074498|581349500|FG001|Part 2 (Upto Day 104)|Other|0|||
160989352|NCT05074498|581349501|FG002|Part 2 (Upto Day 104)|Other|0|||
160989353|NCT05074498|581349502|FG003|Part 2 (Upto Day 104)|Other|0|||
160989354|NCT05074498|581349503|FG004|Part 2 (Upto Day 104)|Other|1|||
160989355|NCT05074498|581349504|FG005|Part 2 (Upto Day 104)|Other|0|||
160989356|NCT01677936|581349507|FG000|Overall Study|Lost to Follow-up|4|||
160989357|NCT01677936|581349508|FG001|Overall Study|Lost to Follow-up|1|||
160822537|NCT00098748|580735928|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
160989358|NCT01677936|581349507|FG000|Overall Study|Protocol Violation|3|||
160989359|NCT01677936|581349508|FG001|Overall Study|Protocol Violation|0|||
160989360|NCT01677936|581349507|FG000|Overall Study|Adverse Event|1|||
160989361|NCT01677936|581349508|FG001|Overall Study|Adverse Event|0|||
160989362|NCT01677936|581349507|FG000|Overall Study|Lost to Follow-up|1|||
160989363|NCT01677936|581349508|FG001|Overall Study|Lost to Follow-up|0|||
160989364|NCT01677936|581349507|FG000|Overall Study|Protocol Violation|0|||
160989365|NCT01677936|581349508|FG001|Overall Study|Protocol Violation|4|||
160989366|NCT01257503|581349512|FG000|Overall Study|Lost to Follow-up|7|||
160989367|NCT01257503|581349513|FG001|Overall Study|Lost to Follow-up|10|||
160989368|NCT01257503|581349512|FG000|Overall Study|Over 5 years old at enrollment|0|||
160989369|NCT01257503|581349513|FG001|Overall Study|Over 5 years old at enrollment|1|||
160989370|NCT01257503|581349512|FG000|Overall Study|strep culture positive at enrollment|1|||
160989371|NCT01257503|581349513|FG001|Overall Study|strep culture positive at enrollment|0|||
160989372|NCT00088465|581349514|FG000|Overall Study|Withdrawal by Subject|290|||
160989373|NCT00088465|581349514|FG000|Overall Study|Adverse Event|77|||
160989374|NCT00088465|581349514|FG000|Overall Study|Lost to Follow-up|57|||
160989375|NCT00088465|581349514|FG000|Overall Study|Physician Decision|45|||
160989376|NCT00088465|581349514|FG000|Overall Study|Sponsor Decision|37|||
160989377|NCT00088465|581349514|FG000|Overall Study|Lack of Efficacy|27|||
160822538|NCT03095027|580737723|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
160822539|NCT03095027|580737724|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
160822540|NCT02982018|580737725|FG000|Overall Study|Incorrect Lens Dispensed|1|||
160822541|NCT02982018|580737726|FG001|Overall Study|Incorrect Lens Dispensed|0|||
160822542|NCT02982018|580737725|FG000|Overall Study|Protocol Violation|1|||
160822543|NCT02982018|580737726|FG001|Overall Study|Protocol Violation|1|||
160822544|NCT02982018|580737725|FG000|Overall Study|Adverse Event|1|||
160822545|NCT02982018|580737726|FG001|Overall Study|Adverse Event|1|||
160989378|NCT00088465|581349514|FG000|Overall Study|Protocol Violation|17|||
160989379|NCT00088465|581349514|FG000|Overall Study|Death|11|||
160989380|NCT04565249|581349515|FG000|Overall Study|Death|0|||
160989381|NCT04565249|581349516|FG001|Overall Study|Death|0|||
160989382|NCT04565249|581349517|FG002|Overall Study|Death|0|||
160989383|NCT04565249|581349518|FG003|Overall Study|Death|1|||
160822546|NCT02982018|580737725|FG000|Overall Study|Lens Discomfort|2|||
160989384|NCT02333630|581349519|FG000|Overall Study|Lost to Follow-up|5|||
160989385|NCT02333630|581349520|FG001|Overall Study|Lost to Follow-up|2|||
160989386|NCT04337489|581349527|FG000|Overall Study|Withdrawal by Subject|1|||
160989387|NCT03255941|581349528|FG000|Overall Study|Not eligible or refused injection|37|||
160989388|NCT03255941|581349529|FG001|Overall Study|Not eligible or refused injection|44|||
160989389|NCT03255941|581349530|FG002|Overall Study|Not eligible or refused injection|5|||
160989390|NCT03255941|581349531|FG003|Overall Study|Not eligible or refused injection|6|||
160822547|NCT02982018|580737726|FG001|Overall Study|Lens Discomfort|0|||
160822548|NCT02982018|580737725|FG000|Overall Study|Withdrawal by Subject|0|||
160989391|NCT03255941|581349528|FG000|Overall Study|Did not complete exit interview|1|||
160822549|NCT02982018|580737726|FG001|Overall Study|Withdrawal by Subject|1|||
160822550|NCT03361189|580737730|FG000|Overall Study|Received heart transplant|1|||
160822551|NCT03361189|580737731|FG001|Overall Study|Received heart transplant|0|||
160989392|NCT03255941|581349529|FG001|Overall Study|Did not complete exit interview|2|||
160989393|NCT03255941|581349530|FG002|Overall Study|Did not complete exit interview|0|||
160989394|NCT03255941|581349531|FG003|Overall Study|Did not complete exit interview|0|||
160989395|NCT00335153|581349543|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
160822552|NCT03361189|580737730|FG000|Overall Study|Pacemake replacement|0|||
160822553|NCT03361189|580737731|FG001|Overall Study|Pacemake replacement|1|||
160901710|NCT02713204|581034068|FG002|From Week 12 up to Week 36|Adverse Event|0|||
160901711|NCT02713204|581034069|FG003|From Week 12 up to Week 36|Adverse Event|1|||
160901712|NCT02713204|581034070|FG004|From Week 12 up to Week 36|Adverse Event|1|||
160901713|NCT02713204|581034071|FG005|From Week 12 up to Week 36|Adverse Event|0|||
160901714|NCT02713204|581034072|FG006|From Week 12 up to Week 36|Adverse Event|2|||
160901715|NCT02713204|581034073|FG007|From Week 12 up to Week 36|Adverse Event|1|||
160901716|NCT02713204|581034066|FG000|From Week 12 up to Week 36|Death|0|||
160901717|NCT02713204|581034067|FG001|From Week 12 up to Week 36|Death|0|||
160901718|NCT02713204|581034068|FG002|From Week 12 up to Week 36|Death|0|||
160901719|NCT02713204|581034069|FG003|From Week 12 up to Week 36|Death|1|||
160901720|NCT02713204|581034070|FG004|From Week 12 up to Week 36|Death|0|||
160901721|NCT02713204|581034071|FG005|From Week 12 up to Week 36|Death|1|||
160901722|NCT02713204|581034072|FG006|From Week 12 up to Week 36|Death|0|||
160901723|NCT02713204|581034073|FG007|From Week 12 up to Week 36|Death|3|||
160901724|NCT02713204|581034066|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
160901725|NCT02713204|581034067|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
160989396|NCT00335153|581349543|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
160989397|NCT00335153|581349543|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
160989398|NCT00335153|581349543|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
160989399|NCT00335153|581349543|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
160989400|NCT00335153|581349543|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
160989401|NCT00335153|581349543|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
160989402|NCT00335153|581349543|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
160989403|NCT00335153|581349543|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
160989404|NCT00335153|581349543|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
160989405|NCT01528709|581349544|FG000|Overall Study|Death|2|||
160989406|NCT01528709|581349545|FG001|Overall Study|Death|0|||
160989407|NCT01528709|581349544|FG000|Overall Study|Withdrawal by Subject|10|||
160989408|NCT01528709|581349545|FG001|Overall Study|Withdrawal by Subject|15|||
160553542|NCT03502330|579753431|FG000|Overall Study|Withdrawal by Subject|0|||
160553543|NCT03502330|579753432|FG001|Overall Study|Withdrawal by Subject|0|||
160989409|NCT01528709|581349544|FG000|Overall Study|allergy|1|||
160989410|NCT01528709|581349545|FG001|Overall Study|allergy|0|||
160989411|NCT03398356|581349548|FG000|Before Treatment|Lost to Follow-up|1|||
160989412|NCT03398356|581349549|FG001|Before Treatment|Lost to Follow-up|2|||
160989413|NCT03398356|581349550|FG002|Before Treatment|Lost to Follow-up|0|||
160989414|NCT03398356|581349548|FG000|Before Treatment|drug intolerance|2|||
160989415|NCT03398356|581349549|FG001|Before Treatment|drug intolerance|1|||
160989416|NCT03398356|581349550|FG002|Before Treatment|drug intolerance|0|||
160822554|NCT03344549|580737732|FG000|Overall Study|Withdrawal by Subject|3|||
160822555|NCT03344549|580737733|FG001|Overall Study|Withdrawal by Subject|2|||
160822556|NCT03344549|580737732|FG000|Overall Study|Dialysis|2|||
160822557|NCT03344549|580737733|FG001|Overall Study|Dialysis|0|||
160822558|NCT03344549|580737732|FG000|Overall Study|Cancer|1|||
160822559|NCT03344549|580737733|FG001|Overall Study|Cancer|0|||
160822560|NCT03344549|580737732|FG000|Overall Study|Lack of electronic device|1|||
160822561|NCT03344549|580737733|FG001|Overall Study|Lack of electronic device|0|||
160822562|NCT03344549|580737732|FG000|Overall Study|Transportation difficulty|0|||
160822563|NCT03344549|580737733|FG001|Overall Study|Transportation difficulty|13|||
160822564|NCT01685801|580737739|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
160822565|NCT01685801|580737740|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
160822566|NCT01685801|580737741|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
160822567|NCT01685801|580737742|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
160822568|NCT01685801|580737739|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
160822569|NCT01685801|580737740|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
160822570|NCT01685801|580737741|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
160822571|NCT01685801|580737742|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
160822572|NCT00113399|580737743|FG000|Overall Study|Death|1|||
160822573|NCT00113399|580737744|FG001|Overall Study|Death|1|||
160822574|NCT00113399|580737743|FG000|Overall Study|Withdrawal by Subject|1|||
160822575|NCT00113399|580737744|FG001|Overall Study|Withdrawal by Subject|2|||
160822576|NCT00113399|580737743|FG000|Overall Study|Complete Response|0|||
160901726|NCT02713204|581034068|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
160901727|NCT02713204|581034069|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
160989417|NCT03398356|581349548|FG000|Before Treatment|Withdrawal by Subject|0|||
160553544|NCT03502330|579753433|FG002|Overall Study|Withdrawal by Subject|0|||
160553545|NCT03502330|579753434|FG003|Overall Study|Withdrawal by Subject|0|||
160822577|NCT00113399|580737744|FG001|Overall Study|Complete Response|1|||
160822578|NCT00113399|580737743|FG000|Overall Study|Other|0|||
160822579|NCT00113399|580737744|FG001|Overall Study|Other|1|||
160822580|NCT00666588|580737745|FG000|Overall Study|ineligible|2|||
160822581|NCT00666588|580737746|FG001|Overall Study|ineligible|0|||
160822582|NCT00666588|580737747|FG002|Overall Study|ineligible|0|||
160901728|NCT02713204|581034070|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
160989418|NCT03398356|581349549|FG001|Before Treatment|Withdrawal by Subject|5|||
160553546|NCT03502330|579753435|FG004|Overall Study|Withdrawal by Subject|0|||
160553547|NCT03502330|579753436|FG005|Overall Study|Withdrawal by Subject|1|||
160553548|NCT03502330|579753437|FG006|Overall Study|Withdrawal by Subject|0|||
160553549|NCT03502330|579753438|FG007|Overall Study|Withdrawal by Subject|1|||
160553550|NCT03502330|579753439|FG008|Overall Study|Withdrawal by Subject|0|||
160553551|NCT03502330|579753431|FG000|Overall Study|Death|0|||
160822583|NCT00666588|580737748|FG003|Overall Study|ineligible|2|||
160822584|NCT00666588|580737745|FG000|Overall Study|inevaluable|2|||
160989419|NCT03398356|581349550|FG002|Before Treatment|Withdrawal by Subject|0|||
160989420|NCT03398356|581349548|FG000|Before Treatment|Physician Decision|0|||
160989421|NCT03398356|581349549|FG001|Before Treatment|Physician Decision|0|||
160989422|NCT03398356|581349550|FG002|Before Treatment|Physician Decision|11|||
160989423|NCT03398356|581349548|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
160989424|NCT03398356|581349549|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
160989425|NCT03398356|581349550|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
160989426|NCT04438785|581349553|FG000|Overall Study|change of weight, give up intervention|2|||
160989427|NCT04438785|581349554|FG001|Overall Study|change of weight, give up intervention|10|||
160989428|NCT04831775|581349555|FG000|Overall Study|Lost to Follow-up|11|||
160989429|NCT04831775|581349556|FG001|Overall Study|Lost to Follow-up|13|||
160989430|NCT02027935|581349557|FG000|Overall Study|Death|1|||
160989431|NCT02027935|581349557|FG000|Overall Study|Lack of Efficacy|5|||
160989432|NCT02027935|581349557|FG000|Overall Study|Study Closure|1|||
160989433|NCT00689104|581349558|FG000|Overall Study|Eligibility criterion not met|5|||
160989434|NCT00689104|581349559|FG001|Overall Study|Eligibility criterion not met|8|||
160989435|NCT00689104|581349560|FG002|Overall Study|Eligibility criterion not met|0|||
160989436|NCT00689104|581349561|FG003|Overall Study|Eligibility criterion not met|4|||
160989437|NCT00689104|581349558|FG000|Overall Study|Adverse Event|13|||
160989438|NCT00689104|581349559|FG001|Overall Study|Adverse Event|25|||
160989439|NCT00689104|581349560|FG002|Overall Study|Adverse Event|16|||
160989440|NCT00689104|581349561|FG003|Overall Study|Adverse Event|24|||
160989441|NCT00689104|581349558|FG000|Overall Study|Lack of Efficacy|5|||
160989442|NCT00689104|581349559|FG001|Overall Study|Lack of Efficacy|6|||
160989443|NCT00689104|581349560|FG002|Overall Study|Lack of Efficacy|2|||
160989444|NCT00689104|581349561|FG003|Overall Study|Lack of Efficacy|3|||
160989445|NCT00689104|581349558|FG000|Overall Study|Withdrawal by Subject|12|||
160989446|NCT00689104|581349559|FG001|Overall Study|Withdrawal by Subject|11|||
160989447|NCT00689104|581349560|FG002|Overall Study|Withdrawal by Subject|18|||
160989448|NCT00689104|581349561|FG003|Overall Study|Withdrawal by Subject|11|||
160989449|NCT00689104|581349558|FG000|Overall Study|Lost to Follow-up|4|||
160989450|NCT00689104|581349559|FG001|Overall Study|Lost to Follow-up|3|||
160989451|NCT00689104|581349560|FG002|Overall Study|Lost to Follow-up|2|||
160989452|NCT00689104|581349561|FG003|Overall Study|Lost to Follow-up|5|||
160989453|NCT00689104|581349558|FG000|Overall Study|Protocol Violation|2|||
160989454|NCT00689104|581349559|FG001|Overall Study|Protocol Violation|3|||
160989455|NCT00689104|581349560|FG002|Overall Study|Protocol Violation|5|||
160989456|NCT00689104|581349561|FG003|Overall Study|Protocol Violation|3|||
160989457|NCT00689104|581349558|FG000|Overall Study|Randomized but never received study drug|2|||
160989458|NCT00689104|581349559|FG001|Overall Study|Randomized but never received study drug|1|||
160989459|NCT00689104|581349560|FG002|Overall Study|Randomized but never received study drug|1|||
160989460|NCT00689104|581349561|FG003|Overall Study|Randomized but never received study drug|0|||
160989461|NCT00689104|581349558|FG000|Overall Study|Physician Decision|1|||
160989462|NCT00689104|581349559|FG001|Overall Study|Physician Decision|0|||
160989463|NCT00689104|581349560|FG002|Overall Study|Physician Decision|0|||
160989464|NCT00689104|581349561|FG003|Overall Study|Physician Decision|0|||
160822585|NCT00666588|580737746|FG001|Overall Study|inevaluable|0|||
160822586|NCT00666588|580737747|FG002|Overall Study|inevaluable|0|||
160822587|NCT00666588|580737748|FG003|Overall Study|inevaluable|0|||
160822588|NCT03405935|580737755|FG000|Overall Study|Adverse Event|3|||
160989465|NCT00689104|581349558|FG000|Overall Study|Non-compliance with study procedures|0|||
160989466|NCT00689104|581349559|FG001|Overall Study|Non-compliance with study procedures|0|||
160989467|NCT00689104|581349560|FG002|Overall Study|Non-compliance with study procedures|1|||
160989468|NCT00689104|581349561|FG003|Overall Study|Non-compliance with study procedures|0|||
160989469|NCT01737268|581349562|FG000|Overall Study|Adverse Event|6|||
160989470|NCT01737268|581349562|FG000|Overall Study|Worsening of Target Disease|2|||
160553552|NCT03502330|579753432|FG001|Overall Study|Death|0|||
160553553|NCT03502330|579753433|FG002|Overall Study|Death|0|||
160553554|NCT03502330|579753434|FG003|Overall Study|Death|0|||
160553555|NCT03502330|579753435|FG004|Overall Study|Death|0|||
160553556|NCT03502330|579753436|FG005|Overall Study|Death|0|||
160822589|NCT03405935|580737755|FG000|Overall Study|Death|2|||
160822590|NCT03405935|580737755|FG000|Overall Study|Withdrawal by Subject|1|||
160822591|NCT03405935|580737755|FG000|Overall Study|Lost to Follow-up|2|||
160822592|NCT04979897|580737761|FG000|Overall Study|Death|1|||
160989471|NCT01737268|581349562|FG000|Overall Study|In consideration of the patient's safety|1|||
160989472|NCT04873817|581349563|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
160989473|NCT04873817|581349563|FG000|Overall Study|Lost to Follow-up|4|||
160989474|NCT04873817|581349563|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
160989475|NCT04873817|581349563|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
160989476|NCT04873817|581349563|FG000|Overall Study|Other Reasons|3|||
160989477|NCT02696226|581349571|FG000|Overall Study|Study terminated - lack of enrollment|1|||
160989478|NCT02696226|581349572|FG001|Overall Study|Study terminated - lack of enrollment|0|||
160989479|NCT02696226|581349573|FG002|Overall Study|Study terminated - lack of enrollment|2|||
160989480|NCT02696226|581349574|FG003|Overall Study|Study terminated - lack of enrollment|0|||
160989481|NCT01394991|581349577|FG000|Overall Study|Adverse Event|0|||
160989482|NCT01394991|581349578|FG001|Overall Study|Adverse Event|4|||
160989483|NCT01394991|581349577|FG000|Overall Study|Lack of Efficacy|5|||
160989484|NCT01394991|581349578|FG001|Overall Study|Lack of Efficacy|7|||
160822593|NCT04979897|580737762|FG001|Overall Study|Death|8|||
160822594|NCT04979897|580737761|FG000|Overall Study|Lost to Follow-up|111|||
160822595|NCT04979897|580737762|FG001|Overall Study|Lost to Follow-up|56|||
160822596|NCT04979897|580737761|FG000|Overall Study|Withdrawal by Subject|7|||
160822597|NCT04979897|580737762|FG001|Overall Study|Withdrawal by Subject|2|||
160822598|NCT01774097|580737763|FG000|Overall Study|Withdrawal by Subject|1|||
160822599|NCT01774097|580737764|FG001|Overall Study|Withdrawal by Subject|1|||
160822600|NCT01774097|580737763|FG000|Overall Study|Adverse Event|1|||
160989485|NCT01394991|581349577|FG000|Overall Study|Lost to Follow-up|6|||
160989486|NCT01394991|581349578|FG001|Overall Study|Lost to Follow-up|8|||
160989487|NCT01394991|581349577|FG000|Overall Study|Physician Decision|1|||
160989488|NCT01394991|581349578|FG001|Overall Study|Physician Decision|3|||
160822601|NCT01774097|580737764|FG001|Overall Study|Adverse Event|1|||
160822602|NCT00543296|580737766|FG000|Overall Study|Physician Decision|7|||
160822603|NCT03136497|580737767|FG000|Overall Study|Screen Failure|1|||
160822604|NCT03136497|580737768|FG001|Overall Study|Screen Failure|0|||
160822605|NCT03136497|580737769|FG002|Overall Study|Screen Failure|0|||
160989489|NCT01394991|581349577|FG000|Overall Study|Protocol Violation|1|||
160989490|NCT01394991|581349578|FG001|Overall Study|Protocol Violation|1|||
160989491|NCT01394991|581349577|FG000|Overall Study|Withdrawal by Subject|20|||
160989492|NCT01394991|581349578|FG001|Overall Study|Withdrawal by Subject|17|||
160989493|NCT01394991|581349577|FG000|Overall Study|Chemotherapy Termination|10|||
160822606|NCT00934947|580737772|FG000|Overall Study|Adverse Event|0|||
160822607|NCT00934947|580737773|FG001|Overall Study|Adverse Event|2|||
160822608|NCT00557310|580737774|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
160822609|NCT00557310|580737774|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
160822610|NCT00557310|580737774|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
160822611|NCT00557310|580737774|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
160822612|NCT00557310|580737774|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
160822613|NCT00557310|580737774|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
160822614|NCT02781792|580737776|FG000|Overall Study|Adverse Event|1|||
160822615|NCT02781792|580737777|FG001|Overall Study|Adverse Event|2|||
160822616|NCT02781792|580737776|FG000|Overall Study|Withdrawal by Subject|3|||
160822617|NCT02781792|580737777|FG001|Overall Study|Withdrawal by Subject|1|||
160822618|NCT02781792|580737776|FG000|Overall Study|Lack of Efficacy|1|||
160822619|NCT02781792|580737777|FG001|Overall Study|Lack of Efficacy|1|||
160989494|NCT01394991|581349578|FG001|Overall Study|Chemotherapy Termination|15|||
160989495|NCT01394991|581349577|FG000|Overall Study|Disease Progression|7|||
160822620|NCT02781792|580737776|FG000|Overall Study|Hospice|0|||
160989496|NCT01394991|581349578|FG001|Overall Study|Disease Progression|7|||
160989497|NCT01394991|581349577|FG000|Overall Study|Prematurely Termination of Trial|9|||
160553557|NCT03502330|579753437|FG006|Overall Study|Death|2|||
160822621|NCT02781792|580737777|FG001|Overall Study|Hospice|1|||
160822622|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
160822623|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
160822624|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
160822625|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
160822626|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
160822627|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
160822628|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
160822629|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822630|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822631|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822632|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
160822633|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
160822634|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160901729|NCT02713204|581034071|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
160901730|NCT02713204|581034072|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
160901731|NCT02713204|581034073|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
160901732|NCT02713204|581034066|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
160901733|NCT02713204|581034067|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
160901734|NCT02713204|581034068|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
160901735|NCT02713204|581034069|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
160901736|NCT02713204|581034070|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
160901737|NCT02713204|581034071|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
160901738|NCT02713204|581034072|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
160901739|NCT02713204|581034073|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
160901740|NCT00474760|581034077|FG000|Overall Study|Death|0|||
160901741|NCT00474760|581034078|FG001|Overall Study|Death|0|||
160901742|NCT00474760|581034079|FG002|Overall Study|Death|0|||
160901743|NCT00474760|581034080|FG003|Overall Study|Death|0|||
160901744|NCT00474760|581034081|FG004|Overall Study|Death|2|||
160901745|NCT00474760|581034082|FG005|Overall Study|Death|0|||
160901746|NCT00474760|581034083|FG006|Overall Study|Death|0|||
160901747|NCT00474760|581034077|FG000|Overall Study|Adverse Event|0|||
160901748|NCT00474760|581034078|FG001|Overall Study|Adverse Event|0|||
160901749|NCT00474760|581034079|FG002|Overall Study|Adverse Event|0|||
160901750|NCT00474760|581034080|FG003|Overall Study|Adverse Event|0|||
160901751|NCT00474760|581034081|FG004|Overall Study|Adverse Event|1|||
160901752|NCT00474760|581034082|FG005|Overall Study|Adverse Event|7|||
160901753|NCT00474760|581034083|FG006|Overall Study|Adverse Event|0|||
160901754|NCT00474760|581034077|FG000|Overall Study|Laboratory abnormality|0|||
160901755|NCT00474760|581034078|FG001|Overall Study|Laboratory abnormality|0|||
160901756|NCT00474760|581034079|FG002|Overall Study|Laboratory abnormality|0|||
160901757|NCT00474760|581034080|FG003|Overall Study|Laboratory abnormality|0|||
160901758|NCT00474760|581034081|FG004|Overall Study|Laboratory abnormality|0|||
160901759|NCT00474760|581034082|FG005|Overall Study|Laboratory abnormality|1|||
160901760|NCT00474760|581034083|FG006|Overall Study|Laboratory abnormality|0|||
160901761|NCT00474760|581034077|FG000|Overall Study|Withdrawal by Subject|0|||
160901762|NCT00474760|581034078|FG001|Overall Study|Withdrawal by Subject|0|||
160901763|NCT00474760|581034079|FG002|Overall Study|Withdrawal by Subject|0|||
160901764|NCT00474760|581034080|FG003|Overall Study|Withdrawal by Subject|1|||
160901765|NCT00474760|581034081|FG004|Overall Study|Withdrawal by Subject|0|||
160901766|NCT00474760|581034082|FG005|Overall Study|Withdrawal by Subject|1|||
160901767|NCT00474760|581034083|FG006|Overall Study|Withdrawal by Subject|1|||
160901768|NCT00474760|581034077|FG000|Overall Study|Other|0|||
160901769|NCT00474760|581034078|FG001|Overall Study|Other|1|||
160901770|NCT00474760|581034079|FG002|Overall Study|Other|0|||
160901771|NCT00474760|581034080|FG003|Overall Study|Other|0|||
160901772|NCT00474760|581034081|FG004|Overall Study|Other|1|||
160901773|NCT00474760|581034082|FG005|Overall Study|Other|0|||
160901774|NCT00474760|581034083|FG006|Overall Study|Other|0|||
160901775|NCT00474760|581034077|FG000|Overall Study|Progressive disease|3|||
160901776|NCT00474760|581034078|FG001|Overall Study|Progressive disease|2|||
160901777|NCT00474760|581034079|FG002|Overall Study|Progressive disease|3|||
160901778|NCT00474760|581034080|FG003|Overall Study|Progressive disease|2|||
160901779|NCT00474760|581034081|FG004|Overall Study|Progressive disease|8|||
160901780|NCT00474760|581034082|FG005|Overall Study|Progressive disease|20|||
160901781|NCT00474760|581034083|FG006|Overall Study|Progressive disease|7|||
160901782|NCT00474760|581034077|FG000|Overall Study|Terminated by sponsor|0|||
160901783|NCT00474760|581034078|FG001|Overall Study|Terminated by sponsor|0|||
160901784|NCT00474760|581034079|FG002|Overall Study|Terminated by sponsor|0|||
160989498|NCT01394991|581349578|FG001|Overall Study|Prematurely Termination of Trial|10|||
160901785|NCT00474760|581034080|FG003|Overall Study|Terminated by sponsor|0|||
160553558|NCT03502330|579753438|FG007|Overall Study|Death|0|||
160822635|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822636|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822637|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822638|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822639|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822640|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
160822641|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822642|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
160822643|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822644|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822645|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
160822646|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
160822647|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822648|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822649|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822650|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822651|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822652|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822653|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822654|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822655|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822656|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822657|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822658|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822659|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822660|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
160822661|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822662|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822663|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822664|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822665|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822666|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822667|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822668|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822669|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822670|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822671|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822672|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822673|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822674|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822675|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822676|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822677|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822678|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
160822679|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822680|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822681|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822682|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822683|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822684|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822685|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822686|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822687|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822688|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822689|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822690|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822691|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822692|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822693|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160901786|NCT00474760|581034081|FG004|Overall Study|Terminated by sponsor|0|||
160901787|NCT00474760|581034082|FG005|Overall Study|Terminated by sponsor|0|||
160901788|NCT00474760|581034083|FG006|Overall Study|Terminated by sponsor|2|||
160901789|NCT01927627|581034085|FG000|Overall Study|Adverse Event|3|||
160901790|NCT01927627|581034085|FG000|Overall Study|Lack of Efficacy|1|||
160553559|NCT03502330|579753439|FG008|Overall Study|Death|0|||
160989499|NCT02337361|581349580|FG000|3-month Follow-up|Lost to Follow-up|19|||
160989500|NCT02337361|581349581|FG001|3-month Follow-up|Lost to Follow-up|14|||
160989501|NCT02337361|581349580|FG000|6-month Follow-up|Lost to Follow-up|2|||
160989502|NCT02337361|581349581|FG001|6-month Follow-up|Lost to Follow-up|4|||
160989503|NCT03073005|581349582|FG000|Overall Study|Death|6|||
160989504|NCT03073005|581349583|FG001|Overall Study|Death|0|||
160989505|NCT03073005|581349584|FG002|Overall Study|Death|7|||
160989506|NCT03073005|581349585|FG003|Overall Study|Death|0|||
160989507|NCT03073005|581349582|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
160989508|NCT03073005|581349583|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
160989509|NCT03073005|581349584|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
160989510|NCT03073005|581349585|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
160989511|NCT03073005|581349582|FG000|Overall Study|Lost to Follow-up|2|||
160989512|NCT03073005|581349583|FG001|Overall Study|Lost to Follow-up|2|||
160989513|NCT03073005|581349584|FG002|Overall Study|Lost to Follow-up|1|||
160989514|NCT03073005|581349585|FG003|Overall Study|Lost to Follow-up|2|||
160989515|NCT03073005|581349582|FG000|Overall Study|Withdrawal by Subject|0|||
160989516|NCT03073005|581349583|FG001|Overall Study|Withdrawal by Subject|4|||
160989517|NCT03073005|581349584|FG002|Overall Study|Withdrawal by Subject|4|||
160989518|NCT03073005|581349585|FG003|Overall Study|Withdrawal by Subject|4|||
160989519|NCT00062868|581349593|FG000|Dose Level 1|Death|2|||
160989520|NCT00062868|581349594|FG001|Dose Level 1|Death|0|||
160989521|NCT00062868|581349595|FG002|Dose Level 1|Death|0|||
160989522|NCT00062868|581349596|FG003|Dose Level 1|Death|2|||
160989523|NCT00062868|581349597|FG004|Dose Level 1|Death|0|||
160989524|NCT00062868|581349598|FG005|Dose Level 1|Death|0|||
160989525|NCT00062868|581349599|FG006|Dose Level 1|Death|3|||
160989526|NCT00062868|581349600|FG007|Dose Level 1|Death|0|||
160989527|NCT00062868|581349601|FG008|Dose Level 1|Death|0|||
160989528|NCT00062868|581349602|FG009|Dose Level 1|Death|0|||
160989529|NCT00062868|581349603|FG010|Dose Level 1|Death|0|||
160989530|NCT00062868|581349604|FG011|Dose Level 1|Death|0|||
160989531|NCT00062868|581349605|FG012|Dose Level 1|Death|0|||
160989532|NCT00062868|581349606|FG013|Dose Level 1|Death|0|||
160989533|NCT00062868|581349607|FG014|Dose Level 1|Death|0|||
160989534|NCT00062868|581349608|FG015|Dose Level 1|Death|0|||
160989535|NCT00062868|581349609|FG016|Dose Level 1|Death|0|||
160989536|NCT00062868|581349610|FG017|Dose Level 1|Death|0|||
160989537|NCT00062868|581349611|FG018|Dose Level 1|Death|7|||
160989538|NCT00062868|581349612|FG019|Dose Level 1|Death|0|||
160989539|NCT00062868|581349613|FG020|Dose Level 1|Death|1|||
160989540|NCT00062868|581349593|FG000|Dose Level 1|Lost to Follow-up|0|||
160822694|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822695|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822696|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822697|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822698|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822699|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822700|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822701|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160989541|NCT00062868|581349594|FG001|Dose Level 1|Lost to Follow-up|0|||
160989542|NCT00062868|581349595|FG002|Dose Level 1|Lost to Follow-up|0|||
160989543|NCT00062868|581349596|FG003|Dose Level 1|Lost to Follow-up|0|||
160989544|NCT00062868|581349597|FG004|Dose Level 1|Lost to Follow-up|0|||
160989545|NCT00062868|581349598|FG005|Dose Level 1|Lost to Follow-up|0|||
160989546|NCT00062868|581349599|FG006|Dose Level 1|Lost to Follow-up|0|||
160989547|NCT00062868|581349600|FG007|Dose Level 1|Lost to Follow-up|0|||
160989548|NCT00062868|581349601|FG008|Dose Level 1|Lost to Follow-up|0|||
160989549|NCT00062868|581349602|FG009|Dose Level 1|Lost to Follow-up|0|||
160989550|NCT00062868|581349603|FG010|Dose Level 1|Lost to Follow-up|0|||
160989551|NCT00062868|581349604|FG011|Dose Level 1|Lost to Follow-up|0|||
160989552|NCT00062868|581349605|FG012|Dose Level 1|Lost to Follow-up|1|||
160989553|NCT00062868|581349606|FG013|Dose Level 1|Lost to Follow-up|0|||
160989554|NCT00062868|581349607|FG014|Dose Level 1|Lost to Follow-up|0|||
160989555|NCT00062868|581349608|FG015|Dose Level 1|Lost to Follow-up|0|||
160989556|NCT00062868|581349609|FG016|Dose Level 1|Lost to Follow-up|0|||
160989557|NCT00062868|581349610|FG017|Dose Level 1|Lost to Follow-up|0|||
160989558|NCT00062868|581349611|FG018|Dose Level 1|Lost to Follow-up|2|||
160989559|NCT00062868|581349612|FG019|Dose Level 1|Lost to Follow-up|0|||
160989560|NCT00062868|581349613|FG020|Dose Level 1|Lost to Follow-up|1|||
160822702|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822703|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822704|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
160822705|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822706|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822707|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822708|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822709|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822710|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822711|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822712|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822713|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822714|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822715|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
160822716|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822717|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
160822718|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822719|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822720|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822721|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160989561|NCT00062868|581349593|FG000|Dose Level 2|Death|0|||
160646435|NCT01464827|580088243|FG008|Overall Study|Adverse Event|0|||
160822722|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822723|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822724|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822725|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822726|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822727|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822728|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822729|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822730|NCT01920568|580737800|FG000|Overall Study|Adverse Event|27|||
160822731|NCT01920568|580737801|FG001|Overall Study|Adverse Event|8|||
160822732|NCT01920568|580737800|FG000|Overall Study|Protocol Violation|5|||
160822733|NCT01920568|580737801|FG001|Overall Study|Protocol Violation|3|||
160822734|NCT01920568|580737800|FG000|Overall Study|Lost to Follow-up|2|||
160822735|NCT01920568|580737801|FG001|Overall Study|Lost to Follow-up|2|||
160822736|NCT01920568|580737800|FG000|Overall Study|Physician Decision|13|||
160822737|NCT01920568|580737801|FG001|Overall Study|Physician Decision|4|||
160822738|NCT01920568|580737800|FG000|Overall Study|Withdrawal by Subject|79|||
160822739|NCT01920568|580737801|FG001|Overall Study|Withdrawal by Subject|55|||
160822740|NCT01920568|580737800|FG000|Overall Study|Death due to disease progression|25|||
160822741|NCT01920568|580737801|FG001|Overall Study|Death due to disease progression|12|||
160822742|NCT04049266|580737805|FG000|Overall Study|Adverse Event|16|||
160822743|NCT04049266|580737806|FG001|Overall Study|Adverse Event|9|||
160822744|NCT04049266|580737805|FG000|Overall Study|Non-compliance with study drug|0|||
160822745|NCT04049266|580737806|FG001|Overall Study|Non-compliance with study drug|3|||
160822746|NCT04049266|580737805|FG000|Overall Study|Withdrawal by Subject|6|||
160822747|NCT04049266|580737806|FG001|Overall Study|Withdrawal by Subject|10|||
160822748|NCT04049266|580737805|FG000|Overall Study|Lost to Follow-up|2|||
160822749|NCT04049266|580737806|FG001|Overall Study|Lost to Follow-up|2|||
160822750|NCT04049266|580737805|FG000|Overall Study|Progressive disease|11|||
160822751|NCT04049266|580737806|FG001|Overall Study|Progressive disease|2|||
160822752|NCT04049266|580737805|FG000|Overall Study|Physician Decision|1|||
160822753|NCT04049266|580737806|FG001|Overall Study|Physician Decision|0|||
160822754|NCT04049266|580737805|FG000|Overall Study|Patient moved out of state|1|||
160822755|NCT04049266|580737806|FG001|Overall Study|Patient moved out of state|0|||
160822756|NCT01703208|580737807|FG000|Overall Study|Death|61|||
160822757|NCT01703208|580737808|FG001|Overall Study|Death|48|||
160822758|NCT01703208|580737807|FG000|Overall Study|Lack of Efficacy|1|||
160822759|NCT01703208|580737808|FG001|Overall Study|Lack of Efficacy|2|||
160989562|NCT00062868|581349594|FG001|Dose Level 2|Death|3|||
160989563|NCT00062868|581349595|FG002|Dose Level 2|Death|0|||
160553560|NCT02804763|579753440|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
160553561|NCT02804763|579753441|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
160553562|NCT02804763|579753442|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
160553563|NCT02804763|579753443|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
160553564|NCT02804763|579753440|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
160553565|NCT02804763|579753441|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
160822760|NCT01703208|580737807|FG000|Overall Study|Lost to Follow-up|68|||
160822761|NCT01703208|580737808|FG001|Overall Study|Lost to Follow-up|62|||
160822762|NCT01703208|580737807|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160822763|NCT01703208|580737808|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160822764|NCT01703208|580737807|FG000|Overall Study|Excluded Medication|1|||
160822765|NCT01703208|580737808|FG001|Overall Study|Excluded Medication|2|||
160822766|NCT01703208|580737807|FG000|Overall Study|Site Discontinued Study Participation|23|||
160822767|NCT01703208|580737808|FG001|Overall Study|Site Discontinued Study Participation|27|||
160822768|NCT01703208|580737807|FG000|Overall Study|Physician Decision|11|||
160822769|NCT01703208|580737808|FG001|Overall Study|Physician Decision|13|||
160822770|NCT01703208|580737807|FG000|Overall Study|Progressive disease|2|||
160822771|NCT01703208|580737808|FG001|Overall Study|Progressive disease|2|||
160822772|NCT01703208|580737807|FG000|Overall Study|Protocol Violation|1|||
160822773|NCT01703208|580737808|FG001|Overall Study|Protocol Violation|1|||
160822774|NCT01703208|580737807|FG000|Overall Study|Study Terminated by Sponsor|1710|||
160822775|NCT01703208|580737808|FG001|Overall Study|Study Terminated by Sponsor|1716|||
160822776|NCT01703208|580737807|FG000|Overall Study|Withdrawal by Subject|205|||
160822777|NCT01703208|580737808|FG001|Overall Study|Withdrawal by Subject|209|||
160822778|NCT01703208|580737807|FG000|Overall Study|Adverse Event|14|||
160822779|NCT01703208|580737808|FG001|Overall Study|Adverse Event|19|||
160822780|NCT01703208|580737807|FG000|Overall Study|Technical Problems|0|||
160822781|NCT01703208|580737808|FG001|Overall Study|Technical Problems|1|||
160822782|NCT01703208|580737807|FG000|Overall Study|Protocol Deviation|2|||
160822783|NCT01703208|580737808|FG001|Overall Study|Protocol Deviation|0|||
160822784|NCT00252694|580737814|FG000|Overall Study|Withdrawal by Subject|83|||
160822785|NCT00252694|580737815|FG001|Overall Study|Withdrawal by Subject|91|||
160822786|NCT00252694|580737814|FG000|Overall Study|Death|36|||
160822787|NCT00252694|580737815|FG001|Overall Study|Death|34|||
160822788|NCT00252694|580737814|FG000|Overall Study|Mostly Lost to Follow Up|8|||
160822789|NCT00252694|580737815|FG001|Overall Study|Mostly Lost to Follow Up|13|||
160822790|NCT00252694|580737814|FG000|Overall Study|Patient Moving|17|||
160822791|NCT00252694|580737815|FG001|Overall Study|Patient Moving|16|||
160822792|NCT02378298|580737819|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
160822793|NCT02378298|580737820|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
160822794|NCT02378298|580737821|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
160822795|NCT02378298|580737819|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
160822796|NCT02378298|580737820|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
160822797|NCT02378298|580737821|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
160822798|NCT02378298|580737819|FG000|Surveillance (19-68 Weeks)|Death|1|||
160822799|NCT02378298|580737820|FG001|Surveillance (19-68 Weeks)|Death|0|||
160822800|NCT02378298|580737821|FG002|Surveillance (19-68 Weeks)|Death|0|||
160822801|NCT04669262|580737823|FG000|Overall Study|Withdrawal by Subject|0|||
160822802|NCT04669262|580737824|FG001|Overall Study|Withdrawal by Subject|0|||
160822803|NCT04669262|580737825|FG002|Overall Study|Withdrawal by Subject|0|||
160822804|NCT04669262|580737826|FG003|Overall Study|Withdrawal by Subject|1|||
160822805|NCT04669262|580737823|FG000|Overall Study|Randomized but Not Treated|0|||
160822806|NCT04669262|580737824|FG001|Overall Study|Randomized but Not Treated|1|||
160822807|NCT04669262|580737825|FG002|Overall Study|Randomized but Not Treated|0|||
160822808|NCT04669262|580737826|FG003|Overall Study|Randomized but Not Treated|0|||
160822809|NCT01638013|580737827|FG000|Overall Study|Adverse Event|36|||
160822810|NCT01638013|580737828|FG001|Overall Study|Adverse Event|29|||
160822811|NCT01638013|580737829|FG002|Overall Study|Adverse Event|48|||
160822812|NCT01638013|580737827|FG000|Overall Study|Lack of Efficacy|39|||
160822813|NCT01638013|580737828|FG001|Overall Study|Lack of Efficacy|11|||
160822814|NCT01638013|580737829|FG002|Overall Study|Lack of Efficacy|14|||
160822815|NCT01638013|580737827|FG000|Overall Study|Protocol Violation|10|||
160822816|NCT01638013|580737828|FG001|Overall Study|Protocol Violation|7|||
160822817|NCT01638013|580737829|FG002|Overall Study|Protocol Violation|11|||
160822818|NCT01638013|580737827|FG000|Overall Study|Met discontinuation criteria|4|||
160822819|NCT01638013|580737828|FG001|Overall Study|Met discontinuation criteria|0|||
160901791|NCT01927627|581034085|FG000|Overall Study|Financial Concerns|1|||
160822820|NCT01638013|580737829|FG002|Overall Study|Met discontinuation criteria|7|||
160901792|NCT02635776|581034086|FG000|Overall Study|Physician Decision|1|||
160822821|NCT01638013|580737827|FG000|Overall Study|Subject Lost to Follow up|1|||
160822822|NCT01638013|580737828|FG001|Overall Study|Subject Lost to Follow up|0|||
160901793|NCT02635776|581034087|FG001|Overall Study|Physician Decision|0|||
160901794|NCT02635776|581034086|FG000|Overall Study|Adverse Event|51|||
160901795|NCT02635776|581034087|FG001|Overall Study|Adverse Event|3|||
160822823|NCT01638013|580737829|FG002|Overall Study|Subject Lost to Follow up|1|||
160822824|NCT01638013|580737827|FG000|Overall Study|Miscellaneous|25|||
160822825|NCT01638013|580737828|FG001|Overall Study|Miscellaneous|19|||
160822826|NCT01638013|580737829|FG002|Overall Study|Miscellaneous|23|||
160822827|NCT01638013|580737827|FG000|Overall Study|Withdrawal of Consent|16|||
160822828|NCT01638013|580737828|FG001|Overall Study|Withdrawal of Consent|12|||
160822829|NCT01638013|580737829|FG002|Overall Study|Withdrawal of Consent|16|||
160822830|NCT01638013|580737827|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
160822831|NCT01638013|580737828|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
160822832|NCT01638013|580737829|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
160822833|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
160822834|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
160822835|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
160822836|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
160822837|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
160822838|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
160822839|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
160822840|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
160822841|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
160822842|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
160822843|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
160822844|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
160822845|NCT03549871|580737834|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
160822846|NCT03549871|580737835|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
160822847|NCT03549871|580737834|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
160822848|NCT03549871|580737835|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
160822849|NCT03549871|580737834|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
160822850|NCT03549871|580737835|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
160822851|NCT03549871|580737834|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
160822852|NCT03549871|580737835|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
160822853|NCT03549871|580737834|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
160822854|NCT03549871|580737835|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
160822855|NCT01133626|580737836|FG000|Overall Study|Adverse Event|0|||
160822856|NCT01133626|580737837|FG001|Overall Study|Adverse Event|1|||
160822857|NCT01133626|580737838|FG002|Overall Study|Adverse Event|0|||
160822858|NCT01133626|580737836|FG000|Overall Study|Withdrawal by Subject|1|||
160822859|NCT01133626|580737837|FG001|Overall Study|Withdrawal by Subject|2|||
160822860|NCT01133626|580737838|FG002|Overall Study|Withdrawal by Subject|2|||
160822861|NCT01133626|580737836|FG000|Overall Study|Other|0|||
160822862|NCT01133626|580737837|FG001|Overall Study|Other|2|||
160822863|NCT01133626|580737838|FG002|Overall Study|Other|0|||
160822864|NCT01960998|580737839|FG000|Overall Study|Lost to Follow-up|3|||
160822865|NCT01960998|580737840|FG001|Overall Study|Lost to Follow-up|7|||
160822866|NCT01960998|580737839|FG000|Overall Study|Death|0|||
160822867|NCT01960998|580737840|FG001|Overall Study|Death|1|||
160822868|NCT01960998|580737839|FG000|Overall Study|Withdrawal by Subject|8|||
160822869|NCT01960998|580737840|FG001|Overall Study|Withdrawal by Subject|2|||
160822870|NCT01960998|580737839|FG000|Overall Study|lost computer access|0|||
160822871|NCT01960998|580737840|FG001|Overall Study|lost computer access|1|||
160822872|NCT01774253|580737844|FG000|Overall Study|Lack of Efficacy|4|||
160822873|NCT01774253|580737844|FG000|Overall Study|Physician Decision|2|||
160822874|NCT01774253|580737844|FG000|Overall Study|Withdrawal by Subject|2|||
160822875|NCT01774253|580737844|FG000|Overall Study|Death|1|||
160822876|NCT00772369|580737845|FG000|Overall Study|Did not return record release form|1|||
160822877|NCT03510468|580737846|FG000|Overall Study|Lost to Follow-up|1|||
160822878|NCT03510468|580737846|FG000|Overall Study|Adverse Event|5|||
160822879|NCT03510468|580737846|FG000|Overall Study|Physician Decision|1|||
160822880|NCT03510468|580737846|FG000|Overall Study|non-compliant with treatment|2|||
160822881|NCT03510468|580737846|FG000|Overall Study|Missed visit|1|||
160822882|NCT00871117|580737848|FG000|Overall Study|Lost to Follow-up|5|||
160822883|NCT00871117|580737849|FG001|Overall Study|Lost to Follow-up|6|||
160822884|NCT00871117|580737848|FG000|Overall Study|Other|0|||
160822885|NCT00871117|580737849|FG001|Overall Study|Other|4|||
160822886|NCT02080481|580737850|FG000|Overall Study|Never received a block.|1|||
160822887|NCT02080481|580737851|FG001|Overall Study|Never received a block.|0|||
160822888|NCT04508751|580737857|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
160822889|NCT04508751|580737858|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
160822890|NCT04508751|580737859|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
160822891|NCT03551665|580737864|FG000|Overall Study|Lost to Follow-up|11|||
160901796|NCT02635776|581034086|FG000|Overall Study|Withdrawal by Subject|41|||
160901797|NCT02635776|581034087|FG001|Overall Study|Withdrawal by Subject|7|||
160989564|NCT00062868|581349596|FG003|Dose Level 2|Death|0|||
160989565|NCT00062868|581349597|FG004|Dose Level 2|Death|2|||
160822892|NCT03551665|580737865|FG001|Overall Study|Lost to Follow-up|2|||
160822893|NCT00840060|580739020|FG000|Overall Study|Withdrawal by Subject|1|||
160989566|NCT00062868|581349598|FG005|Dose Level 2|Death|0|||
160989567|NCT00062868|581349599|FG006|Dose Level 2|Death|0|||
160989568|NCT00062868|581349600|FG007|Dose Level 2|Death|0|||
160989569|NCT00062868|581349601|FG008|Dose Level 2|Death|0|||
160989570|NCT00062868|581349602|FG009|Dose Level 2|Death|0|||
160989571|NCT00062868|581349603|FG010|Dose Level 2|Death|1|||
160989572|NCT00062868|581349604|FG011|Dose Level 2|Death|0|||
160989573|NCT00062868|581349605|FG012|Dose Level 2|Death|0|||
160989574|NCT00062868|581349606|FG013|Dose Level 2|Death|0|||
160822894|NCT00840060|580739021|FG001|Overall Study|Withdrawal by Subject|0|||
160822895|NCT00840060|580739020|FG000|Overall Study|Change in emotional/behavioral status|0|||
160822896|NCT00840060|580739021|FG001|Overall Study|Change in emotional/behavioral status|1|||
160822897|NCT01103063|580739022|FG000|Overall Study|Adverse Event|3|||
160822898|NCT01103063|580739023|FG001|Overall Study|Adverse Event|1|||
160822899|NCT01103063|580739022|FG000|Overall Study|Lost to Follow-up|68|||
160822900|NCT01103063|580739023|FG001|Overall Study|Lost to Follow-up|51|||
160822901|NCT01103063|580739022|FG000|Overall Study|Withdrawal by Subject|60|||
160822902|NCT01103063|580739023|FG001|Overall Study|Withdrawal by Subject|15|||
160822903|NCT01103063|580739022|FG000|Overall Study|Other|16|||
160822904|NCT01103063|580739023|FG001|Overall Study|Other|11|||
160822905|NCT01103063|580739022|FG000|Overall Study|Protocol Violation|1|||
160822906|NCT01103063|580739023|FG001|Overall Study|Protocol Violation|0|||
160822907|NCT01103063|580739022|FG000|Overall Study|Study terminated by Sponsor|326|||
160822908|NCT01103063|580739023|FG001|Overall Study|Study terminated by Sponsor|342|||
160822909|NCT01103063|580739022|FG000|Overall Study|Death|3|||
160822910|NCT01103063|580739023|FG001|Overall Study|Death|1|||
160822911|NCT00798317|580739026|FG000|Overall Study|Physician Decision|0|||
160822912|NCT00798317|580739027|FG001|Overall Study|Physician Decision|1|||
160822913|NCT00798317|580739026|FG000|Overall Study|Withdrawal by Subject|5|||
160822914|NCT00798317|580739027|FG001|Overall Study|Withdrawal by Subject|4|||
160822915|NCT00798317|580739026|FG000|Overall Study|Lost to Follow-up|2|||
160822916|NCT00798317|580739027|FG001|Overall Study|Lost to Follow-up|2|||
160822917|NCT00798317|580739026|FG000|Overall Study|Adverse Event|2|||
160822918|NCT00798317|580739027|FG001|Overall Study|Adverse Event|0|||
160822919|NCT00798317|580739026|FG000|Overall Study|Death|1|||
160822920|NCT00798317|580739027|FG001|Overall Study|Death|0|||
160822921|NCT00919867|580739031|FG000|First Intervention|Withdrawal by Subject|0|||
160822922|NCT00919867|580739032|FG001|First Intervention|Withdrawal by Subject|0|||
160822923|NCT00919867|580739033|FG002|First Intervention|Withdrawal by Subject|1|||
160822924|NCT00919867|580739034|FG003|First Intervention|Withdrawal by Subject|0|||
160989575|NCT00062868|581349607|FG014|Dose Level 2|Death|0|||
160989576|NCT00062868|581349608|FG015|Dose Level 2|Death|0|||
160989577|NCT00062868|581349609|FG016|Dose Level 2|Death|2|||
160989578|NCT00062868|581349610|FG017|Dose Level 2|Death|0|||
160989579|NCT00062868|581349611|FG018|Dose Level 2|Death|0|||
160989580|NCT00062868|581349612|FG019|Dose Level 2|Death|0|||
160989581|NCT00062868|581349613|FG020|Dose Level 2|Death|0|||
160989582|NCT00062868|581349593|FG000|Dose Level 2|Lost to Follow-up|0|||
160989583|NCT00062868|581349594|FG001|Dose Level 2|Lost to Follow-up|0|||
160989584|NCT00062868|581349595|FG002|Dose Level 2|Lost to Follow-up|0|||
160989585|NCT00062868|581349596|FG003|Dose Level 2|Lost to Follow-up|0|||
160989586|NCT00062868|581349597|FG004|Dose Level 2|Lost to Follow-up|0|||
160989587|NCT00062868|581349598|FG005|Dose Level 2|Lost to Follow-up|0|||
160989588|NCT00062868|581349599|FG006|Dose Level 2|Lost to Follow-up|0|||
160989589|NCT00062868|581349600|FG007|Dose Level 2|Lost to Follow-up|0|||
160989590|NCT00062868|581349601|FG008|Dose Level 2|Lost to Follow-up|0|||
160989591|NCT00062868|581349602|FG009|Dose Level 2|Lost to Follow-up|0|||
160989592|NCT00062868|581349603|FG010|Dose Level 2|Lost to Follow-up|0|||
160989593|NCT00062868|581349604|FG011|Dose Level 2|Lost to Follow-up|0|||
160989594|NCT00062868|581349605|FG012|Dose Level 2|Lost to Follow-up|0|||
160989595|NCT00062868|581349606|FG013|Dose Level 2|Lost to Follow-up|1|||
160989596|NCT00062868|581349607|FG014|Dose Level 2|Lost to Follow-up|0|||
160989597|NCT00062868|581349608|FG015|Dose Level 2|Lost to Follow-up|0|||
160989598|NCT00062868|581349609|FG016|Dose Level 2|Lost to Follow-up|1|||
160989599|NCT00062868|581349610|FG017|Dose Level 2|Lost to Follow-up|0|||
160989600|NCT00062868|581349611|FG018|Dose Level 2|Lost to Follow-up|0|||
160989601|NCT00062868|581349612|FG019|Dose Level 2|Lost to Follow-up|0|||
160989602|NCT00062868|581349613|FG020|Dose Level 2|Lost to Follow-up|0|||
160989603|NCT00062868|581349593|FG000|Dose Level 3|Death|0|||
160822925|NCT00919867|580739035|FG004|First Intervention|Withdrawal by Subject|0|||
160822926|NCT00919867|580739036|FG005|First Intervention|Withdrawal by Subject|0|||
160822927|NCT00919867|580739031|FG000|First Intervention|Physician Decision|0|||
160822928|NCT00919867|580739032|FG001|First Intervention|Physician Decision|0|||
160989604|NCT00062868|581349594|FG001|Dose Level 3|Death|0|||
160989605|NCT00062868|581349595|FG002|Dose Level 3|Death|0|||
160989606|NCT00062868|581349596|FG003|Dose Level 3|Death|0|||
160989607|NCT00062868|581349597|FG004|Dose Level 3|Death|0|||
160989608|NCT00062868|581349598|FG005|Dose Level 3|Death|0|||
160989609|NCT00062868|581349599|FG006|Dose Level 3|Death|0|||
160989610|NCT00062868|581349600|FG007|Dose Level 3|Death|0|||
160989611|NCT00062868|581349601|FG008|Dose Level 3|Death|0|||
160989612|NCT00062868|581349602|FG009|Dose Level 3|Death|0|||
160989613|NCT00062868|581349603|FG010|Dose Level 3|Death|0|||
160989614|NCT00062868|581349604|FG011|Dose Level 3|Death|1|||
160989615|NCT00062868|581349605|FG012|Dose Level 3|Death|0|||
160989616|NCT00062868|581349606|FG013|Dose Level 3|Death|0|||
160989617|NCT00062868|581349607|FG014|Dose Level 3|Death|0|||
160989618|NCT00062868|581349608|FG015|Dose Level 3|Death|0|||
160989619|NCT00062868|581349609|FG016|Dose Level 3|Death|0|||
160989620|NCT00062868|581349610|FG017|Dose Level 3|Death|1|||
160989621|NCT00062868|581349611|FG018|Dose Level 3|Death|0|||
160989622|NCT00062868|581349612|FG019|Dose Level 3|Death|0|||
160989623|NCT00062868|581349613|FG020|Dose Level 3|Death|0|||
160989624|NCT00062868|581349593|FG000|Dose Level 3|Lost to Follow-up|0|||
160989625|NCT00062868|581349594|FG001|Dose Level 3|Lost to Follow-up|0|||
160989626|NCT00062868|581349595|FG002|Dose Level 3|Lost to Follow-up|0|||
160989627|NCT00062868|581349596|FG003|Dose Level 3|Lost to Follow-up|0|||
160989628|NCT00062868|581349597|FG004|Dose Level 3|Lost to Follow-up|0|||
160989629|NCT00062868|581349598|FG005|Dose Level 3|Lost to Follow-up|0|||
160989630|NCT00062868|581349599|FG006|Dose Level 3|Lost to Follow-up|0|||
160989631|NCT00062868|581349600|FG007|Dose Level 3|Lost to Follow-up|0|||
160989632|NCT00062868|581349601|FG008|Dose Level 3|Lost to Follow-up|0|||
160989633|NCT00062868|581349602|FG009|Dose Level 3|Lost to Follow-up|0|||
160989634|NCT00062868|581349603|FG010|Dose Level 3|Lost to Follow-up|0|||
160989635|NCT00062868|581349604|FG011|Dose Level 3|Lost to Follow-up|0|||
160989636|NCT00062868|581349605|FG012|Dose Level 3|Lost to Follow-up|0|||
160989637|NCT00062868|581349606|FG013|Dose Level 3|Lost to Follow-up|0|||
160989638|NCT00062868|581349607|FG014|Dose Level 3|Lost to Follow-up|1|||
160989639|NCT00062868|581349608|FG015|Dose Level 3|Lost to Follow-up|0|||
160989640|NCT00062868|581349609|FG016|Dose Level 3|Lost to Follow-up|0|||
160989641|NCT00062868|581349610|FG017|Dose Level 3|Lost to Follow-up|0|||
160989642|NCT00062868|581349611|FG018|Dose Level 3|Lost to Follow-up|0|||
160989643|NCT00062868|581349612|FG019|Dose Level 3|Lost to Follow-up|0|||
160989644|NCT00062868|581349613|FG020|Dose Level 3|Lost to Follow-up|0|||
160989645|NCT00062868|581349593|FG000|Dose Level 3|Withdrew|0|||
160989646|NCT00062868|581349594|FG001|Dose Level 3|Withdrew|0|||
160989647|NCT00062868|581349595|FG002|Dose Level 3|Withdrew|2|||
160989648|NCT00062868|581349596|FG003|Dose Level 3|Withdrew|0|||
160989649|NCT00062868|581349597|FG004|Dose Level 3|Withdrew|0|||
160989650|NCT00062868|581349598|FG005|Dose Level 3|Withdrew|0|||
160989651|NCT00062868|581349599|FG006|Dose Level 3|Withdrew|0|||
160822929|NCT00919867|580739033|FG002|First Intervention|Physician Decision|0|||
160822930|NCT00919867|580739034|FG003|First Intervention|Physician Decision|0|||
160822931|NCT00919867|580739035|FG004|First Intervention|Physician Decision|0|||
160822932|NCT00919867|580739036|FG005|First Intervention|Physician Decision|1|||
160822933|NCT03350256|580739044|FG000|Overall Study|Inclusion/exclusion violation|4|||
160822934|NCT03350256|580739044|FG000|Overall Study|Recommended for other therapies|2|||
160822935|NCT03350256|580739044|FG000|Overall Study|Protocol Violation|3|||
160822936|NCT03350256|580739044|FG000|Overall Study|Non compliance|2|||
160822937|NCT03350256|580739044|FG000|Overall Study|Denial by insurance|1|||
160822938|NCT03350256|580739044|FG000|Overall Study|Adverse Event|2|||
160822939|NCT03350256|580739044|FG000|Overall Study|Trial failure|12|||
160822940|NCT03350256|580739044|FG000|Overall Study|Did not proceed to permanent implant|3|||
160822941|NCT03350256|580739044|FG000|Overall Study|Withdrawal by Subject|3|||
160822942|NCT03350256|580739044|FG000|Overall Study|Subject moving out of state|1|||
160822943|NCT03350256|580739044|FG000|Overall Study|Lost to Follow-up|1|||
160822944|NCT03350256|580739044|FG000|Overall Study|Lack of Efficacy|2|||
160822945|NCT01187446|580739045|FG000|Overall Study|Patient started non-protocol therapy|0|||
160822946|NCT01187446|580739046|FG001|Overall Study|Patient started non-protocol therapy|1|||
160822947|NCT00823212|580739048|FG000|Overall Study|Death|8|||
160822948|NCT00823212|580739049|FG001|Overall Study|Death|10|||
160822949|NCT00823212|580739048|FG000|Overall Study|Withdrawal by Subject|6|||
160822950|NCT00823212|580739049|FG001|Overall Study|Withdrawal by Subject|1|||
160822951|NCT00823212|580739048|FG000|Overall Study|Incarcerated|0|||
160822952|NCT00823212|580739049|FG001|Overall Study|Incarcerated|1|||
160822953|NCT00823212|580739048|FG000|Overall Study|Missed 12-month visit|21|||
160822954|NCT00823212|580739049|FG001|Overall Study|Missed 12-month visit|21|||
160822955|NCT04600076|580739059|FG000|Overall Study|Lost to Follow-up|3|||
160822956|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
160822957|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
160822958|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
160822959|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
160822960|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
160822961|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
160822962|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
160822963|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
160822964|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
160822965|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
160822966|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
160822967|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
160822968|NCT01639339|580739060|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
160822969|NCT01639339|580739061|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
160822970|NCT01639339|580739060|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
160822971|NCT01639339|580739061|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
160822972|NCT01639339|580739060|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
160822973|NCT01639339|580739061|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
160822974|NCT01639339|580739060|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
160822975|NCT01639339|580739061|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
160822976|NCT02891681|580739062|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
160822977|NCT02891681|580739063|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
160901798|NCT02635776|581034086|FG000|Overall Study|Lost to Follow-up|4|||
160901799|NCT02635776|581034087|FG001|Overall Study|Lost to Follow-up|0|||
160822978|NCT02891681|580739064|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
160822979|NCT02891681|580739062|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
160822980|NCT02891681|580739063|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
160822981|NCT02891681|580739064|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
160822982|NCT02891681|580739062|FG000|Overall Study|Taken off study after first imaging appointment|1|||
160901800|NCT02635776|581034086|FG000|Overall Study|Other reasons|5|||
160822983|NCT02891681|580739063|FG001|Overall Study|Taken off study after first imaging appointment|0|||
160822984|NCT02891681|580739064|FG002|Overall Study|Taken off study after first imaging appointment|0|||
160822985|NCT01170598|580739065|FG000|Overall Study|Withdrawal by Subject|1|||
160822986|NCT01170598|580739065|FG000|Overall Study|Death|3|||
160822987|NCT01170598|580739065|FG000|Overall Study|Lost to Follow-up|1|||
160822988|NCT01170598|580739065|FG000|Overall Study|Refused|1|||
160822989|NCT01271712|580739066|FG000|Double Blind Treatment|Death|2|||
160822990|NCT01271712|580739067|FG001|Double Blind Treatment|Death|0|||
160822991|NCT01271712|580739066|FG000|Double Blind Treatment|Lack of Efficacy|1|||
160822992|NCT01271712|580739067|FG001|Double Blind Treatment|Lack of Efficacy|0|||
160822993|NCT01271712|580739066|FG000|Double Blind Treatment|Adverse Event|9|||
160822994|NCT01271712|580739067|FG001|Double Blind Treatment|Adverse Event|4|||
160822995|NCT01271712|580739066|FG000|Double Blind Treatment|Progressive disease|23|||
160822996|NCT01271712|580739067|FG001|Double Blind Treatment|Progressive disease|3|||
160822997|NCT01271712|580739066|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
160822998|NCT01271712|580739067|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
160822999|NCT01271712|580739066|FG000|Double Blind Treatment|Non compliance with study drug|2|||
160823000|NCT01271712|580739067|FG001|Double Blind Treatment|Non compliance with study drug|0|||
160823001|NCT01271712|580739066|FG000|Double Blind Treatment|receive no study drug|1|||
160823002|NCT01271712|580739067|FG001|Double Blind Treatment|receive no study drug|0|||
160823003|NCT01271712|580739066|FG000|Open Label Treatment|Death|6|||
160823004|NCT01271712|580739067|FG001|Open Label Treatment|Death|5|||
160823005|NCT01271712|580739066|FG000|Open Label Treatment|Withdrawal by Subject|6|||
160823006|NCT01271712|580739067|FG001|Open Label Treatment|Withdrawal by Subject|11|||
160823007|NCT01271712|580739066|FG000|Open Label Treatment|Physician Decision|2|||
160823008|NCT01271712|580739067|FG001|Open Label Treatment|Physician Decision|0|||
160823009|NCT01271712|580739066|FG000|Open Label Treatment|Adverse Event|14|||
160823010|NCT01271712|580739067|FG001|Open Label Treatment|Adverse Event|8|||
160823011|NCT01271712|580739066|FG000|Open Label Treatment|Progressive disease|59|||
160823012|NCT01271712|580739067|FG001|Open Label Treatment|Progressive disease|32|||
160823013|NCT01271712|580739066|FG000|Open Label Treatment|transferred to rollover study|1|||
160823014|NCT01271712|580739067|FG001|Open Label Treatment|transferred to rollover study|0|||
160823015|NCT01271712|580739066|FG000|Open Label Treatment|Non-compliance with study drug|1|||
160823016|NCT01271712|580739067|FG001|Open Label Treatment|Non-compliance with study drug|0|||
160823017|NCT01271712|580739066|FG000|Open Label Treatment|Protocol Violation|0|||
160823018|NCT01271712|580739067|FG001|Open Label Treatment|Protocol Violation|1|||
160823019|NCT01271712|580739066|FG000|Open Label Treatment|Switching to other therapy|2|||
160823020|NCT01271712|580739067|FG001|Open Label Treatment|Switching to other therapy|1|||
160823021|NCT01271712|580739066|FG000|Safety Follow-up|Death|11|||
160823022|NCT01271712|580739067|FG001|Safety Follow-up|Death|7|||
160823023|NCT01271712|580739066|FG000|Safety Follow-up|Withdrawal by Subject|4|||
160823024|NCT01271712|580739067|FG001|Safety Follow-up|Withdrawal by Subject|2|||
160823025|NCT01271712|580739066|FG000|Safety Follow-up|Protocol Violation|1|||
160823026|NCT01271712|580739067|FG001|Safety Follow-up|Protocol Violation|1|||
160823027|NCT01271712|580739066|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
160823028|NCT01271712|580739067|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
160823029|NCT01271712|580739066|FG000|Safety Follow-up|No follow-up|1|||
160823030|NCT01271712|580739067|FG001|Safety Follow-up|No follow-up|1|||
160823031|NCT01271712|580739066|FG000|Safety Follow-up|Progressive disease|1|||
160823032|NCT01271712|580739067|FG001|Safety Follow-up|Progressive disease|0|||
160823033|NCT01271712|580739066|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
160823034|NCT01271712|580739067|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
160823035|NCT02685748|580739070|FG000|Overall Study|Withdrawal by Subject|3|||
160823036|NCT02685748|580739071|FG001|Overall Study|Withdrawal by Subject|2|||
160823037|NCT03941964|580739072|FG000|Overall Study|Adverse Event|1|||
160823038|NCT03941964|580739073|FG001|Overall Study|Adverse Event|8|||
160823039|NCT03941964|580739072|FG000|Overall Study|Progressive disease|7|||
160823040|NCT03941964|580739073|FG001|Overall Study|Progressive disease|3|||
160823041|NCT03941964|580739072|FG000|Overall Study|Lack of Efficacy|0|||
160823042|NCT03941964|580739073|FG001|Overall Study|Lack of Efficacy|1|||
160823043|NCT03941964|580739072|FG000|Overall Study|Death|3|||
160823044|NCT03941964|580739073|FG001|Overall Study|Death|1|||
160823045|NCT03941964|580739072|FG000|Overall Study|Withdrew consent|1|||
160823046|NCT03941964|580739073|FG001|Overall Study|Withdrew consent|3|||
160823047|NCT03941964|580739072|FG000|Overall Study|Physician Decision|9|||
160823048|NCT03941964|580739073|FG001|Overall Study|Physician Decision|2|||
160823049|NCT03941964|580739072|FG000|Overall Study|Other, not specified|2|||
160823050|NCT03941964|580739073|FG001|Overall Study|Other, not specified|1|||
160823051|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
160823052|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
160823053|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
160823054|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
160823055|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
160901801|NCT02635776|581034087|FG001|Overall Study|Other reasons|1|||
160989652|NCT00062868|581349600|FG007|Dose Level 3|Withdrew|0|||
160989653|NCT00062868|581349601|FG008|Dose Level 3|Withdrew|0|||
160989654|NCT00062868|581349602|FG009|Dose Level 3|Withdrew|0|||
160989655|NCT00062868|581349603|FG010|Dose Level 3|Withdrew|0|||
160989656|NCT00062868|581349604|FG011|Dose Level 3|Withdrew|0|||
160989657|NCT00062868|581349605|FG012|Dose Level 3|Withdrew|0|||
160989658|NCT00062868|581349606|FG013|Dose Level 3|Withdrew|0|||
160989659|NCT00062868|581349607|FG014|Dose Level 3|Withdrew|0|||
160989660|NCT00062868|581349608|FG015|Dose Level 3|Withdrew|0|||
160989661|NCT00062868|581349609|FG016|Dose Level 3|Withdrew|0|||
160989662|NCT00062868|581349610|FG017|Dose Level 3|Withdrew|0|||
160989663|NCT00062868|581349611|FG018|Dose Level 3|Withdrew|0|||
160989664|NCT00062868|581349612|FG019|Dose Level 3|Withdrew|0|||
160989665|NCT00062868|581349613|FG020|Dose Level 3|Withdrew|0|||
160989666|NCT01734811|581349614|FG000|Overall Study|Lost to Follow-up|2|||
160989667|NCT01734811|581349615|FG001|Overall Study|Lost to Follow-up|3|||
160989668|NCT01734811|581349614|FG000|Overall Study|Withdrawal by Subject|2|||
160989669|NCT01734811|581349615|FG001|Overall Study|Withdrawal by Subject|0|||
160989670|NCT02427646|581349616|FG000|Overall Study|Lack of Efficacy|2|||
160823056|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
160823057|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
160823058|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
160823059|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
160823060|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
160823061|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
160823062|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
160823063|NCT00737568|580739085|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
160823064|NCT00737568|580739086|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
160823065|NCT00737568|580739085|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
160823066|NCT00737568|580739086|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
160823067|NCT00737568|580739085|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
160823068|NCT00737568|580739086|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
160823069|NCT00855933|580739087|FG000|Overall Study|Withdrawal by Subject|0|||
160823070|NCT00855933|580739088|FG001|Overall Study|Withdrawal by Subject|1|||
160823071|NCT00951080|580739089|FG000|Overall Study|Adverse Event|3|||
160823072|NCT00951080|580739090|FG001|Overall Study|Adverse Event|3|||
160823073|NCT00951080|580739089|FG000|Overall Study|Lost to Follow-up|0|||
160823074|NCT00951080|580739090|FG001|Overall Study|Lost to Follow-up|1|||
160823075|NCT00951080|580739089|FG000|Overall Study|Physician Decision|4|||
160823076|NCT00951080|580739090|FG001|Overall Study|Physician Decision|1|||
160823077|NCT00951080|580739089|FG000|Overall Study|Other|19|||
160823078|NCT00951080|580739090|FG001|Overall Study|Other|22|||
160823079|NCT05463744|580739091|FG000|Treatment Period|Withdrawal by Subject|19|||
160823080|NCT05463744|580739092|FG001|Treatment Period|Withdrawal by Subject|16|||
160823081|NCT05463744|580739091|FG000|Treatment Period|Adverse Event|4|||
160823082|NCT05463744|580739092|FG001|Treatment Period|Adverse Event|4|||
160823083|NCT05463744|580739091|FG000|Treatment Period|Pregnancy|0|||
160823084|NCT05463744|580739092|FG001|Treatment Period|Pregnancy|3|||
160823085|NCT05463744|580739091|FG000|Treatment Period|Lost to Follow-up|1|||
160823086|NCT05463744|580739092|FG001|Treatment Period|Lost to Follow-up|3|||
160823087|NCT05463744|580739091|FG000|Treatment Period|Inadvertent enrollment|2|||
160823088|NCT05463744|580739092|FG001|Treatment Period|Inadvertent enrollment|1|||
160823089|NCT05463744|580739091|FG000|Treatment Period|Death|0|||
160823090|NCT05463744|580739092|FG001|Treatment Period|Death|1|||
160823091|NCT05463744|580739091|FG000|Treatment Period|Non-compliance with Study Drug|1|||
160823092|NCT05463744|580739092|FG001|Treatment Period|Non-compliance with Study Drug|0|||
160823093|NCT05463744|580739091|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
160989671|NCT02427646|581349617|FG001|Overall Study|Lack of Efficacy|3|||
160989672|NCT02427646|581349616|FG000|Overall Study|Physician Decision|1|||
160989673|NCT02427646|581349617|FG001|Overall Study|Physician Decision|4|||
160989674|NCT02427646|581349616|FG000|Overall Study|Protocol Violation|3|||
160989675|NCT02427646|581349617|FG001|Overall Study|Protocol Violation|3|||
160989676|NCT02427646|581349616|FG000|Overall Study|Bothersome hand weakness|2|||
160823094|NCT05463744|580739092|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
160823095|NCT05463744|580739091|FG000|Treatment Period|Physician Decision|0|||
160989677|NCT02427646|581349617|FG001|Overall Study|Bothersome hand weakness|4|||
160823096|NCT05463744|580739092|FG001|Treatment Period|Physician Decision|1|||
160989678|NCT03824236|581349618|FG000|Overall Study|Lost to Follow-up|0|||
160989679|NCT03824236|581349619|FG001|Overall Study|Lost to Follow-up|0|||
160823097|NCT05463744|580739091|FG000|Follow-Up Period|Withdrawal by Subject|3|||
160823098|NCT05463744|580739092|FG001|Follow-Up Period|Withdrawal by Subject|1|||
160823099|NCT05463744|580739091|FG000|Follow-Up Period|Lost to Follow-up|1|||
160823100|NCT05463744|580739092|FG001|Follow-Up Period|Lost to Follow-up|1|||
160989680|NCT03824236|581349620|FG002|Overall Study|Lost to Follow-up|1|||
160989681|NCT01641861|581349621|FG000|Overall Study|Lost to Follow-up|21|||
160989682|NCT01641861|581349622|FG001|Overall Study|Lost to Follow-up|16|||
160989683|NCT01641861|581349621|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
160989684|NCT01641861|581349622|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
160989685|NCT01641861|581349621|FG000|Overall Study|Died due to drowning|0|||
160989686|NCT01641861|581349622|FG001|Overall Study|Died due to drowning|1|||
160989687|NCT01101542|581349625|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
160989688|NCT01101542|581349625|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
160989689|NCT01101542|581349625|FG000|Year 4 Surveillance Period|Other|287|||
160989690|NCT01101542|581349625|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
160989691|NCT01101542|581349625|FG000|Year 5 Surveillance Period|Pregnancy|1|||
160989692|NCT01101542|581349625|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
160989693|NCT01101542|581349625|FG000|Year 6 Surveillance Period|Pregnancy|1|||
160989694|NCT01101542|581349625|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
160989695|NCT00701311|581349626|FG000|Overall Study|Lack of Efficacy|3|||
160989696|NCT00701311|581349626|FG000|Overall Study|Adverse Event|3|||
160989697|NCT00701311|581349626|FG000|Overall Study|Withdrawal by Subject|2|||
160989698|NCT04580407|581349627|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
160989699|NCT04949399|581349630|FG000|Overall Study|Lost to Follow-up|11|||
160989700|NCT04949399|581349631|FG001|Overall Study|Lost to Follow-up|6|||
160989701|NCT04949399|581349630|FG000|Overall Study|Withdrawal by Subject|2|||
160989702|NCT04949399|581349631|FG001|Overall Study|Withdrawal by Subject|3|||
160823101|NCT02585830|580739098|FG000|Overall Study|Withdrawal by Subject|3|||
160823102|NCT01904149|580739099|FG000|Overall Study|Adverse Event|3|||
160823103|NCT01904149|580739100|FG001|Overall Study|Adverse Event|4|||
160823104|NCT01904149|580739101|FG002|Overall Study|Adverse Event|0|||
160823105|NCT01904149|580739102|FG003|Overall Study|Adverse Event|1|||
160823106|NCT01904149|580739103|FG004|Overall Study|Adverse Event|1|||
160823107|NCT01904149|580739104|FG005|Overall Study|Adverse Event|2|||
160823108|NCT01904149|580739099|FG000|Overall Study|Lack of Efficacy|0|||
160823109|NCT01904149|580739100|FG001|Overall Study|Lack of Efficacy|3|||
160989703|NCT00814489|581349632|FG000|Overall Study|Other|2|||
160989704|NCT00814489|581349633|FG001|Overall Study|Other|0|||
160989705|NCT00814489|581349634|FG002|Overall Study|Other|1|||
160989706|NCT01712685|581349660|FG000|Overall Study|pt declined to participate before trmt|1|||
160989707|NCT01515319|581349661|FG000|Overall Study|Withdrawal by Subject|0|||
160989708|NCT01515319|581349662|FG001|Overall Study|Withdrawal by Subject|0|||
160989709|NCT01515319|581349663|FG002|Overall Study|Withdrawal by Subject|0|||
160989710|NCT01515319|581349664|FG003|Overall Study|Withdrawal by Subject|0|||
160989711|NCT01515319|581349665|FG004|Overall Study|Withdrawal by Subject|0|||
160989712|NCT01515319|581349666|FG005|Overall Study|Withdrawal by Subject|0|||
160989713|NCT01515319|581349667|FG006|Overall Study|Withdrawal by Subject|1|||
160989714|NCT01515319|581349668|FG007|Overall Study|Withdrawal by Subject|0|||
160989715|NCT01515319|581349669|FG008|Overall Study|Withdrawal by Subject|0|||
160989716|NCT01515319|581349670|FG009|Overall Study|Withdrawal by Subject|0|||
160989717|NCT01515319|581349661|FG000|Overall Study|Adverse Event|0|||
160989718|NCT01515319|581349662|FG001|Overall Study|Adverse Event|0|||
160989719|NCT01515319|581349663|FG002|Overall Study|Adverse Event|0|||
160989720|NCT01515319|581349664|FG003|Overall Study|Adverse Event|0|||
160989721|NCT01515319|581349665|FG004|Overall Study|Adverse Event|0|||
160989722|NCT01515319|581349666|FG005|Overall Study|Adverse Event|0|||
160989723|NCT01515319|581349667|FG006|Overall Study|Adverse Event|0|||
160989724|NCT01515319|581349668|FG007|Overall Study|Adverse Event|0|||
160823110|NCT01904149|580739101|FG002|Overall Study|Lack of Efficacy|1|||
160823111|NCT01904149|580739102|FG003|Overall Study|Lack of Efficacy|3|||
160823112|NCT01904149|580739103|FG004|Overall Study|Lack of Efficacy|3|||
160989725|NCT01515319|581349669|FG008|Overall Study|Adverse Event|3|||
160823113|NCT01904149|580739104|FG005|Overall Study|Lack of Efficacy|1|||
160823114|NCT01904149|580739099|FG000|Overall Study|Withdrawal by Subject|1|||
160823115|NCT01904149|580739100|FG001|Overall Study|Withdrawal by Subject|3|||
160823116|NCT01904149|580739101|FG002|Overall Study|Withdrawal by Subject|1|||
160823117|NCT01904149|580739102|FG003|Overall Study|Withdrawal by Subject|0|||
160823118|NCT01904149|580739103|FG004|Overall Study|Withdrawal by Subject|1|||
160823119|NCT01904149|580739104|FG005|Overall Study|Withdrawal by Subject|0|||
160989726|NCT01515319|581349670|FG009|Overall Study|Adverse Event|0|||
160989727|NCT01515319|581349661|FG000|Overall Study|Protocol Violation|0|||
160989728|NCT01515319|581349662|FG001|Overall Study|Protocol Violation|0|||
160989729|NCT01515319|581349663|FG002|Overall Study|Protocol Violation|0|||
160989730|NCT01515319|581349664|FG003|Overall Study|Protocol Violation|0|||
160989731|NCT01515319|581349665|FG004|Overall Study|Protocol Violation|0|||
160989732|NCT01515319|581349666|FG005|Overall Study|Protocol Violation|0|||
160989733|NCT01515319|581349667|FG006|Overall Study|Protocol Violation|0|||
160989734|NCT01515319|581349668|FG007|Overall Study|Protocol Violation|0|||
160823120|NCT01904149|580739099|FG000|Overall Study|Protocol Violation|0|||
160823121|NCT01904149|580739100|FG001|Overall Study|Protocol Violation|1|||
160823122|NCT01904149|580739101|FG002|Overall Study|Protocol Violation|0|||
160823123|NCT01904149|580739102|FG003|Overall Study|Protocol Violation|0|||
160823124|NCT01904149|580739103|FG004|Overall Study|Protocol Violation|0|||
160823125|NCT01904149|580739104|FG005|Overall Study|Protocol Violation|0|||
160989735|NCT01515319|581349669|FG008|Overall Study|Protocol Violation|2|||
160989736|NCT01515319|581349670|FG009|Overall Study|Protocol Violation|0|||
160989737|NCT04880161|581349671|FG000|Overall Study|Withdrawal by Subject|1|||
160989738|NCT04880161|581349672|FG001|Overall Study|Withdrawal by Subject|0|||
160989739|NCT04880161|581349671|FG000|Overall Study|Lack of Compliance|1|||
160989740|NCT04880161|581349672|FG001|Overall Study|Lack of Compliance|1|||
160989741|NCT04880161|581349671|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
160989742|NCT04880161|581349672|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
160823126|NCT01904149|580739099|FG000|Overall Study|non compliance with study drug|1|||
160823127|NCT01904149|580739100|FG001|Overall Study|non compliance with study drug|0|||
160823128|NCT01904149|580739101|FG002|Overall Study|non compliance with study drug|0|||
160823129|NCT01904149|580739102|FG003|Overall Study|non compliance with study drug|0|||
160823130|NCT01904149|580739103|FG004|Overall Study|non compliance with study drug|0|||
160823131|NCT01904149|580739104|FG005|Overall Study|non compliance with study drug|0|||
160823132|NCT01357161|580739105|FG000|Part 1 (Open Label Run-in)|Death|5|||
160823133|NCT01357161|580739106|FG001|Part 1 (Open Label Run-in)|Death|0|||
160823134|NCT01357161|580739107|FG002|Part 1 (Open Label Run-in)|Death|0|||
160823135|NCT01357161|580739105|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
160823136|NCT01357161|580739106|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
160823137|NCT01357161|580739107|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
160901802|NCT00788073|581034088|FG000|STX209 Then Placebo|Adverse Event|1|||
160901803|NCT00788073|581034089|FG001|STX209 Then Placebo|Adverse Event|0|||
160901804|NCT00788073|581034088|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
160901805|NCT00788073|581034089|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
160901806|NCT00788073|581034088|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
160901807|NCT00788073|581034089|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
160901808|NCT00788073|581034088|FG000|STX209 Then Placebo|unable to return due to travel|0|||
160901809|NCT00788073|581034089|FG001|STX209 Then Placebo|unable to return due to travel|1|||
160901810|NCT00788073|581034088|FG000|Placebo Then STX209|Adverse Event|2|||
160901811|NCT00788073|581034089|FG001|Placebo Then STX209|Adverse Event|0|||
160901812|NCT00788073|581034088|FG000|Placebo Then STX209|Protocol Violation|0|||
160901813|NCT00788073|581034089|FG001|Placebo Then STX209|Protocol Violation|1|||
160901814|NCT03608254|581034090|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
160901815|NCT03608254|581034090|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
160901816|NCT00910273|581034091|FG000|Overall Study|Lack of Efficacy|6|||
160901817|NCT00910273|581034092|FG001|Overall Study|Lack of Efficacy|9|||
160901818|NCT00910273|581034091|FG000|Overall Study|Adverse Event|1|||
160901819|NCT00910273|581034092|FG001|Overall Study|Adverse Event|1|||
160901820|NCT00910273|581034091|FG000|Overall Study|Withdrawal by Subject|1|||
160901821|NCT00910273|581034092|FG001|Overall Study|Withdrawal by Subject|0|||
160901822|NCT00910273|581034091|FG000|Overall Study|Discontinuation of study by sponsor|8|||
160901823|NCT00910273|581034092|FG001|Overall Study|Discontinuation of study by sponsor|2|||
160901824|NCT00910273|581034091|FG000|Overall Study|Protocol Violation|1|||
160901825|NCT00910273|581034092|FG001|Overall Study|Protocol Violation|0|||
160901826|NCT00910273|581034091|FG000|Overall Study|Lost to Follow-up|1|||
160901827|NCT00910273|581034092|FG001|Overall Study|Lost to Follow-up|1|||
160901828|NCT00660673|581034093|FG000|Overall Study|Adverse Event|84|||
160901829|NCT00660673|581034093|FG000|Overall Study|Lack of Efficacy|7|||
160901830|NCT00660673|581034093|FG000|Overall Study|Withdrawal by Subject|22|||
160901831|NCT00660673|581034093|FG000|Overall Study|Administrative|2|||
160901832|NCT00660673|581034093|FG000|Overall Study|Protocol Violation|2|||
160901833|NCT00579098|581034094|FG000|Overall Study|Lost to Follow-up|2|||
160901834|NCT00579098|581034095|FG001|Overall Study|Lost to Follow-up|0|||
160901835|NCT00579098|581034094|FG000|Overall Study|Adverse Event|2|||
160901836|NCT00579098|581034095|FG001|Overall Study|Adverse Event|3|||
160901837|NCT00579098|581034094|FG000|Overall Study|Withdrawal by Subject|2|||
160901838|NCT00579098|581034095|FG001|Overall Study|Withdrawal by Subject|3|||
160901839|NCT00579098|581034094|FG000|Overall Study|AF returned after ablation|3|||
160901840|NCT00579098|581034095|FG001|Overall Study|AF returned after ablation|2|||
160901841|NCT03540030|581034103|FG000|Overall Study|Withdrawal by Subject|2|||
160901842|NCT03540030|581034104|FG001|Overall Study|Withdrawal by Subject|1|||
160901843|NCT03540030|581034103|FG000|Overall Study|screen fail|7|||
160901844|NCT03540030|581034104|FG001|Overall Study|screen fail|1|||
160901845|NCT03540030|581034103|FG000|Overall Study|never had surgery after signing consent|9|||
160901846|NCT03540030|581034104|FG001|Overall Study|never had surgery after signing consent|1|||
160901847|NCT00569270|581034105|FG000|Period: First Intervention|Protocol Violation|0|||
160901848|NCT00569270|581034106|FG001|Period: First Intervention|Protocol Violation|1|||
160901849|NCT01788228|581034112|FG000|Overall Study|Migrated/moved from study area|1|||
160901850|NCT01788228|581034113|FG001|Overall Study|Migrated/moved from study area|0|||
160901851|NCT01972568|581034114|FG000|Overall Study|Other events|3|||
160901852|NCT01972568|581034115|FG001|Overall Study|Other events|0|||
160901853|NCT01972568|581034116|FG002|Overall Study|Other events|0|||
160823138|NCT01357161|580739105|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
160823139|NCT01357161|580739106|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
160823140|NCT01357161|580739107|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
160823141|NCT01357161|580739105|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
160823142|NCT01357161|580739106|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
160823143|NCT01357161|580739107|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
160823144|NCT01357161|580739105|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
160823145|NCT01357161|580739106|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
160823146|NCT01357161|580739107|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
160823147|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
160823148|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
160823149|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
160823150|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
160823151|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
160823152|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
160823153|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
160823154|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
160823155|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
160823156|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
160823157|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
160823158|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
160823159|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
160823160|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
160823161|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
160823162|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
160823163|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
160823164|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
160823165|NCT00068250|580739108|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
160823166|NCT00068250|580739109|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
160823167|NCT00068250|580739110|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
160823168|NCT00068250|580739111|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
160823169|NCT01824823|580739112|FG000|Overall Study|Lack of Efficacy|1|||
160823170|NCT01824823|580739113|FG001|Overall Study|Lack of Efficacy|1|||
160823171|NCT01824823|580739112|FG000|Overall Study|Off-treatment reason not submitted|1|||
160823172|NCT01824823|580739113|FG001|Overall Study|Off-treatment reason not submitted|0|||
160823173|NCT03349645|580739116|FG000|Overall Study|Sponsor Terminated Study|75|||
160823174|NCT03349645|580739116|FG000|Overall Study|Withdrawal by Subject|4|||
160823175|NCT03349645|580739116|FG000|Overall Study|Protocol Violation|1|||
160823176|NCT03349645|580739116|FG000|Overall Study|Other|2|||
160823177|NCT02927925|580739117|FG000|Overall Study|Death|16|||
160823178|NCT02927925|580739117|FG000|Overall Study|Physician Decision|1|||
160823179|NCT02927925|580739117|FG000|Overall Study|Withdrawal by Subject|11|||
160823180|NCT02927925|580739117|FG000|Overall Study|Other|3|||
160823181|NCT02927925|580739117|FG000|Overall Study|Disease progression at clinical cutoff|1|||
160823182|NCT02910401|580739119|FG000|Overall Study|Study closure Study closure|0|||
160823183|NCT02910401|580739120|FG001|Overall Study|Study closure Study closure|0|||
160823184|NCT02910401|580739121|FG002|Overall Study|Study closure Study closure|2|||
160823185|NCT02910401|580739119|FG000|Overall Study|Physician Decision|1|||
160823186|NCT02910401|580739120|FG001|Overall Study|Physician Decision|0|||
160823187|NCT02910401|580739121|FG002|Overall Study|Physician Decision|0|||
160823188|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
160823189|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
160823190|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Death|0|||
160989743|NCT04880161|581349671|FG000|Overall Study|Screen Failure|0|||
160989744|NCT04880161|581349672|FG001|Overall Study|Screen Failure|1|||
160989745|NCT01354106|581349673|FG000|Overall Study|Withdrawal by Subject|2|||
160823191|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Death|0|||
160823192|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
160823193|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
160989746|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Adverse Event|5|||
160823194|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
160823195|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
160823196|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
160823197|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
160989747|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Adverse Event|13|||
160823198|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
160823199|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
160823200|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
160823201|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
160823202|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
160823203|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
160823204|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
160823205|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
160823206|NCT00433160|580739124|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
160823207|NCT00433160|580739125|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
160823208|NCT00433160|580739124|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
160823209|NCT00433160|580739125|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
160823210|NCT00433160|580739124|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
160823211|NCT00433160|580739125|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
160823212|NCT00433160|580739124|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
160823213|NCT00433160|580739125|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
160823214|NCT00433160|580739124|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
160823215|NCT00433160|580739125|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
160823216|NCT00433160|580739124|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
160823217|NCT00433160|580739125|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
160823218|NCT00433160|580739124|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
160823219|NCT00433160|580739125|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
160823220|NCT02240368|580739129|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
160823221|NCT02240368|580739130|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
160823222|NCT02240368|580739131|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
160823223|NCT02240368|580739129|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
160823224|NCT02240368|580739130|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
160823225|NCT02240368|580739131|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
160823226|NCT03372460|580739132|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
160823227|NCT03372460|580739133|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
160823228|NCT00916058|580739140|FG000|Phase 1|Screen Failure|0|||
160823229|NCT00916058|580739141|FG001|Phase 1|Screen Failure|0|||
160823230|NCT00916058|580739142|FG002|Phase 1|Screen Failure|0|||
160823231|NCT00916058|580739143|FG003|Phase 1|Screen Failure|0|||
160823232|NCT00916058|580739144|FG004|Phase 1|Screen Failure|0|||
160823233|NCT00916058|580739145|FG005|Phase 1|Screen Failure|1|||
160823234|NCT00916058|580739146|FG006|Phase 1|Screen Failure|0|||
160823235|NCT00916058|580739140|FG000|Phase 2|Screen Failure|0|||
160823236|NCT00916058|580739141|FG001|Phase 2|Screen Failure|0|||
160823237|NCT00916058|580739142|FG002|Phase 2|Screen Failure|0|||
160823238|NCT00916058|580739143|FG003|Phase 2|Screen Failure|0|||
160823239|NCT00916058|580739144|FG004|Phase 2|Screen Failure|0|||
160823240|NCT00916058|580739145|FG005|Phase 2|Screen Failure|0|||
160823241|NCT00916058|580739146|FG006|Phase 2|Screen Failure|3|||
160823242|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
160823243|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
160823244|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
160823245|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
160823246|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
160823247|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
160823248|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
160823249|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
160823250|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
160823251|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
160823252|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
160823253|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
160901854|NCT01972568|581034114|FG000|Overall Study|Lack of Efficacy|0|||
160901855|NCT01972568|581034115|FG001|Overall Study|Lack of Efficacy|1|||
160901856|NCT01972568|581034116|FG002|Overall Study|Lack of Efficacy|2|||
160901857|NCT01972568|581034114|FG000|Overall Study|Protocol Violation|1|||
160901858|NCT01972568|581034115|FG001|Overall Study|Protocol Violation|2|||
160901859|NCT01972568|581034116|FG002|Overall Study|Protocol Violation|2|||
160901860|NCT01972568|581034114|FG000|Overall Study|Withdrawal by Subject|6|||
160901861|NCT01972568|581034115|FG001|Overall Study|Withdrawal by Subject|3|||
160901862|NCT01972568|581034116|FG002|Overall Study|Withdrawal by Subject|7|||
160901863|NCT01972568|581034114|FG000|Overall Study|Lost to Follow-up|1|||
160901864|NCT01972568|581034115|FG001|Overall Study|Lost to Follow-up|0|||
160823254|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
160823255|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
160901865|NCT01972568|581034116|FG002|Overall Study|Lost to Follow-up|0|||
160901866|NCT01972568|581034114|FG000|Overall Study|Adverse Event|5|||
160901867|NCT01972568|581034115|FG001|Overall Study|Adverse Event|6|||
160989748|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Adverse Event|0|||
160823256|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
160823257|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
160823258|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
160823259|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
160823260|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
160823261|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
160823262|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
160823263|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
160823264|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
160823265|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
160823266|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
160823267|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
160823268|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
160823269|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
160823270|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
160823271|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
160823272|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
160823273|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
160823274|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
160823275|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
160823276|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
160823277|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
160823278|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
160823279|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
160823280|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
160823281|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
160823282|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
160823283|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
160823284|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
160823285|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
160823286|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
160823287|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
160823288|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
160823289|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
160823290|NCT03899064|580740802|FG000|Overall Study|Lost to Follow-up|1|||
160823291|NCT03899064|580740802|FG000|Overall Study|Protocol Violation|2|||
160823292|NCT03899064|580740802|FG000|Overall Study|Withdrawal by Subject|2|||
160823293|NCT03899064|580740802|FG000|Overall Study|Other|2|||
160823294|NCT03283098|580740803|FG000|Overall Study|Withdrawal by Subject|0|||
160823295|NCT03283098|580740804|FG001|Overall Study|Withdrawal by Subject|1|||
160823296|NCT01069861|580740805|FG000|Overall Study|Death|1|||
160823297|NCT01069861|580740805|FG000|Overall Study|Adverse Event|1|||
160823298|NCT01069861|580740805|FG000|Overall Study|Did not meet entrance criteria|1|||
160823299|NCT00354107|580740806|FG000|Overall Study|Adverse Event|2|||
160823300|NCT00354107|580740806|FG000|Overall Study|Physician Decision|2|||
160823301|NCT00354107|580740806|FG000|Overall Study|Withdrawal by Subject|1|||
160823302|NCT02351349|580740807|FG000|Overall Study|Withdrawal by Subject|2|||
160823303|NCT02351349|580740808|FG001|Overall Study|Withdrawal by Subject|3|||
160823304|NCT02649218|580740809|FG000|Overall Study|Adverse Event|8|||
160823305|NCT02649218|580740809|FG000|Overall Study|Lack of Efficacy|8|||
160823306|NCT02649218|580740809|FG000|Overall Study|Pregnancy|3|||
160823307|NCT02649218|580740809|FG000|Overall Study|Protocol Violation|3|||
160823308|NCT02649218|580740809|FG000|Overall Study|Physician Decision|1|||
160823309|NCT02649218|580740809|FG000|Overall Study|Withdrawal by Subject|2|||
160823310|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
160823311|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
160823312|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
160823313|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
160989749|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
160989750|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
160989751|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
160989752|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
160989753|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
160989754|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
160823314|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
160823315|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
160823316|NCT01224821|580740810|FG000|Long-Term Follow-Up|Death|2|||
160823317|NCT01224821|580740810|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
160823318|NCT00683917|580740811|FG000|Overall Study|Study prematurely terminated|10|||
160823319|NCT02174523|580740812|FG000|Overall Study|Withdrawal by Subject|1|||
160989755|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
160989756|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
160989757|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
160989758|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
160989759|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
160989760|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
160989761|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
160989762|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
160989763|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
160989764|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Physician Decision|2|||
160989765|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Physician Decision|3|||
160989766|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Physician Decision|0|||
160989767|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
160989768|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
160989769|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
160989770|NCT01449929|581349674|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
160989771|NCT01449929|581349675|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
160989772|NCT01449929|581349676|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
160989773|NCT01449929|581349674|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
160989774|NCT01449929|581349675|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
160989775|NCT01449929|581349676|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
160989776|NCT01449929|581349674|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
160989777|NCT01449929|581349675|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
160989778|NCT01449929|581349676|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
160989779|NCT00901485|581349677|FG000|Overall Study|Lack of Efficacy|0|||
160989780|NCT00901485|581349678|FG001|Overall Study|Lack of Efficacy|2|||
160989781|NCT00901485|581349677|FG000|Overall Study|Withdrawal by Subject|1|||
160989782|NCT00901485|581349678|FG001|Overall Study|Withdrawal by Subject|2|||
160989783|NCT01871285|581349679|FG000|First Intervention (1 Day)|Adverse Event|1|||
160989784|NCT01871285|581349680|FG001|First Intervention (1 Day)|Adverse Event|0|||
160989785|NCT01871285|581349681|FG002|First Intervention (1 Day)|Adverse Event|0|||
160989786|NCT01871285|581349682|FG003|First Intervention (1 Day)|Adverse Event|0|||
160989787|NCT01871285|581349679|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
160823320|NCT02174523|580740813|FG001|Overall Study|Withdrawal by Subject|0|||
160823321|NCT00794365|580740814|FG000|Overall Study|Lost to Follow-up|38|||
160823322|NCT00794365|580740814|FG000|Overall Study|Other|17|||
160823323|NCT00794365|580740814|FG000|Overall Study|Poor Compliance|11|||
160823324|NCT00794365|580740814|FG000|Overall Study|Adverse Event|10|||
160823325|NCT00794365|580740814|FG000|Overall Study|Lack of Efficacy|3|||
160823326|NCT03538444|580740828|FG000|Overall Study|opioid withdrawal|1|||
160823327|NCT03538444|580740829|FG001|Overall Study|opioid withdrawal|0|||
160823328|NCT03022097|580740832|FG000|Overall Study|Adverse Event|3|||
160823329|NCT03022097|580740833|FG001|Overall Study|Adverse Event|4|||
160823330|NCT03022097|580740834|FG002|Overall Study|Adverse Event|1|||
160823331|NCT03022097|580740835|FG003|Overall Study|Adverse Event|3|||
160823332|NCT03022097|580740832|FG000|Overall Study|Progressive Disease|2|||
160823333|NCT03022097|580740833|FG001|Overall Study|Progressive Disease|0|||
160823334|NCT03022097|580740834|FG002|Overall Study|Progressive Disease|5|||
160823335|NCT03022097|580740835|FG003|Overall Study|Progressive Disease|2|||
160823336|NCT03022097|580740832|FG000|Overall Study|Lack of Efficacy|0|||
160823337|NCT03022097|580740833|FG001|Overall Study|Lack of Efficacy|0|||
160823338|NCT03022097|580740834|FG002|Overall Study|Lack of Efficacy|3|||
160823339|NCT03022097|580740835|FG003|Overall Study|Lack of Efficacy|3|||
160823340|NCT03022097|580740832|FG000|Overall Study|Protocol Violation|1|||
160823341|NCT03022097|580740833|FG001|Overall Study|Protocol Violation|0|||
160823342|NCT03022097|580740834|FG002|Overall Study|Protocol Violation|1|||
160823343|NCT03022097|580740835|FG003|Overall Study|Protocol Violation|0|||
160989788|NCT01871285|581349680|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
160989789|NCT01871285|581349681|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
160989790|NCT01871285|581349682|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
160989791|NCT05397470|581349683|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
160989792|NCT05397470|581349684|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
160646436|NCT01464827|580088244|FG009|Overall Study|Adverse Event|0|||
160646437|NCT01464827|580088245|FG010|Overall Study|Adverse Event|0|||
160823344|NCT03022097|580740832|FG000|Overall Study|Withdrawal by Subject|11|||
160823345|NCT03022097|580740833|FG001|Overall Study|Withdrawal by Subject|13|||
160823346|NCT03022097|580740834|FG002|Overall Study|Withdrawal by Subject|15|||
160823347|NCT03022097|580740835|FG003|Overall Study|Withdrawal by Subject|21|||
160646438|NCT01464827|580088246|FG011|Overall Study|Adverse Event|0|||
160823348|NCT03022097|580740832|FG000|Overall Study|Lost to Follow-up|0|||
160989793|NCT05397470|581349685|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
160989794|NCT05397470|581349683|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
160989795|NCT05397470|581349684|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
160823349|NCT03022097|580740833|FG001|Overall Study|Lost to Follow-up|0|||
160823350|NCT03022097|580740834|FG002|Overall Study|Lost to Follow-up|1|||
160823351|NCT03022097|580740835|FG003|Overall Study|Lost to Follow-up|1|||
160823352|NCT03022097|580740832|FG000|Overall Study|Other|4|||
160823353|NCT03022097|580740833|FG001|Overall Study|Other|1|||
160823354|NCT03022097|580740834|FG002|Overall Study|Other|6|||
160823355|NCT03022097|580740835|FG003|Overall Study|Other|4|||
160823356|NCT03022097|580740832|FG000|Overall Study|Due to COVID-19 pandemic|0|||
160823357|NCT03022097|580740833|FG001|Overall Study|Due to COVID-19 pandemic|1|||
160823358|NCT03022097|580740834|FG002|Overall Study|Due to COVID-19 pandemic|0|||
160823359|NCT03022097|580740835|FG003|Overall Study|Due to COVID-19 pandemic|0|||
160823360|NCT01451931|580740836|FG000|Overall Study|Lost to Follow-up|17|||
160823361|NCT01451931|580740837|FG001|Overall Study|Lost to Follow-up|36|||
160823362|NCT01451931|580740838|FG002|Overall Study|Lost to Follow-up|21|||
160823363|NCT01451931|580740836|FG000|Overall Study|Withdrawal by Subject|16|||
160823364|NCT01451931|580740837|FG001|Overall Study|Withdrawal by Subject|22|||
160823365|NCT01451931|580740838|FG002|Overall Study|Withdrawal by Subject|22|||
160823366|NCT03640052|580740844|FG000|Overall Study|Lost to Follow-up|0|||
160823367|NCT03640052|580740845|FG001|Overall Study|Lost to Follow-up|1|||
160823368|NCT03640052|580740846|FG002|Overall Study|Lost to Follow-up|0|||
160823369|NCT03640052|580740847|FG003|Overall Study|Lost to Follow-up|0|||
160823370|NCT03640052|580740848|FG004|Overall Study|Lost to Follow-up|0|||
160823371|NCT04422561|580740849|FG000|Overall Study|Lost to Follow-up|25|||
160823372|NCT04422561|580740850|FG001|Overall Study|Lost to Follow-up|11|||
160823373|NCT00623545|580740851|FG000|Overall Study|Adverse Event|6|||
160823374|NCT00623545|580740851|FG000|Overall Study|Withdrawal by Subject|4|||
160823375|NCT04239222|580740852|FG000|Baseline|Withdrawal by Subject|0|||
160823376|NCT04239222|580740853|FG001|Baseline|Withdrawal by Subject|0|||
160823377|NCT04239222|580740854|FG002|Baseline|Withdrawal by Subject|1|||
160823378|NCT04239222|580740855|FG003|Baseline|Withdrawal by Subject|1|||
160823379|NCT04239222|580740852|FG000|First Foot Assignment|Withdrawal by Subject|0|||
160823380|NCT04239222|580740853|FG001|First Foot Assignment|Withdrawal by Subject|0|||
160823381|NCT04239222|580740854|FG002|First Foot Assignment|Withdrawal by Subject|1|||
160823382|NCT04239222|580740855|FG003|First Foot Assignment|Withdrawal by Subject|0|||
160823383|NCT04239222|580740852|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
160823384|NCT04239222|580740853|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
160823385|NCT04239222|580740854|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
160823386|NCT04239222|580740855|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
160823387|NCT05479097|580740861|FG000|Overall Study|Withdrawal by Subject|2|||
160823388|NCT04126564|580740862|FG000|Overall Study|Withdrawal by Subject|0|||
160823389|NCT04126564|580740863|FG001|Overall Study|Withdrawal by Subject|2|||
160823390|NCT04126564|580740862|FG000|Overall Study|Lost to Follow-up|0|||
160823391|NCT04126564|580740863|FG001|Overall Study|Lost to Follow-up|1|||
160823392|NCT00457821|580740871|FG000|Part 2|Withdrawal by Subject|0|||
160823393|NCT00457821|580740872|FG001|Part 2|Withdrawal by Subject|0|||
160823394|NCT00457821|580740873|FG002|Part 2|Withdrawal by Subject|0|||
160823395|NCT00457821|580740874|FG003|Part 2|Withdrawal by Subject|0|||
160823396|NCT00457821|580740875|FG004|Part 2|Withdrawal by Subject|0|||
160823397|NCT00457821|580740876|FG005|Part 2|Withdrawal by Subject|0|||
160823398|NCT00457821|580740877|FG006|Part 2|Withdrawal by Subject|0|||
160823399|NCT00457821|580740878|FG007|Part 2|Withdrawal by Subject|1|||
160823400|NCT00790647|580740881|FG000|Overall Study|Adverse Event|1|||
160823401|NCT02437409|580740886|FG000|Overall Study|Withdrawal by Subject|3|||
160823402|NCT02437409|580740886|FG000|Overall Study|Screening failure|12|||
160823403|NCT00027378|580740887|FG000|Overall Study|Physician Decision|0|||
160823404|NCT00027378|580740888|FG001|Overall Study|Physician Decision|3|||
160823405|NCT02701777|580740890|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
160901868|NCT01972568|581034116|FG002|Overall Study|Adverse Event|5|||
160901869|NCT02059408|581034120|FG000|Overall Study|Did not get tested|0|||
160901870|NCT02059408|581034121|FG001|Overall Study|Did not get tested|330|||
160901871|NCT02059408|581034122|FG002|Overall Study|Did not get tested|358|||
160901872|NCT00508755|581034125|FG000|Overall Study|Withdrawal by Subject|1|||
160901873|NCT00957580|581034126|FG000|Overall Study|Ongoing at data cut-off|0|||
160901874|NCT00957580|581034127|FG001|Overall Study|Ongoing at data cut-off|1|||
160901875|NCT00957580|581034128|FG002|Overall Study|Ongoing at data cut-off|0|||
160901876|NCT00957580|581034126|FG000|Overall Study|Enrolled but not treated|0|||
160901877|NCT00957580|581034127|FG001|Overall Study|Enrolled but not treated|1|||
160901878|NCT00957580|581034128|FG002|Overall Study|Enrolled but not treated|0|||
160901879|NCT01187433|581034132|FG000|Overall Study|Protocol Violation|6|||
160901880|NCT01187433|581034133|FG001|Overall Study|Protocol Violation|2|||
160901881|NCT01187433|581034132|FG000|Overall Study|Withdrawal by Subject|5|||
160901882|NCT01187433|581034133|FG001|Overall Study|Withdrawal by Subject|2|||
160901883|NCT00621959|581034134|FG000|Overall Study|Adverse Event|4|||
160901884|NCT00621959|581034135|FG001|Overall Study|Adverse Event|2|||
160901885|NCT00621959|581034134|FG000|Overall Study|Lack of Efficacy|1|||
160901886|NCT00621959|581034135|FG001|Overall Study|Lack of Efficacy|1|||
160901887|NCT00621959|581034134|FG000|Overall Study|Lost to Follow-up|0|||
160901888|NCT00621959|581034135|FG001|Overall Study|Lost to Follow-up|2|||
160901889|NCT00621959|581034134|FG000|Overall Study|Withdrawal by Subject|1|||
160901890|NCT00621959|581034135|FG001|Overall Study|Withdrawal by Subject|1|||
160989796|NCT05397470|581349685|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
160989797|NCT05397470|581349683|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
160823406|NCT02701777|580740891|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
160823407|NCT02701777|580740892|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
160823408|NCT02701777|580740893|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
160823409|NCT02701777|580740890|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
160823410|NCT02701777|580740891|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
160823411|NCT02701777|580740892|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
160823412|NCT02701777|580740893|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
160823413|NCT01369680|580740894|FG000|Overall Study|Lost to Follow-up|0|||
160823414|NCT01369680|580740895|FG001|Overall Study|Lost to Follow-up|0|||
160823415|NCT01369680|580740896|FG002|Overall Study|Lost to Follow-up|1|||
160989798|NCT05397470|581349684|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
160989799|NCT05397470|581349685|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
160989800|NCT05397470|581349683|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
160989801|NCT05397470|581349684|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
160989802|NCT05397470|581349685|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
160989803|NCT05397470|581349683|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
160989804|NCT05397470|581349684|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
160989805|NCT05397470|581349685|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
160989806|NCT05397470|581349683|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
160989807|NCT05397470|581349684|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
160823416|NCT01369680|580740897|FG003|Overall Study|Lost to Follow-up|2|||
160823417|NCT02851407|580740898|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160823418|NCT02851407|580740899|FG001|Overall Study|Withdrawal by parent/guardian|7|||
160823419|NCT02851407|580740898|FG000|Overall Study|Protocol deviation|0|||
160823420|NCT02851407|580740899|FG001|Overall Study|Protocol deviation|1|||
160823421|NCT02851407|580740898|FG000|Overall Study|Transferred to another hospital to continue|1|||
160823422|NCT02851407|580740899|FG001|Overall Study|Transferred to another hospital to continue|0|||
160823423|NCT02851407|580740898|FG000|Overall Study|Other Death|30|||
160823424|NCT02851407|580740899|FG001|Overall Study|Other Death|20|||
160823425|NCT02851407|580740898|FG000|Overall Study|Adverse event, serious fatal|6|||
160823426|NCT02851407|580740899|FG001|Overall Study|Adverse event, serious fatal|8|||
160823427|NCT02851407|580740898|FG000|Overall Study|Consent withdrawn by participant|5|||
160823428|NCT02851407|580740899|FG001|Overall Study|Consent withdrawn by participant|3|||
160823429|NCT02851407|580740898|FG000|Overall Study|Screen failure|2|||
160823430|NCT02851407|580740899|FG001|Overall Study|Screen failure|1|||
160823431|NCT02851407|580740898|FG000|Overall Study|Disease relapse|9|||
160823432|NCT02851407|580740899|FG001|Overall Study|Disease relapse|6|||
160823433|NCT02851407|580740898|FG000|Overall Study|Physician Decision|7|||
160823434|NCT02851407|580740899|FG001|Overall Study|Physician Decision|6|||
160823435|NCT02851407|580740898|FG000|Overall Study|Transferred to hospital closer to home|0|||
160823436|NCT02851407|580740899|FG001|Overall Study|Transferred to hospital closer to home|1|||
160823437|NCT02851407|580740898|FG000|Overall Study|Enrolled in an investigational study|0|||
160823438|NCT02851407|580740899|FG001|Overall Study|Enrolled in an investigational study|1|||
160989808|NCT05397470|581349685|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
160989809|NCT05397470|581349683|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
160989810|NCT05397470|581349684|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
160989811|NCT05397470|581349685|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
160989812|NCT01919619|581349686|FG000|Overall Study|Physician Decision|1|||
160989813|NCT01919619|581349687|FG001|Overall Study|Physician Decision|1|||
160989814|NCT02268396|581351652|FG000|Overall Study|Adverse Event|3|||
160989815|NCT02268396|581351652|FG000|Overall Study|Administrative|2|||
160989816|NCT02268396|581351652|FG000|Overall Study|Withdrawal by Subject|1|||
160989817|NCT02268396|581351652|FG000|Overall Study|Lost to Follow-up|2|||
160989818|NCT02268396|581351652|FG000|Overall Study|Protocol-Specified Criteria|2|||
160989819|NCT02268396|581351652|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
160989820|NCT01311648|581351653|FG000|Main Study|Protocol Violation|0|||
160989821|NCT01311648|581351654|FG001|Main Study|Protocol Violation|1|||
160989822|NCT01311648|581351653|FG000|Main Study|Adverse Event|0|||
160989823|NCT01311648|581351654|FG001|Main Study|Adverse Event|1|||
160823439|NCT02851407|580740898|FG000|Overall Study|Early recovery|1|||
160989824|NCT01311648|581351653|FG000|Main Study|Inhibitor management|0|||
160823440|NCT02851407|580740899|FG001|Overall Study|Early recovery|0|||
160823441|NCT02851407|580740898|FG000|Overall Study|Adverse event, non-fatal|7|||
160823442|NCT02851407|580740899|FG001|Overall Study|Adverse event, non-fatal|5|||
160989825|NCT01311648|581351654|FG001|Main Study|Inhibitor management|17|||
160823443|NCT02851407|580740898|FG000|Overall Study|Lost to Follow-up|0|||
160823444|NCT02851407|580740899|FG001|Overall Study|Lost to Follow-up|2|||
160823445|NCT01713283|580740900|FG000|Overall Study|Lack of Efficacy|10|||
160823446|NCT01713283|580740901|FG001|Overall Study|Lack of Efficacy|2|||
160823447|NCT01713283|580740900|FG000|Overall Study|Lost to Follow-up|1|||
160823448|NCT01713283|580740901|FG001|Overall Study|Lost to Follow-up|1|||
160823449|NCT00835640|580740902|FG000|Second Intervention|Protocol Violation|1|||
160823450|NCT00835640|580740903|FG001|Second Intervention|Protocol Violation|0|||
160823451|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
160823452|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
160823453|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Death|1|||
160823454|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Death|0|||
160823455|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
160823456|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
160823457|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
160823458|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
160823459|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
160823460|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
160823461|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
160823462|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
160823463|NCT00350272|580740904|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
160823464|NCT00350272|580740905|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
160823465|NCT00350272|580740904|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
160823466|NCT00350272|580740905|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
160823467|NCT00350272|580740904|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
160823468|NCT00350272|580740905|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
160823469|NCT00350272|580740904|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
160823470|NCT00350272|580740905|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
160823471|NCT00350272|580740904|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
160823472|NCT00350272|580740905|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
160823473|NCT00812006|580740906|FG000|Overall Study|Lost to Follow-up|0|||
160823474|NCT00812006|580740907|FG001|Overall Study|Lost to Follow-up|0|||
160823475|NCT00812006|580740908|FG002|Overall Study|Lost to Follow-up|2|||
160823476|NCT00812006|580740906|FG000|Overall Study|Physician Decision|0|||
160823477|NCT00812006|580740907|FG001|Overall Study|Physician Decision|0|||
160823478|NCT00812006|580740908|FG002|Overall Study|Physician Decision|1|||
160823479|NCT00812006|580740906|FG000|Overall Study|Withdrawal by Subject|2|||
160823480|NCT00812006|580740907|FG001|Overall Study|Withdrawal by Subject|1|||
160823481|NCT00812006|580740908|FG002|Overall Study|Withdrawal by Subject|1|||
160823482|NCT00812006|580740906|FG000|Overall Study|Lack of Qualifying Event|4|||
160823483|NCT00812006|580740907|FG001|Overall Study|Lack of Qualifying Event|2|||
160823484|NCT00812006|580740908|FG002|Overall Study|Lack of Qualifying Event|2|||
160823485|NCT00235391|580740910|FG000|Overall Study|Adverse Event|4|||
160823486|NCT00235391|580740911|FG001|Overall Study|Adverse Event|5|||
160823487|NCT00235391|580740912|FG002|Overall Study|Adverse Event|10|||
160823488|NCT00235391|580740913|FG003|Overall Study|Adverse Event|72|||
160823489|NCT00235391|580740914|FG004|Overall Study|Adverse Event|5|||
160823490|NCT00235391|580740915|FG005|Overall Study|Adverse Event|2|||
160823491|NCT00235391|580740910|FG000|Overall Study|Abnormal laboratory value(s)|3|||
160823492|NCT00235391|580740911|FG001|Overall Study|Abnormal laboratory value(s)|5|||
160823493|NCT00235391|580740912|FG002|Overall Study|Abnormal laboratory value(s)|4|||
160823494|NCT00235391|580740913|FG003|Overall Study|Abnormal laboratory value(s)|27|||
160823495|NCT00235391|580740914|FG004|Overall Study|Abnormal laboratory value(s)|1|||
160823496|NCT00235391|580740915|FG005|Overall Study|Abnormal laboratory value(s)|2|||
160823497|NCT00235391|580740910|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160823498|NCT00235391|580740911|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160823499|NCT00235391|580740912|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
160823500|NCT00235391|580740913|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
160823501|NCT00235391|580740914|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
160823502|NCT00235391|580740915|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
160823503|NCT00235391|580740910|FG000|Overall Study|Condition no longer requires treatment|3|||
160823504|NCT00235391|580740911|FG001|Overall Study|Condition no longer requires treatment|0|||
160823505|NCT00235391|580740912|FG002|Overall Study|Condition no longer requires treatment|0|||
160823506|NCT00235391|580740913|FG003|Overall Study|Condition no longer requires treatment|11|||
160823507|NCT00235391|580740914|FG004|Overall Study|Condition no longer requires treatment|1|||
160823508|NCT00235391|580740915|FG005|Overall Study|Condition no longer requires treatment|0|||
160823509|NCT00235391|580740910|FG000|Overall Study|Protocol deviation|0|||
160823510|NCT00235391|580740911|FG001|Overall Study|Protocol deviation|0|||
160823511|NCT00235391|580740912|FG002|Overall Study|Protocol deviation|1|||
160901891|NCT00621959|581034134|FG000|Overall Study|Other|1|||
160901892|NCT00621959|581034135|FG001|Overall Study|Other|3|||
160901893|NCT04223973|581034138|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
160901894|NCT04223973|581034139|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
160901895|NCT04223973|581034138|FG000|Overall Study|Adverse Event|4|||
160901896|NCT04223973|581034139|FG001|Overall Study|Adverse Event|0|||
160901897|NCT04223973|581034138|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
160823512|NCT00235391|580740913|FG003|Overall Study|Protocol deviation|11|||
160823513|NCT00235391|580740914|FG004|Overall Study|Protocol deviation|0|||
160989826|NCT01311648|581351653|FG000|Main Study|Withdrawal by Subject|0|||
160989827|NCT01311648|581351654|FG001|Main Study|Withdrawal by Subject|2|||
160823514|NCT00235391|580740915|FG005|Overall Study|Protocol deviation|0|||
160823515|NCT00235391|580740910|FG000|Overall Study|Withdrawal by Subject|2|||
160823516|NCT00235391|580740911|FG001|Overall Study|Withdrawal by Subject|3|||
160823517|NCT00235391|580740912|FG002|Overall Study|Withdrawal by Subject|3|||
160823518|NCT00235391|580740913|FG003|Overall Study|Withdrawal by Subject|61|||
160823519|NCT00235391|580740914|FG004|Overall Study|Withdrawal by Subject|5|||
160823520|NCT00235391|580740915|FG005|Overall Study|Withdrawal by Subject|0|||
160901898|NCT04223973|581034139|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
160989828|NCT01311648|581351653|FG000|Extension Study|Physician Decision|0|||
160989829|NCT01311648|581351654|FG001|Extension Study|Physician Decision|1|||
160989830|NCT01311648|581351653|FG000|Extension Study|ITI therapy with marketed product|0|||
160989831|NCT01311648|581351654|FG001|Extension Study|ITI therapy with marketed product|1|||
160989832|NCT01311648|581351653|FG000|Extension Study|Incorrect visit planning|0|||
160989833|NCT01311648|581351654|FG001|Extension Study|Incorrect visit planning|1|||
160989834|NCT01311648|581351653|FG000|Extension Study|Family's decision|0|||
160989835|NCT01311648|581351654|FG001|Extension Study|Family's decision|1|||
160989836|NCT01311648|581351653|FG000|Extension Study|Failure of ITI therapy|0|||
160989837|NCT01311648|581351654|FG001|Extension Study|Failure of ITI therapy|3|||
160989838|NCT01311648|581351653|FG000|Extension Study|Long travel|0|||
160989839|NCT01311648|581351654|FG001|Extension Study|Long travel|1|||
160989840|NCT01311648|581351653|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
160989841|NCT01311648|581351654|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
160989842|NCT01311648|581351653|FG000|Extension Study|Withdrawal by Subject|0|||
160989843|NCT01311648|581351654|FG001|Extension Study|Withdrawal by Subject|1|||
160989844|NCT01311648|581351653|FG000|Extension Study|Inhibitor management|0|||
160989845|NCT01311648|581351654|FG001|Extension Study|Inhibitor management|2|||
160989846|NCT01645111|581351655|FG000|Overall Study|Did not require Clevidipine|15|||
160989847|NCT01304706|581351658|FG000|Overall Study|Adverse Event|2|||
160989848|NCT01304706|581351658|FG000|Overall Study|Lack of Efficacy|1|||
160989849|NCT01304706|581351658|FG000|Overall Study|Death|3|||
160989850|NCT01304706|581351658|FG000|Overall Study|Withdrawal by Subject|3|||
160989851|NCT01304706|581351658|FG000|Overall Study|Lost to Follow-up|7|||
160989852|NCT01304706|581351658|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
160989853|NCT05526911|581351659|FG000|Overall Study|Adverse Event|2|||
160989854|NCT05025449|581351660|FG000|Overall Study|Withdrawal by Subject|1|||
160989855|NCT05025449|581351660|FG000|Overall Study|Patient emergently taken to operating room|1|||
160989856|NCT01419717|581351661|FG000|Overall Study|Protocol-specified Criteria|62|||
160989857|NCT01419717|581351661|FG000|Overall Study|Adverse Event|19|||
160989858|NCT01419717|581351661|FG000|Overall Study|Death|17|||
160989859|NCT01419717|581351661|FG000|Overall Study|Withdrawal by Subject|10|||
160989860|NCT01419717|581351661|FG000|Overall Study|Disease Progression|9|||
160989861|NCT01419717|581351661|FG000|Overall Study|Other|4|||
160989862|NCT01419717|581351661|FG000|Overall Study|Lost to Follow-up|2|||
160989863|NCT01419717|581351661|FG000|Overall Study|Administrative Decision|1|||
160989864|NCT01419717|581351661|FG000|Overall Study|Noncompliance|1|||
160989865|NCT00587288|581351663|FG000|Overall Study|Adverse Event|0|||
160989866|NCT00587288|581351664|FG001|Overall Study|Adverse Event|1|||
160989867|NCT00587288|581351663|FG000|Overall Study|Lack of Efficacy|2|||
160989868|NCT00587288|581351664|FG001|Overall Study|Lack of Efficacy|8|||
160989869|NCT00587288|581351663|FG000|Overall Study|Protocol Violation|1|||
160901899|NCT04223973|581034138|FG000|Overall Study|Physician Decision|1|||
160901900|NCT04223973|581034139|FG001|Overall Study|Physician Decision|1|||
160901901|NCT04223973|581034138|FG000|Overall Study|Withdrawal by Subject|0|||
160901902|NCT04223973|581034139|FG001|Overall Study|Withdrawal by Subject|1|||
160901903|NCT03360747|581034140|FG000|Overall Study|Voluntary Withdrawal|1|||
160901904|NCT02569671|581034148|FG000|Overall Study|Lost to Follow-up|2|||
160901905|NCT02569671|581034149|FG001|Overall Study|Lost to Follow-up|1|||
160901906|NCT02569671|581034148|FG000|Overall Study|Withdrawal by Subject|1|||
160901907|NCT02569671|581034149|FG001|Overall Study|Withdrawal by Subject|3|||
160901908|NCT01757535|581034150|FG000|Overall Study|Disease Relapse|151|||
160901909|NCT01757535|581034151|FG001|Overall Study|Disease Relapse|181|||
160901910|NCT01757535|581034150|FG000|Overall Study|Other Reasons|28|||
160901911|NCT01757535|581034151|FG001|Overall Study|Other Reasons|27|||
160989870|NCT00587288|581351664|FG001|Overall Study|Protocol Violation|0|||
160989871|NCT01240356|581351665|FG000|Overall Study|Withdrawal by Subject|2|||
160989872|NCT01240356|581351666|FG001|Overall Study|Withdrawal by Subject|0|||
160989873|NCT01240356|581351665|FG000|Overall Study|MRI contraindication|1|||
160989874|NCT01240356|581351666|FG001|Overall Study|MRI contraindication|0|||
160989875|NCT04048135|581351667|FG000|Overall Study|Withdrawal by Subject|1|||
160989876|NCT04048135|581351668|FG001|Overall Study|Withdrawal by Subject|1|||
160989877|NCT04048135|581351669|FG002|Overall Study|Withdrawal by Subject|1|||
160989878|NCT04048135|581351670|FG003|Overall Study|Withdrawal by Subject|2|||
160823521|NCT00235391|580740910|FG000|Overall Study|Lost to Follow-up|0|||
160823522|NCT00235391|580740911|FG001|Overall Study|Lost to Follow-up|3|||
160901912|NCT01757535|581034150|FG000|Overall Study|Adverse Event|31|||
160823523|NCT00235391|580740912|FG002|Overall Study|Lost to Follow-up|3|||
160823524|NCT00235391|580740913|FG003|Overall Study|Lost to Follow-up|16|||
160823525|NCT00235391|580740914|FG004|Overall Study|Lost to Follow-up|0|||
160823526|NCT00235391|580740915|FG005|Overall Study|Lost to Follow-up|0|||
160823527|NCT00235391|580740910|FG000|Overall Study|Administrative problems|0|||
160823528|NCT00235391|580740911|FG001|Overall Study|Administrative problems|0|||
160823529|NCT00235391|580740912|FG002|Overall Study|Administrative problems|0|||
160823530|NCT00235391|580740913|FG003|Overall Study|Administrative problems|1|||
160823531|NCT00235391|580740914|FG004|Overall Study|Administrative problems|0|||
160823532|NCT00235391|580740915|FG005|Overall Study|Administrative problems|0|||
160823533|NCT00235391|580740910|FG000|Overall Study|Death|0|||
160823534|NCT00235391|580740911|FG001|Overall Study|Death|0|||
160823535|NCT00235391|580740912|FG002|Overall Study|Death|1|||
160823536|NCT00235391|580740913|FG003|Overall Study|Death|4|||
160823537|NCT00235391|580740914|FG004|Overall Study|Death|0|||
160823538|NCT00235391|580740915|FG005|Overall Study|Death|0|||
160823539|NCT00075725|580740916|FG000|Overall Study|Adverse Event|6|||
160823540|NCT00075725|580740917|FG001|Overall Study|Adverse Event|6|||
160823541|NCT00075725|580740918|FG002|Overall Study|Adverse Event|20|||
160823542|NCT00075725|580740919|FG003|Overall Study|Adverse Event|8|||
160823543|NCT00075725|580740920|FG004|Overall Study|Adverse Event|4|||
160823544|NCT00075725|580740921|FG005|Overall Study|Adverse Event|38|||
160823545|NCT00075725|580740922|FG006|Overall Study|Adverse Event|3|||
160823546|NCT00075725|580740923|FG007|Overall Study|Adverse Event|51|||
160823547|NCT00075725|580740924|FG008|Overall Study|Adverse Event|15|||
160823548|NCT00075725|580740925|FG009|Overall Study|Adverse Event|4|||
160823549|NCT00075725|580740926|FG010|Overall Study|Adverse Event|2|||
160823550|NCT00075725|580740927|FG011|Overall Study|Adverse Event|2|||
160823551|NCT00075725|580740916|FG000|Overall Study|Death|3|||
160823552|NCT00075725|580740917|FG001|Overall Study|Death|5|||
160823553|NCT00075725|580740918|FG002|Overall Study|Death|10|||
160823554|NCT00075725|580740919|FG003|Overall Study|Death|2|||
160823555|NCT00075725|580740920|FG004|Overall Study|Death|3|||
160823556|NCT00075725|580740921|FG005|Overall Study|Death|25|||
160823557|NCT00075725|580740922|FG006|Overall Study|Death|4|||
160823558|NCT00075725|580740923|FG007|Overall Study|Death|22|||
160823559|NCT00075725|580740924|FG008|Overall Study|Death|14|||
160823560|NCT00075725|580740925|FG009|Overall Study|Death|4|||
160823561|NCT00075725|580740926|FG010|Overall Study|Death|3|||
160823562|NCT00075725|580740927|FG011|Overall Study|Death|0|||
160823563|NCT00075725|580740916|FG000|Overall Study|Lost to Follow-up|1|||
160823564|NCT00075725|580740917|FG001|Overall Study|Lost to Follow-up|1|||
160823565|NCT00075725|580740918|FG002|Overall Study|Lost to Follow-up|4|||
160823566|NCT00075725|580740919|FG003|Overall Study|Lost to Follow-up|1|||
160823567|NCT00075725|580740920|FG004|Overall Study|Lost to Follow-up|0|||
160823568|NCT00075725|580740921|FG005|Overall Study|Lost to Follow-up|13|||
160823569|NCT00075725|580740922|FG006|Overall Study|Lost to Follow-up|2|||
160823570|NCT00075725|580740923|FG007|Overall Study|Lost to Follow-up|4|||
160823571|NCT00075725|580740924|FG008|Overall Study|Lost to Follow-up|1|||
160823572|NCT00075725|580740925|FG009|Overall Study|Lost to Follow-up|0|||
160823573|NCT00075725|580740926|FG010|Overall Study|Lost to Follow-up|0|||
160823574|NCT00075725|580740927|FG011|Overall Study|Lost to Follow-up|0|||
160553566|NCT02804763|579753442|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
160553567|NCT02804763|579753443|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
160553568|NCT02804763|579753440|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
160553569|NCT02804763|579753441|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
160553570|NCT02804763|579753442|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
160553571|NCT02804763|579753443|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
160553572|NCT02804763|579753440|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
160553573|NCT02804763|579753441|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
160553574|NCT02804763|579753442|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
160553575|NCT02804763|579753443|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
160553576|NCT02804763|579753440|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
160553577|NCT02804763|579753441|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
160553578|NCT02804763|579753442|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
160553579|NCT02804763|579753443|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
160553580|NCT02804763|579753440|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
160553581|NCT02804763|579753441|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
160553582|NCT02804763|579753442|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
160553583|NCT02804763|579753443|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
160989879|NCT04048135|581351671|FG004|Overall Study|Withdrawal by Subject|0|||
160823575|NCT00075725|580740916|FG000|Overall Study|Physician Decision|2|||
160823576|NCT00075725|580740917|FG001|Overall Study|Physician Decision|6|||
160823577|NCT00075725|580740918|FG002|Overall Study|Physician Decision|5|||
160823578|NCT00075725|580740919|FG003|Overall Study|Physician Decision|8|||
160823579|NCT00075725|580740920|FG004|Overall Study|Physician Decision|4|||
160823580|NCT00075725|580740921|FG005|Overall Study|Physician Decision|19|||
160823581|NCT00075725|580740922|FG006|Overall Study|Physician Decision|3|||
160823582|NCT00075725|580740923|FG007|Overall Study|Physician Decision|17|||
160823583|NCT00075725|580740924|FG008|Overall Study|Physician Decision|5|||
160823584|NCT00075725|580740925|FG009|Overall Study|Physician Decision|0|||
160823585|NCT00075725|580740926|FG010|Overall Study|Physician Decision|1|||
160553584|NCT02472847|579753444|FG000|Overall Study|Withdrawal by Subject|1|||
160553585|NCT02472847|579753445|FG001|Overall Study|Withdrawal by Subject|5|||
160553586|NCT04656990|579753446|FG000|Baseline|pandemic|20|||
160553587|NCT04656990|579753447|FG001|Baseline|pandemic|24|||
160823586|NCT00075725|580740927|FG011|Overall Study|Physician Decision|0|||
160823587|NCT00075725|580740916|FG000|Overall Study|Pregnancy|0|||
160823588|NCT00075725|580740917|FG001|Overall Study|Pregnancy|0|||
160823589|NCT00075725|580740918|FG002|Overall Study|Pregnancy|0|||
160823590|NCT00075725|580740919|FG003|Overall Study|Pregnancy|0|||
160823591|NCT00075725|580740920|FG004|Overall Study|Pregnancy|0|||
160553588|NCT04656990|579753446|FG000|Follow Up Period|Lost to Follow-up|61|||
160553589|NCT04656990|579753447|FG001|Follow Up Period|Lost to Follow-up|73|||
160553590|NCT03244059|579753448|FG000|Specific Aim 1|Physician Decision|1|||
160553591|NCT03244059|579753449|FG001|Specific Aim 1|Physician Decision|0|||
160553592|NCT03244059|579753448|FG000|Specific Aim 2|Physician Decision|1|||
160553593|NCT03244059|579753449|FG001|Specific Aim 2|Physician Decision|0|||
160553594|NCT05499520|579753450|FG000|Overall Study|Lost to Follow-up|0|||
160553595|NCT05499520|579753451|FG001|Overall Study|Lost to Follow-up|0|||
160553596|NCT05499520|579753452|FG002|Overall Study|Lost to Follow-up|38|||
160553597|NCT05499520|579753453|FG003|Overall Study|Lost to Follow-up|41|||
160553598|NCT05499520|579753454|FG004|Overall Study|Lost to Follow-up|46|||
160823592|NCT00075725|580740921|FG005|Overall Study|Pregnancy|1|||
160823593|NCT00075725|580740922|FG006|Overall Study|Pregnancy|0|||
160823594|NCT00075725|580740923|FG007|Overall Study|Pregnancy|1|||
160823595|NCT00075725|580740924|FG008|Overall Study|Pregnancy|0|||
160823596|NCT00075725|580740925|FG009|Overall Study|Pregnancy|0|||
160823597|NCT00075725|580740926|FG010|Overall Study|Pregnancy|0|||
160823598|NCT00075725|580740927|FG011|Overall Study|Pregnancy|0|||
160823599|NCT00075725|580740916|FG000|Overall Study|Protocol Violation|1|||
160823600|NCT00075725|580740917|FG001|Overall Study|Protocol Violation|1|||
160823601|NCT00075725|580740918|FG002|Overall Study|Protocol Violation|0|||
160823602|NCT00075725|580740919|FG003|Overall Study|Protocol Violation|3|||
160823603|NCT00075725|580740920|FG004|Overall Study|Protocol Violation|3|||
160823604|NCT00075725|580740921|FG005|Overall Study|Protocol Violation|2|||
160823605|NCT00075725|580740922|FG006|Overall Study|Protocol Violation|1|||
160823606|NCT00075725|580740923|FG007|Overall Study|Protocol Violation|2|||
160823607|NCT00075725|580740924|FG008|Overall Study|Protocol Violation|3|||
160823608|NCT00075725|580740925|FG009|Overall Study|Protocol Violation|0|||
160823609|NCT00075725|580740926|FG010|Overall Study|Protocol Violation|0|||
160553599|NCT05499520|579753455|FG005|Overall Study|Lost to Follow-up|0|||
160553600|NCT05499520|579753456|FG006|Overall Study|Lost to Follow-up|31|||
160989880|NCT04048135|581351672|FG005|Overall Study|Withdrawal by Subject|0|||
160553601|NCT05499520|579753457|FG007|Overall Study|Lost to Follow-up|45|||
160553602|NCT05499520|579753458|FG008|Overall Study|Lost to Follow-up|42|||
160553603|NCT05499520|579753459|FG009|Overall Study|Lost to Follow-up|0|||
160553604|NCT05499520|579753460|FG010|Overall Study|Lost to Follow-up|0|||
160553605|NCT05499520|579753461|FG011|Overall Study|Lost to Follow-up|37|||
160553606|NCT05499520|579753462|FG012|Overall Study|Lost to Follow-up|53|||
160553607|NCT05499520|579753463|FG013|Overall Study|Lost to Follow-up|49|||
160823610|NCT00075725|580740927|FG011|Overall Study|Protocol Violation|1|||
160823611|NCT00075725|580740916|FG000|Overall Study|Withdrawal by Subject|12|||
160823612|NCT00075725|580740917|FG001|Overall Study|Withdrawal by Subject|3|||
160823613|NCT00075725|580740918|FG002|Overall Study|Withdrawal by Subject|6|||
160553608|NCT05499520|579753464|FG014|Overall Study|Lost to Follow-up|0|||
160553609|NCT05499520|579753465|FG015|Overall Study|Lost to Follow-up|36|||
160553610|NCT05499520|579753466|FG016|Overall Study|Lost to Follow-up|58|||
160553611|NCT05499520|579753467|FG017|Overall Study|Lost to Follow-up|53|||
160553612|NCT01613326|579753468|FG000|Overall Study|Adverse Event|7|||
160553613|NCT01613326|579753469|FG001|Overall Study|Adverse Event|5|||
160553614|NCT01613326|579753468|FG000|Overall Study|Withdrawal by Subject|3|||
160553615|NCT01613326|579753469|FG001|Overall Study|Withdrawal by Subject|4|||
160823614|NCT00075725|580740919|FG003|Overall Study|Withdrawal by Subject|10|||
160823615|NCT00075725|580740920|FG004|Overall Study|Withdrawal by Subject|6|||
160553616|NCT01613326|579753468|FG000|Overall Study|Abnormal test procedure result(s)|2|||
160553617|NCT01613326|579753469|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160553618|NCT01613326|579753468|FG000|Overall Study|inability to use device|1|||
160553619|NCT01613326|579753469|FG001|Overall Study|inability to use device|0|||
160823616|NCT00075725|580740921|FG005|Overall Study|Withdrawal by Subject|27|||
160553620|NCT01613326|579753468|FG000|Overall Study|Lack of Efficacy|0|||
160823617|NCT00075725|580740922|FG006|Overall Study|Withdrawal by Subject|7|||
160823618|NCT00075725|580740923|FG007|Overall Study|Withdrawal by Subject|31|||
160823619|NCT00075725|580740924|FG008|Overall Study|Withdrawal by Subject|10|||
160823620|NCT00075725|580740925|FG009|Overall Study|Withdrawal by Subject|2|||
160823621|NCT00075725|580740926|FG010|Overall Study|Withdrawal by Subject|0|||
160989881|NCT04048135|581351673|FG006|Overall Study|Withdrawal by Subject|1|||
160989882|NCT04048135|581351674|FG007|Overall Study|Withdrawal by Subject|1|||
160989883|NCT04048135|581351667|FG000|Overall Study|Adverse Event|0|||
160823622|NCT00075725|580740927|FG011|Overall Study|Withdrawal by Subject|0|||
160823623|NCT00075725|580740916|FG000|Overall Study|Disease Progression, all other reasons|17|||
160823624|NCT00075725|580740917|FG001|Overall Study|Disease Progression, all other reasons|5|||
160823625|NCT00075725|580740918|FG002|Overall Study|Disease Progression, all other reasons|33|||
160823626|NCT00075725|580740919|FG003|Overall Study|Disease Progression, all other reasons|6|||
160823627|NCT00075725|580740920|FG004|Overall Study|Disease Progression, all other reasons|21|||
160823628|NCT00075725|580740921|FG005|Overall Study|Disease Progression, all other reasons|59|||
160823629|NCT00075725|580740922|FG006|Overall Study|Disease Progression, all other reasons|20|||
160823630|NCT00075725|580740923|FG007|Overall Study|Disease Progression, all other reasons|46|||
160823631|NCT00075725|580740924|FG008|Overall Study|Disease Progression, all other reasons|21|||
160823632|NCT00075725|580740925|FG009|Overall Study|Disease Progression, all other reasons|4|||
160823633|NCT00075725|580740926|FG010|Overall Study|Disease Progression, all other reasons|0|||
160823634|NCT00075725|580740927|FG011|Overall Study|Disease Progression, all other reasons|5|||
160823635|NCT00075725|580740916|FG000|Overall Study|Patient off treatment|0|||
160823636|NCT00075725|580740917|FG001|Overall Study|Patient off treatment|0|||
160823637|NCT00075725|580740918|FG002|Overall Study|Patient off treatment|1|||
160823638|NCT00075725|580740919|FG003|Overall Study|Patient off treatment|2|||
160823639|NCT00075725|580740920|FG004|Overall Study|Patient off treatment|1|||
160823640|NCT00075725|580740921|FG005|Overall Study|Patient off treatment|0|||
160823641|NCT00075725|580740922|FG006|Overall Study|Patient off treatment|0|||
160823642|NCT00075725|580740923|FG007|Overall Study|Patient off treatment|2|||
160823643|NCT00075725|580740924|FG008|Overall Study|Patient off treatment|1|||
160823644|NCT00075725|580740925|FG009|Overall Study|Patient off treatment|0|||
160823645|NCT00075725|580740926|FG010|Overall Study|Patient off treatment|0|||
160823646|NCT00075725|580740927|FG011|Overall Study|Patient off treatment|0|||
160823647|NCT00075725|580740916|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
160823648|NCT00075725|580740917|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
160823649|NCT00075725|580740918|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
160823650|NCT00075725|580740919|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
160823651|NCT00075725|580740920|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
160823652|NCT00075725|580740921|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
160823653|NCT00075725|580740922|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
160823654|NCT00075725|580740923|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
160823655|NCT00075725|580740924|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
160823656|NCT00075725|580740925|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
160823657|NCT00075725|580740926|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
160823658|NCT00075725|580740927|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
160823659|NCT00075725|580740916|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
160823660|NCT00075725|580740917|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
160989884|NCT04048135|581351668|FG001|Overall Study|Adverse Event|0|||
160989885|NCT04048135|581351669|FG002|Overall Study|Adverse Event|0|||
160989886|NCT04048135|581351670|FG003|Overall Study|Adverse Event|1|||
160989887|NCT04048135|581351671|FG004|Overall Study|Adverse Event|1|||
160989888|NCT04048135|581351672|FG005|Overall Study|Adverse Event|0|||
160989889|NCT04048135|581351673|FG006|Overall Study|Adverse Event|0|||
160989890|NCT04048135|581351674|FG007|Overall Study|Adverse Event|0|||
160989891|NCT04048135|581351667|FG000|Overall Study|Protocol Violation|0|||
160989892|NCT04048135|581351668|FG001|Overall Study|Protocol Violation|0|||
160989893|NCT04048135|581351669|FG002|Overall Study|Protocol Violation|0|||
160989894|NCT04048135|581351670|FG003|Overall Study|Protocol Violation|0|||
160989895|NCT04048135|581351671|FG004|Overall Study|Protocol Violation|0|||
160989896|NCT04048135|581351672|FG005|Overall Study|Protocol Violation|1|||
160989897|NCT04048135|581351673|FG006|Overall Study|Protocol Violation|0|||
160989898|NCT04048135|581351674|FG007|Overall Study|Protocol Violation|0|||
160989899|NCT02359435|581351675|FG000|Overall Study|Lost to Follow-up|4|||
160989900|NCT02359435|581351676|FG001|Overall Study|Lost to Follow-up|4|||
160989901|NCT00315055|581351677|FG000|Overall Study|Protocol Violation|2|||
160989902|NCT00315055|581351678|FG001|Overall Study|Protocol Violation|4|||
160989903|NCT00315055|581351677|FG000|Overall Study|Lost to Follow-up|1|||
160989904|NCT00315055|581351678|FG001|Overall Study|Lost to Follow-up|1|||
160989905|NCT02347943|581351680|FG000|Overall Study|Study was cancelled|140|||
160989906|NCT02347943|581351681|FG001|Overall Study|Study was cancelled|67|||
160553621|NCT01613326|579753469|FG001|Overall Study|Lack of Efficacy|1|||
160823661|NCT00075725|580740918|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
160823662|NCT00075725|580740919|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
160823663|NCT00075725|580740920|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
160823664|NCT00075725|580740921|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
160823665|NCT00075725|580740922|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
160823666|NCT00075725|580740923|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
160989907|NCT02347943|581351682|FG002|Overall Study|Study was cancelled|45|||
160989908|NCT01124162|581351687|FG000|First Intervention|Adverse Event|2|||
160553622|NCT01613326|579753468|FG000|Overall Study|Lost to Follow-up|0|||
160553623|NCT01613326|579753469|FG001|Overall Study|Lost to Follow-up|1|||
160553624|NCT01613326|579753468|FG000|Overall Study|Administrative|0|||
160553625|NCT01613326|579753469|FG001|Overall Study|Administrative|2|||
160553626|NCT01613326|579753468|FG000|Overall Study|Protocol Violation|0|||
160553627|NCT01613326|579753469|FG001|Overall Study|Protocol Violation|1|||
160553628|NCT00605267|579753470|FG000|Overall Study|Adverse Event|0|||
160553629|NCT00605267|579753471|FG001|Overall Study|Adverse Event|1|||
160823667|NCT00075725|580740924|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
160823668|NCT00075725|580740925|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
160823669|NCT00075725|580740926|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
160823670|NCT00075725|580740927|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
160823671|NCT00075725|580740916|FG000|Overall Study|Pt non compliant with therapy|2|||
160823672|NCT00075725|580740917|FG001|Overall Study|Pt non compliant with therapy|1|||
160823673|NCT00075725|580740918|FG002|Overall Study|Pt non compliant with therapy|1|||
160823674|NCT00075725|580740919|FG003|Overall Study|Pt non compliant with therapy|0|||
160823675|NCT00075725|580740920|FG004|Overall Study|Pt non compliant with therapy|2|||
160823676|NCT00075725|580740921|FG005|Overall Study|Pt non compliant with therapy|14|||
160823677|NCT00075725|580740922|FG006|Overall Study|Pt non compliant with therapy|2|||
160823678|NCT00075725|580740923|FG007|Overall Study|Pt non compliant with therapy|5|||
160823679|NCT00075725|580740924|FG008|Overall Study|Pt non compliant with therapy|3|||
160823680|NCT00075725|580740925|FG009|Overall Study|Pt non compliant with therapy|0|||
160823681|NCT00075725|580740926|FG010|Overall Study|Pt non compliant with therapy|0|||
160823682|NCT00075725|580740927|FG011|Overall Study|Pt non compliant with therapy|0|||
160823683|NCT00075725|580740916|FG000|Overall Study|Pt age out of range for treatment|0|||
160823684|NCT00075725|580740917|FG001|Overall Study|Pt age out of range for treatment|1|||
160823685|NCT00075725|580740918|FG002|Overall Study|Pt age out of range for treatment|0|||
160823686|NCT00075725|580740919|FG003|Overall Study|Pt age out of range for treatment|0|||
160823687|NCT00075725|580740920|FG004|Overall Study|Pt age out of range for treatment|0|||
160823688|NCT00075725|580740921|FG005|Overall Study|Pt age out of range for treatment|1|||
160823689|NCT00075725|580740922|FG006|Overall Study|Pt age out of range for treatment|0|||
160823690|NCT00075725|580740923|FG007|Overall Study|Pt age out of range for treatment|1|||
160823691|NCT00075725|580740924|FG008|Overall Study|Pt age out of range for treatment|0|||
160823692|NCT00075725|580740925|FG009|Overall Study|Pt age out of range for treatment|0|||
160823693|NCT00075725|580740926|FG010|Overall Study|Pt age out of range for treatment|0|||
160823694|NCT00075725|580740927|FG011|Overall Study|Pt age out of range for treatment|0|||
160553630|NCT00605267|579753470|FG000|Overall Study|Lack of Efficacy|1|||
160553631|NCT00605267|579753471|FG001|Overall Study|Lack of Efficacy|5|||
160553632|NCT00605267|579753470|FG000|Overall Study|Withdrawal by Subject|2|||
160553633|NCT00605267|579753471|FG001|Overall Study|Withdrawal by Subject|3|||
160553634|NCT00793793|579753472|FG000|Overall Study|Adverse Event|0|||
160553635|NCT00793793|579753473|FG001|Overall Study|Adverse Event|0|||
160553636|NCT00793793|579753474|FG002|Overall Study|Adverse Event|1|||
160553637|NCT00793793|579753475|FG003|Overall Study|Adverse Event|1|||
160553638|NCT00793793|579753476|FG004|Overall Study|Adverse Event|0|||
160553639|NCT00793793|579753477|FG005|Overall Study|Adverse Event|1|||
160553640|NCT00793793|579753478|FG006|Overall Study|Adverse Event|2|||
160553641|NCT00793793|579753479|FG007|Overall Study|Adverse Event|0|||
160553642|NCT00793793|579753480|FG008|Overall Study|Adverse Event|0|||
160553643|NCT00793793|579753481|FG009|Overall Study|Adverse Event|0|||
160553644|NCT00793793|579753482|FG010|Overall Study|Adverse Event|0|||
160553645|NCT00793793|579753483|FG011|Overall Study|Adverse Event|2|||
160553646|NCT00793793|579753472|FG000|Overall Study|Protocol Violation|0|||
160553647|NCT00793793|579753473|FG001|Overall Study|Protocol Violation|0|||
160553648|NCT00793793|579753474|FG002|Overall Study|Protocol Violation|0|||
160553649|NCT00793793|579753475|FG003|Overall Study|Protocol Violation|1|||
160553650|NCT00793793|579753476|FG004|Overall Study|Protocol Violation|0|||
160553651|NCT00793793|579753477|FG005|Overall Study|Protocol Violation|0|||
160553652|NCT00793793|579753478|FG006|Overall Study|Protocol Violation|0|||
160553653|NCT00793793|579753479|FG007|Overall Study|Protocol Violation|0|||
160553654|NCT00793793|579753480|FG008|Overall Study|Protocol Violation|0|||
160553655|NCT00793793|579753481|FG009|Overall Study|Protocol Violation|0|||
160553656|NCT00793793|579753482|FG010|Overall Study|Protocol Violation|0|||
160553657|NCT00793793|579753483|FG011|Overall Study|Protocol Violation|0|||
160553658|NCT00793793|579753472|FG000|Overall Study|Lost to Follow-up|0|||
160553659|NCT00793793|579753473|FG001|Overall Study|Lost to Follow-up|0|||
160553660|NCT00793793|579753474|FG002|Overall Study|Lost to Follow-up|1|||
160553661|NCT00793793|579753475|FG003|Overall Study|Lost to Follow-up|0|||
160553662|NCT00793793|579753476|FG004|Overall Study|Lost to Follow-up|0|||
160553663|NCT00793793|579753477|FG005|Overall Study|Lost to Follow-up|0|||
160553664|NCT00793793|579753478|FG006|Overall Study|Lost to Follow-up|0|||
160553665|NCT00793793|579753479|FG007|Overall Study|Lost to Follow-up|0|||
160553666|NCT00793793|579753480|FG008|Overall Study|Lost to Follow-up|1|||
160553667|NCT00793793|579753481|FG009|Overall Study|Lost to Follow-up|3|||
160553668|NCT00793793|579753482|FG010|Overall Study|Lost to Follow-up|1|||
160553669|NCT00793793|579753483|FG011|Overall Study|Lost to Follow-up|0|||
160646439|NCT01464827|580088247|FG012|Overall Study|Adverse Event|1|||
160646440|NCT01464827|580088248|FG013|Overall Study|Adverse Event|0|||
160646441|NCT01464827|580088235|FG000|Overall Study|Withdrawal by Subject|1|||
160646442|NCT01464827|580088236|FG001|Overall Study|Withdrawal by Subject|0|||
160646443|NCT01464827|580088237|FG002|Overall Study|Withdrawal by Subject|0|||
160646444|NCT01464827|580088238|FG003|Overall Study|Withdrawal by Subject|0|||
160646445|NCT01464827|580088239|FG004|Overall Study|Withdrawal by Subject|1|||
160646446|NCT01464827|580088240|FG005|Overall Study|Withdrawal by Subject|0|||
160646447|NCT01464827|580088241|FG006|Overall Study|Withdrawal by Subject|0|||
160646448|NCT01464827|580088242|FG007|Overall Study|Withdrawal by Subject|1|||
160646449|NCT01464827|580088243|FG008|Overall Study|Withdrawal by Subject|0|||
160646450|NCT01464827|580088244|FG009|Overall Study|Withdrawal by Subject|0|||
160823695|NCT00075725|580740916|FG000|Overall Study|Insurance issues|0|||
160823696|NCT00075725|580740917|FG001|Overall Study|Insurance issues|1|||
160823697|NCT00075725|580740918|FG002|Overall Study|Insurance issues|0|||
160823698|NCT00075725|580740919|FG003|Overall Study|Insurance issues|1|||
160823699|NCT00075725|580740920|FG004|Overall Study|Insurance issues|1|||
160646451|NCT01464827|580088245|FG010|Overall Study|Withdrawal by Subject|0|||
160823700|NCT00075725|580740921|FG005|Overall Study|Insurance issues|1|||
160823701|NCT00075725|580740922|FG006|Overall Study|Insurance issues|0|||
160823702|NCT00075725|580740923|FG007|Overall Study|Insurance issues|1|||
160823703|NCT00075725|580740924|FG008|Overall Study|Insurance issues|0|||
160823704|NCT00075725|580740925|FG009|Overall Study|Insurance issues|0|||
160823705|NCT00075725|580740926|FG010|Overall Study|Insurance issues|0|||
160823706|NCT00075725|580740927|FG011|Overall Study|Insurance issues|0|||
160823707|NCT00075725|580740916|FG000|Overall Study|MRD positive after extended ind|0|||
160823708|NCT00075725|580740917|FG001|Overall Study|MRD positive after extended ind|1|||
160823709|NCT00075725|580740918|FG002|Overall Study|MRD positive after extended ind|1|||
160823710|NCT00075725|580740919|FG003|Overall Study|MRD positive after extended ind|0|||
160823711|NCT00075725|580740920|FG004|Overall Study|MRD positive after extended ind|1|||
160823712|NCT00075725|580740921|FG005|Overall Study|MRD positive after extended ind|2|||
160823713|NCT00075725|580740922|FG006|Overall Study|MRD positive after extended ind|0|||
160823714|NCT00075725|580740923|FG007|Overall Study|MRD positive after extended ind|1|||
160823715|NCT00075725|580740924|FG008|Overall Study|MRD positive after extended ind|0|||
160823716|NCT00075725|580740925|FG009|Overall Study|MRD positive after extended ind|0|||
160823717|NCT00075725|580740926|FG010|Overall Study|MRD positive after extended ind|0|||
160823718|NCT00075725|580740927|FG011|Overall Study|MRD positive after extended ind|0|||
160823719|NCT00075725|580740916|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
160823720|NCT00075725|580740917|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
160823721|NCT00075725|580740918|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
160823722|NCT00075725|580740919|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
160823723|NCT00075725|580740920|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
160823724|NCT00075725|580740921|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
160823725|NCT00075725|580740922|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
160823726|NCT00075725|580740923|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
160823727|NCT00075725|580740924|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
160823728|NCT00075725|580740925|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
160823729|NCT00075725|580740926|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
160823730|NCT00075725|580740927|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
160823731|NCT00075725|580740916|FG000|Overall Study|Inevaluable|1|||
160823732|NCT00075725|580740917|FG001|Overall Study|Inevaluable|1|||
160823733|NCT00075725|580740918|FG002|Overall Study|Inevaluable|4|||
160823734|NCT00075725|580740919|FG003|Overall Study|Inevaluable|2|||
160901913|NCT01757535|581034151|FG001|Overall Study|Adverse Event|11|||
160901914|NCT01757535|581034150|FG000|Overall Study|Withdrew Consent|19|||
160901915|NCT01757535|581034151|FG001|Overall Study|Withdrew Consent|13|||
160901916|NCT01757535|581034150|FG000|Overall Study|Physician Decision|7|||
160646452|NCT01464827|580088246|FG011|Overall Study|Withdrawal by Subject|0|||
160646453|NCT01464827|580088247|FG012|Overall Study|Withdrawal by Subject|0|||
160653395|NCT05665595|580112378|FG001|Overall Study|Lost to Follow-up|0|||
160646454|NCT01464827|580088248|FG013|Overall Study|Withdrawal by Subject|0|||
160646455|NCT01464827|580088235|FG000|Overall Study|Lost to Follow-up|0|||
160646456|NCT01464827|580088236|FG001|Overall Study|Lost to Follow-up|2|||
160646457|NCT01464827|580088237|FG002|Overall Study|Lost to Follow-up|0|||
160823735|NCT00075725|580740920|FG004|Overall Study|Inevaluable|2|||
160823736|NCT00075725|580740921|FG005|Overall Study|Inevaluable|9|||
160823737|NCT00075725|580740922|FG006|Overall Study|Inevaluable|1|||
160823738|NCT00075725|580740923|FG007|Overall Study|Inevaluable|11|||
160823739|NCT00075725|580740924|FG008|Overall Study|Inevaluable|2|||
160823740|NCT00075725|580740925|FG009|Overall Study|Inevaluable|0|||
160823741|NCT00075725|580740926|FG010|Overall Study|Inevaluable|1|||
160823742|NCT00075725|580740927|FG011|Overall Study|Inevaluable|0|||
160823743|NCT00075725|580740916|FG000|Overall Study|Other|4|||
160823744|NCT00075725|580740917|FG001|Overall Study|Other|2|||
160823745|NCT00075725|580740918|FG002|Overall Study|Other|1|||
160823746|NCT00075725|580740919|FG003|Overall Study|Other|1|||
160823747|NCT00075725|580740920|FG004|Overall Study|Other|1|||
160823748|NCT00075725|580740921|FG005|Overall Study|Other|4|||
160823749|NCT00075725|580740922|FG006|Overall Study|Other|2|||
160823750|NCT00075725|580740923|FG007|Overall Study|Other|9|||
160823751|NCT00075725|580740924|FG008|Overall Study|Other|2|||
160823752|NCT00075725|580740925|FG009|Overall Study|Other|1|||
160823753|NCT00075725|580740926|FG010|Overall Study|Other|0|||
160823754|NCT00075725|580740927|FG011|Overall Study|Other|3|||
160823755|NCT00075725|580740916|FG000|Overall Study|Pt trying to find a BM donor|0|||
160823756|NCT00075725|580740917|FG001|Overall Study|Pt trying to find a BM donor|1|||
160823757|NCT00075725|580740918|FG002|Overall Study|Pt trying to find a BM donor|0|||
160823758|NCT00075725|580740919|FG003|Overall Study|Pt trying to find a BM donor|0|||
160823759|NCT00075725|580740920|FG004|Overall Study|Pt trying to find a BM donor|0|||
160823760|NCT00075725|580740921|FG005|Overall Study|Pt trying to find a BM donor|0|||
160823761|NCT00075725|580740922|FG006|Overall Study|Pt trying to find a BM donor|0|||
160823762|NCT00075725|580740923|FG007|Overall Study|Pt trying to find a BM donor|0|||
160823763|NCT00075725|580740924|FG008|Overall Study|Pt trying to find a BM donor|0|||
160823764|NCT00075725|580740925|FG009|Overall Study|Pt trying to find a BM donor|0|||
160823765|NCT00075725|580740926|FG010|Overall Study|Pt trying to find a BM donor|0|||
160823766|NCT00075725|580740927|FG011|Overall Study|Pt trying to find a BM donor|0|||
160823767|NCT00075725|580740916|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
160823768|NCT00075725|580740917|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
160823769|NCT00075725|580740918|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
160823770|NCT00075725|580740919|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
160823771|NCT00075725|580740920|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
160823772|NCT00075725|580740921|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
160823773|NCT00075725|580740922|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
160823774|NCT00075725|580740923|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
160901917|NCT01757535|581034151|FG001|Overall Study|Physician Decision|0|||
160901918|NCT01757535|581034150|FG000|Overall Study|Death|2|||
160901919|NCT01757535|581034151|FG001|Overall Study|Death|2|||
160901920|NCT00589290|581034152|FG000|Overall Study|Withdrawal by Subject|1|||
160901921|NCT03730012|581034153|FG000|Overall Study|Adverse Event|0|||
160901922|NCT03730012|581034154|FG001|Overall Study|Adverse Event|1|||
160901923|NCT03730012|581034153|FG000|Overall Study|Lack of Efficacy|1|||
160901924|NCT03730012|581034154|FG001|Overall Study|Lack of Efficacy|5|||
160901925|NCT03730012|581034153|FG000|Overall Study|Withdrawal by Subject|0|||
160901926|NCT03730012|581034154|FG001|Overall Study|Withdrawal by Subject|1|||
160901927|NCT03730012|581034153|FG000|Overall Study|Miscellaneous|2|||
160901928|NCT03730012|581034154|FG001|Overall Study|Miscellaneous|1|||
160901929|NCT05350410|581035914|FG000|Overall Study|Withdrawal by Subject|1|||
160901930|NCT03750955|581035921|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
160901931|NCT03750955|581035922|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
160901932|NCT03750955|581035921|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
160901933|NCT03750955|581035922|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
160901934|NCT00142935|581035929|FG000|Overall Study|Other reason|1|||
160901935|NCT00142935|581035930|FG001|Overall Study|Other reason|1|||
160901936|NCT00142935|581035931|FG002|Overall Study|Other reason|1|||
160901937|NCT00142935|581035929|FG000|Overall Study|Lost to Follow-up|2|||
160901938|NCT00142935|581035930|FG001|Overall Study|Lost to Follow-up|5|||
160901939|NCT00142935|581035931|FG002|Overall Study|Lost to Follow-up|5|||
160901940|NCT00142935|581035929|FG000|Overall Study|Death|0|||
160901941|NCT00142935|581035930|FG001|Overall Study|Death|2|||
160901942|NCT00142935|581035931|FG002|Overall Study|Death|1|||
160901943|NCT03345914|581035936|FG000|Overall Study|Transition to another study at week 16|80|||
160646458|NCT01464827|580088238|FG003|Overall Study|Lost to Follow-up|2|||
160901944|NCT03345914|581035937|FG001|Overall Study|Transition to another study at week 16|86|||
160823775|NCT00075725|580740924|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
160823776|NCT00075725|580740925|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
160823777|NCT00075725|580740926|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
160823778|NCT00075725|580740927|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
160823779|NCT00075725|580740916|FG000|Overall Study|Unsuccessful institutional transfer|0|||
160823780|NCT00075725|580740917|FG001|Overall Study|Unsuccessful institutional transfer|0|||
160823781|NCT00075725|580740918|FG002|Overall Study|Unsuccessful institutional transfer|2|||
160823782|NCT00075725|580740919|FG003|Overall Study|Unsuccessful institutional transfer|0|||
160823783|NCT00075725|580740920|FG004|Overall Study|Unsuccessful institutional transfer|0|||
160823784|NCT00075725|580740921|FG005|Overall Study|Unsuccessful institutional transfer|0|||
160646459|NCT01464827|580088239|FG004|Overall Study|Lost to Follow-up|3|||
160823785|NCT00075725|580740922|FG006|Overall Study|Unsuccessful institutional transfer|0|||
160823786|NCT00075725|580740923|FG007|Overall Study|Unsuccessful institutional transfer|0|||
160823787|NCT00075725|580740924|FG008|Overall Study|Unsuccessful institutional transfer|0|||
160823788|NCT00075725|580740925|FG009|Overall Study|Unsuccessful institutional transfer|1|||
160823789|NCT00075725|580740926|FG010|Overall Study|Unsuccessful institutional transfer|0|||
160823790|NCT00075725|580740927|FG011|Overall Study|Unsuccessful institutional transfer|0|||
160823791|NCT00075725|580740916|FG000|Overall Study|specimen(s) not submitted|0|||
160823792|NCT00075725|580740917|FG001|Overall Study|specimen(s) not submitted|0|||
160823793|NCT00075725|580740918|FG002|Overall Study|specimen(s) not submitted|2|||
160823794|NCT00075725|580740919|FG003|Overall Study|specimen(s) not submitted|0|||
160823795|NCT00075725|580740920|FG004|Overall Study|specimen(s) not submitted|0|||
160823796|NCT00075725|580740921|FG005|Overall Study|specimen(s) not submitted|0|||
160823797|NCT00075725|580740922|FG006|Overall Study|specimen(s) not submitted|0|||
160823798|NCT00075725|580740923|FG007|Overall Study|specimen(s) not submitted|0|||
160823799|NCT00075725|580740924|FG008|Overall Study|specimen(s) not submitted|0|||
160823800|NCT00075725|580740925|FG009|Overall Study|specimen(s) not submitted|0|||
160823801|NCT00075725|580740926|FG010|Overall Study|specimen(s) not submitted|0|||
160823802|NCT00075725|580740927|FG011|Overall Study|specimen(s) not submitted|0|||
160823803|NCT00075725|580740916|FG000|Overall Study|Pt went to transplant|0|||
160823804|NCT00075725|580740917|FG001|Overall Study|Pt went to transplant|0|||
160823805|NCT00075725|580740918|FG002|Overall Study|Pt went to transplant|0|||
160823806|NCT00075725|580740919|FG003|Overall Study|Pt went to transplant|1|||
160823807|NCT00075725|580740920|FG004|Overall Study|Pt went to transplant|0|||
160823808|NCT00075725|580740921|FG005|Overall Study|Pt went to transplant|1|||
160823809|NCT00075725|580740922|FG006|Overall Study|Pt went to transplant|0|||
160823810|NCT00075725|580740923|FG007|Overall Study|Pt went to transplant|0|||
160823811|NCT00075725|580740924|FG008|Overall Study|Pt went to transplant|0|||
160823812|NCT00075725|580740925|FG009|Overall Study|Pt went to transplant|0|||
160823813|NCT00075725|580740926|FG010|Overall Study|Pt went to transplant|0|||
160823814|NCT00075725|580740927|FG011|Overall Study|Pt went to transplant|0|||
160823815|NCT00075725|580740916|FG000|Overall Study|Pt received additional steroids|0|||
160823816|NCT00075725|580740917|FG001|Overall Study|Pt received additional steroids|0|||
160823817|NCT00075725|580740918|FG002|Overall Study|Pt received additional steroids|0|||
160823818|NCT00075725|580740919|FG003|Overall Study|Pt received additional steroids|1|||
160823819|NCT00075725|580740920|FG004|Overall Study|Pt received additional steroids|0|||
160823820|NCT00075725|580740921|FG005|Overall Study|Pt received additional steroids|0|||
160823821|NCT00075725|580740922|FG006|Overall Study|Pt received additional steroids|0|||
160823822|NCT00075725|580740923|FG007|Overall Study|Pt received additional steroids|0|||
160823823|NCT00075725|580740924|FG008|Overall Study|Pt received additional steroids|0|||
160823824|NCT00075725|580740925|FG009|Overall Study|Pt received additional steroids|0|||
160823825|NCT00075725|580740926|FG010|Overall Study|Pt received additional steroids|0|||
160823826|NCT00075725|580740927|FG011|Overall Study|Pt received additional steroids|0|||
160823827|NCT00075725|580740916|FG000|Overall Study|Pt relocated|0|||
160823828|NCT00075725|580740917|FG001|Overall Study|Pt relocated|0|||
160823829|NCT00075725|580740918|FG002|Overall Study|Pt relocated|0|||
160823830|NCT00075725|580740919|FG003|Overall Study|Pt relocated|2|||
160823831|NCT00075725|580740920|FG004|Overall Study|Pt relocated|0|||
160823832|NCT00075725|580740921|FG005|Overall Study|Pt relocated|1|||
160823833|NCT00075725|580740922|FG006|Overall Study|Pt relocated|1|||
160823834|NCT00075725|580740923|FG007|Overall Study|Pt relocated|2|||
160823835|NCT00075725|580740924|FG008|Overall Study|Pt relocated|1|||
160823836|NCT00075725|580740925|FG009|Overall Study|Pt relocated|0|||
160823837|NCT00075725|580740926|FG010|Overall Study|Pt relocated|0|||
160823838|NCT00075725|580740927|FG011|Overall Study|Pt relocated|0|||
160823839|NCT00075725|580740916|FG000|Overall Study|Institution Terminated|0|||
160823840|NCT00075725|580740917|FG001|Overall Study|Institution Terminated|0|||
160823841|NCT00075725|580740918|FG002|Overall Study|Institution Terminated|0|||
160823842|NCT00075725|580740919|FG003|Overall Study|Institution Terminated|0|||
160823843|NCT00075725|580740920|FG004|Overall Study|Institution Terminated|1|||
160823844|NCT00075725|580740921|FG005|Overall Study|Institution Terminated|0|||
160646460|NCT01464827|580088240|FG005|Overall Study|Lost to Follow-up|1|||
160646461|NCT01464827|580088241|FG006|Overall Study|Lost to Follow-up|2|||
160646462|NCT01464827|580088242|FG007|Overall Study|Lost to Follow-up|2|||
160646463|NCT01464827|580088243|FG008|Overall Study|Lost to Follow-up|0|||
160823845|NCT00075725|580740922|FG006|Overall Study|Institution Terminated|0|||
160823846|NCT00075725|580740923|FG007|Overall Study|Institution Terminated|3|||
160823847|NCT00075725|580740924|FG008|Overall Study|Institution Terminated|0|||
160823848|NCT00075725|580740925|FG009|Overall Study|Institution Terminated|0|||
160823849|NCT00075725|580740926|FG010|Overall Study|Institution Terminated|0|||
160823850|NCT00075725|580740927|FG011|Overall Study|Institution Terminated|0|||
160823851|NCT00075725|580740916|FG000|Overall Study|Study Closure|1|||
160823852|NCT00075725|580740917|FG001|Overall Study|Study Closure|0|||
160823853|NCT00075725|580740918|FG002|Overall Study|Study Closure|0|||
160823854|NCT00075725|580740919|FG003|Overall Study|Study Closure|0|||
160823855|NCT00075725|580740920|FG004|Overall Study|Study Closure|1|||
160823856|NCT00075725|580740921|FG005|Overall Study|Study Closure|3|||
160823857|NCT00075725|580740922|FG006|Overall Study|Study Closure|0|||
160823858|NCT00075725|580740923|FG007|Overall Study|Study Closure|1|||
160823859|NCT00075725|580740924|FG008|Overall Study|Study Closure|0|||
160823860|NCT00075725|580740925|FG009|Overall Study|Study Closure|0|||
160823861|NCT00075725|580740926|FG010|Overall Study|Study Closure|0|||
160823862|NCT00075725|580740927|FG011|Overall Study|Study Closure|0|||
160823863|NCT00075725|580740916|FG000|Overall Study|Other complications|0|||
160823864|NCT00075725|580740917|FG001|Overall Study|Other complications|0|||
160823865|NCT00075725|580740918|FG002|Overall Study|Other complications|0|||
160823866|NCT00075725|580740919|FG003|Overall Study|Other complications|0|||
160823867|NCT00075725|580740920|FG004|Overall Study|Other complications|0|||
160823868|NCT00075725|580740921|FG005|Overall Study|Other complications|1|||
160823869|NCT00075725|580740922|FG006|Overall Study|Other complications|0|||
160823870|NCT00075725|580740923|FG007|Overall Study|Other complications|0|||
160823871|NCT00075725|580740924|FG008|Overall Study|Other complications|0|||
160823872|NCT00075725|580740925|FG009|Overall Study|Other complications|0|||
160823873|NCT00075725|580740926|FG010|Overall Study|Other complications|0|||
160823874|NCT00075725|580740927|FG011|Overall Study|Other complications|0|||
160823875|NCT00075725|580740916|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
160823876|NCT00075725|580740917|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
160823877|NCT00075725|580740918|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
160823878|NCT00075725|580740919|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
160823879|NCT00075725|580740920|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
160823880|NCT00075725|580740921|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
160823881|NCT00075725|580740922|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
160823882|NCT00075725|580740923|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
160823883|NCT00075725|580740924|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
160823884|NCT00075725|580740925|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
160823885|NCT00075725|580740926|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
160823886|NCT00075725|580740927|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
160823887|NCT00075725|580740916|FG000|Overall Study|Pt incarcerated|0|||
160823888|NCT00075725|580740917|FG001|Overall Study|Pt incarcerated|0|||
160823889|NCT00075725|580740918|FG002|Overall Study|Pt incarcerated|0|||
160823890|NCT00075725|580740919|FG003|Overall Study|Pt incarcerated|0|||
160823891|NCT00075725|580740920|FG004|Overall Study|Pt incarcerated|0|||
160823892|NCT00075725|580740921|FG005|Overall Study|Pt incarcerated|0|||
160823893|NCT00075725|580740922|FG006|Overall Study|Pt incarcerated|0|||
160823894|NCT00075725|580740923|FG007|Overall Study|Pt incarcerated|1|||
160823895|NCT00075725|580740924|FG008|Overall Study|Pt incarcerated|0|||
160823896|NCT00075725|580740925|FG009|Overall Study|Pt incarcerated|0|||
160823897|NCT00075725|580740926|FG010|Overall Study|Pt incarcerated|0|||
160823898|NCT00075725|580740927|FG011|Overall Study|Pt incarcerated|0|||
160823899|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Death|1|||
160823900|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Death|1|||
160823901|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Death|0|||
160823902|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Death|0|||
160823903|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Death|1|||
160823904|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Death|0|||
160823905|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Death|0|||
160823906|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Death|0|||
160823907|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Death|0|||
160823908|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Death|0|||
160823909|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
160823910|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
160823911|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
160823912|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823913|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
160823914|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823915|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823916|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823917|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823918|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823919|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823920|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160901945|NCT03345914|581035938|FG002|Overall Study|Transition to another study at week 16|78|||
160989909|NCT01124162|581351688|FG001|First Intervention|Adverse Event|0|||
160553670|NCT00793793|579753472|FG000|Overall Study|Withdrawal by Subject|0|||
160553671|NCT00793793|579753473|FG001|Overall Study|Withdrawal by Subject|0|||
160553672|NCT00793793|579753474|FG002|Overall Study|Withdrawal by Subject|0|||
160553673|NCT00793793|579753475|FG003|Overall Study|Withdrawal by Subject|0|||
160553674|NCT00793793|579753476|FG004|Overall Study|Withdrawal by Subject|1|||
160553675|NCT00793793|579753477|FG005|Overall Study|Withdrawal by Subject|0|||
160553676|NCT00793793|579753478|FG006|Overall Study|Withdrawal by Subject|0|||
160553677|NCT00793793|579753479|FG007|Overall Study|Withdrawal by Subject|0|||
160553678|NCT00793793|579753480|FG008|Overall Study|Withdrawal by Subject|1|||
160553679|NCT00793793|579753481|FG009|Overall Study|Withdrawal by Subject|0|||
160553680|NCT00793793|579753482|FG010|Overall Study|Withdrawal by Subject|0|||
160553681|NCT00793793|579753483|FG011|Overall Study|Withdrawal by Subject|0|||
160553682|NCT00793793|579753472|FG000|Overall Study|reason not specified|0|||
160553683|NCT00793793|579753473|FG001|Overall Study|reason not specified|1|||
160553684|NCT00793793|579753474|FG002|Overall Study|reason not specified|0|||
160823921|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823922|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823923|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
160823924|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823925|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823926|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160553685|NCT00793793|579753475|FG003|Overall Study|reason not specified|1|||
160553686|NCT00793793|579753476|FG004|Overall Study|reason not specified|1|||
160823927|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823928|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823929|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
160823930|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823931|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823932|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823933|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823934|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823935|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823936|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823937|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823938|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823939|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
160823940|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823941|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823942|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
160823943|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
160823944|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823945|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823946|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823947|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823948|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823949|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
160823950|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823951|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823952|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
160823953|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823954|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823955|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823956|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823957|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823958|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823959|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
160823960|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
160823961|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
160823962|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
160823963|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
160823964|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
160823965|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
160823966|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
160823967|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
160553687|NCT00793793|579753477|FG005|Overall Study|reason not specified|1|||
160553688|NCT00793793|579753478|FG006|Overall Study|reason not specified|2|||
160553689|NCT00793793|579753479|FG007|Overall Study|reason not specified|0|||
160646464|NCT01464827|580088244|FG009|Overall Study|Lost to Follow-up|0|||
160823968|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
160553690|NCT00793793|579753480|FG008|Overall Study|reason not specified|7|||
160823969|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
160823970|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
160823971|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
160823972|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823973|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
160823974|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823975|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823976|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823977|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823978|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823979|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
160823980|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823981|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823982|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
160823983|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
160823984|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823985|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823986|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823987|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823988|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823989|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160823990|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160823991|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823992|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160823993|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160823994|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823995|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823996|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823997|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823998|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823999|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824000|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824001|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
160824002|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824003|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
160824004|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160901946|NCT03345914|581035936|FG000|Overall Study|Transition to OLE during follow-up|37|||
160901947|NCT03345914|581035937|FG001|Overall Study|Transition to OLE during follow-up|33|||
160901948|NCT03345914|581035938|FG002|Overall Study|Transition to OLE during follow-up|39|||
160553691|NCT00793793|579753481|FG009|Overall Study|reason not specified|6|||
160553692|NCT00793793|579753482|FG010|Overall Study|reason not specified|2|||
160553693|NCT00793793|579753483|FG011|Overall Study|reason not specified|4|||
160553694|NCT00840827|579753484|FG000|Overall Study|Adverse Event|1|||
160553695|NCT00840827|579753484|FG000|Overall Study|Lack of Efficacy|4|||
160553696|NCT00840827|579753484|FG000|Overall Study|Physician Decision|1|||
160553697|NCT01940484|579753487|FG000|Overall Study|Withdrawal by Subject|3|||
160553698|NCT01940484|579753487|FG000|Overall Study|Underwent transplantation|4|||
160553699|NCT01940484|579753487|FG000|Overall Study|Death|2|||
160553700|NCT01940484|579753487|FG000|Overall Study|Adverse Event|1|||
160553701|NCT01705691|579753489|FG000|Overall Study|Death|1|||
160553702|NCT01705691|579753490|FG001|Overall Study|Death|2|||
160553703|NCT01705691|579753489|FG000|Overall Study|Withdrawal by Subject|1|||
160553704|NCT01705691|579753490|FG001|Overall Study|Withdrawal by Subject|2|||
160553705|NCT01705691|579753489|FG000|Overall Study|Lost to Follow-up|1|||
160553706|NCT01705691|579753490|FG001|Overall Study|Lost to Follow-up|1|||
160553707|NCT01705691|579753489|FG000|Overall Study|Other|0|||
160553708|NCT01705691|579753490|FG001|Overall Study|Other|1|||
160553709|NCT02658448|579753491|FG000|Overall Study|Lost to Follow-up|1|||
160553710|NCT03106779|579753492|FG000|Overall Study|Lack of Efficacy|33|||
160553711|NCT03106779|579753493|FG001|Overall Study|Lack of Efficacy|24|||
160553712|NCT03106779|579753492|FG000|Overall Study|Adverse Event|8|||
160553713|NCT03106779|579753493|FG001|Overall Study|Adverse Event|16|||
160553714|NCT03106779|579753492|FG000|Overall Study|Physician Decision|10|||
160553715|NCT03106779|579753493|FG001|Overall Study|Physician Decision|6|||
160553716|NCT03106779|579753492|FG000|Overall Study|Patient/guardian decision|4|||
160553717|NCT03106779|579753493|FG001|Overall Study|Patient/guardian decision|3|||
160553718|NCT03106779|579753492|FG000|Overall Study|Progressive disease|1|||
160553719|NCT03106779|579753493|FG001|Overall Study|Progressive disease|3|||
160553720|NCT03106779|579753492|FG000|Overall Study|Lost to Follow-up|1|||
160553721|NCT03106779|579753493|FG001|Overall Study|Lost to Follow-up|2|||
160553722|NCT03106779|579753492|FG000|Overall Study|Death|1|||
160553723|NCT03106779|579753493|FG001|Overall Study|Death|0|||
160553724|NCT03106779|579753492|FG000|Overall Study|Protocol Violation|1|||
160553725|NCT03106779|579753493|FG001|Overall Study|Protocol Violation|0|||
160553726|NCT03106779|579753492|FG000|Overall Study|Not treated|1|||
160553727|NCT03106779|579753493|FG001|Overall Study|Not treated|0|||
160553728|NCT04233229|579753494|FG000|Overall Study|Withdrawal by Subject|0|||
160553729|NCT04233229|579753495|FG001|Overall Study|Withdrawal by Subject|1|||
160553730|NCT04233229|579753494|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
160553731|NCT04233229|579753495|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
160553732|NCT04233229|579753494|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
160553733|NCT04233229|579753495|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
160553734|NCT02288247|579753496|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
160553735|NCT02288247|579753497|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
160553736|NCT02288247|579753496|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
160553737|NCT02288247|579753497|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
160553738|NCT02288247|579753496|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
160553739|NCT02288247|579753497|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
160553740|NCT02288247|579753496|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
160553741|NCT02288247|579753497|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
160553742|NCT02288247|579753496|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
160553743|NCT02288247|579753497|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
160553744|NCT02288247|579753496|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
160553745|NCT02288247|579753497|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
160553746|NCT02288247|579753496|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
160553747|NCT02288247|579753497|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
160553748|NCT02288247|579753496|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
160553749|NCT02288247|579753497|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
160553750|NCT02288247|579753496|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
160553751|NCT02288247|579753497|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
160553752|NCT02288247|579753496|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
160553753|NCT02288247|579753497|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
160553754|NCT02288247|579753496|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
160553755|NCT02288247|579753497|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
160553756|NCT02288247|579753496|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
160553757|NCT02288247|579753497|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
160824005|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824006|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824007|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824008|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160553758|NCT02288247|579753496|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
160824009|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
160824010|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
160824011|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
160824012|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
160824013|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
160901949|NCT03345914|581035936|FG000|Overall Study|Physician Decision|0|||
160553759|NCT02288247|579753497|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
160553760|NCT02288247|579753496|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
160553761|NCT02288247|579753497|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
160553762|NCT02288247|579753496|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
160553763|NCT02288247|579753497|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
160824014|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
160824015|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
160824016|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
160824017|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
160824018|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
160824019|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824020|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824021|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824022|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
160824023|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
160824024|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824025|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824026|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824027|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824028|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824029|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
160824030|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824031|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
160824032|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
160824033|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
160824034|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824035|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824036|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824037|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824038|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824039|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
160824040|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824041|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824042|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824043|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
160824044|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824045|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824046|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824047|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824048|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824049|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824050|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824051|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824052|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824053|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
160824054|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824055|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824056|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824057|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824058|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824059|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160553764|NCT02288247|579753496|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
160553765|NCT02288247|579753497|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
160553766|NCT04652804|579753498|FG000|Overall Study|Ineligible post randomization|1|||
160553767|NCT04652804|579753499|FG001|Overall Study|Ineligible post randomization|0|||
160553768|NCT04652804|579753500|FG002|Overall Study|Ineligible post randomization|1|||
160989910|NCT01124162|581351687|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
160553769|NCT04652804|579753501|FG003|Overall Study|Ineligible post randomization|0|||
160553770|NCT04652804|579753502|FG004|Overall Study|Ineligible post randomization|1|||
160646465|NCT01464827|580088245|FG010|Overall Study|Lost to Follow-up|0|||
160824060|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
160824061|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824062|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824063|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
160824064|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824065|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824066|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824067|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824068|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824069|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
160824070|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824071|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824072|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824073|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
160824074|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824075|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824076|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824077|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824078|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824079|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
160824080|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824081|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
160824082|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824083|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
160824084|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824085|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824086|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824087|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824088|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824089|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Other|5|||
160824090|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Other|1|||
160824091|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Other|0|||
160824092|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Other|3|||
160824093|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Other|0|||
160824094|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Other|0|||
160824095|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Other|0|||
160824096|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Other|0|||
160824097|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Other|0|||
160824098|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Other|0|||
160824099|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824100|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824101|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824102|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824103|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
160824104|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824105|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824106|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824107|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824108|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824109|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Death|0|||
160824110|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Death|0|||
160824111|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Death|0|||
160824112|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Death|0|||
160824113|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Death|0|||
160824114|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Death|1|||
160824115|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Death|0|||
160824116|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Death|1|||
160646466|NCT01464827|580088246|FG011|Overall Study|Lost to Follow-up|1|||
160824117|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Death|1|||
160824118|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Death|1|||
160824119|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824120|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824121|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824122|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824123|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824124|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
160824125|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824126|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824127|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824128|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824129|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824130|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824131|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824132|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824133|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824134|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824135|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824136|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824137|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
160824138|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824139|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
160824140|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
160824141|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
160824142|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
160824143|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
160824144|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
160824145|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
160824146|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
160824147|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
160824148|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
160824149|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824150|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824151|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824152|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824153|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824154|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
160901950|NCT03345914|581035937|FG001|Overall Study|Physician Decision|1|||
160901951|NCT03345914|581035938|FG002|Overall Study|Physician Decision|1|||
160901952|NCT03345914|581035936|FG000|Overall Study|Withdrawal by Subject|5|||
160901953|NCT03345914|581035937|FG001|Overall Study|Withdrawal by Subject|1|||
160901954|NCT03345914|581035938|FG002|Overall Study|Withdrawal by Subject|2|||
160901955|NCT03345914|581035936|FG000|Overall Study|Other|1|||
160901956|NCT03345914|581035937|FG001|Overall Study|Other|1|||
160901957|NCT03345914|581035938|FG002|Overall Study|Other|1|||
160901958|NCT03345914|581035936|FG000|Overall Study|Ongoing|0|||
160901959|NCT03345914|581035937|FG001|Overall Study|Ongoing|0|||
160901960|NCT03345914|581035938|FG002|Overall Study|Ongoing|1|||
160901961|NCT02601027|581035941|FG000|Registration to Surgery|Withdrawal by Subject|20|||
160901962|NCT02601027|581035942|FG001|Registration to Surgery|Withdrawal by Subject|10|||
160901963|NCT01330030|581035943|FG000|Overall Study|Lost to Follow-up|16|||
160901964|NCT01330030|581035944|FG001|Overall Study|Lost to Follow-up|17|||
160553771|NCT04652804|579753503|FG005|Overall Study|Ineligible post randomization|1|||
160553772|NCT04652804|579753498|FG000|Overall Study|Missing SVR lab results|2|||
160553773|NCT04652804|579753499|FG001|Overall Study|Missing SVR lab results|0|||
160553774|NCT04652804|579753500|FG002|Overall Study|Missing SVR lab results|0|||
160553775|NCT04652804|579753501|FG003|Overall Study|Missing SVR lab results|0|||
160553776|NCT04652804|579753502|FG004|Overall Study|Missing SVR lab results|0|||
160553777|NCT04652804|579753503|FG005|Overall Study|Missing SVR lab results|0|||
160553778|NCT00584194|579753504|FG000|Overall Study|Other|135|||
160553779|NCT04093531|579753505|FG000|Overall Study|failed screening|4|||
160553780|NCT00648167|579753506|FG000|Overall Study|Adverse Event|6|||
160553781|NCT00648167|579753506|FG000|Overall Study|unable to swallow tablets|1|||
160553782|NCT00927368|579753507|FG000|Overall Study|enrollment in another study|1|||
160553783|NCT00927368|579753508|FG001|Overall Study|enrollment in another study|1|||
160553784|NCT00927368|579753509|FG002|Overall Study|enrollment in another study|2|||
160553785|NCT00927368|579753507|FG000|Overall Study|Lost to Follow-up|4|||
160553786|NCT00927368|579753508|FG001|Overall Study|Lost to Follow-up|0|||
160553787|NCT00927368|579753509|FG002|Overall Study|Lost to Follow-up|0|||
160553788|NCT00927368|579753507|FG000|Overall Study|equipment failure|1|||
160553789|NCT00927368|579753508|FG001|Overall Study|equipment failure|0|||
160553790|NCT00927368|579753509|FG002|Overall Study|equipment failure|0|||
160553791|NCT00927368|579753507|FG000|Overall Study|ineligible post randomization|0|||
160553792|NCT00927368|579753508|FG001|Overall Study|ineligible post randomization|3|||
160553793|NCT00927368|579753509|FG002|Overall Study|ineligible post randomization|1|||
160553794|NCT00927368|579753507|FG000|Overall Study|cancellation of surgery|0|||
160553795|NCT00927368|579753508|FG001|Overall Study|cancellation of surgery|1|||
160553796|NCT00927368|579753509|FG002|Overall Study|cancellation of surgery|2|||
160553797|NCT00191451|579753510|FG000|Overall Study|Withdrawal by Subject|2|||
160553798|NCT00191451|579753511|FG001|Overall Study|Withdrawal by Subject|3|||
160553799|NCT00191451|579753512|FG002|Overall Study|Withdrawal by Subject|5|||
160553800|NCT00191451|579753510|FG000|Overall Study|Physician Decision|2|||
160553801|NCT00191451|579753511|FG001|Overall Study|Physician Decision|9|||
160553802|NCT00191451|579753512|FG002|Overall Study|Physician Decision|6|||
160553803|NCT00191451|579753510|FG000|Overall Study|Sponsor Decision|1|||
160553804|NCT00191451|579753511|FG001|Overall Study|Sponsor Decision|0|||
160553805|NCT00191451|579753512|FG002|Overall Study|Sponsor Decision|0|||
160553806|NCT00191451|579753510|FG000|Overall Study|Ineligible|0|||
160553807|NCT00191451|579753511|FG001|Overall Study|Ineligible|1|||
160553808|NCT00191451|579753512|FG002|Overall Study|Ineligible|0|||
160553809|NCT00191451|579753510|FG000|Overall Study|Reason Not Specified|2|||
160553810|NCT00191451|579753511|FG001|Overall Study|Reason Not Specified|1|||
160553811|NCT00191451|579753512|FG002|Overall Study|Reason Not Specified|3|||
160553812|NCT03222349|579753513|FG000|Overall Study|Treatment B not done|5|||
160553813|NCT03222349|579753514|FG001|Overall Study|Treatment B not done|0|||
160553814|NCT03222349|579753513|FG000|Overall Study|Lost to Follow-up|1|||
160553815|NCT03222349|579753514|FG001|Overall Study|Lost to Follow-up|2|||
160553816|NCT03222349|579753513|FG000|Overall Study|Withdrawal by Subject|1|||
160553817|NCT03222349|579753514|FG001|Overall Study|Withdrawal by Subject|0|||
160553818|NCT03222349|579753513|FG000|Overall Study|Treatment A not done|0|||
160553819|NCT03222349|579753514|FG001|Overall Study|Treatment A not done|5|||
160553820|NCT03222349|579753513|FG000|Overall Study|Study terminated by sponsor|1|||
160553821|NCT03222349|579753514|FG001|Overall Study|Study terminated by sponsor|0|||
160553822|NCT00236080|579753515|FG000|Overall Study|Adverse Event|0|||
160553823|NCT00236080|579753516|FG001|Overall Study|Adverse Event|0|||
160553824|NCT00236080|579753517|FG002|Overall Study|Adverse Event|3|||
160553825|NCT00236080|579753518|FG003|Overall Study|Adverse Event|1|||
160553826|NCT00236080|579753519|FG004|Overall Study|Adverse Event|0|||
160553827|NCT00236080|579753515|FG000|Overall Study|Lost to Follow-up|0|||
160553828|NCT00236080|579753516|FG001|Overall Study|Lost to Follow-up|1|||
160553829|NCT00236080|579753517|FG002|Overall Study|Lost to Follow-up|0|||
160553830|NCT00236080|579753518|FG003|Overall Study|Lost to Follow-up|0|||
160553831|NCT00236080|579753519|FG004|Overall Study|Lost to Follow-up|0|||
160553832|NCT00236080|579753515|FG000|Overall Study|Physician Decision|1|||
160553833|NCT00236080|579753516|FG001|Overall Study|Physician Decision|0|||
160553834|NCT00236080|579753517|FG002|Overall Study|Physician Decision|1|||
160553835|NCT00236080|579753518|FG003|Overall Study|Physician Decision|1|||
160553836|NCT00236080|579753519|FG004|Overall Study|Physician Decision|1|||
160824155|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824156|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
160901965|NCT01365052|581035945|FG000|Overall Study|Adverse Event|4|||
160553837|NCT00236080|579753515|FG000|Overall Study|Withdrawal by Subject|1|||
160553838|NCT00236080|579753516|FG001|Overall Study|Withdrawal by Subject|0|||
160553839|NCT00236080|579753517|FG002|Overall Study|Withdrawal by Subject|0|||
160553840|NCT00236080|579753518|FG003|Overall Study|Withdrawal by Subject|0|||
160553841|NCT00236080|579753519|FG004|Overall Study|Withdrawal by Subject|0|||
160553842|NCT00236080|579753515|FG000|Overall Study|Miscellaneous|0|||
160553843|NCT00236080|579753516|FG001|Overall Study|Miscellaneous|0|||
160553844|NCT00236080|579753517|FG002|Overall Study|Miscellaneous|1|||
160553845|NCT00236080|579753518|FG003|Overall Study|Miscellaneous|0|||
160553846|NCT00236080|579753519|FG004|Overall Study|Miscellaneous|0|||
160553847|NCT01214044|579753520|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
160553848|NCT01214044|579753520|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
160553849|NCT01214044|579753520|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
160553850|NCT01214044|579753520|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
160553851|NCT01214044|579753520|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
160553852|NCT01214044|579753520|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
160553853|NCT03543410|579753521|FG000|Overall Study|Adverse Event|10|||
160553854|NCT03543410|579753522|FG001|Overall Study|Adverse Event|8|||
160553855|NCT03543410|579753523|FG002|Overall Study|Adverse Event|2|||
160553856|NCT03543410|579753521|FG000|Overall Study|Lack of Efficacy|0|||
160553857|NCT03543410|579753522|FG001|Overall Study|Lack of Efficacy|1|||
160553858|NCT03543410|579753523|FG002|Overall Study|Lack of Efficacy|0|||
160553859|NCT03543410|579753521|FG000|Overall Study|Lost to Follow-up|0|||
160553860|NCT03543410|579753522|FG001|Overall Study|Lost to Follow-up|1|||
160553861|NCT03543410|579753523|FG002|Overall Study|Lost to Follow-up|0|||
160553862|NCT03543410|579753521|FG000|Overall Study|Withdrawal by Subject|5|||
160553863|NCT03543410|579753522|FG001|Overall Study|Withdrawal by Subject|2|||
160553864|NCT03543410|579753523|FG002|Overall Study|Withdrawal by Subject|8|||
160553865|NCT03543410|579753521|FG000|Overall Study|Protocol Violation|0|||
160553866|NCT03543410|579753522|FG001|Overall Study|Protocol Violation|1|||
160553867|NCT03543410|579753523|FG002|Overall Study|Protocol Violation|0|||
160553868|NCT03543410|579753521|FG000|Overall Study|Due to COVID-19|4|||
160553869|NCT03543410|579753522|FG001|Overall Study|Due to COVID-19|0|||
160553870|NCT03543410|579753523|FG002|Overall Study|Due to COVID-19|2|||
160553871|NCT03543410|579753521|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
160553872|NCT03543410|579753522|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
160553873|NCT03543410|579753523|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
160553874|NCT03543410|579753521|FG000|Overall Study|Not Due to COVID-19|2|||
160553875|NCT03543410|579753522|FG001|Overall Study|Not Due to COVID-19|0|||
160553876|NCT03543410|579753523|FG002|Overall Study|Not Due to COVID-19|1|||
160553877|NCT01318122|579753524|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160553878|NCT01318122|579753525|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160553879|NCT01318122|579753526|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
160553880|NCT01318122|579753527|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
160553881|NCT01318122|579753524|FG000|Enrolled - Long-Term Extension Study|Other|1|||
160553882|NCT01318122|579753525|FG001|Enrolled - Long-Term Extension Study|Other|0|||
160553883|NCT01318122|579753526|FG002|Enrolled - Long-Term Extension Study|Other|0|||
160553884|NCT01318122|579753527|FG003|Enrolled - Long-Term Extension Study|Other|0|||
160553885|NCT01318122|579753524|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
160553886|NCT01318122|579753525|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
160553887|NCT01318122|579753526|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
160553888|NCT01318122|579753527|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
160553889|NCT01318122|579753524|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
160553890|NCT01318122|579753525|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160553891|NCT01318122|579753526|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160553892|NCT01318122|579753527|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160553893|NCT01318122|579753524|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160553894|NCT01318122|579753525|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
160553895|NCT01318122|579753526|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
160553896|NCT01318122|579753527|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
160553897|NCT01318122|579753524|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
160553898|NCT01318122|579753525|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
160553899|NCT01318122|579753526|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
160553900|NCT01318122|579753527|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
160553901|NCT00820755|579753528|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
160553902|NCT00820755|579753529|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
160553903|NCT00820755|579753530|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
160553904|NCT00820755|579753528|FG000|Period 1: Combination Therapy Phase|Death|28|||
160553905|NCT00820755|579753529|FG001|Period 1: Combination Therapy Phase|Death|0|||
160553906|NCT00820755|579753530|FG002|Period 1: Combination Therapy Phase|Death|0|||
160553907|NCT00820755|579753528|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
160553908|NCT00820755|579753529|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
160553909|NCT00820755|579753530|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
160553910|NCT00820755|579753528|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
160553911|NCT00820755|579753529|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
160553912|NCT00820755|579753530|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
160553913|NCT00820755|579753528|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
160553914|NCT00820755|579753529|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
160824157|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
160824158|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
160824159|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160824160|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160553915|NCT00820755|579753530|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
160553916|NCT00820755|579753528|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
160824161|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160901966|NCT01365052|581035946|FG001|Overall Study|Adverse Event|4|||
160553917|NCT00820755|579753529|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
160553918|NCT00820755|579753530|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
160553919|NCT00820755|579753528|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
160553920|NCT00820755|579753529|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
160553921|NCT00820755|579753530|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
160553922|NCT00820755|579753528|FG000|Period 1: Combination Therapy Phase|Other|11|||
160553923|NCT00820755|579753529|FG001|Period 1: Combination Therapy Phase|Other|0|||
160553924|NCT00820755|579753530|FG002|Period 1: Combination Therapy Phase|Other|0|||
160553925|NCT00820755|579753528|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
160553926|NCT00820755|579753529|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
160553927|NCT00820755|579753530|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
160824162|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160824163|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160824164|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160824165|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160824166|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160824167|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160824168|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160824169|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824170|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824171|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824172|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824173|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824174|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
160824175|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824176|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
160824177|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
160824178|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
160824179|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824180|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824181|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824182|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824183|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824184|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824185|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824186|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824187|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
160824188|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
160824189|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824190|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824191|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824192|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824193|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824194|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824195|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824196|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
160824197|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824198|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824199|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824200|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824201|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824202|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824203|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824204|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824205|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824206|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
160824207|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824208|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824209|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824210|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824211|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160862005|NCT03694353|580887918|FG000|Overall Study|Withdrawal by Subject|1|||
160646467|NCT01464827|580088247|FG012|Overall Study|Lost to Follow-up|0|||
160824212|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824213|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824214|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824215|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824216|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
160824217|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
160824218|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824219|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824220|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824221|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824222|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824223|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824224|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
160824225|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824226|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824227|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
160824228|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824229|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824230|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824231|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824232|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824233|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824234|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824235|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824236|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824237|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824238|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
160824239|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824240|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824241|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824242|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824243|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824244|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824245|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824246|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824247|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
160824248|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
160824249|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824250|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824251|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824252|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824253|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824254|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824255|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824256|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
160824257|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
160824258|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824259|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Other|0|||
160824260|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Other|0|||
160824261|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Other|0|||
160824262|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Other|0|||
160824263|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Other|0|||
160824264|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Other|0|||
160824265|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Other|0|||
160824266|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Other|1|||
160824267|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Other|0|||
160824268|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Other|0|||
160824269|NCT04677660|580740938|FG000|Overall Study|Lost to Follow-up|0|||
160901967|NCT02248701|581035949|FG000|Overall Study|Withdrawal by Subject|2|||
160553928|NCT01486199|579753531|FG000|Two Year Period Between Study Days|Physician Decision|1|||
160901968|NCT02248701|581035950|FG001|Overall Study|Withdrawal by Subject|1|||
160553929|NCT01486199|579753532|FG001|Two Year Period Between Study Days|Physician Decision|0|||
160553930|NCT03604445|579753534|FG000|Overall Study|Death|0|||
160553931|NCT03604445|579753535|FG001|Overall Study|Death|0|||
160553932|NCT03604445|579753536|FG002|Overall Study|Death|0|||
160553933|NCT03604445|579753537|FG003|Overall Study|Death|0|||
160824270|NCT04677660|580740939|FG001|Overall Study|Lost to Follow-up|2|||
160824271|NCT04677660|580740938|FG000|Overall Study|Withdrawal by Subject|0|||
160824272|NCT04677660|580740939|FG001|Overall Study|Withdrawal by Subject|1|||
160824273|NCT04677660|580740938|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
160824274|NCT04677660|580740939|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
160824275|NCT03242772|580740940|FG000|Overall Study|Lost to Follow-up|2|||
160824276|NCT03242772|580740941|FG001|Overall Study|Lost to Follow-up|0|||
160824277|NCT03242772|580740940|FG000|Overall Study|Physician Decision|0|||
160824278|NCT03242772|580740941|FG001|Overall Study|Physician Decision|1|||
160824279|NCT03242772|580740940|FG000|Overall Study|Withdrawal by Subject|1|||
160824280|NCT03242772|580740941|FG001|Overall Study|Withdrawal by Subject|0|||
160824281|NCT02499900|580740942|FG000|Core Study Period|Other|1|||
160824282|NCT02499900|580740943|FG001|Core Study Period|Other|4|||
160824283|NCT02499900|580740942|FG000|Core Study Period|Lost to Follow-up|1|||
160824284|NCT02499900|580740943|FG001|Core Study Period|Lost to Follow-up|2|||
160824285|NCT02499900|580740942|FG000|Core Study Period|Per sponsor request|0|||
160824286|NCT02499900|580740943|FG001|Core Study Period|Per sponsor request|1|||
160824287|NCT02499900|580740942|FG000|Core Study Period|Pregnancy|1|||
160824288|NCT02499900|580740943|FG001|Core Study Period|Pregnancy|0|||
160824289|NCT02499900|580740942|FG000|Core Study Period|Protocol Violation|3|||
160824290|NCT02499900|580740943|FG001|Core Study Period|Protocol Violation|0|||
160824291|NCT02499900|580740942|FG000|Core Study Period|Withdrawal by Subject|11|||
160824292|NCT02499900|580740943|FG001|Core Study Period|Withdrawal by Subject|10|||
160824293|NCT02499900|580740942|FG000|Core Study Period|Adverse Event|18|||
160824294|NCT02499900|580740943|FG001|Core Study Period|Adverse Event|14|||
160824295|NCT02499900|580740942|FG000|Core Study Period|Death|0|||
160824296|NCT02499900|580740943|FG001|Core Study Period|Death|1|||
160824297|NCT02499900|580740942|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
160824298|NCT02499900|580740943|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
160824299|NCT02499900|580740942|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
160824300|NCT02499900|580740943|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
160824301|NCT02499900|580740942|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
160824302|NCT02499900|580740943|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
160824303|NCT02499900|580740942|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
160824304|NCT02499900|580740943|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
160824305|NCT02499900|580740942|FG000|Extension Study Period|Adverse Event|2|||
160824306|NCT02499900|580740943|FG001|Extension Study Period|Adverse Event|4|||
160824307|NCT02499900|580740942|FG000|Extension Study Period|Withdrawal by Subject|5|||
160824308|NCT02499900|580740943|FG001|Extension Study Period|Withdrawal by Subject|2|||
160824309|NCT02499900|580740942|FG000|Extension Study Period|Physician Decision|2|||
160824310|NCT02499900|580740943|FG001|Extension Study Period|Physician Decision|5|||
160824311|NCT02499900|580740942|FG000|Extension Study Period|Pregnancy|1|||
160824312|NCT02499900|580740943|FG001|Extension Study Period|Pregnancy|2|||
160824313|NCT02499900|580740942|FG000|Extension Study Period|Lost to Follow-up|2|||
160824314|NCT02499900|580740943|FG001|Extension Study Period|Lost to Follow-up|5|||
160824315|NCT02499900|580740942|FG000|Extension Study Period|Other|0|||
160824316|NCT02499900|580740943|FG001|Extension Study Period|Other|2|||
160824317|NCT02439450|580740945|FG000|Overall Study|Adverse Event|4|||
160824318|NCT02439450|580740946|FG001|Overall Study|Adverse Event|1|||
160824319|NCT02439450|580740947|FG002|Overall Study|Adverse Event|0|||
160824320|NCT02439450|580740948|FG003|Overall Study|Adverse Event|0|||
160824321|NCT02439450|580740945|FG000|Overall Study|Withdrawal by Subject|1|||
160824322|NCT02439450|580740946|FG001|Overall Study|Withdrawal by Subject|2|||
160824323|NCT02439450|580740947|FG002|Overall Study|Withdrawal by Subject|0|||
160824324|NCT02439450|580740948|FG003|Overall Study|Withdrawal by Subject|0|||
160824325|NCT02439450|580740945|FG000|Overall Study|Death|3|||
160824326|NCT02439450|580740946|FG001|Overall Study|Death|0|||
160901969|NCT02248701|581035949|FG000|Overall Study|Physician Decision|0|||
160901970|NCT02248701|581035950|FG001|Overall Study|Physician Decision|1|||
160553934|NCT03604445|579753538|FG004|Overall Study|Death|0|||
160553935|NCT03604445|579753539|FG005|Overall Study|Death|0|||
160553936|NCT03604445|579753540|FG006|Overall Study|Death|0|||
160553937|NCT03604445|579753541|FG007|Overall Study|Death|0|||
160553938|NCT03604445|579753542|FG008|Overall Study|Death|1|||
160824327|NCT02439450|580740947|FG002|Overall Study|Death|0|||
160824328|NCT02439450|580740948|FG003|Overall Study|Death|1|||
160824329|NCT02439450|580740945|FG000|Overall Study|Progressive Disease|18|||
160824330|NCT02439450|580740946|FG001|Overall Study|Progressive Disease|41|||
160824331|NCT02439450|580740947|FG002|Overall Study|Progressive Disease|2|||
160824332|NCT02439450|580740948|FG003|Overall Study|Progressive Disease|3|||
160824333|NCT03730961|580740951|FG000|Overall Study|Adverse Event|0|||
160824334|NCT03730961|580740952|FG001|Overall Study|Adverse Event|1|||
160824335|NCT01646645|580740955|FG000|Overall Study|No Treated|1|||
160553939|NCT03604445|579753534|FG000|Overall Study|Withdrawal by Subject|0|||
160824336|NCT01646645|580740955|FG000|Overall Study|Inevaluable Donor|29|||
160824337|NCT00717522|580740956|FG000|Overall Study|Disease Progression|5|||
160553940|NCT03604445|579753535|FG001|Overall Study|Withdrawal by Subject|0|||
160824338|NCT00717522|580740956|FG000|Overall Study|Adverse Event|1|||
160824339|NCT00717522|580740956|FG000|Overall Study|Death|1|||
160824340|NCT01799239|580740957|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
160824341|NCT01799239|580740958|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
160824342|NCT01799239|580740957|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
160824343|NCT01799239|580740958|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
160824344|NCT01799239|580740957|FG000|Period 1 (7 Days)|Protocol Violation|0|||
160824345|NCT01799239|580740958|FG001|Period 1 (7 Days)|Protocol Violation|1|||
160824346|NCT01799239|580740957|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
160824347|NCT01799239|580740958|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
160824348|NCT01799239|580740957|FG000|Period 2 (7 Days)|Protocol Violation|1|||
160824349|NCT01799239|580740958|FG001|Period 2 (7 Days)|Protocol Violation|0|||
160824350|NCT04209114|580740959|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
160824351|NCT04209114|580740960|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
160824352|NCT04209114|580740961|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
160824353|NCT04209114|580740959|FG000|Pre-Treatment Phase|Other reasons|0|||
160824354|NCT04209114|580740960|FG001|Pre-Treatment Phase|Other reasons|0|||
160824355|NCT04209114|580740961|FG002|Pre-Treatment Phase|Other reasons|1|||
160824356|NCT04209114|580740959|FG000|Pre-Treatment Phase|Death|0|||
160824357|NCT04209114|580740960|FG001|Pre-Treatment Phase|Death|0|||
160824358|NCT04209114|580740961|FG002|Pre-Treatment Phase|Death|1|||
160824359|NCT04209114|580740959|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
160824360|NCT04209114|580740960|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
160824361|NCT04209114|580740961|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
160824362|NCT04209114|580740959|FG000|Treatment Phase|Other reasons|5|||
160824363|NCT04209114|580740960|FG001|Treatment Phase|Other reasons|3|||
160824364|NCT04209114|580740961|FG002|Treatment Phase|Other reasons|0|||
160824365|NCT04209114|580740959|FG000|Treatment Phase|Lost to Follow-up|1|||
160824366|NCT04209114|580740960|FG001|Treatment Phase|Lost to Follow-up|0|||
160824367|NCT04209114|580740961|FG002|Treatment Phase|Lost to Follow-up|0|||
160824368|NCT04209114|580740959|FG000|Treatment Phase|Participant withdrew consent|1|||
160824369|NCT04209114|580740960|FG001|Treatment Phase|Participant withdrew consent|0|||
160824370|NCT04209114|580740961|FG002|Treatment Phase|Participant withdrew consent|0|||
160824371|NCT04209114|580740959|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
160824372|NCT04209114|580740960|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
160824373|NCT04209114|580740961|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
160824374|NCT04209114|580740959|FG000|Treatment Phase|Death|4|||
160824375|NCT04209114|580740960|FG001|Treatment Phase|Death|1|||
160824376|NCT04209114|580740961|FG002|Treatment Phase|Death|0|||
160824377|NCT04209114|580740959|FG000|Treatment Phase|Study drug toxicity|4|||
160824378|NCT04209114|580740960|FG001|Treatment Phase|Study drug toxicity|6|||
160824379|NCT04209114|580740961|FG002|Treatment Phase|Study drug toxicity|0|||
160824380|NCT04209114|580740959|FG000|Treatment Phase|Disease progression|6|||
160824381|NCT04209114|580740960|FG001|Treatment Phase|Disease progression|9|||
160824382|NCT04209114|580740961|FG002|Treatment Phase|Disease progression|0|||
160824383|NCT01444027|580740974|FG000|Overall Study|Withdrawal by Subject|4|||
160824384|NCT01444027|580740975|FG001|Overall Study|Withdrawal by Subject|10|||
160824385|NCT01444027|580740976|FG002|Overall Study|Withdrawal by Subject|24|||
160824386|NCT01444027|580740974|FG000|Overall Study|Lost to Follow-up|26|||
160824387|NCT01444027|580740975|FG001|Overall Study|Lost to Follow-up|20|||
160824388|NCT01444027|580740976|FG002|Overall Study|Lost to Follow-up|14|||
160824389|NCT03966885|580742720|FG000|Overall Study|Death|1|||
160824390|NCT03966885|580742721|FG001|Overall Study|Death|0|||
160824391|NCT03966885|580742720|FG000|Overall Study|Lost to Follow-up|1|||
160824392|NCT03966885|580742721|FG001|Overall Study|Lost to Follow-up|2|||
160824393|NCT03966885|580742720|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
160824394|NCT03966885|580742721|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
160824395|NCT03966885|580742720|FG000|Overall Study|Moved from study area.|0|||
160901971|NCT02248701|581035949|FG000|Overall Study|Adverse Event|1|||
160901972|NCT02248701|581035950|FG001|Overall Study|Adverse Event|0|||
160901973|NCT02248701|581035949|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
160901974|NCT02248701|581035950|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
160824396|NCT03966885|580742721|FG001|Overall Study|Moved from study area.|2|||
160824397|NCT01514240|580742722|FG000|Overall Study|Adverse Event|4|||
160824398|NCT01514240|580742723|FG001|Overall Study|Adverse Event|4|||
160824399|NCT01514240|580742722|FG000|Overall Study|Subject Decision|2|||
160824400|NCT01514240|580742723|FG001|Overall Study|Subject Decision|7|||
160824401|NCT00428220|580742724|FG000|Overall Study|Participant died|8|||
160824402|NCT00428220|580742724|FG000|Overall Study|Global deterioration of health status|7|||
160824403|NCT00428220|580742724|FG000|Overall Study|Lost to Follow-up|4|||
160824404|NCT00428220|580742724|FG000|Overall Study|Objective progression or relapse|123|||
160824405|NCT00428220|580742724|FG000|Overall Study|Participant refused continued treatment|7|||
160824406|NCT00428220|580742724|FG000|Overall Study|Adverse Event|51|||
160824407|NCT00428220|580742724|FG000|Overall Study|Other|23|||
160824408|NCT00509093|580742725|FG000|Overall Study|Adverse Event|10|||
160553941|NCT03604445|579753536|FG002|Overall Study|Withdrawal by Subject|0|||
160553942|NCT03604445|579753537|FG003|Overall Study|Withdrawal by Subject|0|||
160553943|NCT03604445|579753538|FG004|Overall Study|Withdrawal by Subject|0|||
160553944|NCT03604445|579753539|FG005|Overall Study|Withdrawal by Subject|0|||
160553945|NCT03604445|579753540|FG006|Overall Study|Withdrawal by Subject|1|||
160553946|NCT03604445|579753541|FG007|Overall Study|Withdrawal by Subject|0|||
160553947|NCT03604445|579753542|FG008|Overall Study|Withdrawal by Subject|0|||
160553948|NCT03604445|579753534|FG000|Overall Study|Missing visit|0|||
160553949|NCT03604445|579753535|FG001|Overall Study|Missing visit|0|||
160553950|NCT03604445|579753536|FG002|Overall Study|Missing visit|0|||
160646468|NCT01464827|580088248|FG013|Overall Study|Lost to Follow-up|1|||
160824409|NCT00509093|580742725|FG000|Overall Study|Disease Progression|9|||
160824410|NCT00509093|580742725|FG000|Overall Study|Transformed into MDS|1|||
160824411|NCT00509093|580742725|FG000|Overall Study|Withdrawal by Subject|3|||
160553951|NCT03604445|579753537|FG003|Overall Study|Missing visit|0|||
160824412|NCT00509093|580742725|FG000|Overall Study|Physician Decision|1|||
160646469|NCT01464827|580088235|FG000|Overall Study|Other|2|||
160646470|NCT01464827|580088236|FG001|Overall Study|Other|3|||
160646471|NCT01464827|580088237|FG002|Overall Study|Other|0|||
160646472|NCT01464827|580088238|FG003|Overall Study|Other|2|||
160646473|NCT01464827|580088239|FG004|Overall Study|Other|3|||
160646474|NCT01464827|580088240|FG005|Overall Study|Other|0|||
160646475|NCT01464827|580088241|FG006|Overall Study|Other|1|||
160646476|NCT01464827|580088242|FG007|Overall Study|Other|0|||
160646477|NCT01464827|580088243|FG008|Overall Study|Other|3|||
160646478|NCT01464827|580088244|FG009|Overall Study|Other|1|||
160646479|NCT01464827|580088245|FG010|Overall Study|Other|2|||
160824413|NCT05013424|580742726|FG000|Overall Study|Lost to Follow-up|1|||
160824414|NCT05013424|580742727|FG001|Overall Study|Lost to Follow-up|1|||
160824415|NCT05013424|580742728|FG002|Overall Study|Lost to Follow-up|1|||
160824416|NCT05013424|580742726|FG000|Overall Study|Withdrawal by Subject|0|||
160824417|NCT05013424|580742727|FG001|Overall Study|Withdrawal by Subject|1|||
160824418|NCT05013424|580742728|FG002|Overall Study|Withdrawal by Subject|0|||
160824419|NCT04143217|580742735|FG000|Overall Study|Withdrawal by Subject|42|||
160824420|NCT04143217|580742735|FG000|Overall Study|Adverse Event|29|||
160824421|NCT04143217|580742735|FG000|Overall Study|Lost to Follow-up|29|||
160824422|NCT04143217|580742735|FG000|Overall Study|Lack of Efficacy|15|||
160824423|NCT04143217|580742735|FG000|Overall Study|Physician Decision|1|||
160824424|NCT04143217|580742735|FG000|Overall Study|Non-Compliance With Study Drug|6|||
160824425|NCT04143217|580742735|FG000|Overall Study|Other, Multiple Categories|11|||
160824426|NCT02210832|580742738|FG000|Overall Study|Pregnancy termination .|3|||
160824427|NCT02210832|580742739|FG001|Overall Study|Pregnancy termination .|4|||
160824428|NCT02210832|580742740|FG002|Overall Study|Pregnancy termination .|1|||
160824429|NCT02210832|580742738|FG000|Overall Study|Lost to Follow-up|26|||
160824430|NCT02210832|580742739|FG001|Overall Study|Lost to Follow-up|32|||
160824431|NCT02210832|580742740|FG002|Overall Study|Lost to Follow-up|17|||
160824432|NCT00471887|580742746|FG000|Overall Study|Adverse Event|9|||
160553952|NCT03604445|579753538|FG004|Overall Study|Missing visit|0|||
160553953|NCT03604445|579753539|FG005|Overall Study|Missing visit|1|||
160553954|NCT03604445|579753540|FG006|Overall Study|Missing visit|0|||
160553955|NCT03604445|579753541|FG007|Overall Study|Missing visit|1|||
160553956|NCT03604445|579753542|FG008|Overall Study|Missing visit|0|||
160553957|NCT03604445|579753534|FG000|Overall Study|Adverse Event|0|||
160553958|NCT03604445|579753535|FG001|Overall Study|Adverse Event|0|||
160553959|NCT03604445|579753536|FG002|Overall Study|Adverse Event|0|||
160553960|NCT03604445|579753537|FG003|Overall Study|Adverse Event|1|||
160553961|NCT03604445|579753538|FG004|Overall Study|Adverse Event|0|||
160553962|NCT03604445|579753539|FG005|Overall Study|Adverse Event|0|||
160553963|NCT03604445|579753540|FG006|Overall Study|Adverse Event|0|||
160553964|NCT03604445|579753541|FG007|Overall Study|Adverse Event|0|||
160553965|NCT03604445|579753542|FG008|Overall Study|Adverse Event|1|||
160553966|NCT00611247|579753545|FG000|Overall Study|Death|1|||
160824433|NCT01278407|580742749|FG000|Confirmatory Phase|Adverse Event|5|||
160824434|NCT01278407|580742750|FG001|Confirmatory Phase|Adverse Event|10|||
160824435|NCT01278407|580742751|FG002|Confirmatory Phase|Adverse Event|1|||
160824436|NCT01278407|580742752|FG003|Confirmatory Phase|Adverse Event|0|||
160824437|NCT01278407|580742753|FG004|Confirmatory Phase|Adverse Event|0|||
160824438|NCT01278407|580742749|FG000|Confirmatory Phase|Participant's Choice|3|||
160824439|NCT01278407|580742750|FG001|Confirmatory Phase|Participant's Choice|5|||
160824440|NCT01278407|580742751|FG002|Confirmatory Phase|Participant's Choice|3|||
160824441|NCT01278407|580742752|FG003|Confirmatory Phase|Participant's Choice|0|||
160824442|NCT01278407|580742753|FG004|Confirmatory Phase|Participant's Choice|0|||
160824443|NCT01278407|580742749|FG000|Confirmatory Phase|Other|1|||
160824444|NCT01278407|580742750|FG001|Confirmatory Phase|Other|1|||
160824445|NCT01278407|580742751|FG002|Confirmatory Phase|Other|2|||
160824446|NCT01278407|580742752|FG003|Confirmatory Phase|Other|0|||
160824447|NCT01278407|580742753|FG004|Confirmatory Phase|Other|0|||
160824448|NCT01278407|580742749|FG000|Extension Phase|Adverse Event|0|||
160824449|NCT01278407|580742750|FG001|Extension Phase|Adverse Event|0|||
160824450|NCT01278407|580742751|FG002|Extension Phase|Adverse Event|0|||
160824451|NCT01278407|580742752|FG003|Extension Phase|Adverse Event|7|||
160824452|NCT01278407|580742753|FG004|Extension Phase|Adverse Event|16|||
160824453|NCT01278407|580742749|FG000|Extension Phase|Participant's Choice|0|||
160824454|NCT01278407|580742750|FG001|Extension Phase|Participant's Choice|0|||
160824455|NCT01278407|580742751|FG002|Extension Phase|Participant's Choice|0|||
160824456|NCT01278407|580742752|FG003|Extension Phase|Participant's Choice|4|||
160553967|NCT00611247|579753546|FG001|Overall Study|Death|5|||
160553968|NCT00611247|579753545|FG000|Overall Study|Lack of Efficacy|1|||
160553969|NCT00611247|579753546|FG001|Overall Study|Lack of Efficacy|16|||
160646480|NCT01464827|580088246|FG011|Overall Study|Other|0|||
160646481|NCT01464827|580088247|FG012|Overall Study|Other|1|||
160646482|NCT01464827|580088248|FG013|Overall Study|Other|0|||
160646483|NCT01464827|580088235|FG000|Overall Study|Not Treated|0|||
160553970|NCT02551159|579753547|FG000|Overall Study|Death|352|||
160824457|NCT01278407|580742753|FG004|Extension Phase|Participant's Choice|11|||
160646484|NCT01464827|580088236|FG001|Overall Study|Not Treated|2|||
160646485|NCT01464827|580088237|FG002|Overall Study|Not Treated|0|||
160824458|NCT01278407|580742749|FG000|Extension Phase|Other|0|||
160824459|NCT01278407|580742750|FG001|Extension Phase|Other|0|||
160824460|NCT01278407|580742751|FG002|Extension Phase|Other|0|||
160824461|NCT01278407|580742752|FG003|Extension Phase|Other|1|||
160824462|NCT01278407|580742753|FG004|Extension Phase|Other|3|||
160824463|NCT03710876|580742754|FG000|Overall Study|Death|0|||
160824464|NCT03710876|580742755|FG001|Overall Study|Death|2|||
160824465|NCT03710876|580742754|FG000|Overall Study|Withdrawal by Subject|0|||
160824466|NCT03710876|580742755|FG001|Overall Study|Withdrawal by Subject|2|||
160824467|NCT01460719|580742757|FG000|Overall Study|Adverse Event|1|||
160824468|NCT01460719|580742757|FG000|Overall Study|Withdrawal by Subject|1|||
160824469|NCT01655381|580742763|FG000|Overall Study|Investigator Decision|1|||
160824470|NCT01655381|580742763|FG000|Overall Study|Moved to Another City|1|||
160824471|NCT01655381|580742763|FG000|Overall Study|Insufficient Treatment Response|1|||
160824472|NCT02285114|580742764|FG000|Main Phase|Investigator's Discretion|0|||
160824473|NCT02285114|580742765|FG001|Main Phase|Investigator's Discretion|2|||
160824474|NCT02285114|580742766|FG002|Main Phase|Investigator's Discretion|0|||
160824475|NCT02285114|580742767|FG003|Main Phase|Investigator's Discretion|0|||
160824476|NCT02285114|580742768|FG004|Main Phase|Investigator's Discretion|0|||
160824477|NCT02285114|580742769|FG005|Main Phase|Investigator's Discretion|0|||
160824478|NCT02285114|580742764|FG000|Main Phase|Enrolled but Never Treated|1|||
160824479|NCT02285114|580742765|FG001|Main Phase|Enrolled but Never Treated|0|||
160824480|NCT02285114|580742766|FG002|Main Phase|Enrolled but Never Treated|0|||
160824481|NCT02285114|580742767|FG003|Main Phase|Enrolled but Never Treated|0|||
160824482|NCT02285114|580742768|FG004|Main Phase|Enrolled but Never Treated|0|||
160824483|NCT02285114|580742769|FG005|Main Phase|Enrolled but Never Treated|0|||
160824484|NCT02285114|580742764|FG000|Main Phase|Withdrew Consent|0|||
160824485|NCT02285114|580742765|FG001|Main Phase|Withdrew Consent|0|||
160824486|NCT02285114|580742766|FG002|Main Phase|Withdrew Consent|1|||
160824487|NCT02285114|580742767|FG003|Main Phase|Withdrew Consent|0|||
160824488|NCT02285114|580742768|FG004|Main Phase|Withdrew Consent|0|||
160824489|NCT02285114|580742769|FG005|Main Phase|Withdrew Consent|0|||
160824490|NCT02285114|580742764|FG000|Extension Phase|Investigator's Discretion|0|||
160824491|NCT02285114|580742765|FG001|Extension Phase|Investigator's Discretion|0|||
160824492|NCT02285114|580742766|FG002|Extension Phase|Investigator's Discretion|0|||
160901975|NCT00885846|581035953|FG000|Overall Study|Withdrawal by Subject|2|||
160901976|NCT00885846|581035954|FG001|Overall Study|Withdrawal by Subject|5|||
160901977|NCT00885846|581035955|FG002|Overall Study|Withdrawal by Subject|2|||
160901978|NCT00074984|581035956|FG000|Overall Study|Death|1|||
160901979|NCT00074984|581035957|FG001|Overall Study|Death|2|||
160901980|NCT00074984|581035956|FG000|Overall Study|Withdrawal by Subject|2|||
160553971|NCT02551159|579753548|FG001|Overall Study|Death|174|||
160553972|NCT02551159|579753549|FG002|Overall Study|Death|161|||
160553973|NCT02551159|579753547|FG000|Overall Study|Withdrawal by Subject|8|||
160553974|NCT02551159|579753548|FG001|Overall Study|Withdrawal by Subject|5|||
160553975|NCT02551159|579753549|FG002|Overall Study|Withdrawal by Subject|16|||
160553976|NCT02551159|579753547|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
160553977|NCT02551159|579753548|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
160553978|NCT02551159|579753549|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
160824493|NCT02285114|580742767|FG003|Extension Phase|Investigator's Discretion|14|||
160824494|NCT02285114|580742768|FG004|Extension Phase|Investigator's Discretion|1|||
160824495|NCT02285114|580742769|FG005|Extension Phase|Investigator's Discretion|0|||
160824496|NCT02285114|580742764|FG000|Extension Phase|Lost to Follow-up|0|||
160901981|NCT00074984|581035957|FG001|Overall Study|Withdrawal by Subject|3|||
160901982|NCT00074984|581035956|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
160646486|NCT01464827|580088238|FG003|Overall Study|Not Treated|0|||
160646487|NCT01464827|580088239|FG004|Overall Study|Not Treated|1|||
160824497|NCT02285114|580742765|FG001|Extension Phase|Lost to Follow-up|0|||
160824498|NCT02285114|580742766|FG002|Extension Phase|Lost to Follow-up|0|||
160901983|NCT00074984|581035957|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
160901984|NCT03758443|581035958|FG000|Induction Period|Adverse Event|2|||
160901985|NCT03758443|581035959|FG001|Induction Period|Adverse Event|4|||
160553979|NCT00243659|579753550|FG000|Overall Study|Withdrawal by Subject|1|||
160646488|NCT01464827|580088240|FG005|Overall Study|Not Treated|0|||
160824499|NCT02285114|580742767|FG003|Extension Phase|Lost to Follow-up|1|||
160824500|NCT02285114|580742768|FG004|Extension Phase|Lost to Follow-up|1|||
160824501|NCT02285114|580742769|FG005|Extension Phase|Lost to Follow-up|0|||
160824502|NCT02285114|580742764|FG000|Extension Phase|Non-compliance with Study Drug|0|||
160824503|NCT02285114|580742765|FG001|Extension Phase|Non-compliance with Study Drug|0|||
160824504|NCT02285114|580742766|FG002|Extension Phase|Non-compliance with Study Drug|0|||
160824505|NCT02285114|580742767|FG003|Extension Phase|Non-compliance with Study Drug|2|||
160824506|NCT02285114|580742768|FG004|Extension Phase|Non-compliance with Study Drug|0|||
160824507|NCT02285114|580742769|FG005|Extension Phase|Non-compliance with Study Drug|0|||
160824508|NCT02285114|580742764|FG000|Extension Phase|Pregnancy|0|||
160824509|NCT02285114|580742765|FG001|Extension Phase|Pregnancy|0|||
160824510|NCT02285114|580742766|FG002|Extension Phase|Pregnancy|0|||
160824511|NCT02285114|580742767|FG003|Extension Phase|Pregnancy|1|||
160824512|NCT02285114|580742768|FG004|Extension Phase|Pregnancy|0|||
160824513|NCT02285114|580742769|FG005|Extension Phase|Pregnancy|0|||
160824514|NCT02324205|580742770|FG000|Overall Study|Withdrawal by Subject|37|||
160824515|NCT00320255|580742771|FG000|Overall Study|Lack of Efficacy|1|||
160824516|NCT00320255|580742772|FG001|Overall Study|Lack of Efficacy|0|||
160824517|NCT00320255|580742773|FG002|Overall Study|Lack of Efficacy|0|||
160824518|NCT00320255|580742774|FG003|Overall Study|Lack of Efficacy|0|||
160824519|NCT00320255|580742775|FG004|Overall Study|Lack of Efficacy|0|||
160824520|NCT00320255|580742776|FG005|Overall Study|Lack of Efficacy|0|||
160824521|NCT00320255|580742771|FG000|Overall Study|Adverse Event|5|||
160824522|NCT00320255|580742772|FG001|Overall Study|Adverse Event|2|||
160824523|NCT00320255|580742773|FG002|Overall Study|Adverse Event|3|||
160824524|NCT00320255|580742774|FG003|Overall Study|Adverse Event|2|||
160824525|NCT00320255|580742775|FG004|Overall Study|Adverse Event|0|||
160824526|NCT00320255|580742776|FG005|Overall Study|Adverse Event|0|||
160824527|NCT00320255|580742771|FG000|Overall Study|Withdrawal by Subject|1|||
160824528|NCT00320255|580742772|FG001|Overall Study|Withdrawal by Subject|2|||
160824529|NCT00320255|580742773|FG002|Overall Study|Withdrawal by Subject|2|||
160824530|NCT00320255|580742774|FG003|Overall Study|Withdrawal by Subject|4|||
160824531|NCT00320255|580742775|FG004|Overall Study|Withdrawal by Subject|0|||
160824532|NCT00320255|580742776|FG005|Overall Study|Withdrawal by Subject|0|||
160824533|NCT00320255|580742771|FG000|Overall Study|Poor compliance/noncompliance|1|||
160824534|NCT00320255|580742772|FG001|Overall Study|Poor compliance/noncompliance|1|||
160824535|NCT00320255|580742773|FG002|Overall Study|Poor compliance/noncompliance|0|||
160824536|NCT00320255|580742774|FG003|Overall Study|Poor compliance/noncompliance|1|||
160824537|NCT00320255|580742775|FG004|Overall Study|Poor compliance/noncompliance|0|||
160824538|NCT00320255|580742776|FG005|Overall Study|Poor compliance/noncompliance|0|||
160824539|NCT00320255|580742771|FG000|Overall Study|No longer meets study criteria|0|||
160824540|NCT00320255|580742772|FG001|Overall Study|No longer meets study criteria|0|||
160824541|NCT00320255|580742773|FG002|Overall Study|No longer meets study criteria|0|||
160824542|NCT00320255|580742774|FG003|Overall Study|No longer meets study criteria|1|||
160824543|NCT00320255|580742775|FG004|Overall Study|No longer meets study criteria|0|||
160824544|NCT00320255|580742776|FG005|Overall Study|No longer meets study criteria|0|||
160824545|NCT00320255|580742771|FG000|Overall Study|Other|3|||
160824546|NCT00320255|580742772|FG001|Overall Study|Other|2|||
160824547|NCT00320255|580742773|FG002|Overall Study|Other|1|||
160824548|NCT00320255|580742774|FG003|Overall Study|Other|0|||
160824549|NCT00320255|580742775|FG004|Overall Study|Other|0|||
160824550|NCT00320255|580742776|FG005|Overall Study|Other|0|||
160824551|NCT00230282|580742782|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
160824552|NCT00230282|580742782|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
160824553|NCT00230282|580742782|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
160824554|NCT00230282|580742782|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
160824555|NCT01560637|580742785|FG000|Overall Study|Adverse Event|63|||
160824556|NCT01560637|580742785|FG000|Overall Study|Death|69|||
160824557|NCT01560637|580742785|FG000|Overall Study|Lost to Follow-up|8|||
160824558|NCT01560637|580742785|FG000|Overall Study|Protocol Violation|8|||
160824559|NCT01560637|580742785|FG000|Overall Study|Withdrawal by Subject|24|||
160824560|NCT01560637|580742785|FG000|Overall Study|Progressive Disease|20|||
160824561|NCT01560637|580742785|FG000|Overall Study|Other Reason Not Specified|6|||
160901986|NCT03758443|581035960|FG002|Induction Period|Adverse Event|2|||
160901987|NCT03758443|581035961|FG003|Induction Period|Adverse Event|3|||
160901988|NCT03758443|581035958|FG000|Induction Period|Physician Decision|1|||
160824562|NCT01089023|580742788|FG000|Overall Study|Lost to Follow-up|3|||
160824563|NCT01089023|580742788|FG000|Overall Study|Adverse Event|1|||
160824564|NCT01089023|580742788|FG000|Overall Study|Withdrawal by Subject|1|||
160824565|NCT01089023|580742788|FG000|Overall Study|Protocol Violation|1|||
160824566|NCT01089023|580742788|FG000|Overall Study|Lack of Efficacy|1|||
160824567|NCT02434354|580742791|FG000|Overall Study|screen fail|3|||
160824568|NCT01185964|580742793|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
160824569|NCT01185964|580742794|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
160824570|NCT01185964|580742795|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
160824571|NCT01185964|580742796|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
160824572|NCT01185964|580742793|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
160901989|NCT03758443|581035959|FG001|Induction Period|Physician Decision|1|||
160824573|NCT01185964|580742794|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
160824574|NCT01185964|580742795|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
160824575|NCT01185964|580742796|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
160824576|NCT01185964|580742793|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
160824577|NCT01185964|580742794|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
160824578|NCT01185964|580742795|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
160824579|NCT01185964|580742796|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
160824580|NCT01185964|580742793|FG000|Phase 1b and Phase 2|Adverse Event|1|||
160824581|NCT01185964|580742794|FG001|Phase 1b and Phase 2|Adverse Event|0|||
160824582|NCT01185964|580742795|FG002|Phase 1b and Phase 2|Adverse Event|2|||
160824583|NCT01185964|580742796|FG003|Phase 1b and Phase 2|Adverse Event|0|||
160824584|NCT01185964|580742793|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
160824585|NCT01185964|580742794|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
160824586|NCT01185964|580742795|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
160824587|NCT01185964|580742796|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
160824588|NCT01185964|580742793|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
160824589|NCT01185964|580742794|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
160824590|NCT01185964|580742795|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
160824591|NCT01185964|580742796|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
160824592|NCT01185964|580742793|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
160824593|NCT01185964|580742794|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
160824594|NCT01185964|580742795|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
160824595|NCT01185964|580742796|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
160824596|NCT01185964|580742793|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
160824597|NCT01185964|580742794|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
160824598|NCT01185964|580742795|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
160824599|NCT01185964|580742796|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
160824600|NCT03576755|580742810|FG000|Overall Study|Withdrawal by Subject|1|||
160824601|NCT03576755|580742811|FG001|Overall Study|Withdrawal by Subject|0|||
160824602|NCT03576755|580742812|FG002|Overall Study|Withdrawal by Subject|0|||
160824603|NCT03576755|580742813|FG003|Overall Study|Withdrawal by Subject|0|||
160824604|NCT04962230|580742814|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
160824605|NCT04962230|580742814|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
160824606|NCT02275117|580742815|FG000|Overall Study|Adverse Event|0|||
160824607|NCT02275117|580742816|FG001|Overall Study|Adverse Event|0|||
160824608|NCT02275117|580742817|FG002|Overall Study|Adverse Event|0|||
160824609|NCT02275117|580742818|FG003|Overall Study|Adverse Event|0|||
160824610|NCT02275117|580742819|FG004|Overall Study|Adverse Event|1|||
160824611|NCT02275117|580742815|FG000|Overall Study|Lack of Efficacy|6|||
160824612|NCT02275117|580742816|FG001|Overall Study|Lack of Efficacy|7|||
160824613|NCT02275117|580742817|FG002|Overall Study|Lack of Efficacy|5|||
160824614|NCT02275117|580742818|FG003|Overall Study|Lack of Efficacy|2|||
160824615|NCT02275117|580742819|FG004|Overall Study|Lack of Efficacy|10|||
160824616|NCT02275117|580742815|FG000|Overall Study|Lost to Follow-up|11|||
160824617|NCT02275117|580742816|FG001|Overall Study|Lost to Follow-up|16|||
160824618|NCT02275117|580742817|FG002|Overall Study|Lost to Follow-up|15|||
160824619|NCT02275117|580742818|FG003|Overall Study|Lost to Follow-up|16|||
160824620|NCT02275117|580742819|FG004|Overall Study|Lost to Follow-up|8|||
160824621|NCT02275117|580742815|FG000|Overall Study|Physician Decision|0|||
160824622|NCT02275117|580742816|FG001|Overall Study|Physician Decision|1|||
160824623|NCT02275117|580742817|FG002|Overall Study|Physician Decision|1|||
160824624|NCT02275117|580742818|FG003|Overall Study|Physician Decision|0|||
160901990|NCT03758443|581035960|FG002|Induction Period|Physician Decision|3|||
160901991|NCT03758443|581035961|FG003|Induction Period|Physician Decision|0|||
160901992|NCT03758443|581035958|FG000|Induction Period|Protocol Violation|0|||
160901993|NCT03758443|581035959|FG001|Induction Period|Protocol Violation|0|||
160901994|NCT03758443|581035960|FG002|Induction Period|Protocol Violation|0|||
160901995|NCT03758443|581035961|FG003|Induction Period|Protocol Violation|1|||
160824625|NCT02275117|580742819|FG004|Overall Study|Physician Decision|1|||
160824626|NCT02275117|580742815|FG000|Overall Study|Protocol Violation|1|||
160824627|NCT02275117|580742816|FG001|Overall Study|Protocol Violation|0|||
160824628|NCT02275117|580742817|FG002|Overall Study|Protocol Violation|1|||
160824629|NCT02275117|580742818|FG003|Overall Study|Protocol Violation|1|||
160901996|NCT03758443|581035958|FG000|Induction Period|Withdrawal by Subject|3|||
160901997|NCT03758443|581035959|FG001|Induction Period|Withdrawal by Subject|2|||
160901998|NCT03758443|581035960|FG002|Induction Period|Withdrawal by Subject|2|||
160901999|NCT03758443|581035961|FG003|Induction Period|Withdrawal by Subject|4|||
160902000|NCT03758443|581035958|FG000|Extended Induction Period|Adverse Event|1|||
160902001|NCT03758443|581035959|FG001|Extended Induction Period|Adverse Event|1|||
160902002|NCT03758443|581035960|FG002|Extended Induction Period|Adverse Event|0|||
160902003|NCT03758443|581035961|FG003|Extended Induction Period|Adverse Event|1|||
160902004|NCT03758443|581035958|FG000|Extended Induction Period|Lost to Follow-up|1|||
160902005|NCT03758443|581035959|FG001|Extended Induction Period|Lost to Follow-up|0|||
160646489|NCT01464827|580088241|FG006|Overall Study|Not Treated|1|||
160646490|NCT01464827|580088242|FG007|Overall Study|Not Treated|0|||
160646491|NCT01464827|580088243|FG008|Overall Study|Not Treated|0|||
160646492|NCT01464827|580088244|FG009|Overall Study|Not Treated|2|||
160646493|NCT01464827|580088245|FG010|Overall Study|Not Treated|0|||
160646494|NCT01464827|580088246|FG011|Overall Study|Not Treated|1|||
160646495|NCT01464827|580088247|FG012|Overall Study|Not Treated|0|||
160646496|NCT01464827|580088248|FG013|Overall Study|Not Treated|2|||
160646497|NCT01075763|580088249|FG000|Overall Study|Lost to Follow-up|2|||
160646498|NCT01075763|580088250|FG001|Overall Study|Lost to Follow-up|1|||
160646499|NCT01075763|580088249|FG000|Overall Study|Lack of Efficacy|0|||
160646500|NCT01075763|580088250|FG001|Overall Study|Lack of Efficacy|1|||
160646501|NCT01075763|580088249|FG000|Overall Study|Withdrawal by Subject|2|||
160646502|NCT01075763|580088250|FG001|Overall Study|Withdrawal by Subject|2|||
160646503|NCT00586521|580088251|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
160646504|NCT03083483|580088252|FG000|Overall Study|Adverse Event|1|||
160646505|NCT03083483|580088253|FG001|Overall Study|Adverse Event|1|||
160646506|NCT03083483|580088254|FG002|Overall Study|Adverse Event|1|||
160646507|NCT03083483|580088252|FG000|Overall Study|Lost to Follow-up|2|||
160646508|NCT03083483|580088253|FG001|Overall Study|Lost to Follow-up|1|||
160646509|NCT03083483|580088254|FG002|Overall Study|Lost to Follow-up|1|||
160646510|NCT03083483|580088252|FG000|Overall Study|technological issues|1|||
160646511|NCT03083483|580088253|FG001|Overall Study|technological issues|0|||
160646512|NCT03083483|580088254|FG002|Overall Study|technological issues|1|||
160646513|NCT02710071|580088255|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
160646514|NCT02710071|580088256|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
160646515|NCT02710071|580088255|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
160646516|NCT02710071|580088256|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
160646517|NCT01751412|580088262|FG000|Overall Study|Disease Progression Before Treatment|1|||
160646518|NCT03734237|580088263|FG000|Overall Study|Lost to Follow-up|1|||
160646519|NCT03734237|580088264|FG001|Overall Study|Lost to Follow-up|3|||
160646520|NCT03734237|580088265|FG002|Overall Study|Lost to Follow-up|0|||
160646521|NCT03734237|580088263|FG000|Overall Study|Withdrawal by Subject|7|||
160646522|NCT03734237|580088264|FG001|Overall Study|Withdrawal by Subject|9|||
160646523|NCT03734237|580088265|FG002|Overall Study|Withdrawal by Subject|10|||
160646524|NCT01844583|580088266|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
160646525|NCT01844583|580088267|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
160824630|NCT02275117|580742819|FG004|Overall Study|Protocol Violation|0|||
160824631|NCT02275117|580742815|FG000|Overall Study|Withdrawal by Subject|6|||
160824632|NCT02275117|580742816|FG001|Overall Study|Withdrawal by Subject|4|||
160824633|NCT02275117|580742817|FG002|Overall Study|Withdrawal by Subject|7|||
160824634|NCT02275117|580742818|FG003|Overall Study|Withdrawal by Subject|3|||
160824635|NCT02275117|580742819|FG004|Overall Study|Withdrawal by Subject|3|||
160824636|NCT02275117|580742815|FG000|Overall Study|Terminated by Sponsor|4|||
160824637|NCT02275117|580742816|FG001|Overall Study|Terminated by Sponsor|4|||
160824638|NCT02275117|580742817|FG002|Overall Study|Terminated by Sponsor|4|||
160824639|NCT02275117|580742818|FG003|Overall Study|Terminated by Sponsor|6|||
160824640|NCT02275117|580742819|FG004|Overall Study|Terminated by Sponsor|4|||
160824641|NCT02275117|580742815|FG000|Overall Study|Worsening of Study Indication|0|||
160824642|NCT02275117|580742816|FG001|Overall Study|Worsening of Study Indication|1|||
160824643|NCT02275117|580742817|FG002|Overall Study|Worsening of Study Indication|2|||
160824644|NCT02275117|580742818|FG003|Overall Study|Worsening of Study Indication|0|||
160824645|NCT02275117|580742819|FG004|Overall Study|Worsening of Study Indication|0|||
160824646|NCT02275117|580742815|FG000|Overall Study|Study Burden|5|||
160824647|NCT02275117|580742816|FG001|Overall Study|Study Burden|4|||
160824648|NCT02275117|580742817|FG002|Overall Study|Study Burden|7|||
160824649|NCT02275117|580742818|FG003|Overall Study|Study Burden|5|||
160824650|NCT02275117|580742819|FG004|Overall Study|Study Burden|7|||
160824651|NCT02275117|580742815|FG000|Overall Study|Other|1|||
160824652|NCT02275117|580742816|FG001|Overall Study|Other|0|||
160824653|NCT02275117|580742817|FG002|Overall Study|Other|0|||
160824654|NCT02275117|580742818|FG003|Overall Study|Other|0|||
160824655|NCT02275117|580742819|FG004|Overall Study|Other|2|||
160824656|NCT01081301|580742823|FG000|Overall Study|Bereaved|3|||
160824657|NCT01081301|580742823|FG000|Overall Study|Too busy|5|||
160646526|NCT00958256|580088269|FG000|Overall Study|Adverse Event|3|||
160646527|NCT05431153|580088270|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160824658|NCT01081301|580742823|FG000|Overall Study|Patient too ill|2|||
160646528|NCT05431153|580088271|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160646529|NCT05431153|580088272|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160646530|NCT05431153|580088273|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160646531|NCT05431153|580088274|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
160646532|NCT05431153|580088275|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160824659|NCT01081301|580742823|FG000|Overall Study|Lost to Follow-up|4|||
160824660|NCT02014480|580742824|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160824661|NCT02014480|580742825|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160824662|NCT02014480|580742826|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
160989911|NCT01124162|581351688|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
160824663|NCT02014480|580742827|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160824664|NCT02014480|580742828|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160824665|NCT02014480|580742829|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160824666|NCT02014480|580742824|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160824667|NCT02014480|580742825|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160824668|NCT02014480|580742826|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160824669|NCT02014480|580742827|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
160824670|NCT02014480|580742828|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160824671|NCT02014480|580742829|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160824672|NCT02014480|580742824|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160824673|NCT02014480|580742825|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160824674|NCT02014480|580742826|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
160824675|NCT02014480|580742827|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160824676|NCT02014480|580742828|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160824677|NCT02014480|580742829|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160824678|NCT02014480|580742824|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
160824679|NCT02014480|580742825|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
160824680|NCT02014480|580742826|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
160824681|NCT02014480|580742827|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
160824682|NCT02014480|580742828|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160824683|NCT02014480|580742829|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160824684|NCT02014480|580742824|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160824685|NCT02014480|580742825|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
160824686|NCT02014480|580742826|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160824687|NCT02014480|580742827|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160824688|NCT02014480|580742828|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160824689|NCT02014480|580742829|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160824690|NCT02014480|580742824|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
160824691|NCT02014480|580742825|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
160824692|NCT02014480|580742826|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
160824693|NCT02014480|580742827|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
160824694|NCT02014480|580742828|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
160824695|NCT02014480|580742829|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
160824696|NCT02014480|580742824|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160824697|NCT02014480|580742825|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160824698|NCT02014480|580742826|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160824699|NCT02014480|580742827|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160824700|NCT02014480|580742828|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160824701|NCT02014480|580742829|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
160824702|NCT01865812|580742830|FG000|Primary Treatment Phase|Adverse Event|2|||
160824703|NCT01865812|580742831|FG001|Primary Treatment Phase|Adverse Event|0|||
160824704|NCT01865812|580742830|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
160824705|NCT01865812|580742831|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
160824706|NCT01865812|580742830|FG000|Long-term Safety Extension Phase|Pruritus|0|||
160824707|NCT01865812|580742831|FG001|Long-term Safety Extension Phase|Pruritus|3|||
160824708|NCT01865812|580742830|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
160824709|NCT01865812|580742831|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
160824710|NCT01865812|580742830|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
160824711|NCT01865812|580742831|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
160824712|NCT01338610|580742832|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
160824713|NCT01338610|580742833|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
160824714|NCT01338610|580742834|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
160553980|NCT00243659|579753551|FG001|Overall Study|Withdrawal by Subject|1|||
160824715|NCT01338610|580742832|FG000|Overall Study|Protocol Violation|1|||
160824716|NCT01338610|580742833|FG001|Overall Study|Protocol Violation|0|||
160553981|NCT00243659|579753550|FG000|Overall Study|Protocol Violation|1|||
160553982|NCT00243659|579753551|FG001|Overall Study|Protocol Violation|2|||
160553983|NCT00268242|579753552|FG000|Overall Study|Death|1|||
160824717|NCT01338610|580742834|FG002|Overall Study|Protocol Violation|1|||
160824718|NCT01338610|580742832|FG000|Overall Study|Adverse Event|3|||
160824719|NCT01338610|580742833|FG001|Overall Study|Adverse Event|0|||
160824720|NCT01338610|580742834|FG002|Overall Study|Adverse Event|0|||
160824721|NCT00724854|580742835|FG000|Overall Study|Lack of Efficacy|187|||
160824722|NCT00724854|580742836|FG001|Overall Study|Lack of Efficacy|13|||
160989912|NCT03681691|581351689|FG000|Overall Study|COVID|1|||
160989913|NCT03681691|581351690|FG001|Overall Study|COVID|0|||
160989914|NCT03681691|581351689|FG000|Overall Study|prolonged bleeding|1|||
160824723|NCT00724854|580742835|FG000|Overall Study|Lost to Follow-up|87|||
160824724|NCT00724854|580742836|FG001|Overall Study|Lost to Follow-up|10|||
160824725|NCT00724854|580742835|FG000|Overall Study|Adverse Event|62|||
160902006|NCT03758443|581035960|FG002|Extended Induction Period|Lost to Follow-up|0|||
160553984|NCT01913483|579753553|FG000|Overall Study|Withdrawal by Subject|1|||
160553985|NCT01913483|579753554|FG001|Overall Study|Withdrawal by Subject|2|||
160553986|NCT01913483|579753553|FG000|Overall Study|Lost to Follow-up|6|||
160553987|NCT01913483|579753554|FG001|Overall Study|Lost to Follow-up|3|||
160553988|NCT01913483|579753553|FG000|Overall Study|Death|14|||
160553989|NCT01913483|579753554|FG001|Overall Study|Death|17|||
160553990|NCT03969888|579753555|FG000|Overall Study|Never Received Study Drug|0|||
160553991|NCT03969888|579753556|FG001|Overall Study|Never Received Study Drug|0|||
160553992|NCT03969888|579753557|FG002|Overall Study|Never Received Study Drug|1|||
160553993|NCT03969888|579753558|FG003|Overall Study|Never Received Study Drug|0|||
160553994|NCT03969888|579753559|FG004|Overall Study|Never Received Study Drug|0|||
160553995|NCT03969888|579753560|FG005|Overall Study|Never Received Study Drug|0|||
160553996|NCT03969888|579753561|FG006|Overall Study|Never Received Study Drug|1|||
160553997|NCT03969888|579753562|FG007|Overall Study|Never Received Study Drug|0|||
160553998|NCT03969888|579753555|FG000|Overall Study|Reason Not Specified|0|||
160553999|NCT03969888|579753556|FG001|Overall Study|Reason Not Specified|0|||
160554000|NCT03969888|579753557|FG002|Overall Study|Reason Not Specified|0|||
160554001|NCT03969888|579753558|FG003|Overall Study|Reason Not Specified|0|||
160554002|NCT03969888|579753559|FG004|Overall Study|Reason Not Specified|0|||
160554003|NCT03969888|579753560|FG005|Overall Study|Reason Not Specified|0|||
160554004|NCT03969888|579753561|FG006|Overall Study|Reason Not Specified|0|||
160554005|NCT03969888|579753562|FG007|Overall Study|Reason Not Specified|1|||
160554006|NCT00464178|579753565|FG000|Overall Study|Protocol Violation|1|||
160554007|NCT00464178|579753565|FG000|Overall Study|Withdrawal by Subject|1|||
160554008|NCT04506294|579753566|FG000|Overall Study|Lost to Follow-up|70|||
160554009|NCT04506294|579753567|FG001|Overall Study|Lost to Follow-up|20|||
160554010|NCT04506294|579753566|FG000|Overall Study|Withdrawal by Subject|16|||
160554011|NCT04506294|579753567|FG001|Overall Study|Withdrawal by Subject|2|||
160554012|NCT01469000|579753569|FG000|Overall Study|Withdrawal by Subject|16|||
160554013|NCT01469000|579753570|FG001|Overall Study|Withdrawal by Subject|3|||
160554014|NCT01469000|579753569|FG000|Overall Study|Sponsor Decision|4|||
160554015|NCT01469000|579753570|FG001|Overall Study|Sponsor Decision|1|||
160554016|NCT00769119|579753573|FG000|Overall Study|Voluntary discontinuation|0|||
160554017|NCT00769119|579753574|FG001|Overall Study|Voluntary discontinuation|2|||
160554018|NCT00769119|579753573|FG000|Overall Study|Adverse Event|1|||
160554019|NCT00769119|579753574|FG001|Overall Study|Adverse Event|1|||
160554020|NCT00769119|579753573|FG000|Overall Study|Disallowed medication|1|||
160554021|NCT00769119|579753574|FG001|Overall Study|Disallowed medication|0|||
160554022|NCT01116544|579753577|FG000|Overall Study|Protocol Violation|1|||
160554023|NCT01116544|579753578|FG001|Overall Study|Protocol Violation|0|||
160554024|NCT01116544|579753577|FG000|Overall Study|Withdrawal by Subject|1|||
160554025|NCT01116544|579753578|FG001|Overall Study|Withdrawal by Subject|1|||
160554026|NCT05168267|579753579|FG000|Overall Study|Withdrawal by Subject|2|||
160554027|NCT05168267|579753580|FG001|Overall Study|Withdrawal by Subject|1|||
160554028|NCT05168267|579753579|FG000|Overall Study|Withdrawn by Therapist|1|||
160554029|NCT05168267|579753580|FG001|Overall Study|Withdrawn by Therapist|1|||
160554030|NCT05168267|579753579|FG000|Overall Study|Left Facility|1|||
160554031|NCT05168267|579753580|FG001|Overall Study|Left Facility|0|||
160554032|NCT01738971|579753589|FG000|Overall Study|Lost to Follow-up|19|||
160554033|NCT01738971|579753590|FG001|Overall Study|Lost to Follow-up|30|||
160554034|NCT01738971|579753591|FG002|Overall Study|Lost to Follow-up|17|||
160554035|NCT04698629|579753597|FG000|Overall Study|Adverse Event|1|||
160554036|NCT02320487|579753600|FG000|Overall Study|Reason not Specified|1|||
160554037|NCT02320487|579753600|FG000|Overall Study|Physician Decision|5|||
160554038|NCT02320487|579753600|FG000|Overall Study|Withdrawal by Subject|1|||
160554039|NCT02320487|579753600|FG000|Overall Study|Death|3|||
160554040|NCT02320487|579753600|FG000|Overall Study|Adverse Event|11|||
160902007|NCT03758443|581035961|FG003|Extended Induction Period|Lost to Follow-up|0|||
160902008|NCT03758443|581035958|FG000|Extended Induction Period|Physician Decision|2|||
160902009|NCT03758443|581035959|FG001|Extended Induction Period|Physician Decision|1|||
160902010|NCT03758443|581035960|FG002|Extended Induction Period|Physician Decision|2|||
160902011|NCT03758443|581035961|FG003|Extended Induction Period|Physician Decision|2|||
160902012|NCT03758443|581035958|FG000|Extended Induction Period|Protocol Violation|0|||
160554041|NCT06228586|579753601|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
160554042|NCT06228586|579753602|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
160554043|NCT00865020|579753611|FG000|Overall Study|Withdrawal by Subject|22|||
160902013|NCT03758443|581035959|FG001|Extended Induction Period|Protocol Violation|0|||
160902014|NCT03758443|581035960|FG002|Extended Induction Period|Protocol Violation|0|||
160989915|NCT03681691|581351690|FG001|Overall Study|prolonged bleeding|0|||
160554044|NCT00865020|579753612|FG001|Overall Study|Withdrawal by Subject|16|||
160554045|NCT00865020|579753611|FG000|Overall Study|Adverse Event|9|||
160554046|NCT00865020|579753612|FG001|Overall Study|Adverse Event|14|||
160554047|NCT00865020|579753611|FG000|Overall Study|Abnormal test procedure result(s)|6|||
160554048|NCT00865020|579753612|FG001|Overall Study|Abnormal test procedure result(s)|8|||
160554049|NCT00865020|579753611|FG000|Overall Study|Lost to Follow-up|6|||
160902015|NCT03758443|581035961|FG003|Extended Induction Period|Protocol Violation|1|||
160902016|NCT03758443|581035958|FG000|Extended Induction Period|Withdrawal by Subject|8|||
160902017|NCT03758443|581035959|FG001|Extended Induction Period|Withdrawal by Subject|1|||
160902018|NCT03758443|581035960|FG002|Extended Induction Period|Withdrawal by Subject|7|||
160902019|NCT03758443|581035961|FG003|Extended Induction Period|Withdrawal by Subject|3|||
160902020|NCT03758443|581035958|FG000|Extended Induction Period|Miscellaneous|1|||
160902021|NCT03758443|581035959|FG001|Extended Induction Period|Miscellaneous|0|||
160554050|NCT00865020|579753612|FG001|Overall Study|Lost to Follow-up|4|||
160554051|NCT00865020|579753611|FG000|Overall Study|Protocol deviation|4|||
160554052|NCT00865020|579753612|FG001|Overall Study|Protocol deviation|1|||
160824726|NCT00724854|580742836|FG001|Overall Study|Adverse Event|4|||
160824727|NCT00724854|580742835|FG000|Overall Study|Other|42|||
160824728|NCT00724854|580742836|FG001|Overall Study|Other|3|||
160824729|NCT00724854|580742835|FG000|Overall Study|Death|11|||
160824730|NCT00724854|580742836|FG001|Overall Study|Death|0|||
160824731|NCT00724854|580742835|FG000|Overall Study|Change of treatment|7|||
160824732|NCT00724854|580742836|FG001|Overall Study|Change of treatment|0|||
160824733|NCT00724854|580742835|FG000|Overall Study|Withdrawal by Subject|5|||
160824734|NCT00724854|580742836|FG001|Overall Study|Withdrawal by Subject|0|||
160824735|NCT00724854|580742835|FG000|Overall Study|Adverse event + lack of efficacy|2|||
160824736|NCT00724854|580742836|FG001|Overall Study|Adverse event + lack of efficacy|1|||
160824737|NCT01095653|580742837|FG000|Overall Study|Lack of Efficacy|3|||
160824738|NCT01095653|580742838|FG001|Overall Study|Lack of Efficacy|0|||
160824739|NCT01095653|580742839|FG002|Overall Study|Lack of Efficacy|0|||
160824740|NCT01095653|580742837|FG000|Overall Study|Adverse Event|1|||
160824741|NCT01095653|580742838|FG001|Overall Study|Adverse Event|4|||
160824742|NCT01095653|580742839|FG002|Overall Study|Adverse Event|4|||
160824743|NCT01095653|580742837|FG000|Overall Study|Lost to Follow-up|1|||
160824744|NCT01095653|580742838|FG001|Overall Study|Lost to Follow-up|0|||
160824745|NCT01095653|580742839|FG002|Overall Study|Lost to Follow-up|4|||
160824746|NCT01095653|580742837|FG000|Overall Study|Withdrawal by Subject|4|||
160824747|NCT01095653|580742838|FG001|Overall Study|Withdrawal by Subject|5|||
160824748|NCT01095653|580742839|FG002|Overall Study|Withdrawal by Subject|3|||
160824749|NCT01095653|580742837|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
160824750|NCT01095653|580742838|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
160824751|NCT01095653|580742839|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
160824752|NCT02046226|580742840|FG000|Overall Study|Lost to Follow-up|7|||
160824753|NCT02692040|580742844|FG000|Overall Study|Protocol Violation|0|||
160824754|NCT02692040|580742845|FG001|Overall Study|Protocol Violation|0|||
160824755|NCT02692040|580742846|FG002|Overall Study|Protocol Violation|0|||
160824756|NCT02692040|580742847|FG003|Overall Study|Protocol Violation|0|||
160824757|NCT02692040|580742848|FG004|Overall Study|Protocol Violation|0|||
160824758|NCT02692040|580742849|FG005|Overall Study|Protocol Violation|0|||
160824759|NCT02692040|580742850|FG006|Overall Study|Protocol Violation|0|||
160824760|NCT02692040|580742851|FG007|Overall Study|Protocol Violation|0|||
160824761|NCT02692040|580742852|FG008|Overall Study|Protocol Violation|0|||
160824762|NCT02692040|580742853|FG009|Overall Study|Protocol Violation|0|||
160824763|NCT02692040|580742854|FG010|Overall Study|Protocol Violation|0|||
160824764|NCT02692040|580742855|FG011|Overall Study|Protocol Violation|0|||
160824765|NCT02692040|580742856|FG012|Overall Study|Protocol Violation|1|||
160902022|NCT03758443|581035960|FG002|Extended Induction Period|Miscellaneous|0|||
160902023|NCT03758443|581035961|FG003|Extended Induction Period|Miscellaneous|0|||
160902024|NCT03758443|581035958|FG000|Maintenance Period|Adverse Event|1|||
160554053|NCT00865020|579753611|FG000|Overall Study|Administrative problems|0|||
160554054|NCT00865020|579753612|FG001|Overall Study|Administrative problems|2|||
160554055|NCT00865020|579753611|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160554056|NCT00865020|579753612|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160646533|NCT00989261|580088276|FG000|Overall Study|Still in follow up|12|||
160824766|NCT02692040|580742857|FG013|Overall Study|Protocol Violation|0|||
160824767|NCT02692040|580742858|FG014|Overall Study|Protocol Violation|0|||
160824768|NCT02692040|580742859|FG015|Overall Study|Protocol Violation|0|||
160824769|NCT02692040|580742860|FG016|Overall Study|Protocol Violation|0|||
160824770|NCT02692040|580742844|FG000|Overall Study|Adverse Event|0|||
160824771|NCT02692040|580742845|FG001|Overall Study|Adverse Event|0|||
160824772|NCT02692040|580742846|FG002|Overall Study|Adverse Event|0|||
160902025|NCT03758443|581035959|FG001|Maintenance Period|Adverse Event|2|||
160989916|NCT03681691|581351689|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
160554057|NCT00865020|579753611|FG000|Overall Study|Death|0|||
160646534|NCT00989261|580088277|FG001|Overall Study|Still in follow up|21|||
160554058|NCT00865020|579753612|FG001|Overall Study|Death|1|||
160646535|NCT00989261|580088276|FG000|Overall Study|Withdrawal by Subject|0|||
160646536|NCT00989261|580088277|FG001|Overall Study|Withdrawal by Subject|1|||
160824773|NCT02692040|580742847|FG003|Overall Study|Adverse Event|0|||
160824774|NCT02692040|580742848|FG004|Overall Study|Adverse Event|0|||
160824775|NCT02692040|580742849|FG005|Overall Study|Adverse Event|0|||
160824776|NCT02692040|580742850|FG006|Overall Study|Adverse Event|0|||
160824777|NCT02692040|580742851|FG007|Overall Study|Adverse Event|0|||
160824778|NCT02692040|580742852|FG008|Overall Study|Adverse Event|0|||
160824779|NCT02692040|580742853|FG009|Overall Study|Adverse Event|0|||
160824780|NCT02692040|580742854|FG010|Overall Study|Adverse Event|0|||
160824781|NCT02692040|580742855|FG011|Overall Study|Adverse Event|0|||
160824782|NCT02692040|580742856|FG012|Overall Study|Adverse Event|0|||
160824783|NCT02692040|580742857|FG013|Overall Study|Adverse Event|3|||
160824784|NCT02692040|580742858|FG014|Overall Study|Adverse Event|1|||
160989917|NCT03681691|581351690|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
160989918|NCT03613129|581351691|FG000|Pre-treatment Assessment|Protocol Violation|2|||
160989919|NCT03613129|581351692|FG001|Pre-treatment Assessment|Protocol Violation|0|||
160989920|NCT03613129|581351693|FG002|Pre-treatment Assessment|Protocol Violation|0|||
160989921|NCT03613129|581351694|FG003|Pre-treatment Assessment|Protocol Violation|0|||
160989922|NCT03613129|581351695|FG004|Pre-treatment Assessment|Protocol Violation|0|||
160989923|NCT03613129|581351691|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
160554059|NCT00865020|579753611|FG000|Overall Study|Randomized but discontinued|2|||
160554060|NCT00865020|579753612|FG001|Overall Study|Randomized but discontinued|4|||
160824785|NCT02692040|580742859|FG015|Overall Study|Adverse Event|1|||
160824786|NCT02692040|580742860|FG016|Overall Study|Adverse Event|0|||
160824787|NCT00171925|580742861|FG000|Overall Study|Adverse Event|10|||
160824788|NCT00171925|580742862|FG001|Overall Study|Adverse Event|6|||
160824789|NCT00171925|580742861|FG000|Overall Study|Protocol Violation|1|||
160824790|NCT00171925|580742862|FG001|Overall Study|Protocol Violation|1|||
160824791|NCT00171925|580742861|FG000|Overall Study|Withdrawal by Subject|6|||
160824792|NCT00171925|580742862|FG001|Overall Study|Withdrawal by Subject|9|||
160824793|NCT00171925|580742861|FG000|Overall Study|Lost to Follow-up|2|||
160824794|NCT00171925|580742862|FG001|Overall Study|Lost to Follow-up|2|||
160824795|NCT00171925|580742861|FG000|Overall Study|Administrative problems|10|||
160824796|NCT00171925|580742862|FG001|Overall Study|Administrative problems|11|||
160824797|NCT00171925|580742861|FG000|Overall Study|Death|1|||
160824798|NCT00171925|580742862|FG001|Overall Study|Death|2|||
160824799|NCT01819129|580742865|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
160902026|NCT03758443|581035960|FG002|Maintenance Period|Adverse Event|0|||
160554061|NCT02949128|579755674|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
160554062|NCT02949128|579755674|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
160902027|NCT03758443|581035961|FG003|Maintenance Period|Adverse Event|0|||
160902028|NCT03758443|581035958|FG000|Maintenance Period|Lost to Follow-up|0|||
160902029|NCT03758443|581035959|FG001|Maintenance Period|Lost to Follow-up|0|||
160902030|NCT03758443|581035960|FG002|Maintenance Period|Lost to Follow-up|0|||
160902031|NCT03758443|581035961|FG003|Maintenance Period|Lost to Follow-up|1|||
160902032|NCT03758443|581035958|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
160902033|NCT03758443|581035959|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
160902034|NCT03758443|581035960|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
160902035|NCT03758443|581035961|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
160902036|NCT03758443|581035958|FG000|Maintenance Period|Protocol Violation|0|||
160902037|NCT03758443|581035959|FG001|Maintenance Period|Protocol Violation|1|||
160902038|NCT03758443|581035960|FG002|Maintenance Period|Protocol Violation|0|||
160902039|NCT03758443|581035961|FG003|Maintenance Period|Protocol Violation|0|||
160902040|NCT03758443|581035958|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
160902041|NCT03758443|581035959|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
160902042|NCT03758443|581035960|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
160902043|NCT03758443|581035961|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
160902044|NCT03758443|581035958|FG000|Maintenance Period|Withdrawal by Subject|1|||
160989924|NCT03613129|581351692|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
160989925|NCT03613129|581351693|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
160554063|NCT02949128|579755674|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
160554064|NCT02949128|579755674|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
160554065|NCT02949128|579755674|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
160554066|NCT02949128|579755674|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
160554067|NCT02949128|579755674|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
160554068|NCT02949128|579755674|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
160902045|NCT03758443|581035959|FG001|Maintenance Period|Withdrawal by Subject|0|||
160902046|NCT03758443|581035960|FG002|Maintenance Period|Withdrawal by Subject|1|||
160902047|NCT03758443|581035961|FG003|Maintenance Period|Withdrawal by Subject|1|||
160902048|NCT03758443|581035958|FG000|Maintenance Period|Miscellaneous|0|||
160902049|NCT03758443|581035959|FG001|Maintenance Period|Miscellaneous|0|||
160902050|NCT03758443|581035960|FG002|Maintenance Period|Miscellaneous|1|||
160554069|NCT02949128|579755674|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
160902051|NCT03758443|581035961|FG003|Maintenance Period|Miscellaneous|0|||
160902052|NCT03080454|581035962|FG000|Baseline|Adverse Event|2|||
160646537|NCT00989261|580088276|FG000|Overall Study|Lost to Follow-up|3|||
160824800|NCT01819129|580742866|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
160824801|NCT01819129|580742865|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
160824802|NCT01819129|580742866|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
160824803|NCT01819129|580742865|FG000|Overall Study|Other, Subject moved out of the country|0|||
160554070|NCT02949128|579755674|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
160554071|NCT00670007|579755681|FG000|Overall Study|Drug abuse|1|||
160554072|NCT00670007|579755681|FG000|Overall Study|Lung transplant|1|||
160554073|NCT00670007|579755681|FG000|Overall Study|Travel/Vacation|1|||
160554074|NCT00670007|579755681|FG000|Overall Study|Adverse event, serious fatal|1|||
160554075|NCT00670007|579755681|FG000|Overall Study|Adverse Event|1|||
160554076|NCT00670007|579755681|FG000|Overall Study|Withdrawal by Subject|4|||
160824804|NCT01819129|580742866|FG001|Overall Study|Other, Subject moved out of the country|1|||
160824805|NCT01819129|580742865|FG000|Overall Study|Withdrawal by Subject|15|||
160824806|NCT01819129|580742866|FG001|Overall Study|Withdrawal by Subject|15|||
160824807|NCT01819129|580742865|FG000|Overall Study|Lost to Follow-up|5|||
160824808|NCT01819129|580742866|FG001|Overall Study|Lost to Follow-up|2|||
160824809|NCT01819129|580742865|FG000|Overall Study|Lack of Efficacy|0|||
160824810|NCT01819129|580742866|FG001|Overall Study|Lack of Efficacy|1|||
160824811|NCT01819129|580742865|FG000|Overall Study|Adverse Event|1|||
160824812|NCT01819129|580742866|FG001|Overall Study|Adverse Event|4|||
160824813|NCT01819129|580742865|FG000|Overall Study|Death|1|||
160824814|NCT01819129|580742866|FG001|Overall Study|Death|1|||
160824815|NCT01819129|580742865|FG000|Overall Study|Withdrawal Criteria|20|||
160824816|NCT01819129|580742866|FG001|Overall Study|Withdrawal Criteria|15|||
160824817|NCT02752958|580742868|FG000|Overall Study|Adverse Event|3|||
160824818|NCT02752958|580742868|FG000|Overall Study|Lost to Follow-up|1|||
160824819|NCT02752958|580742868|FG000|Overall Study|Protocol Violation|1|||
160824820|NCT02752958|580742868|FG000|Overall Study|Withdrawal by Subject|2|||
160824821|NCT02752958|580742868|FG000|Overall Study|Other (Reason not specified)|2|||
160824822|NCT00054691|580742871|FG000|Overall Study|Unmeasurable Disease|2|||
160824823|NCT00054691|580742871|FG000|Overall Study|Noncompliant|1|||
160824824|NCT02836873|580742878|FG000|Overall Study|Protocol Violation|0|||
160824825|NCT02836873|580742879|FG001|Overall Study|Protocol Violation|1|||
160824826|NCT02836873|580742878|FG000|Overall Study|Adverse Event|1|||
160824827|NCT02836873|580742879|FG001|Overall Study|Adverse Event|4|||
160824828|NCT02836873|580742878|FG000|Overall Study|Withdrawal by Subject|2|||
160824829|NCT02836873|580742879|FG001|Overall Study|Withdrawal by Subject|2|||
160824830|NCT02836873|580742878|FG000|Overall Study|Lost to Follow-up|1|||
160824831|NCT02836873|580742879|FG001|Overall Study|Lost to Follow-up|3|||
160824832|NCT02836873|580742878|FG000|Overall Study|Physician Decision|0|||
160824833|NCT02836873|580742879|FG001|Overall Study|Physician Decision|1|||
160824834|NCT02836873|580742878|FG000|Overall Study|Other|1|||
160824835|NCT02836873|580742879|FG001|Overall Study|Other|0|||
160824836|NCT00853125|580742882|FG000|Overall Study|Study participant's donor was CMV +|1|||
160824837|NCT02914548|580742887|FG000|Overall Study|Adverse Event|15|||
160554077|NCT00618722|579755682|FG000|Overall Study|Refusal of Treatment|0|||
160554078|NCT00618722|579755683|FG001|Overall Study|Refusal of Treatment|0|||
160554079|NCT00618722|579755684|FG002|Overall Study|Refusal of Treatment|1|||
160554080|NCT00618722|579755685|FG003|Overall Study|Refusal of Treatment|0|||
160554081|NCT00618722|579755682|FG000|Overall Study|Patient Request|1|||
160554082|NCT00618722|579755683|FG001|Overall Study|Patient Request|1|||
160554083|NCT00618722|579755684|FG002|Overall Study|Patient Request|1|||
160554084|NCT00618722|579755685|FG003|Overall Study|Patient Request|1|||
160554085|NCT00618722|579755682|FG000|Overall Study|Inability to Complete Study Procedure|0|||
160554086|NCT00618722|579755683|FG001|Overall Study|Inability to Complete Study Procedure|1|||
160554087|NCT00618722|579755684|FG002|Overall Study|Inability to Complete Study Procedure|0|||
160554088|NCT00618722|579755685|FG003|Overall Study|Inability to Complete Study Procedure|0|||
160554089|NCT00618722|579755682|FG000|Overall Study|Lost to Follow-up|2|||
160554090|NCT00618722|579755683|FG001|Overall Study|Lost to Follow-up|0|||
160554091|NCT00618722|579755684|FG002|Overall Study|Lost to Follow-up|0|||
160554092|NCT00618722|579755685|FG003|Overall Study|Lost to Follow-up|2|||
160554093|NCT00618722|579755682|FG000|Overall Study|Miscellaneous Reasons|0|||
160554094|NCT00618722|579755683|FG001|Overall Study|Miscellaneous Reasons|0|||
160554095|NCT00618722|579755684|FG002|Overall Study|Miscellaneous Reasons|1|||
160554096|NCT00618722|579755685|FG003|Overall Study|Miscellaneous Reasons|1|||
160554097|NCT00127127|579755688|FG000|Overall Study|Adverse Event|0|||
160646538|NCT00989261|580088277|FG001|Overall Study|Lost to Follow-up|0|||
160646539|NCT00782509|580088278|FG000|Overall Study|Adverse Event|20|||
160646540|NCT00782509|580088279|FG001|Overall Study|Adverse Event|10|||
160646541|NCT00782509|580088280|FG002|Overall Study|Adverse Event|20|||
160824838|NCT02914548|580742888|FG001|Overall Study|Adverse Event|7|||
160824839|NCT02914548|580742889|FG002|Overall Study|Adverse Event|15|||
160902053|NCT03080454|581035962|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
160554098|NCT00127127|579755689|FG001|Overall Study|Adverse Event|2|||
160554099|NCT00127127|579755690|FG002|Overall Study|Adverse Event|0|||
160824840|NCT02914548|580742887|FG000|Overall Study|Physician Decision|2|||
160824841|NCT02914548|580742888|FG001|Overall Study|Physician Decision|2|||
160824842|NCT02914548|580742889|FG002|Overall Study|Physician Decision|0|||
160824843|NCT02914548|580742887|FG000|Overall Study|Protocol Violation|1|||
160824844|NCT02914548|580742888|FG001|Overall Study|Protocol Violation|0|||
160824845|NCT02914548|580742889|FG002|Overall Study|Protocol Violation|0|||
160902054|NCT03080454|581035962|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
160824846|NCT02914548|580742887|FG000|Overall Study|Withdrawal by Subject|3|||
160989926|NCT03613129|581351694|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
160989927|NCT03613129|581351695|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
160989928|NCT02334306|581351696|FG000|Double-blind Period|Adverse Event|0|||
160989929|NCT02334306|581351697|FG001|Double-blind Period|Adverse Event|1|||
160989930|NCT02334306|581351696|FG000|Double-blind Period|Withdrawal by Subject|1|||
160989931|NCT02334306|581351697|FG001|Double-blind Period|Withdrawal by Subject|1|||
160989932|NCT01687270|581351698|FG000|Overall Study|Lack of Efficacy|11|||
160989933|NCT01687270|581351698|FG000|Overall Study|Lost to Follow-up|1|||
160989934|NCT00465985|581351699|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
160989935|NCT00465985|581351700|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
160989936|NCT00465985|581351699|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
160824847|NCT02914548|580742888|FG001|Overall Study|Withdrawal by Subject|4|||
160824848|NCT02914548|580742889|FG002|Overall Study|Withdrawal by Subject|4|||
160824849|NCT02914548|580742887|FG000|Overall Study|>40% of body surface area|0|||
160824850|NCT02914548|580742888|FG001|Overall Study|>40% of body surface area|1|||
160824851|NCT02914548|580742889|FG002|Overall Study|>40% of body surface area|1|||
160824852|NCT03746600|580742890|FG000|Overall Study|Withdrawal by Subject|3|||
160824853|NCT03746600|580742891|FG001|Overall Study|Withdrawal by Subject|3|||
160824854|NCT03746600|580742890|FG000|Overall Study|dismissed from study|1|||
160824855|NCT03746600|580742891|FG001|Overall Study|dismissed from study|0|||
160824856|NCT03746600|580742890|FG000|Overall Study|Lost to Follow-up|1|||
160824857|NCT03746600|580742891|FG001|Overall Study|Lost to Follow-up|0|||
160824858|NCT01371643|580742899|FG000|Overall Study|Withdrawal by Subject|3|||
160824859|NCT01371643|580742900|FG001|Overall Study|Withdrawal by Subject|0|||
160824860|NCT02374814|580742901|FG000|Overall Study|Lost to Follow-up|1|||
160824861|NCT02374814|580742902|FG001|Overall Study|Lost to Follow-up|1|||
160824862|NCT02374814|580742903|FG002|Overall Study|Lost to Follow-up|0|||
160824863|NCT02374814|580742904|FG003|Overall Study|Lost to Follow-up|1|||
160824864|NCT02374814|580742905|FG004|Overall Study|Lost to Follow-up|0|||
160824865|NCT02374814|580742906|FG005|Overall Study|Lost to Follow-up|0|||
160824866|NCT02374814|580742901|FG000|Overall Study|Withdrawal by Subject|0|||
160824867|NCT02374814|580742902|FG001|Overall Study|Withdrawal by Subject|0|||
160824868|NCT02374814|580742903|FG002|Overall Study|Withdrawal by Subject|1|||
160824869|NCT02374814|580742904|FG003|Overall Study|Withdrawal by Subject|1|||
160824870|NCT02374814|580742905|FG004|Overall Study|Withdrawal by Subject|0|||
160824871|NCT02374814|580742906|FG005|Overall Study|Withdrawal by Subject|0|||
160824872|NCT00884039|580742907|FG000|Overall Study|Withdrawal by Subject|0|||
160824873|NCT00884039|580742908|FG001|Overall Study|Withdrawal by Subject|1|||
160824874|NCT00884039|580742907|FG000|Overall Study|Lack of Efficacy|2|||
160824875|NCT00884039|580742908|FG001|Overall Study|Lack of Efficacy|0|||
160824876|NCT05291936|580742909|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160824877|NCT05291936|580742910|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
160824878|NCT05291936|580742909|FG000|Period 1|Withdrew Consent during study|1|||
160824879|NCT05291936|580742910|FG001|Period 1|Withdrew Consent during study|0|||
160824880|NCT05291936|580742909|FG000|Period 2|Adverse Event|0|||
160824881|NCT05291936|580742910|FG001|Period 2|Adverse Event|1|||
160824882|NCT05291936|580742909|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
160824883|NCT05291936|580742910|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160824884|NCT01300819|580742911|FG000|Overall Study|Adverse Event|9|||
160824885|NCT01300819|580742912|FG001|Overall Study|Adverse Event|27|||
160824886|NCT01300819|580742911|FG000|Overall Study|Lack of Efficacy|2|||
160824887|NCT01300819|580742912|FG001|Overall Study|Lack of Efficacy|1|||
160824888|NCT01300819|580742911|FG000|Overall Study|Withdrawal by Subject|10|||
160989937|NCT00465985|581351700|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
160989938|NCT00465985|581351699|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
160989939|NCT00465985|581351700|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
160989940|NCT00465985|581351699|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
160989941|NCT00465985|581351700|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
160989942|NCT02534896|581351701|FG000|Overall Study|Adverse Event|2|||
160989943|NCT02534896|581351702|FG001|Overall Study|Adverse Event|1|||
160989944|NCT02534896|581351703|FG002|Overall Study|Adverse Event|1|||
160824889|NCT01300819|580742912|FG001|Overall Study|Withdrawal by Subject|12|||
160989945|NCT02534896|581351701|FG000|Overall Study|Insufficient therapeutic response|2|||
160824890|NCT01300819|580742911|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
160824891|NCT01300819|580742912|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
160824892|NCT01300819|580742911|FG000|Overall Study|Refusal to down titrate study drug|0|||
160824893|NCT01300819|580742912|FG001|Overall Study|Refusal to down titrate study drug|1|||
160824894|NCT01300819|580742911|FG000|Overall Study|Administrative reason|0|||
160824895|NCT01300819|580742912|FG001|Overall Study|Administrative reason|1|||
160824896|NCT01300819|580742911|FG000|Overall Study|Safety follow up not done by mistake|0|||
160554100|NCT00127127|579755691|FG003|Overall Study|Adverse Event|1|||
160554101|NCT00127127|579755688|FG000|Overall Study|Lack of Efficacy|1|||
160554102|NCT00127127|579755689|FG001|Overall Study|Lack of Efficacy|3|||
160554103|NCT00127127|579755690|FG002|Overall Study|Lack of Efficacy|0|||
160554104|NCT00127127|579755691|FG003|Overall Study|Lack of Efficacy|2|||
160554105|NCT00200057|579755692|FG000|Overall Study|Lack of Efficacy|3|||
160554106|NCT00200057|579755692|FG000|Overall Study|Exited due to terminal illness of PI|2|||
160554107|NCT00200057|579755692|FG000|Overall Study|Withdrawal by Subject|1|||
160554108|NCT00200057|579755692|FG000|Overall Study|Change in medical condition|1|||
160554109|NCT00200057|579755692|FG000|Overall Study|Infection|1|||
160554110|NCT00200057|579755692|FG000|Overall Study|Death|1|||
160554111|NCT01059448|579755694|FG000|Overall Study|Adverse Event|1|||
160554112|NCT01059448|579755695|FG001|Overall Study|Adverse Event|3|||
160554113|NCT01059448|579755696|FG002|Overall Study|Adverse Event|0|||
160554114|NCT01059448|579755697|FG003|Overall Study|Adverse Event|1|||
160554115|NCT01059448|579755694|FG000|Overall Study|Withdrawal by Subject|2|||
160554116|NCT01059448|579755695|FG001|Overall Study|Withdrawal by Subject|0|||
160554117|NCT01059448|579755696|FG002|Overall Study|Withdrawal by Subject|2|||
160554118|NCT01059448|579755697|FG003|Overall Study|Withdrawal by Subject|4|||
160554119|NCT01059448|579755694|FG000|Overall Study|Disease Progression|2|||
160554120|NCT01059448|579755695|FG001|Overall Study|Disease Progression|1|||
160554121|NCT01059448|579755696|FG002|Overall Study|Disease Progression|4|||
160554122|NCT01059448|579755697|FG003|Overall Study|Disease Progression|2|||
160554123|NCT01059448|579755694|FG000|Overall Study|Administrative Decision|43|||
160554124|NCT01059448|579755695|FG001|Overall Study|Administrative Decision|49|||
160554125|NCT01059448|579755696|FG002|Overall Study|Administrative Decision|45|||
160554126|NCT01059448|579755697|FG003|Overall Study|Administrative Decision|46|||
160554127|NCT01059448|579755694|FG000|Overall Study|Lost to Follow-up|0|||
160554128|NCT01059448|579755695|FG001|Overall Study|Lost to Follow-up|0|||
160554129|NCT01059448|579755696|FG002|Overall Study|Lost to Follow-up|2|||
160554130|NCT01059448|579755697|FG003|Overall Study|Lost to Follow-up|0|||
160554131|NCT01059448|579755694|FG000|Overall Study|Death|0|||
160554132|NCT01059448|579755695|FG001|Overall Study|Death|1|||
160554133|NCT01059448|579755696|FG002|Overall Study|Death|0|||
160554134|NCT01059448|579755697|FG003|Overall Study|Death|0|||
160554135|NCT01059448|579755694|FG000|Overall Study|Other|1|||
160554136|NCT01059448|579755695|FG001|Overall Study|Other|1|||
160554137|NCT01059448|579755696|FG002|Overall Study|Other|0|||
160554138|NCT01059448|579755697|FG003|Overall Study|Other|1|||
160554139|NCT00778830|579755698|FG000|Overall Study|Ongoing at data cut-off|0|||
160554140|NCT00778830|579755699|FG001|Overall Study|Ongoing at data cut-off|1|||
160554141|NCT05512949|579755700|FG000|Overall Study|Lost to Follow-up|4|||
160554142|NCT05512949|579755701|FG001|Overall Study|Lost to Follow-up|6|||
160554143|NCT05512949|579755702|FG002|Overall Study|Lost to Follow-up|2|||
160554144|NCT05512949|579755700|FG000|Overall Study|Protocol Violation|0|||
160554145|NCT05512949|579755701|FG001|Overall Study|Protocol Violation|0|||
160554146|NCT05512949|579755702|FG002|Overall Study|Protocol Violation|1|||
160554147|NCT05512949|579755700|FG000|Overall Study|Withdrawal by Subject|1|||
160554148|NCT05512949|579755701|FG001|Overall Study|Withdrawal by Subject|1|||
160554149|NCT05512949|579755702|FG002|Overall Study|Withdrawal by Subject|2|||
160554150|NCT05512949|579755700|FG000|Overall Study|Completion status unknown|1|||
160554151|NCT05512949|579755701|FG001|Overall Study|Completion status unknown|3|||
160554152|NCT05512949|579755702|FG002|Overall Study|Completion status unknown|0|||
160554153|NCT01891643|579755703|FG000|Overall Study|Adverse event unrelated to study drug|2|||
160554154|NCT01891643|579755704|FG001|Overall Study|Adverse event unrelated to study drug|5|||
160554155|NCT01891643|579755703|FG000|Overall Study|Disease Progression|4|||
160824897|NCT01300819|580742912|FG001|Overall Study|Safety follow up not done by mistake|1|||
160824898|NCT01300819|580742911|FG000|Overall Study|Follow up call was not done|1|||
160824899|NCT01300819|580742912|FG001|Overall Study|Follow up call was not done|0|||
160824900|NCT02534935|580744900|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
160824901|NCT02534935|580744901|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
160554156|NCT01891643|579755704|FG001|Overall Study|Disease Progression|3|||
160554157|NCT01891643|579755703|FG000|Overall Study|Study Drug Toxicity|3|||
160554158|NCT01891643|579755704|FG001|Overall Study|Study Drug Toxicity|0|||
160554159|NCT01891643|579755703|FG000|Overall Study|Maximum Clinical Benefit|0|||
160554160|NCT01891643|579755704|FG001|Overall Study|Maximum Clinical Benefit|1|||
160554161|NCT01891643|579755703|FG000|Overall Study|Poor/Non-compliance|0|||
160554162|NCT01891643|579755704|FG001|Overall Study|Poor/Non-compliance|1|||
160554163|NCT01891643|579755703|FG000|Overall Study|Participant request to discontinue|1|||
160554164|NCT01891643|579755704|FG001|Overall Study|Participant request to discontinue|0|||
160554165|NCT04047797|579755707|FG000|Overall Study|Progressive Disease|1|||
160554166|NCT00772629|579755708|FG000|Overall Study|Subject was not vaccinated|1|||
160554167|NCT00772629|579755709|FG001|Overall Study|Subject was not vaccinated|0|||
160554168|NCT00132041|579755716|FG000|Baseline|Ineligible|6|||
160554169|NCT00132041|579755716|FG000|3 Months Post Ablation|Transplant|1|||
160554170|NCT00132041|579755716|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
160554171|NCT00132041|579755716|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
160824902|NCT02534935|580744902|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
160824903|NCT02534935|580744900|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
160824904|NCT02534935|580744901|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
160824905|NCT02534935|580744902|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
160824906|NCT02534935|580744900|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
160824907|NCT02534935|580744901|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
160824908|NCT02534935|580744902|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
160824909|NCT02534935|580744900|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
160824910|NCT02534935|580744901|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
160824911|NCT02534935|580744902|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
160824912|NCT02534935|580744900|FG000|Stage 1: 24 Months|Adverse Event|0|||
160824913|NCT02534935|580744901|FG001|Stage 1: 24 Months|Adverse Event|2|||
160824914|NCT02534935|580744902|FG002|Stage 1: 24 Months|Adverse Event|0|||
160824915|NCT02534935|580744900|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
160824916|NCT02534935|580744901|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
160824917|NCT02534935|580744902|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
160824918|NCT02534935|580744900|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
160824919|NCT02534935|580744901|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
160824920|NCT02534935|580744902|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
160824921|NCT03602885|580744903|FG000|Overall Study|Lost to Follow-up|3|||
160824922|NCT03602885|580744904|FG001|Overall Study|Lost to Follow-up|0|||
160824923|NCT01007123|580744909|FG000|Overall Study|Adverse Event|3|||
160824924|NCT01007123|580744910|FG001|Overall Study|Adverse Event|4|||
160824925|NCT01007123|580744911|FG002|Overall Study|Adverse Event|7|||
160824926|NCT01007123|580744912|FG003|Overall Study|Adverse Event|1|||
160824927|NCT01007123|580744909|FG000|Overall Study|Lack of Efficacy|1|||
160824928|NCT01007123|580744910|FG001|Overall Study|Lack of Efficacy|0|||
160824929|NCT01007123|580744911|FG002|Overall Study|Lack of Efficacy|1|||
160824930|NCT01007123|580744912|FG003|Overall Study|Lack of Efficacy|4|||
160824931|NCT01007123|580744909|FG000|Overall Study|Protocol Violation|1|||
160824932|NCT01007123|580744910|FG001|Overall Study|Protocol Violation|1|||
160824933|NCT01007123|580744911|FG002|Overall Study|Protocol Violation|2|||
160824934|NCT01007123|580744912|FG003|Overall Study|Protocol Violation|1|||
160824935|NCT01007123|580744909|FG000|Overall Study|Withdrawal by Subject|1|||
160824936|NCT01007123|580744910|FG001|Overall Study|Withdrawal by Subject|0|||
160824937|NCT01007123|580744911|FG002|Overall Study|Withdrawal by Subject|1|||
160824938|NCT01007123|580744912|FG003|Overall Study|Withdrawal by Subject|0|||
160824939|NCT01007123|580744909|FG000|Overall Study|Lost to Follow-up|0|||
160824940|NCT01007123|580744910|FG001|Overall Study|Lost to Follow-up|1|||
160824941|NCT01007123|580744911|FG002|Overall Study|Lost to Follow-up|0|||
160824942|NCT01007123|580744912|FG003|Overall Study|Lost to Follow-up|0|||
160824943|NCT02838901|580744913|FG000|Overall Study|Withdrawal by Subject|1|||
160824944|NCT02838901|580744914|FG001|Overall Study|Withdrawal by Subject|1|||
160824945|NCT02838901|580744913|FG000|Overall Study|Lost to Follow-up|1|||
160824946|NCT02838901|580744914|FG001|Overall Study|Lost to Follow-up|1|||
160902055|NCT02747875|581035963|FG000|Overall Study|Physician Decision|1|||
160902056|NCT02747875|581035964|FG001|Overall Study|Physician Decision|0|||
160902057|NCT02747875|581035963|FG000|Overall Study|Adverse Event|0|||
160902058|NCT02747875|581035964|FG001|Overall Study|Adverse Event|1|||
160902059|NCT00762385|581035965|FG000|First Intervention|Lens Issue|1|||
160902060|NCT00762385|581035966|FG001|First Intervention|Lens Issue|1|||
160902061|NCT00762385|581035965|FG000|First Intervention|Lost to Follow-up|0|||
160902062|NCT00762385|581035966|FG001|First Intervention|Lost to Follow-up|2|||
160902063|NCT00762385|581035965|FG000|First Intervention|Ineligible|1|||
160902064|NCT00762385|581035966|FG001|First Intervention|Ineligible|0|||
160902065|NCT00762385|581035965|FG000|First Intervention|Protocol Violation|0|||
160902066|NCT00762385|581035966|FG001|First Intervention|Protocol Violation|1|||
160902067|NCT00762385|581035965|FG000|Second Intervention|Protocol Violation|3|||
160902068|NCT00762385|581035966|FG001|Second Intervention|Protocol Violation|3|||
160902069|NCT03863197|581035970|FG000|Overall Study|Lost to Follow-up|2|||
160902070|NCT03863197|581035971|FG001|Overall Study|Lost to Follow-up|3|||
160902071|NCT03863197|581035970|FG000|Overall Study|Withdrawal by Subject|4|||
160902072|NCT03863197|581035971|FG001|Overall Study|Withdrawal by Subject|0|||
160824947|NCT02680041|580744915|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
160824948|NCT02680041|580744915|FG000|Overall Study|Lost to Follow-up|2|||
160824949|NCT04431713|580744916|FG000|Overall Study|Withdrawal by Subject|2|||
160902073|NCT03863197|581035970|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
160902074|NCT03863197|581035971|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
160824950|NCT04431713|580744917|FG001|Overall Study|Withdrawal by Subject|0|||
160824951|NCT04431713|580744916|FG000|Overall Study|Death|2|||
160824952|NCT04431713|580744917|FG001|Overall Study|Death|2|||
160902075|NCT01058655|581035975|FG000|Overall Study|Withdrawal by Subject|1|||
160824953|NCT01344538|580744918|FG000|Overall Study|Adverse Event|1|||
160824954|NCT01344538|580744919|FG001|Overall Study|Adverse Event|1|||
160824955|NCT01344538|580744918|FG000|Overall Study|Lost to Follow-up|1|||
160824956|NCT01344538|580744919|FG001|Overall Study|Lost to Follow-up|0|||
160824957|NCT04195438|580744924|FG000|Overall Study|Withdrawal by Subject|1|||
160824958|NCT00613925|580744925|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
160824959|NCT00613925|580744926|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
160824960|NCT01156389|580744927|FG000|Overall Study|Elevated liver enzymes|4|||
160824961|NCT01156389|580744928|FG001|Overall Study|Elevated liver enzymes|0|||
160824962|NCT01156389|580744927|FG000|Overall Study|Vomiting|0|||
160824963|NCT01156389|580744928|FG001|Overall Study|Vomiting|1|||
160824964|NCT00350623|580744931|FG000|Overall Study|Lost to Follow-up|8|||
160824965|NCT00350623|580744932|FG001|Overall Study|Lost to Follow-up|3|||
160824966|NCT00350623|580744933|FG002|Overall Study|Lost to Follow-up|4|||
160824967|NCT00350623|580744931|FG000|Overall Study|Withdrawal by Subject|0|||
160824968|NCT00350623|580744932|FG001|Overall Study|Withdrawal by Subject|1|||
160824969|NCT00350623|580744933|FG002|Overall Study|Withdrawal by Subject|1|||
160824970|NCT00350623|580744931|FG000|Overall Study|patient traveling outside the country|0|||
160824971|NCT00350623|580744932|FG001|Overall Study|patient traveling outside the country|0|||
160824972|NCT00350623|580744933|FG002|Overall Study|patient traveling outside the country|1|||
160824973|NCT00937404|580744936|FG000|Overall Study|Protocol Violation|1|||
160824974|NCT00937404|580744936|FG000|Overall Study|Withdrawal by Subject|1|||
160824975|NCT00090233|580744943|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
160824976|NCT00090233|580744944|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
160824977|NCT00090233|580744943|FG000|Overall Study|Adverse Event|214|||
160824978|NCT00090233|580744944|FG001|Overall Study|Adverse Event|198|||
160824979|NCT00090233|580744943|FG000|Overall Study|Lost to Follow-up|68|||
160824980|NCT00090233|580744944|FG001|Overall Study|Lost to Follow-up|95|||
160824981|NCT00090233|580744943|FG000|Overall Study|Protocol Violation|960|||
160824982|NCT00090233|580744944|FG001|Overall Study|Protocol Violation|1022|||
160824983|NCT00090233|580744943|FG000|Overall Study|Withdrawal by Subject|182|||
160824984|NCT00090233|580744944|FG001|Overall Study|Withdrawal by Subject|211|||
160824985|NCT00090233|580744943|FG000|Overall Study|Moved|203|||
160824986|NCT00090233|580744944|FG001|Overall Study|Moved|189|||
160824987|NCT00090233|580744943|FG000|Overall Study|Other|1211|||
160824988|NCT00090233|580744944|FG001|Overall Study|Other|1160|||
160824989|NCT00090233|580744943|FG000|Overall Study|Data not available at data cut-off point|1552|||
160824990|NCT00090233|580744944|FG001|Overall Study|Data not available at data cut-off point|1563|||
160824991|NCT04863248|580744945|FG000|Overall Study|Sponsor Terminated|4|||
160824992|NCT04863248|580744946|FG001|Overall Study|Sponsor Terminated|1|||
160824993|NCT04863248|580744945|FG000|Overall Study|Death|0|||
160824994|NCT04863248|580744946|FG001|Overall Study|Death|1|||
160824995|NCT04863248|580744945|FG000|Overall Study|Withdrawal by Subject|0|||
160824996|NCT04863248|580744946|FG001|Overall Study|Withdrawal by Subject|1|||
160824997|NCT02536300|580744947|FG000|Overall Study|Investigator's Discretion|17|||
160824998|NCT02536300|580744948|FG001|Overall Study|Investigator's Discretion|11|||
160824999|NCT02536300|580744949|FG002|Overall Study|Investigator's Discretion|2|||
160825000|NCT02536300|580744947|FG000|Overall Study|Progressive Disease|11|||
160825001|NCT02536300|580744948|FG001|Overall Study|Progressive Disease|7|||
160825002|NCT02536300|580744949|FG002|Overall Study|Progressive Disease|6|||
160825003|NCT02536300|580744947|FG000|Overall Study|Study Terminated by Sponsor|6|||
160825004|NCT02536300|580744948|FG001|Overall Study|Study Terminated by Sponsor|4|||
160825005|NCT02536300|580744949|FG002|Overall Study|Study Terminated by Sponsor|7|||
160825006|NCT02536300|580744947|FG000|Overall Study|Death|7|||
160825007|NCT02536300|580744948|FG001|Overall Study|Death|0|||
160825008|NCT02536300|580744949|FG002|Overall Study|Death|5|||
160825009|NCT02536300|580744947|FG000|Overall Study|Withdrew Consent|4|||
160902076|NCT01058655|581035976|FG001|Overall Study|Withdrawal by Subject|0|||
160902077|NCT01058655|581035977|FG002|Overall Study|Withdrawal by Subject|3|||
160902078|NCT01058655|581035978|FG003|Overall Study|Withdrawal by Subject|4|||
160825010|NCT02536300|580744948|FG001|Overall Study|Withdrew Consent|2|||
160825011|NCT02536300|580744949|FG002|Overall Study|Withdrew Consent|0|||
160825012|NCT02536300|580744947|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
160825013|NCT02536300|580744948|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
160825014|NCT02536300|580744949|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
160825015|NCT02536300|580744947|FG000|Overall Study|Enrolled but Never Treated|0|||
160825016|NCT02536300|580744948|FG001|Overall Study|Enrolled but Never Treated|0|||
160825017|NCT02536300|580744949|FG002|Overall Study|Enrolled but Never Treated|1|||
160825018|NCT02536300|580744947|FG000|Overall Study|Non-compliance With Study Drug|1|||
160825019|NCT02536300|580744948|FG001|Overall Study|Non-compliance With Study Drug|0|||
160825020|NCT02536300|580744949|FG002|Overall Study|Non-compliance With Study Drug|0|||
160825021|NCT02536300|580744947|FG000|Overall Study|Protocol Violation|0|||
160825022|NCT02536300|580744948|FG001|Overall Study|Protocol Violation|1|||
160825023|NCT02536300|580744949|FG002|Overall Study|Protocol Violation|0|||
160825024|NCT01779869|580744950|FG000|Overall Study|Physician Decision|2|||
160902079|NCT01058655|581035975|FG000|Overall Study|Prolonged Treatment Delay|0|||
160825025|NCT01691105|580744958|FG000|1 Month Follow-up|Lost to Follow-up|41|||
160825026|NCT01691105|580744959|FG001|1 Month Follow-up|Lost to Follow-up|38|||
160825027|NCT01691105|580744958|FG000|1 Month Follow-up|Death|2|||
160825028|NCT01691105|580744959|FG001|1 Month Follow-up|Death|3|||
160825029|NCT01691105|580744958|FG000|6 Month Follow-up|Lost to Follow-up|39|||
160825030|NCT01691105|580744959|FG001|6 Month Follow-up|Lost to Follow-up|58|||
160825031|NCT01691105|580744958|FG000|6 Month Follow-up|Death|13|||
160825032|NCT01691105|580744959|FG001|6 Month Follow-up|Death|13|||
160825033|NCT01691105|580744958|FG000|12 Month Follow-up|Lost to Follow-up|50|||
160825034|NCT01691105|580744959|FG001|12 Month Follow-up|Lost to Follow-up|71|||
160825035|NCT01691105|580744958|FG000|12 Month Follow-up|Death|22|||
160825036|NCT01691105|580744959|FG001|12 Month Follow-up|Death|30|||
160825037|NCT01691105|580744958|FG000|12 Month Biochemical Verification|Death|22|||
160825038|NCT01691105|580744959|FG001|12 Month Biochemical Verification|Death|30|||
160825039|NCT01691105|580744958|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
160825040|NCT01691105|580744959|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
160825041|NCT01691105|580744958|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
160825042|NCT01691105|580744959|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
160825043|NCT00957944|580744960|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
160825044|NCT00957944|580744961|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
160825045|NCT01482169|580744963|FG000|Overall Study|Physician Decision|2|||
160825046|NCT00445848|580744966|FG000|Overall Study|Adverse Event|14|||
160825047|NCT00445848|580744966|FG000|Overall Study|Withdrawal by Subject|4|||
160825048|NCT00445848|580744966|FG000|Overall Study|Progression|62|||
160825049|NCT00445848|580744966|FG000|Overall Study|Other-Not protocol specified|5|||
160825050|NCT01777542|580744967|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
160825051|NCT01777542|580744968|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
160825052|NCT05605691|580744971|FG000|Overall Study|Lost to Follow-up|1|||
160825053|NCT01030874|580744972|FG000|Overall Study|Withdrawal by Subject|1|||
160825054|NCT01030874|580744973|FG001|Overall Study|Withdrawal by Subject|0|||
160825055|NCT01030874|580744972|FG000|Overall Study|Discharged in first 2 weeks|17|||
160825056|NCT01030874|580744973|FG001|Overall Study|Discharged in first 2 weeks|16|||
160825057|NCT02279719|580744974|FG000|Overall Study|Patients randomized but never treated|0|||
160825058|NCT02279719|580744975|FG001|Overall Study|Patients randomized but never treated|0|||
160825059|NCT02279719|580744976|FG002|Overall Study|Patients randomized but never treated|0|||
160825060|NCT02279719|580744977|FG003|Overall Study|Patients randomized but never treated|0|||
160825061|NCT02279719|580744978|FG004|Overall Study|Patients randomized but never treated|3|||
160825062|NCT02279719|580744979|FG005|Overall Study|Patients randomized but never treated|0|||
160825063|NCT02279719|580744980|FG006|Overall Study|Patients randomized but never treated|3|||
160825064|NCT04706273|580744981|FG000|Overall Study|Withdrawal by Subject|27|||
160825065|NCT04706273|580744981|FG000|Overall Study|Physician Decision|1|||
160825066|NCT04706273|580744981|FG000|Overall Study|Lost to Follow-up|42|||
160825067|NCT04706273|580744981|FG000|Overall Study|Death|85|||
160825068|NCT04706273|580744981|FG000|Overall Study|Amputation that removes study device|2|||
160825069|NCT04706273|580744981|FG000|Overall Study|Surgical bypass|3|||
160825070|NCT04706273|580744981|FG000|Overall Study|Changing hospital|23|||
160825071|NCT04706273|580744981|FG000|Overall Study|Unable to attend hospital|2|||
160825072|NCT03541187|580744984|FG000|Overall Study|Lost to Follow-up|2|||
160825073|NCT03541187|580744985|FG001|Overall Study|Lost to Follow-up|6|||
160825074|NCT03541187|580744984|FG000|Overall Study|Pregnancy|0|||
160825075|NCT03541187|580744985|FG001|Overall Study|Pregnancy|1|||
160825076|NCT03541187|580744984|FG000|Overall Study|Withdrawal by Subject|6|||
160825077|NCT03541187|580744985|FG001|Overall Study|Withdrawal by Subject|2|||
160825078|NCT03541187|580744984|FG000|Overall Study|Moved out of town|1|||
160825079|NCT03541187|580744985|FG001|Overall Study|Moved out of town|0|||
160825080|NCT03541187|580744984|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
160902080|NCT01058655|581035976|FG001|Overall Study|Prolonged Treatment Delay|0|||
160902081|NCT01058655|581035977|FG002|Overall Study|Prolonged Treatment Delay|0|||
160902082|NCT01058655|581035978|FG003|Overall Study|Prolonged Treatment Delay|2|||
160902083|NCT01058655|581035975|FG000|Overall Study|Symptomatic Deterioration|0|||
160902084|NCT01058655|581035976|FG001|Overall Study|Symptomatic Deterioration|0|||
160902085|NCT01058655|581035977|FG002|Overall Study|Symptomatic Deterioration|0|||
160902086|NCT01058655|581035978|FG003|Overall Study|Symptomatic Deterioration|1|||
160902087|NCT01058655|581035975|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
160902088|NCT01058655|581035976|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
160825081|NCT03541187|580744985|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
160825082|NCT03541187|580744984|FG000|Overall Study|Did not meet randomization criteria|1|||
160825083|NCT03541187|580744985|FG001|Overall Study|Did not meet randomization criteria|1|||
160825084|NCT03541187|580744984|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
160825085|NCT03541187|580744985|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
160825086|NCT03541187|580744984|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
160825087|NCT03541187|580744985|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
160825088|NCT00869050|580744989|FG000|Overall Study|Screen Failure|3|||
160825089|NCT03298984|580744996|FG000|Overall Study|Physician Decision|1|||
160825090|NCT03298984|580744997|FG001|Overall Study|Physician Decision|0|||
160825091|NCT03298984|580744998|FG002|Overall Study|Physician Decision|0|||
160825092|NCT03298984|580744999|FG003|Overall Study|Physician Decision|6|||
160825093|NCT03298984|580744996|FG000|Overall Study|Lack of Efficacy|0|||
160825094|NCT03298984|580744997|FG001|Overall Study|Lack of Efficacy|1|||
160825095|NCT03298984|580744998|FG002|Overall Study|Lack of Efficacy|1|||
160825096|NCT03298984|580744999|FG003|Overall Study|Lack of Efficacy|4|||
160825097|NCT03298984|580744996|FG000|Overall Study|Relapsed disease (following remission)|0|||
160825098|NCT03298984|580744997|FG001|Overall Study|Relapsed disease (following remission)|0|||
160825099|NCT03298984|580744998|FG002|Overall Study|Relapsed disease (following remission)|1|||
160825100|NCT03298984|580744999|FG003|Overall Study|Relapsed disease (following remission)|1|||
160825101|NCT03298984|580744996|FG000|Overall Study|Adverse Event|0|||
160825102|NCT03298984|580744997|FG001|Overall Study|Adverse Event|0|||
160825103|NCT03298984|580744998|FG002|Overall Study|Adverse Event|0|||
160825104|NCT03298984|580744999|FG003|Overall Study|Adverse Event|1|||
160825105|NCT03298984|580744996|FG000|Overall Study|Death|0|||
160825106|NCT03298984|580744997|FG001|Overall Study|Death|0|||
160825107|NCT03298984|580744998|FG002|Overall Study|Death|0|||
160825108|NCT03298984|580744999|FG003|Overall Study|Death|2|||
160825109|NCT03298984|580744996|FG000|Overall Study|Insurance Company Decision|0|||
160825110|NCT03298984|580744997|FG001|Overall Study|Insurance Company Decision|0|||
160825111|NCT03298984|580744998|FG002|Overall Study|Insurance Company Decision|0|||
160825112|NCT03298984|580744999|FG003|Overall Study|Insurance Company Decision|1|||
160825113|NCT01571284|580745000|FG000|Overall Study|Participant's decision|84|||
160825114|NCT01571284|580745000|FG000|Overall Study|Lost to Follow-up|3|||
160825115|NCT01571284|580745000|FG000|Overall Study|Enrolled but not treated|2|||
160825116|NCT01571284|580745000|FG000|Overall Study|Other than specified above|80|||
160825117|NCT03385265|580745004|FG000|Overall Study|Withdrawal by Subject|5|||
160825118|NCT03385265|580745005|FG001|Overall Study|Withdrawal by Subject|2|||
160825119|NCT03385265|580745006|FG002|Overall Study|Withdrawal by Subject|5|||
160825120|NCT03385265|580745007|FG003|Overall Study|Withdrawal by Subject|2|||
160825121|NCT04465877|580745010|FG000|Overall Study|Noncompliant with study requirements|0|||
160825122|NCT04465877|580745011|FG001|Overall Study|Noncompliant with study requirements|0|||
160825123|NCT04465877|580745012|FG002|Overall Study|Noncompliant with study requirements|1|||
160825124|NCT04465877|580745013|FG003|Overall Study|Noncompliant with study requirements|0|||
160825125|NCT02323204|580745015|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
160825126|NCT02323204|580745016|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
160825127|NCT02323204|580745017|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
160825128|NCT02323204|580745018|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
160825129|NCT02323204|580745015|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
160825130|NCT02323204|580745016|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
160825131|NCT02323204|580745017|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
160825132|NCT02323204|580745018|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
160825133|NCT02323204|580745015|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
160825134|NCT02323204|580745016|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
160825135|NCT02323204|580745017|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
160825136|NCT02323204|580745018|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
160825137|NCT02323204|580745015|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
160825138|NCT02323204|580745016|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
160825139|NCT02323204|580745017|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
160825140|NCT02323204|580745018|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
160825141|NCT02323204|580745015|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
160825142|NCT02323204|580745016|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
160825143|NCT02323204|580745017|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
160825144|NCT02323204|580745018|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
160825145|NCT02323204|580745015|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
160825146|NCT02323204|580745016|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
160646542|NCT00782509|580088278|FG000|Overall Study|Lost to Follow-up|1|||
160825147|NCT02323204|580745017|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
160825148|NCT02323204|580745018|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
160825149|NCT02323204|580745015|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
160902089|NCT01058655|581035977|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
160825150|NCT02323204|580745016|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
160825151|NCT02323204|580745017|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
160825152|NCT02323204|580745018|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
160825153|NCT02323204|580745015|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
160825154|NCT02323204|580745016|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
160825155|NCT02323204|580745017|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
160825156|NCT02323204|580745018|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
160646543|NCT00782509|580088279|FG001|Overall Study|Lost to Follow-up|2|||
160646544|NCT00782509|580088280|FG002|Overall Study|Lost to Follow-up|3|||
160646545|NCT00782509|580088278|FG000|Overall Study|Withdrawal by Subject|3|||
160646546|NCT00782509|580088279|FG001|Overall Study|Withdrawal by Subject|5|||
160646547|NCT00782509|580088280|FG002|Overall Study|Withdrawal by Subject|8|||
160646548|NCT00782509|580088278|FG000|Overall Study|Non compliance with protocol|2|||
160646549|NCT00782509|580088279|FG001|Overall Study|Non compliance with protocol|0|||
160646550|NCT00782509|580088280|FG002|Overall Study|Non compliance with protocol|0|||
160646551|NCT00782509|580088278|FG000|Overall Study|Other reasons not stated above|5|||
160646552|NCT00782509|580088279|FG001|Overall Study|Other reasons not stated above|2|||
160646553|NCT00782509|580088280|FG002|Overall Study|Other reasons not stated above|3|||
160646554|NCT00782509|580088278|FG000|Overall Study|Lack of Efficacy|10|||
160646555|NCT00782509|580088279|FG001|Overall Study|Lack of Efficacy|5|||
160646556|NCT00782509|580088280|FG002|Overall Study|Lack of Efficacy|2|||
160646557|NCT00192296|580088283|FG000|Overall Study|Withdrawal by Subject|0|||
160646558|NCT00192296|580088284|FG001|Overall Study|Withdrawal by Subject|1|||
160646559|NCT00192296|580088285|FG002|Overall Study|Withdrawal by Subject|0|||
160646560|NCT00192296|580088286|FG003|Overall Study|Withdrawal by Subject|0|||
160646561|NCT00446654|580088293|FG000|Overall Study|Withdrawal by Subject|1|||
160646562|NCT00446654|580088294|FG001|Overall Study|Withdrawal by Subject|0|||
160646563|NCT00446654|580088293|FG000|Overall Study|Adverse Event|1|||
160646564|NCT00446654|580088294|FG001|Overall Study|Adverse Event|0|||
160646565|NCT01875445|580088296|FG000|Overall Study|Lost to Follow-up|5|||
160646566|NCT01875445|580088297|FG001|Overall Study|Lost to Follow-up|0|||
160646567|NCT01875445|580088296|FG000|Overall Study|Withdrawal by Subject|2|||
160646568|NCT01875445|580088297|FG001|Overall Study|Withdrawal by Subject|0|||
160989946|NCT02534896|581351702|FG001|Overall Study|Insufficient therapeutic response|0|||
160989947|NCT02534896|581351703|FG002|Overall Study|Insufficient therapeutic response|0|||
160646569|NCT03760510|580088298|FG000|Overall Study|Not ventilated for 24 hours|105|||
160646570|NCT03760510|580088299|FG001|Overall Study|Not ventilated for 24 hours|97|||
160646571|NCT03361956|580088300|FG000|Overall Study|Adverse Event|1|||
160989948|NCT00711646|581351704|FG000|Overall Study|Adverse Event|6|||
160989949|NCT00711646|581351705|FG001|Overall Study|Adverse Event|1|||
160989950|NCT00711646|581351704|FG000|Overall Study|Withdrawal by Subject|4|||
160989951|NCT00711646|581351705|FG001|Overall Study|Withdrawal by Subject|0|||
160989952|NCT00711646|581351704|FG000|Overall Study|Protocol Violation|0|||
160989953|NCT00711646|581351705|FG001|Overall Study|Protocol Violation|1|||
160989954|NCT00711646|581351704|FG000|Overall Study|Lost to Follow-up|1|||
160989955|NCT00711646|581351705|FG001|Overall Study|Lost to Follow-up|0|||
160646572|NCT03361956|580088301|FG001|Overall Study|Adverse Event|0|||
160646573|NCT03361956|580088302|FG002|Overall Study|Adverse Event|1|||
160646574|NCT03361956|580088303|FG003|Overall Study|Adverse Event|1|||
160825157|NCT02323204|580745015|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
160825158|NCT02323204|580745016|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
160825159|NCT02323204|580745017|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
160825160|NCT02323204|580745018|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
160825161|NCT03440918|580745024|FG000|Overall Study|Protocol Violation|0|||
160825162|NCT03440918|580745025|FG001|Overall Study|Protocol Violation|16|||
160825163|NCT04346108|580745026|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
160825164|NCT04346108|580745027|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
160825165|NCT04346108|580745028|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
160825166|NCT04346108|580745026|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
160825167|NCT04346108|580745027|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
160825168|NCT04346108|580745028|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
160825169|NCT01598753|580745029|FG000|Overall Study|Adverse Event|1|||
160825170|NCT01598753|580745030|FG001|Overall Study|Adverse Event|9|||
160825171|NCT01598753|580745031|FG002|Overall Study|Adverse Event|1|||
160825172|NCT01598753|580745032|FG003|Overall Study|Adverse Event|7|||
160825173|NCT01598753|580745029|FG000|Overall Study|Lost to Follow-up|4|||
160646575|NCT03361956|580088304|FG004|Overall Study|Adverse Event|0|||
160646576|NCT03361956|580088300|FG000|Overall Study|Other|0|||
160646577|NCT03361956|580088301|FG001|Overall Study|Other|0|||
160646578|NCT03361956|580088302|FG002|Overall Study|Other|0|||
160825174|NCT01598753|580745030|FG001|Overall Study|Lost to Follow-up|3|||
160989956|NCT00711646|581351704|FG000|Overall Study|administrative decision|0|||
160989957|NCT00711646|581351705|FG001|Overall Study|administrative decision|1|||
160646579|NCT03361956|580088303|FG003|Overall Study|Other|1|||
160646580|NCT03361956|580088304|FG004|Overall Study|Other|0|||
160825175|NCT01598753|580745031|FG002|Overall Study|Lost to Follow-up|7|||
160825176|NCT01598753|580745032|FG003|Overall Study|Lost to Follow-up|5|||
160554172|NCT00132041|579755716|FG000|6 Months Post Ablation|Death|2|||
160554173|NCT00132041|579755716|FG000|6 Months Post Ablation|Transplant|6|||
160554174|NCT00132041|579755716|FG000|9 Months Post Ablation|Death|1|||
160554175|NCT00132041|579755716|FG000|9 Months Post Ablation|Transplant|1|||
160554176|NCT00132041|579755716|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
160554177|NCT00132041|579755716|FG000|12 Months Post Ablation|Death|1|||
160554178|NCT00132041|579755716|FG000|12 Months Post Ablation|Transplant|1|||
160554179|NCT00132041|579755716|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
160554180|NCT00132041|579755716|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
160554181|NCT00132041|579755716|FG000|15 Months Post Ablation|Death|1|||
160554182|NCT00132041|579755716|FG000|15 Months Post Ablation|Transplant|5|||
160554183|NCT00132041|579755716|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
160554184|NCT00132041|579755716|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
160554185|NCT00132041|579755716|FG000|18 Months Post Ablation|Transplant|1|||
160554186|NCT00132041|579755716|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
160554187|NCT00132041|579755716|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
160554188|NCT01871090|579755717|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
160554189|NCT01871090|579755718|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
160554190|NCT01871090|579755717|FG000|Overall Study|Interrogation not completed correctly|1|||
160554191|NCT01871090|579755718|FG001|Overall Study|Interrogation not completed correctly|0|||
160554192|NCT01871090|579755717|FG000|Overall Study|Subject Non-Compliance|0|||
160554193|NCT01871090|579755718|FG001|Overall Study|Subject Non-Compliance|1|||
160554194|NCT02911688|579755722|FG000|Washout|Lost to Follow-up|1|||
160554195|NCT02911688|579755723|FG001|Washout|Lost to Follow-up|1|||
160554196|NCT02911688|579755722|FG000|Washout|Withdrawal by Subject|0|||
160554197|NCT02911688|579755723|FG001|Washout|Withdrawal by Subject|1|||
160554198|NCT01307033|579755726|FG000|8-week Double-blind Period|Adverse Event|2|||
160554199|NCT01307033|579755727|FG001|8-week Double-blind Period|Adverse Event|0|||
160554200|NCT01307033|579755728|FG002|8-week Double-blind Period|Adverse Event|0|||
160554201|NCT01307033|579755729|FG003|8-week Double-blind Period|Adverse Event|0|||
160554202|NCT01307033|579755726|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
160554203|NCT01307033|579755727|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
160554204|NCT01307033|579755728|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
160554205|NCT01307033|579755729|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
160554206|NCT01307033|579755726|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
160554207|NCT01307033|579755727|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
160554208|NCT01307033|579755728|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
160554209|NCT01307033|579755729|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
160554210|NCT01307033|579755726|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
160554211|NCT01307033|579755727|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
160554212|NCT01307033|579755728|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
160554213|NCT01307033|579755729|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
160554214|NCT01307033|579755726|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
160554215|NCT01307033|579755727|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
160554216|NCT01307033|579755728|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
160554217|NCT01307033|579755729|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
160554218|NCT01307033|579755726|FG000|44-week Open-label Extension|Adverse Event|0|||
160554219|NCT01307033|579755727|FG001|44-week Open-label Extension|Adverse Event|0|||
160554220|NCT01307033|579755728|FG002|44-week Open-label Extension|Adverse Event|2|||
160554221|NCT01307033|579755729|FG003|44-week Open-label Extension|Adverse Event|1|||
160554222|NCT01307033|579755726|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
160554223|NCT01307033|579755727|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
160554224|NCT01307033|579755728|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
160554225|NCT01307033|579755729|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
160554226|NCT01307033|579755726|FG000|44-week Open-label Extension|Physician Decision|0|||
160554227|NCT01307033|579755727|FG001|44-week Open-label Extension|Physician Decision|0|||
160554228|NCT01307033|579755728|FG002|44-week Open-label Extension|Physician Decision|1|||
160554229|NCT01307033|579755729|FG003|44-week Open-label Extension|Physician Decision|0|||
160554230|NCT01307033|579755726|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
160554231|NCT01307033|579755727|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
160554232|NCT01307033|579755728|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
160554233|NCT01307033|579755729|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
160554234|NCT01307033|579755726|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
160554235|NCT01307033|579755727|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
160554236|NCT01307033|579755728|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
160554237|NCT01307033|579755729|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
160554238|NCT01307033|579755726|FG000|44-week Open-label Extension|Death|0|||
160646581|NCT03361956|580088300|FG000|Overall Study|Withdrawal by Subject|2|||
160554239|NCT01307033|579755727|FG001|44-week Open-label Extension|Death|0|||
160646582|NCT03361956|580088301|FG001|Overall Study|Withdrawal by Subject|2|||
160646583|NCT03361956|580088302|FG002|Overall Study|Withdrawal by Subject|2|||
160646584|NCT03361956|580088303|FG003|Overall Study|Withdrawal by Subject|0|||
160646585|NCT03361956|580088304|FG004|Overall Study|Withdrawal by Subject|3|||
160646586|NCT03361956|580088300|FG000|Overall Study|Disease Relapse|0|||
160646587|NCT03361956|580088301|FG001|Overall Study|Disease Relapse|0|||
160646588|NCT03361956|580088302|FG002|Overall Study|Disease Relapse|1|||
160646589|NCT03361956|580088303|FG003|Overall Study|Disease Relapse|0|||
160646590|NCT03361956|580088304|FG004|Overall Study|Disease Relapse|0|||
160646591|NCT03361956|580088300|FG000|Overall Study|Physician Decision|0|||
160646592|NCT03361956|580088301|FG001|Overall Study|Physician Decision|2|||
160646593|NCT03361956|580088302|FG002|Overall Study|Physician Decision|0|||
160646594|NCT03361956|580088303|FG003|Overall Study|Physician Decision|1|||
160646595|NCT03361956|580088304|FG004|Overall Study|Physician Decision|0|||
160646596|NCT03361956|580088300|FG000|Overall Study|Lost to Follow-up|0|||
160646597|NCT03361956|580088301|FG001|Overall Study|Lost to Follow-up|0|||
160646598|NCT03361956|580088302|FG002|Overall Study|Lost to Follow-up|1|||
160646599|NCT03361956|580088303|FG003|Overall Study|Lost to Follow-up|1|||
160646600|NCT03361956|580088304|FG004|Overall Study|Lost to Follow-up|2|||
160646601|NCT00871728|580088306|FG000|Overall Study|Adverse Event|1|||
160646602|NCT00871728|580088306|FG000|Overall Study|Protocol Violation|7|||
160646603|NCT00871728|580088306|FG000|Overall Study|Lost to Follow-up|2|||
160646604|NCT00871728|580088306|FG000|Overall Study|Failed to Visit Hospital|4|||
160646605|NCT00871728|580088306|FG000|Overall Study|Participant Non-compliance|1|||
160646606|NCT00871728|580088306|FG000|Overall Study|Withdrawal of Informed Consent|5|||
160646607|NCT04147715|580088307|FG000|Overall Study|Adverse Event|0|||
160646608|NCT04147715|580088308|FG001|Overall Study|Adverse Event|0|||
160646609|NCT04147715|580088309|FG002|Overall Study|Adverse Event|0|||
160646610|NCT04147715|580088310|FG003|Overall Study|Adverse Event|0|||
160825177|NCT01598753|580745029|FG000|Overall Study|Physician Decision|0|||
160825178|NCT01598753|580745030|FG001|Overall Study|Physician Decision|1|||
160825179|NCT01598753|580745031|FG002|Overall Study|Physician Decision|0|||
160825180|NCT01598753|580745032|FG003|Overall Study|Physician Decision|2|||
160825181|NCT01598753|580745029|FG000|Overall Study|Withdrawal by Subject|7|||
160825182|NCT01598753|580745030|FG001|Overall Study|Withdrawal by Subject|2|||
160825183|NCT01598753|580745031|FG002|Overall Study|Withdrawal by Subject|0|||
160825184|NCT01598753|580745032|FG003|Overall Study|Withdrawal by Subject|1|||
160825185|NCT02142283|580745033|FG000|Overall Study|Death|20|||
160825186|NCT02142283|580745034|FG001|Overall Study|Death|18|||
160825187|NCT02142283|580745033|FG000|Overall Study|Withdrawal by Subject|1|||
160825188|NCT02142283|580745034|FG001|Overall Study|Withdrawal by Subject|3|||
160825189|NCT01484834|580745035|FG000|Overall Study|Lost to Follow-up|5|||
160825190|NCT01484834|580745036|FG001|Overall Study|Lost to Follow-up|8|||
160825191|NCT01484834|580745037|FG002|Overall Study|Lost to Follow-up|1|||
160825192|NCT01484834|580745038|FG003|Overall Study|Lost to Follow-up|4|||
160825193|NCT00747344|580745039|FG000|Controlled Period|Adverse Event|3|||
160825194|NCT00747344|580745040|FG001|Controlled Period|Adverse Event|0|||
160825195|NCT00747344|580745041|FG002|Controlled Period|Adverse Event|0|||
160825196|NCT00747344|580745042|FG003|Controlled Period|Adverse Event|0|||
160825197|NCT00747344|580745039|FG000|Controlled Period|Lack of Efficacy|2|||
160825198|NCT00747344|580745040|FG001|Controlled Period|Lack of Efficacy|1|||
160825199|NCT00747344|580745041|FG002|Controlled Period|Lack of Efficacy|0|||
160825200|NCT00747344|580745042|FG003|Controlled Period|Lack of Efficacy|0|||
160825201|NCT00747344|580745039|FG000|Controlled Period|Other|0|||
160825202|NCT00747344|580745040|FG001|Controlled Period|Other|3|||
160825203|NCT00747344|580745041|FG002|Controlled Period|Other|0|||
160825204|NCT00747344|580745042|FG003|Controlled Period|Other|0|||
160825205|NCT00747344|580745039|FG000|After Controlled Period|Adverse Event|0|||
160825206|NCT00747344|580745040|FG001|After Controlled Period|Adverse Event|0|||
160825207|NCT00747344|580745041|FG002|After Controlled Period|Adverse Event|0|||
160825208|NCT00747344|580745042|FG003|After Controlled Period|Adverse Event|1|||
160825209|NCT02460783|580745043|FG000|Overall Study|Withdrawal by Subject|1|||
160825210|NCT02460783|580745044|FG001|Overall Study|Withdrawal by Subject|3|||
160825211|NCT02460783|580745043|FG000|Overall Study|Lost to Follow-up|1|||
160825212|NCT02460783|580745044|FG001|Overall Study|Lost to Follow-up|1|||
160825213|NCT03754582|580745047|FG000|Treatment Phase|Adverse Event|0|||
160825214|NCT03754582|580745048|FG001|Treatment Phase|Adverse Event|1|||
160825215|NCT03754582|580745049|FG002|Treatment Phase|Adverse Event|0|||
160825216|NCT03754582|580745047|FG000|Follow-up Phase|Other|0|||
160825217|NCT03754582|580745048|FG001|Follow-up Phase|Other|0|||
160646611|NCT04147715|580088311|FG004|Overall Study|Adverse Event|0|||
160646612|NCT04147715|580088312|FG005|Overall Study|Adverse Event|0|||
160646613|NCT04147715|580088313|FG006|Overall Study|Adverse Event|0|||
160646614|NCT04147715|580088314|FG007|Overall Study|Adverse Event|2|||
160825218|NCT03754582|580745049|FG002|Follow-up Phase|Other|1|||
160825219|NCT01561755|580745050|FG000|Overall Study|Lost to Follow-up|0|||
160825220|NCT01561755|580745051|FG001|Overall Study|Lost to Follow-up|1|||
160825221|NCT00624819|580745052|FG000|Follow-up Period: Year 4|Parents decision|0|||
160825222|NCT00624819|580745053|FG001|Follow-up Period: Year 4|Parents decision|0|||
160825223|NCT00624819|580745054|FG002|Follow-up Period: Year 4|Parents decision|1|||
160825224|NCT00624819|580745055|FG003|Follow-up Period: Year 4|Parents decision|0|||
160825225|NCT00624819|580745052|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
160825226|NCT00624819|580745053|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
160825227|NCT00624819|580745054|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
160825228|NCT00624819|580745055|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
160825229|NCT02847858|580745056|FG000|Overall Study|Lost to Follow-up|401|||
160825230|NCT02847858|580745057|FG001|Overall Study|Lost to Follow-up|269|||
160646615|NCT04147715|580088315|FG008|Overall Study|Adverse Event|1|||
160825231|NCT02826421|580745060|FG000|Overall Study|Adverse Event|1|||
160646616|NCT04147715|580088316|FG009|Overall Study|Adverse Event|0|||
160825232|NCT02826421|580745061|FG001|Overall Study|Adverse Event|0|||
160825233|NCT02826421|580745062|FG002|Overall Study|Adverse Event|0|||
160825234|NCT02826421|580745063|FG003|Overall Study|Adverse Event|1|||
160825235|NCT02826421|580745060|FG000|Overall Study|Withdrawal by Subject|1|||
160825236|NCT02826421|580745061|FG001|Overall Study|Withdrawal by Subject|3|||
160825237|NCT02826421|580745062|FG002|Overall Study|Withdrawal by Subject|1|||
160825238|NCT02826421|580745063|FG003|Overall Study|Withdrawal by Subject|1|||
160825239|NCT02826421|580745060|FG000|Overall Study|Reason not given|1|||
160825240|NCT02826421|580745061|FG001|Overall Study|Reason not given|0|||
160825241|NCT02826421|580745062|FG002|Overall Study|Reason not given|1|||
160825242|NCT02826421|580745063|FG003|Overall Study|Reason not given|0|||
160646617|NCT04147715|580088317|FG010|Overall Study|Adverse Event|0|||
160825243|NCT02210221|580745066|FG000|Overall Study|Lack of Efficacy|7|||
160825244|NCT02210221|580745066|FG000|Overall Study|Withdrawal by Subject|43|||
160825245|NCT04030247|580747084|FG000|Overall Study|Withdrawal by Subject|4|||
160825246|NCT04030247|580747084|FG000|Overall Study|Lost to Follow-up|13|||
160554240|NCT01307033|579755728|FG002|44-week Open-label Extension|Death|0|||
160554241|NCT01307033|579755729|FG003|44-week Open-label Extension|Death|1|||
160554242|NCT00947531|579755734|FG000|Overall Study|Withdrawal by Subject|10|||
160554243|NCT00947531|579755735|FG001|Overall Study|Withdrawal by Subject|7|||
160554244|NCT00947531|579755734|FG000|Overall Study|Administrative Reason|0|||
160554245|NCT00947531|579755735|FG001|Overall Study|Administrative Reason|1|||
160554246|NCT00947531|579755734|FG000|Overall Study|Adverse Event|2|||
160554247|NCT00947531|579755735|FG001|Overall Study|Adverse Event|2|||
160554248|NCT00947531|579755734|FG000|Overall Study|Lack of Efficacy|1|||
160554249|NCT00947531|579755735|FG001|Overall Study|Lack of Efficacy|0|||
160554250|NCT00947531|579755734|FG000|Overall Study|Other|1|||
160554251|NCT00947531|579755735|FG001|Overall Study|Other|1|||
160554252|NCT01773421|579755737|FG000|Treatment Phase|Other|0|||
160554253|NCT01773421|579755738|FG001|Treatment Phase|Other|0|||
160554254|NCT01773421|579755739|FG002|Treatment Phase|Other|2|||
160554255|NCT01773421|579755740|FG003|Treatment Phase|Other|0|||
160554256|NCT01773421|579755741|FG004|Treatment Phase|Other|0|||
160554257|NCT01773421|579755742|FG005|Treatment Phase|Other|0|||
160554258|NCT01773421|579755743|FG006|Treatment Phase|Other|0|||
160554259|NCT01773421|579755737|FG000|Treatment Phase|Adverse Event|0|||
160554260|NCT01773421|579755738|FG001|Treatment Phase|Adverse Event|0|||
160554261|NCT01773421|579755739|FG002|Treatment Phase|Adverse Event|3|||
160554262|NCT01773421|579755740|FG003|Treatment Phase|Adverse Event|1|||
160554263|NCT01773421|579755741|FG004|Treatment Phase|Adverse Event|0|||
160554264|NCT01773421|579755742|FG005|Treatment Phase|Adverse Event|0|||
160554265|NCT01773421|579755743|FG006|Treatment Phase|Adverse Event|0|||
160554266|NCT01773421|579755737|FG000|Treatment Phase|Withdrawal by Subject|0|||
160902090|NCT01058655|581035978|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
160902091|NCT01058655|581035975|FG000|Overall Study|Death|0|||
160902092|NCT01058655|581035976|FG001|Overall Study|Death|1|||
160902093|NCT01058655|581035977|FG002|Overall Study|Death|1|||
160902094|NCT01058655|581035978|FG003|Overall Study|Death|0|||
160902095|NCT01058655|581035975|FG000|Overall Study|Disease Progression|1|||
160902096|NCT01058655|581035976|FG001|Overall Study|Disease Progression|2|||
160902097|NCT01058655|581035977|FG002|Overall Study|Disease Progression|4|||
160902098|NCT01058655|581035978|FG003|Overall Study|Disease Progression|24|||
160902099|NCT01058655|581035975|FG000|Overall Study|Other|0|||
160902100|NCT01058655|581035976|FG001|Overall Study|Other|0|||
160902101|NCT01058655|581035977|FG002|Overall Study|Other|0|||
160902102|NCT01058655|581035978|FG003|Overall Study|Other|4|||
160902103|NCT04545060|581035981|FG000|Overall Study|Adverse Event|0|||
160902104|NCT04545060|581035982|FG001|Overall Study|Adverse Event|1|||
160902105|NCT04545060|581035981|FG000|Overall Study|Death|0|||
160902106|NCT04545060|581035982|FG001|Overall Study|Death|5|||
160902107|NCT04545060|581035981|FG000|Overall Study|Lost to Follow-up|10|||
160902108|NCT04545060|581035982|FG001|Overall Study|Lost to Follow-up|13|||
160902109|NCT04545060|581035981|FG000|Overall Study|Physician Decision|3|||
160902110|NCT04545060|581035982|FG001|Overall Study|Physician Decision|0|||
160902111|NCT04545060|581035981|FG000|Overall Study|Withdrawal by Subject|17|||
160902112|NCT04545060|581035982|FG001|Overall Study|Withdrawal by Subject|22|||
160902113|NCT00619177|581035983|FG000|Overall Study|Adverse Event|18|||
160902114|NCT00619177|581035983|FG000|Overall Study|Lost to Follow-up|2|||
160902115|NCT00619177|581035983|FG000|Overall Study|Lack of Efficacy|1|||
160902116|NCT00619177|581035983|FG000|Overall Study|Missing termination information|481|||
160902117|NCT00619177|581035983|FG000|Overall Study|Not specified reasons|6|||
160902118|NCT01281137|581035984|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
160902119|NCT01281137|581035985|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
160902120|NCT01281137|581035984|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
160902121|NCT01281137|581035985|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
160917934|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
160554267|NCT01773421|579755738|FG001|Treatment Phase|Withdrawal by Subject|0|||
160554268|NCT01773421|579755739|FG002|Treatment Phase|Withdrawal by Subject|1|||
160554269|NCT01773421|579755740|FG003|Treatment Phase|Withdrawal by Subject|1|||
160554270|NCT01773421|579755741|FG004|Treatment Phase|Withdrawal by Subject|0|||
160825247|NCT02032407|580747085|FG000|Overall Study|Lost to Follow-up|2|||
160825248|NCT02032407|580747085|FG000|Overall Study|Pregnancy|1|||
160825249|NCT02032407|580747085|FG000|Overall Study|Other Miscellaneous Reasons|2|||
160825250|NCT05320393|580747086|FG000|Overall Study|Withdrawal by Subject|1|||
160825251|NCT05320393|580747087|FG001|Overall Study|Withdrawal by Subject|0|||
160825252|NCT05320393|580747088|FG002|Overall Study|Withdrawal by Subject|2|||
160825253|NCT05320393|580747086|FG000|Overall Study|Lost to Follow-up|1|||
160825254|NCT05320393|580747087|FG001|Overall Study|Lost to Follow-up|2|||
160825255|NCT05320393|580747088|FG002|Overall Study|Lost to Follow-up|1|||
160825256|NCT05320393|580747086|FG000|Overall Study|Moved; too much driving|0|||
160825257|NCT05320393|580747087|FG001|Overall Study|Moved; too much driving|0|||
160825258|NCT05320393|580747088|FG002|Overall Study|Moved; too much driving|2|||
160825259|NCT05320393|580747086|FG000|Overall Study|Did not receive treatment|0|||
160825260|NCT05320393|580747087|FG001|Overall Study|Did not receive treatment|0|||
160554271|NCT01773421|579755742|FG005|Treatment Phase|Withdrawal by Subject|0|||
160554272|NCT01773421|579755743|FG006|Treatment Phase|Withdrawal by Subject|0|||
160554273|NCT01773421|579755737|FG000|Extension Phase|Other|0|||
160554274|NCT01773421|579755738|FG001|Extension Phase|Other|0|||
160554275|NCT01773421|579755739|FG002|Extension Phase|Other|0|||
160554276|NCT01773421|579755740|FG003|Extension Phase|Other|0|||
160825261|NCT05320393|580747088|FG002|Overall Study|Did not receive treatment|1|||
160825262|NCT04411420|580747089|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
160917935|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
160825263|NCT04411420|580747090|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
160554277|NCT01773421|579755741|FG004|Extension Phase|Other|1|||
160554278|NCT01773421|579755742|FG005|Extension Phase|Other|2|||
160554279|NCT01773421|579755743|FG006|Extension Phase|Other|0|||
160554280|NCT01773421|579755737|FG000|Extension Phase|Adverse Event|0|||
160825264|NCT04411420|580747089|FG000|Survey Subset|Lost to Follow-up|134|||
160825265|NCT04411420|580747090|FG001|Survey Subset|Lost to Follow-up|120|||
160825266|NCT00549900|580747091|FG000|Overall Study|Adverse Event|1|||
160825267|NCT03187834|580747095|FG000|Overall Study|Lost to Follow-up|0|||
160825268|NCT03187834|580747096|FG001|Overall Study|Lost to Follow-up|1|||
160825269|NCT03187834|580747097|FG002|Overall Study|Lost to Follow-up|2|||
160825270|NCT03187834|580747098|FG003|Overall Study|Lost to Follow-up|2|||
160825271|NCT03187834|580747095|FG000|Overall Study|Had invalid anthropometric measurements|5|||
160825272|NCT03187834|580747096|FG001|Overall Study|Had invalid anthropometric measurements|3|||
160825273|NCT03187834|580747097|FG002|Overall Study|Had invalid anthropometric measurements|4|||
160825274|NCT03187834|580747098|FG003|Overall Study|Had invalid anthropometric measurements|2|||
160825275|NCT03559699|580747101|FG000|Overall Study|Withdrawal by Subject|6|||
160825276|NCT03559699|580747101|FG000|Overall Study|Lost to Follow-up|1|||
160825277|NCT00031460|580747102|FG000|Overall Study|Lost to Follow-up|0|||
160825278|NCT00031460|580747103|FG001|Overall Study|Lost to Follow-up|1|||
160825279|NCT00031460|580747102|FG000|Overall Study|Withdrawal by Subject|1|||
160825280|NCT00031460|580747103|FG001|Overall Study|Withdrawal by Subject|1|||
160825281|NCT00031460|580747102|FG000|Overall Study|Non-Compliant|1|||
160825282|NCT00031460|580747103|FG001|Overall Study|Non-Compliant|1|||
160825283|NCT00031460|580747102|FG000|Overall Study|Death|0|||
160825284|NCT00031460|580747103|FG001|Overall Study|Death|1|||
160825285|NCT00031460|580747102|FG000|Overall Study|Reactivation of Disease|5|||
160825286|NCT00031460|580747103|FG001|Overall Study|Reactivation of Disease|9|||
160825287|NCT00031460|580747102|FG000|Overall Study|Disruption of blinded drug supply|2|||
160825288|NCT00031460|580747103|FG001|Overall Study|Disruption of blinded drug supply|0|||
160825289|NCT00031460|580747102|FG000|Overall Study|Confirmed unevaluable|0|||
160825290|NCT00031460|580747103|FG001|Overall Study|Confirmed unevaluable|1|||
160825291|NCT01930890|580747104|FG000|Overall Study|Study Termination|14|||
160825292|NCT01930890|580747105|FG001|Overall Study|Study Termination|28|||
160825293|NCT01930890|580747106|FG002|Overall Study|Study Termination|13|||
160825294|NCT01930890|580747107|FG003|Overall Study|Study Termination|25|||
160825295|NCT01930890|580747104|FG000|Overall Study|Death|0|||
160554281|NCT01773421|579755738|FG001|Extension Phase|Adverse Event|0|||
160554282|NCT01773421|579755739|FG002|Extension Phase|Adverse Event|0|||
160825296|NCT01930890|580747105|FG001|Overall Study|Death|0|||
160825297|NCT01930890|580747106|FG002|Overall Study|Death|0|||
160825298|NCT01930890|580747107|FG003|Overall Study|Death|1|||
160825299|NCT01930890|580747104|FG000|Overall Study|Investigator Decision|0|||
160825300|NCT01930890|580747105|FG001|Overall Study|Investigator Decision|1|||
160825301|NCT01930890|580747106|FG002|Overall Study|Investigator Decision|0|||
160825302|NCT01930890|580747107|FG003|Overall Study|Investigator Decision|0|||
160825303|NCT01930890|580747104|FG000|Overall Study|Consent Withdrawn|0|||
160825304|NCT01930890|580747105|FG001|Overall Study|Consent Withdrawn|3|||
160825305|NCT01930890|580747106|FG002|Overall Study|Consent Withdrawn|0|||
160825306|NCT01930890|580747107|FG003|Overall Study|Consent Withdrawn|1|||
160825307|NCT01930890|580747104|FG000|Overall Study|Adverse Event|0|||
160825308|NCT01930890|580747105|FG001|Overall Study|Adverse Event|1|||
160825309|NCT01930890|580747106|FG002|Overall Study|Adverse Event|0|||
160825310|NCT01930890|580747107|FG003|Overall Study|Adverse Event|0|||
160825311|NCT01176565|580747110|FG000|Overall Study|Lost to Follow-up|12|||
160825312|NCT01176565|580747111|FG001|Overall Study|Lost to Follow-up|16|||
160825313|NCT01176565|580747110|FG000|Overall Study|Withdrawal by Subject|7|||
160825314|NCT01176565|580747111|FG001|Overall Study|Withdrawal by Subject|1|||
160825315|NCT01176565|580747110|FG000|Overall Study|Not Analyzed (any other reason)|1|||
160825316|NCT01176565|580747111|FG001|Overall Study|Not Analyzed (any other reason)|2|||
160825317|NCT02754141|580747112|FG000|Overall Study|Disease progression|11|||
160825318|NCT02754141|580747113|FG001|Overall Study|Disease progression|7|||
160825319|NCT02754141|580747114|FG002|Overall Study|Disease progression|8|||
160825320|NCT02754141|580747115|FG003|Overall Study|Disease progression|5|||
160825321|NCT02754141|580747116|FG004|Overall Study|Disease progression|7|||
160825322|NCT02754141|580747117|FG005|Overall Study|Disease progression|7|||
160825323|NCT02754141|580747118|FG006|Overall Study|Disease progression|7|||
160825324|NCT02754141|580747119|FG007|Overall Study|Disease progression|6|||
160825325|NCT02754141|580747120|FG008|Overall Study|Disease progression|11|||
160825326|NCT02754141|580747121|FG009|Overall Study|Disease progression|16|||
160825327|NCT02754141|580747122|FG010|Overall Study|Disease progression|18|||
160825328|NCT02754141|580747123|FG011|Overall Study|Disease progression|13|||
160825329|NCT02754141|580747124|FG012|Overall Study|Disease progression|10|||
160825330|NCT02754141|580747125|FG013|Overall Study|Disease progression|12|||
160825331|NCT02754141|580747126|FG014|Overall Study|Disease progression|12|||
160825332|NCT02754141|580747127|FG015|Overall Study|Disease progression|14|||
160825333|NCT02754141|580747128|FG016|Overall Study|Disease progression|0|||
160825334|NCT02754141|580747129|FG017|Overall Study|Disease progression|1|||
160825335|NCT02754141|580747112|FG000|Overall Study|Study drug toxicity|1|||
160554283|NCT01773421|579755740|FG003|Extension Phase|Adverse Event|0|||
160825336|NCT02754141|580747113|FG001|Overall Study|Study drug toxicity|1|||
160825337|NCT02754141|580747114|FG002|Overall Study|Study drug toxicity|0|||
160825338|NCT02754141|580747115|FG003|Overall Study|Study drug toxicity|0|||
160825339|NCT02754141|580747116|FG004|Overall Study|Study drug toxicity|0|||
160825340|NCT02754141|580747117|FG005|Overall Study|Study drug toxicity|0|||
160825341|NCT02754141|580747118|FG006|Overall Study|Study drug toxicity|0|||
160825342|NCT02754141|580747119|FG007|Overall Study|Study drug toxicity|0|||
160825343|NCT02754141|580747120|FG008|Overall Study|Study drug toxicity|0|||
160825344|NCT02754141|580747121|FG009|Overall Study|Study drug toxicity|0|||
160825345|NCT02754141|580747122|FG010|Overall Study|Study drug toxicity|2|||
160554284|NCT01773421|579755741|FG004|Extension Phase|Adverse Event|2|||
160554285|NCT01773421|579755742|FG005|Extension Phase|Adverse Event|0|||
160554286|NCT01773421|579755743|FG006|Extension Phase|Adverse Event|0|||
160554287|NCT02327260|579755744|FG000|Overall Study|Lost to Follow-up|2|||
160554288|NCT02327260|579755745|FG001|Overall Study|Lost to Follow-up|3|||
160554289|NCT02327260|579755746|FG002|Overall Study|Lost to Follow-up|2|||
160554290|NCT02327260|579755744|FG000|Overall Study|invalid phone number|1|||
160554291|NCT02327260|579755745|FG001|Overall Study|invalid phone number|1|||
160554292|NCT02327260|579755746|FG002|Overall Study|invalid phone number|0|||
160554293|NCT02327260|579755744|FG000|Overall Study|non-adherence to protocol|2|||
160554294|NCT02327260|579755745|FG001|Overall Study|non-adherence to protocol|0|||
160554295|NCT02327260|579755746|FG002|Overall Study|non-adherence to protocol|0|||
160554296|NCT02327260|579755744|FG000|Overall Study|cognitive concerns|1|||
160554297|NCT02327260|579755745|FG001|Overall Study|cognitive concerns|0|||
160554298|NCT02327260|579755746|FG002|Overall Study|cognitive concerns|0|||
160554299|NCT01400932|579755749|FG000|Overall Study|Adverse Event|10|||
160554300|NCT01400932|579755750|FG001|Overall Study|Adverse Event|5|||
160554301|NCT01400932|579755749|FG000|Overall Study|Lack of Efficacy|0|||
160554302|NCT01400932|579755750|FG001|Overall Study|Lack of Efficacy|3|||
160554303|NCT01400932|579755749|FG000|Overall Study|Withdrawal by Subject|2|||
160554304|NCT01400932|579755750|FG001|Overall Study|Withdrawal by Subject|6|||
160554305|NCT01400932|579755749|FG000|Overall Study|Lost to Follow-up|1|||
160554306|NCT01400932|579755750|FG001|Overall Study|Lost to Follow-up|0|||
160554307|NCT01400932|579755749|FG000|Overall Study|Protocol Deviation|0|||
160554308|NCT01400932|579755750|FG001|Overall Study|Protocol Deviation|1|||
160554309|NCT01400932|579755749|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
160554310|NCT01400932|579755750|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
160554311|NCT00282243|579755751|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
160554312|NCT00282243|579755751|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
160554313|NCT00282243|579755751|FG000|Extension Treatment Period|Adverse Event|15|||
160554314|NCT00282243|579755751|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
160554315|NCT00282243|579755751|FG000|Extension Treatment Period|Non-compliance|2|||
160554316|NCT00282243|579755751|FG000|Extension Treatment Period|Physician Decision|1|||
160554317|NCT01070329|579755752|FG000|Overall Study|Adverse Event|13|||
160554318|NCT01070329|579755753|FG001|Overall Study|Adverse Event|10|||
160554319|NCT01070329|579755752|FG000|Overall Study|Lost to Follow-up|22|||
160554320|NCT01070329|579755753|FG001|Overall Study|Lost to Follow-up|12|||
160554321|NCT01070329|579755752|FG000|Overall Study|Withdrawal by Subject|9|||
160554322|NCT01070329|579755753|FG001|Overall Study|Withdrawal by Subject|11|||
160554323|NCT01070329|579755752|FG000|Overall Study|Protocol Violation|3|||
160554324|NCT01070329|579755753|FG001|Overall Study|Protocol Violation|8|||
160825346|NCT02754141|580747123|FG011|Overall Study|Study drug toxicity|1|||
160825347|NCT02754141|580747124|FG012|Overall Study|Study drug toxicity|1|||
160825348|NCT02754141|580747125|FG013|Overall Study|Study drug toxicity|0|||
160902122|NCT01281137|581035984|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
160902123|NCT01281137|581035985|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
160902124|NCT01281137|581035984|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
160902125|NCT01281137|581035985|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
160902126|NCT01281137|581035984|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
160554325|NCT01070329|579755752|FG000|Overall Study|Lack of Efficacy|2|||
160554326|NCT01070329|579755753|FG001|Overall Study|Lack of Efficacy|6|||
160554327|NCT01070329|579755752|FG000|Overall Study|Physician Decision|2|||
160554328|NCT01070329|579755753|FG001|Overall Study|Physician Decision|1|||
160554329|NCT01070329|579755752|FG000|Overall Study|Entry Criteria Not Met|1|||
160554330|NCT01070329|579755753|FG001|Overall Study|Entry Criteria Not Met|0|||
160554331|NCT01070329|579755752|FG000|Overall Study|Sponsor Decision|0|||
160554332|NCT01070329|579755753|FG001|Overall Study|Sponsor Decision|1|||
160554333|NCT02863848|579755754|FG000|Overall Study|Lost to Follow-up|1|||
160825349|NCT02754141|580747126|FG014|Overall Study|Study drug toxicity|0|||
160825350|NCT02754141|580747127|FG015|Overall Study|Study drug toxicity|0|||
160554334|NCT02863848|579755755|FG001|Overall Study|Lost to Follow-up|1|||
160554335|NCT02863848|579755754|FG000|Overall Study|Protocol Violation|1|||
160554336|NCT02863848|579755755|FG001|Overall Study|Protocol Violation|2|||
160554337|NCT00168831|579755759|FG000|Overall Study|Adverse Event|36|||
160554338|NCT00168831|579755760|FG001|Overall Study|Adverse Event|47|||
160825351|NCT02754141|580747128|FG016|Overall Study|Study drug toxicity|0|||
160825352|NCT02754141|580747129|FG017|Overall Study|Study drug toxicity|0|||
160825353|NCT02754141|580747112|FG000|Overall Study|AE unrelated to study drug|1|||
160825354|NCT02754141|580747113|FG001|Overall Study|AE unrelated to study drug|1|||
160825355|NCT02754141|580747114|FG002|Overall Study|AE unrelated to study drug|0|||
160825356|NCT02754141|580747115|FG003|Overall Study|AE unrelated to study drug|1|||
160825357|NCT02754141|580747116|FG004|Overall Study|AE unrelated to study drug|3|||
160825358|NCT02754141|580747117|FG005|Overall Study|AE unrelated to study drug|2|||
160825359|NCT02754141|580747118|FG006|Overall Study|AE unrelated to study drug|1|||
160825360|NCT02754141|580747119|FG007|Overall Study|AE unrelated to study drug|0|||
160825361|NCT02754141|580747120|FG008|Overall Study|AE unrelated to study drug|0|||
160825362|NCT02754141|580747121|FG009|Overall Study|AE unrelated to study drug|0|||
160825363|NCT02754141|580747122|FG010|Overall Study|AE unrelated to study drug|0|||
160825364|NCT02754141|580747123|FG011|Overall Study|AE unrelated to study drug|0|||
160825365|NCT02754141|580747124|FG012|Overall Study|AE unrelated to study drug|0|||
160825366|NCT02754141|580747125|FG013|Overall Study|AE unrelated to study drug|0|||
160825367|NCT02754141|580747126|FG014|Overall Study|AE unrelated to study drug|0|||
160825368|NCT02754141|580747127|FG015|Overall Study|AE unrelated to study drug|0|||
160825369|NCT02754141|580747128|FG016|Overall Study|AE unrelated to study drug|0|||
160825370|NCT02754141|580747129|FG017|Overall Study|AE unrelated to study drug|0|||
160825371|NCT02754141|580747112|FG000|Overall Study|Request to discontinue|0|||
160825372|NCT02754141|580747113|FG001|Overall Study|Request to discontinue|0|||
160825373|NCT02754141|580747114|FG002|Overall Study|Request to discontinue|0|||
160825374|NCT02754141|580747115|FG003|Overall Study|Request to discontinue|0|||
160825375|NCT02754141|580747116|FG004|Overall Study|Request to discontinue|0|||
160825376|NCT02754141|580747117|FG005|Overall Study|Request to discontinue|0|||
160825377|NCT02754141|580747118|FG006|Overall Study|Request to discontinue|0|||
160825378|NCT02754141|580747119|FG007|Overall Study|Request to discontinue|0|||
160825379|NCT02754141|580747120|FG008|Overall Study|Request to discontinue|1|||
160825380|NCT02754141|580747121|FG009|Overall Study|Request to discontinue|0|||
160825381|NCT02754141|580747122|FG010|Overall Study|Request to discontinue|0|||
160825382|NCT02754141|580747123|FG011|Overall Study|Request to discontinue|0|||
160825383|NCT02754141|580747124|FG012|Overall Study|Request to discontinue|0|||
160825384|NCT02754141|580747125|FG013|Overall Study|Request to discontinue|1|||
160825385|NCT02754141|580747126|FG014|Overall Study|Request to discontinue|1|||
160825386|NCT02754141|580747127|FG015|Overall Study|Request to discontinue|0|||
160825387|NCT02754141|580747128|FG016|Overall Study|Request to discontinue|0|||
160825388|NCT02754141|580747129|FG017|Overall Study|Request to discontinue|0|||
160825389|NCT02754141|580747112|FG000|Overall Study|Withdrew consent|0|||
160825390|NCT02754141|580747113|FG001|Overall Study|Withdrew consent|0|||
160825391|NCT02754141|580747114|FG002|Overall Study|Withdrew consent|0|||
160825392|NCT02754141|580747115|FG003|Overall Study|Withdrew consent|0|||
160825393|NCT02754141|580747116|FG004|Overall Study|Withdrew consent|0|||
160825394|NCT02754141|580747117|FG005|Overall Study|Withdrew consent|0|||
160825395|NCT02754141|580747118|FG006|Overall Study|Withdrew consent|0|||
160825396|NCT02754141|580747119|FG007|Overall Study|Withdrew consent|0|||
160825397|NCT02754141|580747120|FG008|Overall Study|Withdrew consent|0|||
160825398|NCT02754141|580747121|FG009|Overall Study|Withdrew consent|1|||
160825399|NCT02754141|580747122|FG010|Overall Study|Withdrew consent|0|||
160825400|NCT02754141|580747123|FG011|Overall Study|Withdrew consent|0|||
160825401|NCT02754141|580747124|FG012|Overall Study|Withdrew consent|0|||
160825402|NCT02754141|580747125|FG013|Overall Study|Withdrew consent|0|||
160825403|NCT02754141|580747126|FG014|Overall Study|Withdrew consent|0|||
160825404|NCT02754141|580747127|FG015|Overall Study|Withdrew consent|0|||
160825405|NCT02754141|580747128|FG016|Overall Study|Withdrew consent|0|||
160825406|NCT02754141|580747129|FG017|Overall Study|Withdrew consent|0|||
160825407|NCT02754141|580747112|FG000|Overall Study|Maximum clinical benefit|0|||
160825408|NCT02754141|580747113|FG001|Overall Study|Maximum clinical benefit|0|||
160825409|NCT02754141|580747114|FG002|Overall Study|Maximum clinical benefit|0|||
160825410|NCT02754141|580747115|FG003|Overall Study|Maximum clinical benefit|1|||
160825411|NCT02754141|580747116|FG004|Overall Study|Maximum clinical benefit|0|||
160825412|NCT02754141|580747117|FG005|Overall Study|Maximum clinical benefit|0|||
160825413|NCT02754141|580747118|FG006|Overall Study|Maximum clinical benefit|0|||
160646618|NCT04147715|580088318|FG011|Overall Study|Adverse Event|0|||
160825414|NCT02754141|580747119|FG007|Overall Study|Maximum clinical benefit|0|||
160825415|NCT02754141|580747120|FG008|Overall Study|Maximum clinical benefit|0|||
160825416|NCT02754141|580747121|FG009|Overall Study|Maximum clinical benefit|0|||
160825417|NCT02754141|580747122|FG010|Overall Study|Maximum clinical benefit|0|||
160825418|NCT02754141|580747123|FG011|Overall Study|Maximum clinical benefit|0|||
160825419|NCT02754141|580747124|FG012|Overall Study|Maximum clinical benefit|0|||
160825420|NCT02754141|580747125|FG013|Overall Study|Maximum clinical benefit|0|||
160825421|NCT02754141|580747126|FG014|Overall Study|Maximum clinical benefit|0|||
160825422|NCT02754141|580747127|FG015|Overall Study|Maximum clinical benefit|0|||
160825423|NCT02754141|580747128|FG016|Overall Study|Maximum clinical benefit|0|||
160825424|NCT02754141|580747129|FG017|Overall Study|Maximum clinical benefit|0|||
160825425|NCT02754141|580747112|FG000|Overall Study|No longer meets study criteria|0|||
160825426|NCT02754141|580747113|FG001|Overall Study|No longer meets study criteria|0|||
160825427|NCT02754141|580747114|FG002|Overall Study|No longer meets study criteria|0|||
160825428|NCT02754141|580747115|FG003|Overall Study|No longer meets study criteria|1|||
160825429|NCT02754141|580747116|FG004|Overall Study|No longer meets study criteria|0|||
160825430|NCT02754141|580747117|FG005|Overall Study|No longer meets study criteria|0|||
160825431|NCT02754141|580747118|FG006|Overall Study|No longer meets study criteria|0|||
160825432|NCT02754141|580747119|FG007|Overall Study|No longer meets study criteria|0|||
160825433|NCT02754141|580747120|FG008|Overall Study|No longer meets study criteria|0|||
160825434|NCT02754141|580747121|FG009|Overall Study|No longer meets study criteria|0|||
160825435|NCT02754141|580747122|FG010|Overall Study|No longer meets study criteria|0|||
160825436|NCT02754141|580747123|FG011|Overall Study|No longer meets study criteria|0|||
160825437|NCT02754141|580747124|FG012|Overall Study|No longer meets study criteria|0|||
160825438|NCT02754141|580747125|FG013|Overall Study|No longer meets study criteria|0|||
160825439|NCT02754141|580747126|FG014|Overall Study|No longer meets study criteria|0|||
160825440|NCT02754141|580747127|FG015|Overall Study|No longer meets study criteria|0|||
160825441|NCT02754141|580747128|FG016|Overall Study|No longer meets study criteria|0|||
160825442|NCT02754141|580747129|FG017|Overall Study|No longer meets study criteria|0|||
160825443|NCT02754141|580747112|FG000|Overall Study|Other reasons|0|||
160825444|NCT02754141|580747113|FG001|Overall Study|Other reasons|0|||
160825445|NCT02754141|580747114|FG002|Overall Study|Other reasons|0|||
160825446|NCT02754141|580747115|FG003|Overall Study|Other reasons|0|||
160825447|NCT02754141|580747116|FG004|Overall Study|Other reasons|0|||
160825448|NCT02754141|580747117|FG005|Overall Study|Other reasons|0|||
160825449|NCT02754141|580747118|FG006|Overall Study|Other reasons|0|||
160825450|NCT02754141|580747119|FG007|Overall Study|Other reasons|1|||
160825451|NCT02754141|580747120|FG008|Overall Study|Other reasons|0|||
160825452|NCT02754141|580747121|FG009|Overall Study|Other reasons|0|||
160825453|NCT02754141|580747122|FG010|Overall Study|Other reasons|0|||
160825454|NCT02754141|580747123|FG011|Overall Study|Other reasons|0|||
160825455|NCT02754141|580747124|FG012|Overall Study|Other reasons|2|||
160825456|NCT02754141|580747125|FG013|Overall Study|Other reasons|0|||
160989958|NCT00711646|581351704|FG000|Overall Study|patient non-compliance|1|||
160825457|NCT02754141|580747126|FG014|Overall Study|Other reasons|0|||
160825458|NCT02754141|580747127|FG015|Overall Study|Other reasons|0|||
160825459|NCT02754141|580747128|FG016|Overall Study|Other reasons|0|||
160825460|NCT02754141|580747129|FG017|Overall Study|Other reasons|0|||
160825461|NCT02754141|580747112|FG000|Overall Study|Completed treatment as per protocol|0|||
160825462|NCT02754141|580747113|FG001|Overall Study|Completed treatment as per protocol|1|||
160825463|NCT02754141|580747114|FG002|Overall Study|Completed treatment as per protocol|0|||
160825464|NCT02754141|580747115|FG003|Overall Study|Completed treatment as per protocol|0|||
160989959|NCT00711646|581351705|FG001|Overall Study|patient non-compliance|0|||
160825465|NCT02754141|580747116|FG004|Overall Study|Completed treatment as per protocol|0|||
160825466|NCT02754141|580747117|FG005|Overall Study|Completed treatment as per protocol|0|||
160825467|NCT02754141|580747118|FG006|Overall Study|Completed treatment as per protocol|0|||
160989960|NCT03441360|581351706|FG000|Overall Study|Radiological disease progression|5|||
160989961|NCT03441360|581351707|FG001|Overall Study|Radiological disease progression|6|||
160825468|NCT02754141|580747119|FG007|Overall Study|Completed treatment as per protocol|0|||
160825469|NCT02754141|580747120|FG008|Overall Study|Completed treatment as per protocol|0|||
160825470|NCT02754141|580747121|FG009|Overall Study|Completed treatment as per protocol|0|||
160825471|NCT02754141|580747122|FG010|Overall Study|Completed treatment as per protocol|0|||
160825472|NCT02754141|580747123|FG011|Overall Study|Completed treatment as per protocol|0|||
160825473|NCT02754141|580747124|FG012|Overall Study|Completed treatment as per protocol|1|||
160825474|NCT02754141|580747125|FG013|Overall Study|Completed treatment as per protocol|0|||
160825475|NCT02754141|580747126|FG014|Overall Study|Completed treatment as per protocol|0|||
160825476|NCT02754141|580747127|FG015|Overall Study|Completed treatment as per protocol|0|||
160825477|NCT02754141|580747128|FG016|Overall Study|Completed treatment as per protocol|0|||
160825478|NCT02754141|580747129|FG017|Overall Study|Completed treatment as per protocol|0|||
160825479|NCT02754141|580747112|FG000|Overall Study|Not completing monotherapy|0|||
160825480|NCT02754141|580747113|FG001|Overall Study|Not completing monotherapy|0|||
160825481|NCT02754141|580747114|FG002|Overall Study|Not completing monotherapy|0|||
160825482|NCT02754141|580747115|FG003|Overall Study|Not completing monotherapy|0|||
160825483|NCT02754141|580747116|FG004|Overall Study|Not completing monotherapy|0|||
160825484|NCT02754141|580747117|FG005|Overall Study|Not completing monotherapy|0|||
160825485|NCT02754141|580747118|FG006|Overall Study|Not completing monotherapy|0|||
160825486|NCT02754141|580747119|FG007|Overall Study|Not completing monotherapy|0|||
160825487|NCT02754141|580747120|FG008|Overall Study|Not completing monotherapy|0|||
160825488|NCT02754141|580747121|FG009|Overall Study|Not completing monotherapy|0|||
160825489|NCT02754141|580747122|FG010|Overall Study|Not completing monotherapy|0|||
160825490|NCT02754141|580747123|FG011|Overall Study|Not completing monotherapy|0|||
160825491|NCT02754141|580747124|FG012|Overall Study|Not completing monotherapy|0|||
160825492|NCT02754141|580747125|FG013|Overall Study|Not completing monotherapy|1|||
160825493|NCT02754141|580747126|FG014|Overall Study|Not completing monotherapy|0|||
160825494|NCT02754141|580747127|FG015|Overall Study|Not completing monotherapy|0|||
160825495|NCT02754141|580747128|FG016|Overall Study|Not completing monotherapy|0|||
160825496|NCT02754141|580747129|FG017|Overall Study|Not completing monotherapy|0|||
160825497|NCT00759356|580747144|FG000|Overall Study|Adverse Event|0|||
160825498|NCT00759356|580747145|FG001|Overall Study|Adverse Event|1|||
160825499|NCT00759356|580747144|FG000|Overall Study|Withdrawal by Subject|0|||
160825500|NCT00759356|580747145|FG001|Overall Study|Withdrawal by Subject|2|||
160825501|NCT00759356|580747144|FG000|Overall Study|Subject was unable to return|1|||
160825502|NCT00759356|580747145|FG001|Overall Study|Subject was unable to return|0|||
160825503|NCT03199053|580747146|FG000|ST Period|Withdrawal by Subject|2|||
160825504|NCT03199053|580747147|FG001|ST Period|Withdrawal by Subject|4|||
160825505|NCT03199053|580747148|FG002|ST Period|Withdrawal by Subject|6|||
160825506|NCT03199053|580747146|FG000|ST Period|Withdrawal by parent/guardian|1|||
160825507|NCT03199053|580747147|FG001|ST Period|Withdrawal by parent/guardian|1|||
160825508|NCT03199053|580747148|FG002|ST Period|Withdrawal by parent/guardian|1|||
160825509|NCT03199053|580747146|FG000|ST Period|Lost to Follow-up|2|||
160825510|NCT03199053|580747147|FG001|ST Period|Lost to Follow-up|0|||
160825511|NCT03199053|580747148|FG002|ST Period|Lost to Follow-up|1|||
160825512|NCT03199053|580747146|FG000|LT Period|Withdrawal by Subject|1|||
160825513|NCT03199053|580747147|FG001|LT Period|Withdrawal by Subject|3|||
160825514|NCT03199053|580747148|FG002|LT Period|Withdrawal by Subject|3|||
160825515|NCT03199053|580747146|FG000|LT Period|Withdrawal by parent/guardian|0|||
160825516|NCT03199053|580747147|FG001|LT Period|Withdrawal by parent/guardian|0|||
160825517|NCT03199053|580747148|FG002|LT Period|Withdrawal by parent/guardian|1|||
160825518|NCT03199053|580747146|FG000|LT Period|Lost to Follow-up|0|||
160825519|NCT03199053|580747147|FG001|LT Period|Lost to Follow-up|1|||
160825520|NCT03199053|580747148|FG002|LT Period|Lost to Follow-up|1|||
160825521|NCT03199053|580747146|FG000|LT Period|Miscellaneous|0|||
160825522|NCT03199053|580747147|FG001|LT Period|Miscellaneous|0|||
160989962|NCT03441360|581351708|FG002|Overall Study|Radiological disease progression|4|||
160554339|NCT00168831|579755761|FG002|Overall Study|Adverse Event|74|||
160825523|NCT03199053|580747148|FG002|LT Period|Miscellaneous|2|||
160825524|NCT03199053|580747146|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
160825525|NCT03199053|580747147|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
160825526|NCT03199053|580747148|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
160825527|NCT03199053|580747146|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
160825528|NCT03199053|580747147|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
160825529|NCT03199053|580747148|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
160825530|NCT03199053|580747146|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
160825531|NCT03199053|580747147|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
160825532|NCT03199053|580747148|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
160825533|NCT03199053|580747146|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
160825534|NCT03199053|580747147|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
160825535|NCT03199053|580747148|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
160825536|NCT03263923|580747150|FG000|Overall Study|Withdrawal by Subject|10|||
160646619|NCT02418910|580088320|FG000|Overall Study|Lost to Follow-up|3|||
160646620|NCT02418910|580088320|FG000|Overall Study|Withdrawal by Subject|4|||
160646621|NCT02472977|580088327|FG000|Overall Study|Disease progression|4|||
160646622|NCT02472977|580088328|FG001|Overall Study|Disease progression|25|||
160646623|NCT02472977|580088329|FG002|Overall Study|Disease progression|6|||
160646624|NCT02472977|580088327|FG000|Overall Study|Withdrawal by Subject|0|||
160646625|NCT02472977|580088328|FG001|Overall Study|Withdrawal by Subject|1|||
160646626|NCT02472977|580088329|FG002|Overall Study|Withdrawal by Subject|0|||
160646627|NCT02472977|580088327|FG000|Overall Study|Study drug toxicity|2|||
160646628|NCT02472977|580088328|FG001|Overall Study|Study drug toxicity|0|||
160646629|NCT02472977|580088329|FG002|Overall Study|Study drug toxicity|2|||
160646630|NCT02472977|580088327|FG000|Overall Study|Subject request to discontinue treatment|0|||
160646631|NCT02472977|580088328|FG001|Overall Study|Subject request to discontinue treatment|1|||
160646632|NCT02472977|580088329|FG002|Overall Study|Subject request to discontinue treatment|0|||
160646633|NCT03775681|580088335|FG000|Overall Study|Physician Decision|3|||
160646634|NCT00616928|580088336|FG000|Overall Study|Adverse Event|6|||
160646635|NCT00616928|580088337|FG001|Overall Study|Adverse Event|3|||
160646636|NCT00616928|580088338|FG002|Overall Study|Adverse Event|2|||
160646637|NCT00616928|580088339|FG003|Overall Study|Adverse Event|2|||
160646638|NCT00616928|580088336|FG000|Overall Study|Other|51|||
160646639|NCT00616928|580088337|FG001|Overall Study|Other|8|||
160646640|NCT00616928|580088338|FG002|Overall Study|Other|15|||
160646641|NCT00616928|580088339|FG003|Overall Study|Other|5|||
160646642|NCT00616928|580088336|FG000|Overall Study|Lost to Follow-up|5|||
160646643|NCT00616928|580088337|FG001|Overall Study|Lost to Follow-up|7|||
160646644|NCT00616928|580088338|FG002|Overall Study|Lost to Follow-up|0|||
160646645|NCT00616928|580088339|FG003|Overall Study|Lost to Follow-up|0|||
160646646|NCT00895583|580088340|FG000|Overall Study|Adverse Event|28|||
160646647|NCT00895583|580088341|FG001|Overall Study|Adverse Event|4|||
160646648|NCT00895583|580088340|FG000|Overall Study|Death|2|||
160646649|NCT00895583|580088341|FG001|Overall Study|Death|1|||
160902127|NCT01281137|581035985|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
160902128|NCT00810355|581035988|FG000|Overall Study|Lost to Follow-up|13|||
160902129|NCT00810355|581035989|FG001|Overall Study|Lost to Follow-up|17|||
160902130|NCT00810355|581035990|FG002|Overall Study|Lost to Follow-up|11|||
160902131|NCT00810355|581035988|FG000|Overall Study|Withdrawal by Subject|1|||
160902132|NCT00810355|581035989|FG001|Overall Study|Withdrawal by Subject|0|||
160902133|NCT00810355|581035990|FG002|Overall Study|Withdrawal by Subject|0|||
160902134|NCT00657358|581035991|FG000|Overall Study|Lack of Efficacy|6|||
160902135|NCT00400764|581035992|FG000|Phase Ib|Adverse Event|1|||
160902136|NCT00400764|581035993|FG001|Phase Ib|Adverse Event|0|||
160902137|NCT00400764|581035994|FG002|Phase Ib|Adverse Event|0|||
160902138|NCT00400764|581035995|FG003|Phase Ib|Adverse Event|0|||
160902139|NCT00400764|581035996|FG004|Phase Ib|Adverse Event|0|||
160902140|NCT00400764|581035992|FG000|Phase Ib|Death|1|||
160902141|NCT00400764|581035993|FG001|Phase Ib|Death|0|||
160646650|NCT00895583|580088340|FG000|Overall Study|Physician Decision|3|||
160646651|NCT00895583|580088341|FG001|Overall Study|Physician Decision|1|||
160646652|NCT00895583|580088340|FG000|Overall Study|Lost to Follow-up|1|||
160646653|NCT00895583|580088341|FG001|Overall Study|Lost to Follow-up|3|||
160646654|NCT00895583|580088340|FG000|Overall Study|Protocol Violation|1|||
160646655|NCT00895583|580088341|FG001|Overall Study|Protocol Violation|0|||
160902142|NCT00400764|581035994|FG002|Phase Ib|Death|0|||
160902143|NCT00400764|581035995|FG003|Phase Ib|Death|0|||
160825537|NCT03263923|580747151|FG001|Overall Study|Withdrawal by Subject|8|||
160825538|NCT03263923|580747150|FG000|Overall Study|Lost to Follow-up|15|||
160825539|NCT03263923|580747151|FG001|Overall Study|Lost to Follow-up|13|||
160825540|NCT01323270|580747152|FG000|Overall Study|Withdrawal by Subject|19|||
160825541|NCT01323270|580747153|FG001|Overall Study|Withdrawal by Subject|10|||
160825542|NCT01323270|580747152|FG000|Overall Study|Protocol Violation|9|||
160825543|NCT01323270|580747153|FG001|Overall Study|Protocol Violation|7|||
160825544|NCT01323270|580747152|FG000|Overall Study|Lost to Follow-up|4|||
160825545|NCT01323270|580747153|FG001|Overall Study|Lost to Follow-up|6|||
160825546|NCT01323270|580747152|FG000|Overall Study|Adverse Event|8|||
160825547|NCT01323270|580747153|FG001|Overall Study|Adverse Event|0|||
160825548|NCT01323270|580747152|FG000|Overall Study|Other|0|||
160825549|NCT01323270|580747153|FG001|Overall Study|Other|3|||
160825550|NCT01323270|580747152|FG000|Overall Study|Physician Decision|0|||
160825551|NCT01323270|580747153|FG001|Overall Study|Physician Decision|2|||
160825552|NCT01323270|580747152|FG000|Overall Study|Not eligible|1|||
160825553|NCT01323270|580747153|FG001|Overall Study|Not eligible|1|||
160825554|NCT01323270|580747152|FG000|Overall Study|Death|1|||
160825555|NCT01323270|580747153|FG001|Overall Study|Death|0|||
160825556|NCT01323270|580747152|FG000|Overall Study|Randomized, but not vaccinated|1|||
160825557|NCT01323270|580747153|FG001|Overall Study|Randomized, but not vaccinated|0|||
160825558|NCT00246025|580747154|FG000|Overall Study|Adverse Event|7|||
160825559|NCT00246025|580747155|FG001|Overall Study|Adverse Event|9|||
160825560|NCT00246025|580747156|FG002|Overall Study|Adverse Event|9|||
160825561|NCT00246025|580747157|FG003|Overall Study|Adverse Event|10|||
160825562|NCT00246025|580747154|FG000|Overall Study|Withdrawal by Subject|3|||
160825563|NCT00246025|580747155|FG001|Overall Study|Withdrawal by Subject|0|||
160825564|NCT00246025|580747156|FG002|Overall Study|Withdrawal by Subject|1|||
160825565|NCT00246025|580747157|FG003|Overall Study|Withdrawal by Subject|2|||
160825566|NCT00246025|580747154|FG000|Overall Study|unsuitable medical history was found|0|||
160825567|NCT00246025|580747155|FG001|Overall Study|unsuitable medical history was found|0|||
160825568|NCT00246025|580747156|FG002|Overall Study|unsuitable medical history was found|0|||
160825569|NCT00246025|580747157|FG003|Overall Study|unsuitable medical history was found|1|||
160825570|NCT01218100|580747160|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
160825571|NCT01218100|580747161|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
160825572|NCT01218100|580747162|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
160825573|NCT01218100|580747163|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
160825574|NCT01218100|580747160|FG000|Overall Study|Adverse Event|4|||
160825575|NCT01218100|580747161|FG001|Overall Study|Adverse Event|6|||
160825576|NCT01218100|580747162|FG002|Overall Study|Adverse Event|6|||
160825577|NCT01218100|580747163|FG003|Overall Study|Adverse Event|7|||
160825578|NCT01218100|580747160|FG000|Overall Study|Lack of Efficacy|9|||
160825579|NCT01218100|580747161|FG001|Overall Study|Lack of Efficacy|6|||
160825580|NCT01218100|580747162|FG002|Overall Study|Lack of Efficacy|5|||
160825581|NCT01218100|580747163|FG003|Overall Study|Lack of Efficacy|12|||
160825582|NCT01218100|580747160|FG000|Overall Study|Protocol Violation|0|||
160825583|NCT01218100|580747161|FG001|Overall Study|Protocol Violation|0|||
160825584|NCT01218100|580747162|FG002|Overall Study|Protocol Violation|1|||
160825585|NCT01218100|580747163|FG003|Overall Study|Protocol Violation|1|||
160825586|NCT01218100|580747160|FG000|Overall Study|Withdrawal by Subject|5|||
160825587|NCT01218100|580747161|FG001|Overall Study|Withdrawal by Subject|2|||
160825588|NCT01218100|580747162|FG002|Overall Study|Withdrawal by Subject|6|||
160825589|NCT01218100|580747163|FG003|Overall Study|Withdrawal by Subject|7|||
160825590|NCT01218100|580747160|FG000|Overall Study|Lost to Follow-up|3|||
160825591|NCT01218100|580747161|FG001|Overall Study|Lost to Follow-up|8|||
160825592|NCT01218100|580747162|FG002|Overall Study|Lost to Follow-up|2|||
160825593|NCT01218100|580747163|FG003|Overall Study|Lost to Follow-up|1|||
160825594|NCT01218100|580747160|FG000|Overall Study|Other Reason|2|||
160825595|NCT01218100|580747161|FG001|Overall Study|Other Reason|2|||
160825596|NCT01218100|580747162|FG002|Overall Study|Other Reason|6|||
160825597|NCT01218100|580747163|FG003|Overall Study|Other Reason|4|||
160825598|NCT01118520|580747164|FG000|Overall Study|AAA repair|9|||
160825599|NCT01118520|580747165|FG001|Overall Study|AAA repair|7|||
160825600|NCT01118520|580747166|FG002|Overall Study|AAA repair|9|||
160825601|NCT01118520|580747164|FG000|Overall Study|Adverse Event|3|||
160825602|NCT01118520|580747165|FG001|Overall Study|Adverse Event|3|||
160825603|NCT01118520|580747166|FG002|Overall Study|Adverse Event|3|||
160825604|NCT01118520|580747164|FG000|Overall Study|Withdrawal by Subject|8|||
160825605|NCT01118520|580747165|FG001|Overall Study|Withdrawal by Subject|13|||
160825606|NCT01118520|580747166|FG002|Overall Study|Withdrawal by Subject|8|||
160825607|NCT01170065|580747183|FG000|Overall Study|Adverse Event|17|||
160825608|NCT01170065|580747184|FG001|Overall Study|Adverse Event|50|||
160825609|NCT01170065|580747185|FG002|Overall Study|Adverse Event|10|||
160902144|NCT00400764|581035996|FG004|Phase Ib|Death|0|||
160825610|NCT01170065|580747183|FG000|Overall Study|Lost to Follow-up|1|||
160825611|NCT01170065|580747184|FG001|Overall Study|Lost to Follow-up|4|||
160825612|NCT01170065|580747185|FG002|Overall Study|Lost to Follow-up|1|||
160825613|NCT01170065|580747183|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
160825614|NCT01170065|580747184|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
160825615|NCT01170065|580747185|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
160825616|NCT01170065|580747183|FG000|Overall Study|Reason other than specified|3|||
160825617|NCT01170065|580747184|FG001|Overall Study|Reason other than specified|8|||
160825618|NCT01170065|580747185|FG002|Overall Study|Reason other than specified|3|||
160825619|NCT01170065|580747183|FG000|Overall Study|Ongoing after planned observation time|5|||
160825620|NCT01170065|580747184|FG001|Overall Study|Ongoing after planned observation time|26|||
160825621|NCT01170065|580747185|FG002|Overall Study|Ongoing after planned observation time|10|||
160825622|NCT03220581|580747186|FG000|Overall Study|Withdrawal by Subject|0|||
160825623|NCT03220581|580747187|FG001|Overall Study|Withdrawal by Subject|1|||
160554340|NCT00168831|579755759|FG000|Overall Study|Lost to Follow-up|5|||
160554341|NCT00168831|579755760|FG001|Overall Study|Lost to Follow-up|6|||
160554342|NCT00168831|579755761|FG002|Overall Study|Lost to Follow-up|4|||
160554343|NCT00168831|579755759|FG000|Overall Study|Withdrawal by Subject|7|||
160554344|NCT00168831|579755760|FG001|Overall Study|Withdrawal by Subject|14|||
160554345|NCT00168831|579755761|FG002|Overall Study|Withdrawal by Subject|19|||
160554346|NCT00168831|579755759|FG000|Overall Study|Protocol Violation|6|||
160554347|NCT00168831|579755760|FG001|Overall Study|Protocol Violation|11|||
160554348|NCT00168831|579755761|FG002|Overall Study|Protocol Violation|11|||
160554349|NCT00168831|579755759|FG000|Overall Study|Other|6|||
160554350|NCT00168831|579755760|FG001|Overall Study|Other|3|||
160554351|NCT00168831|579755761|FG002|Overall Study|Other|6|||
160554352|NCT01622569|579755762|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
160554353|NCT01622569|579755763|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
160554354|NCT01622569|579755764|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
160554355|NCT01622569|579755765|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
160554356|NCT01622569|579755762|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
160554357|NCT01622569|579755763|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
160554358|NCT01622569|579755764|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
160825624|NCT03220581|580747186|FG000|Overall Study|Lost to Follow-up|3|||
160825625|NCT03220581|580747187|FG001|Overall Study|Lost to Follow-up|6|||
160825626|NCT01071200|580747188|FG000|Overall Study|Lack of ovarian response|1|||
160825627|NCT01071200|580747189|FG001|Overall Study|Lack of ovarian response|1|||
160825628|NCT01071200|580747188|FG000|Overall Study|No fertilization|4|||
160825629|NCT01071200|580747189|FG001|Overall Study|No fertilization|0|||
160825630|NCT01071200|580747188|FG000|Overall Study|No oocytes retrieved|1|||
160825631|NCT01071200|580747189|FG001|Overall Study|No oocytes retrieved|1|||
160825632|NCT01071200|580747188|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
160825633|NCT01071200|580747189|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
160825634|NCT01071200|580747188|FG000|Overall Study|No viable embryos|0|||
160825635|NCT01071200|580747189|FG001|Overall Study|No viable embryos|1|||
160825636|NCT01920893|580747192|FG000|Overall Study|Adverse Event|5|||
160825637|NCT01920893|580747193|FG001|Overall Study|Adverse Event|2|||
160825638|NCT01920893|580747192|FG000|Overall Study|Lack of Efficacy|2|||
160825639|NCT01920893|580747193|FG001|Overall Study|Lack of Efficacy|0|||
160825640|NCT03883113|580747194|FG000|Overall Study|Physician Decision|4|||
160825641|NCT03883113|580747195|FG001|Overall Study|Physician Decision|2|||
160825642|NCT03883113|580747194|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
160825643|NCT03883113|580747195|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
160825644|NCT03883113|580747194|FG000|Overall Study|Pregnancy|1|||
160825645|NCT03883113|580747195|FG001|Overall Study|Pregnancy|0|||
160825646|NCT03883113|580747194|FG000|Overall Study|Adverse Event|0|||
160825647|NCT03883113|580747195|FG001|Overall Study|Adverse Event|1|||
160554359|NCT01622569|579755765|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
160554360|NCT01622569|579755762|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
160554361|NCT01622569|579755763|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
160554362|NCT01622569|579755764|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
160554363|NCT01622569|579755765|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
160554364|NCT01622569|579755762|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
160554365|NCT01622569|579755763|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
160554366|NCT01622569|579755764|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
160653396|NCT05665595|580112377|FG000|Overall Study|Death|6|||
160825648|NCT03883113|580747194|FG000|Overall Study|Withdrawal by Subject|1|||
160825649|NCT03883113|580747195|FG001|Overall Study|Withdrawal by Subject|2|||
160825650|NCT03883113|580747194|FG000|Overall Study|Lost to Follow-up|1|||
160825651|NCT03883113|580747195|FG001|Overall Study|Lost to Follow-up|0|||
160825652|NCT01396265|580747196|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
160825653|NCT01767493|580747197|FG000|Overall Study|screen failures|3|||
160825654|NCT03444766|580747198|FG000|Overall Study|Other Reasons|2|||
160902145|NCT00400764|581035992|FG000|Phase Ib|Disease Progression|4|||
160902146|NCT00400764|581035993|FG001|Phase Ib|Disease Progression|4|||
160902147|NCT00400764|581035994|FG002|Phase Ib|Disease Progression|0|||
160554367|NCT01622569|579755765|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
160825655|NCT03444766|580747198|FG000|Overall Study|Participant Withdrew Consent|5|||
160825656|NCT03444766|580747198|FG000|Overall Study|Lost to Follow-up|2|||
160825657|NCT03444766|580747198|FG000|Overall Study|Death|2|||
160825658|NCT03444766|580747198|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
160825659|NCT03444766|580747198|FG000|Overall Study|Disease Progression|49|||
160825660|NCT03023826|580747200|FG000|Period 1|Withdrawal by Subject|0|||
160825661|NCT03023826|580747201|FG001|Period 1|Withdrawal by Subject|0|||
160825662|NCT03023826|580747202|FG002|Period 1|Withdrawal by Subject|0|||
160825663|NCT03023826|580747203|FG003|Period 1|Withdrawal by Subject|0|||
160825664|NCT03023826|580747204|FG004|Period 1|Withdrawal by Subject|1|||
160825665|NCT03023826|580747205|FG005|Period 1|Withdrawal by Subject|0|||
160825666|NCT00977938|580747206|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
160825667|NCT00977938|580747207|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
160825668|NCT00977938|580747208|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
160825669|NCT00977938|580747209|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
160825670|NCT00977938|580747206|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
160825671|NCT00977938|580747207|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
160825672|NCT00977938|580747208|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
160902148|NCT00400764|581035995|FG003|Phase Ib|Disease Progression|0|||
160554368|NCT01622569|579755762|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
160554369|NCT01622569|579755763|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
160554370|NCT01622569|579755764|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
160554371|NCT01622569|579755765|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
160554372|NCT01622569|579755762|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
160554373|NCT01622569|579755763|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
160554374|NCT01622569|579755764|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
160554375|NCT01622569|579755765|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
160554376|NCT01622569|579755762|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
160554377|NCT01622569|579755763|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
160554378|NCT01622569|579755764|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
160554379|NCT01622569|579755765|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
160554380|NCT01622569|579755762|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
160554381|NCT01622569|579755763|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
160554382|NCT01622569|579755764|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
160646656|NCT00895583|580088340|FG000|Overall Study|Withdrawal by Subject|4|||
160646657|NCT00895583|580088341|FG001|Overall Study|Withdrawal by Subject|2|||
160902149|NCT00400764|581035996|FG004|Phase Ib|Disease Progression|0|||
160902150|NCT00400764|581035992|FG000|Phase II|Death|0|||
160902151|NCT00400764|581035993|FG001|Phase II|Death|0|||
160902152|NCT00400764|581035994|FG002|Phase II|Death|1|||
160902153|NCT00400764|581035995|FG003|Phase II|Death|2|||
160902154|NCT00400764|581035996|FG004|Phase II|Death|0|||
160902155|NCT00400764|581035992|FG000|Phase II|Lost to Follow-up|0|||
160902156|NCT00400764|581035993|FG001|Phase II|Lost to Follow-up|0|||
160902157|NCT00400764|581035994|FG002|Phase II|Lost to Follow-up|1|||
160902158|NCT00400764|581035995|FG003|Phase II|Lost to Follow-up|0|||
160902159|NCT00400764|581035996|FG004|Phase II|Lost to Follow-up|0|||
160902160|NCT00400764|581035992|FG000|Phase II|Physician Decision|0|||
160902161|NCT00400764|581035993|FG001|Phase II|Physician Decision|0|||
160902162|NCT00400764|581035994|FG002|Phase II|Physician Decision|1|||
160902163|NCT00400764|581035995|FG003|Phase II|Physician Decision|1|||
160902164|NCT00400764|581035996|FG004|Phase II|Physician Decision|0|||
160902165|NCT00400764|581035992|FG000|Phase II|Sponsor's decision to terminate|0|||
160902166|NCT00400764|581035993|FG001|Phase II|Sponsor's decision to terminate|0|||
160902167|NCT00400764|581035994|FG002|Phase II|Sponsor's decision to terminate|18|||
160902168|NCT00400764|581035995|FG003|Phase II|Sponsor's decision to terminate|22|||
160902169|NCT00400764|581035996|FG004|Phase II|Sponsor's decision to terminate|11|||
160902170|NCT00400764|581035992|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
160902171|NCT00400764|581035993|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
160902172|NCT00400764|581035994|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
160902173|NCT00400764|581035995|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
160825673|NCT00977938|580747209|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
160825674|NCT00977938|580747206|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
160902174|NCT00400764|581035996|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
160902175|NCT00400764|581035992|FG000|Phase II|Withdrawal by Subject|0|||
160902176|NCT00400764|581035993|FG001|Phase II|Withdrawal by Subject|0|||
160902177|NCT00400764|581035994|FG002|Phase II|Withdrawal by Subject|1|||
160902178|NCT00400764|581035995|FG003|Phase II|Withdrawal by Subject|1|||
160989963|NCT03441360|581351706|FG000|Overall Study|Clinical disease progression|2|||
160825675|NCT00977938|580747207|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
160825676|NCT00977938|580747208|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
160902179|NCT00400764|581035996|FG004|Phase II|Withdrawal by Subject|0|||
160902180|NCT03113916|581036000|FG000|Overall Study|Withdrawal by Subject|9|||
160825677|NCT00977938|580747209|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
160825678|NCT00977938|580747206|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
160825679|NCT00977938|580747207|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
160825680|NCT00977938|580747208|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
160825681|NCT00977938|580747209|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
160825682|NCT00977938|580747206|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
160825683|NCT00977938|580747207|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
160825684|NCT00977938|580747208|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
160825685|NCT00977938|580747209|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
160825686|NCT00977938|580747206|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
160825687|NCT00977938|580747207|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
160825688|NCT00977938|580747208|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
160825689|NCT00977938|580747209|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
160825690|NCT02182440|580747221|FG000|Overall Study|Adverse Event|0|||
160825691|NCT02182440|580747222|FG001|Overall Study|Adverse Event|1|||
160825692|NCT02182440|580747223|FG002|Overall Study|Adverse Event|0|||
160825693|NCT02182440|580747224|FG003|Overall Study|Adverse Event|0|||
160825694|NCT02182440|580747221|FG000|Overall Study|Death|31|||
160825695|NCT02182440|580747222|FG001|Overall Study|Death|8|||
160825696|NCT02182440|580747223|FG002|Overall Study|Death|5|||
160825697|NCT02182440|580747224|FG003|Overall Study|Death|16|||
160825698|NCT02182440|580747221|FG000|Overall Study|Protocol Violation|0|||
160825699|NCT02182440|580747222|FG001|Overall Study|Protocol Violation|1|||
160825700|NCT02182440|580747223|FG002|Overall Study|Protocol Violation|0|||
160825701|NCT02182440|580747224|FG003|Overall Study|Protocol Violation|0|||
160825702|NCT02182440|580747221|FG000|Overall Study|Physician Decision|1|||
160825703|NCT02182440|580747222|FG001|Overall Study|Physician Decision|0|||
160825704|NCT02182440|580747223|FG002|Overall Study|Physician Decision|0|||
160825705|NCT02182440|580747224|FG003|Overall Study|Physician Decision|0|||
160825706|NCT02182440|580747221|FG000|Overall Study|Withdrawal by Subject|1|||
160825707|NCT02182440|580747222|FG001|Overall Study|Withdrawal by Subject|1|||
160825708|NCT02182440|580747223|FG002|Overall Study|Withdrawal by Subject|3|||
160825709|NCT02182440|580747224|FG003|Overall Study|Withdrawal by Subject|4|||
160825710|NCT02182440|580747221|FG000|Overall Study|different, e.g adm other hospital|12|||
160825711|NCT02182440|580747222|FG001|Overall Study|different, e.g adm other hospital|3|||
160825712|NCT02182440|580747223|FG002|Overall Study|different, e.g adm other hospital|3|||
160825713|NCT02182440|580747224|FG003|Overall Study|different, e.g adm other hospital|10|||
160825714|NCT00072293|580747225|FG000|Overall Study|Lost to Follow-up|1|||
160825715|NCT00072293|580747226|FG001|Overall Study|Lost to Follow-up|1|||
160825716|NCT00072293|580747225|FG000|Overall Study|Withdrawal by Subject|0|||
160825717|NCT00072293|580747226|FG001|Overall Study|Withdrawal by Subject|1|||
160825718|NCT02680574|580747227|FG000|Overall Study|Death|137|||
160825719|NCT02680574|580747228|FG001|Overall Study|Death|137|||
160825720|NCT02680574|580747227|FG000|Overall Study|Withdrawal by Subject|17|||
160825721|NCT02680574|580747228|FG001|Overall Study|Withdrawal by Subject|9|||
160825722|NCT02680574|580747227|FG000|Overall Study|Lost to Follow-up|4|||
160825723|NCT02680574|580747228|FG001|Overall Study|Lost to Follow-up|6|||
160825724|NCT01166958|580747229|FG000|Overall Study|Withdrawal by Subject|1|||
160902181|NCT03113916|581036001|FG001|Overall Study|Withdrawal by Subject|7|||
160902182|NCT03113916|581036000|FG000|Overall Study|Pregnancy|1|||
160902183|NCT03113916|581036001|FG001|Overall Study|Pregnancy|3|||
160902184|NCT03113916|581036000|FG000|Overall Study|Lost to Follow-up|1|||
160902185|NCT03113916|581036001|FG001|Overall Study|Lost to Follow-up|2|||
160902186|NCT01893203|581036003|FG000|Overall Study|Withdrawal by Subject|1|||
160902187|NCT01758523|581036004|FG000|Overall Study|Adverse Event|2|||
160902188|NCT01758523|581036005|FG001|Overall Study|Adverse Event|1|||
160902189|NCT01758523|581036004|FG000|Overall Study|Lack of Efficacy|4|||
160902190|NCT01758523|581036005|FG001|Overall Study|Lack of Efficacy|2|||
160825725|NCT01166958|580747230|FG001|Overall Study|Withdrawal by Subject|0|||
160825726|NCT01605227|580747231|FG000|Overall Study|Did not receive study treatment|2|||
160825727|NCT01605227|580747232|FG001|Overall Study|Did not receive study treatment|3|||
160825728|NCT01605227|580747231|FG000|Overall Study|Adverse Event|228|||
160825729|NCT01605227|580747232|FG001|Overall Study|Adverse Event|42|||
160825730|NCT01605227|580747231|FG000|Overall Study|Progressive Disease|132|||
160825731|NCT01605227|580747232|FG001|Overall Study|Progressive Disease|128|||
160902191|NCT01758523|581036004|FG000|Overall Study|Lost to Follow-up|3|||
160902192|NCT01758523|581036005|FG001|Overall Study|Lost to Follow-up|4|||
160902193|NCT01758523|581036004|FG000|Overall Study|Withdrawal by Subject|12|||
160902194|NCT01758523|581036005|FG001|Overall Study|Withdrawal by Subject|7|||
160902195|NCT00722800|581036006|FG000|Overall Study|Withdrawal by Subject|1|||
160825732|NCT01605227|580747231|FG000|Overall Study|Clinical Deterioration|227|||
160825733|NCT01605227|580747232|FG001|Overall Study|Clinical Deterioration|133|||
160902196|NCT00722800|581036007|FG001|Overall Study|Withdrawal by Subject|0|||
160554383|NCT01622569|579755765|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
160825734|NCT01605227|580747231|FG000|Overall Study|Lost to Follow-up|1|||
160825735|NCT01605227|580747232|FG001|Overall Study|Lost to Follow-up|0|||
160825736|NCT01605227|580747231|FG000|Overall Study|Protocol Violation|1|||
160825737|NCT01605227|580747232|FG001|Overall Study|Protocol Violation|0|||
160825738|NCT01605227|580747231|FG000|Overall Study|Physician Decision|9|||
160825739|NCT01605227|580747232|FG001|Overall Study|Physician Decision|7|||
160554384|NCT01505894|579755766|FG000|Overall Study|Adverse Event|1|||
160554385|NCT01505894|579755767|FG001|Overall Study|Adverse Event|0|||
160554386|NCT01505894|579755768|FG002|Overall Study|Adverse Event|0|||
160554387|NCT01505894|579755769|FG003|Overall Study|Adverse Event|0|||
160554388|NCT01505894|579755770|FG004|Overall Study|Adverse Event|0|||
160554389|NCT01505894|579755771|FG005|Overall Study|Adverse Event|0|||
160554390|NCT01505894|579755772|FG006|Overall Study|Adverse Event|0|||
160554391|NCT01505894|579755773|FG007|Overall Study|Adverse Event|0|||
160825740|NCT01605227|580747231|FG000|Overall Study|Withdrawal by Subject|18|||
160825741|NCT01605227|580747232|FG001|Overall Study|Withdrawal by Subject|14|||
160825742|NCT01605227|580747231|FG000|Overall Study|Sponsor Decision|2|||
160825743|NCT01605227|580747232|FG001|Overall Study|Sponsor Decision|0|||
160825744|NCT01605227|580747231|FG000|Overall Study|Started New Therapy|1|||
160825745|NCT01605227|580747232|FG001|Overall Study|Started New Therapy|0|||
160825746|NCT01605227|580747231|FG000|Overall Study|Subject Decision|0|||
160825747|NCT01605227|580747232|FG001|Overall Study|Subject Decision|1|||
160825748|NCT01605227|580747231|FG000|Overall Study|Dose Held >6 weeks|0|||
160825749|NCT01605227|580747232|FG001|Overall Study|Dose Held >6 weeks|1|||
160825750|NCT01286987|580747233|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
160825751|NCT01286987|580747234|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
160825752|NCT01286987|580747235|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
160825753|NCT01286987|580747236|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
160825754|NCT01286987|580747237|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
160825755|NCT01286987|580747238|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
160825756|NCT01286987|580747239|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
160825757|NCT01286987|580747240|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
160825758|NCT01286987|580747241|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
160825759|NCT01286987|580747242|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
160825760|NCT01286987|580747243|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
160825761|NCT01286987|580747244|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
160825762|NCT01286987|580747245|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
160825763|NCT01286987|580747246|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
160825764|NCT01286987|580747247|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
160825765|NCT01286987|580747233|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
160825766|NCT01286987|580747234|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
160825767|NCT01286987|580747235|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
160825768|NCT01286987|580747236|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
160825769|NCT01286987|580747237|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
160825770|NCT01286987|580747238|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
160825771|NCT01286987|580747239|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
160825772|NCT01286987|580747240|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
160902197|NCT00722800|581036006|FG000|Overall Study|Physician Decision|1|||
160902198|NCT00722800|581036007|FG001|Overall Study|Physician Decision|0|||
160902199|NCT04729621|581036008|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
160902200|NCT04729621|581036009|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
160902201|NCT04729621|581036010|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
160902202|NCT04729621|581036011|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
160902203|NCT04729621|581036012|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
160902204|NCT04729621|581036008|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
160902205|NCT04729621|581036009|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
160902206|NCT04729621|581036010|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
160902207|NCT04729621|581036011|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
160902208|NCT04729621|581036012|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
160554392|NCT01505894|579755774|FG008|Overall Study|Adverse Event|0|||
160554393|NCT01505894|579755766|FG000|Overall Study|Other than specified|0|||
160646658|NCT00895583|580088340|FG000|Overall Study|Lack of Efficacy|5|||
160646659|NCT00895583|580088341|FG001|Overall Study|Lack of Efficacy|0|||
160902209|NCT04729621|581036008|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
160902210|NCT04729621|581036009|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
160554394|NCT01505894|579755767|FG001|Overall Study|Other than specified|0|||
160646660|NCT00895583|580088340|FG000|Overall Study|Other|0|||
160825773|NCT01286987|580747241|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
160825774|NCT01286987|580747242|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
160825775|NCT01286987|580747243|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
160825776|NCT01286987|580747244|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
160825777|NCT01286987|580747245|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
160825778|NCT01286987|580747246|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
160825779|NCT01286987|580747247|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
160825780|NCT01286987|580747233|FG000|Part 1: Dose Escalation|Physician Decision|0|||
160825781|NCT01286987|580747234|FG001|Part 1: Dose Escalation|Physician Decision|0|||
160825782|NCT01286987|580747235|FG002|Part 1: Dose Escalation|Physician Decision|0|||
160825783|NCT01286987|580747236|FG003|Part 1: Dose Escalation|Physician Decision|0|||
160825784|NCT01286987|580747237|FG004|Part 1: Dose Escalation|Physician Decision|1|||
160825785|NCT01286987|580747238|FG005|Part 1: Dose Escalation|Physician Decision|0|||
160825786|NCT01286987|580747239|FG006|Part 1: Dose Escalation|Physician Decision|0|||
160825787|NCT01286987|580747240|FG007|Part 1: Dose Escalation|Physician Decision|0|||
160825788|NCT01286987|580747241|FG008|Part 1: Dose Escalation|Physician Decision|0|||
160825789|NCT01286987|580747242|FG009|Part 1: Dose Escalation|Physician Decision|0|||
160825790|NCT01286987|580747243|FG010|Part 1: Dose Escalation|Physician Decision|0|||
160825791|NCT01286987|580747244|FG011|Part 1: Dose Escalation|Physician Decision|0|||
160825792|NCT01286987|580747245|FG012|Part 1: Dose Escalation|Physician Decision|0|||
160825793|NCT01286987|580747246|FG013|Part 1: Dose Escalation|Physician Decision|0|||
160825794|NCT01286987|580747247|FG014|Part 1: Dose Escalation|Physician Decision|0|||
160825795|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Death|0|||
160825796|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Death|0|||
160825797|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Death|0|||
160825798|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Death|0|||
160825799|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Death|0|||
160825800|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Death|0|||
160825801|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Death|0|||
160825802|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Death|0|||
160825803|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Death|0|||
160825804|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Death|0|||
160825805|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Death|0|||
160825806|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Death|0|||
160825807|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Death|1|||
160825808|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Death|1|||
160825809|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Death|0|||
160825810|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Physician Decision|0|||
160825811|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Physician Decision|0|||
160825812|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Physician Decision|0|||
160825813|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Physician Decision|0|||
160825814|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Physician Decision|0|||
160825815|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Physician Decision|0|||
160825816|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Physician Decision|0|||
160825817|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Physician Decision|0|||
160825818|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Physician Decision|0|||
160825819|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Physician Decision|0|||
160825820|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Physician Decision|1|||
160825821|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Physician Decision|1|||
160825822|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Physician Decision|0|||
160825823|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Physician Decision|1|||
160825824|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Physician Decision|0|||
160825825|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Other|0|||
160825826|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Other|0|||
160825827|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Other|0|||
160825828|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Other|0|||
160825829|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Other|0|||
160825830|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Other|0|||
160825831|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Other|0|||
160825832|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Other|0|||
160825833|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Other|0|||
160825834|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Other|0|||
160825835|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Other|0|||
160825836|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Other|0|||
160825837|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Other|0|||
160825838|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Other|1|||
160825839|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Other|0|||
160825840|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
160825841|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
160825842|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
160825843|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
160825844|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
160825845|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
160825846|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
160825847|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
160825848|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
160825849|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
160825850|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
160825851|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
160825852|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
160825853|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
160825854|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
160825855|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
160825856|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
160825857|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
160825858|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
160825859|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
160825860|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
160825861|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
160825862|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
160825863|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
160825864|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
160825865|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
160825866|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
160825867|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
160825868|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
160825869|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
160825870|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825871|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825872|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825873|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825874|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825875|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825876|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825877|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825878|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825879|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825880|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
160825881|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825882|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825883|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825884|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825885|NCT03093974|580747253|FG000|Overall Study|Withdrawal by Subject|32|||
160825886|NCT03093974|580747254|FG001|Overall Study|Withdrawal by Subject|27|||
160825887|NCT03093974|580747253|FG000|Overall Study|Adverse Event|17|||
160825888|NCT03093974|580747254|FG001|Overall Study|Adverse Event|24|||
160825889|NCT03093974|580747253|FG000|Overall Study|Death|0|||
160825890|NCT03093974|580747254|FG001|Overall Study|Death|1|||
160825891|NCT03093974|580747253|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160825892|NCT03093974|580747254|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160825893|NCT03093974|580747253|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
160825894|NCT03093974|580747254|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
160825895|NCT03093974|580747253|FG000|Overall Study|Lost to Follow-up|0|||
160825896|NCT03093974|580747254|FG001|Overall Study|Lost to Follow-up|1|||
160825897|NCT03093974|580747253|FG000|Overall Study|Other|1|||
160825898|NCT03093974|580747254|FG001|Overall Study|Other|2|||
160825899|NCT01009346|580747258|FG000|Overall Study|Adverse Event|4|||
160825900|NCT00033540|580747261|FG000|Overall Study|Adverse Event|14|||
160825901|NCT00033540|580747261|FG000|Overall Study|Death|1|||
160825902|NCT00033540|580747261|FG000|Overall Study|Progression|26|||
160825903|NCT00033540|580747261|FG000|Overall Study|Withdrawal by Subject|6|||
160825904|NCT00033540|580747261|FG000|Overall Study|Other|5|||
160825905|NCT00033540|580747261|FG000|Overall Study|Ineligible|3|||
160825906|NCT00033540|580747261|FG000|Overall Study|Never received treatment|2|||
160825907|NCT00405964|580747262|FG000|Overall Study|Treatment Failure|17|||
160825908|NCT00405964|580747263|FG001|Overall Study|Treatment Failure|45|||
160825909|NCT00405964|580747262|FG000|Overall Study|Adverse Event|7|||
160825910|NCT00405964|580747263|FG001|Overall Study|Adverse Event|16|||
160825911|NCT00405964|580747262|FG000|Overall Study|Lost to Follow-up|5|||
160825912|NCT00405964|580747263|FG001|Overall Study|Lost to Follow-up|5|||
160825913|NCT00405964|580747262|FG000|Overall Study|Withdrawal by Subject|19|||
160989964|NCT03441360|581351707|FG001|Overall Study|Clinical disease progression|2|||
160989965|NCT03441360|581351708|FG002|Overall Study|Clinical disease progression|0|||
160989966|NCT03441360|581351706|FG000|Overall Study|Adverse Event|1|||
160989967|NCT03441360|581351707|FG001|Overall Study|Adverse Event|0|||
160989968|NCT03441360|581351708|FG002|Overall Study|Adverse Event|1|||
160989969|NCT00269399|581351709|FG000|Overall Study|Lack of Efficacy|27|||
160825914|NCT00405964|580747263|FG001|Overall Study|Withdrawal by Subject|23|||
160989970|NCT00269399|581351710|FG001|Overall Study|Lack of Efficacy|10|||
160646661|NCT00895583|580088341|FG001|Overall Study|Other|1|||
160825915|NCT00405964|580747262|FG000|Overall Study|Protocol Violation|11|||
160825916|NCT00405964|580747263|FG001|Overall Study|Protocol Violation|6|||
160825917|NCT01253265|580747266|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
160646662|NCT03507439|580088344|FG000|Overall Study|Other|2|||
160825918|NCT01253265|580747267|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
160825919|NCT01253265|580747268|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
160825920|NCT01253265|580747269|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
160825921|NCT01253265|580747270|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
160825922|NCT01253265|580747266|FG000|Overall Study|Withdrawal by Subject|0|||
160825923|NCT01253265|580747267|FG001|Overall Study|Withdrawal by Subject|0|||
160825924|NCT01253265|580747268|FG002|Overall Study|Withdrawal by Subject|0|||
160825925|NCT01253265|580747269|FG003|Overall Study|Withdrawal by Subject|0|||
160825926|NCT01253265|580747270|FG004|Overall Study|Withdrawal by Subject|1|||
160825927|NCT00066469|580747273|FG000|Overall Study|Death|3|||
160825928|NCT00066469|580747273|FG000|Overall Study|Lack of Efficacy|9|||
160825929|NCT00066469|580747273|FG000|Overall Study|Lost to Follow-up|1|||
160825930|NCT00066469|580747273|FG000|Overall Study|Physician Decision|1|||
160825931|NCT00066469|580747273|FG000|Overall Study|Withdrawal by Subject|1|||
160825932|NCT00066469|580747273|FG000|Overall Study|ineligible|1|||
160825933|NCT03271047|580747274|FG000|Phase 1b: Dose Finding Period|Death|8|||
160825934|NCT03271047|580747275|FG001|Phase 1b: Dose Finding Period|Death|8|||
160825935|NCT03271047|580747276|FG002|Phase 1b: Dose Finding Period|Death|0|||
160825936|NCT03271047|580747277|FG003|Phase 1b: Dose Finding Period|Death|0|||
160825937|NCT03271047|580747274|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
160825938|NCT03271047|580747275|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
160825939|NCT03271047|580747276|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
160825940|NCT03271047|580747277|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
160825941|NCT03271047|580747274|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
160825942|NCT03271047|580747275|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
160825943|NCT03271047|580747276|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
160825944|NCT03271047|580747277|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
160825945|NCT03271047|580747274|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
160825946|NCT03271047|580747275|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
160825947|NCT03271047|580747276|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
160825948|NCT03271047|580747277|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
160825949|NCT03271047|580747274|FG000|Randomized Phase 2 Period|Other|0|||
160825950|NCT03271047|580747275|FG001|Randomized Phase 2 Period|Other|0|||
160825951|NCT03271047|580747276|FG002|Randomized Phase 2 Period|Other|0|||
160825952|NCT03271047|580747277|FG003|Randomized Phase 2 Period|Other|1|||
160825953|NCT03271047|580747274|FG000|Randomized Phase 2 Period|Death|0|||
160825954|NCT03271047|580747275|FG001|Randomized Phase 2 Period|Death|0|||
160825955|NCT03271047|580747276|FG002|Randomized Phase 2 Period|Death|20|||
160825956|NCT03271047|580747277|FG003|Randomized Phase 2 Period|Death|21|||
160825957|NCT03271047|580747274|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
160825958|NCT03271047|580747275|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
160825959|NCT03271047|580747276|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
160825960|NCT03271047|580747277|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
160825961|NCT03271047|580747274|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
160825962|NCT03271047|580747275|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
160825963|NCT03271047|580747276|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
160825964|NCT03271047|580747277|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
160825965|NCT03271047|580747274|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
160825966|NCT03271047|580747275|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
160825967|NCT03271047|580747276|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
160825968|NCT03271047|580747277|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
160825969|NCT00711802|580747278|FG000|Overall Study|Not treated (no further detail)|2|||
160825970|NCT00711802|580747279|FG001|Overall Study|Not treated (no further detail)|1|||
160989971|NCT00269399|581351709|FG000|Overall Study|Adverse Event|10|||
160989972|NCT00269399|581351710|FG001|Overall Study|Adverse Event|4|||
160989973|NCT00269399|581351709|FG000|Overall Study|Withdrawal by Subject|2|||
160989974|NCT00269399|581351710|FG001|Overall Study|Withdrawal by Subject|5|||
160825971|NCT00711802|580747280|FG002|Overall Study|Not treated (no further detail)|2|||
160825972|NCT00711802|580747281|FG003|Overall Study|Not treated (no further detail)|0|||
160825973|NCT00711802|580747282|FG004|Overall Study|Not treated (no further detail)|2|||
160825974|NCT00711802|580747283|FG005|Overall Study|Not treated (no further detail)|0|||
160825975|NCT00711802|580747284|FG006|Overall Study|Not treated (no further detail)|0|||
160825976|NCT00711802|580747285|FG007|Overall Study|Not treated (no further detail)|0|||
160825977|NCT00711802|580747278|FG000|Overall Study|Adverse Event|0|||
160989975|NCT00269399|581351709|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
160989976|NCT00269399|581351710|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
160989977|NCT00269399|581351709|FG000|Overall Study|Other|0|||
160646663|NCT03507439|580088345|FG001|Overall Study|Other|1|||
160825978|NCT00711802|580747279|FG001|Overall Study|Adverse Event|0|||
160825979|NCT00711802|580747280|FG002|Overall Study|Adverse Event|0|||
160825980|NCT00711802|580747281|FG003|Overall Study|Adverse Event|0|||
160825981|NCT00711802|580747282|FG004|Overall Study|Adverse Event|1|||
160825982|NCT00711802|580747283|FG005|Overall Study|Adverse Event|1|||
160825983|NCT00711802|580747284|FG006|Overall Study|Adverse Event|0|||
160825984|NCT00711802|580747285|FG007|Overall Study|Adverse Event|0|||
160825985|NCT00711802|580747278|FG000|Overall Study|Microbiological failure|0|||
160825986|NCT00711802|580747279|FG001|Overall Study|Microbiological failure|1|||
160825987|NCT00711802|580747280|FG002|Overall Study|Microbiological failure|0|||
160825988|NCT00711802|580747281|FG003|Overall Study|Microbiological failure|0|||
160825989|NCT00711802|580747282|FG004|Overall Study|Microbiological failure|0|||
160825990|NCT00711802|580747283|FG005|Overall Study|Microbiological failure|1|||
160825991|NCT00711802|580747284|FG006|Overall Study|Microbiological failure|0|||
160825992|NCT00711802|580747285|FG007|Overall Study|Microbiological failure|0|||
160825993|NCT00711802|580747278|FG000|Overall Study|Protocol Violation|0|||
160825994|NCT00711802|580747279|FG001|Overall Study|Protocol Violation|0|||
160825995|NCT00711802|580747280|FG002|Overall Study|Protocol Violation|0|||
160825996|NCT00711802|580747281|FG003|Overall Study|Protocol Violation|1|||
160825997|NCT00711802|580747282|FG004|Overall Study|Protocol Violation|0|||
160825998|NCT00711802|580747283|FG005|Overall Study|Protocol Violation|0|||
160825999|NCT00711802|580747284|FG006|Overall Study|Protocol Violation|0|||
160826000|NCT00711802|580747285|FG007|Overall Study|Protocol Violation|0|||
160826001|NCT00711802|580747278|FG000|Overall Study|Physician Decision|0|||
160826002|NCT00711802|580747279|FG001|Overall Study|Physician Decision|2|||
160826003|NCT00711802|580747280|FG002|Overall Study|Physician Decision|0|||
160826004|NCT00711802|580747281|FG003|Overall Study|Physician Decision|0|||
160826005|NCT00711802|580747282|FG004|Overall Study|Physician Decision|0|||
160826006|NCT00711802|580747283|FG005|Overall Study|Physician Decision|0|||
160826007|NCT00711802|580747284|FG006|Overall Study|Physician Decision|0|||
160826008|NCT00711802|580747285|FG007|Overall Study|Physician Decision|0|||
160826009|NCT00711802|580747278|FG000|Overall Study|Withdrawal by Subject|0|||
160826010|NCT00711802|580747279|FG001|Overall Study|Withdrawal by Subject|1|||
160826011|NCT00711802|580747280|FG002|Overall Study|Withdrawal by Subject|0|||
160826012|NCT00711802|580747281|FG003|Overall Study|Withdrawal by Subject|1|||
160826013|NCT00711802|580747282|FG004|Overall Study|Withdrawal by Subject|0|||
160826014|NCT00711802|580747283|FG005|Overall Study|Withdrawal by Subject|0|||
160826015|NCT00711802|580747284|FG006|Overall Study|Withdrawal by Subject|0|||
160826016|NCT00711802|580747285|FG007|Overall Study|Withdrawal by Subject|0|||
160826017|NCT00711802|580747278|FG000|Overall Study|Lost to Follow-up|0|||
160826018|NCT00711802|580747279|FG001|Overall Study|Lost to Follow-up|0|||
160826019|NCT00711802|580747280|FG002|Overall Study|Lost to Follow-up|3|||
160826020|NCT00711802|580747281|FG003|Overall Study|Lost to Follow-up|1|||
160826021|NCT00711802|580747282|FG004|Overall Study|Lost to Follow-up|10|||
160826022|NCT00711802|580747283|FG005|Overall Study|Lost to Follow-up|6|||
160826023|NCT00711802|580747284|FG006|Overall Study|Lost to Follow-up|4|||
160826024|NCT00711802|580747285|FG007|Overall Study|Lost to Follow-up|2|||
160826025|NCT00711802|580747278|FG000|Overall Study|Reason not reported|0|||
160826026|NCT00711802|580747279|FG001|Overall Study|Reason not reported|1|||
160826027|NCT00711802|580747280|FG002|Overall Study|Reason not reported|1|||
160826028|NCT00711802|580747281|FG003|Overall Study|Reason not reported|0|||
160826029|NCT00711802|580747282|FG004|Overall Study|Reason not reported|1|||
160826030|NCT00711802|580747283|FG005|Overall Study|Reason not reported|0|||
160826031|NCT00711802|580747284|FG006|Overall Study|Reason not reported|1|||
160826032|NCT00711802|580747285|FG007|Overall Study|Reason not reported|0|||
160826033|NCT03283150|580747287|FG000|Overall Study|Withdrawal by Subject|6|||
160826034|NCT03283150|580747288|FG001|Overall Study|Withdrawal by Subject|0|||
160902211|NCT04729621|581036010|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
160902212|NCT04729621|581036011|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
160902213|NCT04729621|581036012|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
160826035|NCT03283150|580747289|FG002|Overall Study|Withdrawal by Subject|0|||
160826036|NCT00581828|580747290|FG000|Overall Study|Protocol Violation|1|||
160826037|NCT02981407|580747291|FG000|Overall Study|Withdrawal by Subject|2|||
160826038|NCT02981407|580747292|FG001|Overall Study|Withdrawal by Subject|0|||
160826039|NCT02410824|580747295|FG000|First Intervention (One Week)|Headache|0|||
160826040|NCT02410824|580747296|FG001|First Intervention (One Week)|Headache|1|||
160826041|NCT00391391|580747297|FG000|Overall Study|Adverse Event|0|||
160826042|NCT00391391|580747298|FG001|Overall Study|Adverse Event|0|||
160902214|NCT04729621|581036008|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
160989978|NCT00269399|581351710|FG001|Overall Study|Other|4|||
160826043|NCT00391391|580747299|FG002|Overall Study|Adverse Event|0|||
160826044|NCT00391391|580747300|FG003|Overall Study|Adverse Event|1|||
160826045|NCT00391391|580747297|FG000|Overall Study|Lost to Follow-up|1|||
160826046|NCT00391391|580747298|FG001|Overall Study|Lost to Follow-up|3|||
160826047|NCT00391391|580747299|FG002|Overall Study|Lost to Follow-up|7|||
160826048|NCT00391391|580747300|FG003|Overall Study|Lost to Follow-up|4|||
160826049|NCT00391391|580747297|FG000|Overall Study|Protocol Violation|2|||
160826050|NCT00391391|580747298|FG001|Overall Study|Protocol Violation|3|||
160826051|NCT00391391|580747299|FG002|Overall Study|Protocol Violation|6|||
160826052|NCT00391391|580747300|FG003|Overall Study|Protocol Violation|7|||
160826053|NCT00391391|580747297|FG000|Overall Study|Withdrawal by Subject|6|||
160826054|NCT00391391|580747298|FG001|Overall Study|Withdrawal by Subject|4|||
160826055|NCT00391391|580747299|FG002|Overall Study|Withdrawal by Subject|10|||
160826056|NCT00391391|580747300|FG003|Overall Study|Withdrawal by Subject|7|||
160826057|NCT02084238|580747301|FG000|Overall Study|Lost to Follow-up|2|||
160826058|NCT02649855|580747302|FG000|Overall Study|Refused further treatment|2|||
160826059|NCT02649855|580747303|FG001|Overall Study|Refused further treatment|1|||
160826060|NCT02649855|580747304|FG002|Overall Study|Refused further treatment|1|||
160826061|NCT02649855|580747302|FG000|Overall Study|Withdrew consent|0|||
160826062|NCT02649855|580747303|FG001|Overall Study|Withdrew consent|1|||
160826063|NCT02649855|580747304|FG002|Overall Study|Withdrew consent|0|||
160826064|NCT02649855|580747302|FG000|Overall Study|Switched to alternative treatment|0|||
160826065|NCT02649855|580747303|FG001|Overall Study|Switched to alternative treatment|1|||
160826066|NCT02649855|580747304|FG002|Overall Study|Switched to alternative treatment|1|||
160826067|NCT02649855|580747302|FG000|Overall Study|Principal investigator discretion|0|||
160826068|NCT02649855|580747303|FG001|Overall Study|Principal investigator discretion|1|||
160826069|NCT02649855|580747304|FG002|Overall Study|Principal investigator discretion|1|||
160826070|NCT02649855|580747302|FG000|Overall Study|No treatment, per protocol|1|||
160826071|NCT02649855|580747303|FG001|Overall Study|No treatment, per protocol|0|||
160826072|NCT02649855|580747304|FG002|Overall Study|No treatment, per protocol|0|||
160826073|NCT02649855|580747302|FG000|Overall Study|Initiate new treatment|1|||
160826074|NCT02649855|580747303|FG001|Overall Study|Initiate new treatment|0|||
160826075|NCT02649855|580747304|FG002|Overall Study|Initiate new treatment|0|||
160826076|NCT02191605|580749160|FG000|Overall Study|Lost to Follow-up|9|||
160826077|NCT02191605|580749161|FG001|Overall Study|Lost to Follow-up|4|||
160826078|NCT02191605|580749162|FG002|Overall Study|Lost to Follow-up|7|||
160826079|NCT02191605|580749163|FG003|Overall Study|Lost to Follow-up|3|||
160826080|NCT02191605|580749164|FG004|Overall Study|Lost to Follow-up|4|||
160826081|NCT01309269|580749167|FG000|Overall Study|Adverse Event|56|||
160826082|NCT01309269|580749167|FG000|Overall Study|Withdrawal by Subject|25|||
160826083|NCT01309269|580749167|FG000|Overall Study|Lack of Acceptance|15|||
160826084|NCT01309269|580749167|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
160826085|NCT01309269|580749167|FG000|Overall Study|Kidney Transplant|25|||
160826086|NCT01309269|580749167|FG000|Overall Study|Administrative Problems|141|||
160826087|NCT01309269|580749167|FG000|Overall Study|Other|256|||
160826088|NCT01309269|580749167|FG000|Overall Study|Other|1|||
160826089|NCT01309269|580749167|FG000|Overall Study|Study Completion Data Not Recorded|95|||
160826090|NCT01309269|580749167|FG000|Overall Study|Enrolled but not Treated|107|||
160826091|NCT03647267|580749184|FG000|Overall Study|Lost to Follow-up|1|||
160826092|NCT03647267|580749185|FG001|Overall Study|Lost to Follow-up|0|||
160826093|NCT05079477|580749186|FG000|Overall Study|Lost to Follow-up|2|||
160826094|NCT05079477|580749187|FG001|Overall Study|Lost to Follow-up|0|||
160826095|NCT05079477|580749186|FG000|Overall Study|Withdrawal by Subject|1|||
160826096|NCT05079477|580749187|FG001|Overall Study|Withdrawal by Subject|0|||
160826097|NCT05079477|580749186|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
160826098|NCT05079477|580749187|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
160826099|NCT05079477|580749186|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
160826100|NCT05079477|580749187|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
160826101|NCT03131596|580749194|FG000|Overall Study|Protocol Violation|3|||
160826102|NCT03131596|580749195|FG001|Overall Study|Protocol Violation|3|||
160826103|NCT03131596|580749194|FG000|Overall Study|Lost to Follow-up|3|||
160826104|NCT03131596|580749195|FG001|Overall Study|Lost to Follow-up|0|||
160902215|NCT04729621|581036009|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
160902216|NCT04729621|581036010|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
160826105|NCT00734071|580749196|FG000|Overall Study|Adverse Event|4|||
160826106|NCT00734071|580749197|FG001|Overall Study|Adverse Event|3|||
160826107|NCT00734071|580749196|FG000|Overall Study|Lack of Efficacy|3|||
160826108|NCT00734071|580749197|FG001|Overall Study|Lack of Efficacy|1|||
160826109|NCT00734071|580749196|FG000|Overall Study|Noncompliance|2|||
160902217|NCT04729621|581036011|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
160826110|NCT00734071|580749197|FG001|Overall Study|Noncompliance|2|||
160826111|NCT00734071|580749196|FG000|Overall Study|Protocol Deviations|3|||
160826112|NCT00734071|580749197|FG001|Overall Study|Protocol Deviations|4|||
160826113|NCT00734071|580749196|FG000|Overall Study|Voluntary Withdrawal|9|||
160826114|NCT00734071|580749197|FG001|Overall Study|Voluntary Withdrawal|7|||
160826115|NCT00734071|580749196|FG000|Overall Study|Lost to Follow-up|16|||
160826116|NCT00734071|580749197|FG001|Overall Study|Lost to Follow-up|8|||
160826117|NCT00734071|580749196|FG000|Overall Study|Other|1|||
160826118|NCT00734071|580749197|FG001|Overall Study|Other|2|||
160826119|NCT03654885|580749198|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
160826120|NCT03654885|580749199|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
160826121|NCT03654885|580749198|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
160826122|NCT03654885|580749199|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
160826123|NCT03654885|580749198|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
160826124|NCT03654885|580749199|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
160826125|NCT03654885|580749198|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
160826126|NCT03654885|580749199|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
160826127|NCT03654885|580749198|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
160826128|NCT03654885|580749199|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
160826129|NCT03654885|580749198|FG000|Overall Study|Adverse Event in Study Eye|3|||
160826130|NCT03654885|580749199|FG001|Overall Study|Adverse Event in Study Eye|0|||
160826131|NCT03654885|580749198|FG000|Overall Study|Consent Withdrawn|1|||
160826132|NCT03654885|580749199|FG001|Overall Study|Consent Withdrawn|0|||
160826133|NCT03654885|580749198|FG000|Overall Study|Death|3|||
160826134|NCT03654885|580749199|FG001|Overall Study|Death|1|||
160826135|NCT03654885|580749198|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
160826136|NCT03654885|580749199|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
160826137|NCT03654885|580749198|FG000|Overall Study|Lost to Follow-up|3|||
160826138|NCT03654885|580749199|FG001|Overall Study|Lost to Follow-up|3|||
160826139|NCT05275582|580749200|FG000|Overall Study|Lost to Follow-up|1|||
160826140|NCT05275582|580749201|FG001|Overall Study|Lost to Follow-up|0|||
160826141|NCT05275582|580749200|FG000|Overall Study|Withdrawal by Subject|0|||
160826142|NCT05275582|580749201|FG001|Overall Study|Withdrawal by Subject|2|||
160826143|NCT05275582|580749200|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
160826144|NCT05275582|580749201|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
160826145|NCT05275582|580749200|FG000|Overall Study|Death|1|||
160826146|NCT05275582|580749201|FG001|Overall Study|Death|0|||
160826147|NCT05275582|580749200|FG000|Overall Study|Protocol Violation|1|||
160826148|NCT05275582|580749201|FG001|Overall Study|Protocol Violation|0|||
160826149|NCT02091284|580749204|FG000|Overall Study|Withdrawal by Subject|2|||
160826150|NCT02091284|580749205|FG001|Overall Study|Withdrawal by Subject|1|||
160826151|NCT02091284|580749204|FG000|Overall Study|unreliable data|1|||
160826152|NCT02091284|580749205|FG001|Overall Study|unreliable data|0|||
160826153|NCT03383783|580749206|FG000|Overall Study|Withdrawal by Subject|2|||
160826154|NCT01703117|580749212|FG000|Overall Study|Adverse Event|4|||
160826155|NCT01703117|580749213|FG001|Overall Study|Adverse Event|3|||
160826156|NCT01703117|580749212|FG000|Overall Study|Withdrawal by Subject|0|||
160826157|NCT01703117|580749213|FG001|Overall Study|Withdrawal by Subject|1|||
160826158|NCT00440310|580749215|FG000|Overall Study|Lost to Follow-up|4|||
160826159|NCT00440310|580749216|FG001|Overall Study|Lost to Follow-up|5|||
160826160|NCT00440310|580749215|FG000|Overall Study|Protocol Violation|0|||
160826161|NCT00440310|580749216|FG001|Overall Study|Protocol Violation|1|||
160826162|NCT00440310|580749215|FG000|Overall Study|Withdrawal by Subject|15|||
160826163|NCT00440310|580749216|FG001|Overall Study|Withdrawal by Subject|14|||
160826164|NCT00440310|580749215|FG000|Overall Study|No Reply at EOS|7|||
160826165|NCT00440310|580749216|FG001|Overall Study|No Reply at EOS|7|||
160826166|NCT00440310|580749215|FG000|Overall Study|Other|1|||
160826167|NCT00440310|580749216|FG001|Overall Study|Other|0|||
160826168|NCT00440310|580749215|FG000|Overall Study|Status Unknown|1|||
160826169|NCT00440310|580749216|FG001|Overall Study|Status Unknown|3|||
160826170|NCT02119156|580749217|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
160826171|NCT02119156|580749218|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
160826172|NCT02119156|580749219|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
160826173|NCT02119156|580749217|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
160826174|NCT02119156|580749218|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
160826175|NCT02119156|580749219|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
160826176|NCT02119156|580749217|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
160826177|NCT02119156|580749218|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
160826178|NCT02119156|580749219|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
160826179|NCT02119156|580749217|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
160826180|NCT02119156|580749218|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
160826181|NCT02119156|580749219|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
160826182|NCT02119156|580749217|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
160826183|NCT02119156|580749218|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
160826184|NCT02119156|580749219|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
160826185|NCT02469415|580749220|FG000|Overall Study|Withdrawal by Subject|1|||
160826186|NCT02469415|580749220|FG000|Overall Study|Investigational agent placed on hold|2|||
160826187|NCT00330928|580749221|FG000|Overall Study|Lost to Follow-up|6|||
160826188|NCT00330928|580749221|FG000|Overall Study|Physician Decision|9|||
160826189|NCT00330928|580749221|FG000|Overall Study|Death|1|||
160826190|NCT00330928|580749221|FG000|Overall Study|IVUS could not be performed.|1|||
160826191|NCT03028480|580749222|FG000|Overall Study|No revisit after the first prescription date|2|||
160826192|NCT03028480|580749222|FG000|Overall Study|Did not use the drug|1|||
160826193|NCT03028480|580749222|FG000|Overall Study|Violation of the enrollment deadline|10|||
160826194|NCT03028480|580749222|FG000|Overall Study|Case report forms were not collected|21|||
160826195|NCT02403635|580749229|FG000|Overall Study|Not eligible|9|||
160826196|NCT00585221|580749233|FG000|Overall Study|Protocol Violation|8|||
160826197|NCT02229214|580749236|FG000|Overall Study|Adverse Event|2|||
160826198|NCT02229214|580749237|FG001|Overall Study|Adverse Event|0|||
160826199|NCT02229214|580749236|FG000|Overall Study|Withdrawal by Subject|4|||
160826200|NCT02229214|580749237|FG001|Overall Study|Withdrawal by Subject|0|||
160826201|NCT03305081|580749250|FG000|Overall Study|Lost to Follow-up|10|||
160826202|NCT03305081|580749251|FG001|Overall Study|Lost to Follow-up|15|||
160826203|NCT00241631|580749252|FG000|Run in (2 Weeks)|Physician Decision|3|||
160826204|NCT00241631|580749253|FG001|Run in (2 Weeks)|Physician Decision|3|||
160826205|NCT00241631|580749252|FG000|Phase 1 (4 Weeks)|sore throat|1|||
160826206|NCT00241631|580749253|FG001|Phase 1 (4 Weeks)|sore throat|0|||
160826207|NCT00241631|580749252|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
160826208|NCT00241631|580749253|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
160826209|NCT00241631|580749252|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
160826210|NCT00241631|580749253|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
160826211|NCT00241631|580749252|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
160826212|NCT00241631|580749253|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
160826213|NCT02437305|580749254|FG000|Overall Study|Lost to Follow-up|18|||
160826214|NCT02437305|580749255|FG001|Overall Study|Lost to Follow-up|12|||
160826215|NCT02446418|580749257|FG000|Overall Study|Adverse Event|4|||
160826216|NCT02446418|580749258|FG001|Overall Study|Adverse Event|8|||
160826217|NCT02446418|580749257|FG000|Overall Study|Physician Decision|5|||
160826218|NCT02446418|580749258|FG001|Overall Study|Physician Decision|1|||
160826219|NCT02446418|580749257|FG000|Overall Study|Withdrawal by Subject|3|||
160826220|NCT02446418|580749258|FG001|Overall Study|Withdrawal by Subject|3|||
160826221|NCT02446418|580749257|FG000|Overall Study|Lost to Follow-up|2|||
160826222|NCT02446418|580749258|FG001|Overall Study|Lost to Follow-up|2|||
160826223|NCT02446418|580749257|FG000|Overall Study|Protocol Violation|1|||
160826224|NCT02446418|580749258|FG001|Overall Study|Protocol Violation|2|||
160826225|NCT02446418|580749257|FG000|Overall Study|Lack of Efficacy|2|||
160826226|NCT02446418|580749258|FG001|Overall Study|Lack of Efficacy|0|||
160826227|NCT02446418|580749257|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
160826228|NCT02446418|580749258|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
160826229|NCT03421743|580749261|FG000|Overall Study|Lack of Efficacy|1|||
160826230|NCT03421743|580749262|FG001|Overall Study|Lack of Efficacy|0|||
160826231|NCT03421743|580749261|FG000|Overall Study|Adverse Event|2|||
160826232|NCT03421743|580749262|FG001|Overall Study|Adverse Event|1|||
160826233|NCT03421743|580749261|FG000|Overall Study|Withdrawal by Subject|0|||
160826234|NCT03421743|580749262|FG001|Overall Study|Withdrawal by Subject|1|||
160554395|NCT01505894|579755768|FG002|Overall Study|Other than specified|0|||
160554396|NCT01505894|579755769|FG003|Overall Study|Other than specified|0|||
160826235|NCT00435162|580749263|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
160826236|NCT00435162|580749264|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
160826237|NCT00435162|580749265|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
160826238|NCT00435162|580749266|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
160826239|NCT00435162|580749267|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
160826240|NCT00435162|580749268|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
160826241|NCT00694096|580749269|FG000|Overall Study|Withdrawal by Subject|5|||
160826242|NCT00681564|580749276|FG000|Overall Study|Lost to Follow-up|6|||
160826243|NCT00681564|580749277|FG001|Overall Study|Lost to Follow-up|6|||
160826244|NCT00681564|580749276|FG000|Overall Study|Withdrawal by Subject|0|||
160826245|NCT00681564|580749277|FG001|Overall Study|Withdrawal by Subject|1|||
160826246|NCT00681564|580749276|FG000|Overall Study|Death|0|||
160826247|NCT00681564|580749277|FG001|Overall Study|Death|1|||
160826248|NCT02078102|580749282|FG000|Overall Study|Adverse Event|1|||
160826249|NCT02078102|580749283|FG001|Overall Study|Adverse Event|0|||
160826250|NCT02078102|580749282|FG000|Overall Study|Withdrawal by Subject|1|||
160826251|NCT02078102|580749283|FG001|Overall Study|Withdrawal by Subject|0|||
160826252|NCT02078102|580749282|FG000|Overall Study|Physician Decision|0|||
160826253|NCT02078102|580749283|FG001|Overall Study|Physician Decision|1|||
160826254|NCT02185014|580749286|FG000|Overall Study|Adverse Event|18|||
160826255|NCT02185014|580749286|FG000|Overall Study|Withdrew Consent|8|||
160826256|NCT02185014|580749286|FG000|Overall Study|Lost to Follow-up|4|||
160826257|NCT02185014|580749286|FG000|Overall Study|Lack of Efficacy|14|||
160826258|NCT02185014|580749286|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
160826259|NCT02185014|580749286|FG000|Overall Study|Subject Noncompliance|1|||
160826260|NCT02185014|580749286|FG000|Overall Study|Other|4|||
160826261|NCT02141490|580749287|FG000|Overall Study|Screening failures|4|||
160826262|NCT02141490|580749288|FG001|Overall Study|Screening failures|0|||
160826263|NCT02141490|580749289|FG002|Overall Study|Screening failures|0|||
160826264|NCT01813721|580749290|FG000|Overall Study|Ineligibility determined|63|||
160826265|NCT01813721|580749290|FG000|Overall Study|Withdrawal by Subject|1|||
160826266|NCT02387164|580749291|FG000|Overall Study|Lost to Follow-up|2|||
160826267|NCT02387164|580749292|FG001|Overall Study|Lost to Follow-up|0|||
160826268|NCT02387164|580749291|FG000|Overall Study|Diagnosed|1|||
160826269|NCT02387164|580749292|FG001|Overall Study|Diagnosed|2|||
160826270|NCT02133664|580749295|FG000|Overall Study|Lost to Follow-up|2|||
160826271|NCT02133664|580749296|FG001|Overall Study|Lost to Follow-up|1|||
160826272|NCT02133664|580749295|FG000|Overall Study|Adverse Event|3|||
160826273|NCT02133664|580749296|FG001|Overall Study|Adverse Event|6|||
160826274|NCT00882908|580749298|FG000|Overall Study|Adverse Event|0|||
160826275|NCT00882908|580749299|FG001|Overall Study|Adverse Event|0|||
160826276|NCT00882908|580749300|FG002|Overall Study|Adverse Event|1|||
160826277|NCT00882908|580749301|FG003|Overall Study|Adverse Event|0|||
160826278|NCT00882908|580749302|FG004|Overall Study|Adverse Event|1|||
160826279|NCT00882908|580749298|FG000|Overall Study|Lost to Follow-up|3|||
160826280|NCT00882908|580749299|FG001|Overall Study|Lost to Follow-up|5|||
160826281|NCT00882908|580749300|FG002|Overall Study|Lost to Follow-up|3|||
160826282|NCT00882908|580749301|FG003|Overall Study|Lost to Follow-up|1|||
160826283|NCT00882908|580749302|FG004|Overall Study|Lost to Follow-up|2|||
160826284|NCT00882908|580749298|FG000|Overall Study|Protocol Violation|0|||
160826285|NCT00882908|580749299|FG001|Overall Study|Protocol Violation|1|||
160826286|NCT00882908|580749300|FG002|Overall Study|Protocol Violation|0|||
160826287|NCT00882908|580749301|FG003|Overall Study|Protocol Violation|0|||
160826288|NCT00882908|580749302|FG004|Overall Study|Protocol Violation|0|||
160826289|NCT00882908|580749298|FG000|Overall Study|Withdrawal by Subject|0|||
160826290|NCT00882908|580749299|FG001|Overall Study|Withdrawal by Subject|0|||
160826291|NCT00882908|580749300|FG002|Overall Study|Withdrawal by Subject|3|||
160826292|NCT00882908|580749301|FG003|Overall Study|Withdrawal by Subject|5|||
160826293|NCT00882908|580749302|FG004|Overall Study|Withdrawal by Subject|2|||
160826294|NCT00882908|580749298|FG000|Overall Study|Subject reached a virologic endpoint|0|||
160554397|NCT01505894|579755770|FG004|Overall Study|Other than specified|1|||
160554398|NCT01505894|579755771|FG005|Overall Study|Other than specified|0|||
160554399|NCT01505894|579755772|FG006|Overall Study|Other than specified|0|||
160554400|NCT01505894|579755773|FG007|Overall Study|Other than specified|0|||
160554401|NCT01505894|579755774|FG008|Overall Study|Other than specified|0|||
160554402|NCT04173741|579755776|FG000|Overall Study|IVC measurement cannot be done|1|||
160554403|NCT04173741|579755777|FG001|Overall Study|IVC measurement cannot be done|1|||
160554404|NCT02522767|579755778|FG000|Double-blind|Withdrawal by Subject|8|||
160554405|NCT02522767|579755779|FG001|Double-blind|Withdrawal by Subject|11|||
160554406|NCT02522767|579755778|FG000|Double-blind|Lost to Follow-up|1|||
160554407|NCT02522767|579755779|FG001|Double-blind|Lost to Follow-up|0|||
160554408|NCT02522767|579755778|FG000|Double-blind|Adverse Event|1|||
160554409|NCT02522767|579755779|FG001|Double-blind|Adverse Event|10|||
160554410|NCT02522767|579755778|FG000|Double-blind|Protocol Violation|0|||
160554411|NCT02522767|579755779|FG001|Double-blind|Protocol Violation|1|||
160554412|NCT02522767|579755778|FG000|Double-blind|Lack of Efficacy|0|||
160554413|NCT02522767|579755779|FG001|Double-blind|Lack of Efficacy|2|||
160554414|NCT02522767|579755778|FG000|Double-blind|Protocol Deviation|1|||
160554415|NCT02522767|579755779|FG001|Double-blind|Protocol Deviation|0|||
160554416|NCT02522767|579755778|FG000|Open-label|Withdrawal by Subject|2|||
160554417|NCT02522767|579755779|FG001|Open-label|Withdrawal by Subject|3|||
160554418|NCT02522767|579755778|FG000|Open-label|Lost to Follow-up|0|||
160554419|NCT02522767|579755779|FG001|Open-label|Lost to Follow-up|1|||
160554420|NCT02522767|579755778|FG000|Open-label|Adverse Event|2|||
160554421|NCT02522767|579755779|FG001|Open-label|Adverse Event|1|||
160554422|NCT02522767|579755778|FG000|Open-label|Lack of Efficacy|1|||
160554423|NCT02522767|579755779|FG001|Open-label|Lack of Efficacy|1|||
160554424|NCT02522767|579755778|FG000|Open-label|Protocol Violation|0|||
160554425|NCT02522767|579755779|FG001|Open-label|Protocol Violation|1|||
160554426|NCT00254566|579755780|FG000|Overall Study|Death|1|||
160826295|NCT00882908|580749299|FG001|Overall Study|Subject reached a virologic endpoint|0|||
160826296|NCT00882908|580749300|FG002|Overall Study|Subject reached a virologic endpoint|0|||
160826297|NCT00882908|580749301|FG003|Overall Study|Subject reached a virologic endpoint|0|||
160826298|NCT00882908|580749302|FG004|Overall Study|Subject reached a virologic endpoint|1|||
160826299|NCT00882908|580749298|FG000|Overall Study|Study terminated in error|0|||
160826300|NCT00882908|580749299|FG001|Overall Study|Study terminated in error|0|||
160826301|NCT00882908|580749300|FG002|Overall Study|Study terminated in error|0|||
160554427|NCT00254566|579755781|FG001|Overall Study|Death|0|||
160554428|NCT00254566|579755780|FG000|Overall Study|Adverse Event|5|||
160646664|NCT03507439|580088344|FG000|Overall Study|Withdrawal by Subject|1|||
160826302|NCT00882908|580749301|FG003|Overall Study|Study terminated in error|1|||
160826303|NCT00882908|580749302|FG004|Overall Study|Study terminated in error|0|||
160826304|NCT00392808|580749303|FG000|Overall Study|Lost to Follow-up|3|||
160826305|NCT00392808|580749304|FG001|Overall Study|Lost to Follow-up|2|||
160826306|NCT00392808|580749305|FG002|Overall Study|Lost to Follow-up|1|||
160989979|NCT00269399|581351709|FG000|Overall Study|Development of exclusion criteria|0|||
160989980|NCT00269399|581351710|FG001|Overall Study|Development of exclusion criteria|1|||
160989981|NCT03439124|581351711|FG000|Overall Study|Adverse Event|2|||
160989982|NCT03439124|581351712|FG001|Overall Study|Adverse Event|0|||
160989983|NCT03439124|581351711|FG000|Overall Study|Lost to Follow-up|1|||
160989984|NCT03439124|581351712|FG001|Overall Study|Lost to Follow-up|0|||
160989985|NCT03439124|581351711|FG000|Overall Study|Other reasons|1|||
160989986|NCT03439124|581351712|FG001|Overall Study|Other reasons|0|||
160989987|NCT04353037|581351713|FG000|Overall Study|Lost to Follow-up|0|||
160989988|NCT04353037|581351714|FG001|Overall Study|Lost to Follow-up|1|||
160989989|NCT04353037|581351715|FG002|Overall Study|Lost to Follow-up|2|||
160989990|NCT04353037|581351716|FG003|Overall Study|Lost to Follow-up|3|||
160989991|NCT04353037|581351713|FG000|Overall Study|Withdrawal by Subject|0|||
160989992|NCT04353037|581351714|FG001|Overall Study|Withdrawal by Subject|2|||
160989993|NCT04353037|581351715|FG002|Overall Study|Withdrawal by Subject|3|||
160989994|NCT04353037|581351716|FG003|Overall Study|Withdrawal by Subject|5|||
160989995|NCT04353037|581351713|FG000|Overall Study|Adverse Event|0|||
160989996|NCT04353037|581351714|FG001|Overall Study|Adverse Event|0|||
160989997|NCT04353037|581351715|FG002|Overall Study|Adverse Event|2|||
160989998|NCT04353037|581351716|FG003|Overall Study|Adverse Event|0|||
160989999|NCT04353037|581351713|FG000|Overall Study|Exposure Change|0|||
160554429|NCT00254566|579755781|FG001|Overall Study|Adverse Event|4|||
160554430|NCT00254566|579755780|FG000|Overall Study|Lack of Efficacy|12|||
160554431|NCT00254566|579755781|FG001|Overall Study|Lack of Efficacy|9|||
160990000|NCT04353037|581351714|FG001|Overall Study|Exposure Change|0|||
160990001|NCT04353037|581351715|FG002|Overall Study|Exposure Change|0|||
160990002|NCT04353037|581351716|FG003|Overall Study|Exposure Change|2|||
160990003|NCT01360840|581351718|FG000|Overall Study|Ongoing at data cut-off|10|||
160990004|NCT01360840|581351719|FG001|Overall Study|Ongoing at data cut-off|10|||
160990005|NCT01360840|581351720|FG002|Overall Study|Ongoing at data cut-off|9|||
160990006|NCT00920686|581351722|FG000|Overall Study|Lost to Follow-up|2|||
160990007|NCT00920686|581351723|FG001|Overall Study|Lost to Follow-up|3|||
160990008|NCT00920686|581351724|FG002|Overall Study|Lost to Follow-up|1|||
160990009|NCT00920686|581351722|FG000|Overall Study|Study drug dosing criteria not met|17|||
160990010|NCT00920686|581351723|FG001|Overall Study|Study drug dosing criteria not met|19|||
160990011|NCT00920686|581351724|FG002|Overall Study|Study drug dosing criteria not met|12|||
160990012|NCT03006341|581351725|FG000|Overall Study|Not linked in the EMR|25069|||
160990013|NCT03006341|581351726|FG001|Overall Study|Not linked in the EMR|67505|||
160990014|NCT03006341|581351727|FG002|Overall Study|Not linked in the EMR|30993|||
160990015|NCT03006341|581351728|FG003|Overall Study|Not linked in the EMR|10685|||
160990016|NCT00688688|581351729|FG000|Overall Study|Eligibility criterion not met|7|||
160990017|NCT00688688|581351730|FG001|Overall Study|Eligibility criterion not met|7|||
160990018|NCT00688688|581351731|FG002|Overall Study|Eligibility criterion not met|10|||
160990019|NCT00688688|581351729|FG000|Overall Study|Adverse Event|52|||
160990020|NCT00688688|581351730|FG001|Overall Study|Adverse Event|51|||
160990021|NCT00688688|581351731|FG002|Overall Study|Adverse Event|50|||
160990022|NCT00688688|581351729|FG000|Overall Study|Lack of Efficacy|34|||
160990023|NCT00688688|581351730|FG001|Overall Study|Lack of Efficacy|25|||
160990024|NCT00688688|581351731|FG002|Overall Study|Lack of Efficacy|45|||
160990025|NCT00688688|581351729|FG000|Overall Study|Withdrawal by Subject|66|||
160554432|NCT00254566|579755780|FG000|Overall Study|Other|1|||
160554433|NCT00254566|579755781|FG001|Overall Study|Other|5|||
160554434|NCT00254566|579755780|FG000|Overall Study|Withdrawal by Subject|5|||
160554435|NCT00254566|579755781|FG001|Overall Study|Withdrawal by Subject|6|||
160554436|NCT00254566|579755780|FG000|Overall Study|Lost to Follow-up|7|||
160554437|NCT00254566|579755781|FG001|Overall Study|Lost to Follow-up|2|||
160554438|NCT00059202|579755783|FG000|Overall Study|Withdrawal by Subject|5|||
160554439|NCT00059202|579755784|FG001|Overall Study|Withdrawal by Subject|9|||
160554440|NCT00059202|579755783|FG000|Overall Study|Protocol Violation|1|||
160554441|NCT00059202|579755784|FG001|Overall Study|Protocol Violation|3|||
160554442|NCT00059202|579755783|FG000|Overall Study|drug toxicity|0|||
160554443|NCT00059202|579755784|FG001|Overall Study|drug toxicity|3|||
160554444|NCT00548548|579755787|FG000|Overall Study|Death|345|||
160646665|NCT03507439|580088345|FG001|Overall Study|Withdrawal by Subject|0|||
160646666|NCT03507439|580088344|FG000|Overall Study|Death|1|||
160990026|NCT00688688|581351730|FG001|Overall Study|Withdrawal by Subject|75|||
160990027|NCT00688688|581351731|FG002|Overall Study|Withdrawal by Subject|65|||
160990028|NCT00688688|581351729|FG000|Overall Study|Lost to Follow-up|14|||
160646667|NCT03507439|580088345|FG001|Overall Study|Death|1|||
160990029|NCT00688688|581351730|FG001|Overall Study|Lost to Follow-up|7|||
160990030|NCT00688688|581351731|FG002|Overall Study|Lost to Follow-up|7|||
160990031|NCT00688688|581351729|FG000|Overall Study|Protocol Violation|6|||
160990032|NCT00688688|581351730|FG001|Overall Study|Protocol Violation|9|||
160990033|NCT00688688|581351731|FG002|Overall Study|Protocol Violation|11|||
160554445|NCT00548548|579755788|FG001|Overall Study|Death|348|||
160554446|NCT00548548|579755787|FG000|Overall Study|Lost to Follow-up|17|||
160554447|NCT00548548|579755788|FG001|Overall Study|Lost to Follow-up|18|||
160990034|NCT00688688|581351729|FG000|Overall Study|Randomized but never received study drug|1|||
160990035|NCT00688688|581351730|FG001|Overall Study|Randomized but never received study drug|0|||
160990036|NCT00688688|581351731|FG002|Overall Study|Randomized but never received study drug|0|||
160990037|NCT00688688|581351729|FG000|Overall Study|Non-compliance with study procedures|5|||
160990038|NCT00688688|581351730|FG001|Overall Study|Non-compliance with study procedures|3|||
160990039|NCT00688688|581351731|FG002|Overall Study|Non-compliance with study procedures|4|||
160990040|NCT00688688|581351729|FG000|Overall Study|Taking exclusionary medications|1|||
160990041|NCT00688688|581351730|FG001|Overall Study|Taking exclusionary medications|0|||
160646668|NCT04014959|580089930|FG000|Baseline MRI and Assessments|Physician Decision|2|||
160646669|NCT04014959|580089930|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
160646670|NCT04014959|580089930|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
160646671|NCT02004847|580089932|FG000|Overall Study|Protocol Violation|1|||
160646672|NCT02004847|580089933|FG001|Overall Study|Protocol Violation|1|||
160646673|NCT01132118|580089937|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
160646674|NCT01132118|580089938|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
160646675|NCT01132118|580089937|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
160646676|NCT01132118|580089938|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
160646677|NCT01132118|580089937|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
160646678|NCT01132118|580089938|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
160646679|NCT01644890|580089939|FG000|Overall Study|Adverse Event|7|||
160646680|NCT01644890|580089940|FG001|Overall Study|Adverse Event|20|||
160646681|NCT01644890|580089939|FG000|Overall Study|Death|1|||
160646682|NCT01644890|580089940|FG001|Overall Study|Death|3|||
160646683|NCT01644890|580089939|FG000|Overall Study|Physician Decision|3|||
160646684|NCT01644890|580089940|FG001|Overall Study|Physician Decision|9|||
160646685|NCT01644890|580089939|FG000|Overall Study|Protocol Violation|6|||
160646686|NCT01644890|580089940|FG001|Overall Study|Protocol Violation|7|||
160990042|NCT00688688|581351731|FG002|Overall Study|Taking exclusionary medications|0|||
160990043|NCT00688688|581351729|FG000|Overall Study|Site closure|0|||
160990044|NCT00688688|581351730|FG001|Overall Study|Site closure|1|||
160990045|NCT00688688|581351731|FG002|Overall Study|Site closure|0|||
160990046|NCT00688688|581351729|FG000|Overall Study|Violation of exclusion criterion|0|||
160990047|NCT00688688|581351730|FG001|Overall Study|Violation of exclusion criterion|1|||
160990048|NCT00688688|581351731|FG002|Overall Study|Violation of exclusion criterion|0|||
160990049|NCT02950545|581351732|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
160990050|NCT02950545|581351733|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
160990051|NCT02950545|581351734|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
160990052|NCT02950545|581351735|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
160990053|NCT02950545|581351736|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
160990054|NCT02950545|581351737|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
160990055|NCT02950545|581351732|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
160990056|NCT02950545|581351733|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
160990057|NCT02950545|581351734|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
160554448|NCT01482910|579755798|FG000|Overall Study|Adverse Event|6|||
160554449|NCT01482910|579755799|FG001|Overall Study|Adverse Event|5|||
160554450|NCT01482910|579755798|FG000|Overall Study|Lost to Follow-up|0|||
160554451|NCT01482910|579755799|FG001|Overall Study|Lost to Follow-up|1|||
160554452|NCT01482910|579755798|FG000|Overall Study|Protocol Violation|1|||
160554453|NCT01482910|579755799|FG001|Overall Study|Protocol Violation|1|||
160554454|NCT01482910|579755798|FG000|Overall Study|Withdrawal by Subject|7|||
160554455|NCT01482910|579755799|FG001|Overall Study|Withdrawal by Subject|2|||
160554456|NCT01482910|579755798|FG000|Overall Study|Death|1|||
160554457|NCT01482910|579755799|FG001|Overall Study|Death|0|||
160554458|NCT00331409|579755800|FG000|Overall Study|Lack of Efficacy|4|||
160554459|NCT00272987|579755801|FG000|Overall Study|Adverse Event|1|||
160554460|NCT00272987|579755802|FG001|Overall Study|Adverse Event|0|||
160554461|NCT00272987|579755803|FG002|Overall Study|Adverse Event|0|||
160554462|NCT00272987|579755801|FG000|Overall Study|Lost to Follow-up|3|||
160554463|NCT00272987|579755802|FG001|Overall Study|Lost to Follow-up|1|||
160554464|NCT00272987|579755803|FG002|Overall Study|Lost to Follow-up|1|||
160554465|NCT00272987|579755801|FG000|Overall Study|Withdrawal by Subject|1|||
160554466|NCT00272987|579755802|FG001|Overall Study|Withdrawal by Subject|0|||
160554467|NCT00272987|579755803|FG002|Overall Study|Withdrawal by Subject|3|||
160554468|NCT00272987|579755801|FG000|Overall Study|Sponsor Terminated study|0|||
160554469|NCT00272987|579755802|FG001|Overall Study|Sponsor Terminated study|1|||
160554470|NCT00272987|579755803|FG002|Overall Study|Sponsor Terminated study|1|||
160554471|NCT00272987|579755801|FG000|Overall Study|Disease progression|1|||
160554472|NCT00272987|579755802|FG001|Overall Study|Disease progression|1|||
160554473|NCT00272987|579755803|FG002|Overall Study|Disease progression|2|||
160554474|NCT00272987|579755801|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
160646687|NCT01644890|580089939|FG000|Overall Study|Withdrawal by Subject|19|||
160554475|NCT00272987|579755802|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
160554476|NCT00272987|579755803|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
160554477|NCT00272987|579755801|FG000|Overall Study|Death|1|||
160554478|NCT00272987|579755802|FG001|Overall Study|Death|0|||
160646688|NCT01644890|580089940|FG001|Overall Study|Withdrawal by Subject|27|||
160646689|NCT01644890|580089939|FG000|Overall Study|Progression Disease|160|||
160646690|NCT01644890|580089940|FG001|Overall Study|Progression Disease|131|||
160646691|NCT01644890|580089939|FG000|Overall Study|Clinical Progression|6|||
160646692|NCT01644890|580089940|FG001|Overall Study|Clinical Progression|6|||
160646693|NCT01644890|580089939|FG000|Overall Study|> 28 days since last dose of study drug|6|||
160646694|NCT01644890|580089940|FG001|Overall Study|> 28 days since last dose of study drug|3|||
160646695|NCT01644890|580089939|FG000|Overall Study|Other|8|||
160646696|NCT01644890|580089940|FG001|Overall Study|Other|9|||
160646697|NCT00313703|580089944|FG000|Overall Study|Lost to Follow-up|11|||
160646698|NCT00313703|580089945|FG001|Overall Study|Lost to Follow-up|2|||
160646699|NCT00313703|580089946|FG002|Overall Study|Lost to Follow-up|5|||
160646700|NCT00313703|580089947|FG003|Overall Study|Lost to Follow-up|12|||
160646701|NCT02497391|580089948|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
160646702|NCT02497391|580089949|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
160646703|NCT02497391|580089950|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
160646704|NCT02497391|580089951|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
160646705|NCT02497391|580089952|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
160646706|NCT02497391|580089953|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
160646707|NCT02497391|580089948|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
160646708|NCT02497391|580089949|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
160646709|NCT02497391|580089950|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
160646710|NCT02497391|580089951|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
160646711|NCT02497391|580089952|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
160646712|NCT02497391|580089953|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
160646713|NCT02497391|580089948|FG000|Period 3 (14 Days)|Adverse Event|0|||
160646714|NCT02497391|580089949|FG001|Period 3 (14 Days)|Adverse Event|1|||
160646715|NCT02497391|580089950|FG002|Period 3 (14 Days)|Adverse Event|0|||
160646716|NCT02497391|580089951|FG003|Period 3 (14 Days)|Adverse Event|0|||
160646717|NCT02497391|580089952|FG004|Period 3 (14 Days)|Adverse Event|0|||
160826307|NCT00392808|580749306|FG003|Overall Study|Lost to Follow-up|2|||
160826308|NCT00392808|580749303|FG000|Overall Study|Unable to withdraw blood|3|||
160826309|NCT00392808|580749304|FG001|Overall Study|Unable to withdraw blood|1|||
160826310|NCT00392808|580749305|FG002|Overall Study|Unable to withdraw blood|1|||
160826311|NCT00392808|580749306|FG003|Overall Study|Unable to withdraw blood|2|||
160826312|NCT02436408|580749307|FG000|Overall Study|Death|1|||
160826313|NCT01038713|580749308|FG000|Overall Study|Patient to hospice|1|||
160826314|NCT01038713|580749309|FG001|Overall Study|Patient to hospice|1|||
160826315|NCT01038713|580749310|FG002|Overall Study|Patient to hospice|1|||
160826316|NCT01038713|580749308|FG000|Overall Study|Lost to Follow-up|3|||
160826317|NCT01038713|580749309|FG001|Overall Study|Lost to Follow-up|0|||
160826318|NCT01038713|580749310|FG002|Overall Study|Lost to Follow-up|0|||
160826319|NCT01038713|580749308|FG000|Overall Study|Neuroendocrine Tumor|0|||
160826320|NCT01038713|580749309|FG001|Overall Study|Neuroendocrine Tumor|1|||
160826321|NCT01038713|580749310|FG002|Overall Study|Neuroendocrine Tumor|0|||
160826322|NCT01038713|580749308|FG000|Overall Study|died from PEP|0|||
160826323|NCT01038713|580749309|FG001|Overall Study|died from PEP|1|||
160826324|NCT01038713|580749310|FG002|Overall Study|died from PEP|0|||
160826325|NCT01038713|580749308|FG000|Overall Study|Autoimmune Pancreatitis|1|||
160826326|NCT01038713|580749309|FG001|Overall Study|Autoimmune Pancreatitis|0|||
160826327|NCT01038713|580749310|FG002|Overall Study|Autoimmune Pancreatitis|0|||
160826328|NCT02818036|580749311|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
160826329|NCT02818036|580749312|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
160826330|NCT02818036|580749311|FG000|Overall Study|Withdrawal by Subject|1|||
160826331|NCT02818036|580749312|FG001|Overall Study|Withdrawal by Subject|0|||
160826332|NCT01154283|580749313|FG000|0-6 Weeks|Withdrawal by Subject|7|||
160826333|NCT01154283|580749314|FG001|0-6 Weeks|Withdrawal by Subject|2|||
160826334|NCT01154283|580749313|FG000|0-6 Weeks|Death|0|||
160646718|NCT02497391|580089953|FG005|Period 3 (14 Days)|Adverse Event|0|||
160646719|NCT02497391|580089948|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
160646720|NCT02497391|580089949|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
160646721|NCT02497391|580089950|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
160646722|NCT02497391|580089951|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
160646723|NCT02497391|580089952|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
160646724|NCT02497391|580089953|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
160826335|NCT01154283|580749314|FG001|0-6 Weeks|Death|1|||
160826336|NCT01154283|580749313|FG000|7-12 Weeks|Death|1|||
160826337|NCT01154283|580749314|FG001|7-12 Weeks|Death|0|||
160826338|NCT01154283|580749313|FG000|7-12 Weeks|Withdrawal by Subject|0|||
160826339|NCT01154283|580749314|FG001|7-12 Weeks|Withdrawal by Subject|1|||
160826340|NCT03777917|580749315|FG000|Overall Study|Withdrawal by Subject|1|||
160826341|NCT03777917|580749316|FG001|Overall Study|Withdrawal by Subject|0|||
160826342|NCT03777917|580749315|FG000|Overall Study|Physician Decision|1|||
160826343|NCT03777917|580749316|FG001|Overall Study|Physician Decision|0|||
160646725|NCT02497391|580089948|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
160826344|NCT03777917|580749315|FG000|Overall Study|Lost to Follow-up|6|||
160826345|NCT03777917|580749316|FG001|Overall Study|Lost to Follow-up|2|||
160826346|NCT03777917|580749315|FG000|Overall Study|Other|1|||
160826347|NCT03777917|580749316|FG001|Overall Study|Other|0|||
160826348|NCT00320372|580749317|FG000|Overall Study|Physician Decision|4|||
160826349|NCT00320372|580749318|FG001|Overall Study|Physician Decision|7|||
160826350|NCT00320372|580749317|FG000|Overall Study|Death|7|||
160826351|NCT00320372|580749318|FG001|Overall Study|Death|8|||
160826352|NCT00320372|580749317|FG000|Overall Study|Withdrawal by Subject|55|||
160826353|NCT00320372|580749318|FG001|Overall Study|Withdrawal by Subject|37|||
160826354|NCT00320372|580749317|FG000|Overall Study|Non-Compliance|40|||
160826355|NCT00320372|580749318|FG001|Overall Study|Non-Compliance|39|||
160826356|NCT00320372|580749317|FG000|Overall Study|Did not Meet (I/E)|3|||
160826357|NCT00320372|580749318|FG001|Overall Study|Did not Meet (I/E)|1|||
160826358|NCT00320372|580749317|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
160826359|NCT00320372|580749318|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
160826360|NCT04063787|580749319|FG000|Overall Study|Inadequate Doppler data|4|||
160826361|NCT04063787|580749319|FG000|Overall Study|Lost to Follow-up|2|||
160826362|NCT04063787|580749319|FG000|Overall Study|Death|3|||
160826363|NCT01416441|580749320|FG000|Overall Study|Lost to Follow-up|5|||
160826364|NCT01416441|580749320|FG000|Overall Study|Adverse Event|6|||
160826365|NCT01416441|580749320|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
160826366|NCT01416441|580749320|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
160826367|NCT01416441|580749320|FG000|Overall Study|Investigator Withdrew Subject|2|||
160826368|NCT01416441|580749320|FG000|Overall Study|Subject Withdrew Consent|12|||
160826369|NCT01416441|580749320|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
160826370|NCT03515941|580749330|FG000|Overall Study|Adverse Event|1|||
160826371|NCT03515941|580749331|FG001|Overall Study|Adverse Event|0|||
160826372|NCT00240110|580751758|FG000|Overall Study|Lost to Follow-up|6|||
160826373|NCT00240110|580751759|FG001|Overall Study|Lost to Follow-up|7|||
160826374|NCT00583791|580751760|FG000|Overall Study|Other|67|||
160826375|NCT00583791|580751760|FG000|Overall Study|Death|6|||
160826376|NCT00203021|580751761|FG000|Overall Study|Death|4|||
160826377|NCT00203021|580751762|FG001|Overall Study|Death|1|||
160826378|NCT00203021|580751761|FG000|Overall Study|Adverse Event|10|||
160826379|NCT00203021|580751762|FG001|Overall Study|Adverse Event|5|||
160826380|NCT00203021|580751761|FG000|Overall Study|Withdrawal by Subject|45|||
160826381|NCT00203021|580751762|FG001|Overall Study|Withdrawal by Subject|48|||
160826382|NCT00203021|580751761|FG000|Overall Study|Lost to Follow-up|9|||
160826383|NCT00203021|580751762|FG001|Overall Study|Lost to Follow-up|7|||
160826384|NCT00203021|580751761|FG000|Overall Study|Other than specified|11|||
160826385|NCT00203021|580751762|FG001|Overall Study|Other than specified|16|||
160826386|NCT02080260|580751764|FG000|Overall Study|Death|18|||
160826387|NCT02080260|580751764|FG000|Overall Study|Withdrawal by Subject|1|||
160826388|NCT05438602|580751769|FG000|Treatment (15 Days)|Adverse Event|2|||
160826389|NCT05438602|580751770|FG001|Treatment (15 Days)|Adverse Event|1|||
160826390|NCT05438602|580751771|FG002|Treatment (15 Days)|Adverse Event|3|||
160826391|NCT05438602|580751769|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
160826392|NCT05438602|580751770|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
160826393|NCT05438602|580751771|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
160826394|NCT05438602|580751769|FG000|Treatment (15 Days)|Other|0|||
160826395|NCT05438602|580751770|FG001|Treatment (15 Days)|Other|0|||
160826396|NCT05438602|580751771|FG002|Treatment (15 Days)|Other|1|||
160826397|NCT05438602|580751769|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
160826398|NCT05438602|580751770|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
160826399|NCT05438602|580751771|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
160826400|NCT05438602|580751769|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
160826401|NCT05438602|580751770|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
160826402|NCT05438602|580751771|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
160826403|NCT05438602|580751769|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
160826404|NCT05438602|580751770|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
160826405|NCT05438602|580751771|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
160902218|NCT04729621|581036012|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
160902219|NCT04729621|581036008|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
160902220|NCT04729621|581036009|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
160902221|NCT04729621|581036010|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
160902222|NCT04729621|581036011|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
160902223|NCT04729621|581036012|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
160902224|NCT04729621|581036008|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
160826406|NCT05438602|580751769|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
160826407|NCT05438602|580751770|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
160826408|NCT05438602|580751771|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
160902225|NCT04729621|581036009|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
160902226|NCT04729621|581036010|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
160826409|NCT05438602|580751769|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
160826410|NCT05438602|580751770|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
160826411|NCT05438602|580751771|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
160826412|NCT05438602|580751769|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
160826413|NCT05438602|580751770|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
160826414|NCT05438602|580751771|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
160826415|NCT05438602|580751769|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
160826416|NCT05438602|580751770|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
160826417|NCT05438602|580751771|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
160826418|NCT02853435|580751772|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
160826419|NCT02853435|580751773|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
160826420|NCT02853435|580751774|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
160826421|NCT02853435|580751775|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
160826422|NCT02853435|580751776|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
160826423|NCT02853435|580751777|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
160826424|NCT03747120|580751778|FG000|Overall Study|treatment related toxicity|3|||
160826425|NCT03747120|580751779|FG001|Overall Study|treatment related toxicity|0|||
160826426|NCT03747120|580751780|FG002|Overall Study|treatment related toxicity|0|||
160826427|NCT03747120|580751778|FG000|Overall Study|Withdrawal by Subject|0|||
160826428|NCT03747120|580751779|FG001|Overall Study|Withdrawal by Subject|1|||
160826429|NCT03747120|580751780|FG002|Overall Study|Withdrawal by Subject|2|||
160826430|NCT01340937|580751783|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
160826431|NCT01340937|580751784|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
160826432|NCT01340937|580751785|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
160826433|NCT01340937|580751786|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
160826434|NCT01340937|580751783|FG000|Period 1: Infant Series|Adverse Event|0|||
160826435|NCT01340937|580751784|FG001|Period 1: Infant Series|Adverse Event|1|||
160826436|NCT01340937|580751785|FG002|Period 1: Infant Series|Adverse Event|4|||
160826437|NCT01340937|580751786|FG003|Period 1: Infant Series|Adverse Event|0|||
160826438|NCT01340937|580751783|FG000|Period 1: Infant Series|Death|2|||
160826439|NCT01340937|580751784|FG001|Period 1: Infant Series|Death|0|||
160826440|NCT01340937|580751785|FG002|Period 1: Infant Series|Death|2|||
160826441|NCT01340937|580751786|FG003|Period 1: Infant Series|Death|0|||
160826442|NCT01340937|580751783|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
160826443|NCT01340937|580751784|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
160826444|NCT01340937|580751785|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
160826445|NCT01340937|580751786|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
160826446|NCT01340937|580751783|FG000|Period 1: Infant Series|Physician Decision|2|||
160826447|NCT01340937|580751784|FG001|Period 1: Infant Series|Physician Decision|3|||
160826448|NCT01340937|580751785|FG002|Period 1: Infant Series|Physician Decision|1|||
160826449|NCT01340937|580751786|FG003|Period 1: Infant Series|Physician Decision|0|||
160826450|NCT01340937|580751783|FG000|Period 1: Infant Series|Protocol Violation|1|||
160826451|NCT01340937|580751784|FG001|Period 1: Infant Series|Protocol Violation|4|||
160826452|NCT01340937|580751785|FG002|Period 1: Infant Series|Protocol Violation|4|||
160826453|NCT01340937|580751786|FG003|Period 1: Infant Series|Protocol Violation|3|||
160826454|NCT01340937|580751783|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
160902227|NCT04729621|581036011|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
160902228|NCT04729621|581036012|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
160902229|NCT02130297|581036020|FG000|Overall Study|Lost to Follow-up|4|||
160902230|NCT00347360|581036031|FG000|Overall Study|Adverse Event|1|||
160902231|NCT00347360|581036032|FG001|Overall Study|Adverse Event|2|||
160902232|NCT00347360|581036033|FG002|Overall Study|Adverse Event|0|||
160902233|NCT00347360|581036034|FG003|Overall Study|Adverse Event|4|||
160902234|NCT00347360|581036035|FG004|Overall Study|Adverse Event|1|||
160902235|NCT00347360|581036036|FG005|Overall Study|Adverse Event|2|||
160902236|NCT00347360|581036037|FG006|Overall Study|Adverse Event|2|||
160826455|NCT01340937|580751784|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
160826456|NCT01340937|580751785|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
160826457|NCT01340937|580751786|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
160826458|NCT01340937|580751783|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
160826459|NCT01340937|580751784|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
160826460|NCT01340937|580751785|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
160826461|NCT01340937|580751786|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
160826462|NCT01340937|580751783|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
160826463|NCT01340937|580751784|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
160902237|NCT00347360|581036038|FG007|Overall Study|Adverse Event|0|||
160902238|NCT00347360|581036039|FG008|Overall Study|Adverse Event|2|||
160902239|NCT00347360|581036040|FG009|Overall Study|Adverse Event|3|||
160902240|NCT00347360|581036041|FG010|Overall Study|Adverse Event|3|||
160826464|NCT01340937|580751785|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
160902241|NCT00347360|581036042|FG011|Overall Study|Adverse Event|1|||
160826465|NCT01340937|580751786|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
160826466|NCT01340937|580751783|FG000|Period 2: Interim Period|Adverse Event|1|||
160826467|NCT01340937|580751784|FG001|Period 2: Interim Period|Adverse Event|0|||
160826468|NCT01340937|580751785|FG002|Period 2: Interim Period|Adverse Event|1|||
160826469|NCT01340937|580751786|FG003|Period 2: Interim Period|Adverse Event|0|||
160826470|NCT01340937|580751783|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
160826471|NCT01340937|580751784|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
160826472|NCT01340937|580751785|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
160826473|NCT01340937|580751786|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
160826474|NCT01340937|580751783|FG000|Period 2: Interim Period|Physician Decision|0|||
160826475|NCT01340937|580751784|FG001|Period 2: Interim Period|Physician Decision|1|||
160826476|NCT01340937|580751785|FG002|Period 2: Interim Period|Physician Decision|1|||
160826477|NCT01340937|580751786|FG003|Period 2: Interim Period|Physician Decision|0|||
160826478|NCT01340937|580751783|FG000|Period 2: Interim Period|Protocol Violation|5|||
160826479|NCT01340937|580751784|FG001|Period 2: Interim Period|Protocol Violation|3|||
160826480|NCT01340937|580751785|FG002|Period 2: Interim Period|Protocol Violation|6|||
160826481|NCT01340937|580751786|FG003|Period 2: Interim Period|Protocol Violation|3|||
160826482|NCT01340937|580751783|FG000|Period 2: Interim Period|Technical problems|4|||
160826483|NCT01340937|580751784|FG001|Period 2: Interim Period|Technical problems|4|||
160826484|NCT01340937|580751785|FG002|Period 2: Interim Period|Technical problems|6|||
160826485|NCT01340937|580751786|FG003|Period 2: Interim Period|Technical problems|3|||
160826486|NCT01340937|580751783|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
160826487|NCT01340937|580751784|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
160826488|NCT01340937|580751785|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
160826489|NCT01340937|580751786|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
160826490|NCT01340937|580751783|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
160826491|NCT01340937|580751784|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
160826492|NCT01340937|580751785|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
160826493|NCT01340937|580751786|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
160826494|NCT01340937|580751783|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
160826495|NCT01340937|580751784|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
160826496|NCT01340937|580751785|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
160826497|NCT01340937|580751786|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
160826498|NCT01340937|580751783|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
160826499|NCT01340937|580751784|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
160826500|NCT01340937|580751785|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
160826501|NCT01340937|580751786|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
160826502|NCT01657760|580751787|FG000|Overall Study|Withdrawal by Subject|0|||
160826503|NCT01657760|580751788|FG001|Overall Study|Withdrawal by Subject|0|||
160826504|NCT01657760|580751789|FG002|Overall Study|Withdrawal by Subject|0|||
160826505|NCT01657760|580751790|FG003|Overall Study|Withdrawal by Subject|1|||
160826506|NCT01657760|580751787|FG000|Overall Study|Physician Decision|1|||
160826507|NCT01657760|580751788|FG001|Overall Study|Physician Decision|1|||
160826508|NCT01657760|580751789|FG002|Overall Study|Physician Decision|1|||
160826509|NCT01657760|580751790|FG003|Overall Study|Physician Decision|2|||
160826510|NCT00096174|580751795|FG000|Overall Study|Lack of Efficacy|9|||
160826511|NCT00096174|580751795|FG000|Overall Study|Adverse Event|15|||
160826512|NCT00096174|580751795|FG000|Overall Study|Death|6|||
160826513|NCT00096174|580751795|FG000|Overall Study|Withdrawal by Subject|15|||
160826514|NCT00096174|580751795|FG000|Overall Study|Not started protocol therapy|3|||
160826515|NCT00096174|580751795|FG000|Overall Study|Ineligible|6|||
160826516|NCT00096174|580751795|FG000|Overall Study|other reason|8|||
160826517|NCT02509052|580751803|FG000|Overall Study|Non compliance|0|||
160826518|NCT02509052|580751804|FG001|Overall Study|Non compliance|0|||
160554479|NCT00272987|579755803|FG002|Overall Study|Death|0|||
160826519|NCT02509052|580751805|FG002|Overall Study|Non compliance|1|||
160826520|NCT03554772|580751808|FG000|Overall Study|Lost to Follow-up|0|||
160826521|NCT03554772|580751809|FG001|Overall Study|Lost to Follow-up|0|||
160826522|NCT03554772|580751810|FG002|Overall Study|Lost to Follow-up|0|||
160826523|NCT03554772|580751811|FG003|Overall Study|Lost to Follow-up|2|||
160826524|NCT03362931|580751813|FG000|Overall Study|Adverse Event|1|||
160826525|NCT03362931|580751813|FG000|Overall Study|Death|2|||
160826526|NCT01998893|580751814|FG000|Overall Study|Adverse Event|2|||
160826527|NCT01998893|580751814|FG000|Overall Study|Death|1|||
160826528|NCT01998893|580751814|FG000|Overall Study|Lost to Follow-up|8|||
160554480|NCT02614079|579755807|FG000|Overall Study|Withdrawal by Subject|1|||
160554481|NCT03739528|579755810|FG000|Overall Study|Not treated|8|||
160826529|NCT01998893|580751814|FG000|Overall Study|Physician Decision|2|||
160826530|NCT01998893|580751814|FG000|Overall Study|Protocol Violation|2|||
160826531|NCT01998893|580751814|FG000|Overall Study|Withdrawal by Subject|1|||
160826532|NCT01998893|580751814|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
160826533|NCT03276052|580751815|FG000|Overall Study|Withdrawal by Subject|5|||
160826534|NCT03276052|580751815|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
160826535|NCT05136898|580751820|FG000|Overall Study|Adverse Event|2|||
160826536|NCT01994863|580751821|FG000|Period 1|Adverse Event|4|||
160826537|NCT01994863|580751822|FG001|Period 1|Adverse Event|0|||
160826538|NCT01994863|580751821|FG000|Period 1|Withdrawal by Subject|1|||
160826539|NCT01994863|580751822|FG001|Period 1|Withdrawal by Subject|0|||
160826540|NCT01994863|580751821|FG000|Period 1|Trial stopped by sponsor|1|||
160826541|NCT01994863|580751822|FG001|Period 1|Trial stopped by sponsor|3|||
160826542|NCT01994863|580751821|FG000|Period 1|Lack of Efficacy|1|||
160826543|NCT01994863|580751822|FG001|Period 1|Lack of Efficacy|0|||
160826544|NCT01994863|580751821|FG000|Period 2|Adverse Event|0|||
160826545|NCT01994863|580751822|FG001|Period 2|Adverse Event|1|||
160826546|NCT01994863|580751821|FG000|Period 2|Lack of Efficacy|0|||
160826547|NCT01994863|580751822|FG001|Period 2|Lack of Efficacy|2|||
160826548|NCT01994863|580751821|FG000|Period 2|Withdrawal by Subject|1|||
160826549|NCT01994863|580751822|FG001|Period 2|Withdrawal by Subject|1|||
160826550|NCT03784846|580751825|FG000|Pre-COVID Study|Lost to Follow-up|3|||
160826551|NCT03784846|580751826|FG001|Pre-COVID Study|Lost to Follow-up|3|||
160826552|NCT03784846|580751827|FG002|Pre-COVID Study|Lost to Follow-up|2|||
160826553|NCT03784846|580751825|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
160826554|NCT03784846|580751826|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
160826555|NCT03784846|580751827|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
160826556|NCT03784846|580751825|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
160826557|NCT03784846|580751826|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
160826558|NCT03784846|580751827|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
160826559|NCT03784846|580751825|FG000|Post-COVID Study|Lost to Follow-up|3|||
160826560|NCT03784846|580751826|FG001|Post-COVID Study|Lost to Follow-up|5|||
160826561|NCT03784846|580751827|FG002|Post-COVID Study|Lost to Follow-up|1|||
160826562|NCT03784846|580751825|FG000|Post-COVID Study|Withdrawal by Subject|1|||
160826563|NCT03784846|580751826|FG001|Post-COVID Study|Withdrawal by Subject|2|||
160826564|NCT03784846|580751827|FG002|Post-COVID Study|Withdrawal by Subject|0|||
160826565|NCT00931723|580751828|FG000|Overall Study|Withdrawal by Subject|11|||
160826566|NCT00931723|580751829|FG001|Overall Study|Withdrawal by Subject|13|||
160826567|NCT00931723|580751828|FG000|Overall Study|Adverse Event|6|||
160826568|NCT00931723|580751829|FG001|Overall Study|Adverse Event|13|||
160826569|NCT00931723|580751828|FG000|Overall Study|Lithium found in blood|0|||
160826570|NCT00931723|580751829|FG001|Overall Study|Lithium found in blood|1|||
160826571|NCT00931723|580751828|FG000|Overall Study|Condition under investigation worsened|1|||
160826572|NCT00931723|580751829|FG001|Overall Study|Condition under investigation worsened|2|||
160826573|NCT00931723|580751828|FG000|Overall Study|Lost to Follow-up|1|||
160826574|NCT00931723|580751829|FG001|Overall Study|Lost to Follow-up|2|||
160826575|NCT00931723|580751828|FG000|Overall Study|Study-specific discontinuation criteria|1|||
160826576|NCT00931723|580751829|FG001|Overall Study|Study-specific discontinuation criteria|1|||
160826577|NCT00931723|580751828|FG000|Overall Study|Severe non-compliance to protocol|2|||
160826578|NCT00931723|580751829|FG001|Overall Study|Severe non-compliance to protocol|0|||
160826579|NCT00931723|580751828|FG000|Overall Study|Safety reasons|0|||
160826580|NCT00931723|580751829|FG001|Overall Study|Safety reasons|1|||
160826581|NCT00931723|580751828|FG000|Overall Study|Took prohibited concomitant medication|0|||
160826582|NCT00931723|580751829|FG001|Overall Study|Took prohibited concomitant medication|1|||
160826583|NCT00931723|580751828|FG000|Overall Study|Lack or insufficient theraputic response|2|||
160826584|NCT00931723|580751829|FG001|Overall Study|Lack or insufficient theraputic response|5|||
160826585|NCT00931723|580751828|FG000|Overall Study|Sponsor decision|1|||
160826586|NCT00931723|580751829|FG001|Overall Study|Sponsor decision|0|||
160902242|NCT00347360|581036043|FG012|Overall Study|Adverse Event|3|||
160902243|NCT00347360|581036044|FG013|Overall Study|Adverse Event|2|||
160902244|NCT00347360|581036045|FG014|Overall Study|Adverse Event|2|||
160902245|NCT00347360|581036031|FG000|Overall Study|Lost to Follow-up|0|||
160902246|NCT00347360|581036032|FG001|Overall Study|Lost to Follow-up|0|||
160902247|NCT00347360|581036033|FG002|Overall Study|Lost to Follow-up|0|||
160902248|NCT00347360|581036034|FG003|Overall Study|Lost to Follow-up|2|||
160902249|NCT00347360|581036035|FG004|Overall Study|Lost to Follow-up|1|||
160902250|NCT00347360|581036036|FG005|Overall Study|Lost to Follow-up|1|||
160902251|NCT00347360|581036037|FG006|Overall Study|Lost to Follow-up|0|||
160902252|NCT00347360|581036038|FG007|Overall Study|Lost to Follow-up|1|||
160902253|NCT00347360|581036039|FG008|Overall Study|Lost to Follow-up|1|||
160902254|NCT00347360|581036040|FG009|Overall Study|Lost to Follow-up|2|||
160902255|NCT00347360|581036041|FG010|Overall Study|Lost to Follow-up|0|||
160826587|NCT00931723|580751828|FG000|Overall Study|Late hospital discharge|1|||
160826588|NCT00931723|580751829|FG001|Overall Study|Late hospital discharge|0|||
160826589|NCT03054350|580751830|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
160826590|NCT03054350|580751831|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
160826591|NCT03054350|580751832|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
160826592|NCT03054350|580751833|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
160826593|NCT03054350|580751834|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
160826594|NCT03054350|580751835|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
160826595|NCT03054350|580751830|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
160902256|NCT00347360|581036042|FG011|Overall Study|Lost to Follow-up|0|||
160826596|NCT03054350|580751831|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
160826597|NCT03054350|580751832|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
160826598|NCT03054350|580751833|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
160826599|NCT03054350|580751834|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
160826600|NCT03054350|580751835|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
160826601|NCT03054350|580751830|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
160826602|NCT03054350|580751831|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
160826603|NCT03054350|580751832|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
160826604|NCT03054350|580751833|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
160826605|NCT03054350|580751834|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
160826606|NCT03054350|580751835|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
160826607|NCT03054350|580751830|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
160826608|NCT03054350|580751831|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
160826609|NCT03054350|580751832|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
160826610|NCT03054350|580751833|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
160826611|NCT03054350|580751834|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
160826612|NCT03054350|580751835|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
160826613|NCT01643850|580751836|FG000|Overall Study|Withdrawal by Subject|0|||
160826614|NCT01643850|580751837|FG001|Overall Study|Withdrawal by Subject|0|||
160826615|NCT01643850|580751838|FG002|Overall Study|Withdrawal by Subject|0|||
160826616|NCT01643850|580751839|FG003|Overall Study|Withdrawal by Subject|0|||
160826617|NCT01643850|580751840|FG004|Overall Study|Withdrawal by Subject|1|||
160826618|NCT01643850|580751841|FG005|Overall Study|Withdrawal by Subject|0|||
160826619|NCT01643850|580751842|FG006|Overall Study|Withdrawal by Subject|0|||
160826620|NCT01643850|580751843|FG007|Overall Study|Withdrawal by Subject|0|||
160826621|NCT01643850|580751844|FG008|Overall Study|Withdrawal by Subject|0|||
160826622|NCT01643850|580751836|FG000|Overall Study|Lost to Follow-up|0|||
160826623|NCT01643850|580751837|FG001|Overall Study|Lost to Follow-up|0|||
160826624|NCT01643850|580751838|FG002|Overall Study|Lost to Follow-up|0|||
160826625|NCT01643850|580751839|FG003|Overall Study|Lost to Follow-up|0|||
160826626|NCT01643850|580751840|FG004|Overall Study|Lost to Follow-up|0|||
160826627|NCT01643850|580751841|FG005|Overall Study|Lost to Follow-up|0|||
160826628|NCT01643850|580751842|FG006|Overall Study|Lost to Follow-up|1|||
160826629|NCT01643850|580751843|FG007|Overall Study|Lost to Follow-up|0|||
160826630|NCT01643850|580751844|FG008|Overall Study|Lost to Follow-up|1|||
160826631|NCT01643850|580751836|FG000|Overall Study|Adverse Event|0|||
160826632|NCT01643850|580751837|FG001|Overall Study|Adverse Event|0|||
160826633|NCT01643850|580751838|FG002|Overall Study|Adverse Event|0|||
160826634|NCT01643850|580751839|FG003|Overall Study|Adverse Event|0|||
160826635|NCT01643850|580751840|FG004|Overall Study|Adverse Event|1|||
160826636|NCT01643850|580751841|FG005|Overall Study|Adverse Event|0|||
160826637|NCT01643850|580751842|FG006|Overall Study|Adverse Event|0|||
160826638|NCT01643850|580751843|FG007|Overall Study|Adverse Event|0|||
160826639|NCT01643850|580751844|FG008|Overall Study|Adverse Event|0|||
160826640|NCT01643850|580751836|FG000|Overall Study|Administrative Problems|0|||
160826641|NCT01643850|580751837|FG001|Overall Study|Administrative Problems|0|||
160826642|NCT01643850|580751838|FG002|Overall Study|Administrative Problems|1|||
160826643|NCT01643850|580751839|FG003|Overall Study|Administrative Problems|0|||
160826644|NCT01643850|580751840|FG004|Overall Study|Administrative Problems|1|||
160826645|NCT01643850|580751841|FG005|Overall Study|Administrative Problems|0|||
160826646|NCT01643850|580751842|FG006|Overall Study|Administrative Problems|0|||
160826647|NCT01643850|580751843|FG007|Overall Study|Administrative Problems|0|||
160826648|NCT01643850|580751844|FG008|Overall Study|Administrative Problems|0|||
160826649|NCT01133405|580751845|FG000|Period 1|Withdrawal by Subject|0|||
160826650|NCT01133405|580751846|FG001|Period 1|Withdrawal by Subject|1|||
160826651|NCT01133405|580751847|FG002|Period 1|Withdrawal by Subject|0|||
160826652|NCT01133405|580751848|FG003|Period 1|Withdrawal by Subject|1|||
160826653|NCT01133405|580751849|FG004|Period 1|Withdrawal by Subject|0|||
160826654|NCT01133405|580751850|FG005|Period 1|Withdrawal by Subject|1|||
160826655|NCT01133405|580751851|FG006|Period 1|Withdrawal by Subject|0|||
160826656|NCT01133405|580751852|FG007|Period 1|Withdrawal by Subject|0|||
160826657|NCT01133405|580751853|FG008|Period 1|Withdrawal by Subject|0|||
160826658|NCT01133405|580751854|FG009|Period 1|Withdrawal by Subject|0|||
160826659|NCT01133405|580751845|FG000|Period 1|Physician Decision|0|||
160826660|NCT01133405|580751846|FG001|Period 1|Physician Decision|0|||
160826661|NCT01133405|580751847|FG002|Period 1|Physician Decision|0|||
160826662|NCT01133405|580751848|FG003|Period 1|Physician Decision|1|||
160826663|NCT01133405|580751849|FG004|Period 1|Physician Decision|0|||
160826664|NCT01133405|580751850|FG005|Period 1|Physician Decision|0|||
160826665|NCT01133405|580751851|FG006|Period 1|Physician Decision|0|||
160826666|NCT01133405|580751852|FG007|Period 1|Physician Decision|0|||
160826667|NCT01133405|580751853|FG008|Period 1|Physician Decision|0|||
160826668|NCT01133405|580751854|FG009|Period 1|Physician Decision|0|||
160826669|NCT01133405|580751845|FG000|Period 1|Discontinued after randomization|1|||
160826670|NCT01133405|580751846|FG001|Period 1|Discontinued after randomization|0|||
160826671|NCT01133405|580751847|FG002|Period 1|Discontinued after randomization|0|||
160826672|NCT01133405|580751848|FG003|Period 1|Discontinued after randomization|0|||
160826673|NCT01133405|580751849|FG004|Period 1|Discontinued after randomization|0|||
160826674|NCT01133405|580751850|FG005|Period 1|Discontinued after randomization|0|||
160826675|NCT01133405|580751851|FG006|Period 1|Discontinued after randomization|1|||
160826676|NCT01133405|580751852|FG007|Period 1|Discontinued after randomization|0|||
160826677|NCT01133405|580751853|FG008|Period 1|Discontinued after randomization|0|||
160826678|NCT01133405|580751854|FG009|Period 1|Discontinued after randomization|0|||
160826679|NCT01133405|580751845|FG000|Period 1|Received drug only in period 2|0|||
160826680|NCT01133405|580751846|FG001|Period 1|Received drug only in period 2|1|||
160826681|NCT01133405|580751847|FG002|Period 1|Received drug only in period 2|0|||
160826682|NCT01133405|580751848|FG003|Period 1|Received drug only in period 2|2|||
160826683|NCT01133405|580751849|FG004|Period 1|Received drug only in period 2|0|||
160826684|NCT01133405|580751850|FG005|Period 1|Received drug only in period 2|1|||
160826685|NCT01133405|580751851|FG006|Period 1|Received drug only in period 2|0|||
160826686|NCT01133405|580751852|FG007|Period 1|Received drug only in period 2|0|||
160826687|NCT01133405|580751853|FG008|Period 1|Received drug only in period 2|0|||
160826688|NCT01133405|580751854|FG009|Period 1|Received drug only in period 2|0|||
160826689|NCT01133405|580751845|FG000|Period 1|Received drug only in period 3|0|||
160826690|NCT01133405|580751846|FG001|Period 1|Received drug only in period 3|1|||
160826691|NCT01133405|580751847|FG002|Period 1|Received drug only in period 3|1|||
160826692|NCT01133405|580751848|FG003|Period 1|Received drug only in period 3|0|||
160826693|NCT01133405|580751849|FG004|Period 1|Received drug only in period 3|0|||
160826694|NCT01133405|580751850|FG005|Period 1|Received drug only in period 3|0|||
160826695|NCT01133405|580751851|FG006|Period 1|Received drug only in period 3|0|||
160826696|NCT01133405|580751852|FG007|Period 1|Received drug only in period 3|0|||
160826697|NCT01133405|580751853|FG008|Period 1|Received drug only in period 3|0|||
160826698|NCT01133405|580751854|FG009|Period 1|Received drug only in period 3|0|||
160826699|NCT01133405|580751845|FG000|Period 2|Adverse Event|0|||
160826700|NCT01133405|580751846|FG001|Period 2|Adverse Event|0|||
160826701|NCT01133405|580751847|FG002|Period 2|Adverse Event|1|||
160826702|NCT01133405|580751848|FG003|Period 2|Adverse Event|0|||
160826703|NCT01133405|580751849|FG004|Period 2|Adverse Event|0|||
160826704|NCT01133405|580751850|FG005|Period 2|Adverse Event|0|||
160826705|NCT01133405|580751851|FG006|Period 2|Adverse Event|0|||
160826706|NCT01133405|580751852|FG007|Period 2|Adverse Event|0|||
160826707|NCT01133405|580751853|FG008|Period 2|Adverse Event|0|||
160826708|NCT01133405|580751854|FG009|Period 2|Adverse Event|0|||
160826709|NCT01133405|580751845|FG000|Period 2|Withdrawal by Subject|0|||
160826710|NCT01133405|580751846|FG001|Period 2|Withdrawal by Subject|0|||
160826711|NCT01133405|580751847|FG002|Period 2|Withdrawal by Subject|0|||
160826712|NCT01133405|580751848|FG003|Period 2|Withdrawal by Subject|1|||
160826713|NCT01133405|580751849|FG004|Period 2|Withdrawal by Subject|0|||
160826714|NCT01133405|580751850|FG005|Period 2|Withdrawal by Subject|1|||
160826715|NCT01133405|580751851|FG006|Period 2|Withdrawal by Subject|0|||
160826716|NCT01133405|580751852|FG007|Period 2|Withdrawal by Subject|0|||
160826717|NCT01133405|580751853|FG008|Period 2|Withdrawal by Subject|0|||
160826718|NCT01133405|580751854|FG009|Period 2|Withdrawal by Subject|0|||
160826719|NCT01133405|580751845|FG000|Period 2|Entry Criteria Not Met|0|||
160902257|NCT00347360|581036043|FG012|Overall Study|Lost to Follow-up|1|||
160554482|NCT03739528|579755811|FG001|Overall Study|Not treated|12|||
160554483|NCT03739528|579755810|FG000|Overall Study|Treatment and study discontinued|6|||
160554484|NCT03739528|579755811|FG001|Overall Study|Treatment and study discontinued|2|||
160554485|NCT03739528|579755810|FG000|Overall Study|Treatment discontinued + study completed|1|||
160554486|NCT03739528|579755811|FG001|Overall Study|Treatment discontinued + study completed|3|||
160554487|NCT05655377|579755812|FG000|Overall Study|Withdrawal by Subject|2|||
160826720|NCT01133405|580751846|FG001|Period 2|Entry Criteria Not Met|1|||
160826721|NCT01133405|580751847|FG002|Period 2|Entry Criteria Not Met|0|||
160826722|NCT01133405|580751848|FG003|Period 2|Entry Criteria Not Met|0|||
160826723|NCT01133405|580751849|FG004|Period 2|Entry Criteria Not Met|0|||
160826724|NCT01133405|580751850|FG005|Period 2|Entry Criteria Not Met|0|||
160826725|NCT01133405|580751851|FG006|Period 2|Entry Criteria Not Met|0|||
160826726|NCT01133405|580751852|FG007|Period 2|Entry Criteria Not Met|0|||
160826727|NCT01133405|580751853|FG008|Period 2|Entry Criteria Not Met|0|||
160826728|NCT01133405|580751854|FG009|Period 2|Entry Criteria Not Met|0|||
160826729|NCT01133405|580751845|FG000|Period 2|Physician Decision|0|||
160826730|NCT01133405|580751846|FG001|Period 2|Physician Decision|0|||
160826731|NCT01133405|580751847|FG002|Period 2|Physician Decision|0|||
160826732|NCT01133405|580751848|FG003|Period 2|Physician Decision|0|||
160826733|NCT01133405|580751849|FG004|Period 2|Physician Decision|0|||
160826734|NCT01133405|580751850|FG005|Period 2|Physician Decision|1|||
160826735|NCT01133405|580751851|FG006|Period 2|Physician Decision|0|||
160826736|NCT01133405|580751852|FG007|Period 2|Physician Decision|0|||
160826737|NCT01133405|580751853|FG008|Period 2|Physician Decision|0|||
160826738|NCT01133405|580751854|FG009|Period 2|Physician Decision|0|||
160826739|NCT00867087|580751857|FG000|Overall Study|Other|1|||
160826740|NCT00867087|580751857|FG000|Overall Study|Withdrawal by Subject|4|||
160826741|NCT00867087|580751857|FG000|Overall Study|Death|37|||
160826742|NCT03300024|580751858|FG000|Overall Study|Physician Decision|4|||
160826743|NCT03300024|580751859|FG001|Overall Study|Physician Decision|6|||
160826744|NCT02370641|580751860|FG000|Overall Study|dropped study|4|||
160826745|NCT02370641|580751861|FG001|Overall Study|dropped study|2|||
160826746|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
160826747|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
160826748|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
160826749|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
160826750|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
160826751|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
160826752|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
160826753|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
160826754|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
160826755|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
160826756|NCT03906656|580751862|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
160826757|NCT03906656|580751863|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
160826758|NCT03906656|580751862|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
160826759|NCT03906656|580751863|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
160826760|NCT03906656|580751862|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
160826761|NCT03906656|580751863|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
160826762|NCT03906656|580751862|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
160826763|NCT03906656|580751863|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
160826764|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
160826765|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
160826766|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
160826767|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
160826768|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
160826769|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
160826770|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
160826771|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
160826772|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
160826773|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
160826774|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
160826775|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
160826776|NCT03906656|580751862|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
160826777|NCT03906656|580751863|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
160826778|NCT03906656|580751862|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
160826779|NCT03906656|580751863|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
160826780|NCT03906656|580751862|FG000|Home Use 2 (3 Months)|Death|2|||
160826781|NCT03906656|580751863|FG001|Home Use 2 (3 Months)|Death|0|||
160826782|NCT03906656|580751862|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
160826783|NCT03906656|580751863|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
160826784|NCT03906656|580751862|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
160826785|NCT03906656|580751863|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
160826786|NCT01036529|580751864|FG000|Overall Study|Adverse Event|0|||
160826787|NCT01036529|580751865|FG001|Overall Study|Adverse Event|1|||
160826788|NCT01036529|580751864|FG000|Overall Study|Lost to Follow-up|0|||
160826789|NCT01036529|580751865|FG001|Overall Study|Lost to Follow-up|1|||
160826790|NCT01036529|580751864|FG000|Overall Study|Physician Decision|1|||
160826791|NCT01036529|580751865|FG001|Overall Study|Physician Decision|0|||
160826792|NCT01036529|580751864|FG000|Overall Study|Withdrawal by Subject|1|||
160826793|NCT01036529|580751865|FG001|Overall Study|Withdrawal by Subject|1|||
160826794|NCT01036529|580751864|FG000|Overall Study|Sponsor study termination|11|||
160826795|NCT01036529|580751865|FG001|Overall Study|Sponsor study termination|12|||
160826796|NCT00541099|580751868|FG000|Overall Study|Ineligible|3|||
160826797|NCT00343915|580751869|FG000|Primary Study|Withdrawal by Subject|1|||
160826798|NCT00343915|580751870|FG001|Primary Study|Withdrawal by Subject|0|||
160826799|NCT00343915|580751869|FG000|Primary Study|Lost to Follow-up|2|||
160826800|NCT00343915|580751870|FG001|Primary Study|Lost to Follow-up|3|||
160826801|NCT00343915|580751869|FG000|Primary Study|Other|1|||
160826802|NCT00343915|580751870|FG001|Primary Study|Other|0|||
160826803|NCT01719003|580751874|FG000|Overall Study|Non compliant with protocol|1|||
160826804|NCT01719003|580751875|FG001|Overall Study|Non compliant with protocol|1|||
160826805|NCT01719003|580751876|FG002|Overall Study|Non compliant with protocol|0|||
160826806|NCT01719003|580751877|FG003|Overall Study|Non compliant with protocol|1|||
160826807|NCT01719003|580751878|FG004|Overall Study|Non compliant with protocol|2|||
160826808|NCT01719003|580751879|FG005|Overall Study|Non compliant with protocol|1|||
160826809|NCT01719003|580751880|FG006|Overall Study|Non compliant with protocol|2|||
160826810|NCT01719003|580751881|FG007|Overall Study|Non compliant with protocol|3|||
160826811|NCT01719003|580751882|FG008|Overall Study|Non compliant with protocol|0|||
160826812|NCT01719003|580751874|FG000|Overall Study|Adverse Event|6|||
160826813|NCT01719003|580751875|FG001|Overall Study|Adverse Event|5|||
160826814|NCT01719003|580751876|FG002|Overall Study|Adverse Event|4|||
160826815|NCT01719003|580751877|FG003|Overall Study|Adverse Event|3|||
160826816|NCT01719003|580751878|FG004|Overall Study|Adverse Event|4|||
160826817|NCT01719003|580751879|FG005|Overall Study|Adverse Event|3|||
160826818|NCT01719003|580751880|FG006|Overall Study|Adverse Event|6|||
160826819|NCT01719003|580751881|FG007|Overall Study|Adverse Event|5|||
160826820|NCT01719003|580751882|FG008|Overall Study|Adverse Event|0|||
160826821|NCT01719003|580751874|FG000|Overall Study|Lost to Follow-up|0|||
160826822|NCT01719003|580751875|FG001|Overall Study|Lost to Follow-up|6|||
160826823|NCT01719003|580751876|FG002|Overall Study|Lost to Follow-up|7|||
160826824|NCT01719003|580751877|FG003|Overall Study|Lost to Follow-up|2|||
160826825|NCT01719003|580751878|FG004|Overall Study|Lost to Follow-up|3|||
160826826|NCT01719003|580751879|FG005|Overall Study|Lost to Follow-up|4|||
160826827|NCT01719003|580751880|FG006|Overall Study|Lost to Follow-up|3|||
160826828|NCT01719003|580751881|FG007|Overall Study|Lost to Follow-up|2|||
160826829|NCT01719003|580751882|FG008|Overall Study|Lost to Follow-up|2|||
160826830|NCT01719003|580751874|FG000|Overall Study|Refusal to continue, not due to AE|2|||
160826831|NCT01719003|580751875|FG001|Overall Study|Refusal to continue, not due to AE|5|||
160826832|NCT01719003|580751876|FG002|Overall Study|Refusal to continue, not due to AE|4|||
160826833|NCT01719003|580751877|FG003|Overall Study|Refusal to continue, not due to AE|4|||
160826834|NCT01719003|580751878|FG004|Overall Study|Refusal to continue, not due to AE|4|||
160826835|NCT01719003|580751879|FG005|Overall Study|Refusal to continue, not due to AE|3|||
160826836|NCT01719003|580751880|FG006|Overall Study|Refusal to continue, not due to AE|8|||
160826837|NCT01719003|580751881|FG007|Overall Study|Refusal to continue, not due to AE|7|||
160826838|NCT01719003|580751882|FG008|Overall Study|Refusal to continue, not due to AE|1|||
160826839|NCT01719003|580751874|FG000|Overall Study|Reason other than those specified|0|||
160826840|NCT01719003|580751875|FG001|Overall Study|Reason other than those specified|0|||
160826841|NCT01719003|580751876|FG002|Overall Study|Reason other than those specified|2|||
160826842|NCT01719003|580751877|FG003|Overall Study|Reason other than those specified|3|||
160826843|NCT01719003|580751878|FG004|Overall Study|Reason other than those specified|4|||
160826844|NCT01719003|580751879|FG005|Overall Study|Reason other than those specified|1|||
160826845|NCT01719003|580751880|FG006|Overall Study|Reason other than those specified|0|||
160826846|NCT01719003|580751881|FG007|Overall Study|Reason other than those specified|3|||
160826847|NCT01719003|580751882|FG008|Overall Study|Reason other than those specified|1|||
160826848|NCT01719003|580751874|FG000|Overall Study|Lack of Efficacy|0|||
160826849|NCT01719003|580751875|FG001|Overall Study|Lack of Efficacy|0|||
160826850|NCT01719003|580751876|FG002|Overall Study|Lack of Efficacy|0|||
160826851|NCT01719003|580751877|FG003|Overall Study|Lack of Efficacy|0|||
160826852|NCT01719003|580751878|FG004|Overall Study|Lack of Efficacy|0|||
160826853|NCT01719003|580751879|FG005|Overall Study|Lack of Efficacy|0|||
160826854|NCT01719003|580751880|FG006|Overall Study|Lack of Efficacy|1|||
160826855|NCT01719003|580751881|FG007|Overall Study|Lack of Efficacy|0|||
160826856|NCT01719003|580751882|FG008|Overall Study|Lack of Efficacy|0|||
160826857|NCT02370095|580751883|FG000|Overall Study|Withdrawal by Subject|0|||
160826858|NCT02370095|580751884|FG001|Overall Study|Withdrawal by Subject|1|||
160826859|NCT00700102|580751885|FG000|Overall Study|Died|394|||
160826860|NCT00700102|580751886|FG001|Overall Study|Died|385|||
160826861|NCT00700102|580751885|FG000|Overall Study|Lost to Follow-up|8|||
160826862|NCT00700102|580751886|FG001|Overall Study|Lost to Follow-up|10|||
160826863|NCT01667562|580751887|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
160826864|NCT01667562|580751888|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
160826865|NCT01667562|580751887|FG000|Erlotinib Phase|Lost to Follow-up|0|||
160826866|NCT01667562|580751888|FG001|Erlotinib Phase|Lost to Follow-up|1|||
160826867|NCT01667562|580751887|FG000|Erlotinib Phase|Adverse Event|0|||
160826868|NCT01667562|580751888|FG001|Erlotinib Phase|Adverse Event|1|||
160826869|NCT01667562|580751887|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
160902258|NCT00347360|581036044|FG013|Overall Study|Lost to Follow-up|0|||
160902259|NCT00347360|581036045|FG014|Overall Study|Lost to Follow-up|0|||
160902260|NCT00347360|581036031|FG000|Overall Study|Protocol Violation|2|||
160902261|NCT00347360|581036032|FG001|Overall Study|Protocol Violation|3|||
160902262|NCT00347360|581036033|FG002|Overall Study|Protocol Violation|1|||
160902263|NCT00347360|581036034|FG003|Overall Study|Protocol Violation|2|||
160902264|NCT00347360|581036035|FG004|Overall Study|Protocol Violation|1|||
160826870|NCT01667562|580751888|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
160826871|NCT02525939|580751889|FG000|Overall Study|Lost to Follow-up|27|||
160826872|NCT02525939|580751890|FG001|Overall Study|Lost to Follow-up|24|||
160826873|NCT02525939|580751889|FG000|Overall Study|Physician Decision|0|||
160826874|NCT02525939|580751890|FG001|Overall Study|Physician Decision|1|||
160826875|NCT02525939|580751889|FG000|Overall Study|Withdrawal by Subject|24|||
160826876|NCT02525939|580751890|FG001|Overall Study|Withdrawal by Subject|39|||
160826877|NCT02525939|580751889|FG000|Overall Study|Death|180|||
160902265|NCT00347360|581036036|FG005|Overall Study|Protocol Violation|2|||
160902266|NCT00347360|581036037|FG006|Overall Study|Protocol Violation|0|||
160826878|NCT02525939|580751890|FG001|Overall Study|Death|179|||
160826879|NCT02130986|580751891|FG000|Overall Study|Withdrawal by Subject|4|||
160826880|NCT02130986|580751892|FG001|Overall Study|Withdrawal by Subject|4|||
160826881|NCT02130986|580751891|FG000|Overall Study|Lost to Follow-up|151|||
160826882|NCT02130986|580751892|FG001|Overall Study|Lost to Follow-up|160|||
160826883|NCT01028716|580751893|FG000|Overall Study|Physician Decision|1|||
160826884|NCT01129882|580751894|FG000|Overall Study|Adverse Event|39|||
160826885|NCT01129882|580751894|FG000|Overall Study|Death|6|||
160826886|NCT01129882|580751894|FG000|Overall Study|Lack of Efficacy|5|||
160826887|NCT01129882|580751894|FG000|Overall Study|Lost to Follow-up|13|||
160826888|NCT01129882|580751894|FG000|Overall Study|Physician Decision|27|||
160826889|NCT01129882|580751894|FG000|Overall Study|Protocol Deviation|3|||
160826890|NCT01129882|580751894|FG000|Overall Study|Withdrawal Criteria Met|19|||
160826891|NCT01129882|580751894|FG000|Overall Study|Trial Termination by Sponsor|6|||
160826892|NCT01129882|580751894|FG000|Overall Study|Withdrawal by Subject|160|||
160826893|NCT00536874|580751895|FG000|Overall Study|Adverse Event|1|||
160826894|NCT00536874|580751895|FG000|Overall Study|Death|2|||
160826895|NCT00536874|580751895|FG000|Overall Study|Withdrawal by Subject|1|||
160826896|NCT00762996|580751896|FG000|Period One|Protocol Violation|0|||
160826897|NCT00762996|580751897|FG001|Period One|Protocol Violation|0|||
160826898|NCT00762996|580751898|FG002|Period One|Protocol Violation|1|||
160826899|NCT00762996|580751899|FG003|Period One|Protocol Violation|0|||
160826900|NCT00762996|580751896|FG000|Period One|ineligible|0|||
160826901|NCT00762996|580751897|FG001|Period One|ineligible|0|||
160826902|NCT00762996|580751898|FG002|Period One|ineligible|1|||
160826903|NCT00762996|580751899|FG003|Period One|ineligible|1|||
160826904|NCT00762996|580751896|FG000|Period One|Adverse Event|0|||
160826905|NCT00762996|580751897|FG001|Period One|Adverse Event|0|||
160826906|NCT00762996|580751898|FG002|Period One|Adverse Event|1|||
160826907|NCT00762996|580751899|FG003|Period One|Adverse Event|0|||
160826908|NCT00762996|580751896|FG000|Period One|Withdrawal by Subject|0|||
160826909|NCT00762996|580751897|FG001|Period One|Withdrawal by Subject|0|||
160826910|NCT00762996|580751898|FG002|Period One|Withdrawal by Subject|1|||
160826911|NCT00762996|580751899|FG003|Period One|Withdrawal by Subject|0|||
160826912|NCT01853072|580751901|FG000|Overall Study|Adverse event prior to treatment|0|||
160826913|NCT01853072|580751902|FG001|Overall Study|Adverse event prior to treatment|1|||
160826914|NCT01853072|580751901|FG000|Overall Study|Adverse Event|0|||
160826915|NCT01853072|580751902|FG001|Overall Study|Adverse Event|3|||
160826916|NCT01853072|580751901|FG000|Overall Study|Death|1|||
160826917|NCT01853072|580751902|FG001|Overall Study|Death|4|||
160826918|NCT01853072|580751901|FG000|Overall Study|Lost to Follow-up|0|||
160826919|NCT01853072|580751902|FG001|Overall Study|Lost to Follow-up|3|||
160826920|NCT01853072|580751901|FG000|Overall Study|Non-compliance with study drug|0|||
160826921|NCT01853072|580751902|FG001|Overall Study|Non-compliance with study drug|1|||
160826922|NCT01853072|580751901|FG000|Overall Study|Physician Decision|1|||
160826923|NCT01853072|580751902|FG001|Overall Study|Physician Decision|1|||
160826924|NCT01853072|580751901|FG000|Overall Study|Withdrawal by Subject|1|||
160826925|NCT01853072|580751902|FG001|Overall Study|Withdrawal by Subject|2|||
160826926|NCT01853072|580751901|FG000|Overall Study|Reason not specified|9|||
160826927|NCT01853072|580751902|FG001|Overall Study|Reason not specified|6|||
160826928|NCT01287221|580751903|FG000|Overall Study|Lack of Perceived Benefit|1|||
160826929|NCT01287221|580751904|FG001|Overall Study|Lack of Perceived Benefit|1|||
160826930|NCT01287221|580751903|FG000|Overall Study|Adverse Event|3|||
160826931|NCT01287221|580751904|FG001|Overall Study|Adverse Event|3|||
160826932|NCT01287221|580751903|FG000|Overall Study|Withdrawal by Subject|0|||
160826933|NCT01287221|580751904|FG001|Overall Study|Withdrawal by Subject|1|||
160826934|NCT00930969|580751905|FG000|Overall Study|Death|5|||
160826935|NCT00930969|580751905|FG000|Overall Study|Lost to Follow-up|1|||
160826936|NCT00930969|580751905|FG000|Overall Study|Physician Decision|13|||
160826937|NCT00930969|580751905|FG000|Overall Study|Withdrawal by Subject|19|||
160826938|NCT00657150|580751906|FG000|Overall Study|Adverse Event|19|||
160826939|NCT00657150|580751907|FG001|Overall Study|Adverse Event|10|||
160826940|NCT00657150|580751906|FG000|Overall Study|Non-compliant with protocol|5|||
160826941|NCT00657150|580751907|FG001|Overall Study|Non-compliant with protocol|9|||
160826942|NCT00657150|580751906|FG000|Overall Study|Lost to Follow-up|2|||
160826943|NCT00657150|580751907|FG001|Overall Study|Lost to Follow-up|0|||
160826944|NCT00657150|580751906|FG000|Overall Study|Withdrawal by Subject|51|||
160902267|NCT00347360|581036038|FG007|Overall Study|Protocol Violation|0|||
160826945|NCT00657150|580751907|FG001|Overall Study|Withdrawal by Subject|36|||
160826946|NCT00657150|580751906|FG000|Overall Study|Other|38|||
160826947|NCT00657150|580751907|FG001|Overall Study|Other|38|||
160826948|NCT00657150|580751906|FG000|Treatment|Adverse Event|60|||
160826949|NCT00657150|580751907|FG001|Treatment|Adverse Event|53|||
160826950|NCT00657150|580751906|FG000|Treatment|Non-compliant with protocol|10|||
160826951|NCT00657150|580751907|FG001|Treatment|Non-compliant with protocol|9|||
160826952|NCT00657150|580751906|FG000|Treatment|Lost to Follow-up|1|||
160826953|NCT00657150|580751907|FG001|Treatment|Lost to Follow-up|0|||
160826954|NCT00657150|580751906|FG000|Treatment|Withdrawal by Subject|23|||
160826955|NCT00657150|580751907|FG001|Treatment|Withdrawal by Subject|20|||
160826956|NCT00657150|580751906|FG000|Treatment|Other|13|||
160826957|NCT00657150|580751907|FG001|Treatment|Other|15|||
160826958|NCT02966795|580751908|FG000|Overall Study|Patient Left the Country|0|||
160826959|NCT02966795|580751909|FG001|Overall Study|Patient Left the Country|1|||
160826960|NCT00432744|580751910|FG000|Months 0-6|Withdrawal by Subject|4|||
160826961|NCT00432744|580751911|FG001|Months 0-6|Withdrawal by Subject|4|||
160826962|NCT00432744|580751910|FG000|Months 0-6|Too disabled to score|1|||
160826963|NCT00432744|580751911|FG001|Months 0-6|Too disabled to score|0|||
160826964|NCT00432744|580751910|FG000|Months 7 - 12|Withdrawal by Subject|1|||
160826965|NCT00432744|580751911|FG001|Months 7 - 12|Withdrawal by Subject|0|||
160826966|NCT00432744|580751910|FG000|Months 7 - 12|Too disabled to score|0|||
160826967|NCT00432744|580751911|FG001|Months 7 - 12|Too disabled to score|1|||
160826968|NCT01319721|580751919|FG000|Overall Study|Lost to Follow-up|1|||
160826969|NCT01319721|580751920|FG001|Overall Study|Lost to Follow-up|6|||
160826970|NCT02653495|580751921|FG000|Overall Study|Lost to Follow-up|2|||
160826971|NCT02653495|580751922|FG001|Overall Study|Lost to Follow-up|0|||
160826972|NCT02653495|580751921|FG000|Overall Study|Screening Failure|10|||
160826973|NCT02653495|580751922|FG001|Overall Study|Screening Failure|0|||
160902268|NCT00347360|581036039|FG008|Overall Study|Protocol Violation|1|||
160902269|NCT00347360|581036040|FG009|Overall Study|Protocol Violation|2|||
160902270|NCT00347360|581036041|FG010|Overall Study|Protocol Violation|0|||
160902271|NCT00347360|581036042|FG011|Overall Study|Protocol Violation|0|||
160902272|NCT00347360|581036043|FG012|Overall Study|Protocol Violation|0|||
160902273|NCT00347360|581036044|FG013|Overall Study|Protocol Violation|1|||
160902274|NCT00347360|581036045|FG014|Overall Study|Protocol Violation|0|||
160826974|NCT00468845|580751923|FG000|Overall Study|Adverse Event|9|||
160902275|NCT00347360|581036031|FG000|Overall Study|Withdrawal by Subject|0|||
160902276|NCT00347360|581036032|FG001|Overall Study|Withdrawal by Subject|1|||
160902277|NCT00347360|581036033|FG002|Overall Study|Withdrawal by Subject|2|||
160902278|NCT00347360|581036034|FG003|Overall Study|Withdrawal by Subject|4|||
160902279|NCT00347360|581036035|FG004|Overall Study|Withdrawal by Subject|1|||
160554488|NCT04451330|579755813|FG000|Overall Study|Adverse Event|1|||
160554489|NCT04451330|579755814|FG001|Overall Study|Adverse Event|2|||
160554490|NCT04451330|579755813|FG000|Overall Study|Lost to Follow-up|5|||
160554491|NCT04451330|579755814|FG001|Overall Study|Lost to Follow-up|0|||
160826975|NCT00468845|580751924|FG001|Overall Study|Adverse Event|14|||
160826976|NCT00468845|580751925|FG002|Overall Study|Adverse Event|11|||
160826977|NCT00468845|580751923|FG000|Overall Study|Lost to Follow-up|2|||
160554492|NCT04451330|579755813|FG000|Overall Study|Withdrawal by Subject|3|||
160554493|NCT04451330|579755814|FG001|Overall Study|Withdrawal by Subject|1|||
160554494|NCT04451330|579755813|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160554495|NCT04451330|579755814|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160554496|NCT04451330|579755813|FG000|Overall Study|Other than specified|0|||
160554497|NCT04451330|579755814|FG001|Overall Study|Other than specified|1|||
160554498|NCT05099640|579755815|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
160554499|NCT05099640|579755816|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
160554500|NCT05099640|579755817|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
160554501|NCT05099640|579755815|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
160554502|NCT05099640|579755816|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
160554503|NCT05099640|579755817|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
160554504|NCT05099640|579755815|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
160554505|NCT05099640|579755816|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
160554506|NCT05099640|579755817|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
160554507|NCT05099640|579755815|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
160554508|NCT05099640|579755816|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
160554509|NCT05099640|579755817|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
160554510|NCT05099640|579755815|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
160554511|NCT05099640|579755816|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
160554512|NCT05099640|579755817|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
160554513|NCT05099640|579755815|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
160554514|NCT05099640|579755816|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
160554515|NCT05099640|579755817|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
160554516|NCT00179959|579755818|FG000|Overall Study|Lost to Follow-up|3|||
160554517|NCT00179959|579755819|FG001|Overall Study|Lost to Follow-up|1|||
160554518|NCT00179959|579755818|FG000|Overall Study|Withdrawal by Subject|3|||
160554519|NCT00179959|579755819|FG001|Overall Study|Withdrawal by Subject|2|||
160554520|NCT01552681|579755820|FG000|Overall Study|Withdrawal by Subject|4|||
160554521|NCT01552681|579755821|FG001|Overall Study|Withdrawal by Subject|0|||
160554522|NCT01552681|579755820|FG000|Overall Study|Physician Decision|1|||
160554523|NCT01552681|579755821|FG001|Overall Study|Physician Decision|0|||
160554524|NCT01552681|579755820|FG000|Overall Study|Subject moved away|0|||
160554525|NCT01552681|579755821|FG001|Overall Study|Subject moved away|1|||
160554526|NCT03075163|579755822|FG000|Overall Study|not eligible for treatment limb|138|||
160554527|NCT03075163|579755823|FG001|Overall Study|not eligible for treatment limb|138|||
160554528|NCT04698525|579755824|FG000|Overall Study|Lost to Follow-up|1|||
160554529|NCT04698525|579755825|FG001|Overall Study|Lost to Follow-up|2|||
160554530|NCT04698525|579755824|FG000|Overall Study|Three suffered of Covid-19|2|||
160554531|NCT04698525|579755825|FG001|Overall Study|Three suffered of Covid-19|1|||
160554532|NCT01961544|579755826|FG000|Overall Study|Protocol Violation|1|||
160554533|NCT01961544|579755826|FG000|Overall Study|Withdrawal by Subject|7|||
160554534|NCT01961544|579755826|FG000|Overall Study|Adverse Event|1|||
160554535|NCT01961544|579755826|FG000|Overall Study|Physician Decision|2|||
160554536|NCT01961544|579755826|FG000|Overall Study|Poor Tolerance|1|||
160554537|NCT01961544|579755826|FG000|Overall Study|Aggravation of Steral Pain|1|||
160554538|NCT03665285|579755829|FG000|Overall Study|Started New Anticancer Treatment|1|||
160554539|NCT03665285|579755830|FG001|Overall Study|Started New Anticancer Treatment|1|||
160554540|NCT03665285|579755831|FG002|Overall Study|Started New Anticancer Treatment|2|||
160554541|NCT03665285|579755832|FG003|Overall Study|Started New Anticancer Treatment|4|||
160554542|NCT03665285|579755833|FG004|Overall Study|Started New Anticancer Treatment|1|||
160554543|NCT03665285|579755834|FG005|Overall Study|Started New Anticancer Treatment|1|||
160554544|NCT03665285|579755835|FG006|Overall Study|Started New Anticancer Treatment|2|||
160554545|NCT03665285|579755836|FG007|Overall Study|Started New Anticancer Treatment|15|||
160554546|NCT03665285|579755837|FG008|Overall Study|Started New Anticancer Treatment|1|||
160554547|NCT03665285|579755829|FG000|Overall Study|Disease Progression|0|||
160554548|NCT03665285|579755830|FG001|Overall Study|Disease Progression|0|||
160554549|NCT03665285|579755831|FG002|Overall Study|Disease Progression|3|||
160554550|NCT03665285|579755832|FG003|Overall Study|Disease Progression|1|||
160990058|NCT02950545|581351735|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
160990059|NCT02950545|581351736|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
160990060|NCT02950545|581351737|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
160554551|NCT03665285|579755833|FG004|Overall Study|Disease Progression|0|||
160554552|NCT03665285|579755834|FG005|Overall Study|Disease Progression|0|||
160554553|NCT03665285|579755835|FG006|Overall Study|Disease Progression|0|||
160554554|NCT03665285|579755836|FG007|Overall Study|Disease Progression|7|||
160554555|NCT03665285|579755837|FG008|Overall Study|Disease Progression|1|||
160554556|NCT03665285|579755829|FG000|Overall Study|Hospice|0|||
160554557|NCT03665285|579755830|FG001|Overall Study|Hospice|0|||
160554558|NCT03665285|579755831|FG002|Overall Study|Hospice|0|||
160653397|NCT05665595|580112378|FG001|Overall Study|Death|1|||
160554559|NCT03665285|579755832|FG003|Overall Study|Hospice|0|||
160554560|NCT03665285|579755833|FG004|Overall Study|Hospice|0|||
160554561|NCT03665285|579755834|FG005|Overall Study|Hospice|0|||
160554562|NCT03665285|579755835|FG006|Overall Study|Hospice|0|||
160554563|NCT03665285|579755836|FG007|Overall Study|Hospice|2|||
160554564|NCT03665285|579755837|FG008|Overall Study|Hospice|0|||
160554565|NCT03665285|579755829|FG000|Overall Study|Withdrawal by Subject|0|||
160554566|NCT03665285|579755830|FG001|Overall Study|Withdrawal by Subject|0|||
160554567|NCT03665285|579755831|FG002|Overall Study|Withdrawal by Subject|0|||
160554568|NCT03665285|579755832|FG003|Overall Study|Withdrawal by Subject|0|||
160554569|NCT03665285|579755833|FG004|Overall Study|Withdrawal by Subject|1|||
160554570|NCT03665285|579755834|FG005|Overall Study|Withdrawal by Subject|0|||
160554571|NCT03665285|579755835|FG006|Overall Study|Withdrawal by Subject|0|||
160554572|NCT03665285|579755836|FG007|Overall Study|Withdrawal by Subject|2|||
160554573|NCT03665285|579755837|FG008|Overall Study|Withdrawal by Subject|0|||
160554574|NCT03665285|579755829|FG000|Overall Study|Physician Decision|0|||
160554575|NCT03665285|579755830|FG001|Overall Study|Physician Decision|0|||
160554576|NCT03665285|579755831|FG002|Overall Study|Physician Decision|0|||
160554577|NCT03665285|579755832|FG003|Overall Study|Physician Decision|0|||
160554578|NCT03665285|579755833|FG004|Overall Study|Physician Decision|0|||
160554579|NCT03665285|579755834|FG005|Overall Study|Physician Decision|0|||
160554580|NCT03665285|579755835|FG006|Overall Study|Physician Decision|0|||
160554581|NCT03665285|579755836|FG007|Overall Study|Physician Decision|2|||
160554582|NCT03665285|579755837|FG008|Overall Study|Physician Decision|0|||
160554583|NCT02154425|579755845|FG000|Screening Period|Adverse Event|1|||
160554584|NCT02211261|579755846|FG000|Overall Study|Withdrawal by Subject|0|||
160554585|NCT02211261|579755847|FG001|Overall Study|Withdrawal by Subject|0|||
160554586|NCT02211261|579755848|FG002|Overall Study|Withdrawal by Subject|1|||
160554587|NCT02211261|579755849|FG003|Overall Study|Withdrawal by Subject|0|||
160554588|NCT02211261|579755850|FG004|Overall Study|Withdrawal by Subject|2|||
160554589|NCT02211261|579755851|FG005|Overall Study|Withdrawal by Subject|0|||
160554590|NCT02211261|579755852|FG006|Overall Study|Withdrawal by Subject|0|||
160554591|NCT02211261|579755853|FG007|Overall Study|Withdrawal by Subject|0|||
160554592|NCT02211261|579755854|FG008|Overall Study|Withdrawal by Subject|0|||
160554593|NCT02211261|579755855|FG009|Overall Study|Withdrawal by Subject|0|||
160554594|NCT02211261|579755856|FG010|Overall Study|Withdrawal by Subject|0|||
160554595|NCT02211261|579755846|FG000|Overall Study|Other|0|||
160554596|NCT02211261|579755847|FG001|Overall Study|Other|0|||
160554597|NCT02211261|579755848|FG002|Overall Study|Other|0|||
160554598|NCT02211261|579755849|FG003|Overall Study|Other|0|||
160554599|NCT02211261|579755850|FG004|Overall Study|Other|0|||
160554600|NCT02211261|579755851|FG005|Overall Study|Other|1|||
160554601|NCT02211261|579755852|FG006|Overall Study|Other|0|||
160554602|NCT02211261|579755853|FG007|Overall Study|Other|0|||
160554603|NCT02211261|579755854|FG008|Overall Study|Other|0|||
160554604|NCT02211261|579755855|FG009|Overall Study|Other|2|||
160554605|NCT02211261|579755856|FG010|Overall Study|Other|0|||
160554606|NCT02211261|579755846|FG000|Overall Study|Lost to Follow-up|0|||
160554607|NCT02211261|579755847|FG001|Overall Study|Lost to Follow-up|0|||
160554608|NCT02211261|579755848|FG002|Overall Study|Lost to Follow-up|0|||
160554609|NCT02211261|579755849|FG003|Overall Study|Lost to Follow-up|0|||
160554610|NCT02211261|579755850|FG004|Overall Study|Lost to Follow-up|0|||
160554611|NCT02211261|579755851|FG005|Overall Study|Lost to Follow-up|0|||
160554612|NCT02211261|579755852|FG006|Overall Study|Lost to Follow-up|0|||
160554613|NCT02211261|579755853|FG007|Overall Study|Lost to Follow-up|1|||
160554614|NCT02211261|579755854|FG008|Overall Study|Lost to Follow-up|0|||
160554615|NCT02211261|579755855|FG009|Overall Study|Lost to Follow-up|0|||
160554616|NCT02211261|579755856|FG010|Overall Study|Lost to Follow-up|0|||
160826978|NCT00468845|580751924|FG001|Overall Study|Lost to Follow-up|1|||
160826979|NCT00468845|580751925|FG002|Overall Study|Lost to Follow-up|2|||
160826980|NCT00468845|580751923|FG000|Overall Study|Other|4|||
160826981|NCT00468845|580751924|FG001|Overall Study|Other|9|||
160826982|NCT00468845|580751925|FG002|Overall Study|Other|5|||
160826983|NCT00468845|580751923|FG000|Overall Study|No longer willing to participate|5|||
160826984|NCT00468845|580751924|FG001|Overall Study|No longer willing to participate|6|||
160554617|NCT00480857|579755857|FG000|Overall Study|Lack of Efficacy|2|||
160554618|NCT02175680|579755866|FG000|Overall Study|non-compliance|1|||
160554619|NCT02175680|579755866|FG000|Overall Study|other non-medical reason|1|||
160554620|NCT02419508|579755872|FG000|Overall Study|Adverse Event|9|||
160554621|NCT02419508|579755873|FG001|Overall Study|Adverse Event|3|||
160554622|NCT02419508|579755872|FG000|Overall Study|Withdrawal by Subject|1|||
160554623|NCT02419508|579755873|FG001|Overall Study|Withdrawal by Subject|0|||
160554624|NCT02419508|579755872|FG000|Overall Study|Other - Reason not specified|0|||
160826985|NCT00468845|580751925|FG002|Overall Study|No longer willing to participate|10|||
160826986|NCT00468845|580751923|FG000|Overall Study|Randomized, not treated|1|||
160554625|NCT02419508|579755873|FG001|Overall Study|Other - Reason not specified|1|||
160554626|NCT01171820|579757897|FG000|Overall Study|Death|3|||
160554627|NCT01171820|579757898|FG001|Overall Study|Death|3|||
160554628|NCT01171820|579757897|FG000|Overall Study|Lost to Follow-up|0|||
160554629|NCT01171820|579757898|FG001|Overall Study|Lost to Follow-up|1|||
160554630|NCT01171820|579757897|FG000|Overall Study|Withdrawal by Subject|2|||
160554631|NCT01171820|579757898|FG001|Overall Study|Withdrawal by Subject|0|||
160554632|NCT01171820|579757897|FG000|Overall Study|Physician Decision|0|||
160554633|NCT01171820|579757898|FG001|Overall Study|Physician Decision|1|||
160554634|NCT01171820|579757897|FG000|Overall Study|1-Year Missed Visit|1|||
160554635|NCT01171820|579757898|FG001|Overall Study|1-Year Missed Visit|1|||
160554636|NCT03969875|579757899|FG000|Overall Study|did not receive allocated intervention|3|||
160554637|NCT03969875|579757900|FG001|Overall Study|did not receive allocated intervention|3|||
160554638|NCT03969875|579757901|FG002|Overall Study|did not receive allocated intervention|4|||
160554639|NCT03969875|579757899|FG000|Overall Study|Protocol Violation|4|||
160554640|NCT03969875|579757900|FG001|Overall Study|Protocol Violation|2|||
160554641|NCT03969875|579757901|FG002|Overall Study|Protocol Violation|2|||
160554642|NCT00167245|579757902|FG000|Overall Study|Lost to Follow-up|20|||
160554643|NCT00167245|579757903|FG001|Overall Study|Lost to Follow-up|31|||
160554644|NCT00167245|579757902|FG000|Overall Study|Withdrawal by Subject|5|||
160554645|NCT00167245|579757903|FG001|Overall Study|Withdrawal by Subject|8|||
160554646|NCT00167245|579757902|FG000|Overall Study|Incarcerated|3|||
160554647|NCT00167245|579757903|FG001|Overall Study|Incarcerated|2|||
160554648|NCT00167245|579757902|FG000|Overall Study|Drowsy|1|||
160554649|NCT00167245|579757903|FG001|Overall Study|Drowsy|0|||
160554650|NCT00860158|579757909|FG000|Overall Study|Study Terminated|1|||
160554651|NCT00270894|579757912|FG000|Overall Study|Adverse Event|1|||
160554652|NCT00270894|579757912|FG000|Overall Study|Withdrawal by Subject|1|||
160554653|NCT03980938|579757914|FG000|Treatment Period 1|Study Terminated|1|||
160554654|NCT03980938|579757915|FG001|Treatment Period 1|Study Terminated|1|||
160554655|NCT03980938|579757914|FG000|Treatment Period 2|Study Terminated|2|||
160554656|NCT03980938|579757915|FG001|Treatment Period 2|Study Terminated|2|||
160554657|NCT03706365|579757917|FG000|Overall Study|Lost to Follow-up|7|||
160554658|NCT03706365|579757918|FG001|Overall Study|Lost to Follow-up|0|||
160554659|NCT03706365|579757917|FG000|Overall Study|Withdrawal by Subject|17|||
160554660|NCT03706365|579757918|FG001|Overall Study|Withdrawal by Subject|15|||
160554661|NCT03706365|579757917|FG000|Overall Study|On Study Treatment|51|||
160554662|NCT03706365|579757918|FG001|Overall Study|On Study Treatment|51|||
160554663|NCT05195528|579757919|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
160554664|NCT05195528|579757920|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
160554665|NCT05195528|579757921|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
160554666|NCT05195528|579757922|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
160554667|NCT05195528|579757923|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
160554668|NCT05195528|579757919|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
160554669|NCT05195528|579757920|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
160554670|NCT05195528|579757921|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
160554671|NCT05195528|579757922|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
160554672|NCT05195528|579757923|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
160554673|NCT05195528|579757919|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
160554674|NCT05195528|579757920|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
160554675|NCT05195528|579757921|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
160826987|NCT00468845|580751924|FG001|Overall Study|Randomized, not treated|4|||
160826988|NCT00468845|580751925|FG002|Overall Study|Randomized, not treated|2|||
160826989|NCT02761694|580751929|FG000|Overall Study|Lack of Efficacy|0|||
160826990|NCT02761694|580751930|FG001|Overall Study|Lack of Efficacy|0|||
160826991|NCT02761694|580751931|FG002|Overall Study|Lack of Efficacy|0|||
160826992|NCT02761694|580751932|FG003|Overall Study|Lack of Efficacy|0|||
160554676|NCT05195528|579757922|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
160554677|NCT05195528|579757923|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
160554678|NCT05195528|579757919|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
160826993|NCT02761694|580751933|FG004|Overall Study|Lack of Efficacy|0|||
160826994|NCT02761694|580751934|FG005|Overall Study|Lack of Efficacy|0|||
160826995|NCT02761694|580751935|FG006|Overall Study|Lack of Efficacy|6|||
160826996|NCT02761694|580751936|FG007|Overall Study|Lack of Efficacy|0|||
160826997|NCT02761694|580751937|FG008|Overall Study|Lack of Efficacy|0|||
160554679|NCT05195528|579757920|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
160554680|NCT05195528|579757921|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
160554681|NCT05195528|579757922|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
160554682|NCT05195528|579757923|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
160990061|NCT02950545|581351732|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
160554683|NCT05195528|579757919|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
160554684|NCT05195528|579757920|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
160554685|NCT05195528|579757921|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
160554686|NCT05195528|579757922|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
160554687|NCT05195528|579757923|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
160554688|NCT05195528|579757919|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
160554689|NCT05195528|579757920|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
160554690|NCT05195528|579757921|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
160554691|NCT05195528|579757922|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
160554692|NCT05195528|579757923|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
160826998|NCT02761694|580751938|FG009|Overall Study|Lack of Efficacy|1|||
160826999|NCT02761694|580751939|FG010|Overall Study|Lack of Efficacy|1|||
160827000|NCT02761694|580751940|FG011|Overall Study|Lack of Efficacy|4|||
160827001|NCT02761694|580751929|FG000|Overall Study|Death|0|||
160827002|NCT02761694|580751930|FG001|Overall Study|Death|0|||
160827003|NCT02761694|580751931|FG002|Overall Study|Death|0|||
160827004|NCT02761694|580751932|FG003|Overall Study|Death|0|||
160827005|NCT02761694|580751933|FG004|Overall Study|Death|0|||
160827006|NCT02761694|580751934|FG005|Overall Study|Death|0|||
160827007|NCT02761694|580751935|FG006|Overall Study|Death|2|||
160827008|NCT02761694|580751936|FG007|Overall Study|Death|0|||
160827009|NCT02761694|580751937|FG008|Overall Study|Death|2|||
160827010|NCT02761694|580751938|FG009|Overall Study|Death|2|||
160827011|NCT02761694|580751939|FG010|Overall Study|Death|1|||
160827012|NCT02761694|580751940|FG011|Overall Study|Death|0|||
160827013|NCT02761694|580751929|FG000|Overall Study|Physician Decision|0|||
160827014|NCT02761694|580751930|FG001|Overall Study|Physician Decision|0|||
160827015|NCT02761694|580751931|FG002|Overall Study|Physician Decision|0|||
160827016|NCT02761694|580751932|FG003|Overall Study|Physician Decision|0|||
160902280|NCT00347360|581036036|FG005|Overall Study|Withdrawal by Subject|2|||
160902281|NCT00347360|581036037|FG006|Overall Study|Withdrawal by Subject|1|||
160902282|NCT00347360|581036038|FG007|Overall Study|Withdrawal by Subject|1|||
160902283|NCT00347360|581036039|FG008|Overall Study|Withdrawal by Subject|1|||
160902284|NCT00347360|581036040|FG009|Overall Study|Withdrawal by Subject|1|||
160902285|NCT00347360|581036041|FG010|Overall Study|Withdrawal by Subject|0|||
160902286|NCT00347360|581036042|FG011|Overall Study|Withdrawal by Subject|3|||
160902287|NCT00347360|581036043|FG012|Overall Study|Withdrawal by Subject|4|||
160902288|NCT00347360|581036044|FG013|Overall Study|Withdrawal by Subject|2|||
160902289|NCT00347360|581036045|FG014|Overall Study|Withdrawal by Subject|1|||
160902290|NCT00347360|581036031|FG000|Overall Study|Lack of Efficacy|1|||
160902291|NCT00347360|581036032|FG001|Overall Study|Lack of Efficacy|1|||
160902292|NCT00347360|581036033|FG002|Overall Study|Lack of Efficacy|3|||
160902293|NCT00347360|581036034|FG003|Overall Study|Lack of Efficacy|1|||
160902294|NCT00347360|581036035|FG004|Overall Study|Lack of Efficacy|0|||
160902295|NCT00347360|581036036|FG005|Overall Study|Lack of Efficacy|1|||
160902296|NCT00347360|581036037|FG006|Overall Study|Lack of Efficacy|0|||
160902297|NCT00347360|581036038|FG007|Overall Study|Lack of Efficacy|1|||
160902298|NCT00347360|581036039|FG008|Overall Study|Lack of Efficacy|1|||
160902299|NCT00347360|581036040|FG009|Overall Study|Lack of Efficacy|0|||
160902300|NCT00347360|581036041|FG010|Overall Study|Lack of Efficacy|0|||
160902301|NCT00347360|581036042|FG011|Overall Study|Lack of Efficacy|0|||
160902302|NCT00347360|581036043|FG012|Overall Study|Lack of Efficacy|0|||
160902303|NCT00347360|581036044|FG013|Overall Study|Lack of Efficacy|0|||
160902304|NCT00347360|581036045|FG014|Overall Study|Lack of Efficacy|0|||
160902305|NCT00347360|581036031|FG000|Overall Study|Reason not listed/blank|1|||
160902306|NCT00347360|581036032|FG001|Overall Study|Reason not listed/blank|0|||
160902307|NCT00347360|581036033|FG002|Overall Study|Reason not listed/blank|0|||
160902308|NCT00347360|581036034|FG003|Overall Study|Reason not listed/blank|0|||
160902309|NCT00347360|581036035|FG004|Overall Study|Reason not listed/blank|0|||
160902310|NCT00347360|581036036|FG005|Overall Study|Reason not listed/blank|0|||
160902311|NCT00347360|581036037|FG006|Overall Study|Reason not listed/blank|1|||
160902312|NCT00347360|581036038|FG007|Overall Study|Reason not listed/blank|0|||
160902313|NCT00347360|581036039|FG008|Overall Study|Reason not listed/blank|0|||
160902314|NCT00347360|581036040|FG009|Overall Study|Reason not listed/blank|0|||
160902315|NCT00347360|581036041|FG010|Overall Study|Reason not listed/blank|0|||
160902316|NCT00347360|581036042|FG011|Overall Study|Reason not listed/blank|0|||
160554693|NCT05195528|579757919|FG000|Placebo-controlled Treatment Period|Other|0|||
160827017|NCT02761694|580751933|FG004|Overall Study|Physician Decision|0|||
160827018|NCT02761694|580751934|FG005|Overall Study|Physician Decision|0|||
160827019|NCT02761694|580751935|FG006|Overall Study|Physician Decision|1|||
160827020|NCT02761694|580751936|FG007|Overall Study|Physician Decision|0|||
160827021|NCT02761694|580751937|FG008|Overall Study|Physician Decision|0|||
160554694|NCT05195528|579757920|FG001|Placebo-controlled Treatment Period|Other|0|||
160554695|NCT05195528|579757921|FG002|Placebo-controlled Treatment Period|Other|1|||
160554696|NCT05195528|579757922|FG003|Placebo-controlled Treatment Period|Other|0|||
160554697|NCT05195528|579757923|FG004|Placebo-controlled Treatment Period|Other|0|||
160554698|NCT05195528|579757919|FG000|Extension Period|PTE or AE or SAE|0|||
160554699|NCT05195528|579757920|FG001|Extension Period|PTE or AE or SAE|4|||
160554700|NCT05195528|579757921|FG002|Extension Period|PTE or AE or SAE|5|||
160554701|NCT05195528|579757922|FG003|Extension Period|PTE or AE or SAE|4|||
160554702|NCT05195528|579757923|FG004|Extension Period|PTE or AE or SAE|4|||
160554703|NCT05195528|579757919|FG000|Extension Period|Protocol Violation|0|||
160554704|NCT05195528|579757920|FG001|Extension Period|Protocol Violation|2|||
160554705|NCT05195528|579757921|FG002|Extension Period|Protocol Violation|1|||
160554706|NCT05195528|579757922|FG003|Extension Period|Protocol Violation|0|||
160554707|NCT05195528|579757923|FG004|Extension Period|Protocol Violation|1|||
160554708|NCT05195528|579757919|FG000|Extension Period|Lost to Follow-up|0|||
160554709|NCT05195528|579757920|FG001|Extension Period|Lost to Follow-up|6|||
160554710|NCT05195528|579757921|FG002|Extension Period|Lost to Follow-up|13|||
160554711|NCT05195528|579757922|FG003|Extension Period|Lost to Follow-up|3|||
160554712|NCT05195528|579757923|FG004|Extension Period|Lost to Follow-up|7|||
160554713|NCT05195528|579757919|FG000|Extension Period|Withdrawal by Subject|0|||
160554714|NCT05195528|579757920|FG001|Extension Period|Withdrawal by Subject|12|||
160554715|NCT05195528|579757921|FG002|Extension Period|Withdrawal by Subject|9|||
160554716|NCT05195528|579757922|FG003|Extension Period|Withdrawal by Subject|6|||
160554717|NCT05195528|579757923|FG004|Extension Period|Withdrawal by Subject|5|||
160554718|NCT05195528|579757919|FG000|Extension Period|Lack of Efficacy|0|||
160554719|NCT05195528|579757920|FG001|Extension Period|Lack of Efficacy|3|||
160554720|NCT05195528|579757921|FG002|Extension Period|Lack of Efficacy|0|||
160554721|NCT05195528|579757922|FG003|Extension Period|Lack of Efficacy|0|||
160554722|NCT05195528|579757923|FG004|Extension Period|Lack of Efficacy|2|||
160554723|NCT05195528|579757919|FG000|Extension Period|Not Treated|0|||
160554724|NCT05195528|579757920|FG001|Extension Period|Not Treated|0|||
160554725|NCT05195528|579757921|FG002|Extension Period|Not Treated|2|||
160990062|NCT02950545|581351733|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
160990063|NCT02950545|581351734|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
160990064|NCT02950545|581351735|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
160990065|NCT02950545|581351736|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
160554726|NCT05195528|579757922|FG003|Extension Period|Not Treated|3|||
160554727|NCT05195528|579757923|FG004|Extension Period|Not Treated|0|||
160554728|NCT05195528|579757919|FG000|Extension Period|Other|0|||
160554729|NCT05195528|579757920|FG001|Extension Period|Other|1|||
160554730|NCT05195528|579757921|FG002|Extension Period|Other|1|||
160554731|NCT05195528|579757922|FG003|Extension Period|Other|0|||
160554732|NCT05195528|579757923|FG004|Extension Period|Other|0|||
160554733|NCT01552902|579757924|FG000|Overall Study|Adverse Event|1|||
160554734|NCT01552902|579757925|FG001|Overall Study|Adverse Event|15|||
160554735|NCT01552902|579757926|FG002|Overall Study|Adverse Event|14|||
160554736|NCT01552902|579757924|FG000|Overall Study|Protocol Violation|3|||
160554737|NCT01552902|579757925|FG001|Overall Study|Protocol Violation|3|||
160554738|NCT01552902|579757926|FG002|Overall Study|Protocol Violation|3|||
160554739|NCT01552902|579757924|FG000|Overall Study|Lack of Efficacy|4|||
160554740|NCT01552902|579757925|FG001|Overall Study|Lack of Efficacy|3|||
160554741|NCT01552902|579757926|FG002|Overall Study|Lack of Efficacy|1|||
160554742|NCT01552902|579757924|FG000|Overall Study|Withdrawal by Subject|1|||
160554743|NCT01552902|579757925|FG001|Overall Study|Withdrawal by Subject|9|||
160554744|NCT01552902|579757926|FG002|Overall Study|Withdrawal by Subject|6|||
160554745|NCT01552902|579757924|FG000|Overall Study|Lost to Follow-up|1|||
160554746|NCT01552902|579757925|FG001|Overall Study|Lost to Follow-up|3|||
160554747|NCT01552902|579757926|FG002|Overall Study|Lost to Follow-up|6|||
160554748|NCT01552902|579757924|FG000|Overall Study|Other|3|||
160554749|NCT01552902|579757925|FG001|Overall Study|Other|4|||
160554750|NCT01552902|579757926|FG002|Overall Study|Other|3|||
160554751|NCT02487108|579757927|FG000|Overall Study|Adverse Event|1|||
160554752|NCT02487108|579757928|FG001|Overall Study|Adverse Event|6|||
160554753|NCT02487108|579757929|FG002|Overall Study|Adverse Event|12|||
160646726|NCT02497391|580089949|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
160554754|NCT02487108|579757930|FG003|Overall Study|Adverse Event|6|||
160646727|NCT02497391|580089950|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
160554755|NCT02487108|579757927|FG000|Overall Study|Withdrawal by Subject|8|||
160554756|NCT02487108|579757928|FG001|Overall Study|Withdrawal by Subject|5|||
160554757|NCT02487108|579757929|FG002|Overall Study|Withdrawal by Subject|5|||
160554758|NCT02487108|579757930|FG003|Overall Study|Withdrawal by Subject|0|||
160554759|NCT02487108|579757927|FG000|Overall Study|Non-compliance to study medication|3|||
160554760|NCT02487108|579757928|FG001|Overall Study|Non-compliance to study medication|2|||
160554761|NCT02487108|579757929|FG002|Overall Study|Non-compliance to study medication|5|||
160554762|NCT02487108|579757930|FG003|Overall Study|Non-compliance to study medication|4|||
160554763|NCT02487108|579757927|FG000|Overall Study|Protocol Violation|1|||
160554764|NCT02487108|579757928|FG001|Overall Study|Protocol Violation|1|||
160554765|NCT02487108|579757929|FG002|Overall Study|Protocol Violation|2|||
160554766|NCT02487108|579757930|FG003|Overall Study|Protocol Violation|0|||
160554767|NCT02487108|579757927|FG000|Overall Study|Non-compliance to study procedures|0|||
160554768|NCT02487108|579757928|FG001|Overall Study|Non-compliance to study procedures|0|||
160554769|NCT02487108|579757929|FG002|Overall Study|Non-compliance to study procedures|0|||
160554770|NCT02487108|579757930|FG003|Overall Study|Non-compliance to study procedures|1|||
160554771|NCT02487108|579757927|FG000|Overall Study|Other than specified|3|||
160554772|NCT02487108|579757928|FG001|Overall Study|Other than specified|2|||
160554773|NCT02487108|579757929|FG002|Overall Study|Other than specified|2|||
160554774|NCT02487108|579757930|FG003|Overall Study|Other than specified|0|||
160554775|NCT02720757|579757931|FG000|Overall Study|Other reason|5|||
160554776|NCT02720757|579757931|FG000|Overall Study|Loss of contact|4|||
160554777|NCT02720757|579757931|FG000|Overall Study|Informed consent withdrawal|1|||
160554778|NCT02720757|579757931|FG000|Overall Study|Patients wish to withdraw|2|||
160554779|NCT02720757|579757931|FG000|Overall Study|Missing|3|||
160554780|NCT02720757|579757931|FG000|Overall Study|General exclusion|3|||
160554781|NCT00883493|579757932|FG000|Overall Study|Adverse Event|11|||
160554782|NCT00883493|579757933|FG001|Overall Study|Adverse Event|12|||
160827022|NCT02761694|580751938|FG009|Overall Study|Physician Decision|0|||
160827023|NCT02761694|580751939|FG010|Overall Study|Physician Decision|0|||
160827024|NCT02761694|580751940|FG011|Overall Study|Physician Decision|0|||
160827025|NCT02761694|580751929|FG000|Overall Study|Withdrawal by Subject|0|||
160827026|NCT02761694|580751930|FG001|Overall Study|Withdrawal by Subject|0|||
160827027|NCT02761694|580751931|FG002|Overall Study|Withdrawal by Subject|0|||
160827028|NCT02761694|580751932|FG003|Overall Study|Withdrawal by Subject|1|||
160827029|NCT02761694|580751933|FG004|Overall Study|Withdrawal by Subject|0|||
160827030|NCT02761694|580751934|FG005|Overall Study|Withdrawal by Subject|0|||
160827031|NCT02761694|580751935|FG006|Overall Study|Withdrawal by Subject|4|||
160827032|NCT02761694|580751936|FG007|Overall Study|Withdrawal by Subject|0|||
160827033|NCT02761694|580751937|FG008|Overall Study|Withdrawal by Subject|2|||
160827034|NCT02761694|580751938|FG009|Overall Study|Withdrawal by Subject|1|||
160827035|NCT02761694|580751939|FG010|Overall Study|Withdrawal by Subject|0|||
160827036|NCT02761694|580751940|FG011|Overall Study|Withdrawal by Subject|0|||
160827037|NCT02761694|580751929|FG000|Overall Study|Lost to Follow-up|0|||
160827038|NCT02761694|580751930|FG001|Overall Study|Lost to Follow-up|0|||
160827039|NCT02761694|580751931|FG002|Overall Study|Lost to Follow-up|0|||
160827040|NCT02761694|580751932|FG003|Overall Study|Lost to Follow-up|0|||
160827041|NCT02761694|580751933|FG004|Overall Study|Lost to Follow-up|0|||
160827042|NCT02761694|580751934|FG005|Overall Study|Lost to Follow-up|0|||
160827043|NCT02761694|580751935|FG006|Overall Study|Lost to Follow-up|1|||
160827044|NCT02761694|580751936|FG007|Overall Study|Lost to Follow-up|0|||
160827045|NCT02761694|580751937|FG008|Overall Study|Lost to Follow-up|0|||
160827046|NCT02761694|580751938|FG009|Overall Study|Lost to Follow-up|0|||
160827047|NCT02761694|580751939|FG010|Overall Study|Lost to Follow-up|0|||
160827048|NCT02761694|580751940|FG011|Overall Study|Lost to Follow-up|1|||
160827049|NCT02761694|580751929|FG000|Overall Study|Adverse Event|0|||
160827050|NCT02761694|580751930|FG001|Overall Study|Adverse Event|0|||
160827051|NCT02761694|580751931|FG002|Overall Study|Adverse Event|0|||
160827052|NCT02761694|580751932|FG003|Overall Study|Adverse Event|0|||
160827053|NCT02761694|580751933|FG004|Overall Study|Adverse Event|0|||
160827054|NCT02761694|580751934|FG005|Overall Study|Adverse Event|0|||
160827055|NCT02761694|580751935|FG006|Overall Study|Adverse Event|1|||
160827056|NCT02761694|580751936|FG007|Overall Study|Adverse Event|0|||
160827057|NCT02761694|580751937|FG008|Overall Study|Adverse Event|1|||
160554783|NCT00883493|579757932|FG000|Overall Study|Lack of Efficacy|4|||
160554784|NCT00883493|579757933|FG001|Overall Study|Lack of Efficacy|3|||
160554785|NCT00883493|579757932|FG000|Overall Study|Lost to Follow-up|7|||
160554786|NCT00883493|579757933|FG001|Overall Study|Lost to Follow-up|6|||
160554787|NCT00883493|579757932|FG000|Overall Study|Withdrawal by Subject|11|||
160554788|NCT00883493|579757933|FG001|Overall Study|Withdrawal by Subject|20|||
160554789|NCT00883493|579757932|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
160554790|NCT00883493|579757933|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
160554791|NCT00883493|579757932|FG000|Overall Study|Study specific disc. criteria|2|||
160554792|NCT00883493|579757933|FG001|Overall Study|Study specific disc. criteria|0|||
160554793|NCT00883493|579757932|FG000|Overall Study|Other|5|||
160554794|NCT00883493|579757933|FG001|Overall Study|Other|3|||
160554795|NCT04557384|579757934|FG000|Overall Study|Study Terminated by Sponsor|1|||
160554796|NCT04557384|579757934|FG000|Overall Study|Death|1|||
160554797|NCT04088409|579757939|FG000|Part A|Withdrawal by Subject|2|||
160554798|NCT04088409|579757940|FG001|Part A|Withdrawal by Subject|1|||
160554799|NCT04088409|579757939|FG000|Part A|Did Not Meet Randomization Criteria|2|||
160554800|NCT04088409|579757940|FG001|Part A|Did Not Meet Randomization Criteria|0|||
160827058|NCT02761694|580751938|FG009|Overall Study|Adverse Event|0|||
160827059|NCT02761694|580751939|FG010|Overall Study|Adverse Event|0|||
160554801|NCT04088409|579757939|FG000|Part A|Lack of Efficacy|9|||
160827060|NCT02761694|580751940|FG011|Overall Study|Adverse Event|1|||
160827061|NCT02761694|580751929|FG000|Overall Study|Other|4|||
160554802|NCT04088409|579757940|FG001|Part A|Lack of Efficacy|0|||
160554803|NCT04088409|579757939|FG000|Part A|Lost to Follow-up|1|||
160827062|NCT02761694|580751930|FG001|Overall Study|Other|4|||
160990066|NCT02950545|581351737|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
160990067|NCT02950545|581351732|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
160990068|NCT02950545|581351733|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
160990069|NCT02950545|581351734|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
160990070|NCT02950545|581351735|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
160990071|NCT02950545|581351736|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
160990072|NCT02950545|581351737|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
160990073|NCT02950545|581351732|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
160990074|NCT02950545|581351733|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
160990075|NCT02950545|581351734|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
160990076|NCT02950545|581351735|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
160646728|NCT02497391|580089951|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
160646729|NCT02497391|580089952|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
160646730|NCT02497391|580089953|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
160646731|NCT03031899|580089956|FG000|Overall Study|Protocol Violation|1|||
160990077|NCT02950545|581351736|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
160990078|NCT02950545|581351737|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
160990079|NCT04296942|581351738|FG000|Overall Study|Study closure by sponsor|1|||
160990080|NCT04296942|581351739|FG001|Overall Study|Study closure by sponsor|0|||
160990081|NCT04296942|581351740|FG002|Overall Study|Study closure by sponsor|0|||
160646732|NCT03031899|580089956|FG000|Overall Study|lesion disappeared after stopping habit|1|||
160646733|NCT01664052|580089957|FG000|Phase 1|No device placement|6|||
160554804|NCT04088409|579757940|FG001|Part A|Lost to Follow-up|0|||
160554805|NCT04088409|579757939|FG000|Part A|Adverse Event|1|||
160554806|NCT04088409|579757940|FG001|Part A|Adverse Event|0|||
160554807|NCT04088409|579757939|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
160554808|NCT04088409|579757940|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
160554809|NCT04088409|579757939|FG000|Part B|Ongoing Treatment|10|||
160554810|NCT04088409|579757940|FG001|Part B|Ongoing Treatment|0|||
160554811|NCT00841763|579757941|FG000|Overall Study|Withdrawal by Subject|60|||
160554812|NCT00841763|579757942|FG001|Overall Study|Withdrawal by Subject|17|||
160554813|NCT00841763|579757943|FG002|Overall Study|Withdrawal by Subject|4|||
160554814|NCT00841763|579757944|FG003|Overall Study|Withdrawal by Subject|1|||
160554815|NCT00841763|579757941|FG000|Overall Study|Adverse Event|9|||
160554816|NCT00841763|579757942|FG001|Overall Study|Adverse Event|10|||
160554817|NCT00841763|579757943|FG002|Overall Study|Adverse Event|3|||
160554818|NCT00841763|579757944|FG003|Overall Study|Adverse Event|2|||
160554819|NCT00841763|579757941|FG000|Overall Study|Lost to Follow-up|63|||
160554820|NCT00841763|579757942|FG001|Overall Study|Lost to Follow-up|25|||
160554821|NCT00841763|579757943|FG002|Overall Study|Lost to Follow-up|0|||
160554822|NCT00841763|579757944|FG003|Overall Study|Lost to Follow-up|0|||
160554823|NCT00841763|579757941|FG000|Overall Study|Protocol Violation|20|||
160554824|NCT00841763|579757942|FG001|Overall Study|Protocol Violation|3|||
160554825|NCT00841763|579757943|FG002|Overall Study|Protocol Violation|1|||
160554826|NCT00841763|579757944|FG003|Overall Study|Protocol Violation|0|||
160554827|NCT00841763|579757941|FG000|Overall Study|Administrative Reasons|3|||
160554828|NCT00841763|579757942|FG001|Overall Study|Administrative Reasons|1|||
160554829|NCT00841763|579757943|FG002|Overall Study|Administrative Reasons|0|||
160554830|NCT00841763|579757944|FG003|Overall Study|Administrative Reasons|0|||
160554831|NCT00841763|579757941|FG000|Overall Study|Unable to Classify|7|||
160554832|NCT00841763|579757942|FG001|Overall Study|Unable to Classify|1|||
160554833|NCT00841763|579757943|FG002|Overall Study|Unable to Classify|0|||
160554834|NCT00841763|579757944|FG003|Overall Study|Unable to Classify|0|||
160554835|NCT00400400|579757945|FG000|Overall Study|Adverse Event|9|||
160554836|NCT00400400|579757946|FG001|Overall Study|Adverse Event|8|||
160554837|NCT00400400|579757945|FG000|Overall Study|Protocol Violation|2|||
160554838|NCT00400400|579757946|FG001|Overall Study|Protocol Violation|0|||
160554839|NCT00400400|579757945|FG000|Overall Study|Withdrawal by Subject|1|||
160554840|NCT00400400|579757946|FG001|Overall Study|Withdrawal by Subject|3|||
160554841|NCT00400400|579757945|FG000|Overall Study|Administrative Problem|1|||
160554842|NCT00400400|579757946|FG001|Overall Study|Administrative Problem|0|||
160554843|NCT00400400|579757945|FG000|Overall Study|Lost to Follow-up|0|||
160554844|NCT00400400|579757946|FG001|Overall Study|Lost to Follow-up|1|||
160554845|NCT00400400|579757945|FG000|Overall Study|Did not receive study drug|1|||
160554846|NCT00400400|579757946|FG001|Overall Study|Did not receive study drug|3|||
160554847|NCT01848145|579757947|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
160554848|NCT01848145|579757947|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
160554849|NCT01848145|579757947|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
160554850|NCT01848145|579757947|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
160554851|NCT01848145|579757947|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
160554852|NCT01848145|579757947|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
160554853|NCT01848145|579757947|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
160554854|NCT01058096|579757954|FG000|Double-blind Treatment Phase|Adverse Event|11|||
160554855|NCT01058096|579757955|FG001|Double-blind Treatment Phase|Adverse Event|15|||
160554856|NCT01058096|579757954|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
160554857|NCT01058096|579757955|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
160554858|NCT01058096|579757954|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
160554859|NCT01058096|579757955|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
160827063|NCT02761694|580751931|FG002|Overall Study|Other|1|||
160827064|NCT02761694|580751932|FG003|Overall Study|Other|2|||
160827065|NCT02761694|580751933|FG004|Overall Study|Other|3|||
160827066|NCT02761694|580751934|FG005|Overall Study|Other|3|||
160827067|NCT02761694|580751935|FG006|Overall Study|Other|18|||
160827068|NCT02761694|580751936|FG007|Overall Study|Other|8|||
160554860|NCT01058096|579757954|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
160554861|NCT01058096|579757955|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
160554862|NCT01058096|579757954|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
160554863|NCT01058096|579757955|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
160554864|NCT01058096|579757954|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
160554865|NCT01058096|579757955|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
160990082|NCT01579578|581351741|FG000|Overall Study|Death|4|||
160554866|NCT03118947|579757958|FG000|Overall Study|Adverse Event|7|||
160554867|NCT03118947|579757958|FG000|Overall Study|Death|3|||
160554868|NCT03118947|579757958|FG000|Overall Study|Lack of Efficacy|4|||
160554869|NCT03118947|579757958|FG000|Overall Study|Non-compliance with study drug|1|||
160554870|NCT03118947|579757958|FG000|Overall Study|Protocol Violation|2|||
160554871|NCT03118947|579757958|FG000|Overall Study|Withdrawal by Subject|3|||
160827069|NCT02761694|580751937|FG008|Overall Study|Other|0|||
160554872|NCT03118947|579757958|FG000|Overall Study|Withdrawal by caregiver|3|||
160554873|NCT03118947|579757958|FG000|Overall Study|Change in patient's living situation|4|||
160554874|NCT03118947|579757958|FG000|Overall Study|Lost to Follow-up|2|||
160554875|NCT01109940|579757959|FG000|Overall Study|Administrative problems|2|||
160554876|NCT01109940|579757960|FG001|Overall Study|Administrative problems|0|||
160554877|NCT01109940|579757961|FG002|Overall Study|Administrative problems|0|||
160554878|NCT01109940|579757962|FG003|Overall Study|Administrative problems|0|||
160554879|NCT01109940|579757959|FG000|Overall Study|Serious Adverse Event|2|||
160554880|NCT01109940|579757960|FG001|Overall Study|Serious Adverse Event|1|||
160554881|NCT01109940|579757961|FG002|Overall Study|Serious Adverse Event|0|||
160554882|NCT01109940|579757962|FG003|Overall Study|Serious Adverse Event|0|||
160554883|NCT01109940|579757959|FG000|Overall Study|Lost to Follow-up|1|||
160554884|NCT01109940|579757960|FG001|Overall Study|Lost to Follow-up|0|||
160554885|NCT01109940|579757961|FG002|Overall Study|Lost to Follow-up|0|||
160554886|NCT01109940|579757962|FG003|Overall Study|Lost to Follow-up|0|||
160554887|NCT01109940|579757959|FG000|Overall Study|Patient withdrew consent|1|||
160554888|NCT01109940|579757960|FG001|Overall Study|Patient withdrew consent|1|||
160554889|NCT01109940|579757961|FG002|Overall Study|Patient withdrew consent|0|||
160554890|NCT01109940|579757962|FG003|Overall Study|Patient withdrew consent|0|||
160554891|NCT01109940|579757959|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160554892|NCT01109940|579757960|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160554893|NCT01109940|579757961|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
160554894|NCT01109940|579757962|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
160554895|NCT03653390|579757963|FG000|Overall Study|Lost to Follow-up|12|||
160554896|NCT03653390|579757964|FG001|Overall Study|Lost to Follow-up|8|||
160554897|NCT03653390|579757965|FG002|Overall Study|Lost to Follow-up|7|||
160554898|NCT03653390|579757963|FG000|Overall Study|Withdrawal by Subject|6|||
160554899|NCT03653390|579757964|FG001|Overall Study|Withdrawal by Subject|1|||
160554900|NCT03653390|579757965|FG002|Overall Study|Withdrawal by Subject|1|||
160554901|NCT03653390|579757963|FG000|Overall Study|Death|1|||
160554902|NCT03653390|579757964|FG001|Overall Study|Death|0|||
160554903|NCT03653390|579757965|FG002|Overall Study|Death|0|||
160554904|NCT03653390|579757963|FG000|Overall Study|Paper Survey Lost|1|||
160554905|NCT03653390|579757964|FG001|Overall Study|Paper Survey Lost|0|||
160554906|NCT03653390|579757965|FG002|Overall Study|Paper Survey Lost|0|||
160554907|NCT02769624|579757966|FG000|Overall Study|Lost to Follow-up|0|||
160554908|NCT02769624|579757967|FG001|Overall Study|Lost to Follow-up|1|||
160554909|NCT01987908|579757972|FG000|Placebo Lead-in Period|Adverse Event|2|||
160554910|NCT01987908|579757973|FG001|Placebo Lead-in Period|Adverse Event|0|||
160554911|NCT01987908|579757974|FG002|Placebo Lead-in Period|Adverse Event|0|||
160554912|NCT01987908|579757972|FG000|Placebo Lead-in Period|Physician Decision|2|||
160554913|NCT01987908|579757973|FG001|Placebo Lead-in Period|Physician Decision|0|||
160554914|NCT01987908|579757974|FG002|Placebo Lead-in Period|Physician Decision|0|||
160554915|NCT01987908|579757972|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
160554916|NCT01987908|579757973|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
160554917|NCT01987908|579757974|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
160554918|NCT01987908|579757972|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
160554919|NCT01987908|579757973|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
160554920|NCT01987908|579757974|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
160554921|NCT01987908|579757972|FG000|Treatment Period|Adverse Event|0|||
160554922|NCT01987908|579757973|FG001|Treatment Period|Adverse Event|1|||
160554923|NCT01987908|579757974|FG002|Treatment Period|Adverse Event|1|||
160554924|NCT01987908|579757972|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
160554925|NCT01987908|579757973|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
160554926|NCT01987908|579757974|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
160646734|NCT01664052|580089958|FG001|Phase 1|No device placement|0|||
160902317|NCT00347360|581036043|FG012|Overall Study|Reason not listed/blank|0|||
160902318|NCT00347360|581036044|FG013|Overall Study|Reason not listed/blank|1|||
160902319|NCT00347360|581036045|FG014|Overall Study|Reason not listed/blank|0|||
160902320|NCT00347360|581036031|FG000|Overall Study|Per sponsors instruction|0|||
160902321|NCT00347360|581036032|FG001|Overall Study|Per sponsors instruction|1|||
160902322|NCT00347360|581036033|FG002|Overall Study|Per sponsors instruction|0|||
160554927|NCT01987908|579757972|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
160554928|NCT01987908|579757973|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
160554929|NCT01987908|579757974|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
160554930|NCT01869348|579757975|FG000|Overall Study|Withdrawal by Subject|1|||
160554931|NCT01869348|579757976|FG001|Overall Study|Withdrawal by Subject|1|||
160902323|NCT00347360|581036034|FG003|Overall Study|Per sponsors instruction|0|||
160902324|NCT00347360|581036035|FG004|Overall Study|Per sponsors instruction|0|||
160990083|NCT01579578|581351742|FG001|Overall Study|Death|1|||
160554932|NCT02789657|579757977|FG000|Overall Study|Withdrawal by Subject|2|||
160554933|NCT02789657|579757978|FG001|Overall Study|Withdrawal by Subject|0|||
160554934|NCT02789657|579757979|FG002|Overall Study|Withdrawal by Subject|0|||
160990084|NCT01579578|581351741|FG000|Overall Study|Lost to Follow-up|1|||
160554935|NCT02789657|579757980|FG003|Overall Study|Withdrawal by Subject|0|||
160554936|NCT00510276|579757983|FG000|Acute Double-Blind Phase|Adverse Event|21|||
160554937|NCT00510276|579757984|FG001|Acute Double-Blind Phase|Adverse Event|6|||
160554938|NCT00510276|579757983|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
160554939|NCT00510276|579757984|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
160554940|NCT00510276|579757983|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
160554941|NCT00510276|579757984|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
160554942|NCT00510276|579757983|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
160554943|NCT00510276|579757984|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
160554944|NCT00510276|579757983|FG000|Acute Double-Blind Phase|Physician Decision|0|||
160554945|NCT00510276|579757984|FG001|Acute Double-Blind Phase|Physician Decision|3|||
160554946|NCT00510276|579757983|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
160554947|NCT00510276|579757984|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
160554948|NCT00510276|579757983|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
160554949|NCT00510276|579757984|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
160554950|NCT00510276|579757983|FG000|Acute Double-Blind Phase|Subject Decision|26|||
160554951|NCT00510276|579757984|FG001|Acute Double-Blind Phase|Subject Decision|28|||
160554952|NCT00510276|579757983|FG000|Extension Open-Label Phase|Adverse Event|9|||
160554953|NCT00510276|579757984|FG001|Extension Open-Label Phase|Adverse Event|18|||
160554954|NCT00510276|579757983|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
160554955|NCT00510276|579757984|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
160554956|NCT00510276|579757983|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
160554957|NCT00510276|579757984|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
160554958|NCT00510276|579757983|FG000|Extension Open-Label Phase|Physician Decision|2|||
160554959|NCT00510276|579757984|FG001|Extension Open-Label Phase|Physician Decision|3|||
160554960|NCT00510276|579757983|FG000|Extension Open-Label Phase|Protocol Violation|0|||
160554961|NCT00510276|579757984|FG001|Extension Open-Label Phase|Protocol Violation|1|||
160554962|NCT00510276|579757983|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
160554963|NCT00510276|579757984|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
160554964|NCT00510276|579757983|FG000|Extension Open-Label Phase|Subject Decision|7|||
160554965|NCT00510276|579757984|FG001|Extension Open-Label Phase|Subject Decision|9|||
160554966|NCT00441792|579757987|FG000|Overall Study|Lost to Follow-up|0|||
160554967|NCT00441792|579757988|FG001|Overall Study|Lost to Follow-up|2|||
160554968|NCT01731678|579757989|FG000|Overall Study|Withdrawal by Subject|3|||
160554969|NCT01731678|579757989|FG000|Overall Study|Did not meet inclusion criteria|1|||
160554970|NCT01731678|579757989|FG000|Overall Study|RMT too high, making TMS difficult|3|||
160554971|NCT00354601|579757992|FG000|Overall Study|Protocol Violation|1|||
160554972|NCT00354601|579757992|FG000|Overall Study|progression|1|||
160554973|NCT03157531|579757993|FG000|Overall Study|Death|2|||
160554974|NCT03157531|579757993|FG000|Overall Study|Lost to Follow-up|4|||
160554975|NCT00666926|579757996|FG000|Overall Study|Adverse Event|0|||
160554976|NCT00666926|579757997|FG001|Overall Study|Adverse Event|0|||
160554977|NCT00666926|579757998|FG002|Overall Study|Adverse Event|0|||
160554978|NCT00666926|579757999|FG003|Overall Study|Adverse Event|0|||
160554979|NCT00666926|579758000|FG004|Overall Study|Adverse Event|0|||
160554980|NCT00666926|579758001|FG005|Overall Study|Adverse Event|0|||
160554981|NCT00666926|579758002|FG006|Overall Study|Adverse Event|0|||
160554982|NCT00666926|579758003|FG007|Overall Study|Adverse Event|0|||
160554983|NCT00666926|579758004|FG008|Overall Study|Adverse Event|0|||
160554984|NCT00666926|579758005|FG009|Overall Study|Adverse Event|2|||
160554985|NCT00666926|579758006|FG010|Overall Study|Adverse Event|2|||
160554986|NCT00666926|579758007|FG011|Overall Study|Adverse Event|2|||
160554987|NCT00666926|579758008|FG012|Overall Study|Adverse Event|0|||
160554988|NCT00666926|579758009|FG013|Overall Study|Adverse Event|1|||
160554989|NCT00666926|579758010|FG014|Overall Study|Adverse Event|0|||
160554990|NCT00666926|579758011|FG015|Overall Study|Adverse Event|0|||
160554991|NCT00666926|579757996|FG000|Overall Study|Laboratory abnormality|0|||
160902325|NCT00347360|581036036|FG005|Overall Study|Per sponsors instruction|0|||
160902326|NCT00347360|581036037|FG006|Overall Study|Per sponsors instruction|0|||
160902327|NCT00347360|581036038|FG007|Overall Study|Per sponsors instruction|0|||
160902328|NCT00347360|581036039|FG008|Overall Study|Per sponsors instruction|0|||
160902329|NCT00347360|581036040|FG009|Overall Study|Per sponsors instruction|0|||
160554992|NCT00666926|579757997|FG001|Overall Study|Laboratory abnormality|0|||
160554993|NCT00666926|579757998|FG002|Overall Study|Laboratory abnormality|0|||
160554994|NCT00666926|579757999|FG003|Overall Study|Laboratory abnormality|0|||
160646735|NCT01664052|580089957|FG000|Phase 1|No HSG 1 hr post placement|1|||
160902330|NCT00347360|581036041|FG010|Overall Study|Per sponsors instruction|0|||
160902331|NCT00347360|581036042|FG011|Overall Study|Per sponsors instruction|0|||
160902332|NCT00347360|581036043|FG012|Overall Study|Per sponsors instruction|0|||
160990085|NCT01579578|581351742|FG001|Overall Study|Lost to Follow-up|1|||
160554995|NCT00666926|579758000|FG004|Overall Study|Laboratory abnormality|0|||
160554996|NCT00666926|579758001|FG005|Overall Study|Laboratory abnormality|0|||
160554997|NCT00666926|579758002|FG006|Overall Study|Laboratory abnormality|0|||
160554998|NCT00666926|579758003|FG007|Overall Study|Laboratory abnormality|0|||
160646736|NCT01664052|580089958|FG001|Phase 1|No HSG 1 hr post placement|0|||
160554999|NCT00666926|579758004|FG008|Overall Study|Laboratory abnormality|0|||
160555000|NCT00666926|579758005|FG009|Overall Study|Laboratory abnormality|0|||
160555001|NCT00666926|579758006|FG010|Overall Study|Laboratory abnormality|1|||
160555002|NCT00666926|579758007|FG011|Overall Study|Laboratory abnormality|0|||
160555003|NCT00666926|579758008|FG012|Overall Study|Laboratory abnormality|0|||
160555004|NCT00666926|579758009|FG013|Overall Study|Laboratory abnormality|0|||
160555005|NCT00666926|579758010|FG014|Overall Study|Laboratory abnormality|0|||
160555006|NCT00666926|579758011|FG015|Overall Study|Laboratory abnormality|1|||
160555007|NCT00666926|579757996|FG000|Overall Study|Lack of Efficacy|0|||
160555008|NCT00666926|579757997|FG001|Overall Study|Lack of Efficacy|0|||
160555009|NCT00666926|579757998|FG002|Overall Study|Lack of Efficacy|0|||
160902333|NCT00347360|581036044|FG013|Overall Study|Per sponsors instruction|0|||
160902334|NCT00347360|581036045|FG014|Overall Study|Per sponsors instruction|0|||
160902335|NCT00347360|581036031|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
160902336|NCT00347360|581036032|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
160902337|NCT00347360|581036033|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
160902338|NCT00347360|581036034|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
160902339|NCT00347360|581036035|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
160555010|NCT00666926|579757999|FG003|Overall Study|Lack of Efficacy|0|||
160555011|NCT00666926|579758000|FG004|Overall Study|Lack of Efficacy|0|||
160555012|NCT00666926|579758001|FG005|Overall Study|Lack of Efficacy|1|||
160555013|NCT00666926|579758002|FG006|Overall Study|Lack of Efficacy|0|||
160555014|NCT00666926|579758003|FG007|Overall Study|Lack of Efficacy|0|||
160555015|NCT00666926|579758004|FG008|Overall Study|Lack of Efficacy|0|||
160555016|NCT00666926|579758005|FG009|Overall Study|Lack of Efficacy|0|||
160555017|NCT00666926|579758006|FG010|Overall Study|Lack of Efficacy|0|||
160555018|NCT00666926|579758007|FG011|Overall Study|Lack of Efficacy|1|||
160555019|NCT00666926|579758008|FG012|Overall Study|Lack of Efficacy|0|||
160555020|NCT00666926|579758009|FG013|Overall Study|Lack of Efficacy|0|||
160555021|NCT00666926|579758010|FG014|Overall Study|Lack of Efficacy|0|||
160555022|NCT00666926|579758011|FG015|Overall Study|Lack of Efficacy|0|||
160555023|NCT00666926|579757996|FG000|Overall Study|Lost to Follow-up|0|||
160555024|NCT00666926|579757997|FG001|Overall Study|Lost to Follow-up|0|||
160555025|NCT00666926|579757998|FG002|Overall Study|Lost to Follow-up|0|||
160555026|NCT00666926|579757999|FG003|Overall Study|Lost to Follow-up|1|||
160555027|NCT00666926|579758000|FG004|Overall Study|Lost to Follow-up|0|||
160555028|NCT00666926|579758001|FG005|Overall Study|Lost to Follow-up|0|||
160902340|NCT00347360|581036036|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
160902341|NCT00347360|581036037|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
160902342|NCT00347360|581036038|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
160555029|NCT00666926|579758002|FG006|Overall Study|Lost to Follow-up|0|||
160555030|NCT00666926|579758003|FG007|Overall Study|Lost to Follow-up|0|||
160555031|NCT00666926|579758004|FG008|Overall Study|Lost to Follow-up|0|||
160555032|NCT00666926|579758005|FG009|Overall Study|Lost to Follow-up|0|||
160555033|NCT00666926|579758006|FG010|Overall Study|Lost to Follow-up|0|||
160555034|NCT00666926|579758007|FG011|Overall Study|Lost to Follow-up|0|||
160902343|NCT00347360|581036039|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
160902344|NCT00347360|581036040|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
160902345|NCT00347360|581036041|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
160902346|NCT00347360|581036042|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
160555035|NCT00666926|579758008|FG012|Overall Study|Lost to Follow-up|0|||
160555036|NCT00666926|579758009|FG013|Overall Study|Lost to Follow-up|0|||
160555037|NCT00666926|579758010|FG014|Overall Study|Lost to Follow-up|0|||
160555038|NCT00666926|579758011|FG015|Overall Study|Lost to Follow-up|0|||
160555039|NCT00666926|579757996|FG000|Overall Study|Other|2|||
160555040|NCT00666926|579757997|FG001|Overall Study|Other|4|||
160555041|NCT00666926|579757998|FG002|Overall Study|Other|3|||
160555042|NCT00666926|579757999|FG003|Overall Study|Other|3|||
160555043|NCT00666926|579758000|FG004|Overall Study|Other|3|||
160555044|NCT00666926|579758001|FG005|Overall Study|Other|3|||
160555045|NCT00666926|579758002|FG006|Overall Study|Other|4|||
160555046|NCT00666926|579758003|FG007|Overall Study|Other|0|||
160555047|NCT00666926|579758004|FG008|Overall Study|Other|3|||
160555048|NCT00666926|579758005|FG009|Overall Study|Other|5|||
160555049|NCT00666926|579758006|FG010|Overall Study|Other|3|||
160902347|NCT00347360|581036043|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
160902348|NCT00347360|581036044|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
160902349|NCT00347360|581036045|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
160902350|NCT00347360|581036031|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
160902351|NCT00347360|581036032|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
160902352|NCT00347360|581036033|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
160902353|NCT00347360|581036034|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
160902354|NCT00347360|581036035|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
160902355|NCT00347360|581036036|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
160902356|NCT00347360|581036037|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
160902357|NCT00347360|581036038|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
160902358|NCT00347360|581036039|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
160902359|NCT00347360|581036040|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
160902360|NCT00347360|581036041|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
160902361|NCT00347360|581036042|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
160902362|NCT00347360|581036043|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
160902363|NCT00347360|581036044|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
160902364|NCT00347360|581036045|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
160902365|NCT00347360|581036031|FG000|Overall Study|Abnormal lab values|0|||
160902366|NCT00347360|581036032|FG001|Overall Study|Abnormal lab values|0|||
160902367|NCT00347360|581036033|FG002|Overall Study|Abnormal lab values|0|||
160902368|NCT00347360|581036034|FG003|Overall Study|Abnormal lab values|0|||
160902369|NCT00347360|581036035|FG004|Overall Study|Abnormal lab values|0|||
160902370|NCT00347360|581036036|FG005|Overall Study|Abnormal lab values|0|||
160902371|NCT00347360|581036037|FG006|Overall Study|Abnormal lab values|1|||
160902372|NCT00347360|581036038|FG007|Overall Study|Abnormal lab values|0|||
160902373|NCT00347360|581036039|FG008|Overall Study|Abnormal lab values|0|||
160902374|NCT00347360|581036040|FG009|Overall Study|Abnormal lab values|0|||
160902375|NCT00347360|581036041|FG010|Overall Study|Abnormal lab values|0|||
160902376|NCT00347360|581036042|FG011|Overall Study|Abnormal lab values|0|||
160902377|NCT00347360|581036043|FG012|Overall Study|Abnormal lab values|0|||
160902378|NCT00347360|581036044|FG013|Overall Study|Abnormal lab values|0|||
160902379|NCT00347360|581036045|FG014|Overall Study|Abnormal lab values|0|||
160902380|NCT00347360|581036031|FG000|Overall Study|PI recommended early withdrawal|0|||
160902381|NCT00347360|581036032|FG001|Overall Study|PI recommended early withdrawal|0|||
160902382|NCT00347360|581036033|FG002|Overall Study|PI recommended early withdrawal|0|||
160902383|NCT00347360|581036034|FG003|Overall Study|PI recommended early withdrawal|0|||
160902384|NCT00347360|581036035|FG004|Overall Study|PI recommended early withdrawal|0|||
160902385|NCT00347360|581036036|FG005|Overall Study|PI recommended early withdrawal|0|||
160902386|NCT00347360|581036037|FG006|Overall Study|PI recommended early withdrawal|0|||
160902387|NCT00347360|581036038|FG007|Overall Study|PI recommended early withdrawal|0|||
160902388|NCT00347360|581036039|FG008|Overall Study|PI recommended early withdrawal|0|||
160902389|NCT00347360|581036040|FG009|Overall Study|PI recommended early withdrawal|1|||
160902390|NCT00347360|581036041|FG010|Overall Study|PI recommended early withdrawal|0|||
160902391|NCT00347360|581036042|FG011|Overall Study|PI recommended early withdrawal|0|||
160902392|NCT00347360|581036043|FG012|Overall Study|PI recommended early withdrawal|0|||
160902393|NCT00347360|581036044|FG013|Overall Study|PI recommended early withdrawal|0|||
160902394|NCT00347360|581036045|FG014|Overall Study|PI recommended early withdrawal|0|||
160902395|NCT00347360|581036031|FG000|Overall Study|Did not meet criteria before ABPM|0|||
160902396|NCT00347360|581036032|FG001|Overall Study|Did not meet criteria before ABPM|0|||
160902397|NCT00347360|581036033|FG002|Overall Study|Did not meet criteria before ABPM|0|||
160902398|NCT00347360|581036034|FG003|Overall Study|Did not meet criteria before ABPM|0|||
160902399|NCT00347360|581036035|FG004|Overall Study|Did not meet criteria before ABPM|0|||
160902400|NCT00347360|581036036|FG005|Overall Study|Did not meet criteria before ABPM|0|||
160902401|NCT00347360|581036037|FG006|Overall Study|Did not meet criteria before ABPM|0|||
160902402|NCT00347360|581036038|FG007|Overall Study|Did not meet criteria before ABPM|0|||
160902403|NCT00347360|581036039|FG008|Overall Study|Did not meet criteria before ABPM|0|||
160555050|NCT00666926|579758007|FG011|Overall Study|Other|26|||
160555051|NCT00666926|579758008|FG012|Overall Study|Other|3|||
160902404|NCT00347360|581036040|FG009|Overall Study|Did not meet criteria before ABPM|0|||
160555052|NCT00666926|579758009|FG013|Overall Study|Other|2|||
160555053|NCT00666926|579758010|FG014|Overall Study|Other|4|||
160555054|NCT00666926|579758011|FG015|Overall Study|Other|4|||
160555055|NCT00666926|579757996|FG000|Overall Study|Withdrawal by Subject|0|||
160555056|NCT00666926|579757997|FG001|Overall Study|Withdrawal by Subject|0|||
160555057|NCT00666926|579757998|FG002|Overall Study|Withdrawal by Subject|0|||
160555058|NCT00666926|579757999|FG003|Overall Study|Withdrawal by Subject|0|||
160555059|NCT00666926|579758000|FG004|Overall Study|Withdrawal by Subject|0|||
160555060|NCT00666926|579758001|FG005|Overall Study|Withdrawal by Subject|0|||
160555061|NCT00666926|579758002|FG006|Overall Study|Withdrawal by Subject|0|||
160555062|NCT00666926|579758003|FG007|Overall Study|Withdrawal by Subject|1|||
160555063|NCT00666926|579758004|FG008|Overall Study|Withdrawal by Subject|0|||
160555064|NCT00666926|579758005|FG009|Overall Study|Withdrawal by Subject|3|||
160555065|NCT00666926|579758006|FG010|Overall Study|Withdrawal by Subject|0|||
160555066|NCT00666926|579758007|FG011|Overall Study|Withdrawal by Subject|3|||
160555067|NCT00666926|579758008|FG012|Overall Study|Withdrawal by Subject|0|||
160555068|NCT00666926|579758009|FG013|Overall Study|Withdrawal by Subject|1|||
160555069|NCT00666926|579758010|FG014|Overall Study|Withdrawal by Subject|3|||
160555070|NCT00666926|579758011|FG015|Overall Study|Withdrawal by Subject|3|||
160555071|NCT00666926|579757996|FG000|Overall Study|Death|0|||
160555072|NCT00666926|579757997|FG001|Overall Study|Death|0|||
160555073|NCT00666926|579757998|FG002|Overall Study|Death|0|||
160555074|NCT00666926|579757999|FG003|Overall Study|Death|0|||
160555075|NCT00666926|579758000|FG004|Overall Study|Death|0|||
160555076|NCT00666926|579758001|FG005|Overall Study|Death|0|||
160555077|NCT00666926|579758002|FG006|Overall Study|Death|0|||
160555078|NCT00666926|579758003|FG007|Overall Study|Death|0|||
160555079|NCT00666926|579758004|FG008|Overall Study|Death|0|||
160555080|NCT00666926|579758005|FG009|Overall Study|Death|0|||
160555081|NCT00666926|579758006|FG010|Overall Study|Death|0|||
160555082|NCT00666926|579758007|FG011|Overall Study|Death|1|||
160555083|NCT00666926|579758008|FG012|Overall Study|Death|0|||
160555084|NCT00666926|579758009|FG013|Overall Study|Death|0|||
160555085|NCT00666926|579758010|FG014|Overall Study|Death|0|||
160555086|NCT00666926|579758011|FG015|Overall Study|Death|0|||
160555087|NCT01960855|579758012|FG000|Overall Study|Subject noncompliant|1|||
160555088|NCT01960855|579758013|FG001|Overall Study|Subject noncompliant|0|||
160555089|NCT01960855|579758014|FG002|Overall Study|Subject noncompliant|0|||
160555090|NCT01960855|579758015|FG003|Overall Study|Subject noncompliant|0|||
160555091|NCT01960855|579758016|FG004|Overall Study|Subject noncompliant|0|||
160555092|NCT01960855|579758012|FG000|Overall Study|Adverse Event|2|||
160555093|NCT01960855|579758013|FG001|Overall Study|Adverse Event|0|||
160555094|NCT01960855|579758014|FG002|Overall Study|Adverse Event|6|||
160555095|NCT01960855|579758015|FG003|Overall Study|Adverse Event|2|||
160555096|NCT01960855|579758016|FG004|Overall Study|Adverse Event|2|||
160555097|NCT01960855|579758012|FG000|Overall Study|Lack of Efficacy|1|||
160555098|NCT01960855|579758013|FG001|Overall Study|Lack of Efficacy|1|||
160555099|NCT01960855|579758014|FG002|Overall Study|Lack of Efficacy|0|||
160555100|NCT01960855|579758015|FG003|Overall Study|Lack of Efficacy|0|||
160555101|NCT01960855|579758016|FG004|Overall Study|Lack of Efficacy|0|||
160555102|NCT01960855|579758012|FG000|Overall Study|Other|2|||
160555103|NCT01960855|579758013|FG001|Overall Study|Other|1|||
160555104|NCT01960855|579758014|FG002|Overall Study|Other|1|||
160555105|NCT01960855|579758015|FG003|Overall Study|Other|1|||
160555106|NCT01960855|579758016|FG004|Overall Study|Other|0|||
160555107|NCT01960855|579758012|FG000|Overall Study|Consent withdrawn by subject|3|||
160555108|NCT01960855|579758013|FG001|Overall Study|Consent withdrawn by subject|1|||
160555109|NCT01960855|579758014|FG002|Overall Study|Consent withdrawn by subject|2|||
160555110|NCT01960855|579758015|FG003|Overall Study|Consent withdrawn by subject|1|||
160555111|NCT01960855|579758016|FG004|Overall Study|Consent withdrawn by subject|1|||
160555112|NCT01960855|579758012|FG000|Overall Study|Lost to Follow-up|2|||
160555113|NCT01960855|579758013|FG001|Overall Study|Lost to Follow-up|1|||
160555114|NCT01960855|579758014|FG002|Overall Study|Lost to Follow-up|0|||
160555115|NCT01960855|579758015|FG003|Overall Study|Lost to Follow-up|0|||
160555116|NCT01960855|579758016|FG004|Overall Study|Lost to Follow-up|2|||
160555117|NCT02471716|579758017|FG000|Overall Study|Withdrawal by Subject|0|||
160555118|NCT02471716|579758018|FG001|Overall Study|Withdrawal by Subject|1|||
160555119|NCT02471716|579758019|FG002|Overall Study|Withdrawal by Subject|0|||
160555120|NCT02471716|579758020|FG003|Overall Study|Withdrawal by Subject|2|||
160555121|NCT02471716|579758021|FG004|Overall Study|Withdrawal by Subject|5|||
160555122|NCT02471716|579758017|FG000|Overall Study|Study Terminiated by sponsor|0|||
160555123|NCT02471716|579758018|FG001|Overall Study|Study Terminiated by sponsor|0|||
160555124|NCT02471716|579758019|FG002|Overall Study|Study Terminiated by sponsor|0|||
160555125|NCT02471716|579758020|FG003|Overall Study|Study Terminiated by sponsor|1|||
160555126|NCT02471716|579758021|FG004|Overall Study|Study Terminiated by sponsor|0|||
160555127|NCT02471716|579758017|FG000|Overall Study|Lost to Follow-up|0|||
160555128|NCT02471716|579758018|FG001|Overall Study|Lost to Follow-up|0|||
160555129|NCT02471716|579758019|FG002|Overall Study|Lost to Follow-up|0|||
160555130|NCT02471716|579758020|FG003|Overall Study|Lost to Follow-up|3|||
160555131|NCT02471716|579758021|FG004|Overall Study|Lost to Follow-up|2|||
160555132|NCT02471716|579758017|FG000|Overall Study|Death|0|||
160555133|NCT02471716|579758018|FG001|Overall Study|Death|0|||
160555134|NCT02471716|579758019|FG002|Overall Study|Death|0|||
160555135|NCT02471716|579758020|FG003|Overall Study|Death|1|||
160555136|NCT02471716|579758021|FG004|Overall Study|Death|0|||
160555137|NCT02471716|579758017|FG000|Overall Study|Other|0|||
160555138|NCT02471716|579758018|FG001|Overall Study|Other|0|||
160555139|NCT02471716|579758019|FG002|Overall Study|Other|0|||
160555140|NCT02471716|579758020|FG003|Overall Study|Other|8|||
160555141|NCT02471716|579758021|FG004|Overall Study|Other|9|||
160555142|NCT01573910|579758034|FG000|Overall Study|Adverse Event|4|||
160555143|NCT01573910|579758035|FG001|Overall Study|Adverse Event|4|||
160555144|NCT01573910|579758034|FG000|Overall Study|Lost to Follow-up|2|||
160555145|NCT01573910|579758035|FG001|Overall Study|Lost to Follow-up|1|||
160555146|NCT01573910|579758034|FG000|Overall Study|Withdrawal by Subject|0|||
160555147|NCT01573910|579758035|FG001|Overall Study|Withdrawal by Subject|1|||
160555148|NCT01573910|579758034|FG000|Overall Study|Protocol Violation|3|||
160555149|NCT01573910|579758035|FG001|Overall Study|Protocol Violation|0|||
160555150|NCT01573910|579758034|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
160555151|NCT01573910|579758035|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
160555152|NCT02251912|579758036|FG000|Overall Study|Withdrawal by Subject|2|||
160555153|NCT02251912|579758037|FG001|Overall Study|Withdrawal by Subject|3|||
160555154|NCT02251912|579758036|FG000|Overall Study|Adverse Event|0|||
160555155|NCT02251912|579758037|FG001|Overall Study|Adverse Event|2|||
160555156|NCT01162421|579758041|FG000|Overall Study|Did not receive study drug|2|||
160555157|NCT01162421|579758042|FG001|Overall Study|Did not receive study drug|1|||
160555158|NCT01162421|579758041|FG000|Overall Study|Adverse Event|2|||
160555159|NCT01162421|579758042|FG001|Overall Study|Adverse Event|5|||
160555160|NCT01162421|579758041|FG000|Overall Study|Lost to Follow-up|0|||
160555161|NCT01162421|579758042|FG001|Overall Study|Lost to Follow-up|2|||
160555162|NCT01162421|579758041|FG000|Overall Study|Lack of Efficacy|2|||
160555163|NCT01162421|579758042|FG001|Overall Study|Lack of Efficacy|2|||
160555164|NCT01162421|579758041|FG000|Overall Study|Other|2|||
160555165|NCT01162421|579758042|FG001|Overall Study|Other|3|||
160555166|NCT01133171|579758047|FG000|Overall Study|Withdrawal by Subject|1|||
160555167|NCT01133171|579758048|FG001|Overall Study|Withdrawal by Subject|2|||
160555168|NCT01133171|579758049|FG002|Overall Study|Withdrawal by Subject|0|||
160555169|NCT02526550|579758050|FG000|Overall Study|Lost to Follow-up|1|||
160555170|NCT04062214|579758052|FG000|Week 12|Death|1|||
160555171|NCT04062214|579758053|FG001|Week 12|Death|1|||
160555172|NCT04062214|579758052|FG000|Week 12|Withdrawal by Subject|14|||
160555173|NCT04062214|579758053|FG001|Week 12|Withdrawal by Subject|13|||
160555174|NCT04062214|579758052|FG000|Week 12|Lost to Follow-up|55|||
160555175|NCT04062214|579758053|FG001|Week 12|Lost to Follow-up|68|||
160555176|NCT04062214|579758052|FG000|Week 12|Intermittent missing|31|||
160555177|NCT04062214|579758053|FG001|Week 12|Intermittent missing|29|||
160555178|NCT04062214|579758052|FG000|Week 36|Withdrawal by Subject|4|||
160555179|NCT04062214|579758053|FG001|Week 36|Withdrawal by Subject|5|||
160555180|NCT04062214|579758052|FG000|Week 36|Lost to Follow-up|50|||
160555181|NCT04062214|579758053|FG001|Week 36|Lost to Follow-up|46|||
160555182|NCT04062214|579758052|FG000|Week 36|Death|0|||
160555183|NCT04062214|579758053|FG001|Week 36|Death|1|||
160555184|NCT03434379|579758059|FG000|Global Period|Lost to Follow-up|3|||
160555185|NCT03434379|579758060|FG001|Global Period|Lost to Follow-up|6|||
160555186|NCT03434379|579758061|FG002|Global Period|Lost to Follow-up|0|||
160555187|NCT03434379|579758062|FG003|Global Period|Lost to Follow-up|0|||
160555188|NCT03434379|579758059|FG000|Global Period|Death|115|||
160555189|NCT03434379|579758060|FG001|Global Period|Death|228|||
160555190|NCT03434379|579758061|FG002|Global Period|Death|0|||
160555191|NCT03434379|579758062|FG003|Global Period|Death|0|||
160555192|NCT03434379|579758059|FG000|Global Period|Withdrawal by Subject|20|||
160555193|NCT03434379|579758060|FG001|Global Period|Withdrawal by Subject|21|||
160555194|NCT03434379|579758061|FG002|Global Period|Withdrawal by Subject|0|||
160555195|NCT03434379|579758062|FG003|Global Period|Withdrawal by Subject|0|||
160555196|NCT03434379|579758059|FG000|Global Period|Reason Unspecified|0|||
160555197|NCT03434379|579758060|FG001|Global Period|Reason Unspecified|1|||
160555198|NCT03434379|579758061|FG002|Global Period|Reason Unspecified|0|||
160555199|NCT03434379|579758062|FG003|Global Period|Reason Unspecified|0|||
160555200|NCT03434379|579758059|FG000|Global Period|Study Ended by Sponsor|26|||
160555201|NCT03434379|579758060|FG001|Global Period|Study Ended by Sponsor|80|||
160555202|NCT03434379|579758061|FG002|Global Period|Study Ended by Sponsor|0|||
160555203|NCT03434379|579758062|FG003|Global Period|Study Ended by Sponsor|0|||
160555204|NCT03434379|579758059|FG000|Global Period|Physician Decision|1|||
160555205|NCT03434379|579758060|FG001|Global Period|Physician Decision|0|||
160555206|NCT03434379|579758061|FG002|Global Period|Physician Decision|0|||
160555207|NCT03434379|579758062|FG003|Global Period|Physician Decision|0|||
160555208|NCT03434379|579758059|FG000|China Extension Period|Lost to Follow-up|0|||
160555209|NCT03434379|579758060|FG001|China Extension Period|Lost to Follow-up|0|||
160555210|NCT03434379|579758061|FG002|China Extension Period|Lost to Follow-up|2|||
160555211|NCT03434379|579758062|FG003|China Extension Period|Lost to Follow-up|3|||
160555212|NCT03434379|579758059|FG000|China Extension Period|Death|0|||
160555213|NCT03434379|579758060|FG001|China Extension Period|Death|0|||
160555214|NCT03434379|579758061|FG002|China Extension Period|Death|46|||
160555215|NCT03434379|579758062|FG003|China Extension Period|Death|88|||
160555216|NCT03434379|579758059|FG000|China Extension Period|Withdrawal by Subject|0|||
160555217|NCT03434379|579758060|FG001|China Extension Period|Withdrawal by Subject|0|||
160555218|NCT03434379|579758061|FG002|China Extension Period|Withdrawal by Subject|8|||
160555219|NCT03434379|579758062|FG003|China Extension Period|Withdrawal by Subject|6|||
160555220|NCT03434379|579758059|FG000|China Extension Period|Study Ended by Sponsor|0|||
160555221|NCT03434379|579758060|FG001|China Extension Period|Study Ended by Sponsor|0|||
160555222|NCT03434379|579758061|FG002|China Extension Period|Study Ended by Sponsor|5|||
160555223|NCT03434379|579758062|FG003|China Extension Period|Study Ended by Sponsor|36|||
160555224|NCT03179436|579758066|FG000|Overall Study|Withdrawal by Subject|1|||
160555225|NCT03179436|579758067|FG001|Overall Study|Withdrawal by Subject|0|||
160555226|NCT03179436|579758068|FG002|Overall Study|Withdrawal by Subject|0|||
160555227|NCT03179436|579758069|FG003|Overall Study|Withdrawal by Subject|4|||
160555228|NCT03179436|579758070|FG004|Overall Study|Withdrawal by Subject|2|||
160555229|NCT03179436|579758071|FG005|Overall Study|Withdrawal by Subject|2|||
160555230|NCT03179436|579758072|FG006|Overall Study|Withdrawal by Subject|5|||
160555231|NCT03179436|579758073|FG007|Overall Study|Withdrawal by Subject|0|||
160555232|NCT03179436|579758074|FG008|Overall Study|Withdrawal by Subject|3|||
160555233|NCT03179436|579758075|FG009|Overall Study|Withdrawal by Subject|0|||
160555234|NCT03179436|579758076|FG010|Overall Study|Withdrawal by Subject|0|||
160555235|NCT03179436|579758077|FG011|Overall Study|Withdrawal by Subject|0|||
160555236|NCT03179436|579758066|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160555237|NCT03179436|579758067|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160555238|NCT03179436|579758068|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160555239|NCT03179436|579758069|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160555240|NCT03179436|579758070|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
160555241|NCT03179436|579758071|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
160555242|NCT03179436|579758072|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
160555243|NCT03179436|579758073|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
160646737|NCT01664052|580089957|FG000|Phase 2|No device placement|0|||
160555244|NCT03179436|579758074|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
160555245|NCT03179436|579758075|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
160555246|NCT03179436|579758076|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
160646738|NCT01664052|580089958|FG001|Phase 2|No device placement|4|||
160990086|NCT01579578|581351741|FG000|Overall Study|Withdrawal by Subject|2|||
160555247|NCT03179436|579758077|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
160646739|NCT01060670|580089959|FG000|Run In|screen failure|0|||
160555248|NCT03179436|579758066|FG000|Overall Study|Sponsor Decision|0|||
160555249|NCT03179436|579758067|FG001|Overall Study|Sponsor Decision|0|||
160555250|NCT03179436|579758068|FG002|Overall Study|Sponsor Decision|1|||
160555251|NCT03179436|579758069|FG003|Overall Study|Sponsor Decision|3|||
160555252|NCT03179436|579758070|FG004|Overall Study|Sponsor Decision|9|||
160555253|NCT03179436|579758071|FG005|Overall Study|Sponsor Decision|7|||
160555254|NCT03179436|579758072|FG006|Overall Study|Sponsor Decision|2|||
160555255|NCT03179436|579758073|FG007|Overall Study|Sponsor Decision|4|||
160555256|NCT03179436|579758074|FG008|Overall Study|Sponsor Decision|23|||
160555257|NCT03179436|579758075|FG009|Overall Study|Sponsor Decision|6|||
160555258|NCT03179436|579758076|FG010|Overall Study|Sponsor Decision|7|||
160555259|NCT03179436|579758077|FG011|Overall Study|Sponsor Decision|5|||
160555260|NCT03179436|579758066|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
160555261|NCT03179436|579758067|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
160555262|NCT03179436|579758068|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
160555263|NCT03179436|579758069|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
160555264|NCT03179436|579758070|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
160555265|NCT03179436|579758071|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
160555266|NCT03179436|579758072|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
160555267|NCT03179436|579758073|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
160555268|NCT03179436|579758074|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
160555269|NCT03179436|579758075|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
160555270|NCT03179436|579758076|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
160555271|NCT03179436|579758077|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
160555272|NCT03179436|579758066|FG000|Overall Study|Lost to Follow-up|1|||
160555273|NCT03179436|579758067|FG001|Overall Study|Lost to Follow-up|0|||
160555274|NCT03179436|579758068|FG002|Overall Study|Lost to Follow-up|0|||
160555275|NCT03179436|579758069|FG003|Overall Study|Lost to Follow-up|1|||
160555276|NCT03179436|579758070|FG004|Overall Study|Lost to Follow-up|0|||
160555277|NCT03179436|579758071|FG005|Overall Study|Lost to Follow-up|1|||
160555278|NCT03179436|579758072|FG006|Overall Study|Lost to Follow-up|0|||
160555279|NCT03179436|579758073|FG007|Overall Study|Lost to Follow-up|0|||
160555280|NCT03179436|579758074|FG008|Overall Study|Lost to Follow-up|1|||
160555281|NCT03179436|579758075|FG009|Overall Study|Lost to Follow-up|1|||
160555282|NCT03179436|579758076|FG010|Overall Study|Lost to Follow-up|0|||
160555283|NCT03179436|579758077|FG011|Overall Study|Lost to Follow-up|0|||
160555284|NCT03179436|579758066|FG000|Overall Study|Death|12|||
160555285|NCT03179436|579758067|FG001|Overall Study|Death|17|||
160555286|NCT03179436|579758068|FG002|Overall Study|Death|7|||
160555287|NCT03179436|579758069|FG003|Overall Study|Death|32|||
160555288|NCT03179436|579758070|FG004|Overall Study|Death|29|||
160555289|NCT03179436|579758071|FG005|Overall Study|Death|30|||
160555290|NCT03179436|579758072|FG006|Overall Study|Death|33|||
160555291|NCT03179436|579758073|FG007|Overall Study|Death|9|||
160555292|NCT03179436|579758074|FG008|Overall Study|Death|84|||
160555293|NCT03179436|579758075|FG009|Overall Study|Death|33|||
160555294|NCT03179436|579758076|FG010|Overall Study|Death|22|||
160555295|NCT03179436|579758077|FG011|Overall Study|Death|15|||
160555296|NCT01634555|579758078|FG000|Overall Study|Adverse Event|3|||
160555297|NCT01634555|579758078|FG000|Overall Study|Physician Decision|1|||
160555298|NCT01506882|579758079|FG000|Overall Study|Lack of Efficacy|4|||
160555299|NCT01506882|579758080|FG001|Overall Study|Lack of Efficacy|3|||
160555300|NCT01506882|579758079|FG000|Overall Study|Lost to Follow-up|1|||
160555301|NCT01506882|579758080|FG001|Overall Study|Lost to Follow-up|0|||
160555302|NCT01506882|579758079|FG000|Overall Study|Withdrawal by Subject|9|||
160555303|NCT01506882|579758080|FG001|Overall Study|Withdrawal by Subject|3|||
160555304|NCT01506882|579758079|FG000|Overall Study|SAE, non-fatal|2|||
160555305|NCT01506882|579758080|FG001|Overall Study|SAE, non-fatal|0|||
160555306|NCT01506882|579758079|FG000|Overall Study|AE, non-serious non-fatal|3|||
160555307|NCT01506882|579758080|FG001|Overall Study|AE, non-serious non-fatal|1|||
160555308|NCT01506882|579758079|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
160555309|NCT01506882|579758080|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
160555310|NCT01506882|579758079|FG000|Overall Study|Other Reason|2|||
160555311|NCT01506882|579758080|FG001|Overall Study|Other Reason|0|||
160555312|NCT01793792|579759943|FG000|Overall Study|Death|5|||
160555313|NCT01793792|579759943|FG000|Overall Study|Lost to Follow-up|5|||
160555314|NCT01793792|579759943|FG000|Overall Study|Withdrawal by Subject|1|||
160555315|NCT01793792|579759943|FG000|Overall Study|Device Not Implanted|1|||
160555316|NCT00851903|579759944|FG000|Overall Study|Withdrawal by Subject|2|||
160555317|NCT00686127|579759945|FG000|Overall Study|Withdrawal by Subject|14|||
160555318|NCT00686127|579759946|FG001|Overall Study|Withdrawal by Subject|6|||
160555319|NCT00469612|579759952|FG000|Overall Study|Study terminated before data collected|2|||
160555320|NCT00469612|579759953|FG001|Overall Study|Study terminated before data collected|0|||
160555321|NCT00214461|579759954|FG000|Overall Study|Adverse Event|0|||
160555322|NCT00214461|579759955|FG001|Overall Study|Adverse Event|0|||
160555323|NCT00214461|579759956|FG002|Overall Study|Adverse Event|1|||
160555324|NCT00214461|579759957|FG003|Overall Study|Adverse Event|1|||
160555325|NCT00214461|579759954|FG000|Overall Study|Withdrawal by Subject|0|||
160555326|NCT00214461|579759955|FG001|Overall Study|Withdrawal by Subject|0|||
160555327|NCT00214461|579759956|FG002|Overall Study|Withdrawal by Subject|1|||
160555328|NCT00214461|579759957|FG003|Overall Study|Withdrawal by Subject|0|||
160555329|NCT01688050|579759958|FG000|Overall Study|Death|7|||
160555330|NCT01688050|579759958|FG000|Overall Study|Conversion to open repair|1|||
160555331|NCT01688050|579759958|FG000|Overall Study|Lost to Follow-up|13|||
160555332|NCT01688050|579759958|FG000|Overall Study|Withdrawal by Subject|10|||
160555333|NCT00234039|579759959|FG000|Overall Study|Adverse Event|2|||
160555334|NCT00234039|579759959|FG000|Overall Study|Progression/relapse|34|||
160555335|NCT00234039|579759959|FG000|Overall Study|Other - Not Protocol Specified|3|||
160555336|NCT00234039|579759959|FG000|Overall Study|Ineligible|9|||
160555337|NCT00234039|579759959|FG000|Overall Study|No Protocol Treatment Received|2|||
160555338|NCT02239263|579759962|FG000|Overall Study|Protocol Violation|6|||
160555339|NCT04303000|579759963|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
160555340|NCT04303000|579759964|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
160555341|NCT04303000|579759965|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
160555342|NCT04426695|579759966|FG000|Overall Study|Death|2|||
160555343|NCT04426695|579759967|FG001|Overall Study|Death|0|||
160555344|NCT04426695|579759968|FG002|Overall Study|Death|1|||
160555345|NCT04426695|579759969|FG003|Overall Study|Death|27|||
160555346|NCT04426695|579759970|FG004|Overall Study|Death|25|||
160555347|NCT04426695|579759971|FG005|Overall Study|Death|21|||
160555348|NCT04426695|579759972|FG006|Overall Study|Death|42|||
160555349|NCT04426695|579759973|FG007|Overall Study|Death|23|||
160555350|NCT04426695|579759974|FG008|Overall Study|Death|37|||
160555351|NCT04426695|579759975|FG009|Overall Study|Death|14|||
160555352|NCT04426695|579759976|FG010|Overall Study|Death|8|||
160555353|NCT04426695|579759977|FG011|Overall Study|Death|7|||
160555354|NCT04426695|579759978|FG012|Overall Study|Death|13|||
160555355|NCT04426695|579759979|FG013|Overall Study|Death|25|||
160555356|NCT04426695|579759980|FG014|Overall Study|Death|19|||
160555357|NCT04426695|579759981|FG015|Overall Study|Death|7|||
160555358|NCT04426695|579759982|FG016|Overall Study|Death|8|||
160555359|NCT04426695|579759983|FG017|Overall Study|Death|4|||
160555360|NCT04426695|579759966|FG000|Overall Study|Lost to Follow-up|2|||
160555361|NCT04426695|579759967|FG001|Overall Study|Lost to Follow-up|4|||
160555362|NCT04426695|579759968|FG002|Overall Study|Lost to Follow-up|1|||
160555363|NCT04426695|579759969|FG003|Overall Study|Lost to Follow-up|19|||
160555364|NCT04426695|579759970|FG004|Overall Study|Lost to Follow-up|10|||
160555365|NCT04426695|579759971|FG005|Overall Study|Lost to Follow-up|14|||
160555366|NCT04426695|579759972|FG006|Overall Study|Lost to Follow-up|5|||
160555367|NCT04426695|579759973|FG007|Overall Study|Lost to Follow-up|14|||
160555368|NCT04426695|579759974|FG008|Overall Study|Lost to Follow-up|10|||
160555369|NCT04426695|579759975|FG009|Overall Study|Lost to Follow-up|11|||
160555370|NCT04426695|579759976|FG010|Overall Study|Lost to Follow-up|12|||
160555371|NCT04426695|579759977|FG011|Overall Study|Lost to Follow-up|6|||
160827070|NCT02761694|580751938|FG009|Overall Study|Other|1|||
160555372|NCT04426695|579759978|FG012|Overall Study|Lost to Follow-up|2|||
160555373|NCT04426695|579759979|FG013|Overall Study|Lost to Follow-up|2|||
160555374|NCT04426695|579759980|FG014|Overall Study|Lost to Follow-up|2|||
160555375|NCT04426695|579759981|FG015|Overall Study|Lost to Follow-up|0|||
160555376|NCT04426695|579759982|FG016|Overall Study|Lost to Follow-up|0|||
160555377|NCT04426695|579759983|FG017|Overall Study|Lost to Follow-up|0|||
160555378|NCT04426695|579759966|FG000|Overall Study|Participant Decision|1|||
160555379|NCT04426695|579759967|FG001|Overall Study|Participant Decision|2|||
160555380|NCT04426695|579759968|FG002|Overall Study|Participant Decision|2|||
160555381|NCT04426695|579759969|FG003|Overall Study|Participant Decision|12|||
160555382|NCT04426695|579759970|FG004|Overall Study|Participant Decision|18|||
160555383|NCT04426695|579759971|FG005|Overall Study|Participant Decision|22|||
160555384|NCT04426695|579759972|FG006|Overall Study|Participant Decision|13|||
160555385|NCT04426695|579759973|FG007|Overall Study|Participant Decision|13|||
160555386|NCT04426695|579759974|FG008|Overall Study|Participant Decision|10|||
160555387|NCT04426695|579759975|FG009|Overall Study|Participant Decision|15|||
160555388|NCT04426695|579759976|FG010|Overall Study|Participant Decision|16|||
160555389|NCT04426695|579759977|FG011|Overall Study|Participant Decision|17|||
160555390|NCT04426695|579759978|FG012|Overall Study|Participant Decision|2|||
160555391|NCT04426695|579759979|FG013|Overall Study|Participant Decision|1|||
160555392|NCT04426695|579759980|FG014|Overall Study|Participant Decision|2|||
160555393|NCT04426695|579759981|FG015|Overall Study|Participant Decision|0|||
160555394|NCT04426695|579759982|FG016|Overall Study|Participant Decision|0|||
160555395|NCT04426695|579759983|FG017|Overall Study|Participant Decision|0|||
160555396|NCT04426695|579759966|FG000|Overall Study|Adverse Event|0|||
160555397|NCT04426695|579759967|FG001|Overall Study|Adverse Event|0|||
160555398|NCT04426695|579759968|FG002|Overall Study|Adverse Event|0|||
160555399|NCT04426695|579759969|FG003|Overall Study|Adverse Event|0|||
160555400|NCT04426695|579759970|FG004|Overall Study|Adverse Event|0|||
160555401|NCT04426695|579759971|FG005|Overall Study|Adverse Event|0|||
160555402|NCT04426695|579759972|FG006|Overall Study|Adverse Event|0|||
160555403|NCT04426695|579759973|FG007|Overall Study|Adverse Event|1|||
160555404|NCT04426695|579759974|FG008|Overall Study|Adverse Event|0|||
160555405|NCT04426695|579759975|FG009|Overall Study|Adverse Event|0|||
160555406|NCT04426695|579759976|FG010|Overall Study|Adverse Event|1|||
160555407|NCT04426695|579759977|FG011|Overall Study|Adverse Event|1|||
160555408|NCT04426695|579759978|FG012|Overall Study|Adverse Event|0|||
160555409|NCT04426695|579759979|FG013|Overall Study|Adverse Event|0|||
160555410|NCT04426695|579759980|FG014|Overall Study|Adverse Event|0|||
160555411|NCT04426695|579759981|FG015|Overall Study|Adverse Event|0|||
160555412|NCT04426695|579759982|FG016|Overall Study|Adverse Event|0|||
160646740|NCT01060670|580089960|FG001|Run In|screen failure|238|||
160646741|NCT03705351|580089964|FG000|Overall Study|Study termination|3|||
160646742|NCT03705351|580089964|FG000|Overall Study|Death|1|||
160646743|NCT03705351|580089964|FG000|Overall Study|Lack of Efficacy|2|||
160646744|NCT03705351|580089964|FG000|Overall Study|Withdrawal by Subject|1|||
160646745|NCT00633152|580089971|FG000|Overall Study|Adverse Event|1|||
160646746|NCT00633152|580089972|FG001|Overall Study|Adverse Event|0|||
160646747|NCT00633152|580089971|FG000|Overall Study|Randomized, did not receive study drug|5|||
160646748|NCT00633152|580089972|FG001|Overall Study|Randomized, did not receive study drug|2|||
160646749|NCT00633152|580089971|FG000|Overall Study|Withdrawal by Subject|1|||
160646750|NCT00633152|580089972|FG001|Overall Study|Withdrawal by Subject|1|||
160646751|NCT00633152|580089971|FG000|Overall Study|Lost to Follow-up|4|||
160646752|NCT00633152|580089972|FG001|Overall Study|Lost to Follow-up|1|||
160646753|NCT00633152|580089971|FG000|Overall Study|Miscellaneous Other|3|||
160646754|NCT00633152|580089972|FG001|Overall Study|Miscellaneous Other|2|||
160646755|NCT02180061|580089973|FG000|Overall Study|Adverse Event|4|||
160646756|NCT02180061|580089974|FG001|Overall Study|Adverse Event|2|||
160646757|NCT02180061|580089973|FG000|Overall Study|Clinical Progression|5|||
160646758|NCT02180061|580089974|FG001|Overall Study|Clinical Progression|1|||
160646759|NCT02180061|580089973|FG000|Overall Study|Progressive Disease|15|||
160646760|NCT02180061|580089974|FG001|Overall Study|Progressive Disease|5|||
160646761|NCT02180061|580089973|FG000|Overall Study|Physician Decision|1|||
160646762|NCT02180061|580089974|FG001|Overall Study|Physician Decision|0|||
160646763|NCT00056160|580089977|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
160646764|NCT00056160|580089978|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
160646765|NCT00056160|580089977|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
160646766|NCT00056160|580089978|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
160646767|NCT00056160|580089977|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
160646768|NCT00056160|580089978|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
160646769|NCT00056160|580089977|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
160646770|NCT00056160|580089978|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
160646771|NCT00056160|580089977|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
160646772|NCT00056160|580089978|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
160646773|NCT00056160|580089977|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
160646774|NCT00056160|580089978|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
160646775|NCT00056160|580089977|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
160646776|NCT00056160|580089978|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
160646777|NCT00056160|580089977|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
160646778|NCT00056160|580089978|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
160646779|NCT00056160|580089977|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
160646780|NCT00056160|580089978|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
160646781|NCT00056160|580089977|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
160646782|NCT00056160|580089978|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
160646783|NCT00056160|580089977|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
160646784|NCT00056160|580089978|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
160646785|NCT00056160|580089977|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
160646786|NCT00056160|580089978|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
160646787|NCT00056160|580089977|FG000|Final Follow-up|Transferred into expanded access study.|3|||
160646788|NCT00056160|580089978|FG001|Final Follow-up|Transferred into expanded access study.|0|||
160827071|NCT02761694|580751939|FG010|Overall Study|Other|1|||
160555413|NCT04426695|579759983|FG017|Overall Study|Adverse Event|0|||
160555414|NCT04426695|579759966|FG000|Overall Study|Sponsor Request|0|||
160555415|NCT04426695|579759967|FG001|Overall Study|Sponsor Request|0|||
160555416|NCT04426695|579759968|FG002|Overall Study|Sponsor Request|0|||
160555417|NCT04426695|579759969|FG003|Overall Study|Sponsor Request|0|||
160555418|NCT04426695|579759970|FG004|Overall Study|Sponsor Request|0|||
160555419|NCT04426695|579759971|FG005|Overall Study|Sponsor Request|0|||
160555420|NCT04426695|579759972|FG006|Overall Study|Sponsor Request|1|||
160555421|NCT04426695|579759973|FG007|Overall Study|Sponsor Request|0|||
160555422|NCT04426695|579759974|FG008|Overall Study|Sponsor Request|0|||
160555423|NCT04426695|579759975|FG009|Overall Study|Sponsor Request|0|||
160555424|NCT04426695|579759976|FG010|Overall Study|Sponsor Request|0|||
160555425|NCT04426695|579759977|FG011|Overall Study|Sponsor Request|0|||
160555426|NCT04426695|579759978|FG012|Overall Study|Sponsor Request|0|||
160555427|NCT04426695|579759979|FG013|Overall Study|Sponsor Request|0|||
160555428|NCT04426695|579759980|FG014|Overall Study|Sponsor Request|0|||
160555429|NCT04426695|579759981|FG015|Overall Study|Sponsor Request|0|||
160555430|NCT04426695|579759982|FG016|Overall Study|Sponsor Request|0|||
160555431|NCT04426695|579759983|FG017|Overall Study|Sponsor Request|0|||
160555432|NCT04426695|579759966|FG000|Overall Study|Physician Decision|0|||
160555433|NCT04426695|579759967|FG001|Overall Study|Physician Decision|0|||
160555434|NCT04426695|579759968|FG002|Overall Study|Physician Decision|0|||
160555435|NCT04426695|579759969|FG003|Overall Study|Physician Decision|0|||
160555436|NCT04426695|579759970|FG004|Overall Study|Physician Decision|0|||
160555437|NCT04426695|579759971|FG005|Overall Study|Physician Decision|0|||
160555438|NCT04426695|579759972|FG006|Overall Study|Physician Decision|0|||
160555439|NCT04426695|579759973|FG007|Overall Study|Physician Decision|0|||
160555440|NCT04426695|579759974|FG008|Overall Study|Physician Decision|0|||
160555441|NCT04426695|579759975|FG009|Overall Study|Physician Decision|1|||
160555442|NCT04426695|579759976|FG010|Overall Study|Physician Decision|0|||
160555443|NCT04426695|579759977|FG011|Overall Study|Physician Decision|0|||
160555444|NCT04426695|579759978|FG012|Overall Study|Physician Decision|1|||
160555445|NCT04426695|579759979|FG013|Overall Study|Physician Decision|0|||
160555446|NCT04426695|579759980|FG014|Overall Study|Physician Decision|0|||
160555447|NCT04426695|579759981|FG015|Overall Study|Physician Decision|0|||
160555448|NCT04426695|579759982|FG016|Overall Study|Physician Decision|0|||
160555449|NCT04426695|579759983|FG017|Overall Study|Physician Decision|0|||
160555450|NCT04426695|579759966|FG000|Overall Study|Randomized but Never Treated|3|||
160555451|NCT04426695|579759967|FG001|Overall Study|Randomized but Never Treated|1|||
160555452|NCT04426695|579759968|FG002|Overall Study|Randomized but Never Treated|0|||
160555453|NCT04426695|579759969|FG003|Overall Study|Randomized but Never Treated|4|||
160555454|NCT04426695|579759970|FG004|Overall Study|Randomized but Never Treated|5|||
160555455|NCT04426695|579759971|FG005|Overall Study|Randomized but Never Treated|5|||
160555456|NCT04426695|579759972|FG006|Overall Study|Randomized but Never Treated|4|||
160555457|NCT04426695|579759973|FG007|Overall Study|Randomized but Never Treated|6|||
160555458|NCT04426695|579759974|FG008|Overall Study|Randomized but Never Treated|6|||
160555459|NCT04426695|579759975|FG009|Overall Study|Randomized but Never Treated|3|||
160555460|NCT04426695|579759976|FG010|Overall Study|Randomized but Never Treated|3|||
160555461|NCT04426695|579759977|FG011|Overall Study|Randomized but Never Treated|6|||
160555462|NCT04426695|579759978|FG012|Overall Study|Randomized but Never Treated|1|||
160555463|NCT04426695|579759979|FG013|Overall Study|Randomized but Never Treated|2|||
160555464|NCT04426695|579759980|FG014|Overall Study|Randomized but Never Treated|0|||
160555465|NCT04426695|579759981|FG015|Overall Study|Randomized but Never Treated|0|||
160555466|NCT04426695|579759982|FG016|Overall Study|Randomized but Never Treated|0|||
160555467|NCT04426695|579759983|FG017|Overall Study|Randomized but Never Treated|0|||
160555468|NCT00189462|579759998|FG000|Overall Study|Lack of Efficacy|5|||
160555469|NCT00189462|579759999|FG001|Overall Study|Lack of Efficacy|1|||
160555470|NCT00189462|579759998|FG000|Overall Study|Lost to Follow-up|18|||
160555471|NCT00189462|579759999|FG001|Overall Study|Lost to Follow-up|20|||
160555472|NCT00849667|579760000|FG000|Overall Study|Withdrawal by Subject|16|||
160555473|NCT00849667|579760001|FG001|Overall Study|Withdrawal by Subject|33|||
160555474|NCT00849667|579760002|FG002|Overall Study|Withdrawal by Subject|35|||
160555475|NCT00849667|579760000|FG000|Overall Study|Lost to Follow-up|8|||
160555476|NCT00849667|579760001|FG001|Overall Study|Lost to Follow-up|8|||
160555477|NCT00849667|579760002|FG002|Overall Study|Lost to Follow-up|8|||
160555478|NCT00849667|579760000|FG000|Overall Study|Adverse Event|1|||
160555479|NCT00849667|579760001|FG001|Overall Study|Adverse Event|2|||
160555480|NCT00849667|579760002|FG002|Overall Study|Adverse Event|0|||
160555481|NCT00849667|579760000|FG000|Overall Study|Other|18|||
160555482|NCT00849667|579760001|FG001|Overall Study|Other|19|||
160827072|NCT02761694|580751940|FG011|Overall Study|Other|0|||
160555483|NCT00849667|579760002|FG002|Overall Study|Other|18|||
160827073|NCT02395055|580751946|FG000|Overall Study|Withdrawal by Subject|7|||
160555484|NCT00849667|579760000|FG000|Overall Study|Progressive disease|119|||
160555485|NCT00849667|579760001|FG001|Overall Study|Progressive disease|100|||
160555486|NCT00849667|579760002|FG002|Overall Study|Progressive disease|112|||
160827074|NCT02395055|580751947|FG001|Overall Study|Withdrawal by Subject|3|||
160827075|NCT01896271|580751948|FG000|Overall Study|Physician Decision|10|||
160827076|NCT01294462|580751949|FG000|Overall Study|Lost to Follow-up|1|||
160827077|NCT01294462|580751950|FG001|Overall Study|Lost to Follow-up|0|||
160827078|NCT01294462|580751949|FG000|Overall Study|Withdrawal by Subject|65|||
160827079|NCT01294462|580751950|FG001|Overall Study|Withdrawal by Subject|63|||
160555487|NCT00849667|579760000|FG000|Overall Study|Sponsor decision|208|||
160555488|NCT00849667|579760001|FG001|Overall Study|Sponsor decision|204|||
160555489|NCT00849667|579760002|FG002|Overall Study|Sponsor decision|190|||
160555490|NCT00849667|579760000|FG000|Overall Study|Investigator discretion|0|||
160555491|NCT00849667|579760001|FG001|Overall Study|Investigator discretion|0|||
160555492|NCT00849667|579760002|FG002|Overall Study|Investigator discretion|1|||
160555493|NCT00553462|579760003|FG000|Overall Study|Adverse Event|4|||
160555494|NCT00553462|579760003|FG000|Overall Study|Progression|4|||
160555495|NCT00553462|579760003|FG000|Overall Study|Withdrawal by Subject|5|||
160555496|NCT00553462|579760003|FG000|Overall Study|Physician Decision|1|||
160555497|NCT01262625|579760006|FG000|Overall Study|Administrative Error|1|||
160555498|NCT01262625|579760007|FG001|Overall Study|Administrative Error|1|||
160555499|NCT01262625|579760006|FG000|Overall Study|Site Closed|1|||
160555500|NCT01262625|579760007|FG001|Overall Study|Site Closed|0|||
160555501|NCT01728779|579760009|FG000|Overall Study|Withdrawal by Subject|1|||
160555502|NCT01925209|579760010|FG000|Treatment Epoch|Physician Decision|1|||
160555503|NCT01925209|579760011|FG001|Treatment Epoch|Physician Decision|0|||
160555504|NCT01925209|579760012|FG002|Treatment Epoch|Physician Decision|0|||
160555505|NCT01925209|579760013|FG003|Treatment Epoch|Physician Decision|0|||
160555506|NCT01925209|579760010|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
160555507|NCT01925209|579760011|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
160555508|NCT01925209|579760012|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
160990087|NCT01579578|581351742|FG001|Overall Study|Withdrawal by Subject|1|||
160990088|NCT01579578|581351741|FG000|Overall Study|Eligibility criteria|3|||
160990089|NCT01579578|581351742|FG001|Overall Study|Eligibility criteria|9|||
160990090|NCT01579578|581351741|FG000|Overall Study|Ongoing|3|||
160990091|NCT01579578|581351742|FG001|Overall Study|Ongoing|0|||
160990092|NCT01004263|581351747|FG000|Overall Study|Adverse Event|15|||
160990093|NCT01004263|581351747|FG000|Overall Study|Withdrawal by Subject|58|||
160990094|NCT01004263|581351747|FG000|Overall Study|Protocol Violation|10|||
160990095|NCT01004263|581351747|FG000|Overall Study|Lost to Follow-up|64|||
160990096|NCT01004263|581351747|FG000|Overall Study|Lack of Efficacy|13|||
160990097|NCT01004263|581351747|FG000|Overall Study|Pregnancy|2|||
160990098|NCT01004263|581351747|FG000|Overall Study|Physician Decision|15|||
160990099|NCT01004263|581351747|FG000|Overall Study|Lack of Qualifying Event|2|||
160990100|NCT01237678|581351749|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
160990101|NCT01237678|581351750|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
160990102|NCT01237678|581351751|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
160990103|NCT01237678|581351749|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
160990104|NCT01237678|581351750|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
160990105|NCT01237678|581351751|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
160990106|NCT01237678|581351749|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
160990107|NCT01237678|581351750|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
160990108|NCT01237678|581351751|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
160990109|NCT01237678|581351749|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
160990110|NCT01237678|581351750|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
160555509|NCT01925209|579760013|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
160555510|NCT01925209|579760010|FG000|Treatment Epoch|Death|1|||
160555511|NCT01925209|579760011|FG001|Treatment Epoch|Death|0|||
160555512|NCT01925209|579760012|FG002|Treatment Epoch|Death|0|||
160555513|NCT01925209|579760013|FG003|Treatment Epoch|Death|0|||
160555514|NCT01925209|579760010|FG000|Treatment Epoch|Protocol deviation|0|||
160555515|NCT01925209|579760011|FG001|Treatment Epoch|Protocol deviation|0|||
160555516|NCT01925209|579760012|FG002|Treatment Epoch|Protocol deviation|1|||
160555517|NCT01925209|579760013|FG003|Treatment Epoch|Protocol deviation|1|||
160555518|NCT01925209|579760010|FG000|Treatment Epoch|Withdrawal by Subject|4|||
160555519|NCT01925209|579760011|FG001|Treatment Epoch|Withdrawal by Subject|3|||
160555520|NCT01925209|579760012|FG002|Treatment Epoch|Withdrawal by Subject|3|||
160990111|NCT01237678|581351751|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
160555521|NCT01925209|579760013|FG003|Treatment Epoch|Withdrawal by Subject|2|||
160555522|NCT01925209|579760010|FG000|Treatment Epoch|Adverse Event|3|||
160555523|NCT01925209|579760011|FG001|Treatment Epoch|Adverse Event|5|||
160555524|NCT01925209|579760012|FG002|Treatment Epoch|Adverse Event|3|||
160555525|NCT01925209|579760013|FG003|Treatment Epoch|Adverse Event|1|||
160990112|NCT01237678|581351749|FG000|Phase II|Adverse Event|0|||
160990113|NCT01237678|581351750|FG001|Phase II|Adverse Event|39|||
160990114|NCT01237678|581351751|FG002|Phase II|Adverse Event|9|||
160990115|NCT01237678|581351749|FG000|Phase II|Death|0|||
160555526|NCT01925209|579760010|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
160555527|NCT01925209|579760011|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
160555528|NCT01925209|579760012|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
160555529|NCT01925209|579760013|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
160555530|NCT01925209|579760010|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
160555531|NCT01925209|579760011|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
160555532|NCT01925209|579760012|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
160555533|NCT01925209|579760013|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
160555534|NCT01925209|579760010|FG000|Follow-up|Adverse Event|1|||
160555535|NCT01925209|579760011|FG001|Follow-up|Adverse Event|4|||
160555536|NCT01925209|579760012|FG002|Follow-up|Adverse Event|0|||
160555537|NCT01925209|579760013|FG003|Follow-up|Adverse Event|1|||
160555538|NCT01925209|579760010|FG000|Follow-up|Physician Decision|0|||
160555539|NCT01925209|579760011|FG001|Follow-up|Physician Decision|0|||
160555540|NCT01925209|579760012|FG002|Follow-up|Physician Decision|1|||
160555541|NCT01925209|579760013|FG003|Follow-up|Physician Decision|0|||
160555542|NCT01925209|579760010|FG000|Follow-up|Non-compliance with study treatment|0|||
160555543|NCT01925209|579760011|FG001|Follow-up|Non-compliance with study treatment|0|||
160555544|NCT01925209|579760012|FG002|Follow-up|Non-compliance with study treatment|0|||
160555545|NCT01925209|579760013|FG003|Follow-up|Non-compliance with study treatment|1|||
160555546|NCT01925209|579760010|FG000|Follow-up|Withdrawal by Subject|0|||
160555547|NCT01925209|579760011|FG001|Follow-up|Withdrawal by Subject|2|||
160555548|NCT01925209|579760012|FG002|Follow-up|Withdrawal by Subject|0|||
160555549|NCT01925209|579760013|FG003|Follow-up|Withdrawal by Subject|2|||
160555550|NCT00448708|579760014|FG000|Overall Study|Death|21|||
160555551|NCT00448708|579760015|FG001|Overall Study|Death|17|||
160555552|NCT00448708|579760014|FG000|Overall Study|Withdrawal by Subject|8|||
160555553|NCT00448708|579760015|FG001|Overall Study|Withdrawal by Subject|4|||
160555554|NCT00448708|579760014|FG000|Overall Study|Lost to Follow-up|6|||
160555555|NCT00448708|579760015|FG001|Overall Study|Lost to Follow-up|8|||
160555556|NCT00448708|579760014|FG000|Overall Study|not listed|0|||
160555557|NCT00448708|579760015|FG001|Overall Study|not listed|2|||
160555558|NCT00110994|579760016|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
160555559|NCT00110994|579760017|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
160555560|NCT00110994|579760016|FG000|Double-blind (DB) Treatment|Death|1|||
160555561|NCT00110994|579760017|FG001|Double-blind (DB) Treatment|Death|0|||
160555562|NCT00110994|579760016|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
160555563|NCT00110994|579760017|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
160555564|NCT00110994|579760016|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
160555565|NCT00110994|579760017|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
160827080|NCT02743780|580751951|FG000|Part 3 (7 Days)|Adverse Event|0|||
160555566|NCT00110994|579760016|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
160555567|NCT00110994|579760017|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
160555568|NCT00110994|579760016|FG000|Double-blind (DB) Treatment|other reasons|2|||
160555569|NCT00110994|579760017|FG001|Double-blind (DB) Treatment|other reasons|3|||
160555570|NCT00110994|579760016|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
160827081|NCT02743780|580751952|FG001|Part 3 (7 Days)|Adverse Event|0|||
160827082|NCT02743780|580751953|FG002|Part 3 (7 Days)|Adverse Event|1|||
160827083|NCT02743780|580751954|FG003|Part 3 (7 Days)|Adverse Event|0|||
160827084|NCT02743780|580751955|FG004|Part 3 (7 Days)|Adverse Event|0|||
160827085|NCT01460407|580751961|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
160827086|NCT01460407|580751962|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
160827087|NCT00526110|580751963|FG000|Overall Study|Adverse Event|2|||
160827088|NCT00526110|580751964|FG001|Overall Study|Adverse Event|9|||
160827089|NCT00526110|580751963|FG000|Overall Study|Disease Progression|0|||
160827090|NCT00526110|580751964|FG001|Overall Study|Disease Progression|19|||
160827091|NCT00526110|580751963|FG000|Overall Study|Maximal Response|0|||
160827092|NCT00526110|580751964|FG001|Overall Study|Maximal Response|6|||
160827093|NCT00526110|580751963|FG000|Overall Study|Withdrawal by Subject|0|||
160827094|NCT00526110|580751964|FG001|Overall Study|Withdrawal by Subject|2|||
160827095|NCT00526110|580751963|FG000|Overall Study|Poor Tolerance|0|||
160827096|NCT00526110|580751964|FG001|Overall Study|Poor Tolerance|5|||
160827097|NCT01400243|580751965|FG000|Overall Study|Protocol Violation|8|||
160827098|NCT01400243|580751966|FG001|Overall Study|Protocol Violation|11|||
160827099|NCT00953680|580751967|FG000|Period 1|Withdrawal by Subject|0|||
160827100|NCT00953680|580751968|FG001|Period 1|Withdrawal by Subject|1|||
160827101|NCT03762616|580751970|FG000|Overall Study|Protocol Violation|2|||
160827102|NCT03959982|580753704|FG000|Overall Study|Withdrawal by Subject|1|||
160827103|NCT03959982|580753705|FG001|Overall Study|Withdrawal by Subject|0|||
160827104|NCT03959982|580753704|FG000|Overall Study|Physician Decision|2|||
160827105|NCT03959982|580753705|FG001|Overall Study|Physician Decision|0|||
160555571|NCT00110994|579760017|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
160555572|NCT00110994|579760016|FG000|Active Follow-up|Other reasons|0|||
160827106|NCT03959982|580753704|FG000|Overall Study|Lost to Follow-up|1|||
160827107|NCT03959982|580753705|FG001|Overall Study|Lost to Follow-up|0|||
160827108|NCT00758589|580753706|FG000|Overall Study|Adverse Event|3|||
160827109|NCT00758589|580753707|FG001|Overall Study|Adverse Event|2|||
160827110|NCT00758589|580753708|FG002|Overall Study|Adverse Event|5|||
160827111|NCT00758589|580753709|FG003|Overall Study|Adverse Event|4|||
160827112|NCT00758589|580753706|FG000|Overall Study|Withdrawal by Subject|0|||
160990116|NCT01237678|581351750|FG001|Phase II|Death|0|||
160990117|NCT01237678|581351751|FG002|Phase II|Death|2|||
160990118|NCT01237678|581351749|FG000|Phase II|Lack of Efficacy|0|||
160990119|NCT01237678|581351750|FG001|Phase II|Lack of Efficacy|25|||
160990120|NCT01237678|581351751|FG002|Phase II|Lack of Efficacy|3|||
160990121|NCT01237678|581351749|FG000|Phase II|Withdrawal by Subject|0|||
160990122|NCT01237678|581351750|FG001|Phase II|Withdrawal by Subject|1|||
160990123|NCT01237678|581351751|FG002|Phase II|Withdrawal by Subject|5|||
160990124|NCT01237678|581351749|FG000|Phase II|Completed Cycles 4-6|0|||
160990125|NCT01237678|581351750|FG001|Phase II|Completed Cycles 4-6|11|||
160990126|NCT01237678|581351751|FG002|Phase II|Completed Cycles 4-6|21|||
160990127|NCT01237678|581351749|FG000|Phase II|Sponsor Decision/Study Closed|0|||
160990128|NCT01237678|581351750|FG001|Phase II|Sponsor Decision/Study Closed|18|||
160990129|NCT01237678|581351751|FG002|Phase II|Sponsor Decision/Study Closed|7|||
160990130|NCT01237678|581351749|FG000|Phase II|Randomized but were not treated|0|||
160990131|NCT01237678|581351750|FG001|Phase II|Randomized but were not treated|4|||
160990132|NCT01237678|581351751|FG002|Phase II|Randomized but were not treated|3|||
160990133|NCT01982760|581351756|FG000|Overall Study|Physician Decision|1|||
160990134|NCT01982760|581351757|FG001|Overall Study|Physician Decision|0|||
160990135|NCT00821236|581351758|FG000|Overall Study|Lost to Follow-up|3|||
160990136|NCT00530777|581351759|FG000|Overall Study|Lost to Follow-up|0|||
160990137|NCT00530777|581351760|FG001|Overall Study|Lost to Follow-up|1|||
160990138|NCT00530777|581351759|FG000|Overall Study|Death|1|||
160990139|NCT00530777|581351760|FG001|Overall Study|Death|2|||
160990140|NCT00530777|581351759|FG000|Overall Study|Physician Decision|1|||
160990141|NCT00530777|581351760|FG001|Overall Study|Physician Decision|0|||
160990142|NCT00530777|581351759|FG000|Overall Study|Withdrawal by Subject|0|||
160990143|NCT00530777|581351760|FG001|Overall Study|Withdrawal by Subject|1|||
160990144|NCT00530777|581351759|FG000|Overall Study|Unable to adhere to visit schedule|5|||
160990145|NCT00530777|581351760|FG001|Overall Study|Unable to adhere to visit schedule|1|||
160990146|NCT01582243|581351762|FG000|Overall Study|Withdrawal by Subject|1|||
160990147|NCT01582243|581351762|FG000|Overall Study|Adverse Event|1|||
160990148|NCT01582243|581351762|FG000|Overall Study|Lost to Follow-up|1|||
160990149|NCT02954055|581351764|FG000|Overall Study|Did not initiate therapy|6|||
160990150|NCT02954055|581351765|FG001|Overall Study|Did not initiate therapy|1|||
160990151|NCT02096003|581351766|FG000|Overall Study|Protocol Violation|0|||
160990152|NCT02096003|581351767|FG001|Overall Study|Protocol Violation|2|||
160990153|NCT02096003|581351766|FG000|Overall Study|additional surgery|2|||
160990154|NCT02096003|581351767|FG001|Overall Study|additional surgery|1|||
160990155|NCT01763047|581351768|FG000|Period 1|Test Article Not Available|4|||
160990156|NCT01763047|581351769|FG001|Period 1|Test Article Not Available|1|||
160990157|NCT01763047|581351768|FG000|Period 1|Protocol Violation|4|||
160990158|NCT01763047|581351769|FG001|Period 1|Protocol Violation|4|||
160990159|NCT01763047|581351768|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
160990160|NCT01763047|581351769|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
160990161|NCT01763047|581351768|FG000|Period 1|Adverse Event|0|||
160990162|NCT01763047|581351769|FG001|Period 1|Adverse Event|1|||
160990163|NCT01763047|581351768|FG000|Period 1|Unsatisfactory Visual Response|0|||
160990164|NCT01763047|581351769|FG001|Period 1|Unsatisfactory Visual Response|3|||
160827113|NCT00758589|580753707|FG001|Overall Study|Withdrawal by Subject|1|||
160827114|NCT00758589|580753708|FG002|Overall Study|Withdrawal by Subject|1|||
160827115|NCT00758589|580753709|FG003|Overall Study|Withdrawal by Subject|1|||
160827116|NCT00758589|580753706|FG000|Overall Study|Palm stopped to work|0|||
160827117|NCT00758589|580753707|FG001|Overall Study|Palm stopped to work|0|||
160827118|NCT00758589|580753708|FG002|Overall Study|Palm stopped to work|0|||
160827119|NCT00758589|580753709|FG003|Overall Study|Palm stopped to work|1|||
160827120|NCT04524455|580753721|FG000|Overall Study|Death|3|||
160827121|NCT04524455|580753722|FG001|Overall Study|Death|3|||
160827122|NCT04524455|580753721|FG000|Overall Study|Decision by Sponsor|0|||
160827123|NCT04524455|580753722|FG001|Overall Study|Decision by Sponsor|2|||
160990165|NCT01763047|581351768|FG000|Period 1|Lens Power Not Available|0|||
160990166|NCT01763047|581351769|FG001|Period 1|Lens Power Not Available|1|||
160990167|NCT01763047|581351768|FG000|Period 1|Study Site office Closed|0|||
160990168|NCT01763047|581351769|FG001|Period 1|Study Site office Closed|1|||
160990169|NCT01763047|581351768|FG000|Period 2|Lens Discomfort|1|||
160990170|NCT01763047|581351769|FG001|Period 2|Lens Discomfort|0|||
160990171|NCT01763047|581351768|FG000|Period 2|No longer meets Eligibility Criteria|1|||
160990172|NCT01763047|581351769|FG001|Period 2|No longer meets Eligibility Criteria|0|||
160990173|NCT01763047|581351768|FG000|Period 2|Study Site office Closed|1|||
160990174|NCT01763047|581351769|FG001|Period 2|Study Site office Closed|1|||
160990175|NCT01763047|581351768|FG000|Period 2|Unsatisfactory Visual Response|1|||
160990176|NCT01763047|581351769|FG001|Period 2|Unsatisfactory Visual Response|1|||
160827124|NCT04524455|580753721|FG000|Overall Study|Withdrawal of Consent From Study|1|||
160827125|NCT04524455|580753722|FG001|Overall Study|Withdrawal of Consent From Study|0|||
160990177|NCT01763047|581351768|FG000|Period 2|Protocol Violation|0|||
160990178|NCT01763047|581351769|FG001|Period 2|Protocol Violation|2|||
160990179|NCT01763047|581351768|FG000|Period 2|Unsatisfactory lens Fitting|0|||
160990180|NCT01763047|581351769|FG001|Period 2|Unsatisfactory lens Fitting|1|||
160990181|NCT01008748|581351772|FG000|Overall Study|Lost to Follow-up|80|||
160990182|NCT01008748|581351772|FG000|Overall Study|Other|1|||
160990183|NCT01767909|581351773|FG000|Overall Study|Withdrawal by Subject|4|||
160990184|NCT01767909|581351774|FG001|Overall Study|Withdrawal by Subject|7|||
160990185|NCT01767909|581351773|FG000|Overall Study|Adverse Event|3|||
160990186|NCT01767909|581351774|FG001|Overall Study|Adverse Event|1|||
160990187|NCT01767909|581351773|FG000|Overall Study|Withdrawal by Study Partner|3|||
160990188|NCT01767909|581351774|FG001|Overall Study|Withdrawal by Study Partner|1|||
160990189|NCT01767909|581351773|FG000|Overall Study|Non-Compliance|2|||
160990190|NCT01767909|581351774|FG001|Overall Study|Non-Compliance|0|||
160990191|NCT01767909|581351773|FG000|Overall Study|Perceived Lack of Efficacy|1|||
160990192|NCT01767909|581351774|FG001|Overall Study|Perceived Lack of Efficacy|0|||
160990193|NCT01767909|581351773|FG000|Overall Study|Investigator Recommendation|0|||
160990194|NCT01767909|581351774|FG001|Overall Study|Investigator Recommendation|1|||
160990195|NCT01767909|581351773|FG000|Overall Study|Lost to Follow-up|0|||
160990196|NCT01767909|581351774|FG001|Overall Study|Lost to Follow-up|1|||
160990197|NCT01767909|581351773|FG000|Overall Study|LP uncessessful|0|||
160990198|NCT01767909|581351774|FG001|Overall Study|LP uncessessful|1|||
160990199|NCT02696785|581351776|FG000|Blinded Treatment Period|Adverse Event|0|||
160990200|NCT02696785|581351777|FG001|Blinded Treatment Period|Adverse Event|1|||
160990201|NCT02696785|581351778|FG002|Blinded Treatment Period|Adverse Event|3|||
160990202|NCT02696785|581351779|FG003|Blinded Treatment Period|Adverse Event|0|||
160827126|NCT04524455|580753721|FG000|Overall Study|Lost to Follow-up|0|||
160990203|NCT02696785|581351776|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
160990204|NCT02696785|581351777|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
160990205|NCT02696785|581351778|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
160990206|NCT02696785|581351779|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
160827127|NCT04524455|580753722|FG001|Overall Study|Lost to Follow-up|1|||
160555573|NCT00110994|579760017|FG001|Active Follow-up|Other reasons|2|||
160555574|NCT00110994|579760016|FG000|Long Term Follow-up|Death|19|||
160555575|NCT00110994|579760017|FG001|Long Term Follow-up|Death|17|||
160555576|NCT04398732|579760018|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
160555577|NCT01299727|579760020|FG000|Overall Study|Withdrawal by Subject|1|||
160555578|NCT01299727|579760021|FG001|Overall Study|Withdrawal by Subject|0|||
160555579|NCT01299727|579760022|FG002|Overall Study|Withdrawal by Subject|0|||
160555580|NCT01299727|579760020|FG000|Overall Study|Adverse Event|0|||
160555581|NCT01299727|579760021|FG001|Overall Study|Adverse Event|0|||
160990207|NCT02696785|581351776|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
160990208|NCT02696785|581351777|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
160990209|NCT02696785|581351778|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
160990210|NCT02696785|581351779|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
160990211|NCT02696785|581351776|FG000|Blinded Treatment Period|Screen Failure|1|||
160990212|NCT02696785|581351777|FG001|Blinded Treatment Period|Screen Failure|0|||
160990213|NCT02696785|581351778|FG002|Blinded Treatment Period|Screen Failure|0|||
160990214|NCT02696785|581351779|FG003|Blinded Treatment Period|Screen Failure|0|||
160990215|NCT02696785|581351776|FG000|Washout Period|Withdrawal by Subject|0|||
160990216|NCT02696785|581351777|FG001|Washout Period|Withdrawal by Subject|1|||
160990217|NCT02696785|581351778|FG002|Washout Period|Withdrawal by Subject|0|||
160990218|NCT02696785|581351779|FG003|Washout Period|Withdrawal by Subject|0|||
160990219|NCT02696785|581351776|FG000|Washout Period|Lack of Efficacy|0|||
160990220|NCT02696785|581351777|FG001|Washout Period|Lack of Efficacy|1|||
160990221|NCT02696785|581351778|FG002|Washout Period|Lack of Efficacy|0|||
160990222|NCT02696785|581351779|FG003|Washout Period|Lack of Efficacy|0|||
160555582|NCT01299727|579760022|FG002|Overall Study|Adverse Event|1|||
160827128|NCT00046930|580753724|FG000|Overall Study|Ineligible|12|||
160555583|NCT01299727|579760020|FG000|Overall Study|Completed the Treatment Period|3|||
160555584|NCT01299727|579760021|FG001|Overall Study|Completed the Treatment Period|4|||
160555585|NCT01299727|579760022|FG002|Overall Study|Completed the Treatment Period|3|||
160555586|NCT03882424|579760023|FG000|Overall Study|Lost to Follow-up|3|||
160555587|NCT03882424|579760024|FG001|Overall Study|Lost to Follow-up|0|||
160555588|NCT03882424|579760025|FG002|Overall Study|Lost to Follow-up|0|||
160555589|NCT03882424|579760023|FG000|Overall Study|schedule conflict|1|||
160555590|NCT03882424|579760024|FG001|Overall Study|schedule conflict|0|||
160990223|NCT02696785|581351776|FG000|Extended Treatment Period|Adverse Event|2|||
160990224|NCT02696785|581351777|FG001|Extended Treatment Period|Adverse Event|3|||
160990225|NCT02696785|581351778|FG002|Extended Treatment Period|Adverse Event|2|||
160990226|NCT02696785|581351779|FG003|Extended Treatment Period|Adverse Event|1|||
160990227|NCT02696785|581351776|FG000|Extended Treatment Period|Lack of Efficacy|0|||
160990228|NCT02696785|581351777|FG001|Extended Treatment Period|Lack of Efficacy|1|||
160990229|NCT02696785|581351778|FG002|Extended Treatment Period|Lack of Efficacy|0|||
160990230|NCT02696785|581351779|FG003|Extended Treatment Period|Lack of Efficacy|0|||
160555591|NCT03882424|579760025|FG002|Overall Study|schedule conflict|0|||
160555592|NCT02772757|579760031|FG000|Overall Study|Withdrawal by Subject|1|||
160555593|NCT02772757|579760032|FG001|Overall Study|Withdrawal by Subject|0|||
160555594|NCT02772757|579760033|FG002|Overall Study|Withdrawal by Subject|1|||
160555595|NCT02772757|579760031|FG000|Overall Study|Protocol Violation|0|||
160555596|NCT02772757|579760032|FG001|Overall Study|Protocol Violation|0|||
160555597|NCT02772757|579760033|FG002|Overall Study|Protocol Violation|1|||
160555598|NCT02772757|579760031|FG000|Overall Study|Physician Decision|0|||
160555599|NCT02772757|579760032|FG001|Overall Study|Physician Decision|3|||
160555600|NCT02772757|579760033|FG002|Overall Study|Physician Decision|3|||
160555601|NCT01500057|579760041|FG000|Overall Study|Lost to Follow-up|6|||
160555602|NCT01500057|579760042|FG001|Overall Study|Lost to Follow-up|4|||
160555603|NCT00888355|579760045|FG000|Overall Study|Adverse Event|10|||
160555604|NCT00888355|579760046|FG001|Overall Study|Adverse Event|0|||
160555605|NCT00888355|579760047|FG002|Overall Study|Adverse Event|3|||
160555606|NCT00888355|579760048|FG003|Overall Study|Adverse Event|3|||
160555607|NCT00888355|579760045|FG000|Overall Study|Lack of Efficacy|9|||
160555608|NCT00888355|579760046|FG001|Overall Study|Lack of Efficacy|2|||
160555609|NCT00888355|579760047|FG002|Overall Study|Lack of Efficacy|5|||
160555610|NCT00888355|579760048|FG003|Overall Study|Lack of Efficacy|2|||
160555611|NCT00888355|579760045|FG000|Overall Study|Lost to Follow-up|0|||
160555612|NCT00888355|579760046|FG001|Overall Study|Lost to Follow-up|2|||
160555613|NCT00888355|579760047|FG002|Overall Study|Lost to Follow-up|2|||
160555614|NCT00888355|579760048|FG003|Overall Study|Lost to Follow-up|0|||
160555615|NCT00888355|579760045|FG000|Overall Study|Protocol Violation|3|||
160555616|NCT00888355|579760046|FG001|Overall Study|Protocol Violation|2|||
160555617|NCT00888355|579760047|FG002|Overall Study|Protocol Violation|1|||
160827129|NCT00046930|580753725|FG001|Overall Study|Ineligible|4|||
160827130|NCT02317809|580753739|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
160827131|NCT02317809|580753740|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
160990231|NCT02696785|581351776|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
160990232|NCT02696785|581351777|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
160990233|NCT02696785|581351778|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
160990234|NCT02696785|581351779|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
160990235|NCT02696785|581351776|FG000|Follow-up Period|Adverse Event|0|||
160990236|NCT02696785|581351777|FG001|Follow-up Period|Adverse Event|0|||
160990237|NCT02696785|581351778|FG002|Follow-up Period|Adverse Event|8|||
160990238|NCT02696785|581351779|FG003|Follow-up Period|Adverse Event|2|||
160990239|NCT02696785|581351776|FG000|Follow-up Period|Lost to Follow-up|0|||
160990240|NCT02696785|581351777|FG001|Follow-up Period|Lost to Follow-up|0|||
160990241|NCT02696785|581351778|FG002|Follow-up Period|Lost to Follow-up|0|||
160990242|NCT02696785|581351779|FG003|Follow-up Period|Lost to Follow-up|1|||
160990243|NCT02696785|581351776|FG000|Follow-up Period|Lack of Efficacy|0|||
160990244|NCT02696785|581351777|FG001|Follow-up Period|Lack of Efficacy|0|||
160990245|NCT02696785|581351778|FG002|Follow-up Period|Lack of Efficacy|0|||
160990246|NCT02696785|581351779|FG003|Follow-up Period|Lack of Efficacy|1|||
160990247|NCT02696785|581351776|FG000|Follow-up Period|Withdrawal by Subject|1|||
160990248|NCT02696785|581351777|FG001|Follow-up Period|Withdrawal by Subject|0|||
160990249|NCT02696785|581351778|FG002|Follow-up Period|Withdrawal by Subject|5|||
160990250|NCT02696785|581351779|FG003|Follow-up Period|Withdrawal by Subject|4|||
160990251|NCT04863898|581351781|FG000|Overall Study|Away from study clinic during intervention training period|2|||
160990252|NCT04863898|581351781|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
160555618|NCT00888355|579760048|FG003|Overall Study|Protocol Violation|2|||
160555619|NCT00888355|579760045|FG000|Overall Study|Withdrawal by Subject|0|||
160555620|NCT00888355|579760046|FG001|Overall Study|Withdrawal by Subject|3|||
160555621|NCT00888355|579760047|FG002|Overall Study|Withdrawal by Subject|1|||
160555622|NCT00888355|579760048|FG003|Overall Study|Withdrawal by Subject|3|||
160555623|NCT03213366|579760052|FG000|Overall Study|Lost to Follow-up|9|||
160555624|NCT03213366|579760053|FG001|Overall Study|Lost to Follow-up|4|||
160990253|NCT04863898|581351781|FG000|Overall Study|Lost to Follow-up|3|||
160990254|NCT04863898|581351781|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
160990255|NCT04863898|581351781|FG000|Overall Study|No longer employed at clinic|3|||
160990256|NCT02431533|581351782|FG000|Overall Study|Withdrawal by Subject|1|||
160990257|NCT02431533|581351783|FG001|Overall Study|Withdrawal by Subject|3|||
160990258|NCT02431533|581351782|FG000|Overall Study|Developed Exclusionary criteria|1|||
160990259|NCT02431533|581351783|FG001|Overall Study|Developed Exclusionary criteria|0|||
160990260|NCT02320253|581351784|FG000|Overall Study|Withdrawal by Subject|3|||
160990261|NCT02320253|581351785|FG001|Overall Study|Withdrawal by Subject|0|||
160990262|NCT02320253|581351786|FG002|Overall Study|Withdrawal by Subject|0|||
160990263|NCT02320253|581351784|FG000|Overall Study|Lost to Follow-up|2|||
160990264|NCT02320253|581351785|FG001|Overall Study|Lost to Follow-up|2|||
160990265|NCT02320253|581351786|FG002|Overall Study|Lost to Follow-up|1|||
160990266|NCT02320253|581351784|FG000|Overall Study|Death|1|||
160990267|NCT02320253|581351785|FG001|Overall Study|Death|0|||
160990268|NCT02320253|581351786|FG002|Overall Study|Death|1|||
160990269|NCT03251378|581351787|FG000|Overall Study|Death|3|||
160990270|NCT03251378|581351788|FG001|Overall Study|Death|2|||
160990271|NCT03251378|581351789|FG002|Overall Study|Death|3|||
160990272|NCT03251378|581351790|FG003|Overall Study|Death|30|||
160990273|NCT03251378|581351791|FG004|Overall Study|Death|24|||
160990274|NCT03251378|581351792|FG005|Overall Study|Death|12|||
160990275|NCT03251378|581351793|FG006|Overall Study|Death|12|||
160990276|NCT03251378|581351787|FG000|Overall Study|Lost to Follow-up|0|||
160990277|NCT03251378|581351788|FG001|Overall Study|Lost to Follow-up|0|||
160990278|NCT03251378|581351789|FG002|Overall Study|Lost to Follow-up|1|||
160990279|NCT03251378|581351790|FG003|Overall Study|Lost to Follow-up|3|||
160990280|NCT03251378|581351791|FG004|Overall Study|Lost to Follow-up|0|||
160990281|NCT03251378|581351792|FG005|Overall Study|Lost to Follow-up|0|||
160990282|NCT03251378|581351793|FG006|Overall Study|Lost to Follow-up|0|||
160990283|NCT03251378|581351787|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
160990284|NCT03251378|581351788|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
160990285|NCT03251378|581351789|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
160990286|NCT03251378|581351790|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
160990287|NCT03251378|581351791|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
160990288|NCT03251378|581351792|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
160990289|NCT03251378|581351793|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
160990290|NCT03251378|581351787|FG000|Overall Study|Progressive disease|2|||
160990291|NCT03251378|581351788|FG001|Overall Study|Progressive disease|0|||
160990292|NCT03251378|581351789|FG002|Overall Study|Progressive disease|0|||
160990293|NCT03251378|581351790|FG003|Overall Study|Progressive disease|1|||
160990294|NCT03251378|581351791|FG004|Overall Study|Progressive disease|0|||
160990295|NCT03251378|581351792|FG005|Overall Study|Progressive disease|0|||
160990296|NCT03251378|581351793|FG006|Overall Study|Progressive disease|0|||
160990297|NCT03251378|581351787|FG000|Overall Study|Physician Decision|0|||
160990298|NCT03251378|581351788|FG001|Overall Study|Physician Decision|2|||
160990299|NCT03251378|581351789|FG002|Overall Study|Physician Decision|0|||
160990300|NCT03251378|581351790|FG003|Overall Study|Physician Decision|0|||
160990301|NCT03251378|581351791|FG004|Overall Study|Physician Decision|0|||
160990302|NCT03251378|581351792|FG005|Overall Study|Physician Decision|0|||
160990303|NCT03251378|581351793|FG006|Overall Study|Physician Decision|0|||
160990304|NCT03251378|581351787|FG000|Overall Study|Other|2|||
160990305|NCT03251378|581351788|FG001|Overall Study|Other|3|||
160990306|NCT03251378|581351789|FG002|Overall Study|Other|2|||
160555625|NCT02532855|579760054|FG000|Overall Study|Lost to Follow-up|4|||
160555626|NCT02532855|579760055|FG001|Overall Study|Lost to Follow-up|3|||
160555627|NCT02532855|579760054|FG000|Overall Study|Withdrawal by Subject|4|||
160555628|NCT02532855|579760055|FG001|Overall Study|Withdrawal by Subject|8|||
160990307|NCT03251378|581351790|FG003|Overall Study|Other|0|||
160555629|NCT02058147|579760056|FG000|Overall Study|Randomized but not treated|0|||
160555630|NCT02058147|579760057|FG001|Overall Study|Randomized but not treated|0|||
160555631|NCT02058147|579760058|FG002|Overall Study|Randomized but not treated|1|||
160555632|NCT02058147|579760056|FG000|Overall Study|Adverse Event|12|||
160555633|NCT02058147|579760057|FG001|Overall Study|Adverse Event|9|||
160555634|NCT02058147|579760058|FG002|Overall Study|Adverse Event|21|||
160555635|NCT02058147|579760056|FG000|Overall Study|Lack of Efficacy|1|||
160555636|NCT02058147|579760057|FG001|Overall Study|Lack of Efficacy|0|||
160555637|NCT02058147|579760058|FG002|Overall Study|Lack of Efficacy|3|||
160555638|NCT02058147|579760056|FG000|Overall Study|Poor compliance to protocol|8|||
160555639|NCT02058147|579760057|FG001|Overall Study|Poor compliance to protocol|9|||
160555640|NCT02058147|579760058|FG002|Overall Study|Poor compliance to protocol|4|||
160990308|NCT03251378|581351791|FG004|Overall Study|Other|1|||
160990309|NCT03251378|581351792|FG005|Overall Study|Other|1|||
160990310|NCT03251378|581351793|FG006|Overall Study|Other|1|||
160990311|NCT03251378|581351787|FG000|Overall Study|Other|0|||
160990312|NCT03251378|581351788|FG001|Overall Study|Other|0|||
160990313|NCT03251378|581351789|FG002|Overall Study|Other|0|||
160555641|NCT02058147|579760056|FG000|Overall Study|Other than specified|8|||
160555642|NCT02058147|579760057|FG001|Overall Study|Other than specified|9|||
160555643|NCT02058147|579760058|FG002|Overall Study|Other than specified|0|||
160555644|NCT00773279|579760062|FG000|Period 1|Adverse Event|2|||
160555645|NCT00773279|579760063|FG001|Period 1|Adverse Event|1|||
160555646|NCT00773279|579760062|FG000|Period 1|Lack of Efficacy|0|||
160555647|NCT00773279|579760063|FG001|Period 1|Lack of Efficacy|2|||
160555648|NCT00773279|579760062|FG000|Period 1|Unclassified|5|||
160555649|NCT00773279|579760063|FG001|Period 1|Unclassified|1|||
160555650|NCT00773279|579760062|FG000|Period 2|Adverse Event|0|||
160555651|NCT00773279|579760063|FG001|Period 2|Adverse Event|1|||
160555652|NCT00773279|579760062|FG000|Period 2|Lack of Efficacy|1|||
160555653|NCT00773279|579760063|FG001|Period 2|Lack of Efficacy|0|||
160555654|NCT00773279|579760062|FG000|Period 2|Protocol Violation|0|||
160555655|NCT00773279|579760063|FG001|Period 2|Protocol Violation|3|||
160555656|NCT00773279|579760062|FG000|Period 2|Unclassified|2|||
160555657|NCT00773279|579760063|FG001|Period 2|Unclassified|2|||
160555658|NCT04178772|579760066|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
160555659|NCT04178772|579760066|FG000|Overall Study|study terminated early due to COVID-19|7|||
160555660|NCT00330187|579760067|FG000|Overall Study|Lost to Follow-up|12|||
160555661|NCT00330187|579760068|FG001|Overall Study|Lost to Follow-up|13|||
160555662|NCT00330187|579760069|FG002|Overall Study|Lost to Follow-up|14|||
160555663|NCT00330187|579760070|FG003|Overall Study|Lost to Follow-up|10|||
160555664|NCT00330187|579760067|FG000|Overall Study|Withdrawal by Subject|8|||
160555665|NCT00330187|579760068|FG001|Overall Study|Withdrawal by Subject|5|||
160555666|NCT00330187|579760069|FG002|Overall Study|Withdrawal by Subject|4|||
160555667|NCT00330187|579760070|FG003|Overall Study|Withdrawal by Subject|4|||
160555668|NCT01481896|579760074|FG000|Overall Study|Lost to Follow-up|12|||
160555669|NCT00364182|579760077|FG000|First Intervention|Secondary prophylaxis|1|||
160555670|NCT00364182|579760078|FG001|First Intervention|Secondary prophylaxis|0|||
160555671|NCT00364182|579760079|FG002|First Intervention|Secondary prophylaxis|0|||
160555672|NCT00364182|579760077|FG000|First Intervention|Withdrawal by Subject|2|||
160555673|NCT00364182|579760078|FG001|First Intervention|Withdrawal by Subject|0|||
160555674|NCT00364182|579760079|FG002|First Intervention|Withdrawal by Subject|0|||
160555675|NCT00364182|579760077|FG000|Second Intervention|non-compliance|0|||
160555676|NCT00364182|579760078|FG001|Second Intervention|non-compliance|1|||
160555677|NCT00364182|579760079|FG002|Second Intervention|non-compliance|1|||
160555678|NCT00364182|579760077|FG000|Second Intervention|Protocol Violation|0|||
160555679|NCT00364182|579760078|FG001|Second Intervention|Protocol Violation|1|||
160555680|NCT00364182|579760079|FG002|Second Intervention|Protocol Violation|0|||
160555681|NCT00364182|579760077|FG000|Second Intervention|Adverse Event|0|||
160555682|NCT00364182|579760078|FG001|Second Intervention|Adverse Event|0|||
160555683|NCT00364182|579760079|FG002|Second Intervention|Adverse Event|1|||
160555684|NCT00364182|579760077|FG000|Third Intervention|non-compliance|0|||
160555685|NCT00364182|579760078|FG001|Third Intervention|non-compliance|1|||
160555686|NCT00364182|579760079|FG002|Third Intervention|non-compliance|0|||
160990314|NCT03251378|581351790|FG003|Overall Study|Other|4|||
160990315|NCT03251378|581351791|FG004|Overall Study|Other|13|||
160990316|NCT03251378|581351792|FG005|Overall Study|Other|0|||
160990317|NCT03251378|581351793|FG006|Overall Study|Other|0|||
160990318|NCT01516892|581351794|FG000|Overall Study|Adverse Event|25|||
160990319|NCT01516892|581351794|FG000|Overall Study|Lack of Efficacy|35|||
160990320|NCT01516892|581351794|FG000|Overall Study|Pregnancy|5|||
160990321|NCT01516892|581351794|FG000|Overall Study|Lost to Follow-up|82|||
160990322|NCT01516892|581351794|FG000|Overall Study|Subject Withdrew Consent|92|||
160990323|NCT01516892|581351794|FG000|Overall Study|Protocol Violation|60|||
160990324|NCT01516892|581351794|FG000|Overall Study|Other Miscellaneous Reasons|43|||
160990325|NCT01516892|581351794|FG000|Overall Study|Missing|1|||
160990326|NCT02956967|581351795|FG000|Overall Study|Adverse Event|3|||
160990327|NCT02956967|581351795|FG000|Overall Study|Reason non-related to neutropenia|10|||
160990328|NCT02956967|581351795|FG000|Overall Study|Lost to Follow-up|5|||
160990329|NCT02956967|581351795|FG000|Overall Study|Missing|1|||
160990330|NCT02956967|581351795|FG000|Overall Study|Termination of Nivestim administration|29|||
160555687|NCT00364182|579760077|FG000|Third Intervention|Lost to Follow-up|0|||
160555688|NCT00364182|579760078|FG001|Third Intervention|Lost to Follow-up|0|||
160555689|NCT00364182|579760079|FG002|Third Intervention|Lost to Follow-up|1|||
160555690|NCT03336502|579760080|FG000|Overall Study|Physician Decision|0|||
160555691|NCT03336502|579760081|FG001|Overall Study|Physician Decision|1|||
160555692|NCT03336502|579760080|FG000|Overall Study|Prohibited Drugs|1|||
160990331|NCT05780047|581351796|FG000|Overall Study|Did not submit baseline urine test kit|226|||
160990332|NCT05780047|581351796|FG000|Overall Study|Lost to Follow-up|34|||
160555693|NCT03336502|579760081|FG001|Overall Study|Prohibited Drugs|1|||
160555694|NCT03336502|579760080|FG000|Overall Study|Death|1|||
160555695|NCT03336502|579760081|FG001|Overall Study|Death|2|||
160555696|NCT03336502|579760080|FG000|Overall Study|Adverse Event|2|||
160555697|NCT03336502|579760081|FG001|Overall Study|Adverse Event|5|||
160555698|NCT02921425|579760082|FG000|Overall Study|Protocol Violation|9|||
160555699|NCT01227967|579760083|FG000|Overall Study|Protocol Violation|3|||
160555700|NCT01227967|579760084|FG001|Overall Study|Protocol Violation|1|||
160990333|NCT05780047|581351796|FG000|Overall Study|Did not submit second urine test kit|124|||
160555701|NCT01227967|579760083|FG000|Overall Study|Death|0|||
160555702|NCT01227967|579760084|FG001|Overall Study|Death|1|||
160555703|NCT01227967|579760083|FG000|Overall Study|Lost to Follow-up|8|||
160555704|NCT01227967|579760084|FG001|Overall Study|Lost to Follow-up|3|||
160555705|NCT01227967|579760083|FG000|Overall Study|Withdrawal by Subject|4|||
160555706|NCT01227967|579760084|FG001|Overall Study|Withdrawal by Subject|3|||
160555707|NCT01227967|579760083|FG000|Overall Study|Physician Decision|0|||
160555708|NCT01227967|579760084|FG001|Overall Study|Physician Decision|1|||
160555709|NCT01227967|579760083|FG000|Overall Study|Never Started Treatment|0|||
160555710|NCT01227967|579760084|FG001|Overall Study|Never Started Treatment|4|||
160555711|NCT01227967|579760083|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
160555712|NCT01227967|579760084|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
160555713|NCT01107444|579760088|FG000|Overall Study|Withdrawal by Subject|8|||
160555714|NCT01107444|579760089|FG001|Overall Study|Withdrawal by Subject|12|||
160555715|NCT01107444|579760088|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
160555716|NCT01107444|579760089|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
160555717|NCT03310970|579760090|FG000|Overall Study|Withdrawal by Subject|0|||
160555718|NCT03310970|579760091|FG001|Overall Study|Withdrawal by Subject|1|||
160555719|NCT00091832|579760092|FG000|Overall Study|Physician Decision|1|||
160555720|NCT00091832|579760093|FG001|Overall Study|Physician Decision|0|||
160555721|NCT00091832|579760094|FG002|Overall Study|Physician Decision|0|||
160555722|NCT00091832|579760095|FG003|Overall Study|Physician Decision|0|||
160555723|NCT00091832|579760096|FG004|Overall Study|Physician Decision|0|||
160555724|NCT00091832|579760097|FG005|Overall Study|Physician Decision|0|||
160555725|NCT00091832|579760092|FG000|Overall Study|Adverse Event|0|||
160555726|NCT00091832|579760093|FG001|Overall Study|Adverse Event|0|||
160555727|NCT00091832|579760094|FG002|Overall Study|Adverse Event|0|||
160555728|NCT00091832|579760095|FG003|Overall Study|Adverse Event|1|||
160555729|NCT00091832|579760096|FG004|Overall Study|Adverse Event|3|||
160555730|NCT00091832|579760097|FG005|Overall Study|Adverse Event|0|||
160555731|NCT00091832|579760092|FG000|Overall Study|Withdrawal by Subject|4|||
160555732|NCT00091832|579760093|FG001|Overall Study|Withdrawal by Subject|5|||
160555733|NCT00091832|579760094|FG002|Overall Study|Withdrawal by Subject|0|||
160555734|NCT00091832|579760095|FG003|Overall Study|Withdrawal by Subject|1|||
160555735|NCT00091832|579760096|FG004|Overall Study|Withdrawal by Subject|3|||
160555736|NCT00091832|579760097|FG005|Overall Study|Withdrawal by Subject|1|||
160646789|NCT00056160|580089977|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
160646790|NCT00056160|580089978|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
160646791|NCT00056160|580089977|FG000|Final Follow-up|Adverse Event|1|||
160902405|NCT00347360|581036041|FG010|Overall Study|Did not meet criteria before ABPM|1|||
160555737|NCT00091832|579760092|FG000|Overall Study|Death|6|||
160555738|NCT00091832|579760093|FG001|Overall Study|Death|4|||
160555739|NCT00091832|579760094|FG002|Overall Study|Death|5|||
160555740|NCT00091832|579760095|FG003|Overall Study|Death|8|||
160555741|NCT00091832|579760096|FG004|Overall Study|Death|5|||
160555742|NCT00091832|579760097|FG005|Overall Study|Death|6|||
160555743|NCT00091832|579760092|FG000|Overall Study|Disease Progression|2|||
160555744|NCT00091832|579760093|FG001|Overall Study|Disease Progression|0|||
160555745|NCT00091832|579760094|FG002|Overall Study|Disease Progression|0|||
160555746|NCT00091832|579760095|FG003|Overall Study|Disease Progression|1|||
160555747|NCT00091832|579760096|FG004|Overall Study|Disease Progression|1|||
160555748|NCT00091832|579760097|FG005|Overall Study|Disease Progression|2|||
160555749|NCT00091832|579760092|FG000|Overall Study|Ineligibility Determined|0|||
160902406|NCT00347360|581036042|FG011|Overall Study|Did not meet criteria before ABPM|0|||
160902407|NCT00347360|581036043|FG012|Overall Study|Did not meet criteria before ABPM|0|||
160902408|NCT00347360|581036044|FG013|Overall Study|Did not meet criteria before ABPM|0|||
160902409|NCT00347360|581036045|FG014|Overall Study|Did not meet criteria before ABPM|0|||
160902410|NCT00347360|581036031|FG000|Overall Study|Randomized in error|0|||
160902411|NCT00347360|581036032|FG001|Overall Study|Randomized in error|0|||
160902412|NCT00347360|581036033|FG002|Overall Study|Randomized in error|0|||
160902413|NCT00347360|581036034|FG003|Overall Study|Randomized in error|0|||
160902414|NCT00347360|581036035|FG004|Overall Study|Randomized in error|0|||
160555750|NCT00091832|579760093|FG001|Overall Study|Ineligibility Determined|0|||
160555751|NCT00091832|579760094|FG002|Overall Study|Ineligibility Determined|1|||
160555752|NCT00091832|579760095|FG003|Overall Study|Ineligibility Determined|0|||
160555753|NCT00091832|579760096|FG004|Overall Study|Ineligibility Determined|1|||
160555754|NCT00091832|579760097|FG005|Overall Study|Ineligibility Determined|0|||
160555755|NCT00091832|579760092|FG000|Overall Study|Lost to Follow-up|1|||
160902415|NCT00347360|581036036|FG005|Overall Study|Randomized in error|0|||
160902416|NCT00347360|581036037|FG006|Overall Study|Randomized in error|0|||
160902417|NCT00347360|581036038|FG007|Overall Study|Randomized in error|0|||
160902418|NCT00347360|581036039|FG008|Overall Study|Randomized in error|0|||
160902419|NCT00347360|581036040|FG009|Overall Study|Randomized in error|0|||
160555756|NCT00091832|579760093|FG001|Overall Study|Lost to Follow-up|0|||
160990334|NCT00764868|581351806|FG000|Overall Study|Adverse Event|18|||
160990335|NCT00764868|581351806|FG000|Overall Study|Withdrawal by Subject|31|||
160990336|NCT00764868|581351806|FG000|Overall Study|Non-compliance|16|||
160990337|NCT00764868|581351806|FG000|Overall Study|Lost to Follow-up|25|||
160990338|NCT00764868|581351806|FG000|Overall Study|Lack of Efficacy|5|||
160990339|NCT00764868|581351806|FG000|Overall Study|Subject moved|7|||
160990340|NCT00764868|581351806|FG000|Overall Study|Pregnancy|3|||
160990341|NCT00764868|581351806|FG000|Overall Study|Prohibited medication|1|||
160990342|NCT00764868|581351806|FG000|Overall Study|Out of town|1|||
160990343|NCT00764868|581351806|FG000|Overall Study|Misuse and compliance of study drug|1|||
160990344|NCT00764868|581351806|FG000|Overall Study|Subject sent to boarding school|1|||
160990345|NCT00764868|581351806|FG000|Overall Study|Met an exclusion criteria|1|||
160990346|NCT00764868|581351806|FG000|Overall Study|Positive drug screen|2|||
160990347|NCT00764868|581351806|FG000|Overall Study|Sponsor requested withdrawal|1|||
160990348|NCT00783692|581351807|FG000|Induction Phase|Adverse Event|7|||
160990349|NCT00783692|581351808|FG001|Induction Phase|Adverse Event|9|||
160990350|NCT00783692|581351809|FG002|Induction Phase|Adverse Event|24|||
160990351|NCT00783692|581351810|FG003|Induction Phase|Adverse Event|0|||
160990352|NCT00783692|581351811|FG004|Induction Phase|Adverse Event|0|||
160555757|NCT00091832|579760094|FG002|Overall Study|Lost to Follow-up|3|||
160555758|NCT00091832|579760095|FG003|Overall Study|Lost to Follow-up|3|||
160555759|NCT00091832|579760096|FG004|Overall Study|Lost to Follow-up|2|||
160555760|NCT00091832|579760097|FG005|Overall Study|Lost to Follow-up|1|||
160555761|NCT00091832|579760092|FG000|Overall Study|Noncompliance|0|||
160555762|NCT00091832|579760093|FG001|Overall Study|Noncompliance|1|||
160990353|NCT00783692|581351812|FG005|Induction Phase|Adverse Event|0|||
160990354|NCT00783692|581351813|FG006|Induction Phase|Adverse Event|0|||
160555763|NCT00091832|579760094|FG002|Overall Study|Noncompliance|0|||
160555764|NCT00091832|579760095|FG003|Overall Study|Noncompliance|0|||
160555765|NCT00091832|579760096|FG004|Overall Study|Noncompliance|0|||
160646792|NCT00056160|580089978|FG001|Final Follow-up|Adverse Event|0|||
160990355|NCT00783692|581351807|FG000|Induction Phase|Protocol Violation|0|||
160990356|NCT00783692|581351808|FG001|Induction Phase|Protocol Violation|0|||
160555766|NCT00091832|579760097|FG005|Overall Study|Noncompliance|0|||
160555767|NCT00091832|579760092|FG000|Overall Study|Other|0|||
160555768|NCT00091832|579760093|FG001|Overall Study|Other|1|||
160555769|NCT00091832|579760094|FG002|Overall Study|Other|2|||
160555770|NCT00091832|579760095|FG003|Overall Study|Other|0|||
160555771|NCT00091832|579760096|FG004|Overall Study|Other|0|||
160555772|NCT00091832|579760097|FG005|Overall Study|Other|0|||
160555773|NCT00091832|579760092|FG000|Overall Study|Protocol Violation|0|||
160555774|NCT00091832|579760093|FG001|Overall Study|Protocol Violation|0|||
160555775|NCT00091832|579760094|FG002|Overall Study|Protocol Violation|1|||
160555776|NCT00091832|579760095|FG003|Overall Study|Protocol Violation|0|||
160555777|NCT00091832|579760096|FG004|Overall Study|Protocol Violation|0|||
160555778|NCT00091832|579760097|FG005|Overall Study|Protocol Violation|1|||
160555779|NCT01557166|579760100|FG000|Overall Study|Adverse Event|20|||
160555780|NCT01557166|579760101|FG001|Overall Study|Adverse Event|6|||
160555781|NCT01557166|579760100|FG000|Overall Study|Lack of Efficacy|2|||
160555782|NCT01557166|579760101|FG001|Overall Study|Lack of Efficacy|1|||
160555783|NCT01557166|579760100|FG000|Overall Study|Protocol Violation|8|||
160555784|NCT01557166|579760101|FG001|Overall Study|Protocol Violation|5|||
160555785|NCT01557166|579760100|FG000|Overall Study|Withdrawn consent|12|||
160555786|NCT01557166|579760101|FG001|Overall Study|Withdrawn consent|20|||
160555787|NCT01557166|579760100|FG000|Overall Study|Target dose not tolerated|1|||
160555788|NCT01557166|579760101|FG001|Overall Study|Target dose not tolerated|0|||
160555789|NCT01557166|579760100|FG000|Overall Study|Psychiatric disorder|1|||
160555790|NCT01557166|579760101|FG001|Overall Study|Psychiatric disorder|0|||
160555791|NCT01557166|579760100|FG000|Overall Study|Unclassified|2|||
160555792|NCT01557166|579760101|FG001|Overall Study|Unclassified|5|||
160555793|NCT00946309|579760102|FG000|Overall Study|Protocol Violation|1|||
160555794|NCT00946309|579760103|FG001|Overall Study|Protocol Violation|0|||
160555795|NCT00946309|579760102|FG000|Overall Study|Lost to Follow-up|0|||
160555796|NCT00946309|579760103|FG001|Overall Study|Lost to Follow-up|1|||
160555797|NCT00946309|579760102|FG000|Overall Study|Procedure cancelled/discontinued|0|||
160555798|NCT00946309|579760103|FG001|Overall Study|Procedure cancelled/discontinued|3|||
160555799|NCT00686647|579760106|FG000|Overall Study|Lost to Follow-up|1|||
160555800|NCT00686647|579760106|FG000|Overall Study|Death|1|||
160555801|NCT00578643|579760107|FG000|Overall Study|Death|1|||
160555802|NCT00578643|579760107|FG000|Overall Study|Lost to Follow-up|1|||
160555803|NCT01725750|579760108|FG000|Overall Study|Adverse Event|1|||
160555804|NCT01725750|579760109|FG001|Overall Study|Adverse Event|0|||
160555805|NCT01725750|579760108|FG000|Overall Study|Lost to Follow-up|1|||
160555806|NCT01725750|579760109|FG001|Overall Study|Lost to Follow-up|1|||
160555807|NCT01725750|579760108|FG000|Overall Study|Withdrawal by Subject|0|||
160555808|NCT01725750|579760109|FG001|Overall Study|Withdrawal by Subject|9|||
160827132|NCT02317809|580753739|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
160827133|NCT02317809|580753740|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
160827134|NCT02435680|580753741|FG000|Overall Study|Physician Decision|3|||
160827135|NCT02435680|580753742|FG001|Overall Study|Physician Decision|0|||
160827136|NCT02435680|580753743|FG002|Overall Study|Physician Decision|0|||
160827137|NCT02435680|580753741|FG000|Overall Study|subject / guardian decision|0|||
160827138|NCT02435680|580753742|FG001|Overall Study|subject / guardian decision|3|||
160827139|NCT02435680|580753743|FG002|Overall Study|subject / guardian decision|2|||
160827140|NCT02435680|580753741|FG000|Overall Study|Adverse Event|8|||
160827141|NCT02435680|580753742|FG001|Overall Study|Adverse Event|3|||
160827142|NCT02435680|580753743|FG002|Overall Study|Adverse Event|2|||
160827143|NCT02435680|580753741|FG000|Overall Study|progressive disease|10|||
160827144|NCT02435680|580753742|FG001|Overall Study|progressive disease|7|||
160827145|NCT02435680|580753743|FG002|Overall Study|progressive disease|11|||
160827146|NCT02435680|580753741|FG000|Overall Study|not treated|0|||
160827147|NCT02435680|580753742|FG001|Overall Study|not treated|0|||
160827148|NCT02435680|580753743|FG002|Overall Study|not treated|1|||
160827149|NCT00953524|580753744|FG000|Overall Study|Adverse Event|2|||
160827150|NCT00953524|580753745|FG001|Overall Study|Adverse Event|0|||
160827151|NCT00953524|580753746|FG002|Overall Study|Adverse Event|1|||
160827152|NCT00953524|580753747|FG003|Overall Study|Adverse Event|2|||
160827153|NCT00953524|580753744|FG000|Overall Study|Protocol Violation|18|||
160827154|NCT00953524|580753745|FG001|Overall Study|Protocol Violation|10|||
160555809|NCT03828487|579760112|FG000|Overall Study|Physician Decision|1|||
160555810|NCT02474329|579760115|FG000|Overall Study|Withdraw or did not contribute data.|13|||
160555811|NCT04025632|579761411|FG000|Overall Study|Adverse Event|1|||
160555812|NCT04025632|579761412|FG001|Overall Study|Adverse Event|1|||
160555813|NCT04025632|579761411|FG000|Overall Study|Withdrawal by Subject|1|||
160555814|NCT04025632|579761412|FG001|Overall Study|Withdrawal by Subject|1|||
160555815|NCT04025632|579761411|FG000|Overall Study|Study Terminated by Sponsor|10|||
160555816|NCT04025632|579761412|FG001|Overall Study|Study Terminated by Sponsor|9|||
160827155|NCT00953524|580753746|FG002|Overall Study|Protocol Violation|11|||
160827156|NCT00953524|580753747|FG003|Overall Study|Protocol Violation|6|||
160827157|NCT00953524|580753744|FG000|Overall Study|Lost to Follow-up|0|||
160555817|NCT04025632|579761411|FG000|Overall Study|Physician Decision|3|||
160555818|NCT04025632|579761412|FG001|Overall Study|Physician Decision|1|||
160827158|NCT00953524|580753745|FG001|Overall Study|Lost to Follow-up|1|||
160990357|NCT00783692|581351809|FG002|Induction Phase|Protocol Violation|1|||
160990358|NCT00783692|581351810|FG003|Induction Phase|Protocol Violation|0|||
160990359|NCT00783692|581351811|FG004|Induction Phase|Protocol Violation|0|||
160990360|NCT00783692|581351812|FG005|Induction Phase|Protocol Violation|0|||
160990361|NCT00783692|581351813|FG006|Induction Phase|Protocol Violation|0|||
160990362|NCT00783692|581351807|FG000|Induction Phase|Lack of Efficacy|1|||
160990363|NCT00783692|581351808|FG001|Induction Phase|Lack of Efficacy|3|||
160990364|NCT00783692|581351809|FG002|Induction Phase|Lack of Efficacy|28|||
160990365|NCT00783692|581351810|FG003|Induction Phase|Lack of Efficacy|0|||
160990366|NCT00783692|581351811|FG004|Induction Phase|Lack of Efficacy|0|||
160990367|NCT00783692|581351812|FG005|Induction Phase|Lack of Efficacy|0|||
160990368|NCT00783692|581351813|FG006|Induction Phase|Lack of Efficacy|0|||
160990369|NCT00783692|581351807|FG000|Induction Phase|Withdrawal by Subject|3|||
160990370|NCT00783692|581351808|FG001|Induction Phase|Withdrawal by Subject|9|||
160990371|NCT00783692|581351809|FG002|Induction Phase|Withdrawal by Subject|16|||
160990372|NCT00783692|581351810|FG003|Induction Phase|Withdrawal by Subject|0|||
160990373|NCT00783692|581351811|FG004|Induction Phase|Withdrawal by Subject|0|||
160990374|NCT00783692|581351812|FG005|Induction Phase|Withdrawal by Subject|0|||
160990375|NCT00783692|581351813|FG006|Induction Phase|Withdrawal by Subject|0|||
160990376|NCT00783692|581351807|FG000|Induction Phase|Lost to Follow-up|0|||
160990377|NCT00783692|581351808|FG001|Induction Phase|Lost to Follow-up|0|||
160990378|NCT00783692|581351809|FG002|Induction Phase|Lost to Follow-up|3|||
160990379|NCT00783692|581351810|FG003|Induction Phase|Lost to Follow-up|0|||
160990380|NCT00783692|581351811|FG004|Induction Phase|Lost to Follow-up|0|||
160990381|NCT00783692|581351812|FG005|Induction Phase|Lost to Follow-up|0|||
160990382|NCT00783692|581351813|FG006|Induction Phase|Lost to Follow-up|0|||
160990383|NCT00783692|581351807|FG000|Induction Phase|Other|0|||
160990384|NCT00783692|581351808|FG001|Induction Phase|Other|0|||
160990385|NCT00783692|581351809|FG002|Induction Phase|Other|2|||
160990386|NCT00783692|581351810|FG003|Induction Phase|Other|0|||
160990387|NCT00783692|581351811|FG004|Induction Phase|Other|0|||
160990388|NCT00783692|581351812|FG005|Induction Phase|Other|0|||
160990389|NCT00783692|581351813|FG006|Induction Phase|Other|0|||
160990390|NCT00783692|581351807|FG000|Maintenance Phase|Adverse Event|7|||
160990391|NCT00783692|581351808|FG001|Maintenance Phase|Adverse Event|0|||
160990392|NCT00783692|581351809|FG002|Maintenance Phase|Adverse Event|0|||
160990393|NCT00783692|581351810|FG003|Maintenance Phase|Adverse Event|15|||
160990394|NCT00783692|581351811|FG004|Maintenance Phase|Adverse Event|12|||
160990395|NCT00783692|581351812|FG005|Maintenance Phase|Adverse Event|9|||
160990396|NCT00783692|581351813|FG006|Maintenance Phase|Adverse Event|38|||
160990397|NCT00783692|581351807|FG000|Maintenance Phase|Protocol Violation|0|||
160990398|NCT00783692|581351808|FG001|Maintenance Phase|Protocol Violation|0|||
160990399|NCT00783692|581351809|FG002|Maintenance Phase|Protocol Violation|0|||
160990400|NCT00783692|581351810|FG003|Maintenance Phase|Protocol Violation|1|||
160990401|NCT00783692|581351811|FG004|Maintenance Phase|Protocol Violation|2|||
160990402|NCT00783692|581351812|FG005|Maintenance Phase|Protocol Violation|3|||
160990403|NCT00783692|581351813|FG006|Maintenance Phase|Protocol Violation|4|||
160990404|NCT00783692|581351807|FG000|Maintenance Phase|Lack of Efficacy|79|||
160990405|NCT00783692|581351808|FG001|Maintenance Phase|Lack of Efficacy|0|||
160990406|NCT00783692|581351809|FG002|Maintenance Phase|Lack of Efficacy|0|||
160990407|NCT00783692|581351810|FG003|Maintenance Phase|Lack of Efficacy|64|||
160990408|NCT00783692|581351811|FG004|Maintenance Phase|Lack of Efficacy|58|||
160990409|NCT00783692|581351812|FG005|Maintenance Phase|Lack of Efficacy|48|||
160990410|NCT00783692|581351813|FG006|Maintenance Phase|Lack of Efficacy|177|||
160990411|NCT00783692|581351807|FG000|Maintenance Phase|Withdrawal by Subject|7|||
160990412|NCT00783692|581351808|FG001|Maintenance Phase|Withdrawal by Subject|0|||
160990413|NCT00783692|581351809|FG002|Maintenance Phase|Withdrawal by Subject|0|||
160990414|NCT00783692|581351810|FG003|Maintenance Phase|Withdrawal by Subject|7|||
160990415|NCT00783692|581351811|FG004|Maintenance Phase|Withdrawal by Subject|6|||
160990416|NCT00783692|581351812|FG005|Maintenance Phase|Withdrawal by Subject|9|||
160990417|NCT00783692|581351813|FG006|Maintenance Phase|Withdrawal by Subject|24|||
160990418|NCT00783692|581351807|FG000|Maintenance Phase|Lost to Follow-up|2|||
160990419|NCT00783692|581351808|FG001|Maintenance Phase|Lost to Follow-up|0|||
160646793|NCT01469364|580089979|FG000|Overall Study|Adverse Event|1|||
160646794|NCT01469364|580089979|FG000|Overall Study|Withdrawal by Subject|1|||
160990420|NCT00783692|581351809|FG002|Maintenance Phase|Lost to Follow-up|0|||
160990421|NCT00783692|581351810|FG003|Maintenance Phase|Lost to Follow-up|1|||
160990422|NCT00783692|581351811|FG004|Maintenance Phase|Lost to Follow-up|3|||
160990423|NCT00783692|581351812|FG005|Maintenance Phase|Lost to Follow-up|2|||
160990424|NCT00783692|581351813|FG006|Maintenance Phase|Lost to Follow-up|5|||
160990425|NCT00783692|581351807|FG000|Maintenance Phase|Other|0|||
160990426|NCT00783692|581351808|FG001|Maintenance Phase|Other|0|||
160990427|NCT00783692|581351809|FG002|Maintenance Phase|Other|0|||
160827159|NCT00953524|580753746|FG002|Overall Study|Lost to Follow-up|1|||
160990428|NCT00783692|581351810|FG003|Maintenance Phase|Other|1|||
160990429|NCT00783692|581351811|FG004|Maintenance Phase|Other|0|||
160990430|NCT00783692|581351812|FG005|Maintenance Phase|Other|1|||
160990431|NCT00783692|581351813|FG006|Maintenance Phase|Other|1|||
160990432|NCT00819234|581351819|FG000|Overall Study|Withdrawal by Subject|8|||
160990433|NCT00819234|581351820|FG001|Overall Study|Withdrawal by Subject|13|||
160990434|NCT00819234|581351821|FG002|Overall Study|Withdrawal by Subject|6|||
160990435|NCT00819234|581351822|FG003|Overall Study|Withdrawal by Subject|3|||
160990436|NCT00819234|581351823|FG004|Overall Study|Withdrawal by Subject|0|||
160990437|NCT00819234|581351824|FG005|Overall Study|Withdrawal by Subject|4|||
160990438|NCT00819234|581351825|FG006|Overall Study|Withdrawal by Subject|4|||
160990439|NCT00819234|581351826|FG007|Overall Study|Withdrawal by Subject|8|||
160990440|NCT00819234|581351827|FG008|Overall Study|Withdrawal by Subject|5|||
160990441|NCT00819234|581351828|FG009|Overall Study|Withdrawal by Subject|3|||
160990442|NCT00819234|581351819|FG000|Overall Study|Adverse Event|0|||
160990443|NCT00819234|581351820|FG001|Overall Study|Adverse Event|0|||
160990444|NCT00819234|581351821|FG002|Overall Study|Adverse Event|1|||
160990445|NCT00819234|581351822|FG003|Overall Study|Adverse Event|0|||
160990446|NCT00819234|581351823|FG004|Overall Study|Adverse Event|0|||
160990447|NCT00819234|581351824|FG005|Overall Study|Adverse Event|2|||
160990448|NCT00819234|581351825|FG006|Overall Study|Adverse Event|0|||
160990449|NCT00819234|581351826|FG007|Overall Study|Adverse Event|0|||
160990450|NCT00819234|581351827|FG008|Overall Study|Adverse Event|0|||
160990451|NCT00819234|581351828|FG009|Overall Study|Adverse Event|0|||
160990452|NCT00819234|581351819|FG000|Overall Study|Physician Decision|0|||
160990453|NCT00819234|581351820|FG001|Overall Study|Physician Decision|0|||
160990454|NCT00819234|581351821|FG002|Overall Study|Physician Decision|0|||
160990455|NCT00819234|581351822|FG003|Overall Study|Physician Decision|1|||
160990456|NCT00819234|581351823|FG004|Overall Study|Physician Decision|0|||
160990457|NCT00819234|581351824|FG005|Overall Study|Physician Decision|0|||
160990458|NCT00819234|581351825|FG006|Overall Study|Physician Decision|0|||
160990459|NCT00819234|581351826|FG007|Overall Study|Physician Decision|0|||
160990460|NCT00819234|581351827|FG008|Overall Study|Physician Decision|0|||
160990461|NCT00819234|581351828|FG009|Overall Study|Physician Decision|2|||
160990462|NCT00819234|581351819|FG000|Overall Study|Protocol Violation|0|||
160990463|NCT00819234|581351820|FG001|Overall Study|Protocol Violation|0|||
160990464|NCT00819234|581351821|FG002|Overall Study|Protocol Violation|1|||
160990465|NCT00819234|581351822|FG003|Overall Study|Protocol Violation|0|||
160990466|NCT00819234|581351823|FG004|Overall Study|Protocol Violation|0|||
160990467|NCT00819234|581351824|FG005|Overall Study|Protocol Violation|0|||
160990468|NCT00819234|581351825|FG006|Overall Study|Protocol Violation|0|||
160990469|NCT00819234|581351826|FG007|Overall Study|Protocol Violation|0|||
160990470|NCT00819234|581351827|FG008|Overall Study|Protocol Violation|0|||
160990471|NCT00819234|581351828|FG009|Overall Study|Protocol Violation|0|||
160990472|NCT00819234|581351819|FG000|Overall Study|Lost to Follow-up|2|||
160990473|NCT00819234|581351820|FG001|Overall Study|Lost to Follow-up|2|||
160990474|NCT00819234|581351821|FG002|Overall Study|Lost to Follow-up|0|||
160990475|NCT00819234|581351822|FG003|Overall Study|Lost to Follow-up|2|||
160990476|NCT00819234|581351823|FG004|Overall Study|Lost to Follow-up|1|||
160990477|NCT00819234|581351824|FG005|Overall Study|Lost to Follow-up|1|||
160990478|NCT00819234|581351825|FG006|Overall Study|Lost to Follow-up|1|||
160990479|NCT00819234|581351826|FG007|Overall Study|Lost to Follow-up|1|||
160990480|NCT00819234|581351827|FG008|Overall Study|Lost to Follow-up|1|||
160990481|NCT00819234|581351828|FG009|Overall Study|Lost to Follow-up|2|||
160990482|NCT01096056|581351829|FG000|Overall Study|Lost to Follow-up|0|||
160990483|NCT01096056|581351830|FG001|Overall Study|Lost to Follow-up|1|||
160990484|NCT03115346|581351831|FG000|Overall Study|Did not have AAA surgery|28|||
160990485|NCT03115346|581351832|FG001|Overall Study|Did not have AAA surgery|15|||
160990486|NCT03115346|581351831|FG000|Overall Study|Death|3|||
160990487|NCT03115346|581351832|FG001|Overall Study|Death|1|||
160990488|NCT03115346|581351831|FG000|Overall Study|Withdrawal by Subject|0|||
160990489|NCT03115346|581351832|FG001|Overall Study|Withdrawal by Subject|3|||
160990490|NCT03115346|581351831|FG000|Overall Study|Lost to Follow-up|0|||
160990491|NCT03115346|581351832|FG001|Overall Study|Lost to Follow-up|3|||
160990492|NCT00924560|581351833|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
160990493|NCT00924560|581351834|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
160990494|NCT00924560|581351835|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
160990495|NCT00924560|581351833|FG000|Overall Study|Non Compliance with the Protocol|20|||
160990496|NCT00924560|581351834|FG001|Overall Study|Non Compliance with the Protocol|15|||
160555819|NCT00376961|579761413|FG000|Initial Registration|Adverse Event|1|||
160555820|NCT00376961|579761414|FG001|Initial Registration|Adverse Event|0|||
160555821|NCT00376961|579761413|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
160555822|NCT00376961|579761414|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
160555823|NCT00376961|579761413|FG000|Initial Registration|Progression/relapse|1|||
160555824|NCT00376961|579761414|FG001|Initial Registration|Progression/relapse|0|||
160555825|NCT00376961|579761413|FG000|Initial Registration|Ineligible|3|||
160555826|NCT00376961|579761414|FG001|Initial Registration|Ineligible|0|||
160555827|NCT00376961|579761413|FG000|Maintenance|Adverse Event|0|||
160555828|NCT00376961|579761414|FG001|Maintenance|Adverse Event|1|||
160555829|NCT00376961|579761413|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
160555830|NCT00376961|579761414|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
160555831|NCT00376961|579761413|FG000|Maintenance|Progression/relapse|0|||
160555832|NCT00376961|579761414|FG001|Maintenance|Progression/relapse|18|||
160555833|NCT00376961|579761413|FG000|Maintenance|Ineligible|0|||
160555834|NCT00376961|579761414|FG001|Maintenance|Ineligible|3|||
160555835|NCT02591615|579761421|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
160555836|NCT02591615|579761422|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
160555837|NCT02591615|579761423|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
160555838|NCT02591615|579761424|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
160555839|NCT02591615|579761421|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
160555840|NCT02591615|579761422|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
160555841|NCT02591615|579761423|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
160555842|NCT02591615|579761424|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
160555843|NCT02591615|579761421|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
160555844|NCT02591615|579761422|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
160555845|NCT02591615|579761423|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
160555846|NCT02591615|579761424|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
160555847|NCT02591615|579761421|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
160555848|NCT02591615|579761422|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
160555849|NCT02591615|579761423|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
160555850|NCT02591615|579761424|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
160555851|NCT02591615|579761421|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
160555852|NCT02591615|579761422|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
160555853|NCT02591615|579761423|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
160555854|NCT02591615|579761424|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
160555855|NCT02591615|579761421|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
160555856|NCT02591615|579761422|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
160555857|NCT02591615|579761423|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
160555858|NCT02591615|579761424|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
160555859|NCT02591615|579761421|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
160555860|NCT02591615|579761422|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
160555861|NCT02591615|579761423|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
160555862|NCT02591615|579761424|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
160555863|NCT02591615|579761421|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
160555864|NCT02591615|579761422|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
160555865|NCT02591615|579761423|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
160555866|NCT02591615|579761424|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
160555867|NCT02591615|579761421|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
160555868|NCT02591615|579761422|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
160646795|NCT04081337|580089986|FG000|Overall Study|Adverse Event|0|||
160990497|NCT00924560|581351835|FG002|Overall Study|Non Compliance with the Protocol|4|||
160555869|NCT02591615|579761423|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
160555870|NCT02591615|579761424|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
160555871|NCT02591615|579761421|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
160555872|NCT02591615|579761422|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
160827160|NCT00953524|580753747|FG003|Overall Study|Lost to Follow-up|0|||
160827161|NCT00953524|580753744|FG000|Overall Study|Withdrawal by Subject|2|||
160827162|NCT00953524|580753745|FG001|Overall Study|Withdrawal by Subject|4|||
160827163|NCT00953524|580753746|FG002|Overall Study|Withdrawal by Subject|1|||
160827164|NCT00953524|580753747|FG003|Overall Study|Withdrawal by Subject|0|||
160827165|NCT00294645|580753748|FG000|Overall Study|Death|10|||
160827166|NCT00294645|580753749|FG001|Overall Study|Death|18|||
160827167|NCT00294645|580753748|FG000|Overall Study|Lost to Follow-up|1|||
160827168|NCT00294645|580753749|FG001|Overall Study|Lost to Follow-up|10|||
160827169|NCT00294645|580753748|FG000|Overall Study|Withdrawal by Subject|18|||
160827170|NCT00294645|580753749|FG001|Overall Study|Withdrawal by Subject|34|||
160827171|NCT00294645|580753748|FG000|Overall Study|Physician Decision|15|||
160827172|NCT00294645|580753749|FG001|Overall Study|Physician Decision|20|||
160827173|NCT00294645|580753748|FG000|Overall Study|Other|4|||
160827174|NCT00294645|580753749|FG001|Overall Study|Other|10|||
160555873|NCT02591615|579761423|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
160555874|NCT02591615|579761424|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
160555875|NCT02591615|579761421|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
160555876|NCT02591615|579761422|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
160555877|NCT02591615|579761423|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
160555878|NCT02591615|579761424|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
160555879|NCT02591615|579761421|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
160555880|NCT02591615|579761422|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
160555881|NCT02591615|579761423|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
160555882|NCT02591615|579761424|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
160555883|NCT02591615|579761421|FG000|Maintenance MK-3475|Adverse Event|0|||
160555884|NCT02591615|579761422|FG001|Maintenance MK-3475|Adverse Event|3|||
160555885|NCT02591615|579761423|FG002|Maintenance MK-3475|Adverse Event|1|||
160555886|NCT02591615|579761424|FG003|Maintenance MK-3475|Adverse Event|2|||
160555887|NCT02591615|579761421|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
160555888|NCT02591615|579761422|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
160555889|NCT02591615|579761423|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
160555890|NCT02591615|579761424|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
160555891|NCT02591615|579761421|FG000|Maintenance MK-3475|Death|0|||
160555892|NCT02591615|579761422|FG001|Maintenance MK-3475|Death|1|||
160555893|NCT02591615|579761423|FG002|Maintenance MK-3475|Death|1|||
160555894|NCT02591615|579761424|FG003|Maintenance MK-3475|Death|0|||
160555895|NCT02591615|579761421|FG000|Maintenance MK-3475|Physician discretion|0|||
160555896|NCT02591615|579761422|FG001|Maintenance MK-3475|Physician discretion|0|||
160555897|NCT02591615|579761423|FG002|Maintenance MK-3475|Physician discretion|1|||
160555898|NCT02591615|579761424|FG003|Maintenance MK-3475|Physician discretion|0|||
160555899|NCT02591615|579761421|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
160555900|NCT02591615|579761422|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
160555901|NCT02591615|579761423|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
160555902|NCT02591615|579761424|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
160555903|NCT02591615|579761421|FG000|Maintenance MK-3475|In active treatment|2|||
160555904|NCT02591615|579761422|FG001|Maintenance MK-3475|In active treatment|0|||
160555905|NCT02591615|579761423|FG002|Maintenance MK-3475|In active treatment|0|||
160555906|NCT02591615|579761424|FG003|Maintenance MK-3475|In active treatment|1|||
160555907|NCT01097629|579761432|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
160555908|NCT01097629|579761433|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
160555909|NCT01097629|579761434|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
160555910|NCT01097629|579761435|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160555911|NCT01097629|579761436|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160555912|NCT01097629|579761437|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160555913|NCT01097629|579761438|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160555914|NCT01097629|579761439|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160555915|NCT01097629|579761432|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
160555916|NCT01097629|579761433|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
160555917|NCT01097629|579761434|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
160827175|NCT01238835|580753752|FG000|Overall Study|Death|124|||
160827176|NCT01238835|580753752|FG000|Overall Study|Withdrawal by Subject|9|||
160555918|NCT01097629|579761435|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160555919|NCT01097629|579761436|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160555920|NCT01097629|579761437|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160555921|NCT01097629|579761438|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160555922|NCT01097629|579761439|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160555923|NCT01097629|579761432|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
160555924|NCT01097629|579761433|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
160555925|NCT01097629|579761434|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
160555926|NCT01097629|579761435|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160555927|NCT01097629|579761436|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160555928|NCT01097629|579761437|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160827177|NCT01238835|580753752|FG000|Overall Study|Lost to Follow-up|1|||
160555929|NCT01097629|579761438|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160555930|NCT01097629|579761439|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160555931|NCT01097629|579761432|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
160555932|NCT01097629|579761433|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
160555933|NCT01097629|579761434|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
160555934|NCT01097629|579761435|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160555935|NCT01097629|579761436|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160555936|NCT01097629|579761437|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160555937|NCT01097629|579761438|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160555938|NCT01097629|579761439|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160555939|NCT01097629|579761432|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
160555940|NCT01097629|579761433|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
160555941|NCT01097629|579761434|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
160555942|NCT01097629|579761435|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
160555943|NCT01097629|579761436|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
160555944|NCT01097629|579761437|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
160555945|NCT01097629|579761438|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
160555946|NCT01097629|579761439|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
160555947|NCT01097629|579761432|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
160555948|NCT01097629|579761433|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
160555949|NCT01097629|579761434|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160555950|NCT01097629|579761435|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160555951|NCT01097629|579761436|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160555952|NCT01097629|579761437|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160555953|NCT01097629|579761438|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160555954|NCT01097629|579761439|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160555955|NCT01097629|579761432|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
160555956|NCT01097629|579761433|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
160555957|NCT01097629|579761434|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
160555958|NCT01097629|579761435|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160555959|NCT01097629|579761436|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160555960|NCT01097629|579761437|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160555961|NCT01097629|579761438|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160555962|NCT01097629|579761439|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160827178|NCT01238835|580753752|FG000|Overall Study|Site early discontinuation|2|||
160827179|NCT00554619|580753753|FG000|Overall Study|Adverse Event|1|||
160555963|NCT01097629|579761432|FG000|DB RO Phase|Withdrawal by Subject|0|||
160555964|NCT01097629|579761433|FG001|DB RO Phase|Withdrawal by Subject|0|||
160555965|NCT01097629|579761434|FG002|DB RO Phase|Withdrawal by Subject|0|||
160555966|NCT01097629|579761435|FG003|DB RO Phase|Withdrawal by Subject|0|||
160555967|NCT01097629|579761436|FG004|DB RO Phase|Withdrawal by Subject|0|||
160555968|NCT01097629|579761437|FG005|DB RO Phase|Withdrawal by Subject|0|||
160555969|NCT01097629|579761438|FG006|DB RO Phase|Withdrawal by Subject|0|||
160555970|NCT01097629|579761439|FG007|DB RO Phase|Withdrawal by Subject|1|||
160555971|NCT01097629|579761432|FG000|DB RO Phase|Protocol Violation|0|||
160555972|NCT01097629|579761433|FG001|DB RO Phase|Protocol Violation|0|||
160555973|NCT01097629|579761434|FG002|DB RO Phase|Protocol Violation|0|||
160555974|NCT01097629|579761435|FG003|DB RO Phase|Protocol Violation|1|||
160555975|NCT01097629|579761436|FG004|DB RO Phase|Protocol Violation|0|||
160827180|NCT00554619|580753753|FG000|Overall Study|Physician Decision|1|||
160827181|NCT00554619|580753753|FG000|Overall Study|Liver Function Test Abnormality|1|||
160555976|NCT01097629|579761437|FG005|DB RO Phase|Protocol Violation|1|||
160555977|NCT01097629|579761438|FG006|DB RO Phase|Protocol Violation|1|||
160555978|NCT01097629|579761439|FG007|DB RO Phase|Protocol Violation|0|||
160555979|NCT01097629|579761432|FG000|DB RO Phase|Lost to Follow-up|0|||
160555980|NCT01097629|579761433|FG001|DB RO Phase|Lost to Follow-up|0|||
160555981|NCT01097629|579761434|FG002|DB RO Phase|Lost to Follow-up|0|||
160555982|NCT01097629|579761435|FG003|DB RO Phase|Lost to Follow-up|0|||
160555983|NCT01097629|579761436|FG004|DB RO Phase|Lost to Follow-up|0|||
160555984|NCT01097629|579761437|FG005|DB RO Phase|Lost to Follow-up|0|||
160555985|NCT01097629|579761438|FG006|DB RO Phase|Lost to Follow-up|2|||
160555986|NCT01097629|579761439|FG007|DB RO Phase|Lost to Follow-up|0|||
160555987|NCT00956943|579761440|FG000|Overall Study|Lost to Follow-up|9|||
160555988|NCT00956943|579761441|FG001|Overall Study|Lost to Follow-up|10|||
160555989|NCT02663895|579761442|FG000|Overall Study|Adverse Event|3|||
160555990|NCT02663895|579761442|FG000|Overall Study|Physician Decision|2|||
160555991|NCT02663895|579761442|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
160555992|NCT02663895|579761442|FG000|Overall Study|Withdrawal by Subject|1|||
160555993|NCT00809328|579761443|FG000|Overall Study|Lack of Efficacy|18|||
160555994|NCT00809328|579761443|FG000|Overall Study|Adverse Event|6|||
160555995|NCT00809328|579761443|FG000|Overall Study|Protocol Violation|3|||
160555996|NCT00809328|579761443|FG000|Overall Study|Withdrawal by Subject|2|||
160555997|NCT00289913|579761450|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160555998|NCT00289913|579761451|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
160555999|NCT00289913|579761452|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556000|NCT00289913|579761453|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556001|NCT00289913|579761454|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556002|NCT00289913|579761450|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
160556003|NCT00289913|579761451|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
160827182|NCT02088073|580753755|FG000|Acute Phase|Withdrawal by Subject|5|||
160827183|NCT02088073|580753756|FG001|Acute Phase|Withdrawal by Subject|0|||
160827184|NCT02088073|580753757|FG002|Acute Phase|Withdrawal by Subject|0|||
160827185|NCT02088073|580753758|FG003|Acute Phase|Withdrawal by Subject|0|||
160827186|NCT02088073|580753759|FG004|Acute Phase|Withdrawal by Subject|0|||
160827187|NCT02088073|580753755|FG000|Acute Phase|Hyperkalemia|2|||
160827188|NCT02088073|580753756|FG001|Acute Phase|Hyperkalemia|0|||
160827189|NCT02088073|580753757|FG002|Acute Phase|Hyperkalemia|0|||
160827190|NCT02088073|580753758|FG003|Acute Phase|Hyperkalemia|0|||
160827191|NCT02088073|580753759|FG004|Acute Phase|Hyperkalemia|0|||
160827192|NCT02088073|580753755|FG000|Maintanance Phase|Withdrawal by Subject|0|||
160827193|NCT02088073|580753756|FG001|Maintanance Phase|Withdrawal by Subject|2|||
160827194|NCT02088073|580753757|FG002|Maintanance Phase|Withdrawal by Subject|0|||
160827195|NCT02088073|580753758|FG003|Maintanance Phase|Withdrawal by Subject|0|||
160827196|NCT02088073|580753759|FG004|Maintanance Phase|Withdrawal by Subject|0|||
160827197|NCT02088073|580753755|FG000|Maintanance Phase|Adverse Event|0|||
160827198|NCT02088073|580753756|FG001|Maintanance Phase|Adverse Event|0|||
160827199|NCT02088073|580753757|FG002|Maintanance Phase|Adverse Event|3|||
160827200|NCT02088073|580753758|FG003|Maintanance Phase|Adverse Event|0|||
160902420|NCT00347360|581036041|FG010|Overall Study|Randomized in error|0|||
160827201|NCT02088073|580753759|FG004|Maintanance Phase|Adverse Event|1|||
160827202|NCT02088073|580753755|FG000|Maintanance Phase|Physician Decision|0|||
160827203|NCT02088073|580753756|FG001|Maintanance Phase|Physician Decision|0|||
160902421|NCT00347360|581036042|FG011|Overall Study|Randomized in error|1|||
160902422|NCT00347360|581036043|FG012|Overall Study|Randomized in error|0|||
160902423|NCT00347360|581036044|FG013|Overall Study|Randomized in error|0|||
160902424|NCT00347360|581036045|FG014|Overall Study|Randomized in error|0|||
160556004|NCT00289913|579761452|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
160556005|NCT00289913|579761453|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
160556006|NCT00289913|579761454|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
160556007|NCT00289913|579761450|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
160556008|NCT00289913|579761451|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
160556009|NCT00289913|579761452|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
160556010|NCT00289913|579761453|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
160556011|NCT00289913|579761454|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
160902425|NCT00347360|581036031|FG000|Overall Study|Failed inclusion criteria #4|0|||
160556012|NCT00289913|579761450|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
160556013|NCT00289913|579761451|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
160556014|NCT00289913|579761452|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
160827204|NCT02088073|580753757|FG002|Maintanance Phase|Physician Decision|0|||
160827205|NCT02088073|580753758|FG003|Maintanance Phase|Physician Decision|0|||
160902426|NCT00347360|581036032|FG001|Overall Study|Failed inclusion criteria #4|0|||
160827206|NCT02088073|580753759|FG004|Maintanance Phase|Physician Decision|1|||
160827207|NCT02088073|580753755|FG000|Maintanance Phase|Sponsor's decision|0|||
160902427|NCT00347360|581036033|FG002|Overall Study|Failed inclusion criteria #4|0|||
160827208|NCT02088073|580753756|FG001|Maintanance Phase|Sponsor's decision|2|||
160827209|NCT02088073|580753757|FG002|Maintanance Phase|Sponsor's decision|0|||
160990498|NCT00924560|581351833|FG000|Overall Study|Physician Decision|2|||
160990499|NCT00924560|581351834|FG001|Overall Study|Physician Decision|3|||
160990500|NCT00924560|581351835|FG002|Overall Study|Physician Decision|4|||
160990501|NCT00924560|581351833|FG000|Overall Study|Withdrawal by Subject|50|||
160556015|NCT00289913|579761453|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
160556016|NCT00289913|579761454|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
160556017|NCT00289913|579761450|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160556018|NCT00289913|579761451|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160556019|NCT00289913|579761452|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160556020|NCT00289913|579761453|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
160556021|NCT00289913|579761454|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160556022|NCT00289913|579761450|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
160556023|NCT00289913|579761451|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
160556024|NCT00289913|579761452|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
160556025|NCT00289913|579761453|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
160556026|NCT00289913|579761454|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
160556027|NCT00289913|579761450|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
160556028|NCT00289913|579761451|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
160556029|NCT00289913|579761452|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
160556030|NCT00289913|579761453|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
160556031|NCT00289913|579761454|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
160556032|NCT00289913|579761450|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
160556033|NCT00289913|579761451|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
160556034|NCT00289913|579761452|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
160556035|NCT00289913|579761453|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
160556036|NCT00289913|579761454|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
160556037|NCT00289913|579761450|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
160556038|NCT00289913|579761451|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
160556039|NCT00289913|579761452|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
160556040|NCT00289913|579761453|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
160556041|NCT00289913|579761454|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
160556042|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556043|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556044|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
160556045|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556046|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556047|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
160556048|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
160556049|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
160556050|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
160556051|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
160556052|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
160556053|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
160556054|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
160556055|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
160556056|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
160556057|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
160556058|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
160556059|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
160556060|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
160556061|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
160556062|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
160556063|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160556064|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
160646796|NCT04081337|580089987|FG001|Overall Study|Adverse Event|1|||
160646797|NCT04081337|580089986|FG000|Overall Study|Withdrawal by Subject|2|||
160827210|NCT02088073|580753758|FG003|Maintanance Phase|Sponsor's decision|2|||
160827211|NCT02088073|580753759|FG004|Maintanance Phase|Sponsor's decision|1|||
160827212|NCT02088073|580753755|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
160827213|NCT02088073|580753756|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
160990502|NCT00924560|581351834|FG001|Overall Study|Withdrawal by Subject|44|||
160990503|NCT00924560|581351835|FG002|Overall Study|Withdrawal by Subject|18|||
160990504|NCT00924560|581351833|FG000|Overall Study|Adverse Event|39|||
160990505|NCT00924560|581351834|FG001|Overall Study|Adverse Event|33|||
160646798|NCT04081337|580089987|FG001|Overall Study|Withdrawal by Subject|0|||
160646799|NCT04081337|580089986|FG000|Overall Study|Physician Decision|1|||
160646800|NCT04081337|580089987|FG001|Overall Study|Physician Decision|2|||
160646801|NCT04081337|580089986|FG000|Overall Study|Lost to Follow-up|1|||
160646802|NCT04081337|580089987|FG001|Overall Study|Lost to Follow-up|0|||
160646803|NCT01579474|580089988|FG000|Overall Study|Adverse Event|1|||
160646804|NCT01579474|580089989|FG001|Overall Study|Adverse Event|13|||
160646805|NCT01579474|580089990|FG002|Overall Study|Adverse Event|2|||
160646806|NCT01579474|580089991|FG003|Overall Study|Adverse Event|0|||
160646807|NCT01579474|580089992|FG004|Overall Study|Adverse Event|0|||
160646808|NCT01579474|580089993|FG005|Overall Study|Adverse Event|1|||
160646809|NCT01579474|580089988|FG000|Overall Study|Lack of Efficacy|1|||
160646810|NCT01579474|580089989|FG001|Overall Study|Lack of Efficacy|0|||
160827214|NCT02088073|580753757|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
160827215|NCT02088073|580753758|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
160827216|NCT02088073|580753759|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
160827217|NCT02088073|580753755|FG000|Maintanance Phase|Miscellaneous|0|||
160827218|NCT02088073|580753756|FG001|Maintanance Phase|Miscellaneous|2|||
160827219|NCT02088073|580753757|FG002|Maintanance Phase|Miscellaneous|1|||
160827220|NCT02088073|580753758|FG003|Maintanance Phase|Miscellaneous|2|||
160827221|NCT02088073|580753759|FG004|Maintanance Phase|Miscellaneous|1|||
160827222|NCT02088073|580753755|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
160827223|NCT02088073|580753756|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
160827224|NCT02088073|580753757|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
160827225|NCT02088073|580753758|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
160827226|NCT02088073|580753759|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
160827227|NCT02088073|580753755|FG000|Maintanance Phase|Subject compliance|0|||
160827228|NCT02088073|580753756|FG001|Maintanance Phase|Subject compliance|1|||
160827229|NCT02088073|580753757|FG002|Maintanance Phase|Subject compliance|0|||
160827230|NCT02088073|580753758|FG003|Maintanance Phase|Subject compliance|0|||
160827231|NCT02088073|580753759|FG004|Maintanance Phase|Subject compliance|0|||
160827232|NCT00907803|580753760|FG000|Overall Study|Withdrawal of consent - long commute|1|||
160827233|NCT00907803|580753761|FG001|Overall Study|Withdrawal of consent - long commute|0|||
160827234|NCT00907803|580753762|FG002|Overall Study|Withdrawal of consent - long commute|0|||
160827235|NCT00907803|580753760|FG000|Overall Study|Adverse Event|2|||
160827236|NCT00907803|580753761|FG001|Overall Study|Adverse Event|0|||
160827237|NCT00907803|580753762|FG002|Overall Study|Adverse Event|0|||
160827238|NCT00907803|580753760|FG000|Overall Study|Withdrawal by Subject|0|||
160827239|NCT00907803|580753761|FG001|Overall Study|Withdrawal by Subject|1|||
160827240|NCT00907803|580753762|FG002|Overall Study|Withdrawal by Subject|0|||
160827241|NCT00907803|580753760|FG000|Overall Study|Lost to Follow-up|0|||
160827242|NCT00907803|580753761|FG001|Overall Study|Lost to Follow-up|1|||
160827243|NCT00907803|580753762|FG002|Overall Study|Lost to Follow-up|0|||
160827244|NCT00907803|580753760|FG000|Overall Study|Protocol Violation|0|||
160827245|NCT00907803|580753761|FG001|Overall Study|Protocol Violation|1|||
160827246|NCT00907803|580753762|FG002|Overall Study|Protocol Violation|0|||
160827247|NCT04612842|580753767|FG000|Overall Study|Lost to Follow-up|20|||
160827248|NCT04612842|580753768|FG001|Overall Study|Lost to Follow-up|11|||
160827249|NCT04612842|580753767|FG000|Overall Study|Withdrawal by Subject|26|||
160827250|NCT04612842|580753768|FG001|Overall Study|Withdrawal by Subject|15|||
160827251|NCT04612842|580753767|FG000|Overall Study|Death|2|||
160827252|NCT04612842|580753768|FG001|Overall Study|Death|2|||
160827253|NCT02419131|580753769|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
160827254|NCT02419131|580753770|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
160827255|NCT02419131|580753771|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
160827256|NCT02419131|580753769|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
160827257|NCT02419131|580753770|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
160827258|NCT02419131|580753771|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
160827259|NCT05426031|580753772|FG000|Overall Study|Circulatory Arrest|3|||
160990506|NCT00924560|581351835|FG002|Overall Study|Adverse Event|0|||
160990507|NCT00924560|581351833|FG000|Overall Study|Pregnancy|5|||
160646811|NCT01579474|580089990|FG002|Overall Study|Lack of Efficacy|0|||
160827260|NCT05426031|580753773|FG001|Overall Study|Circulatory Arrest|2|||
160827261|NCT03060512|580753774|FG000|Overall Study|Adverse Event|4|||
160827262|NCT03060512|580753775|FG001|Overall Study|Adverse Event|6|||
160646812|NCT01579474|580089991|FG003|Overall Study|Lack of Efficacy|0|||
160827263|NCT03060512|580753774|FG000|Overall Study|Lost to Follow-up|1|||
160827264|NCT03060512|580753775|FG001|Overall Study|Lost to Follow-up|1|||
160827265|NCT03060512|580753774|FG000|Overall Study|Withdrawal by Subject|1|||
160827266|NCT03060512|580753775|FG001|Overall Study|Withdrawal by Subject|0|||
160827267|NCT03060512|580753774|FG000|Overall Study|Non-compliance with study medication|1|||
160646813|NCT01579474|580089992|FG004|Overall Study|Lack of Efficacy|1|||
160646814|NCT01579474|580089993|FG005|Overall Study|Lack of Efficacy|0|||
160646815|NCT01579474|580089988|FG000|Overall Study|Withdrawal by Subject|1|||
160827268|NCT03060512|580753775|FG001|Overall Study|Non-compliance with study medication|2|||
160827269|NCT00089986|580753776|FG000|Overall Study|Adverse Event|6|||
160827270|NCT00089986|580753777|FG001|Overall Study|Adverse Event|9|||
160827271|NCT00089986|580753778|FG002|Overall Study|Adverse Event|6|||
160827272|NCT00089986|580753776|FG000|Overall Study|Lost to Follow-up|3|||
160827273|NCT00089986|580753777|FG001|Overall Study|Lost to Follow-up|1|||
160827274|NCT00089986|580753778|FG002|Overall Study|Lost to Follow-up|1|||
160827275|NCT00089986|580753776|FG000|Overall Study|Protocol Violation|0|||
160827276|NCT00089986|580753777|FG001|Overall Study|Protocol Violation|1|||
160827277|NCT00089986|580753778|FG002|Overall Study|Protocol Violation|0|||
160827278|NCT00089986|580753776|FG000|Overall Study|Patient transferred to another hospital|2|||
160827279|NCT00089986|580753777|FG001|Overall Study|Patient transferred to another hospital|1|||
160827280|NCT00089986|580753778|FG002|Overall Study|Patient transferred to another hospital|0|||
160827281|NCT00089986|580753776|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
160827282|NCT00089986|580753777|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
160827283|NCT00089986|580753778|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
160827284|NCT00089986|580753776|FG000|Overall Study|Hemohlobin stopping rule|0|||
160827285|NCT00089986|580753777|FG001|Overall Study|Hemohlobin stopping rule|1|||
160827286|NCT00089986|580753778|FG002|Overall Study|Hemohlobin stopping rule|0|||
160827287|NCT00089986|580753776|FG000|Overall Study|Investigator decision to withdrew|0|||
160827288|NCT00089986|580753777|FG001|Overall Study|Investigator decision to withdrew|1|||
160827289|NCT00089986|580753778|FG002|Overall Study|Investigator decision to withdrew|0|||
160827290|NCT00089986|580753776|FG000|Overall Study|Enrollment in another study|0|||
160827291|NCT00089986|580753777|FG001|Overall Study|Enrollment in another study|1|||
160827292|NCT00089986|580753778|FG002|Overall Study|Enrollment in another study|0|||
160827293|NCT00089986|580753776|FG000|Overall Study|Family decision|0|||
160827294|NCT00089986|580753777|FG001|Overall Study|Family decision|1|||
160827295|NCT00089986|580753778|FG002|Overall Study|Family decision|0|||
160827296|NCT00089986|580753776|FG000|Overall Study|Do not resuscitate (DNR)|0|||
160827297|NCT00089986|580753777|FG001|Overall Study|Do not resuscitate (DNR)|0|||
160827298|NCT00089986|580753778|FG002|Overall Study|Do not resuscitate (DNR)|1|||
160827299|NCT00089986|580753776|FG000|Overall Study|Withdrawal by Subject|3|||
160827300|NCT00089986|580753777|FG001|Overall Study|Withdrawal by Subject|6|||
160827301|NCT00089986|580753778|FG002|Overall Study|Withdrawal by Subject|2|||
160827302|NCT04065074|580753782|FG000|Overall Study|Adverse Event|1|||
160827303|NCT04065074|580753782|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
160827304|NCT02334683|580753783|FG000|First 12 Week Period|Lost to Follow-up|1|||
160827305|NCT02334683|580753784|FG001|First 12 Week Period|Lost to Follow-up|0|||
160827306|NCT02334683|580753783|FG000|Second 12 Week Period|Adverse Event|0|||
160827307|NCT02334683|580753784|FG001|Second 12 Week Period|Adverse Event|1|||
160827308|NCT01062841|580753785|FG000|Overall Study|Indwelling Device Removed|41|||
160827309|NCT01062841|580753786|FG001|Overall Study|Indwelling Device Removed|48|||
160827310|NCT01062841|580753785|FG000|Overall Study|Death|3|||
160827311|NCT01062841|580753786|FG001|Overall Study|Death|5|||
160827312|NCT01062841|580753785|FG000|Overall Study|Withdrawal by Subject|2|||
160827313|NCT01062841|580753786|FG001|Overall Study|Withdrawal by Subject|0|||
160827314|NCT01062841|580753785|FG000|Overall Study|Withdrawal by Study|3|||
160827315|NCT01062841|580753786|FG001|Overall Study|Withdrawal by Study|0|||
160827316|NCT03958656|580753789|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
160827317|NCT03958656|580753790|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
160827318|NCT03958656|580753791|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
160827319|NCT03958656|580753792|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
160827320|NCT03958656|580753789|FG000|Overall Study|No longer meets eligibility criteria|0|||
160827321|NCT03958656|580753790|FG001|Overall Study|No longer meets eligibility criteria|0|||
160827322|NCT03958656|580753791|FG002|Overall Study|No longer meets eligibility criteria|1|||
160827323|NCT03958656|580753792|FG003|Overall Study|No longer meets eligibility criteria|0|||
160827324|NCT03958656|580753789|FG000|Overall Study|Started anti-cancer treatment|0|||
160827325|NCT03958656|580753790|FG001|Overall Study|Started anti-cancer treatment|0|||
160902428|NCT00347360|581036034|FG003|Overall Study|Failed inclusion criteria #4|0|||
160902429|NCT00347360|581036035|FG004|Overall Study|Failed inclusion criteria #4|0|||
160902430|NCT00347360|581036036|FG005|Overall Study|Failed inclusion criteria #4|0|||
160902431|NCT00347360|581036037|FG006|Overall Study|Failed inclusion criteria #4|0|||
160902432|NCT00347360|581036038|FG007|Overall Study|Failed inclusion criteria #4|0|||
160902433|NCT00347360|581036039|FG008|Overall Study|Failed inclusion criteria #4|0|||
160902434|NCT00347360|581036040|FG009|Overall Study|Failed inclusion criteria #4|0|||
160827326|NCT03958656|580753791|FG002|Overall Study|Started anti-cancer treatment|1|||
160827327|NCT03958656|580753792|FG003|Overall Study|Started anti-cancer treatment|0|||
160827328|NCT03831880|580753793|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
160827329|NCT03831880|580753794|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
160827330|NCT03831880|580753793|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
160827331|NCT03831880|580753794|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
160902435|NCT00347360|581036041|FG010|Overall Study|Failed inclusion criteria #4|0|||
160902436|NCT00347360|581036042|FG011|Overall Study|Failed inclusion criteria #4|1|||
160902437|NCT00347360|581036043|FG012|Overall Study|Failed inclusion criteria #4|0|||
160827332|NCT03158012|580753797|FG000|Overall Study|Withdrawal by Subject|0|||
160827333|NCT03158012|580753798|FG001|Overall Study|Withdrawal by Subject|1|||
160827334|NCT02788201|580753799|FG000|Overall Study|Death|1|||
160827335|NCT02788201|580753800|FG001|Overall Study|Death|1|||
160827336|NCT02788201|580753801|FG002|Overall Study|Death|1|||
160827337|NCT02788201|580753802|FG003|Overall Study|Death|1|||
160827338|NCT02788201|580753803|FG004|Overall Study|Death|0|||
160827339|NCT02788201|580753804|FG005|Overall Study|Death|1|||
160827340|NCT02788201|580753799|FG000|Overall Study|Ineligible|0|||
160827341|NCT02788201|580753800|FG001|Overall Study|Ineligible|0|||
160827342|NCT02788201|580753801|FG002|Overall Study|Ineligible|0|||
160827343|NCT02788201|580753802|FG003|Overall Study|Ineligible|0|||
160827344|NCT02788201|580753803|FG004|Overall Study|Ineligible|0|||
160827345|NCT02788201|580753804|FG005|Overall Study|Ineligible|1|||
160827346|NCT02788201|580753799|FG000|Overall Study|Withdrawal by Subject|0|||
160827347|NCT02788201|580753800|FG001|Overall Study|Withdrawal by Subject|0|||
160827348|NCT02788201|580753801|FG002|Overall Study|Withdrawal by Subject|0|||
160827349|NCT02788201|580753802|FG003|Overall Study|Withdrawal by Subject|0|||
160827350|NCT02788201|580753803|FG004|Overall Study|Withdrawal by Subject|0|||
160827351|NCT02788201|580753804|FG005|Overall Study|Withdrawal by Subject|1|||
160827352|NCT02969590|580753808|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
160827353|NCT02969590|580753809|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
160827354|NCT02969590|580753810|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
160827355|NCT01414205|580753811|FG000|Overall Study|Death|5|||
160827356|NCT01414205|580753812|FG001|Overall Study|Death|1|||
160827357|NCT01414205|580753811|FG000|Overall Study|Lost to Follow-up|1|||
160827358|NCT01414205|580753812|FG001|Overall Study|Lost to Follow-up|4|||
160827359|NCT01414205|580753811|FG000|Overall Study|Physician Decision|0|||
160827360|NCT01414205|580753812|FG001|Overall Study|Physician Decision|1|||
160827361|NCT01414205|580753811|FG000|Overall Study|Randomized but not Treated|1|||
160827362|NCT01414205|580753812|FG001|Overall Study|Randomized but not Treated|1|||
160827363|NCT01166373|580753813|FG000|Overall Study|Lost to Follow-up|3|||
160827364|NCT01166373|580753814|FG001|Overall Study|Lost to Follow-up|2|||
160827365|NCT01166373|580753815|FG002|Overall Study|Lost to Follow-up|2|||
160827366|NCT01166373|580753816|FG003|Overall Study|Lost to Follow-up|2|||
160827367|NCT01166373|580753813|FG000|Overall Study|Withdrawal by Subject|1|||
160827368|NCT01166373|580753814|FG001|Overall Study|Withdrawal by Subject|2|||
160827369|NCT01166373|580753815|FG002|Overall Study|Withdrawal by Subject|2|||
160827370|NCT01166373|580753816|FG003|Overall Study|Withdrawal by Subject|3|||
160827371|NCT01166373|580753813|FG000|Overall Study|Physician Decision|1|||
160827372|NCT01166373|580753814|FG001|Overall Study|Physician Decision|0|||
160827373|NCT01166373|580753815|FG002|Overall Study|Physician Decision|0|||
160827374|NCT01166373|580753816|FG003|Overall Study|Physician Decision|0|||
160827375|NCT02498067|580753817|FG000|Overall Study|Lost to Follow-up|22|||
160827376|NCT02498067|580753817|FG000|Overall Study|Did not meet inclusion criteria|11|||
160827377|NCT01874275|580753818|FG000|Overall Study|Lost to Follow-up|1|||
160827378|NCT01874275|580753819|FG001|Overall Study|Lost to Follow-up|0|||
160827379|NCT02214225|580753824|FG000|Overall Study|Lost to Follow-up|46|||
160827380|NCT02214225|580753825|FG001|Overall Study|Lost to Follow-up|18|||
160827381|NCT02214225|580753826|FG002|Overall Study|Lost to Follow-up|18|||
160827382|NCT02214225|580753824|FG000|Overall Study|Withdrawal by Subject|2|||
160827383|NCT02214225|580753825|FG001|Overall Study|Withdrawal by Subject|0|||
160827384|NCT02214225|580753826|FG002|Overall Study|Withdrawal by Subject|2|||
160827385|NCT02214225|580753824|FG000|Overall Study|Death|5|||
160827386|NCT02214225|580753825|FG001|Overall Study|Death|0|||
160827387|NCT02214225|580753826|FG002|Overall Study|Death|1|||
160827388|NCT02214225|580753824|FG000|Overall Study|randomized in error, not vaccinated|2|||
160827389|NCT02214225|580753825|FG001|Overall Study|randomized in error, not vaccinated|1|||
160827390|NCT02214225|580753826|FG002|Overall Study|randomized in error, not vaccinated|1|||
160827391|NCT03987932|580753827|FG000|Overall Study|Lost to Follow-up|2|||
160827392|NCT03987932|580753828|FG001|Overall Study|Lost to Follow-up|1|||
160827393|NCT03987932|580753829|FG002|Overall Study|Lost to Follow-up|1|||
160827394|NCT03987932|580753827|FG000|Overall Study|Non-study related elective surgery|0|||
160827395|NCT03987932|580753828|FG001|Overall Study|Non-study related elective surgery|0|||
160827396|NCT03987932|580753829|FG002|Overall Study|Non-study related elective surgery|1|||
160827397|NCT01669421|580753830|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
160827398|NCT01669421|580753830|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
160827399|NCT02813668|580753836|FG000|Overall Study|Death|4|||
160827400|NCT02813668|580753836|FG000|Overall Study|Lost to Follow-up|509|||
160827401|NCT02813668|580753836|FG000|Overall Study|Withdrawal by Subject|148|||
160827402|NCT02813668|580753836|FG000|Overall Study|No longer at worksite|85|||
160827403|NCT02813668|580753836|FG000|Overall Study|Medical reasons not related to the study|4|||
160827404|NCT02961790|580753837|FG000|Overall Study|Canceled|4|||
160827405|NCT02961790|580753838|FG001|Overall Study|Canceled|5|||
160827406|NCT02961790|580753839|FG002|Overall Study|Canceled|1|||
160827407|NCT02961790|580753840|FG003|Overall Study|Canceled|4|||
160827408|NCT02961790|580753837|FG000|Overall Study|without baseline data|4|||
160827409|NCT02961790|580753838|FG001|Overall Study|without baseline data|0|||
160827410|NCT02961790|580753839|FG002|Overall Study|without baseline data|1|||
160827411|NCT02961790|580753840|FG003|Overall Study|without baseline data|0|||
160827412|NCT02961790|580753837|FG000|Overall Study|without post baseline data|7|||
160827413|NCT02961790|580753838|FG001|Overall Study|without post baseline data|6|||
160827414|NCT02961790|580753839|FG002|Overall Study|without post baseline data|4|||
160827415|NCT02961790|580753840|FG003|Overall Study|without post baseline data|1|||
160827416|NCT02594098|580753843|FG000|Overall Study|Lack of Efficacy|17|||
160827417|NCT02594098|580753844|FG001|Overall Study|Lack of Efficacy|6|||
160827418|NCT02594098|580753843|FG000|Overall Study|Withdrawal by Subject|1|||
160827419|NCT02594098|580753844|FG001|Overall Study|Withdrawal by Subject|3|||
160827420|NCT02594098|580753843|FG000|Overall Study|Terminated participation|6|||
160827421|NCT02594098|580753844|FG001|Overall Study|Terminated participation|2|||
160827422|NCT02594098|580753843|FG000|Overall Study|Seek alternative treatment|2|||
160827423|NCT02594098|580753844|FG001|Overall Study|Seek alternative treatment|1|||
160827424|NCT02594098|580753843|FG000|Overall Study|Other|0|||
160827425|NCT02594098|580753844|FG001|Overall Study|Other|1|||
160827426|NCT01866423|580753845|FG000|Overall Study|Lack of Efficacy|3|||
160827427|NCT01866423|580753845|FG000|Overall Study|Sponsor Decision|1|||
160646816|NCT01579474|580089989|FG001|Overall Study|Withdrawal by Subject|0|||
160646817|NCT01579474|580089990|FG002|Overall Study|Withdrawal by Subject|0|||
160646818|NCT01579474|580089991|FG003|Overall Study|Withdrawal by Subject|0|||
160646819|NCT01579474|580089992|FG004|Overall Study|Withdrawal by Subject|0|||
160646820|NCT01579474|580089993|FG005|Overall Study|Withdrawal by Subject|0|||
160646821|NCT02295774|580089995|FG000|Overall Study|Physician Decision|1|||
160646822|NCT02295774|580089995|FG000|Overall Study|Withdrawal by Subject|2|||
160646823|NCT00449072|580089996|FG000|Overall Study|Adverse Event|3|||
160646824|NCT00449072|580089997|FG001|Overall Study|Adverse Event|1|||
160646825|NCT00449072|580089996|FG000|Overall Study|Protocol Violation|14|||
160646826|NCT00449072|580089997|FG001|Overall Study|Protocol Violation|12|||
160646827|NCT00449072|580089996|FG000|Overall Study|Lost to Follow-up|5|||
160646828|NCT00449072|580089997|FG001|Overall Study|Lost to Follow-up|7|||
160646829|NCT00449072|580089996|FG000|Overall Study|Withdrawal by Subject|11|||
160646830|NCT00449072|580089997|FG001|Overall Study|Withdrawal by Subject|8|||
160646831|NCT00449072|580089996|FG000|Overall Study|Lack of Efficacy|1|||
160646832|NCT00449072|580089997|FG001|Overall Study|Lack of Efficacy|1|||
160646833|NCT00449072|580089996|FG000|Overall Study|Physician Decision|1|||
160646834|NCT00449072|580089997|FG001|Overall Study|Physician Decision|0|||
160646835|NCT00449072|580089996|FG000|Overall Study|Not treated|0|||
160646836|NCT00449072|580089997|FG001|Overall Study|Not treated|1|||
160646837|NCT00449072|580089996|FG000|Overall Study|Excluded medication|0|||
160646838|NCT00449072|580089997|FG001|Overall Study|Excluded medication|2|||
160646839|NCT00449072|580089996|FG000|Overall Study|Non-compliance|2|||
160646840|NCT00449072|580089997|FG001|Overall Study|Non-compliance|5|||
160646841|NCT00449072|580089996|FG000|Overall Study|Sponsor decision|1|||
160646842|NCT00449072|580089997|FG001|Overall Study|Sponsor decision|3|||
160646843|NCT00449072|580089996|FG000|Overall Study|Relocation|3|||
160646844|NCT00449072|580089997|FG001|Overall Study|Relocation|2|||
160646845|NCT04041570|580090011|FG000|Overall Study|Moved from Area|0|||
160646846|NCT04041570|580090012|FG001|Overall Study|Moved from Area|2|||
160646847|NCT00441584|580090013|FG000|Overall Study|Lack of Efficacy|79|||
160827428|NCT00434759|580753856|FG000|Overall Study|Lack of Efficacy|5|||
160827429|NCT00434759|580753857|FG001|Overall Study|Lack of Efficacy|4|||
160827430|NCT00434759|580753856|FG000|Overall Study|Withdrawal by Subject|17|||
160827431|NCT00434759|580753857|FG001|Overall Study|Withdrawal by Subject|1|||
160827432|NCT00434759|580753856|FG000|Overall Study|family affairs|2|||
160827433|NCT00434759|580753857|FG001|Overall Study|family affairs|0|||
160827434|NCT00787930|580753858|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
160827435|NCT02513823|580753859|FG000|Overall Study|Lost to Follow-up|4|||
160827436|NCT02513823|580753859|FG000|Overall Study|Physician Decision|1|||
160646848|NCT00441584|580090013|FG000|Overall Study|Withdrawal by Subject|8|||
160646849|NCT00441584|580090013|FG000|Overall Study|Adverse Event|6|||
160827437|NCT03002623|580753860|FG000|Overall Study|Lost to Follow-up|1|||
160827438|NCT03002623|580753861|FG001|Overall Study|Lost to Follow-up|0|||
160827439|NCT03002623|580753860|FG000|Overall Study|Physician Decision|1|||
160827440|NCT03002623|580753861|FG001|Overall Study|Physician Decision|1|||
160827441|NCT03204890|580756311|FG000|Overall Study|Withdrawal by Subject|1|||
160827442|NCT01688739|580756319|FG000|Overall Study|Administrative Decision|1|||
160990508|NCT00924560|581351834|FG001|Overall Study|Pregnancy|7|||
160990509|NCT00924560|581351835|FG002|Overall Study|Pregnancy|1|||
160990510|NCT00924560|581351833|FG000|Overall Study|Lost to Follow-up|78|||
160990511|NCT00924560|581351834|FG001|Overall Study|Lost to Follow-up|94|||
160990512|NCT00924560|581351835|FG002|Overall Study|Lost to Follow-up|45|||
160827443|NCT01688739|580756320|FG001|Overall Study|Administrative Decision|0|||
160646850|NCT00441584|580090013|FG000|Overall Study|Protocol Violation|5|||
160646851|NCT00441584|580090013|FG000|Overall Study|Lost to Follow-up|4|||
160646852|NCT00441584|580090013|FG000|Overall Study|Failure to meet eligibility criteria|3|||
160646853|NCT03532009|580090014|FG000|Overall Study|Other|1|||
160827444|NCT01688739|580756321|FG002|Overall Study|Administrative Decision|0|||
160827445|NCT01688739|580756322|FG003|Overall Study|Administrative Decision|0|||
160827446|NCT01688739|580756323|FG004|Overall Study|Administrative Decision|0|||
160827447|NCT01688739|580756324|FG005|Overall Study|Administrative Decision|0|||
160827448|NCT01688739|580756325|FG006|Overall Study|Administrative Decision|0|||
160827449|NCT01688739|580756326|FG007|Overall Study|Administrative Decision|0|||
160827450|NCT01688739|580756327|FG008|Overall Study|Administrative Decision|0|||
160827451|NCT01688739|580756328|FG009|Overall Study|Administrative Decision|0|||
160827452|NCT00490776|580756331|FG000|Overall Study|Withdrawal by Subject|1|||
160827453|NCT00490776|580756331|FG000|Overall Study|Administrative Problems|1|||
160827454|NCT00490776|580756331|FG000|Overall Study|Death|1|||
160827455|NCT00490776|580756331|FG000|Overall Study|New Cancer Therapy|1|||
160827456|NCT00490776|580756331|FG000|Overall Study|Disease Progression|5|||
160827457|NCT00940485|580756336|FG000|Overall Study|HBeAb positive at Baseline|3|||
160827458|NCT00940485|580756337|FG001|Overall Study|HBeAb positive at Baseline|2|||
160827459|NCT00940485|580756336|FG000|Overall Study|Lost to Follow-up|2|||
160827460|NCT00940485|580756337|FG001|Overall Study|Lost to Follow-up|3|||
160827461|NCT00940485|580756336|FG000|Overall Study|Adverse Event|8|||
160827462|NCT00940485|580756337|FG001|Overall Study|Adverse Event|0|||
160827463|NCT00940485|580756336|FG000|Overall Study|Withdrawal by Subject|1|||
160827464|NCT00940485|580756337|FG001|Overall Study|Withdrawal by Subject|1|||
160827465|NCT00940485|580756336|FG000|Overall Study|Others|1|||
160827466|NCT00940485|580756337|FG001|Overall Study|Others|1|||
160827467|NCT01113580|580756338|FG000|Overall Study|Protocol Violation|1|||
160827468|NCT01113580|580756339|FG001|Overall Study|Protocol Violation|0|||
160827469|NCT04599166|580756340|FG000|Overall Study|Technological failure connecting to study app|80|||
160827470|NCT01974752|580756341|FG000|Overall Study|Death|33|||
160827471|NCT01974752|580756342|FG001|Overall Study|Death|11|||
160827472|NCT01974752|580756341|FG000|Overall Study|Lost to Follow-up|2|||
160827473|NCT01974752|580756342|FG001|Overall Study|Lost to Follow-up|0|||
160827474|NCT01974752|580756341|FG000|Overall Study|Withdrawal by Subject|2|||
160827475|NCT01974752|580756342|FG001|Overall Study|Withdrawal by Subject|3|||
160827476|NCT01974752|580756341|FG000|Overall Study|Other Eligibility Criteria|0|||
160827477|NCT01974752|580756342|FG001|Overall Study|Other Eligibility Criteria|1|||
160827478|NCT02233738|580756343|FG000|Overall Study|Lost to Follow-up|5|||
160827479|NCT02233738|580756344|FG001|Overall Study|Lost to Follow-up|12|||
160827480|NCT02233738|580756343|FG000|Overall Study|Death|0|||
160827481|NCT02233738|580756344|FG001|Overall Study|Death|1|||
160827482|NCT02233738|580756343|FG000|Overall Study|Withdrawal by Subject|0|||
160827483|NCT02233738|580756344|FG001|Overall Study|Withdrawal by Subject|1|||
160827484|NCT02233738|580756343|FG000|Overall Study|Did not return after Baseline|3|||
160902438|NCT00347360|581036044|FG013|Overall Study|Failed inclusion criteria #4|0|||
160902439|NCT00347360|581036045|FG014|Overall Study|Failed inclusion criteria #4|0|||
160902440|NCT00347360|581036031|FG000|Overall Study|Prolonged duration between visits|0|||
160902441|NCT00347360|581036032|FG001|Overall Study|Prolonged duration between visits|0|||
160902442|NCT00347360|581036033|FG002|Overall Study|Prolonged duration between visits|0|||
160902443|NCT00347360|581036034|FG003|Overall Study|Prolonged duration between visits|0|||
160902444|NCT00347360|581036035|FG004|Overall Study|Prolonged duration between visits|0|||
160902445|NCT00347360|581036036|FG005|Overall Study|Prolonged duration between visits|0|||
160902446|NCT00347360|581036037|FG006|Overall Study|Prolonged duration between visits|0|||
160902447|NCT00347360|581036038|FG007|Overall Study|Prolonged duration between visits|0|||
160902448|NCT00347360|581036039|FG008|Overall Study|Prolonged duration between visits|0|||
160902449|NCT00347360|581036040|FG009|Overall Study|Prolonged duration between visits|0|||
160902450|NCT00347360|581036041|FG010|Overall Study|Prolonged duration between visits|0|||
160902451|NCT00347360|581036042|FG011|Overall Study|Prolonged duration between visits|0|||
160902452|NCT00347360|581036043|FG012|Overall Study|Prolonged duration between visits|1|||
160902453|NCT00347360|581036044|FG013|Overall Study|Prolonged duration between visits|0|||
160902454|NCT00347360|581036045|FG014|Overall Study|Prolonged duration between visits|0|||
160902455|NCT00347360|581036031|FG000|Overall Study|Subject left town, ran out of study drug|0|||
160902456|NCT00347360|581036032|FG001|Overall Study|Subject left town, ran out of study drug|0|||
160902457|NCT00347360|581036033|FG002|Overall Study|Subject left town, ran out of study drug|0|||
160902458|NCT00347360|581036034|FG003|Overall Study|Subject left town, ran out of study drug|0|||
160990513|NCT00924560|581351833|FG000|Overall Study|Miscellaneous Reasons|13|||
160990514|NCT00924560|581351834|FG001|Overall Study|Miscellaneous Reasons|10|||
160827485|NCT02233738|580756344|FG001|Overall Study|Did not return after Baseline|2|||
160827486|NCT02098369|580756345|FG000|Overall Study|Withdrawal by Subject|1|||
160827487|NCT02098369|580756346|FG001|Overall Study|Withdrawal by Subject|5|||
160827488|NCT02098369|580756347|FG002|Overall Study|Withdrawal by Subject|0|||
160827489|NCT02098369|580756345|FG000|Overall Study|Lost to Follow-up|5|||
160827490|NCT02098369|580756346|FG001|Overall Study|Lost to Follow-up|1|||
160827491|NCT02098369|580756347|FG002|Overall Study|Lost to Follow-up|3|||
160827492|NCT02098369|580756345|FG000|Overall Study|Death|1|||
160827493|NCT02098369|580756346|FG001|Overall Study|Death|1|||
160902459|NCT00347360|581036035|FG004|Overall Study|Subject left town, ran out of study drug|0|||
160902460|NCT00347360|581036036|FG005|Overall Study|Subject left town, ran out of study drug|0|||
160902461|NCT00347360|581036037|FG006|Overall Study|Subject left town, ran out of study drug|0|||
160902462|NCT00347360|581036038|FG007|Overall Study|Subject left town, ran out of study drug|0|||
160902463|NCT00347360|581036039|FG008|Overall Study|Subject left town, ran out of study drug|0|||
160902464|NCT00347360|581036040|FG009|Overall Study|Subject left town, ran out of study drug|0|||
160902465|NCT00347360|581036041|FG010|Overall Study|Subject left town, ran out of study drug|0|||
160902466|NCT00347360|581036042|FG011|Overall Study|Subject left town, ran out of study drug|0|||
160902467|NCT00347360|581036043|FG012|Overall Study|Subject left town, ran out of study drug|0|||
160902468|NCT00347360|581036044|FG013|Overall Study|Subject left town, ran out of study drug|1|||
160902469|NCT00347360|581036045|FG014|Overall Study|Subject left town, ran out of study drug|0|||
160902470|NCT00347360|581036031|FG000|Overall Study|Subject refuse to sign updated consent|0|||
160902471|NCT00347360|581036032|FG001|Overall Study|Subject refuse to sign updated consent|0|||
160902472|NCT00347360|581036033|FG002|Overall Study|Subject refuse to sign updated consent|0|||
160902473|NCT00347360|581036034|FG003|Overall Study|Subject refuse to sign updated consent|0|||
160902474|NCT00347360|581036035|FG004|Overall Study|Subject refuse to sign updated consent|0|||
160902475|NCT00347360|581036036|FG005|Overall Study|Subject refuse to sign updated consent|0|||
160902476|NCT00347360|581036037|FG006|Overall Study|Subject refuse to sign updated consent|0|||
160902477|NCT00347360|581036038|FG007|Overall Study|Subject refuse to sign updated consent|0|||
160902478|NCT00347360|581036039|FG008|Overall Study|Subject refuse to sign updated consent|0|||
160902479|NCT00347360|581036040|FG009|Overall Study|Subject refuse to sign updated consent|0|||
160902480|NCT00347360|581036041|FG010|Overall Study|Subject refuse to sign updated consent|0|||
160902481|NCT00347360|581036042|FG011|Overall Study|Subject refuse to sign updated consent|0|||
160902482|NCT00347360|581036043|FG012|Overall Study|Subject refuse to sign updated consent|0|||
160902483|NCT00347360|581036044|FG013|Overall Study|Subject refuse to sign updated consent|0|||
160902484|NCT00347360|581036045|FG014|Overall Study|Subject refuse to sign updated consent|1|||
160902485|NCT00347360|581036031|FG000|Overall Study|Visits conflicted with new job|0|||
160902486|NCT00347360|581036032|FG001|Overall Study|Visits conflicted with new job|0|||
160902487|NCT00347360|581036033|FG002|Overall Study|Visits conflicted with new job|0|||
160902488|NCT00347360|581036034|FG003|Overall Study|Visits conflicted with new job|0|||
160902489|NCT00347360|581036035|FG004|Overall Study|Visits conflicted with new job|0|||
160902490|NCT00347360|581036036|FG005|Overall Study|Visits conflicted with new job|0|||
160902491|NCT00347360|581036037|FG006|Overall Study|Visits conflicted with new job|1|||
160556065|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160556066|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160556067|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
160556068|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
160556069|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
160556070|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
160556071|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
160556072|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
160556073|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
160556074|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
160556075|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
160556076|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
160556077|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
160556078|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
160556079|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
160556080|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
160556081|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
160556082|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
160556083|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
160556084|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
160556085|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
160556086|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
160556087|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
160556088|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
160556089|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
160556090|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
160556091|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
160556092|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
160556093|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
160902492|NCT00347360|581036038|FG007|Overall Study|Visits conflicted with new job|0|||
160990515|NCT00924560|581351835|FG002|Overall Study|Miscellaneous Reasons|10|||
160990516|NCT03590743|581351838|FG000|Overall Study|Withdrawal by Subject|0|||
160827494|NCT02098369|580756347|FG002|Overall Study|Death|1|||
160827495|NCT02098369|580756345|FG000|Overall Study|Other|0|||
160827496|NCT02098369|580756346|FG001|Overall Study|Other|2|||
160827497|NCT02098369|580756347|FG002|Overall Study|Other|1|||
160827498|NCT00570037|580756349|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
160827499|NCT00570037|580756350|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
160827500|NCT03946124|580756353|FG000|Overall Study|Withdrawal by Subject|19|||
160827501|NCT02046174|580756359|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
160827502|NCT02046174|580756360|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
160827503|NCT00413920|580756364|FG000|Overall Study|Adverse Event|9|||
160827504|NCT00413920|580756365|FG001|Overall Study|Adverse Event|11|||
160827505|NCT00413920|580756364|FG000|Overall Study|Lack of Efficacy|11|||
160827506|NCT00413920|580756365|FG001|Overall Study|Lack of Efficacy|9|||
160827507|NCT00413920|580756364|FG000|Overall Study|Death|3|||
160827508|NCT00413920|580756365|FG001|Overall Study|Death|5|||
160827509|NCT00413920|580756364|FG000|Overall Study|Graft Loss|5|||
160827510|NCT00413920|580756365|FG001|Overall Study|Graft Loss|3|||
160827511|NCT02118597|580756368|FG000|Overall Study|Sponsor terminated the study|14|||
160827512|NCT02118597|580756368|FG000|Overall Study|Serious Adverse Event|1|||
160827513|NCT02118597|580756368|FG000|Overall Study|Investigator's decision|1|||
160827514|NCT01891344|580756369|FG000|Overall Study|Ongoing|6|||
160827515|NCT01891344|580756370|FG001|Overall Study|Ongoing|2|||
160827516|NCT01891344|580756371|FG002|Overall Study|Ongoing|0|||
160827517|NCT01891344|580756372|FG003|Overall Study|Ongoing|1|||
160827518|NCT01891344|580756373|FG004|Overall Study|Ongoing|4|||
160827519|NCT01891344|580756374|FG005|Overall Study|Ongoing|1|||
160827520|NCT01891344|580756375|FG006|Overall Study|Ongoing|0|||
160827521|NCT01891344|580756376|FG007|Overall Study|Ongoing|0|||
160827522|NCT01852825|580756377|FG000|Overall Study|Withdrawal by Subject|2|||
160827523|NCT01852825|580756378|FG001|Overall Study|Withdrawal by Subject|0|||
160827524|NCT01852825|580756379|FG002|Overall Study|Withdrawal by Subject|0|||
160827525|NCT00186537|580756380|FG000|Overall Study|Withdrawal by Subject|4|||
160827526|NCT00186537|580756381|FG001|Overall Study|Withdrawal by Subject|0|||
160827527|NCT00186537|580756382|FG002|Overall Study|Withdrawal by Subject|3|||
160827528|NCT00186537|580756380|FG000|Overall Study|ALT > 1.5 x ULN|3|||
160827529|NCT00186537|580756381|FG001|Overall Study|ALT > 1.5 x ULN|0|||
160827530|NCT00186537|580756382|FG002|Overall Study|ALT > 1.5 x ULN|0|||
160827531|NCT02120365|580756388|FG000|Overall Study|Withdrawal by Subject|0|||
160827532|NCT02120365|580756389|FG001|Overall Study|Withdrawal by Subject|0|||
160827533|NCT02120365|580756390|FG002|Overall Study|Withdrawal by Subject|2|||
160827534|NCT02120365|580756391|FG003|Overall Study|Withdrawal by Subject|4|||
160827535|NCT02120365|580756392|FG004|Overall Study|Withdrawal by Subject|0|||
160827536|NCT02120365|580756393|FG005|Overall Study|Withdrawal by Subject|2|||
160827537|NCT02305849|580756394|FG000|Overall Study|Adverse Event|10|||
160827538|NCT02305849|580756395|FG001|Overall Study|Adverse Event|12|||
160827539|NCT02305849|580756396|FG002|Overall Study|Adverse Event|7|||
160827540|NCT02305849|580756397|FG003|Overall Study|Adverse Event|3|||
160827541|NCT02305849|580756394|FG000|Overall Study|Lack of Efficacy|10|||
160827542|NCT02305849|580756395|FG001|Overall Study|Lack of Efficacy|6|||
160827543|NCT02305849|580756396|FG002|Overall Study|Lack of Efficacy|3|||
160827544|NCT02305849|580756397|FG003|Overall Study|Lack of Efficacy|9|||
160827545|NCT02305849|580756394|FG000|Overall Study|Withdrawal by Subject|2|||
160827546|NCT02305849|580756395|FG001|Overall Study|Withdrawal by Subject|2|||
160827547|NCT02305849|580756396|FG002|Overall Study|Withdrawal by Subject|1|||
160827548|NCT02305849|580756397|FG003|Overall Study|Withdrawal by Subject|4|||
160827549|NCT02305849|580756394|FG000|Overall Study|Lost to Follow-up|0|||
160827550|NCT02305849|580756395|FG001|Overall Study|Lost to Follow-up|2|||
160827551|NCT02305849|580756396|FG002|Overall Study|Lost to Follow-up|0|||
160827552|NCT02305849|580756397|FG003|Overall Study|Lost to Follow-up|0|||
160827553|NCT02305849|580756394|FG000|Overall Study|Protocol Violation|3|||
160827554|NCT02305849|580756395|FG001|Overall Study|Protocol Violation|2|||
160827555|NCT02305849|580756396|FG002|Overall Study|Protocol Violation|1|||
160827556|NCT02305849|580756397|FG003|Overall Study|Protocol Violation|1|||
160827557|NCT02305849|580756394|FG000|Overall Study|Lab data met discontinuation criteria|0|||
160990517|NCT03590743|581351839|FG001|Overall Study|Withdrawal by Subject|1|||
160827558|NCT02305849|580756395|FG001|Overall Study|Lab data met discontinuation criteria|1|||
160827559|NCT02305849|580756396|FG002|Overall Study|Lab data met discontinuation criteria|2|||
160827560|NCT02305849|580756397|FG003|Overall Study|Lab data met discontinuation criteria|1|||
160827561|NCT02305849|580756394|FG000|Overall Study|Miscellaneous|1|||
160827562|NCT02305849|580756395|FG001|Overall Study|Miscellaneous|2|||
160827563|NCT02305849|580756396|FG002|Overall Study|Miscellaneous|4|||
160827564|NCT02305849|580756397|FG003|Overall Study|Miscellaneous|1|||
160827565|NCT02305849|580756394|FG000|Overall Study|Not fulfill eligibility criteria|1|||
160827566|NCT02305849|580756395|FG001|Overall Study|Not fulfill eligibility criteria|1|||
160827567|NCT02305849|580756396|FG002|Overall Study|Not fulfill eligibility criteria|0|||
160827568|NCT02305849|580756397|FG003|Overall Study|Not fulfill eligibility criteria|0|||
160827569|NCT00355342|580756398|FG000|Overall Study|Adverse Event|13|||
160827570|NCT00355342|580756399|FG001|Overall Study|Adverse Event|15|||
160827571|NCT00355342|580756398|FG000|Overall Study|Lost to Follow-up|4|||
160827572|NCT00355342|580756399|FG001|Overall Study|Lost to Follow-up|2|||
160827573|NCT00355342|580756398|FG000|Overall Study|Withdrawal by Subject|14|||
160827574|NCT00355342|580756399|FG001|Overall Study|Withdrawal by Subject|11|||
160827575|NCT00355342|580756398|FG000|Overall Study|Sponsor terminated study|2|||
160827576|NCT00355342|580756399|FG001|Overall Study|Sponsor terminated study|2|||
160827577|NCT00355342|580756398|FG000|Overall Study|Overcompliant-PI discretion|1|||
160827578|NCT00355342|580756399|FG001|Overall Study|Overcompliant-PI discretion|0|||
160827579|NCT00355342|580756398|FG000|Overall Study|Use of prohibited medication|1|||
160827580|NCT00355342|580756399|FG001|Overall Study|Use of prohibited medication|0|||
160827581|NCT00355342|580756398|FG000|Overall Study|COPD exacerbation|1|||
160827582|NCT00355342|580756399|FG001|Overall Study|COPD exacerbation|1|||
160827583|NCT00355342|580756398|FG000|Overall Study|Dispensed wrong study drug kit|1|||
160827584|NCT00355342|580756399|FG001|Overall Study|Dispensed wrong study drug kit|0|||
160827585|NCT00355342|580756398|FG000|Overall Study|Non-compliance with Dexa scans|1|||
160827586|NCT00355342|580756399|FG001|Overall Study|Non-compliance with Dexa scans|0|||
160827587|NCT00355342|580756398|FG000|Overall Study|Withdrawal by participant and physician|1|||
160827588|NCT00355342|580756399|FG001|Overall Study|Withdrawal by participant and physician|0|||
160827589|NCT00355342|580756398|FG000|Overall Study|Participant relocated|0|||
160827590|NCT00355342|580756399|FG001|Overall Study|Participant relocated|1|||
160827591|NCT00355342|580756398|FG000|Overall Study|Participant discontinued study drug|0|||
160827592|NCT00355342|580756399|FG001|Overall Study|Participant discontinued study drug|1|||
160827593|NCT00355342|580756398|FG000|Overall Study|Study management|0|||
160827594|NCT00355342|580756399|FG001|Overall Study|Study management|1|||
160827595|NCT00355342|580756398|FG000|Overall Study|Protocol Violation|0|||
160827596|NCT00355342|580756399|FG001|Overall Study|Protocol Violation|1|||
160827597|NCT00355342|580756398|FG000|Overall Study|Use of protocol excluded medication|0|||
160827598|NCT00355342|580756399|FG001|Overall Study|Use of protocol excluded medication|1|||
160827599|NCT00495521|580756401|FG000|Overall Study|Physician Decision|0|||
160827600|NCT00495521|580756402|FG001|Overall Study|Physician Decision|1|||
160827601|NCT00693472|580756405|FG000|Part 1|Adverse Event|1|||
160827602|NCT00693472|580756406|FG001|Part 1|Adverse Event|1|||
160827603|NCT00693472|580756407|FG002|Part 1|Adverse Event|0|||
160827604|NCT00693472|580756408|FG003|Part 1|Adverse Event|0|||
160827605|NCT00693472|580756405|FG000|Part 1|Lost to Follow-up|0|||
160827606|NCT00693472|580756406|FG001|Part 1|Lost to Follow-up|1|||
160827607|NCT00693472|580756407|FG002|Part 1|Lost to Follow-up|0|||
160990518|NCT01190176|581351840|FG000|Overall Study|Withdrawal by Subject|1|||
160990519|NCT01190176|581351840|FG000|Overall Study|Lost to Follow-up|1|||
160990520|NCT01221181|581351841|FG000|Overall Study|Lost to Follow-up|1|||
160990521|NCT01290094|581351842|FG000|Overall Study|Withdrawal by Subject|1|||
160990522|NCT01290094|581351842|FG000|Overall Study|Lost to Follow-up|5|||
160990523|NCT02738840|581353866|FG000|Overall Study|MRI Scan not Performed|5|||
160990524|NCT02738840|581353866|FG000|Overall Study|Lost to Follow-up|1|||
160990525|NCT02738840|581353866|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
160990526|NCT02738840|581353866|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
160990527|NCT02466516|581353875|FG000|Overall Study|Adverse Event|1|||
160990528|NCT02466516|581353876|FG001|Overall Study|Adverse Event|1|||
160990529|NCT02466516|581353877|FG002|Overall Study|Adverse Event|0|||
160990530|NCT02466516|581353878|FG003|Overall Study|Adverse Event|0|||
160990531|NCT02466516|581353879|FG004|Overall Study|Adverse Event|0|||
160990532|NCT02466516|581353875|FG000|Overall Study|Withdrew Consent|1|||
160827608|NCT00693472|580756408|FG003|Part 1|Lost to Follow-up|0|||
160827609|NCT00693472|580756405|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
160827610|NCT00693472|580756406|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
160827611|NCT00693472|580756407|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
160990533|NCT02466516|581353876|FG001|Overall Study|Withdrew Consent|0|||
160990534|NCT02466516|581353877|FG002|Overall Study|Withdrew Consent|0|||
160990535|NCT02466516|581353878|FG003|Overall Study|Withdrew Consent|0|||
160990536|NCT02466516|581353879|FG004|Overall Study|Withdrew Consent|0|||
160827612|NCT00693472|580756408|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
160827613|NCT00693472|580756405|FG000|Part 2|Adverse Event|0|||
160827614|NCT00693472|580756406|FG001|Part 2|Adverse Event|0|||
160827615|NCT00693472|580756407|FG002|Part 2|Adverse Event|1|||
160827616|NCT00693472|580756408|FG003|Part 2|Adverse Event|0|||
160827617|NCT00693472|580756405|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
160827618|NCT00693472|580756406|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
160827619|NCT00693472|580756407|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
160827620|NCT00693472|580756408|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
160827621|NCT02782325|580756409|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
160827622|NCT02782325|580756410|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
160827623|NCT02782325|580756411|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
160827624|NCT02782325|580756409|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
160827625|NCT02782325|580756410|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
160827626|NCT02782325|580756411|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
160827627|NCT00042432|580756414|FG000|Overall Study|Adverse Event|4|||
160827628|NCT00042432|580756415|FG001|Overall Study|Adverse Event|1|||
160827629|NCT00042432|580756414|FG000|Overall Study|Withdrawal by Subject|1|||
160827630|NCT00042432|580756415|FG001|Overall Study|Withdrawal by Subject|3|||
160827631|NCT00042432|580756414|FG000|Overall Study|Death|0|||
160827632|NCT00042432|580756415|FG001|Overall Study|Death|2|||
160827633|NCT00042432|580756414|FG000|Overall Study|Ineligibility determined|1|||
160827634|NCT00042432|580756415|FG001|Overall Study|Ineligibility determined|0|||
160827635|NCT00042432|580756414|FG000|Overall Study|Initiation of maintenance dialysis|1|||
160827636|NCT00042432|580756415|FG001|Overall Study|Initiation of maintenance dialysis|1|||
160827637|NCT00042432|580756414|FG000|Overall Study|Other|2|||
160827638|NCT00042432|580756415|FG001|Overall Study|Other|0|||
160827639|NCT01527383|580756416|FG000|Overall Study|Adverse Event|5|||
160827640|NCT01527383|580756417|FG001|Overall Study|Adverse Event|0|||
160827641|NCT01527383|580756416|FG000|Overall Study|Lost to Follow-up|3|||
160827642|NCT01527383|580756417|FG001|Overall Study|Lost to Follow-up|0|||
160827643|NCT01527383|580756416|FG000|Overall Study|Physician Decision|2|||
160827644|NCT01527383|580756417|FG001|Overall Study|Physician Decision|0|||
160827645|NCT01527383|580756416|FG000|Overall Study|Pregnancy|1|||
160827646|NCT01527383|580756417|FG001|Overall Study|Pregnancy|0|||
160827647|NCT01527383|580756416|FG000|Overall Study|Protocol Violation|1|||
160827648|NCT01527383|580756417|FG001|Overall Study|Protocol Violation|0|||
160827649|NCT01527383|580756416|FG000|Overall Study|Screen failure|1|||
160827650|NCT01527383|580756417|FG001|Overall Study|Screen failure|0|||
160827651|NCT01527383|580756416|FG000|Overall Study|Participant moved|0|||
160827652|NCT01527383|580756417|FG001|Overall Study|Participant moved|1|||
160827653|NCT01527383|580756416|FG000|Overall Study|Withdrawal by Subject|2|||
160827654|NCT01527383|580756417|FG001|Overall Study|Withdrawal by Subject|3|||
160827655|NCT00849875|580756418|FG000|Overall Study|Death|28|||
160827656|NCT00849875|580756418|FG000|Overall Study|Ongoing (unknown completion status)|11|||
160827657|NCT00849875|580756418|FG000|Overall Study|Others|6|||
160827658|NCT00849875|580756418|FG000|Overall Study|Lost to Follow-up|2|||
160827659|NCT00461305|580756419|FG000|Treatment|Adverse Event|26|||
160827660|NCT00461305|580756420|FG001|Treatment|Adverse Event|3|||
160827661|NCT00461305|580756419|FG000|Treatment|Lost to Follow-up|4|||
160827662|NCT00461305|580756420|FG001|Treatment|Lost to Follow-up|2|||
160827663|NCT00461305|580756419|FG000|Treatment|Protocol Violation|13|||
160827664|NCT00461305|580756420|FG001|Treatment|Protocol Violation|2|||
160827665|NCT00461305|580756419|FG000|Treatment|Withdrawal by Subject|48|||
160827666|NCT00461305|580756420|FG001|Treatment|Withdrawal by Subject|2|||
160827667|NCT00461305|580756419|FG000|Treatment|Never dispensed|5|||
160827668|NCT00461305|580756420|FG001|Treatment|Never dispensed|0|||
160827669|NCT00461305|580756419|FG000|Treatment|Study drug not taken|1|||
160827670|NCT00461305|580756420|FG001|Treatment|Study drug not taken|0|||
160827671|NCT00461305|580756419|FG000|Treatment|Partially missing diary|2|||
160827672|NCT00461305|580756420|FG001|Treatment|Partially missing diary|0|||
160902493|NCT00347360|581036039|FG008|Overall Study|Visits conflicted with new job|0|||
160902494|NCT00347360|581036040|FG009|Overall Study|Visits conflicted with new job|0|||
160902495|NCT00347360|581036041|FG010|Overall Study|Visits conflicted with new job|0|||
160902496|NCT00347360|581036042|FG011|Overall Study|Visits conflicted with new job|0|||
160902497|NCT00347360|581036043|FG012|Overall Study|Visits conflicted with new job|0|||
160902498|NCT00347360|581036044|FG013|Overall Study|Visits conflicted with new job|0|||
160902499|NCT00347360|581036045|FG014|Overall Study|Visits conflicted with new job|0|||
160902500|NCT01449539|581036046|FG000|Overall Study|Withdrawal by Subject|3|||
160902501|NCT01449539|581036046|FG000|Overall Study|Toxicity not study related|1|||
160646854|NCT03532009|580090015|FG001|Overall Study|Other|1|||
160902502|NCT01387789|581036047|FG000|Overall Study|Adverse Event|5|||
160646855|NCT03532009|580090014|FG000|Overall Study|Death|1|||
160827673|NCT00461305|580756419|FG000|Treatment|Other (missing drug etc)|2|||
160827674|NCT00461305|580756420|FG001|Treatment|Other (missing drug etc)|0|||
160827675|NCT00461305|580756419|FG000|Continued Treatment|Adverse Event|26|||
160827676|NCT00461305|580756420|FG001|Continued Treatment|Adverse Event|0|||
160827677|NCT00461305|580756419|FG000|Continued Treatment|Lost to Follow-up|4|||
160827678|NCT00461305|580756420|FG001|Continued Treatment|Lost to Follow-up|0|||
160827679|NCT00461305|580756419|FG000|Continued Treatment|Protocol Violation|13|||
160827680|NCT00461305|580756420|FG001|Continued Treatment|Protocol Violation|0|||
160902503|NCT01387789|581036047|FG000|Overall Study|Lack of Efficacy|2|||
160902504|NCT01387789|581036047|FG000|Overall Study|Lost to Follow-up|1|||
160827681|NCT00461305|580756419|FG000|Continued Treatment|Withdrawal by Subject|48|||
160827682|NCT00461305|580756420|FG001|Continued Treatment|Withdrawal by Subject|0|||
160827683|NCT00461305|580756419|FG000|Continued Treatment|Partially missing diary|2|||
160827684|NCT00461305|580756420|FG001|Continued Treatment|Partially missing diary|0|||
160827685|NCT00461305|580756419|FG000|Continued Treatment|Other (missing drug etc)|2|||
160827686|NCT00461305|580756420|FG001|Continued Treatment|Other (missing drug etc)|0|||
160827687|NCT04342689|580756424|FG000|Overall Study|Withdrawal by Subject|32|||
160827688|NCT04342689|580756425|FG001|Overall Study|Withdrawal by Subject|33|||
160827689|NCT04342689|580756424|FG000|Overall Study|Lost to Follow-up|10|||
160827690|NCT04342689|580756425|FG001|Overall Study|Lost to Follow-up|12|||
160827691|NCT00844805|580756427|FG000|Treatment Phase|Adverse Event|5|||
160827692|NCT00844805|580756428|FG001|Treatment Phase|Adverse Event|1|||
160827693|NCT00844805|580756429|FG002|Treatment Phase|Adverse Event|0|||
160827694|NCT00844805|580756430|FG003|Treatment Phase|Adverse Event|0|||
160827695|NCT00844805|580756427|FG000|Treatment Phase|Withdrawal by Subject|3|||
160827696|NCT00844805|580756428|FG001|Treatment Phase|Withdrawal by Subject|4|||
160827697|NCT00844805|580756429|FG002|Treatment Phase|Withdrawal by Subject|0|||
160827698|NCT00844805|580756430|FG003|Treatment Phase|Withdrawal by Subject|0|||
160827699|NCT00844805|580756427|FG000|Treatment Phase|Noncompliance With Protocol|1|||
160827700|NCT00844805|580756428|FG001|Treatment Phase|Noncompliance With Protocol|0|||
160827701|NCT00844805|580756429|FG002|Treatment Phase|Noncompliance With Protocol|0|||
160827702|NCT00844805|580756430|FG003|Treatment Phase|Noncompliance With Protocol|0|||
160827703|NCT00844805|580756427|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
160827704|NCT00844805|580756428|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
160827705|NCT00844805|580756429|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
160827706|NCT00844805|580756430|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
160827707|NCT00844805|580756427|FG000|Follow-Up Phase|Adverse Event|0|||
160827708|NCT00844805|580756428|FG001|Follow-Up Phase|Adverse Event|0|||
160827709|NCT00844805|580756429|FG002|Follow-Up Phase|Adverse Event|1|||
160827710|NCT00844805|580756430|FG003|Follow-Up Phase|Adverse Event|0|||
160827711|NCT00844805|580756427|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
160827712|NCT00844805|580756428|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
160827713|NCT00844805|580756429|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
160827714|NCT00844805|580756430|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
160827715|NCT00844805|580756427|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
160827716|NCT00844805|580756428|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
160827717|NCT00844805|580756429|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
160827718|NCT00844805|580756430|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
160827719|NCT00844805|580756427|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
160827720|NCT00844805|580756428|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
160827721|NCT00844805|580756429|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
160827722|NCT00844805|580756430|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
160827723|NCT00844805|580756427|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
160827724|NCT00844805|580756428|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
160827725|NCT00844805|580756429|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
160827726|NCT00844805|580756430|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
160827727|NCT00259298|580756434|FG000|Overall Study|Withdrawal by Subject|1|||
160827728|NCT00259298|580756434|FG000|Overall Study|Physician Decision|2|||
160827729|NCT01367704|580756435|FG000|Overall Study|Lost to Follow-up|47|||
160827730|NCT01367704|580756436|FG001|Overall Study|Lost to Follow-up|161|||
160827731|NCT01011933|580756437|FG000|Overall Study|Wrong cell type|1|||
160827732|NCT01011933|580756437|FG000|Overall Study|Improper pre-protocol Rx|1|||
160827733|NCT01011933|580756437|FG000|Overall Study|Inadequate pathology|1|||
160827734|NCT01011933|580756437|FG000|Overall Study|Never treated|1|||
160827735|NCT00475865|580756439|FG000|Overall Study|Adverse Event|0|||
160827736|NCT00475865|580756440|FG001|Overall Study|Adverse Event|3|||
160827737|NCT00475865|580756441|FG002|Overall Study|Adverse Event|4|||
160827738|NCT00475865|580756439|FG000|Overall Study|Lack of Efficacy|1|||
160827739|NCT00475865|580756440|FG001|Overall Study|Lack of Efficacy|0|||
160827740|NCT00475865|580756441|FG002|Overall Study|Lack of Efficacy|0|||
160827741|NCT00475865|580756439|FG000|Overall Study|Progressive disease|0|||
160827742|NCT00475865|580756440|FG001|Overall Study|Progressive disease|1|||
160827743|NCT00475865|580756441|FG002|Overall Study|Progressive disease|2|||
160827744|NCT00475865|580756439|FG000|Overall Study|Participant did not wish to continue|1|||
160827745|NCT00475865|580756440|FG001|Overall Study|Participant did not wish to continue|0|||
160827746|NCT00475865|580756441|FG002|Overall Study|Participant did not wish to continue|0|||
160827747|NCT00475865|580756439|FG000|Overall Study|Other than above|0|||
160827748|NCT00475865|580756440|FG001|Overall Study|Other than above|1|||
160827749|NCT00475865|580756441|FG002|Overall Study|Other than above|0|||
160827750|NCT04316741|580756442|FG000|Baseline Enrollment|Lost to Follow-up|1|||
160827751|NCT04316741|580756443|FG001|Baseline Enrollment|Lost to Follow-up|1|||
160827752|NCT04316741|580756442|FG000|Immediate Post-Test|Lost to Follow-up|5|||
160827753|NCT04316741|580756443|FG001|Immediate Post-Test|Lost to Follow-up|1|||
160827754|NCT04316741|580756442|FG000|1-month Post-test|Lost to Follow-up|7|||
160827755|NCT04316741|580756443|FG001|1-month Post-test|Lost to Follow-up|2|||
160827756|NCT04316741|580756442|FG000|3-month Follow-up|Lost to Follow-up|10|||
160827757|NCT04316741|580756443|FG001|3-month Follow-up|Lost to Follow-up|2|||
160827758|NCT02726880|580756444|FG000|Overall Study|Withdrawal by Subject|2|||
160827759|NCT02726880|580756445|FG001|Overall Study|Withdrawal by Subject|0|||
160827760|NCT02726880|580756444|FG000|Overall Study|Lost to Follow-up|1|||
160827761|NCT02726880|580756445|FG001|Overall Study|Lost to Follow-up|3|||
160827762|NCT00787202|580756446|FG000|Overall Study|Adverse Event|3|||
160827763|NCT00787202|580756447|FG001|Overall Study|Adverse Event|2|||
160827764|NCT00787202|580756448|FG002|Overall Study|Adverse Event|0|||
160827765|NCT00787202|580756449|FG003|Overall Study|Adverse Event|0|||
160827766|NCT00787202|580756450|FG004|Overall Study|Adverse Event|2|||
160827767|NCT00787202|580756446|FG000|Overall Study|Lack of Efficacy|5|||
160827768|NCT00787202|580756447|FG001|Overall Study|Lack of Efficacy|6|||
160827769|NCT00787202|580756448|FG002|Overall Study|Lack of Efficacy|5|||
160827770|NCT00787202|580756449|FG003|Overall Study|Lack of Efficacy|2|||
160827771|NCT00787202|580756450|FG004|Overall Study|Lack of Efficacy|1|||
160827772|NCT00787202|580756446|FG000|Overall Study|Lost to Follow-up|1|||
160827773|NCT00787202|580756447|FG001|Overall Study|Lost to Follow-up|0|||
160827774|NCT00787202|580756448|FG002|Overall Study|Lost to Follow-up|0|||
160827775|NCT00787202|580756449|FG003|Overall Study|Lost to Follow-up|0|||
160827776|NCT00787202|580756450|FG004|Overall Study|Lost to Follow-up|0|||
160827777|NCT00787202|580756446|FG000|Overall Study|Withdrawal by Subject|2|||
160827778|NCT00787202|580756447|FG001|Overall Study|Withdrawal by Subject|2|||
160827779|NCT00787202|580756448|FG002|Overall Study|Withdrawal by Subject|2|||
160827780|NCT00787202|580756449|FG003|Overall Study|Withdrawal by Subject|0|||
160827781|NCT00787202|580756450|FG004|Overall Study|Withdrawal by Subject|0|||
160827782|NCT00787202|580756446|FG000|Overall Study|Protocol Violation|2|||
160827783|NCT00787202|580756447|FG001|Overall Study|Protocol Violation|1|||
160827784|NCT00787202|580756448|FG002|Overall Study|Protocol Violation|0|||
160827785|NCT00787202|580756449|FG003|Overall Study|Protocol Violation|0|||
160827786|NCT00787202|580756450|FG004|Overall Study|Protocol Violation|1|||
160827787|NCT00787202|580756446|FG000|Overall Study|Randomized, not treated|1|||
160827788|NCT00787202|580756447|FG001|Overall Study|Randomized, not treated|0|||
160827789|NCT00787202|580756448|FG002|Overall Study|Randomized, not treated|0|||
160827790|NCT00787202|580756449|FG003|Overall Study|Randomized, not treated|0|||
160827791|NCT00787202|580756450|FG004|Overall Study|Randomized, not treated|0|||
160827792|NCT01510145|580756451|FG000|Overall Study|Adverse Event|6|||
160827793|NCT01510145|580756451|FG000|Overall Study|Lost to Follow-up|5|||
160827794|NCT01510145|580756451|FG000|Overall Study|Withdrawal by Subject|6|||
160556094|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
160556095|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
160556096|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
160556097|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
160556098|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
160556099|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
160556100|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
160556101|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
160556102|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
160556103|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
160556104|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
160556105|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
160556106|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
160556107|NCT00289913|579761450|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
160827795|NCT01510145|580756451|FG000|Overall Study|Relative reported subject withdrew|1|||
160827796|NCT01442064|580756452|FG000|Overall Study|Adverse Event|2|||
160827797|NCT01442064|580756453|FG001|Overall Study|Adverse Event|2|||
160827798|NCT01442064|580756454|FG002|Overall Study|Adverse Event|2|||
160827799|NCT01442064|580756455|FG003|Overall Study|Adverse Event|1|||
160827800|NCT01442064|580756456|FG004|Overall Study|Adverse Event|2|||
160827801|NCT01442064|580756457|FG005|Overall Study|Adverse Event|0|||
160827802|NCT01442064|580756452|FG000|Overall Study|Death|0|||
160827803|NCT01442064|580756453|FG001|Overall Study|Death|1|||
160827804|NCT01442064|580756454|FG002|Overall Study|Death|3|||
160827805|NCT01442064|580756455|FG003|Overall Study|Death|3|||
160827806|NCT01442064|580756456|FG004|Overall Study|Death|1|||
160827807|NCT01442064|580756457|FG005|Overall Study|Death|3|||
160827808|NCT01442064|580756452|FG000|Overall Study|Lost to Follow-up|5|||
160827809|NCT01442064|580756453|FG001|Overall Study|Lost to Follow-up|5|||
160827810|NCT01442064|580756454|FG002|Overall Study|Lost to Follow-up|1|||
160827811|NCT01442064|580756455|FG003|Overall Study|Lost to Follow-up|1|||
160827812|NCT01442064|580756456|FG004|Overall Study|Lost to Follow-up|3|||
160827813|NCT01442064|580756457|FG005|Overall Study|Lost to Follow-up|3|||
160827814|NCT01442064|580756452|FG000|Overall Study|Physician Decision|1|||
160827815|NCT01442064|580756453|FG001|Overall Study|Physician Decision|1|||
160827816|NCT01442064|580756454|FG002|Overall Study|Physician Decision|2|||
160827817|NCT01442064|580756455|FG003|Overall Study|Physician Decision|3|||
160827818|NCT01442064|580756456|FG004|Overall Study|Physician Decision|3|||
160827819|NCT01442064|580756457|FG005|Overall Study|Physician Decision|1|||
160827820|NCT01442064|580756452|FG000|Overall Study|Withdrawal by Subject|6|||
160827821|NCT01442064|580756453|FG001|Overall Study|Withdrawal by Subject|3|||
160827822|NCT01442064|580756454|FG002|Overall Study|Withdrawal by Subject|2|||
160827823|NCT01442064|580756455|FG003|Overall Study|Withdrawal by Subject|2|||
160827824|NCT01442064|580756456|FG004|Overall Study|Withdrawal by Subject|2|||
160827825|NCT01442064|580756457|FG005|Overall Study|Withdrawal by Subject|1|||
160827826|NCT01442064|580756452|FG000|Overall Study|Sponsor decision|82|||
160827827|NCT01442064|580756453|FG001|Overall Study|Sponsor decision|88|||
160827828|NCT01442064|580756454|FG002|Overall Study|Sponsor decision|92|||
160827829|NCT01442064|580756455|FG003|Overall Study|Sponsor decision|88|||
160827830|NCT01442064|580756456|FG004|Overall Study|Sponsor decision|95|||
160827831|NCT01442064|580756457|FG005|Overall Study|Sponsor decision|87|||
160827832|NCT01442064|580756452|FG000|Overall Study|Subject non-compliance|0|||
160827833|NCT01442064|580756453|FG001|Overall Study|Subject non-compliance|0|||
160827834|NCT01442064|580756454|FG002|Overall Study|Subject non-compliance|0|||
160827835|NCT01442064|580756455|FG003|Overall Study|Subject non-compliance|0|||
160827836|NCT01442064|580756456|FG004|Overall Study|Subject non-compliance|0|||
160827837|NCT01442064|580756457|FG005|Overall Study|Subject non-compliance|2|||
160827838|NCT01442064|580756452|FG000|Overall Study|Condition mandated other intervention|1|||
160827839|NCT01442064|580756453|FG001|Overall Study|Condition mandated other intervention|1|||
160827840|NCT01442064|580756454|FG002|Overall Study|Condition mandated other intervention|2|||
160827841|NCT01442064|580756455|FG003|Overall Study|Condition mandated other intervention|0|||
160827842|NCT01442064|580756456|FG004|Overall Study|Condition mandated other intervention|0|||
160827843|NCT01442064|580756457|FG005|Overall Study|Condition mandated other intervention|2|||
160827844|NCT01360398|580756460|FG000|Overall Study|Withdrawal by Subject|14|||
160827845|NCT01360398|580756460|FG000|Overall Study|Other|7|||
160827846|NCT01360398|580756460|FG000|Overall Study|Migrated/moved from study area|1|||
160827847|NCT02153346|580756461|FG000|Overall Study|Lost to Follow-up|11|||
160827848|NCT01710527|580756462|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
160827849|NCT01710527|580756463|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
160827850|NCT01822535|580756464|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
160827851|NCT01822535|580756465|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
160827852|NCT01822535|580756464|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
160827853|NCT01822535|580756465|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
160827854|NCT01822535|580756464|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
160827855|NCT01822535|580756465|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
160827856|NCT02278614|580756468|FG000|Overall Study|Withdrawal by Subject|3|||
160827857|NCT02278614|580756469|FG001|Overall Study|Withdrawal by Subject|5|||
160827858|NCT02278614|580756468|FG000|Overall Study|Adverse Event|1|||
160827859|NCT02278614|580756469|FG001|Overall Study|Adverse Event|0|||
160827860|NCT02278614|580756468|FG000|Overall Study|left eye was not eligible|1|||
160827861|NCT02278614|580756469|FG001|Overall Study|left eye was not eligible|0|||
160902505|NCT00913380|581036050|FG000|Clinical Outcomes|Lost to Follow-up|6|||
160902506|NCT00913380|581036051|FG001|Clinical Outcomes|Lost to Follow-up|6|||
160902507|NCT02187744|581036052|FG000|Study|Participant refused further follow-up|1|||
160902508|NCT02187744|581036053|FG001|Study|Participant refused further follow-up|0|||
160902509|NCT02187744|581036052|FG000|Study|Other|2|||
160902510|NCT02187744|581036053|FG001|Study|Other|1|||
160827862|NCT02279498|580756470|FG000|Overall Study|Adverse Event|3|||
160902511|NCT02187744|581036052|FG000|Study|Lost to Follow-up|0|||
160902512|NCT02187744|581036053|FG001|Study|Lost to Follow-up|2|||
160827863|NCT02279498|580756471|FG001|Overall Study|Adverse Event|0|||
160827864|NCT02279498|580756470|FG000|Overall Study|Lack of Efficacy|4|||
160827865|NCT02279498|580756471|FG001|Overall Study|Lack of Efficacy|0|||
160827866|NCT02279498|580756470|FG000|Overall Study|Lost to Follow-up|0|||
160827867|NCT02279498|580756471|FG001|Overall Study|Lost to Follow-up|1|||
160827868|NCT02279498|580756470|FG000|Overall Study|Withdrawal by Subject|9|||
160827869|NCT02279498|580756471|FG001|Overall Study|Withdrawal by Subject|2|||
160827870|NCT02279498|580756470|FG000|Overall Study|Undefined|2|||
160827871|NCT02279498|580756471|FG001|Overall Study|Undefined|1|||
160827872|NCT00737711|580756474|FG000|Overall Study|Adverse Event|2|||
160902513|NCT02187744|581036052|FG000|Study|Related adverse event, not serious|0|||
160646856|NCT03532009|580090015|FG001|Overall Study|Death|1|||
160646857|NCT03532009|580090014|FG000|Overall Study|Withdrawal by Patient|0|||
160646858|NCT03532009|580090015|FG001|Overall Study|Withdrawal by Patient|2|||
160646859|NCT00368966|580090016|FG000|Infant Series|Withdrawal by Subject|11|||
160646860|NCT00368966|580090017|FG001|Infant Series|Withdrawal by Subject|6|||
160646861|NCT00368966|580090016|FG000|Infant Series|Protocol Violation|2|||
160646862|NCT00368966|580090017|FG001|Infant Series|Protocol Violation|1|||
160646863|NCT00368966|580090016|FG000|Infant Series|Lost to Follow-up|2|||
160646864|NCT00368966|580090017|FG001|Infant Series|Lost to Follow-up|0|||
160646865|NCT00368966|580090016|FG000|Infant Series|Randomization error|0|||
160646866|NCT00368966|580090017|FG001|Infant Series|Randomization error|1|||
160646867|NCT00368966|580090016|FG000|Infant Series|Failed to meet eligibility criteria|0|||
160646868|NCT00368966|580090017|FG001|Infant Series|Failed to meet eligibility criteria|1|||
160646869|NCT00368966|580090016|FG000|Infant Series|Adverse Event|0|||
160646870|NCT00368966|580090017|FG001|Infant Series|Adverse Event|1|||
160646871|NCT00368966|580090016|FG000|Infant Series|Failed to return|1|||
160646872|NCT00368966|580090017|FG001|Infant Series|Failed to return|0|||
160646873|NCT00368966|580090016|FG000|After Infant|Failed to return|3|||
160646874|NCT00368966|580090017|FG001|After Infant|Failed to return|1|||
160646875|NCT00368966|580090016|FG000|After Infant|Adverse Event|1|||
160646876|NCT00368966|580090017|FG001|After Infant|Adverse Event|2|||
160646877|NCT00368966|580090016|FG000|After Infant|Withdrawal by Subject|1|||
160646878|NCT00368966|580090017|FG001|After Infant|Withdrawal by Subject|1|||
160646879|NCT00368966|580090016|FG000|After Infant|Death|1|||
160646880|NCT00368966|580090017|FG001|After Infant|Death|0|||
160646881|NCT00368966|580090016|FG000|After Infant|Lost to Follow-up|0|||
160646882|NCT00368966|580090017|FG001|After Infant|Lost to Follow-up|1|||
160646883|NCT00368966|580090016|FG000|Toddler Dose|Withdrawal by Subject|1|||
160646884|NCT00368966|580090017|FG001|Toddler Dose|Withdrawal by Subject|1|||
160646885|NCT00368966|580090016|FG000|Toddler Dose|Lost to Follow-up|0|||
160646886|NCT00368966|580090017|FG001|Toddler Dose|Lost to Follow-up|2|||
160646887|NCT02866175|580090022|FG000|Overall Study|Adverse Event|56|||
160646888|NCT02866175|580090023|FG001|Overall Study|Adverse Event|54|||
160646889|NCT02866175|580090022|FG000|Overall Study|Withdrawal by Subject|31|||
160646890|NCT02866175|580090023|FG001|Overall Study|Withdrawal by Subject|52|||
160646891|NCT02866175|580090022|FG000|Overall Study|Death|30|||
160646892|NCT02866175|580090023|FG001|Overall Study|Death|23|||
160646893|NCT02866175|580090022|FG000|Overall Study|Other|7|||
160646894|NCT02866175|580090023|FG001|Overall Study|Other|14|||
160646895|NCT02866175|580090022|FG000|Overall Study|Progressive disease|1|||
160646896|NCT02866175|580090023|FG001|Overall Study|Progressive disease|1|||
160646897|NCT02866175|580090022|FG000|Overall Study|Lost to Follow-up|2|||
160646898|NCT02866175|580090023|FG001|Overall Study|Lost to Follow-up|0|||
160646899|NCT02866175|580090022|FG000|Overall Study|Lack of Efficacy|0|||
160646900|NCT02866175|580090023|FG001|Overall Study|Lack of Efficacy|1|||
160827873|NCT00737711|580756474|FG000|Overall Study|Death|8|||
160827874|NCT00737711|580756474|FG000|Overall Study|Failure to return|4|||
160827875|NCT00737711|580756474|FG000|Overall Study|Protocol Violation|1|||
160827876|NCT00737711|580756474|FG000|Overall Study|Withdrawal by Subject|5|||
160827877|NCT00737711|580756474|FG000|Overall Study|Blood transfusion|6|||
160827878|NCT00737711|580756474|FG000|Overall Study|Other|5|||
160827879|NCT02739321|580756475|FG000|Overall Study|Lack of Efficacy|1|||
160827880|NCT02739321|580756476|FG001|Overall Study|Lack of Efficacy|1|||
160827881|NCT02739321|580756475|FG000|Overall Study|Lost to Follow-up|1|||
160827882|NCT02739321|580756476|FG001|Overall Study|Lost to Follow-up|1|||
160827883|NCT02739321|580756475|FG000|Overall Study|Withdrawal by Subject|1|||
160827884|NCT02739321|580756476|FG001|Overall Study|Withdrawal by Subject|2|||
160827885|NCT02558400|580756477|FG000|Overall Study|Adverse Event|47|||
160827886|NCT02558400|580756478|FG001|Overall Study|Adverse Event|53|||
160902514|NCT02187744|581036053|FG001|Study|Related adverse event, not serious|2|||
160902515|NCT02187744|581036052|FG000|Study|Death|1|||
160902516|NCT02187744|581036053|FG001|Study|Death|0|||
160902517|NCT02187744|581036052|FG000|Study|Related adverse event, serious non-fatal|0|||
160902518|NCT02187744|581036053|FG001|Study|Related adverse event, serious non-fatal|1|||
160646901|NCT02866175|580090022|FG000|Overall Study|Physician Decision|3|||
160646902|NCT02866175|580090023|FG001|Overall Study|Physician Decision|15|||
160646903|NCT02866175|580090022|FG000|Overall Study|Did not receive treatment|5|||
160902519|NCT02187744|581036052|FG000|Treatment|Death|1|||
160646904|NCT02866175|580090023|FG001|Overall Study|Did not receive treatment|15|||
160646905|NCT01694485|580090026|FG000|Overall Study|Withdrawal by Subject|20|||
160827887|NCT02558400|580756479|FG002|Overall Study|Adverse Event|4|||
160827888|NCT02558400|580756477|FG000|Overall Study|Withdrawal by Subject|13|||
160646906|NCT01694485|580090027|FG001|Overall Study|Withdrawal by Subject|6|||
160646907|NCT01694485|580090028|FG002|Overall Study|Withdrawal by Subject|7|||
160646908|NCT01694485|580090029|FG003|Overall Study|Withdrawal by Subject|25|||
160646909|NCT01694485|580090030|FG004|Overall Study|Withdrawal by Subject|18|||
160827889|NCT02558400|580756478|FG001|Overall Study|Withdrawal by Subject|9|||
160902520|NCT02187744|581036053|FG001|Treatment|Death|0|||
160902521|NCT02187744|581036052|FG000|Treatment|Related adverse event, serious non-fatal|0|||
160902522|NCT02187744|581036053|FG001|Treatment|Related adverse event, serious non-fatal|1|||
160646910|NCT01694485|580090026|FG000|Overall Study|Sponsor Decision|3|||
160827890|NCT02558400|580756479|FG002|Overall Study|Withdrawal by Subject|8|||
160827891|NCT02558400|580756477|FG000|Overall Study|Non-Compliant|0|||
160827892|NCT02558400|580756478|FG001|Overall Study|Non-Compliant|1|||
160827893|NCT02558400|580756479|FG002|Overall Study|Non-Compliant|3|||
160827894|NCT02558400|580756477|FG000|Overall Study|Lost to Follow-up|5|||
160827895|NCT02558400|580756478|FG001|Overall Study|Lost to Follow-up|5|||
160827896|NCT02558400|580756479|FG002|Overall Study|Lost to Follow-up|4|||
160827897|NCT02558400|580756477|FG000|Overall Study|Lack of Efficacy|0|||
160827898|NCT02558400|580756478|FG001|Overall Study|Lack of Efficacy|13|||
160827899|NCT02558400|580756479|FG002|Overall Study|Lack of Efficacy|1|||
160827900|NCT02558400|580756477|FG000|Overall Study|Disallowed Concurrent Medication|6|||
160827901|NCT02558400|580756478|FG001|Overall Study|Disallowed Concurrent Medication|7|||
160827902|NCT02558400|580756479|FG002|Overall Study|Disallowed Concurrent Medication|5|||
160827903|NCT02558400|580756477|FG000|Overall Study|Physician Decision|2|||
160827904|NCT02558400|580756478|FG001|Overall Study|Physician Decision|2|||
160827905|NCT02558400|580756479|FG002|Overall Study|Physician Decision|0|||
160827906|NCT02558400|580756477|FG000|Overall Study|Protocol Violation|6|||
160827907|NCT02558400|580756478|FG001|Overall Study|Protocol Violation|3|||
160827908|NCT02558400|580756479|FG002|Overall Study|Protocol Violation|8|||
160827909|NCT02558400|580756477|FG000|Overall Study|Death|0|||
160827910|NCT02558400|580756478|FG001|Overall Study|Death|1|||
160827911|NCT02558400|580756479|FG002|Overall Study|Death|0|||
160827912|NCT02558400|580756477|FG000|Overall Study|Ineligible for the study|0|||
160827913|NCT02558400|580756478|FG001|Overall Study|Ineligible for the study|2|||
160827914|NCT02558400|580756479|FG002|Overall Study|Ineligible for the study|0|||
160827915|NCT02230683|580756483|FG000|Overall Study|Adverse Event|1|||
160827916|NCT00624780|580756484|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
160827917|NCT00624780|580756485|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
160827918|NCT00624780|580756486|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
160827919|NCT00624780|580756487|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
160827920|NCT00624780|580756488|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
160827921|NCT00624780|580756489|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
160827922|NCT00624780|580756484|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
160827923|NCT00624780|580756485|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
160827924|NCT00624780|580756486|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
160827925|NCT00624780|580756487|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
160556108|NCT00289913|579761451|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
160556109|NCT00289913|579761452|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
160556110|NCT00289913|579761453|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
160556111|NCT00289913|579761454|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
160556112|NCT00289913|579761450|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556113|NCT00289913|579761451|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
160556114|NCT00289913|579761452|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556115|NCT00289913|579761453|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556116|NCT00289913|579761454|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
160556117|NCT00289913|579761450|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
160556118|NCT00289913|579761451|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
160556119|NCT00289913|579761452|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
160556120|NCT00289913|579761453|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
160556121|NCT00289913|579761454|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
160556122|NCT00289913|579761450|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
160556123|NCT00289913|579761451|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
160556124|NCT00289913|579761452|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
160556125|NCT00289913|579761453|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
160556126|NCT00289913|579761454|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
160556127|NCT00289913|579761450|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160556128|NCT00289913|579761451|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160556129|NCT00289913|579761452|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160556130|NCT00289913|579761453|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160646911|NCT01694485|580090027|FG001|Overall Study|Sponsor Decision|0|||
160827926|NCT00624780|580756488|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
160827927|NCT00624780|580756489|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
160827928|NCT00624780|580756484|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
160827929|NCT00624780|580756485|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
160827930|NCT00624780|580756486|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
160827931|NCT00624780|580756487|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
160827932|NCT00624780|580756488|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
160902523|NCT02187744|581036052|FG000|Treatment|Related adverse event, not serious|0|||
160990537|NCT02466516|581353875|FG000|Overall Study|Lost to Follow-up|2|||
160990538|NCT02466516|581353876|FG001|Overall Study|Lost to Follow-up|0|||
160827933|NCT00624780|580756489|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
160827934|NCT00624780|580756484|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
160827935|NCT00624780|580756485|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
160827936|NCT00624780|580756486|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
160827937|NCT00624780|580756487|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
160827938|NCT00624780|580756488|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
160827939|NCT00624780|580756489|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
160827940|NCT00624780|580756484|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
160827941|NCT00624780|580756485|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
160827942|NCT00624780|580756486|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
160827943|NCT00624780|580756487|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
160827944|NCT00624780|580756488|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
160827945|NCT00624780|580756489|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
160827946|NCT00624780|580756484|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
160827947|NCT00624780|580756485|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
160827948|NCT00624780|580756486|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
160827949|NCT00624780|580756487|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
160827950|NCT00624780|580756488|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
160827951|NCT00624780|580756489|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
160827952|NCT00624780|580756484|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
160827953|NCT00624780|580756485|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
160827954|NCT00624780|580756486|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
160827955|NCT00624780|580756487|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
160827956|NCT00624780|580756488|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
160827957|NCT00624780|580756489|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
160827958|NCT00624780|580756484|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
160827959|NCT00624780|580756485|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
160827960|NCT00624780|580756486|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
160990539|NCT02466516|581353877|FG002|Overall Study|Lost to Follow-up|1|||
160990540|NCT02466516|581353878|FG003|Overall Study|Lost to Follow-up|0|||
160827961|NCT00624780|580756487|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
160827962|NCT00624780|580756488|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
160827963|NCT00624780|580756489|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
160827964|NCT00624780|580756484|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
160827965|NCT00624780|580756485|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
160827966|NCT00624780|580756486|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
160827967|NCT00624780|580756487|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
160827968|NCT00624780|580756488|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
160827969|NCT00624780|580756489|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
160827970|NCT00624780|580756484|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
160827971|NCT00624780|580756485|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
160827972|NCT00624780|580756486|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
160827973|NCT00624780|580756487|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
160827974|NCT00624780|580756488|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
160827975|NCT00624780|580756489|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
160827976|NCT00624780|580756484|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
160827977|NCT00624780|580756485|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
160827978|NCT00624780|580756486|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
160827979|NCT00624780|580756487|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
160827980|NCT00624780|580756488|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
160990541|NCT02466516|581353879|FG004|Overall Study|Lost to Follow-up|0|||
160827981|NCT00624780|580756489|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
160990542|NCT04358549|581353880|FG000|Overall Study|Adverse Event|0|||
160990543|NCT04358549|581353881|FG001|Overall Study|Adverse Event|1|||
160990544|NCT04358549|581353880|FG000|Overall Study|Death|1|||
160990545|NCT04358549|581353881|FG001|Overall Study|Death|0|||
160827982|NCT00624780|580756484|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
160827983|NCT00624780|580756485|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
160827984|NCT00624780|580756486|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
160827985|NCT00624780|580756487|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
160827986|NCT00624780|580756488|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
160827987|NCT00624780|580756489|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
160827988|NCT00624780|580756484|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
160827989|NCT00624780|580756485|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
160990546|NCT04358549|581353880|FG000|Overall Study|Lost to Follow-up|2|||
160990547|NCT04358549|581353881|FG001|Overall Study|Lost to Follow-up|1|||
160646912|NCT01694485|580090028|FG002|Overall Study|Sponsor Decision|0|||
160990548|NCT04358549|581353880|FG000|Overall Study|Withdrawal by Subject|6|||
160990549|NCT04358549|581353881|FG001|Overall Study|Withdrawal by Subject|6|||
160990550|NCT04358549|581353880|FG000|Overall Study|Start remdesivir|1|||
160990551|NCT04358549|581353881|FG001|Overall Study|Start remdesivir|0|||
160990552|NCT00646451|581353882|FG000|Overall Study|Adverse Event|3|||
160990553|NCT00646451|581353883|FG001|Overall Study|Adverse Event|0|||
160990554|NCT00646451|581353882|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
160990555|NCT00646451|581353883|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
160990556|NCT04867902|581353884|FG000|Overall Study|Lost to Follow-up|1|||
160990557|NCT04867902|581353884|FG000|Overall Study|Withdrawal by Subject|2|||
160990558|NCT04867902|581353884|FG000|Overall Study|Protocol Violation|1|||
160990559|NCT00448864|581353887|FG000|Overall Study|Death|1|||
160990560|NCT00448864|581353888|FG001|Overall Study|Death|0|||
160990561|NCT00448864|581353889|FG002|Overall Study|Death|0|||
160990562|NCT00448864|581353887|FG000|Overall Study|Lost to Follow-up|3|||
160990563|NCT00448864|581353888|FG001|Overall Study|Lost to Follow-up|1|||
160990564|NCT00448864|581353889|FG002|Overall Study|Lost to Follow-up|0|||
160990565|NCT00448864|581353887|FG000|Overall Study|Physician Decision|1|||
160990566|NCT00448864|581353888|FG001|Overall Study|Physician Decision|0|||
160990567|NCT00448864|581353889|FG002|Overall Study|Physician Decision|1|||
160990568|NCT00448864|581353887|FG000|Overall Study|Withdrawal by Subject|0|||
160990569|NCT00448864|581353888|FG001|Overall Study|Withdrawal by Subject|2|||
160990570|NCT00448864|581353889|FG002|Overall Study|Withdrawal by Subject|0|||
160990571|NCT00448864|581353887|FG000|Overall Study|Protocol Violation|0|||
160990572|NCT00448864|581353888|FG001|Overall Study|Protocol Violation|2|||
160990573|NCT00448864|581353889|FG002|Overall Study|Protocol Violation|0|||
160990574|NCT01390857|581353890|FG000|Overall Study|Protocol Violation|2|||
160990575|NCT01390857|581353890|FG000|Overall Study|Lost to Follow-up|1|||
160990576|NCT01390857|581353890|FG000|Overall Study|No Visit after the First Visit|7|||
160827990|NCT00624780|580756486|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
160827991|NCT00624780|580756487|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
160827992|NCT00624780|580756488|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
160827993|NCT00624780|580756489|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
160827994|NCT00624780|580756484|FG000|Follow-up (Week 26)|Death|0|||
160827995|NCT00624780|580756485|FG001|Follow-up (Week 26)|Death|0|||
160827996|NCT00624780|580756486|FG002|Follow-up (Week 26)|Death|1|||
160827997|NCT00624780|580756487|FG003|Follow-up (Week 26)|Death|0|||
160827998|NCT00624780|580756488|FG004|Follow-up (Week 26)|Death|0|||
160827999|NCT00624780|580756489|FG005|Follow-up (Week 26)|Death|0|||
160828000|NCT00624780|580756484|FG000|Follow-up (Week 26)|Adverse Event|0|||
160828001|NCT00624780|580756485|FG001|Follow-up (Week 26)|Adverse Event|0|||
160828002|NCT00624780|580756486|FG002|Follow-up (Week 26)|Adverse Event|0|||
160828003|NCT00624780|580756487|FG003|Follow-up (Week 26)|Adverse Event|0|||
160828004|NCT00624780|580756488|FG004|Follow-up (Week 26)|Adverse Event|1|||
160828005|NCT00624780|580756489|FG005|Follow-up (Week 26)|Adverse Event|0|||
160828006|NCT00624780|580756484|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
160828007|NCT00624780|580756485|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
160828008|NCT00624780|580756486|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
160828009|NCT00624780|580756487|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
160828010|NCT00624780|580756488|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
160828011|NCT00624780|580756489|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
160828012|NCT00624780|580756484|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
160828013|NCT00624780|580756485|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
160828014|NCT00624780|580756486|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
160828015|NCT00624780|580756487|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
160990577|NCT01474538|581353892|FG000|Treatment Period 1|Death|1|||
160646913|NCT01694485|580090029|FG003|Overall Study|Sponsor Decision|2|||
160646914|NCT01694485|580090030|FG004|Overall Study|Sponsor Decision|0|||
160646915|NCT01694485|580090026|FG000|Overall Study|Lost to Follow-up|9|||
160646916|NCT01694485|580090027|FG001|Overall Study|Lost to Follow-up|1|||
160646917|NCT01694485|580090028|FG002|Overall Study|Lost to Follow-up|6|||
160646918|NCT01694485|580090029|FG003|Overall Study|Lost to Follow-up|10|||
160828016|NCT00624780|580756488|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
160990578|NCT01474538|581353893|FG001|Treatment Period 1|Death|0|||
160990579|NCT01474538|581353892|FG000|Treatment Period 1|Physician Decision|1|||
160990580|NCT01474538|581353893|FG001|Treatment Period 1|Physician Decision|0|||
160646919|NCT01694485|580090030|FG004|Overall Study|Lost to Follow-up|7|||
160828017|NCT00624780|580756489|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
160828018|NCT00624780|580756484|FG000|Follow-up (Week 26)|Other|1|||
160828019|NCT00624780|580756485|FG001|Follow-up (Week 26)|Other|1|||
160828020|NCT00624780|580756486|FG002|Follow-up (Week 26)|Other|0|||
160828021|NCT00624780|580756487|FG003|Follow-up (Week 26)|Other|0|||
160828022|NCT00624780|580756488|FG004|Follow-up (Week 26)|Other|0|||
160990581|NCT01474538|581353892|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160990582|NCT01474538|581353893|FG001|Treatment Period 1|Withdrawal by Subject|3|||
160990583|NCT01474538|581353892|FG000|Treatment Period 1|Protocol Violation|0|||
160990584|NCT01474538|581353893|FG001|Treatment Period 1|Protocol Violation|1|||
160828023|NCT00624780|580756489|FG005|Follow-up (Week 26)|Other|0|||
160990585|NCT01474538|581353892|FG000|Treatment Period 2|Death|1|||
160828024|NCT04068519|580756491|FG000|Dose Verification|Death|15|||
160828025|NCT04068519|580756491|FG000|Dose Verification|Withdrawal by Subject|1|||
160828026|NCT04068519|580756491|FG000|Pharmacokinetic Sub-study|Death|35|||
160828027|NCT04068519|580756491|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
160828028|NCT04068519|580756491|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
160828029|NCT04068519|580756491|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
160828030|NCT04068519|580756491|FG000|Indication Expansion|Death|152|||
160828031|NCT04068519|580756491|FG000|Indication Expansion|Withdrawal by Subject|10|||
160828032|NCT04068519|580756491|FG000|Indication Expansion|Lost to Follow-up|7|||
160828033|NCT00969761|580756492|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
160828034|NCT00969761|580756493|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828035|NCT00969761|580756494|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828036|NCT00969761|580756495|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
160828037|NCT00969761|580756496|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828038|NCT00969761|580756497|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828039|NCT00969761|580756498|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828040|NCT00969761|580756499|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828041|NCT00969761|580756500|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
160828042|NCT00969761|580756501|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
160828043|NCT00969761|580756502|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828044|NCT00969761|580756503|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828045|NCT00969761|580756492|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828046|NCT00969761|580756493|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828047|NCT00969761|580756494|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
160828048|NCT00969761|580756495|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828049|NCT00969761|580756496|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828050|NCT00969761|580756497|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828051|NCT00969761|580756498|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828052|NCT00969761|580756499|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160990586|NCT01474538|581353893|FG001|Treatment Period 2|Death|0|||
160990587|NCT01474538|581353892|FG000|Treatment Period 2|Adverse Event|1|||
160990588|NCT01474538|581353893|FG001|Treatment Period 2|Adverse Event|1|||
160990589|NCT01474538|581353892|FG000|Treatment Period 2|Withdrawal by Subject|2|||
160990590|NCT01474538|581353893|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160990591|NCT01474538|581353892|FG000|Treatment Period 2|Sponsor decision|1|||
160990592|NCT01474538|581353893|FG001|Treatment Period 2|Sponsor decision|0|||
160556131|NCT00289913|579761454|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
160556132|NCT00289913|579761450|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
160556133|NCT00289913|579761451|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
160556134|NCT00289913|579761452|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
160828053|NCT00969761|580756500|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828054|NCT00969761|580756501|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828055|NCT00969761|580756502|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828056|NCT00969761|580756503|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828057|NCT00969761|580756492|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828058|NCT00969761|580756493|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828059|NCT00969761|580756494|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
160828060|NCT00969761|580756495|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828061|NCT00969761|580756496|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828062|NCT00969761|580756497|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828063|NCT00969761|580756498|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828064|NCT00969761|580756499|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828065|NCT00969761|580756500|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828066|NCT00969761|580756501|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828067|NCT00969761|580756502|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828068|NCT00969761|580756503|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828069|NCT00969761|580756492|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160990593|NCT01474538|581353892|FG000|Treatment Period 2|Physician Decision|0|||
160990594|NCT01474538|581353893|FG001|Treatment Period 2|Physician Decision|1|||
160990595|NCT01474538|581353892|FG000|Treatment Period 2|Protocol Violation|1|||
160556135|NCT00289913|579761453|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
160556136|NCT00289913|579761454|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
160990596|NCT01474538|581353893|FG001|Treatment Period 2|Protocol Violation|0|||
160990597|NCT00367237|581353894|FG000|Overall Study|Adverse Event|7|||
160646920|NCT01694485|580090026|FG000|Overall Study|Death|1|||
160646921|NCT01694485|580090027|FG001|Overall Study|Death|0|||
160646922|NCT01694485|580090028|FG002|Overall Study|Death|0|||
160646923|NCT01694485|580090029|FG003|Overall Study|Death|1|||
160828070|NCT00969761|580756493|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828071|NCT00969761|580756494|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828072|NCT00969761|580756495|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160902524|NCT02187744|581036053|FG001|Treatment|Related adverse event, not serious|2|||
160902525|NCT02187744|581036052|FG000|Treatment|Lost to Follow-up|0|||
160902526|NCT02187744|581036053|FG001|Treatment|Lost to Follow-up|1|||
160902527|NCT02187744|581036052|FG000|Treatment|Other|2|||
160902528|NCT02187744|581036053|FG001|Treatment|Other|0|||
160902529|NCT02187744|581036052|FG000|Treatment|Participant refused continued treatment|1|||
160902530|NCT02187744|581036053|FG001|Treatment|Participant refused continued treatment|1|||
160902531|NCT00945893|581036054|FG000|Overall Study|Lost to Follow-up|2|||
160902532|NCT00945893|581036055|FG001|Overall Study|Lost to Follow-up|8|||
160902533|NCT00945893|581036054|FG000|Overall Study|Withdrawal of consent|1|||
160902534|NCT00945893|581036055|FG001|Overall Study|Withdrawal of consent|2|||
160902535|NCT03113071|581036056|FG000|Overall Study|Withdrawal by Subject|1|||
160828073|NCT00969761|580756496|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828074|NCT00969761|580756497|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828075|NCT00969761|580756498|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828076|NCT00969761|580756499|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828077|NCT00969761|580756500|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
160828078|NCT00969761|580756501|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160902536|NCT03113071|581036057|FG001|Overall Study|Withdrawal by Subject|0|||
160902537|NCT01602120|581036058|FG000|Overall Study|Adverse Event|3|||
160902538|NCT01602120|581036059|FG001|Overall Study|Adverse Event|6|||
160902539|NCT01602120|581036060|FG002|Overall Study|Adverse Event|0|||
160902540|NCT01602120|581036061|FG003|Overall Study|Adverse Event|2|||
160646924|NCT01694485|580090030|FG004|Overall Study|Death|0|||
160646925|NCT02907203|580090031|FG000|Overall Study|Death|1|||
160828079|NCT00969761|580756502|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828080|NCT00969761|580756503|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828081|NCT00969761|580756492|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
160902541|NCT01602120|581036058|FG000|Overall Study|Death|0|||
160828082|NCT00969761|580756493|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828083|NCT00969761|580756494|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
160828084|NCT00969761|580756495|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828085|NCT00969761|580756496|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
160828086|NCT00969761|580756497|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828087|NCT00969761|580756498|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828088|NCT00969761|580756499|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
160828089|NCT00969761|580756500|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
160828090|NCT00969761|580756501|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
160828091|NCT00969761|580756502|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828092|NCT00969761|580756503|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828093|NCT00969761|580756492|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828094|NCT00969761|580756493|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828095|NCT00969761|580756494|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828096|NCT00969761|580756495|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
160828097|NCT00969761|580756496|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
160902542|NCT01602120|581036059|FG001|Overall Study|Death|4|||
160902543|NCT01602120|581036060|FG002|Overall Study|Death|0|||
160902544|NCT01602120|581036061|FG003|Overall Study|Death|0|||
160902545|NCT01602120|581036058|FG000|Overall Study|Lost to Follow-up|0|||
160902546|NCT01602120|581036059|FG001|Overall Study|Lost to Follow-up|1|||
160902547|NCT01602120|581036060|FG002|Overall Study|Lost to Follow-up|0|||
160902548|NCT01602120|581036061|FG003|Overall Study|Lost to Follow-up|1|||
160902549|NCT01602120|581036058|FG000|Overall Study|Protocol Violation|1|||
160902550|NCT01602120|581036059|FG001|Overall Study|Protocol Violation|1|||
160902551|NCT01602120|581036060|FG002|Overall Study|Protocol Violation|0|||
160902552|NCT01602120|581036061|FG003|Overall Study|Protocol Violation|0|||
160902553|NCT01602120|581036058|FG000|Overall Study|Non-compliance|0|||
160902554|NCT01602120|581036059|FG001|Overall Study|Non-compliance|3|||
160902555|NCT01602120|581036060|FG002|Overall Study|Non-compliance|0|||
160902556|NCT01602120|581036061|FG003|Overall Study|Non-compliance|1|||
160902557|NCT01602120|581036058|FG000|Overall Study|Withdrawal by Subject|8|||
160902558|NCT01602120|581036059|FG001|Overall Study|Withdrawal by Subject|17|||
160902559|NCT01602120|581036060|FG002|Overall Study|Withdrawal by Subject|0|||
160902560|NCT01602120|581036061|FG003|Overall Study|Withdrawal by Subject|3|||
160902561|NCT01602120|581036058|FG000|Overall Study|Study Terminated by Sponsor|12|||
160902562|NCT01602120|581036059|FG001|Overall Study|Study Terminated by Sponsor|24|||
160902563|NCT01602120|581036060|FG002|Overall Study|Study Terminated by Sponsor|17|||
160902564|NCT01602120|581036061|FG003|Overall Study|Study Terminated by Sponsor|44|||
160902565|NCT01602120|581036058|FG000|Overall Study|Physician Decision|2|||
160556137|NCT00289913|579761450|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
160556138|NCT00289913|579761451|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
160556139|NCT00289913|579761452|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
160556140|NCT00289913|579761453|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
160556141|NCT00289913|579761454|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
160556142|NCT00289913|579761450|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
160556143|NCT00289913|579761451|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
160556144|NCT00289913|579761452|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
160556145|NCT00289913|579761453|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
160646926|NCT02907203|580090031|FG000|Overall Study|Lost to Follow-up|3|||
160646927|NCT02907203|580090031|FG000|Overall Study|Withdrawal by Subject|3|||
160646928|NCT02907203|580090031|FG000|Overall Study|Surgical bypass|1|||
160646929|NCT01418352|580090032|FG000|Overall Study|Lost to Follow-up|2|||
160646930|NCT01418352|580090033|FG001|Overall Study|Lost to Follow-up|0|||
160646931|NCT01418352|580090034|FG002|Overall Study|Lost to Follow-up|0|||
160646932|NCT01418352|580090035|FG003|Overall Study|Lost to Follow-up|0|||
160646933|NCT01418352|580090032|FG000|Overall Study|Adverse Event|0|||
160646934|NCT01418352|580090033|FG001|Overall Study|Adverse Event|1|||
160646935|NCT01418352|580090034|FG002|Overall Study|Adverse Event|0|||
160828098|NCT00969761|580756497|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160902566|NCT01602120|581036059|FG001|Overall Study|Physician Decision|3|||
160902567|NCT01602120|581036060|FG002|Overall Study|Physician Decision|0|||
160646936|NCT01418352|580090035|FG003|Overall Study|Adverse Event|0|||
160902568|NCT01602120|581036061|FG003|Overall Study|Physician Decision|0|||
160902569|NCT01602120|581036058|FG000|Overall Study|Unspecified Reason|3|||
160902570|NCT01602120|581036059|FG001|Overall Study|Unspecified Reason|1|||
160902571|NCT01602120|581036060|FG002|Overall Study|Unspecified Reason|0|||
160902572|NCT01602120|581036061|FG003|Overall Study|Unspecified Reason|2|||
160902573|NCT04502433|581036062|FG000|Overall Study|Death|2|||
160828099|NCT00969761|580756498|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828100|NCT00969761|580756499|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828101|NCT00969761|580756500|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
160828102|NCT00969761|580756501|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828103|NCT00969761|580756502|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828104|NCT00969761|580756503|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828105|NCT03081858|580758154|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
160828106|NCT03081858|580758155|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
160828107|NCT03081858|580758156|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
160828108|NCT03081858|580758157|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
160828109|NCT02936284|580758160|FG000|Overall Study|Withdrawal by Subject|3|||
160828110|NCT02936284|580758161|FG001|Overall Study|Withdrawal by Subject|1|||
160828111|NCT02936284|580758160|FG000|Overall Study|Lost to Follow-up|7|||
160828112|NCT02936284|580758161|FG001|Overall Study|Lost to Follow-up|8|||
160828113|NCT01610596|580758162|FG000|Overall Study|Lost to Follow-up|0|||
160828114|NCT01610596|580758163|FG001|Overall Study|Lost to Follow-up|1|||
160828115|NCT00799591|580758166|FG000|Overall Study|De-escalation of doses|20|||
160828116|NCT00799591|580758166|FG000|Overall Study|Death|14|||
160828117|NCT00799591|580758166|FG000|Overall Study|Technical failure|12|||
160828118|NCT00799591|580758166|FG000|Overall Study|Resistant germ|11|||
160828119|NCT00799591|580758166|FG000|Overall Study|New infection|4|||
160828120|NCT00799591|580758166|FG000|Overall Study|Resistance germ and technical failure|2|||
160828121|NCT00799591|580758166|FG000|Overall Study|Persistance of fever undetermined origin|1|||
160828122|NCT00799591|580758166|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
160828123|NCT00799591|580758166|FG000|Overall Study|Infectious origin not probable|1|||
160828124|NCT01765426|580758172|FG000|Overall Study|Lost to Follow-up|0|||
160828125|NCT01765426|580758173|FG001|Overall Study|Lost to Follow-up|1|||
160828126|NCT01765426|580758174|FG002|Overall Study|Lost to Follow-up|0|||
160828127|NCT01765426|580758175|FG003|Overall Study|Lost to Follow-up|0|||
160828128|NCT03351114|580758176|FG000|Overall Study|Withdrawal by Subject|1|||
160902574|NCT04502433|581036063|FG001|Overall Study|Death|4|||
160902575|NCT04502433|581036062|FG000|Overall Study|Lost to Follow-up|1|||
160902576|NCT04502433|581036063|FG001|Overall Study|Lost to Follow-up|0|||
160828129|NCT01665430|580758180|FG000|Overall Study|Adverse Event|1|||
160556146|NCT00289913|579761454|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
160556147|NCT00289913|579761450|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
160556148|NCT00289913|579761451|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
160556149|NCT00289913|579761452|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
160556150|NCT00289913|579761453|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
160556151|NCT00289913|579761454|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
160556152|NCT03822884|579761455|FG000|Overall Study|Withdrawal by Subject|0|||
160556153|NCT03822884|579761456|FG001|Overall Study|Withdrawal by Subject|0|||
160556154|NCT03822884|579761457|FG002|Overall Study|Withdrawal by Subject|0|||
160556155|NCT03822884|579761458|FG003|Overall Study|Withdrawal by Subject|0|||
160556156|NCT03822884|579761459|FG004|Overall Study|Withdrawal by Subject|1|||
160556157|NCT03822884|579761460|FG005|Overall Study|Withdrawal by Subject|0|||
160556158|NCT02357420|579761467|FG000|Overall Study|Adverse Event|3|||
160556159|NCT02357420|579761468|FG001|Overall Study|Adverse Event|3|||
160556160|NCT02357420|579761469|FG002|Overall Study|Adverse Event|8|||
160556161|NCT02357420|579761470|FG003|Overall Study|Adverse Event|9|||
160556162|NCT02357420|579761467|FG000|Overall Study|Investigator Decision|1|||
160556163|NCT02357420|579761468|FG001|Overall Study|Investigator Decision|0|||
160556164|NCT02357420|579761469|FG002|Overall Study|Investigator Decision|0|||
160556165|NCT02357420|579761470|FG003|Overall Study|Investigator Decision|0|||
160556166|NCT02357420|579761467|FG000|Overall Study|Prohibited Medication|1|||
160556167|NCT02357420|579761468|FG001|Overall Study|Prohibited Medication|1|||
160556168|NCT02357420|579761469|FG002|Overall Study|Prohibited Medication|0|||
160556169|NCT02357420|579761470|FG003|Overall Study|Prohibited Medication|0|||
160556170|NCT02357420|579761467|FG000|Overall Study|Protocol Non-compliance|0|||
160556171|NCT02357420|579761468|FG001|Overall Study|Protocol Non-compliance|0|||
160556172|NCT02357420|579761469|FG002|Overall Study|Protocol Non-compliance|0|||
160556173|NCT02357420|579761470|FG003|Overall Study|Protocol Non-compliance|1|||
160556174|NCT02357420|579761467|FG000|Overall Study|Withdrawn Consent|4|||
160828130|NCT01665430|580758180|FG000|Overall Study|Withdrawal by Subject|6|||
160828131|NCT01665430|580758180|FG000|Overall Study|Other Unspecified|2|||
160828132|NCT02310230|580758181|FG000|Overall Study|Physician Decision|1|||
160556175|NCT02357420|579761468|FG001|Overall Study|Withdrawn Consent|8|||
160556176|NCT02357420|579761469|FG002|Overall Study|Withdrawn Consent|6|||
160556177|NCT02357420|579761470|FG003|Overall Study|Withdrawn Consent|6|||
160556178|NCT02357420|579761467|FG000|Overall Study|Lost to Follow-up|3|||
160828133|NCT02310230|580758182|FG001|Overall Study|Physician Decision|3|||
160828134|NCT02310230|580758181|FG000|Overall Study|monitor baseline taken after induction|2|||
160828135|NCT02310230|580758182|FG001|Overall Study|monitor baseline taken after induction|7|||
160828136|NCT02310230|580758181|FG000|Overall Study|Poor signal quality|5|||
160828137|NCT02310230|580758182|FG001|Overall Study|Poor signal quality|8|||
160828138|NCT02310230|580758181|FG000|Overall Study|Case cancelled|1|||
160828139|NCT02310230|580758182|FG001|Overall Study|Case cancelled|0|||
160828140|NCT00989235|580758183|FG000|Overall Study|Death|0|||
160828141|NCT00989235|580758184|FG001|Overall Study|Death|1|||
160828142|NCT00989235|580758183|FG000|Overall Study|Adverse Event|0|||
160902577|NCT04502433|581036062|FG000|Overall Study|Physician Decision|0|||
160902578|NCT04502433|581036063|FG001|Overall Study|Physician Decision|1|||
160902579|NCT02369016|581036066|FG000|Overall Study|AE associated with clinical disease progression|2|||
160902580|NCT02369016|581036067|FG001|Overall Study|AE associated with clinical disease progression|1|||
160902581|NCT02369016|581036066|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
160556179|NCT02357420|579761468|FG001|Overall Study|Lost to Follow-up|0|||
160556180|NCT02357420|579761469|FG002|Overall Study|Lost to Follow-up|2|||
160556181|NCT02357420|579761470|FG003|Overall Study|Lost to Follow-up|3|||
160556182|NCT03617705|579761471|FG000|Overall Study|Withdrawal by Subject|2|||
160556183|NCT03617705|579761471|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
160556184|NCT03617705|579761471|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
160556185|NCT00364689|579761473|FG000|Overall Study|Lost to Follow-up|1|||
160556186|NCT01554579|579761475|FG000|Overall Study|Adverse Event|6|||
160556187|NCT01554579|579761476|FG001|Overall Study|Adverse Event|25|||
160556188|NCT01554579|579761475|FG000|Overall Study|Lack of Efficacy|2|||
160556189|NCT01554579|579761476|FG001|Overall Study|Lack of Efficacy|1|||
160556190|NCT01554579|579761475|FG000|Overall Study|Withdrawal by Subject|2|||
160556191|NCT01554579|579761476|FG001|Overall Study|Withdrawal by Subject|1|||
160556192|NCT01808612|579761477|FG000|Treatment Period|Adverse Event|8|||
160556193|NCT01808612|579761478|FG001|Treatment Period|Adverse Event|4|||
160556194|NCT01808612|579761479|FG002|Treatment Period|Adverse Event|3|||
160556195|NCT01808612|579761477|FG000|Treatment Period|Lost to Follow-up|2|||
160556196|NCT01808612|579761478|FG001|Treatment Period|Lost to Follow-up|2|||
160556197|NCT01808612|579761479|FG002|Treatment Period|Lost to Follow-up|1|||
160556198|NCT01808612|579761477|FG000|Treatment Period|Protocol Violation|1|||
160556199|NCT01808612|579761478|FG001|Treatment Period|Protocol Violation|0|||
160556200|NCT01808612|579761479|FG002|Treatment Period|Protocol Violation|0|||
160556201|NCT01808612|579761477|FG000|Treatment Period|Withdrawal by Subject|1|||
160556202|NCT01808612|579761478|FG001|Treatment Period|Withdrawal by Subject|0|||
160556203|NCT01808612|579761479|FG002|Treatment Period|Withdrawal by Subject|4|||
160556204|NCT01808612|579761477|FG000|Treatment Period|Physician Decision|1|||
160556205|NCT01808612|579761478|FG001|Treatment Period|Physician Decision|0|||
160556206|NCT01808612|579761479|FG002|Treatment Period|Physician Decision|4|||
160556207|NCT01808612|579761477|FG000|Treatment Period|Sponsor Decision|1|||
160556208|NCT01808612|579761478|FG001|Treatment Period|Sponsor Decision|0|||
160990598|NCT00367237|581353895|FG001|Overall Study|Adverse Event|2|||
160556209|NCT01808612|579761479|FG002|Treatment Period|Sponsor Decision|0|||
160556210|NCT01808612|579761477|FG000|Treatment Period|Lack of Efficacy|1|||
160556211|NCT01808612|579761478|FG001|Treatment Period|Lack of Efficacy|1|||
160828143|NCT00989235|580758184|FG001|Overall Study|Adverse Event|1|||
160828144|NCT00989235|580758183|FG000|Overall Study|Lack of Efficacy|1|||
160828145|NCT00989235|580758184|FG001|Overall Study|Lack of Efficacy|0|||
160828146|NCT00989235|580758183|FG000|Overall Study|Withdrawal of Consent|1|||
160828147|NCT00989235|580758184|FG001|Overall Study|Withdrawal of Consent|1|||
160828148|NCT00989235|580758183|FG000|Overall Study|Desire to Become Pregnant|1|||
160828149|NCT00989235|580758184|FG001|Overall Study|Desire to Become Pregnant|0|||
160828150|NCT00989235|580758183|FG000|Overall Study|Randomized by Mistake|0|||
160828151|NCT00989235|580758184|FG001|Overall Study|Randomized by Mistake|2|||
160828152|NCT00989235|580758183|FG000|Overall Study|Lost to Follow-up|0|||
160828153|NCT00989235|580758184|FG001|Overall Study|Lost to Follow-up|1|||
160828154|NCT03249935|580758185|FG000|Overall Study|Discharged from facility early|36|||
160828155|NCT03249935|580758185|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
160828156|NCT03249935|580758185|FG000|Overall Study|Protocol Violation|5|||
160828157|NCT00545532|580758186|FG000|Overall Study|Withdrawal by Subject|1|||
160828158|NCT00545532|580758187|FG001|Overall Study|Withdrawal by Subject|3|||
160828159|NCT00545532|580758186|FG000|Overall Study|Lost to Follow-up|5|||
160828160|NCT00545532|580758187|FG001|Overall Study|Lost to Follow-up|6|||
160828161|NCT00545532|580758186|FG000|Overall Study|Death|0|||
160828162|NCT00545532|580758187|FG001|Overall Study|Death|1|||
160828163|NCT03593681|580758190|FG000|Overall Study|Inadequate sample collected|12|||
160828164|NCT03593681|580758190|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
160828165|NCT03593681|580758190|FG000|Overall Study|Protocol Violation|3|||
160828166|NCT03593681|580758190|FG000|Overall Study|Withdrawal by Subject|3|||
160828167|NCT03593681|580758190|FG000|Overall Study|Procedure not attempted|3|||
160828168|NCT03593681|580758190|FG000|Overall Study|Adverse Event|2|||
160828169|NCT03593681|580758190|FG000|Overall Study|Physician Decision|1|||
160828170|NCT01149486|580758191|FG000|First Intervention|Adverse Event|0|||
160828171|NCT01149486|580758192|FG001|First Intervention|Adverse Event|1|||
160828172|NCT03630302|580758193|FG000|Surgery|hardware issue prevented LFP recordings|1|||
160828173|NCT03630302|580758193|FG000|3 Month Visit|Adverse Event|2|||
160828174|NCT03630302|580758193|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
160828175|NCT04662073|580758194|FG000|Overall Study|Withdrawal by Subject|1|||
160828176|NCT04662073|580758195|FG001|Overall Study|Withdrawal by Subject|0|||
160828177|NCT01135914|580758196|FG000|Overall Study|Withdrawal by Subject|1|||
160990599|NCT00367237|581353894|FG000|Overall Study|Lost to Follow-up|1|||
160990600|NCT00367237|581353895|FG001|Overall Study|Lost to Follow-up|0|||
160990601|NCT00367237|581353894|FG000|Overall Study|Withdrawal by Subject|0|||
160990602|NCT00367237|581353895|FG001|Overall Study|Withdrawal by Subject|4|||
160828178|NCT01135914|580758197|FG001|Overall Study|Withdrawal by Subject|3|||
160828179|NCT01135914|580758198|FG002|Overall Study|Withdrawal by Subject|6|||
160990603|NCT00367237|581353894|FG000|Overall Study|Protocol Violation|2|||
160828180|NCT01135914|580758196|FG000|Overall Study|Lost to Follow-up|1|||
160828181|NCT01135914|580758197|FG001|Overall Study|Lost to Follow-up|0|||
160902582|NCT02369016|581036067|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
160902583|NCT02369016|581036066|FG000|Overall Study|Progressive disease - clinical progression|1|||
160902584|NCT02369016|581036067|FG001|Overall Study|Progressive disease - clinical progression|4|||
160902585|NCT02369016|581036066|FG000|Overall Study|withdrawal by patient|4|||
160902586|NCT02369016|581036067|FG001|Overall Study|withdrawal by patient|0|||
160902587|NCT02369016|581036066|FG000|Overall Study|Progressive disease - radiological progression|6|||
160902588|NCT02369016|581036067|FG001|Overall Study|Progressive disease - radiological progression|2|||
160556212|NCT01808612|579761479|FG002|Treatment Period|Lack of Efficacy|2|||
160902589|NCT04203797|581036068|FG000|Overall Study|Adverse Event|1|||
160902590|NCT04203797|581036069|FG001|Overall Study|Adverse Event|0|||
160902591|NCT04203797|581036068|FG000|Overall Study|Did not complete End of Study follow-up|1|||
160902592|NCT04203797|581036069|FG001|Overall Study|Did not complete End of Study follow-up|0|||
160902593|NCT00300274|581036070|FG000|Overall Study|Withdrawal by Subject|12|||
160902594|NCT00300274|581036071|FG001|Overall Study|Withdrawal by Subject|3|||
160902595|NCT00300274|581036072|FG002|Overall Study|Withdrawal by Subject|14|||
160902596|NCT00300274|581036070|FG000|Overall Study|Lost to Follow-up|3|||
160902597|NCT00300274|581036071|FG001|Overall Study|Lost to Follow-up|4|||
160902598|NCT00300274|581036072|FG002|Overall Study|Lost to Follow-up|5|||
160902599|NCT00300274|581036070|FG000|Overall Study|Death|31|||
160902600|NCT00300274|581036071|FG001|Overall Study|Death|20|||
160902601|NCT00300274|581036072|FG002|Overall Study|Death|25|||
160902602|NCT00300274|581036070|FG000|Overall Study|Re-transplant|0|||
160902603|NCT00300274|581036071|FG001|Overall Study|Re-transplant|0|||
160556213|NCT01808612|579761477|FG000|Discontinuation Period|Adverse Event|1|||
160556214|NCT01808612|579761478|FG001|Discontinuation Period|Adverse Event|0|||
160556215|NCT01808612|579761479|FG002|Discontinuation Period|Adverse Event|0|||
160556216|NCT01808612|579761477|FG000|Discontinuation Period|Physician Decision|1|||
160556217|NCT01808612|579761478|FG001|Discontinuation Period|Physician Decision|0|||
160556218|NCT01808612|579761479|FG002|Discontinuation Period|Physician Decision|0|||
160556219|NCT01808612|579761477|FG000|Discontinuation Period|Lost to Follow-up|0|||
160556220|NCT01808612|579761478|FG001|Discontinuation Period|Lost to Follow-up|1|||
160556221|NCT01808612|579761479|FG002|Discontinuation Period|Lost to Follow-up|0|||
160556222|NCT03683394|579761480|FG000|Overall Study|Withdrawal by Subject|4|||
160556223|NCT03683394|579761481|FG001|Overall Study|Withdrawal by Subject|8|||
160556224|NCT03683394|579761480|FG000|Overall Study|Lost to Follow-up|7|||
160556225|NCT03683394|579761481|FG001|Overall Study|Lost to Follow-up|0|||
160556226|NCT03683394|579761480|FG000|Overall Study|Death|3|||
160556227|NCT03683394|579761481|FG001|Overall Study|Death|1|||
160556228|NCT00110019|579761482|FG000|Overall Study|Lack of Efficacy|253|||
160556229|NCT00110019|579761483|FG001|Overall Study|Lack of Efficacy|285|||
160556230|NCT00110019|579761482|FG000|Overall Study|Adverse Event|61|||
160556231|NCT00110019|579761483|FG001|Overall Study|Adverse Event|40|||
160556232|NCT00110019|579761482|FG000|Overall Study|Death|13|||
160556233|NCT00110019|579761483|FG001|Overall Study|Death|15|||
160556234|NCT00110019|579761482|FG000|Overall Study|Withdrawal by Subject|21|||
160556235|NCT00110019|579761483|FG001|Overall Study|Withdrawal by Subject|9|||
160556236|NCT00110019|579761482|FG000|Overall Study|alternative therapy|5|||
160556237|NCT00110019|579761483|FG001|Overall Study|alternative therapy|1|||
160556238|NCT00110019|579761482|FG000|Overall Study|complicating disease|1|||
160556239|NCT00110019|579761483|FG001|Overall Study|complicating disease|1|||
160556240|NCT00110019|579761482|FG000|Overall Study|symptom deterioration|13|||
160556241|NCT00110019|579761483|FG001|Overall Study|symptom deterioration|16|||
160556242|NCT00110019|579761482|FG000|Overall Study|Not start protocol therapy|17|||
160556243|NCT00110019|579761483|FG001|Overall Study|Not start protocol therapy|16|||
160556244|NCT00110019|579761482|FG000|Overall Study|other reasons|22|||
160556245|NCT00110019|579761483|FG001|Overall Study|other reasons|30|||
160556246|NCT03072160|579761484|FG000|Overall Study|Adverse Event|3|||
160556247|NCT03072160|579761485|FG001|Overall Study|Adverse Event|1|||
160556248|NCT03072160|579761484|FG000|Overall Study|Refused further treatment|6|||
160556249|NCT03072160|579761485|FG001|Overall Study|Refused further treatment|1|||
160556250|NCT03072160|579761484|FG000|Overall Study|Physician Decision|1|||
160556251|NCT03072160|579761485|FG001|Overall Study|Physician Decision|0|||
160556252|NCT03072160|579761484|FG000|Overall Study|Disease progression on study|1|||
160556253|NCT03072160|579761485|FG001|Overall Study|Disease progression on study|1|||
160556254|NCT03072160|579761484|FG000|Overall Study|No contact|0|||
160556255|NCT03072160|579761485|FG001|Overall Study|No contact|1|||
160556256|NCT01046695|579761486|FG000|Overall Study|Subject had a pacemaker|0|||
160556257|NCT01046695|579761487|FG001|Overall Study|Subject had a pacemaker|1|||
160556258|NCT01046695|579761486|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
160556259|NCT01046695|579761487|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
160556260|NCT00531960|579761488|FG000|Overall Study|Adverse Event|5|||
160556261|NCT00531960|579761489|FG001|Overall Study|Adverse Event|4|||
160556262|NCT00531960|579761488|FG000|Overall Study|Death|3|||
160556263|NCT00531960|579761489|FG001|Overall Study|Death|2|||
160556264|NCT00531960|579761488|FG000|Overall Study|Lack of Efficacy|42|||
160828182|NCT01135914|580758198|FG002|Overall Study|Lost to Follow-up|1|||
160828183|NCT01135914|580758196|FG000|Overall Study|Protocol Violation|0|||
160828184|NCT01135914|580758197|FG001|Overall Study|Protocol Violation|0|||
160828185|NCT01135914|580758198|FG002|Overall Study|Protocol Violation|3|||
160828186|NCT01135914|580758196|FG000|Overall Study|Lack of Efficacy|2|||
160828187|NCT01135914|580758197|FG001|Overall Study|Lack of Efficacy|1|||
160828188|NCT01135914|580758198|FG002|Overall Study|Lack of Efficacy|10|||
160828189|NCT01135914|580758196|FG000|Overall Study|Adverse Event|0|||
160828190|NCT01135914|580758197|FG001|Overall Study|Adverse Event|1|||
160828191|NCT01135914|580758198|FG002|Overall Study|Adverse Event|2|||
160828192|NCT00598078|580758199|FG000|Period 2 (Day 2)|Adverse Event|1|||
160828193|NCT00598078|580758200|FG001|Period 2 (Day 2)|Adverse Event|0|||
160828194|NCT01479595|580758205|FG000|Overall Study|Protocol deviation|0|||
160828195|NCT01479595|580758206|FG001|Overall Study|Protocol deviation|1|||
160828196|NCT01479595|580758205|FG000|Overall Study|Adverse Event|2|||
160828197|NCT01479595|580758206|FG001|Overall Study|Adverse Event|1|||
160828198|NCT03366103|580758207|FG000|Overall Study|Disease Progression|3|||
160828199|NCT03366103|580758208|FG001|Overall Study|Disease Progression|1|||
160828200|NCT03366103|580758209|FG002|Overall Study|Disease Progression|0|||
160828201|NCT03366103|580758207|FG000|Overall Study|Adverse Event|0|||
160828202|NCT03366103|580758208|FG001|Overall Study|Adverse Event|1|||
160828203|NCT03366103|580758209|FG002|Overall Study|Adverse Event|0|||
160828204|NCT01344629|580758214|FG000|Crossover Period 2|Withdrawal by Subject|0|||
160828205|NCT01344629|580758215|FG001|Crossover Period 2|Withdrawal by Subject|1|||
160828206|NCT00900146|580758216|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
160828207|NCT00900146|580758217|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
160828208|NCT00900146|580758218|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
160828209|NCT00900146|580758219|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
160828210|NCT00900146|580758220|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
160828211|NCT00900146|580758216|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
160828212|NCT00900146|580758217|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
160828213|NCT00900146|580758218|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
160828214|NCT00900146|580758219|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
160828215|NCT00900146|580758220|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
160828216|NCT00900146|580758216|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
160828217|NCT00900146|580758217|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
160828218|NCT00900146|580758218|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
160828219|NCT00900146|580758219|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
160828220|NCT00900146|580758220|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
160828221|NCT00900146|580758216|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
160902604|NCT00300274|581036072|FG002|Overall Study|Re-transplant|1|||
160902605|NCT00242216|581036073|FG000|Overall Study|Lost to Follow-up|12|||
160902606|NCT00242216|581036074|FG001|Overall Study|Lost to Follow-up|17|||
160902607|NCT00242216|581036073|FG000|Overall Study|Death|4|||
160902608|NCT00242216|581036074|FG001|Overall Study|Death|2|||
160902609|NCT00242216|581036073|FG000|Overall Study|Lack of Efficacy|1|||
160902610|NCT00242216|581036074|FG001|Overall Study|Lack of Efficacy|2|||
160902611|NCT00242216|581036073|FG000|Overall Study|no medicaiton dispensed|1|||
160902612|NCT00242216|581036074|FG001|Overall Study|no medicaiton dispensed|1|||
160902613|NCT02484690|581036075|FG000|Overall Study|Adverse Event|1|||
160902614|NCT02484690|581036076|FG001|Overall Study|Adverse Event|3|||
160902615|NCT02484690|581036077|FG002|Overall Study|Adverse Event|0|||
160902616|NCT02484690|581036078|FG003|Overall Study|Adverse Event|0|||
160902617|NCT02484690|581036079|FG004|Overall Study|Adverse Event|5|||
160902618|NCT02484690|581036075|FG000|Overall Study|Death|0|||
160902619|NCT02484690|581036076|FG001|Overall Study|Death|0|||
160902620|NCT02484690|581036077|FG002|Overall Study|Death|0|||
160902621|NCT02484690|581036078|FG003|Overall Study|Death|0|||
160902622|NCT02484690|581036079|FG004|Overall Study|Death|1|||
160902623|NCT02484690|581036075|FG000|Overall Study|Withdrawal by Subject|1|||
160902624|NCT02484690|581036076|FG001|Overall Study|Withdrawal by Subject|3|||
160990604|NCT00367237|581353895|FG001|Overall Study|Protocol Violation|5|||
160990605|NCT02501629|581353896|FG000|Overall Study|Death|0|||
160828222|NCT00900146|580758217|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
160828223|NCT00900146|580758218|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
160828224|NCT00900146|580758219|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
160828225|NCT00900146|580758220|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
160828226|NCT00900146|580758216|FG000|Intermediate: Period III|Lost to Follow-up|2|||
160902625|NCT02484690|581036077|FG002|Overall Study|Withdrawal by Subject|1|||
160902626|NCT02484690|581036078|FG003|Overall Study|Withdrawal by Subject|2|||
160902627|NCT02484690|581036079|FG004|Overall Study|Withdrawal by Subject|0|||
160902628|NCT02484690|581036075|FG000|Overall Study|Physician Decision|2|||
160902629|NCT02484690|581036076|FG001|Overall Study|Physician Decision|0|||
160902630|NCT02484690|581036077|FG002|Overall Study|Physician Decision|1|||
160902631|NCT02484690|581036078|FG003|Overall Study|Physician Decision|0|||
160828227|NCT00900146|580758217|FG001|Intermediate: Period III|Lost to Follow-up|0|||
160828228|NCT00900146|580758218|FG002|Intermediate: Period III|Lost to Follow-up|0|||
160828229|NCT00900146|580758219|FG003|Intermediate: Period III|Lost to Follow-up|0|||
160828230|NCT00900146|580758220|FG004|Intermediate: Period III|Lost to Follow-up|1|||
160828231|NCT00900146|580758216|FG000|Intermediate: Period III|Administrative problems|85|||
160828232|NCT00900146|580758217|FG001|Intermediate: Period III|Administrative problems|92|||
160828233|NCT00900146|580758218|FG002|Intermediate: Period III|Administrative problems|84|||
160828234|NCT00900146|580758219|FG003|Intermediate: Period III|Administrative problems|90|||
160828235|NCT00900146|580758220|FG004|Intermediate: Period III|Administrative problems|163|||
160828236|NCT05590000|580758224|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
160828237|NCT00933244|580758225|FG000|Overall Study|Withdrawal by Subject|5|||
160828238|NCT00933244|580758226|FG001|Overall Study|Withdrawal by Subject|1|||
160828239|NCT00933244|580758227|FG002|Overall Study|Withdrawal by Subject|3|||
160828240|NCT01174004|580758228|FG000|Overall Study|Adverse Event|2|||
160828241|NCT01174004|580758229|FG001|Overall Study|Adverse Event|10|||
160828242|NCT01174004|580758228|FG000|Overall Study|Withdrawal by Subject|2|||
160828243|NCT01174004|580758229|FG001|Overall Study|Withdrawal by Subject|3|||
160828244|NCT01174004|580758228|FG000|Overall Study|At Discretion of Sponsor|2|||
160828245|NCT01174004|580758229|FG001|Overall Study|At Discretion of Sponsor|2|||
160828246|NCT01174004|580758228|FG000|Overall Study|Protocol Violation|0|||
160828247|NCT01174004|580758229|FG001|Overall Study|Protocol Violation|1|||
160556265|NCT00531960|579761489|FG001|Overall Study|Lack of Efficacy|41|||
160556266|NCT00531960|579761488|FG000|Overall Study|Violation of Selection Criteria|2|||
160556267|NCT00531960|579761489|FG001|Overall Study|Violation of Selection Criteria|0|||
160556268|NCT00531960|579761488|FG000|Overall Study|Refused Treatment|5|||
160556269|NCT00531960|579761489|FG001|Overall Study|Refused Treatment|6|||
160556270|NCT00531960|579761488|FG000|Overall Study|Other|4|||
160556271|NCT00531960|579761489|FG001|Overall Study|Other|10|||
160556272|NCT03603652|579761495|FG000|Overall Study|Death|2|||
160556273|NCT01014585|579761498|FG000|Overall Study|Adverse Event|0|||
160556274|NCT01014585|579761499|FG001|Overall Study|Adverse Event|2|||
160556275|NCT01014585|579761500|FG002|Overall Study|Adverse Event|0|||
160556276|NCT01014585|579761501|FG003|Overall Study|Adverse Event|3|||
160556277|NCT01014585|579761498|FG000|Overall Study|Withdrawal by Subject|2|||
160556278|NCT01014585|579761499|FG001|Overall Study|Withdrawal by Subject|0|||
160556279|NCT01014585|579761500|FG002|Overall Study|Withdrawal by Subject|1|||
160556280|NCT01014585|579761501|FG003|Overall Study|Withdrawal by Subject|3|||
160556281|NCT01014585|579761498|FG000|Overall Study|Lost to Follow-up|0|||
160556282|NCT01014585|579761499|FG001|Overall Study|Lost to Follow-up|0|||
160556283|NCT01014585|579761500|FG002|Overall Study|Lost to Follow-up|0|||
160556284|NCT01014585|579761501|FG003|Overall Study|Lost to Follow-up|2|||
160556285|NCT01014585|579761498|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
160556286|NCT01014585|579761499|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
160556287|NCT01014585|579761500|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
160556288|NCT01014585|579761501|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
160556289|NCT00508391|579761505|FG000|First Treatment|Withdrawal by Subject|6|||
160556290|NCT00508391|579761506|FG001|First Treatment|Withdrawal by Subject|3|||
160556291|NCT00508391|579761505|FG000|Second Treatment|Withdrawal by Subject|2|||
160556292|NCT00508391|579761506|FG001|Second Treatment|Withdrawal by Subject|0|||
160556293|NCT00880256|579761507|FG000|Overall Study|Lost to Follow-up|28|||
160556294|NCT01686568|579761511|FG000|Main Study|Withdrawal by Subject|1|||
160556295|NCT01686568|579761512|FG001|Main Study|Withdrawal by Subject|3|||
160556296|NCT01686568|579761511|FG000|Main Study|Noncompliance with protocol|0|||
160556297|NCT01686568|579761512|FG001|Main Study|Noncompliance with protocol|1|||
160556298|NCT01686568|579761511|FG000|Main Study|Liver enzymes above range of exclusion|1|||
160556299|NCT01686568|579761512|FG001|Main Study|Liver enzymes above range of exclusion|0|||
160556300|NCT01686568|579761511|FG000|Sub-Study|Not consented for sub-study|2|||
160556301|NCT01686568|579761512|FG001|Sub-Study|Not consented for sub-study|2|||
160828248|NCT01174004|580758228|FG000|Overall Study|Physician Decision|1|||
160828249|NCT01174004|580758229|FG001|Overall Study|Physician Decision|0|||
160828250|NCT02689076|580758230|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
160828251|NCT02689076|580758231|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
160828252|NCT02689076|580758232|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
160828253|NCT02689076|580758230|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
160828254|NCT02689076|580758231|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
160828255|NCT02689076|580758232|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
160828256|NCT02689076|580758230|FG000|Overall Study|Did not have an HIE match|2|||
160556302|NCT02601573|579761513|FG000|Overall Study|Lost to Follow-up|0|||
160556303|NCT02601573|579761514|FG001|Overall Study|Lost to Follow-up|3|||
160556304|NCT02601573|579761515|FG002|Overall Study|Lost to Follow-up|1|||
160556305|NCT02601573|579761516|FG003|Overall Study|Lost to Follow-up|0|||
160556306|NCT02601573|579761517|FG004|Overall Study|Lost to Follow-up|2|||
160556307|NCT02601573|579761513|FG000|Overall Study|Withdrawal by Subject|0|||
160556308|NCT02601573|579761514|FG001|Overall Study|Withdrawal by Subject|1|||
160556309|NCT02601573|579761515|FG002|Overall Study|Withdrawal by Subject|0|||
160556310|NCT02601573|579761516|FG003|Overall Study|Withdrawal by Subject|1|||
160556311|NCT02601573|579761517|FG004|Overall Study|Withdrawal by Subject|0|||
160556312|NCT01850615|579761518|FG000|Overall Study|Protocol Violation|4|||
160556313|NCT01850615|579761519|FG001|Overall Study|Protocol Violation|1|||
160556314|NCT01850615|579761518|FG000|Overall Study|Adverse Event|2|||
160556315|NCT01850615|579761519|FG001|Overall Study|Adverse Event|1|||
160556316|NCT01850615|579761518|FG000|Overall Study|Withdrawal by Subject|3|||
160556317|NCT01850615|579761519|FG001|Overall Study|Withdrawal by Subject|1|||
160556318|NCT01850615|579761518|FG000|Overall Study|Lost to Follow-up|0|||
160556319|NCT01850615|579761519|FG001|Overall Study|Lost to Follow-up|1|||
160556320|NCT01850615|579761518|FG000|Overall Study|Unclassified|0|||
160556321|NCT01850615|579761519|FG001|Overall Study|Unclassified|1|||
160556322|NCT00706628|579761520|FG000|Overall Study|Other Adverse Event|16|||
160556323|NCT00706628|579761521|FG001|Overall Study|Other Adverse Event|5|||
160556324|NCT00706628|579761522|FG002|Overall Study|Other Adverse Event|5|||
160556325|NCT00706628|579761523|FG003|Overall Study|Other Adverse Event|2|||
160556326|NCT00706628|579761520|FG000|Overall Study|Non compliant with protocol|0|||
160556327|NCT00706628|579761521|FG001|Overall Study|Non compliant with protocol|1|||
160556328|NCT00706628|579761522|FG002|Overall Study|Non compliant with protocol|0|||
160556329|NCT00706628|579761523|FG003|Overall Study|Non compliant with protocol|0|||
160556330|NCT00706628|579761520|FG000|Overall Study|Consent withdrawn|6|||
160556331|NCT00706628|579761521|FG001|Overall Study|Consent withdrawn|1|||
160556332|NCT00706628|579761522|FG002|Overall Study|Consent withdrawn|3|||
160556333|NCT00706628|579761523|FG003|Overall Study|Consent withdrawn|0|||
160556334|NCT00706628|579761520|FG000|Overall Study|Progressive disease|20|||
160556335|NCT00706628|579761521|FG001|Overall Study|Progressive disease|13|||
160556336|NCT00706628|579761522|FG002|Overall Study|Progressive disease|8|||
160556337|NCT00706628|579761523|FG003|Overall Study|Progressive disease|1|||
160556338|NCT00706628|579761520|FG000|Overall Study|Other than those stated above|4|||
160556339|NCT00706628|579761521|FG001|Overall Study|Other than those stated above|0|||
160556340|NCT00706628|579761522|FG002|Overall Study|Other than those stated above|0|||
160556341|NCT00706628|579761523|FG003|Overall Study|Other than those stated above|0|||
160556342|NCT00706628|579761520|FG000|Overall Study|Not treated|1|||
160556343|NCT00706628|579761521|FG001|Overall Study|Not treated|1|||
160556344|NCT00706628|579761522|FG002|Overall Study|Not treated|0|||
160556345|NCT00706628|579761523|FG003|Overall Study|Not treated|0|||
160556346|NCT03403400|579761524|FG000|Overall Study|Lost to Follow-up|1|||
160556347|NCT03403400|579761525|FG001|Overall Study|Lost to Follow-up|0|||
160556348|NCT03403400|579761526|FG002|Overall Study|Lost to Follow-up|1|||
160556349|NCT03403400|579761524|FG000|Overall Study|Hospitalization|1|||
160556350|NCT03403400|579761525|FG001|Overall Study|Hospitalization|0|||
160556351|NCT03403400|579761526|FG002|Overall Study|Hospitalization|0|||
160556352|NCT03403400|579761524|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
160556353|NCT03403400|579761525|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
160556354|NCT03403400|579761526|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
160556355|NCT01948830|579761530|FG000|Overall Study|Physician Decision|1|||
160556356|NCT01948830|579761531|FG001|Overall Study|Physician Decision|3|||
160556357|NCT01948830|579761530|FG000|Overall Study|Protocol deviation|1|||
160556358|NCT01948830|579761531|FG001|Overall Study|Protocol deviation|2|||
160556359|NCT01948830|579761530|FG000|Overall Study|Lost to Follow-up|5|||
160556360|NCT01948830|579761531|FG001|Overall Study|Lost to Follow-up|4|||
160646937|NCT01418352|580090032|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
160828257|NCT02689076|580758231|FG001|Overall Study|Did not have an HIE match|0|||
160828258|NCT02689076|580758232|FG002|Overall Study|Did not have an HIE match|0|||
160828259|NCT02689076|580758230|FG000|Overall Study|Death during non-VA encounter|2|||
160828260|NCT02689076|580758231|FG001|Overall Study|Death during non-VA encounter|5|||
160828261|NCT02689076|580758232|FG002|Overall Study|Death during non-VA encounter|0|||
160828262|NCT02689076|580758230|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
160828263|NCT02689076|580758231|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
160828264|NCT02689076|580758232|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
160828265|NCT02689076|580758230|FG000|Overall Study|Participant no longer active in VA system|1|||
160828266|NCT02689076|580758231|FG001|Overall Study|Participant no longer active in VA system|0|||
160828267|NCT02689076|580758232|FG002|Overall Study|Participant no longer active in VA system|0|||
160828268|NCT02689076|580758230|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
160902632|NCT02484690|581036079|FG004|Overall Study|Physician Decision|0|||
160556361|NCT01948830|579761530|FG000|Overall Study|Withdrawal by Subject|14|||
160556362|NCT01948830|579761531|FG001|Overall Study|Withdrawal by Subject|17|||
160556363|NCT01948830|579761530|FG000|Overall Study|Adverse Event|9|||
160556364|NCT01948830|579761531|FG001|Overall Study|Adverse Event|2|||
160556365|NCT01948830|579761530|FG000|Overall Study|Death|3|||
160556366|NCT01948830|579761531|FG001|Overall Study|Death|4|||
160556367|NCT01145560|579761532|FG000|Overall Study|Withdrawal by Subject|2|||
160556368|NCT01145560|579761533|FG001|Overall Study|Withdrawal by Subject|1|||
160556369|NCT01145560|579761534|FG002|Overall Study|Withdrawal by Subject|0|||
160556370|NCT01145560|579761532|FG000|Overall Study|Lost to Follow-up|1|||
160556371|NCT01145560|579761533|FG001|Overall Study|Lost to Follow-up|1|||
160556372|NCT01145560|579761534|FG002|Overall Study|Lost to Follow-up|1|||
160556373|NCT01145560|579761532|FG000|Overall Study|No study drug by 24h after organ failure|1|||
160556374|NCT01145560|579761533|FG001|Overall Study|No study drug by 24h after organ failure|0|||
160556375|NCT01145560|579761534|FG002|Overall Study|No study drug by 24h after organ failure|0|||
160556376|NCT01145560|579761532|FG000|Overall Study|Accidental unblinding of study treatment|0|||
160556377|NCT01145560|579761533|FG001|Overall Study|Accidental unblinding of study treatment|1|||
160556378|NCT01145560|579761534|FG002|Overall Study|Accidental unblinding of study treatment|0|||
160556379|NCT01145560|579761532|FG000|Overall Study|False insurance information|0|||
160556380|NCT01145560|579761533|FG001|Overall Study|False insurance information|1|||
160556381|NCT01145560|579761534|FG002|Overall Study|False insurance information|0|||
160556382|NCT01145560|579761532|FG000|Overall Study|Withdrawal of therapy|0|||
160556383|NCT01145560|579761533|FG001|Overall Study|Withdrawal of therapy|0|||
160556384|NCT01145560|579761534|FG002|Overall Study|Withdrawal of therapy|1|||
160556385|NCT01446419|579761538|FG000|Overall Study|Death|1|||
160556386|NCT01446419|579761539|FG001|Overall Study|Death|0|||
160556387|NCT01446419|579761538|FG000|Overall Study|Withdrawal by Subject|1|||
160556388|NCT01446419|579761539|FG001|Overall Study|Withdrawal by Subject|1|||
160556389|NCT01446419|579761538|FG000|Overall Study|Terminated per protocol|3|||
160556390|NCT01446419|579761539|FG001|Overall Study|Terminated per protocol|0|||
160556391|NCT01465659|579761540|FG000|Completed 1 Cycle of Treatment|Death|0|||
160556392|NCT01465659|579761541|FG001|Completed 1 Cycle of Treatment|Death|1|||
160556393|NCT01465659|579761542|FG002|Completed 1 Cycle of Treatment|Death|0|||
160556394|NCT01465659|579761543|FG003|Completed 1 Cycle of Treatment|Death|0|||
160556395|NCT01465659|579761540|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
160556396|NCT01465659|579761541|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
160556397|NCT01465659|579761542|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
160556398|NCT01465659|579761543|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
160556399|NCT01465659|579761540|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
160556400|NCT01465659|579761541|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
160556401|NCT01465659|579761542|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
160556402|NCT01465659|579761543|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
160556403|NCT01465659|579761540|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
160556404|NCT01465659|579761541|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
160556405|NCT01465659|579761542|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
160556406|NCT01465659|579761543|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
160556407|NCT01465659|579761540|FG000|Completed Follow for 1 Year|Death|6|||
160556408|NCT01465659|579761541|FG001|Completed Follow for 1 Year|Death|3|||
160556409|NCT01465659|579761542|FG002|Completed Follow for 1 Year|Death|2|||
160556410|NCT01465659|579761543|FG003|Completed Follow for 1 Year|Death|4|||
160556411|NCT02411747|579761546|FG000|Overall Study|Withdrawal by Subject|1|||
160556412|NCT02411747|579761547|FG001|Overall Study|Withdrawal by Subject|0|||
160556413|NCT02411747|579761546|FG000|Overall Study|Protocol Violation|2|||
160556414|NCT02411747|579761547|FG001|Overall Study|Protocol Violation|4|||
160556415|NCT02149810|579761548|FG000|Overall Study|Physician Decision|1|||
160556416|NCT02149810|579761549|FG001|Overall Study|Physician Decision|2|||
160556417|NCT02149810|579761548|FG000|Overall Study|Lost to Follow-up|2|||
160556418|NCT02149810|579761549|FG001|Overall Study|Lost to Follow-up|1|||
160556419|NCT02149810|579761548|FG000|Overall Study|Withdrawal by Subject|5|||
160556420|NCT02149810|579761549|FG001|Overall Study|Withdrawal by Subject|1|||
160556421|NCT00428597|579761550|FG000|Overall Study|Randomized but not treated|3|||
160556422|NCT00428597|579761551|FG001|Overall Study|Randomized but not treated|3|||
160556423|NCT00428597|579761550|FG000|Overall Study|Objective Progression or Relapse|19|||
160556424|NCT00428597|579761551|FG001|Overall Study|Objective Progression or Relapse|47|||
160556425|NCT00428597|579761550|FG000|Overall Study|Study Terminated by Sponsor|41|||
160556426|NCT00428597|579761551|FG001|Overall Study|Study Terminated by Sponsor|16|||
160556427|NCT00428597|579761550|FG000|Overall Study|Adverse Event|15|||
160556428|NCT00428597|579761551|FG001|Overall Study|Adverse Event|7|||
160556429|NCT00428597|579761550|FG000|Overall Study|Global Deterioration of Health Status|1|||
160556430|NCT00428597|579761551|FG001|Overall Study|Global Deterioration of Health Status|5|||
160556431|NCT00428597|579761550|FG000|Overall Study|Protocol Violation|2|||
160556432|NCT00428597|579761551|FG001|Overall Study|Protocol Violation|1|||
160556433|NCT00428597|579761550|FG000|Overall Study|Withdrawal by Subject|2|||
160556434|NCT00428597|579761551|FG001|Overall Study|Withdrawal by Subject|1|||
160556435|NCT00428597|579761550|FG000|Overall Study|Other|1|||
160556436|NCT00428597|579761551|FG001|Overall Study|Other|1|||
160556437|NCT00428597|579761550|FG000|Overall Study|Lost to Follow-up|0|||
160828269|NCT02689076|580758231|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
160556438|NCT00428597|579761551|FG001|Overall Study|Lost to Follow-up|1|||
160828270|NCT02689076|580758232|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
160828271|NCT01143896|580758237|FG000|Overall Study|Did not complete Baseline Interview|5|||
160828272|NCT01143896|580758238|FG001|Overall Study|Did not complete Baseline Interview|4|||
160828273|NCT01143896|580758237|FG000|Overall Study|Lost to Follow-up|18|||
160828274|NCT01143896|580758238|FG001|Overall Study|Lost to Follow-up|13|||
160828275|NCT01143896|580758237|FG000|Overall Study|Withdrawal by Subject|13|||
160828276|NCT01143896|580758238|FG001|Overall Study|Withdrawal by Subject|5|||
160828277|NCT01143896|580758237|FG000|Overall Study|Death|6|||
160828278|NCT01143896|580758238|FG001|Overall Study|Death|3|||
160828279|NCT01318070|580758239|FG000|Overall Study|Adverse Event|1|||
160828280|NCT01318070|580758240|FG001|Overall Study|Adverse Event|1|||
160828281|NCT01318070|580758241|FG002|Overall Study|Adverse Event|5|||
160828282|NCT01318070|580758239|FG000|Overall Study|Withdrawal by Subject|0|||
160828283|NCT01318070|580758240|FG001|Overall Study|Withdrawal by Subject|1|||
160828284|NCT01318070|580758241|FG002|Overall Study|Withdrawal by Subject|1|||
160828285|NCT01318070|580758239|FG000|Overall Study|Lack of Efficacy|0|||
160828286|NCT01318070|580758240|FG001|Overall Study|Lack of Efficacy|0|||
160828287|NCT01318070|580758241|FG002|Overall Study|Lack of Efficacy|1|||
160828288|NCT01318070|580758239|FG000|Overall Study|Principal Investigator Discretion|1|||
160828289|NCT01318070|580758240|FG001|Overall Study|Principal Investigator Discretion|0|||
160828290|NCT01318070|580758241|FG002|Overall Study|Principal Investigator Discretion|0|||
160828291|NCT00334282|580758247|FG000|Overall Study|Lost to Follow-up|11|||
160828292|NCT00334282|580758248|FG001|Overall Study|Lost to Follow-up|5|||
160828293|NCT00334282|580758247|FG000|Overall Study|Withdrawal by Subject|17|||
160828294|NCT00334282|580758248|FG001|Overall Study|Withdrawal by Subject|3|||
160828295|NCT00334282|580758247|FG000|Overall Study|Death|194|||
160828296|NCT00334282|580758248|FG001|Overall Study|Death|100|||
160828297|NCT00276094|580758253|FG000|Overall Study|Adverse Event|15|||
160828298|NCT00276094|580758254|FG001|Overall Study|Adverse Event|13|||
160828299|NCT00276094|580758255|FG002|Overall Study|Adverse Event|11|||
160828300|NCT00276094|580758253|FG000|Overall Study|Withdrawal by Subject|14|||
160828301|NCT00276094|580758254|FG001|Overall Study|Withdrawal by Subject|14|||
160828302|NCT00276094|580758255|FG002|Overall Study|Withdrawal by Subject|12|||
160828303|NCT00276094|580758253|FG000|Overall Study|Protocol Violation|16|||
160828304|NCT00276094|580758254|FG001|Overall Study|Protocol Violation|7|||
160828305|NCT00276094|580758255|FG002|Overall Study|Protocol Violation|10|||
160828306|NCT00276094|580758253|FG000|Overall Study|Lost to Follow-up|8|||
160828307|NCT00276094|580758254|FG001|Overall Study|Lost to Follow-up|6|||
160828308|NCT00276094|580758255|FG002|Overall Study|Lost to Follow-up|4|||
160828309|NCT00276094|580758253|FG000|Overall Study|Other-Subject moved out of country|1|||
160828310|NCT00276094|580758254|FG001|Overall Study|Other-Subject moved out of country|0|||
160828311|NCT00276094|580758255|FG002|Overall Study|Other-Subject moved out of country|0|||
160828312|NCT00276094|580758253|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
160828313|NCT00276094|580758254|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
160828314|NCT00276094|580758255|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
160828315|NCT00276094|580758253|FG000|Overall Study|Other-Lack of efficacy|1|||
160828316|NCT00276094|580758254|FG001|Overall Study|Other-Lack of efficacy|0|||
160828317|NCT00276094|580758255|FG002|Overall Study|Other-Lack of efficacy|0|||
160828318|NCT00276094|580758253|FG000|Overall Study|Other-Refused follow-up visit|1|||
160828319|NCT00276094|580758254|FG001|Overall Study|Other-Refused follow-up visit|0|||
160828320|NCT00276094|580758255|FG002|Overall Study|Other-Refused follow-up visit|0|||
160828321|NCT00276094|580758253|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
160828322|NCT00276094|580758254|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
160828323|NCT00276094|580758255|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
160828324|NCT00276094|580758253|FG000|Overall Study|Other-Relocation|0|||
160828325|NCT00276094|580758254|FG001|Overall Study|Other-Relocation|1|||
160828326|NCT00276094|580758255|FG002|Overall Study|Other-Relocation|0|||
160556439|NCT00428597|579761550|FG000|Overall Study|Pregnancy|1|||
160828327|NCT00276094|580758253|FG000|Overall Study|Other-Study medication lost|0|||
160828328|NCT00276094|580758254|FG001|Overall Study|Other-Study medication lost|0|||
160828329|NCT00276094|580758255|FG002|Overall Study|Other-Study medication lost|1|||
160828330|NCT00787137|580758258|FG000|Overall Study|Study Termination|0|||
160828331|NCT00787137|580758259|FG001|Overall Study|Study Termination|0|||
160828332|NCT00787137|580758260|FG002|Overall Study|Study Termination|1|||
160828333|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
160828334|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
160828335|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
160902633|NCT02484690|581036075|FG000|Overall Study|Lost to Follow-up|0|||
160902634|NCT02484690|581036076|FG001|Overall Study|Lost to Follow-up|0|||
160902635|NCT02484690|581036077|FG002|Overall Study|Lost to Follow-up|1|||
160902636|NCT02484690|581036078|FG003|Overall Study|Lost to Follow-up|0|||
160902637|NCT02484690|581036079|FG004|Overall Study|Lost to Follow-up|0|||
160902638|NCT01759511|581036080|FG000|Overall Study|Adverse Event|4|||
160556440|NCT00428597|579761551|FG001|Overall Study|Pregnancy|0|||
160556441|NCT00428597|579761550|FG000|Overall Study|Death|1|||
160556442|NCT00428597|579761551|FG001|Overall Study|Death|3|||
160556443|NCT00675597|579761552|FG000|Overall Study|Withdrawal by Subject|3|||
160556444|NCT00560755|579761554|FG000|Overall Study|Protocol Violation|15|||
160556445|NCT00560755|579761554|FG000|Overall Study|Withdrawal by Subject|26|||
160556446|NCT00560755|579761554|FG000|Overall Study|Lost to Follow-up|9|||
160556447|NCT00560755|579761554|FG000|Overall Study|Adverse Event|8|||
160556448|NCT00560755|579761554|FG000|Overall Study|Physician Decision|2|||
160556449|NCT05032950|579761556|FG000|Overall Study|Adverse Event|0|||
160556450|NCT05032950|579761557|FG001|Overall Study|Adverse Event|0|||
160556451|NCT05032950|579761558|FG002|Overall Study|Adverse Event|1|||
160556452|NCT05032950|579761559|FG003|Overall Study|Adverse Event|1|||
160556453|NCT05032950|579761560|FG004|Overall Study|Adverse Event|0|||
160902639|NCT01759511|581036080|FG000|Overall Study|Death|2|||
160556454|NCT05032950|579761561|FG005|Overall Study|Adverse Event|0|||
160556455|NCT01356589|579761564|FG000|Overall Study|Enrolled, but not treated|3|||
160556456|NCT01356589|579761564|FG000|Overall Study|Dose data not recorded|2|||
160556457|NCT02447848|579761565|FG000|Overall Study|Patient discharged|3|||
160556458|NCT02447848|579761565|FG000|Overall Study|Lack of Efficacy|4|||
160556459|NCT02447848|579761565|FG000|Overall Study|Withdrawal by Subject|4|||
160556460|NCT02307370|579761566|FG000|Overall Study|Death|5|||
160556461|NCT02307370|579761566|FG000|Overall Study|Lost to Follow-up|1|||
160556462|NCT02307370|579761566|FG000|Overall Study|Withdrawal by Subject|1|||
160556463|NCT02307370|579761566|FG000|Overall Study|Declined Addendum ICF|6|||
160556464|NCT02307370|579761566|FG000|Overall Study|No response during telephone contact|5|||
160556465|NCT02307370|579761566|FG000|Overall Study|Protocol Violation|1|||
160556466|NCT04188197|579763649|FG000|Overall Study|Lost to Follow-up|4|||
160556467|NCT04188197|579763650|FG001|Overall Study|Lost to Follow-up|1|||
160556468|NCT04188197|579763649|FG000|Overall Study|Withdrawal by Subject|1|||
160556469|NCT04188197|579763650|FG001|Overall Study|Withdrawal by Subject|1|||
160556470|NCT04188197|579763649|FG000|Overall Study|Pregnancy|0|||
160556471|NCT04188197|579763650|FG001|Overall Study|Pregnancy|1|||
160556472|NCT02613208|579763651|FG000|Overall Study|Withdrawal by Subject|1|||
160556473|NCT02613208|579763651|FG000|Overall Study|Change of address|2|||
160902640|NCT01759511|581036080|FG000|Overall Study|Lack of Efficacy|2|||
160902641|NCT01759511|581036080|FG000|Overall Study|Physician Decision|1|||
160902642|NCT01759511|581036080|FG000|Overall Study|Progressive Disease|5|||
160902643|NCT01759511|581036080|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
160902644|NCT01759511|581036080|FG000|Overall Study|Study Terminated by Sponsor|13|||
160902645|NCT01759511|581036080|FG000|Overall Study|Withdrawal by Subject|3|||
160902646|NCT04439201|581036083|FG000|Overall Study|Ineligible|2|||
160902647|NCT04439201|581036083|FG000|Overall Study|Never start protocol therapy|1|||
160902648|NCT04439201|581036083|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
160902649|NCT04439201|581036083|FG000|Overall Study|Mutation status not confirmed|4|||
160902650|NCT04439201|581036083|FG000|Overall Study|Adverse Event|1|||
160902651|NCT04439201|581036083|FG000|Overall Study|Death|7|||
160902652|NCT04439201|581036083|FG000|Overall Study|Withdrawal by Subject|2|||
160902653|NCT04439201|581036083|FG000|Overall Study|Disease progression|20|||
160902654|NCT04439201|581036083|FG000|Overall Study|Alternative therapy|1|||
160902655|NCT04439201|581036083|FG000|Overall Study|Physician Decision|1|||
160902656|NCT01995825|581037769|FG000|Overall Study|Withdrawal by Subject|1|||
160902657|NCT01995825|581037770|FG001|Overall Study|Withdrawal by Subject|0|||
160902658|NCT01367002|581037771|FG000|Overall Study|Withdrawal by Subject|1|||
160902659|NCT01367002|581037772|FG001|Overall Study|Withdrawal by Subject|0|||
160902660|NCT01367002|581037771|FG000|Overall Study|Physician Decision|0|||
160902661|NCT01367002|581037772|FG001|Overall Study|Physician Decision|2|||
160902662|NCT01516437|581037773|FG000|Overall Study|Reason not specified|0|||
160902663|NCT01516437|581037774|FG001|Overall Study|Reason not specified|0|||
160902664|NCT01516437|581037775|FG002|Overall Study|Reason not specified|1|||
160902665|NCT01516437|581037776|FG003|Overall Study|Reason not specified|1|||
160902666|NCT00403234|581037777|FG000|Overall Study|Withdrawal by Subject|0|||
160902667|NCT00403234|581037778|FG001|Overall Study|Withdrawal by Subject|1|||
160902668|NCT00403234|581037779|FG002|Overall Study|Withdrawal by Subject|0|||
160902669|NCT00403234|581037780|FG003|Overall Study|Withdrawal by Subject|0|||
160902670|NCT00403234|581037777|FG000|Overall Study|Adverse Event|1|||
160556474|NCT02613208|579763651|FG000|Overall Study|Physician Decision|2|||
160646938|NCT01418352|580090033|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
160646939|NCT01418352|580090034|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
160646940|NCT01418352|580090035|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
160646941|NCT01418352|580090032|FG000|Overall Study|Subject Withdrew Consent|0|||
160646942|NCT01418352|580090033|FG001|Overall Study|Subject Withdrew Consent|1|||
160902671|NCT00403234|581037778|FG001|Overall Study|Adverse Event|0|||
160902672|NCT00403234|581037779|FG002|Overall Study|Adverse Event|1|||
160902673|NCT00403234|581037780|FG003|Overall Study|Adverse Event|0|||
160556475|NCT02613208|579763651|FG000|Overall Study|Lost to Follow-up|5|||
160556476|NCT02613208|579763651|FG000|Overall Study|Death|37|||
160902674|NCT00560105|581037783|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
160902675|NCT00560105|581037784|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
160902676|NCT01550289|581037785|FG000|Overall Study|Protocol Violation|1|||
160990606|NCT02501629|581353897|FG001|Overall Study|Death|1|||
160556477|NCT04574999|579763652|FG000|Overall Study|Adverse Event|1|||
160556478|NCT04574999|579763653|FG001|Overall Study|Adverse Event|0|||
160556479|NCT04574999|579763652|FG000|Overall Study|Lack of Efficacy|2|||
160646943|NCT01418352|580090034|FG002|Overall Study|Subject Withdrew Consent|2|||
160646944|NCT01418352|580090035|FG003|Overall Study|Subject Withdrew Consent|1|||
160646945|NCT01418352|580090032|FG000|Overall Study|Protocol Deviation|0|||
160646946|NCT01418352|580090033|FG001|Overall Study|Protocol Deviation|0|||
160646947|NCT01418352|580090034|FG002|Overall Study|Protocol Deviation|1|||
160646948|NCT01418352|580090035|FG003|Overall Study|Protocol Deviation|0|||
160646949|NCT01418352|580090032|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
160646950|NCT01418352|580090033|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
160646951|NCT01418352|580090034|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
160646952|NCT01418352|580090035|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
160646953|NCT00619619|580090036|FG000|Overall Study|Physician Decision|0|||
160646954|NCT00619619|580090037|FG001|Overall Study|Physician Decision|0|||
160646955|NCT00619619|580090038|FG002|Overall Study|Physician Decision|1|||
160646956|NCT00619619|580090039|FG003|Overall Study|Physician Decision|0|||
160646957|NCT00619619|580090040|FG004|Overall Study|Physician Decision|0|||
160646958|NCT00619619|580090041|FG005|Overall Study|Physician Decision|0|||
160646959|NCT00619619|580090042|FG006|Overall Study|Physician Decision|0|||
160646960|NCT00619619|580090043|FG007|Overall Study|Physician Decision|0|||
160646961|NCT00619619|580090036|FG000|Overall Study|Protocol Violation|0|||
160646962|NCT00619619|580090037|FG001|Overall Study|Protocol Violation|0|||
160646963|NCT00619619|580090038|FG002|Overall Study|Protocol Violation|0|||
160646964|NCT00619619|580090039|FG003|Overall Study|Protocol Violation|1|||
160646965|NCT00619619|580090040|FG004|Overall Study|Protocol Violation|0|||
160646966|NCT00619619|580090041|FG005|Overall Study|Protocol Violation|0|||
160646967|NCT00619619|580090042|FG006|Overall Study|Protocol Violation|1|||
160646968|NCT00619619|580090043|FG007|Overall Study|Protocol Violation|1|||
160646969|NCT00619619|580090036|FG000|Overall Study|Adverse Event|0|||
160646970|NCT00619619|580090037|FG001|Overall Study|Adverse Event|0|||
160646971|NCT00619619|580090038|FG002|Overall Study|Adverse Event|0|||
160646972|NCT00619619|580090039|FG003|Overall Study|Adverse Event|0|||
160646973|NCT00619619|580090040|FG004|Overall Study|Adverse Event|2|||
160646974|NCT00619619|580090041|FG005|Overall Study|Adverse Event|0|||
160646975|NCT00619619|580090042|FG006|Overall Study|Adverse Event|0|||
160646976|NCT00619619|580090043|FG007|Overall Study|Adverse Event|2|||
160646977|NCT01507896|580090044|FG000|Overall Study|Withdrawal by Subject|1|||
160646978|NCT01507896|580090044|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
160646979|NCT00490061|580090045|FG000|Overall Study|Physician Decision|1|||
160646980|NCT00952484|580090046|FG000|Overall Study|Withdrawal by Subject|0|||
160646981|NCT00952484|580090047|FG001|Overall Study|Withdrawal by Subject|1|||
160646982|NCT00952484|580090048|FG002|Overall Study|Withdrawal by Subject|0|||
160646983|NCT02750306|580090054|FG000|Overall Study|Withdrawal by Subject|5|||
160646984|NCT02750306|580090055|FG001|Overall Study|Withdrawal by Subject|2|||
160646985|NCT02750306|580090054|FG000|Overall Study|Protocol Violation|1|||
160646986|NCT02750306|580090055|FG001|Overall Study|Protocol Violation|0|||
160646987|NCT00585351|580090056|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
160646988|NCT00585351|580090057|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
160646989|NCT00585351|580090058|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
160646990|NCT00585351|580090059|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
160646991|NCT00585351|580090060|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
160646992|NCT00585351|580090061|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
160646993|NCT00585351|580090062|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
160646994|NCT00585351|580090063|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
160646995|NCT00585351|580090056|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
160828336|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
160828337|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
160828338|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
160828339|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
160828340|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160828341|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
160828342|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
160646996|NCT00585351|580090057|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
160828343|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
160828344|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
160646997|NCT00585351|580090058|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
160646998|NCT00585351|580090059|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
160646999|NCT00585351|580090060|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
160902677|NCT01550289|581037786|FG001|Overall Study|Protocol Violation|0|||
160902678|NCT01550289|581037785|FG000|Overall Study|Lost to Follow-up|1|||
160902679|NCT01550289|581037786|FG001|Overall Study|Lost to Follow-up|1|||
160902680|NCT01550289|581037785|FG000|Overall Study|Withdrawal by Subject|11|||
160902681|NCT01550289|581037786|FG001|Overall Study|Withdrawal by Subject|3|||
160902682|NCT03539081|581037787|FG000|Overall Study|Withdrawal by Subject|2|||
160902683|NCT03539081|581037788|FG001|Overall Study|Withdrawal by Subject|3|||
160556480|NCT04574999|579763653|FG001|Overall Study|Lack of Efficacy|3|||
160556481|NCT04574999|579763652|FG000|Overall Study|Protocol Violation|1|||
160556482|NCT04574999|579763653|FG001|Overall Study|Protocol Violation|0|||
160556483|NCT04574999|579763652|FG000|Overall Study|Withdrawal by Subject|2|||
160556484|NCT04574999|579763653|FG001|Overall Study|Withdrawal by Subject|2|||
160556485|NCT04574999|579763652|FG000|Overall Study|Lost to Follow-up|1|||
160556486|NCT04574999|579763653|FG001|Overall Study|Lost to Follow-up|0|||
160556487|NCT04574999|579763652|FG000|Overall Study|Personal problems|1|||
160556488|NCT04574999|579763653|FG001|Overall Study|Personal problems|0|||
160556489|NCT04574999|579763652|FG000|Overall Study|Previous planned surgery|1|||
160556490|NCT04574999|579763653|FG001|Overall Study|Previous planned surgery|0|||
160556491|NCT00008385|579763654|FG000|Overall Study|Off treatment reasons not reported|79|||
160556492|NCT00008385|579763655|FG001|Overall Study|Off treatment reasons not reported|70|||
160556493|NCT00008385|579763654|FG000|Overall Study|Progressive disease|52|||
160556494|NCT00008385|579763655|FG001|Overall Study|Progressive disease|117|||
160556495|NCT00008385|579763654|FG000|Overall Study|Adverse Event|8|||
160556496|NCT00008385|579763655|FG001|Overall Study|Adverse Event|20|||
160556497|NCT00008385|579763654|FG000|Overall Study|Death|12|||
160556498|NCT00008385|579763655|FG001|Overall Study|Death|18|||
160556499|NCT00008385|579763654|FG000|Overall Study|Withdrawal by Subject|67|||
160556500|NCT00008385|579763655|FG001|Overall Study|Withdrawal by Subject|157|||
160556501|NCT00008385|579763654|FG000|Overall Study|Start non-protocol therapy|3|||
160556502|NCT00008385|579763655|FG001|Overall Study|Start non-protocol therapy|1|||
160556503|NCT00008385|579763654|FG000|Overall Study|Other complicating disease|17|||
160556504|NCT00008385|579763655|FG001|Overall Study|Other complicating disease|30|||
160556505|NCT00008385|579763654|FG000|Overall Study|Maximum dose reached|0|||
160556506|NCT00008385|579763655|FG001|Overall Study|Maximum dose reached|2|||
160990607|NCT02501629|581353896|FG000|Overall Study|Withdrawn from study by sponsor|1|||
160990608|NCT02501629|581353897|FG001|Overall Study|Withdrawn from study by sponsor|0|||
160990609|NCT02501629|581353896|FG000|Overall Study|Early termination by sponsor|1|||
160556507|NCT00008385|579763654|FG000|Overall Study|Other|105|||
160556508|NCT00008385|579763655|FG001|Overall Study|Other|212|||
160990610|NCT02501629|581353897|FG001|Overall Study|Early termination by sponsor|0|||
160990611|NCT02501629|581353896|FG000|Overall Study|Withdrawal by Subject|3|||
160828345|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
160828346|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
160828347|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
160828348|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
160828349|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
160828350|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
160828351|NCT00554099|580758262|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
160828352|NCT00554099|580758263|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
160828353|NCT00554099|580758264|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
160828354|NCT00554099|580758262|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
160828355|NCT00554099|580758263|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
160828356|NCT00554099|580758264|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
160828357|NCT00554099|580758262|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
160828358|NCT00554099|580758263|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
160828359|NCT00554099|580758264|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
160990612|NCT02501629|581353897|FG001|Overall Study|Withdrawal by Subject|5|||
160556509|NCT00008385|579763654|FG000|Overall Study|Not start protocol therapy|44|||
160556510|NCT00008385|579763655|FG001|Overall Study|Not start protocol therapy|175|||
160556511|NCT05148884|579763656|FG000|Overall Study|Withdrawal by Subject|3|||
160556512|NCT05148884|579763657|FG001|Overall Study|Withdrawal by Subject|0|||
160556513|NCT05148884|579763656|FG000|Overall Study|Deep brain stimulation operation|0|||
160556514|NCT05148884|579763657|FG001|Overall Study|Deep brain stimulation operation|1|||
160556515|NCT01719757|579763660|FG000|Overall Study|Adverse Event|38|||
160990613|NCT02501629|581353896|FG000|Overall Study|Subject did not return to site|0|||
160990614|NCT02501629|581353897|FG001|Overall Study|Subject did not return to site|1|||
160990615|NCT00868231|581353900|FG000|Treatment Period 1|Adverse Event|0|||
160990616|NCT00868231|581353901|FG001|Treatment Period 1|Adverse Event|0|||
160990617|NCT00868231|581353902|FG002|Treatment Period 1|Adverse Event|0|||
160990618|NCT00868231|581353903|FG003|Treatment Period 1|Adverse Event|0|||
160990619|NCT00868231|581353904|FG004|Treatment Period 1|Adverse Event|1|||
160990620|NCT00868231|581353905|FG005|Treatment Period 1|Adverse Event|0|||
160990621|NCT00868231|581353900|FG000|Treatment Period 2|Adverse Event|1|||
160990622|NCT00868231|581353901|FG001|Treatment Period 2|Adverse Event|0|||
160990623|NCT00868231|581353902|FG002|Treatment Period 2|Adverse Event|0|||
160990624|NCT00868231|581353903|FG003|Treatment Period 2|Adverse Event|0|||
160990625|NCT00868231|581353904|FG004|Treatment Period 2|Adverse Event|0|||
160990626|NCT00868231|581353905|FG005|Treatment Period 2|Adverse Event|0|||
160990627|NCT00868231|581353900|FG000|Treatment Period 3|Adverse Event|0|||
160990628|NCT00868231|581353901|FG001|Treatment Period 3|Adverse Event|0|||
160556516|NCT01719757|579763660|FG000|Overall Study|Withdrawal by Subject|15|||
160556517|NCT01719757|579763660|FG000|Overall Study|Lost to Follow-up|20|||
160556518|NCT01719757|579763660|FG000|Overall Study|Protocol Violation|1|||
160556519|NCT01719757|579763660|FG000|Overall Study|well controlled pain|27|||
160556520|NCT03312218|579763666|FG000|Overall Study|Never signed in to access the app|54|||
160556521|NCT03312218|579763667|FG001|Overall Study|Never signed in to access the app|58|||
160556522|NCT05742984|579763668|FG000|Overall Study|Adverse Event|0|||
160556523|NCT05742984|579763669|FG001|Overall Study|Adverse Event|0|||
160556524|NCT05742984|579763670|FG002|Overall Study|Adverse Event|1|||
160556525|NCT05742984|579763671|FG003|Overall Study|Adverse Event|0|||
160556526|NCT05742984|579763672|FG004|Overall Study|Adverse Event|1|||
160556527|NCT05742984|579763673|FG005|Overall Study|Adverse Event|1|||
160556528|NCT05742984|579763668|FG000|Overall Study|Withdrawal by Subject|0|||
160556529|NCT05742984|579763669|FG001|Overall Study|Withdrawal by Subject|1|||
160556530|NCT05742984|579763670|FG002|Overall Study|Withdrawal by Subject|0|||
160556531|NCT05742984|579763671|FG003|Overall Study|Withdrawal by Subject|0|||
160556532|NCT05742984|579763672|FG004|Overall Study|Withdrawal by Subject|0|||
160556533|NCT05742984|579763673|FG005|Overall Study|Withdrawal by Subject|2|||
160556534|NCT02162862|579763674|FG000|Overall Study|Lost to Follow-up|0|||
160556535|NCT02162862|579763675|FG001|Overall Study|Lost to Follow-up|11|||
160556536|NCT02162862|579763676|FG002|Overall Study|Lost to Follow-up|0|||
160556537|NCT02162862|579763674|FG000|Overall Study|Subject did not feel the med was needed|0|||
160556538|NCT02162862|579763675|FG001|Overall Study|Subject did not feel the med was needed|0|||
160556539|NCT02162862|579763676|FG002|Overall Study|Subject did not feel the med was needed|4|||
160556540|NCT03116113|579763677|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
160556541|NCT03116113|579763678|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
160556542|NCT03116113|579763679|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
160556543|NCT03116113|579763680|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
160556544|NCT03116113|579763681|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
160556545|NCT03116113|579763682|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
160556546|NCT03116113|579763683|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
160556547|NCT03116113|579763684|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
160556548|NCT03116113|579763685|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
160556549|NCT02159807|579763686|FG000|Overall Study|Adverse Event|0|||
160556550|NCT02159807|579763687|FG001|Overall Study|Adverse Event|0|||
160990629|NCT00868231|581353902|FG002|Treatment Period 3|Adverse Event|1|||
160990630|NCT00868231|581353903|FG003|Treatment Period 3|Adverse Event|0|||
160990631|NCT00868231|581353904|FG004|Treatment Period 3|Adverse Event|0|||
160556551|NCT02159807|579763688|FG002|Overall Study|Adverse Event|1|||
160556552|NCT02159807|579763686|FG000|Overall Study|No CSF|1|||
160556553|NCT02159807|579763687|FG001|Overall Study|No CSF|1|||
160556554|NCT02159807|579763688|FG002|Overall Study|No CSF|1|||
160556555|NCT02159807|579763686|FG000|Overall Study|elevated blood pressure|0|||
160556556|NCT02159807|579763687|FG001|Overall Study|elevated blood pressure|0|||
160556557|NCT02159807|579763688|FG002|Overall Study|elevated blood pressure|1|||
160556558|NCT00950170|579763689|FG000|Overall Study|Parent/Legal Guardian Request|1|||
160556559|NCT00950170|579763689|FG000|Overall Study|Adverse Event|2|||
160556560|NCT00950170|579763689|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
160556561|NCT02367521|579763695|FG000|Overall Study|severe headache after intervention|2|||
160990632|NCT00868231|581353905|FG005|Treatment Period 3|Adverse Event|0|||
160556562|NCT02367521|579763696|FG001|Overall Study|severe headache after intervention|0|||
160556563|NCT02367521|579763695|FG000|Overall Study|unable to find transportation|2|||
160556564|NCT02367521|579763696|FG001|Overall Study|unable to find transportation|0|||
160556565|NCT00600171|579763697|FG000|Overall Study|Adverse Event|0|||
160556566|NCT00600171|579763698|FG001|Overall Study|Adverse Event|1|||
160556567|NCT00600171|579763699|FG002|Overall Study|Adverse Event|0|||
160556568|NCT00600171|579763700|FG003|Overall Study|Adverse Event|0|||
160556569|NCT00600171|579763701|FG004|Overall Study|Adverse Event|1|||
160556570|NCT00600171|579763702|FG005|Overall Study|Adverse Event|0|||
160556571|NCT00600171|579763697|FG000|Overall Study|Lack of Efficacy|9|||
160556572|NCT00600171|579763698|FG001|Overall Study|Lack of Efficacy|12|||
160556573|NCT00600171|579763699|FG002|Overall Study|Lack of Efficacy|3|||
160556574|NCT00600171|579763700|FG003|Overall Study|Lack of Efficacy|5|||
160556575|NCT00600171|579763701|FG004|Overall Study|Lack of Efficacy|4|||
160556576|NCT00600171|579763702|FG005|Overall Study|Lack of Efficacy|0|||
160556577|NCT00600171|579763697|FG000|Overall Study|Protocol Violation|1|||
160556578|NCT00600171|579763698|FG001|Overall Study|Protocol Violation|2|||
160556579|NCT00600171|579763699|FG002|Overall Study|Protocol Violation|0|||
160556580|NCT00600171|579763700|FG003|Overall Study|Protocol Violation|1|||
160556581|NCT00600171|579763701|FG004|Overall Study|Protocol Violation|0|||
160556582|NCT00600171|579763702|FG005|Overall Study|Protocol Violation|0|||
160556583|NCT00600171|579763697|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
160556584|NCT00600171|579763698|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
160556585|NCT00600171|579763699|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
160556586|NCT00600171|579763700|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
160556587|NCT00600171|579763701|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
160556588|NCT00600171|579763702|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
160556589|NCT00600171|579763697|FG000|Overall Study|Withdrawal by Subject|3|||
160556590|NCT00600171|579763698|FG001|Overall Study|Withdrawal by Subject|0|||
160556591|NCT00600171|579763699|FG002|Overall Study|Withdrawal by Subject|0|||
160556592|NCT00600171|579763700|FG003|Overall Study|Withdrawal by Subject|1|||
160556593|NCT00600171|579763701|FG004|Overall Study|Withdrawal by Subject|1|||
160556594|NCT00600171|579763702|FG005|Overall Study|Withdrawal by Subject|1|||
160556595|NCT00600171|579763697|FG000|Overall Study|Physician Decision|0|||
160902684|NCT03539081|581037789|FG002|Overall Study|Withdrawal by Subject|0|||
160902685|NCT03539081|581037787|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
160902686|NCT03539081|581037788|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
160902687|NCT03539081|581037789|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
160902688|NCT00354744|581037793|FG000|Overall Study|Adverse Event|2|||
160902689|NCT00354744|581037793|FG000|Overall Study|Death|2|||
160902690|NCT00354744|581037793|FG000|Overall Study|Lack of Efficacy|11|||
160902691|NCT00354744|581037793|FG000|Overall Study|Lost to Follow-up|2|||
160902692|NCT00354744|581037793|FG000|Overall Study|Physician Decision|11|||
160902693|NCT00354744|581037793|FG000|Overall Study|Withdrawal by Subject|14|||
160902694|NCT00541931|581037794|FG000|Overall Study|Adverse Event|1|||
160902695|NCT00541931|581037795|FG001|Overall Study|Adverse Event|0|||
160902696|NCT00541931|581037794|FG000|Overall Study|Lost to Follow-up|3|||
160902697|NCT00541931|581037795|FG001|Overall Study|Lost to Follow-up|3|||
160902698|NCT00541931|581037794|FG000|Overall Study|Withdrawal by Subject|1|||
160902699|NCT00541931|581037795|FG001|Overall Study|Withdrawal by Subject|0|||
160902700|NCT00541931|581037794|FG000|Overall Study|Transportation Issue|0|||
160902701|NCT00541931|581037795|FG001|Overall Study|Transportation Issue|1|||
160902702|NCT02555683|581037799|FG000|Overall Study|Physician Decision|1|||
160902703|NCT02555683|581037800|FG001|Overall Study|Physician Decision|0|||
160902704|NCT02555683|581037801|FG002|Overall Study|Physician Decision|2|||
160902705|NCT02555683|581037799|FG000|Overall Study|Lost to Follow-up|2|||
160902706|NCT02555683|581037800|FG001|Overall Study|Lost to Follow-up|1|||
160902707|NCT02555683|581037801|FG002|Overall Study|Lost to Follow-up|2|||
160902708|NCT02555683|581037799|FG000|Overall Study|Technical Problems|1|||
160556596|NCT00600171|579763698|FG001|Overall Study|Physician Decision|1|||
160556597|NCT00600171|579763699|FG002|Overall Study|Physician Decision|0|||
160556598|NCT00600171|579763700|FG003|Overall Study|Physician Decision|1|||
160902709|NCT02555683|581037800|FG001|Overall Study|Technical Problems|1|||
160556599|NCT00600171|579763701|FG004|Overall Study|Physician Decision|0|||
160556600|NCT00600171|579763702|FG005|Overall Study|Physician Decision|2|||
160556601|NCT00600171|579763697|FG000|Overall Study|Lost to Follow-up|0|||
160556602|NCT00600171|579763698|FG001|Overall Study|Lost to Follow-up|0|||
160556603|NCT00600171|579763699|FG002|Overall Study|Lost to Follow-up|0|||
160556604|NCT00600171|579763700|FG003|Overall Study|Lost to Follow-up|1|||
160556605|NCT00600171|579763701|FG004|Overall Study|Lost to Follow-up|0|||
160902710|NCT02555683|581037801|FG002|Overall Study|Technical Problems|0|||
160902711|NCT02555683|581037799|FG000|Overall Study|Protocol deviation|0|||
160902712|NCT02555683|581037800|FG001|Overall Study|Protocol deviation|1|||
160902713|NCT02555683|581037801|FG002|Overall Study|Protocol deviation|0|||
160902714|NCT02555683|581037799|FG000|Overall Study|Lack of Efficacy|2|||
160902715|NCT02555683|581037800|FG001|Overall Study|Lack of Efficacy|0|||
160556606|NCT00600171|579763702|FG005|Overall Study|Lost to Follow-up|0|||
160556607|NCT00542191|579763706|FG000|Overall Study|Death|3|||
160556608|NCT00434967|579763707|FG000|Overall Study|Adverse Event|2|||
160556609|NCT00434967|579763708|FG001|Overall Study|Adverse Event|4|||
160556610|NCT00434967|579763709|FG002|Overall Study|Adverse Event|3|||
160556611|NCT00434967|579763710|FG003|Overall Study|Adverse Event|3|||
160556612|NCT00434967|579763707|FG000|Overall Study|Lost to Follow-up|0|||
160556613|NCT00434967|579763708|FG001|Overall Study|Lost to Follow-up|0|||
160556614|NCT00434967|579763709|FG002|Overall Study|Lost to Follow-up|1|||
160556615|NCT00434967|579763710|FG003|Overall Study|Lost to Follow-up|0|||
160556616|NCT00434967|579763707|FG000|Overall Study|Withdrawal by Subject|2|||
160556617|NCT00434967|579763708|FG001|Overall Study|Withdrawal by Subject|2|||
160556618|NCT00434967|579763709|FG002|Overall Study|Withdrawal by Subject|4|||
160556619|NCT00434967|579763710|FG003|Overall Study|Withdrawal by Subject|6|||
160556620|NCT00434967|579763707|FG000|Overall Study|Randomized in error|0|||
160556621|NCT00434967|579763708|FG001|Overall Study|Randomized in error|0|||
160556622|NCT00434967|579763709|FG002|Overall Study|Randomized in error|0|||
160556623|NCT00434967|579763710|FG003|Overall Study|Randomized in error|1|||
160556624|NCT00434967|579763707|FG000|Overall Study|Protocol Violation|0|||
160556625|NCT00434967|579763708|FG001|Overall Study|Protocol Violation|1|||
160556626|NCT00434967|579763709|FG002|Overall Study|Protocol Violation|0|||
160556627|NCT00434967|579763710|FG003|Overall Study|Protocol Violation|1|||
160556628|NCT00434967|579763707|FG000|Overall Study|Physician Decision|1|||
160556629|NCT00434967|579763708|FG001|Overall Study|Physician Decision|1|||
160556630|NCT00434967|579763709|FG002|Overall Study|Physician Decision|1|||
160556631|NCT00434967|579763710|FG003|Overall Study|Physician Decision|0|||
160556632|NCT00434967|579763707|FG000|Overall Study|Patient Disposition Challenges|2|||
160556633|NCT00434967|579763708|FG001|Overall Study|Patient Disposition Challenges|0|||
160556634|NCT00434967|579763709|FG002|Overall Study|Patient Disposition Challenges|0|||
160556635|NCT00434967|579763710|FG003|Overall Study|Patient Disposition Challenges|3|||
160556636|NCT03502187|579763713|FG000|Overall Study|Withdrawal by Subject|4|||
160556637|NCT03502187|579763714|FG001|Overall Study|Withdrawal by Subject|3|||
160556638|NCT03502187|579763715|FG002|Overall Study|Withdrawal by Subject|3|||
160556639|NCT03502187|579763713|FG000|Overall Study|Lost to Follow-up|5|||
160556640|NCT03502187|579763714|FG001|Overall Study|Lost to Follow-up|4|||
160556641|NCT03502187|579763715|FG002|Overall Study|Lost to Follow-up|5|||
160828360|NCT02075632|580758265|FG000|Overall Study|Adverse Event|1|||
160828361|NCT02075632|580758266|FG001|Overall Study|Adverse Event|1|||
160828362|NCT02075632|580758265|FG000|Overall Study|Lost to Follow-up|0|||
160828363|NCT02075632|580758266|FG001|Overall Study|Lost to Follow-up|3|||
160828364|NCT02075632|580758265|FG000|Overall Study|Withdrawal by Subject|0|||
160828365|NCT02075632|580758266|FG001|Overall Study|Withdrawal by Subject|1|||
160828366|NCT04957758|580758274|FG000|Overall Study|Adverse Event|1|||
160828367|NCT04957758|580758275|FG001|Overall Study|Adverse Event|0|||
160828368|NCT04957758|580758274|FG000|Overall Study|Lost to Follow-up|0|||
160828369|NCT04957758|580758275|FG001|Overall Study|Lost to Follow-up|2|||
160828370|NCT04957758|580758274|FG000|Overall Study|Withdrawal by Subject|4|||
160828371|NCT04957758|580758275|FG001|Overall Study|Withdrawal by Subject|2|||
160828372|NCT04957758|580758274|FG000|Overall Study|Protocol Violation|0|||
160828373|NCT04957758|580758275|FG001|Overall Study|Protocol Violation|1|||
160828374|NCT03353922|580758276|FG000|Overall Study|Withdrawal by Subject|1|||
160828375|NCT03353922|580758277|FG001|Overall Study|Withdrawal by Subject|0|||
160828376|NCT03353922|580758278|FG002|Overall Study|Withdrawal by Subject|1|||
160828377|NCT03353922|580758279|FG003|Overall Study|Withdrawal by Subject|1|||
160828378|NCT03353922|580758280|FG004|Overall Study|Withdrawal by Subject|0|||
160828379|NCT03353922|580758281|FG005|Overall Study|Withdrawal by Subject|0|||
160828380|NCT03353922|580758276|FG000|Overall Study|Adverse Event|0|||
160828381|NCT03353922|580758277|FG001|Overall Study|Adverse Event|1|||
160828382|NCT03353922|580758278|FG002|Overall Study|Adverse Event|0|||
160556642|NCT06118385|579763716|FG000|Overall Study|Protocol Violation|0|||
160556643|NCT06118385|579763717|FG001|Overall Study|Protocol Violation|0|||
160556644|NCT06118385|579763718|FG002|Overall Study|Protocol Violation|0|||
160556645|NCT06118385|579763719|FG003|Overall Study|Protocol Violation|0|||
160556646|NCT06118385|579763720|FG004|Overall Study|Protocol Violation|0|||
160556647|NCT06118385|579763721|FG005|Overall Study|Protocol Violation|0|||
160828383|NCT03353922|580758279|FG003|Overall Study|Adverse Event|0|||
160828384|NCT03353922|580758280|FG004|Overall Study|Adverse Event|0|||
160828385|NCT03353922|580758281|FG005|Overall Study|Adverse Event|0|||
160828386|NCT00740714|580758282|FG000|Overall Study|Withdrawal by Subject|17|||
160828387|NCT00740714|580758283|FG001|Overall Study|Withdrawal by Subject|19|||
160556648|NCT06118385|579763722|FG006|Overall Study|Protocol Violation|0|||
160556649|NCT06118385|579763723|FG007|Overall Study|Protocol Violation|0|||
160647000|NCT00585351|580090061|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
160828388|NCT00740714|580758284|FG002|Overall Study|Withdrawal by Subject|29|||
160828389|NCT03688555|580758285|FG000|Treatment Period|Adverse Event|0|||
160828390|NCT03688555|580758286|FG001|Treatment Period|Adverse Event|0|||
160828391|NCT03688555|580758287|FG002|Treatment Period|Adverse Event|1|||
160828392|NCT00886119|580758291|FG000|Period 1|Did not meet inclusion criteria|1|||
160556650|NCT06118385|579763724|FG008|Overall Study|Protocol Violation|1|||
160828393|NCT00886119|580758292|FG001|Period 1|Did not meet inclusion criteria|0|||
160828394|NCT00394901|580758293|FG000|Baseline Phase|Protocol Violation|0|||
160828395|NCT00394901|580758294|FG001|Baseline Phase|Protocol Violation|0|||
160828396|NCT00394901|580758295|FG002|Baseline Phase|Protocol Violation|1|||
160828397|NCT00394901|580758296|FG003|Baseline Phase|Protocol Violation|0|||
160828398|NCT00394901|580758293|FG000|Double-blind Phase|Adverse Event|5|||
160828399|NCT00394901|580758294|FG001|Double-blind Phase|Adverse Event|7|||
160828400|NCT00394901|580758295|FG002|Double-blind Phase|Adverse Event|16|||
160828401|NCT00394901|580758296|FG003|Double-blind Phase|Adverse Event|20|||
160828402|NCT00394901|580758293|FG000|Double-blind Phase|Lack of Efficacy|6|||
160556651|NCT06118385|579763725|FG009|Overall Study|Protocol Violation|0|||
160828403|NCT00394901|580758294|FG001|Double-blind Phase|Lack of Efficacy|4|||
160828404|NCT00394901|580758295|FG002|Double-blind Phase|Lack of Efficacy|1|||
160902716|NCT02555683|581037801|FG002|Overall Study|Lack of Efficacy|0|||
160902717|NCT02555683|581037799|FG000|Overall Study|Death|0|||
160902718|NCT02555683|581037800|FG001|Overall Study|Death|1|||
160902719|NCT02555683|581037801|FG002|Overall Study|Death|2|||
160902720|NCT02555683|581037799|FG000|Overall Study|Adverse Event|1|||
160556652|NCT06118385|579763726|FG010|Overall Study|Protocol Violation|0|||
160556653|NCT06118385|579763727|FG011|Overall Study|Protocol Violation|0|||
160556654|NCT06118385|579763716|FG000|Overall Study|Out-of-range blood tests|0|||
160556655|NCT06118385|579763717|FG001|Overall Study|Out-of-range blood tests|0|||
160556656|NCT06118385|579763718|FG002|Overall Study|Out-of-range blood tests|0|||
160556657|NCT06118385|579763719|FG003|Overall Study|Out-of-range blood tests|0|||
160556658|NCT06118385|579763720|FG004|Overall Study|Out-of-range blood tests|0|||
160556659|NCT06118385|579763721|FG005|Overall Study|Out-of-range blood tests|0|||
160556660|NCT06118385|579763722|FG006|Overall Study|Out-of-range blood tests|0|||
160556661|NCT06118385|579763723|FG007|Overall Study|Out-of-range blood tests|0|||
160556662|NCT06118385|579763724|FG008|Overall Study|Out-of-range blood tests|1|||
160556663|NCT06118385|579763725|FG009|Overall Study|Out-of-range blood tests|0|||
160556664|NCT06118385|579763726|FG010|Overall Study|Out-of-range blood tests|0|||
160556665|NCT06118385|579763727|FG011|Overall Study|Out-of-range blood tests|0|||
160556666|NCT02411448|579763728|FG000|Overall Study|Withdrawal by Subject|1|||
160556667|NCT02411448|579763729|FG001|Overall Study|Withdrawal by Subject|14|||
160556668|NCT02411448|579763730|FG002|Overall Study|Withdrawal by Subject|9|||
160556669|NCT02411448|579763728|FG000|Overall Study|Other|0|||
160556670|NCT02411448|579763729|FG001|Overall Study|Other|2|||
160556671|NCT02411448|579763730|FG002|Overall Study|Other|0|||
160556672|NCT02411448|579763728|FG000|Overall Study|Did not receive study treatment|0|||
160556673|NCT02411448|579763729|FG001|Overall Study|Did not receive study treatment|3|||
160556674|NCT02411448|579763730|FG002|Overall Study|Did not receive study treatment|0|||
160828405|NCT00394901|580758296|FG003|Double-blind Phase|Lack of Efficacy|3|||
160828406|NCT00394901|580758293|FG000|Double-blind Phase|Withdrawal by Subject|2|||
160556675|NCT02411448|579763728|FG000|Overall Study|Alive on study treatment|3|||
160556676|NCT02411448|579763729|FG001|Overall Study|Alive on study treatment|64|||
160556677|NCT02411448|579763730|FG002|Overall Study|Alive on study treatment|43|||
160556678|NCT02631538|579763733|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
160556679|NCT02631538|579763734|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
160556680|NCT02631538|579763735|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
160556681|NCT02631538|579763736|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
160556682|NCT02631538|579763733|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
160556683|NCT02631538|579763734|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
160556684|NCT02631538|579763735|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
160556685|NCT02631538|579763736|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
160556686|NCT02631538|579763733|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
160556687|NCT02631538|579763734|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
160556688|NCT02631538|579763735|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
160556689|NCT02631538|579763736|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
160556690|NCT02631538|579763733|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
160556691|NCT02631538|579763734|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
160556692|NCT02631538|579763735|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
160556693|NCT02631538|579763736|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
160556694|NCT02631538|579763733|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
160556695|NCT02631538|579763734|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
160556696|NCT02631538|579763735|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
160556697|NCT02631538|579763736|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
160556698|NCT02631538|579763733|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
160556699|NCT02631538|579763734|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
160556700|NCT02631538|579763735|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
160556701|NCT02631538|579763736|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
160556702|NCT00440726|579763737|FG000|Phase 1|Dose-Limiting Toxicity|0|||
160556703|NCT00440726|579763738|FG001|Phase 1|Dose-Limiting Toxicity|1|||
160556704|NCT00440726|579763739|FG002|Phase 1|Dose-Limiting Toxicity|0|||
160556705|NCT00440726|579763737|FG000|Phase 1|Physician Decision|1|||
160556706|NCT00440726|579763738|FG001|Phase 1|Physician Decision|0|||
160647001|NCT00585351|580090062|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
160828407|NCT00394901|580758294|FG001|Double-blind Phase|Withdrawal by Subject|0|||
160828408|NCT00394901|580758295|FG002|Double-blind Phase|Withdrawal by Subject|0|||
160828409|NCT00394901|580758296|FG003|Double-blind Phase|Withdrawal by Subject|0|||
160828410|NCT00394901|580758293|FG000|Double-blind Phase|Lost to Follow-up|0|||
160828411|NCT00394901|580758294|FG001|Double-blind Phase|Lost to Follow-up|0|||
160828412|NCT00394901|580758295|FG002|Double-blind Phase|Lost to Follow-up|0|||
160828413|NCT00394901|580758296|FG003|Double-blind Phase|Lost to Follow-up|1|||
160828414|NCT00394901|580758293|FG000|Double-blind Phase|Protocol Violation|0|||
160828415|NCT00394901|580758294|FG001|Double-blind Phase|Protocol Violation|0|||
160828416|NCT00394901|580758295|FG002|Double-blind Phase|Protocol Violation|0|||
160990633|NCT03120676|581353906|FG000|Overall Study|Not treated|1|||
160556707|NCT00440726|579763739|FG002|Phase 1|Physician Decision|0|||
160828417|NCT00394901|580758296|FG003|Double-blind Phase|Protocol Violation|1|||
160828418|NCT00394901|580758293|FG000|Double-blind Phase|Death|1|||
160828419|NCT00394901|580758294|FG001|Double-blind Phase|Death|0|||
160556708|NCT00440726|579763737|FG000|Phase 2|Death|0|||
160556709|NCT00440726|579763738|FG001|Phase 2|Death|0|||
160556710|NCT00440726|579763739|FG002|Phase 2|Death|1|||
160556711|NCT00440726|579763737|FG000|Phase 2|Adverse Event|0|||
160556712|NCT00440726|579763738|FG001|Phase 2|Adverse Event|0|||
160556713|NCT00440726|579763739|FG002|Phase 2|Adverse Event|1|||
160556714|NCT00559273|579763743|FG000|Correction Period (20 Weeks)|Death|3|||
160556715|NCT00559273|579763744|FG001|Correction Period (20 Weeks)|Death|4|||
160556716|NCT00559273|579763743|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
160556717|NCT00559273|579763744|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
160556718|NCT00559273|579763743|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
160556719|NCT00559273|579763744|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
160556720|NCT00559273|579763743|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
160556721|NCT00559273|579763744|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
160556722|NCT00559273|579763743|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
160556723|NCT00559273|579763744|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
160556724|NCT00559273|579763743|FG000|Evaluation Period (8 Weeks)|Death|1|||
160556725|NCT00559273|579763744|FG001|Evaluation Period (8 Weeks)|Death|3|||
160556726|NCT00559273|579763743|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
160556727|NCT00559273|579763744|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
160556728|NCT00559273|579763743|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
160556729|NCT00559273|579763744|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
160556730|NCT00559273|579763743|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
160556731|NCT00559273|579763744|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
160556732|NCT04276207|579763745|FG000|Period 1|Withdrawal by Subject|0|||
160556733|NCT04276207|579763746|FG001|Period 1|Withdrawal by Subject|1|||
160556734|NCT01256177|579763747|FG000|Overall Study|Withdrawal by Subject|23|||
160556735|NCT01256177|579763748|FG001|Overall Study|Withdrawal by Subject|22|||
160556736|NCT01256177|579763747|FG000|Overall Study|Lost to Follow-up|2|||
160556737|NCT01256177|579763748|FG001|Overall Study|Lost to Follow-up|2|||
160556738|NCT01256177|579763747|FG000|Overall Study|Adverse Event|8|||
160556739|NCT01256177|579763748|FG001|Overall Study|Adverse Event|9|||
160556740|NCT01256177|579763747|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
160556741|NCT01256177|579763748|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
160556742|NCT01256177|579763747|FG000|Overall Study|Condition under Investigation Worsened|1|||
160556743|NCT01256177|579763748|FG001|Overall Study|Condition under Investigation Worsened|0|||
160556744|NCT01256177|579763747|FG000|Overall Study|Lack of Efficacy|11|||
160556745|NCT01256177|579763748|FG001|Overall Study|Lack of Efficacy|2|||
160556746|NCT01256177|579763747|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
160556747|NCT01256177|579763748|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
160556748|NCT01596257|579763750|FG000|Overall Study|Inadequate Collection|23|||
160556749|NCT01596257|579763751|FG001|Overall Study|Inadequate Collection|19|||
160556750|NCT02318784|579763752|FG000|Overall Study|Adverse Event|13|||
160556751|NCT02318784|579763752|FG000|Overall Study|Death|2|||
160556752|NCT02318784|579763752|FG000|Overall Study|Progressive Disease|37|||
160556753|NCT02318784|579763752|FG000|Overall Study|Withdrawal by Subject|10|||
160556754|NCT01879410|579763758|FG000|Overall Study|Adverse Event|9|||
160556755|NCT01879410|579763759|FG001|Overall Study|Adverse Event|14|||
160556756|NCT01879410|579763758|FG000|Overall Study|Lack of Efficacy|4|||
160647002|NCT00585351|580090063|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
160647003|NCT00585351|580090056|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
160828420|NCT00394901|580758295|FG002|Double-blind Phase|Death|0|||
160828421|NCT00394901|580758296|FG003|Double-blind Phase|Death|0|||
160828422|NCT00394901|580758293|FG000|Double-blind Phase|Subject's Personal Reason|1|||
160828423|NCT00394901|580758294|FG001|Double-blind Phase|Subject's Personal Reason|0|||
160828424|NCT00394901|580758295|FG002|Double-blind Phase|Subject's Personal Reason|0|||
160828425|NCT00394901|580758296|FG003|Double-blind Phase|Subject's Personal Reason|1|||
160828426|NCT00394901|580758293|FG000|Double-blind Phase|Lack of Compliance|0|||
160828427|NCT00394901|580758294|FG001|Double-blind Phase|Lack of Compliance|3|||
160828428|NCT00394901|580758295|FG002|Double-blind Phase|Lack of Compliance|0|||
160828429|NCT00394901|580758296|FG003|Double-blind Phase|Lack of Compliance|0|||
160902721|NCT02555683|581037800|FG001|Overall Study|Adverse Event|0|||
160902722|NCT02555683|581037801|FG002|Overall Study|Adverse Event|1|||
160902723|NCT02555683|581037799|FG000|Overall Study|Subject/guardian decision|12|||
160556757|NCT01879410|579763759|FG001|Overall Study|Lack of Efficacy|6|||
160556758|NCT01879410|579763758|FG000|Overall Study|Protocol Violation|1|||
160556759|NCT01879410|579763759|FG001|Overall Study|Protocol Violation|7|||
160556760|NCT01879410|579763758|FG000|Overall Study|Lost to Follow-up|2|||
160556761|NCT01879410|579763759|FG001|Overall Study|Lost to Follow-up|1|||
160556762|NCT01879410|579763758|FG000|Overall Study|Withdrawal by Subject|7|||
160556763|NCT01879410|579763759|FG001|Overall Study|Withdrawal by Subject|8|||
160556764|NCT01879410|579763758|FG000|Overall Study|Randomised in Error|1|||
160828430|NCT00394901|580758293|FG000|Double-blind Phase|Entry into another study was found|0|||
160556765|NCT01879410|579763759|FG001|Overall Study|Randomised in Error|2|||
160902724|NCT02555683|581037800|FG001|Overall Study|Subject/guardian decision|12|||
160556766|NCT00238264|579763760|FG000|Overall Study|Death|7|||
160556767|NCT00238264|579763760|FG000|Overall Study|Lost to Follow-up|18|||
160556768|NCT00238264|579763760|FG000|Overall Study|Withdrawal by Subject|4|||
160556769|NCT00238264|579763760|FG000|Overall Study|Ineligible|7|||
160556770|NCT01737931|579763764|FG000|Overall Study|Withdrawal by Subject|0|||
160556771|NCT01737931|579763765|FG001|Overall Study|Withdrawal by Subject|1|||
160556772|NCT01737931|579763766|FG002|Overall Study|Withdrawal by Subject|1|||
160556773|NCT01737931|579763764|FG000|Overall Study|Physician Decision|0|||
160556774|NCT01737931|579763765|FG001|Overall Study|Physician Decision|1|||
160556775|NCT01737931|579763766|FG002|Overall Study|Physician Decision|0|||
160556776|NCT04897867|579763767|FG000|Overall Study|Withdrawal of Consent|1|||
160828431|NCT00394901|580758294|FG001|Double-blind Phase|Entry into another study was found|0|||
160828432|NCT00394901|580758295|FG002|Double-blind Phase|Entry into another study was found|1|||
160828433|NCT00394901|580758296|FG003|Double-blind Phase|Entry into another study was found|0|||
160828434|NCT00394901|580758293|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
160828435|NCT00394901|580758294|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
160828436|NCT00394901|580758295|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
160828437|NCT00394901|580758296|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
160828438|NCT03158272|580758306|FG000|Overall Study|Disease progression|3|||
160828439|NCT03158272|580758307|FG001|Overall Study|Disease progression|3|||
160828440|NCT03158272|580758308|FG002|Overall Study|Disease progression|4|||
160828441|NCT03158272|580758309|FG003|Overall Study|Disease progression|6|||
160828442|NCT03158272|580758306|FG000|Overall Study|Death|0|||
160828443|NCT03158272|580758307|FG001|Overall Study|Death|0|||
160828444|NCT03158272|580758308|FG002|Overall Study|Death|1|||
160828445|NCT03158272|580758309|FG003|Overall Study|Death|0|||
160828446|NCT03158272|580758306|FG000|Overall Study|Other reasons|0|||
160828447|NCT03158272|580758307|FG001|Overall Study|Other reasons|0|||
160828448|NCT03158272|580758308|FG002|Overall Study|Other reasons|1|||
160828449|NCT03158272|580758309|FG003|Overall Study|Other reasons|0|||
160828450|NCT03158272|580758306|FG000|Overall Study|Adverse event unrelated to the drug|0|||
160828451|NCT03158272|580758307|FG001|Overall Study|Adverse event unrelated to the drug|1|||
160828452|NCT03158272|580758308|FG002|Overall Study|Adverse event unrelated to the drug|0|||
160828453|NCT03158272|580758309|FG003|Overall Study|Adverse event unrelated to the drug|0|||
160828454|NCT01688921|580758310|FG000|Overall Study|Lost to Follow-up|7|||
160828455|NCT01688921|580758311|FG001|Overall Study|Lost to Follow-up|13|||
160990634|NCT00886613|581353911|FG000|Overall Study|Protocol deviation (Part B)|1|||
160556777|NCT04897867|579763767|FG000|Overall Study|Pregnancy|1|||
160556778|NCT04897867|579763767|FG000|Overall Study|Lost to Follow-up|7|||
160556779|NCT04897867|579763767|FG000|Overall Study|Reason not Specified|2|||
160556780|NCT02041962|579763768|FG000|Overall Study|Lost Aetna Coverage|43|||
160556781|NCT02041962|579763769|FG001|Overall Study|Lost Aetna Coverage|40|||
160556782|NCT02041962|579763768|FG000|Overall Study|Death|1|||
160556783|NCT02041962|579763769|FG001|Overall Study|Death|1|||
160828456|NCT01688921|580758310|FG000|Overall Study|Physician Decision|6|||
160828457|NCT01688921|580758311|FG001|Overall Study|Physician Decision|1|||
160828458|NCT01688921|580758310|FG000|Overall Study|Protocol Violation|0|||
160828459|NCT01688921|580758311|FG001|Overall Study|Protocol Violation|1|||
160828460|NCT01688921|580758310|FG000|Overall Study|informed consent|3|||
160556784|NCT02041962|579763768|FG000|Overall Study|Lost to Follow-up|37|||
160556785|NCT02041962|579763769|FG001|Overall Study|Lost to Follow-up|32|||
160828461|NCT01688921|580758311|FG001|Overall Study|informed consent|0|||
160556786|NCT02041962|579763768|FG000|Overall Study|Withdrawal by Subject|0|||
160556787|NCT02041962|579763769|FG001|Overall Study|Withdrawal by Subject|11|||
160556788|NCT01838044|579763770|FG000|Overall Study|Adverse Event|4|||
160828462|NCT00664326|580759803|FG000|Overall Study|Adverse Event|14|||
160828463|NCT00664326|580759803|FG000|Overall Study|Noncompliance with study medication|3|||
160828464|NCT00664326|580759803|FG000|Overall Study|Withdrawal by Subject|1|||
160828465|NCT00664326|580759803|FG000|Overall Study|Physician Decision|1|||
160828466|NCT00664326|580759803|FG000|Overall Study|Other Reasons|3|||
160828467|NCT00664326|580759803|FG000|Overall Study|Death|2|||
160828468|NCT00664326|580759803|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
160828469|NCT00262847|580759804|FG000|Overall Study|Disease Progression|309|||
160828470|NCT00262847|580759805|FG001|Overall Study|Disease Progression|274|||
160828471|NCT00262847|580759806|FG002|Overall Study|Disease Progression|195|||
160828472|NCT00262847|580759804|FG000|Overall Study|Patient Refusal|41|||
160828473|NCT00262847|580759805|FG001|Overall Study|Patient Refusal|52|||
160828474|NCT00262847|580759806|FG002|Overall Study|Patient Refusal|47|||
160828475|NCT00262847|580759804|FG000|Overall Study|Adverse Event|74|||
160828476|NCT00262847|580759805|FG001|Overall Study|Adverse Event|88|||
160828477|NCT00262847|580759806|FG002|Overall Study|Adverse Event|108|||
160828478|NCT00262847|580759804|FG000|Overall Study|Death|8|||
160828479|NCT00262847|580759805|FG001|Overall Study|Death|8|||
160828480|NCT00262847|580759806|FG002|Overall Study|Death|11|||
160828481|NCT00262847|580759804|FG000|Overall Study|Concomitant disease|3|||
160828482|NCT00262847|580759805|FG001|Overall Study|Concomitant disease|2|||
160828483|NCT00262847|580759806|FG002|Overall Study|Concomitant disease|4|||
160828484|NCT00262847|580759804|FG000|Overall Study|Other Reasons|79|||
160990635|NCT00886613|581353912|FG001|Overall Study|Protocol deviation (Part B)|0|||
160990636|NCT00886613|581353913|FG002|Overall Study|Protocol deviation (Part B)|0|||
160990637|NCT00886613|581353911|FG000|Overall Study|Lost to follow-up (Part B)|1|||
160990638|NCT00886613|581353912|FG001|Overall Study|Lost to follow-up (Part B)|0|||
160990639|NCT00886613|581353913|FG002|Overall Study|Lost to follow-up (Part B)|1|||
160990640|NCT00886613|581353911|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
160990641|NCT00886613|581353912|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
160990642|NCT00886613|581353913|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
160990643|NCT00463151|581353914|FG000|Overall Study|Adverse Event|0|||
160990644|NCT00463151|581353915|FG001|Overall Study|Adverse Event|0|||
160990645|NCT00463151|581353916|FG002|Overall Study|Adverse Event|1|||
160990646|NCT00463151|581353917|FG003|Overall Study|Adverse Event|0|||
160990647|NCT00463151|581353914|FG000|Overall Study|Lack of Efficacy|2|||
160990648|NCT00463151|581353915|FG001|Overall Study|Lack of Efficacy|5|||
160990649|NCT00463151|581353916|FG002|Overall Study|Lack of Efficacy|2|||
160990650|NCT00463151|581353917|FG003|Overall Study|Lack of Efficacy|5|||
160990651|NCT00463151|581353914|FG000|Overall Study|Protocol Violation|0|||
160990652|NCT00463151|581353915|FG001|Overall Study|Protocol Violation|0|||
160990653|NCT00463151|581353916|FG002|Overall Study|Protocol Violation|0|||
160990654|NCT00463151|581353917|FG003|Overall Study|Protocol Violation|1|||
160990655|NCT00463151|581353914|FG000|Overall Study|Withdrawal by Subject|0|||
160990656|NCT00463151|581353915|FG001|Overall Study|Withdrawal by Subject|0|||
160990657|NCT00463151|581353916|FG002|Overall Study|Withdrawal by Subject|0|||
160556789|NCT01838044|579763771|FG001|Overall Study|Adverse Event|6|||
160556790|NCT01838044|579763770|FG000|Overall Study|Protocol Violation|3|||
160556791|NCT01838044|579763771|FG001|Overall Study|Protocol Violation|3|||
160556792|NCT01838044|579763770|FG000|Overall Study|Withdrawal by Subject|0|||
160556793|NCT01838044|579763771|FG001|Overall Study|Withdrawal by Subject|2|||
160556794|NCT01838044|579763770|FG000|Overall Study|Insufficient clinical response|1|||
160556795|NCT01838044|579763771|FG001|Overall Study|Insufficient clinical response|2|||
160556796|NCT01838044|579763770|FG000|Overall Study|Medication error without associated AE|0|||
160556797|NCT01838044|579763771|FG001|Overall Study|Medication error without associated AE|1|||
160556798|NCT01838044|579763770|FG000|Overall Study|Lost to Follow-up|0|||
160556799|NCT01838044|579763771|FG001|Overall Study|Lost to Follow-up|2|||
160556800|NCT01413958|579763772|FG000|Overall Study|Lost to Follow-up|0|||
160556801|NCT01413958|579763773|FG001|Overall Study|Lost to Follow-up|1|||
160556802|NCT00974220|579763775|FG000|Treatment Period 1|Adverse Event|2|||
160556803|NCT00974220|579763776|FG001|Treatment Period 1|Adverse Event|1|||
160556804|NCT00974220|579763775|FG000|Treatment Period 1|noncompliant subjects|0|||
160556805|NCT00974220|579763776|FG001|Treatment Period 1|noncompliant subjects|1|||
160556806|NCT00737529|579763780|FG000|Overall Study|Disease Progression|95|||
160556807|NCT00737529|579763780|FG000|Overall Study|Adverse Event|24|||
160556808|NCT00737529|579763780|FG000|Overall Study|Withdrawal by Subject|5|||
160556809|NCT00737529|579763780|FG000|Overall Study|Death|4|||
160556810|NCT00737529|579763780|FG000|Overall Study|Protocol Violation|1|||
160556811|NCT00737529|579763780|FG000|Overall Study|Other|4|||
160556812|NCT00712348|579763781|FG000|Overall Study|Withdrawal by Subject|1|||
160556813|NCT01375764|579763784|FG000|Overall Study|Lost to Follow-up|0|||
160556814|NCT01375764|579763785|FG001|Overall Study|Lost to Follow-up|1|||
160556815|NCT01375764|579763786|FG002|Overall Study|Lost to Follow-up|0|||
160556816|NCT01375764|579763787|FG003|Overall Study|Lost to Follow-up|0|||
160556817|NCT01375764|579763788|FG004|Overall Study|Lost to Follow-up|0|||
160556818|NCT01375764|579763784|FG000|Overall Study|Withdrawal by Subject|2|||
160556819|NCT01375764|579763785|FG001|Overall Study|Withdrawal by Subject|0|||
160556820|NCT01375764|579763786|FG002|Overall Study|Withdrawal by Subject|0|||
160556821|NCT01375764|579763787|FG003|Overall Study|Withdrawal by Subject|0|||
160556822|NCT01375764|579763788|FG004|Overall Study|Withdrawal by Subject|1|||
160556823|NCT01375764|579763784|FG000|Overall Study|Other|0|||
160556824|NCT01375764|579763785|FG001|Overall Study|Other|0|||
160556825|NCT01375764|579763786|FG002|Overall Study|Other|0|||
160556826|NCT01375764|579763787|FG003|Overall Study|Other|1|||
160556827|NCT01375764|579763788|FG004|Overall Study|Other|0|||
160556828|NCT02445586|579763792|FG000|Overall Study|Death|14|||
160556829|NCT02445586|579763792|FG000|Overall Study|Withdrawal by Subject|13|||
160556830|NCT02445586|579763792|FG000|Overall Study|Disease Progression|10|||
160556831|NCT02445586|579763792|FG000|Overall Study|Protocol Violation|1|||
160556832|NCT02445586|579763792|FG000|Overall Study|Medical Condition|1|||
160556833|NCT01194440|579763793|FG000|Baseline (First Dose)|Reason not specified|4|||
160556834|NCT01194440|579763793|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
160556835|NCT01194440|579763793|FG000|Baseline (First Dose)|Change in therapy|1|||
160556836|NCT01194440|579763793|FG000|Baseline (First Dose)|Adverse Event|1|||
160556837|NCT01194440|579763793|FG000|6-months (2nd Dose)|Change in therapy|4|||
160556838|NCT02959814|579763806|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
160556839|NCT02959814|579763806|FG000|Overall Study|Excluded based on anatomical criteria|2|||
160556840|NCT02959814|579763806|FG000|Overall Study|Protocol Violation|7|||
160556841|NCT02959814|579763806|FG000|Overall Study|FFR not measured|2|||
160556842|NCT02959814|579763806|FG000|Overall Study|In-procedure QFR not computed|6|||
160556843|NCT02959814|579763806|FG000|Overall Study|Excluded by FFR core-lab|24|||
160556844|NCT04343651|579763810|FG000|Overall Study|Physician Decision|2|||
160556845|NCT04343651|579763811|FG001|Overall Study|Physician Decision|1|||
160556846|NCT04343651|579763810|FG000|Overall Study|Lost to Follow-up|2|||
160556847|NCT04343651|579763811|FG001|Overall Study|Lost to Follow-up|1|||
160556848|NCT04343651|579763810|FG000|Overall Study|Protocol Violation|4|||
160556849|NCT04343651|579763811|FG001|Overall Study|Protocol Violation|6|||
160556850|NCT04343651|579763810|FG000|Overall Study|Missing|3|||
160556851|NCT04343651|579763811|FG001|Overall Study|Missing|9|||
160556852|NCT04343651|579763810|FG000|Overall Study|Withdrawal by Subject|0|||
160556853|NCT04343651|579763811|FG001|Overall Study|Withdrawal by Subject|4|||
160556854|NCT04343651|579763810|FG000|Overall Study|Death|0|||
160556855|NCT04343651|579763811|FG001|Overall Study|Death|1|||
160556856|NCT04343651|579763810|FG000|Overall Study|Did not start treatment|1|||
160556857|NCT04343651|579763811|FG001|Overall Study|Did not start treatment|1|||
160556858|NCT04343651|579763810|FG000|Overall Study|Patient did not complete visits 3-6|0|||
160556859|NCT04343651|579763811|FG001|Overall Study|Patient did not complete visits 3-6|1|||
160556860|NCT03219164|579766180|FG000|Overall Study|Study Terminated by Sponsor|16|||
160556861|NCT03219164|579766181|FG001|Overall Study|Study Terminated by Sponsor|12|||
160556862|NCT03219164|579766180|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
160556863|NCT03219164|579766181|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
160556864|NCT03219164|579766180|FG000|Overall Study|Lost to Follow-up|1|||
160556865|NCT03219164|579766181|FG001|Overall Study|Lost to Follow-up|1|||
160556866|NCT03219164|579766180|FG000|Overall Study|Adverse Event|1|||
160556867|NCT03219164|579766181|FG001|Overall Study|Adverse Event|0|||
160556868|NCT03219164|579766180|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160556869|NCT03219164|579766181|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160556870|NCT03219164|579766180|FG000|Overall Study|Protocol Violation|0|||
160556871|NCT03219164|579766181|FG001|Overall Study|Protocol Violation|1|||
160556872|NCT03219164|579766180|FG000|Overall Study|Withdrew Assent|1|||
160556873|NCT03219164|579766181|FG001|Overall Study|Withdrew Assent|0|||
160556874|NCT00206726|579766186|FG000|Overall Study|Delayed recovery of blood counts|1|||
160556875|NCT00206726|579766186|FG000|Overall Study|Progressive disease or relapsed disease|18|||
160556876|NCT00206726|579766186|FG000|Overall Study|Placed on new protocol|1|||
160556877|NCT00206726|579766186|FG000|Overall Study|Bone marrow transplant|1|||
160556878|NCT00206726|579766186|FG000|Overall Study|Adverse Event|17|||
160556879|NCT00206726|579766186|FG000|Overall Study|Death|4|||
160556880|NCT00206726|579766186|FG000|Overall Study|Protocol Violation|1|||
160556881|NCT00206726|579766186|FG000|Overall Study|Withdrawal by Subject|8|||
160556882|NCT01341457|579766189|FG000|Overall Study|Adverse Event|2|||
160556883|NCT01341457|579766190|FG001|Overall Study|Adverse Event|0|||
160556884|NCT00365989|579766191|FG000|Overall Study|Withdrawal by Subject|1|||
160556885|NCT00365989|579766191|FG000|Overall Study|Non-compliance|1|||
160828485|NCT00262847|580759805|FG001|Overall Study|Other Reasons|88|||
160990658|NCT00463151|581353917|FG003|Overall Study|Withdrawal by Subject|1|||
160556886|NCT00832819|579766194|FG000|Overall Study|Adverse Event|0|||
160556887|NCT00832819|579766195|FG001|Overall Study|Adverse Event|1|||
160556888|NCT00832819|579766196|FG002|Overall Study|Adverse Event|0|||
160556889|NCT00832819|579766194|FG000|Overall Study|Protocol Violation|0|||
160556890|NCT00832819|579766195|FG001|Overall Study|Protocol Violation|0|||
160556891|NCT00832819|579766196|FG002|Overall Study|Protocol Violation|1|||
160556892|NCT00317044|579766197|FG000|Overall Study|Protocol Violation|28|||
160556893|NCT00317044|579766198|FG001|Overall Study|Protocol Violation|22|||
160556894|NCT00317044|579766199|FG002|Overall Study|Protocol Violation|20|||
160556895|NCT00317044|579766197|FG000|Overall Study|Adverse Event|4|||
160556896|NCT00317044|579766198|FG001|Overall Study|Adverse Event|7|||
160556897|NCT00317044|579766199|FG002|Overall Study|Adverse Event|4|||
160556898|NCT00317044|579766197|FG000|Overall Study|Withdrawal by Subject|10|||
160556899|NCT00317044|579766198|FG001|Overall Study|Withdrawal by Subject|7|||
160828486|NCT00262847|580759806|FG002|Overall Study|Other Reasons|27|||
160990659|NCT05349084|581353918|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
160556900|NCT00317044|579766199|FG002|Overall Study|Withdrawal by Subject|12|||
160556901|NCT00317044|579766197|FG000|Overall Study|Lost to Follow-up|0|||
160556902|NCT00317044|579766198|FG001|Overall Study|Lost to Follow-up|2|||
160556903|NCT00317044|579766199|FG002|Overall Study|Lost to Follow-up|3|||
160556904|NCT00317044|579766197|FG000|Overall Study|Multiple Reasons|6|||
160556905|NCT00317044|579766198|FG001|Overall Study|Multiple Reasons|2|||
160556906|NCT00317044|579766199|FG002|Overall Study|Multiple Reasons|6|||
160556907|NCT04317690|579766200|FG000|Overall Study|did not have complete information for primary outcome|0|||
160990660|NCT00972543|581353919|FG000|Overall Study|Adverse Event|1|||
160556908|NCT04317690|579766201|FG001|Overall Study|did not have complete information for primary outcome|4|||
160556909|NCT04317690|579766202|FG002|Overall Study|did not have complete information for primary outcome|0|||
160556910|NCT04317690|579766203|FG003|Overall Study|did not have complete information for primary outcome|2|||
160556911|NCT04317690|579766204|FG004|Overall Study|did not have complete information for primary outcome|0|||
160556912|NCT02318095|579766205|FG000|Overall Study|Adverse Event|1|||
160828487|NCT00262847|580759804|FG000|Overall Study|Did not receive study treatment|4|||
160828488|NCT00262847|580759805|FG001|Overall Study|Did not receive study treatment|1|||
160828489|NCT00262847|580759806|FG002|Overall Study|Did not receive study treatment|4|||
160828490|NCT00387647|580759807|FG000|Overall Study|Death|18|||
160828491|NCT05160766|580759808|FG000|Overall Study|Adverse Event|0|||
160828492|NCT05160766|580759809|FG001|Overall Study|Adverse Event|1|||
160828493|NCT05160766|580759810|FG002|Overall Study|Adverse Event|0|||
160828494|NCT05160766|580759811|FG003|Overall Study|Adverse Event|0|||
160828495|NCT05160766|580759808|FG000|Overall Study|COVID-19 infection|0|||
160828496|NCT05160766|580759809|FG001|Overall Study|COVID-19 infection|1|||
160828497|NCT05160766|580759810|FG002|Overall Study|COVID-19 infection|0|||
160828498|NCT05160766|580759811|FG003|Overall Study|COVID-19 infection|0|||
160828499|NCT05160766|580759808|FG000|Overall Study|travel time|1|||
160828500|NCT05160766|580759809|FG001|Overall Study|travel time|0|||
160828501|NCT05160766|580759810|FG002|Overall Study|travel time|0|||
160828502|NCT05160766|580759811|FG003|Overall Study|travel time|1|||
160828503|NCT05160766|580759808|FG000|Overall Study|Withdrawal by Subject|3|||
160828504|NCT05160766|580759809|FG001|Overall Study|Withdrawal by Subject|5|||
160828505|NCT05160766|580759810|FG002|Overall Study|Withdrawal by Subject|4|||
160828506|NCT05160766|580759811|FG003|Overall Study|Withdrawal by Subject|2|||
160828507|NCT05160766|580759808|FG000|Overall Study|Death|0|||
160556913|NCT01717638|579766206|FG000|Overall Study|Lost to Follow-up|0|||
160556914|NCT01717638|579766207|FG001|Overall Study|Lost to Follow-up|0|||
160828508|NCT05160766|580759809|FG001|Overall Study|Death|0|||
160828509|NCT05160766|580759810|FG002|Overall Study|Death|2|||
160828510|NCT05160766|580759811|FG003|Overall Study|Death|5|||
160828511|NCT05160766|580759808|FG000|Overall Study|Lost to Follow-up|0|||
160828512|NCT05160766|580759809|FG001|Overall Study|Lost to Follow-up|0|||
160828513|NCT05160766|580759810|FG002|Overall Study|Lost to Follow-up|1|||
160828514|NCT05160766|580759811|FG003|Overall Study|Lost to Follow-up|2|||
160828515|NCT05160766|580759808|FG000|Overall Study|No show|0|||
160828516|NCT05160766|580759809|FG001|Overall Study|No show|0|||
160828517|NCT05160766|580759810|FG002|Overall Study|No show|1|||
160828518|NCT05160766|580759811|FG003|Overall Study|No show|1|||
160828519|NCT05160766|580759808|FG000|Overall Study|Physician Decision|0|||
160828520|NCT05160766|580759809|FG001|Overall Study|Physician Decision|0|||
160828521|NCT05160766|580759810|FG002|Overall Study|Physician Decision|0|||
160828522|NCT05160766|580759811|FG003|Overall Study|Physician Decision|1|||
160828523|NCT05160766|580759808|FG000|Overall Study|Protocol Violation|0|||
160828524|NCT05160766|580759809|FG001|Overall Study|Protocol Violation|0|||
160828525|NCT05160766|580759810|FG002|Overall Study|Protocol Violation|1|||
160828526|NCT05160766|580759811|FG003|Overall Study|Protocol Violation|0|||
160828527|NCT02943915|580759812|FG000|Overall Study|Withdrawal by Subject|2|||
160556915|NCT01717638|579766208|FG002|Overall Study|Lost to Follow-up|0|||
160828528|NCT02943915|580759813|FG001|Overall Study|Withdrawal by Subject|1|||
160828529|NCT02943915|580759814|FG002|Overall Study|Withdrawal by Subject|0|||
160828530|NCT02943915|580759815|FG003|Overall Study|Withdrawal by Subject|0|||
160828531|NCT02943915|580759812|FG000|Overall Study|Lost to Follow-up|3|||
160828532|NCT02943915|580759813|FG001|Overall Study|Lost to Follow-up|1|||
160828533|NCT02943915|580759814|FG002|Overall Study|Lost to Follow-up|0|||
160828534|NCT02943915|580759815|FG003|Overall Study|Lost to Follow-up|0|||
160828535|NCT02943915|580759812|FG000|Overall Study|excluded|0|||
160828536|NCT02943915|580759813|FG001|Overall Study|excluded|1|||
160556916|NCT01717638|579766209|FG003|Overall Study|Lost to Follow-up|0|||
160556917|NCT01717638|579766210|FG004|Overall Study|Lost to Follow-up|0|||
160556918|NCT01717638|579766211|FG005|Overall Study|Lost to Follow-up|1|||
160556919|NCT01717638|579766212|FG006|Overall Study|Lost to Follow-up|0|||
160556920|NCT01717638|579766213|FG007|Overall Study|Lost to Follow-up|0|||
160556921|NCT01717638|579766214|FG008|Overall Study|Lost to Follow-up|0|||
160556922|NCT01717638|579766215|FG009|Overall Study|Lost to Follow-up|0|||
160556923|NCT01717638|579766216|FG010|Overall Study|Lost to Follow-up|0|||
160556924|NCT01717638|579766217|FG011|Overall Study|Lost to Follow-up|0|||
160556925|NCT01717638|579766218|FG012|Overall Study|Lost to Follow-up|0|||
160556926|NCT01717638|579766206|FG000|Overall Study|Father in hospital|0|||
160556927|NCT01717638|579766207|FG001|Overall Study|Father in hospital|0|||
160556928|NCT01717638|579766208|FG002|Overall Study|Father in hospital|0|||
160556929|NCT01717638|579766209|FG003|Overall Study|Father in hospital|0|||
160556930|NCT01717638|579766210|FG004|Overall Study|Father in hospital|0|||
160556931|NCT01717638|579766211|FG005|Overall Study|Father in hospital|0|||
160556932|NCT01717638|579766212|FG006|Overall Study|Father in hospital|0|||
160556933|NCT01717638|579766213|FG007|Overall Study|Father in hospital|0|||
160556934|NCT01717638|579766214|FG008|Overall Study|Father in hospital|0|||
160556935|NCT01717638|579766215|FG009|Overall Study|Father in hospital|0|||
160556936|NCT01717638|579766216|FG010|Overall Study|Father in hospital|0|||
160828537|NCT02943915|580759814|FG002|Overall Study|excluded|0|||
160828538|NCT02943915|580759815|FG003|Overall Study|excluded|0|||
160828539|NCT03769311|580759816|FG000|Overall Study|Withdrawal by Subject|1|||
160828540|NCT03627065|580759817|FG000|Overall Study|Study Terminated by sponsor|1|||
160828541|NCT03627065|580759817|FG000|Overall Study|Withdrawal by Subject|2|||
160828542|NCT00076336|580759818|FG000|Overall Study|Death|13|||
160828543|NCT00076336|580759819|FG001|Overall Study|Death|17|||
160828544|NCT00076336|580759818|FG000|Overall Study|Adverse Event|4|||
160828545|NCT00076336|580759819|FG001|Overall Study|Adverse Event|4|||
160828546|NCT00076336|580759818|FG000|Overall Study|Lost to Follow-up|4|||
160828547|NCT00076336|580759819|FG001|Overall Study|Lost to Follow-up|4|||
160828548|NCT00076336|580759818|FG000|Overall Study|Non-Compliance|2|||
160828549|NCT00076336|580759819|FG001|Overall Study|Non-Compliance|0|||
160828550|NCT00076336|580759818|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
160828551|NCT00076336|580759819|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
160828552|NCT00076336|580759818|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
160828553|NCT00076336|580759819|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
160828554|NCT00076336|580759818|FG000|Overall Study|Liver Transplantation|3|||
160556937|NCT01717638|579766217|FG011|Overall Study|Father in hospital|0|||
160556938|NCT01717638|579766218|FG012|Overall Study|Father in hospital|1|||
160556939|NCT01717638|579766206|FG000|Overall Study|Withdrawal by Subject|0|||
160556940|NCT01717638|579766207|FG001|Overall Study|Withdrawal by Subject|1|||
160556941|NCT01717638|579766208|FG002|Overall Study|Withdrawal by Subject|1|||
160556942|NCT01717638|579766209|FG003|Overall Study|Withdrawal by Subject|0|||
160556943|NCT01717638|579766210|FG004|Overall Study|Withdrawal by Subject|1|||
160556944|NCT01717638|579766211|FG005|Overall Study|Withdrawal by Subject|0|||
160556945|NCT01717638|579766212|FG006|Overall Study|Withdrawal by Subject|2|||
160556946|NCT01717638|579766213|FG007|Overall Study|Withdrawal by Subject|1|||
160556947|NCT01717638|579766214|FG008|Overall Study|Withdrawal by Subject|2|||
160556948|NCT01717638|579766215|FG009|Overall Study|Withdrawal by Subject|1|||
160556949|NCT01717638|579766216|FG010|Overall Study|Withdrawal by Subject|0|||
160556950|NCT01717638|579766217|FG011|Overall Study|Withdrawal by Subject|0|||
160556951|NCT01717638|579766218|FG012|Overall Study|Withdrawal by Subject|18|||
160556952|NCT02626338|579766219|FG000|Overall Study|Lack of Efficacy|3|||
160556953|NCT02626338|579766220|FG001|Overall Study|Lack of Efficacy|2|||
160556954|NCT02626338|579766221|FG002|Overall Study|Lack of Efficacy|0|||
160556955|NCT01901224|579766222|FG000|Overall Study|study was not funded and terminated|2|||
160647004|NCT00585351|580090057|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
160556956|NCT06441877|579766223|FG000|Overall Study|Withdrawal by Subject|0|||
160556957|NCT06441877|579766224|FG001|Overall Study|Withdrawal by Subject|2|||
160647005|NCT00585351|580090058|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
160828555|NCT00076336|580759819|FG001|Overall Study|Liver Transplantation|3|||
160556958|NCT06441877|579766225|FG002|Overall Study|Withdrawal by Subject|0|||
160556959|NCT06441877|579766226|FG003|Overall Study|Withdrawal by Subject|0|||
160556960|NCT01279057|579766227|FG000|Overall Study|Adverse Event|1|||
160556961|NCT01279057|579766228|FG001|Overall Study|Adverse Event|0|||
160556962|NCT01279057|579766229|FG002|Overall Study|Adverse Event|1|||
160556963|NCT01279057|579766227|FG000|Overall Study|Insufficient therapeutic response|0|||
160556964|NCT01279057|579766228|FG001|Overall Study|Insufficient therapeutic response|0|||
160556965|NCT01279057|579766229|FG002|Overall Study|Insufficient therapeutic response|1|||
160647006|NCT00585351|580090059|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
160556966|NCT01279057|579766227|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
160828556|NCT00076336|580759818|FG000|Overall Study|Virologic Breakthrough|14|||
160828557|NCT00076336|580759819|FG001|Overall Study|Virologic Breakthrough|16|||
160828558|NCT00076336|580759818|FG000|Overall Study|Treatment failure|4|||
160647007|NCT00585351|580090060|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
160828559|NCT00076336|580759819|FG001|Overall Study|Treatment failure|5|||
160828560|NCT00524589|580759820|FG000|Overall Study|Withdrawal by Subject|2|||
160828561|NCT00524589|580759820|FG000|Overall Study|Disease Progression|16|||
160828562|NCT01519674|580759826|FG000|Overall Study|Adverse Event|3|||
160828563|NCT01519674|580759827|FG001|Overall Study|Adverse Event|3|||
160828564|NCT01519674|580759828|FG002|Overall Study|Adverse Event|0|||
160828565|NCT01519674|580759826|FG000|Overall Study|Lack of Efficacy|1|||
160828566|NCT01519674|580759827|FG001|Overall Study|Lack of Efficacy|1|||
160828567|NCT01519674|580759828|FG002|Overall Study|Lack of Efficacy|1|||
160828568|NCT01519674|580759826|FG000|Overall Study|Protocol Violation|0|||
160828569|NCT01519674|580759827|FG001|Overall Study|Protocol Violation|3|||
160828570|NCT01519674|580759828|FG002|Overall Study|Protocol Violation|1|||
160828571|NCT01519674|580759826|FG000|Overall Study|Withdrawal Criteria|7|||
160828572|NCT01519674|580759827|FG001|Overall Study|Withdrawal Criteria|2|||
160828573|NCT01519674|580759828|FG002|Overall Study|Withdrawal Criteria|7|||
160828574|NCT01519674|580759826|FG000|Overall Study|Unsclassified|10|||
160828575|NCT01519674|580759827|FG001|Overall Study|Unsclassified|4|||
160828576|NCT01519674|580759828|FG002|Overall Study|Unsclassified|3|||
160828577|NCT01510184|580759833|FG000|Overall Study|Sponsor discretion|28|||
160828578|NCT01510184|580759834|FG001|Overall Study|Sponsor discretion|28|||
160828579|NCT01510184|580759833|FG000|Overall Study|Death|1|||
160828580|NCT01510184|580759834|FG001|Overall Study|Death|2|||
160828581|NCT01510184|580759833|FG000|Overall Study|Withdrawal by Subject|1|||
160556967|NCT01279057|579766228|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
160556968|NCT01279057|579766229|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
160556969|NCT01279057|579766227|FG000|Overall Study|Withdrew consent|2|||
160556970|NCT01279057|579766228|FG001|Overall Study|Withdrew consent|0|||
160556971|NCT01279057|579766229|FG002|Overall Study|Withdrew consent|1|||
160556972|NCT01279057|579766227|FG000|Overall Study|Pregnancy|0|||
160556973|NCT01279057|579766228|FG001|Overall Study|Pregnancy|1|||
160556974|NCT01279057|579766229|FG002|Overall Study|Pregnancy|0|||
160556975|NCT01279057|579766227|FG000|Overall Study|Other|3|||
160556976|NCT01279057|579766228|FG001|Overall Study|Other|3|||
160556977|NCT01279057|579766229|FG002|Overall Study|Other|0|||
160556978|NCT01427309|579766230|FG000|Overall Study|Lost to Follow-up|130|||
160556979|NCT01427309|579766231|FG001|Overall Study|Lost to Follow-up|145|||
160556980|NCT01427309|579766232|FG002|Overall Study|Lost to Follow-up|122|||
160556981|NCT01427309|579766233|FG003|Overall Study|Lost to Follow-up|135|||
160556982|NCT01427309|579766230|FG000|Overall Study|Protocol Violation|42|||
160556983|NCT01427309|579766231|FG001|Overall Study|Protocol Violation|69|||
160556984|NCT01427309|579766232|FG002|Overall Study|Protocol Violation|125|||
160556985|NCT01427309|579766233|FG003|Overall Study|Protocol Violation|124|||
160556986|NCT01427309|579766230|FG000|Overall Study|Adverse Event|0|||
160556987|NCT01427309|579766231|FG001|Overall Study|Adverse Event|0|||
160556988|NCT01427309|579766232|FG002|Overall Study|Adverse Event|3|||
160556989|NCT01427309|579766233|FG003|Overall Study|Adverse Event|1|||
160556990|NCT01427309|579766230|FG000|Overall Study|Serious adverse event|52|||
160556991|NCT01427309|579766231|FG001|Overall Study|Serious adverse event|45|||
160556992|NCT01427309|579766232|FG002|Overall Study|Serious adverse event|50|||
160556993|NCT01427309|579766233|FG003|Overall Study|Serious adverse event|61|||
160556994|NCT01427309|579766230|FG000|Overall Study|Withdrawal by Subject|148|||
160556995|NCT01427309|579766231|FG001|Overall Study|Withdrawal by Subject|148|||
160556996|NCT01427309|579766232|FG002|Overall Study|Withdrawal by Subject|61|||
160556997|NCT01427309|579766233|FG003|Overall Study|Withdrawal by Subject|55|||
160556998|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
160556999|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
160557000|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
160557001|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
160557002|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
160557003|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
160557004|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
160557005|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
160557006|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
160557007|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
160557008|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
160557009|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
160902725|NCT02555683|581037801|FG002|Overall Study|Subject/guardian decision|22|||
160902726|NCT02555683|581037799|FG000|Overall Study|Death post Treatment/safety period|0|||
160902727|NCT02555683|581037800|FG001|Overall Study|Death post Treatment/safety period|1|||
160557010|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
160557011|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
160557012|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
160557013|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
160557014|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
160557015|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
160557016|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
160557017|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
160557018|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
160557019|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
160557020|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
160557021|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
160557022|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
160557023|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
160557024|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
160557025|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
160557026|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
160557027|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
160557028|NCT00849017|579766234|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
160557029|NCT00849017|579766235|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
160557030|NCT00849017|579766236|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
160902728|NCT02555683|581037801|FG002|Overall Study|Death post Treatment/safety period|0|||
160557031|NCT00849017|579766234|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
160557032|NCT00849017|579766235|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
160557033|NCT00849017|579766236|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
160557034|NCT00849017|579766234|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
160557035|NCT00849017|579766235|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
160557036|NCT00849017|579766236|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
160557037|NCT00849017|579766234|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
160647008|NCT00585351|580090061|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
160647009|NCT00585351|580090062|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
160647010|NCT00585351|580090063|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
160647011|NCT00585351|580090056|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
160647012|NCT00585351|580090057|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
160647013|NCT00585351|580090058|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
160647014|NCT00585351|580090059|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
160647015|NCT00585351|580090060|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
160647016|NCT00585351|580090061|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
160647017|NCT00585351|580090062|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
160647018|NCT00585351|580090063|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
160647019|NCT00585351|580090056|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
160647020|NCT00585351|580090057|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
160647021|NCT00585351|580090058|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
160647022|NCT00585351|580090059|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
160647023|NCT00585351|580090060|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
160647024|NCT00585351|580090061|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
160647025|NCT00585351|580090062|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
160647026|NCT00585351|580090063|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
160647027|NCT00585351|580090056|FG000|Enrollment Period (Intervention)|Death|0|||
160647028|NCT00585351|580090057|FG001|Enrollment Period (Intervention)|Death|0|||
160647029|NCT00585351|580090058|FG002|Enrollment Period (Intervention)|Death|0|||
160647030|NCT00585351|580090059|FG003|Enrollment Period (Intervention)|Death|0|||
160647031|NCT00585351|580090060|FG004|Enrollment Period (Intervention)|Death|1|||
160647032|NCT00585351|580090061|FG005|Enrollment Period (Intervention)|Death|0|||
160647033|NCT00585351|580090062|FG006|Enrollment Period (Intervention)|Death|1|||
160647034|NCT00585351|580090063|FG007|Enrollment Period (Intervention)|Death|0|||
160647035|NCT00585351|580090056|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
160647036|NCT00585351|580090057|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
160647037|NCT00585351|580090058|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
160647038|NCT00585351|580090059|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
160647039|NCT00585351|580090060|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
160647040|NCT00585351|580090061|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
160647041|NCT00585351|580090062|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
160647042|NCT00585351|580090063|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
160647043|NCT04317781|580090066|FG000|Overall Study|Adverse Event|1|||
160647044|NCT04317781|580090066|FG000|Overall Study|Disease relapse|1|||
160647045|NCT04317781|580090066|FG000|Overall Study|Withdrawal by Subject|1|||
160647046|NCT02330081|580090070|FG000|Overall Study|Adverse Event|1|||
160647047|NCT02330081|580090070|FG000|Overall Study|Donation did not meet criteria|1|||
160647048|NCT02330081|580090070|FG000|Overall Study|Protocol Violation|6|||
160647049|NCT02277769|580090071|FG000|Overall Study|Protocol Violation|3|||
160647050|NCT02277769|580090072|FG001|Overall Study|Protocol Violation|3|||
160647051|NCT02277769|580090073|FG002|Overall Study|Protocol Violation|5|||
160647052|NCT02277769|580090071|FG000|Overall Study|Lack of Efficacy|17|||
160647053|NCT02277769|580090072|FG001|Overall Study|Lack of Efficacy|0|||
160647054|NCT02277769|580090073|FG002|Overall Study|Lack of Efficacy|4|||
160557038|NCT00849017|579766235|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
160557039|NCT00849017|579766236|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
160557040|NCT00849017|579766234|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
160557041|NCT00849017|579766235|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
160557042|NCT00849017|579766236|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
160557043|NCT00849017|579766234|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
160557044|NCT00849017|579766235|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
160557045|NCT00849017|579766236|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
160557046|NCT00849017|579766234|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
160557047|NCT00849017|579766235|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
160557048|NCT00849017|579766236|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
160647055|NCT02277769|580090071|FG000|Overall Study|Adverse Event|14|||
160647056|NCT02277769|580090072|FG001|Overall Study|Adverse Event|2|||
160647057|NCT02277769|580090073|FG002|Overall Study|Adverse Event|4|||
160647058|NCT02277769|580090071|FG000|Overall Study|Other than specified above|12|||
160647059|NCT02277769|580090072|FG001|Overall Study|Other than specified above|8|||
160647060|NCT02277769|580090073|FG002|Overall Study|Other than specified above|5|||
160647061|NCT04535583|580090082|FG000|Overall Study|Lost to Follow-up|1|||
160557049|NCT00849017|579766234|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
160557050|NCT00849017|579766235|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
160557051|NCT00849017|579766236|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
160557052|NCT00849017|579766234|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
160557053|NCT00849017|579766235|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
160557054|NCT00849017|579766236|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
160557055|NCT02913313|579766237|FG000|Overall Study|DISEASE PROGRESSION|1|||
160557056|NCT02913313|579766238|FG001|Overall Study|DISEASE PROGRESSION|2|||
160557057|NCT02913313|579766239|FG002|Overall Study|DISEASE PROGRESSION|2|||
160557058|NCT02913313|579766240|FG003|Overall Study|DISEASE PROGRESSION|4|||
160557059|NCT02913313|579766241|FG004|Overall Study|DISEASE PROGRESSION|6|||
160557060|NCT02913313|579766242|FG005|Overall Study|DISEASE PROGRESSION|4|||
160557061|NCT02913313|579766243|FG006|Overall Study|DISEASE PROGRESSION|19|||
160557062|NCT02913313|579766244|FG007|Overall Study|DISEASE PROGRESSION|3|||
160557063|NCT02913313|579766245|FG008|Overall Study|DISEASE PROGRESSION|4|||
160557064|NCT02913313|579766246|FG009|Overall Study|DISEASE PROGRESSION|4|||
160557065|NCT02913313|579766247|FG010|Overall Study|DISEASE PROGRESSION|11|||
160557066|NCT02913313|579766248|FG011|Overall Study|DISEASE PROGRESSION|5|||
160557067|NCT02913313|579766249|FG012|Overall Study|DISEASE PROGRESSION|14|||
160557068|NCT02913313|579766250|FG013|Overall Study|DISEASE PROGRESSION|3|||
160557069|NCT02913313|579766237|FG000|Overall Study|Not Reported|0|||
160557070|NCT02913313|579766238|FG001|Overall Study|Not Reported|0|||
160557071|NCT02913313|579766239|FG002|Overall Study|Not Reported|0|||
160557072|NCT02913313|579766240|FG003|Overall Study|Not Reported|0|||
160557073|NCT02913313|579766241|FG004|Overall Study|Not Reported|1|||
160557074|NCT02913313|579766242|FG005|Overall Study|Not Reported|0|||
160557075|NCT02913313|579766243|FG006|Overall Study|Not Reported|0|||
160557076|NCT02913313|579766244|FG007|Overall Study|Not Reported|0|||
160557077|NCT02913313|579766245|FG008|Overall Study|Not Reported|0|||
160557078|NCT02913313|579766246|FG009|Overall Study|Not Reported|0|||
160557079|NCT02913313|579766247|FG010|Overall Study|Not Reported|4|||
160557080|NCT02913313|579766248|FG011|Overall Study|Not Reported|0|||
160557081|NCT02913313|579766249|FG012|Overall Study|Not Reported|0|||
160557082|NCT02913313|579766250|FG013|Overall Study|Not Reported|0|||
160557083|NCT02913313|579766237|FG000|Overall Study|Other reasons|0|||
160557084|NCT02913313|579766238|FG001|Overall Study|Other reasons|0|||
160557085|NCT02913313|579766239|FG002|Overall Study|Other reasons|0|||
160557086|NCT02913313|579766240|FG003|Overall Study|Other reasons|0|||
160557087|NCT02913313|579766241|FG004|Overall Study|Other reasons|1|||
160557088|NCT02913313|579766242|FG005|Overall Study|Other reasons|0|||
160557089|NCT02913313|579766243|FG006|Overall Study|Other reasons|0|||
160557090|NCT02913313|579766244|FG007|Overall Study|Other reasons|0|||
160557091|NCT02913313|579766245|FG008|Overall Study|Other reasons|0|||
160557092|NCT02913313|579766246|FG009|Overall Study|Other reasons|0|||
160557093|NCT02913313|579766247|FG010|Overall Study|Other reasons|1|||
160557094|NCT02913313|579766248|FG011|Overall Study|Other reasons|0|||
160557095|NCT02913313|579766249|FG012|Overall Study|Other reasons|0|||
160557096|NCT02913313|579766250|FG013|Overall Study|Other reasons|0|||
160557097|NCT02913313|579766237|FG000|Overall Study|Withdrawal by Subject|0|||
160902729|NCT01397890|581037811|FG000|Overall Study|Withdrawal by Subject|7|||
160902730|NCT01397890|581037812|FG001|Overall Study|Withdrawal by Subject|11|||
160902731|NCT01397890|581037811|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
160902732|NCT01397890|581037812|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
160902733|NCT01397890|581037811|FG000|Overall Study|Death|2|||
160902734|NCT01397890|581037812|FG001|Overall Study|Death|3|||
160902735|NCT01397890|581037811|FG000|Overall Study|Lost to Follow-up|1|||
160902736|NCT01397890|581037812|FG001|Overall Study|Lost to Follow-up|4|||
160902737|NCT01397890|581037811|FG000|Overall Study|Condition under Investigation Worsened|1|||
160902738|NCT01397890|581037812|FG001|Overall Study|Condition under Investigation Worsened|3|||
160902739|NCT01397890|581037811|FG000|Overall Study|Adverse Event|1|||
160902740|NCT01397890|581037812|FG001|Overall Study|Adverse Event|2|||
160902741|NCT01397890|581037811|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
160902742|NCT01397890|581037812|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
160902743|NCT01397890|581037811|FG000|Overall Study|Others|2|||
160902744|NCT01397890|581037812|FG001|Overall Study|Others|1|||
160557098|NCT02913313|579766238|FG001|Overall Study|Withdrawal by Subject|0|||
160557099|NCT02913313|579766239|FG002|Overall Study|Withdrawal by Subject|1|||
160557100|NCT02913313|579766240|FG003|Overall Study|Withdrawal by Subject|0|||
160557101|NCT02913313|579766241|FG004|Overall Study|Withdrawal by Subject|0|||
160557102|NCT02913313|579766242|FG005|Overall Study|Withdrawal by Subject|0|||
160557103|NCT02913313|579766243|FG006|Overall Study|Withdrawal by Subject|1|||
160902745|NCT03094169|581037813|FG000|Overall Study|Lack of Efficacy|0|||
160557104|NCT02913313|579766244|FG007|Overall Study|Withdrawal by Subject|1|||
160557105|NCT02913313|579766245|FG008|Overall Study|Withdrawal by Subject|0|||
160557106|NCT02913313|579766246|FG009|Overall Study|Withdrawal by Subject|0|||
160557107|NCT02913313|579766247|FG010|Overall Study|Withdrawal by Subject|1|||
160902746|NCT03094169|581037814|FG001|Overall Study|Lack of Efficacy|0|||
160902747|NCT03094169|581037815|FG002|Overall Study|Lack of Efficacy|0|||
160902748|NCT03094169|581037816|FG003|Overall Study|Lack of Efficacy|0|||
160557108|NCT02913313|579766248|FG011|Overall Study|Withdrawal by Subject|0|||
160557109|NCT02913313|579766249|FG012|Overall Study|Withdrawal by Subject|0|||
160557110|NCT02913313|579766250|FG013|Overall Study|Withdrawal by Subject|0|||
160557111|NCT02913313|579766237|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557112|NCT02913313|579766238|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557113|NCT02913313|579766239|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557114|NCT02913313|579766240|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557115|NCT02913313|579766241|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557116|NCT02913313|579766242|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557117|NCT02913313|579766243|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557118|NCT02913313|579766244|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557119|NCT02913313|579766245|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557120|NCT02913313|579766246|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557121|NCT02913313|579766247|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
160557122|NCT02913313|579766248|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160557123|NCT02913313|579766249|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
160557124|NCT02913313|579766250|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
160557125|NCT02913313|579766237|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
160557126|NCT02913313|579766238|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
160557127|NCT02913313|579766239|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
160557128|NCT02913313|579766240|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
160557129|NCT02913313|579766241|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
160557130|NCT02913313|579766242|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
160557131|NCT02913313|579766243|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
160557132|NCT02913313|579766244|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
160557133|NCT02913313|579766245|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
160557134|NCT02913313|579766246|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
160557135|NCT02913313|579766247|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
160557136|NCT02913313|579766248|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
160557137|NCT02913313|579766249|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
160557138|NCT02913313|579766250|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
160557139|NCT02024971|579766253|FG000|Overall Study|Data Not Available|30|||
160557140|NCT02024971|579766253|FG000|Overall Study|Lost to Follow-up|6|||
160557141|NCT02908100|579766254|FG000|Overall Study|Adverse Event|7|||
160557142|NCT02908100|579766255|FG001|Overall Study|Adverse Event|6|||
160557143|NCT02908100|579766256|FG002|Overall Study|Adverse Event|9|||
160557144|NCT02908100|579766254|FG000|Overall Study|Death|2|||
160557145|NCT02908100|579766255|FG001|Overall Study|Death|0|||
160557146|NCT02908100|579766256|FG002|Overall Study|Death|0|||
160557147|NCT02908100|579766254|FG000|Overall Study|Lack of Efficacy|2|||
160557148|NCT02908100|579766255|FG001|Overall Study|Lack of Efficacy|3|||
160557149|NCT02908100|579766256|FG002|Overall Study|Lack of Efficacy|3|||
160902749|NCT03094169|581037817|FG004|Overall Study|Lack of Efficacy|0|||
160902750|NCT03094169|581037818|FG005|Overall Study|Lack of Efficacy|0|||
160902751|NCT03094169|581037819|FG006|Overall Study|Lack of Efficacy|0|||
160902752|NCT03094169|581037820|FG007|Overall Study|Lack of Efficacy|21|||
160902753|NCT03094169|581037813|FG000|Overall Study|Adverse Event|0|||
160902754|NCT03094169|581037814|FG001|Overall Study|Adverse Event|0|||
160902755|NCT03094169|581037815|FG002|Overall Study|Adverse Event|0|||
160902756|NCT03094169|581037816|FG003|Overall Study|Adverse Event|0|||
160902757|NCT03094169|581037817|FG004|Overall Study|Adverse Event|0|||
160902758|NCT03094169|581037818|FG005|Overall Study|Adverse Event|0|||
160902759|NCT03094169|581037819|FG006|Overall Study|Adverse Event|0|||
160902760|NCT03094169|581037820|FG007|Overall Study|Adverse Event|2|||
160902761|NCT03094169|581037813|FG000|Overall Study|Withdrawal by Subject|0|||
160902762|NCT03094169|581037814|FG001|Overall Study|Withdrawal by Subject|0|||
160902763|NCT03094169|581037815|FG002|Overall Study|Withdrawal by Subject|0|||
160902764|NCT03094169|581037816|FG003|Overall Study|Withdrawal by Subject|0|||
160902765|NCT03094169|581037817|FG004|Overall Study|Withdrawal by Subject|0|||
160902766|NCT03094169|581037818|FG005|Overall Study|Withdrawal by Subject|0|||
160902767|NCT03094169|581037819|FG006|Overall Study|Withdrawal by Subject|1|||
160902768|NCT03094169|581037820|FG007|Overall Study|Withdrawal by Subject|1|||
160902769|NCT03094169|581037813|FG000|Overall Study|Trial Termination|0|||
160902770|NCT03094169|581037814|FG001|Overall Study|Trial Termination|0|||
160902771|NCT03094169|581037815|FG002|Overall Study|Trial Termination|0|||
160902772|NCT03094169|581037816|FG003|Overall Study|Trial Termination|0|||
160902773|NCT03094169|581037817|FG004|Overall Study|Trial Termination|0|||
160902774|NCT03094169|581037818|FG005|Overall Study|Trial Termination|0|||
160902775|NCT03094169|581037819|FG006|Overall Study|Trial Termination|0|||
160902776|NCT03094169|581037820|FG007|Overall Study|Trial Termination|1|||
160902777|NCT04622306|581037821|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
160902778|NCT04622306|581037822|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
160557150|NCT02908100|579766254|FG000|Overall Study|Lost to Follow-up|0|||
160902779|NCT04622306|581037823|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
160902780|NCT04622306|581037824|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
160902781|NCT04622306|581037825|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
160990661|NCT00972543|581353920|FG001|Overall Study|Adverse Event|0|||
160990662|NCT00972543|581353919|FG000|Overall Study|Early study termination by sponsor|4|||
160990663|NCT00972543|581353920|FG001|Overall Study|Early study termination by sponsor|1|||
160990664|NCT00293462|581353921|FG000|Overall Study|Withdrawal by Subject|4|||
160990665|NCT00293462|581353922|FG001|Overall Study|Withdrawal by Subject|3|||
160990666|NCT00293462|581353923|FG002|Overall Study|Withdrawal by Subject|8|||
160990667|NCT00293462|581353921|FG000|Overall Study|Death|1|||
160990668|NCT00293462|581353922|FG001|Overall Study|Death|0|||
160990669|NCT00293462|581353923|FG002|Overall Study|Death|0|||
160990670|NCT00293462|581353921|FG000|Overall Study|Lost to Follow-up|0|||
160990671|NCT00293462|581353922|FG001|Overall Study|Lost to Follow-up|1|||
160557151|NCT02908100|579766255|FG001|Overall Study|Lost to Follow-up|1|||
160557152|NCT02908100|579766256|FG002|Overall Study|Lost to Follow-up|2|||
160557153|NCT02908100|579766254|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160557154|NCT02908100|579766255|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160557155|NCT02908100|579766256|FG002|Overall Study|Non-Compliance With Study Drug|2|||
160557156|NCT02908100|579766254|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
160557157|NCT02908100|579766255|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
160557158|NCT02908100|579766256|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
160557159|NCT02908100|579766254|FG000|Overall Study|Physician Decision|0|||
160557160|NCT02908100|579766255|FG001|Overall Study|Physician Decision|1|||
160557161|NCT02908100|579766256|FG002|Overall Study|Physician Decision|0|||
160557162|NCT02908100|579766254|FG000|Overall Study|Pregnancy|1|||
160557163|NCT02908100|579766255|FG001|Overall Study|Pregnancy|2|||
160557164|NCT02908100|579766256|FG002|Overall Study|Pregnancy|0|||
160557165|NCT02908100|579766254|FG000|Overall Study|Withdrawal by Subject|8|||
160557166|NCT02908100|579766255|FG001|Overall Study|Withdrawal by Subject|7|||
160557167|NCT02908100|579766256|FG002|Overall Study|Withdrawal by Subject|5|||
160557168|NCT02908100|579766254|FG000|Overall Study|Randomised in Error|1|||
160557169|NCT02908100|579766255|FG001|Overall Study|Randomised in Error|0|||
160557170|NCT02908100|579766256|FG002|Overall Study|Randomised in Error|0|||
160557171|NCT05254418|579766257|FG000|Overall Study|Adverse Event|2|||
160557172|NCT02690194|579766258|FG000|Overall Study|Withdrawal by Subject|1|||
160557173|NCT02690194|579766259|FG001|Overall Study|Withdrawal by Subject|4|||
160557174|NCT02690194|579766260|FG002|Overall Study|Withdrawal by Subject|0|||
160557175|NCT00944034|579766265|FG000|Overall Study|Inappropriate enrollment|0|||
160557176|NCT00944034|579766266|FG001|Overall Study|Inappropriate enrollment|1|||
160557177|NCT00944034|579766267|FG002|Overall Study|Inappropriate enrollment|0|||
160557178|NCT00944034|579766268|FG003|Overall Study|Inappropriate enrollment|1|||
160557179|NCT00944034|579766269|FG004|Overall Study|Inappropriate enrollment|2|||
160557180|NCT00944034|579766270|FG005|Overall Study|Inappropriate enrollment|1|||
160557181|NCT00944034|579766271|FG006|Overall Study|Inappropriate enrollment|0|||
160557182|NCT00944034|579766272|FG007|Overall Study|Inappropriate enrollment|0|||
160557183|NCT00944034|579766273|FG008|Overall Study|Inappropriate enrollment|1|||
160557184|NCT00944034|579766274|FG009|Overall Study|Inappropriate enrollment|1|||
160557185|NCT00944034|579766275|FG010|Overall Study|Inappropriate enrollment|0|||
160557186|NCT00944034|579766276|FG011|Overall Study|Inappropriate enrollment|0|||
160557187|NCT00944034|579766265|FG000|Overall Study|Withdrawal by Subject|3|||
160557188|NCT00944034|579766266|FG001|Overall Study|Withdrawal by Subject|2|||
160557189|NCT00944034|579766267|FG002|Overall Study|Withdrawal by Subject|6|||
160557190|NCT00944034|579766268|FG003|Overall Study|Withdrawal by Subject|2|||
160557191|NCT00944034|579766269|FG004|Overall Study|Withdrawal by Subject|5|||
160557192|NCT00944034|579766270|FG005|Overall Study|Withdrawal by Subject|8|||
160557193|NCT00944034|579766271|FG006|Overall Study|Withdrawal by Subject|2|||
160557194|NCT00944034|579766272|FG007|Overall Study|Withdrawal by Subject|2|||
160557195|NCT00944034|579766273|FG008|Overall Study|Withdrawal by Subject|3|||
160557196|NCT00944034|579766274|FG009|Overall Study|Withdrawal by Subject|4|||
160557197|NCT00944034|579766275|FG010|Overall Study|Withdrawal by Subject|0|||
160557198|NCT00944034|579766276|FG011|Overall Study|Withdrawal by Subject|4|||
160557199|NCT00944034|579766265|FG000|Overall Study|Lost to Follow-up|0|||
160557200|NCT00944034|579766266|FG001|Overall Study|Lost to Follow-up|4|||
160557201|NCT00944034|579766267|FG002|Overall Study|Lost to Follow-up|2|||
160557202|NCT00944034|579766268|FG003|Overall Study|Lost to Follow-up|0|||
160557203|NCT00944034|579766269|FG004|Overall Study|Lost to Follow-up|5|||
160557204|NCT00944034|579766270|FG005|Overall Study|Lost to Follow-up|7|||
160557205|NCT00944034|579766271|FG006|Overall Study|Lost to Follow-up|0|||
160557206|NCT00944034|579766272|FG007|Overall Study|Lost to Follow-up|1|||
160557207|NCT00944034|579766273|FG008|Overall Study|Lost to Follow-up|5|||
160557208|NCT00944034|579766274|FG009|Overall Study|Lost to Follow-up|1|||
160557209|NCT00944034|579766275|FG010|Overall Study|Lost to Follow-up|1|||
160557210|NCT00944034|579766276|FG011|Overall Study|Lost to Follow-up|0|||
160990672|NCT00293462|581353923|FG002|Overall Study|Lost to Follow-up|0|||
160990673|NCT00293462|581353921|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
160557211|NCT00944034|579766265|FG000|Overall Study|Death|0|||
160557212|NCT00944034|579766266|FG001|Overall Study|Death|0|||
160557213|NCT00944034|579766267|FG002|Overall Study|Death|1|||
160557214|NCT00944034|579766268|FG003|Overall Study|Death|0|||
160557215|NCT00944034|579766269|FG004|Overall Study|Death|0|||
160557216|NCT00944034|579766270|FG005|Overall Study|Death|0|||
160557217|NCT00944034|579766271|FG006|Overall Study|Death|0|||
160557218|NCT00944034|579766272|FG007|Overall Study|Death|0|||
160557219|NCT00944034|579766273|FG008|Overall Study|Death|0|||
160557220|NCT00944034|579766274|FG009|Overall Study|Death|0|||
160557221|NCT00944034|579766275|FG010|Overall Study|Death|0|||
160557222|NCT00944034|579766276|FG011|Overall Study|Death|0|||
160557223|NCT00944034|579766265|FG000|Overall Study|Protocol Violation|2|||
160557224|NCT00944034|579766266|FG001|Overall Study|Protocol Violation|0|||
160557225|NCT00944034|579766267|FG002|Overall Study|Protocol Violation|0|||
160557226|NCT00944034|579766268|FG003|Overall Study|Protocol Violation|1|||
160557227|NCT00944034|579766269|FG004|Overall Study|Protocol Violation|2|||
160557228|NCT00944034|579766270|FG005|Overall Study|Protocol Violation|3|||
160557229|NCT00944034|579766271|FG006|Overall Study|Protocol Violation|0|||
160557230|NCT00944034|579766272|FG007|Overall Study|Protocol Violation|1|||
160557231|NCT00944034|579766273|FG008|Overall Study|Protocol Violation|1|||
160557232|NCT00944034|579766274|FG009|Overall Study|Protocol Violation|4|||
160557233|NCT00944034|579766275|FG010|Overall Study|Protocol Violation|0|||
160557234|NCT00944034|579766276|FG011|Overall Study|Protocol Violation|0|||
160557235|NCT00944034|579766265|FG000|Overall Study|Unable to classify|0|||
160557236|NCT00944034|579766266|FG001|Overall Study|Unable to classify|0|||
160557237|NCT00944034|579766267|FG002|Overall Study|Unable to classify|0|||
160557238|NCT00944034|579766268|FG003|Overall Study|Unable to classify|0|||
160557239|NCT00944034|579766269|FG004|Overall Study|Unable to classify|0|||
160557240|NCT00944034|579766270|FG005|Overall Study|Unable to classify|1|||
160557241|NCT00944034|579766271|FG006|Overall Study|Unable to classify|1|||
160557242|NCT00944034|579766272|FG007|Overall Study|Unable to classify|1|||
160557243|NCT00944034|579766273|FG008|Overall Study|Unable to classify|0|||
160557244|NCT00944034|579766274|FG009|Overall Study|Unable to classify|0|||
160557245|NCT00944034|579766275|FG010|Overall Study|Unable to classify|0|||
160557246|NCT00944034|579766276|FG011|Overall Study|Unable to classify|0|||
160557247|NCT00944034|579766265|FG000|Overall Study|Administrative reason|0|||
160557248|NCT00944034|579766266|FG001|Overall Study|Administrative reason|0|||
160557249|NCT00944034|579766267|FG002|Overall Study|Administrative reason|0|||
160557250|NCT00944034|579766268|FG003|Overall Study|Administrative reason|0|||
160557251|NCT00944034|579766269|FG004|Overall Study|Administrative reason|0|||
160557252|NCT00944034|579766270|FG005|Overall Study|Administrative reason|0|||
160557253|NCT00944034|579766271|FG006|Overall Study|Administrative reason|1|||
160557254|NCT00944034|579766272|FG007|Overall Study|Administrative reason|0|||
160557255|NCT00944034|579766273|FG008|Overall Study|Administrative reason|0|||
160557256|NCT00944034|579766274|FG009|Overall Study|Administrative reason|0|||
160557257|NCT00944034|579766275|FG010|Overall Study|Administrative reason|0|||
160557258|NCT00944034|579766276|FG011|Overall Study|Administrative reason|0|||
160557259|NCT01570244|579766280|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
160557260|NCT03486392|579766281|FG000|Overall Study|Lost to Follow-up|0|||
160557261|NCT03486392|579766282|FG001|Overall Study|Lost to Follow-up|0|||
160557262|NCT03486392|579766283|FG002|Overall Study|Lost to Follow-up|8|||
160557263|NCT03486392|579766284|FG003|Overall Study|Lost to Follow-up|5|||
160557264|NCT03486392|579766285|FG004|Overall Study|Lost to Follow-up|2|||
160557265|NCT03486392|579766281|FG000|Overall Study|Withdrawal by Subject|3|||
160557266|NCT03486392|579766282|FG001|Overall Study|Withdrawal by Subject|0|||
160557267|NCT03486392|579766283|FG002|Overall Study|Withdrawal by Subject|6|||
160557268|NCT03486392|579766284|FG003|Overall Study|Withdrawal by Subject|4|||
160557269|NCT03486392|579766285|FG004|Overall Study|Withdrawal by Subject|1|||
160557270|NCT03486392|579766281|FG000|Overall Study|Death|0|||
160557271|NCT03486392|579766282|FG001|Overall Study|Death|0|||
160557272|NCT03486392|579766283|FG002|Overall Study|Death|0|||
160557273|NCT03486392|579766284|FG003|Overall Study|Death|0|||
160557274|NCT03486392|579766285|FG004|Overall Study|Death|1|||
160557275|NCT00331006|579766286|FG000|Screening Phase|Withdrawal by Subject|1|||
160557276|NCT00331006|579766286|FG000|Screening Phase|enrollment halted|1|||
160557277|NCT00331006|579766286|FG000|Screening Phase|Lost to Follow-up|1|||
160828582|NCT01510184|580759834|FG001|Overall Study|Withdrawal by Subject|4|||
160557278|NCT00331006|579766286|FG000|Screening Phase|Ineligible for treatment phase|4|||
160557279|NCT00331006|579766286|FG000|Treatment Phase|Withdrawal by Subject|1|||
160557280|NCT00331006|579766286|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
160557281|NCT00331006|579766286|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
160557282|NCT01950819|579766287|FG000|Overall Study|Graft Loss|35|||
160557283|NCT01950819|579766288|FG001|Overall Study|Graft Loss|30|||
160557284|NCT01950819|579766287|FG000|Overall Study|Death|29|||
160557285|NCT01950819|579766288|FG001|Overall Study|Death|34|||
160557286|NCT01950819|579766287|FG000|Overall Study|Subject / Gardian decision|54|||
160557287|NCT01950819|579766288|FG001|Overall Study|Subject / Gardian decision|51|||
160557288|NCT01950819|579766287|FG000|Overall Study|technical problems|2|||
160557289|NCT01950819|579766288|FG001|Overall Study|technical problems|0|||
160557290|NCT01950819|579766287|FG000|Overall Study|Pregnancy|0|||
160557291|NCT01950819|579766288|FG001|Overall Study|Pregnancy|2|||
160557292|NCT01950819|579766287|FG000|Overall Study|Lost to Follow-up|9|||
160557293|NCT01950819|579766288|FG001|Overall Study|Lost to Follow-up|17|||
160557294|NCT01360645|579766293|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
160557295|NCT01360645|579766294|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
160557296|NCT01360645|579766295|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
160557297|NCT01360645|579766296|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
160557298|NCT01360645|579766293|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
160557299|NCT01360645|579766294|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
160557300|NCT01360645|579766295|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
160557301|NCT01360645|579766296|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
160557302|NCT01360645|579766293|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
160557303|NCT01360645|579766294|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
160557304|NCT01360645|579766295|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
160557305|NCT01360645|579766296|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
160557306|NCT01360645|579766293|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
160557307|NCT01360645|579766294|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
160557308|NCT01360645|579766295|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
160557309|NCT01360645|579766296|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
160557310|NCT01360645|579766293|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
160557311|NCT01360645|579766294|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
160557312|NCT01360645|579766295|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
160557313|NCT01360645|579766296|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
160557314|NCT01360645|579766293|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
160557315|NCT01360645|579766294|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
160557316|NCT01360645|579766295|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
160557317|NCT01360645|579766296|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
160557318|NCT01360645|579766293|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
160557319|NCT01360645|579766294|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
160557320|NCT01360645|579766295|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
160557321|NCT01360645|579766296|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
160557322|NCT01360645|579766293|FG000|Phase B (6 Weeks)|Adverse Event|0|||
160557323|NCT01360645|579766294|FG001|Phase B (6 Weeks)|Adverse Event|6|||
160557324|NCT01360645|579766295|FG002|Phase B (6 Weeks)|Adverse Event|0|||
160557325|NCT01360645|579766296|FG003|Phase B (6 Weeks)|Adverse Event|0|||
160557326|NCT01360645|579766293|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
160557327|NCT01360645|579766294|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
160557328|NCT01360645|579766295|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
160557329|NCT01360645|579766296|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
160557330|NCT01360645|579766293|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
160557331|NCT01360645|579766294|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
160557332|NCT01360645|579766295|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
160557333|NCT01360645|579766296|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
160557334|NCT01360645|579766293|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
160557335|NCT01360645|579766294|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
160557336|NCT01360645|579766295|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
160557337|NCT01360645|579766296|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
160557338|NCT01360645|579766293|FG000|Phase A+|Lost to Follow-up|0|||
160557339|NCT01360645|579766294|FG001|Phase A+|Lost to Follow-up|0|||
160557340|NCT01360645|579766295|FG002|Phase A+|Lost to Follow-up|0|||
160557341|NCT01360645|579766296|FG003|Phase A+|Lost to Follow-up|7|||
160557342|NCT01360645|579766293|FG000|Phase A+|Adverse Event|0|||
160557343|NCT01360645|579766294|FG001|Phase A+|Adverse Event|0|||
160557344|NCT01360645|579766295|FG002|Phase A+|Adverse Event|0|||
160557345|NCT01360645|579766296|FG003|Phase A+|Adverse Event|2|||
160557346|NCT01360645|579766293|FG000|Phase A+|Met Withdrawal Criteria|0|||
160557347|NCT01360645|579766294|FG001|Phase A+|Met Withdrawal Criteria|0|||
160557348|NCT01360645|579766295|FG002|Phase A+|Met Withdrawal Criteria|0|||
160557349|NCT01360645|579766296|FG003|Phase A+|Met Withdrawal Criteria|4|||
160557350|NCT01360645|579766293|FG000|Phase A+|Physician Decision|0|||
160557351|NCT01360645|579766294|FG001|Phase A+|Physician Decision|0|||
160557352|NCT01360645|579766295|FG002|Phase A+|Physician Decision|0|||
160557353|NCT01360645|579766296|FG003|Phase A+|Physician Decision|2|||
160557354|NCT01360645|579766293|FG000|Phase A+|Withdrawal by Subject|0|||
160557355|NCT01360645|579766294|FG001|Phase A+|Withdrawal by Subject|0|||
160557356|NCT01360645|579766295|FG002|Phase A+|Withdrawal by Subject|0|||
160557357|NCT01360645|579766296|FG003|Phase A+|Withdrawal by Subject|5|||
160557358|NCT01360645|579766293|FG000|Phase A+|Protocol Deviation|0|||
160557359|NCT01360645|579766294|FG001|Phase A+|Protocol Deviation|0|||
160902782|NCT04622306|581037826|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
160902783|NCT04622306|581037821|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
160557360|NCT01360645|579766295|FG002|Phase A+|Protocol Deviation|0|||
160557361|NCT01360645|579766296|FG003|Phase A+|Protocol Deviation|4|||
160557362|NCT00713219|579766297|FG000|Overall Study|Death|1|||
160557363|NCT00713219|579766297|FG000|Overall Study|Protocol Violation|1|||
160557364|NCT03183128|579766298|FG000|Overall Study|Adverse Event|1|||
160557365|NCT03183128|579766299|FG001|Overall Study|Adverse Event|2|||
160557366|NCT03183128|579766298|FG000|Overall Study|Withdrawal by Subject|1|||
160557367|NCT03183128|579766299|FG001|Overall Study|Withdrawal by Subject|8|||
160557368|NCT03183128|579766298|FG000|Overall Study|Protocol Violation|2|||
160557369|NCT03183128|579766299|FG001|Overall Study|Protocol Violation|0|||
160557370|NCT03183128|579766298|FG000|Overall Study|Lack of Efficacy|4|||
160557371|NCT03183128|579766299|FG001|Overall Study|Lack of Efficacy|27|||
160557372|NCT03183128|579766298|FG000|Overall Study|Lost to Follow-up|1|||
160557373|NCT03183128|579766299|FG001|Overall Study|Lost to Follow-up|0|||
160557374|NCT03183128|579766298|FG000|Overall Study|Death|2|||
160557375|NCT03183128|579766299|FG001|Overall Study|Death|0|||
160902784|NCT04622306|581037822|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
160557376|NCT03183128|579766298|FG000|Overall Study|Physician Decision|1|||
160557377|NCT03183128|579766299|FG001|Overall Study|Physician Decision|0|||
160557378|NCT02908516|579766302|FG000|Overall Study|Study Terminated|3|||
160557379|NCT02908516|579766303|FG001|Overall Study|Study Terminated|3|||
160557380|NCT01225562|579766304|FG000|Overall Study|Withdrawal by Subject|52|||
160557381|NCT01225562|579766305|FG001|Overall Study|Withdrawal by Subject|50|||
160557382|NCT01225562|579766306|FG002|Overall Study|Withdrawal by Subject|52|||
160557383|NCT01225562|579766304|FG000|Overall Study|Lost to Follow-up|3|||
160557384|NCT01225562|579766305|FG001|Overall Study|Lost to Follow-up|6|||
160557385|NCT01225562|579766306|FG002|Overall Study|Lost to Follow-up|1|||
160557386|NCT02928952|579766309|FG000|Overall Study|Lost to Follow-up|5|||
160557387|NCT02928952|579766310|FG001|Overall Study|Lost to Follow-up|5|||
160557388|NCT02928952|579766309|FG000|Overall Study|Withdrawal by Subject|5|||
160557389|NCT02928952|579766310|FG001|Overall Study|Withdrawal by Subject|1|||
160557390|NCT02928952|579766309|FG000|Overall Study|Physician Decision|0|||
160557391|NCT02928952|579766310|FG001|Overall Study|Physician Decision|1|||
160902785|NCT04622306|581037823|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
160902786|NCT04622306|581037824|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
160902787|NCT04622306|581037825|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
160902788|NCT04622306|581037826|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
160902789|NCT00617851|581037827|FG000|Overall Study|Death|0|||
160902790|NCT00617851|581037828|FG001|Overall Study|Death|0|||
160902791|NCT00617851|581037829|FG002|Overall Study|Death|0|||
160902792|NCT00617851|581037830|FG003|Overall Study|Death|1|||
160902793|NCT00617851|581037827|FG000|Overall Study|Withdrawal by Subject|14|||
160902794|NCT00617851|581037828|FG001|Overall Study|Withdrawal by Subject|7|||
160902795|NCT00617851|581037829|FG002|Overall Study|Withdrawal by Subject|12|||
160902796|NCT00617851|581037830|FG003|Overall Study|Withdrawal by Subject|4|||
160902797|NCT00617851|581037827|FG000|Overall Study|Lost to Follow-up|27|||
160902798|NCT00617851|581037828|FG001|Overall Study|Lost to Follow-up|29|||
160902799|NCT00617851|581037829|FG002|Overall Study|Lost to Follow-up|31|||
160902800|NCT00617851|581037830|FG003|Overall Study|Lost to Follow-up|19|||
160902801|NCT00617851|581037827|FG000|Overall Study|Inappropriate Enrollment|5|||
160902802|NCT00617851|581037828|FG001|Overall Study|Inappropriate Enrollment|4|||
160902803|NCT00617851|581037829|FG002|Overall Study|Inappropriate Enrollment|1|||
160902804|NCT00617851|581037830|FG003|Overall Study|Inappropriate Enrollment|1|||
160902805|NCT00617851|581037827|FG000|Overall Study|Unable to classify|1|||
160902806|NCT00617851|581037828|FG001|Overall Study|Unable to classify|0|||
160902807|NCT00617851|581037829|FG002|Overall Study|Unable to classify|1|||
160902808|NCT00617851|581037830|FG003|Overall Study|Unable to classify|0|||
160902809|NCT00697788|581037833|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902810|NCT00697788|581037834|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
160902811|NCT00697788|581037835|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902812|NCT00697788|581037836|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902813|NCT00697788|581037837|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902814|NCT00697788|581037838|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902815|NCT00697788|581037839|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902816|NCT00697788|581037840|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902817|NCT00697788|581037833|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160902818|NCT00697788|581037834|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160902819|NCT00697788|581037835|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160990674|NCT00293462|581353922|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
160902820|NCT00697788|581037836|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160902821|NCT00697788|581037837|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
160902822|NCT00697788|581037838|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160902823|NCT00697788|581037839|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160902824|NCT00697788|581037840|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160557392|NCT02266433|579766311|FG000|Overall Study|Lost to Follow-up|54|||
160557393|NCT02266433|579766312|FG001|Overall Study|Lost to Follow-up|46|||
160557394|NCT02266433|579766311|FG000|Overall Study|Withdrawal by Subject|5|||
160557395|NCT02266433|579766312|FG001|Overall Study|Withdrawal by Subject|7|||
160557396|NCT01273064|579766313|FG000|Overall Study|Adverse Event|5|||
160557397|NCT01273064|579766314|FG001|Overall Study|Adverse Event|1|||
160557398|NCT01273064|579766315|FG002|Overall Study|Adverse Event|3|||
160557399|NCT01273064|579766316|FG003|Overall Study|Adverse Event|2|||
160557400|NCT01273064|579766317|FG004|Overall Study|Adverse Event|1|||
160557401|NCT01273064|579766313|FG000|Overall Study|Withdrawal by Subject|4|||
160557402|NCT01273064|579766314|FG001|Overall Study|Withdrawal by Subject|2|||
160557403|NCT01273064|579766315|FG002|Overall Study|Withdrawal by Subject|2|||
160557404|NCT01273064|579766316|FG003|Overall Study|Withdrawal by Subject|2|||
160557405|NCT01273064|579766317|FG004|Overall Study|Withdrawal by Subject|0|||
160557406|NCT01273064|579766313|FG000|Overall Study|Study Termination|13|||
160557407|NCT01273064|579766314|FG001|Overall Study|Study Termination|27|||
160557408|NCT01273064|579766315|FG002|Overall Study|Study Termination|26|||
160557409|NCT01273064|579766316|FG003|Overall Study|Study Termination|16|||
160557410|NCT01273064|579766317|FG004|Overall Study|Study Termination|8|||
160557411|NCT01273064|579766313|FG000|Overall Study|Lost to Follow-up|1|||
160557412|NCT01273064|579766314|FG001|Overall Study|Lost to Follow-up|0|||
160557413|NCT01273064|579766315|FG002|Overall Study|Lost to Follow-up|0|||
160557414|NCT01273064|579766316|FG003|Overall Study|Lost to Follow-up|0|||
160557415|NCT01273064|579766317|FG004|Overall Study|Lost to Follow-up|0|||
160557416|NCT01273064|579766313|FG000|Overall Study|Physician Decision|0|||
160557417|NCT01273064|579766314|FG001|Overall Study|Physician Decision|0|||
160557418|NCT01273064|579766315|FG002|Overall Study|Physician Decision|0|||
160557419|NCT01273064|579766316|FG003|Overall Study|Physician Decision|0|||
160557420|NCT01273064|579766317|FG004|Overall Study|Physician Decision|1|||
160557421|NCT04666038|579766318|FG000|Overall Study|Progressive Disease|2|||
160557422|NCT04666038|579766319|FG001|Overall Study|Progressive Disease|0|||
160557423|NCT04666038|579766318|FG000|Overall Study|Death|38|||
160557424|NCT04666038|579766319|FG001|Overall Study|Death|32|||
160557425|NCT04666038|579766318|FG000|Overall Study|Withdrawal by Subject|10|||
160557426|NCT04666038|579766319|FG001|Overall Study|Withdrawal by Subject|19|||
160557427|NCT04666038|579766318|FG000|Overall Study|Lost to Follow-up|0|||
160557428|NCT04666038|579766319|FG001|Overall Study|Lost to Follow-up|2|||
160557429|NCT04666038|579766318|FG000|Overall Study|On Study Treatment|46|||
160557430|NCT04666038|579766319|FG001|Overall Study|On Study Treatment|5|||
160557431|NCT04666038|579766318|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
160557432|NCT04666038|579766319|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
160557433|NCT02867761|579766325|FG000|Overall Study|Participant withdrawn by investigator|0|||
160557434|NCT02867761|579766326|FG001|Overall Study|Participant withdrawn by investigator|1|||
160557435|NCT02867761|579766325|FG000|Overall Study|Lost to Follow-up|25|||
160557436|NCT02867761|579766326|FG001|Overall Study|Lost to Follow-up|18|||
160557437|NCT02867761|579766325|FG000|Overall Study|Unable to complete protocol|3|||
160557438|NCT02867761|579766326|FG001|Overall Study|Unable to complete protocol|7|||
160557439|NCT03595280|579766327|FG000|Overall Study|Lost to Follow-up|6|||
160557440|NCT03595280|579766328|FG001|Overall Study|Lost to Follow-up|9|||
160557441|NCT03595280|579766329|FG002|Overall Study|Lost to Follow-up|15|||
160557442|NCT01512264|579766330|FG000|Overall Study|Lost to Follow-up|0|||
160557443|NCT01512264|579766331|FG001|Overall Study|Lost to Follow-up|0|||
160557444|NCT01512264|579766332|FG002|Overall Study|Lost to Follow-up|0|||
160557445|NCT01512264|579766333|FG003|Overall Study|Lost to Follow-up|1|||
160557446|NCT01931059|579766334|FG000|Day 1|Pregnancy|0|||
160557447|NCT01931059|579766335|FG001|Day 1|Pregnancy|1|||
160557448|NCT01931059|579766334|FG000|Day3|Lost to Follow-up|1|||
160557449|NCT01931059|579766335|FG001|Day3|Lost to Follow-up|0|||
160557450|NCT02675075|579766337|FG000|Overall Study|Lost to Follow-up|3|||
160557451|NCT02675075|579766338|FG001|Overall Study|Lost to Follow-up|0|||
160557452|NCT02292212|579766339|FG000|ViE Phase|Withdrawal by Subject|1|||
160557453|NCT02292212|579766339|FG000|ViE Phase|Protocol Violation|2|||
160557454|NCT04957290|579766348|FG000|Overall Study|Progressive disease|3|||
160557455|NCT04957290|579766349|FG001|Overall Study|Progressive disease|3|||
160557456|NCT04957290|579766350|FG002|Overall Study|Progressive disease|2|||
160557457|NCT04957290|579766351|FG003|Overall Study|Progressive disease|0|||
160557458|NCT04957290|579766352|FG004|Overall Study|Progressive disease|0|||
160557459|NCT04957290|579766353|FG005|Overall Study|Progressive disease|0|||
160557460|NCT04957290|579766348|FG000|Overall Study|Withdrawal by Subject|1|||
160557461|NCT04957290|579766349|FG001|Overall Study|Withdrawal by Subject|0|||
160557462|NCT04957290|579766350|FG002|Overall Study|Withdrawal by Subject|1|||
160557463|NCT04957290|579766351|FG003|Overall Study|Withdrawal by Subject|0|||
160557464|NCT04957290|579766352|FG004|Overall Study|Withdrawal by Subject|0|||
160557465|NCT04957290|579766353|FG005|Overall Study|Withdrawal by Subject|0|||
160557466|NCT04957290|579766348|FG000|Overall Study|Death|0|||
160557467|NCT04957290|579766349|FG001|Overall Study|Death|2|||
160557468|NCT04957290|579766350|FG002|Overall Study|Death|1|||
160557469|NCT04957290|579766351|FG003|Overall Study|Death|0|||
160557470|NCT04957290|579766352|FG004|Overall Study|Death|0|||
160557471|NCT04957290|579766353|FG005|Overall Study|Death|0|||
160557472|NCT04957290|579766348|FG000|Overall Study|non compliance with study drug|0|||
160557473|NCT04957290|579766349|FG001|Overall Study|non compliance with study drug|1|||
160557474|NCT04957290|579766350|FG002|Overall Study|non compliance with study drug|0|||
160557475|NCT04957290|579766351|FG003|Overall Study|non compliance with study drug|0|||
160557476|NCT04957290|579766352|FG004|Overall Study|non compliance with study drug|0|||
160557477|NCT04957290|579766353|FG005|Overall Study|non compliance with study drug|0|||
160557478|NCT04957290|579766348|FG000|Overall Study|none specified.|0|||
160557479|NCT04957290|579766349|FG001|Overall Study|none specified.|1|||
160557480|NCT04957290|579766350|FG002|Overall Study|none specified.|2|||
160557481|NCT04957290|579766351|FG003|Overall Study|none specified.|0|||
160557482|NCT04957290|579766352|FG004|Overall Study|none specified.|0|||
160557483|NCT04957290|579766353|FG005|Overall Study|none specified.|0|||
160557484|NCT04957290|579766348|FG000|Overall Study|unacceptable toxicity|0|||
160557485|NCT04957290|579766349|FG001|Overall Study|unacceptable toxicity|0|||
160557486|NCT04957290|579766350|FG002|Overall Study|unacceptable toxicity|1|||
160557487|NCT04957290|579766351|FG003|Overall Study|unacceptable toxicity|0|||
160557488|NCT04957290|579766352|FG004|Overall Study|unacceptable toxicity|0|||
160557489|NCT04957290|579766353|FG005|Overall Study|unacceptable toxicity|0|||
160557490|NCT04957290|579766348|FG000|Overall Study|Adverse Event|0|||
160557491|NCT04957290|579766349|FG001|Overall Study|Adverse Event|0|||
160557492|NCT04957290|579766350|FG002|Overall Study|Adverse Event|1|||
160557493|NCT04957290|579766351|FG003|Overall Study|Adverse Event|0|||
160557494|NCT04957290|579766352|FG004|Overall Study|Adverse Event|0|||
160557495|NCT04957290|579766353|FG005|Overall Study|Adverse Event|0|||
160557496|NCT04957290|579766348|FG000|Overall Study|study terminated by sponsor|0|||
160557497|NCT04957290|579766349|FG001|Overall Study|study terminated by sponsor|0|||
160557498|NCT04957290|579766350|FG002|Overall Study|study terminated by sponsor|2|||
160557499|NCT04957290|579766351|FG003|Overall Study|study terminated by sponsor|0|||
160557500|NCT04957290|579766352|FG004|Overall Study|study terminated by sponsor|0|||
160557501|NCT04957290|579766353|FG005|Overall Study|study terminated by sponsor|0|||
160557502|NCT00896532|579766354|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557503|NCT00896532|579766355|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557504|NCT00896532|579766356|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557505|NCT00896532|579766357|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
160557506|NCT00896532|579766358|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557507|NCT00896532|579766359|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
160557508|NCT00896532|579766360|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160990675|NCT00293462|581353923|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
160990676|NCT00293462|581353921|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
160990677|NCT00293462|581353922|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
160990678|NCT00293462|581353923|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
160990679|NCT00293462|581353921|FG000|Overall Study|Refuse Radiation Treatment|1|||
160990680|NCT00293462|581353922|FG001|Overall Study|Refuse Radiation Treatment|0|||
160990681|NCT00293462|581353923|FG002|Overall Study|Refuse Radiation Treatment|0|||
160990682|NCT00293462|581353921|FG000|Overall Study|No Show|0|||
160990683|NCT00293462|581353922|FG001|Overall Study|No Show|0|||
160990684|NCT00293462|581353923|FG002|Overall Study|No Show|1|||
160990685|NCT00293462|581353921|FG000|Overall Study|Went back to his home country|0|||
160990686|NCT00293462|581353922|FG001|Overall Study|Went back to his home country|0|||
160557509|NCT00896532|579766361|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557510|NCT00896532|579766362|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557511|NCT00896532|579766363|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557512|NCT00896532|579766364|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557513|NCT00896532|579766365|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557514|NCT00896532|579766366|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557515|NCT00896532|579766367|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557516|NCT00896532|579766368|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557517|NCT00896532|579766369|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557518|NCT00896532|579766370|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557519|NCT00896532|579766371|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557520|NCT00896532|579766372|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557521|NCT00896532|579766373|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557522|NCT00896532|579766374|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557523|NCT00896532|579766375|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557524|NCT00896532|579766376|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
160557525|NCT00896532|579766354|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
160557526|NCT00896532|579766355|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
160557527|NCT00896532|579766356|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
160557528|NCT00896532|579766357|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
160557529|NCT00896532|579766358|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
160557530|NCT00896532|579766359|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
160557531|NCT00896532|579766360|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
160557532|NCT00896532|579766361|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557533|NCT00896532|579766362|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557534|NCT00896532|579766363|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557535|NCT00896532|579766364|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557536|NCT00896532|579766365|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557537|NCT00896532|579766366|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557538|NCT00896532|579766367|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557539|NCT00896532|579766368|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557540|NCT00896532|579766369|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557541|NCT00896532|579766370|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557542|NCT00896532|579766371|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557543|NCT00896532|579766372|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160990687|NCT00293462|581353923|FG002|Overall Study|Went back to his home country|1|||
160990688|NCT00293462|581353921|FG000|Overall Study|Blood clot after chemotherapy|0|||
160990689|NCT00293462|581353922|FG001|Overall Study|Blood clot after chemotherapy|0|||
160990690|NCT00293462|581353923|FG002|Overall Study|Blood clot after chemotherapy|1|||
160990691|NCT00293462|581353921|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
160990692|NCT00293462|581353922|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
160990693|NCT00293462|581353923|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
160990694|NCT00293462|581353921|FG000|Overall Study|Possible Tracheostomy leakage|0|||
160990695|NCT00293462|581353922|FG001|Overall Study|Possible Tracheostomy leakage|1|||
160990696|NCT00293462|581353923|FG002|Overall Study|Possible Tracheostomy leakage|0|||
160990697|NCT00293462|581353921|FG000|Overall Study|Low radiation dose in oral cavity|0|||
160990698|NCT00293462|581353922|FG001|Overall Study|Low radiation dose in oral cavity|1|||
160990699|NCT00293462|581353923|FG002|Overall Study|Low radiation dose in oral cavity|0|||
160990700|NCT00293462|581353921|FG000|Overall Study|Physician Decision|0|||
160990701|NCT00293462|581353922|FG001|Overall Study|Physician Decision|1|||
160990702|NCT00293462|581353923|FG002|Overall Study|Physician Decision|0|||
160990703|NCT00372060|581353924|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
160990704|NCT00372060|581353925|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
160990705|NCT00372060|581353924|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
160990706|NCT00372060|581353925|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
160902825|NCT01180985|581037841|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
160557544|NCT00896532|579766373|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557545|NCT00896532|579766374|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557546|NCT00896532|579766375|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557547|NCT00896532|579766376|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
160557548|NCT00896532|579766354|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
160557549|NCT00896532|579766355|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
160557550|NCT00896532|579766356|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
160557551|NCT00896532|579766357|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
160557552|NCT00896532|579766358|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
160557553|NCT00896532|579766359|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
160557554|NCT00896532|579766360|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
160557555|NCT00896532|579766361|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
160557556|NCT00896532|579766362|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557557|NCT00896532|579766363|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557558|NCT00896532|579766364|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557559|NCT00896532|579766365|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557560|NCT00896532|579766366|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557561|NCT00896532|579766367|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557562|NCT00896532|579766368|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557563|NCT00896532|579766369|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557564|NCT00896532|579766370|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557565|NCT00896532|579766371|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557566|NCT00896532|579766372|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557567|NCT00896532|579766373|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557568|NCT00896532|579766374|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557569|NCT00896532|579766375|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557570|NCT00896532|579766376|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
160557571|NCT00896532|579766354|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557572|NCT00896532|579766355|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557573|NCT00896532|579766356|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
160557574|NCT00896532|579766357|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557575|NCT00896532|579766358|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
160557576|NCT00896532|579766359|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557577|NCT00896532|579766360|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557578|NCT00896532|579766361|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557579|NCT00896532|579766362|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557580|NCT00896532|579766363|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557581|NCT00896532|579766364|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557582|NCT00896532|579766365|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557583|NCT00896532|579766366|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557584|NCT00896532|579766367|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557585|NCT00896532|579766368|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557586|NCT00896532|579766369|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557587|NCT00896532|579766370|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557588|NCT00896532|579766371|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557589|NCT00896532|579766372|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557590|NCT00896532|579766373|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557591|NCT00896532|579766374|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557592|NCT00896532|579766375|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557593|NCT00896532|579766376|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
160557594|NCT00896532|579766354|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
160902826|NCT01180985|581037842|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
160557595|NCT00896532|579766355|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557596|NCT00896532|579766356|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557597|NCT00896532|579766357|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
160557598|NCT00896532|579766358|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557599|NCT00896532|579766359|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557600|NCT00896532|579766360|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557601|NCT00896532|579766361|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557602|NCT00896532|579766362|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557603|NCT00896532|579766363|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557604|NCT00896532|579766364|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557605|NCT00896532|579766365|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557606|NCT00896532|579766366|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557607|NCT00896532|579766367|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557608|NCT00896532|579766368|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557609|NCT00896532|579766369|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557610|NCT00896532|579766370|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557611|NCT00896532|579766371|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557612|NCT00896532|579766372|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557613|NCT00896532|579766373|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557614|NCT00896532|579766374|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557615|NCT00896532|579766375|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557616|NCT00896532|579766376|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
160557617|NCT00896532|579766354|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557618|NCT00896532|579766355|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557619|NCT00896532|579766356|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
160557620|NCT00896532|579766357|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557621|NCT00896532|579766358|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557622|NCT00896532|579766359|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557623|NCT00896532|579766360|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557624|NCT00896532|579766361|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557625|NCT00896532|579766362|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557626|NCT00896532|579766363|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557627|NCT00896532|579766364|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557628|NCT00896532|579766365|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557629|NCT00896532|579766366|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557630|NCT00896532|579766367|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557631|NCT00896532|579766368|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557632|NCT00896532|579766369|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557633|NCT00896532|579766370|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557634|NCT00896532|579766371|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557635|NCT00896532|579766372|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557636|NCT00896532|579766373|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557637|NCT00896532|579766374|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557638|NCT00896532|579766375|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557639|NCT00896532|579766376|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160557640|NCT00896532|579766354|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557641|NCT00896532|579766355|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557642|NCT00896532|579766356|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
160557643|NCT00896532|579766357|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557644|NCT00896532|579766358|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557645|NCT00896532|579766359|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557646|NCT00896532|579766360|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557647|NCT00896532|579766361|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557648|NCT00896532|579766362|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557649|NCT00896532|579766363|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557650|NCT00896532|579766364|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557651|NCT00896532|579766365|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557652|NCT00896532|579766366|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557653|NCT00896532|579766367|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557654|NCT00896532|579766368|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557655|NCT00896532|579766369|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557656|NCT00896532|579766370|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557657|NCT00896532|579766371|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557658|NCT00896532|579766372|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557659|NCT00896532|579766373|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557660|NCT00896532|579766374|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557661|NCT00896532|579766375|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557662|NCT00896532|579766376|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
160557663|NCT00896532|579766354|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557664|NCT00896532|579766355|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557665|NCT00896532|579766356|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557666|NCT00896532|579766357|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
160557667|NCT00896532|579766358|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557668|NCT00896532|579766359|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557669|NCT00896532|579766360|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557670|NCT00896532|579766361|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557671|NCT00896532|579766362|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557672|NCT00896532|579766363|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557673|NCT00896532|579766364|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557674|NCT00896532|579766365|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557675|NCT00896532|579766366|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160996829|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
160557676|NCT00896532|579766367|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557677|NCT00896532|579766368|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557678|NCT00896532|579766369|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557679|NCT00896532|579766370|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557680|NCT00896532|579766371|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557681|NCT00896532|579766372|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557682|NCT00896532|579766373|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557683|NCT00896532|579766374|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557684|NCT00896532|579766375|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557685|NCT00896532|579766376|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
160557686|NCT00896532|579766354|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557687|NCT00896532|579766355|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
160557688|NCT00896532|579766356|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557689|NCT00896532|579766357|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
160557690|NCT00896532|579766358|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
160557691|NCT00896532|579766359|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557692|NCT00896532|579766360|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557693|NCT00896532|579766361|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557694|NCT00896532|579766362|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557695|NCT00896532|579766363|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557696|NCT00896532|579766364|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557697|NCT00896532|579766365|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557698|NCT00896532|579766366|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557699|NCT00896532|579766367|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557700|NCT00896532|579766368|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557701|NCT00896532|579766369|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557702|NCT00896532|579766370|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557703|NCT00896532|579766371|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557704|NCT00896532|579766372|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557705|NCT00896532|579766373|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557706|NCT00896532|579766374|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557707|NCT00896532|579766375|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557708|NCT00896532|579766376|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160557709|NCT00896532|579766354|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557710|NCT00896532|579766355|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557711|NCT00896532|579766356|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557712|NCT00896532|579766357|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557713|NCT00896532|579766358|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557714|NCT00896532|579766359|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557715|NCT00896532|579766360|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557716|NCT00896532|579766361|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557717|NCT00896532|579766362|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
160557718|NCT00896532|579766363|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557719|NCT00896532|579766364|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557720|NCT00896532|579766365|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557721|NCT00896532|579766366|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557722|NCT00896532|579766367|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557723|NCT00896532|579766368|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557724|NCT00896532|579766369|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557725|NCT00896532|579766370|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557726|NCT00896532|579766371|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557727|NCT00896532|579766372|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557728|NCT00896532|579766373|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557729|NCT00896532|579766374|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557730|NCT00896532|579766375|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557731|NCT00896532|579766376|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
160557732|NCT00896532|579766354|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557733|NCT00896532|579766355|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557734|NCT00896532|579766356|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557735|NCT00896532|579766357|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557736|NCT00896532|579766358|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557737|NCT00896532|579766359|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557738|NCT00896532|579766360|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557739|NCT00896532|579766361|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557740|NCT00896532|579766362|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557741|NCT00896532|579766363|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557742|NCT00896532|579766364|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557743|NCT00896532|579766365|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557744|NCT00896532|579766366|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
160557745|NCT00896532|579766367|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557746|NCT00896532|579766368|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557747|NCT00896532|579766369|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557748|NCT00896532|579766370|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557749|NCT00896532|579766371|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557750|NCT00896532|579766372|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557751|NCT00896532|579766373|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557752|NCT00896532|579766374|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557753|NCT00896532|579766375|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557754|NCT00896532|579766376|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
160557755|NCT00896532|579766354|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557756|NCT00896532|579766355|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557757|NCT00896532|579766356|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557758|NCT00896532|579766357|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557759|NCT00896532|579766358|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557760|NCT00896532|579766359|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557761|NCT00896532|579766360|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557762|NCT00896532|579766361|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557763|NCT00896532|579766362|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557764|NCT00896532|579766363|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557765|NCT00896532|579766364|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
160557766|NCT00896532|579766365|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557767|NCT00896532|579766366|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
160557768|NCT00896532|579766367|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557769|NCT00896532|579766368|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557770|NCT00896532|579766369|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557771|NCT00896532|579766370|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557772|NCT00896532|579766371|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557773|NCT00896532|579766372|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557774|NCT00896532|579766373|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557775|NCT00896532|579766374|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557776|NCT00896532|579766375|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557777|NCT00896532|579766376|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160557778|NCT00896532|579766354|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557779|NCT00896532|579766355|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557780|NCT00896532|579766356|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557781|NCT00896532|579766357|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557782|NCT00896532|579766358|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557783|NCT00896532|579766359|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557784|NCT00896532|579766360|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557785|NCT00896532|579766361|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160990707|NCT00372060|581353924|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
160557786|NCT00896532|579766362|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557787|NCT00896532|579766363|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557788|NCT00896532|579766364|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557789|NCT00896532|579766365|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557790|NCT00896532|579766366|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
160557791|NCT00896532|579766367|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
160557792|NCT00896532|579766368|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557793|NCT00896532|579766369|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557794|NCT00896532|579766370|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557795|NCT00896532|579766371|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557796|NCT00896532|579766372|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160828583|NCT01510184|580759833|FG000|Overall Study|Other|0|||
160828584|NCT01510184|580759834|FG001|Overall Study|Other|1|||
160828585|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
160828586|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
160828587|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
160990708|NCT00372060|581353925|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
160647062|NCT04535583|580090082|FG000|Overall Study|Physician Decision|1|||
160647063|NCT04535583|580090082|FG000|Overall Study|Withdrawal by Subject|1|||
160647064|NCT01078090|580090083|FG000|Overall Study|Lost to Follow-up|2363|||
160647065|NCT01078090|580090083|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
160647066|NCT01078090|580090083|FG000|Overall Study|Lack of Efficacy|1193|||
160647067|NCT01078090|580090083|FG000|Overall Study|ADR and lack of efficacy|61|||
160647068|NCT01078090|580090083|FG000|Overall Study|Other|523|||
160647069|NCT01748890|580090085|FG000|Overall Study|Insufficient recruitment for analysis|4|||
160647070|NCT02669264|580090086|FG000|Overall Study|Death|5|||
160647071|NCT02669264|580090087|FG001|Overall Study|Death|5|||
160647072|NCT02669264|580090088|FG002|Overall Study|Death|3|||
160647073|NCT02669264|580090089|FG003|Overall Study|Death|3|||
160647074|NCT02669264|580090090|FG004|Overall Study|Death|3|||
160647075|NCT02669264|580090091|FG005|Overall Study|Death|6|||
160647076|NCT02669264|580090092|FG006|Overall Study|Death|3|||
160647077|NCT02669264|580090086|FG000|Overall Study|Withdrawal by Subject|0|||
160647078|NCT02669264|580090087|FG001|Overall Study|Withdrawal by Subject|1|||
160647079|NCT02669264|580090088|FG002|Overall Study|Withdrawal by Subject|0|||
160647080|NCT02669264|580090089|FG003|Overall Study|Withdrawal by Subject|0|||
160647081|NCT02669264|580090090|FG004|Overall Study|Withdrawal by Subject|1|||
160647082|NCT02669264|580090091|FG005|Overall Study|Withdrawal by Subject|0|||
160647083|NCT02669264|580090092|FG006|Overall Study|Withdrawal by Subject|0|||
160647084|NCT02669264|580090086|FG000|Overall Study|Lost to Follow-up|0|||
160647085|NCT02669264|580090087|FG001|Overall Study|Lost to Follow-up|0|||
160647086|NCT02669264|580090088|FG002|Overall Study|Lost to Follow-up|0|||
160647087|NCT02669264|580090089|FG003|Overall Study|Lost to Follow-up|0|||
160647088|NCT02669264|580090090|FG004|Overall Study|Lost to Follow-up|1|||
160647089|NCT02669264|580090091|FG005|Overall Study|Lost to Follow-up|0|||
160647090|NCT02669264|580090092|FG006|Overall Study|Lost to Follow-up|0|||
160647091|NCT02669264|580090086|FG000|Overall Study|Miscellaneous|0|||
160647092|NCT02669264|580090087|FG001|Overall Study|Miscellaneous|0|||
160647093|NCT02669264|580090088|FG002|Overall Study|Miscellaneous|0|||
160647094|NCT02669264|580090089|FG003|Overall Study|Miscellaneous|0|||
160647095|NCT02669264|580090090|FG004|Overall Study|Miscellaneous|0|||
160647096|NCT02669264|580090091|FG005|Overall Study|Miscellaneous|0|||
160647097|NCT02669264|580090092|FG006|Overall Study|Miscellaneous|2|||
160647098|NCT03035227|580090093|FG000|Overall Study|study stopped due to PI leaving institut|1|||
160647099|NCT03035227|580090094|FG001|Overall Study|study stopped due to PI leaving institut|1|||
160647100|NCT02100956|580090095|FG000|At Least One Week Between Injections|Adverse Event|0|||
160828588|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
160828589|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
160557797|NCT00896532|579766373|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557798|NCT00896532|579766374|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557799|NCT00896532|579766375|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557800|NCT00896532|579766376|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160557801|NCT00896532|579766354|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
160557802|NCT00896532|579766355|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
160557803|NCT00896532|579766356|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
160557804|NCT00896532|579766357|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
160557805|NCT00896532|579766358|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
160557806|NCT00896532|579766359|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
160557807|NCT00896532|579766360|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
160557808|NCT00896532|579766361|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
160557809|NCT00896532|579766362|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
160557810|NCT00896532|579766363|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
160557811|NCT00896532|579766364|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
160557812|NCT00896532|579766365|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
160557813|NCT00896532|579766366|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
160557814|NCT00896532|579766367|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
160557815|NCT00896532|579766368|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
160557816|NCT00896532|579766369|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
160557817|NCT00896532|579766370|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
160557818|NCT00896532|579766371|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
160557819|NCT00896532|579766372|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
160557820|NCT00896532|579766373|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
160557821|NCT00896532|579766374|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
160557822|NCT00896532|579766375|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
160557823|NCT00896532|579766376|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
160557824|NCT00896532|579766354|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557825|NCT00896532|579766355|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557826|NCT00896532|579766356|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557827|NCT00896532|579766357|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557828|NCT00896532|579766358|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160647101|NCT02100956|580090096|FG001|At Least One Week Between Injections|Adverse Event|1|||
160647102|NCT03529955|580090097|FG000|Overall Study|Adverse Event|1|||
160647103|NCT03529955|580090097|FG000|Overall Study|Lack of Efficacy|1|||
160647104|NCT03016078|580090101|FG000|Overall Study|Protocol Violation|1|||
160647105|NCT03016078|580090101|FG000|Overall Study|Protocol Violation|1|||
160647106|NCT01098240|580090102|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
160647107|NCT01098240|580090103|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
160902827|NCT00705289|581037843|FG000|Overall Study|Subject or treating physician's choice|131|||
160902828|NCT02763462|581037849|FG000|Overall Study|Protocol Violation|6|||
160902829|NCT00129272|581037850|FG000|Overall Study|Lost to Follow-up|12|||
160902830|NCT00129272|581037851|FG001|Overall Study|Lost to Follow-up|11|||
160902831|NCT00129272|581037850|FG000|Overall Study|Withdrawal by Subject|5|||
160647108|NCT01098240|580090104|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
160647109|NCT01098240|580090102|FG000|Open-Label Phase|Protocol Violation|4|||
160647110|NCT01098240|580090103|FG001|Open-Label Phase|Protocol Violation|0|||
160647111|NCT01098240|580090104|FG002|Open-Label Phase|Protocol Violation|0|||
160647112|NCT01098240|580090102|FG000|Open-Label Phase|Lost to Follow-up|13|||
160647113|NCT01098240|580090103|FG001|Open-Label Phase|Lost to Follow-up|0|||
160647114|NCT01098240|580090104|FG002|Open-Label Phase|Lost to Follow-up|0|||
160647115|NCT01098240|580090102|FG000|Open-Label Phase|Other|19|||
160647116|NCT01098240|580090103|FG001|Open-Label Phase|Other|0|||
160647117|NCT01098240|580090104|FG002|Open-Label Phase|Other|0|||
160647118|NCT01098240|580090102|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
160647119|NCT01098240|580090103|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
160647120|NCT01098240|580090104|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
160902832|NCT00129272|581037851|FG001|Overall Study|Withdrawal by Subject|11|||
160902833|NCT00675948|581037853|FG000|Overall Study|Adverse Event|23|||
160902834|NCT00675948|581037854|FG001|Overall Study|Adverse Event|1|||
160990709|NCT00372060|581353924|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
160990710|NCT00372060|581353925|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
160990711|NCT00372060|581353924|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
160902835|NCT00675948|581037853|FG000|Overall Study|Lack of Efficacy|3|||
160902836|NCT00675948|581037854|FG001|Overall Study|Lack of Efficacy|0|||
160557829|NCT00896532|579766359|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557830|NCT00896532|579766360|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557831|NCT00896532|579766361|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557832|NCT00896532|579766362|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557833|NCT00896532|579766363|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557834|NCT00896532|579766364|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557835|NCT00896532|579766365|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160647121|NCT01098240|580090102|FG000|Open-Label Phase|Pregnancy|1|||
160557836|NCT00896532|579766366|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160647122|NCT01098240|580090103|FG001|Open-Label Phase|Pregnancy|0|||
160647123|NCT01098240|580090104|FG002|Open-Label Phase|Pregnancy|0|||
160647124|NCT01098240|580090102|FG000|Open-Label Phase|Withdrawal by Subject|9|||
160647125|NCT01098240|580090103|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160647126|NCT01098240|580090104|FG002|Open-Label Phase|Withdrawal by Subject|0|||
160647127|NCT01098240|580090102|FG000|Open-Label Phase|Adverse Event|12|||
160647128|NCT01098240|580090103|FG001|Open-Label Phase|Adverse Event|0|||
160647129|NCT01098240|580090104|FG002|Open-Label Phase|Adverse Event|0|||
160647130|NCT01098240|580090102|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
160647131|NCT01098240|580090103|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
160647132|NCT01098240|580090104|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
160647133|NCT01098240|580090102|FG000|Double-Blind Phase|Protocol Violation|0|||
160647134|NCT01098240|580090103|FG001|Double-Blind Phase|Protocol Violation|2|||
160647135|NCT01098240|580090104|FG002|Double-Blind Phase|Protocol Violation|4|||
160647136|NCT01098240|580090102|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160647137|NCT01098240|580090103|FG001|Double-Blind Phase|Lost to Follow-up|2|||
160647138|NCT01098240|580090104|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160557837|NCT00896532|579766367|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557838|NCT00896532|579766368|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557839|NCT00896532|579766369|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
160557840|NCT00896532|579766370|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
160557841|NCT00896532|579766371|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557842|NCT00896532|579766372|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557843|NCT00896532|579766373|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557844|NCT00896532|579766374|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557845|NCT00896532|579766375|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160557846|NCT00896532|579766376|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160647139|NCT01098240|580090102|FG000|Double-Blind Phase|Other|0|||
160647140|NCT01098240|580090103|FG001|Double-Blind Phase|Other|2|||
160647141|NCT01098240|580090104|FG002|Double-Blind Phase|Other|2|||
160647142|NCT01098240|580090102|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
160647143|NCT01098240|580090103|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
160647144|NCT01098240|580090104|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
160647145|NCT01098240|580090102|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
160647146|NCT01098240|580090103|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
160647147|NCT01098240|580090104|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
160647148|NCT01098240|580090102|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
160647149|NCT01098240|580090103|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
160647150|NCT01098240|580090104|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
160647151|NCT01098240|580090102|FG000|Double-Blind Phase|Adverse Event|0|||
160647152|NCT01098240|580090103|FG001|Double-Blind Phase|Adverse Event|3|||
160647153|NCT01098240|580090104|FG002|Double-Blind Phase|Adverse Event|3|||
160647154|NCT00874757|580090105|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
160828590|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
160828591|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
160828592|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
160828593|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
160828594|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
160828595|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Other|4|||
160828596|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Other|0|||
160828597|NCT01352741|580759837|FG000|Double-blind Comparative Period|Protocol Violation|2|||
160902837|NCT00675948|581037853|FG000|Overall Study|Withdrawal by Subject|7|||
160557847|NCT00896532|579766354|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557848|NCT00896532|579766355|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557849|NCT00896532|579766356|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557850|NCT00896532|579766357|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557851|NCT00896532|579766358|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557852|NCT00896532|579766359|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557853|NCT00896532|579766360|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557854|NCT00896532|579766361|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557855|NCT00896532|579766362|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557856|NCT00896532|579766363|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557857|NCT00896532|579766364|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557858|NCT00896532|579766365|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557859|NCT00896532|579766366|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557860|NCT00896532|579766367|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557861|NCT00896532|579766368|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557862|NCT00896532|579766369|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
160557863|NCT00896532|579766370|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
160557864|NCT00896532|579766371|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
160557865|NCT00896532|579766372|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557866|NCT00896532|579766373|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557867|NCT00896532|579766374|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557868|NCT00896532|579766375|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557869|NCT00896532|579766376|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160557870|NCT00896532|579766354|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557871|NCT00896532|579766355|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557872|NCT00896532|579766356|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557873|NCT00896532|579766357|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557874|NCT00896532|579766358|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557875|NCT00896532|579766359|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557876|NCT00896532|579766360|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557877|NCT00896532|579766361|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557878|NCT00896532|579766362|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557879|NCT00896532|579766363|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557880|NCT00896532|579766364|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557881|NCT00896532|579766365|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557882|NCT00896532|579766366|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557883|NCT00896532|579766367|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557884|NCT00896532|579766368|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557885|NCT00896532|579766369|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557886|NCT00896532|579766370|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
160557887|NCT00896532|579766371|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557888|NCT00896532|579766372|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557889|NCT00896532|579766373|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557890|NCT00896532|579766374|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557891|NCT00896532|579766375|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557892|NCT00896532|579766376|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160557893|NCT00896532|579766354|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
160557894|NCT00896532|579766355|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
160557895|NCT00896532|579766356|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
160557896|NCT00896532|579766357|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
160557897|NCT00896532|579766358|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
160557898|NCT00896532|579766359|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
160557899|NCT00896532|579766360|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
160557900|NCT00896532|579766361|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
160557901|NCT00896532|579766362|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
160557902|NCT00896532|579766363|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
160557903|NCT00896532|579766364|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
160557904|NCT00896532|579766365|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
160557905|NCT00896532|579766366|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
160557906|NCT00896532|579766367|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
160557907|NCT00896532|579766368|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
160557908|NCT00896532|579766369|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
160557909|NCT00896532|579766370|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
160557910|NCT00896532|579766371|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
160557911|NCT00896532|579766372|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
160557912|NCT00896532|579766373|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
160557913|NCT00896532|579766374|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
160557914|NCT00896532|579766375|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
160557915|NCT00896532|579766376|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
160557916|NCT00896532|579766354|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557917|NCT00896532|579766355|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557918|NCT00896532|579766356|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557919|NCT00896532|579766357|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557920|NCT00896532|579766358|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557921|NCT00896532|579766359|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557922|NCT00896532|579766360|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557923|NCT00896532|579766361|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557924|NCT00896532|579766362|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557925|NCT00896532|579766363|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557926|NCT00896532|579766364|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557927|NCT00896532|579766365|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557928|NCT00896532|579766366|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557929|NCT00896532|579766367|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557930|NCT00896532|579766368|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557931|NCT00896532|579766369|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557932|NCT00896532|579766370|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
160557933|NCT00896532|579766371|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557934|NCT00896532|579766372|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557935|NCT00896532|579766373|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557936|NCT00896532|579766374|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557937|NCT00896532|579766375|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557938|NCT00896532|579766376|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
160557939|NCT00896532|579766354|FG000|Months 48-72: Follow-on Phase|Death|0|||
160902838|NCT00675948|581037854|FG001|Overall Study|Withdrawal by Subject|0|||
160902839|NCT00675948|581037853|FG000|Overall Study|Lost to Follow-up|2|||
160557940|NCT00896532|579766355|FG001|Months 48-72: Follow-on Phase|Death|0|||
160557941|NCT00896532|579766356|FG002|Months 48-72: Follow-on Phase|Death|0|||
160557942|NCT00896532|579766357|FG003|Months 48-72: Follow-on Phase|Death|0|||
160557943|NCT00896532|579766358|FG004|Months 48-72: Follow-on Phase|Death|0|||
160557944|NCT00896532|579766359|FG005|Months 48-72: Follow-on Phase|Death|0|||
160557945|NCT00896532|579766360|FG006|Months 48-72: Follow-on Phase|Death|0|||
160557946|NCT00896532|579766361|FG007|Months 48-72: Follow-on Phase|Death|0|||
160828598|NCT01352741|580759838|FG001|Double-blind Comparative Period|Protocol Violation|0|||
160828599|NCT01352741|580759837|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
160828600|NCT01352741|580759838|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
160902840|NCT00675948|581037854|FG001|Overall Study|Lost to Follow-up|0|||
160902841|NCT00675948|581037853|FG000|Overall Study|Protocol Violation|1|||
160902842|NCT00675948|581037854|FG001|Overall Study|Protocol Violation|0|||
160902843|NCT00675948|581037853|FG000|Overall Study|Pain under control|1|||
160902844|NCT00675948|581037854|FG001|Overall Study|Pain under control|0|||
160902845|NCT00675948|581037853|FG000|Overall Study|Sponsor decision|0|||
160902846|NCT00675948|581037854|FG001|Overall Study|Sponsor decision|1|||
160902847|NCT00675948|581037853|FG000|Overall Study|Patient died|1|||
160902848|NCT00675948|581037854|FG001|Overall Study|Patient died|0|||
160902849|NCT00675948|581037853|FG000|Overall Study|Patient unable to comply with diaries|1|||
160902850|NCT00675948|581037854|FG001|Overall Study|Patient unable to comply with diaries|0|||
160902851|NCT00675948|581037853|FG000|Overall Study|Patient feels unable to take medication|0|||
160557947|NCT00896532|579766362|FG008|Months 48-72: Follow-on Phase|Death|0|||
160557948|NCT00896532|579766363|FG009|Months 48-72: Follow-on Phase|Death|0|||
160557949|NCT00896532|579766364|FG010|Months 48-72: Follow-on Phase|Death|0|||
160557950|NCT00896532|579766365|FG011|Months 48-72: Follow-on Phase|Death|0|||
160557951|NCT00896532|579766366|FG012|Months 48-72: Follow-on Phase|Death|0|||
160557952|NCT00896532|579766367|FG013|Months 48-72: Follow-on Phase|Death|0|||
160557953|NCT00896532|579766368|FG014|Months 48-72: Follow-on Phase|Death|0|||
160557954|NCT00896532|579766369|FG015|Months 48-72: Follow-on Phase|Death|0|||
160557955|NCT00896532|579766370|FG016|Months 48-72: Follow-on Phase|Death|0|||
160557956|NCT00896532|579766371|FG017|Months 48-72: Follow-on Phase|Death|0|||
160557957|NCT00896532|579766372|FG018|Months 48-72: Follow-on Phase|Death|1|||
160557958|NCT00896532|579766373|FG019|Months 48-72: Follow-on Phase|Death|0|||
160557959|NCT00896532|579766374|FG020|Months 48-72: Follow-on Phase|Death|0|||
160557960|NCT00896532|579766375|FG021|Months 48-72: Follow-on Phase|Death|0|||
160557961|NCT00896532|579766376|FG022|Months 48-72: Follow-on Phase|Death|0|||
160557962|NCT00896532|579766354|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557963|NCT00896532|579766355|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557964|NCT00896532|579766356|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557965|NCT00896532|579766357|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557966|NCT00896532|579766358|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557967|NCT00896532|579766359|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557968|NCT00896532|579766360|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557969|NCT00896532|579766361|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557970|NCT00896532|579766362|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557971|NCT00896532|579766363|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557972|NCT00896532|579766364|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557973|NCT00896532|579766365|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557974|NCT00896532|579766366|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557975|NCT00896532|579766367|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557976|NCT00896532|579766368|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557977|NCT00896532|579766369|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557978|NCT00896532|579766370|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557979|NCT00896532|579766371|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557980|NCT00896532|579766372|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557981|NCT00896532|579766373|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557982|NCT00896532|579766374|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557983|NCT00896532|579766375|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
160557984|NCT00896532|579766376|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160557985|NCT00896532|579766354|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557986|NCT00896532|579766355|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557987|NCT00896532|579766356|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557988|NCT00896532|579766357|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557989|NCT00896532|579766358|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557990|NCT00896532|579766359|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557991|NCT00896532|579766360|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557992|NCT00896532|579766361|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557993|NCT00896532|579766362|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160902852|NCT00675948|581037854|FG001|Overall Study|Patient feels unable to take medication|1|||
160557994|NCT00896532|579766363|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557995|NCT00896532|579766364|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557996|NCT00896532|579766365|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557997|NCT00896532|579766366|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557998|NCT00896532|579766367|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160557999|NCT00896532|579766368|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160558000|NCT00896532|579766369|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160558001|NCT00896532|579766370|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160558002|NCT00896532|579766371|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160558003|NCT00896532|579766372|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160558004|NCT00896532|579766373|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160558005|NCT00896532|579766374|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160558006|NCT00896532|579766375|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
160558007|NCT00896532|579766376|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160558008|NCT01176916|579766377|FG000|Overall Study|Adverse Event|61|||
160558009|NCT01176916|579766377|FG000|Overall Study|Death|1|||
160558010|NCT01176916|579766377|FG000|Overall Study|Lost to Follow-up|15|||
160558011|NCT01176916|579766377|FG000|Overall Study|Objective progression or relapse|17|||
160558012|NCT01176916|579766377|FG000|Overall Study|Protocol Violation|24|||
160558013|NCT01176916|579766377|FG000|Overall Study|Withdrawal by Subject|37|||
160558014|NCT01176916|579766377|FG000|Overall Study|Other|6|||
160558015|NCT01176916|579766377|FG000|Overall Study|Withdrawal prior to Treatment|6|||
160558016|NCT03158220|579766380|FG000|Overall Study|Screen Failure|0|||
160558017|NCT03158220|579766381|FG001|Overall Study|Screen Failure|1|||
160558018|NCT03158220|579766380|FG000|Overall Study|Withdrawal by Subject|8|||
160558019|NCT03158220|579766381|FG001|Overall Study|Withdrawal by Subject|9|||
160558020|NCT03158220|579766380|FG000|Overall Study|Status unknown|0|||
160558021|NCT03158220|579766381|FG001|Overall Study|Status unknown|1|||
160558022|NCT03158220|579766380|FG000|Overall Study|Lost to Follow-up|8|||
160558023|NCT03158220|579766381|FG001|Overall Study|Lost to Follow-up|5|||
160558024|NCT03158220|579766380|FG000|Overall Study|Physician Decision|1|||
160558025|NCT03158220|579766381|FG001|Overall Study|Physician Decision|0|||
160558026|NCT01439945|579766386|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
160558027|NCT01439945|579766387|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
160558028|NCT01439945|579766388|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
160558029|NCT01439945|579766389|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
160558030|NCT01439945|579766386|FG000|Double-Blind Treatment Phase|Ineligible|1|||
160558031|NCT01439945|579766387|FG001|Double-Blind Treatment Phase|Ineligible|2|||
160558032|NCT01439945|579766388|FG002|Double-Blind Treatment Phase|Ineligible|0|||
160558033|NCT01439945|579766389|FG003|Double-Blind Treatment Phase|Ineligible|1|||
160558034|NCT04082663|579766390|FG000|Overall Study|Adverse Event|6|||
160558035|NCT04082663|579766390|FG000|Overall Study|Lost to Follow-up|1|||
160558036|NCT02542072|579766391|FG000|First Intervention (1 Month)|Adverse Event|1|||
160558037|NCT02542072|579766392|FG001|First Intervention (1 Month)|Adverse Event|1|||
160558038|NCT02542072|579766391|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
160558039|NCT02542072|579766392|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
160558040|NCT02542072|579766391|FG000|First Intervention (1 Month)|Lens discomfort|1|||
160558041|NCT02542072|579766392|FG001|First Intervention (1 Month)|Lens discomfort|2|||
160558042|NCT02542072|579766391|FG000|First Intervention (1 Month)|Protocol Violation|1|||
160558043|NCT02542072|579766392|FG001|First Intervention (1 Month)|Protocol Violation|0|||
160558044|NCT02542072|579766391|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
160558045|NCT02542072|579766392|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
160558046|NCT02542072|579766391|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
160558047|NCT02542072|579766392|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
160558048|NCT01990261|579766393|FG000|Overall Study|Death Before Treatment Start|2|||
160558049|NCT01990261|579766393|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
160558050|NCT01990261|579766393|FG000|Overall Study|Death From other Causes|1|||
160558051|NCT01990261|579766393|FG000|Overall Study|Disease Progression (PD)|8|||
160558052|NCT01990261|579766393|FG000|Overall Study|PD Before Treatment Start|1|||
160558053|NCT01990261|579766393|FG000|Overall Study|Dossier not Approved|1|||
160558054|NCT01990261|579766393|FG000|Overall Study|Lost to Follow-up|2|||
160558055|NCT04722991|579766394|FG000|Overall Study|Adverse Event|12|||
160558056|NCT04722991|579766395|FG001|Overall Study|Adverse Event|4|||
160558057|NCT04722991|579766394|FG000|Overall Study|Death|2|||
160558058|NCT04722991|579766395|FG001|Overall Study|Death|0|||
160558059|NCT04722991|579766394|FG000|Overall Study|Lost to Follow-up|1|||
160902853|NCT02100514|581037858|FG000|Treatment Period|Adverse Event|0|||
160558060|NCT04722991|579766395|FG001|Overall Study|Lost to Follow-up|1|||
160558061|NCT04722991|579766394|FG000|Overall Study|Withdrawal cirterion met|2|||
160902854|NCT02100514|581037859|FG001|Treatment Period|Adverse Event|5|||
160902855|NCT02100514|581037860|FG002|Treatment Period|Adverse Event|0|||
160558062|NCT04722991|579766395|FG001|Overall Study|Withdrawal cirterion met|2|||
160558063|NCT04722991|579766394|FG000|Overall Study|Other|1|||
160558064|NCT04722991|579766395|FG001|Overall Study|Other|0|||
160558065|NCT04722991|579766394|FG000|Overall Study|Non-compliance|0|||
160558066|NCT04722991|579766395|FG001|Overall Study|Non-compliance|1|||
160558067|NCT04722991|579766394|FG000|Overall Study|Withdrawal by Subject|0|||
160558068|NCT04722991|579766395|FG001|Overall Study|Withdrawal by Subject|1|||
160558069|NCT03186989|579766396|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
160558070|NCT03186989|579766397|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
160558071|NCT03186989|579766398|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
160558072|NCT03186989|579766399|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
160558073|NCT03186989|579766400|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
160558074|NCT03186989|579766401|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
160558075|NCT03186989|579766402|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
160828601|NCT01352741|580759837|FG000|Double-blind Comparative Period|Adverse Event|16|||
160828602|NCT01352741|580759838|FG001|Double-blind Comparative Period|Adverse Event|17|||
160828603|NCT01352741|580759837|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
160558076|NCT03186989|579766403|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
160558077|NCT03186989|579766404|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
160558078|NCT03186989|579766405|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
160558079|NCT03186989|579766406|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
160558080|NCT03186989|579766396|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160558081|NCT03186989|579766397|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160558082|NCT03186989|579766398|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160558083|NCT03186989|579766399|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160558084|NCT03186989|579766400|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160558085|NCT03186989|579766401|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
160558086|NCT03186989|579766402|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160558087|NCT03186989|579766403|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160558088|NCT03186989|579766404|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160558089|NCT03186989|579766405|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160558090|NCT03186989|579766406|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160558091|NCT03186989|579766396|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
160558092|NCT03186989|579766397|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
160558093|NCT03186989|579766398|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
160558094|NCT03186989|579766399|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
160558095|NCT03186989|579766400|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
160558096|NCT03186989|579766401|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
160558097|NCT03186989|579766402|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
160558098|NCT03186989|579766403|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
160558099|NCT03186989|579766404|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
160558100|NCT03186989|579766405|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
160558101|NCT03186989|579766406|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
160558102|NCT03186989|579766396|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
160558103|NCT03186989|579766397|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
160558104|NCT03186989|579766398|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
160558105|NCT03186989|579766399|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
160558106|NCT03186989|579766400|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
160558107|NCT03186989|579766401|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
160558108|NCT03186989|579766402|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
160558109|NCT03186989|579766403|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
160558110|NCT03186989|579766404|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
160558111|NCT03186989|579766405|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
160558112|NCT03186989|579766406|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
160558113|NCT02246621|579766410|FG000|Overall Study|Withdrawal by Subject|28|||
160558114|NCT02246621|579766411|FG001|Overall Study|Withdrawal by Subject|16|||
160558115|NCT02246621|579766410|FG000|Overall Study|Lost to Follow-up|1|||
160558116|NCT02246621|579766411|FG001|Overall Study|Lost to Follow-up|0|||
160558117|NCT02246621|579766410|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
160558118|NCT02246621|579766411|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
160558119|NCT01583374|579766415|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
160558120|NCT01583374|579766416|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
160558121|NCT01583374|579766417|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
160558122|NCT01583374|579766418|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160558123|NCT01583374|579766419|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160558124|NCT01583374|579766420|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160558125|NCT01583374|579766421|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160558126|NCT01583374|579766422|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160558127|NCT01583374|579766423|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160558128|NCT01583374|579766415|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
160558129|NCT01583374|579766416|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
160558130|NCT01583374|579766417|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
160558131|NCT01583374|579766418|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160558132|NCT01583374|579766419|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160558133|NCT01583374|579766420|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160558134|NCT01583374|579766421|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160558135|NCT01583374|579766422|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160558136|NCT01583374|579766423|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160558137|NCT01583374|579766415|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
160558138|NCT01583374|579766416|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
160558139|NCT01583374|579766417|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160558140|NCT01583374|579766418|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160558141|NCT01583374|579766419|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160558142|NCT01583374|579766420|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160558143|NCT01583374|579766421|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160558144|NCT01583374|579766422|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160558145|NCT01583374|579766423|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160558146|NCT01583374|579766415|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
160558147|NCT01583374|579766416|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
160828604|NCT01352741|580759838|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
160828605|NCT01352741|580759837|FG000|Double-blind Comparative Period|Death|0|||
160828606|NCT01352741|580759838|FG001|Double-blind Comparative Period|Death|1|||
160902856|NCT02100514|581037861|FG003|Treatment Period|Adverse Event|0|||
160902857|NCT02100514|581037862|FG004|Treatment Period|Adverse Event|0|||
160902858|NCT02100514|581037858|FG000|Treatment Period|Death|2|||
160902859|NCT02100514|581037859|FG001|Treatment Period|Death|2|||
160902860|NCT02100514|581037860|FG002|Treatment Period|Death|0|||
160902861|NCT02100514|581037861|FG003|Treatment Period|Death|0|||
160902862|NCT02100514|581037862|FG004|Treatment Period|Death|0|||
160902863|NCT02100514|581037858|FG000|Treatment Period|Lost to Follow-up|5|||
160902864|NCT02100514|581037859|FG001|Treatment Period|Lost to Follow-up|17|||
160902865|NCT02100514|581037860|FG002|Treatment Period|Lost to Follow-up|0|||
160902866|NCT02100514|581037861|FG003|Treatment Period|Lost to Follow-up|0|||
160902867|NCT02100514|581037862|FG004|Treatment Period|Lost to Follow-up|0|||
160902868|NCT02100514|581037858|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
160902869|NCT02100514|581037859|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
160902870|NCT02100514|581037860|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
160902871|NCT02100514|581037861|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
160902872|NCT02100514|581037862|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
160902873|NCT02100514|581037858|FG000|Treatment Period|Protocol Violation|1|||
160902874|NCT02100514|581037859|FG001|Treatment Period|Protocol Violation|1|||
160902875|NCT02100514|581037860|FG002|Treatment Period|Protocol Violation|0|||
160902876|NCT02100514|581037861|FG003|Treatment Period|Protocol Violation|0|||
160902877|NCT02100514|581037862|FG004|Treatment Period|Protocol Violation|0|||
160902878|NCT02100514|581037858|FG000|Treatment Period|Withdrawal by Subject|12|||
160902879|NCT02100514|581037859|FG001|Treatment Period|Withdrawal by Subject|37|||
160902880|NCT02100514|581037860|FG002|Treatment Period|Withdrawal by Subject|0|||
160902881|NCT02100514|581037861|FG003|Treatment Period|Withdrawal by Subject|0|||
160902882|NCT02100514|581037862|FG004|Treatment Period|Withdrawal by Subject|0|||
160902883|NCT02100514|581037858|FG000|Treatment Period|Other|9|||
160902884|NCT02100514|581037859|FG001|Treatment Period|Other|11|||
160902885|NCT02100514|581037860|FG002|Treatment Period|Other|0|||
160902886|NCT02100514|581037861|FG003|Treatment Period|Other|0|||
160902887|NCT02100514|581037862|FG004|Treatment Period|Other|0|||
160902888|NCT02100514|581037858|FG000|Extension Period|Withdrew consent|0|||
160902889|NCT02100514|581037859|FG001|Extension Period|Withdrew consent|0|||
160902890|NCT02100514|581037860|FG002|Extension Period|Withdrew consent|2|||
160902891|NCT02100514|581037861|FG003|Extension Period|Withdrew consent|0|||
160902892|NCT02100514|581037862|FG004|Extension Period|Withdrew consent|0|||
160558148|NCT01583374|579766417|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
160558149|NCT01583374|579766418|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160828607|NCT01352741|580759837|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
160828608|NCT01352741|580759838|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
160828609|NCT01352741|580759837|FG000|Double-blind Comparative Period|Other|1|||
160828610|NCT01352741|580759838|FG001|Double-blind Comparative Period|Other|2|||
160828611|NCT01352741|580759837|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
160828612|NCT01352741|580759838|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
160828613|NCT01352741|580759837|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
160828614|NCT01352741|580759838|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
160828615|NCT01352741|580759837|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
160828616|NCT01352741|580759838|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
160902893|NCT01896102|581037863|FG000|Overall Study|Death|1|||
160902894|NCT01896102|581037863|FG000|Overall Study|Participant to receive allogenic transplant|2|||
160902895|NCT01145625|581037864|FG000|Overall Study|Lost to Follow-up|8|||
160902896|NCT01145625|581037865|FG001|Overall Study|Lost to Follow-up|9|||
160902897|NCT01145625|581037864|FG000|Overall Study|Adverse Event|6|||
160902898|NCT01145625|581037865|FG001|Overall Study|Adverse Event|4|||
160902899|NCT01145625|581037864|FG000|Overall Study|Protocol Violation|3|||
160902900|NCT01145625|581037865|FG001|Overall Study|Protocol Violation|1|||
160902901|NCT01145625|581037864|FG000|Overall Study|Withdrawal by Subject|7|||
160558150|NCT01583374|579766419|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160558151|NCT01583374|579766420|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160558152|NCT01583374|579766421|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160558153|NCT01583374|579766422|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160558154|NCT01583374|579766423|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160558155|NCT01583374|579766415|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
160558156|NCT01583374|579766416|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
160558157|NCT01583374|579766417|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
160558158|NCT01583374|579766418|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
160558159|NCT01583374|579766419|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
160558160|NCT01583374|579766420|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
160558161|NCT01583374|579766421|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
160558162|NCT01583374|579766422|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
160558163|NCT01583374|579766423|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
160558164|NCT01583374|579766415|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160558165|NCT01583374|579766416|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160558166|NCT01583374|579766417|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
160558167|NCT01583374|579766418|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160558168|NCT01583374|579766419|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160558169|NCT01583374|579766420|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160558170|NCT01583374|579766421|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160558171|NCT01583374|579766422|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160558172|NCT01583374|579766423|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160558173|NCT01583374|579766415|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
160558174|NCT01583374|579766416|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
160558175|NCT01583374|579766417|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
160558176|NCT01583374|579766418|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
160558177|NCT01583374|579766419|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
160558178|NCT01583374|579766420|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
160558179|NCT01583374|579766421|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
160558180|NCT01583374|579766422|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
160558181|NCT01583374|579766423|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
160558182|NCT01583374|579766415|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
160558183|NCT01583374|579766416|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
160558184|NCT01583374|579766417|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
160558185|NCT01583374|579766418|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
160558186|NCT01583374|579766419|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
160558187|NCT01583374|579766420|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
160558188|NCT01583374|579766421|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
160558189|NCT01583374|579766422|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
160902902|NCT01145625|581037865|FG001|Overall Study|Withdrawal by Subject|16|||
160902903|NCT01145625|581037864|FG000|Overall Study|Pregnancy|0|||
160558190|NCT01583374|579766423|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
160558191|NCT01583374|579766415|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
160902904|NCT01145625|581037865|FG001|Overall Study|Pregnancy|1|||
160558192|NCT01583374|579766416|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
160558193|NCT01583374|579766417|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
160558194|NCT01583374|579766418|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
160558195|NCT01583374|579766419|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
160558196|NCT01583374|579766420|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
160558197|NCT01583374|579766421|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
160558198|NCT01583374|579766422|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
160558199|NCT01583374|579766423|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
160558200|NCT01583374|579766415|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
160558201|NCT01583374|579766416|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
160558202|NCT01583374|579766417|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
160558203|NCT01583374|579766418|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
160558204|NCT01583374|579766419|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
160558205|NCT01583374|579766420|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
160558206|NCT01583374|579766421|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
160558207|NCT01583374|579766422|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
160558208|NCT01583374|579766423|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
160558209|NCT01583374|579766415|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
160558210|NCT01583374|579766416|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
160558211|NCT01583374|579766417|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
160558212|NCT01583374|579766418|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
160558213|NCT01583374|579766419|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
160558214|NCT01583374|579766420|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
160558215|NCT01583374|579766421|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
160558216|NCT01583374|579766422|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
160558217|NCT01583374|579766423|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
160558218|NCT01583374|579766415|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160558219|NCT01583374|579766416|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160558220|NCT01583374|579766417|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
160558221|NCT01583374|579766418|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160558222|NCT01583374|579766419|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
160558223|NCT01583374|579766420|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
160558224|NCT01583374|579766421|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160558225|NCT01583374|579766422|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160558226|NCT01583374|579766423|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160558227|NCT01583374|579766415|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
160558228|NCT01583374|579766416|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
160558229|NCT01583374|579766417|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
160558230|NCT01583374|579766418|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
160558231|NCT01583374|579766419|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
160558232|NCT01583374|579766420|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
160558233|NCT01583374|579766421|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
160558234|NCT01583374|579766422|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
160558235|NCT01583374|579766423|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
160558236|NCT01583374|579766415|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
160558237|NCT01583374|579766416|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
160558238|NCT01583374|579766417|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
160558239|NCT01583374|579766418|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
160558240|NCT01583374|579766419|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
160558241|NCT01583374|579766420|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
160558242|NCT01583374|579766421|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
160558243|NCT01583374|579766422|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
160558244|NCT01583374|579766423|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
160558245|NCT01583374|579766415|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
160558246|NCT01583374|579766416|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
160558247|NCT01583374|579766417|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
160558248|NCT01583374|579766418|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
160558249|NCT01583374|579766419|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
160558250|NCT01583374|579766420|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
160558251|NCT01583374|579766421|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
160902905|NCT01751178|581037867|FG000|Overall Study|Adverse Event|2|||
160902906|NCT01751178|581037868|FG001|Overall Study|Adverse Event|0|||
160558252|NCT01583374|579766422|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
160558253|NCT01583374|579766423|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
160558254|NCT01583374|579766415|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
160558255|NCT01583374|579766416|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
160558256|NCT01583374|579766417|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
160558257|NCT01583374|579766418|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
160558258|NCT01583374|579766419|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
160558259|NCT01583374|579766420|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
160558260|NCT01583374|579766421|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
160558261|NCT01583374|579766422|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
160558262|NCT01583374|579766423|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
160558263|NCT01583374|579766415|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
160558264|NCT01583374|579766416|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
160558265|NCT01583374|579766417|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
160558266|NCT01583374|579766418|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
160558267|NCT01583374|579766419|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
160558268|NCT01583374|579766420|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
160558269|NCT01583374|579766421|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
160558270|NCT01583374|579766422|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
160558271|NCT01583374|579766423|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
160558272|NCT01583374|579766415|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
160558273|NCT01583374|579766416|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
160558274|NCT01583374|579766417|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
160558275|NCT01583374|579766418|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
160558276|NCT01583374|579766419|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
160558277|NCT01583374|579766420|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
160558278|NCT01583374|579766421|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
160558279|NCT01583374|579766422|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
160558280|NCT01583374|579766423|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
160558281|NCT01583374|579766415|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
160558282|NCT01583374|579766416|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
160558283|NCT01583374|579766417|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
160558284|NCT01583374|579766418|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
160558285|NCT01583374|579766419|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
160558286|NCT01583374|579766420|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
160558287|NCT01583374|579766421|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
160558288|NCT01583374|579766422|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
160558289|NCT01583374|579766423|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
160558290|NCT01292057|579766426|FG000|Overall Study|Protocol Violation|1|||
160558291|NCT01292057|579766427|FG001|Overall Study|Protocol Violation|1|||
160558292|NCT01292057|579766426|FG000|Overall Study|Lost to Follow-up|1|||
160558293|NCT01292057|579766427|FG001|Overall Study|Lost to Follow-up|1|||
160558294|NCT00821678|579766429|FG000|Overall Study|Withdrawal by Subject|8|||
160828617|NCT01352741|580759837|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
160828618|NCT01352741|580759838|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
160828619|NCT04070326|580759840|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
160828620|NCT04070326|580759841|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
160828621|NCT00645528|580759842|FG000|Overall Study|Did not show up for Visit 2|7|||
160828622|NCT03077698|580759843|FG000|Progestin Monotherapy|Stable Disease|8|||
160828623|NCT03077698|580759844|FG001|Progestin Monotherapy|Stable Disease|0|||
160828624|NCT03077698|580759843|FG000|Progestin Monotherapy|Adverse Event|1|||
160902907|NCT01751178|581037869|FG002|Overall Study|Adverse Event|0|||
160902908|NCT01751178|581037867|FG000|Overall Study|Other Reason (unknown)|1|||
160558295|NCT00821678|579766430|FG001|Overall Study|Withdrawal by Subject|0|||
160558296|NCT00821678|579766429|FG000|Overall Study|Lost to Follow-up|13|||
160558297|NCT00821678|579766430|FG001|Overall Study|Lost to Follow-up|12|||
160558298|NCT00821678|579766429|FG000|Overall Study|Death|0|||
160558299|NCT00821678|579766430|FG001|Overall Study|Death|2|||
160558300|NCT03641560|579766440|FG000|Overall Study|Withdrawal by Subject|6|||
160558301|NCT03641560|579766440|FG000|Overall Study|Progressive disease|40|||
160558302|NCT03641560|579766440|FG000|Overall Study|Death|6|||
160558303|NCT02732951|579767909|FG000|Overall Study|Other than listed|1|||
160558304|NCT02732951|579767910|FG001|Overall Study|Other than listed|0|||
160558305|NCT02732951|579767909|FG000|Overall Study|Lost to Follow-up|0|||
160558306|NCT02732951|579767910|FG001|Overall Study|Lost to Follow-up|1|||
160558307|NCT02732951|579767909|FG000|Overall Study|Adverse Event|4|||
160558308|NCT02732951|579767910|FG001|Overall Study|Adverse Event|4|||
160558309|NCT02732951|579767909|FG000|Overall Study|Protocol Violation|0|||
160558310|NCT02732951|579767910|FG001|Overall Study|Protocol Violation|1|||
160558311|NCT03658889|579767915|FG000|Overall Study|Protocol Violation|2|||
160558312|NCT03658889|579767916|FG001|Overall Study|Protocol Violation|0|||
160558313|NCT01524991|579767921|FG000|Overall Study|Adverse Event|12|||
160558314|NCT01524991|579767921|FG000|Overall Study|Death|1|||
160558315|NCT01524991|579767921|FG000|Overall Study|Disease ProgressionDu|17|||
160828625|NCT03077698|580759844|FG001|Progestin Monotherapy|Adverse Event|0|||
160828626|NCT03077698|580759843|FG000|Progestin Monotherapy|Death|1|||
160828627|NCT03077698|580759844|FG001|Progestin Monotherapy|Death|0|||
160828628|NCT03077698|580759843|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
160828629|NCT03077698|580759844|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
160828630|NCT03077698|580759843|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
160828631|NCT03077698|580759844|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
160828632|NCT03077698|580759843|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
160828633|NCT03077698|580759844|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
160828634|NCT03077698|580759843|FG000|Safety Follow Up|Withdrawal by Subject|2|||
160828635|NCT03077698|580759844|FG001|Safety Follow Up|Withdrawal by Subject|1|||
160828636|NCT03077698|580759843|FG000|Safety Follow Up|Transfer of care to hospice|1|||
160828637|NCT03077698|580759844|FG001|Safety Follow Up|Transfer of care to hospice|0|||
160828638|NCT01886690|580759846|FG000|Overall Study|Protocol Violation|0|||
160828639|NCT01886690|580759847|FG001|Overall Study|Protocol Violation|1|||
160828640|NCT01886690|580759846|FG000|Overall Study|Personal Reasons|0|||
160828641|NCT01886690|580759847|FG001|Overall Study|Personal Reasons|1|||
160828642|NCT01140568|580759848|FG000|Overall Study|disease progression|31|||
160828643|NCT01140568|580759848|FG000|Overall Study|Withdrawal by Subject|1|||
160828644|NCT01140568|580759848|FG000|Overall Study|Screen Fail|4|||
160828645|NCT03618628|580759849|FG000|Overall Study|Death|1|||
160828646|NCT03618628|580759849|FG000|Overall Study|Lost to Follow-up|1|||
160828647|NCT01969500|580759850|FG000|Overall Study|Death|0|||
160828648|NCT01969500|580759851|FG001|Overall Study|Death|1|||
160828649|NCT01969500|580759850|FG000|Overall Study|extended hospitalization|1|||
160828650|NCT01969500|580759851|FG001|Overall Study|extended hospitalization|1|||
160828651|NCT02193087|580759852|FG000|Overall Study|Adverse Event|2|||
160828652|NCT02193087|580759853|FG001|Overall Study|Adverse Event|0|||
160828653|NCT02193087|580759854|FG002|Overall Study|Adverse Event|0|||
160828654|NCT02193087|580759855|FG003|Overall Study|Adverse Event|11|||
160828655|NCT02193087|580759852|FG000|Overall Study|Lost to Follow-up|14|||
160828656|NCT02193087|580759853|FG001|Overall Study|Lost to Follow-up|6|||
160828657|NCT02193087|580759854|FG002|Overall Study|Lost to Follow-up|4|||
160828658|NCT02193087|580759855|FG003|Overall Study|Lost to Follow-up|37|||
160828659|NCT02193087|580759852|FG000|Overall Study|Protocol Violation|2|||
160828660|NCT02193087|580759853|FG001|Overall Study|Protocol Violation|0|||
160828661|NCT02193087|580759854|FG002|Overall Study|Protocol Violation|1|||
160828662|NCT02193087|580759855|FG003|Overall Study|Protocol Violation|2|||
160828663|NCT02193087|580759852|FG000|Overall Study|Withdrawal by Subject|10|||
160828664|NCT02193087|580759853|FG001|Overall Study|Withdrawal by Subject|3|||
160828665|NCT02193087|580759854|FG002|Overall Study|Withdrawal by Subject|1|||
160828666|NCT02193087|580759855|FG003|Overall Study|Withdrawal by Subject|19|||
160828667|NCT02193087|580759852|FG000|Overall Study|Other Reason Not Specified|7|||
160828668|NCT02193087|580759853|FG001|Overall Study|Other Reason Not Specified|2|||
160828669|NCT02193087|580759854|FG002|Overall Study|Other Reason Not Specified|1|||
160828670|NCT02193087|580759855|FG003|Overall Study|Other Reason Not Specified|9|||
160828671|NCT02193087|580759852|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
160828672|NCT02193087|580759853|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
160828673|NCT02193087|580759854|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
160828674|NCT02193087|580759855|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
160828675|NCT04096820|580759856|FG000|Overall Study|Did not return for intervention|2|||
160828676|NCT04096820|580759856|FG000|Overall Study|Death|1|||
160828677|NCT02463032|580759857|FG000|Overall Study|Lack of Efficacy|61|||
160828678|NCT02463032|580759858|FG001|Overall Study|Lack of Efficacy|50|||
160558316|NCT01524991|579767921|FG000|Overall Study|Other complicating disease|1|||
160558317|NCT01524991|579767921|FG000|Overall Study|Withdrawal by Subject|2|||
160558318|NCT01524991|579767921|FG000|Overall Study|Symptomatic Deterioration|1|||
160558319|NCT01805180|579767922|FG000|Lead-in Donor Phase|screen failure|1|||
160558320|NCT01805180|579767923|FG001|Lead-in Donor Phase|screen failure|0|||
160558321|NCT01805180|579767924|FG002|Lead-in Donor Phase|screen failure|0|||
160558322|NCT01254669|579767927|FG000|Overall Study|Withdrawal by Subject|0|||
160558323|NCT01254669|579767928|FG001|Overall Study|Withdrawal by Subject|1|||
160558324|NCT01254669|579767927|FG000|Overall Study|time constraint|2|||
160558325|NCT01254669|579767928|FG001|Overall Study|time constraint|2|||
160558326|NCT01254669|579767927|FG000|Overall Study|called to clinic during intervention|1|||
160558327|NCT01254669|579767928|FG001|Overall Study|called to clinic during intervention|1|||
160558328|NCT00103012|579767929|FG000|Overall Study|Withdrawal by Subject|2|||
160558329|NCT00103012|579767930|FG001|Overall Study|Withdrawal by Subject|1|||
160558330|NCT00103012|579767931|FG002|Overall Study|Withdrawal by Subject|2|||
160558331|NCT00103012|579767929|FG000|Overall Study|Pregnancy|1|||
160558332|NCT00103012|579767930|FG001|Overall Study|Pregnancy|0|||
160558333|NCT00103012|579767931|FG002|Overall Study|Pregnancy|0|||
160558334|NCT00103012|579767929|FG000|Overall Study|Adverse Event|0|||
160558335|NCT00103012|579767930|FG001|Overall Study|Adverse Event|0|||
160558336|NCT00103012|579767931|FG002|Overall Study|Adverse Event|1|||
160990712|NCT00372060|581353925|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
160558337|NCT00103012|579767929|FG000|Overall Study|Subject non-compliant with medications|0|||
160558338|NCT00103012|579767930|FG001|Overall Study|Subject non-compliant with medications|0|||
160558339|NCT00103012|579767931|FG002|Overall Study|Subject non-compliant with medications|1|||
160558340|NCT00393718|579767941|FG000|Overall Study|Adverse Event|20|||
160558341|NCT00393718|579767942|FG001|Overall Study|Adverse Event|8|||
160558342|NCT00393718|579767941|FG000|Overall Study|Protocol Violation|1|||
160558343|NCT00393718|579767942|FG001|Overall Study|Protocol Violation|2|||
160558344|NCT00393718|579767941|FG000|Overall Study|Lack of Efficacy|10|||
160558345|NCT00393718|579767942|FG001|Overall Study|Lack of Efficacy|9|||
160558346|NCT00393718|579767941|FG000|Overall Study|Hypoglycaemia|3|||
160558347|NCT00393718|579767942|FG001|Overall Study|Hypoglycaemia|2|||
160558348|NCT00393718|579767941|FG000|Overall Study|Subject decision|5|||
160558349|NCT00393718|579767942|FG001|Overall Study|Subject decision|0|||
160558350|NCT00393718|579767941|FG000|Overall Study|Withdrawal of consent|2|||
160558351|NCT00393718|579767942|FG001|Overall Study|Withdrawal of consent|1|||
160558352|NCT00393718|579767941|FG000|Overall Study|Missed measurement|1|||
160558353|NCT00393718|579767942|FG001|Overall Study|Missed measurement|0|||
160558354|NCT00393718|579767941|FG000|Overall Study|Move|1|||
160558355|NCT00393718|579767942|FG001|Overall Study|Move|0|||
160558356|NCT01084551|579767944|FG000|Overall Study|Adverse Event|2|||
160558357|NCT01084551|579767945|FG001|Overall Study|Adverse Event|9|||
160558358|NCT01084551|579767946|FG002|Overall Study|Adverse Event|4|||
160558359|NCT01084551|579767944|FG000|Overall Study|Lack of Efficacy|2|||
160558360|NCT01084551|579767945|FG001|Overall Study|Lack of Efficacy|0|||
160558361|NCT01084551|579767946|FG002|Overall Study|Lack of Efficacy|1|||
160558362|NCT01084551|579767944|FG000|Overall Study|Withdrawal by Subject|2|||
160558363|NCT01084551|579767945|FG001|Overall Study|Withdrawal by Subject|1|||
160558364|NCT01084551|579767946|FG002|Overall Study|Withdrawal by Subject|0|||
160558365|NCT01084551|579767944|FG000|Overall Study|Protocol Violation|2|||
160558366|NCT01084551|579767945|FG001|Overall Study|Protocol Violation|4|||
160558367|NCT01084551|579767946|FG002|Overall Study|Protocol Violation|0|||
160558368|NCT01084551|579767944|FG000|Overall Study|Lost to Follow-up|0|||
160558369|NCT01084551|579767945|FG001|Overall Study|Lost to Follow-up|0|||
160558370|NCT01084551|579767946|FG002|Overall Study|Lost to Follow-up|3|||
160558371|NCT01084551|579767944|FG000|Overall Study|Physician Decision|1|||
160558372|NCT01084551|579767945|FG001|Overall Study|Physician Decision|0|||
160558373|NCT01084551|579767946|FG002|Overall Study|Physician Decision|0|||
160558374|NCT03902080|579767947|FG000|Overall Study|Adverse Event|17|||
160558375|NCT03902080|579767948|FG001|Overall Study|Adverse Event|15|||
160558376|NCT03902080|579767947|FG000|Overall Study|Withdrawal by Subject|28|||
160558377|NCT03902080|579767948|FG001|Overall Study|Withdrawal by Subject|35|||
160558378|NCT03902080|579767947|FG000|Overall Study|Lost to Follow-up|6|||
160558379|NCT03902080|579767948|FG001|Overall Study|Lost to Follow-up|7|||
160558380|NCT03902080|579767947|FG000|Overall Study|Other|3|||
160558381|NCT03902080|579767948|FG001|Overall Study|Other|5|||
160558382|NCT03902080|579767947|FG000|Overall Study|Non compliance|4|||
160558383|NCT03902080|579767948|FG001|Overall Study|Non compliance|3|||
160558384|NCT03902080|579767947|FG000|Overall Study|Physician Decision|5|||
160558385|NCT03902080|579767948|FG001|Overall Study|Physician Decision|1|||
160558386|NCT03902080|579767947|FG000|Overall Study|Protocol Violation|3|||
160558387|NCT03902080|579767948|FG001|Overall Study|Protocol Violation|3|||
160558388|NCT03902080|579767947|FG000|Overall Study|Lack of Efficacy|1|||
160558389|NCT03902080|579767948|FG001|Overall Study|Lack of Efficacy|3|||
160558390|NCT03902080|579767947|FG000|Overall Study|Withdrawn prior to dosing|0|||
160558391|NCT03902080|579767948|FG001|Overall Study|Withdrawn prior to dosing|1|||
160558392|NCT04684420|579767949|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160558393|NCT04684420|579767950|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160558394|NCT04684420|579767951|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
160558395|NCT04684420|579767952|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
160558396|NCT04684420|579767949|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
160558397|NCT04684420|579767950|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
160558398|NCT04684420|579767951|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
160558399|NCT04684420|579767952|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
160558400|NCT00463476|579767953|FG000|Overall Study|Withdrawal by Subject|1|||
160558401|NCT00463476|579767954|FG001|Overall Study|Withdrawal by Subject|2|||
160558402|NCT00463476|579767953|FG000|Overall Study|Lost to Follow-up|1|||
160558403|NCT00463476|579767954|FG001|Overall Study|Lost to Follow-up|1|||
160558404|NCT01703000|579767957|FG000|Overall Study|Death|1|||
160558405|NCT01061008|579767960|FG000|Overall Study|Badiocephalic fistula failed|3|||
160558406|NCT01061008|579767961|FG001|Overall Study|Badiocephalic fistula failed|2|||
160558407|NCT01061008|579767960|FG000|Overall Study|Death|1|||
160558408|NCT01061008|579767961|FG001|Overall Study|Death|0|||
160558409|NCT01061008|579767960|FG000|Overall Study|Withdrawal by Subject|1|||
160558410|NCT01061008|579767961|FG001|Overall Study|Withdrawal by Subject|3|||
160558411|NCT01061008|579767960|FG000|Overall Study|Unable to exercise following surgery|1|||
160558412|NCT01061008|579767961|FG001|Overall Study|Unable to exercise following surgery|0|||
160558413|NCT01061008|579767960|FG000|Overall Study|Adverse Event|0|||
160558414|NCT01061008|579767961|FG001|Overall Study|Adverse Event|1|||
160558415|NCT04067518|579767966|FG000|Overall Study|Adverse Event|1|||
160558416|NCT04067518|579767967|FG001|Overall Study|Adverse Event|3|||
160558417|NCT04067518|579767966|FG000|Overall Study|Screen failures|0|||
160558418|NCT04067518|579767967|FG001|Overall Study|Screen failures|1|||
160558419|NCT04067518|579767966|FG000|Overall Study|Enrolled but not treated|0|||
160902909|NCT01751178|581037868|FG001|Overall Study|Other Reason (unknown)|0|||
160902910|NCT01751178|581037869|FG002|Overall Study|Other Reason (unknown)|2|||
160902911|NCT04289623|581037870|FG000|Wave 1 Emails|Email was not delivered|268|||
160902912|NCT04289623|581037871|FG001|Wave 1 Emails|Email was not delivered|257|||
160902913|NCT04289623|581037872|FG002|Wave 1 Emails|Email was not delivered|0|||
160902914|NCT04289623|581037873|FG003|Wave 1 Emails|Email was not delivered|0|||
160902915|NCT04289623|581037874|FG004|Wave 1 Emails|Email was not delivered|0|||
160902916|NCT04289623|581037875|FG005|Wave 1 Emails|Email was not delivered|0|||
160902917|NCT04138810|581037882|FG000|Overall Study|Withdrawal by Subject|0|||
160902918|NCT04138810|581037883|FG001|Overall Study|Withdrawal by Subject|1|||
160902919|NCT04138810|581037882|FG000|Overall Study|Subject cancelled surgery|1|||
160902920|NCT04138810|581037883|FG001|Overall Study|Subject cancelled surgery|0|||
160902921|NCT00696800|581037884|FG000|Overall Study|Adverse Event|16|||
160902922|NCT00696800|581037885|FG001|Overall Study|Adverse Event|3|||
160902923|NCT00696800|581037884|FG000|Overall Study|Insufficient compliance with medication|2|||
160902924|NCT00696800|581037885|FG001|Overall Study|Insufficient compliance with medication|1|||
160902925|NCT00696800|581037884|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
160902926|NCT00696800|581037885|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
160902927|NCT00696800|581037884|FG000|Overall Study|Insufficient ovarian response|4|||
160902928|NCT00696800|581037885|FG001|Overall Study|Insufficient ovarian response|1|||
160902929|NCT00696800|581037884|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
160902930|NCT00696800|581037885|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
160902931|NCT00696800|581037884|FG000|Overall Study|Too high ovarian response|6|||
160902932|NCT00696800|581037885|FG001|Overall Study|Too high ovarian response|1|||
160902933|NCT00696800|581037884|FG000|Overall Study|No/too few/bad quality oocytes|4|||
160902934|NCT00696800|581037885|FG001|Overall Study|No/too few/bad quality oocytes|3|||
160902935|NCT00696800|581037884|FG000|Overall Study|No/abnormal fertilization|11|||
160902936|NCT00696800|581037885|FG001|Overall Study|No/abnormal fertilization|13|||
160902937|NCT00696800|581037884|FG000|Overall Study|No/too few/bad quality embryos|24|||
160902938|NCT00696800|581037885|FG001|Overall Study|No/too few/bad quality embryos|18|||
160902939|NCT00696800|581037884|FG000|Overall Study|Other Reasons|5|||
160902940|NCT00696800|581037885|FG001|Overall Study|Other Reasons|3|||
160902941|NCT00696800|581037884|FG000|Overall Study|Not treated|1|||
160902942|NCT00696800|581037885|FG001|Overall Study|Not treated|2|||
160902943|NCT00591344|581037886|FG000|Overall Study|Transportation issues|1|||
160902944|NCT00591344|581037887|FG001|Overall Study|Transportation issues|0|||
160902945|NCT00591344|581037886|FG000|Overall Study|Moved out of state|1|||
160902946|NCT00591344|581037887|FG001|Overall Study|Moved out of state|0|||
160902947|NCT00591344|581037886|FG000|Overall Study|Medical complications|1|||
160902948|NCT00591344|581037887|FG001|Overall Study|Medical complications|3|||
160902949|NCT00591344|581037886|FG000|Overall Study|Underwent DBS|2|||
160902950|NCT00591344|581037887|FG001|Overall Study|Underwent DBS|2|||
160902951|NCT00591344|581037886|FG000|Overall Study|Death|0|||
160902952|NCT00591344|581037887|FG001|Overall Study|Death|1|||
160902953|NCT00591344|581037886|FG000|Overall Study|Lost to Follow-up|0|||
160902954|NCT00591344|581037887|FG001|Overall Study|Lost to Follow-up|1|||
160902955|NCT00591344|581037886|FG000|Overall Study|Did not want to come off medication|0|||
160902956|NCT00591344|581037887|FG001|Overall Study|Did not want to come off medication|1|||
160902957|NCT00493025|581037888|FG000|Overall Study|Physician Decision|19|||
160902958|NCT02435147|581037890|FG000|Overall Study|non-evaluable DXA scan|11|||
160902959|NCT02939079|581037891|FG000|Overall Study|Adverse Event|2|||
160902960|NCT02939079|581037892|FG001|Overall Study|Adverse Event|1|||
160902961|NCT02939079|581037891|FG000|Overall Study|Lost to Follow-up|0|||
160902962|NCT02939079|581037892|FG001|Overall Study|Lost to Follow-up|2|||
160902963|NCT02939079|581037891|FG000|Overall Study|Protocol Violation|1|||
160902964|NCT02939079|581037892|FG001|Overall Study|Protocol Violation|0|||
160902965|NCT02939079|581037891|FG000|Overall Study|Withdrawal by Subject|0|||
160902966|NCT02939079|581037892|FG001|Overall Study|Withdrawal by Subject|1|||
160902967|NCT02939079|581037891|FG000|Overall Study|relapse during the study|1|||
160902968|NCT02939079|581037892|FG001|Overall Study|relapse during the study|1|||
160558420|NCT04067518|579767967|FG001|Overall Study|Enrolled but not treated|1|||
160558421|NCT03624946|579767968|FG000|Overall Study|Lost to Follow-up|0|||
160558422|NCT03624946|579767969|FG001|Overall Study|Lost to Follow-up|1|||
160558423|NCT00862251|579767970|FG000|Overall Study|Adverse Event|8|||
160558424|NCT00862251|579767971|FG001|Overall Study|Adverse Event|3|||
160558425|NCT00862251|579767972|FG002|Overall Study|Adverse Event|1|||
160558426|NCT00862251|579767970|FG000|Overall Study|Lost to Follow-up|0|||
160558427|NCT00862251|579767971|FG001|Overall Study|Lost to Follow-up|0|||
160558428|NCT00862251|579767972|FG002|Overall Study|Lost to Follow-up|1|||
160558429|NCT00862251|579767970|FG000|Overall Study|Protocol Violation|2|||
160558430|NCT00862251|579767971|FG001|Overall Study|Protocol Violation|0|||
160558431|NCT00862251|579767972|FG002|Overall Study|Protocol Violation|1|||
160558432|NCT00862251|579767970|FG000|Overall Study|Withdrawal by Subject|9|||
160558433|NCT00862251|579767971|FG001|Overall Study|Withdrawal by Subject|2|||
160558434|NCT00862251|579767972|FG002|Overall Study|Withdrawal by Subject|6|||
160558435|NCT00624520|579767973|FG000|Overall Study|Withdrawal by Subject|12|||
160558436|NCT00624520|579767974|FG001|Overall Study|Withdrawal by Subject|7|||
160558437|NCT00624520|579767973|FG000|Overall Study|Death|0|||
160558438|NCT00624520|579767974|FG001|Overall Study|Death|1|||
160558439|NCT02796755|579767975|FG000|Overall Study|Adverse Event|2|||
160558440|NCT02796755|579767976|FG001|Overall Study|Adverse Event|0|||
160558441|NCT00675025|579767977|FG000|Overall Study|Study Terminated by Sponsor|38|||
160558442|NCT00675025|579767978|FG001|Overall Study|Study Terminated by Sponsor|42|||
160558443|NCT00675025|579767977|FG000|Overall Study|Adverse Event|6|||
160558444|NCT00675025|579767978|FG001|Overall Study|Adverse Event|11|||
160558445|NCT00675025|579767977|FG000|Overall Study|Lost to Follow-up|6|||
160558446|NCT00675025|579767978|FG001|Overall Study|Lost to Follow-up|4|||
160558447|NCT00675025|579767977|FG000|Overall Study|Withdrawal by Subject|4|||
160558448|NCT00675025|579767978|FG001|Overall Study|Withdrawal by Subject|6|||
160558449|NCT02347631|579767987|FG000|First Intervention (2 Months)|Adverse Event|1|||
160558450|NCT02347631|579767988|FG001|First Intervention (2 Months)|Adverse Event|1|||
160558451|NCT02347631|579767987|FG000|First Intervention (2 Months)|Pregnancy|1|||
160558452|NCT02347631|579767988|FG001|First Intervention (2 Months)|Pregnancy|0|||
160558453|NCT02347631|579767987|FG000|First Intervention (2 Months)|Moved out of area|0|||
160558454|NCT02347631|579767988|FG001|First Intervention (2 Months)|Moved out of area|2|||
160558455|NCT02347631|579767987|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
160558456|NCT02347631|579767988|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
160558457|NCT02347631|579767987|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
160558458|NCT02347631|579767988|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
160558459|NCT02347631|579767987|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
160558460|NCT02347631|579767988|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
160558461|NCT02347631|579767987|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
160558462|NCT02347631|579767988|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
160558463|NCT02347631|579767987|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
160558464|NCT02347631|579767988|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
160558465|NCT02304926|579767991|FG000|Overall Study|Lost to Follow-up|2|||
160558466|NCT02304926|579767992|FG001|Overall Study|Lost to Follow-up|1|||
160558467|NCT04007159|579767993|FG000|Induction Phase|(missed study visits)|16|||
160558468|NCT04007159|579767993|FG000|Induction Phase|Withdrawal by Subject|4|||
160558469|NCT04007159|579767993|FG000|Induction Phase|Adverse Event|2|||
160558470|NCT04007159|579767993|FG000|Challenge Phase|missed study visits|3|||
160558471|NCT04258579|579767994|FG000|Overall Study|Withdrawal by Subject|7|||
160558472|NCT04258579|579767994|FG000|Overall Study|Lost to Follow-up|3|||
160558473|NCT04258579|579767994|FG000|Overall Study|Protocol Violation|2|||
160558474|NCT04258579|579767994|FG000|Overall Study|Adverse Event|1|||
160558475|NCT02076165|579767997|FG000|Overall Study|Lost to Follow-up|7|||
160558476|NCT02076165|579767998|FG001|Overall Study|Lost to Follow-up|5|||
160558477|NCT02076165|579767997|FG000|Overall Study|Refused follow-up assessment|1|||
160558478|NCT02076165|579767998|FG001|Overall Study|Refused follow-up assessment|1|||
160558479|NCT03804684|579767999|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
160558480|NCT03804684|579768000|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
160902969|NCT01609231|581037893|FG000|Overall Study|Adverse Event|1|||
160902970|NCT01609231|581037894|FG001|Overall Study|Adverse Event|3|||
160558481|NCT02429856|579768001|FG000|Overall Study|Death|12|||
160990713|NCT00372060|581353924|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
160990714|NCT00372060|581353925|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
160990715|NCT00647348|581353926|FG000|Overall Study|Lost to Follow-up|3|||
160990716|NCT00647348|581353927|FG001|Overall Study|Lost to Follow-up|6|||
160990717|NCT03382821|581353931|FG000|Overall Study|Did not receive allocated intervention.|0|||
160990718|NCT03382821|581353932|FG001|Overall Study|Did not receive allocated intervention.|3|||
160990719|NCT00282438|581353933|FG000|Overall Study|Lack of Efficacy|1|||
160990720|NCT00282438|581353934|FG001|Overall Study|Lack of Efficacy|0|||
160990721|NCT00282438|581353933|FG000|Overall Study|Death|0|||
160990722|NCT00282438|581353934|FG001|Overall Study|Death|1|||
160990723|NCT01119703|581353943|FG000|Overall Study|Adverse Event|0|||
160990724|NCT01119703|581353944|FG001|Overall Study|Adverse Event|1|||
160990725|NCT01511250|581353945|FG000|Overall Study|Withdrawal of Consent|1|||
160990726|NCT01511250|581353946|FG001|Overall Study|Withdrawal of Consent|0|||
160990727|NCT01511250|581353947|FG002|Overall Study|Withdrawal of Consent|0|||
160990728|NCT01511250|581353948|FG003|Overall Study|Withdrawal of Consent|0|||
160990729|NCT01511250|581353949|FG004|Overall Study|Withdrawal of Consent|0|||
160558482|NCT02429856|579768002|FG001|Overall Study|Death|13|||
160558483|NCT02429856|579768001|FG000|Overall Study|Lost to Follow-up|6|||
160558484|NCT02429856|579768002|FG001|Overall Study|Lost to Follow-up|5|||
160558485|NCT02429856|579768001|FG000|Overall Study|Withdrawal by Subject|1|||
160558486|NCT02429856|579768002|FG001|Overall Study|Withdrawal by Subject|1|||
160558487|NCT02978222|579768003|FG000|Overall Study|Withdrawal by Subject|2|||
160990730|NCT01511250|581353950|FG005|Overall Study|Withdrawal of Consent|0|||
160990731|NCT01511250|581353951|FG006|Overall Study|Withdrawal of Consent|0|||
160990732|NCT01511250|581353952|FG007|Overall Study|Withdrawal of Consent|1|||
160990733|NCT01511250|581353953|FG008|Overall Study|Withdrawal of Consent|1|||
160990734|NCT01511250|581353954|FG009|Overall Study|Withdrawal of Consent|0|||
160990735|NCT01511250|581353945|FG000|Overall Study|Sponsor/Investigator Decision|1|||
160990736|NCT01511250|581353946|FG001|Overall Study|Sponsor/Investigator Decision|0|||
160990737|NCT01511250|581353947|FG002|Overall Study|Sponsor/Investigator Decision|0|||
160990738|NCT01511250|581353948|FG003|Overall Study|Sponsor/Investigator Decision|0|||
160990739|NCT01511250|581353949|FG004|Overall Study|Sponsor/Investigator Decision|0|||
160558488|NCT02978222|579768004|FG001|Overall Study|Withdrawal by Subject|2|||
160558489|NCT02978222|579768003|FG000|Overall Study|Physician Decision|2|||
160558490|NCT02978222|579768004|FG001|Overall Study|Physician Decision|0|||
160558491|NCT02978222|579768003|FG000|Overall Study|Adverse Event|0|||
160558492|NCT02978222|579768004|FG001|Overall Study|Adverse Event|1|||
160558493|NCT02978222|579768003|FG000|Overall Study|Death|1|||
160558494|NCT02978222|579768004|FG001|Overall Study|Death|0|||
160558495|NCT02978222|579768003|FG000|Overall Study|Disease Progression|32|||
160990740|NCT01511250|581353950|FG005|Overall Study|Sponsor/Investigator Decision|0|||
160990741|NCT01511250|581353951|FG006|Overall Study|Sponsor/Investigator Decision|0|||
160558496|NCT02978222|579768004|FG001|Overall Study|Disease Progression|32|||
160558497|NCT02978222|579768003|FG000|Overall Study|Early Study Termination|24|||
160558498|NCT02978222|579768004|FG001|Overall Study|Early Study Termination|21|||
160558499|NCT00348140|579768005|FG000|Overall Study|Adverse Event|46|||
160558500|NCT00348140|579768006|FG001|Overall Study|Adverse Event|49|||
160558501|NCT00348140|579768007|FG002|Overall Study|Adverse Event|78|||
160558502|NCT00348140|579768005|FG000|Overall Study|Lost to Follow-up|4|||
160558503|NCT00348140|579768006|FG001|Overall Study|Lost to Follow-up|4|||
160558504|NCT00348140|579768007|FG002|Overall Study|Lost to Follow-up|4|||
160558505|NCT00348140|579768005|FG000|Overall Study|Protocol Violation|12|||
160558506|NCT00348140|579768006|FG001|Overall Study|Protocol Violation|13|||
160558507|NCT00348140|579768007|FG002|Overall Study|Protocol Violation|14|||
160558508|NCT00348140|579768005|FG000|Overall Study|Withdrawal by Subject|32|||
160558509|NCT00348140|579768006|FG001|Overall Study|Withdrawal by Subject|40|||
160558510|NCT00348140|579768007|FG002|Overall Study|Withdrawal by Subject|40|||
160558511|NCT00348140|579768005|FG000|Overall Study|Non-compliance|8|||
160558512|NCT00348140|579768006|FG001|Overall Study|Non-compliance|13|||
160558513|NCT00348140|579768007|FG002|Overall Study|Non-compliance|5|||
160558514|NCT00348140|579768005|FG000|Overall Study|Participant at risk due to study drug|2|||
160558515|NCT00348140|579768006|FG001|Overall Study|Participant at risk due to study drug|0|||
160558516|NCT00348140|579768007|FG002|Overall Study|Participant at risk due to study drug|0|||
160558517|NCT00348140|579768005|FG000|Overall Study|Conditional medication increased dose|1|||
160828679|NCT02463032|580759857|FG000|Overall Study|Death|8|||
160828680|NCT02463032|580759858|FG001|Overall Study|Death|8|||
160828681|NCT02463032|580759857|FG000|Overall Study|Adverse Event|2|||
160828682|NCT02463032|580759858|FG001|Overall Study|Adverse Event|6|||
160828683|NCT00612508|580759859|FG000|Overall Study|Withdrawal by Subject|3|||
160828684|NCT00612508|580759860|FG001|Overall Study|Withdrawal by Subject|4|||
160828685|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
160828686|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
160828687|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
160828688|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
160558518|NCT00348140|579768006|FG001|Overall Study|Conditional medication increased dose|0|||
160558519|NCT00348140|579768007|FG002|Overall Study|Conditional medication increased dose|0|||
160558520|NCT00348140|579768005|FG000|Overall Study|Caregiver related|4|||
160558521|NCT00348140|579768006|FG001|Overall Study|Caregiver related|7|||
160558522|NCT00348140|579768007|FG002|Overall Study|Caregiver related|3|||
160558523|NCT00348140|579768005|FG000|Overall Study|Participant hospitalised|3|||
160558524|NCT00348140|579768006|FG001|Overall Study|Participant hospitalised|0|||
160558525|NCT00348140|579768007|FG002|Overall Study|Participant hospitalised|0|||
160558526|NCT00348140|579768005|FG000|Overall Study|Efficacy related|1|||
160558527|NCT00348140|579768006|FG001|Overall Study|Efficacy related|1|||
160558528|NCT00348140|579768007|FG002|Overall Study|Efficacy related|0|||
160558529|NCT00348140|579768005|FG000|Overall Study|Administration related|3|||
160558530|NCT00348140|579768006|FG001|Overall Study|Administration related|1|||
160558531|NCT00348140|579768007|FG002|Overall Study|Administration related|1|||
160558532|NCT00348140|579768005|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
160558533|NCT00348140|579768006|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
160558534|NCT00348140|579768007|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
160558535|NCT00348140|579768005|FG000|Overall Study|Participant unwell|1|||
160558536|NCT00348140|579768006|FG001|Overall Study|Participant unwell|0|||
160558537|NCT00348140|579768007|FG002|Overall Study|Participant unwell|0|||
160558538|NCT00348140|579768005|FG000|Overall Study|Screen failure|1|||
160558539|NCT00348140|579768006|FG001|Overall Study|Screen failure|0|||
160558540|NCT00348140|579768007|FG002|Overall Study|Screen failure|0|||
160558541|NCT00348140|579768005|FG000|Overall Study|Investigator decided to discontinue|4|||
160558542|NCT00348140|579768006|FG001|Overall Study|Investigator decided to discontinue|1|||
160558543|NCT00348140|579768007|FG002|Overall Study|Investigator decided to discontinue|4|||
160558544|NCT00348140|579768005|FG000|Overall Study|Decided to discontinue on their own|1|||
160558545|NCT00348140|579768006|FG001|Overall Study|Decided to discontinue on their own|4|||
160558546|NCT00348140|579768007|FG002|Overall Study|Decided to discontinue on their own|1|||
160558547|NCT00348140|579768005|FG000|Overall Study|Use of prohibited drug|1|||
160558548|NCT00348140|579768006|FG001|Overall Study|Use of prohibited drug|0|||
160558549|NCT00348140|579768007|FG002|Overall Study|Use of prohibited drug|2|||
160558550|NCT00348140|579768005|FG000|Overall Study|Disease progression|1|||
160558551|NCT00348140|579768006|FG001|Overall Study|Disease progression|2|||
160558552|NCT00348140|579768007|FG002|Overall Study|Disease progression|5|||
160558553|NCT00348140|579768005|FG000|Overall Study|Increased risk of cardiac infarction|0|||
160558554|NCT00348140|579768006|FG001|Overall Study|Increased risk of cardiac infarction|1|||
160558555|NCT00348140|579768007|FG002|Overall Study|Increased risk of cardiac infarction|0|||
160558556|NCT00348140|579768005|FG000|Overall Study|Serious adverse event|0|||
160558557|NCT00348140|579768006|FG001|Overall Study|Serious adverse event|1|||
160558558|NCT00348140|579768007|FG002|Overall Study|Serious adverse event|0|||
160558559|NCT00348140|579768005|FG000|Overall Study|Abnormal ECG|0|||
160558560|NCT00348140|579768006|FG001|Overall Study|Abnormal ECG|1|||
160558561|NCT00348140|579768007|FG002|Overall Study|Abnormal ECG|3|||
160558562|NCT00348140|579768005|FG000|Overall Study|Participant died|0|||
160558563|NCT00348140|579768006|FG001|Overall Study|Participant died|1|||
160558564|NCT00348140|579768007|FG002|Overall Study|Participant died|0|||
160558565|NCT00348140|579768005|FG000|Overall Study|Exclusion criteria met|0|||
160558566|NCT00348140|579768006|FG001|Overall Study|Exclusion criteria met|0|||
160558567|NCT00348140|579768007|FG002|Overall Study|Exclusion criteria met|1|||
160558568|NCT00348140|579768005|FG000|Overall Study|Memory declined|0|||
160558569|NCT00348140|579768006|FG001|Overall Study|Memory declined|0|||
160558570|NCT00348140|579768007|FG002|Overall Study|Memory declined|1|||
160558571|NCT01662648|579768008|FG000|Overall Study|Death|1|||
160558572|NCT01662648|579768009|FG001|Overall Study|Death|3|||
160558573|NCT01662648|579768008|FG000|Overall Study|Adverse Event|40|||
160558574|NCT01662648|579768009|FG001|Overall Study|Adverse Event|37|||
160558575|NCT01662648|579768008|FG000|Overall Study|Lack of Efficacy|17|||
160558576|NCT01662648|579768009|FG001|Overall Study|Lack of Efficacy|16|||
160558577|NCT01662648|579768008|FG000|Overall Study|Participant ineligible to continue trial|1|||
160558578|NCT01662648|579768009|FG001|Overall Study|Participant ineligible to continue trial|1|||
160558579|NCT01662648|579768008|FG000|Overall Study|Lost to Follow-up|24|||
160558580|NCT01662648|579768009|FG001|Overall Study|Lost to Follow-up|36|||
160558581|NCT01662648|579768008|FG000|Overall Study|Withdrawal by Subject|36|||
160558582|NCT01662648|579768009|FG001|Overall Study|Withdrawal by Subject|53|||
160558583|NCT01662648|579768008|FG000|Overall Study|Participant non-compliant|16|||
160558584|NCT01662648|579768009|FG001|Overall Study|Participant non-compliant|20|||
160558585|NCT01662648|579768008|FG000|Overall Study|Other|8|||
160558586|NCT01662648|579768009|FG001|Overall Study|Other|11|||
160558587|NCT01662648|579768008|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
160558588|NCT01662648|579768009|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
160558589|NCT01662648|579768008|FG000|Overall Study|LOE and other reason unspecified|1|||
160558590|NCT01662648|579768009|FG001|Overall Study|LOE and other reason unspecified|0|||
160558591|NCT01662648|579768008|FG000|Overall Study|LOE and Participant non-compliant|0|||
160558592|NCT01662648|579768009|FG001|Overall Study|LOE and Participant non-compliant|1|||
160558593|NCT00848120|579768014|FG000|Overall Study|Adverse Event|1|||
160558594|NCT01961115|579768022|FG000|Overall Study|Disease Progression|1|||
160558595|NCT01961115|579768023|FG001|Overall Study|Disease Progression|0|||
160558596|NCT01961115|579768024|FG002|Overall Study|Disease Progression|3|||
160558597|NCT01961115|579768022|FG000|Overall Study|Adverse Event|1|||
160558598|NCT01961115|579768023|FG001|Overall Study|Adverse Event|0|||
160558599|NCT01961115|579768024|FG002|Overall Study|Adverse Event|1|||
160558600|NCT00705263|579768030|FG000|Overall Study|Withdrawal by Subject|2|||
160558601|NCT05501119|579768031|FG000|Overall Study|Withdrawal by Subject|2|||
160558602|NCT05501119|579768031|FG000|Overall Study|Lost to Follow-up|5|||
160558603|NCT01752023|579768032|FG000|Overall Study|Physician Decision|2|||
160558604|NCT01752023|579768033|FG001|Overall Study|Physician Decision|1|||
160558605|NCT02899156|579768034|FG000|Overall Study|Death|1|||
160558606|NCT02899156|579768035|FG001|Overall Study|Death|0|||
160902971|NCT01609231|581037893|FG000|Overall Study|Physician Decision|1|||
160902972|NCT01609231|581037894|FG001|Overall Study|Physician Decision|0|||
160902973|NCT01609231|581037893|FG000|Overall Study|Withdrawal by Subject|1|||
160902974|NCT01609231|581037894|FG001|Overall Study|Withdrawal by Subject|0|||
160902975|NCT00973674|581037895|FG000|Overall Study|Protocol Violation|2|||
160902976|NCT00973674|581037896|FG001|Overall Study|Protocol Violation|0|||
160902977|NCT02846324|581037899|FG000|Overall Study|Other|1|||
160902978|NCT02846324|581037900|FG001|Overall Study|Other|0|||
160902979|NCT02846324|581037901|FG002|Overall Study|Other|0|||
160902980|NCT02846324|581037902|FG003|Overall Study|Other|0|||
160902981|NCT02846324|581037899|FG000|Overall Study|Withdrawal by Subject|1|||
160902982|NCT02846324|581037900|FG001|Overall Study|Withdrawal by Subject|0|||
160902983|NCT02846324|581037901|FG002|Overall Study|Withdrawal by Subject|4|||
160902984|NCT02846324|581037902|FG003|Overall Study|Withdrawal by Subject|0|||
160902985|NCT00516074|581037909|FG000|Overall Study|Adverse Event|0|||
160902986|NCT00516074|581037910|FG001|Overall Study|Adverse Event|1|||
160902987|NCT00516074|581037909|FG000|Overall Study|Subject Decision|4|||
160902988|NCT00516074|581037910|FG001|Overall Study|Subject Decision|2|||
160902989|NCT00516074|581037909|FG000|Overall Study|Loss of Glucose Control|2|||
160902990|NCT00516074|581037910|FG001|Overall Study|Loss of Glucose Control|0|||
160902991|NCT00369824|581037911|FG000|Overall Study|Adverse Event|0|||
160902992|NCT00369824|581037912|FG001|Overall Study|Adverse Event|2|||
160902993|NCT00369824|581037913|FG002|Overall Study|Adverse Event|0|||
160902994|NCT00369824|581037914|FG003|Overall Study|Adverse Event|0|||
160902995|NCT00369824|581037915|FG004|Overall Study|Adverse Event|1|||
160902996|NCT00369824|581037916|FG005|Overall Study|Adverse Event|0|||
160902997|NCT00369824|581037911|FG000|Overall Study|Protocol Violation|0|||
160902998|NCT00369824|581037912|FG001|Overall Study|Protocol Violation|1|||
160902999|NCT00369824|581037913|FG002|Overall Study|Protocol Violation|0|||
160903000|NCT00369824|581037914|FG003|Overall Study|Protocol Violation|1|||
160903001|NCT00369824|581037915|FG004|Overall Study|Protocol Violation|1|||
160903002|NCT00369824|581037916|FG005|Overall Study|Protocol Violation|0|||
160903003|NCT00369824|581037911|FG000|Overall Study|Withdrawal by Subject|9|||
160903004|NCT00369824|581037912|FG001|Overall Study|Withdrawal by Subject|5|||
160903005|NCT00369824|581037913|FG002|Overall Study|Withdrawal by Subject|5|||
160903006|NCT00369824|581037914|FG003|Overall Study|Withdrawal by Subject|4|||
160903007|NCT00369824|581037915|FG004|Overall Study|Withdrawal by Subject|6|||
160903008|NCT00369824|581037916|FG005|Overall Study|Withdrawal by Subject|2|||
160903009|NCT00369824|581037911|FG000|Overall Study|Lost to Follow-up|6|||
160903010|NCT00369824|581037912|FG001|Overall Study|Lost to Follow-up|11|||
160903011|NCT00369824|581037913|FG002|Overall Study|Lost to Follow-up|7|||
160903012|NCT00369824|581037914|FG003|Overall Study|Lost to Follow-up|8|||
160903013|NCT00369824|581037915|FG004|Overall Study|Lost to Follow-up|9|||
160903014|NCT00369824|581037916|FG005|Overall Study|Lost to Follow-up|6|||
160903015|NCT00369824|581037911|FG000|Overall Study|Other|0|||
160903016|NCT00369824|581037912|FG001|Overall Study|Other|0|||
160903017|NCT00369824|581037913|FG002|Overall Study|Other|0|||
160903018|NCT00369824|581037914|FG003|Overall Study|Other|2|||
160903019|NCT00369824|581037915|FG004|Overall Study|Other|1|||
160903020|NCT00369824|581037916|FG005|Overall Study|Other|3|||
160903021|NCT03822182|581037919|FG000|Overall Study|Protocol Violation|0|||
160903022|NCT03822182|581037920|FG001|Overall Study|Protocol Violation|1|||
160903023|NCT03822182|581037921|FG002|Overall Study|Protocol Violation|1|||
160903024|NCT01611155|581037924|FG000|Overall Study|Adverse Event|1|||
160903025|NCT01611155|581037925|FG001|Overall Study|Adverse Event|1|||
160903026|NCT01611155|581037924|FG000|Overall Study|Refused further treatment|6|||
160903027|NCT01611155|581037925|FG001|Overall Study|Refused further treatment|4|||
160903028|NCT01611155|581037924|FG000|Overall Study|Disease progression|1|||
160903029|NCT01611155|581037925|FG001|Overall Study|Disease progression|0|||
160903030|NCT01611155|581037924|FG000|Overall Study|Withdrawal by Subject|1|||
160903031|NCT01611155|581037925|FG001|Overall Study|Withdrawal by Subject|0|||
160903032|NCT01611155|581037924|FG000|Overall Study|Alternative treatment|0|||
160903033|NCT01611155|581037925|FG001|Overall Study|Alternative treatment|1|||
160558607|NCT02899156|579768034|FG000|Overall Study|Physician Decision|0|||
160903034|NCT01611155|581037924|FG000|Overall Study|Ineligible patient|0|||
160558608|NCT02899156|579768035|FG001|Overall Study|Physician Decision|1|||
160558609|NCT02440581|579768038|FG000|Overall Study|Death|0|||
160558610|NCT02440581|579768039|FG001|Overall Study|Death|0|||
160558611|NCT02440581|579768040|FG002|Overall Study|Death|7|||
160558612|NCT02440581|579768041|FG003|Overall Study|Death|5|||
160558613|NCT02440581|579768038|FG000|Overall Study|Transplanted|1|||
160558614|NCT02440581|579768039|FG001|Overall Study|Transplanted|0|||
160558615|NCT02440581|579768040|FG002|Overall Study|Transplanted|3|||
160558616|NCT02440581|579768041|FG003|Overall Study|Transplanted|2|||
160558617|NCT02440581|579768038|FG000|Overall Study|Withdrawal by Subject|4|||
160558618|NCT02440581|579768039|FG001|Overall Study|Withdrawal by Subject|11|||
160558619|NCT02440581|579768040|FG002|Overall Study|Withdrawal by Subject|3|||
160558620|NCT02440581|579768041|FG003|Overall Study|Withdrawal by Subject|7|||
160558621|NCT00484315|579768043|FG000|12-Month Clinical Follow-up|Death|6|||
160558622|NCT00484315|579768044|FG001|12-Month Clinical Follow-up|Death|2|||
160558623|NCT00484315|579768043|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
160558624|NCT00484315|579768044|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
160558625|NCT00484315|579768043|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
160558626|NCT00484315|579768044|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
160558627|NCT00484315|579768043|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
160558628|NCT00484315|579768044|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
160558629|NCT00484315|579768043|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
160558630|NCT00484315|579768044|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
160558631|NCT00484315|579768043|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
160558632|NCT00484315|579768044|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
160558633|NCT00484315|579768043|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
160558634|NCT00484315|579768044|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
160558635|NCT00943683|579768045|FG000|Overall Study|Adverse Event|3|||
160558636|NCT00943683|579768046|FG001|Overall Study|Adverse Event|3|||
160558637|NCT00943683|579768045|FG000|Overall Study|Lost to Follow-up|1|||
160558638|NCT00943683|579768046|FG001|Overall Study|Lost to Follow-up|1|||
160558639|NCT00943683|579768045|FG000|Overall Study|Protocol Violation|1|||
160558640|NCT00943683|579768046|FG001|Overall Study|Protocol Violation|2|||
160558641|NCT00943683|579768045|FG000|Overall Study|Withdrawal by Subject|1|||
160558642|NCT00943683|579768046|FG001|Overall Study|Withdrawal by Subject|0|||
160558643|NCT00943683|579768045|FG000|Overall Study|Patient Moved|1|||
160558644|NCT00943683|579768046|FG001|Overall Study|Patient Moved|0|||
160558645|NCT01245673|579768047|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
160558646|NCT01078805|579768053|FG000|Overall Study|Clinically significant abnormal lab|5|||
160558647|NCT01078805|579768053|FG000|Overall Study|Death|134|||
160558648|NCT01078805|579768053|FG000|Overall Study|Lost to Follow-up|676|||
160558649|NCT01078805|579768053|FG000|Overall Study|Physician Decision|169|||
160558650|NCT01078805|579768053|FG000|Overall Study|Serious adverse event|26|||
160558651|NCT01078805|579768053|FG000|Overall Study|Sponsor decision|46|||
160558652|NCT01078805|579768053|FG000|Overall Study|Withdrawal by Subject|739|||
160558653|NCT01078805|579768053|FG000|Overall Study|Other|173|||
160558654|NCT01078805|579768053|FG000|Overall Study|Didn't take study drug|82|||
160558655|NCT01609842|579768054|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
160558656|NCT01609842|579768055|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
160558657|NCT00891202|579768064|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
160558658|NCT00891202|579768065|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
160558659|NCT00891202|579768066|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
160558660|NCT00891202|579768067|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
160558661|NCT00891202|579768064|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
160558662|NCT00891202|579768065|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
160558663|NCT00891202|579768066|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
160558664|NCT00891202|579768067|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
160558665|NCT00891202|579768064|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
160558666|NCT00891202|579768065|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
160558667|NCT00891202|579768066|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
160558668|NCT00891202|579768067|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
160558669|NCT00891202|579768064|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
160558670|NCT00891202|579768065|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
160558671|NCT00891202|579768066|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
160558672|NCT00891202|579768067|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
160558673|NCT01750918|579769878|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
160558674|NCT01750918|579769879|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
160558675|NCT01750918|579769880|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
160558676|NCT01750918|579769881|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
160558677|NCT01750918|579769882|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
160558678|NCT01750918|579769883|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
160558679|NCT01750918|579769884|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
160558680|NCT01750918|579769885|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
160558681|NCT01750918|579769878|FG000|Overall Study|Lost to Follow-up|0|||
160558682|NCT01750918|579769879|FG001|Overall Study|Lost to Follow-up|0|||
160558683|NCT01750918|579769880|FG002|Overall Study|Lost to Follow-up|2|||
160558684|NCT01750918|579769881|FG003|Overall Study|Lost to Follow-up|2|||
160558685|NCT01750918|579769882|FG004|Overall Study|Lost to Follow-up|0|||
160558686|NCT01750918|579769883|FG005|Overall Study|Lost to Follow-up|0|||
160828689|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
160828690|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
160828691|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
160828692|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
160558687|NCT01750918|579769884|FG006|Overall Study|Lost to Follow-up|0|||
160558688|NCT01750918|579769885|FG007|Overall Study|Lost to Follow-up|1|||
160558689|NCT01750918|579769878|FG000|Overall Study|Withdrawal by Subject|0|||
160558690|NCT01750918|579769879|FG001|Overall Study|Withdrawal by Subject|0|||
160558691|NCT01750918|579769880|FG002|Overall Study|Withdrawal by Subject|1|||
160558692|NCT01750918|579769881|FG003|Overall Study|Withdrawal by Subject|2|||
160558693|NCT01750918|579769882|FG004|Overall Study|Withdrawal by Subject|1|||
160558694|NCT01750918|579769883|FG005|Overall Study|Withdrawal by Subject|1|||
160558695|NCT01750918|579769884|FG006|Overall Study|Withdrawal by Subject|2|||
160558696|NCT01750918|579769885|FG007|Overall Study|Withdrawal by Subject|2|||
160558697|NCT02031679|579769886|FG000|Overall Study|Protocol Violation|0|||
160558698|NCT02031679|579769887|FG001|Overall Study|Protocol Violation|1|||
160558699|NCT02031679|579769886|FG000|Overall Study|Lack of Efficacy|0|||
160558700|NCT02031679|579769887|FG001|Overall Study|Lack of Efficacy|1|||
160558701|NCT01974817|579769888|FG000|Overall Study|Death|4|||
160558702|NCT01974817|579769888|FG000|Overall Study|Lost to Follow-up|2|||
160558703|NCT01974817|579769888|FG000|Overall Study|Protocol Violation|2|||
160558704|NCT05047523|579769889|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
160558705|NCT05047523|579769890|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
160558706|NCT05047523|579769891|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
160558707|NCT05047523|579769892|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
160558708|NCT05047523|579769893|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
160558709|NCT05047523|579769894|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
160558710|NCT05047523|579769889|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
160558711|NCT05047523|579769890|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
160558712|NCT05047523|579769891|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
160558713|NCT05047523|579769892|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
160558714|NCT05047523|579769893|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
160558715|NCT05047523|579769894|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
160558716|NCT05047523|579769889|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
160558717|NCT05047523|579769890|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
160558718|NCT05047523|579769891|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
160558719|NCT05047523|579769892|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
160558720|NCT05047523|579769893|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
160558721|NCT05047523|579769894|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
160558722|NCT05047523|579769889|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
160558723|NCT05047523|579769890|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
160558724|NCT05047523|579769891|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
160558725|NCT05047523|579769892|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
160558726|NCT05047523|579769893|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
160558727|NCT05047523|579769894|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
160558728|NCT05047523|579769889|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
160558729|NCT05047523|579769890|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
160558730|NCT05047523|579769891|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
160558731|NCT05047523|579769892|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
160558732|NCT05047523|579769893|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
160558733|NCT05047523|579769894|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
160558734|NCT05047523|579769889|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
160558735|NCT05047523|579769890|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
160558736|NCT05047523|579769891|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
160558737|NCT05047523|579769892|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
160558738|NCT05047523|579769893|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
160558739|NCT05047523|579769894|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
160558740|NCT00224016|579769895|FG000|Titration Period|Withdrawal by Subject|0|||
160558741|NCT00224016|579769896|FG001|Titration Period|Withdrawal by Subject|1|||
160558742|NCT00224016|579769895|FG000|Titration Period|Lost to Follow-up|1|||
160558743|NCT00224016|579769896|FG001|Titration Period|Lost to Follow-up|0|||
160990742|NCT01511250|581353952|FG007|Overall Study|Sponsor/Investigator Decision|0|||
160990743|NCT01511250|581353953|FG008|Overall Study|Sponsor/Investigator Decision|0|||
160990744|NCT01511250|581353954|FG009|Overall Study|Sponsor/Investigator Decision|0|||
160990745|NCT01511250|581353945|FG000|Overall Study|Lost to Follow-up|7|||
160558744|NCT00224016|579769895|FG000|Maintenance Period|Withdrawal by Subject|2|||
160990746|NCT01511250|581353946|FG001|Overall Study|Lost to Follow-up|3|||
160558745|NCT00224016|579769896|FG001|Maintenance Period|Withdrawal by Subject|0|||
160558746|NCT00224016|579769895|FG000|Maintenance Period|Lost to Follow-up|0|||
160558747|NCT00224016|579769896|FG001|Maintenance Period|Lost to Follow-up|1|||
160558748|NCT00928070|579769899|FG000|Overall Study|Lost to Follow-up|1|||
160558749|NCT00928070|579769900|FG001|Overall Study|Lost to Follow-up|2|||
160558750|NCT00928070|579769899|FG000|Overall Study|Withdrawal by Subject|10|||
160558751|NCT00928070|579769900|FG001|Overall Study|Withdrawal by Subject|3|||
160558752|NCT00928070|579769899|FG000|Overall Study|Adverse Event|14|||
160558753|NCT00928070|579769900|FG001|Overall Study|Adverse Event|26|||
160558754|NCT00928070|579769899|FG000|Overall Study|Lack of Efficacy|9|||
160558755|NCT00928070|579769900|FG001|Overall Study|Lack of Efficacy|5|||
160558756|NCT00928070|579769899|FG000|Overall Study|Did not meet entrance criteria|16|||
160558757|NCT00928070|579769900|FG001|Overall Study|Did not meet entrance criteria|9|||
160558758|NCT00928070|579769899|FG000|Overall Study|Protocol Violation|6|||
160558759|NCT00928070|579769900|FG001|Overall Study|Protocol Violation|5|||
160558760|NCT00928070|579769899|FG000|Overall Study|Randomized but not treated|2|||
160558761|NCT00928070|579769900|FG001|Overall Study|Randomized but not treated|2|||
160558762|NCT00928070|579769899|FG000|Overall Study|Other|5|||
160558763|NCT00928070|579769900|FG001|Overall Study|Other|5|||
160558764|NCT01919307|579769905|FG000|Overall Study|Withdrawal by Subject|9|||
160558765|NCT05052723|579769907|FG000|Overall Study|Death|19|||
160558766|NCT02771522|579769908|FG000|Overall Study|Lost to Follow-up|3|||
160558767|NCT02771522|579769908|FG000|Overall Study|Withdrawal by Subject|2|||
160558768|NCT02771522|579769908|FG000|Overall Study|No white spot lesions|3|||
160558769|NCT00556426|579769914|FG000|Overall Study|Withdrawal by Subject|3|||
160558770|NCT00556426|579769914|FG000|Overall Study|Death|6|||
160558771|NCT03049449|579769915|FG000|Overall Study|Did not receive treatment.|0|||
160558772|NCT03049449|579769916|FG001|Overall Study|Did not receive treatment.|0|||
160558773|NCT03049449|579769917|FG002|Overall Study|Did not receive treatment.|0|||
160558774|NCT03049449|579769918|FG003|Overall Study|Did not receive treatment.|0|||
160558775|NCT03049449|579769919|FG004|Overall Study|Did not receive treatment.|0|||
160558776|NCT03049449|579769920|FG005|Overall Study|Did not receive treatment.|0|||
160558777|NCT03049449|579769921|FG006|Overall Study|Did not receive treatment.|0|||
160558778|NCT03049449|579769922|FG007|Overall Study|Did not receive treatment.|0|||
160558779|NCT03049449|579769923|FG008|Overall Study|Did not receive treatment.|1|||
160558780|NCT03049449|579769924|FG009|Overall Study|Did not receive treatment.|0|||
160558781|NCT03049449|579769915|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
160558782|NCT03049449|579769916|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
160558783|NCT03049449|579769917|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
160558784|NCT03049449|579769918|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
160558785|NCT03049449|579769919|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
160558786|NCT03049449|579769920|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
160558787|NCT03049449|579769921|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
160558788|NCT03049449|579769922|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
160558789|NCT03049449|579769923|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
160558790|NCT03049449|579769924|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
160558791|NCT03049449|579769915|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
160558792|NCT03049449|579769916|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
160558793|NCT03049449|579769917|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
160558794|NCT03049449|579769918|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
160558795|NCT03049449|579769919|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
160558796|NCT03049449|579769920|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
160558797|NCT03049449|579769921|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
160558798|NCT03049449|579769922|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
160558799|NCT03049449|579769923|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
160558800|NCT03049449|579769924|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
160558801|NCT02054702|579769927|FG000|Overall Study|Lost to Follow-up|3|||
160558802|NCT02054702|579769928|FG001|Overall Study|Lost to Follow-up|5|||
160558803|NCT02054702|579769927|FG000|Overall Study|Adverse Event|3|||
160558804|NCT02054702|579769928|FG001|Overall Study|Adverse Event|1|||
160558805|NCT02054702|579769927|FG000|Overall Study|Met Withdrawal Criteria|4|||
160558806|NCT02054702|579769928|FG001|Overall Study|Met Withdrawal Criteria|1|||
160558807|NCT02054702|579769927|FG000|Overall Study|Physician Decision|0|||
160558808|NCT02054702|579769928|FG001|Overall Study|Physician Decision|1|||
160558809|NCT02054702|579769927|FG000|Overall Study|Withdrawal by Subject|14|||
160558810|NCT02054702|579769928|FG001|Overall Study|Withdrawal by Subject|4|||
160558811|NCT01262898|579769929|FG000|Overall Study|Protocol Violation|1|||
160558812|NCT01262898|579769930|FG001|Overall Study|Protocol Violation|1|||
160558813|NCT01262898|579769931|FG002|Overall Study|Protocol Violation|0|||
160558814|NCT01262898|579769932|FG003|Overall Study|Protocol Violation|0|||
160558815|NCT01262898|579769929|FG000|Overall Study|Lost to Follow-up|1|||
160558816|NCT01262898|579769930|FG001|Overall Study|Lost to Follow-up|0|||
160558817|NCT01262898|579769931|FG002|Overall Study|Lost to Follow-up|0|||
160558818|NCT01262898|579769932|FG003|Overall Study|Lost to Follow-up|0|||
160558819|NCT01262898|579769929|FG000|Overall Study|Withdrawal by Subject|1|||
160558820|NCT01262898|579769930|FG001|Overall Study|Withdrawal by Subject|1|||
160558821|NCT01262898|579769931|FG002|Overall Study|Withdrawal by Subject|0|||
160558822|NCT01262898|579769932|FG003|Overall Study|Withdrawal by Subject|0|||
160558823|NCT02388295|579769938|FG000|Dose Escalation Week 1|Adverse Event|1|||
160558824|NCT02388295|579769939|FG001|Dose Escalation Week 1|Adverse Event|2|||
160558825|NCT02388295|579769940|FG002|Dose Escalation Week 1|Adverse Event|1|||
160558826|NCT02388295|579769938|FG000|Dose Escalation Week 1|Determined not eligible|1|||
160558827|NCT02388295|579769939|FG001|Dose Escalation Week 1|Determined not eligible|1|||
160558828|NCT02388295|579769940|FG002|Dose Escalation Week 1|Determined not eligible|1|||
160558829|NCT02388295|579769938|FG000|Dose Escalation Week 2|Protocol Violation|0|||
160558830|NCT02388295|579769939|FG001|Dose Escalation Week 2|Protocol Violation|1|||
160558831|NCT02388295|579769940|FG002|Dose Escalation Week 2|Protocol Violation|0|||
160558832|NCT02388295|579769938|FG000|Dose Escalation Week 2|Determined not eligible|1|||
160558833|NCT02388295|579769939|FG001|Dose Escalation Week 2|Determined not eligible|1|||
160558834|NCT02388295|579769940|FG002|Dose Escalation Week 2|Determined not eligible|1|||
160558835|NCT02388295|579769938|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
160558836|NCT02388295|579769939|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
160558837|NCT02388295|579769940|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
160558838|NCT01551693|579769941|FG000|Overall Study|Disease Progression|1|||
160558839|NCT01551693|579769942|FG001|Overall Study|Disease Progression|0|||
160558840|NCT01551693|579769941|FG000|Overall Study|Adverse Event|0|||
160558841|NCT01551693|579769942|FG001|Overall Study|Adverse Event|1|||
160558842|NCT01551693|579769941|FG000|Overall Study|Withdrawal by Subject|0|||
160558843|NCT01551693|579769942|FG001|Overall Study|Withdrawal by Subject|1|||
160558844|NCT04134494|579769947|FG000|Overall Study|Lost to Follow-up|2|||
160558845|NCT00781365|579769948|FG000|Overall Study|Withdrawal by Subject|13|||
160558846|NCT00781365|579769949|FG001|Overall Study|Withdrawal by Subject|8|||
160558847|NCT00781365|579769948|FG000|Overall Study|Did Not Attend Visit|20|||
160558848|NCT00781365|579769949|FG001|Overall Study|Did Not Attend Visit|28|||
160558849|NCT00781365|579769948|FG000|Overall Study|Language barrier|1|||
160558850|NCT00781365|579769949|FG001|Overall Study|Language barrier|0|||
160558851|NCT00802360|579769952|FG000|Overall Study|Stimulation failure|4|||
160558852|NCT00802360|579769953|FG001|Overall Study|Stimulation failure|0|||
160558853|NCT00802360|579769954|FG002|Overall Study|Stimulation failure|3|||
160558854|NCT00802360|579769955|FG003|Overall Study|Stimulation failure|3|||
160558855|NCT00802360|579769952|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
160558856|NCT00802360|579769953|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
160558857|NCT00802360|579769954|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
160558858|NCT00802360|579769955|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
160828693|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
160828694|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
160828695|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
160828696|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
160828697|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
160828698|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
160828699|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
160828700|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
160828701|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
160828702|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
160828703|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
160903035|NCT01611155|581037925|FG001|Overall Study|Ineligible patient|1|||
160903036|NCT01681472|581037926|FG000|Overall Study|Adverse Event|0|||
160558859|NCT00802360|579769952|FG000|Overall Study|Cycle cancelled|0|||
160558860|NCT00802360|579769953|FG001|Overall Study|Cycle cancelled|1|||
160558861|NCT00802360|579769954|FG002|Overall Study|Cycle cancelled|1|||
160558862|NCT00802360|579769955|FG003|Overall Study|Cycle cancelled|1|||
160558863|NCT00802360|579769952|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
160558864|NCT00802360|579769953|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
160828704|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
160558865|NCT00802360|579769954|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
160558866|NCT00802360|579769955|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
160558867|NCT00802360|579769952|FG000|Overall Study|No positive serum pregnancy|17|||
160558868|NCT00802360|579769953|FG001|Overall Study|No positive serum pregnancy|20|||
160558869|NCT00802360|579769954|FG002|Overall Study|No positive serum pregnancy|14|||
160558870|NCT00802360|579769955|FG003|Overall Study|No positive serum pregnancy|10|||
160558871|NCT00802360|579769952|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
160558872|NCT00802360|579769953|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
160558873|NCT00802360|579769954|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
160558874|NCT00802360|579769955|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
160558875|NCT00802360|579769952|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
160558876|NCT00802360|579769953|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
160558877|NCT00802360|579769954|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
160558878|NCT00802360|579769955|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
160558879|NCT00802360|579769952|FG000|Overall Study|Other|2|||
160558880|NCT00802360|579769953|FG001|Overall Study|Other|3|||
160558881|NCT00802360|579769954|FG002|Overall Study|Other|6|||
160558882|NCT00802360|579769955|FG003|Overall Study|Other|3|||
160558883|NCT03258814|579769966|FG000|Overall Study|Early Termination|4|||
160558884|NCT03258814|579769967|FG001|Overall Study|Early Termination|3|||
160558885|NCT03258814|579769968|FG002|Overall Study|Early Termination|10|||
160558886|NCT01900002|579769969|FG000|Overall Study|Withdrawal by Subject|2|||
160558887|NCT01900002|579769969|FG000|Overall Study|ineligible for Y-90|4|||
160558888|NCT00868790|579769978|FG000|Period 1|Adverse Event|1|||
160558889|NCT00868790|579769979|FG001|Period 1|Adverse Event|0|||
160558890|NCT00868790|579769980|FG002|Period 1|Adverse Event|0|||
160558891|NCT00868790|579769981|FG003|Period 1|Adverse Event|0|||
160558892|NCT00868790|579769982|FG004|Period 1|Adverse Event|0|||
160558893|NCT00868790|579769983|FG005|Period 1|Adverse Event|0|||
160558894|NCT00868790|579769984|FG006|Period 1|Adverse Event|0|||
160558895|NCT00868790|579769985|FG007|Period 1|Adverse Event|3|||
160558896|NCT00868790|579769986|FG008|Period 1|Adverse Event|1|||
160558897|NCT00868790|579769987|FG009|Period 1|Adverse Event|0|||
160558898|NCT00868790|579769988|FG010|Period 1|Adverse Event|0|||
160558899|NCT00868790|579769989|FG011|Period 1|Adverse Event|0|||
160558900|NCT00868790|579769990|FG012|Period 1|Adverse Event|0|||
160558901|NCT00868790|579769991|FG013|Period 1|Adverse Event|1|||
160558902|NCT00868790|579769978|FG000|Period 1|Protocol Violation|1|||
160558903|NCT00868790|579769979|FG001|Period 1|Protocol Violation|0|||
160558904|NCT00868790|579769980|FG002|Period 1|Protocol Violation|0|||
160558905|NCT00868790|579769981|FG003|Period 1|Protocol Violation|0|||
160558906|NCT00868790|579769982|FG004|Period 1|Protocol Violation|0|||
160558907|NCT00868790|579769983|FG005|Period 1|Protocol Violation|0|||
160558908|NCT00868790|579769984|FG006|Period 1|Protocol Violation|0|||
160558909|NCT00868790|579769985|FG007|Period 1|Protocol Violation|0|||
160558910|NCT00868790|579769986|FG008|Period 1|Protocol Violation|0|||
160558911|NCT00868790|579769987|FG009|Period 1|Protocol Violation|0|||
160558912|NCT00868790|579769988|FG010|Period 1|Protocol Violation|0|||
160558913|NCT00868790|579769989|FG011|Period 1|Protocol Violation|0|||
160558914|NCT00868790|579769990|FG012|Period 1|Protocol Violation|0|||
160558915|NCT00868790|579769991|FG013|Period 1|Protocol Violation|0|||
160558916|NCT00868790|579769978|FG000|Period 1|Withdrawal by Subject|0|||
160558917|NCT00868790|579769979|FG001|Period 1|Withdrawal by Subject|1|||
160558918|NCT00868790|579769980|FG002|Period 1|Withdrawal by Subject|0|||
160558919|NCT00868790|579769981|FG003|Period 1|Withdrawal by Subject|0|||
160558920|NCT00868790|579769982|FG004|Period 1|Withdrawal by Subject|0|||
160558921|NCT00868790|579769983|FG005|Period 1|Withdrawal by Subject|0|||
160558922|NCT00868790|579769984|FG006|Period 1|Withdrawal by Subject|0|||
160558923|NCT00868790|579769985|FG007|Period 1|Withdrawal by Subject|0|||
160558924|NCT00868790|579769986|FG008|Period 1|Withdrawal by Subject|0|||
160558925|NCT00868790|579769987|FG009|Period 1|Withdrawal by Subject|0|||
160828705|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
160828706|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
160828707|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
160903037|NCT01681472|581037927|FG001|Overall Study|Adverse Event|1|||
160828708|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
160828709|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
160828710|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
160828711|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
160828712|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
160828713|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
160828714|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
160558926|NCT00868790|579769988|FG010|Period 1|Withdrawal by Subject|0|||
160558927|NCT00868790|579769989|FG011|Period 1|Withdrawal by Subject|0|||
160558928|NCT00868790|579769990|FG012|Period 1|Withdrawal by Subject|0|||
160558929|NCT00868790|579769991|FG013|Period 1|Withdrawal by Subject|1|||
160558930|NCT00868790|579769978|FG000|Period 1|Abnormal Triglycerides|0|||
160558931|NCT00868790|579769979|FG001|Period 1|Abnormal Triglycerides|0|||
160558932|NCT00868790|579769980|FG002|Period 1|Abnormal Triglycerides|0|||
160558933|NCT00868790|579769981|FG003|Period 1|Abnormal Triglycerides|0|||
160558934|NCT00868790|579769982|FG004|Period 1|Abnormal Triglycerides|1|||
160558935|NCT00868790|579769983|FG005|Period 1|Abnormal Triglycerides|0|||
160558936|NCT00868790|579769984|FG006|Period 1|Abnormal Triglycerides|0|||
160558937|NCT00868790|579769985|FG007|Period 1|Abnormal Triglycerides|0|||
160558938|NCT00868790|579769986|FG008|Period 1|Abnormal Triglycerides|0|||
160558939|NCT00868790|579769987|FG009|Period 1|Abnormal Triglycerides|0|||
160558940|NCT00868790|579769988|FG010|Period 1|Abnormal Triglycerides|0|||
160558941|NCT00868790|579769989|FG011|Period 1|Abnormal Triglycerides|0|||
160558942|NCT00868790|579769990|FG012|Period 1|Abnormal Triglycerides|0|||
160558943|NCT00868790|579769991|FG013|Period 1|Abnormal Triglycerides|0|||
160558944|NCT00868790|579769978|FG000|Period 1|Lost to Follow-up|0|||
160558945|NCT00868790|579769979|FG001|Period 1|Lost to Follow-up|0|||
160558946|NCT00868790|579769980|FG002|Period 1|Lost to Follow-up|0|||
160558947|NCT00868790|579769981|FG003|Period 1|Lost to Follow-up|0|||
160558948|NCT00868790|579769982|FG004|Period 1|Lost to Follow-up|0|||
160558949|NCT00868790|579769983|FG005|Period 1|Lost to Follow-up|1|||
160558950|NCT00868790|579769984|FG006|Period 1|Lost to Follow-up|0|||
160558951|NCT00868790|579769985|FG007|Period 1|Lost to Follow-up|0|||
160558952|NCT00868790|579769986|FG008|Period 1|Lost to Follow-up|0|||
160558953|NCT00868790|579769987|FG009|Period 1|Lost to Follow-up|0|||
160558954|NCT00868790|579769988|FG010|Period 1|Lost to Follow-up|0|||
160558955|NCT00868790|579769989|FG011|Period 1|Lost to Follow-up|0|||
160558956|NCT00868790|579769990|FG012|Period 1|Lost to Follow-up|0|||
160558957|NCT00868790|579769991|FG013|Period 1|Lost to Follow-up|0|||
160558958|NCT00868790|579769978|FG000|Period 2|Adverse Event|0|||
160558959|NCT00868790|579769979|FG001|Period 2|Adverse Event|0|||
160558960|NCT00868790|579769980|FG002|Period 2|Adverse Event|0|||
160558961|NCT00868790|579769981|FG003|Period 2|Adverse Event|0|||
160558962|NCT00868790|579769982|FG004|Period 2|Adverse Event|0|||
160558963|NCT00868790|579769983|FG005|Period 2|Adverse Event|0|||
160558964|NCT00868790|579769984|FG006|Period 2|Adverse Event|0|||
160558965|NCT00868790|579769985|FG007|Period 2|Adverse Event|0|||
160558966|NCT00868790|579769986|FG008|Period 2|Adverse Event|1|||
160558967|NCT00868790|579769987|FG009|Period 2|Adverse Event|0|||
160558968|NCT00868790|579769988|FG010|Period 2|Adverse Event|0|||
160558969|NCT00868790|579769989|FG011|Period 2|Adverse Event|0|||
160558970|NCT00868790|579769990|FG012|Period 2|Adverse Event|0|||
160828715|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
160828716|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
160828717|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
160828718|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
160828719|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
160828720|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
160828721|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
160990747|NCT01511250|581353947|FG002|Overall Study|Lost to Follow-up|3|||
160990748|NCT01511250|581353948|FG003|Overall Study|Lost to Follow-up|3|||
160990749|NCT01511250|581353949|FG004|Overall Study|Lost to Follow-up|0|||
160558971|NCT00868790|579769991|FG013|Period 2|Adverse Event|0|||
160558972|NCT00868790|579769978|FG000|Period 2|Lost to Follow-up|0|||
160558973|NCT00868790|579769979|FG001|Period 2|Lost to Follow-up|1|||
160558974|NCT00868790|579769980|FG002|Period 2|Lost to Follow-up|0|||
160558975|NCT00868790|579769981|FG003|Period 2|Lost to Follow-up|0|||
160558976|NCT00868790|579769982|FG004|Period 2|Lost to Follow-up|0|||
160558977|NCT00868790|579769983|FG005|Period 2|Lost to Follow-up|1|||
160558978|NCT00868790|579769984|FG006|Period 2|Lost to Follow-up|0|||
160558979|NCT00868790|579769985|FG007|Period 2|Lost to Follow-up|0|||
160558980|NCT00868790|579769986|FG008|Period 2|Lost to Follow-up|0|||
160558981|NCT00868790|579769987|FG009|Period 2|Lost to Follow-up|0|||
160558982|NCT00868790|579769988|FG010|Period 2|Lost to Follow-up|0|||
160558983|NCT00868790|579769989|FG011|Period 2|Lost to Follow-up|0|||
160558984|NCT00868790|579769990|FG012|Period 2|Lost to Follow-up|0|||
160558985|NCT00868790|579769991|FG013|Period 2|Lost to Follow-up|0|||
160558986|NCT00868790|579769978|FG000|Period 2|Withdrawal by Subject|0|||
160558987|NCT00868790|579769979|FG001|Period 2|Withdrawal by Subject|0|||
160558988|NCT00868790|579769980|FG002|Period 2|Withdrawal by Subject|0|||
160558989|NCT00868790|579769981|FG003|Period 2|Withdrawal by Subject|0|||
160558990|NCT00868790|579769982|FG004|Period 2|Withdrawal by Subject|0|||
160558991|NCT00868790|579769983|FG005|Period 2|Withdrawal by Subject|0|||
160558992|NCT00868790|579769984|FG006|Period 2|Withdrawal by Subject|0|||
160558993|NCT00868790|579769985|FG007|Period 2|Withdrawal by Subject|0|||
160558994|NCT00868790|579769986|FG008|Period 2|Withdrawal by Subject|1|||
160558995|NCT00868790|579769987|FG009|Period 2|Withdrawal by Subject|0|||
160558996|NCT00868790|579769988|FG010|Period 2|Withdrawal by Subject|0|||
160558997|NCT00868790|579769989|FG011|Period 2|Withdrawal by Subject|0|||
160558998|NCT00868790|579769990|FG012|Period 2|Withdrawal by Subject|0|||
160558999|NCT00868790|579769991|FG013|Period 2|Withdrawal by Subject|1|||
160559000|NCT00868790|579769978|FG000|Period 3|Adverse Event|0|||
160559001|NCT00868790|579769979|FG001|Period 3|Adverse Event|0|||
160559002|NCT00868790|579769980|FG002|Period 3|Adverse Event|0|||
160559003|NCT00868790|579769981|FG003|Period 3|Adverse Event|0|||
160559004|NCT00868790|579769982|FG004|Period 3|Adverse Event|0|||
160559005|NCT00868790|579769983|FG005|Period 3|Adverse Event|0|||
160559006|NCT00868790|579769984|FG006|Period 3|Adverse Event|0|||
160559007|NCT00868790|579769985|FG007|Period 3|Adverse Event|0|||
160559008|NCT00868790|579769986|FG008|Period 3|Adverse Event|0|||
160559009|NCT00868790|579769987|FG009|Period 3|Adverse Event|1|||
160559010|NCT00868790|579769988|FG010|Period 3|Adverse Event|0|||
160559011|NCT00868790|579769989|FG011|Period 3|Adverse Event|0|||
160559012|NCT00868790|579769990|FG012|Period 3|Adverse Event|0|||
160559013|NCT00868790|579769991|FG013|Period 3|Adverse Event|0|||
160559014|NCT00868790|579769978|FG000|Period 3|Protocol Violation|0|||
160559015|NCT00868790|579769979|FG001|Period 3|Protocol Violation|0|||
160559016|NCT00868790|579769980|FG002|Period 3|Protocol Violation|0|||
160559017|NCT00868790|579769981|FG003|Period 3|Protocol Violation|0|||
160828722|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
160828723|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
160828724|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
160828725|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
160828726|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
160828727|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
160828728|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
160828729|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
160828730|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
160828731|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
160828732|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
160828733|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
160862006|NCT03694353|580887918|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
160559018|NCT00868790|579769982|FG004|Period 3|Protocol Violation|0|||
160559019|NCT00868790|579769983|FG005|Period 3|Protocol Violation|0|||
160559020|NCT00868790|579769984|FG006|Period 3|Protocol Violation|0|||
160559021|NCT00868790|579769985|FG007|Period 3|Protocol Violation|0|||
160559022|NCT00868790|579769986|FG008|Period 3|Protocol Violation|0|||
160559023|NCT00868790|579769987|FG009|Period 3|Protocol Violation|0|||
160559024|NCT00868790|579769988|FG010|Period 3|Protocol Violation|1|||
160559025|NCT00868790|579769989|FG011|Period 3|Protocol Violation|0|||
160559026|NCT00868790|579769990|FG012|Period 3|Protocol Violation|0|||
160559027|NCT00868790|579769991|FG013|Period 3|Protocol Violation|0|||
160559028|NCT00868790|579769978|FG000|Period 3|Study Terminated by Sponsor|0|||
160559029|NCT00868790|579769979|FG001|Period 3|Study Terminated by Sponsor|0|||
160559030|NCT00868790|579769980|FG002|Period 3|Study Terminated by Sponsor|0|||
160559031|NCT00868790|579769981|FG003|Period 3|Study Terminated by Sponsor|1|||
160559032|NCT00868790|579769982|FG004|Period 3|Study Terminated by Sponsor|0|||
160559033|NCT00868790|579769983|FG005|Period 3|Study Terminated by Sponsor|0|||
160559034|NCT00868790|579769984|FG006|Period 3|Study Terminated by Sponsor|0|||
160559035|NCT00868790|579769985|FG007|Period 3|Study Terminated by Sponsor|0|||
160559036|NCT00868790|579769986|FG008|Period 3|Study Terminated by Sponsor|0|||
160559037|NCT00868790|579769987|FG009|Period 3|Study Terminated by Sponsor|0|||
160559038|NCT00868790|579769988|FG010|Period 3|Study Terminated by Sponsor|0|||
160559039|NCT00868790|579769989|FG011|Period 3|Study Terminated by Sponsor|0|||
160559040|NCT00868790|579769990|FG012|Period 3|Study Terminated by Sponsor|0|||
160559041|NCT00868790|579769991|FG013|Period 3|Study Terminated by Sponsor|0|||
160559042|NCT00868790|579769978|FG000|Period 4|Adverse Event|0|||
160559043|NCT00868790|579769979|FG001|Period 4|Adverse Event|0|||
160559044|NCT00868790|579769980|FG002|Period 4|Adverse Event|0|||
160559045|NCT00868790|579769981|FG003|Period 4|Adverse Event|0|||
160559046|NCT00868790|579769982|FG004|Period 4|Adverse Event|0|||
160559047|NCT00868790|579769983|FG005|Period 4|Adverse Event|0|||
160559048|NCT00868790|579769984|FG006|Period 4|Adverse Event|0|||
160559049|NCT00868790|579769985|FG007|Period 4|Adverse Event|1|||
160559050|NCT00868790|579769986|FG008|Period 4|Adverse Event|0|||
160559051|NCT00868790|579769987|FG009|Period 4|Adverse Event|0|||
160559052|NCT00868790|579769988|FG010|Period 4|Adverse Event|1|||
160559053|NCT00868790|579769989|FG011|Period 4|Adverse Event|0|||
160559054|NCT00868790|579769990|FG012|Period 4|Adverse Event|1|||
160559055|NCT00868790|579769991|FG013|Period 4|Adverse Event|0|||
160559056|NCT00868790|579769978|FG000|Period 4|Lost to Follow-up|0|||
160559057|NCT00868790|579769979|FG001|Period 4|Lost to Follow-up|0|||
160559058|NCT00868790|579769980|FG002|Period 4|Lost to Follow-up|0|||
160559059|NCT00868790|579769981|FG003|Period 4|Lost to Follow-up|0|||
160559060|NCT00868790|579769982|FG004|Period 4|Lost to Follow-up|0|||
160559061|NCT00868790|579769983|FG005|Period 4|Lost to Follow-up|0|||
160559062|NCT00868790|579769984|FG006|Period 4|Lost to Follow-up|0|||
160559063|NCT00868790|579769985|FG007|Period 4|Lost to Follow-up|1|||
160559064|NCT00868790|579769986|FG008|Period 4|Lost to Follow-up|0|||
160559065|NCT00868790|579769987|FG009|Period 4|Lost to Follow-up|0|||
160559066|NCT00868790|579769988|FG010|Period 4|Lost to Follow-up|0|||
160559067|NCT00868790|579769989|FG011|Period 4|Lost to Follow-up|0|||
160559068|NCT00868790|579769990|FG012|Period 4|Lost to Follow-up|0|||
160559069|NCT00868790|579769991|FG013|Period 4|Lost to Follow-up|0|||
160559070|NCT00868790|579769978|FG000|Period 4|Study Terminated by Sponsor|2|||
160559071|NCT00868790|579769979|FG001|Period 4|Study Terminated by Sponsor|0|||
160559072|NCT00868790|579769980|FG002|Period 4|Study Terminated by Sponsor|0|||
160559073|NCT00868790|579769981|FG003|Period 4|Study Terminated by Sponsor|0|||
160559074|NCT00868790|579769982|FG004|Period 4|Study Terminated by Sponsor|0|||
160559075|NCT00868790|579769983|FG005|Period 4|Study Terminated by Sponsor|0|||
160559076|NCT00868790|579769984|FG006|Period 4|Study Terminated by Sponsor|0|||
160559077|NCT00868790|579769985|FG007|Period 4|Study Terminated by Sponsor|1|||
160559078|NCT00868790|579769986|FG008|Period 4|Study Terminated by Sponsor|2|||
160559079|NCT00868790|579769987|FG009|Period 4|Study Terminated by Sponsor|0|||
160559080|NCT00868790|579769988|FG010|Period 4|Study Terminated by Sponsor|2|||
160559081|NCT00868790|579769989|FG011|Period 4|Study Terminated by Sponsor|1|||
160559082|NCT00868790|579769990|FG012|Period 4|Study Terminated by Sponsor|0|||
160559083|NCT00868790|579769991|FG013|Period 4|Study Terminated by Sponsor|1|||
160559084|NCT00868790|579769978|FG000|Period 4|Abnormal ALT/AST|0|||
160559085|NCT00868790|579769979|FG001|Period 4|Abnormal ALT/AST|0|||
160559086|NCT00868790|579769980|FG002|Period 4|Abnormal ALT/AST|1|||
160559087|NCT00868790|579769981|FG003|Period 4|Abnormal ALT/AST|0|||
160559088|NCT00868790|579769982|FG004|Period 4|Abnormal ALT/AST|0|||
160559089|NCT00868790|579769983|FG005|Period 4|Abnormal ALT/AST|0|||
160559090|NCT00868790|579769984|FG006|Period 4|Abnormal ALT/AST|0|||
160559091|NCT00868790|579769985|FG007|Period 4|Abnormal ALT/AST|0|||
160559092|NCT00868790|579769986|FG008|Period 4|Abnormal ALT/AST|0|||
160559093|NCT00868790|579769987|FG009|Period 4|Abnormal ALT/AST|0|||
160559094|NCT00868790|579769988|FG010|Period 4|Abnormal ALT/AST|0|||
160559095|NCT00868790|579769989|FG011|Period 4|Abnormal ALT/AST|0|||
160559096|NCT00868790|579769990|FG012|Period 4|Abnormal ALT/AST|0|||
160559097|NCT00868790|579769991|FG013|Period 4|Abnormal ALT/AST|0|||
160559098|NCT00868790|579769978|FG000|Post-study|Withdrawal by Subject|0|||
160559099|NCT00868790|579769979|FG001|Post-study|Withdrawal by Subject|0|||
160559100|NCT00868790|579769980|FG002|Post-study|Withdrawal by Subject|0|||
160559101|NCT00868790|579769981|FG003|Post-study|Withdrawal by Subject|0|||
160559102|NCT00868790|579769982|FG004|Post-study|Withdrawal by Subject|1|||
160559103|NCT00868790|579769983|FG005|Post-study|Withdrawal by Subject|0|||
160559104|NCT00868790|579769984|FG006|Post-study|Withdrawal by Subject|0|||
160559105|NCT00868790|579769985|FG007|Post-study|Withdrawal by Subject|0|||
160559106|NCT00868790|579769986|FG008|Post-study|Withdrawal by Subject|0|||
160559107|NCT00868790|579769987|FG009|Post-study|Withdrawal by Subject|0|||
160559108|NCT00868790|579769988|FG010|Post-study|Withdrawal by Subject|0|||
160559109|NCT00868790|579769989|FG011|Post-study|Withdrawal by Subject|0|||
160559110|NCT00868790|579769990|FG012|Post-study|Withdrawal by Subject|0|||
160559111|NCT00868790|579769991|FG013|Post-study|Withdrawal by Subject|0|||
160559112|NCT00868790|579769978|FG000|Post-study|Excluded Medication|0|||
160559113|NCT00868790|579769979|FG001|Post-study|Excluded Medication|0|||
160559114|NCT00868790|579769980|FG002|Post-study|Excluded Medication|0|||
160559115|NCT00868790|579769981|FG003|Post-study|Excluded Medication|0|||
160559116|NCT00868790|579769982|FG004|Post-study|Excluded Medication|0|||
160559117|NCT00868790|579769983|FG005|Post-study|Excluded Medication|0|||
160559118|NCT00868790|579769984|FG006|Post-study|Excluded Medication|0|||
160559119|NCT00868790|579769985|FG007|Post-study|Excluded Medication|2|||
160559120|NCT00868790|579769986|FG008|Post-study|Excluded Medication|0|||
160559121|NCT00868790|579769987|FG009|Post-study|Excluded Medication|1|||
160559122|NCT00868790|579769988|FG010|Post-study|Excluded Medication|0|||
160559123|NCT00868790|579769989|FG011|Post-study|Excluded Medication|0|||
160559124|NCT00868790|579769990|FG012|Post-study|Excluded Medication|0|||
160559125|NCT00868790|579769991|FG013|Post-study|Excluded Medication|0|||
160559126|NCT01264939|579769992|FG000|Overall Study|Adverse Event|1|||
160559127|NCT01264939|579769993|FG001|Overall Study|Adverse Event|3|||
160559128|NCT01264939|579769992|FG000|Overall Study|Lost to Follow-up|0|||
160559129|NCT01264939|579769993|FG001|Overall Study|Lost to Follow-up|3|||
160559130|NCT01264939|579769992|FG000|Overall Study|Physician Decision|1|||
160559131|NCT01264939|579769993|FG001|Overall Study|Physician Decision|1|||
160559132|NCT01264939|579769992|FG000|Overall Study|Patient/Guardian Decision|8|||
160559133|NCT01264939|579769993|FG001|Overall Study|Patient/Guardian Decision|10|||
160559134|NCT01264939|579769992|FG000|Overall Study|Disease Progression|8|||
160559135|NCT01264939|579769993|FG001|Overall Study|Disease Progression|11|||
160559136|NCT01171612|579769995|FG000|Overall Study|Lost to Follow-up|51|||
160559137|NCT02909153|579769996|FG000|Overall Study|Withdrawal by Subject|0|||
160559138|NCT02909153|579769997|FG001|Overall Study|Withdrawal by Subject|1|||
160559139|NCT02909153|579769998|FG002|Overall Study|Withdrawal by Subject|0|||
160559140|NCT02909153|579769999|FG003|Overall Study|Withdrawal by Subject|0|||
160559141|NCT02909153|579770000|FG004|Overall Study|Withdrawal by Subject|0|||
160559142|NCT03040024|579770001|FG000|Overall Study|Adverse Event|0|||
160559143|NCT03040024|579770002|FG001|Overall Study|Adverse Event|1|||
160559144|NCT03040024|579770003|FG002|Overall Study|Adverse Event|0|||
160559145|NCT03040024|579770001|FG000|Overall Study|Death|0|||
160559146|NCT03040024|579770002|FG001|Overall Study|Death|1|||
160559147|NCT03040024|579770003|FG002|Overall Study|Death|0|||
160559148|NCT03040024|579770001|FG000|Overall Study|Physician Decision|0|||
160559149|NCT03040024|579770002|FG001|Overall Study|Physician Decision|0|||
160559150|NCT03040024|579770003|FG002|Overall Study|Physician Decision|1|||
160559151|NCT02658812|579770006|FG000|Overall Study|Disease Progression|7|||
160559152|NCT02658812|579770006|FG000|Overall Study|Unrelated to study treatment|1|||
160559153|NCT02658812|579770006|FG000|Overall Study|Adverse Event|1|||
160559154|NCT00854828|579770009|FG000|Overall Study|Death|1|||
160559155|NCT00854828|579770010|FG001|Overall Study|Death|0|||
160559156|NCT00854828|579770011|FG002|Overall Study|Death|0|||
160559157|NCT00854828|579770012|FG003|Overall Study|Death|0|||
160559158|NCT00854828|579770009|FG000|Overall Study|Withdrawal by Subject|1|||
160559159|NCT00854828|579770010|FG001|Overall Study|Withdrawal by Subject|1|||
160559160|NCT00854828|579770011|FG002|Overall Study|Withdrawal by Subject|0|||
160559161|NCT00854828|579770012|FG003|Overall Study|Withdrawal by Subject|9|||
160559162|NCT00854828|579770009|FG000|Overall Study|Missed 24mo visit|1|||
160559163|NCT00854828|579770010|FG001|Overall Study|Missed 24mo visit|1|||
160559164|NCT00854828|579770011|FG002|Overall Study|Missed 24mo visit|8|||
160559165|NCT00854828|579770012|FG003|Overall Study|Missed 24mo visit|8|||
160559166|NCT01282229|579770013|FG000|Overall Study|Protocol Violation|2|||
160559167|NCT00996203|579770014|FG000|Overall Study|Adverse Event|3|||
160559168|NCT00996203|579770014|FG000|Overall Study|Lost to Follow-up|1|||
160559169|NCT00996203|579770014|FG000|Overall Study|Lack of Efficacy|1|||
160559170|NCT00996203|579770014|FG000|Overall Study|Protocol Violation|2|||
160559171|NCT01671280|579770015|FG000|Overall Study|Withdrawal by Subject|2|||
160559172|NCT01959165|579770016|FG000|Overall Study|Adverse Event|0|||
160559173|NCT01959165|579770017|FG001|Overall Study|Adverse Event|0|||
160559174|NCT01959165|579770018|FG002|Overall Study|Adverse Event|0|||
160559175|NCT01959165|579770019|FG003|Overall Study|Adverse Event|1|||
160559176|NCT01959165|579770016|FG000|Overall Study|Lack of Efficacy|1|||
160559177|NCT01959165|579770017|FG001|Overall Study|Lack of Efficacy|0|||
160559178|NCT01959165|579770018|FG002|Overall Study|Lack of Efficacy|0|||
160559179|NCT01959165|579770019|FG003|Overall Study|Lack of Efficacy|0|||
160559180|NCT01959165|579770016|FG000|Overall Study|overdose|0|||
160559181|NCT01959165|579770017|FG001|Overall Study|overdose|0|||
160559182|NCT01959165|579770018|FG002|Overall Study|overdose|0|||
160903038|NCT01681472|581037928|FG002|Overall Study|Adverse Event|0|||
160903039|NCT01681472|581037929|FG003|Overall Study|Adverse Event|0|||
160903040|NCT01696071|581037942|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
160903041|NCT01696071|581037943|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
160559183|NCT01959165|579770019|FG003|Overall Study|overdose|1|||
160559184|NCT01959165|579770016|FG000|Overall Study|Welfare recipient|0|||
160559185|NCT01959165|579770017|FG001|Overall Study|Welfare recipient|1|||
160559186|NCT01959165|579770018|FG002|Overall Study|Welfare recipient|0|||
160559187|NCT01959165|579770019|FG003|Overall Study|Welfare recipient|0|||
160559188|NCT03686969|579770020|FG000|Overall Study|Study terminated|1|||
160559189|NCT03686969|579770021|FG001|Overall Study|Study terminated|0|||
160559190|NCT01988090|579770025|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
160559191|NCT01988090|579770026|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
160559192|NCT01988090|579770025|FG000|Start Treament After Randomization|Protocol Violation|0|||
160559193|NCT01988090|579770026|FG001|Start Treament After Randomization|Protocol Violation|1|||
160559194|NCT01988090|579770025|FG000|Complete Study After Start|Withdrawal by Subject|2|||
160903042|NCT00678080|581037947|FG000|Overall Study|Physician Decision|2|||
160903043|NCT00678080|581037948|FG001|Overall Study|Physician Decision|0|||
160559195|NCT01988090|579770026|FG001|Complete Study After Start|Withdrawal by Subject|0|||
160559196|NCT01988090|579770025|FG000|Complete Study After Start|Protocol Violation|1|||
160559197|NCT01988090|579770026|FG001|Complete Study After Start|Protocol Violation|1|||
160559198|NCT03887130|579770029|FG000|Overall Study|Progressive disease|23|||
160559199|NCT03887130|579770030|FG001|Overall Study|Progressive disease|14|||
160559200|NCT03887130|579770031|FG002|Overall Study|Progressive disease|7|||
160559201|NCT03887130|579770029|FG000|Overall Study|Protocol Violation|3|||
160559202|NCT03887130|579770030|FG001|Overall Study|Protocol Violation|1|||
160559203|NCT03887130|579770031|FG002|Overall Study|Protocol Violation|2|||
160559204|NCT03887130|579770029|FG000|Overall Study|Drug related toxicity|7|||
160559205|NCT03887130|579770030|FG001|Overall Study|Drug related toxicity|7|||
160559206|NCT03887130|579770031|FG002|Overall Study|Drug related toxicity|13|||
160990750|NCT01511250|581353950|FG005|Overall Study|Lost to Follow-up|0|||
160990751|NCT01511250|581353951|FG006|Overall Study|Lost to Follow-up|2|||
160990752|NCT01511250|581353952|FG007|Overall Study|Lost to Follow-up|3|||
160990753|NCT01511250|581353953|FG008|Overall Study|Lost to Follow-up|13|||
160990754|NCT01511250|581353954|FG009|Overall Study|Lost to Follow-up|5|||
160990755|NCT01511250|581353945|FG000|Overall Study|Protocol Violation|0|||
160990756|NCT01511250|581353946|FG001|Overall Study|Protocol Violation|2|||
160990757|NCT01511250|581353947|FG002|Overall Study|Protocol Violation|1|||
160990758|NCT01511250|581353948|FG003|Overall Study|Protocol Violation|0|||
160990759|NCT01511250|581353949|FG004|Overall Study|Protocol Violation|0|||
160990760|NCT01511250|581353950|FG005|Overall Study|Protocol Violation|0|||
160990761|NCT01511250|581353951|FG006|Overall Study|Protocol Violation|0|||
160990762|NCT01511250|581353952|FG007|Overall Study|Protocol Violation|0|||
160990763|NCT01511250|581353953|FG008|Overall Study|Protocol Violation|0|||
160990764|NCT01511250|581353954|FG009|Overall Study|Protocol Violation|0|||
160990765|NCT02095158|581353960|FG000|Overall Study|Adverse Event|14|||
160990766|NCT02095158|581353960|FG000|Overall Study|Lack of Efficacy|3|||
160990767|NCT02095158|581353960|FG000|Overall Study|Pregnancy|1|||
160990768|NCT02095158|581353960|FG000|Overall Study|Lost to Follow-up|20|||
160990769|NCT02095158|581353960|FG000|Overall Study|Personal Reasons|35|||
160990770|NCT02095158|581353960|FG000|Overall Study|Protocol Violation|1|||
160990771|NCT02095158|581353960|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160990772|NCT01941316|581353961|FG000|Overall Study|Adverse Event|0|||
160990773|NCT01941316|581353962|FG001|Overall Study|Adverse Event|1|||
160990774|NCT01941316|581353963|FG002|Overall Study|Adverse Event|0|||
160990775|NCT01941316|581353964|FG003|Overall Study|Adverse Event|7|||
160990776|NCT01941316|581353961|FG000|Overall Study|Progressive Disease|3|||
160990777|NCT01941316|581353962|FG001|Overall Study|Progressive Disease|6|||
160990778|NCT01941316|581353963|FG002|Overall Study|Progressive Disease|2|||
160990779|NCT01941316|581353964|FG003|Overall Study|Progressive Disease|29|||
160990780|NCT01941316|581353961|FG000|Overall Study|Withdrawal by Subject|0|||
160990781|NCT01941316|581353962|FG001|Overall Study|Withdrawal by Subject|2|||
160990782|NCT01941316|581353963|FG002|Overall Study|Withdrawal by Subject|1|||
160990783|NCT01941316|581353964|FG003|Overall Study|Withdrawal by Subject|8|||
160990784|NCT01941316|581353961|FG000|Overall Study|Death|0|||
160990785|NCT01941316|581353962|FG001|Overall Study|Death|0|||
160990786|NCT01941316|581353963|FG002|Overall Study|Death|0|||
160990787|NCT01941316|581353964|FG003|Overall Study|Death|3|||
160990788|NCT01941316|581353961|FG000|Overall Study|Physician Decision|0|||
160990789|NCT01941316|581353962|FG001|Overall Study|Physician Decision|0|||
160559207|NCT03887130|579770029|FG000|Overall Study|Non drug related toxicity|3|||
160559208|NCT03887130|579770030|FG001|Overall Study|Non drug related toxicity|0|||
160559209|NCT03887130|579770031|FG002|Overall Study|Non drug related toxicity|0|||
160559210|NCT03887130|579770029|FG000|Overall Study|Death|2|||
160828734|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
160828735|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
160828736|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
160828737|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
160828738|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
160828739|NCT02008357|580759861|FG000|Open-label Extension Period|Adverse Event|8|||
160828740|NCT02008357|580759862|FG001|Open-label Extension Period|Adverse Event|7|||
160828741|NCT02008357|580759861|FG000|Open-label Extension Period|Death|7|||
160828742|NCT02008357|580759862|FG001|Open-label Extension Period|Death|4|||
160828743|NCT02008357|580759861|FG000|Open-label Extension Period|Lack of Efficacy|9|||
160828744|NCT02008357|580759862|FG001|Open-label Extension Period|Lack of Efficacy|5|||
160828745|NCT02008357|580759861|FG000|Open-label Extension Period|Lost to Follow-up|2|||
160828746|NCT02008357|580759862|FG001|Open-label Extension Period|Lost to Follow-up|2|||
160828747|NCT02008357|580759861|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
160828748|NCT02008357|580759862|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
160828749|NCT02008357|580759861|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
160828750|NCT02008357|580759862|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
160828751|NCT02008357|580759861|FG000|Open-label Extension Period|Safety Risk|2|||
160990790|NCT01941316|581353963|FG002|Overall Study|Physician Decision|0|||
160990791|NCT01941316|581353964|FG003|Overall Study|Physician Decision|3|||
160990792|NCT01941316|581353961|FG000|Overall Study|Protocol Violation|0|||
160990793|NCT01941316|581353962|FG001|Overall Study|Protocol Violation|0|||
160990794|NCT01941316|581353963|FG002|Overall Study|Protocol Violation|0|||
160559211|NCT03887130|579770030|FG001|Overall Study|Death|2|||
160559212|NCT03887130|579770031|FG002|Overall Study|Death|1|||
160559213|NCT03887130|579770029|FG000|Overall Study|Withdrawal by Subject|7|||
160559214|NCT03887130|579770030|FG001|Overall Study|Withdrawal by Subject|6|||
160559215|NCT03887130|579770031|FG002|Overall Study|Withdrawal by Subject|11|||
160559216|NCT03887130|579770029|FG000|Overall Study|other reason|6|||
160559217|NCT03887130|579770030|FG001|Overall Study|other reason|20|||
160559218|NCT03887130|579770031|FG002|Overall Study|other reason|17|||
160559219|NCT00927563|579770032|FG000|Overall Study|Lost to Follow-up|1|||
160559220|NCT00927563|579770032|FG000|Overall Study|Withdrawal by Subject|1|||
160559221|NCT02497001|579770035|FG000|Overall Study|Lost to Follow-up|10|||
160559222|NCT02497001|579770036|FG001|Overall Study|Lost to Follow-up|2|||
160559223|NCT02497001|579770037|FG002|Overall Study|Lost to Follow-up|0|||
160559224|NCT02497001|579770038|FG003|Overall Study|Lost to Follow-up|2|||
160559225|NCT02497001|579770035|FG000|Overall Study|Adverse Event|28|||
160559226|NCT02497001|579770036|FG001|Overall Study|Adverse Event|30|||
160559227|NCT02497001|579770037|FG002|Overall Study|Adverse Event|11|||
160990795|NCT01941316|581353964|FG003|Overall Study|Protocol Violation|3|||
160990796|NCT01941316|581353961|FG000|Overall Study|Intercurrent illness|0|||
160990797|NCT01941316|581353962|FG001|Overall Study|Intercurrent illness|0|||
160990798|NCT01941316|581353963|FG002|Overall Study|Intercurrent illness|0|||
160990799|NCT01941316|581353964|FG003|Overall Study|Intercurrent illness|1|||
160990800|NCT01941316|581353961|FG000|Overall Study|Other, not specified|0|||
160990801|NCT01941316|581353962|FG001|Overall Study|Other, not specified|0|||
160990802|NCT01941316|581353963|FG002|Overall Study|Other, not specified|0|||
160990803|NCT01941316|581353964|FG003|Overall Study|Other, not specified|1|||
160990804|NCT02775435|581353965|FG000|Overall Study|Adverse Event|32|||
160990805|NCT02775435|581353966|FG001|Overall Study|Adverse Event|27|||
160990806|NCT02775435|581353965|FG000|Overall Study|Lost to Follow-up|2|||
160990807|NCT02775435|581353966|FG001|Overall Study|Lost to Follow-up|2|||
160990808|NCT02775435|581353965|FG000|Overall Study|Sponsor decision|44|||
160990809|NCT02775435|581353966|FG001|Overall Study|Sponsor decision|19|||
160990810|NCT02775435|581353965|FG000|Overall Study|Withdrawal by Subject|4|||
160990811|NCT02775435|581353966|FG001|Overall Study|Withdrawal by Subject|9|||
160559228|NCT02497001|579770038|FG003|Overall Study|Adverse Event|11|||
160559229|NCT02497001|579770035|FG000|Overall Study|Withdrawal by Subject|14|||
160559230|NCT02497001|579770036|FG001|Overall Study|Withdrawal by Subject|37|||
160559231|NCT02497001|579770037|FG002|Overall Study|Withdrawal by Subject|19|||
160559232|NCT02497001|579770038|FG003|Overall Study|Withdrawal by Subject|15|||
160559233|NCT02497001|579770035|FG000|Overall Study|Physician Decision|5|||
160990812|NCT02775435|581353965|FG000|Overall Study|Death|196|||
160990813|NCT02775435|581353966|FG001|Overall Study|Death|224|||
160559234|NCT02497001|579770036|FG001|Overall Study|Physician Decision|11|||
160559235|NCT02497001|579770037|FG002|Overall Study|Physician Decision|5|||
160559236|NCT02497001|579770038|FG003|Overall Study|Physician Decision|1|||
160559237|NCT02497001|579770035|FG000|Overall Study|subjects that were not treated|1|||
160559238|NCT02497001|579770036|FG001|Overall Study|subjects that were not treated|2|||
160559239|NCT02497001|579770037|FG002|Overall Study|subjects that were not treated|2|||
160559240|NCT02497001|579770038|FG003|Overall Study|subjects that were not treated|1|||
160559241|NCT02497001|579770035|FG000|Overall Study|Major Protocol Deviation|3|||
160559242|NCT02497001|579770036|FG001|Overall Study|Major Protocol Deviation|4|||
160559243|NCT02497001|579770037|FG002|Overall Study|Major Protocol Deviation|4|||
160559244|NCT02497001|579770038|FG003|Overall Study|Major Protocol Deviation|4|||
160559245|NCT02497001|579770035|FG000|Overall Study|Lack of Efficacy|10|||
160559246|NCT02497001|579770036|FG001|Overall Study|Lack of Efficacy|16|||
160828752|NCT02008357|580759862|FG001|Open-label Extension Period|Safety Risk|1|||
160828753|NCT02008357|580759861|FG000|Open-label Extension Period|Non-Compliance|0|||
160828754|NCT02008357|580759862|FG001|Open-label Extension Period|Non-Compliance|1|||
160828755|NCT02008357|580759861|FG000|Open-label Extension Period|Investigator Recommendation|0|||
160828756|NCT02008357|580759862|FG001|Open-label Extension Period|Investigator Recommendation|1|||
160828757|NCT02008357|580759861|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
160828758|NCT02008357|580759862|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
160828759|NCT02008357|580759861|FG000|Open-label Extension Period|Coordinating Center Request|2|||
160828760|NCT02008357|580759862|FG001|Open-label Extension Period|Coordinating Center Request|4|||
160828761|NCT02008357|580759861|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
160990814|NCT00320489|581353967|FG000|Overall Study|Adverse Event|26|||
160990815|NCT00320489|581353968|FG001|Overall Study|Adverse Event|25|||
160559247|NCT02497001|579770037|FG002|Overall Study|Lack of Efficacy|6|||
160559248|NCT02497001|579770038|FG003|Overall Study|Lack of Efficacy|6|||
160559249|NCT02497001|579770035|FG000|Overall Study|Protocol Violation|3|||
160559250|NCT02497001|579770036|FG001|Overall Study|Protocol Violation|1|||
160559251|NCT02497001|579770037|FG002|Overall Study|Protocol Violation|3|||
160559252|NCT02497001|579770038|FG003|Overall Study|Protocol Violation|1|||
160559253|NCT00654498|579770042|FG000|Overall Study|Not Treated|1|||
160559254|NCT00654498|579770043|FG001|Overall Study|Not Treated|0|||
160559255|NCT00654498|579770042|FG000|Overall Study|Adverse Event|6|||
160559256|NCT00654498|579770043|FG001|Overall Study|Adverse Event|1|||
160559257|NCT00654498|579770042|FG000|Overall Study|Protocol Violation|1|||
160559258|NCT00654498|579770043|FG001|Overall Study|Protocol Violation|1|||
160559259|NCT00654498|579770042|FG000|Overall Study|Lost to Follow-up|1|||
160559260|NCT00654498|579770043|FG001|Overall Study|Lost to Follow-up|5|||
160559261|NCT00654498|579770042|FG000|Overall Study|Withdrawal by Subject|1|||
160559262|NCT00654498|579770043|FG001|Overall Study|Withdrawal by Subject|0|||
160559263|NCT00654498|579770042|FG000|Overall Study|Other reason not defined above|4|||
160559264|NCT00654498|579770043|FG001|Overall Study|Other reason not defined above|5|||
160559265|NCT00787787|579770044|FG000|Overall Study|Lack of Efficacy|4|||
160559266|NCT00787787|579770044|FG000|Overall Study|Adverse Event|3|||
160559267|NCT01468987|579770045|FG000|Overall Study|Adverse Event|12|||
160559268|NCT01468987|579770046|FG001|Overall Study|Adverse Event|9|||
160559269|NCT01468987|579770045|FG000|Overall Study|Death|4|||
160559270|NCT01468987|579770046|FG001|Overall Study|Death|1|||
160559271|NCT01468987|579770045|FG000|Overall Study|Lost to Follow-up|10|||
160559272|NCT01468987|579770046|FG001|Overall Study|Lost to Follow-up|5|||
160559273|NCT01468987|579770045|FG000|Overall Study|Protocol Violation|8|||
160559274|NCT01468987|579770046|FG001|Overall Study|Protocol Violation|2|||
160559275|NCT01468987|579770045|FG000|Overall Study|Withdrawal by Subject|28|||
160559276|NCT01468987|579770046|FG001|Overall Study|Withdrawal by Subject|28|||
160559277|NCT01468987|579770045|FG000|Overall Study|Physician Decision|8|||
160559278|NCT01468987|579770046|FG001|Overall Study|Physician Decision|15|||
160559279|NCT01468987|579770045|FG000|Overall Study|Sponsor Decision|1|||
160559280|NCT01468987|579770046|FG001|Overall Study|Sponsor Decision|0|||
160559281|NCT03430986|579770048|FG000|24-week Control Period|Adverse Event|1|||
160559282|NCT03430986|579770049|FG001|24-week Control Period|Adverse Event|0|||
160559283|NCT03430986|579770048|FG000|24-week Control Period|Lost to Follow-up|2|||
160559284|NCT03430986|579770049|FG001|24-week Control Period|Lost to Follow-up|2|||
160559285|NCT03430986|579770048|FG000|24-week Control Period|Withdrawal by Participant|5|||
160559286|NCT03430986|579770049|FG001|24-week Control Period|Withdrawal by Participant|0|||
160559287|NCT03430986|579770048|FG000|24-week Control Period|Protocol Deviation|0|||
160559288|NCT03430986|579770049|FG001|24-week Control Period|Protocol Deviation|2|||
160559289|NCT03430986|579770048|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
160559290|NCT03430986|579770049|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
160559291|NCT03430986|579770048|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
160559292|NCT03430986|579770049|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
160559293|NCT01889602|579770052|FG000|First Intervention|Adverse Event|1|||
160559294|NCT01889602|579770053|FG001|First Intervention|Adverse Event|1|||
160559295|NCT01889602|579770054|FG002|First Intervention|Adverse Event|1|||
160559296|NCT01889602|579770052|FG000|First Intervention|Protocol Violation|0|||
160559297|NCT01889602|579770053|FG001|First Intervention|Protocol Violation|1|||
160559298|NCT01889602|579770054|FG002|First Intervention|Protocol Violation|1|||
160828762|NCT02008357|580759862|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
160828763|NCT02008357|580759861|FG000|Open-label Extension Period|Study Ended|20|||
160828764|NCT02008357|580759862|FG001|Open-label Extension Period|Study Ended|25|||
160828765|NCT02008357|580759861|FG000|Open-label Extension Period|Personal Reasons|0|||
160828766|NCT02008357|580759862|FG001|Open-label Extension Period|Personal Reasons|1|||
160828767|NCT02008357|580759861|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
160828768|NCT02008357|580759862|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
160828769|NCT02008357|580759861|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
160828770|NCT02008357|580759862|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
160828771|NCT02008357|580759861|FG000|Open-label Extension Period|Other|2|||
160828772|NCT02008357|580759862|FG001|Open-label Extension Period|Other|0|||
160828773|NCT02312219|580759864|FG000|Overall Study|Withdrawal by Subject|1|||
160828774|NCT02312219|580759865|FG001|Overall Study|Withdrawal by Subject|2|||
160828775|NCT02312219|580759864|FG000|Overall Study|could not schedule imaging in time|0|||
160828776|NCT02312219|580759865|FG001|Overall Study|could not schedule imaging in time|2|||
160828777|NCT02312219|580759864|FG000|Overall Study|Other|0|||
160828778|NCT02312219|580759865|FG001|Overall Study|Other|1|||
160828779|NCT02312219|580759864|FG000|Overall Study|Not randomized. Ineligible|0|||
160828780|NCT02312219|580759865|FG001|Overall Study|Not randomized. Ineligible|1|||
160828781|NCT03553498|580759866|FG000|Overall Study|Missing primary outcome|1|||
160828782|NCT03553498|580759867|FG001|Overall Study|Missing primary outcome|2|||
160828783|NCT04941807|580759868|FG000|Overall Study|Lost to Follow-up|1|||
160828784|NCT04941807|580759869|FG001|Overall Study|Lost to Follow-up|1|||
160828785|NCT02741570|580759870|FG000|Pre-Treatment Period|Other reasons|0|||
160990816|NCT00320489|581353967|FG000|Overall Study|Clinical Relapse|26|||
160828786|NCT02741570|580759871|FG001|Pre-Treatment Period|Other reasons|3|||
160559299|NCT01889602|579770052|FG000|First Intervention|Study ending|0|||
160559300|NCT01889602|579770053|FG001|First Intervention|Study ending|1|||
160559301|NCT01889602|579770054|FG002|First Intervention|Study ending|0|||
160559302|NCT01889602|579770052|FG000|Second Intervention|Adverse Event|0|||
160559303|NCT01889602|579770053|FG001|Second Intervention|Adverse Event|0|||
160559304|NCT01889602|579770054|FG002|Second Intervention|Adverse Event|1|||
160559305|NCT01889602|579770052|FG000|Second Intervention|Study ending|1|||
160559306|NCT01889602|579770053|FG001|Second Intervention|Study ending|0|||
160559307|NCT01889602|579770054|FG002|Second Intervention|Study ending|0|||
160559308|NCT01889602|579770052|FG000|Second Intervention|Withdrawal by Subject|0|||
160559309|NCT01889602|579770053|FG001|Second Intervention|Withdrawal by Subject|0|||
160559310|NCT01889602|579770054|FG002|Second Intervention|Withdrawal by Subject|1|||
160559311|NCT01889602|579770052|FG000|Third Intervention|Protocol Violation|1|||
160559312|NCT01889602|579770053|FG001|Third Intervention|Protocol Violation|0|||
160559313|NCT01889602|579770054|FG002|Third Intervention|Protocol Violation|0|||
160559314|NCT01889602|579770052|FG000|Third Intervention|Withdrawal by Subject|2|||
160559315|NCT01889602|579770053|FG001|Third Intervention|Withdrawal by Subject|2|||
160559316|NCT01889602|579770054|FG002|Third Intervention|Withdrawal by Subject|0|||
160559317|NCT01412957|579770055|FG000|Overall Study|Withdrawal by Subject|6|||
160559318|NCT01412957|579770056|FG001|Overall Study|Withdrawal by Subject|22|||
160559319|NCT01412957|579770055|FG000|Overall Study|Lost to Follow-up|7|||
160559320|NCT01412957|579770056|FG001|Overall Study|Lost to Follow-up|2|||
160559321|NCT01412957|579770055|FG000|Overall Study|Death|136|||
160559322|NCT01412957|579770056|FG001|Overall Study|Death|133|||
160559323|NCT01445678|579770062|FG000|Overall Study|Adverse Event|12|||
160559324|NCT01445678|579770063|FG001|Overall Study|Adverse Event|8|||
160559325|NCT01445678|579770062|FG000|Overall Study|Lack of Efficacy|0|||
160559326|NCT01445678|579770063|FG001|Overall Study|Lack of Efficacy|2|||
160559327|NCT01445678|579770062|FG000|Overall Study|Lost to Follow-up|8|||
160559328|NCT01445678|579770063|FG001|Overall Study|Lost to Follow-up|5|||
160559329|NCT01445678|579770062|FG000|Overall Study|Protocol Violation|1|||
160559330|NCT01445678|579770063|FG001|Overall Study|Protocol Violation|1|||
160559331|NCT01445678|579770062|FG000|Overall Study|Withdrawal by Subject|9|||
160559332|NCT01445678|579770063|FG001|Overall Study|Withdrawal by Subject|5|||
160559333|NCT01459614|579770066|FG000|Overall Study|Adverse Event|1|||
160559334|NCT01459614|579770067|FG001|Overall Study|Adverse Event|0|||
160559335|NCT01565980|579770068|FG000|Overall Study|Death|1|||
160559336|NCT01565980|579770069|FG001|Overall Study|Death|0|||
160559337|NCT01565980|579770068|FG000|Overall Study|Lost to Follow-up|1|||
160559338|NCT01565980|579770069|FG001|Overall Study|Lost to Follow-up|0|||
160559339|NCT01565980|579770068|FG000|Overall Study|health complications|1|||
160559340|NCT01565980|579770069|FG001|Overall Study|health complications|1|||
160559341|NCT01565980|579770068|FG000|Overall Study|stopped medical treatment|1|||
160559342|NCT01565980|579770069|FG001|Overall Study|stopped medical treatment|0|||
160559343|NCT01565980|579770068|FG000|Overall Study|Withdrawal by Subject|0|||
160559344|NCT01565980|579770069|FG001|Overall Study|Withdrawal by Subject|3|||
160559345|NCT02078219|579770072|FG000|Overall Study|Other|2|||
160559346|NCT02078219|579770073|FG001|Overall Study|Other|2|||
160559347|NCT02078219|579770074|FG002|Overall Study|Other|3|||
160559348|NCT02078219|579770075|FG003|Overall Study|Other|0|||
160559349|NCT02078219|579770076|FG004|Overall Study|Other|1|||
160559350|NCT02078219|579770072|FG000|Overall Study|Withdrawal by Subject|0|||
160559351|NCT02078219|579770073|FG001|Overall Study|Withdrawal by Subject|1|||
160559352|NCT02078219|579770074|FG002|Overall Study|Withdrawal by Subject|0|||
160559353|NCT02078219|579770075|FG003|Overall Study|Withdrawal by Subject|1|||
160559354|NCT02078219|579770076|FG004|Overall Study|Withdrawal by Subject|1|||
160559355|NCT02078219|579770072|FG000|Overall Study|Protocol Violation|0|||
160559356|NCT02078219|579770073|FG001|Overall Study|Protocol Violation|0|||
160559357|NCT02078219|579770074|FG002|Overall Study|Protocol Violation|0|||
160559358|NCT02078219|579770075|FG003|Overall Study|Protocol Violation|1|||
160559359|NCT02078219|579770076|FG004|Overall Study|Protocol Violation|0|||
160559360|NCT02078219|579770072|FG000|Overall Study|Death|0|||
160559361|NCT02078219|579770073|FG001|Overall Study|Death|0|||
160559362|NCT02078219|579770074|FG002|Overall Study|Death|0|||
160559363|NCT02078219|579770075|FG003|Overall Study|Death|1|||
160559364|NCT02078219|579770076|FG004|Overall Study|Death|0|||
160559365|NCT02078219|579770072|FG000|Overall Study|Adverse Event|1|||
160903044|NCT00678080|581037947|FG000|Overall Study|Lost to Follow-up|1|||
160903045|NCT00678080|581037948|FG001|Overall Study|Lost to Follow-up|0|||
160903046|NCT00678080|581037947|FG000|Overall Study|Withdrawal by Subject|0|||
160559366|NCT02078219|579770073|FG001|Overall Study|Adverse Event|1|||
160559367|NCT02078219|579770074|FG002|Overall Study|Adverse Event|3|||
160559368|NCT02078219|579770075|FG003|Overall Study|Adverse Event|1|||
160559369|NCT02078219|579770076|FG004|Overall Study|Adverse Event|0|||
160559370|NCT01468311|579770077|FG000|Overall Study|mobilization failure|1|||
160559371|NCT01468311|579770077|FG000|Overall Study|Withdrawal by Subject|1|||
160559372|NCT04439279|579771998|FG000|Overall Study|Adverse Event|7|||
160559373|NCT04439279|579771998|FG000|Overall Study|Death|4|||
160559374|NCT04439279|579771998|FG000|Overall Study|Disease progression|17|||
160559375|NCT04439279|579771998|FG000|Overall Study|Complicating disease|3|||
160559376|NCT04439279|579771998|FG000|Overall Study|Withdrawal by Subject|2|||
160559377|NCT04439279|579771998|FG000|Overall Study|Ineligible|1|||
160559378|NCT04439279|579771998|FG000|Overall Study|Treatment still ongoing|1|||
160559379|NCT02689492|579771999|FG000|Overall Study|Lost to Follow-up|61|||
160559380|NCT02689492|579771999|FG000|Overall Study|Withdrawal by Subject|11|||
160559381|NCT02689492|579771999|FG000|Overall Study|Death|9|||
160559382|NCT02689492|579771999|FG000|Overall Study|Physician Decision|2|||
160559383|NCT02689492|579771999|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
160903047|NCT00678080|581037948|FG001|Overall Study|Withdrawal by Subject|1|||
160903048|NCT05136690|581037949|FG000|Period 1|Withdrawal by Subject|0|||
160903049|NCT05136690|581037950|FG001|Period 1|Withdrawal by Subject|1|||
160903050|NCT05136690|581037949|FG000|Period 2|Lost to Follow-up|0|||
160903051|NCT05136690|581037950|FG001|Period 2|Lost to Follow-up|3|||
160903052|NCT05136690|581037949|FG000|Period 2|Withdrawal by Subject|0|||
160903053|NCT05136690|581037950|FG001|Period 2|Withdrawal by Subject|1|||
160903054|NCT01453361|581037951|FG000|Overall Study|Disease Progression|6|||
160559384|NCT02689492|579771999|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
160559385|NCT02689492|579771999|FG000|Overall Study|Other than listed|1|||
160559386|NCT02338843|579772005|FG000|Overall Study|Adverse Event|2|||
160559387|NCT02338843|579772006|FG001|Overall Study|Adverse Event|1|||
160559388|NCT02338843|579772005|FG000|Overall Study|Death|40|||
160559389|NCT02338843|579772006|FG001|Overall Study|Death|53|||
160559390|NCT02338843|579772005|FG000|Overall Study|Physician Decision|1|||
160559391|NCT02338843|579772006|FG001|Overall Study|Physician Decision|0|||
160559392|NCT02338843|579772005|FG000|Overall Study|Withdrawal by Subject|0|||
160559393|NCT02338843|579772006|FG001|Overall Study|Withdrawal by Subject|2|||
160559394|NCT02338843|579772005|FG000|Overall Study|Subject Recovered|0|||
160559395|NCT02338843|579772006|FG001|Overall Study|Subject Recovered|2|||
160559396|NCT02338843|579772005|FG000|Overall Study|Discontinued prior to randomizat|1|||
160559397|NCT02338843|579772006|FG001|Overall Study|Discontinued prior to randomizat|0|||
160559398|NCT00110305|579772007|FG000|Overall Study|Adverse Event|46|||
160559399|NCT00110305|579772008|FG001|Overall Study|Adverse Event|13|||
160559400|NCT00110305|579772007|FG000|Overall Study|Sponsors Decision|1|||
160559401|NCT00110305|579772008|FG001|Overall Study|Sponsors Decision|0|||
160559402|NCT00110305|579772007|FG000|Overall Study|Subject Non-Compliant|9|||
160559403|NCT00110305|579772008|FG001|Overall Study|Subject Non-Compliant|2|||
160559404|NCT00110305|579772007|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
160559405|NCT00110305|579772008|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
160559406|NCT00110305|579772007|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
160559407|NCT00110305|579772008|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
160559408|NCT00110305|579772007|FG000|Overall Study|Protocol Violation|0|||
160559409|NCT00110305|579772008|FG001|Overall Study|Protocol Violation|1|||
160559410|NCT00110305|579772007|FG000|Overall Study|Withdrawal by Subject|7|||
160559411|NCT00110305|579772008|FG001|Overall Study|Withdrawal by Subject|7|||
160559412|NCT00110305|579772007|FG000|Overall Study|Lost to Follow-up|20|||
160559413|NCT00110305|579772008|FG001|Overall Study|Lost to Follow-up|3|||
160559414|NCT00110305|579772007|FG000|Overall Study|Other|8|||
160559415|NCT00110305|579772008|FG001|Overall Study|Other|2|||
160559416|NCT01609933|579772019|FG000|Overall Study|Adverse Event|1|||
160559417|NCT01609933|579772019|FG000|Overall Study|Withdrawal by Subject|3|||
160559418|NCT01252966|579772020|FG000|Overall Study|Lost to Follow-up|16|||
160559419|NCT01252966|579772021|FG001|Overall Study|Lost to Follow-up|10|||
160559420|NCT01252966|579772020|FG000|Overall Study|Withdrawal by Subject|7|||
160559421|NCT01252966|579772021|FG001|Overall Study|Withdrawal by Subject|3|||
160559422|NCT04854499|579772025|FG000|Overall Study|Study Terminated by Sponsor|5|||
160559423|NCT04854499|579772026|FG001|Overall Study|Study Terminated by Sponsor|27|||
160559424|NCT04854499|579772027|FG002|Overall Study|Study Terminated by Sponsor|28|||
160559425|NCT04854499|579772028|FG003|Overall Study|Study Terminated by Sponsor|19|||
160559426|NCT04854499|579772029|FG004|Overall Study|Study Terminated by Sponsor|1|||
160559427|NCT04854499|579772030|FG005|Overall Study|Study Terminated by Sponsor|10|||
160559428|NCT04854499|579772025|FG000|Overall Study|Death|1|||
160559429|NCT04854499|579772026|FG001|Overall Study|Death|23|||
160559430|NCT04854499|579772027|FG002|Overall Study|Death|21|||
160559431|NCT04854499|579772028|FG003|Overall Study|Death|7|||
160559432|NCT04854499|579772029|FG004|Overall Study|Death|6|||
160559433|NCT04854499|579772030|FG005|Overall Study|Death|24|||
160559434|NCT04854499|579772025|FG000|Overall Study|Investigator's Discretion|0|||
160559435|NCT04854499|579772026|FG001|Overall Study|Investigator's Discretion|1|||
160559436|NCT04854499|579772027|FG002|Overall Study|Investigator's Discretion|3|||
160559437|NCT04854499|579772028|FG003|Overall Study|Investigator's Discretion|4|||
160559438|NCT04854499|579772029|FG004|Overall Study|Investigator's Discretion|1|||
160559439|NCT04854499|579772030|FG005|Overall Study|Investigator's Discretion|5|||
160990817|NCT00320489|581353968|FG001|Overall Study|Clinical Relapse|20|||
160990818|NCT00320489|581353967|FG000|Overall Study|Death|0|||
160559440|NCT04854499|579772025|FG000|Overall Study|Withdrew Consent|0|||
160559441|NCT04854499|579772026|FG001|Overall Study|Withdrew Consent|1|||
160559442|NCT04854499|579772027|FG002|Overall Study|Withdrew Consent|2|||
160862007|NCT03804528|580887919|FG000|Overall Study|Time Commitment|18|||
160990819|NCT00320489|581353968|FG001|Overall Study|Death|2|||
160559443|NCT04854499|579772028|FG003|Overall Study|Withdrew Consent|2|||
160559444|NCT04854499|579772029|FG004|Overall Study|Withdrew Consent|0|||
160559445|NCT04854499|579772030|FG005|Overall Study|Withdrew Consent|1|||
160559446|NCT04854499|579772025|FG000|Overall Study|Lost to Follow-up|0|||
160559447|NCT04854499|579772026|FG001|Overall Study|Lost to Follow-up|0|||
160559448|NCT04854499|579772027|FG002|Overall Study|Lost to Follow-up|0|||
160559449|NCT04854499|579772028|FG003|Overall Study|Lost to Follow-up|0|||
160559450|NCT04854499|579772029|FG004|Overall Study|Lost to Follow-up|0|||
160559451|NCT04854499|579772030|FG005|Overall Study|Lost to Follow-up|1|||
160559452|NCT00398112|579772048|FG000|Overall Study|Adverse Event|4|||
160559453|NCT00398112|579772048|FG000|Overall Study|Disease progression|9|||
160559454|NCT00398112|579772048|FG000|Overall Study|Alternative treatment|1|||
160559455|NCT00398112|579772048|FG000|Overall Study|Withdrawal by Subject|3|||
160559456|NCT00398112|579772048|FG000|Overall Study|Death|1|||
160559457|NCT00582556|579772049|FG000|Overall Study|Withdrawal by Subject|0|||
160559458|NCT00582556|579772050|FG001|Overall Study|Withdrawal by Subject|1|||
160559459|NCT00582556|579772051|FG002|Overall Study|Withdrawal by Subject|1|||
160559460|NCT00582556|579772049|FG000|Overall Study|Physician Decision|0|||
160559461|NCT00582556|579772050|FG001|Overall Study|Physician Decision|0|||
160559462|NCT00582556|579772051|FG002|Overall Study|Physician Decision|1|||
160559463|NCT01993888|579772052|FG000|Overall Study|Death|1|||
160559464|NCT01993888|579772053|FG001|Overall Study|Death|1|||
160559465|NCT01993888|579772052|FG000|Overall Study|Lost to Follow-up|1|||
160559466|NCT01993888|579772053|FG001|Overall Study|Lost to Follow-up|1|||
160559467|NCT01993888|579772052|FG000|Overall Study|Withdrawal by Subject|0|||
160559468|NCT01993888|579772053|FG001|Overall Study|Withdrawal by Subject|1|||
160559469|NCT00522392|579772061|FG000|Overall Study|Disease progression|0|||
160559470|NCT00522392|579772062|FG001|Overall Study|Disease progression|3|||
160559471|NCT00522392|579772061|FG000|Overall Study|Adverse Event|7|||
160559472|NCT00522392|579772062|FG001|Overall Study|Adverse Event|7|||
160559473|NCT00522392|579772061|FG000|Overall Study|Withdrawal by Subject|1|||
160559474|NCT00522392|579772062|FG001|Overall Study|Withdrawal by Subject|1|||
160559475|NCT00522392|579772061|FG000|Overall Study|Physician Decision|0|||
160559476|NCT00522392|579772062|FG001|Overall Study|Physician Decision|1|||
160559477|NCT00522392|579772061|FG000|Overall Study|Non-compliance|0|||
160559478|NCT00522392|579772062|FG001|Overall Study|Non-compliance|1|||
160559479|NCT00430755|579772065|FG000|Overall Study|Withdrawal by Subject|53|||
160559480|NCT01154101|579772066|FG000|Overall Study|Adverse Event|0|||
160559481|NCT01154101|579772067|FG001|Overall Study|Adverse Event|2|||
160559482|NCT01154101|579772068|FG002|Overall Study|Adverse Event|1|||
160559483|NCT01154101|579772069|FG003|Overall Study|Adverse Event|1|||
160559484|NCT01154101|579772070|FG004|Overall Study|Adverse Event|0|||
160559485|NCT01154101|579772066|FG000|Overall Study|Lost to Follow-up|0|||
160990820|NCT00320489|581353967|FG000|Overall Study|Entry Criteria Exclusion|2|||
160990821|NCT00320489|581353968|FG001|Overall Study|Entry Criteria Exclusion|4|||
160990822|NCT00320489|581353967|FG000|Overall Study|Lack of Efficacy|16|||
160990823|NCT00320489|581353968|FG001|Overall Study|Lack of Efficacy|7|||
160990824|NCT00320489|581353967|FG000|Overall Study|Lost to Follow-up|21|||
160990825|NCT00320489|581353968|FG001|Overall Study|Lost to Follow-up|22|||
160990826|NCT00320489|581353967|FG000|Overall Study|Physician Decision|8|||
160990827|NCT00320489|581353968|FG001|Overall Study|Physician Decision|8|||
160990828|NCT00320489|581353967|FG000|Overall Study|Protocol Violation|4|||
160990829|NCT00320489|581353968|FG001|Overall Study|Protocol Violation|4|||
160990830|NCT00320489|581353967|FG000|Overall Study|Sponsor Decision|3|||
160990831|NCT00320489|581353968|FG001|Overall Study|Sponsor Decision|3|||
160990832|NCT00320489|581353967|FG000|Overall Study|Withdrawal by Subject|39|||
160990833|NCT00320489|581353968|FG001|Overall Study|Withdrawal by Subject|41|||
160990834|NCT02282527|581353969|FG000|Overall Study|Lost to Follow-up|0|||
160990835|NCT02282527|581353970|FG001|Overall Study|Lost to Follow-up|1|||
160990836|NCT02282527|581353969|FG000|Overall Study|Lack of home health aid|1|||
160990837|NCT02282527|581353970|FG001|Overall Study|Lack of home health aid|0|||
160990838|NCT00941031|581353971|FG000|Induction Period|Lack of Efficacy|2|||
160559486|NCT01154101|579772067|FG001|Overall Study|Lost to Follow-up|1|||
160559487|NCT01154101|579772068|FG002|Overall Study|Lost to Follow-up|0|||
160559488|NCT01154101|579772069|FG003|Overall Study|Lost to Follow-up|1|||
160559489|NCT01154101|579772070|FG004|Overall Study|Lost to Follow-up|0|||
160559490|NCT01154101|579772066|FG000|Overall Study|Withdrawal by Subject|0|||
160559491|NCT01154101|579772067|FG001|Overall Study|Withdrawal by Subject|1|||
160559492|NCT01154101|579772068|FG002|Overall Study|Withdrawal by Subject|2|||
160559493|NCT01154101|579772069|FG003|Overall Study|Withdrawal by Subject|0|||
160559494|NCT01154101|579772070|FG004|Overall Study|Withdrawal by Subject|1|||
160559495|NCT05019131|579772071|FG000|Overall Study|Lost to Follow-up|0|||
160559496|NCT05019131|579772072|FG001|Overall Study|Lost to Follow-up|3|||
160559497|NCT03575104|579772073|FG000|Overall Study|Adverse Event|4|||
160559498|NCT03575104|579772074|FG001|Overall Study|Adverse Event|3|||
160990839|NCT00941031|581353972|FG001|Induction Period|Lack of Efficacy|1|||
160559499|NCT03575104|579772075|FG002|Overall Study|Adverse Event|4|||
160559500|NCT03575104|579772073|FG000|Overall Study|Withdrawal by Subject|13|||
160990840|NCT00941031|581353973|FG002|Induction Period|Lack of Efficacy|0|||
160559501|NCT03575104|579772074|FG001|Overall Study|Withdrawal by Subject|16|||
160559502|NCT03575104|579772075|FG002|Overall Study|Withdrawal by Subject|11|||
160559503|NCT03575104|579772073|FG000|Overall Study|Other reasons|6|||
160559504|NCT03575104|579772074|FG001|Overall Study|Other reasons|8|||
160559505|NCT03575104|579772075|FG002|Overall Study|Other reasons|6|||
160990841|NCT00941031|581353974|FG003|Induction Period|Lack of Efficacy|5|||
160828787|NCT02741570|580759870|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
160828788|NCT02741570|580759871|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
160828789|NCT02741570|580759870|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
160828790|NCT02741570|580759871|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
160828791|NCT02741570|580759870|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
160828792|NCT02741570|580759871|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
160828793|NCT02741570|580759870|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
160828794|NCT02741570|580759871|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
160903055|NCT01453361|581037951|FG000|Overall Study|Screen-Failures|10|||
160903056|NCT01752985|581037952|FG000|Treatment Period|Subject request to discontinue treatment|1|||
160903057|NCT01752985|581037953|FG001|Treatment Period|Subject request to discontinue treatment|0|||
160903058|NCT01752985|581037954|FG002|Treatment Period|Subject request to discontinue treatment|1|||
160903059|NCT01752985|581037952|FG000|Treatment Period|Subject no longer meets study criteria|0|||
160903060|NCT01752985|581037953|FG001|Treatment Period|Subject no longer meets study criteria|1|||
160903061|NCT01752985|581037954|FG002|Treatment Period|Subject no longer meets study criteria|1|||
160903062|NCT01752985|581037952|FG000|Treatment Period|Adverse Event|2|||
160903063|NCT01752985|581037953|FG001|Treatment Period|Adverse Event|1|||
160903064|NCT01752985|581037954|FG002|Treatment Period|Adverse Event|2|||
160903065|NCT01752985|581037952|FG000|Treatment Period|Withdrawal by Subject|1|||
160903066|NCT01752985|581037953|FG001|Treatment Period|Withdrawal by Subject|1|||
160903067|NCT01752985|581037954|FG002|Treatment Period|Withdrawal by Subject|0|||
160903068|NCT01752985|581037952|FG000|Treatment Period|Lost to Follow-up|0|||
160903069|NCT01752985|581037953|FG001|Treatment Period|Lost to Follow-up|0|||
160903070|NCT01752985|581037954|FG002|Treatment Period|Lost to Follow-up|1|||
160903071|NCT02025621|581038994|FG000|Overall Study|Withdrawal by Subject|1|||
160559506|NCT03575104|579772073|FG000|Overall Study|Lost to Follow-up|1|||
160559507|NCT03575104|579772074|FG001|Overall Study|Lost to Follow-up|2|||
160559508|NCT03575104|579772075|FG002|Overall Study|Lost to Follow-up|1|||
160559509|NCT00332709|579772076|FG000|Overall Study|Adverse Event|11|||
160559510|NCT00332709|579772077|FG001|Overall Study|Adverse Event|14|||
160559511|NCT00332709|579772076|FG000|Overall Study|Withdrawal by Subject|2|||
160559512|NCT00332709|579772077|FG001|Overall Study|Withdrawal by Subject|3|||
160559513|NCT00332709|579772076|FG000|Overall Study|Lost to Follow-up|2|||
160559514|NCT00332709|579772077|FG001|Overall Study|Lost to Follow-up|0|||
160559515|NCT00332709|579772076|FG000|Overall Study|Administrative Problems|0|||
160559516|NCT00332709|579772077|FG001|Overall Study|Administrative Problems|3|||
160559517|NCT00332709|579772076|FG000|Overall Study|Abnormal test procedure result|1|||
160559518|NCT00332709|579772077|FG001|Overall Study|Abnormal test procedure result|0|||
160559519|NCT00988247|579772078|FG000|Overall Study|Adverse Event|17|||
160559520|NCT00988247|579772079|FG001|Overall Study|Adverse Event|3|||
160559521|NCT00988247|579772078|FG000|Overall Study|Withdrawal by Subject|44|||
160559522|NCT00988247|579772079|FG001|Overall Study|Withdrawal by Subject|13|||
160559523|NCT00988247|579772078|FG000|Overall Study|Pregnancy|1|||
160559524|NCT00988247|579772079|FG001|Overall Study|Pregnancy|2|||
160559525|NCT00988247|579772078|FG000|Overall Study|Lost to Follow-up|11|||
160559526|NCT00988247|579772079|FG001|Overall Study|Lost to Follow-up|2|||
160559527|NCT00988247|579772078|FG000|Overall Study|Protocol Violation|4|||
160559528|NCT00988247|579772079|FG001|Overall Study|Protocol Violation|5|||
160559529|NCT00988247|579772078|FG000|Overall Study|Sponsor requested withdrawal|3|||
160559530|NCT00988247|579772079|FG001|Overall Study|Sponsor requested withdrawal|1|||
160559531|NCT00988247|579772078|FG000|Overall Study|Other|3|||
160559532|NCT00988247|579772079|FG001|Overall Study|Other|0|||
160559533|NCT01409928|579772080|FG000|Overall Study|Physician Decision|12|||
160559534|NCT02661594|579772081|FG000|Overall Study|Protocol Violation|1|||
160559535|NCT02661594|579772082|FG001|Overall Study|Protocol Violation|0|||
160559536|NCT02661594|579772083|FG002|Overall Study|Protocol Violation|1|||
160559537|NCT02661594|579772084|FG003|Overall Study|Protocol Violation|0|||
160559538|NCT00432237|579772085|FG000|Overall Study|Adverse Event|0|||
160559539|NCT00432237|579772086|FG001|Overall Study|Adverse Event|0|||
160559540|NCT00432237|579772087|FG002|Overall Study|Adverse Event|0|||
160559541|NCT00432237|579772088|FG003|Overall Study|Adverse Event|1|||
160559542|NCT00432237|579772085|FG000|Overall Study|Lack of Efficacy|0|||
160559543|NCT00432237|579772086|FG001|Overall Study|Lack of Efficacy|0|||
160559544|NCT00432237|579772087|FG002|Overall Study|Lack of Efficacy|0|||
160559545|NCT00432237|579772088|FG003|Overall Study|Lack of Efficacy|1|||
160559546|NCT00432237|579772085|FG000|Overall Study|Lost to Follow-up|10|||
160559547|NCT00432237|579772086|FG001|Overall Study|Lost to Follow-up|10|||
160903072|NCT02025621|581038995|FG001|Overall Study|Withdrawal by Subject|0|||
160559548|NCT00432237|579772087|FG002|Overall Study|Lost to Follow-up|18|||
160903073|NCT02025621|581038994|FG000|Overall Study|Death|0|||
160903074|NCT02025621|581038995|FG001|Overall Study|Death|1|||
160903075|NCT02025621|581038994|FG000|Overall Study|No longer eligible|10|||
160903076|NCT02025621|581038995|FG001|Overall Study|No longer eligible|15|||
160903077|NCT02025621|581038994|FG000|Overall Study|Surgery initiated before infusion|3|||
160903078|NCT02025621|581038995|FG001|Overall Study|Surgery initiated before infusion|3|||
160903079|NCT00739674|581038996|FG000|Overall Study|Screening failures|19|||
160559549|NCT00432237|579772088|FG003|Overall Study|Lost to Follow-up|18|||
160559550|NCT00432237|579772085|FG000|Overall Study|Physician Decision|1|||
160559551|NCT00432237|579772086|FG001|Overall Study|Physician Decision|3|||
160559552|NCT00432237|579772087|FG002|Overall Study|Physician Decision|2|||
160559553|NCT00432237|579772088|FG003|Overall Study|Physician Decision|1|||
160559554|NCT00432237|579772085|FG000|Overall Study|Pregnancy|0|||
160559555|NCT00432237|579772086|FG001|Overall Study|Pregnancy|1|||
160559556|NCT00432237|579772087|FG002|Overall Study|Pregnancy|0|||
160559557|NCT00432237|579772088|FG003|Overall Study|Pregnancy|0|||
160559558|NCT00432237|579772085|FG000|Overall Study|Protocol Violation|13|||
160559559|NCT00432237|579772086|FG001|Overall Study|Protocol Violation|10|||
160559560|NCT00432237|579772087|FG002|Overall Study|Protocol Violation|11|||
160559561|NCT00432237|579772088|FG003|Overall Study|Protocol Violation|8|||
160559562|NCT00432237|579772085|FG000|Overall Study|Withdrawal by Subject|5|||
160559563|NCT00432237|579772086|FG001|Overall Study|Withdrawal by Subject|6|||
160559564|NCT00432237|579772087|FG002|Overall Study|Withdrawal by Subject|9|||
160559565|NCT00432237|579772088|FG003|Overall Study|Withdrawal by Subject|11|||
160559566|NCT00432237|579772085|FG000|Overall Study|Lack of Qualifying Event|38|||
160559567|NCT00432237|579772086|FG001|Overall Study|Lack of Qualifying Event|71|||
160559568|NCT00432237|579772087|FG002|Overall Study|Lack of Qualifying Event|69|||
160559569|NCT00432237|579772088|FG003|Overall Study|Lack of Qualifying Event|84|||
160559570|NCT01354132|579772089|FG000|Randomization|Physician Decision|1|||
160559571|NCT01354132|579772090|FG001|Randomization|Physician Decision|0|||
160559572|NCT01354132|579772089|FG000|Randomization|Withdrawal by Subject|0|||
160559573|NCT01354132|579772090|FG001|Randomization|Withdrawal by Subject|1|||
160559574|NCT01354132|579772089|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
160559575|NCT01354132|579772090|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
160559576|NCT01354132|579772089|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
160559577|NCT01354132|579772090|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
160559578|NCT01354132|579772089|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
160559579|NCT01354132|579772090|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
160559580|NCT02360098|579772091|FG000|Overall Study|Physician Decision|7|||
160559581|NCT03838484|579772093|FG000|Overall Study|Lost to Follow-up|0|||
160559582|NCT03838484|579772094|FG001|Overall Study|Lost to Follow-up|1|||
160559583|NCT03838484|579772095|FG002|Overall Study|Lost to Follow-up|0|||
160559584|NCT03838484|579772096|FG003|Overall Study|Lost to Follow-up|0|||
160559585|NCT01614964|579772097|FG000|Overall Study|Withdrawal by Subject|2|||
160559586|NCT01614964|579772098|FG001|Overall Study|Withdrawal by Subject|0|||
160559587|NCT01614964|579772097|FG000|Overall Study|Lost to Follow-up|3|||
160559588|NCT01614964|579772098|FG001|Overall Study|Lost to Follow-up|0|||
160559589|NCT00860470|579772107|FG000|Overall Study|Death|6|||
160559590|NCT00860470|579772108|FG001|Overall Study|Death|10|||
160559591|NCT00860470|579772107|FG000|Overall Study|Moved away|8|||
160559592|NCT00860470|579772108|FG001|Overall Study|Moved away|10|||
160559593|NCT00860470|579772107|FG000|Overall Study|Lost to Follow-up|34|||
160559594|NCT00860470|579772108|FG001|Overall Study|Lost to Follow-up|39|||
160559595|NCT00888238|579772109|FG000|Washout Period After Period 2|Adverse Event|0|||
160559596|NCT00888238|579772110|FG001|Washout Period After Period 2|Adverse Event|0|||
160559597|NCT00888238|579772111|FG002|Washout Period After Period 2|Adverse Event|1|||
160559598|NCT01032629|579772112|FG000|Overall Study|Closed Site|21|||
160559599|NCT01032629|579772113|FG001|Overall Study|Closed Site|18|||
160559600|NCT01032629|579772114|FG002|Overall Study|Closed Site|16|||
160559601|NCT01032629|579772112|FG000|Overall Study|Withdrawal by Subject|50|||
160559602|NCT01032629|579772113|FG001|Overall Study|Withdrawal by Subject|36|||
160559603|NCT01032629|579772114|FG002|Overall Study|Withdrawal by Subject|35|||
160559604|NCT01032629|579772112|FG000|Overall Study|Lost to Follow-up|74|||
160559605|NCT01032629|579772113|FG001|Overall Study|Lost to Follow-up|47|||
160559606|NCT01032629|579772114|FG002|Overall Study|Lost to Follow-up|37|||
160559607|NCT03371355|579772115|FG000|Overall Study|Investigator judgment|0|||
160559608|NCT03371355|579772116|FG001|Overall Study|Investigator judgment|0|||
160559609|NCT03371355|579772117|FG002|Overall Study|Investigator judgment|1|||
160559610|NCT03371355|579772118|FG003|Overall Study|Investigator judgment|1|||
160559611|NCT03371355|579772115|FG000|Overall Study|Voluntary withdrawal|1|||
160559612|NCT03371355|579772116|FG001|Overall Study|Voluntary withdrawal|0|||
160559613|NCT03371355|579772117|FG002|Overall Study|Voluntary withdrawal|1|||
160559614|NCT03371355|579772118|FG003|Overall Study|Voluntary withdrawal|2|||
160559615|NCT03371355|579772115|FG000|Overall Study|Adverse Event|0|||
160559616|NCT03371355|579772116|FG001|Overall Study|Adverse Event|1|||
160559617|NCT03371355|579772117|FG002|Overall Study|Adverse Event|2|||
160559618|NCT03371355|579772118|FG003|Overall Study|Adverse Event|3|||
160559619|NCT03371355|579772115|FG000|Overall Study|Reason not Specified|0|||
160828795|NCT02741570|580759870|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
160559620|NCT03371355|579772116|FG001|Overall Study|Reason not Specified|1|||
160559621|NCT03371355|579772117|FG002|Overall Study|Reason not Specified|0|||
160828796|NCT02741570|580759871|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
160559622|NCT03371355|579772118|FG003|Overall Study|Reason not Specified|1|||
160559623|NCT00619957|579772119|FG000|Month 24 Double-Blind|Adverse Event|9|||
160559624|NCT00619957|579772120|FG001|Month 24 Double-Blind|Adverse Event|7|||
160559625|NCT00619957|579772119|FG000|Month 24 Double-Blind|Protocol Violation|1|||
160559626|NCT00619957|579772120|FG001|Month 24 Double-Blind|Protocol Violation|0|||
160559627|NCT00619957|579772119|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
160559628|NCT00619957|579772120|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
160559629|NCT00619957|579772119|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
160559630|NCT00619957|579772120|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
160559631|NCT00619957|579772119|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
160559632|NCT00619957|579772120|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
160559633|NCT00619957|579772119|FG000|Month 48 Open-Label|Adverse Event|4|||
160559634|NCT00619957|579772120|FG001|Month 48 Open-Label|Adverse Event|4|||
160559635|NCT00619957|579772119|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
160559636|NCT00619957|579772120|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
160559637|NCT00619957|579772119|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
160559638|NCT00619957|579772120|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
160559639|NCT00723957|579772121|FG000|Overall Study|Adverse event unrelated to study drug|1|||
160559640|NCT00723957|579772122|FG001|Overall Study|Adverse event unrelated to study drug|4|||
160559641|NCT00723957|579772121|FG000|Overall Study|Death|3|||
160559642|NCT00723957|579772122|FG001|Overall Study|Death|4|||
160559643|NCT00723957|579772121|FG000|Overall Study|Disease progression|27|||
160559644|NCT00723957|579772122|FG001|Overall Study|Disease progression|25|||
160559645|NCT00723957|579772121|FG000|Overall Study|Maximum clinical benefit|4|||
160559646|NCT00723957|579772122|FG001|Overall Study|Maximum clinical benefit|5|||
160559647|NCT00723957|579772121|FG000|Overall Study|Investigator decision|1|||
160559648|NCT00723957|579772122|FG001|Overall Study|Investigator decision|1|||
160559649|NCT00723957|579772121|FG000|Overall Study|Study drug toxicity|4|||
160559650|NCT00723957|579772122|FG001|Overall Study|Study drug toxicity|6|||
160559651|NCT00723957|579772121|FG000|Overall Study|Withdrawal by Subject|7|||
160559652|NCT00723957|579772122|FG001|Overall Study|Withdrawal by Subject|5|||
160559653|NCT00723957|579772121|FG000|Overall Study|Reason not analyzed|1|||
160559654|NCT00723957|579772122|FG001|Overall Study|Reason not analyzed|0|||
160559655|NCT00723957|579772121|FG000|Overall Study|Never received treatment|3|||
160559656|NCT00723957|579772122|FG001|Overall Study|Never received treatment|3|||
160559657|NCT01763164|579772124|FG000|Treatment Phase|Participant/Guardian decision|26|||
160559658|NCT01763164|579772125|FG001|Treatment Phase|Participant/Guardian decision|14|||
160559659|NCT01763164|579772124|FG000|Treatment Phase|Protocol Violation|1|||
160559660|NCT01763164|579772125|FG001|Treatment Phase|Protocol Violation|1|||
160559661|NCT01763164|579772124|FG000|Treatment Phase|Progressive Disease|142|||
160559662|NCT01763164|579772125|FG001|Treatment Phase|Progressive Disease|76|||
160559663|NCT01763164|579772124|FG000|Treatment Phase|Physician Decision|24|||
160559664|NCT01763164|579772125|FG001|Treatment Phase|Physician Decision|13|||
160559665|NCT01763164|579772124|FG000|Treatment Phase|Death|10|||
160559666|NCT01763164|579772125|FG001|Treatment Phase|Death|1|||
160559667|NCT01763164|579772124|FG000|Treatment Phase|Adverse Event|66|||
160559668|NCT01763164|579772125|FG001|Treatment Phase|Adverse Event|8|||
160559669|NCT01763164|579772124|FG000|Treatment Phase|Randomized but not Treated|0|||
160559670|NCT01763164|579772125|FG001|Treatment Phase|Randomized but not Treated|19|||
160559671|NCT01763164|579772124|FG000|Treatment Phase|Other|0|||
160559672|NCT01763164|579772125|FG001|Treatment Phase|Other|1|||
160559673|NCT01763164|579772124|FG000|Follow up Phase|New therapy for study indication|12|||
160559674|NCT01763164|579772125|FG001|Follow up Phase|New therapy for study indication|3|||
160559675|NCT01763164|579772124|FG000|Follow up Phase|Death|21|||
160559676|NCT01763164|579772125|FG001|Follow up Phase|Death|4|||
160559677|NCT01763164|579772124|FG000|Follow up Phase|Subject/guardian decision|9|||
160559678|NCT01763164|579772125|FG001|Follow up Phase|Subject/guardian decision|2|||
160559679|NCT01763164|579772124|FG000|Follow up Phase|Progressive disease|127|||
160559680|NCT01763164|579772125|FG001|Follow up Phase|Progressive disease|62|||
160559681|NCT01763164|579772124|FG000|Follow up Phase|Physician Decision|10|||
160559682|NCT01763164|579772125|FG001|Follow up Phase|Physician Decision|3|||
160559683|NCT01763164|579772124|FG000|Follow up Phase|Lost to Follow-up|1|||
160559684|NCT01763164|579772125|FG001|Follow up Phase|Lost to Follow-up|0|||
160559685|NCT01763164|579772124|FG000|Follow up Phase|Adverse Event|17|||
160559686|NCT01763164|579772125|FG001|Follow up Phase|Adverse Event|1|||
160559687|NCT04964258|579772126|FG000|Overall Study|Lost to Follow-up|1|||
160559688|NCT04964258|579772127|FG001|Overall Study|Lost to Follow-up|0|||
160559689|NCT04964258|579772128|FG002|Overall Study|Lost to Follow-up|0|||
160559690|NCT04964258|579772129|FG003|Overall Study|Lost to Follow-up|0|||
160559691|NCT04964258|579772130|FG004|Overall Study|Lost to Follow-up|0|||
160559692|NCT04964258|579772131|FG005|Overall Study|Lost to Follow-up|1|||
160559693|NCT04964258|579772132|FG006|Overall Study|Lost to Follow-up|0|||
160559694|NCT04964258|579772133|FG007|Overall Study|Lost to Follow-up|0|||
160559695|NCT04964258|579772134|FG008|Overall Study|Lost to Follow-up|0|||
160559696|NCT04964258|579772135|FG009|Overall Study|Lost to Follow-up|0|||
160559697|NCT04964258|579772136|FG010|Overall Study|Lost to Follow-up|0|||
160559698|NCT02965378|579772137|FG000|Overall Study|Progression|16|||
160559699|NCT02965378|579772138|FG001|Overall Study|Progression|4|||
160559700|NCT02965378|579772137|FG000|Overall Study|Adverse Event|5|||
160559701|NCT02965378|579772138|FG001|Overall Study|Adverse Event|2|||
160559702|NCT02965378|579772137|FG000|Overall Study|Death|2|||
160559703|NCT02965378|579772138|FG001|Overall Study|Death|0|||
160559704|NCT02965378|579772137|FG000|Overall Study|Refusal|2|||
160559705|NCT02965378|579772138|FG001|Overall Study|Refusal|1|||
160559706|NCT02965378|579772137|FG000|Overall Study|Not protocol specified|0|||
160559707|NCT02965378|579772138|FG001|Overall Study|Not protocol specified|2|||
160559708|NCT01384292|579772141|FG000|Part B|Severe non-compliance to protocol|1|||
160559709|NCT01384292|579772142|FG001|Part B|Severe non-compliance to protocol|0|||
160559710|NCT01384292|579772143|FG002|Part B|Severe non-compliance to protocol|0|||
160559711|NCT04525703|579772145|FG000|Overall Study|Lost to Follow-up|6|||
160903080|NCT00739674|581038997|FG001|Overall Study|Screening failures|17|||
160903081|NCT00739674|581038996|FG000|Overall Study|Site 212 removal|19|||
160903082|NCT00739674|581038997|FG001|Overall Study|Site 212 removal|13|||
160903083|NCT00739674|581038996|FG000|Overall Study|No follow-up data|33|||
160903084|NCT00739674|581038997|FG001|Overall Study|No follow-up data|18|||
160903085|NCT00739674|581038996|FG000|Overall Study|Dietician consultation >30 days|1|||
160903086|NCT00739674|581038997|FG001|Overall Study|Dietician consultation >30 days|9|||
160903087|NCT00739674|581038996|FG000|Overall Study|Adverse Event|22|||
160903088|NCT00739674|581038997|FG001|Overall Study|Adverse Event|13|||
160903089|NCT00739674|581038996|FG000|Overall Study|Death|1|||
160903090|NCT00739674|581038997|FG001|Overall Study|Death|0|||
160903091|NCT00739674|581038996|FG000|Overall Study|Lack of Efficacy|1|||
160903092|NCT00739674|581038997|FG001|Overall Study|Lack of Efficacy|0|||
160903093|NCT00739674|581038996|FG000|Overall Study|Lost to Follow-up|52|||
160903094|NCT00739674|581038997|FG001|Overall Study|Lost to Follow-up|30|||
160903095|NCT00739674|581038996|FG000|Overall Study|Protocol Violation|5|||
160903096|NCT00739674|581038997|FG001|Overall Study|Protocol Violation|5|||
160828797|NCT02741570|580759870|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
160828798|NCT02741570|580759871|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
160828799|NCT02741570|580759870|FG000|Pre-Treatment Period|Death|0|||
160828800|NCT02741570|580759871|FG001|Pre-Treatment Period|Death|1|||
160828801|NCT02741570|580759870|FG000|Pre-Treatment Period|Disease progression|0|||
160828802|NCT02741570|580759871|FG001|Pre-Treatment Period|Disease progression|1|||
160828803|NCT02741570|580759870|FG000|Treatment Period|Other reasons|47|||
160828804|NCT02741570|580759871|FG001|Treatment Period|Other reasons|12|||
160828805|NCT02741570|580759870|FG000|Treatment Period|Poor/non-compliance|0|||
160828806|NCT02741570|580759871|FG001|Treatment Period|Poor/non-compliance|2|||
160828807|NCT02741570|580759870|FG000|Treatment Period|Maximum clinical benefit|4|||
160828808|NCT02741570|580759871|FG001|Treatment Period|Maximum clinical benefit|6|||
160828809|NCT02741570|580759870|FG000|Treatment Period|Lost to Follow-up|1|||
160828810|NCT02741570|580759871|FG001|Treatment Period|Lost to Follow-up|3|||
160828811|NCT02741570|580759870|FG000|Treatment Period|Participant withdrew consent|9|||
160828812|NCT02741570|580759871|FG001|Treatment Period|Participant withdrew consent|13|||
160828813|NCT02741570|580759870|FG000|Treatment Period|Participant request to discontinue treatment|8|||
160828814|NCT02741570|580759871|FG001|Treatment Period|Participant request to discontinue treatment|23|||
160828815|NCT02741570|580759870|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
160828816|NCT02741570|580759871|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
160828817|NCT02741570|580759870|FG000|Treatment Period|Death|9|||
160828818|NCT02741570|580759871|FG001|Treatment Period|Death|7|||
160828819|NCT02741570|580759870|FG000|Treatment Period|Study drug toxicity|55|||
160828820|NCT02741570|580759871|FG001|Treatment Period|Study drug toxicity|47|||
160828821|NCT02741570|580759870|FG000|Treatment Period|Disease progression|294|||
160828822|NCT02741570|580759871|FG001|Treatment Period|Disease progression|301|||
160828823|NCT02741570|580759870|FG000|Treatment Period|Administrative reason by sponsor|0|||
160828824|NCT02741570|580759871|FG001|Treatment Period|Administrative reason by sponsor|1|||
160828825|NCT01100567|580759872|FG000|Overall Study|Withdrawal by Subject|5|||
160828826|NCT01100567|580759873|FG001|Overall Study|Withdrawal by Subject|8|||
160828827|NCT01100567|580759872|FG000|Overall Study|Early Hospital Discharge|6|||
160828828|NCT01100567|580759873|FG001|Overall Study|Early Hospital Discharge|4|||
160828829|NCT01100567|580759872|FG000|Overall Study|Lost to Follow-up|1|||
160828830|NCT01100567|580759873|FG001|Overall Study|Lost to Follow-up|2|||
160828831|NCT01100567|580759872|FG000|Overall Study|Physician Decision|0|||
160828832|NCT01100567|580759873|FG001|Overall Study|Physician Decision|1|||
160828833|NCT01100567|580759872|FG000|Overall Study|Deemed ineligible after consent|0|||
160903097|NCT00739674|581038996|FG000|Overall Study|Withdrawal by Subject|9|||
160903098|NCT00739674|581038997|FG001|Overall Study|Withdrawal by Subject|9|||
160903099|NCT00739674|581038996|FG000|Overall Study|Reason missing|2|||
160903100|NCT00739674|581038997|FG001|Overall Study|Reason missing|0|||
160828834|NCT01100567|580759873|FG001|Overall Study|Deemed ineligible after consent|1|||
160828835|NCT01498185|580759874|FG000|Overall Study|Adverse Event|0|||
160828836|NCT01498185|580759875|FG001|Overall Study|Adverse Event|0|||
160903101|NCT00739674|581038996|FG000|Overall Study|Clinic closed|6|||
160828837|NCT01498185|580759876|FG002|Overall Study|Adverse Event|0|||
160828838|NCT01498185|580759877|FG003|Overall Study|Adverse Event|1|||
160828839|NCT01498185|580759878|FG004|Overall Study|Adverse Event|0|||
160903102|NCT00739674|581038997|FG001|Overall Study|Clinic closed|4|||
160903103|NCT00739674|581038996|FG000|Overall Study|Patient moved|3|||
160903104|NCT00739674|581038997|FG001|Overall Study|Patient moved|2|||
160903105|NCT00739674|581038996|FG000|Overall Study|Non compliant|4|||
160903106|NCT00739674|581038997|FG001|Overall Study|Non compliant|0|||
160903107|NCT00739674|581038996|FG000|Overall Study|Unable to attend visit|3|||
160990842|NCT00941031|581353975|FG004|Induction Period|Lack of Efficacy|0|||
160828840|NCT01498185|580759874|FG000|Overall Study|Withdrawal by Subject|1|||
160828841|NCT01498185|580759875|FG001|Overall Study|Withdrawal by Subject|1|||
160828842|NCT01498185|580759876|FG002|Overall Study|Withdrawal by Subject|0|||
160828843|NCT01498185|580759877|FG003|Overall Study|Withdrawal by Subject|2|||
160828844|NCT01498185|580759878|FG004|Overall Study|Withdrawal by Subject|1|||
160828845|NCT01498185|580759874|FG000|Overall Study|No longer met criteria, etc|0|||
160828846|NCT01498185|580759875|FG001|Overall Study|No longer met criteria, etc|0|||
160828847|NCT01498185|580759876|FG002|Overall Study|No longer met criteria, etc|0|||
160828848|NCT01498185|580759877|FG003|Overall Study|No longer met criteria, etc|0|||
160828849|NCT01498185|580759878|FG004|Overall Study|No longer met criteria, etc|2|||
160828850|NCT00946322|580759879|FG000|Pre-treatment|participant failure to follow up|1|||
160828851|NCT00946322|580759879|FG000|Post-treatment|participant failure to follow up|2|||
160828852|NCT01453946|580759880|FG000|Overall Study|Did not receive drug for the taper phase|1|||
160828853|NCT01453946|580759880|FG000|Overall Study|Protocol Violation|2|||
160828854|NCT01453946|580759880|FG000|Overall Study|Lack of Efficacy|3|||
160828855|NCT01453946|580759880|FG000|Overall Study|Adverse Event|3|||
160828856|NCT00846040|580759881|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
160828857|NCT00846040|580759882|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
160828858|NCT00846040|580759883|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
160828859|NCT00846040|580759881|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
160828860|NCT00846040|580759882|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
160828861|NCT00846040|580759883|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
160828862|NCT03352453|580759885|FG000|Overall Study|Miscellaneous Reasons|1|||
160828863|NCT03352453|580759886|FG001|Overall Study|Miscellaneous Reasons|2|||
160828864|NCT03352453|580759885|FG000|Overall Study|Lack of Efficacy|1|||
160828865|NCT03352453|580759886|FG001|Overall Study|Lack of Efficacy|0|||
160828866|NCT03352453|580759885|FG000|Overall Study|Withdrawal by Subject|8|||
160828867|NCT03352453|580759886|FG001|Overall Study|Withdrawal by Subject|14|||
160828868|NCT03352453|580759885|FG000|Overall Study|Study Terminated by Sponsor|2|||
160828869|NCT03352453|580759886|FG001|Overall Study|Study Terminated by Sponsor|1|||
160828870|NCT03352453|580759885|FG000|Overall Study|Protocol Deviation|1|||
160828871|NCT03352453|580759886|FG001|Overall Study|Protocol Deviation|0|||
160828872|NCT03352453|580759885|FG000|Overall Study|Lost to Follow-up|7|||
160828873|NCT03352453|580759886|FG001|Overall Study|Lost to Follow-up|6|||
160828874|NCT03352453|580759885|FG000|Overall Study|Adverse Event|2|||
160828875|NCT03352453|580759886|FG001|Overall Study|Adverse Event|9|||
160828876|NCT02827500|580759889|FG000|Overall Study|Death|7|||
160828877|NCT02827500|580759890|FG001|Overall Study|Death|3|||
160828878|NCT02827500|580759889|FG000|Overall Study|Lost to Follow-up|1|||
160828879|NCT02827500|580759890|FG001|Overall Study|Lost to Follow-up|1|||
160828880|NCT02827500|580759889|FG000|Overall Study|Withdrawal by Subject|3|||
160828881|NCT02827500|580759890|FG001|Overall Study|Withdrawal by Subject|1|||
160828882|NCT02827500|580759889|FG000|Overall Study|Missing primary endpoint data|3|||
160828883|NCT02827500|580759890|FG001|Overall Study|Missing primary endpoint data|1|||
160828884|NCT02827500|580759889|FG000|Overall Study|Other|5|||
160828885|NCT02827500|580759890|FG001|Overall Study|Other|1|||
160828886|NCT01241760|580759893|FG000|Overall Study|Adverse Event|1|||
160828887|NCT01241760|580759894|FG001|Overall Study|Adverse Event|0|||
160828888|NCT01241760|580759893|FG000|Overall Study|Lost to Follow-up|18|||
160903108|NCT00739674|581038997|FG001|Overall Study|Unable to attend visit|1|||
160903109|NCT00739674|581038996|FG000|Overall Study|Home monitoring off meds|1|||
160903110|NCT00739674|581038997|FG001|Overall Study|Home monitoring off meds|0|||
160903111|NCT00739674|581038996|FG000|Overall Study|Erectile dysfunction|0|||
160903112|NCT00739674|581038997|FG001|Overall Study|Erectile dysfunction|1|||
160903113|NCT01897454|581038999|FG000|Overall Study|Withdrawal by Subject|1|||
160903114|NCT02195583|581039003|FG000|Overall Study|Lost to Follow-up|1|||
160559712|NCT04525703|579772146|FG001|Overall Study|Lost to Follow-up|15|||
160559713|NCT04525703|579772147|FG002|Overall Study|Lost to Follow-up|8|||
160559714|NCT01285349|579772148|FG000|Overall Study|Lost to Follow-up|27|||
160559715|NCT01285349|579772149|FG001|Overall Study|Lost to Follow-up|20|||
160559716|NCT01285349|579772150|FG002|Overall Study|Lost to Follow-up|27|||
160559717|NCT00565617|579772151|FG000|Overall Study|Withdrawal by Subject|1|||
160559718|NCT01526148|579772157|FG000|Overall Study|Adverse Event|6|||
160559719|NCT01526148|579772158|FG001|Overall Study|Adverse Event|5|||
160828889|NCT01241760|580759894|FG001|Overall Study|Lost to Follow-up|22|||
160828890|NCT01241760|580759893|FG000|Overall Study|Withdrawal by Subject|13|||
160828891|NCT01241760|580759894|FG001|Overall Study|Withdrawal by Subject|13|||
160828892|NCT01241760|580759893|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
160828893|NCT01241760|580759894|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
160828894|NCT01241760|580759893|FG000|Overall Study|Other|1|||
160828895|NCT01241760|580759894|FG001|Overall Study|Other|1|||
160828896|NCT00514020|580759895|FG000|Overall Study|Adverse Event|6|||
160828897|NCT00514020|580759895|FG000|Overall Study|Withdrawal by Subject|3|||
160828898|NCT00514020|580759895|FG000|Overall Study|Physician Decision|1|||
160828899|NCT00514020|580759895|FG000|Overall Study|disease progression|9|||
160903115|NCT02195583|581039003|FG000|Overall Study|Withdrawal by Subject|4|||
160559720|NCT01526148|579772157|FG000|Overall Study|Lost to Follow-up|3|||
160828900|NCT00514020|580759895|FG000|Overall Study|other complicating disease|2|||
160828901|NCT00514020|580759895|FG000|Overall Study|patient went to radiation treatment|1|||
160828902|NCT00514020|580759895|FG000|Overall Study|"patients moved to the no tx group"|6|||
160828903|NCT01636713|580759900|FG000|Overall Study|Adverse Event|16|||
160828904|NCT01636713|580759901|FG001|Overall Study|Adverse Event|16|||
160828905|NCT01636713|580759902|FG002|Overall Study|Adverse Event|7|||
160828906|NCT01636713|580759900|FG000|Overall Study|Lack of Efficacy|6|||
160828907|NCT01636713|580759901|FG001|Overall Study|Lack of Efficacy|6|||
160828908|NCT01636713|580759902|FG002|Overall Study|Lack of Efficacy|2|||
160828909|NCT01636713|580759900|FG000|Overall Study|Protocol Violation|3|||
160828910|NCT01636713|580759901|FG001|Overall Study|Protocol Violation|0|||
160828911|NCT01636713|580759902|FG002|Overall Study|Protocol Violation|1|||
160828912|NCT01636713|580759900|FG000|Overall Study|Lost to Follow-up|0|||
160828913|NCT01636713|580759901|FG001|Overall Study|Lost to Follow-up|0|||
160828914|NCT01636713|580759902|FG002|Overall Study|Lost to Follow-up|1|||
160828915|NCT01636713|580759900|FG000|Overall Study|Withdrawal by Subject|5|||
160828916|NCT01636713|580759901|FG001|Overall Study|Withdrawal by Subject|4|||
160828917|NCT01636713|580759902|FG002|Overall Study|Withdrawal by Subject|8|||
160828918|NCT01636713|580759900|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
160828919|NCT01636713|580759901|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
160828920|NCT01636713|580759902|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
160828921|NCT03697993|580759907|FG000|Overall Study|Became Ineligible after Enrollment|1|||
160828922|NCT03697993|580759908|FG001|Overall Study|Became Ineligible after Enrollment|3|||
160828923|NCT03697993|580759907|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
160828924|NCT03697993|580759908|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
160828925|NCT03697993|580759907|FG000|Overall Study|Lost to Follow-up|3|||
160828926|NCT03697993|580759908|FG001|Overall Study|Lost to Follow-up|0|||
160828927|NCT03697993|580759907|FG000|Overall Study|Physician Decision|4|||
160828928|NCT03697993|580759908|FG001|Overall Study|Physician Decision|0|||
160828929|NCT03697993|580759907|FG000|Overall Study|Initial Urine Culture Negative|0|||
160828930|NCT03697993|580759908|FG001|Overall Study|Initial Urine Culture Negative|1|||
160828931|NCT04384107|580759909|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
160828932|NCT04384107|580759910|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
160828933|NCT04384107|580759909|FG000|Overall Study|Lost to Follow-up|1|||
160828934|NCT04384107|580759910|FG001|Overall Study|Lost to Follow-up|0|||
160828935|NCT00276614|580759913|FG000|Overall Study|Progression of disease under study|3|||
160828936|NCT01048866|580759918|FG000|Overall Study|Adverse Event|1|||
160828937|NCT01048866|580759919|FG001|Overall Study|Adverse Event|0|||
160828938|NCT01048866|580759918|FG000|Overall Study|Protocol Violation|1|||
160828939|NCT01048866|580759919|FG001|Overall Study|Protocol Violation|0|||
160828940|NCT01048866|580759918|FG000|Overall Study|Physician Decision|1|||
160828941|NCT01048866|580759919|FG001|Overall Study|Physician Decision|0|||
160828942|NCT01048866|580759918|FG000|Overall Study|Withdrawal by Subject|0|||
160828943|NCT01048866|580759919|FG001|Overall Study|Withdrawal by Subject|2|||
160828944|NCT01048866|580759918|FG000|Overall Study|Lost to Follow-up|0|||
160828945|NCT01048866|580759919|FG001|Overall Study|Lost to Follow-up|2|||
160828946|NCT01048866|580759918|FG000|Overall Study|Other|1|||
160828947|NCT01048866|580759919|FG001|Overall Study|Other|1|||
160828948|NCT03582813|580759920|FG000|Overall Study|Lost to Follow-up|18|||
160828949|NCT03582813|580759921|FG001|Overall Study|Lost to Follow-up|21|||
160828950|NCT03582813|580759920|FG000|Overall Study|Withdrawal by Subject|1|||
160828951|NCT03582813|580759921|FG001|Overall Study|Withdrawal by Subject|0|||
160828952|NCT02525094|580759926|FG000|Overall Study|Lost to Follow-up|2|||
160828953|NCT02525094|580759927|FG001|Overall Study|Lost to Follow-up|1|||
160828954|NCT02525094|580759926|FG000|Overall Study|Withdrawal by Subject|5|||
160828955|NCT02525094|580759927|FG001|Overall Study|Withdrawal by Subject|6|||
160828956|NCT02525094|580759926|FG000|Overall Study|Not Treated|1|||
160828957|NCT02525094|580759927|FG001|Overall Study|Not Treated|1|||
160828958|NCT01591863|580759928|FG000|Overall Study|Adverse Event|3|||
160828959|NCT01591863|580759928|FG000|Overall Study|Withdrawal by Subject|1|||
160828960|NCT01591863|580759928|FG000|Overall Study|recurrence|9|||
160828961|NCT01591863|580759928|FG000|Overall Study|Lack of Efficacy|1|||
160828962|NCT01751776|580759931|FG000|Overall Study|Adverse Event|0|||
160828963|NCT01751776|580759932|FG001|Overall Study|Adverse Event|0|||
160828964|NCT01751776|580759933|FG002|Overall Study|Adverse Event|0|||
160828965|NCT01751776|580759934|FG003|Overall Study|Adverse Event|0|||
160828966|NCT01751776|580759935|FG004|Overall Study|Adverse Event|0|||
160828967|NCT01751776|580759936|FG005|Overall Study|Adverse Event|0|||
160828968|NCT01751776|580759937|FG006|Overall Study|Adverse Event|4|||
160828969|NCT01751776|580759938|FG007|Overall Study|Adverse Event|2|||
160828970|NCT01751776|580759931|FG000|Overall Study|Consent withdrawn|0|||
160828971|NCT01751776|580759932|FG001|Overall Study|Consent withdrawn|0|||
160828972|NCT01751776|580759933|FG002|Overall Study|Consent withdrawn|0|||
160828973|NCT01751776|580759934|FG003|Overall Study|Consent withdrawn|0|||
160828974|NCT01751776|580759935|FG004|Overall Study|Consent withdrawn|0|||
160828975|NCT01751776|580759936|FG005|Overall Study|Consent withdrawn|0|||
160828976|NCT01751776|580759937|FG006|Overall Study|Consent withdrawn|0|||
160828977|NCT01751776|580759938|FG007|Overall Study|Consent withdrawn|1|||
160828978|NCT01751776|580759931|FG000|Overall Study|Other reason not specified above|0|||
160828979|NCT01751776|580759932|FG001|Overall Study|Other reason not specified above|0|||
160828980|NCT01751776|580759933|FG002|Overall Study|Other reason not specified above|0|||
160828981|NCT01751776|580759934|FG003|Overall Study|Other reason not specified above|0|||
160828982|NCT01751776|580759935|FG004|Overall Study|Other reason not specified above|0|||
160828983|NCT01751776|580759936|FG005|Overall Study|Other reason not specified above|0|||
160828984|NCT01751776|580759937|FG006|Overall Study|Other reason not specified above|0|||
160828985|NCT01751776|580759938|FG007|Overall Study|Other reason not specified above|1|||
160828986|NCT00160654|580759939|FG000|Overall Study|Adverse Event|14|||
160828987|NCT00160654|580759939|FG000|Overall Study|Lack of Efficacy|4|||
160828988|NCT00160654|580759939|FG000|Overall Study|Lost to Follow-up|2|||
160828989|NCT00160654|580759939|FG000|Overall Study|Intake of expired drug|7|||
160828990|NCT00160654|580759939|FG000|Overall Study|Psychological trauma|1|||
160828991|NCT00160654|580759939|FG000|Overall Study|Sponsor decision|1|||
160828992|NCT00160654|580759939|FG000|Overall Study|Patient met exclusion criteria|1|||
160828993|NCT00160654|580759939|FG000|Overall Study|Patient decision|1|||
160828994|NCT00160654|580759939|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
160828995|NCT00160654|580759939|FG000|Overall Study|Met exclusion criteria|1|||
160828996|NCT00831701|580759940|FG000|Overall Study|Withdrawal by Subject|2|||
160828997|NCT00831701|580759941|FG001|Overall Study|Withdrawal by Subject|0|||
160828998|NCT00831701|580759940|FG000|Overall Study|Stone expulsion before first medication|2|||
160828999|NCT00831701|580759941|FG001|Overall Study|Stone expulsion before first medication|2|||
160829000|NCT00831701|580759940|FG000|Overall Study|Lost to Follow-up|1|||
160829001|NCT00831701|580759941|FG001|Overall Study|Lost to Follow-up|3|||
160829002|NCT02366767|580759942|FG000|Overall Study|left for home after 1 day at camp|1|||
160829003|NCT02366767|580759943|FG001|Overall Study|left for home after 1 day at camp|0|||
160829004|NCT02117349|580759944|FG000|Overall Study|Withdrawal by Subject|1|||
160829005|NCT02117349|580759945|FG001|Overall Study|Withdrawal by Subject|0|||
160829006|NCT02117349|580759944|FG000|Overall Study|Lost to Follow-up|1|||
160829007|NCT02117349|580759945|FG001|Overall Study|Lost to Follow-up|1|||
160829008|NCT02117349|580759944|FG000|Overall Study|Death|1|||
160829009|NCT02117349|580759945|FG001|Overall Study|Death|0|||
160829010|NCT00546260|580759948|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
160829011|NCT00546260|580759949|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
160829012|NCT03780959|580759950|FG000|Part 1|Adverse Event|1|||
160829013|NCT03780959|580759951|FG001|Part 1|Adverse Event|0|||
160829014|NCT03780959|580759952|FG002|Part 1|Adverse Event|0|||
160829015|NCT03780959|580759950|FG000|Part 1|Withdrawal by Subject|1|||
160829016|NCT03780959|580759951|FG001|Part 1|Withdrawal by Subject|0|||
160829017|NCT03780959|580759952|FG002|Part 1|Withdrawal by Subject|0|||
160829018|NCT03780959|580759950|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
160990843|NCT00941031|581353976|FG005|Induction Period|Lack of Efficacy|0|||
160990844|NCT00941031|581353977|FG006|Induction Period|Lack of Efficacy|0|||
160559721|NCT01526148|579772158|FG001|Overall Study|Lost to Follow-up|6|||
160559722|NCT01526148|579772157|FG000|Overall Study|Withdrawal by Subject|2|||
160559723|NCT01526148|579772158|FG001|Overall Study|Withdrawal by Subject|0|||
160559724|NCT01526148|579772157|FG000|Overall Study|Unstable Medical Condition|1|||
160559725|NCT01526148|579772158|FG001|Overall Study|Unstable Medical Condition|0|||
160559726|NCT01526148|579772157|FG000|Overall Study|Unable to discontinue concomitant med|1|||
160559727|NCT01526148|579772158|FG001|Overall Study|Unable to discontinue concomitant med|0|||
160559728|NCT01526148|579772157|FG000|Overall Study|Moved out of state|1|||
160559729|NCT01526148|579772158|FG001|Overall Study|Moved out of state|0|||
160559730|NCT01526148|579772157|FG000|Overall Study|Incarcerated|0|||
160559731|NCT01526148|579772158|FG001|Overall Study|Incarcerated|2|||
160559732|NCT01173653|579772159|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
160559733|NCT01173653|579772160|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
160559734|NCT03529409|579772170|FG000|Randomized|Lost to Follow-up|0|||
160559735|NCT03529409|579772171|FG001|Randomized|Lost to Follow-up|0|||
160559736|NCT03529409|579772172|FG002|Randomized|Lost to Follow-up|4|||
160559737|NCT03529409|579772170|FG000|Randomized|Excluded|0|||
160559738|NCT03529409|579772171|FG001|Randomized|Excluded|0|||
160559739|NCT03529409|579772172|FG002|Randomized|Excluded|1|||
160559740|NCT03529409|579772170|FG000|Post-treatment Assessment|Death|1|||
160559741|NCT03529409|579772171|FG001|Post-treatment Assessment|Death|0|||
160559742|NCT03529409|579772172|FG002|Post-treatment Assessment|Death|0|||
160559743|NCT03529409|579772170|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
160559744|NCT03529409|579772171|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
160559745|NCT03529409|579772172|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
160559746|NCT03529409|579772170|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
160829019|NCT03780959|580759951|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
160829020|NCT03780959|580759952|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
160829021|NCT03780959|580759950|FG000|Part 1|Response Status|2|||
160829022|NCT03780959|580759951|FG001|Part 1|Response Status|0|||
160829023|NCT03780959|580759952|FG002|Part 1|Response Status|0|||
160829024|NCT03780959|580759950|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
160829025|NCT03780959|580759951|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
160829026|NCT03780959|580759952|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
160829027|NCT03780959|580759950|FG000|Part 2|Response Status|0|||
160829028|NCT03780959|580759951|FG001|Part 2|Response Status|18|||
160829029|NCT03780959|580759952|FG002|Part 2|Response Status|6|||
160829030|NCT03172130|580761549|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
160829031|NCT03172130|580761550|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
160829032|NCT01825941|580761554|FG000|Overall Study|Lost to Follow-up|4|||
160829033|NCT01825941|580761555|FG001|Overall Study|Lost to Follow-up|1|||
160829034|NCT00528996|580761556|FG000|Overall Study|Other reasons than listing|6|||
160829035|NCT00528996|580761557|FG001|Overall Study|Other reasons than listing|7|||
160829036|NCT00528996|580761558|FG002|Overall Study|Other reasons than listing|14|||
160829037|NCT00528996|580761559|FG003|Overall Study|Other reasons than listing|11|||
160829038|NCT00528996|580761560|FG004|Overall Study|Other reasons than listing|5|||
160829039|NCT00528996|580761556|FG000|Overall Study|Refused continue medication|16|||
160829040|NCT00528996|580761557|FG001|Overall Study|Refused continue medication|0|||
160829041|NCT00528996|580761558|FG002|Overall Study|Refused continue medication|3|||
160829042|NCT00528996|580761559|FG003|Overall Study|Refused continue medication|3|||
160829043|NCT00528996|580761560|FG004|Overall Study|Refused continue medication|6|||
160829044|NCT00528996|580761556|FG000|Overall Study|Lost to Follow-up|2|||
160829045|NCT00528996|580761557|FG001|Overall Study|Lost to Follow-up|0|||
160829046|NCT00528996|580761558|FG002|Overall Study|Lost to Follow-up|4|||
160829047|NCT00528996|580761559|FG003|Overall Study|Lost to Follow-up|1|||
160829048|NCT00528996|580761560|FG004|Overall Study|Lost to Follow-up|3|||
160829049|NCT00528996|580761556|FG000|Overall Study|Protocol Violation|1|||
160829050|NCT00528996|580761557|FG001|Overall Study|Protocol Violation|2|||
160829051|NCT00528996|580761558|FG002|Overall Study|Protocol Violation|3|||
160829052|NCT00528996|580761559|FG003|Overall Study|Protocol Violation|3|||
160829053|NCT00528996|580761560|FG004|Overall Study|Protocol Violation|2|||
160829054|NCT00528996|580761556|FG000|Overall Study|Lack of Efficacy|7|||
160829055|NCT00528996|580761557|FG001|Overall Study|Lack of Efficacy|2|||
160829056|NCT00528996|580761558|FG002|Overall Study|Lack of Efficacy|1|||
160829057|NCT00528996|580761559|FG003|Overall Study|Lack of Efficacy|3|||
160829058|NCT00528996|580761560|FG004|Overall Study|Lack of Efficacy|3|||
160829059|NCT00528996|580761556|FG000|Overall Study|Adverse Event|32|||
160829060|NCT00528996|580761557|FG001|Overall Study|Adverse Event|13|||
160829061|NCT00528996|580761558|FG002|Overall Study|Adverse Event|18|||
160829062|NCT00528996|580761559|FG003|Overall Study|Adverse Event|29|||
160829063|NCT00528996|580761560|FG004|Overall Study|Adverse Event|18|||
160829064|NCT02831933|580761562|FG000|Overall Study|Physician Decision|11|||
160829065|NCT03495102|580761563|FG000|Overall Study|Adverse Event|5|||
160829066|NCT03495102|580761564|FG001|Overall Study|Adverse Event|7|||
160829067|NCT03495102|580761565|FG002|Overall Study|Adverse Event|10|||
160829068|NCT03495102|580761563|FG000|Overall Study|Death|3|||
160829069|NCT03495102|580761564|FG001|Overall Study|Death|4|||
160829070|NCT03495102|580761565|FG002|Overall Study|Death|4|||
160829071|NCT03495102|580761563|FG000|Overall Study|Lost to Follow-up|15|||
160829072|NCT03495102|580761564|FG001|Overall Study|Lost to Follow-up|16|||
160829073|NCT03495102|580761565|FG002|Overall Study|Lost to Follow-up|17|||
160829074|NCT03495102|580761563|FG000|Overall Study|Physician Decision|2|||
160829075|NCT03495102|580761564|FG001|Overall Study|Physician Decision|0|||
160829076|NCT03495102|580761565|FG002|Overall Study|Physician Decision|2|||
160829077|NCT03495102|580761563|FG000|Overall Study|Withdrawal by Subject|25|||
160829078|NCT03495102|580761564|FG001|Overall Study|Withdrawal by Subject|36|||
160829079|NCT03495102|580761565|FG002|Overall Study|Withdrawal by Subject|18|||
160829080|NCT03495102|580761563|FG000|Overall Study|Protocol Violation|1|||
160829081|NCT03495102|580761564|FG001|Overall Study|Protocol Violation|1|||
160829082|NCT03495102|580761565|FG002|Overall Study|Protocol Violation|0|||
160829083|NCT03495102|580761563|FG000|Overall Study|Site Closure|3|||
160829084|NCT03495102|580761564|FG001|Overall Study|Site Closure|1|||
160829085|NCT03495102|580761565|FG002|Overall Study|Site Closure|2|||
160829086|NCT03495102|580761563|FG000|Overall Study|Non-compliance|1|||
160829087|NCT03495102|580761564|FG001|Overall Study|Non-compliance|0|||
160829088|NCT03495102|580761565|FG002|Overall Study|Non-compliance|0|||
160829089|NCT03495102|580761563|FG000|Overall Study|Participant Duplicated at Another Site|0|||
160829090|NCT03495102|580761564|FG001|Overall Study|Participant Duplicated at Another Site|0|||
160829091|NCT03495102|580761565|FG002|Overall Study|Participant Duplicated at Another Site|1|||
160829092|NCT03495102|580761563|FG000|Overall Study|Primary Care Physician Recommendation|0|||
160829093|NCT03495102|580761564|FG001|Overall Study|Primary Care Physician Recommendation|1|||
160829094|NCT03495102|580761565|FG002|Overall Study|Primary Care Physician Recommendation|0|||
160829095|NCT03495102|580761563|FG000|Overall Study|Relocated to Another Country|0|||
160829096|NCT03495102|580761564|FG001|Overall Study|Relocated to Another Country|1|||
160829097|NCT03495102|580761565|FG002|Overall Study|Relocated to Another Country|0|||
160829098|NCT03495102|580761563|FG000|Overall Study|Participant was in Rehabilitation|1|||
160829099|NCT03495102|580761564|FG001|Overall Study|Participant was in Rehabilitation|0|||
160829100|NCT03495102|580761565|FG002|Overall Study|Participant was in Rehabilitation|0|||
160829101|NCT01161537|580761568|FG000|Part B|Withdrawal by Subject|2|||
160829102|NCT00358436|580761573|FG000|Overall Study|Adverse Event|29|||
160829103|NCT00358436|580761574|FG001|Overall Study|Adverse Event|13|||
160829104|NCT00358436|580761573|FG000|Overall Study|Lack of Efficacy|34|||
160829105|NCT00358436|580761574|FG001|Overall Study|Lack of Efficacy|36|||
160829106|NCT00358436|580761573|FG000|Overall Study|Lost to Follow-up|11|||
160829107|NCT00358436|580761574|FG001|Overall Study|Lost to Follow-up|6|||
160829108|NCT00358436|580761573|FG000|Overall Study|Protocol Violation|8|||
160829109|NCT00358436|580761574|FG001|Overall Study|Protocol Violation|3|||
160829110|NCT00358436|580761573|FG000|Overall Study|Withdrawal by Subject|40|||
160829111|NCT00358436|580761574|FG001|Overall Study|Withdrawal by Subject|17|||
160829112|NCT00358436|580761573|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
160829113|NCT00358436|580761574|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
160829114|NCT00358436|580761573|FG000|Overall Study|COPD exacerbation|22|||
160829115|NCT00358436|580761574|FG001|Overall Study|COPD exacerbation|10|||
160829116|NCT00358436|580761573|FG000|Overall Study|Other|6|||
160829117|NCT00358436|580761574|FG001|Overall Study|Other|1|||
160829118|NCT05065190|580761576|FG000|Overall Study|Other than listed|2|||
160829119|NCT05065190|580761577|FG001|Overall Study|Other than listed|12|||
160829120|NCT05065190|580761576|FG000|Overall Study|Lack of Efficacy|4|||
160829121|NCT05065190|580761577|FG001|Overall Study|Lack of Efficacy|0|||
160559747|NCT03529409|579772171|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
160559748|NCT03529409|579772172|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
160829122|NCT05065190|580761576|FG000|Overall Study|Adverse Event|1|||
160829123|NCT05065190|580761577|FG001|Overall Study|Adverse Event|10|||
160829124|NCT03938324|580761585|FG000|Overall Study|Lost to Follow-up|42|||
160829125|NCT03938324|580761586|FG001|Overall Study|Lost to Follow-up|21|||
160829126|NCT03938324|580761585|FG000|Overall Study|Withdrawal by Subject|6|||
160829127|NCT03938324|580761586|FG001|Overall Study|Withdrawal by Subject|1|||
160829128|NCT02769962|580761587|FG000|Overall Study|Physician Decision|0|||
160829129|NCT02769962|580761588|FG001|Overall Study|Physician Decision|0|||
160829130|NCT02769962|580761589|FG002|Overall Study|Physician Decision|0|||
160829131|NCT02769962|580761590|FG003|Overall Study|Physician Decision|0|||
160829132|NCT02769962|580761591|FG004|Overall Study|Physician Decision|0|||
160829133|NCT02769962|580761592|FG005|Overall Study|Physician Decision|1|||
160829134|NCT02769962|580761593|FG006|Overall Study|Physician Decision|0|||
160829135|NCT02769962|580761594|FG007|Overall Study|Physician Decision|1|||
160829136|NCT02769962|580761587|FG000|Overall Study|Refused further treatment|0|||
160829137|NCT02769962|580761588|FG001|Overall Study|Refused further treatment|0|||
160829138|NCT02769962|580761589|FG002|Overall Study|Refused further treatment|0|||
160829139|NCT02769962|580761590|FG003|Overall Study|Refused further treatment|0|||
160829140|NCT02769962|580761591|FG004|Overall Study|Refused further treatment|0|||
160829141|NCT02769962|580761592|FG005|Overall Study|Refused further treatment|1|||
160829142|NCT02769962|580761593|FG006|Overall Study|Refused further treatment|1|||
160829143|NCT02769962|580761594|FG007|Overall Study|Refused further treatment|0|||
160829144|NCT02559414|580761601|FG000|Overall Study|Lost to Follow-up|0|||
160829145|NCT02559414|580761602|FG001|Overall Study|Lost to Follow-up|1|||
160829146|NCT02559414|580761603|FG002|Overall Study|Lost to Follow-up|0|||
160829147|NCT02559414|580761601|FG000|Overall Study|Withdrawal by Subject|1|||
160829148|NCT02559414|580761602|FG001|Overall Study|Withdrawal by Subject|0|||
160829149|NCT02559414|580761603|FG002|Overall Study|Withdrawal by Subject|1|||
160829150|NCT02559414|580761601|FG000|Overall Study|Other|0|||
160829151|NCT02559414|580761602|FG001|Overall Study|Other|1|||
160829152|NCT02559414|580761603|FG002|Overall Study|Other|1|||
160829153|NCT00004445|580761604|FG000|Overall Study|Physician Decision|2|||
160829154|NCT00004445|580761604|FG000|Overall Study|Withdrawal by Subject|1|||
160829155|NCT01266317|580761605|FG000|Overall Study|Withdrawal by Subject|2|||
160829156|NCT02753127|580761608|FG000|Overall Study|Lost to Follow-up|13|||
160829157|NCT02753127|580761609|FG001|Overall Study|Lost to Follow-up|11|||
160829158|NCT02753127|580761608|FG000|Overall Study|Withdrawal by Subject|37|||
160829159|NCT02753127|580761609|FG001|Overall Study|Withdrawal by Subject|47|||
160829160|NCT02753127|580761608|FG000|Overall Study|Other|3|||
160829161|NCT02753127|580761609|FG001|Overall Study|Other|8|||
160829162|NCT02753127|580761608|FG000|Overall Study|Hospice|0|||
160829163|NCT02753127|580761609|FG001|Overall Study|Hospice|2|||
160829164|NCT00098722|580761610|FG000|Double Blind Phase|Adverse Event|7|||
160829165|NCT00098722|580761611|FG001|Double Blind Phase|Adverse Event|7|||
160829166|NCT00098722|580761612|FG002|Double Blind Phase|Adverse Event|3|||
160903116|NCT02195583|581039003|FG000|Overall Study|Adverse Event|2|||
160903117|NCT02195583|581039003|FG000|Overall Study|Other Reason|2|||
160903118|NCT01560403|581039004|FG000|Overall Study|Lost to Follow-up|0|||
160903119|NCT01560403|581039005|FG001|Overall Study|Lost to Follow-up|1|||
160903120|NCT00983437|581039007|FG000|Overall Study|Adverse Event|9|||
160829167|NCT00098722|580761613|FG003|Double Blind Phase|Adverse Event|0|||
160829168|NCT00098722|580761614|FG004|Double Blind Phase|Adverse Event|0|||
160829169|NCT00098722|580761615|FG005|Double Blind Phase|Adverse Event|0|||
160829170|NCT00098722|580761616|FG006|Double Blind Phase|Adverse Event|0|||
160829171|NCT00098722|580761610|FG000|Double Blind Phase|Death|2|||
160829172|NCT00098722|580761611|FG001|Double Blind Phase|Death|5|||
160829173|NCT00098722|580761612|FG002|Double Blind Phase|Death|0|||
160829174|NCT00098722|580761613|FG003|Double Blind Phase|Death|0|||
160829175|NCT00098722|580761614|FG004|Double Blind Phase|Death|0|||
160829176|NCT00098722|580761615|FG005|Double Blind Phase|Death|0|||
160829177|NCT00098722|580761616|FG006|Double Blind Phase|Death|0|||
160829178|NCT00098722|580761610|FG000|Double Blind Phase|Lack of Efficacy|21|||
160829179|NCT00098722|580761611|FG001|Double Blind Phase|Lack of Efficacy|23|||
160829180|NCT00098722|580761612|FG002|Double Blind Phase|Lack of Efficacy|15|||
160829181|NCT00098722|580761613|FG003|Double Blind Phase|Lack of Efficacy|0|||
160829182|NCT00098722|580761614|FG004|Double Blind Phase|Lack of Efficacy|0|||
160829183|NCT00098722|580761615|FG005|Double Blind Phase|Lack of Efficacy|0|||
160829184|NCT00098722|580761616|FG006|Double Blind Phase|Lack of Efficacy|0|||
160829185|NCT00098722|580761610|FG000|Double Blind Phase|Participant defaulted|16|||
160829186|NCT00098722|580761611|FG001|Double Blind Phase|Participant defaulted|11|||
160829187|NCT00098722|580761612|FG002|Double Blind Phase|Participant defaulted|9|||
160829188|NCT00098722|580761613|FG003|Double Blind Phase|Participant defaulted|0|||
160829189|NCT00098722|580761614|FG004|Double Blind Phase|Participant defaulted|0|||
160829190|NCT00098722|580761615|FG005|Double Blind Phase|Participant defaulted|0|||
160829191|NCT00098722|580761616|FG006|Double Blind Phase|Participant defaulted|0|||
160829192|NCT00098722|580761610|FG000|Double Blind Phase|Pregnancy|1|||
160829193|NCT00098722|580761611|FG001|Double Blind Phase|Pregnancy|0|||
160829194|NCT00098722|580761612|FG002|Double Blind Phase|Pregnancy|0|||
160829195|NCT00098722|580761613|FG003|Double Blind Phase|Pregnancy|0|||
160829196|NCT00098722|580761614|FG004|Double Blind Phase|Pregnancy|0|||
160829197|NCT00098722|580761615|FG005|Double Blind Phase|Pregnancy|0|||
160829198|NCT00098722|580761616|FG006|Double Blind Phase|Pregnancy|0|||
160829199|NCT00098722|580761610|FG000|Double Blind Phase|Randomized, not treated|4|||
160829200|NCT00098722|580761611|FG001|Double Blind Phase|Randomized, not treated|3|||
160829201|NCT00098722|580761612|FG002|Double Blind Phase|Randomized, not treated|3|||
160829202|NCT00098722|580761613|FG003|Double Blind Phase|Randomized, not treated|0|||
160829203|NCT00098722|580761614|FG004|Double Blind Phase|Randomized, not treated|0|||
160829204|NCT00098722|580761615|FG005|Double Blind Phase|Randomized, not treated|0|||
160829205|NCT00098722|580761616|FG006|Double Blind Phase|Randomized, not treated|0|||
160829206|NCT00098722|580761610|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
160829207|NCT00098722|580761611|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
160829208|NCT00098722|580761612|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
160829209|NCT00098722|580761613|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
160829210|NCT00098722|580761614|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
160829211|NCT00098722|580761615|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
160829212|NCT00098722|580761616|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
160829213|NCT00098722|580761610|FG000|Double Blind Phase|Other|7|||
160829214|NCT00098722|580761611|FG001|Double Blind Phase|Other|8|||
160829215|NCT00098722|580761612|FG002|Double Blind Phase|Other|7|||
160829216|NCT00098722|580761613|FG003|Double Blind Phase|Other|0|||
160829217|NCT00098722|580761614|FG004|Double Blind Phase|Other|0|||
160829218|NCT00098722|580761615|FG005|Double Blind Phase|Other|0|||
160829219|NCT00098722|580761616|FG006|Double Blind Phase|Other|0|||
160829220|NCT00098722|580761610|FG000|Open Label Phase|Adverse Event|0|||
160829221|NCT00098722|580761611|FG001|Open Label Phase|Adverse Event|0|||
160829222|NCT00098722|580761612|FG002|Open Label Phase|Adverse Event|0|||
160829223|NCT00098722|580761613|FG003|Open Label Phase|Adverse Event|5|||
160829224|NCT00098722|580761614|FG004|Open Label Phase|Adverse Event|0|||
160829225|NCT00098722|580761615|FG005|Open Label Phase|Adverse Event|0|||
160829226|NCT00098722|580761616|FG006|Open Label Phase|Adverse Event|0|||
160829227|NCT00098722|580761610|FG000|Open Label Phase|Death|0|||
160829228|NCT00098722|580761611|FG001|Open Label Phase|Death|0|||
160829229|NCT00098722|580761612|FG002|Open Label Phase|Death|0|||
160829230|NCT00098722|580761613|FG003|Open Label Phase|Death|2|||
160829231|NCT00098722|580761614|FG004|Open Label Phase|Death|0|||
160829232|NCT00098722|580761615|FG005|Open Label Phase|Death|0|||
160829233|NCT00098722|580761616|FG006|Open Label Phase|Death|0|||
160903121|NCT00983437|581039007|FG000|Overall Study|Lack of Efficacy|1|||
160829234|NCT00098722|580761610|FG000|Open Label Phase|Lack of Efficacy|0|||
160829235|NCT00098722|580761611|FG001|Open Label Phase|Lack of Efficacy|0|||
160829236|NCT00098722|580761612|FG002|Open Label Phase|Lack of Efficacy|0|||
160829237|NCT00098722|580761613|FG003|Open Label Phase|Lack of Efficacy|8|||
160829238|NCT00098722|580761614|FG004|Open Label Phase|Lack of Efficacy|0|||
160829239|NCT00098722|580761615|FG005|Open Label Phase|Lack of Efficacy|0|||
160829240|NCT00098722|580761616|FG006|Open Label Phase|Lack of Efficacy|0|||
160829241|NCT00098722|580761610|FG000|Open Label Phase|Pregnancy|0|||
160829242|NCT00098722|580761611|FG001|Open Label Phase|Pregnancy|0|||
160829243|NCT00098722|580761612|FG002|Open Label Phase|Pregnancy|0|||
160829244|NCT00098722|580761613|FG003|Open Label Phase|Pregnancy|1|||
160829245|NCT00098722|580761614|FG004|Open Label Phase|Pregnancy|0|||
160829246|NCT00098722|580761615|FG005|Open Label Phase|Pregnancy|0|||
160829247|NCT00098722|580761616|FG006|Open Label Phase|Pregnancy|0|||
160829248|NCT00098722|580761610|FG000|Open Label Phase|Participant defaulted|0|||
160829249|NCT00098722|580761611|FG001|Open Label Phase|Participant defaulted|0|||
160829250|NCT00098722|580761612|FG002|Open Label Phase|Participant defaulted|0|||
160829251|NCT00098722|580761613|FG003|Open Label Phase|Participant defaulted|18|||
160829252|NCT00098722|580761614|FG004|Open Label Phase|Participant defaulted|0|||
160829253|NCT00098722|580761615|FG005|Open Label Phase|Participant defaulted|0|||
160829254|NCT00098722|580761616|FG006|Open Label Phase|Participant defaulted|0|||
160829255|NCT00098722|580761610|FG000|Open Label Phase|Ongoing at cut-off date|0|||
160829256|NCT00098722|580761611|FG001|Open Label Phase|Ongoing at cut-off date|0|||
160829257|NCT00098722|580761612|FG002|Open Label Phase|Ongoing at cut-off date|0|||
160829258|NCT00098722|580761613|FG003|Open Label Phase|Ongoing at cut-off date|220|||
160829259|NCT00098722|580761614|FG004|Open Label Phase|Ongoing at cut-off date|50|||
160829260|NCT00098722|580761615|FG005|Open Label Phase|Ongoing at cut-off date|0|||
160829261|NCT00098722|580761616|FG006|Open Label Phase|Ongoing at cut-off date|0|||
160829262|NCT00098722|580761610|FG000|Open Label Phase|Other|0|||
160829263|NCT00098722|580761611|FG001|Open Label Phase|Other|0|||
160829264|NCT00098722|580761612|FG002|Open Label Phase|Other|0|||
160829265|NCT00098722|580761613|FG003|Open Label Phase|Other|18|||
160829266|NCT00098722|580761614|FG004|Open Label Phase|Other|0|||
160829267|NCT00098722|580761615|FG005|Open Label Phase|Other|0|||
160829268|NCT00098722|580761616|FG006|Open Label Phase|Other|0|||
160829269|NCT00098722|580761610|FG000|Observation Phase|Death|0|||
160829270|NCT00098722|580761611|FG001|Observation Phase|Death|0|||
160829271|NCT00098722|580761612|FG002|Observation Phase|Death|0|||
160829272|NCT00098722|580761613|FG003|Observation Phase|Death|0|||
160829273|NCT00098722|580761614|FG004|Observation Phase|Death|0|||
160829274|NCT00098722|580761615|FG005|Observation Phase|Death|5|||
160829275|NCT00098722|580761616|FG006|Observation Phase|Death|3|||
160829276|NCT00098722|580761610|FG000|Observation Phase|Lack of Efficacy|0|||
160829277|NCT00098722|580761611|FG001|Observation Phase|Lack of Efficacy|0|||
160829278|NCT00098722|580761612|FG002|Observation Phase|Lack of Efficacy|0|||
160829279|NCT00098722|580761613|FG003|Observation Phase|Lack of Efficacy|0|||
160829280|NCT00098722|580761614|FG004|Observation Phase|Lack of Efficacy|0|||
160829281|NCT00098722|580761615|FG005|Observation Phase|Lack of Efficacy|2|||
160829282|NCT00098722|580761616|FG006|Observation Phase|Lack of Efficacy|0|||
160829283|NCT00098722|580761610|FG000|Observation Phase|Participant defaulted|0|||
160829284|NCT00098722|580761611|FG001|Observation Phase|Participant defaulted|0|||
160829285|NCT00098722|580761612|FG002|Observation Phase|Participant defaulted|0|||
160829286|NCT00098722|580761613|FG003|Observation Phase|Participant defaulted|0|||
160829287|NCT00098722|580761614|FG004|Observation Phase|Participant defaulted|0|||
160829288|NCT00098722|580761615|FG005|Observation Phase|Participant defaulted|17|||
160829289|NCT00098722|580761616|FG006|Observation Phase|Participant defaulted|4|||
160829290|NCT00098722|580761610|FG000|Observation Phase|Other|0|||
160829291|NCT00098722|580761611|FG001|Observation Phase|Other|0|||
160829292|NCT00098722|580761612|FG002|Observation Phase|Other|0|||
160829293|NCT00098722|580761613|FG003|Observation Phase|Other|0|||
160829294|NCT00098722|580761614|FG004|Observation Phase|Other|0|||
160829295|NCT00098722|580761615|FG005|Observation Phase|Other|21|||
160829296|NCT00098722|580761616|FG006|Observation Phase|Other|10|||
160829297|NCT01143051|580761621|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
160829298|NCT01143051|580761622|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
160829299|NCT01143051|580761623|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
160829300|NCT01143051|580761624|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
160829301|NCT01143051|580761625|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
160829302|NCT01143051|580761626|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
160829303|NCT01143051|580761621|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
160829304|NCT01143051|580761622|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
160829305|NCT01143051|580761623|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
160829306|NCT01143051|580761624|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
160903122|NCT00983437|581039007|FG000|Overall Study|Withdrawal by Subject|8|||
160829307|NCT01143051|580761625|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
160990845|NCT00941031|581353971|FG000|Induction Period|Withdrawal by Subject|1|||
160990846|NCT00941031|581353972|FG001|Induction Period|Withdrawal by Subject|2|||
160990847|NCT00941031|581353973|FG002|Induction Period|Withdrawal by Subject|2|||
160990848|NCT00941031|581353974|FG003|Induction Period|Withdrawal by Subject|2|||
160990849|NCT00941031|581353975|FG004|Induction Period|Withdrawal by Subject|0|||
160990850|NCT00941031|581353976|FG005|Induction Period|Withdrawal by Subject|0|||
160990851|NCT00941031|581353977|FG006|Induction Period|Withdrawal by Subject|0|||
160990852|NCT00941031|581353971|FG000|Induction Period|Adminstative Problems|1|||
160990853|NCT00941031|581353972|FG001|Induction Period|Adminstative Problems|1|||
160829308|NCT01143051|580761626|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
160829309|NCT01146288|580761627|FG000|First Intervention(1 Day)|Adverse Event|0|||
160829310|NCT01146288|580761628|FG001|First Intervention(1 Day)|Adverse Event|1|||
160829311|NCT02677844|580761629|FG000|Period 3|Withdrawal by Subject|0|||
160829312|NCT02677844|580761630|FG001|Period 3|Withdrawal by Subject|0|||
160829313|NCT02677844|580761631|FG002|Period 3|Withdrawal by Subject|0|||
160829314|NCT02677844|580761632|FG003|Period 3|Withdrawal by Subject|1|||
160829315|NCT02677844|580761633|FG004|Period 3|Withdrawal by Subject|0|||
160829316|NCT02677844|580761634|FG005|Period 3|Withdrawal by Subject|0|||
160829317|NCT02677844|580761635|FG006|Period 3|Withdrawal by Subject|0|||
160829318|NCT00765882|580761636|FG000|Overall Study|Adverse Event|10|||
160829319|NCT00765882|580761637|FG001|Overall Study|Adverse Event|21|||
160829320|NCT00765882|580761638|FG002|Overall Study|Adverse Event|20|||
160829321|NCT00765882|580761636|FG000|Overall Study|Lack of Efficacy|4|||
160829322|NCT00765882|580761637|FG001|Overall Study|Lack of Efficacy|0|||
160829323|NCT00765882|580761638|FG002|Overall Study|Lack of Efficacy|1|||
160829324|NCT00765882|580761636|FG000|Overall Study|Protocol Violation|4|||
160829325|NCT00765882|580761637|FG001|Overall Study|Protocol Violation|3|||
160829326|NCT00765882|580761638|FG002|Overall Study|Protocol Violation|1|||
160829327|NCT00765882|580761636|FG000|Overall Study|Withdrawal by Subject|2|||
160829328|NCT00765882|580761637|FG001|Overall Study|Withdrawal by Subject|6|||
160829329|NCT00765882|580761638|FG002|Overall Study|Withdrawal by Subject|6|||
160903123|NCT00983437|581039007|FG000|Overall Study|Noncompliance to Study Procedures|1|||
160903124|NCT00983437|581039007|FG000|Overall Study|Lost to Follow-up|2|||
160903125|NCT00983437|581039007|FG000|Overall Study|Other Reason|26|||
160903126|NCT04019288|581039008|FG000|Overall Study|Death|1|||
160903127|NCT04019288|581039009|FG001|Overall Study|Death|0|||
160903128|NCT04019288|581039010|FG002|Overall Study|Death|0|||
160903129|NCT00094172|581039012|FG000|Overall Study|Adverse Event|0|||
160903130|NCT00094172|581039013|FG001|Overall Study|Adverse Event|1|||
160903131|NCT00094172|581039012|FG000|Overall Study|Lost to Follow-up|2|||
160903132|NCT00094172|581039013|FG001|Overall Study|Lost to Follow-up|0|||
160990854|NCT00941031|581353973|FG002|Induction Period|Adminstative Problems|1|||
160990855|NCT00941031|581353974|FG003|Induction Period|Adminstative Problems|0|||
160990856|NCT00941031|581353975|FG004|Induction Period|Adminstative Problems|0|||
160990857|NCT00941031|581353976|FG005|Induction Period|Adminstative Problems|0|||
160990858|NCT00941031|581353977|FG006|Induction Period|Adminstative Problems|0|||
160990859|NCT00941031|581353971|FG000|Induction Period|Adverse Event|1|||
160990860|NCT00941031|581353972|FG001|Induction Period|Adverse Event|0|||
160990861|NCT00941031|581353973|FG002|Induction Period|Adverse Event|3|||
160990862|NCT00941031|581353974|FG003|Induction Period|Adverse Event|2|||
160990863|NCT00941031|581353975|FG004|Induction Period|Adverse Event|0|||
160990864|NCT00941031|581353976|FG005|Induction Period|Adverse Event|0|||
160559749|NCT03529409|579772170|FG000|Follow-up Assessment|Death|1|||
160559750|NCT03529409|579772171|FG001|Follow-up Assessment|Death|0|||
160559751|NCT03529409|579772172|FG002|Follow-up Assessment|Death|0|||
160559752|NCT03529409|579772170|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
160559753|NCT03529409|579772171|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
160559754|NCT03529409|579772172|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
160559755|NCT01497262|579772173|FG000|Overall Study|Abnormal Lab Values|4|||
160559756|NCT01497262|579772173|FG000|Overall Study|Abnormal Test Procedure Result|1|||
160829330|NCT00765882|580761636|FG000|Overall Study|Lost to Follow-up|1|||
160829331|NCT00765882|580761637|FG001|Overall Study|Lost to Follow-up|9|||
160829332|NCT00765882|580761638|FG002|Overall Study|Lost to Follow-up|6|||
160829333|NCT00765882|580761636|FG000|Overall Study|Other Reason|3|||
160829334|NCT00765882|580761637|FG001|Overall Study|Other Reason|1|||
160903133|NCT00094172|581039012|FG000|Overall Study|Protocol Violation|0|||
160903134|NCT00094172|581039013|FG001|Overall Study|Protocol Violation|1|||
160903135|NCT00094172|581039012|FG000|Overall Study|Withdrawal by Subject|10|||
160903136|NCT00094172|581039013|FG001|Overall Study|Withdrawal by Subject|5|||
160903137|NCT00094172|581039012|FG000|Overall Study|Primary endpoint met.|1|||
160990865|NCT00941031|581353977|FG006|Induction Period|Adverse Event|0|||
160990866|NCT00941031|581353971|FG000|Maintenance Period|Withdrawal by Subject|0|||
160829335|NCT00765882|580761638|FG002|Overall Study|Other Reason|2|||
160829336|NCT03532932|580761643|FG000|Overall Study|Protocol Deviation|33|||
160829337|NCT03532932|580761644|FG001|Overall Study|Protocol Deviation|31|||
160829338|NCT03532932|580761643|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
160829339|NCT03532932|580761644|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
160990867|NCT00941031|581353972|FG001|Maintenance Period|Withdrawal by Subject|0|||
160990868|NCT00941031|581353973|FG002|Maintenance Period|Withdrawal by Subject|0|||
160990869|NCT00941031|581353974|FG003|Maintenance Period|Withdrawal by Subject|0|||
160990870|NCT00941031|581353975|FG004|Maintenance Period|Withdrawal by Subject|6|||
160990871|NCT00941031|581353976|FG005|Maintenance Period|Withdrawal by Subject|2|||
160990872|NCT00941031|581353977|FG006|Maintenance Period|Withdrawal by Subject|13|||
160990873|NCT00941031|581353971|FG000|Maintenance Period|Administrative Problems|0|||
160990874|NCT00941031|581353972|FG001|Maintenance Period|Administrative Problems|0|||
160829340|NCT03532932|580761643|FG000|Overall Study|Withdrawal by Subject|2|||
160829341|NCT03532932|580761644|FG001|Overall Study|Withdrawal by Subject|0|||
160829342|NCT03532932|580761643|FG000|Overall Study|Lost to Follow-up|15|||
160829343|NCT03532932|580761644|FG001|Overall Study|Lost to Follow-up|9|||
160829344|NCT03532932|580761643|FG000|Overall Study|Adverse Event|4|||
160829345|NCT03532932|580761644|FG001|Overall Study|Adverse Event|3|||
160829346|NCT03532932|580761643|FG000|Overall Study|Death|0|||
160829347|NCT03532932|580761644|FG001|Overall Study|Death|2|||
160829348|NCT03532932|580761643|FG000|Overall Study|Other|11|||
160829349|NCT03532932|580761644|FG001|Overall Study|Other|16|||
160829350|NCT02255565|580761645|FG000|Overall Study|Withdrawal by Subject|0|||
160829351|NCT02255565|580761646|FG001|Overall Study|Withdrawal by Subject|1|||
160829352|NCT02255565|580761647|FG002|Overall Study|Withdrawal by Subject|0|||
160829353|NCT00810901|580761648|FG000|Overall Study|Lost to Follow-up|88|||
160829354|NCT00810901|580761649|FG001|Overall Study|Lost to Follow-up|58|||
160829355|NCT03689712|580761650|FG000|Overall Study|Adverse Event|1|||
160829356|NCT03689712|580761651|FG001|Overall Study|Adverse Event|0|||
160829357|NCT03689712|580761650|FG000|Overall Study|Death|20|||
160829358|NCT03689712|580761651|FG001|Overall Study|Death|10|||
160829359|NCT03689712|580761650|FG000|Overall Study|Lost to Follow-up|6|||
160829360|NCT03689712|580761651|FG001|Overall Study|Lost to Follow-up|6|||
160829361|NCT03689712|580761650|FG000|Overall Study|Other|1|||
160829362|NCT03689712|580761651|FG001|Overall Study|Other|0|||
160829363|NCT03689712|580761650|FG000|Overall Study|Patient Non-Compliance|0|||
160829364|NCT03689712|580761651|FG001|Overall Study|Patient Non-Compliance|1|||
160829365|NCT03689712|580761650|FG000|Overall Study|Withdrawal by Subject|20|||
160829366|NCT03689712|580761651|FG001|Overall Study|Withdrawal by Subject|4|||
160829367|NCT03689712|580761650|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
160829368|NCT03689712|580761651|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
160829369|NCT03689712|580761650|FG000|Overall Study|Randomized but not Treated|13|||
160829370|NCT03689712|580761651|FG001|Overall Study|Randomized but not Treated|7|||
160829371|NCT03689712|580761650|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
160829372|NCT03689712|580761651|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
160829373|NCT00931801|580761652|FG000|Overall Study|Adverse Event|0|||
160829374|NCT00931801|580761653|FG001|Overall Study|Adverse Event|0|||
160829375|NCT00931801|580761654|FG002|Overall Study|Adverse Event|1|||
160829376|NCT00931801|580761652|FG000|Overall Study|Lost to Follow-up|0|||
160829377|NCT00931801|580761653|FG001|Overall Study|Lost to Follow-up|1|||
160829378|NCT00931801|580761654|FG002|Overall Study|Lost to Follow-up|0|||
160829379|NCT00931801|580761652|FG000|Overall Study|Withdrawal by Subject|1|||
160829380|NCT00931801|580761653|FG001|Overall Study|Withdrawal by Subject|0|||
160829381|NCT00931801|580761654|FG002|Overall Study|Withdrawal by Subject|0|||
160829382|NCT00931801|580761652|FG000|Overall Study|Confirmed Virologic Failure|0|||
160829383|NCT00931801|580761653|FG001|Overall Study|Confirmed Virologic Failure|0|||
160829384|NCT00931801|580761654|FG002|Overall Study|Confirmed Virologic Failure|3|||
160829385|NCT01635764|580761659|FG000|Overall Study|Adverse Event|46|||
160829386|NCT01635764|580761659|FG000|Overall Study|Lack of Efficacy|76|||
160829387|NCT01635764|580761659|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
160829388|NCT01635764|580761659|FG000|Overall Study|Protocol Deviation|1|||
160829389|NCT01635764|580761659|FG000|Overall Study|Withdrew Consent|67|||
160829390|NCT01635764|580761659|FG000|Overall Study|Lost to Follow-up|53|||
160829391|NCT01635764|580761659|FG000|Overall Study|Other|28|||
160829392|NCT01816906|580761663|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
160829393|NCT01816906|580761664|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
160829394|NCT01816906|580761663|FG000|Six Months|Lost to Follow-up|14|||
160990875|NCT00941031|581353973|FG002|Maintenance Period|Administrative Problems|0|||
160990876|NCT00941031|581353974|FG003|Maintenance Period|Administrative Problems|0|||
160829395|NCT01816906|580761664|FG001|Six Months|Lost to Follow-up|16|||
160829396|NCT01816906|580761663|FG000|12 Months|Adverse Event|2|||
160829397|NCT01816906|580761664|FG001|12 Months|Adverse Event|2|||
160829398|NCT01816906|580761663|FG000|12 Months|Death|0|||
160990877|NCT00941031|581353975|FG004|Maintenance Period|Administrative Problems|1|||
160829399|NCT01816906|580761664|FG001|12 Months|Death|2|||
160829400|NCT01816906|580761663|FG000|12 Months|Lost to Follow-up|2|||
160829401|NCT01816906|580761664|FG001|12 Months|Lost to Follow-up|1|||
160829402|NCT04375397|580761665|FG000|Overall Study|Death|1|||
160829403|NCT04375397|580761666|FG001|Overall Study|Death|1|||
160829404|NCT04375397|580761665|FG000|Overall Study|Withdrew consent|2|||
160829405|NCT04375397|580761666|FG001|Overall Study|Withdrew consent|0|||
160559757|NCT01497262|579772173|FG000|Overall Study|Physician Decision|1|||
160829406|NCT04375397|580761665|FG000|Overall Study|Lost to Follow-up|6|||
160829407|NCT04375397|580761666|FG001|Overall Study|Lost to Follow-up|4|||
160829408|NCT04375397|580761665|FG000|Overall Study|Other, not specified|0|||
160829409|NCT04375397|580761666|FG001|Overall Study|Other, not specified|1|||
160829410|NCT00746733|580761667|FG000|Second Intervention|Adverse Event|1|||
160829411|NCT00746733|580761668|FG001|Second Intervention|Adverse Event|0|||
160829412|NCT00746733|580761667|FG000|Third Intervention|Withdrawal by Subject|1|||
160829413|NCT00746733|580761668|FG001|Third Intervention|Withdrawal by Subject|1|||
160829414|NCT00610441|580761672|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
160829415|NCT00610441|580761673|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
160829416|NCT00610441|580761674|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
160829417|NCT00610441|580761675|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
160829418|NCT00610441|580761672|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
160829419|NCT00610441|580761673|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
160829420|NCT00610441|580761674|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
160829421|NCT00610441|580761675|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
160829422|NCT00610441|580761672|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
160829423|NCT00610441|580761673|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
160829424|NCT00610441|580761674|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
160829425|NCT00610441|580761675|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
160829426|NCT00610441|580761672|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
160829427|NCT00610441|580761673|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
160829428|NCT00610441|580761674|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
160829429|NCT00610441|580761675|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
160829430|NCT00610441|580761672|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
160829431|NCT00610441|580761673|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
160829432|NCT00610441|580761674|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
160829433|NCT00610441|580761675|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
160829434|NCT00610441|580761672|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
160829435|NCT00610441|580761673|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
160829436|NCT00610441|580761674|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
160829437|NCT00610441|580761675|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
160829438|NCT00610441|580761672|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
160829439|NCT00610441|580761673|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
160829440|NCT00610441|580761674|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
160829441|NCT00610441|580761675|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
160829442|NCT00610441|580761672|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
160829443|NCT00610441|580761673|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
160829444|NCT00610441|580761674|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
160829445|NCT00610441|580761675|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
160829446|NCT00610441|580761672|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
160829447|NCT00610441|580761673|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
160829448|NCT00610441|580761674|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
160829449|NCT00610441|580761675|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
160829450|NCT01945775|580761679|FG000|Overall Study|Death|214|||
160829451|NCT01945775|580761680|FG001|Overall Study|Death|98|||
160829452|NCT01945775|580761679|FG000|Overall Study|Lost to Follow-up|12|||
160829453|NCT01945775|580761680|FG001|Overall Study|Lost to Follow-up|7|||
160829454|NCT01945775|580761679|FG000|Overall Study|Withdrawal by Subject|11|||
160829455|NCT01945775|580761680|FG001|Overall Study|Withdrawal by Subject|21|||
160829456|NCT01945775|580761679|FG000|Overall Study|Other|50|||
160829457|NCT01945775|580761680|FG001|Overall Study|Other|18|||
160829458|NCT02876328|580761681|FG000|Overall Study|Death|2|||
160829459|NCT02876328|580761682|FG001|Overall Study|Death|1|||
160829460|NCT02876328|580761683|FG002|Overall Study|Death|3|||
160829461|NCT02876328|580761684|FG003|Overall Study|Death|0|||
160829462|NCT02876328|580761685|FG004|Overall Study|Death|0|||
160829463|NCT02876328|580761686|FG005|Overall Study|Death|0|||
160829464|NCT02876328|580761687|FG006|Overall Study|Death|1|||
160829465|NCT02876328|580761688|FG007|Overall Study|Death|3|||
160829466|NCT02876328|580761689|FG008|Overall Study|Death|0|||
160829467|NCT02876328|580761690|FG009|Overall Study|Death|1|||
160829468|NCT02876328|580761691|FG010|Overall Study|Death|1|||
160829469|NCT02876328|580761692|FG011|Overall Study|Death|0|||
160829470|NCT02876328|580761693|FG012|Overall Study|Death|0|||
160829471|NCT02876328|580761694|FG013|Overall Study|Death|0|||
160829472|NCT02876328|580761695|FG014|Overall Study|Death|0|||
160559758|NCT01497262|579772173|FG000|Overall Study|Withdrawal by Subject|2|||
160559759|NCT01497262|579772173|FG000|Overall Study|Adverse Event|2|||
160829473|NCT02876328|580761696|FG015|Overall Study|Death|0|||
160829474|NCT02876328|580761697|FG016|Overall Study|Death|1|||
160829475|NCT02876328|580761698|FG017|Overall Study|Death|1|||
160829476|NCT02876328|580761699|FG018|Overall Study|Death|0|||
160829477|NCT02876328|580761700|FG019|Overall Study|Death|0|||
160829478|NCT02876328|580761701|FG020|Overall Study|Death|0|||
160829479|NCT02876328|580761702|FG021|Overall Study|Death|1|||
160829480|NCT02876328|580761703|FG022|Overall Study|Death|0|||
160829481|NCT02876328|580761704|FG023|Overall Study|Death|0|||
160829482|NCT02876328|580761681|FG000|Overall Study|Withdrawal by Subject|0|||
160829483|NCT02876328|580761682|FG001|Overall Study|Withdrawal by Subject|2|||
160829484|NCT02876328|580761683|FG002|Overall Study|Withdrawal by Subject|3|||
160829485|NCT02876328|580761684|FG003|Overall Study|Withdrawal by Subject|3|||
160829486|NCT02876328|580761685|FG004|Overall Study|Withdrawal by Subject|0|||
160829487|NCT02876328|580761686|FG005|Overall Study|Withdrawal by Subject|1|||
160829488|NCT02876328|580761687|FG006|Overall Study|Withdrawal by Subject|0|||
160829489|NCT02876328|580761688|FG007|Overall Study|Withdrawal by Subject|1|||
160829490|NCT02876328|580761689|FG008|Overall Study|Withdrawal by Subject|1|||
160829491|NCT02876328|580761690|FG009|Overall Study|Withdrawal by Subject|2|||
160829492|NCT02876328|580761691|FG010|Overall Study|Withdrawal by Subject|0|||
160829493|NCT02876328|580761692|FG011|Overall Study|Withdrawal by Subject|0|||
160829494|NCT02876328|580761693|FG012|Overall Study|Withdrawal by Subject|0|||
160829495|NCT02876328|580761694|FG013|Overall Study|Withdrawal by Subject|0|||
160829496|NCT02876328|580761695|FG014|Overall Study|Withdrawal by Subject|0|||
160829497|NCT02876328|580761696|FG015|Overall Study|Withdrawal by Subject|0|||
160829498|NCT02876328|580761697|FG016|Overall Study|Withdrawal by Subject|1|||
160829499|NCT02876328|580761698|FG017|Overall Study|Withdrawal by Subject|3|||
160829500|NCT02876328|580761699|FG018|Overall Study|Withdrawal by Subject|0|||
160559760|NCT01497262|579772173|FG000|Overall Study|Protocol Violation|1|||
160559761|NCT03898063|579772176|FG000|Overall Study|Withdrawal by Subject|10|||
160829501|NCT02876328|580761700|FG019|Overall Study|Withdrawal by Subject|0|||
160829502|NCT02876328|580761701|FG020|Overall Study|Withdrawal by Subject|1|||
160829503|NCT02876328|580761702|FG021|Overall Study|Withdrawal by Subject|0|||
160829504|NCT02876328|580761703|FG022|Overall Study|Withdrawal by Subject|0|||
160829505|NCT02876328|580761704|FG023|Overall Study|Withdrawal by Subject|0|||
160829506|NCT02876328|580761681|FG000|Overall Study|Missed 12 Month Visit|15|||
160829507|NCT02876328|580761682|FG001|Overall Study|Missed 12 Month Visit|10|||
160829508|NCT02876328|580761683|FG002|Overall Study|Missed 12 Month Visit|11|||
160829509|NCT02876328|580761684|FG003|Overall Study|Missed 12 Month Visit|6|||
160829510|NCT02876328|580761685|FG004|Overall Study|Missed 12 Month Visit|10|||
160829511|NCT02876328|580761686|FG005|Overall Study|Missed 12 Month Visit|14|||
160829512|NCT02876328|580761687|FG006|Overall Study|Missed 12 Month Visit|3|||
160829513|NCT02876328|580761688|FG007|Overall Study|Missed 12 Month Visit|8|||
160829514|NCT02876328|580761689|FG008|Overall Study|Missed 12 Month Visit|9|||
160829515|NCT02876328|580761690|FG009|Overall Study|Missed 12 Month Visit|5|||
160829516|NCT02876328|580761691|FG010|Overall Study|Missed 12 Month Visit|4|||
160829517|NCT02876328|580761692|FG011|Overall Study|Missed 12 Month Visit|1|||
160829518|NCT02876328|580761693|FG012|Overall Study|Missed 12 Month Visit|5|||
160559762|NCT03898063|579772177|FG001|Overall Study|Withdrawal by Subject|8|||
160829519|NCT02876328|580761694|FG013|Overall Study|Missed 12 Month Visit|4|||
160829520|NCT02876328|580761695|FG014|Overall Study|Missed 12 Month Visit|4|||
160829521|NCT02876328|580761696|FG015|Overall Study|Missed 12 Month Visit|4|||
160829522|NCT02876328|580761697|FG016|Overall Study|Missed 12 Month Visit|3|||
160829523|NCT02876328|580761698|FG017|Overall Study|Missed 12 Month Visit|6|||
160829524|NCT02876328|580761699|FG018|Overall Study|Missed 12 Month Visit|2|||
160829525|NCT02876328|580761700|FG019|Overall Study|Missed 12 Month Visit|2|||
160829526|NCT02876328|580761701|FG020|Overall Study|Missed 12 Month Visit|11|||
160829527|NCT02876328|580761702|FG021|Overall Study|Missed 12 Month Visit|7|||
160559763|NCT00961961|579772180|FG000|Phase I|Withdrawal by Subject|7|||
160829528|NCT02876328|580761703|FG022|Overall Study|Missed 12 Month Visit|1|||
160829529|NCT02876328|580761704|FG023|Overall Study|Missed 12 Month Visit|0|||
160829530|NCT00837876|580761708|FG000|Overall Study|Death|2|||
160903138|NCT00094172|581039013|FG001|Overall Study|Primary endpoint met.|0|||
160903139|NCT00094172|581039012|FG000|Overall Study|Started other MS therapy due to disease|1|||
160903140|NCT00094172|581039013|FG001|Overall Study|Started other MS therapy due to disease|0|||
160903141|NCT01020981|581039016|FG000|Overall Study|Did not return mailed survey|74|||
160559764|NCT00961961|579772181|FG001|Phase I|Withdrawal by Subject|0|||
160903142|NCT01020981|581039017|FG001|Overall Study|Did not return mailed survey|58|||
160903143|NCT01020981|581039016|FG000|Overall Study|Survey returned undeliverable|8|||
160829531|NCT00837876|580761708|FG000|Overall Study|Adverse Event|7|||
160829532|NCT00837876|580761708|FG000|Overall Study|Physician Decision|1|||
160829533|NCT00837876|580761708|FG000|Overall Study|Withdrawal by Subject|3|||
160829534|NCT00837876|580761708|FG000|Overall Study|disease progression|24|||
160829535|NCT03464422|580761712|FG000|Overall Study|Lost to Follow-up|2|||
160829536|NCT03464422|580761712|FG000|Overall Study|Withdrawal by Subject|2|||
160829537|NCT01628367|580761713|FG000|Overall Study|Adverse Event|1|||
160829538|NCT01628367|580761714|FG001|Overall Study|Adverse Event|0|||
160829539|NCT03461406|580761721|FG000|Overall Study|Death|1|||
160829540|NCT03461406|580761722|FG001|Overall Study|Death|2|||
160829541|NCT03461406|580761721|FG000|Overall Study|Consent Withdrawn by Participant|0|||
160829542|NCT03461406|580761722|FG001|Overall Study|Consent Withdrawn by Participant|1|||
160829543|NCT03461406|580761721|FG000|Overall Study|Screen Failure|3|||
160829544|NCT03461406|580761722|FG001|Overall Study|Screen Failure|1|||
160829545|NCT03461406|580761721|FG000|Overall Study|Reason not Specified|1|||
160829546|NCT03461406|580761722|FG001|Overall Study|Reason not Specified|3|||
160829547|NCT03461406|580761721|FG000|Overall Study|Lost to Follow-up|3|||
160829548|NCT03461406|580761722|FG001|Overall Study|Lost to Follow-up|0|||
160829549|NCT01439074|580761723|FG000|Overall Study|Lost to Follow-up|3|||
160829550|NCT01439074|580761724|FG001|Overall Study|Lost to Follow-up|4|||
160829551|NCT01439074|580761723|FG000|Overall Study|Subject shedding|1|||
160829552|NCT01439074|580761724|FG001|Overall Study|Subject shedding|0|||
160829553|NCT01439074|580761723|FG000|Overall Study|Withdrawal by Subject|1|||
160829554|NCT01439074|580761724|FG001|Overall Study|Withdrawal by Subject|5|||
160829555|NCT01439074|580761723|FG000|Overall Study|Other|4|||
160829556|NCT01439074|580761724|FG001|Overall Study|Other|4|||
160829557|NCT02242981|580761729|FG000|Overall Study|Withdrawal by Subject|1|||
160829558|NCT03474081|580761730|FG000|Overall Study|Adverse Event|6|||
160829559|NCT03474081|580761731|FG001|Overall Study|Adverse Event|3|||
160829560|NCT03474081|580761730|FG000|Overall Study|Lost to Follow-up|2|||
160829561|NCT03474081|580761731|FG001|Overall Study|Lost to Follow-up|1|||
160829562|NCT03474081|580761730|FG000|Overall Study|Physician Decision|3|||
160829563|NCT03474081|580761731|FG001|Overall Study|Physician Decision|2|||
160829564|NCT03474081|580761730|FG000|Overall Study|Withdrawal by Subject|5|||
160829565|NCT03474081|580761731|FG001|Overall Study|Withdrawal by Subject|7|||
160829566|NCT03474081|580761730|FG000|Overall Study|Investigator site closed|1|||
160829567|NCT03474081|580761731|FG001|Overall Study|Investigator site closed|0|||
160829568|NCT01977690|580761732|FG000|Overall Study|Withdrawal by Subject|0|||
160829569|NCT01977690|580761733|FG001|Overall Study|Withdrawal by Subject|4|||
160829570|NCT01711866|580761737|FG000|Overall Study|Noncompliant|3|||
160829571|NCT01711866|580761737|FG000|Overall Study|Withdrawal by Subject|3|||
160829572|NCT01711866|580761737|FG000|Overall Study|Adverse Event|2|||
160829573|NCT00459537|580761738|FG000|Overall Study|Adverse Event|1|||
160829574|NCT00459537|580761739|FG001|Overall Study|Adverse Event|6|||
160829575|NCT00459537|580761738|FG000|Overall Study|Lack of Efficacy|10|||
160829576|NCT00459537|580761739|FG001|Overall Study|Lack of Efficacy|11|||
160829577|NCT00459537|580761738|FG000|Overall Study|Withdrawal by Subject|20|||
160829578|NCT00459537|580761739|FG001|Overall Study|Withdrawal by Subject|26|||
160829579|NCT00459537|580761738|FG000|Overall Study|Lost to Follow-up|27|||
160829580|NCT00459537|580761739|FG001|Overall Study|Lost to Follow-up|30|||
160829581|NCT00459537|580761738|FG000|Overall Study|Administrative problems|3|||
160829582|NCT00459537|580761739|FG001|Overall Study|Administrative problems|0|||
160829583|NCT00459537|580761738|FG000|Overall Study|Protocol Violation|4|||
160829584|NCT00459537|580761739|FG001|Overall Study|Protocol Violation|3|||
160829585|NCT00459537|580761738|FG000|Overall Study|Missing|1|||
160829586|NCT00459537|580761739|FG001|Overall Study|Missing|0|||
160829587|NCT00456599|580761741|FG000|Overall Study|Non-compliance|1|||
160829588|NCT00456599|580761741|FG000|Overall Study|Withdrawal by Subject|2|||
160829589|NCT00260065|580761742|FG000|Overall Study|Progressive Disease|22|||
160829590|NCT00260065|580761742|FG000|Overall Study|Adverse Event|17|||
160829591|NCT00260065|580761742|FG000|Overall Study|Death|13|||
160829592|NCT00260065|580761742|FG000|Overall Study|Withdrawal by Subject|13|||
160829593|NCT00260065|580761742|FG000|Overall Study|Physician Decision|19|||
160829594|NCT00260065|580761742|FG000|Overall Study|Not otherwise specified|8|||
160829595|NCT00260065|580761742|FG000|Overall Study|Medication Noncompliance|1|||
160829596|NCT02198235|580761743|FG000|Overall Study|Lost to Follow-up|3|||
160829597|NCT02198235|580761744|FG001|Overall Study|Lost to Follow-up|2|||
160559765|NCT00961961|579772182|FG002|Phase I|Withdrawal by Subject|0|||
160559766|NCT00961961|579772183|FG003|Phase I|Withdrawal by Subject|0|||
160559767|NCT00961961|579772180|FG000|Phase I|Lost to Follow-up|10|||
160559768|NCT00961961|579772181|FG001|Phase I|Lost to Follow-up|0|||
160559769|NCT00961961|579772182|FG002|Phase I|Lost to Follow-up|0|||
160559770|NCT00961961|579772183|FG003|Phase I|Lost to Follow-up|0|||
160829598|NCT02198235|580761745|FG002|Overall Study|Lost to Follow-up|2|||
160829599|NCT05565937|580763847|FG000|Overall Study|Adverse Event|0|||
160829600|NCT05565937|580763848|FG001|Overall Study|Adverse Event|1|||
160559771|NCT00961961|579772180|FG000|Phase I|Lack of Efficacy|94|||
160559772|NCT00961961|579772181|FG001|Phase I|Lack of Efficacy|0|||
160559773|NCT00961961|579772182|FG002|Phase I|Lack of Efficacy|0|||
160829601|NCT05565937|580763847|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
160829602|NCT05565937|580763848|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
160829603|NCT05565937|580763847|FG000|Overall Study|Lost to Follow-up|2|||
160829604|NCT05565937|580763848|FG001|Overall Study|Lost to Follow-up|0|||
160829605|NCT05565937|580763847|FG000|Overall Study|Pregnancy|0|||
160829606|NCT05565937|580763848|FG001|Overall Study|Pregnancy|2|||
160829607|NCT05565937|580763847|FG000|Overall Study|Anisometropia|0|||
160829608|NCT05565937|580763848|FG001|Overall Study|Anisometropia|1|||
160829609|NCT04544683|580763849|FG000|Overall Study|Lost to Follow-up|2|||
160829610|NCT04544683|580763849|FG000|Overall Study|Underwent cervical spine surgery|6|||
160829611|NCT00151372|580763850|FG000|Overall Study|Death|12|||
160829612|NCT00151372|580763851|FG001|Overall Study|Death|11|||
160829613|NCT00151372|580763850|FG000|Overall Study|Lost to Follow-up|5|||
160829614|NCT00151372|580763851|FG001|Overall Study|Lost to Follow-up|5|||
160829615|NCT00151372|580763850|FG000|Overall Study|Too sick medically to continue|5|||
160829616|NCT00151372|580763851|FG001|Overall Study|Too sick medically to continue|6|||
160829617|NCT00151372|580763850|FG000|Overall Study|Withdrawal by Subject|7|||
160829618|NCT00151372|580763851|FG001|Overall Study|Withdrawal by Subject|7|||
160829619|NCT04732949|580763852|FG000|Overall Study|Withdrawal by Subject|23|||
160829620|NCT04732949|580763853|FG001|Overall Study|Withdrawal by Subject|27|||
160829621|NCT04732949|580763852|FG000|Overall Study|Protocol Violation|0|||
160829622|NCT04732949|580763853|FG001|Overall Study|Protocol Violation|1|||
160829623|NCT04732949|580763852|FG000|Overall Study|Non-compliance|0|||
160829624|NCT04732949|580763853|FG001|Overall Study|Non-compliance|2|||
160829625|NCT04732949|580763852|FG000|Overall Study|Physician Decision|2|||
160829626|NCT04732949|580763853|FG001|Overall Study|Physician Decision|1|||
160829627|NCT04732949|580763852|FG000|Overall Study|Serious adverse event (Fatal)|16|||
160829628|NCT04732949|580763853|FG001|Overall Study|Serious adverse event (Fatal)|18|||
160829629|NCT04732949|580763852|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
160829630|NCT04732949|580763853|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
160829631|NCT04732949|580763852|FG000|Overall Study|Non-serious adverse event|1|||
160829632|NCT04732949|580763853|FG001|Overall Study|Non-serious adverse event|3|||
160829633|NCT04732949|580763852|FG000|Overall Study|Lost to Follow-up|26|||
160829634|NCT04732949|580763853|FG001|Overall Study|Lost to Follow-up|27|||
160829635|NCT04732949|580763852|FG000|Overall Study|Other|6|||
160829636|NCT04732949|580763853|FG001|Overall Study|Other|3|||
160829637|NCT01023672|580763854|FG000|Overall Study|Worsening disease|2|||
160829638|NCT01023672|580763854|FG000|Overall Study|Death|1|||
160829639|NCT01286077|580763855|FG000|Overall Study|Adverse Event|2|||
160829640|NCT01286077|580763856|FG001|Overall Study|Adverse Event|0|||
160829641|NCT01286077|580763855|FG000|Overall Study|Death|1|||
160829642|NCT01286077|580763856|FG001|Overall Study|Death|0|||
160829643|NCT01286077|580763855|FG000|Overall Study|Protocol Violation|1|||
160829644|NCT01286077|580763856|FG001|Overall Study|Protocol Violation|1|||
160829645|NCT01286077|580763855|FG000|Overall Study|Withdrawal by Subject|0|||
160829646|NCT01286077|580763856|FG001|Overall Study|Withdrawal by Subject|2|||
160829647|NCT01286077|580763855|FG000|Overall Study|Intercurrent illness|1|||
160829648|NCT01286077|580763856|FG001|Overall Study|Intercurrent illness|0|||
160829649|NCT01286077|580763855|FG000|Overall Study|Non-compliance|1|||
160829650|NCT01286077|580763856|FG001|Overall Study|Non-compliance|0|||
160829651|NCT01286077|580763855|FG000|Overall Study|The subject starts with alternative MMY|0|||
160829652|NCT01286077|580763856|FG001|Overall Study|The subject starts with alternative MMY|3|||
160829653|NCT01286077|580763855|FG000|Overall Study|Patient's decision to stop treatment|3|||
160829654|NCT01286077|580763856|FG001|Overall Study|Patient's decision to stop treatment|0|||
160829655|NCT01286077|580763855|FG000|Overall Study|Progression of disease|0|||
160829656|NCT01286077|580763856|FG001|Overall Study|Progression of disease|1|||
160829657|NCT01286077|580763855|FG000|Overall Study|refill medication not received in time|1|||
160829658|NCT01286077|580763856|FG001|Overall Study|refill medication not received in time|0|||
160829659|NCT01282294|580763857|FG000|Overall Study|Lost to Follow-up|14|||
160829660|NCT01282294|580763857|FG000|Overall Study|Screening failure|1|||
160829661|NCT01282294|580763857|FG000|Overall Study|Adverse Event|1|||
160903144|NCT01020981|581039017|FG001|Overall Study|Survey returned undeliverable|32|||
160903145|NCT01020981|581039016|FG000|Overall Study|Participant declined to complete survey|2|||
160903146|NCT01020981|581039017|FG001|Overall Study|Participant declined to complete survey|0|||
160903147|NCT00289133|581039024|FG000|Overall Study|Non-study device implanted|12|||
160903148|NCT00289133|581039025|FG001|Overall Study|Non-study device implanted|0|||
160903149|NCT00289133|581039024|FG000|Overall Study|Protocol Violation|32|||
160903150|NCT00289133|581039025|FG001|Overall Study|Protocol Violation|38|||
160903151|NCT00289133|581039024|FG000|Overall Study|Withdrawal by Subject|9|||
160903152|NCT00289133|581039025|FG001|Overall Study|Withdrawal by Subject|10|||
160829662|NCT01282294|580763857|FG000|Overall Study|Patient non-compliance|2|||
160829663|NCT01282294|580763857|FG000|Overall Study|Physician Decision|1|||
160559774|NCT00961961|579772183|FG003|Phase I|Lack of Efficacy|0|||
160829664|NCT02408523|580763858|FG000|Overall Study|Adverse Event|4|||
160829665|NCT02408523|580763859|FG001|Overall Study|Adverse Event|10|||
160903153|NCT00289133|581039024|FG000|Overall Study|Death|5|||
160829666|NCT02408523|580763858|FG000|Overall Study|Lack of Efficacy|0|||
160829667|NCT02408523|580763859|FG001|Overall Study|Lack of Efficacy|1|||
160829668|NCT02408523|580763858|FG000|Overall Study|Protocol Violation|1|||
160829669|NCT02408523|580763859|FG001|Overall Study|Protocol Violation|2|||
160829670|NCT02408523|580763858|FG000|Overall Study|Lost to Follow-up|2|||
160829671|NCT02408523|580763859|FG001|Overall Study|Lost to Follow-up|3|||
160903154|NCT00289133|581039025|FG001|Overall Study|Death|10|||
160829672|NCT02408523|580763858|FG000|Overall Study|Withdrawal by Subject|3|||
160829673|NCT02408523|580763859|FG001|Overall Study|Withdrawal by Subject|1|||
160829674|NCT02408523|580763858|FG000|Overall Study|Sponsor request|1|||
160829675|NCT02408523|580763859|FG001|Overall Study|Sponsor request|0|||
160829676|NCT02408523|580763858|FG000|Overall Study|Did not satisfy extension conditions|0|||
160829677|NCT02408523|580763859|FG001|Overall Study|Did not satisfy extension conditions|1|||
160829678|NCT00996801|580763863|FG000|Overall Study|Adverse Event|6|||
160829679|NCT00996801|580763864|FG001|Overall Study|Adverse Event|4|||
160829680|NCT00996801|580763865|FG002|Overall Study|Adverse Event|12|||
160829681|NCT00996801|580763866|FG003|Overall Study|Adverse Event|17|||
160829682|NCT00996801|580763867|FG004|Overall Study|Adverse Event|31|||
160829683|NCT00996801|580763868|FG005|Overall Study|Adverse Event|3|||
160829684|NCT00996801|580763863|FG000|Overall Study|Lack of Efficacy|3|||
160829685|NCT00996801|580763864|FG001|Overall Study|Lack of Efficacy|0|||
160829686|NCT00996801|580763865|FG002|Overall Study|Lack of Efficacy|1|||
160829687|NCT00996801|580763866|FG003|Overall Study|Lack of Efficacy|3|||
160829688|NCT00996801|580763867|FG004|Overall Study|Lack of Efficacy|0|||
160829689|NCT00996801|580763868|FG005|Overall Study|Lack of Efficacy|1|||
160829690|NCT00996801|580763863|FG000|Overall Study|Lost to Follow-up|0|||
160829691|NCT00996801|580763864|FG001|Overall Study|Lost to Follow-up|0|||
160829692|NCT00996801|580763865|FG002|Overall Study|Lost to Follow-up|0|||
160829693|NCT00996801|580763866|FG003|Overall Study|Lost to Follow-up|3|||
160829694|NCT00996801|580763867|FG004|Overall Study|Lost to Follow-up|3|||
160829695|NCT00996801|580763868|FG005|Overall Study|Lost to Follow-up|2|||
160829696|NCT00996801|580763863|FG000|Overall Study|Physician Decision|0|||
160829697|NCT00996801|580763864|FG001|Overall Study|Physician Decision|0|||
160829698|NCT00996801|580763865|FG002|Overall Study|Physician Decision|0|||
160829699|NCT00996801|580763866|FG003|Overall Study|Physician Decision|1|||
160829700|NCT00996801|580763867|FG004|Overall Study|Physician Decision|0|||
160829701|NCT00996801|580763868|FG005|Overall Study|Physician Decision|0|||
160829702|NCT00996801|580763863|FG000|Overall Study|Progressive Disease|0|||
160829703|NCT00996801|580763864|FG001|Overall Study|Progressive Disease|1|||
160829704|NCT00996801|580763865|FG002|Overall Study|Progressive Disease|0|||
160829705|NCT00996801|580763866|FG003|Overall Study|Progressive Disease|0|||
160829706|NCT00996801|580763867|FG004|Overall Study|Progressive Disease|0|||
160829707|NCT00996801|580763868|FG005|Overall Study|Progressive Disease|0|||
160829708|NCT00996801|580763863|FG000|Overall Study|Protocol Violation|3|||
160829709|NCT00996801|580763864|FG001|Overall Study|Protocol Violation|4|||
160829710|NCT00996801|580763865|FG002|Overall Study|Protocol Violation|1|||
160829711|NCT00996801|580763866|FG003|Overall Study|Protocol Violation|2|||
160829712|NCT00996801|580763867|FG004|Overall Study|Protocol Violation|3|||
160829713|NCT00996801|580763868|FG005|Overall Study|Protocol Violation|4|||
160829714|NCT00996801|580763863|FG000|Overall Study|Study Terminated by Sponsor|0|||
160829715|NCT00996801|580763864|FG001|Overall Study|Study Terminated by Sponsor|1|||
160829716|NCT00996801|580763865|FG002|Overall Study|Study Terminated by Sponsor|0|||
160829717|NCT00996801|580763866|FG003|Overall Study|Study Terminated by Sponsor|0|||
160829718|NCT00996801|580763867|FG004|Overall Study|Study Terminated by Sponsor|46|||
160829719|NCT00996801|580763868|FG005|Overall Study|Study Terminated by Sponsor|0|||
160829720|NCT00996801|580763863|FG000|Overall Study|Withdrawal by Subject|8|||
160829721|NCT00996801|580763864|FG001|Overall Study|Withdrawal by Subject|6|||
160829722|NCT00996801|580763865|FG002|Overall Study|Withdrawal by Subject|9|||
160829723|NCT00996801|580763866|FG003|Overall Study|Withdrawal by Subject|5|||
160829724|NCT00996801|580763867|FG004|Overall Study|Withdrawal by Subject|5|||
160829725|NCT00996801|580763868|FG005|Overall Study|Withdrawal by Subject|9|||
160829726|NCT00289198|580763869|FG000|Overall Study|Adverse Event|0|||
160829727|NCT00289198|580763870|FG001|Overall Study|Adverse Event|2|||
160829728|NCT00289198|580763869|FG000|Overall Study|Protocol Violation|2|||
160829729|NCT00289198|580763870|FG001|Overall Study|Protocol Violation|1|||
160829730|NCT00289198|580763869|FG000|Overall Study|Withdrawal by Subject|4|||
160829731|NCT00289198|580763870|FG001|Overall Study|Withdrawal by Subject|1|||
160829732|NCT00289198|580763869|FG000|Overall Study|Lack of Efficacy|2|||
160829733|NCT00289198|580763870|FG001|Overall Study|Lack of Efficacy|0|||
160829734|NCT00289198|580763869|FG000|Overall Study|Other: Low compliance|0|||
160829735|NCT00289198|580763870|FG001|Overall Study|Other: Low compliance|1|||
160829736|NCT00289198|580763869|FG000|Overall Study|Other: Physician's decision|0|||
160829737|NCT00289198|580763870|FG001|Overall Study|Other: Physician's decision|1|||
160829738|NCT00289198|580763869|FG000|Overall Study|Other: Unable to attend on schedule|2|||
160829739|NCT00289198|580763870|FG001|Overall Study|Other: Unable to attend on schedule|1|||
160829740|NCT00289198|580763869|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
160829741|NCT00289198|580763870|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
160829742|NCT00289198|580763869|FG000|Overall Study|Other: Impossible to come on visit|0|||
160829743|NCT00289198|580763870|FG001|Overall Study|Other: Impossible to come on visit|1|||
160829744|NCT03369431|580763872|FG000|Overall Study|Lost to Follow-up|1|||
160829745|NCT03369431|580763873|FG001|Overall Study|Lost to Follow-up|3|||
160829746|NCT03369431|580763872|FG000|Overall Study|Withdrawal by Subject|2|||
160829747|NCT03369431|580763873|FG001|Overall Study|Withdrawal by Subject|3|||
160829748|NCT03369431|580763872|FG000|Overall Study|Protocol Violation|1|||
160559775|NCT00961961|579772180|FG000|Phase I|Adverse Event|7|||
160829749|NCT03369431|580763873|FG001|Overall Study|Protocol Violation|1|||
160829750|NCT01062061|580763874|FG000|Overall Study|Enrolled more than once|2|||
160829751|NCT01062061|580763874|FG000|Overall Study|Investigated before study start|13|||
160829752|NCT01062061|580763874|FG000|Overall Study|Outside chief indications|10|||
160829753|NCT01062061|580763874|FG000|Overall Study|Failed to meet inclusion criteria|2|||
160829754|NCT06250738|580763875|FG000|Overall Study|Lost to Follow-up|1|||
160829755|NCT02046070|580763880|FG000|Overall Study|Progressive Disease|18|||
160829756|NCT02046070|580763881|FG001|Overall Study|Progressive Disease|11|||
160829757|NCT02046070|580763882|FG002|Overall Study|Progressive Disease|40|||
160829758|NCT02046070|580763880|FG000|Overall Study|Adverse Event|8|||
160829759|NCT02046070|580763881|FG001|Overall Study|Adverse Event|10|||
160829760|NCT02046070|580763882|FG002|Overall Study|Adverse Event|17|||
160829761|NCT02046070|580763880|FG000|Overall Study|Withdrawal by Subject|1|||
160829762|NCT02046070|580763881|FG001|Overall Study|Withdrawal by Subject|2|||
160829763|NCT02046070|580763882|FG002|Overall Study|Withdrawal by Subject|6|||
160829764|NCT02046070|580763880|FG000|Overall Study|Study Terminated by Sponsor|1|||
160829765|NCT02046070|580763881|FG001|Overall Study|Study Terminated by Sponsor|1|||
160829766|NCT02046070|580763882|FG002|Overall Study|Study Terminated by Sponsor|1|||
160829767|NCT02046070|580763880|FG000|Overall Study|Reason not Specified|4|||
160829768|NCT02046070|580763881|FG001|Overall Study|Reason not Specified|4|||
160829769|NCT02046070|580763882|FG002|Overall Study|Reason not Specified|6|||
160829770|NCT04619004|580763885|FG000|Overall Study|Death|114|||
160829771|NCT04619004|580763886|FG001|Overall Study|Death|28|||
160829772|NCT04619004|580763885|FG000|Overall Study|Lost to Follow-up|1|||
160829773|NCT04619004|580763886|FG001|Overall Study|Lost to Follow-up|1|||
160829774|NCT04619004|580763885|FG000|Overall Study|Withdrawal by Subject|24|||
160829775|NCT04619004|580763886|FG001|Overall Study|Withdrawal by Subject|7|||
160829776|NCT04619004|580763885|FG000|Overall Study|Other - Not specified|0|||
160829777|NCT04619004|580763886|FG001|Overall Study|Other - Not specified|1|||
160829778|NCT04030962|580763887|FG000|Stage 2|Adverse Event|0|||
160829779|NCT04030962|580763888|FG001|Stage 2|Adverse Event|0|||
160829780|NCT04030962|580763889|FG002|Stage 2|Adverse Event|0|||
160829781|NCT04030962|580763890|FG003|Stage 2|Adverse Event|0|||
160829782|NCT04030962|580763891|FG004|Stage 2|Adverse Event|0|||
160829783|NCT04030962|580763892|FG005|Stage 2|Adverse Event|0|||
160829784|NCT04030962|580763893|FG006|Stage 2|Adverse Event|0|||
160829785|NCT04030962|580763894|FG007|Stage 2|Adverse Event|0|||
160829786|NCT04030962|580763895|FG008|Stage 2|Adverse Event|1|||
160829787|NCT04030962|580763896|FG009|Stage 2|Adverse Event|0|||
160829788|NCT04030962|580763897|FG010|Stage 2|Adverse Event|1|||
160829789|NCT04030962|580763898|FG011|Stage 2|Adverse Event|1|||
160829790|NCT04030962|580763899|FG012|Stage 2|Adverse Event|1|||
160829791|NCT04030962|580763887|FG000|Stage 2|Withdrawal by Subject|0|||
160829792|NCT04030962|580763888|FG001|Stage 2|Withdrawal by Subject|0|||
160829793|NCT04030962|580763889|FG002|Stage 2|Withdrawal by Subject|0|||
160829794|NCT04030962|580763890|FG003|Stage 2|Withdrawal by Subject|0|||
160829795|NCT04030962|580763891|FG004|Stage 2|Withdrawal by Subject|0|||
160829796|NCT04030962|580763892|FG005|Stage 2|Withdrawal by Subject|0|||
160829797|NCT04030962|580763893|FG006|Stage 2|Withdrawal by Subject|0|||
160829798|NCT04030962|580763894|FG007|Stage 2|Withdrawal by Subject|0|||
160829799|NCT04030962|580763895|FG008|Stage 2|Withdrawal by Subject|1|||
160829800|NCT04030962|580763896|FG009|Stage 2|Withdrawal by Subject|0|||
160829801|NCT04030962|580763897|FG010|Stage 2|Withdrawal by Subject|0|||
160829802|NCT04030962|580763898|FG011|Stage 2|Withdrawal by Subject|2|||
160829803|NCT04030962|580763899|FG012|Stage 2|Withdrawal by Subject|1|||
160829804|NCT04030962|580763887|FG000|Stage 2|Lost to Follow-up|0|||
160559776|NCT00961961|579772181|FG001|Phase I|Adverse Event|0|||
160559777|NCT00961961|579772182|FG002|Phase I|Adverse Event|0|||
160559778|NCT00961961|579772183|FG003|Phase I|Adverse Event|0|||
160559779|NCT00961961|579772180|FG000|Phase I|Physician Decision|8|||
160559780|NCT00961961|579772181|FG001|Phase I|Physician Decision|0|||
160559781|NCT00961961|579772182|FG002|Phase I|Physician Decision|0|||
160559782|NCT00961961|579772183|FG003|Phase I|Physician Decision|0|||
160559783|NCT00961961|579772180|FG000|Phase II|Lost to Follow-up|0|||
160559784|NCT00961961|579772181|FG001|Phase II|Lost to Follow-up|0|||
160829805|NCT04030962|580763888|FG001|Stage 2|Lost to Follow-up|0|||
160829806|NCT04030962|580763889|FG002|Stage 2|Lost to Follow-up|0|||
160829807|NCT04030962|580763890|FG003|Stage 2|Lost to Follow-up|0|||
160829808|NCT04030962|580763891|FG004|Stage 2|Lost to Follow-up|0|||
160829809|NCT04030962|580763892|FG005|Stage 2|Lost to Follow-up|0|||
160829810|NCT04030962|580763893|FG006|Stage 2|Lost to Follow-up|0|||
160559785|NCT00961961|579772182|FG002|Phase II|Lost to Follow-up|10|||
160829811|NCT04030962|580763894|FG007|Stage 2|Lost to Follow-up|0|||
160829812|NCT04030962|580763895|FG008|Stage 2|Lost to Follow-up|1|||
160829813|NCT04030962|580763896|FG009|Stage 2|Lost to Follow-up|0|||
160829814|NCT04030962|580763897|FG010|Stage 2|Lost to Follow-up|0|||
160829815|NCT04030962|580763898|FG011|Stage 2|Lost to Follow-up|0|||
160829816|NCT04030962|580763899|FG012|Stage 2|Lost to Follow-up|0|||
160829817|NCT04030962|580763887|FG000|Stage 2|Technical Problems|0|||
160829818|NCT04030962|580763888|FG001|Stage 2|Technical Problems|0|||
160829819|NCT04030962|580763889|FG002|Stage 2|Technical Problems|0|||
160829820|NCT04030962|580763890|FG003|Stage 2|Technical Problems|0|||
160829821|NCT04030962|580763891|FG004|Stage 2|Technical Problems|0|||
160829822|NCT04030962|580763892|FG005|Stage 2|Technical Problems|0|||
160829823|NCT04030962|580763893|FG006|Stage 2|Technical Problems|0|||
160829824|NCT04030962|580763894|FG007|Stage 2|Technical Problems|0|||
160903155|NCT00289133|581039024|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
160559786|NCT00961961|579772183|FG003|Phase II|Lost to Follow-up|7|||
160559787|NCT00961961|579772180|FG000|Phase II|Adverse Event|0|||
160559788|NCT00961961|579772181|FG001|Phase II|Adverse Event|0|||
160559789|NCT00961961|579772182|FG002|Phase II|Adverse Event|0|||
160559790|NCT00961961|579772183|FG003|Phase II|Adverse Event|1|||
160559791|NCT00961961|579772180|FG000|Phase II|Physician Decision|0|||
160559792|NCT00961961|579772181|FG001|Phase II|Physician Decision|0|||
160559793|NCT00961961|579772182|FG002|Phase II|Physician Decision|1|||
160559794|NCT00961961|579772183|FG003|Phase II|Physician Decision|0|||
160559795|NCT00961961|579772180|FG000|Phase II|Withdrawal by Subject|0|||
160559796|NCT00961961|579772181|FG001|Phase II|Withdrawal by Subject|0|||
160559797|NCT00961961|579772182|FG002|Phase II|Withdrawal by Subject|1|||
160559798|NCT00961961|579772183|FG003|Phase II|Withdrawal by Subject|0|||
160559799|NCT01870739|579772184|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
160559800|NCT01870739|579772185|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
160559801|NCT01870739|579772184|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
160559802|NCT01870739|579772185|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
160559803|NCT01870739|579772184|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
160559804|NCT01870739|579772185|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
160559805|NCT01870739|579772184|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
160559806|NCT01870739|579772185|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
160559807|NCT01870739|579772184|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
160559808|NCT01870739|579772185|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
160559809|NCT01870739|579772184|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
160559810|NCT01870739|579772185|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
160559811|NCT01870739|579772184|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
160559812|NCT01870739|579772185|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
160559813|NCT02425098|579772192|FG000|Overall Study|Lost to Follow-up|7|||
160829825|NCT04030962|580763895|FG008|Stage 2|Technical Problems|0|||
160829826|NCT04030962|580763896|FG009|Stage 2|Technical Problems|0|||
160829827|NCT04030962|580763897|FG010|Stage 2|Technical Problems|0|||
160903156|NCT00289133|581039025|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
160903157|NCT00289133|581039024|FG000|Overall Study|Physician Decision|41|||
160903158|NCT00289133|581039025|FG001|Overall Study|Physician Decision|45|||
160559814|NCT02425098|579772193|FG001|Overall Study|Lost to Follow-up|7|||
160559815|NCT02425098|579772192|FG000|Overall Study|Withdrawal by Subject|4|||
160559816|NCT02425098|579772193|FG001|Overall Study|Withdrawal by Subject|8|||
160829828|NCT04030962|580763898|FG011|Stage 2|Technical Problems|1|||
160829829|NCT04030962|580763899|FG012|Stage 2|Technical Problems|0|||
160829830|NCT05601102|580763903|FG000|Overall Study|Death|1|||
160559817|NCT02425098|579772192|FG000|Overall Study|Pregnancy|2|||
160559818|NCT02425098|579772193|FG001|Overall Study|Pregnancy|0|||
160559819|NCT02425098|579772192|FG000|Overall Study|Reason not Specified|0|||
160559820|NCT02425098|579772193|FG001|Overall Study|Reason not Specified|1|||
160559821|NCT01926626|579772198|FG000|Overall Study|Withdrawal by Subject|15|||
160559822|NCT01926626|579772198|FG000|Overall Study|Lost to Follow-up|7|||
160829831|NCT05601102|580763904|FG001|Overall Study|Death|2|||
160829832|NCT05601102|580763903|FG000|Overall Study|Withdrawal by Subject|1|||
160903159|NCT00289133|581039024|FG000|Overall Study|Revision|8|||
160829833|NCT05601102|580763904|FG001|Overall Study|Withdrawal by Subject|1|||
160829834|NCT05601102|580763903|FG000|Overall Study|Lost to Follow-up|0|||
160829835|NCT05601102|580763904|FG001|Overall Study|Lost to Follow-up|2|||
160829836|NCT01114360|580763911|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
160829837|NCT01114360|580763912|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
160829838|NCT03007745|580763913|FG000|Overall Study|Sleep test negative for OSA|53|||
160829839|NCT03007745|580763914|FG001|Overall Study|Sleep test negative for OSA|49|||
160829840|NCT03007745|580763913|FG000|Overall Study|Physician Decision|6|||
160829841|NCT03007745|580763914|FG001|Overall Study|Physician Decision|9|||
160829842|NCT03007745|580763913|FG000|Overall Study|Withdrawal by Subject|38|||
160829843|NCT03007745|580763914|FG001|Overall Study|Withdrawal by Subject|16|||
160829844|NCT03007745|580763913|FG000|Overall Study|Lost to Follow-up|19|||
160829845|NCT03007745|580763914|FG001|Overall Study|Lost to Follow-up|25|||
160829846|NCT03007745|580763913|FG000|Overall Study|Unable to login to website|17|||
160829847|NCT03007745|580763914|FG001|Overall Study|Unable to login to website|4|||
160829848|NCT03344172|580763915|FG000|Overall Study|Received <1 dose of treatment|1|||
160829849|NCT03344172|580763916|FG001|Overall Study|Received <1 dose of treatment|0|||
160829850|NCT04912895|580763917|FG000|Overall Study|Unable to provide specimen|2|||
160829851|NCT04912895|580763918|FG001|Overall Study|Unable to provide specimen|0|||
160829852|NCT04912895|580763919|FG002|Overall Study|Unable to provide specimen|0|||
160829853|NCT04284813|580763920|FG000|Overall Study|Withdrawal by Subject|1|||
160829854|NCT01145053|580763926|FG000|Overall Study|Adverse Event|22|||
160829855|NCT01145053|580763926|FG000|Overall Study|Lost to Follow-up|28|||
160829856|NCT01145053|580763926|FG000|Overall Study|Withdrawal by Subject|25|||
160829857|NCT01145053|580763926|FG000|Overall Study|Other|18|||
160559823|NCT03283085|579772199|FG000|Overall Study|Adverse Event|18|||
160559824|NCT03283085|579772200|FG001|Overall Study|Adverse Event|3|||
160559825|NCT03283085|579772201|FG002|Overall Study|Adverse Event|13|||
160559826|NCT03283085|579772202|FG003|Overall Study|Adverse Event|0|||
160559827|NCT03283085|579772203|FG004|Overall Study|Adverse Event|0|||
160559828|NCT03283085|579772204|FG005|Overall Study|Adverse Event|5|||
160559829|NCT03283085|579772199|FG000|Overall Study|Death|0|||
160559830|NCT03283085|579772200|FG001|Overall Study|Death|0|||
160559831|NCT03283085|579772201|FG002|Overall Study|Death|3|||
160559832|NCT03283085|579772202|FG003|Overall Study|Death|1|||
160559833|NCT03283085|579772203|FG004|Overall Study|Death|0|||
160559834|NCT03283085|579772204|FG005|Overall Study|Death|0|||
160559835|NCT03283085|579772199|FG000|Overall Study|Withdrawal by Subject|42|||
160559836|NCT03283085|579772200|FG001|Overall Study|Withdrawal by Subject|21|||
160559837|NCT03283085|579772201|FG002|Overall Study|Withdrawal by Subject|66|||
160559838|NCT03283085|579772202|FG003|Overall Study|Withdrawal by Subject|3|||
160559839|NCT03283085|579772203|FG004|Overall Study|Withdrawal by Subject|3|||
160559840|NCT03283085|579772204|FG005|Overall Study|Withdrawal by Subject|5|||
160559841|NCT03283085|579772199|FG000|Overall Study|Physician Decision|14|||
160559842|NCT03283085|579772200|FG001|Overall Study|Physician Decision|8|||
160559843|NCT03283085|579772201|FG002|Overall Study|Physician Decision|19|||
160559844|NCT03283085|579772202|FG003|Overall Study|Physician Decision|0|||
160559845|NCT03283085|579772203|FG004|Overall Study|Physician Decision|0|||
160559846|NCT03283085|579772204|FG005|Overall Study|Physician Decision|2|||
160559847|NCT03283085|579772199|FG000|Overall Study|Site Terminated by Sponsor|1|||
160559848|NCT03283085|579772200|FG001|Overall Study|Site Terminated by Sponsor|0|||
160559849|NCT03283085|579772201|FG002|Overall Study|Site Terminated by Sponsor|3|||
160559850|NCT03283085|579772202|FG003|Overall Study|Site Terminated by Sponsor|0|||
160559851|NCT03283085|579772203|FG004|Overall Study|Site Terminated by Sponsor|0|||
160559852|NCT03283085|579772204|FG005|Overall Study|Site Terminated by Sponsor|0|||
160559853|NCT03283085|579772199|FG000|Overall Study|Lost to Follow-up|2|||
160559854|NCT03283085|579772200|FG001|Overall Study|Lost to Follow-up|0|||
160559855|NCT03283085|579772201|FG002|Overall Study|Lost to Follow-up|2|||
160559856|NCT03283085|579772202|FG003|Overall Study|Lost to Follow-up|0|||
160829858|NCT00293709|580763927|FG000|Overall Study|Other|47|||
160829859|NCT02785458|580763928|FG000|1 Month|Withdrawal by Subject|2|||
160829860|NCT02785458|580763929|FG001|1 Month|Withdrawal by Subject|1|||
160829861|NCT02785458|580763928|FG000|1 Month|Lost to Follow-up|38|||
160829862|NCT02785458|580763929|FG001|1 Month|Lost to Follow-up|31|||
160559857|NCT03283085|579772203|FG004|Overall Study|Lost to Follow-up|0|||
160829863|NCT02785458|580763928|FG000|1 Month|Deemed Ineligible|1|||
160829864|NCT02785458|580763929|FG001|1 Month|Deemed Ineligible|0|||
160829865|NCT02785458|580763928|FG000|1 Month|Completed Evaluation by Baseline|42|||
160559858|NCT03283085|579772204|FG005|Overall Study|Lost to Follow-up|1|||
160559859|NCT03283085|579772199|FG000|Overall Study|Pregnancy|0|||
160559860|NCT03283085|579772200|FG001|Overall Study|Pregnancy|0|||
160559861|NCT03283085|579772201|FG002|Overall Study|Pregnancy|1|||
160559862|NCT03283085|579772202|FG003|Overall Study|Pregnancy|0|||
160559863|NCT03283085|579772203|FG004|Overall Study|Pregnancy|0|||
160559864|NCT03283085|579772204|FG005|Overall Study|Pregnancy|0|||
160559865|NCT03283085|579772199|FG000|Overall Study|Lack of Efficacy|12|||
160559866|NCT03283085|579772200|FG001|Overall Study|Lack of Efficacy|6|||
160559867|NCT03283085|579772201|FG002|Overall Study|Lack of Efficacy|24|||
160829866|NCT02785458|580763929|FG001|1 Month|Completed Evaluation by Baseline|39|||
160829867|NCT02785458|580763928|FG000|1 Month|Partial Interview|0|||
160829868|NCT02785458|580763929|FG001|1 Month|Partial Interview|4|||
160829869|NCT02785458|580763928|FG000|3 Months|Withdrawal by Subject|3|||
160829870|NCT02785458|580763929|FG001|3 Months|Withdrawal by Subject|1|||
160829871|NCT02785458|580763928|FG000|3 Months|Lost to Follow-up|25|||
160829872|NCT02785458|580763929|FG001|3 Months|Lost to Follow-up|21|||
160559868|NCT03283085|579772202|FG003|Overall Study|Lack of Efficacy|1|||
160559869|NCT03283085|579772203|FG004|Overall Study|Lack of Efficacy|1|||
160559870|NCT03283085|579772204|FG005|Overall Study|Lack of Efficacy|0|||
160559871|NCT03283085|579772199|FG000|Overall Study|Reason not Specified|0|||
160559872|NCT03283085|579772200|FG001|Overall Study|Reason not Specified|4|||
160559873|NCT03283085|579772201|FG002|Overall Study|Reason not Specified|8|||
160559874|NCT03283085|579772202|FG003|Overall Study|Reason not Specified|0|||
160559875|NCT03283085|579772203|FG004|Overall Study|Reason not Specified|0|||
160559876|NCT03283085|579772204|FG005|Overall Study|Reason not Specified|1|||
160559877|NCT03636906|579772205|FG000|Overall Study|Adverse Event|0|||
160559878|NCT03636906|579772206|FG001|Overall Study|Adverse Event|0|||
160559879|NCT03636906|579772207|FG002|Overall Study|Adverse Event|1|||
160559880|NCT03636906|579772205|FG000|Overall Study|Lost to Follow-up|1|||
160559881|NCT03636906|579772206|FG001|Overall Study|Lost to Follow-up|0|||
160559882|NCT03636906|579772207|FG002|Overall Study|Lost to Follow-up|0|||
160559883|NCT03636906|579772205|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
160559884|NCT03636906|579772206|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
160559885|NCT03636906|579772207|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
160559886|NCT03636906|579772205|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
160559887|NCT03636906|579772206|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
160559888|NCT03636906|579772207|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
160559889|NCT03636906|579772205|FG000|Overall Study|Other|0|||
160559890|NCT03636906|579772206|FG001|Overall Study|Other|0|||
160559891|NCT03636906|579772207|FG002|Overall Study|Other|1|||
160559892|NCT02292771|579772213|FG000|Overall Study|Withdrawal by Subject|2|||
160559893|NCT02292771|579772214|FG001|Overall Study|Withdrawal by Subject|1|||
160559894|NCT02292771|579772213|FG000|Overall Study|Lost to Follow-up|2|||
160559895|NCT02292771|579772214|FG001|Overall Study|Lost to Follow-up|1|||
160559896|NCT04280081|579772216|FG000|Overall Study|Adverse Event|4|||
160559897|NCT04280081|579772216|FG000|Overall Study|Death|2|||
160559898|NCT04280081|579772216|FG000|Overall Study|Progressive Disease|6|||
160559899|NCT06001307|579774003|FG000|Overall Study|Lost to Follow-up|1|||
160559900|NCT06001307|579774004|FG001|Overall Study|Lost to Follow-up|2|||
160559901|NCT02660580|579774011|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
160559902|NCT02660580|579774012|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
160559903|NCT02660580|579774013|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
160559904|NCT02660580|579774014|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
160559905|NCT02660580|579774015|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
160559906|NCT02660580|579774011|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
160559907|NCT02660580|579774012|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
160559908|NCT02660580|579774013|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
160559909|NCT02660580|579774014|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
160559910|NCT02660580|579774015|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
160559911|NCT02660580|579774011|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
160559912|NCT02660580|579774012|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
160559913|NCT02660580|579774013|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
160559914|NCT02660580|579774014|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
160559915|NCT02660580|579774015|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
160559916|NCT02660580|579774011|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
160559917|NCT02660580|579774012|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
160559918|NCT02660580|579774013|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
160559919|NCT02660580|579774014|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
160559920|NCT02660580|579774015|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
160559921|NCT02660580|579774011|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
160559922|NCT02660580|579774012|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
160559923|NCT02660580|579774013|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
160559924|NCT02660580|579774014|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
160829873|NCT02785458|580763928|FG000|3 Months|Completed Evaluation at 1 Month|100|||
160829874|NCT02785458|580763929|FG001|3 Months|Completed Evaluation at 1 Month|89|||
160829875|NCT01146652|580763930|FG000|Overall Study|Adverse Event|506|||
160559925|NCT02660580|579774015|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
160559926|NCT02660580|579774011|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
160559927|NCT02660580|579774012|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
160559928|NCT02660580|579774013|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
160829876|NCT01146652|580763931|FG001|Overall Study|Adverse Event|15|||
160829877|NCT01146652|580763930|FG000|Overall Study|Lack of Efficacy|91|||
160829878|NCT01146652|580763931|FG001|Overall Study|Lack of Efficacy|7|||
160829879|NCT01146652|580763930|FG000|Overall Study|Poor compliance to protocol|38|||
160829880|NCT01146652|580763931|FG001|Overall Study|Poor compliance to protocol|1|||
160829881|NCT01146652|580763930|FG000|Overall Study|Other unspecified reasons|314|||
160829882|NCT01146652|580763931|FG001|Overall Study|Other unspecified reasons|22|||
160829883|NCT01146652|580763930|FG000|Overall Study|Enrolled but not treated|2|||
160829884|NCT01146652|580763931|FG001|Overall Study|Enrolled but not treated|0|||
160829885|NCT02590562|580763937|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
160829886|NCT01457950|580763938|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
160829887|NCT01457950|580763939|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
160829888|NCT01457950|580763940|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
160829889|NCT01457950|580763941|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
160829890|NCT01457950|580763938|FG000|Double-Blind Phase|Protocol Violation|2|||
160829891|NCT01457950|580763939|FG001|Double-Blind Phase|Protocol Violation|1|||
160829892|NCT01457950|580763940|FG002|Double-Blind Phase|Protocol Violation|0|||
160829893|NCT01457950|580763941|FG003|Double-Blind Phase|Protocol Violation|0|||
160829894|NCT01457950|580763938|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
160829895|NCT01457950|580763939|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
160829896|NCT01457950|580763940|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160829897|NCT01457950|580763941|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160829898|NCT01457950|580763938|FG000|Open-Label Phase|Adverse Event|0|||
160829899|NCT01457950|580763939|FG001|Open-Label Phase|Adverse Event|0|||
160829900|NCT01457950|580763940|FG002|Open-Label Phase|Adverse Event|0|||
160829901|NCT01457950|580763941|FG003|Open-Label Phase|Adverse Event|1|||
160829902|NCT01457950|580763938|FG000|Open-Label Phase|Protocol Violation|0|||
160829903|NCT01457950|580763939|FG001|Open-Label Phase|Protocol Violation|0|||
160829904|NCT01457950|580763940|FG002|Open-Label Phase|Protocol Violation|0|||
160829905|NCT01457950|580763941|FG003|Open-Label Phase|Protocol Violation|1|||
160829906|NCT01457950|580763938|FG000|Open-Label Phase|Withdrawal by Subject|0|||
160829907|NCT01457950|580763939|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160829908|NCT01457950|580763940|FG002|Open-Label Phase|Withdrawal by Subject|2|||
160829909|NCT01457950|580763941|FG003|Open-Label Phase|Withdrawal by Subject|0|||
160903160|NCT00289133|581039025|FG001|Overall Study|Revision|6|||
160903161|NCT00289133|581039024|FG000|Overall Study|Lost to Follow-up|92|||
160903162|NCT00289133|581039025|FG001|Overall Study|Lost to Follow-up|115|||
160903163|NCT03372096|581039031|FG000|Overall Study|Study Closed|8|||
160903164|NCT00040365|581039032|FG000|Overall Study|Death|1|||
160559929|NCT02660580|579774014|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
160559930|NCT02660580|579774015|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
160559931|NCT02660580|579774011|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
160559932|NCT02660580|579774012|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
160559933|NCT02660580|579774013|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
160559934|NCT02660580|579774014|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
160559935|NCT02660580|579774015|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
160559936|NCT02660580|579774011|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
160559937|NCT02660580|579774012|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
160559938|NCT02660580|579774013|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
160559939|NCT02660580|579774014|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
160559940|NCT02660580|579774015|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
160559941|NCT02660580|579774011|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
160559942|NCT02660580|579774012|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
160559943|NCT02660580|579774013|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
160559944|NCT02660580|579774014|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
160559945|NCT02660580|579774015|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
160559946|NCT02660580|579774011|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
160559947|NCT02660580|579774012|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
160559948|NCT02660580|579774013|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
160559949|NCT02660580|579774014|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
160559950|NCT02660580|579774015|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
160559951|NCT02660580|579774011|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
160903165|NCT00040365|581039032|FG000|Overall Study|Progressive disease|7|||
160903166|NCT00040365|581039032|FG000|Overall Study|Lost to Follow-up|3|||
160903167|NCT00319553|581039037|FG000|Overall Study|Protocol Violation|1|||
160829910|NCT03684304|580763942|FG000|Overall Study|Lost to Follow-up|19|||
160829911|NCT03684304|580763943|FG001|Overall Study|Lost to Follow-up|17|||
160829912|NCT00824005|580763944|FG000|Overall Study|Death|0|||
160829913|NCT00824005|580763945|FG001|Overall Study|Death|1|||
160829914|NCT00824005|580763944|FG000|Overall Study|Lost to Follow-up|0|||
160903168|NCT00319553|581039038|FG001|Overall Study|Protocol Violation|2|||
160829915|NCT00824005|580763945|FG001|Overall Study|Lost to Follow-up|1|||
160829916|NCT03458702|580763946|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
160829917|NCT03458702|580763947|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
160829918|NCT03458702|580763946|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
160829919|NCT03458702|580763947|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
160829920|NCT02231762|580763950|FG000|Combination Phase|Adverse Event|10|||
160829921|NCT02231762|580763951|FG001|Combination Phase|Adverse Event|0|||
160829922|NCT02231762|580763952|FG002|Combination Phase|Adverse Event|0|||
160829923|NCT02231762|580763953|FG003|Combination Phase|Adverse Event|0|||
160829924|NCT02231762|580763950|FG000|Combination Phase|Withdrawal by Subject|2|||
160829925|NCT02231762|580763951|FG001|Combination Phase|Withdrawal by Subject|0|||
160903169|NCT00319553|581039037|FG000|Overall Study|Lost to Follow-up|2|||
160903170|NCT00319553|581039038|FG001|Overall Study|Lost to Follow-up|1|||
160903171|NCT00319553|581039037|FG000|Overall Study|Withdrawal by Subject|1|||
160903172|NCT00319553|581039038|FG001|Overall Study|Withdrawal by Subject|1|||
160903173|NCT02329080|581039039|FG000|Overall Study|Adverse Event|1|||
160903174|NCT02329080|581039039|FG000|Overall Study|Death|4|||
160903175|NCT02329080|581039039|FG000|Overall Study|Lack of Efficacy|22|||
160903176|NCT02329080|581039039|FG000|Overall Study|Lost to Follow-up|1|||
160903177|NCT02329080|581039039|FG000|Overall Study|Physician Decision|2|||
160903178|NCT02329080|581039039|FG000|Overall Study|Partial response|4|||
160903179|NCT02329080|581039039|FG000|Overall Study|Complete response|4|||
160903180|NCT00413244|581039041|FG000|Overall Study|Withdrawal by Subject|10|||
160903181|NCT00413244|581039042|FG001|Overall Study|Withdrawal by Subject|1|||
160903182|NCT03082261|581039047|FG000|Overall Study|Death|4|||
160829926|NCT02231762|580763952|FG002|Combination Phase|Withdrawal by Subject|0|||
160829927|NCT02231762|580763953|FG003|Combination Phase|Withdrawal by Subject|0|||
160829928|NCT02231762|580763950|FG000|Combination Phase|Disease Progression|6|||
160829929|NCT02231762|580763951|FG001|Combination Phase|Disease Progression|0|||
160829930|NCT02231762|580763952|FG002|Combination Phase|Disease Progression|0|||
160829931|NCT02231762|580763953|FG003|Combination Phase|Disease Progression|0|||
160829932|NCT02231762|580763950|FG000|Combination Phase|Did not meet inclusion criteria|1|||
160829933|NCT02231762|580763951|FG001|Combination Phase|Did not meet inclusion criteria|0|||
160829934|NCT02231762|580763952|FG002|Combination Phase|Did not meet inclusion criteria|0|||
160829935|NCT02231762|580763953|FG003|Combination Phase|Did not meet inclusion criteria|0|||
160829936|NCT02231762|580763950|FG000|Combination Phase|Protocol Violation|1|||
160829937|NCT02231762|580763951|FG001|Combination Phase|Protocol Violation|0|||
160829938|NCT02231762|580763952|FG002|Combination Phase|Protocol Violation|0|||
160829939|NCT02231762|580763953|FG003|Combination Phase|Protocol Violation|0|||
160829940|NCT02231762|580763950|FG000|Maintenance Phase|Disease progression|0|||
160829941|NCT02231762|580763951|FG001|Maintenance Phase|Disease progression|3|||
160829942|NCT02231762|580763952|FG002|Maintenance Phase|Disease progression|4|||
160829943|NCT02231762|580763953|FG003|Maintenance Phase|Disease progression|3|||
160829944|NCT02231762|580763950|FG000|Maintenance Phase|Adverse Event|0|||
160829945|NCT02231762|580763951|FG001|Maintenance Phase|Adverse Event|0|||
160829946|NCT02231762|580763952|FG002|Maintenance Phase|Adverse Event|1|||
160829947|NCT02231762|580763953|FG003|Maintenance Phase|Adverse Event|2|||
160829948|NCT01697462|580763954|FG000|Overall Study|Disease Progression|1|||
160829949|NCT01697462|580763954|FG000|Overall Study|Adverse Event|6|||
160903183|NCT03082261|581039047|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
160903184|NCT03082261|581039047|FG000|Overall Study|Insurance denial|1|||
160903185|NCT03082261|581039047|FG000|Overall Study|Peripheral lead added|1|||
160903186|NCT03082261|581039047|FG000|Overall Study|Withdrawal by Subject|40|||
160903187|NCT03082261|581039047|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
160903188|NCT03082261|581039047|FG000|Overall Study|Subject implanted with device other than study device|1|||
160829950|NCT01697462|580763954|FG000|Overall Study|Lost to Follow-up|21|||
160829951|NCT01697462|580763954|FG000|Overall Study|Withdrawal by Subject|12|||
160829952|NCT01697462|580763954|FG000|Overall Study|Investigator Decision|21|||
160829953|NCT01697462|580763954|FG000|Overall Study|Death|1|||
160559952|NCT02660580|579774012|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
160559953|NCT02660580|579774013|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
160559954|NCT02660580|579774014|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
160559955|NCT02660580|579774015|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
160829954|NCT01697462|580763954|FG000|Overall Study|Other|10|||
160829955|NCT01697462|580763954|FG000|Overall Study|Missing|5|||
160829956|NCT02699450|580763956|FG000|Overall Study|Death|2|||
160829957|NCT02699450|580763957|FG001|Overall Study|Death|1|||
160829958|NCT02699450|580763958|FG002|Overall Study|Death|2|||
160829959|NCT02699450|580763956|FG000|Overall Study|Met Criteria for Study Exit|0|||
160829960|NCT02699450|580763957|FG001|Overall Study|Met Criteria for Study Exit|0|||
160829961|NCT02699450|580763958|FG002|Overall Study|Met Criteria for Study Exit|1|||
160829962|NCT02699450|580763956|FG000|Overall Study|Protocol Violation|4|||
160829963|NCT02699450|580763957|FG001|Overall Study|Protocol Violation|3|||
160829964|NCT02699450|580763958|FG002|Overall Study|Protocol Violation|5|||
160829965|NCT02699450|580763956|FG000|Overall Study|Lost to Follow-up|3|||
160829966|NCT02699450|580763957|FG001|Overall Study|Lost to Follow-up|0|||
160829967|NCT02699450|580763958|FG002|Overall Study|Lost to Follow-up|5|||
160829968|NCT02699450|580763956|FG000|Overall Study|Physician Decision|2|||
160829969|NCT02699450|580763957|FG001|Overall Study|Physician Decision|0|||
160829970|NCT02699450|580763958|FG002|Overall Study|Physician Decision|0|||
160829971|NCT02699450|580763956|FG000|Overall Study|Withdrawal by Subject|3|||
160829972|NCT02699450|580763957|FG001|Overall Study|Withdrawal by Subject|1|||
160829973|NCT02699450|580763958|FG002|Overall Study|Withdrawal by Subject|2|||
160829974|NCT02699450|580763956|FG000|Overall Study|Adverse Event|1|||
160903189|NCT03082261|581039047|FG000|Overall Study|Lost to Follow-up|14|||
160903190|NCT03082261|581039047|FG000|Overall Study|Subject moved to a different state|1|||
160903191|NCT03082261|581039047|FG000|Overall Study|Subject non-compliance|2|||
160903192|NCT03082261|581039047|FG000|Overall Study|Subject participation terminated by investigator|9|||
160903193|NCT03082261|581039047|FG000|Overall Study|Subject participation terminated by sponsor|4|||
160903194|NCT03082261|581039047|FG000|Overall Study|System explant|19|||
160903195|NCT03082261|581039047|FG000|Overall Study|Unable to place lead(s)|2|||
160903196|NCT03082261|581039047|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
160903197|NCT00839852|581039048|FG000|Overall Study|Adverse Event|10|||
160903198|NCT00839852|581039048|FG000|Overall Study|Insufficient Therapeutic Response|3|||
160903199|NCT00839852|581039048|FG000|Overall Study|Protocol Violation|9|||
160903200|NCT00839852|581039048|FG000|Overall Study|Withdrawal of Consent|16|||
160903201|NCT00839852|581039048|FG000|Overall Study|Lost to Follow-up|7|||
160903202|NCT00839852|581039048|FG000|Overall Study|Lack of Compliance While in Jail|1|||
160903203|NCT00839852|581039048|FG000|Overall Study|Pregnancy|1|||
160903204|NCT00494299|581039051|FG000|Overall Study|Adverse Event|93|||
160903205|NCT00494299|581039052|FG001|Overall Study|Adverse Event|13|||
160903206|NCT00494299|581039051|FG000|Overall Study|Lost to Follow-up|1|||
160903207|NCT00494299|581039052|FG001|Overall Study|Lost to Follow-up|0|||
160903208|NCT00494299|581039051|FG000|Overall Study|Physician Decision|0|||
160903209|NCT00494299|581039052|FG001|Overall Study|Physician Decision|2|||
160903210|NCT00494299|581039051|FG000|Overall Study|Protocol Violation|1|||
160903211|NCT00494299|581039052|FG001|Overall Study|Protocol Violation|2|||
160903212|NCT00494299|581039051|FG000|Overall Study|Withdrawal by Subject|8|||
160903213|NCT00494299|581039052|FG001|Overall Study|Withdrawal by Subject|3|||
160903214|NCT00494299|581039051|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
160903215|NCT00494299|581039052|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
160903216|NCT00494299|581039051|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
160903217|NCT00494299|581039052|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
160903218|NCT00494299|581039051|FG000|Overall Study|Site Closed by Sponsor|6|||
160903219|NCT00494299|581039052|FG001|Overall Study|Site Closed by Sponsor|0|||
160903220|NCT00494299|581039051|FG000|Overall Study|Protocol Driven Decision Point|11|||
160903221|NCT00494299|581039052|FG001|Overall Study|Protocol Driven Decision Point|22|||
160903222|NCT00467857|581039054|FG000|Overall Study|Adverse Event|1|||
160903223|NCT00467857|581039055|FG001|Overall Study|Adverse Event|0|||
160903224|NCT00467857|581039054|FG000|Overall Study|Withdrew consent|2|||
160559956|NCT02660580|579774011|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
160829975|NCT02699450|580763957|FG001|Overall Study|Adverse Event|0|||
160829976|NCT02699450|580763958|FG002|Overall Study|Adverse Event|0|||
160829977|NCT01133275|580763959|FG000|Overall Study|Withdrawal by Subject|1|||
160903225|NCT00467857|581039055|FG001|Overall Study|Withdrew consent|0|||
160903226|NCT00467857|581039054|FG000|Overall Study|Death|0|||
160559957|NCT02660580|579774012|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
160829978|NCT01133275|580763959|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
160903227|NCT00467857|581039055|FG001|Overall Study|Death|1|||
160903228|NCT00467857|581039054|FG000|Overall Study|Discharged from court service|0|||
160903229|NCT00467857|581039055|FG001|Overall Study|Discharged from court service|1|||
160903230|NCT00467857|581039054|FG000|Overall Study|Emergency care required|0|||
160903231|NCT00467857|581039055|FG001|Overall Study|Emergency care required|1|||
160903232|NCT00467857|581039054|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
160559958|NCT02660580|579774013|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
160559959|NCT02660580|579774014|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
160559960|NCT02660580|579774015|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
160559961|NCT02660580|579774011|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
160829979|NCT02266875|580763961|FG000|Overall Study|Withdrawal by Subject|9|||
160829980|NCT02266875|580763962|FG001|Overall Study|Withdrawal by Subject|0|||
160829981|NCT02266875|580763961|FG000|Overall Study|Lost to Follow-up|2|||
160829982|NCT02266875|580763962|FG001|Overall Study|Lost to Follow-up|0|||
160829983|NCT00086502|580763963|FG000|Overall Study|Adverse Event|11|||
160829984|NCT00086502|580763964|FG001|Overall Study|Adverse Event|2|||
160829985|NCT00086502|580763963|FG000|Overall Study|Lack of Efficacy|0|||
160829986|NCT00086502|580763964|FG001|Overall Study|Lack of Efficacy|2|||
160829987|NCT00086502|580763963|FG000|Overall Study|Lost to Follow-up|3|||
160829988|NCT00086502|580763964|FG001|Overall Study|Lost to Follow-up|1|||
160829989|NCT00086502|580763963|FG000|Overall Study|Physician Decision|1|||
160829990|NCT00086502|580763964|FG001|Overall Study|Physician Decision|1|||
160829991|NCT00086502|580763963|FG000|Overall Study|Pregnancy|0|||
160829992|NCT00086502|580763964|FG001|Overall Study|Pregnancy|1|||
160829993|NCT00086502|580763963|FG000|Overall Study|Protocol Violation|3|||
160829994|NCT00086502|580763964|FG001|Overall Study|Protocol Violation|3|||
160829995|NCT00086502|580763963|FG000|Overall Study|Withdrawal by Subject|5|||
160829996|NCT00086502|580763964|FG001|Overall Study|Withdrawal by Subject|6|||
160829997|NCT00086502|580763963|FG000|Overall Study|Patient Moved|1|||
160829998|NCT00086502|580763964|FG001|Overall Study|Patient Moved|1|||
160829999|NCT00086502|580763963|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
160830000|NCT00086502|580763964|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
160830001|NCT00086502|580763963|FG000|Overall Study|Patient Accidentally Unblinded|1|||
160830002|NCT00086502|580763964|FG001|Overall Study|Patient Accidentally Unblinded|0|||
160830003|NCT01304329|580763965|FG000|Third Intervention (3 Days)|Adverse Event|0|||
160830004|NCT01304329|580763966|FG001|Third Intervention (3 Days)|Adverse Event|1|||
160830005|NCT01304329|580763967|FG002|Third Intervention (3 Days)|Adverse Event|0|||
160830006|NCT01304329|580763968|FG003|Third Intervention (3 Days)|Adverse Event|0|||
160830007|NCT01304329|580763969|FG004|Third Intervention (3 Days)|Adverse Event|0|||
160830008|NCT01304329|580763970|FG005|Third Intervention (3 Days)|Adverse Event|0|||
160830009|NCT05545644|580763972|FG000|Overall Study|Lost to Follow-up|4|||
160830010|NCT05545644|580763973|FG001|Overall Study|Lost to Follow-up|3|||
160830011|NCT01420627|580763974|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
160830012|NCT01490294|580763975|FG000|Overall Study|Prematurely discontinuation|4|||
160830013|NCT01490294|580763976|FG001|Overall Study|Prematurely discontinuation|0|||
160830014|NCT01490294|580763977|FG002|Overall Study|Prematurely discontinuation|1|||
160830015|NCT01490294|580763978|FG003|Overall Study|Prematurely discontinuation|1|||
160830016|NCT01490294|580763975|FG000|Overall Study|Adverse Event|1|||
160830017|NCT01490294|580763976|FG001|Overall Study|Adverse Event|0|||
160830018|NCT01490294|580763977|FG002|Overall Study|Adverse Event|0|||
160830019|NCT01490294|580763978|FG003|Overall Study|Adverse Event|0|||
160830029|NCT02210091|580763993|FG000|Overall Study|Physician Decision|0|||
160830030|NCT02210091|580763994|FG001|Overall Study|Physician Decision|1|||
160830031|NCT02210091|580763993|FG000|Overall Study|Withdrawal by Sponsor|0|||
160830032|NCT02210091|580763994|FG001|Overall Study|Withdrawal by Sponsor|1|||
160830033|NCT01831817|580763995|FG000|Overall Study|Lost to Follow-up|1|||
160830034|NCT01831817|580763996|FG001|Overall Study|Lost to Follow-up|0|||
160830035|NCT01831817|580763997|FG002|Overall Study|Lost to Follow-up|0|||
160903233|NCT00467857|581039055|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
160559962|NCT02660580|579774012|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
160830036|NCT01831817|580763998|FG003|Overall Study|Lost to Follow-up|0|||
160830037|NCT01831817|580763995|FG000|Overall Study|Withdrawl of Consent|3|||
160830038|NCT01831817|580763996|FG001|Overall Study|Withdrawl of Consent|0|||
160830039|NCT01831817|580763997|FG002|Overall Study|Withdrawl of Consent|0|||
160830040|NCT01831817|580763998|FG003|Overall Study|Withdrawl of Consent|0|||
160830041|NCT00958217|580763999|FG000|Overall Study|Death|2|||
160830042|NCT00958217|580764000|FG001|Overall Study|Death|1|||
160830043|NCT00958217|580763999|FG000|Overall Study|Withdrawal by Subject|4|||
160830044|NCT00958217|580764000|FG001|Overall Study|Withdrawal by Subject|3|||
160830045|NCT00958217|580763999|FG000|Overall Study|Lost to Follow-up|17|||
160830046|NCT00958217|580764000|FG001|Overall Study|Lost to Follow-up|19|||
160830047|NCT00958217|580763999|FG000|Overall Study|Moved out of area|1|||
160903234|NCT00467857|581039054|FG000|Overall Study|Discontinuation reason missing|0|||
160830048|NCT00958217|580764000|FG001|Overall Study|Moved out of area|1|||
160830049|NCT00958217|580763999|FG000|Overall Study|Inpatient hospitalization|0|||
160830050|NCT00958217|580764000|FG001|Overall Study|Inpatient hospitalization|1|||
160830051|NCT02440789|580764001|FG000|Overall Study|Withdrawal by Subject|3|||
160830052|NCT02440789|580764001|FG000|Overall Study|Not willing to adhere to reqs|1|||
160830053|NCT01999218|580764002|FG000|Overall Study|Hyperglycemia|18|||
160830054|NCT01999218|580764003|FG001|Overall Study|Hyperglycemia|17|||
160830055|NCT01999218|580764004|FG002|Overall Study|Hyperglycemia|17|||
160830056|NCT01999218|580764002|FG000|Overall Study|Lack of Efficacy|1|||
160830057|NCT01999218|580764003|FG001|Overall Study|Lack of Efficacy|0|||
160830058|NCT01999218|580764004|FG002|Overall Study|Lack of Efficacy|1|||
160830059|NCT01999218|580764002|FG000|Overall Study|Lost to Follow-up|22|||
160830060|NCT01999218|580764003|FG001|Overall Study|Lost to Follow-up|17|||
160830061|NCT01999218|580764004|FG002|Overall Study|Lost to Follow-up|18|||
160830062|NCT01999218|580764002|FG000|Overall Study|Non-Compliance With Study Drug|6|||
160830063|NCT01999218|580764003|FG001|Overall Study|Non-Compliance With Study Drug|4|||
160830064|NCT01999218|580764004|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160830065|NCT01999218|580764002|FG000|Overall Study|Physician Decision|1|||
160830066|NCT01999218|580764003|FG001|Overall Study|Physician Decision|4|||
160830067|NCT01999218|580764004|FG002|Overall Study|Physician Decision|6|||
160830068|NCT01999218|580764002|FG000|Overall Study|Protocol Violation|4|||
160830069|NCT01999218|580764003|FG001|Overall Study|Protocol Violation|5|||
160830070|NCT01999218|580764004|FG002|Overall Study|Protocol Violation|4|||
160830071|NCT01999218|580764002|FG000|Overall Study|Screen failure|0|||
160830072|NCT01999218|580764003|FG001|Overall Study|Screen failure|1|||
160830073|NCT01999218|580764004|FG002|Overall Study|Screen failure|0|||
160830074|NCT01999218|580764002|FG000|Overall Study|Study Terminated By Sponsor|7|||
160830075|NCT01999218|580764003|FG001|Overall Study|Study Terminated By Sponsor|5|||
160830076|NCT01999218|580764004|FG002|Overall Study|Study Terminated By Sponsor|12|||
160830077|NCT01999218|580764002|FG000|Overall Study|Participant moves|2|||
160830078|NCT01999218|580764003|FG001|Overall Study|Participant moves|5|||
160830079|NCT01999218|580764004|FG002|Overall Study|Participant moves|3|||
160830080|NCT01999218|580764002|FG000|Overall Study|Withdrawal by Subject|28|||
160830081|NCT01999218|580764003|FG001|Overall Study|Withdrawal by Subject|29|||
160830082|NCT01999218|580764004|FG002|Overall Study|Withdrawal by Subject|34|||
160830083|NCT01999218|580764002|FG000|Overall Study|Creatinine/eGFR|0|||
160830084|NCT01999218|580764003|FG001|Overall Study|Creatinine/eGFR|0|||
160830085|NCT01999218|580764004|FG002|Overall Study|Creatinine/eGFR|1|||
160830086|NCT01999218|580764002|FG000|Overall Study|Death|7|||
160830087|NCT01999218|580764003|FG001|Overall Study|Death|1|||
160830088|NCT01999218|580764004|FG002|Overall Study|Death|2|||
160830089|NCT01999218|580764002|FG000|Overall Study|Excluded Medication|1|||
160830090|NCT01999218|580764003|FG001|Overall Study|Excluded Medication|1|||
160830091|NCT01999218|580764004|FG002|Overall Study|Excluded Medication|2|||
160830092|NCT01999218|580764002|FG000|Overall Study|Adverse Event|9|||
160830093|NCT01999218|580764003|FG001|Overall Study|Adverse Event|7|||
160830094|NCT01999218|580764004|FG002|Overall Study|Adverse Event|7|||
160830095|NCT01999218|580764002|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
160830096|NCT01999218|580764003|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
160830097|NCT01999218|580764004|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
160830098|NCT01266590|580765910|FG000|Overall Study|Adverse Event|3|||
160830099|NCT01266590|580765910|FG000|Overall Study|Lost to Follow-up|1|||
160830100|NCT01266590|580765910|FG000|Overall Study|Withdrawal by Subject|1|||
160830101|NCT01266590|580765910|FG000|Overall Study|Physician Decision|1|||
160830102|NCT02654236|580765913|FG000|Overall Study|Withdrawal by Subject|0|||
160830103|NCT02654236|580765914|FG001|Overall Study|Withdrawal by Subject|0|||
160830104|NCT02654236|580765915|FG002|Overall Study|Withdrawal by Subject|2|||
160830105|NCT01549873|580765916|FG000|Overall Study|Physician Decision|0|||
160830106|NCT01549873|580765917|FG001|Overall Study|Physician Decision|1|||
160830107|NCT02905006|580765918|FG000|Overall Study|Adverse Event|1|||
160830108|NCT02905006|580765919|FG001|Overall Study|Adverse Event|1|||
160830109|NCT02905006|580765920|FG002|Overall Study|Adverse Event|1|||
160830110|NCT02905006|580765921|FG003|Overall Study|Adverse Event|1|||
160830111|NCT02905006|580765922|FG004|Overall Study|Adverse Event|0|||
160830112|NCT02905006|580765923|FG005|Overall Study|Adverse Event|1|||
160830113|NCT02905006|580765918|FG000|Overall Study|Lack of Efficacy|1|||
160830114|NCT02905006|580765919|FG001|Overall Study|Lack of Efficacy|0|||
160830115|NCT02905006|580765920|FG002|Overall Study|Lack of Efficacy|0|||
160830116|NCT02905006|580765921|FG003|Overall Study|Lack of Efficacy|0|||
160830117|NCT02905006|580765922|FG004|Overall Study|Lack of Efficacy|0|||
160830118|NCT02905006|580765923|FG005|Overall Study|Lack of Efficacy|0|||
160830119|NCT02905006|580765918|FG000|Overall Study|Protocol Violation|2|||
160830120|NCT02905006|580765919|FG001|Overall Study|Protocol Violation|0|||
160830121|NCT02905006|580765920|FG002|Overall Study|Protocol Violation|0|||
160830122|NCT02905006|580765921|FG003|Overall Study|Protocol Violation|0|||
160830123|NCT02905006|580765922|FG004|Overall Study|Protocol Violation|0|||
160830124|NCT02905006|580765923|FG005|Overall Study|Protocol Violation|0|||
160830125|NCT02905006|580765918|FG000|Overall Study|Lost to Follow-up|0|||
160830126|NCT02905006|580765919|FG001|Overall Study|Lost to Follow-up|0|||
160830127|NCT02905006|580765920|FG002|Overall Study|Lost to Follow-up|0|||
160830128|NCT02905006|580765921|FG003|Overall Study|Lost to Follow-up|1|||
160830129|NCT02905006|580765922|FG004|Overall Study|Lost to Follow-up|1|||
160830130|NCT02905006|580765923|FG005|Overall Study|Lost to Follow-up|0|||
160830131|NCT02905006|580765918|FG000|Overall Study|Withdrawal by Subject|0|||
160830132|NCT02905006|580765919|FG001|Overall Study|Withdrawal by Subject|0|||
160830133|NCT02905006|580765920|FG002|Overall Study|Withdrawal by Subject|1|||
160830134|NCT02905006|580765921|FG003|Overall Study|Withdrawal by Subject|1|||
160559963|NCT02660580|579774013|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
160559964|NCT02660580|579774014|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
160559965|NCT02660580|579774015|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
160559966|NCT02185521|579774016|FG000|Overall Study|Withdrawal by Subject|1|||
160559967|NCT02185521|579774016|FG000|Overall Study|Protocol Violation|1|||
160559968|NCT01028352|579774018|FG000|Overall Study|Ineligible due to baseline average pain|5|||
160559969|NCT01028352|579774018|FG000|Overall Study|Withdrawal by Subject|1|||
160559970|NCT03124459|579774019|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
160830135|NCT02905006|580765922|FG004|Overall Study|Withdrawal by Subject|0|||
160830136|NCT02905006|580765923|FG005|Overall Study|Withdrawal by Subject|1|||
160830137|NCT02905006|580765918|FG000|Overall Study|Screening exclusion criteria met|1|||
160830138|NCT02905006|580765919|FG001|Overall Study|Screening exclusion criteria met|0|||
160830139|NCT02905006|580765920|FG002|Overall Study|Screening exclusion criteria met|0|||
160830140|NCT02905006|580765921|FG003|Overall Study|Screening exclusion criteria met|0|||
160830141|NCT02905006|580765922|FG004|Overall Study|Screening exclusion criteria met|0|||
160830142|NCT02905006|580765923|FG005|Overall Study|Screening exclusion criteria met|0|||
160830143|NCT02905006|580765918|FG000|Overall Study|Lab withdrawal criterion met|0|||
160830144|NCT02905006|580765919|FG001|Overall Study|Lab withdrawal criterion met|1|||
160830145|NCT02905006|580765920|FG002|Overall Study|Lab withdrawal criterion met|2|||
160830146|NCT02905006|580765921|FG003|Overall Study|Lab withdrawal criterion met|2|||
160830147|NCT02905006|580765922|FG004|Overall Study|Lab withdrawal criterion met|2|||
160830148|NCT02905006|580765923|FG005|Overall Study|Lab withdrawal criterion met|1|||
160830149|NCT02905006|580765918|FG000|Overall Study|Positive for Tuberculosis|0|||
160830150|NCT02905006|580765919|FG001|Overall Study|Positive for Tuberculosis|1|||
160830151|NCT02905006|580765920|FG002|Overall Study|Positive for Tuberculosis|0|||
160830152|NCT02905006|580765921|FG003|Overall Study|Positive for Tuberculosis|0|||
160830153|NCT02905006|580765922|FG004|Overall Study|Positive for Tuberculosis|0|||
160830154|NCT02905006|580765923|FG005|Overall Study|Positive for Tuberculosis|0|||
160830155|NCT02905006|580765918|FG000|Overall Study|Subject positive for Hep B|0|||
160830156|NCT02905006|580765919|FG001|Overall Study|Subject positive for Hep B|0|||
160830157|NCT02905006|580765920|FG002|Overall Study|Subject positive for Hep B|1|||
160830158|NCT02905006|580765921|FG003|Overall Study|Subject positive for Hep B|0|||
160830159|NCT02905006|580765922|FG004|Overall Study|Subject positive for Hep B|0|||
160830160|NCT02905006|580765923|FG005|Overall Study|Subject positive for Hep B|0|||
160830161|NCT02905006|580765918|FG000|Overall Study|Patient moved abroad|0|||
160830162|NCT02905006|580765919|FG001|Overall Study|Patient moved abroad|0|||
160830163|NCT02905006|580765920|FG002|Overall Study|Patient moved abroad|0|||
160830164|NCT02905006|580765921|FG003|Overall Study|Patient moved abroad|1|||
160830165|NCT02905006|580765922|FG004|Overall Study|Patient moved abroad|0|||
160830166|NCT02905006|580765923|FG005|Overall Study|Patient moved abroad|0|||
160830167|NCT02905006|580765918|FG000|Overall Study|Patient randomized by mistake|0|||
160830168|NCT02905006|580765919|FG001|Overall Study|Patient randomized by mistake|0|||
160830169|NCT02905006|580765920|FG002|Overall Study|Patient randomized by mistake|0|||
160830170|NCT02905006|580765921|FG003|Overall Study|Patient randomized by mistake|0|||
160559971|NCT03124459|579774020|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
160559972|NCT03124459|579774021|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
160559973|NCT03124459|579774022|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
160830171|NCT02905006|580765922|FG004|Overall Study|Patient randomized by mistake|0|||
160830172|NCT02905006|580765923|FG005|Overall Study|Patient randomized by mistake|1|||
160559974|NCT03124459|579774023|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
160559975|NCT03124459|579774024|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
160830173|NCT04435600|580765924|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830174|NCT04435600|580765925|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830175|NCT04435600|580765926|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
160830176|NCT04435600|580765927|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830177|NCT04435600|580765928|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830178|NCT04435600|580765929|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830179|NCT04435600|580765930|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830180|NCT04435600|580765931|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830181|NCT04435600|580765932|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830182|NCT04435600|580765933|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830183|NCT04435600|580765924|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830184|NCT04435600|580765925|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830185|NCT04435600|580765926|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830186|NCT04435600|580765927|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830187|NCT04435600|580765928|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830188|NCT04435600|580765929|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830189|NCT04435600|580765930|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830190|NCT04435600|580765931|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830191|NCT04435600|580765932|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830192|NCT04435600|580765933|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
160830193|NCT04435600|580765924|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830194|NCT04435600|580765925|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830195|NCT04435600|580765926|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830196|NCT04435600|580765927|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830197|NCT04435600|580765928|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830198|NCT04435600|580765929|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830199|NCT04435600|580765930|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830200|NCT04435600|580765931|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830201|NCT04435600|580765932|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830202|NCT04435600|580765933|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
160830203|NCT04435600|580765924|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830204|NCT04435600|580765925|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830205|NCT04435600|580765926|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830206|NCT04435600|580765927|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830207|NCT04435600|580765928|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830208|NCT04435600|580765929|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830209|NCT04435600|580765930|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830210|NCT04435600|580765931|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830211|NCT04435600|580765932|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830212|NCT04435600|580765933|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
160830213|NCT02797184|580765938|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
160830214|NCT02797184|580765939|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
160830215|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
160830216|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
160830217|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
160830218|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
160830219|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
160830220|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
160830221|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
160830222|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
160830223|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
160830224|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
160830225|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
160830226|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
160830227|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
160830228|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
160830229|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
160830230|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
160830231|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
160830232|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
160830233|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
160830234|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
160830235|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
160830236|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
160830237|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
160830238|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
160830239|NCT05149313|580765940|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
160830240|NCT05149313|580765941|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
160830241|NCT05149313|580765942|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
160830242|NCT05149313|580765943|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
160830243|NCT05149313|580765940|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160830244|NCT05149313|580765941|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160830245|NCT05149313|580765942|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
160830246|NCT05149313|580765943|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
160830247|NCT05149313|580765940|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
160830248|NCT05149313|580765941|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
160830249|NCT05149313|580765942|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
160830250|NCT05149313|580765943|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
160830251|NCT05149313|580765940|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160830252|NCT05149313|580765941|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160830253|NCT05149313|580765942|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
160830254|NCT05149313|580765943|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160830255|NCT05149313|580765940|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
160830256|NCT05149313|580765941|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
160830257|NCT05149313|580765942|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
160830258|NCT05149313|580765943|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
160830259|NCT02212678|580765952|FG000|Overall Study|Adverse Event|1|||
160830260|NCT05288166|580765954|FG000|Overall Study|Adverse Event|1|||
160830261|NCT05288166|580765955|FG001|Overall Study|Adverse Event|0|||
160830262|NCT05288166|580765954|FG000|Overall Study|Lost to Follow-up|2|||
160830263|NCT05288166|580765955|FG001|Overall Study|Lost to Follow-up|0|||
160830264|NCT05288166|580765954|FG000|Overall Study|Physician Decision|0|||
160830265|NCT05288166|580765955|FG001|Overall Study|Physician Decision|2|||
160830266|NCT05288166|580765954|FG000|Overall Study|Screen Failure|1|||
160559976|NCT03124459|579774019|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
160559977|NCT03124459|579774020|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
160559978|NCT03124459|579774021|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
160559979|NCT03124459|579774022|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
160559980|NCT03124459|579774023|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
160559981|NCT03124459|579774024|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
160559982|NCT03124459|579774019|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
160559983|NCT03124459|579774020|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
160559984|NCT03124459|579774021|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
160559985|NCT03124459|579774022|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
160559986|NCT03124459|579774023|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
160559987|NCT03124459|579774024|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
160559988|NCT03124459|579774019|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
160559989|NCT03124459|579774020|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
160559990|NCT03124459|579774021|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
160559991|NCT03124459|579774022|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
160559992|NCT03124459|579774023|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
160559993|NCT03124459|579774024|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
160559994|NCT03124459|579774019|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
160559995|NCT03124459|579774020|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
160559996|NCT03124459|579774021|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
160559997|NCT03124459|579774022|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
160559998|NCT03124459|579774023|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
160559999|NCT03124459|579774024|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
160560000|NCT03124459|579774019|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
160560001|NCT03124459|579774020|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
160560002|NCT03124459|579774021|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
160560003|NCT03124459|579774022|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
160830267|NCT05288166|580765955|FG001|Overall Study|Screen Failure|1|||
160830268|NCT05288166|580765954|FG000|Overall Study|Withdrawal by Subject|4|||
160830269|NCT05288166|580765955|FG001|Overall Study|Withdrawal by Subject|2|||
160560004|NCT03124459|579774023|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
160560005|NCT03124459|579774024|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
160560006|NCT01903876|579774025|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
160560007|NCT01903876|579774026|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
160560008|NCT01903876|579774025|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
160560009|NCT01903876|579774026|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
160560010|NCT00826748|579774036|FG000|Overall Study|Withdrawal by Subject|0|||
160560011|NCT00826748|579774037|FG001|Overall Study|Withdrawal by Subject|0|||
160560012|NCT00826748|579774038|FG002|Overall Study|Withdrawal by Subject|2|||
160560013|NCT00826748|579774036|FG000|Overall Study|Physician Decision|0|||
160560014|NCT00826748|579774037|FG001|Overall Study|Physician Decision|0|||
160560015|NCT00826748|579774038|FG002|Overall Study|Physician Decision|1|||
160560016|NCT00826748|579774036|FG000|Overall Study|Samples Did Not pass QC|0|||
160560017|NCT00826748|579774037|FG001|Overall Study|Samples Did Not pass QC|0|||
160560018|NCT00826748|579774038|FG002|Overall Study|Samples Did Not pass QC|1|||
160560019|NCT02300129|579774040|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
160560020|NCT02300129|579774041|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
160560021|NCT02300129|579774042|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
160560022|NCT02300129|579774043|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
160560023|NCT02300129|579774040|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
160560024|NCT02300129|579774041|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
160830270|NCT05288166|580765954|FG000|Overall Study|On Study Treatment|408|||
160830271|NCT05288166|580765955|FG001|Overall Study|On Study Treatment|418|||
160830272|NCT03106415|580765958|FG000|Phase 1|Withdrawal by Subject|1|||
160830273|NCT03106415|580765959|FG001|Phase 1|Withdrawal by Subject|0|||
160830274|NCT03106415|580765960|FG002|Phase 1|Withdrawal by Subject|0|||
160830275|NCT03106415|580765958|FG000|Phase 1|Adverse Event|1|||
160830276|NCT03106415|580765959|FG001|Phase 1|Adverse Event|1|||
160830277|NCT03106415|580765960|FG002|Phase 1|Adverse Event|0|||
160830278|NCT03106415|580765958|FG000|Phase 1|Protocol Violation|0|||
160830279|NCT03106415|580765959|FG001|Phase 1|Protocol Violation|1|||
160830280|NCT03106415|580765960|FG002|Phase 1|Protocol Violation|0|||
160830281|NCT00520013|580765961|FG000|Overall Study|Withdrawal by Subject|0|||
160830282|NCT00520013|580765962|FG001|Overall Study|Withdrawal by Subject|0|||
160830283|NCT00520013|580765963|FG002|Overall Study|Withdrawal by Subject|1|||
160830284|NCT00520013|580765961|FG000|Overall Study|Adverse Event|2|||
160830285|NCT00520013|580765962|FG001|Overall Study|Adverse Event|10|||
160830286|NCT00520013|580765963|FG002|Overall Study|Adverse Event|7|||
160830287|NCT00520013|580765961|FG000|Overall Study|Progressive Disease|7|||
160830288|NCT00520013|580765962|FG001|Overall Study|Progressive Disease|3|||
160830289|NCT00520013|580765963|FG002|Overall Study|Progressive Disease|0|||
160830290|NCT00520013|580765961|FG000|Overall Study|Clinical Progression|3|||
160830291|NCT00520013|580765962|FG001|Overall Study|Clinical Progression|1|||
160830292|NCT00520013|580765963|FG002|Overall Study|Clinical Progression|0|||
160830293|NCT00520013|580765961|FG000|Overall Study|Death|0|||
160830294|NCT00520013|580765962|FG001|Overall Study|Death|1|||
160830295|NCT00520013|580765963|FG002|Overall Study|Death|0|||
160830296|NCT00520013|580765961|FG000|Overall Study|Physician Decision|0|||
160830297|NCT00520013|580765962|FG001|Overall Study|Physician Decision|0|||
160830298|NCT00520013|580765963|FG002|Overall Study|Physician Decision|3|||
160830299|NCT02981524|580765964|FG000|Overall Study|Progressive Disease|14|||
160830300|NCT02981524|580765964|FG000|Overall Study|Death (unrelated)|1|||
160830301|NCT02981524|580765964|FG000|Overall Study|Treatment Related Toxicity|1|||
160830302|NCT02981524|580765964|FG000|Overall Study|Withdrawal by Subject|1|||
160830303|NCT00159913|580765965|FG000|Overall Study|Adverse Event|1|||
160830304|NCT00159913|580765966|FG001|Overall Study|Adverse Event|0|||
160830305|NCT00159913|580765967|FG002|Overall Study|Adverse Event|1|||
160830306|NCT00159913|580765968|FG003|Overall Study|Adverse Event|0|||
160830307|NCT00159913|580765965|FG000|Overall Study|Withdrawal by Subject|0|||
160830308|NCT00159913|580765966|FG001|Overall Study|Withdrawal by Subject|0|||
160830309|NCT00159913|580765967|FG002|Overall Study|Withdrawal by Subject|0|||
160830310|NCT00159913|580765968|FG003|Overall Study|Withdrawal by Subject|1|||
160830311|NCT00159913|580765965|FG000|Overall Study|Lost to Follow-up|0|||
160830312|NCT00159913|580765966|FG001|Overall Study|Lost to Follow-up|0|||
160830313|NCT00159913|580765967|FG002|Overall Study|Lost to Follow-up|0|||
160830314|NCT00159913|580765968|FG003|Overall Study|Lost to Follow-up|1|||
160830315|NCT00159913|580765965|FG000|Overall Study|Protocol Violation|1|||
160830316|NCT00159913|580765966|FG001|Overall Study|Protocol Violation|0|||
160830317|NCT00159913|580765967|FG002|Overall Study|Protocol Violation|1|||
160830318|NCT00159913|580765968|FG003|Overall Study|Protocol Violation|0|||
160830319|NCT03294135|580765969|FG000|Overall Study|Serious Adverse Event|1|||
160830320|NCT03294135|580765970|FG001|Overall Study|Serious Adverse Event|0|||
160830321|NCT03294135|580765971|FG002|Overall Study|Serious Adverse Event|0|||
160830322|NCT03294135|580765969|FG000|Overall Study|Lost to Follow-up|1|||
160830323|NCT03294135|580765970|FG001|Overall Study|Lost to Follow-up|0|||
160560025|NCT02300129|579774042|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
160830324|NCT03294135|580765971|FG002|Overall Study|Lost to Follow-up|1|||
160830325|NCT03294135|580765969|FG000|Overall Study|Withdrawal by Subject|0|||
160560026|NCT02300129|579774043|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
160830326|NCT03294135|580765970|FG001|Overall Study|Withdrawal by Subject|0|||
160830327|NCT03294135|580765971|FG002|Overall Study|Withdrawal by Subject|1|||
160830328|NCT03294135|580765969|FG000|Overall Study|Other|2|||
160830329|NCT03294135|580765970|FG001|Overall Study|Other|0|||
160830330|NCT03294135|580765971|FG002|Overall Study|Other|0|||
160830331|NCT02763254|580765973|FG000|Overall Study|Adverse Event|1|||
160903235|NCT00467857|581039055|FG001|Overall Study|Discontinuation reason missing|3|||
160830332|NCT00431951|580765974|FG000|Overall Study|Inability to follow study procedures|1|||
160830333|NCT00431951|580765975|FG001|Overall Study|Inability to follow study procedures|0|||
160830334|NCT00431951|580765976|FG002|Overall Study|Inability to follow study procedures|1|||
160830335|NCT00431951|580765977|FG003|Overall Study|Inability to follow study procedures|2|||
160830336|NCT00431951|580765974|FG000|Overall Study|Lost to Follow-up|0|||
160830337|NCT00431951|580765975|FG001|Overall Study|Lost to Follow-up|1|||
160830338|NCT00431951|580765976|FG002|Overall Study|Lost to Follow-up|0|||
160830339|NCT00431951|580765977|FG003|Overall Study|Lost to Follow-up|0|||
160830340|NCT00431951|580765974|FG000|Overall Study|Withdrawal by Subject|0|||
160830341|NCT00431951|580765975|FG001|Overall Study|Withdrawal by Subject|1|||
160830342|NCT00431951|580765976|FG002|Overall Study|Withdrawal by Subject|0|||
160830343|NCT00431951|580765977|FG003|Overall Study|Withdrawal by Subject|0|||
160830344|NCT00431951|580765974|FG000|Overall Study|Adverse Event|0|||
160830345|NCT00431951|580765975|FG001|Overall Study|Adverse Event|0|||
160830346|NCT00431951|580765976|FG002|Overall Study|Adverse Event|1|||
160830347|NCT00431951|580765977|FG003|Overall Study|Adverse Event|0|||
160830348|NCT00385723|580765978|FG000|Overall Study|Lost to Follow-up|1|||
160830349|NCT00385723|580765979|FG001|Overall Study|Lost to Follow-up|1|||
160830350|NCT00385723|580765980|FG002|Overall Study|Lost to Follow-up|0|||
160830351|NCT00385723|580765978|FG000|Overall Study|Withdrawal by Subject|1|||
160830352|NCT00385723|580765979|FG001|Overall Study|Withdrawal by Subject|0|||
160830353|NCT00385723|580765980|FG002|Overall Study|Withdrawal by Subject|2|||
160830354|NCT01390779|580765981|FG000|Overall Study|Physician Decision|1|||
160830355|NCT00168103|580765982|FG000|Overall Study|Withdrawal by Subject|1|||
160830356|NCT00168103|580765983|FG001|Overall Study|Withdrawal by Subject|2|||
160830357|NCT00168103|580765984|FG002|Overall Study|Withdrawal by Subject|1|||
160830358|NCT00168103|580765985|FG003|Overall Study|Withdrawal by Subject|0|||
160830359|NCT00168103|580765982|FG000|Overall Study|Lost to Follow-up|1|||
160830360|NCT00168103|580765983|FG001|Overall Study|Lost to Follow-up|3|||
160830361|NCT00168103|580765984|FG002|Overall Study|Lost to Follow-up|0|||
160830362|NCT00168103|580765985|FG003|Overall Study|Lost to Follow-up|0|||
160830363|NCT00689793|580765992|FG000|Overall Study|Lost to Follow-up|4|||
160830364|NCT00689793|580765993|FG001|Overall Study|Lost to Follow-up|5|||
160830365|NCT02956850|580765999|FG000|Overall Study|Withdrawal by Subject|0|||
160830366|NCT02956850|580766000|FG001|Overall Study|Withdrawal by Subject|0|||
160990878|NCT00941031|581353976|FG005|Maintenance Period|Administrative Problems|0|||
160560027|NCT02300129|579774040|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
160830367|NCT02956850|580766001|FG002|Overall Study|Withdrawal by Subject|0|||
160830368|NCT02956850|580766002|FG003|Overall Study|Withdrawal by Subject|0|||
160830369|NCT02956850|580766003|FG004|Overall Study|Withdrawal by Subject|0|||
160830370|NCT02956850|580766004|FG005|Overall Study|Withdrawal by Subject|0|||
160830371|NCT02956850|580766005|FG006|Overall Study|Withdrawal by Subject|0|||
160830372|NCT02956850|580766006|FG007|Overall Study|Withdrawal by Subject|0|||
160830373|NCT02956850|580766007|FG008|Overall Study|Withdrawal by Subject|0|||
160830374|NCT02956850|580766008|FG009|Overall Study|Withdrawal by Subject|0|||
160830375|NCT02956850|580766009|FG010|Overall Study|Withdrawal by Subject|0|||
160830376|NCT02956850|580766010|FG011|Overall Study|Withdrawal by Subject|0|||
160830377|NCT02956850|580766011|FG012|Overall Study|Withdrawal by Subject|0|||
160830378|NCT02956850|580766012|FG013|Overall Study|Withdrawal by Subject|0|||
160830379|NCT02956850|580766013|FG014|Overall Study|Withdrawal by Subject|0|||
160830380|NCT02956850|580766014|FG015|Overall Study|Withdrawal by Subject|0|||
160830381|NCT02956850|580766015|FG016|Overall Study|Withdrawal by Subject|0|||
160830382|NCT02956850|580766016|FG017|Overall Study|Withdrawal by Subject|1|||
160830383|NCT01920152|580766017|FG000|Overall Study|Withdrawal by Subject|1|||
160830384|NCT01920152|580766018|FG001|Overall Study|Withdrawal by Subject|2|||
160830385|NCT00708734|580766019|FG000|Overall Study|scheduling conflict|2|||
160830386|NCT00708734|580766019|FG000|Overall Study|moved|1|||
160830387|NCT00708734|580766019|FG000|Overall Study|leg injury|1|||
160830388|NCT00708734|580766019|FG000|Overall Study|knee replacement|1|||
160830389|NCT00708734|580766019|FG000|Overall Study|vertigo|1|||
160830390|NCT00708734|580766019|FG000|Overall Study|leg fracture|1|||
160830391|NCT03412604|580766020|FG000|Overall Study|Withdrawal by Subject|1|||
160830392|NCT02634606|580766021|FG000|Overall Study|unable to obtain the drug at start|13|||
160830393|NCT01287195|580766031|FG000|Overall Study|Withdrawal by Subject|2|||
160830394|NCT01995552|580766032|FG000|Overall Study|Protocol Violation|1|||
160830395|NCT01995552|580766032|FG000|Overall Study|Lack of Efficacy|15|||
160830396|NCT01995552|580766032|FG000|Overall Study|Death|1|||
160830397|NCT02068118|580766035|FG000|18-month Comparative Study Period|Death|90|||
160830398|NCT02068118|580766036|FG001|18-month Comparative Study Period|Death|97|||
160830399|NCT02068118|580766035|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
160830400|NCT02068118|580766036|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
160830401|NCT02068118|580766035|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
160830402|NCT02068118|580766036|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
160830403|NCT02068118|580766035|FG000|18-month Comparative Study Period|Heart transplant|9|||
160830404|NCT02068118|580766036|FG001|18-month Comparative Study Period|Heart transplant|15|||
160830405|NCT02068118|580766035|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
160830406|NCT02068118|580766036|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
160830407|NCT02068118|580766035|FG000|18-month Comparative Study Period|Hemiplegia|0|||
160830408|NCT02068118|580766036|FG001|18-month Comparative Study Period|Hemiplegia|1|||
160830409|NCT02068118|580766035|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
160830410|NCT02068118|580766036|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
160830411|NCT02068118|580766035|FG000|18-month Comparative Study Period|Move|0|||
160830412|NCT02068118|580766036|FG001|18-month Comparative Study Period|Move|1|||
160830413|NCT02068118|580766035|FG000|18-month Comparative Study Period|Hearing loss|0|||
160830414|NCT02068118|580766036|FG001|18-month Comparative Study Period|Hearing loss|1|||
160830415|NCT02068118|580766035|FG000|Extension Period|Death|0|||
160830416|NCT02068118|580766036|FG001|Extension Period|Death|2|||
160830417|NCT02068118|580766035|FG000|Extension Period|Withdrawal by Subject|1|||
160830418|NCT02068118|580766036|FG001|Extension Period|Withdrawal by Subject|0|||
160830419|NCT02068118|580766035|FG000|Extension Period|Heart transplant|1|||
160830420|NCT02068118|580766036|FG001|Extension Period|Heart transplant|0|||
160830421|NCT02068118|580766035|FG000|Extension Period|Wrong device use|0|||
160830422|NCT02068118|580766036|FG001|Extension Period|Wrong device use|1|||
160830423|NCT00283868|580766041|FG000|Overall Study|Lost to Follow-up|7|||
160830424|NCT00283868|580766042|FG001|Overall Study|Lost to Follow-up|8|||
160830425|NCT00353873|580766043|FG000|Overall Study|Protocol Violation|1|||
160830426|NCT00353873|580766044|FG001|Overall Study|Protocol Violation|2|||
160830427|NCT00353873|580766043|FG000|Overall Study|Exacerbation|1|||
160830428|NCT00353873|580766044|FG001|Overall Study|Exacerbation|0|||
160830429|NCT00353873|580766043|FG000|Overall Study|Adverse Event|1|||
160830430|NCT00353873|580766044|FG001|Overall Study|Adverse Event|0|||
160830431|NCT00353873|580766043|FG000|Overall Study|Physician Decision|2|||
160830432|NCT00353873|580766044|FG001|Overall Study|Physician Decision|0|||
160830433|NCT00353873|580766043|FG000|Overall Study|Withdrawal by Subject|1|||
160830434|NCT00353873|580766044|FG001|Overall Study|Withdrawal by Subject|1|||
160830435|NCT01515475|580766045|FG000|Overall Study|Lost to Follow-up|20|||
160830436|NCT01515475|580766046|FG001|Overall Study|Lost to Follow-up|15|||
160830437|NCT01515475|580766047|FG002|Overall Study|Lost to Follow-up|12|||
160830438|NCT01515475|580766048|FG003|Overall Study|Lost to Follow-up|12|||
160830439|NCT00453973|580766051|FG000|Overall Study|Adverse Event|4|||
160830440|NCT00453973|580766052|FG001|Overall Study|Adverse Event|9|||
160560028|NCT02300129|579774041|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
160830441|NCT00453973|580766051|FG000|Overall Study|Withdrawal by Subject|7|||
160830442|NCT00453973|580766052|FG001|Overall Study|Withdrawal by Subject|6|||
160830443|NCT00453973|580766051|FG000|Overall Study|PI Decision|0|||
160830444|NCT00453973|580766052|FG001|Overall Study|PI Decision|2|||
160560029|NCT02300129|579774042|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
160560030|NCT02300129|579774043|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
160560031|NCT01887912|579774044|FG000|Overall Study|Serious adverse event|400|||
160560032|NCT01887912|579774045|FG001|Overall Study|Serious adverse event|198|||
160560033|NCT01887912|579774044|FG000|Overall Study|Other Adverse Event|34|||
160560034|NCT01887912|579774045|FG001|Overall Study|Other Adverse Event|15|||
160560035|NCT01887912|579774044|FG000|Overall Study|Protocol Violation|67|||
160560036|NCT01887912|579774045|FG001|Overall Study|Protocol Violation|37|||
160560037|NCT01887912|579774044|FG000|Overall Study|Lost to Follow-up|163|||
160560038|NCT01887912|579774045|FG001|Overall Study|Lost to Follow-up|74|||
160560039|NCT01887912|579774044|FG000|Overall Study|Withdrawal by Subject|606|||
160560040|NCT01887912|579774045|FG001|Overall Study|Withdrawal by Subject|349|||
160560041|NCT01887912|579774044|FG000|Overall Study|Other|122|||
160560042|NCT01887912|579774045|FG001|Overall Study|Other|58|||
160560043|NCT04462536|579774046|FG000|Overall Study|Withdrawal by Subject|3|||
160560044|NCT04462536|579774047|FG001|Overall Study|Withdrawal by Subject|9|||
160560045|NCT04462536|579774046|FG000|Overall Study|Lost to Follow-up|2|||
160560046|NCT04462536|579774047|FG001|Overall Study|Lost to Follow-up|4|||
160560047|NCT02747927|579774048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
160560048|NCT02747927|579774049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
160560049|NCT02747927|579774048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
160560050|NCT02747927|579774049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
160830445|NCT00453973|580766051|FG000|Overall Study|Relocation|1|||
160830446|NCT00453973|580766052|FG001|Overall Study|Relocation|0|||
160560051|NCT02747927|579774048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
160560052|NCT02747927|579774049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
160560053|NCT02747927|579774048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
160560054|NCT02747927|579774049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
160560055|NCT02747927|579774048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
160560056|NCT02747927|579774049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
160560057|NCT02747927|579774048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
160560058|NCT02747927|579774049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
160560059|NCT02747927|579774048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
160560060|NCT02747927|579774049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
160560061|NCT02747927|579774048|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
160560062|NCT02747927|579774049|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
160560063|NCT02747927|579774048|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
160560064|NCT02747927|579774049|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
160560065|NCT02747927|579774048|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
160560066|NCT02747927|579774049|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
160560067|NCT02747927|579774048|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
160560068|NCT02747927|579774049|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
160560069|NCT02747927|579774048|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
160560070|NCT02747927|579774049|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
160560071|NCT02747927|579774048|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
160560072|NCT02747927|579774049|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
160560073|NCT02747927|579774048|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
160560074|NCT02747927|579774049|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
160560075|NCT02747927|579774048|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
160560076|NCT02747927|579774049|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
160560077|NCT02747927|579774048|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
160560078|NCT02747927|579774049|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
160560079|NCT02747927|579774048|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
160560080|NCT02747927|579774049|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
160560081|NCT02747927|579774048|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
160560082|NCT02747927|579774049|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
160560083|NCT02747927|579774048|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
160560084|NCT02747927|579774049|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
160560085|NCT02747927|579774048|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
160830447|NCT00453973|580766051|FG000|Overall Study|Renal transplant|1|||
160830448|NCT00453973|580766052|FG001|Overall Study|Renal transplant|1|||
160830449|NCT00453973|580766051|FG000|Overall Study|Site closed by sponsor|3|||
160903236|NCT03576495|581039056|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
160903237|NCT03576495|581039057|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
160903238|NCT05306977|581039060|FG000|Overall Study|Withdrawal by Subject|1|||
160903239|NCT01484275|581039065|FG000|Overall Study|Study terminated by sponsor|28|||
160903240|NCT01484275|581039066|FG001|Overall Study|Study terminated by sponsor|32|||
160903241|NCT01484275|581039065|FG000|Overall Study|Other|10|||
160903242|NCT01484275|581039066|FG001|Overall Study|Other|0|||
160903243|NCT01484275|581039065|FG000|Overall Study|Death|3|||
160903244|NCT01484275|581039066|FG001|Overall Study|Death|4|||
160903245|NCT01484275|581039065|FG000|Overall Study|Withdrawal by Subject|1|||
160903246|NCT01484275|581039066|FG001|Overall Study|Withdrawal by Subject|5|||
160903247|NCT01484275|581039065|FG000|Overall Study|Lost to Follow-up|1|||
160903248|NCT01484275|581039066|FG001|Overall Study|Lost to Follow-up|1|||
160903249|NCT00003487|581039067|FG000|Overall Study|Not evaluable|2|||
160903250|NCT04154930|581039070|FG000|Overall Study|Withdrawal by Subject|15|||
160903251|NCT04154930|581039071|FG001|Overall Study|Withdrawal by Subject|6|||
160903252|NCT04154930|581039070|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
160903253|NCT04154930|581039071|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
160903254|NCT04154930|581039070|FG000|Overall Study|Lost to Follow-up|14|||
160903255|NCT04154930|581039071|FG001|Overall Study|Lost to Follow-up|6|||
160903256|NCT04154930|581039070|FG000|Overall Study|Other|6|||
160903257|NCT04154930|581039071|FG001|Overall Study|Other|0|||
160903258|NCT02020577|581039075|FG000|Overall Study|Progressive disease|3|||
160903259|NCT02020577|581039076|FG001|Overall Study|Progressive disease|38|||
160903260|NCT02020577|581039075|FG000|Overall Study|Other AE or clinical progression|0|||
160903261|NCT02020577|581039076|FG001|Overall Study|Other AE or clinical progression|15|||
160903262|NCT02020577|581039075|FG000|Overall Study|Withdrawal by Subject|0|||
160903263|NCT02020577|581039076|FG001|Overall Study|Withdrawal by Subject|1|||
160903264|NCT02020577|581039075|FG000|Overall Study|Other than stated above|0|||
160903265|NCT02020577|581039076|FG001|Overall Study|Other than stated above|1|||
160903266|NCT02628938|581039077|FG000|Overall Study|Did not attend the follow up recall|2|||
160903267|NCT02628938|581039078|FG001|Overall Study|Did not attend the follow up recall|2|||
160560086|NCT02747927|579774049|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
160560087|NCT02747927|579774048|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
160560088|NCT02747927|579774049|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
160560089|NCT02747927|579774048|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
160560090|NCT02747927|579774049|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
160560091|NCT02747927|579774048|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
160903268|NCT02628938|581039079|FG002|Overall Study|Did not attend the follow up recall|1|||
160903269|NCT02628938|581039077|FG000|Overall Study|Failure to comply with the instructions|3|||
160903270|NCT02628938|581039078|FG001|Overall Study|Failure to comply with the instructions|0|||
160903271|NCT02628938|581039079|FG002|Overall Study|Failure to comply with the instructions|3|||
160903272|NCT02058693|581039080|FG000|Phase 1|Withdrawal by Subject|3|||
160903273|NCT02058693|581039081|FG001|Phase 1|Withdrawal by Subject|2|||
160903274|NCT02058693|581039080|FG000|Phase 1|Adverse Event|0|||
160903275|NCT02058693|581039081|FG001|Phase 1|Adverse Event|1|||
160903276|NCT02058693|581039080|FG000|Phase 1|Lack of Efficacy|1|||
160903277|NCT02058693|581039081|FG001|Phase 1|Lack of Efficacy|0|||
160903278|NCT02058693|581039080|FG000|Phase 1|Physician Decision|1|||
160903279|NCT02058693|581039081|FG001|Phase 1|Physician Decision|1|||
160903280|NCT02058693|581039080|FG000|Phase 2|Withdrawal by Subject|0|||
160903281|NCT02058693|581039081|FG001|Phase 2|Withdrawal by Subject|2|||
160903282|NCT03855228|581039082|FG000|Overall Study|Adverse Event|2|||
160903283|NCT03855228|581039083|FG001|Overall Study|Adverse Event|4|||
160903284|NCT03855228|581039084|FG002|Overall Study|Adverse Event|4|||
160903285|NCT03855228|581039085|FG003|Overall Study|Adverse Event|8|||
160903286|NCT03855228|581039082|FG000|Overall Study|Treatment Failure|1|||
160903287|NCT03855228|581039083|FG001|Overall Study|Treatment Failure|2|||
160560092|NCT02747927|579774049|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
160560093|NCT02747927|579774048|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
160560094|NCT02747927|579774049|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
160571872|NCT00491530|579816846|FG000|Overall Study|Withdrawal by Subject|3|||
160903288|NCT03855228|581039084|FG002|Overall Study|Treatment Failure|1|||
160903289|NCT03855228|581039085|FG003|Overall Study|Treatment Failure|8|||
160903290|NCT03855228|581039082|FG000|Overall Study|Lost to Follow-up|0|||
160903291|NCT03855228|581039083|FG001|Overall Study|Lost to Follow-up|0|||
160903292|NCT03855228|581039084|FG002|Overall Study|Lost to Follow-up|0|||
160903293|NCT03855228|581039085|FG003|Overall Study|Lost to Follow-up|1|||
160903294|NCT03855228|581039082|FG000|Overall Study|Protocol Violation|0|||
160903295|NCT03855228|581039083|FG001|Overall Study|Protocol Violation|1|||
160903296|NCT03855228|581039084|FG002|Overall Study|Protocol Violation|2|||
160903297|NCT03855228|581039085|FG003|Overall Study|Protocol Violation|1|||
160903298|NCT03855228|581039082|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
160903299|NCT03855228|581039083|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
160903300|NCT03855228|581039084|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
160647509|NCT03346538|580092733|FG000|Overall Study|Physician Decision|0|||
160647510|NCT03346538|580092734|FG001|Overall Study|Physician Decision|1|||
160647511|NCT03346538|580092735|FG002|Overall Study|Physician Decision|0|||
160647512|NCT03346538|580092733|FG000|Overall Study|Withdrawal by Subject|3|||
160647513|NCT03346538|580092734|FG001|Overall Study|Withdrawal by Subject|2|||
160647514|NCT03346538|580092735|FG002|Overall Study|Withdrawal by Subject|0|||
160647515|NCT03346538|580092733|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
160647516|NCT03346538|580092734|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
160647517|NCT03346538|580092735|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
160647523|NCT02220920|580092737|FG000|Overall Study|Adverse Event|1|||
160647524|NCT02220920|580092738|FG001|Overall Study|Adverse Event|0|||
160647525|NCT02220920|580092737|FG000|Overall Study|Lack of Efficacy|0|||
160647526|NCT02220920|580092738|FG001|Overall Study|Lack of Efficacy|1|||
160647527|NCT02220920|580092737|FG000|Overall Study|Withdrawal by Subject|1|||
160647528|NCT02220920|580092738|FG001|Overall Study|Withdrawal by Subject|0|||
160647529|NCT02220920|580092737|FG000|Overall Study|Conflict with the stopping criteria|1|||
160647530|NCT02220920|580092738|FG001|Overall Study|Conflict with the stopping criteria|2|||
160647541|NCT01413204|580092749|FG000|Overall Study|Adverse Event|1|||
160647542|NCT01413204|580092750|FG001|Overall Study|Adverse Event|2|||
160647543|NCT01413204|580092751|FG002|Overall Study|Adverse Event|2|||
160647544|NCT01413204|580092749|FG000|Overall Study|Physician Decision|3|||
160647545|NCT01413204|580092750|FG001|Overall Study|Physician Decision|0|||
160647546|NCT01413204|580092751|FG002|Overall Study|Physician Decision|2|||
160830450|NCT00453973|580766052|FG001|Overall Study|Site closed by sponsor|0|||
160830451|NCT00453973|580766051|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
160830452|NCT00453973|580766052|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
160830453|NCT03743064|580766053|FG000|Overall Study|Adverse Event|7|||
160830454|NCT03743064|580766054|FG001|Overall Study|Adverse Event|9|||
160830455|NCT03743064|580766053|FG000|Overall Study|Death|25|||
160830456|NCT03743064|580766054|FG001|Overall Study|Death|28|||
160830457|NCT03743064|580766053|FG000|Overall Study|Lost to Follow-up|3|||
160647547|NCT01413204|580092749|FG000|Overall Study|Withdrawal by Subject|1|||
160647548|NCT01413204|580092750|FG001|Overall Study|Withdrawal by Subject|4|||
160647549|NCT01413204|580092751|FG002|Overall Study|Withdrawal by Subject|4|||
160647550|NCT01413204|580092749|FG000|Overall Study|Clearly not eligible for the study|0|||
160647551|NCT01413204|580092750|FG001|Overall Study|Clearly not eligible for the study|0|||
160903301|NCT03855228|581039085|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
160647552|NCT01413204|580092751|FG002|Overall Study|Clearly not eligible for the study|1|||
160647553|NCT01413204|580092749|FG000|Overall Study|Fasting plasma glucose level increased|1|||
160647554|NCT01413204|580092750|FG001|Overall Study|Fasting plasma glucose level increased|0|||
160647555|NCT01413204|580092751|FG002|Overall Study|Fasting plasma glucose level increased|10|||
160830458|NCT03743064|580766054|FG001|Overall Study|Lost to Follow-up|6|||
160830459|NCT03743064|580766053|FG000|Overall Study|Withdrawal by Subject|28|||
160830460|NCT03743064|580766054|FG001|Overall Study|Withdrawal by Subject|25|||
160830461|NCT03743064|580766053|FG000|Overall Study|Physician Decision|2|||
160830462|NCT03743064|580766054|FG001|Overall Study|Physician Decision|4|||
160830463|NCT03743064|580766053|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
160830464|NCT03743064|580766054|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
160830465|NCT01996592|580766059|FG000|Overall Study|no response to text/no diary entry|32|||
160830466|NCT01996592|580766059|FG000|Overall Study|change in surgical date|4|||
160830467|NCT01996592|580766059|FG000|Overall Study|Withdrawal by Subject|5|||
160830468|NCT01996592|580766059|FG000|Overall Study|change in mode of delivery|4|||
160830469|NCT02759315|580766060|FG000|Overall Study|Adverse Event|0|||
160830470|NCT02759315|580766061|FG001|Overall Study|Adverse Event|0|||
160830471|NCT02759315|580766062|FG002|Overall Study|Adverse Event|0|||
160830472|NCT02759315|580766063|FG003|Overall Study|Adverse Event|1|||
160830473|NCT02759315|580766064|FG004|Overall Study|Adverse Event|0|||
160830474|NCT02759315|580766060|FG000|Overall Study|Death|0|||
160830475|NCT02759315|580766061|FG001|Overall Study|Death|0|||
160830476|NCT02759315|580766062|FG002|Overall Study|Death|1|||
160830477|NCT02759315|580766063|FG003|Overall Study|Death|0|||
160830478|NCT02759315|580766064|FG004|Overall Study|Death|0|||
160903302|NCT00590135|581039086|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
160830479|NCT02759315|580766060|FG000|Overall Study|Lost to Follow-up|2|||
160830480|NCT02759315|580766061|FG001|Overall Study|Lost to Follow-up|0|||
160830481|NCT02759315|580766062|FG002|Overall Study|Lost to Follow-up|4|||
160830482|NCT02759315|580766063|FG003|Overall Study|Lost to Follow-up|0|||
160830483|NCT02759315|580766064|FG004|Overall Study|Lost to Follow-up|0|||
160830484|NCT02759315|580766060|FG000|Overall Study|Protocol Violation|0|||
160830485|NCT02759315|580766061|FG001|Overall Study|Protocol Violation|1|||
160830486|NCT02759315|580766062|FG002|Overall Study|Protocol Violation|0|||
160830487|NCT02759315|580766063|FG003|Overall Study|Protocol Violation|0|||
160830488|NCT02759315|580766064|FG004|Overall Study|Protocol Violation|0|||
160830489|NCT02759315|580766060|FG000|Overall Study|Study terminated prior to completion|2|||
160830490|NCT02759315|580766061|FG001|Overall Study|Study terminated prior to completion|0|||
160830491|NCT02759315|580766062|FG002|Overall Study|Study terminated prior to completion|5|||
160830492|NCT02759315|580766063|FG003|Overall Study|Study terminated prior to completion|0|||
160830493|NCT02759315|580766064|FG004|Overall Study|Study terminated prior to completion|1|||
160830494|NCT00870194|580766067|FG000|Overall Study|Adverse Event|10|||
160830495|NCT00870194|580766068|FG001|Overall Study|Adverse Event|5|||
160990879|NCT00941031|581353977|FG006|Maintenance Period|Administrative Problems|1|||
160990880|NCT00941031|581353971|FG000|Maintenance Period|Protocol Violation|0|||
160990881|NCT00941031|581353972|FG001|Maintenance Period|Protocol Violation|0|||
160560095|NCT02747927|579774048|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
160560096|NCT02747927|579774049|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
160560097|NCT02747927|579774048|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
160560098|NCT02747927|579774049|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
160560099|NCT02747927|579774048|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
160560100|NCT02747927|579774049|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
160560101|NCT02747927|579774048|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
160560102|NCT02747927|579774049|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
160560103|NCT02747927|579774048|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
160560104|NCT02747927|579774049|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
160560105|NCT02747927|579774048|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
160560106|NCT02747927|579774049|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
160560107|NCT02747927|579774048|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
160560108|NCT02747927|579774049|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
160560109|NCT02747927|579774048|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
160560110|NCT02747927|579774049|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
160560111|NCT00450580|579774052|FG000|Overall Study|Adverse Event|5|||
160560112|NCT00450580|579774053|FG001|Overall Study|Adverse Event|7|||
160560113|NCT00450580|579774052|FG000|Overall Study|Lost to Follow-up|4|||
160560114|NCT00450580|579774053|FG001|Overall Study|Lost to Follow-up|5|||
160560115|NCT00450580|579774052|FG000|Overall Study|Withdrawal by Subject|2|||
160560116|NCT00450580|579774053|FG001|Overall Study|Withdrawal by Subject|2|||
160560117|NCT00450580|579774052|FG000|Overall Study|Protocol Violation|1|||
160560118|NCT00450580|579774053|FG001|Overall Study|Protocol Violation|1|||
160560119|NCT00450580|579774052|FG000|Overall Study|Protocol-defined virologic failure|1|||
160560120|NCT00450580|579774053|FG001|Overall Study|Protocol-defined virologic failure|0|||
160560121|NCT00450580|579774052|FG000|Overall Study|Could not comply with scheduled visits|1|||
160560122|NCT00450580|579774053|FG001|Overall Study|Could not comply with scheduled visits|0|||
160560123|NCT00450580|579774052|FG000|Overall Study|Patient went to Brazil|1|||
160560124|NCT00450580|579774053|FG001|Overall Study|Patient went to Brazil|0|||
160560125|NCT00450580|579774052|FG000|Overall Study|Patient could not swallow Norvir|1|||
160560126|NCT00450580|579774053|FG001|Overall Study|Patient could not swallow Norvir|0|||
160560127|NCT00450580|579774052|FG000|Overall Study|Withdrawal due to pregnancy|0|||
160560128|NCT00450580|579774053|FG001|Overall Study|Withdrawal due to pregnancy|1|||
160560129|NCT03932812|579774058|FG000|Overall Study|Lost to Follow-up|12|||
160560130|NCT03932812|579774059|FG001|Overall Study|Lost to Follow-up|14|||
160560131|NCT03932812|579774058|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
160990882|NCT00941031|581353973|FG002|Maintenance Period|Protocol Violation|0|||
160990883|NCT00941031|581353974|FG003|Maintenance Period|Protocol Violation|0|||
160990884|NCT00941031|581353975|FG004|Maintenance Period|Protocol Violation|0|||
160990885|NCT00941031|581353976|FG005|Maintenance Period|Protocol Violation|0|||
160990886|NCT00941031|581353977|FG006|Maintenance Period|Protocol Violation|1|||
160990887|NCT00941031|581353971|FG000|Maintenance Period|Adverse Event|0|||
160990888|NCT00941031|581353972|FG001|Maintenance Period|Adverse Event|0|||
160990889|NCT00941031|581353973|FG002|Maintenance Period|Adverse Event|0|||
160990890|NCT00941031|581353974|FG003|Maintenance Period|Adverse Event|0|||
160560132|NCT03932812|579774059|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
160560133|NCT01169779|579774066|FG000|Overall Study|Adverse Event|3|||
160560134|NCT01169779|579774067|FG001|Overall Study|Adverse Event|11|||
160560135|NCT01169779|579774066|FG000|Overall Study|Lack of Efficacy|1|||
160560136|NCT01169779|579774067|FG001|Overall Study|Lack of Efficacy|0|||
160560137|NCT01169779|579774066|FG000|Overall Study|Protocol Violation|1|||
160990891|NCT00941031|581353975|FG004|Maintenance Period|Adverse Event|0|||
160990892|NCT00941031|581353976|FG005|Maintenance Period|Adverse Event|2|||
160990893|NCT00941031|581353977|FG006|Maintenance Period|Adverse Event|8|||
160990894|NCT00941031|581353971|FG000|Maintenance Period|Lost to Follow-up|0|||
160990895|NCT00941031|581353972|FG001|Maintenance Period|Lost to Follow-up|0|||
160990896|NCT00941031|581353973|FG002|Maintenance Period|Lost to Follow-up|0|||
160990897|NCT00941031|581353974|FG003|Maintenance Period|Lost to Follow-up|0|||
160990898|NCT00941031|581353975|FG004|Maintenance Period|Lost to Follow-up|2|||
160990899|NCT00941031|581353976|FG005|Maintenance Period|Lost to Follow-up|2|||
160990900|NCT00941031|581353977|FG006|Maintenance Period|Lost to Follow-up|7|||
160990901|NCT00941031|581353971|FG000|Maintenance Period|Lack of Efficacy|0|||
160990902|NCT00941031|581353972|FG001|Maintenance Period|Lack of Efficacy|0|||
160990903|NCT00941031|581353973|FG002|Maintenance Period|Lack of Efficacy|0|||
160990904|NCT00941031|581353974|FG003|Maintenance Period|Lack of Efficacy|0|||
160990905|NCT00941031|581353975|FG004|Maintenance Period|Lack of Efficacy|0|||
160990906|NCT00941031|581353976|FG005|Maintenance Period|Lack of Efficacy|0|||
160990907|NCT00941031|581353977|FG006|Maintenance Period|Lack of Efficacy|13|||
160990908|NCT03441984|581353978|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990909|NCT03441984|581353979|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990910|NCT03441984|581353980|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
160990911|NCT03441984|581353981|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990912|NCT03441984|581353982|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990913|NCT03441984|581353983|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990914|NCT03441984|581353984|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990915|NCT03441984|581353985|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990916|NCT03441984|581353986|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990917|NCT03441984|581353987|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990918|NCT03441984|581353988|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990919|NCT03441984|581353989|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990920|NCT01872611|581353990|FG000|Overall Study|Adverse Event|3|||
160990921|NCT01872611|581353991|FG001|Overall Study|Adverse Event|1|||
160990922|NCT01872611|581353990|FG000|Overall Study|Adverse Event, prior to treatment|0|||
160990923|NCT01872611|581353991|FG001|Overall Study|Adverse Event, prior to treatment|1|||
160990924|NCT01872611|581353990|FG000|Overall Study|Death|0|||
160990925|NCT01872611|581353991|FG001|Overall Study|Death|1|||
160990926|NCT01872611|581353990|FG000|Overall Study|Death, prior to treatment|0|||
160990927|NCT01872611|581353991|FG001|Overall Study|Death, prior to treatment|1|||
160990928|NCT01872611|581353990|FG000|Overall Study|Lost to Follow-up|8|||
160990929|NCT01872611|581353991|FG001|Overall Study|Lost to Follow-up|1|||
160990930|NCT01872611|581353990|FG000|Overall Study|Physician Decision|1|||
160990931|NCT01872611|581353991|FG001|Overall Study|Physician Decision|0|||
160990932|NCT01872611|581353990|FG000|Overall Study|Withdrawal by Subject|6|||
160990933|NCT01872611|581353991|FG001|Overall Study|Withdrawal by Subject|1|||
160990934|NCT01872611|581353990|FG000|Overall Study|Reason not provided|6|||
160990935|NCT01872611|581353991|FG001|Overall Study|Reason not provided|6|||
160990936|NCT04555044|581353994|FG000|Overall Study|Adverse Event|0|||
160990937|NCT04555044|581353995|FG001|Overall Study|Adverse Event|1|||
160990938|NCT04088188|581353998|FG000|Overall Study|Withdrawal by Subject|2|||
160990939|NCT04088188|581353999|FG001|Overall Study|Withdrawal by Subject|0|||
160990940|NCT04088188|581353998|FG000|Overall Study|Adverse Event|2|||
160990941|NCT04088188|581353999|FG001|Overall Study|Adverse Event|0|||
160990942|NCT00631917|581354000|FG000|Overall Study|Adverse Event|34|||
160990943|NCT00631917|581354001|FG001|Overall Study|Adverse Event|45|||
160990944|NCT00631917|581354000|FG000|Overall Study|Abnormal laboratory value(s)|2|||
160990945|NCT00631917|581354001|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160990946|NCT00631917|581354000|FG000|Overall Study|Abnormal test procedure result(s)|3|||
160990947|NCT00631917|581354001|FG001|Overall Study|Abnormal test procedure result(s)|2|||
160560138|NCT01169779|579774067|FG001|Overall Study|Protocol Violation|1|||
160560139|NCT01169779|579774066|FG000|Overall Study|Withdrawal by Subject|3|||
160560140|NCT01169779|579774067|FG001|Overall Study|Withdrawal by Subject|2|||
160560141|NCT01169779|579774066|FG000|Overall Study|Familial and personal reasons|3|||
160560142|NCT01169779|579774067|FG001|Overall Study|Familial and personal reasons|3|||
160990948|NCT00631917|581354000|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
160990949|NCT00631917|581354001|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
160560143|NCT00191854|579774072|FG000|Overall Study|Death|26|||
160560144|NCT00191854|579774073|FG001|Overall Study|Death|23|||
160560145|NCT00191854|579774074|FG002|Overall Study|Death|29|||
160830496|NCT00870194|580766067|FG000|Overall Study|Lack of Efficacy|0|||
160990950|NCT00631917|581354000|FG000|Overall Study|No longer required study drug|0|||
160990951|NCT00631917|581354001|FG001|Overall Study|No longer required study drug|1|||
160990952|NCT00631917|581354000|FG000|Overall Study|Protocol deviation|6|||
160990953|NCT00631917|581354001|FG001|Overall Study|Protocol deviation|5|||
160990954|NCT00631917|581354000|FG000|Overall Study|Subject withdrew consent|25|||
160990955|NCT00631917|581354001|FG001|Overall Study|Subject withdrew consent|33|||
160990956|NCT00631917|581354000|FG000|Overall Study|Lost to Follow-up|7|||
160830497|NCT00870194|580766068|FG001|Overall Study|Lack of Efficacy|1|||
160990957|NCT00631917|581354001|FG001|Overall Study|Lost to Follow-up|7|||
160990958|NCT00631917|581354000|FG000|Overall Study|Administrative problems|2|||
160990959|NCT00631917|581354001|FG001|Overall Study|Administrative problems|0|||
160990960|NCT00631917|581354000|FG000|Overall Study|Death|1|||
160990961|NCT00631917|581354001|FG001|Overall Study|Death|0|||
160990962|NCT03686384|581354002|FG000|Overall Study|Lack of Efficacy|4|||
160990963|NCT03686384|581354003|FG001|Overall Study|Lack of Efficacy|13|||
160990964|NCT03686384|581354002|FG000|Overall Study|Lost to Follow-up|3|||
160990965|NCT03686384|581354003|FG001|Overall Study|Lost to Follow-up|0|||
160990966|NCT03686384|581354002|FG000|Overall Study|Physician Decision|0|||
160990967|NCT03686384|581354003|FG001|Overall Study|Physician Decision|1|||
160990968|NCT03686384|581354002|FG000|Overall Study|Took prohibited medication|0|||
160990969|NCT03686384|581354003|FG001|Overall Study|Took prohibited medication|1|||
160990970|NCT00614744|581354014|FG000|Overall Study|Lost to Follow-up|5|||
160990971|NCT00614744|581354015|FG001|Overall Study|Lost to Follow-up|4|||
160990972|NCT00614744|581354014|FG000|Overall Study|Incomplete for Behavior Issues|0|||
160990973|NCT00614744|581354015|FG001|Overall Study|Incomplete for Behavior Issues|2|||
160990974|NCT00877851|581354016|FG000|Overall Study|Lost to Follow-up|5|||
160990975|NCT00877851|581354017|FG001|Overall Study|Lost to Follow-up|5|||
160990976|NCT00877851|581354016|FG000|Overall Study|computer problem|3|||
160990977|NCT00877851|581354017|FG001|Overall Study|computer problem|0|||
160990978|NCT00877851|581354016|FG000|Overall Study|no longer interested in participating|1|||
160990979|NCT00877851|581354017|FG001|Overall Study|no longer interested in participating|0|||
160990980|NCT03285711|581354018|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
160990981|NCT03285711|581354019|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
160990982|NCT03285711|581354020|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
160990983|NCT03285711|581354021|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
160990984|NCT03285711|581354018|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
160990985|NCT03285711|581354019|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
160990986|NCT03285711|581354020|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
160990987|NCT03285711|581354021|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
160990988|NCT03285711|581354018|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
160990989|NCT03285711|581354019|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
160990990|NCT03285711|581354020|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
160990991|NCT03285711|581354021|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
160990992|NCT03285711|581354018|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
160990993|NCT03285711|581354019|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
160990994|NCT03285711|581354020|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
160990995|NCT03285711|581354021|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
160990996|NCT00209274|581354028|FG000|Overall Study|Missed visit|3|||
160990997|NCT00209274|581354029|FG001|Overall Study|Missed visit|2|||
160990998|NCT00209274|581354028|FG000|Overall Study|Death|32|||
160990999|NCT00209274|581354029|FG001|Overall Study|Death|15|||
160991000|NCT00209274|581354028|FG000|Overall Study|Withdrawal by Subject|30|||
160991001|NCT00209274|581354029|FG001|Overall Study|Withdrawal by Subject|15|||
160991002|NCT00209274|581354028|FG000|Overall Study|Randomized not treated (RNT)|6|||
160991003|NCT00209274|581354029|FG001|Overall Study|Randomized not treated (RNT)|15|||
160991004|NCT02753530|581354031|FG000|Overall Study|Adverse Event|7|||
160991005|NCT02753530|581354032|FG001|Overall Study|Adverse Event|1|||
160991006|NCT02753530|581354031|FG000|Overall Study|Death|0|||
160991007|NCT02753530|581354032|FG001|Overall Study|Death|1|||
160991008|NCT02753530|581354031|FG000|Overall Study|Physician Decision|0|||
160991009|NCT02753530|581354032|FG001|Overall Study|Physician Decision|1|||
160991010|NCT02753530|581354031|FG000|Overall Study|Protocol Violation|1|||
160991011|NCT02753530|581354032|FG001|Overall Study|Protocol Violation|0|||
160991012|NCT02753530|581354031|FG000|Overall Study|Withdrawal by Subject|4|||
160991013|NCT02753530|581354032|FG001|Overall Study|Withdrawal by Subject|3|||
160991014|NCT00256308|581355439|FG000|Overall Study|Death|2|||
160991015|NCT03712930|581355440|FG000|Overall Study|Death|7|||
160991016|NCT03712930|581355440|FG000|Overall Study|Physician Decision|1|||
160991017|NCT03712930|581355440|FG000|Overall Study|Study Terminated by Sponsor|3|||
160991018|NCT03712930|581355440|FG000|Overall Study|Progressive Disease|2|||
160991019|NCT01062126|581355444|FG000|Overall Study|Death|209|||
160991020|NCT01062126|581355444|FG000|Overall Study|All Withdrawals|324|||
160991021|NCT03784963|581355445|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
160991022|NCT03784963|581355446|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
160991023|NCT03784963|581355447|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
160991024|NCT03784963|581355448|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
160991025|NCT00349908|581355449|FG000|Overall Study|Withdrawal by Subject|0|||
160991026|NCT00349908|581355450|FG001|Overall Study|Withdrawal by Subject|4|||
160991027|NCT01289119|581355454|FG000|Overall Study|Adverse Event|2|||
160560146|NCT00191854|579774072|FG000|Overall Study|Lost to Follow-up|7|||
160560147|NCT00191854|579774073|FG001|Overall Study|Lost to Follow-up|5|||
160560148|NCT00191854|579774074|FG002|Overall Study|Lost to Follow-up|5|||
160560149|NCT00191854|579774072|FG000|Overall Study|Withdrawal by Subject|4|||
160560150|NCT00191854|579774073|FG001|Overall Study|Withdrawal by Subject|2|||
160560151|NCT00191854|579774074|FG002|Overall Study|Withdrawal by Subject|3|||
160560152|NCT00191854|579774072|FG000|Overall Study|Sponsor Decision|0|||
160991028|NCT01289119|581355455|FG001|Overall Study|Adverse Event|1|||
160991029|NCT01289119|581355456|FG002|Overall Study|Adverse Event|0|||
160991030|NCT01289119|581355457|FG003|Overall Study|Adverse Event|2|||
160991031|NCT01289119|581355458|FG004|Overall Study|Adverse Event|1|||
160991032|NCT01289119|581355459|FG005|Overall Study|Adverse Event|0|||
160991033|NCT01289119|581355454|FG000|Overall Study|Major Protocol Deviation|2|||
160991034|NCT01289119|581355455|FG001|Overall Study|Major Protocol Deviation|1|||
160991035|NCT01289119|581355456|FG002|Overall Study|Major Protocol Deviation|3|||
160991036|NCT01289119|581355457|FG003|Overall Study|Major Protocol Deviation|0|||
160991037|NCT01289119|581355458|FG004|Overall Study|Major Protocol Deviation|2|||
160991038|NCT01289119|581355459|FG005|Overall Study|Major Protocol Deviation|1|||
160991039|NCT01289119|581355454|FG000|Overall Study|Lost to Follow-up|0|||
160991040|NCT01289119|581355455|FG001|Overall Study|Lost to Follow-up|3|||
160991041|NCT01289119|581355456|FG002|Overall Study|Lost to Follow-up|0|||
160991042|NCT01289119|581355457|FG003|Overall Study|Lost to Follow-up|0|||
160991043|NCT01289119|581355458|FG004|Overall Study|Lost to Follow-up|0|||
160991044|NCT01289119|581355459|FG005|Overall Study|Lost to Follow-up|1|||
160991045|NCT01289119|581355454|FG000|Overall Study|Withdrawal by Subject|4|||
160991046|NCT01289119|581355455|FG001|Overall Study|Withdrawal by Subject|2|||
160991047|NCT01289119|581355456|FG002|Overall Study|Withdrawal by Subject|4|||
160991048|NCT01289119|581355457|FG003|Overall Study|Withdrawal by Subject|3|||
160991049|NCT01289119|581355458|FG004|Overall Study|Withdrawal by Subject|1|||
160991050|NCT01289119|581355459|FG005|Overall Study|Withdrawal by Subject|1|||
160991051|NCT01289119|581355454|FG000|Overall Study|Pregnancy|0|||
160991052|NCT01289119|581355455|FG001|Overall Study|Pregnancy|1|||
160991053|NCT01289119|581355456|FG002|Overall Study|Pregnancy|0|||
160991054|NCT01289119|581355457|FG003|Overall Study|Pregnancy|0|||
160991055|NCT01289119|581355458|FG004|Overall Study|Pregnancy|0|||
160991056|NCT01289119|581355459|FG005|Overall Study|Pregnancy|0|||
160991057|NCT01289119|581355454|FG000|Overall Study|Lack of Efficacy|0|||
160991058|NCT01289119|581355455|FG001|Overall Study|Lack of Efficacy|1|||
160991059|NCT01289119|581355456|FG002|Overall Study|Lack of Efficacy|1|||
160991060|NCT01289119|581355457|FG003|Overall Study|Lack of Efficacy|1|||
160991061|NCT01289119|581355458|FG004|Overall Study|Lack of Efficacy|1|||
160991062|NCT01289119|581355459|FG005|Overall Study|Lack of Efficacy|1|||
160991063|NCT01289119|581355454|FG000|Overall Study|Other|1|||
160991064|NCT01289119|581355455|FG001|Overall Study|Other|0|||
160991065|NCT01289119|581355456|FG002|Overall Study|Other|1|||
160830498|NCT00870194|580766067|FG000|Overall Study|Lost to Follow-up|2|||
160830499|NCT00870194|580766068|FG001|Overall Study|Lost to Follow-up|0|||
160830500|NCT00870194|580766067|FG000|Overall Study|Physician Decision|3|||
160991066|NCT01289119|581355457|FG003|Overall Study|Other|0|||
160991067|NCT01289119|581355458|FG004|Overall Study|Other|0|||
160991068|NCT01289119|581355459|FG005|Overall Study|Other|0|||
160991069|NCT01704846|581355460|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160991070|NCT01704846|581355461|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160991071|NCT00530335|581355464|FG000|Overall Study|Adverse Event|3|||
160991072|NCT00530335|581355464|FG000|Overall Study|Protocol Violation|1|||
160991073|NCT00530335|581355464|FG000|Overall Study|Withdrawal by Subject|1|||
160991074|NCT00530335|581355464|FG000|Overall Study|Physician Decision|1|||
160560153|NCT00191854|579774073|FG001|Overall Study|Sponsor Decision|0|||
160560154|NCT00191854|579774074|FG002|Overall Study|Sponsor Decision|1|||
160830501|NCT00870194|580766068|FG001|Overall Study|Physician Decision|1|||
160830502|NCT00870194|580766067|FG000|Overall Study|Protocol Violation|3|||
160830503|NCT00870194|580766068|FG001|Overall Study|Protocol Violation|3|||
160830504|NCT00870194|580766067|FG000|Overall Study|Entry Criteria Not Met|1|||
160830505|NCT00870194|580766068|FG001|Overall Study|Entry Criteria Not Met|2|||
160830506|NCT00870194|580766067|FG000|Overall Study|Subject Decision|7|||
160830507|NCT00870194|580766068|FG001|Overall Study|Subject Decision|2|||
160830508|NCT01406015|580766069|FG000|Overall Study|Withdrawal by Subject|3|||
160830509|NCT01406015|580766070|FG001|Overall Study|Withdrawal by Subject|3|||
160830510|NCT00707746|580766072|FG000|Treatment Period|Adverse Event|2|||
160830511|NCT00707746|580766073|FG001|Treatment Period|Adverse Event|4|||
160991075|NCT01244984|581355466|FG000|Overall Study|Adverse Event|2|||
160991076|NCT01244984|581355467|FG001|Overall Study|Adverse Event|11|||
160991077|NCT01244984|581355468|FG002|Overall Study|Adverse Event|2|||
160991078|NCT01244984|581355466|FG000|Overall Study|Protocol Violation|1|||
160991079|NCT01244984|581355467|FG001|Overall Study|Protocol Violation|0|||
160991080|NCT01244984|581355468|FG002|Overall Study|Protocol Violation|0|||
160991081|NCT01244984|581355466|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
160991082|NCT01244984|581355467|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
160991083|NCT01244984|581355468|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
160560155|NCT00191854|579774072|FG000|Overall Study|Screen Failure|0|||
160991084|NCT01244984|581355466|FG000|Overall Study|Withdrawal by Subject|1|||
160991085|NCT01244984|581355467|FG001|Overall Study|Withdrawal by Subject|2|||
160991086|NCT01244984|581355468|FG002|Overall Study|Withdrawal by Subject|2|||
160991087|NCT04577183|581355469|FG000|Overall Study|Death|1|||
160991088|NCT04577183|581355469|FG000|Overall Study|Withdrawal by Subject|3|||
160991089|NCT04577183|581355469|FG000|Overall Study|Early termination|2|||
160991090|NCT00672256|581355475|FG000|Overall Study|PI dropped, bad data|44|||
160991091|NCT02072226|581355479|FG000|Overall Study|Lost to Follow-up|11|||
160991092|NCT02072226|581355480|FG001|Overall Study|Lost to Follow-up|7|||
160991093|NCT02072226|581355479|FG000|Overall Study|Patient Non-compliance|2|||
160991094|NCT02072226|581355480|FG001|Overall Study|Patient Non-compliance|3|||
160991095|NCT02072226|581355479|FG000|Overall Study|Death|1|||
160991096|NCT02072226|581355480|FG001|Overall Study|Death|0|||
160991097|NCT02072226|581355479|FG000|Overall Study|Patient Withdrawal of Consent|1|||
160991098|NCT02072226|581355480|FG001|Overall Study|Patient Withdrawal of Consent|0|||
160991099|NCT03255018|581355481|FG000|Overall Study|Death on study|0|||
160991100|NCT03255018|581355482|FG001|Overall Study|Death on study|5|||
160991101|NCT03255018|581355481|FG000|Overall Study|Withdrawal by Subject|0|||
160991102|NCT03255018|581355482|FG001|Overall Study|Withdrawal by Subject|2|||
160991103|NCT01720043|581355484|FG000|Overall Study|Withdrawal by Subject|1|||
160991104|NCT01688973|581355485|FG000|Overall Study|Ineligible|2|||
160991105|NCT01688973|581355486|FG001|Overall Study|Ineligible|3|||
160991106|NCT03467724|581355495|FG000|Overall Study|Lost to Follow-up|5|||
160991107|NCT03467724|581355495|FG000|Overall Study|Withdrawal by Subject|1|||
160991108|NCT03467724|581355495|FG000|Overall Study|Protocol Violation|1|||
160991109|NCT03467724|581355495|FG000|Overall Study|Adverse Event|1|||
160991110|NCT03710564|581355496|FG000|Overall Study|Study Terminated by Sponsor|104|||
160991111|NCT03710564|581355497|FG001|Overall Study|Study Terminated by Sponsor|55|||
160991112|NCT03710564|581355496|FG000|Overall Study|Withdrawal by Subject|57|||
160991113|NCT03710564|581355497|FG001|Overall Study|Withdrawal by Subject|25|||
160991114|NCT03710564|581355496|FG000|Overall Study|Death|10|||
160991115|NCT03710564|581355497|FG001|Overall Study|Death|4|||
160991116|NCT03710564|581355496|FG000|Overall Study|Lost to Follow-up|5|||
160991117|NCT03710564|581355497|FG001|Overall Study|Lost to Follow-up|4|||
160991118|NCT03710564|581355496|FG000|Overall Study|Protocol Violation|3|||
160991119|NCT03710564|581355497|FG001|Overall Study|Protocol Violation|2|||
160991120|NCT03710564|581355496|FG000|Overall Study|Adverse Event|3|||
160991121|NCT03710564|581355497|FG001|Overall Study|Adverse Event|0|||
160991122|NCT03710564|581355496|FG000|Overall Study|Physician Decision|2|||
160991123|NCT03710564|581355497|FG001|Overall Study|Physician Decision|3|||
160991124|NCT02397889|581355498|FG000|Overall Study|Physician Decision|1|||
160991125|NCT02397889|581355499|FG001|Overall Study|Physician Decision|0|||
160991126|NCT01928940|581355503|FG000|Overall Study|Adverse Event|0|||
160991127|NCT01928940|581355504|FG001|Overall Study|Adverse Event|1|||
160991128|NCT04668144|581355507|FG000|Overall Study|Protocol Violation|0|||
160991129|NCT04668144|581355508|FG001|Overall Study|Protocol Violation|1|||
160991130|NCT04668144|581355509|FG002|Overall Study|Protocol Violation|2|||
160991131|NCT00770211|581355510|FG000|Overall Study|Lost to Follow-up|1|||
160991132|NCT00770211|581355511|FG001|Overall Study|Lost to Follow-up|0|||
160991133|NCT00770211|581355510|FG000|Overall Study|Withdrawal by Subject|0|||
160991134|NCT00770211|581355511|FG001|Overall Study|Withdrawal by Subject|2|||
160991135|NCT01446003|581355512|FG000|Period 1|Protocol Violation|2|||
160991136|NCT01446003|581355513|FG001|Period 1|Protocol Violation|0|||
160991137|NCT01446003|581355512|FG000|Period 2|Adverse Event|1|||
160991138|NCT01446003|581355513|FG001|Period 2|Adverse Event|0|||
160991139|NCT00318656|581355515|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
160991140|NCT00318656|581355516|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
160991141|NCT00318656|581355515|FG000|Overall Study|Did not receive any treatment|0|||
160991142|NCT00318656|581355516|FG001|Overall Study|Did not receive any treatment|1|||
160991143|NCT01740557|581355517|FG000|Overall Study|Ineligible|1|||
160991144|NCT01740557|581355517|FG000|Overall Study|Screen failure|1|||
160991145|NCT00490555|581355518|FG000|Overall Study|noncompliant with drug administration|0|||
160991146|NCT00490555|581355519|FG001|Overall Study|noncompliant with drug administration|0|||
160991147|NCT00490555|581355520|FG002|Overall Study|noncompliant with drug administration|2|||
160991148|NCT00490555|581355521|FG003|Overall Study|noncompliant with drug administration|0|||
160991149|NCT01007149|581355522|FG000|Overall Study|Administrative problems|0|||
160991150|NCT01007149|581355523|FG001|Overall Study|Administrative problems|1|||
160991151|NCT03568162|581355524|FG000|Overall Study|Adverse Event|0|||
160991152|NCT03568162|581355525|FG001|Overall Study|Adverse Event|1|||
160991153|NCT03568162|581355526|FG002|Overall Study|Adverse Event|2|||
160560156|NCT00191854|579774073|FG001|Overall Study|Screen Failure|0|||
160991154|NCT03568162|581355527|FG003|Overall Study|Adverse Event|0|||
160991155|NCT03568162|581355528|FG004|Overall Study|Adverse Event|0|||
160991156|NCT03568162|581355529|FG005|Overall Study|Adverse Event|1|||
160991157|NCT03568162|581355524|FG000|Overall Study|Death|0|||
160560157|NCT00191854|579774074|FG002|Overall Study|Screen Failure|1|||
160560158|NCT03293654|579774075|FG000|Overall Study|Lost to Follow-up|0|||
160991158|NCT03568162|581355525|FG001|Overall Study|Death|0|||
160991159|NCT03568162|581355526|FG002|Overall Study|Death|0|||
160830512|NCT00707746|580766072|FG000|Treatment Period|Ineligibility|0|||
160830513|NCT00707746|580766073|FG001|Treatment Period|Ineligibility|1|||
160830514|NCT00357656|580766078|FG000|Overall Study|Other, No surgery performed|0|||
160830515|NCT00357656|580766079|FG001|Overall Study|Other, No surgery performed|3|||
160991160|NCT03568162|581355527|FG003|Overall Study|Death|0|||
160991161|NCT03568162|581355528|FG004|Overall Study|Death|1|||
160991162|NCT03568162|581355529|FG005|Overall Study|Death|0|||
160991163|NCT03568162|581355524|FG000|Overall Study|Lost to Follow-up|3|||
160991164|NCT03568162|581355525|FG001|Overall Study|Lost to Follow-up|2|||
160991165|NCT03568162|581355526|FG002|Overall Study|Lost to Follow-up|4|||
160991166|NCT03568162|581355527|FG003|Overall Study|Lost to Follow-up|2|||
160991167|NCT03568162|581355528|FG004|Overall Study|Lost to Follow-up|3|||
160830516|NCT02573246|580766083|FG000|Overall Study|Lost to Follow-up|2|||
160830517|NCT02573246|580766084|FG001|Overall Study|Lost to Follow-up|0|||
160830518|NCT02573246|580766085|FG002|Overall Study|Lost to Follow-up|0|||
160830519|NCT02573246|580766086|FG003|Overall Study|Lost to Follow-up|0|||
160830520|NCT02573246|580766087|FG004|Overall Study|Lost to Follow-up|1|||
160830521|NCT02573246|580766083|FG000|Overall Study|Withdrawal by Subject|0|||
160830522|NCT02573246|580766084|FG001|Overall Study|Withdrawal by Subject|0|||
160830523|NCT02573246|580766085|FG002|Overall Study|Withdrawal by Subject|0|||
160830524|NCT02573246|580766086|FG003|Overall Study|Withdrawal by Subject|0|||
160830525|NCT02573246|580766087|FG004|Overall Study|Withdrawal by Subject|1|||
160830526|NCT02573246|580766083|FG000|Overall Study|Physician Decision|1|||
160830527|NCT02573246|580766084|FG001|Overall Study|Physician Decision|1|||
160830528|NCT02573246|580766085|FG002|Overall Study|Physician Decision|3|||
160830529|NCT02573246|580766086|FG003|Overall Study|Physician Decision|2|||
160830530|NCT02573246|580766087|FG004|Overall Study|Physician Decision|2|||
160830531|NCT01219933|580766088|FG000|Overall Study|Adverse Event|8|||
160830532|NCT01219933|580766088|FG000|Overall Study|No LDA reached|5|||
160830533|NCT01219933|580766088|FG000|Overall Study|No LDA maintained|7|||
160830534|NCT01219933|580766088|FG000|Overall Study|Lost to Follow-up|3|||
160830535|NCT01219933|580766088|FG000|Overall Study|GC free|1|||
160830536|NCT01219933|580766088|FG000|Overall Study|Withdrawal by Subject|5|||
160830537|NCT01219933|580766088|FG000|Overall Study|Protocol Violation|8|||
160830538|NCT01219933|580766088|FG000|Overall Study|Lack of Efficacy|1|||
160830539|NCT02256267|580766089|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
160830540|NCT02256267|580766089|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
160830541|NCT01685983|580766090|FG000|Overall Study|Adverse Event|7|||
160830542|NCT01685983|580766090|FG000|Overall Study|Death|1|||
160830543|NCT01685983|580766090|FG000|Overall Study|Withdrawal by Subject|19|||
160830544|NCT01685983|580766090|FG000|Overall Study|Protocol Violation|2|||
160830545|NCT01685983|580766090|FG000|Overall Study|Physician Decision|13|||
160830546|NCT01685983|580766090|FG000|Overall Study|Other|7|||
160830547|NCT01685983|580766090|FG000|Overall Study|Progressive Disease|32|||
160830548|NCT01685983|580766090|FG000|Overall Study|Noncompliance with Study Drug|1|||
160830549|NCT00582738|580766091|FG000|Overall Study|Administrative Problems|7|||
160830550|NCT00582738|580766092|FG001|Overall Study|Administrative Problems|8|||
160830551|NCT00582738|580766091|FG000|Overall Study|Adverse Event|0|||
160830552|NCT00582738|580766092|FG001|Overall Study|Adverse Event|5|||
160830553|NCT00582738|580766091|FG000|Overall Study|Graft Lost|0|||
160830554|NCT00582738|580766092|FG001|Overall Study|Graft Lost|1|||
160830555|NCT00582738|580766091|FG000|Overall Study|Other|1|||
160830556|NCT00582738|580766092|FG001|Overall Study|Other|0|||
160830557|NCT00582738|580766091|FG000|Overall Study|Protocol Violation|1|||
160830558|NCT00582738|580766092|FG001|Overall Study|Protocol Violation|1|||
160830559|NCT00582738|580766091|FG000|Overall Study|Withdrawal by Subject|0|||
160830560|NCT00582738|580766092|FG001|Overall Study|Withdrawal by Subject|3|||
160830561|NCT01269385|580766093|FG000|Overall Study|Adverse Event|1|||
160991168|NCT03568162|581355529|FG005|Overall Study|Lost to Follow-up|2|||
160991169|NCT03568162|581355524|FG000|Overall Study|Physician Decision|0|||
160991170|NCT03568162|581355525|FG001|Overall Study|Physician Decision|1|||
160830562|NCT01269385|580766094|FG001|Overall Study|Adverse Event|1|||
160830563|NCT01269385|580766095|FG002|Overall Study|Adverse Event|0|||
160830564|NCT01269385|580766096|FG003|Overall Study|Adverse Event|0|||
160830565|NCT01073930|580767461|FG000|Overall Study|Withdrawal by Subject|3|||
160991171|NCT03568162|581355526|FG002|Overall Study|Physician Decision|1|||
160830566|NCT01073930|580767462|FG001|Overall Study|Withdrawal by Subject|2|||
160830567|NCT01073930|580767461|FG000|Overall Study|Lost to Follow-up|0|||
160830568|NCT01073930|580767462|FG001|Overall Study|Lost to Follow-up|1|||
160830569|NCT01073930|580767461|FG000|Overall Study|Adverse Event|0|||
160830570|NCT01073930|580767462|FG001|Overall Study|Adverse Event|1|||
160830571|NCT01073930|580767461|FG000|Overall Study|Noncompliance with study drug|0|||
160830572|NCT01073930|580767462|FG001|Overall Study|Noncompliance with study drug|1|||
160830573|NCT01073930|580767461|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
160830574|NCT01073930|580767462|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
160830575|NCT00541346|580767463|FG000|Follow-up|Adverse Event|1|||
160830576|NCT02008773|580767464|FG000|Overall Study|Adverse Event|3|||
160830577|NCT02008773|580767465|FG001|Overall Study|Adverse Event|3|||
160830578|NCT02008773|580767466|FG002|Overall Study|Adverse Event|1|||
160830579|NCT02008773|580767467|FG003|Overall Study|Adverse Event|2|||
160830580|NCT02008773|580767464|FG000|Overall Study|Medication Non-compliance|2|||
160830581|NCT02008773|580767465|FG001|Overall Study|Medication Non-compliance|1|||
160830582|NCT02008773|580767466|FG002|Overall Study|Medication Non-compliance|3|||
160830583|NCT02008773|580767467|FG003|Overall Study|Medication Non-compliance|2|||
160830584|NCT02008773|580767464|FG000|Overall Study|Withdrawal by Subject|8|||
160830585|NCT02008773|580767465|FG001|Overall Study|Withdrawal by Subject|4|||
160830586|NCT02008773|580767466|FG002|Overall Study|Withdrawal by Subject|7|||
160830587|NCT02008773|580767467|FG003|Overall Study|Withdrawal by Subject|6|||
160830588|NCT02008773|580767464|FG000|Overall Study|Lost to Follow-up|0|||
160830589|NCT02008773|580767465|FG001|Overall Study|Lost to Follow-up|1|||
160830590|NCT02008773|580767466|FG002|Overall Study|Lost to Follow-up|3|||
160830591|NCT02008773|580767467|FG003|Overall Study|Lost to Follow-up|2|||
160830592|NCT03320330|580767470|FG000|Overall Study|Lack of Efficacy|5|||
160830593|NCT03320330|580767471|FG001|Overall Study|Lack of Efficacy|5|||
160830594|NCT03320330|580767472|FG002|Overall Study|Lack of Efficacy|14|||
160830595|NCT03320330|580767470|FG000|Overall Study|Physician Decision|1|||
160830596|NCT03320330|580767471|FG001|Overall Study|Physician Decision|0|||
160830597|NCT03320330|580767472|FG002|Overall Study|Physician Decision|0|||
160830598|NCT03323736|580767473|FG000|Overall Study|Screen Failure|14|||
160830599|NCT03323736|580767474|FG001|Overall Study|Screen Failure|9|||
160830600|NCT03323736|580767475|FG002|Overall Study|Screen Failure|1|||
160830601|NCT03323736|580767473|FG000|Overall Study|Withdrawal Before Treatment|3|||
160830602|NCT03323736|580767474|FG001|Overall Study|Withdrawal Before Treatment|1|||
160830603|NCT03323736|580767475|FG002|Overall Study|Withdrawal Before Treatment|1|||
160830604|NCT03323736|580767473|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
160830605|NCT03323736|580767474|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
160830606|NCT03323736|580767475|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
160830607|NCT00701805|580767478|FG000|Overall Study|Withdrawal by Subject|3|||
160830608|NCT00701805|580767479|FG001|Overall Study|Withdrawal by Subject|1|||
160830609|NCT00701805|580767480|FG002|Overall Study|Withdrawal by Subject|4|||
160830610|NCT00701805|580767481|FG003|Overall Study|Withdrawal by Subject|3|||
160830611|NCT00701805|580767478|FG000|Overall Study|Adverse Event|0|||
160830612|NCT00701805|580767479|FG001|Overall Study|Adverse Event|1|||
160830613|NCT00701805|580767480|FG002|Overall Study|Adverse Event|1|||
160830614|NCT00701805|580767481|FG003|Overall Study|Adverse Event|0|||
160830615|NCT00701805|580767478|FG000|Overall Study|Missed 7 consecutive doses|0|||
160830616|NCT00701805|580767479|FG001|Overall Study|Missed 7 consecutive doses|1|||
160830617|NCT00701805|580767480|FG002|Overall Study|Missed 7 consecutive doses|0|||
160830618|NCT00701805|580767481|FG003|Overall Study|Missed 7 consecutive doses|0|||
160830619|NCT00701805|580767478|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
160830620|NCT00701805|580767479|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
160830621|NCT00701805|580767480|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
160830622|NCT00701805|580767481|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
160830623|NCT00701805|580767478|FG000|Overall Study|Physician decision, change of therapy|0|||
160830624|NCT00701805|580767479|FG001|Overall Study|Physician decision, change of therapy|0|||
160830625|NCT00701805|580767480|FG002|Overall Study|Physician decision, change of therapy|0|||
160830626|NCT00701805|580767481|FG003|Overall Study|Physician decision, change of therapy|1|||
160830627|NCT00701805|580767478|FG000|Overall Study|Difficult to travel to dialysis site|0|||
160560159|NCT03293654|579774076|FG001|Overall Study|Lost to Follow-up|1|||
160560160|NCT03293654|579774077|FG002|Overall Study|Lost to Follow-up|0|||
160560161|NCT01933932|579774079|FG000|Overall Study|Death|173|||
160560162|NCT01933932|579774080|FG001|Overall Study|Death|163|||
160560163|NCT01933932|579774079|FG000|Overall Study|Withdrawal by Subject|11|||
160560164|NCT01933932|579774080|FG001|Overall Study|Withdrawal by Subject|14|||
160560165|NCT01933932|579774079|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160560166|NCT01933932|579774080|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160560167|NCT00763009|579774085|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
160560168|NCT02013544|579774086|FG000|Overall Study|Adverse Event|5|||
160560169|NCT02013544|579774087|FG001|Overall Study|Adverse Event|5|||
160560170|NCT02013544|579774086|FG000|Overall Study|Lost to Follow-up|2|||
160830628|NCT00701805|580767479|FG001|Overall Study|Difficult to travel to dialysis site|0|||
160830629|NCT00701805|580767480|FG002|Overall Study|Difficult to travel to dialysis site|1|||
160830630|NCT00701805|580767481|FG003|Overall Study|Difficult to travel to dialysis site|0|||
160830631|NCT00701805|580767478|FG000|Overall Study|Resumption criteria were not met|0|||
160830632|NCT00701805|580767479|FG001|Overall Study|Resumption criteria were not met|1|||
160560171|NCT02013544|579774087|FG001|Overall Study|Lost to Follow-up|3|||
160560172|NCT02013544|579774086|FG000|Overall Study|Withdrawal by Subject|2|||
160560173|NCT02013544|579774087|FG001|Overall Study|Withdrawal by Subject|8|||
160830633|NCT00701805|580767480|FG002|Overall Study|Resumption criteria were not met|0|||
160830634|NCT00701805|580767481|FG003|Overall Study|Resumption criteria were not met|0|||
160830635|NCT03826342|580767488|FG000|Overall Study|Withdrawal by Subject|8|||
160830636|NCT03826342|580767489|FG001|Overall Study|Withdrawal by Subject|1|||
160830637|NCT03826342|580767488|FG000|Overall Study|Lost to Follow-up|7|||
160830638|NCT03826342|580767489|FG001|Overall Study|Lost to Follow-up|7|||
160830639|NCT03826342|580767488|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
160830640|NCT03826342|580767489|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
160830641|NCT01804582|580767490|FG000|Overall Study|Lost to Follow-up|47|||
160830642|NCT01804582|580767491|FG001|Overall Study|Lost to Follow-up|56|||
160830643|NCT01804582|580767490|FG000|Overall Study|Physician Decision|2|||
160830644|NCT01804582|580767491|FG001|Overall Study|Physician Decision|0|||
160830645|NCT03455829|580767492|FG000|Overall Study|Death|2|||
160830646|NCT03455829|580767493|FG001|Overall Study|Death|3|||
160830647|NCT03455829|580767494|FG002|Overall Study|Death|2|||
160830648|NCT03455829|580767495|FG003|Overall Study|Death|4|||
160830649|NCT03455829|580767496|FG004|Overall Study|Death|2|||
160830650|NCT03455829|580767492|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
160830651|NCT03455829|580767493|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
160830652|NCT03455829|580767494|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
160830653|NCT03455829|580767495|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
160830654|NCT03455829|580767496|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
160830655|NCT03455829|580767492|FG000|Overall Study|Disease progression|0|||
160830656|NCT03455829|580767493|FG001|Overall Study|Disease progression|0|||
160830657|NCT03455829|580767494|FG002|Overall Study|Disease progression|0|||
160830658|NCT03455829|580767495|FG003|Overall Study|Disease progression|1|||
160830659|NCT03455829|580767496|FG004|Overall Study|Disease progression|1|||
160830660|NCT02258529|580767506|FG000|Overall Study|Study Terminated by Sponsor|9|||
160830661|NCT02258529|580767506|FG000|Overall Study|Adverse Event|1|||
160830662|NCT00413010|580767507|FG000|Overall Study|Adverse Event|8|||
160830663|NCT00413010|580767508|FG001|Overall Study|Adverse Event|4|||
160830664|NCT00413010|580767507|FG000|Overall Study|Laboratory abnormality|0|||
160830665|NCT00413010|580767508|FG001|Overall Study|Laboratory abnormality|2|||
160830666|NCT00413010|580767507|FG000|Overall Study|Lack of Efficacy|0|||
160830667|NCT00413010|580767508|FG001|Overall Study|Lack of Efficacy|3|||
160830668|NCT00413010|580767507|FG000|Overall Study|Lost to Follow-up|3|||
160830669|NCT00413010|580767508|FG001|Overall Study|Lost to Follow-up|0|||
160830670|NCT00413010|580767507|FG000|Overall Study|Withdrawal by Subject|7|||
160830671|NCT00413010|580767508|FG001|Overall Study|Withdrawal by Subject|2|||
160830672|NCT00413010|580767507|FG000|Overall Study|Due to termination of the study|54|||
160830673|NCT00413010|580767508|FG001|Overall Study|Due to termination of the study|52|||
160830674|NCT00875056|580767509|FG000|Overall Study|Adverse Event|6|||
160830675|NCT00875056|580767510|FG001|Overall Study|Adverse Event|1|||
160830676|NCT00875056|580767511|FG002|Overall Study|Adverse Event|2|||
160830677|NCT00875056|580767509|FG000|Overall Study|Progressive Disease|14|||
160830678|NCT00875056|580767510|FG001|Overall Study|Progressive Disease|8|||
160830679|NCT00875056|580767511|FG002|Overall Study|Progressive Disease|3|||
160830680|NCT00875056|580767509|FG000|Overall Study|Withdrawal by Subject|3|||
160830681|NCT00875056|580767510|FG001|Overall Study|Withdrawal by Subject|0|||
160830682|NCT00875056|580767511|FG002|Overall Study|Withdrawal by Subject|1|||
160830683|NCT01842581|580767519|FG000|Overall Study|Adverse Event|6|||
160830684|NCT01842581|580767520|FG001|Overall Study|Adverse Event|4|||
160830685|NCT01842581|580767519|FG000|Overall Study|HE breakthrough|26|||
160830686|NCT01842581|580767520|FG001|Overall Study|HE breakthrough|13|||
160830687|NCT01842581|580767519|FG000|Overall Study|Liver transplant|2|||
160830688|NCT01842581|580767520|FG001|Overall Study|Liver transplant|0|||
160830689|NCT01842581|580767519|FG000|Overall Study|Lost to Follow-up|2|||
160830690|NCT01842581|580767520|FG001|Overall Study|Lost to Follow-up|5|||
160830691|NCT01842581|580767519|FG000|Overall Study|Withdrawal by Subject|5|||
160830692|NCT01842581|580767520|FG001|Overall Study|Withdrawal by Subject|7|||
160830693|NCT01842581|580767519|FG000|Overall Study|Other than specified|3|||
160830694|NCT01842581|580767520|FG001|Overall Study|Other than specified|1|||
160830695|NCT00993499|580767523|FG000|Run-in Period (8 Days)|Adverse Event|0|||
160830696|NCT00993499|580767524|FG001|Run-in Period (8 Days)|Adverse Event|1|||
160830697|NCT00993499|580767525|FG002|Run-in Period (8 Days)|Adverse Event|0|||
160830698|NCT00993499|580767526|FG003|Run-in Period (8 Days)|Adverse Event|0|||
160560174|NCT02013544|579774086|FG000|Overall Study|Physician Decision|0|||
160560175|NCT02013544|579774087|FG001|Overall Study|Physician Decision|1|||
160560176|NCT02013544|579774086|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
160560177|NCT02013544|579774087|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
160560178|NCT01295125|579774088|FG000|Overall Study|Study stopped prematurely|9|||
160830699|NCT00993499|580767527|FG004|Run-in Period (8 Days)|Adverse Event|0|||
160830700|NCT00993499|580767528|FG005|Run-in Period (8 Days)|Adverse Event|0|||
160830701|NCT00993499|580767523|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
160830702|NCT00993499|580767524|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
160830703|NCT00993499|580767525|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
160830704|NCT00993499|580767526|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
160830705|NCT00993499|580767527|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
160830706|NCT00993499|580767528|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
160830707|NCT00993499|580767523|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
160830708|NCT00993499|580767524|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
160830709|NCT00993499|580767525|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
160830710|NCT00993499|580767526|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
160830711|NCT00993499|580767527|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
160830712|NCT00993499|580767528|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
160830713|NCT00993499|580767523|FG000|Run-in Period (8 Days)|Progressive disease|0|||
160830714|NCT00993499|580767524|FG001|Run-in Period (8 Days)|Progressive disease|1|||
160830715|NCT00993499|580767525|FG002|Run-in Period (8 Days)|Progressive disease|1|||
160830716|NCT00993499|580767526|FG003|Run-in Period (8 Days)|Progressive disease|0|||
160830717|NCT00993499|580767527|FG004|Run-in Period (8 Days)|Progressive disease|0|||
160830718|NCT00993499|580767528|FG005|Run-in Period (8 Days)|Progressive disease|0|||
160830719|NCT00993499|580767523|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
160830720|NCT00993499|580767524|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
160830721|NCT00993499|580767525|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
160830722|NCT00993499|580767526|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
160830723|NCT00993499|580767527|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
160830724|NCT00993499|580767528|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
160830725|NCT00993499|580767523|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
160830726|NCT00993499|580767524|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
160830727|NCT00993499|580767525|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
160830728|NCT00993499|580767526|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
160830729|NCT00993499|580767527|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
160830730|NCT00993499|580767528|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
160830731|NCT00993499|580767523|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
160830732|NCT00993499|580767524|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
160830733|NCT00993499|580767525|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
160830734|NCT00993499|580767526|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
160830735|NCT00993499|580767527|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
160830736|NCT00993499|580767528|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
160830737|NCT00993499|580767523|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
160830738|NCT00993499|580767524|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
160830739|NCT00993499|580767525|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
160830740|NCT00993499|580767526|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
160830741|NCT00993499|580767527|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
160830742|NCT00993499|580767528|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
160830743|NCT00993499|580767523|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
160830744|NCT00993499|580767524|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
160830745|NCT00993499|580767525|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
160830746|NCT00993499|580767526|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
160830747|NCT00993499|580767527|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
160830748|NCT00993499|580767528|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
160830749|NCT00993499|580767523|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
160830750|NCT00993499|580767524|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
160830751|NCT00993499|580767525|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
160830752|NCT00993499|580767526|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
160830753|NCT00993499|580767527|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
160830754|NCT00993499|580767528|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
160830755|NCT00993499|580767523|FG000|Discontinued After Starting Course 3|DLT|1|||
160830756|NCT00993499|580767524|FG001|Discontinued After Starting Course 3|DLT|0|||
160830757|NCT00993499|580767525|FG002|Discontinued After Starting Course 3|DLT|2|||
160830758|NCT00993499|580767526|FG003|Discontinued After Starting Course 3|DLT|1|||
160830759|NCT00993499|580767527|FG004|Discontinued After Starting Course 3|DLT|0|||
160830760|NCT00993499|580767528|FG005|Discontinued After Starting Course 3|DLT|0|||
160830761|NCT00993499|580767523|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
160830762|NCT00993499|580767524|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
160830763|NCT00993499|580767525|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
160830764|NCT00993499|580767526|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
160830765|NCT00993499|580767527|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
160830766|NCT00993499|580767528|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
160560179|NCT00891735|579774089|FG000|Overall Study|Adverse Event|2|||
160560180|NCT00891735|579774090|FG001|Overall Study|Adverse Event|0|||
160560181|NCT00891735|579774091|FG002|Overall Study|Adverse Event|2|||
160560182|NCT00891735|579774092|FG003|Overall Study|Adverse Event|0|||
160830767|NCT05432167|580767529|FG000|Overall Study|Adverse Event|0|||
160830768|NCT05432167|580767530|FG001|Overall Study|Adverse Event|2|||
160830769|NCT05432167|580767531|FG002|Overall Study|Adverse Event|1|||
160830770|NCT05432167|580767529|FG000|Overall Study|Lost to Follow-up|3|||
160830771|NCT05432167|580767530|FG001|Overall Study|Lost to Follow-up|3|||
160830772|NCT05432167|580767531|FG002|Overall Study|Lost to Follow-up|2|||
160830773|NCT05432167|580767529|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
160830774|NCT05432167|580767530|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
160830775|NCT05432167|580767531|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
160830776|NCT05432167|580767529|FG000|Overall Study|Physician Decision|1|||
160830777|NCT05432167|580767530|FG001|Overall Study|Physician Decision|0|||
160830778|NCT05432167|580767531|FG002|Overall Study|Physician Decision|0|||
160830779|NCT05432167|580767529|FG000|Overall Study|Withdrawal by Subject|7|||
160830780|NCT05432167|580767530|FG001|Overall Study|Withdrawal by Subject|4|||
160830781|NCT05432167|580767531|FG002|Overall Study|Withdrawal by Subject|11|||
160830782|NCT05432167|580767529|FG000|Overall Study|Other|0|||
160830783|NCT05432167|580767530|FG001|Overall Study|Other|0|||
160830784|NCT05432167|580767531|FG002|Overall Study|Other|1|||
160830785|NCT01902888|580767532|FG000|Overall Study|Study Terminated|3|||
160830786|NCT03149003|580767533|FG000|Overall Study|Randomized but not treated|0|||
160830787|NCT03149003|580767534|FG001|Overall Study|Randomized but not treated|1|||
160830788|NCT03149003|580767535|FG002|Overall Study|Randomized but not treated|18|||
160830789|NCT01443130|580767536|FG000|Overall Study|Lost to Follow-up|44|||
160830790|NCT01443130|580767537|FG001|Overall Study|Lost to Follow-up|42|||
160830791|NCT01443130|580767538|FG002|Overall Study|Lost to Follow-up|50|||
160830792|NCT01443130|580767539|FG003|Overall Study|Lost to Follow-up|23|||
160830793|NCT01443130|580767540|FG004|Overall Study|Lost to Follow-up|25|||
160830794|NCT01443130|580767541|FG005|Overall Study|Lost to Follow-up|21|||
160830795|NCT01443130|580767536|FG000|Overall Study|Death|0|||
160830796|NCT01443130|580767537|FG001|Overall Study|Death|1|||
160830797|NCT01443130|580767538|FG002|Overall Study|Death|0|||
160830798|NCT01443130|580767539|FG003|Overall Study|Death|7|||
160830799|NCT01443130|580767540|FG004|Overall Study|Death|10|||
160830800|NCT01443130|580767541|FG005|Overall Study|Death|8|||
160830801|NCT01443130|580767536|FG000|Overall Study|Adverse Event|2|||
160830802|NCT01443130|580767537|FG001|Overall Study|Adverse Event|1|||
160830803|NCT01443130|580767538|FG002|Overall Study|Adverse Event|1|||
160830804|NCT01443130|580767539|FG003|Overall Study|Adverse Event|0|||
160830805|NCT01443130|580767540|FG004|Overall Study|Adverse Event|0|||
160830806|NCT01443130|580767541|FG005|Overall Study|Adverse Event|0|||
160830807|NCT01443130|580767536|FG000|Overall Study|Protocol Violation|2|||
160830808|NCT01443130|580767537|FG001|Overall Study|Protocol Violation|1|||
160830809|NCT01443130|580767538|FG002|Overall Study|Protocol Violation|3|||
160830810|NCT01443130|580767539|FG003|Overall Study|Protocol Violation|2|||
160830811|NCT01443130|580767540|FG004|Overall Study|Protocol Violation|2|||
160830812|NCT01443130|580767541|FG005|Overall Study|Protocol Violation|3|||
160830813|NCT01443130|580767536|FG000|Overall Study|Withdrawal by Subject|15|||
160830814|NCT01443130|580767537|FG001|Overall Study|Withdrawal by Subject|14|||
160830815|NCT01443130|580767538|FG002|Overall Study|Withdrawal by Subject|12|||
160830816|NCT01443130|580767539|FG003|Overall Study|Withdrawal by Subject|7|||
160830817|NCT01443130|580767540|FG004|Overall Study|Withdrawal by Subject|7|||
160830818|NCT01443130|580767541|FG005|Overall Study|Withdrawal by Subject|2|||
160830819|NCT01443130|580767536|FG000|Overall Study|Death of Subject's Infant|5|||
160830820|NCT01443130|580767537|FG001|Overall Study|Death of Subject's Infant|10|||
160830821|NCT01443130|580767538|FG002|Overall Study|Death of Subject's Infant|11|||
160830822|NCT01443130|580767539|FG003|Overall Study|Death of Subject's Infant|0|||
160830823|NCT01443130|580767540|FG004|Overall Study|Death of Subject's Infant|0|||
160830824|NCT01443130|580767541|FG005|Overall Study|Death of Subject's Infant|0|||
160830825|NCT00364533|580767545|FG000|Overall Study|Adverse Event|8|||
160830826|NCT00364533|580767546|FG001|Overall Study|Adverse Event|7|||
160830827|NCT00364533|580767547|FG002|Overall Study|Adverse Event|15|||
160830828|NCT00364533|580767548|FG003|Overall Study|Adverse Event|5|||
160830829|NCT00364533|580767549|FG004|Overall Study|Adverse Event|2|||
160830830|NCT00364533|580767545|FG000|Overall Study|Withdrawal by Subject|4|||
160830831|NCT00364533|580767546|FG001|Overall Study|Withdrawal by Subject|8|||
160830832|NCT00364533|580767547|FG002|Overall Study|Withdrawal by Subject|6|||
160830833|NCT00364533|580767548|FG003|Overall Study|Withdrawal by Subject|6|||
160830834|NCT00364533|580767549|FG004|Overall Study|Withdrawal by Subject|6|||
160830835|NCT00364533|580767545|FG000|Overall Study|Lack of Efficacy|22|||
160830836|NCT00364533|580767546|FG001|Overall Study|Lack of Efficacy|22|||
160830837|NCT00364533|580767547|FG002|Overall Study|Lack of Efficacy|21|||
160830838|NCT00364533|580767548|FG003|Overall Study|Lack of Efficacy|17|||
160830839|NCT00364533|580767549|FG004|Overall Study|Lack of Efficacy|42|||
160830840|NCT00364533|580767545|FG000|Overall Study|Subject discharged from hospital|4|||
160560183|NCT00891735|579774089|FG000|Overall Study|Death|8|||
160830841|NCT00364533|580767546|FG001|Overall Study|Subject discharged from hospital|1|||
160830842|NCT00364533|580767547|FG002|Overall Study|Subject discharged from hospital|2|||
160830843|NCT00364533|580767548|FG003|Overall Study|Subject discharged from hospital|3|||
160830844|NCT00364533|580767549|FG004|Overall Study|Subject discharged from hospital|1|||
160830845|NCT00364533|580767545|FG000|Overall Study|Variations in drug compliance|2|||
160830846|NCT00364533|580767546|FG001|Overall Study|Variations in drug compliance|1|||
160830847|NCT00364533|580767547|FG002|Overall Study|Variations in drug compliance|1|||
160830848|NCT00364533|580767548|FG003|Overall Study|Variations in drug compliance|0|||
160830849|NCT00364533|580767549|FG004|Overall Study|Variations in drug compliance|0|||
160830850|NCT00364533|580767545|FG000|Overall Study|Non-compliance|1|||
160830851|NCT00364533|580767546|FG001|Overall Study|Non-compliance|0|||
160830852|NCT00364533|580767547|FG002|Overall Study|Non-compliance|0|||
160830853|NCT00364533|580767548|FG003|Overall Study|Non-compliance|0|||
160830854|NCT00364533|580767549|FG004|Overall Study|Non-compliance|0|||
160830855|NCT00364533|580767545|FG000|Overall Study|Protocol Violation|1|||
160830856|NCT00364533|580767546|FG001|Overall Study|Protocol Violation|1|||
160830857|NCT00364533|580767547|FG002|Overall Study|Protocol Violation|0|||
160830858|NCT00364533|580767548|FG003|Overall Study|Protocol Violation|0|||
160830859|NCT00364533|580767549|FG004|Overall Study|Protocol Violation|0|||
160830860|NCT02758301|580767550|FG000|Overall Study|Death|12|||
160830861|NCT02758301|580767551|FG001|Overall Study|Death|0|||
160830862|NCT02758301|580767550|FG000|Overall Study|Physician Decision|10|||
160830863|NCT02758301|580767551|FG001|Overall Study|Physician Decision|1|||
160830864|NCT02758301|580767550|FG000|Overall Study|Withdrawal by Subject|5|||
160830865|NCT02758301|580767551|FG001|Overall Study|Withdrawal by Subject|6|||
160830866|NCT02758301|580767550|FG000|Overall Study|Lost to Follow-up|7|||
160830867|NCT02758301|580767551|FG001|Overall Study|Lost to Follow-up|0|||
160830868|NCT02758301|580767550|FG000|Overall Study|Protocol Violation|0|||
160830869|NCT02758301|580767551|FG001|Overall Study|Protocol Violation|1|||
160830870|NCT01167907|580767554|FG000|Overall Study|Protocol Violation|1|||
160830871|NCT01167907|580767555|FG001|Overall Study|Protocol Violation|0|||
160830872|NCT01167907|580767554|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
160830873|NCT01167907|580767555|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
160830874|NCT00815191|580767558|FG000|Overall Study|Protocol Violation|1|||
160830875|NCT00815191|580767559|FG001|Overall Study|Protocol Violation|1|||
160830876|NCT01814670|580767564|FG000|Overall Study|Protocol Violation|12|||
160830877|NCT01873729|580767565|FG000|Overall Study|Withdrawal by Subject|1|||
160830878|NCT01741532|580767566|FG000|Overall Study|Adverse Event|4|||
160830879|NCT01741532|580767567|FG001|Overall Study|Adverse Event|0|||
160830880|NCT01741532|580767566|FG000|Overall Study|Withdrawal by Subject|1|||
160830881|NCT01741532|580767567|FG001|Overall Study|Withdrawal by Subject|1|||
160830882|NCT01741532|580767566|FG000|Overall Study|Protocol Violation|0|||
160830883|NCT01741532|580767567|FG001|Overall Study|Protocol Violation|1|||
160830884|NCT01741532|580767566|FG000|Overall Study|Worsening of the disease|3|||
160830885|NCT01741532|580767567|FG001|Overall Study|Worsening of the disease|1|||
160830886|NCT01741532|580767566|FG000|Overall Study|Sponsor decision|1|||
160830887|NCT01741532|580767567|FG001|Overall Study|Sponsor decision|0|||
160830888|NCT01741532|580767566|FG000|Overall Study|Medical event|1|||
160830889|NCT01741532|580767567|FG001|Overall Study|Medical event|0|||
160830890|NCT00973102|580767568|FG000|Overall Study|Protocol Violation|1|||
160830891|NCT00973102|580767569|FG001|Overall Study|Protocol Violation|0|||
160830892|NCT00973102|580767568|FG000|Overall Study|Prisoner|0|||
160830893|NCT00973102|580767569|FG001|Overall Study|Prisoner|1|||
160830894|NCT01066780|580767570|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
160830895|NCT01066780|580767571|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
160830896|NCT00613080|580767572|FG000|Overall Study|Ineligible / no protocol treatment|11|||
160830897|NCT02360293|580767573|FG000|Overall Study|Lost to Follow-up|73|||
160830898|NCT02360293|580767574|FG001|Overall Study|Lost to Follow-up|95|||
160830899|NCT02360293|580767573|FG000|Overall Study|Withdrawal by Subject|2|||
160830900|NCT02360293|580767574|FG001|Overall Study|Withdrawal by Subject|1|||
160830901|NCT02360293|580767573|FG000|Overall Study|Excluded|1|||
160830902|NCT02360293|580767574|FG001|Overall Study|Excluded|0|||
160830903|NCT02226549|580767575|FG000|Overall Study|Randomized but Never Treated|1|||
160830904|NCT02226549|580767576|FG001|Overall Study|Randomized but Never Treated|0|||
160830905|NCT02226549|580767575|FG000|Overall Study|Lost to Follow-up|0|||
160830906|NCT02226549|580767576|FG001|Overall Study|Lost to Follow-up|1|||
160830907|NCT02012686|580767578|FG000|Overall Study|muscle contraction|0|||
160830908|NCT02012686|580767579|FG001|Overall Study|muscle contraction|1|||
160830909|NCT02012686|580767578|FG000|Overall Study|electrocardiography monitoring noise|0|||
160830910|NCT02012686|580767579|FG001|Overall Study|electrocardiography monitoring noise|1|||
160830911|NCT03099148|580767580|FG000|Wash-out|scheduling conflict|0|||
160830912|NCT03099148|580767581|FG001|Wash-out|scheduling conflict|1|||
160830913|NCT03099148|580767582|FG002|Wash-out|scheduling conflict|0|||
160830914|NCT03099148|580767583|FG003|Wash-out|scheduling conflict|0|||
160830915|NCT03099148|580767580|FG000|Wash-out|Adverse Event|0|||
160830916|NCT03099148|580767581|FG001|Wash-out|Adverse Event|1|||
160830917|NCT03099148|580767582|FG002|Wash-out|Adverse Event|0|||
160830918|NCT03099148|580767583|FG003|Wash-out|Adverse Event|0|||
160830919|NCT01703065|580767586|FG000|Overall Study|Lack of Efficacy|1|||
160830920|NCT01703065|580767587|FG001|Overall Study|Lack of Efficacy|0|||
160830921|NCT00687609|580767590|FG000|Overall Study|Physician Decision|1|||
160830922|NCT00687609|580767590|FG000|Overall Study|Withdrawal by Subject|2|||
160830923|NCT02713529|580767591|FG000|Overall Study|Withdrawal by Subject|3|||
160830924|NCT02713529|580767592|FG001|Overall Study|Withdrawal by Subject|1|||
160830925|NCT02713529|580767593|FG002|Overall Study|Withdrawal by Subject|4|||
160830926|NCT02713529|580767594|FG003|Overall Study|Withdrawal by Subject|2|||
160830927|NCT02713529|580767595|FG004|Overall Study|Withdrawal by Subject|0|||
160830928|NCT02713529|580767596|FG005|Overall Study|Withdrawal by Subject|1|||
160830929|NCT02713529|580767597|FG006|Overall Study|Withdrawal by Subject|1|||
160830930|NCT02713529|580767591|FG000|Overall Study|Lost to Follow-up|1|||
160830931|NCT02713529|580767592|FG001|Overall Study|Lost to Follow-up|0|||
160830932|NCT02713529|580767593|FG002|Overall Study|Lost to Follow-up|1|||
160830933|NCT02713529|580767594|FG003|Overall Study|Lost to Follow-up|0|||
160830934|NCT02713529|580767595|FG004|Overall Study|Lost to Follow-up|0|||
160830935|NCT02713529|580767596|FG005|Overall Study|Lost to Follow-up|0|||
160830936|NCT02713529|580767597|FG006|Overall Study|Lost to Follow-up|0|||
160830937|NCT02713529|580767591|FG000|Overall Study|Death|3|||
160830938|NCT02713529|580767592|FG001|Overall Study|Death|3|||
160830939|NCT02713529|580767593|FG002|Overall Study|Death|26|||
160830940|NCT02713529|580767594|FG003|Overall Study|Death|27|||
160830941|NCT02713529|580767595|FG004|Overall Study|Death|3|||
160830942|NCT02713529|580767596|FG005|Overall Study|Death|13|||
160830943|NCT02713529|580767597|FG006|Overall Study|Death|3|||
160830944|NCT02449018|580767603|FG000|Overall Study|Abnormal laboratory value|0|||
160830945|NCT02449018|580767604|FG001|Overall Study|Abnormal laboratory value|1|||
160830946|NCT02449018|580767603|FG000|Overall Study|Administrative problems|1|||
160830947|NCT02449018|580767604|FG001|Overall Study|Administrative problems|0|||
160830948|NCT02449018|580767603|FG000|Overall Study|Adverse Event|5|||
160830949|NCT02449018|580767604|FG001|Overall Study|Adverse Event|1|||
160830950|NCT02449018|580767603|FG000|Overall Study|Protocol deviation|4|||
160830951|NCT02449018|580767604|FG001|Overall Study|Protocol deviation|0|||
160830952|NCT02449018|580767603|FG000|Overall Study|Patient decision|2|||
160830953|NCT02449018|580767604|FG001|Overall Study|Patient decision|0|||
160830954|NCT02698371|580767612|FG000|All Participants Flow|Lost to Follow-up|3|||
160830955|NCT02698371|580767612|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
160830956|NCT02698371|580767612|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
160830957|NCT02698371|580767612|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
160830958|NCT02698371|580767612|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
160830959|NCT02698371|580767612|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
160830960|NCT02698371|580767612|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
160830961|NCT01192568|580768781|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
160830962|NCT01192568|580768782|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
160830963|NCT01192568|580768783|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
160830964|NCT01192568|580768784|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
160830965|NCT01192568|580768781|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
160830966|NCT01192568|580768782|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
160830967|NCT01192568|580768783|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
160830968|NCT01192568|580768784|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
160830969|NCT02593825|580768785|FG000|Intervention|Lost to Follow-up|10|||
160830970|NCT02593825|580768786|FG001|Intervention|Lost to Follow-up|12|||
160830971|NCT06359080|580768787|FG000|Overall Study|Withdrawal by Subject|3|||
160830972|NCT00511134|580768790|FG000|Overall Study|Withdrawal by Subject|0|||
160830973|NCT00511134|580768791|FG001|Overall Study|Withdrawal by Subject|2|||
160830974|NCT01949090|580768794|FG000|Overall Study|Serious Adverse Event|0|||
160830975|NCT01949090|580768795|FG001|Overall Study|Serious Adverse Event|1|||
160830976|NCT01949090|580768796|FG002|Overall Study|Serious Adverse Event|2|||
160830977|NCT01949090|580768797|FG003|Overall Study|Serious Adverse Event|0|||
160830978|NCT01949090|580768798|FG004|Overall Study|Serious Adverse Event|1|||
160830979|NCT01949090|580768794|FG000|Overall Study|Withdrawal by Subject|2|||
160830980|NCT01949090|580768795|FG001|Overall Study|Withdrawal by Subject|0|||
160830981|NCT01949090|580768796|FG002|Overall Study|Withdrawal by Subject|0|||
160830982|NCT01949090|580768797|FG003|Overall Study|Withdrawal by Subject|0|||
160830983|NCT01949090|580768798|FG004|Overall Study|Withdrawal by Subject|1|||
160830984|NCT01949090|580768794|FG000|Overall Study|Protocol non-compliance|0|||
160830985|NCT01949090|580768795|FG001|Overall Study|Protocol non-compliance|0|||
160830986|NCT01949090|580768796|FG002|Overall Study|Protocol non-compliance|0|||
160830987|NCT01949090|580768797|FG003|Overall Study|Protocol non-compliance|0|||
160830988|NCT01949090|580768798|FG004|Overall Study|Protocol non-compliance|1|||
160830989|NCT01949090|580768794|FG000|Overall Study|Lost to Follow-up|2|||
160830990|NCT01949090|580768795|FG001|Overall Study|Lost to Follow-up|1|||
160830991|NCT01949090|580768796|FG002|Overall Study|Lost to Follow-up|0|||
160830992|NCT01949090|580768797|FG003|Overall Study|Lost to Follow-up|1|||
160830993|NCT01949090|580768798|FG004|Overall Study|Lost to Follow-up|1|||
160830994|NCT02783170|580768799|FG000|Overall Study|Randomized but not Vaccinated|1|||
160830995|NCT02783170|580768800|FG001|Overall Study|Randomized but not Vaccinated|0|||
160830996|NCT04938037|580768801|FG000|Overall Study|Lost to Follow-up|4|||
160830997|NCT04938037|580768802|FG001|Overall Study|Lost to Follow-up|3|||
160830998|NCT01806064|580768804|FG000|Overall Study|Randomized Not Enrolled|0|||
160830999|NCT01806064|580768805|FG001|Overall Study|Randomized Not Enrolled|0|||
160831000|NCT01806064|580768806|FG002|Overall Study|Randomized Not Enrolled|0|||
160831001|NCT01806064|580768807|FG003|Overall Study|Randomized Not Enrolled|1|||
160831002|NCT01806064|580768808|FG004|Overall Study|Randomized Not Enrolled|2|||
160831003|NCT05063539|580768809|FG000|Overall Study|Adverse Event|1|||
160831004|NCT05063539|580768810|FG001|Overall Study|Adverse Event|2|||
160831005|NCT05063539|580768811|FG002|Overall Study|Adverse Event|1|||
160831006|NCT05063539|580768809|FG000|Overall Study|Death|0|||
160831007|NCT05063539|580768810|FG001|Overall Study|Death|1|||
160831008|NCT05063539|580768811|FG002|Overall Study|Death|1|||
160831009|NCT05063539|580768809|FG000|Overall Study|Lost to Follow-up|0|||
160831010|NCT05063539|580768810|FG001|Overall Study|Lost to Follow-up|1|||
160831011|NCT05063539|580768811|FG002|Overall Study|Lost to Follow-up|0|||
160831012|NCT05063539|580768809|FG000|Overall Study|Physician Decision|4|||
160831013|NCT05063539|580768810|FG001|Overall Study|Physician Decision|3|||
160831014|NCT05063539|580768811|FG002|Overall Study|Physician Decision|1|||
160831015|NCT05063539|580768809|FG000|Overall Study|Progressive Disease|0|||
160831016|NCT05063539|580768810|FG001|Overall Study|Progressive Disease|2|||
160831017|NCT05063539|580768811|FG002|Overall Study|Progressive Disease|0|||
160991172|NCT03568162|581355527|FG003|Overall Study|Physician Decision|0|||
160991173|NCT03568162|581355528|FG004|Overall Study|Physician Decision|1|||
160991174|NCT03568162|581355529|FG005|Overall Study|Physician Decision|0|||
160991175|NCT03568162|581355524|FG000|Overall Study|Pregnancy|0|||
160991176|NCT03568162|581355525|FG001|Overall Study|Pregnancy|0|||
160991177|NCT03568162|581355526|FG002|Overall Study|Pregnancy|0|||
160991178|NCT03568162|581355527|FG003|Overall Study|Pregnancy|1|||
160991179|NCT03568162|581355528|FG004|Overall Study|Pregnancy|0|||
160991180|NCT03568162|581355529|FG005|Overall Study|Pregnancy|0|||
160991181|NCT03568162|581355524|FG000|Overall Study|Protocol Violation|1|||
160991182|NCT03568162|581355525|FG001|Overall Study|Protocol Violation|0|||
160991183|NCT03568162|581355526|FG002|Overall Study|Protocol Violation|1|||
160991184|NCT03568162|581355527|FG003|Overall Study|Protocol Violation|1|||
160991185|NCT03568162|581355528|FG004|Overall Study|Protocol Violation|1|||
160991186|NCT03568162|581355529|FG005|Overall Study|Protocol Violation|1|||
160991187|NCT03568162|581355524|FG000|Overall Study|Withdrawal by Subject|15|||
160991188|NCT03568162|581355525|FG001|Overall Study|Withdrawal by Subject|15|||
160991189|NCT03568162|581355526|FG002|Overall Study|Withdrawal by Subject|26|||
160991190|NCT03568162|581355527|FG003|Overall Study|Withdrawal by Subject|22|||
160991191|NCT03568162|581355528|FG004|Overall Study|Withdrawal by Subject|6|||
160991192|NCT03568162|581355529|FG005|Overall Study|Withdrawal by Subject|9|||
160991193|NCT03568162|581355524|FG000|Overall Study|Others|3|||
160991194|NCT03568162|581355525|FG001|Overall Study|Others|4|||
160991195|NCT03568162|581355526|FG002|Overall Study|Others|1|||
160991196|NCT03568162|581355527|FG003|Overall Study|Others|4|||
160991197|NCT03568162|581355528|FG004|Overall Study|Others|2|||
160991198|NCT03568162|581355529|FG005|Overall Study|Others|1|||
160831018|NCT05063539|580768809|FG000|Overall Study|Withdrawal by Subject|17|||
160831019|NCT05063539|580768810|FG001|Overall Study|Withdrawal by Subject|26|||
160831020|NCT05063539|580768811|FG002|Overall Study|Withdrawal by Subject|14|||
160831021|NCT05063539|580768809|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
160831022|NCT05063539|580768810|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
160831023|NCT05063539|580768811|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
160831024|NCT05063539|580768809|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
160831025|NCT05063539|580768810|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
160831026|NCT05063539|580768811|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
160831027|NCT05063539|580768809|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
160831028|NCT05063539|580768810|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
160831029|NCT05063539|580768811|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
160831030|NCT05063539|580768809|FG000|Overall Study|Discontinued due to Common Close Design|0|||
160831031|NCT05063539|580768810|FG001|Overall Study|Discontinued due to Common Close Design|1|||
160831032|NCT05063539|580768811|FG002|Overall Study|Discontinued due to Common Close Design|0|||
160831033|NCT05063539|580768809|FG000|Overall Study|Participant not co-operative|0|||
160831034|NCT05063539|580768810|FG001|Overall Study|Participant not co-operative|1|||
160991199|NCT00337818|581355530|FG000|Overall Study|Lost to Follow-up|289|||
160991200|NCT00337818|581355531|FG001|Overall Study|Lost to Follow-up|91|||
160991201|NCT00337818|581355532|FG002|Overall Study|Lost to Follow-up|107|||
160831035|NCT05063539|580768811|FG002|Overall Study|Participant not co-operative|0|||
160991202|NCT00938340|581355534|FG000|Overall Study|Withdrawal by Subject|3|||
160831036|NCT05063539|580768809|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
160831037|NCT05063539|580768810|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
160831038|NCT05063539|580768811|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
160831039|NCT05063539|580768809|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
160831040|NCT05063539|580768810|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
160831041|NCT05063539|580768811|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
160831042|NCT04256512|580768812|FG000|Overall Study|Withdrawal by Subject|1|||
160831043|NCT02804750|580768816|FG000|Period 1|Adverse Event|0|||
160831044|NCT02804750|580768817|FG001|Period 1|Adverse Event|2|||
160831045|NCT02804750|580768816|FG000|Period 1|Withdrawal by Subject|0|||
160831046|NCT02804750|580768817|FG001|Period 1|Withdrawal by Subject|1|||
160831047|NCT02804750|580768816|FG000|Period 2|Adverse Event|1|||
160831048|NCT02804750|580768817|FG001|Period 2|Adverse Event|0|||
160831049|NCT02804750|580768816|FG000|Period 3|Adverse Event|0|||
160831050|NCT02804750|580768817|FG001|Period 3|Adverse Event|2|||
160831051|NCT02804750|580768816|FG000|Period 4|Adverse Event|0|||
160831052|NCT02804750|580768817|FG001|Period 4|Adverse Event|5|||
160831053|NCT04692077|580768825|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
160831054|NCT01751139|580768830|FG000|Overall Study|Other|135|||
160831055|NCT01751139|580768830|FG000|Overall Study|Sponsor study termination|1609|||
160831056|NCT01751139|580768830|FG000|Overall Study|Lost to Follow-up|240|||
160831057|NCT01751139|580768830|FG000|Overall Study|Withdrawal by Subject|251|||
160831058|NCT01751139|580768830|FG000|Overall Study|Adverse Event|1|||
160831059|NCT01751139|580768830|FG000|Overall Study|Death|31|||
160831060|NCT03199391|580768831|FG000|Overall Study|Death|1|||
160831061|NCT03199391|580768831|FG000|Overall Study|Lost to Follow-up|3|||
160831062|NCT03199391|580768831|FG000|Overall Study|Adverse Event|2|||
160831063|NCT03199391|580768831|FG000|Overall Study|Withdrawal by Subject|10|||
160831064|NCT01867086|580768832|FG000|Overall Study|Disease Progression|1|||
160831065|NCT04271475|580768837|FG000|DB Period: Day 1 up to EODBT|Death|1|||
160831066|NCT04271475|580768838|FG001|DB Period: Day 1 up to EODBT|Death|0|||
160831067|NCT04271475|580768839|FG002|DB Period: Day 1 up to EODBT|Death|0|||
160831068|NCT04271475|580768840|FG003|DB Period: Day 1 up to EODBT|Death|0|||
160831069|NCT04271475|580768837|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
160831070|NCT04271475|580768838|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
160831071|NCT04271475|580768839|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
160831072|NCT04271475|580768840|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
160831073|NCT04271475|580768837|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
160831074|NCT04271475|580768838|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
160831075|NCT04271475|580768839|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
160831076|NCT04271475|580768840|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
160831077|NCT04271475|580768837|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
160831078|NCT04271475|580768838|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
160831079|NCT04271475|580768839|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
160831080|NCT04271475|580768840|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
160831081|NCT04271475|580768837|FG000|DB Period: Day 1 up to EODBT|Other|8|||
160831082|NCT04271475|580768838|FG001|DB Period: Day 1 up to EODBT|Other|5|||
160831083|NCT04271475|580768839|FG002|DB Period: Day 1 up to EODBT|Other|0|||
160831084|NCT04271475|580768840|FG003|DB Period: Day 1 up to EODBT|Other|0|||
160831085|NCT04271475|580768837|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
160831086|NCT04271475|580768838|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
160831087|NCT04271475|580768839|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
160831088|NCT04271475|580768840|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
160831089|NCT04271475|580768837|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
160831090|NCT04271475|580768838|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
160831091|NCT04271475|580768839|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
160831092|NCT04271475|580768840|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
160831093|NCT02337634|580768841|FG000|Overall Study|Protocol Violation|3|||
160831094|NCT02337634|580768842|FG001|Overall Study|Protocol Violation|1|||
160831095|NCT02337634|580768841|FG000|Overall Study|Lost to Follow-up|1|||
160831096|NCT02337634|580768842|FG001|Overall Study|Lost to Follow-up|0|||
160831097|NCT02428205|580768846|FG000|Overall Study|Lack of Efficacy|1|||
160831098|NCT02428205|580768847|FG001|Overall Study|Lack of Efficacy|0|||
160831099|NCT02428205|580768846|FG000|Overall Study|Lost to Follow-up|1|||
160831100|NCT02428205|580768847|FG001|Overall Study|Lost to Follow-up|1|||
160831101|NCT02428205|580768846|FG000|Overall Study|Worse behavior|0|||
160831102|NCT02428205|580768847|FG001|Overall Study|Worse behavior|1|||
160831103|NCT01818284|580768848|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
160831104|NCT01818284|580768849|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
160831105|NCT01818284|580768848|FG000|Overall Study|Death|0|||
160831106|NCT01818284|580768849|FG001|Overall Study|Death|2|||
160560184|NCT00891735|579774090|FG001|Overall Study|Death|5|||
160831107|NCT02888743|580768850|FG000|Overall Study|Withdrawal by Subject|1|||
160831108|NCT02888743|580768851|FG001|Overall Study|Withdrawal by Subject|2|||
160831109|NCT02888743|580768852|FG002|Overall Study|Withdrawal by Subject|2|||
160831110|NCT02888743|580768853|FG003|Overall Study|Withdrawal by Subject|0|||
160831111|NCT02888743|580768854|FG004|Overall Study|Withdrawal by Subject|1|||
160831112|NCT02888743|580768850|FG000|Overall Study|Disease progression before treatment|2|||
160831113|NCT02888743|580768851|FG001|Overall Study|Disease progression before treatment|0|||
160831114|NCT02888743|580768852|FG002|Overall Study|Disease progression before treatment|2|||
160831115|NCT02888743|580768853|FG003|Overall Study|Disease progression before treatment|0|||
160831116|NCT02888743|580768854|FG004|Overall Study|Disease progression before treatment|0|||
160831117|NCT02888743|580768850|FG000|Overall Study|Patient ineligible|1|||
160831118|NCT02888743|580768851|FG001|Overall Study|Patient ineligible|2|||
160831119|NCT02888743|580768852|FG002|Overall Study|Patient ineligible|0|||
160831120|NCT02888743|580768853|FG003|Overall Study|Patient ineligible|0|||
160831121|NCT02888743|580768854|FG004|Overall Study|Patient ineligible|0|||
160831122|NCT00527319|580768855|FG000|Overall Study|Withdrawal by Subject|5|||
160831123|NCT00527319|580768856|FG001|Overall Study|Withdrawal by Subject|0|||
160831124|NCT00527319|580768857|FG002|Overall Study|Withdrawal by Subject|1|||
160831125|NCT00527319|580768855|FG000|Overall Study|Lost to Follow-up|1|||
160831126|NCT00527319|580768856|FG001|Overall Study|Lost to Follow-up|0|||
160831127|NCT00527319|580768857|FG002|Overall Study|Lost to Follow-up|0|||
160831128|NCT00527319|580768855|FG000|Overall Study|Death|0|||
160831129|NCT00527319|580768856|FG001|Overall Study|Death|3|||
160831130|NCT00527319|580768857|FG002|Overall Study|Death|1|||
160831131|NCT00527319|580768855|FG000|Overall Study|Intercurrent Medical Illness|0|||
160831132|NCT00527319|580768856|FG001|Overall Study|Intercurrent Medical Illness|1|||
160831133|NCT00527319|580768857|FG002|Overall Study|Intercurrent Medical Illness|3|||
160831134|NCT00527319|580768855|FG000|Overall Study|Adverse Event|0|||
160831135|NCT00527319|580768856|FG001|Overall Study|Adverse Event|0|||
160831136|NCT00527319|580768857|FG002|Overall Study|Adverse Event|1|||
160831137|NCT01299571|580768863|FG000|Overall Study|Protocol Violation|107|||
160831138|NCT02900170|580768864|FG000|Overall Study|Lost to Follow-up|8|||
160831139|NCT02635347|580768867|FG000|Overall Study|Failed screening|20|||
160831140|NCT02635347|580768868|FG001|Overall Study|Failed screening|7|||
160831141|NCT01739803|580768869|FG000|Overall Study|Lost to Follow-up|9|||
160831142|NCT01739803|580768870|FG001|Overall Study|Lost to Follow-up|6|||
160831143|NCT03759041|580768871|FG000|Overall Study|Withdrawal by Subject|4|||
160831144|NCT03759041|580768872|FG001|Overall Study|Withdrawal by Subject|10|||
160831145|NCT03759041|580768873|FG002|Overall Study|Withdrawal by Subject|10|||
160831146|NCT03759041|580768871|FG000|Overall Study|Adverse Event|1|||
160831147|NCT03759041|580768872|FG001|Overall Study|Adverse Event|3|||
160831148|NCT03759041|580768873|FG002|Overall Study|Adverse Event|4|||
160831149|NCT03759041|580768871|FG000|Overall Study|Lack of Efficacy|0|||
160831150|NCT03759041|580768872|FG001|Overall Study|Lack of Efficacy|0|||
160831151|NCT03759041|580768873|FG002|Overall Study|Lack of Efficacy|1|||
160831152|NCT03759041|580768871|FG000|Overall Study|Study Terminated by Sponsor|15|||
160831153|NCT03759041|580768872|FG001|Overall Study|Study Terminated by Sponsor|16|||
160831154|NCT03759041|580768873|FG002|Overall Study|Study Terminated by Sponsor|10|||
160831155|NCT03759041|580768871|FG000|Overall Study|Other reason for discontinuation|0|||
160831156|NCT03759041|580768872|FG001|Overall Study|Other reason for discontinuation|2|||
160831157|NCT03759041|580768873|FG002|Overall Study|Other reason for discontinuation|1|||
160831158|NCT03759041|580768871|FG000|Overall Study|Lost to Follow-up|7|||
160831159|NCT03759041|580768872|FG001|Overall Study|Lost to Follow-up|2|||
160831160|NCT03759041|580768873|FG002|Overall Study|Lost to Follow-up|2|||
160831161|NCT03759041|580768871|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
160831162|NCT03759041|580768872|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
160831163|NCT03759041|580768873|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
160831164|NCT00525824|580768875|FG000|Overall Study|Adverse Event|7|||
160831165|NCT00525824|580768876|FG001|Overall Study|Adverse Event|11|||
160831166|NCT00525824|580768877|FG002|Overall Study|Adverse Event|6|||
160831167|NCT00525824|580768878|FG003|Overall Study|Adverse Event|7|||
160831168|NCT00525824|580768875|FG000|Overall Study|Withdrawal by Subject|5|||
160831169|NCT00525824|580768876|FG001|Overall Study|Withdrawal by Subject|9|||
160831170|NCT00525824|580768877|FG002|Overall Study|Withdrawal by Subject|3|||
160831171|NCT00525824|580768878|FG003|Overall Study|Withdrawal by Subject|4|||
160831172|NCT00525824|580768875|FG000|Overall Study|Lost to Follow-up|4|||
160831173|NCT00525824|580768876|FG001|Overall Study|Lost to Follow-up|2|||
160831174|NCT00525824|580768877|FG002|Overall Study|Lost to Follow-up|4|||
160831175|NCT00525824|580768878|FG003|Overall Study|Lost to Follow-up|0|||
160831176|NCT00525824|580768875|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
160831177|NCT00525824|580768876|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
160831178|NCT00525824|580768877|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
160831179|NCT00525824|580768878|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
160831180|NCT00525824|580768875|FG000|Overall Study|Severe non-compliance|0|||
160831181|NCT00525824|580768876|FG001|Overall Study|Severe non-compliance|1|||
160831182|NCT00525824|580768877|FG002|Overall Study|Severe non-compliance|1|||
160831183|NCT00525824|580768878|FG003|Overall Study|Severe non-compliance|1|||
160831184|NCT00525824|580768875|FG000|Overall Study|Safety reasons|1|||
160831185|NCT00525824|580768876|FG001|Overall Study|Safety reasons|0|||
160831186|NCT00525824|580768877|FG002|Overall Study|Safety reasons|1|||
160831187|NCT00525824|580768878|FG003|Overall Study|Safety reasons|0|||
160831188|NCT00525824|580768875|FG000|Overall Study|Other|1|||
160831189|NCT00525824|580768876|FG001|Overall Study|Other|3|||
160831190|NCT00525824|580768877|FG002|Overall Study|Other|3|||
160831191|NCT00525824|580768878|FG003|Overall Study|Other|1|||
160831192|NCT01522404|580768879|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
160831193|NCT01522404|580768880|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
160831194|NCT01522404|580768879|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
160831195|NCT01522404|580768880|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
160831196|NCT01522404|580768879|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
160831197|NCT01522404|580768880|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
160831198|NCT00897390|580768888|FG000|Overall Study|Adverse Event|2|||
160831199|NCT00897390|580768888|FG000|Overall Study|No Longer Met Study Criteria|1|||
160831200|NCT00897390|580768888|FG000|Overall Study|Personal Reasons|1|||
160831201|NCT00897390|580768888|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
160831202|NCT03159104|580768889|FG000|Overall Study|Violation of inclusion criteria|1|||
160831203|NCT03159104|580768890|FG001|Overall Study|Violation of inclusion criteria|2|||
160831204|NCT01216683|580770174|FG000|Induction|Never started treatment|0|||
160831205|NCT01216683|580770175|FG001|Induction|Never started treatment|6|||
160831206|NCT01216683|580770176|FG002|Induction|Never started treatment|3|||
160831207|NCT01216683|580770174|FG000|Induction|Lack of Efficacy|4|||
160831208|NCT01216683|580770175|FG001|Induction|Lack of Efficacy|3|||
160831209|NCT01216683|580770176|FG002|Induction|Lack of Efficacy|7|||
160831210|NCT01216683|580770174|FG000|Induction|Adverse Event|0|||
160831211|NCT01216683|580770175|FG001|Induction|Adverse Event|5|||
160831212|NCT01216683|580770176|FG002|Induction|Adverse Event|5|||
160831213|NCT01216683|580770174|FG000|Induction|Death|0|||
160831214|NCT01216683|580770175|FG001|Induction|Death|0|||
160831215|NCT01216683|580770176|FG002|Induction|Death|2|||
160831216|NCT01216683|580770174|FG000|Induction|Withdrawal by Subject|0|||
160831217|NCT01216683|580770175|FG001|Induction|Withdrawal by Subject|4|||
160831218|NCT01216683|580770176|FG002|Induction|Withdrawal by Subject|2|||
160831219|NCT01216683|580770174|FG000|Induction|Other disease|0|||
160831220|NCT01216683|580770175|FG001|Induction|Other disease|1|||
160831221|NCT01216683|580770176|FG002|Induction|Other disease|2|||
160831222|NCT01216683|580770174|FG000|Continuation|Lack of Efficacy|3|||
160831223|NCT01216683|580770175|FG001|Continuation|Lack of Efficacy|2|||
160831224|NCT01216683|580770176|FG002|Continuation|Lack of Efficacy|7|||
160831225|NCT01216683|580770174|FG000|Continuation|Adverse Event|5|||
160831226|NCT01216683|580770175|FG001|Continuation|Adverse Event|3|||
160831227|NCT01216683|580770176|FG002|Continuation|Adverse Event|16|||
160831228|NCT01216683|580770174|FG000|Continuation|Death|1|||
160831229|NCT01216683|580770175|FG001|Continuation|Death|0|||
160831230|NCT01216683|580770176|FG002|Continuation|Death|2|||
160831231|NCT01216683|580770174|FG000|Continuation|Withdrawal by Subject|4|||
160831232|NCT01216683|580770175|FG001|Continuation|Withdrawal by Subject|5|||
160831233|NCT01216683|580770176|FG002|Continuation|Withdrawal by Subject|9|||
160831234|NCT01216683|580770174|FG000|Continuation|Other diseases|0|||
160831235|NCT01216683|580770175|FG001|Continuation|Other diseases|2|||
160831236|NCT01216683|580770176|FG002|Continuation|Other diseases|1|||
160903303|NCT00190671|581039087|FG000|Overall Study|Satisfactory Response|4|||
160903304|NCT00190671|581039088|FG001|Overall Study|Satisfactory Response|7|||
160903305|NCT00190671|581039087|FG000|Overall Study|Lack of Efficacy|19|||
160903306|NCT00190671|581039088|FG001|Overall Study|Lack of Efficacy|24|||
160560185|NCT00891735|579774091|FG002|Overall Study|Death|4|||
160831237|NCT01216683|580770174|FG000|Continuation|Physician Decision|1|||
160831238|NCT01216683|580770175|FG001|Continuation|Physician Decision|0|||
160831239|NCT01216683|580770176|FG002|Continuation|Physician Decision|1|||
160831240|NCT01216683|580770174|FG000|Continuation|Non-compliance|1|||
160831241|NCT01216683|580770175|FG001|Continuation|Non-compliance|0|||
160831242|NCT01216683|580770176|FG002|Continuation|Non-compliance|1|||
160831243|NCT01216683|580770174|FG000|Continuation|Insurance change|0|||
160831244|NCT01216683|580770175|FG001|Continuation|Insurance change|1|||
160831245|NCT01216683|580770176|FG002|Continuation|Insurance change|0|||
160903307|NCT00190671|581039087|FG000|Overall Study|Death from Study Disease|1|||
160831246|NCT01216683|580770174|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
160903308|NCT00190671|581039088|FG001|Overall Study|Death from Study Disease|1|||
160831247|NCT01216683|580770175|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
160831248|NCT01216683|580770176|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
160831249|NCT01216683|580770174|FG000|Continuation|Not reported|0|||
160831250|NCT01216683|580770175|FG001|Continuation|Not reported|0|||
160831251|NCT01216683|580770176|FG002|Continuation|Not reported|1|||
160831252|NCT01216683|580770174|FG000|Continuation|Never started treatment|0|||
160831253|NCT01216683|580770175|FG001|Continuation|Never started treatment|1|||
160560186|NCT00891735|579774092|FG003|Overall Study|Death|5|||
160560187|NCT00891735|579774089|FG000|Overall Study|Lost to Follow-up|2|||
160560188|NCT00891735|579774090|FG001|Overall Study|Lost to Follow-up|2|||
160560189|NCT00891735|579774091|FG002|Overall Study|Lost to Follow-up|2|||
160560190|NCT00891735|579774092|FG003|Overall Study|Lost to Follow-up|2|||
160560191|NCT00891735|579774089|FG000|Overall Study|Physician's decision to withdraw patient|1|||
160831254|NCT01216683|580770176|FG002|Continuation|Never started treatment|5|||
160831255|NCT05011513|580770177|FG000|Overall Study|Death|0|||
160831256|NCT05011513|580770178|FG001|Overall Study|Death|1|||
160831257|NCT05011513|580770177|FG000|Overall Study|Lost to Follow-up|4|||
160831258|NCT05011513|580770178|FG001|Overall Study|Lost to Follow-up|0|||
160831259|NCT05011513|580770177|FG000|Overall Study|Withdrawal by Subject|18|||
160831260|NCT05011513|580770178|FG001|Overall Study|Withdrawal by Subject|17|||
160831261|NCT05011513|580770177|FG000|Overall Study|Other|4|||
160831262|NCT05011513|580770178|FG001|Overall Study|Other|2|||
160831263|NCT03667690|580770179|FG000|Overall Study|Adverse Event|0|||
160831264|NCT03667690|580770180|FG001|Overall Study|Adverse Event|3|||
160831265|NCT03667690|580770179|FG000|Overall Study|Death|22|||
160831266|NCT03667690|580770180|FG001|Overall Study|Death|21|||
160831267|NCT03667690|580770179|FG000|Overall Study|Lost to Follow-up|4|||
160831268|NCT03667690|580770180|FG001|Overall Study|Lost to Follow-up|5|||
160831269|NCT03667690|580770179|FG000|Overall Study|Withdrawal by Subject|7|||
160831270|NCT03667690|580770180|FG001|Overall Study|Withdrawal by Subject|8|||
160831271|NCT03667690|580770179|FG000|Overall Study|Subject could not return for additional investigational product|1|||
160831272|NCT03667690|580770180|FG001|Overall Study|Subject could not return for additional investigational product|0|||
160831273|NCT03667690|580770179|FG000|Overall Study|Subject discharged to hospice care|2|||
160831274|NCT03667690|580770180|FG001|Overall Study|Subject discharged to hospice care|0|||
160831275|NCT03667690|580770179|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
160831276|NCT03667690|580770180|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
160831277|NCT03667690|580770179|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
160831278|NCT03667690|580770180|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
160831279|NCT03667690|580770179|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
160831280|NCT03667690|580770180|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
160831281|NCT03667690|580770179|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
160831282|NCT03667690|580770180|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
160831283|NCT03667690|580770179|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
160831284|NCT03667690|580770180|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
160831285|NCT01350115|580770189|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
160831286|NCT01350115|580770190|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
160831287|NCT01350115|580770189|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
160831288|NCT01350115|580770190|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
160831289|NCT01350115|580770189|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
160831290|NCT01350115|580770190|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
160831291|NCT04327024|580770191|FG000|Overall Study|Death|1|||
160831292|NCT04327024|580770192|FG001|Overall Study|Death|2|||
160831293|NCT04327024|580770193|FG002|Overall Study|Death|1|||
160831294|NCT04327024|580770191|FG000|Overall Study|Non-compliance with study drug|0|||
160831295|NCT04327024|580770192|FG001|Overall Study|Non-compliance with study drug|1|||
160831296|NCT04327024|580770193|FG002|Overall Study|Non-compliance with study drug|0|||
160831297|NCT04327024|580770191|FG000|Overall Study|Withdrawal by Subject|1|||
160831298|NCT04327024|580770192|FG001|Overall Study|Withdrawal by Subject|1|||
160831299|NCT04327024|580770193|FG002|Overall Study|Withdrawal by Subject|2|||
160831300|NCT00837759|580770197|FG000|Overall Study|Protocol Violation|3|||
160831301|NCT00837759|580770197|FG000|Overall Study|Lost to Follow-up|1|||
160831302|NCT01597635|580770198|FG000|Part A|Adverse Event|3|||
160831303|NCT01597635|580770199|FG001|Part A|Adverse Event|0|||
160831304|NCT01597635|580770200|FG002|Part A|Adverse Event|0|||
160831305|NCT01597635|580770198|FG000|Part B|Adverse Event|0|||
160831306|NCT01597635|580770199|FG001|Part B|Adverse Event|0|||
160831307|NCT01597635|580770200|FG002|Part B|Adverse Event|1|||
160831308|NCT01597635|580770198|FG000|Part B|Protocol Violation|0|||
160831309|NCT01597635|580770199|FG001|Part B|Protocol Violation|1|||
160831310|NCT01597635|580770200|FG002|Part B|Protocol Violation|0|||
160831311|NCT01597635|580770198|FG000|Part B|Protocol-defined stopping criteria|0|||
160831312|NCT01597635|580770199|FG001|Part B|Protocol-defined stopping criteria|4|||
160831313|NCT01597635|580770200|FG002|Part B|Protocol-defined stopping criteria|3|||
160831314|NCT01597635|580770198|FG000|Part B|Withdrawal by Subject|0|||
160831315|NCT01597635|580770199|FG001|Part B|Withdrawal by Subject|1|||
160831316|NCT01597635|580770200|FG002|Part B|Withdrawal by Subject|0|||
160831317|NCT01300351|580770207|FG000|Overall Study|Did not receive treatment|2|||
160560192|NCT00891735|579774090|FG001|Overall Study|Physician's decision to withdraw patient|0|||
160560193|NCT00891735|579774091|FG002|Overall Study|Physician's decision to withdraw patient|0|||
160647562|NCT02811861|580092760|FG000|Overall Study|Radiological Disease Progression|123|||
160831318|NCT01300351|580770208|FG001|Overall Study|Did not receive treatment|0|||
160831319|NCT01300351|580770207|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
160831320|NCT01300351|580770208|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
160831321|NCT01300351|580770207|FG000|Overall Study|Lost to Follow-up|0|||
160831322|NCT01300351|580770208|FG001|Overall Study|Lost to Follow-up|1|||
160831323|NCT01300351|580770207|FG000|Overall Study|Adverse Event|0|||
160831324|NCT01300351|580770208|FG001|Overall Study|Adverse Event|4|||
160831325|NCT01300351|580770207|FG000|Overall Study|Withdrawal by Subject|7|||
160831326|NCT01300351|580770208|FG001|Overall Study|Withdrawal by Subject|10|||
160831327|NCT05824936|580770211|FG000|Overall Study|Lost to Follow-up|1|||
160831328|NCT00673881|580770212|FG000|Overall Study|Withdrawal by Subject|1|||
160831329|NCT00096018|580770213|FG000|Overall Study|Became Ineligible (not treated)|0|||
160831330|NCT00096018|580770214|FG001|Overall Study|Became Ineligible (not treated)|3|||
160831331|NCT00096018|580770213|FG000|Overall Study|Miscellaneous (not treated)|0|||
160831332|NCT00096018|580770214|FG001|Overall Study|Miscellaneous (not treated)|2|||
160831333|NCT00096018|580770213|FG000|Overall Study|Adverse Event|0|||
160831334|NCT00096018|580770214|FG001|Overall Study|Adverse Event|5|||
160831335|NCT00096018|580770213|FG000|Overall Study|Death|0|||
160831336|NCT00096018|580770214|FG001|Overall Study|Death|1|||
160831337|NCT00096018|580770213|FG000|Overall Study|Withdrawal by Subject|0|||
160831338|NCT00096018|580770214|FG001|Overall Study|Withdrawal by Subject|2|||
160831339|NCT00096018|580770213|FG000|Overall Study|Miscellaneous|2|||
160831340|NCT00096018|580770214|FG001|Overall Study|Miscellaneous|1|||
160831341|NCT00483041|580770215|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
160831342|NCT00483041|580770216|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
160831343|NCT03968159|580770217|FG000|Overall Study|Adverse Event|4|||
160831344|NCT03968159|580770218|FG001|Overall Study|Adverse Event|4|||
160831345|NCT03968159|580770217|FG000|Overall Study|Lost to Follow-up|1|||
160831346|NCT03968159|580770218|FG001|Overall Study|Lost to Follow-up|1|||
160831347|NCT03968159|580770217|FG000|Overall Study|Use of prohibited medication|0|||
160831348|NCT03968159|580770218|FG001|Overall Study|Use of prohibited medication|1|||
160831349|NCT03968159|580770217|FG000|Overall Study|Protocol Violation|2|||
160831350|NCT03968159|580770218|FG001|Overall Study|Protocol Violation|2|||
160831351|NCT03968159|580770217|FG000|Overall Study|Withdrawal by Subject|4|||
160831352|NCT03968159|580770218|FG001|Overall Study|Withdrawal by Subject|6|||
160831353|NCT03968159|580770217|FG000|Overall Study|Lack of Efficacy|0|||
160831354|NCT03968159|580770218|FG001|Overall Study|Lack of Efficacy|1|||
160831355|NCT03968159|580770217|FG000|Overall Study|Not further specified|2|||
160831356|NCT03968159|580770218|FG001|Overall Study|Not further specified|0|||
160831357|NCT00864851|580770219|FG000|Overall Study|Withdrawal by Subject|0|||
160831358|NCT00864851|580770220|FG001|Overall Study|Withdrawal by Subject|1|||
160831359|NCT00864851|580770221|FG002|Overall Study|Withdrawal by Subject|0|||
160831360|NCT00864851|580770219|FG000|Overall Study|Physician Decision|1|||
160831361|NCT00864851|580770220|FG001|Overall Study|Physician Decision|0|||
160831362|NCT00864851|580770221|FG002|Overall Study|Physician Decision|0|||
160831363|NCT00864851|580770219|FG000|Overall Study|Death|1|||
160831364|NCT00864851|580770220|FG001|Overall Study|Death|0|||
160831365|NCT00864851|580770221|FG002|Overall Study|Death|0|||
160831366|NCT00864851|580770219|FG000|Overall Study|Patient uncooperative|1|||
160831367|NCT00864851|580770220|FG001|Overall Study|Patient uncooperative|0|||
160831368|NCT00864851|580770221|FG002|Overall Study|Patient uncooperative|0|||
160831369|NCT00443781|580770222|FG000|Overall Study|Lost to Follow-up|10|||
160831370|NCT00443781|580770222|FG000|Overall Study|Physician Decision|2|||
160831371|NCT00443781|580770222|FG000|Overall Study|Protocol Violation|1|||
160647563|NCT02811861|580092761|FG001|Overall Study|Radiological Disease Progression|97|||
160831372|NCT00443781|580770222|FG000|Overall Study|Withdrawal by Subject|6|||
160831373|NCT00443781|580770222|FG000|Overall Study|Unable to comply with study follow up|2|||
160647564|NCT02811861|580092762|FG002|Overall Study|Radiological Disease Progression|174|||
160647565|NCT02811861|580092760|FG000|Overall Study|Clinical Disease Progression|20|||
160831374|NCT00443781|580770222|FG000|Overall Study|Investigator terminated participation|1|||
160831375|NCT00443781|580770222|FG000|Overall Study|Insurance not covered|2|||
160831376|NCT00443781|580770222|FG000|Overall Study|PD/FAD not done|1|||
160647566|NCT02811861|580092761|FG001|Overall Study|Clinical Disease Progression|19|||
160831377|NCT00430937|580770223|FG000|Overall Study|Adverse Event|3|||
160831378|NCT00430937|580770224|FG001|Overall Study|Adverse Event|8|||
160831379|NCT00430937|580770223|FG000|Overall Study|Death|0|||
160647567|NCT02811861|580092762|FG002|Overall Study|Clinical Disease Progression|22|||
160831380|NCT00430937|580770224|FG001|Overall Study|Death|1|||
160831381|NCT00430937|580770223|FG000|Overall Study|Lost to Follow-up|6|||
160831382|NCT00430937|580770224|FG001|Overall Study|Lost to Follow-up|6|||
160903309|NCT00190671|581039087|FG000|Overall Study|Adverse Event|3|||
160903310|NCT00190671|581039088|FG001|Overall Study|Adverse Event|2|||
160647568|NCT02811861|580092760|FG000|Overall Study|Adverse Event|63|||
160831383|NCT00430937|580770223|FG000|Overall Study|Withdrawal by Subject|5|||
160831384|NCT00430937|580770224|FG001|Overall Study|Withdrawal by Subject|2|||
160831385|NCT00430937|580770223|FG000|Overall Study|Protocol Violation|3|||
160831386|NCT00430937|580770224|FG001|Overall Study|Protocol Violation|2|||
160831387|NCT00430937|580770223|FG000|Overall Study|Lack of Efficacy|6|||
160831388|NCT00430937|580770224|FG001|Overall Study|Lack of Efficacy|5|||
160831389|NCT00430937|580770223|FG000|Overall Study|Inappropriate enrollment|2|||
160831390|NCT00430937|580770224|FG001|Overall Study|Inappropriate enrollment|1|||
160831391|NCT00430937|580770223|FG000|Overall Study|Administrative reasons|1|||
160831392|NCT00430937|580770224|FG001|Overall Study|Administrative reasons|0|||
160831393|NCT00430937|580770223|FG000|Overall Study|Protocol discontinuation criteria met|1|||
160831394|NCT00430937|580770224|FG001|Overall Study|Protocol discontinuation criteria met|2|||
160831395|NCT00430937|580770223|FG000|Overall Study|Unable to classify|0|||
160831396|NCT00430937|580770224|FG001|Overall Study|Unable to classify|1|||
160831397|NCT01533922|580770225|FG000|Overall Study|Adverse Event|5|||
160831398|NCT01533922|580770226|FG001|Overall Study|Adverse Event|8|||
160831399|NCT01533922|580770227|FG002|Overall Study|Adverse Event|6|||
160831400|NCT01533922|580770228|FG003|Overall Study|Adverse Event|3|||
160831401|NCT01533922|580770229|FG004|Overall Study|Adverse Event|4|||
160831402|NCT01533922|580770225|FG000|Overall Study|Lack of Efficacy|0|||
160831403|NCT01533922|580770226|FG001|Overall Study|Lack of Efficacy|0|||
160831404|NCT01533922|580770227|FG002|Overall Study|Lack of Efficacy|1|||
160831405|NCT01533922|580770228|FG003|Overall Study|Lack of Efficacy|0|||
160831406|NCT01533922|580770229|FG004|Overall Study|Lack of Efficacy|0|||
160831407|NCT01533922|580770225|FG000|Overall Study|Protocol Violation|0|||
160831408|NCT01533922|580770226|FG001|Overall Study|Protocol Violation|3|||
160831409|NCT01533922|580770227|FG002|Overall Study|Protocol Violation|0|||
160831410|NCT01533922|580770228|FG003|Overall Study|Protocol Violation|0|||
160831411|NCT01533922|580770229|FG004|Overall Study|Protocol Violation|1|||
160831412|NCT01533922|580770225|FG000|Overall Study|Withdrawal by Subject|3|||
160831413|NCT01533922|580770226|FG001|Overall Study|Withdrawal by Subject|1|||
160831414|NCT01533922|580770227|FG002|Overall Study|Withdrawal by Subject|2|||
160831415|NCT01533922|580770228|FG003|Overall Study|Withdrawal by Subject|2|||
160831416|NCT01533922|580770229|FG004|Overall Study|Withdrawal by Subject|1|||
160831417|NCT01533922|580770225|FG000|Overall Study|Other reason not defined above|2|||
160831418|NCT01533922|580770226|FG001|Overall Study|Other reason not defined above|0|||
160831419|NCT01533922|580770227|FG002|Overall Study|Other reason not defined above|1|||
160831420|NCT01533922|580770228|FG003|Overall Study|Other reason not defined above|0|||
160831421|NCT01533922|580770229|FG004|Overall Study|Other reason not defined above|0|||
160831422|NCT01267175|580770235|FG000|Overall Study|Withdrawal by Subject|1|||
160831423|NCT01267175|580770235|FG000|Overall Study|Lost to Follow-up|1|||
160831424|NCT00895661|580770237|FG000|Overall Study|Death|1|||
160831425|NCT00895661|580770237|FG000|Overall Study|reason unknown|2|||
160831426|NCT02006069|580770238|FG000|Overall Study|MPP other programming|239|||
160831427|NCT02006069|580770239|FG001|Overall Study|MPP other programming|0|||
160831428|NCT02006069|580770238|FG000|Overall Study|RV only pacing|0|||
160831429|NCT02006069|580770239|FG001|Overall Study|RV only pacing|3|||
160831430|NCT02989805|580770242|FG000|Overall Study|invalid consent|6|||
160831431|NCT02989805|580770243|FG001|Overall Study|invalid consent|4|||
160831432|NCT00286221|580770244|FG000|Overall Study|Protocol Violation|2|||
160831433|NCT00286221|580770245|FG001|Overall Study|Protocol Violation|1|||
160831434|NCT00286221|580770246|FG002|Overall Study|Protocol Violation|6|||
160831435|NCT00286221|580770247|FG003|Overall Study|Protocol Violation|4|||
160831436|NCT00286221|580770244|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
160831437|NCT00286221|580770245|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
160831438|NCT00286221|580770246|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
160831439|NCT00286221|580770247|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
160831440|NCT00286221|580770244|FG000|Overall Study|Inability to trigger PCA|2|||
160831441|NCT00286221|580770245|FG001|Overall Study|Inability to trigger PCA|0|||
160831442|NCT00286221|580770246|FG002|Overall Study|Inability to trigger PCA|0|||
160831443|NCT00286221|580770247|FG003|Overall Study|Inability to trigger PCA|0|||
160831444|NCT00286221|580770244|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
160831445|NCT00286221|580770245|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
160831446|NCT00286221|580770246|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
160831447|NCT00286221|580770247|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
160831448|NCT02771626|580770250|FG000|Overall Study|Adverse Event|1|||
160903311|NCT00190671|581039087|FG000|Overall Study|Clinical Relapse|0|||
160831449|NCT02771626|580770251|FG001|Overall Study|Adverse Event|5|||
160831450|NCT02771626|580770252|FG002|Overall Study|Adverse Event|3|||
160831451|NCT02771626|580770253|FG003|Overall Study|Adverse Event|0|||
160831452|NCT02771626|580770254|FG004|Overall Study|Adverse Event|1|||
160831453|NCT02771626|580770255|FG005|Overall Study|Adverse Event|1|||
160831454|NCT02771626|580770250|FG000|Overall Study|Radiologic Disease Progression|6|||
160831455|NCT02771626|580770251|FG001|Overall Study|Radiologic Disease Progression|13|||
160831456|NCT02771626|580770252|FG002|Overall Study|Radiologic Disease Progression|10|||
160831457|NCT02771626|580770253|FG003|Overall Study|Radiologic Disease Progression|7|||
160831458|NCT02771626|580770254|FG004|Overall Study|Radiologic Disease Progression|28|||
160831459|NCT02771626|580770255|FG005|Overall Study|Radiologic Disease Progression|15|||
160831460|NCT02771626|580770250|FG000|Overall Study|Symptomatic Deterioration|0|||
160831461|NCT02771626|580770251|FG001|Overall Study|Symptomatic Deterioration|4|||
160831462|NCT02771626|580770252|FG002|Overall Study|Symptomatic Deterioration|2|||
160831463|NCT02771626|580770253|FG003|Overall Study|Symptomatic Deterioration|0|||
160831464|NCT02771626|580770254|FG004|Overall Study|Symptomatic Deterioration|5|||
160831465|NCT02771626|580770255|FG005|Overall Study|Symptomatic Deterioration|2|||
160831466|NCT02771626|580770250|FG000|Overall Study|Participant Request|0|||
160831467|NCT02771626|580770251|FG001|Overall Study|Participant Request|1|||
160831468|NCT02771626|580770252|FG002|Overall Study|Participant Request|0|||
160831469|NCT02771626|580770253|FG003|Overall Study|Participant Request|2|||
160831470|NCT02771626|580770254|FG004|Overall Study|Participant Request|0|||
160831471|NCT02771626|580770255|FG005|Overall Study|Participant Request|1|||
160831472|NCT02771626|580770250|FG000|Overall Study|Investigator Decision|0|||
160831473|NCT02771626|580770251|FG001|Overall Study|Investigator Decision|1|||
160831474|NCT02771626|580770252|FG002|Overall Study|Investigator Decision|0|||
160831475|NCT02771626|580770253|FG003|Overall Study|Investigator Decision|0|||
160831476|NCT02771626|580770254|FG004|Overall Study|Investigator Decision|1|||
160831477|NCT02771626|580770255|FG005|Overall Study|Investigator Decision|0|||
160831478|NCT02771626|580770250|FG000|Overall Study|Study Termination by Sponsor|0|||
160831479|NCT02771626|580770251|FG001|Overall Study|Study Termination by Sponsor|2|||
160831480|NCT02771626|580770252|FG002|Overall Study|Study Termination by Sponsor|1|||
160831481|NCT02771626|580770253|FG003|Overall Study|Study Termination by Sponsor|0|||
160831482|NCT02771626|580770254|FG004|Overall Study|Study Termination by Sponsor|1|||
160831483|NCT02771626|580770255|FG005|Overall Study|Study Termination by Sponsor|0|||
160831484|NCT02771626|580770250|FG000|Overall Study|Informed Consent Withdrawn|0|||
160831485|NCT02771626|580770251|FG001|Overall Study|Informed Consent Withdrawn|0|||
160831486|NCT02771626|580770252|FG002|Overall Study|Informed Consent Withdrawn|1|||
160831487|NCT02771626|580770253|FG003|Overall Study|Informed Consent Withdrawn|0|||
160831488|NCT02771626|580770254|FG004|Overall Study|Informed Consent Withdrawn|1|||
160831489|NCT02771626|580770255|FG005|Overall Study|Informed Consent Withdrawn|1|||
160831490|NCT02771626|580770250|FG000|Overall Study|Other, Not Specified|1|||
160831491|NCT02771626|580770251|FG001|Overall Study|Other, Not Specified|0|||
160831492|NCT02771626|580770252|FG002|Overall Study|Other, Not Specified|0|||
160831493|NCT02771626|580770253|FG003|Overall Study|Other, Not Specified|0|||
160831494|NCT02771626|580770254|FG004|Overall Study|Other, Not Specified|0|||
160831495|NCT02771626|580770255|FG005|Overall Study|Other, Not Specified|1|||
160831496|NCT02553538|580770258|FG000|Overall Study|Could Not Reach by Telephone|133|||
160831497|NCT02553538|580770259|FG001|Overall Study|Could Not Reach by Telephone|0|||
160831498|NCT02553538|580770258|FG000|Overall Study|Died or Left Network|54|||
160831499|NCT02553538|580770259|FG001|Overall Study|Died or Left Network|56|||
160831500|NCT02648217|580770260|FG000|Overall Study|Adverse Event|0|||
160831501|NCT02648217|580770261|FG001|Overall Study|Adverse Event|1|||
160831502|NCT02648217|580770260|FG000|Overall Study|Lost to Follow-up|1|||
160831503|NCT02648217|580770261|FG001|Overall Study|Lost to Follow-up|1|||
160831504|NCT02648217|580770260|FG000|Overall Study|Withdrawal by Subject|4|||
160831505|NCT02648217|580770261|FG001|Overall Study|Withdrawal by Subject|3|||
160831506|NCT02648217|580770260|FG000|Overall Study|Unclassified|5|||
160831507|NCT02648217|580770261|FG001|Overall Study|Unclassified|0|||
160831508|NCT04094584|580770262|FG000|Overall Study|No interest in study|88|||
160831509|NCT04094584|580770262|FG000|Overall Study|Unwilling to undergo screening tests|36|||
160831510|NCT04094584|580770262|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
160831511|NCT04094584|580770262|FG000|Overall Study|Opioid use|7|||
160831512|NCT04094584|580770262|FG000|Overall Study|Need for major surgery in study period|4|||
160831513|NCT04094584|580770262|FG000|Overall Study|eligible but declined enrollment|4|||
160831514|NCT04094584|580770262|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
160831515|NCT04094584|580770262|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
160831516|NCT04094584|580770262|FG000|Overall Study|Lost to Follow-up|3|||
160831517|NCT04094584|580770262|FG000|Overall Study|Withdrawal by Subject|2|||
160831518|NCT02690649|580770263|FG000|Overall Study|Withdrawal by Subject|1|||
160831519|NCT02690649|580770264|FG001|Overall Study|Withdrawal by Subject|1|||
160831520|NCT02690649|580770263|FG000|Overall Study|Protocol Violation|0|||
160831521|NCT02690649|580770264|FG001|Overall Study|Protocol Violation|3|||
160831522|NCT02276547|580770265|FG000|Overall Study|Death|2|||
160831523|NCT02276547|580770265|FG000|Overall Study|Explant|2|||
160831524|NCT02066129|580770266|FG000|Overall Study|Lost to Follow-up|13|||
160831525|NCT02066129|580770267|FG001|Overall Study|Lost to Follow-up|12|||
160831526|NCT02066129|580770266|FG000|Overall Study|Withdrawal by Subject|7|||
160831527|NCT02066129|580770267|FG001|Overall Study|Withdrawal by Subject|10|||
160831528|NCT02066129|580770266|FG000|Overall Study|Lack of Efficacy|8|||
160831529|NCT02066129|580770267|FG001|Overall Study|Lack of Efficacy|10|||
160831530|NCT02066129|580770266|FG000|Overall Study|Physician Decision|1|||
160831531|NCT02066129|580770267|FG001|Overall Study|Physician Decision|1|||
160831532|NCT02776033|580770269|FG000|Overall Study|Withdrawal by Subject|0|||
160831533|NCT02776033|580770270|FG001|Overall Study|Withdrawal by Subject|0|||
160831534|NCT02776033|580770271|FG002|Overall Study|Withdrawal by Subject|2|||
160831535|NCT02776033|580770269|FG000|Overall Study|Physician Decision|2|||
160831536|NCT02776033|580770270|FG001|Overall Study|Physician Decision|0|||
160831537|NCT02776033|580770271|FG002|Overall Study|Physician Decision|0|||
160831538|NCT02776033|580770269|FG000|Overall Study|Lost to Follow-up|1|||
160831539|NCT02776033|580770270|FG001|Overall Study|Lost to Follow-up|0|||
160831540|NCT02776033|580770271|FG002|Overall Study|Lost to Follow-up|0|||
160831541|NCT02776033|580770269|FG000|Overall Study|Adverse Event|1|||
160831542|NCT02776033|580770270|FG001|Overall Study|Adverse Event|2|||
160831543|NCT02776033|580770271|FG002|Overall Study|Adverse Event|0|||
160831544|NCT00685373|580770275|FG000|Overall Study|Adverse Event|3|||
160831545|NCT00685373|580770275|FG000|Overall Study|Withdrawal by Subject|5|||
160831546|NCT00685373|580770275|FG000|Overall Study|Lack of Efficacy|3|||
160831547|NCT00685373|580770275|FG000|Overall Study|Condition no longer requires study drug|1|||
160831548|NCT00685373|580770275|FG000|Overall Study|Lost to Follow-up|2|||
160831549|NCT00685373|580770275|FG000|Overall Study|Protocol Violation|1|||
160831550|NCT02639338|580770278|FG000|Overall Study|Lost to Follow-up|2|||
160831551|NCT02639338|580770279|FG001|Overall Study|Lost to Follow-up|2|||
160831552|NCT02639338|580770278|FG000|Overall Study|Withdrew Consent|1|||
160831553|NCT02639338|580770279|FG001|Overall Study|Withdrew Consent|2|||
160831554|NCT02639338|580770278|FG000|Overall Study|Death|1|||
160831555|NCT02639338|580770279|FG001|Overall Study|Death|0|||
160831556|NCT02639338|580770278|FG000|Overall Study|Randomized but Not Treated|0|||
160831557|NCT02639338|580770279|FG001|Overall Study|Randomized but Not Treated|1|||
160831558|NCT00160199|580770283|FG000|Overall Study|Adverse Event|5|||
160831559|NCT00160199|580770284|FG001|Overall Study|Adverse Event|14|||
160831560|NCT00160199|580770283|FG000|Overall Study|Lack of Efficacy|0|||
160831561|NCT00160199|580770284|FG001|Overall Study|Lack of Efficacy|1|||
160831562|NCT00160199|580770283|FG000|Overall Study|Lost to Follow-up|7|||
160831563|NCT00160199|580770284|FG001|Overall Study|Lost to Follow-up|7|||
160831564|NCT00160199|580770283|FG000|Overall Study|Withdrawal by Subject|4|||
160831565|NCT00160199|580770284|FG001|Overall Study|Withdrawal by Subject|6|||
160831566|NCT00160199|580770283|FG000|Overall Study|Administrative|0|||
160831567|NCT00160199|580770284|FG001|Overall Study|Administrative|1|||
160831568|NCT00160199|580770283|FG000|Overall Study|Protocol Violation|8|||
160831569|NCT00160199|580770284|FG001|Overall Study|Protocol Violation|8|||
160831570|NCT02124772|580770285|FG000|Overall Study|Lack of Efficacy|2|||
160831571|NCT02124772|580770286|FG001|Overall Study|Lack of Efficacy|0|||
160831572|NCT02124772|580770287|FG002|Overall Study|Lack of Efficacy|0|||
160831573|NCT02124772|580770288|FG003|Overall Study|Lack of Efficacy|1|||
160831574|NCT02124772|580770289|FG004|Overall Study|Lack of Efficacy|2|||
160831575|NCT02124772|580770290|FG005|Overall Study|Lack of Efficacy|3|||
160831576|NCT02124772|580770291|FG006|Overall Study|Lack of Efficacy|0|||
160831577|NCT02124772|580770292|FG007|Overall Study|Lack of Efficacy|2|||
160831578|NCT02124772|580770293|FG008|Overall Study|Lack of Efficacy|0|||
160831579|NCT02124772|580770294|FG009|Overall Study|Lack of Efficacy|1|||
160831580|NCT02124772|580770295|FG010|Overall Study|Lack of Efficacy|0|||
160831581|NCT02124772|580770296|FG011|Overall Study|Lack of Efficacy|0|||
160831582|NCT02124772|580770297|FG012|Overall Study|Lack of Efficacy|1|||
160831583|NCT02124772|580770285|FG000|Overall Study|Adverse Event|1|||
160831584|NCT02124772|580770286|FG001|Overall Study|Adverse Event|4|||
160831585|NCT02124772|580770287|FG002|Overall Study|Adverse Event|1|||
160831586|NCT02124772|580770288|FG003|Overall Study|Adverse Event|5|||
160831587|NCT02124772|580770289|FG004|Overall Study|Adverse Event|2|||
160831588|NCT02124772|580770290|FG005|Overall Study|Adverse Event|1|||
160831589|NCT02124772|580770291|FG006|Overall Study|Adverse Event|1|||
160831590|NCT02124772|580770292|FG007|Overall Study|Adverse Event|5|||
160831591|NCT02124772|580770293|FG008|Overall Study|Adverse Event|0|||
160831592|NCT02124772|580770294|FG009|Overall Study|Adverse Event|3|||
160831593|NCT02124772|580770295|FG010|Overall Study|Adverse Event|1|||
160831594|NCT02124772|580770296|FG011|Overall Study|Adverse Event|3|||
160831595|NCT02124772|580770297|FG012|Overall Study|Adverse Event|1|||
160831596|NCT02124772|580770285|FG000|Overall Study|Withdrawal consent|0|||
160831597|NCT02124772|580770286|FG001|Overall Study|Withdrawal consent|1|||
160831598|NCT02124772|580770287|FG002|Overall Study|Withdrawal consent|1|||
160831599|NCT02124772|580770288|FG003|Overall Study|Withdrawal consent|1|||
160831600|NCT02124772|580770289|FG004|Overall Study|Withdrawal consent|0|||
160831601|NCT02124772|580770290|FG005|Overall Study|Withdrawal consent|1|||
160831602|NCT02124772|580770291|FG006|Overall Study|Withdrawal consent|1|||
160831603|NCT02124772|580770292|FG007|Overall Study|Withdrawal consent|0|||
160831604|NCT02124772|580770293|FG008|Overall Study|Withdrawal consent|0|||
160831605|NCT02124772|580770294|FG009|Overall Study|Withdrawal consent|1|||
160831606|NCT02124772|580770295|FG010|Overall Study|Withdrawal consent|0|||
160831607|NCT02124772|580770296|FG011|Overall Study|Withdrawal consent|1|||
160831608|NCT02124772|580770297|FG012|Overall Study|Withdrawal consent|0|||
160831609|NCT02124772|580770285|FG000|Overall Study|Investigator discretion|0|||
160831610|NCT02124772|580770286|FG001|Overall Study|Investigator discretion|2|||
160831611|NCT02124772|580770287|FG002|Overall Study|Investigator discretion|2|||
160831612|NCT02124772|580770288|FG003|Overall Study|Investigator discretion|1|||
160831613|NCT02124772|580770289|FG004|Overall Study|Investigator discretion|1|||
160831614|NCT02124772|580770290|FG005|Overall Study|Investigator discretion|0|||
160831615|NCT02124772|580770291|FG006|Overall Study|Investigator discretion|1|||
160831616|NCT02124772|580770292|FG007|Overall Study|Investigator discretion|0|||
160831617|NCT02124772|580770293|FG008|Overall Study|Investigator discretion|0|||
160831618|NCT02124772|580770294|FG009|Overall Study|Investigator discretion|1|||
160831619|NCT02124772|580770295|FG010|Overall Study|Investigator discretion|0|||
160831620|NCT02124772|580770296|FG011|Overall Study|Investigator discretion|1|||
160831621|NCT02124772|580770297|FG012|Overall Study|Investigator discretion|0|||
160831622|NCT02124772|580770285|FG000|Overall Study|Progressive disease|0|||
160831623|NCT02124772|580770286|FG001|Overall Study|Progressive disease|0|||
160831624|NCT02124772|580770287|FG002|Overall Study|Progressive disease|0|||
160831625|NCT02124772|580770288|FG003|Overall Study|Progressive disease|0|||
160831626|NCT02124772|580770289|FG004|Overall Study|Progressive disease|0|||
160831627|NCT02124772|580770290|FG005|Overall Study|Progressive disease|0|||
160831628|NCT02124772|580770291|FG006|Overall Study|Progressive disease|1|||
160831629|NCT02124772|580770292|FG007|Overall Study|Progressive disease|1|||
160831630|NCT02124772|580770293|FG008|Overall Study|Progressive disease|0|||
160831631|NCT02124772|580770294|FG009|Overall Study|Progressive disease|0|||
160831632|NCT02124772|580770295|FG010|Overall Study|Progressive disease|0|||
160831633|NCT02124772|580770296|FG011|Overall Study|Progressive disease|0|||
160831634|NCT02124772|580770297|FG012|Overall Study|Progressive disease|0|||
160831635|NCT02124772|580770285|FG000|Overall Study|Other|0|||
160831636|NCT02124772|580770286|FG001|Overall Study|Other|7|||
160831637|NCT02124772|580770287|FG002|Overall Study|Other|2|||
160831638|NCT02124772|580770288|FG003|Overall Study|Other|5|||
160831639|NCT02124772|580770289|FG004|Overall Study|Other|4|||
160831640|NCT02124772|580770290|FG005|Overall Study|Other|3|||
160831641|NCT02124772|580770291|FG006|Overall Study|Other|4|||
160831642|NCT02124772|580770292|FG007|Overall Study|Other|1|||
160831643|NCT02124772|580770293|FG008|Overall Study|Other|1|||
160831644|NCT02124772|580770294|FG009|Overall Study|Other|1|||
160831645|NCT02124772|580770295|FG010|Overall Study|Other|1|||
160831646|NCT02124772|580770296|FG011|Overall Study|Other|1|||
160831647|NCT02124772|580770297|FG012|Overall Study|Other|0|||
160831648|NCT01827332|580770298|FG000|Overall Study|Lost to Follow-up|2|||
160831649|NCT01827332|580770299|FG001|Overall Study|Lost to Follow-up|1|||
160831650|NCT02725593|580770300|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
160831651|NCT02725593|580770301|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
160831652|NCT02725593|580770300|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
160831653|NCT02725593|580770301|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
160831654|NCT02725593|580770300|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
160831655|NCT02725593|580770301|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
160831656|NCT02725593|580770300|FG000|Long Term Extension|Withdrawal by Subject|1|||
160831657|NCT02725593|580770301|FG001|Long Term Extension|Withdrawal by Subject|3|||
160831658|NCT01440881|580770306|FG000|Overall Study|Death|0|||
160831659|NCT01440881|580770307|FG001|Overall Study|Death|1|||
160831660|NCT02644356|580770309|FG000|Overall Study|Withdrawal by Subject|2|||
160831661|NCT02290938|580770310|FG000|Overall Study|Lost to Follow-up|14|||
160831662|NCT02290938|580770311|FG001|Overall Study|Lost to Follow-up|43|||
160831663|NCT03779503|580771930|FG000|First Intervention|Adverse Event|0|||
160831664|NCT03779503|580771931|FG001|First Intervention|Adverse Event|1|||
160831665|NCT03779503|580771930|FG000|First Intervention|Withdrawal by Subject|1|||
160831666|NCT03779503|580771931|FG001|First Intervention|Withdrawal by Subject|0|||
160831667|NCT02616393|580771932|FG000|Overall Study|Death|5|||
160831668|NCT02616393|580771933|FG001|Overall Study|Death|12|||
160831669|NCT02616393|580771934|FG002|Overall Study|Death|1|||
160831670|NCT02616393|580771932|FG000|Overall Study|Termination by Sponsor|4|||
160991203|NCT00938340|581355534|FG000|Overall Study|Protocol Violation|1|||
160560194|NCT00891735|579774092|FG003|Overall Study|Physician's decision to withdraw patient|0|||
160560195|NCT00891735|579774089|FG000|Overall Study|Patient's decision to withdraw|4|||
160560196|NCT00891735|579774090|FG001|Overall Study|Patient's decision to withdraw|9|||
160560197|NCT00891735|579774091|FG002|Overall Study|Patient's decision to withdraw|4|||
160560198|NCT00891735|579774092|FG003|Overall Study|Patient's decision to withdraw|8|||
160560199|NCT01355289|579774095|FG000|Core Study|Adverse Event, Non-Fatal|1|||
160560200|NCT01355289|579774096|FG001|Core Study|Adverse Event, Non-Fatal|0|||
160831671|NCT02616393|580771933|FG001|Overall Study|Termination by Sponsor|5|||
160831672|NCT02616393|580771934|FG002|Overall Study|Termination by Sponsor|2|||
160831673|NCT02616393|580771932|FG000|Overall Study|Other|3|||
160560201|NCT01355289|579774097|FG002|Core Study|Adverse Event, Non-Fatal|0|||
160831674|NCT02616393|580771933|FG001|Overall Study|Other|0|||
160831675|NCT02616393|580771934|FG002|Overall Study|Other|0|||
160831676|NCT02616393|580771932|FG000|Overall Study|Withdrawal by Subject|1|||
160831677|NCT02616393|580771933|FG001|Overall Study|Withdrawal by Subject|1|||
160831678|NCT02616393|580771934|FG002|Overall Study|Withdrawal by Subject|0|||
160831679|NCT02616393|580771932|FG000|Overall Study|Lost to Follow-up|0|||
160831680|NCT02616393|580771933|FG001|Overall Study|Lost to Follow-up|2|||
160831681|NCT02616393|580771934|FG002|Overall Study|Lost to Follow-up|0|||
160831682|NCT02642965|580771935|FG000|Overall Study|Lack of Efficacy|4|||
160831683|NCT02642965|580771935|FG000|Overall Study|Physician Decision|9|||
160831684|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
160831685|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
160831686|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
160831687|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
160831688|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
160831689|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
160831690|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
160831691|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
160831692|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
160831693|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
160831694|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
160831695|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
160831696|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
160831697|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
160831698|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
160831699|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
160831700|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
160831701|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
160831702|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
160831703|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
160831704|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
160831705|NCT01302054|580771942|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
160831706|NCT01302054|580771943|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
160831707|NCT01302054|580771944|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
160831708|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
160831709|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
160831710|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
160831711|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160831712|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
160831713|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
160831714|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
160831715|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
160831716|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
160831717|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
160831718|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
160831719|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
160831720|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
160831721|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
160831722|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
160831723|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
160831724|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
160831725|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
160831726|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Other|0|||
160831727|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Other|4|||
160831728|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Other|9|||
160831729|NCT02713867|580771945|FG000|Randomization|Other Reason|2|||
160831730|NCT02713867|580771946|FG001|Randomization|Other Reason|1|||
160831731|NCT02713867|580771945|FG000|Randomization|Participant Withdrew consent|0|||
160831732|NCT02713867|580771946|FG001|Randomization|Participant Withdrew consent|2|||
160831733|NCT02713867|580771945|FG000|Treatment Period|Other Reasons|22|||
160831734|NCT02713867|580771946|FG001|Treatment Period|Other Reasons|28|||
160831735|NCT02713867|580771945|FG000|Treatment Period|Administrative reason by sponsor|21|||
160831736|NCT02713867|580771946|FG001|Treatment Period|Administrative reason by sponsor|16|||
160831737|NCT02713867|580771945|FG000|Treatment Period|No longer meets study criteria|2|||
160831738|NCT02713867|580771946|FG001|Treatment Period|No longer meets study criteria|1|||
160831739|NCT02713867|580771945|FG000|Treatment Period|Poor/Non Compliance|1|||
160831740|NCT02713867|580771946|FG001|Treatment Period|Poor/Non Compliance|0|||
160831741|NCT02713867|580771945|FG000|Treatment Period|Maximum Clinical Benefit|5|||
160831742|NCT02713867|580771946|FG001|Treatment Period|Maximum Clinical Benefit|6|||
160831743|NCT02713867|580771945|FG000|Treatment Period|Withdrew consent|3|||
160831744|NCT02713867|580771946|FG001|Treatment Period|Withdrew consent|6|||
160831745|NCT02713867|580771945|FG000|Treatment Period|Requested to Discontinue|8|||
160831746|NCT02713867|580771946|FG001|Treatment Period|Requested to Discontinue|8|||
160831747|NCT02713867|580771945|FG000|Treatment Period|AE unrelated to Study Drug|11|||
160831748|NCT02713867|580771946|FG001|Treatment Period|AE unrelated to Study Drug|10|||
160831749|NCT02713867|580771945|FG000|Treatment Period|Death|7|||
160831750|NCT02713867|580771946|FG001|Treatment Period|Death|3|||
160831751|NCT02713867|580771945|FG000|Treatment Period|Study Drug Toxicity|16|||
160831752|NCT02713867|580771946|FG001|Treatment Period|Study Drug Toxicity|19|||
160991204|NCT00938340|581355534|FG000|Overall Study|Adverse Event|1|||
160991205|NCT05174065|581355536|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
160560202|NCT01355289|579774098|FG003|Core Study|Adverse Event, Non-Fatal|0|||
160560203|NCT01355289|579774099|FG004|Core Study|Adverse Event, Non-Fatal|0|||
160560204|NCT01355289|579774095|FG000|Core Study|Inadequate Therapeutic Effect|0|||
160560205|NCT01355289|579774096|FG001|Core Study|Inadequate Therapeutic Effect|0|||
160560206|NCT01355289|579774097|FG002|Core Study|Inadequate Therapeutic Effect|0|||
160831753|NCT02713867|580771945|FG000|Treatment Period|Disease Progression|82|||
160831754|NCT02713867|580771946|FG001|Treatment Period|Disease Progression|83|||
160831755|NCT00857948|580771947|FG000|Overall Study|Withdrawal by Subject|2|||
160831756|NCT00857948|580771948|FG001|Overall Study|Withdrawal by Subject|0|||
160831757|NCT00857948|580771949|FG002|Overall Study|Withdrawal by Subject|0|||
160831758|NCT00857948|580771950|FG003|Overall Study|Withdrawal by Subject|0|||
160831759|NCT00857948|580771947|FG000|Overall Study|Protocol Violation|1|||
160831760|NCT00857948|580771948|FG001|Overall Study|Protocol Violation|0|||
160831761|NCT00857948|580771949|FG002|Overall Study|Protocol Violation|1|||
160831762|NCT00857948|580771950|FG003|Overall Study|Protocol Violation|0|||
160831763|NCT00493636|580771954|FG000|Overall Study|Withdrawal by Subject|1|||
160831764|NCT00493636|580771955|FG001|Overall Study|Withdrawal by Subject|0|||
160831765|NCT00493636|580771954|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
160831766|NCT00493636|580771955|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
160831767|NCT00493636|580771954|FG000|Overall Study|Mis-randomization|1|||
160831768|NCT00493636|580771955|FG001|Overall Study|Mis-randomization|1|||
160831769|NCT02715726|580771960|FG000|Overall Study|Adverse Event|2|||
160831770|NCT02715726|580771961|FG001|Overall Study|Adverse Event|6|||
160831771|NCT02715726|580771960|FG000|Overall Study|Protocol Violation|1|||
160831772|NCT02715726|580771961|FG001|Overall Study|Protocol Violation|0|||
160831773|NCT02715726|580771960|FG000|Overall Study|Death|2|||
160831774|NCT02715726|580771961|FG001|Overall Study|Death|1|||
160831775|NCT02715726|580771960|FG000|Overall Study|Participant moved|1|||
160831776|NCT02715726|580771961|FG001|Overall Study|Participant moved|3|||
160831777|NCT02715726|580771960|FG000|Overall Study|Other than specified above|11|||
160831778|NCT02715726|580771961|FG001|Overall Study|Other than specified above|15|||
160831779|NCT02715726|580771960|FG000|Overall Study|Randomized but not treated|1|||
160831780|NCT02715726|580771961|FG001|Overall Study|Randomized but not treated|2|||
160831781|NCT02445573|580771962|FG000|Overall Study|Withdrawal by Subject|1|||
160831782|NCT02445573|580771963|FG001|Overall Study|Withdrawal by Subject|1|||
160831783|NCT02445573|580771962|FG000|Overall Study|Lost to Follow-up|0|||
160831784|NCT02445573|580771963|FG001|Overall Study|Lost to Follow-up|1|||
160831785|NCT04047420|580771964|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
160831786|NCT04047420|580771964|FG000|Washout Period|Refused Participation|2|||
160831787|NCT03757130|580771965|FG000|Overall Study|Lost to Follow-up|0|||
160831788|NCT03757130|580771966|FG001|Overall Study|Lost to Follow-up|0|||
160831789|NCT03757130|580771967|FG002|Overall Study|Lost to Follow-up|0|||
160831790|NCT03757130|580771968|FG003|Overall Study|Lost to Follow-up|1|||
160831791|NCT03757130|580771969|FG004|Overall Study|Lost to Follow-up|0|||
160831792|NCT03757130|580771970|FG005|Overall Study|Lost to Follow-up|0|||
160831793|NCT03757130|580771971|FG006|Overall Study|Lost to Follow-up|0|||
160831794|NCT03757130|580771972|FG007|Overall Study|Lost to Follow-up|1|||
160831795|NCT03757130|580771965|FG000|Overall Study|Withdrawal by Subject|0|||
160831796|NCT03757130|580771966|FG001|Overall Study|Withdrawal by Subject|0|||
160831797|NCT03757130|580771967|FG002|Overall Study|Withdrawal by Subject|0|||
160831798|NCT03757130|580771968|FG003|Overall Study|Withdrawal by Subject|0|||
160831799|NCT03757130|580771969|FG004|Overall Study|Withdrawal by Subject|0|||
160831800|NCT03757130|580771970|FG005|Overall Study|Withdrawal by Subject|0|||
160831801|NCT03757130|580771971|FG006|Overall Study|Withdrawal by Subject|1|||
160831802|NCT03757130|580771972|FG007|Overall Study|Withdrawal by Subject|0|||
160831803|NCT01639755|580771973|FG000|Overall Study|Study Ongoing|15|||
160831804|NCT01639755|580771973|FG000|Overall Study|Patient had device explantation|4|||
160831805|NCT00966719|580771974|FG000|Overall Study|Lost to Follow-up|6|||
160831806|NCT00966719|580771975|FG001|Overall Study|Lost to Follow-up|11|||
160831807|NCT01439126|580771976|FG000|Overall Study|Adverse Event|2|||
160831808|NCT01439126|580771977|FG001|Overall Study|Adverse Event|0|||
160831809|NCT01439126|580771976|FG000|Overall Study|Withdrawal by Subject|5|||
160831810|NCT01439126|580771977|FG001|Overall Study|Withdrawal by Subject|21|||
160831811|NCT01439126|580771976|FG000|Overall Study|Protocol Violation|6|||
160831812|NCT01439126|580771977|FG001|Overall Study|Protocol Violation|4|||
160831813|NCT01439126|580771976|FG000|Overall Study|Lost to Follow-up|6|||
160831814|NCT01439126|580771977|FG001|Overall Study|Lost to Follow-up|3|||
160903312|NCT00190671|581039088|FG001|Overall Study|Clinical Relapse|1|||
160903313|NCT00190671|581039087|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
160903314|NCT00190671|581039088|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
160903315|NCT00190671|581039087|FG000|Overall Study|Death from Other Causes|0|||
160903316|NCT00190671|581039088|FG001|Overall Study|Death from Other Causes|2|||
160903317|NCT00190671|581039087|FG000|Overall Study|Protocol Violation|0|||
160903318|NCT00190671|581039088|FG001|Overall Study|Protocol Violation|1|||
160560207|NCT01355289|579774098|FG003|Core Study|Inadequate Therapeutic Effect|1|||
160831815|NCT01439126|580771976|FG000|Overall Study|Other-Use of prohibited treatment|0|||
160831816|NCT01439126|580771977|FG001|Overall Study|Other-Use of prohibited treatment|2|||
160831817|NCT01439126|580771976|FG000|Overall Study|Other-Miscellaneous|12|||
160831818|NCT01439126|580771977|FG001|Overall Study|Other-Miscellaneous|12|||
160831819|NCT03242018|580771979|FG000|Overall Study|Adverse Event|7|||
160831820|NCT03242018|580771980|FG001|Overall Study|Adverse Event|7|||
160831821|NCT03242018|580771981|FG002|Overall Study|Adverse Event|6|||
160831822|NCT03242018|580771979|FG000|Overall Study|Lost to Follow-up|2|||
160831823|NCT03242018|580771980|FG001|Overall Study|Lost to Follow-up|2|||
160831824|NCT03242018|580771981|FG002|Overall Study|Lost to Follow-up|2|||
160831825|NCT03242018|580771979|FG000|Overall Study|At the Participant's Own Request|5|||
160831826|NCT03242018|580771980|FG001|Overall Study|At the Participant's Own Request|1|||
160831827|NCT03242018|580771981|FG002|Overall Study|At the Participant's Own Request|4|||
160831828|NCT03242018|580771979|FG000|Overall Study|Reason Not Specified|3|||
160831829|NCT03242018|580771980|FG001|Overall Study|Reason Not Specified|4|||
160831830|NCT03242018|580771981|FG002|Overall Study|Reason Not Specified|1|||
160831831|NCT03242018|580771979|FG000|Overall Study|Study Terminated by Sponsor|1|||
160831832|NCT03242018|580771980|FG001|Overall Study|Study Terminated by Sponsor|0|||
160831833|NCT03242018|580771981|FG002|Overall Study|Study Terminated by Sponsor|1|||
160831834|NCT00477269|580771985|FG000|Core Study|Adverse Event|6|||
160831835|NCT00477269|580771986|FG001|Core Study|Adverse Event|4|||
160831836|NCT00477269|580771987|FG002|Core Study|Adverse Event|0|||
160831837|NCT00477269|580771985|FG000|Core Study|Death|3|||
160831838|NCT00477269|580771986|FG001|Core Study|Death|3|||
160831839|NCT00477269|580771987|FG002|Core Study|Death|0|||
160831840|NCT00477269|580771985|FG000|Core Study|Withdrawn Consent|0|||
160831841|NCT00477269|580771986|FG001|Core Study|Withdrawn Consent|1|||
160831842|NCT00477269|580771987|FG002|Core Study|Withdrawn Consent|0|||
160831843|NCT00477269|580771985|FG000|Open Label Extension|Adverse Event|0|||
160831844|NCT00477269|580771986|FG001|Open Label Extension|Adverse Event|0|||
160831845|NCT00477269|580771987|FG002|Open Label Extension|Adverse Event|4|||
160831846|NCT00477269|580771985|FG000|Open Label Extension|Abnormal laboratory values|0|||
160831847|NCT00477269|580771986|FG001|Open Label Extension|Abnormal laboratory values|0|||
160831848|NCT00477269|580771987|FG002|Open Label Extension|Abnormal laboratory values|1|||
160831849|NCT00477269|580771985|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
160831850|NCT00477269|580771986|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
160831851|NCT00477269|580771987|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
160831852|NCT00477269|580771985|FG000|Open Label Extension|Adminiatrative problems|0|||
160831853|NCT00477269|580771986|FG001|Open Label Extension|Adminiatrative problems|0|||
160831854|NCT00477269|580771987|FG002|Open Label Extension|Adminiatrative problems|2|||
160831855|NCT00477269|580771985|FG000|Open Label Extension|Death|0|||
160831856|NCT00477269|580771986|FG001|Open Label Extension|Death|0|||
160831857|NCT00477269|580771987|FG002|Open Label Extension|Death|4|||
160831858|NCT03089944|580771988|FG000|Overall Study|Lost to Follow-up|8|||
160831859|NCT03089944|580771988|FG000|Overall Study|Withdrew Consent|2|||
160831860|NCT03089944|580771988|FG000|Overall Study|Adverse Event|1|||
160831861|NCT03089944|580771988|FG000|Overall Study|Other|1|||
160831862|NCT03689244|580771989|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
160831863|NCT03689244|580771990|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
160831864|NCT03689244|580771991|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
160831865|NCT03689244|580771992|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
160831866|NCT03689244|580771989|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
160831867|NCT03689244|580771990|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
160831868|NCT03689244|580771991|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
160831869|NCT03689244|580771992|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
160831870|NCT03689244|580771989|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
160831871|NCT03689244|580771990|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
160831872|NCT03689244|580771991|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
160831873|NCT03689244|580771992|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
160831874|NCT03689244|580771989|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
160831875|NCT03689244|580771990|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
160831876|NCT03689244|580771991|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
160831877|NCT03689244|580771992|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
160831878|NCT03689244|580771989|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
160831879|NCT03689244|580771990|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
160991206|NCT05174065|581355537|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
160991207|NCT05174065|581355538|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
160831880|NCT03689244|580771991|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
160831881|NCT03689244|580771992|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
160831882|NCT03689244|580771989|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
160831883|NCT03689244|580771990|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
160831884|NCT03689244|580771991|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
160831885|NCT03689244|580771992|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
160831886|NCT03689244|580771989|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
160831887|NCT03689244|580771990|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
160831888|NCT03689244|580771991|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
160831889|NCT03689244|580771992|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
160831890|NCT03689244|580771989|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
160831891|NCT03689244|580771990|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
160831892|NCT03689244|580771991|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
160831893|NCT03689244|580771992|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
160831894|NCT00806442|580772017|FG000|Overall Study|Lost to Follow-up|3|||
160831895|NCT00806442|580772018|FG001|Overall Study|Lost to Follow-up|2|||
160831896|NCT00806442|580772017|FG000|Overall Study|Withdrawal by Subject|1|||
160831897|NCT00806442|580772018|FG001|Overall Study|Withdrawal by Subject|5|||
160831898|NCT00654004|580772022|FG000|Overall Study|Lost to Follow-up|1|||
160831899|NCT00654004|580772023|FG001|Overall Study|Lost to Follow-up|0|||
160831900|NCT00444067|580772029|FG000|Overall Study|Lost to Follow-up|0|||
160831901|NCT00444067|580772030|FG001|Overall Study|Lost to Follow-up|1|||
160831902|NCT02528357|580772034|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831903|NCT02528357|580772035|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
160831904|NCT02528357|580772036|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831905|NCT02528357|580772037|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831906|NCT02528357|580772038|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831907|NCT02528357|580772039|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831908|NCT02528357|580772040|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831909|NCT02528357|580772041|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831910|NCT02528357|580772042|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831911|NCT02528357|580772043|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831912|NCT02528357|580772044|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831913|NCT02528357|580772045|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831914|NCT02528357|580772046|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831915|NCT02528357|580772047|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831916|NCT02528357|580772048|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831917|NCT02528357|580772049|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831918|NCT02528357|580772050|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831919|NCT02528357|580772051|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831920|NCT02528357|580772052|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831921|NCT02528357|580772034|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831922|NCT02528357|580772035|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831923|NCT02528357|580772036|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831924|NCT02528357|580772037|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
160831925|NCT02528357|580772038|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831926|NCT02528357|580772039|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
160831927|NCT02528357|580772040|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831928|NCT02528357|580772041|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
160831929|NCT02528357|580772042|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831930|NCT02528357|580772043|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831931|NCT02528357|580772044|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831932|NCT02528357|580772045|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831933|NCT02528357|580772046|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831934|NCT02528357|580772047|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831935|NCT02528357|580772048|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831936|NCT02528357|580772049|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831937|NCT02528357|580772050|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831938|NCT02528357|580772051|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831939|NCT02528357|580772052|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831940|NCT02528357|580772034|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831941|NCT02528357|580772035|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831942|NCT02528357|580772036|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
160831943|NCT02528357|580772037|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831944|NCT02528357|580772038|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
160831945|NCT02528357|580772039|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831946|NCT02528357|580772040|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
160831947|NCT02528357|580772041|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
160903319|NCT00190671|581039087|FG000|Overall Study|Withdrawal by Subject|0|||
160903320|NCT00190671|581039088|FG001|Overall Study|Withdrawal by Subject|2|||
160647569|NCT02811861|580092761|FG001|Overall Study|Adverse Event|60|||
160831948|NCT02528357|580772042|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831949|NCT02528357|580772043|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831950|NCT02528357|580772044|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831951|NCT02528357|580772045|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831952|NCT02528357|580772046|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831953|NCT02528357|580772047|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831954|NCT02528357|580772048|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831955|NCT02528357|580772049|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831956|NCT02528357|580772050|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831957|NCT02528357|580772051|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831958|NCT02528357|580772052|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831959|NCT02528357|580772034|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831960|NCT02528357|580772035|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831961|NCT02528357|580772036|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831962|NCT02528357|580772037|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831963|NCT02528357|580772038|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160831964|NCT02528357|580772039|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831965|NCT02528357|580772040|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831966|NCT02528357|580772041|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831967|NCT02528357|580772042|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831968|NCT02528357|580772043|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831969|NCT02528357|580772044|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831970|NCT02528357|580772045|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831971|NCT02528357|580772046|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831972|NCT02528357|580772047|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831973|NCT02528357|580772048|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831974|NCT02528357|580772049|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831975|NCT02528357|580772050|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831976|NCT02528357|580772051|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831977|NCT02528357|580772052|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831978|NCT02528357|580772034|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831979|NCT02528357|580772035|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831980|NCT02528357|580772036|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831981|NCT02528357|580772037|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831982|NCT02528357|580772038|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831983|NCT02528357|580772039|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831984|NCT02528357|580772040|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831985|NCT02528357|580772041|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831986|NCT02528357|580772042|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831987|NCT02528357|580772043|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831988|NCT02528357|580772044|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831989|NCT02528357|580772045|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831990|NCT02528357|580772046|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831991|NCT02528357|580772047|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
160831992|NCT02528357|580772048|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
160831993|NCT02528357|580772049|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831994|NCT02528357|580772050|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831995|NCT02528357|580772051|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831996|NCT02528357|580772052|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831997|NCT02528357|580772034|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160647570|NCT02811861|580092762|FG002|Overall Study|Adverse Event|41|||
160647571|NCT02811861|580092760|FG000|Overall Study|Lost to Follow-up|0|||
160831998|NCT02528357|580772035|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160831999|NCT02528357|580772036|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832000|NCT02528357|580772037|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832001|NCT02528357|580772038|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832002|NCT02528357|580772039|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832003|NCT02528357|580772040|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832004|NCT02528357|580772041|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832005|NCT02528357|580772042|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832006|NCT02528357|580772043|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832007|NCT02528357|580772044|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832008|NCT02528357|580772045|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832009|NCT02528357|580772046|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832010|NCT02528357|580772047|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
160832011|NCT02528357|580772048|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832012|NCT02528357|580772049|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832013|NCT02528357|580772050|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832014|NCT02528357|580772051|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832015|NCT02528357|580772052|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832016|NCT02528357|580772034|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832017|NCT02528357|580772035|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832018|NCT02528357|580772036|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832019|NCT02528357|580772037|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832020|NCT02528357|580772038|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832021|NCT02528357|580772039|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832022|NCT02528357|580772040|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832023|NCT02528357|580772041|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832024|NCT02528357|580772042|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832025|NCT02528357|580772043|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832026|NCT02528357|580772044|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
160832027|NCT02528357|580772045|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832028|NCT02528357|580772046|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
160832029|NCT02528357|580772047|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
160832030|NCT02528357|580772048|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
160832031|NCT02528357|580772049|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832032|NCT02528357|580772050|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832033|NCT02528357|580772051|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832034|NCT02528357|580772052|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832035|NCT02528357|580772034|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832036|NCT02528357|580772035|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832037|NCT02528357|580772036|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832038|NCT02528357|580772037|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832039|NCT02528357|580772038|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832040|NCT02528357|580772039|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832041|NCT02528357|580772040|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832042|NCT02528357|580772041|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832043|NCT02528357|580772042|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160832044|NCT02528357|580772043|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160832045|NCT02528357|580772044|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832046|NCT02528357|580772045|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
160832047|NCT02528357|580772046|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
160832048|NCT02528357|580772047|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160832049|NCT02528357|580772048|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160832050|NCT02528357|580772049|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832051|NCT02528357|580772050|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832052|NCT02528357|580772051|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832053|NCT02528357|580772052|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832054|NCT02528357|580772034|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832055|NCT02528357|580772035|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832056|NCT02528357|580772036|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832057|NCT02528357|580772037|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832058|NCT02528357|580772038|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832059|NCT02528357|580772039|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832060|NCT02528357|580772040|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832061|NCT02528357|580772041|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832062|NCT02528357|580772042|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832063|NCT02528357|580772043|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832064|NCT02528357|580772044|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832065|NCT02528357|580772045|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832066|NCT02528357|580772046|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832067|NCT02528357|580772047|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832068|NCT02528357|580772048|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832069|NCT02528357|580772049|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832070|NCT02528357|580772050|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
160832071|NCT02528357|580772051|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832072|NCT02528357|580772052|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832073|NCT02528357|580772034|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832074|NCT02528357|580772035|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832075|NCT02528357|580772036|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832076|NCT02528357|580772037|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832077|NCT02528357|580772038|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832078|NCT02528357|580772039|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832079|NCT02528357|580772040|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832080|NCT02528357|580772041|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832081|NCT02528357|580772042|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832082|NCT02528357|580772043|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832083|NCT02528357|580772044|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832084|NCT02528357|580772045|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832085|NCT02528357|580772046|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832086|NCT02528357|580772047|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832087|NCT02528357|580772048|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832088|NCT02528357|580772049|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832089|NCT02528357|580772050|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160832090|NCT02528357|580772051|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
160832091|NCT02528357|580772052|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
160832092|NCT01455220|580772056|FG000|Overall Study|screen fail|30|||
160832093|NCT00267150|580772057|FG000|Overall Study|Adverse Event|1|||
160832094|NCT00969436|580772062|FG000|Overall Study|Protocol Violation|1|||
160832095|NCT00969436|580772063|FG001|Overall Study|Protocol Violation|3|||
160832096|NCT00969436|580772064|FG002|Overall Study|Protocol Violation|0|||
160832097|NCT00969436|580772062|FG000|Overall Study|Migrated/moved from study area|12|||
160832098|NCT00969436|580772063|FG001|Overall Study|Migrated/moved from study area|10|||
160832099|NCT00969436|580772064|FG002|Overall Study|Migrated/moved from study area|2|||
160832100|NCT00969436|580772062|FG000|Overall Study|Father - serious health problem|0|||
160832101|NCT00969436|580772063|FG001|Overall Study|Father - serious health problem|0|||
160832102|NCT00969436|580772064|FG002|Overall Study|Father - serious health problem|1|||
160832103|NCT00969436|580772062|FG000|Overall Study|Parents personal problem|0|||
160832104|NCT00969436|580772063|FG001|Overall Study|Parents personal problem|0|||
160832105|NCT00969436|580772064|FG002|Overall Study|Parents personal problem|1|||
160832106|NCT00969436|580772062|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
160832107|NCT00969436|580772063|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
160832108|NCT00969436|580772064|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
160832109|NCT00969436|580772062|FG000|Overall Study|Withdrawal by Subject|3|||
160832110|NCT00969436|580772063|FG001|Overall Study|Withdrawal by Subject|0|||
160832111|NCT00969436|580772064|FG002|Overall Study|Withdrawal by Subject|2|||
160903321|NCT00967668|581040456|FG000|Overall Study|Withdrawal by Subject|13|||
160903322|NCT00967668|581040457|FG001|Overall Study|Withdrawal by Subject|8|||
160903323|NCT00967668|581040458|FG002|Overall Study|Withdrawal by Subject|8|||
160903324|NCT00967668|581040456|FG000|Overall Study|Death|0|||
160832112|NCT00969436|580772062|FG000|Overall Study|Lost to Follow-up|8|||
160832113|NCT00969436|580772063|FG001|Overall Study|Lost to Follow-up|8|||
160832114|NCT00969436|580772064|FG002|Overall Study|Lost to Follow-up|5|||
160832115|NCT00351273|580772065|FG000|Overall Study|Lost to Follow-up|1|||
160832116|NCT00351273|580772066|FG001|Overall Study|Lost to Follow-up|2|||
160832117|NCT00351273|580772067|FG002|Overall Study|Lost to Follow-up|5|||
160832118|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
160832119|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
160832120|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
160832121|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
160832122|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
160832123|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
160832124|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
160832125|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
160832126|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
160832127|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
160832128|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
160832129|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
160832130|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
160832131|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
160832132|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
160832133|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
160832134|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
160832135|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
160832136|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
160832137|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
160832138|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
160832139|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
160832140|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
160832141|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
160832142|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
160832143|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
160832144|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
160832145|NCT01672866|580772068|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
160832146|NCT01672866|580772069|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
160832147|NCT01672866|580772070|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
160832148|NCT01672866|580772068|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
160832149|NCT01672866|580772069|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
160832150|NCT01672866|580772070|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
160832151|NCT01672866|580772068|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
160832152|NCT01672866|580772069|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
160832153|NCT01672866|580772070|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
160832154|NCT01672866|580772068|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
160832155|NCT01672866|580772069|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
160832156|NCT01672866|580772070|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
160832157|NCT02544373|580772073|FG000|Overall Study|Lost to Follow-up|5|||
160832158|NCT02544373|580772074|FG001|Overall Study|Lost to Follow-up|3|||
160832159|NCT02544373|580772073|FG000|Overall Study|Withdrawal by Subject|8|||
160832160|NCT02544373|580772074|FG001|Overall Study|Withdrawal by Subject|2|||
160832161|NCT04208087|580772075|FG000|Overall Study|Adverse Event|1|||
160832162|NCT04208087|580772076|FG001|Overall Study|Adverse Event|0|||
160832163|NCT04208087|580772077|FG002|Overall Study|Adverse Event|0|||
160832164|NCT04208087|580772078|FG003|Overall Study|Adverse Event|0|||
160832165|NCT04208087|580772079|FG004|Overall Study|Adverse Event|0|||
160832166|NCT04208087|580772075|FG000|Overall Study|Withdrawal by Subject|0|||
160832167|NCT04208087|580772076|FG001|Overall Study|Withdrawal by Subject|0|||
160832168|NCT04208087|580772077|FG002|Overall Study|Withdrawal by Subject|1|||
160832169|NCT04208087|580772078|FG003|Overall Study|Withdrawal by Subject|0|||
160832170|NCT04208087|580772079|FG004|Overall Study|Withdrawal by Subject|0|||
160832171|NCT04208087|580772075|FG000|Overall Study|Other|0|||
160832172|NCT04208087|580772076|FG001|Overall Study|Other|0|||
160903325|NCT00967668|581040457|FG001|Overall Study|Death|2|||
160832173|NCT04208087|580772077|FG002|Overall Study|Other|0|||
160903326|NCT00967668|581040458|FG002|Overall Study|Death|4|||
160832174|NCT04208087|580772078|FG003|Overall Study|Other|0|||
160832175|NCT04208087|580772079|FG004|Overall Study|Other|1|||
160903327|NCT00967668|581040456|FG000|Overall Study|Removed due to behavior|1|||
160832176|NCT01198509|580772080|FG000|Overall Study|Withdrawal by Subject|1|||
160832177|NCT01198509|580772081|FG001|Overall Study|Withdrawal by Subject|0|||
160832178|NCT01198509|580772082|FG002|Overall Study|Withdrawal by Subject|0|||
160903328|NCT00967668|581040457|FG001|Overall Study|Removed due to behavior|1|||
160903329|NCT00967668|581040458|FG002|Overall Study|Removed due to behavior|2|||
160832179|NCT01198509|580772083|FG003|Overall Study|Withdrawal by Subject|0|||
160832180|NCT01198509|580772084|FG004|Overall Study|Withdrawal by Subject|0|||
160832181|NCT01198509|580772085|FG005|Overall Study|Withdrawal by Subject|0|||
160832182|NCT02621073|580772086|FG000|Overall Study|Lost to Follow-up|0|||
160832183|NCT02621073|580772087|FG001|Overall Study|Lost to Follow-up|1|||
160832184|NCT02621073|580772086|FG000|Overall Study|Physician Decision|3|||
160832185|NCT02621073|580772087|FG001|Overall Study|Physician Decision|2|||
160832186|NCT01595581|580772088|FG000|Overall Study|Withdrawal by Subject|1|||
160832187|NCT01595581|580772089|FG001|Overall Study|Withdrawal by Subject|0|||
160832188|NCT01969721|580772100|FG000|Overall Study|Adverse Event|3|||
160832189|NCT01969721|580772101|FG001|Overall Study|Adverse Event|8|||
160832190|NCT01969721|580772102|FG002|Overall Study|Adverse Event|3|||
160832191|NCT01969721|580772103|FG003|Overall Study|Adverse Event|2|||
160832192|NCT01969721|580772100|FG000|Overall Study|Lack of Efficacy|0|||
160832193|NCT01969721|580772101|FG001|Overall Study|Lack of Efficacy|0|||
160832194|NCT01969721|580772102|FG002|Overall Study|Lack of Efficacy|1|||
160832195|NCT01969721|580772103|FG003|Overall Study|Lack of Efficacy|0|||
160832196|NCT01969721|580772100|FG000|Overall Study|Non compliant with protocol|1|||
160832197|NCT01969721|580772101|FG001|Overall Study|Non compliant with protocol|1|||
160832198|NCT01969721|580772102|FG002|Overall Study|Non compliant with protocol|0|||
160832199|NCT01969721|580772103|FG003|Overall Study|Non compliant with protocol|2|||
160832200|NCT01969721|580772100|FG000|Overall Study|Other not defined above|0|||
160832201|NCT01969721|580772101|FG001|Overall Study|Other not defined above|2|||
160832202|NCT01969721|580772102|FG002|Overall Study|Other not defined above|0|||
160832203|NCT01969721|580772103|FG003|Overall Study|Other not defined above|0|||
160832204|NCT01969721|580772100|FG000|Overall Study|Discontinued during washout periods.|0|||
160832205|NCT01969721|580772101|FG001|Overall Study|Discontinued during washout periods.|1|||
160832206|NCT01969721|580772102|FG002|Overall Study|Discontinued during washout periods.|1|||
160832207|NCT01969721|580772103|FG003|Overall Study|Discontinued during washout periods.|2|||
160832208|NCT00495755|580772104|FG000|Overall Study|Adverse Event|3|||
160832209|NCT02920957|580772105|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
160832210|NCT02920957|580772106|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
160832211|NCT02920957|580772105|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
160832212|NCT02920957|580772106|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
160832213|NCT02920957|580772105|FG000|First Intervention : 1 Month|Adverse Event|1|||
160832214|NCT02920957|580772106|FG001|First Intervention : 1 Month|Adverse Event|0|||
160832215|NCT02920957|580772105|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
160832216|NCT02920957|580772106|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
160832217|NCT01789606|580772107|FG000|Overall Study|Participant not Purchased the Product|0|||
160832218|NCT01789606|580772108|FG001|Overall Study|Participant not Purchased the Product|20|||
160832219|NCT01789606|580772107|FG000|Overall Study|Withdrawal by Subject|0|||
160832220|NCT01789606|580772108|FG001|Overall Study|Withdrawal by Subject|1|||
160832221|NCT01789606|580772107|FG000|Overall Study|Ineligible|6|||
160832222|NCT01789606|580772108|FG001|Overall Study|Ineligible|2|||
160832223|NCT01789606|580772107|FG000|Overall Study|Administrative Reasons|17|||
160832224|NCT01789606|580772108|FG001|Overall Study|Administrative Reasons|6|||
160832225|NCT01789606|580772107|FG000|Overall Study|No Study Medication Taken|0|||
160832226|NCT01789606|580772108|FG001|Overall Study|No Study Medication Taken|1|||
160832227|NCT01789606|580772107|FG000|Overall Study|Protocol Violation|0|||
160832228|NCT01789606|580772108|FG001|Overall Study|Protocol Violation|55|||
160832229|NCT01789606|580772107|FG000|Overall Study|Adverse Event|0|||
160832230|NCT01789606|580772108|FG001|Overall Study|Adverse Event|3|||
160832231|NCT01789606|580772107|FG000|Overall Study|Lost to Follow-up|0|||
160832232|NCT01789606|580772108|FG001|Overall Study|Lost to Follow-up|14|||
160832233|NCT01789606|580772107|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
160832234|NCT01789606|580772108|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
160832235|NCT03180307|580772109|FG000|Overall Study|Lost to Follow-up|2|||
160832236|NCT03180307|580772110|FG001|Overall Study|Lost to Follow-up|0|||
160832237|NCT03180307|580772109|FG000|Overall Study|Death|1|||
160832238|NCT03180307|580772110|FG001|Overall Study|Death|0|||
160832239|NCT03180307|580772109|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
160832240|NCT03180307|580772110|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
160832241|NCT01563172|580772116|FG000|Overall Study|Adverse Event|5|||
160832242|NCT01563172|580772116|FG000|Overall Study|Lost to Follow-up|2|||
160832243|NCT01563172|580772116|FG000|Overall Study|Other (Protocol deviation)|5|||
160832244|NCT01563172|580772116|FG000|Overall Study|Other (Not specified)|1|||
160832245|NCT00720343|580773805|FG000|Overall Study|Lost to Follow-up|1|||
160832246|NCT00720343|580773806|FG001|Overall Study|Lost to Follow-up|0|||
160832247|NCT00720343|580773805|FG000|Overall Study|Protocol Violation|0|||
160832248|NCT00720343|580773806|FG001|Overall Study|Protocol Violation|2|||
160832249|NCT03459365|580773809|FG000|Overall Study|Withdrawal by Subject|6|||
160832250|NCT03459365|580773809|FG000|Overall Study|Protocol Violation|8|||
160832251|NCT00344500|580773811|FG000|Overall Study|Adverse Event|6|||
160832252|NCT00344500|580773812|FG001|Overall Study|Adverse Event|2|||
160832253|NCT00344500|580773813|FG002|Overall Study|Adverse Event|0|||
160832254|NCT00344500|580773811|FG000|Overall Study|Lost to Follow-up|5|||
160832255|NCT00344500|580773812|FG001|Overall Study|Lost to Follow-up|13|||
160832256|NCT00344500|580773813|FG002|Overall Study|Lost to Follow-up|1|||
160832257|NCT00344500|580773811|FG000|Overall Study|Withdrawal by Subject|7|||
160832258|NCT00344500|580773812|FG001|Overall Study|Withdrawal by Subject|10|||
160832259|NCT00344500|580773813|FG002|Overall Study|Withdrawal by Subject|0|||
160832260|NCT00344500|580773811|FG000|Overall Study|Protocol Violation|4|||
160832261|NCT00344500|580773812|FG001|Overall Study|Protocol Violation|7|||
160832262|NCT00344500|580773813|FG002|Overall Study|Protocol Violation|1|||
160832263|NCT00344500|580773811|FG000|Overall Study|Not Noted|1|||
160832264|NCT00344500|580773812|FG001|Overall Study|Not Noted|3|||
160832265|NCT00344500|580773813|FG002|Overall Study|Not Noted|0|||
160832266|NCT00599755|580773814|FG000|Overall Study|Adverse Event|11|||
160832267|NCT00599755|580773814|FG000|Overall Study|Withdrawal by Subject|2|||
160832268|NCT00599755|580773814|FG000|Overall Study|Progression of Disease|3|||
160832269|NCT00599755|580773814|FG000|Overall Study|Other Reason|2|||
160832270|NCT00599755|580773814|FG000|Overall Study|No data available|1|||
160832271|NCT04037254|580773815|FG000|Overall Study|Protocol Violation|1|||
160832272|NCT04037254|580773816|FG001|Overall Study|Protocol Violation|0|||
160832273|NCT04037254|580773817|FG002|Overall Study|Protocol Violation|0|||
160832274|NCT04037254|580773818|FG003|Overall Study|Protocol Violation|0|||
160832275|NCT04037254|580773819|FG004|Overall Study|Protocol Violation|0|||
160832276|NCT04037254|580773815|FG000|Overall Study|Withdrawal by Subject|0|||
160832277|NCT04037254|580773816|FG001|Overall Study|Withdrawal by Subject|0|||
160832278|NCT04037254|580773817|FG002|Overall Study|Withdrawal by Subject|1|||
160832279|NCT04037254|580773818|FG003|Overall Study|Withdrawal by Subject|0|||
160832280|NCT04037254|580773819|FG004|Overall Study|Withdrawal by Subject|0|||
160832281|NCT04037254|580773815|FG000|Overall Study|Delayed or incomplete treatment|0|||
160832282|NCT04037254|580773816|FG001|Overall Study|Delayed or incomplete treatment|2|||
160832283|NCT04037254|580773817|FG002|Overall Study|Delayed or incomplete treatment|1|||
160832284|NCT04037254|580773818|FG003|Overall Study|Delayed or incomplete treatment|0|||
160832285|NCT04037254|580773819|FG004|Overall Study|Delayed or incomplete treatment|0|||
160832286|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
160832287|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
160832288|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
160832289|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
160832290|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
160832291|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
160832292|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
160832293|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
160832294|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
160832295|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
160832296|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
160832297|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
160832298|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
160832299|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
160832300|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
160832301|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
160832302|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
160832303|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
160832304|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
160832305|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
160832306|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
160832307|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
160832308|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
160832309|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
160903330|NCT00967668|581040456|FG000|Overall Study|Refused Year 2|11|||
160903331|NCT00967668|581040457|FG001|Overall Study|Refused Year 2|6|||
160903332|NCT00967668|581040458|FG002|Overall Study|Refused Year 2|4|||
160903333|NCT00967668|581040456|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
160903334|NCT00967668|581040457|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
160903335|NCT00967668|581040458|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
160903336|NCT00967668|581040456|FG000|Overall Study|Lost to Follow-up|15|||
160832310|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
160832311|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
160832312|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
160832313|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
160832314|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
160832315|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
160832316|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
160903337|NCT00967668|581040457|FG001|Overall Study|Lost to Follow-up|9|||
160903338|NCT00967668|581040458|FG002|Overall Study|Lost to Follow-up|16|||
160903339|NCT00967668|581040456|FG000|Overall Study|Refused 12-mo assessment|3|||
160903340|NCT00967668|581040457|FG001|Overall Study|Refused 12-mo assessment|1|||
160832317|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
160832318|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
160832319|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
160832320|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
160832321|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
160832322|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
160832323|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
160832324|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
160832325|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
160832326|NCT02198794|580773820|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
160832327|NCT02198794|580773821|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
160832328|NCT02198794|580773822|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
160832329|NCT02198794|580773823|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
160832330|NCT02198794|580773820|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
160832331|NCT02198794|580773821|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
160832332|NCT02198794|580773822|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
160832333|NCT02198794|580773823|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
160832334|NCT02198794|580773820|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
160832335|NCT02198794|580773821|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
160832336|NCT02198794|580773822|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
160832337|NCT02198794|580773823|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
160832338|NCT02198794|580773820|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
160832339|NCT02198794|580773821|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
160832340|NCT02198794|580773822|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
160832341|NCT02198794|580773823|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
160832342|NCT02198794|580773820|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
160832343|NCT02198794|580773821|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
160832344|NCT02198794|580773822|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
160832345|NCT02198794|580773823|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
160832346|NCT01306656|580773824|FG000|Overall Study|Lost to Follow-up|1|||
160832347|NCT01306656|580773825|FG001|Overall Study|Lost to Follow-up|0|||
160832348|NCT01918332|580773829|FG000|Overall Study|Adverse Event|0|||
160832349|NCT01918332|580773830|FG001|Overall Study|Adverse Event|0|||
160832350|NCT01918332|580773831|FG002|Overall Study|Adverse Event|0|||
160832351|NCT01918332|580773832|FG003|Overall Study|Adverse Event|1|||
160832352|NCT01918332|580773829|FG000|Overall Study|Withdrawal by Subject|2|||
160832353|NCT01918332|580773830|FG001|Overall Study|Withdrawal by Subject|3|||
160832354|NCT01918332|580773831|FG002|Overall Study|Withdrawal by Subject|2|||
160832355|NCT01918332|580773832|FG003|Overall Study|Withdrawal by Subject|3|||
160832356|NCT01918332|580773829|FG000|Overall Study|Protocol Violation|6|||
160832357|NCT01918332|580773830|FG001|Overall Study|Protocol Violation|2|||
160832358|NCT01918332|580773831|FG002|Overall Study|Protocol Violation|6|||
160832359|NCT01918332|580773832|FG003|Overall Study|Protocol Violation|3|||
160832360|NCT01918332|580773829|FG000|Overall Study|lipid result by central lab did not meet|0|||
160832361|NCT01918332|580773830|FG001|Overall Study|lipid result by central lab did not meet|0|||
160832362|NCT01918332|580773831|FG002|Overall Study|lipid result by central lab did not meet|1|||
160832363|NCT01918332|580773832|FG003|Overall Study|lipid result by central lab did not meet|0|||
160832364|NCT01939366|580773835|FG000|Overall Study|Adverse Event|8|||
160832365|NCT01939366|580773836|FG001|Overall Study|Adverse Event|17|||
160832366|NCT01939366|580773837|FG002|Overall Study|Adverse Event|30|||
160832367|NCT01939366|580773838|FG003|Overall Study|Adverse Event|8|||
160832368|NCT01939366|580773839|FG004|Overall Study|Adverse Event|5|||
160832369|NCT01939366|580773835|FG000|Overall Study|Lack of Efficacy|2|||
160832370|NCT01939366|580773836|FG001|Overall Study|Lack of Efficacy|1|||
160832371|NCT01939366|580773837|FG002|Overall Study|Lack of Efficacy|1|||
160832372|NCT01939366|580773838|FG003|Overall Study|Lack of Efficacy|1|||
160832373|NCT01939366|580773839|FG004|Overall Study|Lack of Efficacy|3|||
160832374|NCT01939366|580773835|FG000|Overall Study|Lost to Follow-up|1|||
160832375|NCT01939366|580773836|FG001|Overall Study|Lost to Follow-up|1|||
160903341|NCT00967668|581040458|FG002|Overall Study|Refused 12-mo assessment|9|||
160903342|NCT00967668|581040456|FG000|Overall Study|Pregnancy|1|||
160903343|NCT00967668|581040457|FG001|Overall Study|Pregnancy|0|||
160903344|NCT00967668|581040458|FG002|Overall Study|Pregnancy|0|||
160832376|NCT01939366|580773837|FG002|Overall Study|Lost to Follow-up|0|||
160832377|NCT01939366|580773838|FG003|Overall Study|Lost to Follow-up|0|||
160832378|NCT01939366|580773839|FG004|Overall Study|Lost to Follow-up|0|||
160832379|NCT01939366|580773835|FG000|Overall Study|Withdrawal by Subject|1|||
160832380|NCT01939366|580773836|FG001|Overall Study|Withdrawal by Subject|0|||
160832381|NCT01939366|580773837|FG002|Overall Study|Withdrawal by Subject|2|||
160832382|NCT01939366|580773838|FG003|Overall Study|Withdrawal by Subject|2|||
160903345|NCT00825682|581040459|FG000|Overall Study|personal reasons/ inconvenience|13|||
160903346|NCT00825682|581040460|FG001|Overall Study|personal reasons/ inconvenience|5|||
160903347|NCT02400333|581040463|FG000|Overall Study|Withdrawal by Subject|0|||
160560208|NCT01355289|579774099|FG004|Core Study|Inadequate Therapeutic Effect|0|||
160832383|NCT01939366|580773839|FG004|Overall Study|Withdrawal by Subject|3|||
160832384|NCT01939366|580773835|FG000|Overall Study|Inclusion criteria not met|0|||
160832385|NCT01939366|580773836|FG001|Overall Study|Inclusion criteria not met|1|||
160832386|NCT01939366|580773837|FG002|Overall Study|Inclusion criteria not met|1|||
160832387|NCT01939366|580773838|FG003|Overall Study|Inclusion criteria not met|0|||
160832388|NCT01939366|580773839|FG004|Overall Study|Inclusion criteria not met|1|||
160832389|NCT01939366|580773835|FG000|Overall Study|Other|0|||
160832390|NCT01939366|580773836|FG001|Overall Study|Other|0|||
160832391|NCT01939366|580773837|FG002|Overall Study|Other|2|||
160832392|NCT01939366|580773838|FG003|Overall Study|Other|2|||
160832393|NCT01939366|580773839|FG004|Overall Study|Other|1|||
160832394|NCT01939366|580773835|FG000|Overall Study|Protocol Violation|0|||
160832395|NCT01939366|580773836|FG001|Overall Study|Protocol Violation|0|||
160832396|NCT01939366|580773837|FG002|Overall Study|Protocol Violation|0|||
160832397|NCT01939366|580773838|FG003|Overall Study|Protocol Violation|1|||
160832398|NCT01939366|580773839|FG004|Overall Study|Protocol Violation|0|||
160832399|NCT01939366|580773835|FG000|Overall Study|Sponsor decision|0|||
160832400|NCT01939366|580773836|FG001|Overall Study|Sponsor decision|0|||
160832401|NCT01939366|580773837|FG002|Overall Study|Sponsor decision|0|||
160832402|NCT01939366|580773838|FG003|Overall Study|Sponsor decision|0|||
160832403|NCT01939366|580773839|FG004|Overall Study|Sponsor decision|2|||
160832404|NCT01939366|580773835|FG000|Overall Study|GCP non-compliance at site|2|||
160832405|NCT01939366|580773836|FG001|Overall Study|GCP non-compliance at site|3|||
160832406|NCT01939366|580773837|FG002|Overall Study|GCP non-compliance at site|2|||
160832407|NCT01939366|580773838|FG003|Overall Study|GCP non-compliance at site|3|||
160832408|NCT01939366|580773839|FG004|Overall Study|GCP non-compliance at site|3|||
160832409|NCT02252965|580773840|FG000|Overall Study|Adverse Event|9|||
160832410|NCT02252965|580773841|FG001|Overall Study|Adverse Event|14|||
160832411|NCT02252965|580773840|FG000|Overall Study|Lost to Follow-up|16|||
160832412|NCT02252965|580773841|FG001|Overall Study|Lost to Follow-up|8|||
160832413|NCT02252965|580773840|FG000|Overall Study|Protocol Violation|4|||
160832414|NCT02252965|580773841|FG001|Overall Study|Protocol Violation|5|||
160832415|NCT02252965|580773840|FG000|Overall Study|Lack of Efficacy|0|||
160832416|NCT02252965|580773841|FG001|Overall Study|Lack of Efficacy|2|||
160832417|NCT02252965|580773840|FG000|Overall Study|Withdrawal by Subject|7|||
160832418|NCT02252965|580773841|FG001|Overall Study|Withdrawal by Subject|9|||
160832419|NCT02252965|580773840|FG000|Overall Study|Other|4|||
160832420|NCT02252965|580773841|FG001|Overall Study|Other|5|||
160903348|NCT02400333|581040464|FG001|Overall Study|Withdrawal by Subject|1|||
160903349|NCT02400333|581040465|FG002|Overall Study|Withdrawal by Subject|0|||
160903350|NCT02400333|581040466|FG003|Overall Study|Withdrawal by Subject|1|||
160903351|NCT02400333|581040463|FG000|Overall Study|Protocol Violation|1|||
160903352|NCT02400333|581040464|FG001|Overall Study|Protocol Violation|0|||
160903353|NCT02400333|581040465|FG002|Overall Study|Protocol Violation|2|||
160903354|NCT02400333|581040466|FG003|Overall Study|Protocol Violation|1|||
160903355|NCT02468674|581040467|FG000|Overall Study|Adverse Event|0|||
160903356|NCT02468674|581040468|FG001|Overall Study|Adverse Event|0|||
160903357|NCT02468674|581040469|FG002|Overall Study|Adverse Event|0|||
160903358|NCT02468674|581040470|FG003|Overall Study|Adverse Event|1|||
160903359|NCT02468674|581040471|FG004|Overall Study|Adverse Event|0|||
160903360|NCT02468674|581040472|FG005|Overall Study|Adverse Event|1|||
160903361|NCT02468674|581040473|FG006|Overall Study|Adverse Event|0|||
160903362|NCT02468674|581040474|FG007|Overall Study|Adverse Event|0|||
160903363|NCT02468674|581040475|FG008|Overall Study|Adverse Event|0|||
160903364|NCT02468674|581040467|FG000|Overall Study|Lost to Follow-up|1|||
160903365|NCT02468674|581040468|FG001|Overall Study|Lost to Follow-up|0|||
160903366|NCT02468674|581040469|FG002|Overall Study|Lost to Follow-up|0|||
160903367|NCT02468674|581040470|FG003|Overall Study|Lost to Follow-up|0|||
160560209|NCT01355289|579774095|FG000|Core Study|Other|0|||
160560210|NCT01355289|579774096|FG001|Core Study|Other|0|||
160560211|NCT01355289|579774097|FG002|Core Study|Other|0|||
160560212|NCT01355289|579774098|FG003|Core Study|Other|1|||
160560213|NCT01355289|579774099|FG004|Core Study|Other|0|||
160560214|NCT01355289|579774095|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
160560215|NCT01355289|579774096|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
160560216|NCT01355289|579774097|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
160560217|NCT01355289|579774098|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
160560218|NCT01355289|579774099|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
160560219|NCT01355289|579774095|FG000|Open Label Extension|Lost to Follow-up|0|||
160560220|NCT01355289|579774096|FG001|Open Label Extension|Lost to Follow-up|0|||
160560221|NCT01355289|579774097|FG002|Open Label Extension|Lost to Follow-up|0|||
160560222|NCT01355289|579774098|FG003|Open Label Extension|Lost to Follow-up|0|||
160832421|NCT00680368|580773846|FG000|Overall Study|not supervised, not eligible|15|||
160832422|NCT02066415|580773847|FG000|Overall Study|Decision by Sponsor|5|||
160903368|NCT02468674|581040471|FG004|Overall Study|Lost to Follow-up|0|||
160903369|NCT02468674|581040472|FG005|Overall Study|Lost to Follow-up|0|||
160903370|NCT02468674|581040473|FG006|Overall Study|Lost to Follow-up|0|||
160903371|NCT02468674|581040474|FG007|Overall Study|Lost to Follow-up|1|||
160991208|NCT05174065|581355536|FG000|Placebo-controlled Period|Other|0|||
160832423|NCT02066415|580773848|FG001|Overall Study|Decision by Sponsor|4|||
160832424|NCT02066415|580773849|FG002|Overall Study|Decision by Sponsor|2|||
160832425|NCT02066415|580773847|FG000|Overall Study|Withdrawal by Subject|9|||
160832426|NCT02066415|580773848|FG001|Overall Study|Withdrawal by Subject|1|||
160832427|NCT02066415|580773849|FG002|Overall Study|Withdrawal by Subject|4|||
160832428|NCT02066415|580773847|FG000|Overall Study|Lost to Follow-up|7|||
160832429|NCT02066415|580773848|FG001|Overall Study|Lost to Follow-up|2|||
160832430|NCT02066415|580773849|FG002|Overall Study|Lost to Follow-up|2|||
160832431|NCT03242252|580773851|FG000|Overall Study|At the Participant's own Request|18|||
160832432|NCT03242252|580773852|FG001|Overall Study|At the Participant's own Request|10|||
160832433|NCT03242252|580773853|FG002|Overall Study|At the Participant's own Request|15|||
160832434|NCT03242252|580773851|FG000|Overall Study|Adverse Event|8|||
160832435|NCT03242252|580773852|FG001|Overall Study|Adverse Event|6|||
160832436|NCT03242252|580773853|FG002|Overall Study|Adverse Event|9|||
160832437|NCT03242252|580773851|FG000|Overall Study|Poor Compliance to Protocol|0|||
160832438|NCT03242252|580773852|FG001|Overall Study|Poor Compliance to Protocol|2|||
160832439|NCT03242252|580773853|FG002|Overall Study|Poor Compliance to Protocol|3|||
160832440|NCT03242252|580773851|FG000|Overall Study|Study Terminated by Sponsor|1|||
160832441|NCT03242252|580773852|FG001|Overall Study|Study Terminated by Sponsor|0|||
160832442|NCT03242252|580773853|FG002|Overall Study|Study Terminated by Sponsor|0|||
160832443|NCT03242252|580773851|FG000|Overall Study|Reason not Specified|4|||
160832444|NCT03242252|580773852|FG001|Overall Study|Reason not Specified|4|||
160832445|NCT03242252|580773853|FG002|Overall Study|Reason not Specified|1|||
160832446|NCT03242252|580773851|FG000|Overall Study|Lost to Follow-up|5|||
160832447|NCT03242252|580773852|FG001|Overall Study|Lost to Follow-up|1|||
160832448|NCT03242252|580773853|FG002|Overall Study|Lost to Follow-up|4|||
160832449|NCT00106691|580773855|FG000|Overall Study|Adverse Event|60|||
160832450|NCT00106691|580773856|FG001|Overall Study|Adverse Event|64|||
160832451|NCT00106691|580773855|FG000|Overall Study|Lost to Follow-up|23|||
160832452|NCT00106691|580773856|FG001|Overall Study|Lost to Follow-up|18|||
160832453|NCT00106691|580773855|FG000|Overall Study|Physician Decision|18|||
160832454|NCT00106691|580773856|FG001|Overall Study|Physician Decision|21|||
160832455|NCT00106691|580773855|FG000|Overall Study|Protocol Violation|13|||
160832456|NCT00106691|580773856|FG001|Overall Study|Protocol Violation|18|||
160832457|NCT00106691|580773855|FG000|Overall Study|Withdrawal by Subject|75|||
160832458|NCT00106691|580773856|FG001|Overall Study|Withdrawal by Subject|70|||
160832459|NCT00106691|580773855|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
160832460|NCT00106691|580773856|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
160832461|NCT00106691|580773855|FG000|Overall Study|QTc>480|3|||
160832462|NCT00106691|580773856|FG001|Overall Study|QTc>480|1|||
160832463|NCT00106691|580773855|FG000|Overall Study|mililtary deployment|2|||
160832464|NCT00106691|580773856|FG001|Overall Study|mililtary deployment|0|||
160832465|NCT00106691|580773855|FG000|Overall Study|Study Site Closing/PI Moved|1|||
160832466|NCT00106691|580773856|FG001|Overall Study|Study Site Closing/PI Moved|2|||
160832467|NCT00106691|580773855|FG000|Overall Study|Cardiologist recommendation|1|||
160832468|NCT00106691|580773856|FG001|Overall Study|Cardiologist recommendation|0|||
160832469|NCT00106691|580773855|FG000|Overall Study|Pt. moved to another state|1|||
160560223|NCT01355289|579774099|FG004|Open Label Extension|Lost to Follow-up|1|||
160560224|NCT01355289|579774095|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
160560225|NCT01355289|579774096|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
160560226|NCT01355289|579774097|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
160560227|NCT01355289|579774098|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
160560228|NCT01355289|579774099|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
160560229|NCT01355289|579774095|FG000|Open Label Extension|Other|0|||
160560230|NCT01355289|579774096|FG001|Open Label Extension|Other|0|||
160560231|NCT01355289|579774097|FG002|Open Label Extension|Other|0|||
160560232|NCT01355289|579774098|FG003|Open Label Extension|Other|0|||
160560233|NCT01355289|579774099|FG004|Open Label Extension|Other|3|||
160560234|NCT01756456|579774105|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
160560235|NCT01756456|579774106|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
160560236|NCT01756456|579774107|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
160560237|NCT01756456|579774108|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
160560238|NCT01756456|579774109|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
160832470|NCT00106691|580773856|FG001|Overall Study|Pt. moved to another state|0|||
160832471|NCT00106691|580773855|FG000|Overall Study|Taking exclusionary avodart|1|||
160832472|NCT00106691|580773856|FG001|Overall Study|Taking exclusionary avodart|0|||
160832473|NCT00106691|580773855|FG000|Overall Study|Not able to discontinue plavix|0|||
160832474|NCT00106691|580773856|FG001|Overall Study|Not able to discontinue plavix|1|||
160832475|NCT01754194|580773857|FG000|Overall Study|Lost to Follow-up|39|||
160832476|NCT01754194|580773858|FG001|Overall Study|Lost to Follow-up|14|||
160832477|NCT01754194|580773857|FG000|Overall Study|Withdrawal by Subject|4|||
160832478|NCT01754194|580773858|FG001|Overall Study|Withdrawal by Subject|5|||
160832479|NCT01754194|580773857|FG000|Overall Study|Other|9|||
160832480|NCT01754194|580773858|FG001|Overall Study|Other|8|||
160832481|NCT00530920|580773859|FG000|Overall Study|Randomized but not treated|0|||
160560239|NCT01756456|579774110|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
160560240|NCT01756456|579774105|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
160560241|NCT01756456|579774106|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
160832482|NCT00530920|580773860|FG001|Overall Study|Randomized but not treated|2|||
160832483|NCT00530920|580773861|FG002|Overall Study|Randomized but not treated|0|||
160832484|NCT00530920|580773859|FG000|Overall Study|Adverse Event|0|||
160832485|NCT00530920|580773860|FG001|Overall Study|Adverse Event|0|||
160832486|NCT00530920|580773861|FG002|Overall Study|Adverse Event|3|||
160832487|NCT00530920|580773859|FG000|Overall Study|Withdrawal by Subject|0|||
160832488|NCT00530920|580773860|FG001|Overall Study|Withdrawal by Subject|0|||
160832489|NCT00530920|580773861|FG002|Overall Study|Withdrawal by Subject|1|||
160832490|NCT00907296|580773862|FG000|Overall Study|Ineligibility Determined|1|||
160832491|NCT00907296|580773863|FG001|Overall Study|Ineligibility Determined|0|||
160832492|NCT00907296|580773864|FG002|Overall Study|Ineligibility Determined|0|||
160832493|NCT00907296|580773865|FG003|Overall Study|Ineligibility Determined|1|||
160832494|NCT00907296|580773866|FG004|Overall Study|Ineligibility Determined|0|||
160832495|NCT00907296|580773867|FG005|Overall Study|Ineligibility Determined|0|||
160832496|NCT00907296|580773868|FG006|Overall Study|Ineligibility Determined|0|||
160832497|NCT00907296|580773869|FG007|Overall Study|Ineligibility Determined|1|||
160832498|NCT00907296|580773870|FG008|Overall Study|Ineligibility Determined|0|||
160832499|NCT00907296|580773871|FG009|Overall Study|Ineligibility Determined|0|||
160832500|NCT00907296|580773862|FG000|Overall Study|Protocol Deviation|0|||
160832501|NCT00907296|580773863|FG001|Overall Study|Protocol Deviation|1|||
160832502|NCT00907296|580773864|FG002|Overall Study|Protocol Deviation|0|||
160832503|NCT00907296|580773865|FG003|Overall Study|Protocol Deviation|0|||
160832504|NCT00907296|580773866|FG004|Overall Study|Protocol Deviation|0|||
160832505|NCT00907296|580773867|FG005|Overall Study|Protocol Deviation|0|||
160832506|NCT00907296|580773868|FG006|Overall Study|Protocol Deviation|0|||
160832507|NCT00907296|580773869|FG007|Overall Study|Protocol Deviation|0|||
160832508|NCT00907296|580773870|FG008|Overall Study|Protocol Deviation|0|||
160832509|NCT00907296|580773871|FG009|Overall Study|Protocol Deviation|0|||
160832510|NCT00907296|580773862|FG000|Overall Study|Noncompliance|1|||
160832511|NCT00907296|580773863|FG001|Overall Study|Noncompliance|1|||
160832512|NCT00907296|580773864|FG002|Overall Study|Noncompliance|1|||
160832513|NCT00907296|580773865|FG003|Overall Study|Noncompliance|0|||
160832514|NCT00907296|580773866|FG004|Overall Study|Noncompliance|0|||
160832515|NCT00907296|580773867|FG005|Overall Study|Noncompliance|1|||
160832516|NCT00907296|580773868|FG006|Overall Study|Noncompliance|0|||
160832517|NCT00907296|580773869|FG007|Overall Study|Noncompliance|2|||
160832518|NCT00907296|580773870|FG008|Overall Study|Noncompliance|0|||
160832519|NCT00907296|580773871|FG009|Overall Study|Noncompliance|0|||
160832520|NCT00907296|580773862|FG000|Overall Study|Adverse Event|2|||
160832521|NCT00907296|580773863|FG001|Overall Study|Adverse Event|0|||
160832522|NCT00907296|580773864|FG002|Overall Study|Adverse Event|0|||
160832523|NCT00907296|580773865|FG003|Overall Study|Adverse Event|0|||
160832524|NCT00907296|580773866|FG004|Overall Study|Adverse Event|0|||
160832525|NCT00907296|580773867|FG005|Overall Study|Adverse Event|0|||
160832526|NCT00907296|580773868|FG006|Overall Study|Adverse Event|1|||
160832527|NCT00907296|580773869|FG007|Overall Study|Adverse Event|0|||
160832528|NCT00907296|580773870|FG008|Overall Study|Adverse Event|0|||
160832529|NCT00907296|580773871|FG009|Overall Study|Adverse Event|1|||
160832530|NCT00907296|580773862|FG000|Overall Study|Withdrawal by Subject|7|||
160832531|NCT00907296|580773863|FG001|Overall Study|Withdrawal by Subject|2|||
160832532|NCT00907296|580773864|FG002|Overall Study|Withdrawal by Subject|1|||
160560242|NCT01756456|579774107|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
160560243|NCT01756456|579774108|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
160560244|NCT01756456|579774109|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
160560245|NCT01756456|579774110|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
160832533|NCT00907296|580773865|FG003|Overall Study|Withdrawal by Subject|1|||
160832534|NCT00907296|580773866|FG004|Overall Study|Withdrawal by Subject|1|||
160832535|NCT00907296|580773867|FG005|Overall Study|Withdrawal by Subject|5|||
160832536|NCT00907296|580773868|FG006|Overall Study|Withdrawal by Subject|3|||
160832537|NCT00907296|580773869|FG007|Overall Study|Withdrawal by Subject|2|||
160832538|NCT00907296|580773870|FG008|Overall Study|Withdrawal by Subject|4|||
160832539|NCT00907296|580773871|FG009|Overall Study|Withdrawal by Subject|2|||
160832540|NCT00907296|580773862|FG000|Overall Study|Lost to Follow-up|9|||
160832541|NCT00907296|580773863|FG001|Overall Study|Lost to Follow-up|1|||
160832542|NCT00907296|580773864|FG002|Overall Study|Lost to Follow-up|0|||
160832543|NCT00907296|580773865|FG003|Overall Study|Lost to Follow-up|2|||
160832544|NCT00907296|580773866|FG004|Overall Study|Lost to Follow-up|0|||
160832545|NCT00907296|580773867|FG005|Overall Study|Lost to Follow-up|3|||
160832546|NCT00907296|580773868|FG006|Overall Study|Lost to Follow-up|2|||
160832547|NCT00907296|580773869|FG007|Overall Study|Lost to Follow-up|2|||
160832548|NCT00907296|580773870|FG008|Overall Study|Lost to Follow-up|0|||
160832549|NCT00907296|580773871|FG009|Overall Study|Lost to Follow-up|4|||
160832550|NCT02392403|580773873|FG000|Overall Study|Adverse Event|1|||
160832551|NCT02392403|580773873|FG000|Overall Study|Death|1|||
160832552|NCT02392403|580773873|FG000|Overall Study|Withdrawal by Subject|1|||
160832553|NCT00316888|580773879|FG000|Overall Study|Adverse Event|4|||
160832554|NCT00316888|580773880|FG001|Overall Study|Adverse Event|5|||
160832555|NCT00316888|580773879|FG000|Overall Study|Withdrawal by Subject|2|||
160832556|NCT00316888|580773880|FG001|Overall Study|Withdrawal by Subject|2|||
160832557|NCT00316888|580773879|FG000|Overall Study|Not start protocol therapy|0|||
160832558|NCT00316888|580773880|FG001|Overall Study|Not start protocol therapy|1|||
160832559|NCT00657371|580773884|FG000|Overall Study|Poor bowel preparation|15|||
160832560|NCT00657371|580773884|FG000|Overall Study|Unable to intubate the cecum|5|||
160832561|NCT00657371|580773884|FG000|Overall Study|Protocol Violation|2|||
160832562|NCT00657371|580773884|FG000|Overall Study|Device- related reasons|13|||
160832563|NCT00657371|580773884|FG000|Overall Study|Pre-existing medical condition|4|||
160832564|NCT00652899|580773885|FG000|Overall Study|Death|1|||
160832565|NCT00652899|580773885|FG000|Overall Study|Treating physician decision|1|||
160832566|NCT04135859|580773886|FG000|Overall Study|Withdrawal by Subject|1|||
160832567|NCT04135859|580773887|FG001|Overall Study|Withdrawal by Subject|0|||
160832568|NCT04135859|580773886|FG000|Overall Study|Withdrawal due to screening failure|1|||
160832569|NCT04135859|580773887|FG001|Overall Study|Withdrawal due to screening failure|2|||
160832570|NCT04135859|580773886|FG000|Overall Study|Did not complete stress test|3|||
160832571|NCT04135859|580773887|FG001|Overall Study|Did not complete stress test|3|||
160832572|NCT04135859|580773886|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
160832573|NCT04135859|580773887|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
160832574|NCT01600053|580773888|FG000|Overall Study|Adverse Event|2|||
160832575|NCT01600053|580773888|FG000|Overall Study|trial will not meet the interim endpoint|9|||
160832576|NCT01565941|580773889|FG000|Overall Study|Withdrawn by parent/guardian|3|||
160832577|NCT01565941|580773890|FG001|Overall Study|Withdrawn by parent/guardian|2|||
160832578|NCT01565941|580773889|FG000|Overall Study|Randomized; did not receive intevention|8|||
160832579|NCT01565941|580773890|FG001|Overall Study|Randomized; did not receive intevention|2|||
160832580|NCT03230292|580773893|FG000|Overall Study|Adverse Event|1|||
160832581|NCT03230292|580773893|FG000|Overall Study|Protocol Violation|1|||
160832582|NCT03230292|580773893|FG000|Overall Study|Lost to Follow-up|1|||
160832583|NCT03230292|580773893|FG000|Overall Study|Withdrawal by Subject|3|||
160832584|NCT02855944|580773894|FG000|Period 1: Treatment|Ongoing|14|||
160832585|NCT02855944|580773895|FG001|Period 1: Treatment|Ongoing|0|||
160832586|NCT02855944|580773894|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
160832587|NCT02855944|580773895|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
160832588|NCT02855944|580773894|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
160832589|NCT02855944|580773895|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
160832590|NCT03629912|580773903|FG000|Overall Study|Lost to Follow-up|19|||
160832591|NCT03629912|580773904|FG001|Overall Study|Lost to Follow-up|7|||
160832592|NCT03629912|580773905|FG002|Overall Study|Lost to Follow-up|5|||
160832593|NCT03629912|580773906|FG003|Overall Study|Lost to Follow-up|1|||
160832594|NCT03629912|580773903|FG000|Overall Study|Withdrawal by Subject|6|||
160832595|NCT03629912|580773904|FG001|Overall Study|Withdrawal by Subject|0|||
160832596|NCT03629912|580773905|FG002|Overall Study|Withdrawal by Subject|1|||
160832597|NCT03629912|580773906|FG003|Overall Study|Withdrawal by Subject|2|||
160832598|NCT03629912|580773903|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
160832599|NCT03629912|580773904|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
160832600|NCT03629912|580773905|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
160832601|NCT03629912|580773906|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
160832602|NCT03629912|580773903|FG000|Overall Study|Death|1|||
160832603|NCT03629912|580773904|FG001|Overall Study|Death|0|||
160832604|NCT03629912|580773905|FG002|Overall Study|Death|0|||
160832605|NCT03629912|580773906|FG003|Overall Study|Death|0|||
160832606|NCT02365285|580773909|FG000|Overall Study|Physician Decision|0|||
160832607|NCT02365285|580773910|FG001|Overall Study|Physician Decision|1|||
160832608|NCT02365285|580773911|FG002|Overall Study|Physician Decision|1|||
160832609|NCT02365285|580773912|FG003|Overall Study|Physician Decision|0|||
160832610|NCT02365285|580773909|FG000|Overall Study|Adverse Event|0|||
160832611|NCT02365285|580773910|FG001|Overall Study|Adverse Event|0|||
160832612|NCT02365285|580773911|FG002|Overall Study|Adverse Event|0|||
160832613|NCT02365285|580773912|FG003|Overall Study|Adverse Event|2|||
160832614|NCT03262116|580773913|FG000|Overall Study|Physician Decision|0|||
160832615|NCT03262116|580773914|FG001|Overall Study|Physician Decision|2|||
160832616|NCT03262116|580773915|FG002|Overall Study|Physician Decision|1|||
160832617|NCT03262116|580773916|FG003|Overall Study|Physician Decision|1|||
160832618|NCT03262116|580773917|FG004|Overall Study|Physician Decision|1|||
160832619|NCT03262116|580773918|FG005|Overall Study|Physician Decision|2|||
160832620|NCT02608450|580773921|FG000|Overall Study|Lost to Follow-up|39|||
160832621|NCT02608450|580773922|FG001|Overall Study|Lost to Follow-up|32|||
160832622|NCT02608450|580773921|FG000|Overall Study|Withdrawal by Subject|21|||
160832623|NCT02608450|580773922|FG001|Overall Study|Withdrawal by Subject|15|||
160832624|NCT02608450|580773921|FG000|Overall Study|Adverse Event|3|||
160832625|NCT02608450|580773922|FG001|Overall Study|Adverse Event|6|||
160832626|NCT02608450|580773921|FG000|Overall Study|Withdrawal by parent|2|||
160832627|NCT02608450|580773922|FG001|Overall Study|Withdrawal by parent|3|||
160832628|NCT02608450|580773921|FG000|Overall Study|Lack of Efficacy|0|||
160832629|NCT02608450|580773922|FG001|Overall Study|Lack of Efficacy|3|||
160832630|NCT02608450|580773921|FG000|Overall Study|Noncompliance with study drug|0|||
160832631|NCT02608450|580773922|FG001|Overall Study|Noncompliance with study drug|2|||
160832632|NCT02608450|580773921|FG000|Overall Study|Physician Decision|0|||
160832633|NCT02608450|580773922|FG001|Overall Study|Physician Decision|1|||
160832634|NCT02608450|580773921|FG000|Overall Study|Pregnancy|0|||
160832635|NCT02608450|580773922|FG001|Overall Study|Pregnancy|1|||
160832636|NCT02608450|580773921|FG000|Overall Study|Progressive disease|1|||
160832637|NCT02608450|580773922|FG001|Overall Study|Progressive disease|0|||
160832638|NCT02608450|580773921|FG000|Overall Study|Multiple reasons|0|||
160832639|NCT02608450|580773922|FG001|Overall Study|Multiple reasons|2|||
160832640|NCT00635089|580773924|FG000|Overall Study|Adverse Event|7|||
160832641|NCT00635089|580773924|FG000|Overall Study|Lack of Efficacy|28|||
160832642|NCT00635089|580773924|FG000|Overall Study|Protocol Deviation|4|||
160832643|NCT00635089|580773924|FG000|Overall Study|Lost to Follow-up|8|||
160832644|NCT00635089|580773924|FG000|Overall Study|Other|31|||
160832645|NCT01617447|580773925|FG000|Overall Study|Adverse Event|0|||
160832646|NCT01617447|580773926|FG001|Overall Study|Adverse Event|1|||
160832647|NCT01617447|580773925|FG000|Overall Study|Physician Decision|0|||
160832648|NCT01617447|580773926|FG001|Overall Study|Physician Decision|2|||
160832649|NCT02636946|580773928|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
160832650|NCT02636946|580773929|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
160832651|NCT02636946|580773928|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
160832652|NCT02636946|580773929|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
160832653|NCT02636946|580773928|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
160832654|NCT02636946|580773929|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
160832655|NCT02636946|580773928|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
160832656|NCT02636946|580773929|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
160832657|NCT02636946|580773928|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
160832658|NCT02636946|580773929|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
160832659|NCT02636946|580773928|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
160832660|NCT02636946|580773929|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
160832661|NCT01283542|580773930|FG000|Main Phase|Acute or progressive vision loss|1|||
160832662|NCT01283542|580773930|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
160832663|NCT01283542|580773930|FG000|Main Phase|abnormal laboratory values|5|||
160832664|NCT01283542|580773930|FG000|Extension Phase|Physician Decision|1|||
160832665|NCT01283542|580773930|FG000|Extension Phase|Adverse Event|1|||
160832666|NCT01283542|580773930|FG000|Extension Phase|Administrative problems|1|||
160832667|NCT05059977|580773931|FG000|Overall Study|Withdrawal by Subject|0|||
160832668|NCT05059977|580773932|FG001|Overall Study|Withdrawal by Subject|0|||
160832669|NCT05059977|580773933|FG002|Overall Study|Withdrawal by Subject|1|||
160832670|NCT04405245|580773934|FG000|Overall Study|Adverse Event|0|||
160832671|NCT04405245|580773935|FG001|Overall Study|Adverse Event|1|||
160832672|NCT04405245|580773936|FG002|Overall Study|Adverse Event|0|||
160832673|NCT00576472|580773938|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832674|NCT00576472|580773939|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832675|NCT00576472|580773940|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832676|NCT00576472|580773941|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
160832677|NCT00576472|580773942|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832678|NCT00576472|580773943|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832679|NCT00576472|580773944|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832680|NCT00576472|580773945|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832681|NCT00576472|580773946|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832682|NCT00576472|580773947|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
160991209|NCT05174065|581355537|FG001|Placebo-controlled Period|Other|1|||
160832683|NCT00576472|580773948|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832684|NCT00576472|580773949|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832685|NCT00576472|580773950|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832686|NCT00576472|580773951|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832687|NCT00576472|580773952|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832688|NCT00576472|580773938|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
160832689|NCT00576472|580773939|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
160832690|NCT00576472|580773940|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
160832691|NCT00576472|580773941|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
160832692|NCT00576472|580773942|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
160832693|NCT00576472|580773943|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
160832694|NCT00576472|580773944|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
160832695|NCT00576472|580773945|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
160832696|NCT00576472|580773946|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
160832697|NCT00576472|580773947|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
160832698|NCT00576472|580773948|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
160832699|NCT00576472|580773949|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
160832700|NCT00576472|580773950|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
160832701|NCT00576472|580773951|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
160832702|NCT00576472|580773952|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
160832703|NCT00576472|580773938|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832704|NCT00576472|580773939|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832705|NCT00576472|580773940|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832706|NCT00576472|580773941|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
160832707|NCT00576472|580773942|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832708|NCT00576472|580773943|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832709|NCT00576472|580773944|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832710|NCT00576472|580773945|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832711|NCT00576472|580773946|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832712|NCT00576472|580773947|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832713|NCT00576472|580773948|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832714|NCT00576472|580773949|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832715|NCT00576472|580773950|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832716|NCT00576472|580773951|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832717|NCT00576472|580773952|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832718|NCT00576472|580773938|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
160832719|NCT00576472|580773939|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
160832720|NCT00576472|580773940|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
160832721|NCT00576472|580773941|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
160832722|NCT00576472|580773942|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
160832723|NCT00576472|580773943|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
160832724|NCT00576472|580773944|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
160832725|NCT00576472|580773945|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
160832726|NCT00576472|580773946|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
160832727|NCT00576472|580773947|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
160832728|NCT00576472|580773948|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
160832729|NCT00576472|580773949|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
160832730|NCT00576472|580773950|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
160832731|NCT00576472|580773951|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
160832732|NCT00576472|580773952|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
160832733|NCT00576472|580773938|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832734|NCT00576472|580773939|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832735|NCT00576472|580773940|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832736|NCT00576472|580773941|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
160832737|NCT00576472|580773942|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832738|NCT00576472|580773943|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832739|NCT00576472|580773944|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832740|NCT00576472|580773945|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832741|NCT00576472|580773946|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832742|NCT00576472|580773947|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832743|NCT00576472|580773948|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832744|NCT00576472|580773949|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832745|NCT00576472|580773950|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832746|NCT00576472|580773951|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832747|NCT00576472|580773952|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832748|NCT00576472|580773938|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832749|NCT00576472|580773939|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832750|NCT00576472|580773940|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832751|NCT00576472|580773941|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832752|NCT00576472|580773942|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832753|NCT00576472|580773943|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832754|NCT00576472|580773944|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
160903372|NCT02468674|581040475|FG008|Overall Study|Lost to Follow-up|1|||
160903373|NCT02468674|581040467|FG000|Overall Study|Physician Decision|0|||
160560246|NCT01756456|579774105|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
160560247|NCT01756456|579774106|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
160903374|NCT02468674|581040468|FG001|Overall Study|Physician Decision|0|||
160903375|NCT02468674|581040469|FG002|Overall Study|Physician Decision|0|||
160832755|NCT00576472|580773945|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832756|NCT00576472|580773946|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832757|NCT00576472|580773947|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832758|NCT00576472|580773948|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832759|NCT00576472|580773949|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832760|NCT00576472|580773950|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832761|NCT00576472|580773951|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832762|NCT00576472|580773952|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
160903376|NCT02468674|581040470|FG003|Overall Study|Physician Decision|0|||
160832763|NCT00576472|580773938|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
160832764|NCT00576472|580773939|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
160832765|NCT00576472|580773940|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
160832766|NCT00576472|580773941|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
160832767|NCT00576472|580773942|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
160832768|NCT00576472|580773943|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
160832769|NCT00576472|580773944|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
160832770|NCT00576472|580773945|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
160832771|NCT00576472|580773946|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
160832772|NCT00576472|580773947|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
160832773|NCT00576472|580773948|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
160832774|NCT00576472|580773949|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
160832775|NCT00576472|580773950|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
160832776|NCT00576472|580773951|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
160832777|NCT00576472|580773952|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
160832778|NCT00576472|580773938|FG000|MPH Cross Over Phase|Physician Decision|0|||
160832779|NCT00576472|580773939|FG001|MPH Cross Over Phase|Physician Decision|0|||
160832780|NCT00576472|580773940|FG002|MPH Cross Over Phase|Physician Decision|0|||
160832781|NCT00576472|580773941|FG003|MPH Cross Over Phase|Physician Decision|0|||
160832782|NCT00576472|580773942|FG004|MPH Cross Over Phase|Physician Decision|0|||
160832783|NCT00576472|580773943|FG005|MPH Cross Over Phase|Physician Decision|0|||
160832784|NCT00576472|580773944|FG006|MPH Cross Over Phase|Physician Decision|4|||
160832785|NCT00576472|580773945|FG007|MPH Cross Over Phase|Physician Decision|0|||
160832786|NCT00576472|580773946|FG008|MPH Cross Over Phase|Physician Decision|0|||
160832787|NCT00576472|580773947|FG009|MPH Cross Over Phase|Physician Decision|0|||
160832788|NCT00576472|580773948|FG010|MPH Cross Over Phase|Physician Decision|0|||
160832789|NCT00576472|580773949|FG011|MPH Cross Over Phase|Physician Decision|0|||
160832790|NCT00576472|580773950|FG012|MPH Cross Over Phase|Physician Decision|0|||
160832791|NCT00576472|580773951|FG013|MPH Cross Over Phase|Physician Decision|0|||
160832792|NCT00576472|580773952|FG014|MPH Cross Over Phase|Physician Decision|0|||
160832793|NCT00576472|580773938|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832794|NCT00576472|580773939|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832795|NCT00576472|580773940|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832796|NCT00576472|580773941|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832797|NCT00576472|580773942|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832798|NCT00576472|580773943|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832799|NCT00576472|580773944|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832800|NCT00576472|580773945|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832801|NCT00576472|580773946|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
160832802|NCT00576472|580773947|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832803|NCT00576472|580773948|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
160832804|NCT00576472|580773949|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
160832805|NCT00576472|580773950|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832806|NCT00576472|580773951|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832807|NCT00576472|580773952|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832808|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832809|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832810|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832811|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832812|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832813|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832814|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832815|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832816|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832817|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832818|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832819|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832820|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832821|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
160832822|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832823|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
160832824|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
160832825|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
160832826|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
160832827|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
160832828|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
160560248|NCT01756456|579774107|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
160560249|NCT01756456|579774108|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
160560250|NCT01756456|579774109|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
160560251|NCT01756456|579774110|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
160560252|NCT01756456|579774105|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
160560253|NCT01756456|579774106|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
160560254|NCT01756456|579774107|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
160560255|NCT01756456|579774108|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
160560256|NCT01756456|579774109|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
160560257|NCT01756456|579774110|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
160560258|NCT01756456|579774105|FG000|Treatment Period: Phase I/II|Other causes|0|||
160560259|NCT01756456|579774106|FG001|Treatment Period: Phase I/II|Other causes|0|||
160560260|NCT01756456|579774107|FG002|Treatment Period: Phase I/II|Other causes|0|||
160560261|NCT01756456|579774108|FG003|Treatment Period: Phase I/II|Other causes|1|||
160560262|NCT01756456|579774109|FG004|Treatment Period: Phase I/II|Other causes|2|||
160560263|NCT01756456|579774110|FG005|Treatment Period: Phase I/II|Other causes|2|||
160560264|NCT01756456|579774105|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
160560265|NCT01756456|579774106|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
160560266|NCT01756456|579774107|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
160560267|NCT01756456|579774108|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
160560268|NCT01756456|579774109|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
160560269|NCT01756456|579774110|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
160560270|NCT01756456|579774105|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
160560271|NCT01756456|579774106|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
160832829|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
160832830|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
160832831|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
160832832|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
160832833|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
160832834|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
160832835|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
160832836|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
160832837|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
160832838|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
160832839|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
160832840|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
160832841|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
160832842|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
160832843|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
160832844|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
160832845|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
160832846|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
160832847|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
160832848|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
160832849|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
160832850|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
160832851|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
160832852|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
160832853|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Side effects|0|||
160832854|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Side effects|0|||
160832855|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Side effects|0|||
160832856|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Side effects|0|||
160832857|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Side effects|0|||
160832858|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Side effects|0|||
160560272|NCT01756456|579774107|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
160560273|NCT01756456|579774108|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
160560274|NCT01756456|579774109|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
160560275|NCT01756456|579774110|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
160560276|NCT01756456|579774105|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
160560277|NCT01756456|579774106|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
160560278|NCT01756456|579774107|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
160832859|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Side effects|0|||
160832860|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Side effects|0|||
160832861|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Side effects|0|||
160832862|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Side effects|0|||
160832863|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Side effects|0|||
160832864|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Side effects|0|||
160832865|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Side effects|0|||
160832866|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Side effects|0|||
160832867|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Side effects|8|||
160832868|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832869|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832870|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832871|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832872|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832873|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832874|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832875|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832876|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832877|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832878|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832879|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832880|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832881|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832882|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
160832883|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
160832884|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
160832885|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
160832886|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
160832887|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
160832888|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
160832889|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
160832890|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
160832891|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
160832892|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
160832893|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
160832894|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
160832895|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
160832896|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
160832897|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
160832898|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832899|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832900|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832901|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832902|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832903|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832904|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832905|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832906|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832907|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832908|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832909|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832910|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832911|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160560279|NCT01756456|579774108|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
160560280|NCT01756456|579774109|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
160560281|NCT01756456|579774110|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
160560282|NCT01756456|579774105|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
160560283|NCT01756456|579774106|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
160560284|NCT01756456|579774107|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
160560285|NCT01756456|579774108|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
160560286|NCT01756456|579774109|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
160560287|NCT01756456|579774110|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
160560288|NCT01756456|579774105|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
160560289|NCT01756456|579774106|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
160560290|NCT01756456|579774107|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
160560291|NCT01756456|579774108|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
160560292|NCT01756456|579774109|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
160560293|NCT01756456|579774110|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
160560294|NCT01756456|579774105|FG000|Follow Up Period Phase I/II|Other causes|0|||
160560295|NCT01756456|579774106|FG001|Follow Up Period Phase I/II|Other causes|0|||
160832912|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
160832913|NCT03443427|580773953|FG000|Overall Study|Adverse Event|2|||
160832914|NCT03443427|580773954|FG001|Overall Study|Adverse Event|3|||
160832915|NCT03443427|580773953|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
160832916|NCT03443427|580773954|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
160832917|NCT03443427|580773953|FG000|Overall Study|Other|4|||
160832918|NCT03443427|580773954|FG001|Overall Study|Other|6|||
160832919|NCT00780273|580773957|FG000|Overall Study|Death|1|||
160832920|NCT00780273|580773957|FG000|Overall Study|Lost to Follow-up|1|||
160832921|NCT02576860|580773958|FG000|Overall Study|Adverse Event|6|||
160832922|NCT02576860|580773959|FG001|Overall Study|Adverse Event|6|||
160832923|NCT02576860|580773958|FG000|Overall Study|Lost to Follow-up|5|||
160832924|NCT02576860|580773959|FG001|Overall Study|Lost to Follow-up|7|||
160832925|NCT02576860|580773958|FG000|Overall Study|Physician Decision|0|||
160832926|NCT02576860|580773959|FG001|Overall Study|Physician Decision|1|||
160832927|NCT02576860|580773958|FG000|Overall Study|Protocol Violation|0|||
160832928|NCT02576860|580773959|FG001|Overall Study|Protocol Violation|2|||
160832929|NCT02576860|580773958|FG000|Overall Study|Withdrawal by Subject|13|||
160832930|NCT02576860|580773959|FG001|Overall Study|Withdrawal by Subject|8|||
160832931|NCT02576860|580773958|FG000|Overall Study|Disallowed medication|1|||
160832932|NCT02576860|580773959|FG001|Overall Study|Disallowed medication|0|||
160832933|NCT02391961|580773960|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
160832934|NCT02391961|580773961|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
160832935|NCT02391961|580773960|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
160832936|NCT02391961|580773961|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
160832937|NCT02391961|580773960|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160832938|NCT02391961|580773961|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160832939|NCT02308488|580773964|FG000|Overall Study|Withdrawal by Subject|2|||
160832940|NCT01541917|580773965|FG000|Overall Study|Lost to Follow-up|2|||
160832941|NCT01541917|580773966|FG001|Overall Study|Lost to Follow-up|2|||
160832942|NCT01541917|580773965|FG000|Overall Study|Withdrawal by Subject|13|||
160832943|NCT01541917|580773966|FG001|Overall Study|Withdrawal by Subject|7|||
160832944|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
160832945|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
160832946|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
160832947|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
160832948|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
160832949|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
160832950|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
160832951|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
160647572|NCT02811861|580092761|FG001|Overall Study|Lost to Follow-up|0|||
160647573|NCT02811861|580092762|FG002|Overall Study|Lost to Follow-up|1|||
160832952|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
160832953|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
160832954|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
160832955|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
160560296|NCT01756456|579774107|FG002|Follow Up Period Phase I/II|Other causes|0|||
160647574|NCT02811861|580092760|FG000|Overall Study|Subject Choice|29|||
160832956|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
160832957|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
160832958|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
160832959|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
160832960|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
160832961|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
160832962|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
160862008|NCT03804528|580887919|FG000|Overall Study|Health Reasons|5|||
160560297|NCT01756456|579774108|FG003|Follow Up Period Phase I/II|Other causes|1|||
160560298|NCT01756456|579774109|FG004|Follow Up Period Phase I/II|Other causes|3|||
160560299|NCT01756456|579774110|FG005|Follow Up Period Phase I/II|Other causes|5|||
160560300|NCT02706938|579774113|FG000|First Period, 6 Weeks|Adverse Event|8|||
160560301|NCT02706938|579774114|FG001|First Period, 6 Weeks|Adverse Event|0|||
160560302|NCT02706938|579774113|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
160560303|NCT02706938|579774114|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
160560304|NCT02706938|579774113|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
160560305|NCT02706938|579774114|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
160560306|NCT02706938|579774113|FG000|Second Period, 6 Weeks|Adverse Event|0|||
160560307|NCT02706938|579774114|FG001|Second Period, 6 Weeks|Adverse Event|7|||
160560308|NCT02706938|579774113|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
160560309|NCT02706938|579774114|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
160560310|NCT02507349|579774115|FG000|Overall Study|Death|12|||
160560311|NCT02507349|579774116|FG001|Overall Study|Death|16|||
160560312|NCT02507349|579774115|FG000|Overall Study|Withdrawal by Subject|1|||
160560313|NCT02507349|579774116|FG001|Overall Study|Withdrawal by Subject|1|||
160560314|NCT02507349|579774115|FG000|Overall Study|Lost to Follow-up|174|||
160560315|NCT02507349|579774116|FG001|Overall Study|Lost to Follow-up|144|||
160560316|NCT00813995|579774117|FG000|Overall Study|Clinical adverse event|9|||
160560317|NCT00813995|579774118|FG001|Overall Study|Clinical adverse event|3|||
160560318|NCT00813995|579774117|FG000|Overall Study|Laboratory adverse event|0|||
160560319|NCT00813995|579774118|FG001|Overall Study|Laboratory adverse event|2|||
160832963|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
160832964|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
160832965|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
160832966|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
160832967|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
160832968|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
160832969|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
160832970|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
160832971|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
160832972|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
160832973|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
160832974|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Other Reason|1|||
160832975|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Other Reason|0|||
160832976|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Other Reason|0|||
160560320|NCT00813995|579774117|FG000|Overall Study|Lack of Efficacy|1|||
160560321|NCT00813995|579774118|FG001|Overall Study|Lack of Efficacy|0|||
160832977|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Other Reason|0|||
160832978|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Other Reason|0|||
160832979|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
160832980|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
160832981|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
160832982|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
160832983|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
160832984|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
160832985|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
160832986|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
160832987|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
160832988|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
160832989|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
160832990|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
160832991|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
160903377|NCT02468674|581040471|FG004|Overall Study|Physician Decision|0|||
160903378|NCT02468674|581040472|FG005|Overall Study|Physician Decision|0|||
160903379|NCT02468674|581040473|FG006|Overall Study|Physician Decision|1|||
160903380|NCT02468674|581040474|FG007|Overall Study|Physician Decision|0|||
160903381|NCT02468674|581040475|FG008|Overall Study|Physician Decision|0|||
160903382|NCT02468674|581040467|FG000|Overall Study|Patient/Guardian Decision|0|||
160903383|NCT02468674|581040468|FG001|Overall Study|Patient/Guardian Decision|0|||
160903384|NCT02468674|581040469|FG002|Overall Study|Patient/Guardian Decision|0|||
160903385|NCT02468674|581040470|FG003|Overall Study|Patient/Guardian Decision|0|||
160903386|NCT02468674|581040471|FG004|Overall Study|Patient/Guardian Decision|1|||
160903387|NCT02468674|581040472|FG005|Overall Study|Patient/Guardian Decision|0|||
160903388|NCT02468674|581040473|FG006|Overall Study|Patient/Guardian Decision|0|||
160560322|NCT00813995|579774117|FG000|Overall Study|Lost to Follow-up|4|||
160560323|NCT00813995|579774118|FG001|Overall Study|Lost to Follow-up|2|||
160560324|NCT00813995|579774117|FG000|Overall Study|Other reason|2|||
160560325|NCT00813995|579774118|FG001|Overall Study|Other reason|2|||
160560326|NCT00813995|579774117|FG000|Overall Study|Protocol Violation|3|||
160560327|NCT00813995|579774118|FG001|Overall Study|Protocol Violation|2|||
160560328|NCT00813995|579774117|FG000|Overall Study|Subject moved|4|||
160832992|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
160832993|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
160832994|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
160832995|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
160832996|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
160832997|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
160832998|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
160832999|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
160833000|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
160833001|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
160833002|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
160833003|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
160833004|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
160833005|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
160833006|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
160833007|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
160833008|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
160833009|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
160833010|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
160833011|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
160833012|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
160833013|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
160833014|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
160833015|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
160833016|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
160833017|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
160833018|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
160833019|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Death|0|||
160833020|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Death|0|||
160833021|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Death|0|||
160833022|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Death|1|||
160833023|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Death|0|||
160833024|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Missing|0|||
160833025|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Missing|0|||
160833026|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Missing|1|||
160833027|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Missing|0|||
160833028|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Missing|0|||
160833029|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
160833030|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
160833031|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
160903389|NCT02468674|581040474|FG007|Overall Study|Patient/Guardian Decision|2|||
160560329|NCT00813995|579774118|FG001|Overall Study|Subject moved|0|||
160560330|NCT00813995|579774117|FG000|Overall Study|Withdrawal by Subject|0|||
160833032|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
160833033|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
160903390|NCT02468674|581040475|FG008|Overall Study|Patient/Guardian Decision|1|||
160903391|NCT02468674|581040467|FG000|Overall Study|Protocol Deviation|0|||
160903392|NCT02468674|581040468|FG001|Overall Study|Protocol Deviation|0|||
160560331|NCT00813995|579774118|FG001|Overall Study|Withdrawal by Subject|5|||
160833034|NCT03263780|580773972|FG000|Overall Study|Withdrawal by Subject|3|||
160560332|NCT02700984|579774120|FG000|Overall Study|Death|2|||
160560333|NCT02700984|579774121|FG001|Overall Study|Death|1|||
160560334|NCT02700984|579774120|FG000|Overall Study|Lost to Follow-up|2|||
160560335|NCT02700984|579774121|FG001|Overall Study|Lost to Follow-up|1|||
160560336|NCT02700984|579774120|FG000|Overall Study|Physician Decision|0|||
160560337|NCT02700984|579774121|FG001|Overall Study|Physician Decision|1|||
160560338|NCT02700984|579774120|FG000|Overall Study|Withdrawal by Subject|8|||
160833035|NCT03263780|580773972|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
160833036|NCT01565564|580773983|FG000|Overall Study|Lost to Follow-up|5|||
160833037|NCT01565564|580773984|FG001|Overall Study|Lost to Follow-up|1|||
160833038|NCT03995355|580773985|FG000|Overall Study|Adverse Event|1|||
160560339|NCT02700984|579774121|FG001|Overall Study|Withdrawal by Subject|9|||
160560340|NCT02700984|579774120|FG000|Overall Study|Reason not specified|3|||
160560341|NCT02700984|579774121|FG001|Overall Study|Reason not specified|2|||
160560342|NCT02868892|579774122|FG000|Overall Study|Investigator left site and no follow-up|6|||
160560343|NCT01360996|579774130|FG000|Overall Study|Withdrawal by Subject|4|||
160560344|NCT01360996|579774131|FG001|Overall Study|Withdrawal by Subject|3|||
160560345|NCT01360996|579774132|FG002|Overall Study|Withdrawal by Subject|2|||
160560346|NCT01360996|579774130|FG000|Overall Study|Noncompliant|2|||
160560347|NCT01360996|579774131|FG001|Overall Study|Noncompliant|0|||
160560348|NCT01360996|579774132|FG002|Overall Study|Noncompliant|0|||
160560349|NCT03377634|579774133|FG000|Study Period|Adverse Event|1|||
160560350|NCT03377634|579774134|FG001|Study Period|Adverse Event|0|||
160560351|NCT03377634|579774133|FG000|Study Period|Withdrawal by Subject|1|||
160560352|NCT03377634|579774134|FG001|Study Period|Withdrawal by Subject|0|||
160560353|NCT01454076|579774135|FG000|Overall Study|Other|2|||
160560354|NCT01454076|579774136|FG001|Overall Study|Other|0|||
160560355|NCT01454076|579774137|FG002|Overall Study|Other|0|||
160560356|NCT01454076|579774138|FG003|Overall Study|Other|1|||
160560357|NCT01454076|579774139|FG004|Overall Study|Other|2|||
160560358|NCT01454076|579774135|FG000|Overall Study|Withdrawal by Subject|3|||
160560359|NCT01454076|579774136|FG001|Overall Study|Withdrawal by Subject|4|||
160560360|NCT01454076|579774137|FG002|Overall Study|Withdrawal by Subject|2|||
160560361|NCT01454076|579774138|FG003|Overall Study|Withdrawal by Subject|1|||
160560362|NCT01454076|579774139|FG004|Overall Study|Withdrawal by Subject|2|||
160560363|NCT01454076|579774135|FG000|Overall Study|Adverse Event|8|||
160560364|NCT01454076|579774136|FG001|Overall Study|Adverse Event|2|||
160560365|NCT01454076|579774137|FG002|Overall Study|Adverse Event|7|||
160560366|NCT01454076|579774138|FG003|Overall Study|Adverse Event|0|||
160560367|NCT01454076|579774139|FG004|Overall Study|Adverse Event|2|||
160560368|NCT00291551|579774141|FG000|Overall Study|Death|7|||
160560369|NCT00291551|579774141|FG000|Overall Study|Withdrawal by Subject|6|||
160560370|NCT02452762|579774142|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
160560371|NCT02452762|579774143|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
160560372|NCT02452762|579774142|FG000|Overall Study|Withdrawal by Subject|1|||
160560373|NCT02452762|579774143|FG001|Overall Study|Withdrawal by Subject|0|||
160560374|NCT00631137|579774144|FG000|Overall Study|Withdrawal by Subject|1|||
160560375|NCT00631137|579774145|FG001|Overall Study|Withdrawal by Subject|0|||
160560376|NCT01015833|579774146|FG000|Overall Study|Death|1|||
160560377|NCT01015833|579774147|FG001|Overall Study|Death|0|||
160560378|NCT01015833|579774146|FG000|Overall Study|Withdrawal by Subject|3|||
160560379|NCT01015833|579774147|FG001|Overall Study|Withdrawal by Subject|2|||
160560380|NCT01015833|579774146|FG000|Overall Study|Adverse Event|0|||
160560381|NCT01015833|579774147|FG001|Overall Study|Adverse Event|1|||
160560382|NCT01015833|579774146|FG000|Overall Study|Physician Decision|2|||
160560383|NCT01015833|579774147|FG001|Overall Study|Physician Decision|0|||
160560384|NCT01015833|579774146|FG000|Overall Study|Symptomatic deterioration|0|||
160560385|NCT01015833|579774147|FG001|Overall Study|Symptomatic deterioration|1|||
160560386|NCT01015833|579774146|FG000|Overall Study|Other|5|||
160560387|NCT01015833|579774147|FG001|Overall Study|Other|1|||
160833039|NCT03995355|580773986|FG001|Overall Study|Adverse Event|0|||
160833040|NCT03995355|580773985|FG000|Overall Study|Withdrawal by Subject|1|||
160833041|NCT03995355|580773986|FG001|Overall Study|Withdrawal by Subject|0|||
160833042|NCT03995355|580773985|FG000|Overall Study|Scheduling Issues|0|||
160833043|NCT03995355|580773986|FG001|Overall Study|Scheduling Issues|1|||
160560388|NCT01015833|579774146|FG000|Overall Study|Motor Vehicle Accidents|1|||
160833044|NCT00249613|580773987|FG000|12 Month Follow-up|Death|1|||
160833045|NCT00249613|580773988|FG001|12 Month Follow-up|Death|1|||
160560389|NCT01015833|579774147|FG001|Overall Study|Motor Vehicle Accidents|0|||
160560390|NCT01015833|579774146|FG000|Overall Study|Did not start treatment|1|||
160560391|NCT01015833|579774147|FG001|Overall Study|Did not start treatment|0|||
160560392|NCT02040142|579774148|FG000|Overall Study|Lost to Follow-up|5|||
160560393|NCT02040142|579774148|FG000|Overall Study|Death|17|||
160560394|NCT02040142|579774148|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
160560395|NCT03538743|579774149|FG000|Overall Study|Adverse Event|0|||
160560396|NCT03538743|579774150|FG001|Overall Study|Adverse Event|0|||
160833046|NCT00249613|580773987|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
160833047|NCT00249613|580773988|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
160560397|NCT03538743|579774151|FG002|Overall Study|Adverse Event|1|||
160833048|NCT00249613|580773987|FG000|12 Month Follow-up|Lost to Follow-up|10|||
160833049|NCT00249613|580773988|FG001|12 Month Follow-up|Lost to Follow-up|8|||
160833050|NCT00094107|580773989|FG000|Overall Study|Lack of Efficacy|23|||
160833051|NCT00094107|580773989|FG000|Overall Study|Death|5|||
160833052|NCT00094107|580773989|FG000|Overall Study|Adverse Event|3|||
160560398|NCT03538743|579774152|FG003|Overall Study|Adverse Event|1|||
160560399|NCT03538743|579774153|FG004|Overall Study|Adverse Event|0|||
160560400|NCT03538743|579774154|FG005|Overall Study|Adverse Event|0|||
160560401|NCT03538743|579774155|FG006|Overall Study|Adverse Event|0|||
160560402|NCT03538743|579774156|FG007|Overall Study|Adverse Event|0|||
160560403|NCT03538743|579774157|FG008|Overall Study|Adverse Event|0|||
160560404|NCT03538743|579774149|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
160560405|NCT03538743|579774150|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
160560406|NCT03538743|579774151|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
160560407|NCT03538743|579774152|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
160560408|NCT03538743|579774153|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
160560409|NCT03538743|579774154|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
160560410|NCT03538743|579774155|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
160560411|NCT03538743|579774156|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
160560412|NCT03538743|579774157|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
160560413|NCT03538743|579774149|FG000|Overall Study|Withdrawal by Subject|0|||
160560414|NCT03538743|579774150|FG001|Overall Study|Withdrawal by Subject|0|||
160560415|NCT03538743|579774151|FG002|Overall Study|Withdrawal by Subject|0|||
160560416|NCT03538743|579774152|FG003|Overall Study|Withdrawal by Subject|1|||
160560417|NCT03538743|579774153|FG004|Overall Study|Withdrawal by Subject|0|||
160560418|NCT03538743|579774154|FG005|Overall Study|Withdrawal by Subject|0|||
160560419|NCT03538743|579774155|FG006|Overall Study|Withdrawal by Subject|0|||
160560420|NCT03538743|579774156|FG007|Overall Study|Withdrawal by Subject|0|||
160560421|NCT03538743|579774157|FG008|Overall Study|Withdrawal by Subject|0|||
160560422|NCT01929135|579774166|FG000|Overall Study|Lost to Follow-up|1|||
160560423|NCT01929135|579774167|FG001|Overall Study|Lost to Follow-up|1|||
160560424|NCT03136107|579774170|FG000|Overall Study|Other (Not specified)|1|||
160560425|NCT01817790|579774171|FG000|Overall Study|Adverse Event|0|||
160560426|NCT01817790|579774172|FG001|Overall Study|Adverse Event|2|||
160560427|NCT01817790|579774171|FG000|Overall Study|Lost to Follow-up|0|||
160560428|NCT01817790|579774172|FG001|Overall Study|Lost to Follow-up|1|||
160560429|NCT01817790|579774171|FG000|Overall Study|Protocol Violation|2|||
160560430|NCT01817790|579774172|FG001|Overall Study|Protocol Violation|1|||
160560431|NCT01817790|579774171|FG000|Overall Study|Withdrawal by Subject|1|||
160560432|NCT01817790|579774172|FG001|Overall Study|Withdrawal by Subject|3|||
160560433|NCT01817790|579774171|FG000|Overall Study|Other: Could not attend appointment|1|||
160560434|NCT01817790|579774172|FG001|Overall Study|Other: Could not attend appointment|1|||
160560435|NCT01671345|579774173|FG000|Overall Study|Lost to Follow-up|10|||
160560436|NCT01671345|579774174|FG001|Overall Study|Lost to Follow-up|6|||
160560437|NCT01671345|579774173|FG000|Overall Study|visit with non-participating physician|3|||
160560438|NCT01671345|579774174|FG001|Overall Study|visit with non-participating physician|3|||
160560439|NCT03690869|579774175|FG000|Overall Study|Adverse Event|0|||
160560440|NCT03690869|579774176|FG001|Overall Study|Adverse Event|0|||
160560441|NCT03690869|579774177|FG002|Overall Study|Adverse Event|0|||
160560442|NCT03690869|579774178|FG003|Overall Study|Adverse Event|1|||
160560443|NCT03690869|579774179|FG004|Overall Study|Adverse Event|0|||
160560444|NCT03690869|579774180|FG005|Overall Study|Adverse Event|0|||
160560445|NCT03690869|579774181|FG006|Overall Study|Adverse Event|0|||
160560446|NCT03690869|579774182|FG007|Overall Study|Adverse Event|1|||
160560447|NCT03690869|579774183|FG008|Overall Study|Adverse Event|0|||
160560448|NCT03690869|579774184|FG009|Overall Study|Adverse Event|1|||
160560449|NCT03690869|579774175|FG000|Overall Study|Death|1|||
160560450|NCT03690869|579774176|FG001|Overall Study|Death|1|||
160560451|NCT03690869|579774177|FG002|Overall Study|Death|1|||
160560452|NCT03690869|579774178|FG003|Overall Study|Death|4|||
160560453|NCT03690869|579774179|FG004|Overall Study|Death|2|||
160560454|NCT03690869|579774180|FG005|Overall Study|Death|5|||
160560455|NCT03690869|579774181|FG006|Overall Study|Death|3|||
160560456|NCT03690869|579774182|FG007|Overall Study|Death|2|||
160560457|NCT03690869|579774183|FG008|Overall Study|Death|0|||
160560458|NCT03690869|579774184|FG009|Overall Study|Death|3|||
160560459|NCT03690869|579774175|FG000|Overall Study|Lost to Follow-up|0|||
160560460|NCT03690869|579774176|FG001|Overall Study|Lost to Follow-up|0|||
160560461|NCT03690869|579774177|FG002|Overall Study|Lost to Follow-up|1|||
160833053|NCT00094107|580773989|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
160560462|NCT03690869|579774178|FG003|Overall Study|Lost to Follow-up|0|||
160560463|NCT03690869|579774179|FG004|Overall Study|Lost to Follow-up|0|||
160833054|NCT03268941|580775922|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160560464|NCT03690869|579774180|FG005|Overall Study|Lost to Follow-up|0|||
160560465|NCT03690869|579774181|FG006|Overall Study|Lost to Follow-up|0|||
160560466|NCT03690869|579774182|FG007|Overall Study|Lost to Follow-up|0|||
160560467|NCT03690869|579774183|FG008|Overall Study|Lost to Follow-up|0|||
160560468|NCT03690869|579774184|FG009|Overall Study|Lost to Follow-up|0|||
160560469|NCT03690869|579774175|FG000|Overall Study|Other Treatment|1|||
160560470|NCT03690869|579774176|FG001|Overall Study|Other Treatment|1|||
160560471|NCT03690869|579774177|FG002|Overall Study|Other Treatment|1|||
160560472|NCT03690869|579774178|FG003|Overall Study|Other Treatment|2|||
160560473|NCT03690869|579774179|FG004|Overall Study|Other Treatment|3|||
160560474|NCT03690869|579774180|FG005|Overall Study|Other Treatment|1|||
160560475|NCT03690869|579774181|FG006|Overall Study|Other Treatment|2|||
160560476|NCT03690869|579774182|FG007|Overall Study|Other Treatment|7|||
160560477|NCT03690869|579774183|FG008|Overall Study|Other Treatment|0|||
160560478|NCT03690869|579774184|FG009|Overall Study|Other Treatment|3|||
160560479|NCT03690869|579774175|FG000|Overall Study|Physician Decision|0|||
160560480|NCT03690869|579774176|FG001|Overall Study|Physician Decision|1|||
160560481|NCT03690869|579774177|FG002|Overall Study|Physician Decision|0|||
160560482|NCT03690869|579774178|FG003|Overall Study|Physician Decision|0|||
160560483|NCT03690869|579774179|FG004|Overall Study|Physician Decision|0|||
160560484|NCT03690869|579774180|FG005|Overall Study|Physician Decision|0|||
160560485|NCT03690869|579774181|FG006|Overall Study|Physician Decision|0|||
160560486|NCT03690869|579774182|FG007|Overall Study|Physician Decision|0|||
160560487|NCT03690869|579774183|FG008|Overall Study|Physician Decision|0|||
160560488|NCT03690869|579774184|FG009|Overall Study|Physician Decision|0|||
160560489|NCT03690869|579774175|FG000|Overall Study|Progressive Disease|1|||
160560490|NCT03690869|579774176|FG001|Overall Study|Progressive Disease|2|||
160560491|NCT03690869|579774177|FG002|Overall Study|Progressive Disease|0|||
160560492|NCT03690869|579774178|FG003|Overall Study|Progressive Disease|1|||
160560493|NCT03690869|579774179|FG004|Overall Study|Progressive Disease|0|||
160560494|NCT03690869|579774180|FG005|Overall Study|Progressive Disease|0|||
160560495|NCT03690869|579774181|FG006|Overall Study|Progressive Disease|0|||
160560496|NCT03690869|579774182|FG007|Overall Study|Progressive Disease|0|||
160560497|NCT03690869|579774183|FG008|Overall Study|Progressive Disease|1|||
160560498|NCT03690869|579774184|FG009|Overall Study|Progressive Disease|1|||
160560499|NCT03690869|579774175|FG000|Overall Study|Subject Decision|0|||
160560500|NCT03690869|579774176|FG001|Overall Study|Subject Decision|0|||
160560501|NCT03690869|579774177|FG002|Overall Study|Subject Decision|0|||
160560502|NCT03690869|579774178|FG003|Overall Study|Subject Decision|1|||
160560503|NCT03690869|579774179|FG004|Overall Study|Subject Decision|0|||
160560504|NCT03690869|579774180|FG005|Overall Study|Subject Decision|0|||
160560505|NCT03690869|579774181|FG006|Overall Study|Subject Decision|0|||
160560506|NCT03690869|579774182|FG007|Overall Study|Subject Decision|1|||
160560507|NCT03690869|579774183|FG008|Overall Study|Subject Decision|0|||
160560508|NCT03690869|579774184|FG009|Overall Study|Subject Decision|0|||
160560509|NCT03532100|579775796|FG000|Overall Study|Intervention malfunction|1|||
160560510|NCT03896581|579775797|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
160560511|NCT03896581|579775798|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
160560512|NCT03896581|579775797|FG000|Overall Study|Withdrawal by Subject|4|||
160560513|NCT03896581|579775798|FG001|Overall Study|Withdrawal by Subject|1|||
160560514|NCT03896581|579775797|FG000|Overall Study|Lost to Follow-up|1|||
160560515|NCT03896581|579775798|FG001|Overall Study|Lost to Follow-up|0|||
160560516|NCT03896581|579775797|FG000|Overall Study|Lack of Efficacy|2|||
160560517|NCT03896581|579775798|FG001|Overall Study|Lack of Efficacy|1|||
160560518|NCT03896581|579775797|FG000|Overall Study|Adverse event, non-fatal|0|||
160560519|NCT03896581|579775798|FG001|Overall Study|Adverse event, non-fatal|2|||
160560520|NCT00162773|579775799|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
160560521|NCT05415449|579775804|FG000|Overall Study|Lost to Follow-up|2|||
160560522|NCT05415449|579775804|FG000|Overall Study|Withdrawal by Subject|4|||
160560523|NCT03480802|579775811|FG000|Overall Study|Lost to Follow-up|5|||
160560524|NCT03480802|579775812|FG001|Overall Study|Lost to Follow-up|1|||
160560525|NCT03480802|579775811|FG000|Overall Study|Withdrawal by Subject|2|||
160560526|NCT03480802|579775812|FG001|Overall Study|Withdrawal by Subject|1|||
160560527|NCT03480802|579775811|FG000|Overall Study|Relocated|0|||
160560528|NCT03480802|579775812|FG001|Overall Study|Relocated|1|||
160560529|NCT02601950|579775817|FG000|Overall Study|Participant enrolled in rollover study|0|||
160560530|NCT02601950|579775818|FG001|Overall Study|Participant enrolled in rollover study|0|||
160560531|NCT02601950|579775819|FG002|Overall Study|Participant enrolled in rollover study|1|||
160560532|NCT02601950|579775820|FG003|Overall Study|Participant enrolled in rollover study|0|||
160560533|NCT02601950|579775821|FG004|Overall Study|Participant enrolled in rollover study|1|||
160560534|NCT02601950|579775822|FG005|Overall Study|Participant enrolled in rollover study|1|||
160560535|NCT02601950|579775823|FG006|Overall Study|Participant enrolled in rollover study|1|||
160560536|NCT02601950|579775824|FG007|Overall Study|Participant enrolled in rollover study|0|||
160560537|NCT02601950|579775817|FG000|Overall Study|Disease progression - radiological|21|||
160560538|NCT02601950|579775818|FG001|Overall Study|Disease progression - radiological|26|||
160560539|NCT02601950|579775819|FG002|Overall Study|Disease progression - radiological|22|||
160560540|NCT02601950|579775820|FG003|Overall Study|Disease progression - radiological|11|||
160560541|NCT02601950|579775821|FG004|Overall Study|Disease progression - radiological|46|||
160560542|NCT02601950|579775822|FG005|Overall Study|Disease progression - radiological|52|||
160560543|NCT02601950|579775823|FG006|Overall Study|Disease progression - radiological|7|||
160560544|NCT02601950|579775824|FG007|Overall Study|Disease progression - radiological|5|||
160560545|NCT02601950|579775817|FG000|Overall Study|Disease progression - clinical|3|||
160560546|NCT02601950|579775818|FG001|Overall Study|Disease progression - clinical|5|||
160560547|NCT02601950|579775819|FG002|Overall Study|Disease progression - clinical|4|||
160560548|NCT02601950|579775820|FG003|Overall Study|Disease progression - clinical|2|||
160560549|NCT02601950|579775821|FG004|Overall Study|Disease progression - clinical|6|||
160560550|NCT02601950|579775822|FG005|Overall Study|Disease progression - clinical|6|||
160560551|NCT02601950|579775823|FG006|Overall Study|Disease progression - clinical|5|||
160560552|NCT02601950|579775824|FG007|Overall Study|Disease progression - clinical|1|||
160560553|NCT02601950|579775817|FG000|Overall Study|Death|6|||
160560554|NCT02601950|579775818|FG001|Overall Study|Death|0|||
160560555|NCT02601950|579775819|FG002|Overall Study|Death|3|||
160560556|NCT02601950|579775820|FG003|Overall Study|Death|1|||
160560557|NCT02601950|579775821|FG004|Overall Study|Death|4|||
160560558|NCT02601950|579775822|FG005|Overall Study|Death|1|||
160560559|NCT02601950|579775823|FG006|Overall Study|Death|0|||
160560560|NCT02601950|579775824|FG007|Overall Study|Death|0|||
160560561|NCT02601950|579775817|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
160560562|NCT02601950|579775818|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
160560563|NCT02601950|579775819|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
160560564|NCT02601950|579775820|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
160560565|NCT02601950|579775821|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
160560566|NCT02601950|579775822|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
160560567|NCT02601950|579775823|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
160560568|NCT02601950|579775824|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
160560569|NCT02601950|579775817|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
160560570|NCT02601950|579775818|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
160560571|NCT02601950|579775819|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
160560572|NCT02601950|579775820|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
160560573|NCT02601950|579775821|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
160560574|NCT02601950|579775822|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
160560575|NCT02601950|579775823|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
160560576|NCT02601950|579775824|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
160560577|NCT02601950|579775817|FG000|Overall Study|Non-compliance|0|||
160560578|NCT02601950|579775818|FG001|Overall Study|Non-compliance|1|||
160560579|NCT02601950|579775819|FG002|Overall Study|Non-compliance|0|||
160560580|NCT02601950|579775820|FG003|Overall Study|Non-compliance|0|||
160560581|NCT02601950|579775821|FG004|Overall Study|Non-compliance|0|||
160560582|NCT02601950|579775822|FG005|Overall Study|Non-compliance|1|||
160560583|NCT02601950|579775823|FG006|Overall Study|Non-compliance|1|||
160560584|NCT02601950|579775824|FG007|Overall Study|Non-compliance|0|||
160560585|NCT02601950|579775817|FG000|Overall Study|Participant refused further study treatment|0|||
160560586|NCT02601950|579775818|FG001|Overall Study|Participant refused further study treatment|1|||
160560587|NCT02601950|579775819|FG002|Overall Study|Participant refused further study treatment|1|||
160560588|NCT02601950|579775820|FG003|Overall Study|Participant refused further study treatment|0|||
160560589|NCT02601950|579775821|FG004|Overall Study|Participant refused further study treatment|2|||
160560590|NCT02601950|579775822|FG005|Overall Study|Participant refused further study treatment|2|||
160560591|NCT02601950|579775823|FG006|Overall Study|Participant refused further study treatment|2|||
160560592|NCT02601950|579775824|FG007|Overall Study|Participant refused further study treatment|1|||
160560593|NCT02601950|579775817|FG000|Overall Study|Investigator discretion|1|||
160560594|NCT02601950|579775818|FG001|Overall Study|Investigator discretion|0|||
160560595|NCT02601950|579775819|FG002|Overall Study|Investigator discretion|1|||
160560596|NCT02601950|579775820|FG003|Overall Study|Investigator discretion|0|||
160560597|NCT02601950|579775821|FG004|Overall Study|Investigator discretion|1|||
160560598|NCT02601950|579775822|FG005|Overall Study|Investigator discretion|1|||
160560599|NCT02601950|579775823|FG006|Overall Study|Investigator discretion|1|||
160560600|NCT02601950|579775824|FG007|Overall Study|Investigator discretion|0|||
160560601|NCT02601950|579775817|FG000|Overall Study|Other|0|||
160560602|NCT02601950|579775818|FG001|Overall Study|Other|0|||
160560603|NCT02601950|579775819|FG002|Overall Study|Other|0|||
160560604|NCT02601950|579775820|FG003|Overall Study|Other|0|||
160560605|NCT02601950|579775821|FG004|Overall Study|Other|2|||
160560606|NCT02601950|579775822|FG005|Overall Study|Other|2|||
160560607|NCT02601950|579775823|FG006|Overall Study|Other|1|||
160560608|NCT02601950|579775824|FG007|Overall Study|Other|0|||
160560609|NCT02157883|579775825|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
160560610|NCT02157883|579775825|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
160560611|NCT02157883|579775825|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
160560612|NCT02157883|579775825|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
160560613|NCT02157883|579775825|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
160560614|NCT01701258|579775826|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
160560615|NCT01701258|579775827|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
160560616|NCT01701258|579775828|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
160560617|NCT01701258|579775829|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
160560618|NCT01701258|579775830|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
160560619|NCT01701258|579775831|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
160560620|NCT01701258|579775832|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
160560621|NCT01701258|579775833|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
160560622|NCT01701258|579775834|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
160560623|NCT01701258|579775835|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
160560624|NCT01701258|579775836|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
160560625|NCT01701258|579775837|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
160560626|NCT01701258|579775838|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
160560627|NCT01701258|579775826|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
160560628|NCT01701258|579775827|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
160560629|NCT01701258|579775828|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
160560630|NCT01701258|579775829|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
160560631|NCT01701258|579775830|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
160560632|NCT01701258|579775831|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
160560633|NCT01701258|579775832|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
160560634|NCT01701258|579775833|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
160560635|NCT01701258|579775834|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
160560636|NCT01701258|579775835|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
160560637|NCT01701258|579775836|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
160560638|NCT01701258|579775837|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
160560639|NCT01701258|579775838|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
160560640|NCT01701258|579775826|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
160560641|NCT01701258|579775827|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
160560642|NCT01701258|579775828|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
160560643|NCT01701258|579775829|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
160560644|NCT01701258|579775830|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
160560645|NCT01701258|579775831|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
160560646|NCT01701258|579775832|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
160560647|NCT01701258|579775833|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
160560648|NCT01701258|579775834|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
160560649|NCT01701258|579775835|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
160560650|NCT01701258|579775836|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
160560651|NCT01701258|579775837|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
160560652|NCT01701258|579775838|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
160560653|NCT01701258|579775826|FG000|Assessment and Scheduling|Investigator Terminated|2|||
160560654|NCT01701258|579775827|FG001|Assessment and Scheduling|Investigator Terminated|0|||
160560655|NCT01701258|579775828|FG002|Assessment and Scheduling|Investigator Terminated|0|||
160560656|NCT01701258|579775829|FG003|Assessment and Scheduling|Investigator Terminated|0|||
160560657|NCT01701258|579775830|FG004|Assessment and Scheduling|Investigator Terminated|0|||
160560658|NCT01701258|579775831|FG005|Assessment and Scheduling|Investigator Terminated|0|||
160560659|NCT01701258|579775832|FG006|Assessment and Scheduling|Investigator Terminated|0|||
160560660|NCT01701258|579775833|FG007|Assessment and Scheduling|Investigator Terminated|0|||
160560661|NCT01701258|579775834|FG008|Assessment and Scheduling|Investigator Terminated|0|||
160560662|NCT01701258|579775835|FG009|Assessment and Scheduling|Investigator Terminated|0|||
160560663|NCT01701258|579775836|FG010|Assessment and Scheduling|Investigator Terminated|0|||
160560664|NCT01701258|579775837|FG011|Assessment and Scheduling|Investigator Terminated|0|||
160560665|NCT01701258|579775838|FG012|Assessment and Scheduling|Investigator Terminated|0|||
160560666|NCT01323478|579775839|FG000|Overall Study|Adverse Event|7|||
160560667|NCT01323478|579775839|FG000|Overall Study|Lack of Efficacy|4|||
160560668|NCT01323478|579775839|FG000|Overall Study|Non-compliance With Study Product|3|||
160560669|NCT01323478|579775839|FG000|Overall Study|Protocol Violation|1|||
160560670|NCT01323478|579775839|FG000|Overall Study|Withdrawal of Consent|1|||
160560671|NCT01323478|579775839|FG000|Overall Study|Administrative or Other Reasons|8|||
160560672|NCT00934102|579775843|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
160560673|NCT00934102|579775844|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
160560674|NCT00934102|579775845|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
160560675|NCT00792298|579775846|FG000|Treatment Period 1|Adverse Event|0|||
160560676|NCT00792298|579775847|FG001|Treatment Period 1|Adverse Event|1|||
160560677|NCT00792298|579775848|FG002|Treatment Period 1|Adverse Event|0|||
160560678|NCT00792298|579775849|FG003|Treatment Period 1|Adverse Event|1|||
160560679|NCT00792298|579775850|FG004|Treatment Period 1|Adverse Event|0|||
160560680|NCT00792298|579775851|FG005|Treatment Period 1|Adverse Event|1|||
160903393|NCT02468674|581040469|FG002|Overall Study|Protocol Deviation|0|||
160560681|NCT00792298|579775852|FG006|Treatment Period 1|Adverse Event|1|||
160560682|NCT00792298|579775853|FG007|Treatment Period 1|Adverse Event|0|||
160560683|NCT00792298|579775846|FG000|Treatment Period 1|Lack of Efficacy|0|||
160560684|NCT00792298|579775847|FG001|Treatment Period 1|Lack of Efficacy|0|||
160560685|NCT00792298|579775848|FG002|Treatment Period 1|Lack of Efficacy|1|||
160560686|NCT00792298|579775849|FG003|Treatment Period 1|Lack of Efficacy|0|||
160560687|NCT00792298|579775850|FG004|Treatment Period 1|Lack of Efficacy|0|||
160560688|NCT00792298|579775851|FG005|Treatment Period 1|Lack of Efficacy|0|||
160560689|NCT00792298|579775852|FG006|Treatment Period 1|Lack of Efficacy|0|||
160560690|NCT00792298|579775853|FG007|Treatment Period 1|Lack of Efficacy|0|||
160560691|NCT00792298|579775846|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160560692|NCT00792298|579775847|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160560693|NCT00792298|579775848|FG002|Treatment Period 1|Withdrawal by Subject|1|||
160560694|NCT00792298|579775849|FG003|Treatment Period 1|Withdrawal by Subject|2|||
160560695|NCT00792298|579775850|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160560696|NCT00792298|579775851|FG005|Treatment Period 1|Withdrawal by Subject|2|||
160560697|NCT00792298|579775852|FG006|Treatment Period 1|Withdrawal by Subject|1|||
160560698|NCT00792298|579775853|FG007|Treatment Period 1|Withdrawal by Subject|0|||
160560699|NCT00792298|579775846|FG000|Treatment Period 1|Lost to Follow-up|0|||
160560700|NCT00792298|579775847|FG001|Treatment Period 1|Lost to Follow-up|0|||
160560701|NCT00792298|579775848|FG002|Treatment Period 1|Lost to Follow-up|0|||
160560702|NCT00792298|579775849|FG003|Treatment Period 1|Lost to Follow-up|0|||
160560703|NCT00792298|579775850|FG004|Treatment Period 1|Lost to Follow-up|0|||
160560704|NCT00792298|579775851|FG005|Treatment Period 1|Lost to Follow-up|0|||
160560705|NCT00792298|579775852|FG006|Treatment Period 1|Lost to Follow-up|1|||
160560706|NCT00792298|579775853|FG007|Treatment Period 1|Lost to Follow-up|0|||
160560707|NCT00792298|579775846|FG000|Treatment Period 1|Physician Decision|0|||
160560708|NCT00792298|579775847|FG001|Treatment Period 1|Physician Decision|0|||
160560709|NCT00792298|579775848|FG002|Treatment Period 1|Physician Decision|0|||
160647575|NCT02811861|580092761|FG001|Overall Study|Subject Choice|17|||
160833055|NCT03268941|580775923|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160903394|NCT02468674|581040470|FG003|Overall Study|Protocol Deviation|0|||
160903395|NCT02468674|581040471|FG004|Overall Study|Protocol Deviation|0|||
160903396|NCT02468674|581040472|FG005|Overall Study|Protocol Deviation|0|||
160903397|NCT02468674|581040473|FG006|Overall Study|Protocol Deviation|0|||
160903398|NCT02468674|581040474|FG007|Overall Study|Protocol Deviation|1|||
160903399|NCT02468674|581040475|FG008|Overall Study|Protocol Deviation|1|||
160903400|NCT03281577|581040483|FG000|Overall Study|Adverse Event|0|||
160903401|NCT03281577|581040484|FG001|Overall Study|Adverse Event|0|||
160903402|NCT03281577|581040485|FG002|Overall Study|Adverse Event|0|||
160903403|NCT03281577|581040486|FG003|Overall Study|Adverse Event|1|||
160903404|NCT03281577|581040483|FG000|Overall Study|Withdrawal by Subject|1|||
160903405|NCT03281577|581040484|FG001|Overall Study|Withdrawal by Subject|0|||
160903406|NCT03281577|581040485|FG002|Overall Study|Withdrawal by Subject|0|||
160903407|NCT03281577|581040486|FG003|Overall Study|Withdrawal by Subject|0|||
160560710|NCT00792298|579775849|FG003|Treatment Period 1|Physician Decision|1|||
160560711|NCT00792298|579775850|FG004|Treatment Period 1|Physician Decision|0|||
160560712|NCT00792298|579775851|FG005|Treatment Period 1|Physician Decision|0|||
160560713|NCT00792298|579775852|FG006|Treatment Period 1|Physician Decision|1|||
160647576|NCT02811861|580092762|FG002|Overall Study|Subject Choice|23|||
160833056|NCT03268941|580775924|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160833057|NCT03268941|580775925|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
160833058|NCT03268941|580775926|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160833059|NCT03268941|580775927|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160833060|NCT03268941|580775928|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160833061|NCT03268941|580775922|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
160833062|NCT03268941|580775923|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
160833063|NCT03268941|580775924|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
160833064|NCT03268941|580775925|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
160833065|NCT03268941|580775926|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
160833066|NCT03268941|580775927|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
160833067|NCT03268941|580775928|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
160903408|NCT01644565|581040487|FG000|Overall Study|Undisclosed Medical History|1|||
160903409|NCT01644565|581040488|FG001|Overall Study|Undisclosed Medical History|0|||
160903410|NCT01644565|581040489|FG002|Overall Study|Undisclosed Medical History|0|||
160903411|NCT01644565|581040490|FG003|Overall Study|Undisclosed Medical History|0|||
160903412|NCT01644565|581040491|FG004|Overall Study|Undisclosed Medical History|0|||
160903413|NCT01644565|581040492|FG005|Overall Study|Undisclosed Medical History|0|||
160991210|NCT05174065|581355538|FG002|Placebo-controlled Period|Other|0|||
160991211|NCT05174065|581355536|FG000|Placebo-controlled Period|Adverse Event|1|||
160991212|NCT05174065|581355537|FG001|Placebo-controlled Period|Adverse Event|1|||
160991213|NCT05174065|581355538|FG002|Placebo-controlled Period|Adverse Event|0|||
160991214|NCT05174065|581355536|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
160991215|NCT05174065|581355537|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
160991216|NCT05174065|581355538|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
160991217|NCT05174065|581355536|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
160991218|NCT05174065|581355537|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
160991219|NCT05174065|581355538|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
160991220|NCT05174065|581355536|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
160991221|NCT05174065|581355537|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
160991222|NCT05174065|581355538|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
160991223|NCT02909101|581355540|FG000|Overall Study|Lost to Follow-up|1|||
160991224|NCT02909101|581355541|FG001|Overall Study|Lost to Follow-up|1|||
160991225|NCT00604786|581355542|FG000|Overall Study|Lost to Follow-up|2|||
160560714|NCT00792298|579775853|FG007|Treatment Period 1|Physician Decision|0|||
160560715|NCT00792298|579775846|FG000|Treatment Period 1|Protocol Violation|0|||
160560716|NCT00792298|579775847|FG001|Treatment Period 1|Protocol Violation|0|||
160560717|NCT00792298|579775848|FG002|Treatment Period 1|Protocol Violation|0|||
160560718|NCT00792298|579775849|FG003|Treatment Period 1|Protocol Violation|0|||
160560719|NCT00792298|579775850|FG004|Treatment Period 1|Protocol Violation|0|||
160560720|NCT00792298|579775851|FG005|Treatment Period 1|Protocol Violation|0|||
160560721|NCT00792298|579775852|FG006|Treatment Period 1|Protocol Violation|0|||
160903414|NCT01644565|581040493|FG006|Overall Study|Undisclosed Medical History|0|||
160903415|NCT01644565|581040494|FG007|Overall Study|Undisclosed Medical History|0|||
160903416|NCT01644565|581040495|FG008|Overall Study|Undisclosed Medical History|0|||
160903417|NCT01644565|581040487|FG000|Overall Study|Lost to Follow-up|0|||
160903418|NCT01644565|581040488|FG001|Overall Study|Lost to Follow-up|0|||
160903419|NCT01644565|581040489|FG002|Overall Study|Lost to Follow-up|0|||
160903420|NCT01644565|581040490|FG003|Overall Study|Lost to Follow-up|1|||
160903421|NCT01644565|581040491|FG004|Overall Study|Lost to Follow-up|0|||
160903422|NCT01644565|581040492|FG005|Overall Study|Lost to Follow-up|0|||
160903423|NCT01644565|581040493|FG006|Overall Study|Lost to Follow-up|0|||
160903424|NCT01644565|581040494|FG007|Overall Study|Lost to Follow-up|2|||
160903425|NCT01644565|581040495|FG008|Overall Study|Lost to Follow-up|0|||
160903426|NCT01644565|581040487|FG000|Overall Study|Family emergency|0|||
160903427|NCT01644565|581040488|FG001|Overall Study|Family emergency|0|||
160903428|NCT01644565|581040489|FG002|Overall Study|Family emergency|0|||
160903429|NCT01644565|581040490|FG003|Overall Study|Family emergency|0|||
160903430|NCT01644565|581040491|FG004|Overall Study|Family emergency|1|||
160903431|NCT01644565|581040492|FG005|Overall Study|Family emergency|0|||
160903432|NCT01644565|581040493|FG006|Overall Study|Family emergency|0|||
160903433|NCT01644565|581040494|FG007|Overall Study|Family emergency|0|||
160903434|NCT01644565|581040495|FG008|Overall Study|Family emergency|0|||
160903435|NCT01644565|581040487|FG000|Overall Study|Relocation|0|||
160903436|NCT01644565|581040488|FG001|Overall Study|Relocation|0|||
160903437|NCT01644565|581040489|FG002|Overall Study|Relocation|0|||
160903438|NCT01644565|581040490|FG003|Overall Study|Relocation|0|||
160903439|NCT01644565|581040491|FG004|Overall Study|Relocation|0|||
160903440|NCT01644565|581040492|FG005|Overall Study|Relocation|0|||
160903441|NCT01644565|581040493|FG006|Overall Study|Relocation|0|||
160903442|NCT01644565|581040494|FG007|Overall Study|Relocation|0|||
160903443|NCT01644565|581040495|FG008|Overall Study|Relocation|1|||
160903444|NCT01687998|581040496|FG000|Overall Study|Withdrawal by Subject|49|||
160903445|NCT01687998|581040497|FG001|Overall Study|Withdrawal by Subject|51|||
160903446|NCT01687998|581040496|FG000|Overall Study|Known to be Alive at Study End|54|||
160903447|NCT01687998|581040497|FG001|Overall Study|Known to be Alive at Study End|62|||
160903448|NCT01687998|581040496|FG000|Overall Study|Lost to Follow-up|9|||
160991226|NCT00604786|581355543|FG001|Overall Study|Lost to Follow-up|0|||
160560722|NCT00792298|579775853|FG007|Treatment Period 1|Protocol Violation|1|||
160991227|NCT03697460|581355544|FG000|Overall Study|Withdrawal by Subject|3|||
160560723|NCT00792298|579775846|FG000|Washout|Adverse Event|0|||
160647577|NCT02811861|580092760|FG000|Overall Study|Withdrawal by Subject|4|||
160903449|NCT01687998|581040497|FG001|Overall Study|Lost to Follow-up|7|||
160903450|NCT00443261|581040500|FG000|Overall Study|Death|1|||
160903451|NCT01663532|581040501|FG000|Overall Study|Lost to Follow-up|9|||
160560724|NCT00792298|579775847|FG001|Washout|Adverse Event|0|||
160903452|NCT01663532|581040502|FG001|Overall Study|Lost to Follow-up|10|||
160903453|NCT01663532|581040501|FG000|Overall Study|Adverse Event|7|||
160903454|NCT01663532|581040502|FG001|Overall Study|Adverse Event|13|||
160903455|NCT01663532|581040501|FG000|Overall Study|Met Withdrawal Criteria|7|||
160560725|NCT00792298|579775848|FG002|Washout|Adverse Event|0|||
160560726|NCT00792298|579775849|FG003|Washout|Adverse Event|0|||
160560727|NCT00792298|579775850|FG004|Washout|Adverse Event|0|||
160560728|NCT00792298|579775851|FG005|Washout|Adverse Event|1|||
160560729|NCT00792298|579775852|FG006|Washout|Adverse Event|0|||
160560730|NCT00792298|579775853|FG007|Washout|Adverse Event|0|||
160560731|NCT00792298|579775846|FG000|Washout|Withdrawal by Subject|0|||
160560732|NCT00792298|579775847|FG001|Washout|Withdrawal by Subject|0|||
160560733|NCT00792298|579775848|FG002|Washout|Withdrawal by Subject|1|||
160560734|NCT00792298|579775849|FG003|Washout|Withdrawal by Subject|0|||
160560735|NCT00792298|579775850|FG004|Washout|Withdrawal by Subject|0|||
160560736|NCT00792298|579775851|FG005|Washout|Withdrawal by Subject|1|||
160560737|NCT00792298|579775852|FG006|Washout|Withdrawal by Subject|0|||
160560738|NCT00792298|579775853|FG007|Washout|Withdrawal by Subject|0|||
160560739|NCT00792298|579775846|FG000|Treatment Period 2|Lack of Efficacy|0|||
160560740|NCT00792298|579775847|FG001|Treatment Period 2|Lack of Efficacy|0|||
160560741|NCT00792298|579775848|FG002|Treatment Period 2|Lack of Efficacy|0|||
160560742|NCT00792298|579775849|FG003|Treatment Period 2|Lack of Efficacy|0|||
160560743|NCT00792298|579775850|FG004|Treatment Period 2|Lack of Efficacy|1|||
160560744|NCT00792298|579775851|FG005|Treatment Period 2|Lack of Efficacy|0|||
160560745|NCT00792298|579775852|FG006|Treatment Period 2|Lack of Efficacy|0|||
160560746|NCT00792298|579775853|FG007|Treatment Period 2|Lack of Efficacy|0|||
160560747|NCT00792298|579775846|FG000|Treatment Period 2|Physician Decision|0|||
160560748|NCT00792298|579775847|FG001|Treatment Period 2|Physician Decision|0|||
160560749|NCT00792298|579775848|FG002|Treatment Period 2|Physician Decision|0|||
160560750|NCT00792298|579775849|FG003|Treatment Period 2|Physician Decision|0|||
160560751|NCT00792298|579775850|FG004|Treatment Period 2|Physician Decision|0|||
160560752|NCT00792298|579775851|FG005|Treatment Period 2|Physician Decision|0|||
160560753|NCT00792298|579775852|FG006|Treatment Period 2|Physician Decision|1|||
160560754|NCT00792298|579775853|FG007|Treatment Period 2|Physician Decision|0|||
160560755|NCT00792298|579775846|FG000|Treatment Period 2|Pregnancy|0|||
160560756|NCT00792298|579775847|FG001|Treatment Period 2|Pregnancy|0|||
160560757|NCT00792298|579775848|FG002|Treatment Period 2|Pregnancy|1|||
160560758|NCT00792298|579775849|FG003|Treatment Period 2|Pregnancy|0|||
160560759|NCT00792298|579775850|FG004|Treatment Period 2|Pregnancy|0|||
160560760|NCT00792298|579775851|FG005|Treatment Period 2|Pregnancy|0|||
160560761|NCT00792298|579775852|FG006|Treatment Period 2|Pregnancy|0|||
160560762|NCT00792298|579775853|FG007|Treatment Period 2|Pregnancy|0|||
160560763|NCT00792298|579775846|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160560764|NCT00792298|579775847|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160560765|NCT00792298|579775848|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160560766|NCT00792298|579775849|FG003|Treatment Period 2|Withdrawal by Subject|2|||
160560767|NCT00792298|579775850|FG004|Treatment Period 2|Withdrawal by Subject|1|||
160560768|NCT00792298|579775851|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160560769|NCT00792298|579775852|FG006|Treatment Period 2|Withdrawal by Subject|0|||
160560770|NCT00792298|579775853|FG007|Treatment Period 2|Withdrawal by Subject|2|||
160560771|NCT03304522|579775854|FG000|Overall Study|Adverse Event|0|||
160560772|NCT03304522|579775855|FG001|Overall Study|Adverse Event|4|||
160560773|NCT03304522|579775854|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
160560774|NCT03304522|579775855|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
160560775|NCT03304522|579775854|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
160560776|NCT03304522|579775855|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
160560777|NCT03304522|579775854|FG000|Overall Study|Other|0|||
160560778|NCT03304522|579775855|FG001|Overall Study|Other|1|||
160560779|NCT00486603|579775857|FG000|Overall Study|Withdrawal by Subject|1|||
160560780|NCT00486603|579775858|FG001|Overall Study|Withdrawal by Subject|0|||
160560781|NCT00486603|579775859|FG002|Overall Study|Withdrawal by Subject|0|||
160560782|NCT00486603|579775860|FG003|Overall Study|Withdrawal by Subject|0|||
160560783|NCT00486603|579775861|FG004|Overall Study|Withdrawal by Subject|0|||
160560784|NCT00486603|579775857|FG000|Overall Study|Physician Decision|0|||
160560785|NCT00486603|579775858|FG001|Overall Study|Physician Decision|1|||
160560786|NCT00486603|579775859|FG002|Overall Study|Physician Decision|0|||
160560787|NCT00486603|579775860|FG003|Overall Study|Physician Decision|0|||
160560788|NCT00486603|579775861|FG004|Overall Study|Physician Decision|0|||
160560789|NCT02649634|579775862|FG000|Overall Study|Withdrawal by Subject|3|||
160560790|NCT02649634|579775863|FG001|Overall Study|Withdrawal by Subject|5|||
160560791|NCT02649634|579775862|FG000|Overall Study|Lost to Follow-up|0|||
160560792|NCT02649634|579775863|FG001|Overall Study|Lost to Follow-up|1|||
160560793|NCT01670994|579775865|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
160560794|NCT01670994|579775866|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
160560795|NCT01670994|579775865|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
160560796|NCT01670994|579775866|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
160560797|NCT01670994|579775865|FG000|Overall Study|Patient experienced DLT|0|||
160560798|NCT01670994|579775866|FG001|Overall Study|Patient experienced DLT|1|||
160560799|NCT01111604|579775867|FG000|Overall Study|Lost to Follow-up|0|||
160560800|NCT01111604|579775868|FG001|Overall Study|Lost to Follow-up|0|||
160560801|NCT01111604|579775869|FG002|Overall Study|Lost to Follow-up|1|||
160560802|NCT01111604|579775867|FG000|Overall Study|Withdrew Consent|3|||
160560803|NCT01111604|579775868|FG001|Overall Study|Withdrew Consent|0|||
160833068|NCT03268941|580775922|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
160833069|NCT03268941|580775923|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833070|NCT03268941|580775924|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833071|NCT03268941|580775925|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833072|NCT03268941|580775926|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833073|NCT03268941|580775927|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833074|NCT03268941|580775928|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833075|NCT03268941|580775922|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
160833076|NCT03268941|580775923|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
160833077|NCT03268941|580775924|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
160833078|NCT03268941|580775925|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
160833079|NCT03268941|580775926|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
160833080|NCT03268941|580775927|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
160560804|NCT01111604|579775869|FG002|Overall Study|Withdrew Consent|2|||
160560805|NCT01111604|579775867|FG000|Overall Study|Withdrawal by Subject|2|||
160560806|NCT01111604|579775868|FG001|Overall Study|Withdrawal by Subject|0|||
160560807|NCT01111604|579775869|FG002|Overall Study|Withdrawal by Subject|0|||
160560808|NCT01111604|579775867|FG000|Overall Study|Death|1|||
160560809|NCT01111604|579775868|FG001|Overall Study|Death|0|||
160560810|NCT01111604|579775869|FG002|Overall Study|Death|0|||
160560811|NCT01111604|579775867|FG000|Overall Study|Met Exclusion Criteria|2|||
160833081|NCT03268941|580775928|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
160833082|NCT03268941|580775922|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160560812|NCT01111604|579775868|FG001|Overall Study|Met Exclusion Criteria|0|||
160560813|NCT01111604|579775869|FG002|Overall Study|Met Exclusion Criteria|0|||
160647578|NCT02811861|580092761|FG001|Overall Study|Withdrawal by Subject|4|||
160647579|NCT02811861|580092762|FG002|Overall Study|Withdrawal by Subject|9|||
160647580|NCT02811861|580092760|FG000|Overall Study|Other|4|||
160833083|NCT03268941|580775923|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160833084|NCT03268941|580775924|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160833085|NCT03268941|580775925|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160833086|NCT03268941|580775926|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160833087|NCT03268941|580775927|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160833088|NCT03268941|580775928|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
160833089|NCT02720692|580775933|FG000|Overall Study|Withdrawal by Subject|3|||
160833090|NCT02720692|580775934|FG001|Overall Study|Withdrawal by Subject|0|||
160833091|NCT02720692|580775933|FG000|Overall Study|Physician Decision|1|||
160833092|NCT02720692|580775934|FG001|Overall Study|Physician Decision|0|||
160833093|NCT02720692|580775933|FG000|Overall Study|Lost to Follow-up|8|||
160833094|NCT02720692|580775934|FG001|Overall Study|Lost to Follow-up|3|||
160833095|NCT02720692|580775933|FG000|Overall Study|Subject unable to return for visit|1|||
160833096|NCT02720692|580775934|FG001|Overall Study|Subject unable to return for visit|0|||
160833097|NCT03878758|580775935|FG000|Overall Study|Withdrawal by Subject|1|||
160833098|NCT03878758|580775935|FG000|Overall Study|Protocol defined|2|||
160833099|NCT03878758|580775935|FG000|Overall Study|Improper consent documentation|1|||
160833100|NCT03614325|580775936|FG000|Overall Study|Withdrawal by Subject|0|||
160833101|NCT03614325|580775937|FG001|Overall Study|Withdrawal by Subject|2|||
160833102|NCT03614325|580775936|FG000|Overall Study|Surgery Cancelled|2|||
160833103|NCT03614325|580775937|FG001|Overall Study|Surgery Cancelled|1|||
160833104|NCT03614325|580775936|FG000|Overall Study|Lost to Follow-up|2|||
160833105|NCT03614325|580775937|FG001|Overall Study|Lost to Follow-up|1|||
160833106|NCT03614325|580775936|FG000|Overall Study|Surgery never scheduled|1|||
160833107|NCT03614325|580775937|FG001|Overall Study|Surgery never scheduled|0|||
160833108|NCT00652951|580775943|FG000|Booster Phase|Adverse event, non-fatal|0|||
160991228|NCT03369951|581355545|FG000|Overall Study|Withdrawal by Subject|3|||
160560814|NCT00584870|579775871|FG000|Overall Study|Adverse Event|4|||
160833109|NCT00652951|580775944|FG001|Booster Phase|Adverse event, non-fatal|1|||
160833110|NCT00652951|580775945|FG002|Booster Phase|Adverse event, non-fatal|0|||
160833111|NCT00652951|580775943|FG000|Booster Phase|Other|1|||
160833112|NCT00652951|580775944|FG001|Booster Phase|Other|0|||
160833113|NCT00652951|580775945|FG002|Booster Phase|Other|0|||
160833114|NCT01022424|580775946|FG000|Overall Study|Adverse Event|1|||
160833115|NCT01022424|580775946|FG000|Overall Study|Physician Decision|1|||
160833116|NCT01022424|580775946|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
160833117|NCT01206582|580775947|FG000|Overall Study|Withdrew prior to study|1|||
160833118|NCT01206582|580775948|FG001|Overall Study|Withdrew prior to study|0|||
160833119|NCT01206582|580775947|FG000|Overall Study|Discontinued intervention before week 8|1|||
160833120|NCT01206582|580775948|FG001|Overall Study|Discontinued intervention before week 8|2|||
160833121|NCT04736628|580775949|FG000|Overall Study|Not treated|0|||
160833122|NCT04736628|580775950|FG001|Overall Study|Not treated|0|||
160833123|NCT04736628|580775951|FG002|Overall Study|Not treated|0|||
160833124|NCT04736628|580775952|FG003|Overall Study|Not treated|2|||
160833125|NCT04736628|580775949|FG000|Overall Study|Other reason than listed|1|||
160833126|NCT04736628|580775950|FG001|Overall Study|Other reason than listed|2|||
160833127|NCT04736628|580775951|FG002|Overall Study|Other reason than listed|2|||
160991229|NCT03369951|581355545|FG000|Overall Study|Death|1|||
160833128|NCT04736628|580775952|FG003|Overall Study|Other reason than listed|3|||
160833129|NCT04736628|580775949|FG000|Overall Study|Protocol deviation|0|||
160833130|NCT04736628|580775950|FG001|Overall Study|Protocol deviation|0|||
160833131|NCT04736628|580775951|FG002|Overall Study|Protocol deviation|0|||
160833132|NCT04736628|580775952|FG003|Overall Study|Protocol deviation|1|||
160833133|NCT04736628|580775949|FG000|Overall Study|Burden of study procedures|1|||
160833134|NCT04736628|580775950|FG001|Overall Study|Burden of study procedures|0|||
160833135|NCT04736628|580775951|FG002|Overall Study|Burden of study procedures|0|||
160833136|NCT04736628|580775952|FG003|Overall Study|Burden of study procedures|1|||
160833137|NCT04736628|580775949|FG000|Overall Study|Change of residence|0|||
160833138|NCT04736628|580775950|FG001|Overall Study|Change of residence|1|||
160833139|NCT04736628|580775951|FG002|Overall Study|Change of residence|0|||
160903456|NCT01663532|581040502|FG001|Overall Study|Met Withdrawal Criteria|6|||
160903457|NCT01663532|581040501|FG000|Overall Study|Physician Decision|1|||
160903458|NCT01663532|581040502|FG001|Overall Study|Physician Decision|1|||
160903459|NCT01663532|581040501|FG000|Overall Study|Withdrawal by Subject|35|||
160833140|NCT04736628|580775952|FG003|Overall Study|Change of residence|0|||
160833141|NCT04736628|580775949|FG000|Overall Study|Perceived lack of efficacy|1|||
160833142|NCT04736628|580775950|FG001|Overall Study|Perceived lack of efficacy|0|||
160833143|NCT04736628|580775951|FG002|Overall Study|Perceived lack of efficacy|0|||
160833144|NCT04736628|580775952|FG003|Overall Study|Perceived lack of efficacy|1|||
160833145|NCT04736628|580775949|FG000|Overall Study|Adverse Event|3|||
160833146|NCT04736628|580775950|FG001|Overall Study|Adverse Event|2|||
160833147|NCT04736628|580775951|FG002|Overall Study|Adverse Event|4|||
160833148|NCT04736628|580775952|FG003|Overall Study|Adverse Event|3|||
160903460|NCT01663532|581040502|FG001|Overall Study|Withdrawal by Subject|17|||
160903461|NCT01663532|581040501|FG000|Overall Study|Lack of Efficacy|15|||
160903462|NCT01663532|581040502|FG001|Overall Study|Lack of Efficacy|60|||
160903463|NCT00680017|581040508|FG000|Overall Study|Adverse Event|13|||
160903464|NCT00680017|581040509|FG001|Overall Study|Adverse Event|7|||
160903465|NCT00680017|581040508|FG000|Overall Study|Withdrawal by Subject|2|||
160903466|NCT00680017|581040509|FG001|Overall Study|Withdrawal by Subject|5|||
160903467|NCT00680017|581040508|FG000|Overall Study|Lost to Follow-up|2|||
160903468|NCT00680017|581040509|FG001|Overall Study|Lost to Follow-up|0|||
160903469|NCT01434667|581040510|FG000|Overall Study|Lost to Follow-up|5|||
160903470|NCT01434667|581040511|FG001|Overall Study|Lost to Follow-up|10|||
160903471|NCT02034110|581040514|FG000|Overall Study|Physician Decision|0|||
160903472|NCT02034110|581040515|FG001|Overall Study|Physician Decision|0|||
160903473|NCT02034110|581040516|FG002|Overall Study|Physician Decision|0|||
160903474|NCT02034110|581040517|FG003|Overall Study|Physician Decision|0|||
160903475|NCT02034110|581040518|FG004|Overall Study|Physician Decision|2|||
160903476|NCT02034110|581040519|FG005|Overall Study|Physician Decision|0|||
160903477|NCT02034110|581040520|FG006|Overall Study|Physician Decision|1|||
160903478|NCT02034110|581040521|FG007|Overall Study|Physician Decision|0|||
160903479|NCT02034110|581040514|FG000|Overall Study|Lost to Follow-up|1|||
160903480|NCT02034110|581040515|FG001|Overall Study|Lost to Follow-up|0|||
160560815|NCT00584870|579775872|FG001|Overall Study|Adverse Event|3|||
160560816|NCT00584870|579775873|FG002|Overall Study|Adverse Event|2|||
160833149|NCT04279613|580775953|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
160833150|NCT04279613|580775954|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
160833151|NCT04279613|580775955|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
160833152|NCT04279613|580775956|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
160833153|NCT04279613|580775957|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
160833154|NCT04279613|580775953|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
160833155|NCT04279613|580775954|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
160833156|NCT04279613|580775955|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
160833157|NCT04279613|580775956|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
160833158|NCT04279613|580775957|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
160833159|NCT04279613|580775953|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
160833160|NCT04279613|580775954|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
160833161|NCT04279613|580775955|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
160833162|NCT04279613|580775956|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
160833163|NCT04279613|580775957|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
160833164|NCT04279613|580775953|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
160833165|NCT04279613|580775954|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
160833166|NCT04279613|580775955|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
160833167|NCT04279613|580775956|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
160833168|NCT04279613|580775957|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
160833169|NCT04279613|580775953|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
160833170|NCT04279613|580775954|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
160833171|NCT04279613|580775955|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
160833172|NCT04279613|580775956|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
160833173|NCT04279613|580775957|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
160833174|NCT02478164|580775958|FG000|Overall Study|Lack of Efficacy|13|||
160833175|NCT02478164|580775958|FG000|Overall Study|Adverse Event|1|||
160833176|NCT02478164|580775958|FG000|Overall Study|Withdrawal by Subject|1|||
160833177|NCT04051827|580775959|FG000|Overall Study|Death|1|||
160833178|NCT04051827|580775959|FG000|Overall Study|Withdrawal by Subject|4|||
160833179|NCT04051827|580775959|FG000|Overall Study|Progressive disease|16|||
160833180|NCT04051827|580775959|FG000|Overall Study|Physician Decision|1|||
160833181|NCT04051827|580775959|FG000|Overall Study|Other|4|||
160833182|NCT05779007|580775960|FG000|Overall Study|not meeting eligibility criteria|3517|||
160833183|NCT05779007|580775961|FG001|Overall Study|not meeting eligibility criteria|2009|||
160833184|NCT01424566|580775962|FG000|Single-blind Treatment|Adverse Event|71|||
160833185|NCT01424566|580775963|FG001|Single-blind Treatment|Adverse Event|0|||
160833186|NCT01424566|580775964|FG002|Single-blind Treatment|Adverse Event|0|||
160833187|NCT01424566|580775962|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
160833188|NCT01424566|580775963|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
160833189|NCT01424566|580775964|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
160833190|NCT01424566|580775962|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
160833191|NCT01424566|580775963|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
160833192|NCT01424566|580775964|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
160833193|NCT01424566|580775962|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
160833194|NCT01424566|580775963|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
160833195|NCT01424566|580775964|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
160560817|NCT00584870|579775871|FG000|Overall Study|Lost to Follow-up|4|||
160560818|NCT00584870|579775872|FG001|Overall Study|Lost to Follow-up|1|||
160560819|NCT00584870|579775873|FG002|Overall Study|Lost to Follow-up|1|||
160560820|NCT00584870|579775871|FG000|Overall Study|Lack of Efficacy|7|||
160560821|NCT00584870|579775872|FG001|Overall Study|Lack of Efficacy|14|||
160560822|NCT00584870|579775873|FG002|Overall Study|Lack of Efficacy|8|||
160560823|NCT00584870|579775871|FG000|Overall Study|Withdrawal by Subject|10|||
160560824|NCT00584870|579775872|FG001|Overall Study|Withdrawal by Subject|5|||
160560825|NCT00584870|579775873|FG002|Overall Study|Withdrawal by Subject|3|||
160560826|NCT00584870|579775871|FG000|Overall Study|Protocol Violation|1|||
160560827|NCT00584870|579775872|FG001|Overall Study|Protocol Violation|1|||
160647581|NCT02811861|580092761|FG001|Overall Study|Other|13|||
160647582|NCT02811861|580092762|FG002|Overall Study|Other|3|||
160833196|NCT01424566|580775962|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
160833197|NCT01424566|580775963|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
160833198|NCT01424566|580775964|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
160833199|NCT01424566|580775962|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
160833200|NCT01424566|580775963|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
160833201|NCT01424566|580775964|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
160833202|NCT01424566|580775962|FG000|Double-blind Treatment|Adverse Event|0|||
160560828|NCT00584870|579775873|FG002|Overall Study|Protocol Violation|2|||
160560829|NCT00584870|579775871|FG000|Overall Study|Did not met entrance criteria|1|||
160560830|NCT00584870|579775872|FG001|Overall Study|Did not met entrance criteria|0|||
160560831|NCT00584870|579775873|FG002|Overall Study|Did not met entrance criteria|0|||
160560832|NCT00584870|579775871|FG000|Overall Study|Other|2|||
160903481|NCT02034110|581040516|FG002|Overall Study|Lost to Follow-up|0|||
160903482|NCT02034110|581040517|FG003|Overall Study|Lost to Follow-up|0|||
160903483|NCT02034110|581040518|FG004|Overall Study|Lost to Follow-up|1|||
160903484|NCT02034110|581040519|FG005|Overall Study|Lost to Follow-up|0|||
160903485|NCT02034110|581040520|FG006|Overall Study|Lost to Follow-up|1|||
160903486|NCT02034110|581040521|FG007|Overall Study|Lost to Follow-up|0|||
160903487|NCT02034110|581040514|FG000|Overall Study|Withdrawal by Subject|5|||
160903488|NCT02034110|581040515|FG001|Overall Study|Withdrawal by Subject|7|||
160903489|NCT02034110|581040516|FG002|Overall Study|Withdrawal by Subject|0|||
160903490|NCT02034110|581040517|FG003|Overall Study|Withdrawal by Subject|3|||
160903491|NCT02034110|581040518|FG004|Overall Study|Withdrawal by Subject|7|||
160903492|NCT02034110|581040519|FG005|Overall Study|Withdrawal by Subject|0|||
160903493|NCT02034110|581040520|FG006|Overall Study|Withdrawal by Subject|3|||
160903494|NCT02034110|581040521|FG007|Overall Study|Withdrawal by Subject|1|||
160903495|NCT02034110|581040514|FG000|Overall Study|Study closed by sponsor|6|||
160903496|NCT02034110|581040515|FG001|Overall Study|Study closed by sponsor|2|||
160903497|NCT02034110|581040516|FG002|Overall Study|Study closed by sponsor|0|||
160903498|NCT02034110|581040517|FG003|Overall Study|Study closed by sponsor|6|||
160903499|NCT02034110|581040518|FG004|Overall Study|Study closed by sponsor|7|||
160903500|NCT02034110|581040519|FG005|Overall Study|Study closed by sponsor|0|||
160903501|NCT02034110|581040520|FG006|Overall Study|Study closed by sponsor|42|||
160903502|NCT02034110|581040521|FG007|Overall Study|Study closed by sponsor|0|||
160903503|NCT00064337|581040522|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
160903504|NCT00064337|581040522|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
160903505|NCT00064337|581040522|FG000|PBSCC or Induction/PBSCC|Progression|3|||
160903506|NCT00064337|581040522|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
160903507|NCT00064337|581040522|FG000|PBSCC or Induction/PBSCC|Death|2|||
160903508|NCT00064337|581040522|FG000|Transplant|Adverse Event|9|||
160903509|NCT00064337|581040522|FG000|Transplant|Not protocol-specified|5|||
160903510|NCT00064337|581040522|FG000|Transplant|Death|3|||
160903511|NCT00064337|581040522|FG000|Transplant|Patient Refusal|2|||
160903512|NCT00064337|581040522|FG000|Transplant|Progression|2|||
160903513|NCT00064337|581040522|FG000|Maintenance|Adverse Event|3|||
160903514|NCT00064337|581040522|FG000|Maintenance|Progression|2|||
160903515|NCT00064337|581040522|FG000|Maintenance|On treatment at time of analysis|2|||
160903516|NCT00064337|581040522|FG000|Maintenance|Not protocol-specified|2|||
160903517|NCT00064337|581040522|FG000|Maintenance|Death|1|||
160903518|NCT02279420|581040523|FG000|Overall Study|Lost to Follow-up|23|||
160903519|NCT03535844|581040526|FG000|Overall Study|Withdrawal by Subject|0|||
160903520|NCT03535844|581040527|FG001|Overall Study|Withdrawal by Subject|1|||
160903521|NCT00612040|581040528|FG000|Overall Study|Adverse Event|0|||
160903522|NCT00612040|581040529|FG001|Overall Study|Adverse Event|2|||
160903523|NCT00612040|581040530|FG002|Overall Study|Adverse Event|1|||
160903524|NCT00612040|581040528|FG000|Overall Study|Protocol Violation|1|||
160903525|NCT00612040|581040529|FG001|Overall Study|Protocol Violation|2|||
160903526|NCT00612040|581040530|FG002|Overall Study|Protocol Violation|1|||
160903527|NCT00612040|581040528|FG000|Overall Study|Lack of Efficacy|2|||
160903528|NCT00612040|581040529|FG001|Overall Study|Lack of Efficacy|1|||
160903529|NCT00612040|581040530|FG002|Overall Study|Lack of Efficacy|0|||
160903530|NCT00612040|581040528|FG000|Overall Study|Unclassified|2|||
160903531|NCT00612040|581040529|FG001|Overall Study|Unclassified|2|||
160903532|NCT00612040|581040530|FG002|Overall Study|Unclassified|5|||
160903533|NCT00297830|581040531|FG000|6 Month Visit|Death|1|||
160903534|NCT00297830|581040532|FG001|6 Month Visit|Death|0|||
160903535|NCT00297830|581040533|FG002|6 Month Visit|Death|2|||
160903536|NCT00297830|581040531|FG000|6 Month Visit|Withdrawal by Subject|2|||
160903537|NCT00297830|581040532|FG001|6 Month Visit|Withdrawal by Subject|1|||
160903538|NCT00297830|581040533|FG002|6 Month Visit|Withdrawal by Subject|1|||
160903539|NCT00297830|581040531|FG000|6 Month Visit|Adverse Event|0|||
160903540|NCT00297830|581040532|FG001|6 Month Visit|Adverse Event|1|||
160903541|NCT00297830|581040533|FG002|6 Month Visit|Adverse Event|0|||
160903542|NCT00297830|581040531|FG000|12 Month Visit|Lost to Follow-up|1|||
160903543|NCT00297830|581040532|FG001|12 Month Visit|Lost to Follow-up|0|||
160903544|NCT00297830|581040533|FG002|12 Month Visit|Lost to Follow-up|0|||
160903545|NCT00297830|581040531|FG000|12 Month Visit|Adverse Event|0|||
160903546|NCT00297830|581040532|FG001|12 Month Visit|Adverse Event|3|||
160903547|NCT00297830|581040533|FG002|12 Month Visit|Adverse Event|0|||
160903548|NCT00297830|581040531|FG000|12 Month Visit|Withdrawal by Subject|0|||
160903549|NCT00297830|581040532|FG001|12 Month Visit|Withdrawal by Subject|3|||
160903550|NCT00297830|581040533|FG002|12 Month Visit|Withdrawal by Subject|0|||
160903551|NCT02835820|581040534|FG000|Overall Study|Baseline Screen Failure|0|||
160903552|NCT02835820|581040535|FG001|Overall Study|Baseline Screen Failure|3|||
160903553|NCT00827502|581040536|FG000|Overall Study|randomized but not treated|11|||
160560833|NCT00584870|579775872|FG001|Overall Study|Other|0|||
160560834|NCT00584870|579775873|FG002|Overall Study|Other|0|||
160560835|NCT00584870|579775871|FG000|Overall Study|Randomized but not treated|0|||
160560836|NCT00584870|579775872|FG001|Overall Study|Randomized but not treated|1|||
160560837|NCT00584870|579775873|FG002|Overall Study|Randomized but not treated|2|||
160560838|NCT03682120|579775874|FG000|Overall Study|Lost to Follow-up|11|||
160560839|NCT03682120|579775875|FG001|Overall Study|Lost to Follow-up|4|||
160560840|NCT03682120|579775876|FG002|Overall Study|Lost to Follow-up|5|||
160560841|NCT03682120|579775877|FG003|Overall Study|Lost to Follow-up|2|||
160560842|NCT03682120|579775874|FG000|Overall Study|Physician Decision|1|||
160560843|NCT03682120|579775875|FG001|Overall Study|Physician Decision|0|||
160560844|NCT03682120|579775876|FG002|Overall Study|Physician Decision|0|||
160560845|NCT03682120|579775877|FG003|Overall Study|Physician Decision|0|||
160560846|NCT03682120|579775874|FG000|Overall Study|Withdrawal by Subject|1|||
160560847|NCT03682120|579775875|FG001|Overall Study|Withdrawal by Subject|2|||
160560848|NCT03682120|579775876|FG002|Overall Study|Withdrawal by Subject|3|||
160560849|NCT03682120|579775877|FG003|Overall Study|Withdrawal by Subject|0|||
160560850|NCT03682120|579775874|FG000|Overall Study|Death|0|||
160560851|NCT03682120|579775875|FG001|Overall Study|Death|1|||
160560852|NCT03682120|579775876|FG002|Overall Study|Death|0|||
160560853|NCT03682120|579775877|FG003|Overall Study|Death|0|||
160560854|NCT03682120|579775874|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
160560855|NCT03682120|579775875|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
160560856|NCT03682120|579775876|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
160560857|NCT03682120|579775877|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
160560858|NCT01651780|579775878|FG000|Overall Study|Physician decision: No 30-day visit|2|||
160560859|NCT01651780|579775879|FG001|Overall Study|Physician decision: No 30-day visit|1|||
160560860|NCT01651780|579775878|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
160560861|NCT01651780|579775879|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
160560862|NCT01651780|579775878|FG000|Overall Study|Withdrawal by Subject|2|||
160560863|NCT01651780|579775879|FG001|Overall Study|Withdrawal by Subject|0|||
160560864|NCT01651780|579775878|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
160560865|NCT01651780|579775879|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160560866|NCT01651780|579775878|FG000|Overall Study|Lost to Follow-up|1|||
160560867|NCT01651780|579775879|FG001|Overall Study|Lost to Follow-up|2|||
160560868|NCT01651780|579775878|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
160560869|NCT01651780|579775879|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
160833203|NCT01424566|580775963|FG001|Double-blind Treatment|Adverse Event|21|||
160833204|NCT01424566|580775964|FG002|Double-blind Treatment|Adverse Event|13|||
160833205|NCT01424566|580775962|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
160833206|NCT01424566|580775963|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
160833207|NCT01424566|580775964|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
160833208|NCT01424566|580775962|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
160833209|NCT01424566|580775963|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
160833210|NCT01424566|580775964|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
160833211|NCT01424566|580775962|FG000|Double-blind Treatment|Lack of Efficacy|0|||
160833212|NCT01424566|580775963|FG001|Double-blind Treatment|Lack of Efficacy|1|||
160833213|NCT01424566|580775964|FG002|Double-blind Treatment|Lack of Efficacy|1|||
160833214|NCT02708485|580775969|FG000|Overall Study|Withdrawal by Subject|3|||
160833215|NCT02708485|580775970|FG001|Overall Study|Withdrawal by Subject|2|||
160833216|NCT00231413|580775971|FG000|Overall Study|Non-serious AE|0|||
160833217|NCT00231413|580775972|FG001|Overall Study|Non-serious AE|0|||
160833218|NCT00231413|580775973|FG002|Overall Study|Non-serious AE|1|||
160833219|NCT00231413|580775974|FG003|Overall Study|Non-serious AE|0|||
160833220|NCT00231413|580775975|FG004|Overall Study|Non-serious AE|0|||
160833221|NCT00231413|580775976|FG005|Overall Study|Non-serious AE|0|||
160833222|NCT00231413|580775977|FG006|Overall Study|Non-serious AE|1|||
160833223|NCT00231413|580775971|FG000|Overall Study|Withdrawal by Subject|3|||
160833224|NCT00231413|580775972|FG001|Overall Study|Withdrawal by Subject|1|||
160833225|NCT00231413|580775973|FG002|Overall Study|Withdrawal by Subject|4|||
160560870|NCT02949830|579775880|FG000|Overall Study|Adverse Event|1|||
160560871|NCT02949830|579775880|FG000|Overall Study|Withdrawal by Subject|1|||
160560872|NCT01290887|579775881|FG000|Overall Study|Adverse Event|6|||
160833226|NCT00231413|580775974|FG003|Overall Study|Withdrawal by Subject|2|||
160833227|NCT00231413|580775975|FG004|Overall Study|Withdrawal by Subject|2|||
160647583|NCT02811861|580092760|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
160833228|NCT00231413|580775976|FG005|Overall Study|Withdrawal by Subject|0|||
160833229|NCT00231413|580775977|FG006|Overall Study|Withdrawal by Subject|3|||
160560873|NCT01290887|579775882|FG001|Overall Study|Adverse Event|11|||
160560874|NCT01290887|579775881|FG000|Overall Study|Lack of Efficacy|4|||
160560875|NCT01290887|579775882|FG001|Overall Study|Lack of Efficacy|5|||
160560876|NCT01290887|579775881|FG000|Overall Study|Withdrawal by Subject|26|||
160560877|NCT01290887|579775882|FG001|Overall Study|Withdrawal by Subject|32|||
160560878|NCT01290887|579775881|FG000|Overall Study|Protocol Violation|2|||
160560879|NCT01290887|579775882|FG001|Overall Study|Protocol Violation|1|||
160560880|NCT01290887|579775881|FG000|Overall Study|Lost to Follow-up|4|||
160833230|NCT00231413|580775971|FG000|Overall Study|Migrated/moved from study area|0|||
160833231|NCT00231413|580775972|FG001|Overall Study|Migrated/moved from study area|0|||
160833232|NCT00231413|580775973|FG002|Overall Study|Migrated/moved from study area|1|||
160833233|NCT00231413|580775974|FG003|Overall Study|Migrated/moved from study area|0|||
160833234|NCT00231413|580775975|FG004|Overall Study|Migrated/moved from study area|0|||
160833235|NCT00231413|580775976|FG005|Overall Study|Migrated/moved from study area|1|||
160833236|NCT00231413|580775977|FG006|Overall Study|Migrated/moved from study area|0|||
160833237|NCT00231413|580775971|FG000|Overall Study|Lost to Follow-up|4|||
160833238|NCT00231413|580775972|FG001|Overall Study|Lost to Follow-up|4|||
160833239|NCT00231413|580775973|FG002|Overall Study|Lost to Follow-up|1|||
160833240|NCT00231413|580775974|FG003|Overall Study|Lost to Follow-up|1|||
160833241|NCT00231413|580775975|FG004|Overall Study|Lost to Follow-up|1|||
160833242|NCT00231413|580775976|FG005|Overall Study|Lost to Follow-up|4|||
160833243|NCT00231413|580775977|FG006|Overall Study|Lost to Follow-up|0|||
160833244|NCT00231413|580775971|FG000|Overall Study|Pregnancy|1|||
160833245|NCT00231413|580775972|FG001|Overall Study|Pregnancy|0|||
160833246|NCT00231413|580775973|FG002|Overall Study|Pregnancy|0|||
160833247|NCT00231413|580775974|FG003|Overall Study|Pregnancy|0|||
160833248|NCT00231413|580775975|FG004|Overall Study|Pregnancy|0|||
160833249|NCT00231413|580775976|FG005|Overall Study|Pregnancy|0|||
160833250|NCT00231413|580775977|FG006|Overall Study|Pregnancy|0|||
160833251|NCT01100528|580775981|FG000|Overall Study|Death|1|||
160833252|NCT01100528|580775981|FG000|Overall Study|Withdrawal by Subject|2|||
160833253|NCT01659255|580775982|FG000|Overall Study|Adverse Event|0|||
160833254|NCT01659255|580775983|FG001|Overall Study|Adverse Event|0|||
160833255|NCT01659255|580775984|FG002|Overall Study|Adverse Event|0|||
160833256|NCT01659255|580775985|FG003|Overall Study|Adverse Event|0|||
160903554|NCT00827502|581040536|FG000|Overall Study|Adverse Event|1|||
160903555|NCT00827502|581040536|FG000|Overall Study|Lost to Follow-up|4|||
160903556|NCT00827502|581040536|FG000|Overall Study|Withdrawal by Subject|5|||
160903557|NCT05096221|581040537|FG000|Part 2|Physician Decision|0|||
160833257|NCT01659255|580775986|FG004|Overall Study|Adverse Event|0|||
160833258|NCT01659255|580775987|FG005|Overall Study|Adverse Event|1|||
160833259|NCT01659255|580775988|FG006|Overall Study|Adverse Event|1|||
160833260|NCT01659255|580775989|FG007|Overall Study|Adverse Event|0|||
160833261|NCT01659255|580775990|FG008|Overall Study|Adverse Event|0|||
160833262|NCT01659255|580775991|FG009|Overall Study|Adverse Event|1|||
160833263|NCT01659255|580775992|FG010|Overall Study|Adverse Event|0|||
160903558|NCT05096221|581040538|FG001|Part 2|Physician Decision|1|||
160560881|NCT01290887|579775882|FG001|Overall Study|Lost to Follow-up|4|||
160560882|NCT01290887|579775881|FG000|Overall Study|Non-compliance to study procedures|0|||
160560883|NCT01290887|579775882|FG001|Overall Study|Non-compliance to study procedures|1|||
160833264|NCT01659255|580775993|FG011|Overall Study|Adverse Event|1|||
160833265|NCT01659255|580775994|FG012|Overall Study|Adverse Event|0|||
160833266|NCT01659255|580775995|FG013|Overall Study|Adverse Event|2|||
160833267|NCT01659255|580775996|FG014|Overall Study|Adverse Event|0|||
160833268|NCT01659255|580775997|FG015|Overall Study|Adverse Event|1|||
160833269|NCT01659255|580775998|FG016|Overall Study|Adverse Event|0|||
160833270|NCT01659255|580775982|FG000|Overall Study|Death|0|||
160833271|NCT01659255|580775983|FG001|Overall Study|Death|1|||
160833272|NCT01659255|580775984|FG002|Overall Study|Death|0|||
160833273|NCT01659255|580775985|FG003|Overall Study|Death|0|||
160833274|NCT01659255|580775986|FG004|Overall Study|Death|0|||
160833275|NCT01659255|580775987|FG005|Overall Study|Death|0|||
160833276|NCT01659255|580775988|FG006|Overall Study|Death|0|||
160833277|NCT01659255|580775989|FG007|Overall Study|Death|1|||
160833278|NCT01659255|580775990|FG008|Overall Study|Death|1|||
160833279|NCT01659255|580775991|FG009|Overall Study|Death|0|||
160833280|NCT01659255|580775992|FG010|Overall Study|Death|0|||
160833281|NCT01659255|580775993|FG011|Overall Study|Death|0|||
160833282|NCT01659255|580775994|FG012|Overall Study|Death|1|||
160833283|NCT01659255|580775995|FG013|Overall Study|Death|1|||
160833284|NCT01659255|580775996|FG014|Overall Study|Death|2|||
160833285|NCT01659255|580775997|FG015|Overall Study|Death|1|||
160833286|NCT01659255|580775998|FG016|Overall Study|Death|0|||
160833287|NCT01659255|580775982|FG000|Overall Study|Progressive Disease|2|||
160833288|NCT01659255|580775983|FG001|Overall Study|Progressive Disease|0|||
160833289|NCT01659255|580775984|FG002|Overall Study|Progressive Disease|0|||
160833290|NCT01659255|580775985|FG003|Overall Study|Progressive Disease|0|||
160833291|NCT01659255|580775986|FG004|Overall Study|Progressive Disease|0|||
160833292|NCT01659255|580775987|FG005|Overall Study|Progressive Disease|0|||
160833293|NCT01659255|580775988|FG006|Overall Study|Progressive Disease|0|||
160833294|NCT01659255|580775989|FG007|Overall Study|Progressive Disease|1|||
160833295|NCT01659255|580775990|FG008|Overall Study|Progressive Disease|0|||
160833296|NCT01659255|580775991|FG009|Overall Study|Progressive Disease|2|||
160833297|NCT01659255|580775992|FG010|Overall Study|Progressive Disease|2|||
160833298|NCT01659255|580775993|FG011|Overall Study|Progressive Disease|3|||
160833299|NCT01659255|580775994|FG012|Overall Study|Progressive Disease|5|||
160833300|NCT01659255|580775995|FG013|Overall Study|Progressive Disease|13|||
160833301|NCT01659255|580775996|FG014|Overall Study|Progressive Disease|6|||
160833302|NCT01659255|580775997|FG015|Overall Study|Progressive Disease|2|||
160833303|NCT01659255|580775998|FG016|Overall Study|Progressive Disease|3|||
160833304|NCT01659255|580775982|FG000|Overall Study|Withdrew Consent|0|||
160833305|NCT01659255|580775983|FG001|Overall Study|Withdrew Consent|0|||
160833306|NCT01659255|580775984|FG002|Overall Study|Withdrew Consent|0|||
160833307|NCT01659255|580775985|FG003|Overall Study|Withdrew Consent|0|||
160833308|NCT01659255|580775986|FG004|Overall Study|Withdrew Consent|0|||
160833309|NCT01659255|580775987|FG005|Overall Study|Withdrew Consent|0|||
160833310|NCT01659255|580775988|FG006|Overall Study|Withdrew Consent|0|||
160833311|NCT01659255|580775989|FG007|Overall Study|Withdrew Consent|0|||
160833312|NCT01659255|580775990|FG008|Overall Study|Withdrew Consent|0|||
160833313|NCT01659255|580775991|FG009|Overall Study|Withdrew Consent|0|||
160833314|NCT01659255|580775992|FG010|Overall Study|Withdrew Consent|1|||
160833315|NCT01659255|580775993|FG011|Overall Study|Withdrew Consent|0|||
160833316|NCT01659255|580775994|FG012|Overall Study|Withdrew Consent|0|||
160833317|NCT01659255|580775995|FG013|Overall Study|Withdrew Consent|1|||
160833318|NCT01659255|580775996|FG014|Overall Study|Withdrew Consent|0|||
160833319|NCT01659255|580775997|FG015|Overall Study|Withdrew Consent|0|||
160833320|NCT01659255|580775998|FG016|Overall Study|Withdrew Consent|0|||
160833321|NCT01659255|580775982|FG000|Overall Study|Investigator Decision|0|||
160833322|NCT01659255|580775983|FG001|Overall Study|Investigator Decision|0|||
160833323|NCT01659255|580775984|FG002|Overall Study|Investigator Decision|0|||
160833324|NCT01659255|580775985|FG003|Overall Study|Investigator Decision|0|||
160833325|NCT01659255|580775986|FG004|Overall Study|Investigator Decision|0|||
160833326|NCT01659255|580775987|FG005|Overall Study|Investigator Decision|0|||
160833327|NCT01659255|580775988|FG006|Overall Study|Investigator Decision|0|||
160833328|NCT01659255|580775989|FG007|Overall Study|Investigator Decision|0|||
160833329|NCT01659255|580775990|FG008|Overall Study|Investigator Decision|0|||
160833330|NCT01659255|580775991|FG009|Overall Study|Investigator Decision|0|||
160833331|NCT01659255|580775992|FG010|Overall Study|Investigator Decision|0|||
160833332|NCT01659255|580775993|FG011|Overall Study|Investigator Decision|0|||
160833333|NCT01659255|580775994|FG012|Overall Study|Investigator Decision|1|||
160833334|NCT01659255|580775995|FG013|Overall Study|Investigator Decision|1|||
160833335|NCT01659255|580775996|FG014|Overall Study|Investigator Decision|0|||
160833336|NCT01659255|580775997|FG015|Overall Study|Investigator Decision|0|||
160833337|NCT01659255|580775998|FG016|Overall Study|Investigator Decision|0|||
160833338|NCT01659255|580775982|FG000|Overall Study|Sponsor's Decision|0|||
160833339|NCT01659255|580775983|FG001|Overall Study|Sponsor's Decision|0|||
160833340|NCT01659255|580775984|FG002|Overall Study|Sponsor's Decision|0|||
160833341|NCT01659255|580775985|FG003|Overall Study|Sponsor's Decision|0|||
160833342|NCT01659255|580775986|FG004|Overall Study|Sponsor's Decision|0|||
160833343|NCT01659255|580775987|FG005|Overall Study|Sponsor's Decision|0|||
160833344|NCT01659255|580775988|FG006|Overall Study|Sponsor's Decision|1|||
160833345|NCT01659255|580775989|FG007|Overall Study|Sponsor's Decision|0|||
160833346|NCT01659255|580775990|FG008|Overall Study|Sponsor's Decision|0|||
160833347|NCT01659255|580775991|FG009|Overall Study|Sponsor's Decision|0|||
160833348|NCT01659255|580775992|FG010|Overall Study|Sponsor's Decision|0|||
160833349|NCT01659255|580775993|FG011|Overall Study|Sponsor's Decision|0|||
160833350|NCT01659255|580775994|FG012|Overall Study|Sponsor's Decision|0|||
160833351|NCT01659255|580775995|FG013|Overall Study|Sponsor's Decision|0|||
160833352|NCT01659255|580775996|FG014|Overall Study|Sponsor's Decision|0|||
160833353|NCT01659255|580775997|FG015|Overall Study|Sponsor's Decision|0|||
160991230|NCT03369951|581355545|FG000|Overall Study|Lost to Follow-up|1|||
160560884|NCT01290887|579775881|FG000|Overall Study|Non-compliance to study medications|1|||
160560885|NCT01290887|579775882|FG001|Overall Study|Non-compliance to study medications|0|||
160560886|NCT01290887|579775881|FG000|Overall Study|Sponsor closure of study|420|||
160560887|NCT01290887|579775882|FG001|Overall Study|Sponsor closure of study|476|||
160560888|NCT01290887|579775881|FG000|Overall Study|Other|3|||
160560889|NCT01290887|579775882|FG001|Overall Study|Other|6|||
160560890|NCT01628926|579775883|FG000|Overall Study|Adverse Event|13|||
160560891|NCT01628926|579775884|FG001|Overall Study|Adverse Event|11|||
160560892|NCT01628926|579775885|FG002|Overall Study|Adverse Event|9|||
160560893|NCT01628926|579775883|FG000|Overall Study|Lack of Efficacy|2|||
160560894|NCT01628926|579775884|FG001|Overall Study|Lack of Efficacy|1|||
160560895|NCT01628926|579775885|FG002|Overall Study|Lack of Efficacy|5|||
160560896|NCT01628926|579775883|FG000|Overall Study|Withdrawal by Subject|6|||
160560897|NCT01628926|579775884|FG001|Overall Study|Withdrawal by Subject|4|||
160560898|NCT01628926|579775885|FG002|Overall Study|Withdrawal by Subject|2|||
160560899|NCT01628926|579775883|FG000|Overall Study|Protocol Violation|0|||
160560900|NCT01628926|579775884|FG001|Overall Study|Protocol Violation|1|||
160560901|NCT01628926|579775885|FG002|Overall Study|Protocol Violation|0|||
160560902|NCT01628926|579775883|FG000|Overall Study|Discontinuation criteria|3|||
160560903|NCT01628926|579775884|FG001|Overall Study|Discontinuation criteria|4|||
160560904|NCT01628926|579775885|FG002|Overall Study|Discontinuation criteria|0|||
160560905|NCT01628926|579775883|FG000|Overall Study|Physician Decision|2|||
160560906|NCT01628926|579775884|FG001|Overall Study|Physician Decision|2|||
160560907|NCT01628926|579775885|FG002|Overall Study|Physician Decision|1|||
160560908|NCT02116621|579775886|FG000|Baseline|Withdrawal by Subject|0|||
160560909|NCT02116621|579775887|FG001|Baseline|Withdrawal by Subject|4|||
160560910|NCT02116621|579775886|FG000|Three Month Follow-up|Death|1|||
160560911|NCT02116621|579775887|FG001|Three Month Follow-up|Death|1|||
160560912|NCT02116621|579775886|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
160560913|NCT02116621|579775887|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
160560914|NCT02116621|579775886|FG000|Three Month Follow-up|Lost to Follow-up|0|||
160560915|NCT02116621|579775887|FG001|Three Month Follow-up|Lost to Follow-up|1|||
160560916|NCT02116621|579775886|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
160560917|NCT02116621|579775887|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
160560918|NCT02116621|579775886|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
160560919|NCT02116621|579775887|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
160560920|NCT02116621|579775886|FG000|Six Month Follow-up|Lost to Follow-up|2|||
160560921|NCT02116621|579775887|FG001|Six Month Follow-up|Lost to Follow-up|1|||
160560922|NCT02116621|579775886|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
160560923|NCT02116621|579775887|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
160560924|NCT02116621|579775886|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
160560925|NCT02116621|579775887|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
160560926|NCT02116621|579775886|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
160560927|NCT02116621|579775887|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
160560928|NCT02116621|579775886|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
160560929|NCT02116621|579775887|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
160560930|NCT02116621|579775886|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
160560931|NCT02116621|579775887|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
160560932|NCT03437447|579775888|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160560933|NCT03437447|579775889|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160833354|NCT01659255|580775998|FG016|Overall Study|Sponsor's Decision|0|||
160833355|NCT01659255|580775982|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833356|NCT01659255|580775983|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160560934|NCT03437447|579775890|FG002|Treatment Period 1|Withdrawal by Subject|1|||
160560935|NCT04752384|579775891|FG000|Overall Study|Withdrawal by Subject|1|||
160560936|NCT04752384|579775891|FG000|Overall Study|Death|1|||
160560937|NCT04439331|579775898|FG000|Overall Study|Never Start Protocol Therapy|2|||
160560938|NCT04439331|579775898|FG000|Overall Study|Ineligible|2|||
160560939|NCT04439331|579775898|FG000|Overall Study|Mutation Status Not Confirmed|1|||
160560940|NCT04439331|579775898|FG000|Overall Study|Adverse Event|1|||
160560941|NCT04439331|579775898|FG000|Overall Study|Death|1|||
160991231|NCT03369951|581355545|FG000|Overall Study|Protocol Violation|1|||
160560942|NCT04439331|579775898|FG000|Overall Study|Disease Progression|20|||
160560943|NCT04439331|579775898|FG000|Overall Study|Withdrawal by Subject|6|||
160560944|NCT04439331|579775898|FG000|Overall Study|Physician Decision|1|||
160560945|NCT04439331|579775898|FG000|Overall Study|Other Complicating Disease|1|||
160560946|NCT03726268|579775899|FG000|Overall Study|Physician Decision|2|||
160560947|NCT03726268|579775900|FG001|Overall Study|Physician Decision|8|||
160560948|NCT03726268|579775901|FG002|Overall Study|Physician Decision|6|||
160560949|NCT03726268|579775902|FG003|Overall Study|Physician Decision|3|||
160560950|NCT03726268|579775899|FG000|Overall Study|Withdrawal by Subject|11|||
160560951|NCT03726268|579775900|FG001|Overall Study|Withdrawal by Subject|5|||
160560952|NCT03726268|579775901|FG002|Overall Study|Withdrawal by Subject|9|||
160560953|NCT03726268|579775902|FG003|Overall Study|Withdrawal by Subject|8|||
160560954|NCT00630331|579775905|FG000|Overall Study|Death|2|||
160560955|NCT00630331|579775906|FG001|Overall Study|Death|1|||
160833357|NCT01659255|580775984|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833358|NCT01659255|580775985|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160560956|NCT00630331|579775907|FG002|Overall Study|Death|1|||
160560957|NCT00630331|579775905|FG000|Overall Study|Adverse Event|1|||
160560958|NCT00630331|579775906|FG001|Overall Study|Adverse Event|0|||
160560959|NCT00630331|579775907|FG002|Overall Study|Adverse Event|0|||
160560960|NCT00630331|579775905|FG000|Overall Study|Withdrawal by Subject|12|||
160560961|NCT00630331|579775906|FG001|Overall Study|Withdrawal by Subject|7|||
160560962|NCT00630331|579775907|FG002|Overall Study|Withdrawal by Subject|5|||
160560963|NCT00630331|579775905|FG000|Overall Study|Lost to Follow-up|175|||
160560964|NCT00630331|579775906|FG001|Overall Study|Lost to Follow-up|143|||
160560965|NCT00630331|579775907|FG002|Overall Study|Lost to Follow-up|170|||
160560966|NCT00630331|579775905|FG000|Overall Study|Inappropriate enrollment|3|||
160560967|NCT00630331|579775906|FG001|Overall Study|Inappropriate enrollment|6|||
160560968|NCT00630331|579775907|FG002|Overall Study|Inappropriate enrollment|3|||
160560969|NCT00630331|579775905|FG000|Overall Study|Unable to classify|9|||
160560970|NCT00630331|579775906|FG001|Overall Study|Unable to classify|4|||
160560971|NCT00630331|579775907|FG002|Overall Study|Unable to classify|3|||
160833359|NCT01659255|580775986|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833360|NCT01659255|580775987|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833361|NCT01659255|580775988|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833362|NCT01659255|580775989|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833363|NCT01659255|580775990|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833364|NCT01659255|580775991|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833365|NCT01659255|580775992|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833366|NCT01659255|580775993|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833367|NCT01659255|580775994|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833368|NCT01659255|580775995|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833369|NCT01659255|580775996|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833370|NCT01659255|580775997|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
160833371|NCT01659255|580775998|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833372|NCT01659255|580775982|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
160833373|NCT01659255|580775983|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
160833374|NCT01659255|580775984|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
160833375|NCT01659255|580775985|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
160833376|NCT01659255|580775986|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
160560972|NCT00630331|579775905|FG000|Overall Study|Protocol Violation|4|||
160560973|NCT00630331|579775906|FG001|Overall Study|Protocol Violation|5|||
160833377|NCT01659255|580775987|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
160833378|NCT01659255|580775988|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
160833379|NCT01659255|580775989|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
160833380|NCT01659255|580775990|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
160833381|NCT01659255|580775991|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
160833382|NCT01659255|580775992|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
160833383|NCT01659255|580775993|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
160903559|NCT02478632|581040545|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
160903560|NCT02478632|581040546|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
160903561|NCT02478632|581040545|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
160903562|NCT02478632|581040546|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
160903563|NCT02478632|581040545|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
160560974|NCT00630331|579775907|FG002|Overall Study|Protocol Violation|6|||
160560975|NCT01955707|579775909|FG000|Overall Study|Adverse Event|1|||
160560976|NCT01955707|579775910|FG001|Overall Study|Adverse Event|2|||
160560977|NCT01955707|579775909|FG000|Overall Study|Lost to Follow-up|2|||
160560978|NCT01955707|579775910|FG001|Overall Study|Lost to Follow-up|1|||
160560979|NCT01955707|579775909|FG000|Overall Study|Withdrawal by Subject|0|||
160560980|NCT01955707|579775910|FG001|Overall Study|Withdrawal by Subject|3|||
160560981|NCT01955707|579775909|FG000|Overall Study|Death|13|||
160833384|NCT01659255|580775994|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
160833385|NCT01659255|580775995|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
160833386|NCT01659255|580775996|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
160833387|NCT01659255|580775997|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
160833388|NCT01659255|580775998|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
160833389|NCT01116427|580775999|FG000|Core Phase|Adverse Event|0|||
160833390|NCT01116427|580776000|FG001|Core Phase|Adverse Event|1|||
160833391|NCT01116427|580775999|FG000|Core Phase|Lost to Follow-up|1|||
160833392|NCT01116427|580776000|FG001|Core Phase|Lost to Follow-up|0|||
160833393|NCT01116427|580775999|FG000|Core Phase|Withdrawal by Subject|3|||
160833394|NCT01116427|580776000|FG001|Core Phase|Withdrawal by Subject|0|||
160833395|NCT01116427|580775999|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
160833396|NCT01116427|580776000|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
160833397|NCT01116427|580775999|FG000|Extension Phase|Adverse Event|1|||
160833398|NCT01116427|580776000|FG001|Extension Phase|Adverse Event|1|||
160833399|NCT01116427|580775999|FG000|Extension Phase|Lost to Follow-up|2|||
160833400|NCT01116427|580776000|FG001|Extension Phase|Lost to Follow-up|0|||
160833401|NCT01116427|580775999|FG000|Extension Phase|Withdrawal by Subject|5|||
160833402|NCT01116427|580776000|FG001|Extension Phase|Withdrawal by Subject|1|||
160833403|NCT01116427|580775999|FG000|Extension Phase|Not using appropriate birth control|1|||
160833404|NCT01116427|580776000|FG001|Extension Phase|Not using appropriate birth control|0|||
160833405|NCT02211313|580776003|FG000|Overall Study|Treatment Failure|5|||
160833406|NCT02211313|580776004|FG001|Overall Study|Treatment Failure|2|||
160833407|NCT02211313|580776003|FG000|Overall Study|No Follow up Questionnaires|1|||
160833408|NCT02211313|580776004|FG001|Overall Study|No Follow up Questionnaires|1|||
160833409|NCT01423916|580776005|FG000|Overall Study|Adverse Event|5|||
160833410|NCT01423916|580776006|FG001|Overall Study|Adverse Event|9|||
160833411|NCT01423916|580776007|FG002|Overall Study|Adverse Event|2|||
160833412|NCT01423916|580776005|FG000|Overall Study|Met Withdrawal Criteria|1|||
160833413|NCT01423916|580776006|FG001|Overall Study|Met Withdrawal Criteria|1|||
160903564|NCT02478632|581040546|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
160903565|NCT01867424|581040547|FG000|Overall Study|Patient noncompliance|2|||
160903566|NCT01867424|581040548|FG001|Overall Study|Patient noncompliance|1|||
160903567|NCT04645953|581040549|FG000|Overall Study|Lost to Follow-up|2|||
160833414|NCT01423916|580776007|FG002|Overall Study|Met Withdrawal Criteria|1|||
160833415|NCT01423916|580776005|FG000|Overall Study|Physician Decision|1|||
160833416|NCT01423916|580776006|FG001|Overall Study|Physician Decision|0|||
160833417|NCT01423916|580776007|FG002|Overall Study|Physician Decision|1|||
160833418|NCT01423916|580776005|FG000|Overall Study|Withdrawal by Subject|3|||
160833419|NCT01423916|580776006|FG001|Overall Study|Withdrawal by Subject|10|||
160833420|NCT01423916|580776007|FG002|Overall Study|Withdrawal by Subject|3|||
160833421|NCT01423916|580776005|FG000|Overall Study|Protocol Deviation|1|||
160903568|NCT04645953|581040550|FG001|Overall Study|Lost to Follow-up|1|||
160833422|NCT01423916|580776006|FG001|Overall Study|Protocol Deviation|0|||
160833423|NCT01423916|580776007|FG002|Overall Study|Protocol Deviation|0|||
160833424|NCT03316950|580776008|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
160833425|NCT03316950|580776009|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
160903569|NCT04645953|581040551|FG002|Overall Study|Lost to Follow-up|1|||
160903570|NCT04645953|581040549|FG000|Overall Study|Withdrawal by Subject|0|||
160903571|NCT04645953|581040550|FG001|Overall Study|Withdrawal by Subject|1|||
160903572|NCT04645953|581040551|FG002|Overall Study|Withdrawal by Subject|0|||
160903573|NCT04645953|581040549|FG000|Overall Study|Physician Decision|0|||
160903574|NCT04645953|581040550|FG001|Overall Study|Physician Decision|1|||
160903575|NCT04645953|581040551|FG002|Overall Study|Physician Decision|0|||
160903576|NCT04645953|581040549|FG000|Overall Study|Discontinued Prior to Dosing|0|||
160903577|NCT04645953|581040550|FG001|Overall Study|Discontinued Prior to Dosing|0|||
160903578|NCT04645953|581040551|FG002|Overall Study|Discontinued Prior to Dosing|2|||
160903579|NCT04613375|581040552|FG000|Overall Study|Death|198|||
160647584|NCT02811861|580092761|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
160647585|NCT02811861|580092762|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
160903580|NCT04613375|581040552|FG000|Overall Study|Withdrawal by Subject|3|||
160903581|NCT00002651|581040553|FG000|Induction|Adverse Event|44|||
160903582|NCT00002651|581040554|FG001|Induction|Adverse Event|0|||
160903583|NCT00002651|581040555|FG002|Induction|Adverse Event|0|||
160903584|NCT00002651|581040553|FG000|Induction|Refusal unrelated to adverse event|50|||
160647586|NCT02811861|580092760|FG000|Overall Study|Randomized but not treated|2|||
160903585|NCT00002651|581040554|FG001|Induction|Refusal unrelated to adverse event|0|||
160903586|NCT00002651|581040555|FG002|Induction|Refusal unrelated to adverse event|0|||
160647587|NCT02811861|580092761|FG001|Overall Study|Randomized but not treated|3|||
160903587|NCT00002651|581040553|FG000|Induction|Progression/relapse|274|||
160833426|NCT03316950|580776010|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
160833427|NCT03316950|580776011|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
160833428|NCT03316950|580776008|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
160833429|NCT03316950|580776009|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
160833430|NCT03316950|580776010|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
160833431|NCT03316950|580776011|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
160833432|NCT03316950|580776008|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
160833433|NCT03316950|580776009|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
160833434|NCT03316950|580776010|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
160833435|NCT03316950|580776011|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
160833436|NCT00791557|580776012|FG000|Overall Study|Adverse Event|1|||
160833437|NCT01079936|580776013|FG000|Phase I: MTD|First Remission Status|2|||
160833438|NCT01079936|580776014|FG001|Phase I: MTD|First Remission Status|0|||
160833439|NCT01079936|580776015|FG002|Phase I: MTD|First Remission Status|0|||
160833440|NCT01079936|580776016|FG003|Phase I: MTD|First Remission Status|0|||
160833441|NCT01079936|580776017|FG004|Phase I: MTD|First Remission Status|0|||
160833442|NCT01079936|580776013|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
160833443|NCT01079936|580776014|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
160833444|NCT01079936|580776015|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
160833445|NCT01079936|580776016|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
160833446|NCT01079936|580776017|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
160833447|NCT01079936|580776013|FG000|Phase II|Adverse Event|0|||
160833448|NCT01079936|580776014|FG001|Phase II|Adverse Event|0|||
160833449|NCT01079936|580776015|FG002|Phase II|Adverse Event|1|||
160833450|NCT01079936|580776016|FG003|Phase II|Adverse Event|0|||
160833451|NCT01079936|580776017|FG004|Phase II|Adverse Event|0|||
160833452|NCT01079936|580776013|FG000|Phase II|Insurance Issue|0|||
160833453|NCT01079936|580776014|FG001|Phase II|Insurance Issue|0|||
160833454|NCT01079936|580776015|FG002|Phase II|Insurance Issue|0|||
160833455|NCT01079936|580776016|FG003|Phase II|Insurance Issue|0|||
160833456|NCT01079936|580776017|FG004|Phase II|Insurance Issue|1|||
160833457|NCT02322190|580776018|FG000|Overall Study|Death on study|1|||
160833458|NCT02322190|580776019|FG001|Overall Study|Death on study|0|||
160833459|NCT03344640|580776020|FG000|Overall Study|Adverse Event|1|||
160833460|NCT03344640|580776021|FG001|Overall Study|Adverse Event|0|||
160833461|NCT03344640|580776020|FG000|Overall Study|Physician Decision|1|||
160833462|NCT03344640|580776021|FG001|Overall Study|Physician Decision|1|||
160833463|NCT03344640|580776020|FG000|Overall Study|Withdrawal by Subject|1|||
160833464|NCT03344640|580776021|FG001|Overall Study|Withdrawal by Subject|2|||
160833465|NCT03344640|580776020|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
160833466|NCT03344640|580776021|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
160833467|NCT01177969|580776027|FG000|Overall Study|Protocol Violation|2|||
160833468|NCT01177969|580776028|FG001|Overall Study|Protocol Violation|1|||
160991232|NCT03677375|581355546|FG000|Overall Study|Incomplete procedure|8|||
160991233|NCT03677375|581355546|FG000|Overall Study|Adverse Event|3|||
160991234|NCT03677375|581355546|FG000|Overall Study|Physician Decision|1|||
160991235|NCT00725010|581355552|FG000|Overall Study|Toxicity|9|||
160991236|NCT00725010|581355552|FG000|Overall Study|Tumor Progression|7|||
160991237|NCT00725010|581355552|FG000|Overall Study|Withdrawal by Subject|2|||
160991238|NCT00725010|581355552|FG000|Overall Study|Death|1|||
160991239|NCT00725010|581355552|FG000|Overall Study|Lost to Follow-up|1|||
160991240|NCT00725010|581355552|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
160991241|NCT00725010|581355552|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
160991242|NCT00725010|581355552|FG000|Overall Study|No further documentation|1|||
160991243|NCT00725010|581355552|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
160991244|NCT02414828|581355553|FG000|Overall Study|Lost to Follow-up|0|||
160991245|NCT02414828|581355554|FG001|Overall Study|Lost to Follow-up|1|||
160991246|NCT02414828|581355555|FG002|Overall Study|Lost to Follow-up|1|||
160991247|NCT02414828|581355556|FG003|Overall Study|Lost to Follow-up|2|||
160991248|NCT00670540|581355560|FG000|Overall Study|ineligible|17|||
160991249|NCT00670540|581355560|FG000|Overall Study|not living in France|348|||
160991250|NCT00670540|581355560|FG000|Overall Study|refused to participate|189|||
160833469|NCT01177969|580776027|FG000|Overall Study|Withdrawal by Subject|1|||
160833470|NCT01177969|580776028|FG001|Overall Study|Withdrawal by Subject|2|||
160833471|NCT02565810|580776029|FG000|Overall Study|Withdrawal by Subject|1|||
160833472|NCT01792518|580776040|FG000|Overall Study|Adverse Event|3|||
160991251|NCT00670540|581355560|FG000|Overall Study|controls randomised for no follow up|2770|||
160991252|NCT00670540|581355560|FG000|Overall Study|missing information inclusion criteria|1|||
160991253|NCT01866917|581355561|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
160833473|NCT01792518|580776041|FG001|Overall Study|Adverse Event|4|||
160991254|NCT01866917|581355562|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
160833474|NCT01792518|580776040|FG000|Overall Study|Protocol Violation|0|||
160833475|NCT01792518|580776041|FG001|Overall Study|Protocol Violation|1|||
160833476|NCT01792518|580776040|FG000|Overall Study|Lost to Follow-up|3|||
160833477|NCT01792518|580776041|FG001|Overall Study|Lost to Follow-up|1|||
160833478|NCT01792518|580776040|FG000|Overall Study|Withdrawal by Subject|2|||
160833479|NCT01792518|580776041|FG001|Overall Study|Withdrawal by Subject|0|||
160833480|NCT01792518|580776040|FG000|Overall Study|Other Reason|0|||
160833481|NCT01792518|580776041|FG001|Overall Study|Other Reason|1|||
160833482|NCT01504204|580776042|FG000|Overall Study|Lost to Follow-up|1|||
160833483|NCT01504204|580776043|FG001|Overall Study|Lost to Follow-up|1|||
160833484|NCT03869333|580776048|FG000|Overall Study|Lost to Follow-up|1|||
160833485|NCT03869333|580776049|FG001|Overall Study|Lost to Follow-up|0|||
160833486|NCT03869333|580776050|FG002|Overall Study|Lost to Follow-up|0|||
160833487|NCT03869333|580776051|FG003|Overall Study|Lost to Follow-up|0|||
160833488|NCT03869333|580776048|FG000|Overall Study|Pregnancy|1|||
160833489|NCT03869333|580776049|FG001|Overall Study|Pregnancy|0|||
160833490|NCT03869333|580776050|FG002|Overall Study|Pregnancy|0|||
160833491|NCT03869333|580776051|FG003|Overall Study|Pregnancy|0|||
160833492|NCT03869333|580776048|FG000|Overall Study|Physician Decision|0|||
160833493|NCT03869333|580776049|FG001|Overall Study|Physician Decision|1|||
160833494|NCT03869333|580776050|FG002|Overall Study|Physician Decision|0|||
160833495|NCT03869333|580776051|FG003|Overall Study|Physician Decision|0|||
160833496|NCT02966015|580776055|FG000|Inclusion Visit|did not answer questionnaire|8|||
160833497|NCT02966015|580776056|FG001|Inclusion Visit|did not answer questionnaire|3|||
160833498|NCT02241187|580776057|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
160833499|NCT02356887|580776058|FG000|Overall Study|poor compliance|2|||
160833500|NCT00199888|580776059|FG000|Overall Study|Lost to Follow-up|1|||
160833501|NCT02177838|580776060|FG000|Overall Study|Withdrawal by Subject|1|||
160833502|NCT02177838|580776060|FG000|Overall Study|Physician Decision|1|||
160833503|NCT02177838|580776060|FG000|Overall Study|Death|1|||
160833504|NCT01839656|580776061|FG000|Overall Study|Withdrawal by Subject|1|||
160833505|NCT01839656|580776062|FG001|Overall Study|Withdrawal by Subject|1|||
160833506|NCT01839656|580776061|FG000|Overall Study|Adverse event, serious fatal|1|||
160833507|NCT01839656|580776062|FG001|Overall Study|Adverse event, serious fatal|4|||
160833508|NCT01839656|580776061|FG000|Overall Study|Early study closure|0|||
160833509|NCT01839656|580776062|FG001|Overall Study|Early study closure|11|||
160833510|NCT01839656|580776061|FG000|Overall Study|Adverse Event|1|||
160833511|NCT01839656|580776062|FG001|Overall Study|Adverse Event|0|||
160833512|NCT02273960|580776065|FG000|Short Term Period|Lost to Follow-up|1|||
160833513|NCT02273960|580776066|FG001|Short Term Period|Lost to Follow-up|0|||
160833514|NCT02273960|580776067|FG002|Short Term Period|Lost to Follow-up|0|||
160903588|NCT00002651|581040554|FG001|Induction|Progression/relapse|0|||
160903589|NCT00002651|581040555|FG002|Induction|Progression/relapse|0|||
160903590|NCT00002651|581040553|FG000|Induction|Death|62|||
160903591|NCT00002651|581040554|FG001|Induction|Death|0|||
160833515|NCT02273960|580776068|FG003|Short Term Period|Lost to Follow-up|0|||
160833516|NCT02273960|580776065|FG000|Short Term Period|Lack of Efficacy|0|||
160833517|NCT02273960|580776066|FG001|Short Term Period|Lack of Efficacy|0|||
160833518|NCT02273960|580776067|FG002|Short Term Period|Lack of Efficacy|0|||
160903592|NCT00002651|581040555|FG002|Induction|Death|0|||
160560982|NCT01955707|579775910|FG001|Overall Study|Death|14|||
160560983|NCT01955707|579775909|FG000|Overall Study|Other|4|||
160560984|NCT01955707|579775910|FG001|Overall Study|Other|2|||
160560985|NCT02847598|579775917|FG000|Overall Study|Adverse Event|0|||
160560986|NCT02847598|579775918|FG001|Overall Study|Adverse Event|0|||
160560987|NCT02847598|579775919|FG002|Overall Study|Adverse Event|0|||
160560988|NCT02847598|579775920|FG003|Overall Study|Adverse Event|0|||
160560989|NCT02847598|579775921|FG004|Overall Study|Adverse Event|0|||
160560990|NCT02847598|579775922|FG005|Overall Study|Adverse Event|0|||
160560991|NCT02847598|579775923|FG006|Overall Study|Adverse Event|0|||
160560992|NCT02847598|579775924|FG007|Overall Study|Adverse Event|1|||
160560993|NCT02847598|579775917|FG000|Overall Study|Consent withdrawn|2|||
160560994|NCT02847598|579775918|FG001|Overall Study|Consent withdrawn|0|||
160560995|NCT02847598|579775919|FG002|Overall Study|Consent withdrawn|0|||
160560996|NCT02847598|579775920|FG003|Overall Study|Consent withdrawn|4|||
160560997|NCT02847598|579775921|FG004|Overall Study|Consent withdrawn|3|||
160560998|NCT02847598|579775922|FG005|Overall Study|Consent withdrawn|2|||
160560999|NCT02847598|579775923|FG006|Overall Study|Consent withdrawn|1|||
160561000|NCT02847598|579775924|FG007|Overall Study|Consent withdrawn|3|||
160561001|NCT02847598|579775917|FG000|Overall Study|Death|3|||
160561002|NCT02847598|579775918|FG001|Overall Study|Death|0|||
160561003|NCT02847598|579775919|FG002|Overall Study|Death|0|||
160561004|NCT02847598|579775920|FG003|Overall Study|Death|0|||
160561005|NCT02847598|579775921|FG004|Overall Study|Death|0|||
160561006|NCT02847598|579775922|FG005|Overall Study|Death|0|||
160561007|NCT02847598|579775923|FG006|Overall Study|Death|0|||
160833519|NCT02273960|580776068|FG003|Short Term Period|Lack of Efficacy|1|||
160833520|NCT02273960|580776065|FG000|Short Term Period|ST complete, not entering LTE|4|||
160833521|NCT02273960|580776066|FG001|Short Term Period|ST complete, not entering LTE|6|||
160833522|NCT02273960|580776067|FG002|Short Term Period|ST complete, not entering LTE|4|||
160833523|NCT02273960|580776068|FG003|Short Term Period|ST complete, not entering LTE|5|||
160833524|NCT02273960|580776065|FG000|Long Term Extension|Death|0|||
160833525|NCT02273960|580776066|FG001|Long Term Extension|Death|0|||
160833526|NCT02273960|580776067|FG002|Long Term Extension|Death|0|||
160833527|NCT02273960|580776068|FG003|Long Term Extension|Death|1|||
160833528|NCT01012323|580776069|FG000|Overall Study|Investigator Judgment|1|||
160833529|NCT00558272|580776072|FG000|Overall Study|Adverse Event|10|||
160833530|NCT00558272|580776073|FG001|Overall Study|Adverse Event|0|||
160833531|NCT00558272|580776072|FG000|Overall Study|Death|1|||
160833532|NCT00558272|580776073|FG001|Overall Study|Death|0|||
160833533|NCT00558272|580776072|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
160833534|NCT00558272|580776073|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
160833535|NCT00558272|580776072|FG000|Overall Study|AZ study team decision|0|||
160833536|NCT00558272|580776073|FG001|Overall Study|AZ study team decision|1|||
160833537|NCT00558272|580776072|FG000|Overall Study|Incorrectly enrolled|1|||
160833538|NCT00558272|580776073|FG001|Overall Study|Incorrectly enrolled|0|||
160833539|NCT00558272|580776072|FG000|Overall Study|Withdrawal by Subject|0|||
160833540|NCT00558272|580776073|FG001|Overall Study|Withdrawal by Subject|1|||
160833541|NCT01105377|580776076|FG000|Overall Study|Withdrawal by Subject|0|||
160833542|NCT01105377|580776077|FG001|Overall Study|Withdrawal by Subject|1|||
160833543|NCT01638559|580776079|FG000|Overall Study|Lost to Follow-up|1|||
160833544|NCT01638559|580776079|FG000|Overall Study|Withdrawal by Subject|1|||
160833545|NCT01638559|580776079|FG000|Overall Study|Subject declined to travel for biopsy|1|||
160833546|NCT03442296|580776083|FG000|3 Month Follow-up|Death|3|||
160833547|NCT03442296|580776084|FG001|3 Month Follow-up|Death|1|||
160903593|NCT00002651|581040553|FG000|Induction|Other|823|||
160903594|NCT00002651|581040554|FG001|Induction|Other|0|||
160903595|NCT00002651|581040555|FG002|Induction|Other|0|||
160903596|NCT00002651|581040553|FG000|Induction|not eligible|90|||
160903597|NCT00002651|581040554|FG001|Induction|not eligible|0|||
160903598|NCT00002651|581040555|FG002|Induction|not eligible|0|||
160903599|NCT00002651|581040553|FG000|Consolidation and Randomization|Adverse Event|0|||
160903600|NCT00002651|581040554|FG001|Consolidation and Randomization|Adverse Event|36|||
160903601|NCT00002651|581040555|FG002|Consolidation and Randomization|Adverse Event|14|||
160833548|NCT03442296|580776083|FG000|3 Month Follow-up|Lost to Follow-up|1|||
160833549|NCT03442296|580776084|FG001|3 Month Follow-up|Lost to Follow-up|1|||
160903602|NCT00002651|581040553|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
160561008|NCT02847598|579775924|FG007|Overall Study|Death|0|||
160561009|NCT02847598|579775917|FG000|Overall Study|Lost to Follow-up|0|||
160561010|NCT02847598|579775918|FG001|Overall Study|Lost to Follow-up|0|||
160561011|NCT02847598|579775919|FG002|Overall Study|Lost to Follow-up|0|||
160561012|NCT02847598|579775920|FG003|Overall Study|Lost to Follow-up|0|||
160833550|NCT03442296|580776083|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
160833551|NCT03442296|580776084|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
160561013|NCT02847598|579775921|FG004|Overall Study|Lost to Follow-up|0|||
160561014|NCT02847598|579775922|FG005|Overall Study|Lost to Follow-up|1|||
160561015|NCT02847598|579775923|FG006|Overall Study|Lost to Follow-up|1|||
160561016|NCT02847598|579775924|FG007|Overall Study|Lost to Follow-up|0|||
160561017|NCT00960076|579777425|FG000|Overall Study|Adverse Event|1|||
160561018|NCT00960076|579777426|FG001|Overall Study|Adverse Event|7|||
160561019|NCT00960076|579777425|FG000|Overall Study|No longer met study criteria|1|||
160561020|NCT00960076|579777426|FG001|Overall Study|No longer met study criteria|5|||
160561021|NCT00960076|579777425|FG000|Overall Study|Withdrawal by Subject|1|||
160561022|NCT00960076|579777426|FG001|Overall Study|Withdrawal by Subject|2|||
160561023|NCT00960076|579777425|FG000|Overall Study|Lost to Follow-up|3|||
160561024|NCT00960076|579777426|FG001|Overall Study|Lost to Follow-up|3|||
160561025|NCT00960076|579777425|FG000|Overall Study|Severe non-compliance to protocol|1|||
160561026|NCT00960076|579777426|FG001|Overall Study|Severe non-compliance to protocol|2|||
160561027|NCT00960076|579777425|FG000|Overall Study|Hyperglycemia|1|||
160561028|NCT00960076|579777426|FG001|Overall Study|Hyperglycemia|5|||
160647588|NCT02811861|580092762|FG002|Overall Study|Randomized but not treated|17|||
160647589|NCT06624072|580092765|FG000|Washout Period 1 (7 days)|Adverse Event|0|||
160647590|NCT06624072|580092766|FG001|Washout Period 1 (7 days)|Adverse Event|0|||
160561029|NCT00960076|579777425|FG000|Overall Study|Did not attend the termination visit|0|||
160561030|NCT00960076|579777426|FG001|Overall Study|Did not attend the termination visit|1|||
160561031|NCT02029976|579777427|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
160561032|NCT02029976|579777428|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
160561033|NCT02029976|579777427|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
160561034|NCT02029976|579777428|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
160561035|NCT02029976|579777427|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
160561036|NCT02029976|579777428|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
160561037|NCT02029976|579777427|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
160561038|NCT02029976|579777428|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
160561039|NCT03263806|579777429|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
160561040|NCT03263806|579777430|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
160561041|NCT03263806|579777429|FG000|Overall Study|Withdrawal by Subject|0|||
160561042|NCT03263806|579777430|FG001|Overall Study|Withdrawal by Subject|1|||
160561043|NCT03263806|579777429|FG000|Overall Study|Study Termination|5|||
160561044|NCT03263806|579777430|FG001|Overall Study|Study Termination|6|||
160561045|NCT04840667|579777431|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
160561046|NCT01445171|579777432|FG000|Overall Study|Lost to Follow-up|11|||
160561047|NCT01445171|579777432|FG000|Overall Study|Withdrawal by Subject|16|||
160561048|NCT01445171|579777432|FG000|Overall Study|Death|51|||
160561049|NCT01445171|579777432|FG000|Overall Study|Subjects declined to return for followup|9|||
160561050|NCT01445171|579777432|FG000|Overall Study|Consented but did not receive device|8|||
160561051|NCT00023322|579777433|FG000|Overall Study|Lost to Follow-up|1|||
160561052|NCT05194345|579777436|FG000|Overall Study|Withdrawal by Subject|6|||
160561053|NCT05194345|579777437|FG001|Overall Study|Withdrawal by Subject|4|||
160561054|NCT05194345|579777438|FG002|Overall Study|Withdrawal by Subject|0|||
160561055|NCT05194345|579777436|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
160561056|NCT05194345|579777437|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
160561057|NCT05194345|579777438|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
160561058|NCT02612909|579777439|FG000|Phase 2|Withdrawal by Subject|2|||
160561059|NCT02612909|579777440|FG001|Phase 2|Withdrawal by Subject|5|||
160561060|NCT02612909|579777441|FG002|Phase 2|Withdrawal by Subject|0|||
160561061|NCT02612909|579777442|FG003|Phase 2|Withdrawal by Subject|0|||
160561062|NCT02612909|579777443|FG004|Phase 2|Withdrawal by Subject|0|||
160561063|NCT02612909|579777439|FG000|Phase 2|Pregnancy|0|||
160561064|NCT02612909|579777440|FG001|Phase 2|Pregnancy|0|||
160561065|NCT02612909|579777441|FG002|Phase 2|Pregnancy|1|||
160561066|NCT02612909|579777442|FG003|Phase 2|Pregnancy|0|||
160561067|NCT02612909|579777443|FG004|Phase 2|Pregnancy|0|||
160561068|NCT02612909|579777439|FG000|Phase 3|Withdrawal by Subject|0|||
160561069|NCT02612909|579777440|FG001|Phase 3|Withdrawal by Subject|0|||
160561070|NCT02612909|579777441|FG002|Phase 3|Withdrawal by Subject|0|||
160561071|NCT02612909|579777442|FG003|Phase 3|Withdrawal by Subject|1|||
160561072|NCT02612909|579777443|FG004|Phase 3|Withdrawal by Subject|0|||
160561073|NCT05067127|579777448|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
160561074|NCT05067127|579777449|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
160561075|NCT05067127|579777450|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
160561076|NCT05067127|579777451|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
160561077|NCT05067127|579777448|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
160561078|NCT05067127|579777449|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
160561079|NCT05067127|579777450|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
160561080|NCT05067127|579777451|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
160833552|NCT03442296|580776083|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
160833553|NCT03442296|580776084|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
160833554|NCT03442296|580776083|FG000|12 Month Follow-up|Incomplete measurement|1|||
160561081|NCT05067127|579777448|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
160833555|NCT03442296|580776084|FG001|12 Month Follow-up|Incomplete measurement|1|||
160833556|NCT02651220|580776085|FG000|Overall Study|Adverse Event|1|||
160833557|NCT02651220|580776086|FG001|Overall Study|Adverse Event|5|||
160833558|NCT02651220|580776087|FG002|Overall Study|Adverse Event|1|||
160833559|NCT02651220|580776085|FG000|Overall Study|Lost to Follow-up|8|||
160833560|NCT02651220|580776086|FG001|Overall Study|Lost to Follow-up|14|||
160833561|NCT02651220|580776087|FG002|Overall Study|Lost to Follow-up|14|||
160833562|NCT02651220|580776085|FG000|Overall Study|Non-Compliance with Study Drug|4|||
160833563|NCT02651220|580776086|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160833564|NCT02651220|580776087|FG002|Overall Study|Non-Compliance with Study Drug|1|||
160833565|NCT02651220|580776085|FG000|Overall Study|Pregnancy|1|||
160561082|NCT05067127|579777449|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
160561083|NCT05067127|579777450|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
160561084|NCT05067127|579777451|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
160561085|NCT05067127|579777448|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
160561086|NCT05067127|579777449|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
160561087|NCT05067127|579777450|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
160561088|NCT05067127|579777451|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
160561089|NCT05067127|579777448|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
160561090|NCT05067127|579777449|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
160561091|NCT05067127|579777450|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
160561092|NCT05067127|579777451|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
160561093|NCT05067127|579777448|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
160561094|NCT05067127|579777449|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
160561095|NCT05067127|579777450|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
160561096|NCT05067127|579777451|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
160561097|NCT05067127|579777448|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
160561098|NCT05067127|579777449|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
160561099|NCT05067127|579777450|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
160561100|NCT05067127|579777451|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
160561101|NCT03615222|579777453|FG000|Overall Study|Ineligible|26|||
160561102|NCT03615222|579777453|FG000|Overall Study|Withdrawal by Subject|7|||
160561103|NCT03615222|579777453|FG000|Overall Study|Death|1|||
160561104|NCT04572633|579777454|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
160561105|NCT03155997|579777457|FG000|Overall Study|Withdrawal by Subject|119|||
160561106|NCT03155997|579777458|FG001|Overall Study|Withdrawal by Subject|134|||
160561107|NCT03155997|579777457|FG000|Overall Study|Lost to Follow-up|12|||
160561108|NCT03155997|579777458|FG001|Overall Study|Lost to Follow-up|13|||
160561109|NCT03155997|579777457|FG000|Overall Study|Missing disposition data|0|||
160561110|NCT03155997|579777458|FG001|Overall Study|Missing disposition data|1|||
160561111|NCT03155997|579777457|FG000|Overall Study|On study treatment|2027|||
160561112|NCT03155997|579777458|FG001|Overall Study|On study treatment|2074|||
160561113|NCT03367871|579777463|FG000|Overall Study|Lost to Follow-up|1|||
160561114|NCT00885365|579777467|FG000|4 Weeks ON Treatment|Adverse Event|2|||
160561115|NCT00885365|579777468|FG001|4 Weeks ON Treatment|Adverse Event|4|||
160561116|NCT00885365|579777467|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
160561117|NCT00885365|579777468|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
160561118|NCT00885365|579777467|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
160561119|NCT00885365|579777468|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
160561120|NCT01824979|579777469|FG000|Overall Study|Withdrawal by Subject|5|||
160561121|NCT01824979|579777470|FG001|Overall Study|Withdrawal by Subject|0|||
160561122|NCT01824979|579777469|FG000|Overall Study|Physician Decision|2|||
160561123|NCT01824979|579777470|FG001|Overall Study|Physician Decision|0|||
160561124|NCT01824979|579777469|FG000|Overall Study|Protocol Violation|6|||
160561125|NCT01824979|579777470|FG001|Overall Study|Protocol Violation|13|||
160561126|NCT03094195|579777474|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
160561127|NCT03094195|579777475|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
160561128|NCT03094195|579777476|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
160561129|NCT03094195|579777477|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
160561130|NCT03094195|579777478|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
160561131|NCT03094195|579777479|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
160561132|NCT03094195|579777480|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
160561133|NCT03094195|579777481|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
160561134|NCT03094195|579777474|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
160561135|NCT03094195|579777475|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
160561136|NCT03094195|579777476|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
160561137|NCT03094195|579777477|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160561138|NCT03094195|579777478|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160561139|NCT03094195|579777479|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160561140|NCT03094195|579777480|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160561141|NCT03094195|579777481|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160561142|NCT03094195|579777474|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
160561143|NCT03094195|579777475|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
160561144|NCT03094195|579777476|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
160561145|NCT03094195|579777477|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
160561146|NCT03094195|579777478|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
160991255|NCT01959880|581355567|FG000|Overall Study|Withdrawal by Subject|11|||
160991256|NCT01959880|581355568|FG001|Overall Study|Withdrawal by Subject|13|||
160991257|NCT01959880|581355569|FG002|Overall Study|Withdrawal by Subject|8|||
160991258|NCT01959880|581355570|FG003|Overall Study|Withdrawal by Subject|7|||
160991259|NCT01959880|581355567|FG000|Overall Study|Death|1|||
160561147|NCT03094195|579777479|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
160561148|NCT03094195|579777480|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
160561149|NCT03094195|579777481|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
160561150|NCT03094195|579777474|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160561151|NCT03094195|579777475|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
160991260|NCT01959880|581355568|FG001|Overall Study|Death|10|||
160991261|NCT01959880|581355569|FG002|Overall Study|Death|1|||
160561152|NCT03094195|579777476|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
160561153|NCT03094195|579777477|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160561154|NCT03094195|579777478|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160833566|NCT02651220|580776086|FG001|Overall Study|Pregnancy|0|||
160833567|NCT02651220|580776087|FG002|Overall Study|Pregnancy|1|||
160833568|NCT02651220|580776085|FG000|Overall Study|Protocol Violation|0|||
160833569|NCT02651220|580776086|FG001|Overall Study|Protocol Violation|0|||
160833570|NCT02651220|580776087|FG002|Overall Study|Protocol Violation|1|||
160833571|NCT02651220|580776085|FG000|Overall Study|Withdrawal by Subject|5|||
160833572|NCT02651220|580776086|FG001|Overall Study|Withdrawal by Subject|6|||
160833573|NCT02651220|580776087|FG002|Overall Study|Withdrawal by Subject|8|||
160833574|NCT02651220|580776085|FG000|Overall Study|Miscellaneous|4|||
160833575|NCT02651220|580776086|FG001|Overall Study|Miscellaneous|1|||
160833576|NCT02651220|580776087|FG002|Overall Study|Miscellaneous|2|||
160833577|NCT02651220|580776085|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160833578|NCT02651220|580776086|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160833579|NCT02651220|580776087|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
160833580|NCT00447122|580776088|FG000|Overall Study|worsening medical condition -came off|0|||
160833581|NCT00447122|580776089|FG001|Overall Study|worsening medical condition -came off|1|||
160833582|NCT00447122|580776090|FG002|Overall Study|worsening medical condition -came off|0|||
160833583|NCT00447122|580776091|FG003|Overall Study|worsening medical condition -came off|0|||
160833584|NCT02409342|580776092|FG000|Overall Study|Death|211|||
160833585|NCT02409342|580776093|FG001|Overall Study|Death|201|||
160833586|NCT02409342|580776092|FG000|Overall Study|Withdrawal by Subject|24|||
160833587|NCT02409342|580776093|FG001|Overall Study|Withdrawal by Subject|17|||
160833588|NCT02409342|580776092|FG000|Overall Study|Study Terminated By Sponsor|48|||
160833589|NCT02409342|580776093|FG001|Overall Study|Study Terminated By Sponsor|59|||
160833590|NCT02409342|580776092|FG000|Overall Study|Lost to Follow-up|3|||
160833591|NCT02409342|580776093|FG001|Overall Study|Lost to Follow-up|5|||
160833592|NCT02409342|580776092|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
160833593|NCT02409342|580776093|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
160833594|NCT02409342|580776092|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
160833595|NCT02409342|580776093|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
160833596|NCT02409342|580776092|FG000|Overall Study|Sponsor Decision|1|||
160833597|NCT02409342|580776093|FG001|Overall Study|Sponsor Decision|0|||
160833598|NCT00279812|580776094|FG000|Overall Study|Protocol Violation|1|||
160833599|NCT00279812|580776095|FG001|Overall Study|Protocol Violation|1|||
160903603|NCT00002651|581040554|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
160991262|NCT01959880|581355570|FG003|Overall Study|Death|2|||
160833600|NCT00279812|580776096|FG002|Overall Study|Protocol Violation|0|||
160561155|NCT03094195|579777479|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160561156|NCT03094195|579777480|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160561157|NCT03094195|579777481|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160561158|NCT00054132|579777482|FG000|Overall Study|Not Treated|1|||
160561159|NCT03029832|579777483|FG000|Overall Study|Safety Follow-Up Completed|2|||
160561160|NCT03029832|579777484|FG001|Overall Study|Safety Follow-Up Completed|0|||
160561161|NCT03029832|579777483|FG000|Overall Study|Death due to Disease Progression|1|||
160561162|NCT03029832|579777484|FG001|Overall Study|Death due to Disease Progression|0|||
160561163|NCT03029832|579777483|FG000|Overall Study|Study Terminated By Sponsor|1|||
160561164|NCT03029832|579777484|FG001|Overall Study|Study Terminated By Sponsor|1|||
160561165|NCT04373460|579777485|FG000|Overall Study|Did not receive tranfusion|18|||
160561166|NCT04373460|579777486|FG001|Overall Study|Did not receive tranfusion|26|||
160561167|NCT01412229|579777487|FG000|Overall Study|Physician Decision|1|||
160561168|NCT00454207|579777488|FG000|Overall Study|Adverse Event|3|||
160561169|NCT00454207|579777489|FG001|Overall Study|Adverse Event|1|||
160561170|NCT00454207|579777488|FG000|Overall Study|Lack of Efficacy|1|||
160561171|NCT00454207|579777489|FG001|Overall Study|Lack of Efficacy|0|||
160561172|NCT00454207|579777488|FG000|Overall Study|Protocol Violation|0|||
160561173|NCT00454207|579777489|FG001|Overall Study|Protocol Violation|1|||
160561174|NCT01672957|579777490|FG000|Overall Study|Protocol Violation|48|||
160561175|NCT01672957|579777490|FG000|Overall Study|Death|2|||
160561176|NCT01672957|579777490|FG000|Overall Study|ICF Signed After Transplantation|5|||
160561177|NCT01795547|579777493|FG000|Overall Study|Adverse Event|16|||
160561178|NCT01795547|579777494|FG001|Overall Study|Adverse Event|27|||
160647591|NCT06624072|580092767|FG002|Washout Period 1 (7 days)|Adverse Event|1|||
160833601|NCT00279812|580776097|FG003|Overall Study|Protocol Violation|0|||
160561179|NCT01795547|579777493|FG000|Overall Study|Lack of Efficacy|8|||
160561180|NCT01795547|579777494|FG001|Overall Study|Lack of Efficacy|3|||
160561181|NCT01795547|579777493|FG000|Overall Study|Protocol Violation|6|||
160833602|NCT00279812|580776098|FG004|Overall Study|Protocol Violation|1|||
160833603|NCT00279812|580776099|FG005|Overall Study|Protocol Violation|0|||
160561182|NCT01795547|579777494|FG001|Overall Study|Protocol Violation|4|||
160561183|NCT01795547|579777493|FG000|Overall Study|Lost to Follow-up|2|||
160561184|NCT01795547|579777494|FG001|Overall Study|Lost to Follow-up|5|||
160561185|NCT01795547|579777493|FG000|Overall Study|Withdrawal of consent|7|||
160561186|NCT01795547|579777494|FG001|Overall Study|Withdrawal of consent|12|||
160561187|NCT01795547|579777493|FG000|Overall Study|Not Treated|4|||
160561188|NCT01795547|579777494|FG001|Overall Study|Not Treated|10|||
160561189|NCT01795547|579777493|FG000|Overall Study|Non-compliance with IMP|1|||
160561190|NCT01795547|579777494|FG001|Overall Study|Non-compliance with IMP|1|||
160561191|NCT01795547|579777493|FG000|Overall Study|Others|4|||
160561192|NCT01795547|579777494|FG001|Overall Study|Others|1|||
160561193|NCT01795547|579777493|FG000|Overall Study|Not stated|0|||
160561194|NCT01795547|579777494|FG001|Overall Study|Not stated|1|||
160561195|NCT00642642|579777498|FG000|Treatment & Follow Up|Adverse Event|2|||
160561196|NCT00642642|579777498|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
160561197|NCT00642642|579777498|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
160561198|NCT00151892|579777499|FG000|Overall Study|Lack of Efficacy|50|||
160833604|NCT00279812|580776094|FG000|Overall Study|Withdrawal by Subject|0|||
160833605|NCT00279812|580776095|FG001|Overall Study|Withdrawal by Subject|4|||
160833606|NCT00279812|580776096|FG002|Overall Study|Withdrawal by Subject|2|||
160833607|NCT00279812|580776097|FG003|Overall Study|Withdrawal by Subject|0|||
160833608|NCT00279812|580776098|FG004|Overall Study|Withdrawal by Subject|0|||
160991263|NCT01959880|581355567|FG000|Overall Study|Lost to Follow-up|95|||
160561199|NCT00151892|579777500|FG001|Overall Study|Lack of Efficacy|57|||
160561200|NCT00151892|579777499|FG000|Overall Study|Patient request|10|||
160561201|NCT00151892|579777500|FG001|Overall Study|Patient request|7|||
160561202|NCT00151892|579777499|FG000|Overall Study|Lost to Follow-up|5|||
160561203|NCT00151892|579777500|FG001|Overall Study|Lost to Follow-up|10|||
160991264|NCT01959880|581355568|FG001|Overall Study|Lost to Follow-up|18|||
160991265|NCT01959880|581355569|FG002|Overall Study|Lost to Follow-up|15|||
160561204|NCT00151892|579777499|FG000|Overall Study|Adverse Event|6|||
160561205|NCT00151892|579777500|FG001|Overall Study|Adverse Event|3|||
160561206|NCT00151892|579777499|FG000|Overall Study|Protocol Violation|3|||
160561207|NCT00151892|579777500|FG001|Overall Study|Protocol Violation|3|||
160561208|NCT00151892|579777499|FG000|Overall Study|Non-compliance|0|||
160561209|NCT00151892|579777500|FG001|Overall Study|Non-compliance|1|||
160561210|NCT00151892|579777499|FG000|Overall Study|Pregnancy|0|||
160561211|NCT00151892|579777500|FG001|Overall Study|Pregnancy|1|||
160833609|NCT00279812|580776099|FG005|Overall Study|Withdrawal by Subject|0|||
160833610|NCT00279812|580776094|FG000|Overall Study|Adverse Event|0|||
160833611|NCT00279812|580776095|FG001|Overall Study|Adverse Event|1|||
160833612|NCT00279812|580776096|FG002|Overall Study|Adverse Event|1|||
160833613|NCT00279812|580776097|FG003|Overall Study|Adverse Event|0|||
160833614|NCT00279812|580776098|FG004|Overall Study|Adverse Event|2|||
160833615|NCT00279812|580776099|FG005|Overall Study|Adverse Event|1|||
160833616|NCT04046250|580776107|FG000|Overall Study|Death|0|||
160833617|NCT04046250|580776108|FG001|Overall Study|Death|1|||
160833618|NCT04046250|580776107|FG000|Overall Study|Withdrawal by Subject|3|||
160833619|NCT04046250|580776108|FG001|Overall Study|Withdrawal by Subject|3|||
160833620|NCT03834220|580776113|FG000|Overall Study|Adverse Event|1|||
160833621|NCT03834220|580776114|FG001|Overall Study|Adverse Event|0|||
160833622|NCT03834220|580776115|FG002|Overall Study|Adverse Event|0|||
160833623|NCT03834220|580776113|FG000|Overall Study|Death|8|||
160833624|NCT03834220|580776114|FG001|Overall Study|Death|1|||
160833625|NCT03834220|580776115|FG002|Overall Study|Death|17|||
160833626|NCT03834220|580776113|FG000|Overall Study|Reason not Specified|9|||
160833627|NCT03834220|580776114|FG001|Overall Study|Reason not Specified|0|||
160833628|NCT03834220|580776115|FG002|Overall Study|Reason not Specified|6|||
160833629|NCT03834220|580776113|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
160833630|NCT03834220|580776114|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
160833631|NCT03834220|580776115|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
160833632|NCT03834220|580776113|FG000|Overall Study|Withdrawal of Consent|2|||
160833633|NCT03834220|580776114|FG001|Overall Study|Withdrawal of Consent|2|||
160833634|NCT03834220|580776115|FG002|Overall Study|Withdrawal of Consent|2|||
160833635|NCT00527332|580776117|FG000|Overall Study|Protocol Violation|4|||
160833636|NCT00527332|580776118|FG001|Overall Study|Protocol Violation|8|||
160833637|NCT00527332|580776117|FG000|Overall Study|Withdrew consent|5|||
160833638|NCT00527332|580776118|FG001|Overall Study|Withdrew consent|1|||
160833639|NCT03684694|580776121|FG000|Phase 1|Withdrawal by Subject|1|||
160833640|NCT03684694|580776122|FG001|Phase 1|Withdrawal by Subject|0|||
160833641|NCT03684694|580776123|FG002|Phase 1|Withdrawal by Subject|0|||
160833642|NCT03684694|580776124|FG003|Phase 1|Withdrawal by Subject|0|||
160833643|NCT03684694|580776125|FG004|Phase 1|Withdrawal by Subject|0|||
160833644|NCT03684694|580776126|FG005|Phase 1|Withdrawal by Subject|0|||
160833645|NCT03684694|580776121|FG000|Phase 1|Investigator/Sponsor Decision|12|||
160833646|NCT03684694|580776122|FG001|Phase 1|Investigator/Sponsor Decision|2|||
160833647|NCT03684694|580776123|FG002|Phase 1|Investigator/Sponsor Decision|1|||
160833648|NCT03684694|580776124|FG003|Phase 1|Investigator/Sponsor Decision|0|||
160833649|NCT03684694|580776125|FG004|Phase 1|Investigator/Sponsor Decision|0|||
160833650|NCT03684694|580776126|FG005|Phase 1|Investigator/Sponsor Decision|0|||
160833651|NCT03684694|580776121|FG000|Phase 1|Death|24|||
160833652|NCT03684694|580776122|FG001|Phase 1|Death|0|||
160833653|NCT03684694|580776123|FG002|Phase 1|Death|3|||
160833654|NCT03684694|580776124|FG003|Phase 1|Death|0|||
160833655|NCT03684694|580776125|FG004|Phase 1|Death|0|||
160833656|NCT03684694|580776126|FG005|Phase 1|Death|0|||
160833657|NCT03684694|580776121|FG000|Phase 1|Lost to Follow-up|0|||
160833658|NCT03684694|580776122|FG001|Phase 1|Lost to Follow-up|0|||
160833659|NCT03684694|580776123|FG002|Phase 1|Lost to Follow-up|1|||
160833660|NCT03684694|580776124|FG003|Phase 1|Lost to Follow-up|0|||
160833661|NCT03684694|580776125|FG004|Phase 1|Lost to Follow-up|0|||
160833662|NCT03684694|580776126|FG005|Phase 1|Lost to Follow-up|0|||
160833663|NCT03684694|580776121|FG000|Phase 1|Miscellaneous|0|||
160833664|NCT03684694|580776122|FG001|Phase 1|Miscellaneous|1|||
160833665|NCT03684694|580776123|FG002|Phase 1|Miscellaneous|0|||
160833666|NCT03684694|580776124|FG003|Phase 1|Miscellaneous|0|||
160833667|NCT03684694|580776125|FG004|Phase 1|Miscellaneous|0|||
160833668|NCT03684694|580776126|FG005|Phase 1|Miscellaneous|0|||
160833669|NCT03684694|580776121|FG000|Phase 2|Withdrawal by Subject|0|||
160833670|NCT03684694|580776122|FG001|Phase 2|Withdrawal by Subject|0|||
160833671|NCT03684694|580776123|FG002|Phase 2|Withdrawal by Subject|0|||
160833672|NCT03684694|580776124|FG003|Phase 2|Withdrawal by Subject|0|||
160833673|NCT03684694|580776125|FG004|Phase 2|Withdrawal by Subject|0|||
160833674|NCT03684694|580776126|FG005|Phase 2|Withdrawal by Subject|1|||
160833675|NCT03684694|580776121|FG000|Phase 2|Investigator/Sponsor Decision|0|||
160833676|NCT03684694|580776122|FG001|Phase 2|Investigator/Sponsor Decision|0|||
160833677|NCT03684694|580776123|FG002|Phase 2|Investigator/Sponsor Decision|0|||
160833678|NCT03684694|580776124|FG003|Phase 2|Investigator/Sponsor Decision|17|||
160833679|NCT03684694|580776125|FG004|Phase 2|Investigator/Sponsor Decision|16|||
160833680|NCT03684694|580776126|FG005|Phase 2|Investigator/Sponsor Decision|6|||
160833681|NCT03684694|580776121|FG000|Phase 2|Death|0|||
160561212|NCT00151892|579777499|FG000|Overall Study|Did not return for a visit|1|||
160833682|NCT03684694|580776122|FG001|Phase 2|Death|0|||
160833683|NCT03684694|580776123|FG002|Phase 2|Death|0|||
160833684|NCT03684694|580776124|FG003|Phase 2|Death|28|||
160833685|NCT03684694|580776125|FG004|Phase 2|Death|14|||
160833686|NCT03684694|580776126|FG005|Phase 2|Death|3|||
160833687|NCT03684694|580776121|FG000|Phase 2|Lost to Follow-up|0|||
160833688|NCT03684694|580776122|FG001|Phase 2|Lost to Follow-up|0|||
160833689|NCT03684694|580776123|FG002|Phase 2|Lost to Follow-up|0|||
160833690|NCT03684694|580776124|FG003|Phase 2|Lost to Follow-up|1|||
160833691|NCT03684694|580776125|FG004|Phase 2|Lost to Follow-up|0|||
160833692|NCT03684694|580776126|FG005|Phase 2|Lost to Follow-up|0|||
160833693|NCT03684694|580776121|FG000|Phase 2|Miscellaneous|0|||
160833694|NCT03684694|580776122|FG001|Phase 2|Miscellaneous|0|||
160833695|NCT03684694|580776123|FG002|Phase 2|Miscellaneous|0|||
160833696|NCT03684694|580776124|FG003|Phase 2|Miscellaneous|3|||
160833697|NCT03684694|580776125|FG004|Phase 2|Miscellaneous|0|||
160833698|NCT03684694|580776126|FG005|Phase 2|Miscellaneous|0|||
160833699|NCT02100475|580778205|FG000|Overall Study|Unclassified|1|||
160833700|NCT02100475|580778206|FG001|Overall Study|Unclassified|2|||
160833701|NCT02100475|580778205|FG000|Overall Study|Withdrawal criteria|1|||
160833702|NCT02100475|580778206|FG001|Overall Study|Withdrawal criteria|0|||
160833703|NCT02806960|580778207|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
160833704|NCT02806960|580778208|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
160833705|NCT02806960|580778209|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
160833706|NCT02806960|580778210|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
160833707|NCT01769196|580778211|FG000|Overall Study|Adverse Event|24|||
160833708|NCT01769196|580778212|FG001|Overall Study|Adverse Event|20|||
160833709|NCT01769196|580778211|FG000|Overall Study|Death|21|||
160833710|NCT01769196|580778212|FG001|Overall Study|Death|26|||
160833711|NCT01769196|580778211|FG000|Overall Study|Investigator Discretion|7|||
160833712|NCT01769196|580778212|FG001|Overall Study|Investigator Discretion|3|||
160833713|NCT01769196|580778211|FG000|Overall Study|Lack of Efficacy|3|||
160833714|NCT01769196|580778212|FG001|Overall Study|Lack of Efficacy|2|||
160833715|NCT01769196|580778211|FG000|Overall Study|Progressive disease|11|||
160833716|NCT01769196|580778212|FG001|Overall Study|Progressive disease|6|||
160833717|NCT01769196|580778211|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
160833718|NCT01769196|580778212|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
160833719|NCT01769196|580778211|FG000|Overall Study|Protocol Violation|0|||
160833720|NCT01769196|580778212|FG001|Overall Study|Protocol Violation|3|||
160833721|NCT01769196|580778211|FG000|Overall Study|Study terminated by sponsor|160|||
160833722|NCT01769196|580778212|FG001|Overall Study|Study terminated by sponsor|161|||
160833723|NCT01769196|580778211|FG000|Overall Study|Participant never dosed with study drug|1|||
160833724|NCT01769196|580778212|FG001|Overall Study|Participant never dosed with study drug|0|||
160833725|NCT01769196|580778211|FG000|Overall Study|Withdrew consent|36|||
160833726|NCT01769196|580778212|FG001|Overall Study|Withdrew consent|40|||
160833727|NCT00765063|580778213|FG000|Overall Study|Lack of Efficacy|5|||
160833728|NCT00765063|580778213|FG000|Overall Study|Withdrawal by Subject|1|||
160833729|NCT00765063|580778213|FG000|Overall Study|Other|16|||
160833730|NCT00765063|580778213|FG000|Overall Study|Protocol Violation|6|||
160833731|NCT00765063|580778213|FG000|Overall Study|Adverse Event|4|||
160833732|NCT00321464|580778214|FG000|Overall Study|Death|169|||
160833733|NCT00321464|580778215|FG001|Overall Study|Death|174|||
160833734|NCT00321464|580778214|FG000|Overall Study|Disease progression|124|||
160833735|NCT00321464|580778215|FG001|Overall Study|Disease progression|124|||
160833736|NCT00321464|580778214|FG000|Overall Study|Withdrawal by Subject|117|||
160833737|NCT00321464|580778215|FG001|Overall Study|Withdrawal by Subject|118|||
160833738|NCT00321464|580778214|FG000|Overall Study|Participant request|57|||
160833739|NCT00321464|580778215|FG001|Overall Study|Participant request|61|||
160833740|NCT00321464|580778214|FG000|Overall Study|Adverse Event|43|||
160561213|NCT00151892|579777500|FG001|Overall Study|Did not return for a visit|0|||
160561214|NCT00151892|579777499|FG000|Overall Study|Used prohibited corticosteroids|1|||
160561215|NCT00151892|579777500|FG001|Overall Study|Used prohibited corticosteroids|0|||
160561216|NCT00151892|579777499|FG000|Overall Study|Lack of study medication at center|0|||
160561217|NCT00151892|579777500|FG001|Overall Study|Lack of study medication at center|1|||
160561218|NCT04223609|579777503|FG000|Overall Study|Adverse Event|0|||
160561219|NCT04223609|579777504|FG001|Overall Study|Adverse Event|1|||
160561220|NCT04223609|579777503|FG000|Overall Study|Missed last visit|0|||
160561221|NCT04223609|579777504|FG001|Overall Study|Missed last visit|1|||
160561222|NCT03440944|579777507|FG000|Overall Study|Physician Decision|1|||
160561223|NCT03440944|579777508|FG001|Overall Study|Physician Decision|0|||
160561224|NCT03440944|579777507|FG000|Overall Study|No Acceptable Vasculature|0|||
160561225|NCT03440944|579777508|FG001|Overall Study|No Acceptable Vasculature|1|||
160561226|NCT00591734|579777509|FG000|Overall Study|Lack of Efficacy|35|||
160561227|NCT00591734|579777509|FG000|Overall Study|Adverse Event|5|||
160561228|NCT00591734|579777509|FG000|Overall Study|Physician Decision|5|||
160561229|NCT00591734|579777509|FG000|Overall Study|Intercurrent Illness|8|||
160561230|NCT04672083|579777510|FG000|Overall Study|Lost to Follow-up|1|||
160561231|NCT04672083|579777511|FG001|Overall Study|Lost to Follow-up|0|||
160561232|NCT04672083|579777512|FG002|Overall Study|Lost to Follow-up|0|||
160561233|NCT04672083|579777513|FG003|Overall Study|Lost to Follow-up|0|||
160561234|NCT04672083|579777514|FG004|Overall Study|Lost to Follow-up|0|||
160561235|NCT01551745|579777515|FG000|Overall Study|Withdrawal by Subject|1|||
160561236|NCT01551745|579777515|FG000|Overall Study|Disease Progression|2|||
160561237|NCT01661790|579777516|FG000|Overall Study|Lost to Follow-up|0|||
160561238|NCT01661790|579777517|FG001|Overall Study|Lost to Follow-up|2|||
160561239|NCT02764541|579777518|FG000|Overall Study|Withdrawal by Subject|0|||
160561240|NCT02764541|579777519|FG001|Overall Study|Withdrawal by Subject|0|||
160561241|NCT02764541|579777520|FG002|Overall Study|Withdrawal by Subject|0|||
160561242|NCT02764541|579777521|FG003|Overall Study|Withdrawal by Subject|0|||
160561243|NCT02764541|579777522|FG004|Overall Study|Withdrawal by Subject|1|||
160561244|NCT02764541|579777523|FG005|Overall Study|Withdrawal by Subject|1|||
160561245|NCT02764541|579777524|FG006|Overall Study|Withdrawal by Subject|0|||
160561246|NCT02764541|579777525|FG007|Overall Study|Withdrawal by Subject|1|||
160561247|NCT02764541|579777518|FG000|Overall Study|Adverse Event|1|||
160561248|NCT02764541|579777519|FG001|Overall Study|Adverse Event|0|||
160561249|NCT02764541|579777520|FG002|Overall Study|Adverse Event|0|||
160561250|NCT02764541|579777521|FG003|Overall Study|Adverse Event|0|||
160561251|NCT02764541|579777522|FG004|Overall Study|Adverse Event|0|||
160561252|NCT02764541|579777523|FG005|Overall Study|Adverse Event|0|||
160561253|NCT02764541|579777524|FG006|Overall Study|Adverse Event|1|||
160561254|NCT02764541|579777525|FG007|Overall Study|Adverse Event|0|||
160561255|NCT02764541|579777518|FG000|Overall Study|Metastasis|1|||
160561256|NCT02764541|579777519|FG001|Overall Study|Metastasis|0|||
160561257|NCT02764541|579777520|FG002|Overall Study|Metastasis|0|||
160561258|NCT02764541|579777521|FG003|Overall Study|Metastasis|0|||
160561259|NCT02764541|579777522|FG004|Overall Study|Metastasis|0|||
160561260|NCT02764541|579777523|FG005|Overall Study|Metastasis|0|||
160561261|NCT02764541|579777524|FG006|Overall Study|Metastasis|0|||
160561262|NCT02764541|579777525|FG007|Overall Study|Metastasis|0|||
160561263|NCT02764541|579777518|FG000|Overall Study|Disease progression|1|||
160561264|NCT02764541|579777519|FG001|Overall Study|Disease progression|1|||
160561265|NCT02764541|579777520|FG002|Overall Study|Disease progression|0|||
160561266|NCT02764541|579777521|FG003|Overall Study|Disease progression|0|||
160561267|NCT02764541|579777522|FG004|Overall Study|Disease progression|0|||
160561268|NCT02764541|579777523|FG005|Overall Study|Disease progression|0|||
160561269|NCT02764541|579777524|FG006|Overall Study|Disease progression|0|||
160561270|NCT02764541|579777525|FG007|Overall Study|Disease progression|1|||
160561271|NCT02764541|579777518|FG000|Overall Study|Protocol Violation|0|||
160833741|NCT00321464|580778215|FG001|Overall Study|Adverse Event|28|||
160561272|NCT02764541|579777519|FG001|Overall Study|Protocol Violation|0|||
160561273|NCT02764541|579777520|FG002|Overall Study|Protocol Violation|0|||
160561274|NCT02764541|579777521|FG003|Overall Study|Protocol Violation|1|||
160561275|NCT02764541|579777522|FG004|Overall Study|Protocol Violation|0|||
160561276|NCT02764541|579777523|FG005|Overall Study|Protocol Violation|1|||
160561277|NCT02764541|579777524|FG006|Overall Study|Protocol Violation|0|||
160561278|NCT02764541|579777525|FG007|Overall Study|Protocol Violation|0|||
160561279|NCT02764541|579777518|FG000|Overall Study|Physician Decision|0|||
160561280|NCT02764541|579777519|FG001|Overall Study|Physician Decision|0|||
160561281|NCT02764541|579777520|FG002|Overall Study|Physician Decision|0|||
160561282|NCT02764541|579777521|FG003|Overall Study|Physician Decision|1|||
160833742|NCT00321464|580778214|FG000|Overall Study|Physician Decision|15|||
160833743|NCT00321464|580778215|FG001|Overall Study|Physician Decision|14|||
160833744|NCT00321464|580778214|FG000|Overall Study|Noncompliance|4|||
160833745|NCT00321464|580778215|FG001|Overall Study|Noncompliance|10|||
160833746|NCT00321464|580778214|FG000|Overall Study|Lost to Follow-up|7|||
160833747|NCT00321464|580778215|FG001|Overall Study|Lost to Follow-up|8|||
160833748|NCT00321464|580778214|FG000|Overall Study|Protocol deviation|0|||
160833749|NCT00321464|580778215|FG001|Overall Study|Protocol deviation|2|||
160833750|NCT00321464|580778214|FG000|Overall Study|Ineligibility determined|2|||
160561283|NCT02764541|579777522|FG004|Overall Study|Physician Decision|0|||
160561284|NCT02764541|579777523|FG005|Overall Study|Physician Decision|0|||
160561285|NCT02764541|579777524|FG006|Overall Study|Physician Decision|0|||
160561286|NCT02764541|579777525|FG007|Overall Study|Physician Decision|1|||
160561287|NCT02764541|579777518|FG000|Overall Study|Three Cycles completed before surgery|0|||
160561288|NCT02764541|579777519|FG001|Overall Study|Three Cycles completed before surgery|0|||
160561289|NCT02764541|579777520|FG002|Overall Study|Three Cycles completed before surgery|0|||
160561290|NCT02764541|579777521|FG003|Overall Study|Three Cycles completed before surgery|1|||
160561291|NCT02764541|579777522|FG004|Overall Study|Three Cycles completed before surgery|0|||
160561292|NCT02764541|579777523|FG005|Overall Study|Three Cycles completed before surgery|0|||
160561293|NCT02764541|579777524|FG006|Overall Study|Three Cycles completed before surgery|0|||
160561294|NCT02764541|579777525|FG007|Overall Study|Three Cycles completed before surgery|0|||
160561295|NCT02764541|579777518|FG000|Overall Study|Patient Compliance|0|||
160561296|NCT02764541|579777519|FG001|Overall Study|Patient Compliance|0|||
160561297|NCT02764541|579777520|FG002|Overall Study|Patient Compliance|1|||
160561298|NCT02764541|579777521|FG003|Overall Study|Patient Compliance|0|||
160561299|NCT02764541|579777522|FG004|Overall Study|Patient Compliance|0|||
160561300|NCT02764541|579777523|FG005|Overall Study|Patient Compliance|0|||
160561301|NCT02764541|579777524|FG006|Overall Study|Patient Compliance|0|||
160561302|NCT02764541|579777525|FG007|Overall Study|Patient Compliance|0|||
160561303|NCT02764541|579777518|FG000|Overall Study|Death|0|||
160561304|NCT02764541|579777519|FG001|Overall Study|Death|0|||
160561305|NCT02764541|579777520|FG002|Overall Study|Death|0|||
160561306|NCT02764541|579777521|FG003|Overall Study|Death|0|||
160561307|NCT02764541|579777522|FG004|Overall Study|Death|0|||
160561308|NCT02764541|579777523|FG005|Overall Study|Death|0|||
160561309|NCT02764541|579777524|FG006|Overall Study|Death|1|||
160561310|NCT02764541|579777525|FG007|Overall Study|Death|0|||
160561311|NCT02764541|579777518|FG000|Overall Study|Insurance reasons|0|||
160833751|NCT00321464|580778215|FG001|Overall Study|Ineligibility determined|1|||
160833752|NCT00321464|580778214|FG000|Overall Study|Other|21|||
160833753|NCT00321464|580778215|FG001|Overall Study|Other|18|||
160833754|NCT01673620|580778216|FG000|Overall Study|Adverse Event|1|||
160833755|NCT01673620|580778217|FG001|Overall Study|Adverse Event|0|||
160833756|NCT02522325|580778219|FG000|Overall Study|Adverse Event|0|||
160903604|NCT00002651|581040555|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
160903605|NCT00002651|581040553|FG000|Consolidation and Randomization|Progression/relapse|0|||
160561312|NCT02764541|579777519|FG001|Overall Study|Insurance reasons|0|||
160561313|NCT02764541|579777520|FG002|Overall Study|Insurance reasons|0|||
160561314|NCT02764541|579777521|FG003|Overall Study|Insurance reasons|0|||
160561315|NCT02764541|579777522|FG004|Overall Study|Insurance reasons|0|||
160561316|NCT02764541|579777523|FG005|Overall Study|Insurance reasons|0|||
160561317|NCT02764541|579777524|FG006|Overall Study|Insurance reasons|1|||
160561318|NCT02764541|579777525|FG007|Overall Study|Insurance reasons|0|||
160561319|NCT02048904|579777528|FG000|Overall Study|Withdrawal by Subject|7|||
160561320|NCT02048904|579777528|FG000|Overall Study|Physician Decision|70|||
160561321|NCT00749190|579777531|FG000|Overall Study|Adverse Event|0|||
160561322|NCT00749190|579777532|FG001|Overall Study|Adverse Event|2|||
160561323|NCT00749190|579777533|FG002|Overall Study|Adverse Event|0|||
160561324|NCT00749190|579777534|FG003|Overall Study|Adverse Event|4|||
160561325|NCT00749190|579777535|FG004|Overall Study|Adverse Event|0|||
160561326|NCT00749190|579777536|FG005|Overall Study|Adverse Event|3|||
160561327|NCT00749190|579777537|FG006|Overall Study|Adverse Event|0|||
160561328|NCT00749190|579777531|FG000|Overall Study|Lack of Efficacy|3|||
160561329|NCT00749190|579777532|FG001|Overall Study|Lack of Efficacy|1|||
160561330|NCT00749190|579777533|FG002|Overall Study|Lack of Efficacy|1|||
160561331|NCT00749190|579777534|FG003|Overall Study|Lack of Efficacy|0|||
160561332|NCT00749190|579777535|FG004|Overall Study|Lack of Efficacy|0|||
160833757|NCT02522325|580778220|FG001|Overall Study|Adverse Event|1|||
160833758|NCT02100969|580778221|FG000|Overall Study|Did not pass screening phase|1|||
160903606|NCT00002651|581040554|FG001|Consolidation and Randomization|Progression/relapse|295|||
160561333|NCT00749190|579777536|FG005|Overall Study|Lack of Efficacy|1|||
160561334|NCT00749190|579777537|FG006|Overall Study|Lack of Efficacy|0|||
160561335|NCT00749190|579777531|FG000|Overall Study|Withdrawal by Subject|2|||
160561336|NCT00749190|579777532|FG001|Overall Study|Withdrawal by Subject|1|||
160561337|NCT00749190|579777533|FG002|Overall Study|Withdrawal by Subject|0|||
160561338|NCT00749190|579777534|FG003|Overall Study|Withdrawal by Subject|0|||
160561339|NCT00749190|579777535|FG004|Overall Study|Withdrawal by Subject|0|||
160561340|NCT00749190|579777536|FG005|Overall Study|Withdrawal by Subject|1|||
160561341|NCT00749190|579777537|FG006|Overall Study|Withdrawal by Subject|0|||
160561342|NCT00749190|579777531|FG000|Overall Study|Protocol Violation|0|||
160561343|NCT00749190|579777532|FG001|Overall Study|Protocol Violation|1|||
160561344|NCT00749190|579777533|FG002|Overall Study|Protocol Violation|0|||
160561345|NCT00749190|579777534|FG003|Overall Study|Protocol Violation|0|||
160833759|NCT01629953|580778222|FG000|Overall Study|Death|3|||
160833760|NCT01629953|580778223|FG001|Overall Study|Death|1|||
160833761|NCT01629953|580778222|FG000|Overall Study|Lost to Follow-up|10|||
160833762|NCT01629953|580778223|FG001|Overall Study|Lost to Follow-up|14|||
160833763|NCT00528801|580778226|FG000|Overall Study|Withdrawal by Subject|1|||
160833764|NCT00528801|580778227|FG001|Overall Study|Withdrawal by Subject|1|||
160833765|NCT00528801|580778226|FG000|Overall Study|Protocol Violation|11|||
160833766|NCT00528801|580778227|FG001|Overall Study|Protocol Violation|5|||
160833767|NCT00528801|580778226|FG000|Overall Study|Lost to Follow-up|15|||
160833768|NCT00528801|580778227|FG001|Overall Study|Lost to Follow-up|4|||
160833769|NCT00528801|580778226|FG000|Overall Study|Administrative Reasons|0|||
160833770|NCT00528801|580778227|FG001|Overall Study|Administrative Reasons|1|||
160833771|NCT02207491|580778228|FG000|Overall Study|Adverse Event|20|||
160833772|NCT02207491|580778229|FG001|Overall Study|Adverse Event|4|||
160833773|NCT02207491|580778228|FG000|Overall Study|Withdrawal by Subject|3|||
160833774|NCT02207491|580778229|FG001|Overall Study|Withdrawal by Subject|2|||
160833775|NCT02207491|580778228|FG000|Overall Study|Non-compliant|0|||
160833776|NCT02207491|580778229|FG001|Overall Study|Non-compliant|1|||
160833777|NCT02207491|580778228|FG000|Overall Study|Lost to Follow-up|0|||
160833778|NCT02207491|580778229|FG001|Overall Study|Lost to Follow-up|1|||
160833779|NCT02207491|580778228|FG000|Overall Study|Lack of Efficacy|3|||
160833780|NCT02207491|580778229|FG001|Overall Study|Lack of Efficacy|0|||
160833781|NCT02207491|580778228|FG000|Overall Study|Physician Decision|2|||
160833782|NCT02207491|580778229|FG001|Overall Study|Physician Decision|0|||
160833783|NCT02207491|580778228|FG000|Overall Study|Protocol Violation|3|||
160833784|NCT02207491|580778229|FG001|Overall Study|Protocol Violation|5|||
160833785|NCT00477152|580778232|FG000|Overall Study|Parent withdrew consent|2|||
160833786|NCT00477152|580778232|FG000|Overall Study|Adverse Event|1|||
160833787|NCT00372697|580778233|FG000|Overall Study|Protocol Violation|1|||
160833788|NCT00372697|580778234|FG001|Overall Study|Protocol Violation|1|||
160833789|NCT03221842|580778235|FG000|Period 1 (Open-label)|Adverse Event|4|||
160833790|NCT03221842|580778236|FG001|Period 1 (Open-label)|Adverse Event|0|||
160833791|NCT03221842|580778235|FG000|Period 1 (Open-label)|Physician Decision|2|||
160833792|NCT03221842|580778236|FG001|Period 1 (Open-label)|Physician Decision|0|||
160833793|NCT03221842|580778235|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
160833794|NCT03221842|580778236|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
160833795|NCT03221842|580778235|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
160833796|NCT03221842|580778236|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
160833797|NCT03221842|580778235|FG000|Period 1 (Open-label)|Other|2|||
160833798|NCT03221842|580778236|FG001|Period 1 (Open-label)|Other|0|||
160833799|NCT03221842|580778235|FG000|Period 2 (Randomized, Blinded)|Death|0|||
160833800|NCT03221842|580778236|FG001|Period 2 (Randomized, Blinded)|Death|1|||
160833801|NCT03221842|580778235|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
160833802|NCT03221842|580778236|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
160903607|NCT00002651|581040555|FG002|Consolidation and Randomization|Progression/relapse|298|||
160903608|NCT00002651|581040553|FG000|Consolidation and Randomization|Death|0|||
160903609|NCT00002651|581040554|FG001|Consolidation and Randomization|Death|38|||
160561346|NCT00749190|579777535|FG004|Overall Study|Protocol Violation|0|||
160561347|NCT00749190|579777536|FG005|Overall Study|Protocol Violation|0|||
160561348|NCT00749190|579777537|FG006|Overall Study|Protocol Violation|1|||
160561349|NCT00749190|579777531|FG000|Overall Study|Other reason not defined above|0|||
160561350|NCT00749190|579777532|FG001|Overall Study|Other reason not defined above|0|||
160561351|NCT00749190|579777533|FG002|Overall Study|Other reason not defined above|0|||
160833803|NCT02504580|580778237|FG000|Overall Study|Other|1|||
160833804|NCT02504580|580778238|FG001|Overall Study|Other|0|||
160833805|NCT02504580|580778239|FG002|Overall Study|Other|0|||
160833806|NCT02504580|580778240|FG003|Overall Study|Other|2|||
160833807|NCT02504580|580778241|FG004|Overall Study|Other|1|||
160833808|NCT02504580|580778242|FG005|Overall Study|Other|1|||
160833809|NCT02504580|580778243|FG006|Overall Study|Other|1|||
160833810|NCT02504580|580778244|FG007|Overall Study|Other|2|||
160833811|NCT02504580|580778245|FG008|Overall Study|Other|0|||
160833812|NCT02504580|580778246|FG009|Overall Study|Other|0|||
160833813|NCT02504580|580778247|FG010|Overall Study|Other|0|||
160833814|NCT02504580|580778248|FG011|Overall Study|Other|2|||
160561352|NCT00749190|579777534|FG003|Overall Study|Other reason not defined above|1|||
160833815|NCT02504580|580778237|FG000|Overall Study|Subject refusal to continue|0|||
160833816|NCT02504580|580778238|FG001|Overall Study|Subject refusal to continue|1|||
160833817|NCT02504580|580778239|FG002|Overall Study|Subject refusal to continue|0|||
160833818|NCT02504580|580778240|FG003|Overall Study|Subject refusal to continue|0|||
160833819|NCT02504580|580778241|FG004|Overall Study|Subject refusal to continue|0|||
160833820|NCT02504580|580778242|FG005|Overall Study|Subject refusal to continue|0|||
160833821|NCT02504580|580778243|FG006|Overall Study|Subject refusal to continue|0|||
160561353|NCT00749190|579777535|FG004|Overall Study|Other reason not defined above|0|||
160561354|NCT00749190|579777536|FG005|Overall Study|Other reason not defined above|0|||
160833822|NCT02504580|580778244|FG007|Overall Study|Subject refusal to continue|0|||
160833823|NCT02504580|580778245|FG008|Overall Study|Subject refusal to continue|0|||
160833824|NCT02504580|580778246|FG009|Overall Study|Subject refusal to continue|0|||
160833825|NCT02504580|580778247|FG010|Overall Study|Subject refusal to continue|0|||
160833826|NCT02504580|580778248|FG011|Overall Study|Subject refusal to continue|0|||
160833827|NCT01353911|580778251|FG000|Overall Study|Lost to Follow-up|2|||
160833828|NCT01353911|580778252|FG001|Overall Study|Lost to Follow-up|6|||
160833829|NCT01353911|580778253|FG002|Overall Study|Lost to Follow-up|4|||
160833830|NCT01353911|580778254|FG003|Overall Study|Lost to Follow-up|0|||
160833831|NCT01353911|580778255|FG004|Overall Study|Lost to Follow-up|4|||
160833832|NCT01353911|580778256|FG005|Overall Study|Lost to Follow-up|4|||
160833833|NCT01353911|580778257|FG006|Overall Study|Lost to Follow-up|3|||
160833834|NCT01353911|580778258|FG007|Overall Study|Lost to Follow-up|6|||
160833835|NCT01353911|580778251|FG000|Overall Study|Withdrawal by Subject|2|||
160833836|NCT01353911|580778252|FG001|Overall Study|Withdrawal by Subject|3|||
160833837|NCT01353911|580778253|FG002|Overall Study|Withdrawal by Subject|4|||
160833838|NCT01353911|580778254|FG003|Overall Study|Withdrawal by Subject|2|||
160833839|NCT01353911|580778255|FG004|Overall Study|Withdrawal by Subject|2|||
160833840|NCT01353911|580778256|FG005|Overall Study|Withdrawal by Subject|3|||
160833841|NCT01353911|580778257|FG006|Overall Study|Withdrawal by Subject|3|||
160833842|NCT01353911|580778258|FG007|Overall Study|Withdrawal by Subject|9|||
160833843|NCT01353911|580778251|FG000|Overall Study|Status Not Recorded|4|||
160833844|NCT01353911|580778252|FG001|Overall Study|Status Not Recorded|0|||
160833845|NCT01353911|580778253|FG002|Overall Study|Status Not Recorded|1|||
160833846|NCT01353911|580778254|FG003|Overall Study|Status Not Recorded|0|||
160833847|NCT01353911|580778255|FG004|Overall Study|Status Not Recorded|0|||
160833848|NCT01353911|580778256|FG005|Overall Study|Status Not Recorded|0|||
160833849|NCT01353911|580778257|FG006|Overall Study|Status Not Recorded|0|||
160833850|NCT01353911|580778258|FG007|Overall Study|Status Not Recorded|0|||
160833851|NCT02049138|580778261|FG000|Overall Study|Adverse Event|46|||
160833852|NCT02049138|580778262|FG001|Overall Study|Adverse Event|25|||
160833853|NCT02049138|580778263|FG002|Overall Study|Adverse Event|1|||
160833854|NCT02049138|580778261|FG000|Overall Study|Withdrawal by Subject|57|||
160833855|NCT02049138|580778262|FG001|Overall Study|Withdrawal by Subject|21|||
160833856|NCT02049138|580778263|FG002|Overall Study|Withdrawal by Subject|5|||
160833857|NCT02049138|580778261|FG000|Overall Study|Lost to Follow-up|18|||
160833858|NCT02049138|580778262|FG001|Overall Study|Lost to Follow-up|5|||
160833859|NCT02049138|580778263|FG002|Overall Study|Lost to Follow-up|1|||
160833860|NCT02049138|580778261|FG000|Overall Study|Lack of Efficacy|10|||
160833861|NCT02049138|580778262|FG001|Overall Study|Lack of Efficacy|26|||
160833862|NCT02049138|580778263|FG002|Overall Study|Lack of Efficacy|1|||
160833863|NCT02049138|580778261|FG000|Overall Study|Non-Compliance|15|||
160833864|NCT02049138|580778262|FG001|Overall Study|Non-Compliance|6|||
160833865|NCT02049138|580778263|FG002|Overall Study|Non-Compliance|0|||
160833866|NCT02049138|580778261|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
160833867|NCT02049138|580778262|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
160833868|NCT02049138|580778263|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
160833869|NCT02049138|580778261|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
160833870|NCT02049138|580778262|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
160833871|NCT02049138|580778263|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
160833872|NCT02049138|580778261|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
160833873|NCT02049138|580778262|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
160833874|NCT02049138|580778263|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
160833875|NCT02049138|580778261|FG000|Overall Study|Other|15|||
160833876|NCT02049138|580778262|FG001|Overall Study|Other|13|||
160833877|NCT02049138|580778263|FG002|Overall Study|Other|0|||
160833878|NCT02049138|580778261|FG000|Overall Study|Missing|0|||
160833879|NCT02049138|580778262|FG001|Overall Study|Missing|1|||
160833880|NCT02049138|580778263|FG002|Overall Study|Missing|0|||
160833881|NCT05086510|580778264|FG000|Overall Study|Lost to Follow-up|0|||
160833882|NCT05086510|580778265|FG001|Overall Study|Lost to Follow-up|2|||
160454065|NCT02038777|579394023|FG001|Overall Study|Started Chemotherapy|0|||
160833883|NCT05086510|580778264|FG000|Overall Study|Death|0|||
160833884|NCT05086510|580778265|FG001|Overall Study|Death|2|||
160833885|NCT00587847|580778266|FG000|Overall Study|Lack of Efficacy|5|||
160833886|NCT00587847|580778266|FG000|Overall Study|Adverse Event|2|||
160833887|NCT00343382|580778267|FG000|Overall Study|Adverse Event|2|||
160833888|NCT00343382|580778268|FG001|Overall Study|Adverse Event|10|||
160833889|NCT00343382|580778269|FG002|Overall Study|Adverse Event|7|||
160833890|NCT00343382|580778267|FG000|Overall Study|Withdrawal by Subject|1|||
160833891|NCT00343382|580778268|FG001|Overall Study|Withdrawal by Subject|2|||
160833892|NCT00343382|580778269|FG002|Overall Study|Withdrawal by Subject|6|||
160561355|NCT00749190|579777537|FG006|Overall Study|Other reason not defined above|0|||
160561356|NCT00490542|579777540|FG000|Overall Study|Lost to Follow-up|3|||
160561357|NCT00490542|579777541|FG001|Overall Study|Lost to Follow-up|0|||
160561358|NCT00490542|579777540|FG000|Overall Study|Adverse Event|3|||
160561359|NCT00490542|579777541|FG001|Overall Study|Adverse Event|3|||
160561360|NCT00490542|579777540|FG000|Overall Study|Lack of Efficacy|1|||
160561361|NCT00490542|579777541|FG001|Overall Study|Lack of Efficacy|1|||
160561362|NCT04370509|579777542|FG000|Overall Study|Adverse Event|1|||
160561363|NCT04370509|579777543|FG001|Overall Study|Adverse Event|0|||
160561364|NCT04370509|579777542|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
160561365|NCT04370509|579777543|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
160561366|NCT04743856|579777544|FG000|Overall Study|Lost to Follow-up|6|||
160561367|NCT04743856|579777545|FG001|Overall Study|Lost to Follow-up|7|||
160561368|NCT04743856|579777544|FG000|Overall Study|Withdrawal by Subject|1|||
160561369|NCT04743856|579777545|FG001|Overall Study|Withdrawal by Subject|0|||
160561370|NCT04696861|579777546|FG000|Overall Study|Death|1|||
160561371|NCT04696861|579777547|FG001|Overall Study|Death|0|||
160833893|NCT00343382|580778267|FG000|Overall Study|Other Reason Not Specified|1|||
160833894|NCT00343382|580778268|FG001|Overall Study|Other Reason Not Specified|2|||
160833895|NCT00343382|580778269|FG002|Overall Study|Other Reason Not Specified|4|||
160833896|NCT02337725|580778274|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
160833897|NCT02337725|580778275|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
160833898|NCT02337725|580778274|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
160833899|NCT02337725|580778275|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
160833900|NCT02337725|580778274|FG000|Overall Study|Major Protocol Deviation|0|||
160833901|NCT02337725|580778275|FG001|Overall Study|Major Protocol Deviation|1|||
160833902|NCT02337725|580778274|FG000|Overall Study|Voluntary Withdrawal|14|||
160833903|NCT02337725|580778275|FG001|Overall Study|Voluntary Withdrawal|3|||
160561372|NCT04696861|579777546|FG000|Overall Study|Lost to Follow-up|3|||
160561373|NCT04696861|579777547|FG001|Overall Study|Lost to Follow-up|0|||
160561374|NCT04439188|579777548|FG000|Overall Study|Ineligible|3|||
160561375|NCT04439188|579777548|FG000|Overall Study|Adverse Event|4|||
160561376|NCT04439188|579777548|FG000|Overall Study|Death|1|||
160561377|NCT04439188|579777548|FG000|Overall Study|Disease Progression|25|||
160561378|NCT04439188|579777548|FG000|Overall Study|Withdrawal by Subject|2|||
160561379|NCT00413959|579777549|FG000|Overall Study|Pt had only one cycle.|1|||
160561380|NCT01813890|579777552|FG000|Overall Study|Adverse Event|0|||
160561381|NCT01813890|579777553|FG001|Overall Study|Adverse Event|3|||
160561382|NCT01813890|579777554|FG002|Overall Study|Adverse Event|4|||
160561383|NCT01813890|579777552|FG000|Overall Study|Lack of Efficacy|9|||
160561384|NCT01813890|579777553|FG001|Overall Study|Lack of Efficacy|1|||
160561385|NCT01813890|579777554|FG002|Overall Study|Lack of Efficacy|2|||
160561386|NCT04482647|579777555|FG000|Overall Study|Time constraints|2|||
160561387|NCT04482647|579777555|FG000|Overall Study|Health issues|1|||
160561388|NCT04482647|579777555|FG000|Overall Study|Death in the family|1|||
160561389|NCT04482647|579777555|FG000|Overall Study|Disliked the intervention|1|||
160561390|NCT04482647|579777555|FG000|Overall Study|No reasons specified|7|||
160561391|NCT03952559|579777556|FG000|Double Blind Treatment Period|Adverse Event|0|||
160561392|NCT03952559|579777557|FG001|Double Blind Treatment Period|Adverse Event|2|||
160561393|NCT03952559|579777558|FG002|Double Blind Treatment Period|Adverse Event|1|||
160561394|NCT03952559|579777559|FG003|Double Blind Treatment Period|Adverse Event|0|||
160561395|NCT03952559|579777560|FG004|Double Blind Treatment Period|Adverse Event|1|||
160561396|NCT03952559|579777556|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
160561397|NCT03952559|579777557|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
160561398|NCT03952559|579777558|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
160561399|NCT03952559|579777559|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
160561400|NCT03952559|579777560|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
160561401|NCT03952559|579777556|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
160561402|NCT03952559|579777557|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
160833904|NCT02337725|580778274|FG000|Overall Study|Lack of Efficacy|4|||
160833905|NCT02337725|580778275|FG001|Overall Study|Lack of Efficacy|0|||
160833906|NCT01571453|580778276|FG000|Overall Study|Adverse Event|14|||
160833907|NCT01571453|580778277|FG001|Overall Study|Adverse Event|32|||
160561403|NCT03952559|579777558|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
160561404|NCT03952559|579777559|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
160561405|NCT03952559|579777560|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
160561406|NCT03952559|579777556|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
160561407|NCT03952559|579777557|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
160561408|NCT03952559|579777558|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
160561409|NCT03952559|579777559|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
160561410|NCT03952559|579777560|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
160561411|NCT02875223|579777561|FG000|Overall Study|Other reasons|0|||
160561412|NCT02875223|579777562|FG001|Overall Study|Other reasons|0|||
160833908|NCT01571453|580778276|FG000|Overall Study|Lack of Efficacy|8|||
160833909|NCT01571453|580778277|FG001|Overall Study|Lack of Efficacy|3|||
160561413|NCT02875223|579777563|FG002|Overall Study|Other reasons|1|||
160561414|NCT02875223|579777564|FG003|Overall Study|Other reasons|0|||
160561415|NCT02875223|579777565|FG004|Overall Study|Other reasons|1|||
160561416|NCT02875223|579777566|FG005|Overall Study|Other reasons|2|||
160561417|NCT02875223|579777567|FG006|Overall Study|Other reasons|0|||
160561418|NCT02875223|579777568|FG007|Overall Study|Other reasons|2|||
160561419|NCT02875223|579777569|FG008|Overall Study|Other reasons|0|||
160561420|NCT02875223|579777570|FG009|Overall Study|Other reasons|0|||
160561421|NCT02875223|579777571|FG010|Overall Study|Other reasons|0|||
160561422|NCT02875223|579777572|FG011|Overall Study|Other reasons|0|||
160561423|NCT02875223|579777573|FG012|Overall Study|Other reasons|0|||
160561424|NCT02875223|579777561|FG000|Overall Study|Withdrawal by Subject|0|||
160561425|NCT02875223|579777562|FG001|Overall Study|Withdrawal by Subject|0|||
160561426|NCT02875223|579777563|FG002|Overall Study|Withdrawal by Subject|0|||
160561427|NCT02875223|579777564|FG003|Overall Study|Withdrawal by Subject|0|||
160561428|NCT02875223|579777565|FG004|Overall Study|Withdrawal by Subject|1|||
160561429|NCT02875223|579777566|FG005|Overall Study|Withdrawal by Subject|1|||
160561430|NCT02875223|579777567|FG006|Overall Study|Withdrawal by Subject|0|||
160561431|NCT02875223|579777568|FG007|Overall Study|Withdrawal by Subject|0|||
160561432|NCT02875223|579777569|FG008|Overall Study|Withdrawal by Subject|1|||
160561433|NCT02875223|579777570|FG009|Overall Study|Withdrawal by Subject|0|||
160561434|NCT02875223|579777571|FG010|Overall Study|Withdrawal by Subject|0|||
160561435|NCT02875223|579777572|FG011|Overall Study|Withdrawal by Subject|0|||
160561436|NCT02875223|579777573|FG012|Overall Study|Withdrawal by Subject|0|||
160561437|NCT02875223|579777561|FG000|Overall Study|Progressive disease|0|||
160561438|NCT02875223|579777562|FG001|Overall Study|Progressive disease|0|||
160561439|NCT02875223|579777563|FG002|Overall Study|Progressive disease|1|||
160561440|NCT02875223|579777564|FG003|Overall Study|Progressive disease|0|||
160561441|NCT02875223|579777565|FG004|Overall Study|Progressive disease|0|||
160561442|NCT02875223|579777566|FG005|Overall Study|Progressive disease|0|||
160561443|NCT02875223|579777567|FG006|Overall Study|Progressive disease|0|||
160561444|NCT02875223|579777568|FG007|Overall Study|Progressive disease|0|||
160561445|NCT02875223|579777569|FG008|Overall Study|Progressive disease|0|||
160561446|NCT02875223|579777570|FG009|Overall Study|Progressive disease|12|||
160561447|NCT02875223|579777571|FG010|Overall Study|Progressive disease|2|||
160561448|NCT02875223|579777572|FG011|Overall Study|Progressive disease|3|||
160561449|NCT02875223|579777573|FG012|Overall Study|Progressive disease|6|||
160561450|NCT02875223|579777561|FG000|Overall Study|Death|4|||
160561451|NCT02875223|579777562|FG001|Overall Study|Death|4|||
160561452|NCT02875223|579777563|FG002|Overall Study|Death|3|||
160561453|NCT02875223|579777564|FG003|Overall Study|Death|4|||
160561454|NCT02875223|579777565|FG004|Overall Study|Death|2|||
160561455|NCT02875223|579777566|FG005|Overall Study|Death|3|||
160561456|NCT02875223|579777567|FG006|Overall Study|Death|5|||
160561457|NCT02875223|579777568|FG007|Overall Study|Death|7|||
160561458|NCT02875223|579777569|FG008|Overall Study|Death|3|||
160561459|NCT02875223|579777570|FG009|Overall Study|Death|2|||
160561460|NCT02875223|579777571|FG010|Overall Study|Death|0|||
160561461|NCT02875223|579777572|FG011|Overall Study|Death|0|||
160561462|NCT02875223|579777573|FG012|Overall Study|Death|0|||
160561463|NCT02875223|579777561|FG000|Overall Study|Lost to Follow-up|0|||
160561464|NCT02875223|579777562|FG001|Overall Study|Lost to Follow-up|1|||
160561465|NCT02875223|579777563|FG002|Overall Study|Lost to Follow-up|1|||
160561466|NCT02875223|579777564|FG003|Overall Study|Lost to Follow-up|0|||
160561467|NCT02875223|579777565|FG004|Overall Study|Lost to Follow-up|1|||
160561468|NCT02875223|579777566|FG005|Overall Study|Lost to Follow-up|0|||
160561469|NCT02875223|579777567|FG006|Overall Study|Lost to Follow-up|1|||
160561470|NCT02875223|579777568|FG007|Overall Study|Lost to Follow-up|1|||
160561471|NCT02875223|579777569|FG008|Overall Study|Lost to Follow-up|0|||
160561472|NCT02875223|579777570|FG009|Overall Study|Lost to Follow-up|0|||
160561473|NCT02875223|579777571|FG010|Overall Study|Lost to Follow-up|0|||
160561474|NCT02875223|579777572|FG011|Overall Study|Lost to Follow-up|0|||
160561475|NCT02875223|579777573|FG012|Overall Study|Lost to Follow-up|0|||
160561476|NCT01986062|579777576|FG000|Overall Study|Lost to Follow-up|1|||
160561477|NCT01986062|579777577|FG001|Overall Study|Lost to Follow-up|0|||
160561478|NCT01986062|579777576|FG000|Overall Study|Withdrawal by Subject|0|||
160561479|NCT01986062|579777577|FG001|Overall Study|Withdrawal by Subject|1|||
160561480|NCT01827384|579777578|FG000|Overall Study|Switched to alternative treatment|0|||
160561481|NCT01827384|579777579|FG001|Overall Study|Switched to alternative treatment|0|||
160561482|NCT01827384|579777580|FG002|Overall Study|Switched to alternative treatment|0|||
160561483|NCT01827384|579777581|FG003|Overall Study|Switched to alternative treatment|0|||
160561484|NCT01827384|579777582|FG004|Overall Study|Switched to alternative treatment|0|||
160561485|NCT01827384|579777583|FG005|Overall Study|Switched to alternative treatment|0|||
160561486|NCT01827384|579777584|FG006|Overall Study|Switched to alternative treatment|0|||
160561487|NCT01827384|579777585|FG007|Overall Study|Switched to alternative treatment|0|||
160561488|NCT01827384|579777586|FG008|Overall Study|Switched to alternative treatment|0|||
160561489|NCT01827384|579777587|FG009|Overall Study|Switched to alternative treatment|0|||
160561490|NCT01827384|579777588|FG010|Overall Study|Switched to alternative treatment|0|||
160561491|NCT01827384|579777589|FG011|Overall Study|Switched to alternative treatment|0|||
160561492|NCT01827384|579777590|FG012|Overall Study|Switched to alternative treatment|0|||
160561493|NCT01827384|579777591|FG013|Overall Study|Switched to alternative treatment|2|||
160561494|NCT01827384|579777578|FG000|Overall Study|Disease progression before treatment|0|||
160561495|NCT01827384|579777579|FG001|Overall Study|Disease progression before treatment|0|||
160561496|NCT01827384|579777580|FG002|Overall Study|Disease progression before treatment|0|||
160561497|NCT01827384|579777581|FG003|Overall Study|Disease progression before treatment|0|||
160561498|NCT01827384|579777582|FG004|Overall Study|Disease progression before treatment|0|||
160561499|NCT01827384|579777583|FG005|Overall Study|Disease progression before treatment|0|||
160561500|NCT01827384|579777584|FG006|Overall Study|Disease progression before treatment|0|||
160561501|NCT01827384|579777585|FG007|Overall Study|Disease progression before treatment|0|||
160561502|NCT01827384|579777586|FG008|Overall Study|Disease progression before treatment|0|||
160561503|NCT01827384|579777587|FG009|Overall Study|Disease progression before treatment|0|||
160833910|NCT01571453|580778276|FG000|Overall Study|Non-compliance|2|||
160833911|NCT01571453|580778277|FG001|Overall Study|Non-compliance|4|||
160833912|NCT01571453|580778276|FG000|Overall Study|Protocol Violation|1|||
160833913|NCT01571453|580778277|FG001|Overall Study|Protocol Violation|5|||
160833914|NCT01571453|580778276|FG000|Overall Study|Withdrawal of consent|5|||
160833915|NCT01571453|580778277|FG001|Overall Study|Withdrawal of consent|13|||
160833916|NCT01571453|580778276|FG000|Overall Study|Lost to Follow-up|4|||
160833917|NCT01571453|580778277|FG001|Overall Study|Lost to Follow-up|2|||
160561504|NCT01827384|579777588|FG010|Overall Study|Disease progression before treatment|0|||
160561505|NCT01827384|579777589|FG011|Overall Study|Disease progression before treatment|0|||
160561506|NCT01827384|579777590|FG012|Overall Study|Disease progression before treatment|0|||
160561507|NCT01827384|579777591|FG013|Overall Study|Disease progression before treatment|4|||
160561508|NCT01827384|579777578|FG000|Overall Study|Ineligible|0|||
160561509|NCT01827384|579777579|FG001|Overall Study|Ineligible|0|||
160561510|NCT01827384|579777580|FG002|Overall Study|Ineligible|0|||
160561511|NCT01827384|579777581|FG003|Overall Study|Ineligible|0|||
160561512|NCT01827384|579777582|FG004|Overall Study|Ineligible|0|||
160561513|NCT01827384|579777583|FG005|Overall Study|Ineligible|0|||
160561514|NCT01827384|579777584|FG006|Overall Study|Ineligible|0|||
160561515|NCT01827384|579777585|FG007|Overall Study|Ineligible|0|||
160561516|NCT01827384|579777586|FG008|Overall Study|Ineligible|0|||
160561517|NCT01827384|579777587|FG009|Overall Study|Ineligible|0|||
160561518|NCT01827384|579777588|FG010|Overall Study|Ineligible|0|||
160833918|NCT01571453|580778276|FG000|Overall Study|Administrative or other reason(s)|4|||
160833919|NCT01571453|580778277|FG001|Overall Study|Administrative or other reason(s)|3|||
160561519|NCT01827384|579777589|FG011|Overall Study|Ineligible|0|||
160561520|NCT01827384|579777590|FG012|Overall Study|Ineligible|0|||
160561521|NCT01827384|579777591|FG013|Overall Study|Ineligible|19|||
160561522|NCT01827384|579777578|FG000|Overall Study|Participant died before treatment|0|||
160561523|NCT01827384|579777579|FG001|Overall Study|Participant died before treatment|0|||
160561524|NCT01827384|579777580|FG002|Overall Study|Participant died before treatment|0|||
160561525|NCT01827384|579777581|FG003|Overall Study|Participant died before treatment|0|||
160561526|NCT01827384|579777582|FG004|Overall Study|Participant died before treatment|0|||
160561527|NCT01827384|579777583|FG005|Overall Study|Participant died before treatment|0|||
160561528|NCT01827384|579777584|FG006|Overall Study|Participant died before treatment|0|||
160561529|NCT01827384|579777585|FG007|Overall Study|Participant died before treatment|0|||
160561530|NCT01827384|579777586|FG008|Overall Study|Participant died before treatment|0|||
160561531|NCT01827384|579777587|FG009|Overall Study|Participant died before treatment|0|||
160561532|NCT01827384|579777588|FG010|Overall Study|Participant died before treatment|0|||
160833920|NCT00500760|580778278|FG000|Overall Study|Death|32|||
160833921|NCT00500760|580778279|FG001|Overall Study|Death|15|||
160833922|NCT00500760|580778278|FG000|Overall Study|Withdrawal by Subject|5|||
160561533|NCT01827384|579777589|FG011|Overall Study|Participant died before treatment|0|||
160561534|NCT01827384|579777590|FG012|Overall Study|Participant died before treatment|0|||
160561535|NCT01827384|579777591|FG013|Overall Study|Participant died before treatment|5|||
160561536|NCT01827384|579777578|FG000|Overall Study|Insufficient tumor cells|0|||
160833923|NCT00500760|580778279|FG001|Overall Study|Withdrawal by Subject|7|||
160833924|NCT00500760|580778278|FG000|Overall Study|Administrative decision|2|||
160561537|NCT01827384|579777579|FG001|Overall Study|Insufficient tumor cells|0|||
160561538|NCT01827384|579777580|FG002|Overall Study|Insufficient tumor cells|0|||
160833925|NCT00500760|580778279|FG001|Overall Study|Administrative decision|0|||
160561539|NCT01827384|579777581|FG003|Overall Study|Insufficient tumor cells|0|||
160561540|NCT01827384|579777582|FG004|Overall Study|Insufficient tumor cells|0|||
160561541|NCT01827384|579777583|FG005|Overall Study|Insufficient tumor cells|0|||
160561542|NCT01827384|579777584|FG006|Overall Study|Insufficient tumor cells|0|||
160561543|NCT01827384|579777585|FG007|Overall Study|Insufficient tumor cells|0|||
160561544|NCT01827384|579777586|FG008|Overall Study|Insufficient tumor cells|0|||
160561545|NCT01827384|579777587|FG009|Overall Study|Insufficient tumor cells|0|||
160561546|NCT01827384|579777588|FG010|Overall Study|Insufficient tumor cells|0|||
160833926|NCT00500760|580778278|FG000|Overall Study|Lost to Follow-up|3|||
160833927|NCT00500760|580778279|FG001|Overall Study|Lost to Follow-up|0|||
160833928|NCT00500760|580778278|FG000|Overall Study|Other|1|||
160561547|NCT01827384|579777589|FG011|Overall Study|Insufficient tumor cells|0|||
160561548|NCT01827384|579777590|FG012|Overall Study|Insufficient tumor cells|0|||
160561549|NCT01827384|579777591|FG013|Overall Study|Insufficient tumor cells|13|||
160561550|NCT01827384|579777578|FG000|Overall Study|No actionable mutation|0|||
160561551|NCT01827384|579777579|FG001|Overall Study|No actionable mutation|0|||
160561552|NCT01827384|579777580|FG002|Overall Study|No actionable mutation|0|||
160561553|NCT01827384|579777581|FG003|Overall Study|No actionable mutation|0|||
160561554|NCT01827384|579777582|FG004|Overall Study|No actionable mutation|0|||
160561555|NCT01827384|579777583|FG005|Overall Study|No actionable mutation|0|||
160561556|NCT01827384|579777584|FG006|Overall Study|No actionable mutation|0|||
160561557|NCT01827384|579777585|FG007|Overall Study|No actionable mutation|0|||
160561558|NCT01827384|579777586|FG008|Overall Study|No actionable mutation|0|||
160561559|NCT01827384|579777587|FG009|Overall Study|No actionable mutation|0|||
160561560|NCT01827384|579777588|FG010|Overall Study|No actionable mutation|0|||
160561561|NCT01827384|579777589|FG011|Overall Study|No actionable mutation|0|||
160561562|NCT01827384|579777590|FG012|Overall Study|No actionable mutation|0|||
160561563|NCT01827384|579777591|FG013|Overall Study|No actionable mutation|73|||
160561564|NCT01827384|579777578|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
160561565|NCT01827384|579777579|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
160561566|NCT01827384|579777580|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
160561567|NCT01827384|579777581|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
160561568|NCT01827384|579777582|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
160561569|NCT01827384|579777583|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
160561570|NCT01827384|579777584|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
160561571|NCT01827384|579777585|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
160561572|NCT01827384|579777586|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
160561573|NCT01827384|579777587|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
160561574|NCT01827384|579777588|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
160561575|NCT01827384|579777589|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
160561576|NCT01827384|579777590|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
160561577|NCT01827384|579777591|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
160561578|NCT01707992|579777592|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
160561579|NCT01707992|579777593|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
160561580|NCT01707992|579777594|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
160561581|NCT01707992|579777595|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
160561582|NCT01707992|579777596|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
160561583|NCT01707992|579777597|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
160561584|NCT01707992|579777592|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
160561585|NCT01707992|579777593|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
160561586|NCT01707992|579777594|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
160561587|NCT01707992|579777595|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
160561588|NCT01707992|579777596|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
160561589|NCT01707992|579777597|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
160561590|NCT01707992|579777592|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
160561591|NCT01707992|579777593|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
160561592|NCT01707992|579777594|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
160561593|NCT01707992|579777595|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
160561594|NCT01707992|579777596|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
160561595|NCT01707992|579777597|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
160561596|NCT01707992|579777592|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
160561597|NCT01707992|579777593|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
160561598|NCT01707992|579777594|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
160561599|NCT01707992|579777595|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
160833929|NCT00500760|580778279|FG001|Overall Study|Other|2|||
160833930|NCT01264770|580778280|FG000|Overall Study|Not reported|0|||
160833931|NCT01264770|580778281|FG001|Overall Study|Not reported|0|||
160833932|NCT01264770|580778282|FG002|Overall Study|Not reported|1|||
160833933|NCT01264770|580778283|FG003|Overall Study|Not reported|0|||
160833934|NCT01264770|580778284|FG004|Overall Study|Not reported|0|||
160833935|NCT01264770|580778285|FG005|Overall Study|Not reported|0|||
160833936|NCT01264770|580778280|FG000|Overall Study|e.g., change in circumstances|8|||
160561600|NCT01707992|579777596|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
160561601|NCT01707992|579777597|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
160833937|NCT01264770|580778281|FG001|Overall Study|e.g., change in circumstances|3|||
160833938|NCT01264770|580778282|FG002|Overall Study|e.g., change in circumstances|3|||
160561602|NCT01707992|579777592|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
160561603|NCT01707992|579777593|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
160561604|NCT01707992|579777594|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
160561605|NCT01707992|579777595|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
160561606|NCT01707992|579777596|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
160833939|NCT01264770|580778283|FG003|Overall Study|e.g., change in circumstances|3|||
160561607|NCT01707992|579777597|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
160561608|NCT01707992|579777592|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
160561609|NCT01707992|579777593|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
160561610|NCT01707992|579777594|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
160561611|NCT01707992|579777595|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
160561612|NCT01707992|579777596|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
160561613|NCT01707992|579777597|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
160561614|NCT01707992|579777592|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
160561615|NCT01707992|579777593|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
160561616|NCT01707992|579777594|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
160561617|NCT01707992|579777595|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
160561618|NCT01707992|579777596|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
160561619|NCT01707992|579777597|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
160561620|NCT01707992|579777592|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
160561621|NCT01707992|579777593|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
160561622|NCT01707992|579777594|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
160561623|NCT01707992|579777595|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
160561624|NCT01707992|579777596|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
160833940|NCT01264770|580778284|FG004|Overall Study|e.g., change in circumstances|4|||
160833941|NCT01264770|580778285|FG005|Overall Study|e.g., change in circumstances|4|||
160833942|NCT01264770|580778280|FG000|Overall Study|Severe non-compliance to protocol|0|||
160833943|NCT01264770|580778281|FG001|Overall Study|Severe non-compliance to protocol|0|||
160833944|NCT01264770|580778282|FG002|Overall Study|Severe non-compliance to protocol|1|||
160833945|NCT01264770|580778283|FG003|Overall Study|Severe non-compliance to protocol|1|||
160833946|NCT01264770|580778284|FG004|Overall Study|Severe non-compliance to protocol|0|||
160833947|NCT01264770|580778285|FG005|Overall Study|Severe non-compliance to protocol|0|||
160833948|NCT01264770|580778280|FG000|Overall Study|Lack of therapeutic response|1|||
160833949|NCT01264770|580778281|FG001|Overall Study|Lack of therapeutic response|0|||
160833950|NCT01264770|580778282|FG002|Overall Study|Lack of therapeutic response|2|||
160833951|NCT01264770|580778283|FG003|Overall Study|Lack of therapeutic response|1|||
160833952|NCT01264770|580778284|FG004|Overall Study|Lack of therapeutic response|1|||
160833953|NCT01264770|580778285|FG005|Overall Study|Lack of therapeutic response|0|||
160833954|NCT01264770|580778280|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
160833955|NCT01264770|580778281|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
160833956|NCT01264770|580778282|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
160833957|NCT01264770|580778283|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
160561625|NCT01707992|579777597|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
160833958|NCT01264770|580778284|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
160903610|NCT00002651|581040555|FG002|Consolidation and Randomization|Death|48|||
160903611|NCT00002651|581040553|FG000|Consolidation and Randomization|Other|0|||
160903612|NCT00002651|581040554|FG001|Consolidation and Randomization|Other|314|||
160903613|NCT00002651|581040555|FG002|Consolidation and Randomization|Other|313|||
160903614|NCT00002651|581040553|FG000|Consolidation and Randomization|not eligible|0|||
160903615|NCT00002651|581040554|FG001|Consolidation and Randomization|not eligible|102|||
160903616|NCT00002651|581040555|FG002|Consolidation and Randomization|not eligible|112|||
160903617|NCT03641339|581040560|FG000|Overall Study|Physician Decision|1|||
160903618|NCT03641339|581040561|FG001|Overall Study|Physician Decision|0|||
160903619|NCT03641339|581040562|FG002|Overall Study|Physician Decision|0|||
160903620|NCT03641339|581040563|FG003|Overall Study|Physician Decision|0|||
160903621|NCT03641339|581040564|FG004|Overall Study|Physician Decision|0|||
160991266|NCT01959880|581355570|FG003|Overall Study|Lost to Follow-up|8|||
160561626|NCT01707992|579777592|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
160561627|NCT01707992|579777593|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
160561628|NCT01707992|579777594|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
160561629|NCT01707992|579777595|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
160561630|NCT01707992|579777596|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
160833959|NCT01264770|580778285|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
160833960|NCT01264770|580778280|FG000|Overall Study|Lost to Follow-up|0|||
160833961|NCT01264770|580778281|FG001|Overall Study|Lost to Follow-up|0|||
160647608|NCT00416520|580092782|FG000|Open-label Period|Adverse Event|28|||
160903622|NCT03641339|581040565|FG005|Overall Study|Physician Decision|0|||
160903623|NCT03641339|581040560|FG000|Overall Study|Withdrawal by Subject|0|||
160903624|NCT03641339|581040561|FG001|Overall Study|Withdrawal by Subject|2|||
160903625|NCT03641339|581040562|FG002|Overall Study|Withdrawal by Subject|0|||
160903626|NCT03641339|581040563|FG003|Overall Study|Withdrawal by Subject|2|||
160903627|NCT03641339|581040564|FG004|Overall Study|Withdrawal by Subject|0|||
160903628|NCT03641339|581040565|FG005|Overall Study|Withdrawal by Subject|1|||
160903629|NCT02319837|581040568|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
160903630|NCT02319837|581040569|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
160903631|NCT02319837|581040570|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
160903632|NCT02319837|581040568|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
160903633|NCT02319837|581040569|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
160903634|NCT02319837|581040570|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
160903635|NCT02319837|581040568|FG000|Study Treatment Phase|Adverse Event|73|||
160903636|NCT02319837|581040569|FG001|Study Treatment Phase|Adverse Event|36|||
160903637|NCT02319837|581040570|FG002|Study Treatment Phase|Adverse Event|63|||
160903638|NCT02319837|581040568|FG000|Study Treatment Phase|Development of castration resistance|0|||
160903639|NCT02319837|581040569|FG001|Study Treatment Phase|Development of castration resistance|2|||
160903640|NCT02319837|581040570|FG002|Study Treatment Phase|Development of castration resistance|0|||
160903641|NCT02319837|581040568|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
160903642|NCT02319837|581040569|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
160903643|NCT02319837|581040570|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
160903644|NCT02319837|581040568|FG000|Study Treatment Phase|Protocol Violation|2|||
160903645|NCT02319837|581040569|FG001|Study Treatment Phase|Protocol Violation|2|||
160903646|NCT02319837|581040570|FG002|Study Treatment Phase|Protocol Violation|1|||
160903647|NCT02319837|581040568|FG000|Study Treatment Phase|Lost to Follow-up|0|||
160903648|NCT02319837|581040569|FG001|Study Treatment Phase|Lost to Follow-up|1|||
160903649|NCT02319837|581040570|FG002|Study Treatment Phase|Lost to Follow-up|0|||
160903650|NCT02319837|581040568|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
160903651|NCT02319837|581040569|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
160903652|NCT02319837|581040570|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
160903653|NCT02319837|581040568|FG000|Study Treatment Phase|Other|0|||
160903654|NCT02319837|581040569|FG001|Study Treatment Phase|Other|1|||
160903655|NCT02319837|581040570|FG002|Study Treatment Phase|Other|0|||
160903656|NCT02319837|581040568|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
160903657|NCT02319837|581040569|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
160903658|NCT02319837|581040570|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
160903659|NCT02319837|581040568|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
160903660|NCT02319837|581040569|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
160903661|NCT02319837|581040570|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
160903662|NCT02319837|581040568|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
160903663|NCT02319837|581040569|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
160903664|NCT02319837|581040570|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
160903665|NCT02319837|581040568|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
160903666|NCT02319837|581040569|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
160903667|NCT02319837|581040570|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
160903668|NCT02319837|581040568|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
160903669|NCT02319837|581040569|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
160903670|NCT02319837|581040570|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
160903671|NCT02319837|581040568|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
160903672|NCT02319837|581040569|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
160903673|NCT02319837|581040570|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
160903674|NCT02319837|581040568|FG000|Long-Term Follow-Up Phase|Death|33|||
160903675|NCT02319837|581040569|FG001|Long-Term Follow-Up Phase|Death|54|||
160561631|NCT01707992|579777597|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
160561632|NCT01707992|579777592|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
160561633|NCT01707992|579777593|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
160561634|NCT01707992|579777594|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
160561635|NCT01707992|579777595|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
160561636|NCT01707992|579777596|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
160561637|NCT01707992|579777597|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
160561638|NCT01707992|579777592|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
160561639|NCT01707992|579777593|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
160561640|NCT01707992|579777594|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
160647609|NCT00416520|580092783|FG001|Open-label Period|Adverse Event|10|||
160903676|NCT02319837|581040570|FG002|Long-Term Follow-Up Phase|Death|42|||
160903677|NCT01313312|581040576|FG000|Overall Study|Adverse Event|5|||
160903678|NCT01313312|581040576|FG000|Overall Study|Withdrawal by Subject|18|||
160903679|NCT01313312|581040576|FG000|Overall Study|Lack of Efficacy|3|||
160903680|NCT01313312|581040576|FG000|Overall Study|Investigator Decision|1|||
160903681|NCT01313312|581040576|FG000|Overall Study|Observational Phase|1|||
160903682|NCT01313312|581040576|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
160903683|NCT01313312|581040576|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
160903684|NCT01206166|581040584|FG000|Overall Study|No evaluable data|2|||
160903685|NCT01206166|581040585|FG001|Overall Study|No evaluable data|3|||
160903686|NCT02716805|581040586|FG000|Overall Study|Progressive disease|2|||
160903687|NCT02716805|581040587|FG001|Overall Study|Progressive disease|0|||
160903688|NCT02716805|581040588|FG002|Overall Study|Progressive disease|0|||
160903689|NCT02716805|581040589|FG003|Overall Study|Progressive disease|0|||
160903690|NCT00066365|581040590|FG000|Overall Study|Adverse Event|1|||
160903691|NCT00066365|581040591|FG001|Overall Study|Adverse Event|0|||
160903692|NCT00066365|581040590|FG000|Overall Study|Lack of Efficacy|15|||
160903693|NCT00066365|581040591|FG001|Overall Study|Lack of Efficacy|12|||
160903694|NCT00066365|581040590|FG000|Overall Study|Physician Decision|1|||
160903695|NCT00066365|581040591|FG001|Overall Study|Physician Decision|0|||
160903696|NCT00066365|581040590|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
160903697|NCT00066365|581040591|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
160903698|NCT00066365|581040590|FG000|Overall Study|Ineligible|4|||
160903699|NCT00066365|581040591|FG001|Overall Study|Ineligible|2|||
160903700|NCT01443078|581040596|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
160903701|NCT01443078|581040596|FG000|Overall Study|Withdrawal by Subject|1|||
160903702|NCT01443078|581040596|FG000|Overall Study|Patient had brain mets|1|||
160903703|NCT01390649|581040597|FG000|Overall Study|Physician Decision|1|||
160903704|NCT00415168|581040598|FG000|Overall Study|Death|26|||
160903705|NCT00415168|581040598|FG000|Overall Study|Lost to Follow-up|3|||
160903706|NCT00415168|581040598|FG000|Overall Study|Physician Decision|13|||
160903707|NCT00415168|581040598|FG000|Overall Study|Sponsor Decision|4|||
160903708|NCT00415168|581040598|FG000|Overall Study|Withdrawal by Subject|6|||
160903709|NCT01612858|581040599|FG000|Overall Study|Withdrawal by Subject|5|||
160833962|NCT01264770|580778282|FG002|Overall Study|Lost to Follow-up|1|||
160833963|NCT01264770|580778283|FG003|Overall Study|Lost to Follow-up|1|||
160833964|NCT01264770|580778284|FG004|Overall Study|Lost to Follow-up|0|||
160833965|NCT01264770|580778285|FG005|Overall Study|Lost to Follow-up|0|||
160833966|NCT01264770|580778280|FG000|Overall Study|Adverse Event|7|||
160833967|NCT01264770|580778281|FG001|Overall Study|Adverse Event|7|||
160833968|NCT01264770|580778282|FG002|Overall Study|Adverse Event|8|||
160833969|NCT01264770|580778283|FG003|Overall Study|Adverse Event|0|||
160833970|NCT01264770|580778284|FG004|Overall Study|Adverse Event|2|||
160833971|NCT01264770|580778285|FG005|Overall Study|Adverse Event|1|||
160833972|NCT00129961|580778286|FG000|Overall Study|Adverse Event|1|||
160833973|NCT00129961|580778287|FG001|Overall Study|Adverse Event|0|||
160833974|NCT00129961|580778286|FG000|Overall Study|Death|1|||
160833975|NCT00129961|580778287|FG001|Overall Study|Death|1|||
160833976|NCT00129961|580778286|FG000|Overall Study|Withdrawal by Sponsor|14|||
160833977|NCT00129961|580778287|FG001|Overall Study|Withdrawal by Sponsor|20|||
160833978|NCT00129961|580778286|FG000|Overall Study|Physician Decision|1|||
160833979|NCT00129961|580778287|FG001|Overall Study|Physician Decision|0|||
160833980|NCT00129961|580778286|FG000|Overall Study|Withdrawal by Subject|2|||
160833981|NCT00129961|580778287|FG001|Overall Study|Withdrawal by Subject|1|||
160833982|NCT00129961|580778286|FG000|Overall Study|Missing Record|0|||
160833983|NCT00129961|580778287|FG001|Overall Study|Missing Record|1|||
160833984|NCT01985360|580778290|FG000|Overall Study|Withdrawal by Subject|4|||
160833985|NCT01985360|580778291|FG001|Overall Study|Withdrawal by Subject|0|||
160833986|NCT01985360|580778290|FG000|Overall Study|Lost to Follow-up|5|||
160903710|NCT01612858|581040600|FG001|Overall Study|Withdrawal by Subject|1|||
160903711|NCT00005044|581040601|FG000|Overall Study|Protocol Violation|37|||
160903712|NCT00005044|581040602|FG001|Overall Study|Protocol Violation|46|||
160903713|NCT00005044|581040601|FG000|Overall Study|Withdrawal by Subject|1|||
160903714|NCT00005044|581040602|FG001|Overall Study|Withdrawal by Subject|5|||
160903715|NCT00005044|581040601|FG000|Overall Study|No protocol treatment|0|||
160903716|NCT00005044|581040602|FG001|Overall Study|No protocol treatment|1|||
160903717|NCT00241358|581040603|FG000|Overall Study|Determined to be not ineligible|0|||
160833987|NCT01985360|580778291|FG001|Overall Study|Lost to Follow-up|3|||
160833988|NCT00084487|580778292|FG000|Overall Study|Death|1|||
160833989|NCT03691779|580778297|FG000|Part B (24 Weeks)|Adverse Event|0|||
160833990|NCT03691779|580778298|FG001|Part B (24 Weeks)|Adverse Event|1|||
160833991|NCT03691779|580778297|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
160903718|NCT00241358|581040604|FG001|Overall Study|Determined to be not ineligible|1|||
160903719|NCT00241358|581040605|FG002|Overall Study|Determined to be not ineligible|1|||
160903720|NCT00843856|581040606|FG000|Overall Study|Lost to Follow-up|1|||
160833992|NCT03691779|580778298|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
160833993|NCT04881747|580778299|FG000|Period 2 Washout|Adverse Event|1|||
160903721|NCT00843856|581040607|FG001|Overall Study|Lost to Follow-up|2|||
160833994|NCT04881747|580778300|FG001|Period 2 Washout|Adverse Event|0|||
160833995|NCT04881747|580778301|FG002|Period 2 Washout|Adverse Event|0|||
160833996|NCT04881747|580778302|FG003|Period 2 Washout|Adverse Event|0|||
160833997|NCT04881747|580778303|FG004|Period 2 Washout|Adverse Event|1|||
160833998|NCT04881747|580778304|FG005|Period 2 Washout|Adverse Event|0|||
160833999|NCT04881747|580778299|FG000|Period 2 Washout|Withdrawal by Subject|1|||
160834000|NCT04881747|580778300|FG001|Period 2 Washout|Withdrawal by Subject|0|||
160834001|NCT04881747|580778301|FG002|Period 2 Washout|Withdrawal by Subject|0|||
160834002|NCT04881747|580778302|FG003|Period 2 Washout|Withdrawal by Subject|1|||
160834003|NCT04881747|580778303|FG004|Period 2 Washout|Withdrawal by Subject|0|||
160834004|NCT04881747|580778304|FG005|Period 2 Washout|Withdrawal by Subject|0|||
160834005|NCT00521222|580778305|FG000|Overall Study|Lost to Follow-up|0|||
160834006|NCT00521222|580778306|FG001|Overall Study|Lost to Follow-up|0|||
160834007|NCT00521222|580778307|FG002|Overall Study|Lost to Follow-up|1|||
160834008|NCT00521222|580778308|FG003|Overall Study|Lost to Follow-up|1|||
160834009|NCT00521222|580778305|FG000|Overall Study|Withdrawal by Subject|0|||
160834010|NCT00521222|580778306|FG001|Overall Study|Withdrawal by Subject|0|||
160834011|NCT00521222|580778307|FG002|Overall Study|Withdrawal by Subject|2|||
160834012|NCT00521222|580778308|FG003|Overall Study|Withdrawal by Subject|0|||
160834013|NCT00521222|580778305|FG000|Overall Study|Physician Decision|0|||
160834014|NCT00521222|580778306|FG001|Overall Study|Physician Decision|1|||
160834015|NCT00521222|580778307|FG002|Overall Study|Physician Decision|0|||
160834016|NCT00521222|580778308|FG003|Overall Study|Physician Decision|1|||
160834017|NCT04598269|580778310|FG000|Overall Study|Adverse Event|0|||
160834018|NCT04598269|580778311|FG001|Overall Study|Adverse Event|3|||
160834019|NCT04598269|580778310|FG000|Overall Study|Withdrawal by Subject|1|||
160834020|NCT04598269|580778311|FG001|Overall Study|Withdrawal by Subject|4|||
160834021|NCT04598269|580778310|FG000|Overall Study|Lost to Follow-up|1|||
160834022|NCT04598269|580778311|FG001|Overall Study|Lost to Follow-up|0|||
160834023|NCT04598269|580778310|FG000|Overall Study|Not Treated|2|||
160834024|NCT04598269|580778311|FG001|Overall Study|Not Treated|0|||
160834025|NCT00424190|580778312|FG000|Overall Study|Withdrew consent|3|||
160647610|NCT00416520|580092784|FG002|Open-label Period|Adverse Event|0|||
160647611|NCT00416520|580092785|FG003|Open-label Period|Adverse Event|0|||
160834026|NCT00424190|580778313|FG001|Overall Study|Withdrew consent|4|||
160834027|NCT00424190|580778312|FG000|Overall Study|Death|3|||
160834028|NCT00424190|580778313|FG001|Overall Study|Death|0|||
160561641|NCT01707992|579777595|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
160561642|NCT01707992|579777596|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
160561643|NCT01707992|579777597|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
160561644|NCT01707992|579777592|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
160561645|NCT01707992|579777593|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
160561646|NCT01707992|579777594|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
160561647|NCT01707992|579777595|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
160561648|NCT01707992|579777596|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
160561649|NCT01707992|579777597|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
160561650|NCT01707992|579777592|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
160561651|NCT01707992|579777593|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
160561652|NCT01707992|579777594|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
160561653|NCT01707992|579777595|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
160561654|NCT01707992|579777596|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
160561655|NCT01707992|579777597|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
160561656|NCT01707992|579777592|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
160561657|NCT01707992|579777593|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
160561658|NCT01707992|579777594|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
160561659|NCT01707992|579777595|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
160647612|NCT00416520|580092782|FG000|Open-label Period|Death|2|||
160834029|NCT00424190|580778312|FG000|Overall Study|Noncompliance|1|||
160834030|NCT00424190|580778313|FG001|Overall Study|Noncompliance|2|||
160834031|NCT00424190|580778312|FG000|Overall Study|Request of sponsor or investigator|0|||
160834032|NCT00424190|580778313|FG001|Overall Study|Request of sponsor or investigator|2|||
160834033|NCT00424190|580778312|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
160834034|NCT00424190|580778313|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
160834035|NCT00424190|580778312|FG000|Overall Study|Other|15|||
160834036|NCT00424190|580778313|FG001|Overall Study|Other|21|||
160834037|NCT01927055|580778318|FG000|Open-label|Adverse Event|6|||
160834038|NCT01927055|580778319|FG001|Open-label|Adverse Event|0|||
160834039|NCT01927055|580778320|FG002|Open-label|Adverse Event|0|||
160834040|NCT01927055|580778318|FG000|Open-label|Withdrawal by Subject|1|||
160834041|NCT01927055|580778319|FG001|Open-label|Withdrawal by Subject|0|||
160834042|NCT01927055|580778320|FG002|Open-label|Withdrawal by Subject|0|||
160834043|NCT01927055|580778318|FG000|Open-label|Study Stopped|4|||
160834044|NCT01927055|580778319|FG001|Open-label|Study Stopped|0|||
160834045|NCT01927055|580778320|FG002|Open-label|Study Stopped|0|||
160834046|NCT01927055|580778318|FG000|Open-label|Supine Hypertension|4|||
160834047|NCT01927055|580778319|FG001|Open-label|Supine Hypertension|0|||
160834048|NCT01927055|580778320|FG002|Open-label|Supine Hypertension|0|||
160834049|NCT01927055|580778318|FG000|Open-label|Difficulty attending study visits|1|||
160834050|NCT01927055|580778319|FG001|Open-label|Difficulty attending study visits|0|||
160834051|NCT01927055|580778320|FG002|Open-label|Difficulty attending study visits|0|||
160834052|NCT01927055|580778318|FG000|Double-Blind|Adverse Event|0|||
160834053|NCT01927055|580778319|FG001|Double-Blind|Adverse Event|1|||
160834054|NCT01927055|580778320|FG002|Double-Blind|Adverse Event|1|||
160834055|NCT01927055|580778318|FG000|Double-Blind|Protocol Violation|0|||
160834056|NCT01927055|580778319|FG001|Double-Blind|Protocol Violation|0|||
160834057|NCT01927055|580778320|FG002|Double-Blind|Protocol Violation|1|||
160834058|NCT01927055|580778318|FG000|Double-Blind|Withdrawal by Subject|0|||
160834059|NCT01927055|580778319|FG001|Double-Blind|Withdrawal by Subject|2|||
160834060|NCT01927055|580778320|FG002|Double-Blind|Withdrawal by Subject|3|||
160834061|NCT01927055|580778318|FG000|Double-Blind|Study Stopped|0|||
160834062|NCT01927055|580778319|FG001|Double-Blind|Study Stopped|7|||
160834063|NCT01927055|580778320|FG002|Double-Blind|Study Stopped|7|||
160834064|NCT01927055|580778318|FG000|Double-Blind|Supine Hypertension|0|||
160834065|NCT01927055|580778319|FG001|Double-Blind|Supine Hypertension|0|||
160834066|NCT01927055|580778320|FG002|Double-Blind|Supine Hypertension|1|||
160834067|NCT01927055|580778318|FG000|Double-Blind|Extended Vacation|0|||
160834068|NCT01927055|580778319|FG001|Double-Blind|Extended Vacation|1|||
160834069|NCT01927055|580778320|FG002|Double-Blind|Extended Vacation|0|||
160834070|NCT02598128|580778321|FG000|Period A: Days -7 to -1|Adverse Event|1|||
160834071|NCT02598128|580778322|FG001|Period A: Days -7 to -1|Adverse Event|0|||
160834072|NCT02598128|580778323|FG002|Period A: Days -7 to -1|Adverse Event|0|||
160834073|NCT02598128|580778324|FG003|Period A: Days -7 to -1|Adverse Event|0|||
160834074|NCT01378429|580778325|FG000|Overall Study|Noncompliance with study drug|1|||
160834075|NCT01378429|580778326|FG001|Overall Study|Noncompliance with study drug|0|||
160834076|NCT01064687|580778328|FG000|Overall Study|Adverse Event|9|||
160834077|NCT01064687|580778329|FG001|Overall Study|Adverse Event|4|||
160834078|NCT01064687|580778330|FG002|Overall Study|Adverse Event|10|||
160834079|NCT01064687|580778331|FG003|Overall Study|Adverse Event|3|||
160834080|NCT01064687|580778328|FG000|Overall Study|Death|1|||
160834081|NCT01064687|580778329|FG001|Overall Study|Death|1|||
160834082|NCT01064687|580778330|FG002|Overall Study|Death|0|||
160834083|NCT01064687|580778331|FG003|Overall Study|Death|0|||
160903722|NCT02993757|581040612|FG000|Overall Study|Non compliance with the protocol|155|||
160834084|NCT01064687|580778328|FG000|Overall Study|Entry Criteria Not Met|3|||
160834085|NCT01064687|580778329|FG001|Overall Study|Entry Criteria Not Met|0|||
160834086|NCT01064687|580778330|FG002|Overall Study|Entry Criteria Not Met|0|||
160834087|NCT01064687|580778331|FG003|Overall Study|Entry Criteria Not Met|0|||
160834088|NCT01064687|580778328|FG000|Overall Study|Lack of Efficacy|1|||
160834089|NCT01064687|580778329|FG001|Overall Study|Lack of Efficacy|0|||
160834090|NCT01064687|580778330|FG002|Overall Study|Lack of Efficacy|2|||
160834091|NCT01064687|580778331|FG003|Overall Study|Lack of Efficacy|3|||
160834092|NCT01064687|580778328|FG000|Overall Study|Lost to Follow-up|7|||
160834093|NCT01064687|580778329|FG001|Overall Study|Lost to Follow-up|10|||
160834094|NCT01064687|580778330|FG002|Overall Study|Lost to Follow-up|13|||
160834095|NCT01064687|580778331|FG003|Overall Study|Lost to Follow-up|5|||
160834096|NCT01064687|580778328|FG000|Overall Study|Physician Decision|2|||
160834097|NCT01064687|580778329|FG001|Overall Study|Physician Decision|2|||
160834098|NCT01064687|580778330|FG002|Overall Study|Physician Decision|0|||
160834099|NCT01064687|580778331|FG003|Overall Study|Physician Decision|0|||
160834100|NCT01064687|580778328|FG000|Overall Study|Protocol Violation|1|||
160834101|NCT01064687|580778329|FG001|Overall Study|Protocol Violation|1|||
160834102|NCT01064687|580778330|FG002|Overall Study|Protocol Violation|0|||
160834103|NCT01064687|580778331|FG003|Overall Study|Protocol Violation|1|||
160834104|NCT01064687|580778328|FG000|Overall Study|Sponsor Decision|0|||
160834105|NCT01064687|580778329|FG001|Overall Study|Sponsor Decision|0|||
160834106|NCT01064687|580778330|FG002|Overall Study|Sponsor Decision|3|||
160834107|NCT01064687|580778331|FG003|Overall Study|Sponsor Decision|0|||
160834108|NCT01064687|580778328|FG000|Overall Study|Withdrawal by Subject|9|||
160834109|NCT01064687|580778329|FG001|Overall Study|Withdrawal by Subject|7|||
160834110|NCT01064687|580778330|FG002|Overall Study|Withdrawal by Subject|12|||
160834111|NCT01064687|580778331|FG003|Overall Study|Withdrawal by Subject|5|||
160834112|NCT01064687|580778328|FG000|Overall Study|Treatment Noncompliance|1|||
160834113|NCT01064687|580778329|FG001|Overall Study|Treatment Noncompliance|1|||
160834114|NCT01064687|580778330|FG002|Overall Study|Treatment Noncompliance|1|||
160834115|NCT01064687|580778331|FG003|Overall Study|Treatment Noncompliance|0|||
160834116|NCT00619489|580778332|FG000|Overall Study|Adverse Event|0|||
160834117|NCT00619489|580778333|FG001|Overall Study|Adverse Event|7|||
160834118|NCT00619489|580778332|FG000|Overall Study|Withdrawal by Subject|1|||
160834119|NCT00619489|580778333|FG001|Overall Study|Withdrawal by Subject|1|||
160834120|NCT00619489|580778332|FG000|Overall Study|Lack of Efficacy|0|||
160834121|NCT00619489|580778333|FG001|Overall Study|Lack of Efficacy|11|||
160834122|NCT00619489|580778332|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
160834123|NCT00619489|580778333|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
160834124|NCT05219669|580778338|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
160834125|NCT05219669|580778339|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
160561660|NCT01707992|579777596|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
160561661|NCT01707992|579777597|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
160561662|NCT01707992|579777592|FG000|Active Treatment Phase (24 Months)|Death|0|||
160561663|NCT01707992|579777593|FG001|Active Treatment Phase (24 Months)|Death|0|||
160561664|NCT01707992|579777594|FG002|Active Treatment Phase (24 Months)|Death|0|||
160561665|NCT01707992|579777595|FG003|Active Treatment Phase (24 Months)|Death|2|||
160561666|NCT01707992|579777596|FG004|Active Treatment Phase (24 Months)|Death|0|||
160561667|NCT01707992|579777597|FG005|Active Treatment Phase (24 Months)|Death|0|||
160561668|NCT01707992|579777592|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
160561669|NCT01707992|579777593|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
160561670|NCT01707992|579777594|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
160561671|NCT01707992|579777595|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
160561672|NCT01707992|579777596|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
160561673|NCT01707992|579777597|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
160561674|NCT01707992|579777592|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
160561675|NCT01707992|579777593|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
160561676|NCT01707992|579777594|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
160561677|NCT01707992|579777595|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
160561678|NCT01707992|579777596|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
160561679|NCT01707992|579777597|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
160834126|NCT05219669|580778340|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
160834127|NCT05219669|580778341|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
160834128|NCT05219669|580778342|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
160834129|NCT05219669|580778343|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
160834130|NCT03134183|580778347|FG000|Overall Study|Withdrawal by Subject|1|||
160834131|NCT03134183|580778348|FG001|Overall Study|Withdrawal by Subject|1|||
160834132|NCT02404649|580778350|FG000|Overall Study|Adverse Event|1|||
160834133|NCT02404649|580778351|FG001|Overall Study|Adverse Event|2|||
160834134|NCT02299076|580778355|FG000|Overall Study|Fraudulent Entries|20|||
160834135|NCT02299076|580778356|FG001|Overall Study|Fraudulent Entries|14|||
160834136|NCT00162266|580778357|FG000|Double-Blind Period|Adverse Event|5|||
160834137|NCT00162266|580778358|FG001|Double-Blind Period|Adverse Event|9|||
160834138|NCT00162266|580778359|FG002|Double-Blind Period|Adverse Event|11|||
160834139|NCT00162266|580778360|FG003|Double-Blind Period|Adverse Event|0|||
160561680|NCT01707992|579777592|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
160561681|NCT01707992|579777593|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
160561682|NCT01707992|579777594|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
160561683|NCT01707992|579777595|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
160561684|NCT01707992|579777596|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
160561685|NCT01707992|579777597|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
160561686|NCT01707992|579777592|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
160561687|NCT01707992|579777593|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
160561688|NCT01707992|579777594|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
160561689|NCT01707992|579777595|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
160561690|NCT01707992|579777596|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
160561691|NCT01707992|579777597|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
160561692|NCT03498521|579777598|FG000|Overall Study|Death|227|||
160561693|NCT03498521|579777599|FG001|Overall Study|Death|79|||
160561694|NCT03498521|579777600|FG002|Overall Study|Death|84|||
160561695|NCT03498521|579777598|FG000|Overall Study|Exclusion criteria|1|||
160561696|NCT03498521|579777599|FG001|Overall Study|Exclusion criteria|0|||
160561697|NCT03498521|579777600|FG002|Overall Study|Exclusion criteria|0|||
160561698|NCT03498521|579777598|FG000|Overall Study|Lost to Follow-up|4|||
160561699|NCT03498521|579777599|FG001|Overall Study|Lost to Follow-up|3|||
160561700|NCT03498521|579777600|FG002|Overall Study|Lost to Follow-up|3|||
160561701|NCT03498521|579777598|FG000|Overall Study|No profile due to technical failure|1|||
160561702|NCT03498521|579777599|FG001|Overall Study|No profile due to technical failure|0|||
160561703|NCT03498521|579777600|FG002|Overall Study|No profile due to technical failure|0|||
160561704|NCT03498521|579777598|FG000|Overall Study|Physician Decision|3|||
160561705|NCT03498521|579777599|FG001|Overall Study|Physician Decision|1|||
160561706|NCT03498521|579777600|FG002|Overall Study|Physician Decision|0|||
160561707|NCT03498521|579777598|FG000|Overall Study|Withdrawal by Subject|11|||
160561708|NCT03498521|579777599|FG001|Overall Study|Withdrawal by Subject|6|||
160561709|NCT03498521|579777600|FG002|Overall Study|Withdrawal by Subject|2|||
160561710|NCT03498521|579777598|FG000|Overall Study|Study terminated by sponsor|79|||
160561711|NCT03498521|579777599|FG001|Overall Study|Study terminated by sponsor|21|||
160561712|NCT03498521|579777600|FG002|Overall Study|Study terminated by sponsor|4|||
160561713|NCT01552057|579779080|FG000|Overall Study|Adverse Event|14|||
160561714|NCT01552057|579779081|FG001|Overall Study|Adverse Event|15|||
160561715|NCT01552057|579779080|FG000|Overall Study|Lack of Efficacy|8|||
160561716|NCT01552057|579779081|FG001|Overall Study|Lack of Efficacy|23|||
160561717|NCT01552057|579779080|FG000|Overall Study|Withdrawal by Subject|5|||
160561718|NCT01552057|579779081|FG001|Overall Study|Withdrawal by Subject|8|||
160561719|NCT01552057|579779080|FG000|Overall Study|Entry Criteria Not Met|2|||
160561720|NCT01552057|579779081|FG001|Overall Study|Entry Criteria Not Met|2|||
160561721|NCT01552057|579779080|FG000|Overall Study|Physician Decision|1|||
160561722|NCT01552057|579779081|FG001|Overall Study|Physician Decision|0|||
160561723|NCT00476086|579779082|FG000|Overall Study|Alternative therapy|1|||
160561724|NCT00476086|579779082|FG000|Overall Study|Progressive Disease|4|||
160561725|NCT02900092|579779083|FG000|Overall Study|Adverse Event|1|||
160561726|NCT03895203|579779084|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
160561727|NCT03895203|579779085|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
160561728|NCT03895203|579779086|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
160561729|NCT03895203|579779087|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
160561730|NCT03895203|579779088|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
160561731|NCT03895203|579779089|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
160561732|NCT03895203|579779084|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
160561733|NCT03895203|579779085|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
160561734|NCT03895203|579779086|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
160561735|NCT03895203|579779087|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
160561736|NCT03895203|579779088|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
160561737|NCT03895203|579779089|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
160561738|NCT03895203|579779084|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
160561739|NCT03895203|579779085|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
160561740|NCT03895203|579779086|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
160561741|NCT03895203|579779087|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
160561742|NCT03895203|579779088|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
160561743|NCT03895203|579779089|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
160561744|NCT03895203|579779084|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
160561745|NCT03895203|579779085|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
160561746|NCT03895203|579779086|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
160561747|NCT03895203|579779087|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
160647613|NCT00416520|580092783|FG001|Open-label Period|Death|1|||
160561748|NCT03895203|579779088|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
160561749|NCT03895203|579779089|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
160561750|NCT03895203|579779084|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
160561751|NCT03895203|579779085|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
160561752|NCT03895203|579779086|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
160561753|NCT03895203|579779087|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
160561754|NCT03895203|579779088|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
160561755|NCT03895203|579779089|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
160561756|NCT03895203|579779084|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
160561757|NCT03895203|579779085|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
160561758|NCT03895203|579779086|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
160561759|NCT03895203|579779087|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
160561760|NCT03895203|579779088|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
160561761|NCT03895203|579779089|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
160561762|NCT03895203|579779084|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
160561763|NCT03895203|579779085|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
160561764|NCT03895203|579779086|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
160561765|NCT03895203|579779087|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
160561766|NCT03895203|579779088|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
160561767|NCT03895203|579779089|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
160561768|NCT03895203|579779084|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
160561769|NCT03895203|579779085|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
160561770|NCT03895203|579779086|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
160561771|NCT03895203|579779087|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
160561772|NCT03895203|579779088|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
160561773|NCT03895203|579779089|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
160561774|NCT03895203|579779084|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
160561775|NCT03895203|579779085|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
160561776|NCT03895203|579779086|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
160561777|NCT03895203|579779087|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
160561778|NCT03895203|579779088|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
160561779|NCT03895203|579779089|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
160561780|NCT03895203|579779084|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
160561781|NCT03895203|579779085|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
160561782|NCT03895203|579779086|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
160561783|NCT03895203|579779087|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
160561784|NCT03895203|579779088|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
160561785|NCT03895203|579779089|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
160561786|NCT03895203|579779084|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
160834140|NCT00162266|580778357|FG000|Double-Blind Period|Death|0|||
160834141|NCT00162266|580778358|FG001|Double-Blind Period|Death|1|||
160834142|NCT00162266|580778359|FG002|Double-Blind Period|Death|0|||
160834143|NCT00162266|580778360|FG003|Double-Blind Period|Death|0|||
160834144|NCT00162266|580778357|FG000|Double-Blind Period|Lost to Follow-up|1|||
160834145|NCT00162266|580778358|FG001|Double-Blind Period|Lost to Follow-up|2|||
160834146|NCT00162266|580778359|FG002|Double-Blind Period|Lost to Follow-up|0|||
160834147|NCT00162266|580778360|FG003|Double-Blind Period|Lost to Follow-up|0|||
160834148|NCT00162266|580778357|FG000|Double-Blind Period|Other Reason|1|||
160834149|NCT00162266|580778358|FG001|Double-Blind Period|Other Reason|0|||
160834150|NCT00162266|580778359|FG002|Double-Blind Period|Other Reason|1|||
160834151|NCT00162266|580778360|FG003|Double-Blind Period|Other Reason|0|||
160834152|NCT00162266|580778357|FG000|Double-Blind Period|Lack of Efficacy|13|||
160834153|NCT00162266|580778358|FG001|Double-Blind Period|Lack of Efficacy|17|||
160834154|NCT00162266|580778359|FG002|Double-Blind Period|Lack of Efficacy|30|||
160834155|NCT00162266|580778360|FG003|Double-Blind Period|Lack of Efficacy|0|||
160834156|NCT00162266|580778357|FG000|Double-Blind Period|Withdrawal by Subject|5|||
160834157|NCT00162266|580778358|FG001|Double-Blind Period|Withdrawal by Subject|2|||
160834158|NCT00162266|580778359|FG002|Double-Blind Period|Withdrawal by Subject|6|||
160834159|NCT00162266|580778360|FG003|Double-Blind Period|Withdrawal by Subject|0|||
160834160|NCT00162266|580778357|FG000|Open-Label Period|Death|0|||
160834161|NCT00162266|580778358|FG001|Open-Label Period|Death|0|||
160834162|NCT00162266|580778359|FG002|Open-Label Period|Death|0|||
160834163|NCT00162266|580778360|FG003|Open-Label Period|Death|7|||
160834164|NCT00162266|580778357|FG000|Open-Label Period|Adverse Event|0|||
160834165|NCT00162266|580778358|FG001|Open-Label Period|Adverse Event|0|||
160834166|NCT00162266|580778359|FG002|Open-Label Period|Adverse Event|0|||
160834167|NCT00162266|580778360|FG003|Open-Label Period|Adverse Event|46|||
160834168|NCT00162266|580778357|FG000|Open-Label Period|Lack of Efficacy|0|||
160834169|NCT00162266|580778358|FG001|Open-Label Period|Lack of Efficacy|0|||
160834170|NCT00162266|580778359|FG002|Open-Label Period|Lack of Efficacy|0|||
160834171|NCT00162266|580778360|FG003|Open-Label Period|Lack of Efficacy|26|||
160561787|NCT03895203|579779085|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
160561788|NCT03895203|579779086|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
160561789|NCT03895203|579779087|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
160561790|NCT03895203|579779088|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
160561791|NCT03895203|579779089|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
160561792|NCT03895203|579779084|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
160561793|NCT03895203|579779085|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
160561794|NCT03895203|579779086|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
160561795|NCT03895203|579779087|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
160561796|NCT03895203|579779088|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
160561797|NCT03895203|579779089|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
160561798|NCT03895203|579779084|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
160561799|NCT03895203|579779085|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
160561800|NCT03895203|579779086|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
160561801|NCT03895203|579779087|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
160561802|NCT03895203|579779088|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
160561803|NCT03895203|579779089|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
160561804|NCT03895203|579779084|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
160561805|NCT03895203|579779085|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
160561806|NCT03895203|579779086|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
160561807|NCT03895203|579779087|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
160561808|NCT03895203|579779088|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
160561809|NCT03895203|579779089|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
160561810|NCT01389245|579779090|FG000|Overall Study|Protocol Violation|10|||
160561811|NCT01389245|579779090|FG000|Overall Study|Lost to Follow-up|3|||
160561812|NCT01389245|579779090|FG000|Overall Study|Withdrawal by Subject|2|||
160561813|NCT05540652|579779091|FG000|Overall Study|Withdrawal by Subject|1|||
160561814|NCT05113940|579779092|FG000|Part A (18 Days)|Adverse Event|0|||
160561815|NCT05113940|579779093|FG001|Part A (18 Days)|Adverse Event|0|||
160561816|NCT05113940|579779094|FG002|Part A (18 Days)|Adverse Event|1|||
160561817|NCT05113940|579779095|FG003|Part A (18 Days)|Adverse Event|1|||
160561818|NCT05113940|579779096|FG004|Part A (18 Days)|Adverse Event|1|||
160561819|NCT05113940|579779097|FG005|Part A (18 Days)|Adverse Event|0|||
160561820|NCT05113940|579779098|FG006|Part A (18 Days)|Adverse Event|0|||
160561821|NCT05113940|579779099|FG007|Part A (18 Days)|Adverse Event|0|||
160561822|NCT05113940|579779100|FG008|Part A (18 Days)|Adverse Event|0|||
160561823|NCT05113940|579779101|FG009|Part A (18 Days)|Adverse Event|0|||
160561824|NCT05113940|579779102|FG010|Part A (18 Days)|Adverse Event|0|||
160561825|NCT05113940|579779103|FG011|Part A (18 Days)|Adverse Event|2|||
160561826|NCT05113940|579779104|FG012|Part A (18 Days)|Adverse Event|0|||
160561827|NCT05113940|579779105|FG013|Part A (18 Days)|Adverse Event|0|||
160561828|NCT05113940|579779106|FG014|Part A (18 Days)|Adverse Event|0|||
160834172|NCT00162266|580778357|FG000|Open-Label Period|Lost to Follow-up|0|||
160834173|NCT00162266|580778358|FG001|Open-Label Period|Lost to Follow-up|0|||
160834174|NCT00162266|580778359|FG002|Open-Label Period|Lost to Follow-up|0|||
160834175|NCT00162266|580778360|FG003|Open-Label Period|Lost to Follow-up|3|||
160834176|NCT00162266|580778357|FG000|Open-Label Period|Withdrawal by Subject|0|||
160834177|NCT00162266|580778358|FG001|Open-Label Period|Withdrawal by Subject|0|||
160834178|NCT00162266|580778359|FG002|Open-Label Period|Withdrawal by Subject|0|||
160834179|NCT00162266|580778360|FG003|Open-Label Period|Withdrawal by Subject|31|||
160834180|NCT00162266|580778357|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
160834181|NCT00162266|580778358|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
160834182|NCT00162266|580778359|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
160834183|NCT00162266|580778360|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
160834184|NCT00162266|580778357|FG000|Open-Label Period|Other Reasons|0|||
160834185|NCT00162266|580778358|FG001|Open-Label Period|Other Reasons|0|||
160561829|NCT05113940|579779092|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561830|NCT05113940|579779093|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
160834186|NCT00162266|580778359|FG002|Open-Label Period|Other Reasons|0|||
160561831|NCT05113940|579779094|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561832|NCT05113940|579779095|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561833|NCT05113940|579779096|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561834|NCT05113940|579779097|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561835|NCT05113940|579779098|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561836|NCT05113940|579779099|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561837|NCT05113940|579779100|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561838|NCT05113940|579779101|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
160834187|NCT00162266|580778360|FG003|Open-Label Period|Other Reasons|15|||
160561839|NCT05113940|579779102|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561840|NCT05113940|579779103|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561841|NCT05113940|579779104|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561842|NCT05113940|579779105|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
160561843|NCT05113940|579779106|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
160561844|NCT04454489|579779107|FG000|Overall Study|Disease progression|12|||
160561845|NCT04454489|579779107|FG000|Overall Study|Death|4|||
160561846|NCT04454489|579779107|FG000|Overall Study|Adverse Event|1|||
160561847|NCT04454489|579779107|FG000|Overall Study|Physician Decision|1|||
160561848|NCT01756274|579779111|FG000|Overall Study|Protocol Violation|2|||
160561849|NCT01756274|579779111|FG000|Overall Study|Laboratory error|1|||
160561850|NCT03514914|579779112|FG000|Overall Study|Death|3|||
160561851|NCT03514914|579779113|FG001|Overall Study|Death|3|||
160561852|NCT03514914|579779112|FG000|Overall Study|Lost to Follow-up|117|||
160561853|NCT03514914|579779113|FG001|Overall Study|Lost to Follow-up|89|||
160561854|NCT03926143|579779119|FG000|Overall Study|Physician Decision|3|||
160561855|NCT03926143|579779119|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
160561856|NCT03926143|579779119|FG000|Overall Study|Adverse Event|2|||
160561857|NCT03926143|579779119|FG000|Overall Study|Progressive disease|3|||
160561858|NCT00727402|579779122|FG000|Overall Study|Physician Decision|116|||
160561859|NCT01818297|579779123|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
160561860|NCT01818297|579779124|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
160561861|NCT01818297|579779123|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
160561862|NCT01818297|579779124|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
160561863|NCT01818297|579779123|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
160561864|NCT01818297|579779124|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
160561865|NCT00481065|579779125|FG000|Overall Study|Adverse event or death|1|||
160561866|NCT00481065|579779126|FG001|Overall Study|Adverse event or death|1|||
160561867|NCT00481065|579779127|FG002|Overall Study|Adverse event or death|3|||
160561868|NCT00481065|579779128|FG003|Overall Study|Adverse event or death|0|||
160561869|NCT00481065|579779129|FG004|Overall Study|Adverse event or death|2|||
160561870|NCT00481065|579779130|FG005|Overall Study|Adverse event or death|0|||
160561871|NCT00481065|579779131|FG006|Overall Study|Adverse event or death|1|||
160561872|NCT00481065|579779132|FG007|Overall Study|Adverse event or death|1|||
160561873|NCT00481065|579779125|FG000|Overall Study|Withdrawal by Subject|11|||
160561874|NCT00481065|579779126|FG001|Overall Study|Withdrawal by Subject|12|||
160561875|NCT00481065|579779127|FG002|Overall Study|Withdrawal by Subject|7|||
160561876|NCT00481065|579779128|FG003|Overall Study|Withdrawal by Subject|11|||
160561877|NCT00481065|579779129|FG004|Overall Study|Withdrawal by Subject|13|||
160561878|NCT00481065|579779130|FG005|Overall Study|Withdrawal by Subject|12|||
160561879|NCT00481065|579779131|FG006|Overall Study|Withdrawal by Subject|9|||
160561880|NCT00481065|579779132|FG007|Overall Study|Withdrawal by Subject|10|||
160561881|NCT00481065|579779125|FG000|Overall Study|Lost to Follow-up|4|||
160561882|NCT00481065|579779126|FG001|Overall Study|Lost to Follow-up|2|||
160561883|NCT00481065|579779127|FG002|Overall Study|Lost to Follow-up|4|||
160561884|NCT00481065|579779128|FG003|Overall Study|Lost to Follow-up|3|||
160561885|NCT00481065|579779129|FG004|Overall Study|Lost to Follow-up|3|||
160561886|NCT00481065|579779130|FG005|Overall Study|Lost to Follow-up|3|||
160561887|NCT00481065|579779131|FG006|Overall Study|Lost to Follow-up|2|||
160561888|NCT00481065|579779132|FG007|Overall Study|Lost to Follow-up|5|||
160561889|NCT00481065|579779125|FG000|Overall Study|Inappropriate enrollment|4|||
160561890|NCT00481065|579779126|FG001|Overall Study|Inappropriate enrollment|0|||
160561891|NCT00481065|579779127|FG002|Overall Study|Inappropriate enrollment|2|||
160561892|NCT00481065|579779128|FG003|Overall Study|Inappropriate enrollment|0|||
160561893|NCT00481065|579779129|FG004|Overall Study|Inappropriate enrollment|2|||
160991267|NCT01959880|581355567|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
160991268|NCT01959880|581355568|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
160991269|NCT01959880|581355569|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
160991270|NCT01959880|581355570|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
160991271|NCT01959880|581355567|FG000|Overall Study|Study completed early-FDA approved|1003|||
160991272|NCT01959880|581355568|FG001|Overall Study|Study completed early-FDA approved|311|||
160561894|NCT00481065|579779130|FG005|Overall Study|Inappropriate enrollment|1|||
160561895|NCT00481065|579779131|FG006|Overall Study|Inappropriate enrollment|0|||
160561896|NCT00481065|579779132|FG007|Overall Study|Inappropriate enrollment|1|||
160561897|NCT00481065|579779125|FG000|Overall Study|Administrative reason|0|||
160561898|NCT00481065|579779126|FG001|Overall Study|Administrative reason|0|||
160561899|NCT00481065|579779127|FG002|Overall Study|Administrative reason|0|||
160561900|NCT00481065|579779128|FG003|Overall Study|Administrative reason|0|||
160647614|NCT00416520|580092784|FG002|Open-label Period|Death|0|||
160561901|NCT00481065|579779129|FG004|Overall Study|Administrative reason|0|||
160561902|NCT00481065|579779130|FG005|Overall Study|Administrative reason|2|||
160561903|NCT00481065|579779131|FG006|Overall Study|Administrative reason|1|||
160561904|NCT00481065|579779132|FG007|Overall Study|Administrative reason|0|||
160561905|NCT00481065|579779125|FG000|Overall Study|Protocol Violation|2|||
160561906|NCT00481065|579779126|FG001|Overall Study|Protocol Violation|1|||
160561907|NCT00481065|579779127|FG002|Overall Study|Protocol Violation|1|||
160991273|NCT01959880|581355569|FG002|Overall Study|Study completed early-FDA approved|179|||
160561908|NCT00481065|579779128|FG003|Overall Study|Protocol Violation|1|||
160561909|NCT00481065|579779129|FG004|Overall Study|Protocol Violation|2|||
160561910|NCT00481065|579779130|FG005|Overall Study|Protocol Violation|6|||
160561911|NCT00481065|579779131|FG006|Overall Study|Protocol Violation|3|||
160561912|NCT00481065|579779132|FG007|Overall Study|Protocol Violation|2|||
160561913|NCT00481065|579779125|FG000|Overall Study|Unable to classify|0|||
160561914|NCT00481065|579779126|FG001|Overall Study|Unable to classify|1|||
160561915|NCT00481065|579779127|FG002|Overall Study|Unable to classify|2|||
160561916|NCT00481065|579779128|FG003|Overall Study|Unable to classify|0|||
160561917|NCT00481065|579779129|FG004|Overall Study|Unable to classify|1|||
160561918|NCT00481065|579779130|FG005|Overall Study|Unable to classify|0|||
160561919|NCT00481065|579779131|FG006|Overall Study|Unable to classify|0|||
160561920|NCT00481065|579779132|FG007|Overall Study|Unable to classify|0|||
160561921|NCT00772447|579779133|FG000|Overall Study|Withdrawal by Subject|9|||
160561922|NCT00772447|579779134|FG001|Overall Study|Withdrawal by Subject|5|||
160561923|NCT00772447|579779133|FG000|Overall Study|Physician Decision|4|||
160561924|NCT00772447|579779134|FG001|Overall Study|Physician Decision|8|||
160561925|NCT00772447|579779133|FG000|Overall Study|Lost to Follow-up|2|||
160561926|NCT00772447|579779134|FG001|Overall Study|Lost to Follow-up|4|||
160561927|NCT00772447|579779133|FG000|Overall Study|incorrect enrolment|3|||
160561928|NCT00772447|579779134|FG001|Overall Study|incorrect enrolment|4|||
160561929|NCT00772447|579779133|FG000|Overall Study|Protocol Violation|0|||
160561930|NCT00772447|579779134|FG001|Overall Study|Protocol Violation|1|||
160561931|NCT00772447|579779133|FG000|Overall Study|all others|2|||
160834188|NCT00330668|580778361|FG000|BID Dosing Period|Adverse Event|1|||
160834189|NCT00330668|580778361|FG000|BID Dosing Period|Lost to Follow-up|7|||
160561932|NCT00772447|579779134|FG001|Overall Study|all others|2|||
160561933|NCT04439344|579779135|FG000|Overall Study|Never started threapy|3|||
160561934|NCT04439344|579779135|FG000|Overall Study|Ineligible|3|||
160561935|NCT04439344|579779135|FG000|Overall Study|Adverse Event|13|||
160561936|NCT04439344|579779135|FG000|Overall Study|Death|2|||
160561937|NCT04439344|579779135|FG000|Overall Study|Disease progression|29|||
160561938|NCT04439344|579779135|FG000|Overall Study|Withdrawal by Subject|2|||
160561939|NCT04439344|579779135|FG000|Overall Study|Alternative therapy|1|||
160561940|NCT03770403|579779141|FG000|Overall Study|Adverse Event|8|||
160561941|NCT03770403|579779141|FG000|Overall Study|Death|5|||
160834190|NCT00330668|580778361|FG000|BID Dosing Period|Non-Compliance|5|||
160834191|NCT00330668|580778361|FG000|BID Dosing Period|Withdrawal by Subject|19|||
160834192|NCT00330668|580778361|FG000|BID Dosing Period|Sponsor's decision|1|||
160561942|NCT03770403|579779141|FG000|Overall Study|Physician Decision|1|||
160561943|NCT03770403|579779141|FG000|Overall Study|Sponsor decision|1|||
160561944|NCT03770403|579779141|FG000|Overall Study|Study terminated by Sponsor|1|||
160561945|NCT03770403|579779141|FG000|Overall Study|Withdrawal by Subject|13|||
160561946|NCT03770403|579779141|FG000|Overall Study|Other|88|||
160561947|NCT03896295|579779142|FG000|Overall Study|Adverse Event|0|||
160561948|NCT03896295|579779143|FG001|Overall Study|Adverse Event|1|||
160561949|NCT03896295|579779142|FG000|Overall Study|COVID-19|7|||
160561950|NCT03896295|579779143|FG001|Overall Study|COVID-19|29|||
160561951|NCT01957137|579779144|FG000|Randomized Portion|Adverse Event|1|||
160561952|NCT01957137|579779144|FG000|Randomized Portion|Withdrawal by Subject|1|||
160561953|NCT00700804|579779156|FG000|Overall Study|Withdrawal by Subject|1|||
160561954|NCT00700804|579779157|FG001|Overall Study|Withdrawal by Subject|2|||
160561955|NCT00700804|579779156|FG000|Overall Study|Protocol Violation|1|||
160561956|NCT00700804|579779157|FG001|Overall Study|Protocol Violation|1|||
160561957|NCT00700804|579779156|FG000|Overall Study|Loose Stools|1|||
160561958|NCT00700804|579779157|FG001|Overall Study|Loose Stools|1|||
160561959|NCT02901431|579779158|FG000|PK Part|Adverse Event|0|||
160561960|NCT02901431|579779159|FG001|PK Part|Adverse Event|1|||
160561961|NCT02901431|579779160|FG002|PK Part|Adverse Event|0|||
160561962|NCT02901431|579779161|FG003|PK Part|Adverse Event|0|||
160561963|NCT02901431|579779162|FG004|PK Part|Adverse Event|0|||
160561964|NCT02901431|579779163|FG005|PK Part|Adverse Event|0|||
160647615|NCT00416520|580092785|FG003|Open-label Period|Death|0|||
160834193|NCT00330668|580778361|FG000|BID Dosing Period|Other|3|||
160834194|NCT00330668|580778361|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
160834195|NCT00330668|580778361|FG000|QD Dosing Period|Other|1|||
160561965|NCT02901431|579779164|FG006|PK Part|Adverse Event|0|||
160561966|NCT02901431|579779165|FG007|PK Part|Adverse Event|0|||
160561967|NCT02901431|579779166|FG008|PK Part|Adverse Event|0|||
160561968|NCT02901431|579779167|FG009|PK Part|Adverse Event|0|||
160561969|NCT02901431|579779168|FG010|PK Part|Adverse Event|0|||
160561970|NCT02901431|579779169|FG011|PK Part|Adverse Event|0|||
160903723|NCT02993757|581040613|FG001|Overall Study|Non compliance with the protocol|170|||
160561971|NCT02901431|579779170|FG012|PK Part|Adverse Event|0|||
160561972|NCT02901431|579779158|FG000|PK Part|Lost to Follow-up|0|||
160561973|NCT02901431|579779159|FG001|PK Part|Lost to Follow-up|0|||
160561974|NCT02901431|579779160|FG002|PK Part|Lost to Follow-up|1|||
160561975|NCT02901431|579779161|FG003|PK Part|Lost to Follow-up|0|||
160561976|NCT02901431|579779162|FG004|PK Part|Lost to Follow-up|0|||
160561977|NCT02901431|579779163|FG005|PK Part|Lost to Follow-up|0|||
160561978|NCT02901431|579779164|FG006|PK Part|Lost to Follow-up|0|||
160561979|NCT02901431|579779165|FG007|PK Part|Lost to Follow-up|0|||
160647616|NCT00416520|580092782|FG000|Open-label Period|Lack of Efficacy|8|||
160647617|NCT00416520|580092783|FG001|Open-label Period|Lack of Efficacy|1|||
160647618|NCT00416520|580092784|FG002|Open-label Period|Lack of Efficacy|0|||
160561980|NCT02901431|579779166|FG008|PK Part|Lost to Follow-up|0|||
160561981|NCT02901431|579779167|FG009|PK Part|Lost to Follow-up|0|||
160561982|NCT02901431|579779168|FG010|PK Part|Lost to Follow-up|0|||
160561983|NCT02901431|579779169|FG011|PK Part|Lost to Follow-up|0|||
160561984|NCT02901431|579779170|FG012|PK Part|Lost to Follow-up|0|||
160561985|NCT02901431|579779158|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
160561986|NCT02901431|579779159|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561987|NCT02901431|579779160|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561988|NCT02901431|579779161|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561989|NCT02901431|579779162|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561990|NCT02901431|579779163|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561991|NCT02901431|579779164|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561992|NCT02901431|579779165|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561993|NCT02901431|579779166|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561994|NCT02901431|579779167|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561995|NCT02901431|579779168|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561996|NCT02901431|579779169|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561997|NCT02901431|579779170|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160561998|NCT02901431|579779158|FG000|PK Part|Pending dose confirmation|0|||
160561999|NCT02901431|579779159|FG001|PK Part|Pending dose confirmation|1|||
160562000|NCT02901431|579779160|FG002|PK Part|Pending dose confirmation|0|||
160562001|NCT02901431|579779161|FG003|PK Part|Pending dose confirmation|0|||
160562002|NCT02901431|579779162|FG004|PK Part|Pending dose confirmation|0|||
160562003|NCT02901431|579779163|FG005|PK Part|Pending dose confirmation|0|||
160562004|NCT02901431|579779164|FG006|PK Part|Pending dose confirmation|0|||
160562005|NCT02901431|579779165|FG007|PK Part|Pending dose confirmation|0|||
160562006|NCT02901431|579779166|FG008|PK Part|Pending dose confirmation|0|||
160562007|NCT02901431|579779167|FG009|PK Part|Pending dose confirmation|0|||
160562008|NCT02901431|579779168|FG010|PK Part|Pending dose confirmation|0|||
160562009|NCT02901431|579779169|FG011|PK Part|Pending dose confirmation|0|||
160562010|NCT02901431|579779170|FG012|PK Part|Pending dose confirmation|0|||
160562011|NCT02901431|579779158|FG000|PK Part|8 weeks of treatment ran out|2|||
160562012|NCT02901431|579779159|FG001|PK Part|8 weeks of treatment ran out|0|||
160562013|NCT02901431|579779160|FG002|PK Part|8 weeks of treatment ran out|0|||
160562014|NCT02901431|579779161|FG003|PK Part|8 weeks of treatment ran out|0|||
160562015|NCT02901431|579779162|FG004|PK Part|8 weeks of treatment ran out|0|||
160562016|NCT02901431|579779163|FG005|PK Part|8 weeks of treatment ran out|0|||
160562017|NCT02901431|579779164|FG006|PK Part|8 weeks of treatment ran out|0|||
160562018|NCT02901431|579779165|FG007|PK Part|8 weeks of treatment ran out|0|||
160562019|NCT02901431|579779166|FG008|PK Part|8 weeks of treatment ran out|0|||
160562020|NCT02901431|579779167|FG009|PK Part|8 weeks of treatment ran out|0|||
160562021|NCT02901431|579779168|FG010|PK Part|8 weeks of treatment ran out|0|||
160562022|NCT02901431|579779169|FG011|PK Part|8 weeks of treatment ran out|0|||
160562023|NCT02901431|579779170|FG012|PK Part|8 weeks of treatment ran out|0|||
160562024|NCT02901431|579779158|FG000|PK Part|Stopped treatment after 8 weeks|1|||
160562025|NCT02901431|579779159|FG001|PK Part|Stopped treatment after 8 weeks|0|||
160647619|NCT00416520|580092785|FG003|Open-label Period|Lack of Efficacy|0|||
160647620|NCT00416520|580092782|FG000|Open-label Period|Protocol Violation|3|||
160647621|NCT00416520|580092783|FG001|Open-label Period|Protocol Violation|3|||
160647622|NCT00416520|580092784|FG002|Open-label Period|Protocol Violation|0|||
160647623|NCT00416520|580092785|FG003|Open-label Period|Protocol Violation|0|||
160647624|NCT00416520|580092782|FG000|Open-label Period|Withdrawal by Subject|16|||
160647625|NCT00416520|580092783|FG001|Open-label Period|Withdrawal by Subject|5|||
160647626|NCT00416520|580092784|FG002|Open-label Period|Withdrawal by Subject|0|||
160647627|NCT00416520|580092785|FG003|Open-label Period|Withdrawal by Subject|0|||
160647628|NCT00416520|580092782|FG000|Open-label Period|Other Reasons|3|||
160647629|NCT00416520|580092783|FG001|Open-label Period|Other Reasons|12|||
160562026|NCT02901431|579779160|FG002|PK Part|Stopped treatment after 8 weeks|1|||
160562027|NCT02901431|579779161|FG003|PK Part|Stopped treatment after 8 weeks|0|||
160562028|NCT02901431|579779162|FG004|PK Part|Stopped treatment after 8 weeks|0|||
160562029|NCT02901431|579779163|FG005|PK Part|Stopped treatment after 8 weeks|0|||
160562030|NCT02901431|579779164|FG006|PK Part|Stopped treatment after 8 weeks|0|||
160562031|NCT02901431|579779165|FG007|PK Part|Stopped treatment after 8 weeks|0|||
160562032|NCT02901431|579779166|FG008|PK Part|Stopped treatment after 8 weeks|0|||
160562033|NCT02901431|579779167|FG009|PK Part|Stopped treatment after 8 weeks|0|||
160562034|NCT02901431|579779168|FG010|PK Part|Stopped treatment after 8 weeks|0|||
160562035|NCT02901431|579779169|FG011|PK Part|Stopped treatment after 8 weeks|0|||
160647630|NCT00416520|580092784|FG002|Open-label Period|Other Reasons|0|||
160562036|NCT02901431|579779170|FG012|PK Part|Stopped treatment after 8 weeks|0|||
160562037|NCT02901431|579779158|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
160562038|NCT02901431|579779159|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562039|NCT02901431|579779160|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
160562040|NCT02901431|579779161|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562041|NCT02901431|579779162|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562042|NCT02901431|579779163|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562043|NCT02901431|579779164|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562044|NCT02901431|579779165|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562045|NCT02901431|579779166|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562046|NCT02901431|579779167|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562047|NCT02901431|579779168|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562048|NCT02901431|579779169|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562049|NCT02901431|579779170|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
160562050|NCT02901431|579779158|FG000|PK Part|Discontinued per Sponsor|0|||
160562051|NCT02901431|579779159|FG001|PK Part|Discontinued per Sponsor|3|||
160562052|NCT02901431|579779160|FG002|PK Part|Discontinued per Sponsor|0|||
160562053|NCT02901431|579779161|FG003|PK Part|Discontinued per Sponsor|0|||
160834196|NCT00330668|580778361|FG000|QD Dosing Period|Withdrawal by Subject|1|||
160834197|NCT00330668|580778361|FG000|QD Dosing Period|Lost to Follow-up|2|||
160834198|NCT00499746|580778367|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
160834199|NCT00499746|580778367|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
160834200|NCT00499746|580778367|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
160834201|NCT00499746|580778367|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
160834202|NCT04311463|580778368|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
160834203|NCT04311463|580778369|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
160562054|NCT02901431|579779162|FG004|PK Part|Discontinued per Sponsor|0|||
160562055|NCT02901431|579779163|FG005|PK Part|Discontinued per Sponsor|0|||
160562056|NCT02901431|579779164|FG006|PK Part|Discontinued per Sponsor|0|||
160562057|NCT02901431|579779165|FG007|PK Part|Discontinued per Sponsor|0|||
160562058|NCT02901431|579779166|FG008|PK Part|Discontinued per Sponsor|0|||
160562059|NCT02901431|579779167|FG009|PK Part|Discontinued per Sponsor|0|||
160562060|NCT02901431|579779168|FG010|PK Part|Discontinued per Sponsor|0|||
160562061|NCT02901431|579779169|FG011|PK Part|Discontinued per Sponsor|0|||
160562062|NCT02901431|579779170|FG012|PK Part|Discontinued per Sponsor|0|||
160562063|NCT02901431|579779158|FG000|PK Part|Withdrawal by Subject|1|||
160562064|NCT02901431|579779159|FG001|PK Part|Withdrawal by Subject|1|||
160562065|NCT02901431|579779160|FG002|PK Part|Withdrawal by Subject|3|||
160562066|NCT02901431|579779161|FG003|PK Part|Withdrawal by Subject|0|||
160562067|NCT02901431|579779162|FG004|PK Part|Withdrawal by Subject|0|||
160562068|NCT02901431|579779163|FG005|PK Part|Withdrawal by Subject|0|||
160562069|NCT02901431|579779164|FG006|PK Part|Withdrawal by Subject|0|||
160562070|NCT02901431|579779165|FG007|PK Part|Withdrawal by Subject|0|||
160562071|NCT02901431|579779166|FG008|PK Part|Withdrawal by Subject|0|||
160562072|NCT02901431|579779167|FG009|PK Part|Withdrawal by Subject|0|||
160562073|NCT02901431|579779168|FG010|PK Part|Withdrawal by Subject|0|||
160562074|NCT02901431|579779169|FG011|PK Part|Withdrawal by Subject|0|||
160562075|NCT02901431|579779170|FG012|PK Part|Withdrawal by Subject|0|||
160562076|NCT02901431|579779158|FG000|Main Treatment Part|Adverse Event|0|||
160562077|NCT02901431|579779159|FG001|Main Treatment Part|Adverse Event|0|||
160562078|NCT02901431|579779160|FG002|Main Treatment Part|Adverse Event|0|||
160562079|NCT02901431|579779161|FG003|Main Treatment Part|Adverse Event|3|||
160562080|NCT02901431|579779162|FG004|Main Treatment Part|Adverse Event|3|||
160562081|NCT02901431|579779163|FG005|Main Treatment Part|Adverse Event|4|||
160562082|NCT02901431|579779164|FG006|Main Treatment Part|Adverse Event|1|||
160562083|NCT02901431|579779165|FG007|Main Treatment Part|Adverse Event|0|||
160562084|NCT02901431|579779166|FG008|Main Treatment Part|Adverse Event|0|||
160562085|NCT02901431|579779167|FG009|Main Treatment Part|Adverse Event|0|||
160562086|NCT02901431|579779168|FG010|Main Treatment Part|Adverse Event|0|||
160562087|NCT02901431|579779169|FG011|Main Treatment Part|Adverse Event|0|||
160562088|NCT02901431|579779170|FG012|Main Treatment Part|Adverse Event|0|||
160562089|NCT02901431|579779158|FG000|Main Treatment Part|Lack of Efficacy|0|||
160562090|NCT02901431|579779159|FG001|Main Treatment Part|Lack of Efficacy|0|||
160562091|NCT02901431|579779160|FG002|Main Treatment Part|Lack of Efficacy|0|||
160562092|NCT02901431|579779161|FG003|Main Treatment Part|Lack of Efficacy|1|||
160562093|NCT02901431|579779162|FG004|Main Treatment Part|Lack of Efficacy|0|||
160562094|NCT02901431|579779163|FG005|Main Treatment Part|Lack of Efficacy|0|||
160562095|NCT02901431|579779164|FG006|Main Treatment Part|Lack of Efficacy|0|||
160562096|NCT02901431|579779165|FG007|Main Treatment Part|Lack of Efficacy|0|||
160562097|NCT02901431|579779166|FG008|Main Treatment Part|Lack of Efficacy|0|||
160562098|NCT02901431|579779167|FG009|Main Treatment Part|Lack of Efficacy|0|||
160562099|NCT02901431|579779168|FG010|Main Treatment Part|Lack of Efficacy|0|||
160562100|NCT02901431|579779169|FG011|Main Treatment Part|Lack of Efficacy|0|||
160562101|NCT02901431|579779170|FG012|Main Treatment Part|Lack of Efficacy|0|||
160562102|NCT02901431|579779158|FG000|Main Treatment Part|Lost to Follow-up|0|||
160903724|NCT02993757|581040612|FG000|Overall Study|Lost to Follow-up|1|||
160903725|NCT02993757|581040613|FG001|Overall Study|Lost to Follow-up|0|||
160562103|NCT02901431|579779159|FG001|Main Treatment Part|Lost to Follow-up|0|||
160562104|NCT02901431|579779160|FG002|Main Treatment Part|Lost to Follow-up|0|||
160562105|NCT02901431|579779161|FG003|Main Treatment Part|Lost to Follow-up|3|||
160562106|NCT02901431|579779162|FG004|Main Treatment Part|Lost to Follow-up|1|||
160562107|NCT02901431|579779163|FG005|Main Treatment Part|Lost to Follow-up|2|||
160562108|NCT02901431|579779164|FG006|Main Treatment Part|Lost to Follow-up|3|||
160562109|NCT02901431|579779165|FG007|Main Treatment Part|Lost to Follow-up|0|||
160562110|NCT02901431|579779166|FG008|Main Treatment Part|Lost to Follow-up|0|||
160562111|NCT02901431|579779167|FG009|Main Treatment Part|Lost to Follow-up|0|||
160562112|NCT02901431|579779168|FG010|Main Treatment Part|Lost to Follow-up|0|||
160562113|NCT02901431|579779169|FG011|Main Treatment Part|Lost to Follow-up|0|||
160562114|NCT02901431|579779170|FG012|Main Treatment Part|Lost to Follow-up|0|||
160562115|NCT02901431|579779158|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
160562116|NCT02901431|579779159|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
160562117|NCT02901431|579779160|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
160562118|NCT02901431|579779161|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
160562119|NCT02901431|579779162|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
160562120|NCT02901431|579779163|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
160562121|NCT02901431|579779164|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
160562122|NCT02901431|579779165|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
160562123|NCT02901431|579779166|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
160562124|NCT02901431|579779167|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
160562125|NCT02901431|579779168|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
160562126|NCT02901431|579779169|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
160562127|NCT02901431|579779170|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
160562128|NCT02901431|579779158|FG000|Main Treatment Part|Physician Decision|0|||
160562129|NCT02901431|579779159|FG001|Main Treatment Part|Physician Decision|0|||
160562130|NCT02901431|579779160|FG002|Main Treatment Part|Physician Decision|0|||
160562131|NCT02901431|579779161|FG003|Main Treatment Part|Physician Decision|1|||
160562132|NCT02901431|579779162|FG004|Main Treatment Part|Physician Decision|0|||
160562133|NCT02901431|579779163|FG005|Main Treatment Part|Physician Decision|0|||
160562134|NCT02901431|579779164|FG006|Main Treatment Part|Physician Decision|1|||
160562135|NCT02901431|579779165|FG007|Main Treatment Part|Physician Decision|0|||
160562136|NCT02901431|579779166|FG008|Main Treatment Part|Physician Decision|0|||
160562137|NCT02901431|579779167|FG009|Main Treatment Part|Physician Decision|0|||
160562138|NCT02901431|579779168|FG010|Main Treatment Part|Physician Decision|0|||
160562139|NCT02901431|579779169|FG011|Main Treatment Part|Physician Decision|0|||
160562140|NCT02901431|579779170|FG012|Main Treatment Part|Physician Decision|0|||
160562141|NCT02901431|579779158|FG000|Main Treatment Part|Withdrawal by Subject|0|||
160562142|NCT02901431|579779159|FG001|Main Treatment Part|Withdrawal by Subject|0|||
160562143|NCT02901431|579779160|FG002|Main Treatment Part|Withdrawal by Subject|0|||
160562144|NCT02901431|579779161|FG003|Main Treatment Part|Withdrawal by Subject|18|||
160562145|NCT02901431|579779162|FG004|Main Treatment Part|Withdrawal by Subject|3|||
160562146|NCT02901431|579779163|FG005|Main Treatment Part|Withdrawal by Subject|5|||
160562147|NCT02901431|579779164|FG006|Main Treatment Part|Withdrawal by Subject|6|||
160834204|NCT04311463|580778368|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
160834205|NCT04311463|580778369|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
160834206|NCT04311463|580778368|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
160834207|NCT04311463|580778369|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
160834208|NCT00737633|580778376|FG000|Overall Study|Study terminated by sponsor|44|||
160834209|NCT00737633|580778377|FG001|Overall Study|Study terminated by sponsor|55|||
160834210|NCT00737633|580778376|FG000|Overall Study|Lost to Follow-up|0|||
160834211|NCT00737633|580778377|FG001|Overall Study|Lost to Follow-up|1|||
160834212|NCT00737633|580778376|FG000|Overall Study|protocol non-compliance|0|||
160834213|NCT00737633|580778377|FG001|Overall Study|protocol non-compliance|1|||
160834214|NCT03480009|580778381|FG000|Overall Study|Lost to Follow-up|4|||
160834215|NCT03480009|580778382|FG001|Overall Study|Lost to Follow-up|5|||
160834216|NCT03480009|580778383|FG002|Overall Study|Lost to Follow-up|4|||
160834217|NCT03480009|580778384|FG003|Overall Study|Lost to Follow-up|0|||
160834218|NCT02014584|580778385|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
160834219|NCT02014584|580778386|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
160834220|NCT02014584|580778387|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
160834221|NCT02014584|580778388|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
160834222|NCT02014584|580778389|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
160903726|NCT02993757|581040612|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
160834223|NCT02014584|580778390|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
160834224|NCT02014584|580778385|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
160834225|NCT02014584|580778386|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
160834226|NCT02014584|580778387|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
160834227|NCT02014584|580778388|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
160562148|NCT02901431|579779165|FG007|Main Treatment Part|Withdrawal by Subject|0|||
160562149|NCT02901431|579779166|FG008|Main Treatment Part|Withdrawal by Subject|0|||
160562150|NCT02901431|579779167|FG009|Main Treatment Part|Withdrawal by Subject|0|||
160562151|NCT02901431|579779168|FG010|Main Treatment Part|Withdrawal by Subject|0|||
160562152|NCT02901431|579779169|FG011|Main Treatment Part|Withdrawal by Subject|0|||
160562153|NCT02901431|579779170|FG012|Main Treatment Part|Withdrawal by Subject|0|||
160562154|NCT02901431|579779158|FG000|Open Label Part|Adverse Event|0|||
160562155|NCT02901431|579779159|FG001|Open Label Part|Adverse Event|0|||
160562156|NCT02901431|579779160|FG002|Open Label Part|Adverse Event|0|||
160562157|NCT02901431|579779161|FG003|Open Label Part|Adverse Event|0|||
160562158|NCT02901431|579779162|FG004|Open Label Part|Adverse Event|0|||
160562159|NCT02901431|579779163|FG005|Open Label Part|Adverse Event|0|||
160562160|NCT02901431|579779164|FG006|Open Label Part|Adverse Event|0|||
160562161|NCT02901431|579779165|FG007|Open Label Part|Adverse Event|0|||
160562162|NCT02901431|579779166|FG008|Open Label Part|Adverse Event|4|||
160562163|NCT02901431|579779167|FG009|Open Label Part|Adverse Event|4|||
160562164|NCT02901431|579779168|FG010|Open Label Part|Adverse Event|0|||
160562165|NCT02901431|579779169|FG011|Open Label Part|Adverse Event|4|||
160562166|NCT02901431|579779170|FG012|Open Label Part|Adverse Event|1|||
160562167|NCT02901431|579779158|FG000|Open Label Part|Lost to Follow-up|0|||
160562168|NCT02901431|579779159|FG001|Open Label Part|Lost to Follow-up|0|||
160562169|NCT02901431|579779160|FG002|Open Label Part|Lost to Follow-up|0|||
160562170|NCT02901431|579779161|FG003|Open Label Part|Lost to Follow-up|0|||
160562171|NCT02901431|579779162|FG004|Open Label Part|Lost to Follow-up|0|||
160562172|NCT02901431|579779163|FG005|Open Label Part|Lost to Follow-up|0|||
160562173|NCT02901431|579779164|FG006|Open Label Part|Lost to Follow-up|0|||
160562174|NCT02901431|579779165|FG007|Open Label Part|Lost to Follow-up|0|||
160562175|NCT02901431|579779166|FG008|Open Label Part|Lost to Follow-up|2|||
160562176|NCT02901431|579779167|FG009|Open Label Part|Lost to Follow-up|2|||
160562177|NCT02901431|579779168|FG010|Open Label Part|Lost to Follow-up|1|||
160562178|NCT02901431|579779169|FG011|Open Label Part|Lost to Follow-up|1|||
160562179|NCT02901431|579779170|FG012|Open Label Part|Lost to Follow-up|1|||
160562180|NCT02901431|579779158|FG000|Open Label Part|Physician Decision|0|||
160562181|NCT02901431|579779159|FG001|Open Label Part|Physician Decision|0|||
160562182|NCT02901431|579779160|FG002|Open Label Part|Physician Decision|0|||
160562183|NCT02901431|579779161|FG003|Open Label Part|Physician Decision|0|||
160562184|NCT02901431|579779162|FG004|Open Label Part|Physician Decision|0|||
160562185|NCT02901431|579779163|FG005|Open Label Part|Physician Decision|0|||
160562186|NCT02901431|579779164|FG006|Open Label Part|Physician Decision|0|||
160562187|NCT02901431|579779165|FG007|Open Label Part|Physician Decision|0|||
160562188|NCT02901431|579779166|FG008|Open Label Part|Physician Decision|1|||
160562189|NCT02901431|579779167|FG009|Open Label Part|Physician Decision|1|||
160562190|NCT02901431|579779168|FG010|Open Label Part|Physician Decision|0|||
160562191|NCT02901431|579779169|FG011|Open Label Part|Physician Decision|0|||
160562192|NCT02901431|579779170|FG012|Open Label Part|Physician Decision|0|||
160562193|NCT02901431|579779158|FG000|Open Label Part|Study Terminated By Sponsor|0|||
160562194|NCT02901431|579779159|FG001|Open Label Part|Study Terminated By Sponsor|0|||
160562195|NCT02901431|579779160|FG002|Open Label Part|Study Terminated By Sponsor|0|||
160562196|NCT02901431|579779161|FG003|Open Label Part|Study Terminated By Sponsor|0|||
160562197|NCT02901431|579779162|FG004|Open Label Part|Study Terminated By Sponsor|0|||
160562198|NCT02901431|579779163|FG005|Open Label Part|Study Terminated By Sponsor|0|||
160562199|NCT02901431|579779164|FG006|Open Label Part|Study Terminated By Sponsor|0|||
160562200|NCT02901431|579779165|FG007|Open Label Part|Study Terminated By Sponsor|0|||
160562201|NCT02901431|579779166|FG008|Open Label Part|Study Terminated By Sponsor|35|||
160562202|NCT02901431|579779167|FG009|Open Label Part|Study Terminated By Sponsor|12|||
160562203|NCT02901431|579779168|FG010|Open Label Part|Study Terminated By Sponsor|21|||
160562204|NCT02901431|579779169|FG011|Open Label Part|Study Terminated By Sponsor|31|||
160562205|NCT02901431|579779170|FG012|Open Label Part|Study Terminated By Sponsor|0|||
160562206|NCT02901431|579779158|FG000|Open Label Part|Withdrawal by Subject|0|||
160562207|NCT02901431|579779159|FG001|Open Label Part|Withdrawal by Subject|0|||
160562208|NCT02901431|579779160|FG002|Open Label Part|Withdrawal by Subject|0|||
160562209|NCT02901431|579779161|FG003|Open Label Part|Withdrawal by Subject|0|||
160562210|NCT02901431|579779162|FG004|Open Label Part|Withdrawal by Subject|0|||
160562211|NCT02901431|579779163|FG005|Open Label Part|Withdrawal by Subject|0|||
160562212|NCT02901431|579779164|FG006|Open Label Part|Withdrawal by Subject|0|||
160562213|NCT02901431|579779165|FG007|Open Label Part|Withdrawal by Subject|0|||
160562214|NCT02901431|579779166|FG008|Open Label Part|Withdrawal by Subject|6|||
160562215|NCT02901431|579779167|FG009|Open Label Part|Withdrawal by Subject|5|||
160562216|NCT02901431|579779168|FG010|Open Label Part|Withdrawal by Subject|7|||
160562217|NCT02901431|579779169|FG011|Open Label Part|Withdrawal by Subject|3|||
160562218|NCT02901431|579779170|FG012|Open Label Part|Withdrawal by Subject|1|||
160647631|NCT00416520|580092785|FG003|Open-label Period|Other Reasons|0|||
160647632|NCT00416520|580092782|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
160562219|NCT03832387|579779173|FG000|Overall Study|Protocol Violation|2|||
160562220|NCT03832387|579779174|FG001|Overall Study|Protocol Violation|6|||
160562221|NCT03832387|579779173|FG000|Overall Study|EXCLUSION CRITERIA|3|||
160562222|NCT03832387|579779174|FG001|Overall Study|EXCLUSION CRITERIA|1|||
160562223|NCT00784758|579779175|FG000|Overall Study|Withdrawal by Subject|3|||
160562224|NCT00784758|579779176|FG001|Overall Study|Withdrawal by Subject|0|||
160562225|NCT00784758|579779175|FG000|Overall Study|Adverse Event|1|||
160562226|NCT00784758|579779176|FG001|Overall Study|Adverse Event|0|||
160562227|NCT05775289|579779177|FG000|Overall Study|Study Ongoing|20|||
160562228|NCT05775289|579779178|FG001|Overall Study|Study Ongoing|53|||
160562229|NCT05775289|579779179|FG002|Overall Study|Study Ongoing|15|||
160562230|NCT05775289|579779180|FG003|Overall Study|Study Ongoing|55|||
160562231|NCT05775289|579779177|FG000|Overall Study|Death|4|||
160562232|NCT05775289|579779178|FG001|Overall Study|Death|11|||
160562233|NCT05775289|579779179|FG002|Overall Study|Death|8|||
160562234|NCT05775289|579779180|FG003|Overall Study|Death|12|||
160562235|NCT05775289|579779177|FG000|Overall Study|Lost to Follow-up|0|||
160562236|NCT05775289|579779178|FG001|Overall Study|Lost to Follow-up|1|||
160562237|NCT05775289|579779179|FG002|Overall Study|Lost to Follow-up|0|||
160562238|NCT05775289|579779180|FG003|Overall Study|Lost to Follow-up|0|||
160562239|NCT05775289|579779177|FG000|Overall Study|Progressive Disease|0|||
160562240|NCT05775289|579779178|FG001|Overall Study|Progressive Disease|0|||
160562241|NCT05775289|579779179|FG002|Overall Study|Progressive Disease|1|||
160562242|NCT05775289|579779180|FG003|Overall Study|Progressive Disease|0|||
160562243|NCT05775289|579779177|FG000|Overall Study|Withdrawal by Subject|1|||
160562244|NCT05775289|579779178|FG001|Overall Study|Withdrawal by Subject|1|||
160562245|NCT05775289|579779179|FG002|Overall Study|Withdrawal by Subject|0|||
160562246|NCT05775289|579779180|FG003|Overall Study|Withdrawal by Subject|0|||
160562247|NCT02330419|579779185|FG000|Overall Study|Lost to Follow-up|3|||
160562248|NCT02330419|579779186|FG001|Overall Study|Lost to Follow-up|7|||
160562249|NCT00998738|579779188|FG000|Overall Study|Uknown|1|||
160562250|NCT02848833|579779197|FG000|Overall Study|subject who are duplicated|1|||
160562251|NCT02848833|579779197|FG000|Overall Study|have not taken the study drug|11|||
160562252|NCT02848833|579779197|FG000|Overall Study|follow-up failure|6|||
160562253|NCT02848833|579779197|FG000|Overall Study|Protocol Violation|119|||
160562254|NCT04980391|579779198|FG000|Overall Study|Death|0|||
160562255|NCT04980391|579779199|FG001|Overall Study|Death|0|||
160562256|NCT04980391|579779200|FG002|Overall Study|Death|1|||
160562257|NCT04980391|579779201|FG003|Overall Study|Death|1|||
160562258|NCT04980391|579779198|FG000|Overall Study|Lost to Follow-up|3|||
160562259|NCT04980391|579779199|FG001|Overall Study|Lost to Follow-up|3|||
160562260|NCT04980391|579779200|FG002|Overall Study|Lost to Follow-up|2|||
160562261|NCT04980391|579779201|FG003|Overall Study|Lost to Follow-up|3|||
160562262|NCT04980391|579779198|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
160562263|NCT04980391|579779199|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
160562264|NCT04980391|579779200|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
160562265|NCT04980391|579779201|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
160562266|NCT04980391|579779198|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160562267|NCT04980391|579779199|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160562268|NCT04980391|579779200|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
160562269|NCT04980391|579779201|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160562270|NCT04980391|579779198|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
160562271|NCT04980391|579779199|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
160562272|NCT04980391|579779200|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
160562273|NCT04980391|579779201|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
160562274|NCT04167345|579779202|FG000|Overall Study|Other|1|||
160562275|NCT04167345|579779203|FG001|Overall Study|Other|1|||
160562276|NCT04167345|579779204|FG002|Overall Study|Other|0|||
160562277|NCT04167345|579779205|FG003|Overall Study|Other|0|||
160562278|NCT04167345|579779206|FG004|Overall Study|Other|0|||
160562279|NCT04375761|579781560|FG000|Overall Study|Death|1|||
160562280|NCT04375761|579781561|FG001|Overall Study|Death|2|||
160562281|NCT04375761|579781560|FG000|Overall Study|Lost to Follow-up|203|||
160562282|NCT04375761|579781561|FG001|Overall Study|Lost to Follow-up|380|||
160562283|NCT04375761|579781560|FG000|Overall Study|Withdrawal by Subject|47|||
160562284|NCT04375761|579781561|FG001|Overall Study|Withdrawal by Subject|98|||
160562285|NCT04375761|579781560|FG000|Overall Study|Noncompliance with study procedure|121|||
160562286|NCT04375761|579781561|FG001|Overall Study|Noncompliance with study procedure|251|||
160562287|NCT04375761|579781560|FG000|Overall Study|Reimbursement not enough|1|||
160562288|NCT04375761|579781561|FG001|Overall Study|Reimbursement not enough|2|||
160562289|NCT04375761|579781560|FG000|Overall Study|Unforeseen family circumstances|1|||
160562290|NCT04375761|579781561|FG001|Overall Study|Unforeseen family circumstances|3|||
160562291|NCT04375761|579781560|FG000|Overall Study|Test too painful|1|||
160562292|NCT04375761|579781561|FG001|Overall Study|Test too painful|1|||
160562293|NCT04375761|579781560|FG000|Overall Study|Moved|0|||
160562294|NCT04375761|579781561|FG001|Overall Study|Moved|2|||
160562295|NCT04375761|579781560|FG000|Overall Study|Nonresponsive|0|||
160562296|NCT04375761|579781561|FG001|Overall Study|Nonresponsive|5|||
160562297|NCT03797001|579781562|FG000|Overall Study|Withdrawn due to COVID19|4|||
160562298|NCT03797001|579781563|FG001|Overall Study|Withdrawn due to COVID19|0|||
160562299|NCT03797001|579781562|FG000|Overall Study|Withdrawal by Subject|7|||
160562300|NCT03797001|579781563|FG001|Overall Study|Withdrawal by Subject|6|||
160562301|NCT03797001|579781562|FG000|Overall Study|Adverse Event|0|||
160562302|NCT03797001|579781563|FG001|Overall Study|Adverse Event|1|||
160562303|NCT00500266|579781575|FG000|Overall Study|Death|3|||
160834228|NCT02014584|580778389|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
160834229|NCT02014584|580778390|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
160834230|NCT02014584|580778385|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
160834231|NCT02014584|580778386|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
160834232|NCT02014584|580778387|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
160834233|NCT02014584|580778388|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
160834234|NCT02014584|580778389|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
160834235|NCT02014584|580778390|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
160834236|NCT02014584|580778385|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
160834237|NCT02014584|580778386|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
160834238|NCT02014584|580778387|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
160834239|NCT02014584|580778388|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
160834240|NCT02014584|580778389|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
160834241|NCT02014584|580778390|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
160834242|NCT02014584|580778385|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
160834243|NCT02014584|580778386|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
160834244|NCT02014584|580778387|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
160834245|NCT02014584|580778388|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
160834246|NCT02014584|580778389|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
160834247|NCT02014584|580778390|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
160834248|NCT00483002|580778391|FG000|Overall Study|Adverse Event|68|||
160834249|NCT00483002|580778391|FG000|Overall Study|Lack of Efficacy|555|||
160834250|NCT00483002|580778391|FG000|Overall Study|Lost to Follow-up|962|||
160834251|NCT00483002|580778391|FG000|Overall Study|Other|2|||
160834252|NCT00483002|580778391|FG000|Overall Study|Other|967|||
160834253|NCT01274429|580778396|FG000|Overall Study|Study closed do to lack of funding|5|||
160834254|NCT01439373|580778397|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
160834255|NCT01439373|580778398|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
160834256|NCT01439373|580778397|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
160834257|NCT01439373|580778398|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
160991274|NCT01959880|581355570|FG003|Overall Study|Study completed early-FDA approved|152|||
160991275|NCT01537133|581357724|FG000|Overall Study|Withdrawal by Subject|2|||
160991276|NCT01537133|581357725|FG001|Overall Study|Withdrawal by Subject|0|||
160991277|NCT01537133|581357726|FG002|Overall Study|Withdrawal by Subject|0|||
160991278|NCT01537133|581357727|FG003|Overall Study|Withdrawal by Subject|0|||
160991279|NCT01537133|581357724|FG000|Overall Study|Lost to Follow-up|1|||
160562304|NCT00500266|579781575|FG000|Overall Study|Lost to Follow-up|3|||
160562305|NCT00500266|579781575|FG000|Overall Study|Withdrawal by Subject|3|||
160834258|NCT04576897|580778401|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
160834259|NCT02593318|580778404|FG000|Overall Study|Withdrawal by Subject|1|||
160834260|NCT02593318|580778405|FG001|Overall Study|Withdrawal by Subject|1|||
160834261|NCT00448747|580780050|FG000|Overall Study|collapsed veins|1|||
160834262|NCT00448747|580780051|FG001|Overall Study|collapsed veins|0|||
160834263|NCT00387725|580780052|FG000|Overall Study|Adverse Event|0|||
160834264|NCT00387725|580780053|FG001|Overall Study|Adverse Event|0|||
160834265|NCT00387725|580780054|FG002|Overall Study|Adverse Event|0|||
160834266|NCT00387725|580780055|FG003|Overall Study|Adverse Event|1|||
160834267|NCT00387725|580780052|FG000|Overall Study|Protocol Violation|0|||
160834268|NCT00387725|580780053|FG001|Overall Study|Protocol Violation|1|||
160834269|NCT00387725|580780054|FG002|Overall Study|Protocol Violation|0|||
160834270|NCT00387725|580780055|FG003|Overall Study|Protocol Violation|0|||
160834271|NCT00387725|580780052|FG000|Overall Study|Withdrawal by Subject|1|||
160834272|NCT00387725|580780053|FG001|Overall Study|Withdrawal by Subject|0|||
160834273|NCT00387725|580780054|FG002|Overall Study|Withdrawal by Subject|1|||
160834274|NCT00387725|580780055|FG003|Overall Study|Withdrawal by Subject|0|||
160834275|NCT00387725|580780052|FG000|Overall Study|Parent/legal guardian request|0|||
160834276|NCT00387725|580780053|FG001|Overall Study|Parent/legal guardian request|0|||
160834277|NCT00387725|580780054|FG002|Overall Study|Parent/legal guardian request|1|||
160834278|NCT00387725|580780055|FG003|Overall Study|Parent/legal guardian request|1|||
160562306|NCT00500266|579781575|FG000|Overall Study|Assigned, not treated|4|||
160562307|NCT02251743|579781576|FG000|Overall Study|Withdrawal by Subject|1|||
160562308|NCT02251743|579781577|FG001|Overall Study|Withdrawal by Subject|1|||
160562309|NCT04439266|579781579|FG000|Overall Study|Ineligible|1|||
160834279|NCT00568126|580780056|FG000|Overall Study|Adverse Event|3|||
160834280|NCT00568126|580780057|FG001|Overall Study|Adverse Event|0|||
160834281|NCT00568126|580780056|FG000|Overall Study|Withdrawal by Subject|2|||
160834282|NCT00568126|580780057|FG001|Overall Study|Withdrawal by Subject|3|||
160834283|NCT00568126|580780056|FG000|Overall Study|Lost to Follow-up|4|||
160834284|NCT00568126|580780057|FG001|Overall Study|Lost to Follow-up|3|||
160834285|NCT00568126|580780056|FG000|Overall Study|Lack of Efficacy|0|||
160834286|NCT00568126|580780057|FG001|Overall Study|Lack of Efficacy|1|||
160834287|NCT00568126|580780056|FG000|Overall Study|Physician Decision|2|||
160834288|NCT00568126|580780057|FG001|Overall Study|Physician Decision|2|||
160834289|NCT00527982|580780059|FG000|Overall Study|Physician Decision|1|||
160834290|NCT00527982|580780060|FG001|Overall Study|Physician Decision|0|||
160834291|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
160834292|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
160834293|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
160834294|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
160834295|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
160834296|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
160834297|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
160834298|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
160834299|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
160834300|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
160562310|NCT04439266|579781579|FG000|Overall Study|Adverse Event|1|||
160834301|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
160834302|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
160903727|NCT02993757|581040613|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
160562311|NCT04439266|579781579|FG000|Overall Study|Death|1|||
160562312|NCT04439266|579781579|FG000|Overall Study|Disease progression|1|||
160562313|NCT04439266|579781579|FG000|Overall Study|Still on treatment|1|||
160562314|NCT06161012|579781581|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
160562315|NCT06161012|579781582|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
160562316|NCT00408005|579781583|FG000|Induction|Adverse Event|19|||
160562317|NCT00408005|579781584|FG001|Induction|Adverse Event|3|||
160562318|NCT00408005|579781585|FG002|Induction|Adverse Event|0|||
160903728|NCT00087607|581040623|FG000|Overall Study|Adverse Event|14|||
160903729|NCT00087607|581040624|FG001|Overall Study|Adverse Event|24|||
160903730|NCT00087607|581040623|FG000|Overall Study|Death|0|||
160562319|NCT00408005|579781586|FG003|Induction|Adverse Event|0|||
160562320|NCT00408005|579781587|FG004|Induction|Adverse Event|0|||
160834303|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
160834304|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
160834305|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
160834306|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
160903731|NCT00087607|581040624|FG001|Overall Study|Death|1|||
160562321|NCT00408005|579781588|FG005|Induction|Adverse Event|0|||
160562322|NCT00408005|579781589|FG006|Induction|Adverse Event|0|||
160562323|NCT00408005|579781590|FG007|Induction|Adverse Event|0|||
160834307|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
160834308|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
160903732|NCT00087607|581040623|FG000|Overall Study|Insufficient Therapeutic Response|53|||
160834309|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
160834310|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
160834311|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
160834312|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
160834313|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
160834314|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
160834315|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
160991280|NCT01537133|581357725|FG001|Overall Study|Lost to Follow-up|0|||
160991281|NCT01537133|581357726|FG002|Overall Study|Lost to Follow-up|0|||
160991282|NCT01537133|581357727|FG003|Overall Study|Lost to Follow-up|0|||
160991283|NCT03837028|581357728|FG000|Overall Study|Lost to Follow-up|4|||
160991284|NCT03837028|581357729|FG001|Overall Study|Lost to Follow-up|0|||
160991285|NCT03837028|581357730|FG002|Overall Study|Lost to Follow-up|2|||
160991286|NCT03837028|581357731|FG003|Overall Study|Lost to Follow-up|0|||
160991287|NCT03837028|581357728|FG000|Overall Study|Withdrawal by Subject|12|||
160991288|NCT03837028|581357729|FG001|Overall Study|Withdrawal by Subject|11|||
160991289|NCT03837028|581357730|FG002|Overall Study|Withdrawal by Subject|11|||
160991290|NCT03837028|581357731|FG003|Overall Study|Withdrawal by Subject|7|||
160991291|NCT00157014|581357732|FG000|Overall Study|Death|4|||
160991292|NCT00157014|581357733|FG001|Overall Study|Death|2|||
160834316|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
160834317|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
160834318|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
160834319|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
160991293|NCT00157014|581357734|FG002|Overall Study|Death|1|||
160991294|NCT00157014|581357735|FG003|Overall Study|Death|1|||
160991295|NCT00157014|581357732|FG000|Overall Study|Physician Decision|0|||
160834320|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
160834321|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
160834322|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
160834323|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
160834324|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
160834325|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
160834326|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
160834327|NCT02615691|580780068|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
160834328|NCT02615691|580780068|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
160834329|NCT02615691|580780068|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
160834330|NCT02615691|580780068|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
160834331|NCT04201093|580780069|FG000|Overall Study|Adverse Event|6|||
160834332|NCT04201093|580780070|FG001|Overall Study|Adverse Event|29|||
160834333|NCT04201093|580780071|FG002|Overall Study|Adverse Event|35|||
160834334|NCT04201093|580780069|FG000|Overall Study|Death|2|||
160562324|NCT00408005|579781583|FG000|Induction|Death|6|||
160562325|NCT00408005|579781584|FG001|Induction|Death|0|||
160562326|NCT00408005|579781585|FG002|Induction|Death|0|||
160562327|NCT00408005|579781586|FG003|Induction|Death|0|||
160562328|NCT00408005|579781587|FG004|Induction|Death|0|||
160562329|NCT00408005|579781588|FG005|Induction|Death|0|||
160562330|NCT00408005|579781589|FG006|Induction|Death|0|||
160562331|NCT00408005|579781590|FG007|Induction|Death|0|||
160562332|NCT00408005|579781583|FG000|Induction|Physician Decision|83|||
160834335|NCT04201093|580780070|FG001|Overall Study|Death|1|||
160834336|NCT04201093|580780071|FG002|Overall Study|Death|0|||
160834337|NCT04201093|580780069|FG000|Overall Study|Lack of Efficacy|5|||
160834338|NCT04201093|580780070|FG001|Overall Study|Lack of Efficacy|1|||
160834339|NCT04201093|580780071|FG002|Overall Study|Lack of Efficacy|2|||
160834340|NCT04201093|580780069|FG000|Overall Study|Lost to Follow-up|0|||
160834341|NCT04201093|580780070|FG001|Overall Study|Lost to Follow-up|0|||
160834342|NCT04201093|580780071|FG002|Overall Study|Lost to Follow-up|1|||
160834343|NCT04201093|580780069|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
160834344|NCT04201093|580780070|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
160834345|NCT04201093|580780071|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
160834346|NCT04201093|580780069|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
160834347|NCT04201093|580780070|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
160834348|NCT04201093|580780071|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
160834349|NCT04201093|580780069|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
160834350|NCT04201093|580780070|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
160834351|NCT04201093|580780071|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
160834352|NCT04201093|580780069|FG000|Overall Study|Physician Decision|1|||
160834353|NCT04201093|580780070|FG001|Overall Study|Physician Decision|0|||
160834354|NCT04201093|580780071|FG002|Overall Study|Physician Decision|0|||
160834355|NCT04201093|580780069|FG000|Overall Study|Protocol Deviation|1|||
160562333|NCT00408005|579781584|FG001|Induction|Physician Decision|9|||
160562334|NCT00408005|579781585|FG002|Induction|Physician Decision|0|||
160562335|NCT00408005|579781586|FG003|Induction|Physician Decision|0|||
160562336|NCT00408005|579781587|FG004|Induction|Physician Decision|0|||
160562337|NCT00408005|579781588|FG005|Induction|Physician Decision|0|||
160562338|NCT00408005|579781589|FG006|Induction|Physician Decision|0|||
160562339|NCT00408005|579781590|FG007|Induction|Physician Decision|0|||
160562340|NCT00408005|579781583|FG000|Induction|Withdrawal by Subject|2|||
160562341|NCT00408005|579781584|FG001|Induction|Withdrawal by Subject|4|||
160562342|NCT00408005|579781585|FG002|Induction|Withdrawal by Subject|0|||
160562343|NCT00408005|579781586|FG003|Induction|Withdrawal by Subject|0|||
160562344|NCT00408005|579781587|FG004|Induction|Withdrawal by Subject|0|||
160562345|NCT00408005|579781588|FG005|Induction|Withdrawal by Subject|0|||
160562346|NCT00408005|579781589|FG006|Induction|Withdrawal by Subject|0|||
160562347|NCT00408005|579781590|FG007|Induction|Withdrawal by Subject|0|||
160562348|NCT00408005|579781583|FG000|Induction|Ineligible|33|||
160562349|NCT00408005|579781584|FG001|Induction|Ineligible|14|||
160562350|NCT00408005|579781585|FG002|Induction|Ineligible|0|||
160834356|NCT04201093|580780070|FG001|Overall Study|Protocol Deviation|0|||
160834357|NCT04201093|580780071|FG002|Overall Study|Protocol Deviation|0|||
160834358|NCT04201093|580780069|FG000|Overall Study|Site Terminated by Sponsor|5|||
160834359|NCT04201093|580780070|FG001|Overall Study|Site Terminated by Sponsor|3|||
160834360|NCT04201093|580780071|FG002|Overall Study|Site Terminated by Sponsor|1|||
160834361|NCT04201093|580780069|FG000|Overall Study|Withdrawal by Subject|7|||
160834362|NCT04201093|580780070|FG001|Overall Study|Withdrawal by Subject|8|||
160562351|NCT00408005|579781586|FG003|Induction|Ineligible|0|||
160562352|NCT00408005|579781587|FG004|Induction|Ineligible|0|||
160562353|NCT00408005|579781588|FG005|Induction|Ineligible|0|||
160562354|NCT00408005|579781589|FG006|Induction|Ineligible|0|||
160562355|NCT00408005|579781590|FG007|Induction|Ineligible|0|||
160562356|NCT00408005|579781583|FG000|Induction|Refusal of Further Protocol Therapy|225|||
160562357|NCT00408005|579781584|FG001|Induction|Refusal of Further Protocol Therapy|44|||
160834363|NCT04201093|580780071|FG002|Overall Study|Withdrawal by Subject|15|||
160834364|NCT04201093|580780069|FG000|Overall Study|Other|0|||
160834365|NCT04201093|580780070|FG001|Overall Study|Other|1|||
160834366|NCT04201093|580780071|FG002|Overall Study|Other|2|||
160834367|NCT00007020|580780072|FG000|Overall Study|Death|16|||
160834368|NCT00007020|580780072|FG000|Overall Study|Lost to Follow-up|13|||
160834369|NCT00007020|580780072|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
160834370|NCT00007020|580780072|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
160834371|NCT00007020|580780072|FG000|Overall Study|Pt cared for by outside physician|4|||
160834372|NCT00007020|580780072|FG000|Overall Study|No evidence of treatment|6|||
160834373|NCT00881504|580780073|FG000|Overall Study|Withdrawal by Subject|1|||
160834374|NCT01276223|580780074|FG000|Overall Study|Adverse Event|7|||
160834375|NCT01276223|580780075|FG001|Overall Study|Adverse Event|4|||
160834376|NCT01276223|580780076|FG002|Overall Study|Adverse Event|1|||
160562358|NCT00408005|579781585|FG002|Induction|Refusal of Further Protocol Therapy|0|||
160562359|NCT00408005|579781586|FG003|Induction|Refusal of Further Protocol Therapy|0|||
160562360|NCT00408005|579781587|FG004|Induction|Refusal of Further Protocol Therapy|0|||
160562361|NCT00408005|579781588|FG005|Induction|Refusal of Further Protocol Therapy|0|||
160562362|NCT00408005|579781589|FG006|Induction|Refusal of Further Protocol Therapy|0|||
160562363|NCT00408005|579781590|FG007|Induction|Refusal of Further Protocol Therapy|0|||
160834377|NCT01276223|580780074|FG000|Overall Study|Lost to Follow-up|0|||
160834378|NCT01276223|580780075|FG001|Overall Study|Lost to Follow-up|0|||
160834379|NCT01276223|580780076|FG002|Overall Study|Lost to Follow-up|1|||
160834380|NCT01276223|580780074|FG000|Overall Study|Other|0|||
160834381|NCT01276223|580780075|FG001|Overall Study|Other|0|||
160562364|NCT00408005|579781583|FG000|Induction|Entered another COG therapeutic protocol|4|||
160562365|NCT00408005|579781584|FG001|Induction|Entered another COG therapeutic protocol|0|||
160562366|NCT00408005|579781585|FG002|Induction|Entered another COG therapeutic protocol|0|||
160562367|NCT00408005|579781586|FG003|Induction|Entered another COG therapeutic protocol|0|||
160562368|NCT00408005|579781587|FG004|Induction|Entered another COG therapeutic protocol|0|||
160562369|NCT00408005|579781588|FG005|Induction|Entered another COG therapeutic protocol|0|||
160562370|NCT00408005|579781589|FG006|Induction|Entered another COG therapeutic protocol|0|||
160562371|NCT00408005|579781590|FG007|Induction|Entered another COG therapeutic protocol|0|||
160562372|NCT00408005|579781583|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
160562373|NCT00408005|579781584|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
160562374|NCT00408005|579781585|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
160562375|NCT00408005|579781586|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
160562376|NCT00408005|579781587|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
160562377|NCT00408005|579781588|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
160562378|NCT00408005|579781589|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
160562379|NCT00408005|579781590|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
160562380|NCT00408005|579781583|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
160562381|NCT00408005|579781584|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
160562382|NCT00408005|579781585|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
160562383|NCT00408005|579781586|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
160562384|NCT00408005|579781587|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
160562385|NCT00408005|579781588|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
160562386|NCT00408005|579781589|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
160562387|NCT00408005|579781590|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
160562388|NCT00408005|579781583|FG000|Induction|Progressive Disease|0|||
160562389|NCT00408005|579781584|FG001|Induction|Progressive Disease|1|||
160562390|NCT00408005|579781585|FG002|Induction|Progressive Disease|0|||
160562391|NCT00408005|579781586|FG003|Induction|Progressive Disease|0|||
160562392|NCT00408005|579781587|FG004|Induction|Progressive Disease|0|||
160562393|NCT00408005|579781588|FG005|Induction|Progressive Disease|0|||
160562394|NCT00408005|579781589|FG006|Induction|Progressive Disease|0|||
160562395|NCT00408005|579781590|FG007|Induction|Progressive Disease|0|||
160562396|NCT00408005|579781583|FG000|Induction|Inevaluable|18|||
160562397|NCT00408005|579781584|FG001|Induction|Inevaluable|14|||
160562398|NCT00408005|579781585|FG002|Induction|Inevaluable|0|||
160562399|NCT00408005|579781586|FG003|Induction|Inevaluable|0|||
160562400|NCT00408005|579781587|FG004|Induction|Inevaluable|0|||
160562401|NCT00408005|579781588|FG005|Induction|Inevaluable|0|||
160562402|NCT00408005|579781589|FG006|Induction|Inevaluable|0|||
160834382|NCT01276223|580780076|FG002|Overall Study|Other|1|||
160834383|NCT01276223|580780074|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
160834384|NCT01276223|580780075|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
160834385|NCT01276223|580780076|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
160562403|NCT00408005|579781590|FG007|Induction|Inevaluable|0|||
160562404|NCT00408005|579781583|FG000|Induction|Failed to Complete Randomization|3|||
160562405|NCT00408005|579781584|FG001|Induction|Failed to Complete Randomization|2|||
160562406|NCT00408005|579781585|FG002|Induction|Failed to Complete Randomization|0|||
160834386|NCT01276223|580780074|FG000|Overall Study|Protocol Violation|1|||
160834387|NCT01276223|580780075|FG001|Overall Study|Protocol Violation|0|||
160834388|NCT01276223|580780076|FG002|Overall Study|Protocol Violation|0|||
160834389|NCT02017522|580780077|FG000|Overall Study|Withdrawal by Subject|1|||
160834390|NCT02596230|580780078|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
160834391|NCT02596230|580780079|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
160834392|NCT02596230|580780080|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
160834393|NCT02596230|580780081|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
160834394|NCT02596230|580780082|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
160834395|NCT02596230|580780078|FG000|Objective 2, One Year|Lost to Follow-up|0|||
160834396|NCT02596230|580780079|FG001|Objective 2, One Year|Lost to Follow-up|41|||
160834397|NCT02596230|580780080|FG002|Objective 2, One Year|Lost to Follow-up|41|||
160834398|NCT02596230|580780081|FG003|Objective 2, One Year|Lost to Follow-up|32|||
160834399|NCT02596230|580780082|FG004|Objective 2, One Year|Lost to Follow-up|46|||
160834400|NCT02596230|580780078|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
160834401|NCT02596230|580780079|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
160834402|NCT02596230|580780080|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
160834403|NCT02596230|580780081|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
160834404|NCT02596230|580780082|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
160834405|NCT02596230|580780078|FG000|Objective 2, One Year|Adverse drug reaction|0|||
160834406|NCT02596230|580780079|FG001|Objective 2, One Year|Adverse drug reaction|1|||
160834407|NCT02596230|580780080|FG002|Objective 2, One Year|Adverse drug reaction|0|||
160834408|NCT02596230|580780081|FG003|Objective 2, One Year|Adverse drug reaction|0|||
160834409|NCT02596230|580780082|FG004|Objective 2, One Year|Adverse drug reaction|0|||
160834410|NCT02596230|580780078|FG000|Objective 2, One Year|Death|0|||
160834411|NCT02596230|580780079|FG001|Objective 2, One Year|Death|12|||
160834412|NCT02596230|580780080|FG002|Objective 2, One Year|Death|41|||
160834413|NCT02596230|580780081|FG003|Objective 2, One Year|Death|21|||
160834414|NCT02596230|580780082|FG004|Objective 2, One Year|Death|30|||
160834415|NCT02596230|580780078|FG000|Objective 2, One Year|Other|0|||
160834416|NCT02596230|580780079|FG001|Objective 2, One Year|Other|3|||
160834417|NCT02596230|580780080|FG002|Objective 2, One Year|Other|2|||
160834418|NCT02596230|580780081|FG003|Objective 2, One Year|Other|0|||
160834419|NCT02596230|580780082|FG004|Objective 2, One Year|Other|0|||
160834420|NCT00771615|580780083|FG000|Overall Study|Withdrawal by Subject|0|||
160834421|NCT00771615|580780084|FG001|Overall Study|Withdrawal by Subject|1|||
160834422|NCT00771615|580780085|FG002|Overall Study|Withdrawal by Subject|0|||
160834423|NCT00771615|580780086|FG003|Overall Study|Withdrawal by Subject|0|||
160834424|NCT00771615|580780087|FG004|Overall Study|Withdrawal by Subject|0|||
160834425|NCT00771615|580780088|FG005|Overall Study|Withdrawal by Subject|0|||
160834426|NCT00771615|580780089|FG006|Overall Study|Withdrawal by Subject|0|||
160834427|NCT00771615|580780090|FG007|Overall Study|Withdrawal by Subject|1|||
160834428|NCT00771615|580780091|FG008|Overall Study|Withdrawal by Subject|0|||
160834429|NCT00771615|580780083|FG000|Overall Study|Lost to Follow-up|1|||
160834430|NCT00771615|580780084|FG001|Overall Study|Lost to Follow-up|1|||
160834431|NCT00771615|580780085|FG002|Overall Study|Lost to Follow-up|1|||
160834432|NCT00771615|580780086|FG003|Overall Study|Lost to Follow-up|1|||
160834433|NCT00771615|580780087|FG004|Overall Study|Lost to Follow-up|0|||
160834434|NCT00771615|580780088|FG005|Overall Study|Lost to Follow-up|1|||
160834435|NCT00771615|580780089|FG006|Overall Study|Lost to Follow-up|1|||
160834436|NCT00771615|580780090|FG007|Overall Study|Lost to Follow-up|0|||
160834437|NCT00771615|580780091|FG008|Overall Study|Lost to Follow-up|0|||
160834438|NCT02704689|580780093|FG000|Overall Study|Physician Decision|1|||
160834439|NCT02704689|580780093|FG000|Overall Study|Study device not implanted|2|||
160834440|NCT00802893|580780094|FG000|Overall Study|study terminated|3|||
160991296|NCT00157014|581357733|FG001|Overall Study|Physician Decision|1|||
160562407|NCT00408005|579781586|FG003|Induction|Failed to Complete Randomization|0|||
160562408|NCT00408005|579781587|FG004|Induction|Failed to Complete Randomization|0|||
160562409|NCT00408005|579781588|FG005|Induction|Failed to Complete Randomization|0|||
160562410|NCT00408005|579781589|FG006|Induction|Failed to Complete Randomization|0|||
160562411|NCT00408005|579781590|FG007|Induction|Failed to Complete Randomization|0|||
160562412|NCT00408005|579781583|FG000|Induction|Protocol Deviation|3|||
160562413|NCT00408005|579781584|FG001|Induction|Protocol Deviation|1|||
160562414|NCT00408005|579781585|FG002|Induction|Protocol Deviation|0|||
160562415|NCT00408005|579781586|FG003|Induction|Protocol Deviation|0|||
160562416|NCT00408005|579781587|FG004|Induction|Protocol Deviation|0|||
160562417|NCT00408005|579781588|FG005|Induction|Protocol Deviation|0|||
160834441|NCT00320424|580780095|FG000|Overall Study|Adverse Event|3|||
160991297|NCT00157014|581357734|FG002|Overall Study|Physician Decision|0|||
160834442|NCT00320424|580780095|FG000|Overall Study|Other|3|||
160834443|NCT02294734|580780099|FG000|Overall Study|Adverse Event|5|||
160834444|NCT02294734|580780100|FG001|Overall Study|Adverse Event|5|||
160834445|NCT02294734|580780099|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
160834446|NCT02294734|580780100|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
160834447|NCT02294734|580780099|FG000|Overall Study|Lost to Follow-up|2|||
160834448|NCT02294734|580780100|FG001|Overall Study|Lost to Follow-up|0|||
160834449|NCT02294734|580780099|FG000|Overall Study|Physician Decision|2|||
160834450|NCT02294734|580780100|FG001|Overall Study|Physician Decision|1|||
160834451|NCT02294734|580780099|FG000|Overall Study|Withdrawal by Subject|4|||
160834452|NCT02294734|580780100|FG001|Overall Study|Withdrawal by Subject|2|||
160834453|NCT03157583|580780101|FG000|Overall Study|Other (did not meet study criteria)|1|||
160834454|NCT02809053|580780105|FG000|Overall Study|Death|0|||
160834455|NCT02809053|580780106|FG001|Overall Study|Death|1|||
160834456|NCT02809053|580780105|FG000|Overall Study|Lost to Follow-up|3|||
160834457|NCT02809053|580780106|FG001|Overall Study|Lost to Follow-up|1|||
160834458|NCT02809053|580780105|FG000|Overall Study|Withdrawal by Subject|2|||
160834459|NCT02809053|580780106|FG001|Overall Study|Withdrawal by Subject|3|||
160834460|NCT02809053|580780105|FG000|Overall Study|Disease Progression|2|||
160834461|NCT02809053|580780106|FG001|Overall Study|Disease Progression|1|||
160834462|NCT01943552|580780108|FG000|Overall Study|Adverse Event|3|||
160834463|NCT01943552|580780109|FG001|Overall Study|Adverse Event|2|||
160834464|NCT01943552|580780108|FG000|Overall Study|Withdrawal by Subject|6|||
160834465|NCT01943552|580780109|FG001|Overall Study|Withdrawal by Subject|6|||
160834466|NCT01943552|580780108|FG000|Overall Study|Other Reasons|16|||
160834467|NCT01943552|580780109|FG001|Overall Study|Other Reasons|17|||
160834468|NCT00908037|580780111|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834469|NCT00908037|580780112|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834470|NCT00908037|580780113|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834471|NCT00908037|580780114|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834472|NCT00908037|580780115|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
160834473|NCT00908037|580780116|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834474|NCT00908037|580780117|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
160834475|NCT00908037|580780118|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834476|NCT00908037|580780119|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
160834477|NCT00908037|580780120|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834478|NCT00908037|580780121|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834479|NCT00908037|580780122|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834480|NCT00908037|580780111|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834481|NCT00908037|580780112|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834482|NCT00908037|580780113|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834483|NCT00908037|580780114|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834484|NCT00908037|580780115|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
160834485|NCT00908037|580780116|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834486|NCT00908037|580780117|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834487|NCT00908037|580780118|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834488|NCT00908037|580780119|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
160834489|NCT00908037|580780120|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834490|NCT00908037|580780121|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834491|NCT00908037|580780122|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834492|NCT00908037|580780111|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834493|NCT00908037|580780112|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834494|NCT00908037|580780113|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834495|NCT00908037|580780114|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
160834496|NCT00908037|580780115|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834497|NCT00908037|580780116|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834498|NCT00908037|580780117|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
160834499|NCT00908037|580780118|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834500|NCT00908037|580780119|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834501|NCT00908037|580780120|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834502|NCT00908037|580780121|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834503|NCT00908037|580780122|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834504|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834505|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834506|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834507|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834508|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834509|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834510|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834511|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834512|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834513|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160903733|NCT00087607|581040624|FG001|Overall Study|Insufficient Therapeutic Response|42|||
160903734|NCT00087607|581040623|FG000|Overall Study|Failure to return|21|||
160834514|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160903735|NCT00087607|581040624|FG001|Overall Study|Failure to return|17|||
160562418|NCT00408005|579781589|FG006|Induction|Protocol Deviation|0|||
160562419|NCT00408005|579781590|FG007|Induction|Protocol Deviation|0|||
160834515|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
160834516|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834517|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834518|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834519|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834520|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834521|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834522|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834523|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834524|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834525|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
160834526|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834527|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
160834528|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834529|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834530|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834531|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160562420|NCT00408005|579781583|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
160834532|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834533|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834534|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834535|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834536|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834537|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
160834538|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834539|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834540|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834541|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834542|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834543|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834544|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834545|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834546|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834547|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834548|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834549|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834550|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
160834551|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834552|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834553|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834554|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834555|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834556|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834557|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834558|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834559|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834560|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834561|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
160834562|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834563|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834564|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834565|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160562421|NCT00408005|579781584|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
160562422|NCT00408005|579781585|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
160562423|NCT00408005|579781586|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
160562424|NCT00408005|579781587|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
160834566|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834567|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834568|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834569|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834570|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834571|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834572|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834573|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834574|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
160834575|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834576|NCT01147900|580780123|FG000|At Year 10|Lost to Follow-up|0|||
160834577|NCT01147900|580780124|FG001|At Year 10|Lost to Follow-up|1|||
160834578|NCT01147900|580780125|FG002|At Year 10|Lost to Follow-up|0|||
160834579|NCT00257660|580780127|FG000|Overall Study|Lack of Efficacy|5|||
160834580|NCT00257660|580780128|FG001|Overall Study|Lack of Efficacy|23|||
160834581|NCT00257660|580780127|FG000|Overall Study|Withdrawal by Subject|2|||
160834582|NCT00257660|580780128|FG001|Overall Study|Withdrawal by Subject|0|||
160834583|NCT00257660|580780127|FG000|Overall Study|Lost to Follow-up|1|||
160834584|NCT00257660|580780128|FG001|Overall Study|Lost to Follow-up|0|||
160903736|NCT00087607|581040623|FG000|Overall Study|Withdrew Consent|12|||
160903737|NCT00087607|581040624|FG001|Overall Study|Withdrew Consent|16|||
160903738|NCT00087607|581040623|FG000|Overall Study|Administrative|12|||
160903739|NCT00087607|581040624|FG001|Overall Study|Administrative|12|||
160903740|NCT00087607|581040623|FG000|Overall Study|Refused Treatment|5|||
160903741|NCT00087607|581040624|FG001|Overall Study|Refused Treatment|7|||
160903742|NCT00087607|581040623|FG000|Overall Study|Other Protocol Violation|5|||
160903743|NCT00087607|581040624|FG001|Overall Study|Other Protocol Violation|2|||
160903744|NCT00087607|581040623|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
160903745|NCT00087607|581040624|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
160903746|NCT02699593|581040625|FG000|Period 1|Unsatisfactory Visual Response|0|||
160903747|NCT02699593|581040626|FG001|Period 1|Unsatisfactory Visual Response|1|||
160903748|NCT02699593|581040625|FG000|Period 1|Torn Contact Len|4|||
160903749|NCT02699593|581040626|FG001|Period 1|Torn Contact Len|3|||
160903750|NCT02699593|581040625|FG000|Period 1|Protocol Violation|0|||
160903751|NCT02699593|581040626|FG001|Period 1|Protocol Violation|1|||
160903752|NCT02699593|581040625|FG000|Period 1|Withdrawal by Subject|0|||
160903753|NCT02699593|581040626|FG001|Period 1|Withdrawal by Subject|1|||
160903754|NCT02699593|581040625|FG000|Period 1|Adverse Event|1|||
160903755|NCT02699593|581040626|FG001|Period 1|Adverse Event|1|||
160903756|NCT02699593|581040625|FG000|Period 2|Adverse Event|1|||
160903757|NCT02699593|581040626|FG001|Period 2|Adverse Event|1|||
160903758|NCT02699593|581040625|FG000|Period 2|Lost Contact Lens|0|||
160903759|NCT02699593|581040626|FG001|Period 2|Lost Contact Lens|1|||
160903760|NCT02699593|581040625|FG000|Period 2|Torn Contact Lens|1|||
160903761|NCT02699593|581040626|FG001|Period 2|Torn Contact Lens|0|||
160903762|NCT02015754|581040627|FG000|Overall Study|Disease progression|5|||
160562425|NCT00408005|579781588|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
160562426|NCT00408005|579781589|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
160562427|NCT00408005|579781590|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
160562428|NCT00408005|579781583|FG000|Induction|Recurrent leukemia|1|||
160562429|NCT00408005|579781584|FG001|Induction|Recurrent leukemia|0|||
160562430|NCT00408005|579781585|FG002|Induction|Recurrent leukemia|0|||
160562431|NCT00408005|579781586|FG003|Induction|Recurrent leukemia|0|||
160562432|NCT00408005|579781587|FG004|Induction|Recurrent leukemia|0|||
160903763|NCT02015754|581040627|FG000|Overall Study|Change in treatment modality|5|||
160903764|NCT02015754|581040627|FG000|Overall Study|Lost to Follow-up|1|||
160903765|NCT02229383|581040628|FG000|Overall Study|Adverse Event|7|||
160903766|NCT02229383|581040629|FG001|Overall Study|Adverse Event|4|||
160562433|NCT00408005|579781588|FG005|Induction|Recurrent leukemia|0|||
160562434|NCT00408005|579781589|FG006|Induction|Recurrent leukemia|0|||
160903767|NCT02229383|581040628|FG000|Overall Study|Death|0|||
160903768|NCT02229383|581040629|FG001|Overall Study|Death|1|||
160903769|NCT02229383|581040628|FG000|Overall Study|Lost to Follow-up|5|||
160903770|NCT02229383|581040629|FG001|Overall Study|Lost to Follow-up|3|||
160834585|NCT00257660|580780127|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
160834586|NCT00257660|580780128|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
160834587|NCT00257660|580780127|FG000|Overall Study|No longer wanted to do blood draws|1|||
160834588|NCT00257660|580780128|FG001|Overall Study|No longer wanted to do blood draws|0|||
160834589|NCT04109976|580780129|FG000|Overall Study|Withdrawal by Subject|1|||
160834590|NCT04109976|580780130|FG001|Overall Study|Withdrawal by Subject|0|||
160834591|NCT00491608|580780131|FG000|Overall Study|Death|2|||
160834592|NCT00491608|580780131|FG000|Overall Study|Withdrawal by Subject|1|||
160834593|NCT00025155|580780134|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
160834594|NCT00025155|580780134|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
160834595|NCT03022981|580780135|FG000|Overall Study|Adverse Event|0|||
160834596|NCT03022981|580780136|FG001|Overall Study|Adverse Event|1|||
160834597|NCT03022981|580780137|FG002|Overall Study|Adverse Event|0|||
160834598|NCT03022981|580780135|FG000|Overall Study|Investigator's Discretion|0|||
160834599|NCT03022981|580780136|FG001|Overall Study|Investigator's Discretion|1|||
160834600|NCT03022981|580780137|FG002|Overall Study|Investigator's Discretion|2|||
160834601|NCT03022981|580780135|FG000|Overall Study|Lost to Follow-up|6|||
160834602|NCT03022981|580780136|FG001|Overall Study|Lost to Follow-up|2|||
160834603|NCT03022981|580780137|FG002|Overall Study|Lost to Follow-up|1|||
160834604|NCT03022981|580780135|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160834605|NCT03022981|580780136|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160834606|NCT03022981|580780137|FG002|Overall Study|Non-Compliance With Study Drug|2|||
160834607|NCT03022981|580780135|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
160834608|NCT03022981|580780136|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
160834609|NCT03022981|580780137|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
160834610|NCT02437084|580780138|FG000|Overall Study|Withdrawal by Subject|2|||
160834611|NCT02437084|580780138|FG000|Overall Study|Physician Decision|1|||
160834612|NCT00884832|580780139|FG000|Overall Study|Withdrawal by Subject|0|||
160834613|NCT00884832|580780140|FG001|Overall Study|Withdrawal by Subject|1|||
160834614|NCT00079677|580780142|FG000|Overall Study|Adverse Event|5|||
160834615|NCT00079677|580780143|FG001|Overall Study|Adverse Event|6|||
160834616|NCT00079677|580780142|FG000|Overall Study|Lack of Efficacy|1|||
160834617|NCT00079677|580780143|FG001|Overall Study|Lack of Efficacy|0|||
160834618|NCT00079677|580780142|FG000|Overall Study|Lost to Follow-up|2|||
160834619|NCT00079677|580780143|FG001|Overall Study|Lost to Follow-up|2|||
160834620|NCT00079677|580780142|FG000|Overall Study|Physician Decision|3|||
160834621|NCT00079677|580780143|FG001|Overall Study|Physician Decision|0|||
160834622|NCT00079677|580780142|FG000|Overall Study|Protocol Violation|2|||
160834623|NCT00079677|580780143|FG001|Overall Study|Protocol Violation|3|||
160834624|NCT00079677|580780142|FG000|Overall Study|Withdrawal by Subject|5|||
160834625|NCT00079677|580780143|FG001|Overall Study|Withdrawal by Subject|3|||
160834626|NCT00079677|580780142|FG000|Overall Study|Miscellaneous|2|||
160834627|NCT00079677|580780143|FG001|Overall Study|Miscellaneous|0|||
160834628|NCT02265796|580780144|FG000|Overall Study|Death|1|||
160834629|NCT02265796|580780145|FG001|Overall Study|Death|0|||
160834630|NCT02265796|580780144|FG000|Overall Study|started on excluded medication|1|||
160834631|NCT02265796|580780145|FG001|Overall Study|started on excluded medication|0|||
160834632|NCT02265796|580780144|FG000|Overall Study|Withdrawal by Subject|1|||
160834633|NCT02265796|580780145|FG001|Overall Study|Withdrawal by Subject|1|||
160834634|NCT02477553|580780146|FG000|Overall Study|Screening up-to-date|12|||
160834635|NCT02477553|580780147|FG001|Overall Study|Screening up-to-date|13|||
160834636|NCT02477553|580780146|FG000|Overall Study|No MD visit|1|||
160834637|NCT02477553|580780147|FG001|Overall Study|No MD visit|1|||
160834638|NCT02477553|580780146|FG000|Overall Study|Workup consistent w/CRC|1|||
160834639|NCT02477553|580780147|FG001|Overall Study|Workup consistent w/CRC|1|||
160834640|NCT02477553|580780146|FG000|Overall Study|Technical issues with intervention|2|||
160834641|NCT02477553|580780147|FG001|Overall Study|Technical issues with intervention|0|||
160834642|NCT02477553|580780146|FG000|Overall Study|Elevated risk for CRC|2|||
160562435|NCT00408005|579781590|FG007|Induction|Recurrent leukemia|0|||
160562436|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
160562437|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
160562438|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
160562439|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
160562440|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
160834643|NCT02477553|580780147|FG001|Overall Study|Elevated risk for CRC|2|||
160834644|NCT02477553|580780146|FG000|Overall Study|MD advised against screening|1|||
160834645|NCT02477553|580780147|FG001|Overall Study|MD advised against screening|3|||
160834646|NCT02477553|580780146|FG000|Overall Study|patient deceased|1|||
160834647|NCT02477553|580780147|FG001|Overall Study|patient deceased|0|||
160834648|NCT04023682|580780148|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
160834649|NCT00454649|580780149|FG000|Overall Study|Lack of Efficacy|2|||
160834650|NCT00454649|580780150|FG001|Overall Study|Lack of Efficacy|2|||
160834651|NCT00454649|580780151|FG002|Overall Study|Lack of Efficacy|10|||
160834652|NCT00454649|580780152|FG003|Overall Study|Lack of Efficacy|3|||
160834653|NCT00454649|580780153|FG004|Overall Study|Lack of Efficacy|0|||
160834654|NCT00454649|580780154|FG005|Overall Study|Lack of Efficacy|4|||
160834655|NCT00454649|580780155|FG006|Overall Study|Lack of Efficacy|5|||
160834656|NCT00454649|580780156|FG007|Overall Study|Lack of Efficacy|13|||
160834657|NCT00454649|580780157|FG008|Overall Study|Lack of Efficacy|10|||
160834658|NCT00454649|580780158|FG009|Overall Study|Lack of Efficacy|2|||
160834659|NCT00454649|580780149|FG000|Overall Study|Adverse Event|0|||
160834660|NCT00454649|580780150|FG001|Overall Study|Adverse Event|1|||
160834661|NCT00454649|580780151|FG002|Overall Study|Adverse Event|3|||
160834662|NCT00454649|580780152|FG003|Overall Study|Adverse Event|0|||
160834663|NCT00454649|580780153|FG004|Overall Study|Adverse Event|1|||
160834664|NCT00454649|580780154|FG005|Overall Study|Adverse Event|2|||
160834665|NCT00454649|580780155|FG006|Overall Study|Adverse Event|3|||
160834666|NCT00454649|580780156|FG007|Overall Study|Adverse Event|4|||
160834667|NCT00454649|580780157|FG008|Overall Study|Adverse Event|6|||
160834668|NCT00454649|580780158|FG009|Overall Study|Adverse Event|2|||
160834669|NCT00454649|580780149|FG000|Overall Study|Lost to Follow-up|0|||
160834670|NCT00454649|580780150|FG001|Overall Study|Lost to Follow-up|0|||
160834671|NCT00454649|580780151|FG002|Overall Study|Lost to Follow-up|1|||
160834672|NCT00454649|580780152|FG003|Overall Study|Lost to Follow-up|0|||
160834673|NCT00454649|580780153|FG004|Overall Study|Lost to Follow-up|0|||
160834674|NCT00454649|580780154|FG005|Overall Study|Lost to Follow-up|0|||
160834675|NCT00454649|580780155|FG006|Overall Study|Lost to Follow-up|1|||
160834676|NCT00454649|580780156|FG007|Overall Study|Lost to Follow-up|0|||
160834677|NCT00454649|580780157|FG008|Overall Study|Lost to Follow-up|0|||
160834678|NCT00454649|580780158|FG009|Overall Study|Lost to Follow-up|0|||
160834679|NCT00454649|580780149|FG000|Overall Study|Other|1|||
160834680|NCT00454649|580780150|FG001|Overall Study|Other|1|||
160834681|NCT00454649|580780151|FG002|Overall Study|Other|5|||
160834682|NCT00454649|580780152|FG003|Overall Study|Other|3|||
160834683|NCT00454649|580780153|FG004|Overall Study|Other|0|||
160834684|NCT00454649|580780154|FG005|Overall Study|Other|0|||
160834685|NCT00454649|580780155|FG006|Overall Study|Other|0|||
160834686|NCT00454649|580780156|FG007|Overall Study|Other|0|||
160834687|NCT00454649|580780157|FG008|Overall Study|Other|3|||
160834688|NCT00454649|580780158|FG009|Overall Study|Other|1|||
160834689|NCT00454649|580780149|FG000|Overall Study|Withdrawal by Subject|0|||
160834690|NCT00454649|580780150|FG001|Overall Study|Withdrawal by Subject|0|||
160834691|NCT00454649|580780151|FG002|Overall Study|Withdrawal by Subject|0|||
160834692|NCT00454649|580780152|FG003|Overall Study|Withdrawal by Subject|0|||
160834693|NCT00454649|580780153|FG004|Overall Study|Withdrawal by Subject|0|||
160834694|NCT00454649|580780154|FG005|Overall Study|Withdrawal by Subject|1|||
160834695|NCT00454649|580780155|FG006|Overall Study|Withdrawal by Subject|0|||
160834696|NCT00454649|580780156|FG007|Overall Study|Withdrawal by Subject|2|||
160834697|NCT00454649|580780157|FG008|Overall Study|Withdrawal by Subject|1|||
160834698|NCT00454649|580780158|FG009|Overall Study|Withdrawal by Subject|0|||
160834699|NCT02745535|580780160|FG000|Overall Study|Death|1|||
160834700|NCT02745535|580780160|FG000|Overall Study|Adverse Event|3|||
160834701|NCT02745535|580780160|FG000|Overall Study|Lost to Follow-up|2|||
160834702|NCT00377364|580780165|FG000|Overall Study|Lost to Follow-up|1|||
160834703|NCT00377364|580780166|FG001|Overall Study|Lost to Follow-up|0|||
160834704|NCT00377364|580780165|FG000|Overall Study|Withdrawal by Subject|1|||
160834705|NCT00377364|580780166|FG001|Overall Study|Withdrawal by Subject|0|||
160834706|NCT01291277|580780167|FG000|Overall Study|Death|2|||
160834707|NCT01291277|580780168|FG001|Overall Study|Death|2|||
160834708|NCT01291277|580780167|FG000|Overall Study|Lost to Follow-up|3|||
160834709|NCT01291277|580780168|FG001|Overall Study|Lost to Follow-up|1|||
160834710|NCT02963701|580780172|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
160834711|NCT02963701|580780173|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
160834712|NCT01345682|580780176|FG000|Overall Study|Progressive disease per RECIST|226|||
160834713|NCT01345682|580780177|FG001|Overall Study|Progressive disease per RECIST|93|||
160834714|NCT01345682|580780176|FG000|Overall Study|Worsening of underlying cancer disease|23|||
160834715|NCT01345682|580780177|FG001|Overall Study|Worsening of underlying cancer disease|12|||
160834716|NCT01345682|580780176|FG000|Overall Study|Adverse Event|51|||
160834717|NCT01345682|580780177|FG001|Overall Study|Adverse Event|41|||
160834718|NCT01345682|580780176|FG000|Overall Study|Non-compliance with protocol|0|||
160834719|NCT01345682|580780177|FG001|Overall Study|Non-compliance with protocol|1|||
160834720|NCT01345682|580780176|FG000|Overall Study|Lost to Follow-up|0|||
160834721|NCT01345682|580780177|FG001|Overall Study|Lost to Follow-up|1|||
160834722|NCT01345682|580780176|FG000|Overall Study|Refused to continue trial medication|16|||
160834723|NCT01345682|580780177|FG001|Overall Study|Refused to continue trial medication|9|||
160834724|NCT01345682|580780176|FG000|Overall Study|Not treated|2|||
160834725|NCT01345682|580780177|FG001|Overall Study|Not treated|1|||
160834726|NCT01345682|580780176|FG000|Overall Study|Reason other than those specified above|4|||
160834727|NCT01345682|580780177|FG001|Overall Study|Reason other than those specified above|3|||
160834728|NCT00637572|580780178|FG000|Overall Study|Adverse Event|1|||
160834729|NCT00637572|580780179|FG001|Overall Study|Adverse Event|2|||
160834730|NCT00637572|580780178|FG000|Overall Study|Death|0|||
160834731|NCT00637572|580780179|FG001|Overall Study|Death|1|||
160834732|NCT00637572|580780178|FG000|Overall Study|Lost to Follow-up|0|||
160834733|NCT00637572|580780179|FG001|Overall Study|Lost to Follow-up|1|||
160834734|NCT00637572|580780178|FG000|Overall Study|Physician Decision|1|||
160834735|NCT00637572|580780179|FG001|Overall Study|Physician Decision|1|||
160834736|NCT00637572|580780178|FG000|Overall Study|Withdrawal by Subject|0|||
160834737|NCT00637572|580780179|FG001|Overall Study|Withdrawal by Subject|2|||
160834738|NCT00637572|580780178|FG000|Overall Study|Illicit Drug Use|1|||
160834739|NCT00637572|580780179|FG001|Overall Study|Illicit Drug Use|0|||
160834740|NCT00896649|580780180|FG000|Overall Study|Physician Decision|1|||
160834741|NCT00896649|580780180|FG000|Overall Study|Pregnancy|1|||
160834742|NCT00896649|580780180|FG000|Overall Study|missing documentation|1|||
160834743|NCT00896649|580780180|FG000|Overall Study|technical difficulties|2|||
160834744|NCT04268745|580780181|FG000|Overall Study|Lost to Follow-up|2|||
160834745|NCT04268745|580780182|FG001|Overall Study|Lost to Follow-up|3|||
160834746|NCT04268745|580780181|FG000|Overall Study|Withdrawal by Subject|4|||
160834747|NCT04268745|580780182|FG001|Overall Study|Withdrawal by Subject|2|||
160834748|NCT04268745|580780181|FG000|Overall Study|Death in the family|1|||
160834749|NCT04268745|580780182|FG001|Overall Study|Death in the family|0|||
160834750|NCT01887353|580780183|FG000|Overall Study|Study stopped early|4|||
160834751|NCT01887353|580780184|FG001|Overall Study|Study stopped early|3|||
160834752|NCT03109184|580781690|FG000|Overall Study|Lost to Follow-up|6|||
160834753|NCT03109184|580781691|FG001|Overall Study|Lost to Follow-up|6|||
160834754|NCT03109184|580781690|FG000|Overall Study|Withdrawal by Subject|1|||
160834755|NCT03109184|580781691|FG001|Overall Study|Withdrawal by Subject|1|||
160834756|NCT00602420|580781692|FG000|Overall Study|Death|1|||
160834757|NCT00602420|580781693|FG001|Overall Study|Death|4|||
160834758|NCT00602420|580781692|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
160834759|NCT00602420|580781693|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
160834760|NCT00602420|580781692|FG000|Overall Study|Withdrawal by Subject|18|||
160991298|NCT00157014|581357735|FG003|Overall Study|Physician Decision|0|||
160991299|NCT00157014|581357732|FG000|Overall Study|Medications withdrawn on family request|0|||
160991300|NCT00157014|581357733|FG001|Overall Study|Medications withdrawn on family request|1|||
160991301|NCT00157014|581357734|FG002|Overall Study|Medications withdrawn on family request|0|||
160991302|NCT00157014|581357735|FG003|Overall Study|Medications withdrawn on family request|0|||
160991303|NCT00157014|581357732|FG000|Overall Study|Patient withdrawn by investigator|1|||
160991304|NCT00157014|581357733|FG001|Overall Study|Patient withdrawn by investigator|0|||
160834761|NCT00602420|580781693|FG001|Overall Study|Withdrawal by Subject|17|||
160834762|NCT00602420|580781692|FG000|Overall Study|Adverse Event|1|||
160834763|NCT00602420|580781693|FG001|Overall Study|Adverse Event|0|||
160834764|NCT01209078|580781705|FG000|Overall Study|Adverse Event|5|||
160834765|NCT01209078|580781706|FG001|Overall Study|Adverse Event|0|||
160834766|NCT01209078|580781705|FG000|Overall Study|Lost to Follow-up|4|||
160834767|NCT01209078|580781706|FG001|Overall Study|Lost to Follow-up|0|||
160991305|NCT00157014|581357734|FG002|Overall Study|Patient withdrawn by investigator|0|||
160834768|NCT01209078|580781705|FG000|Overall Study|Physician Decision|5|||
160834769|NCT01209078|580781706|FG001|Overall Study|Physician Decision|2|||
160834770|NCT01209078|580781705|FG000|Overall Study|Withdrawal by Subject|2|||
160834771|NCT01209078|580781706|FG001|Overall Study|Withdrawal by Subject|1|||
160834772|NCT02540668|580781707|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
160834773|NCT02540668|580781708|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
160834774|NCT03270891|580781709|FG000|Overall Study|Lost to Follow-up|3|||
160834775|NCT03270891|580781710|FG001|Overall Study|Lost to Follow-up|6|||
160834776|NCT03270891|580781711|FG002|Overall Study|Lost to Follow-up|0|||
160834777|NCT03270891|580781709|FG000|Overall Study|Withdrawal by Subject|1|||
160834778|NCT03270891|580781710|FG001|Overall Study|Withdrawal by Subject|0|||
160834779|NCT03270891|580781711|FG002|Overall Study|Withdrawal by Subject|0|||
160862009|NCT05138653|580887920|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
160834780|NCT03270891|580781709|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
160834781|NCT03270891|580781710|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
160834782|NCT03270891|580781711|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
160834783|NCT00849108|580781712|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
160834784|NCT00849108|580781713|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
160834785|NCT00849108|580781712|FG000|Cohort 2 Efficacy|Adverse Event|0|||
160834786|NCT00849108|580781713|FG001|Cohort 2 Efficacy|Adverse Event|1|||
160834787|NCT00849108|580781712|FG000|Cohort 2 Efficacy|Other|0|||
160834788|NCT00849108|580781713|FG001|Cohort 2 Efficacy|Other|9|||
160834789|NCT01475162|580781716|FG000|Overall Study|Physician Decision|1|||
160834790|NCT01475162|580781716|FG000|Overall Study|Death|10|||
160834791|NCT01475162|580781716|FG000|Overall Study|Study closed for safety|3|||
160834792|NCT00545103|580781717|FG000|Overall Study|Lack of Efficacy|48|||
160834793|NCT00545103|580781718|FG001|Overall Study|Lack of Efficacy|45|||
160834794|NCT00545103|580781719|FG002|Overall Study|Lack of Efficacy|31|||
160834795|NCT00545103|580781720|FG003|Overall Study|Lack of Efficacy|27|||
160834796|NCT00545103|580781717|FG000|Overall Study|Withdrawal by Subject|6|||
160834797|NCT00545103|580781718|FG001|Overall Study|Withdrawal by Subject|10|||
160834798|NCT00545103|580781719|FG002|Overall Study|Withdrawal by Subject|18|||
160834799|NCT00545103|580781720|FG003|Overall Study|Withdrawal by Subject|22|||
160834800|NCT00545103|580781717|FG000|Overall Study|Adverse Event|11|||
160834801|NCT00545103|580781718|FG001|Overall Study|Adverse Event|12|||
160834802|NCT00545103|580781719|FG002|Overall Study|Adverse Event|17|||
160834803|NCT00545103|580781720|FG003|Overall Study|Adverse Event|10|||
160834804|NCT00545103|580781717|FG000|Overall Study|Lost to Follow-up|4|||
160834805|NCT00545103|580781718|FG001|Overall Study|Lost to Follow-up|6|||
160834806|NCT00545103|580781719|FG002|Overall Study|Lost to Follow-up|3|||
160834807|NCT00545103|580781720|FG003|Overall Study|Lost to Follow-up|4|||
160834808|NCT00545103|580781717|FG000|Overall Study|Protocol Violation|1|||
160834809|NCT00545103|580781718|FG001|Overall Study|Protocol Violation|2|||
160834810|NCT00545103|580781719|FG002|Overall Study|Protocol Violation|3|||
160834811|NCT00545103|580781720|FG003|Overall Study|Protocol Violation|0|||
160834812|NCT00545103|580781717|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
160834813|NCT00545103|580781718|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
160834814|NCT00545103|580781719|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
160834815|NCT00545103|580781720|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
160834816|NCT00545103|580781717|FG000|Overall Study|Difficult to open package|0|||
160834817|NCT00545103|580781718|FG001|Overall Study|Difficult to open package|0|||
160834818|NCT00545103|580781719|FG002|Overall Study|Difficult to open package|0|||
160834819|NCT00545103|580781720|FG003|Overall Study|Difficult to open package|1|||
160834820|NCT00545103|580781717|FG000|Overall Study|Investigational product not taken|1|||
160834821|NCT00545103|580781718|FG001|Overall Study|Investigational product not taken|0|||
160834822|NCT00545103|580781719|FG002|Overall Study|Investigational product not taken|0|||
160834823|NCT00545103|580781720|FG003|Overall Study|Investigational product not taken|1|||
160834824|NCT00545103|580781717|FG000|Overall Study|Wish to start a family|0|||
160834825|NCT00545103|580781718|FG001|Overall Study|Wish to start a family|0|||
160834826|NCT00545103|580781719|FG002|Overall Study|Wish to start a family|0|||
160834827|NCT00545103|580781720|FG003|Overall Study|Wish to start a family|1|||
160834828|NCT00545103|580781717|FG000|Overall Study|Diverticulitis crisis|0|||
160834829|NCT00545103|580781718|FG001|Overall Study|Diverticulitis crisis|0|||
160834830|NCT00545103|580781719|FG002|Overall Study|Diverticulitis crisis|0|||
160834831|NCT00545103|580781720|FG003|Overall Study|Diverticulitis crisis|1|||
160834832|NCT00545103|580781717|FG000|Overall Study|Personal reasons|1|||
160834833|NCT00545103|580781718|FG001|Overall Study|Personal reasons|0|||
160834834|NCT00545103|580781719|FG002|Overall Study|Personal reasons|0|||
160834835|NCT00545103|580781720|FG003|Overall Study|Personal reasons|0|||
160834836|NCT00545103|580781717|FG000|Overall Study|Subject's decision|1|||
160834837|NCT00545103|580781718|FG001|Overall Study|Subject's decision|0|||
160834838|NCT00545103|580781719|FG002|Overall Study|Subject's decision|0|||
160834839|NCT00545103|580781720|FG003|Overall Study|Subject's decision|0|||
160834840|NCT00545103|580781717|FG000|Overall Study|Noncompliance|0|||
160834841|NCT00545103|580781718|FG001|Overall Study|Noncompliance|1|||
160834842|NCT00545103|580781719|FG002|Overall Study|Noncompliance|0|||
160834843|NCT00545103|580781720|FG003|Overall Study|Noncompliance|0|||
160834844|NCT00545103|580781717|FG000|Overall Study|Investigator decision|0|||
160834845|NCT00545103|580781718|FG001|Overall Study|Investigator decision|0|||
160834846|NCT00545103|580781719|FG002|Overall Study|Investigator decision|1|||
160834847|NCT00545103|580781720|FG003|Overall Study|Investigator decision|0|||
160834848|NCT00545103|580781717|FG000|Overall Study|Subject moved|0|||
160834849|NCT00545103|580781718|FG001|Overall Study|Subject moved|1|||
160834850|NCT00545103|580781719|FG002|Overall Study|Subject moved|0|||
160834851|NCT00545103|580781720|FG003|Overall Study|Subject moved|0|||
160834852|NCT00545103|580781717|FG000|Overall Study|Use of prohibited medication|0|||
160834853|NCT00545103|580781718|FG001|Overall Study|Use of prohibited medication|0|||
160834854|NCT00545103|580781719|FG002|Overall Study|Use of prohibited medication|1|||
160834855|NCT00545103|580781720|FG003|Overall Study|Use of prohibited medication|0|||
160834856|NCT00545103|580781717|FG000|Overall Study|Does not want to take study drug anymore|1|||
160834857|NCT00545103|580781718|FG001|Overall Study|Does not want to take study drug anymore|0|||
160834858|NCT00545103|580781719|FG002|Overall Study|Does not want to take study drug anymore|1|||
160834859|NCT00545103|580781720|FG003|Overall Study|Does not want to take study drug anymore|0|||
160834860|NCT00545103|580781717|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
160834861|NCT00545103|580781718|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
160834862|NCT00545103|580781719|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
160834863|NCT00545103|580781720|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
160834864|NCT00545103|580781717|FG000|Overall Study|Death|0|||
160834865|NCT00545103|580781718|FG001|Overall Study|Death|1|||
160834866|NCT00545103|580781719|FG002|Overall Study|Death|0|||
160834867|NCT00545103|580781720|FG003|Overall Study|Death|0|||
160834868|NCT05026853|580781721|FG000|Overall Study|Cancelled appointment|1|||
160834869|NCT05026853|580781722|FG001|Overall Study|Cancelled appointment|0|||
160834870|NCT05026853|580781721|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
160834871|NCT05026853|580781722|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
160834872|NCT05026853|580781721|FG000|Overall Study|Did not complete 12-week survey|16|||
160834873|NCT05026853|580781722|FG001|Overall Study|Did not complete 12-week survey|16|||
160834874|NCT02358044|580781723|FG000|Overall Study|Adverse Event|0|||
160834875|NCT02358044|580781724|FG001|Overall Study|Adverse Event|1|||
160834876|NCT02358044|580781723|FG000|Overall Study|Lost to Follow-up|2|||
160834877|NCT02358044|580781724|FG001|Overall Study|Lost to Follow-up|1|||
160834878|NCT02358044|580781723|FG000|Overall Study|Physician Decision|0|||
160903771|NCT02229383|581040628|FG000|Overall Study|Withdrawal by Subject|4|||
160903772|NCT02229383|581040629|FG001|Overall Study|Withdrawal by Subject|6|||
160903773|NCT02229383|581040628|FG000|Overall Study|Did not receive treatment|1|||
160903774|NCT02229383|581040629|FG001|Overall Study|Did not receive treatment|0|||
160903775|NCT02229383|581040628|FG000|Overall Study|Other|3|||
160903776|NCT02229383|581040629|FG001|Overall Study|Other|8|||
160903777|NCT01218113|581043013|FG000|Overall Study|Withdrawal by Subject|1|||
160903778|NCT01218113|581043014|FG001|Overall Study|Withdrawal by Subject|0|||
160903779|NCT01218113|581043015|FG002|Overall Study|Withdrawal by Subject|1|||
160903780|NCT01218113|581043013|FG000|Overall Study|Lost to Follow-up|4|||
160903781|NCT01218113|581043014|FG001|Overall Study|Lost to Follow-up|1|||
160903782|NCT01218113|581043015|FG002|Overall Study|Lost to Follow-up|4|||
160903783|NCT01218113|581043013|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
160903784|NCT01218113|581043014|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
160903785|NCT01218113|581043015|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
160903786|NCT01385566|581043017|FG000|Overall Study|Lost to Follow-up|1|||
160903787|NCT01385566|581043018|FG001|Overall Study|Lost to Follow-up|0|||
160903788|NCT01385566|581043019|FG002|Overall Study|Lost to Follow-up|0|||
160903789|NCT01385566|581043020|FG003|Overall Study|Lost to Follow-up|0|||
160903790|NCT01385566|581043021|FG004|Overall Study|Lost to Follow-up|0|||
160903791|NCT01385566|581043022|FG005|Overall Study|Lost to Follow-up|0|||
160903792|NCT01385566|581043017|FG000|Overall Study|Withdrawal by Subject|0|||
160903793|NCT01385566|581043018|FG001|Overall Study|Withdrawal by Subject|0|||
160903794|NCT01385566|581043019|FG002|Overall Study|Withdrawal by Subject|0|||
160903795|NCT01385566|581043020|FG003|Overall Study|Withdrawal by Subject|1|||
160903796|NCT01385566|581043021|FG004|Overall Study|Withdrawal by Subject|0|||
160903797|NCT01385566|581043022|FG005|Overall Study|Withdrawal by Subject|0|||
160903798|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
160903799|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
160834879|NCT02358044|580781724|FG001|Overall Study|Physician Decision|1|||
160834880|NCT02358044|580781723|FG000|Overall Study|Withdrawal by Subject|0|||
160834881|NCT02358044|580781724|FG001|Overall Study|Withdrawal by Subject|4|||
160903800|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
160903801|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
160834882|NCT01732913|580781725|FG000|Overall Study|Study Terminated by Sponsor|105|||
160903802|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
160903803|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
160903804|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
160903805|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
160834883|NCT01732913|580781726|FG001|Overall Study|Study Terminated by Sponsor|55|||
160834884|NCT01732913|580781725|FG000|Overall Study|Withdrawal by Subject|27|||
160834885|NCT01732913|580781726|FG001|Overall Study|Withdrawal by Subject|4|||
160834886|NCT01732913|580781725|FG000|Overall Study|Physician Decision|14|||
160834887|NCT01732913|580781726|FG001|Overall Study|Physician Decision|7|||
160834888|NCT01732913|580781725|FG000|Overall Study|Other|7|||
160834889|NCT01732913|580781726|FG001|Overall Study|Other|1|||
160834890|NCT01732913|580781725|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
160834891|NCT01732913|580781726|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
160834892|NCT00903331|580781727|FG000|Overall Study|Death|4|||
160991306|NCT00157014|581357735|FG003|Overall Study|Patient withdrawn by investigator|0|||
160991307|NCT00157014|581357732|FG000|Overall Study|Patient unable to return in nursing home|1|||
160991308|NCT00157014|581357733|FG001|Overall Study|Patient unable to return in nursing home|0|||
160991309|NCT00157014|581357734|FG002|Overall Study|Patient unable to return in nursing home|0|||
160991310|NCT00157014|581357735|FG003|Overall Study|Patient unable to return in nursing home|0|||
160991311|NCT00157014|581357732|FG000|Overall Study|Patient would not receive transplant|0|||
160991312|NCT00157014|581357733|FG001|Overall Study|Patient would not receive transplant|1|||
160991313|NCT00157014|581357734|FG002|Overall Study|Patient would not receive transplant|0|||
160991314|NCT00157014|581357735|FG003|Overall Study|Patient would not receive transplant|0|||
160991315|NCT00157014|581357732|FG000|Overall Study|Withdrawal by Subject|1|||
160991316|NCT00157014|581357733|FG001|Overall Study|Withdrawal by Subject|0|||
160991317|NCT00157014|581357734|FG002|Overall Study|Withdrawal by Subject|0|||
160991318|NCT00157014|581357735|FG003|Overall Study|Withdrawal by Subject|0|||
160991319|NCT01362491|581357736|FG000|Overall Study|Ineligible|1|||
160991320|NCT01362491|581357737|FG001|Overall Study|Ineligible|0|||
160991321|NCT01362491|581357738|FG002|Overall Study|Ineligible|0|||
160991322|NCT05355116|581357739|FG000|Overall Study|Withdrawal by Subject|2|||
160991323|NCT01168401|581357743|FG000|Overall Study|Lost to Follow-up|1|||
160991324|NCT01168401|581357744|FG001|Overall Study|Lost to Follow-up|1|||
160991325|NCT01168401|581357745|FG002|Overall Study|Lost to Follow-up|2|||
160991326|NCT01168401|581357746|FG003|Overall Study|Lost to Follow-up|1|||
160991327|NCT01168401|581357747|FG004|Overall Study|Lost to Follow-up|0|||
160991328|NCT01168401|581357748|FG005|Overall Study|Lost to Follow-up|0|||
160991329|NCT01168401|581357749|FG006|Overall Study|Lost to Follow-up|0|||
160991330|NCT01168401|581357750|FG007|Overall Study|Lost to Follow-up|0|||
160991331|NCT01168401|581357751|FG008|Overall Study|Lost to Follow-up|0|||
160991332|NCT01168401|581357752|FG009|Overall Study|Lost to Follow-up|0|||
160991333|NCT01168401|581357753|FG010|Overall Study|Lost to Follow-up|0|||
160562441|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
160562442|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
160562443|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
160562444|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
160562445|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
160562446|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
160562447|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
160562448|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
160562449|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
160562450|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
160562451|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
160562452|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
160562453|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
160562454|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
160562455|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
160647633|NCT00416520|580092783|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
160834893|NCT00903331|580781728|FG001|Overall Study|Death|8|||
160834894|NCT00903331|580781727|FG000|Overall Study|Withdrawal of consent|1|||
160834895|NCT00903331|580781728|FG001|Overall Study|Withdrawal of consent|8|||
160834896|NCT00903331|580781727|FG000|Overall Study|Lung transplant|0|||
160834897|NCT00903331|580781728|FG001|Overall Study|Lung transplant|2|||
160991334|NCT01168401|581357743|FG000|Overall Study|Withdrawal by Subject|0|||
160991335|NCT01168401|581357744|FG001|Overall Study|Withdrawal by Subject|0|||
160991336|NCT01168401|581357745|FG002|Overall Study|Withdrawal by Subject|0|||
160562456|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
160562457|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
160834898|NCT02723175|580781729|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
160834899|NCT02723175|580781730|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
160834900|NCT02723175|580781729|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
160834901|NCT02723175|580781730|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
160991337|NCT01168401|581357746|FG003|Overall Study|Withdrawal by Subject|1|||
160991338|NCT01168401|581357747|FG004|Overall Study|Withdrawal by Subject|0|||
160834902|NCT03233438|580781731|FG000|Overall Study|Lost to Follow-up|4|||
160991339|NCT01168401|581357748|FG005|Overall Study|Withdrawal by Subject|0|||
160991340|NCT01168401|581357749|FG006|Overall Study|Withdrawal by Subject|0|||
160991341|NCT01168401|581357750|FG007|Overall Study|Withdrawal by Subject|0|||
160834903|NCT03233438|580781732|FG001|Overall Study|Lost to Follow-up|9|||
160834904|NCT03233438|580781731|FG000|Overall Study|Withdrawal by Subject|2|||
160834905|NCT03233438|580781732|FG001|Overall Study|Withdrawal by Subject|1|||
160834906|NCT03233438|580781731|FG000|Overall Study|No recording of dalbavancin|0|||
160834907|NCT03233438|580781732|FG001|Overall Study|No recording of dalbavancin|1|||
160834908|NCT02925741|580781736|FG000|Overall Study|Withdrawal by Subject|11|||
160834909|NCT02925741|580781737|FG001|Overall Study|Withdrawal by Subject|0|||
160834910|NCT00413374|580781740|FG000|Overall Study|Ineligible due to screening criteria.|3|||
160834911|NCT00413374|580781741|FG001|Overall Study|Ineligible due to screening criteria.|0|||
160834912|NCT00413374|580781740|FG000|Overall Study|Adverse Event|1|||
160834913|NCT00413374|580781741|FG001|Overall Study|Adverse Event|0|||
160834914|NCT00413374|580781740|FG000|Overall Study|Lost to Follow-up|1|||
160834915|NCT00413374|580781741|FG001|Overall Study|Lost to Follow-up|0|||
160834916|NCT00413374|580781740|FG000|Overall Study|Surgery|1|||
160834917|NCT00413374|580781741|FG001|Overall Study|Surgery|0|||
160834918|NCT00552760|580781744|FG000|Overall Study|Adverse Event|3|||
160834919|NCT00552760|580781745|FG001|Overall Study|Adverse Event|5|||
160834920|NCT00552760|580781744|FG000|Overall Study|Relapsed- Depressed Event|10|||
160834921|NCT00552760|580781745|FG001|Overall Study|Relapsed- Depressed Event|16|||
160834922|NCT00552760|580781744|FG000|Overall Study|Relapse- Manic Event|3|||
160834923|NCT00552760|580781745|FG001|Overall Study|Relapse- Manic Event|3|||
160834924|NCT00552760|580781744|FG000|Overall Study|Relapsed- Mixed Event|3|||
160834925|NCT00552760|580781745|FG001|Overall Study|Relapsed- Mixed Event|5|||
160834926|NCT00552760|580781744|FG000|Overall Study|Protocol Violation|0|||
160834927|NCT00552760|580781745|FG001|Overall Study|Protocol Violation|1|||
160834928|NCT00552760|580781744|FG000|Overall Study|Lost to Follow-up|1|||
160834929|NCT00552760|580781745|FG001|Overall Study|Lost to Follow-up|1|||
160834930|NCT00552760|580781744|FG000|Overall Study|Non-compliance|1|||
160834931|NCT00552760|580781745|FG001|Overall Study|Non-compliance|1|||
160834932|NCT00552760|580781744|FG000|Overall Study|Medical Condition|1|||
160834933|NCT00552760|580781745|FG001|Overall Study|Medical Condition|1|||
160834934|NCT00552760|580781744|FG000|Overall Study|Withdrawal by Subject|3|||
160834935|NCT00552760|580781745|FG001|Overall Study|Withdrawal by Subject|0|||
160834936|NCT00552760|580781744|FG000|Overall Study|Medication Change|1|||
160834937|NCT00552760|580781745|FG001|Overall Study|Medication Change|0|||
160834938|NCT00494507|580781747|FG000|Double-Blind Phase|Adverse Event|2|||
160834939|NCT00494507|580781748|FG001|Double-Blind Phase|Adverse Event|0|||
160834940|NCT00494507|580781749|FG002|Double-Blind Phase|Adverse Event|1|||
160834941|NCT00494507|580781750|FG003|Double-Blind Phase|Adverse Event|0|||
160903806|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
160903807|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
160903808|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
160903809|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
160903810|NCT00787891|581043023|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
160834942|NCT00494507|580781747|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
160834943|NCT00494507|580781748|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
160903811|NCT00787891|581043024|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
160903812|NCT00787891|581043023|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
160903813|NCT00787891|581043024|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
160903814|NCT00787891|581043023|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
160903815|NCT00787891|581043024|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
160903816|NCT00787891|581043023|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
160903817|NCT00787891|581043024|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
160903818|NCT01594281|581043025|FG000|Interventional Core Phase|Protocol Deviation|1|||
160903819|NCT01594281|581043026|FG001|Interventional Core Phase|Protocol Deviation|0|||
160903820|NCT01594281|581043027|FG002|Interventional Core Phase|Protocol Deviation|0|||
160903821|NCT01594281|581043025|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
160903822|NCT01594281|581043026|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
160903823|NCT01594281|581043027|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
160903824|NCT01594281|581043025|FG000|Interventional Core Phase|Death|1|||
160991342|NCT01168401|581357751|FG008|Overall Study|Withdrawal by Subject|0|||
160991343|NCT01168401|581357752|FG009|Overall Study|Withdrawal by Subject|0|||
160834944|NCT00494507|580781749|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160834945|NCT00494507|580781750|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160834946|NCT00494507|580781747|FG000|Double-Blind Phase|Subject Non-compliance|0|||
160834947|NCT00494507|580781748|FG001|Double-Blind Phase|Subject Non-compliance|0|||
160834948|NCT00494507|580781749|FG002|Double-Blind Phase|Subject Non-compliance|1|||
160834949|NCT00494507|580781750|FG003|Double-Blind Phase|Subject Non-compliance|0|||
160834950|NCT00494507|580781747|FG000|Double-Blind Phase|Negative DNA test|0|||
160834951|NCT00494507|580781748|FG001|Double-Blind Phase|Negative DNA test|0|||
160903825|NCT01594281|581043026|FG001|Interventional Core Phase|Death|1|||
160834952|NCT00494507|580781749|FG002|Double-Blind Phase|Negative DNA test|0|||
160834953|NCT00494507|580781750|FG003|Double-Blind Phase|Negative DNA test|1|||
160834954|NCT00494507|580781747|FG000|Open-Label Phase|Adverse Event|0|||
160991344|NCT01168401|581357753|FG010|Overall Study|Withdrawal by Subject|0|||
160991345|NCT01801930|581357755|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
160991346|NCT01801930|581357756|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
160991347|NCT01801930|581357757|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
160991348|NCT01801930|581357758|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
160991349|NCT01801930|581357755|FG000|Overall Study|DLT occurs|0|||
160991350|NCT01801930|581357756|FG001|Overall Study|DLT occurs|1|||
160834955|NCT00494507|580781748|FG001|Open-Label Phase|Adverse Event|1|||
160834956|NCT00494507|580781749|FG002|Open-Label Phase|Adverse Event|5|||
160834957|NCT00494507|580781750|FG003|Open-Label Phase|Adverse Event|3|||
160834958|NCT00494507|580781747|FG000|Open-Label Phase|Worsening Disease|0|||
160834959|NCT00494507|580781748|FG001|Open-Label Phase|Worsening Disease|0|||
160834960|NCT00494507|580781749|FG002|Open-Label Phase|Worsening Disease|0|||
160834961|NCT00494507|580781750|FG003|Open-Label Phase|Worsening Disease|2|||
160834962|NCT03615066|580781753|FG000|Main Study|Withdrew Consent|0|||
160834963|NCT03615066|580781754|FG001|Main Study|Withdrew Consent|1|||
160991351|NCT01801930|581357757|FG002|Overall Study|DLT occurs|0|||
160991352|NCT01801930|581357758|FG003|Overall Study|DLT occurs|0|||
160991353|NCT03396835|581357766|FG000|Overall Study|Withdrawn prior to completion|1|||
160991354|NCT03396835|581357766|FG000|Overall Study|Did not meet criteria for data analysis|1|||
160991355|NCT01451814|581357767|FG000|Overall Study|Withdrawal by Subject|1|||
160991356|NCT01451814|581357768|FG001|Overall Study|Withdrawal by Subject|1|||
160991357|NCT01451814|581357767|FG000|Overall Study|Lost to Follow-up|5|||
160991358|NCT01451814|581357768|FG001|Overall Study|Lost to Follow-up|4|||
160991359|NCT02049866|581357769|FG000|Overall Study|Withdrawal by Subject|1|||
160991360|NCT03101592|581357772|FG000|Overall Study|participant files could not be located|111|||
160991361|NCT03101592|581357773|FG001|Overall Study|participant files could not be located|170|||
160991362|NCT03101592|581357774|FG002|Overall Study|participant files could not be located|118|||
160991363|NCT02219490|581357778|FG000|Overall Study|Adverse Event|24|||
160991364|NCT02219490|581357778|FG000|Overall Study|Withdrew consent|96|||
160991365|NCT02219490|581357778|FG000|Overall Study|Lost to Follow-up|126|||
160834964|NCT03615066|580781755|FG002|Main Study|Withdrew Consent|1|||
160834965|NCT03615066|580781753|FG000|Main Study|Lost to Follow-up|0|||
160834966|NCT03615066|580781754|FG001|Main Study|Lost to Follow-up|0|||
160834967|NCT03615066|580781755|FG002|Main Study|Lost to Follow-up|1|||
160834968|NCT03615066|580781753|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
160834969|NCT03615066|580781754|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
160834970|NCT03615066|580781755|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
160834971|NCT03615066|580781753|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
160834972|NCT03615066|580781754|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
160834973|NCT03615066|580781755|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
160834974|NCT03615066|580781753|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
160834975|NCT03615066|580781754|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
160834976|NCT03615066|580781755|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
160834977|NCT00924404|580781756|FG000|Overall Study|Lost to Follow-up|6|||
160834978|NCT00924404|580781757|FG001|Overall Study|Lost to Follow-up|4|||
160834979|NCT03426631|580781760|FG000|Overall Study|Lost to Follow-up|0|||
160834980|NCT03426631|580781761|FG001|Overall Study|Lost to Follow-up|1|||
160834981|NCT03831945|580781762|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
160834982|NCT03831945|580781763|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
160834983|NCT03831945|580781762|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
160834984|NCT03831945|580781763|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
160834985|NCT03831945|580781762|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
160834986|NCT03831945|580781763|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
160834987|NCT00454181|580781764|FG000|Overall Study|Adverse Event|1|||
160834988|NCT00454181|580781765|FG001|Overall Study|Adverse Event|1|||
160834989|NCT00454181|580781764|FG000|Overall Study|Lost to Follow-up|11|||
160834990|NCT00454181|580781765|FG001|Overall Study|Lost to Follow-up|1|||
160834991|NCT00454181|580781764|FG000|Overall Study|Protocol Violation|1|||
160834992|NCT00454181|580781765|FG001|Overall Study|Protocol Violation|1|||
160834993|NCT00454181|580781764|FG000|Overall Study|Withdrawal by Subject|2|||
160834994|NCT00454181|580781765|FG001|Overall Study|Withdrawal by Subject|0|||
160834995|NCT02613169|580781768|FG000|Overall Study|Withdrawal by Subject|4|||
160834996|NCT02613169|580781769|FG001|Overall Study|Withdrawal by Subject|1|||
160834997|NCT02613169|580781768|FG000|Overall Study|Lost to Follow-up|0|||
160834998|NCT02613169|580781769|FG001|Overall Study|Lost to Follow-up|5|||
160834999|NCT02613169|580781768|FG000|Overall Study|HIV|0|||
160835000|NCT02613169|580781769|FG001|Overall Study|HIV|2|||
160835001|NCT02613169|580781768|FG000|Overall Study|No TB infection endpoint|14|||
160835002|NCT02613169|580781769|FG001|Overall Study|No TB infection endpoint|9|||
160835003|NCT04032080|580781770|FG000|Overall Study|Death|6|||
160835004|NCT03729245|580781771|FG000|Overall Study|Lost to Follow-up|5|||
160835005|NCT03729245|580781772|FG001|Overall Study|Lost to Follow-up|6|||
160835006|NCT03729245|580781771|FG000|Overall Study|Withdrawal by Subject|16|||
160835007|NCT03729245|580781772|FG001|Overall Study|Withdrawal by Subject|19|||
160835008|NCT03729245|580781771|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
160835009|NCT03729245|580781772|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
160835010|NCT02096263|580781773|FG000|Overall Study|Adverse Event|1|||
160835011|NCT02096263|580781774|FG001|Overall Study|Adverse Event|0|||
160835012|NCT02096263|580781775|FG002|Overall Study|Adverse Event|1|||
160835013|NCT02096263|580781773|FG000|Overall Study|Lost to Follow-up|14|||
160835014|NCT02096263|580781774|FG001|Overall Study|Lost to Follow-up|18|||
160835015|NCT02096263|580781775|FG002|Overall Study|Lost to Follow-up|15|||
160835016|NCT02096263|580781773|FG000|Overall Study|Other|7|||
160835017|NCT02096263|580781774|FG001|Overall Study|Other|9|||
160835018|NCT02096263|580781775|FG002|Overall Study|Other|6|||
160835019|NCT02096263|580781773|FG000|Overall Study|Sponsor study termination|0|||
160835020|NCT02096263|580781774|FG001|Overall Study|Sponsor study termination|0|||
160835021|NCT02096263|580781775|FG002|Overall Study|Sponsor study termination|1|||
160835022|NCT02096263|580781773|FG000|Overall Study|Protocol Violation|7|||
160835023|NCT02096263|580781774|FG001|Overall Study|Protocol Violation|2|||
160835024|NCT02096263|580781775|FG002|Overall Study|Protocol Violation|8|||
160835025|NCT02096263|580781773|FG000|Overall Study|Withdrawal by Subject|5|||
160835026|NCT02096263|580781774|FG001|Overall Study|Withdrawal by Subject|7|||
160835027|NCT02096263|580781775|FG002|Overall Study|Withdrawal by Subject|8|||
160835028|NCT00845065|580781788|FG000|Overall Study|Adverse Event|3|||
160835029|NCT00845065|580781789|FG001|Overall Study|Adverse Event|23|||
160835030|NCT00845065|580781788|FG000|Overall Study|Lack of Efficacy|43|||
160835031|NCT00845065|580781789|FG001|Overall Study|Lack of Efficacy|21|||
160835032|NCT00845065|580781788|FG000|Overall Study|Non-Medical Reasons|1|||
160835033|NCT00845065|580781789|FG001|Overall Study|Non-Medical Reasons|11|||
160835034|NCT03652675|580781794|FG000|Overall Study|Lost to Follow-up|4|||
160835035|NCT03652675|580781795|FG001|Overall Study|Lost to Follow-up|4|||
160835036|NCT03101085|580781797|FG000|Overall Study|Lost to Follow-up|0|||
160835037|NCT03101085|580781798|FG001|Overall Study|Lost to Follow-up|1|||
160835038|NCT00695864|580781805|FG000|Placebo|Withdrawal by Subject|1|||
160835039|NCT00695864|580781805|FG000|Placebo|Physician Decision|4|||
160835040|NCT01624090|580781806|FG000|Overall Study|DLT, taken off therapy|0|||
160835041|NCT01624090|580781807|FG001|Overall Study|DLT, taken off therapy|1|||
160835042|NCT01624090|580781808|FG002|Overall Study|DLT, taken off therapy|0|||
160835043|NCT01624090|580781809|FG003|Overall Study|DLT, taken off therapy|0|||
160835044|NCT01624090|580781806|FG000|Overall Study|Withdrew prior to treatment|0|||
160835045|NCT01624090|580781807|FG001|Overall Study|Withdrew prior to treatment|1|||
160835046|NCT01624090|580781808|FG002|Overall Study|Withdrew prior to treatment|0|||
160835047|NCT01624090|580781809|FG003|Overall Study|Withdrew prior to treatment|0|||
160835048|NCT01624090|580781806|FG000|Overall Study|Died on study|0|||
160835049|NCT01624090|580781807|FG001|Overall Study|Died on study|0|||
160835050|NCT01624090|580781808|FG002|Overall Study|Died on study|2|||
160835051|NCT01624090|580781809|FG003|Overall Study|Died on study|0|||
160835052|NCT01624090|580781806|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
160835053|NCT01624090|580781807|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
160835054|NCT01624090|580781808|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
160835055|NCT01624090|580781809|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
160835056|NCT01624090|580781806|FG000|Overall Study|Dose escalated|0|||
160835057|NCT01624090|580781807|FG001|Overall Study|Dose escalated|0|||
160835058|NCT01624090|580781808|FG002|Overall Study|Dose escalated|3|||
160835059|NCT01624090|580781809|FG003|Overall Study|Dose escalated|0|||
160835060|NCT00752726|580781810|FG000|Overall Study|Lost to Follow-up|2|||
160835061|NCT00752726|580781811|FG001|Overall Study|Lost to Follow-up|1|||
160835062|NCT00752726|580781810|FG000|Overall Study|Adverse Event|3|||
160835063|NCT00752726|580781811|FG001|Overall Study|Adverse Event|0|||
160835064|NCT00752726|580781810|FG000|Overall Study|Withdrawal by Subject|5|||
160835065|NCT00752726|580781811|FG001|Overall Study|Withdrawal by Subject|10|||
160835066|NCT00752726|580781810|FG000|Overall Study|Other Reason|1|||
160835067|NCT00752726|580781811|FG001|Overall Study|Other Reason|2|||
160835068|NCT01895309|580781812|FG000|Overall Study|Adverse Event|13|||
160835069|NCT01895309|580781813|FG001|Overall Study|Adverse Event|17|||
160835070|NCT01895309|580781812|FG000|Overall Study|Protocol Violation|1|||
160835071|NCT01895309|580781813|FG001|Overall Study|Protocol Violation|0|||
160835072|NCT01895309|580781812|FG000|Overall Study|Lack of Efficacy|1|||
160835073|NCT01895309|580781813|FG001|Overall Study|Lack of Efficacy|3|||
160835074|NCT01895309|580781812|FG000|Overall Study|Lost to Follow-up|1|||
160835075|NCT01895309|580781813|FG001|Overall Study|Lost to Follow-up|3|||
160835076|NCT01895309|580781812|FG000|Overall Study|Physician Decision|15|||
160835077|NCT01895309|580781813|FG001|Overall Study|Physician Decision|10|||
160835078|NCT01895309|580781812|FG000|Overall Study|Withdrawal by Subject|9|||
160835079|NCT01895309|580781813|FG001|Overall Study|Withdrawal by Subject|18|||
160835080|NCT04232215|580781814|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
160835081|NCT04232215|580781815|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
160835082|NCT01555125|580781818|FG000|Induction Period|Lost to Follow-up|0|||
160835083|NCT01555125|580781819|FG001|Induction Period|Lost to Follow-up|2|||
160835084|NCT01555125|580781820|FG002|Induction Period|Lost to Follow-up|0|||
160835085|NCT01555125|580781821|FG003|Induction Period|Lost to Follow-up|0|||
160835086|NCT01555125|580781822|FG004|Induction Period|Lost to Follow-up|0|||
160835087|NCT01555125|580781818|FG000|Induction Period|Adverse Event|0|||
160835088|NCT01555125|580781819|FG001|Induction Period|Adverse Event|1|||
160835089|NCT01555125|580781820|FG002|Induction Period|Adverse Event|0|||
160835090|NCT01555125|580781821|FG003|Induction Period|Adverse Event|0|||
160835091|NCT01555125|580781822|FG004|Induction Period|Adverse Event|1|||
160835092|NCT01555125|580781818|FG000|Induction Period|Subject / guardian decision|0|||
160835093|NCT01555125|580781819|FG001|Induction Period|Subject / guardian decision|0|||
160835094|NCT01555125|580781820|FG002|Induction Period|Subject / guardian decision|0|||
160835095|NCT01555125|580781821|FG003|Induction Period|Subject / guardian decision|0|||
160835096|NCT01555125|580781822|FG004|Induction Period|Subject / guardian decision|2|||
160835097|NCT01555125|580781818|FG000|Induction Period|Death|1|||
160835098|NCT01555125|580781819|FG001|Induction Period|Death|0|||
160835099|NCT01555125|580781820|FG002|Induction Period|Death|0|||
160835100|NCT01555125|580781821|FG003|Induction Period|Death|0|||
160835101|NCT01555125|580781822|FG004|Induction Period|Death|0|||
160835102|NCT01555125|580781818|FG000|Maintenance Period|Adverse Event|1|||
160835103|NCT01555125|580781819|FG001|Maintenance Period|Adverse Event|1|||
160835104|NCT01555125|580781820|FG002|Maintenance Period|Adverse Event|0|||
160835105|NCT01555125|580781821|FG003|Maintenance Period|Adverse Event|0|||
160835106|NCT01555125|580781822|FG004|Maintenance Period|Adverse Event|0|||
160835107|NCT01555125|580781818|FG000|Maintenance Period|Subject / guardian decision|1|||
160835108|NCT01555125|580781819|FG001|Maintenance Period|Subject / guardian decision|2|||
160835109|NCT01555125|580781820|FG002|Maintenance Period|Subject / guardian decision|0|||
160835110|NCT01555125|580781821|FG003|Maintenance Period|Subject / guardian decision|0|||
160835111|NCT01555125|580781822|FG004|Maintenance Period|Subject / guardian decision|0|||
160835112|NCT01555125|580781818|FG000|Maintenance Period|Lost to Follow-up|2|||
160835113|NCT01555125|580781819|FG001|Maintenance Period|Lost to Follow-up|0|||
160835114|NCT01555125|580781820|FG002|Maintenance Period|Lost to Follow-up|0|||
160835115|NCT01555125|580781821|FG003|Maintenance Period|Lost to Follow-up|1|||
160835116|NCT01555125|580781822|FG004|Maintenance Period|Lost to Follow-up|0|||
160835117|NCT01555125|580781818|FG000|Maintenance Period|Lack of Efficacy|6|||
160835118|NCT01555125|580781819|FG001|Maintenance Period|Lack of Efficacy|1|||
160835119|NCT01555125|580781820|FG002|Maintenance Period|Lack of Efficacy|3|||
160835120|NCT01555125|580781821|FG003|Maintenance Period|Lack of Efficacy|0|||
160835121|NCT01555125|580781822|FG004|Maintenance Period|Lack of Efficacy|0|||
160835122|NCT01555125|580781818|FG000|Maintenance Period|Physician Decision|0|||
160835123|NCT01555125|580781819|FG001|Maintenance Period|Physician Decision|0|||
160835124|NCT01555125|580781820|FG002|Maintenance Period|Physician Decision|1|||
160562458|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
160835125|NCT01555125|580781821|FG003|Maintenance Period|Physician Decision|0|||
160835126|NCT01555125|580781822|FG004|Maintenance Period|Physician Decision|0|||
160835127|NCT01555125|580781818|FG000|Maintenance Period|Death|0|||
160835128|NCT01555125|580781819|FG001|Maintenance Period|Death|0|||
160835129|NCT01555125|580781820|FG002|Maintenance Period|Death|0|||
160835130|NCT01555125|580781821|FG003|Maintenance Period|Death|1|||
160835131|NCT01555125|580781822|FG004|Maintenance Period|Death|0|||
160835132|NCT01555125|580781818|FG000|Extension|Adverse Event|1|||
160835133|NCT01555125|580781819|FG001|Extension|Adverse Event|2|||
160835134|NCT01555125|580781820|FG002|Extension|Adverse Event|1|||
160835135|NCT01555125|580781821|FG003|Extension|Adverse Event|1|||
160835136|NCT01555125|580781822|FG004|Extension|Adverse Event|0|||
160835137|NCT01555125|580781818|FG000|Extension|Protocol deviation|1|||
160835138|NCT01555125|580781819|FG001|Extension|Protocol deviation|0|||
160835139|NCT01555125|580781820|FG002|Extension|Protocol deviation|0|||
160835140|NCT01555125|580781821|FG003|Extension|Protocol deviation|0|||
160835141|NCT01555125|580781822|FG004|Extension|Protocol deviation|0|||
160835142|NCT01555125|580781818|FG000|Extension|Lack of Efficacy|7|||
160835143|NCT01555125|580781819|FG001|Extension|Lack of Efficacy|6|||
160835144|NCT01555125|580781820|FG002|Extension|Lack of Efficacy|3|||
160835145|NCT01555125|580781821|FG003|Extension|Lack of Efficacy|0|||
160835146|NCT01555125|580781822|FG004|Extension|Lack of Efficacy|0|||
160835147|NCT01555125|580781818|FG000|Extension|Lost to Follow-up|2|||
160835148|NCT01555125|580781819|FG001|Extension|Lost to Follow-up|1|||
160835149|NCT01555125|580781820|FG002|Extension|Lost to Follow-up|2|||
160835150|NCT01555125|580781821|FG003|Extension|Lost to Follow-up|0|||
160835151|NCT01555125|580781822|FG004|Extension|Lost to Follow-up|0|||
160835152|NCT01555125|580781818|FG000|Extension|Study terminated by sponsor|32|||
160835153|NCT01555125|580781819|FG001|Extension|Study terminated by sponsor|33|||
160835154|NCT01555125|580781820|FG002|Extension|Study terminated by sponsor|16|||
160835155|NCT01555125|580781821|FG003|Extension|Study terminated by sponsor|20|||
160835156|NCT01555125|580781822|FG004|Extension|Study terminated by sponsor|0|||
160835157|NCT01555125|580781818|FG000|Extension|Subject/guardian decision|1|||
160835158|NCT01555125|580781819|FG001|Extension|Subject/guardian decision|9|||
160835159|NCT01555125|580781820|FG002|Extension|Subject/guardian decision|1|||
160835160|NCT01555125|580781821|FG003|Extension|Subject/guardian decision|0|||
160835161|NCT01555125|580781822|FG004|Extension|Subject/guardian decision|0|||
160835162|NCT01555125|580781818|FG000|Extension|Technical Problems|1|||
160562459|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
160562460|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
160562461|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
160835163|NCT01555125|580781819|FG001|Extension|Technical Problems|0|||
160835164|NCT01555125|580781820|FG002|Extension|Technical Problems|0|||
160835165|NCT01555125|580781821|FG003|Extension|Technical Problems|1|||
160835166|NCT01555125|580781822|FG004|Extension|Technical Problems|0|||
160835167|NCT01555125|580781818|FG000|Follow-Up Period|Lost to Follow-up|1|||
160835168|NCT01555125|580781819|FG001|Follow-Up Period|Lost to Follow-up|0|||
160562462|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
160562463|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
160562464|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
160562465|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
160562466|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
160562467|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
160835169|NCT01555125|580781820|FG002|Follow-Up Period|Lost to Follow-up|0|||
160835170|NCT01555125|580781821|FG003|Follow-Up Period|Lost to Follow-up|0|||
160835171|NCT01555125|580781822|FG004|Follow-Up Period|Lost to Follow-up|0|||
160835172|NCT01555125|580781818|FG000|Follow-Up Period|Subject / guardian decision|3|||
160835173|NCT01555125|580781819|FG001|Follow-Up Period|Subject / guardian decision|1|||
160835174|NCT01555125|580781820|FG002|Follow-Up Period|Subject / guardian decision|1|||
160835175|NCT01555125|580781821|FG003|Follow-Up Period|Subject / guardian decision|1|||
160835176|NCT01555125|580781822|FG004|Follow-Up Period|Subject / guardian decision|0|||
160835177|NCT02039856|580781824|FG000|Overall Study|Death|5|||
160835178|NCT02039856|580781825|FG001|Overall Study|Death|3|||
160835179|NCT02039856|580781824|FG000|Overall Study|Partial survey completion|61|||
160835180|NCT02039856|580781825|FG001|Overall Study|Partial survey completion|26|||
160835181|NCT02039856|580781824|FG000|Overall Study|Lost to Follow-up|388|||
160835182|NCT02039856|580781825|FG001|Overall Study|Lost to Follow-up|206|||
160835183|NCT02039856|580781824|FG000|Overall Study|Withdrawal by Subject|1573|||
160835184|NCT02039856|580781825|FG001|Overall Study|Withdrawal by Subject|618|||
160835185|NCT05327361|580781839|FG000|Overall Study|Lost to Follow-up|4|||
160835186|NCT00626405|580781840|FG000|Overall Study|Deemed Ineligible|1|||
160835187|NCT00626405|580781841|FG001|Overall Study|Deemed Ineligible|0|||
160835188|NCT00626405|580781840|FG000|Overall Study|Withdrawal by Subject|0|||
160835189|NCT00626405|580781841|FG001|Overall Study|Withdrawal by Subject|1|||
160835190|NCT01174173|580781842|FG000|Overall Study|drug-drug interaction|1|||
160835191|NCT00649428|580784275|FG000|Overall Study|Adverse Event|2|||
160835192|NCT00649428|580784276|FG001|Overall Study|Adverse Event|2|||
160835193|NCT00649428|580784275|FG000|Overall Study|Withdrawal by Subject|6|||
160835194|NCT00649428|580784276|FG001|Overall Study|Withdrawal by Subject|6|||
160835195|NCT00649428|580784275|FG000|Overall Study|Lost to Follow-up|1|||
160835196|NCT00649428|580784276|FG001|Overall Study|Lost to Follow-up|3|||
160835197|NCT00649428|580784275|FG000|Overall Study|Insufficient manufacturing yield|5|||
160562468|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
160835198|NCT00649428|580784276|FG001|Overall Study|Insufficient manufacturing yield|1|||
160835199|NCT00649428|580784275|FG000|Overall Study|Protocol Violation|6|||
160835200|NCT00649428|580784276|FG001|Overall Study|Protocol Violation|2|||
160835201|NCT00649428|580784275|FG000|Overall Study|Physician Decision|0|||
160835202|NCT00649428|580784276|FG001|Overall Study|Physician Decision|1|||
160835203|NCT02503501|580784277|FG000|Overall Study|Physician Decision|1|||
160835204|NCT02503501|580784278|FG001|Overall Study|Physician Decision|0|||
160835205|NCT02503501|580784277|FG000|Overall Study|Protocol Violation|0|||
160835206|NCT02503501|580784278|FG001|Overall Study|Protocol Violation|1|||
160835207|NCT02503501|580784277|FG000|Overall Study|Withdrawal by Subject|0|||
160835208|NCT02503501|580784278|FG001|Overall Study|Withdrawal by Subject|2|||
160835209|NCT01740401|580784279|FG000|Overall Study|Progression of disease|6|||
160835210|NCT01740401|580784279|FG000|Overall Study|Adverse Event|2|||
160835211|NCT01740401|580784279|FG000|Overall Study|Did not reach primary endpoint|2|||
160835212|NCT02315560|580784280|FG000|Overall Study|noncompliance by subjects|3|||
160835213|NCT02008227|580784281|FG000|Overall Study|Lost to Follow-up|7|||
160835214|NCT02008227|580784282|FG001|Overall Study|Lost to Follow-up|9|||
160835215|NCT02008227|580784281|FG000|Overall Study|Death|494|||
160835216|NCT02008227|580784282|FG001|Overall Study|Death|485|||
160835217|NCT02008227|580784281|FG000|Overall Study|Withdrawal by Subject|67|||
160835218|NCT02008227|580784282|FG001|Overall Study|Withdrawal by Subject|36|||
160835219|NCT02008227|580784281|FG000|Overall Study|Study Terminated By Sponsor|44|||
160835220|NCT02008227|580784282|FG001|Overall Study|Study Terminated By Sponsor|83|||
160835221|NCT04599465|580784283|FG000|Overall Study|Physician Decision|1|||
160835222|NCT04599465|580784283|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
160835223|NCT04566601|580784284|FG000|Overall Study|Other than listed|13|||
160835224|NCT04566601|580784285|FG001|Overall Study|Other than listed|4|||
160835225|NCT04566601|580784286|FG002|Overall Study|Other than listed|2|||
160835226|NCT04566601|580784287|FG003|Overall Study|Other than listed|1|||
160835227|NCT04566601|580784288|FG004|Overall Study|Other than listed|4|||
160835228|NCT04566601|580784284|FG000|Overall Study|Protocol deviation|3|||
160835229|NCT04566601|580784285|FG001|Overall Study|Protocol deviation|0|||
160835230|NCT04566601|580784286|FG002|Overall Study|Protocol deviation|1|||
160835231|NCT04566601|580784287|FG003|Overall Study|Protocol deviation|1|||
160835232|NCT04566601|580784288|FG004|Overall Study|Protocol deviation|1|||
160835233|NCT04566601|580784284|FG000|Overall Study|Technical problems|0|||
160835234|NCT04566601|580784285|FG001|Overall Study|Technical problems|0|||
160835235|NCT04566601|580784286|FG002|Overall Study|Technical problems|1|||
160835236|NCT04566601|580784287|FG003|Overall Study|Technical problems|0|||
160835237|NCT04566601|580784288|FG004|Overall Study|Technical problems|0|||
160835238|NCT04566601|580784284|FG000|Overall Study|No reason available|3|||
160835239|NCT04566601|580784285|FG001|Overall Study|No reason available|2|||
160835240|NCT04566601|580784286|FG002|Overall Study|No reason available|7|||
160835241|NCT04566601|580784287|FG003|Overall Study|No reason available|1|||
160835242|NCT04566601|580784288|FG004|Overall Study|No reason available|5|||
160835243|NCT04566601|580784284|FG000|Overall Study|Burden of study procedures|3|||
160562469|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
160562470|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
160562471|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
160562472|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
160562473|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
160562474|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
160562475|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
160562476|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
160562477|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
160562478|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
160562479|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
160562480|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
160562481|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
160562482|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
160562483|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
160562484|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
160562485|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
160562486|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
160562487|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
160562488|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
160647634|NCT00416520|580092784|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
160647635|NCT00416520|580092785|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
160835244|NCT04566601|580784285|FG001|Overall Study|Burden of study procedures|0|||
160835245|NCT04566601|580784286|FG002|Overall Study|Burden of study procedures|0|||
160835246|NCT04566601|580784287|FG003|Overall Study|Burden of study procedures|3|||
160835247|NCT04566601|580784288|FG004|Overall Study|Burden of study procedures|1|||
160835248|NCT04566601|580784284|FG000|Overall Study|Change of residence|2|||
160835249|NCT04566601|580784285|FG001|Overall Study|Change of residence|2|||
160835250|NCT04566601|580784286|FG002|Overall Study|Change of residence|0|||
160835251|NCT04566601|580784287|FG003|Overall Study|Change of residence|1|||
160835252|NCT04566601|580784288|FG004|Overall Study|Change of residence|2|||
160835253|NCT04566601|580784284|FG000|Overall Study|Perceived lack of efficacy|2|||
160835254|NCT04566601|580784285|FG001|Overall Study|Perceived lack of efficacy|0|||
160835255|NCT04566601|580784286|FG002|Overall Study|Perceived lack of efficacy|1|||
160835256|NCT04566601|580784287|FG003|Overall Study|Perceived lack of efficacy|1|||
160835257|NCT04566601|580784288|FG004|Overall Study|Perceived lack of efficacy|2|||
160835258|NCT04566601|580784284|FG000|Overall Study|Adverse Event|7|||
160835259|NCT04566601|580784285|FG001|Overall Study|Adverse Event|4|||
160835260|NCT04566601|580784286|FG002|Overall Study|Adverse Event|6|||
160835261|NCT04566601|580784287|FG003|Overall Study|Adverse Event|5|||
160835262|NCT04566601|580784288|FG004|Overall Study|Adverse Event|12|||
160835263|NCT01272635|580784291|FG000|Overall Study|Lost to Follow-up|31|||
160835264|NCT01272635|580784292|FG001|Overall Study|Lost to Follow-up|20|||
160835265|NCT01272635|580784293|FG002|Overall Study|Lost to Follow-up|31|||
160835266|NCT01272635|580784294|FG003|Overall Study|Lost to Follow-up|23|||
160835267|NCT01543776|580784297|FG000|Overall Study|Withdrawal by Subject|2|||
160835268|NCT01543776|580784298|FG001|Overall Study|Withdrawal by Subject|2|||
160835269|NCT00306527|580784299|FG000|Overall Study|Lost to Follow-up|3|||
160835270|NCT00306527|580784300|FG001|Overall Study|Lost to Follow-up|4|||
160835271|NCT00306527|580784301|FG002|Overall Study|Lost to Follow-up|3|||
160835272|NCT00306527|580784302|FG003|Overall Study|Lost to Follow-up|0|||
160835273|NCT00306527|580784299|FG000|Overall Study|Withdrawal by Subject|2|||
160835274|NCT00306527|580784300|FG001|Overall Study|Withdrawal by Subject|3|||
160835275|NCT00306527|580784301|FG002|Overall Study|Withdrawal by Subject|0|||
160835276|NCT00306527|580784302|FG003|Overall Study|Withdrawal by Subject|3|||
160835277|NCT00306527|580784299|FG000|Overall Study|Adverse Event|0|||
160835278|NCT00306527|580784300|FG001|Overall Study|Adverse Event|0|||
160835279|NCT00306527|580784301|FG002|Overall Study|Adverse Event|1|||
160835280|NCT00306527|580784302|FG003|Overall Study|Adverse Event|1|||
160835281|NCT00306527|580784299|FG000|Overall Study|Death|1|||
160835282|NCT00306527|580784300|FG001|Overall Study|Death|0|||
160835283|NCT00306527|580784301|FG002|Overall Study|Death|1|||
160835284|NCT00306527|580784302|FG003|Overall Study|Death|2|||
160835285|NCT02702180|580784303|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
160903826|NCT01594281|581043027|FG002|Interventional Core Phase|Death|2|||
160835286|NCT02702180|580784304|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
160835287|NCT02702180|580784305|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160835288|NCT02702180|580784303|FG000|Double-blind Treatment Period|Adverse Event|0|||
160835289|NCT02702180|580784304|FG001|Double-blind Treatment Period|Adverse Event|0|||
160835290|NCT02702180|580784305|FG002|Double-blind Treatment Period|Adverse Event|1|||
160835291|NCT02702180|580784303|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
160835292|NCT02702180|580784304|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
160835293|NCT02702180|580784305|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
160835294|NCT02702180|580784303|FG000|Double-blind Treatment Period|Protocol Violation|0|||
160835295|NCT02702180|580784304|FG001|Double-blind Treatment Period|Protocol Violation|0|||
160835296|NCT02702180|580784305|FG002|Double-blind Treatment Period|Protocol Violation|2|||
160835297|NCT02702180|580784303|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
160835298|NCT02702180|580784304|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
160835299|NCT02702180|580784305|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
160835300|NCT02702180|580784303|FG000|Open-label Treatment Period|Withdrawn in error|0|||
160835301|NCT02702180|580784304|FG001|Open-label Treatment Period|Withdrawn in error|0|||
160835302|NCT02702180|580784305|FG002|Open-label Treatment Period|Withdrawn in error|1|||
160835303|NCT00567359|580784306|FG000|Overall Study|Withdrawal by Subject|1|||
160835304|NCT00785980|580784307|FG000|7 Day Washout Period|Protocol Violation|3|||
160835305|NCT02397057|580784308|FG000|Overall Study|Withdrawal by Subject|6|||
160835306|NCT02397057|580784309|FG001|Overall Study|Withdrawal by Subject|7|||
160835307|NCT02397057|580784308|FG000|Overall Study|Lost to Follow-up|4|||
160835308|NCT02397057|580784309|FG001|Overall Study|Lost to Follow-up|3|||
160835309|NCT02397057|580784308|FG000|Overall Study|Death|1|||
160835310|NCT02397057|580784309|FG001|Overall Study|Death|0|||
160835311|NCT02397057|580784308|FG000|Overall Study|Adverse Event|0|||
160562489|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
160835312|NCT02397057|580784309|FG001|Overall Study|Adverse Event|1|||
160835313|NCT02397057|580784308|FG000|Overall Study|Physician Decision|0|||
160835314|NCT02397057|580784309|FG001|Overall Study|Physician Decision|1|||
160835315|NCT02397057|580784308|FG000|Overall Study|Subject did not receive study drug|0|||
160991366|NCT02219490|581357778|FG000|Overall Study|COVID-19 infection|2|||
160562490|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
160562491|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
160562492|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
160562493|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
160562494|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
160562495|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
160562496|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
160562497|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
160835316|NCT02397057|580784309|FG001|Overall Study|Subject did not receive study drug|1|||
160835317|NCT02352753|580784310|FG000|6-Month Dosing Period|Decision by sponsor|2|||
160835318|NCT02352753|580784310|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
160835319|NCT02352753|580784310|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
160835320|NCT02352753|580784310|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
160835321|NCT02352753|580784310|FG000|3-Month Dosing Period|Decision by sponsor|14|||
160835322|NCT02352753|580784310|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
160835323|NCT00539305|580784311|FG000|Overall Study|Adverse Event|1|||
160835324|NCT00539305|580784312|FG001|Overall Study|Adverse Event|0|||
160835325|NCT00539305|580784311|FG000|Overall Study|Substance Use|0|||
160562498|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
160562499|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
160835326|NCT00539305|580784312|FG001|Overall Study|Substance Use|1|||
160835327|NCT00539305|580784311|FG000|Overall Study|Withdrawal by Subject|0|||
160835328|NCT00539305|580784312|FG001|Overall Study|Withdrawal by Subject|1|||
160835329|NCT00126776|580784314|FG000|Overall Study|follow up complete on all patients|0|||
160835330|NCT00126776|580784315|FG001|Overall Study|follow up complete on all patients|0|||
160835331|NCT00679172|580784319|FG000|Overall Study|Non-compliance|1|||
160835332|NCT00679172|580784320|FG001|Overall Study|Non-compliance|1|||
160835333|NCT00679172|580784321|FG002|Overall Study|Non-compliance|0|||
160835334|NCT00679172|580784322|FG003|Overall Study|Non-compliance|1|||
160835335|NCT00679172|580784323|FG004|Overall Study|Non-compliance|0|||
160835336|NCT00679172|580784319|FG000|Overall Study|Other not specified|0|||
160835337|NCT00679172|580784320|FG001|Overall Study|Other not specified|0|||
160835338|NCT00679172|580784321|FG002|Overall Study|Other not specified|1|||
160835339|NCT00679172|580784322|FG003|Overall Study|Other not specified|0|||
160835340|NCT00679172|580784323|FG004|Overall Study|Other not specified|0|||
160835341|NCT00417963|580784335|FG000|Overall Study|Lost to Follow-up|3|||
160835342|NCT00417963|580784335|FG000|Overall Study|Withdrawal by Subject|18|||
160835343|NCT00417963|580784335|FG000|Overall Study|Death|17|||
160835344|NCT00417963|580784335|FG000|Overall Study|Study device could not be deployed|3|||
160835345|NCT01815840|580784337|FG000|Overall Study|Missing|1|||
160835346|NCT01815840|580784338|FG001|Overall Study|Missing|0|||
160835347|NCT01815840|580784337|FG000|Overall Study|Withdrew Consent|31|||
160835348|NCT01815840|580784338|FG001|Overall Study|Withdrew Consent|30|||
160835349|NCT01815840|580784337|FG000|Overall Study|Administrative/Other|1|||
160835350|NCT01815840|580784338|FG001|Overall Study|Administrative/Other|3|||
160835351|NCT01815840|580784337|FG000|Overall Study|Adverse Event|10|||
160562500|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
160562501|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
160562502|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
160835352|NCT01815840|580784338|FG001|Overall Study|Adverse Event|16|||
160835353|NCT01815840|580784337|FG000|Overall Study|Death|2|||
160835354|NCT01815840|580784338|FG001|Overall Study|Death|2|||
160835355|NCT01815840|580784337|FG000|Overall Study|Disease progression|3|||
160835356|NCT01815840|580784338|FG001|Overall Study|Disease progression|2|||
160835357|NCT01815840|580784337|FG000|Overall Study|Investigators Decision|2|||
160835358|NCT01815840|580784338|FG001|Overall Study|Investigators Decision|3|||
160835359|NCT01815840|580784337|FG000|Overall Study|Lost to Follow-up|3|||
160903827|NCT01594281|581043025|FG000|Interventional Core Phase|Lost to Follow-up|1|||
160835360|NCT01815840|580784338|FG001|Overall Study|Lost to Follow-up|6|||
160835361|NCT01815840|580784337|FG000|Overall Study|Refused Treatment|5|||
160835362|NCT01815840|580784338|FG001|Overall Study|Refused Treatment|1|||
160835363|NCT01815840|580784337|FG000|Overall Study|Sponsor Termination Treatment|1|||
160835364|NCT01815840|580784338|FG001|Overall Study|Sponsor Termination Treatment|0|||
160835365|NCT00434642|580784339|FG000|Blinded Treatment Phase|Adverse Event|12|||
160835366|NCT00434642|580784340|FG001|Blinded Treatment Phase|Adverse Event|58|||
160835367|NCT00434642|580784339|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
160835368|NCT00434642|580784340|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
160835369|NCT00434642|580784339|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
160835370|NCT00434642|580784340|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
160835371|NCT00434642|580784339|FG000|Blinded Treatment Phase|Physician Decision|19|||
160835372|NCT00434642|580784340|FG001|Blinded Treatment Phase|Physician Decision|27|||
160903828|NCT01594281|581043026|FG001|Interventional Core Phase|Lost to Follow-up|4|||
160835373|NCT00434642|580784339|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
160835374|NCT00434642|580784340|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
160835375|NCT00434642|580784339|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
160835376|NCT00434642|580784340|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
160835377|NCT00434642|580784339|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
160835378|NCT00434642|580784340|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
160835379|NCT00434642|580784339|FG000|Open-label Treatment Phase|Adverse Event|0|||
160835380|NCT00434642|580784340|FG001|Open-label Treatment Phase|Adverse Event|5|||
160835381|NCT00434642|580784339|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
160835382|NCT00434642|580784340|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
160835383|NCT02241343|580784343|FG000|Overall Study|Adverse Event|1|||
160835384|NCT04680975|580784344|FG000|Overall Study|Adverse Event|3|||
160835385|NCT04680975|580784344|FG000|Overall Study|Death|1|||
160835386|NCT04680975|580784344|FG000|Overall Study|Progressive Disease|1|||
160835387|NCT04680975|580784344|FG000|Overall Study|Withdrawal by Subject|1|||
160835388|NCT00753454|580784345|FG000|Overall Study|Adverse Event|4|||
160835389|NCT00753454|580784345|FG000|Overall Study|Lack of Efficacy|1|||
160835390|NCT00753454|580784345|FG000|Overall Study|Lost to Follow-up|3|||
160835391|NCT00753454|580784345|FG000|Overall Study|Withdrawal by Subject|5|||
160835392|NCT00753454|580784345|FG000|Overall Study|Investigator Decision|1|||
160835393|NCT05856227|580784348|FG000|Overall Study|Adverse Event|0|||
160835394|NCT05856227|580784349|FG001|Overall Study|Adverse Event|1|||
160835395|NCT05856227|580784348|FG000|Overall Study|Due to Investigator absence|1|||
160835396|NCT05856227|580784349|FG001|Overall Study|Due to Investigator absence|0|||
160835397|NCT05856227|580784348|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
160835398|NCT05856227|580784349|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
160835399|NCT05011058|580784350|FG000|Overall Study|Sponsor Decision|2|||
160835400|NCT05011058|580784351|FG001|Overall Study|Sponsor Decision|0|||
160835401|NCT05011058|580784352|FG002|Overall Study|Sponsor Decision|14|||
160835402|NCT05011058|580784353|FG003|Overall Study|Sponsor Decision|0|||
160835403|NCT05011058|580784354|FG004|Overall Study|Sponsor Decision|0|||
160647636|NCT00416520|580092782|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
160835404|NCT05011058|580784355|FG005|Overall Study|Sponsor Decision|1|||
160835405|NCT05011058|580784356|FG006|Overall Study|Sponsor Decision|0|||
160835406|NCT05011058|580784357|FG007|Overall Study|Sponsor Decision|5|||
160835407|NCT01571232|580784358|FG000|Overall Study|Lost to Follow-up|0|||
160835408|NCT01571232|580784359|FG001|Overall Study|Lost to Follow-up|1|||
160835409|NCT01571232|580784358|FG000|Overall Study|Withdrawal by Subject|1|||
160835410|NCT01571232|580784359|FG001|Overall Study|Withdrawal by Subject|0|||
160835411|NCT01272869|580784360|FG000|Period 2 (14 Days)|Adverse Event|1|||
160835412|NCT01272869|580784361|FG001|Period 2 (14 Days)|Adverse Event|0|||
160835413|NCT02271945|580784362|FG000|Overall Study|Death|3|||
160835414|NCT02271945|580784363|FG001|Overall Study|Death|3|||
160835415|NCT02271945|580784362|FG000|Overall Study|Withdrawal by Subject|1|||
160835416|NCT02271945|580784363|FG001|Overall Study|Withdrawal by Subject|1|||
160835417|NCT02271945|580784362|FG000|Overall Study|Other|1|||
160835418|NCT02271945|580784363|FG001|Overall Study|Other|1|||
160835419|NCT02455076|580784364|FG000|Inpatient|Withdrawal by Subject|1|||
160835420|NCT02455076|580784365|FG001|Inpatient|Withdrawal by Subject|0|||
160835421|NCT02455076|580784366|FG002|Inpatient|Withdrawal by Subject|0|||
160835422|NCT02455076|580784367|FG003|Inpatient|Withdrawal by Subject|0|||
160835423|NCT02455076|580784368|FG004|Inpatient|Withdrawal by Subject|0|||
160835424|NCT02455076|580784364|FG000|Inpatient|Discharged <24 h after admission|0|||
160835425|NCT02455076|580784365|FG001|Inpatient|Discharged <24 h after admission|1|||
160835426|NCT02455076|580784366|FG002|Inpatient|Discharged <24 h after admission|0|||
160835427|NCT02455076|580784367|FG003|Inpatient|Discharged <24 h after admission|0|||
160835428|NCT02455076|580784368|FG004|Inpatient|Discharged <24 h after admission|0|||
160835429|NCT02455076|580784364|FG000|Inpatient|Adverse Event|3|||
160835430|NCT02455076|580784365|FG001|Inpatient|Adverse Event|0|||
160835431|NCT02455076|580784366|FG002|Inpatient|Adverse Event|0|||
160835432|NCT02455076|580784367|FG003|Inpatient|Adverse Event|0|||
160835433|NCT02455076|580784368|FG004|Inpatient|Adverse Event|0|||
160835434|NCT02455076|580784364|FG000|Outpatient|Adverse Event|0|||
160835435|NCT02455076|580784365|FG001|Outpatient|Adverse Event|0|||
160835436|NCT02455076|580784366|FG002|Outpatient|Adverse Event|0|||
160835437|NCT02455076|580784367|FG003|Outpatient|Adverse Event|5|||
160835438|NCT02455076|580784368|FG004|Outpatient|Adverse Event|0|||
160835439|NCT02455076|580784364|FG000|Outpatient|Lost to Follow-up|0|||
160835440|NCT02455076|580784365|FG001|Outpatient|Lost to Follow-up|0|||
160835441|NCT02455076|580784366|FG002|Outpatient|Lost to Follow-up|0|||
160835442|NCT02455076|580784367|FG003|Outpatient|Lost to Follow-up|1|||
160835443|NCT02455076|580784368|FG004|Outpatient|Lost to Follow-up|12|||
160835444|NCT03908476|580784370|FG000|Overall Study|Death|3|||
160835445|NCT03908476|580784371|FG001|Overall Study|Death|0|||
160835446|NCT03908476|580784370|FG000|Overall Study|Lost to Follow-up|3|||
160835447|NCT03908476|580784371|FG001|Overall Study|Lost to Follow-up|1|||
160835448|NCT03908476|580784370|FG000|Overall Study|Withdrawal by Subject|7|||
160835449|NCT03908476|580784371|FG001|Overall Study|Withdrawal by Subject|1|||
160835450|NCT03908476|580784370|FG000|Overall Study|Physician Decision|2|||
160835451|NCT03908476|580784371|FG001|Overall Study|Physician Decision|0|||
160835452|NCT03908476|580784370|FG000|Overall Study|System Explanted and not Replaced|4|||
160835453|NCT03908476|580784371|FG001|Overall Study|System Explanted and not Replaced|0|||
160835454|NCT03908476|580784370|FG000|Overall Study|Intrathecal Pump|1|||
160835455|NCT03908476|580784371|FG001|Overall Study|Intrathecal Pump|0|||
160835456|NCT03908476|580784370|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
160835457|NCT03908476|580784371|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
160835458|NCT05194267|580784372|FG000|Overall Study|Withdrawal by Subject|2|||
160835459|NCT02868229|580784373|FG000|Overall Study|Adverse Event|1|||
160835460|NCT02868229|580784374|FG001|Overall Study|Adverse Event|0|||
160835461|NCT02868229|580784375|FG002|Overall Study|Adverse Event|0|||
160835462|NCT02868229|580784376|FG003|Overall Study|Adverse Event|1|||
160835463|NCT02868229|580784373|FG000|Overall Study|Death|0|||
160835464|NCT02868229|580784374|FG001|Overall Study|Death|0|||
160835465|NCT02868229|580784375|FG002|Overall Study|Death|1|||
160835466|NCT02868229|580784376|FG003|Overall Study|Death|1|||
160835467|NCT02868229|580784373|FG000|Overall Study|Missed dose|0|||
160835468|NCT02868229|580784374|FG001|Overall Study|Missed dose|0|||
160835469|NCT02868229|580784375|FG002|Overall Study|Missed dose|0|||
160835470|NCT02868229|580784376|FG003|Overall Study|Missed dose|3|||
160835471|NCT06151288|580784377|FG000|Overall Study|Lost to Follow-up|4|||
160835472|NCT06151288|580784378|FG001|Overall Study|Lost to Follow-up|2|||
160835473|NCT06151288|580784379|FG002|Overall Study|Lost to Follow-up|4|||
160835474|NCT06151288|580784380|FG003|Overall Study|Lost to Follow-up|3|||
160991367|NCT02219490|581357778|FG000|Overall Study|COVID-19 logistical restrictions|33|||
160991368|NCT02219490|581357778|FG000|Overall Study|Other, not specified|57|||
160991369|NCT01352507|581357781|FG000|Treatment Period 1|Adverse Event|3|||
160991370|NCT01352507|581357782|FG001|Treatment Period 1|Adverse Event|0|||
160991371|NCT01352507|581357781|FG000|Treatment Period 1|Lost to Follow-up|3|||
160991372|NCT01352507|581357782|FG001|Treatment Period 1|Lost to Follow-up|4|||
160991373|NCT01352507|581357781|FG000|Treatment Period 1|Withdrawal by Subject|7|||
160991374|NCT01352507|581357782|FG001|Treatment Period 1|Withdrawal by Subject|5|||
160991375|NCT01352507|581357781|FG000|Treatment Period 1|Physician Decision|1|||
160991376|NCT01352507|581357782|FG001|Treatment Period 1|Physician Decision|0|||
160991377|NCT01352507|581357781|FG000|Washout Period|Withdrawal by Subject|0|||
160991378|NCT01352507|581357782|FG001|Washout Period|Withdrawal by Subject|1|||
160991379|NCT01352507|581357781|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
160991380|NCT01352507|581357782|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
160991381|NCT01352507|581357781|FG000|Treatment Period 2|Withdrawal by Subject|4|||
160991382|NCT01352507|581357782|FG001|Treatment Period 2|Withdrawal by Subject|3|||
160991383|NCT01352507|581357781|FG000|Treatment Period 2|Lack of Efficacy|1|||
160991384|NCT01352507|581357782|FG001|Treatment Period 2|Lack of Efficacy|0|||
160991385|NCT03178201|581357783|FG000|Overall Study|Off study|5|||
160991386|NCT03537651|581357788|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
160991387|NCT03537651|581357788|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
160991388|NCT03537651|581357788|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
160991389|NCT03537651|581357788|FG000|Part A (Up to 96 Weeks)|Other|1|||
160991390|NCT03537651|581357788|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
160991391|NCT03537651|581357788|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
160991392|NCT03537651|581357788|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
160991393|NCT03537651|581357788|FG000|Part B (Up to 192 Weeks)|Other|1|||
160991394|NCT00197236|581357789|FG000|Overall Study|Adverse Event|1|||
160991395|NCT00197236|581357790|FG001|Overall Study|Adverse Event|0|||
160991396|NCT00197236|581357791|FG002|Overall Study|Adverse Event|1|||
160991397|NCT00197236|581357789|FG000|Overall Study|Lost to Follow-up|5|||
160991398|NCT00197236|581357790|FG001|Overall Study|Lost to Follow-up|14|||
160991399|NCT00197236|581357791|FG002|Overall Study|Lost to Follow-up|6|||
160991400|NCT00197236|581357789|FG000|Overall Study|Protocol Violation|0|||
160991401|NCT00197236|581357790|FG001|Overall Study|Protocol Violation|0|||
160991402|NCT00197236|581357791|FG002|Overall Study|Protocol Violation|1|||
160991403|NCT00197236|581357789|FG000|Overall Study|Withdrawal by Subject|7|||
160991404|NCT00197236|581357790|FG001|Overall Study|Withdrawal by Subject|3|||
160835475|NCT06151288|580784377|FG000|Overall Study|Withdrawal by Subject|4|||
160835476|NCT06151288|580784378|FG001|Overall Study|Withdrawal by Subject|5|||
160835477|NCT06151288|580784379|FG002|Overall Study|Withdrawal by Subject|1|||
160835478|NCT06151288|580784380|FG003|Overall Study|Withdrawal by Subject|1|||
160835479|NCT01286740|580784385|FG000|Overall Study|Enrolled but not treated|1|||
160835480|NCT01286740|580784385|FG000|Overall Study|Protocol Violation|1|||
160835481|NCT01646203|580784386|FG000|Overall Study|Adverse Event|2|||
160835482|NCT01646203|580784387|FG001|Overall Study|Adverse Event|0|||
160835483|NCT01646203|580784388|FG002|Overall Study|Adverse Event|1|||
160835484|NCT01646203|580784386|FG000|Overall Study|Withdrawal by Subject|0|||
160835485|NCT01646203|580784387|FG001|Overall Study|Withdrawal by Subject|1|||
160835486|NCT01646203|580784388|FG002|Overall Study|Withdrawal by Subject|0|||
160991405|NCT00197236|581357791|FG002|Overall Study|Withdrawal by Subject|11|||
160835487|NCT01646203|580784386|FG000|Overall Study|Physician's Decision|0|||
160835488|NCT01646203|580784387|FG001|Overall Study|Physician's Decision|1|||
160835489|NCT01646203|580784388|FG002|Overall Study|Physician's Decision|0|||
160835490|NCT04676867|580784389|FG000|Overall Study|Screen failure|0|||
160835491|NCT04676867|580784390|FG001|Overall Study|Screen failure|0|||
160835492|NCT04676867|580784391|FG002|Overall Study|Screen failure|6|||
160835493|NCT04676867|580784392|FG003|Overall Study|Screen failure|2|||
160835494|NCT04676867|580784389|FG000|Overall Study|Death|0|||
160835495|NCT04676867|580784390|FG001|Overall Study|Death|0|||
160835496|NCT04676867|580784391|FG002|Overall Study|Death|1|||
160835497|NCT04676867|580784392|FG003|Overall Study|Death|0|||
160835498|NCT04676867|580784389|FG000|Overall Study|Withdrawal by Subject|2|||
160835499|NCT04676867|580784390|FG001|Overall Study|Withdrawal by Subject|2|||
160835500|NCT04676867|580784391|FG002|Overall Study|Withdrawal by Subject|4|||
160835501|NCT04676867|580784392|FG003|Overall Study|Withdrawal by Subject|4|||
160835502|NCT04676867|580784389|FG000|Overall Study|Lost to Follow-up|1|||
160835503|NCT04676867|580784390|FG001|Overall Study|Lost to Follow-up|0|||
160835504|NCT04676867|580784391|FG002|Overall Study|Lost to Follow-up|0|||
160835505|NCT04676867|580784392|FG003|Overall Study|Lost to Follow-up|0|||
160835506|NCT02717130|580784396|FG000|Overall Study|Withdrawal by Subject|1|||
160835507|NCT02717130|580784396|FG000|Overall Study|Adverse Event|1|||
160835508|NCT02717130|580784396|FG000|Overall Study|Physician Decision|1|||
160835509|NCT02717130|580784396|FG000|Overall Study|Study Closure|4|||
160835510|NCT02335424|580784399|FG000|Overall Study|Withdrawal by Subject|19|||
160835511|NCT02335424|580784399|FG000|Overall Study|Adverse Event|25|||
160835512|NCT02335424|580784399|FG000|Overall Study|Death|273|||
160835513|NCT02335424|580784399|FG000|Overall Study|Lost to Follow-up|3|||
160835514|NCT02335424|580784399|FG000|Overall Study|Physician Decision|13|||
160835515|NCT02335424|580784399|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
160835516|NCT02335424|580784399|FG000|Overall Study|Protocol Violation|1|||
160835517|NCT02335424|580784399|FG000|Overall Study|Screen failure|1|||
160835518|NCT00548717|580784400|FG000|Overall Study|Death|5|||
160835519|NCT00548717|580784401|FG001|Overall Study|Death|2|||
160835520|NCT00548717|580784400|FG000|Overall Study|Relapse|3|||
160835521|NCT00548717|580784401|FG001|Overall Study|Relapse|0|||
160835522|NCT00548717|580784400|FG000|Overall Study|Alternative treatment for GVHD|1|||
160835523|NCT00548717|580784401|FG001|Overall Study|Alternative treatment for GVHD|0|||
160835524|NCT00551291|580784405|FG000|Overall Study|Physician Decision|1|||
160835525|NCT04268173|580784406|FG000|Overall Study|Lost to Follow-up|75|||
160835526|NCT04268173|580784407|FG001|Overall Study|Lost to Follow-up|108|||
160835527|NCT01953913|580784408|FG000|Overall Study|Disease Progression|349|||
160835528|NCT01953913|580784408|FG000|Overall Study|Worsening of underlying cancer|22|||
160835529|NCT01953913|580784408|FG000|Overall Study|Adverse Event|20|||
160835530|NCT01953913|580784408|FG000|Overall Study|Protocol Violation|6|||
160835531|NCT01953913|580784408|FG000|Overall Study|Lost to Follow-up|4|||
160835532|NCT01953913|580784408|FG000|Overall Study|Withdrawal by Subject|32|||
160835533|NCT01953913|580784408|FG000|Overall Study|Other than listed|108|||
160835534|NCT01953913|580784408|FG000|Overall Study|Not Treated|1|||
160835535|NCT00710385|580784409|FG000|Overall Study|Did not qualify|1|||
160835536|NCT00710385|580784409|FG000|Overall Study|Withdrawal by Subject|1|||
160835537|NCT00710385|580784409|FG000|Overall Study|Undisclosed back pain|1|||
160835538|NCT00710385|580784409|FG000|Overall Study|Physician Decision|1|||
160835539|NCT00710385|580784409|FG000|Overall Study|Undisclosed excessive methadone use|1|||
160903829|NCT01594281|581043027|FG002|Interventional Core Phase|Lost to Follow-up|1|||
160835540|NCT01600092|580784410|FG000|Overall Study|Adverse Event|2|||
160903830|NCT01594281|581043025|FG000|Interventional Core Phase|Adverse Event|4|||
160835541|NCT01600092|580784411|FG001|Overall Study|Adverse Event|0|||
160835542|NCT01600092|580784410|FG000|Overall Study|Lost to Follow-up|4|||
160835543|NCT01600092|580784411|FG001|Overall Study|Lost to Follow-up|6|||
160835544|NCT01600092|580784410|FG000|Overall Study|Withdrawal by parent/guardian|8|||
160835545|NCT01600092|580784411|FG001|Overall Study|Withdrawal by parent/guardian|6|||
160835546|NCT01600092|580784410|FG000|Overall Study|Physician Decision|1|||
160835547|NCT01600092|580784411|FG001|Overall Study|Physician Decision|1|||
160835548|NCT01600092|580784410|FG000|Overall Study|Randomized but not vaccinated|3|||
160991406|NCT00197236|581357789|FG000|Overall Study|Study drug/medication expiration|1|||
160991407|NCT00197236|581357790|FG001|Overall Study|Study drug/medication expiration|0|||
160835549|NCT01600092|580784411|FG001|Overall Study|Randomized but not vaccinated|3|||
160991408|NCT00197236|581357791|FG002|Overall Study|Study drug/medication expiration|3|||
160991409|NCT00197236|581357789|FG000|Overall Study|Returned out of specified time window|0|||
160562503|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
160562504|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
160562505|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
160562506|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
160562507|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
160562508|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
160562509|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
160562510|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
160562511|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
160835550|NCT02976103|580784412|FG000|Overall Study|Withdrawal by Subject|1|||
160835551|NCT02976103|580784413|FG001|Overall Study|Withdrawal by Subject|0|||
160835552|NCT02976103|580784412|FG000|Overall Study|Lost to Follow-up|12|||
160835553|NCT02976103|580784413|FG001|Overall Study|Lost to Follow-up|8|||
160835554|NCT01561963|580784414|FG000|Overall Study|Adverse Event|1|||
160835555|NCT03040986|580784415|FG000|Overall Study|Hospice|1|||
160835556|NCT03040986|580784416|FG001|Overall Study|Hospice|0|||
160835557|NCT03040986|580784415|FG000|Overall Study|Adverse Event|2|||
160835558|NCT03040986|580784416|FG001|Overall Study|Adverse Event|1|||
160835559|NCT03040986|580784415|FG000|Overall Study|Disease progression on study|3|||
160835560|NCT03040986|580784416|FG001|Overall Study|Disease progression on study|1|||
160835561|NCT02228096|580784420|FG000|Overall Study|Study terminated by Sponsor|24|||
160835562|NCT02228096|580784420|FG000|Overall Study|Lack of Efficacy|18|||
160835563|NCT02228096|580784420|FG000|Overall Study|Death|12|||
160835564|NCT02228096|580784420|FG000|Overall Study|Physician Decision|3|||
160835565|NCT02228096|580784420|FG000|Overall Study|Subject/guardian decision|2|||
160835566|NCT02228096|580784420|FG000|Overall Study|New therapy for study indication|1|||
160835567|NCT02228096|580784420|FG000|Overall Study|Enrolled, not infused|11|||
160835568|NCT02383433|580784421|FG000|Overall Study|Disease progression|2|||
160835569|NCT00952614|580784424|FG000|Overall Study|Death|3|||
160835570|NCT00952614|580784424|FG000|Overall Study|Lost to Follow-up|3|||
160835571|NCT00952614|580784424|FG000|Overall Study|other reason|1|||
160835572|NCT02925728|580784425|FG000|Overall Study|Death|3|||
160835573|NCT02925728|580784426|FG001|Overall Study|Death|5|||
160835574|NCT02925728|580784425|FG000|Overall Study|Physician Decision|1|||
160835575|NCT02925728|580784426|FG001|Overall Study|Physician Decision|0|||
160835576|NCT02925728|580784425|FG000|Overall Study|Withdrawal by Subject|1|||
160835577|NCT02925728|580784426|FG001|Overall Study|Withdrawal by Subject|0|||
160835578|NCT01075984|580784427|FG000|Treatment Phase|Adverse Event|0|||
160835579|NCT01075984|580784428|FG001|Treatment Phase|Adverse Event|1|||
160835580|NCT01075984|580784429|FG002|Treatment Phase|Adverse Event|3|||
160835581|NCT01075984|580784430|FG003|Treatment Phase|Adverse Event|7|||
160835582|NCT01075984|580784431|FG004|Treatment Phase|Adverse Event|35|||
160835583|NCT01075984|580784427|FG000|Treatment Phase|Protocol Violation|0|||
160835584|NCT01075984|580784428|FG001|Treatment Phase|Protocol Violation|0|||
160835585|NCT01075984|580784429|FG002|Treatment Phase|Protocol Violation|1|||
160835586|NCT01075984|580784430|FG003|Treatment Phase|Protocol Violation|0|||
160835587|NCT01075984|580784431|FG004|Treatment Phase|Protocol Violation|3|||
160835588|NCT01075984|580784427|FG000|Treatment Phase|Withdrawal by Subject|0|||
160835589|NCT01075984|580784428|FG001|Treatment Phase|Withdrawal by Subject|0|||
160835590|NCT01075984|580784429|FG002|Treatment Phase|Withdrawal by Subject|2|||
160835591|NCT01075984|580784430|FG003|Treatment Phase|Withdrawal by Subject|0|||
160835592|NCT01075984|580784431|FG004|Treatment Phase|Withdrawal by Subject|15|||
160835593|NCT01075984|580784427|FG000|Treatment Phase|Treatment Failure|0|||
160835594|NCT01075984|580784428|FG001|Treatment Phase|Treatment Failure|0|||
160835595|NCT01075984|580784429|FG002|Treatment Phase|Treatment Failure|1|||
160835596|NCT01075984|580784430|FG003|Treatment Phase|Treatment Failure|0|||
160835597|NCT01075984|580784431|FG004|Treatment Phase|Treatment Failure|5|||
160835598|NCT01075984|580784427|FG000|Treatment Phase|Progression of disease|0|||
160835599|NCT01075984|580784428|FG001|Treatment Phase|Progression of disease|0|||
160835600|NCT01075984|580784429|FG002|Treatment Phase|Progression of disease|0|||
160835601|NCT01075984|580784430|FG003|Treatment Phase|Progression of disease|0|||
160835602|NCT01075984|580784431|FG004|Treatment Phase|Progression of disease|2|||
160835603|NCT01075984|580784427|FG000|Follow-up Phase|Protocol Violation|0|||
160835604|NCT01075984|580784428|FG001|Follow-up Phase|Protocol Violation|0|||
160835605|NCT01075984|580784429|FG002|Follow-up Phase|Protocol Violation|1|||
160835606|NCT01075984|580784430|FG003|Follow-up Phase|Protocol Violation|0|||
160835607|NCT01075984|580784431|FG004|Follow-up Phase|Protocol Violation|3|||
160835608|NCT01075984|580784427|FG000|Follow-up Phase|Adverse Event|0|||
160835609|NCT01075984|580784428|FG001|Follow-up Phase|Adverse Event|0|||
160835610|NCT01075984|580784429|FG002|Follow-up Phase|Adverse Event|0|||
160835611|NCT01075984|580784430|FG003|Follow-up Phase|Adverse Event|2|||
160835612|NCT01075984|580784431|FG004|Follow-up Phase|Adverse Event|27|||
160835613|NCT01075984|580784427|FG000|Follow-up Phase|Administrative|0|||
160835614|NCT01075984|580784428|FG001|Follow-up Phase|Administrative|0|||
160835615|NCT01075984|580784429|FG002|Follow-up Phase|Administrative|0|||
160835616|NCT01075984|580784430|FG003|Follow-up Phase|Administrative|0|||
160835617|NCT01075984|580784431|FG004|Follow-up Phase|Administrative|1|||
160835618|NCT01075984|580784427|FG000|Follow-up Phase|Withdrawal by Subject|0|||
160835619|NCT01075984|580784428|FG001|Follow-up Phase|Withdrawal by Subject|0|||
160835620|NCT01075984|580784429|FG002|Follow-up Phase|Withdrawal by Subject|0|||
160835621|NCT01075984|580784430|FG003|Follow-up Phase|Withdrawal by Subject|0|||
160835622|NCT01075984|580784431|FG004|Follow-up Phase|Withdrawal by Subject|10|||
160835623|NCT01075984|580784427|FG000|Follow-up Phase|Progression of disease|0|||
160835624|NCT01075984|580784428|FG001|Follow-up Phase|Progression of disease|0|||
160835625|NCT01075984|580784429|FG002|Follow-up Phase|Progression of disease|0|||
160903831|NCT01594281|581043026|FG001|Interventional Core Phase|Adverse Event|4|||
160903832|NCT01594281|581043027|FG002|Interventional Core Phase|Adverse Event|4|||
160903833|NCT01594281|581043025|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
160903834|NCT01594281|581043026|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
160903835|NCT01594281|581043027|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
160903836|NCT01594281|581043025|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
160903837|NCT01594281|581043026|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
160903838|NCT01594281|581043027|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
160903839|NCT01594281|581043025|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
160903840|NCT01594281|581043026|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
160903841|NCT01594281|581043027|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
160903842|NCT01871532|581043028|FG000|Overall Study|Withdrawal by Subject|1|||
160903843|NCT01871532|581043029|FG001|Overall Study|Withdrawal by Subject|2|||
160903844|NCT00283400|581043030|FG000|Overall Study|Withdrawal by Subject|1|||
160903845|NCT00283400|581043031|FG001|Overall Study|Withdrawal by Subject|1|||
160903846|NCT00283400|581043032|FG002|Overall Study|Withdrawal by Subject|0|||
160903847|NCT00283400|581043033|FG003|Overall Study|Withdrawal by Subject|0|||
160903848|NCT00283400|581043030|FG000|Overall Study|Death|1|||
160903849|NCT00283400|581043031|FG001|Overall Study|Death|0|||
160903850|NCT00283400|581043032|FG002|Overall Study|Death|1|||
160903851|NCT00283400|581043033|FG003|Overall Study|Death|0|||
160903852|NCT02550106|581043038|FG000|Overall Study|Adverse Event|1|||
160903853|NCT02550106|581043038|FG000|Overall Study|Lack of Efficacy|3|||
160903854|NCT02550106|581043038|FG000|Overall Study|Protocol Violation|6|||
160903855|NCT02550106|581043038|FG000|Overall Study|Withdrawal by Subject|2|||
160903856|NCT01890473|581043039|FG000|Overall Study|Lost to Follow-up|1|||
160903857|NCT01890473|581043040|FG001|Overall Study|Lost to Follow-up|0|||
160903858|NCT01890473|581043039|FG000|Overall Study|Poor/non-compliance|1|||
160903859|NCT01890473|581043040|FG001|Overall Study|Poor/non-compliance|0|||
160903860|NCT00934089|581043041|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
160903861|NCT00934089|581043042|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
160903862|NCT00934089|581043041|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
160903863|NCT00934089|581043042|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
160903864|NCT00926328|581043043|FG000|Overall Study|Lost to Follow-up|12|||
160903865|NCT00926328|581043044|FG001|Overall Study|Lost to Follow-up|14|||
160903866|NCT00726986|581043045|FG000|Induction Phase|Adverse Event|4|||
160903867|NCT00726986|581043045|FG000|Induction Phase|Withdrawal by Subject|2|||
160903868|NCT00726986|581043045|FG000|Induction Phase|Death|2|||
160903869|NCT00726986|581043045|FG000|Induction Phase|Lack of Efficacy|5|||
160903870|NCT00726986|581043045|FG000|Induction Phase|Secondary Disease|2|||
160903871|NCT00726986|581043045|FG000|Maintenance Phase|Adverse Event|1|||
160903872|NCT00726986|581043045|FG000|Maintenance Phase|Lack of Efficacy|2|||
160903873|NCT01819831|581043048|FG000|Overall Study|Withdrawal by Subject|1|||
160903874|NCT05074667|581043049|FG000|Overall Study|Death|1|||
160903875|NCT05074667|581043049|FG000|Overall Study|Withdrawal by Subject|4|||
160903876|NCT05074667|581043049|FG000|Overall Study|Lost to Follow-up|10|||
160903877|NCT01947582|581043050|FG000|Overall Study|Withdrawal by Subject|1|||
160903878|NCT01086033|581043051|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
160835626|NCT01075984|580784430|FG003|Follow-up Phase|Progression of disease|0|||
160903879|NCT01086033|581043051|FG000|Overall Study|Lost to Follow-up|86|||
160835627|NCT01075984|580784431|FG004|Follow-up Phase|Progression of disease|2|||
160835628|NCT01075984|580784427|FG000|Follow-up Phase|Treatment failure|0|||
160835629|NCT01075984|580784428|FG001|Follow-up Phase|Treatment failure|0|||
160835630|NCT01075984|580784429|FG002|Follow-up Phase|Treatment failure|0|||
160835631|NCT01075984|580784430|FG003|Follow-up Phase|Treatment failure|0|||
160835632|NCT01075984|580784431|FG004|Follow-up Phase|Treatment failure|4|||
160903880|NCT01086033|581043051|FG000|Overall Study|Adverse Event|42|||
160903881|NCT01086033|581043051|FG000|Overall Study|Withdrawal by Subject|41|||
160903882|NCT01086033|581043051|FG000|Overall Study|Other|14|||
160903883|NCT01086033|581043051|FG000|Overall Study|Other|13|||
160835633|NCT02986854|580784432|FG000|Overall Study|Withdrawal by Subject|0|||
160835634|NCT02986854|580784433|FG001|Overall Study|Withdrawal by Subject|1|||
160835635|NCT02986854|580784434|FG002|Overall Study|Withdrawal by Subject|1|||
160835636|NCT02986854|580784432|FG000|Overall Study|Lost to Follow-up|3|||
160835637|NCT02986854|580784433|FG001|Overall Study|Lost to Follow-up|11|||
160835638|NCT02986854|580784434|FG002|Overall Study|Lost to Follow-up|2|||
160835639|NCT00086411|580784435|FG000|Overall Study|Lost to Follow-up|11|||
160835640|NCT00086411|580784436|FG001|Overall Study|Lost to Follow-up|11|||
160835641|NCT00086411|580784437|FG002|Overall Study|Lost to Follow-up|13|||
160835642|NCT00086411|580784438|FG003|Overall Study|Lost to Follow-up|12|||
160835643|NCT01403116|580784444|FG000|Overall Study|Adverse Event|7|||
160835644|NCT01403116|580784445|FG001|Overall Study|Adverse Event|4|||
160835645|NCT01403116|580784444|FG000|Overall Study|Lost to Follow-up|7|||
160835646|NCT01403116|580784445|FG001|Overall Study|Lost to Follow-up|5|||
160835647|NCT01403116|580784444|FG000|Overall Study|Withdrawal by Subject|12|||
160835648|NCT01403116|580784445|FG001|Overall Study|Withdrawal by Subject|15|||
160835649|NCT01403116|580784444|FG000|Overall Study|Non-compliance of study drug|3|||
160835650|NCT01403116|580784445|FG001|Overall Study|Non-compliance of study drug|0|||
160835651|NCT01403116|580784444|FG000|Overall Study|Protocol Violation|0|||
160835652|NCT01403116|580784445|FG001|Overall Study|Protocol Violation|1|||
160835653|NCT01403116|580784444|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
160835654|NCT01403116|580784445|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
160835655|NCT01403116|580784444|FG000|Overall Study|Hct >54%|2|||
160835656|NCT01403116|580784445|FG001|Overall Study|Hct >54%|0|||
160835657|NCT01403116|580784444|FG000|Overall Study|unable to keep appointments|0|||
160835658|NCT01403116|580784445|FG001|Overall Study|unable to keep appointments|2|||
160835659|NCT00042666|580784446|FG000|Overall Study|Adverse Event|2|||
160835660|NCT00042666|580784446|FG000|Overall Study|Death|4|||
160835661|NCT00042666|580784446|FG000|Overall Study|Protocol Violation|1|||
160835662|NCT00042666|580784446|FG000|Overall Study|Participant/Physician Perception|1|||
160835663|NCT00042666|580784446|FG000|Overall Study|Progressive Disease|41|||
160835664|NCT00042666|580784446|FG000|Overall Study|Other|1|||
160835665|NCT00042666|580784446|FG000|Overall Study|Other|4|||
160862010|NCT05138653|580887921|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862011|NCT05138653|580887922|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862012|NCT05138653|580887923|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862013|NCT05138653|580887924|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862014|NCT05138653|580887925|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862015|NCT05138653|580887926|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862016|NCT05138653|580887927|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862017|NCT05138653|580887928|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862018|NCT05138653|580887929|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862019|NCT05138653|580887930|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862020|NCT05138653|580887931|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862021|NCT05138653|580887932|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160562512|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
160862022|NCT05138653|580887933|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862023|NCT05138653|580887934|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862024|NCT05138653|580887935|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862025|NCT05138653|580887920|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862026|NCT05138653|580887921|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
160862027|NCT05138653|580887922|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862028|NCT05138653|580887923|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862029|NCT05138653|580887924|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862030|NCT05138653|580887925|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862031|NCT05138653|580887926|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862032|NCT05138653|580887927|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862033|NCT05138653|580887928|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
160862034|NCT05138653|580887929|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862035|NCT05138653|580887930|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862036|NCT05138653|580887931|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862037|NCT05138653|580887932|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862038|NCT05138653|580887933|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862039|NCT05138653|580887934|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160562513|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
160562514|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
160562515|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
160562516|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
160562517|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
160562518|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
160562519|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
160562520|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
160562521|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
160562522|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
160562523|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
160562524|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
160562525|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
160562526|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
160562527|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
160562528|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
160571873|NCT00491530|579816847|FG001|Overall Study|Withdrawal by Subject|0|||
160835666|NCT03343626|580786321|FG000|Overall Study|Lost to Follow-up|4|||
160835667|NCT03343626|580786322|FG001|Overall Study|Lost to Follow-up|3|||
160835668|NCT03343626|580786323|FG002|Overall Study|Lost to Follow-up|2|||
160835669|NCT03343626|580786324|FG003|Overall Study|Lost to Follow-up|5|||
160835670|NCT03343626|580786325|FG004|Overall Study|Lost to Follow-up|4|||
160835671|NCT03343626|580786326|FG005|Overall Study|Lost to Follow-up|4|||
160835672|NCT03343626|580786327|FG006|Overall Study|Lost to Follow-up|4|||
160835673|NCT03343626|580786328|FG007|Overall Study|Lost to Follow-up|7|||
160835674|NCT03343626|580786321|FG000|Overall Study|Withdrawal of Consent|2|||
160835675|NCT03343626|580786322|FG001|Overall Study|Withdrawal of Consent|1|||
160835676|NCT03343626|580786323|FG002|Overall Study|Withdrawal of Consent|0|||
160835677|NCT03343626|580786324|FG003|Overall Study|Withdrawal of Consent|3|||
160835678|NCT03343626|580786325|FG004|Overall Study|Withdrawal of Consent|3|||
160835679|NCT03343626|580786326|FG005|Overall Study|Withdrawal of Consent|1|||
160835680|NCT03343626|580786327|FG006|Overall Study|Withdrawal of Consent|1|||
160835681|NCT03343626|580786328|FG007|Overall Study|Withdrawal of Consent|2|||
160835682|NCT03343626|580786321|FG000|Overall Study|Reason not Specified|0|||
160835683|NCT03343626|580786322|FG001|Overall Study|Reason not Specified|1|||
160835684|NCT03343626|580786323|FG002|Overall Study|Reason not Specified|0|||
160835685|NCT03343626|580786324|FG003|Overall Study|Reason not Specified|0|||
160835686|NCT03343626|580786325|FG004|Overall Study|Reason not Specified|0|||
160835687|NCT03343626|580786326|FG005|Overall Study|Reason not Specified|0|||
160835688|NCT03343626|580786327|FG006|Overall Study|Reason not Specified|0|||
160835689|NCT03343626|580786328|FG007|Overall Study|Reason not Specified|1|||
160835690|NCT03343626|580786321|FG000|Overall Study|Data Entry Error|0|||
160835691|NCT03343626|580786322|FG001|Overall Study|Data Entry Error|0|||
160835692|NCT03343626|580786323|FG002|Overall Study|Data Entry Error|0|||
160835693|NCT03343626|580786324|FG003|Overall Study|Data Entry Error|0|||
160835694|NCT03343626|580786325|FG004|Overall Study|Data Entry Error|0|||
160835695|NCT03343626|580786326|FG005|Overall Study|Data Entry Error|0|||
160835696|NCT03343626|580786327|FG006|Overall Study|Data Entry Error|0|||
160835697|NCT03343626|580786328|FG007|Overall Study|Data Entry Error|1|||
160835698|NCT00742417|580786331|FG000|Randomized|Withdrawal by legal representative|0|||
160835699|NCT00742417|580786332|FG001|Randomized|Withdrawal by legal representative|1|||
160835700|NCT00742417|580786331|FG000|Randomized|Withdrawal by Subject|1|||
160835701|NCT00742417|580786332|FG001|Randomized|Withdrawal by Subject|0|||
160835702|NCT00742417|580786331|FG000|Randomized|Physician Decision|1|||
160835703|NCT00742417|580786332|FG001|Randomized|Physician Decision|0|||
160835704|NCT00742417|580786331|FG000|Intensive Period|Withdrawal by Subject|1|||
160835705|NCT00742417|580786332|FG001|Intensive Period|Withdrawal by Subject|1|||
160835706|NCT00742417|580786331|FG000|Intensive Period|Adverse Event|2|||
160835707|NCT00742417|580786332|FG001|Intensive Period|Adverse Event|0|||
160835708|NCT00965575|580786337|FG000|Overall Study|subject unwillingness to swallow study c|1|||
160835709|NCT00965575|580786338|FG001|Overall Study|subject unwillingness to swallow study c|0|||
160835710|NCT01041287|580786341|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
160835711|NCT01041287|580786342|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
160835712|NCT01041287|580786341|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
160835713|NCT01041287|580786342|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
160835714|NCT03775512|580786350|FG000|Overall Study|Death|1|||
160835715|NCT03775512|580786351|FG001|Overall Study|Death|1|||
160835716|NCT03775512|580786350|FG000|Overall Study|Withdrawal by Subject|7|||
160835717|NCT03775512|580786351|FG001|Overall Study|Withdrawal by Subject|4|||
160835718|NCT03775512|580786350|FG000|Overall Study|Lost to Follow-up|5|||
160835719|NCT03775512|580786351|FG001|Overall Study|Lost to Follow-up|5|||
160835720|NCT03775512|580786350|FG000|Overall Study|Excluded before Catheter insertion|14|||
160562529|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
160562530|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
160562531|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
160562532|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
160562533|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
160562534|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
160562535|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
160562536|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
160562537|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
160562538|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
160562539|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
160562540|NCT00408005|579781583|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
160562541|NCT00408005|579781584|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
160562542|NCT00408005|579781585|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
160562543|NCT00408005|579781586|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
160562544|NCT00408005|579781587|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
160562545|NCT00408005|579781588|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
160562546|NCT00408005|579781589|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
160562547|NCT00408005|579781590|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
160562548|NCT05817045|579781591|FG000|Overall Study|Protocol Violation|0|||
160562549|NCT05817045|579781592|FG001|Overall Study|Protocol Violation|3|||
160562550|NCT05817045|579781591|FG000|Overall Study|Withdrawal by Subject|10|||
160562551|NCT05817045|579781592|FG001|Overall Study|Withdrawal by Subject|7|||
160562552|NCT05817045|579781591|FG000|Overall Study|Physician Decision|3|||
160562553|NCT05817045|579781592|FG001|Overall Study|Physician Decision|0|||
160562554|NCT05817045|579781591|FG000|Overall Study|Lost to Follow-up|0|||
160562555|NCT05817045|579781592|FG001|Overall Study|Lost to Follow-up|1|||
160562556|NCT05817045|579781591|FG000|Overall Study|Device Deficiency|1|||
160562557|NCT05817045|579781592|FG001|Overall Study|Device Deficiency|0|||
160562558|NCT05817045|579781591|FG000|Overall Study|System Error|1|||
160562559|NCT05817045|579781592|FG001|Overall Study|System Error|0|||
160562560|NCT05424276|579781593|FG000|Overall Study|Adverse Event|1|||
160562561|NCT05424276|579781594|FG001|Overall Study|Adverse Event|0|||
160562562|NCT05424276|579781595|FG002|Overall Study|Adverse Event|0|||
160562563|NCT05424276|579781596|FG003|Overall Study|Adverse Event|2|||
160562564|NCT05424276|579781593|FG000|Overall Study|Withdrawal by Subject|0|||
160562565|NCT05424276|579781594|FG001|Overall Study|Withdrawal by Subject|0|||
160562566|NCT05424276|579781595|FG002|Overall Study|Withdrawal by Subject|2|||
160562567|NCT05424276|579781596|FG003|Overall Study|Withdrawal by Subject|0|||
160562568|NCT05424276|579781593|FG000|Overall Study|Protocol Violation|0|||
160562569|NCT05424276|579781594|FG001|Overall Study|Protocol Violation|1|||
160562570|NCT05424276|579781595|FG002|Overall Study|Protocol Violation|0|||
160562571|NCT05424276|579781596|FG003|Overall Study|Protocol Violation|0|||
160562572|NCT05424276|579781593|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
160562573|NCT05424276|579781594|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
160562574|NCT05424276|579781595|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
160562575|NCT05424276|579781596|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
160562576|NCT00442598|579781597|FG000|Overall Study|Adverse Event|1|||
160562577|NCT00442598|579781598|FG001|Overall Study|Adverse Event|0|||
160562578|NCT00442598|579781599|FG002|Overall Study|Adverse Event|0|||
160562579|NCT00442598|579781597|FG000|Overall Study|Tumor progression|3|||
160562580|NCT00442598|579781598|FG001|Overall Study|Tumor progression|4|||
160562581|NCT00442598|579781599|FG002|Overall Study|Tumor progression|0|||
160562582|NCT00442598|579781597|FG000|Overall Study|Clinical deterioration|1|||
160562583|NCT00442598|579781598|FG001|Overall Study|Clinical deterioration|2|||
160562584|NCT00442598|579781599|FG002|Overall Study|Clinical deterioration|0|||
160562585|NCT00442598|579781597|FG000|Overall Study|CA125 progression|0|||
160562586|NCT00442598|579781598|FG001|Overall Study|CA125 progression|1|||
160562587|NCT00442598|579781599|FG002|Overall Study|CA125 progression|0|||
160562588|NCT00442598|579781597|FG000|Overall Study|Reduced creatinine clearance|1|||
160903884|NCT01086033|581043051|FG000|Overall Study|AE and Withdrew Consent|5|||
160903885|NCT01086033|581043051|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
160903886|NCT01086033|581043051|FG000|Overall Study|Withdrew consent and Other Reason|4|||
160903887|NCT01086033|581043051|FG000|Overall Study|AE and Lack of Efficacy|4|||
160562589|NCT00442598|579781598|FG001|Overall Study|Reduced creatinine clearance|0|||
160562590|NCT00442598|579781599|FG002|Overall Study|Reduced creatinine clearance|0|||
160562591|NCT00442598|579781597|FG000|Overall Study|Death|0|||
160562592|NCT00442598|579781598|FG001|Overall Study|Death|1|||
160562593|NCT00442598|579781599|FG002|Overall Study|Death|0|||
160562594|NCT02886702|579781600|FG000|Overall Study|Other|4|||
160903888|NCT01086033|581043051|FG000|Overall Study|Death|1|||
160562595|NCT02886702|579781601|FG001|Overall Study|Other|3|||
160562596|NCT02886702|579781602|FG002|Overall Study|Other|9|||
160562597|NCT02886702|579781600|FG000|Overall Study|Withdrawal by Subject|24|||
160562598|NCT02886702|579781601|FG001|Overall Study|Withdrawal by Subject|18|||
160562599|NCT02886702|579781602|FG002|Overall Study|Withdrawal by Subject|22|||
160562600|NCT02886702|579781600|FG000|Overall Study|Significant Worsening of Condition|0|||
160562601|NCT02886702|579781601|FG001|Overall Study|Significant Worsening of Condition|1|||
160562602|NCT02886702|579781602|FG002|Overall Study|Significant Worsening of Condition|0|||
160562603|NCT02886702|579781600|FG000|Overall Study|Protocol Violation|2|||
160562604|NCT02886702|579781601|FG001|Overall Study|Protocol Violation|2|||
160562605|NCT02886702|579781602|FG002|Overall Study|Protocol Violation|1|||
160562606|NCT02886702|579781600|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160562607|NCT02886702|579781601|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160562608|NCT02886702|579781602|FG002|Overall Study|Non-Compliance With Study Drug|4|||
160562609|NCT02886702|579781600|FG000|Overall Study|Lost to Follow-up|11|||
160562610|NCT02886702|579781601|FG001|Overall Study|Lost to Follow-up|13|||
160562611|NCT02886702|579781602|FG002|Overall Study|Lost to Follow-up|8|||
160562612|NCT02886702|579781600|FG000|Overall Study|Lack of Efficacy|3|||
160562613|NCT02886702|579781601|FG001|Overall Study|Lack of Efficacy|4|||
160562614|NCT02886702|579781602|FG002|Overall Study|Lack of Efficacy|5|||
160562615|NCT02886702|579781600|FG000|Overall Study|Adverse Event|4|||
160562616|NCT02886702|579781601|FG001|Overall Study|Adverse Event|9|||
160562617|NCT02886702|579781602|FG002|Overall Study|Adverse Event|3|||
160562618|NCT02886702|579781600|FG000|Overall Study|Administrative Reasons|0|||
160562619|NCT02886702|579781601|FG001|Overall Study|Administrative Reasons|0|||
160562620|NCT02886702|579781602|FG002|Overall Study|Administrative Reasons|1|||
160562621|NCT01085682|579781612|FG000|Overall Study|Withdrawal by Subject|25|||
160562622|NCT01085682|579781613|FG001|Overall Study|Withdrawal by Subject|25|||
160562623|NCT02561156|579781616|FG000|Part 2|Adverse Event|0|||
160562624|NCT02561156|579781617|FG001|Part 2|Adverse Event|0|||
160562625|NCT02561156|579781618|FG002|Part 2|Adverse Event|0|||
160562626|NCT02561156|579781619|FG003|Part 2|Adverse Event|0|||
160562627|NCT02561156|579781620|FG004|Part 2|Adverse Event|0|||
160562628|NCT02561156|579781621|FG005|Part 2|Adverse Event|0|||
160562629|NCT02561156|579781622|FG006|Part 2|Adverse Event|0|||
160562630|NCT02561156|579781623|FG007|Part 2|Adverse Event|0|||
160562631|NCT02561156|579781624|FG008|Part 2|Adverse Event|0|||
160562632|NCT02561156|579781625|FG009|Part 2|Adverse Event|0|||
160562633|NCT02561156|579781626|FG010|Part 2|Adverse Event|0|||
160835721|NCT03775512|580786351|FG001|Overall Study|Excluded before Catheter insertion|5|||
160835722|NCT03775512|580786350|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
160835723|NCT03775512|580786351|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
160835724|NCT03775512|580786350|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
160835725|NCT03775512|580786351|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
160835726|NCT01610336|580786352|FG000|Overall Study|Progressive Disease|4|||
160835727|NCT01610336|580786353|FG001|Overall Study|Progressive Disease|6|||
160835728|NCT01610336|580786354|FG002|Overall Study|Progressive Disease|6|||
160835729|NCT01610336|580786355|FG003|Overall Study|Progressive Disease|5|||
160835730|NCT01610336|580786356|FG004|Overall Study|Progressive Disease|3|||
160835731|NCT01610336|580786357|FG005|Overall Study|Progressive Disease|10|||
160835732|NCT01610336|580786358|FG006|Overall Study|Progressive Disease|1|||
160835733|NCT01610336|580786359|FG007|Overall Study|Progressive Disease|6|||
160835734|NCT01610336|580786360|FG008|Overall Study|Progressive Disease|6|||
160835735|NCT01610336|580786361|FG009|Overall Study|Progressive Disease|40|||
160835736|NCT01610336|580786362|FG010|Overall Study|Progressive Disease|36|||
160835737|NCT01610336|580786352|FG000|Overall Study|Adverse Event|0|||
160835738|NCT01610336|580786353|FG001|Overall Study|Adverse Event|0|||
160835739|NCT01610336|580786354|FG002|Overall Study|Adverse Event|0|||
160835740|NCT01610336|580786355|FG003|Overall Study|Adverse Event|1|||
160835741|NCT01610336|580786356|FG004|Overall Study|Adverse Event|1|||
160835742|NCT01610336|580786357|FG005|Overall Study|Adverse Event|1|||
160835743|NCT01610336|580786358|FG006|Overall Study|Adverse Event|0|||
160835744|NCT01610336|580786359|FG007|Overall Study|Adverse Event|0|||
160835745|NCT01610336|580786360|FG008|Overall Study|Adverse Event|2|||
160835746|NCT01610336|580786361|FG009|Overall Study|Adverse Event|8|||
160835747|NCT01610336|580786362|FG010|Overall Study|Adverse Event|6|||
160835748|NCT01610336|580786352|FG000|Overall Study|Subject/Guardian decision|1|||
160562634|NCT02561156|579781627|FG011|Part 2|Adverse Event|1|||
160562635|NCT02561156|579781628|FG012|Part 2|Adverse Event|0|||
160562636|NCT01071070|579781633|FG000|Overall Study|Adverse Event|0|||
160562637|NCT01071070|579781634|FG001|Overall Study|Adverse Event|3|||
160562638|NCT01071070|579781633|FG000|Overall Study|Withdrawal by Subject|1|||
160835749|NCT01610336|580786353|FG001|Overall Study|Subject/Guardian decision|1|||
160835750|NCT01610336|580786354|FG002|Overall Study|Subject/Guardian decision|0|||
160835751|NCT01610336|580786355|FG003|Overall Study|Subject/Guardian decision|1|||
160835752|NCT01610336|580786356|FG004|Overall Study|Subject/Guardian decision|0|||
160835753|NCT01610336|580786357|FG005|Overall Study|Subject/Guardian decision|0|||
160835754|NCT01610336|580786358|FG006|Overall Study|Subject/Guardian decision|0|||
160562639|NCT01071070|579781634|FG001|Overall Study|Withdrawal by Subject|0|||
160562640|NCT01071070|579781633|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
160562641|NCT01071070|579781634|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
160562642|NCT01071070|579781633|FG000|Overall Study|Hypercalcemia|1|||
160562643|NCT01071070|579781634|FG001|Overall Study|Hypercalcemia|0|||
160562644|NCT00473876|579781640|FG000|Overall Study|Lost to Follow-up|3|||
160562645|NCT00473876|579781641|FG001|Overall Study|Lost to Follow-up|1|||
160562646|NCT02393209|579781644|FG000|Overall Study|Study Terminated by Sponsor|1|||
160562647|NCT02393209|579781645|FG001|Overall Study|Study Terminated by Sponsor|1|||
160562648|NCT02393209|579781646|FG002|Overall Study|Study Terminated by Sponsor|0|||
160562649|NCT02393209|579781647|FG003|Overall Study|Study Terminated by Sponsor|0|||
160562650|NCT02393209|579781644|FG000|Overall Study|Withdrawal by Patient|1|||
160562651|NCT02393209|579781645|FG001|Overall Study|Withdrawal by Patient|0|||
160562652|NCT02393209|579781646|FG002|Overall Study|Withdrawal by Patient|0|||
160562653|NCT02393209|579781647|FG003|Overall Study|Withdrawal by Patient|0|||
160562654|NCT02393209|579781644|FG000|Overall Study|Death|2|||
160562655|NCT02393209|579781645|FG001|Overall Study|Death|2|||
160562656|NCT02393209|579781646|FG002|Overall Study|Death|0|||
160562657|NCT02393209|579781647|FG003|Overall Study|Death|0|||
160562658|NCT02393209|579781644|FG000|Overall Study|Death due to Disease Progression|2|||
160562659|NCT02393209|579781645|FG001|Overall Study|Death due to Disease Progression|2|||
160562660|NCT02393209|579781646|FG002|Overall Study|Death due to Disease Progression|0|||
160562661|NCT02393209|579781647|FG003|Overall Study|Death due to Disease Progression|0|||
160562662|NCT02393209|579781644|FG000|Overall Study|Death from Legionella Infection|0|||
160562663|NCT02393209|579781645|FG001|Overall Study|Death from Legionella Infection|1|||
160835755|NCT01610336|580786359|FG007|Overall Study|Subject/Guardian decision|1|||
160835756|NCT01610336|580786360|FG008|Overall Study|Subject/Guardian decision|0|||
160835757|NCT01610336|580786361|FG009|Overall Study|Subject/Guardian decision|2|||
160835758|NCT01610336|580786362|FG010|Overall Study|Subject/Guardian decision|2|||
160835759|NCT01610336|580786352|FG000|Overall Study|Death|0|||
160835760|NCT01610336|580786353|FG001|Overall Study|Death|0|||
160835761|NCT01610336|580786354|FG002|Overall Study|Death|0|||
160835762|NCT01610336|580786355|FG003|Overall Study|Death|0|||
160835763|NCT01610336|580786356|FG004|Overall Study|Death|0|||
160835764|NCT01610336|580786357|FG005|Overall Study|Death|1|||
160835765|NCT01610336|580786358|FG006|Overall Study|Death|3|||
160835766|NCT01610336|580786359|FG007|Overall Study|Death|0|||
160835767|NCT01610336|580786360|FG008|Overall Study|Death|0|||
160991410|NCT00197236|581357790|FG001|Overall Study|Returned out of specified time window|0|||
160991411|NCT00197236|581357791|FG002|Overall Study|Returned out of specified time window|1|||
160991412|NCT02524288|581357792|FG000|Overall Study|Adverse Event|115|||
160991413|NCT02524288|581357792|FG000|Overall Study|Lost to Follow-up|216|||
160991414|NCT02524288|581357792|FG000|Overall Study|Non-Compliance With Protocol|32|||
160991415|NCT02524288|581357792|FG000|Overall Study|Non-Compliance With Study Drug|14|||
160991416|NCT02524288|581357792|FG000|Overall Study|Pregnancy Wish|6|||
160991417|NCT02524288|581357792|FG000|Overall Study|Protocol Violation|6|||
160991418|NCT02524288|581357792|FG000|Overall Study|Screen Failure|2|||
160991419|NCT02524288|581357792|FG000|Overall Study|Site Discontinued Study Participation|1|||
160991420|NCT02524288|581357792|FG000|Overall Study|Study Terminated By Sponsor|1417|||
160991421|NCT02524288|581357792|FG000|Overall Study|Subject Moved|32|||
160991422|NCT02524288|581357792|FG000|Overall Study|Withdrawal by Subject|76|||
160991423|NCT02524288|581357792|FG000|Overall Study|Pregnancy|22|||
160991424|NCT02524288|581357792|FG000|Overall Study|Physician Decision|2|||
160991425|NCT01835899|581357794|FG000|Overall Study|Adverse Event|0|||
160991426|NCT01835899|581357795|FG001|Overall Study|Adverse Event|0|||
160991427|NCT01835899|581357796|FG002|Overall Study|Adverse Event|1|||
160991428|NCT01835899|581357794|FG000|Overall Study|Other than stated above|0|||
160991429|NCT01835899|581357795|FG001|Overall Study|Other than stated above|1|||
160991430|NCT01835899|581357796|FG002|Overall Study|Other than stated above|0|||
160991431|NCT02616263|581357797|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
160647637|NCT00416520|580092783|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
160835768|NCT01610336|580786361|FG009|Overall Study|Death|1|||
160835769|NCT01610336|580786362|FG010|Overall Study|Death|2|||
160562664|NCT02393209|579781646|FG002|Overall Study|Death from Legionella Infection|0|||
160991432|NCT02616263|581357798|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
160991433|NCT02616263|581357797|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
160991434|NCT02616263|581357798|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
160991435|NCT02616263|581357797|FG000|6 Month to 1.5 Year|Death|1|||
160991436|NCT02616263|581357798|FG001|6 Month to 1.5 Year|Death|0|||
160991437|NCT02616263|581357797|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
160562665|NCT02393209|579781647|FG003|Overall Study|Death from Legionella Infection|0|||
160562666|NCT02393209|579781644|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
160835770|NCT01610336|580786352|FG000|Overall Study|Non-Compliance with study treatment|0|||
160835771|NCT01610336|580786353|FG001|Overall Study|Non-Compliance with study treatment|0|||
160835772|NCT01610336|580786354|FG002|Overall Study|Non-Compliance with study treatment|0|||
160562667|NCT02393209|579781645|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
160562668|NCT02393209|579781646|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
160562669|NCT02393209|579781647|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
160562670|NCT02393209|579781644|FG000|Overall Study|Lost to Follow-up|0|||
160562671|NCT02393209|579781645|FG001|Overall Study|Lost to Follow-up|1|||
160562672|NCT02393209|579781646|FG002|Overall Study|Lost to Follow-up|0|||
160562673|NCT02393209|579781647|FG003|Overall Study|Lost to Follow-up|0|||
160562674|NCT00755079|579781648|FG000|Overall Study|Lost to Follow-up|1|||
160562675|NCT00755079|579781649|FG001|Overall Study|Lost to Follow-up|3|||
160562676|NCT00755079|579781648|FG000|Overall Study|Adverse Event|0|||
160562677|NCT00755079|579781649|FG001|Overall Study|Adverse Event|1|||
160562678|NCT00755079|579781648|FG000|Overall Study|Withdrawal by Subject|0|||
160562679|NCT00755079|579781649|FG001|Overall Study|Withdrawal by Subject|2|||
160562680|NCT03545282|579781650|FG000|Overall Study|Lost to Follow-up|15|||
160562681|NCT03545282|579781651|FG001|Overall Study|Lost to Follow-up|10|||
160562682|NCT03545282|579781650|FG000|Overall Study|Withdrawal by Subject|2|||
160562683|NCT03545282|579781651|FG001|Overall Study|Withdrawal by Subject|2|||
160562684|NCT03751111|579781652|FG000|Overall Study|Lack of Efficacy|9|||
160562685|NCT03751111|579781653|FG001|Overall Study|Lack of Efficacy|30|||
160562686|NCT03751111|579781652|FG000|Overall Study|Adverse Event|3|||
160562687|NCT03751111|579781653|FG001|Overall Study|Adverse Event|2|||
160562688|NCT02582671|579781654|FG000|Overall Study|Failure to return|1|||
160562689|NCT02582671|579781654|FG000|Overall Study|Other, not specified|1|||
160562690|NCT01287104|579781655|FG000|Overall Study|Patient developed progressive disease|1|||
160562691|NCT01287104|579781656|FG001|Overall Study|Patient developed progressive disease|1|||
160562692|NCT01287104|579781657|FG002|Overall Study|Patient developed progressive disease|3|||
160562693|NCT01287104|579781658|FG003|Overall Study|Patient developed progressive disease|2|||
160562694|NCT01287104|579781655|FG000|Overall Study|Donor anaphylaxis|0|||
160562695|NCT01287104|579781656|FG001|Overall Study|Donor anaphylaxis|1|||
160562696|NCT01287104|579781657|FG002|Overall Study|Donor anaphylaxis|0|||
160562697|NCT01287104|579781658|FG003|Overall Study|Donor anaphylaxis|1|||
160835773|NCT01610336|580786355|FG003|Overall Study|Non-Compliance with study treatment|0|||
160835774|NCT01610336|580786356|FG004|Overall Study|Non-Compliance with study treatment|0|||
160835775|NCT01610336|580786357|FG005|Overall Study|Non-Compliance with study treatment|0|||
160835776|NCT01610336|580786358|FG006|Overall Study|Non-Compliance with study treatment|0|||
160835777|NCT01610336|580786359|FG007|Overall Study|Non-Compliance with study treatment|0|||
160835778|NCT01610336|580786360|FG008|Overall Study|Non-Compliance with study treatment|0|||
160835779|NCT01610336|580786361|FG009|Overall Study|Non-Compliance with study treatment|1|||
160835780|NCT01610336|580786362|FG010|Overall Study|Non-Compliance with study treatment|0|||
160835781|NCT01610336|580786352|FG000|Overall Study|Physician Decision|0|||
160835782|NCT01610336|580786353|FG001|Overall Study|Physician Decision|0|||
160835783|NCT01610336|580786354|FG002|Overall Study|Physician Decision|0|||
160835784|NCT01610336|580786355|FG003|Overall Study|Physician Decision|0|||
160835785|NCT01610336|580786356|FG004|Overall Study|Physician Decision|0|||
160835786|NCT01610336|580786357|FG005|Overall Study|Physician Decision|0|||
160835787|NCT01610336|580786358|FG006|Overall Study|Physician Decision|1|||
160835788|NCT01610336|580786359|FG007|Overall Study|Physician Decision|0|||
160835789|NCT01610336|580786360|FG008|Overall Study|Physician Decision|0|||
160835790|NCT01610336|580786361|FG009|Overall Study|Physician Decision|0|||
160835791|NCT01610336|580786362|FG010|Overall Study|Physician Decision|0|||
160835792|NCT01610336|580786352|FG000|Overall Study|Protocol Deviation|0|||
160835793|NCT01610336|580786353|FG001|Overall Study|Protocol Deviation|0|||
160835794|NCT01610336|580786354|FG002|Overall Study|Protocol Deviation|0|||
160835795|NCT01610336|580786355|FG003|Overall Study|Protocol Deviation|0|||
160903889|NCT01086033|581043051|FG000|Overall Study|AE and Lost to Follow-up|1|||
160562698|NCT01287104|579781655|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
160562699|NCT01287104|579781656|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
160562700|NCT01287104|579781657|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
160562701|NCT01287104|579781658|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
160562702|NCT01287104|579781655|FG000|Overall Study|Low donor chimerism|0|||
160562703|NCT01287104|579781656|FG001|Overall Study|Low donor chimerism|1|||
160562704|NCT01287104|579781657|FG002|Overall Study|Low donor chimerism|0|||
160562705|NCT01287104|579781658|FG003|Overall Study|Low donor chimerism|0|||
160562706|NCT01287104|579781655|FG000|Overall Study|NK cells did not meet release criteria|0|||
160562707|NCT01287104|579781656|FG001|Overall Study|NK cells did not meet release criteria|1|||
160562708|NCT01287104|579781657|FG002|Overall Study|NK cells did not meet release criteria|0|||
160562709|NCT01287104|579781658|FG003|Overall Study|NK cells did not meet release criteria|0|||
160562710|NCT01276288|579781667|FG000|Overall Study|Adverse Event|1|||
160562711|NCT01276288|579781668|FG001|Overall Study|Adverse Event|1|||
160562712|NCT01276288|579781669|FG002|Overall Study|Adverse Event|0|||
160562713|NCT01276288|579781670|FG003|Overall Study|Adverse Event|0|||
160835796|NCT01610336|580786356|FG004|Overall Study|Protocol Deviation|0|||
160835797|NCT01610336|580786357|FG005|Overall Study|Protocol Deviation|0|||
160835798|NCT01610336|580786358|FG006|Overall Study|Protocol Deviation|0|||
160835799|NCT01610336|580786359|FG007|Overall Study|Protocol Deviation|0|||
160835800|NCT01610336|580786360|FG008|Overall Study|Protocol Deviation|0|||
160835801|NCT01610336|580786361|FG009|Overall Study|Protocol Deviation|1|||
160903890|NCT01086033|581043051|FG000|Overall Study|AE and Other Reason|1|||
160903891|NCT01086033|581043051|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
160903892|NCT02193867|581043053|FG000|Overall Study|Death|2|||
160903893|NCT02193867|581043053|FG000|Overall Study|Sponsor Study Termination|2|||
160903894|NCT02924571|581043054|FG000|Overall Study|Lost to Follow-up|1|||
160903895|NCT02924571|581043055|FG001|Overall Study|Lost to Follow-up|1|||
160903896|NCT02924571|581043056|FG002|Overall Study|Lost to Follow-up|0|||
160903897|NCT00434954|581043060|FG000|Overall Study|Adverse Event|17|||
160903898|NCT00434954|581043061|FG001|Overall Study|Adverse Event|2|||
160903899|NCT00434954|581043060|FG000|Overall Study|Entry criteria not met|14|||
160903900|NCT00434954|581043061|FG001|Overall Study|Entry criteria not met|16|||
160903901|NCT00434954|581043060|FG000|Overall Study|Lost to Follow-up|0|||
160903902|NCT00434954|581043061|FG001|Overall Study|Lost to Follow-up|1|||
160903903|NCT00434954|581043060|FG000|Overall Study|Physician Decision|6|||
160835802|NCT01610336|580786362|FG010|Overall Study|Protocol Deviation|0|||
160835803|NCT01610336|580786352|FG000|Overall Study|Transfer to another trial|0|||
160835804|NCT01610336|580786353|FG001|Overall Study|Transfer to another trial|0|||
160835805|NCT01610336|580786354|FG002|Overall Study|Transfer to another trial|0|||
160835806|NCT01610336|580786355|FG003|Overall Study|Transfer to another trial|0|||
160835807|NCT01610336|580786356|FG004|Overall Study|Transfer to another trial|0|||
160835808|NCT01610336|580786357|FG005|Overall Study|Transfer to another trial|0|||
160835809|NCT01610336|580786358|FG006|Overall Study|Transfer to another trial|0|||
160835810|NCT01610336|580786359|FG007|Overall Study|Transfer to another trial|0|||
160835811|NCT01610336|580786360|FG008|Overall Study|Transfer to another trial|0|||
160835812|NCT01610336|580786361|FG009|Overall Study|Transfer to another trial|0|||
160835813|NCT01610336|580786362|FG010|Overall Study|Transfer to another trial|1|||
160835814|NCT02629822|580786363|FG000|Base Study|Lost to Follow-up|2|||
160835815|NCT02629822|580786363|FG000|Base Study|Non-Compliance With Study Drug|1|||
160835816|NCT02629822|580786363|FG000|Extension Study|Adverse Event|1|||
160835817|NCT02629822|580786363|FG000|Extension Study|Lost to Follow-up|1|||
160835818|NCT00082407|580786364|FG000|Overall Study|Adverse Event|20|||
160835819|NCT00082407|580786365|FG001|Overall Study|Adverse Event|0|||
160835820|NCT00082407|580786364|FG000|Overall Study|Protocol Violation|14|||
160835821|NCT00082407|580786365|FG001|Overall Study|Protocol Violation|12|||
160835822|NCT00082407|580786364|FG000|Overall Study|Patient Decision|13|||
160835823|NCT00082407|580786365|FG001|Overall Study|Patient Decision|6|||
160835824|NCT00082407|580786364|FG000|Overall Study|Physician Decision|5|||
160835825|NCT00082407|580786365|FG001|Overall Study|Physician Decision|3|||
160835826|NCT00082407|580786364|FG000|Overall Study|Loss of Glucose Control|2|||
160835827|NCT00082407|580786365|FG001|Overall Study|Loss of Glucose Control|2|||
160835828|NCT00082407|580786364|FG000|Overall Study|Death|2|||
160903904|NCT00434954|581043061|FG001|Overall Study|Physician Decision|3|||
160903905|NCT00434954|581043060|FG000|Overall Study|Protocol Violation|36|||
160903906|NCT00434954|581043061|FG001|Overall Study|Protocol Violation|27|||
160903907|NCT00434954|581043060|FG000|Overall Study|Sponsor decision|1|||
160903908|NCT00434954|581043061|FG001|Overall Study|Sponsor decision|0|||
160903909|NCT00434954|581043060|FG000|Overall Study|Subject decision|8|||
160903910|NCT00434954|581043061|FG001|Overall Study|Subject decision|22|||
160903911|NCT01705730|581043062|FG000|Overall Study|Lack of Efficacy|1|||
160903912|NCT01705730|581043062|FG000|Overall Study|Adverse Event|3|||
160903913|NCT01705730|581043062|FG000|Overall Study|Lost to Follow-up|1|||
160903914|NCT01705730|581043062|FG000|Overall Study|Reason not Specified|4|||
160903915|NCT03417219|581043065|FG000|Overall Study|Lost to Follow-up|0|||
160903916|NCT03417219|581043066|FG001|Overall Study|Lost to Follow-up|3|||
160903917|NCT02589405|581043070|FG000|Overall Study|Adverse Event|3|||
160903918|NCT02589405|581043070|FG000|Overall Study|Withdrawal by Subject|1|||
160903919|NCT00446251|581043073|FG000|Overall Study|On-study Transplants|2|||
160903920|NCT00446251|581043073|FG000|Overall Study|Rituximab Infusion Reaction|2|||
160991438|NCT02616263|581357798|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
160835829|NCT00082407|580786365|FG001|Overall Study|Death|1|||
160835830|NCT00082407|580786364|FG000|Overall Study|Lost to Follow-up|0|||
160991439|NCT02616263|581357797|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
160835831|NCT00082407|580786365|FG001|Overall Study|Lost to Follow-up|3|||
160835832|NCT03464019|580786366|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
160835833|NCT03464019|580786367|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
160835834|NCT03464019|580786368|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
160835835|NCT03464019|580786366|FG000|NODE-301 Part 1|Ablation|0|||
160903921|NCT00446251|581043073|FG000|Overall Study|Lost to Follow-up|1|||
160991440|NCT02616263|581357798|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
160991441|NCT02616263|581357797|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
160991442|NCT02616263|581357798|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
160991443|NCT02939183|581357804|FG000|Overall Study|Death|0|||
160835836|NCT03464019|580786367|FG001|NODE-301 Part 1|Ablation|0|||
160835837|NCT03464019|580786368|FG002|NODE-301 Part 1|Ablation|16|||
160835838|NCT03464019|580786366|FG000|NODE-301 Part 1|Test Dose Failure|0|||
160835839|NCT03464019|580786367|FG001|NODE-301 Part 1|Test Dose Failure|0|||
160903922|NCT02264639|581043078|FG000|Overall Study|Death (after completing single-dose phase)|1|||
160903923|NCT02264639|581043079|FG001|Overall Study|Death (after completing single-dose phase)|0|||
160991444|NCT02939183|581357805|FG001|Overall Study|Death|0|||
160991445|NCT02939183|581357806|FG002|Overall Study|Death|1|||
160991446|NCT02939183|581357807|FG003|Overall Study|Death|0|||
160991447|NCT02939183|581357808|FG004|Overall Study|Death|0|||
160991448|NCT02939183|581357809|FG005|Overall Study|Death|2|||
160991449|NCT02939183|581357810|FG006|Overall Study|Death|1|||
160991450|NCT02939183|581357811|FG007|Overall Study|Death|0|||
160991451|NCT02939183|581357812|FG008|Overall Study|Death|0|||
160991452|NCT02939183|581357804|FG000|Overall Study|Sponsor decision|0|||
160991453|NCT02939183|581357805|FG001|Overall Study|Sponsor decision|1|||
160835840|NCT03464019|580786368|FG002|NODE-301 Part 1|Test Dose Failure|8|||
160835841|NCT03464019|580786366|FG000|NODE-301 Part 1|Adverse Event|0|||
160835842|NCT03464019|580786367|FG001|NODE-301 Part 1|Adverse Event|0|||
160835843|NCT03464019|580786368|FG002|NODE-301 Part 1|Adverse Event|5|||
160835844|NCT03464019|580786366|FG000|NODE-301 Part 1|Physician Decision|0|||
160835845|NCT03464019|580786367|FG001|NODE-301 Part 1|Physician Decision|0|||
160835846|NCT03464019|580786368|FG002|NODE-301 Part 1|Physician Decision|4|||
160835847|NCT03464019|580786366|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
160835848|NCT03464019|580786367|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
160835849|NCT03464019|580786368|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
160835850|NCT03464019|580786366|FG000|NODE-301 Part 1|Protocol Violation|0|||
160835851|NCT03464019|580786367|FG001|NODE-301 Part 1|Protocol Violation|0|||
160835852|NCT03464019|580786368|FG002|NODE-301 Part 1|Protocol Violation|2|||
160835853|NCT03464019|580786366|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
160835854|NCT03464019|580786367|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
160835855|NCT03464019|580786368|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
160835856|NCT03464019|580786366|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
160835857|NCT03464019|580786367|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
160835858|NCT03464019|580786368|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
160835859|NCT03464019|580786366|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
160835860|NCT03464019|580786367|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
160835861|NCT03464019|580786368|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
160835862|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
160835863|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
160835864|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
160835865|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
160835866|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
160835867|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
160835868|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
160835869|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
160835870|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
160835871|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
160835872|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
160835873|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
160835874|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
160835875|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
160835876|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
160835877|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
160835878|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
160835879|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
160835880|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
160835881|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
160835882|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
160835883|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
160835884|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
160835885|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
160835886|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
160835887|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
160835888|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
160991454|NCT02939183|581357806|FG002|Overall Study|Sponsor decision|0|||
160991455|NCT02939183|581357807|FG003|Overall Study|Sponsor decision|1|||
160991456|NCT02939183|581357808|FG004|Overall Study|Sponsor decision|2|||
160991457|NCT02939183|581357809|FG005|Overall Study|Sponsor decision|0|||
160991458|NCT02939183|581357810|FG006|Overall Study|Sponsor decision|3|||
160991459|NCT02939183|581357811|FG007|Overall Study|Sponsor decision|1|||
160991460|NCT02939183|581357812|FG008|Overall Study|Sponsor decision|4|||
160991461|NCT02939183|581357804|FG000|Overall Study|Withdrawal by Subject|0|||
160991462|NCT02939183|581357805|FG001|Overall Study|Withdrawal by Subject|2|||
160991463|NCT02939183|581357806|FG002|Overall Study|Withdrawal by Subject|0|||
160991464|NCT02939183|581357807|FG003|Overall Study|Withdrawal by Subject|1|||
160991465|NCT02939183|581357808|FG004|Overall Study|Withdrawal by Subject|0|||
160991466|NCT02939183|581357809|FG005|Overall Study|Withdrawal by Subject|0|||
160991467|NCT02939183|581357810|FG006|Overall Study|Withdrawal by Subject|2|||
160991468|NCT02939183|581357811|FG007|Overall Study|Withdrawal by Subject|2|||
160835889|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
160835890|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
160835891|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
160835892|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
160835893|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
160835894|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
160835895|NCT00767806|580786369|FG000|Overall Study|Adverse Event|30|||
160835896|NCT00767806|580786370|FG001|Overall Study|Adverse Event|11|||
160835897|NCT00767806|580786369|FG000|Overall Study|Withdrawal by Subject|8|||
160835898|NCT00767806|580786370|FG001|Overall Study|Withdrawal by Subject|13|||
160835899|NCT00767806|580786369|FG000|Overall Study|Protocol Violation|6|||
160835900|NCT00767806|580786370|FG001|Overall Study|Protocol Violation|5|||
160835901|NCT00767806|580786369|FG000|Overall Study|Lack of Efficacy|1|||
160835902|NCT00767806|580786370|FG001|Overall Study|Lack of Efficacy|9|||
160835903|NCT00767806|580786369|FG000|Overall Study|Physician Decision|4|||
160835904|NCT00767806|580786370|FG001|Overall Study|Physician Decision|3|||
160835905|NCT00767806|580786369|FG000|Overall Study|Lost to Follow-up|1|||
160835906|NCT00767806|580786370|FG001|Overall Study|Lost to Follow-up|4|||
160835907|NCT00767806|580786369|FG000|Overall Study|Entry Criteria Not Met|1|||
160835908|NCT00767806|580786370|FG001|Overall Study|Entry Criteria Not Met|1|||
160835909|NCT00767806|580786369|FG000|Overall Study|Sponsor Decision|0|||
160835910|NCT00767806|580786370|FG001|Overall Study|Sponsor Decision|1|||
160835911|NCT02489942|580786371|FG000|Overall Study|Request by patient|602|||
160835912|NCT02489942|580786371|FG000|Overall Study|Improvement/remission|157|||
160835913|NCT02489942|580786371|FG000|Overall Study|No change/Progressive disease|263|||
160835914|NCT02489942|580786371|FG000|Overall Study|Adverse Event|522|||
160835915|NCT02489942|580786371|FG000|Overall Study|Other personal reasons|1218|||
160835916|NCT02489942|580786371|FG000|Overall Study|Lost to Follow-up|456|||
160835917|NCT02489942|580786371|FG000|Overall Study|Not continuously investigated|7|||
160835918|NCT02489942|580786371|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
160835919|NCT02489942|580786371|FG000|Overall Study|Multiple registration|1|||
160835920|NCT02489942|580786371|FG000|Overall Study|No patient visit after entry|100|||
160835921|NCT02489942|580786371|FG000|Overall Study|No treatment with Jardiance|2|||
160835922|NCT02489942|580786371|FG000|Overall Study|Patient received Jardiance before registration|1|||
160835923|NCT02489942|580786371|FG000|Overall Study|No CRF collected|86|||
160835924|NCT00858208|580786372|FG000|Overall Study|Adverse Event|3|||
160835925|NCT00858208|580786372|FG000|Overall Study|Lost to Follow-up|26|||
160835926|NCT00858208|580786372|FG000|Overall Study|Participant refused|40|||
160562714|NCT01276288|579781667|FG000|Overall Study|not treated|1|||
160562715|NCT01276288|579781668|FG001|Overall Study|not treated|0|||
160835927|NCT00858208|580786372|FG000|Overall Study|Other|10|||
160835928|NCT00704288|580786374|FG000|Overall Treatment Period|Adverse Event|11|||
160835929|NCT00704288|580786375|FG001|Overall Treatment Period|Adverse Event|8|||
160835930|NCT00704288|580786376|FG002|Overall Treatment Period|Adverse Event|22|||
160835931|NCT00704288|580786374|FG000|Overall Treatment Period|Death|0|||
160835932|NCT00704288|580786375|FG001|Overall Treatment Period|Death|0|||
160835933|NCT00704288|580786376|FG002|Overall Treatment Period|Death|1|||
160835934|NCT00704288|580786374|FG000|Overall Treatment Period|Physician Decision|0|||
160835935|NCT00704288|580786375|FG001|Overall Treatment Period|Physician Decision|2|||
160835936|NCT00704288|580786376|FG002|Overall Treatment Period|Physician Decision|0|||
160835937|NCT00704288|580786374|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
160835938|NCT00704288|580786375|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
160835939|NCT00704288|580786376|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
160835940|NCT00704288|580786374|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
160835941|NCT00704288|580786375|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
160835942|NCT00704288|580786376|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
160835943|NCT00704288|580786374|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
160835944|NCT00704288|580786375|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
160562716|NCT01276288|579781669|FG002|Overall Study|not treated|0|||
160562717|NCT01276288|579781670|FG003|Overall Study|not treated|0|||
160562718|NCT01478958|579781677|FG000|Overall Study|Withdrawal by Subject|1|||
160562719|NCT01478958|579781678|FG001|Overall Study|Withdrawal by Subject|1|||
160562720|NCT01478958|579781679|FG002|Overall Study|Withdrawal by Subject|1|||
160562721|NCT01478958|579781677|FG000|Overall Study|Weight loss|1|||
160835945|NCT00704288|580786376|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
160835946|NCT00704288|580786374|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
160835947|NCT00704288|580786375|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
160835948|NCT00704288|580786376|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
160835949|NCT00704288|580786374|FG000|Overall Treatment Period|Roll-over to another study|1|||
160562722|NCT01478958|579781678|FG001|Overall Study|Weight loss|0|||
160562723|NCT01478958|579781679|FG002|Overall Study|Weight loss|0|||
160562724|NCT01478958|579781677|FG000|Overall Study|Re-located|0|||
160835950|NCT00704288|580786375|FG001|Overall Treatment Period|Roll-over to another study|0|||
160835951|NCT00704288|580786376|FG002|Overall Treatment Period|Roll-over to another study|4|||
160835952|NCT00704288|580786374|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
160835953|NCT00704288|580786375|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
160835954|NCT00704288|580786376|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
160835955|NCT00704288|580786374|FG000|Extended Post Treatment Follow Up Period|Death|41|||
160835956|NCT00704288|580786375|FG001|Extended Post Treatment Follow Up Period|Death|50|||
160835957|NCT00704288|580786376|FG002|Extended Post Treatment Follow Up Period|Death|93|||
160835958|NCT00704288|580786374|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
160835959|NCT00704288|580786375|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
160835960|NCT00704288|580786376|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
160835961|NCT00704288|580786374|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
160835962|NCT00704288|580786375|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
160835963|NCT00704288|580786376|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
160835964|NCT00704288|580786374|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
160835965|NCT00704288|580786375|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
160835966|NCT00704288|580786376|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
160835967|NCT01055314|580786377|FG000|Overall Study|Adverse Event|7|||
160835968|NCT01055314|580786378|FG001|Overall Study|Adverse Event|4|||
160835969|NCT01055314|580786377|FG000|Overall Study|Death|2|||
160835970|NCT01055314|580786378|FG001|Overall Study|Death|1|||
160835971|NCT01055314|580786377|FG000|Overall Study|Lack of Efficacy|11|||
160835972|NCT01055314|580786378|FG001|Overall Study|Lack of Efficacy|19|||
160835973|NCT01055314|580786377|FG000|Overall Study|Physician Decision|10|||
160835974|NCT01055314|580786378|FG001|Overall Study|Physician Decision|5|||
160835975|NCT01055314|580786377|FG000|Overall Study|Withdrawal by Subject|1|||
160835976|NCT01055314|580786378|FG001|Overall Study|Withdrawal by Subject|0|||
160835977|NCT01055314|580786377|FG000|Overall Study|Ineligible|3|||
160835978|NCT01055314|580786378|FG001|Overall Study|Ineligible|5|||
160835979|NCT01055314|580786377|FG000|Overall Study|Refusal of further protocol therapy|10|||
160835980|NCT01055314|580786378|FG001|Overall Study|Refusal of further protocol therapy|4|||
160835981|NCT01055314|580786377|FG000|Overall Study|No treatment|1|||
160835982|NCT01055314|580786378|FG001|Overall Study|No treatment|0|||
160835983|NCT04395690|580786379|FG000|Overall Study|Lost to Follow-up|1|||
160835984|NCT04395690|580786380|FG001|Overall Study|Lost to Follow-up|1|||
160835985|NCT03927144|580786381|FG000|Core Phase|Adverse Event|9|||
160835986|NCT03927144|580786382|FG001|Core Phase|Adverse Event|5|||
160835987|NCT03927144|580786381|FG000|Core Phase|Lost to Follow-up|3|||
160835988|NCT03927144|580786382|FG001|Core Phase|Lost to Follow-up|2|||
160835989|NCT03927144|580786381|FG000|Core Phase|New Therapy for Study Indication|0|||
160835990|NCT03927144|580786382|FG001|Core Phase|New Therapy for Study Indication|1|||
160835991|NCT03927144|580786381|FG000|Core Phase|No Longer Clinically Benefiting|4|||
160835992|NCT03927144|580786382|FG001|Core Phase|No Longer Clinically Benefiting|4|||
160835993|NCT03927144|580786381|FG000|Core Phase|Physician Decision|2|||
160835994|NCT03927144|580786382|FG001|Core Phase|Physician Decision|8|||
160835995|NCT03927144|580786381|FG000|Core Phase|Protocol Violation|2|||
160835996|NCT03927144|580786382|FG001|Core Phase|Protocol Violation|2|||
160835997|NCT03927144|580786381|FG000|Core Phase|Withdrawal by Subject|16|||
160835998|NCT03927144|580786382|FG001|Core Phase|Withdrawal by Subject|40|||
160835999|NCT03927144|580786381|FG000|Extension Phase|Adverse Event|2|||
160836000|NCT03927144|580786382|FG001|Extension Phase|Adverse Event|1|||
160836001|NCT03927144|580786381|FG000|Extension Phase|No longer clinically benefiting|4|||
160836002|NCT03927144|580786382|FG001|Extension Phase|No longer clinically benefiting|5|||
160836003|NCT03927144|580786381|FG000|Extension Phase|Pregnancy|1|||
160562725|NCT01478958|579781678|FG001|Overall Study|Re-located|1|||
160562726|NCT01478958|579781679|FG002|Overall Study|Re-located|0|||
160562727|NCT01478958|579781677|FG000|Overall Study|Unable to comply|0|||
160562728|NCT01478958|579781678|FG001|Overall Study|Unable to comply|0|||
160562729|NCT01478958|579781679|FG002|Overall Study|Unable to comply|2|||
160562730|NCT00629083|579781680|FG000|Overall Study|Adverse Event|0|||
160562731|NCT00629083|579781681|FG001|Overall Study|Adverse Event|2|||
160562732|NCT00629083|579781680|FG000|Overall Study|Lack of Efficacy|3|||
160562733|NCT00629083|579781681|FG001|Overall Study|Lack of Efficacy|1|||
160562734|NCT00629083|579781680|FG000|Overall Study|Withdrawal by Subject|10|||
160836004|NCT03927144|580786382|FG001|Extension Phase|Pregnancy|0|||
160836005|NCT03927144|580786381|FG000|Extension Phase|Protocol Violation|0|||
160836006|NCT03927144|580786382|FG001|Extension Phase|Protocol Violation|1|||
160836007|NCT03927144|580786381|FG000|Extension Phase|Withdrawal by Subject|8|||
160836008|NCT03927144|580786382|FG001|Extension Phase|Withdrawal by Subject|3|||
160836009|NCT03909152|580786383|FG000|Overall Study|Adverse Event|14|||
160836010|NCT03909152|580786384|FG001|Overall Study|Adverse Event|5|||
160836011|NCT03909152|580786385|FG002|Overall Study|Adverse Event|1|||
160562735|NCT00629083|579781681|FG001|Overall Study|Withdrawal by Subject|2|||
160562736|NCT00629083|579781680|FG000|Overall Study|Lost to Follow-up|12|||
160562737|NCT00629083|579781681|FG001|Overall Study|Lost to Follow-up|8|||
160836012|NCT03909152|580786386|FG003|Overall Study|Adverse Event|14|||
160836013|NCT00719680|580786391|FG000|Overall Study|Adverse Event|1|||
160836014|NCT00719680|580786391|FG000|Overall Study|Lost to Follow-up|1|||
160836015|NCT00719680|580786391|FG000|Overall Study|Withdrawal by Subject|3|||
160836016|NCT04071158|580786393|FG000|Overall Study|Lost to Follow-up|1|||
160836017|NCT04071158|580786394|FG001|Overall Study|Lost to Follow-up|2|||
160836018|NCT04071158|580786395|FG002|Overall Study|Lost to Follow-up|3|||
160836019|NCT04071158|580786396|FG003|Overall Study|Lost to Follow-up|3|||
160836020|NCT04071158|580786397|FG004|Overall Study|Lost to Follow-up|5|||
160562738|NCT00629083|579781680|FG000|Overall Study|Moved out of country/state|2|||
160836021|NCT04071158|580786393|FG000|Overall Study|Randomized but not treated|2|||
160836022|NCT04071158|580786394|FG001|Overall Study|Randomized but not treated|2|||
160836023|NCT04071158|580786395|FG002|Overall Study|Randomized but not treated|0|||
160836024|NCT04071158|580786396|FG003|Overall Study|Randomized but not treated|0|||
160836025|NCT04071158|580786397|FG004|Overall Study|Randomized but not treated|0|||
160836026|NCT01178099|580786398|FG000|Overall Study|Physician Decision|0|||
160836027|NCT01178099|580786399|FG001|Overall Study|Physician Decision|1|||
160836028|NCT02473367|580786400|FG000|Wait 1|Withdrawal by Subject|1|||
160836029|NCT02473367|580786400|FG000|Period 4|Lost to Follow-up|1|||
160836030|NCT04816721|580786401|FG000|Overall Study|Withdrawal by Subject|0|||
160836031|NCT04816721|580786402|FG001|Overall Study|Withdrawal by Subject|2|||
160903924|NCT02264639|581043080|FG002|Overall Study|Death (after completing single-dose phase)|0|||
160903925|NCT02264639|581043081|FG003|Overall Study|Death (after completing single-dose phase)|0|||
160903926|NCT02264639|581043082|FG004|Overall Study|Death (after completing single-dose phase)|0|||
160903927|NCT02264639|581043078|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
160903928|NCT02264639|581043079|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
160903929|NCT02264639|581043080|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
160903930|NCT02264639|581043081|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
160903931|NCT02264639|581043082|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
160903932|NCT02264639|581043078|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
160903933|NCT02264639|581043079|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
160903934|NCT02264639|581043080|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
160903935|NCT02264639|581043081|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
160903936|NCT02264639|581043082|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
160903937|NCT02264639|581043078|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
160903938|NCT02264639|581043079|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
160903939|NCT02264639|581043080|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
160903940|NCT02264639|581043081|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
160903941|NCT02264639|581043082|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
160903942|NCT01416272|581043084|FG000|Overall Study|Unacceptable distance visual acuity|2|||
160903943|NCT01416272|581043084|FG000|Overall Study|Lost to Follow-up|1|||
160903944|NCT01416272|581043084|FG000|Overall Study|Study related complaints|1|||
160903945|NCT02693119|581043085|FG000|Open-Label Period|Withdrawal by Subject|0|||
160903946|NCT02693119|581043086|FG001|Open-Label Period|Withdrawal by Subject|1|||
160903947|NCT01719783|581043087|FG000|Dose 2|Physician Decision|1|||
160903948|NCT01719783|581043088|FG001|Dose 2|Physician Decision|0|||
160903949|NCT01350492|581043089|FG000|Intervention|Lost to Follow-up|2|||
160903950|NCT01350492|581043090|FG001|Intervention|Lost to Follow-up|5|||
160903951|NCT01350492|581043089|FG000|Intervention|Withdrawal by Subject|3|||
160903952|NCT01350492|581043090|FG001|Intervention|Withdrawal by Subject|1|||
160903953|NCT01350492|581043089|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
160903954|NCT01350492|581043090|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
160903955|NCT01350492|581043089|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
160903956|NCT01350492|581043090|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
160903957|NCT00753766|581043091|FG000|Overall Study|Physician Decision|1|||
160903958|NCT00753766|581043092|FG001|Overall Study|Physician Decision|0|||
160903959|NCT03800173|581043095|FG000|Overall Study|Lost to Follow-up|0|||
160903960|NCT03800173|581043096|FG001|Overall Study|Lost to Follow-up|0|||
160903961|NCT03800173|581043097|FG002|Overall Study|Lost to Follow-up|0|||
160903962|NCT03800173|581043098|FG003|Overall Study|Lost to Follow-up|0|||
160903963|NCT03800173|581043099|FG004|Overall Study|Lost to Follow-up|1|||
160562739|NCT00629083|579781681|FG001|Overall Study|Moved out of country/state|1|||
160562740|NCT00629083|579781680|FG000|Overall Study|Refused to return for 12 month visit|1|||
160562741|NCT00629083|579781681|FG001|Overall Study|Refused to return for 12 month visit|0|||
160562742|NCT03401749|579781682|FG000|Overall Study|Lost to Follow-up|20|||
160903964|NCT00932126|581043102|FG000|Overall Study|Adverse Event|0|||
160903965|NCT00932126|581043103|FG001|Overall Study|Adverse Event|0|||
160836032|NCT04816721|580786403|FG002|Overall Study|Withdrawal by Subject|0|||
160836033|NCT04816721|580786404|FG003|Overall Study|Withdrawal by Subject|1|||
160836034|NCT04816721|580786405|FG004|Overall Study|Withdrawal by Subject|1|||
160836035|NCT04816721|580786406|FG005|Overall Study|Withdrawal by Subject|0|||
160836036|NCT04816721|580786407|FG006|Overall Study|Withdrawal by Subject|0|||
160836037|NCT04816721|580786408|FG007|Overall Study|Withdrawal by Subject|0|||
160836038|NCT04816721|580786401|FG000|Overall Study|Miscellaneous|0|||
160836039|NCT04816721|580786402|FG001|Overall Study|Miscellaneous|0|||
160836040|NCT04816721|580786403|FG002|Overall Study|Miscellaneous|0|||
160836041|NCT04816721|580786404|FG003|Overall Study|Miscellaneous|0|||
160836042|NCT04816721|580786405|FG004|Overall Study|Miscellaneous|0|||
160836043|NCT04816721|580786406|FG005|Overall Study|Miscellaneous|1|||
160836044|NCT04816721|580786407|FG006|Overall Study|Miscellaneous|0|||
160836045|NCT04816721|580786408|FG007|Overall Study|Miscellaneous|0|||
160836046|NCT04816721|580786401|FG000|Overall Study|Lost to Follow-up|0|||
160836047|NCT04816721|580786402|FG001|Overall Study|Lost to Follow-up|0|||
160836048|NCT04816721|580786403|FG002|Overall Study|Lost to Follow-up|0|||
160836049|NCT04816721|580786404|FG003|Overall Study|Lost to Follow-up|1|||
160836050|NCT04816721|580786405|FG004|Overall Study|Lost to Follow-up|0|||
160836051|NCT04816721|580786406|FG005|Overall Study|Lost to Follow-up|0|||
160836052|NCT04816721|580786407|FG006|Overall Study|Lost to Follow-up|0|||
160836053|NCT04816721|580786408|FG007|Overall Study|Lost to Follow-up|0|||
160836054|NCT03194438|580786420|FG000|Overall Study|Withdrawal by Subject|2|||
160836055|NCT00549770|580786423|FG000|Overall Study|Protocol deviation|1|||
160836056|NCT00549770|580786424|FG001|Overall Study|Protocol deviation|1|||
160836057|NCT00549770|580786425|FG002|Overall Study|Protocol deviation|1|||
160836058|NCT00549770|580786426|FG003|Overall Study|Protocol deviation|2|||
160836059|NCT00549770|580786427|FG004|Overall Study|Protocol deviation|2|||
160836060|NCT00549770|580786428|FG005|Overall Study|Protocol deviation|2|||
160836061|NCT00549770|580786429|FG006|Overall Study|Protocol deviation|1|||
160836062|NCT00549770|580786430|FG007|Overall Study|Protocol deviation|2|||
160836063|NCT00549770|580786423|FG000|Overall Study|Administrative problems|0|||
160836064|NCT00549770|580786424|FG001|Overall Study|Administrative problems|1|||
160836065|NCT00549770|580786425|FG002|Overall Study|Administrative problems|0|||
160836066|NCT00549770|580786426|FG003|Overall Study|Administrative problems|0|||
160836067|NCT00549770|580786427|FG004|Overall Study|Administrative problems|0|||
160836068|NCT00549770|580786428|FG005|Overall Study|Administrative problems|0|||
160836069|NCT00549770|580786429|FG006|Overall Study|Administrative problems|0|||
160836070|NCT00549770|580786430|FG007|Overall Study|Administrative problems|1|||
160836071|NCT00549770|580786423|FG000|Overall Study|Lost to Follow-up|0|||
160836072|NCT00549770|580786424|FG001|Overall Study|Lost to Follow-up|0|||
160836073|NCT00549770|580786425|FG002|Overall Study|Lost to Follow-up|2|||
160836074|NCT00549770|580786426|FG003|Overall Study|Lost to Follow-up|2|||
160836075|NCT00549770|580786427|FG004|Overall Study|Lost to Follow-up|3|||
160836076|NCT00549770|580786428|FG005|Overall Study|Lost to Follow-up|2|||
160836077|NCT00549770|580786429|FG006|Overall Study|Lost to Follow-up|0|||
160836078|NCT00549770|580786430|FG007|Overall Study|Lost to Follow-up|0|||
160836079|NCT00549770|580786423|FG000|Overall Study|Withdrawal by Subject|4|||
160836080|NCT00549770|580786424|FG001|Overall Study|Withdrawal by Subject|6|||
160836081|NCT00549770|580786425|FG002|Overall Study|Withdrawal by Subject|4|||
160836082|NCT00549770|580786426|FG003|Overall Study|Withdrawal by Subject|5|||
160836083|NCT00549770|580786427|FG004|Overall Study|Withdrawal by Subject|6|||
160836084|NCT00549770|580786428|FG005|Overall Study|Withdrawal by Subject|6|||
160836085|NCT00549770|580786429|FG006|Overall Study|Withdrawal by Subject|4|||
160836086|NCT00549770|580786430|FG007|Overall Study|Withdrawal by Subject|9|||
160836087|NCT00549770|580786423|FG000|Overall Study|Lack of Efficacy|1|||
160836088|NCT00549770|580786424|FG001|Overall Study|Lack of Efficacy|0|||
160836089|NCT00549770|580786425|FG002|Overall Study|Lack of Efficacy|2|||
160903966|NCT00932126|581043104|FG002|Overall Study|Adverse Event|0|||
160903967|NCT00932126|581043105|FG003|Overall Study|Adverse Event|0|||
160903968|NCT00932126|581043106|FG004|Overall Study|Adverse Event|0|||
160903969|NCT00932126|581043107|FG005|Overall Study|Adverse Event|0|||
160903970|NCT00932126|581043108|FG006|Overall Study|Adverse Event|1|||
160903971|NCT00932126|581043109|FG007|Overall Study|Adverse Event|2|||
160836090|NCT00549770|580786426|FG003|Overall Study|Lack of Efficacy|3|||
160836091|NCT00549770|580786427|FG004|Overall Study|Lack of Efficacy|5|||
160836092|NCT00549770|580786428|FG005|Overall Study|Lack of Efficacy|1|||
160836093|NCT00549770|580786429|FG006|Overall Study|Lack of Efficacy|3|||
160836094|NCT00549770|580786430|FG007|Overall Study|Lack of Efficacy|8|||
160836095|NCT00549770|580786423|FG000|Overall Study|Abnormal test procedure results|0|||
160836096|NCT00549770|580786424|FG001|Overall Study|Abnormal test procedure results|0|||
160836097|NCT00549770|580786425|FG002|Overall Study|Abnormal test procedure results|0|||
160903972|NCT00932126|581043102|FG000|Overall Study|Protocol Violation|0|||
160903973|NCT00932126|581043103|FG001|Overall Study|Protocol Violation|0|||
160903974|NCT00932126|581043104|FG002|Overall Study|Protocol Violation|0|||
160562743|NCT03401749|579781683|FG001|Overall Study|Lost to Follow-up|16|||
160562744|NCT03401749|579781684|FG002|Overall Study|Lost to Follow-up|26|||
160562745|NCT01193686|579781685|FG000|Overall Study|Withdrawal by Subject|4|||
160836098|NCT00549770|580786426|FG003|Overall Study|Abnormal test procedure results|2|||
160836099|NCT00549770|580786427|FG004|Overall Study|Abnormal test procedure results|0|||
160836100|NCT00549770|580786428|FG005|Overall Study|Abnormal test procedure results|1|||
160836101|NCT00549770|580786429|FG006|Overall Study|Abnormal test procedure results|1|||
160836102|NCT00549770|580786430|FG007|Overall Study|Abnormal test procedure results|1|||
160836103|NCT00549770|580786423|FG000|Overall Study|Abnormal laboratory values|0|||
160836104|NCT00549770|580786424|FG001|Overall Study|Abnormal laboratory values|0|||
160836105|NCT00549770|580786425|FG002|Overall Study|Abnormal laboratory values|0|||
160836106|NCT00549770|580786426|FG003|Overall Study|Abnormal laboratory values|0|||
160836107|NCT00549770|580786427|FG004|Overall Study|Abnormal laboratory values|0|||
160836108|NCT00549770|580786428|FG005|Overall Study|Abnormal laboratory values|1|||
160836109|NCT00549770|580786429|FG006|Overall Study|Abnormal laboratory values|0|||
160836110|NCT00549770|580786430|FG007|Overall Study|Abnormal laboratory values|0|||
160903975|NCT00932126|581043105|FG003|Overall Study|Protocol Violation|0|||
160903976|NCT00932126|581043106|FG004|Overall Study|Protocol Violation|1|||
160903977|NCT00932126|581043107|FG005|Overall Study|Protocol Violation|0|||
160903978|NCT00932126|581043108|FG006|Overall Study|Protocol Violation|0|||
160903979|NCT00932126|581043109|FG007|Overall Study|Protocol Violation|0|||
160903980|NCT00932126|581043102|FG000|Overall Study|Withdrawal by Subject|0|||
160903981|NCT00932126|581043103|FG001|Overall Study|Withdrawal by Subject|0|||
160903982|NCT00932126|581043104|FG002|Overall Study|Withdrawal by Subject|1|||
160903983|NCT00932126|581043105|FG003|Overall Study|Withdrawal by Subject|0|||
160903984|NCT00932126|581043106|FG004|Overall Study|Withdrawal by Subject|0|||
160903985|NCT00932126|581043107|FG005|Overall Study|Withdrawal by Subject|0|||
160903986|NCT00932126|581043108|FG006|Overall Study|Withdrawal by Subject|0|||
160903987|NCT00932126|581043109|FG007|Overall Study|Withdrawal by Subject|1|||
160903988|NCT00932126|581043102|FG000|Overall Study|Objective progression or relapse|3|||
160903989|NCT00932126|581043103|FG001|Overall Study|Objective progression or relapse|3|||
160903990|NCT00932126|581043104|FG002|Overall Study|Objective progression or relapse|2|||
160903991|NCT00932126|581043105|FG003|Overall Study|Objective progression or relapse|3|||
160903992|NCT00932126|581043106|FG004|Overall Study|Objective progression or relapse|3|||
160903993|NCT00932126|581043107|FG005|Overall Study|Objective progression or relapse|3|||
160903994|NCT00932126|581043108|FG006|Overall Study|Objective progression or relapse|3|||
160903995|NCT00932126|581043109|FG007|Overall Study|Objective progression or relapse|5|||
160903996|NCT00932126|581043102|FG000|Overall Study|Other|0|||
160903997|NCT00932126|581043103|FG001|Overall Study|Other|0|||
160903998|NCT00932126|581043104|FG002|Overall Study|Other|0|||
160903999|NCT00932126|581043105|FG003|Overall Study|Other|0|||
160904000|NCT00932126|581043106|FG004|Overall Study|Other|1|||
160904001|NCT00932126|581043107|FG005|Overall Study|Other|0|||
160904002|NCT00932126|581043108|FG006|Overall Study|Other|1|||
160904003|NCT00932126|581043109|FG007|Overall Study|Other|2|||
160904004|NCT02121522|581043117|FG000|Overall Study|Adverse Event|1|||
160904005|NCT01235689|581043118|FG000|Overall Study|Adverse Event|12|||
160904006|NCT01235689|581043119|FG001|Overall Study|Adverse Event|16|||
160904007|NCT01235689|581043118|FG000|Overall Study|Lack of Efficacy|12|||
160904008|NCT01235689|581043119|FG001|Overall Study|Lack of Efficacy|5|||
160904009|NCT01235689|581043118|FG000|Overall Study|Withdrawal by Subject|3|||
160904010|NCT01235689|581043119|FG001|Overall Study|Withdrawal by Subject|4|||
160904011|NCT01235689|581043118|FG000|Overall Study|Lost to Follow-up|1|||
160904012|NCT01235689|581043119|FG001|Overall Study|Lost to Follow-up|2|||
160904013|NCT01235689|581043118|FG000|Overall Study|Miscellaneous|1|||
160904014|NCT01235689|581043119|FG001|Overall Study|Miscellaneous|5|||
160562746|NCT01193686|579781686|FG001|Overall Study|Withdrawal by Subject|1|||
160836111|NCT00549770|580786423|FG000|Overall Study|Adverse Event|1|||
160836112|NCT00549770|580786424|FG001|Overall Study|Adverse Event|3|||
160836113|NCT00549770|580786425|FG002|Overall Study|Adverse Event|1|||
160836114|NCT00549770|580786426|FG003|Overall Study|Adverse Event|2|||
160836115|NCT00549770|580786427|FG004|Overall Study|Adverse Event|1|||
160904015|NCT02217878|581043120|FG000|Overall Study|required morphine due to chest pain|1|||
160904016|NCT02217878|581043121|FG001|Overall Study|required morphine due to chest pain|2|||
160904017|NCT02217878|581043120|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
160904018|NCT02217878|581043121|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
160904019|NCT00806351|581043124|FG000|Overall Study|Death|5|||
160904020|NCT00806351|581043125|FG001|Overall Study|Death|4|||
160904021|NCT02151110|581043126|FG000|Overall Study|Withdrawal by Subject|0|||
160904022|NCT02151110|581043127|FG001|Overall Study|Withdrawal by Subject|0|||
160904023|NCT02151110|581043128|FG002|Overall Study|Withdrawal by Subject|0|||
160904024|NCT02151110|581043129|FG003|Overall Study|Withdrawal by Subject|0|||
160904025|NCT02151110|581043130|FG004|Overall Study|Withdrawal by Subject|0|||
160904026|NCT02151110|581043131|FG005|Overall Study|Withdrawal by Subject|0|||
160904027|NCT02151110|581043132|FG006|Overall Study|Withdrawal by Subject|0|||
160904028|NCT02151110|581043133|FG007|Overall Study|Withdrawal by Subject|1|||
160562747|NCT01193686|579781685|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
160562748|NCT01193686|579781686|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
160562749|NCT01307423|579781689|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
160562750|NCT01307423|579781690|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
160562751|NCT01307423|579781691|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
160562752|NCT01307423|579781692|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160562753|NCT01307423|579781693|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160562754|NCT01307423|579781694|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160562755|NCT01307423|579781695|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160562756|NCT01307423|579781696|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160562757|NCT01307423|579781697|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160562758|NCT01307423|579781689|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
160562759|NCT01307423|579781690|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
160562760|NCT01307423|579781691|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
160562761|NCT01307423|579781692|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160562762|NCT01307423|579781693|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160562763|NCT01307423|579781694|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160562764|NCT01307423|579781695|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160562765|NCT01307423|579781696|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160562766|NCT01307423|579781697|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160562767|NCT01307423|579781689|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
160562768|NCT01307423|579781690|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
160562769|NCT01307423|579781691|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
160562770|NCT01307423|579781692|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160836116|NCT00549770|580786428|FG005|Overall Study|Adverse Event|0|||
160836117|NCT00549770|580786429|FG006|Overall Study|Adverse Event|5|||
160836118|NCT00549770|580786430|FG007|Overall Study|Adverse Event|4|||
160836119|NCT02712424|580786431|FG000|Overall Study|Lost to Follow-up|34|||
160836120|NCT02712424|580786432|FG001|Overall Study|Lost to Follow-up|32|||
160836121|NCT01141478|580786433|FG000|Overall Study|Withdrawal by Subject|1|||
160836122|NCT01141478|580786434|FG001|Overall Study|Withdrawal by Subject|1|||
160836123|NCT02760810|580786439|FG000|Overall Study|Protocol Violation|1|||
160836124|NCT01581619|580786440|FG000|Overall Study|Withdrawal by Subject|1|||
160836125|NCT01581619|580786440|FG000|Overall Study|Lost to Follow-up|1|||
160836126|NCT00290498|580786441|FG000|Overall Study|Death|2|||
160904029|NCT02151110|581043126|FG000|Overall Study|Lost to Follow-up|0|||
160904030|NCT02151110|581043127|FG001|Overall Study|Lost to Follow-up|0|||
160904031|NCT02151110|581043128|FG002|Overall Study|Lost to Follow-up|0|||
160991469|NCT02939183|581357812|FG008|Overall Study|Withdrawal by Subject|2|||
160991470|NCT02939183|581357804|FG000|Overall Study|Not treated due to adverse event|0|||
160991471|NCT02939183|581357805|FG001|Overall Study|Not treated due to adverse event|0|||
160991472|NCT02939183|581357806|FG002|Overall Study|Not treated due to adverse event|0|||
160991473|NCT02939183|581357807|FG003|Overall Study|Not treated due to adverse event|1|||
160991474|NCT02939183|581357808|FG004|Overall Study|Not treated due to adverse event|0|||
160991475|NCT02939183|581357809|FG005|Overall Study|Not treated due to adverse event|0|||
160991476|NCT02939183|581357810|FG006|Overall Study|Not treated due to adverse event|1|||
160991477|NCT02939183|581357811|FG007|Overall Study|Not treated due to adverse event|0|||
160991478|NCT02939183|581357812|FG008|Overall Study|Not treated due to adverse event|0|||
160991479|NCT05015478|581357813|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
160991480|NCT05015478|581357814|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
160991481|NCT05015478|581357815|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
160991482|NCT05015478|581357816|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
160991483|NCT04939428|581357817|FG000|Overall Study|Death|0|||
160991484|NCT04939428|581357818|FG001|Overall Study|Death|1|||
160562771|NCT01307423|579781693|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160562772|NCT01307423|579781694|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160562773|NCT01307423|579781695|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160562774|NCT01307423|579781696|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160562775|NCT01307423|579781697|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160562776|NCT01307423|579781689|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160836127|NCT00290498|580786442|FG001|Overall Study|Death|0|||
160836128|NCT00290498|580786441|FG000|Overall Study|Physician Decision|1|||
160904032|NCT02151110|581043129|FG003|Overall Study|Lost to Follow-up|0|||
160904033|NCT02151110|581043130|FG004|Overall Study|Lost to Follow-up|0|||
160904034|NCT02151110|581043131|FG005|Overall Study|Lost to Follow-up|0|||
160904035|NCT02151110|581043132|FG006|Overall Study|Lost to Follow-up|0|||
160904036|NCT02151110|581043133|FG007|Overall Study|Lost to Follow-up|2|||
160904037|NCT00672646|581043137|FG000|Overall Study|Lost to Follow-up|0|||
160904038|NCT00672646|581043138|FG001|Overall Study|Lost to Follow-up|1|||
160904039|NCT00672646|581043139|FG002|Overall Study|Lost to Follow-up|2|||
160904040|NCT00672646|581043137|FG000|Overall Study|Withdrawal by Subject|0|||
160904041|NCT00672646|581043138|FG001|Overall Study|Withdrawal by Subject|0|||
160562777|NCT01307423|579781690|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160562778|NCT01307423|579781691|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
160904042|NCT00672646|581043139|FG002|Overall Study|Withdrawal by Subject|1|||
160904043|NCT01999179|581043140|FG000|Overall Study|Adverse Event|1|||
160904044|NCT01999179|581043140|FG000|Overall Study|Lost to Follow-up|1|||
160904045|NCT01999179|581043140|FG000|Overall Study|Change in Therapy|3|||
160904046|NCT01999179|581043140|FG000|Overall Study|New catheter|2|||
160904047|NCT00289783|581043143|FG000|Primary Phase|Adverse Event|10|||
160904048|NCT00289783|581043144|FG001|Primary Phase|Adverse Event|1|||
160904049|NCT00289783|581043143|FG000|Primary Phase|Protocol Violation|27|||
160904050|NCT00289783|581043144|FG001|Primary Phase|Protocol Violation|6|||
160904051|NCT00289783|581043143|FG000|Primary Phase|Withdrawal by Subject|93|||
160904052|NCT00289783|581043144|FG001|Primary Phase|Withdrawal by Subject|40|||
160904053|NCT00289783|581043143|FG000|Primary Phase|Lost to Follow-up|60|||
160904054|NCT00289783|581043144|FG001|Primary Phase|Lost to Follow-up|14|||
160991485|NCT04939428|581357819|FG002|Overall Study|Death|0|||
160991486|NCT04939428|581357817|FG000|Overall Study|Lost to Follow-up|0|||
160836129|NCT00290498|580786442|FG001|Overall Study|Physician Decision|0|||
160836130|NCT00290498|580786441|FG000|Overall Study|Withdrawal by Subject|1|||
160836131|NCT00290498|580786442|FG001|Overall Study|Withdrawal by Subject|0|||
160836132|NCT00290498|580786441|FG000|Overall Study|Ineligible|3|||
160836133|NCT00290498|580786442|FG001|Overall Study|Ineligible|0|||
160836134|NCT00290498|580786441|FG000|Overall Study|Non-Compliance|1|||
160836135|NCT00290498|580786442|FG001|Overall Study|Non-Compliance|0|||
160836136|NCT03847909|580786447|FG000|Overall Study|Withdrawal by Subject|1|||
160836137|NCT03847909|580786448|FG001|Overall Study|Withdrawal by Subject|1|||
160836138|NCT00490022|580786449|FG000|Overall Study|Adverse Event|0|||
160836139|NCT00490022|580786450|FG001|Overall Study|Adverse Event|2|||
160836140|NCT00490022|580786449|FG000|Overall Study|Withdrawal by Subject|1|||
160836141|NCT00490022|580786450|FG001|Overall Study|Withdrawal by Subject|0|||
160836142|NCT00490022|580786449|FG000|Overall Study|Subject failed to disclose concommitant|0|||
160836143|NCT00490022|580786450|FG001|Overall Study|Subject failed to disclose concommitant|1|||
160836144|NCT01375608|580786451|FG000|Overall Study|Withdrawal by Subject|2|||
160836145|NCT00694304|580786452|FG000|Overall Study|Adverse Event|42|||
160836146|NCT00694304|580786452|FG000|Overall Study|Lack of Efficacy|35|||
160836147|NCT00694304|580786452|FG000|Overall Study|Non-compliance With Study Product|16|||
160836148|NCT00694304|580786452|FG000|Overall Study|Protocol Violation|6|||
160836149|NCT00694304|580786452|FG000|Overall Study|Withdrawal of Consent|61|||
160836150|NCT00694304|580786452|FG000|Overall Study|Lost to Follow-up|15|||
160836151|NCT00694304|580786452|FG000|Overall Study|Administrative or Other Reasons|32|||
160836152|NCT02102399|580786460|FG000|Overall Study|Withdrawal by Subject|6|||
160991487|NCT04939428|581357818|FG001|Overall Study|Lost to Follow-up|5|||
160991488|NCT04939428|581357819|FG002|Overall Study|Lost to Follow-up|0|||
160991489|NCT04939428|581357817|FG000|Overall Study|Physician Decision|1|||
160991490|NCT04939428|581357818|FG001|Overall Study|Physician Decision|0|||
160991491|NCT04939428|581357819|FG002|Overall Study|Physician Decision|0|||
160991492|NCT04939428|581357817|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160991493|NCT04939428|581357818|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160991494|NCT04939428|581357819|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160991495|NCT04939428|581357817|FG000|Overall Study|Withdrawal by Subject|10|||
160991496|NCT04939428|581357818|FG001|Overall Study|Withdrawal by Subject|11|||
160991497|NCT04939428|581357819|FG002|Overall Study|Withdrawal by Subject|0|||
160991498|NCT04939428|581357817|FG000|Overall Study|Unkown|6|||
160991499|NCT04939428|581357818|FG001|Overall Study|Unkown|3|||
160991500|NCT04939428|581357819|FG002|Overall Study|Unkown|0|||
160991501|NCT04939428|581357817|FG000|Overall Study|Discotinued per protocol|0|||
160991502|NCT04939428|581357818|FG001|Overall Study|Discotinued per protocol|0|||
160991503|NCT04939428|581357819|FG002|Overall Study|Discotinued per protocol|902|||
160991504|NCT04319094|581357822|FG000|Baseline|Lost to Follow-up|4|||
160991505|NCT04319094|581357823|FG001|Baseline|Lost to Follow-up|5|||
160991506|NCT04319094|581357822|FG000|Baseline|Protocol Violation|0|||
160991507|NCT04319094|581357823|FG001|Baseline|Protocol Violation|3|||
160991508|NCT04319094|581357822|FG000|Baseline|Withdrawal by Subject|2|||
160991509|NCT04319094|581357823|FG001|Baseline|Withdrawal by Subject|1|||
160991510|NCT04319094|581357822|FG000|Post-Intervention|Death|0|||
160991511|NCT04319094|581357823|FG001|Post-Intervention|Death|1|||
160991512|NCT04319094|581357822|FG000|Post-Intervention|Lost to Follow-up|4|||
160991513|NCT04319094|581357823|FG001|Post-Intervention|Lost to Follow-up|4|||
160991514|NCT04319094|581357822|FG000|Post-Intervention|Withdrawal by Subject|8|||
160991515|NCT04319094|581357823|FG001|Post-Intervention|Withdrawal by Subject|5|||
160991516|NCT04319094|581357822|FG000|Post-Intervention|Incomplete Data Collection|1|||
160991517|NCT04319094|581357823|FG001|Post-Intervention|Incomplete Data Collection|3|||
160562779|NCT01307423|579781692|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160836153|NCT02102399|580786461|FG001|Overall Study|Withdrawal by Subject|4|||
160836154|NCT00772109|580786464|FG000|Overall Study|Serious adverse event|1|||
160836155|NCT00772109|580786465|FG001|Overall Study|Serious adverse event|0|||
160836156|NCT00772109|580786466|FG002|Overall Study|Serious adverse event|1|||
160836157|NCT00772109|580786467|FG003|Overall Study|Serious adverse event|0|||
160836158|NCT00772109|580786464|FG000|Overall Study|Protocol Violation|5|||
160836159|NCT00772109|580786465|FG001|Overall Study|Protocol Violation|8|||
160836160|NCT00772109|580786466|FG002|Overall Study|Protocol Violation|7|||
160836161|NCT00772109|580786467|FG003|Overall Study|Protocol Violation|6|||
160836162|NCT00772109|580786464|FG000|Overall Study|Lost to Follow-up|7|||
160836163|NCT00772109|580786465|FG001|Overall Study|Lost to Follow-up|3|||
160836164|NCT00772109|580786466|FG002|Overall Study|Lost to Follow-up|5|||
160836165|NCT00772109|580786467|FG003|Overall Study|Lost to Follow-up|9|||
160836166|NCT00772109|580786464|FG000|Overall Study|Withdrawal by Subject|8|||
160836167|NCT00772109|580786465|FG001|Overall Study|Withdrawal by Subject|8|||
160836168|NCT00772109|580786466|FG002|Overall Study|Withdrawal by Subject|6|||
160836169|NCT00772109|580786467|FG003|Overall Study|Withdrawal by Subject|16|||
160836170|NCT00410605|580786468|FG000|Overall Study|Adverse Event|12|||
160836171|NCT00410605|580786468|FG000|Overall Study|Physician Decision|3|||
160836172|NCT00410605|580786468|FG000|Overall Study|Withdrawal by Subject|5|||
160991518|NCT04319094|581357822|FG000|3-month|Death|1|||
160562780|NCT01307423|579781693|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160562781|NCT01307423|579781694|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160562782|NCT01307423|579781695|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160562783|NCT01307423|579781696|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160836173|NCT00410605|580786468|FG000|Overall Study|Started Non-Protocol Therapy|3|||
160836174|NCT00410605|580786468|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
160836175|NCT00410605|580786468|FG000|Overall Study|Transferred to another Institution|1|||
160836176|NCT04667104|580786472|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
160836177|NCT04667104|580786473|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
160562784|NCT01307423|579781697|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160562785|NCT01307423|579781689|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
160562786|NCT01307423|579781690|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
160562787|NCT01307423|579781691|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
160562788|NCT01307423|579781692|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160562789|NCT01307423|579781693|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160562790|NCT01307423|579781694|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160562791|NCT01307423|579781695|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160562792|NCT01307423|579781696|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160562793|NCT01307423|579781697|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160562794|NCT01307423|579781689|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
160562795|NCT01307423|579781690|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160647638|NCT00416520|580092784|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
160647639|NCT00416520|580092785|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
160836178|NCT04667104|580786474|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
160836179|NCT01078168|580786475|FG000|Overall Study|Physician Decision|0|||
160836180|NCT01078168|580786476|FG001|Overall Study|Physician Decision|1|||
160836181|NCT05066165|580788345|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
160836182|NCT05066165|580788346|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
160836183|NCT05066165|580788345|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
160836184|NCT05066165|580788346|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
160836185|NCT03210961|580788347|FG000|Overall Study|Adverse Event|0|||
160836186|NCT03210961|580788348|FG001|Overall Study|Adverse Event|0|||
160836187|NCT03210961|580788349|FG002|Overall Study|Adverse Event|0|||
160836188|NCT03210961|580788350|FG003|Overall Study|Adverse Event|0|||
160836189|NCT03210961|580788351|FG004|Overall Study|Adverse Event|0|||
160836190|NCT03210961|580788352|FG005|Overall Study|Adverse Event|0|||
160836191|NCT03210961|580788353|FG006|Overall Study|Adverse Event|0|||
160836192|NCT03210961|580788354|FG007|Overall Study|Adverse Event|0|||
160836193|NCT03210961|580788355|FG008|Overall Study|Adverse Event|0|||
160836194|NCT03210961|580788356|FG009|Overall Study|Adverse Event|0|||
160836195|NCT03210961|580788357|FG010|Overall Study|Adverse Event|0|||
160836196|NCT03210961|580788358|FG011|Overall Study|Adverse Event|0|||
160836197|NCT03210961|580788359|FG012|Overall Study|Adverse Event|0|||
160836198|NCT03210961|580788360|FG013|Overall Study|Adverse Event|1|||
160836199|NCT03210961|580788361|FG014|Overall Study|Adverse Event|0|||
160836200|NCT03210961|580788347|FG000|Overall Study|Lost to Follow-up|0|||
160836201|NCT03210961|580788348|FG001|Overall Study|Lost to Follow-up|0|||
160836202|NCT03210961|580788349|FG002|Overall Study|Lost to Follow-up|0|||
160836203|NCT03210961|580788350|FG003|Overall Study|Lost to Follow-up|0|||
160836204|NCT03210961|580788351|FG004|Overall Study|Lost to Follow-up|0|||
160836205|NCT03210961|580788352|FG005|Overall Study|Lost to Follow-up|0|||
160836206|NCT03210961|580788353|FG006|Overall Study|Lost to Follow-up|0|||
160836207|NCT03210961|580788354|FG007|Overall Study|Lost to Follow-up|0|||
160836208|NCT03210961|580788355|FG008|Overall Study|Lost to Follow-up|0|||
160836209|NCT03210961|580788356|FG009|Overall Study|Lost to Follow-up|0|||
160836210|NCT03210961|580788357|FG010|Overall Study|Lost to Follow-up|0|||
160836211|NCT03210961|580788358|FG011|Overall Study|Lost to Follow-up|0|||
160836212|NCT03210961|580788359|FG012|Overall Study|Lost to Follow-up|0|||
160836213|NCT03210961|580788360|FG013|Overall Study|Lost to Follow-up|0|||
160836214|NCT03210961|580788361|FG014|Overall Study|Lost to Follow-up|1|||
160836215|NCT03210961|580788347|FG000|Overall Study|Withdrawal by Subject|0|||
160836216|NCT03210961|580788348|FG001|Overall Study|Withdrawal by Subject|0|||
160836217|NCT03210961|580788349|FG002|Overall Study|Withdrawal by Subject|0|||
160836218|NCT03210961|580788350|FG003|Overall Study|Withdrawal by Subject|0|||
160904055|NCT00289783|581043143|FG000|Primary Phase|Migration from the study area|26|||
160904056|NCT00289783|581043144|FG001|Primary Phase|Migration from the study area|10|||
160836219|NCT03210961|580788351|FG004|Overall Study|Withdrawal by Subject|0|||
160836220|NCT03210961|580788352|FG005|Overall Study|Withdrawal by Subject|0|||
160836221|NCT03210961|580788353|FG006|Overall Study|Withdrawal by Subject|0|||
160904057|NCT00289783|581043143|FG000|Primary Phase|Other|32|||
160836222|NCT03210961|580788354|FG007|Overall Study|Withdrawal by Subject|0|||
160904058|NCT00289783|581043144|FG001|Primary Phase|Other|12|||
160904059|NCT00289783|581043143|FG000|Fourth Dose Phase|Adverse Event|1|||
160562796|NCT01307423|579781691|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160562797|NCT01307423|579781692|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160562798|NCT01307423|579781693|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160562799|NCT01307423|579781694|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160562800|NCT01307423|579781695|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160562801|NCT01307423|579781696|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160562802|NCT01307423|579781697|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160562803|NCT01307423|579781689|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
160562804|NCT01307423|579781690|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
160562805|NCT01307423|579781691|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160562806|NCT01307423|579781692|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160562807|NCT01307423|579781693|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160562808|NCT01307423|579781694|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160562809|NCT01307423|579781695|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160562810|NCT01307423|579781696|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160562811|NCT01307423|579781697|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160562812|NCT01307423|579781689|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
160562813|NCT01307423|579781690|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
160562814|NCT01307423|579781691|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
160562815|NCT01307423|579781692|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
160562816|NCT01307423|579781693|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
160562817|NCT01307423|579781694|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
160562818|NCT01307423|579781695|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
160562819|NCT01307423|579781696|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
160836223|NCT03210961|580788355|FG008|Overall Study|Withdrawal by Subject|0|||
160836224|NCT03210961|580788356|FG009|Overall Study|Withdrawal by Subject|0|||
160836225|NCT03210961|580788357|FG010|Overall Study|Withdrawal by Subject|0|||
160562820|NCT01307423|579781697|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
160562821|NCT01307423|579781689|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
160562822|NCT01307423|579781690|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
160562823|NCT01307423|579781691|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
160562824|NCT01307423|579781692|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
160562825|NCT01307423|579781693|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
160562826|NCT01307423|579781694|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
160562827|NCT01307423|579781695|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
160562828|NCT01307423|579781696|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
160562829|NCT01307423|579781697|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
160562830|NCT01307423|579781689|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
160562831|NCT01307423|579781690|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
160562832|NCT01307423|579781691|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
160562833|NCT01307423|579781692|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
160562834|NCT01307423|579781693|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
160836226|NCT03210961|580788358|FG011|Overall Study|Withdrawal by Subject|0|||
160836227|NCT03210961|580788359|FG012|Overall Study|Withdrawal by Subject|0|||
160836228|NCT03210961|580788360|FG013|Overall Study|Withdrawal by Subject|0|||
160836229|NCT03210961|580788361|FG014|Overall Study|Withdrawal by Subject|1|||
160836230|NCT03210961|580788347|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836231|NCT03210961|580788348|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836232|NCT03210961|580788349|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836233|NCT03210961|580788350|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836234|NCT03210961|580788351|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836235|NCT03210961|580788352|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836236|NCT03210961|580788353|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
160562835|NCT01307423|579781694|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
160562836|NCT01307423|579781695|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
160562837|NCT01307423|579781696|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
160562838|NCT01307423|579781697|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
160836237|NCT03210961|580788354|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836238|NCT03210961|580788355|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836239|NCT03210961|580788356|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836240|NCT03210961|580788357|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836241|NCT03210961|580788358|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836242|NCT03210961|580788359|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836243|NCT03210961|580788360|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
160904060|NCT00289783|581043144|FG001|Fourth Dose Phase|Adverse Event|0|||
160904061|NCT00289783|581043143|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
160904062|NCT00289783|581043144|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
160836244|NCT03210961|580788361|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
160562839|NCT01307423|579781689|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
160562840|NCT01307423|579781690|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
160562841|NCT01307423|579781691|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
160562842|NCT01307423|579781692|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
160562843|NCT01307423|579781693|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
160562844|NCT01307423|579781694|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
160562845|NCT01307423|579781695|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
160562846|NCT01307423|579781696|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
160562847|NCT01307423|579781697|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
160562848|NCT01307423|579781689|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
160562849|NCT01307423|579781690|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
160836245|NCT03210961|580788347|FG000|Overall Study|Other|0|||
160836246|NCT03210961|580788348|FG001|Overall Study|Other|0|||
160836247|NCT03210961|580788349|FG002|Overall Study|Other|0|||
160836248|NCT03210961|580788350|FG003|Overall Study|Other|1|||
160836249|NCT03210961|580788351|FG004|Overall Study|Other|0|||
160836250|NCT03210961|580788352|FG005|Overall Study|Other|0|||
160836251|NCT03210961|580788353|FG006|Overall Study|Other|1|||
160836252|NCT03210961|580788354|FG007|Overall Study|Other|0|||
160836253|NCT03210961|580788355|FG008|Overall Study|Other|0|||
160836254|NCT03210961|580788356|FG009|Overall Study|Other|0|||
160836255|NCT03210961|580788357|FG010|Overall Study|Other|1|||
160836256|NCT03210961|580788358|FG011|Overall Study|Other|0|||
160836257|NCT03210961|580788359|FG012|Overall Study|Other|2|||
160836258|NCT03210961|580788360|FG013|Overall Study|Other|2|||
160836259|NCT03210961|580788361|FG014|Overall Study|Other|0|||
160836260|NCT02467582|580788362|FG000|Allocation|Withdrawal by Subject|1|||
160836261|NCT02467582|580788363|FG001|Allocation|Withdrawal by Subject|0|||
160836262|NCT02467582|580788362|FG000|Follow-up|Death|5|||
160836263|NCT02467582|580788363|FG001|Follow-up|Death|4|||
160836264|NCT02467582|580788362|FG000|Follow-up|Lost to Follow-up|6|||
160836265|NCT02467582|580788363|FG001|Follow-up|Lost to Follow-up|5|||
160836266|NCT03047031|580788367|FG000|Overall Study|Other than listed|1|||
160836267|NCT03047031|580788368|FG001|Overall Study|Other than listed|0|||
160836268|NCT03047031|580788369|FG002|Overall Study|Other than listed|0|||
160836269|NCT03047031|580788367|FG000|Overall Study|Lost to Follow-up|4|||
160904063|NCT00289783|581043143|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
160904064|NCT00289783|581043144|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
160904065|NCT00289783|581043143|FG000|Fourth Dose Phase|Migration from the study area|1|||
160904066|NCT00289783|581043144|FG001|Fourth Dose Phase|Migration from the study area|1|||
160904067|NCT00289783|581043143|FG000|Fourth Dose Phase|Other|22|||
160904068|NCT00289783|581043144|FG001|Fourth Dose Phase|Other|10|||
160904069|NCT05248867|581043145|FG000|Double-blind Period|Lost to Follow-up|0|||
160904070|NCT05248867|581043146|FG001|Double-blind Period|Lost to Follow-up|3|||
160904071|NCT05248867|581043147|FG002|Double-blind Period|Lost to Follow-up|0|||
160904072|NCT05248867|581043148|FG003|Double-blind Period|Lost to Follow-up|0|||
160904073|NCT05248867|581043149|FG004|Double-blind Period|Lost to Follow-up|0|||
160904074|NCT05248867|581043150|FG005|Double-blind Period|Lost to Follow-up|0|||
160904075|NCT05248867|581043145|FG000|Double-blind Period|Withdrawal by Subject|5|||
160904076|NCT05248867|581043146|FG001|Double-blind Period|Withdrawal by Subject|14|||
160904077|NCT05248867|581043147|FG002|Double-blind Period|Withdrawal by Subject|0|||
160904078|NCT05248867|581043148|FG003|Double-blind Period|Withdrawal by Subject|0|||
160904079|NCT05248867|581043149|FG004|Double-blind Period|Withdrawal by Subject|0|||
160904080|NCT05248867|581043150|FG005|Double-blind Period|Withdrawal by Subject|0|||
160904081|NCT05248867|581043145|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
160904082|NCT05248867|581043146|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
160904083|NCT05248867|581043147|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
160904084|NCT05248867|581043148|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
160904085|NCT05248867|581043149|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
160836270|NCT03047031|580788368|FG001|Overall Study|Lost to Follow-up|0|||
160836271|NCT03047031|580788369|FG002|Overall Study|Lost to Follow-up|0|||
160836272|NCT03047031|580788367|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
160904086|NCT05248867|581043150|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
160904087|NCT05248867|581043145|FG000|Double-blind Period|Other, not specified|3|||
160904088|NCT05248867|581043146|FG001|Double-blind Period|Other, not specified|8|||
160904089|NCT05248867|581043147|FG002|Double-blind Period|Other, not specified|0|||
160991519|NCT04319094|581357823|FG001|3-month|Death|0|||
160836273|NCT03047031|580788368|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
160836274|NCT03047031|580788369|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
160836275|NCT03047031|580788367|FG000|Overall Study|Adverse Event|1|||
160836276|NCT03047031|580788368|FG001|Overall Study|Adverse Event|0|||
160836277|NCT03047031|580788369|FG002|Overall Study|Adverse Event|0|||
160836278|NCT03047031|580788367|FG000|Overall Study|Withdrawal by Subject|2|||
160836279|NCT03047031|580788368|FG001|Overall Study|Withdrawal by Subject|0|||
160836280|NCT03047031|580788369|FG002|Overall Study|Withdrawal by Subject|0|||
160836281|NCT03047031|580788367|FG000|Overall Study|Change to other medication|2|||
160836282|NCT03047031|580788368|FG001|Overall Study|Change to other medication|0|||
160836283|NCT03047031|580788369|FG002|Overall Study|Change to other medication|0|||
160836284|NCT03047031|580788367|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
160836285|NCT03047031|580788368|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
160836286|NCT03047031|580788369|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
160836287|NCT02814175|580788370|FG000|Part 1|Adverse Event|2|||
160836288|NCT02814175|580788371|FG001|Part 1|Adverse Event|3|||
160836289|NCT02814175|580788372|FG002|Part 1|Adverse Event|0|||
160836290|NCT02814175|580788373|FG003|Part 1|Adverse Event|0|||
160836291|NCT02814175|580788374|FG004|Part 1|Adverse Event|0|||
160836292|NCT02814175|580788375|FG005|Part 1|Adverse Event|0|||
160836293|NCT02814175|580788370|FG000|Part 1|Withdrawal Consent|8|||
160836294|NCT02814175|580788371|FG001|Part 1|Withdrawal Consent|1|||
160836295|NCT02814175|580788372|FG002|Part 1|Withdrawal Consent|0|||
160836296|NCT02814175|580788373|FG003|Part 1|Withdrawal Consent|0|||
160836297|NCT02814175|580788374|FG004|Part 1|Withdrawal Consent|0|||
160836298|NCT02814175|580788375|FG005|Part 1|Withdrawal Consent|0|||
160836299|NCT02814175|580788370|FG000|Part 1|Lost to Follow-up|1|||
160836300|NCT02814175|580788371|FG001|Part 1|Lost to Follow-up|0|||
160836301|NCT02814175|580788372|FG002|Part 1|Lost to Follow-up|0|||
160836302|NCT02814175|580788373|FG003|Part 1|Lost to Follow-up|0|||
160836303|NCT02814175|580788374|FG004|Part 1|Lost to Follow-up|0|||
160836304|NCT02814175|580788375|FG005|Part 1|Lost to Follow-up|0|||
160836305|NCT02814175|580788370|FG000|Part 1|Lack of Efficacy|1|||
160836306|NCT02814175|580788371|FG001|Part 1|Lack of Efficacy|2|||
160836307|NCT02814175|580788372|FG002|Part 1|Lack of Efficacy|0|||
160836308|NCT02814175|580788373|FG003|Part 1|Lack of Efficacy|0|||
160836309|NCT02814175|580788374|FG004|Part 1|Lack of Efficacy|0|||
160836310|NCT02814175|580788375|FG005|Part 1|Lack of Efficacy|0|||
160836311|NCT02814175|580788370|FG000|Part 2|Adverse Event|0|||
160836312|NCT02814175|580788371|FG001|Part 2|Adverse Event|0|||
160836313|NCT02814175|580788372|FG002|Part 2|Adverse Event|0|||
160836314|NCT02814175|580788373|FG003|Part 2|Adverse Event|1|||
160836315|NCT02814175|580788374|FG004|Part 2|Adverse Event|1|||
160836316|NCT02814175|580788375|FG005|Part 2|Adverse Event|2|||
160836317|NCT02814175|580788370|FG000|Part 2|Withdrawal Consent|0|||
160836318|NCT02814175|580788371|FG001|Part 2|Withdrawal Consent|0|||
160836319|NCT02814175|580788372|FG002|Part 2|Withdrawal Consent|0|||
160836320|NCT02814175|580788373|FG003|Part 2|Withdrawal Consent|2|||
160836321|NCT02814175|580788374|FG004|Part 2|Withdrawal Consent|1|||
160836322|NCT02814175|580788375|FG005|Part 2|Withdrawal Consent|1|||
160836323|NCT02814175|580788370|FG000|Part 2|Lost to Follow-up|0|||
160836324|NCT02814175|580788371|FG001|Part 2|Lost to Follow-up|0|||
160904090|NCT05248867|581043148|FG003|Double-blind Period|Other, not specified|0|||
160904091|NCT05248867|581043149|FG004|Double-blind Period|Other, not specified|0|||
160836325|NCT02814175|580788372|FG002|Part 2|Lost to Follow-up|0|||
160836326|NCT02814175|580788373|FG003|Part 2|Lost to Follow-up|1|||
160836327|NCT02814175|580788374|FG004|Part 2|Lost to Follow-up|0|||
160836328|NCT02814175|580788375|FG005|Part 2|Lost to Follow-up|0|||
160836329|NCT02814175|580788370|FG000|Part 2|Lack of Efficacy|0|||
160836330|NCT02814175|580788371|FG001|Part 2|Lack of Efficacy|0|||
160836331|NCT02814175|580788372|FG002|Part 2|Lack of Efficacy|0|||
160836332|NCT02814175|580788373|FG003|Part 2|Lack of Efficacy|0|||
160836333|NCT02814175|580788374|FG004|Part 2|Lack of Efficacy|0|||
160836334|NCT02814175|580788375|FG005|Part 2|Lack of Efficacy|3|||
160836335|NCT02702414|580788386|FG000|Overall Study|Death|96|||
160836336|NCT02702414|580788387|FG001|Overall Study|Death|42|||
160836337|NCT02702414|580788386|FG000|Overall Study|Lost to Follow-up|0|||
160836338|NCT02702414|580788387|FG001|Overall Study|Lost to Follow-up|1|||
160836339|NCT02702414|580788386|FG000|Overall Study|Withdrawal by Subject|0|||
160836340|NCT02702414|580788387|FG001|Overall Study|Withdrawal by Subject|1|||
160836341|NCT02702414|580788386|FG000|Overall Study|Protocol Violation|1|||
160904092|NCT05248867|581043150|FG005|Double-blind Period|Other, not specified|0|||
160836342|NCT02702414|580788387|FG001|Overall Study|Protocol Violation|0|||
160836343|NCT02702414|580788386|FG000|Overall Study|Sponsor Decision|8|||
160836344|NCT02702414|580788387|FG001|Overall Study|Sponsor Decision|7|||
160836345|NCT04541628|580788388|FG000|Overall Study|Study Terminated|1|||
160836346|NCT04541628|580788389|FG001|Overall Study|Study Terminated|1|||
160836347|NCT04541628|580788390|FG002|Overall Study|Study Terminated|1|||
160836348|NCT00859937|580788394|FG000|Overall Study|Protocol Violation|1|||
160836349|NCT00859937|580788395|FG001|Overall Study|Protocol Violation|0|||
160836350|NCT00615030|580788396|FG000|Period I|Administrative problem|0|||
160836351|NCT00615030|580788397|FG001|Period I|Administrative problem|0|||
160836352|NCT00615030|580788398|FG002|Period I|Administrative problem|0|||
160836353|NCT00615030|580788399|FG003|Period I|Administrative problem|0|||
160836354|NCT00615030|580788400|FG004|Period I|Administrative problem|1|||
160836355|NCT00615030|580788401|FG005|Period I|Administrative problem|0|||
160836356|NCT00615030|580788402|FG006|Period I|Administrative problem|0|||
160836357|NCT00615030|580788403|FG007|Period I|Administrative problem|0|||
160836358|NCT00615030|580788404|FG008|Period I|Administrative problem|0|||
160562850|NCT01307423|579781691|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
160562851|NCT01307423|579781692|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
160562852|NCT01307423|579781693|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
160562853|NCT01307423|579781694|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
160562854|NCT01307423|579781695|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
160562855|NCT01307423|579781696|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
160562856|NCT01307423|579781697|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
160562857|NCT01307423|579781689|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
160562858|NCT01307423|579781690|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
160562859|NCT01307423|579781691|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
160562860|NCT01307423|579781692|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
160562861|NCT01307423|579781693|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
160562862|NCT01307423|579781694|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
160562863|NCT01307423|579781695|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
160562864|NCT01307423|579781696|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
160562865|NCT01307423|579781697|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
160562866|NCT01307423|579781689|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
160562867|NCT01307423|579781690|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
160562868|NCT01307423|579781691|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
160562869|NCT01307423|579781692|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
160562870|NCT01307423|579781693|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
160562871|NCT01307423|579781694|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
160562872|NCT01307423|579781695|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
160904093|NCT05248867|581043145|FG000|Open-label Period|Withdrawal by Subject|0|||
160904094|NCT05248867|581043146|FG001|Open-label Period|Withdrawal by Subject|0|||
160904095|NCT05248867|581043147|FG002|Open-label Period|Withdrawal by Subject|3|||
160904096|NCT05248867|581043148|FG003|Open-label Period|Withdrawal by Subject|1|||
160904097|NCT05248867|581043149|FG004|Open-label Period|Withdrawal by Subject|7|||
160904098|NCT05248867|581043150|FG005|Open-label Period|Withdrawal by Subject|9|||
160904099|NCT05248867|581043145|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
160904100|NCT05248867|581043146|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
160904101|NCT05248867|581043147|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
160904102|NCT05248867|581043148|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
160904103|NCT05248867|581043149|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
160904104|NCT05248867|581043150|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
160904105|NCT05248867|581043145|FG000|Open-label Period|Lost to Follow-up|0|||
160904106|NCT05248867|581043146|FG001|Open-label Period|Lost to Follow-up|0|||
160904107|NCT05248867|581043147|FG002|Open-label Period|Lost to Follow-up|0|||
160904108|NCT05248867|581043148|FG003|Open-label Period|Lost to Follow-up|0|||
160904109|NCT05248867|581043149|FG004|Open-label Period|Lost to Follow-up|5|||
160562873|NCT01307423|579781696|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
160562874|NCT01307423|579781697|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
160562875|NCT01307423|579781689|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
160836359|NCT00615030|580788405|FG009|Period I|Administrative problem|0|||
160836360|NCT00615030|580788406|FG010|Period I|Administrative problem|0|||
160836361|NCT00615030|580788407|FG011|Period I|Administrative problem|0|||
160836362|NCT00615030|580788396|FG000|Period I|Protocol deviation|1|||
160836363|NCT00615030|580788397|FG001|Period I|Protocol deviation|0|||
160836364|NCT00615030|580788398|FG002|Period I|Protocol deviation|0|||
160836365|NCT00615030|580788399|FG003|Period I|Protocol deviation|0|||
160836366|NCT00615030|580788400|FG004|Period I|Protocol deviation|0|||
160836367|NCT00615030|580788401|FG005|Period I|Protocol deviation|0|||
160836368|NCT00615030|580788402|FG006|Period I|Protocol deviation|0|||
160836369|NCT00615030|580788403|FG007|Period I|Protocol deviation|0|||
160836370|NCT00615030|580788404|FG008|Period I|Protocol deviation|0|||
160836371|NCT00615030|580788405|FG009|Period I|Protocol deviation|0|||
160836372|NCT00615030|580788406|FG010|Period I|Protocol deviation|0|||
160836373|NCT00615030|580788407|FG011|Period I|Protocol deviation|0|||
160836374|NCT00615030|580788396|FG000|Period I|Subject withdrew consent|0|||
160836375|NCT00615030|580788397|FG001|Period I|Subject withdrew consent|0|||
160836376|NCT00615030|580788398|FG002|Period I|Subject withdrew consent|0|||
160836377|NCT00615030|580788399|FG003|Period I|Subject withdrew consent|0|||
160836378|NCT00615030|580788400|FG004|Period I|Subject withdrew consent|0|||
160836379|NCT00615030|580788401|FG005|Period I|Subject withdrew consent|0|||
160836380|NCT00615030|580788402|FG006|Period I|Subject withdrew consent|0|||
160836381|NCT00615030|580788403|FG007|Period I|Subject withdrew consent|0|||
160836382|NCT00615030|580788404|FG008|Period I|Subject withdrew consent|1|||
160991520|NCT04319094|581357822|FG000|3-month|Lost to Follow-up|2|||
160991521|NCT04319094|581357823|FG001|3-month|Lost to Follow-up|2|||
160836383|NCT00615030|580788405|FG009|Period I|Subject withdrew consent|0|||
160836384|NCT00615030|580788406|FG010|Period I|Subject withdrew consent|1|||
160836385|NCT00615030|580788407|FG011|Period I|Subject withdrew consent|1|||
160991522|NCT04319094|581357822|FG000|3-month|Withdrawal by Subject|0|||
160991523|NCT04319094|581357823|FG001|3-month|Withdrawal by Subject|3|||
160991524|NCT04319094|581357822|FG000|3-month|Incomplete data collection|9|||
160991525|NCT04319094|581357823|FG001|3-month|Incomplete data collection|7|||
160991526|NCT04319094|581357822|FG000|6-month|Lost to Follow-up|1|||
160991527|NCT04319094|581357823|FG001|6-month|Lost to Follow-up|1|||
160991528|NCT04319094|581357822|FG000|6-month|Withdrawal by Subject|0|||
160991529|NCT04319094|581357823|FG001|6-month|Withdrawal by Subject|3|||
160991530|NCT04319094|581357822|FG000|6-month|Incomplete data collection|14|||
160991531|NCT04319094|581357823|FG001|6-month|Incomplete data collection|9|||
160991532|NCT04319094|581357822|FG000|9-month|Lost to Follow-up|8|||
160991533|NCT04319094|581357823|FG001|9-month|Lost to Follow-up|4|||
160991534|NCT04319094|581357822|FG000|9-month|Withdrawal by Subject|0|||
160991535|NCT04319094|581357823|FG001|9-month|Withdrawal by Subject|1|||
160991536|NCT04319094|581357822|FG000|9-month|Incomplete data collection|8|||
160991537|NCT04319094|581357823|FG001|9-month|Incomplete data collection|5|||
160991538|NCT04319094|581357822|FG000|12-month|Lost to Follow-up|11|||
160991539|NCT04319094|581357823|FG001|12-month|Lost to Follow-up|8|||
160991540|NCT04639947|581357826|FG000|Overall Study|Screen fail|1|||
160991541|NCT01018511|581357828|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
160991542|NCT01018511|581357829|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
160991543|NCT01018511|581357830|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
160991544|NCT01018511|581357831|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
160991545|NCT01018511|581357828|FG000|Overall Study|Adverse Event|5|||
160991546|NCT01018511|581357829|FG001|Overall Study|Adverse Event|9|||
160991547|NCT01018511|581357830|FG002|Overall Study|Adverse Event|13|||
160991548|NCT01018511|581357831|FG003|Overall Study|Adverse Event|10|||
160991549|NCT01018511|581357828|FG000|Overall Study|Lack of Efficacy|4|||
160991550|NCT01018511|581357829|FG001|Overall Study|Lack of Efficacy|1|||
160991551|NCT01018511|581357830|FG002|Overall Study|Lack of Efficacy|1|||
160991552|NCT01018511|581357831|FG003|Overall Study|Lack of Efficacy|2|||
160991553|NCT01018511|581357828|FG000|Overall Study|Withdrawal by Subject|6|||
160991554|NCT01018511|581357829|FG001|Overall Study|Withdrawal by Subject|5|||
160991555|NCT01018511|581357830|FG002|Overall Study|Withdrawal by Subject|11|||
160991556|NCT01018511|581357831|FG003|Overall Study|Withdrawal by Subject|9|||
160991557|NCT01018511|581357828|FG000|Overall Study|Lost to Follow-up|0|||
160562876|NCT01307423|579781690|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
160562877|NCT01307423|579781691|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
160836386|NCT00615030|580788396|FG000|Period I|Abnormal laboratory value(s)|0|||
160836387|NCT00615030|580788397|FG001|Period I|Abnormal laboratory value(s)|0|||
160836388|NCT00615030|580788398|FG002|Period I|Abnormal laboratory value(s)|0|||
160836389|NCT00615030|580788399|FG003|Period I|Abnormal laboratory value(s)|0|||
160836390|NCT00615030|580788400|FG004|Period I|Abnormal laboratory value(s)|0|||
160836391|NCT00615030|580788401|FG005|Period I|Abnormal laboratory value(s)|1|||
160836392|NCT00615030|580788402|FG006|Period I|Abnormal laboratory value(s)|0|||
160836393|NCT00615030|580788403|FG007|Period I|Abnormal laboratory value(s)|0|||
160836394|NCT00615030|580788404|FG008|Period I|Abnormal laboratory value(s)|0|||
160836395|NCT00615030|580788405|FG009|Period I|Abnormal laboratory value(s)|0|||
160836396|NCT00615030|580788406|FG010|Period I|Abnormal laboratory value(s)|0|||
160836397|NCT00615030|580788407|FG011|Period I|Abnormal laboratory value(s)|0|||
160836398|NCT00615030|580788396|FG000|Period II|Adverse Event|0|||
160836399|NCT00615030|580788397|FG001|Period II|Adverse Event|0|||
160836400|NCT00615030|580788398|FG002|Period II|Adverse Event|1|||
160836401|NCT00615030|580788399|FG003|Period II|Adverse Event|0|||
160836402|NCT00615030|580788400|FG004|Period II|Adverse Event|0|||
160836403|NCT00615030|580788401|FG005|Period II|Adverse Event|0|||
160836404|NCT00615030|580788402|FG006|Period II|Adverse Event|0|||
160836405|NCT00615030|580788403|FG007|Period II|Adverse Event|0|||
160836406|NCT00615030|580788404|FG008|Period II|Adverse Event|1|||
160836407|NCT00615030|580788405|FG009|Period II|Adverse Event|0|||
160836408|NCT00615030|580788406|FG010|Period II|Adverse Event|0|||
160836409|NCT00615030|580788407|FG011|Period II|Adverse Event|0|||
160836410|NCT00615030|580788396|FG000|Period II|Subject withdrew consent|0|||
160836411|NCT00615030|580788397|FG001|Period II|Subject withdrew consent|0|||
160836412|NCT00615030|580788398|FG002|Period II|Subject withdrew consent|0|||
160836413|NCT00615030|580788399|FG003|Period II|Subject withdrew consent|1|||
160836414|NCT00615030|580788400|FG004|Period II|Subject withdrew consent|0|||
160836415|NCT00615030|580788401|FG005|Period II|Subject withdrew consent|0|||
160836416|NCT00615030|580788402|FG006|Period II|Subject withdrew consent|1|||
160836417|NCT00615030|580788403|FG007|Period II|Subject withdrew consent|0|||
160836418|NCT00615030|580788404|FG008|Period II|Subject withdrew consent|0|||
160836419|NCT00615030|580788405|FG009|Period II|Subject withdrew consent|0|||
160836420|NCT00615030|580788406|FG010|Period II|Subject withdrew consent|0|||
160836421|NCT00615030|580788407|FG011|Period II|Subject withdrew consent|0|||
160836422|NCT00615030|580788396|FG000|Period III|Administrative problems|1|||
160836423|NCT00615030|580788397|FG001|Period III|Administrative problems|0|||
160836424|NCT00615030|580788398|FG002|Period III|Administrative problems|0|||
160562878|NCT01307423|579781692|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
160562879|NCT01307423|579781693|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
160562880|NCT01307423|579781694|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
160562881|NCT01307423|579781695|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
160836425|NCT00615030|580788399|FG003|Period III|Administrative problems|1|||
160836426|NCT00615030|580788400|FG004|Period III|Administrative problems|0|||
160836427|NCT00615030|580788401|FG005|Period III|Administrative problems|0|||
160836428|NCT00615030|580788402|FG006|Period III|Administrative problems|0|||
160836429|NCT00615030|580788403|FG007|Period III|Administrative problems|0|||
160836430|NCT00615030|580788404|FG008|Period III|Administrative problems|0|||
160836431|NCT00615030|580788405|FG009|Period III|Administrative problems|0|||
160836432|NCT00615030|580788406|FG010|Period III|Administrative problems|0|||
160836433|NCT00615030|580788407|FG011|Period III|Administrative problems|0|||
160836434|NCT00151476|580788408|FG000|FAP Identified Subjects|Protocol Violation|0|||
160836435|NCT00151476|580788409|FG001|FAP Identified Subjects|Protocol Violation|1|||
160836436|NCT00151476|580788408|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
160836437|NCT00151476|580788409|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
160836438|NCT00151476|580788408|FG000|FAP Analyzed Subjects|Other study participation|0|||
160836439|NCT00151476|580788409|FG001|FAP Analyzed Subjects|Other study participation|1|||
160836440|NCT03446456|580788410|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
160836441|NCT03446456|580788411|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
160836442|NCT03446456|580788410|FG000|Overall Study|Lost to Follow-up|1|||
160904110|NCT05248867|581043150|FG005|Open-label Period|Lost to Follow-up|2|||
160904111|NCT05248867|581043145|FG000|Open-label Period|COVID-19 Infection|0|||
160904112|NCT05248867|581043146|FG001|Open-label Period|COVID-19 Infection|0|||
160904113|NCT05248867|581043147|FG002|Open-label Period|COVID-19 Infection|0|||
160904114|NCT05248867|581043148|FG003|Open-label Period|COVID-19 Infection|0|||
160904115|NCT05248867|581043149|FG004|Open-label Period|COVID-19 Infection|1|||
160904116|NCT05248867|581043150|FG005|Open-label Period|COVID-19 Infection|0|||
160904117|NCT05248867|581043145|FG000|Open-label Period|Other, not specified|0|||
160904118|NCT05248867|581043146|FG001|Open-label Period|Other, not specified|0|||
160562882|NCT01307423|579781696|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
160836443|NCT03446456|580788411|FG001|Overall Study|Lost to Follow-up|3|||
160836444|NCT03446456|580788410|FG000|Overall Study|Participant failed the toxicology test|1|||
160836445|NCT03446456|580788411|FG001|Overall Study|Participant failed the toxicology test|0|||
160836446|NCT03446456|580788410|FG000|Overall Study|Break down of the experimental equipment|1|||
160836447|NCT03446456|580788411|FG001|Overall Study|Break down of the experimental equipment|0|||
160836448|NCT03002311|580788426|FG000|Overall Study|Lost to Follow-up|13|||
160836449|NCT03002311|580788427|FG001|Overall Study|Lost to Follow-up|26|||
160836450|NCT03002311|580788426|FG000|Overall Study|Referral provider called to schedule app|3|||
160836451|NCT03002311|580788427|FG001|Overall Study|Referral provider called to schedule app|3|||
160836452|NCT03002311|580788426|FG000|Overall Study|Physician Decision|3|||
160836453|NCT03002311|580788427|FG001|Overall Study|Physician Decision|1|||
160836454|NCT00308074|580788428|FG000|Overall Study|Withdrawal by Subject|1|||
160836455|NCT01329939|580788432|FG000|Overall Study|Lost to Follow-up|3|||
160836456|NCT01329939|580788433|FG001|Overall Study|Lost to Follow-up|0|||
160836457|NCT01329939|580788434|FG002|Overall Study|Lost to Follow-up|1|||
160836458|NCT01329939|580788435|FG003|Overall Study|Lost to Follow-up|2|||
160836459|NCT01329939|580788432|FG000|Overall Study|Withdrawal by Subject|0|||
160836460|NCT01329939|580788433|FG001|Overall Study|Withdrawal by Subject|1|||
160836461|NCT01329939|580788434|FG002|Overall Study|Withdrawal by Subject|0|||
160836462|NCT01329939|580788435|FG003|Overall Study|Withdrawal by Subject|0|||
160836463|NCT01329939|580788432|FG000|Overall Study|Adverse Event|0|||
160836464|NCT01329939|580788433|FG001|Overall Study|Adverse Event|0|||
160836465|NCT01329939|580788434|FG002|Overall Study|Adverse Event|0|||
160836466|NCT01329939|580788435|FG003|Overall Study|Adverse Event|3|||
160836467|NCT03722524|580788436|FG000|Overall Study|Protocol Violation|86|||
160836468|NCT03722524|580788436|FG000|Overall Study|Adverse Event|7|||
160836469|NCT03722524|580788436|FG000|Overall Study|Lost to Follow-up|1|||
160836470|NCT03722524|580788436|FG000|Overall Study|Reason is not stated|1|||
160836471|NCT03722524|580788436|FG000|Overall Study|Physician Decision|1|||
160836472|NCT03722524|580788436|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
160836473|NCT04369950|580788438|FG000|Overall Study|Protocol Violation|2|||
160836474|NCT04369950|580788439|FG001|Overall Study|Protocol Violation|2|||
160836475|NCT00989963|580788440|FG000|Overall Study|Adverse Event|1|||
160836476|NCT00989963|580788441|FG001|Overall Study|Adverse Event|1|||
160904119|NCT05248867|581043147|FG002|Open-label Period|Other, not specified|0|||
160904120|NCT05248867|581043148|FG003|Open-label Period|Other, not specified|0|||
160904121|NCT05248867|581043149|FG004|Open-label Period|Other, not specified|4|||
160904122|NCT05248867|581043150|FG005|Open-label Period|Other, not specified|0|||
160904123|NCT00873015|581043152|FG000|Overall Study|Withdrawal by Subject|0|||
160904124|NCT00873015|581043153|FG001|Overall Study|Withdrawal by Subject|1|||
160904125|NCT00873015|581043154|FG002|Overall Study|Withdrawal by Subject|0|||
160904126|NCT00873015|581043155|FG003|Overall Study|Withdrawal by Subject|0|||
160904127|NCT03128411|581043156|FG000|Treatment Phase|Adverse Event|21|||
160904128|NCT03128411|581043156|FG000|Treatment Phase|Physician Decision|1|||
160904129|NCT03128411|581043156|FG000|Treatment Phase|Other|2|||
160904130|NCT03128411|581043156|FG000|Long Term Follow-up Phase|Death|2|||
160904131|NCT00345839|581043157|FG000|Overall Study|Withdrawal by Subject|91|||
160904132|NCT00345839|581043158|FG001|Overall Study|Withdrawal by Subject|98|||
160904133|NCT00345839|581043157|FG000|Overall Study|Lost to Follow-up|58|||
160904134|NCT00345839|581043158|FG001|Overall Study|Lost to Follow-up|61|||
160904135|NCT03298867|581043176|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
160904136|NCT03298867|581043177|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
160904137|NCT03298867|581043176|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
160904138|NCT03298867|581043177|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
160904139|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
160904140|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
160904141|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
160904142|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
160904143|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
160904144|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
160904145|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
160904146|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
160904147|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
160904148|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
160991558|NCT01018511|581357829|FG001|Overall Study|Lost to Follow-up|0|||
160991559|NCT01018511|581357830|FG002|Overall Study|Lost to Follow-up|1|||
160991560|NCT01018511|581357831|FG003|Overall Study|Lost to Follow-up|0|||
160991561|NCT01018511|581357828|FG000|Overall Study|Protocol Violation|5|||
160991562|NCT01018511|581357829|FG001|Overall Study|Protocol Violation|8|||
160991563|NCT01018511|581357830|FG002|Overall Study|Protocol Violation|7|||
160991564|NCT01018511|581357831|FG003|Overall Study|Protocol Violation|9|||
160991565|NCT01018511|581357828|FG000|Overall Study|Miscellaneous|0|||
160991566|NCT01018511|581357829|FG001|Overall Study|Miscellaneous|2|||
160991567|NCT01018511|581357830|FG002|Overall Study|Miscellaneous|0|||
160991568|NCT01018511|581357831|FG003|Overall Study|Miscellaneous|0|||
160991569|NCT00654238|581357832|FG000|Overall Study|Screen Failures|4|||
160991570|NCT03424239|581357833|FG000|Overall Study|Withdrawal by Subject|2|||
160991571|NCT04927975|581357843|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
160991572|NCT04927975|581357844|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
160991573|NCT04927975|581357845|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
160991574|NCT04927975|581357846|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
160991575|NCT04927975|581357847|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
160991576|NCT04927975|581357848|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
160991577|NCT04927975|581357843|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
160991578|NCT04927975|581357844|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
160836477|NCT00989963|580788442|FG002|Overall Study|Adverse Event|1|||
160836478|NCT01240200|580788449|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
160836479|NCT01240200|580788450|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
160836480|NCT00869401|580788453|FG000|Overall Study|Withdrawal by Subject|0|||
160836481|NCT00869401|580788454|FG001|Overall Study|Withdrawal by Subject|0|||
160836482|NCT00869401|580788455|FG002|Overall Study|Withdrawal by Subject|0|||
160836483|NCT00869401|580788456|FG003|Overall Study|Withdrawal by Subject|5|||
160836484|NCT00869401|580788457|FG004|Overall Study|Withdrawal by Subject|3|||
160836485|NCT00975143|580788460|FG000|Overall Study|Adverse Event|19|||
160836486|NCT00975143|580788461|FG001|Overall Study|Adverse Event|15|||
160836487|NCT00975143|580788460|FG000|Overall Study|Withdrawal by Subject|15|||
160836488|NCT00975143|580788461|FG001|Overall Study|Withdrawal by Subject|15|||
160836489|NCT00975143|580788460|FG000|Overall Study|Lost to Follow-up|20|||
160836490|NCT00975143|580788461|FG001|Overall Study|Lost to Follow-up|16|||
160836491|NCT00975143|580788460|FG000|Overall Study|Non-compliance|5|||
160836492|NCT00975143|580788461|FG001|Overall Study|Non-compliance|8|||
160836493|NCT00975143|580788460|FG000|Overall Study|Physician Decision|1|||
160836494|NCT00975143|580788461|FG001|Overall Study|Physician Decision|2|||
160836495|NCT00975143|580788460|FG000|Overall Study|Details not available|10|||
160836496|NCT00975143|580788461|FG001|Overall Study|Details not available|4|||
160836497|NCT01753401|580788462|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
160836498|NCT01753401|580788463|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
160836499|NCT01753401|580788464|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
160836500|NCT01753401|580788465|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
160836501|NCT01753401|580788462|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
160836502|NCT01753401|580788463|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
160836503|NCT01753401|580788464|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
160836504|NCT01753401|580788465|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
160836505|NCT01753401|580788462|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
160836506|NCT01753401|580788463|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
160991579|NCT04927975|581357845|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
160991580|NCT04927975|581357846|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
160991581|NCT04927975|581357847|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
160647640|NCT00416520|580092782|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
160836507|NCT01753401|580788464|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
160836508|NCT01753401|580788465|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
160836509|NCT01753401|580788462|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
160836510|NCT01753401|580788463|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
160836511|NCT01753401|580788464|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
160836512|NCT01753401|580788465|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
160836513|NCT01753401|580788462|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
160836514|NCT01753401|580788463|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
160991582|NCT04927975|581357848|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
160836515|NCT01753401|580788464|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
160836516|NCT01753401|580788465|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
160836517|NCT01753401|580788462|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
160836518|NCT01753401|580788463|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
160991583|NCT04927975|581357843|FG000|Period 1 (Baseline-Week 24)|Death|0|||
160991584|NCT04927975|581357844|FG001|Period 1 (Baseline-Week 24)|Death|0|||
160991585|NCT04927975|581357845|FG002|Period 1 (Baseline-Week 24)|Death|0|||
160991586|NCT04927975|581357846|FG003|Period 1 (Baseline-Week 24)|Death|0|||
160991587|NCT04927975|581357847|FG004|Period 1 (Baseline-Week 24)|Death|0|||
160991588|NCT04927975|581357848|FG005|Period 1 (Baseline-Week 24)|Death|1|||
160836519|NCT01753401|580788464|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
160836520|NCT01753401|580788465|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
160562883|NCT01307423|579781697|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
160562884|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160562885|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
160562886|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
160562887|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160562888|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160562889|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160562890|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160836521|NCT01753401|580788462|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
160836522|NCT01753401|580788463|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
160836523|NCT01753401|580788464|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
160836524|NCT01753401|580788465|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
160836525|NCT00581360|580788466|FG000|Overall Study|Withdrawal by Subject|1|||
160836526|NCT03129360|580788467|FG000|Overall Study|Did not meet entry criteria|0|||
160836527|NCT03129360|580788468|FG001|Overall Study|Did not meet entry criteria|2|||
160836528|NCT03129360|580788469|FG002|Overall Study|Did not meet entry criteria|1|||
160836529|NCT03129360|580788467|FG000|Overall Study|Excluded due to motion in scanner|1|||
160836530|NCT03129360|580788468|FG001|Overall Study|Excluded due to motion in scanner|0|||
160836531|NCT03129360|580788469|FG002|Overall Study|Excluded due to motion in scanner|0|||
160836532|NCT00599638|580788470|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
160836533|NCT00599638|580788471|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
160836534|NCT00599638|580788472|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
160836535|NCT00599638|580788473|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
160836536|NCT00599638|580788470|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
160836537|NCT00599638|580788471|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
160836538|NCT00599638|580788472|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
160836539|NCT00599638|580788473|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
160836540|NCT00599638|580788470|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
160836541|NCT00599638|580788471|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
160836542|NCT00599638|580788472|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
160836543|NCT00599638|580788473|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
160836544|NCT00599638|580788470|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
160836545|NCT00599638|580788471|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
160836546|NCT00599638|580788472|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
160836547|NCT00599638|580788473|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
160562891|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
160562892|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
160836548|NCT00599638|580788470|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
160836549|NCT00599638|580788471|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
160836550|NCT00599638|580788472|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
160836551|NCT00599638|580788473|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
160836552|NCT00599638|580788470|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
160836553|NCT00599638|580788471|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
160836554|NCT00599638|580788472|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
160836555|NCT00599638|580788473|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
160836556|NCT00599638|580788470|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
160836557|NCT00599638|580788471|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
160836558|NCT00599638|580788472|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
160836559|NCT00599638|580788473|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
160836560|NCT00599638|580788470|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
160836561|NCT00599638|580788471|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
160836562|NCT00599638|580788472|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
160836563|NCT00599638|580788473|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
160836564|NCT00599638|580788470|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
160562893|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
160836565|NCT00599638|580788471|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
160836566|NCT00599638|580788472|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
160836567|NCT00599638|580788473|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
160836568|NCT03006887|580788477|FG000|Overall Study|Adverse Event|1|||
160836569|NCT03836677|580788478|FG000|Period 1|Adverse Event|0|||
160836570|NCT03836677|580788479|FG001|Period 1|Adverse Event|1|||
160836571|NCT03836677|580788478|FG000|Period 2|Severe non-compliance to protocol|1|||
160836572|NCT03836677|580788479|FG001|Period 2|Severe non-compliance to protocol|0|||
160836573|NCT02895945|580788480|FG000|Overall Study|Physician Decision|2|||
160836574|NCT02895945|580788481|FG001|Overall Study|Physician Decision|1|||
160836575|NCT00462748|580788482|FG000|Overall Study|Adverse Event|7|||
160836576|NCT00462748|580788483|FG001|Overall Study|Adverse Event|5|||
160562894|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
160836577|NCT00462748|580788484|FG002|Overall Study|Adverse Event|9|||
160836578|NCT00462748|580788482|FG000|Overall Study|Protocol Violation|0|||
160836579|NCT00462748|580788483|FG001|Overall Study|Protocol Violation|2|||
160836580|NCT00462748|580788484|FG002|Overall Study|Protocol Violation|1|||
160836581|NCT00462748|580788482|FG000|Overall Study|Withdrew consent|3|||
160836582|NCT00462748|580788483|FG001|Overall Study|Withdrew consent|3|||
160836583|NCT00462748|580788484|FG002|Overall Study|Withdrew consent|0|||
160836584|NCT00462748|580788482|FG000|Overall Study|Lost to Follow-up|1|||
160836585|NCT00462748|580788483|FG001|Overall Study|Lost to Follow-up|1|||
160836586|NCT00462748|580788484|FG002|Overall Study|Lost to Follow-up|1|||
160836587|NCT00462748|580788482|FG000|Overall Study|Discontinued after 41 days Rx|1|||
160836588|NCT00462748|580788483|FG001|Overall Study|Discontinued after 41 days Rx|0|||
160836589|NCT00462748|580788484|FG002|Overall Study|Discontinued after 41 days Rx|0|||
160836590|NCT03429543|580788485|FG000|Overall Study|Adverse Event|1|||
160836591|NCT03429543|580788486|FG001|Overall Study|Adverse Event|1|||
160836592|NCT03429543|580788487|FG002|Overall Study|Adverse Event|0|||
160836593|NCT03429543|580788488|FG003|Overall Study|Adverse Event|0|||
160836594|NCT03429543|580788489|FG004|Overall Study|Adverse Event|0|||
160836595|NCT03429543|580788490|FG005|Overall Study|Adverse Event|2|||
160836596|NCT03429543|580788491|FG006|Overall Study|Adverse Event|0|||
160836597|NCT03429543|580788485|FG000|Overall Study|Lost to Follow-up|1|||
160836598|NCT03429543|580788486|FG001|Overall Study|Lost to Follow-up|0|||
160836599|NCT03429543|580788487|FG002|Overall Study|Lost to Follow-up|0|||
160836600|NCT03429543|580788488|FG003|Overall Study|Lost to Follow-up|0|||
160836601|NCT03429543|580788489|FG004|Overall Study|Lost to Follow-up|1|||
160836602|NCT03429543|580788490|FG005|Overall Study|Lost to Follow-up|0|||
160836603|NCT03429543|580788491|FG006|Overall Study|Lost to Follow-up|0|||
160836604|NCT03429543|580788485|FG000|Overall Study|Withdrawal by Subject|5|||
160836605|NCT03429543|580788486|FG001|Overall Study|Withdrawal by Subject|0|||
160836606|NCT03429543|580788487|FG002|Overall Study|Withdrawal by Subject|1|||
160836607|NCT03429543|580788488|FG003|Overall Study|Withdrawal by Subject|2|||
160836608|NCT03429543|580788489|FG004|Overall Study|Withdrawal by Subject|6|||
160836609|NCT03429543|580788490|FG005|Overall Study|Withdrawal by Subject|3|||
160836610|NCT03429543|580788491|FG006|Overall Study|Withdrawal by Subject|1|||
160836611|NCT03429543|580788485|FG000|Overall Study|Other reason than listed|0|||
160836612|NCT03429543|580788486|FG001|Overall Study|Other reason than listed|1|||
160836613|NCT03429543|580788487|FG002|Overall Study|Other reason than listed|0|||
160836614|NCT03429543|580788488|FG003|Overall Study|Other reason than listed|0|||
160836615|NCT03429543|580788489|FG004|Overall Study|Other reason than listed|4|||
160836616|NCT03429543|580788490|FG005|Overall Study|Other reason than listed|4|||
160836617|NCT03429543|580788491|FG006|Overall Study|Other reason than listed|0|||
160836618|NCT03429543|580788485|FG000|Overall Study|Not treated|0|||
160836619|NCT03429543|580788486|FG001|Overall Study|Not treated|0|||
160836620|NCT03429543|580788487|FG002|Overall Study|Not treated|0|||
160836621|NCT03429543|580788488|FG003|Overall Study|Not treated|0|||
160836622|NCT03429543|580788489|FG004|Overall Study|Not treated|1|||
160836623|NCT03429543|580788490|FG005|Overall Study|Not treated|0|||
160836624|NCT03429543|580788491|FG006|Overall Study|Not treated|0|||
160836625|NCT01729208|580788492|FG000|Baseline|Physician Decision|5|||
160836626|NCT01729208|580788493|FG001|Baseline|Physician Decision|4|||
160836627|NCT01729208|580788492|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
160836628|NCT01729208|580788493|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
160836629|NCT01729208|580788492|FG000|12 Months Follow-up|Lost to Follow-up|3|||
160836630|NCT01729208|580788493|FG001|12 Months Follow-up|Lost to Follow-up|3|||
160836631|NCT01729208|580788492|FG000|24 Months Follow-up|Lost to Follow-up|3|||
160836632|NCT01729208|580788493|FG001|24 Months Follow-up|Lost to Follow-up|0|||
160836633|NCT01729208|580788492|FG000|36 Months Follow-up|Physician Decision|1|||
160836634|NCT01729208|580788493|FG001|36 Months Follow-up|Physician Decision|0|||
160836635|NCT01729208|580788492|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
160836636|NCT01729208|580788493|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
160836637|NCT00082381|580788494|FG000|Overall Study|Adverse Event|27|||
160836638|NCT00082381|580788495|FG001|Overall Study|Adverse Event|2|||
160917936|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
160454066|NCT02038777|579394024|FG002|Overall Study|Started Chemotherapy|3|||
160836639|NCT00082381|580788494|FG000|Overall Study|Lost to Follow-up|5|||
160836640|NCT00082381|580788495|FG001|Overall Study|Lost to Follow-up|7|||
160836641|NCT00082381|580788494|FG000|Overall Study|Patient Decision|8|||
160836642|NCT00082381|580788495|FG001|Overall Study|Patient Decision|4|||
160836643|NCT00082381|580788494|FG000|Overall Study|Physician Decision|1|||
160836644|NCT00082381|580788495|FG001|Overall Study|Physician Decision|2|||
160836645|NCT00082381|580788494|FG000|Overall Study|Protocol Violation|10|||
160836646|NCT00082381|580788495|FG001|Overall Study|Protocol Violation|11|||
160836647|NCT00082381|580788494|FG000|Overall Study|Loss of Glucose Control|4|||
160836648|NCT00082381|580788495|FG001|Overall Study|Loss of Glucose Control|0|||
160836649|NCT02428413|580788496|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
160836650|NCT02428413|580788497|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
160836651|NCT02428413|580788496|FG000|Overall Study|Protocol Violation|1|||
160836652|NCT02428413|580788497|FG001|Overall Study|Protocol Violation|2|||
160836653|NCT02428413|580788496|FG000|Overall Study|Case Cancelled|2|||
160836654|NCT02428413|580788497|FG001|Overall Study|Case Cancelled|0|||
160836655|NCT02428413|580788496|FG000|Overall Study|Missed Cases|1|||
160836656|NCT02428413|580788497|FG001|Overall Study|Missed Cases|2|||
160836657|NCT02428413|580788496|FG000|Overall Study|Nurse Refusal|1|||
160836658|NCT02428413|580788497|FG001|Overall Study|Nurse Refusal|0|||
160836659|NCT02345330|580788501|FG000|Overall Study|Death|1|||
160836660|NCT02345330|580788501|FG000|Overall Study|Progressive Disease|2|||
160836661|NCT00295932|580788502|FG000|Overall Study|Not Treated|0|||
160836662|NCT00295932|580788503|FG001|Overall Study|Not Treated|0|||
160836663|NCT00295932|580788504|FG002|Overall Study|Not Treated|0|||
160836664|NCT00295932|580788505|FG003|Overall Study|Not Treated|0|||
160836665|NCT00295932|580788506|FG004|Overall Study|Not Treated|0|||
160836666|NCT00295932|580788507|FG005|Overall Study|Not Treated|0|||
160836667|NCT00295932|580788508|FG006|Overall Study|Not Treated|0|||
160836668|NCT00295932|580788509|FG007|Overall Study|Not Treated|0|||
160836669|NCT00295932|580788510|FG008|Overall Study|Not Treated|0|||
160836670|NCT00295932|580788511|FG009|Overall Study|Not Treated|0|||
160836671|NCT00295932|580788512|FG010|Overall Study|Not Treated|1|||
160836672|NCT00109577|580788513|FG000|Overall Study|Withdrawal by Subject|3|||
160836673|NCT00109577|580788514|FG001|Overall Study|Withdrawal by Subject|3|||
160836674|NCT03322423|580788515|FG000|Period 1|Subject no longer eligible|0|||
160836675|NCT03322423|580788516|FG001|Period 1|Subject no longer eligible|1|||
160836676|NCT03322423|580788515|FG000|Period 1|Withdrawal by Subject|0|||
160836677|NCT03322423|580788516|FG001|Period 1|Withdrawal by Subject|1|||
160836678|NCT03322423|580788515|FG000|Period 1|Incorrect Lens Dispensed|1|||
160836679|NCT03322423|580788516|FG001|Period 1|Incorrect Lens Dispensed|0|||
160836680|NCT03322423|580788515|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
160836681|NCT03322423|580788516|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
160836682|NCT03322423|580788515|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
160836683|NCT03322423|580788516|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
160836684|NCT03322423|580788515|FG000|Period 2|Protocol Violation|1|||
160836685|NCT03322423|580788516|FG001|Period 2|Protocol Violation|0|||
160836686|NCT03322423|580788515|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
160836687|NCT03322423|580788516|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
160836688|NCT04891107|580788517|FG000|Overall Study|Physician Decision|1|||
160836689|NCT04891107|580788517|FG000|Overall Study|Withdrawal by Subject|1|||
160836690|NCT04891107|580788517|FG000|Overall Study|Screen failure after consent|1|||
160836691|NCT02453555|580788518|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
160836692|NCT02453555|580788519|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
160836693|NCT02453555|580788520|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
160836694|NCT02453555|580788521|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
160836695|NCT02453555|580788522|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
160836696|NCT02453555|580788523|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
160836697|NCT02453555|580788518|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
160836698|NCT02453555|580788519|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
160836699|NCT02453555|580788520|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
160836700|NCT02453555|580788521|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
160836701|NCT02453555|580788522|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
160836702|NCT02453555|580788523|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
160836703|NCT02453555|580788518|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
160836704|NCT02453555|580788519|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
160836705|NCT02453555|580788520|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160836706|NCT02453555|580788521|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160836707|NCT02453555|580788522|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160836708|NCT02453555|580788523|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160836709|NCT02453555|580788518|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
160904149|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
160904150|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
160904151|NCT03298867|581043176|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
160562895|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
160562896|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
160562897|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
160562898|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
160562899|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
160562900|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
160562901|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
160562902|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
160562903|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
160562904|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
160836710|NCT02453555|580788519|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
160836711|NCT02453555|580788520|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
160836712|NCT02453555|580788521|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
160836713|NCT02453555|580788522|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
160836714|NCT02453555|580788523|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
160836715|NCT02453555|580788518|FG000|Extension Period|Adverse Event|0|||
160836716|NCT02453555|580788519|FG001|Extension Period|Adverse Event|0|||
160836717|NCT02453555|580788520|FG002|Extension Period|Adverse Event|1|||
160836718|NCT02453555|580788521|FG003|Extension Period|Adverse Event|2|||
160836719|NCT02453555|580788522|FG004|Extension Period|Adverse Event|1|||
160836720|NCT02453555|580788523|FG005|Extension Period|Adverse Event|1|||
160836721|NCT02453555|580788518|FG000|Extension Period|Protocol Violation|0|||
160836722|NCT02453555|580788519|FG001|Extension Period|Protocol Violation|0|||
160836723|NCT02453555|580788520|FG002|Extension Period|Protocol Violation|1|||
160836724|NCT02453555|580788521|FG003|Extension Period|Protocol Violation|0|||
160836725|NCT02453555|580788522|FG004|Extension Period|Protocol Violation|0|||
160836726|NCT02453555|580788523|FG005|Extension Period|Protocol Violation|0|||
160836727|NCT02453555|580788518|FG000|Extension Period|Withdrawal by Subject|0|||
160836728|NCT02453555|580788519|FG001|Extension Period|Withdrawal by Subject|0|||
160836729|NCT02453555|580788520|FG002|Extension Period|Withdrawal by Subject|1|||
160836730|NCT02453555|580788521|FG003|Extension Period|Withdrawal by Subject|0|||
160836731|NCT02453555|580788522|FG004|Extension Period|Withdrawal by Subject|0|||
160836732|NCT02453555|580788523|FG005|Extension Period|Withdrawal by Subject|0|||
160836733|NCT03689855|580788528|FG000|Overall Study|Adverse Event|3|||
160836734|NCT03689855|580788528|FG000|Overall Study|Withdrawal by Subject|1|||
160836735|NCT03178669|580788529|FG000|Overall Study|Adverse Event|4|||
160836736|NCT03178669|580788530|FG001|Overall Study|Adverse Event|1|||
160562905|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
160562906|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
160562907|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
160562908|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
160562909|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
160562910|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
160562911|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160562912|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
160562913|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
160562914|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160562915|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160562916|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160562917|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160562918|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
160836737|NCT03178669|580788531|FG002|Overall Study|Adverse Event|4|||
160836738|NCT03178669|580788532|FG003|Overall Study|Adverse Event|2|||
160836739|NCT03178669|580788533|FG004|Overall Study|Adverse Event|2|||
160836740|NCT03178669|580788529|FG000|Overall Study|Lack of Efficacy|0|||
160836741|NCT03178669|580788530|FG001|Overall Study|Lack of Efficacy|0|||
160836742|NCT03178669|580788531|FG002|Overall Study|Lack of Efficacy|2|||
160562919|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
160562920|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160836743|NCT03178669|580788532|FG003|Overall Study|Lack of Efficacy|0|||
160836744|NCT03178669|580788533|FG004|Overall Study|Lack of Efficacy|1|||
160836745|NCT03178669|580788529|FG000|Overall Study|Physician Decision|0|||
160836746|NCT03178669|580788530|FG001|Overall Study|Physician Decision|0|||
160836747|NCT03178669|580788531|FG002|Overall Study|Physician Decision|0|||
160836748|NCT03178669|580788532|FG003|Overall Study|Physician Decision|0|||
160991589|NCT04927975|581357843|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
160836749|NCT03178669|580788533|FG004|Overall Study|Physician Decision|1|||
160836750|NCT03178669|580788529|FG000|Overall Study|Withdrawal by Subject|1|||
160991590|NCT04927975|581357844|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
160991591|NCT04927975|581357845|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
160836751|NCT03178669|580788530|FG001|Overall Study|Withdrawal by Subject|0|||
160836752|NCT03178669|580788531|FG002|Overall Study|Withdrawal by Subject|1|||
160836753|NCT03178669|580788532|FG003|Overall Study|Withdrawal by Subject|1|||
160836754|NCT03178669|580788533|FG004|Overall Study|Withdrawal by Subject|0|||
160836755|NCT03178669|580788529|FG000|Overall Study|Lost to Follow-up|0|||
160836756|NCT03178669|580788530|FG001|Overall Study|Lost to Follow-up|0|||
160836757|NCT03178669|580788531|FG002|Overall Study|Lost to Follow-up|0|||
160836758|NCT03178669|580788532|FG003|Overall Study|Lost to Follow-up|1|||
160836759|NCT03178669|580788533|FG004|Overall Study|Lost to Follow-up|0|||
160836760|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
160836761|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
160836762|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
160836763|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
160836764|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
160836765|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
160836766|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
160836767|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
160836768|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
160836769|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
160836770|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
160836771|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
160836772|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
160836773|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
160836774|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836775|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
160836776|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
160836777|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836778|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836779|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836780|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836781|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836782|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836783|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
160836784|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
160836785|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
160836786|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
160836787|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
160836788|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836789|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836790|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836791|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836792|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836793|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
160836794|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
160836795|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
160836796|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836797|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
160836798|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
160836799|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836800|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836801|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836802|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836803|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836804|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836805|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836806|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
160836807|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836808|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836809|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
160836810|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836811|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836812|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836813|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836814|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836815|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
160836816|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836817|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836818|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836819|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836820|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836821|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836822|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836823|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836824|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160904152|NCT03298867|581043177|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
160904153|NCT06934993|581043182|FG000|Overall Study|Withdrawal by Subject|29|||
160904154|NCT06934993|581043182|FG000|Overall Study|elevated postoperative creatinine level|11|||
160904155|NCT06934993|581043182|FG000|Overall Study|Death|3|||
160904156|NCT03749447|581044885|FG000|Overall Study|Adverse Event|11|||
160904157|NCT03749447|581044886|FG001|Overall Study|Adverse Event|3|||
160904158|NCT03749447|581044885|FG000|Overall Study|Death|1|||
160904159|NCT03749447|581044886|FG001|Overall Study|Death|1|||
160904160|NCT03749447|581044885|FG000|Overall Study|Lost to Follow-up|2|||
160904161|NCT03749447|581044886|FG001|Overall Study|Lost to Follow-up|2|||
160904162|NCT03749447|581044885|FG000|Overall Study|Reason Not Specified|0|||
160904163|NCT03749447|581044886|FG001|Overall Study|Reason Not Specified|3|||
160904164|NCT03749447|581044885|FG000|Overall Study|Physician Decision|4|||
160904165|NCT03749447|581044886|FG001|Overall Study|Physician Decision|3|||
160904166|NCT03749447|581044885|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
160904167|NCT03749447|581044886|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
160904168|NCT03749447|581044885|FG000|Overall Study|Study Terminated By Sponsor|112|||
160904169|NCT03749447|581044886|FG001|Overall Study|Study Terminated By Sponsor|105|||
160904170|NCT03749447|581044885|FG000|Overall Study|Withdrawal by Subject|12|||
160904171|NCT03749447|581044886|FG001|Overall Study|Withdrawal by Subject|6|||
160904172|NCT03749447|581044885|FG000|Overall Study|Non-compliance With Study Drug|0|||
160904173|NCT03749447|581044886|FG001|Overall Study|Non-compliance With Study Drug|1|||
160904174|NCT01673867|581044890|FG000|Randomization|Adverse event unrelated to study drug|1|||
160904175|NCT01673867|581044891|FG001|Randomization|Adverse event unrelated to study drug|0|||
160904176|NCT01673867|581044890|FG000|Randomization|Participant request to discontinue study treatment|0|||
160904177|NCT01673867|581044891|FG001|Randomization|Participant request to discontinue study treatment|4|||
160904178|NCT01673867|581044890|FG000|Randomization|Withdrawal by participant|0|||
160904179|NCT01673867|581044891|FG001|Randomization|Withdrawal by participant|12|||
160904180|NCT01673867|581044890|FG000|Randomization|Lost to Follow-up|0|||
160904181|NCT01673867|581044891|FG001|Randomization|Lost to Follow-up|1|||
160904182|NCT01673867|581044890|FG000|Randomization|Participant no longer meets study criteria|4|||
160904183|NCT01673867|581044891|FG001|Randomization|Participant no longer meets study criteria|5|||
160904184|NCT01673867|581044890|FG000|Treatment|Disease Progression|208|||
160904185|NCT01673867|581044891|FG001|Treatment|Disease Progression|178|||
160836825|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836826|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836827|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836828|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
160836829|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836830|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836831|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836832|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836833|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836834|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836835|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836836|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836837|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
160904186|NCT01673867|581044890|FG000|Treatment|Study Drug Toxicity|23|||
160904187|NCT01673867|581044891|FG001|Treatment|Study Drug Toxicity|43|||
160904188|NCT01673867|581044890|FG000|Treatment|Death|2|||
160904189|NCT01673867|581044891|FG001|Treatment|Death|3|||
160904190|NCT01673867|581044890|FG000|Treatment|Adverse event unrelated to study drug|23|||
160904191|NCT01673867|581044891|FG001|Treatment|Adverse event unrelated to study drug|10|||
160904192|NCT01673867|581044890|FG000|Treatment|Participant request to discontinue study treatment|7|||
160904193|NCT01673867|581044891|FG001|Treatment|Participant request to discontinue study treatment|17|||
160562921|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
160562922|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160562923|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160562924|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160562925|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160562926|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160562927|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
160562928|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
160836838|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836839|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
160836840|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
160836841|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
160836842|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
160836843|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836844|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836845|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836846|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836847|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836848|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836849|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836850|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836851|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836852|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836853|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836854|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
160836855|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
160836856|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
160836857|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
160836858|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
160836859|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836860|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836861|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836862|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836863|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836864|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836865|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
160836866|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
160836867|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
160562929|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160562930|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
160562931|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
160562932|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160562933|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160836868|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
160836869|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
160904194|NCT01673867|581044890|FG000|Treatment|Withdrawal by participant|5|||
160904195|NCT01673867|581044891|FG001|Treatment|Withdrawal by participant|5|||
160904196|NCT01673867|581044890|FG000|Treatment|Maximum clinical benefit|1|||
160904197|NCT01673867|581044891|FG001|Treatment|Maximum clinical benefit|10|||
160904198|NCT01673867|581044890|FG000|Treatment|Participant no longer meets study criteria|2|||
160904199|NCT01673867|581044891|FG001|Treatment|Participant no longer meets study criteria|0|||
160904200|NCT01673867|581044890|FG000|Treatment|Administrative reason by sponsor|3|||
160904201|NCT01673867|581044891|FG001|Treatment|Administrative reason by sponsor|0|||
160904202|NCT01673867|581044890|FG000|Treatment|Other reason|11|||
160904203|NCT01673867|581044891|FG001|Treatment|Other reason|2|||
160904204|NCT01709513|581044892|FG000|Overall Study|Randomized but not treated|0|||
160904205|NCT01709513|581044893|FG001|Overall Study|Randomized but not treated|1|||
160904206|NCT01709513|581044894|FG002|Overall Study|Randomized but not treated|0|||
160904207|NCT01709513|581044892|FG000|Overall Study|Adverse Event|16|||
160904208|NCT01709513|581044893|FG001|Overall Study|Adverse Event|31|||
160904209|NCT01709513|581044894|FG002|Overall Study|Adverse Event|23|||
160904210|NCT01709513|581044892|FG000|Overall Study|Poor compliance to protocol|2|||
160904211|NCT01709513|581044893|FG001|Overall Study|Poor compliance to protocol|0|||
160904212|NCT01709513|581044894|FG002|Overall Study|Poor compliance to protocol|0|||
160904213|NCT01709513|581044892|FG000|Overall Study|Other|3|||
160904214|NCT01709513|581044893|FG001|Overall Study|Other|11|||
160904215|NCT01709513|581044894|FG002|Overall Study|Other|7|||
160904216|NCT01193530|581044897|FG000|Overall Study|Withdrawal by Subject|2|||
160562934|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160562935|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160562936|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
160562937|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
160562938|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160562939|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
160562940|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
160562941|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160562942|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160562943|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160562944|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160562945|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
160562946|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
160562947|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
160562948|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
160562949|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
160562950|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
160562951|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
160562952|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
160562953|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
160562954|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
160562955|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
160562956|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160562957|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
160562958|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
160562959|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160562960|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160562961|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160562962|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160562963|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
160562964|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
160562965|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160562966|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
160562967|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
160562968|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160562969|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160562970|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160562971|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160562972|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
160562973|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
160562974|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160562975|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
160562976|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160562977|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160562978|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160562979|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160836870|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836871|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836872|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836873|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836874|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836875|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836876|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
160836877|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
160836878|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
160836879|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
160836880|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
160836881|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836882|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160562980|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160562981|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
160562982|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160562983|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160562984|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
160562985|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160562986|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160562987|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160562988|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160562989|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160836883|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160562990|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160562991|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160562992|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160562993|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
160562994|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160562995|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160562996|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160562997|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160562998|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160562999|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160563000|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
160563001|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160563002|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
160563003|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
160563004|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160563005|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160563006|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160563007|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160563008|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
160563009|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
160836884|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836885|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836886|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836887|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
160836888|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836889|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
160836890|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836891|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
160836892|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836893|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836894|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836895|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836896|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836897|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836898|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
160836899|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836900|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
160836901|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
160836902|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
160836903|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836904|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836905|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836906|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836907|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836908|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836909|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
160836910|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836911|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
160836912|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836913|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836914|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160904217|NCT01193530|581044898|FG001|Overall Study|Withdrawal by Subject|2|||
160904218|NCT01193530|581044897|FG000|Overall Study|Began Contraindicated Therapy|1|||
160904219|NCT01193530|581044898|FG001|Overall Study|Began Contraindicated Therapy|0|||
160563010|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160836915|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836916|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836917|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160904220|NCT01193530|581044897|FG000|Overall Study|Lost Light Box|0|||
160904221|NCT01193530|581044898|FG001|Overall Study|Lost Light Box|1|||
160904222|NCT01193530|581044897|FG000|Overall Study|Returned home - out of state|0|||
160904223|NCT01193530|581044898|FG001|Overall Study|Returned home - out of state|1|||
160563011|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160563012|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
160836918|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836919|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836920|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836921|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836922|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
160836923|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836924|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836925|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836926|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836927|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836928|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836929|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836930|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836931|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
160836932|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836933|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836934|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836935|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836936|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836937|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836938|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836939|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836940|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836941|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836942|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836943|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836944|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
160836945|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
160836946|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
160836947|NCT01300455|580788546|FG000|Washout|Withdrawal by Subject|1|||
160836948|NCT01300455|580788547|FG001|Washout|Withdrawal by Subject|0|||
160836949|NCT00565136|580788548|FG000|Overall Study|Lost to Follow-up|1|||
160836950|NCT00565136|580788548|FG000|Overall Study|Withdrawal by Subject|1|||
160836951|NCT00565136|580788548|FG000|Overall Study|Protocol Violation|1|||
160836952|NCT03332160|580788559|FG000|Overall Study|Withdrawal by Subject|1|||
160836953|NCT03332160|580788560|FG001|Overall Study|Withdrawal by Subject|1|||
160563013|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160563014|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160563015|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160563016|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160563017|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160563018|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160563019|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160563020|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160563021|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160563022|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160563023|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160563024|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160563025|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160563026|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
160836954|NCT03332160|580788559|FG000|Overall Study|Adverse Event|0|||
160836955|NCT03332160|580788560|FG001|Overall Study|Adverse Event|1|||
160836956|NCT03332160|580788559|FG000|Overall Study|Developed Exclusion Criteria|0|||
160836957|NCT03332160|580788560|FG001|Overall Study|Developed Exclusion Criteria|1|||
160836958|NCT03332160|580788559|FG000|Overall Study|Non-adherence to treatment|0|||
160836959|NCT03332160|580788560|FG001|Overall Study|Non-adherence to treatment|2|||
160836960|NCT01459913|580788564|FG000|Overall Study|Adverse Event|0|||
160836961|NCT01459913|580788565|FG001|Overall Study|Adverse Event|0|||
160836962|NCT01459913|580788566|FG002|Overall Study|Adverse Event|0|||
160836963|NCT01459913|580788567|FG003|Overall Study|Adverse Event|3|||
160836964|NCT01459913|580788564|FG000|Overall Study|Withdrawal by Subject|4|||
160836965|NCT01459913|580788565|FG001|Overall Study|Withdrawal by Subject|0|||
160836966|NCT01459913|580788566|FG002|Overall Study|Withdrawal by Subject|0|||
160836967|NCT01459913|580788567|FG003|Overall Study|Withdrawal by Subject|5|||
160836968|NCT01459913|580788564|FG000|Overall Study|Lost to Follow-up|7|||
160836969|NCT01459913|580788565|FG001|Overall Study|Lost to Follow-up|4|||
160563027|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160836970|NCT01459913|580788566|FG002|Overall Study|Lost to Follow-up|1|||
160563028|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160563029|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
160836971|NCT01459913|580788567|FG003|Overall Study|Lost to Follow-up|8|||
160836972|NCT01459913|580788564|FG000|Overall Study|Death|0|||
160836973|NCT01459913|580788565|FG001|Overall Study|Death|0|||
160836974|NCT01459913|580788566|FG002|Overall Study|Death|0|||
160836975|NCT01459913|580788567|FG003|Overall Study|Death|1|||
160836976|NCT01459913|580788564|FG000|Overall Study|Non- Compliance|0|||
160836977|NCT01459913|580788565|FG001|Overall Study|Non- Compliance|0|||
160836978|NCT01459913|580788566|FG002|Overall Study|Non- Compliance|0|||
160836979|NCT01459913|580788567|FG003|Overall Study|Non- Compliance|3|||
160836980|NCT01459913|580788564|FG000|Overall Study|Physician Decision|0|||
160836981|NCT01459913|580788565|FG001|Overall Study|Physician Decision|1|||
160836982|NCT01459913|580788566|FG002|Overall Study|Physician Decision|0|||
160836983|NCT01459913|580788567|FG003|Overall Study|Physician Decision|0|||
160836984|NCT01459913|580788564|FG000|Overall Study|Study Terminated by Sponsor|30|||
160836985|NCT01459913|580788565|FG001|Overall Study|Study Terminated by Sponsor|15|||
160836986|NCT01459913|580788566|FG002|Overall Study|Study Terminated by Sponsor|9|||
160836987|NCT01459913|580788567|FG003|Overall Study|Study Terminated by Sponsor|11|||
160836988|NCT01459913|580788564|FG000|Overall Study|Other|0|||
160836989|NCT01459913|580788565|FG001|Overall Study|Other|0|||
160836990|NCT01459913|580788566|FG002|Overall Study|Other|3|||
160836991|NCT01459913|580788567|FG003|Overall Study|Other|1|||
160836992|NCT01459913|580788564|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
160836993|NCT01459913|580788565|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
160836994|NCT01459913|580788566|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
160836995|NCT01459913|580788567|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
160836996|NCT00576576|580788570|FG000|Overall Study|Lost to Follow-up|6|||
160836997|NCT00576576|580788570|FG000|Overall Study|Protocol Violation|1|||
160836998|NCT05096312|580788571|FG000|Overall Study|Lost to Follow-up|2|||
160836999|NCT05096312|580788572|FG001|Overall Study|Lost to Follow-up|4|||
160837000|NCT05096312|580788571|FG000|Overall Study|Adverse Event|1|||
160837001|NCT05096312|580788572|FG001|Overall Study|Adverse Event|0|||
160837002|NCT03135210|580788573|FG000|Overall Study|Death|0|||
160563030|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
160563031|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160563032|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160563033|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160837003|NCT03135210|580788574|FG001|Overall Study|Death|1|||
160837004|NCT02666105|580788577|FG000|Overall Study|Death|1|||
160563034|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160563035|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160837005|NCT01264419|580788578|FG000|Overall Study|Lost to Follow-up|3|||
160837006|NCT01370265|580790147|FG000|First Intervention|Adverse Event|1|||
160837007|NCT01370265|580790148|FG001|First Intervention|Adverse Event|1|||
160837008|NCT00703924|580790149|FG000|Overall Study|Withdrawal by Subject|1|||
160837009|NCT00703924|580790150|FG001|Overall Study|Withdrawal by Subject|1|||
160837010|NCT01031979|580790151|FG000|Overall Study|Lost to Follow-up|5|||
160837011|NCT01031979|580790152|FG001|Overall Study|Lost to Follow-up|4|||
160837012|NCT03592368|580790154|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
160837013|NCT03592368|580790155|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
160837014|NCT03592368|580790156|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
160837015|NCT03592368|580790157|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
160837016|NCT03592368|580790154|FG000|Overall Study|Adverse Event|0|||
160837017|NCT03592368|580790155|FG001|Overall Study|Adverse Event|0|||
160837018|NCT03592368|580790156|FG002|Overall Study|Adverse Event|0|||
160837019|NCT03592368|580790157|FG003|Overall Study|Adverse Event|1|||
160837020|NCT03592368|580790154|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
160837021|NCT03592368|580790155|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
160563036|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
160563037|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160837022|NCT03592368|580790156|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
160837023|NCT03592368|580790157|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
160837024|NCT03831100|580790158|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
160837025|NCT03831100|580790159|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
160837026|NCT02454478|580790168|FG000|Overall Study|Incomplete DLT Evaluation|1|||
160837027|NCT01732770|580790175|FG000|Overall Study|Lost to Follow-up|2|||
160837028|NCT01732770|580790176|FG001|Overall Study|Lost to Follow-up|3|||
160837029|NCT01732770|580790175|FG000|Overall Study|Withdrawal by Subject|5|||
160837030|NCT01732770|580790176|FG001|Overall Study|Withdrawal by Subject|3|||
160837031|NCT01732770|580790175|FG000|Overall Study|Decision by Sponsor|2|||
160837032|NCT01732770|580790176|FG001|Overall Study|Decision by Sponsor|2|||
160837033|NCT01732770|580790175|FG000|Overall Study|Death|1|||
160837034|NCT01732770|580790176|FG001|Overall Study|Death|0|||
160837035|NCT01959841|580790179|FG000|Overall Study|Adverse Event|1|||
160563038|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
160563039|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
160563040|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160563041|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160563042|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160563043|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160991592|NCT04927975|581357846|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
160991593|NCT04927975|581357847|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
160991594|NCT04927975|581357848|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
160991595|NCT04927975|581357843|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
160991596|NCT04927975|581357844|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
160991597|NCT04927975|581357845|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
160991598|NCT04927975|581357846|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
160991599|NCT04927975|581357847|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
160991600|NCT04927975|581357848|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
160563044|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160563045|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160563046|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160563047|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
160563048|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
160563049|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160563050|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160563051|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160837036|NCT01959841|580790180|FG001|Overall Study|Adverse Event|3|||
160837037|NCT01959841|580790181|FG002|Overall Study|Adverse Event|2|||
160837038|NCT01959841|580790179|FG000|Overall Study|Lack of Efficacy|5|||
160837039|NCT01959841|580790180|FG001|Overall Study|Lack of Efficacy|0|||
160837040|NCT01959841|580790181|FG002|Overall Study|Lack of Efficacy|0|||
160837041|NCT01959841|580790179|FG000|Overall Study|Lost to Follow-up|1|||
160837042|NCT01959841|580790180|FG001|Overall Study|Lost to Follow-up|1|||
160837043|NCT01959841|580790181|FG002|Overall Study|Lost to Follow-up|0|||
160837044|NCT01959841|580790179|FG000|Overall Study|Physician Decision|0|||
160837045|NCT01959841|580790180|FG001|Overall Study|Physician Decision|2|||
160837046|NCT01959841|580790181|FG002|Overall Study|Physician Decision|3|||
160991601|NCT00768066|581357851|FG000|Overall Study|Did not receive study product injection.|3|||
160991602|NCT00768066|581357852|FG001|Overall Study|Did not receive study product injection.|3|||
160991603|NCT00768066|581357853|FG002|Overall Study|Did not receive study product injection.|0|||
160991604|NCT05550337|581357854|FG000|Overall Study|Lack of Efficacy|0|||
160991605|NCT05550337|581357855|FG001|Overall Study|Lack of Efficacy|0|||
160563052|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160563053|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160563054|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
160563055|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
160563056|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
160563057|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
160563058|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
160563059|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
160991606|NCT05550337|581357856|FG002|Overall Study|Lack of Efficacy|1|||
160991607|NCT05550337|581357854|FG000|Overall Study|Adverse Event|1|||
160563060|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
160563061|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
160563062|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
160563063|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
160563064|NCT01307423|579781689|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160563065|NCT01307423|579781690|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160563066|NCT01307423|579781691|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
160563067|NCT01307423|579781692|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160563068|NCT01307423|579781693|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160563069|NCT01307423|579781694|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160837047|NCT01959841|580790179|FG000|Overall Study|Protocol Violation|16|||
160563070|NCT01307423|579781695|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160563071|NCT01307423|579781696|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
160563072|NCT01307423|579781697|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
160563073|NCT03406962|579781698|FG000|Overall Study|Death|2|||
160837048|NCT01959841|580790180|FG001|Overall Study|Protocol Violation|23|||
160837049|NCT01959841|580790181|FG002|Overall Study|Protocol Violation|16|||
160837050|NCT01959841|580790179|FG000|Overall Study|Withdrawal by Subject|7|||
160837051|NCT01959841|580790180|FG001|Overall Study|Withdrawal by Subject|7|||
160837052|NCT01959841|580790181|FG002|Overall Study|Withdrawal by Subject|5|||
160837053|NCT01959841|580790179|FG000|Overall Study|Clinical laboratory value|2|||
160991608|NCT05550337|581357855|FG001|Overall Study|Adverse Event|5|||
160991609|NCT05550337|581357856|FG002|Overall Study|Adverse Event|0|||
160991610|NCT05550337|581357854|FG000|Overall Study|Withdrawal by Subject|8|||
160837054|NCT01959841|580790180|FG001|Overall Study|Clinical laboratory value|6|||
160837055|NCT01959841|580790181|FG002|Overall Study|Clinical laboratory value|6|||
160837056|NCT01959841|580790179|FG000|Overall Study|Platelet count below on day1 or 4|11|||
160837057|NCT01959841|580790180|FG001|Overall Study|Platelet count below on day1 or 4|15|||
160837058|NCT01959841|580790181|FG002|Overall Study|Platelet count below on day1 or 4|11|||
160837059|NCT01450098|580790183|FG000|Period 3|Protocol Violation|0|||
160837060|NCT01450098|580790184|FG001|Period 3|Protocol Violation|1|||
160837061|NCT01450098|580790183|FG000|Period 3|Withdrawal by Subject|0|||
160837062|NCT01450098|580790184|FG001|Period 3|Withdrawal by Subject|2|||
160837063|NCT04207749|580790194|FG000|Overall Study|Lost to Follow-up|0|||
160837064|NCT04207749|580790195|FG001|Overall Study|Lost to Follow-up|2|||
160837065|NCT04207749|580790194|FG000|Overall Study|Protocol Violation|0|||
160837066|NCT04207749|580790195|FG001|Overall Study|Protocol Violation|1|||
160837067|NCT04207749|580790194|FG000|Overall Study|Withdrawal by Subject|3|||
160837068|NCT04207749|580790195|FG001|Overall Study|Withdrawal by Subject|0|||
160837069|NCT04207749|580790194|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
160837070|NCT04207749|580790195|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
160837071|NCT00655629|580790196|FG000|Overall Study|Adverse Event|4|||
160837072|NCT00655629|580790197|FG001|Overall Study|Adverse Event|1|||
160837073|NCT00655629|580790196|FG000|Overall Study|Lack of Efficacy|2|||
160837074|NCT00655629|580790197|FG001|Overall Study|Lack of Efficacy|12|||
160837075|NCT00655629|580790196|FG000|Overall Study|Lost to Follow-up|4|||
160837076|NCT00655629|580790197|FG001|Overall Study|Lost to Follow-up|3|||
160837077|NCT00655629|580790196|FG000|Overall Study|Protocol Violation|5|||
160837078|NCT00655629|580790197|FG001|Overall Study|Protocol Violation|3|||
160837079|NCT00655629|580790196|FG000|Overall Study|consent withdrawn|6|||
160837080|NCT00655629|580790197|FG001|Overall Study|consent withdrawn|4|||
160837081|NCT01971008|580790198|FG000|Overall Study|Protocol Violation|2|||
160837082|NCT01971008|580790199|FG001|Overall Study|Protocol Violation|1|||
160837083|NCT03416127|580790200|FG000|Overall Study|Withdrawal by Subject|0|||
160837084|NCT03416127|580790201|FG001|Overall Study|Withdrawal by Subject|1|||
160837085|NCT03416127|580790202|FG002|Overall Study|Withdrawal by Subject|1|||
160837086|NCT00924508|580790203|FG000|Overall Study|Withdrawal by Subject|3|||
160837087|NCT00495625|580790204|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
160837088|NCT03679624|580790205|FG000|Overall Study|Adverse Event|1|||
160837089|NCT03679624|580790206|FG001|Overall Study|Adverse Event|0|||
160837090|NCT01912339|580790207|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
160837091|NCT01912339|580790208|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
160837092|NCT01912339|580790209|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
160837093|NCT01912339|580790207|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
160837094|NCT01912339|580790208|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
160837095|NCT01912339|580790209|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
160837096|NCT01912339|580790207|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
160837097|NCT01912339|580790208|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
160837098|NCT01912339|580790209|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
160837099|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
160837100|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
160837101|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
160837102|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
160837103|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
160837104|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
160837105|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
160837106|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
160837107|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
160837108|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
160837109|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
160837110|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
160837111|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
160837112|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
160837113|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
160837114|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
160837115|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
160837116|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
160837117|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
160837118|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
160904224|NCT01193530|581044897|FG000|Overall Study|Non-Compliance|0|||
160563074|NCT03406962|579781698|FG000|Overall Study|Adverse Event|1|||
160563075|NCT03853694|579781699|FG000|Overall Study|Protocol Violation|3|||
160563076|NCT03853694|579781700|FG001|Overall Study|Protocol Violation|5|||
160563077|NCT03853694|579781701|FG002|Overall Study|Protocol Violation|3|||
160563078|NCT03853694|579781699|FG000|Overall Study|Delivered early|0|||
160837119|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
160837120|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
160837121|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
160837122|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
160837123|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
160837124|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
160837125|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
160837126|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
160837127|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
160837128|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
160837129|NCT00741013|580790210|FG000|Overall Study|Adverse Event|1|||
160837130|NCT00741013|580790211|FG001|Overall Study|Adverse Event|0|||
160837131|NCT00741013|580790212|FG002|Overall Study|Adverse Event|0|||
160837132|NCT00741013|580790210|FG000|Overall Study|Withdrawal by Subject|0|||
160837133|NCT00741013|580790211|FG001|Overall Study|Withdrawal by Subject|0|||
160837134|NCT00741013|580790212|FG002|Overall Study|Withdrawal by Subject|1|||
160837135|NCT00741013|580790210|FG000|Overall Study|Discovered failed screen after enrolled|0|||
160837136|NCT00741013|580790211|FG001|Overall Study|Discovered failed screen after enrolled|2|||
160837137|NCT00741013|580790212|FG002|Overall Study|Discovered failed screen after enrolled|0|||
160837138|NCT01754493|580790214|FG000|Overall Study|Adverse Event|1|||
160837139|NCT01754493|580790214|FG000|Overall Study|Lost to Follow-up|3|||
160837140|NCT01754493|580790214|FG000|Overall Study|Withdrawal by Subject|1|||
160837141|NCT01754493|580790214|FG000|Overall Study|Moved out of town|1|||
160837142|NCT01754493|580790214|FG000|Overall Study|Scheduling conflict|1|||
160837143|NCT04512976|580790215|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
160837144|NCT04512976|580790216|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
160837145|NCT04512976|580790217|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
160837146|NCT04512976|580790218|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
160837147|NCT04512976|580790219|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
160837148|NCT04512976|580790220|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
160837149|NCT05249569|580790225|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
160837150|NCT01452919|580790227|FG000|Open-Label Treatment|Adverse Event|5|||
160837151|NCT01452919|580790228|FG001|Open-Label Treatment|Adverse Event|0|||
160837152|NCT01452919|580790229|FG002|Open-Label Treatment|Adverse Event|0|||
160837153|NCT01452919|580790227|FG000|Open-Label Treatment|Lost to Follow-up|4|||
160837154|NCT01452919|580790228|FG001|Open-Label Treatment|Lost to Follow-up|0|||
160837155|NCT01452919|580790229|FG002|Open-Label Treatment|Lost to Follow-up|0|||
160837156|NCT01452919|580790227|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
160837157|NCT01452919|580790228|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
160837158|NCT01452919|580790229|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
160837159|NCT01452919|580790227|FG000|Open-Label Treatment|Protocol Violation|4|||
160837160|NCT01452919|580790228|FG001|Open-Label Treatment|Protocol Violation|0|||
160837161|NCT01452919|580790229|FG002|Open-Label Treatment|Protocol Violation|0|||
160837162|NCT01452919|580790227|FG000|Open-Label Treatment|Sponsor Decision|1|||
160837163|NCT01452919|580790228|FG001|Open-Label Treatment|Sponsor Decision|0|||
160837164|NCT01452919|580790229|FG002|Open-Label Treatment|Sponsor Decision|0|||
160563079|NCT03853694|579781700|FG001|Overall Study|Delivered early|1|||
160563080|NCT03853694|579781701|FG002|Overall Study|Delivered early|0|||
160563081|NCT03853694|579781699|FG000|Overall Study|not suitable to proceed|0|||
160563082|NCT03853694|579781700|FG001|Overall Study|not suitable to proceed|1|||
160563083|NCT03853694|579781701|FG002|Overall Study|not suitable to proceed|0|||
160563084|NCT03853694|579781699|FG000|Overall Study|difficult surgery|0|||
160563085|NCT03853694|579781700|FG001|Overall Study|difficult surgery|0|||
160837165|NCT01452919|580790227|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
160837166|NCT01452919|580790228|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
160837167|NCT01452919|580790229|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
160837168|NCT01452919|580790227|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
160837169|NCT01452919|580790228|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
160563086|NCT03853694|579781701|FG002|Overall Study|difficult surgery|1|||
160563087|NCT03853694|579781699|FG000|Overall Study|Lost to Follow-up|0|||
160837170|NCT01452919|580790229|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
160837171|NCT01452919|580790227|FG000|Randomization Treatment|Adverse Event|0|||
160837172|NCT01452919|580790228|FG001|Randomization Treatment|Adverse Event|0|||
160837173|NCT01452919|580790229|FG002|Randomization Treatment|Adverse Event|2|||
160837174|NCT01452919|580790227|FG000|Randomization Treatment|Sponsor Decision|0|||
160563088|NCT03853694|579781700|FG001|Overall Study|Lost to Follow-up|1|||
160837175|NCT01452919|580790228|FG001|Randomization Treatment|Sponsor Decision|1|||
160837176|NCT01452919|580790229|FG002|Randomization Treatment|Sponsor Decision|0|||
160837177|NCT01452919|580790227|FG000|Randomization Treatment|Withdrawal by Subject|0|||
160837178|NCT01452919|580790228|FG001|Randomization Treatment|Withdrawal by Subject|1|||
160837179|NCT01452919|580790229|FG002|Randomization Treatment|Withdrawal by Subject|0|||
160837180|NCT01452919|580790227|FG000|Randomization Treatment|Subject is moving or has moved|0|||
160837181|NCT01452919|580790228|FG001|Randomization Treatment|Subject is moving or has moved|1|||
160837182|NCT01452919|580790229|FG002|Randomization Treatment|Subject is moving or has moved|0|||
160837183|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
160837184|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
160837185|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
160837186|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
160837187|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
160837188|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
160837189|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Death|1|||
160837190|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Death|4|||
160837191|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
160837192|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
160837193|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Not eligible|1|||
160837194|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Not eligible|2|||
160837195|NCT00658814|580790230|FG000|Consolidation Therapy|Not protocol specified|0|||
160837196|NCT00658814|580790231|FG001|Consolidation Therapy|Not protocol specified|1|||
160837197|NCT00658814|580790230|FG000|Consolidation Therapy|Not eligible|2|||
160837198|NCT00658814|580790231|FG001|Consolidation Therapy|Not eligible|2|||
160837199|NCT00658814|580790230|FG000|Maintenance Therapy|Adverse Event|1|||
160837200|NCT00658814|580790231|FG001|Maintenance Therapy|Adverse Event|1|||
160837201|NCT00658814|580790230|FG000|Maintenance Therapy|Not protocol specified|1|||
160837202|NCT00658814|580790231|FG001|Maintenance Therapy|Not protocol specified|0|||
160837203|NCT00658814|580790230|FG000|Maintenance Therapy|Not eligible|1|||
160837204|NCT00658814|580790231|FG001|Maintenance Therapy|Not eligible|0|||
160837205|NCT00455143|580790237|FG000|Overall Study|Physician Decision|1|||
160837206|NCT00455143|580790237|FG000|Overall Study|Withdrawal by Subject|1|||
160837207|NCT00455143|580790237|FG000|Overall Study|Staff was not avail to follow patient|2|||
160837208|NCT00455143|580790237|FG000|Overall Study|No longer met Inclusion Criteria|1|||
160837209|NCT00455143|580790237|FG000|Overall Study|Surgical time, staff not available|1|||
160837210|NCT05222555|580790240|FG000|Overall Study|Ongoing|2|||
160837211|NCT05222555|580790241|FG001|Overall Study|Ongoing|18|||
160837212|NCT05222555|580790240|FG000|Overall Study|Adverse Event|1|||
160837213|NCT05222555|580790241|FG001|Overall Study|Adverse Event|1|||
160837214|NCT05222555|580790240|FG000|Overall Study|Death|0|||
160837215|NCT05222555|580790241|FG001|Overall Study|Death|6|||
160837216|NCT05222555|580790240|FG000|Overall Study|Withdrawal by Subject|0|||
160837217|NCT05222555|580790241|FG001|Overall Study|Withdrawal by Subject|11|||
160837218|NCT04856904|580790244|FG000|Overall Study|Physician Decision|1|||
160837219|NCT04856904|580790245|FG001|Overall Study|Physician Decision|1|||
160837220|NCT04856904|580790244|FG000|Overall Study|Withdrawal by Subject|13|||
160837221|NCT04856904|580790245|FG001|Overall Study|Withdrawal by Subject|13|||
160837222|NCT04856904|580790244|FG000|Overall Study|Adverse Event|1|||
160837223|NCT04856904|580790245|FG001|Overall Study|Adverse Event|1|||
160837224|NCT04856904|580790244|FG000|Overall Study|Non-compliance with study drug|1|||
160837225|NCT04856904|580790245|FG001|Overall Study|Non-compliance with study drug|1|||
160837226|NCT04856904|580790244|FG000|Overall Study|Lost to Follow-up|4|||
160837227|NCT04856904|580790245|FG001|Overall Study|Lost to Follow-up|4|||
160837228|NCT04856904|580790244|FG000|Overall Study|Withdrawal by Subject|1|||
160837229|NCT04856904|580790245|FG001|Overall Study|Withdrawal by Subject|1|||
160837230|NCT04856904|580790244|FG000|Overall Study|Protocol Violation|1|||
160837231|NCT04856904|580790245|FG001|Overall Study|Protocol Violation|1|||
160837232|NCT00847015|580790246|FG000|Overall Study|Withdrawal by Subject|1|||
160837233|NCT00847015|580790246|FG000|Overall Study|declined any surgery|1|||
160837234|NCT00847015|580790246|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
160837235|NCT01641822|580790247|FG000|Run-in Phase|Noncompliance with study drug|1|||
160837236|NCT01641822|580790248|FG001|Run-in Phase|Noncompliance with study drug|0|||
160837237|NCT01641822|580790249|FG002|Run-in Phase|Noncompliance with study drug|0|||
160837238|NCT01641822|580790247|FG000|Run-in Phase|Adverse Event|3|||
160837239|NCT01641822|580790248|FG001|Run-in Phase|Adverse Event|0|||
160837240|NCT01641822|580790249|FG002|Run-in Phase|Adverse Event|0|||
160837241|NCT01641822|580790247|FG000|Run-in Phase|Withdrew consent|1|||
160837242|NCT01641822|580790248|FG001|Run-in Phase|Withdrew consent|0|||
160837243|NCT01641822|580790249|FG002|Run-in Phase|Withdrew consent|0|||
160837244|NCT01641822|580790247|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
160837245|NCT01641822|580790248|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
160837246|NCT01641822|580790249|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
160837247|NCT01641822|580790247|FG000|Comparative Phase|Noncompliance with study drug|0|||
160837248|NCT01641822|580790248|FG001|Comparative Phase|Noncompliance with study drug|1|||
160837249|NCT01641822|580790249|FG002|Comparative Phase|Noncompliance with study drug|0|||
160837250|NCT01641822|580790247|FG000|Comparative Phase|Investigator's discretion|0|||
160837251|NCT01641822|580790248|FG001|Comparative Phase|Investigator's discretion|0|||
160837252|NCT01641822|580790249|FG002|Comparative Phase|Investigator's discretion|1|||
160837253|NCT01641822|580790247|FG000|Comparative Phase|Pregnancy|0|||
160837254|NCT01641822|580790248|FG001|Comparative Phase|Pregnancy|0|||
160837255|NCT01641822|580790249|FG002|Comparative Phase|Pregnancy|1|||
160837256|NCT01641822|580790247|FG000|Comparative Phase|Adverse event, serious fatal|0|||
160837257|NCT01641822|580790248|FG001|Comparative Phase|Adverse event, serious fatal|1|||
160837258|NCT01641822|580790249|FG002|Comparative Phase|Adverse event, serious fatal|0|||
160837259|NCT01641822|580790247|FG000|Comparative Phase|Withdrew consent|0|||
160837260|NCT01641822|580790248|FG001|Comparative Phase|Withdrew consent|3|||
160837261|NCT01641822|580790249|FG002|Comparative Phase|Withdrew consent|7|||
160837262|NCT01641822|580790247|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
160837263|NCT01641822|580790248|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
160837264|NCT01641822|580790249|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
160837265|NCT00454584|580790250|FG000|Controlled Period|Adverse Event|5|||
160837266|NCT00454584|580790251|FG001|Controlled Period|Adverse Event|2|||
160837267|NCT00454584|580790252|FG002|Controlled Period|Adverse Event|1|||
160837268|NCT00454584|580790253|FG003|Controlled Period|Adverse Event|0|||
160837269|NCT00454584|580790254|FG004|Controlled Period|Adverse Event|0|||
160837270|NCT00454584|580790255|FG005|Controlled Period|Adverse Event|0|||
160837271|NCT00454584|580790250|FG000|Controlled Period|Lost to Follow-up|1|||
160563089|NCT03853694|579781701|FG002|Overall Study|Lost to Follow-up|0|||
160837272|NCT00454584|580790251|FG001|Controlled Period|Lost to Follow-up|2|||
160837273|NCT00454584|580790252|FG002|Controlled Period|Lost to Follow-up|2|||
160837274|NCT00454584|580790253|FG003|Controlled Period|Lost to Follow-up|0|||
160837275|NCT00454584|580790254|FG004|Controlled Period|Lost to Follow-up|0|||
160837276|NCT00454584|580790255|FG005|Controlled Period|Lost to Follow-up|0|||
160837277|NCT00454584|580790250|FG000|Controlled Period|Other|5|||
160837278|NCT00454584|580790251|FG001|Controlled Period|Other|4|||
160837279|NCT00454584|580790252|FG002|Controlled Period|Other|2|||
160837280|NCT00454584|580790253|FG003|Controlled Period|Other|0|||
160837281|NCT00454584|580790254|FG004|Controlled Period|Other|0|||
160837282|NCT00454584|580790255|FG005|Controlled Period|Other|0|||
160837283|NCT00454584|580790250|FG000|After Controlled Period|Adverse Event|0|||
160837284|NCT00454584|580790251|FG001|After Controlled Period|Adverse Event|0|||
160837285|NCT00454584|580790252|FG002|After Controlled Period|Adverse Event|0|||
160837286|NCT00454584|580790253|FG003|After Controlled Period|Adverse Event|9|||
160563090|NCT03853694|579781699|FG000|Overall Study|Withdrawal by Subject|0|||
160837287|NCT00454584|580790254|FG004|After Controlled Period|Adverse Event|3|||
160837288|NCT00454584|580790255|FG005|After Controlled Period|Adverse Event|9|||
160837289|NCT00454584|580790250|FG000|After Controlled Period|Lack of Efficacy|0|||
160837290|NCT00454584|580790251|FG001|After Controlled Period|Lack of Efficacy|0|||
160837291|NCT00454584|580790252|FG002|After Controlled Period|Lack of Efficacy|0|||
160837292|NCT00454584|580790253|FG003|After Controlled Period|Lack of Efficacy|1|||
160837293|NCT00454584|580790254|FG004|After Controlled Period|Lack of Efficacy|0|||
160837294|NCT00454584|580790255|FG005|After Controlled Period|Lack of Efficacy|0|||
160837295|NCT00454584|580790250|FG000|After Controlled Period|Lost to Follow-up|0|||
160837296|NCT00454584|580790251|FG001|After Controlled Period|Lost to Follow-up|0|||
160837297|NCT00454584|580790252|FG002|After Controlled Period|Lost to Follow-up|0|||
160837298|NCT00454584|580790253|FG003|After Controlled Period|Lost to Follow-up|2|||
160837299|NCT00454584|580790254|FG004|After Controlled Period|Lost to Follow-up|4|||
160837300|NCT00454584|580790255|FG005|After Controlled Period|Lost to Follow-up|6|||
160837301|NCT00454584|580790250|FG000|After Controlled Period|Other|0|||
160837302|NCT00454584|580790251|FG001|After Controlled Period|Other|0|||
160837303|NCT00454584|580790252|FG002|After Controlled Period|Other|0|||
160837304|NCT00454584|580790253|FG003|After Controlled Period|Other|1|||
160837305|NCT00454584|580790254|FG004|After Controlled Period|Other|0|||
160837306|NCT00454584|580790255|FG005|After Controlled Period|Other|0|||
160837307|NCT00454584|580790250|FG000|After Controlled Period|Other|0|||
160837308|NCT00454584|580790251|FG001|After Controlled Period|Other|0|||
160837309|NCT00454584|580790252|FG002|After Controlled Period|Other|0|||
160837310|NCT00454584|580790253|FG003|After Controlled Period|Other|13|||
160837311|NCT00454584|580790254|FG004|After Controlled Period|Other|5|||
160837312|NCT00454584|580790255|FG005|After Controlled Period|Other|17|||
160837313|NCT02421601|580790256|FG000|Overall Study|Adverse Event|4|||
160837314|NCT02421601|580790256|FG000|Overall Study|Lack of Efficacy|5|||
160837315|NCT02421601|580790256|FG000|Overall Study|Physician Decision|1|||
160837316|NCT02421601|580790256|FG000|Overall Study|Withdrawal by Subject|31|||
160837317|NCT02421601|580790256|FG000|Overall Study|Others|41|||
160837318|NCT02250664|580790257|FG000|Overall Study|Lost to Follow-up|18|||
160837319|NCT02250664|580790258|FG001|Overall Study|Lost to Follow-up|28|||
160837320|NCT02250664|580790259|FG002|Overall Study|Lost to Follow-up|33|||
160837321|NCT02250664|580790257|FG000|Overall Study|Personal Reasons|7|||
160837322|NCT02250664|580790258|FG001|Overall Study|Personal Reasons|8|||
160837323|NCT02250664|580790259|FG002|Overall Study|Personal Reasons|14|||
160837324|NCT02250664|580790257|FG000|Overall Study|Adverse Event|6|||
160837325|NCT02250664|580790258|FG001|Overall Study|Adverse Event|3|||
160837326|NCT02250664|580790259|FG002|Overall Study|Adverse Event|8|||
160837327|NCT02250664|580790257|FG000|Overall Study|Incarcerated|2|||
160837328|NCT02250664|580790258|FG001|Overall Study|Incarcerated|1|||
160837329|NCT02250664|580790259|FG002|Overall Study|Incarcerated|2|||
160837330|NCT02250664|580790257|FG000|Overall Study|Withdrawal by Subject|0|||
160837331|NCT02250664|580790258|FG001|Overall Study|Withdrawal by Subject|1|||
160837332|NCT02250664|580790259|FG002|Overall Study|Withdrawal by Subject|2|||
160837333|NCT02250664|580790257|FG000|Overall Study|Death|0|||
160837334|NCT02250664|580790258|FG001|Overall Study|Death|1|||
160837335|NCT02250664|580790259|FG002|Overall Study|Death|1|||
160837336|NCT02250664|580790257|FG000|Overall Study|Physician Decision|1|||
160837337|NCT02250664|580790258|FG001|Overall Study|Physician Decision|3|||
160837338|NCT02250664|580790259|FG002|Overall Study|Physician Decision|1|||
160837339|NCT02250664|580790257|FG000|Overall Study|Protocol Violation|1|||
160837340|NCT02250664|580790258|FG001|Overall Study|Protocol Violation|0|||
160837341|NCT02250664|580790259|FG002|Overall Study|Protocol Violation|1|||
160837342|NCT02250664|580790257|FG000|Overall Study|Reason unknown|1|||
160837343|NCT02250664|580790258|FG001|Overall Study|Reason unknown|0|||
160837344|NCT02250664|580790259|FG002|Overall Study|Reason unknown|0|||
160837345|NCT00778895|580790266|FG000|Active Phase|Adverse Event|3|||
160837346|NCT00778895|580790267|FG001|Active Phase|Adverse Event|1|||
160837347|NCT00778895|580790268|FG002|Active Phase|Adverse Event|0|||
160837348|NCT00778895|580790266|FG000|Active Phase|Withdrawal by Subject|1|||
160837349|NCT00778895|580790267|FG001|Active Phase|Withdrawal by Subject|4|||
160837350|NCT00778895|580790268|FG002|Active Phase|Withdrawal by Subject|0|||
160837351|NCT00778895|580790266|FG000|Active Phase|Lost to Follow-up|1|||
160837352|NCT00778895|580790267|FG001|Active Phase|Lost to Follow-up|1|||
160837353|NCT00778895|580790268|FG002|Active Phase|Lost to Follow-up|0|||
160837354|NCT00778895|580790266|FG000|Active Phase|Other|2|||
160837355|NCT00778895|580790267|FG001|Active Phase|Other|0|||
160837356|NCT00778895|580790268|FG002|Active Phase|Other|0|||
160837357|NCT00778895|580790266|FG000|ESFU Phase|Adverse Event|2|||
160837358|NCT00778895|580790267|FG001|ESFU Phase|Adverse Event|1|||
160837359|NCT00778895|580790268|FG002|ESFU Phase|Adverse Event|0|||
160837360|NCT00778895|580790266|FG000|ESFU Phase|Withdrawal by Subject|1|||
160837361|NCT00778895|580790267|FG001|ESFU Phase|Withdrawal by Subject|4|||
160837362|NCT00778895|580790268|FG002|ESFU Phase|Withdrawal by Subject|0|||
160837363|NCT00778895|580790266|FG000|ESFU Phase|Lost to Follow-up|6|||
160837364|NCT00778895|580790267|FG001|ESFU Phase|Lost to Follow-up|7|||
160837365|NCT00778895|580790268|FG002|ESFU Phase|Lost to Follow-up|2|||
160837366|NCT00778895|580790266|FG000|ESFU Phase|Other|2|||
160837367|NCT00778895|580790267|FG001|ESFU Phase|Other|0|||
160837368|NCT00778895|580790268|FG002|ESFU Phase|Other|0|||
160837369|NCT03517566|580790271|FG000|Overall Study|Adverse Event|5|||
160837370|NCT03517566|580790272|FG001|Overall Study|Adverse Event|2|||
160837371|NCT03517566|580790273|FG002|Overall Study|Adverse Event|2|||
160837372|NCT03517566|580790274|FG003|Overall Study|Adverse Event|8|||
160837373|NCT03517566|580790275|FG004|Overall Study|Adverse Event|7|||
160837374|NCT03517566|580790271|FG000|Overall Study|Lack of Efficacy|3|||
160837375|NCT03517566|580790272|FG001|Overall Study|Lack of Efficacy|2|||
160837376|NCT03517566|580790273|FG002|Overall Study|Lack of Efficacy|1|||
160837377|NCT03517566|580790274|FG003|Overall Study|Lack of Efficacy|1|||
160837378|NCT03517566|580790275|FG004|Overall Study|Lack of Efficacy|4|||
160837379|NCT03517566|580790271|FG000|Overall Study|Lost to Follow-up|3|||
160837380|NCT03517566|580790272|FG001|Overall Study|Lost to Follow-up|1|||
160837381|NCT03517566|580790273|FG002|Overall Study|Lost to Follow-up|1|||
160837382|NCT03517566|580790274|FG003|Overall Study|Lost to Follow-up|1|||
160837383|NCT03517566|580790275|FG004|Overall Study|Lost to Follow-up|0|||
160837384|NCT03517566|580790271|FG000|Overall Study|Physician Decision|1|||
160837385|NCT03517566|580790272|FG001|Overall Study|Physician Decision|1|||
160837386|NCT03517566|580790273|FG002|Overall Study|Physician Decision|0|||
160837387|NCT03517566|580790274|FG003|Overall Study|Physician Decision|1|||
160837388|NCT03517566|580790275|FG004|Overall Study|Physician Decision|0|||
160837389|NCT03517566|580790271|FG000|Overall Study|Pregnancy|0|||
160837390|NCT03517566|580790272|FG001|Overall Study|Pregnancy|1|||
160837391|NCT03517566|580790273|FG002|Overall Study|Pregnancy|0|||
160837392|NCT03517566|580790274|FG003|Overall Study|Pregnancy|0|||
160837393|NCT03517566|580790275|FG004|Overall Study|Pregnancy|0|||
160837394|NCT03517566|580790271|FG000|Overall Study|Protocol Deviation|0|||
160837395|NCT03517566|580790272|FG001|Overall Study|Protocol Deviation|1|||
160837396|NCT03517566|580790273|FG002|Overall Study|Protocol Deviation|0|||
160837397|NCT03517566|580790274|FG003|Overall Study|Protocol Deviation|1|||
160837398|NCT03517566|580790275|FG004|Overall Study|Protocol Deviation|1|||
160904225|NCT01193530|581044898|FG001|Overall Study|Non-Compliance|1|||
160904226|NCT04218695|581044899|FG000|Overall Study|Adverse Event|1|||
160904227|NCT04218695|581044900|FG001|Overall Study|Adverse Event|0|||
160904228|NCT03166735|581044901|FG000|Overall Study|Not Treated|1|||
160904229|NCT03166735|581044902|FG001|Overall Study|Not Treated|0|||
160904230|NCT03166735|581044903|FG002|Overall Study|Not Treated|0|||
160904231|NCT03166735|581044904|FG003|Overall Study|Not Treated|0|||
160904232|NCT03166735|581044905|FG004|Overall Study|Not Treated|0|||
160904233|NCT03166735|581044901|FG000|Overall Study|follow-up not completed as planned|0|||
160904234|NCT03166735|581044902|FG001|Overall Study|follow-up not completed as planned|1|||
160904235|NCT03166735|581044903|FG002|Overall Study|follow-up not completed as planned|1|||
160904236|NCT03166735|581044904|FG003|Overall Study|follow-up not completed as planned|0|||
160904237|NCT03166735|581044905|FG004|Overall Study|follow-up not completed as planned|1|||
160991611|NCT05550337|581357855|FG001|Overall Study|Withdrawal by Subject|14|||
160991612|NCT05550337|581357856|FG002|Overall Study|Withdrawal by Subject|10|||
160991613|NCT05550337|581357854|FG000|Overall Study|Pregnancy|0|||
160991614|NCT05550337|581357855|FG001|Overall Study|Pregnancy|0|||
160991615|NCT05550337|581357856|FG002|Overall Study|Pregnancy|1|||
160991616|NCT05550337|581357854|FG000|Overall Study|Protocol Violation|1|||
160991617|NCT05550337|581357855|FG001|Overall Study|Protocol Violation|3|||
160991618|NCT05550337|581357856|FG002|Overall Study|Protocol Violation|4|||
160991619|NCT05550337|581357854|FG000|Overall Study|Physician Decision|2|||
160991620|NCT05550337|581357855|FG001|Overall Study|Physician Decision|1|||
160991621|NCT05550337|581357856|FG002|Overall Study|Physician Decision|1|||
160991622|NCT05550337|581357854|FG000|Overall Study|Lost to Follow-up|16|||
160991623|NCT05550337|581357855|FG001|Overall Study|Lost to Follow-up|11|||
160991624|NCT05550337|581357856|FG002|Overall Study|Lost to Follow-up|11|||
160991625|NCT02189863|581357857|FG000|First 2 Weeks|Motion Sickness|4|||
160991626|NCT02189863|581357858|FG001|First 2 Weeks|Motion Sickness|2|||
160991627|NCT02926937|581357865|FG000|Overall Study|Adverse Event|0|||
160991628|NCT02926937|581357866|FG001|Overall Study|Adverse Event|1|||
160991629|NCT02926937|581357867|FG002|Overall Study|Adverse Event|1|||
160991630|NCT02926937|581357865|FG000|Overall Study|Poor Compliance to Protocol|1|||
160991631|NCT02926937|581357866|FG001|Overall Study|Poor Compliance to Protocol|0|||
160991632|NCT02926937|581357867|FG002|Overall Study|Poor Compliance to Protocol|0|||
160991633|NCT02926937|581357865|FG000|Overall Study|Lost to Follow-up|4|||
160991634|NCT02926937|581357866|FG001|Overall Study|Lost to Follow-up|5|||
160991635|NCT02926937|581357867|FG002|Overall Study|Lost to Follow-up|0|||
160991636|NCT02926937|581357865|FG000|Overall Study|At the Participant's own Request|11|||
160991637|NCT02926937|581357866|FG001|Overall Study|At the Participant's own Request|5|||
160991638|NCT02926937|581357867|FG002|Overall Study|At the Participant's own Request|8|||
160991639|NCT02926937|581357865|FG000|Overall Study|Reason not Specified|3|||
160991640|NCT02926937|581357866|FG001|Overall Study|Reason not Specified|4|||
160991641|NCT02926937|581357867|FG002|Overall Study|Reason not Specified|2|||
160991642|NCT01559090|581357868|FG000|Stage I|Withdrawal by Subject|2|||
160991643|NCT01559090|581357869|FG001|Stage I|Withdrawal by Subject|2|||
160991644|NCT01559090|581357870|FG002|Stage I|Withdrawal by Subject|3|||
160991645|NCT01559090|581357868|FG000|Stage II|Withdrawal by Subject|1|||
160991646|NCT01559090|581357869|FG001|Stage II|Withdrawal by Subject|0|||
160991647|NCT01559090|581357870|FG002|Stage II|Withdrawal by Subject|0|||
160991648|NCT03499600|581357874|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
160991649|NCT03499600|581357875|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
160991650|NCT00561574|581357876|FG000|Overall Study|Adverse Event|21|||
160991651|NCT00561574|581357877|FG001|Overall Study|Adverse Event|24|||
160991652|NCT00561574|581357876|FG000|Overall Study|Lack of Efficacy|11|||
160991653|NCT00561574|581357877|FG001|Overall Study|Lack of Efficacy|21|||
160991654|NCT00561574|581357876|FG000|Overall Study|Withdrawal by Subject|4|||
160904238|NCT03166735|581044901|FG000|Overall Study|Withdrawal by Subject|0|||
160904239|NCT03166735|581044902|FG001|Overall Study|Withdrawal by Subject|0|||
160904240|NCT03166735|581044903|FG002|Overall Study|Withdrawal by Subject|1|||
160904241|NCT03166735|581044904|FG003|Overall Study|Withdrawal by Subject|1|||
160904242|NCT03166735|581044905|FG004|Overall Study|Withdrawal by Subject|2|||
160904243|NCT03166735|581044901|FG000|Overall Study|Lost to Follow-up|0|||
160904244|NCT03166735|581044902|FG001|Overall Study|Lost to Follow-up|2|||
160991655|NCT00561574|581357877|FG001|Overall Study|Withdrawal by Subject|4|||
160991656|NCT00561574|581357876|FG000|Overall Study|Reason Unrelated to Trial|6|||
160991657|NCT00561574|581357877|FG001|Overall Study|Reason Unrelated to Trial|2|||
160991658|NCT00561574|581357876|FG000|Overall Study|Lost to Follow-up|1|||
160991659|NCT00561574|581357877|FG001|Overall Study|Lost to Follow-up|0|||
160991660|NCT00561574|581357876|FG000|Overall Study|Other|5|||
160991661|NCT00561574|581357877|FG001|Overall Study|Other|7|||
160991662|NCT00445692|581357878|FG000|Overall Study|Adverse Event|11|||
160991663|NCT00445692|581357878|FG000|Overall Study|Lack of Efficacy|5|||
160991664|NCT01729871|581357879|FG000|Overall Study|Adverse Event|7|||
160991665|NCT01729871|581357880|FG001|Overall Study|Adverse Event|7|||
160837399|NCT03517566|580790271|FG000|Overall Study|Study terminated by Sponsor|11|||
160837400|NCT03517566|580790272|FG001|Overall Study|Study terminated by Sponsor|5|||
160837401|NCT03517566|580790273|FG002|Overall Study|Study terminated by Sponsor|6|||
160837402|NCT03517566|580790274|FG003|Overall Study|Study terminated by Sponsor|14|||
160837403|NCT03517566|580790275|FG004|Overall Study|Study terminated by Sponsor|12|||
160837404|NCT03517566|580790271|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
160837405|NCT03517566|580790272|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
160837406|NCT03517566|580790273|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
160837407|NCT03517566|580790274|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
160837408|NCT03517566|580790275|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
160837409|NCT00671437|580790276|FG000|Overall Study|Progressive disease before C1 week 8|8|||
160837410|NCT00671437|580790276|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
160837411|NCT00671437|580790276|FG000|Overall Study|Adverse Event|3|||
160837412|NCT00671437|580790276|FG000|Overall Study|Ineligible post-hoc|1|||
160837413|NCT04349033|580790281|FG000|Overall Study|Lost to Follow-up|3|||
160837414|NCT04349033|580790282|FG001|Overall Study|Lost to Follow-up|1|||
160837415|NCT04349033|580790283|FG002|Overall Study|Lost to Follow-up|1|||
160837416|NCT01704456|580790287|FG000|Overall Study|Lost to Follow-up|8|||
160837417|NCT01704456|580790288|FG001|Overall Study|Lost to Follow-up|14|||
160837418|NCT00718770|580790289|FG000|Overall Study|Adverse Event|1|||
160837419|NCT00718770|580790289|FG000|Overall Study|Lack of Efficacy|1|||
160837420|NCT00718770|580790289|FG000|Overall Study|Lack of Efficacy|1|||
160837421|NCT00718770|580790289|FG000|Overall Study|Adverse Event|1|||
160837422|NCT00718770|580790289|FG000|Overall Study|Lack of Efficacy|1|||
160837423|NCT00718770|580790289|FG000|Overall Study|Adverse Event|1|||
160837424|NCT00718770|580790289|FG000|Overall Study|Lack of Efficacy|1|||
160837425|NCT00718770|580790289|FG000|Overall Study|Adverse Event|1|||
160837426|NCT04583956|580790290|FG000|Overall Study|Death|9|||
160837427|NCT04583956|580790291|FG001|Overall Study|Death|11|||
160837428|NCT04583956|580790290|FG000|Overall Study|Lost to Follow-up|7|||
160837429|NCT04583956|580790291|FG001|Overall Study|Lost to Follow-up|9|||
160837430|NCT04583956|580790290|FG000|Overall Study|Protocol Violation|2|||
160837431|NCT04583956|580790291|FG001|Overall Study|Protocol Violation|0|||
160837432|NCT04583956|580790290|FG000|Overall Study|Withdrawal by Subject|0|||
160837433|NCT04583956|580790291|FG001|Overall Study|Withdrawal by Subject|2|||
160837434|NCT04583956|580790290|FG000|Overall Study|Randomized but not dosed|2|||
160837435|NCT04583956|580790291|FG001|Overall Study|Randomized but not dosed|3|||
160837436|NCT04583956|580790290|FG000|Overall Study|Withdrawal of consent before product administration|1|||
160837437|NCT04583956|580790291|FG001|Overall Study|Withdrawal of consent before product administration|0|||
160837438|NCT00915551|580790297|FG000|Overall Study|Withdrawal by Subject|0|||
160837439|NCT00915551|580790298|FG001|Overall Study|Withdrawal by Subject|1|||
160837440|NCT02540291|580790299|FG000|Overall Study|Death|7|||
160837441|NCT02540291|580790300|FG001|Overall Study|Death|7|||
160837442|NCT02540291|580790301|FG002|Overall Study|Death|5|||
160837443|NCT02540291|580790302|FG003|Overall Study|Death|7|||
160837444|NCT02540291|580790299|FG000|Overall Study|Lost to Follow-up|0|||
160837445|NCT02540291|580790300|FG001|Overall Study|Lost to Follow-up|0|||
160837446|NCT02540291|580790301|FG002|Overall Study|Lost to Follow-up|1|||
160837447|NCT02540291|580790302|FG003|Overall Study|Lost to Follow-up|0|||
160837448|NCT02540291|580790299|FG000|Overall Study|Withdrawal Of Consent|0|||
160837449|NCT02540291|580790300|FG001|Overall Study|Withdrawal Of Consent|1|||
160837450|NCT02540291|580790301|FG002|Overall Study|Withdrawal Of Consent|0|||
160904245|NCT03166735|581044903|FG002|Overall Study|Lost to Follow-up|1|||
160904246|NCT03166735|581044904|FG003|Overall Study|Lost to Follow-up|0|||
160904247|NCT03166735|581044905|FG004|Overall Study|Lost to Follow-up|1|||
160904248|NCT01543958|581044906|FG000|Overall Study|Loss to follow-up|3|||
160904249|NCT01543958|581044906|FG000|Overall Study|ART initiation|1|||
160904250|NCT01945281|581044907|FG000|Overall Study|Adverse Event|1|||
160904251|NCT01945281|581044908|FG001|Overall Study|Adverse Event|0|||
160904252|NCT01945281|581044907|FG000|Overall Study|Death|3|||
160904253|NCT01945281|581044908|FG001|Overall Study|Death|3|||
160837451|NCT02540291|580790302|FG003|Overall Study|Withdrawal Of Consent|0|||
160837452|NCT02540291|580790299|FG000|Overall Study|Study Terminated By Sponsor|1|||
160837453|NCT02540291|580790300|FG001|Overall Study|Study Terminated By Sponsor|0|||
160904254|NCT01945281|581044907|FG000|Overall Study|Physician Decision|1|||
160904255|NCT01945281|581044908|FG001|Overall Study|Physician Decision|1|||
160904256|NCT01945281|581044907|FG000|Overall Study|Technical Problems|1|||
160904257|NCT01945281|581044908|FG001|Overall Study|Technical Problems|0|||
160904258|NCT01513343|581044911|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
160563091|NCT03853694|579781700|FG001|Overall Study|Withdrawal by Subject|1|||
160837454|NCT02540291|580790301|FG002|Overall Study|Study Terminated By Sponsor|0|||
160837455|NCT02540291|580790302|FG003|Overall Study|Study Terminated By Sponsor|0|||
160837456|NCT02540291|580790299|FG000|Overall Study|Other|0|||
160837457|NCT02540291|580790300|FG001|Overall Study|Other|0|||
160837458|NCT02540291|580790301|FG002|Overall Study|Other|1|||
160837459|NCT02540291|580790302|FG003|Overall Study|Other|0|||
160837460|NCT01879072|580790304|FG000|Overall Study|Withdrawal by Subject|121|||
160837461|NCT01879072|580790304|FG000|Overall Study|Not Transplanted|30|||
160563092|NCT03853694|579781701|FG002|Overall Study|Withdrawal by Subject|0|||
160563093|NCT00805207|579781702|FG000|Overall Study|Protocol Violation|0|||
160563094|NCT00805207|579781703|FG001|Overall Study|Protocol Violation|0|||
160563095|NCT00805207|579781704|FG002|Overall Study|Protocol Violation|1|||
160563096|NCT00805207|579781705|FG003|Overall Study|Protocol Violation|0|||
160563097|NCT00805207|579781706|FG004|Overall Study|Protocol Violation|0|||
160563098|NCT00805207|579781707|FG005|Overall Study|Protocol Violation|0|||
160563099|NCT00805207|579781708|FG006|Overall Study|Protocol Violation|0|||
160563100|NCT00805207|579781709|FG007|Overall Study|Protocol Violation|0|||
160563101|NCT00805207|579781710|FG008|Overall Study|Protocol Violation|0|||
160563102|NCT00805207|579781702|FG000|Overall Study|Physician Decision|0|||
160563103|NCT00805207|579781703|FG001|Overall Study|Physician Decision|1|||
160563104|NCT00805207|579781704|FG002|Overall Study|Physician Decision|0|||
160563105|NCT00805207|579781705|FG003|Overall Study|Physician Decision|0|||
160563106|NCT00805207|579781706|FG004|Overall Study|Physician Decision|0|||
160563107|NCT00805207|579781707|FG005|Overall Study|Physician Decision|1|||
160563108|NCT00805207|579781708|FG006|Overall Study|Physician Decision|0|||
160563109|NCT00805207|579781709|FG007|Overall Study|Physician Decision|0|||
160563110|NCT00805207|579781710|FG008|Overall Study|Physician Decision|0|||
160563111|NCT00805207|579781702|FG000|Overall Study|Withdrawal by Subject|0|||
160563112|NCT00805207|579781703|FG001|Overall Study|Withdrawal by Subject|1|||
160563113|NCT00805207|579781704|FG002|Overall Study|Withdrawal by Subject|0|||
160563114|NCT00805207|579781705|FG003|Overall Study|Withdrawal by Subject|0|||
160563115|NCT00805207|579781706|FG004|Overall Study|Withdrawal by Subject|1|||
160563116|NCT00805207|579781707|FG005|Overall Study|Withdrawal by Subject|2|||
160563117|NCT00805207|579781708|FG006|Overall Study|Withdrawal by Subject|0|||
160563118|NCT00805207|579781709|FG007|Overall Study|Withdrawal by Subject|0|||
160563119|NCT00805207|579781710|FG008|Overall Study|Withdrawal by Subject|0|||
160563120|NCT00064701|579781711|FG000|One Year Post-transplant|Did not receive study drug|7|||
160563121|NCT00064701|579781712|FG001|One Year Post-transplant|Did not receive study drug|12|||
160563122|NCT00064701|579781713|FG002|One Year Post-transplant|Did not receive study drug|11|||
160563123|NCT00064701|579781711|FG000|One Year Post-transplant|Adverse Event|23|||
160563124|NCT00064701|579781712|FG001|One Year Post-transplant|Adverse Event|19|||
160837462|NCT00659230|580790319|FG000|Overall Study|Lost to Follow-up|2|||
160837463|NCT00659230|580790320|FG001|Overall Study|Lost to Follow-up|5|||
160837464|NCT00659230|580790319|FG000|Overall Study|Lost source documentation|5|||
160837465|NCT00659230|580790320|FG001|Overall Study|Lost source documentation|4|||
160837466|NCT00659230|580790319|FG000|Overall Study|Did not return post-randomization|2|||
160837467|NCT00659230|580790320|FG001|Overall Study|Did not return post-randomization|3|||
160837468|NCT01900054|580792075|FG000|Overall Study|Physician Decision|1|||
160837469|NCT01900054|580792075|FG000|Overall Study|Withdrawal by Subject|1|||
160837470|NCT03229109|580792079|FG000|Overall Study|Withdrawal by Subject|0|||
160837471|NCT03229109|580792080|FG001|Overall Study|Withdrawal by Subject|0|||
160837472|NCT03229109|580792081|FG002|Overall Study|Withdrawal by Subject|0|||
160837473|NCT03229109|580792082|FG003|Overall Study|Withdrawal by Subject|1|||
160837474|NCT01835223|580792085|FG000|Overall Study|Adverse Event|1|||
160837475|NCT01835223|580792086|FG001|Overall Study|Adverse Event|0|||
160837476|NCT01835223|580792085|FG000|Overall Study|Withdrawal by Subject|2|||
160837477|NCT01835223|580792086|FG001|Overall Study|Withdrawal by Subject|0|||
160837478|NCT01835223|580792085|FG000|Overall Study|Disease progression|2|||
160837479|NCT01835223|580792086|FG001|Overall Study|Disease progression|1|||
160837480|NCT01835223|580792085|FG000|Overall Study|Became Inelligible|4|||
160837481|NCT01835223|580792086|FG001|Overall Study|Became Inelligible|0|||
160837482|NCT03329196|580792090|FG000|Overall Study|Adverse Event|10|||
160837483|NCT03329196|580792091|FG001|Overall Study|Adverse Event|5|||
160837484|NCT03329196|580792090|FG000|Overall Study|Physician Decision|2|||
160837485|NCT03329196|580792091|FG001|Overall Study|Physician Decision|2|||
160837486|NCT03329196|580792090|FG000|Overall Study|Withdrawal by Subject|11|||
160837487|NCT03329196|580792091|FG001|Overall Study|Withdrawal by Subject|3|||
160837488|NCT03329196|580792090|FG000|Overall Study|Hepatic function abnormalities|0|||
160837489|NCT03329196|580792091|FG001|Overall Study|Hepatic function abnormalities|1|||
160837490|NCT03329196|580792090|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
160837491|NCT03329196|580792091|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
160837492|NCT03329196|580792090|FG000|Overall Study|Difficult to control Hb|2|||
160837493|NCT03329196|580792091|FG001|Overall Study|Difficult to control Hb|3|||
160837494|NCT03329196|580792090|FG000|Overall Study|Dialysis or renal transplant|13|||
160837495|NCT03329196|580792091|FG001|Overall Study|Dialysis or renal transplant|15|||
160837496|NCT04481750|580792095|FG000|Period 1 (Fasted)|Adverse Event|0|||
160837497|NCT04481750|580792096|FG001|Period 1 (Fasted)|Adverse Event|0|||
160563125|NCT00064701|579781713|FG002|One Year Post-transplant|Adverse Event|37|||
160563126|NCT00064701|579781711|FG000|One Year Post-transplant|Rejection|0|||
160563127|NCT00064701|579781712|FG001|One Year Post-transplant|Rejection|1|||
160563128|NCT00064701|579781713|FG002|One Year Post-transplant|Rejection|16|||
160563129|NCT00064701|579781711|FG000|One Year Post-transplant|Non-compliance|4|||
160563130|NCT00064701|579781712|FG001|One Year Post-transplant|Non-compliance|2|||
160837498|NCT04481750|580792097|FG002|Period 1 (Fasted)|Adverse Event|1|||
160837499|NCT04481750|580792098|FG003|Period 1 (Fasted)|Adverse Event|0|||
160837500|NCT04481750|580792099|FG004|Period 1 (Fasted)|Adverse Event|0|||
160837501|NCT04481750|580792100|FG005|Period 1 (Fasted)|Adverse Event|0|||
160837502|NCT04481750|580792101|FG006|Period 1 (Fasted)|Adverse Event|0|||
160837503|NCT04481750|580792102|FG007|Period 1 (Fasted)|Adverse Event|0|||
160837504|NCT04481750|580792103|FG008|Period 1 (Fasted)|Adverse Event|0|||
160837505|NCT04481750|580792104|FG009|Period 1 (Fasted)|Adverse Event|0|||
160837506|NCT04481750|580792105|FG010|Period 1 (Fasted)|Adverse Event|0|||
160837507|NCT03176771|580792106|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
160837508|NCT03176771|580792107|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
160837509|NCT03176771|580792108|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
160837510|NCT03176771|580792109|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
160837511|NCT03176771|580792110|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
160837512|NCT03176771|580792106|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
160837513|NCT03176771|580792107|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
160837514|NCT03176771|580792108|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
160837515|NCT03176771|580792109|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
160837516|NCT03176771|580792110|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
160837517|NCT03176771|580792106|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
160837518|NCT03176771|580792107|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
160837519|NCT03176771|580792108|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
160837520|NCT03176771|580792109|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
160837521|NCT03176771|580792110|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
160837522|NCT03176771|580792106|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
160837523|NCT03176771|580792107|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
160837524|NCT03176771|580792108|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
160837525|NCT03176771|580792109|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
160837526|NCT03176771|580792110|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
160837527|NCT03176771|580792106|FG000|Double-Blind Extension Period|Adverse Event|0|||
160837528|NCT03176771|580792107|FG001|Double-Blind Extension Period|Adverse Event|0|||
160837529|NCT03176771|580792108|FG002|Double-Blind Extension Period|Adverse Event|0|||
160837530|NCT03176771|580792109|FG003|Double-Blind Extension Period|Adverse Event|15|||
160837531|NCT03176771|580792110|FG004|Double-Blind Extension Period|Adverse Event|18|||
160837532|NCT03176771|580792106|FG000|Double-Blind Extension Period|Death|0|||
160837533|NCT03176771|580792107|FG001|Double-Blind Extension Period|Death|0|||
160837534|NCT03176771|580792108|FG002|Double-Blind Extension Period|Death|0|||
160837535|NCT03176771|580792109|FG003|Double-Blind Extension Period|Death|3|||
160837536|NCT03176771|580792110|FG004|Double-Blind Extension Period|Death|4|||
160837537|NCT03176771|580792106|FG000|Double-Blind Extension Period|Physician Decision|0|||
160837538|NCT03176771|580792107|FG001|Double-Blind Extension Period|Physician Decision|0|||
160837539|NCT03176771|580792108|FG002|Double-Blind Extension Period|Physician Decision|0|||
160837540|NCT03176771|580792109|FG003|Double-Blind Extension Period|Physician Decision|3|||
160837541|NCT03176771|580792110|FG004|Double-Blind Extension Period|Physician Decision|1|||
160837542|NCT03176771|580792106|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
160837543|NCT03176771|580792107|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
160837544|NCT03176771|580792108|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
160837545|NCT03176771|580792109|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
160837546|NCT03176771|580792110|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
160837547|NCT03439137|580792111|FG000|Overall Study|Adverse Event|16|||
160837548|NCT03439137|580792112|FG001|Overall Study|Adverse Event|12|||
160837549|NCT03439137|580792111|FG000|Overall Study|Physician Decision|0|||
160837550|NCT03439137|580792112|FG001|Overall Study|Physician Decision|5|||
160837551|NCT03439137|580792111|FG000|Overall Study|Withdrawal by Subject|14|||
160837552|NCT03439137|580792112|FG001|Overall Study|Withdrawal by Subject|4|||
160837553|NCT03439137|580792111|FG000|Overall Study|Conducting rescue therapy|2|||
160837554|NCT03439137|580792112|FG001|Overall Study|Conducting rescue therapy|1|||
160837555|NCT03439137|580792111|FG000|Overall Study|Difficult to control Hb|10|||
160837556|NCT03439137|580792112|FG001|Overall Study|Difficult to control Hb|2|||
160837557|NCT03439137|580792111|FG000|Overall Study|Initiation of a renal transplant|0|||
160837558|NCT03439137|580792112|FG001|Overall Study|Initiation of a renal transplant|2|||
160904259|NCT01513343|581044912|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
160904260|NCT01513343|581044911|FG000|Post Data Collection|Dropped/withdrew from study|7|||
160904261|NCT01513343|581044912|FG001|Post Data Collection|Dropped/withdrew from study|1|||
160837559|NCT04097379|580792113|FG000|Overall Study|Adverse Event|1|||
160837560|NCT04097379|580792114|FG001|Overall Study|Adverse Event|0|||
160837561|NCT04097379|580792115|FG002|Overall Study|Adverse Event|0|||
160837562|NCT04097379|580792116|FG003|Overall Study|Adverse Event|0|||
160837563|NCT04097379|580792113|FG000|Overall Study|Physician Decision|0|||
160904262|NCT01513343|581044911|FG000|Post Data Collection|Lost to Follow-up|10|||
160904263|NCT01513343|581044912|FG001|Post Data Collection|Lost to Follow-up|23|||
160563131|NCT00064701|579781713|FG002|One Year Post-transplant|Non-compliance|5|||
160837564|NCT04097379|580792114|FG001|Overall Study|Physician Decision|1|||
160837565|NCT04097379|580792115|FG002|Overall Study|Physician Decision|0|||
160837566|NCT04097379|580792116|FG003|Overall Study|Physician Decision|0|||
160837567|NCT03387020|580792117|FG000|Overall Study|Adverse Event|0|||
160837568|NCT03387020|580792118|FG001|Overall Study|Adverse Event|2|||
160837569|NCT03387020|580792119|FG002|Overall Study|Adverse Event|0|||
160837570|NCT03387020|580792117|FG000|Overall Study|Withdrawal by Subject|2|||
160837571|NCT03387020|580792118|FG001|Overall Study|Withdrawal by Subject|0|||
160837572|NCT03387020|580792119|FG002|Overall Study|Withdrawal by Subject|0|||
160837573|NCT01425632|580792120|FG000|Overall Study|Adverse Event|0|||
160837574|NCT01425632|580792121|FG001|Overall Study|Adverse Event|1|||
160837575|NCT01425632|580792122|FG002|Overall Study|Adverse Event|1|||
160837576|NCT01425632|580792120|FG000|Overall Study|Physician Decision|1|||
160837577|NCT01425632|580792121|FG001|Overall Study|Physician Decision|0|||
160837578|NCT01425632|580792122|FG002|Overall Study|Physician Decision|0|||
160837579|NCT01425632|580792120|FG000|Overall Study|Protocol Violation|0|||
160837580|NCT01425632|580792121|FG001|Overall Study|Protocol Violation|0|||
160837581|NCT01425632|580792122|FG002|Overall Study|Protocol Violation|2|||
160837582|NCT01425632|580792120|FG000|Overall Study|Withdrawal by Subject|0|||
160837583|NCT01425632|580792121|FG001|Overall Study|Withdrawal by Subject|0|||
160837584|NCT01425632|580792122|FG002|Overall Study|Withdrawal by Subject|1|||
160837585|NCT03461146|580792126|FG000|Overall Study|Adverse Event|2|||
160837586|NCT03461146|580792126|FG000|Overall Study|Physician Decision|1|||
160837587|NCT02140047|580792127|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160837588|NCT02140047|580792128|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160837589|NCT02140047|580792129|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160837590|NCT04617496|580792130|FG000|Overall Study|Death|2|||
160837591|NCT04617496|580792131|FG001|Overall Study|Death|1|||
160837592|NCT04617496|580792130|FG000|Overall Study|Lost to Follow-up|3|||
160837593|NCT04617496|580792131|FG001|Overall Study|Lost to Follow-up|3|||
160837594|NCT00200356|580792136|FG000|Overall Study|Lack of Efficacy|3|||
160837595|NCT00200356|580792137|FG001|Overall Study|Lack of Efficacy|3|||
160837596|NCT00200356|580792136|FG000|Overall Study|Protocol Violation|4|||
160837597|NCT00200356|580792137|FG001|Overall Study|Protocol Violation|4|||
160837598|NCT00200356|580792136|FG000|Overall Study|Nontreatment|1|||
160837599|NCT00200356|580792137|FG001|Overall Study|Nontreatment|0|||
160837600|NCT04530552|580792140|FG000|Overall Study|Physician Decision|0|||
160837601|NCT04530552|580792141|FG001|Overall Study|Physician Decision|1|||
160991666|NCT01729871|581357879|FG000|Overall Study|Death|0|||
160991667|NCT01729871|581357880|FG001|Overall Study|Death|1|||
160991668|NCT01729871|581357879|FG000|Overall Study|Lack of Efficacy|0|||
160991669|NCT01729871|581357880|FG001|Overall Study|Lack of Efficacy|1|||
160991670|NCT01729871|581357879|FG000|Overall Study|Physician Decision|0|||
160991671|NCT01729871|581357880|FG001|Overall Study|Physician Decision|2|||
160991672|NCT01729871|581357879|FG000|Overall Study|Protocol Violation|1|||
160991673|NCT01729871|581357880|FG001|Overall Study|Protocol Violation|0|||
160991674|NCT01729871|581357879|FG000|Overall Study|Withdrawal by Subject|0|||
160563132|NCT00064701|579781711|FG000|One Year Post-transplant|Graft Failure|3|||
160563133|NCT00064701|579781712|FG001|One Year Post-transplant|Graft Failure|2|||
160563134|NCT00064701|579781713|FG002|One Year Post-transplant|Graft Failure|1|||
160563135|NCT00064701|579781711|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
160837602|NCT04530552|580792140|FG000|Overall Study|Withdrawal by Subject|0|||
160837603|NCT04530552|580792141|FG001|Overall Study|Withdrawal by Subject|1|||
160837604|NCT04530552|580792140|FG000|Overall Study|Adverse Event|0|||
160837605|NCT04530552|580792141|FG001|Overall Study|Adverse Event|1|||
160837606|NCT04530552|580792140|FG000|Overall Study|No surgery|0|||
160837607|NCT04530552|580792141|FG001|Overall Study|No surgery|1|||
160837608|NCT03703856|580792144|FG000|Enrolled in study|Withdrawal by Subject|23|||
160837609|NCT03703856|580792144|FG000|Titrated to full dose|Withdrawal by Subject|5|||
160837610|NCT03703856|580792144|FG000|16 week assessment|Withdrawal by Subject|1|||
160563136|NCT00064701|579781712|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
160837611|NCT03703856|580792144|FG000|24 week assessment|Withdrawal by Subject|1|||
160837612|NCT01596335|580792145|FG000|Overall Study|exacerbation of primary disease|5|||
160837613|NCT01596335|580792146|FG001|Overall Study|exacerbation of primary disease|9|||
160991675|NCT01729871|581357880|FG001|Overall Study|Withdrawal by Subject|3|||
160991676|NCT01729871|581357879|FG000|Overall Study|Other|4|||
160837614|NCT05138419|580792147|FG000|Overall Study|Study terminated before participant completed.|0|||
160837615|NCT05138419|580792148|FG001|Overall Study|Study terminated before participant completed.|0|||
160991677|NCT01729871|581357880|FG001|Overall Study|Other|9|||
160837616|NCT05138419|580792149|FG002|Overall Study|Study terminated before participant completed.|1|||
160837617|NCT01532570|580792153|FG000|Overall Study|Lack of Efficacy|1|||
160837618|NCT01532570|580792154|FG001|Overall Study|Lack of Efficacy|0|||
160837619|NCT01532570|580792155|FG002|Overall Study|Lack of Efficacy|0|||
160837620|NCT01532570|580792156|FG003|Overall Study|Lack of Efficacy|0|||
160837621|NCT01532570|580792153|FG000|Overall Study|Withdrawal by Subject|0|||
160837622|NCT01532570|580792154|FG001|Overall Study|Withdrawal by Subject|1|||
160837623|NCT01532570|580792155|FG002|Overall Study|Withdrawal by Subject|0|||
160837624|NCT01532570|580792156|FG003|Overall Study|Withdrawal by Subject|0|||
160837625|NCT01585155|580792157|FG000|Overall Study|Adverse Event|1|||
160837626|NCT01585155|580792157|FG000|Overall Study|Lack of Efficacy|2|||
160837627|NCT01585155|580792157|FG000|Overall Study|Worsening ulcerative colitis|2|||
160837628|NCT01192412|580792159|FG000|Overall Study|Lost to Follow-up|2|||
160837629|NCT01192412|580792160|FG001|Overall Study|Lost to Follow-up|1|||
160837630|NCT01192412|580792159|FG000|Overall Study|Withdrawal by Subject|2|||
160837631|NCT01192412|580792160|FG001|Overall Study|Withdrawal by Subject|1|||
160837632|NCT02421588|580792161|FG000|Overall Study|Non-treatment-related AE|8|||
160837633|NCT02421588|580792162|FG001|Overall Study|Non-treatment-related AE|8|||
160837634|NCT02421588|580792161|FG000|Overall Study|Progressive disease|152|||
160837635|NCT02421588|580792162|FG001|Overall Study|Progressive disease|135|||
160837636|NCT02421588|580792161|FG000|Overall Study|Death|11|||
160837637|NCT02421588|580792162|FG001|Overall Study|Death|3|||
160837638|NCT02421588|580792161|FG000|Overall Study|Physician Decision|8|||
160837639|NCT02421588|580792162|FG001|Overall Study|Physician Decision|17|||
160837640|NCT02421588|580792161|FG000|Overall Study|Other reason not specified|3|||
160837641|NCT02421588|580792162|FG001|Overall Study|Other reason not specified|1|||
160837642|NCT02421588|580792161|FG000|Overall Study|Symptomatic deterioration|13|||
160837643|NCT02421588|580792162|FG001|Overall Study|Symptomatic deterioration|19|||
160837644|NCT02421588|580792161|FG000|Overall Study|Treatment-related AE|10|||
160904264|NCT01513343|581044911|FG000|6-month Follow-up|Lost to Follow-up|28|||
160904265|NCT01513343|581044912|FG001|6-month Follow-up|Lost to Follow-up|17|||
160904266|NCT01513343|581044911|FG000|12-month Follow-up|Lost to Follow-up|10|||
160904267|NCT01513343|581044912|FG001|12-month Follow-up|Lost to Follow-up|3|||
160904268|NCT00599924|581044913|FG000|Overall Study|Lack of Efficacy|3|||
160904269|NCT00599924|581044914|FG001|Overall Study|Lack of Efficacy|5|||
160904270|NCT00599924|581044915|FG002|Overall Study|Lack of Efficacy|1|||
160904271|NCT00599924|581044916|FG003|Overall Study|Lack of Efficacy|2|||
160904272|NCT00599924|581044917|FG004|Overall Study|Lack of Efficacy|3|||
160904273|NCT00599924|581044918|FG005|Overall Study|Lack of Efficacy|2|||
160904274|NCT00599924|581044919|FG006|Overall Study|Lack of Efficacy|0|||
160904275|NCT00599924|581044913|FG000|Overall Study|Adverse Event|0|||
160904276|NCT00599924|581044914|FG001|Overall Study|Adverse Event|0|||
160904277|NCT00599924|581044915|FG002|Overall Study|Adverse Event|0|||
160904278|NCT00599924|581044916|FG003|Overall Study|Adverse Event|2|||
160904279|NCT00599924|581044917|FG004|Overall Study|Adverse Event|0|||
160904280|NCT00599924|581044918|FG005|Overall Study|Adverse Event|0|||
160904281|NCT00599924|581044919|FG006|Overall Study|Adverse Event|2|||
160904282|NCT00599924|581044913|FG000|Overall Study|Death|0|||
160904283|NCT00599924|581044914|FG001|Overall Study|Death|0|||
160904284|NCT00599924|581044915|FG002|Overall Study|Death|0|||
160904285|NCT00599924|581044916|FG003|Overall Study|Death|2|||
160904286|NCT00599924|581044917|FG004|Overall Study|Death|0|||
160904287|NCT00599924|581044918|FG005|Overall Study|Death|2|||
160837645|NCT02421588|580792162|FG001|Overall Study|Treatment-related AE|14|||
160837646|NCT02421588|580792161|FG000|Overall Study|Withdrawal by Subject|14|||
160837647|NCT02421588|580792162|FG001|Overall Study|Withdrawal by Subject|16|||
160837648|NCT02421588|580792161|FG000|Overall Study|Not treated|2|||
160837649|NCT02421588|580792162|FG001|Overall Study|Not treated|8|||
160837650|NCT01359943|580792163|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
160837651|NCT01359943|580792164|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
160904288|NCT00599924|581044919|FG006|Overall Study|Death|1|||
160904289|NCT00599924|581044913|FG000|Overall Study|Protocol Violation|0|||
160904290|NCT00599924|581044914|FG001|Overall Study|Protocol Violation|0|||
160904291|NCT00599924|581044915|FG002|Overall Study|Protocol Violation|0|||
160904292|NCT00599924|581044916|FG003|Overall Study|Protocol Violation|1|||
160904293|NCT00599924|581044917|FG004|Overall Study|Protocol Violation|0|||
160904294|NCT00599924|581044918|FG005|Overall Study|Protocol Violation|0|||
160904295|NCT00599924|581044919|FG006|Overall Study|Protocol Violation|0|||
160904296|NCT00599924|581044913|FG000|Overall Study|Withdrawal by Subject|0|||
160837652|NCT01359943|580792165|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
160837653|NCT01359943|580792163|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
160837654|NCT01359943|580792164|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
160837655|NCT01359943|580792165|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
160837656|NCT01359943|580792163|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
160837657|NCT01359943|580792164|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
160837658|NCT01359943|580792165|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
160904297|NCT00599924|581044914|FG001|Overall Study|Withdrawal by Subject|0|||
160904298|NCT00599924|581044915|FG002|Overall Study|Withdrawal by Subject|1|||
160563137|NCT00064701|579781713|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
160563138|NCT00064701|579781711|FG000|One Year Post-transplant|Lost to Follow-up|1|||
160563139|NCT00064701|579781712|FG001|One Year Post-transplant|Lost to Follow-up|0|||
160563140|NCT00064701|579781713|FG002|One Year Post-transplant|Lost to Follow-up|0|||
160563141|NCT00064701|579781711|FG000|One Year Post-transplant|Converted to rapamycin|1|||
160563142|NCT00064701|579781712|FG001|One Year Post-transplant|Converted to rapamycin|0|||
160563143|NCT00064701|579781713|FG002|One Year Post-transplant|Converted to rapamycin|0|||
160563144|NCT00064701|579781711|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
160563145|NCT00064701|579781712|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
160563146|NCT00064701|579781713|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
160563147|NCT00064701|579781711|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
160563148|NCT00064701|579781712|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
160563149|NCT00064701|579781713|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
160563150|NCT00064701|579781711|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
160563151|NCT00064701|579781712|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
160563152|NCT00064701|579781713|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
160563153|NCT00064701|579781711|FG000|One Year Post-transplant|Poor absorption|0|||
160563154|NCT00064701|579781712|FG001|One Year Post-transplant|Poor absorption|1|||
160563155|NCT00064701|579781713|FG002|One Year Post-transplant|Poor absorption|0|||
160563156|NCT00064701|579781711|FG000|One Year Post-transplant|Pancreas transplant|0|||
160563157|NCT00064701|579781712|FG001|One Year Post-transplant|Pancreas transplant|0|||
160563158|NCT00064701|579781713|FG002|One Year Post-transplant|Pancreas transplant|1|||
160563159|NCT00064701|579781711|FG000|Clinical Continuation Phase|Adverse Event|12|||
160563160|NCT00064701|579781712|FG001|Clinical Continuation Phase|Adverse Event|21|||
160563161|NCT00064701|579781713|FG002|Clinical Continuation Phase|Adverse Event|14|||
160563162|NCT00064701|579781711|FG000|Clinical Continuation Phase|Non-compliance|8|||
160563163|NCT00064701|579781712|FG001|Clinical Continuation Phase|Non-compliance|6|||
160563164|NCT00064701|579781713|FG002|Clinical Continuation Phase|Non-compliance|7|||
160563165|NCT00064701|579781711|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
160563166|NCT00064701|579781712|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
160563167|NCT00064701|579781713|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
160563168|NCT00064701|579781711|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
160563169|NCT00064701|579781712|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
160563170|NCT00064701|579781713|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
160563171|NCT00064701|579781711|FG000|Clinical Continuation Phase|Graft Failure|5|||
160563172|NCT00064701|579781712|FG001|Clinical Continuation Phase|Graft Failure|5|||
160563173|NCT00064701|579781713|FG002|Clinical Continuation Phase|Graft Failure|2|||
160563174|NCT00064701|579781711|FG000|Clinical Continuation Phase|Rejection|1|||
160563175|NCT00064701|579781712|FG001|Clinical Continuation Phase|Rejection|2|||
160563176|NCT00064701|579781713|FG002|Clinical Continuation Phase|Rejection|2|||
160563177|NCT00064701|579781711|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
160563178|NCT00064701|579781712|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
160563179|NCT00064701|579781713|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
160563180|NCT00064701|579781711|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
160563181|NCT00064701|579781712|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
160563182|NCT00064701|579781713|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
160563183|NCT00064701|579781711|FG000|Clinical Continuation Phase|Physician Decision|1|||
160563184|NCT00064701|579781712|FG001|Clinical Continuation Phase|Physician Decision|3|||
160563185|NCT00064701|579781713|FG002|Clinical Continuation Phase|Physician Decision|0|||
160837659|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
160837660|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
160837661|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
160837662|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
160837663|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
160837664|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
160837665|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
160837666|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
160563186|NCT00064701|579781711|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
160563187|NCT00064701|579781712|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
160563188|NCT00064701|579781713|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
160837667|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
160837668|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
160837669|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
160563189|NCT00064701|579781711|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
160837670|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
160837671|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
160837672|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
160991678|NCT03971357|581357881|FG000|Overall Study|Lack of Efficacy|0|||
160563190|NCT00064701|579781712|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
160837673|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
160837674|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
160837675|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
160837676|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
160837677|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
160837678|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
160837679|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
160837680|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
160837681|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
160837682|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
160837683|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
160837684|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
160837685|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
160837686|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
160837687|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
160837688|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
160837689|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
160837690|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
160837691|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
160837692|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
160991679|NCT03971357|581357882|FG001|Overall Study|Lack of Efficacy|1|||
160837693|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
160837694|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
160837695|NCT01529034|580792166|FG000|Overall Study|Discontinued prior to study treatment|14|||
160837696|NCT01529034|580792166|FG000|Overall Study|Site closure|62|||
160837697|NCT01529034|580792166|FG000|Overall Study|Study termination|29|||
160837698|NCT01529034|580792166|FG000|Overall Study|Withdrawal by Subject|25|||
160837699|NCT01529034|580792166|FG000|Overall Study|No treated SCs within protocol window|13|||
160837700|NCT01529034|580792166|FG000|Overall Study|Noncompliance|8|||
160837701|NCT01529034|580792166|FG000|Overall Study|Caregiver no longer available|7|||
160837702|NCT01529034|580792166|FG000|Overall Study|Adverse Event|4|||
160837703|NCT01529034|580792166|FG000|Overall Study|Protocol Violation|4|||
160837704|NCT01529034|580792166|FG000|Overall Study|Lack of Efficacy|4|||
160837705|NCT01529034|580792166|FG000|Overall Study|Investigator no longer available|2|||
160837706|NCT01529034|580792166|FG000|Overall Study|Study drug not available|2|||
160837707|NCT04588389|580792167|FG000|Overall Study|Issues with anesthesia during surgery|2|||
160837708|NCT04588389|580792168|FG001|Overall Study|Issues with anesthesia during surgery|0|||
160837709|NCT04588389|580792169|FG002|Overall Study|Issues with anesthesia during surgery|0|||
160837710|NCT02911142|580792170|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
160837711|NCT02911142|580792170|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
160837712|NCT02911142|580792170|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
160837713|NCT02911142|580792170|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
160837714|NCT02678923|580792171|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
160837715|NCT02678923|580792172|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
160837716|NCT02678923|580792171|FG000|Overall Study|Withdrawal by Subject|3|||
160837717|NCT02678923|580792172|FG001|Overall Study|Withdrawal by Subject|2|||
160837718|NCT02678923|580792171|FG000|Overall Study|Lost to Follow-up|1|||
160837719|NCT02678923|580792172|FG001|Overall Study|Lost to Follow-up|0|||
160837720|NCT02678923|580792171|FG000|Overall Study|Did Not Return for Study Visits|1|||
160837721|NCT02678923|580792172|FG001|Overall Study|Did Not Return for Study Visits|0|||
160837722|NCT03266172|580792173|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
160837723|NCT03266172|580792174|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
160837724|NCT03266172|580792175|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
160837725|NCT03266172|580792173|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
160837726|NCT03266172|580792174|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
160837727|NCT03266172|580792175|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
160837728|NCT03266172|580792173|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
160837729|NCT03266172|580792174|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
160837730|NCT03266172|580792175|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
160837731|NCT03266172|580792173|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
160837732|NCT03266172|580792174|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
160837733|NCT03266172|580792175|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
160837734|NCT03266172|580792173|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
160837735|NCT03266172|580792174|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
160837736|NCT03266172|580792175|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
160991680|NCT01143077|581357886|FG000|Overall Study|Lack of Efficacy|0|||
160991681|NCT01143077|581357887|FG001|Overall Study|Lack of Efficacy|2|||
160991682|NCT01143077|581357888|FG002|Overall Study|Lack of Efficacy|1|||
160991683|NCT01143077|581357886|FG000|Overall Study|Adverse Event|5|||
160991684|NCT01143077|581357887|FG001|Overall Study|Adverse Event|6|||
160991685|NCT01143077|581357888|FG002|Overall Study|Adverse Event|5|||
160991686|NCT01143077|581357886|FG000|Overall Study|Lost to Follow-up|2|||
160991687|NCT01143077|581357887|FG001|Overall Study|Lost to Follow-up|3|||
160991688|NCT01143077|581357888|FG002|Overall Study|Lost to Follow-up|4|||
160991689|NCT01143077|581357886|FG000|Overall Study|Protocol Violation|2|||
160991690|NCT01143077|581357887|FG001|Overall Study|Protocol Violation|0|||
160991691|NCT01143077|581357888|FG002|Overall Study|Protocol Violation|0|||
160991692|NCT01143077|581357886|FG000|Overall Study|Withdrawal by Subject|4|||
160991693|NCT01143077|581357887|FG001|Overall Study|Withdrawal by Subject|3|||
160991694|NCT01143077|581357888|FG002|Overall Study|Withdrawal by Subject|3|||
160991695|NCT01143077|581357886|FG000|Overall Study|Non-compliance with study drug|0|||
160991696|NCT01143077|581357887|FG001|Overall Study|Non-compliance with study drug|1|||
160991697|NCT01143077|581357888|FG002|Overall Study|Non-compliance with study drug|1|||
160991698|NCT01143077|581357886|FG000|Overall Study|Administrative|1|||
160991699|NCT01143077|581357887|FG001|Overall Study|Administrative|0|||
160991700|NCT01143077|581357888|FG002|Overall Study|Administrative|0|||
160991701|NCT01143077|581357886|FG000|Overall Study|Principal Investigator Decision|2|||
160991702|NCT01143077|581357887|FG001|Overall Study|Principal Investigator Decision|0|||
160991703|NCT01143077|581357888|FG002|Overall Study|Principal Investigator Decision|1|||
160991704|NCT00630864|581357892|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
160991705|NCT00630864|581357892|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
160991706|NCT00430677|581357893|FG000|Short-term Period|Death|1|||
160991707|NCT00430677|581357894|FG001|Short-term Period|Death|1|||
160991708|NCT00430677|581357895|FG002|Short-term Period|Death|5|||
160991709|NCT00430677|581357893|FG000|Short-term Period|Adverse Event|15|||
160991710|NCT00430677|581357894|FG001|Short-term Period|Adverse Event|13|||
160991711|NCT00430677|581357895|FG002|Short-term Period|Adverse Event|9|||
160991712|NCT00430677|581357893|FG000|Short-term Period|Lack of Efficacy|5|||
160991713|NCT00430677|581357894|FG001|Short-term Period|Lack of Efficacy|6|||
160991714|NCT00430677|581357895|FG002|Short-term Period|Lack of Efficacy|4|||
160991715|NCT00430677|581357893|FG000|Short-term Period|Withdrawal by Subject|1|||
160837737|NCT03266172|580792173|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
160837738|NCT03266172|580792174|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
160837739|NCT03266172|580792175|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
160991716|NCT00430677|581357894|FG001|Short-term Period|Withdrawal by Subject|1|||
160991717|NCT00430677|581357895|FG002|Short-term Period|Withdrawal by Subject|2|||
160991718|NCT00430677|581357893|FG000|Short-term Period|Participant no longer met study criteria|1|||
160991719|NCT00430677|581357894|FG001|Short-term Period|Participant no longer met study criteria|1|||
160991720|NCT00430677|581357895|FG002|Short-term Period|Participant no longer met study criteria|2|||
160991721|NCT00430677|581357893|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
160991722|NCT00430677|581357894|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
160991723|NCT00430677|581357895|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
160991724|NCT00430677|581357893|FG000|Short-term Period|Pregnancy|0|||
160991725|NCT00430677|581357894|FG001|Short-term Period|Pregnancy|2|||
160991726|NCT00430677|581357895|FG002|Short-term Period|Pregnancy|0|||
160991727|NCT00430677|581357893|FG000|Long-term Extension Period|Death|1|||
160991728|NCT00430677|581357894|FG001|Long-term Extension Period|Death|0|||
160563191|NCT00064701|579781713|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
160563192|NCT00064701|579781711|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
160563193|NCT00064701|579781712|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
160563194|NCT00064701|579781713|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
160837740|NCT01554514|580792176|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
160837741|NCT01554514|580792176|FG000|Overall Study|Physician Decision|1|||
160991729|NCT00430677|581357895|FG002|Long-term Extension Period|Death|0|||
160991730|NCT00430677|581357893|FG000|Long-term Extension Period|Adverse Event|3|||
160991731|NCT00430677|581357894|FG001|Long-term Extension Period|Adverse Event|2|||
160991732|NCT00430677|581357895|FG002|Long-term Extension Period|Adverse Event|5|||
160991733|NCT00430677|581357893|FG000|Long-term Extension Period|Lack of Efficacy|5|||
160991734|NCT00430677|581357894|FG001|Long-term Extension Period|Lack of Efficacy|3|||
160991735|NCT00430677|581357895|FG002|Long-term Extension Period|Lack of Efficacy|8|||
160991736|NCT00430677|581357893|FG000|Long-term Extension Period|Lost to Follow-up|1|||
160991737|NCT00430677|581357894|FG001|Long-term Extension Period|Lost to Follow-up|1|||
160837742|NCT01966445|580792179|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
160837743|NCT01966445|580792180|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
160837744|NCT01966445|580792181|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
160837745|NCT01966445|580792182|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
160837746|NCT01966445|580792183|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
160563195|NCT00064701|579781711|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
160563196|NCT00064701|579781712|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
160563197|NCT00064701|579781713|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
160563198|NCT00064701|579781711|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
160563199|NCT00064701|579781712|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
160563200|NCT00064701|579781713|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
160563201|NCT00064701|579781711|FG000|Clinical Continuation Phase|Patient opted out|0|||
160563202|NCT00064701|579781712|FG001|Clinical Continuation Phase|Patient opted out|0|||
160563203|NCT00064701|579781713|FG002|Clinical Continuation Phase|Patient opted out|1|||
160563204|NCT03308188|579781714|FG000|Overall Study|Withdrawal by Subject|0|||
160563205|NCT03308188|579781715|FG001|Overall Study|Withdrawal by Subject|3|||
160563206|NCT03308188|579781714|FG000|Overall Study|Death|0|||
160563207|NCT03308188|579781715|FG001|Overall Study|Death|1|||
160563208|NCT01709331|579781716|FG000|Overall Study|Adverse Event|1|||
160563209|NCT00552110|579781717|FG000|Overall Study|Serious or Life-Threatening AE|0|||
160563210|NCT00552110|579781718|FG001|Overall Study|Serious or Life-Threatening AE|0|||
160563211|NCT00552110|579781719|FG002|Overall Study|Serious or Life-Threatening AE|1|||
160563212|NCT00552110|579781720|FG003|Overall Study|Serious or Life-Threatening AE|0|||
160563213|NCT00552110|579781721|FG004|Overall Study|Serious or Life-Threatening AE|0|||
160563214|NCT00552110|579781717|FG000|Overall Study|Lack of Efficacy|1|||
160563215|NCT00552110|579781718|FG001|Overall Study|Lack of Efficacy|0|||
160563216|NCT00552110|579781719|FG002|Overall Study|Lack of Efficacy|0|||
160563217|NCT00552110|579781720|FG003|Overall Study|Lack of Efficacy|1|||
160563218|NCT00552110|579781721|FG004|Overall Study|Lack of Efficacy|4|||
160563219|NCT00552110|579781717|FG000|Overall Study|Withdrawal by Subject|0|||
160563220|NCT00552110|579781718|FG001|Overall Study|Withdrawal by Subject|2|||
160563221|NCT00552110|579781719|FG002|Overall Study|Withdrawal by Subject|0|||
160563222|NCT00552110|579781720|FG003|Overall Study|Withdrawal by Subject|3|||
160563223|NCT00552110|579781721|FG004|Overall Study|Withdrawal by Subject|2|||
160563224|NCT00552110|579781717|FG000|Overall Study|Lost to Follow-up|0|||
160563225|NCT00552110|579781718|FG001|Overall Study|Lost to Follow-up|0|||
160563226|NCT00552110|579781719|FG002|Overall Study|Lost to Follow-up|0|||
160563227|NCT00552110|579781720|FG003|Overall Study|Lost to Follow-up|1|||
160563228|NCT00552110|579781721|FG004|Overall Study|Lost to Follow-up|1|||
160563229|NCT00552110|579781717|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
160563230|NCT00552110|579781718|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
160563231|NCT00552110|579781719|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
160563232|NCT00552110|579781720|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
160563233|NCT00552110|579781721|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
160563234|NCT00552110|579781717|FG000|Overall Study|Withdrawn per Sponsor|0|||
160563235|NCT00552110|579781718|FG001|Overall Study|Withdrawn per Sponsor|1|||
160563236|NCT00552110|579781719|FG002|Overall Study|Withdrawn per Sponsor|0|||
160563237|NCT00552110|579781720|FG003|Overall Study|Withdrawn per Sponsor|0|||
160837747|NCT01966445|580792184|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
160563238|NCT00552110|579781721|FG004|Overall Study|Withdrawn per Sponsor|1|||
160563239|NCT00552110|579781717|FG000|Overall Study|Use of Prohibited Medication|1|||
160563240|NCT00552110|579781718|FG001|Overall Study|Use of Prohibited Medication|1|||
160563241|NCT00552110|579781719|FG002|Overall Study|Use of Prohibited Medication|0|||
160563242|NCT00552110|579781720|FG003|Overall Study|Use of Prohibited Medication|0|||
160837748|NCT01966445|580792185|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
160837749|NCT01966445|580792179|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
160837750|NCT01966445|580792180|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
160837751|NCT01966445|580792181|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
160837752|NCT01966445|580792182|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
160837753|NCT01966445|580792183|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
160837754|NCT01966445|580792184|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
160837755|NCT01966445|580792185|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
160837756|NCT01966445|580792179|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
160837757|NCT01966445|580792180|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
160837758|NCT01966445|580792181|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
160837759|NCT01966445|580792182|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
160837760|NCT01966445|580792183|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
160837761|NCT01966445|580792184|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
160837762|NCT01966445|580792185|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
160837763|NCT01966445|580792179|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160837764|NCT01966445|580792180|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160837765|NCT01966445|580792181|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160837766|NCT01966445|580792182|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160563243|NCT00552110|579781721|FG004|Overall Study|Use of Prohibited Medication|0|||
160563244|NCT00552110|579781717|FG000|Overall Study|Delay of Study due to Relabeling|0|||
160837767|NCT01966445|580792183|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160837768|NCT01966445|580792184|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160837769|NCT01966445|580792185|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
160837770|NCT01966445|580792179|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837771|NCT01966445|580792180|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837772|NCT01966445|580792181|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837773|NCT01966445|580792182|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837774|NCT01966445|580792183|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837775|NCT01966445|580792184|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837776|NCT01966445|580792185|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
160837777|NCT01374178|580792186|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
160837778|NCT01374178|580792187|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
160837779|NCT01374178|580792186|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
160837780|NCT01374178|580792187|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
160837781|NCT01422824|580792188|FG000|Overall Study|Case record form not evaluated|1|||
160837782|NCT01422824|580792188|FG000|Overall Study|Lost to Follow-up|37|||
160837783|NCT01716104|580792189|FG000|Overall Study|Do not meet inclusion criteria|6|||
160837784|NCT01716104|580792190|FG001|Overall Study|Do not meet inclusion criteria|7|||
160904299|NCT00599924|581044916|FG003|Overall Study|Withdrawal by Subject|0|||
160904300|NCT00599924|581044917|FG004|Overall Study|Withdrawal by Subject|1|||
160904301|NCT00599924|581044918|FG005|Overall Study|Withdrawal by Subject|0|||
160904302|NCT00599924|581044919|FG006|Overall Study|Withdrawal by Subject|0|||
160904303|NCT00599924|581044913|FG000|Overall Study|Other|0|||
160904304|NCT00599924|581044914|FG001|Overall Study|Other|0|||
160904305|NCT00599924|581044915|FG002|Overall Study|Other|0|||
160904306|NCT00599924|581044916|FG003|Overall Study|Other|1|||
160904307|NCT00599924|581044917|FG004|Overall Study|Other|2|||
160904308|NCT00599924|581044918|FG005|Overall Study|Other|0|||
160904309|NCT00599924|581044919|FG006|Overall Study|Other|2|||
160904310|NCT02587234|581044920|FG000|Overall Study|Withdrawal by Subject|1|||
160904311|NCT02587234|581044921|FG001|Overall Study|Withdrawal by Subject|1|||
160904312|NCT02587234|581044920|FG000|Overall Study|Lost to Follow-up|0|||
160904313|NCT02587234|581044921|FG001|Overall Study|Lost to Follow-up|2|||
160904314|NCT02165215|581044922|FG000|Induction Phase|Adverse Event|1|||
160904315|NCT02165215|581044923|FG001|Induction Phase|Adverse Event|0|||
160904316|NCT02165215|581044924|FG002|Induction Phase|Adverse Event|0|||
160904317|NCT02165215|581044922|FG000|Induction Phase|Withdrawal by Subject|10|||
160904318|NCT02165215|581044923|FG001|Induction Phase|Withdrawal by Subject|0|||
160904319|NCT02165215|581044924|FG002|Induction Phase|Withdrawal by Subject|0|||
160904320|NCT02165215|581044922|FG000|Induction Phase|Protocol Violation|1|||
160904321|NCT02165215|581044923|FG001|Induction Phase|Protocol Violation|0|||
160904322|NCT02165215|581044924|FG002|Induction Phase|Protocol Violation|0|||
160904323|NCT02165215|581044922|FG000|Induction Phase|Physician Decision|1|||
160904324|NCT02165215|581044923|FG001|Induction Phase|Physician Decision|0|||
160904325|NCT02165215|581044924|FG002|Induction Phase|Physician Decision|0|||
160904326|NCT02165215|581044922|FG000|Induction Phase|Lack of Efficacy|2|||
160904327|NCT02165215|581044923|FG001|Induction Phase|Lack of Efficacy|0|||
160904328|NCT02165215|581044924|FG002|Induction Phase|Lack of Efficacy|0|||
160904329|NCT02165215|581044922|FG000|Induction Phase|Non-Compliance|2|||
160904330|NCT02165215|581044923|FG001|Induction Phase|Non-Compliance|0|||
160904331|NCT02165215|581044924|FG002|Induction Phase|Non-Compliance|0|||
160904332|NCT02165215|581044922|FG000|Induction Phase|Lost to Follow-up|6|||
160904333|NCT02165215|581044923|FG001|Induction Phase|Lost to Follow-up|0|||
160904334|NCT02165215|581044924|FG002|Induction Phase|Lost to Follow-up|0|||
160904335|NCT02165215|581044922|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160837785|NCT00117793|580792191|FG000|Overall Study|Withdrawal by Subject|12|||
160837786|NCT00470418|580792196|FG000|Overall Study|Withdrawal by Subject|1|||
160837787|NCT00470418|580792197|FG001|Overall Study|Withdrawal by Subject|0|||
160837788|NCT01818492|580792198|FG000|Overall Study|Adverse Event|2|||
160837789|NCT01818492|580792198|FG000|Overall Study|Death|3|||
160837790|NCT01818492|580792198|FG000|Overall Study|Withdrawal by Subject|1|||
160837791|NCT01818492|580792198|FG000|Overall Study|Additional therapy when not allowed PP|4|||
160904336|NCT02165215|581044923|FG001|Maintenance Phase|Withdrawal by Subject|7|||
160904337|NCT02165215|581044924|FG002|Maintenance Phase|Withdrawal by Subject|3|||
160837792|NCT02409719|580792201|FG000|Overall Study|Lost to Follow-up|3|||
160837793|NCT02409719|580792202|FG001|Overall Study|Lost to Follow-up|3|||
160837794|NCT02438813|580792203|FG000|Overall Study|Patient Decision|59|||
160904338|NCT02165215|581044922|FG000|Maintenance Phase|Multiple reasons|0|||
160904339|NCT02165215|581044923|FG001|Maintenance Phase|Multiple reasons|2|||
160904340|NCT02165215|581044924|FG002|Maintenance Phase|Multiple reasons|1|||
160904341|NCT02165215|581044922|FG000|Maintenance Phase|Lost to Follow-up|0|||
160904342|NCT02165215|581044923|FG001|Maintenance Phase|Lost to Follow-up|2|||
160837795|NCT02438813|580792203|FG000|Overall Study|Patient Lost to Follow-Up|137|||
160837796|NCT02438813|580792203|FG000|Overall Study|Study Ended by Sponsor|80|||
160837797|NCT02438813|580792203|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
160837798|NCT01026220|580792204|FG000|Induction|Death|1|||
160837799|NCT01026220|580792205|FG001|Induction|Death|0|||
160837800|NCT01026220|580792206|FG002|Induction|Death|0|||
160837801|NCT01026220|580792204|FG000|Induction|Lack of Efficacy|2|||
160837802|NCT01026220|580792205|FG001|Induction|Lack of Efficacy|0|||
160837803|NCT01026220|580792206|FG002|Induction|Lack of Efficacy|0|||
160837804|NCT01026220|580792204|FG000|Induction|Physician Decision|12|||
160837805|NCT01026220|580792205|FG001|Induction|Physician Decision|0|||
160837806|NCT01026220|580792206|FG002|Induction|Physician Decision|0|||
160837807|NCT01026220|580792204|FG000|Induction|Withdrawal by Subject|9|||
160837808|NCT01026220|580792205|FG001|Induction|Withdrawal by Subject|0|||
160837809|NCT01026220|580792206|FG002|Induction|Withdrawal by Subject|0|||
160837810|NCT01026220|580792204|FG000|Induction|Ineligible|1|||
160837811|NCT01026220|580792205|FG001|Induction|Ineligible|0|||
160837812|NCT01026220|580792206|FG002|Induction|Ineligible|0|||
160837813|NCT01026220|580792204|FG000|Consolidation Maintenance|Death|0|||
160837814|NCT01026220|580792205|FG001|Consolidation Maintenance|Death|1|||
160837815|NCT01026220|580792206|FG002|Consolidation Maintenance|Death|0|||
160837816|NCT01026220|580792204|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
160837817|NCT01026220|580792205|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
160837818|NCT01026220|580792206|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
160837819|NCT01026220|580792204|FG000|Consolidation Maintenance|Physician Decision|0|||
160837820|NCT01026220|580792205|FG001|Consolidation Maintenance|Physician Decision|2|||
160837821|NCT01026220|580792206|FG002|Consolidation Maintenance|Physician Decision|7|||
160837822|NCT01026220|580792204|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
160837823|NCT01026220|580792205|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
160837824|NCT01026220|580792206|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
160837825|NCT00409344|580792208|FG000|Overall Study|no enrollment|0|||
160837826|NCT00409344|580792209|FG001|Overall Study|no enrollment|0|||
160837827|NCT02879578|580792212|FG000|Overall Study|Adverse Event|1|||
160837828|NCT02879578|580792213|FG001|Overall Study|Adverse Event|2|||
160837829|NCT02879578|580792214|FG002|Overall Study|Adverse Event|14|||
160837830|NCT02879578|580792212|FG000|Overall Study|Protocol Violation|0|||
160837831|NCT02879578|580792213|FG001|Overall Study|Protocol Violation|1|||
160837832|NCT02879578|580792214|FG002|Overall Study|Protocol Violation|1|||
160837833|NCT02879578|580792212|FG000|Overall Study|Withdrawal by Subject|8|||
160837834|NCT02879578|580792213|FG001|Overall Study|Withdrawal by Subject|6|||
160837835|NCT02879578|580792214|FG002|Overall Study|Withdrawal by Subject|9|||
160837836|NCT02879578|580792212|FG000|Overall Study|Lost to Follow-up|1|||
160837837|NCT02879578|580792213|FG001|Overall Study|Lost to Follow-up|0|||
160837838|NCT02879578|580792214|FG002|Overall Study|Lost to Follow-up|4|||
160837839|NCT02879578|580792212|FG000|Overall Study|Physician Decision|0|||
160837840|NCT02879578|580792213|FG001|Overall Study|Physician Decision|0|||
160837841|NCT02879578|580792214|FG002|Overall Study|Physician Decision|4|||
160837842|NCT04390841|580792220|FG000|Overall Study|Withdrawal by Subject|2|||
160837843|NCT00411632|580792221|FG000|Overall Study|Death|1|||
160837844|NCT00691028|580793151|FG000|Open-label Period|Adverse Event|0|||
160837845|NCT00691028|580793152|FG001|Open-label Period|Adverse Event|0|||
160837846|NCT00691028|580793153|FG002|Open-label Period|Adverse Event|0|||
160837847|NCT00691028|580793154|FG003|Open-label Period|Adverse Event|16|||
160837848|NCT00691028|580793151|FG000|Open-label Period|Withdrawal by Subject|0|||
160837849|NCT00691028|580793152|FG001|Open-label Period|Withdrawal by Subject|0|||
160837850|NCT00691028|580793153|FG002|Open-label Period|Withdrawal by Subject|0|||
160837851|NCT00691028|580793154|FG003|Open-label Period|Withdrawal by Subject|3|||
160837852|NCT00691028|580793151|FG000|Open-label Period|not come to a hospital|0|||
160837853|NCT00691028|580793152|FG001|Open-label Period|not come to a hospital|0|||
160837854|NCT00691028|580793153|FG002|Open-label Period|not come to a hospital|0|||
160837855|NCT00691028|580793154|FG003|Open-label Period|not come to a hospital|1|||
160837856|NCT00691028|580793151|FG000|Double-blind Period|Adverse Event|8|||
160837857|NCT00691028|580793152|FG001|Double-blind Period|Adverse Event|9|||
160837858|NCT00691028|580793153|FG002|Double-blind Period|Adverse Event|6|||
160837859|NCT00691028|580793154|FG003|Double-blind Period|Adverse Event|0|||
160837860|NCT00691028|580793151|FG000|Double-blind Period|Lack of Efficacy|4|||
160837861|NCT00691028|580793152|FG001|Double-blind Period|Lack of Efficacy|3|||
160837862|NCT00691028|580793153|FG002|Double-blind Period|Lack of Efficacy|2|||
160837863|NCT00691028|580793154|FG003|Double-blind Period|Lack of Efficacy|0|||
160837864|NCT00691028|580793151|FG000|Double-blind Period|Withdrawal by Subject|1|||
160837865|NCT00691028|580793152|FG001|Double-blind Period|Withdrawal by Subject|0|||
160837866|NCT00691028|580793153|FG002|Double-blind Period|Withdrawal by Subject|1|||
160837867|NCT00691028|580793154|FG003|Double-blind Period|Withdrawal by Subject|0|||
160837868|NCT00691028|580793151|FG000|Double-blind Period|not come to a hospital.|0|||
160837869|NCT00691028|580793152|FG001|Double-blind Period|not come to a hospital.|1|||
160837870|NCT00691028|580793153|FG002|Double-blind Period|not come to a hospital.|0|||
160837871|NCT00691028|580793154|FG003|Double-blind Period|not come to a hospital.|0|||
160837872|NCT03402386|580793157|FG000|Overall Study|Adverse Event|3|||
160563245|NCT00552110|579781718|FG001|Overall Study|Delay of Study due to Relabeling|0|||
160563246|NCT00552110|579781719|FG002|Overall Study|Delay of Study due to Relabeling|0|||
160563247|NCT00552110|579781720|FG003|Overall Study|Delay of Study due to Relabeling|1|||
160563248|NCT00552110|579781721|FG004|Overall Study|Delay of Study due to Relabeling|0|||
160563249|NCT00552110|579781717|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
160563250|NCT00552110|579781718|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
160563251|NCT00552110|579781719|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
160563252|NCT00552110|579781720|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
160563253|NCT00552110|579781721|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
160563254|NCT00552110|579781717|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
160563255|NCT00552110|579781718|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
160837873|NCT03402386|580793157|FG000|Overall Study|Physician Decision|1|||
160837874|NCT03402386|580793157|FG000|Overall Study|Difficult to control Hb|2|||
160837875|NCT01048853|580793158|FG000|Overall Study|Death|1|||
160837876|NCT01048853|580793159|FG001|Overall Study|Death|0|||
160837877|NCT01048853|580793160|FG002|Overall Study|Death|0|||
160837878|NCT01048853|580793158|FG000|Overall Study|Lost to Follow-up|1|||
160837879|NCT01048853|580793159|FG001|Overall Study|Lost to Follow-up|4|||
160837880|NCT01048853|580793160|FG002|Overall Study|Lost to Follow-up|0|||
160837881|NCT00805766|580793167|FG000|Screening Period|Adverse Event|1|||
160837882|NCT00805766|580793167|FG000|Screening Period|Lack of Efficacy|2|||
160837883|NCT00805766|580793167|FG000|Screening Period|Pregnancy|1|||
160837884|NCT00805766|580793167|FG000|Screening Period|Responder|2|||
160837885|NCT00805766|580793167|FG000|Increased Dose Period|Adverse Event|4|||
160837886|NCT00805766|580793167|FG000|Increased Dose Period|Lack of Efficacy|7|||
160837887|NCT00805766|580793167|FG000|Increased Dose Period|Pregnancy|1|||
160837888|NCT00805766|580793167|FG000|Increased Dose Period|Withdrawal by Subject|1|||
160837889|NCT04254913|580793168|FG000|Overall Study|Adverse Event|1|||
160837890|NCT00971243|580793169|FG000|Double Blind Period|Adverse Event|2|||
160837891|NCT00971243|580793170|FG001|Double Blind Period|Adverse Event|3|||
160563256|NCT00552110|579781719|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
160563257|NCT00552110|579781720|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
160563258|NCT00552110|579781721|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
160563259|NCT02500537|579781723|FG000|Overall Study|Death|2|||
160563260|NCT02500537|579781724|FG001|Overall Study|Death|0|||
160563261|NCT02500537|579781723|FG000|Overall Study|Lost to Follow-up|0|||
160563262|NCT02500537|579781724|FG001|Overall Study|Lost to Follow-up|1|||
160563263|NCT02500537|579781723|FG000|Overall Study|Withdrawal by Subject|1|||
160563264|NCT02500537|579781724|FG001|Overall Study|Withdrawal by Subject|0|||
160563265|NCT00355121|579781725|FG000|Overall Study|Did not receive study vaccine|1|||
160563266|NCT00355121|579781726|FG001|Overall Study|Did not receive study vaccine|0|||
160563267|NCT00355121|579781727|FG002|Overall Study|Did not receive study vaccine|1|||
160563268|NCT00355121|579781725|FG000|Overall Study|Adverse Event|0|||
160563269|NCT00355121|579781726|FG001|Overall Study|Adverse Event|1|||
160563270|NCT00355121|579781727|FG002|Overall Study|Adverse Event|0|||
160563271|NCT00355121|579781725|FG000|Overall Study|Protocol Violation|7|||
160563272|NCT00355121|579781726|FG001|Overall Study|Protocol Violation|9|||
160563273|NCT00355121|579781727|FG002|Overall Study|Protocol Violation|1|||
160563274|NCT00355121|579781725|FG000|Overall Study|Lost to Follow-up|4|||
160563275|NCT00355121|579781726|FG001|Overall Study|Lost to Follow-up|7|||
160563276|NCT00355121|579781727|FG002|Overall Study|Lost to Follow-up|1|||
160563277|NCT00355121|579781725|FG000|Overall Study|Withdrawal by Subject|9|||
160563278|NCT00355121|579781726|FG001|Overall Study|Withdrawal by Subject|10|||
160563279|NCT00355121|579781727|FG002|Overall Study|Withdrawal by Subject|2|||
160563280|NCT00355121|579781725|FG000|Overall Study|Serious adverse events|0|||
160563281|NCT00355121|579781726|FG001|Overall Study|Serious adverse events|2|||
160563282|NCT00355121|579781727|FG002|Overall Study|Serious adverse events|0|||
160563283|NCT01587989|579781731|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
160563284|NCT01587989|579781732|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
160563285|NCT01587989|579781733|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
160563286|NCT01587989|579781731|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
160563287|NCT01587989|579781732|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
160563288|NCT01587989|579781733|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
160563289|NCT01587989|579781731|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
160563290|NCT01587989|579781732|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
160563291|NCT01587989|579781733|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
160563292|NCT01587989|579781731|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
160563293|NCT01587989|579781732|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
160563294|NCT01587989|579781733|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
160563295|NCT01587989|579781731|FG000|Randomized Study Treatment|Screening failure|0|||
160563296|NCT01587989|579781732|FG001|Randomized Study Treatment|Screening failure|1|||
160563297|NCT01587989|579781733|FG002|Randomized Study Treatment|Screening failure|0|||
160563298|NCT01587989|579781731|FG000|Randomized Study Treatment|Physician Decision|0|||
160563299|NCT01587989|579781732|FG001|Randomized Study Treatment|Physician Decision|0|||
160563300|NCT01587989|579781733|FG002|Randomized Study Treatment|Physician Decision|1|||
160563301|NCT03313050|579781734|FG000|Stage 2: 12 Months|Adverse Event|0|||
160563302|NCT03313050|579781735|FG001|Stage 2: 12 Months|Adverse Event|0|||
160563303|NCT03313050|579781736|FG002|Stage 2: 12 Months|Adverse Event|0|||
160563304|NCT03313050|579781737|FG003|Stage 2: 12 Months|Adverse Event|1|||
160563305|NCT03313050|579781734|FG000|Stage 2: 12 Months|Death|0|||
160563306|NCT03313050|579781735|FG001|Stage 2: 12 Months|Death|0|||
160563307|NCT03313050|579781736|FG002|Stage 2: 12 Months|Death|3|||
160563308|NCT03313050|579781737|FG003|Stage 2: 12 Months|Death|0|||
160563309|NCT03313050|579781734|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
160563310|NCT03313050|579781735|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
160563311|NCT03313050|579781736|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
160837892|NCT00971243|580793171|FG002|Double Blind Period|Adverse Event|2|||
160837893|NCT00971243|580793172|FG003|Double Blind Period|Adverse Event|2|||
160837894|NCT00971243|580793173|FG004|Double Blind Period|Adverse Event|3|||
160837895|NCT00971243|580793169|FG000|Double Blind Period|Lost to Follow-up|0|||
160837896|NCT00971243|580793170|FG001|Double Blind Period|Lost to Follow-up|1|||
160837897|NCT00971243|580793171|FG002|Double Blind Period|Lost to Follow-up|1|||
160563312|NCT03313050|579781737|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
160837898|NCT00971243|580793172|FG003|Double Blind Period|Lost to Follow-up|0|||
160563313|NCT03313050|579781734|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
160563314|NCT03313050|579781735|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
160563315|NCT03313050|579781736|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
160563316|NCT03313050|579781737|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
160563317|NCT03313050|579781734|FG000|Stage 2: 12 Months|Protocol deviation|0|||
160563318|NCT03313050|579781735|FG001|Stage 2: 12 Months|Protocol deviation|0|||
160837899|NCT00971243|580793173|FG004|Double Blind Period|Lost to Follow-up|1|||
160837900|NCT00971243|580793169|FG000|Double Blind Period|Physician Decision|10|||
160837901|NCT00971243|580793170|FG001|Double Blind Period|Physician Decision|6|||
160563319|NCT03313050|579781736|FG002|Stage 2: 12 Months|Protocol deviation|7|||
160837902|NCT00971243|580793171|FG002|Double Blind Period|Physician Decision|7|||
160837903|NCT00971243|580793172|FG003|Double Blind Period|Physician Decision|6|||
160837904|NCT00971243|580793173|FG004|Double Blind Period|Physician Decision|7|||
160837905|NCT00971243|580793169|FG000|Double Blind Period|Protocol Violation|2|||
160837906|NCT00971243|580793170|FG001|Double Blind Period|Protocol Violation|0|||
160837907|NCT00971243|580793171|FG002|Double Blind Period|Protocol Violation|3|||
160837908|NCT00971243|580793172|FG003|Double Blind Period|Protocol Violation|2|||
160837909|NCT00971243|580793173|FG004|Double Blind Period|Protocol Violation|2|||
160837910|NCT00971243|580793169|FG000|Double Blind Period|Withdrawal by Subject|4|||
160837911|NCT00971243|580793170|FG001|Double Blind Period|Withdrawal by Subject|1|||
160837912|NCT00971243|580793171|FG002|Double Blind Period|Withdrawal by Subject|4|||
160837913|NCT00971243|580793172|FG003|Double Blind Period|Withdrawal by Subject|4|||
160837914|NCT00971243|580793173|FG004|Double Blind Period|Withdrawal by Subject|4|||
160837915|NCT00971243|580793169|FG000|Double Blind Period|Other reasons|1|||
160837916|NCT00971243|580793170|FG001|Double Blind Period|Other reasons|0|||
160837917|NCT00971243|580793171|FG002|Double Blind Period|Other reasons|2|||
160837918|NCT00971243|580793172|FG003|Double Blind Period|Other reasons|0|||
160837919|NCT00971243|580793173|FG004|Double Blind Period|Other reasons|1|||
160837920|NCT00971243|580793169|FG000|Open-label Period|Adverse Event|1|||
160837921|NCT00971243|580793170|FG001|Open-label Period|Adverse Event|0|||
160837922|NCT00971243|580793171|FG002|Open-label Period|Adverse Event|1|||
160837923|NCT00971243|580793172|FG003|Open-label Period|Adverse Event|1|||
160837924|NCT00971243|580793173|FG004|Open-label Period|Adverse Event|0|||
160837925|NCT00971243|580793169|FG000|Open-label Period|Physician Decision|5|||
160837926|NCT00971243|580793170|FG001|Open-label Period|Physician Decision|9|||
160837927|NCT00971243|580793171|FG002|Open-label Period|Physician Decision|3|||
160837928|NCT00971243|580793172|FG003|Open-label Period|Physician Decision|7|||
160837929|NCT00971243|580793173|FG004|Open-label Period|Physician Decision|2|||
160837930|NCT00971243|580793169|FG000|Open-label Period|Protocol Violation|1|||
160837931|NCT00971243|580793170|FG001|Open-label Period|Protocol Violation|1|||
160837932|NCT00971243|580793171|FG002|Open-label Period|Protocol Violation|1|||
160837933|NCT00971243|580793172|FG003|Open-label Period|Protocol Violation|0|||
160837934|NCT00971243|580793173|FG004|Open-label Period|Protocol Violation|1|||
160837935|NCT00971243|580793169|FG000|Open-label Period|Withdrawal by Subject|1|||
160837936|NCT00971243|580793170|FG001|Open-label Period|Withdrawal by Subject|0|||
160837937|NCT00971243|580793171|FG002|Open-label Period|Withdrawal by Subject|0|||
160837938|NCT00971243|580793172|FG003|Open-label Period|Withdrawal by Subject|2|||
160837939|NCT00971243|580793173|FG004|Open-label Period|Withdrawal by Subject|1|||
160837940|NCT00971243|580793169|FG000|Open-label Period|Other reason|0|||
160837941|NCT00971243|580793170|FG001|Open-label Period|Other reason|0|||
160837942|NCT00971243|580793171|FG002|Open-label Period|Other reason|0|||
160837943|NCT00971243|580793172|FG003|Open-label Period|Other reason|0|||
160837944|NCT00971243|580793173|FG004|Open-label Period|Other reason|2|||
160837945|NCT01004952|580793174|FG000|Overall Study|Lost to Follow-up|0|||
160837946|NCT01004952|580793175|FG001|Overall Study|Lost to Follow-up|11|||
160837947|NCT01004952|580793174|FG000|Overall Study|Withdrawal by Subject|0|||
160837948|NCT01004952|580793175|FG001|Overall Study|Withdrawal by Subject|5|||
160837949|NCT02354222|580793179|FG000|Overall Study|Adverse Event|0|||
160837950|NCT02354222|580793180|FG001|Overall Study|Adverse Event|3|||
160837951|NCT02354222|580793179|FG000|Overall Study|Physician Decision|1|||
160837952|NCT02354222|580793180|FG001|Overall Study|Physician Decision|1|||
160837953|NCT02354222|580793179|FG000|Overall Study|Pregnancy|1|||
160837954|NCT02354222|580793180|FG001|Overall Study|Pregnancy|0|||
160837955|NCT02354222|580793179|FG000|Overall Study|Withdrawal by Subject|2|||
160837956|NCT02354222|580793180|FG001|Overall Study|Withdrawal by Subject|3|||
160837957|NCT02354222|580793179|FG000|Overall Study|Conflict with the stopping criteria|0|||
160837958|NCT02354222|580793180|FG001|Overall Study|Conflict with the stopping criteria|4|||
160837959|NCT04300218|580793181|FG000|Overall Study|Lost to Follow-up|6|||
160837960|NCT04300218|580793182|FG001|Overall Study|Lost to Follow-up|8|||
160837961|NCT04099511|580793183|FG000|Overall Study|Lost to Follow-up|2|||
160837962|NCT04099511|580793184|FG001|Overall Study|Lost to Follow-up|2|||
160837963|NCT04099511|580793183|FG000|Overall Study|Withdrawal by Subject|8|||
160837964|NCT04099511|580793184|FG001|Overall Study|Withdrawal by Subject|4|||
160837965|NCT06581094|580793187|FG000|Overall Study|Lost to Follow-up|1|||
160837966|NCT06581094|580793188|FG001|Overall Study|Lost to Follow-up|1|||
160837967|NCT05740618|580793189|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|1|||
160837968|NCT05740618|580793189|FG000|Overall Study|Physician Decision|1|||
160837969|NCT02354235|580793195|FG000|Overall Study|Adverse Event|2|||
160837970|NCT02354235|580793196|FG001|Overall Study|Adverse Event|2|||
160837971|NCT02354235|580793195|FG000|Overall Study|Physician Decision|0|||
160837972|NCT02354235|580793196|FG001|Overall Study|Physician Decision|1|||
160837973|NCT02354235|580793195|FG000|Overall Study|Withdrawal by Subject|1|||
160837974|NCT02354235|580793196|FG001|Overall Study|Withdrawal by Subject|3|||
160837975|NCT02354235|580793195|FG000|Overall Study|Conflict with the stopping criteria|0|||
160837976|NCT02354235|580793196|FG001|Overall Study|Conflict with the stopping criteria|1|||
160837977|NCT05451940|580793197|FG000|Treatment Period|Physician Decision|1|||
160837978|NCT03436693|580793198|FG000|Overall Study|Adverse Event|22|||
160837979|NCT03436693|580793199|FG001|Overall Study|Adverse Event|10|||
160837980|NCT03436693|580793198|FG000|Overall Study|Physician Decision|3|||
160837981|NCT03436693|580793199|FG001|Overall Study|Physician Decision|3|||
160837982|NCT03436693|580793198|FG000|Overall Study|Withdrawal by Subject|4|||
160837983|NCT03436693|580793199|FG001|Overall Study|Withdrawal by Subject|13|||
160837984|NCT03436693|580793198|FG000|Overall Study|Progressive Disease|1|||
160837985|NCT03436693|580793199|FG001|Overall Study|Progressive Disease|1|||
160837986|NCT04481789|580793200|FG000|Period 1|Withdrawal by Subject|1|||
160837987|NCT04481789|580793201|FG001|Period 1|Withdrawal by Subject|0|||
160837988|NCT04481789|580793202|FG002|Period 1|Withdrawal by Subject|0|||
160837989|NCT04481789|580793203|FG003|Period 1|Withdrawal by Subject|0|||
160837990|NCT04481789|580793204|FG004|Period 1|Withdrawal by Subject|0|||
160837991|NCT04481789|580793205|FG005|Period 1|Withdrawal by Subject|0|||
160837992|NCT05216224|580793206|FG000|Overall Study|Adverse Event|6|||
160837993|NCT05216224|580793207|FG001|Overall Study|Adverse Event|3|||
160837994|NCT05216224|580793206|FG000|Overall Study|Lack of Efficacy|1|||
160837995|NCT05216224|580793207|FG001|Overall Study|Lack of Efficacy|0|||
160837996|NCT05216224|580793206|FG000|Overall Study|Lost to Follow-up|8|||
160837997|NCT05216224|580793207|FG001|Overall Study|Lost to Follow-up|6|||
160837998|NCT05216224|580793206|FG000|Overall Study|Protocol Violation|1|||
160837999|NCT05216224|580793207|FG001|Overall Study|Protocol Violation|1|||
160838000|NCT05216224|580793206|FG000|Overall Study|Withdrawal by Subject|6|||
160838001|NCT05216224|580793207|FG001|Overall Study|Withdrawal by Subject|5|||
160838002|NCT05216224|580793206|FG000|Overall Study|Other than specified|1|||
160838003|NCT05216224|580793207|FG001|Overall Study|Other than specified|0|||
160838004|NCT03245008|580793208|FG000|Overall Study|Adverse Event|15|||
160838005|NCT03245008|580793209|FG001|Overall Study|Adverse Event|18|||
160838006|NCT03245008|580793210|FG002|Overall Study|Adverse Event|15|||
160838007|NCT03245008|580793211|FG003|Overall Study|Adverse Event|0|||
160838008|NCT03245008|580793212|FG004|Overall Study|Adverse Event|1|||
160838009|NCT03245008|580793208|FG000|Overall Study|Lack of Efficacy|0|||
160838010|NCT03245008|580793209|FG001|Overall Study|Lack of Efficacy|1|||
160838011|NCT03245008|580793210|FG002|Overall Study|Lack of Efficacy|0|||
160838012|NCT03245008|580793211|FG003|Overall Study|Lack of Efficacy|0|||
160838013|NCT03245008|580793212|FG004|Overall Study|Lack of Efficacy|0|||
160838014|NCT03245008|580793208|FG000|Overall Study|Lost to Follow-up|4|||
160838015|NCT03245008|580793209|FG001|Overall Study|Lost to Follow-up|1|||
160838016|NCT03245008|580793210|FG002|Overall Study|Lost to Follow-up|0|||
160838017|NCT03245008|580793211|FG003|Overall Study|Lost to Follow-up|0|||
160838018|NCT03245008|580793212|FG004|Overall Study|Lost to Follow-up|1|||
160838019|NCT03245008|580793208|FG000|Overall Study|Physician Decision|1|||
160838020|NCT03245008|580793209|FG001|Overall Study|Physician Decision|3|||
160838021|NCT03245008|580793210|FG002|Overall Study|Physician Decision|4|||
160838022|NCT03245008|580793211|FG003|Overall Study|Physician Decision|0|||
160838023|NCT03245008|580793212|FG004|Overall Study|Physician Decision|0|||
160838024|NCT03245008|580793208|FG000|Overall Study|Protocol Violation|0|||
160838025|NCT03245008|580793209|FG001|Overall Study|Protocol Violation|1|||
160838026|NCT03245008|580793210|FG002|Overall Study|Protocol Violation|0|||
160838027|NCT03245008|580793211|FG003|Overall Study|Protocol Violation|0|||
160838028|NCT03245008|580793212|FG004|Overall Study|Protocol Violation|0|||
160838029|NCT03245008|580793208|FG000|Overall Study|Withdrawal by Subject|20|||
160838030|NCT03245008|580793209|FG001|Overall Study|Withdrawal by Subject|19|||
160838031|NCT03245008|580793210|FG002|Overall Study|Withdrawal by Subject|11|||
160838032|NCT03245008|580793211|FG003|Overall Study|Withdrawal by Subject|0|||
160838033|NCT03245008|580793212|FG004|Overall Study|Withdrawal by Subject|0|||
160838034|NCT03245008|580793208|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
160838035|NCT03245008|580793209|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
160838036|NCT03245008|580793210|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
160838037|NCT03245008|580793211|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
160838038|NCT03245008|580793212|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
160838039|NCT03245008|580793208|FG000|Overall Study|Failure to meet randomization criteria|0|||
160838040|NCT03245008|580793209|FG001|Overall Study|Failure to meet randomization criteria|1|||
160838041|NCT03245008|580793210|FG002|Overall Study|Failure to meet randomization criteria|0|||
160838042|NCT03245008|580793211|FG003|Overall Study|Failure to meet randomization criteria|1|||
160838043|NCT03245008|580793212|FG004|Overall Study|Failure to meet randomization criteria|0|||
160838044|NCT04655144|580793218|FG000|Overall Study|Consumed THC|1|||
160838045|NCT04655144|580793219|FG001|Overall Study|Consumed THC|0|||
160838046|NCT04655144|580793218|FG000|Overall Study|Unilateral embolization|0|||
160838047|NCT04655144|580793219|FG001|Overall Study|Unilateral embolization|1|||
160838048|NCT04317742|580793220|FG000|Overall Study|Lost to Follow-up|57|||
160838049|NCT04317742|580793221|FG001|Overall Study|Lost to Follow-up|59|||
160838050|NCT04317742|580793220|FG000|Overall Study|Pregnancy|1|||
160838051|NCT04317742|580793221|FG001|Overall Study|Pregnancy|1|||
160838052|NCT04317742|580793220|FG000|Overall Study|Withdrawal by Subject|46|||
160838053|NCT04317742|580793221|FG001|Overall Study|Withdrawal by Subject|24|||
160838054|NCT03645863|580793222|FG000|Overall Study|Withdrawal by Subject|1|||
160838055|NCT03645863|580793223|FG001|Overall Study|Withdrawal by Subject|0|||
160838056|NCT03645863|580793224|FG002|Overall Study|Withdrawal by Subject|0|||
160838057|NCT01580670|580793225|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
160838058|NCT01580670|580793225|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
160838059|NCT02220907|580793226|FG000|Overall Study|Adverse Event|7|||
160838060|NCT02220907|580793226|FG000|Overall Study|Physician Decision|1|||
160838061|NCT02220907|580793226|FG000|Overall Study|Withdrawal by Subject|2|||
160838062|NCT02220907|580793226|FG000|Overall Study|Conflict with the stopping criteria|1|||
160838063|NCT00542815|580793227|FG000|Overall Study|Adverse Event|19|||
160838064|NCT00542815|580793228|FG001|Overall Study|Adverse Event|6|||
160838065|NCT00542815|580793229|FG002|Overall Study|Adverse Event|9|||
160838066|NCT00542815|580793227|FG000|Overall Study|Death|10|||
160838067|NCT00542815|580793228|FG001|Overall Study|Death|7|||
160838068|NCT00542815|580793229|FG002|Overall Study|Death|3|||
160838069|NCT00542815|580793227|FG000|Overall Study|Lack of Efficacy|9|||
160838070|NCT00542815|580793228|FG001|Overall Study|Lack of Efficacy|2|||
160838071|NCT00542815|580793229|FG002|Overall Study|Lack of Efficacy|0|||
160838072|NCT00542815|580793227|FG000|Overall Study|Physician Decision|2|||
160838073|NCT00542815|580793228|FG001|Overall Study|Physician Decision|1|||
160838074|NCT00542815|580793229|FG002|Overall Study|Physician Decision|0|||
160838075|NCT00542815|580793227|FG000|Overall Study|Protocol Violation|1|||
160838076|NCT00542815|580793228|FG001|Overall Study|Protocol Violation|1|||
160838077|NCT00542815|580793229|FG002|Overall Study|Protocol Violation|2|||
160838078|NCT00542815|580793227|FG000|Overall Study|Withdrawal by Subject|41|||
160838079|NCT00542815|580793228|FG001|Overall Study|Withdrawal by Subject|5|||
160838080|NCT00542815|580793229|FG002|Overall Study|Withdrawal by Subject|8|||
160838081|NCT00542815|580793227|FG000|Overall Study|Other reasons|24|||
160838082|NCT00542815|580793228|FG001|Overall Study|Other reasons|10|||
160838083|NCT00542815|580793229|FG002|Overall Study|Other reasons|10|||
160838084|NCT06045507|580793883|FG000|Overall Study|Death|0|||
160838085|NCT06045507|580793884|FG001|Overall Study|Death|0|||
160838086|NCT06045507|580793885|FG002|Overall Study|Death|1|||
160563320|NCT03313050|579781737|FG003|Stage 2: 12 Months|Protocol deviation|7|||
160563321|NCT03313050|579781734|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
160563322|NCT03313050|579781735|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
160838087|NCT06045507|580793886|FG003|Overall Study|Death|0|||
160838088|NCT06045507|580793883|FG000|Overall Study|Lost to Follow-up|3|||
160838089|NCT06045507|580793884|FG001|Overall Study|Lost to Follow-up|3|||
160838090|NCT06045507|580793885|FG002|Overall Study|Lost to Follow-up|0|||
160838091|NCT06045507|580793886|FG003|Overall Study|Lost to Follow-up|0|||
160563323|NCT03313050|579781736|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
160563324|NCT03313050|579781737|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
160563325|NCT03313050|579781734|FG000|Stage 2: 12 Months|Other|0|||
160838092|NCT06045507|580793883|FG000|Overall Study|Randomized by mistake (no study treatment given)|0|||
160838093|NCT06045507|580793884|FG001|Overall Study|Randomized by mistake (no study treatment given)|1|||
160838094|NCT06045507|580793885|FG002|Overall Study|Randomized by mistake (no study treatment given)|1|||
160838095|NCT06045507|580793886|FG003|Overall Study|Randomized by mistake (no study treatment given)|0|||
160838096|NCT06045507|580793883|FG000|Overall Study|Withdrawal by Subject|4|||
160563326|NCT03313050|579781735|FG001|Stage 2: 12 Months|Other|0|||
160563327|NCT03313050|579781736|FG002|Stage 2: 12 Months|Other|0|||
160838097|NCT06045507|580793884|FG001|Overall Study|Withdrawal by Subject|1|||
160838098|NCT06045507|580793885|FG002|Overall Study|Withdrawal by Subject|0|||
160838099|NCT06045507|580793886|FG003|Overall Study|Withdrawal by Subject|2|||
160838100|NCT06045507|580793883|FG000|Overall Study|Miscellaneous|2|||
160838101|NCT06045507|580793884|FG001|Overall Study|Miscellaneous|0|||
160838102|NCT06045507|580793885|FG002|Overall Study|Miscellaneous|0|||
160838103|NCT06045507|580793886|FG003|Overall Study|Miscellaneous|1|||
160838104|NCT03688100|580793891|FG000|Overall Study|Lost to Follow-up|21|||
160838105|NCT03688100|580793892|FG001|Overall Study|Lost to Follow-up|15|||
160838106|NCT03688100|580793893|FG002|Overall Study|Lost to Follow-up|15|||
160838107|NCT03688100|580793894|FG003|Overall Study|Lost to Follow-up|18|||
160838108|NCT03688100|580793891|FG000|Overall Study|Withdrawal by Subject|19|||
160838109|NCT03688100|580793892|FG001|Overall Study|Withdrawal by Subject|16|||
160838110|NCT03688100|580793893|FG002|Overall Study|Withdrawal by Subject|0|||
160904343|NCT02165215|581044924|FG002|Maintenance Phase|Lost to Follow-up|0|||
160904344|NCT02165215|581044922|FG000|Maintenance Phase|Adverse Event|0|||
160904345|NCT02165215|581044923|FG001|Maintenance Phase|Adverse Event|1|||
160904346|NCT02165215|581044924|FG002|Maintenance Phase|Adverse Event|1|||
160904347|NCT00592384|581044925|FG000|Overall Study|Withdrawal by Subject|5|||
160904348|NCT00592384|581044926|FG001|Overall Study|Withdrawal by Subject|6|||
160904349|NCT01153347|581044934|FG000|Overall Study|Withdrawal by Subject|7|||
160904350|NCT01153347|581044935|FG001|Overall Study|Withdrawal by Subject|7|||
160904351|NCT01153347|581044936|FG002|Overall Study|Withdrawal by Subject|7|||
160904352|NCT01153347|581044937|FG003|Overall Study|Withdrawal by Subject|7|||
160904353|NCT01153347|581044934|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160904354|NCT01153347|581044935|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160904355|NCT01153347|581044936|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
160904356|NCT01153347|581044937|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
160904357|NCT01153347|581044934|FG000|Overall Study|Adverse Event|3|||
160904358|NCT01153347|581044935|FG001|Overall Study|Adverse Event|9|||
160904359|NCT01153347|581044936|FG002|Overall Study|Adverse Event|21|||
160904360|NCT01153347|581044937|FG003|Overall Study|Adverse Event|7|||
160904361|NCT01153347|581044934|FG000|Overall Study|Severe non-compliance to protocol|6|||
160904362|NCT01153347|581044935|FG001|Overall Study|Severe non-compliance to protocol|7|||
160904363|NCT01153347|581044936|FG002|Overall Study|Severe non-compliance to protocol|4|||
160904364|NCT01153347|581044937|FG003|Overall Study|Severe non-compliance to protocol|3|||
160904365|NCT01153347|581044934|FG000|Overall Study|Condition under investigation worsened|1|||
160904366|NCT01153347|581044935|FG001|Overall Study|Condition under investigation worsened|1|||
160904367|NCT01153347|581044936|FG002|Overall Study|Condition under investigation worsened|0|||
160904368|NCT01153347|581044937|FG003|Overall Study|Condition under investigation worsened|0|||
160904369|NCT01153347|581044934|FG000|Overall Study|Lack of Efficacy|2|||
160904370|NCT01153347|581044935|FG001|Overall Study|Lack of Efficacy|2|||
160904371|NCT01153347|581044936|FG002|Overall Study|Lack of Efficacy|0|||
160904372|NCT01153347|581044937|FG003|Overall Study|Lack of Efficacy|4|||
160904373|NCT01153347|581044934|FG000|Overall Study|Study-specific withdrawal criteria|4|||
160904374|NCT01153347|581044935|FG001|Overall Study|Study-specific withdrawal criteria|3|||
160904375|NCT01153347|581044936|FG002|Overall Study|Study-specific withdrawal criteria|1|||
160904376|NCT01153347|581044937|FG003|Overall Study|Study-specific withdrawal criteria|2|||
160904377|NCT01153347|581044934|FG000|Overall Study|Lost to Follow-up|4|||
160904378|NCT01153347|581044935|FG001|Overall Study|Lost to Follow-up|9|||
160904379|NCT01153347|581044936|FG002|Overall Study|Lost to Follow-up|11|||
160904380|NCT01153347|581044937|FG003|Overall Study|Lost to Follow-up|8|||
160904381|NCT01153347|581044934|FG000|Overall Study|Other|5|||
160904382|NCT01153347|581044935|FG001|Overall Study|Other|5|||
160904383|NCT01153347|581044936|FG002|Overall Study|Other|4|||
160904384|NCT01153347|581044937|FG003|Overall Study|Other|0|||
160904385|NCT01153347|581044934|FG000|Overall Study|Death|1|||
160904386|NCT01153347|581044935|FG001|Overall Study|Death|0|||
160904387|NCT01153347|581044936|FG002|Overall Study|Death|0|||
160904388|NCT01153347|581044937|FG003|Overall Study|Death|0|||
160904389|NCT00003473|581044941|FG000|Overall Study|Three patients were not evaluable.|3|||
160904390|NCT04401423|581044942|FG000|Overall Study|Withdrawal by Subject|3|||
160838111|NCT03688100|580793894|FG003|Overall Study|Withdrawal by Subject|0|||
160838112|NCT03688100|580793891|FG000|Overall Study|Death|36|||
160838113|NCT03688100|580793892|FG001|Overall Study|Death|27|||
160904391|NCT04401423|581044943|FG001|Overall Study|Withdrawal by Subject|1|||
160904392|NCT04401423|581044942|FG000|Overall Study|Physician Decision|2|||
160904393|NCT04401423|581044943|FG001|Overall Study|Physician Decision|1|||
160904394|NCT04678661|581044944|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
160904395|NCT04678661|581044945|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
160904396|NCT04678661|581044944|FG000|Overall Study|Protocol Violation|2|||
160904397|NCT04678661|581044945|FG001|Overall Study|Protocol Violation|0|||
160904398|NCT04678661|581044944|FG000|Overall Study|Withdrawal by Subject|1|||
160838114|NCT03688100|580793893|FG002|Overall Study|Death|0|||
160838115|NCT03688100|580793894|FG003|Overall Study|Death|0|||
160838116|NCT02479139|580793900|FG000|Overall Study|Lost to Follow-up|2|||
160838117|NCT02479139|580793901|FG001|Overall Study|Lost to Follow-up|4|||
160838118|NCT02479139|580793902|FG002|Overall Study|Lost to Follow-up|4|||
160838119|NCT02479139|580793903|FG003|Overall Study|Lost to Follow-up|2|||
160838120|NCT02479139|580793904|FG004|Overall Study|Lost to Follow-up|3|||
160838121|NCT02479139|580793905|FG005|Overall Study|Lost to Follow-up|5|||
160838122|NCT02479139|580793900|FG000|Overall Study|Withdrew Consent|5|||
160838123|NCT02479139|580793901|FG001|Overall Study|Withdrew Consent|6|||
160838124|NCT02479139|580793902|FG002|Overall Study|Withdrew Consent|1|||
160838125|NCT02479139|580793903|FG003|Overall Study|Withdrew Consent|4|||
160838126|NCT02479139|580793904|FG004|Overall Study|Withdrew Consent|1|||
160838127|NCT02479139|580793905|FG005|Overall Study|Withdrew Consent|1|||
160838128|NCT02479139|580793900|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
160838129|NCT02479139|580793901|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
160838130|NCT02479139|580793902|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
160904399|NCT04678661|581044945|FG001|Overall Study|Withdrawal by Subject|0|||
160904400|NCT04678661|581044944|FG000|Overall Study|Lost to Follow-up|2|||
160904401|NCT04678661|581044945|FG001|Overall Study|Lost to Follow-up|0|||
160904402|NCT04678661|581044944|FG000|Overall Study|Death|2|||
160904403|NCT04678661|581044945|FG001|Overall Study|Death|0|||
160904404|NCT03039283|581044949|FG000|Overall Study|Protocol Violation|2|||
160904405|NCT03639935|581044950|FG000|Overall Study|Death|3|||
160904406|NCT03639935|581044950|FG000|Overall Study|Adverse Event|1|||
160904407|NCT00864721|581044951|FG000|Overall Study|Patient request|11|||
160904408|NCT00864721|581044951|FG000|Overall Study|Hospitalized|1|||
160904409|NCT00864721|581044951|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
160904410|NCT00864721|581044951|FG000|Overall Study|Adverse Event|21|||
160904411|NCT01921387|581044954|FG000|Overall Study|Adverse Event|1|||
160904412|NCT01773733|581044955|FG000|Overall Study|Adverse Event|3286|||
160904413|NCT01773733|581044956|FG001|Overall Study|Adverse Event|540|||
160904414|NCT01773733|581044955|FG000|Overall Study|Pregnancy|28|||
160904415|NCT01773733|581044956|FG001|Overall Study|Pregnancy|0|||
160904416|NCT01773733|581044955|FG000|Overall Study|Other different categories of not compl|55415|||
160904417|NCT01773733|581044956|FG001|Overall Study|Other different categories of not compl|7781|||
160904418|NCT03741062|581044957|FG000|Overall Study|Protocol Violation|1|||
160904419|NCT03741062|581044958|FG001|Overall Study|Protocol Violation|0|||
160904420|NCT00261807|581044959|FG000|Overall Study|Lost to Follow-up|2|||
160904421|NCT00261807|581044959|FG000|Overall Study|Adverse Event|2|||
160904422|NCT00261807|581044959|FG000|Overall Study|Death|1|||
160904423|NCT00261807|581044959|FG000|Overall Study|Protocol Violation|2|||
160904424|NCT02527161|581044961|FG000|Overall Study|Failed MRI|52|||
160904425|NCT02527161|581044961|FG000|Overall Study|Withdrawal by Subject|19|||
160904426|NCT02527161|581044961|FG000|Overall Study|Delay in or unfit for surgery|16|||
160904427|NCT02527161|581044961|FG000|Overall Study|MRI contraindication|6|||
160904428|NCT02527161|581044961|FG000|Overall Study|Consent violation|4|||
160904429|NCT02527161|581044961|FG000|Overall Study|Only Recruited to Part A|27|||
160904430|NCT02527161|581044961|FG000|Overall Study|Physician Decision|1|||
160904431|NCT02527161|581044961|FG000|Overall Study|Adverse Event|1|||
160904432|NCT02527161|581044961|FG000|Overall Study|Lost to Follow-up|6|||
160904433|NCT00762229|581044964|FG000|Overall Study|Lost to Follow-up|1|||
160904434|NCT00762229|581044965|FG001|Overall Study|Lost to Follow-up|1|||
160838131|NCT02479139|580793903|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
160838132|NCT02479139|580793904|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
160838133|NCT02479139|580793905|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
160838134|NCT02479139|580793900|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160838135|NCT02479139|580793901|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160838136|NCT02479139|580793902|FG002|Overall Study|Other Miscellaneous Reasons|1|||
160838137|NCT02479139|580793903|FG003|Overall Study|Other Miscellaneous Reasons|1|||
160838138|NCT02479139|580793904|FG004|Overall Study|Other Miscellaneous Reasons|1|||
160838139|NCT02479139|580793905|FG005|Overall Study|Other Miscellaneous Reasons|0|||
160904435|NCT00762229|581044964|FG000|Overall Study|did not recveive intervention|0|||
160904436|NCT00762229|581044965|FG001|Overall Study|did not recveive intervention|1|||
160904437|NCT02609828|581044966|FG000|Overall Study|Adverse Event|8|||
160904438|NCT02609828|581044967|FG001|Overall Study|Adverse Event|1|||
160904439|NCT02609828|581044968|FG002|Overall Study|Adverse Event|0|||
160904440|NCT02609828|581044969|FG003|Overall Study|Adverse Event|6|||
160904441|NCT02609828|581044966|FG000|Overall Study|Death|15|||
160904442|NCT02609828|581044967|FG001|Overall Study|Death|1|||
160904443|NCT02609828|581044968|FG002|Overall Study|Death|1|||
160904444|NCT02609828|581044969|FG003|Overall Study|Death|19|||
160838140|NCT00885482|580793906|FG000|Overall Study|Pregnancy|1|||
160838141|NCT00885482|580793906|FG000|Overall Study|Lack of Efficacy|1|||
160838142|NCT00885482|580793906|FG000|Overall Study|Death|1|||
160838143|NCT00885482|580793906|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
160838144|NCT00084656|580793907|FG000|Overall Study|Other reasons|0|||
160838145|NCT00084656|580793908|FG001|Overall Study|Other reasons|12|||
160838146|NCT00084656|580793909|FG002|Overall Study|Other reasons|11|||
160838147|NCT00084656|580793907|FG000|Overall Study|Withdrawal by Subject|15|||
160838148|NCT00084656|580793908|FG001|Overall Study|Withdrawal by Subject|4|||
160838149|NCT00084656|580793909|FG002|Overall Study|Withdrawal by Subject|4|||
160838150|NCT00084656|580793907|FG000|Overall Study|Disease relapse|0|||
160838151|NCT00084656|580793908|FG001|Overall Study|Disease relapse|9|||
160838152|NCT00084656|580793909|FG002|Overall Study|Disease relapse|10|||
160838153|NCT00084656|580793907|FG000|Overall Study|Disease progression|9|||
160838154|NCT00084656|580793908|FG001|Overall Study|Disease progression|0|||
160838155|NCT00084656|580793909|FG002|Overall Study|Disease progression|0|||
160838156|NCT00084656|580793907|FG000|Overall Study|Lost to Follow-up|1|||
160838157|NCT00084656|580793908|FG001|Overall Study|Lost to Follow-up|0|||
160838158|NCT00084656|580793909|FG002|Overall Study|Lost to Follow-up|1|||
160838159|NCT02772978|580793910|FG000|Overall Study|Withdrawal by Subject|1|||
160838160|NCT02772978|580793911|FG001|Overall Study|Withdrawal by Subject|1|||
160838161|NCT00989781|580793912|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
160838162|NCT00989781|580793913|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
160838163|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
160838164|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
160838165|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
160838166|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
160838167|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
160838168|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
160838169|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
160838170|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
160838171|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
160838172|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
160838173|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
160838174|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
160838175|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
160838176|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
160838177|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
160838178|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
160838179|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
160838180|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
160838181|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
160838182|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
160838183|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
160838184|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
160838185|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
160838186|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
160838187|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
160838188|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
160838189|NCT01532869|580793914|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
160838190|NCT01532869|580793915|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
160838191|NCT01532869|580793914|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
160838192|NCT01532869|580793915|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
160838193|NCT01532869|580793914|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
160838194|NCT01532869|580793915|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
160838195|NCT01532869|580793914|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
160838196|NCT01532869|580793915|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
160838197|NCT01069705|580793919|FG000|Overall Study|Adverse Event|1|||
160838198|NCT01069705|580793919|FG000|Overall Study|Withdrawal by Subject|2|||
160838199|NCT03624127|580793920|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
160838200|NCT03624127|580793921|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
160838201|NCT03624127|580793922|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
160838202|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
160563328|NCT03313050|579781737|FG003|Stage 2: 12 Months|Other|1|||
160563329|NCT04211337|579781738|FG000|Overall Study|On Treatment|175|||
160563330|NCT04211337|579781739|FG001|Overall Study|On Treatment|40|||
160838203|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
160838204|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
160838205|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Death|0|||
160563331|NCT04211337|579781738|FG000|Overall Study|Withdrawal by Subject|0|||
160563332|NCT04211337|579781739|FG001|Overall Study|Withdrawal by Subject|2|||
160838206|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Death|1|||
160838207|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Death|0|||
160838208|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
160838209|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
160838210|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
160838211|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
160838212|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
160838213|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
160838214|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
160838215|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
160838216|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
160563333|NCT01291017|579781740|FG000|Overall Study|Lost to Follow-up|2|||
160563334|NCT01291017|579781740|FG000|Overall Study|Withdrawal by Subject|3|||
160838217|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
160838218|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
160838219|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
160838220|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
160563335|NCT00215150|579784443|FG000|Open Label Phase|Lost to Follow-up|7|||
160563336|NCT00215150|579784443|FG000|Open Label Phase|Withdrawal by Subject|1|||
160563337|NCT00215150|579784443|FG000|Open Label Phase|Did not complete a post base visit|13|||
160563338|NCT00215150|579784443|FG000|Open Label Phase|Did not meet randomization criteria|9|||
160563339|NCT00215150|579784443|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
160563340|NCT00215150|579784443|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
160563341|NCT00215150|579784443|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
160563342|NCT02091440|579784447|FG000|Overall Study|Death|2|||
160563343|NCT00278629|579784454|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
160563344|NCT03323749|579784455|FG000|Double-blind Period|Lost to Follow-up|4|||
160563345|NCT03323749|579784456|FG001|Double-blind Period|Lost to Follow-up|5|||
160563346|NCT03323749|579784455|FG000|Double-blind Period|Adverse Event|3|||
160563347|NCT03323749|579784456|FG001|Double-blind Period|Adverse Event|1|||
160563348|NCT03323749|579784455|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
160563349|NCT03323749|579784456|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
160563350|NCT03323749|579784455|FG000|Open-Label Period|Adverse Event|3|||
160563351|NCT03323749|579784456|FG001|Open-Label Period|Adverse Event|10|||
160563352|NCT03323749|579784455|FG000|Open-Label Period|Withdrawal by Subject|7|||
160563353|NCT03323749|579784456|FG001|Open-Label Period|Withdrawal by Subject|5|||
160838221|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
160838222|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
160838223|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
160838224|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
160838225|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
160838226|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
160838227|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
160838228|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
160838229|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
160838230|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
160838231|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
160838232|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
160838233|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
160838234|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
160838235|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
160838236|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
160838237|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
160838238|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
160838239|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
160838240|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
160838241|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
160838242|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
160838243|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
160838244|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
160838245|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
160838246|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
160838247|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
160838248|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
160838249|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
160838250|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
160563354|NCT01821963|579784457|FG000|Overall Study|Adverse Event|1|||
160563355|NCT00783289|579784458|FG000|Overall Study|Protocol Violation|0|||
160838251|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
160838252|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
160563356|NCT00783289|579784459|FG001|Overall Study|Protocol Violation|1|||
160838253|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
160838254|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
160838255|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
160838256|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
160838257|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
160838258|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
160838259|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
160838260|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
160838261|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
160838262|NCT01817959|580793923|FG000|Overall Study|Graft loss|1|||
160838263|NCT01817959|580793924|FG001|Overall Study|Graft loss|1|||
160838264|NCT01817959|580793923|FG000|Overall Study|forbidden medication|1|||
160838265|NCT01817959|580793924|FG001|Overall Study|forbidden medication|1|||
160838266|NCT01817959|580793923|FG000|Overall Study|Adverse Event|1|||
160838267|NCT01817959|580793924|FG001|Overall Study|Adverse Event|0|||
160838268|NCT01817959|580793923|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
160838269|NCT01817959|580793924|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
160838270|NCT01123707|580793925|FG000|Overall Study|Lost to Follow-up|3|||
160838271|NCT01123707|580793926|FG001|Overall Study|Lost to Follow-up|1|||
160838272|NCT01123707|580793927|FG002|Overall Study|Lost to Follow-up|3|||
160838273|NCT01123707|580793928|FG003|Overall Study|Lost to Follow-up|2|||
160838274|NCT01123707|580793925|FG000|Overall Study|Adverse Event|5|||
160838275|NCT01123707|580793926|FG001|Overall Study|Adverse Event|7|||
160838276|NCT01123707|580793927|FG002|Overall Study|Adverse Event|5|||
160838277|NCT01123707|580793928|FG003|Overall Study|Adverse Event|3|||
160838278|NCT01123707|580793925|FG000|Overall Study|Sponsor Discontinued Study|30|||
160838279|NCT01123707|580793926|FG001|Overall Study|Sponsor Discontinued Study|24|||
160838280|NCT01123707|580793927|FG002|Overall Study|Sponsor Discontinued Study|25|||
160838281|NCT01123707|580793928|FG003|Overall Study|Sponsor Discontinued Study|40|||
160838282|NCT01123707|580793925|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
160838283|NCT01123707|580793926|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
160838284|NCT01123707|580793927|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
160838285|NCT01123707|580793928|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
160838286|NCT01123707|580793925|FG000|Overall Study|Investigator Withdrew Participant|0|||
160838287|NCT01123707|580793926|FG001|Overall Study|Investigator Withdrew Participant|1|||
160838288|NCT01123707|580793927|FG002|Overall Study|Investigator Withdrew Participant|1|||
160838289|NCT01123707|580793928|FG003|Overall Study|Investigator Withdrew Participant|1|||
160838290|NCT01123707|580793925|FG000|Overall Study|Subject Withdrew Consent|4|||
160838291|NCT01123707|580793926|FG001|Overall Study|Subject Withdrew Consent|5|||
160838292|NCT01123707|580793927|FG002|Overall Study|Subject Withdrew Consent|1|||
160838293|NCT01123707|580793928|FG003|Overall Study|Subject Withdrew Consent|2|||
160838294|NCT01123707|580793925|FG000|Overall Study|Lack of Efficacy|1|||
160838295|NCT01123707|580793926|FG001|Overall Study|Lack of Efficacy|2|||
160838296|NCT01123707|580793927|FG002|Overall Study|Lack of Efficacy|1|||
160904445|NCT02609828|581044966|FG000|Overall Study|Insufficient clinical response|2|||
160904446|NCT02609828|581044967|FG001|Overall Study|Insufficient clinical response|1|||
160904447|NCT02609828|581044968|FG002|Overall Study|Insufficient clinical response|0|||
160904448|NCT02609828|581044969|FG003|Overall Study|Insufficient clinical response|0|||
160904449|NCT02609828|581044966|FG000|Overall Study|Lost to Follow-up|0|||
160904450|NCT02609828|581044967|FG001|Overall Study|Lost to Follow-up|0|||
160904451|NCT02609828|581044968|FG002|Overall Study|Lost to Follow-up|0|||
160904452|NCT02609828|581044969|FG003|Overall Study|Lost to Follow-up|1|||
160563357|NCT00783289|579784460|FG002|Overall Study|Protocol Violation|0|||
160563358|NCT00783289|579784461|FG003|Overall Study|Protocol Violation|0|||
160563359|NCT00506389|579784462|FG000|In-treatment Period|Other|3|||
160563360|NCT00506389|579784463|FG001|In-treatment Period|Other|3|||
160563361|NCT00506389|579784464|FG002|In-treatment Period|Other|4|||
160563362|NCT00506389|579784462|FG000|In-treatment Period|Lost to Follow-up|0|||
160563363|NCT00506389|579784463|FG001|In-treatment Period|Lost to Follow-up|0|||
160563364|NCT00506389|579784464|FG002|In-treatment Period|Lost to Follow-up|1|||
160563365|NCT00506389|579784462|FG000|In-treatment Period|Lack of compliance|1|||
160563366|NCT00506389|579784463|FG001|In-treatment Period|Lack of compliance|0|||
160563367|NCT00506389|579784464|FG002|In-treatment Period|Lack of compliance|0|||
160563368|NCT00506389|579784462|FG000|In-treatment Period|Reasons not related to trial|4|||
160563369|NCT00506389|579784463|FG001|In-treatment Period|Reasons not related to trial|1|||
160563370|NCT00506389|579784464|FG002|In-treatment Period|Reasons not related to trial|0|||
160563371|NCT00506389|579784462|FG000|In-treatment Period|Withdrawal by Subject|3|||
160563372|NCT00506389|579784463|FG001|In-treatment Period|Withdrawal by Subject|3|||
160563373|NCT00506389|579784464|FG002|In-treatment Period|Withdrawal by Subject|4|||
160563374|NCT00506389|579784462|FG000|In-treatment Period|Lack of Efficacy|0|||
160563375|NCT00506389|579784463|FG001|In-treatment Period|Lack of Efficacy|2|||
160563376|NCT00506389|579784464|FG002|In-treatment Period|Lack of Efficacy|0|||
160563377|NCT00506389|579784462|FG000|In-treatment Period|Adverse Event|11|||
160563378|NCT00506389|579784463|FG001|In-treatment Period|Adverse Event|5|||
160563379|NCT00506389|579784464|FG002|In-treatment Period|Adverse Event|2|||
160563380|NCT00506389|579784462|FG000|In-treatment Period|Randomized but not treated|4|||
160563381|NCT00506389|579784463|FG001|In-treatment Period|Randomized but not treated|1|||
160563382|NCT00506389|579784464|FG002|In-treatment Period|Randomized but not treated|1|||
160563383|NCT05224258|579784466|FG000|Overall Study|Withdrawal by Subject|1|||
160563384|NCT05224258|579784467|FG001|Overall Study|Withdrawal by Subject|1|||
160563385|NCT05224258|579784466|FG000|Overall Study|Physician Decision|1|||
160563386|NCT05224258|579784467|FG001|Overall Study|Physician Decision|1|||
160563387|NCT05224258|579784466|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160563388|NCT05224258|579784467|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160563389|NCT05224258|579784466|FG000|Overall Study|Study Product No Longer in Use|1|||
160563390|NCT05224258|579784467|FG001|Overall Study|Study Product No Longer in Use|0|||
160563391|NCT05224258|579784466|FG000|Overall Study|Adverse Event|0|||
160563392|NCT05224258|579784467|FG001|Overall Study|Adverse Event|1|||
160563393|NCT05224258|579784466|FG000|Overall Study|Protocol Deviation|0|||
160563394|NCT05224258|579784467|FG001|Overall Study|Protocol Deviation|1|||
160563395|NCT03095703|579784469|FG000|Overall Study|Withdrawal by Subject|1|||
160563396|NCT03539432|579784470|FG000|Overall Study|Lost to Follow-up|0|||
160563397|NCT03539432|579784471|FG001|Overall Study|Lost to Follow-up|1|||
160563398|NCT01381094|579784472|FG000|Overall Study|Adverse Event|1|||
160563399|NCT01381094|579784473|FG001|Overall Study|Adverse Event|2|||
160563400|NCT01381094|579784474|FG002|Overall Study|Adverse Event|0|||
160563401|NCT01381094|579784475|FG003|Overall Study|Adverse Event|1|||
160563402|NCT01381094|579784476|FG004|Overall Study|Adverse Event|0|||
160563403|NCT01381094|579784472|FG000|Overall Study|Lost to Follow-up|0|||
160563404|NCT01381094|579784473|FG001|Overall Study|Lost to Follow-up|0|||
160563405|NCT01381094|579784474|FG002|Overall Study|Lost to Follow-up|0|||
160563406|NCT01381094|579784475|FG003|Overall Study|Lost to Follow-up|0|||
160563407|NCT01381094|579784476|FG004|Overall Study|Lost to Follow-up|1|||
160563408|NCT01381094|579784472|FG000|Overall Study|Withdrawal of informed consent|0|||
160563409|NCT01381094|579784473|FG001|Overall Study|Withdrawal of informed consent|1|||
160563410|NCT01381094|579784474|FG002|Overall Study|Withdrawal of informed consent|0|||
160563411|NCT01381094|579784475|FG003|Overall Study|Withdrawal of informed consent|0|||
160563412|NCT01381094|579784476|FG004|Overall Study|Withdrawal of informed consent|0|||
160563413|NCT01381094|579784472|FG000|Overall Study|Participant given Aranesp injection|1|||
160563414|NCT01381094|579784473|FG001|Overall Study|Participant given Aranesp injection|0|||
160563415|NCT01381094|579784474|FG002|Overall Study|Participant given Aranesp injection|0|||
160563416|NCT01381094|579784475|FG003|Overall Study|Participant given Aranesp injection|0|||
160563417|NCT01381094|579784476|FG004|Overall Study|Participant given Aranesp injection|0|||
160563418|NCT02443402|579784479|FG000|Overall Study|Withdrawal by Subject|3|||
160563419|NCT02443402|579784480|FG001|Overall Study|Withdrawal by Subject|1|||
160991738|NCT00430677|581357895|FG002|Long-term Extension Period|Lost to Follow-up|1|||
160991739|NCT00430677|581357893|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
160991740|NCT00430677|581357894|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
160991741|NCT00430677|581357895|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
160991742|NCT00430677|581357893|FG000|Long-term Extension Period|Pregnancy|1|||
160991743|NCT00430677|581357894|FG001|Long-term Extension Period|Pregnancy|1|||
160991744|NCT00430677|581357895|FG002|Long-term Extension Period|Pregnancy|0|||
160991745|NCT00430677|581357893|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
160991746|NCT00430677|581357894|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
160991747|NCT00430677|581357895|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
160991748|NCT00430677|581357893|FG000|Long-term Extension Period|Other|2|||
160991749|NCT00430677|581357894|FG001|Long-term Extension Period|Other|1|||
160991750|NCT00430677|581357895|FG002|Long-term Extension Period|Other|1|||
160991751|NCT00430677|581357893|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
160991752|NCT00430677|581357894|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
160991753|NCT00430677|581357895|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
160991754|NCT01555762|581357896|FG000|Overall Study|No information on Bevacizumab intake|11|||
160991755|NCT01555762|581357896|FG000|Overall Study|Missing start date of infusion|8|||
160991756|NCT01555762|581357896|FG000|Overall Study|75 years old or more ticked No|1|||
160991757|NCT01555762|581357896|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
160991758|NCT01555762|581357896|FG000|Overall Study|Death linked to progression of disease|165|||
160991759|NCT01555762|581357896|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
160991760|NCT01555762|581357896|FG000|Overall Study|Investigator's decision|10|||
160991761|NCT01555762|581357896|FG000|Overall Study|Participant not wishing to continue|5|||
160991762|NCT01555762|581357896|FG000|Overall Study|Missing data|1|||
160991763|NCT01555762|581357896|FG000|Overall Study|Death linked to an adverse event|14|||
160991764|NCT00299702|581357903|FG000|Overall Study|Death|1|||
160991765|NCT00299702|581357904|FG001|Overall Study|Death|0|||
160991766|NCT00299702|581357903|FG000|Overall Study|Adverse Event|0|||
160991767|NCT00299702|581357904|FG001|Overall Study|Adverse Event|4|||
160991768|NCT00299702|581357903|FG000|Overall Study|Lost to Follow-up|18|||
160991769|NCT00299702|581357904|FG001|Overall Study|Lost to Follow-up|10|||
160991770|NCT00299702|581357903|FG000|Overall Study|Withdrawal by Subject|25|||
160991771|NCT00299702|581357904|FG001|Overall Study|Withdrawal by Subject|23|||
160991772|NCT00299702|581357903|FG000|Overall Study|Pregnancy|0|||
160563420|NCT02443402|579784479|FG000|Overall Study|Screen Failure|1|||
160563421|NCT02443402|579784480|FG001|Overall Study|Screen Failure|2|||
160563422|NCT01934504|579784482|FG000|Overall Study|Protocol Deviation|0|||
160563423|NCT01934504|579784483|FG001|Overall Study|Protocol Deviation|0|||
160563424|NCT01934504|579784484|FG002|Overall Study|Protocol Deviation|0|||
160563425|NCT01934504|579784485|FG003|Overall Study|Protocol Deviation|2|||
160563426|NCT01934504|579784482|FG000|Overall Study|Study Terminated by Sponsor|1|||
160991773|NCT00299702|581357904|FG001|Overall Study|Pregnancy|1|||
160563427|NCT01934504|579784483|FG001|Overall Study|Study Terminated by Sponsor|0|||
160563428|NCT01934504|579784484|FG002|Overall Study|Study Terminated by Sponsor|5|||
160563429|NCT01934504|579784485|FG003|Overall Study|Study Terminated by Sponsor|5|||
160563430|NCT02665689|579784486|FG000|Overall Study|Adverse Event|1|||
160563431|NCT02665689|579784487|FG001|Overall Study|Adverse Event|0|||
160563432|NCT02665689|579784486|FG000|Overall Study|Trial termination|1|||
160991774|NCT00299702|581357903|FG000|Overall Study|Insufficient Response|4|||
160991775|NCT00299702|581357904|FG001|Overall Study|Insufficient Response|3|||
160991776|NCT00299702|581357903|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
160838297|NCT01123707|580793928|FG003|Overall Study|Lack of Efficacy|0|||
160838298|NCT01123707|580793925|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
160838299|NCT01123707|580793926|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
160838300|NCT01123707|580793927|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
160838301|NCT01123707|580793928|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
160838302|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
160838303|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
160838304|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
160838305|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
160838306|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
160838307|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
160838308|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
160838309|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
160991777|NCT00299702|581357904|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
160838310|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Death|0|||
160838311|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Death|1|||
160838312|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
160838313|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
160838314|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Other|0|||
160838315|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Other|2|||
160838316|NCT03281304|580793931|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
160838317|NCT03281304|580793932|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
160838318|NCT00858637|580793933|FG000|Active Comparison Phase|Adverse Event|14|||
160838319|NCT00858637|580793934|FG001|Active Comparison Phase|Adverse Event|0|||
160838320|NCT00858637|580793935|FG002|Active Comparison Phase|Adverse Event|0|||
160838321|NCT00858637|580793936|FG003|Active Comparison Phase|Adverse Event|9|||
160838322|NCT00858637|580793937|FG004|Active Comparison Phase|Adverse Event|0|||
160838323|NCT00858637|580793938|FG005|Active Comparison Phase|Adverse Event|0|||
160838324|NCT00858637|580793933|FG000|Active Comparison Phase|Death|1|||
160838325|NCT00858637|580793934|FG001|Active Comparison Phase|Death|0|||
160838326|NCT00858637|580793935|FG002|Active Comparison Phase|Death|0|||
160838327|NCT00858637|580793936|FG003|Active Comparison Phase|Death|1|||
160838328|NCT00858637|580793937|FG004|Active Comparison Phase|Death|0|||
160838329|NCT00858637|580793938|FG005|Active Comparison Phase|Death|0|||
160838330|NCT00858637|580793933|FG000|Active Comparison Phase|Physician Decision|1|||
160838331|NCT00858637|580793934|FG001|Active Comparison Phase|Physician Decision|0|||
160838332|NCT00858637|580793935|FG002|Active Comparison Phase|Physician Decision|0|||
160838333|NCT00858637|580793936|FG003|Active Comparison Phase|Physician Decision|1|||
160838334|NCT00858637|580793937|FG004|Active Comparison Phase|Physician Decision|0|||
160838335|NCT00858637|580793938|FG005|Active Comparison Phase|Physician Decision|0|||
160838336|NCT00858637|580793933|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
160991778|NCT03905135|581359889|FG000|Dose Escalation|Adverse Event|1|||
160563433|NCT02665689|579784487|FG001|Overall Study|Trial termination|1|||
160563434|NCT02665689|579784486|FG000|Overall Study|Lost to Follow-up|0|||
160563435|NCT02665689|579784487|FG001|Overall Study|Lost to Follow-up|1|||
160563436|NCT00824564|579784488|FG000|Overall Study|Lost to Follow-up|5|||
160563437|NCT00824564|579784489|FG001|Overall Study|Lost to Follow-up|7|||
160563438|NCT00824564|579784488|FG000|Overall Study|Withdrawal by Subject|1|||
160563439|NCT00824564|579784489|FG001|Overall Study|Withdrawal by Subject|1|||
160563440|NCT00824564|579784488|FG000|Overall Study|Other|1|||
160563441|NCT00824564|579784489|FG001|Overall Study|Other|2|||
160563442|NCT00824564|579784488|FG000|Overall Study|Randomized, but not treated|1|||
160563443|NCT00824564|579784489|FG001|Overall Study|Randomized, but not treated|0|||
160563444|NCT00996840|579784496|FG000|Overall Study|Adverse Event|0|||
160563445|NCT00996840|579784497|FG001|Overall Study|Adverse Event|1|||
160563446|NCT00996840|579784498|FG002|Overall Study|Adverse Event|0|||
160563447|NCT00996840|579784499|FG003|Overall Study|Adverse Event|0|||
160563448|NCT00996840|579784500|FG004|Overall Study|Adverse Event|0|||
160563449|NCT00996840|579784496|FG000|Overall Study|Physician Decision|0|||
160563450|NCT00996840|579784497|FG001|Overall Study|Physician Decision|0|||
160563451|NCT00996840|579784498|FG002|Overall Study|Physician Decision|1|||
160563452|NCT00996840|579784499|FG003|Overall Study|Physician Decision|1|||
160563453|NCT00996840|579784500|FG004|Overall Study|Physician Decision|2|||
160563454|NCT00996840|579784496|FG000|Overall Study|Withdrawal by Subject|1|||
160563455|NCT00996840|579784497|FG001|Overall Study|Withdrawal by Subject|1|||
160563456|NCT00996840|579784498|FG002|Overall Study|Withdrawal by Subject|0|||
160563457|NCT00996840|579784499|FG003|Overall Study|Withdrawal by Subject|0|||
160563458|NCT00996840|579784500|FG004|Overall Study|Withdrawal by Subject|0|||
160563459|NCT00603239|579784501|FG000|Overall Study|Adverse Event|4|||
160563460|NCT00603239|579784502|FG001|Overall Study|Adverse Event|1|||
160563461|NCT00603239|579784501|FG000|Overall Study|Entry criteria not met|0|||
160838337|NCT00858637|580793934|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
160838338|NCT00858637|580793935|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
160838339|NCT00858637|580793936|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
160838340|NCT00858637|580793937|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
160838341|NCT00858637|580793938|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
160838342|NCT00858637|580793933|FG000|Active Comparison Phase|Other Reasons|1|||
160838343|NCT00858637|580793934|FG001|Active Comparison Phase|Other Reasons|0|||
160838344|NCT00858637|580793935|FG002|Active Comparison Phase|Other Reasons|0|||
160838345|NCT00858637|580793936|FG003|Active Comparison Phase|Other Reasons|1|||
160838346|NCT00858637|580793937|FG004|Active Comparison Phase|Other Reasons|0|||
160838347|NCT00858637|580793938|FG005|Active Comparison Phase|Other Reasons|0|||
160838348|NCT00858637|580793933|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
160838349|NCT00858637|580793934|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
160838350|NCT00858637|580793935|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
160838351|NCT00858637|580793936|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
160838352|NCT00858637|580793937|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
160838353|NCT00858637|580793938|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
160838354|NCT00858637|580793933|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
160838355|NCT00858637|580793934|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
160838356|NCT00858637|580793935|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
160838357|NCT00858637|580793936|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
160838358|NCT00858637|580793937|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
160838359|NCT00858637|580793938|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
160838360|NCT00605345|580793941|FG000|Overall Study|Withdrawal by Subject|1|||
160838361|NCT00605345|580793942|FG001|Overall Study|Withdrawal by Subject|0|||
160904453|NCT02609828|581044966|FG000|Overall Study|Protocol Violation|2|||
160563462|NCT00603239|579784502|FG001|Overall Study|Entry criteria not met|1|||
160563463|NCT00603239|579784501|FG000|Overall Study|Loss of glucose control|3|||
160838362|NCT00605345|580793941|FG000|Overall Study|Adverse Event|0|||
160838363|NCT00605345|580793942|FG001|Overall Study|Adverse Event|1|||
160838364|NCT00605345|580793941|FG000|Overall Study|Protocol Violation|0|||
160838365|NCT00605345|580793942|FG001|Overall Study|Protocol Violation|2|||
160838366|NCT02577016|580793943|FG000|Overall Study|Adverse Event|2|||
160838367|NCT02577016|580793944|FG001|Overall Study|Adverse Event|1|||
160904454|NCT02609828|581044967|FG001|Overall Study|Protocol Violation|0|||
160563464|NCT00603239|579784502|FG001|Overall Study|Loss of glucose control|0|||
160563465|NCT00603239|579784501|FG000|Overall Study|Lost to Follow-up|2|||
160838368|NCT02577016|580793943|FG000|Overall Study|Physician Decision|0|||
160904455|NCT02609828|581044968|FG002|Overall Study|Protocol Violation|0|||
160904456|NCT02609828|581044969|FG003|Overall Study|Protocol Violation|1|||
160563466|NCT00603239|579784502|FG001|Overall Study|Lost to Follow-up|1|||
160563467|NCT00603239|579784501|FG000|Overall Study|Physician Decision|2|||
160563468|NCT00603239|579784502|FG001|Overall Study|Physician Decision|0|||
160563469|NCT00603239|579784501|FG000|Overall Study|Protocol Violation|2|||
160563470|NCT00603239|579784502|FG001|Overall Study|Protocol Violation|0|||
160563471|NCT00603239|579784501|FG000|Overall Study|Subject decision|2|||
160563472|NCT00603239|579784502|FG001|Overall Study|Subject decision|1|||
160563473|NCT02292849|579784503|FG000|Overall Study|Lost to Follow-up|0|||
160838369|NCT02577016|580793944|FG001|Overall Study|Physician Decision|1|||
160838370|NCT02126839|580793945|FG000|Overall Study|Adverse Event|0|||
160838371|NCT02126839|580793946|FG001|Overall Study|Adverse Event|1|||
160838372|NCT02126839|580793945|FG000|Overall Study|Withdrawal by Subject|1|||
160838373|NCT02126839|580793946|FG001|Overall Study|Withdrawal by Subject|0|||
160838374|NCT02126839|580793945|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160838375|NCT02126839|580793946|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160838376|NCT02126839|580793945|FG000|Overall Study|Protocol Violation|2|||
160838377|NCT02126839|580793946|FG001|Overall Study|Protocol Violation|3|||
160838378|NCT02126839|580793945|FG000|Overall Study|Sponsor request|0|||
160838379|NCT02126839|580793946|FG001|Overall Study|Sponsor request|1|||
160838380|NCT02126839|580793945|FG000|Overall Study|Lost to Follow-up|1|||
160838381|NCT02126839|580793946|FG001|Overall Study|Lost to Follow-up|4|||
160838382|NCT02126839|580793945|FG000|Overall Study|Other|5|||
160838383|NCT02126839|580793946|FG001|Overall Study|Other|5|||
160838384|NCT00687531|580793949|FG000|Overall Study|Did not meet protocol eligibility|104|||
160838385|NCT00687531|580793949|FG000|Overall Study|Adverse Event|5|||
160838386|NCT00687531|580793949|FG000|Overall Study|Lost to Follow-up|26|||
160838387|NCT00666224|580795681|FG000|Double-Blind|Adverse Event|15|||
160838388|NCT00666224|580795682|FG001|Double-Blind|Adverse Event|5|||
160838389|NCT00666224|580795681|FG000|Double-Blind|Lost to Follow-up|2|||
160838390|NCT00666224|580795682|FG001|Double-Blind|Lost to Follow-up|2|||
160838391|NCT00666224|580795681|FG000|Double-Blind|Withdrawal by Subject|18|||
160838392|NCT00666224|580795682|FG001|Double-Blind|Withdrawal by Subject|14|||
160838393|NCT00666224|580795681|FG000|Double-Blind|Physician Decision|0|||
160838394|NCT00666224|580795682|FG001|Double-Blind|Physician Decision|3|||
160838395|NCT00666224|580795681|FG000|Double-Blind|Sponsor decision|1|||
160838396|NCT00666224|580795682|FG001|Double-Blind|Sponsor decision|0|||
160838397|NCT00666224|580795681|FG000|Double-Blind|Pregnancy|3|||
160838398|NCT00666224|580795682|FG001|Double-Blind|Pregnancy|2|||
160838399|NCT00666224|580795681|FG000|Double-Blind|Noncompliance|1|||
160838400|NCT00666224|580795682|FG001|Double-Blind|Noncompliance|0|||
160838401|NCT00666224|580795681|FG000|Double-Blind|Death|1|||
160838402|NCT00666224|580795682|FG001|Double-Blind|Death|0|||
160838403|NCT00666224|580795681|FG000|Double-Blind|Undefined/Unknown|4|||
160838404|NCT00666224|580795682|FG001|Double-Blind|Undefined/Unknown|1|||
160838405|NCT00666224|580795681|FG000|Open-Label|Adverse Event|8|||
160838406|NCT00666224|580795682|FG001|Open-Label|Adverse Event|43|||
160838407|NCT00666224|580795681|FG000|Open-Label|Lost to Follow-up|4|||
160838408|NCT00666224|580795682|FG001|Open-Label|Lost to Follow-up|5|||
160838409|NCT00666224|580795681|FG000|Open-Label|Withdrawal by Subject|12|||
160838410|NCT00666224|580795682|FG001|Open-Label|Withdrawal by Subject|25|||
160838411|NCT00666224|580795681|FG000|Open-Label|Physician Decision|7|||
160838412|NCT00666224|580795682|FG001|Open-Label|Physician Decision|5|||
160838413|NCT00666224|580795681|FG000|Open-Label|Pregnancy|1|||
160838414|NCT00666224|580795682|FG001|Open-Label|Pregnancy|5|||
160838415|NCT00666224|580795681|FG000|Open-Label|Noncompliance|2|||
160838416|NCT00666224|580795682|FG001|Open-Label|Noncompliance|1|||
160838417|NCT00666224|580795681|FG000|Open-Label|Undefined/Unknown|1|||
160838418|NCT00666224|580795682|FG001|Open-Label|Undefined/Unknown|1|||
160838419|NCT03521141|580795683|FG000|Overall Study|Death|1|||
160838420|NCT03521141|580795684|FG001|Overall Study|Death|0|||
160838421|NCT03521141|580795685|FG002|Overall Study|Death|1|||
160838422|NCT03828617|580795687|FG000|Overall Study|Lost to Follow-up|22|||
160838423|NCT03828617|580795688|FG001|Overall Study|Lost to Follow-up|12|||
160838424|NCT03828617|580795689|FG002|Overall Study|Lost to Follow-up|23|||
160838425|NCT03828617|580795690|FG003|Overall Study|Lost to Follow-up|7|||
160838426|NCT03828617|580795687|FG000|Overall Study|No longer met eligibility criteria|0|||
160838427|NCT03828617|580795688|FG001|Overall Study|No longer met eligibility criteria|1|||
160838428|NCT03828617|580795689|FG002|Overall Study|No longer met eligibility criteria|1|||
160838429|NCT03828617|580795690|FG003|Overall Study|No longer met eligibility criteria|3|||
160838430|NCT03828617|580795687|FG000|Overall Study|Protocol Violation|0|||
160838431|NCT03828617|580795688|FG001|Overall Study|Protocol Violation|2|||
160838432|NCT03828617|580795689|FG002|Overall Study|Protocol Violation|0|||
160838433|NCT03828617|580795690|FG003|Overall Study|Protocol Violation|0|||
160838434|NCT03828617|580795687|FG000|Overall Study|Withdrawal by Subject|2|||
160838435|NCT03828617|580795688|FG001|Overall Study|Withdrawal by Subject|0|||
160838436|NCT03828617|580795689|FG002|Overall Study|Withdrawal by Subject|2|||
160838437|NCT03828617|580795690|FG003|Overall Study|Withdrawal by Subject|0|||
160838438|NCT03354273|580795691|FG000|Overall Study|Adverse Event|5|||
160838439|NCT03354273|580795691|FG000|Overall Study|Screen Failure|21|||
160838440|NCT03354273|580795691|FG000|Overall Study|Withdrawal by Subject|34|||
160838441|NCT03354273|580795691|FG000|Overall Study|Technical Problems|30|||
160838442|NCT03354273|580795691|FG000|Overall Study|Lost to Follow-up|4|||
160838443|NCT03354273|580795691|FG000|Overall Study|Investigator Decision|3|||
160838444|NCT03354273|580795691|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
160838445|NCT03354273|580795691|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
160838446|NCT03354273|580795691|FG000|Overall Study|COVID-19 Restrictions|9|||
160838447|NCT03354273|580795691|FG000|Overall Study|Other|5|||
160838448|NCT00303485|580795692|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
160563474|NCT02292849|579784504|FG001|Overall Study|Lost to Follow-up|2|||
160563475|NCT02292849|579784505|FG002|Overall Study|Lost to Follow-up|2|||
160563476|NCT02292849|579784503|FG000|Overall Study|Physician Decision|4|||
160563477|NCT02292849|579784504|FG001|Overall Study|Physician Decision|0|||
160563478|NCT02292849|579784505|FG002|Overall Study|Physician Decision|0|||
160563479|NCT01562028|579784507|FG000|Overall Study|Withdrawal by Subject|1|||
160563480|NCT01562028|579784508|FG001|Overall Study|Withdrawal by Subject|1|||
160563481|NCT01562028|579784507|FG000|Overall Study|Lost to Follow-up|2|||
160563482|NCT01562028|579784508|FG001|Overall Study|Lost to Follow-up|1|||
160563483|NCT00097539|579784509|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
160563484|NCT00097539|579784510|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
160563485|NCT00097539|579784511|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
160563486|NCT00097539|579784512|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
160563487|NCT00097539|579784513|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
160563488|NCT00097539|579784514|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
160563489|NCT00097539|579784515|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
160563490|NCT00097539|579784509|FG000|Overall Study|Withdrawal by Subject|925|||
160563491|NCT00097539|579784510|FG001|Overall Study|Withdrawal by Subject|323|||
160563492|NCT00097539|579784511|FG002|Overall Study|Withdrawal by Subject|346|||
160563493|NCT00097539|579784512|FG003|Overall Study|Withdrawal by Subject|217|||
160563494|NCT00097539|579784513|FG004|Overall Study|Withdrawal by Subject|68|||
160563495|NCT00097539|579784514|FG005|Overall Study|Withdrawal by Subject|229|||
160563496|NCT00097539|579784515|FG006|Overall Study|Withdrawal by Subject|3|||
160563497|NCT00097539|579784509|FG000|Overall Study|Participant Non-compliant|2140|||
160563498|NCT00097539|579784510|FG001|Overall Study|Participant Non-compliant|567|||
160563499|NCT00097539|579784511|FG002|Overall Study|Participant Non-compliant|1067|||
160563500|NCT00097539|579784512|FG003|Overall Study|Participant Non-compliant|353|||
160563501|NCT00097539|579784513|FG004|Overall Study|Participant Non-compliant|136|||
160563502|NCT00097539|579784514|FG005|Overall Study|Participant Non-compliant|543|||
160563503|NCT00097539|579784515|FG006|Overall Study|Participant Non-compliant|18|||
160563504|NCT00097539|579784509|FG000|Overall Study|Lack of Efficacy|249|||
160563505|NCT00097539|579784510|FG001|Overall Study|Lack of Efficacy|122|||
160563506|NCT00097539|579784511|FG002|Overall Study|Lack of Efficacy|202|||
160563507|NCT00097539|579784512|FG003|Overall Study|Lack of Efficacy|105|||
160563508|NCT00097539|579784513|FG004|Overall Study|Lack of Efficacy|45|||
160563509|NCT00097539|579784514|FG005|Overall Study|Lack of Efficacy|228|||
160563510|NCT00097539|579784515|FG006|Overall Study|Lack of Efficacy|5|||
160563511|NCT00097539|579784509|FG000|Overall Study|Adverse Event|78|||
160563512|NCT00097539|579784510|FG001|Overall Study|Adverse Event|133|||
160563513|NCT00097539|579784511|FG002|Overall Study|Adverse Event|37|||
160838449|NCT00303485|580795693|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
160838450|NCT00303485|580795692|FG000|Overall Study|Failure to return|0|||
160838451|NCT00303485|580795693|FG001|Overall Study|Failure to return|1|||
160838452|NCT00303485|580795692|FG000|Overall Study|Withdrawal by Subject|1|||
160838453|NCT00303485|580795693|FG001|Overall Study|Withdrawal by Subject|0|||
160838454|NCT00902174|580795701|FG000|Overall Study|Adverse Event|27|||
160838455|NCT00902174|580795702|FG001|Overall Study|Adverse Event|7|||
160838456|NCT00902174|580795701|FG000|Overall Study|Lack of Efficacy|1|||
160838457|NCT00902174|580795702|FG001|Overall Study|Lack of Efficacy|5|||
160838458|NCT00902174|580795701|FG000|Overall Study|Death|2|||
160838459|NCT00902174|580795702|FG001|Overall Study|Death|2|||
160838460|NCT00902174|580795701|FG000|Overall Study|Withdrawal by Subject|2|||
160838461|NCT00902174|580795702|FG001|Overall Study|Withdrawal by Subject|1|||
160838462|NCT00902174|580795701|FG000|Overall Study|Abnormal labs|1|||
160838463|NCT00902174|580795702|FG001|Overall Study|Abnormal labs|1|||
160838464|NCT00902174|580795701|FG000|Overall Study|Protocol Violation|1|||
160838465|NCT00902174|580795702|FG001|Overall Study|Protocol Violation|1|||
160838466|NCT00902174|580795701|FG000|Overall Study|Administration problem|0|||
160838467|NCT00902174|580795702|FG001|Overall Study|Administration problem|1|||
160838468|NCT00764673|580795703|FG000|Overall Study|Death|1|||
160838469|NCT00764673|580795703|FG000|Overall Study|Lost to Follow-up|3|||
160838470|NCT00764673|580795703|FG000|Overall Study|Withdrawal by Subject|6|||
160838471|NCT00764673|580795703|FG000|Overall Study|Revision of Device|2|||
160838472|NCT01331291|580795704|FG000|Overall Study|Lack of Efficacy|2|||
160838473|NCT01331291|580795705|FG001|Overall Study|Lack of Efficacy|8|||
160838474|NCT01331291|580795704|FG000|Overall Study|Death|0|||
160838475|NCT01331291|580795705|FG001|Overall Study|Death|1|||
160563514|NCT00097539|579784512|FG003|Overall Study|Adverse Event|27|||
160563515|NCT00097539|579784513|FG004|Overall Study|Adverse Event|30|||
160563516|NCT00097539|579784514|FG005|Overall Study|Adverse Event|59|||
160563517|NCT00097539|579784515|FG006|Overall Study|Adverse Event|1|||
160563518|NCT00097539|579784509|FG000|Overall Study|Death|2|||
160563519|NCT00097539|579784510|FG001|Overall Study|Death|7|||
160563520|NCT00097539|579784511|FG002|Overall Study|Death|0|||
160563521|NCT00097539|579784512|FG003|Overall Study|Death|0|||
160563522|NCT00097539|579784513|FG004|Overall Study|Death|1|||
160563523|NCT00097539|579784514|FG005|Overall Study|Death|3|||
160563524|NCT00097539|579784515|FG006|Overall Study|Death|0|||
160563525|NCT00097539|579784509|FG000|Overall Study|Reasons Other Than Above|3602|||
160563526|NCT00097539|579784510|FG001|Overall Study|Reasons Other Than Above|1382|||
160563527|NCT00097539|579784511|FG002|Overall Study|Reasons Other Than Above|1757|||
160563528|NCT00097539|579784512|FG003|Overall Study|Reasons Other Than Above|692|||
160563529|NCT00097539|579784513|FG004|Overall Study|Reasons Other Than Above|361|||
160563530|NCT00097539|579784514|FG005|Overall Study|Reasons Other Than Above|1244|||
160563531|NCT00097539|579784515|FG006|Overall Study|Reasons Other Than Above|34|||
160563532|NCT00097539|579784509|FG000|Overall Study|Reason not Specified|111|||
160563533|NCT00097539|579784510|FG001|Overall Study|Reason not Specified|49|||
160563534|NCT00097539|579784511|FG002|Overall Study|Reason not Specified|53|||
160563535|NCT00097539|579784512|FG003|Overall Study|Reason not Specified|21|||
160563536|NCT00097539|579784513|FG004|Overall Study|Reason not Specified|11|||
160563537|NCT00097539|579784514|FG005|Overall Study|Reason not Specified|40|||
160563538|NCT00097539|579784515|FG006|Overall Study|Reason not Specified|2|||
160563539|NCT04938648|579784516|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
160563540|NCT04938648|579784517|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
160563541|NCT04938648|579784516|FG000|Overall Study|Patient too ill|0|||
160563542|NCT04938648|579784517|FG001|Overall Study|Patient too ill|1|||
160563543|NCT04938648|579784516|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
160563544|NCT04938648|579784517|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
160563545|NCT04938648|579784516|FG000|Overall Study|Patient did not have memory problems|1|||
160563546|NCT04938648|579784517|FG001|Overall Study|Patient did not have memory problems|1|||
160563547|NCT04938648|579784516|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
160563548|NCT04938648|579784517|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
160563549|NCT04938648|579784516|FG000|Overall Study|Care partner could not be reached|0|||
160563550|NCT04938648|579784517|FG001|Overall Study|Care partner could not be reached|1|||
160563551|NCT04938648|579784516|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
160563552|NCT04938648|579784517|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
160563553|NCT04938648|579784516|FG000|Overall Study|Withdrawal by Subject|2|||
160563554|NCT04938648|579784517|FG001|Overall Study|Withdrawal by Subject|1|||
160563555|NCT05127486|579784518|FG000|Overall Study|Adverse Event|2|||
160563556|NCT05127486|579784519|FG001|Overall Study|Adverse Event|4|||
160563557|NCT05127486|579784518|FG000|Overall Study|Lack of Efficacy|1|||
160563558|NCT05127486|579784519|FG001|Overall Study|Lack of Efficacy|0|||
160563559|NCT05127486|579784518|FG000|Overall Study|Pregnancy|0|||
160563560|NCT05127486|579784519|FG001|Overall Study|Pregnancy|1|||
160563561|NCT05127486|579784518|FG000|Overall Study|Physician Decision|4|||
160563562|NCT05127486|579784519|FG001|Overall Study|Physician Decision|1|||
160563563|NCT05127486|579784518|FG000|Overall Study|Withdrawal by Subject|14|||
160563564|NCT05127486|579784519|FG001|Overall Study|Withdrawal by Subject|13|||
160563565|NCT05127486|579784518|FG000|Overall Study|Lost to Follow-up|5|||
160563566|NCT05127486|579784519|FG001|Overall Study|Lost to Follow-up|8|||
160563567|NCT00775021|579784523|FG000|First Intervention|Lost to Follow-up|1|||
160563568|NCT00775021|579784524|FG001|First Intervention|Lost to Follow-up|0|||
160563569|NCT00775021|579784523|FG000|Second Intervention|Adverse Event|0|||
160563570|NCT00775021|579784524|FG001|Second Intervention|Adverse Event|1|||
160563571|NCT00363415|579784525|FG000|Overall Study|Progressive Disease|196|||
160563572|NCT00363415|579784526|FG001|Overall Study|Progressive Disease|107|||
160563573|NCT00363415|579784525|FG000|Overall Study|Sponsor Decision|67|||
160563574|NCT00363415|579784526|FG001|Overall Study|Sponsor Decision|31|||
160563575|NCT00363415|579784525|FG000|Overall Study|Death|32|||
160563576|NCT00363415|579784526|FG001|Overall Study|Death|29|||
160563577|NCT00363415|579784525|FG000|Overall Study|Adverse Event|24|||
160563578|NCT00363415|579784526|FG001|Overall Study|Adverse Event|15|||
160563579|NCT00363415|579784525|FG000|Overall Study|Physician Decision|18|||
160563580|NCT00363415|579784526|FG001|Overall Study|Physician Decision|35|||
160563581|NCT00363415|579784525|FG000|Overall Study|Entry Criteria Not Met|11|||
160563582|NCT00363415|579784526|FG001|Overall Study|Entry Criteria Not Met|10|||
160838476|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
160838477|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
160838478|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
160838479|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
160838480|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
160838481|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
160838482|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
160563583|NCT00363415|579784525|FG000|Overall Study|Withdrawal by Subject|9|||
160563584|NCT00363415|579784526|FG001|Overall Study|Withdrawal by Subject|15|||
160563585|NCT00363415|579784525|FG000|Overall Study|Lost to Follow-up|3|||
160563586|NCT00363415|579784526|FG001|Overall Study|Lost to Follow-up|3|||
160563587|NCT00363415|579784525|FG000|Overall Study|Protocol Violation|1|||
160563588|NCT00363415|579784526|FG001|Overall Study|Protocol Violation|4|||
160563589|NCT01287754|579784529|FG000|Overall Study|Death|2|||
160563590|NCT01287754|579784530|FG001|Overall Study|Death|12|||
160563591|NCT01287754|579784529|FG000|Overall Study|Lost to Follow-up|1|||
160563592|NCT01287754|579784530|FG001|Overall Study|Lost to Follow-up|6|||
160563593|NCT01287754|579784529|FG000|Overall Study|Protocol Violation|0|||
160563594|NCT01287754|579784530|FG001|Overall Study|Protocol Violation|3|||
160563595|NCT05027802|579784541|FG000|Overall Study|Adverse Event|2|||
160563596|NCT05027802|579784541|FG000|Overall Study|Withdrawal by Subject|18|||
160563597|NCT05027802|579784541|FG000|Overall Study|Death|2|||
160563598|NCT05027802|579784541|FG000|Overall Study|Other|1|||
160563599|NCT00001337|579784548|FG000|Overall Study|Switched to alternate treatment|2|||
160563600|NCT00001337|579784549|FG001|Overall Study|Switched to alternate treatment|2|||
160563601|NCT00001337|579784550|FG002|Overall Study|Switched to alternate treatment|0|||
160563602|NCT00001337|579784548|FG000|Overall Study|Refused further treatment|2|||
160563603|NCT00001337|579784549|FG001|Overall Study|Refused further treatment|1|||
160563604|NCT00001337|579784550|FG002|Overall Study|Refused further treatment|0|||
160563605|NCT00001337|579784548|FG000|Overall Study|Began other Tx|1|||
160563606|NCT00001337|579784549|FG001|Overall Study|Began other Tx|0|||
160563607|NCT00001337|579784550|FG002|Overall Study|Began other Tx|0|||
160563608|NCT00001337|579784548|FG000|Overall Study|Physician Decision|3|||
160563609|NCT00001337|579784549|FG001|Overall Study|Physician Decision|1|||
160563610|NCT00001337|579784550|FG002|Overall Study|Physician Decision|0|||
160563611|NCT00001337|579784548|FG000|Overall Study|Doesn't have NHL|0|||
160563612|NCT00001337|579784549|FG001|Overall Study|Doesn't have NHL|1|||
160563613|NCT00001337|579784550|FG002|Overall Study|Doesn't have NHL|0|||
160563614|NCT00001337|579784548|FG000|Overall Study|Non protocol tx needed|3|||
160563615|NCT00001337|579784549|FG001|Overall Study|Non protocol tx needed|1|||
160563616|NCT00001337|579784550|FG002|Overall Study|Non protocol tx needed|0|||
160563617|NCT00001337|579784548|FG000|Overall Study|Protocol change|1|||
160563618|NCT00001337|579784549|FG001|Overall Study|Protocol change|0|||
160563619|NCT00001337|579784550|FG002|Overall Study|Protocol change|0|||
160563620|NCT00001337|579784548|FG000|Overall Study|2nd primary disease|0|||
160563621|NCT00001337|579784549|FG001|Overall Study|2nd primary disease|0|||
160563622|NCT00001337|579784550|FG002|Overall Study|2nd primary disease|1|||
160563623|NCT00001337|579784548|FG000|Overall Study|Death during follow up period|9|||
160563624|NCT00001337|579784549|FG001|Overall Study|Death during follow up period|4|||
160563625|NCT00001337|579784550|FG002|Overall Study|Death during follow up period|0|||
160563626|NCT00001337|579784548|FG000|Overall Study|Death on study|19|||
160563627|NCT00001337|579784549|FG001|Overall Study|Death on study|9|||
160563628|NCT00001337|579784550|FG002|Overall Study|Death on study|0|||
160563629|NCT00001337|579784548|FG000|Overall Study|Disease progression during follow-up period|3|||
160563630|NCT00001337|579784549|FG001|Overall Study|Disease progression during follow-up period|1|||
160563631|NCT00001337|579784550|FG002|Overall Study|Disease progression during follow-up period|0|||
160563632|NCT00001337|579784548|FG000|Overall Study|Disease progression on study|33|||
160563633|NCT00001337|579784549|FG001|Overall Study|Disease progression on study|41|||
160563634|NCT00001337|579784550|FG002|Overall Study|Disease progression on study|0|||
160563635|NCT00001337|579784548|FG000|Overall Study|Lost to further follow-up|10|||
160563636|NCT00001337|579784549|FG001|Overall Study|Lost to further follow-up|6|||
160563637|NCT00001337|579784550|FG002|Overall Study|Lost to further follow-up|0|||
160563638|NCT00001337|579784548|FG000|Overall Study|2nd malignancy|1|||
160838483|NCT01389323|580795711|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
160838484|NCT01389323|580795711|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
160838485|NCT01389323|580795711|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
160838486|NCT01389323|580795711|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
160838487|NCT01805037|580795713|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
160563639|NCT00001337|579784549|FG001|Overall Study|2nd malignancy|0|||
160563640|NCT00001337|579784550|FG002|Overall Study|2nd malignancy|0|||
160563641|NCT00001337|579784548|FG000|Overall Study|Treatment for second lymphoma|0|||
160563642|NCT00001337|579784549|FG001|Overall Study|Treatment for second lymphoma|1|||
160838488|NCT01805037|580795714|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
160838489|NCT01805037|580795713|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
160838490|NCT01805037|580795714|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
160838491|NCT01805037|580795713|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
160838492|NCT01805037|580795714|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
160838493|NCT01805037|580795713|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
160991779|NCT03905135|581359890|FG001|Dose Escalation|Adverse Event|1|||
160563643|NCT00001337|579784550|FG002|Overall Study|Treatment for second lymphoma|0|||
160563644|NCT00001337|579784548|FG000|Overall Study|Transfer to transplant|0|||
160563645|NCT00001337|579784549|FG001|Overall Study|Transfer to transplant|1|||
160563646|NCT00001337|579784550|FG002|Overall Study|Transfer to transplant|0|||
160563647|NCT01506141|579784555|FG000|Overall Study|Adverse Event|0|||
160563648|NCT01506141|579784556|FG001|Overall Study|Adverse Event|2|||
160563649|NCT01506141|579784555|FG000|Overall Study|Participation Terminated by Investigator|1|||
160563650|NCT01506141|579784556|FG001|Overall Study|Participation Terminated by Investigator|1|||
160563651|NCT01506141|579784555|FG000|Overall Study|Site Terminated by Sponsor|2|||
160563652|NCT01506141|579784556|FG001|Overall Study|Site Terminated by Sponsor|0|||
160563653|NCT01506141|579784555|FG000|Overall Study|Reason Not Specified|4|||
160838494|NCT01805037|580795714|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
160563654|NCT01506141|579784556|FG001|Overall Study|Reason Not Specified|2|||
160563655|NCT04889209|579784557|FG000|All Cohorts Except 15E|Adverse Event|0|||
160563656|NCT04889209|579784558|FG001|All Cohorts Except 15E|Adverse Event|0|||
160563657|NCT04889209|579784559|FG002|All Cohorts Except 15E|Adverse Event|0|||
160563658|NCT04889209|579784560|FG003|All Cohorts Except 15E|Adverse Event|0|||
160563659|NCT04889209|579784561|FG004|All Cohorts Except 15E|Adverse Event|0|||
160563660|NCT04889209|579784562|FG005|All Cohorts Except 15E|Adverse Event|0|||
160563661|NCT04889209|579784563|FG006|All Cohorts Except 15E|Adverse Event|1|||
160563662|NCT04889209|579784564|FG007|All Cohorts Except 15E|Adverse Event|0|||
160838495|NCT01805037|580795713|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
160838496|NCT01805037|580795714|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
160838497|NCT01805037|580795713|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
160838498|NCT01805037|580795714|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
160838499|NCT01805037|580795713|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
160838500|NCT01805037|580795714|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
160838501|NCT01805037|580795713|FG000|Follow Up (up to 3 Years)|Death|0|||
160838502|NCT01805037|580795714|FG001|Follow Up (up to 3 Years)|Death|2|||
160838503|NCT01805037|580795713|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
160838504|NCT01805037|580795714|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
160838505|NCT01805037|580795713|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
160838506|NCT01805037|580795714|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
160838507|NCT01270256|580795715|FG000|Overall Study|Withdrawal by Subject|1|||
160838508|NCT01270256|580795716|FG001|Overall Study|Withdrawal by Subject|0|||
160904457|NCT02609828|581044966|FG000|Overall Study|Withdrawal by Subject|12|||
160904458|NCT02609828|581044967|FG001|Overall Study|Withdrawal by Subject|1|||
160904459|NCT02609828|581044968|FG002|Overall Study|Withdrawal by Subject|0|||
160904460|NCT02609828|581044969|FG003|Overall Study|Withdrawal by Subject|10|||
160904461|NCT02609828|581044966|FG000|Overall Study|Other|3|||
160904462|NCT02609828|581044967|FG001|Overall Study|Other|0|||
160904463|NCT02609828|581044968|FG002|Overall Study|Other|0|||
160904464|NCT02609828|581044969|FG003|Overall Study|Other|6|||
160904465|NCT02609828|581044966|FG000|Overall Study|Randomized but not treated|1|||
160904466|NCT02609828|581044967|FG001|Overall Study|Randomized but not treated|0|||
160904467|NCT02609828|581044968|FG002|Overall Study|Randomized but not treated|0|||
160904468|NCT02609828|581044969|FG003|Overall Study|Randomized but not treated|0|||
160904469|NCT01081678|581044971|FG000|Overall Study|Ineligibility Determined|0|||
160904470|NCT01081678|581044972|FG001|Overall Study|Ineligibility Determined|0|||
160904471|NCT01081678|581044973|FG002|Overall Study|Ineligibility Determined|1|||
160904472|NCT01081678|581044974|FG003|Overall Study|Ineligibility Determined|1|||
160904473|NCT01081678|581044971|FG000|Overall Study|Noncompliance|3|||
160904474|NCT01081678|581044972|FG001|Overall Study|Noncompliance|4|||
160904475|NCT01081678|581044973|FG002|Overall Study|Noncompliance|5|||
160904476|NCT01081678|581044974|FG003|Overall Study|Noncompliance|2|||
160904477|NCT01081678|581044971|FG000|Overall Study|Adverse Event|2|||
160904478|NCT01081678|581044972|FG001|Overall Study|Adverse Event|1|||
160904479|NCT01081678|581044973|FG002|Overall Study|Adverse Event|2|||
160904480|NCT01081678|581044974|FG003|Overall Study|Adverse Event|2|||
160904481|NCT01081678|581044971|FG000|Overall Study|Withdrawal by Subject|15|||
160904482|NCT01081678|581044972|FG001|Overall Study|Withdrawal by Subject|7|||
160904483|NCT01081678|581044973|FG002|Overall Study|Withdrawal by Subject|17|||
160904484|NCT01081678|581044974|FG003|Overall Study|Withdrawal by Subject|14|||
160904485|NCT01081678|581044971|FG000|Overall Study|Administrative Decision|1|||
160904486|NCT01081678|581044972|FG001|Overall Study|Administrative Decision|0|||
160904487|NCT01081678|581044973|FG002|Overall Study|Administrative Decision|0|||
160904488|NCT01081678|581044974|FG003|Overall Study|Administrative Decision|1|||
160904489|NCT01081678|581044971|FG000|Overall Study|Lost to Follow-up|4|||
160904490|NCT01081678|581044972|FG001|Overall Study|Lost to Follow-up|1|||
160991780|NCT03905135|581359889|FG000|Dose Escalation|Progressive disease|3|||
160838509|NCT04566692|580795720|FG000|Overall Study|Adverse Event|2|||
160991781|NCT03905135|581359890|FG001|Dose Escalation|Progressive disease|1|||
160991782|NCT03905135|581359889|FG000|Dose Escalation|Intercurrent illness|1|||
160838510|NCT04566692|580795721|FG001|Overall Study|Adverse Event|0|||
160838511|NCT04566692|580795720|FG000|Overall Study|Withdrawal by Subject|1|||
160904491|NCT01081678|581044973|FG002|Overall Study|Lost to Follow-up|4|||
160904492|NCT01081678|581044974|FG003|Overall Study|Lost to Follow-up|3|||
160904493|NCT01081678|581044971|FG000|Overall Study|Death|2|||
160563663|NCT04889209|579784565|FG008|All Cohorts Except 15E|Adverse Event|0|||
160563664|NCT04889209|579784566|FG009|All Cohorts Except 15E|Adverse Event|0|||
160563665|NCT04889209|579784567|FG010|All Cohorts Except 15E|Adverse Event|0|||
160838512|NCT04566692|580795721|FG001|Overall Study|Withdrawal by Subject|1|||
160904494|NCT01081678|581044972|FG001|Overall Study|Death|2|||
160904495|NCT01081678|581044973|FG002|Overall Study|Death|2|||
160904496|NCT01081678|581044974|FG003|Overall Study|Death|6|||
160904497|NCT01081678|581044971|FG000|Overall Study|Other|0|||
160904498|NCT01081678|581044972|FG001|Overall Study|Other|1|||
160991783|NCT03905135|581359890|FG001|Dose Escalation|Intercurrent illness|0|||
160904499|NCT01081678|581044973|FG002|Overall Study|Other|0|||
160838513|NCT01183468|580795722|FG000|Overall Study|Lost to Follow-up|2|||
160838514|NCT01183468|580795723|FG001|Overall Study|Lost to Follow-up|1|||
160838515|NCT01183468|580795724|FG002|Overall Study|Lost to Follow-up|0|||
160838516|NCT01183468|580795725|FG003|Overall Study|Lost to Follow-up|0|||
160838517|NCT01183468|580795722|FG000|Overall Study|Physician Decision|1|||
160838518|NCT01183468|580795723|FG001|Overall Study|Physician Decision|0|||
160838519|NCT01183468|580795724|FG002|Overall Study|Physician Decision|0|||
160838520|NCT01183468|580795725|FG003|Overall Study|Physician Decision|0|||
160838521|NCT01183468|580795722|FG000|Overall Study|Withdrawal by Subject|0|||
160838522|NCT01183468|580795723|FG001|Overall Study|Withdrawal by Subject|1|||
160838523|NCT01183468|580795724|FG002|Overall Study|Withdrawal by Subject|0|||
160838524|NCT01183468|580795725|FG003|Overall Study|Withdrawal by Subject|0|||
160838525|NCT00590577|580795726|FG000|Overall Study|Lack of Efficacy|31|||
160838526|NCT00590577|580795727|FG001|Overall Study|Lack of Efficacy|28|||
160838527|NCT00590577|580795728|FG002|Overall Study|Lack of Efficacy|23|||
160838528|NCT00590577|580795729|FG003|Overall Study|Lack of Efficacy|45|||
160904500|NCT01081678|581044974|FG003|Overall Study|Other|0|||
160904501|NCT01619423|581044979|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
160904502|NCT01619423|581044980|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
160904503|NCT01619423|581044981|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
160904504|NCT01619423|581044982|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
160904505|NCT01281865|581044989|FG000|Overall Study|Adverse Event|1|||
160904506|NCT01281865|581044990|FG001|Overall Study|Adverse Event|1|||
160904507|NCT01281865|581044989|FG000|Overall Study|Withdrawal by Subject|1|||
160904508|NCT01281865|581044990|FG001|Overall Study|Withdrawal by Subject|0|||
160904509|NCT01281865|581044989|FG000|Overall Study|Lack of Efficacy|1|||
160904510|NCT01281865|581044990|FG001|Overall Study|Lack of Efficacy|0|||
160904511|NCT03478657|581044992|FG000|Overall Study|Withdrawal by Subject|0|||
160904512|NCT03478657|581044993|FG001|Overall Study|Withdrawal by Subject|1|||
160904513|NCT02590003|581044994|FG000|Overall Study|Death|1|||
160904514|NCT02590003|581044995|FG001|Overall Study|Death|2|||
160904515|NCT03733470|581044998|FG000|Overall Study|PI Decision|1|||
160904516|NCT03733470|581044999|FG001|Overall Study|PI Decision|1|||
160904517|NCT01786668|581045000|FG000|Overall Study|Adverse Event|0|||
160904518|NCT01786668|581045001|FG001|Overall Study|Adverse Event|1|||
160904519|NCT01786668|581045002|FG002|Overall Study|Adverse Event|1|||
160904520|NCT01786668|581045003|FG003|Overall Study|Adverse Event|2|||
160904521|NCT01786668|581045000|FG000|Overall Study|Withdrawal by Subject|0|||
160904522|NCT01786668|581045001|FG001|Overall Study|Withdrawal by Subject|0|||
160904523|NCT01786668|581045002|FG002|Overall Study|Withdrawal by Subject|3|||
160904524|NCT01786668|581045003|FG003|Overall Study|Withdrawal by Subject|1|||
160904525|NCT01786668|581045000|FG000|Overall Study|Pregnancy|0|||
160904526|NCT01786668|581045001|FG001|Overall Study|Pregnancy|0|||
160904527|NCT01786668|581045002|FG002|Overall Study|Pregnancy|0|||
160904528|NCT01786668|581045003|FG003|Overall Study|Pregnancy|1|||
160904529|NCT01786668|581045000|FG000|Overall Study|Lost to Follow-up|1|||
160904530|NCT01786668|581045001|FG001|Overall Study|Lost to Follow-up|0|||
160904531|NCT01786668|581045002|FG002|Overall Study|Lost to Follow-up|1|||
160904532|NCT01786668|581045003|FG003|Overall Study|Lost to Follow-up|0|||
160904533|NCT04891978|581045009|FG000|Baseline|Protocol Violation|2|||
160904534|NCT04891978|581045010|FG001|Baseline|Protocol Violation|1|||
160904535|NCT04891978|581045011|FG002|Baseline|Protocol Violation|0|||
160904536|NCT04891978|581045009|FG000|Baseline|Missing AIRQ|1|||
160904537|NCT04891978|581045010|FG001|Baseline|Missing AIRQ|0|||
160904538|NCT04891978|581045011|FG002|Baseline|Missing AIRQ|0|||
160904539|NCT04891978|581045009|FG000|Baseline|Did not attend a baseline visit|0|||
160904540|NCT04891978|581045010|FG001|Baseline|Did not attend a baseline visit|0|||
160904541|NCT04891978|581045011|FG002|Baseline|Did not attend a baseline visit|9|||
160991784|NCT04523181|581359891|FG000|Overall Study|Withdrawal by Subject|4|||
160904542|NCT01776840|581045012|FG000|Overall Study|Lost to Follow-up|12|||
160904543|NCT01776840|581045013|FG001|Overall Study|Lost to Follow-up|7|||
160904544|NCT01776840|581045012|FG000|Overall Study|Withdrawal by Subject|32|||
160904545|NCT01776840|581045013|FG001|Overall Study|Withdrawal by Subject|48|||
160991785|NCT04523181|581359892|FG001|Overall Study|Withdrawal by Subject|5|||
160904546|NCT01776840|581045012|FG000|Overall Study|Sponsor decision|89|||
160904547|NCT01776840|581045013|FG001|Overall Study|Sponsor decision|87|||
160904548|NCT03068455|581045014|FG000|Pre-treatment Period|Disease progression|0|||
160904549|NCT03068455|581045015|FG001|Pre-treatment Period|Disease progression|1|||
160904550|NCT03068455|581045014|FG000|Pre-treatment Period|Participant withdrew consent|1|||
160647641|NCT00416520|580092783|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
160647642|NCT00416520|580092784|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
160647643|NCT00416520|580092785|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
160838529|NCT00590577|580795726|FG000|Overall Study|Withdrawal by Subject|23|||
160838530|NCT00590577|580795727|FG001|Overall Study|Withdrawal by Subject|28|||
160838531|NCT00590577|580795728|FG002|Overall Study|Withdrawal by Subject|30|||
160838532|NCT00590577|580795729|FG003|Overall Study|Withdrawal by Subject|26|||
160838533|NCT00590577|580795726|FG000|Overall Study|Adverse Event|10|||
160838534|NCT00590577|580795727|FG001|Overall Study|Adverse Event|10|||
160838535|NCT00590577|580795728|FG002|Overall Study|Adverse Event|13|||
160838536|NCT00590577|580795729|FG003|Overall Study|Adverse Event|11|||
160838537|NCT00590577|580795726|FG000|Overall Study|Lost to Follow-up|12|||
160838538|NCT00590577|580795727|FG001|Overall Study|Lost to Follow-up|6|||
160838539|NCT00590577|580795728|FG002|Overall Study|Lost to Follow-up|6|||
160838540|NCT00590577|580795729|FG003|Overall Study|Lost to Follow-up|9|||
160838541|NCT00590577|580795726|FG000|Overall Study|Pregnancy|0|||
160838542|NCT00590577|580795727|FG001|Overall Study|Pregnancy|1|||
160838543|NCT00590577|580795728|FG002|Overall Study|Pregnancy|0|||
160838544|NCT00590577|580795729|FG003|Overall Study|Pregnancy|0|||
160838545|NCT00590577|580795726|FG000|Overall Study|Various reasons|1|||
160838546|NCT00590577|580795727|FG001|Overall Study|Various reasons|3|||
160838547|NCT00590577|580795728|FG002|Overall Study|Various reasons|1|||
160838548|NCT00590577|580795729|FG003|Overall Study|Various reasons|2|||
160838549|NCT03927404|580795731|FG000|Overall Study|Withdrawal by Subject|1|||
160838550|NCT01229449|580795732|FG000|Overall Study|Withdrawal by Subject|0|||
160838551|NCT01229449|580795733|FG001|Overall Study|Withdrawal by Subject|3|||
160838552|NCT01229449|580795734|FG002|Overall Study|Withdrawal by Subject|0|||
160838553|NCT01229449|580795735|FG003|Overall Study|Withdrawal by Subject|1|||
160838554|NCT01229449|580795736|FG004|Overall Study|Withdrawal by Subject|1|||
160838555|NCT01229449|580795732|FG000|Overall Study|Lost to Follow-up|1|||
160838556|NCT01229449|580795733|FG001|Overall Study|Lost to Follow-up|1|||
160838557|NCT01229449|580795734|FG002|Overall Study|Lost to Follow-up|1|||
160838558|NCT01229449|580795735|FG003|Overall Study|Lost to Follow-up|0|||
160838559|NCT01229449|580795736|FG004|Overall Study|Lost to Follow-up|0|||
160838560|NCT01229449|580795732|FG000|Overall Study|Physician Decision|0|||
160838561|NCT01229449|580795733|FG001|Overall Study|Physician Decision|0|||
160838562|NCT01229449|580795734|FG002|Overall Study|Physician Decision|1|||
160838563|NCT01229449|580795735|FG003|Overall Study|Physician Decision|0|||
160838564|NCT01229449|580795736|FG004|Overall Study|Physician Decision|0|||
160838565|NCT03203291|580795740|FG000|Overall Study|Withdrawal by Subject|1|||
160838566|NCT01300260|580795741|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
160838567|NCT01300260|580795742|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
160838568|NCT01300260|580795741|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
160838569|NCT01300260|580795742|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
160838570|NCT01300260|580795741|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
160838571|NCT01300260|580795742|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
160838572|NCT05098509|580795746|FG000|Overall Study|Withdrawal by Subject|0|||
160838573|NCT05098509|580795747|FG001|Overall Study|Withdrawal by Subject|0|||
160838574|NCT05098509|580795748|FG002|Overall Study|Withdrawal by Subject|1|||
160838575|NCT05098509|580795749|FG003|Overall Study|Withdrawal by Subject|0|||
160838576|NCT05098509|580795746|FG000|Overall Study|Early study termination|1|||
160838577|NCT05098509|580795747|FG001|Overall Study|Early study termination|1|||
160838578|NCT05098509|580795748|FG002|Overall Study|Early study termination|1|||
160838579|NCT05098509|580795749|FG003|Overall Study|Early study termination|0|||
160838580|NCT01147848|580795752|FG000|Run-in Period|Screen Failure|623|||
160991786|NCT04523181|581359891|FG000|Overall Study|Lost to Follow-up|2|||
160991787|NCT04523181|581359892|FG001|Overall Study|Lost to Follow-up|3|||
160991788|NCT04523181|581359891|FG000|Overall Study|Physician Decision|1|||
160991789|NCT04523181|581359892|FG001|Overall Study|Physician Decision|0|||
160991790|NCT04523181|581359891|FG000|Overall Study|Transferred to external facility.|1|||
160647644|NCT01387737|580092786|FG000|Overall Study|Adverse Event|20|||
160647645|NCT01387737|580092787|FG001|Overall Study|Adverse Event|30|||
160647646|NCT01387737|580092786|FG000|Overall Study|Lack of Efficacy|1|||
160838581|NCT01147848|580795753|FG001|Run-in Period|Screen Failure|0|||
160838582|NCT01147848|580795754|FG002|Run-in Period|Screen Failure|0|||
160838583|NCT01147848|580795752|FG000|Run-in Period|Run-in Failure|135|||
160838584|NCT01147848|580795753|FG001|Run-in Period|Run-in Failure|0|||
160838585|NCT01147848|580795754|FG002|Run-in Period|Run-in Failure|0|||
160838586|NCT01147848|580795752|FG000|Randomized Phase|Adverse Event|0|||
160838587|NCT01147848|580795753|FG001|Randomized Phase|Adverse Event|6|||
160838588|NCT01147848|580795754|FG002|Randomized Phase|Adverse Event|8|||
160838589|NCT01147848|580795752|FG000|Randomized Phase|Lack of Efficacy|0|||
160838590|NCT01147848|580795753|FG001|Randomized Phase|Lack of Efficacy|20|||
160838591|NCT01147848|580795754|FG002|Randomized Phase|Lack of Efficacy|11|||
160838592|NCT01147848|580795752|FG000|Randomized Phase|Protocol Violation|0|||
160838593|NCT01147848|580795753|FG001|Randomized Phase|Protocol Violation|7|||
160904551|NCT03068455|581045015|FG001|Pre-treatment Period|Participant withdrew consent|1|||
160904552|NCT03068455|581045014|FG000|Pre-treatment Period|Poor/non-compliance|0|||
160904553|NCT03068455|581045015|FG001|Pre-treatment Period|Poor/non-compliance|1|||
160904554|NCT03068455|581045014|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
160904555|NCT03068455|581045015|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
160904556|NCT03068455|581045014|FG000|Pre-treatment Period|Not reported|2|||
160904557|NCT03068455|581045015|FG001|Pre-treatment Period|Not reported|1|||
160904558|NCT03068455|581045014|FG000|Treatment Period|Disease progression|166|||
160904559|NCT03068455|581045015|FG001|Treatment Period|Disease progression|208|||
160904560|NCT03068455|581045014|FG000|Treatment Period|Study drug toxicity|317|||
160904561|NCT03068455|581045015|FG001|Treatment Period|Study drug toxicity|104|||
160904562|NCT03068455|581045014|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
160904563|NCT03068455|581045015|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
160904564|NCT03068455|581045014|FG000|Treatment Period|Participant request to stop therapy|33|||
160904565|NCT03068455|581045015|FG001|Treatment Period|Participant request to stop therapy|20|||
160904566|NCT03068455|581045014|FG000|Treatment Period|Participant withdrew consent|5|||
160563666|NCT04889209|579784568|FG011|All Cohorts Except 15E|Adverse Event|0|||
160563667|NCT04889209|579784569|FG012|All Cohorts Except 15E|Adverse Event|0|||
160563668|NCT04889209|579784570|FG013|All Cohorts Except 15E|Adverse Event|0|||
160563669|NCT04889209|579784571|FG014|All Cohorts Except 15E|Adverse Event|0|||
160563670|NCT04889209|579784572|FG015|All Cohorts Except 15E|Adverse Event|0|||
160563671|NCT04889209|579784573|FG016|All Cohorts Except 15E|Adverse Event|0|||
160563672|NCT04889209|579784574|FG017|All Cohorts Except 15E|Adverse Event|0|||
160563673|NCT04889209|579784557|FG000|All Cohorts Except 15E|Death|0|||
160563674|NCT04889209|579784558|FG001|All Cohorts Except 15E|Death|1|||
160563675|NCT04889209|579784559|FG002|All Cohorts Except 15E|Death|0|||
160838594|NCT01147848|580795754|FG002|Randomized Phase|Protocol Violation|10|||
160838595|NCT01147848|580795752|FG000|Randomized Phase|Lost to Follow-up|0|||
160838596|NCT01147848|580795753|FG001|Randomized Phase|Lost to Follow-up|5|||
160838597|NCT01147848|580795754|FG002|Randomized Phase|Lost to Follow-up|7|||
160838598|NCT01147848|580795752|FG000|Randomized Phase|Physician Decision|0|||
160838599|NCT01147848|580795753|FG001|Randomized Phase|Physician Decision|0|||
160838600|NCT01147848|580795754|FG002|Randomized Phase|Physician Decision|1|||
160563676|NCT04889209|579784560|FG003|All Cohorts Except 15E|Death|0|||
160563677|NCT04889209|579784561|FG004|All Cohorts Except 15E|Death|0|||
160563678|NCT04889209|579784562|FG005|All Cohorts Except 15E|Death|0|||
160563679|NCT04889209|579784563|FG006|All Cohorts Except 15E|Death|0|||
160563680|NCT04889209|579784564|FG007|All Cohorts Except 15E|Death|0|||
160563681|NCT04889209|579784565|FG008|All Cohorts Except 15E|Death|0|||
160563682|NCT04889209|579784566|FG009|All Cohorts Except 15E|Death|0|||
160563683|NCT04889209|579784567|FG010|All Cohorts Except 15E|Death|0|||
160563684|NCT04889209|579784568|FG011|All Cohorts Except 15E|Death|0|||
160563685|NCT04889209|579784569|FG012|All Cohorts Except 15E|Death|0|||
160838601|NCT01147848|580795752|FG000|Randomized Phase|Withdrawal by Subject|0|||
160838602|NCT01147848|580795753|FG001|Randomized Phase|Withdrawal by Subject|7|||
160563686|NCT04889209|579784570|FG013|All Cohorts Except 15E|Death|0|||
160563687|NCT04889209|579784571|FG014|All Cohorts Except 15E|Death|0|||
160563688|NCT04889209|579784572|FG015|All Cohorts Except 15E|Death|0|||
160563689|NCT04889209|579784573|FG016|All Cohorts Except 15E|Death|0|||
160563690|NCT04889209|579784574|FG017|All Cohorts Except 15E|Death|0|||
160563691|NCT04889209|579784557|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
160563692|NCT04889209|579784558|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
160563693|NCT04889209|579784559|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
160563694|NCT04889209|579784560|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
160563695|NCT04889209|579784561|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
160563696|NCT04889209|579784562|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
160563697|NCT04889209|579784563|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
160563698|NCT04889209|579784564|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
160563699|NCT04889209|579784565|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
160563700|NCT04889209|579784566|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
160563701|NCT04889209|579784567|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
160838603|NCT01147848|580795754|FG002|Randomized Phase|Withdrawal by Subject|9|||
160838604|NCT04033068|580795755|FG000|Overall Study|Withdrawal by Subject|0|||
160838605|NCT04033068|580795756|FG001|Overall Study|Withdrawal by Subject|0|||
160838606|NCT04033068|580795757|FG002|Overall Study|Withdrawal by Subject|1|||
160838607|NCT04033068|580795758|FG003|Overall Study|Withdrawal by Subject|0|||
160838608|NCT04033068|580795755|FG000|Overall Study|Lost to Follow-up|0|||
160838609|NCT04033068|580795756|FG001|Overall Study|Lost to Follow-up|1|||
160838610|NCT04033068|580795757|FG002|Overall Study|Lost to Follow-up|0|||
160838611|NCT04033068|580795758|FG003|Overall Study|Lost to Follow-up|0|||
160838612|NCT04033068|580795755|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
160838613|NCT04033068|580795756|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
160838614|NCT04033068|580795757|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
160838615|NCT04033068|580795758|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
160991791|NCT04523181|581359892|FG001|Overall Study|Transferred to external facility.|1|||
160563702|NCT04889209|579784568|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
160563703|NCT04889209|579784569|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
160563704|NCT04889209|579784570|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
160563705|NCT04889209|579784571|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
160838616|NCT02540265|580795759|FG000|Overall Study|Lost to Follow-up|0|||
160563706|NCT04889209|579784572|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
160563707|NCT04889209|579784573|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
160563708|NCT04889209|579784574|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
160563709|NCT04889209|579784557|FG000|All Cohorts Except 15E|Physician Decision|0|||
160563710|NCT04889209|579784558|FG001|All Cohorts Except 15E|Physician Decision|0|||
160563711|NCT04889209|579784559|FG002|All Cohorts Except 15E|Physician Decision|0|||
160563712|NCT04889209|579784560|FG003|All Cohorts Except 15E|Physician Decision|0|||
160563713|NCT04889209|579784561|FG004|All Cohorts Except 15E|Physician Decision|1|||
160563714|NCT04889209|579784562|FG005|All Cohorts Except 15E|Physician Decision|0|||
160563715|NCT04889209|579784563|FG006|All Cohorts Except 15E|Physician Decision|0|||
160563716|NCT04889209|579784564|FG007|All Cohorts Except 15E|Physician Decision|1|||
160563717|NCT04889209|579784565|FG008|All Cohorts Except 15E|Physician Decision|0|||
160563718|NCT04889209|579784566|FG009|All Cohorts Except 15E|Physician Decision|1|||
160563719|NCT04889209|579784567|FG010|All Cohorts Except 15E|Physician Decision|0|||
160563720|NCT04889209|579784568|FG011|All Cohorts Except 15E|Physician Decision|1|||
160563721|NCT04889209|579784569|FG012|All Cohorts Except 15E|Physician Decision|1|||
160563722|NCT04889209|579784570|FG013|All Cohorts Except 15E|Physician Decision|0|||
160563723|NCT04889209|579784571|FG014|All Cohorts Except 15E|Physician Decision|0|||
160563724|NCT04889209|579784572|FG015|All Cohorts Except 15E|Physician Decision|0|||
160563725|NCT04889209|579784573|FG016|All Cohorts Except 15E|Physician Decision|0|||
160563726|NCT04889209|579784574|FG017|All Cohorts Except 15E|Physician Decision|0|||
160563727|NCT04889209|579784557|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
160563728|NCT04889209|579784558|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
160563729|NCT04889209|579784559|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
160563730|NCT04889209|579784560|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
160563731|NCT04889209|579784561|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
160838617|NCT02540265|580795760|FG001|Overall Study|Lost to Follow-up|0|||
160838618|NCT02540265|580795761|FG002|Overall Study|Lost to Follow-up|1|||
160838619|NCT03157037|580795764|FG000|Overall Study|Death|1|||
160563732|NCT04889209|579784562|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
160563733|NCT04889209|579784563|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
160563734|NCT04889209|579784564|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
160563735|NCT04889209|579784565|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
160563736|NCT04889209|579784566|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
160563737|NCT04889209|579784567|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
160563738|NCT04889209|579784568|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
160838620|NCT00324233|580795765|FG000|First Period|unable to insert catheter|1|||
160838621|NCT00324233|580795766|FG001|First Period|unable to insert catheter|0|||
160838622|NCT00324233|580795765|FG000|Second Period|unable to insert catheter|1|||
160838623|NCT00324233|580795766|FG001|Second Period|unable to insert catheter|1|||
160838624|NCT00324233|580795765|FG000|Second Period|Protocol Violation|4|||
160838625|NCT00324233|580795766|FG001|Second Period|Protocol Violation|6|||
160838626|NCT01972789|580795767|FG000|Overall Study|Adverse Event|11|||
160838627|NCT01972789|580795768|FG001|Overall Study|Adverse Event|4|||
160838628|NCT01972789|580795767|FG000|Overall Study|Subject withdrew consent|14|||
160838629|NCT01972789|580795768|FG001|Overall Study|Subject withdrew consent|12|||
160838630|NCT01972789|580795767|FG000|Overall Study|Lost to Follow-up|4|||
160838631|NCT01972789|580795768|FG001|Overall Study|Lost to Follow-up|7|||
160838632|NCT01972789|580795767|FG000|Overall Study|Death|7|||
160838633|NCT01972789|580795768|FG001|Overall Study|Death|5|||
160838634|NCT01972789|580795767|FG000|Overall Study|Protocol deviation|1|||
160838635|NCT01972789|580795768|FG001|Overall Study|Protocol deviation|0|||
160838636|NCT01972789|580795767|FG000|Overall Study|Physician Decision|3|||
160838637|NCT01972789|580795768|FG001|Overall Study|Physician Decision|2|||
160838638|NCT00498355|580795774|FG000|Overall Study|Lost to Follow-up|1|||
160838639|NCT03596450|580795775|FG000|Overall Study|Death|9|||
160838640|NCT03596450|580795776|FG001|Overall Study|Death|9|||
160838641|NCT03596450|580795775|FG000|Overall Study|Protocol Violation|18|||
160838642|NCT03596450|580795776|FG001|Overall Study|Protocol Violation|26|||
160838643|NCT03596450|580795775|FG000|Overall Study|Lost to Follow-up|50|||
160838644|NCT03596450|580795776|FG001|Overall Study|Lost to Follow-up|56|||
160838645|NCT03596450|580795775|FG000|Overall Study|Adverse Event|14|||
160838646|NCT03596450|580795776|FG001|Overall Study|Adverse Event|7|||
160838647|NCT03596450|580795775|FG000|Overall Study|Withdrawal by Subject|38|||
160838648|NCT03596450|580795776|FG001|Overall Study|Withdrawal by Subject|36|||
160838649|NCT03596450|580795775|FG000|Overall Study|Accidentally Randomized|2|||
160838650|NCT03596450|580795776|FG001|Overall Study|Accidentally Randomized|0|||
160838651|NCT03596450|580795775|FG000|Overall Study|Other reasons|48|||
160838652|NCT03596450|580795776|FG001|Overall Study|Other reasons|53|||
160563739|NCT04889209|579784569|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
160563740|NCT04889209|579784570|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
160563741|NCT04889209|579784571|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
160838653|NCT03596450|580795775|FG000|Overall Study|Pregnancy|2|||
160838654|NCT03596450|580795776|FG001|Overall Study|Pregnancy|0|||
160838655|NCT03262441|580795787|FG000|Overall Study|Withdrawal by Subject|1|||
160838656|NCT02607228|580795788|FG000|Overall Study|Progressive Disease|4|||
160563742|NCT04889209|579784572|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
160563743|NCT04889209|579784573|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
160563744|NCT04889209|579784574|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
160838657|NCT02607228|580795789|FG001|Overall Study|Progressive Disease|3|||
160838658|NCT02607228|580795790|FG002|Overall Study|Progressive Disease|1|||
160563745|NCT04889209|579784557|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
160563746|NCT04889209|579784558|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
160563747|NCT04889209|579784559|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563748|NCT04889209|579784560|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563749|NCT04889209|579784561|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563750|NCT04889209|579784562|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
160563751|NCT04889209|579784563|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563752|NCT04889209|579784564|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
160563753|NCT04889209|579784565|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563754|NCT04889209|579784566|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
160563755|NCT04889209|579784567|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563756|NCT04889209|579784568|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563757|NCT04889209|579784569|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563758|NCT04889209|579784570|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563759|NCT04889209|579784571|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563760|NCT04889209|579784572|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563761|NCT04889209|579784573|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
160563762|NCT04889209|579784574|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
160904567|NCT03068455|581045015|FG001|Treatment Period|Participant withdrew consent|10|||
160904568|NCT03068455|581045014|FG000|Treatment Period|Poor/non-compliance|3|||
160904569|NCT03068455|581045015|FG001|Treatment Period|Poor/non-compliance|0|||
160904570|NCT03068455|581045014|FG000|Treatment Period|Participant no longer meets study criteria|1|||
160904571|NCT03068455|581045015|FG001|Treatment Period|Participant no longer meets study criteria|3|||
160904572|NCT03068455|581045014|FG000|Treatment Period|Other reasons|12|||
160904573|NCT03068455|581045015|FG001|Treatment Period|Other reasons|4|||
160904574|NCT05338216|581045017|FG000|Overall Study|Withdrawal by Subject|1|||
160904575|NCT05338216|581045018|FG001|Overall Study|Withdrawal by Subject|1|||
160904576|NCT04457336|581045019|FG000|Period 2: Part A|Withdrawal by Subject|0|||
160904577|NCT04457336|581045020|FG001|Period 2: Part A|Withdrawal by Subject|1|||
160904578|NCT04457336|581045021|FG002|Period 2: Part A|Withdrawal by Subject|1|||
160904579|NCT04457336|581045022|FG003|Period 2: Part A|Withdrawal by Subject|1|||
160904580|NCT04457336|581045023|FG004|Period 2: Part A|Withdrawal by Subject|0|||
160904581|NCT04457336|581045024|FG005|Period 2: Part A|Withdrawal by Subject|0|||
160904582|NCT04457336|581045025|FG006|Period 2: Part A|Withdrawal by Subject|0|||
160904583|NCT04457336|581045026|FG007|Period 2: Part A|Withdrawal by Subject|0|||
160904584|NCT04457336|581045019|FG000|Period 2: Part A|Adverse Event|0|||
160904585|NCT04457336|581045020|FG001|Period 2: Part A|Adverse Event|0|||
160904586|NCT04457336|581045021|FG002|Period 2: Part A|Adverse Event|1|||
160904587|NCT04457336|581045022|FG003|Period 2: Part A|Adverse Event|1|||
160904588|NCT04457336|581045023|FG004|Period 2: Part A|Adverse Event|0|||
160904589|NCT04457336|581045024|FG005|Period 2: Part A|Adverse Event|0|||
160904590|NCT04457336|581045025|FG006|Period 2: Part A|Adverse Event|0|||
160904591|NCT04457336|581045026|FG007|Period 2: Part A|Adverse Event|0|||
160904592|NCT04457336|581045019|FG000|Period 2: Part A|Study Terminated|0|||
160904593|NCT04457336|581045020|FG001|Period 2: Part A|Study Terminated|0|||
160904594|NCT04457336|581045021|FG002|Period 2: Part A|Study Terminated|1|||
160904595|NCT04457336|581045022|FG003|Period 2: Part A|Study Terminated|0|||
160904596|NCT04457336|581045023|FG004|Period 2: Part A|Study Terminated|0|||
160904597|NCT04457336|581045024|FG005|Period 2: Part A|Study Terminated|0|||
160904598|NCT04457336|581045025|FG006|Period 2: Part A|Study Terminated|0|||
160904599|NCT04457336|581045026|FG007|Period 2: Part A|Study Terminated|0|||
160904600|NCT04457336|581045019|FG000|Period 2: Part A|Protocol Violation|0|||
160904601|NCT04457336|581045020|FG001|Period 2: Part A|Protocol Violation|1|||
160904602|NCT04457336|581045021|FG002|Period 2: Part A|Protocol Violation|0|||
160904603|NCT04457336|581045022|FG003|Period 2: Part A|Protocol Violation|0|||
160904604|NCT04457336|581045023|FG004|Period 2: Part A|Protocol Violation|0|||
160904605|NCT04457336|581045024|FG005|Period 2: Part A|Protocol Violation|0|||
160904606|NCT04457336|581045025|FG006|Period 2: Part A|Protocol Violation|0|||
160904607|NCT04457336|581045026|FG007|Period 2: Part A|Protocol Violation|0|||
160904608|NCT04457336|581045019|FG000|Period 2: Part A|Lost to Follow-up|0|||
160904609|NCT04457336|581045020|FG001|Period 2: Part A|Lost to Follow-up|1|||
160904610|NCT04457336|581045021|FG002|Period 2: Part A|Lost to Follow-up|0|||
160904611|NCT04457336|581045022|FG003|Period 2: Part A|Lost to Follow-up|0|||
160904612|NCT04457336|581045023|FG004|Period 2: Part A|Lost to Follow-up|0|||
160904613|NCT04457336|581045024|FG005|Period 2: Part A|Lost to Follow-up|0|||
160904614|NCT04457336|581045025|FG006|Period 2: Part A|Lost to Follow-up|0|||
160904615|NCT04457336|581045026|FG007|Period 2: Part A|Lost to Follow-up|0|||
160904616|NCT04457336|581045019|FG000|Period 2: Part A|Other|0|||
160904617|NCT04457336|581045020|FG001|Period 2: Part A|Other|1|||
160904618|NCT04457336|581045021|FG002|Period 2: Part A|Other|0|||
160904619|NCT04457336|581045022|FG003|Period 2: Part A|Other|0|||
160563763|NCT04889209|579784557|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563764|NCT04889209|579784558|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563765|NCT04889209|579784559|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563766|NCT04889209|579784560|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
160563767|NCT04889209|579784561|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563768|NCT04889209|579784562|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563769|NCT04889209|579784563|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563770|NCT04889209|579784564|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563771|NCT04889209|579784565|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563772|NCT04889209|579784566|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563773|NCT04889209|579784567|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160647647|NCT01387737|580092787|FG001|Overall Study|Lack of Efficacy|0|||
160838659|NCT02607228|580795791|FG003|Overall Study|Progressive Disease|5|||
160838660|NCT02607228|580795792|FG004|Overall Study|Progressive Disease|4|||
160838661|NCT02607228|580795793|FG005|Overall Study|Progressive Disease|3|||
160838662|NCT02607228|580795794|FG006|Overall Study|Progressive Disease|1|||
160838663|NCT02607228|580795788|FG000|Overall Study|Adverse Event|1|||
160838664|NCT02607228|580795789|FG001|Overall Study|Adverse Event|0|||
160838665|NCT02607228|580795790|FG002|Overall Study|Adverse Event|1|||
160838666|NCT02607228|580795791|FG003|Overall Study|Adverse Event|0|||
160838667|NCT02607228|580795792|FG004|Overall Study|Adverse Event|1|||
160838668|NCT02607228|580795793|FG005|Overall Study|Adverse Event|1|||
160838669|NCT02607228|580795794|FG006|Overall Study|Adverse Event|1|||
160838670|NCT02607228|580795788|FG000|Overall Study|Investigator's Discretion|0|||
160838671|NCT02607228|580795789|FG001|Overall Study|Investigator's Discretion|0|||
160838672|NCT02607228|580795790|FG002|Overall Study|Investigator's Discretion|1|||
160838673|NCT02607228|580795791|FG003|Overall Study|Investigator's Discretion|0|||
160838674|NCT02607228|580795792|FG004|Overall Study|Investigator's Discretion|0|||
160838675|NCT02607228|580795793|FG005|Overall Study|Investigator's Discretion|1|||
160838676|NCT02607228|580795794|FG006|Overall Study|Investigator's Discretion|0|||
160838677|NCT02607228|580795788|FG000|Overall Study|Withdrew Consent|0|||
160838678|NCT02607228|580795789|FG001|Overall Study|Withdrew Consent|1|||
160838679|NCT02607228|580795790|FG002|Overall Study|Withdrew Consent|0|||
160838680|NCT02607228|580795791|FG003|Overall Study|Withdrew Consent|0|||
160838681|NCT02607228|580795792|FG004|Overall Study|Withdrew Consent|0|||
160838682|NCT02607228|580795793|FG005|Overall Study|Withdrew Consent|1|||
160838683|NCT02607228|580795794|FG006|Overall Study|Withdrew Consent|0|||
160838684|NCT02607228|580795788|FG000|Overall Study|Study Terminated by Sponsor|0|||
160838685|NCT02607228|580795789|FG001|Overall Study|Study Terminated by Sponsor|0|||
160838686|NCT02607228|580795790|FG002|Overall Study|Study Terminated by Sponsor|0|||
160838687|NCT02607228|580795791|FG003|Overall Study|Study Terminated by Sponsor|1|||
160838688|NCT02607228|580795792|FG004|Overall Study|Study Terminated by Sponsor|0|||
160838689|NCT02607228|580795793|FG005|Overall Study|Study Terminated by Sponsor|0|||
160838690|NCT02607228|580795794|FG006|Overall Study|Study Terminated by Sponsor|0|||
160838691|NCT03235089|580795795|FG000|Overall Study|Lost to Follow-up|1|||
160838692|NCT03235089|580795796|FG001|Overall Study|Lost to Follow-up|1|||
160838693|NCT03235089|580795795|FG000|Overall Study|Physician Decision|2|||
160838694|NCT03235089|580795796|FG001|Overall Study|Physician Decision|2|||
160838695|NCT03238924|580795806|FG000|Overall Study|Withdrawal by Subject|2|||
160838696|NCT03238924|580795807|FG001|Overall Study|Withdrawal by Subject|2|||
160838697|NCT03576716|580795810|FG000|Overall Study|Withdrawal by Subject|0|||
160838698|NCT03576716|580795811|FG001|Overall Study|Withdrawal by Subject|1|||
160838699|NCT00559988|580795812|FG000|Overall Study|Death|147|||
160838700|NCT00559988|580795813|FG001|Overall Study|Death|140|||
160838701|NCT00559988|580795812|FG000|Overall Study|Withdrawal by Subject|152|||
160838702|NCT00559988|580795813|FG001|Overall Study|Withdrawal by Subject|139|||
160838703|NCT00559988|580795812|FG000|Overall Study|Lost to Follow-up|42|||
160838704|NCT00559988|580795813|FG001|Overall Study|Lost to Follow-up|56|||
160838705|NCT00559988|580795812|FG000|Overall Study|ICD device explanted|10|||
160838706|NCT00559988|580795813|FG001|Overall Study|ICD device explanted|17|||
160838707|NCT02891382|580795814|FG000|Overall Study|Lost to Follow-up|3|||
160838708|NCT02891382|580795815|FG001|Overall Study|Lost to Follow-up|4|||
160838709|NCT02891382|580795816|FG002|Overall Study|Lost to Follow-up|5|||
160838710|NCT02891382|580795817|FG003|Overall Study|Lost to Follow-up|3|||
160838711|NCT02891382|580795818|FG004|Overall Study|Lost to Follow-up|4|||
160838712|NCT02516228|580795819|FG000|Overall Study|Lost to Follow-up|1|||
160838713|NCT02516228|580795819|FG000|Overall Study|Withdrawal by Subject|1|||
160838714|NCT02516228|580795819|FG000|Overall Study|Physician Decision|1|||
160838715|NCT03916484|580795820|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160838716|NCT03916484|580795821|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
160838717|NCT03916484|580795822|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160838718|NCT03916484|580795823|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160563774|NCT04889209|579784568|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563775|NCT04889209|579784569|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563776|NCT04889209|579784570|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563777|NCT04889209|579784571|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563778|NCT04889209|579784572|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563779|NCT04889209|579784573|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563780|NCT04889209|579784574|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
160563781|NCT04889209|579784557|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160563782|NCT04889209|579784558|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160563783|NCT04889209|579784559|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160563784|NCT04889209|579784560|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160563785|NCT04889209|579784561|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
160563786|NCT04889209|579784562|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160563787|NCT04889209|579784563|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
160563788|NCT04889209|579784564|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
160563789|NCT04889209|579784565|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160563790|NCT04889209|579784566|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
160563791|NCT04889209|579784567|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
160563792|NCT04889209|579784568|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160647648|NCT01387737|580092786|FG000|Overall Study|Physician Decision|3|||
160647649|NCT01387737|580092787|FG001|Overall Study|Physician Decision|10|||
160838719|NCT03916484|580795820|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
160838720|NCT03916484|580795821|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
160838721|NCT03916484|580795822|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
160838722|NCT03916484|580795823|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
160838723|NCT02292706|580795825|FG000|Overall Study|Lost to Follow-up|20|||
160838724|NCT02292706|580795826|FG001|Overall Study|Lost to Follow-up|44|||
160838725|NCT02292706|580795827|FG002|Overall Study|Lost to Follow-up|24|||
160838726|NCT02292706|580795828|FG003|Overall Study|Lost to Follow-up|61|||
160904620|NCT04457336|581045023|FG004|Period 2: Part A|Other|0|||
160904621|NCT04457336|581045024|FG005|Period 2: Part A|Other|0|||
160904622|NCT04457336|581045025|FG006|Period 2: Part A|Other|0|||
160904623|NCT04457336|581045026|FG007|Period 2: Part A|Other|0|||
160904624|NCT04457336|581045019|FG000|Period 2: Part A|Physician Decision|0|||
160904625|NCT04457336|581045020|FG001|Period 2: Part A|Physician Decision|0|||
160904626|NCT04457336|581045021|FG002|Period 2: Part A|Physician Decision|0|||
160904627|NCT04457336|581045022|FG003|Period 2: Part A|Physician Decision|1|||
160904628|NCT04457336|581045023|FG004|Period 2: Part A|Physician Decision|0|||
160904629|NCT04457336|581045024|FG005|Period 2: Part A|Physician Decision|0|||
160904630|NCT04457336|581045025|FG006|Period 2: Part A|Physician Decision|0|||
160904631|NCT04457336|581045026|FG007|Period 2: Part A|Physician Decision|0|||
160904632|NCT04457336|581045019|FG000|Period 3: Part B|Study Terminated|0|||
160904633|NCT04457336|581045020|FG001|Period 3: Part B|Study Terminated|0|||
160904634|NCT04457336|581045021|FG002|Period 3: Part B|Study Terminated|0|||
160904635|NCT04457336|581045022|FG003|Period 3: Part B|Study Terminated|0|||
160904636|NCT04457336|581045023|FG004|Period 3: Part B|Study Terminated|1|||
160904637|NCT04457336|581045024|FG005|Period 3: Part B|Study Terminated|10|||
160904638|NCT04457336|581045025|FG006|Period 3: Part B|Study Terminated|13|||
160904639|NCT04457336|581045026|FG007|Period 3: Part B|Study Terminated|0|||
160904640|NCT04457336|581045019|FG000|Period 3: Part B|Withdrawal by Subject|0|||
160904641|NCT04457336|581045020|FG001|Period 3: Part B|Withdrawal by Subject|0|||
160904642|NCT04457336|581045021|FG002|Period 3: Part B|Withdrawal by Subject|0|||
160904643|NCT04457336|581045022|FG003|Period 3: Part B|Withdrawal by Subject|0|||
160904644|NCT04457336|581045023|FG004|Period 3: Part B|Withdrawal by Subject|0|||
160904645|NCT04457336|581045024|FG005|Period 3: Part B|Withdrawal by Subject|1|||
160904646|NCT04457336|581045025|FG006|Period 3: Part B|Withdrawal by Subject|2|||
160904647|NCT04457336|581045026|FG007|Period 3: Part B|Withdrawal by Subject|0|||
160904648|NCT04457336|581045019|FG000|Period 4: Part C|Study Terminated|0|||
160904649|NCT04457336|581045020|FG001|Period 4: Part C|Study Terminated|0|||
160904650|NCT04457336|581045021|FG002|Period 4: Part C|Study Terminated|0|||
160904651|NCT04457336|581045022|FG003|Period 4: Part C|Study Terminated|0|||
160904652|NCT04457336|581045023|FG004|Period 4: Part C|Study Terminated|0|||
160904653|NCT04457336|581045024|FG005|Period 4: Part C|Study Terminated|0|||
160904654|NCT04457336|581045025|FG006|Period 4: Part C|Study Terminated|0|||
160904655|NCT04457336|581045026|FG007|Period 4: Part C|Study Terminated|30|||
160904656|NCT04457336|581045019|FG000|Period 4: Part C|Adverse Event|0|||
160904657|NCT04457336|581045020|FG001|Period 4: Part C|Adverse Event|0|||
160904658|NCT04457336|581045021|FG002|Period 4: Part C|Adverse Event|0|||
160904659|NCT04457336|581045022|FG003|Period 4: Part C|Adverse Event|0|||
160904660|NCT04457336|581045023|FG004|Period 4: Part C|Adverse Event|0|||
160904661|NCT04457336|581045024|FG005|Period 4: Part C|Adverse Event|0|||
160904662|NCT04457336|581045025|FG006|Period 4: Part C|Adverse Event|0|||
160904663|NCT04457336|581045026|FG007|Period 4: Part C|Adverse Event|2|||
160904664|NCT04457336|581045019|FG000|Period 4: Part C|Site Terminated|0|||
160904665|NCT04457336|581045020|FG001|Period 4: Part C|Site Terminated|0|||
160904666|NCT04457336|581045021|FG002|Period 4: Part C|Site Terminated|0|||
160904667|NCT04457336|581045022|FG003|Period 4: Part C|Site Terminated|0|||
160904668|NCT04457336|581045023|FG004|Period 4: Part C|Site Terminated|0|||
160904669|NCT04457336|581045024|FG005|Period 4: Part C|Site Terminated|0|||
160904670|NCT04457336|581045025|FG006|Period 4: Part C|Site Terminated|0|||
160904671|NCT04457336|581045026|FG007|Period 4: Part C|Site Terminated|1|||
160904672|NCT04457336|581045019|FG000|Period 4: Part C|Other|0|||
160904673|NCT04457336|581045020|FG001|Period 4: Part C|Other|0|||
160904674|NCT04457336|581045021|FG002|Period 4: Part C|Other|0|||
160904675|NCT04457336|581045022|FG003|Period 4: Part C|Other|0|||
160904676|NCT04457336|581045023|FG004|Period 4: Part C|Other|0|||
160904677|NCT04457336|581045024|FG005|Period 4: Part C|Other|0|||
160904678|NCT04457336|581045025|FG006|Period 4: Part C|Other|0|||
160904679|NCT04457336|581045026|FG007|Period 4: Part C|Other|2|||
160904680|NCT04457336|581045019|FG000|Period 4: Part C|Withdrawal by Subject|0|||
160904681|NCT04457336|581045020|FG001|Period 4: Part C|Withdrawal by Subject|0|||
160904682|NCT04457336|581045021|FG002|Period 4: Part C|Withdrawal by Subject|0|||
160904683|NCT04457336|581045022|FG003|Period 4: Part C|Withdrawal by Subject|0|||
160904684|NCT04457336|581045023|FG004|Period 4: Part C|Withdrawal by Subject|0|||
160904685|NCT04457336|581045024|FG005|Period 4: Part C|Withdrawal by Subject|0|||
160904686|NCT04457336|581045025|FG006|Period 4: Part C|Withdrawal by Subject|0|||
160904687|NCT04457336|581045026|FG007|Period 4: Part C|Withdrawal by Subject|3|||
160904688|NCT05379231|581045027|FG000|Home Visit|Withdrawal by Subject|2|||
160904689|NCT05379231|581045027|FG000|In-lab Visit|Withdrawal by Subject|2|||
160904690|NCT01201785|581045039|FG000|Overall Study|Lost to Follow-up|16|||
160904691|NCT01064310|581045040|FG000|Period 1|Adverse Event|7|||
160904692|NCT01064310|581045041|FG001|Period 1|Adverse Event|10|||
160904693|NCT01064310|581045042|FG002|Period 1|Adverse Event|0|||
160904694|NCT01064310|581045040|FG000|Period 1|Physician Decision|1|||
160904695|NCT01064310|581045041|FG001|Period 1|Physician Decision|0|||
160904696|NCT01064310|581045042|FG002|Period 1|Physician Decision|0|||
160904697|NCT01064310|581045040|FG000|Period 1|Withdrawal by Subject|2|||
160904698|NCT01064310|581045041|FG001|Period 1|Withdrawal by Subject|2|||
160904699|NCT01064310|581045042|FG002|Period 1|Withdrawal by Subject|0|||
160904700|NCT01064310|581045040|FG000|Period 1|Lack of Efficacy|3|||
160904701|NCT01064310|581045041|FG001|Period 1|Lack of Efficacy|5|||
160904702|NCT01064310|581045042|FG002|Period 1|Lack of Efficacy|0|||
160904703|NCT01064310|581045040|FG000|Period 1|Entered Open-label Period|1|||
160991792|NCT02042443|581359895|FG000|Overall Study|Adverse Event|2|||
160991793|NCT02042443|581359896|FG001|Overall Study|Adverse Event|1|||
160991794|NCT02042443|581359895|FG000|Overall Study|Withdrawal by Subject|0|||
160991795|NCT02042443|581359896|FG001|Overall Study|Withdrawal by Subject|1|||
160991796|NCT02042443|581359895|FG000|Overall Study|Progression|21|||
160991797|NCT02042443|581359896|FG001|Overall Study|Progression|17|||
160991798|NCT02042443|581359895|FG000|Overall Study|not protocol specified|1|||
160991799|NCT02042443|581359896|FG001|Overall Study|not protocol specified|1|||
160991800|NCT02042443|581359895|FG000|Overall Study|Not eligible/not analyzable|3|||
160991801|NCT02042443|581359896|FG001|Overall Study|Not eligible/not analyzable|6|||
160991802|NCT01649427|581359897|FG000|Overall Study|Adverse Event|1|||
160991803|NCT01649427|581359898|FG001|Overall Study|Adverse Event|1|||
160991804|NCT01649427|581359897|FG000|Overall Study|Withdrawal by Subject|8|||
160991805|NCT01649427|581359898|FG001|Overall Study|Withdrawal by Subject|7|||
160991806|NCT01649427|581359897|FG000|Overall Study|Lost to Follow-up|0|||
160991807|NCT01649427|581359898|FG001|Overall Study|Lost to Follow-up|1|||
160991808|NCT01649427|581359897|FG000|Overall Study|Graft loss|0|||
160991809|NCT01649427|581359898|FG001|Overall Study|Graft loss|1|||
160991810|NCT01649427|581359897|FG000|Overall Study|Surgical problems during nephrectomy|2|||
160991811|NCT01649427|581359898|FG001|Overall Study|Surgical problems during nephrectomy|2|||
160991812|NCT02138916|581359899|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
160991813|NCT02138916|581359900|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
160991814|NCT02138916|581359901|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
160991815|NCT02138916|581359899|FG000|Overall Study|Death|14|||
160991816|NCT02138916|581359900|FG001|Overall Study|Death|11|||
160991817|NCT02138916|581359901|FG002|Overall Study|Death|12|||
160991818|NCT02138916|581359899|FG000|Overall Study|Withdrawal by Subject|27|||
160991819|NCT02138916|581359900|FG001|Overall Study|Withdrawal by Subject|31|||
160991820|NCT02138916|581359901|FG002|Overall Study|Withdrawal by Subject|32|||
160991821|NCT02138916|581359899|FG000|Overall Study|Study specific withdrawal criteria|0|||
160991822|NCT02138916|581359900|FG001|Overall Study|Study specific withdrawal criteria|0|||
160991823|NCT02138916|581359901|FG002|Overall Study|Study specific withdrawal criteria|1|||
160991824|NCT02138916|581359899|FG000|Overall Study|incorrect enrolment|1|||
160991825|NCT02138916|581359900|FG001|Overall Study|incorrect enrolment|1|||
160563793|NCT04889209|579784569|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
160563794|NCT04889209|579784570|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160563795|NCT04889209|579784571|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160563796|NCT04889209|579784572|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160838727|NCT02292706|580795829|FG004|Overall Study|Lost to Follow-up|21|||
160838728|NCT02292706|580795830|FG005|Overall Study|Lost to Follow-up|52|||
160838729|NCT02292706|580795831|FG006|Overall Study|Lost to Follow-up|25|||
160838730|NCT02292706|580795832|FG007|Overall Study|Lost to Follow-up|0|||
160838731|NCT02292706|580795825|FG000|Overall Study|Withdrew consent|15|||
160838732|NCT02292706|580795826|FG001|Overall Study|Withdrew consent|56|||
160838733|NCT02292706|580795827|FG002|Overall Study|Withdrew consent|43|||
160838734|NCT02292706|580795828|FG003|Overall Study|Withdrew consent|36|||
160838735|NCT02292706|580795829|FG004|Overall Study|Withdrew consent|13|||
160838736|NCT02292706|580795830|FG005|Overall Study|Withdrew consent|51|||
160838737|NCT02292706|580795831|FG006|Overall Study|Withdrew consent|20|||
160838738|NCT02292706|580795832|FG007|Overall Study|Withdrew consent|0|||
160838739|NCT02292706|580795825|FG000|Overall Study|Death|3|||
160991826|NCT02138916|581359901|FG002|Overall Study|incorrect enrolment|0|||
160991827|NCT02138916|581359899|FG000|Overall Study|Severe non-compliance|1|||
160991828|NCT02138916|581359900|FG001|Overall Study|Severe non-compliance|2|||
160991829|NCT02138916|581359901|FG002|Overall Study|Severe non-compliance|1|||
160991830|NCT02138916|581359899|FG000|Overall Study|Lost to Follow-up|4|||
160991831|NCT02138916|581359900|FG001|Overall Study|Lost to Follow-up|2|||
160991832|NCT02138916|581359901|FG002|Overall Study|Lost to Follow-up|3|||
160991833|NCT02138916|581359899|FG000|Overall Study|Adverse Event|4|||
160991834|NCT02138916|581359900|FG001|Overall Study|Adverse Event|4|||
160991835|NCT02138916|581359901|FG002|Overall Study|Adverse Event|3|||
160991836|NCT01913340|581359902|FG000|Overall Study|Death|2|||
160563797|NCT04889209|579784573|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
160838740|NCT02292706|580795826|FG001|Overall Study|Death|11|||
160838741|NCT02292706|580795827|FG002|Overall Study|Death|16|||
160838742|NCT02292706|580795828|FG003|Overall Study|Death|22|||
160904704|NCT01064310|581045041|FG001|Period 1|Entered Open-label Period|1|||
160904705|NCT01064310|581045042|FG002|Period 1|Entered Open-label Period|0|||
160904706|NCT01064310|581045040|FG000|Period 2|Adverse Event|2|||
160904707|NCT01064310|581045041|FG001|Period 2|Adverse Event|1|||
160904708|NCT01064310|581045042|FG002|Period 2|Adverse Event|0|||
160904709|NCT01064310|581045040|FG000|Period 2|Physician Decision|0|||
160904710|NCT01064310|581045041|FG001|Period 2|Physician Decision|1|||
160904711|NCT01064310|581045042|FG002|Period 2|Physician Decision|0|||
160904712|NCT01064310|581045040|FG000|Period 2|Entered Open-label Period|1|||
160991837|NCT01913340|581359903|FG001|Overall Study|Death|5|||
160991838|NCT01913340|581359902|FG000|Overall Study|Lost to Follow-up|1|||
160904713|NCT01064310|581045041|FG001|Period 2|Entered Open-label Period|0|||
160904714|NCT01064310|581045042|FG002|Period 2|Entered Open-label Period|0|||
160904715|NCT01064310|581045040|FG000|Period 2|Lack of Efficacy|1|||
160904716|NCT01064310|581045041|FG001|Period 2|Lack of Efficacy|4|||
160904717|NCT01064310|581045042|FG002|Period 2|Lack of Efficacy|0|||
160904718|NCT01064310|581045040|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
160904719|NCT01064310|581045041|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
160904720|NCT01064310|581045042|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
160904721|NCT01064310|581045040|FG000|Open Label Pazopinib|Adverse Event|0|||
160904722|NCT01064310|581045041|FG001|Open Label Pazopinib|Adverse Event|0|||
160904723|NCT01064310|581045042|FG002|Open Label Pazopinib|Adverse Event|12|||
160904724|NCT01064310|581045040|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
160904725|NCT01064310|581045041|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
160904726|NCT01064310|581045042|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
160904727|NCT01064310|581045040|FG000|Open Label Pazopinib|Physician Decision|0|||
160904728|NCT01064310|581045041|FG001|Open Label Pazopinib|Physician Decision|0|||
160904729|NCT01064310|581045042|FG002|Open Label Pazopinib|Physician Decision|20|||
160904730|NCT00660699|581045043|FG000|Overall Study|Withdrawal by Subject|2|||
160904731|NCT05147428|581045044|FG000|Overall Study|Removed prior to mailing|289|||
160904732|NCT05147428|581045045|FG001|Overall Study|Removed prior to mailing|306|||
160904733|NCT05147428|581045046|FG002|Overall Study|Removed prior to mailing|270|||
160904734|NCT05147428|581045044|FG000|Overall Study|Died or disenrolled during blackout period|239|||
160904735|NCT05147428|581045045|FG001|Overall Study|Died or disenrolled during blackout period|278|||
160904736|NCT05147428|581045046|FG002|Overall Study|Died or disenrolled during blackout period|273|||
160904737|NCT03128047|581045047|FG000|Overall Study|Withdrawal by Subject|1|||
160904738|NCT00688753|581046292|FG000|Overall Study|Disease progression|55|||
160904739|NCT00688753|581046292|FG000|Overall Study|Missing|1|||
160904740|NCT00688753|581046292|FG000|Overall Study|Death|9|||
160904741|NCT00688753|581046292|FG000|Overall Study|Withdrawal by Subject|3|||
160904742|NCT00688753|581046292|FG000|Overall Study|Adverse Event|20|||
160904743|NCT00688753|581046292|FG000|Overall Study|Protocol Violation|1|||
160904744|NCT00688753|581046292|FG000|Overall Study|Lost to Follow-up|3|||
160904745|NCT05996718|581046294|FG000|Overall Study|Lost to Follow-up|3|||
160904746|NCT01713686|581046295|FG000|Overall Study|Lost to Follow-up|9|||
160904747|NCT01713686|581046295|FG000|Overall Study|Withdrawal by Subject|6|||
160904748|NCT03187197|581046297|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
160904749|NCT03187197|581046298|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
160904750|NCT03187197|581046299|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
160904751|NCT03187197|581046297|FG000|Overall Study|Withdrawal by Subject|8|||
160904752|NCT03187197|581046298|FG001|Overall Study|Withdrawal by Subject|63|||
160904753|NCT03187197|581046299|FG002|Overall Study|Withdrawal by Subject|4|||
160904754|NCT03187197|581046297|FG000|Overall Study|Lost to Follow-up|1|||
160904755|NCT03187197|581046298|FG001|Overall Study|Lost to Follow-up|60|||
160904756|NCT03187197|581046299|FG002|Overall Study|Lost to Follow-up|7|||
160904757|NCT03187197|581046297|FG000|Overall Study|Adverse Event|6|||
160904758|NCT03187197|581046298|FG001|Overall Study|Adverse Event|29|||
160904759|NCT03187197|581046299|FG002|Overall Study|Adverse Event|0|||
160904760|NCT03187197|581046297|FG000|Overall Study|Death|0|||
160904761|NCT03187197|581046298|FG001|Overall Study|Death|11|||
160904762|NCT03187197|581046299|FG002|Overall Study|Death|0|||
160904763|NCT03187197|581046297|FG000|Overall Study|Administrative problem|1|||
160904764|NCT03187197|581046298|FG001|Overall Study|Administrative problem|1|||
160904765|NCT03187197|581046299|FG002|Overall Study|Administrative problem|0|||
160904766|NCT03187197|581046297|FG000|Overall Study|Reason not listed|2|||
160904767|NCT03187197|581046298|FG001|Overall Study|Reason not listed|54|||
160904768|NCT03187197|581046299|FG002|Overall Study|Reason not listed|1|||
160904769|NCT03187197|581046297|FG000|Overall Study|Missing|1|||
160904770|NCT03187197|581046298|FG001|Overall Study|Missing|32|||
160904771|NCT03187197|581046299|FG002|Overall Study|Missing|3|||
160904772|NCT03187197|581046297|FG000|Overall Study|Status missing|2|||
160904773|NCT03187197|581046298|FG001|Overall Study|Status missing|33|||
160904774|NCT03187197|581046299|FG002|Overall Study|Status missing|3|||
160904775|NCT03187197|581046297|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
160904776|NCT03187197|581046298|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
160904777|NCT03187197|581046299|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
160904778|NCT02385045|581046300|FG000|Overall Study|Endoscopy could not be completed|4|||
160904779|NCT00115739|581046301|FG000|Overall Study|Lost to Follow-up|3|||
160904780|NCT00259649|581046304|FG000|Overall Study|Lost to Follow-up|7|||
160904781|NCT00259649|581046304|FG000|Overall Study|irregular menses|3|||
160904782|NCT02200211|581046306|FG000|Overall Study|Lost to Follow-up|7|||
160904783|NCT02200211|581046307|FG001|Overall Study|Lost to Follow-up|7|||
160904784|NCT02200211|581046308|FG002|Overall Study|Lost to Follow-up|1|||
160904785|NCT02200211|581046309|FG003|Overall Study|Lost to Follow-up|2|||
160904786|NCT02200211|581046306|FG000|Overall Study|Withdrawal by Subject|1|||
160904787|NCT02200211|581046307|FG001|Overall Study|Withdrawal by Subject|0|||
160904788|NCT02200211|581046308|FG002|Overall Study|Withdrawal by Subject|0|||
160904789|NCT02200211|581046309|FG003|Overall Study|Withdrawal by Subject|0|||
160991839|NCT01913340|581359903|FG001|Overall Study|Lost to Follow-up|1|||
160838743|NCT02292706|580795829|FG004|Overall Study|Death|8|||
160838744|NCT02292706|580795830|FG005|Overall Study|Death|17|||
160838745|NCT02292706|580795831|FG006|Overall Study|Death|3|||
160838746|NCT02292706|580795832|FG007|Overall Study|Death|0|||
160838747|NCT02292706|580795825|FG000|Overall Study|Study terminated by sponsor|0|||
160838748|NCT02292706|580795826|FG001|Overall Study|Study terminated by sponsor|9|||
160838749|NCT02292706|580795827|FG002|Overall Study|Study terminated by sponsor|4|||
160838750|NCT02292706|580795828|FG003|Overall Study|Study terminated by sponsor|21|||
160838751|NCT02292706|580795829|FG004|Overall Study|Study terminated by sponsor|11|||
160838752|NCT02292706|580795830|FG005|Overall Study|Study terminated by sponsor|13|||
160991840|NCT02784704|581359904|FG000|Overall Study|Adverse Event|4|||
160991841|NCT02784704|581359905|FG001|Overall Study|Adverse Event|2|||
160991842|NCT02784704|581359904|FG000|Overall Study|Lost to Follow-up|6|||
160991843|NCT02784704|581359905|FG001|Overall Study|Lost to Follow-up|4|||
160991844|NCT02784704|581359904|FG000|Overall Study|Withdrawal by Subject|1|||
160991845|NCT02784704|581359905|FG001|Overall Study|Withdrawal by Subject|3|||
160991846|NCT02784704|581359904|FG000|Overall Study|Subject Non Compliance|2|||
160991847|NCT02784704|581359905|FG001|Overall Study|Subject Non Compliance|0|||
160991848|NCT00603538|581359906|FG000|Overall Study|Adverse Event|0|||
160991849|NCT00603538|581359907|FG001|Overall Study|Adverse Event|4|||
160991850|NCT00603538|581359908|FG002|Overall Study|Adverse Event|2|||
160991851|NCT00603538|581359906|FG000|Overall Study|Objective progression or relapse|3|||
160991852|NCT00603538|581359907|FG001|Overall Study|Objective progression or relapse|0|||
160991853|NCT00603538|581359908|FG002|Overall Study|Objective progression or relapse|0|||
160991854|NCT05750745|581359911|FG000|Overall Study|Adverse Event|1|||
160991855|NCT05750745|581359912|FG001|Overall Study|Adverse Event|0|||
160991856|NCT05750745|581359913|FG002|Overall Study|Adverse Event|0|||
160991857|NCT05750745|581359911|FG000|Overall Study|Protocol Violation|1|||
160991858|NCT05750745|581359912|FG001|Overall Study|Protocol Violation|0|||
160991859|NCT05750745|581359913|FG002|Overall Study|Protocol Violation|0|||
160991860|NCT05750745|581359911|FG000|Overall Study|Withdrawal by Subject|0|||
160991861|NCT05750745|581359912|FG001|Overall Study|Withdrawal by Subject|1|||
160991862|NCT05750745|581359913|FG002|Overall Study|Withdrawal by Subject|0|||
160991863|NCT05096884|581359915|FG000|Overall Study|Excluded based on negative tilt table test|4|||
160991864|NCT04794179|581359916|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
160991865|NCT04794179|581359917|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
160991866|NCT02482233|581359924|FG000|Overall Study|Lost to Follow-up|1|||
160991867|NCT02482233|581359925|FG001|Overall Study|Lost to Follow-up|1|||
160991868|NCT04888585|581359926|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
160991869|NCT04888585|581359927|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
160991870|NCT04888585|581359928|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
160991871|NCT04888585|581359929|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
160991872|NCT04888585|581359930|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
160991873|NCT04888585|581359931|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991874|NCT04888585|581359932|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991875|NCT04888585|581359933|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991876|NCT04888585|581359934|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991877|NCT04888585|581359935|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991878|NCT04888585|581359936|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991879|NCT04888585|581359926|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160991880|NCT04888585|581359927|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
160991881|NCT04888585|581359928|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
160991882|NCT04888585|581359929|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
160991883|NCT04888585|581359930|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
160991884|NCT04888585|581359931|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160991885|NCT04888585|581359932|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160838753|NCT02292706|580795831|FG006|Overall Study|Study terminated by sponsor|3|||
160838754|NCT02292706|580795832|FG007|Overall Study|Study terminated by sponsor|0|||
160838755|NCT02292706|580795825|FG000|Overall Study|Investigator's discretion|4|||
160838756|NCT02292706|580795826|FG001|Overall Study|Investigator's discretion|9|||
160838757|NCT02292706|580795827|FG002|Overall Study|Investigator's discretion|7|||
160838758|NCT02292706|580795828|FG003|Overall Study|Investigator's discretion|11|||
160838759|NCT02292706|580795829|FG004|Overall Study|Investigator's discretion|4|||
160838760|NCT02292706|580795830|FG005|Overall Study|Investigator's discretion|10|||
160838761|NCT02292706|580795831|FG006|Overall Study|Investigator's discretion|1|||
160991886|NCT04888585|581359933|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160647650|NCT01387737|580092786|FG000|Overall Study|Withdrawal by Subject|27|||
160647651|NCT01387737|580092787|FG001|Overall Study|Withdrawal by Subject|31|||
160647652|NCT01387737|580092786|FG000|Overall Study|Clearly not eligible for the study|1|||
160838762|NCT02292706|580795832|FG007|Overall Study|Investigator's discretion|0|||
160838763|NCT02292706|580795825|FG000|Overall Study|Liver transplant|1|||
160838764|NCT02292706|580795826|FG001|Overall Study|Liver transplant|1|||
160838765|NCT02292706|580795827|FG002|Overall Study|Liver transplant|11|||
160838766|NCT02292706|580795828|FG003|Overall Study|Liver transplant|16|||
160838767|NCT02292706|580795829|FG004|Overall Study|Liver transplant|5|||
160838768|NCT02292706|580795830|FG005|Overall Study|Liver transplant|6|||
160838769|NCT02292706|580795831|FG006|Overall Study|Liver transplant|5|||
160838770|NCT02292706|580795832|FG007|Overall Study|Liver transplant|0|||
160838771|NCT02292706|580795825|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
160838772|NCT02292706|580795826|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
160838773|NCT02292706|580795827|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
160838774|NCT02292706|580795828|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
160838775|NCT02292706|580795829|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
160838776|NCT02292706|580795830|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
160838777|NCT02292706|580795831|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
160838778|NCT02292706|580795832|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
160838779|NCT02292706|580795825|FG000|Overall Study|Subject terminated by sponsor|1|||
160838780|NCT02292706|580795826|FG001|Overall Study|Subject terminated by sponsor|0|||
160838781|NCT02292706|580795827|FG002|Overall Study|Subject terminated by sponsor|0|||
160838782|NCT02292706|580795828|FG003|Overall Study|Subject terminated by sponsor|2|||
160838783|NCT02292706|580795829|FG004|Overall Study|Subject terminated by sponsor|1|||
160904790|NCT00381485|581046310|FG000|Open-Label Run-In Period|Adverse Event|9|||
160563798|NCT04889209|579784574|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160563799|NCT04889209|579784557|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563800|NCT04889209|579784558|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563801|NCT04889209|579784559|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160838784|NCT02292706|580795830|FG005|Overall Study|Subject terminated by sponsor|0|||
160838785|NCT02292706|580795831|FG006|Overall Study|Subject terminated by sponsor|0|||
160838786|NCT02292706|580795832|FG007|Overall Study|Subject terminated by sponsor|0|||
160838787|NCT02292706|580795825|FG000|Overall Study|Missing|0|||
160838788|NCT02292706|580795826|FG001|Overall Study|Missing|0|||
160838789|NCT02292706|580795827|FG002|Overall Study|Missing|1|||
160838790|NCT02292706|580795828|FG003|Overall Study|Missing|1|||
160838791|NCT02292706|580795829|FG004|Overall Study|Missing|0|||
160838792|NCT02292706|580795830|FG005|Overall Study|Missing|1|||
160838793|NCT02292706|580795831|FG006|Overall Study|Missing|0|||
160838794|NCT02292706|580795832|FG007|Overall Study|Missing|0|||
160838795|NCT02292706|580795825|FG000|Overall Study|Virologic relapse or reinfection|1|||
160838796|NCT02292706|580795826|FG001|Overall Study|Virologic relapse or reinfection|0|||
160563802|NCT04889209|579784560|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563803|NCT04889209|579784561|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563804|NCT04889209|579784562|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563805|NCT04889209|579784563|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563806|NCT04889209|579784564|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563807|NCT04889209|579784565|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563808|NCT04889209|579784566|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563809|NCT04889209|579784567|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563810|NCT04889209|579784568|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160647653|NCT01387737|580092787|FG001|Overall Study|Clearly not eligible for the study|3|||
160838797|NCT02292706|580795827|FG002|Overall Study|Virologic relapse or reinfection|0|||
160838798|NCT02292706|580795828|FG003|Overall Study|Virologic relapse or reinfection|1|||
160838799|NCT02292706|580795829|FG004|Overall Study|Virologic relapse or reinfection|0|||
160838800|NCT02292706|580795830|FG005|Overall Study|Virologic relapse or reinfection|1|||
160838801|NCT02292706|580795831|FG006|Overall Study|Virologic relapse or reinfection|0|||
160838802|NCT02292706|580795832|FG007|Overall Study|Virologic relapse or reinfection|0|||
160838803|NCT01990612|580795837|FG000|Overall Study|Lost to Follow-up|2|||
160838804|NCT01990612|580795838|FG001|Overall Study|Lost to Follow-up|1|||
160838805|NCT01990612|580795837|FG000|Overall Study|Withdrawal by Subject|5|||
160838806|NCT01990612|580795838|FG001|Overall Study|Withdrawal by Subject|2|||
160838807|NCT02725866|580795839|FG000|Overall Study|Failure to return|6|||
160838808|NCT02725866|580795839|FG000|Overall Study|Withdrew consent|3|||
160838809|NCT02725866|580795839|FG000|Overall Study|Insufficient virological response|1|||
160838810|NCT02725866|580795839|FG000|Overall Study|Other, not specified|4|||
160838811|NCT02188849|580795842|FG000|Overall Study|Lost to Follow-up|3|||
160838812|NCT02188849|580795843|FG001|Overall Study|Lost to Follow-up|8|||
160838813|NCT02980133|580795845|FG000|Overall Study|Other than specified|1|||
160838814|NCT02980133|580795846|FG001|Overall Study|Other than specified|1|||
160838815|NCT02980133|580795847|FG002|Overall Study|Other than specified|2|||
160838816|NCT02980133|580795848|FG003|Overall Study|Other than specified|2|||
160838817|NCT02980133|580795845|FG000|Overall Study|Lost to Follow-up|0|||
160838818|NCT02980133|580795846|FG001|Overall Study|Lost to Follow-up|0|||
160838819|NCT02980133|580795847|FG002|Overall Study|Lost to Follow-up|1|||
160838820|NCT02980133|580795848|FG003|Overall Study|Lost to Follow-up|3|||
160838821|NCT02980133|580795845|FG000|Overall Study|Protocol Violation|0|||
160838822|NCT02980133|580795846|FG001|Overall Study|Protocol Violation|1|||
160838823|NCT02980133|580795847|FG002|Overall Study|Protocol Violation|0|||
160838824|NCT02980133|580795848|FG003|Overall Study|Protocol Violation|0|||
160838825|NCT02980133|580795845|FG000|Overall Study|Withdrawal by parent/guardian|6|||
160838826|NCT02980133|580795846|FG001|Overall Study|Withdrawal by parent/guardian|3|||
160838827|NCT02980133|580795847|FG002|Overall Study|Withdrawal by parent/guardian|3|||
160838828|NCT02980133|580795848|FG003|Overall Study|Withdrawal by parent/guardian|1|||
160838829|NCT02980133|580795845|FG000|Overall Study|Withdrawal by Subject|0|||
160838830|NCT02980133|580795846|FG001|Overall Study|Withdrawal by Subject|0|||
160838831|NCT02980133|580795847|FG002|Overall Study|Withdrawal by Subject|1|||
160838832|NCT02980133|580795848|FG003|Overall Study|Withdrawal by Subject|0|||
160904791|NCT00381485|581046311|FG001|Open-Label Run-In Period|Adverse Event|0|||
160904792|NCT00381485|581046312|FG002|Open-Label Run-In Period|Adverse Event|0|||
160838833|NCT03208088|580795856|FG000|Period 2|Withdrawal by Subject|0|||
160838834|NCT03208088|580795857|FG001|Period 2|Withdrawal by Subject|0|||
160838835|NCT03208088|580795858|FG002|Period 2|Withdrawal by Subject|0|||
160838836|NCT03208088|580795859|FG003|Period 2|Withdrawal by Subject|0|||
160838837|NCT03208088|580795860|FG004|Period 2|Withdrawal by Subject|0|||
160838838|NCT03208088|580795861|FG005|Period 2|Withdrawal by Subject|0|||
160838839|NCT03208088|580795862|FG006|Period 2|Withdrawal by Subject|0|||
160838840|NCT03208088|580795863|FG007|Period 2|Withdrawal by Subject|0|||
160838841|NCT03208088|580795864|FG008|Period 2|Withdrawal by Subject|1|||
160838842|NCT03208088|580795865|FG009|Period 2|Withdrawal by Subject|0|||
160563811|NCT04889209|579784569|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563812|NCT04889209|579784570|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563813|NCT04889209|579784571|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563814|NCT04889209|579784572|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160563815|NCT04889209|579784573|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
160838843|NCT03208088|580795856|FG000|Period 3|Unsatisfactory Test Article|0|||
160838844|NCT03208088|580795857|FG001|Period 3|Unsatisfactory Test Article|0|||
160838845|NCT03208088|580795858|FG002|Period 3|Unsatisfactory Test Article|0|||
160838846|NCT03208088|580795859|FG003|Period 3|Unsatisfactory Test Article|1|||
160838847|NCT03208088|580795860|FG004|Period 3|Unsatisfactory Test Article|0|||
160838848|NCT03208088|580795861|FG005|Period 3|Unsatisfactory Test Article|0|||
160838849|NCT03208088|580795862|FG006|Period 3|Unsatisfactory Test Article|0|||
160838850|NCT03208088|580795863|FG007|Period 3|Unsatisfactory Test Article|0|||
160838851|NCT03208088|580795864|FG008|Period 3|Unsatisfactory Test Article|0|||
160838852|NCT03208088|580795865|FG009|Period 3|Unsatisfactory Test Article|0|||
160838853|NCT03208088|580795856|FG000|Period 4|Unsatisfactory Test Article|0|||
160838854|NCT03208088|580795857|FG001|Period 4|Unsatisfactory Test Article|0|||
160838855|NCT03208088|580795858|FG002|Period 4|Unsatisfactory Test Article|0|||
160838856|NCT03208088|580795859|FG003|Period 4|Unsatisfactory Test Article|1|||
160838857|NCT03208088|580795860|FG004|Period 4|Unsatisfactory Test Article|0|||
160838858|NCT03208088|580795861|FG005|Period 4|Unsatisfactory Test Article|0|||
160838859|NCT03208088|580795862|FG006|Period 4|Unsatisfactory Test Article|0|||
160838860|NCT03208088|580795863|FG007|Period 4|Unsatisfactory Test Article|0|||
160838861|NCT03208088|580795864|FG008|Period 4|Unsatisfactory Test Article|0|||
160838862|NCT03208088|580795865|FG009|Period 4|Unsatisfactory Test Article|0|||
160838863|NCT01108523|580795870|FG000|Overall Study|Protocol Violation|4|||
160838864|NCT00547521|580795871|FG000|Short Term Study (4 Months)|Adverse Event|1|||
160838865|NCT00547521|580795872|FG001|Short Term Study (4 Months)|Adverse Event|0|||
160838866|NCT00547521|580795871|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
160647654|NCT00707954|580092788|FG000|Overall Study|Physician Decision|0|||
160838867|NCT00547521|580795872|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
160838868|NCT00547521|580795871|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
160838869|NCT00547521|580795872|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
160838870|NCT00547521|580795871|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
160838871|NCT00547521|580795872|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
160838872|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
160838873|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
160838874|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
160838875|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
160838876|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
160838877|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
160838878|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
160838879|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
160838880|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Other|0|||
160838881|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Other|2|||
160838882|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
160838883|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
160838884|NCT00705367|580797774|FG000|Long-term Extension Period|Adverse Event|2|||
160838885|NCT00705367|580797775|FG001|Long-term Extension Period|Adverse Event|0|||
160838886|NCT00705367|580797774|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
160838887|NCT00705367|580797775|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
160838888|NCT00705367|580797774|FG000|Long-term Extension Period|Lack of Efficacy|1|||
160838889|NCT00705367|580797775|FG001|Long-term Extension Period|Lack of Efficacy|0|||
160838890|NCT00705367|580797774|FG000|Long-term Extension Period|No longer met study criteria|1|||
160838891|NCT00705367|580797775|FG001|Long-term Extension Period|No longer met study criteria|0|||
160838892|NCT00705367|580797774|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
160838893|NCT00705367|580797775|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
160838894|NCT01832155|580797779|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
160838895|NCT01832155|580797780|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
160838896|NCT01832155|580797779|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
160838897|NCT01832155|580797780|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
160838898|NCT01279616|580797781|FG000|Overall Study|donor could not be located|5|||
160838899|NCT01279616|580797781|FG000|Overall Study|no signs of sickle cell disease|2|||
160838900|NCT01369641|580797784|FG000|Overall Study|Withdrawal by Subject|1|||
160838901|NCT00842543|580797785|FG000|Overall Study|Withdrawal by Subject|2|||
160838902|NCT00842543|580797786|FG001|Overall Study|Withdrawal by Subject|0|||
160838903|NCT00842543|580797787|FG002|Overall Study|Withdrawal by Subject|3|||
160838904|NCT00842543|580797788|FG003|Overall Study|Withdrawal by Subject|4|||
160838905|NCT01483183|580797793|FG000|Overall Study|Physician Decision|0|||
160838906|NCT01483183|580797794|FG001|Overall Study|Physician Decision|0|||
160904793|NCT00381485|581046313|FG003|Open-Label Run-In Period|Adverse Event|0|||
160904794|NCT00381485|581046310|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
160904795|NCT00381485|581046311|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
160904796|NCT00381485|581046312|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
160904797|NCT00381485|581046313|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
160904798|NCT00381485|581046310|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
160904799|NCT00381485|581046311|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
160904800|NCT00381485|581046312|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
160904801|NCT00381485|581046313|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
160904802|NCT00381485|581046310|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
160904803|NCT00381485|581046311|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
160904804|NCT00381485|581046312|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
160904805|NCT00381485|581046313|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
160904806|NCT00381485|581046310|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
160904807|NCT00381485|581046311|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
160904808|NCT00381485|581046312|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
160904809|NCT00381485|581046313|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
160904810|NCT00381485|581046310|FG000|Open-Label Run-In Period|Treatment failure|1|||
160904811|NCT00381485|581046311|FG001|Open-Label Run-In Period|Treatment failure|0|||
160904812|NCT00381485|581046312|FG002|Open-Label Run-In Period|Treatment failure|0|||
160904813|NCT00381485|581046313|FG003|Open-Label Run-In Period|Treatment failure|0|||
160904814|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160904815|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Adverse Event|2|||
160904816|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Adverse Event|2|||
160904817|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Adverse Event|5|||
160904818|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
160904819|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
160904820|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
160904821|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
160904822|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160904823|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
160904824|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
160904825|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
160904826|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
160904827|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
160904828|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
160904829|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
160838907|NCT01483183|580797795|FG002|Overall Study|Physician Decision|0|||
160838908|NCT01483183|580797796|FG003|Overall Study|Physician Decision|0|||
160838909|NCT01483183|580797797|FG004|Overall Study|Physician Decision|0|||
160838910|NCT01483183|580797798|FG005|Overall Study|Physician Decision|0|||
160838911|NCT01483183|580797799|FG006|Overall Study|Physician Decision|2|||
160838912|NCT01483183|580797800|FG007|Overall Study|Physician Decision|0|||
160647655|NCT00707954|580092789|FG001|Overall Study|Physician Decision|0|||
160838913|NCT01483183|580797801|FG008|Overall Study|Physician Decision|0|||
160838914|NCT01483183|580797802|FG009|Overall Study|Physician Decision|0|||
160838915|NCT01483183|580797793|FG000|Overall Study|Withdrawal by Subject|0|||
160838916|NCT01483183|580797794|FG001|Overall Study|Withdrawal by Subject|0|||
160838917|NCT01483183|580797795|FG002|Overall Study|Withdrawal by Subject|0|||
160838918|NCT01483183|580797796|FG003|Overall Study|Withdrawal by Subject|0|||
160838919|NCT01483183|580797797|FG004|Overall Study|Withdrawal by Subject|0|||
160838920|NCT01483183|580797798|FG005|Overall Study|Withdrawal by Subject|0|||
160838921|NCT01483183|580797799|FG006|Overall Study|Withdrawal by Subject|0|||
160838922|NCT01483183|580797800|FG007|Overall Study|Withdrawal by Subject|0|||
160838923|NCT01483183|580797801|FG008|Overall Study|Withdrawal by Subject|0|||
160838924|NCT01483183|580797802|FG009|Overall Study|Withdrawal by Subject|1|||
160838925|NCT00239928|580797803|FG000|Overall Study|Lack of Efficacy|1|||
160838926|NCT00239928|580797803|FG000|Overall Study|Adverse Event|4|||
160838927|NCT00239928|580797803|FG000|Overall Study|Not need to continue study|3|||
160904830|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
160838928|NCT00239928|580797803|FG000|Overall Study|Withdrawal by Subject|2|||
160838929|NCT02942485|580797805|FG000|Overall Study|Lost to Follow-up|1|||
160838930|NCT02942485|580797806|FG001|Overall Study|Lost to Follow-up|0|||
160838931|NCT04302545|580797813|FG000|Overall Study|Lost to Follow-up|3|||
160838932|NCT04302545|580797814|FG001|Overall Study|Lost to Follow-up|4|||
160838933|NCT02516592|580797815|FG000|Overall Study|Patient withdrew consent|5|||
160838934|NCT02516592|580797816|FG001|Overall Study|Patient withdrew consent|2|||
160838935|NCT02516592|580797815|FG000|Overall Study|Protocol deviation|4|||
160838936|NCT02516592|580797816|FG001|Overall Study|Protocol deviation|4|||
160838937|NCT02516592|580797815|FG000|Overall Study|Lost to Follow-up|2|||
160838938|NCT02516592|580797816|FG001|Overall Study|Lost to Follow-up|3|||
160838939|NCT02516592|580797815|FG000|Overall Study|Patient/guardian decision|2|||
160838940|NCT02516592|580797816|FG001|Overall Study|Patient/guardian decision|1|||
160838941|NCT02516592|580797815|FG000|Overall Study|Adverse Event|1|||
160838942|NCT02516592|580797816|FG001|Overall Study|Adverse Event|2|||
160838943|NCT02516592|580797815|FG000|Overall Study|Abnormal test procedure result|1|||
160838944|NCT02516592|580797816|FG001|Overall Study|Abnormal test procedure result|0|||
160838945|NCT02516592|580797815|FG000|Overall Study|Death|1|||
160838946|NCT02516592|580797816|FG001|Overall Study|Death|1|||
160838947|NCT00300365|580797820|FG000|Overall Study|Lost to Follow-up|1|||
160838948|NCT00300365|580797821|FG001|Overall Study|Lost to Follow-up|0|||
160838949|NCT00300365|580797820|FG000|Overall Study|Physician Decision|2|||
160838950|NCT00300365|580797821|FG001|Overall Study|Physician Decision|0|||
160838951|NCT00300365|580797820|FG000|Overall Study|Withdrawal by Subject|1|||
160838952|NCT00300365|580797821|FG001|Overall Study|Withdrawal by Subject|0|||
160838953|NCT00300365|580797820|FG000|Overall Study|Adverse Event|0|||
160838954|NCT00300365|580797821|FG001|Overall Study|Adverse Event|2|||
160838955|NCT01438177|580797823|FG000|Overall Study|Withdrawal by Subject|1|||
160838956|NCT01438177|580797823|FG000|Overall Study|Initiation of new therapy|1|||
160838957|NCT01727336|580797824|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
160838958|NCT01727336|580797825|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
160838959|NCT01727336|580797826|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
160838960|NCT01727336|580797827|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
160838961|NCT01727336|580797828|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
160838962|NCT01727336|580797829|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
160838963|NCT01727336|580797824|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
160838964|NCT01727336|580797825|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
160838965|NCT01727336|580797826|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
160838966|NCT01727336|580797827|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
160838967|NCT01727336|580797828|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
160838968|NCT01727336|580797829|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
160838969|NCT01727336|580797824|FG000|Part 2 Blinded|Death|0|||
160838970|NCT01727336|580797825|FG001|Part 2 Blinded|Death|0|||
160838971|NCT01727336|580797826|FG002|Part 2 Blinded|Death|0|||
160838972|NCT01727336|580797827|FG003|Part 2 Blinded|Death|0|||
160838973|NCT01727336|580797828|FG004|Part 2 Blinded|Death|20|||
160838974|NCT01727336|580797829|FG005|Part 2 Blinded|Death|16|||
160838975|NCT01727336|580797824|FG000|Part 2 Blinded|Lack of Efficacy|0|||
160838976|NCT01727336|580797825|FG001|Part 2 Blinded|Lack of Efficacy|0|||
160563816|NCT04889209|579784574|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
160563817|NCT04889209|579784557|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563818|NCT04889209|579784558|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563819|NCT04889209|579784559|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563820|NCT04889209|579784560|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563821|NCT04889209|579784561|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563822|NCT04889209|579784562|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160838977|NCT01727336|580797826|FG002|Part 2 Blinded|Lack of Efficacy|0|||
160838978|NCT01727336|580797827|FG003|Part 2 Blinded|Lack of Efficacy|0|||
160838979|NCT01727336|580797828|FG004|Part 2 Blinded|Lack of Efficacy|42|||
160838980|NCT01727336|580797829|FG005|Part 2 Blinded|Lack of Efficacy|44|||
160838981|NCT01727336|580797824|FG000|Part 2 Blinded|Lost to Follow-up|0|||
160838982|NCT01727336|580797825|FG001|Part 2 Blinded|Lost to Follow-up|0|||
160838983|NCT01727336|580797826|FG002|Part 2 Blinded|Lost to Follow-up|0|||
160904831|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
160904832|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
160904833|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
160563823|NCT04889209|579784563|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563824|NCT04889209|579784564|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563825|NCT04889209|579784565|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563826|NCT04889209|579784566|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563827|NCT04889209|579784567|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563828|NCT04889209|579784568|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563829|NCT04889209|579784569|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563830|NCT04889209|579784570|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563831|NCT04889209|579784571|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563832|NCT04889209|579784572|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563833|NCT04889209|579784573|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
160563834|NCT04889209|579784574|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
160563835|NCT04889209|579784557|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563836|NCT04889209|579784558|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563837|NCT04889209|579784559|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563838|NCT04889209|579784560|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563839|NCT04889209|579784561|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563840|NCT04889209|579784562|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563841|NCT04889209|579784563|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563842|NCT04889209|579784564|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563843|NCT04889209|579784565|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563844|NCT04889209|579784566|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563845|NCT04889209|579784567|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563846|NCT04889209|579784568|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563847|NCT04889209|579784569|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563848|NCT04889209|579784570|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160838984|NCT01727336|580797827|FG003|Part 2 Blinded|Lost to Follow-up|0|||
160904834|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
160904835|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
160904836|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
160904837|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
160904838|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
160904839|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
160904840|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
160904841|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
160904842|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Administrative|0|||
160904843|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Administrative|1|||
160563849|NCT04889209|579784571|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
160563850|NCT04889209|579784572|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563851|NCT04889209|579784573|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563852|NCT04889209|579784574|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160563853|NCT04607408|579784575|FG000|Overall Study|Lost to Follow-up|0|||
160563854|NCT04607408|579784576|FG001|Overall Study|Lost to Follow-up|0|||
160838985|NCT01727336|580797828|FG004|Part 2 Blinded|Lost to Follow-up|0|||
160838986|NCT01727336|580797829|FG005|Part 2 Blinded|Lost to Follow-up|1|||
160904844|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Administrative|0|||
160904845|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Administrative|1|||
160904846|NCT01235351|581046314|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
160838987|NCT01727336|580797824|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
160563855|NCT04607408|579784577|FG002|Overall Study|Lost to Follow-up|0|||
160563856|NCT04607408|579784578|FG003|Overall Study|Lost to Follow-up|1|||
160563857|NCT04607408|579784579|FG004|Overall Study|Lost to Follow-up|0|||
160563858|NCT04607408|579784575|FG000|Overall Study|Withdrawal by Subject|0|||
160563859|NCT04607408|579784576|FG001|Overall Study|Withdrawal by Subject|1|||
160563860|NCT04607408|579784577|FG002|Overall Study|Withdrawal by Subject|0|||
160838988|NCT01727336|580797825|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
160838989|NCT01727336|580797826|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
160838990|NCT01727336|580797827|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
160838991|NCT01727336|580797828|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
160838992|NCT01727336|580797829|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
160838993|NCT01727336|580797824|FG000|Part 2 Blinded|use of prohibited medications|0|||
160838994|NCT01727336|580797825|FG001|Part 2 Blinded|use of prohibited medications|0|||
160838995|NCT01727336|580797826|FG002|Part 2 Blinded|use of prohibited medications|0|||
160838996|NCT01727336|580797827|FG003|Part 2 Blinded|use of prohibited medications|0|||
160838997|NCT01727336|580797828|FG004|Part 2 Blinded|use of prohibited medications|1|||
160838998|NCT01727336|580797829|FG005|Part 2 Blinded|use of prohibited medications|3|||
160838999|NCT00619099|580797832|FG000|Overall Study|Progressive Disease|7|||
160839000|NCT00619099|580797833|FG001|Overall Study|Progressive Disease|5|||
160839001|NCT00619099|580797832|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
160839002|NCT00619099|580797833|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
160991887|NCT04888585|581359934|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160991888|NCT04888585|581359935|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160991889|NCT04888585|581359936|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160991890|NCT04888585|581359926|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991891|NCT04888585|581359927|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991892|NCT04888585|581359928|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
160991893|NCT04888585|581359929|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991894|NCT04888585|581359930|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
160991895|NCT04888585|581359931|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991896|NCT04888585|581359932|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160839003|NCT00619099|580797832|FG000|Overall Study|Adverse Event|4|||
160839004|NCT00619099|580797833|FG001|Overall Study|Adverse Event|3|||
160839005|NCT00619099|580797832|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
160839006|NCT00619099|580797833|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
160839007|NCT00619099|580797832|FG000|Overall Study|Withdrawal by Subject|10|||
160839008|NCT00619099|580797833|FG001|Overall Study|Withdrawal by Subject|2|||
160839009|NCT00619099|580797832|FG000|Overall Study|Physician Decision|9|||
160839010|NCT00619099|580797833|FG001|Overall Study|Physician Decision|6|||
160839011|NCT00666965|580797836|FG000|Overall Study|Adverse Event|0|||
160839012|NCT00666965|580797837|FG001|Overall Study|Adverse Event|2|||
160839013|NCT00666965|580797838|FG002|Overall Study|Adverse Event|1|||
160839014|NCT00666965|580797839|FG003|Overall Study|Adverse Event|9|||
160839015|NCT00666965|580797836|FG000|Overall Study|Lack of Efficacy|1|||
160839016|NCT00666965|580797837|FG001|Overall Study|Lack of Efficacy|1|||
160839017|NCT00666965|580797838|FG002|Overall Study|Lack of Efficacy|0|||
160839018|NCT00666965|580797839|FG003|Overall Study|Lack of Efficacy|0|||
160839019|NCT00666965|580797836|FG000|Overall Study|Protocol Violation|0|||
160839020|NCT00666965|580797837|FG001|Overall Study|Protocol Violation|0|||
160839021|NCT00666965|580797838|FG002|Overall Study|Protocol Violation|0|||
160839022|NCT00666965|580797839|FG003|Overall Study|Protocol Violation|2|||
160839023|NCT00666965|580797836|FG000|Overall Study|Discontinuation criteria|2|||
160839024|NCT00666965|580797837|FG001|Overall Study|Discontinuation criteria|1|||
160839025|NCT00666965|580797838|FG002|Overall Study|Discontinuation criteria|1|||
160839026|NCT00666965|580797839|FG003|Overall Study|Discontinuation criteria|2|||
160839027|NCT00666965|580797836|FG000|Overall Study|Withdrawal by Subject|0|||
160839028|NCT00666965|580797837|FG001|Overall Study|Withdrawal by Subject|0|||
160991897|NCT04888585|581359933|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991898|NCT04888585|581359934|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991899|NCT04888585|581359935|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991900|NCT04888585|581359936|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160563861|NCT04607408|579784578|FG003|Overall Study|Withdrawal by Subject|1|||
160647656|NCT00707954|580092790|FG002|Overall Study|Physician Decision|0|||
160563862|NCT04607408|579784579|FG004|Overall Study|Withdrawal by Subject|0|||
160563863|NCT01725165|579784586|FG000|Overall Study|Death|11|||
160563864|NCT01725165|579784587|FG001|Overall Study|Death|18|||
160839029|NCT00666965|580797838|FG002|Overall Study|Withdrawal by Subject|0|||
160839030|NCT00666965|580797839|FG003|Overall Study|Withdrawal by Subject|2|||
160839031|NCT01455194|580797840|FG000|Overall Study|Screen Failure|20|||
160839032|NCT01455194|580797841|FG001|Overall Study|Screen Failure|0|||
160647657|NCT00707954|580092791|FG003|Overall Study|Physician Decision|0|||
160839033|NCT01455194|580797842|FG002|Overall Study|Screen Failure|0|||
160839034|NCT01455194|580797843|FG003|Overall Study|Screen Failure|0|||
160839035|NCT01455194|580797840|FG000|Overall Study|Randomisation Failure|90|||
160839036|NCT01455194|580797841|FG001|Overall Study|Randomisation Failure|0|||
160839037|NCT01455194|580797842|FG002|Overall Study|Randomisation Failure|0|||
160839038|NCT01455194|580797843|FG003|Overall Study|Randomisation Failure|0|||
160839039|NCT01455194|580797840|FG000|Overall Study|Deterioration in asthma|12|||
160839040|NCT01455194|580797841|FG001|Overall Study|Deterioration in asthma|6|||
160839041|NCT01455194|580797842|FG002|Overall Study|Deterioration in asthma|14|||
160563865|NCT02688647|579784591|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
160563866|NCT02688647|579784592|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
160563867|NCT02688647|579784591|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
160563868|NCT02688647|579784592|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
160563869|NCT02688647|579784591|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
160563870|NCT02688647|579784592|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
160563871|NCT02688647|579784591|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
160563872|NCT02688647|579784592|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
160563873|NCT02688647|579784591|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
160563874|NCT02688647|579784592|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
160563875|NCT02688647|579784591|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
160563876|NCT02688647|579784592|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
160563877|NCT02688647|579784591|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
160563878|NCT02688647|579784592|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
160563879|NCT03619213|579784593|FG000|Overall Study|Lost to Follow-up|2|||
160563880|NCT03619213|579784594|FG001|Overall Study|Lost to Follow-up|1|||
160563881|NCT03619213|579784593|FG000|Overall Study|Withdrawal by Subject|8|||
160563882|NCT03619213|579784594|FG001|Overall Study|Withdrawal by Subject|10|||
160563883|NCT00382967|579784595|FG000|Overall Study|Protocol Violation|1|||
160563884|NCT00382967|579784596|FG001|Overall Study|Protocol Violation|1|||
160563885|NCT02542267|579784598|FG000|Overall Study|Withdrawal by Subject|10|||
160563886|NCT02542267|579784598|FG000|Overall Study|Physician Decision|6|||
160563887|NCT02542267|579784598|FG000|Overall Study|Lost to Follow-up|4|||
160563888|NCT02542267|579784598|FG000|Overall Study|Death|13|||
160563889|NCT02542267|579784598|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
160563890|NCT02542267|579784598|FG000|Overall Study|Other|9|||
160563891|NCT03093402|579784599|FG000|Overall Study|Lost to Follow-up|1|||
160563892|NCT03093402|579784600|FG001|Overall Study|Lost to Follow-up|0|||
160563893|NCT03093402|579784601|FG002|Overall Study|Lost to Follow-up|0|||
160563894|NCT03093402|579784602|FG003|Overall Study|Lost to Follow-up|0|||
160563895|NCT03093402|579784599|FG000|Overall Study|Withdrawal by Subject|3|||
160563896|NCT03093402|579784600|FG001|Overall Study|Withdrawal by Subject|3|||
160563897|NCT03093402|579784601|FG002|Overall Study|Withdrawal by Subject|0|||
160563898|NCT03093402|579784602|FG003|Overall Study|Withdrawal by Subject|1|||
160563899|NCT03093402|579784599|FG000|Overall Study|Withdrew prior to dosing|2|||
160563900|NCT03093402|579784600|FG001|Overall Study|Withdrew prior to dosing|1|||
160563901|NCT03093402|579784601|FG002|Overall Study|Withdrew prior to dosing|2|||
160563902|NCT03093402|579784602|FG003|Overall Study|Withdrew prior to dosing|3|||
160563903|NCT03093402|579784599|FG000|Overall Study|Ineligible for study|1|||
160563904|NCT03093402|579784600|FG001|Overall Study|Ineligible for study|0|||
160563905|NCT03093402|579784601|FG002|Overall Study|Ineligible for study|0|||
160563906|NCT03093402|579784602|FG003|Overall Study|Ineligible for study|0|||
160563907|NCT03093402|579784599|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
160563908|NCT03093402|579784600|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
160563909|NCT03093402|579784601|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
160563910|NCT03093402|579784602|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
160563911|NCT01147497|579784607|FG000|Overall Study|failed insertion|2|||
160563912|NCT01147497|579784608|FG001|Overall Study|failed insertion|0|||
160563913|NCT00501228|579784609|FG000|Overall Study|Withdrawal by Subject|1|||
160563914|NCT04026568|579784610|FG000|Overall Study|study terminated|0|||
160563915|NCT04026568|579784611|FG001|Overall Study|study terminated|1|||
160563916|NCT00461175|579784612|FG000|Overall Study|Protocol Violation|522|||
160563917|NCT00461175|579784613|FG001|Overall Study|Protocol Violation|365|||
160563918|NCT00331760|579784614|FG000|Overall Study|Ineligible / no protocol treatment|15|||
160563919|NCT00331760|579784615|FG001|Overall Study|Ineligible / no protocol treatment|8|||
160563920|NCT01147926|579784616|FG000|Overall Study|Subject Withdrew Consent|9|||
160563921|NCT01147926|579784617|FG001|Overall Study|Subject Withdrew Consent|10|||
160563922|NCT01147926|579784616|FG000|Overall Study|Adverse Event|7|||
160563923|NCT01147926|579784617|FG001|Overall Study|Adverse Event|6|||
160563924|NCT01147926|579784616|FG000|Overall Study|Subject Non-Compliant|5|||
160563925|NCT01147926|579784617|FG001|Overall Study|Subject Non-Compliant|4|||
160563926|NCT01147926|579784616|FG000|Overall Study|Principal investigator left hospital|1|||
160563927|NCT01147926|579784617|FG001|Overall Study|Principal investigator left hospital|3|||
160839042|NCT01455194|580797843|FG003|Overall Study|Deterioration in asthma|9|||
160563928|NCT01147926|579784616|FG000|Overall Study|Selection criteria not met|3|||
160839043|NCT01455194|580797840|FG000|Overall Study|Adverse Event|1|||
160563929|NCT01147926|579784617|FG001|Overall Study|Selection criteria not met|1|||
160563930|NCT01147926|579784616|FG000|Overall Study|Lost to Follow-up|0|||
160563931|NCT01147926|579784617|FG001|Overall Study|Lost to Follow-up|2|||
160563932|NCT01147926|579784616|FG000|Overall Study|Sponsor's Decision|0|||
160563933|NCT01147926|579784617|FG001|Overall Study|Sponsor's Decision|1|||
160563934|NCT01147926|579784616|FG000|Overall Study|Lack of Efficacy|1|||
160563935|NCT01147926|579784617|FG001|Overall Study|Lack of Efficacy|0|||
160563936|NCT01147926|579784616|FG000|Overall Study|Too busy, no time for study|1|||
160563937|NCT01147926|579784617|FG001|Overall Study|Too busy, no time for study|0|||
160563938|NCT01147926|579784616|FG000|Overall Study|Went on holiday|0|||
160563939|NCT01147926|579784617|FG001|Overall Study|Went on holiday|1|||
160563940|NCT01147926|579784616|FG000|Overall Study|Colonoscopy result|0|||
160563941|NCT01147926|579784617|FG001|Overall Study|Colonoscopy result|1|||
160563942|NCT02207907|579784618|FG000|Overall Study|Lost to Follow-up|3|||
160563943|NCT02207907|579784619|FG001|Overall Study|Lost to Follow-up|1|||
160563944|NCT02207907|579784618|FG000|Overall Study|Withdrawal by Subject|5|||
160563945|NCT02207907|579784619|FG001|Overall Study|Withdrawal by Subject|6|||
160839044|NCT01455194|580797841|FG001|Overall Study|Adverse Event|1|||
160839045|NCT01455194|580797842|FG002|Overall Study|Adverse Event|1|||
160839046|NCT01455194|580797843|FG003|Overall Study|Adverse Event|3|||
160839047|NCT01455194|580797840|FG000|Overall Study|Withdrawal by Subject|21|||
160839048|NCT01455194|580797841|FG001|Overall Study|Withdrawal by Subject|16|||
160839049|NCT01455194|580797842|FG002|Overall Study|Withdrawal by Subject|12|||
160839050|NCT01455194|580797843|FG003|Overall Study|Withdrawal by Subject|9|||
160563946|NCT02207907|579784618|FG000|Overall Study|Did not meet study criteria|3|||
160563947|NCT02207907|579784619|FG001|Overall Study|Did not meet study criteria|0|||
160904847|NCT01235351|581046315|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
160904848|NCT00745823|581046316|FG000|Overall Study|Adverse Event|5|||
160563948|NCT02207907|579784618|FG000|Overall Study|Pregnancy|0|||
160904849|NCT00745823|581046317|FG001|Overall Study|Adverse Event|3|||
160904850|NCT00745823|581046316|FG000|Overall Study|Lack of Efficacy|20|||
160563949|NCT02207907|579784619|FG001|Overall Study|Pregnancy|1|||
160563950|NCT00158184|579784620|FG000|Overall Study|personal issues|3|||
160563951|NCT00158184|579784621|FG001|Overall Study|personal issues|1|||
160563952|NCT00158184|579784620|FG000|Overall Study|failed for follow unit/study rules|2|||
160563953|NCT00158184|579784621|FG001|Overall Study|failed for follow unit/study rules|0|||
160563954|NCT00158184|579784620|FG000|Overall Study|Adverse Event|1|||
160563955|NCT00158184|579784621|FG001|Overall Study|Adverse Event|1|||
160563956|NCT01025635|579784625|FG000|Overall Study|Withdrawal by Subject|6|||
160563957|NCT01025635|579784626|FG001|Overall Study|Withdrawal by Subject|7|||
160563958|NCT01025635|579784625|FG000|Overall Study|Protocol Violation|4|||
160563959|NCT01025635|579784626|FG001|Overall Study|Protocol Violation|2|||
160563960|NCT01025635|579784625|FG000|Overall Study|Lack of Efficacy|0|||
160563961|NCT01025635|579784626|FG001|Overall Study|Lack of Efficacy|1|||
160563962|NCT01025635|579784625|FG000|Overall Study|Lost to Follow-up|9|||
160563963|NCT01025635|579784626|FG001|Overall Study|Lost to Follow-up|13|||
160563964|NCT01025635|579784625|FG000|Overall Study|Reason not known|4|||
160563965|NCT01025635|579784626|FG001|Overall Study|Reason not known|2|||
160563966|NCT00929240|579784627|FG000|Initial Treatment Phase|Adverse Event|31|||
160563967|NCT00929240|579784628|FG001|Initial Treatment Phase|Adverse Event|0|||
160563968|NCT00929240|579784629|FG002|Initial Treatment Phase|Adverse Event|0|||
160563969|NCT00929240|579784627|FG000|Initial Treatment Phase|Disease progression|41|||
160563970|NCT00929240|579784628|FG001|Initial Treatment Phase|Disease progression|0|||
160563971|NCT00929240|579784629|FG002|Initial Treatment Phase|Disease progression|0|||
160563972|NCT00929240|579784627|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
160563973|NCT00929240|579784628|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
160563974|NCT00929240|579784629|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
160563975|NCT00929240|579784627|FG000|Initial Treatment Phase|Protocol Violation|5|||
160563976|NCT00929240|579784628|FG001|Initial Treatment Phase|Protocol Violation|0|||
160563977|NCT00929240|579784629|FG002|Initial Treatment Phase|Protocol Violation|0|||
160563978|NCT00929240|579784627|FG000|Initial Treatment Phase|Death|2|||
160563979|NCT00929240|579784628|FG001|Initial Treatment Phase|Death|0|||
160563980|NCT00929240|579784629|FG002|Initial Treatment Phase|Death|0|||
160563981|NCT00929240|579784627|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
160563982|NCT00929240|579784628|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
160563983|NCT00929240|579784629|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
160563984|NCT00929240|579784627|FG000|Initial Treatment Phase|Physician Decision|4|||
160563985|NCT00929240|579784628|FG001|Initial Treatment Phase|Physician Decision|0|||
160563986|NCT00929240|579784629|FG002|Initial Treatment Phase|Physician Decision|0|||
160563987|NCT00929240|579784627|FG000|Maintenance Phase|Disease progression|0|||
160563988|NCT00929240|579784628|FG001|Maintenance Phase|Disease progression|73|||
160563989|NCT00929240|579784629|FG002|Maintenance Phase|Disease progression|60|||
160563990|NCT00929240|579784627|FG000|Maintenance Phase|Adverse Event|0|||
160839051|NCT01455194|580797840|FG000|Overall Study|Lost to Follow-up|2|||
160839052|NCT01455194|580797841|FG001|Overall Study|Lost to Follow-up|0|||
160904851|NCT00745823|581046317|FG001|Overall Study|Lack of Efficacy|6|||
160839053|NCT01455194|580797842|FG002|Overall Study|Lost to Follow-up|1|||
160839054|NCT01455194|580797843|FG003|Overall Study|Lost to Follow-up|1|||
160839055|NCT01455194|580797840|FG000|Overall Study|Pregnancy|0|||
160839056|NCT01455194|580797841|FG001|Overall Study|Pregnancy|1|||
160839057|NCT01455194|580797842|FG002|Overall Study|Pregnancy|1|||
160839058|NCT01455194|580797843|FG003|Overall Study|Pregnancy|0|||
160839059|NCT01455194|580797840|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
160839060|NCT01455194|580797841|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
160839061|NCT01455194|580797842|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
160839062|NCT01455194|580797843|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
160839063|NCT01455194|580797840|FG000|Overall Study|Miscellaneous|4|||
160839064|NCT01455194|580797841|FG001|Overall Study|Miscellaneous|5|||
160839065|NCT01455194|580797842|FG002|Overall Study|Miscellaneous|1|||
160839066|NCT01455194|580797843|FG003|Overall Study|Miscellaneous|4|||
160839067|NCT00504894|580797844|FG000|Overall Study|fMRI technical problems|1|||
160839068|NCT00504894|580797845|FG001|Overall Study|fMRI technical problems|1|||
160839069|NCT00504894|580797846|FG002|Overall Study|fMRI technical problems|0|||
160839070|NCT00504894|580797844|FG000|Overall Study|Withdrawal by Subject|0|||
160839071|NCT00504894|580797845|FG001|Overall Study|Withdrawal by Subject|1|||
160839072|NCT00504894|580797846|FG002|Overall Study|Withdrawal by Subject|0|||
160839073|NCT00504894|580797844|FG000|Overall Study|Infusion technical problems|0|||
160839074|NCT00504894|580797845|FG001|Overall Study|Infusion technical problems|1|||
160839075|NCT00504894|580797846|FG002|Overall Study|Infusion technical problems|0|||
160839076|NCT00504894|580797844|FG000|Overall Study|poor subject data|2|||
160839077|NCT00504894|580797845|FG001|Overall Study|poor subject data|0|||
160839078|NCT00504894|580797846|FG002|Overall Study|poor subject data|0|||
160839079|NCT01196416|580797847|FG000|Overall Study|Withdrawal by Subject|2|||
160839080|NCT05090852|580797848|FG000|Overall Study|Physician Decision|5|||
160904852|NCT00745823|581046316|FG000|Overall Study|Lost to Follow-up|10|||
160991901|NCT04888585|581359926|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991902|NCT04888585|581359927|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991903|NCT04888585|581359928|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991904|NCT04888585|581359929|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991905|NCT04888585|581359930|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991906|NCT04888585|581359931|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
160904853|NCT00745823|581046317|FG001|Overall Study|Lost to Follow-up|11|||
160904854|NCT00745823|581046316|FG000|Overall Study|Physician Decision|10|||
160904855|NCT00745823|581046317|FG001|Overall Study|Physician Decision|5|||
160904856|NCT00745823|581046316|FG000|Overall Study|Pregnancy|0|||
160904857|NCT00745823|581046317|FG001|Overall Study|Pregnancy|4|||
160904858|NCT00745823|581046316|FG000|Overall Study|Withdrawal by Subject|14|||
160904859|NCT00745823|581046317|FG001|Overall Study|Withdrawal by Subject|8|||
160904860|NCT00745823|581046316|FG000|Overall Study|Study Terminated by Sponsor|326|||
160904861|NCT00745823|581046317|FG001|Overall Study|Study Terminated by Sponsor|349|||
160904862|NCT02980601|581046327|FG000|Overall Study|Lost to Follow-up|2|||
160904863|NCT02980601|581046328|FG001|Overall Study|Lost to Follow-up|2|||
160904864|NCT02980601|581046327|FG000|Overall Study|Death|0|||
160904865|NCT02980601|581046328|FG001|Overall Study|Death|1|||
160904866|NCT02980601|581046327|FG000|Overall Study|Graft loss|1|||
160904867|NCT02980601|581046328|FG001|Overall Study|Graft loss|0|||
160904868|NCT02980601|581046327|FG000|Overall Study|Failed to sign consent|2|||
160904869|NCT02980601|581046328|FG001|Overall Study|Failed to sign consent|0|||
160904870|NCT01575769|581046329|FG000|Overall Study|Adverse Event|1|||
160904871|NCT01575769|581046329|FG000|Overall Study|Study terminated by sponsor|40|||
160904872|NCT00290888|581046330|FG000|Overall Study|Physician Decision|3|||
160904873|NCT00290888|581046331|FG001|Overall Study|Physician Decision|1|||
160904874|NCT01473836|581046332|FG000|Overall Study|Adverse Event|4|||
160904875|NCT01473836|581046332|FG000|Overall Study|Lack of Efficacy|1|||
160904876|NCT01473836|581046332|FG000|Overall Study|Does not meet entrance criteria|1|||
160904877|NCT01034631|581046333|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
160904878|NCT01034631|581046334|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
160904879|NCT01034631|581046335|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
160904880|NCT01034631|581046333|FG000|Phase II|Not Evaluable per protocol|0|||
160904881|NCT01034631|581046334|FG001|Phase II|Not Evaluable per protocol|0|||
160904882|NCT01034631|581046335|FG002|Phase II|Not Evaluable per protocol|2|||
160904883|NCT01034631|581046333|FG000|Phase II|Determined Ineligible per protocol|0|||
160991907|NCT04888585|581359932|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
160839081|NCT00148941|580797849|FG000|Overall Study|Lost to Follow-up|17|||
160839082|NCT00148941|580797850|FG001|Overall Study|Lost to Follow-up|24|||
160839083|NCT00148941|580797851|FG002|Overall Study|Lost to Follow-up|18|||
160839084|NCT00148941|580797852|FG003|Overall Study|Lost to Follow-up|22|||
160839085|NCT00148941|580797849|FG000|Overall Study|Withdrawal by Subject|1|||
160839086|NCT00148941|580797850|FG001|Overall Study|Withdrawal by Subject|0|||
160839087|NCT00148941|580797851|FG002|Overall Study|Withdrawal by Subject|1|||
160839088|NCT00148941|580797852|FG003|Overall Study|Withdrawal by Subject|0|||
160904884|NCT01034631|581046334|FG001|Phase II|Determined Ineligible per protocol|1|||
160839089|NCT00148941|580797849|FG000|Overall Study|Other|0|||
160839090|NCT00148941|580797850|FG001|Overall Study|Other|0|||
160839091|NCT00148941|580797851|FG002|Overall Study|Other|1|||
160839092|NCT00148941|580797852|FG003|Overall Study|Other|2|||
160839093|NCT02673684|580797855|FG000|Overall Study|Study not completed d/t loss of funding|9|||
160839094|NCT02673684|580797856|FG001|Overall Study|Study not completed d/t loss of funding|8|||
160839095|NCT01092663|580797857|FG000|Overall Study|Withdrawal by Subject|3|||
160839096|NCT01092663|580797858|FG001|Overall Study|Withdrawal by Subject|2|||
160647658|NCT00707954|580092792|FG004|Overall Study|Physician Decision|1|||
160647675|NCT06509100|580092803|FG000|Overall Study|Withdrawal by Subject|1|||
160647676|NCT06509100|580092803|FG000|Overall Study|Lost to Follow-up|1|||
160839097|NCT01092663|580797857|FG000|Overall Study|Glucose >300mg/dL|1|||
160839098|NCT01092663|580797858|FG001|Overall Study|Glucose >300mg/dL|0|||
160839099|NCT01092663|580797857|FG000|Overall Study|High fasting triglyceride|2|||
160839100|NCT01092663|580797858|FG001|Overall Study|High fasting triglyceride|0|||
160839101|NCT01092663|580797857|FG000|Overall Study|Adverse Event|1|||
160839102|NCT01092663|580797858|FG001|Overall Study|Adverse Event|1|||
160839103|NCT01092663|580797857|FG000|Overall Study|Protocol Violation|0|||
160839104|NCT01092663|580797858|FG001|Overall Study|Protocol Violation|1|||
160839105|NCT00788710|580797859|FG000|Overall Study|Adverse Event|1|||
160839106|NCT00788710|580797860|FG001|Overall Study|Adverse Event|3|||
160839107|NCT00788710|580797861|FG002|Overall Study|Adverse Event|4|||
160839108|NCT00788710|580797859|FG000|Overall Study|Lack of Efficacy|0|||
160839109|NCT00788710|580797860|FG001|Overall Study|Lack of Efficacy|0|||
160839110|NCT00788710|580797861|FG002|Overall Study|Lack of Efficacy|1|||
160839111|NCT00788710|580797859|FG000|Overall Study|Lost to Follow-up|0|||
160839112|NCT00788710|580797860|FG001|Overall Study|Lost to Follow-up|1|||
160839113|NCT00788710|580797861|FG002|Overall Study|Lost to Follow-up|0|||
160839114|NCT00788710|580797859|FG000|Overall Study|Physician Decision|2|||
160904885|NCT01034631|581046335|FG002|Phase II|Determined Ineligible per protocol|0|||
160839115|NCT00788710|580797860|FG001|Overall Study|Physician Decision|1|||
160839116|NCT00788710|580797861|FG002|Overall Study|Physician Decision|0|||
160839117|NCT00788710|580797859|FG000|Overall Study|Protocol Violation|0|||
160839118|NCT00788710|580797860|FG001|Overall Study|Protocol Violation|1|||
160839119|NCT00788710|580797861|FG002|Overall Study|Protocol Violation|1|||
160839120|NCT00788710|580797859|FG000|Overall Study|Withdrawal by Subject|2|||
160839121|NCT00788710|580797860|FG001|Overall Study|Withdrawal by Subject|2|||
160839122|NCT00788710|580797861|FG002|Overall Study|Withdrawal by Subject|0|||
160839123|NCT01008904|580797862|FG000|Overall Study|Lost to Follow-up|1|||
160839124|NCT01008904|580797862|FG000|Overall Study|Adverse Event|2|||
160839125|NCT01008904|580797862|FG000|Overall Study|unexpected unrelated surgery|1|||
160904886|NCT00799383|581046336|FG000|Overall Study|Protocol Violation|1|||
160904887|NCT00799383|581046337|FG001|Overall Study|Protocol Violation|1|||
160904888|NCT00799383|581046336|FG000|Overall Study|Adverse Event|0|||
160904889|NCT00799383|581046337|FG001|Overall Study|Adverse Event|1|||
160904890|NCT00799383|581046336|FG000|Overall Study|Lost to Follow-up|1|||
160904891|NCT00799383|581046337|FG001|Overall Study|Lost to Follow-up|2|||
160839126|NCT04407234|580797863|FG000|Overall Study|Adverse Event|3|||
160839127|NCT04407234|580797864|FG001|Overall Study|Adverse Event|3|||
160839128|NCT03908970|580797865|FG000|Overall Study|Adverse Event|7|||
160839129|NCT03908970|580797866|FG001|Overall Study|Adverse Event|21|||
160839130|NCT03908970|580797865|FG000|Overall Study|Physician Decision|1|||
160839131|NCT03908970|580797866|FG001|Overall Study|Physician Decision|4|||
160839132|NCT03908970|580797865|FG000|Overall Study|Withdrawal by Subject|9|||
160839133|NCT03908970|580797866|FG001|Overall Study|Withdrawal by Subject|22|||
160839134|NCT00727558|580797872|FG000|Overall Study|Lens issue|0|||
160839135|NCT00727558|580797873|FG001|Overall Study|Lens issue|1|||
160839136|NCT00727558|580797872|FG000|Overall Study|Adverse Event|0|||
160839137|NCT00727558|580797873|FG001|Overall Study|Adverse Event|1|||
160839138|NCT00727558|580797872|FG000|Overall Study|Subject unable to return for follow-up|1|||
160839139|NCT00727558|580797873|FG001|Overall Study|Subject unable to return for follow-up|1|||
160839140|NCT00727558|580797872|FG000|Overall Study|Lost to Follow-up|1|||
160839141|NCT00727558|580797873|FG001|Overall Study|Lost to Follow-up|0|||
160839142|NCT01717326|580797880|FG000|Overall Study|Death|0|||
160839143|NCT01717326|580797881|FG001|Overall Study|Death|0|||
160839144|NCT01717326|580797882|FG002|Overall Study|Death|0|||
160839145|NCT01717326|580797883|FG003|Overall Study|Death|0|||
160839146|NCT01717326|580797884|FG004|Overall Study|Death|0|||
160839147|NCT01717326|580797885|FG005|Overall Study|Death|0|||
160839148|NCT01717326|580797886|FG006|Overall Study|Death|0|||
160839149|NCT01717326|580797887|FG007|Overall Study|Death|0|||
160839150|NCT01717326|580797888|FG008|Overall Study|Death|0|||
160839151|NCT01717326|580797889|FG009|Overall Study|Death|0|||
160839152|NCT01717326|580797890|FG010|Overall Study|Death|1|||
160904892|NCT00799383|581046336|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
160904893|NCT00799383|581046337|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
160839153|NCT01717326|580797891|FG011|Overall Study|Death|0|||
160839154|NCT01717326|580797892|FG012|Overall Study|Death|0|||
160904894|NCT00799383|581046336|FG000|Overall Study|Withdrawal by Subject|0|||
160904895|NCT00799383|581046337|FG001|Overall Study|Withdrawal by Subject|1|||
160904896|NCT03486223|581046347|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
160904897|NCT03486223|581046348|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
160904898|NCT01806298|581046357|FG000|Overall Study|Adverse Event|3|||
160904899|NCT01806298|581046357|FG000|Overall Study|Protocol Non-compliance|1|||
160904900|NCT01806298|581046357|FG000|Overall Study|Withdrawal by Subject|1|||
160904901|NCT01806298|581046357|FG000|Overall Study|Other|5|||
160904902|NCT01877265|581046358|FG000|Treatment Period 1|Sponsor Decision|0|||
160904903|NCT01877265|581046359|FG001|Treatment Period 1|Sponsor Decision|0|||
160991908|NCT04888585|581359933|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
160991909|NCT04888585|581359934|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991910|NCT04888585|581359935|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991911|NCT04888585|581359936|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
160991912|NCT04888585|581359926|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
160991913|NCT04888585|581359927|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
160991914|NCT04888585|581359928|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
160991915|NCT04888585|581359929|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
160991916|NCT04888585|581359930|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
160991917|NCT04888585|581359931|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
160991918|NCT04888585|581359932|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
160991919|NCT04888585|581359933|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
160991920|NCT04888585|581359934|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
160991921|NCT04888585|581359935|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
160991922|NCT04888585|581359936|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
160991923|NCT04888585|581359926|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
160991924|NCT04888585|581359927|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
160904904|NCT01877265|581046360|FG002|Treatment Period 1|Sponsor Decision|1|||
160839155|NCT01717326|580797893|FG013|Overall Study|Death|0|||
160839156|NCT01717326|580797894|FG014|Overall Study|Death|0|||
160839157|NCT01717326|580797895|FG015|Overall Study|Death|0|||
160839158|NCT01717326|580797896|FG016|Overall Study|Death|0|||
160839159|NCT01717326|580797897|FG017|Overall Study|Death|0|||
160839160|NCT01717326|580797898|FG018|Overall Study|Death|0|||
160839161|NCT01717326|580797899|FG019|Overall Study|Death|0|||
160904905|NCT01877265|581046361|FG003|Treatment Period 1|Sponsor Decision|0|||
160839162|NCT01717326|580797880|FG000|Overall Study|Lost to Follow-up|3|||
160839163|NCT01717326|580797881|FG001|Overall Study|Lost to Follow-up|0|||
160839164|NCT01717326|580797882|FG002|Overall Study|Lost to Follow-up|0|||
160839165|NCT01717326|580797883|FG003|Overall Study|Lost to Follow-up|2|||
160839166|NCT01717326|580797884|FG004|Overall Study|Lost to Follow-up|1|||
160839167|NCT01717326|580797885|FG005|Overall Study|Lost to Follow-up|0|||
160839168|NCT01717326|580797886|FG006|Overall Study|Lost to Follow-up|1|||
160839169|NCT01717326|580797887|FG007|Overall Study|Lost to Follow-up|0|||
160839170|NCT01717326|580797888|FG008|Overall Study|Lost to Follow-up|0|||
160839171|NCT01717326|580797889|FG009|Overall Study|Lost to Follow-up|0|||
160839172|NCT01717326|580797890|FG010|Overall Study|Lost to Follow-up|1|||
160839173|NCT01717326|580797891|FG011|Overall Study|Lost to Follow-up|0|||
160839174|NCT01717326|580797892|FG012|Overall Study|Lost to Follow-up|0|||
160839175|NCT01717326|580797893|FG013|Overall Study|Lost to Follow-up|0|||
160839176|NCT01717326|580797894|FG014|Overall Study|Lost to Follow-up|0|||
160839177|NCT01717326|580797895|FG015|Overall Study|Lost to Follow-up|2|||
160839178|NCT01717326|580797896|FG016|Overall Study|Lost to Follow-up|1|||
160839179|NCT01717326|580797897|FG017|Overall Study|Lost to Follow-up|0|||
160839180|NCT01717326|580797898|FG018|Overall Study|Lost to Follow-up|2|||
160839181|NCT01717326|580797899|FG019|Overall Study|Lost to Follow-up|3|||
160839182|NCT01717326|580797880|FG000|Overall Study|Physician Decision|0|||
160839183|NCT01717326|580797881|FG001|Overall Study|Physician Decision|0|||
160839184|NCT01717326|580797882|FG002|Overall Study|Physician Decision|0|||
160839185|NCT01717326|580797883|FG003|Overall Study|Physician Decision|0|||
160839186|NCT01717326|580797884|FG004|Overall Study|Physician Decision|0|||
160839187|NCT01717326|580797885|FG005|Overall Study|Physician Decision|0|||
160839188|NCT01717326|580797886|FG006|Overall Study|Physician Decision|0|||
160839189|NCT01717326|580797887|FG007|Overall Study|Physician Decision|0|||
160839190|NCT01717326|580797888|FG008|Overall Study|Physician Decision|0|||
160839191|NCT01717326|580797889|FG009|Overall Study|Physician Decision|1|||
160839192|NCT01717326|580797890|FG010|Overall Study|Physician Decision|0|||
160839193|NCT01717326|580797891|FG011|Overall Study|Physician Decision|0|||
160839194|NCT01717326|580797892|FG012|Overall Study|Physician Decision|0|||
160839195|NCT01717326|580797893|FG013|Overall Study|Physician Decision|0|||
160991925|NCT04888585|581359928|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
160991926|NCT04888585|581359929|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
160904906|NCT01877265|581046362|FG004|Treatment Period 1|Sponsor Decision|0|||
160904907|NCT01877265|581046363|FG005|Treatment Period 1|Sponsor Decision|0|||
160904908|NCT01877265|581046358|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
160904909|NCT01877265|581046359|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
160904910|NCT01877265|581046360|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
160904911|NCT01877265|581046361|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
160904912|NCT01877265|581046362|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
160904913|NCT01877265|581046363|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
160904914|NCT01877265|581046358|FG000|Treatment Period 3|Lost to Follow-up|1|||
160904915|NCT01877265|581046359|FG001|Treatment Period 3|Lost to Follow-up|0|||
160904916|NCT01877265|581046360|FG002|Treatment Period 3|Lost to Follow-up|0|||
160904917|NCT01877265|581046361|FG003|Treatment Period 3|Lost to Follow-up|0|||
160904918|NCT01877265|581046362|FG004|Treatment Period 3|Lost to Follow-up|0|||
160904919|NCT01877265|581046363|FG005|Treatment Period 3|Lost to Follow-up|0|||
160904920|NCT00702689|581046364|FG000|Overall Study|Withdrawal by Subject|4|||
160904921|NCT00702689|581046364|FG000|Overall Study|Recurrent malignancy|1|||
160904922|NCT00702689|581046364|FG000|Overall Study|Adverse Event|1|||
160904923|NCT01986907|581046367|FG000|Overall Study|Adverse Event|11|||
160904924|NCT01986907|581046367|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
160904925|NCT01986907|581046367|FG000|Overall Study|Protocol Violation|4|||
160904926|NCT01986907|581046367|FG000|Overall Study|Withdrawal by Subject|76|||
160904927|NCT01986907|581046367|FG000|Overall Study|Lost to Follow-up|38|||
160904928|NCT01986907|581046367|FG000|Overall Study|Death|9|||
160904929|NCT02805972|581046370|FG000|Washout Period|Lost to Follow-up|3|||
160904930|NCT02805972|581046371|FG001|Washout Period|Lost to Follow-up|0|||
160904931|NCT00939640|581046373|FG000|Overall Study|Physician Decision|1|||
160904932|NCT00239590|581046374|FG000|Randomized|Lost to Follow-up|0|||
160904933|NCT00239590|581046375|FG001|Randomized|Lost to Follow-up|1|||
160904934|NCT00239590|581046374|FG000|Randomized|Withdrawal by Subject|0|||
160904935|NCT00239590|581046375|FG001|Randomized|Withdrawal by Subject|1|||
160904936|NCT00239590|581046374|FG000|Completed Study Protocol|Adverse Event|1|||
160904937|NCT00239590|581046375|FG001|Completed Study Protocol|Adverse Event|1|||
160904938|NCT00239590|581046374|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
160904939|NCT00239590|581046375|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
160904940|NCT00892047|581046380|FG000|Overall Study|Adverse Event|2|||
160904941|NCT00892047|581046381|FG001|Overall Study|Adverse Event|2|||
160904942|NCT00892047|581046380|FG000|Overall Study|subject burden|2|||
160904943|NCT00892047|581046381|FG001|Overall Study|subject burden|3|||
160904944|NCT00892047|581046380|FG000|Overall Study|Lack of Efficacy|0|||
160904945|NCT00892047|581046381|FG001|Overall Study|Lack of Efficacy|2|||
160904946|NCT00389597|581046388|FG000|Overall Study|Lost to Follow-up|8|||
160904947|NCT00389597|581046389|FG001|Overall Study|Lost to Follow-up|6|||
160904948|NCT00389597|581046390|FG002|Overall Study|Lost to Follow-up|4|||
160904949|NCT00389597|581046391|FG003|Overall Study|Lost to Follow-up|6|||
160904950|NCT00306189|581046392|FG000|Overall Study|Physician Decision|0|||
160904951|NCT00306189|581046393|FG001|Overall Study|Physician Decision|0|||
160904952|NCT00306189|581046394|FG002|Overall Study|Physician Decision|0|||
160904953|NCT00306189|581046395|FG003|Overall Study|Physician Decision|1|||
160904954|NCT00306189|581046392|FG000|Overall Study|Adverse Event|3|||
160904955|NCT00306189|581046393|FG001|Overall Study|Adverse Event|3|||
160904956|NCT00306189|581046394|FG002|Overall Study|Adverse Event|2|||
160904957|NCT00306189|581046395|FG003|Overall Study|Adverse Event|2|||
160904958|NCT00306189|581046392|FG000|Overall Study|Withdrawal by Subject|4|||
160904959|NCT00306189|581046393|FG001|Overall Study|Withdrawal by Subject|2|||
160904960|NCT00306189|581046394|FG002|Overall Study|Withdrawal by Subject|8|||
160904961|NCT00306189|581046395|FG003|Overall Study|Withdrawal by Subject|1|||
160904962|NCT00306189|581046392|FG000|Overall Study|Ineligibility determined|1|||
160904963|NCT00306189|581046393|FG001|Overall Study|Ineligibility determined|1|||
160904964|NCT00306189|581046394|FG002|Overall Study|Ineligibility determined|1|||
160904965|NCT00306189|581046395|FG003|Overall Study|Ineligibility determined|1|||
160904966|NCT00306189|581046392|FG000|Overall Study|Other|1|||
160904967|NCT00306189|581046393|FG001|Overall Study|Other|0|||
160904968|NCT00306189|581046394|FG002|Overall Study|Other|0|||
160904969|NCT00306189|581046395|FG003|Overall Study|Other|0|||
160904970|NCT00259610|581046396|FG000|Overall Study|Withdrawal by Subject|33|||
160904971|NCT00259610|581046397|FG001|Overall Study|Withdrawal by Subject|25|||
160904972|NCT00259610|581046398|FG002|Overall Study|Withdrawal by Subject|29|||
160904973|NCT00259610|581046399|FG003|Overall Study|Withdrawal by Subject|19|||
160904974|NCT00259610|581046396|FG000|Overall Study|Lost to Follow-up|19|||
160904975|NCT00259610|581046397|FG001|Overall Study|Lost to Follow-up|8|||
160904976|NCT00259610|581046398|FG002|Overall Study|Lost to Follow-up|18|||
160904977|NCT00259610|581046399|FG003|Overall Study|Lost to Follow-up|15|||
160904978|NCT00259610|581046396|FG000|Overall Study|Physician Decision|6|||
160904979|NCT00259610|581046397|FG001|Overall Study|Physician Decision|4|||
160904980|NCT00259610|581046398|FG002|Overall Study|Physician Decision|7|||
160904981|NCT00259610|581046399|FG003|Overall Study|Physician Decision|2|||
160904982|NCT00259610|581046396|FG000|Overall Study|Death|1|||
160904983|NCT00259610|581046397|FG001|Overall Study|Death|1|||
160839196|NCT01717326|580797894|FG014|Overall Study|Physician Decision|0|||
160839197|NCT01717326|580797895|FG015|Overall Study|Physician Decision|0|||
160839198|NCT01717326|580797896|FG016|Overall Study|Physician Decision|0|||
160839199|NCT01717326|580797897|FG017|Overall Study|Physician Decision|0|||
160839200|NCT01717326|580797898|FG018|Overall Study|Physician Decision|0|||
160839201|NCT01717326|580797899|FG019|Overall Study|Physician Decision|0|||
160839202|NCT01717326|580797880|FG000|Overall Study|Protocol Violation|0|||
160839203|NCT01717326|580797881|FG001|Overall Study|Protocol Violation|0|||
160839204|NCT01717326|580797882|FG002|Overall Study|Protocol Violation|0|||
160839205|NCT01717326|580797883|FG003|Overall Study|Protocol Violation|0|||
160839206|NCT01717326|580797884|FG004|Overall Study|Protocol Violation|1|||
160839207|NCT01717326|580797885|FG005|Overall Study|Protocol Violation|0|||
160839208|NCT01717326|580797886|FG006|Overall Study|Protocol Violation|0|||
160839209|NCT01717326|580797887|FG007|Overall Study|Protocol Violation|0|||
160839210|NCT01717326|580797888|FG008|Overall Study|Protocol Violation|0|||
160839211|NCT01717326|580797889|FG009|Overall Study|Protocol Violation|0|||
160839212|NCT01717326|580797890|FG010|Overall Study|Protocol Violation|0|||
160839213|NCT01717326|580797891|FG011|Overall Study|Protocol Violation|0|||
160839214|NCT01717326|580797892|FG012|Overall Study|Protocol Violation|0|||
160839215|NCT01717326|580797893|FG013|Overall Study|Protocol Violation|0|||
160839216|NCT01717326|580797894|FG014|Overall Study|Protocol Violation|0|||
160839217|NCT01717326|580797895|FG015|Overall Study|Protocol Violation|0|||
160839218|NCT01717326|580797896|FG016|Overall Study|Protocol Violation|0|||
160839219|NCT01717326|580797897|FG017|Overall Study|Protocol Violation|0|||
160839220|NCT01717326|580797898|FG018|Overall Study|Protocol Violation|0|||
160839221|NCT01717326|580797899|FG019|Overall Study|Protocol Violation|0|||
160839222|NCT01717326|580797880|FG000|Overall Study|Withdrawal by Subject|0|||
160839223|NCT01717326|580797881|FG001|Overall Study|Withdrawal by Subject|1|||
160839224|NCT01717326|580797882|FG002|Overall Study|Withdrawal by Subject|0|||
160839225|NCT01717326|580797883|FG003|Overall Study|Withdrawal by Subject|0|||
160839226|NCT01717326|580797884|FG004|Overall Study|Withdrawal by Subject|0|||
160839227|NCT01717326|580797885|FG005|Overall Study|Withdrawal by Subject|0|||
160839228|NCT01717326|580797886|FG006|Overall Study|Withdrawal by Subject|0|||
160839229|NCT01717326|580797887|FG007|Overall Study|Withdrawal by Subject|0|||
160839230|NCT01717326|580797888|FG008|Overall Study|Withdrawal by Subject|0|||
160839231|NCT01717326|580797889|FG009|Overall Study|Withdrawal by Subject|1|||
160839232|NCT01717326|580797890|FG010|Overall Study|Withdrawal by Subject|0|||
160839233|NCT01717326|580797891|FG011|Overall Study|Withdrawal by Subject|0|||
160839234|NCT01717326|580797892|FG012|Overall Study|Withdrawal by Subject|1|||
160839235|NCT01717326|580797893|FG013|Overall Study|Withdrawal by Subject|0|||
160839236|NCT01717326|580797894|FG014|Overall Study|Withdrawal by Subject|0|||
160839237|NCT01717326|580797895|FG015|Overall Study|Withdrawal by Subject|1|||
160839238|NCT01717326|580797896|FG016|Overall Study|Withdrawal by Subject|0|||
160839239|NCT01717326|580797897|FG017|Overall Study|Withdrawal by Subject|0|||
160839240|NCT01717326|580797898|FG018|Overall Study|Withdrawal by Subject|2|||
160839241|NCT01717326|580797899|FG019|Overall Study|Withdrawal by Subject|3|||
160839242|NCT02262754|580797901|FG000|Overall Study|Adverse Event|3|||
160839243|NCT02262754|580797902|FG001|Overall Study|Adverse Event|4|||
160839244|NCT02262754|580797903|FG002|Overall Study|Adverse Event|0|||
160839245|NCT02262754|580797901|FG000|Overall Study|Lack of Efficacy|2|||
160839246|NCT02262754|580797902|FG001|Overall Study|Lack of Efficacy|0|||
160839247|NCT02262754|580797903|FG002|Overall Study|Lack of Efficacy|1|||
160839248|NCT02262754|580797901|FG000|Overall Study|Lost to Follow-up|0|||
160839249|NCT02262754|580797902|FG001|Overall Study|Lost to Follow-up|0|||
160839250|NCT02262754|580797903|FG002|Overall Study|Lost to Follow-up|1|||
160839251|NCT02262754|580797901|FG000|Overall Study|No longer meets eligibility criteria|0|||
160839252|NCT02262754|580797902|FG001|Overall Study|No longer meets eligibility criteria|1|||
160839253|NCT02262754|580797903|FG002|Overall Study|No longer meets eligibility criteria|0|||
160839254|NCT02262754|580797901|FG000|Overall Study|Study terminated by sponsor|5|||
160839255|NCT02262754|580797902|FG001|Overall Study|Study terminated by sponsor|4|||
160839256|NCT02262754|580797903|FG002|Overall Study|Study terminated by sponsor|4|||
160839257|NCT02262754|580797901|FG000|Overall Study|Protocol Violation|1|||
160839258|NCT02262754|580797902|FG001|Overall Study|Protocol Violation|0|||
160839259|NCT02262754|580797903|FG002|Overall Study|Protocol Violation|0|||
160839260|NCT02262754|580797901|FG000|Overall Study|Withdrawal by Subject|1|||
160839261|NCT02262754|580797902|FG001|Overall Study|Withdrawal by Subject|0|||
160839262|NCT02262754|580797903|FG002|Overall Study|Withdrawal by Subject|1|||
160839263|NCT02262754|580797901|FG000|Overall Study|Other|4|||
160839264|NCT02262754|580797902|FG001|Overall Study|Other|0|||
160839265|NCT02262754|580797903|FG002|Overall Study|Other|2|||
160839266|NCT01299116|580797907|FG000|Overall Study|Lost to Follow-up|65|||
160839267|NCT01299116|580797908|FG001|Overall Study|Lost to Follow-up|9|||
160839268|NCT01299116|580797909|FG002|Overall Study|Lost to Follow-up|11|||
160839269|NCT04079114|580797910|FG000|Overall Study|Study prematuely terminated.|166|||
160839270|NCT00629798|580797917|FG000|Overall Study|Not Treated|4|||
160839271|NCT01114438|580797918|FG000|Overall Study|Adverse Event|10|||
160839272|NCT01114438|580797918|FG000|Overall Study|concomitant medication|1|||
160839273|NCT01114438|580797918|FG000|Overall Study|Physician Decision|1|||
160839274|NCT01114438|580797918|FG000|Overall Study|Withdrawal by Subject|2|||
160839275|NCT00428844|580797921|FG000|Completed Study Drug Treatment|Adverse Event|2|||
160839276|NCT00428844|580797922|FG001|Completed Study Drug Treatment|Adverse Event|4|||
160839277|NCT00428844|580797923|FG002|Completed Study Drug Treatment|Adverse Event|4|||
160839278|NCT00428844|580797921|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
160839279|NCT00428844|580797922|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
160839280|NCT00428844|580797923|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
160839281|NCT00428844|580797921|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
160839282|NCT00428844|580797922|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
160839283|NCT00428844|580797923|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
160839284|NCT00428844|580797921|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
160839285|NCT00428844|580797922|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
160839286|NCT00428844|580797923|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
160839287|NCT00428844|580797921|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
160839288|NCT00428844|580797922|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
160839289|NCT00428844|580797923|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
160839290|NCT00428844|580797921|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
160839291|NCT00428844|580797922|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
160839292|NCT00428844|580797923|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
160839293|NCT00428844|580797921|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
160839294|NCT00428844|580797922|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
160839295|NCT00428844|580797923|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
160839296|NCT00428844|580797921|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
160839297|NCT00428844|580797922|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
160839298|NCT00428844|580797923|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
160839299|NCT00428844|580797921|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
160839300|NCT00428844|580797922|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
160839301|NCT00428844|580797923|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
160839302|NCT00488826|580797926|FG000|Overall Study|Withdrawal by Subject|40|||
160839303|NCT00488826|580797927|FG001|Overall Study|Withdrawal by Subject|35|||
160839304|NCT00488826|580797928|FG002|Overall Study|Withdrawal by Subject|19|||
160839305|NCT00488826|580797926|FG000|Overall Study|Protocol Violation|0|||
160839306|NCT00488826|580797927|FG001|Overall Study|Protocol Violation|0|||
160839307|NCT00488826|580797928|FG002|Overall Study|Protocol Violation|2|||
160839308|NCT00488826|580797926|FG000|Overall Study|Adverse Event|9|||
160839309|NCT00488826|580797927|FG001|Overall Study|Adverse Event|15|||
160839310|NCT00488826|580797928|FG002|Overall Study|Adverse Event|4|||
160839311|NCT00488826|580797926|FG000|Overall Study|Lost to Follow-up|5|||
160839312|NCT00488826|580797927|FG001|Overall Study|Lost to Follow-up|1|||
160839313|NCT00488826|580797928|FG002|Overall Study|Lost to Follow-up|0|||
160839314|NCT00488826|580797926|FG000|Overall Study|Protocol Deviations|2|||
160839315|NCT00488826|580797927|FG001|Overall Study|Protocol Deviations|1|||
160839316|NCT00488826|580797928|FG002|Overall Study|Protocol Deviations|1|||
160563991|NCT00929240|579784628|FG001|Maintenance Phase|Adverse Event|9|||
160563992|NCT00929240|579784629|FG002|Maintenance Phase|Adverse Event|12|||
160563993|NCT00929240|579784627|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160563994|NCT00929240|579784628|FG001|Maintenance Phase|Withdrawal by Subject|2|||
160839317|NCT00812565|580797935|FG000|Overall Study|Did Not Receive Study Medication|1|||
160839318|NCT00812565|580797936|FG001|Overall Study|Did Not Receive Study Medication|1|||
160839319|NCT00812565|580797937|FG002|Overall Study|Did Not Receive Study Medication|0|||
160904984|NCT00259610|581046398|FG002|Overall Study|Death|2|||
160563995|NCT00929240|579784629|FG002|Maintenance Phase|Withdrawal by Subject|6|||
160563996|NCT00929240|579784627|FG000|Maintenance Phase|Protocol Violation|0|||
160839320|NCT00812565|580797938|FG003|Overall Study|Did Not Receive Study Medication|0|||
160563997|NCT00929240|579784628|FG001|Maintenance Phase|Protocol Violation|1|||
160839321|NCT00812565|580797939|FG004|Overall Study|Did Not Receive Study Medication|0|||
160839322|NCT00812565|580797940|FG005|Overall Study|Did Not Receive Study Medication|0|||
160839323|NCT00812565|580797941|FG006|Overall Study|Did Not Receive Study Medication|0|||
160839324|NCT00812565|580797942|FG007|Overall Study|Did Not Receive Study Medication|0|||
160839325|NCT00812565|580797935|FG000|Overall Study|Adverse Event|0|||
160839326|NCT00812565|580797936|FG001|Overall Study|Adverse Event|0|||
160839327|NCT00812565|580797937|FG002|Overall Study|Adverse Event|0|||
160839328|NCT00812565|580797938|FG003|Overall Study|Adverse Event|2|||
160839329|NCT00812565|580797939|FG004|Overall Study|Adverse Event|0|||
160839330|NCT00812565|580797940|FG005|Overall Study|Adverse Event|0|||
160839331|NCT00812565|580797941|FG006|Overall Study|Adverse Event|0|||
160839332|NCT00812565|580797942|FG007|Overall Study|Adverse Event|1|||
160839333|NCT00812565|580797935|FG000|Overall Study|Did Not Come to Study Visit|1|||
160839334|NCT00812565|580797936|FG001|Overall Study|Did Not Come to Study Visit|0|||
160839335|NCT00812565|580797937|FG002|Overall Study|Did Not Come to Study Visit|0|||
160839336|NCT00812565|580797938|FG003|Overall Study|Did Not Come to Study Visit|0|||
160839337|NCT00812565|580797939|FG004|Overall Study|Did Not Come to Study Visit|0|||
160839338|NCT00812565|580797940|FG005|Overall Study|Did Not Come to Study Visit|0|||
160839339|NCT00812565|580797941|FG006|Overall Study|Did Not Come to Study Visit|0|||
160839340|NCT00812565|580797942|FG007|Overall Study|Did Not Come to Study Visit|0|||
160839341|NCT00812565|580797935|FG000|Overall Study|Withdrawal of Consent|1|||
160839342|NCT00812565|580797936|FG001|Overall Study|Withdrawal of Consent|0|||
160839343|NCT00812565|580797937|FG002|Overall Study|Withdrawal of Consent|0|||
160839344|NCT00812565|580797938|FG003|Overall Study|Withdrawal of Consent|0|||
160839345|NCT00812565|580797939|FG004|Overall Study|Withdrawal of Consent|1|||
160839346|NCT00812565|580797940|FG005|Overall Study|Withdrawal of Consent|0|||
160839347|NCT00812565|580797941|FG006|Overall Study|Withdrawal of Consent|0|||
160839348|NCT00812565|580797942|FG007|Overall Study|Withdrawal of Consent|0|||
160839349|NCT00812565|580797935|FG000|Overall Study|Reason Not Specified|0|||
160839350|NCT00812565|580797936|FG001|Overall Study|Reason Not Specified|0|||
160839351|NCT00812565|580797937|FG002|Overall Study|Reason Not Specified|0|||
160839352|NCT00812565|580797938|FG003|Overall Study|Reason Not Specified|0|||
160839353|NCT00812565|580797939|FG004|Overall Study|Reason Not Specified|0|||
160839354|NCT00812565|580797940|FG005|Overall Study|Reason Not Specified|1|||
160839355|NCT00812565|580797941|FG006|Overall Study|Reason Not Specified|0|||
160839356|NCT00812565|580797942|FG007|Overall Study|Reason Not Specified|0|||
160839357|NCT00422383|580797943|FG000|Overall Study|Adverse Event|5|||
160839358|NCT00422383|580797944|FG001|Overall Study|Adverse Event|3|||
160839359|NCT00422383|580797945|FG002|Overall Study|Adverse Event|1|||
160839360|NCT00422383|580797946|FG003|Overall Study|Adverse Event|1|||
160839361|NCT00422383|580797947|FG004|Overall Study|Adverse Event|0|||
160839362|NCT00422383|580797943|FG000|Overall Study|Lack of Efficacy|4|||
160839363|NCT00422383|580797944|FG001|Overall Study|Lack of Efficacy|4|||
160839364|NCT00422383|580797945|FG002|Overall Study|Lack of Efficacy|2|||
160839365|NCT00422383|580797946|FG003|Overall Study|Lack of Efficacy|1|||
160839366|NCT00422383|580797947|FG004|Overall Study|Lack of Efficacy|1|||
160839367|NCT00422383|580797943|FG000|Overall Study|Lost to Follow-up|0|||
160839368|NCT00422383|580797944|FG001|Overall Study|Lost to Follow-up|1|||
160839369|NCT00422383|580797945|FG002|Overall Study|Lost to Follow-up|0|||
160839370|NCT00422383|580797946|FG003|Overall Study|Lost to Follow-up|0|||
160839371|NCT00422383|580797947|FG004|Overall Study|Lost to Follow-up|1|||
160839372|NCT00422383|580797943|FG000|Overall Study|Protocol Violation|1|||
160839373|NCT00422383|580797944|FG001|Overall Study|Protocol Violation|1|||
160839374|NCT00422383|580797945|FG002|Overall Study|Protocol Violation|1|||
160839375|NCT00422383|580797946|FG003|Overall Study|Protocol Violation|0|||
160839376|NCT00422383|580797947|FG004|Overall Study|Protocol Violation|0|||
160839377|NCT00422383|580797943|FG000|Overall Study|Withdrawal by Subject|5|||
160839378|NCT00422383|580797944|FG001|Overall Study|Withdrawal by Subject|5|||
160839379|NCT00422383|580797945|FG002|Overall Study|Withdrawal by Subject|0|||
160839380|NCT00422383|580797946|FG003|Overall Study|Withdrawal by Subject|0|||
160839381|NCT00422383|580797947|FG004|Overall Study|Withdrawal by Subject|1|||
160839382|NCT00566254|580797948|FG000|Overall Study|Adverse Event|3|||
160839383|NCT00566254|580797949|FG001|Overall Study|Adverse Event|1|||
160839384|NCT00566254|580797948|FG000|Overall Study|Protocol Violation|1|||
160839385|NCT00566254|580797949|FG001|Overall Study|Protocol Violation|3|||
160839386|NCT00566254|580797948|FG000|Overall Study|Withdrawal by Subject|1|||
160839387|NCT00566254|580797949|FG001|Overall Study|Withdrawal by Subject|2|||
160839388|NCT00566254|580797948|FG000|Overall Study|Lack of Efficacy|5|||
160839389|NCT00566254|580797949|FG001|Overall Study|Lack of Efficacy|6|||
160839390|NCT00566254|580797948|FG000|Overall Study|Other|0|||
160839391|NCT00566254|580797949|FG001|Overall Study|Other|2|||
160839392|NCT00238238|580797950|FG000|Overall Study|Withdrawal by Subject|0|||
160839393|NCT00238238|580797951|FG001|Overall Study|Withdrawal by Subject|3|||
160839394|NCT00238238|580797952|FG002|Overall Study|Withdrawal by Subject|0|||
160839395|NCT01007838|580797954|FG000|Overall Study|Withdrawal by Subject|1|||
160839396|NCT01007838|580797955|FG001|Overall Study|Withdrawal by Subject|0|||
160839397|NCT01007838|580797956|FG002|Overall Study|Withdrawal by Subject|0|||
160839398|NCT01007838|580797957|FG003|Overall Study|Withdrawal by Subject|0|||
160839399|NCT01007838|580797954|FG000|Overall Study|Physician Decision|1|||
160839400|NCT01007838|580797955|FG001|Overall Study|Physician Decision|0|||
160839401|NCT01007838|580797956|FG002|Overall Study|Physician Decision|0|||
160839402|NCT01007838|580797957|FG003|Overall Study|Physician Decision|0|||
160839403|NCT01007838|580797954|FG000|Overall Study|Started home haemodialysis|1|||
160839404|NCT01007838|580797955|FG001|Overall Study|Started home haemodialysis|0|||
160839405|NCT01007838|580797956|FG002|Overall Study|Started home haemodialysis|0|||
160839406|NCT01007838|580797957|FG003|Overall Study|Started home haemodialysis|0|||
160839407|NCT02277119|580797960|FG000|Overall Study|Lack of Efficacy|1|||
160839408|NCT02277119|580797961|FG001|Overall Study|Lack of Efficacy|1|||
160839409|NCT02277119|580797962|FG002|Overall Study|Lack of Efficacy|1|||
160839410|NCT02277119|580797960|FG000|Overall Study|Protocol Violation|2|||
160839411|NCT02277119|580797961|FG001|Overall Study|Protocol Violation|3|||
160839412|NCT02277119|580797962|FG002|Overall Study|Protocol Violation|7|||
160839413|NCT01345669|580797963|FG000|Overall Study|Primary tumour recurrence|53|||
160839414|NCT01345669|580797964|FG001|Overall Study|Primary tumour recurrence|32|||
160839415|NCT01345669|580797963|FG000|Overall Study|Second primary tumour|4|||
160839416|NCT01345669|580797964|FG001|Overall Study|Second primary tumour|3|||
160839417|NCT01345669|580797963|FG000|Overall Study|Adverse Event|63|||
160839418|NCT01345669|580797964|FG001|Overall Study|Adverse Event|9|||
160839419|NCT01345669|580797963|FG000|Overall Study|Protocol Violation|3|||
160839420|NCT01345669|580797964|FG001|Overall Study|Protocol Violation|1|||
160839421|NCT01345669|580797963|FG000|Overall Study|Lost to Follow-up|1|||
160839422|NCT01345669|580797964|FG001|Overall Study|Lost to Follow-up|1|||
160839423|NCT01345669|580797963|FG000|Overall Study|Withdrawal by Subject|52|||
160839424|NCT01345669|580797964|FG001|Overall Study|Withdrawal by Subject|13|||
160839425|NCT01345669|580797963|FG000|Overall Study|Other Reasons|111|||
160839426|NCT01345669|580797964|FG001|Overall Study|Other Reasons|60|||
160839427|NCT01793883|580797965|FG000|Overall Study|Withdrawal by Subject|3|||
160839428|NCT01793883|580797966|FG001|Overall Study|Withdrawal by Subject|7|||
160839429|NCT01793883|580797967|FG002|Overall Study|Withdrawal by Subject|3|||
160839430|NCT01793883|580797965|FG000|Overall Study|Subject noncompliance|0|||
160839431|NCT01793883|580797966|FG001|Overall Study|Subject noncompliance|1|||
160839432|NCT01793883|580797967|FG002|Overall Study|Subject noncompliance|1|||
160839433|NCT01793883|580797965|FG000|Overall Study|Lost to Follow-up|5|||
160839434|NCT01793883|580797966|FG001|Overall Study|Lost to Follow-up|1|||
160839435|NCT01793883|580797967|FG002|Overall Study|Lost to Follow-up|3|||
160839436|NCT01793883|580797965|FG000|Overall Study|Randomized in error|1|||
160839437|NCT01793883|580797966|FG001|Overall Study|Randomized in error|0|||
160839438|NCT01793883|580797967|FG002|Overall Study|Randomized in error|0|||
160839439|NCT01793883|580797965|FG000|Overall Study|Unable to complete spriometry|1|||
160839440|NCT01793883|580797966|FG001|Overall Study|Unable to complete spriometry|0|||
160839441|NCT01793883|580797967|FG002|Overall Study|Unable to complete spriometry|0|||
160839442|NCT01793883|580797965|FG000|Overall Study|Unable to complete measurements|1|||
160839443|NCT01793883|580797966|FG001|Overall Study|Unable to complete measurements|0|||
160839444|NCT01793883|580797967|FG002|Overall Study|Unable to complete measurements|0|||
160839445|NCT01793883|580797965|FG000|Overall Study|Met exclusion criteria|1|||
160839446|NCT01793883|580797966|FG001|Overall Study|Met exclusion criteria|0|||
160839447|NCT01793883|580797967|FG002|Overall Study|Met exclusion criteria|0|||
160839448|NCT01793883|580797965|FG000|Overall Study|Dosing error|0|||
160839449|NCT01793883|580797966|FG001|Overall Study|Dosing error|1|||
160839450|NCT01793883|580797967|FG002|Overall Study|Dosing error|0|||
160839451|NCT01793883|580797965|FG000|Overall Study|Respiratory distress during spirometry|0|||
160839452|NCT01793883|580797966|FG001|Overall Study|Respiratory distress during spirometry|0|||
160839453|NCT01793883|580797967|FG002|Overall Study|Respiratory distress during spirometry|1|||
160839454|NCT00761527|580797968|FG000|Overall Study|Adverse Event|3|||
160904985|NCT00259610|581046399|FG003|Overall Study|Death|0|||
160904986|NCT00259610|581046396|FG000|Overall Study|non medical reason|6|||
160904987|NCT00259610|581046397|FG001|Overall Study|non medical reason|2|||
160904988|NCT00259610|581046398|FG002|Overall Study|non medical reason|10|||
160904989|NCT00259610|581046399|FG003|Overall Study|non medical reason|3|||
160904990|NCT00259610|581046396|FG000|Overall Study|Adverse Event|3|||
160904991|NCT00259610|581046397|FG001|Overall Study|Adverse Event|4|||
160839455|NCT00761527|580797968|FG000|Overall Study|Poor Compliance|8|||
160839456|NCT00761527|580797968|FG000|Overall Study|Lost to Follow-up|9|||
160839457|NCT00761527|580797968|FG000|Overall Study|Unknown reason|2|||
160839458|NCT02353728|580797969|FG000|Overall Study|Subject non-compliance|1|||
160839459|NCT02301624|580797970|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
160839460|NCT02301624|580797971|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
160839461|NCT02301624|580797970|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
160839462|NCT02301624|580797971|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
160839463|NCT02301624|580797970|FG000|Open-label Maintenance Phase|Adverse Event|2|||
160839464|NCT02301624|580797971|FG001|Open-label Maintenance Phase|Adverse Event|5|||
160839465|NCT02301624|580797970|FG000|Open-label Maintenance Phase|Physician Decision|3|||
160904992|NCT00259610|581046398|FG002|Overall Study|Adverse Event|5|||
160904993|NCT00259610|581046399|FG003|Overall Study|Adverse Event|2|||
160839466|NCT02301624|580797971|FG001|Open-label Maintenance Phase|Physician Decision|3|||
160563998|NCT00929240|579784629|FG002|Maintenance Phase|Protocol Violation|0|||
160839467|NCT02301624|580797970|FG000|Open-label Maintenance Phase|Death|2|||
160839468|NCT02301624|580797971|FG001|Open-label Maintenance Phase|Death|1|||
160839469|NCT02301624|580797970|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
160839470|NCT02301624|580797971|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
160839471|NCT00895310|580797972|FG000|Overall Study|Withdrawal by Subject|1|||
160839472|NCT02611817|580799648|FG000|Open-label Induction Phase|Reason not Specified|9|||
160839473|NCT02611817|580799649|FG001|Open-label Induction Phase|Reason not Specified|0|||
160839474|NCT02611817|580799650|FG002|Open-label Induction Phase|Reason not Specified|0|||
160839475|NCT02611817|580799648|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
160839476|NCT02611817|580799649|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
160839477|NCT02611817|580799650|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
160839478|NCT02611817|580799648|FG000|Open-label Induction Phase|Pregnancy|1|||
160839479|NCT02611817|580799649|FG001|Open-label Induction Phase|Pregnancy|0|||
160563999|NCT00929240|579784627|FG000|Maintenance Phase|Health authority/Study termination|0|||
160564000|NCT00929240|579784628|FG001|Maintenance Phase|Health authority/Study termination|1|||
160564001|NCT00929240|579784629|FG002|Maintenance Phase|Health authority/Study termination|2|||
160564002|NCT00929240|579784627|FG000|Maintenance Phase|Physician Decision|0|||
160564003|NCT00929240|579784628|FG001|Maintenance Phase|Physician Decision|2|||
160564004|NCT00929240|579784629|FG002|Maintenance Phase|Physician Decision|1|||
160564005|NCT00929240|579784627|FG000|Maintenance Phase|Change of treatment|0|||
160564006|NCT00929240|579784628|FG001|Maintenance Phase|Change of treatment|4|||
160564007|NCT00929240|579784629|FG002|Maintenance Phase|Change of treatment|0|||
160564008|NCT00929240|579784627|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
160564009|NCT00929240|579784628|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
160564010|NCT00929240|579784629|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
160564011|NCT00929240|579784627|FG000|Maintenance Phase|Participant not treated|0|||
160564012|NCT00929240|579784628|FG001|Maintenance Phase|Participant not treated|2|||
160564013|NCT00929240|579784629|FG002|Maintenance Phase|Participant not treated|0|||
160564014|NCT01147809|579784630|FG000|Phase I (168 Days)|Adverse Event|0|||
160564015|NCT01147809|579784631|FG001|Phase I (168 Days)|Adverse Event|0|||
160564016|NCT01147809|579784632|FG002|Phase I (168 Days)|Adverse Event|0|||
160564017|NCT01147809|579784633|FG003|Phase I (168 Days)|Adverse Event|1|||
160564018|NCT01147809|579784634|FG004|Phase I (168 Days)|Adverse Event|0|||
160564019|NCT01147809|579784635|FG005|Phase I (168 Days)|Adverse Event|0|||
160564020|NCT01147809|579784630|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
160564021|NCT01147809|579784631|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
160564022|NCT01147809|579784632|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
160564023|NCT01147809|579784633|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
160564024|NCT01147809|579784634|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
160839480|NCT02611817|580799650|FG002|Open-label Induction Phase|Pregnancy|0|||
160839481|NCT02611817|580799648|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
160839482|NCT02611817|580799649|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
160839483|NCT02611817|580799650|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
160839484|NCT02611817|580799648|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
160839485|NCT02611817|580799649|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
160564025|NCT01147809|579784635|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
160564026|NCT01147809|579784630|FG000|Phase I (168 Days)|Physician Decision|0|||
160564027|NCT01147809|579784631|FG001|Phase I (168 Days)|Physician Decision|1|||
160564028|NCT01147809|579784632|FG002|Phase I (168 Days)|Physician Decision|2|||
160564029|NCT01147809|579784633|FG003|Phase I (168 Days)|Physician Decision|0|||
160564030|NCT01147809|579784634|FG004|Phase I (168 Days)|Physician Decision|0|||
160564031|NCT01147809|579784635|FG005|Phase I (168 Days)|Physician Decision|0|||
160564032|NCT01147809|579784630|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
160564033|NCT01147809|579784631|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
160564034|NCT01147809|579784632|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
160564035|NCT01147809|579784633|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
160564036|NCT01147809|579784634|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
160564037|NCT01147809|579784635|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
160564038|NCT01147809|579784630|FG000|Phase II (168 Days)|Adverse Event|0|||
160564039|NCT01147809|579784631|FG001|Phase II (168 Days)|Adverse Event|0|||
160564040|NCT01147809|579784632|FG002|Phase II (168 Days)|Adverse Event|0|||
160564041|NCT01147809|579784633|FG003|Phase II (168 Days)|Adverse Event|0|||
160564042|NCT01147809|579784634|FG004|Phase II (168 Days)|Adverse Event|3|||
160564043|NCT01147809|579784635|FG005|Phase II (168 Days)|Adverse Event|6|||
160564044|NCT01147809|579784630|FG000|Phase II (168 Days)|Protocol Violation|0|||
160564045|NCT01147809|579784631|FG001|Phase II (168 Days)|Protocol Violation|0|||
160564046|NCT01147809|579784632|FG002|Phase II (168 Days)|Protocol Violation|0|||
160564047|NCT01147809|579784633|FG003|Phase II (168 Days)|Protocol Violation|0|||
160564048|NCT01147809|579784634|FG004|Phase II (168 Days)|Protocol Violation|0|||
160564049|NCT01147809|579784635|FG005|Phase II (168 Days)|Protocol Violation|1|||
160564050|NCT01147809|579784630|FG000|Phase II (168 Days)|Physician Decision|0|||
160564051|NCT01147809|579784631|FG001|Phase II (168 Days)|Physician Decision|0|||
160564052|NCT01147809|579784632|FG002|Phase II (168 Days)|Physician Decision|0|||
160564053|NCT01147809|579784633|FG003|Phase II (168 Days)|Physician Decision|0|||
160564054|NCT01147809|579784634|FG004|Phase II (168 Days)|Physician Decision|5|||
160564055|NCT01147809|579784635|FG005|Phase II (168 Days)|Physician Decision|11|||
160564056|NCT01147809|579784630|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
160564057|NCT01147809|579784631|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
160564058|NCT01147809|579784632|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
160564059|NCT01147809|579784633|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
160564060|NCT01147809|579784634|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
160564061|NCT01147809|579784635|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
160564062|NCT01147809|579784630|FG000|Phase II (168 Days)|Ongoing|0|||
160564063|NCT01147809|579784631|FG001|Phase II (168 Days)|Ongoing|0|||
160564064|NCT01147809|579784632|FG002|Phase II (168 Days)|Ongoing|0|||
160564065|NCT01147809|579784633|FG003|Phase II (168 Days)|Ongoing|0|||
160564066|NCT01147809|579784634|FG004|Phase II (168 Days)|Ongoing|1|||
160564067|NCT01147809|579784635|FG005|Phase II (168 Days)|Ongoing|0|||
160564068|NCT01499290|579784638|FG000|Overall Study|Withdrawal by Subject|22|||
160564069|NCT01499290|579784639|FG001|Overall Study|Withdrawal by Subject|15|||
160564070|NCT01499290|579784638|FG000|Overall Study|Not specified in study report|11|||
160564071|NCT01499290|579784639|FG001|Overall Study|Not specified in study report|5|||
160564072|NCT01499290|579784638|FG000|Overall Study|Condition improved/subject recovered|1|||
160564073|NCT01499290|579784639|FG001|Overall Study|Condition improved/subject recovered|0|||
160564074|NCT01499290|579784638|FG000|Overall Study|Lack of Efficacy|7|||
160564075|NCT01499290|579784639|FG001|Overall Study|Lack of Efficacy|8|||
160564076|NCT01499290|579784638|FG000|Overall Study|Adverse Event|14|||
160564077|NCT01499290|579784639|FG001|Overall Study|Adverse Event|7|||
160564078|NCT02209766|579784640|FG000|Overall Study|Withdrawal by Subject|0|||
160564079|NCT02209766|579784641|FG001|Overall Study|Withdrawal by Subject|0|||
160564080|NCT02209766|579784642|FG002|Overall Study|Withdrawal by Subject|0|||
160564081|NCT02209766|579784643|FG003|Overall Study|Withdrawal by Subject|1|||
160564082|NCT02209766|579784644|FG004|Overall Study|Withdrawal by Subject|0|||
160564083|NCT01791855|579784645|FG000|Overall Study|Adverse Event|0|||
160564084|NCT01791855|579784646|FG001|Overall Study|Adverse Event|0|||
160564085|NCT01791855|579784647|FG002|Overall Study|Adverse Event|0|||
160839486|NCT02611817|580799650|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
160991927|NCT04888585|581359930|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
160564086|NCT01791855|579784648|FG003|Overall Study|Adverse Event|1|||
160564087|NCT01791855|579784645|FG000|Overall Study|Randomized, not treated|0|||
160564088|NCT01791855|579784646|FG001|Overall Study|Randomized, not treated|1|||
160564089|NCT01791855|579784647|FG002|Overall Study|Randomized, not treated|0|||
160564090|NCT01791855|579784648|FG003|Overall Study|Randomized, not treated|0|||
160564091|NCT01431287|579786538|FG000|Overall Study|not treated|0|||
160564092|NCT01431287|579786539|FG001|Overall Study|not treated|0|||
160564093|NCT01431287|579786540|FG002|Overall Study|not treated|1|||
160564094|NCT01431287|579786541|FG003|Overall Study|not treated|0|||
160564095|NCT01431287|579786542|FG004|Overall Study|not treated|0|||
160564096|NCT01431287|579786538|FG000|Overall Study|Adverse Event|59|||
160564097|NCT01431287|579786539|FG001|Overall Study|Adverse Event|57|||
160564098|NCT01431287|579786540|FG002|Overall Study|Adverse Event|53|||
160564099|NCT01431287|579786541|FG003|Overall Study|Adverse Event|33|||
160564100|NCT01431287|579786542|FG004|Overall Study|Adverse Event|41|||
160564101|NCT01431287|579786538|FG000|Overall Study|Non compliant with protocol|6|||
160564102|NCT01431287|579786539|FG001|Overall Study|Non compliant with protocol|6|||
160564103|NCT01431287|579786540|FG002|Overall Study|Non compliant with protocol|5|||
160564104|NCT01431287|579786541|FG003|Overall Study|Non compliant with protocol|6|||
160564105|NCT01431287|579786542|FG004|Overall Study|Non compliant with protocol|5|||
160564106|NCT01431287|579786538|FG000|Overall Study|Lost to Follow-up|0|||
160564107|NCT01431287|579786539|FG001|Overall Study|Lost to Follow-up|3|||
160564108|NCT01431287|579786540|FG002|Overall Study|Lost to Follow-up|2|||
160839487|NCT02611817|580799648|FG000|Open-label Induction Phase|Protocol Violation|5|||
160839488|NCT02611817|580799649|FG001|Open-label Induction Phase|Protocol Violation|0|||
160839489|NCT02611817|580799650|FG002|Open-label Induction Phase|Protocol Violation|0|||
160839490|NCT02611817|580799648|FG000|Open-label Induction Phase|Adverse Event|16|||
160839491|NCT02611817|580799649|FG001|Open-label Induction Phase|Adverse Event|0|||
160839492|NCT02611817|580799650|FG002|Open-label Induction Phase|Adverse Event|0|||
160839493|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
160839494|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
160839495|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
160839496|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
160839497|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
160839498|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
160839499|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
160839500|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
160839501|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
160839502|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
160839503|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
160839504|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
160839505|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
160839506|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
160839507|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
160839508|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
160839509|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
160839510|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
160839511|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
160839512|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
160839513|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
160904994|NCT00259610|581046396|FG000|Overall Study|Serious Adverse Event|8|||
160904995|NCT00259610|581046397|FG001|Overall Study|Serious Adverse Event|2|||
160904996|NCT00259610|581046398|FG002|Overall Study|Serious Adverse Event|2|||
160904997|NCT00259610|581046399|FG003|Overall Study|Serious Adverse Event|2|||
160904998|NCT00282984|581046403|FG000|Overall Study|Death|2|||
160904999|NCT00282984|581046404|FG001|Overall Study|Death|5|||
160905000|NCT00282984|581046403|FG000|Overall Study|Adverse Event|8|||
160839514|NCT03077919|580799651|FG000|Overall Study|Lost to Follow-up|4|||
160839515|NCT03077919|580799652|FG001|Overall Study|Lost to Follow-up|1|||
160905001|NCT00282984|581046404|FG001|Overall Study|Adverse Event|5|||
160905002|NCT00282984|581046403|FG000|Overall Study|Lack of Efficacy|0|||
160905003|NCT00282984|581046404|FG001|Overall Study|Lack of Efficacy|2|||
160905004|NCT00282984|581046403|FG000|Overall Study|Lost to Follow-up|14|||
160905005|NCT00282984|581046404|FG001|Overall Study|Lost to Follow-up|10|||
160905006|NCT00282984|581046403|FG000|Overall Study|Withdrawal by Participant|22|||
160905007|NCT00282984|581046404|FG001|Overall Study|Withdrawal by Participant|34|||
160905008|NCT00282984|581046403|FG000|Overall Study|Participant stopped study medication|2|||
160905009|NCT00282984|581046404|FG001|Overall Study|Participant stopped study medication|2|||
160905010|NCT00282984|581046403|FG000|Overall Study|Participant only allowed phone follow-up|0|||
160905011|NCT00282984|581046404|FG001|Overall Study|Participant only allowed phone follow-up|1|||
160905012|NCT00282984|581046403|FG000|Overall Study|Participant used antipsychosis meds|0|||
160905013|NCT00282984|581046404|FG001|Overall Study|Participant used antipsychosis meds|1|||
160905014|NCT00282984|581046403|FG000|Overall Study|lack of motivation|1|||
160905015|NCT00282984|581046404|FG001|Overall Study|lack of motivation|0|||
160905016|NCT00282984|581046403|FG000|Overall Study|in prison|0|||
160905017|NCT00282984|581046404|FG001|Overall Study|in prison|1|||
160905018|NCT00282984|581046403|FG000|Overall Study|Protocol Violation|2|||
160905019|NCT00282984|581046404|FG001|Overall Study|Protocol Violation|0|||
160905020|NCT00868608|581046405|FG000|Overall Study|Withdrawal by Subject|3|||
160905021|NCT00868608|581046406|FG001|Overall Study|Withdrawal by Subject|1|||
160905022|NCT00868608|581046407|FG002|Overall Study|Withdrawal by Subject|0|||
160905023|NCT00868608|581046405|FG000|Overall Study|Lost to Follow-up|3|||
160905024|NCT00868608|581046406|FG001|Overall Study|Lost to Follow-up|0|||
160905025|NCT00868608|581046407|FG002|Overall Study|Lost to Follow-up|1|||
160905026|NCT00868608|581046405|FG000|Overall Study|Death|16|||
160905027|NCT00868608|581046406|FG001|Overall Study|Death|2|||
160905028|NCT00868608|581046407|FG002|Overall Study|Death|4|||
160839516|NCT03738618|580799653|FG000|Overall Study|Protocol deviation|23|||
160905029|NCT00868608|581046405|FG000|Overall Study|Other - Unspecified|1|||
160905030|NCT00868608|581046406|FG001|Overall Study|Other - Unspecified|0|||
160905031|NCT00868608|581046407|FG002|Overall Study|Other - Unspecified|0|||
160905032|NCT00457301|581046408|FG000|Overall Study|Withdrawal by Subject|3|||
160905033|NCT00457301|581046409|FG001|Overall Study|Withdrawal by Subject|3|||
160905034|NCT00457301|581046408|FG000|Overall Study|Censored out of the study|15|||
160905035|NCT00457301|581046409|FG001|Overall Study|Censored out of the study|14|||
160905036|NCT00457301|581046408|FG000|Overall Study|Death|5|||
160905037|NCT00457301|581046409|FG001|Overall Study|Death|7|||
160905038|NCT00191269|581046410|FG000|Overall Study|Protocol Violation|0|||
160564109|NCT01431287|579786541|FG003|Overall Study|Lost to Follow-up|3|||
160564110|NCT01431287|579786542|FG004|Overall Study|Lost to Follow-up|1|||
160564111|NCT01431287|579786538|FG000|Overall Study|Consent withdrawn not due to AE|29|||
160839517|NCT03738618|580799654|FG001|Overall Study|Protocol deviation|0|||
160839518|NCT03738618|580799653|FG000|Overall Study|Adverse Event|4|||
160839519|NCT03738618|580799654|FG001|Overall Study|Adverse Event|0|||
160839520|NCT03738618|580799653|FG000|Overall Study|Lost to Follow-up|2|||
160839521|NCT03738618|580799654|FG001|Overall Study|Lost to Follow-up|0|||
160839522|NCT03738618|580799653|FG000|Overall Study|Randomization failure|1|||
160839523|NCT03738618|580799654|FG001|Overall Study|Randomization failure|0|||
160839524|NCT03738618|580799653|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
160839525|NCT03738618|580799654|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
160839526|NCT03738618|580799653|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
160839527|NCT03738618|580799654|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
160839528|NCT00826618|580799655|FG000|Overall Study|Withdrawal by Subject|1|||
160839529|NCT01487265|580799660|FG000|Overall Study|Adverse Event|8|||
160839530|NCT01487265|580799660|FG000|Overall Study|Withdrawal by Subject|5|||
160839531|NCT01487265|580799660|FG000|Overall Study|Disease Progression|21|||
160839532|NCT01487265|580799660|FG000|Overall Study|Death|2|||
160839533|NCT01487265|580799660|FG000|Overall Study|Still on Treatment|1|||
160839534|NCT01016600|580799661|FG000|Overall Study|Did not start treatment|1|||
160839535|NCT01016600|580799662|FG001|Overall Study|Did not start treatment|0|||
160839536|NCT01016600|580799663|FG002|Overall Study|Did not start treatment|0|||
160839537|NCT01016600|580799664|FG003|Overall Study|Did not start treatment|0|||
160839538|NCT01271725|580799667|FG000|Part A|Progressive disease according to RECIST|8|||
160839539|NCT01271725|580799668|FG001|Part A|Progressive disease according to RECIST|0|||
160839540|NCT01271725|580799667|FG000|Part A|Clinical signs/symptoms of progression|2|||
160839541|NCT01271725|580799668|FG001|Part A|Clinical signs/symptoms of progression|0|||
160839542|NCT01271725|580799667|FG000|Part A|Other Adverse Event|8|||
160839543|NCT01271725|580799668|FG001|Part A|Other Adverse Event|0|||
160839544|NCT01271725|580799667|FG000|Part A|Lost to Follow-up|1|||
160839545|NCT01271725|580799668|FG001|Part A|Lost to Follow-up|0|||
160839546|NCT01271725|580799667|FG000|Part A|Withdrawal by Subject|12|||
160839547|NCT01271725|580799668|FG001|Part A|Withdrawal by Subject|0|||
160839548|NCT01271725|580799667|FG000|Part A|Other than specified|3|||
160839549|NCT01271725|580799668|FG001|Part A|Other than specified|0|||
160905039|NCT00191269|581046411|FG001|Overall Study|Protocol Violation|2|||
160905040|NCT00191269|581046410|FG000|Overall Study|Adverse Event|1|||
160905041|NCT00191269|581046411|FG001|Overall Study|Adverse Event|4|||
160905042|NCT00191269|581046410|FG000|Overall Study|Progression of Disease|4|||
160905043|NCT00191269|581046411|FG001|Overall Study|Progression of Disease|42|||
160905044|NCT00191269|581046410|FG000|Overall Study|Lack of Efficacy|1|||
160905045|NCT00191269|581046411|FG001|Overall Study|Lack of Efficacy|5|||
160905046|NCT00191269|581046410|FG000|Overall Study|Withdrawal by Subject|0|||
160905047|NCT00191269|581046411|FG001|Overall Study|Withdrawal by Subject|1|||
160905048|NCT00191269|581046410|FG000|Overall Study|Pathologic Aggrevation|0|||
160905049|NCT00191269|581046411|FG001|Overall Study|Pathologic Aggrevation|1|||
160905050|NCT00191269|581046410|FG000|Overall Study|Physician Decision|0|||
160905051|NCT00191269|581046411|FG001|Overall Study|Physician Decision|3|||
160905052|NCT00674362|581046412|FG000|Double Blind|Adverse Event|6|||
160905053|NCT00674362|581046413|FG001|Double Blind|Adverse Event|6|||
160905054|NCT00674362|581046412|FG000|Double Blind|Lack of Efficacy|2|||
160905055|NCT00674362|581046413|FG001|Double Blind|Lack of Efficacy|6|||
160905056|NCT00674362|581046412|FG000|Double Blind|Loss of efficacy|0|||
160905057|NCT00674362|581046413|FG001|Double Blind|Loss of efficacy|1|||
160905058|NCT00674362|581046412|FG000|Double Blind|Withdrawal by Subject|4|||
160905059|NCT00674362|581046413|FG001|Double Blind|Withdrawal by Subject|3|||
160905060|NCT00674362|581046412|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
160905061|NCT00674362|581046413|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
160905062|NCT00674362|581046412|FG000|Double Blind|Other: Surgery|0|||
160905063|NCT00674362|581046413|FG001|Double Blind|Other: Surgery|1|||
160905064|NCT00674362|581046412|FG000|Open Label|Adverse Event|1|||
160905065|NCT00674362|581046413|FG001|Open Label|Adverse Event|0|||
160905066|NCT00674362|581046412|FG000|Open Label|Other: Subject moved to extension study|1|||
160905067|NCT00674362|581046413|FG001|Open Label|Other: Subject moved to extension study|0|||
160905068|NCT00939770|581046416|FG000|Overall Study|Adverse Event|1|||
160905069|NCT00939770|581046417|FG001|Overall Study|Adverse Event|1|||
160905070|NCT00939770|581046418|FG002|Overall Study|Adverse Event|0|||
160905071|NCT00939770|581046419|FG003|Overall Study|Adverse Event|0|||
160564112|NCT01431287|579786539|FG001|Overall Study|Consent withdrawn not due to AE|30|||
160839550|NCT01271725|580799667|FG000|Part A|Protocol Violation|1|||
160839551|NCT01271725|580799668|FG001|Part A|Protocol Violation|0|||
160839552|NCT01271725|580799667|FG000|Part B|Other than specified|0|||
160905072|NCT00939770|581046420|FG004|Overall Study|Adverse Event|6|||
160996830|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
160839553|NCT01271725|580799668|FG001|Part B|Other than specified|2|||
160839554|NCT01271725|580799667|FG000|Part B|Clinical signs/symptoms of progression|0|||
160839555|NCT01271725|580799668|FG001|Part B|Clinical signs/symptoms of progression|2|||
160839556|NCT01271725|580799667|FG000|Part B|Other Adverse Event|0|||
160839557|NCT01271725|580799668|FG001|Part B|Other Adverse Event|1|||
160839558|NCT01271725|580799667|FG000|Part B|Protocol Violation|0|||
160839559|NCT01271725|580799668|FG001|Part B|Protocol Violation|1|||
160839560|NCT01271725|580799667|FG000|Part B|Withdrawal by Subject|0|||
160839561|NCT01271725|580799668|FG001|Part B|Withdrawal by Subject|6|||
160839562|NCT00801229|580799669|FG000|Signed Consent|Withdrawal by Subject|2|||
160839563|NCT00801229|580799670|FG001|Signed Consent|Withdrawal by Subject|2|||
160839564|NCT00801229|580799669|FG000|Signed Consent|Found Ineligible|1|||
160839565|NCT00801229|580799670|FG001|Signed Consent|Found Ineligible|1|||
160839566|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
160839567|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
160839568|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
160839569|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
160839570|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
160839571|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
160839572|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
160839573|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
160839574|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
160839575|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
160991928|NCT04888585|581359931|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
160564113|NCT01431287|579786540|FG002|Overall Study|Consent withdrawn not due to AE|34|||
160564114|NCT01431287|579786541|FG003|Overall Study|Consent withdrawn not due to AE|19|||
160839576|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Adverse Event|1|||
160839577|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Adverse Event|1|||
160839578|NCT03826186|580799671|FG000|Overall Study|Protocol Violation|2|||
160839579|NCT03826186|580799672|FG001|Overall Study|Protocol Violation|0|||
160839580|NCT03826186|580799671|FG000|Overall Study|Withdrawal by Subject|1|||
160839581|NCT03826186|580799672|FG001|Overall Study|Withdrawal by Subject|0|||
160839582|NCT02950480|580799675|FG000|Overall Study|Withdrawal by Subject|1|||
160839583|NCT02950480|580799676|FG001|Overall Study|Withdrawal by Subject|0|||
160839584|NCT01363661|580799677|FG000|Overall Study|Adverse Event|9|||
160839585|NCT01363661|580799678|FG001|Overall Study|Adverse Event|2|||
160839586|NCT01363661|580799677|FG000|Overall Study|Withdrawal by Subject|1|||
160839587|NCT01363661|580799678|FG001|Overall Study|Withdrawal by Subject|1|||
160839588|NCT01363661|580799677|FG000|Overall Study|Protocol Violation|1|||
160839589|NCT01363661|580799678|FG001|Overall Study|Protocol Violation|0|||
160839590|NCT01363661|580799677|FG000|Overall Study|Lost to Follow-up|3|||
160839591|NCT01363661|580799678|FG001|Overall Study|Lost to Follow-up|1|||
160839592|NCT01959139|580799681|FG000|Phase II|Disease progression|0|||
160839593|NCT01959139|580799682|FG001|Phase II|Disease progression|0|||
160839594|NCT01959139|580799683|FG002|Phase II|Disease progression|26|||
160839595|NCT01959139|580799684|FG003|Phase II|Disease progression|34|||
160839596|NCT01959139|580799681|FG000|Phase II|Adverse Event|0|||
160839597|NCT01959139|580799682|FG001|Phase II|Adverse Event|0|||
160839598|NCT01959139|580799683|FG002|Phase II|Adverse Event|10|||
160839599|NCT01959139|580799684|FG003|Phase II|Adverse Event|11|||
160839600|NCT01959139|580799681|FG000|Phase II|Patient Refusal|0|||
160839601|NCT01959139|580799682|FG001|Phase II|Patient Refusal|0|||
160839602|NCT01959139|580799683|FG002|Phase II|Patient Refusal|5|||
160839603|NCT01959139|580799684|FG003|Phase II|Patient Refusal|4|||
160839604|NCT01959139|580799681|FG000|Phase II|Death|0|||
160839605|NCT01959139|580799682|FG001|Phase II|Death|0|||
160839606|NCT01959139|580799683|FG002|Phase II|Death|3|||
160839607|NCT01959139|580799684|FG003|Phase II|Death|1|||
160839608|NCT01959139|580799681|FG000|Phase II|Other/Unknown|0|||
160839609|NCT01959139|580799682|FG001|Phase II|Other/Unknown|0|||
160839610|NCT01959139|580799683|FG002|Phase II|Other/Unknown|8|||
160839611|NCT01959139|580799684|FG003|Phase II|Other/Unknown|5|||
160839612|NCT01959139|580799681|FG000|Phase II|On treatment|0|||
160839613|NCT01959139|580799682|FG001|Phase II|On treatment|0|||
160839614|NCT01959139|580799683|FG002|Phase II|On treatment|4|||
160839615|NCT01959139|580799684|FG003|Phase II|On treatment|0|||
160839616|NCT01378325|580799687|FG000|Overall Study|Protocol Violation|0|||
160839617|NCT01378325|580799688|FG001|Overall Study|Protocol Violation|1|||
160839618|NCT01559675|580799689|FG000|Overall Study|Protocol Violation|1|||
160839619|NCT01559675|580799690|FG001|Overall Study|Protocol Violation|2|||
160905073|NCT00939770|581046421|FG005|Overall Study|Adverse Event|2|||
160905074|NCT00939770|581046422|FG006|Overall Study|Adverse Event|1|||
160564115|NCT01431287|579786542|FG004|Overall Study|Consent withdrawn not due to AE|29|||
160564116|NCT01431287|579786538|FG000|Overall Study|not stated above|4|||
160564117|NCT01431287|579786539|FG001|Overall Study|not stated above|2|||
160564118|NCT01431287|579786540|FG002|Overall Study|not stated above|2|||
160564119|NCT01431287|579786541|FG003|Overall Study|not stated above|2|||
160564120|NCT01431287|579786542|FG004|Overall Study|not stated above|1|||
160564121|NCT00364793|579786552|FG000|Overall Study|Adverse Event|2|||
160564122|NCT00364793|579786553|FG001|Overall Study|Adverse Event|0|||
160564123|NCT00364793|579786554|FG002|Overall Study|Adverse Event|0|||
160564124|NCT00364793|579786555|FG003|Overall Study|Adverse Event|0|||
160905075|NCT00939770|581046423|FG007|Overall Study|Adverse Event|1|||
160905076|NCT00939770|581046416|FG000|Overall Study|Lack of Efficacy|4|||
160564125|NCT00364793|579786552|FG000|Overall Study|Death|1|||
160564126|NCT00364793|579786553|FG001|Overall Study|Death|0|||
160564127|NCT00364793|579786554|FG002|Overall Study|Death|1|||
160564128|NCT00364793|579786555|FG003|Overall Study|Death|0|||
160839620|NCT01559675|580799689|FG000|Overall Study|2nd operation on same patient excluded|14|||
160839621|NCT01559675|580799690|FG001|Overall Study|2nd operation on same patient excluded|12|||
160839622|NCT01496469|580799691|FG000|Overall Study|Adverse Event|1|||
160839623|NCT01496469|580799692|FG001|Overall Study|Adverse Event|0|||
160839624|NCT01496469|580799691|FG000|Overall Study|Protocol Violation|2|||
160839625|NCT01496469|580799692|FG001|Overall Study|Protocol Violation|0|||
160839626|NCT01496469|580799691|FG000|Overall Study|Lost to Follow-up|1|||
160905077|NCT00939770|581046417|FG001|Overall Study|Lack of Efficacy|6|||
160564129|NCT00364793|579786552|FG000|Overall Study|Lack of Efficacy|3|||
160564130|NCT00364793|579786553|FG001|Overall Study|Lack of Efficacy|3|||
160564131|NCT00364793|579786554|FG002|Overall Study|Lack of Efficacy|1|||
160564132|NCT00364793|579786555|FG003|Overall Study|Lack of Efficacy|1|||
160564133|NCT00364793|579786552|FG000|Overall Study|Lost to Follow-up|1|||
160839627|NCT01496469|580799692|FG001|Overall Study|Lost to Follow-up|1|||
160839628|NCT01496469|580799691|FG000|Overall Study|Withdrawal by Subject|4|||
160839629|NCT01496469|580799692|FG001|Overall Study|Withdrawal by Subject|4|||
160839630|NCT01496469|580799691|FG000|Overall Study|BP exceeds protocol limits|1|||
160839631|NCT01496469|580799692|FG001|Overall Study|BP exceeds protocol limits|2|||
160839632|NCT01496469|580799691|FG000|Overall Study|Other|1|||
160839633|NCT01496469|580799692|FG001|Overall Study|Other|1|||
160839634|NCT00193180|580799696|FG000|Overall Study|Lack of Efficacy|1|||
160839635|NCT00193180|580799696|FG000|Overall Study|Adverse Event|8|||
160839636|NCT00193180|580799696|FG000|Overall Study|Protocol Violation|1|||
160839637|NCT02219334|580799697|FG000|Overall Study|Withdrawal by Subject|1|||
160839638|NCT02219334|580799698|FG001|Overall Study|Withdrawal by Subject|0|||
160839639|NCT02219334|580799697|FG000|Overall Study|Protocol Violation|7|||
160839640|NCT02219334|580799698|FG001|Overall Study|Protocol Violation|3|||
160839641|NCT00891228|580799700|FG000|Overall Study|Adverse Event|0|||
160839642|NCT00891228|580799701|FG001|Overall Study|Adverse Event|2|||
160839643|NCT00891228|580799702|FG002|Overall Study|Adverse Event|3|||
160839644|NCT00891228|580799700|FG000|Overall Study|Withdrawal by Subject|2|||
160839645|NCT00891228|580799701|FG001|Overall Study|Withdrawal by Subject|4|||
160839646|NCT00891228|580799702|FG002|Overall Study|Withdrawal by Subject|5|||
160839647|NCT00891228|580799700|FG000|Overall Study|Protocol Violation|3|||
160839648|NCT00891228|580799701|FG001|Overall Study|Protocol Violation|1|||
160839649|NCT00891228|580799702|FG002|Overall Study|Protocol Violation|2|||
160839650|NCT00891228|580799700|FG000|Overall Study|Physician Decision|2|||
160839651|NCT00891228|580799701|FG001|Overall Study|Physician Decision|1|||
160839652|NCT00891228|580799702|FG002|Overall Study|Physician Decision|0|||
160839653|NCT00891228|580799700|FG000|Overall Study|Lost to Follow-up|4|||
160839654|NCT00891228|580799701|FG001|Overall Study|Lost to Follow-up|4|||
160839655|NCT00891228|580799702|FG002|Overall Study|Lost to Follow-up|5|||
160839656|NCT00891228|580799700|FG000|Overall Study|Pregnancy|0|||
160839657|NCT00891228|580799701|FG001|Overall Study|Pregnancy|1|||
160839658|NCT00891228|580799702|FG002|Overall Study|Pregnancy|0|||
160839659|NCT02688985|580799711|FG000|Overall Study|Adverse Event|1|||
160839660|NCT02688985|580799712|FG001|Overall Study|Adverse Event|2|||
160839661|NCT02688985|580799713|FG002|Overall Study|Adverse Event|2|||
160839662|NCT02688985|580799714|FG003|Overall Study|Adverse Event|0|||
160839663|NCT02688985|580799715|FG004|Overall Study|Adverse Event|0|||
160839664|NCT02688985|580799711|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
160839665|NCT02688985|580799712|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
160839666|NCT02688985|580799713|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
160839667|NCT02688985|580799714|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
160839668|NCT02688985|580799715|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
160839669|NCT02688985|580799711|FG000|Overall Study|Death|0|||
160839670|NCT02688985|580799712|FG001|Overall Study|Death|0|||
160839671|NCT02688985|580799713|FG002|Overall Study|Death|0|||
160839672|NCT02688985|580799714|FG003|Overall Study|Death|0|||
160839673|NCT02688985|580799715|FG004|Overall Study|Death|1|||
160839674|NCT02688985|580799711|FG000|Overall Study|Lack of Efficacy|0|||
160839675|NCT02688985|580799712|FG001|Overall Study|Lack of Efficacy|0|||
160839676|NCT02688985|580799713|FG002|Overall Study|Lack of Efficacy|0|||
160839677|NCT02688985|580799714|FG003|Overall Study|Lack of Efficacy|0|||
160839678|NCT02688985|580799715|FG004|Overall Study|Lack of Efficacy|1|||
160839679|NCT02688985|580799711|FG000|Overall Study|Lost to Follow-up|2|||
160839680|NCT02688985|580799712|FG001|Overall Study|Lost to Follow-up|0|||
160839681|NCT02688985|580799713|FG002|Overall Study|Lost to Follow-up|1|||
160839682|NCT02688985|580799714|FG003|Overall Study|Lost to Follow-up|1|||
160839683|NCT02688985|580799715|FG004|Overall Study|Lost to Follow-up|1|||
160839684|NCT02688985|580799711|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160839685|NCT02688985|580799712|FG001|Overall Study|Non-Compliance With Study Drug|3|||
160839686|NCT02688985|580799713|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160839687|NCT02688985|580799714|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160839688|NCT02688985|580799715|FG004|Overall Study|Non-Compliance With Study Drug|1|||
160839689|NCT02688985|580799711|FG000|Overall Study|Other|3|||
160839690|NCT02688985|580799712|FG001|Overall Study|Other|4|||
160564134|NCT00364793|579786553|FG001|Overall Study|Lost to Follow-up|0|||
160564135|NCT00364793|579786554|FG002|Overall Study|Lost to Follow-up|2|||
160839691|NCT02688985|580799713|FG002|Overall Study|Other|1|||
160839692|NCT02688985|580799714|FG003|Overall Study|Other|0|||
160839693|NCT02688985|580799715|FG004|Overall Study|Other|0|||
160839694|NCT02688985|580799711|FG000|Overall Study|Physician Decision|2|||
160839695|NCT02688985|580799712|FG001|Overall Study|Physician Decision|2|||
160839696|NCT02688985|580799713|FG002|Overall Study|Physician Decision|0|||
160839697|NCT02688985|580799714|FG003|Overall Study|Physician Decision|0|||
160839698|NCT02688985|580799715|FG004|Overall Study|Physician Decision|1|||
160839699|NCT02688985|580799711|FG000|Overall Study|Pregnancy|0|||
160839700|NCT02688985|580799712|FG001|Overall Study|Pregnancy|0|||
160839701|NCT02688985|580799713|FG002|Overall Study|Pregnancy|2|||
160839702|NCT02688985|580799714|FG003|Overall Study|Pregnancy|1|||
160839703|NCT02688985|580799715|FG004|Overall Study|Pregnancy|0|||
160839704|NCT02688985|580799711|FG000|Overall Study|Study Terminated By Sponsor|0|||
160839705|NCT02688985|580799712|FG001|Overall Study|Study Terminated By Sponsor|0|||
160839706|NCT02688985|580799713|FG002|Overall Study|Study Terminated By Sponsor|0|||
160839707|NCT02688985|580799714|FG003|Overall Study|Study Terminated By Sponsor|1|||
160839708|NCT02688985|580799715|FG004|Overall Study|Study Terminated By Sponsor|0|||
160839709|NCT02688985|580799711|FG000|Overall Study|Withdrawal by Subject|2|||
160839710|NCT02688985|580799712|FG001|Overall Study|Withdrawal by Subject|8|||
160839711|NCT02688985|580799713|FG002|Overall Study|Withdrawal by Subject|7|||
160839712|NCT02688985|580799714|FG003|Overall Study|Withdrawal by Subject|1|||
160839713|NCT02688985|580799715|FG004|Overall Study|Withdrawal by Subject|4|||
160839714|NCT01964963|580799718|FG000|Overall Study|Case Report Forms Uncollected|888|||
160839715|NCT01964963|580799718|FG000|Overall Study|Protocol Deviation|50|||
160839716|NCT01964963|580799718|FG000|Overall Study|Data Reliability was not Assured|5|||
160839717|NCT00930553|580799719|FG000|Overall Study|Adverse Event|1|||
160839718|NCT00930553|580799719|FG000|Overall Study|Lack of Efficacy|7|||
160839719|NCT00930553|580799719|FG000|Overall Study|Physician Decision|39|||
160839720|NCT00930553|580799719|FG000|Overall Study|Protocol Violation|1|||
160839721|NCT00930553|580799719|FG000|Overall Study|Pregnancy|1|||
160839722|NCT00930553|580799719|FG000|Overall Study|Withdrawal by Subject|88|||
160839723|NCT00930553|580799719|FG000|Overall Study|Lost to Follow-up|25|||
160839724|NCT00930553|580799719|FG000|Overall Study|Death|9|||
160839725|NCT00930553|580799719|FG000|Overall Study|Study terminated by sponsor|24|||
160839726|NCT00930553|580799719|FG000|Overall Study|Other than specified above|28|||
160839727|NCT01726582|580799720|FG000|Overall Study|Physician Decision|99|||
160839728|NCT01726582|580799720|FG000|Overall Study|Death|85|||
160839729|NCT01235234|580799721|FG000|Overall Study|Adverse Event|2|||
160839730|NCT01235234|580799722|FG001|Overall Study|Adverse Event|2|||
160839731|NCT01235234|580799723|FG002|Overall Study|Adverse Event|1|||
160839732|NCT02630472|580799724|FG000|Overall Study|Physician Decision|10|||
160839733|NCT02630472|580799725|FG001|Overall Study|Physician Decision|0|||
160839734|NCT03704688|580799734|FG000|Overall Study|Adverse Event|0|||
160839735|NCT03704688|580799735|FG001|Overall Study|Adverse Event|0|||
160839736|NCT03704688|580799736|FG002|Overall Study|Adverse Event|0|||
160839737|NCT03704688|580799737|FG003|Overall Study|Adverse Event|4|||
160839738|NCT03704688|580799738|FG004|Overall Study|Adverse Event|1|||
160839739|NCT03704688|580799739|FG005|Overall Study|Adverse Event|0|||
160839740|NCT03704688|580799734|FG000|Overall Study|Disease Progression|0|||
160839741|NCT03704688|580799735|FG001|Overall Study|Disease Progression|0|||
160839742|NCT03704688|580799736|FG002|Overall Study|Disease Progression|0|||
160564136|NCT00364793|579786555|FG003|Overall Study|Lost to Follow-up|0|||
160564137|NCT00364793|579786552|FG000|Overall Study|Poor or non-compliance|1|||
160564138|NCT00364793|579786553|FG001|Overall Study|Poor or non-compliance|1|||
160564139|NCT00364793|579786554|FG002|Overall Study|Poor or non-compliance|0|||
160564140|NCT00364793|579786555|FG003|Overall Study|Poor or non-compliance|1|||
160564141|NCT00364793|579786552|FG000|Overall Study|No longer meets criteria|0|||
160564142|NCT00364793|579786553|FG001|Overall Study|No longer meets criteria|0|||
160564143|NCT00364793|579786554|FG002|Overall Study|No longer meets criteria|0|||
160564144|NCT00364793|579786555|FG003|Overall Study|No longer meets criteria|1|||
160564145|NCT00364793|579786552|FG000|Overall Study|Withdrawal by Subject|0|||
160564146|NCT00364793|579786553|FG001|Overall Study|Withdrawal by Subject|1|||
160839743|NCT03704688|580799737|FG003|Overall Study|Disease Progression|3|||
160839744|NCT03704688|580799738|FG004|Overall Study|Disease Progression|1|||
160839745|NCT03704688|580799739|FG005|Overall Study|Disease Progression|0|||
160839746|NCT03704688|580799734|FG000|Overall Study|Death|0|||
160839747|NCT03704688|580799735|FG001|Overall Study|Death|0|||
160839748|NCT03704688|580799736|FG002|Overall Study|Death|0|||
160839749|NCT03704688|580799737|FG003|Overall Study|Death|0|||
160839750|NCT03704688|580799738|FG004|Overall Study|Death|3|||
160839751|NCT03704688|580799739|FG005|Overall Study|Death|0|||
160564147|NCT00364793|579786554|FG002|Overall Study|Withdrawal by Subject|0|||
160564148|NCT00364793|579786555|FG003|Overall Study|Withdrawal by Subject|0|||
160564149|NCT02731742|579786560|FG000|Overall Study|Death|1|||
160564150|NCT02731742|579786561|FG001|Overall Study|Death|2|||
160564151|NCT02731742|579786562|FG002|Overall Study|Death|5|||
160564152|NCT02731742|579786563|FG003|Overall Study|Death|0|||
160564153|NCT02731742|579786560|FG000|Overall Study|Physician Decision|0|||
160564154|NCT02731742|579786561|FG001|Overall Study|Physician Decision|0|||
160564155|NCT02731742|579786562|FG002|Overall Study|Physician Decision|0|||
160564156|NCT02731742|579786563|FG003|Overall Study|Physician Decision|1|||
160564157|NCT02731742|579786560|FG000|Overall Study|Study Terminated by Sponsor|2|||
160564158|NCT02731742|579786561|FG001|Overall Study|Study Terminated by Sponsor|1|||
160564159|NCT02731742|579786562|FG002|Overall Study|Study Terminated by Sponsor|1|||
160564160|NCT02731742|579786563|FG003|Overall Study|Study Terminated by Sponsor|1|||
160564161|NCT01974323|579786564|FG000|Overall Study|Other Reasons|25|||
160564162|NCT01974323|579786565|FG001|Overall Study|Other Reasons|28|||
160564163|NCT01974323|579786564|FG000|Overall Study|Protocol Violation|2|||
160564164|NCT01974323|579786565|FG001|Overall Study|Protocol Violation|2|||
160564165|NCT01974323|579786564|FG000|Overall Study|Personal Reasons|15|||
160564166|NCT01974323|579786565|FG001|Overall Study|Personal Reasons|19|||
160564167|NCT01974323|579786564|FG000|Overall Study|Lost to Follow-up|45|||
160564168|NCT01974323|579786565|FG001|Overall Study|Lost to Follow-up|40|||
160564169|NCT01974323|579786564|FG000|Overall Study|Pregnancy|2|||
160564170|NCT01974323|579786565|FG001|Overall Study|Pregnancy|1|||
160564171|NCT01974323|579786564|FG000|Overall Study|Lack of Efficacy|1|||
160564172|NCT01974323|579786565|FG001|Overall Study|Lack of Efficacy|1|||
160564173|NCT01974323|579786564|FG000|Overall Study|Adverse Event|2|||
160564174|NCT01974323|579786565|FG001|Overall Study|Adverse Event|2|||
160564175|NCT03417440|579786569|FG000|Overall Study|Lost to Follow-up|0|||
160564176|NCT03417440|579786570|FG001|Overall Study|Lost to Follow-up|1|||
160564177|NCT03417440|579786571|FG002|Overall Study|Lost to Follow-up|0|||
160564178|NCT03417440|579786572|FG003|Overall Study|Lost to Follow-up|0|||
160564179|NCT03417440|579786573|FG004|Overall Study|Lost to Follow-up|1|||
160564180|NCT03417440|579786574|FG005|Overall Study|Lost to Follow-up|0|||
160991929|NCT04888585|581359932|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
160991930|NCT04888585|581359933|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
160991931|NCT04888585|581359934|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
160991932|NCT04888585|581359935|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
160991933|NCT04888585|581359936|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
160991934|NCT04888585|581359926|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
160991935|NCT04888585|581359927|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
160991936|NCT04888585|581359928|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
160991937|NCT04888585|581359929|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
160991938|NCT04888585|581359930|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
160991939|NCT04888585|581359931|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
160991940|NCT04888585|581359932|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
160991941|NCT04888585|581359933|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
160991942|NCT04888585|581359934|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
160991943|NCT04888585|581359935|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
160991944|NCT04888585|581359936|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
160564181|NCT03417440|579786575|FG006|Overall Study|Lost to Follow-up|0|||
160564182|NCT03417440|579786576|FG007|Overall Study|Lost to Follow-up|0|||
160564183|NCT03417440|579786569|FG000|Overall Study|Withdrawal by Subject|2|||
160564184|NCT03417440|579786570|FG001|Overall Study|Withdrawal by Subject|0|||
160564185|NCT03417440|579786571|FG002|Overall Study|Withdrawal by Subject|2|||
160564186|NCT03417440|579786572|FG003|Overall Study|Withdrawal by Subject|1|||
160564187|NCT03417440|579786573|FG004|Overall Study|Withdrawal by Subject|1|||
160564188|NCT03417440|579786574|FG005|Overall Study|Withdrawal by Subject|0|||
160564189|NCT03417440|579786575|FG006|Overall Study|Withdrawal by Subject|0|||
160564190|NCT03417440|579786576|FG007|Overall Study|Withdrawal by Subject|1|||
160991945|NCT04888585|581359926|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160564191|NCT02786901|579786577|FG000|Overall Study|Adverse Event|1|||
160564192|NCT02786901|579786578|FG001|Overall Study|Adverse Event|1|||
160564193|NCT02786901|579786579|FG002|Overall Study|Adverse Event|2|||
160991946|NCT04888585|581359927|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160991947|NCT04888585|581359928|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160564194|NCT02786901|579786577|FG000|Overall Study|Physician Decision|1|||
160839752|NCT00787189|580799741|FG000|Overall Study|Lost to Follow-up|2|||
160564195|NCT02786901|579786578|FG001|Overall Study|Physician Decision|0|||
160564196|NCT02786901|579786579|FG002|Overall Study|Physician Decision|0|||
160564197|NCT02786901|579786577|FG000|Overall Study|Rescue Therapy Use|71|||
160564198|NCT02786901|579786578|FG001|Overall Study|Rescue Therapy Use|49|||
160564199|NCT02786901|579786579|FG002|Overall Study|Rescue Therapy Use|33|||
160564200|NCT02786901|579786577|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
160564201|NCT02786901|579786578|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
160564202|NCT02786901|579786579|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
160564203|NCT02786901|579786577|FG000|Overall Study|Disallowed medication|1|||
160564204|NCT02786901|579786578|FG001|Overall Study|Disallowed medication|1|||
160564205|NCT02786901|579786579|FG002|Overall Study|Disallowed medication|0|||
160564206|NCT02786901|579786577|FG000|Overall Study|Randomized in error|2|||
160564207|NCT02786901|579786578|FG001|Overall Study|Randomized in error|0|||
160564208|NCT02786901|579786579|FG002|Overall Study|Randomized in error|1|||
160564209|NCT00316264|579786580|FG000|Overall Study|Lost to Follow-up|0|||
160564210|NCT00316264|579786581|FG001|Overall Study|Lost to Follow-up|1|||
160564211|NCT00316264|579786582|FG002|Overall Study|Lost to Follow-up|0|||
160564212|NCT00316264|579786580|FG000|Overall Study|Withdrawal of Consent|3|||
160564213|NCT00316264|579786581|FG001|Overall Study|Withdrawal of Consent|5|||
160564214|NCT00316264|579786582|FG002|Overall Study|Withdrawal of Consent|6|||
160564215|NCT00316264|579786580|FG000|Overall Study|Death|2|||
160839753|NCT00787189|580799742|FG001|Overall Study|Lost to Follow-up|2|||
160839754|NCT00847886|580799743|FG000|Overall Study|Adverse Event|0|||
160839755|NCT00847886|580799744|FG001|Overall Study|Adverse Event|1|||
160564216|NCT00316264|579786581|FG001|Overall Study|Death|0|||
160564217|NCT00316264|579786582|FG002|Overall Study|Death|0|||
160564218|NCT00316264|579786580|FG000|Overall Study|Other|1|||
160564219|NCT00316264|579786581|FG001|Overall Study|Other|1|||
160839756|NCT00413036|580799745|FG000|Overall Study|Adverse Event|44|||
160839757|NCT00413036|580799745|FG000|Overall Study|Lack of Efficacy|129|||
160839758|NCT00413036|580799745|FG000|Overall Study|Withdrawal by Subject|7|||
160564220|NCT00316264|579786582|FG002|Overall Study|Other|0|||
160564221|NCT00607048|579786583|FG000|Overall Study|Adverse Event|0|||
160564222|NCT00607048|579786584|FG001|Overall Study|Adverse Event|1|||
160564223|NCT00607048|579786585|FG002|Overall Study|Adverse Event|0|||
160564224|NCT00607048|579786586|FG003|Overall Study|Adverse Event|0|||
160564225|NCT00607048|579786587|FG004|Overall Study|Adverse Event|4|||
160564226|NCT00607048|579786588|FG005|Overall Study|Adverse Event|0|||
160564227|NCT00607048|579786583|FG000|Overall Study|Global deterioration of health|1|||
160564228|NCT00607048|579786584|FG001|Overall Study|Global deterioration of health|0|||
160564229|NCT00607048|579786585|FG002|Overall Study|Global deterioration of health|0|||
160564230|NCT00607048|579786586|FG003|Overall Study|Global deterioration of health|0|||
160564231|NCT00607048|579786587|FG004|Overall Study|Global deterioration of health|0|||
160564232|NCT00607048|579786588|FG005|Overall Study|Global deterioration of health|0|||
160564233|NCT00607048|579786583|FG000|Overall Study|Objective disease progression - relapse|1|||
160564234|NCT00607048|579786584|FG001|Overall Study|Objective disease progression - relapse|2|||
160564235|NCT00607048|579786585|FG002|Overall Study|Objective disease progression - relapse|4|||
160564236|NCT00607048|579786586|FG003|Overall Study|Objective disease progression - relapse|2|||
160564237|NCT00607048|579786587|FG004|Overall Study|Objective disease progression - relapse|2|||
160839759|NCT00413036|580799745|FG000|Overall Study|Death|9|||
160839760|NCT00413036|580799745|FG000|Overall Study|Other|26|||
160839761|NCT00413036|580799745|FG000|Overall Study|Missing|2|||
160839762|NCT00183625|580799746|FG000|Overall Study|Withdrawal by Subject|18|||
160839763|NCT00183625|580799747|FG001|Overall Study|Withdrawal by Subject|18|||
160839764|NCT00183625|580799748|FG002|Overall Study|Withdrawal by Subject|19|||
160839765|NCT00183625|580799749|FG003|Overall Study|Withdrawal by Subject|14|||
160839766|NCT02524158|580799750|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
160839767|NCT02524158|580799751|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
160839768|NCT02524158|580799750|FG000|12-weeks Assessment|Lost to Follow-up|18|||
160839769|NCT02524158|580799751|FG001|12-weeks Assessment|Lost to Follow-up|12|||
160839770|NCT02524158|580799750|FG000|6-month Assessment|Withdrawal by Subject|1|||
160839771|NCT02524158|580799751|FG001|6-month Assessment|Withdrawal by Subject|1|||
160839772|NCT02524158|580799750|FG000|6-month Assessment|Lost to Follow-up|21|||
160839773|NCT02524158|580799751|FG001|6-month Assessment|Lost to Follow-up|20|||
160839774|NCT00887926|580799752|FG000|Overall Study|Withdrawal by Subject|0|||
160839775|NCT00887926|580799753|FG001|Overall Study|Withdrawal by Subject|1|||
160839776|NCT00887926|580799754|FG002|Overall Study|Withdrawal by Subject|0|||
160839777|NCT00887926|580799755|FG003|Overall Study|Withdrawal by Subject|0|||
160839778|NCT01110382|580799756|FG000|Overall Study|Withdrawal by Subject|0|||
160839779|NCT01110382|580799757|FG001|Overall Study|Withdrawal by Subject|1|||
160564238|NCT00607048|579786588|FG005|Overall Study|Objective disease progression - relapse|2|||
160839780|NCT01110382|580799756|FG000|Overall Study|Protocol Violation|0|||
160839781|NCT01110382|580799757|FG001|Overall Study|Protocol Violation|1|||
160839782|NCT00098306|580799758|FG000|Double Blind|Randomized, not treated|9|||
160839783|NCT00098306|580799759|FG001|Double Blind|Randomized, not treated|5|||
160839784|NCT00098306|580799760|FG002|Double Blind|Randomized, not treated|2|||
160839785|NCT00098306|580799761|FG003|Double Blind|Randomized, not treated|0|||
160564239|NCT00607048|579786583|FG000|Overall Study|Withdrawal by Subject|0|||
160564240|NCT00607048|579786584|FG001|Overall Study|Withdrawal by Subject|0|||
160564241|NCT00607048|579786585|FG002|Overall Study|Withdrawal by Subject|0|||
160564242|NCT00607048|579786586|FG003|Overall Study|Withdrawal by Subject|1|||
160564243|NCT00607048|579786587|FG004|Overall Study|Withdrawal by Subject|0|||
160564244|NCT00607048|579786588|FG005|Overall Study|Withdrawal by Subject|2|||
160564245|NCT00607048|579786583|FG000|Overall Study|Other|1|||
160839786|NCT00098306|580799762|FG004|Double Blind|Randomized, not treated|0|||
160839787|NCT00098306|580799763|FG005|Double Blind|Randomized, not treated|0|||
160839788|NCT00098306|580799764|FG006|Double Blind|Randomized, not treated|0|||
160839789|NCT00098306|580799758|FG000|Double Blind|Ongoing at cut-off date|151|||
160839790|NCT00098306|580799759|FG001|Double Blind|Ongoing at cut-off date|166|||
160839791|NCT00098306|580799760|FG002|Double Blind|Ongoing at cut-off date|72|||
160839792|NCT00098306|580799761|FG003|Double Blind|Ongoing at cut-off date|0|||
160839793|NCT00098306|580799762|FG004|Double Blind|Ongoing at cut-off date|0|||
160839794|NCT00098306|580799763|FG005|Double Blind|Ongoing at cut-off date|0|||
160839795|NCT00098306|580799764|FG006|Double Blind|Ongoing at cut-off date|0|||
160839796|NCT00098306|580799758|FG000|Double Blind|Adverse Event|11|||
160839797|NCT00098306|580799759|FG001|Double Blind|Adverse Event|10|||
160839798|NCT00098306|580799760|FG002|Double Blind|Adverse Event|6|||
160839799|NCT00098306|580799761|FG003|Double Blind|Adverse Event|0|||
160839800|NCT00098306|580799762|FG004|Double Blind|Adverse Event|0|||
160839801|NCT00098306|580799763|FG005|Double Blind|Adverse Event|0|||
160905078|NCT00939770|581046418|FG002|Overall Study|Lack of Efficacy|13|||
160905079|NCT00939770|581046419|FG003|Overall Study|Lack of Efficacy|9|||
160905080|NCT00939770|581046420|FG004|Overall Study|Lack of Efficacy|16|||
160905081|NCT00939770|581046421|FG005|Overall Study|Lack of Efficacy|8|||
160905082|NCT00939770|581046422|FG006|Overall Study|Lack of Efficacy|11|||
160905083|NCT00939770|581046423|FG007|Overall Study|Lack of Efficacy|1|||
160905084|NCT00939770|581046416|FG000|Overall Study|Lost to Follow-up|0|||
160905085|NCT00939770|581046417|FG001|Overall Study|Lost to Follow-up|0|||
160905086|NCT00939770|581046418|FG002|Overall Study|Lost to Follow-up|0|||
160905087|NCT00939770|581046419|FG003|Overall Study|Lost to Follow-up|0|||
160905088|NCT00939770|581046420|FG004|Overall Study|Lost to Follow-up|1|||
160905089|NCT00939770|581046421|FG005|Overall Study|Lost to Follow-up|0|||
160905090|NCT00939770|581046422|FG006|Overall Study|Lost to Follow-up|0|||
160905091|NCT00939770|581046423|FG007|Overall Study|Lost to Follow-up|0|||
160905092|NCT00939770|581046416|FG000|Overall Study|Physician Decision|0|||
160905093|NCT00939770|581046417|FG001|Overall Study|Physician Decision|0|||
160905094|NCT00939770|581046418|FG002|Overall Study|Physician Decision|2|||
160905095|NCT00939770|581046419|FG003|Overall Study|Physician Decision|0|||
160905096|NCT00939770|581046420|FG004|Overall Study|Physician Decision|7|||
160905097|NCT00939770|581046421|FG005|Overall Study|Physician Decision|1|||
160905098|NCT00939770|581046422|FG006|Overall Study|Physician Decision|0|||
160905099|NCT00939770|581046423|FG007|Overall Study|Physician Decision|6|||
160905100|NCT00939770|581046416|FG000|Overall Study|Protocol Violation|0|||
160905101|NCT00939770|581046417|FG001|Overall Study|Protocol Violation|0|||
160905102|NCT00939770|581046418|FG002|Overall Study|Protocol Violation|0|||
160905103|NCT00939770|581046419|FG003|Overall Study|Protocol Violation|0|||
160905104|NCT00939770|581046420|FG004|Overall Study|Protocol Violation|1|||
160905105|NCT00939770|581046421|FG005|Overall Study|Protocol Violation|0|||
160905106|NCT00939770|581046422|FG006|Overall Study|Protocol Violation|0|||
160905107|NCT00939770|581046423|FG007|Overall Study|Protocol Violation|0|||
160905108|NCT00939770|581046416|FG000|Overall Study|Withdrawal by Subject|0|||
160905109|NCT00939770|581046417|FG001|Overall Study|Withdrawal by Subject|1|||
160905110|NCT00939770|581046418|FG002|Overall Study|Withdrawal by Subject|5|||
160905111|NCT00939770|581046419|FG003|Overall Study|Withdrawal by Subject|2|||
160905112|NCT00939770|581046420|FG004|Overall Study|Withdrawal by Subject|6|||
160905113|NCT00939770|581046421|FG005|Overall Study|Withdrawal by Subject|0|||
160905114|NCT00939770|581046422|FG006|Overall Study|Withdrawal by Subject|2|||
160905115|NCT00939770|581046423|FG007|Overall Study|Withdrawal by Subject|2|||
160905116|NCT04665856|581046424|FG000|Overall Study|Site Terminated by Sponsor|1|||
160905117|NCT04665856|581046425|FG001|Overall Study|Site Terminated by Sponsor|0|||
160905118|NCT04665856|581046424|FG000|Overall Study|Withdrawal by Subject|2|||
160905119|NCT04665856|581046425|FG001|Overall Study|Withdrawal by Subject|0|||
160905120|NCT04665856|581046424|FG000|Overall Study|Lost to Follow-up|3|||
160905121|NCT04665856|581046425|FG001|Overall Study|Lost to Follow-up|2|||
160905122|NCT04665856|581046424|FG000|Overall Study|Death|39|||
160905123|NCT04665856|581046425|FG001|Overall Study|Death|44|||
160905124|NCT04665856|581046424|FG000|Overall Study|Ongoing in study|17|||
160905125|NCT04665856|581046425|FG001|Overall Study|Ongoing in study|15|||
160905126|NCT03386448|581046426|FG000|Overall Study|Adverse Event|0|||
160905127|NCT03386448|581046427|FG001|Overall Study|Adverse Event|2|||
160905128|NCT01146665|581046428|FG000|Overall Study|Withdrawal by Subject|10|||
160905129|NCT01146665|581046429|FG001|Overall Study|Withdrawal by Subject|16|||
160905130|NCT00001880|581046430|FG000|Overall Study|Death|14|||
160905131|NCT02639065|581046431|FG000|Study Treatment|Disease Progression|13|||
160564246|NCT00607048|579786584|FG001|Overall Study|Other|1|||
160839802|NCT00098306|580799764|FG006|Double Blind|Adverse Event|0|||
160839803|NCT00098306|580799758|FG000|Double Blind|Lack of Efficacy|43|||
160839804|NCT00098306|580799759|FG001|Double Blind|Lack of Efficacy|34|||
160839805|NCT00098306|580799760|FG002|Double Blind|Lack of Efficacy|17|||
160839806|NCT00098306|580799761|FG003|Double Blind|Lack of Efficacy|0|||
160839807|NCT00098306|580799762|FG004|Double Blind|Lack of Efficacy|0|||
160839808|NCT00098306|580799763|FG005|Double Blind|Lack of Efficacy|0|||
160839809|NCT00098306|580799764|FG006|Double Blind|Lack of Efficacy|0|||
160839810|NCT00098306|580799758|FG000|Double Blind|Death|1|||
160839811|NCT00098306|580799759|FG001|Double Blind|Death|4|||
160564247|NCT00607048|579786585|FG002|Overall Study|Other|0|||
160564248|NCT00607048|579786586|FG003|Overall Study|Other|0|||
160564249|NCT00607048|579786587|FG004|Overall Study|Other|0|||
160564250|NCT00607048|579786588|FG005|Overall Study|Other|1|||
160564251|NCT00466505|579786589|FG000|Overall Study|disease progression|13|||
160839812|NCT00098306|580799760|FG002|Double Blind|Death|1|||
160839813|NCT00098306|580799761|FG003|Double Blind|Death|0|||
160839814|NCT00098306|580799762|FG004|Double Blind|Death|0|||
160839815|NCT00098306|580799763|FG005|Double Blind|Death|0|||
160839816|NCT00098306|580799764|FG006|Double Blind|Death|0|||
160839817|NCT00098306|580799758|FG000|Double Blind|Participant defaulted|19|||
160839818|NCT00098306|580799759|FG001|Double Blind|Participant defaulted|18|||
160839819|NCT00098306|580799760|FG002|Double Blind|Participant defaulted|11|||
160839820|NCT00098306|580799761|FG003|Double Blind|Participant defaulted|0|||
160839821|NCT00098306|580799762|FG004|Double Blind|Participant defaulted|0|||
160839822|NCT00098306|580799763|FG005|Double Blind|Participant defaulted|0|||
160839823|NCT00098306|580799764|FG006|Double Blind|Participant defaulted|0|||
160839824|NCT00098306|580799758|FG000|Double Blind|Un-specified|7|||
160839825|NCT00098306|580799759|FG001|Double Blind|Un-specified|3|||
160839826|NCT00098306|580799760|FG002|Double Blind|Un-specified|11|||
160839827|NCT00098306|580799761|FG003|Double Blind|Un-specified|0|||
160839828|NCT00098306|580799762|FG004|Double Blind|Un-specified|0|||
160839829|NCT00098306|580799763|FG005|Double Blind|Un-specified|0|||
160839830|NCT00098306|580799764|FG006|Double Blind|Un-specified|0|||
160839831|NCT00098306|580799758|FG000|Open Label|Lack of Efficacy|0|||
160839832|NCT00098306|580799759|FG001|Open Label|Lack of Efficacy|0|||
160839833|NCT00098306|580799760|FG002|Open Label|Lack of Efficacy|0|||
160839834|NCT00098306|580799761|FG003|Open Label|Lack of Efficacy|13|||
160839835|NCT00098306|580799762|FG004|Open Label|Lack of Efficacy|0|||
160839836|NCT00098306|580799763|FG005|Open Label|Lack of Efficacy|0|||
160839837|NCT00098306|580799764|FG006|Open Label|Lack of Efficacy|0|||
160839838|NCT00098306|580799758|FG000|Open Label|Adverse Event|0|||
160839839|NCT00098306|580799759|FG001|Open Label|Adverse Event|0|||
160839840|NCT00098306|580799760|FG002|Open Label|Adverse Event|0|||
160839841|NCT00098306|580799761|FG003|Open Label|Adverse Event|2|||
160839842|NCT00098306|580799762|FG004|Open Label|Adverse Event|0|||
160839843|NCT00098306|580799763|FG005|Open Label|Adverse Event|0|||
160839844|NCT00098306|580799764|FG006|Open Label|Adverse Event|0|||
160839845|NCT00098306|580799758|FG000|Open Label|Death|0|||
160839846|NCT00098306|580799759|FG001|Open Label|Death|0|||
160839847|NCT00098306|580799760|FG002|Open Label|Death|0|||
160839848|NCT00098306|580799761|FG003|Open Label|Death|4|||
160839849|NCT00098306|580799762|FG004|Open Label|Death|0|||
160839850|NCT00098306|580799763|FG005|Open Label|Death|0|||
160839851|NCT00098306|580799764|FG006|Open Label|Death|0|||
160839852|NCT00098306|580799758|FG000|Open Label|Participant defaulted|0|||
160839853|NCT00098306|580799759|FG001|Open Label|Participant defaulted|0|||
160839854|NCT00098306|580799760|FG002|Open Label|Participant defaulted|0|||
160839855|NCT00098306|580799761|FG003|Open Label|Participant defaulted|24|||
160839856|NCT00098306|580799762|FG004|Open Label|Participant defaulted|0|||
160564252|NCT00466505|579786589|FG000|Overall Study|Adverse Event|4|||
160564253|NCT00699192|579786590|FG000|Overall Study|Missing|1|||
160564254|NCT00699192|579786591|FG001|Overall Study|Missing|1|||
160564255|NCT00699192|579786592|FG002|Overall Study|Missing|1|||
160647695|NCT05002569|580092809|FG000|Randomized|Withdrew Consent|3|||
160839857|NCT00098306|580799763|FG005|Open Label|Participant defaulted|0|||
160839858|NCT00098306|580799764|FG006|Open Label|Participant defaulted|0|||
160839859|NCT00098306|580799758|FG000|Open Label|Un-specified|0|||
160839860|NCT00098306|580799759|FG001|Open Label|Un-specified|0|||
160839861|NCT00098306|580799760|FG002|Open Label|Un-specified|0|||
160839862|NCT00098306|580799761|FG003|Open Label|Un-specified|15|||
160839863|NCT00098306|580799762|FG004|Open Label|Un-specified|0|||
160839864|NCT00098306|580799763|FG005|Open Label|Un-specified|0|||
160839865|NCT00098306|580799764|FG006|Open Label|Un-specified|0|||
160839866|NCT00098306|580799758|FG000|Open Label|Ongoing at cut-off date|0|||
160839867|NCT00098306|580799759|FG001|Open Label|Ongoing at cut-off date|0|||
160564256|NCT00699192|579786590|FG000|Overall Study|Adverse Event|9|||
160839868|NCT00098306|580799760|FG002|Open Label|Ongoing at cut-off date|0|||
160839869|NCT00098306|580799761|FG003|Open Label|Ongoing at cut-off date|269|||
160839870|NCT00098306|580799762|FG004|Open Label|Ongoing at cut-off date|62|||
160839871|NCT00098306|580799763|FG005|Open Label|Ongoing at cut-off date|0|||
160839872|NCT00098306|580799764|FG006|Open Label|Ongoing at cut-off date|0|||
160839873|NCT00098306|580799758|FG000|Observational Phase|Death|0|||
160564257|NCT00699192|579786591|FG001|Overall Study|Adverse Event|4|||
160564258|NCT00699192|579786592|FG002|Overall Study|Adverse Event|3|||
160564259|NCT00699192|579786590|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160564260|NCT00699192|579786591|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160564261|NCT00699192|579786592|FG002|Overall Study|Abnormal test procedure result(s)|1|||
160564262|NCT00699192|579786590|FG000|Overall Study|Lack of Efficacy|0|||
160564263|NCT00699192|579786591|FG001|Overall Study|Lack of Efficacy|0|||
160564264|NCT00699192|579786592|FG002|Overall Study|Lack of Efficacy|1|||
160564265|NCT00699192|579786590|FG000|Overall Study|Withdrawal by Subject|3|||
160564266|NCT00699192|579786591|FG001|Overall Study|Withdrawal by Subject|2|||
160564267|NCT00699192|579786592|FG002|Overall Study|Withdrawal by Subject|4|||
160564268|NCT00699192|579786590|FG000|Overall Study|Administrative problems|1|||
160564269|NCT00699192|579786591|FG001|Overall Study|Administrative problems|3|||
160564270|NCT00699192|579786592|FG002|Overall Study|Administrative problems|1|||
160564271|NCT00699192|579786590|FG000|Overall Study|Protocol Violation|2|||
160564272|NCT00699192|579786591|FG001|Overall Study|Protocol Violation|2|||
160564273|NCT00699192|579786592|FG002|Overall Study|Protocol Violation|0|||
160564274|NCT01451645|579786593|FG000|Overall Study|Protocol Violation|1|||
160564275|NCT01451645|579786594|FG001|Overall Study|Protocol Violation|0|||
160564276|NCT01451645|579786593|FG000|Overall Study|Adverse Event|0|||
160564277|NCT01451645|579786594|FG001|Overall Study|Adverse Event|3|||
160564278|NCT01451645|579786593|FG000|Overall Study|Withdrawal by Subject|4|||
160564279|NCT01451645|579786594|FG001|Overall Study|Withdrawal by Subject|2|||
160564280|NCT01451645|579786593|FG000|Overall Study|Lost to Follow-up|4|||
160564281|NCT01451645|579786594|FG001|Overall Study|Lost to Follow-up|3|||
160564282|NCT02620020|579786604|FG000|Overall Study|Adverse Event|8|||
160564283|NCT02620020|579786605|FG001|Overall Study|Adverse Event|4|||
160564284|NCT02620020|579786606|FG002|Overall Study|Adverse Event|3|||
160564285|NCT02620020|579786607|FG003|Overall Study|Adverse Event|5|||
160564286|NCT02620020|579786604|FG000|Overall Study|Lost to Follow-up|4|||
160564287|NCT02620020|579786605|FG001|Overall Study|Lost to Follow-up|8|||
160564288|NCT02620020|579786606|FG002|Overall Study|Lost to Follow-up|1|||
160564289|NCT02620020|579786607|FG003|Overall Study|Lost to Follow-up|4|||
160564290|NCT02620020|579786604|FG000|Overall Study|Physician Decision|7|||
160564291|NCT02620020|579786605|FG001|Overall Study|Physician Decision|4|||
160564292|NCT02620020|579786606|FG002|Overall Study|Physician Decision|3|||
160564293|NCT02620020|579786607|FG003|Overall Study|Physician Decision|4|||
160564294|NCT02620020|579786604|FG000|Overall Study|Protocol Violation|5|||
160564295|NCT02620020|579786605|FG001|Overall Study|Protocol Violation|2|||
160564296|NCT02620020|579786606|FG002|Overall Study|Protocol Violation|1|||
160564297|NCT02620020|579786607|FG003|Overall Study|Protocol Violation|1|||
160564298|NCT02620020|579786604|FG000|Overall Study|Withdrawal by Subject|20|||
160564299|NCT02620020|579786605|FG001|Overall Study|Withdrawal by Subject|16|||
160564300|NCT02620020|579786606|FG002|Overall Study|Withdrawal by Subject|17|||
160564301|NCT02620020|579786607|FG003|Overall Study|Withdrawal by Subject|12|||
160564302|NCT02620020|579786604|FG000|Overall Study|Death|0|||
160564303|NCT02620020|579786605|FG001|Overall Study|Death|1|||
160564304|NCT02620020|579786606|FG002|Overall Study|Death|0|||
160564305|NCT02620020|579786607|FG003|Overall Study|Death|0|||
160564306|NCT02209506|579786609|FG000|Overall Study|Withdrawal by Subject|0|||
160564307|NCT02209506|579786610|FG001|Overall Study|Withdrawal by Subject|0|||
160564308|NCT02209506|579786611|FG002|Overall Study|Withdrawal by Subject|0|||
160564309|NCT02209506|579786612|FG003|Overall Study|Withdrawal by Subject|0|||
160564310|NCT02209506|579786613|FG004|Overall Study|Withdrawal by Subject|1|||
160564311|NCT00098787|579786614|FG000|Overall Study|Never started treatment|3|||
160564312|NCT00098787|579786615|FG001|Overall Study|Never started treatment|2|||
160564313|NCT00098787|579786616|FG002|Overall Study|Never started treatment|1|||
160564314|NCT00098787|579786614|FG000|Overall Study|Ineligible|9|||
160564315|NCT00098787|579786615|FG001|Overall Study|Ineligible|7|||
160564316|NCT00098787|579786616|FG002|Overall Study|Ineligible|3|||
160564317|NCT00098787|579786614|FG000|Overall Study|Disease progression|28|||
160647696|NCT05002569|580092810|FG001|Randomized|Withdrew Consent|0|||
160647697|NCT05002569|580092809|FG000|Randomized|No longer meets study criteria|0|||
160564318|NCT00098787|579786615|FG001|Overall Study|Disease progression|17|||
160564319|NCT00098787|579786616|FG002|Overall Study|Disease progression|23|||
160564320|NCT00098787|579786614|FG000|Overall Study|Adverse Event|8|||
160564321|NCT00098787|579786615|FG001|Overall Study|Adverse Event|17|||
160564322|NCT00098787|579786616|FG002|Overall Study|Adverse Event|8|||
160564323|NCT00098787|579786614|FG000|Overall Study|Death|6|||
160564324|NCT00098787|579786615|FG001|Overall Study|Death|1|||
160564325|NCT00098787|579786616|FG002|Overall Study|Death|0|||
160564326|NCT00098787|579786614|FG000|Overall Study|Withdrawal by Subject|4|||
160564327|NCT00098787|579786615|FG001|Overall Study|Withdrawal by Subject|12|||
160564328|NCT00098787|579786616|FG002|Overall Study|Withdrawal by Subject|6|||
160564329|NCT00098787|579786614|FG000|Overall Study|Alternative therapy|8|||
160564330|NCT00098787|579786615|FG001|Overall Study|Alternative therapy|13|||
160564331|NCT00098787|579786616|FG002|Overall Study|Alternative therapy|13|||
160564332|NCT00098787|579786614|FG000|Overall Study|Other|7|||
160564333|NCT00098787|579786615|FG001|Overall Study|Other|6|||
160564334|NCT00098787|579786616|FG002|Overall Study|Other|9|||
160839874|NCT00098306|580799759|FG001|Observational Phase|Death|0|||
160839875|NCT00098306|580799760|FG002|Observational Phase|Death|0|||
160839876|NCT00098306|580799761|FG003|Observational Phase|Death|0|||
160839877|NCT00098306|580799762|FG004|Observational Phase|Death|0|||
160839878|NCT00098306|580799763|FG005|Observational Phase|Death|5|||
160839879|NCT00098306|580799764|FG006|Observational Phase|Death|4|||
160839880|NCT00098306|580799758|FG000|Observational Phase|Participant defaulted|0|||
160839881|NCT00098306|580799759|FG001|Observational Phase|Participant defaulted|0|||
160839882|NCT00098306|580799760|FG002|Observational Phase|Participant defaulted|0|||
160839883|NCT00098306|580799761|FG003|Observational Phase|Participant defaulted|0|||
160839884|NCT00098306|580799762|FG004|Observational Phase|Participant defaulted|0|||
160839885|NCT00098306|580799763|FG005|Observational Phase|Participant defaulted|34|||
160839886|NCT00098306|580799764|FG006|Observational Phase|Participant defaulted|18|||
160839887|NCT00098306|580799758|FG000|Observational Phase|Un-specified|0|||
160839888|NCT00098306|580799759|FG001|Observational Phase|Un-specified|0|||
160839889|NCT00098306|580799760|FG002|Observational Phase|Un-specified|0|||
160839890|NCT00098306|580799761|FG003|Observational Phase|Un-specified|0|||
160839891|NCT00098306|580799762|FG004|Observational Phase|Un-specified|0|||
160839892|NCT00098306|580799763|FG005|Observational Phase|Un-specified|7|||
160839893|NCT00098306|580799764|FG006|Observational Phase|Un-specified|4|||
160839894|NCT00077649|580799765|FG000|Overall Study|Adverse Event|5|||
160839895|NCT00077649|580799766|FG001|Overall Study|Adverse Event|1|||
160839896|NCT00077649|580799767|FG002|Overall Study|Adverse Event|7|||
160839897|NCT00077649|580799768|FG003|Overall Study|Adverse Event|9|||
160839898|NCT00077649|580799765|FG000|Overall Study|Lack of Efficacy|5|||
160839899|NCT00077649|580799766|FG001|Overall Study|Lack of Efficacy|3|||
160839900|NCT00077649|580799767|FG002|Overall Study|Lack of Efficacy|3|||
160839901|NCT00077649|580799768|FG003|Overall Study|Lack of Efficacy|2|||
160839902|NCT00077649|580799765|FG000|Overall Study|Withdrawal by Subject|0|||
160839903|NCT00077649|580799766|FG001|Overall Study|Withdrawal by Subject|1|||
160839904|NCT00077649|580799767|FG002|Overall Study|Withdrawal by Subject|1|||
160839905|NCT00077649|580799768|FG003|Overall Study|Withdrawal by Subject|2|||
160839906|NCT00077649|580799765|FG000|Overall Study|Lost to Follow-up|2|||
160905132|NCT02639065|581046431|FG000|Study Treatment|Adverse Event|9|||
160905133|NCT02639065|581046431|FG000|Study Treatment|Withdrawal by Subject|1|||
160839907|NCT00077649|580799766|FG001|Overall Study|Lost to Follow-up|2|||
160839908|NCT00077649|580799767|FG002|Overall Study|Lost to Follow-up|3|||
160905134|NCT02639065|581046431|FG000|Follow up|Subject refused to follow up|1|||
160905135|NCT02639065|581046431|FG000|Follow up|Symptomatic Deterioration|2|||
160905136|NCT02639065|581046431|FG000|Follow up|Death|2|||
160905137|NCT02639065|581046431|FG000|Follow up|Study Terminated|1|||
160905138|NCT02639065|581046431|FG000|Follow up|Disease Progression|3|||
160905139|NCT00674700|581048126|FG000|Year 1|Adverse Event|17|||
160905140|NCT00674700|581048127|FG001|Year 1|Adverse Event|20|||
160905141|NCT00674700|581048128|FG002|Year 1|Adverse Event|5|||
160905142|NCT00674700|581048126|FG000|Year 1|Withdrawal by Subject|7|||
160905143|NCT00674700|581048127|FG001|Year 1|Withdrawal by Subject|7|||
160905144|NCT00674700|581048128|FG002|Year 1|Withdrawal by Subject|6|||
160905145|NCT00674700|581048126|FG000|Year 1|Any other reason not above-mentioned|7|||
160905146|NCT00674700|581048127|FG001|Year 1|Any other reason not above-mentioned|7|||
160905147|NCT00674700|581048128|FG002|Year 1|Any other reason not above-mentioned|6|||
160905148|NCT00674700|581048126|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
160905149|NCT00674700|581048127|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
160905150|NCT00674700|581048128|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
160905151|NCT00674700|581048126|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
160905152|NCT00674700|581048127|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
160905153|NCT00674700|581048128|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
160905154|NCT00674700|581048126|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
160905155|NCT00674700|581048127|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
160905156|NCT00674700|581048128|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
160905157|NCT02954237|581048129|FG000|Overall Study|Withdrawal by Subject|25|||
160905158|NCT02954237|581048129|FG000|Overall Study|Missed visit|16|||
160905159|NCT02954237|581048129|FG000|Overall Study|Death|2|||
160905160|NCT00621985|581048140|FG000|Dexamethasone Admission|Adverse Event|1|||
160839909|NCT00077649|580799768|FG003|Overall Study|Lost to Follow-up|2|||
160839910|NCT00077649|580799765|FG000|Overall Study|Abnormality of Laboratory Test|1|||
160905161|NCT03068130|581048143|FG000|Overall Study|Adverse Event|19|||
160905162|NCT03068130|581048143|FG000|Overall Study|Death|14|||
160905163|NCT03068130|581048143|FG000|Overall Study|Lost to Follow-up|4|||
160839911|NCT00077649|580799766|FG001|Overall Study|Abnormality of Laboratory Test|2|||
160839912|NCT00077649|580799767|FG002|Overall Study|Abnormality of Laboratory Test|1|||
160839913|NCT00077649|580799768|FG003|Overall Study|Abnormality of Laboratory Test|2|||
160839914|NCT00077649|580799765|FG000|Overall Study|Randomized but never dosed|1|||
160839915|NCT00077649|580799766|FG001|Overall Study|Randomized but never dosed|0|||
160905164|NCT03068130|581048143|FG000|Overall Study|Withdrawal by Subject|26|||
160905165|NCT03068130|581048143|FG000|Overall Study|Administrative Reasons|3|||
160905166|NCT03068130|581048143|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
160564335|NCT00684814|579786617|FG000|Washout Period of 7 Days|Adverse Event|1|||
160839916|NCT00077649|580799767|FG002|Overall Study|Randomized but never dosed|0|||
160839917|NCT00077649|580799768|FG003|Overall Study|Randomized but never dosed|0|||
160839918|NCT00293020|580799771|FG000|Overall Study|Withdrawal by Subject|34|||
160839919|NCT00293020|580799771|FG000|Overall Study|Adverse Event|30|||
160839920|NCT00293020|580799771|FG000|Overall Study|Death|32|||
160839921|NCT00293020|580799771|FG000|Overall Study|Lack of Efficacy|12|||
160839922|NCT00293020|580799771|FG000|Overall Study|Lost to Follow-up|4|||
160839923|NCT00293020|580799771|FG000|Overall Study|Protocol Violation|6|||
160839924|NCT00293020|580799771|FG000|Overall Study|Physician Decision|21|||
160839925|NCT00293020|580799771|FG000|Overall Study|Other Reason|22|||
160839926|NCT00293020|580799771|FG000|Overall Study|No dose taken|1|||
160839927|NCT01336023|580799772|FG000|Week 0 to Week 26|Adverse Event|8|||
160839928|NCT01336023|580799773|FG001|Week 0 to Week 26|Adverse Event|10|||
160839929|NCT01336023|580799774|FG002|Week 0 to Week 26|Adverse Event|24|||
160839930|NCT01336023|580799772|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
160839931|NCT01336023|580799773|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
160839932|NCT01336023|580799774|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
160839933|NCT01336023|580799772|FG000|Week 0 to Week 26|Protocol Violation|1|||
160839934|NCT01336023|580799773|FG001|Week 0 to Week 26|Protocol Violation|2|||
160839935|NCT01336023|580799774|FG002|Week 0 to Week 26|Protocol Violation|0|||
160839936|NCT01336023|580799772|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
160839937|NCT01336023|580799773|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
160839938|NCT01336023|580799774|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
160839939|NCT01336023|580799772|FG000|Week 0 to Week 26|Unclassified|5|||
160839940|NCT01336023|580799773|FG001|Week 0 to Week 26|Unclassified|16|||
160839941|NCT01336023|580799774|FG002|Week 0 to Week 26|Unclassified|9|||
160839942|NCT01336023|580799772|FG000|Week 27 to 52|Adverse Event|1|||
160839943|NCT01336023|580799773|FG001|Week 27 to 52|Adverse Event|5|||
160839944|NCT01336023|580799774|FG002|Week 27 to 52|Adverse Event|2|||
160839945|NCT01336023|580799772|FG000|Week 27 to 52|Protocol Violation|0|||
160839946|NCT01336023|580799773|FG001|Week 27 to 52|Protocol Violation|2|||
160839947|NCT01336023|580799774|FG002|Week 27 to 52|Protocol Violation|1|||
160839948|NCT01336023|580799772|FG000|Week 27 to 52|Withdrawal Criteria|14|||
160839949|NCT01336023|580799773|FG001|Week 27 to 52|Withdrawal Criteria|19|||
160839950|NCT01336023|580799774|FG002|Week 27 to 52|Withdrawal Criteria|16|||
160839951|NCT01336023|580799772|FG000|Week 27 to 52|Unclassified|13|||
160839952|NCT01336023|580799773|FG001|Week 27 to 52|Unclassified|18|||
160839953|NCT01336023|580799774|FG002|Week 27 to 52|Unclassified|9|||
160839954|NCT04058886|580799779|FG000|Overall Study|Withdrawal by Subject|4|||
160839955|NCT04058886|580799779|FG000|Overall Study|Inadequate deafness interpreter service|1|||
160839956|NCT00699335|580799785|FG000|Overall Study|Combination of multiple reasons|176|||
160839957|NCT00699335|580799785|FG000|Overall Study|Missing data|52|||
160839958|NCT03043651|580799786|FG000|Overall Study|Death|1|||
160839959|NCT03043651|580799786|FG000|Overall Study|Progressive Disease|2|||
160839960|NCT03043651|580799786|FG000|Overall Study|Adverse Event|2|||
160839961|NCT03043651|580799786|FG000|Overall Study|Withdrawal by Subject|4|||
160839962|NCT03043651|580799786|FG000|Overall Study|Study Terminated by Sponsor|39|||
160839963|NCT02974842|580799787|FG000|Overall Study|Withdrawal by Subject|4|||
160839964|NCT02974842|580799787|FG000|Overall Study|Screen failures|4|||
160839965|NCT01959243|580799788|FG000|Overall Study|Investigator Decision|3|||
160839966|NCT01959243|580799789|FG001|Overall Study|Investigator Decision|0|||
160839967|NCT01959243|580799788|FG000|Overall Study|Adverse Event|5|||
160839968|NCT01959243|580799789|FG001|Overall Study|Adverse Event|2|||
160839969|NCT01959243|580799788|FG000|Overall Study|Administrative reasons|2|||
160839970|NCT01959243|580799789|FG001|Overall Study|Administrative reasons|1|||
160839971|NCT01959243|580799788|FG000|Overall Study|Lost to Follow-up|3|||
160839972|NCT01959243|580799789|FG001|Overall Study|Lost to Follow-up|1|||
160839973|NCT02596945|580799790|FG000|Overall Study|No documentation of study drug dosing|3|||
160839974|NCT02596945|580799790|FG000|Overall Study|Other|32|||
160839975|NCT02596945|580799790|FG000|Overall Study|Change to hemodialysis|15|||
160839976|NCT02596945|580799790|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
160839977|NCT02596945|580799790|FG000|Overall Study|Withdrawal by Subject|1|||
160839978|NCT02596945|580799790|FG000|Overall Study|Missing|1|||
160905167|NCT03068130|581048143|FG000|Overall Study|Study terminated by sponsor|194|||
160905168|NCT00590720|581048144|FG000|Overall Study|Lost to Follow-up|1|||
160905169|NCT00590720|581048145|FG001|Overall Study|Lost to Follow-up|0|||
160905170|NCT00590720|581048144|FG000|Overall Study|Withdrawal by Subject|0|||
160564336|NCT00684814|579786618|FG001|Washout Period of 7 Days|Adverse Event|2|||
160564337|NCT00684814|579786617|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
160839979|NCT04699461|580799791|FG000|Overall Study|Withdrawal by Subject|1|||
160564338|NCT00684814|579786618|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
160839980|NCT04699461|580799792|FG001|Overall Study|Withdrawal by Subject|0|||
160839981|NCT04699461|580799791|FG000|Overall Study|Study termination by sponsor|2|||
160839982|NCT04699461|580799792|FG001|Overall Study|Study termination by sponsor|1|||
160839983|NCT04699461|580799791|FG000|Overall Study|Death|1|||
160839984|NCT04699461|580799792|FG001|Overall Study|Death|0|||
160905171|NCT00590720|581048145|FG001|Overall Study|Withdrawal by Subject|1|||
160564339|NCT00684814|579786617|FG000|Second Intervention|Adverse Event|1|||
160564340|NCT00684814|579786618|FG001|Second Intervention|Adverse Event|0|||
160564341|NCT02203149|579786619|FG000|Part 1|Adverse Event|0|||
160564342|NCT02203149|579786620|FG001|Part 1|Adverse Event|1|||
160564343|NCT02203149|579786621|FG002|Part 1|Adverse Event|0|||
160564344|NCT02203149|579786622|FG003|Part 1|Adverse Event|0|||
160564345|NCT02203149|579786623|FG004|Part 1|Adverse Event|0|||
160564346|NCT02203149|579786619|FG000|Part 2|Death|0|||
160564347|NCT02203149|579786620|FG001|Part 2|Death|0|||
160564348|NCT02203149|579786621|FG002|Part 2|Death|1|||
160564349|NCT02203149|579786622|FG003|Part 2|Death|1|||
160564350|NCT02203149|579786623|FG004|Part 2|Death|0|||
160564351|NCT02203149|579786619|FG000|Part 2|Withdrawal by Subject|0|||
160564352|NCT02203149|579786620|FG001|Part 2|Withdrawal by Subject|0|||
160564353|NCT02203149|579786621|FG002|Part 2|Withdrawal by Subject|0|||
160564354|NCT02203149|579786622|FG003|Part 2|Withdrawal by Subject|1|||
160564355|NCT02203149|579786623|FG004|Part 2|Withdrawal by Subject|0|||
160564356|NCT02203149|579786619|FG000|Part 2|Adverse Event|0|||
160564357|NCT02203149|579786620|FG001|Part 2|Adverse Event|0|||
160564358|NCT02203149|579786621|FG002|Part 2|Adverse Event|0|||
160564359|NCT02203149|579786622|FG003|Part 2|Adverse Event|1|||
160564360|NCT02203149|579786623|FG004|Part 2|Adverse Event|1|||
160564361|NCT02537678|579786624|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
160564362|NCT02537678|579786625|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
160564363|NCT02537678|579786624|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
160564364|NCT02537678|579786625|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
160564365|NCT02537678|579786624|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
160564366|NCT02537678|579786625|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
160564367|NCT02537678|579786624|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
160564368|NCT02537678|579786625|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
160564369|NCT02537678|579786624|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
160564370|NCT02537678|579786625|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
160564371|NCT02537678|579786624|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
160564372|NCT02537678|579786625|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
160564373|NCT02537678|579786624|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
160564374|NCT02537678|579786625|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
160839985|NCT04699461|580799791|FG000|Overall Study|Radiographic progression|0|||
160839986|NCT04699461|580799792|FG001|Overall Study|Radiographic progression|1|||
160839987|NCT02478255|580799793|FG000|Overall Study|Physician Decision|6|||
160839988|NCT02478255|580799794|FG001|Overall Study|Physician Decision|0|||
160839989|NCT02478255|580799793|FG000|Overall Study|Withdrawal by Subject|2|||
160839990|NCT02478255|580799794|FG001|Overall Study|Withdrawal by Subject|0|||
160839991|NCT03068767|580799801|FG000|Overall Study|Lost to Follow-up|7|||
160839992|NCT03068767|580799802|FG001|Overall Study|Lost to Follow-up|3|||
160839993|NCT03068767|580799801|FG000|Overall Study|Protocol Violation|3|||
160839994|NCT03068767|580799802|FG001|Overall Study|Protocol Violation|0|||
160839995|NCT00061633|580799805|FG000|Overall Study|Adverse Event|1|||
160839996|NCT00061633|580799806|FG001|Overall Study|Adverse Event|2|||
160839997|NCT00061633|580799805|FG000|Overall Study|Withdrawal by Subject|2|||
160839998|NCT00061633|580799806|FG001|Overall Study|Withdrawal by Subject|2|||
160839999|NCT00061633|580799805|FG000|Overall Study|Lost to Follow-up|1|||
160840000|NCT00061633|580799806|FG001|Overall Study|Lost to Follow-up|4|||
160840001|NCT00061633|580799805|FG000|Overall Study|Other|1|||
160840002|NCT00061633|580799806|FG001|Overall Study|Other|1|||
160840003|NCT00061633|580799805|FG000|Overall Study|Never received study treatment|0|||
160840004|NCT00061633|580799806|FG001|Overall Study|Never received study treatment|2|||
160840005|NCT01431963|580799807|FG000|Overall Study|Adverse Event|18|||
160564375|NCT04348851|579786626|FG000|Post-Test 1|Withdrawal by Subject|0|||
160564376|NCT04348851|579786627|FG001|Post-Test 1|Withdrawal by Subject|1|||
160564377|NCT04348851|579786628|FG002|Post-Test 1|Withdrawal by Subject|0|||
160564378|NCT04348851|579786629|FG003|Post-Test 1|Withdrawal by Subject|0|||
160564379|NCT04348851|579786626|FG000|Post-Test 1|Lost to Follow-up|0|||
160564380|NCT04348851|579786627|FG001|Post-Test 1|Lost to Follow-up|1|||
160840006|NCT01431963|580799807|FG000|Overall Study|Lack of Efficacy|7|||
160840007|NCT01431963|580799807|FG000|Overall Study|Protocol Violation|1|||
160840008|NCT01431963|580799807|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
160840009|NCT01431963|580799807|FG000|Overall Study|Physician Decision|4|||
160564381|NCT04348851|579786628|FG002|Post-Test 1|Lost to Follow-up|0|||
160840010|NCT01431963|580799807|FG000|Overall Study|Withdrawal by Subject|3|||
160840011|NCT02737475|580802418|FG000|Overall Study|Other reasons|0|||
160840012|NCT02737475|580802419|FG001|Overall Study|Other reasons|0|||
160840013|NCT02737475|580802420|FG002|Overall Study|Other reasons|0|||
160840014|NCT02737475|580802421|FG003|Overall Study|Other reasons|0|||
160840015|NCT02737475|580802422|FG004|Overall Study|Other reasons|1|||
160840016|NCT02737475|580802423|FG005|Overall Study|Other reasons|1|||
160840017|NCT02737475|580802424|FG006|Overall Study|Other reasons|0|||
160840018|NCT02737475|580802425|FG007|Overall Study|Other reasons|0|||
160840019|NCT02737475|580802426|FG008|Overall Study|Other reasons|1|||
160840020|NCT02737475|580802427|FG009|Overall Study|Other reasons|0|||
160840021|NCT02737475|580802428|FG010|Overall Study|Other reasons|1|||
160840022|NCT02737475|580802429|FG011|Overall Study|Other reasons|0|||
160840023|NCT02737475|580802430|FG012|Overall Study|Other reasons|0|||
160840024|NCT02737475|580802431|FG013|Overall Study|Other reasons|0|||
160840025|NCT02737475|580802432|FG014|Overall Study|Other reasons|0|||
160840026|NCT02737475|580802433|FG015|Overall Study|Other reasons|0|||
160840027|NCT02737475|580802434|FG016|Overall Study|Other reasons|0|||
160840028|NCT02737475|580802435|FG017|Overall Study|Other reasons|0|||
160840029|NCT02737475|580802436|FG018|Overall Study|Other reasons|0|||
160840030|NCT02737475|580802437|FG019|Overall Study|Other reasons|0|||
160840031|NCT02737475|580802438|FG020|Overall Study|Other reasons|0|||
160840032|NCT02737475|580802439|FG021|Overall Study|Other reasons|1|||
160840033|NCT02737475|580802440|FG022|Overall Study|Other reasons|0|||
160840034|NCT02737475|580802441|FG023|Overall Study|Other reasons|1|||
160840035|NCT02737475|580802442|FG024|Overall Study|Other reasons|1|||
160840036|NCT02737475|580802443|FG025|Overall Study|Other reasons|1|||
160840037|NCT02737475|580802444|FG026|Overall Study|Other reasons|0|||
160840038|NCT02737475|580802418|FG000|Overall Study|Death|1|||
160840039|NCT02737475|580802419|FG001|Overall Study|Death|0|||
160840040|NCT02737475|580802420|FG002|Overall Study|Death|0|||
160840041|NCT02737475|580802421|FG003|Overall Study|Death|1|||
160840042|NCT02737475|580802422|FG004|Overall Study|Death|0|||
160840043|NCT02737475|580802423|FG005|Overall Study|Death|0|||
160840044|NCT02737475|580802424|FG006|Overall Study|Death|0|||
160840045|NCT02737475|580802425|FG007|Overall Study|Death|2|||
160840046|NCT02737475|580802426|FG008|Overall Study|Death|0|||
160840047|NCT02737475|580802427|FG009|Overall Study|Death|0|||
160840048|NCT02737475|580802428|FG010|Overall Study|Death|0|||
160840049|NCT02737475|580802429|FG011|Overall Study|Death|4|||
160840050|NCT02737475|580802430|FG012|Overall Study|Death|2|||
160840051|NCT02737475|580802431|FG013|Overall Study|Death|2|||
160840052|NCT02737475|580802432|FG014|Overall Study|Death|0|||
160840053|NCT02737475|580802433|FG015|Overall Study|Death|2|||
160840054|NCT02737475|580802434|FG016|Overall Study|Death|2|||
160840055|NCT02737475|580802435|FG017|Overall Study|Death|2|||
160840056|NCT02737475|580802436|FG018|Overall Study|Death|1|||
160840057|NCT02737475|580802437|FG019|Overall Study|Death|0|||
160840058|NCT02737475|580802438|FG020|Overall Study|Death|0|||
160840059|NCT02737475|580802439|FG021|Overall Study|Death|0|||
160840060|NCT02737475|580802440|FG022|Overall Study|Death|0|||
160840061|NCT02737475|580802441|FG023|Overall Study|Death|0|||
160840062|NCT02737475|580802442|FG024|Overall Study|Death|0|||
160840063|NCT02737475|580802443|FG025|Overall Study|Death|0|||
160840064|NCT02737475|580802444|FG026|Overall Study|Death|0|||
160840065|NCT02737475|580802418|FG000|Overall Study|Participant withdrew consent|0|||
160840066|NCT02737475|580802419|FG001|Overall Study|Participant withdrew consent|0|||
160840067|NCT02737475|580802420|FG002|Overall Study|Participant withdrew consent|0|||
160840068|NCT02737475|580802421|FG003|Overall Study|Participant withdrew consent|0|||
160840069|NCT02737475|580802422|FG004|Overall Study|Participant withdrew consent|0|||
160840070|NCT02737475|580802423|FG005|Overall Study|Participant withdrew consent|2|||
160840071|NCT02737475|580802424|FG006|Overall Study|Participant withdrew consent|0|||
160840072|NCT02737475|580802425|FG007|Overall Study|Participant withdrew consent|0|||
160840073|NCT02737475|580802426|FG008|Overall Study|Participant withdrew consent|0|||
160840074|NCT02737475|580802427|FG009|Overall Study|Participant withdrew consent|0|||
160840075|NCT02737475|580802428|FG010|Overall Study|Participant withdrew consent|0|||
160840076|NCT02737475|580802429|FG011|Overall Study|Participant withdrew consent|0|||
160840077|NCT02737475|580802430|FG012|Overall Study|Participant withdrew consent|0|||
160840078|NCT02737475|580802431|FG013|Overall Study|Participant withdrew consent|0|||
160840079|NCT02737475|580802432|FG014|Overall Study|Participant withdrew consent|1|||
160840080|NCT02737475|580802433|FG015|Overall Study|Participant withdrew consent|0|||
160840081|NCT02737475|580802434|FG016|Overall Study|Participant withdrew consent|0|||
160840082|NCT02737475|580802435|FG017|Overall Study|Participant withdrew consent|2|||
160840083|NCT02737475|580802436|FG018|Overall Study|Participant withdrew consent|1|||
160840084|NCT02737475|580802437|FG019|Overall Study|Participant withdrew consent|0|||
160840085|NCT02737475|580802438|FG020|Overall Study|Participant withdrew consent|2|||
160840086|NCT02737475|580802439|FG021|Overall Study|Participant withdrew consent|0|||
160840087|NCT02737475|580802440|FG022|Overall Study|Participant withdrew consent|0|||
160840088|NCT02737475|580802441|FG023|Overall Study|Participant withdrew consent|0|||
160840089|NCT02737475|580802442|FG024|Overall Study|Participant withdrew consent|0|||
160840090|NCT02737475|580802443|FG025|Overall Study|Participant withdrew consent|0|||
160840091|NCT02737475|580802444|FG026|Overall Study|Participant withdrew consent|0|||
160840092|NCT02737475|580802418|FG000|Overall Study|Lost to Follow-up|0|||
160840093|NCT02737475|580802419|FG001|Overall Study|Lost to Follow-up|0|||
160840094|NCT02737475|580802420|FG002|Overall Study|Lost to Follow-up|0|||
160840095|NCT02737475|580802421|FG003|Overall Study|Lost to Follow-up|0|||
160840096|NCT02737475|580802422|FG004|Overall Study|Lost to Follow-up|0|||
160840097|NCT02737475|580802423|FG005|Overall Study|Lost to Follow-up|0|||
160840098|NCT02737475|580802424|FG006|Overall Study|Lost to Follow-up|0|||
160840099|NCT02737475|580802425|FG007|Overall Study|Lost to Follow-up|0|||
160840100|NCT02737475|580802426|FG008|Overall Study|Lost to Follow-up|0|||
160840101|NCT02737475|580802427|FG009|Overall Study|Lost to Follow-up|0|||
160840102|NCT02737475|580802428|FG010|Overall Study|Lost to Follow-up|0|||
160840103|NCT02737475|580802429|FG011|Overall Study|Lost to Follow-up|0|||
160840104|NCT02737475|580802430|FG012|Overall Study|Lost to Follow-up|0|||
160840105|NCT02737475|580802431|FG013|Overall Study|Lost to Follow-up|0|||
160840106|NCT02737475|580802432|FG014|Overall Study|Lost to Follow-up|0|||
160840107|NCT02737475|580802433|FG015|Overall Study|Lost to Follow-up|1|||
160840108|NCT02737475|580802434|FG016|Overall Study|Lost to Follow-up|0|||
160840109|NCT02737475|580802435|FG017|Overall Study|Lost to Follow-up|0|||
160840110|NCT02737475|580802436|FG018|Overall Study|Lost to Follow-up|0|||
160840111|NCT02737475|580802437|FG019|Overall Study|Lost to Follow-up|0|||
160840112|NCT02737475|580802438|FG020|Overall Study|Lost to Follow-up|0|||
160840113|NCT02737475|580802439|FG021|Overall Study|Lost to Follow-up|0|||
160840114|NCT02737475|580802440|FG022|Overall Study|Lost to Follow-up|0|||
160840115|NCT02737475|580802441|FG023|Overall Study|Lost to Follow-up|0|||
160840116|NCT02737475|580802442|FG024|Overall Study|Lost to Follow-up|0|||
160840117|NCT02737475|580802443|FG025|Overall Study|Lost to Follow-up|0|||
160840118|NCT02737475|580802444|FG026|Overall Study|Lost to Follow-up|0|||
160840119|NCT02737475|580802418|FG000|Overall Study|Disease Progression|0|||
160840120|NCT02737475|580802419|FG001|Overall Study|Disease Progression|0|||
160840121|NCT02737475|580802420|FG002|Overall Study|Disease Progression|0|||
160840122|NCT02737475|580802421|FG003|Overall Study|Disease Progression|0|||
160840123|NCT02737475|580802422|FG004|Overall Study|Disease Progression|0|||
160840124|NCT02737475|580802423|FG005|Overall Study|Disease Progression|0|||
160840125|NCT02737475|580802424|FG006|Overall Study|Disease Progression|0|||
160840126|NCT02737475|580802425|FG007|Overall Study|Disease Progression|0|||
160840127|NCT02737475|580802426|FG008|Overall Study|Disease Progression|0|||
160840128|NCT02737475|580802427|FG009|Overall Study|Disease Progression|0|||
160840129|NCT02737475|580802428|FG010|Overall Study|Disease Progression|0|||
160840130|NCT02737475|580802429|FG011|Overall Study|Disease Progression|0|||
160840131|NCT02737475|580802430|FG012|Overall Study|Disease Progression|0|||
160840132|NCT02737475|580802431|FG013|Overall Study|Disease Progression|0|||
160840133|NCT02737475|580802432|FG014|Overall Study|Disease Progression|0|||
160840134|NCT02737475|580802433|FG015|Overall Study|Disease Progression|0|||
160840135|NCT02737475|580802434|FG016|Overall Study|Disease Progression|0|||
160840136|NCT02737475|580802435|FG017|Overall Study|Disease Progression|0|||
160840137|NCT02737475|580802436|FG018|Overall Study|Disease Progression|0|||
160840138|NCT02737475|580802437|FG019|Overall Study|Disease Progression|0|||
160840139|NCT02737475|580802438|FG020|Overall Study|Disease Progression|0|||
160840140|NCT02737475|580802439|FG021|Overall Study|Disease Progression|0|||
160840141|NCT02737475|580802440|FG022|Overall Study|Disease Progression|0|||
160840142|NCT02737475|580802441|FG023|Overall Study|Disease Progression|0|||
160840143|NCT02737475|580802442|FG024|Overall Study|Disease Progression|0|||
160840144|NCT02737475|580802443|FG025|Overall Study|Disease Progression|0|||
160840145|NCT02737475|580802444|FG026|Overall Study|Disease Progression|1|||
160840146|NCT02255461|580802455|FG000|Overall Study|Adverse Event|0|||
160840147|NCT02255461|580802456|FG001|Overall Study|Adverse Event|1|||
160840148|NCT02255461|580802457|FG002|Overall Study|Adverse Event|0|||
160840149|NCT02255461|580802458|FG003|Overall Study|Adverse Event|0|||
160840150|NCT02255461|580802459|FG004|Overall Study|Adverse Event|1|||
160840151|NCT02255461|580802455|FG000|Overall Study|Withdrawal by Subject|0|||
160840152|NCT02255461|580802456|FG001|Overall Study|Withdrawal by Subject|0|||
160840153|NCT02255461|580802457|FG002|Overall Study|Withdrawal by Subject|1|||
160840154|NCT02255461|580802458|FG003|Overall Study|Withdrawal by Subject|0|||
160840155|NCT02255461|580802459|FG004|Overall Study|Withdrawal by Subject|1|||
160840156|NCT02255461|580802455|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
160840157|NCT02255461|580802456|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
160840158|NCT02255461|580802457|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
160840159|NCT02255461|580802458|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
160840160|NCT02255461|580802459|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
160564382|NCT04348851|579786629|FG003|Post-Test 1|Lost to Follow-up|0|||
160564383|NCT04348851|579786626|FG000|Post-Test 2|Stroke survivor death|0|||
160840161|NCT01357551|580802462|FG000|Overall Study|Withdrawal by Subject|6|||
160840162|NCT01357551|580802463|FG001|Overall Study|Withdrawal by Subject|4|||
160840163|NCT01357551|580802462|FG000|Overall Study|Death|0|||
160564384|NCT04348851|579786627|FG001|Post-Test 2|Stroke survivor death|1|||
160564385|NCT04348851|579786628|FG002|Post-Test 2|Stroke survivor death|0|||
160840164|NCT01357551|580802463|FG001|Overall Study|Death|1|||
160840165|NCT01357551|580802462|FG000|Overall Study|Lost to Follow-up|16|||
160840166|NCT01357551|580802463|FG001|Overall Study|Lost to Follow-up|6|||
160564386|NCT04348851|579786629|FG003|Post-Test 2|Stroke survivor death|1|||
160840167|NCT00711971|580802475|FG000|Overall Study|Lost to Follow-up|3|||
160840168|NCT00711971|580802476|FG001|Overall Study|Lost to Follow-up|4|||
160840169|NCT00711971|580802477|FG002|Overall Study|Lost to Follow-up|1|||
160840170|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840171|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160564387|NCT00195650|579786630|FG000|Overall Study|Adverse Event|194|||
160564388|NCT00195650|579786630|FG000|Overall Study|Lack of Efficacy|99|||
160564389|NCT00195650|579786630|FG000|Overall Study|Withdrawal by Subject|67|||
160564390|NCT00195650|579786630|FG000|Overall Study|Lost to Follow-up|44|||
160840172|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
160840173|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
160840174|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
160840175|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840176|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
160840177|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
160840178|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
160840179|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840180|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840181|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840182|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840183|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
160840184|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
160840185|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
160840186|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
160840187|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
160840188|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
160840189|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
160840190|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
160840191|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
160840192|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
160840193|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
160840194|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
160840195|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
160840196|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840197|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
160840198|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
160840199|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840200|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840201|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
160840202|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
160840203|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840204|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840205|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840206|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840207|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840208|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840209|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840210|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
160840211|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
160840212|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840213|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840214|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840215|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
160840216|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840217|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
160840218|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840219|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840220|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840221|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840222|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840223|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840224|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840225|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
160840226|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840227|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840228|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840229|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
160840230|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160905172|NCT01001377|581048146|FG000|Overall Study|Ineligibility determined|2|||
160905173|NCT01001377|581048147|FG001|Overall Study|Ineligibility determined|0|||
160905174|NCT01001377|581048146|FG000|Overall Study|Withdrawal by Subject|19|||
160564391|NCT00195650|579786630|FG000|Overall Study|Death|23|||
160564392|NCT00195650|579786630|FG000|Overall Study|Protocol Violation|15|||
160564393|NCT00195650|579786630|FG000|Overall Study|Administrative reasons|83|||
160840231|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840232|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840233|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840234|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840235|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840236|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160564394|NCT00432809|579786631|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
160564395|NCT00432809|579786632|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
160564396|NCT00432809|579786633|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
160564397|NCT00432809|579786631|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
160564398|NCT00432809|579786632|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
160564399|NCT00432809|579786633|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
160564400|NCT04052139|579786634|FG000|Overall Study|Lost to Follow-up|2|||
160564401|NCT04052139|579786635|FG001|Overall Study|Lost to Follow-up|0|||
160564402|NCT04052139|579786636|FG002|Overall Study|Lost to Follow-up|0|||
160564403|NCT04052139|579786634|FG000|Overall Study|Withdrawal by Subject|1|||
160564404|NCT04052139|579786635|FG001|Overall Study|Withdrawal by Subject|0|||
160564405|NCT04052139|579786636|FG002|Overall Study|Withdrawal by Subject|0|||
160564406|NCT00707577|579786637|FG000|Overall Study|Withdrawal by Subject|3|||
160564407|NCT00707577|579786638|FG001|Overall Study|Withdrawal by Subject|2|||
160564408|NCT00707577|579786637|FG000|Overall Study|Lost to Follow-up|34|||
160564409|NCT00707577|579786638|FG001|Overall Study|Lost to Follow-up|25|||
160564410|NCT00707577|579786637|FG000|Overall Study|Left employment|13|||
160564411|NCT00707577|579786638|FG001|Overall Study|Left employment|10|||
160564412|NCT00707577|579786637|FG000|Overall Study|Pregnancy|4|||
160564413|NCT00707577|579786638|FG001|Overall Study|Pregnancy|1|||
160564414|NCT00190775|579786639|FG000|Overall Study|Adverse Event|57|||
160564415|NCT00190775|579786640|FG001|Overall Study|Adverse Event|22|||
160564416|NCT00190775|579786639|FG000|Overall Study|Satisfactory Response|1|||
160564417|NCT00190775|579786640|FG001|Overall Study|Satisfactory Response|0|||
160564418|NCT00190775|579786639|FG000|Overall Study|Lack of Efficacy|28|||
160564419|NCT00190775|579786640|FG001|Overall Study|Lack of Efficacy|32|||
160564420|NCT00190775|579786639|FG000|Overall Study|Lost to Follow-up|31|||
160564421|NCT00190775|579786640|FG001|Overall Study|Lost to Follow-up|23|||
160564422|NCT00190775|579786639|FG000|Overall Study|Participant Moved|0|||
160564423|NCT00190775|579786640|FG001|Overall Study|Participant Moved|1|||
160564424|NCT00190775|579786639|FG000|Overall Study|Withdrawal by Subject|24|||
160564425|NCT00190775|579786640|FG001|Overall Study|Withdrawal by Subject|13|||
160564426|NCT00190775|579786639|FG000|Overall Study|Sponsor Decision|1|||
160564427|NCT00190775|579786640|FG001|Overall Study|Sponsor Decision|0|||
160564428|NCT00190775|579786639|FG000|Overall Study|Physician Decision|3|||
160564429|NCT00190775|579786640|FG001|Overall Study|Physician Decision|0|||
160564430|NCT00190775|579786639|FG000|Overall Study|Noncompliance|3|||
160564431|NCT00190775|579786640|FG001|Overall Study|Noncompliance|5|||
160564432|NCT00190775|579786639|FG000|Overall Study|Protocol Violation|0|||
160564433|NCT00190775|579786640|FG001|Overall Study|Protocol Violation|1|||
160564434|NCT00190775|579786639|FG000|Overall Study|Exclusion Criteria Met|1|||
160564435|NCT00190775|579786640|FG001|Overall Study|Exclusion Criteria Met|3|||
160564436|NCT01794780|579786641|FG000|Overall Study|Adverse Event|0|||
160564437|NCT01794780|579786642|FG001|Overall Study|Adverse Event|1|||
160564438|NCT01794780|579786643|FG002|Overall Study|Adverse Event|2|||
160564439|NCT01794780|579786644|FG003|Overall Study|Adverse Event|0|||
160564440|NCT01794780|579786645|FG004|Overall Study|Adverse Event|0|||
160564441|NCT01794780|579786646|FG005|Overall Study|Adverse Event|0|||
160564442|NCT01794780|579786647|FG006|Overall Study|Adverse Event|0|||
160840237|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840238|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
160840239|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160564443|NCT01794780|579786648|FG007|Overall Study|Adverse Event|0|||
160564444|NCT01794780|579786641|FG000|Overall Study|Death|0|||
160564445|NCT01794780|579786642|FG001|Overall Study|Death|2|||
160564446|NCT01794780|579786643|FG002|Overall Study|Death|14|||
160564447|NCT01794780|579786644|FG003|Overall Study|Death|1|||
160840240|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840241|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
160564448|NCT01794780|579786645|FG004|Overall Study|Death|0|||
160564449|NCT01794780|579786646|FG005|Overall Study|Death|9|||
160564450|NCT01794780|579786647|FG006|Overall Study|Death|4|||
160564451|NCT01794780|579786648|FG007|Overall Study|Death|0|||
160564452|NCT01794780|579786641|FG000|Overall Study|Lost to Follow-up|10|||
160564453|NCT01794780|579786642|FG001|Overall Study|Lost to Follow-up|64|||
160564454|NCT01794780|579786643|FG002|Overall Study|Lost to Follow-up|165|||
160564455|NCT01794780|579786644|FG003|Overall Study|Lost to Follow-up|53|||
160564456|NCT01794780|579786645|FG004|Overall Study|Lost to Follow-up|2|||
160564457|NCT01794780|579786646|FG005|Overall Study|Lost to Follow-up|99|||
160840242|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840243|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840244|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840245|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160564458|NCT01794780|579786647|FG006|Overall Study|Lost to Follow-up|30|||
160564459|NCT01794780|579786648|FG007|Overall Study|Lost to Follow-up|5|||
160564460|NCT01794780|579786641|FG000|Overall Study|Withdrew informed consent|7|||
160564461|NCT01794780|579786642|FG001|Overall Study|Withdrew informed consent|17|||
160564462|NCT01794780|579786643|FG002|Overall Study|Withdrew informed consent|36|||
160564463|NCT01794780|579786644|FG003|Overall Study|Withdrew informed consent|9|||
160564464|NCT01794780|579786645|FG004|Overall Study|Withdrew informed consent|0|||
160564465|NCT01794780|579786646|FG005|Overall Study|Withdrew informed consent|48|||
160564466|NCT01794780|579786647|FG006|Overall Study|Withdrew informed consent|4|||
160564467|NCT01794780|579786648|FG007|Overall Study|Withdrew informed consent|3|||
160564468|NCT01794780|579786641|FG000|Overall Study|Other|0|||
160564469|NCT01794780|579786642|FG001|Overall Study|Other|12|||
160564470|NCT01794780|579786643|FG002|Overall Study|Other|25|||
160564471|NCT01794780|579786644|FG003|Overall Study|Other|20|||
160564472|NCT01794780|579786645|FG004|Overall Study|Other|1|||
160564473|NCT01794780|579786646|FG005|Overall Study|Other|24|||
160564474|NCT01794780|579786647|FG006|Overall Study|Other|4|||
160564475|NCT01794780|579786648|FG007|Overall Study|Other|1|||
160564476|NCT00327444|579786650|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
160564477|NCT00327444|579786651|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
160564478|NCT00327444|579786650|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
160564479|NCT00327444|579786651|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
160564480|NCT00327444|579786650|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
160564481|NCT00327444|579786651|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
160564482|NCT00327444|579786650|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
160564483|NCT00327444|579786651|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
160564484|NCT00327444|579786650|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
160564485|NCT00327444|579786651|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
160564486|NCT00327444|579786650|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
160564487|NCT00327444|579786651|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
160564488|NCT00327444|579786650|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
160564489|NCT00327444|579786651|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
160564490|NCT00327444|579786650|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
160564491|NCT00327444|579786651|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
160564492|NCT01658514|579786653|FG000|Overall Study|Protocol Violation|1|||
160564493|NCT01658514|579786654|FG001|Overall Study|Protocol Violation|0|||
160564494|NCT01658514|579786655|FG002|Overall Study|Protocol Violation|2|||
160564495|NCT00144170|579786657|FG000|Overall Study|Adverse Event|84|||
160564496|NCT00144170|579786658|FG001|Overall Study|Adverse Event|41|||
160564497|NCT00144170|579786657|FG000|Overall Study|Protocol Violation|23|||
160564498|NCT00144170|579786658|FG001|Overall Study|Protocol Violation|16|||
160564499|NCT00144170|579786657|FG000|Overall Study|Lost to Follow-up|5|||
160564500|NCT00144170|579786658|FG001|Overall Study|Lost to Follow-up|10|||
160564501|NCT00144170|579786657|FG000|Overall Study|Withdrawal by Subject|29|||
160564502|NCT00144170|579786658|FG001|Overall Study|Withdrawal by Subject|13|||
160564503|NCT00144170|579786657|FG000|Overall Study|Other reason not defined above|211|||
160564504|NCT00144170|579786658|FG001|Overall Study|Other reason not defined above|316|||
160564505|NCT00981526|579786659|FG000|Overall Study|Withdrawal by Subject|0|||
160564506|NCT00981526|579786660|FG001|Overall Study|Withdrawal by Subject|2|||
160564507|NCT00981526|579786659|FG000|Overall Study|Physician Decision|4|||
160564508|NCT00981526|579786660|FG001|Overall Study|Physician Decision|4|||
160840246|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840247|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840248|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840249|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
160840250|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840251|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160564509|NCT00332202|579786661|FG000|Overall Study|Adverse Event|72|||
160564510|NCT00332202|579786662|FG001|Overall Study|Adverse Event|28|||
160564511|NCT00332202|579786661|FG000|Overall Study|Lost to Follow-up|2|||
160564512|NCT00332202|579786662|FG001|Overall Study|Lost to Follow-up|1|||
160564513|NCT00332202|579786661|FG000|Overall Study|Physician Decision|6|||
160564514|NCT00332202|579786662|FG001|Overall Study|Physician Decision|8|||
160564515|NCT00332202|579786661|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
160564516|NCT00332202|579786662|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
160564517|NCT00332202|579786661|FG000|Overall Study|Protocol Violation|7|||
160564518|NCT00332202|579786662|FG001|Overall Study|Protocol Violation|2|||
160564519|NCT00332202|579786661|FG000|Overall Study|Sponsor Decision|1|||
160564520|NCT00332202|579786662|FG001|Overall Study|Sponsor Decision|2|||
160564521|NCT00332202|579786661|FG000|Overall Study|Withdrawal by Subject|36|||
160840252|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840253|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840254|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840255|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840256|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840257|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840258|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840259|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840260|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840261|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
160840262|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840263|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840264|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840265|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840266|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840267|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840268|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840269|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840270|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840271|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840272|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160564522|NCT00332202|579786662|FG001|Overall Study|Withdrawal by Subject|17|||
160564523|NCT00332202|579786661|FG000|Overall Study|Progressive Disease|106|||
160564524|NCT00332202|579786662|FG001|Overall Study|Progressive Disease|60|||
160564525|NCT00332202|579786661|FG000|Overall Study|Death|5|||
160564526|NCT00332202|579786662|FG001|Overall Study|Death|2|||
160564527|NCT00957853|579786663|FG000|Overall Study|Withdrawal by Subject|1|||
160564528|NCT00957853|579786664|FG001|Overall Study|Withdrawal by Subject|0|||
160564529|NCT00957853|579786665|FG002|Overall Study|Withdrawal by Subject|0|||
160564530|NCT00655928|579786667|FG000|Overall Study|Withdrawal by Subject|2|||
160564531|NCT00655928|579786668|FG001|Overall Study|Withdrawal by Subject|1|||
160564532|NCT00655928|579786667|FG000|Overall Study|Physician Decision|1|||
160564533|NCT00655928|579786668|FG001|Overall Study|Physician Decision|1|||
160564534|NCT00275561|579786672|FG000|Overall Study|Withdrawal by Subject|0|||
160564535|NCT00275561|579786673|FG001|Overall Study|Withdrawal by Subject|1|||
160564536|NCT00275561|579786672|FG000|Overall Study|Travel|1|||
160564537|NCT00275561|579786673|FG001|Overall Study|Travel|1|||
160564538|NCT00275561|579786672|FG000|Overall Study|Scheduling|1|||
160564539|NCT00275561|579786673|FG001|Overall Study|Scheduling|2|||
160564540|NCT00275561|579786672|FG000|Overall Study|Family Issues|0|||
160564541|NCT00275561|579786673|FG001|Overall Study|Family Issues|2|||
160564542|NCT01769105|579786674|FG000|First Intervention|Protocol Violation|2|||
160564543|NCT01769105|579786675|FG001|First Intervention|Protocol Violation|2|||
160564544|NCT01769105|579786674|FG000|Cross-over|Lost to Follow-up|5|||
160564545|NCT01769105|579786675|FG001|Cross-over|Lost to Follow-up|0|||
160564546|NCT05630846|579788636|FG000|Overall Study|Death|1|||
160564547|NCT05630846|579788637|FG001|Overall Study|Death|0|||
160564548|NCT05630846|579788638|FG002|Overall Study|Death|0|||
160564549|NCT05630846|579788639|FG003|Overall Study|Death|0|||
160564550|NCT05630846|579788636|FG000|Overall Study|Withdrawal by Subject|3|||
160564551|NCT05630846|579788637|FG001|Overall Study|Withdrawal by Subject|3|||
160840273|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840274|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840275|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840276|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840277|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840278|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840279|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160564552|NCT05630846|579788638|FG002|Overall Study|Withdrawal by Subject|4|||
160564553|NCT05630846|579788639|FG003|Overall Study|Withdrawal by Subject|1|||
160564554|NCT05630846|579788636|FG000|Overall Study|Lost to Follow-up|6|||
160564555|NCT05630846|579788637|FG001|Overall Study|Lost to Follow-up|5|||
160564556|NCT05630846|579788638|FG002|Overall Study|Lost to Follow-up|2|||
160840280|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
160564557|NCT05630846|579788639|FG003|Overall Study|Lost to Follow-up|5|||
160840281|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840282|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840283|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840284|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840285|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840286|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840287|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840288|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840289|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160564558|NCT05630846|579788636|FG000|Overall Study|Other|1|||
160564559|NCT05630846|579788637|FG001|Overall Study|Other|0|||
160840290|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840291|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840292|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840293|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160564560|NCT05630846|579788638|FG002|Overall Study|Other|0|||
160564561|NCT05630846|579788639|FG003|Overall Study|Other|0|||
160564562|NCT03019549|579788640|FG000|Washout|DId not meet genotype criteria|11|||
160564563|NCT03019549|579788640|FG000|Period 2|Adverse Event|2|||
160564564|NCT03019549|579788640|FG000|Period 2|Physician Decision|2|||
160564565|NCT03019549|579788640|FG000|Period 2|Withdrawal by Subject|1|||
160564566|NCT04030195|579788641|FG000|Overall Study|Withdrawal by Subject|2|||
160564567|NCT04030195|579788642|FG001|Overall Study|Withdrawal by Subject|0|||
160564568|NCT04030195|579788643|FG002|Overall Study|Withdrawal by Subject|0|||
160564569|NCT01412879|579788644|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
160564570|NCT01412879|579788645|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
160564571|NCT01412879|579788646|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
160564572|NCT01412879|579788644|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
160564573|NCT01412879|579788645|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
160564574|NCT01412879|579788646|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
160564575|NCT01412879|579788644|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
160564576|NCT01412879|579788645|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
160564577|NCT01412879|579788646|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
160564578|NCT01412879|579788644|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
160564579|NCT01412879|579788645|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
160564580|NCT01412879|579788646|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
160564581|NCT01412879|579788644|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
160564582|NCT01412879|579788645|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
160564583|NCT01412879|579788646|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
160564584|NCT01056107|579788648|FG000|Overall Study|Withdrawal by Subject|0|||
160564585|NCT01056107|579788649|FG001|Overall Study|Withdrawal by Subject|1|||
160564586|NCT01056107|579788650|FG002|Overall Study|Withdrawal by Subject|3|||
160564587|NCT01056107|579788651|FG003|Overall Study|Withdrawal by Subject|0|||
160564588|NCT00377962|579788652|FG000|Core Study: 0-12 Months|Adverse Event|18|||
160564589|NCT00377962|579788653|FG001|Core Study: 0-12 Months|Adverse Event|2|||
160564590|NCT00377962|579788652|FG000|Core Study: 0-12 Months|Death|3|||
160564591|NCT00377962|579788653|FG001|Core Study: 0-12 Months|Death|0|||
160564592|NCT00377962|579788652|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
160564593|NCT00377962|579788653|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
160564594|NCT00377962|579788652|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
160564595|NCT00377962|579788653|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
160564596|NCT00377962|579788652|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
160564597|NCT00377962|579788653|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
160564598|NCT00377962|579788652|FG000|Extension Study: 12-24 Months|Death|1|||
160564599|NCT00377962|579788653|FG001|Extension Study: 12-24 Months|Death|1|||
160564600|NCT00377962|579788652|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
160564601|NCT00377962|579788653|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
160564602|NCT00377962|579788652|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
160564603|NCT00377962|579788653|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
160564604|NCT00377962|579788652|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
160564605|NCT00377962|579788653|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
160564606|NCT00496366|579788660|FG000|Overall Study|Death|1|||
160564607|NCT00260208|579788661|FG000|Overall Study|Subject withdrew consent|11|||
160564608|NCT00260208|579788662|FG001|Overall Study|Subject withdrew consent|7|||
160564609|NCT00260208|579788661|FG000|Overall Study|Lost to Follow-up|6|||
160564610|NCT00260208|579788662|FG001|Overall Study|Lost to Follow-up|1|||
160564611|NCT00260208|579788661|FG000|Overall Study|Death|12|||
160564612|NCT00260208|579788662|FG001|Overall Study|Death|10|||
160564613|NCT00260208|579788661|FG000|Overall Study|Missing|18|||
160564614|NCT00260208|579788662|FG001|Overall Study|Missing|16|||
160564615|NCT00768222|579788663|FG000|Overall Study|Lost to Follow-up|1|||
160564616|NCT00768222|579788664|FG001|Overall Study|Lost to Follow-up|1|||
160564617|NCT00768222|579788663|FG000|Overall Study|Withdrawal by Subject|3|||
160564618|NCT00768222|579788664|FG001|Overall Study|Withdrawal by Subject|1|||
160564619|NCT00768222|579788663|FG000|Overall Study|Protocol Violation|0|||
160564620|NCT00768222|579788664|FG001|Overall Study|Protocol Violation|2|||
160564621|NCT03263091|579788666|FG000|OL Component|Withdrawal by Subject|1|||
160564622|NCT03263091|579788667|FG001|OL Component|Withdrawal by Subject|1|||
160564623|NCT03263091|579788668|FG002|OL Component|Withdrawal by Subject|0|||
160564624|NCT03263091|579788669|FG003|OL Component|Withdrawal by Subject|0|||
160564625|NCT03263091|579788670|FG004|OL Component|Withdrawal by Subject|0|||
160564626|NCT03263091|579788671|FG005|OL Component|Withdrawal by Subject|0|||
160564627|NCT03263091|579788666|FG000|OL Component|Physician Decision|0|||
160564628|NCT03263091|579788667|FG001|OL Component|Physician Decision|1|||
160564629|NCT03263091|579788668|FG002|OL Component|Physician Decision|2|||
160564630|NCT03263091|579788669|FG003|OL Component|Physician Decision|0|||
160564631|NCT03263091|579788670|FG004|OL Component|Physician Decision|0|||
160564632|NCT03263091|579788671|FG005|OL Component|Physician Decision|0|||
160564633|NCT03263091|579788666|FG000|OL Component|Death|1|||
160564634|NCT03263091|579788667|FG001|OL Component|Death|0|||
160564635|NCT03263091|579788668|FG002|OL Component|Death|0|||
160564636|NCT03263091|579788669|FG003|OL Component|Death|0|||
160564637|NCT03263091|579788670|FG004|OL Component|Death|0|||
160564638|NCT03263091|579788671|FG005|OL Component|Death|0|||
160564639|NCT03263091|579788666|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
160564640|NCT03263091|579788667|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
160564641|NCT03263091|579788668|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
160564642|NCT03263091|579788669|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
160564643|NCT03263091|579788670|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
160564644|NCT03263091|579788671|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
160564645|NCT03263091|579788666|FG000|OL High-EPO Component|Physician Decision|0|||
160564646|NCT03263091|579788667|FG001|OL High-EPO Component|Physician Decision|0|||
160564647|NCT03263091|579788668|FG002|OL High-EPO Component|Physician Decision|0|||
160564648|NCT03263091|579788669|FG003|OL High-EPO Component|Physician Decision|1|||
160564649|NCT03263091|579788670|FG004|OL High-EPO Component|Physician Decision|0|||
160564650|NCT03263091|579788671|FG005|OL High-EPO Component|Physician Decision|0|||
160564651|NCT03263091|579788666|FG000|OL High-EPO Component|Death|0|||
160564652|NCT03263091|579788667|FG001|OL High-EPO Component|Death|0|||
160564653|NCT03263091|579788668|FG002|OL High-EPO Component|Death|0|||
160564654|NCT03263091|579788669|FG003|OL High-EPO Component|Death|3|||
160564655|NCT03263091|579788670|FG004|OL High-EPO Component|Death|0|||
160564656|NCT03263091|579788671|FG005|OL High-EPO Component|Death|0|||
160564657|NCT03263091|579788666|FG000|DB Component|Withdrawal by Subject|0|||
160564658|NCT03263091|579788667|FG001|DB Component|Withdrawal by Subject|0|||
160840294|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840295|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840296|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840297|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
160840298|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
160840299|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
160840300|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840301|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840302|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840303|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840304|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840305|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840306|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840307|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840308|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840309|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840310|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
160840311|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
160840312|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840313|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840314|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840315|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840316|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840317|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160564659|NCT03263091|579788668|FG002|DB Component|Withdrawal by Subject|0|||
160564660|NCT03263091|579788669|FG003|DB Component|Withdrawal by Subject|0|||
160564661|NCT03263091|579788670|FG004|DB Component|Withdrawal by Subject|22|||
160564662|NCT03263091|579788671|FG005|DB Component|Withdrawal by Subject|8|||
160564663|NCT03263091|579788666|FG000|DB Component|Physician Decision|0|||
160564664|NCT03263091|579788667|FG001|DB Component|Physician Decision|0|||
160564665|NCT03263091|579788668|FG002|DB Component|Physician Decision|0|||
160564666|NCT03263091|579788669|FG003|DB Component|Physician Decision|0|||
160840318|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840319|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160564667|NCT03263091|579788670|FG004|DB Component|Physician Decision|3|||
160564668|NCT03263091|579788671|FG005|DB Component|Physician Decision|1|||
160564669|NCT03263091|579788666|FG000|DB Component|Adverse Event|0|||
160564670|NCT03263091|579788667|FG001|DB Component|Adverse Event|0|||
160564671|NCT03263091|579788668|FG002|DB Component|Adverse Event|0|||
160564672|NCT03263091|579788669|FG003|DB Component|Adverse Event|0|||
160564673|NCT03263091|579788670|FG004|DB Component|Adverse Event|2|||
160564674|NCT03263091|579788671|FG005|DB Component|Adverse Event|1|||
160840320|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840321|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840322|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
160840323|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
160840324|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840325|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
160840326|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840327|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840328|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840329|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840330|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840331|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840332|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840333|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840334|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840335|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840336|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
160840337|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840338|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840339|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840340|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840341|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840342|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840343|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840344|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840345|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840346|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840347|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840348|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840349|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840350|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840351|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
160840352|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840353|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840354|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840355|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840356|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840357|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840358|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840359|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840360|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840361|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
160840362|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840363|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160991948|NCT04888585|581359929|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160991949|NCT04888585|581359930|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160840364|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840365|NCT01067144|580802497|FG000|Treatment|Did not receive allocated intervention|4|||
160840366|NCT01067144|580802498|FG001|Treatment|Did not receive allocated intervention|7|||
160840367|NCT01067144|580802497|FG000|Follow-up|Lost to Follow-up|22|||
160840368|NCT01067144|580802498|FG001|Follow-up|Lost to Follow-up|12|||
160840369|NCT01067144|580802497|FG000|Follow-up|Censored owing to second surgery|19|||
160840370|NCT01067144|580802498|FG001|Follow-up|Censored owing to second surgery|28|||
160840371|NCT01067144|580802497|FG000|Follow-up|Withdrawal by Subject|18|||
160840372|NCT01067144|580802498|FG001|Follow-up|Withdrawal by Subject|14|||
160840373|NCT01067144|580802497|FG000|Follow-up|Surgery cancelled|0|||
160840374|NCT01067144|580802498|FG001|Follow-up|Surgery cancelled|1|||
160840375|NCT01067144|580802497|FG000|Follow-up|Death|0|||
160840376|NCT01067144|580802498|FG001|Follow-up|Death|1|||
160840377|NCT02718716|580802500|FG000|Overall Study|Lack of Efficacy|1|||
160840378|NCT02718716|580802501|FG001|Overall Study|Lack of Efficacy|0|||
160840379|NCT02718716|580802502|FG002|Overall Study|Lack of Efficacy|0|||
160840380|NCT02718716|580802503|FG003|Overall Study|Lack of Efficacy|0|||
160840381|NCT02718716|580802504|FG004|Overall Study|Lack of Efficacy|0|||
160840382|NCT01835158|580802505|FG000|Overall Study|Withdrawal by Subject|1|||
160991950|NCT04888585|581359931|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160840383|NCT01835158|580802506|FG001|Overall Study|Withdrawal by Subject|6|||
160840384|NCT00596830|580802509|FG000|Overall Study|Death|258|||
160840385|NCT00596830|580802510|FG001|Overall Study|Death|247|||
160840386|NCT00596830|580802509|FG000|Overall Study|Lost to Follow-up|7|||
160840387|NCT00596830|580802510|FG001|Overall Study|Lost to Follow-up|11|||
160840388|NCT00596830|580802509|FG000|Overall Study|Withdrawal by Subject|22|||
160840389|NCT00596830|580802510|FG001|Overall Study|Withdrawal by Subject|12|||
160840390|NCT00596830|580802509|FG000|Overall Study|Study terminated by sponsor|51|||
160840391|NCT00596830|580802510|FG001|Overall Study|Study terminated by sponsor|62|||
160840392|NCT00596830|580802509|FG000|Overall Study|Follow-up was discontinued|1|||
160840393|NCT00596830|580802510|FG001|Overall Study|Follow-up was discontinued|0|||
160840394|NCT00596830|580802509|FG000|Overall Study|Randomized but not treated|3|||
160840395|NCT00596830|580802510|FG001|Overall Study|Randomized but not treated|7|||
160840396|NCT01919801|580802513|FG000|Overall Study|Withdrawal by Subject|1|||
160840397|NCT01919801|580802514|FG001|Overall Study|Withdrawal by Subject|0|||
160840398|NCT01919801|580802513|FG000|Overall Study|Physician Decision|0|||
160840399|NCT01919801|580802514|FG001|Overall Study|Physician Decision|1|||
160840400|NCT01919801|580802513|FG000|Overall Study|Lost to Follow-up|0|||
160840401|NCT01919801|580802514|FG001|Overall Study|Lost to Follow-up|1|||
160840402|NCT01919801|580802513|FG000|Overall Study|Other|0|||
160840403|NCT01919801|580802514|FG001|Overall Study|Other|1|||
160840404|NCT01677858|580802519|FG000|Overall Study|Adverse Event|0|||
160840405|NCT01677858|580802520|FG001|Overall Study|Adverse Event|0|||
160840406|NCT01677858|580802521|FG002|Overall Study|Adverse Event|2|||
160840407|NCT01677858|580802522|FG003|Overall Study|Adverse Event|3|||
160840408|NCT01677858|580802523|FG004|Overall Study|Adverse Event|13|||
160840409|NCT01677858|580802519|FG000|Overall Study|Death|0|||
160840410|NCT01677858|580802520|FG001|Overall Study|Death|0|||
160840411|NCT01677858|580802521|FG002|Overall Study|Death|0|||
160840412|NCT01677858|580802522|FG003|Overall Study|Death|0|||
160840413|NCT01677858|580802523|FG004|Overall Study|Death|1|||
160840414|NCT01677858|580802519|FG000|Overall Study|Physician Decision|1|||
160840415|NCT01677858|580802520|FG001|Overall Study|Physician Decision|0|||
160840416|NCT01677858|580802521|FG002|Overall Study|Physician Decision|2|||
160840417|NCT01677858|580802522|FG003|Overall Study|Physician Decision|0|||
160840418|NCT01677858|580802523|FG004|Overall Study|Physician Decision|12|||
160840419|NCT01677858|580802519|FG000|Overall Study|Progressive Disease|2|||
160840420|NCT01677858|580802520|FG001|Overall Study|Progressive Disease|1|||
160840421|NCT01677858|580802521|FG002|Overall Study|Progressive Disease|9|||
160840422|NCT01677858|580802522|FG003|Overall Study|Progressive Disease|3|||
160840423|NCT01677858|580802523|FG004|Overall Study|Progressive Disease|43|||
160840424|NCT01677858|580802519|FG000|Overall Study|Withdrawal by Subject|0|||
160840425|NCT01677858|580802520|FG001|Overall Study|Withdrawal by Subject|1|||
160840426|NCT01677858|580802521|FG002|Overall Study|Withdrawal by Subject|1|||
160840427|NCT01677858|580802522|FG003|Overall Study|Withdrawal by Subject|0|||
160840428|NCT01677858|580802523|FG004|Overall Study|Withdrawal by Subject|15|||
160840429|NCT01677858|580802519|FG000|Overall Study|Lost to Follow-up|0|||
160840430|NCT01677858|580802520|FG001|Overall Study|Lost to Follow-up|0|||
160840431|NCT01677858|580802521|FG002|Overall Study|Lost to Follow-up|0|||
160840432|NCT01677858|580802522|FG003|Overall Study|Lost to Follow-up|0|||
160840433|NCT01677858|580802523|FG004|Overall Study|Lost to Follow-up|1|||
160840434|NCT00988091|580802524|FG000|Double-blind Period|Withdrawal by Subject|15|||
160840435|NCT00988091|580802525|FG001|Double-blind Period|Withdrawal by Subject|13|||
160840436|NCT00988091|580802524|FG000|Double-blind Period|Lost to Follow-up|12|||
160840437|NCT00988091|580802525|FG001|Double-blind Period|Lost to Follow-up|14|||
160840438|NCT00988091|580802524|FG000|Double-blind Period|Other|8|||
160840439|NCT00988091|580802525|FG001|Double-blind Period|Other|8|||
160840440|NCT00988091|580802524|FG000|Double-blind Period|Adverse Event|6|||
160840441|NCT00988091|580802525|FG001|Double-blind Period|Adverse Event|9|||
160840442|NCT00988091|580802524|FG000|Double-blind Period|Use of exclusionary medication|2|||
160840443|NCT00988091|580802525|FG001|Double-blind Period|Use of exclusionary medication|3|||
160840444|NCT00988091|580802524|FG000|Open-label Period|Adverse Event|4|||
160840445|NCT00988091|580802525|FG001|Open-label Period|Adverse Event|7|||
160840446|NCT00988091|580802524|FG000|Open-label Period|Use of exclusionary medication|1|||
160840447|NCT00988091|580802525|FG001|Open-label Period|Use of exclusionary medication|1|||
160840448|NCT00988091|580802524|FG000|Open-label Period|Protocol Violation|1|||
160840449|NCT00988091|580802525|FG001|Open-label Period|Protocol Violation|1|||
160840450|NCT00988091|580802524|FG000|Open-label Period|Withdrawal by Subject|10|||
160840451|NCT00988091|580802525|FG001|Open-label Period|Withdrawal by Subject|16|||
160840452|NCT00988091|580802524|FG000|Open-label Period|Lost to Follow-up|3|||
160905175|NCT01001377|581048147|FG001|Overall Study|Withdrawal by Subject|20|||
160905176|NCT01001377|581048146|FG000|Overall Study|Lost to Follow-up|14|||
160905177|NCT01001377|581048147|FG001|Overall Study|Lost to Follow-up|17|||
160905178|NCT01001377|581048146|FG000|Overall Study|Death|391|||
160905179|NCT01001377|581048147|FG001|Overall Study|Death|384|||
160905180|NCT02732119|581048150|FG000|Phase I|Adverse Event|1|||
160905181|NCT02732119|581048151|FG001|Phase I|Adverse Event|3|||
160905182|NCT02732119|581048152|FG002|Phase I|Adverse Event|1|||
160905183|NCT02732119|581048153|FG003|Phase I|Adverse Event|0|||
160905184|NCT02732119|581048154|FG004|Phase I|Adverse Event|0|||
160905185|NCT02732119|581048150|FG000|Phase I|Progressive disease|7|||
160905186|NCT02732119|581048151|FG001|Phase I|Progressive disease|3|||
160905187|NCT02732119|581048152|FG002|Phase I|Progressive disease|2|||
160905188|NCT02732119|581048153|FG003|Phase I|Progressive disease|0|||
160905189|NCT02732119|581048154|FG004|Phase I|Progressive disease|0|||
160905190|NCT02732119|581048150|FG000|Phase I|Protocol deviation|0|||
160905191|NCT02732119|581048151|FG001|Phase I|Protocol deviation|1|||
160905192|NCT02732119|581048152|FG002|Phase I|Protocol deviation|0|||
160905193|NCT02732119|581048153|FG003|Phase I|Protocol deviation|0|||
160905194|NCT02732119|581048154|FG004|Phase I|Protocol deviation|0|||
160905195|NCT02732119|581048150|FG000|Phase I|Physician Decision|0|||
160905196|NCT02732119|581048151|FG001|Phase I|Physician Decision|3|||
160905197|NCT02732119|581048152|FG002|Phase I|Physician Decision|4|||
160905198|NCT02732119|581048153|FG003|Phase I|Physician Decision|0|||
160905199|NCT02732119|581048154|FG004|Phase I|Physician Decision|0|||
160905200|NCT02732119|581048150|FG000|Phase II|Adverse Event|0|||
160905201|NCT02732119|581048151|FG001|Phase II|Adverse Event|0|||
160905202|NCT02732119|581048152|FG002|Phase II|Adverse Event|0|||
160905203|NCT02732119|581048153|FG003|Phase II|Adverse Event|3|||
160905204|NCT02732119|581048154|FG004|Phase II|Adverse Event|3|||
160905205|NCT02732119|581048150|FG000|Phase II|Death|0|||
160905206|NCT02732119|581048151|FG001|Phase II|Death|0|||
160905207|NCT02732119|581048152|FG002|Phase II|Death|0|||
160905208|NCT02732119|581048153|FG003|Phase II|Death|1|||
160905209|NCT02732119|581048154|FG004|Phase II|Death|0|||
160905210|NCT02732119|581048150|FG000|Phase II|Progressive dissease|0|||
160905211|NCT02732119|581048151|FG001|Phase II|Progressive dissease|0|||
160905212|NCT02732119|581048152|FG002|Phase II|Progressive dissease|0|||
160905213|NCT02732119|581048153|FG003|Phase II|Progressive dissease|30|||
160905214|NCT02732119|581048154|FG004|Phase II|Progressive dissease|23|||
160905215|NCT02732119|581048150|FG000|Phase II|Study terminated by sponsor|0|||
160905216|NCT02732119|581048151|FG001|Phase II|Study terminated by sponsor|0|||
160905217|NCT02732119|581048152|FG002|Phase II|Study terminated by sponsor|0|||
160905218|NCT02732119|581048153|FG003|Phase II|Study terminated by sponsor|2|||
160905219|NCT02732119|581048154|FG004|Phase II|Study terminated by sponsor|2|||
160905220|NCT02732119|581048150|FG000|Phase II|Other|0|||
160905221|NCT02732119|581048151|FG001|Phase II|Other|0|||
160905222|NCT02732119|581048152|FG002|Phase II|Other|0|||
160905223|NCT02732119|581048153|FG003|Phase II|Other|2|||
160905224|NCT02732119|581048154|FG004|Phase II|Other|0|||
160905225|NCT02732119|581048150|FG000|Phase II|Physician Decision|0|||
160905226|NCT02732119|581048151|FG001|Phase II|Physician Decision|0|||
160905227|NCT02732119|581048152|FG002|Phase II|Physician Decision|0|||
160905228|NCT02732119|581048153|FG003|Phase II|Physician Decision|8|||
160905229|NCT02732119|581048154|FG004|Phase II|Physician Decision|5|||
160905230|NCT00964860|581048155|FG000|Overall Study|Withdrawal by Subject|0|||
160905231|NCT00964860|581048156|FG001|Overall Study|Withdrawal by Subject|1|||
160905232|NCT00867568|581048157|FG000|Overall Study|Lack of Efficacy|10|||
160905233|NCT00867568|581048157|FG000|Overall Study|Adverse Event|4|||
160905234|NCT00867568|581048157|FG000|Overall Study|Withdrawal by Subject|1|||
160905235|NCT04343261|581048158|FG000|Overall Study|Adverse Event|1|||
160905236|NCT04343261|581048158|FG000|Overall Study|received inadequate amount of antibodies|7|||
160905237|NCT01056653|581048159|FG000|Overall Study|Lost to Follow-up|0|||
160905238|NCT01056653|581048160|FG001|Overall Study|Lost to Follow-up|0|||
160905239|NCT01056653|581048161|FG002|Overall Study|Lost to Follow-up|2|||
160905240|NCT05275400|581048162|FG000|Treatment Period|Adverse Event|7|||
160905241|NCT05275400|581048163|FG001|Treatment Period|Adverse Event|1|||
160905242|NCT05275400|581048162|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
160905243|NCT05275400|581048163|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
160905244|NCT05275400|581048162|FG000|Treatment Period|Death|5|||
160905245|NCT05275400|581048163|FG001|Treatment Period|Death|2|||
160905246|NCT05275400|581048162|FG000|Treatment Period|Protocol Violation|1|||
160905247|NCT05275400|581048163|FG001|Treatment Period|Protocol Violation|0|||
160905248|NCT05275400|581048162|FG000|Treatment Period|Physician Decision|5|||
160905249|NCT05275400|581048163|FG001|Treatment Period|Physician Decision|4|||
160905250|NCT05275400|581048162|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
160905251|NCT05275400|581048163|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
160905252|NCT05275400|581048162|FG000|Treatment Period|Withdrawal by Subject|30|||
160905253|NCT05275400|581048163|FG001|Treatment Period|Withdrawal by Subject|12|||
160905254|NCT05275400|581048162|FG000|Treatment Period|Lost to Follow-up|1|||
160905255|NCT05275400|581048163|FG001|Treatment Period|Lost to Follow-up|5|||
160905256|NCT05275400|581048162|FG000|Treatment Period|Lack of Efficacy|1|||
160840453|NCT00988091|580802525|FG001|Open-label Period|Lost to Follow-up|5|||
160564675|NCT03263091|579788666|FG000|DB Component|Lost to Follow-up|0|||
160564676|NCT03263091|579788667|FG001|DB Component|Lost to Follow-up|0|||
160564677|NCT03263091|579788668|FG002|DB Component|Lost to Follow-up|0|||
160564678|NCT03263091|579788669|FG003|DB Component|Lost to Follow-up|0|||
160840454|NCT00988091|580802524|FG000|Open-label Period|Other|2|||
160840455|NCT00988091|580802525|FG001|Open-label Period|Other|3|||
160840456|NCT03078855|580802529|FG000|Overall Study|Lack of Efficacy|62|||
160840457|NCT03078855|580802530|FG001|Overall Study|Lack of Efficacy|31|||
160564679|NCT03263091|579788670|FG004|DB Component|Lost to Follow-up|2|||
160564680|NCT03263091|579788671|FG005|DB Component|Lost to Follow-up|1|||
160564681|NCT03263091|579788666|FG000|DB Component|Death|0|||
160564682|NCT03263091|579788667|FG001|DB Component|Death|0|||
160564683|NCT03263091|579788668|FG002|DB Component|Death|0|||
160564684|NCT03263091|579788669|FG003|DB Component|Death|0|||
160564685|NCT03263091|579788670|FG004|DB Component|Death|7|||
160564686|NCT03263091|579788671|FG005|DB Component|Death|4|||
160564687|NCT03263091|579788666|FG000|DB Component|Other than specified|0|||
160564688|NCT03263091|579788667|FG001|DB Component|Other than specified|0|||
160564689|NCT03263091|579788668|FG002|DB Component|Other than specified|0|||
160564690|NCT03263091|579788669|FG003|DB Component|Other than specified|0|||
160564691|NCT03263091|579788670|FG004|DB Component|Other than specified|8|||
160564692|NCT03263091|579788671|FG005|DB Component|Other than specified|6|||
160564693|NCT00265941|579788673|FG000|Overall Study|Protocol Violation|22|||
160564694|NCT00265941|579788674|FG001|Overall Study|Protocol Violation|25|||
160564695|NCT00265941|579788673|FG000|Overall Study|Lost to Follow-up|1|||
160564696|NCT00265941|579788674|FG001|Overall Study|Lost to Follow-up|1|||
160564697|NCT03976401|579788684|FG000|Overall Study|Adverse Event|2|||
160564698|NCT03976401|579788685|FG001|Overall Study|Adverse Event|0|||
160564699|NCT03976401|579788686|FG002|Overall Study|Adverse Event|4|||
160564700|NCT03976401|579788687|FG003|Overall Study|Adverse Event|1|||
160564701|NCT03976401|579788688|FG004|Overall Study|Adverse Event|1|||
160564702|NCT03976401|579788689|FG005|Overall Study|Adverse Event|0|||
160564703|NCT03976401|579788684|FG000|Overall Study|Withdrawal by Subject|0|||
160564704|NCT03976401|579788685|FG001|Overall Study|Withdrawal by Subject|1|||
160564705|NCT03976401|579788686|FG002|Overall Study|Withdrawal by Subject|0|||
160564706|NCT03976401|579788687|FG003|Overall Study|Withdrawal by Subject|0|||
160564707|NCT03976401|579788688|FG004|Overall Study|Withdrawal by Subject|0|||
160564708|NCT03976401|579788689|FG005|Overall Study|Withdrawal by Subject|1|||
160564709|NCT03976401|579788684|FG000|Overall Study|Physician Decision|0|||
160564710|NCT03976401|579788685|FG001|Overall Study|Physician Decision|0|||
160564711|NCT03976401|579788686|FG002|Overall Study|Physician Decision|1|||
160840458|NCT03078855|580802529|FG000|Overall Study|Death|1|||
160840459|NCT03078855|580802530|FG001|Overall Study|Death|0|||
160840460|NCT03078855|580802529|FG000|Overall Study|Withdrawal by Subject|12|||
160840461|NCT03078855|580802530|FG001|Overall Study|Withdrawal by Subject|6|||
160840462|NCT03078855|580802529|FG000|Overall Study|Physician Decision|3|||
160840463|NCT03078855|580802530|FG001|Overall Study|Physician Decision|2|||
160840464|NCT03078855|580802529|FG000|Overall Study|Second Malignancy|4|||
160905257|NCT05275400|581048163|FG001|Treatment Period|Lack of Efficacy|0|||
160840465|NCT03078855|580802530|FG001|Overall Study|Second Malignancy|0|||
160840466|NCT03078855|580802529|FG000|Overall Study|Ineligible|2|||
160840467|NCT03078855|580802530|FG001|Overall Study|Ineligible|0|||
160840468|NCT03078855|580802529|FG000|Overall Study|Withdrew before day 1 treatment|2|||
160840469|NCT03078855|580802530|FG001|Overall Study|Withdrew before day 1 treatment|1|||
160905258|NCT05275400|581048162|FG000|Treatment Period|Sponsor Decision|1|||
160905259|NCT05275400|581048163|FG001|Treatment Period|Sponsor Decision|0|||
160905260|NCT05275400|581048162|FG000|Follow-Up Period|Death|2|||
160905261|NCT05275400|581048163|FG001|Follow-Up Period|Death|0|||
160905262|NCT05275400|581048162|FG000|Follow-Up Period|Protocol Violation|1|||
160905263|NCT05275400|581048163|FG001|Follow-Up Period|Protocol Violation|0|||
160564712|NCT03976401|579788687|FG003|Overall Study|Physician Decision|0|||
160564713|NCT03976401|579788688|FG004|Overall Study|Physician Decision|0|||
160840470|NCT03194646|580802531|FG000|Overall Study|Adverse Event|24|||
160840471|NCT03194646|580802532|FG001|Overall Study|Adverse Event|25|||
160840472|NCT03194646|580802533|FG002|Overall Study|Adverse Event|14|||
160840473|NCT03194646|580802534|FG003|Overall Study|Adverse Event|17|||
160840474|NCT03194646|580802531|FG000|Overall Study|Lack of Efficacy|4|||
160840475|NCT03194646|580802532|FG001|Overall Study|Lack of Efficacy|2|||
160564714|NCT03976401|579788689|FG005|Overall Study|Physician Decision|0|||
160564715|NCT03976401|579788684|FG000|Overall Study|Lost to Follow-up|1|||
160564716|NCT03976401|579788685|FG001|Overall Study|Lost to Follow-up|2|||
160564717|NCT03976401|579788686|FG002|Overall Study|Lost to Follow-up|0|||
160564718|NCT03976401|579788687|FG003|Overall Study|Lost to Follow-up|0|||
160564719|NCT03976401|579788688|FG004|Overall Study|Lost to Follow-up|0|||
160564720|NCT03976401|579788689|FG005|Overall Study|Lost to Follow-up|0|||
160564721|NCT03976401|579788684|FG000|Overall Study|Protocol Violation|0|||
160564722|NCT03976401|579788685|FG001|Overall Study|Protocol Violation|1|||
160840476|NCT03194646|580802533|FG002|Overall Study|Lack of Efficacy|2|||
160905264|NCT05275400|581048162|FG000|Follow-Up Period|Withdrawal by Subject|3|||
160905265|NCT05275400|581048163|FG001|Follow-Up Period|Withdrawal by Subject|0|||
160564723|NCT03976401|579788686|FG002|Overall Study|Protocol Violation|0|||
160564724|NCT03976401|579788687|FG003|Overall Study|Protocol Violation|0|||
160564725|NCT03976401|579788688|FG004|Overall Study|Protocol Violation|0|||
160564726|NCT03976401|579788689|FG005|Overall Study|Protocol Violation|0|||
160564727|NCT03976401|579788684|FG000|Overall Study|Withdrew Consent|0|||
160564728|NCT03976401|579788685|FG001|Overall Study|Withdrew Consent|0|||
160564729|NCT03976401|579788686|FG002|Overall Study|Withdrew Consent|0|||
160564730|NCT03976401|579788687|FG003|Overall Study|Withdrew Consent|1|||
160564731|NCT03976401|579788688|FG004|Overall Study|Withdrew Consent|0|||
160564732|NCT03976401|579788689|FG005|Overall Study|Withdrew Consent|0|||
160564733|NCT04125680|579788690|FG000|Overall Study|Lost to Follow-up|15|||
160564734|NCT02210780|579788691|FG000|Overall Study|Adverse Event|0|||
160564735|NCT02210780|579788692|FG001|Overall Study|Adverse Event|5|||
160564736|NCT02210780|579788691|FG000|Overall Study|Lost to Follow-up|2|||
160564737|NCT02210780|579788692|FG001|Overall Study|Lost to Follow-up|1|||
160564738|NCT02210780|579788691|FG000|Overall Study|Withdrawal by Subject|1|||
160564739|NCT02210780|579788692|FG001|Overall Study|Withdrawal by Subject|1|||
160564740|NCT02210780|579788691|FG000|Overall Study|Physician Decision|1|||
160564741|NCT02210780|579788692|FG001|Overall Study|Physician Decision|0|||
160564742|NCT02210780|579788691|FG000|Overall Study|Protocol Violation|1|||
160564743|NCT02210780|579788692|FG001|Overall Study|Protocol Violation|0|||
160564744|NCT02210780|579788691|FG000|Overall Study|Other than specified above|0|||
160564745|NCT02210780|579788692|FG001|Overall Study|Other than specified above|1|||
160564746|NCT00391976|579788693|FG000|Overall Study|Adverse Event|0|||
160564747|NCT00391976|579788694|FG001|Overall Study|Adverse Event|0|||
160564748|NCT00391976|579788695|FG002|Overall Study|Adverse Event|1|||
160564749|NCT00391976|579788693|FG000|Overall Study|Withdrawal of consent|0|||
160564750|NCT00391976|579788694|FG001|Overall Study|Withdrawal of consent|1|||
160564751|NCT00391976|579788695|FG002|Overall Study|Withdrawal of consent|1|||
160564752|NCT00391976|579788693|FG000|Overall Study|Lost to Follow-up|1|||
160564753|NCT00391976|579788694|FG001|Overall Study|Lost to Follow-up|2|||
160564754|NCT00391976|579788695|FG002|Overall Study|Lost to Follow-up|0|||
160564755|NCT00391976|579788693|FG000|Overall Study|Inappropriate enrollment|1|||
160564756|NCT00391976|579788694|FG001|Overall Study|Inappropriate enrollment|1|||
160564757|NCT00391976|579788695|FG002|Overall Study|Inappropriate enrollment|0|||
160564758|NCT00391976|579788693|FG000|Overall Study|Protocol deviation/violation|4|||
160564759|NCT00391976|579788694|FG001|Overall Study|Protocol deviation/violation|2|||
160564760|NCT00391976|579788695|FG002|Overall Study|Protocol deviation/violation|1|||
160564761|NCT00391976|579788693|FG000|Overall Study|Recurrence/no eradication of infection|21|||
160564762|NCT00391976|579788694|FG001|Overall Study|Recurrence/no eradication of infection|19|||
160564763|NCT00391976|579788695|FG002|Overall Study|Recurrence/no eradication of infection|0|||
160564764|NCT00391976|579788693|FG000|Overall Study|Unable to classify|0|||
160564765|NCT00391976|579788694|FG001|Overall Study|Unable to classify|0|||
160840477|NCT03194646|580802534|FG003|Overall Study|Lack of Efficacy|12|||
160840478|NCT03194646|580802531|FG000|Overall Study|Lost to Follow-up|30|||
160840479|NCT03194646|580802532|FG001|Overall Study|Lost to Follow-up|22|||
160840480|NCT03194646|580802533|FG002|Overall Study|Lost to Follow-up|12|||
160840481|NCT03194646|580802534|FG003|Overall Study|Lost to Follow-up|35|||
160840482|NCT03194646|580802531|FG000|Overall Study|Non-compliance with study drug|4|||
160840483|NCT03194646|580802532|FG001|Overall Study|Non-compliance with study drug|0|||
160840484|NCT03194646|580802533|FG002|Overall Study|Non-compliance with study drug|1|||
160840485|NCT03194646|580802534|FG003|Overall Study|Non-compliance with study drug|1|||
160840486|NCT03194646|580802531|FG000|Overall Study|Other|89|||
160840487|NCT03194646|580802532|FG001|Overall Study|Other|68|||
160840488|NCT03194646|580802533|FG002|Overall Study|Other|34|||
160840489|NCT03194646|580802534|FG003|Overall Study|Other|31|||
160840490|NCT03194646|580802531|FG000|Overall Study|Physician Decision|7|||
160840491|NCT03194646|580802532|FG001|Overall Study|Physician Decision|9|||
160840492|NCT03194646|580802533|FG002|Overall Study|Physician Decision|5|||
160991951|NCT04888585|581359932|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
160564766|NCT00391976|579788695|FG002|Overall Study|Unable to classify|1|||
160564767|NCT00391976|579788693|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
160564768|NCT00391976|579788694|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
160564769|NCT00391976|579788695|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
160564770|NCT00049127|579788696|FG000|Overall Study|Withdrawal by Subject|0|||
160564771|NCT00049127|579788697|FG001|Overall Study|Withdrawal by Subject|0|||
160564772|NCT00049127|579788698|FG002|Overall Study|Withdrawal by Subject|1|||
160564773|NCT00049127|579788699|FG003|Overall Study|Withdrawal by Subject|0|||
160564774|NCT00049127|579788700|FG004|Overall Study|Withdrawal by Subject|0|||
160564775|NCT02582515|579788701|FG000|Overall Study|Withdrawal by Subject|0|||
160564776|NCT02582515|579788702|FG001|Overall Study|Withdrawal by Subject|1|||
160564777|NCT02197377|579788707|FG000|Overall Study|Insertion Failure|0|||
160564778|NCT02197377|579788708|FG001|Overall Study|Insertion Failure|3|||
160840493|NCT03194646|580802534|FG003|Overall Study|Physician Decision|4|||
160840494|NCT03194646|580802531|FG000|Overall Study|Pregnancy|4|||
160840495|NCT03194646|580802532|FG001|Overall Study|Pregnancy|5|||
160840496|NCT03194646|580802533|FG002|Overall Study|Pregnancy|1|||
160840497|NCT03194646|580802534|FG003|Overall Study|Pregnancy|2|||
160840498|NCT03194646|580802531|FG000|Overall Study|Protocol Violation|4|||
160840499|NCT03194646|580802532|FG001|Overall Study|Protocol Violation|2|||
160840500|NCT03194646|580802533|FG002|Overall Study|Protocol Violation|1|||
160840501|NCT03194646|580802534|FG003|Overall Study|Protocol Violation|1|||
160840502|NCT03194646|580802531|FG000|Overall Study|Site terminated by sponsor|0|||
160840503|NCT03194646|580802532|FG001|Overall Study|Site terminated by sponsor|0|||
160840504|NCT03194646|580802533|FG002|Overall Study|Site terminated by sponsor|2|||
160840505|NCT03194646|580802534|FG003|Overall Study|Site terminated by sponsor|0|||
160840506|NCT03194646|580802531|FG000|Overall Study|Study terminated by sponsor|62|||
160840507|NCT03194646|580802532|FG001|Overall Study|Study terminated by sponsor|61|||
160840508|NCT03194646|580802533|FG002|Overall Study|Study terminated by sponsor|30|||
160840509|NCT03194646|580802534|FG003|Overall Study|Study terminated by sponsor|34|||
160840510|NCT03194646|580802531|FG000|Overall Study|Withdrawal by Subject|75|||
160840511|NCT03194646|580802532|FG001|Overall Study|Withdrawal by Subject|74|||
160840512|NCT03194646|580802533|FG002|Overall Study|Withdrawal by Subject|36|||
160840513|NCT03194646|580802534|FG003|Overall Study|Withdrawal by Subject|131|||
160840514|NCT03194646|580802531|FG000|Overall Study|Missing|1|||
160840515|NCT03194646|580802532|FG001|Overall Study|Missing|0|||
160840516|NCT03194646|580802533|FG002|Overall Study|Missing|1|||
160840517|NCT03194646|580802534|FG003|Overall Study|Missing|12|||
160840518|NCT04869358|580802535|FG000|Overall Study|Wish to have children.|1|||
160840519|NCT04869358|580802536|FG001|Overall Study|Wish to have children.|0|||
160840520|NCT04869358|580802537|FG002|Overall Study|Wish to have children.|0|||
160840521|NCT04869358|580802538|FG003|Overall Study|Wish to have children.|0|||
160840522|NCT04427072|580802539|FG000|Randomized Treatment Phase|Progressive disease|9|||
160840523|NCT04427072|580802540|FG001|Randomized Treatment Phase|Progressive disease|4|||
160840524|NCT04427072|580802539|FG000|Randomized Treatment Phase|Adverse Event|3|||
160840525|NCT04427072|580802540|FG001|Randomized Treatment Phase|Adverse Event|1|||
160840526|NCT04427072|580802539|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
160840527|NCT04427072|580802540|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
160840528|NCT04427072|580802539|FG000|Randomized Treatment Phase|Death|0|||
160840529|NCT04427072|580802540|FG001|Randomized Treatment Phase|Death|1|||
160840530|NCT04427072|580802539|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
160840531|NCT04427072|580802540|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
160840532|NCT04427072|580802539|FG000|Extension Treatment Phase|Progressive disease|0|||
160840533|NCT04427072|580802540|FG001|Extension Treatment Phase|Progressive disease|5|||
160840534|NCT03550404|580802545|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
160840535|NCT03550404|580802546|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
160840536|NCT03550404|580802547|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
160840537|NCT03550404|580802545|FG000|Phase 2|Vacated position|1|||
160840538|NCT03550404|580802546|FG001|Phase 2|Vacated position|0|||
160840539|NCT03550404|580802547|FG002|Phase 2|Vacated position|0|||
160840540|NCT00820222|580802550|FG000|Overall Study|Lost to Follow-up|10|||
160840541|NCT00820222|580802551|FG001|Overall Study|Lost to Follow-up|9|||
160840542|NCT00820222|580802550|FG000|Overall Study|Withdrawal by Subject|19|||
160840543|NCT00820222|580802551|FG001|Overall Study|Withdrawal by Subject|21|||
160840544|NCT00820222|580802550|FG000|Overall Study|Physician Decision|93|||
160840545|NCT00820222|580802551|FG001|Overall Study|Physician Decision|88|||
160840546|NCT00820222|580802550|FG000|Overall Study|Sponsor Terminated Study|43|||
160840547|NCT00820222|580802551|FG001|Overall Study|Sponsor Terminated Study|65|||
160840548|NCT00820222|580802550|FG000|Overall Study|Unkown|11|||
160840549|NCT00820222|580802551|FG001|Overall Study|Unkown|7|||
160840550|NCT02690714|580802552|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
160840551|NCT02690714|580802552|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
160840552|NCT01894022|580802563|FG000|Overall Study|Death|1|||
160840553|NCT01894022|580802564|FG001|Overall Study|Death|0|||
160840554|NCT01894022|580802563|FG000|Overall Study|Adverse Event, non-fatal|1|||
160840555|NCT01894022|580802564|FG001|Overall Study|Adverse Event, non-fatal|0|||
160905266|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Physician Decision|0|||
160840556|NCT01894022|580802563|FG000|Overall Study|Study Closed/terminated|7|||
160840557|NCT01894022|580802564|FG001|Overall Study|Study Closed/terminated|10|||
160840558|NCT02202538|580802566|FG000|Overall Study|Withdrawal by Subject|5|||
160840559|NCT02202538|580802566|FG000|Overall Study|Did not meet all inclusion criteria|2|||
160840560|NCT02202538|580802566|FG000|Overall Study|Investigator Decision|1|||
160840561|NCT04496453|580802567|FG000|Overall Study|Lost to Follow-up|6|||
160840562|NCT00767819|580802568|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
160840563|NCT00767819|580802569|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
160840564|NCT00767819|580802570|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160840565|NCT00767819|580802568|FG000|Overall Study|Withdrawal by Subject|1|||
160840566|NCT00767819|580802569|FG001|Overall Study|Withdrawal by Subject|1|||
160840567|NCT00767819|580802570|FG002|Overall Study|Withdrawal by Subject|0|||
160840568|NCT00767819|580802568|FG000|Overall Study|Administrative problems|0|||
160564779|NCT00502840|579788709|FG000|Overall Study|Adverse Event|5|||
160840569|NCT00767819|580802569|FG001|Overall Study|Administrative problems|1|||
160840570|NCT00767819|580802570|FG002|Overall Study|Administrative problems|0|||
160840571|NCT00767819|580802568|FG000|Overall Study|Death|2|||
160840572|NCT00767819|580802569|FG001|Overall Study|Death|3|||
160840573|NCT00767819|580802570|FG002|Overall Study|Death|0|||
160840574|NCT00767819|580802568|FG000|Overall Study|Adverse Event|2|||
160840575|NCT00767819|580802569|FG001|Overall Study|Adverse Event|0|||
160840576|NCT00767819|580802570|FG002|Overall Study|Adverse Event|0|||
160840577|NCT00767819|580802568|FG000|Overall Study|Abnormal lab values|1|||
160840578|NCT00767819|580802569|FG001|Overall Study|Abnormal lab values|0|||
160840579|NCT00767819|580802570|FG002|Overall Study|Abnormal lab values|0|||
160840580|NCT00767819|580802568|FG000|Overall Study|Lost to Follow-up|1|||
160840581|NCT00767819|580802569|FG001|Overall Study|Lost to Follow-up|0|||
160840582|NCT00767819|580802570|FG002|Overall Study|Lost to Follow-up|0|||
160840583|NCT03916081|580802571|FG000|Overall Study|Adverse Event|1|||
160840584|NCT03916081|580802572|FG001|Overall Study|Adverse Event|0|||
160840585|NCT03916081|580802573|FG002|Overall Study|Adverse Event|0|||
160840586|NCT03916081|580802571|FG000|Overall Study|Physician Decision|0|||
160840587|NCT03916081|580802572|FG001|Overall Study|Physician Decision|0|||
160840588|NCT03916081|580802573|FG002|Overall Study|Physician Decision|1|||
160840589|NCT03916081|580802571|FG000|Overall Study|Lost to Follow-up|0|||
160840590|NCT03916081|580802572|FG001|Overall Study|Lost to Follow-up|1|||
160840591|NCT03916081|580802573|FG002|Overall Study|Lost to Follow-up|0|||
160840592|NCT03916081|580802571|FG000|Overall Study|Withdrawal by Subject|3|||
160840593|NCT03916081|580802572|FG001|Overall Study|Withdrawal by Subject|0|||
160840594|NCT03916081|580802573|FG002|Overall Study|Withdrawal by Subject|1|||
160840595|NCT03916081|580802571|FG000|Overall Study|Worsening of AD|0|||
160840596|NCT03916081|580802572|FG001|Overall Study|Worsening of AD|0|||
160840597|NCT03916081|580802573|FG002|Overall Study|Worsening of AD|1|||
160840598|NCT01371305|580802577|FG000|Overall Study|Adverse Event|0|||
160840599|NCT01371305|580802578|FG001|Overall Study|Adverse Event|0|||
160840600|NCT01371305|580802579|FG002|Overall Study|Adverse Event|0|||
160840601|NCT01371305|580802580|FG003|Overall Study|Adverse Event|2|||
160840602|NCT01371305|580802581|FG004|Overall Study|Adverse Event|1|||
160840603|NCT01371305|580802582|FG005|Overall Study|Adverse Event|0|||
160840604|NCT01371305|580802577|FG000|Overall Study|Study terminated by sponsor|0|||
160905267|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Physician Decision|1|||
160905268|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Physician Decision|0|||
160905269|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
160905270|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
160905271|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
160905272|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
160905273|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
160564780|NCT00502840|579788709|FG000|Overall Study|Additional or changed therapy|48|||
160564781|NCT00502840|579788709|FG000|Overall Study|Lack of Efficacy|11|||
160564782|NCT00502840|579788709|FG000|Overall Study|Protocol Violation|4|||
160564783|NCT00502840|579788709|FG000|Overall Study|Withdrawal by Subject|5|||
160564784|NCT00502840|579788709|FG000|Overall Study|Lost to Follow-up|6|||
160905274|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
160905275|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Other|4|||
160905276|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Other|4|||
160905277|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Other|0|||
160564785|NCT00502840|579788709|FG000|Overall Study|Administrative problems|1|||
160564786|NCT00502840|579788709|FG000|Overall Study|Other|20|||
160564787|NCT00809133|579788710|FG000|Overall Study|Progressive disease|2|||
160564788|NCT00809133|579788711|FG001|Overall Study|Progressive disease|5|||
160564789|NCT00809133|579788712|FG002|Overall Study|Progressive disease|5|||
160564790|NCT00809133|579788713|FG003|Overall Study|Progressive disease|3|||
160905278|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
160905279|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
160905280|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
160564791|NCT00809133|579788714|FG004|Overall Study|Progressive disease|4|||
160564792|NCT00809133|579788715|FG005|Overall Study|Progressive disease|1|||
160840605|NCT01371305|580802578|FG001|Overall Study|Study terminated by sponsor|0|||
160840606|NCT01371305|580802579|FG002|Overall Study|Study terminated by sponsor|0|||
160840607|NCT01371305|580802580|FG003|Overall Study|Study terminated by sponsor|0|||
160840608|NCT01371305|580802581|FG004|Overall Study|Study terminated by sponsor|3|||
160840609|NCT01371305|580802582|FG005|Overall Study|Study terminated by sponsor|1|||
160840610|NCT01371305|580802577|FG000|Overall Study|Subject request|0|||
160840611|NCT01371305|580802578|FG001|Overall Study|Subject request|0|||
160840612|NCT01371305|580802579|FG002|Overall Study|Subject request|0|||
160840613|NCT01371305|580802580|FG003|Overall Study|Subject request|0|||
160840614|NCT01371305|580802581|FG004|Overall Study|Subject request|0|||
160840615|NCT01371305|580802582|FG005|Overall Study|Subject request|1|||
160840616|NCT00235716|580802583|FG000|Overall Study|Death|26|||
160840617|NCT00235716|580802584|FG001|Overall Study|Death|39|||
160840618|NCT00235716|580802585|FG002|Overall Study|Death|32|||
160840619|NCT00235716|580802586|FG003|Overall Study|Death|31|||
160905281|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Screen Failure|0|||
160564793|NCT00809133|579788716|FG006|Overall Study|Progressive disease|3|||
160564794|NCT00809133|579788717|FG007|Overall Study|Progressive disease|3|||
160564795|NCT00809133|579788718|FG008|Overall Study|Progressive disease|3|||
160564796|NCT00809133|579788719|FG009|Overall Study|Progressive disease|9|||
160564797|NCT00809133|579788720|FG010|Overall Study|Progressive disease|5|||
160564798|NCT00809133|579788721|FG011|Overall Study|Progressive disease|7|||
160564799|NCT00809133|579788722|FG012|Overall Study|Progressive disease|5|||
160564800|NCT00809133|579788723|FG013|Overall Study|Progressive disease|4|||
160564801|NCT00809133|579788710|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160564802|NCT00809133|579788711|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160564803|NCT00809133|579788712|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160564804|NCT00809133|579788713|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160564805|NCT00809133|579788714|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160840620|NCT00235716|580802583|FG000|Overall Study|Withdrawal by Subject|23|||
160840621|NCT00235716|580802584|FG001|Overall Study|Withdrawal by Subject|19|||
160564806|NCT00809133|579788715|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160564807|NCT00809133|579788716|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160564808|NCT00809133|579788717|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160564809|NCT00809133|579788718|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160564810|NCT00809133|579788719|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160564811|NCT00809133|579788720|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160564812|NCT00809133|579788721|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160564813|NCT00809133|579788722|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160564814|NCT00809133|579788723|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
160564815|NCT00809133|579788710|FG000|Overall Study|Other adverse event|1|||
160564816|NCT00809133|579788711|FG001|Overall Study|Other adverse event|1|||
160564817|NCT00809133|579788712|FG002|Overall Study|Other adverse event|1|||
160564818|NCT00809133|579788713|FG003|Overall Study|Other adverse event|0|||
160564819|NCT00809133|579788714|FG004|Overall Study|Other adverse event|0|||
160564820|NCT00809133|579788715|FG005|Overall Study|Other adverse event|3|||
160840622|NCT00235716|580802585|FG002|Overall Study|Withdrawal by Subject|17|||
160840623|NCT00235716|580802586|FG003|Overall Study|Withdrawal by Subject|18|||
160840624|NCT00235716|580802583|FG000|Overall Study|Lost to Follow-up|12|||
160840625|NCT00235716|580802584|FG001|Overall Study|Lost to Follow-up|7|||
160840626|NCT00235716|580802585|FG002|Overall Study|Lost to Follow-up|14|||
160840627|NCT00235716|580802586|FG003|Overall Study|Lost to Follow-up|10|||
160840628|NCT00235716|580802583|FG000|Overall Study|Adverse Event|1|||
160840629|NCT00235716|580802584|FG001|Overall Study|Adverse Event|1|||
160840630|NCT00235716|580802585|FG002|Overall Study|Adverse Event|1|||
160840631|NCT00235716|580802586|FG003|Overall Study|Adverse Event|0|||
160840632|NCT00235716|580802583|FG000|Overall Study|Physician Decision|0|||
160840633|NCT00235716|580802584|FG001|Overall Study|Physician Decision|1|||
160991952|NCT04888585|581359933|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
160991953|NCT04888585|581359934|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
160991954|NCT04888585|581359935|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
160991955|NCT04888585|581359936|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160991956|NCT03822351|581359937|FG000|Overall Study|Death|27|||
160991957|NCT03822351|581359938|FG001|Overall Study|Death|23|||
160991958|NCT03822351|581359939|FG002|Overall Study|Death|24|||
160840634|NCT00235716|580802585|FG002|Overall Study|Physician Decision|1|||
160840635|NCT00235716|580802586|FG003|Overall Study|Physician Decision|3|||
160840636|NCT02999633|580802587|FG000|Overall Study|Adverse Event|2|||
160840637|NCT02999633|580802587|FG000|Overall Study|Progressive disease|12|||
160840638|NCT01545050|580802588|FG000|Overall Study|Lack of Efficacy|0|||
160840639|NCT01545050|580802589|FG001|Overall Study|Lack of Efficacy|0|||
160840640|NCT01545050|580802590|FG002|Overall Study|Lack of Efficacy|0|||
160840641|NCT01545050|580802591|FG003|Overall Study|Lack of Efficacy|3|||
160840642|NCT01545050|580802592|FG004|Overall Study|Lack of Efficacy|2|||
160840643|NCT01545050|580802588|FG000|Overall Study|Adverse Event|1|||
160991959|NCT03822351|581359937|FG000|Overall Study|Lost to Follow-up|6|||
160991960|NCT03822351|581359938|FG001|Overall Study|Lost to Follow-up|2|||
160991961|NCT03822351|581359939|FG002|Overall Study|Lost to Follow-up|1|||
160991962|NCT03822351|581359937|FG000|Overall Study|Withdrawal by Subject|10|||
160840644|NCT01545050|580802589|FG001|Overall Study|Adverse Event|1|||
160991963|NCT03822351|581359938|FG001|Overall Study|Withdrawal by Subject|4|||
160991964|NCT03822351|581359939|FG002|Overall Study|Withdrawal by Subject|6|||
160991965|NCT03822351|581359937|FG000|Overall Study|Progressive Disease|2|||
160564821|NCT00809133|579788716|FG006|Overall Study|Other adverse event|2|||
160564822|NCT00809133|579788717|FG007|Overall Study|Other adverse event|4|||
160564823|NCT00809133|579788718|FG008|Overall Study|Other adverse event|0|||
160564824|NCT00809133|579788719|FG009|Overall Study|Other adverse event|0|||
160564825|NCT00809133|579788720|FG010|Overall Study|Other adverse event|1|||
160564826|NCT00809133|579788721|FG011|Overall Study|Other adverse event|1|||
160564827|NCT00809133|579788722|FG012|Overall Study|Other adverse event|0|||
160564828|NCT00809133|579788723|FG013|Overall Study|Other adverse event|1|||
160840645|NCT01545050|580802590|FG002|Overall Study|Adverse Event|2|||
160840646|NCT01545050|580802591|FG003|Overall Study|Adverse Event|2|||
160840647|NCT01545050|580802592|FG004|Overall Study|Adverse Event|0|||
160840648|NCT01545050|580802588|FG000|Overall Study|Discontinued study treatment|1|||
160840649|NCT01545050|580802589|FG001|Overall Study|Discontinued study treatment|0|||
160840650|NCT01545050|580802590|FG002|Overall Study|Discontinued study treatment|0|||
160840651|NCT01545050|580802591|FG003|Overall Study|Discontinued study treatment|0|||
160840652|NCT01545050|580802592|FG004|Overall Study|Discontinued study treatment|0|||
160840653|NCT01545050|580802588|FG000|Overall Study|Withdrawal by Subject|1|||
160840654|NCT01545050|580802589|FG001|Overall Study|Withdrawal by Subject|0|||
160905282|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Screen Failure|0|||
160905283|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Screen Failure|1|||
160905284|NCT02585960|581048164|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
160905285|NCT02585960|581048165|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
160905286|NCT02585960|581048166|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
160840655|NCT01545050|580802590|FG002|Overall Study|Withdrawal by Subject|0|||
160840656|NCT01545050|580802591|FG003|Overall Study|Withdrawal by Subject|2|||
160840657|NCT01545050|580802592|FG004|Overall Study|Withdrawal by Subject|1|||
160840658|NCT01545050|580802588|FG000|Overall Study|Participant no longer meets study criteria|0|||
160840659|NCT01545050|580802589|FG001|Overall Study|Participant no longer meets study criteria|2|||
160840660|NCT01545050|580802590|FG002|Overall Study|Participant no longer meets study criteria|0|||
160840661|NCT01545050|580802591|FG003|Overall Study|Participant no longer meets study criteria|0|||
160840662|NCT01545050|580802592|FG004|Overall Study|Participant no longer meets study criteria|1|||
160840663|NCT01545050|580802588|FG000|Overall Study|Administrative reason by sponsor|4|||
160840664|NCT01545050|580802589|FG001|Overall Study|Administrative reason by sponsor|2|||
160840665|NCT01545050|580802590|FG002|Overall Study|Administrative reason by sponsor|3|||
160840666|NCT01545050|580802591|FG003|Overall Study|Administrative reason by sponsor|5|||
160840667|NCT01545050|580802592|FG004|Overall Study|Administrative reason by sponsor|5|||
160840668|NCT02249182|580802595|FG000|Treatment Phase|Lost to Follow-up|4|||
160840669|NCT02249182|580802596|FG001|Treatment Phase|Lost to Follow-up|0|||
160840670|NCT02249182|580802597|FG002|Treatment Phase|Lost to Follow-up|0|||
160840671|NCT02249182|580802598|FG003|Treatment Phase|Lost to Follow-up|0|||
160840672|NCT02249182|580802599|FG004|Treatment Phase|Lost to Follow-up|0|||
160840673|NCT03244826|580802608|FG000|Overall Study|Withdrawal by Subject|2|||
160840674|NCT03244826|580802609|FG001|Overall Study|Withdrawal by Subject|0|||
160840675|NCT03244826|580802608|FG000|Overall Study|Transplant delayed or withdrawn|12|||
160840676|NCT03244826|580802609|FG001|Overall Study|Transplant delayed or withdrawn|10|||
160840677|NCT04356040|580802610|FG000|Overall Study|Death|2|||
160840678|NCT04356040|580802611|FG001|Overall Study|Death|0|||
160840679|NCT04356040|580802610|FG000|Overall Study|Lost to Follow-up|1|||
160840680|NCT04356040|580802611|FG001|Overall Study|Lost to Follow-up|0|||
160840681|NCT04356040|580802610|FG000|Overall Study|Physician Decision|0|||
160840682|NCT04356040|580802611|FG001|Overall Study|Physician Decision|1|||
160840683|NCT04356040|580802610|FG000|Overall Study|Withdrawal by Subject|13|||
160840684|NCT04356040|580802611|FG001|Overall Study|Withdrawal by Subject|1|||
160840685|NCT04356040|580802610|FG000|Overall Study|Enrollment Pause|10|||
160840686|NCT04356040|580802611|FG001|Overall Study|Enrollment Pause|0|||
160840687|NCT04356040|580802610|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
160840688|NCT04356040|580802611|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
160840689|NCT04356040|580802610|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
160840690|NCT04356040|580802611|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
160840691|NCT04356040|580802610|FG000|Overall Study|PI left institution|3|||
160840692|NCT04356040|580802611|FG001|Overall Study|PI left institution|0|||
160840693|NCT00416455|580802612|FG000|Overall Study|PET / CT not done|3|||
160840694|NCT00416455|580802613|FG001|Overall Study|PET / CT not done|5|||
160840695|NCT00416455|580802612|FG000|Overall Study|PET / CT poor quality|2|||
160840696|NCT00416455|580802613|FG001|Overall Study|PET / CT poor quality|1|||
160840697|NCT00416455|580802612|FG000|Overall Study|Inadequate pathology|11|||
160840698|NCT00416455|580802613|FG001|Overall Study|Inadequate pathology|2|||
160840699|NCT02456857|580802614|FG000|Overall Study|Disease Progression|4|||
160905287|NCT02585960|581048164|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
160905288|NCT02585960|581048165|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
160905289|NCT02585960|581048166|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
160905290|NCT06333613|581048168|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
160905291|NCT03727230|581048169|FG000|Overall Study|Lost to Follow-up|12|||
160905292|NCT00134082|581048171|FG000|Overall Study|Adverse Event|2|||
160905293|NCT00134082|581048171|FG000|Overall Study|Death|1|||
160905294|NCT00724932|581048174|FG000|Overall Study|Lost to Follow-up|1|||
160905295|NCT00724932|581048175|FG001|Overall Study|Lost to Follow-up|0|||
160840700|NCT00781859|580802615|FG000|Overall Study|Adverse Event|2|||
160840701|NCT00781859|580802616|FG001|Overall Study|Adverse Event|2|||
160905296|NCT00724932|581048174|FG000|Overall Study|Not treated|4|||
160840702|NCT00781859|580802615|FG000|Overall Study|Withdrawal by Subject|8|||
160840703|NCT00781859|580802616|FG001|Overall Study|Withdrawal by Subject|4|||
160840704|NCT00781859|580802615|FG000|Overall Study|Lost to Follow-up|6|||
160840705|NCT00781859|580802616|FG001|Overall Study|Lost to Follow-up|3|||
160840706|NCT00781859|580802615|FG000|Overall Study|Death|3|||
160840707|NCT00781859|580802616|FG001|Overall Study|Death|0|||
160840708|NCT01138501|580802617|FG000|Overall Study|Protocol Violation|2|||
160840709|NCT01138501|580802617|FG000|Overall Study|Withdrawal by Subject|3|||
160840710|NCT00360568|580802618|FG000|Overall Study|Adverse Event|1|||
160840711|NCT00360568|580802619|FG001|Overall Study|Adverse Event|2|||
160840712|NCT00360568|580802618|FG000|Overall Study|Lack of Efficacy|1|||
160840713|NCT00360568|580802619|FG001|Overall Study|Lack of Efficacy|0|||
160840714|NCT00360568|580802618|FG000|Overall Study|Withdrawal by Subject|0|||
160991966|NCT03822351|581359938|FG001|Overall Study|Progressive Disease|1|||
160840715|NCT00360568|580802619|FG001|Overall Study|Withdrawal by Subject|3|||
160840716|NCT01008449|580802620|FG000|Overall Study|Lost to Follow-up|29|||
160840717|NCT01008449|580802621|FG001|Overall Study|Lost to Follow-up|19|||
160840718|NCT01220180|580802622|FG000|Overall Study|Lost to Follow-up|76|||
160840719|NCT01220180|580802622|FG000|Overall Study|Other|72|||
160840720|NCT01220180|580802622|FG000|Overall Study|Adverse Event|35|||
160840721|NCT01220180|580802622|FG000|Overall Study|Lack of Efficacy|22|||
160840722|NCT01220180|580802622|FG000|Overall Study|Death|1|||
160840723|NCT01220180|580802622|FG000|Overall Study|Randomized but not treated|1|||
160840724|NCT00348309|580802623|FG000|Overall Study|Adverse Event|56|||
160840725|NCT00348309|580802624|FG001|Overall Study|Adverse Event|28|||
160840726|NCT00348309|580802625|FG002|Overall Study|Adverse Event|63|||
160840727|NCT00348309|580802623|FG000|Overall Study|Lost to Follow-up|6|||
160840728|NCT00348309|580802624|FG001|Overall Study|Lost to Follow-up|7|||
160840729|NCT00348309|580802625|FG002|Overall Study|Lost to Follow-up|4|||
160840730|NCT00348309|580802623|FG000|Overall Study|Protocol Violation|7|||
160840731|NCT00348309|580802624|FG001|Overall Study|Protocol Violation|12|||
160840732|NCT00348309|580802625|FG002|Overall Study|Protocol Violation|7|||
160840733|NCT00348309|580802623|FG000|Overall Study|Withdrawal by Subject|33|||
160840734|NCT00348309|580802624|FG001|Overall Study|Withdrawal by Subject|37|||
160840735|NCT00348309|580802625|FG002|Overall Study|Withdrawal by Subject|40|||
160840736|NCT00348309|580802623|FG000|Overall Study|Non-compliance|8|||
160840737|NCT00348309|580802624|FG001|Overall Study|Non-compliance|6|||
160840738|NCT00348309|580802625|FG002|Overall Study|Non-compliance|8|||
160840739|NCT00348309|580802623|FG000|Overall Study|Death of caregiver|1|||
160840740|NCT00348309|580802624|FG001|Overall Study|Death of caregiver|0|||
160840741|NCT00348309|580802625|FG002|Overall Study|Death of caregiver|1|||
160840742|NCT00348309|580802623|FG000|Overall Study|Lack of insight, dementia|1|||
160840743|NCT00348309|580802624|FG001|Overall Study|Lack of insight, dementia|0|||
160840744|NCT00348309|580802625|FG002|Overall Study|Lack of insight, dementia|0|||
160840745|NCT00348309|580802623|FG000|Overall Study|Wrong bottle allocated|1|||
160840746|NCT00348309|580802624|FG001|Overall Study|Wrong bottle allocated|0|||
160840747|NCT00348309|580802625|FG002|Overall Study|Wrong bottle allocated|0|||
160840748|NCT00348309|580802623|FG000|Overall Study|Caregiver sick|1|||
160840749|NCT00348309|580802624|FG001|Overall Study|Caregiver sick|0|||
160840750|NCT00348309|580802625|FG002|Overall Study|Caregiver sick|0|||
160840751|NCT00348309|580802623|FG000|Overall Study|Use of prohibited medication|5|||
160840752|NCT00348309|580802624|FG001|Overall Study|Use of prohibited medication|2|||
160840753|NCT00348309|580802625|FG002|Overall Study|Use of prohibited medication|2|||
160840754|NCT00348309|580802623|FG000|Overall Study|Caregiver withdrawal|3|||
160840755|NCT00348309|580802624|FG001|Overall Study|Caregiver withdrawal|0|||
160840756|NCT00348309|580802625|FG002|Overall Study|Caregiver withdrawal|7|||
160840757|NCT00348309|580802623|FG000|Overall Study|Unable to complete ET visit|1|||
160840758|NCT00348309|580802624|FG001|Overall Study|Unable to complete ET visit|0|||
160840759|NCT00348309|580802625|FG002|Overall Study|Unable to complete ET visit|0|||
160840760|NCT00348309|580802623|FG000|Overall Study|PI closing medical practice|1|||
160840761|NCT00348309|580802624|FG001|Overall Study|PI closing medical practice|0|||
160564829|NCT00809133|579788710|FG000|Overall Study|Lost to Follow-up|0|||
160564830|NCT00809133|579788711|FG001|Overall Study|Lost to Follow-up|0|||
160840762|NCT00348309|580802625|FG002|Overall Study|PI closing medical practice|0|||
160991967|NCT03822351|581359939|FG002|Overall Study|Progressive Disease|0|||
160991968|NCT03822351|581359937|FG000|Overall Study|Not Treated|1|||
160564831|NCT00809133|579788712|FG002|Overall Study|Lost to Follow-up|0|||
160564832|NCT00809133|579788713|FG003|Overall Study|Lost to Follow-up|0|||
160840763|NCT00348309|580802623|FG000|Overall Study|Principal investigator's decision|1|||
160840764|NCT00348309|580802624|FG001|Overall Study|Principal investigator's decision|0|||
160840765|NCT00348309|580802625|FG002|Overall Study|Principal investigator's decision|0|||
160840766|NCT00348309|580802623|FG000|Overall Study|No disponibility of medication|1|||
160840767|NCT00348309|580802624|FG001|Overall Study|No disponibility of medication|0|||
160840768|NCT00348309|580802625|FG002|Overall Study|No disponibility of medication|0|||
160840769|NCT00348309|580802623|FG000|Overall Study|Worsened neurodegenerative disease|1|||
160840770|NCT00348309|580802624|FG001|Overall Study|Worsened neurodegenerative disease|0|||
160840771|NCT00348309|580802625|FG002|Overall Study|Worsened neurodegenerative disease|0|||
160840772|NCT00348309|580802623|FG000|Overall Study|Cognitive and behaviour worsening|2|||
160564833|NCT00809133|579788714|FG004|Overall Study|Lost to Follow-up|0|||
160564834|NCT00809133|579788715|FG005|Overall Study|Lost to Follow-up|1|||
160840773|NCT00348309|580802624|FG001|Overall Study|Cognitive and behaviour worsening|0|||
160840774|NCT00348309|580802625|FG002|Overall Study|Cognitive and behaviour worsening|0|||
160840775|NCT00348309|580802623|FG000|Overall Study|Worsening of alzheimer|1|||
160840776|NCT00348309|580802624|FG001|Overall Study|Worsening of alzheimer|0|||
160840777|NCT00348309|580802625|FG002|Overall Study|Worsening of alzheimer|1|||
160840778|NCT00348309|580802623|FG000|Overall Study|Did not appear in time for Visit 3|1|||
160840779|NCT00348309|580802624|FG001|Overall Study|Did not appear in time for Visit 3|0|||
160840780|NCT00348309|580802625|FG002|Overall Study|Did not appear in time for Visit 3|0|||
160840781|NCT00348309|580802623|FG000|Overall Study|Participant died|2|||
160840782|NCT00348309|580802624|FG001|Overall Study|Participant died|1|||
160840783|NCT00348309|580802625|FG002|Overall Study|Participant died|1|||
160840784|NCT00348309|580802623|FG000|Overall Study|Decision of sponsor|1|||
160840785|NCT00348309|580802624|FG001|Overall Study|Decision of sponsor|0|||
160840786|NCT00348309|580802625|FG002|Overall Study|Decision of sponsor|0|||
160840787|NCT00348309|580802623|FG000|Overall Study|Ineffectiveness of treatment|0|||
160840788|NCT00348309|580802624|FG001|Overall Study|Ineffectiveness of treatment|1|||
160840789|NCT00348309|580802625|FG002|Overall Study|Ineffectiveness of treatment|0|||
160840790|NCT00348309|580802623|FG000|Overall Study|A foul of exclusion criteria|0|||
160840791|NCT00348309|580802624|FG001|Overall Study|A foul of exclusion criteria|1|||
160840792|NCT00348309|580802625|FG002|Overall Study|A foul of exclusion criteria|0|||
160840793|NCT00348309|580802623|FG000|Overall Study|Participant was hospitalized|0|||
160840794|NCT00348309|580802624|FG001|Overall Study|Participant was hospitalized|1|||
160840795|NCT00348309|580802625|FG002|Overall Study|Participant was hospitalized|0|||
160840796|NCT00348309|580802623|FG000|Overall Study|Sponsor refuseal|0|||
160840797|NCT00348309|580802624|FG001|Overall Study|Sponsor refuseal|1|||
160840798|NCT00348309|580802625|FG002|Overall Study|Sponsor refuseal|1|||
160840799|NCT00348309|580802623|FG000|Overall Study|Forgot often medication|0|||
160840800|NCT00348309|580802624|FG001|Overall Study|Forgot often medication|1|||
160991969|NCT03822351|581359938|FG001|Overall Study|Not Treated|1|||
160564835|NCT00809133|579788716|FG006|Overall Study|Lost to Follow-up|0|||
160840801|NCT00348309|580802625|FG002|Overall Study|Forgot often medication|0|||
160840802|NCT00348309|580802623|FG000|Overall Study|Medical Monitor decision|0|||
160840803|NCT00348309|580802624|FG001|Overall Study|Medical Monitor decision|0|||
160840804|NCT00348309|580802625|FG002|Overall Study|Medical Monitor decision|1|||
160840805|NCT00348309|580802623|FG000|Overall Study|Increased dose of Aricept|0|||
160991970|NCT03822351|581359939|FG002|Overall Study|Not Treated|1|||
160991971|NCT03781804|581359945|FG000|Overall Study|Adverse Event|2|||
160991972|NCT03781804|581359946|FG001|Overall Study|Adverse Event|2|||
160991973|NCT03781804|581359947|FG002|Overall Study|Adverse Event|3|||
160991974|NCT03781804|581359945|FG000|Overall Study|Lost to Follow-up|1|||
160991975|NCT03781804|581359946|FG001|Overall Study|Lost to Follow-up|1|||
160991976|NCT03781804|581359947|FG002|Overall Study|Lost to Follow-up|2|||
160991977|NCT03781804|581359945|FG000|Overall Study|Lack of Efficacy|4|||
160991978|NCT03781804|581359946|FG001|Overall Study|Lack of Efficacy|2|||
160991979|NCT03781804|581359947|FG002|Overall Study|Lack of Efficacy|9|||
160991980|NCT03781804|581359945|FG000|Overall Study|Protocol Violation|0|||
160991981|NCT03781804|581359946|FG001|Overall Study|Protocol Violation|0|||
160991982|NCT03781804|581359947|FG002|Overall Study|Protocol Violation|1|||
160991983|NCT03781804|581359945|FG000|Overall Study|Withdrawal by Subject|0|||
160991984|NCT03781804|581359946|FG001|Overall Study|Withdrawal by Subject|1|||
160991985|NCT03781804|581359947|FG002|Overall Study|Withdrawal by Subject|1|||
160991986|NCT03781804|581359945|FG000|Overall Study|Reason not provided|2|||
160991987|NCT03781804|581359946|FG001|Overall Study|Reason not provided|2|||
160991988|NCT03781804|581359947|FG002|Overall Study|Reason not provided|0|||
160991989|NCT03717194|581359948|FG000|Overall Study|Withdrawal by Subject|2|||
160991990|NCT03717194|581359949|FG001|Overall Study|Withdrawal by Subject|4|||
160991991|NCT03717194|581359948|FG000|Overall Study|Adverse Event|1|||
160991992|NCT03717194|581359949|FG001|Overall Study|Adverse Event|1|||
160991993|NCT04678830|581359950|FG000|Overall Study|Lack of Efficacy|2|||
160991994|NCT04678830|581359951|FG001|Overall Study|Lack of Efficacy|0|||
160991995|NCT04678830|581359950|FG000|Overall Study|Withdrawal by Subject|0|||
160991996|NCT04678830|581359951|FG001|Overall Study|Withdrawal by Subject|1|||
160991997|NCT01836458|581359954|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
160991998|NCT01836458|581359955|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160991999|NCT01836458|581359956|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
160992000|NCT01836458|581359957|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
160564836|NCT00809133|579788717|FG007|Overall Study|Lost to Follow-up|0|||
160840806|NCT00348309|580802624|FG001|Overall Study|Increased dose of Aricept|0|||
160840807|NCT00348309|580802625|FG002|Overall Study|Increased dose of Aricept|1|||
160840808|NCT00348309|580802623|FG000|Overall Study|Site closure|0|||
160840809|NCT00348309|580802624|FG001|Overall Study|Site closure|0|||
160992001|NCT00429793|581359958|FG000|Overall Study|Improper pre-protocol treatment|3|||
160992002|NCT00429793|581359958|FG000|Overall Study|Required test not done|1|||
160840810|NCT00348309|580802625|FG002|Overall Study|Site closure|1|||
160992003|NCT00429793|581359958|FG000|Overall Study|Never treated|1|||
160992004|NCT00429793|581359958|FG000|Overall Study|Non-measurable|1|||
160992005|NCT00813488|581359959|FG000|Titration Period 1|Adverse Event|6|||
160992006|NCT00813488|581359960|FG001|Titration Period 1|Adverse Event|1|||
160564837|NCT00809133|579788718|FG008|Overall Study|Lost to Follow-up|0|||
160992007|NCT00813488|581359959|FG000|Titration Period 1|Lack of Efficacy|9|||
160992008|NCT00813488|581359960|FG001|Titration Period 1|Lack of Efficacy|7|||
160992009|NCT00813488|581359959|FG000|Titration Period 1|Withdrawal by Subject|2|||
160992010|NCT00813488|581359960|FG001|Titration Period 1|Withdrawal by Subject|2|||
160992011|NCT00813488|581359959|FG000|Titration Period 1|Protocol Violation|4|||
160992012|NCT00813488|581359960|FG001|Titration Period 1|Protocol Violation|3|||
160992013|NCT00813488|581359959|FG000|Titration Period 1|Non-compliance to study medication|4|||
160992014|NCT00813488|581359960|FG001|Titration Period 1|Non-compliance to study medication|1|||
160992015|NCT00813488|581359959|FG000|Titration Period 1|Non-compliance to study procedures|2|||
160992016|NCT00813488|581359960|FG001|Titration Period 1|Non-compliance to study procedures|2|||
160992017|NCT00813488|581359959|FG000|Titration Period 1|Technical Difficulties|0|||
160992018|NCT00813488|581359960|FG001|Titration Period 1|Technical Difficulties|1|||
160992019|NCT00813488|581359959|FG000|Titration Period 2|Adverse Event|2|||
160992020|NCT00813488|581359960|FG001|Titration Period 2|Adverse Event|3|||
160992021|NCT00813488|581359959|FG000|Titration Period 2|Lack of Efficacy|8|||
160992022|NCT00813488|581359960|FG001|Titration Period 2|Lack of Efficacy|4|||
160992023|NCT00813488|581359959|FG000|Titration Period 2|Protocol Violation|3|||
160992024|NCT00813488|581359960|FG001|Titration Period 2|Protocol Violation|2|||
160992025|NCT00813488|581359959|FG000|Titration Period 2|Lost to Follow-up|1|||
160992026|NCT00813488|581359960|FG001|Titration Period 2|Lost to Follow-up|0|||
160992027|NCT00813488|581359959|FG000|Titration Period 2|Non-compliance with study procedures|2|||
160992028|NCT00813488|581359960|FG001|Titration Period 2|Non-compliance with study procedures|1|||
160992029|NCT00813488|581359959|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
160992030|NCT00813488|581359960|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
160992031|NCT00813488|581359959|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
160992032|NCT00813488|581359960|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
160992033|NCT00813488|581359959|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
160992034|NCT00813488|581359960|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
160992035|NCT00813488|581359959|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
160992036|NCT00813488|581359960|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
160992037|NCT00813488|581359959|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
160992038|NCT00813488|581359960|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
160992039|NCT00813488|581359959|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
160992040|NCT00813488|581359960|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
160992041|NCT00813488|581359959|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
160992042|NCT00813488|581359960|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
160992043|NCT00813488|581359959|FG000|Double-blind Treatment Period 2|Other|1|||
160992044|NCT00813488|581359960|FG001|Double-blind Treatment Period 2|Other|0|||
160992045|NCT00813488|581359959|FG000|Open-label Extension|Adverse Event|1|||
160992046|NCT00813488|581359960|FG001|Open-label Extension|Adverse Event|2|||
160992047|NCT00813488|581359959|FG000|Open-label Extension|Lack of Efficacy|3|||
160992048|NCT00813488|581359960|FG001|Open-label Extension|Lack of Efficacy|0|||
160992049|NCT00813488|581359959|FG000|Open-label Extension|Withdrawal by Subject|0|||
160992050|NCT00813488|581359960|FG001|Open-label Extension|Withdrawal by Subject|2|||
160992051|NCT00813488|581359959|FG000|Open-label Extension|Protocol Violation|1|||
160992052|NCT00813488|581359960|FG001|Open-label Extension|Protocol Violation|2|||
160992053|NCT00813488|581359959|FG000|Open-label Extension|Non-compliance study medication|4|||
160992054|NCT00813488|581359960|FG001|Open-label Extension|Non-compliance study medication|0|||
160992055|NCT00813488|581359959|FG000|Open-label Extension|Non-compliance study procedures|2|||
160992056|NCT00813488|581359960|FG001|Open-label Extension|Non-compliance study procedures|1|||
160992057|NCT00813488|581359959|FG000|Open-label Extension|Other|1|||
160992058|NCT00813488|581359960|FG001|Open-label Extension|Other|0|||
160992059|NCT01333514|581359963|FG000|Overall Study|Withdrawal by Subject|1|||
160992060|NCT01333514|581359964|FG001|Overall Study|Withdrawal by Subject|0|||
160992061|NCT00836810|581359965|FG000|Overall Study|New diagnosis|1|||
160992062|NCT00836810|581359966|FG001|Overall Study|New diagnosis|0|||
160992063|NCT00819910|581359967|FG000|Overall Study|Adverse Event|0|||
160992064|NCT00819910|581359968|FG001|Overall Study|Adverse Event|0|||
160992065|NCT00819910|581359969|FG002|Overall Study|Adverse Event|2|||
160992066|NCT00819910|581359970|FG003|Overall Study|Adverse Event|1|||
160992067|NCT00819910|581359967|FG000|Overall Study|Withdrawal by Subject|1|||
160992068|NCT00819910|581359968|FG001|Overall Study|Withdrawal by Subject|1|||
160992069|NCT00819910|581359969|FG002|Overall Study|Withdrawal by Subject|1|||
160992070|NCT00819910|581359970|FG003|Overall Study|Withdrawal by Subject|0|||
160564838|NCT00809133|579788719|FG009|Overall Study|Lost to Follow-up|0|||
160564839|NCT00809133|579788720|FG010|Overall Study|Lost to Follow-up|0|||
160992071|NCT00819910|581359967|FG000|Overall Study|Lost to Follow-up|1|||
160992072|NCT00819910|581359968|FG001|Overall Study|Lost to Follow-up|0|||
160992073|NCT00819910|581359969|FG002|Overall Study|Lost to Follow-up|0|||
160992074|NCT00819910|581359970|FG003|Overall Study|Lost to Follow-up|0|||
160564840|NCT00809133|579788721|FG011|Overall Study|Lost to Follow-up|0|||
160564841|NCT00809133|579788722|FG012|Overall Study|Lost to Follow-up|0|||
160840811|NCT00348309|580802623|FG000|Overall Study|Adverse event not attended|0|||
160840812|NCT00348309|580802624|FG001|Overall Study|Adverse event not attended|0|||
160840813|NCT00348309|580802625|FG002|Overall Study|Adverse event not attended|1|||
160840814|NCT00348309|580802623|FG000|Overall Study|ECG abnormal|0|||
160840815|NCT00348309|580802624|FG001|Overall Study|ECG abnormal|0|||
160840816|NCT00348309|580802625|FG002|Overall Study|ECG abnormal|2|||
160840817|NCT00348309|580802623|FG000|Overall Study|Cardiologist recommendations|0|||
160840818|NCT00348309|580802624|FG001|Overall Study|Cardiologist recommendations|0|||
160840819|NCT00348309|580802625|FG002|Overall Study|Cardiologist recommendations|1|||
160840820|NCT00348309|580802623|FG000|Overall Study|HCV career|0|||
160840821|NCT00348309|580802624|FG001|Overall Study|HCV career|0|||
160840822|NCT00348309|580802625|FG002|Overall Study|HCV career|1|||
160840823|NCT01364389|580802628|FG000|Overall Study|Withdrawal by Subject|0|||
160840824|NCT01364389|580802629|FG001|Overall Study|Withdrawal by Subject|1|||
160840825|NCT01364389|580802630|FG002|Overall Study|Withdrawal by Subject|0|||
160840826|NCT01364389|580802628|FG000|Overall Study|Protocol deviation|0|||
160840827|NCT01364389|580802629|FG001|Overall Study|Protocol deviation|0|||
160840828|NCT01364389|580802630|FG002|Overall Study|Protocol deviation|1|||
160840829|NCT01364389|580802628|FG000|Overall Study|Administrative problems|1|||
160840830|NCT01364389|580802629|FG001|Overall Study|Administrative problems|0|||
160840831|NCT01364389|580802630|FG002|Overall Study|Administrative problems|0|||
160840832|NCT01364389|580802628|FG000|Overall Study|Adverse Event|1|||
160840833|NCT01364389|580802629|FG001|Overall Study|Adverse Event|0|||
160840834|NCT01364389|580802630|FG002|Overall Study|Adverse Event|0|||
160840835|NCT01534195|580802631|FG000|Overall Study|Withdrawal by Subject|1|||
160840836|NCT01534195|580802632|FG001|Overall Study|Withdrawal by Subject|1|||
160840837|NCT02554981|580802633|FG000|Overall Study|Adverse Event|1|||
160840838|NCT02554981|580802633|FG000|Overall Study|Administrative Reasons|1|||
160840839|NCT02554981|580802633|FG000|Overall Study|Other Miscellaneous Reasons|3|||
160840840|NCT01630889|580802634|FG000|Overall Study|Death|2|||
160840841|NCT01630889|580802634|FG000|Overall Study|Withdrawal by Subject|1|||
160840842|NCT01630889|580802634|FG000|Overall Study|Other than Specified|2|||
160840843|NCT01630889|580802634|FG000|Overall Study|Lost to Follow-up|4|||
160840844|NCT01630889|580802634|FG000|Overall Study|Other|1|||
160840845|NCT02475278|580804967|FG000|Overall Study|Lost to Follow-up|1|||
160840846|NCT02475278|580804967|FG000|Overall Study|Reason Not Specified|1|||
160840847|NCT01946152|580804968|FG000|Overall Study|Adverse Event|1|||
160840848|NCT01946152|580804969|FG001|Overall Study|Adverse Event|0|||
160840849|NCT01946152|580804970|FG002|Overall Study|Adverse Event|0|||
160840850|NCT01946152|580804971|FG003|Overall Study|Adverse Event|0|||
160840851|NCT01946152|580804968|FG000|Overall Study|Withdrawal by Subject|0|||
160840852|NCT01946152|580804969|FG001|Overall Study|Withdrawal by Subject|2|||
160840853|NCT01946152|580804970|FG002|Overall Study|Withdrawal by Subject|0|||
160840854|NCT01946152|580804971|FG003|Overall Study|Withdrawal by Subject|0|||
160840855|NCT01946152|580804968|FG000|Overall Study|Progression|0|||
160840856|NCT01946152|580804969|FG001|Overall Study|Progression|1|||
160840857|NCT01946152|580804970|FG002|Overall Study|Progression|4|||
160840858|NCT01946152|580804971|FG003|Overall Study|Progression|7|||
160840859|NCT01946152|580804968|FG000|Overall Study|Physician Decision|0|||
160840860|NCT01946152|580804969|FG001|Overall Study|Physician Decision|0|||
160840861|NCT01946152|580804970|FG002|Overall Study|Physician Decision|1|||
160840862|NCT01946152|580804971|FG003|Overall Study|Physician Decision|0|||
160840863|NCT01946152|580804968|FG000|Overall Study|Second malignancy|0|||
160840864|NCT01946152|580804969|FG001|Overall Study|Second malignancy|0|||
160840865|NCT01946152|580804970|FG002|Overall Study|Second malignancy|1|||
160840866|NCT01946152|580804971|FG003|Overall Study|Second malignancy|0|||
160840867|NCT01946152|580804968|FG000|Overall Study|Adverse Event|0|||
160840868|NCT01946152|580804969|FG001|Overall Study|Adverse Event|0|||
160840869|NCT01946152|580804970|FG002|Overall Study|Adverse Event|0|||
160840870|NCT01946152|580804971|FG003|Overall Study|Adverse Event|1|||
160840871|NCT03712787|580804972|FG000|Overall Study|Adverse Event|2|||
160840872|NCT03712787|580804973|FG001|Overall Study|Adverse Event|3|||
160840873|NCT03712787|580804974|FG002|Overall Study|Adverse Event|0|||
160840874|NCT03712787|580804975|FG003|Overall Study|Adverse Event|4|||
160840875|NCT03712787|580804972|FG000|Overall Study|Withdrawal by Subject|4|||
160840876|NCT03712787|580804973|FG001|Overall Study|Withdrawal by Subject|14|||
160840877|NCT03712787|580804974|FG002|Overall Study|Withdrawal by Subject|12|||
160840878|NCT03712787|580804975|FG003|Overall Study|Withdrawal by Subject|8|||
160840879|NCT03712787|580804972|FG000|Overall Study|Lost to Follow-up|1|||
160564842|NCT00809133|579788723|FG013|Overall Study|Lost to Follow-up|0|||
160564843|NCT00809133|579788710|FG000|Overall Study|Consent withdrawn|0|||
160564844|NCT00809133|579788711|FG001|Overall Study|Consent withdrawn|0|||
160564845|NCT00809133|579788712|FG002|Overall Study|Consent withdrawn|0|||
160564846|NCT00809133|579788713|FG003|Overall Study|Consent withdrawn|0|||
160564847|NCT00809133|579788714|FG004|Overall Study|Consent withdrawn|1|||
160564848|NCT00809133|579788715|FG005|Overall Study|Consent withdrawn|0|||
160564849|NCT00809133|579788716|FG006|Overall Study|Consent withdrawn|0|||
160564850|NCT00809133|579788717|FG007|Overall Study|Consent withdrawn|0|||
160840880|NCT03712787|580804973|FG001|Overall Study|Lost to Follow-up|1|||
160840881|NCT03712787|580804974|FG002|Overall Study|Lost to Follow-up|2|||
160840882|NCT03712787|580804975|FG003|Overall Study|Lost to Follow-up|1|||
160840883|NCT03712787|580804972|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
160564851|NCT00809133|579788718|FG008|Overall Study|Consent withdrawn|0|||
160564852|NCT00809133|579788719|FG009|Overall Study|Consent withdrawn|0|||
160564853|NCT00809133|579788720|FG010|Overall Study|Consent withdrawn|0|||
160564854|NCT00809133|579788721|FG011|Overall Study|Consent withdrawn|0|||
160564855|NCT00809133|579788722|FG012|Overall Study|Consent withdrawn|0|||
160564856|NCT00809133|579788723|FG013|Overall Study|Consent withdrawn|0|||
160564857|NCT00809133|579788710|FG000|Overall Study|Other not mentioned above|0|||
160564858|NCT00809133|579788711|FG001|Overall Study|Other not mentioned above|1|||
160564859|NCT00809133|579788712|FG002|Overall Study|Other not mentioned above|0|||
160564860|NCT00809133|579788713|FG003|Overall Study|Other not mentioned above|0|||
160564861|NCT00809133|579788714|FG004|Overall Study|Other not mentioned above|0|||
160564862|NCT00809133|579788715|FG005|Overall Study|Other not mentioned above|1|||
160564863|NCT00809133|579788716|FG006|Overall Study|Other not mentioned above|0|||
160564864|NCT00809133|579788717|FG007|Overall Study|Other not mentioned above|0|||
160564865|NCT00809133|579788718|FG008|Overall Study|Other not mentioned above|0|||
160564866|NCT00809133|579788719|FG009|Overall Study|Other not mentioned above|0|||
160564867|NCT00809133|579788720|FG010|Overall Study|Other not mentioned above|0|||
160564868|NCT00809133|579788721|FG011|Overall Study|Other not mentioned above|0|||
160564869|NCT00809133|579788722|FG012|Overall Study|Other not mentioned above|0|||
160840884|NCT03712787|580804973|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
160840885|NCT03712787|580804974|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
160840886|NCT03712787|580804975|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
160840887|NCT03712787|580804972|FG000|Overall Study|COVID-19 Infection|0|||
160840888|NCT03712787|580804973|FG001|Overall Study|COVID-19 Infection|1|||
160840889|NCT03712787|580804974|FG002|Overall Study|COVID-19 Infection|0|||
160840890|NCT03712787|580804975|FG003|Overall Study|COVID-19 Infection|0|||
160840891|NCT03712787|580804972|FG000|Overall Study|Other, Not Specified|79|||
160840892|NCT03712787|580804973|FG001|Overall Study|Other, Not Specified|77|||
160840893|NCT03712787|580804974|FG002|Overall Study|Other, Not Specified|74|||
160840894|NCT03712787|580804975|FG003|Overall Study|Other, Not Specified|78|||
160840895|NCT01865448|580804976|FG000|Overall Study|Adverse Event|1|||
160840896|NCT01865448|580804977|FG001|Overall Study|Adverse Event|1|||
160840897|NCT01865448|580804976|FG000|Overall Study|Pregnancy|0|||
160840898|NCT01865448|580804977|FG001|Overall Study|Pregnancy|1|||
160840899|NCT01865448|580804976|FG000|Overall Study|dropout unrelated to study|1|||
160840900|NCT01865448|580804977|FG001|Overall Study|dropout unrelated to study|1|||
160840901|NCT03499314|580804978|FG000|Overall Study|Time Commitment|1|||
160840902|NCT03499314|580804979|FG001|Overall Study|Time Commitment|2|||
160840903|NCT03499314|580804978|FG000|Overall Study|Medical issue unrelated to research study|1|||
160840904|NCT03499314|580804979|FG001|Overall Study|Medical issue unrelated to research study|1|||
160840905|NCT01618695|580804980|FG000|Core Phase|Adverse Event|4|||
160840906|NCT01618695|580804981|FG001|Core Phase|Adverse Event|5|||
160840907|NCT01618695|580804982|FG002|Core Phase|Adverse Event|15|||
160840908|NCT01618695|580804983|FG003|Core Phase|Adverse Event|20|||
160840909|NCT01618695|580804980|FG000|Core Phase|Lost to Follow-up|0|||
160840910|NCT01618695|580804981|FG001|Core Phase|Lost to Follow-up|0|||
160840911|NCT01618695|580804982|FG002|Core Phase|Lost to Follow-up|1|||
160840912|NCT01618695|580804983|FG003|Core Phase|Lost to Follow-up|0|||
160840913|NCT01618695|580804980|FG000|Core Phase|Withdrawal by Subject|16|||
160905297|NCT00724932|581048175|FG001|Overall Study|Not treated|3|||
160564870|NCT00809133|579788723|FG013|Overall Study|Other not mentioned above|0|||
160564871|NCT00833092|579788724|FG000|Overall Study|Withdrawal by Subject|2|||
160564872|NCT00833092|579788725|FG001|Overall Study|Withdrawal by Subject|3|||
160840914|NCT01618695|580804981|FG001|Core Phase|Withdrawal by Subject|11|||
160840915|NCT01618695|580804982|FG002|Core Phase|Withdrawal by Subject|9|||
160840916|NCT01618695|580804983|FG003|Core Phase|Withdrawal by Subject|13|||
160840917|NCT01618695|580804980|FG000|Core Phase|Pregnancy|2|||
160840918|NCT01618695|580804981|FG001|Core Phase|Pregnancy|0|||
160905298|NCT02849678|581048176|FG000|Overall Study|Protocol Violation|3|||
160905299|NCT02849678|581048177|FG001|Overall Study|Protocol Violation|6|||
160564873|NCT00833092|579788724|FG000|Overall Study|Protocol Violation|2|||
160564874|NCT00833092|579788725|FG001|Overall Study|Protocol Violation|1|||
160564875|NCT00833092|579788724|FG000|Overall Study|Diarrhea|0|||
160840919|NCT01618695|580804982|FG002|Core Phase|Pregnancy|0|||
160840920|NCT01618695|580804983|FG003|Core Phase|Pregnancy|0|||
160840921|NCT01618695|580804980|FG000|Core Phase|Lack of Efficacy|1|||
160840922|NCT01618695|580804981|FG001|Core Phase|Lack of Efficacy|2|||
160840923|NCT01618695|580804982|FG002|Core Phase|Lack of Efficacy|1|||
160840924|NCT01618695|580804983|FG003|Core Phase|Lack of Efficacy|1|||
160840925|NCT01618695|580804980|FG000|Core Phase|Other than specified|1|||
160840926|NCT01618695|580804981|FG001|Core Phase|Other than specified|2|||
160840927|NCT01618695|580804982|FG002|Core Phase|Other than specified|2|||
160840928|NCT01618695|580804983|FG003|Core Phase|Other than specified|2|||
160840929|NCT01618695|580804980|FG000|Core Phase|Not treated|1|||
160840930|NCT01618695|580804981|FG001|Core Phase|Not treated|0|||
160840931|NCT01618695|580804982|FG002|Core Phase|Not treated|2|||
160840932|NCT01618695|580804983|FG003|Core Phase|Not treated|0|||
160840933|NCT01618695|580804980|FG000|Extension Phase|Lack of Efficacy|17|||
160840934|NCT01618695|580804981|FG001|Extension Phase|Lack of Efficacy|33|||
160840935|NCT01618695|580804982|FG002|Extension Phase|Lack of Efficacy|26|||
160840936|NCT01618695|580804983|FG003|Extension Phase|Lack of Efficacy|24|||
160840937|NCT01618695|580804980|FG000|Extension Phase|Pregnancy|2|||
160840938|NCT01618695|580804981|FG001|Extension Phase|Pregnancy|0|||
160840939|NCT01618695|580804982|FG002|Extension Phase|Pregnancy|1|||
160840940|NCT01618695|580804983|FG003|Extension Phase|Pregnancy|1|||
160840941|NCT01618695|580804980|FG000|Extension Phase|Withdrawal by Subject|43|||
160840942|NCT01618695|580804981|FG001|Extension Phase|Withdrawal by Subject|48|||
160840943|NCT01618695|580804982|FG002|Extension Phase|Withdrawal by Subject|42|||
160840944|NCT01618695|580804983|FG003|Extension Phase|Withdrawal by Subject|33|||
160840945|NCT01618695|580804980|FG000|Extension Phase|Adverse Event|18|||
160840946|NCT01618695|580804981|FG001|Extension Phase|Adverse Event|16|||
160840947|NCT01618695|580804982|FG002|Extension Phase|Adverse Event|9|||
160840948|NCT01618695|580804983|FG003|Extension Phase|Adverse Event|20|||
160840949|NCT01618695|580804980|FG000|Extension Phase|Lost to Follow-up|2|||
160840950|NCT01618695|580804981|FG001|Extension Phase|Lost to Follow-up|1|||
160840951|NCT01618695|580804982|FG002|Extension Phase|Lost to Follow-up|1|||
160840952|NCT01618695|580804983|FG003|Extension Phase|Lost to Follow-up|1|||
160840953|NCT01618695|580804980|FG000|Extension Phase|Other than specified|13|||
160840954|NCT01618695|580804981|FG001|Extension Phase|Other than specified|18|||
160840955|NCT01618695|580804982|FG002|Extension Phase|Other than specified|13|||
160840956|NCT01618695|580804983|FG003|Extension Phase|Other than specified|18|||
160840957|NCT02291419|580804987|FG000|Overall Study|Early study termination|1|||
160840958|NCT02291419|580804988|FG001|Overall Study|Early study termination|5|||
160840959|NCT00931606|580804989|FG000|Overall Study|Death|1|||
160840960|NCT00931606|580804990|FG001|Overall Study|Death|3|||
160840961|NCT00931606|580804991|FG002|Overall Study|Death|2|||
160840962|NCT00931606|580804992|FG003|Overall Study|Death|0|||
160840963|NCT00931606|580804989|FG000|Overall Study|Lost to Follow-up|0|||
160840964|NCT00931606|580804990|FG001|Overall Study|Lost to Follow-up|1|||
160840965|NCT00931606|580804991|FG002|Overall Study|Lost to Follow-up|0|||
160840966|NCT00931606|580804992|FG003|Overall Study|Lost to Follow-up|0|||
160840967|NCT00931606|580804989|FG000|Overall Study|Physician Decision|0|||
160840968|NCT00931606|580804990|FG001|Overall Study|Physician Decision|0|||
160840969|NCT00931606|580804991|FG002|Overall Study|Physician Decision|3|||
160840970|NCT00931606|580804992|FG003|Overall Study|Physician Decision|0|||
160840971|NCT00931606|580804989|FG000|Overall Study|Sponsor Decision|1|||
160840972|NCT00931606|580804990|FG001|Overall Study|Sponsor Decision|4|||
160840973|NCT00931606|580804991|FG002|Overall Study|Sponsor Decision|0|||
160840974|NCT00931606|580804992|FG003|Overall Study|Sponsor Decision|2|||
160840975|NCT00931606|580804989|FG000|Overall Study|Withdrawal by Subject|3|||
160840976|NCT00931606|580804990|FG001|Overall Study|Withdrawal by Subject|1|||
160840977|NCT00931606|580804991|FG002|Overall Study|Withdrawal by Subject|1|||
160840978|NCT00931606|580804992|FG003|Overall Study|Withdrawal by Subject|1|||
160840979|NCT00871338|580804993|FG000|Prior to Booster|Withdrawal by Subject|1|||
160840980|NCT00871338|580804994|FG001|Prior to Booster|Withdrawal by Subject|3|||
160840981|NCT00871338|580804993|FG000|Prior to Booster|Lost to Follow-up|1|||
160840982|NCT00871338|580804994|FG001|Prior to Booster|Lost to Follow-up|0|||
160840983|NCT02391363|580804995|FG000|Overall Study|Lost to Follow-up|5|||
160840984|NCT02391363|580804996|FG001|Overall Study|Lost to Follow-up|5|||
160840985|NCT02391363|580804995|FG000|Overall Study|Withdrawal by Subject|6|||
160905300|NCT00288054|581048183|FG000|Overall Study|Protocol Violation|2|||
160905301|NCT00288054|581048183|FG000|Overall Study|Lack of Efficacy|16|||
160905302|NCT00288054|581048183|FG000|Overall Study|Adverse Event|3|||
160564876|NCT00833092|579788725|FG001|Overall Study|Diarrhea|2|||
160840986|NCT02391363|580804996|FG001|Overall Study|Withdrawal by Subject|3|||
160840987|NCT00799266|580804997|FG000|Overall Study|Adverse Event|0|||
160840988|NCT00799266|580804998|FG001|Overall Study|Adverse Event|1|||
160840989|NCT00799266|580804997|FG000|Overall Study|Subject withdrew consent|3|||
160840990|NCT00799266|580804998|FG001|Overall Study|Subject withdrew consent|0|||
160840991|NCT00872599|580804999|FG000|Second Washout Period|Adverse Event|1|||
160840992|NCT00872599|580805000|FG001|Second Washout Period|Adverse Event|1|||
160840993|NCT04794270|580805001|FG000|Period 1|Non Compliance|1|||
160840994|NCT04794270|580805002|FG001|Period 1|Non Compliance|0|||
160840995|NCT04794270|580805001|FG000|Period 1|Adverse Event|1|||
160840996|NCT04794270|580805002|FG001|Period 1|Adverse Event|0|||
160840997|NCT04794270|580805001|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
160564877|NCT00833092|579788724|FG000|Overall Study|constipation|0|||
160564878|NCT00833092|579788725|FG001|Overall Study|constipation|1|||
160564879|NCT00619229|579788726|FG000|Overall Study|Withdrawal by Subject|1|||
160564880|NCT00619229|579788727|FG001|Overall Study|Withdrawal by Subject|1|||
160564881|NCT00619229|579788726|FG000|Overall Study|Lost to Follow-up|1|||
160564882|NCT00619229|579788727|FG001|Overall Study|Lost to Follow-up|0|||
160564883|NCT00619229|579788726|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
160564884|NCT00619229|579788727|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
160564885|NCT00619229|579788726|FG000|Overall Study|Investigator planned Cataract Operation|1|||
160564886|NCT00619229|579788727|FG001|Overall Study|Investigator planned Cataract Operation|0|||
160564887|NCT02983604|579788728|FG000|Overall Study|Enrolled but not Treated|0|||
160564888|NCT02983604|579788729|FG001|Overall Study|Enrolled but not Treated|0|||
160564889|NCT02983604|579788730|FG002|Overall Study|Enrolled but not Treated|1|||
160564890|NCT02983604|579788731|FG003|Overall Study|Enrolled but not Treated|0|||
160564891|NCT00355264|579788733|FG000|Extension (Variable Duration)|Adverse Event|1|||
160564892|NCT00355264|579788733|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
160564893|NCT04336163|579788734|FG000|Overall Study|Lost to Follow-up|55|||
160564894|NCT04336163|579788735|FG001|Overall Study|Lost to Follow-up|0|||
160564895|NCT00826514|579788736|FG000|Overall Study|Adverse Event|1|||
160564896|NCT00826514|579788737|FG001|Overall Study|Adverse Event|1|||
160564897|NCT00826514|579788736|FG000|Overall Study|Lack of Efficacy|0|||
160564898|NCT00826514|579788737|FG001|Overall Study|Lack of Efficacy|1|||
160564899|NCT00826514|579788736|FG000|Overall Study|Withdrawal by Subject|2|||
160564900|NCT00826514|579788737|FG001|Overall Study|Withdrawal by Subject|3|||
160564901|NCT01773473|579788738|FG000|Overall Study|Adverse Event|3|||
160564902|NCT01773473|579788739|FG001|Overall Study|Adverse Event|2|||
160564903|NCT01773473|579788738|FG000|Overall Study|Protocol Violation|0|||
160564904|NCT01773473|579788739|FG001|Overall Study|Protocol Violation|4|||
160564905|NCT01773473|579788738|FG000|Overall Study|Physician Decision|3|||
160564906|NCT01773473|579788739|FG001|Overall Study|Physician Decision|5|||
160564907|NCT01773473|579788738|FG000|Overall Study|Sponsor Decision|2|||
160564908|NCT01773473|579788739|FG001|Overall Study|Sponsor Decision|0|||
160564909|NCT01773473|579788738|FG000|Overall Study|Lack of Efficacy|0|||
160564910|NCT01773473|579788739|FG001|Overall Study|Lack of Efficacy|1|||
160564911|NCT01773473|579788738|FG000|Overall Study|Non-Compliance with study drug|1|||
160564912|NCT01773473|579788739|FG001|Overall Study|Non-Compliance with study drug|4|||
160564913|NCT01773473|579788738|FG000|Overall Study|Withdrawal by Subject|5|||
160564914|NCT01773473|579788739|FG001|Overall Study|Withdrawal by Subject|3|||
160564915|NCT01773473|579788738|FG000|Overall Study|Lost to Follow-up|2|||
160564916|NCT01773473|579788739|FG001|Overall Study|Lost to Follow-up|0|||
160564917|NCT03663166|579788740|FG000|Overall Study|Withdrawal by Subject|1|||
160564918|NCT04927312|579788741|FG000|Overall Study|Adverse Event|1|||
160564919|NCT04927312|579788741|FG000|Overall Study|Death|1|||
160564920|NCT04927312|579788741|FG000|Overall Study|Withdrawal by Subject|1|||
160564921|NCT04927312|579788741|FG000|Overall Study|Other|1|||
160564922|NCT04919564|579788747|FG000|Overall Study|Lost to Follow-up|1|||
160564923|NCT04919564|579788748|FG001|Overall Study|Lost to Follow-up|0|||
160840998|NCT04794270|580805002|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
160840999|NCT00265317|580805006|FG000|Lead-In|Objective progression or relapse|6|||
160841000|NCT00265317|580805007|FG001|Lead-In|Objective progression or relapse|11|||
160841001|NCT00265317|580805008|FG002|Lead-In|Objective progression or relapse|0|||
160841002|NCT00265317|580805009|FG003|Lead-In|Objective progression or relapse|0|||
160841003|NCT00265317|580805006|FG000|Lead-In|Adverse Event|2|||
160841004|NCT00265317|580805007|FG001|Lead-In|Adverse Event|1|||
160564924|NCT04919564|579788747|FG000|Overall Study|Physician Decision|1|||
160564925|NCT04919564|579788748|FG001|Overall Study|Physician Decision|1|||
160841005|NCT00265317|580805008|FG002|Lead-In|Adverse Event|0|||
160841006|NCT00265317|580805009|FG003|Lead-In|Adverse Event|0|||
160841007|NCT00265317|580805006|FG000|Lead-In|Death|3|||
160841008|NCT00265317|580805007|FG001|Lead-In|Death|5|||
160841009|NCT00265317|580805008|FG002|Lead-In|Death|0|||
160841010|NCT00265317|580805009|FG003|Lead-In|Death|0|||
160841011|NCT00265317|580805006|FG000|Lead-In|Withdrawal/other than adverse event|1|||
160841012|NCT00265317|580805007|FG001|Lead-In|Withdrawal/other than adverse event|0|||
160841013|NCT00265317|580805008|FG002|Lead-In|Withdrawal/other than adverse event|0|||
160841014|NCT00265317|580805009|FG003|Lead-In|Withdrawal/other than adverse event|0|||
160841015|NCT00265317|580805006|FG000|Phase 2|Objective progression or relapse|0|||
160841016|NCT00265317|580805007|FG001|Phase 2|Objective progression or relapse|0|||
160841017|NCT00265317|580805008|FG002|Phase 2|Objective progression or relapse|37|||
160841018|NCT00265317|580805009|FG003|Phase 2|Objective progression or relapse|38|||
160564926|NCT05292755|579788752|FG000|Overall Study|Lost to Follow-up|5|||
160564927|NCT05292755|579788753|FG001|Overall Study|Lost to Follow-up|9|||
160841019|NCT00265317|580805006|FG000|Phase 2|Global deterioration of health status|0|||
160841020|NCT00265317|580805007|FG001|Phase 2|Global deterioration of health status|0|||
160841021|NCT00265317|580805008|FG002|Phase 2|Global deterioration of health status|3|||
160564928|NCT00519077|579788754|FG000|Overall Study|Death|6|||
160564929|NCT00519077|579788754|FG000|Overall Study|Other|2|||
160841022|NCT00265317|580805009|FG003|Phase 2|Global deterioration of health status|0|||
160564930|NCT02286102|579788755|FG000|Overall Study|Screen Failure|1|||
160564931|NCT02286102|579788756|FG001|Overall Study|Screen Failure|1|||
160564932|NCT01967225|579788757|FG000|Overall Study|Adverse Event|3|||
160564933|NCT01967225|579788758|FG001|Overall Study|Adverse Event|1|||
160564934|NCT01967225|579788757|FG000|Overall Study|Withdrawal by Subject|2|||
160564935|NCT01967225|579788758|FG001|Overall Study|Withdrawal by Subject|1|||
160564936|NCT01967225|579788757|FG000|Overall Study|Lack of Efficacy|1|||
160841023|NCT00265317|580805006|FG000|Phase 2|Adverse Event|0|||
160841024|NCT00265317|580805007|FG001|Phase 2|Adverse Event|0|||
160841025|NCT00265317|580805008|FG002|Phase 2|Adverse Event|7|||
160841026|NCT00265317|580805009|FG003|Phase 2|Adverse Event|5|||
160841027|NCT00265317|580805006|FG000|Phase 2|Death|0|||
160841028|NCT00265317|580805007|FG001|Phase 2|Death|0|||
160841029|NCT00265317|580805008|FG002|Phase 2|Death|12|||
160841030|NCT00265317|580805009|FG003|Phase 2|Death|15|||
160841031|NCT00265317|580805006|FG000|Phase 2|Protocol Violation|0|||
160841032|NCT00265317|580805007|FG001|Phase 2|Protocol Violation|0|||
160841033|NCT00265317|580805008|FG002|Phase 2|Protocol Violation|1|||
160841034|NCT00265317|580805009|FG003|Phase 2|Protocol Violation|4|||
160841035|NCT00265317|580805006|FG000|Phase 2|Lost to Follow-up|0|||
160841036|NCT00265317|580805007|FG001|Phase 2|Lost to Follow-up|0|||
160841037|NCT00265317|580805008|FG002|Phase 2|Lost to Follow-up|0|||
160841038|NCT00265317|580805009|FG003|Phase 2|Lost to Follow-up|1|||
160841039|NCT00265317|580805006|FG000|Phase 2|Withdrawal/other than adverse event|0|||
160841040|NCT00265317|580805007|FG001|Phase 2|Withdrawal/other than adverse event|0|||
160841041|NCT00265317|580805008|FG002|Phase 2|Withdrawal/other than adverse event|2|||
160841042|NCT00265317|580805009|FG003|Phase 2|Withdrawal/other than adverse event|1|||
160905303|NCT00288054|581048183|FG000|Overall Study|Withdrawal by Subject|1|||
160905304|NCT00288054|581048183|FG000|Overall Study|Not protocol specified|2|||
160905305|NCT00289991|581048184|FG000|Overall Study|Death|35|||
160905306|NCT00289991|581048185|FG001|Overall Study|Death|38|||
160905307|NCT00289991|581048184|FG000|Overall Study|Adverse Event|15|||
160992075|NCT00871429|581359972|FG000|Overall Study|Lost to Follow-up|6|||
160992076|NCT00871429|581359972|FG000|Overall Study|Withdrawal by Subject|17|||
160992077|NCT00871429|581359972|FG000|Overall Study|Questionnaire not completed|1|||
160992078|NCT03102242|581359973|FG000|Overall Study|Adverse Event|2|||
160992079|NCT00389519|581359974|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
160992080|NCT00389519|581359975|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
160992081|NCT00389519|581359976|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
160992082|NCT00389519|581359977|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
160992083|NCT00389519|581359974|FG000|Placebo Run-In|Withdrawal by Subject|19|||
160992084|NCT00389519|581359975|FG001|Placebo Run-In|Withdrawal by Subject|0|||
160992085|NCT00389519|581359976|FG002|Placebo Run-In|Withdrawal by Subject|0|||
160992086|NCT00389519|581359977|FG003|Placebo Run-In|Withdrawal by Subject|0|||
160992087|NCT00389519|581359974|FG000|Placebo Run-In|Reason not specified|40|||
160992088|NCT00389519|581359975|FG001|Placebo Run-In|Reason not specified|0|||
160992089|NCT00389519|581359976|FG002|Placebo Run-In|Reason not specified|0|||
160992090|NCT00389519|581359977|FG003|Placebo Run-In|Reason not specified|0|||
160992091|NCT00389519|581359974|FG000|Randomized|Did not receive study drug|2|||
160992092|NCT00389519|581359975|FG001|Randomized|Did not receive study drug|0|||
160992093|NCT00389519|581359976|FG002|Randomized|Did not receive study drug|0|||
160992094|NCT00389519|581359977|FG003|Randomized|Did not receive study drug|0|||
160564937|NCT01967225|579788758|FG001|Overall Study|Lack of Efficacy|1|||
160905308|NCT00289991|581048185|FG001|Overall Study|Adverse Event|13|||
160905309|NCT00289991|581048184|FG000|Overall Study|Failure of prophylaxis|1|||
160905310|NCT00289991|581048185|FG001|Overall Study|Failure of prophylaxis|1|||
160905311|NCT00289991|581048184|FG000|Overall Study|Fungal breakthrough infection|0|||
160905312|NCT00289991|581048185|FG001|Overall Study|Fungal breakthrough infection|1|||
160905313|NCT00289991|581048184|FG000|Overall Study|Lost to Follow-up|0|||
160905314|NCT00289991|581048185|FG001|Overall Study|Lost to Follow-up|1|||
160905315|NCT00289991|581048184|FG000|Overall Study|Withdrawal by Subject|2|||
160905316|NCT00289991|581048185|FG001|Overall Study|Withdrawal by Subject|12|||
160905317|NCT00289991|581048184|FG000|Overall Study|Other|5|||
160905318|NCT00289991|581048185|FG001|Overall Study|Other|14|||
160905319|NCT01091974|581048186|FG000|Overall Study|Did not start intervention|3|||
160992095|NCT00389519|581359974|FG000|Treated|Adverse Event|1|||
160992096|NCT00389519|581359975|FG001|Treated|Adverse Event|0|||
160992097|NCT00389519|581359976|FG002|Treated|Adverse Event|0|||
160841043|NCT00265317|580805006|FG000|Phase 2|Study terminated by sponsor|0|||
160905320|NCT01091974|581048187|FG001|Overall Study|Did not start intervention|1|||
160841044|NCT00265317|580805007|FG001|Phase 2|Study terminated by sponsor|0|||
160905321|NCT01091974|581048188|FG002|Overall Study|Did not start intervention|3|||
160905322|NCT01091974|581048189|FG003|Overall Study|Did not start intervention|1|||
160992098|NCT00389519|581359977|FG003|Treated|Adverse Event|2|||
160564938|NCT01967225|579788757|FG000|Overall Study|Switching to other therapy|2|||
160564939|NCT01967225|579788758|FG001|Overall Study|Switching to other therapy|0|||
160841045|NCT00265317|580805008|FG002|Phase 2|Study terminated by sponsor|1|||
160841046|NCT00265317|580805009|FG003|Phase 2|Study terminated by sponsor|0|||
160841047|NCT00265317|580805006|FG000|Phase 2|Other|0|||
160841048|NCT00265317|580805007|FG001|Phase 2|Other|0|||
160841049|NCT00265317|580805008|FG002|Phase 2|Other|1|||
160841050|NCT00265317|580805009|FG003|Phase 2|Other|1|||
160841051|NCT00732875|580805012|FG000|Overall Study|Adverse Event|16|||
160841052|NCT00732875|580805012|FG000|Overall Study|Withdrawal by Subject|6|||
160841053|NCT00732875|580805012|FG000|Overall Study|Lack of Efficacy|13|||
160841054|NCT02300259|580805013|FG000|Period 1|Adverse Event|0|||
160841055|NCT02300259|580805014|FG001|Period 1|Adverse Event|0|||
160905323|NCT01091974|581048186|FG000|Overall Study|resumed sleep medication|0|||
160905324|NCT01091974|581048187|FG001|Overall Study|resumed sleep medication|0|||
160905325|NCT01091974|581048188|FG002|Overall Study|resumed sleep medication|1|||
160905326|NCT01091974|581048189|FG003|Overall Study|resumed sleep medication|2|||
160905327|NCT01091974|581048186|FG000|Overall Study|Withdrawal by Subject|1|||
160905328|NCT01091974|581048187|FG001|Overall Study|Withdrawal by Subject|3|||
160905329|NCT01091974|581048188|FG002|Overall Study|Withdrawal by Subject|2|||
160905330|NCT01091974|581048189|FG003|Overall Study|Withdrawal by Subject|2|||
160905331|NCT01091974|581048186|FG000|Overall Study|side-effects|1|||
160905332|NCT01091974|581048187|FG001|Overall Study|side-effects|1|||
160905333|NCT01091974|581048188|FG002|Overall Study|side-effects|0|||
160905334|NCT01091974|581048189|FG003|Overall Study|side-effects|2|||
160905335|NCT00205881|581048190|FG000|Overall Study|Withdrawal by Subject|16|||
160905336|NCT04203498|581048193|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
160905337|NCT04203498|581048194|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
160905338|NCT04203498|581048193|FG000|Overall Study|Withdrawal of patient consent|7|||
160905339|NCT04203498|581048194|FG001|Overall Study|Withdrawal of patient consent|2|||
160905340|NCT04203498|581048193|FG000|Overall Study|Adverse Event|4|||
160905341|NCT04203498|581048194|FG001|Overall Study|Adverse Event|1|||
160905342|NCT04203498|581048193|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
160905343|NCT04203498|581048194|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
160905344|NCT04203498|581048193|FG000|Overall Study|Did not receive IMP|2|||
160905345|NCT04203498|581048194|FG001|Overall Study|Did not receive IMP|0|||
160905346|NCT00334958|581048196|FG000|Overall Study|Medication Noncompliance|0|||
160905347|NCT00334958|581048197|FG001|Overall Study|Medication Noncompliance|3|||
160905348|NCT00334958|581048196|FG000|Overall Study|Protocol Violation|2|||
160905349|NCT00334958|581048197|FG001|Overall Study|Protocol Violation|2|||
160905350|NCT00334958|581048196|FG000|Overall Study|Request of the investigator or sponsor|0|||
160905351|NCT00334958|581048197|FG001|Overall Study|Request of the investigator or sponsor|1|||
160905352|NCT00334958|581048196|FG000|Overall Study|Withdrawal by Subject|7|||
160905353|NCT00334958|581048197|FG001|Overall Study|Withdrawal by Subject|4|||
160905354|NCT00334958|581048196|FG000|Overall Study|Adverse Event|27|||
160905355|NCT00334958|581048197|FG001|Overall Study|Adverse Event|12|||
160905356|NCT00334958|581048196|FG000|Overall Study|Other|1|||
160905357|NCT00334958|581048197|FG001|Overall Study|Other|2|||
160905358|NCT01548287|581048198|FG000|Screening|No reason provided|0|||
160905359|NCT01548287|581048199|FG001|Screening|No reason provided|0|||
160905360|NCT01548287|581048200|FG002|Screening|No reason provided|0|||
160905361|NCT01548287|581048201|FG003|Screening|No reason provided|0|||
160905362|NCT01548287|581048202|FG004|Screening|No reason provided|9|||
160905363|NCT01548287|581048198|FG000|Screening|Did not meet eligibility criteria|0|||
160905364|NCT01548287|581048199|FG001|Screening|Did not meet eligibility criteria|0|||
160905365|NCT01548287|581048200|FG002|Screening|Did not meet eligibility criteria|0|||
160905366|NCT01548287|581048201|FG003|Screening|Did not meet eligibility criteria|0|||
160905367|NCT01548287|581048202|FG004|Screening|Did not meet eligibility criteria|74|||
160905368|NCT01548287|581048198|FG000|Randomized Period|Did not meet inclusion criteria|0|||
160905369|NCT01548287|581048199|FG001|Randomized Period|Did not meet inclusion criteria|0|||
160905370|NCT01548287|581048200|FG002|Randomized Period|Did not meet inclusion criteria|2|||
160905371|NCT01548287|581048201|FG003|Randomized Period|Did not meet inclusion criteria|0|||
160905372|NCT01548287|581048202|FG004|Randomized Period|Did not meet inclusion criteria|0|||
160905373|NCT01548287|581048198|FG000|Randomized Period|Adverse Event|0|||
160992099|NCT00389519|581359974|FG000|Treated|Reason not specified|1|||
160992100|NCT00389519|581359975|FG001|Treated|Reason not specified|1|||
160905374|NCT01548287|581048199|FG001|Randomized Period|Adverse Event|2|||
160905375|NCT01548287|581048200|FG002|Randomized Period|Adverse Event|5|||
160905376|NCT01548287|581048201|FG003|Randomized Period|Adverse Event|0|||
160905377|NCT01548287|581048202|FG004|Randomized Period|Adverse Event|0|||
160905378|NCT02762578|581048207|FG000|Overall Study|Adverse Event|1|||
160905379|NCT02762578|581048208|FG001|Overall Study|Adverse Event|6|||
160905380|NCT02762578|581048207|FG000|Overall Study|Protocol Violation|4|||
160905381|NCT02762578|581048208|FG001|Overall Study|Protocol Violation|2|||
160905382|NCT02762578|581048207|FG000|Overall Study|Withdrawal by Subject|4|||
160905383|NCT02762578|581048208|FG001|Overall Study|Withdrawal by Subject|2|||
160905384|NCT02762578|581048207|FG000|Overall Study|Unclassified|6|||
160992101|NCT00389519|581359976|FG002|Treated|Reason not specified|0|||
160841056|NCT02300259|580805015|FG002|Period 1|Adverse Event|1|||
160841057|NCT02300259|580805013|FG000|Period 1|Withdrawal by Subject|0|||
160841058|NCT02300259|580805014|FG001|Period 1|Withdrawal by Subject|0|||
160841059|NCT02300259|580805015|FG002|Period 1|Withdrawal by Subject|1|||
160564940|NCT01967225|579788757|FG000|Overall Study|Protocol driven decision point|1|||
160564941|NCT01967225|579788758|FG001|Overall Study|Protocol driven decision point|0|||
160564942|NCT01967225|579788757|FG000|Overall Study|Logistical difficulties|1|||
160564943|NCT01967225|579788758|FG001|Overall Study|Logistical difficulties|0|||
160841060|NCT02300259|580805013|FG000|Period 2|Adverse Event|1|||
160841061|NCT02300259|580805014|FG001|Period 2|Adverse Event|0|||
160841062|NCT02300259|580805015|FG002|Period 2|Adverse Event|0|||
160841063|NCT02300259|580805013|FG000|Period 2|Withdrawal by Subject|0|||
160564944|NCT01967225|579788757|FG000|Overall Study|Protocol Violation|2|||
160564945|NCT01967225|579788758|FG001|Overall Study|Protocol Violation|0|||
160564946|NCT01440101|579788759|FG000|Overall Study|Adverse Event|2|||
160564947|NCT01440101|579788760|FG001|Overall Study|Adverse Event|0|||
160564948|NCT01440101|579788761|FG002|Overall Study|Adverse Event|0|||
160564949|NCT01440101|579788759|FG000|Overall Study|Withdrawal by Subject|0|||
160564950|NCT01440101|579788760|FG001|Overall Study|Withdrawal by Subject|3|||
160564951|NCT01440101|579788761|FG002|Overall Study|Withdrawal by Subject|1|||
160564952|NCT01440101|579788759|FG000|Overall Study|Other|0|||
160564953|NCT01440101|579788760|FG001|Overall Study|Other|1|||
160564954|NCT01440101|579788761|FG002|Overall Study|Other|0|||
160564955|NCT02305563|579788764|FG000|Treatment Period|Disease progression|0|||
160564956|NCT02305563|579788765|FG001|Treatment Period|Disease progression|0|||
160564957|NCT02305563|579788766|FG002|Treatment Period|Disease progression|15|||
160564958|NCT02305563|579788767|FG003|Treatment Period|Disease progression|6|||
160564959|NCT02305563|579788768|FG004|Treatment Period|Disease progression|6|||
160564960|NCT02305563|579788764|FG000|Treatment Period|Study drug toxicity|0|||
160564961|NCT02305563|579788765|FG001|Treatment Period|Study drug toxicity|0|||
160564962|NCT02305563|579788766|FG002|Treatment Period|Study drug toxicity|0|||
160564963|NCT02305563|579788767|FG003|Treatment Period|Study drug toxicity|1|||
160564964|NCT02305563|579788768|FG004|Treatment Period|Study drug toxicity|2|||
160564965|NCT02305563|579788764|FG000|Treatment Period|Death|0|||
160564966|NCT02305563|579788765|FG001|Treatment Period|Death|0|||
160564967|NCT02305563|579788766|FG002|Treatment Period|Death|1|||
160564968|NCT02305563|579788767|FG003|Treatment Period|Death|2|||
160564969|NCT02305563|579788768|FG004|Treatment Period|Death|1|||
160564970|NCT02305563|579788764|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
160564971|NCT02305563|579788765|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
160564972|NCT02305563|579788766|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
160564973|NCT02305563|579788767|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
160564974|NCT02305563|579788768|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
160564975|NCT02305563|579788764|FG000|Treatment Period|Participant request to stop therapy|0|||
160564976|NCT02305563|579788765|FG001|Treatment Period|Participant request to stop therapy|2|||
160564977|NCT02305563|579788766|FG002|Treatment Period|Participant request to stop therapy|0|||
160564978|NCT02305563|579788767|FG003|Treatment Period|Participant request to stop therapy|1|||
160564979|NCT02305563|579788768|FG004|Treatment Period|Participant request to stop therapy|0|||
160564980|NCT02305563|579788764|FG000|Treatment Period|Participant withdrew consent|0|||
160564981|NCT02305563|579788765|FG001|Treatment Period|Participant withdrew consent|0|||
160564982|NCT02305563|579788766|FG002|Treatment Period|Participant withdrew consent|1|||
160564983|NCT02305563|579788767|FG003|Treatment Period|Participant withdrew consent|1|||
160564984|NCT02305563|579788768|FG004|Treatment Period|Participant withdrew consent|1|||
160564985|NCT02305563|579788764|FG000|Treatment Period|Maximum clinical benefit|0|||
160564986|NCT02305563|579788765|FG001|Treatment Period|Maximum clinical benefit|0|||
160564987|NCT02305563|579788766|FG002|Treatment Period|Maximum clinical benefit|0|||
160564988|NCT02305563|579788767|FG003|Treatment Period|Maximum clinical benefit|0|||
160564989|NCT02305563|579788768|FG004|Treatment Period|Maximum clinical benefit|1|||
160564990|NCT02305563|579788764|FG000|Treatment Period|Poor/non-compliance|0|||
160564991|NCT02305563|579788765|FG001|Treatment Period|Poor/non-compliance|0|||
160841064|NCT02300259|580805014|FG001|Period 2|Withdrawal by Subject|0|||
160564992|NCT02305563|579788766|FG002|Treatment Period|Poor/non-compliance|0|||
160564993|NCT02305563|579788767|FG003|Treatment Period|Poor/non-compliance|0|||
160564994|NCT02305563|579788768|FG004|Treatment Period|Poor/non-compliance|1|||
160564995|NCT02305563|579788764|FG000|Treatment Period|Administrative reason by Sponsor|0|||
160564996|NCT02305563|579788765|FG001|Treatment Period|Administrative reason by Sponsor|0|||
160564997|NCT02305563|579788766|FG002|Treatment Period|Administrative reason by Sponsor|0|||
160564998|NCT02305563|579788767|FG003|Treatment Period|Administrative reason by Sponsor|0|||
160564999|NCT02305563|579788768|FG004|Treatment Period|Administrative reason by Sponsor|1|||
160565000|NCT02305563|579788764|FG000|Treatment Period|other reason|2|||
160565001|NCT02305563|579788765|FG001|Treatment Period|other reason|0|||
160841065|NCT02300259|580805015|FG002|Period 2|Withdrawal by Subject|1|||
160841066|NCT02510001|580805016|FG000|Overall Study|Early disease progression|0|||
160565002|NCT02305563|579788766|FG002|Treatment Period|other reason|2|||
160565003|NCT02305563|579788767|FG003|Treatment Period|other reason|2|||
160565004|NCT02305563|579788768|FG004|Treatment Period|other reason|1|||
160565005|NCT02305563|579788764|FG000|Treatment Period|Randomized but not treated|0|||
160565006|NCT02305563|579788765|FG001|Treatment Period|Randomized but not treated|0|||
160565007|NCT02305563|579788766|FG002|Treatment Period|Randomized but not treated|0|||
160992102|NCT00389519|581359977|FG003|Treated|Reason not specified|2|||
160992103|NCT03425539|581359980|FG000|Overall Study|Randomized but not treated|0|||
160992104|NCT03425539|581359981|FG001|Overall Study|Randomized but not treated|1|||
160992105|NCT03425539|581359980|FG000|Overall Study|Adverse Event|2|||
160992106|NCT03425539|581359981|FG001|Overall Study|Adverse Event|2|||
160565008|NCT02305563|579788767|FG003|Treatment Period|Randomized but not treated|0|||
160565009|NCT02305563|579788768|FG004|Treatment Period|Randomized but not treated|2|||
160565010|NCT02305563|579788764|FG000|Treatment Period|added ULO, then disease progression|0|||
160565011|NCT02305563|579788765|FG001|Treatment Period|added ULO, then disease progression|0|||
160565012|NCT02305563|579788766|FG002|Treatment Period|added ULO, then disease progression|0|||
160565013|NCT02305563|579788767|FG003|Treatment Period|added ULO, then disease progression|0|||
160565014|NCT02305563|579788768|FG004|Treatment Period|added ULO, then disease progression|4|||
160565015|NCT02305563|579788764|FG000|Treatment Period|added ULO; then other reason|0|||
160565016|NCT02305563|579788765|FG001|Treatment Period|added ULO; then other reason|0|||
160565017|NCT02305563|579788766|FG002|Treatment Period|added ULO; then other reason|0|||
160565018|NCT02305563|579788767|FG003|Treatment Period|added ULO; then other reason|0|||
160565019|NCT02305563|579788768|FG004|Treatment Period|added ULO; then other reason|1|||
160565020|NCT02305563|579788764|FG000|Treatment Period|added ULO, then request to stop|0|||
160565021|NCT02305563|579788765|FG001|Treatment Period|added ULO, then request to stop|0|||
160565022|NCT02305563|579788766|FG002|Treatment Period|added ULO, then request to stop|0|||
160565023|NCT02305563|579788767|FG003|Treatment Period|added ULO, then request to stop|0|||
160565024|NCT02305563|579788768|FG004|Treatment Period|added ULO, then request to stop|1|||
160565025|NCT02305563|579788764|FG000|Follow-up Period|Death|0|||
160565026|NCT02305563|579788765|FG001|Follow-up Period|Death|0|||
160565027|NCT02305563|579788766|FG002|Follow-up Period|Death|5|||
160565028|NCT02305563|579788767|FG003|Follow-up Period|Death|4|||
160841067|NCT02510001|580805017|FG001|Overall Study|Early disease progression|0|||
160841068|NCT02510001|580805018|FG002|Overall Study|Early disease progression|0|||
160841069|NCT02510001|580805019|FG003|Overall Study|Early disease progression|1|||
160841070|NCT02510001|580805020|FG004|Overall Study|Early disease progression|1|||
160841071|NCT02510001|580805021|FG005|Overall Study|Early disease progression|1|||
160841072|NCT02510001|580805022|FG006|Overall Study|Early disease progression|0|||
160841073|NCT02510001|580805023|FG007|Overall Study|Early disease progression|0|||
160841074|NCT02510001|580805016|FG000|Overall Study|Adverse Event|0|||
160841075|NCT02510001|580805017|FG001|Overall Study|Adverse Event|0|||
160841076|NCT02510001|580805018|FG002|Overall Study|Adverse Event|0|||
160841077|NCT02510001|580805019|FG003|Overall Study|Adverse Event|1|||
160841078|NCT02510001|580805020|FG004|Overall Study|Adverse Event|2|||
160841079|NCT02510001|580805021|FG005|Overall Study|Adverse Event|1|||
160841080|NCT02510001|580805022|FG006|Overall Study|Adverse Event|2|||
160841081|NCT02510001|580805023|FG007|Overall Study|Adverse Event|5|||
160841082|NCT02510001|580805016|FG000|Overall Study|Physician Decision|0|||
160841083|NCT02510001|580805017|FG001|Overall Study|Physician Decision|0|||
160841084|NCT02510001|580805018|FG002|Overall Study|Physician Decision|0|||
160841085|NCT02510001|580805019|FG003|Overall Study|Physician Decision|0|||
160841086|NCT02510001|580805020|FG004|Overall Study|Physician Decision|1|||
160841087|NCT02510001|580805021|FG005|Overall Study|Physician Decision|0|||
160841088|NCT02510001|580805022|FG006|Overall Study|Physician Decision|0|||
160841089|NCT02510001|580805023|FG007|Overall Study|Physician Decision|0|||
160841090|NCT02510001|580805016|FG000|Overall Study|Withdrawal by Subject|0|||
160841091|NCT02510001|580805017|FG001|Overall Study|Withdrawal by Subject|0|||
160841092|NCT02510001|580805018|FG002|Overall Study|Withdrawal by Subject|0|||
160841093|NCT02510001|580805019|FG003|Overall Study|Withdrawal by Subject|0|||
160841094|NCT02510001|580805020|FG004|Overall Study|Withdrawal by Subject|0|||
160841095|NCT02510001|580805021|FG005|Overall Study|Withdrawal by Subject|0|||
160841096|NCT02510001|580805022|FG006|Overall Study|Withdrawal by Subject|0|||
160841097|NCT02510001|580805023|FG007|Overall Study|Withdrawal by Subject|2|||
160841098|NCT01504841|580805030|FG000|Overall Study|Withdrawal by Subject|1|||
160841099|NCT01504841|580805031|FG001|Overall Study|Withdrawal by Subject|1|||
160841100|NCT01504841|580805032|FG002|Overall Study|Withdrawal by Subject|0|||
160841101|NCT03149055|580805039|FG000|Overall Study|Not treated|4|||
160841102|NCT04440813|580805040|FG000|Overall Study|Lost to Follow-up|5|||
160992107|NCT03425539|581359980|FG000|Overall Study|Withdrawal by Subject|3|||
160992108|NCT03425539|581359981|FG001|Overall Study|Withdrawal by Subject|0|||
160992109|NCT03425539|581359980|FG000|Overall Study|Lost to Follow-up|0|||
160992110|NCT03425539|581359981|FG001|Overall Study|Lost to Follow-up|1|||
160992111|NCT02040844|581359982|FG000|Overall Study|Adverse Event|0|||
160841103|NCT04440813|580805041|FG001|Overall Study|Lost to Follow-up|5|||
160565029|NCT02305563|579788768|FG004|Follow-up Period|Death|7|||
160565030|NCT02305563|579788764|FG000|Follow-up Period|Participant withdrew consent|0|||
160565031|NCT02305563|579788765|FG001|Follow-up Period|Participant withdrew consent|0|||
160565032|NCT02305563|579788766|FG002|Follow-up Period|Participant withdrew consent|2|||
160841104|NCT00660179|580805042|FG000|Overall Study|Death|44|||
160841105|NCT00660179|580805043|FG001|Overall Study|Death|47|||
160841106|NCT00660179|580805044|FG002|Overall Study|Death|34|||
160841107|NCT00660179|580805042|FG000|Overall Study|Withdrawal of consent|4|||
160841108|NCT00660179|580805043|FG001|Overall Study|Withdrawal of consent|6|||
160841109|NCT00660179|580805044|FG002|Overall Study|Withdrawal of consent|4|||
160841110|NCT00660179|580805042|FG000|Overall Study|Lost to Follow-up|7|||
160841111|NCT00660179|580805043|FG001|Overall Study|Lost to Follow-up|5|||
160841112|NCT00660179|580805044|FG002|Overall Study|Lost to Follow-up|2|||
160841113|NCT00660179|580805042|FG000|Overall Study|Administrative reason|0|||
160841114|NCT00660179|580805043|FG001|Overall Study|Administrative reason|0|||
160841115|NCT00660179|580805044|FG002|Overall Study|Administrative reason|1|||
160841116|NCT00660179|580805042|FG000|Overall Study|Incorrect randomization|1|||
160841117|NCT00660179|580805043|FG001|Overall Study|Incorrect randomization|0|||
160841118|NCT00660179|580805044|FG002|Overall Study|Incorrect randomization|0|||
160841119|NCT00291018|580805051|FG000|Overall Study|Not Consented or Declined PAS|12|||
160841120|NCT00291018|580805052|FG001|Overall Study|Not Consented or Declined PAS|15|||
160841121|NCT00291018|580805053|FG002|Overall Study|Not Consented or Declined PAS|15|||
160841122|NCT00291018|580805051|FG000|Overall Study|Death|3|||
160841123|NCT00291018|580805052|FG001|Overall Study|Death|3|||
160841124|NCT00291018|580805053|FG002|Overall Study|Death|4|||
160841125|NCT00291018|580805051|FG000|Overall Study|Withdrawal by Subject|2|||
160841126|NCT00291018|580805052|FG001|Overall Study|Withdrawal by Subject|8|||
160841127|NCT00291018|580805053|FG002|Overall Study|Withdrawal by Subject|1|||
160841128|NCT00291018|580805051|FG000|Overall Study|Failures|5|||
160841129|NCT00291018|580805052|FG001|Overall Study|Failures|12|||
160841130|NCT00291018|580805053|FG002|Overall Study|Failures|5|||
160841131|NCT00291018|580805051|FG000|Overall Study|Lost to Follow-up|3|||
160841132|NCT00291018|580805052|FG001|Overall Study|Lost to Follow-up|4|||
160841133|NCT00291018|580805053|FG002|Overall Study|Lost to Follow-up|18|||
160841134|NCT05362058|580805058|FG000|Treatment Period|Adverse Event|3|||
160841135|NCT05362058|580805059|FG001|Treatment Period|Adverse Event|3|||
160841136|NCT05362058|580805058|FG000|Treatment Period|Assigned treatment by mistake|3|||
160841137|NCT05362058|580805059|FG001|Treatment Period|Assigned treatment by mistake|4|||
160841138|NCT05362058|580805058|FG000|Treatment Period|Death|1|||
160841139|NCT05362058|580805059|FG001|Treatment Period|Death|1|||
160841140|NCT05362058|580805058|FG000|Treatment Period|Lost to Follow-up|6|||
160841141|NCT05362058|580805059|FG001|Treatment Period|Lost to Follow-up|3|||
160841142|NCT05362058|580805058|FG000|Treatment Period|Non-compliance with study drug|0|||
160841143|NCT05362058|580805059|FG001|Treatment Period|Non-compliance with study drug|1|||
160841144|NCT05362058|580805058|FG000|Treatment Period|Physician Decision|1|||
160841145|NCT05362058|580805059|FG001|Treatment Period|Physician Decision|0|||
160841146|NCT05362058|580805058|FG000|Treatment Period|Protocol deviation|1|||
160905385|NCT02762578|581048208|FG001|Overall Study|Unclassified|0|||
160905386|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
160905387|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
160905388|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
160905389|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
160905390|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
160905391|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
160905392|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
160905393|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
160905394|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905395|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
160905396|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905397|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905398|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905399|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905400|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905401|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
160905402|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905403|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905404|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
160905405|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905406|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905407|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905408|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905409|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905410|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Other|0|||
160841147|NCT05362058|580805059|FG001|Treatment Period|Protocol deviation|0|||
160841148|NCT05362058|580805058|FG000|Treatment Period|Withdrawal by Subject|10|||
160841149|NCT05362058|580805059|FG001|Treatment Period|Withdrawal by Subject|11|||
160841150|NCT05362058|580805058|FG000|Follow-Up Period|Death|1|||
160841151|NCT05362058|580805059|FG001|Follow-Up Period|Death|0|||
160841152|NCT05362058|580805058|FG000|Follow-Up Period|Lost to Follow-up|2|||
160841153|NCT05362058|580805059|FG001|Follow-Up Period|Lost to Follow-up|1|||
160841154|NCT05362058|580805058|FG000|Follow-Up Period|Protocol deviation|1|||
160841155|NCT05362058|580805059|FG001|Follow-Up Period|Protocol deviation|1|||
160841156|NCT05362058|580805058|FG000|Follow-Up Period|Withdrawal by Subject|0|||
160841157|NCT05362058|580805059|FG001|Follow-Up Period|Withdrawal by Subject|3|||
160841158|NCT00887549|580805062|FG000|Induction Therapy|Adverse Event|8|||
160841159|NCT00887549|580805062|FG000|Induction Therapy|Physician Decision|1|||
160841160|NCT00887549|580805062|FG000|Induction Therapy|Progressive Disease|13|||
160841161|NCT00887549|580805062|FG000|Induction Therapy|Death due to Study Disease|4|||
160841162|NCT00887549|580805062|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
160841163|NCT00887549|580805062|FG000|Maintenance Therapy|Adverse Event|16|||
160841164|NCT00887549|580805062|FG000|Maintenance Therapy|Physician Decision|1|||
160841165|NCT00887549|580805062|FG000|Maintenance Therapy|Progressive Disease|25|||
160841166|NCT00887549|580805062|FG000|Maintenance Therapy|Death due to adverse event|1|||
160841167|NCT01858740|580805063|FG000|Overall Study|Death|4|||
160841168|NCT03671304|580805064|FG000|Overall Study|study terminated|7|||
160841169|NCT02097030|580805069|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
160841170|NCT02097030|580805070|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
160841171|NCT02097030|580805069|FG000|First Intervention (3 Days)|Visual Acuity|0|||
160841172|NCT02097030|580805070|FG001|First Intervention (3 Days)|Visual Acuity|1|||
160841173|NCT00391027|580805071|FG000|Overall Study|Adverse Event|8|||
160841174|NCT00391027|580805072|FG001|Overall Study|Adverse Event|8|||
160841175|NCT00391027|580805071|FG000|Overall Study|Lack of Efficacy|3|||
160841176|NCT00391027|580805072|FG001|Overall Study|Lack of Efficacy|0|||
160841177|NCT00391027|580805071|FG000|Overall Study|Withdrawal by Subject|10|||
160841178|NCT00391027|580805072|FG001|Overall Study|Withdrawal by Subject|1|||
160841179|NCT00391027|580805071|FG000|Overall Study|Other|4|||
160841180|NCT00391027|580805072|FG001|Overall Study|Other|3|||
160841181|NCT05232864|580805073|FG000|Overall Study|Adverse Event|0|||
160841182|NCT05232864|580805074|FG001|Overall Study|Adverse Event|1|||
160565033|NCT02305563|579788767|FG003|Follow-up Period|Participant withdrew consent|1|||
160565034|NCT02305563|579788768|FG004|Follow-up Period|Participant withdrew consent|0|||
160565035|NCT02305563|579788764|FG000|Follow-up Period|other reason|0|||
160565036|NCT02305563|579788765|FG001|Follow-up Period|other reason|0|||
160565037|NCT02305563|579788766|FG002|Follow-up Period|other reason|0|||
160565038|NCT02305563|579788767|FG003|Follow-up Period|other reason|0|||
160565039|NCT02305563|579788768|FG004|Follow-up Period|other reason|1|||
160565040|NCT02305563|579788764|FG000|Follow-up Period|Followup no longer required per protocol|3|||
160565041|NCT02305563|579788765|FG001|Follow-up Period|Followup no longer required per protocol|3|||
160841183|NCT05232864|580805073|FG000|Overall Study|Study terminated by sponsor|16|||
160841184|NCT05232864|580805074|FG001|Overall Study|Study terminated by sponsor|14|||
160841185|NCT04765202|580805080|FG000|Overall Study|Lost to Follow-up|1|||
160841186|NCT04765202|580805081|FG001|Overall Study|Lost to Follow-up|1|||
160841187|NCT04765202|580805082|FG002|Overall Study|Lost to Follow-up|2|||
160841188|NCT04765202|580805083|FG003|Overall Study|Lost to Follow-up|2|||
160841189|NCT04765202|580805080|FG000|Overall Study|Physician Decision|0|||
160841190|NCT04765202|580805081|FG001|Overall Study|Physician Decision|0|||
160841191|NCT04765202|580805082|FG002|Overall Study|Physician Decision|1|||
160841192|NCT04765202|580805083|FG003|Overall Study|Physician Decision|1|||
160841193|NCT04929249|580805084|FG000|Overall Study|Adverse Event|2|||
160841194|NCT04929249|580805085|FG001|Overall Study|Adverse Event|1|||
160841195|NCT04929249|580805084|FG000|Overall Study|Death|2|||
160841196|NCT04929249|580805085|FG001|Overall Study|Death|1|||
160841197|NCT04929249|580805084|FG000|Overall Study|Lost to Follow-up|3|||
160841198|NCT04929249|580805085|FG001|Overall Study|Lost to Follow-up|11|||
160841199|NCT04929249|580805084|FG000|Overall Study|Technical problems|0|||
160841200|NCT04929249|580805085|FG001|Overall Study|Technical problems|1|||
160841201|NCT04929249|580805084|FG000|Overall Study|Subject decision|6|||
160841202|NCT04929249|580805085|FG001|Overall Study|Subject decision|8|||
160841203|NCT04929249|580805084|FG000|Overall Study|Withdrew consent|0|||
160841204|NCT04929249|580805085|FG001|Overall Study|Withdrew consent|8|||
160841205|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
160841206|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
160565042|NCT02305563|579788766|FG002|Follow-up Period|Followup no longer required per protocol|4|||
160565043|NCT02305563|579788767|FG003|Follow-up Period|Followup no longer required per protocol|1|||
160565044|NCT02305563|579788768|FG004|Follow-up Period|Followup no longer required per protocol|4|||
160565045|NCT01275222|579788771|FG000|Phase l by Treatment|Adverse Event|1|||
160565046|NCT01275222|579788772|FG001|Phase l by Treatment|Adverse Event|4|||
160841207|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
160841208|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
160841209|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Death|2|||
160841210|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Death|2|||
160841211|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Death|0|||
160841212|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Death|0|||
160841213|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
160841214|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
160841215|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
160841216|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
160841217|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
160841218|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
160841219|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
160841220|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
160841221|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
160841222|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
160841223|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
160841224|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
160841225|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
160841226|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
160841227|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
160841228|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
160841229|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
160841230|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
160841231|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
160841232|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
160841233|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
160841234|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
160841235|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
160841236|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
160841237|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
160841238|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
160841239|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
160841240|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
160841241|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Death|0|||
160841242|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Death|0|||
160841243|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Death|0|||
160841244|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Death|1|||
160841245|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
160841246|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
160841247|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
160841248|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
160841249|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
160841250|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
160841251|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
160841252|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
160841253|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
160841254|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
160841255|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
160841256|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
160841257|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
160841258|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
160841259|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
160841260|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
160841261|NCT00129467|580805090|FG000|Received Intervention|Death|1|||
160841262|NCT00129467|580805091|FG001|Received Intervention|Death|1|||
160841263|NCT00129467|580805090|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
160841264|NCT00129467|580805091|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
160841265|NCT00129467|580805090|FG000|Received Intervention|Delirium|2|||
160841266|NCT00129467|580805091|FG001|Received Intervention|Delirium|0|||
160841267|NCT00129467|580805090|FG000|Received Intervention|Withdrawal by Subject|1|||
160841268|NCT00129467|580805091|FG001|Received Intervention|Withdrawal by Subject|0|||
160841269|NCT00129467|580805090|FG000|Received Intervention|Nausea|1|||
160841270|NCT00129467|580805091|FG001|Received Intervention|Nausea|0|||
160841271|NCT00129467|580805090|FG000|Received Intervention|Intolerance to citalopram|0|||
160992112|NCT02040844|581359983|FG001|Overall Study|Adverse Event|0|||
160992113|NCT02040844|581359984|FG002|Overall Study|Adverse Event|1|||
160992114|NCT02040844|581359982|FG000|Overall Study|Withdrawal by Subject|16|||
160992115|NCT02040844|581359983|FG001|Overall Study|Withdrawal by Subject|22|||
160992116|NCT02040844|581359984|FG002|Overall Study|Withdrawal by Subject|25|||
160992117|NCT02040844|581359982|FG000|Overall Study|Lost to Follow-up|12|||
160992118|NCT02040844|581359983|FG001|Overall Study|Lost to Follow-up|9|||
160992119|NCT02040844|581359984|FG002|Overall Study|Lost to Follow-up|13|||
160992120|NCT02040844|581359982|FG000|Overall Study|Missing|13|||
160841272|NCT00129467|580805091|FG001|Received Intervention|Intolerance to citalopram|1|||
160841273|NCT00129467|580805090|FG000|Received Intervention|Dizzyness, fatigue|0|||
160992121|NCT02040844|581359983|FG001|Overall Study|Missing|3|||
160841274|NCT00129467|580805091|FG001|Received Intervention|Dizzyness, fatigue|1|||
160841275|NCT00129467|580805090|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
160841276|NCT00129467|580805091|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
160841277|NCT00129467|580805090|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
160841278|NCT00129467|580805091|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
160841279|NCT01009086|580805092|FG000|Overall Study|Lack of Efficacy|16|||
160841280|NCT01009086|580805093|FG001|Overall Study|Lack of Efficacy|15|||
160841281|NCT01009086|580805094|FG002|Overall Study|Lack of Efficacy|9|||
160841282|NCT01009086|580805092|FG000|Overall Study|Lost to Follow-up|4|||
160841283|NCT01009086|580805093|FG001|Overall Study|Lost to Follow-up|5|||
160841284|NCT01009086|580805094|FG002|Overall Study|Lost to Follow-up|3|||
160841285|NCT01009086|580805092|FG000|Overall Study|Adverse Event|12|||
160841286|NCT01009086|580805093|FG001|Overall Study|Adverse Event|11|||
160841287|NCT01009086|580805094|FG002|Overall Study|Adverse Event|8|||
160841288|NCT01009086|580805092|FG000|Overall Study|Withdrawal by Subject|9|||
160841289|NCT01009086|580805093|FG001|Overall Study|Withdrawal by Subject|11|||
160841290|NCT01009086|580805094|FG002|Overall Study|Withdrawal by Subject|13|||
160841291|NCT01009086|580805092|FG000|Overall Study|Other|3|||
160841292|NCT01009086|580805093|FG001|Overall Study|Other|5|||
160841293|NCT01009086|580805094|FG002|Overall Study|Other|1|||
160841294|NCT01853878|580805095|FG000|Overall Study|Recurrence|2|||
160841295|NCT01853878|580805096|FG001|Overall Study|Recurrence|0|||
160841296|NCT01853878|580805095|FG000|Overall Study|Adverse Event|2|||
160841297|NCT01853878|580805096|FG001|Overall Study|Adverse Event|0|||
160841298|NCT01853878|580805095|FG000|Overall Study|Withdrawal by Subject|3|||
160841299|NCT01853878|580805096|FG001|Overall Study|Withdrawal by Subject|1|||
160841300|NCT01853878|580805095|FG000|Overall Study|Migrated/moved from the study area|1|||
160841301|NCT01853878|580805096|FG001|Overall Study|Migrated/moved from the study area|0|||
160841302|NCT01853878|580805095|FG000|Overall Study|Other|55|||
160841303|NCT01853878|580805096|FG001|Overall Study|Other|43|||
160841304|NCT01846741|580805097|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
160841305|NCT01361178|580805098|FG000|Overall Study|Death|13|||
160841306|NCT01361178|580805099|FG001|Overall Study|Death|0|||
160841307|NCT04294147|580805102|FG000|Overall Study|Protocol Violation|2|||
160841308|NCT04294147|580805103|FG001|Overall Study|Protocol Violation|0|||
160841309|NCT04038567|580805108|FG000|Overall Study|Lost to Follow-up|6|||
160841310|NCT04038567|580805109|FG001|Overall Study|Lost to Follow-up|4|||
160841311|NCT04038567|580805110|FG002|Overall Study|Lost to Follow-up|5|||
160841312|NCT04038567|580805111|FG003|Overall Study|Lost to Follow-up|4|||
160841313|NCT04038567|580805112|FG004|Overall Study|Lost to Follow-up|6|||
160841314|NCT04038567|580805113|FG005|Overall Study|Lost to Follow-up|4|||
160841315|NCT04038567|580805114|FG006|Overall Study|Lost to Follow-up|4|||
160841316|NCT04038567|580805115|FG007|Overall Study|Lost to Follow-up|1|||
160841317|NCT04038567|580805108|FG000|Overall Study|Withdrawal by Subject|2|||
160841318|NCT04038567|580805109|FG001|Overall Study|Withdrawal by Subject|1|||
160841319|NCT04038567|580805110|FG002|Overall Study|Withdrawal by Subject|1|||
160841320|NCT04038567|580805111|FG003|Overall Study|Withdrawal by Subject|1|||
160841321|NCT04038567|580805112|FG004|Overall Study|Withdrawal by Subject|4|||
160841322|NCT04038567|580805113|FG005|Overall Study|Withdrawal by Subject|1|||
160841323|NCT04038567|580805114|FG006|Overall Study|Withdrawal by Subject|1|||
160841324|NCT04038567|580805115|FG007|Overall Study|Withdrawal by Subject|1|||
160905411|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Other|0|||
160905412|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Other|1|||
160905413|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Other|1|||
160905414|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Other|2|||
160905415|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Other|0|||
160905416|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Other|0|||
160905417|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Other|0|||
160905418|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905419|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905420|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905421|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905422|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
160905423|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905424|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
160992122|NCT02040844|581359984|FG002|Overall Study|Missing|2|||
160841325|NCT04038567|580805108|FG000|Overall Study|missed survey window|1|||
160841326|NCT04038567|580805109|FG001|Overall Study|missed survey window|2|||
160841327|NCT04038567|580805110|FG002|Overall Study|missed survey window|0|||
160841328|NCT04038567|580805111|FG003|Overall Study|missed survey window|0|||
160841329|NCT04038567|580805112|FG004|Overall Study|missed survey window|1|||
160841330|NCT04038567|580805113|FG005|Overall Study|missed survey window|1|||
160841331|NCT04038567|580805114|FG006|Overall Study|missed survey window|2|||
160841332|NCT04038567|580805115|FG007|Overall Study|missed survey window|2|||
160841333|NCT04038567|580805108|FG000|Overall Study|technical issues|0|||
160841334|NCT04038567|580805109|FG001|Overall Study|technical issues|0|||
160841335|NCT04038567|580805110|FG002|Overall Study|technical issues|0|||
160841336|NCT04038567|580805111|FG003|Overall Study|technical issues|0|||
160841337|NCT04038567|580805112|FG004|Overall Study|technical issues|0|||
160841338|NCT04038567|580805113|FG005|Overall Study|technical issues|0|||
160841339|NCT04038567|580805114|FG006|Overall Study|technical issues|1|||
160841340|NCT04038567|580805115|FG007|Overall Study|technical issues|0|||
160841341|NCT04038567|580805108|FG000|Overall Study|Medical issues (i.e., illness)|0|||
160841342|NCT04038567|580805109|FG001|Overall Study|Medical issues (i.e., illness)|1|||
160841343|NCT04038567|580805110|FG002|Overall Study|Medical issues (i.e., illness)|2|||
160841344|NCT04038567|580805111|FG003|Overall Study|Medical issues (i.e., illness)|1|||
160841345|NCT04038567|580805112|FG004|Overall Study|Medical issues (i.e., illness)|1|||
160841346|NCT04038567|580805113|FG005|Overall Study|Medical issues (i.e., illness)|1|||
160841347|NCT04038567|580805114|FG006|Overall Study|Medical issues (i.e., illness)|0|||
160841348|NCT04038567|580805115|FG007|Overall Study|Medical issues (i.e., illness)|0|||
160841349|NCT04038567|580805108|FG000|Overall Study|Death|0|||
160841350|NCT04038567|580805109|FG001|Overall Study|Death|0|||
160841351|NCT04038567|580805110|FG002|Overall Study|Death|0|||
160841352|NCT04038567|580805111|FG003|Overall Study|Death|1|||
160841353|NCT04038567|580805112|FG004|Overall Study|Death|1|||
160841354|NCT04038567|580805113|FG005|Overall Study|Death|0|||
160841355|NCT04038567|580805114|FG006|Overall Study|Death|0|||
160841356|NCT04038567|580805115|FG007|Overall Study|Death|1|||
160841357|NCT02726022|580805116|FG000|Overall Study|Adverse Event|14|||
160841358|NCT02726022|580805116|FG000|Overall Study|Treatment Failure|8|||
160841359|NCT02726022|580805116|FG000|Overall Study|Poor Compliance|13|||
160841360|NCT02726022|580805116|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
160841361|NCT01990859|580805118|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
160841362|NCT01990859|580805118|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
160841363|NCT00622388|580805119|FG000|Overall Study|Disease Progression|47|||
160841364|NCT00622388|580805119|FG000|Overall Study|Adverse Event|6|||
160841365|NCT00622388|580805119|FG000|Overall Study|Protocol Violation|3|||
160841366|NCT00622388|580805119|FG000|Overall Study|Participant Refusal|1|||
160841367|NCT00622388|580805119|FG000|Overall Study|Death|3|||
160841368|NCT00622388|580805119|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
160841369|NCT00622388|580805119|FG000|Overall Study|Took Prohibited Medication|2|||
160841370|NCT00622388|580805119|FG000|Overall Study|Withdrew Consent|1|||
160841371|NCT00622388|580805119|FG000|Overall Study|Insurance Expired|1|||
160841372|NCT01068158|580805120|FG000|Overall Study|Withdrawal by Subject|1|||
160841373|NCT01068158|580805121|FG001|Overall Study|Withdrawal by Subject|2|||
160841374|NCT01068158|580805120|FG000|Overall Study|Lost to Follow-up|7|||
160841375|NCT01068158|580805121|FG001|Overall Study|Lost to Follow-up|0|||
160841376|NCT01068158|580805120|FG000|Overall Study|Protocol Violation|0|||
160841377|NCT01068158|580805121|FG001|Overall Study|Protocol Violation|2|||
160841378|NCT01300572|580805128|FG000|Overall Study|HAMA + post dosimetry|1|||
160841379|NCT01368081|580805129|FG000|Overall Study|Adverse Event|4|||
160841380|NCT01368081|580805130|FG001|Overall Study|Adverse Event|4|||
160841381|NCT01368081|580805131|FG002|Overall Study|Adverse Event|3|||
160841382|NCT01368081|580805132|FG003|Overall Study|Adverse Event|2|||
160841383|NCT01368081|580805133|FG004|Overall Study|Adverse Event|2|||
160841384|NCT01368081|580805134|FG005|Overall Study|Adverse Event|5|||
160841385|NCT01368081|580805135|FG006|Overall Study|Adverse Event|6|||
160841386|NCT01368081|580805136|FG007|Overall Study|Adverse Event|2|||
160841387|NCT01368081|580805137|FG008|Overall Study|Adverse Event|3|||
160841388|NCT01368081|580805138|FG009|Overall Study|Adverse Event|5|||
160841389|NCT01368081|580805139|FG010|Overall Study|Adverse Event|6|||
160841390|NCT01368081|580805140|FG011|Overall Study|Adverse Event|1|||
160841391|NCT01368081|580805141|FG012|Overall Study|Adverse Event|3|||
160841392|NCT01368081|580805129|FG000|Overall Study|Lack of Efficacy|0|||
160841393|NCT01368081|580805130|FG001|Overall Study|Lack of Efficacy|1|||
160841394|NCT01368081|580805131|FG002|Overall Study|Lack of Efficacy|0|||
160841395|NCT01368081|580805132|FG003|Overall Study|Lack of Efficacy|1|||
160841396|NCT01368081|580805133|FG004|Overall Study|Lack of Efficacy|0|||
160841397|NCT01368081|580805134|FG005|Overall Study|Lack of Efficacy|0|||
160841398|NCT01368081|580805135|FG006|Overall Study|Lack of Efficacy|0|||
160841399|NCT01368081|580805136|FG007|Overall Study|Lack of Efficacy|2|||
160841400|NCT01368081|580805137|FG008|Overall Study|Lack of Efficacy|0|||
160841401|NCT01368081|580805138|FG009|Overall Study|Lack of Efficacy|0|||
160841402|NCT01368081|580805139|FG010|Overall Study|Lack of Efficacy|0|||
160841403|NCT01368081|580805140|FG011|Overall Study|Lack of Efficacy|0|||
160841404|NCT01368081|580805141|FG012|Overall Study|Lack of Efficacy|0|||
160841405|NCT01368081|580805129|FG000|Overall Study|Protocol Violation|0|||
160841406|NCT01368081|580805130|FG001|Overall Study|Protocol Violation|0|||
160992123|NCT02040844|581359982|FG000|Overall Study|Non-specified|8|||
160841407|NCT01368081|580805131|FG002|Overall Study|Protocol Violation|0|||
160841408|NCT01368081|580805132|FG003|Overall Study|Protocol Violation|0|||
160841409|NCT01368081|580805133|FG004|Overall Study|Protocol Violation|0|||
160841410|NCT01368081|580805134|FG005|Overall Study|Protocol Violation|1|||
160841411|NCT01368081|580805135|FG006|Overall Study|Protocol Violation|0|||
160841412|NCT01368081|580805136|FG007|Overall Study|Protocol Violation|1|||
160841413|NCT01368081|580805137|FG008|Overall Study|Protocol Violation|0|||
160565047|NCT01275222|579788773|FG002|Phase l by Treatment|Adverse Event|2|||
160565048|NCT01275222|579788774|FG003|Phase l by Treatment|Adverse Event|3|||
160565049|NCT01275222|579788775|FG004|Phase l by Treatment|Adverse Event|0|||
160565050|NCT01275222|579788776|FG005|Phase l by Treatment|Adverse Event|0|||
160841414|NCT01368081|580805138|FG009|Overall Study|Protocol Violation|0|||
160841415|NCT01368081|580805139|FG010|Overall Study|Protocol Violation|0|||
160841416|NCT01368081|580805140|FG011|Overall Study|Protocol Violation|0|||
160841417|NCT01368081|580805141|FG012|Overall Study|Protocol Violation|0|||
160841418|NCT01368081|580805129|FG000|Overall Study|Lost to Follow-up|0|||
160841419|NCT01368081|580805130|FG001|Overall Study|Lost to Follow-up|0|||
160841420|NCT01368081|580805131|FG002|Overall Study|Lost to Follow-up|0|||
160841421|NCT01368081|580805132|FG003|Overall Study|Lost to Follow-up|0|||
160905425|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905426|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
160565051|NCT01275222|579788771|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
160565052|NCT01275222|579788772|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
160565053|NCT01275222|579788773|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
160565054|NCT01275222|579788774|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
160565055|NCT01275222|579788775|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
160565056|NCT01275222|579788776|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
160565057|NCT01275222|579788771|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
160565058|NCT01275222|579788772|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
160565059|NCT01275222|579788773|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
160565060|NCT01275222|579788774|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
160565061|NCT01275222|579788775|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
160565062|NCT01275222|579788776|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
160565063|NCT01275222|579788771|FG000|Phase l by Treatment|Disease progression|12|||
160565064|NCT01275222|579788772|FG001|Phase l by Treatment|Disease progression|8|||
160565065|NCT01275222|579788773|FG002|Phase l by Treatment|Disease progression|2|||
160565066|NCT01275222|579788774|FG003|Phase l by Treatment|Disease progression|5|||
160565067|NCT01275222|579788775|FG004|Phase l by Treatment|Disease progression|0|||
160565068|NCT01275222|579788776|FG005|Phase l by Treatment|Disease progression|0|||
160565069|NCT01275222|579788771|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
160565070|NCT01275222|579788772|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
160565071|NCT01275222|579788773|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
160565072|NCT01275222|579788774|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
160565073|NCT01275222|579788775|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
160565074|NCT01275222|579788776|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
160565075|NCT01275222|579788771|FG000|Phase l by Treatment|Death|0|||
160565076|NCT01275222|579788772|FG001|Phase l by Treatment|Death|1|||
160565077|NCT01275222|579788773|FG002|Phase l by Treatment|Death|0|||
160565078|NCT01275222|579788774|FG003|Phase l by Treatment|Death|1|||
160565079|NCT01275222|579788775|FG004|Phase l by Treatment|Death|0|||
160565080|NCT01275222|579788776|FG005|Phase l by Treatment|Death|0|||
160565081|NCT01275222|579788771|FG000|Phase ll by Stratum|Adverse Event|0|||
160565082|NCT01275222|579788772|FG001|Phase ll by Stratum|Adverse Event|0|||
160565083|NCT01275222|579788773|FG002|Phase ll by Stratum|Adverse Event|0|||
160565084|NCT01275222|579788774|FG003|Phase ll by Stratum|Adverse Event|0|||
160565085|NCT01275222|579788775|FG004|Phase ll by Stratum|Adverse Event|2|||
160565086|NCT01275222|579788776|FG005|Phase ll by Stratum|Adverse Event|10|||
160565087|NCT01275222|579788771|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
160565088|NCT01275222|579788772|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
160565089|NCT01275222|579788773|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
160565090|NCT01275222|579788774|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
160565091|NCT01275222|579788775|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
160565092|NCT01275222|579788776|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
160565093|NCT01275222|579788771|FG000|Phase ll by Stratum|Disease progression|0|||
160565094|NCT01275222|579788772|FG001|Phase ll by Stratum|Disease progression|0|||
160565095|NCT01275222|579788773|FG002|Phase ll by Stratum|Disease progression|0|||
160565096|NCT01275222|579788774|FG003|Phase ll by Stratum|Disease progression|0|||
160565097|NCT01275222|579788775|FG004|Phase ll by Stratum|Disease progression|23|||
160565098|NCT01275222|579788776|FG005|Phase ll by Stratum|Disease progression|31|||
160565099|NCT01275222|579788771|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
160565100|NCT01275222|579788772|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
160565101|NCT01275222|579788773|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
160565102|NCT01275222|579788774|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
160565103|NCT01275222|579788775|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
160565104|NCT01275222|579788776|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
160565105|NCT01275222|579788771|FG000|Phase ll by Stratum|Death|0|||
160565106|NCT01275222|579788772|FG001|Phase ll by Stratum|Death|0|||
160841422|NCT01368081|580805133|FG004|Overall Study|Lost to Follow-up|0|||
160841423|NCT01368081|580805134|FG005|Overall Study|Lost to Follow-up|0|||
160565107|NCT01275222|579788773|FG002|Phase ll by Stratum|Death|0|||
160841424|NCT01368081|580805135|FG006|Overall Study|Lost to Follow-up|0|||
160841425|NCT01368081|580805136|FG007|Overall Study|Lost to Follow-up|0|||
160565108|NCT01275222|579788774|FG003|Phase ll by Stratum|Death|0|||
160565109|NCT01275222|579788775|FG004|Phase ll by Stratum|Death|1|||
160565110|NCT01275222|579788776|FG005|Phase ll by Stratum|Death|1|||
160565111|NCT02495948|579788779|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
160841426|NCT01368081|580805137|FG008|Overall Study|Lost to Follow-up|0|||
160841427|NCT01368081|580805138|FG009|Overall Study|Lost to Follow-up|0|||
160841428|NCT01368081|580805139|FG010|Overall Study|Lost to Follow-up|0|||
160841429|NCT01368081|580805140|FG011|Overall Study|Lost to Follow-up|0|||
160841430|NCT01368081|580805141|FG012|Overall Study|Lost to Follow-up|1|||
160841431|NCT01368081|580805129|FG000|Overall Study|Withdrawal by Subject|4|||
160841432|NCT01368081|580805130|FG001|Overall Study|Withdrawal by Subject|4|||
160841433|NCT01368081|580805131|FG002|Overall Study|Withdrawal by Subject|1|||
160841434|NCT01368081|580805132|FG003|Overall Study|Withdrawal by Subject|1|||
160841435|NCT01368081|580805133|FG004|Overall Study|Withdrawal by Subject|0|||
160841436|NCT01368081|580805134|FG005|Overall Study|Withdrawal by Subject|3|||
160841437|NCT01368081|580805135|FG006|Overall Study|Withdrawal by Subject|4|||
160841438|NCT01368081|580805136|FG007|Overall Study|Withdrawal by Subject|2|||
160841439|NCT01368081|580805137|FG008|Overall Study|Withdrawal by Subject|5|||
160841440|NCT01368081|580805138|FG009|Overall Study|Withdrawal by Subject|4|||
160841441|NCT01368081|580805139|FG010|Overall Study|Withdrawal by Subject|3|||
160841442|NCT01368081|580805140|FG011|Overall Study|Withdrawal by Subject|2|||
160841443|NCT01368081|580805141|FG012|Overall Study|Withdrawal by Subject|0|||
160841444|NCT01368081|580805129|FG000|Overall Study|Other reason not defined above|2|||
160841445|NCT01368081|580805130|FG001|Overall Study|Other reason not defined above|0|||
160841446|NCT01368081|580805131|FG002|Overall Study|Other reason not defined above|0|||
160841447|NCT01368081|580805132|FG003|Overall Study|Other reason not defined above|1|||
160841448|NCT01368081|580805133|FG004|Overall Study|Other reason not defined above|0|||
160841449|NCT01368081|580805134|FG005|Overall Study|Other reason not defined above|1|||
160841450|NCT01368081|580805135|FG006|Overall Study|Other reason not defined above|2|||
160841451|NCT01368081|580805136|FG007|Overall Study|Other reason not defined above|0|||
160841452|NCT01368081|580805137|FG008|Overall Study|Other reason not defined above|0|||
160841453|NCT01368081|580805138|FG009|Overall Study|Other reason not defined above|1|||
160841454|NCT01368081|580805139|FG010|Overall Study|Other reason not defined above|0|||
160841455|NCT01368081|580805140|FG011|Overall Study|Other reason not defined above|0|||
160841456|NCT01368081|580805141|FG012|Overall Study|Other reason not defined above|3|||
160841457|NCT01504412|580807448|FG000|Overall Study|Adverse Event|1|||
160841458|NCT01504412|580807449|FG001|Overall Study|Adverse Event|8|||
160841459|NCT01504412|580807450|FG002|Overall Study|Adverse Event|1|||
160841460|NCT01504412|580807451|FG003|Overall Study|Adverse Event|7|||
160841461|NCT01504412|580807452|FG004|Overall Study|Adverse Event|10|||
160841462|NCT01504412|580807448|FG000|Overall Study|Withdrawal by Subject|2|||
160841463|NCT01504412|580807449|FG001|Overall Study|Withdrawal by Subject|1|||
160841464|NCT01504412|580807450|FG002|Overall Study|Withdrawal by Subject|1|||
160841465|NCT01504412|580807451|FG003|Overall Study|Withdrawal by Subject|5|||
160841466|NCT01504412|580807452|FG004|Overall Study|Withdrawal by Subject|1|||
160841467|NCT01504412|580807448|FG000|Overall Study|Other|2|||
160841468|NCT01504412|580807449|FG001|Overall Study|Other|1|||
160841469|NCT01504412|580807450|FG002|Overall Study|Other|1|||
160841470|NCT01504412|580807451|FG003|Overall Study|Other|6|||
160841471|NCT01504412|580807452|FG004|Overall Study|Other|1|||
160841472|NCT01504412|580807448|FG000|Overall Study|Lost to Follow-up|0|||
160841473|NCT01504412|580807449|FG001|Overall Study|Lost to Follow-up|2|||
160841474|NCT01504412|580807450|FG002|Overall Study|Lost to Follow-up|0|||
160841475|NCT01504412|580807451|FG003|Overall Study|Lost to Follow-up|0|||
160841476|NCT01504412|580807452|FG004|Overall Study|Lost to Follow-up|0|||
160841477|NCT01504412|580807448|FG000|Overall Study|Lack of Efficacy|0|||
160841478|NCT01504412|580807449|FG001|Overall Study|Lack of Efficacy|0|||
160841479|NCT01504412|580807450|FG002|Overall Study|Lack of Efficacy|1|||
160841480|NCT01504412|580807451|FG003|Overall Study|Lack of Efficacy|0|||
160841481|NCT01504412|580807452|FG004|Overall Study|Lack of Efficacy|1|||
160841482|NCT01504412|580807448|FG000|Overall Study|Death|0|||
160841483|NCT01504412|580807449|FG001|Overall Study|Death|0|||
160841484|NCT01504412|580807450|FG002|Overall Study|Death|0|||
160841485|NCT01504412|580807451|FG003|Overall Study|Death|1|||
160841486|NCT01504412|580807452|FG004|Overall Study|Death|0|||
160841487|NCT00630344|580807453|FG000|Overall Study|Adverse Event|5|||
160841488|NCT00630344|580807453|FG000|Overall Study|Progressive Disease|19|||
160841489|NCT00630344|580807453|FG000|Overall Study|Physician Decision|9|||
160841490|NCT00630344|580807453|FG000|Overall Study|Withdrawal by Subject|1|||
160841491|NCT00630344|580807453|FG000|Overall Study|Intercurrent Illness|1|||
160841492|NCT00630344|580807453|FG000|Overall Study|Other|1|||
160841493|NCT04774926|580807454|FG000|Overall Study|Adverse Event|15|||
160841494|NCT04774926|580807454|FG000|Overall Study|Lost to Follow-up|3|||
160841495|NCT04774926|580807454|FG000|Overall Study|Physician Decision|6|||
160841496|NCT04774926|580807454|FG000|Overall Study|Withdrawal by Subject|3|||
160841497|NCT04774926|580807454|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
160841498|NCT01393639|580807455|FG000|Overall Study|Protocol Violation|0|||
160841499|NCT01393639|580807456|FG001|Overall Study|Protocol Violation|0|||
160841500|NCT01393639|580807457|FG002|Overall Study|Protocol Violation|0|||
160841501|NCT01393639|580807458|FG003|Overall Study|Protocol Violation|1|||
160841502|NCT01393639|580807459|FG004|Overall Study|Protocol Violation|0|||
160841503|NCT01393639|580807460|FG005|Overall Study|Protocol Violation|0|||
160841504|NCT01393639|580807461|FG006|Overall Study|Protocol Violation|0|||
160841505|NCT01393639|580807455|FG000|Overall Study|Other|0|||
160841506|NCT01393639|580807456|FG001|Overall Study|Other|2|||
160841507|NCT01393639|580807457|FG002|Overall Study|Other|0|||
160841508|NCT01393639|580807458|FG003|Overall Study|Other|2|||
160841509|NCT01393639|580807459|FG004|Overall Study|Other|1|||
160841510|NCT01393639|580807460|FG005|Overall Study|Other|0|||
160841511|NCT01393639|580807461|FG006|Overall Study|Other|1|||
160841512|NCT01393639|580807455|FG000|Overall Study|Withdrawal by Subject|1|||
160841513|NCT01393639|580807456|FG001|Overall Study|Withdrawal by Subject|1|||
160841514|NCT01393639|580807457|FG002|Overall Study|Withdrawal by Subject|0|||
160841515|NCT01393639|580807458|FG003|Overall Study|Withdrawal by Subject|0|||
160841516|NCT01393639|580807459|FG004|Overall Study|Withdrawal by Subject|0|||
160841517|NCT01393639|580807460|FG005|Overall Study|Withdrawal by Subject|0|||
160841518|NCT01393639|580807461|FG006|Overall Study|Withdrawal by Subject|1|||
160841519|NCT01393639|580807455|FG000|Overall Study|Medication error without associated AE|0|||
160841520|NCT01393639|580807456|FG001|Overall Study|Medication error without associated AE|0|||
160841521|NCT01393639|580807457|FG002|Overall Study|Medication error without associated AE|0|||
160841522|NCT01393639|580807458|FG003|Overall Study|Medication error without associated AE|0|||
160841523|NCT01393639|580807459|FG004|Overall Study|Medication error without associated AE|0|||
160841524|NCT01393639|580807460|FG005|Overall Study|Medication error without associated AE|0|||
160841525|NCT01393639|580807461|FG006|Overall Study|Medication error without associated AE|1|||
160841526|NCT01393639|580807455|FG000|Overall Study|Lost to Follow-up|0|||
160841527|NCT01393639|580807456|FG001|Overall Study|Lost to Follow-up|1|||
160841528|NCT01393639|580807457|FG002|Overall Study|Lost to Follow-up|0|||
160841529|NCT01393639|580807458|FG003|Overall Study|Lost to Follow-up|0|||
160841530|NCT01393639|580807459|FG004|Overall Study|Lost to Follow-up|0|||
160841531|NCT01393639|580807460|FG005|Overall Study|Lost to Follow-up|0|||
160841532|NCT01393639|580807461|FG006|Overall Study|Lost to Follow-up|1|||
160841533|NCT01393639|580807455|FG000|Overall Study|Lack of Efficacy|0|||
160841534|NCT01393639|580807456|FG001|Overall Study|Lack of Efficacy|0|||
160841535|NCT01393639|580807457|FG002|Overall Study|Lack of Efficacy|0|||
160841536|NCT01393639|580807458|FG003|Overall Study|Lack of Efficacy|0|||
160841537|NCT01393639|580807459|FG004|Overall Study|Lack of Efficacy|0|||
160841538|NCT01393639|580807460|FG005|Overall Study|Lack of Efficacy|0|||
160841539|NCT01393639|580807461|FG006|Overall Study|Lack of Efficacy|1|||
160841540|NCT01393639|580807455|FG000|Overall Study|Adverse Event|2|||
160841541|NCT01393639|580807456|FG001|Overall Study|Adverse Event|3|||
160841542|NCT01393639|580807457|FG002|Overall Study|Adverse Event|1|||
160905427|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
160905428|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
160905429|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
160905430|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
160905431|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
160905432|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
160905433|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
160905434|NCT01090492|581048209|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
160905435|NCT01090492|581048210|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
160841543|NCT01393639|580807458|FG003|Overall Study|Adverse Event|2|||
160841544|NCT01393639|580807459|FG004|Overall Study|Adverse Event|0|||
160841545|NCT01393639|580807460|FG005|Overall Study|Adverse Event|2|||
160841546|NCT01393639|580807461|FG006|Overall Study|Adverse Event|3|||
160841547|NCT03626545|580807462|FG000|Overall Study|Progressive disease|3|||
160841548|NCT03626545|580807463|FG001|Overall Study|Progressive disease|82|||
160841549|NCT03626545|580807464|FG002|Overall Study|Progressive disease|85|||
160841550|NCT03626545|580807462|FG000|Overall Study|Adverse Event|3|||
160841551|NCT03626545|580807463|FG001|Overall Study|Adverse Event|13|||
160841552|NCT03626545|580807464|FG002|Overall Study|Adverse Event|10|||
160841553|NCT03626545|580807462|FG000|Overall Study|Physician Decision|1|||
160841554|NCT03626545|580807463|FG001|Overall Study|Physician Decision|18|||
160841555|NCT03626545|580807464|FG002|Overall Study|Physician Decision|14|||
160841556|NCT03626545|580807462|FG000|Overall Study|Subject Decision|0|||
160841557|NCT03626545|580807463|FG001|Overall Study|Subject Decision|5|||
160841558|NCT03626545|580807464|FG002|Overall Study|Subject Decision|5|||
160841559|NCT03626545|580807462|FG000|Overall Study|Death|1|||
160841560|NCT03626545|580807463|FG001|Overall Study|Death|1|||
160841561|NCT03626545|580807464|FG002|Overall Study|Death|1|||
160841562|NCT03626545|580807462|FG000|Overall Study|Protocol Deviation|0|||
160841563|NCT03626545|580807463|FG001|Overall Study|Protocol Deviation|1|||
160841564|NCT03626545|580807464|FG002|Overall Study|Protocol Deviation|1|||
160841565|NCT03626545|580807462|FG000|Overall Study|Guardian Decision|0|||
160841566|NCT03626545|580807463|FG001|Overall Study|Guardian Decision|0|||
160841567|NCT03626545|580807464|FG002|Overall Study|Guardian Decision|1|||
160841568|NCT00793325|580807466|FG000|Overall Study|Protocol Violation|18|||
160841569|NCT00793325|580807466|FG000|Overall Study|Lost to Follow-up|1|||
160841570|NCT01440816|580807467|FG000|Overall Study|Disease Progression|0|||
160841571|NCT01440816|580807468|FG001|Overall Study|Disease Progression|9|||
160841572|NCT01440816|580807467|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
160841573|NCT01440816|580807468|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
160841574|NCT02462720|580807472|FG000|Part 2|Withdrawal by Subject|1|||
160841575|NCT02462720|580807473|FG001|Part 2|Withdrawal by Subject|0|||
160841576|NCT02462720|580807472|FG000|Part 2|Protocol Violation|0|||
160841577|NCT02462720|580807473|FG001|Part 2|Protocol Violation|1|||
160841578|NCT03250182|580807478|FG000|Overall Study|Withdrawal by Subject|1|||
160841579|NCT05173012|580807481|FG000|Overall Study|Adverse Event|2|||
160841580|NCT05173012|580807482|FG001|Overall Study|Adverse Event|3|||
160841581|NCT05173012|580807483|FG002|Overall Study|Adverse Event|4|||
160841582|NCT05173012|580807484|FG003|Overall Study|Adverse Event|13|||
160841583|NCT05173012|580807485|FG004|Overall Study|Adverse Event|0|||
160841584|NCT05173012|580807486|FG005|Overall Study|Adverse Event|0|||
160841585|NCT05173012|580807487|FG006|Overall Study|Adverse Event|2|||
160841586|NCT05173012|580807488|FG007|Overall Study|Adverse Event|4|||
160841587|NCT05173012|580807481|FG000|Overall Study|Lost to Follow-up|0|||
160841588|NCT05173012|580807482|FG001|Overall Study|Lost to Follow-up|0|||
160841589|NCT05173012|580807483|FG002|Overall Study|Lost to Follow-up|0|||
160841590|NCT05173012|580807484|FG003|Overall Study|Lost to Follow-up|1|||
160841591|NCT05173012|580807485|FG004|Overall Study|Lost to Follow-up|0|||
160841592|NCT05173012|580807486|FG005|Overall Study|Lost to Follow-up|0|||
160841593|NCT05173012|580807487|FG006|Overall Study|Lost to Follow-up|0|||
160841594|NCT05173012|580807488|FG007|Overall Study|Lost to Follow-up|0|||
160841595|NCT05173012|580807481|FG000|Overall Study|Withdrawal by Subject|1|||
160841596|NCT05173012|580807482|FG001|Overall Study|Withdrawal by Subject|0|||
160841597|NCT05173012|580807483|FG002|Overall Study|Withdrawal by Subject|1|||
160841598|NCT05173012|580807484|FG003|Overall Study|Withdrawal by Subject|3|||
160841599|NCT05173012|580807485|FG004|Overall Study|Withdrawal by Subject|1|||
160841600|NCT05173012|580807486|FG005|Overall Study|Withdrawal by Subject|0|||
160841601|NCT05173012|580807487|FG006|Overall Study|Withdrawal by Subject|1|||
160841602|NCT05173012|580807488|FG007|Overall Study|Withdrawal by Subject|0|||
160841603|NCT05173012|580807481|FG000|Overall Study|Protocol Deviation|0|||
160841604|NCT05173012|580807482|FG001|Overall Study|Protocol Deviation|0|||
160841605|NCT05173012|580807483|FG002|Overall Study|Protocol Deviation|0|||
160841606|NCT05173012|580807484|FG003|Overall Study|Protocol Deviation|1|||
160841607|NCT05173012|580807485|FG004|Overall Study|Protocol Deviation|0|||
160841608|NCT05173012|580807486|FG005|Overall Study|Protocol Deviation|0|||
160841609|NCT05173012|580807487|FG006|Overall Study|Protocol Deviation|0|||
160841610|NCT05173012|580807488|FG007|Overall Study|Protocol Deviation|0|||
160841611|NCT05173012|580807481|FG000|Overall Study|Other|0|||
160841612|NCT05173012|580807482|FG001|Overall Study|Other|0|||
160841613|NCT05173012|580807483|FG002|Overall Study|Other|0|||
160841614|NCT05173012|580807484|FG003|Overall Study|Other|2|||
160841615|NCT05173012|580807485|FG004|Overall Study|Other|0|||
160841616|NCT05173012|580807486|FG005|Overall Study|Other|0|||
160841617|NCT05173012|580807487|FG006|Overall Study|Other|0|||
160841618|NCT05173012|580807488|FG007|Overall Study|Other|0|||
160841619|NCT03472950|580807489|FG000|Overall Study|Lost to Follow-up|0|||
160841620|NCT03472950|580807490|FG001|Overall Study|Lost to Follow-up|1|||
160841621|NCT03472950|580807489|FG000|Overall Study|Adverse Event|0|||
160841622|NCT03472950|580807490|FG001|Overall Study|Adverse Event|3|||
160841623|NCT03668613|580807491|FG000|Overall Study|Adverse Event|1|||
160841624|NCT03668613|580807492|FG001|Overall Study|Adverse Event|2|||
160841625|NCT03668613|580807491|FG000|Overall Study|Lack of Efficacy|5|||
160841626|NCT03668613|580807492|FG001|Overall Study|Lack of Efficacy|1|||
160841627|NCT03668613|580807491|FG000|Overall Study|Pregnancy|0|||
160841628|NCT03668613|580807492|FG001|Overall Study|Pregnancy|2|||
160841629|NCT03668613|580807491|FG000|Overall Study|Protocol Violation|1|||
160841630|NCT03668613|580807492|FG001|Overall Study|Protocol Violation|0|||
160841631|NCT03668613|580807491|FG000|Overall Study|Physician Decision|1|||
160841632|NCT03668613|580807492|FG001|Overall Study|Physician Decision|0|||
160841633|NCT03668613|580807491|FG000|Overall Study|Withdrawal by Subject|2|||
160841634|NCT03668613|580807492|FG001|Overall Study|Withdrawal by Subject|1|||
160841635|NCT03668613|580807491|FG000|Overall Study|Guardian decision|1|||
160841636|NCT03668613|580807492|FG001|Overall Study|Guardian decision|0|||
160841637|NCT03386487|580807495|FG000|Overall Study|Lost to Follow-up|5|||
160841638|NCT03386487|580807496|FG001|Overall Study|Lost to Follow-up|6|||
160841639|NCT03386487|580807495|FG000|Overall Study|Withdrawal by Subject|11|||
160905436|NCT01090492|581048211|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
160905437|NCT01090492|581048212|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
160905438|NCT01090492|581048213|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
160905439|NCT01090492|581048214|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
160905440|NCT01090492|581048215|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
160905441|NCT01090492|581048216|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
160905442|NCT01090492|581048209|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905443|NCT01090492|581048210|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
160905444|NCT01090492|581048211|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905445|NCT01090492|581048212|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905446|NCT01090492|581048213|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905447|NCT01090492|581048214|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905448|NCT01090492|581048215|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905449|NCT01090492|581048216|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905450|NCT01090492|581048209|FG000|Second Intervention Period (4 Weeks)|Other|0|||
160905451|NCT01090492|581048210|FG001|Second Intervention Period (4 Weeks)|Other|1|||
160905452|NCT01090492|581048211|FG002|Second Intervention Period (4 Weeks)|Other|1|||
160905453|NCT01090492|581048212|FG003|Second Intervention Period (4 Weeks)|Other|0|||
160905454|NCT01090492|581048213|FG004|Second Intervention Period (4 Weeks)|Other|0|||
160905455|NCT01090492|581048214|FG005|Second Intervention Period (4 Weeks)|Other|0|||
160905456|NCT01090492|581048215|FG006|Second Intervention Period (4 Weeks)|Other|0|||
160905457|NCT01090492|581048216|FG007|Second Intervention Period (4 Weeks)|Other|0|||
160905458|NCT01090492|581048209|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
160841640|NCT03386487|580807496|FG001|Overall Study|Withdrawal by Subject|7|||
160841641|NCT03386487|580807495|FG000|Overall Study|Physician Decision|11|||
160841642|NCT03386487|580807496|FG001|Overall Study|Physician Decision|8|||
160841643|NCT01068769|580807497|FG000|Overall Study|Ineligible|1|||
160841644|NCT00894361|580807502|FG000|Overall Study|deaths and less than 2 years followup|24|||
160841645|NCT00894361|580807503|FG001|Overall Study|deaths and less than 2 years followup|64|||
160905459|NCT01090492|581048210|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
160905460|NCT01090492|581048211|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
160841646|NCT00286494|580807504|FG000|Overall Study|Hyperglycemic rescue|12|||
160841647|NCT00286494|580807505|FG001|Overall Study|Hyperglycemic rescue|19|||
160841648|NCT00286494|580807506|FG002|Overall Study|Hyperglycemic rescue|18|||
160841649|NCT00286494|580807504|FG000|Overall Study|Withdrawal by Subject|2|||
160841650|NCT00286494|580807505|FG001|Overall Study|Withdrawal by Subject|10|||
160841651|NCT00286494|580807506|FG002|Overall Study|Withdrawal by Subject|9|||
160841652|NCT00286494|580807504|FG000|Overall Study|Adverse Event|3|||
160841653|NCT00286494|580807505|FG001|Overall Study|Adverse Event|8|||
160905461|NCT01090492|581048212|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
160905462|NCT01090492|581048213|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
160905463|NCT01090492|581048214|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
160905464|NCT01090492|581048215|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
160905465|NCT01090492|581048216|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
160905466|NCT01090492|581048209|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905467|NCT01090492|581048210|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905468|NCT01090492|581048211|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905469|NCT01090492|581048212|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905470|NCT01090492|581048213|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905471|NCT01090492|581048214|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905472|NCT01090492|581048215|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
160905473|NCT01090492|581048216|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905474|NCT02083965|581048217|FG000|Treatment Period|Other|1|||
160905475|NCT02083965|581048218|FG001|Treatment Period|Other|0|||
160905476|NCT00911547|581048220|FG000|Overall Study|Adverse Event|8|||
160905477|NCT00911547|581048221|FG001|Overall Study|Adverse Event|27|||
160905478|NCT00911547|581048222|FG002|Overall Study|Adverse Event|11|||
160905479|NCT00911547|581048223|FG003|Overall Study|Adverse Event|6|||
160905480|NCT00911547|581048220|FG000|Overall Study|Lost to Follow-up|0|||
160905481|NCT00911547|581048221|FG001|Overall Study|Lost to Follow-up|0|||
160905482|NCT00911547|581048222|FG002|Overall Study|Lost to Follow-up|2|||
160905483|NCT00911547|581048223|FG003|Overall Study|Lost to Follow-up|1|||
160905484|NCT00911547|581048220|FG000|Overall Study|Protocol Violation|0|||
160905485|NCT00911547|581048221|FG001|Overall Study|Protocol Violation|5|||
160905486|NCT00911547|581048222|FG002|Overall Study|Protocol Violation|5|||
160905487|NCT00911547|581048223|FG003|Overall Study|Protocol Violation|1|||
160905488|NCT00911547|581048220|FG000|Overall Study|Withdrawal by Subject|3|||
160905489|NCT00911547|581048221|FG001|Overall Study|Withdrawal by Subject|10|||
160905490|NCT00911547|581048222|FG002|Overall Study|Withdrawal by Subject|4|||
160905491|NCT00911547|581048223|FG003|Overall Study|Withdrawal by Subject|8|||
160905492|NCT02564796|581048226|FG000|Overall Study|Physician Decision|2|||
160565112|NCT02495948|579788780|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
160565113|NCT02495948|579788779|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
160565114|NCT02495948|579788780|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
160905493|NCT02564796|581048227|FG001|Overall Study|Physician Decision|2|||
160905494|NCT03583697|581048228|FG000|Overall Study|Withdrawal by Subject|0|||
160905495|NCT03583697|581048229|FG001|Overall Study|Withdrawal by Subject|0|||
160905496|NCT03583697|581048230|FG002|Overall Study|Withdrawal by Subject|1|||
160905497|NCT03583697|581048228|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
160905498|NCT03583697|581048229|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
160905499|NCT03583697|581048230|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
160905500|NCT00114530|581048232|FG000|Overall Study|Death|3|||
160905501|NCT00114530|581048233|FG001|Overall Study|Death|11|||
160905502|NCT00114530|581048232|FG000|Overall Study|Lost to Follow-up|1|||
160905503|NCT00114530|581048233|FG001|Overall Study|Lost to Follow-up|1|||
160905504|NCT00114530|581048232|FG000|Overall Study|Physician Decision|1|||
160565115|NCT00100048|579788782|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
160841654|NCT00286494|580807506|FG002|Overall Study|Adverse Event|6|||
160841655|NCT00286494|580807504|FG000|Overall Study|Physician Decision|5|||
160841656|NCT00286494|580807505|FG001|Overall Study|Physician Decision|5|||
160841657|NCT00286494|580807506|FG002|Overall Study|Physician Decision|1|||
160841658|NCT00286494|580807504|FG000|Overall Study|Lost to Follow-up|3|||
160841659|NCT00286494|580807505|FG001|Overall Study|Lost to Follow-up|1|||
160841660|NCT00286494|580807506|FG002|Overall Study|Lost to Follow-up|3|||
160841661|NCT00286494|580807504|FG000|Overall Study|Protocol Violation|1|||
160841662|NCT00286494|580807505|FG001|Overall Study|Protocol Violation|1|||
160841663|NCT00286494|580807506|FG002|Overall Study|Protocol Violation|2|||
160841664|NCT04776317|580807507|FG000|Overall Study|Physician Decision|0|||
160841665|NCT04776317|580807508|FG001|Overall Study|Physician Decision|1|||
160841666|NCT04776317|580807509|FG002|Overall Study|Physician Decision|0|||
160841667|NCT04776317|580807510|FG003|Overall Study|Physician Decision|0|||
160841668|NCT04776317|580807511|FG004|Overall Study|Physician Decision|0|||
160841669|NCT04776317|580807512|FG005|Overall Study|Physician Decision|0|||
160841670|NCT04776317|580807513|FG006|Overall Study|Physician Decision|0|||
160841671|NCT04776317|580807514|FG007|Overall Study|Physician Decision|0|||
160841672|NCT04776317|580807515|FG008|Overall Study|Physician Decision|0|||
160841673|NCT04776317|580807516|FG009|Overall Study|Physician Decision|0|||
160841674|NCT04776317|580807517|FG010|Overall Study|Physician Decision|0|||
160841675|NCT04776317|580807518|FG011|Overall Study|Physician Decision|0|||
160841676|NCT04776317|580807519|FG012|Overall Study|Physician Decision|0|||
160841677|NCT04776317|580807520|FG013|Overall Study|Physician Decision|0|||
160841678|NCT04776317|580807521|FG014|Overall Study|Physician Decision|0|||
160841679|NCT04776317|580807507|FG000|Overall Study|Protocol Violation|0|||
160841680|NCT04776317|580807508|FG001|Overall Study|Protocol Violation|0|||
160841681|NCT04776317|580807509|FG002|Overall Study|Protocol Violation|1|||
160841682|NCT04776317|580807510|FG003|Overall Study|Protocol Violation|0|||
160841683|NCT04776317|580807511|FG004|Overall Study|Protocol Violation|0|||
160841684|NCT04776317|580807512|FG005|Overall Study|Protocol Violation|0|||
160841685|NCT04776317|580807513|FG006|Overall Study|Protocol Violation|0|||
160841686|NCT04776317|580807514|FG007|Overall Study|Protocol Violation|0|||
160841687|NCT04776317|580807515|FG008|Overall Study|Protocol Violation|0|||
160841688|NCT04776317|580807516|FG009|Overall Study|Protocol Violation|0|||
160841689|NCT04776317|580807517|FG010|Overall Study|Protocol Violation|0|||
160841690|NCT04776317|580807518|FG011|Overall Study|Protocol Violation|0|||
160841691|NCT04776317|580807519|FG012|Overall Study|Protocol Violation|0|||
160841692|NCT04776317|580807520|FG013|Overall Study|Protocol Violation|0|||
160841693|NCT04776317|580807521|FG014|Overall Study|Protocol Violation|0|||
160841694|NCT04776317|580807507|FG000|Overall Study|Withdrawal by Subject|0|||
160841695|NCT04776317|580807508|FG001|Overall Study|Withdrawal by Subject|0|||
160841696|NCT04776317|580807509|FG002|Overall Study|Withdrawal by Subject|0|||
160841697|NCT04776317|580807510|FG003|Overall Study|Withdrawal by Subject|0|||
160841698|NCT04776317|580807511|FG004|Overall Study|Withdrawal by Subject|1|||
160841699|NCT04776317|580807512|FG005|Overall Study|Withdrawal by Subject|0|||
160841700|NCT04776317|580807513|FG006|Overall Study|Withdrawal by Subject|0|||
160841701|NCT04776317|580807514|FG007|Overall Study|Withdrawal by Subject|0|||
160841702|NCT04776317|580807515|FG008|Overall Study|Withdrawal by Subject|0|||
160841703|NCT04776317|580807516|FG009|Overall Study|Withdrawal by Subject|0|||
160841704|NCT04776317|580807517|FG010|Overall Study|Withdrawal by Subject|0|||
160841705|NCT04776317|580807518|FG011|Overall Study|Withdrawal by Subject|0|||
160841706|NCT04776317|580807519|FG012|Overall Study|Withdrawal by Subject|0|||
160841707|NCT04776317|580807520|FG013|Overall Study|Withdrawal by Subject|0|||
160841708|NCT04776317|580807521|FG014|Overall Study|Withdrawal by Subject|0|||
160841709|NCT04207060|580807522|FG000|Overall Study|Lost to Follow-up|2|||
160841710|NCT04207060|580807523|FG001|Overall Study|Lost to Follow-up|0|||
160841711|NCT00774800|580807524|FG000|Intervention 4|Withdrawal by Subject|1|||
160841712|NCT00532298|580807525|FG000|Overall Study|Adverse Event|1|||
160841713|NCT00532298|580807526|FG001|Overall Study|Adverse Event|0|||
160841714|NCT00532298|580807527|FG002|Overall Study|Adverse Event|0|||
160841715|NCT00532298|580807528|FG003|Overall Study|Adverse Event|0|||
160841716|NCT00532298|580807529|FG004|Overall Study|Adverse Event|1|||
160841717|NCT00532298|580807530|FG005|Overall Study|Adverse Event|1|||
160841718|NCT00532298|580807525|FG000|Overall Study|Lost to Follow-up|1|||
160841719|NCT00532298|580807526|FG001|Overall Study|Lost to Follow-up|1|||
160841720|NCT00532298|580807527|FG002|Overall Study|Lost to Follow-up|1|||
160841721|NCT00532298|580807528|FG003|Overall Study|Lost to Follow-up|0|||
160841722|NCT00532298|580807529|FG004|Overall Study|Lost to Follow-up|0|||
160841723|NCT00532298|580807530|FG005|Overall Study|Lost to Follow-up|1|||
160841724|NCT00479856|580807531|FG000|Overall Study|Adverse Event|1|||
160841725|NCT00479856|580807531|FG000|Overall Study|Withdrawal by Subject|1|||
160565116|NCT00100048|579788783|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
160565117|NCT00100048|579788784|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
160841726|NCT00479856|580807531|FG000|Overall Study|Physician Decision|1|||
160841727|NCT04164732|580807536|FG000|Treatment run-in Period|Adverse Event|4|||
160841728|NCT04164732|580807537|FG001|Treatment run-in Period|Adverse Event|0|||
160841729|NCT04164732|580807538|FG002|Treatment run-in Period|Adverse Event|0|||
160841730|NCT04164732|580807536|FG000|Treatment run-in Period|Physician Decision|1|||
160841731|NCT04164732|580807537|FG001|Treatment run-in Period|Physician Decision|0|||
160841732|NCT04164732|580807538|FG002|Treatment run-in Period|Physician Decision|0|||
160841733|NCT04164732|580807536|FG000|Treatment run-in Period|Screen Failure|1|||
160841734|NCT04164732|580807537|FG001|Treatment run-in Period|Screen Failure|0|||
160841735|NCT04164732|580807538|FG002|Treatment run-in Period|Screen Failure|0|||
160841736|NCT04164732|580807536|FG000|Randomized Treatment Period|Adverse Event|0|||
160841737|NCT04164732|580807537|FG001|Randomized Treatment Period|Adverse Event|1|||
160841738|NCT04164732|580807538|FG002|Randomized Treatment Period|Adverse Event|0|||
160841739|NCT04164732|580807536|FG000|Randomized Treatment Period|Protocol Deviation|0|||
160841740|NCT04164732|580807537|FG001|Randomized Treatment Period|Protocol Deviation|1|||
160841741|NCT04164732|580807538|FG002|Randomized Treatment Period|Protocol Deviation|1|||
160565118|NCT00100048|579788785|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
160841742|NCT04164732|580807536|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
160841743|NCT04164732|580807537|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
160841744|NCT04164732|580807538|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
160841745|NCT02141360|580807539|FG000|Overall Study|Withdrawal by Subject|6|||
160841746|NCT02141360|580807540|FG001|Overall Study|Withdrawal by Subject|0|||
160841747|NCT02141360|580807541|FG002|Overall Study|Withdrawal by Subject|0|||
160841748|NCT02141360|580807539|FG000|Overall Study|Study Terminated before Visit|1|||
160841749|NCT02141360|580807540|FG001|Overall Study|Study Terminated before Visit|0|||
160841750|NCT02141360|580807541|FG002|Overall Study|Study Terminated before Visit|0|||
160841751|NCT00646399|580807542|FG000|Overall Study|Death|63|||
160841752|NCT00646399|580807543|FG001|Overall Study|Death|53|||
160841753|NCT00646399|580807542|FG000|Overall Study|Withdrawal by Subject|9|||
160841754|NCT00646399|580807543|FG001|Overall Study|Withdrawal by Subject|10|||
160841755|NCT00646399|580807542|FG000|Overall Study|Other Reason|11|||
160841756|NCT00646399|580807543|FG001|Overall Study|Other Reason|11|||
160841757|NCT00661622|580807544|FG000|Overall Study|Protocol Violation|1|||
160841758|NCT00661622|580807545|FG001|Overall Study|Protocol Violation|0|||
160841759|NCT02332291|580807548|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
160841760|NCT02332291|580807549|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
160841761|NCT02332291|580807548|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
160841762|NCT02332291|580807549|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
160841763|NCT02332291|580807548|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
160841764|NCT02332291|580807549|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
160841765|NCT02332291|580807548|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
160841766|NCT02332291|580807549|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
160841767|NCT02332291|580807548|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
160841768|NCT02332291|580807549|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
160841769|NCT02332291|580807548|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
160841770|NCT02332291|580807549|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
160841771|NCT00395850|580807556|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
160841772|NCT00395850|580807557|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
160841773|NCT00395850|580807558|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
160841774|NCT00395850|580807559|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
160841775|NCT00395850|580807556|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
160841776|NCT00395850|580807557|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
160841777|NCT00395850|580807558|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
160841778|NCT00395850|580807559|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
160841779|NCT00395850|580807556|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
160841780|NCT00395850|580807557|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
160841781|NCT00395850|580807558|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
160841782|NCT00395850|580807559|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
160841783|NCT00395850|580807556|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
160841784|NCT00395850|580807557|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
160841785|NCT00395850|580807558|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
160841786|NCT00395850|580807559|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
160841787|NCT00395850|580807556|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
160841788|NCT00395850|580807557|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
160841789|NCT00395850|580807558|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
160841790|NCT00395850|580807559|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
160841791|NCT00395850|580807556|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
160841792|NCT00395850|580807557|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
160841793|NCT00395850|580807558|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
160841794|NCT00395850|580807559|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
160841795|NCT00395850|580807556|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
160841796|NCT00395850|580807557|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
160841797|NCT00395850|580807558|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
160841798|NCT00395850|580807559|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
160841799|NCT01424228|580807563|FG000|Overall Study|Withdrawal by Subject|27|||
160841800|NCT01424228|580807564|FG001|Overall Study|Withdrawal by Subject|11|||
160841801|NCT01424228|580807563|FG000|Overall Study|Adverse Event|10|||
160841802|NCT01424228|580807564|FG001|Overall Study|Adverse Event|14|||
160841803|NCT01424228|580807563|FG000|Overall Study|Sponsor's decision|9|||
160841804|NCT01424228|580807564|FG001|Overall Study|Sponsor's decision|12|||
160841805|NCT01424228|580807563|FG000|Overall Study|Lack of Efficacy|5|||
160841806|NCT01424228|580807564|FG001|Overall Study|Lack of Efficacy|7|||
160841807|NCT01424228|580807563|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
160841808|NCT01424228|580807564|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
160841809|NCT01424228|580807563|FG000|Overall Study|Non-compliance|2|||
160841810|NCT01424228|580807564|FG001|Overall Study|Non-compliance|0|||
160841811|NCT01424228|580807563|FG000|Overall Study|Worsening of symptoms|1|||
160905505|NCT00114530|581048233|FG001|Overall Study|Physician Decision|1|||
160905506|NCT00114530|581048232|FG000|Overall Study|Withdrawal by Subject|2|||
160905507|NCT00114530|581048233|FG001|Overall Study|Withdrawal by Subject|6|||
160905508|NCT00114530|581048232|FG000|Overall Study|Breast Cancer|1|||
160905509|NCT00114530|581048233|FG001|Overall Study|Breast Cancer|0|||
160905510|NCT00114530|581048232|FG000|Overall Study|Subject decision after endpoint failure|0|||
160905511|NCT00114530|581048233|FG001|Overall Study|Subject decision after endpoint failure|1|||
160905512|NCT00114530|581048232|FG000|Overall Study|Ineligible|1|||
160841812|NCT01424228|580807564|FG001|Overall Study|Worsening of symptoms|0|||
160841813|NCT01424228|580807563|FG000|Overall Study|Unplanned journey|0|||
160841814|NCT01424228|580807564|FG001|Overall Study|Unplanned journey|1|||
160841815|NCT00844558|580807565|FG000|Overall Study|Withdrawal by Subject|9|||
160841816|NCT00844558|580807566|FG001|Overall Study|Withdrawal by Subject|2|||
160841817|NCT00844558|580807565|FG000|Overall Study|Death|1|||
160841818|NCT00844558|580807566|FG001|Overall Study|Death|0|||
160841819|NCT00844558|580807565|FG000|Overall Study|Protocol Violation|1|||
160841820|NCT00844558|580807566|FG001|Overall Study|Protocol Violation|1|||
160841821|NCT00844558|580807565|FG000|Overall Study|Lost to Follow-up|0|||
160841822|NCT00844558|580807566|FG001|Overall Study|Lost to Follow-up|1|||
160841823|NCT00844558|580807565|FG000|Overall Study|Physician Decision|1|||
160841824|NCT00844558|580807566|FG001|Overall Study|Physician Decision|0|||
160841825|NCT00588094|580807567|FG000|Overall Study|Adverse Event|3|||
160841826|NCT00588094|580807567|FG000|Overall Study|Progression of Disease|2|||
160841827|NCT02951429|580807574|FG000|Overall Study|Adverse Event|3|||
160841828|NCT02951429|580807575|FG001|Overall Study|Adverse Event|7|||
160841829|NCT02951429|580807574|FG000|Overall Study|Death|28|||
160841830|NCT02951429|580807575|FG001|Overall Study|Death|36|||
160841831|NCT02951429|580807574|FG000|Overall Study|Lack of Efficacy|0|||
160841832|NCT02951429|580807575|FG001|Overall Study|Lack of Efficacy|1|||
160841833|NCT02951429|580807574|FG000|Overall Study|Lost to Follow-up|0|||
160841834|NCT02951429|580807575|FG001|Overall Study|Lost to Follow-up|1|||
160841835|NCT02951429|580807574|FG000|Overall Study|Lung Transplantation|9|||
160841836|NCT02951429|580807575|FG001|Overall Study|Lung Transplantation|6|||
160841837|NCT02951429|580807574|FG000|Overall Study|Other|1|||
160841838|NCT02951429|580807575|FG001|Overall Study|Other|3|||
160841839|NCT02951429|580807574|FG000|Overall Study|Progressive Disease|1|||
160841840|NCT02951429|580807575|FG001|Overall Study|Progressive Disease|1|||
160841841|NCT02951429|580807574|FG000|Overall Study|Withdrawal by Subject|7|||
160841842|NCT02951429|580807575|FG001|Overall Study|Withdrawal by Subject|11|||
160841843|NCT02951429|580807574|FG000|Overall Study|Participant ongoing in the study|23|||
160841844|NCT02951429|580807575|FG001|Overall Study|Participant ongoing in the study|17|||
160841845|NCT03997825|580807584|FG000|Overall Study|Death|3|||
160841846|NCT03997825|580807584|FG000|Overall Study|Lost to Follow-up|10|||
160841847|NCT03997825|580807584|FG000|Overall Study|Withdrawal by Subject|3|||
160841848|NCT03997825|580807584|FG000|Overall Study|Refused participation|1|||
160841849|NCT01153698|580807585|FG000|Overall Study|Adverse Event|12|||
160841850|NCT01153698|580807585|FG000|Overall Study|Lost to Follow-up|4|||
160841851|NCT01153698|580807585|FG000|Overall Study|Withdrawal by Subject|2|||
160841852|NCT01153698|580807585|FG000|Overall Study|Switch to other anticoagulants|4|||
160841853|NCT01153698|580807585|FG000|Overall Study|Other|2|||
160841854|NCT01153698|580807585|FG000|Overall Study|Not treated with Pradaxa|5|||
160841855|NCT00465647|580807587|FG000|Overall Study|Administrative|2|||
160841856|NCT00465647|580807588|FG001|Overall Study|Administrative|2|||
160841857|NCT00465647|580807589|FG002|Overall Study|Administrative|3|||
160841858|NCT00465647|580807590|FG003|Overall Study|Administrative|2|||
160841859|NCT00465647|580807587|FG000|Overall Study|Adverse Event|2|||
160841860|NCT00465647|580807588|FG001|Overall Study|Adverse Event|0|||
160841861|NCT00465647|580807589|FG002|Overall Study|Adverse Event|3|||
160841862|NCT00465647|580807590|FG003|Overall Study|Adverse Event|2|||
160841863|NCT00465647|580807587|FG000|Overall Study|Withdrawal by Subject|1|||
160841864|NCT00465647|580807588|FG001|Overall Study|Withdrawal by Subject|2|||
160841865|NCT00465647|580807589|FG002|Overall Study|Withdrawal by Subject|2|||
160841866|NCT00465647|580807590|FG003|Overall Study|Withdrawal by Subject|7|||
160841867|NCT00465647|580807587|FG000|Overall Study|"The other reasons included loss of IV"|8|||
160841868|NCT00465647|580807588|FG001|Overall Study|"The other reasons included loss of IV"|4|||
160841869|NCT00465647|580807589|FG002|Overall Study|"The other reasons included loss of IV"|3|||
160841870|NCT00465647|580807590|FG003|Overall Study|"The other reasons included loss of IV"|2|||
160905513|NCT00114530|581048233|FG001|Overall Study|Ineligible|0|||
160905514|NCT02538029|581048235|FG000|Overall Study|unable to complete cognitive assessments|1|||
160905515|NCT02538029|581048236|FG001|Overall Study|unable to complete cognitive assessments|0|||
160841871|NCT01240135|580807591|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
160841872|NCT01240135|580807592|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
160841873|NCT01240135|580807591|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
160841874|NCT01240135|580807592|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
160841875|NCT02220712|580807593|FG000|Overall Study|Adverse Event|1|||
160841876|NCT02220712|580807593|FG000|Overall Study|Withdrawal by Subject|2|||
160841877|NCT02220712|580807593|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
160841878|NCT00760838|580807594|FG000|Overall Study|Adverse Event|1|||
160841879|NCT00760838|580807595|FG001|Overall Study|Adverse Event|1|||
160841880|NCT00760838|580807594|FG000|Overall Study|Lack of Efficacy|1|||
160841881|NCT00760838|580807595|FG001|Overall Study|Lack of Efficacy|0|||
160841882|NCT00760838|580807594|FG000|Overall Study|Lost to Follow-up|2|||
160841883|NCT00760838|580807595|FG001|Overall Study|Lost to Follow-up|0|||
160841884|NCT00760838|580807594|FG000|Overall Study|Withdrawal by Subject|1|||
160841885|NCT00760838|580807595|FG001|Overall Study|Withdrawal by Subject|1|||
160841886|NCT01628965|580807596|FG000|Overall Study|Adverse Event|30|||
160841887|NCT01628965|580807596|FG000|Overall Study|Lack of Efficacy|7|||
160565119|NCT00100048|579788786|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
160565120|NCT00100048|579788787|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
160565121|NCT00100048|579788782|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
160565122|NCT00100048|579788783|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
160841888|NCT01628965|580807596|FG000|Overall Study|Withdrawal by Subject|3|||
160841889|NCT01628965|580807596|FG000|Overall Study|Lost to Follow-up|1|||
160841890|NCT01628965|580807596|FG000|Overall Study|Discontinuation criteria|8|||
160841891|NCT04356352|580807601|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
160841892|NCT04356352|580807602|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
160841893|NCT04356352|580807603|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
160841894|NCT04356352|580807601|FG000|Overall Study|Protocol Violation|0|||
160841895|NCT04356352|580807602|FG001|Overall Study|Protocol Violation|3|||
160841896|NCT04356352|580807603|FG002|Overall Study|Protocol Violation|1|||
160841897|NCT01983774|580807609|FG000|Overall Study|Lung Transplant|0|||
160841898|NCT01983774|580807610|FG001|Overall Study|Lung Transplant|1|||
160841899|NCT01983774|580807609|FG000|Overall Study|Lost to Follow-up|1|||
160841900|NCT01983774|580807610|FG001|Overall Study|Lost to Follow-up|0|||
160841901|NCT01339897|580807611|FG000|Overall Study|Adverse Event|1|||
160841902|NCT01339897|580807612|FG001|Overall Study|Adverse Event|0|||
160841903|NCT01339897|580807613|FG002|Overall Study|Adverse Event|0|||
160841904|NCT01339897|580807614|FG003|Overall Study|Adverse Event|1|||
160841905|NCT03657095|580807615|FG000|Overall Study|Withdrawal by Subject|1|||
160841906|NCT03657095|580807616|FG001|Overall Study|Withdrawal by Subject|1|||
160841907|NCT03657095|580807615|FG000|Overall Study|Adverse Event|0|||
160841908|NCT03657095|580807616|FG001|Overall Study|Adverse Event|3|||
160841909|NCT03657095|580807615|FG000|Overall Study|Study Terminated by Sponsor|58|||
160841910|NCT03657095|580807616|FG001|Overall Study|Study Terminated by Sponsor|49|||
160841911|NCT00847197|580807617|FG000|Overall Study|Adverse Event|21|||
160841912|NCT00847197|580807618|FG001|Overall Study|Adverse Event|3|||
160841913|NCT00847197|580807617|FG000|Overall Study|Protocol Violation|0|||
160841914|NCT00847197|580807618|FG001|Overall Study|Protocol Violation|1|||
160841915|NCT00847197|580807617|FG000|Overall Study|Withdrawal by Subject|3|||
160841916|NCT00847197|580807618|FG001|Overall Study|Withdrawal by Subject|1|||
160841917|NCT01743040|580807621|FG000|Overall Study|Death|1|||
160841918|NCT01743040|580807621|FG000|Overall Study|Lost to Follow-up|66|||
160841919|NCT01743040|580807621|FG000|Overall Study|Physician Decision|40|||
160841920|NCT01743040|580807621|FG000|Overall Study|Protocol Violation|1|||
160841921|NCT01743040|580807621|FG000|Overall Study|Withdrawal by Subject|121|||
160841922|NCT03824587|580807622|FG000|Run-in Period|Screen Failure|0|||
160841923|NCT03824587|580807623|FG001|Run-in Period|Screen Failure|275|||
160841924|NCT03824587|580807622|FG000|Treatment Period|Adverse Event|4|||
160841925|NCT03824587|580807623|FG001|Treatment Period|Adverse Event|1|||
160841926|NCT03824587|580807622|FG000|Treatment Period|Withdrawal by Subject|0|||
160841927|NCT03824587|580807623|FG001|Treatment Period|Withdrawal by Subject|1|||
160841928|NCT03824587|580807622|FG000|Treatment Period|Kidney Transplant|1|||
160841929|NCT03824587|580807623|FG001|Treatment Period|Kidney Transplant|1|||
160841930|NCT02813889|580809683|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
160841931|NCT02813889|580809684|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
160841932|NCT05128578|580809685|FG000|Overall Study|Withdrawal by Subject|9|||
160841933|NCT05128578|580809685|FG000|Overall Study|Lost to Follow-up|5|||
160841934|NCT01128244|580809689|FG000|Overall Study|Adverse Event|1|||
160841935|NCT01128244|580809689|FG000|Overall Study|Scheduling conflict|2|||
160841936|NCT02974257|580809690|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
160841937|NCT02974257|580809691|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
160841938|NCT02974257|580809690|FG000|Overall Study|Clinical indication for thiamine|1|||
160841939|NCT02974257|580809691|FG001|Overall Study|Clinical indication for thiamine|0|||
160841940|NCT02974257|580809690|FG000|Overall Study|Already on thiamine|1|||
160841941|NCT02974257|580809691|FG001|Overall Study|Already on thiamine|0|||
160841942|NCT02974257|580809690|FG000|Overall Study|Extubated prior to study drug|0|||
160841943|NCT02974257|580809691|FG001|Overall Study|Extubated prior to study drug|1|||
160841944|NCT02974257|580809690|FG000|Overall Study|Death|0|||
160841945|NCT02974257|580809691|FG001|Overall Study|Death|1|||
160841946|NCT00398567|580809692|FG000|Overall Study|Disease Progression|3|||
160841947|NCT00398567|580809693|FG001|Overall Study|Disease Progression|4|||
160841948|NCT00398567|580809694|FG002|Overall Study|Disease Progression|27|||
160841949|NCT00398567|580809692|FG000|Overall Study|Withdrawal by Subject|1|||
160841950|NCT00398567|580809693|FG001|Overall Study|Withdrawal by Subject|0|||
160565123|NCT00100048|579788784|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
160565124|NCT00100048|579788785|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
160841951|NCT00398567|580809694|FG002|Overall Study|Withdrawal by Subject|4|||
160841952|NCT00398567|580809692|FG000|Overall Study|Adverse Event|0|||
160841953|NCT00398567|580809693|FG001|Overall Study|Adverse Event|0|||
160841954|NCT00398567|580809694|FG002|Overall Study|Adverse Event|2|||
160841955|NCT00398567|580809692|FG000|Overall Study|Protocol Violation|0|||
160841956|NCT00398567|580809693|FG001|Overall Study|Protocol Violation|0|||
160841957|NCT00398567|580809694|FG002|Overall Study|Protocol Violation|1|||
160841958|NCT03437577|580809697|FG000|Pre-Randomization|Withdrawal by Subject|0|||
160841959|NCT03437577|580809698|FG001|Pre-Randomization|Withdrawal by Subject|0|||
160841960|NCT03437577|580809699|FG002|Pre-Randomization|Withdrawal by Subject|10|||
160841961|NCT03437577|580809697|FG000|Post-Randomization|Physician Decision|0|||
160841962|NCT03437577|580809698|FG001|Post-Randomization|Physician Decision|2|||
160841963|NCT03437577|580809699|FG002|Post-Randomization|Physician Decision|0|||
160841964|NCT04273893|580809700|FG000|Overall Study|Withdrawal by Subject|0|||
160841965|NCT04273893|580809701|FG001|Overall Study|Withdrawal by Subject|2|||
160841966|NCT04273893|580809700|FG000|Overall Study|Treatment of Disease Progression|0|||
160841967|NCT04273893|580809701|FG001|Overall Study|Treatment of Disease Progression|2|||
160841968|NCT04273893|580809700|FG000|Overall Study|Death|1|||
160841969|NCT04273893|580809701|FG001|Overall Study|Death|2|||
160841970|NCT04273893|580809700|FG000|Overall Study|Lost to Follow-up|0|||
160841971|NCT04273893|580809701|FG001|Overall Study|Lost to Follow-up|2|||
160841972|NCT04273893|580809700|FG000|Overall Study|Physician Decision|1|||
160841973|NCT04273893|580809701|FG001|Overall Study|Physician Decision|0|||
160841974|NCT00100789|580809709|FG000|Overall Study|Adverse Event|10|||
160841975|NCT00100789|580809709|FG000|Overall Study|Withdrawal by Subject|1|||
160841976|NCT00100789|580809709|FG000|Overall Study|Progression/relapse|42|||
160841977|NCT00100789|580809709|FG000|Overall Study|Death|2|||
160841978|NCT00100789|580809709|FG000|Overall Study|Not protocol specified|5|||
160841979|NCT00100789|580809709|FG000|Overall Study|Ineligible|3|||
160841980|NCT00100789|580809709|FG000|Overall Study|Never received treatment|1|||
160841981|NCT02936843|580809710|FG000|Overall Study|Lost to Follow-up|3|||
160841982|NCT02936843|580809711|FG001|Overall Study|Lost to Follow-up|1|||
160841983|NCT02936843|580809710|FG000|Overall Study|Withdrawal by Subject|1|||
160841984|NCT02936843|580809711|FG001|Overall Study|Withdrawal by Subject|1|||
160841985|NCT01393821|580809712|FG000|Overall Study|Cancel|1|||
160841986|NCT01393821|580809713|FG001|Overall Study|Cancel|1|||
160841987|NCT01393821|580809712|FG000|Overall Study|not evaluable for primary endpoint|4|||
160841988|NCT01393821|580809713|FG001|Overall Study|not evaluable for primary endpoint|2|||
160841989|NCT00517361|580809725|FG000|Overall Study|Death|6|||
160841990|NCT00517361|580809725|FG000|Overall Study|The study was terminated|5|||
160841991|NCT01948063|580809726|FG000|Overall Study|Boston MCI halted research protocol|0|||
160841992|NCT01948063|580809727|FG001|Overall Study|Boston MCI halted research protocol|1|||
160841993|NCT01948063|580809726|FG000|Overall Study|Discovered an enrollment in other study|0|||
160841994|NCT01948063|580809727|FG001|Overall Study|Discovered an enrollment in other study|1|||
160841995|NCT01948063|580809726|FG000|Overall Study|Blood samples were accidentally thawed|1|||
160841996|NCT01948063|580809727|FG001|Overall Study|Blood samples were accidentally thawed|0|||
160841997|NCT01858766|580809728|FG000|Overall Study|Randomized but Never Treated|0|||
160841998|NCT01858766|580809729|FG001|Overall Study|Randomized but Never Treated|0|||
160841999|NCT01858766|580809730|FG002|Overall Study|Randomized but Never Treated|0|||
160842000|NCT01858766|580809731|FG003|Overall Study|Randomized but Never Treated|0|||
160842001|NCT01858766|580809732|FG004|Overall Study|Randomized but Never Treated|0|||
160842002|NCT01858766|580809733|FG005|Overall Study|Randomized but Never Treated|1|||
160842003|NCT01858766|580809734|FG006|Overall Study|Randomized but Never Treated|0|||
160842004|NCT01858766|580809735|FG007|Overall Study|Randomized but Never Treated|0|||
160842005|NCT01858766|580809736|FG008|Overall Study|Randomized but Never Treated|0|||
160842006|NCT01858766|580809737|FG009|Overall Study|Randomized but Never Treated|0|||
160842007|NCT01858766|580809738|FG010|Overall Study|Randomized but Never Treated|0|||
160842008|NCT01858766|580809739|FG011|Overall Study|Randomized but Never Treated|0|||
160842009|NCT01858766|580809740|FG012|Overall Study|Randomized but Never Treated|0|||
160842010|NCT01858766|580809741|FG013|Overall Study|Randomized but Never Treated|0|||
160842011|NCT01858766|580809742|FG014|Overall Study|Randomized but Never Treated|0|||
160842012|NCT01858766|580809743|FG015|Overall Study|Randomized but Never Treated|0|||
160647698|NCT05002569|580092810|FG001|Randomized|No longer meets study criteria|1|||
160647699|NCT05002569|580092809|FG000|Randomized|AE unrelated to study drug|1|||
160647700|NCT05002569|580092810|FG001|Randomized|AE unrelated to study drug|0|||
160647701|NCT05002569|580092809|FG000|Treatment Period|Requested to Discontinue|26|||
160647702|NCT05002569|580092810|FG001|Treatment Period|Requested to Discontinue|5|||
160842013|NCT01858766|580809744|FG016|Overall Study|Randomized but Never Treated|0|||
160842014|NCT01858766|580809745|FG017|Overall Study|Randomized but Never Treated|1|||
160842015|NCT01858766|580809746|FG018|Overall Study|Randomized but Never Treated|0|||
160842016|NCT01858766|580809728|FG000|Overall Study|Death|0|||
160842017|NCT01858766|580809729|FG001|Overall Study|Death|0|||
160842018|NCT01858766|580809730|FG002|Overall Study|Death|1|||
160842019|NCT01858766|580809731|FG003|Overall Study|Death|0|||
160842020|NCT01858766|580809732|FG004|Overall Study|Death|0|||
160842021|NCT01858766|580809733|FG005|Overall Study|Death|0|||
160647703|NCT05002569|580092809|FG000|Treatment Period|Withdrew Consent|7|||
160842022|NCT01858766|580809734|FG006|Overall Study|Death|0|||
160842023|NCT01858766|580809735|FG007|Overall Study|Death|0|||
160842024|NCT01858766|580809736|FG008|Overall Study|Death|0|||
160842025|NCT01858766|580809737|FG009|Overall Study|Death|0|||
160842026|NCT01858766|580809738|FG010|Overall Study|Death|0|||
160842027|NCT01858766|580809739|FG011|Overall Study|Death|0|||
160842028|NCT01858766|580809740|FG012|Overall Study|Death|0|||
160842029|NCT01858766|580809741|FG013|Overall Study|Death|0|||
160842030|NCT01858766|580809742|FG014|Overall Study|Death|0|||
160842031|NCT01858766|580809743|FG015|Overall Study|Death|0|||
160842032|NCT01858766|580809744|FG016|Overall Study|Death|0|||
160842033|NCT01858766|580809745|FG017|Overall Study|Death|0|||
160842034|NCT01858766|580809746|FG018|Overall Study|Death|0|||
160842035|NCT01858766|580809728|FG000|Overall Study|Lack of Efficacy|1|||
160842036|NCT01858766|580809729|FG001|Overall Study|Lack of Efficacy|0|||
160842037|NCT01858766|580809730|FG002|Overall Study|Lack of Efficacy|0|||
160842038|NCT01858766|580809731|FG003|Overall Study|Lack of Efficacy|0|||
160842039|NCT01858766|580809732|FG004|Overall Study|Lack of Efficacy|1|||
160842040|NCT01858766|580809733|FG005|Overall Study|Lack of Efficacy|2|||
160842041|NCT01858766|580809734|FG006|Overall Study|Lack of Efficacy|0|||
160842042|NCT01858766|580809735|FG007|Overall Study|Lack of Efficacy|0|||
160842043|NCT01858766|580809736|FG008|Overall Study|Lack of Efficacy|0|||
160842044|NCT01858766|580809737|FG009|Overall Study|Lack of Efficacy|0|||
160842045|NCT01858766|580809738|FG010|Overall Study|Lack of Efficacy|0|||
160842046|NCT01858766|580809739|FG011|Overall Study|Lack of Efficacy|3|||
160842047|NCT01858766|580809740|FG012|Overall Study|Lack of Efficacy|5|||
160842048|NCT01858766|580809741|FG013|Overall Study|Lack of Efficacy|3|||
160842049|NCT01858766|580809742|FG014|Overall Study|Lack of Efficacy|5|||
160842050|NCT01858766|580809743|FG015|Overall Study|Lack of Efficacy|5|||
160842051|NCT01858766|580809744|FG016|Overall Study|Lack of Efficacy|2|||
160842052|NCT01858766|580809745|FG017|Overall Study|Lack of Efficacy|3|||
160842053|NCT01858766|580809746|FG018|Overall Study|Lack of Efficacy|3|||
160842054|NCT01858766|580809728|FG000|Overall Study|Lost to Follow-up|0|||
160842055|NCT01858766|580809729|FG001|Overall Study|Lost to Follow-up|0|||
160842056|NCT01858766|580809730|FG002|Overall Study|Lost to Follow-up|0|||
160842057|NCT01858766|580809731|FG003|Overall Study|Lost to Follow-up|0|||
160842058|NCT01858766|580809732|FG004|Overall Study|Lost to Follow-up|0|||
160842059|NCT01858766|580809733|FG005|Overall Study|Lost to Follow-up|1|||
160842060|NCT01858766|580809734|FG006|Overall Study|Lost to Follow-up|0|||
160842061|NCT01858766|580809735|FG007|Overall Study|Lost to Follow-up|2|||
160842062|NCT01858766|580809736|FG008|Overall Study|Lost to Follow-up|0|||
160842063|NCT01858766|580809737|FG009|Overall Study|Lost to Follow-up|0|||
160842064|NCT01858766|580809738|FG010|Overall Study|Lost to Follow-up|0|||
160842065|NCT01858766|580809739|FG011|Overall Study|Lost to Follow-up|1|||
160842066|NCT01858766|580809740|FG012|Overall Study|Lost to Follow-up|0|||
160842067|NCT01858766|580809741|FG013|Overall Study|Lost to Follow-up|0|||
160842068|NCT01858766|580809742|FG014|Overall Study|Lost to Follow-up|3|||
160842069|NCT01858766|580809743|FG015|Overall Study|Lost to Follow-up|1|||
160842070|NCT01858766|580809744|FG016|Overall Study|Lost to Follow-up|1|||
160647704|NCT05002569|580092810|FG001|Treatment Period|Withdrew Consent|1|||
160842071|NCT01858766|580809745|FG017|Overall Study|Lost to Follow-up|0|||
160842072|NCT01858766|580809746|FG018|Overall Study|Lost to Follow-up|1|||
160842073|NCT01858766|580809728|FG000|Overall Study|Withdrew Consent|0|||
160842074|NCT01858766|580809729|FG001|Overall Study|Withdrew Consent|0|||
160842075|NCT01858766|580809730|FG002|Overall Study|Withdrew Consent|0|||
160842076|NCT01858766|580809731|FG003|Overall Study|Withdrew Consent|0|||
160842077|NCT01858766|580809732|FG004|Overall Study|Withdrew Consent|0|||
160842078|NCT01858766|580809733|FG005|Overall Study|Withdrew Consent|0|||
160842079|NCT01858766|580809734|FG006|Overall Study|Withdrew Consent|0|||
160842080|NCT01858766|580809735|FG007|Overall Study|Withdrew Consent|0|||
160842081|NCT01858766|580809736|FG008|Overall Study|Withdrew Consent|0|||
160842082|NCT01858766|580809737|FG009|Overall Study|Withdrew Consent|0|||
160842083|NCT01858766|580809738|FG010|Overall Study|Withdrew Consent|0|||
160842084|NCT01858766|580809739|FG011|Overall Study|Withdrew Consent|1|||
160842085|NCT01858766|580809740|FG012|Overall Study|Withdrew Consent|0|||
160842086|NCT01858766|580809741|FG013|Overall Study|Withdrew Consent|0|||
160842087|NCT01858766|580809742|FG014|Overall Study|Withdrew Consent|0|||
160842088|NCT01858766|580809743|FG015|Overall Study|Withdrew Consent|0|||
160842089|NCT01858766|580809744|FG016|Overall Study|Withdrew Consent|0|||
160842090|NCT01858766|580809745|FG017|Overall Study|Withdrew Consent|0|||
160842091|NCT01858766|580809746|FG018|Overall Study|Withdrew Consent|0|||
160842092|NCT05438576|580809761|FG000|Overall Study|Death|1|||
160842093|NCT05438576|580809762|FG001|Overall Study|Death|1|||
160842094|NCT05438576|580809761|FG000|Overall Study|Withdrawal by Subject|4|||
160842095|NCT05438576|580809762|FG001|Overall Study|Withdrawal by Subject|2|||
160842096|NCT05438576|580809761|FG000|Overall Study|Not Eligible|2|||
160842097|NCT05438576|580809762|FG001|Overall Study|Not Eligible|1|||
160842098|NCT05438576|580809761|FG000|Overall Study|Did not complete baseline testing|22|||
160842099|NCT05438576|580809762|FG001|Overall Study|Did not complete baseline testing|4|||
160842100|NCT02881762|580809765|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
160842101|NCT02881762|580809766|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160842102|NCT00245037|580809767|FG000|Overall Study|Death|17|||
160842103|NCT00296140|580809769|FG000|Overall Study|Lost to Follow-up|1|||
160842104|NCT00296140|580809770|FG001|Overall Study|Lost to Follow-up|0|||
160842105|NCT00296140|580809769|FG000|Overall Study|Withdrawal by Subject|1|||
160905516|NCT02538029|581048237|FG002|Overall Study|unable to complete cognitive assessments|1|||
160905517|NCT00404235|581048240|FG000|Overall Study|Withdrawal by Subject|1|||
160905518|NCT00404235|581048241|FG001|Overall Study|Withdrawal by Subject|2|||
160905519|NCT00679432|581048242|FG000|Overall Study|Adverse Event|5|||
160905520|NCT00679432|581048243|FG001|Overall Study|Adverse Event|6|||
160905521|NCT00679432|581048244|FG002|Overall Study|Adverse Event|10|||
160905522|NCT00679432|581048245|FG003|Overall Study|Adverse Event|7|||
160905523|NCT00679432|581048242|FG000|Overall Study|Protocol Violation|1|||
160905524|NCT00679432|581048243|FG001|Overall Study|Protocol Violation|1|||
160565125|NCT00100048|579788786|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
160565126|NCT00100048|579788787|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
160565127|NCT00100048|579788782|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
160565128|NCT00100048|579788783|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
160565129|NCT00100048|579788784|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
160565130|NCT00100048|579788785|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
160565131|NCT00100048|579788786|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
160565132|NCT00100048|579788787|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
160565133|NCT00100048|579788782|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
160565134|NCT00100048|579788783|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
160565135|NCT00100048|579788784|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
160565136|NCT00100048|579788785|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
160565137|NCT00100048|579788786|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
160565138|NCT00100048|579788787|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
160565139|NCT00100048|579788782|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
160565140|NCT00100048|579788783|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
160842106|NCT00296140|580809770|FG001|Overall Study|Withdrawal by Subject|0|||
160842107|NCT00296140|580809769|FG000|Overall Study|Discharge to Nursing Home|1|||
160842108|NCT00296140|580809770|FG001|Overall Study|Discharge to Nursing Home|0|||
160842109|NCT00880191|580809777|FG000|Overall Study|Refused further treatment|4|||
160842110|NCT00880191|580809778|FG001|Overall Study|Refused further treatment|1|||
160842111|NCT00880191|580809777|FG000|Overall Study|Adverse Event|8|||
160842112|NCT00880191|580809778|FG001|Overall Study|Adverse Event|6|||
160842113|NCT00880191|580809777|FG000|Overall Study|Hospitalization/efficacy|1|||
160842114|NCT00880191|580809778|FG001|Overall Study|Hospitalization/efficacy|1|||
160842115|NCT01843062|580809780|FG000|Overall Study|Protocol Violation|1|||
160842116|NCT01843062|580809781|FG001|Overall Study|Protocol Violation|0|||
160842117|NCT01843062|580809780|FG000|Overall Study|New treatment following progression|2|||
160842118|NCT01843062|580809781|FG001|Overall Study|New treatment following progression|0|||
160842119|NCT01843062|580809780|FG000|Overall Study|Pregnancy|1|||
160842120|NCT01843062|580809781|FG001|Overall Study|Pregnancy|0|||
160842121|NCT01843062|580809780|FG000|Overall Study|Adverse Event|2|||
160842122|NCT01843062|580809781|FG001|Overall Study|Adverse Event|0|||
160842123|NCT01843062|580809780|FG000|Overall Study|Incorrect randomisation|1|||
160842124|NCT01843062|580809781|FG001|Overall Study|Incorrect randomisation|0|||
160842125|NCT01843062|580809780|FG000|Overall Study|Withdrawal by Subject|12|||
160842126|NCT01843062|580809781|FG001|Overall Study|Withdrawal by Subject|3|||
160842127|NCT01843062|580809780|FG000|Overall Study|Death|1|||
160842128|NCT01843062|580809781|FG001|Overall Study|Death|2|||
160842129|NCT01843062|580809780|FG000|Overall Study|Lost to Follow-up|2|||
160842130|NCT01843062|580809781|FG001|Overall Study|Lost to Follow-up|4|||
160842131|NCT00994422|580809785|FG000|Overall Study|Lost to Follow-up|7|||
160842132|NCT00994422|580809786|FG001|Overall Study|Lost to Follow-up|1|||
160905525|NCT00679432|581048244|FG002|Overall Study|Protocol Violation|2|||
160905526|NCT00679432|581048245|FG003|Overall Study|Protocol Violation|1|||
160905527|NCT00679432|581048242|FG000|Overall Study|Withdrawal by Subject|8|||
160905528|NCT00679432|581048243|FG001|Overall Study|Withdrawal by Subject|11|||
160647705|NCT05002569|580092809|FG000|Treatment Period|Study Drug Toxicity|114|||
160647706|NCT05002569|580092810|FG001|Treatment Period|Study Drug Toxicity|64|||
160842133|NCT02669212|580809787|FG000|Overall Study|Lost to Follow-up|1|||
160842134|NCT02669212|580809788|FG001|Overall Study|Lost to Follow-up|0|||
160842135|NCT02669212|580809787|FG000|Overall Study|Medical Condition|3|||
160905529|NCT00679432|581048244|FG002|Overall Study|Withdrawal by Subject|10|||
160842136|NCT02669212|580809788|FG001|Overall Study|Medical Condition|4|||
160842137|NCT02669212|580809787|FG000|Overall Study|Withdrawal by Subject|0|||
160842138|NCT02669212|580809788|FG001|Overall Study|Withdrawal by Subject|2|||
160842139|NCT02669212|580809787|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
160905530|NCT00679432|581048245|FG003|Overall Study|Withdrawal by Subject|9|||
160842140|NCT02669212|580809788|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
160842141|NCT03549104|580809791|FG000|Overall Study|Withdrawal by Subject|5|||
160842142|NCT03549104|580809792|FG001|Overall Study|Withdrawal by Subject|2|||
160842143|NCT03549104|580809791|FG000|Overall Study|Covid shelter in place|1|||
160842144|NCT03549104|580809792|FG001|Overall Study|Covid shelter in place|2|||
160842145|NCT04124705|580809793|FG000|Titration Period|Adverse Event|9|||
160842146|NCT04124705|580809794|FG001|Titration Period|Adverse Event|5|||
160842147|NCT04124705|580809793|FG000|Titration Period|Withdrawal by Subject|6|||
160905531|NCT00679432|581048242|FG000|Overall Study|Lost to Follow-up|1|||
160905532|NCT00679432|581048243|FG001|Overall Study|Lost to Follow-up|5|||
160905533|NCT00679432|581048244|FG002|Overall Study|Lost to Follow-up|4|||
160905534|NCT00679432|581048245|FG003|Overall Study|Lost to Follow-up|2|||
160905535|NCT00679432|581048242|FG000|Overall Study|Physician Decision|3|||
160905536|NCT00679432|581048243|FG001|Overall Study|Physician Decision|2|||
160842148|NCT04124705|580809794|FG001|Titration Period|Withdrawal by Subject|3|||
160842149|NCT04124705|580809793|FG000|Titration Period|Lost to Follow-up|0|||
160842150|NCT04124705|580809794|FG001|Titration Period|Lost to Follow-up|1|||
160842151|NCT04124705|580809793|FG000|Titration Period|Death|1|||
160842152|NCT04124705|580809794|FG001|Titration Period|Death|1|||
160842153|NCT04124705|580809793|FG000|Titration Period|Lack of Efficacy|2|||
160842154|NCT04124705|580809794|FG001|Titration Period|Lack of Efficacy|0|||
160905537|NCT00679432|581048244|FG002|Overall Study|Physician Decision|2|||
160905538|NCT00679432|581048245|FG003|Overall Study|Physician Decision|2|||
160905539|NCT00679432|581048242|FG000|Overall Study|Sponsor decision|1|||
160905540|NCT00679432|581048243|FG001|Overall Study|Sponsor decision|0|||
160905541|NCT00679432|581048244|FG002|Overall Study|Sponsor decision|0|||
160905542|NCT00679432|581048245|FG003|Overall Study|Sponsor decision|0|||
160905543|NCT00679432|581048242|FG000|Overall Study|Lack of Efficacy|13|||
160905544|NCT00679432|581048243|FG001|Overall Study|Lack of Efficacy|9|||
160905545|NCT00679432|581048244|FG002|Overall Study|Lack of Efficacy|14|||
160905546|NCT00679432|581048245|FG003|Overall Study|Lack of Efficacy|8|||
160905547|NCT00679432|581048242|FG000|Overall Study|Infectious colitis, normal histology|5|||
160992124|NCT02040844|581359983|FG001|Overall Study|Non-specified|2|||
160992125|NCT02040844|581359984|FG002|Overall Study|Non-specified|5|||
160992126|NCT02040844|581359982|FG000|Overall Study|Concomitant medication|1|||
160992127|NCT02040844|581359983|FG001|Overall Study|Concomitant medication|3|||
160992128|NCT02040844|581359984|FG002|Overall Study|Concomitant medication|1|||
160992129|NCT01772719|581359985|FG000|Overall Study|Withdrawal by Subject|3|||
160992130|NCT01772719|581359985|FG000|Overall Study|Adverse Event|2|||
160992131|NCT01772719|581359985|FG000|Overall Study|Protocol Violation|1|||
160992132|NCT01772719|581359985|FG000|Overall Study|Lost to Follow-up|1|||
160992133|NCT00946192|581359986|FG000|Overall Study|Lost to Follow-up|6|||
160992134|NCT00946192|581359987|FG001|Overall Study|Lost to Follow-up|11|||
160992135|NCT00946192|581359988|FG002|Overall Study|Lost to Follow-up|9|||
160992136|NCT00946192|581359986|FG000|Overall Study|Withdrawal by Subject|10|||
160992137|NCT00946192|581359987|FG001|Overall Study|Withdrawal by Subject|7|||
160992138|NCT00946192|581359988|FG002|Overall Study|Withdrawal by Subject|3|||
160992139|NCT00946192|581359986|FG000|Overall Study|Did not start medication|2|||
160992140|NCT00946192|581359987|FG001|Overall Study|Did not start medication|0|||
160992141|NCT00946192|581359988|FG002|Overall Study|Did not start medication|0|||
160992142|NCT00477412|581359989|FG000|Overall Study|Death|0|||
160992143|NCT00477412|581359990|FG001|Overall Study|Death|0|||
160992144|NCT00477412|581359991|FG002|Overall Study|Death|0|||
160992145|NCT00477412|581359992|FG003|Overall Study|Death|4|||
160992146|NCT00477412|581359989|FG000|Overall Study|Lost to Follow-up|0|||
160992147|NCT00477412|581359990|FG001|Overall Study|Lost to Follow-up|0|||
160842155|NCT04124705|580809793|FG000|Titration Period|Physician Decision|2|||
160842156|NCT04124705|580809794|FG001|Titration Period|Physician Decision|0|||
160842157|NCT04124705|580809793|FG000|Titration Period|Non-compliance with Study Drug|2|||
160905548|NCT00679432|581048243|FG001|Overall Study|Infectious colitis, normal histology|4|||
160905549|NCT00679432|581048244|FG002|Overall Study|Infectious colitis, normal histology|8|||
160905550|NCT00679432|581048245|FG003|Overall Study|Infectious colitis, normal histology|3|||
160905551|NCT00679432|581048242|FG000|Overall Study|Randomization error, return to prior Rx|0|||
160905552|NCT00679432|581048243|FG001|Overall Study|Randomization error, return to prior Rx|0|||
160992148|NCT00477412|581359991|FG002|Overall Study|Lost to Follow-up|0|||
160992149|NCT00477412|581359992|FG003|Overall Study|Lost to Follow-up|1|||
160992150|NCT00477412|581359989|FG000|Overall Study|Withdrawal by Subject|0|||
160842158|NCT04124705|580809794|FG001|Titration Period|Non-compliance with Study Drug|0|||
160842159|NCT04124705|580809793|FG000|Titration Period|Other|4|||
160842160|NCT04124705|580809794|FG001|Titration Period|Other|9|||
160842161|NCT04124705|580809793|FG000|Stabilization Period|Adverse Event|4|||
160905553|NCT00679432|581048244|FG002|Overall Study|Randomization error, return to prior Rx|3|||
160905554|NCT00679432|581048245|FG003|Overall Study|Randomization error, return to prior Rx|0|||
160905555|NCT00824720|581048246|FG000|Overall Study|failed plug insertion|3|||
160905556|NCT00824720|581048247|FG001|Overall Study|failed plug insertion|1|||
160905557|NCT00824720|581048248|FG002|Overall Study|failed plug insertion|0|||
160992151|NCT00477412|581359990|FG001|Overall Study|Withdrawal by Subject|0|||
160842162|NCT04124705|580809794|FG001|Stabilization Period|Adverse Event|2|||
160842163|NCT04124705|580809793|FG000|Stabilization Period|Withdrawal by Subject|1|||
160842164|NCT04124705|580809794|FG001|Stabilization Period|Withdrawal by Subject|1|||
160842165|NCT04124705|580809793|FG000|Stabilization Period|Lost to Follow-up|0|||
160842166|NCT04124705|580809794|FG001|Stabilization Period|Lost to Follow-up|1|||
160842167|NCT04124705|580809793|FG000|Stabilization Period|Lack of Efficacy|4|||
160842168|NCT04124705|580809794|FG001|Stabilization Period|Lack of Efficacy|2|||
160842169|NCT04124705|580809793|FG000|Stabilization Period|Protocol Deviation|0|||
160842170|NCT04124705|580809794|FG001|Stabilization Period|Protocol Deviation|2|||
160842171|NCT04124705|580809793|FG000|Stabilization Period|Other|2|||
160842172|NCT04124705|580809794|FG001|Stabilization Period|Other|2|||
160842173|NCT03422536|580809795|FG000|Randomized|Physician Decision|1|||
160842174|NCT03422536|580809796|FG001|Randomized|Physician Decision|1|||
160842175|NCT03422536|580809795|FG000|Allocation - Received Intervention|Disease progression|19|||
160842176|NCT03422536|580809796|FG001|Allocation - Received Intervention|Disease progression|25|||
160842177|NCT03422536|580809795|FG000|Allocation - Received Intervention|Death|1|||
160842178|NCT03422536|580809796|FG001|Allocation - Received Intervention|Death|3|||
160842179|NCT03422536|580809795|FG000|Allocation - Received Intervention|Adverse Event|1|||
160842180|NCT03422536|580809796|FG001|Allocation - Received Intervention|Adverse Event|0|||
160842181|NCT03422536|580809795|FG000|Allocation - Received Intervention|Physician Decision|1|||
160842182|NCT03422536|580809796|FG001|Allocation - Received Intervention|Physician Decision|1|||
160842183|NCT03422536|580809795|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
160842184|NCT03422536|580809796|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
160842185|NCT03422536|580809795|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
160842186|NCT03422536|580809796|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
160842187|NCT01973998|580809797|FG000|Overall Study|Death|2|||
160842188|NCT01973998|580809798|FG001|Overall Study|Death|2|||
160842189|NCT02540993|580809804|FG000|Overall Study|Lost to Follow-up|5|||
160842190|NCT02540993|580809805|FG001|Overall Study|Lost to Follow-up|3|||
160842191|NCT02540993|580809804|FG000|Overall Study|Withdrawal by Subject|4|||
160842192|NCT02540993|580809805|FG001|Overall Study|Withdrawal by Subject|6|||
160842193|NCT02540993|580809804|FG000|Overall Study|GCP violations|33|||
160842194|NCT02540993|580809805|FG001|Overall Study|GCP violations|27|||
160842195|NCT00932165|580809808|FG000|Overall Study|Lost to Follow-up|1|||
160842196|NCT01620528|580809809|FG000|Treatment Period|Did Not Receive Study Drug|0|||
160842197|NCT01620528|580809810|FG001|Treatment Period|Did Not Receive Study Drug|0|||
160842198|NCT01620528|580809811|FG002|Treatment Period|Did Not Receive Study Drug|1|||
160842199|NCT01620528|580809809|FG000|Treatment Period|Withdrawal by Subject|35|||
160842200|NCT01620528|580809810|FG001|Treatment Period|Withdrawal by Subject|21|||
160842201|NCT01620528|580809811|FG002|Treatment Period|Withdrawal by Subject|16|||
160842202|NCT01620528|580809809|FG000|Treatment Period|Adverse Event|17|||
160842203|NCT01620528|580809810|FG001|Treatment Period|Adverse Event|13|||
160842204|NCT01620528|580809811|FG002|Treatment Period|Adverse Event|21|||
160842205|NCT01620528|580809809|FG000|Treatment Period|Lost to Follow-up|16|||
160842206|NCT01620528|580809810|FG001|Treatment Period|Lost to Follow-up|8|||
160842207|NCT01620528|580809811|FG002|Treatment Period|Lost to Follow-up|14|||
160842208|NCT01620528|580809809|FG000|Treatment Period|Other|9|||
160842209|NCT01620528|580809810|FG001|Treatment Period|Other|5|||
160842210|NCT01620528|580809811|FG002|Treatment Period|Other|7|||
160842211|NCT01620528|580809809|FG000|Treatment Period|Subject Noncompliant|11|||
160842212|NCT01620528|580809810|FG001|Treatment Period|Subject Noncompliant|2|||
160842213|NCT01620528|580809811|FG002|Treatment Period|Subject Noncompliant|2|||
160842214|NCT01620528|580809809|FG000|Treatment Period|Pregnancy|7|||
160842215|NCT01620528|580809810|FG001|Treatment Period|Pregnancy|2|||
160842216|NCT01620528|580809811|FG002|Treatment Period|Pregnancy|2|||
160842217|NCT01620528|580809809|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
160842218|NCT01620528|580809810|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
160842219|NCT01620528|580809811|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
160842220|NCT01620528|580809809|FG000|Treatment Period|Exclusionary Medication Received|0|||
160842221|NCT01620528|580809810|FG001|Treatment Period|Exclusionary Medication Received|1|||
160842222|NCT01620528|580809811|FG002|Treatment Period|Exclusionary Medication Received|0|||
160842223|NCT01620528|580809809|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
160842224|NCT01620528|580809810|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
160647707|NCT05002569|580092809|FG000|Treatment Period|AE unrelated to study drug|6|||
160647708|NCT05002569|580092810|FG001|Treatment Period|AE unrelated to study drug|12|||
160842225|NCT01620528|580809811|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
160842226|NCT01620528|580809809|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
160842227|NCT01620528|580809810|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
160842228|NCT01620528|580809811|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
160842229|NCT01620528|580809809|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
160842230|NCT01620528|580809810|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
160842231|NCT01620528|580809811|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
160842232|NCT01620528|580809809|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
160842233|NCT01620528|580809810|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
160842234|NCT01620528|580809811|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
160842235|NCT01620528|580809809|FG000|Post-Treatment Follow-Up Period|Other|6|||
160842236|NCT01620528|580809810|FG001|Post-Treatment Follow-Up Period|Other|4|||
160842237|NCT01620528|580809811|FG002|Post-Treatment Follow-Up Period|Other|2|||
160842238|NCT01457846|580809812|FG000|Overall Study|Death before treatment|1|||
160842239|NCT01457846|580809813|FG001|Overall Study|Death before treatment|2|||
160842240|NCT01457846|580809812|FG000|Overall Study|Did not receive treatment|0|||
160842241|NCT01457846|580809813|FG001|Overall Study|Did not receive treatment|1|||
160842242|NCT01457846|580809812|FG000|Overall Study|Death|27|||
160842243|NCT01457846|580809813|FG001|Overall Study|Death|16|||
160842244|NCT01457846|580809812|FG000|Overall Study|Unclassified reason for not completed|11|||
160842245|NCT01457846|580809813|FG001|Overall Study|Unclassified reason for not completed|10|||
160842246|NCT01457846|580809812|FG000|Overall Study|Withdrawal by Subject|1|||
160842247|NCT01457846|580809813|FG001|Overall Study|Withdrawal by Subject|1|||
160842248|NCT01457846|580809812|FG000|Overall Study|Lost to Follow-up|1|||
160842249|NCT01457846|580809813|FG001|Overall Study|Lost to Follow-up|0|||
160842250|NCT03688620|580809818|FG000|Overall Study|Other|0|||
160842251|NCT03688620|580809819|FG001|Overall Study|Other|0|||
160842252|NCT03688620|580809820|FG002|Overall Study|Other|1|||
160842253|NCT03688620|580809818|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
160842254|NCT03688620|580809819|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
160842255|NCT03688620|580809820|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
160842256|NCT03688620|580809818|FG000|Overall Study|Lost to Follow-up|16|||
160842257|NCT03688620|580809819|FG001|Overall Study|Lost to Follow-up|0|||
160842258|NCT03688620|580809820|FG002|Overall Study|Lost to Follow-up|1|||
160842259|NCT03688620|580809818|FG000|Overall Study|Withdrawal by Subject|0|||
160842260|NCT03688620|580809819|FG001|Overall Study|Withdrawal by Subject|0|||
160842261|NCT03688620|580809820|FG002|Overall Study|Withdrawal by Subject|6|||
160842262|NCT02828020|580809821|FG000|Treatment Period|Adverse Event|3|||
160842263|NCT02828020|580809822|FG001|Treatment Period|Adverse Event|1|||
160842264|NCT02828020|580809823|FG002|Treatment Period|Adverse Event|1|||
160842265|NCT02828020|580809821|FG000|Treatment Period|Withdrawal of Consent|10|||
160842266|NCT02828020|580809822|FG001|Treatment Period|Withdrawal of Consent|14|||
160842267|NCT02828020|580809823|FG002|Treatment Period|Withdrawal of Consent|9|||
160842268|NCT02828020|580809821|FG000|Treatment Period|Lost to Follow-up|21|||
160842269|NCT02828020|580809822|FG001|Treatment Period|Lost to Follow-up|24|||
160842270|NCT02828020|580809823|FG002|Treatment Period|Lost to Follow-up|18|||
160842271|NCT02828020|580809821|FG000|Treatment Period|Lack of Qualifying Event|44|||
160842272|NCT02828020|580809822|FG001|Treatment Period|Lack of Qualifying Event|53|||
160842273|NCT02828020|580809823|FG002|Treatment Period|Lack of Qualifying Event|43|||
160842274|NCT02828020|580809821|FG000|Treatment Period|Pregnancy|0|||
160842275|NCT02828020|580809822|FG001|Treatment Period|Pregnancy|2|||
160842276|NCT02828020|580809823|FG002|Treatment Period|Pregnancy|0|||
160842277|NCT02828020|580809821|FG000|Treatment Period|Protocol Violation|2|||
160842278|NCT02828020|580809822|FG001|Treatment Period|Protocol Violation|4|||
160842279|NCT02828020|580809823|FG002|Treatment Period|Protocol Violation|7|||
160842280|NCT02828020|580809821|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
160842281|NCT02828020|580809822|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
160842282|NCT02828020|580809823|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
160842283|NCT02828020|580809821|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
160842284|NCT02828020|580809822|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
160842285|NCT02828020|580809823|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
160842286|NCT02828020|580809821|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
160842287|NCT02828020|580809822|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
160842288|NCT02828020|580809823|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
160842289|NCT02828020|580809821|FG000|Safety Follow-up Period|Protocol Violation|0|||
160842290|NCT02828020|580809822|FG001|Safety Follow-up Period|Protocol Violation|2|||
160842291|NCT02828020|580809823|FG002|Safety Follow-up Period|Protocol Violation|1|||
160842292|NCT02828020|580809821|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
160842293|NCT02828020|580809822|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
160842294|NCT02828020|580809823|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
160842295|NCT00828750|580809824|FG000|Overall Study|Lack of Efficacy|3|||
160842296|NCT00828750|580809824|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
160565141|NCT00100048|579788784|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
160565142|NCT00100048|579788785|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
160565143|NCT00100048|579788786|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
160565144|NCT00100048|579788787|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
160565145|NCT00100048|579788782|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
160565146|NCT00100048|579788783|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
160565147|NCT00100048|579788784|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
160565148|NCT00100048|579788785|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
160565149|NCT00100048|579788786|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
160565150|NCT00100048|579788787|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
160565151|NCT00100048|579788782|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
160565152|NCT00100048|579788783|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
160565153|NCT00100048|579788784|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
160565154|NCT00100048|579788785|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
160565155|NCT00100048|579788786|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
160565156|NCT00100048|579788787|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
160565157|NCT00100048|579788782|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
160565158|NCT00100048|579788783|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
160565159|NCT00100048|579788784|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
160565160|NCT00100048|579788785|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
160565161|NCT00100048|579788786|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
160565162|NCT00100048|579788787|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
160565163|NCT01237951|579788792|FG000|Overall Study|Death|1|||
160565164|NCT02970929|579788795|FG000|Overall Study|Adverse Event|18|||
160565165|NCT02970929|579788795|FG000|Overall Study|Lack of Efficacy|8|||
160565166|NCT02970929|579788795|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
160565167|NCT02970929|579788795|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
160565168|NCT02970929|579788795|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
160565169|NCT02970929|579788795|FG000|Overall Study|LOST TO FOLLOWUP|6|||
160565170|NCT02970929|579788795|FG000|Overall Study|MOVED OUT OF STATE|1|||
160842297|NCT01067469|580809825|FG000|Overall Study|Withdrawal by Subject|0|||
160842298|NCT01067469|580809826|FG001|Overall Study|Withdrawal by Subject|1|||
160842299|NCT01067469|580809825|FG000|Overall Study|Disease Progression|0|||
160842300|NCT01067469|580809826|FG001|Overall Study|Disease Progression|1|||
160842301|NCT04006392|580809827|FG000|Overall Study|Lost to Follow-up|0|||
160842302|NCT04006392|580809828|FG001|Overall Study|Lost to Follow-up|1|||
160842303|NCT04378114|580809829|FG000|Overall Study|Withdrawal by Subject|5|||
160842304|NCT00830180|580809830|FG000|Overall Study|Adverse Event|6|||
160842305|NCT00830180|580809830|FG000|Overall Study|Death|11|||
160842306|NCT00830180|580809830|FG000|Overall Study|Insufficient clinical response|1|||
160842307|NCT00830180|580809830|FG000|Overall Study|Withdrawal by Subject|5|||
160842308|NCT00830180|580809830|FG000|Overall Study|Progressive disease|2|||
160842309|NCT00830180|580809830|FG000|Overall Study|Other - Unspecified|1|||
160842310|NCT01832532|580809832|FG000|Overall Study|Withdrawal by Subject|5|||
160842311|NCT01832532|580809833|FG001|Overall Study|Withdrawal by Subject|2|||
160842312|NCT01736618|580809837|FG000|Overall Study|Death|294|||
160842313|NCT01736618|580809837|FG000|Overall Study|Lost to Follow-up|193|||
160842314|NCT01736618|580809837|FG000|Overall Study|Withdrawal by Subject|54|||
160842315|NCT01736618|580809837|FG000|Overall Study|Subject unable to be followed at study location|223|||
160842316|NCT01736618|580809837|FG000|Overall Study|Physician Decision|33|||
160842317|NCT01736618|580809837|FG000|Overall Study|Transplant or removal of target organ|19|||
160842318|NCT01736618|580809837|FG000|Overall Study|Change in indication or condition|78|||
160842319|NCT01736618|580809837|FG000|Overall Study|Study device explant|103|||
160842320|NCT01736618|580809837|FG000|Overall Study|Unable to complete implant|2|||
160842321|NCT01748825|580809841|FG000|Dose Escalation|Refused further treatment|2|||
160842322|NCT01748825|580809842|FG001|Dose Escalation|Refused further treatment|2|||
160842323|NCT01748825|580809843|FG002|Dose Escalation|Refused further treatment|0|||
160842324|NCT01748825|580809844|FG003|Dose Escalation|Refused further treatment|0|||
160842325|NCT01748825|580809845|FG004|Dose Escalation|Refused further treatment|1|||
160842326|NCT01748825|580809846|FG005|Dose Escalation|Refused further treatment|2|||
160842327|NCT01748825|580809847|FG006|Dose Escalation|Refused further treatment|0|||
160842328|NCT01748825|580809848|FG007|Dose Escalation|Refused further treatment|0|||
160842329|NCT01748825|580809849|FG008|Dose Escalation|Refused further treatment|0|||
160842330|NCT01748825|580809850|FG009|Dose Escalation|Refused further treatment|0|||
160842331|NCT01748825|580809841|FG000|Dose Escalation|Switched to alternative treatment|0|||
160842332|NCT01748825|580809842|FG001|Dose Escalation|Switched to alternative treatment|0|||
160842333|NCT01748825|580809843|FG002|Dose Escalation|Switched to alternative treatment|0|||
160905558|NCT00824720|581048246|FG000|Overall Study|Protocol Violation|0|||
160842334|NCT01748825|580809844|FG003|Dose Escalation|Switched to alternative treatment|1|||
160842335|NCT01748825|580809845|FG004|Dose Escalation|Switched to alternative treatment|0|||
160842336|NCT01748825|580809846|FG005|Dose Escalation|Switched to alternative treatment|0|||
160842337|NCT01748825|580809847|FG006|Dose Escalation|Switched to alternative treatment|0|||
160842338|NCT01748825|580809848|FG007|Dose Escalation|Switched to alternative treatment|0|||
160842339|NCT01748825|580809849|FG008|Dose Escalation|Switched to alternative treatment|0|||
160842340|NCT01748825|580809850|FG009|Dose Escalation|Switched to alternative treatment|0|||
160842341|NCT01748825|580809841|FG000|Dose Escalation|Adverse Event|0|||
160842342|NCT01748825|580809842|FG001|Dose Escalation|Adverse Event|0|||
160842343|NCT01748825|580809843|FG002|Dose Escalation|Adverse Event|0|||
160842344|NCT01748825|580809844|FG003|Dose Escalation|Adverse Event|0|||
160842345|NCT01748825|580809845|FG004|Dose Escalation|Adverse Event|0|||
160842346|NCT01748825|580809846|FG005|Dose Escalation|Adverse Event|0|||
160842347|NCT01748825|580809847|FG006|Dose Escalation|Adverse Event|1|||
160842348|NCT01748825|580809848|FG007|Dose Escalation|Adverse Event|0|||
160842349|NCT01748825|580809849|FG008|Dose Escalation|Adverse Event|0|||
160842350|NCT01748825|580809850|FG009|Dose Escalation|Adverse Event|0|||
160842351|NCT01748825|580809841|FG000|Dose Expansion|Refused further treatment|0|||
160842352|NCT01748825|580809842|FG001|Dose Expansion|Refused further treatment|0|||
160842353|NCT01748825|580809843|FG002|Dose Expansion|Refused further treatment|0|||
160842354|NCT01748825|580809844|FG003|Dose Expansion|Refused further treatment|0|||
160842355|NCT01748825|580809845|FG004|Dose Expansion|Refused further treatment|0|||
160842356|NCT01748825|580809846|FG005|Dose Expansion|Refused further treatment|0|||
160842357|NCT01748825|580809847|FG006|Dose Expansion|Refused further treatment|0|||
160842358|NCT01748825|580809848|FG007|Dose Expansion|Refused further treatment|0|||
160842359|NCT01748825|580809849|FG008|Dose Expansion|Refused further treatment|1|||
160842360|NCT01748825|580809850|FG009|Dose Expansion|Refused further treatment|1|||
160842361|NCT01748825|580809841|FG000|Dose Expansion|Switched to alternative treatment|0|||
160842362|NCT01748825|580809842|FG001|Dose Expansion|Switched to alternative treatment|0|||
160842363|NCT01748825|580809843|FG002|Dose Expansion|Switched to alternative treatment|0|||
160842364|NCT01748825|580809844|FG003|Dose Expansion|Switched to alternative treatment|0|||
160842365|NCT01748825|580809845|FG004|Dose Expansion|Switched to alternative treatment|0|||
160842366|NCT01748825|580809846|FG005|Dose Expansion|Switched to alternative treatment|0|||
160842367|NCT01748825|580809847|FG006|Dose Expansion|Switched to alternative treatment|0|||
160842368|NCT01748825|580809848|FG007|Dose Expansion|Switched to alternative treatment|0|||
160842369|NCT01748825|580809849|FG008|Dose Expansion|Switched to alternative treatment|0|||
160842370|NCT01748825|580809850|FG009|Dose Expansion|Switched to alternative treatment|1|||
160842371|NCT01748825|580809841|FG000|Dose Expansion|Adverse Event|0|||
160842372|NCT01748825|580809842|FG001|Dose Expansion|Adverse Event|0|||
160842373|NCT01748825|580809843|FG002|Dose Expansion|Adverse Event|0|||
160842374|NCT01748825|580809844|FG003|Dose Expansion|Adverse Event|0|||
160842375|NCT01748825|580809845|FG004|Dose Expansion|Adverse Event|0|||
160842376|NCT01748825|580809846|FG005|Dose Expansion|Adverse Event|0|||
160842377|NCT01748825|580809847|FG006|Dose Expansion|Adverse Event|0|||
160842378|NCT01748825|580809848|FG007|Dose Expansion|Adverse Event|0|||
160842379|NCT01748825|580809849|FG008|Dose Expansion|Adverse Event|0|||
160842380|NCT01748825|580809850|FG009|Dose Expansion|Adverse Event|3|||
160842381|NCT01748825|580809841|FG000|Dose Expansion|Physician Decision|0|||
160842382|NCT01748825|580809842|FG001|Dose Expansion|Physician Decision|0|||
160842383|NCT01748825|580809843|FG002|Dose Expansion|Physician Decision|0|||
160842384|NCT01748825|580809844|FG003|Dose Expansion|Physician Decision|0|||
160842385|NCT01748825|580809845|FG004|Dose Expansion|Physician Decision|0|||
160842386|NCT01748825|580809846|FG005|Dose Expansion|Physician Decision|0|||
160842387|NCT01748825|580809847|FG006|Dose Expansion|Physician Decision|0|||
160842388|NCT01748825|580809848|FG007|Dose Expansion|Physician Decision|0|||
160842389|NCT01748825|580809849|FG008|Dose Expansion|Physician Decision|1|||
160842390|NCT01748825|580809850|FG009|Dose Expansion|Physician Decision|0|||
160842391|NCT01730586|580809854|FG000|Overall Study|Progressive Disease|2|||
160842392|NCT01730586|580809854|FG000|Overall Study|Inadequate Trial|8|||
160842393|NCT01730586|580809854|FG000|Overall Study|Adverse Event|2|||
160842394|NCT01730586|580809854|FG000|Overall Study|Hospice|1|||
160842395|NCT02461745|580809855|FG000|Overall Study|Lack of Efficacy|9|||
160842396|NCT02461745|580809856|FG001|Overall Study|Lack of Efficacy|1|||
160565171|NCT02970929|579788795|FG000|Overall Study|Withdrawal by Subject|16|||
160842397|NCT02461745|580809855|FG000|Overall Study|Lost to Follow-up|2|||
160842398|NCT02461745|580809856|FG001|Overall Study|Lost to Follow-up|2|||
160842399|NCT02461745|580809855|FG000|Overall Study|Withdrawal by Subject|3|||
160842400|NCT02461745|580809856|FG001|Overall Study|Withdrawal by Subject|1|||
160842401|NCT02921087|580809857|FG000|Overall Study|Withdrawal by Subject|0|||
160842402|NCT02921087|580809858|FG001|Overall Study|Withdrawal by Subject|1|||
160842403|NCT05111249|580811529|FG000|Overall Study|Lost to Follow-up|0|||
160842404|NCT05111249|580811530|FG001|Overall Study|Lost to Follow-up|2|||
160842405|NCT05111249|580811529|FG000|Overall Study|Physician Decision|0|||
160842406|NCT05111249|580811530|FG001|Overall Study|Physician Decision|1|||
160842407|NCT05111249|580811529|FG000|Overall Study|Participant decision|1|||
160842408|NCT05111249|580811530|FG001|Overall Study|Participant decision|5|||
160842409|NCT02610777|580811536|FG000|Overall Study|Lost to Follow-up|1|||
160842410|NCT02610777|580811537|FG001|Overall Study|Lost to Follow-up|0|||
160842411|NCT02610777|580811536|FG000|Overall Study|Site Terminated by Sponsor|9|||
160842412|NCT02610777|580811537|FG001|Overall Study|Site Terminated by Sponsor|8|||
160842413|NCT02610777|580811536|FG000|Overall Study|Withdrawal by Subject|2|||
160842414|NCT02610777|580811537|FG001|Overall Study|Withdrawal by Subject|2|||
160842415|NCT02610777|580811536|FG000|Overall Study|Reason not Specified|0|||
160842416|NCT02610777|580811537|FG001|Overall Study|Reason not Specified|1|||
160842417|NCT02610777|580811536|FG000|Overall Study|Death|50|||
160842418|NCT02610777|580811537|FG001|Overall Study|Death|47|||
160842419|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
160842420|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160842421|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160842422|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160842423|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160842424|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
160842425|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160842426|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160842427|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160842428|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160842429|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
160842430|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160842431|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160842432|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160842433|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160842434|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
160842435|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160842436|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160842437|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160842438|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160842439|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
160842440|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160842441|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160842442|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160842443|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160842444|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
160842445|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160842446|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160842447|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160842448|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160842449|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
160842450|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160842451|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160842452|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160842453|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160842454|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
160842455|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
160842456|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
160842457|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
160842458|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
160842459|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
160842460|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
160842461|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
160565172|NCT00666562|579788798|FG000|Overall Study|Withdrawal by Subject|0|||
160565173|NCT00666562|579788799|FG001|Overall Study|Withdrawal by Subject|1|||
160842462|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
160842463|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
160842464|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
160842465|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
160842466|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
160842467|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
160842468|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
160842469|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
160842470|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
160842471|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
160565174|NCT00666562|579788800|FG002|Overall Study|Withdrawal by Subject|0|||
160565175|NCT00666562|579788798|FG000|Overall Study|Concomitant Medication|0|||
160905559|NCT00824720|581048247|FG001|Overall Study|Protocol Violation|0|||
160565176|NCT00666562|579788799|FG001|Overall Study|Concomitant Medication|1|||
160905560|NCT00824720|581048248|FG002|Overall Study|Protocol Violation|1|||
160905561|NCT01558271|581048251|FG000|Overall Study|Adverse Event|6|||
160842472|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
160842473|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
160842474|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
160842475|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
160905562|NCT01558271|581048252|FG001|Overall Study|Adverse Event|3|||
160905563|NCT01558271|581048253|FG002|Overall Study|Adverse Event|4|||
160905564|NCT01558271|581048251|FG000|Overall Study|Lost to Follow-up|1|||
160905565|NCT01558271|581048252|FG001|Overall Study|Lost to Follow-up|0|||
160905566|NCT01558271|581048253|FG002|Overall Study|Lost to Follow-up|0|||
160905567|NCT01558271|581048251|FG000|Overall Study|Protocol Violation|1|||
160905568|NCT01558271|581048252|FG001|Overall Study|Protocol Violation|0|||
160905569|NCT01558271|581048253|FG002|Overall Study|Protocol Violation|0|||
160905570|NCT01558271|581048251|FG000|Overall Study|Withdrawal by Subject|10|||
160905571|NCT01558271|581048252|FG001|Overall Study|Withdrawal by Subject|6|||
160905572|NCT01558271|581048253|FG002|Overall Study|Withdrawal by Subject|12|||
160905573|NCT01558271|581048251|FG000|Overall Study|Physician Decision|0|||
160905574|NCT01558271|581048252|FG001|Overall Study|Physician Decision|2|||
160905575|NCT01558271|581048253|FG002|Overall Study|Physician Decision|1|||
160905576|NCT02610725|581048254|FG000|Overall Study|Lost to Follow-up|197|||
160905577|NCT02610725|581048254|FG000|Overall Study|self-reported contraindication|9|||
160905578|NCT00743483|581048255|FG000|Baseline Period|Physician Decision|1|||
160905579|NCT00743483|581048255|FG000|Treatment Period|Adverse Event|1|||
160905580|NCT01084083|581048256|FG000|Overall Study|Adverse Event|5|||
160905581|NCT01084083|581048256|FG000|Overall Study|Death|1|||
160842476|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
160842477|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
160842478|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
160842479|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
160842480|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
160842481|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
160842482|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
160842483|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
160842484|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
160842485|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
160842486|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
160842487|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
160842488|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
160842489|NCT04737278|580811545|FG000|Overall Study|Lost to Follow-up|1|||
160842490|NCT04737278|580811546|FG001|Overall Study|Lost to Follow-up|1|||
160905582|NCT01084083|581048256|FG000|Overall Study|Withdrawal by Subject|2|||
160905583|NCT01084083|581048256|FG000|Overall Study|Complicating disease|1|||
160905584|NCT01084083|581048256|FG000|Overall Study|Other|2|||
160905585|NCT01084083|581048256|FG000|Overall Study|Never started assigned therapy|1|||
160905586|NCT00873912|581048257|FG000|Overall Study|Withdrawal by Subject|1|||
160905587|NCT00873912|581048258|FG001|Overall Study|Withdrawal by Subject|0|||
160905588|NCT00873912|581048257|FG000|Overall Study|Lost to Follow-up|2|||
160905589|NCT00873912|581048258|FG001|Overall Study|Lost to Follow-up|0|||
160905590|NCT01466153|581048261|FG000|Overall Study|Disease Progression|2|||
160905591|NCT01466153|581048262|FG001|Overall Study|Disease Progression|2|||
160905592|NCT01466153|581048263|FG002|Overall Study|Disease Progression|0|||
160905593|NCT01466153|581048261|FG000|Overall Study|Adverse Event|14|||
160905594|NCT01466153|581048262|FG001|Overall Study|Adverse Event|13|||
160905595|NCT01466153|581048263|FG002|Overall Study|Adverse Event|17|||
160905596|NCT01466153|581048261|FG000|Overall Study|Withdrawal of Consent|2|||
160905597|NCT01466153|581048262|FG001|Overall Study|Withdrawal of Consent|0|||
160905598|NCT01466153|581048263|FG002|Overall Study|Withdrawal of Consent|0|||
160565177|NCT00666562|579788800|FG002|Overall Study|Concomitant Medication|0|||
160565178|NCT02370121|579788805|FG000|Overall Study|Lost to Follow-up|1|||
160565179|NCT02370121|579788806|FG001|Overall Study|Lost to Follow-up|1|||
160565180|NCT02654002|579788809|FG000|Overall Study|Adverse Event|0|||
160565181|NCT02654002|579788810|FG001|Overall Study|Adverse Event|0|||
160565182|NCT02654002|579788811|FG002|Overall Study|Adverse Event|0|||
160565183|NCT02654002|579788812|FG003|Overall Study|Adverse Event|0|||
160565184|NCT02654002|579788813|FG004|Overall Study|Adverse Event|0|||
160905599|NCT01466153|581048261|FG000|Overall Study|Investigator Discretion|3|||
160905600|NCT01466153|581048262|FG001|Overall Study|Investigator Discretion|2|||
160905601|NCT01466153|581048263|FG002|Overall Study|Investigator Discretion|2|||
160565185|NCT02654002|579788814|FG005|Overall Study|Adverse Event|0|||
160565186|NCT02654002|579788815|FG006|Overall Study|Adverse Event|1|||
160842491|NCT04737278|580811545|FG000|Overall Study|Withdrawal by Subject|1|||
160842492|NCT04737278|580811546|FG001|Overall Study|Withdrawal by Subject|0|||
160842493|NCT04737278|580811545|FG000|Overall Study|Protocol Violation|1|||
160905602|NCT01466153|581048261|FG000|Overall Study|Randomized-Not Treated|2|||
160842494|NCT04737278|580811546|FG001|Overall Study|Protocol Violation|1|||
160842495|NCT04737278|580811545|FG000|Overall Study|failure to complete questionnaire|1|||
160842496|NCT04737278|580811546|FG001|Overall Study|failure to complete questionnaire|1|||
160842497|NCT02828436|580811555|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
160842498|NCT02828436|580811556|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
160842499|NCT02828436|580811555|FG000|Period 1|Lost to Follow-up|0|||
160842500|NCT02828436|580811556|FG001|Period 1|Lost to Follow-up|1|||
160842501|NCT02828436|580811555|FG000|Period 2|Withdrawal by Subject|4|||
160842502|NCT02828436|580811556|FG001|Period 2|Withdrawal by Subject|0|||
160842503|NCT02828436|580811555|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
160842504|NCT02828436|580811556|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
160842505|NCT02828436|580811555|FG000|Period 2|Lost to Follow-up|1|||
160842506|NCT02828436|580811556|FG001|Period 2|Lost to Follow-up|0|||
160842507|NCT02837029|580811557|FG000|Screening|Failed to meet screening requirements.|7|||
160842508|NCT02837029|580811558|FG001|Screening|Failed to meet screening requirements.|3|||
160842509|NCT02837029|580811559|FG002|Screening|Failed to meet screening requirements.|0|||
160842510|NCT02837029|580811557|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
160842511|NCT02837029|580811558|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
160842512|NCT02837029|580811559|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
160842513|NCT02837029|580811557|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
160842514|NCT02837029|580811558|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
160842515|NCT02837029|580811559|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
160842516|NCT02837029|580811557|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
160842517|NCT02837029|580811558|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
160842518|NCT02837029|580811559|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
160842519|NCT02837029|580811557|FG000|Cycle 2 and Beyond|Adverse Event|1|||
160842520|NCT02837029|580811558|FG001|Cycle 2 and Beyond|Adverse Event|0|||
160842521|NCT02837029|580811559|FG002|Cycle 2 and Beyond|Adverse Event|0|||
160842522|NCT02837029|580811557|FG000|2 Year Follow-up|Death|6|||
160842523|NCT02837029|580811558|FG001|2 Year Follow-up|Death|7|||
160842524|NCT02837029|580811559|FG002|2 Year Follow-up|Death|0|||
160842525|NCT01363908|580811560|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
160842526|NCT01363908|580811561|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
160842527|NCT01363908|580811560|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
160842528|NCT01363908|580811561|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
160842529|NCT01363908|580811560|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
160842530|NCT01363908|580811561|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
160842531|NCT01363908|580811560|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
160842532|NCT01363908|580811561|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
160842533|NCT02644343|580811562|FG000|Overall Study|Withdrawal by Subject|1|||
160842534|NCT05258149|580811563|FG000|Period 1|Protocol Deviation|1|||
160842535|NCT05258149|580811564|FG001|Period 1|Protocol Deviation|0|||
160842536|NCT05258149|580811563|FG000|Period 1|Adverse Event|0|||
160842537|NCT05258149|580811564|FG001|Period 1|Adverse Event|1|||
160842538|NCT05258149|580811563|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
160842539|NCT05258149|580811564|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160842540|NCT05258149|580811563|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
160842541|NCT05258149|580811564|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
160842542|NCT05258149|580811563|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
160842543|NCT05258149|580811564|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
160842544|NCT00536471|580811567|FG000|Overall Study|Lost to Follow-up|48|||
160842545|NCT00536471|580811568|FG001|Overall Study|Lost to Follow-up|23|||
160842546|NCT00536471|580811569|FG002|Overall Study|Lost to Follow-up|48|||
160842547|NCT00536471|580811570|FG003|Overall Study|Lost to Follow-up|22|||
160842548|NCT00536471|580811567|FG000|Overall Study|Adverse Event|32|||
160842549|NCT00536471|580811568|FG001|Overall Study|Adverse Event|16|||
160842550|NCT00536471|580811569|FG002|Overall Study|Adverse Event|28|||
160842551|NCT00536471|580811570|FG003|Overall Study|Adverse Event|13|||
160565187|NCT02654002|579788816|FG007|Overall Study|Adverse Event|0|||
160565188|NCT02654002|579788817|FG008|Overall Study|Adverse Event|0|||
160565189|NCT02654002|579788809|FG000|Overall Study|Withdrew Consent|0|||
160565190|NCT02654002|579788810|FG001|Overall Study|Withdrew Consent|0|||
160842552|NCT00536471|580811567|FG000|Overall Study|Withdrawal by Subject|40|||
160842553|NCT00536471|580811568|FG001|Overall Study|Withdrawal by Subject|24|||
160842554|NCT00536471|580811569|FG002|Overall Study|Withdrawal by Subject|43|||
160842555|NCT00536471|580811570|FG003|Overall Study|Withdrawal by Subject|21|||
160842556|NCT00536471|580811567|FG000|Overall Study|Lack of Efficacy|17|||
160842557|NCT00536471|580811568|FG001|Overall Study|Lack of Efficacy|18|||
160842558|NCT00536471|580811569|FG002|Overall Study|Lack of Efficacy|11|||
160842559|NCT00536471|580811570|FG003|Overall Study|Lack of Efficacy|9|||
160842560|NCT00536471|580811567|FG000|Overall Study|Protocol Violation|8|||
160842561|NCT00536471|580811568|FG001|Overall Study|Protocol Violation|1|||
160842562|NCT00536471|580811569|FG002|Overall Study|Protocol Violation|2|||
160842563|NCT00536471|580811570|FG003|Overall Study|Protocol Violation|3|||
160842564|NCT00536471|580811567|FG000|Overall Study|Physician Decision|11|||
160842565|NCT00536471|580811568|FG001|Overall Study|Physician Decision|1|||
160842566|NCT00536471|580811569|FG002|Overall Study|Physician Decision|3|||
160842567|NCT00536471|580811570|FG003|Overall Study|Physician Decision|2|||
160842568|NCT00536471|580811567|FG000|Overall Study|Death|0|||
160842569|NCT00536471|580811568|FG001|Overall Study|Death|0|||
160842570|NCT00536471|580811569|FG002|Overall Study|Death|1|||
160842571|NCT00536471|580811570|FG003|Overall Study|Death|2|||
160842572|NCT00536471|580811567|FG000|Overall Study|Sponsor Decision|0|||
160842573|NCT00536471|580811568|FG001|Overall Study|Sponsor Decision|1|||
160842574|NCT00536471|580811569|FG002|Overall Study|Sponsor Decision|3|||
160842575|NCT00536471|580811570|FG003|Overall Study|Sponsor Decision|2|||
160842576|NCT01442714|580811573|FG000|Overall Study|Death|11|||
160842577|NCT01442714|580811573|FG000|Overall Study|Withdrawal by Subject|1|||
160842578|NCT01979952|580811589|FG000|Overall Study|Adverse Event|4|||
160842579|NCT01979952|580811590|FG001|Overall Study|Adverse Event|5|||
160842580|NCT01979952|580811589|FG000|Overall Study|Protocol Violation|1|||
160842581|NCT01979952|580811590|FG001|Overall Study|Protocol Violation|0|||
160842582|NCT01979952|580811589|FG000|Overall Study|Withdrawal by Subject|2|||
160842583|NCT01979952|580811590|FG001|Overall Study|Withdrawal by Subject|1|||
160842584|NCT01979952|580811589|FG000|Overall Study|Other than specified above|1|||
160842585|NCT01979952|580811590|FG001|Overall Study|Other than specified above|0|||
160842586|NCT03781414|580811591|FG000|Overall Study|Study terminated by sponsor|39|||
160842587|NCT03781414|580811592|FG001|Overall Study|Study terminated by sponsor|34|||
160842588|NCT03781414|580811593|FG002|Overall Study|Study terminated by sponsor|25|||
160842589|NCT03781414|580811591|FG000|Overall Study|Adverse Event|3|||
160842590|NCT03781414|580811592|FG001|Overall Study|Adverse Event|6|||
160842591|NCT03781414|580811593|FG002|Overall Study|Adverse Event|3|||
160842592|NCT03781414|580811591|FG000|Overall Study|Physician Decision|2|||
160842593|NCT03781414|580811592|FG001|Overall Study|Physician Decision|0|||
160842594|NCT03781414|580811593|FG002|Overall Study|Physician Decision|1|||
160842595|NCT03781414|580811591|FG000|Overall Study|Withdrawal by Subject|2|||
160842596|NCT03781414|580811592|FG001|Overall Study|Withdrawal by Subject|3|||
160842597|NCT03781414|580811593|FG002|Overall Study|Withdrawal by Subject|3|||
160842598|NCT03781414|580811591|FG000|Overall Study|Death|1|||
160842599|NCT03781414|580811592|FG001|Overall Study|Death|4|||
160842600|NCT03781414|580811593|FG002|Overall Study|Death|0|||
160842601|NCT03781414|580811591|FG000|Overall Study|Lost to Follow-up|1|||
160842602|NCT03781414|580811592|FG001|Overall Study|Lost to Follow-up|1|||
160842603|NCT03781414|580811593|FG002|Overall Study|Lost to Follow-up|0|||
160842604|NCT00203424|580811595|FG000|Treatment Period|Withdrawal by Subject|4|||
160842605|NCT00203424|580811595|FG000|Treatment Period|Adverse Event|5|||
160842606|NCT00203424|580811595|FG000|Treatment Period|progressive disease|2|||
160842607|NCT00203424|580811595|FG000|Follow-up Period|Withdrawal by Subject|1|||
160842608|NCT00203424|580811595|FG000|Follow-up Period|progressive disease|4|||
160842609|NCT00203424|580811595|FG000|Follow-up Period|Lost to Follow-up|1|||
160842610|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
160842611|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160842612|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160842613|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160842614|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160842615|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160842616|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
160842617|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160842618|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160842619|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160842620|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160842621|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160842622|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
160842623|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160842624|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160565191|NCT02654002|579788811|FG002|Overall Study|Withdrew Consent|0|||
160842625|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160842626|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160842627|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160565192|NCT02654002|579788812|FG003|Overall Study|Withdrew Consent|0|||
160842628|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
160842629|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
160842630|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
160842631|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
160565193|NCT02654002|579788813|FG004|Overall Study|Withdrew Consent|0|||
160565194|NCT02654002|579788814|FG005|Overall Study|Withdrew Consent|1|||
160565195|NCT02654002|579788815|FG006|Overall Study|Withdrew Consent|0|||
160842632|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
160842633|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
160842634|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
160842635|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
160842636|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
160842637|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
160842638|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
160842639|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
160842640|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
160842641|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160842642|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160842643|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160842644|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160842645|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160842646|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
160842647|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
160842648|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
160842649|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
160842650|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
160842651|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
160842652|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160842653|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
160842654|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
160842655|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
160842656|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
160842657|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160842658|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
160842659|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
160842660|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
160842661|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
160842662|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
160842663|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
160842664|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
160842665|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
160842666|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
160842667|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
160842668|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
160842669|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
160842670|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
160842671|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
160842672|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
160842673|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
160862040|NCT05138653|580887935|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862041|NCT05138653|580887920|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862042|NCT05138653|580887921|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
160862043|NCT05138653|580887922|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862044|NCT05138653|580887923|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862045|NCT05138653|580887924|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
160862046|NCT05138653|580887925|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862047|NCT05138653|580887926|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862048|NCT05138653|580887927|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862049|NCT05138653|580887928|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862050|NCT05138653|580887929|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862051|NCT05138653|580887930|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160842674|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
160842675|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
160842676|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160842677|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
160842678|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160842679|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
160842680|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
160842681|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
160842682|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
160842683|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
160842684|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
160842685|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
160842686|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
160842687|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
160842688|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
160842689|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
160842690|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
160842691|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
160842692|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
160842693|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
160842694|NCT01922271|580811603|FG000|WASHOUT Period|Withdrawal by Subject|1|||
160842695|NCT01922271|580811604|FG001|WASHOUT Period|Withdrawal by Subject|0|||
160842696|NCT00719355|580811605|FG000|Overall Study|Death|0|||
160842697|NCT00719355|580811606|FG001|Overall Study|Death|1|||
160842698|NCT00719355|580811605|FG000|Overall Study|Medical|14|||
160842699|NCT00719355|580811606|FG001|Overall Study|Medical|5|||
160842700|NCT00719355|580811605|FG000|Overall Study|Compliance|4|||
160842701|NCT00719355|580811606|FG001|Overall Study|Compliance|6|||
160842702|NCT00719355|580811605|FG000|Overall Study|Moved|0|||
160842703|NCT00719355|580811606|FG001|Overall Study|Moved|1|||
160842704|NCT01856582|580811607|FG000|Overall Study|Died prior to Boost infusion|1|||
160842705|NCT01824355|580811608|FG000|Overall Study|Adverse Event|2|||
160842706|NCT01824355|580811608|FG000|Overall Study|unevaluable reference method results per|1|||
160842707|NCT01331109|580811609|FG000|Overall Study|Adverse Event|6|||
160842708|NCT01331109|580811609|FG000|Overall Study|Lack of Efficacy|2|||
160842709|NCT01331109|580811609|FG000|Overall Study|Protocol Violation|3|||
160842710|NCT01331109|580811609|FG000|Overall Study|Withdrawal by Subject|7|||
160842711|NCT01331109|580811609|FG000|Overall Study|Lost to Follow-up|1|||
160842712|NCT01331109|580811609|FG000|Overall Study|Study Terminated by Sponsor|38|||
160842713|NCT00773747|580811610|FG000|Overall Study|Lack of Efficacy|112|||
160842714|NCT00773747|580811611|FG001|Overall Study|Lack of Efficacy|144|||
160842715|NCT00773747|580811610|FG000|Overall Study|Physician Decision|26|||
160842716|NCT00773747|580811611|FG001|Overall Study|Physician Decision|18|||
160842717|NCT00773747|580811610|FG000|Overall Study|Lost to Follow-up|0|||
160842718|NCT00773747|580811611|FG001|Overall Study|Lost to Follow-up|1|||
160842719|NCT00773747|580811610|FG000|Overall Study|Protocol Violation|2|||
160842720|NCT00773747|580811611|FG001|Overall Study|Protocol Violation|2|||
160842721|NCT00773747|580811610|FG000|Overall Study|Withdrawal by Subject|89|||
160842722|NCT00773747|580811611|FG001|Overall Study|Withdrawal by Subject|61|||
160842723|NCT00773747|580811610|FG000|Overall Study|Adverse Event|61|||
160842724|NCT00773747|580811611|FG001|Overall Study|Adverse Event|62|||
160842725|NCT00773747|580811610|FG000|Overall Study|Death|5|||
160842726|NCT00773747|580811611|FG001|Overall Study|Death|8|||
160842727|NCT00773747|580811610|FG000|Overall Study|Not Treated|2|||
160842728|NCT00773747|580811611|FG001|Overall Study|Not Treated|0|||
160842729|NCT00836186|580811614|FG000|Overall Study|Blood could not be drawn|1|||
160842730|NCT04079816|580811615|FG000|Overall Study|Request of Subject|2|||
160842731|NCT04079816|580811615|FG000|Overall Study|Unable to draw samples|1|||
160842732|NCT01636986|580811616|FG000|Overall Study|Withdrawal by Subject|0|||
160842733|NCT01636986|580811617|FG001|Overall Study|Withdrawal by Subject|1|||
160842734|NCT01636986|580811616|FG000|Overall Study|Corneal Staining|0|||
160842735|NCT01636986|580811617|FG001|Overall Study|Corneal Staining|1|||
160842736|NCT02160145|580811620|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
160842737|NCT02160145|580811621|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
160842738|NCT02160145|580811622|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
160842739|NCT02160145|580811620|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
160842740|NCT02160145|580811621|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
160842741|NCT02160145|580811622|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
160842742|NCT02160145|580811620|FG000|Randomized Double-blind Period|Subject decision|0|||
160842743|NCT02160145|580811621|FG001|Randomized Double-blind Period|Subject decision|21|||
160565196|NCT02654002|579788816|FG007|Overall Study|Withdrew Consent|1|||
160565197|NCT02654002|579788817|FG008|Overall Study|Withdrew Consent|0|||
160565198|NCT05262764|579788818|FG000|Overall Study|Case report form not collected|9|||
160565199|NCT05262764|579788818|FG000|Overall Study|No patient visits after entry|23|||
160565200|NCT05262764|579788818|FG000|Overall Study|Registration rule not followed|2|||
160565201|NCT05262764|579788818|FG000|Overall Study|Patient of non-chronic heart failure|1|||
160565202|NCT01392183|579788819|FG000|First Drug Administration|Adverse Event|3|||
160842744|NCT02160145|580811622|FG002|Randomized Double-blind Period|Subject decision|20|||
160565203|NCT01392183|579788820|FG001|First Drug Administration|Adverse Event|2|||
160565204|NCT01392183|579788819|FG000|First Drug Administration|Death|1|||
160842745|NCT02160145|580811620|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
160842746|NCT02160145|580811621|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
160842747|NCT02160145|580811622|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
160842748|NCT02160145|580811620|FG000|Randomized Double-blind Period|Physician Decision|0|||
160842749|NCT02160145|580811621|FG001|Randomized Double-blind Period|Physician Decision|7|||
160842750|NCT02160145|580811622|FG002|Randomized Double-blind Period|Physician Decision|5|||
160842751|NCT00705146|580811624|FG000|Overall Study|Lost to Follow-up|1|||
160842752|NCT00705146|580811625|FG001|Overall Study|Lost to Follow-up|1|||
160842753|NCT00383162|580811626|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
160842754|NCT00383162|580811627|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
160842755|NCT00383162|580811626|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
160842756|NCT00383162|580811627|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
160842757|NCT00383162|580811626|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
160842758|NCT00383162|580811627|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
160842759|NCT00383162|580811626|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
160842760|NCT00383162|580811627|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
160842761|NCT00383162|580811626|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
160842762|NCT00383162|580811627|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
160842763|NCT00383162|580811626|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
160842764|NCT00383162|580811627|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
160842765|NCT00383162|580811626|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
160842766|NCT00383162|580811627|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
160842767|NCT00383162|580811626|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
160842768|NCT00383162|580811627|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
160842769|NCT00383162|580811626|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
160842770|NCT00383162|580811627|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
160842771|NCT05392803|580811630|FG000|Overall Study|Lost to Follow-up|0|||
160842772|NCT05392803|580811631|FG001|Overall Study|Lost to Follow-up|2|||
160842773|NCT00923845|580811635|FG000|Induction Therapy|Poor performance status|0|||
160842774|NCT00923845|580811636|FG001|Induction Therapy|Poor performance status|2|||
160842775|NCT01183065|580811637|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
160842776|NCT02578186|580811639|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
160842777|NCT02578186|580811640|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
160842778|NCT02578186|580811639|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
160842779|NCT02578186|580811640|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
160842780|NCT01894243|580811641|FG000|Overall Study|Adverse Event|0|||
160842781|NCT01894243|580811642|FG001|Overall Study|Adverse Event|1|||
160842782|NCT01894243|580811643|FG002|Overall Study|Adverse Event|2|||
160842783|NCT01894243|580811641|FG000|Overall Study|Death|0|||
160842784|NCT01894243|580811642|FG001|Overall Study|Death|0|||
160842785|NCT01894243|580811643|FG002|Overall Study|Death|3|||
160842786|NCT01894243|580811641|FG000|Overall Study|Lack of Efficacy|3|||
160842787|NCT01894243|580811642|FG001|Overall Study|Lack of Efficacy|3|||
160842788|NCT01894243|580811643|FG002|Overall Study|Lack of Efficacy|1|||
160842789|NCT01894243|580811641|FG000|Overall Study|Condition under investigation worsened|8|||
160842790|NCT01894243|580811642|FG001|Overall Study|Condition under investigation worsened|6|||
160565205|NCT01392183|579788820|FG001|First Drug Administration|Death|0|||
160647709|NCT05002569|580092809|FG000|Treatment Period|Disease Recurrence|102|||
160647710|NCT05002569|580092810|FG001|Treatment Period|Disease Recurrence|128|||
160647711|NCT05002569|580092809|FG000|Treatment Period|Other Reasons|4|||
160842791|NCT01894243|580811643|FG002|Overall Study|Condition under investigation worsened|2|||
160842792|NCT01894243|580811641|FG000|Overall Study|Subject decision|1|||
160842793|NCT01894243|580811642|FG001|Overall Study|Subject decision|0|||
160842794|NCT01894243|580811643|FG002|Overall Study|Subject decision|0|||
160842795|NCT01894243|580811641|FG000|Overall Study|Other|1|||
160842796|NCT01894243|580811642|FG001|Overall Study|Other|0|||
160842797|NCT01894243|580811643|FG002|Overall Study|Other|0|||
160842798|NCT01620944|580811646|FG000|Overall Study|Early termination of Study|2|||
160842799|NCT01620944|580811647|FG001|Overall Study|Early termination of Study|1|||
160842800|NCT00392990|580811648|FG000|Treatment on Study|Adverse Event|3|||
160842801|NCT00392990|580811649|FG001|Treatment on Study|Adverse Event|1|||
160565206|NCT01392183|579788819|FG000|First Drug Administration|Withdrawal by Subject|10|||
160647712|NCT05002569|580092810|FG001|Treatment Period|Other Reasons|7|||
160842802|NCT00392990|580811648|FG000|Follow up for 2 Years|Death|4|||
160842803|NCT00392990|580811649|FG001|Follow up for 2 Years|Death|0|||
160842804|NCT00825812|580811650|FG000|Overall Study|Never entered follow up|0|||
160842805|NCT00825812|580811651|FG001|Overall Study|Never entered follow up|0|||
160842806|NCT00825812|580811652|FG002|Overall Study|Never entered follow up|0|||
160842807|NCT00825812|580811653|FG003|Overall Study|Never entered follow up|1|||
160565207|NCT01392183|579788820|FG001|First Drug Administration|Withdrawal by Subject|17|||
160565208|NCT00963807|579788823|FG000|Overall Study|Physician Decision|2|||
160565209|NCT00963807|579788823|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
160565210|NCT00963807|579788823|FG000|Overall Study|Disease progression|15|||
160565211|NCT00684177|579788826|FG000|Overall Study|Adverse Event|4|||
160565212|NCT00684177|579788827|FG001|Overall Study|Adverse Event|3|||
160565213|NCT00684177|579788826|FG000|Overall Study|Lack of Efficacy|10|||
160565214|NCT00684177|579788827|FG001|Overall Study|Lack of Efficacy|15|||
160565215|NCT00684177|579788826|FG000|Overall Study|Protocol Violation|1|||
160565216|NCT00684177|579788827|FG001|Overall Study|Protocol Violation|0|||
160565217|NCT00684177|579788826|FG000|Overall Study|Lost to Follow-up|2|||
160565218|NCT00684177|579788827|FG001|Overall Study|Lost to Follow-up|1|||
160565219|NCT00684177|579788826|FG000|Overall Study|Physician Decision|2|||
160647713|NCT05002569|580092809|FG000|Treatment Period|Death|1|||
160842808|NCT00825812|580811650|FG000|Overall Study|Adverse Event|0|||
160842809|NCT00825812|580811651|FG001|Overall Study|Adverse Event|0|||
160842810|NCT00825812|580811652|FG002|Overall Study|Adverse Event|0|||
160842811|NCT00825812|580811653|FG003|Overall Study|Adverse Event|1|||
160842812|NCT00825812|580811650|FG000|Overall Study|Subject withdrew consent|0|||
160842813|NCT00825812|580811651|FG001|Overall Study|Subject withdrew consent|0|||
160842814|NCT00825812|580811652|FG002|Overall Study|Subject withdrew consent|3|||
160842815|NCT00825812|580811653|FG003|Overall Study|Subject withdrew consent|2|||
160842816|NCT00825812|580811650|FG000|Overall Study|Non-compliance with protocol|0|||
160842817|NCT00825812|580811651|FG001|Overall Study|Non-compliance with protocol|0|||
160842818|NCT00825812|580811652|FG002|Overall Study|Non-compliance with protocol|0|||
160842819|NCT00825812|580811653|FG003|Overall Study|Non-compliance with protocol|1|||
160565220|NCT00684177|579788827|FG001|Overall Study|Physician Decision|0|||
160565221|NCT00684177|579788826|FG000|Overall Study|Withdrawal by Subject|1|||
160647714|NCT05002569|580092810|FG001|Treatment Period|Death|1|||
160842820|NCT00825812|580811650|FG000|Overall Study|Administrative|0|||
160842821|NCT00825812|580811651|FG001|Overall Study|Administrative|1|||
160842822|NCT00825812|580811652|FG002|Overall Study|Administrative|3|||
160842823|NCT00825812|580811653|FG003|Overall Study|Administrative|5|||
160842824|NCT00991406|580811655|FG000|Overall Study|One participant did not respond to FES.|1|||
160842825|NCT00986362|580811656|FG000|Overall Study|Death|2|||
160842826|NCT00986362|580811657|FG001|Overall Study|Death|0|||
160842827|NCT00986362|580811656|FG000|Overall Study|Lost to Follow-up|0|||
160842828|NCT00986362|580811657|FG001|Overall Study|Lost to Follow-up|1|||
160842829|NCT03597061|580811658|FG000|Overall Study|Lost to Follow-up|1|||
160842830|NCT03597061|580811659|FG001|Overall Study|Lost to Follow-up|0|||
160842831|NCT03597061|580811658|FG000|Overall Study|Protocol Violation|0|||
160842832|NCT03597061|580811659|FG001|Overall Study|Protocol Violation|1|||
160842833|NCT03755661|580811664|FG000|Overall Study|Lost to Follow-up|1|||
160842834|NCT03755661|580811665|FG001|Overall Study|Lost to Follow-up|0|||
160842835|NCT02038075|580811666|FG000|Overall Study|Withdrawal by Subject|3|||
160842836|NCT02038075|580811667|FG001|Overall Study|Withdrawal by Subject|0|||
160842837|NCT04000581|580811668|FG000|Overall Study|Withdrawal by Subject|0|||
160842838|NCT04000581|580811669|FG001|Overall Study|Withdrawal by Subject|1|||
160842839|NCT00895453|580811673|FG000|Overall Study|Lost to Follow-up|25|||
160842840|NCT00895453|580811674|FG001|Overall Study|Lost to Follow-up|25|||
160842841|NCT00895453|580811675|FG002|Overall Study|Lost to Follow-up|23|||
160842842|NCT02519595|580811676|FG000|Overall Study|Protocol Violation|8|||
160842843|NCT02519595|580811677|FG001|Overall Study|Protocol Violation|22|||
160842844|NCT02519595|580811678|FG002|Overall Study|Protocol Violation|16|||
160842845|NCT03188510|580811681|FG000|Overall Study|Inappropriate behavior with site staff|0|||
160842846|NCT03188510|580811682|FG001|Overall Study|Inappropriate behavior with site staff|1|||
160842847|NCT03188510|580811683|FG002|Overall Study|Inappropriate behavior with site staff|0|||
160842848|NCT04167137|580811686|FG000|Overall Study|Disease progression|1|||
160842849|NCT04167137|580811687|FG001|Overall Study|Disease progression|1|||
160842850|NCT04167137|580811688|FG002|Overall Study|Disease progression|3|||
160842851|NCT04167137|580811689|FG003|Overall Study|Disease progression|3|||
160842852|NCT04167137|580811690|FG004|Overall Study|Disease progression|2|||
160842853|NCT04167137|580811691|FG005|Overall Study|Disease progression|3|||
160842854|NCT04167137|580811692|FG006|Overall Study|Disease progression|2|||
160842855|NCT04167137|580811693|FG007|Overall Study|Disease progression|2|||
160842856|NCT04167137|580811686|FG000|Overall Study|Withdrawal by Subject|1|||
160842857|NCT04167137|580811687|FG001|Overall Study|Withdrawal by Subject|0|||
160842858|NCT04167137|580811688|FG002|Overall Study|Withdrawal by Subject|0|||
160842859|NCT04167137|580811689|FG003|Overall Study|Withdrawal by Subject|1|||
160842860|NCT04167137|580811690|FG004|Overall Study|Withdrawal by Subject|0|||
160565222|NCT00684177|579788827|FG001|Overall Study|Withdrawal by Subject|2|||
160565223|NCT00684177|579788826|FG000|Overall Study|Other|1|||
160842861|NCT04167137|580811691|FG005|Overall Study|Withdrawal by Subject|2|||
160842862|NCT04167137|580811692|FG006|Overall Study|Withdrawal by Subject|1|||
160842863|NCT04167137|580811693|FG007|Overall Study|Withdrawal by Subject|0|||
160842864|NCT04167137|580811686|FG000|Overall Study|Adverse Event|0|||
160842865|NCT04167137|580811687|FG001|Overall Study|Adverse Event|0|||
160842866|NCT04167137|580811688|FG002|Overall Study|Adverse Event|0|||
160842867|NCT04167137|580811689|FG003|Overall Study|Adverse Event|0|||
160842868|NCT04167137|580811690|FG004|Overall Study|Adverse Event|0|||
160842869|NCT04167137|580811691|FG005|Overall Study|Adverse Event|1|||
160842870|NCT04167137|580811692|FG006|Overall Study|Adverse Event|0|||
160842871|NCT04167137|580811693|FG007|Overall Study|Adverse Event|1|||
160842872|NCT04167137|580811686|FG000|Overall Study|Physician Decision|0|||
160842873|NCT04167137|580811687|FG001|Overall Study|Physician Decision|0|||
160842874|NCT04167137|580811688|FG002|Overall Study|Physician Decision|0|||
160842875|NCT04167137|580811689|FG003|Overall Study|Physician Decision|1|||
160842876|NCT04167137|580811690|FG004|Overall Study|Physician Decision|0|||
160842877|NCT04167137|580811691|FG005|Overall Study|Physician Decision|0|||
160842878|NCT04167137|580811692|FG006|Overall Study|Physician Decision|1|||
160842879|NCT04167137|580811693|FG007|Overall Study|Physician Decision|0|||
160842880|NCT04167137|580811686|FG000|Overall Study|Death|0|||
160842881|NCT04167137|580811687|FG001|Overall Study|Death|1|||
160842882|NCT04167137|580811688|FG002|Overall Study|Death|0|||
160842883|NCT04167137|580811689|FG003|Overall Study|Death|0|||
160842884|NCT04167137|580811690|FG004|Overall Study|Death|0|||
160842885|NCT04167137|580811691|FG005|Overall Study|Death|0|||
160842886|NCT04167137|580811692|FG006|Overall Study|Death|0|||
160842887|NCT04167137|580811693|FG007|Overall Study|Death|0|||
160842888|NCT04167137|580811686|FG000|Overall Study|Study terminated by Sponsor|0|||
160842889|NCT04167137|580811687|FG001|Overall Study|Study terminated by Sponsor|0|||
160842890|NCT04167137|580811688|FG002|Overall Study|Study terminated by Sponsor|0|||
160905603|NCT01466153|581048262|FG001|Overall Study|Randomized-Not Treated|3|||
160905604|NCT01466153|581048263|FG002|Overall Study|Randomized-Not Treated|4|||
160905605|NCT01466153|581048261|FG000|Overall Study|Other-Unspecified|6|||
160905606|NCT01466153|581048262|FG001|Overall Study|Other-Unspecified|4|||
160905607|NCT01466153|581048263|FG002|Overall Study|Other-Unspecified|2|||
160905608|NCT01088997|581048266|FG000|Overall Study|Physician Decision|1|||
160905609|NCT01088997|581048267|FG001|Overall Study|Physician Decision|1|||
160565224|NCT00684177|579788827|FG001|Overall Study|Other|2|||
160905610|NCT01088997|581048266|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
160905611|NCT01088997|581048267|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
160905612|NCT01088997|581048266|FG000|Overall Study|Excluded prior to receiving drug|1|||
160905613|NCT01088997|581048267|FG001|Overall Study|Excluded prior to receiving drug|1|||
160905614|NCT05570500|581048272|FG000|Overall Study|Lost to Follow-up|7|||
160905615|NCT05570500|581048273|FG001|Overall Study|Lost to Follow-up|5|||
160905616|NCT01095731|581048274|FG000|Overall Study|Protocol Violation|1|||
160905617|NCT01095731|581048275|FG001|Overall Study|Protocol Violation|1|||
160905618|NCT01095731|581048274|FG000|Overall Study|Withdrawal by Subject|0|||
160905619|NCT01095731|581048275|FG001|Overall Study|Withdrawal by Subject|1|||
160905620|NCT02302807|581048278|FG000|Overall Study|Withdrawal by Subject|28|||
160905621|NCT02302807|581048279|FG001|Overall Study|Withdrawal by Subject|11|||
160905622|NCT02302807|581048278|FG000|Overall Study|Lost to Follow-up|4|||
160905623|NCT02302807|581048279|FG001|Overall Study|Lost to Follow-up|6|||
160905624|NCT02302807|581048278|FG000|Overall Study|Death|397|||
160905625|NCT02302807|581048279|FG001|Overall Study|Death|385|||
160905626|NCT02302807|581048278|FG000|Overall Study|Study Terminated By Sponsor|35|||
160905627|NCT02302807|581048279|FG001|Overall Study|Study Terminated By Sponsor|64|||
160905628|NCT02302807|581048278|FG000|Overall Study|Physician Decision|0|||
160905629|NCT02302807|581048279|FG001|Overall Study|Physician Decision|1|||
160565225|NCT02109029|579790279|FG000|Part B|Adverse Event|0|||
160842891|NCT04167137|580811689|FG003|Overall Study|Study terminated by Sponsor|0|||
160842892|NCT04167137|580811690|FG004|Overall Study|Study terminated by Sponsor|0|||
160842893|NCT04167137|580811691|FG005|Overall Study|Study terminated by Sponsor|0|||
160842894|NCT04167137|580811692|FG006|Overall Study|Study terminated by Sponsor|0|||
160842895|NCT04167137|580811693|FG007|Overall Study|Study terminated by Sponsor|1|||
160842896|NCT00211887|580811694|FG000|Overall Study|Adverse Event|8|||
160842897|NCT00211887|580811695|FG001|Overall Study|Adverse Event|4|||
160842898|NCT00211887|580811696|FG002|Overall Study|Adverse Event|6|||
160842899|NCT00211887|580811694|FG000|Overall Study|Death|1|||
160842900|NCT00211887|580811695|FG001|Overall Study|Death|1|||
160905630|NCT01980940|581048281|FG000|Overall Study|Protocol Violation|0|||
160905631|NCT01980940|581048282|FG001|Overall Study|Protocol Violation|0|||
160905632|NCT01980940|581048283|FG002|Overall Study|Protocol Violation|0|||
160905633|NCT01980940|581048284|FG003|Overall Study|Protocol Violation|0|||
160992152|NCT00477412|581359991|FG002|Overall Study|Withdrawal by Subject|0|||
160842901|NCT00211887|580811696|FG002|Overall Study|Death|1|||
160842902|NCT00211887|580811694|FG000|Overall Study|Lost to Follow-up|28|||
160842903|NCT00211887|580811695|FG001|Overall Study|Lost to Follow-up|13|||
160842904|NCT00211887|580811696|FG002|Overall Study|Lost to Follow-up|9|||
160842905|NCT00211887|580811694|FG000|Overall Study|Non-medical reason|31|||
160905634|NCT01980940|581048285|FG004|Overall Study|Protocol Violation|0|||
160842906|NCT00211887|580811695|FG001|Overall Study|Non-medical reason|14|||
160842907|NCT00211887|580811696|FG002|Overall Study|Non-medical reason|8|||
160842908|NCT00211887|580811694|FG000|Overall Study|Other medical reason|15|||
160842909|NCT00211887|580811695|FG001|Overall Study|Other medical reason|11|||
160842910|NCT00211887|580811696|FG002|Overall Study|Other medical reason|7|||
160842911|NCT00211887|580811694|FG000|Overall Study|Side effects|19|||
160842912|NCT00211887|580811695|FG001|Overall Study|Side effects|13|||
160842913|NCT00211887|580811696|FG002|Overall Study|Side effects|5|||
160842914|NCT03058692|580813214|FG000|Overall Study|Lost to Follow-up|2|||
160842915|NCT03058692|580813215|FG001|Overall Study|Lost to Follow-up|1|||
160842916|NCT03058692|580813214|FG000|Overall Study|Withdrawal by Subject|1|||
160842917|NCT03058692|580813215|FG001|Overall Study|Withdrawal by Subject|1|||
160842918|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
160842919|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
160842920|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
160842921|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
160842922|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
160842923|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
160842924|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
160842925|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
160842926|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
160842927|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
160842928|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
160842929|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
160842930|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
160842931|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
160842932|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
160842933|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
160842934|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
160842935|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
160842936|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
160842937|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
160842938|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
160842939|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
160842940|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
160842941|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
160842942|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
160842943|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
160842944|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
160842945|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
160842946|NCT03777059|580813216|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
160842947|NCT03777059|580813217|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
160842948|NCT03777059|580813218|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
160842949|NCT03777059|580813219|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
160842950|NCT03777059|580813216|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
160842951|NCT03777059|580813217|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
160842952|NCT03777059|580813218|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
160842953|NCT03777059|580813219|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
160842954|NCT03777059|580813216|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
160842955|NCT03777059|580813217|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
160842956|NCT03777059|580813218|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
160842957|NCT03777059|580813219|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
160842958|NCT03777059|580813216|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
160842959|NCT03777059|580813217|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
160842960|NCT03777059|580813218|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
160842961|NCT03777059|580813219|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
160565226|NCT02109029|579790280|FG001|Part B|Adverse Event|0|||
160565227|NCT02109029|579790281|FG002|Part B|Adverse Event|0|||
160565228|NCT02109029|579790282|FG003|Part B|Adverse Event|0|||
160565229|NCT02109029|579790283|FG004|Part B|Adverse Event|1|||
160565230|NCT02109029|579790284|FG005|Part B|Adverse Event|1|||
160565231|NCT03195894|579790285|FG000|Overall Study|"An example is Started other treatment."|4|||
160565232|NCT03195894|579790286|FG001|Overall Study|"An example is Started other treatment."|5|||
160565233|NCT03195894|579790285|FG000|Overall Study|Withdrawal by Subject|15|||
160842962|NCT01702025|580813222|FG000|Overall Study|Equipment failure|1|||
160842963|NCT01702025|580813223|FG001|Overall Study|Equipment failure|0|||
160842964|NCT01702025|580813224|FG002|Overall Study|Equipment failure|0|||
160842965|NCT01702025|580813225|FG003|Overall Study|Equipment failure|0|||
160842966|NCT01702025|580813222|FG000|Overall Study|Adverse Event|1|||
160565234|NCT03195894|579790286|FG001|Overall Study|Withdrawal by Subject|4|||
160842967|NCT01702025|580813223|FG001|Overall Study|Adverse Event|1|||
160842968|NCT01702025|580813224|FG002|Overall Study|Adverse Event|1|||
160842969|NCT01702025|580813225|FG003|Overall Study|Adverse Event|0|||
160842970|NCT02679755|580813226|FG000|Overall Study|Death|0|||
160842971|NCT02679755|580813227|FG001|Overall Study|Death|3|||
160842972|NCT02679755|580813226|FG000|Overall Study|Global deterioration of health status|1|||
160842973|NCT02679755|580813227|FG001|Overall Study|Global deterioration of health status|8|||
160842974|NCT02679755|580813226|FG000|Overall Study|Lost to Follow-up|1|||
160842975|NCT02679755|580813227|FG001|Overall Study|Lost to Follow-up|0|||
160842976|NCT02679755|580813226|FG000|Overall Study|Objective progression or relapse|24|||
160842977|NCT02679755|580813227|FG001|Overall Study|Objective progression or relapse|83|||
160842978|NCT02679755|580813226|FG000|Overall Study|Not defined|0|||
160842979|NCT02679755|580813227|FG001|Overall Study|Not defined|2|||
160842980|NCT02679755|580813226|FG000|Overall Study|Withdrawal by participant|6|||
160842981|NCT02679755|580813227|FG001|Overall Study|Withdrawal by participant|3|||
160842982|NCT02679755|580813226|FG000|Overall Study|Adverse Event|1|||
160842983|NCT02679755|580813227|FG001|Overall Study|Adverse Event|4|||
160842984|NCT02679755|580813226|FG000|Overall Study|Adverse events not related to study drug|1|||
160842985|NCT02679755|580813227|FG001|Overall Study|Adverse events not related to study drug|2|||
160842986|NCT01061359|580813228|FG000|Overall Study|Death|32|||
160842987|NCT01061359|580813228|FG000|Overall Study|Lost to Follow-up|1072|||
160842988|NCT01061359|580813228|FG000|Overall Study|Relapse|187|||
160842989|NCT01061359|580813228|FG000|Overall Study|Secondary neoplasm|11|||
160842990|NCT03038126|580813230|FG000|Overall Study|Death|1|||
160842991|NCT03038126|580813231|FG001|Overall Study|Death|1|||
160842992|NCT03038126|580813230|FG000|Overall Study|Withdrawal by Subject|5|||
160842993|NCT03038126|580813231|FG001|Overall Study|Withdrawal by Subject|0|||
160842994|NCT03038126|580813230|FG000|Overall Study|Lost to Follow-up|0|||
160842995|NCT03038126|580813231|FG001|Overall Study|Lost to Follow-up|1|||
160842996|NCT03038126|580813230|FG000|Overall Study|Long Term Hospitalization|2|||
160842997|NCT03038126|580813231|FG001|Overall Study|Long Term Hospitalization|0|||
160842998|NCT03038126|580813230|FG000|Overall Study|Too Ill to Participate|1|||
160842999|NCT03038126|580813231|FG001|Overall Study|Too Ill to Participate|2|||
160843000|NCT01724866|580813232|FG000|Overall Study|Adverse Event|0|||
160843001|NCT01724866|580813233|FG001|Overall Study|Adverse Event|0|||
160843002|NCT01724866|580813234|FG002|Overall Study|Adverse Event|1|||
160843003|NCT01724866|580813235|FG003|Overall Study|Adverse Event|1|||
160843004|NCT01724866|580813232|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
160843005|NCT01724866|580813233|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
160843006|NCT01724866|580813234|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
160843007|NCT01724866|580813235|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
160843008|NCT01724866|580813232|FG000|Overall Study|Investigator's Discretion|0|||
160843009|NCT01724866|580813233|FG001|Overall Study|Investigator's Discretion|1|||
160843010|NCT01724866|580813234|FG002|Overall Study|Investigator's Discretion|1|||
160843011|NCT01724866|580813235|FG003|Overall Study|Investigator's Discretion|0|||
160843012|NCT01724866|580813232|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
160843013|NCT01724866|580813233|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
160843014|NCT01724866|580813234|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
160843015|NCT01724866|580813235|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
160843016|NCT01724866|580813232|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
160843017|NCT01724866|580813233|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
160843018|NCT01724866|580813234|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
160843019|NCT01724866|580813235|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
160843020|NCT00411671|580813238|FG000|Overall Study|Adverse Event|15|||
160843021|NCT00411671|580813238|FG000|Overall Study|Death|2|||
160843022|NCT00411671|580813238|FG000|Overall Study|Lost to Follow-up|3|||
160843023|NCT00546000|580813243|FG000|Overall Study|Adverse Event|1|||
160843024|NCT00546000|580813243|FG000|Overall Study|Lost to Follow-up|1|||
160843025|NCT00546000|580813243|FG000|Overall Study|Baseline HPA Axis Supression|2|||
160843026|NCT03688074|580813248|FG000|Overall Study|Adverse Event|0|||
160905635|NCT01980940|581048286|FG005|Overall Study|Protocol Violation|2|||
160905636|NCT01980940|581048287|FG006|Overall Study|Protocol Violation|0|||
160905637|NCT01980940|581048288|FG007|Overall Study|Protocol Violation|0|||
160905638|NCT03192462|581050254|FG000|Overall Study|Death|13|||
160843027|NCT03688074|580813249|FG001|Overall Study|Adverse Event|1|||
160843028|NCT03688074|580813248|FG000|Overall Study|Other|1|||
160843029|NCT03688074|580813249|FG001|Overall Study|Other|0|||
160843030|NCT01362608|580813250|FG000|Overall Study|Protocol Violation|0|||
160905639|NCT03192462|581050255|FG001|Overall Study|Death|11|||
160843031|NCT01362608|580813251|FG001|Overall Study|Protocol Violation|1|||
160905640|NCT03192462|581050256|FG002|Overall Study|Death|10|||
160843032|NCT01362608|580813250|FG000|Overall Study|Lost to Follow-up|3|||
160905641|NCT03192462|581050254|FG000|Overall Study|Lost to Follow-up|0|||
160905642|NCT03192462|581050255|FG001|Overall Study|Lost to Follow-up|1|||
160905643|NCT03192462|581050256|FG002|Overall Study|Lost to Follow-up|0|||
160905644|NCT04840615|581050257|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
160905645|NCT04840615|581050258|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
160905646|NCT04840615|581050259|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
160905647|NCT00982137|581050262|FG000|Overall Study|Lost to Follow-up|0|||
160905648|NCT00982137|581050263|FG001|Overall Study|Lost to Follow-up|0|||
160905649|NCT00982137|581050264|FG002|Overall Study|Lost to Follow-up|0|||
160905650|NCT00982137|581050265|FG003|Overall Study|Lost to Follow-up|1|||
160843033|NCT01362608|580813251|FG001|Overall Study|Lost to Follow-up|1|||
160905651|NCT00982137|581050262|FG000|Overall Study|Withdrawal by Subject|0|||
160905652|NCT00982137|581050263|FG001|Overall Study|Withdrawal by Subject|1|||
160905653|NCT00982137|581050264|FG002|Overall Study|Withdrawal by Subject|0|||
160905654|NCT00982137|581050265|FG003|Overall Study|Withdrawal by Subject|0|||
160905655|NCT00126191|581050266|FG000|Overall Study|Physician Decision|0|||
160905656|NCT00126191|581050267|FG001|Overall Study|Physician Decision|1|||
160905657|NCT00126191|581050266|FG000|Overall Study|Death|0|||
160905658|NCT00126191|581050267|FG001|Overall Study|Death|1|||
160905659|NCT02469298|581050269|FG000|Overall Study|Protocol Violation|0|||
160905660|NCT02469298|581050270|FG001|Overall Study|Protocol Violation|1|||
160905661|NCT02469298|581050271|FG002|Overall Study|Protocol Violation|1|||
160905662|NCT02469298|581050272|FG003|Overall Study|Protocol Violation|0|||
160905663|NCT02469298|581050269|FG000|Overall Study|Lost to Follow-up|1|||
160905664|NCT02469298|581050270|FG001|Overall Study|Lost to Follow-up|0|||
160905665|NCT02469298|581050271|FG002|Overall Study|Lost to Follow-up|1|||
160843034|NCT01362608|580813250|FG000|Overall Study|Withdrawal by Subject|1|||
160843035|NCT01362608|580813251|FG001|Overall Study|Withdrawal by Subject|2|||
160843036|NCT01362608|580813250|FG000|Overall Study|Lack of Efficacy|0|||
160843037|NCT01362608|580813251|FG001|Overall Study|Lack of Efficacy|2|||
160843038|NCT01362608|580813250|FG000|Overall Study|Adverse Event|0|||
160843039|NCT01362608|580813251|FG001|Overall Study|Adverse Event|2|||
160843040|NCT03056339|580813254|FG000|Overall Study|Failed Requirements|0|||
160843041|NCT03056339|580813255|FG001|Overall Study|Failed Requirements|2|||
160843042|NCT03056339|580813256|FG002|Overall Study|Failed Requirements|7|||
160905666|NCT02469298|581050272|FG003|Overall Study|Lost to Follow-up|0|||
160905667|NCT02469298|581050269|FG000|Overall Study|Physician Decision|0|||
160905668|NCT02469298|581050270|FG001|Overall Study|Physician Decision|0|||
160905669|NCT02469298|581050271|FG002|Overall Study|Physician Decision|0|||
160905670|NCT02469298|581050272|FG003|Overall Study|Physician Decision|1|||
160905671|NCT02469298|581050269|FG000|Overall Study|Withdrawal by Subject|0|||
160905672|NCT02469298|581050270|FG001|Overall Study|Withdrawal by Subject|0|||
160905673|NCT02469298|581050271|FG002|Overall Study|Withdrawal by Subject|0|||
160905674|NCT02469298|581050272|FG003|Overall Study|Withdrawal by Subject|1|||
160905675|NCT01433991|581050281|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
160905676|NCT01433991|581050282|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
160905677|NCT01433991|581050283|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
160905678|NCT01433991|581050284|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
160905679|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
160905680|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
160905681|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
160905682|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
160905683|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
160905684|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
160905685|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
160905686|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
160905687|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
160905688|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
160905689|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
160905690|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
160905691|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
160905692|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
160905693|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
160905694|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
160905695|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
160843043|NCT03056339|580813257|FG003|Overall Study|Failed Requirements|1|||
160843044|NCT04171219|580813260|FG000|Overall Study|Adverse Event|1|||
160843045|NCT04171219|580813261|FG001|Overall Study|Adverse Event|0|||
160905696|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
160905697|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
160905698|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
160843046|NCT04171219|580813260|FG000|Overall Study|Death|0|||
160843047|NCT04171219|580813261|FG001|Overall Study|Death|1|||
160843048|NCT04171219|580813260|FG000|Overall Study|Lack of Efficacy|9|||
160843049|NCT04171219|580813261|FG001|Overall Study|Lack of Efficacy|13|||
160843050|NCT04171219|580813260|FG000|Overall Study|Withdrawal by Subject|1|||
160843051|NCT04171219|580813261|FG001|Overall Study|Withdrawal by Subject|2|||
160843052|NCT04171219|580813260|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
160843053|NCT04171219|580813261|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
160843054|NCT04171219|580813260|FG000|Overall Study|Clinical PD/Patient choice|1|||
160843055|NCT04171219|580813261|FG001|Overall Study|Clinical PD/Patient choice|0|||
160843056|NCT04171219|580813260|FG000|Overall Study|Toxicity/ Patient choice|1|||
160843057|NCT04171219|580813261|FG001|Overall Study|Toxicity/ Patient choice|0|||
160843058|NCT04809285|580813262|FG000|Phase 1|Lost to Follow-up|6|||
160843059|NCT04809285|580813262|FG000|Phase 1|Protocol Violation|2|||
160843060|NCT04809285|580813262|FG000|Phase 1|Physician Decision|3|||
160843061|NCT04809285|580813262|FG000|Phase 1|Withdrawal by Subject|29|||
160843062|NCT04809285|580813262|FG000|Phase 2|Protocol Violation|3|||
160843063|NCT04809285|580813262|FG000|Phase 2|Withdrawal by Subject|4|||
160843064|NCT03350815|580813264|FG000|Period 1|Adverse Event|10|||
160843065|NCT03350815|580813265|FG001|Period 1|Adverse Event|0|||
160843066|NCT03350815|580813266|FG002|Period 1|Adverse Event|0|||
160843067|NCT03350815|580813267|FG003|Period 1|Adverse Event|0|||
160843068|NCT03350815|580813264|FG000|Period 1|Technical problems|1|||
160843069|NCT03350815|580813265|FG001|Period 1|Technical problems|0|||
160843070|NCT03350815|580813266|FG002|Period 1|Technical problems|0|||
160843071|NCT03350815|580813267|FG003|Period 1|Technical problems|0|||
160843072|NCT03350815|580813264|FG000|Period 1|Lost to Follow-up|3|||
160843073|NCT03350815|580813265|FG001|Period 1|Lost to Follow-up|0|||
160843074|NCT03350815|580813266|FG002|Period 1|Lost to Follow-up|0|||
160843075|NCT03350815|580813267|FG003|Period 1|Lost to Follow-up|0|||
160843076|NCT03350815|580813264|FG000|Period 1|Physician Decision|1|||
160843077|NCT03350815|580813265|FG001|Period 1|Physician Decision|0|||
160843078|NCT03350815|580813266|FG002|Period 1|Physician Decision|0|||
160843079|NCT03350815|580813267|FG003|Period 1|Physician Decision|0|||
160843080|NCT03350815|580813264|FG000|Period 1|Withdrawal by Subject|8|||
160843081|NCT03350815|580813265|FG001|Period 1|Withdrawal by Subject|0|||
160843082|NCT03350815|580813266|FG002|Period 1|Withdrawal by Subject|0|||
160843083|NCT03350815|580813267|FG003|Period 1|Withdrawal by Subject|0|||
160843084|NCT03350815|580813264|FG000|Period 1|Lack of Efficacy|15|||
160843085|NCT03350815|580813265|FG001|Period 1|Lack of Efficacy|0|||
160843086|NCT03350815|580813266|FG002|Period 1|Lack of Efficacy|0|||
160843087|NCT03350815|580813267|FG003|Period 1|Lack of Efficacy|0|||
160843088|NCT03350815|580813264|FG000|Period 1|Non-compliance with study treatment|2|||
160843089|NCT03350815|580813265|FG001|Period 1|Non-compliance with study treatment|0|||
160843090|NCT03350815|580813266|FG002|Period 1|Non-compliance with study treatment|0|||
160843091|NCT03350815|580813267|FG003|Period 1|Non-compliance with study treatment|0|||
160843092|NCT03350815|580813264|FG000|Period 1|Protocol Violation|3|||
160843093|NCT03350815|580813265|FG001|Period 1|Protocol Violation|0|||
160843094|NCT03350815|580813266|FG002|Period 1|Protocol Violation|0|||
160843095|NCT03350815|580813267|FG003|Period 1|Protocol Violation|0|||
160843096|NCT03350815|580813264|FG000|Period 2|Adverse Event|0|||
160843097|NCT03350815|580813265|FG001|Period 2|Adverse Event|3|||
160843098|NCT03350815|580813266|FG002|Period 2|Adverse Event|5|||
160843099|NCT03350815|580813267|FG003|Period 2|Adverse Event|0|||
160843100|NCT03350815|580813264|FG000|Period 2|Technical problem|0|||
160843101|NCT03350815|580813265|FG001|Period 2|Technical problem|1|||
160843102|NCT03350815|580813266|FG002|Period 2|Technical problem|0|||
160843103|NCT03350815|580813267|FG003|Period 2|Technical problem|0|||
160843104|NCT03350815|580813264|FG000|Period 2|Lost to Follow-up|0|||
160843105|NCT03350815|580813265|FG001|Period 2|Lost to Follow-up|3|||
160843106|NCT03350815|580813266|FG002|Period 2|Lost to Follow-up|3|||
160843107|NCT03350815|580813267|FG003|Period 2|Lost to Follow-up|0|||
160843108|NCT03350815|580813264|FG000|Period 2|Physician Decision|0|||
160843109|NCT03350815|580813265|FG001|Period 2|Physician Decision|0|||
160843110|NCT03350815|580813266|FG002|Period 2|Physician Decision|1|||
160843111|NCT03350815|580813267|FG003|Period 2|Physician Decision|0|||
160843112|NCT03350815|580813264|FG000|Period 2|Withdrawal by Subject|0|||
160843113|NCT03350815|580813265|FG001|Period 2|Withdrawal by Subject|3|||
160843114|NCT03350815|580813266|FG002|Period 2|Withdrawal by Subject|4|||
160843115|NCT03350815|580813267|FG003|Period 2|Withdrawal by Subject|0|||
160843116|NCT03350815|580813264|FG000|Period 2|Lack of Efficacy|0|||
160843117|NCT03350815|580813265|FG001|Period 2|Lack of Efficacy|6|||
160843118|NCT03350815|580813266|FG002|Period 2|Lack of Efficacy|2|||
160843119|NCT03350815|580813267|FG003|Period 2|Lack of Efficacy|0|||
160843120|NCT03350815|580813264|FG000|Period 2|Protocol Violation|0|||
160843121|NCT03350815|580813265|FG001|Period 2|Protocol Violation|0|||
160843122|NCT03350815|580813266|FG002|Period 2|Protocol Violation|1|||
160992153|NCT00477412|581359992|FG003|Overall Study|Withdrawal by Subject|2|||
160843123|NCT03350815|580813267|FG003|Period 2|Protocol Violation|0|||
160843124|NCT03350815|580813264|FG000|Period 2|New therapy for study indication|0|||
160843125|NCT03350815|580813265|FG001|Period 2|New therapy for study indication|0|||
160843126|NCT03350815|580813266|FG002|Period 2|New therapy for study indication|1|||
160843127|NCT03350815|580813267|FG003|Period 2|New therapy for study indication|0|||
160843128|NCT03526146|580813268|FG000|Overall Study|Lost to Follow-up|5|||
160843129|NCT03526146|580813268|FG000|Overall Study|Withdrawal by Subject|6|||
160843130|NCT03526146|580813268|FG000|Overall Study|class canceled due to COVID-19|4|||
160843131|NCT02517541|580813273|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
160843132|NCT02517541|580813273|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
160843133|NCT02517541|580813273|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
160843134|NCT02517541|580813273|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
160843135|NCT02517541|580813273|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
160843136|NCT02517541|580813273|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
160843137|NCT00699608|580813274|FG000|First Intervention|Withdrawal by Subject|0|||
160843138|NCT00699608|580813275|FG001|First Intervention|Withdrawal by Subject|0|||
160843139|NCT00699608|580813276|FG002|First Intervention|Withdrawal by Subject|1|||
160843140|NCT00699608|580813277|FG003|First Intervention|Withdrawal by Subject|0|||
160843141|NCT00699608|580813278|FG004|First Intervention|Withdrawal by Subject|0|||
160843142|NCT00699608|580813279|FG005|First Intervention|Withdrawal by Subject|0|||
160843143|NCT00699608|580813274|FG000|First Intervention|Protocol Violation|0|||
160843144|NCT00699608|580813275|FG001|First Intervention|Protocol Violation|0|||
160843145|NCT00699608|580813276|FG002|First Intervention|Protocol Violation|0|||
160843146|NCT00699608|580813277|FG003|First Intervention|Protocol Violation|0|||
160843147|NCT00699608|580813278|FG004|First Intervention|Protocol Violation|1|||
160843148|NCT00699608|580813279|FG005|First Intervention|Protocol Violation|0|||
160843149|NCT00699608|580813274|FG000|Second Intervention|Adverse Event|0|||
160843150|NCT00699608|580813275|FG001|Second Intervention|Adverse Event|0|||
160843151|NCT00699608|580813276|FG002|Second Intervention|Adverse Event|1|||
160843152|NCT00699608|580813277|FG003|Second Intervention|Adverse Event|0|||
160843153|NCT00699608|580813278|FG004|Second Intervention|Adverse Event|0|||
160843154|NCT00699608|580813279|FG005|Second Intervention|Adverse Event|0|||
160843155|NCT00699608|580813274|FG000|Second Intervention|Withdrawal by Subject|0|||
160843156|NCT00699608|580813275|FG001|Second Intervention|Withdrawal by Subject|0|||
160843157|NCT00699608|580813276|FG002|Second Intervention|Withdrawal by Subject|0|||
160843158|NCT00699608|580813277|FG003|Second Intervention|Withdrawal by Subject|1|||
160843159|NCT00699608|580813278|FG004|Second Intervention|Withdrawal by Subject|0|||
160843160|NCT00699608|580813279|FG005|Second Intervention|Withdrawal by Subject|0|||
160843161|NCT02034877|580813280|FG000|Overall Study|Lost to Follow-up|0|||
160843162|NCT02034877|580813281|FG001|Overall Study|Lost to Follow-up|3|||
160843163|NCT02034877|580813280|FG000|Overall Study|No Longer Willing to Participate|0|||
160843164|NCT02034877|580813281|FG001|Overall Study|No Longer Willing to Participate|3|||
160843165|NCT01036321|580813285|FG000|Overall Study|Ineligible after randomization|0|||
160843166|NCT01036321|580813286|FG001|Overall Study|Ineligible after randomization|1|||
160843167|NCT01036321|580813285|FG000|Overall Study|Withdrawal by Subject|3|||
160843168|NCT01036321|580813286|FG001|Overall Study|Withdrawal by Subject|2|||
160843169|NCT01036321|580813285|FG000|Overall Study|Adverse Event|2|||
160843170|NCT01036321|580813286|FG001|Overall Study|Adverse Event|1|||
160843171|NCT00381693|580813287|FG000|Overall Study|Death|1|||
160843172|NCT00381693|580813287|FG000|Overall Study|Adverse Event|4|||
160843173|NCT00381693|580813287|FG000|Overall Study|Patient Choice|1|||
160843174|NCT00381693|580813287|FG000|Overall Study|Progression|2|||
160843175|NCT02598297|580813288|FG000|Overall Study|Study terminated by Sponsor|21|||
160843176|NCT02598297|580813289|FG001|Overall Study|Study terminated by Sponsor|23|||
160843177|NCT02598297|580813288|FG000|Overall Study|Adverse Event|1|||
160843178|NCT02598297|580813289|FG001|Overall Study|Adverse Event|1|||
160843179|NCT02598297|580813288|FG000|Overall Study|Physician Decision|1|||
160843180|NCT02598297|580813289|FG001|Overall Study|Physician Decision|0|||
160843181|NCT02598297|580813288|FG000|Overall Study|Subject/guardian decision|1|||
160843182|NCT02598297|580813289|FG001|Overall Study|Subject/guardian decision|0|||
160843183|NCT02598297|580813288|FG000|Overall Study|Followed for survival|1|||
160843184|NCT02598297|580813289|FG001|Overall Study|Followed for survival|0|||
160843185|NCT04112303|580813293|FG000|Overall Study|Death|1|||
160843186|NCT01685697|580813294|FG000|Overall Study|Protocol Violation|3|||
160843187|NCT01685697|580813295|FG001|Overall Study|Protocol Violation|3|||
160843188|NCT02703324|580813296|FG000|Period Two|Withdrawal by Subject|0|||
160843189|NCT02703324|580813297|FG001|Period Two|Withdrawal by Subject|0|||
160843190|NCT02703324|580813298|FG002|Period Two|Withdrawal by Subject|1|||
160843191|NCT02703324|580813299|FG003|Period Two|Withdrawal by Subject|0|||
160843192|NCT02703324|580813300|FG004|Period Two|Withdrawal by Subject|0|||
160843193|NCT02703324|580813301|FG005|Period Two|Withdrawal by Subject|0|||
160843194|NCT04303572|580813304|FG000|Overall Study|Study closed due to poor enrollment|1|||
160843195|NCT06312592|580813305|FG000|Overall Study|Lost to Follow-up|29|||
160843196|NCT06312592|580813306|FG001|Overall Study|Lost to Follow-up|13|||
160843197|NCT03517228|580813309|FG000|Overall Study|Withdrawal by Subject|2|||
160843198|NCT03517228|580813309|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
160843199|NCT03517228|580813309|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
160905699|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
160843200|NCT03517228|580813309|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
160565235|NCT03195894|579790285|FG000|Overall Study|Lost to Follow-up|14|||
160843201|NCT03517228|580813309|FG000|Overall Study|Canceled due to device being updated|1|||
160843202|NCT03517228|580813309|FG000|Overall Study|No V Cares in stock|1|||
160843203|NCT03517228|580813309|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
160843204|NCT01620762|580813320|FG000|Overall Study|Protocol Violation|1|||
160843205|NCT01620762|580813321|FG001|Overall Study|Protocol Violation|1|||
160843206|NCT01620762|580813322|FG002|Overall Study|Protocol Violation|1|||
160843207|NCT01620762|580813320|FG000|Overall Study|Adverse Event|9|||
160843208|NCT01620762|580813321|FG001|Overall Study|Adverse Event|5|||
160843209|NCT01620762|580813322|FG002|Overall Study|Adverse Event|2|||
160843210|NCT01620762|580813320|FG000|Overall Study|Withdrawal by Subject|23|||
160843211|NCT01620762|580813321|FG001|Overall Study|Withdrawal by Subject|26|||
160843212|NCT01620762|580813322|FG002|Overall Study|Withdrawal by Subject|27|||
160843213|NCT01620762|580813320|FG000|Overall Study|Lost to Follow-up|11|||
160843214|NCT01620762|580813321|FG001|Overall Study|Lost to Follow-up|17|||
160843215|NCT01620762|580813322|FG002|Overall Study|Lost to Follow-up|10|||
160843216|NCT01620762|580813320|FG000|Overall Study|Protocol deviation|1|||
160843217|NCT01620762|580813321|FG001|Overall Study|Protocol deviation|1|||
160843218|NCT01620762|580813322|FG002|Overall Study|Protocol deviation|6|||
160843219|NCT01620762|580813320|FG000|Overall Study|Subject deterioration|0|||
160843220|NCT01620762|580813321|FG001|Overall Study|Subject deterioration|1|||
160843221|NCT01620762|580813322|FG002|Overall Study|Subject deterioration|1|||
160843222|NCT01620762|580813320|FG000|Overall Study|Non-specified|3|||
160843223|NCT01620762|580813321|FG001|Overall Study|Non-specified|6|||
160843224|NCT01620762|580813322|FG002|Overall Study|Non-specified|5|||
160843225|NCT01620762|580813320|FG000|Overall Study|Use of prohibted therapies|0|||
160843226|NCT01620762|580813321|FG001|Overall Study|Use of prohibted therapies|1|||
160843227|NCT01620762|580813322|FG002|Overall Study|Use of prohibted therapies|1|||
160843228|NCT03664765|580813327|FG000|Overall Study|Withdrawal by Subject|4|||
160843229|NCT03664765|580813328|FG001|Overall Study|Withdrawal by Subject|1|||
160843230|NCT03664765|580813327|FG000|Overall Study|Lost to Follow-up|0|||
160843231|NCT03664765|580813328|FG001|Overall Study|Lost to Follow-up|1|||
160843232|NCT01496846|580813329|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
160843233|NCT01496846|580813330|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
160843234|NCT01496846|580813331|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
160843235|NCT01496846|580813332|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
160843236|NCT01496846|580813333|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
160843237|NCT01496846|580813334|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
160843238|NCT01772576|580813335|FG000|Overall Study|Death|15|||
160843239|NCT01772576|580813335|FG000|Overall Study|Protocol Violation|1|||
160843240|NCT01772576|580813335|FG000|Overall Study|Lost to Follow-up|3|||
160843241|NCT01772576|580813335|FG000|Overall Study|Study device not used|3|||
160843242|NCT01772576|580813335|FG000|Overall Study|Adverse Event|6|||
160843243|NCT01772576|580813335|FG000|Overall Study|Withdrawal by Subject|6|||
160843244|NCT00527904|580813339|FG000|Overall Study|Adverse Event|45|||
160843245|NCT00527904|580813339|FG000|Overall Study|Withdrawal by Subject|21|||
160843246|NCT00527904|580813339|FG000|Overall Study|Lost to Follow-up|8|||
160843247|NCT00527904|580813339|FG000|Overall Study|misc|22|||
160843248|NCT02873338|580813343|FG000|Overall Study|Adverse Event|0|||
160843249|NCT02873338|580813344|FG001|Overall Study|Adverse Event|2|||
160843250|NCT02873338|580813345|FG002|Overall Study|Adverse Event|1|||
160843251|NCT02873338|580813343|FG000|Overall Study|Death|2|||
160843252|NCT02873338|580813344|FG001|Overall Study|Death|1|||
160843253|NCT02873338|580813345|FG002|Overall Study|Death|1|||
160843254|NCT02873338|580813343|FG000|Overall Study|Withdrawal by Subject|2|||
160843255|NCT02873338|580813344|FG001|Overall Study|Withdrawal by Subject|1|||
160843256|NCT02873338|580813345|FG002|Overall Study|Withdrawal by Subject|3|||
160843257|NCT02873338|580813343|FG000|Overall Study|Lack of Efficacy|0|||
160565236|NCT03195894|579790286|FG001|Overall Study|Lost to Follow-up|19|||
160843258|NCT02873338|580813344|FG001|Overall Study|Lack of Efficacy|2|||
160843259|NCT02873338|580813345|FG002|Overall Study|Lack of Efficacy|0|||
160905700|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
160905701|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
160905702|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
160565237|NCT01217606|579790295|FG000|Initial Treatment Phase|Other Reasons|0|||
160565238|NCT01217606|579790296|FG001|Initial Treatment Phase|Other Reasons|2|||
160647715|NCT05002569|580092809|FG000|Follow Up|Death|78|||
160843260|NCT02873338|580813343|FG000|Overall Study|Other or Missing|14|||
160843261|NCT02873338|580813344|FG001|Overall Study|Other or Missing|15|||
160843262|NCT02873338|580813345|FG002|Overall Study|Other or Missing|13|||
160843263|NCT03477838|580813355|FG000|Overall Study|Lost to Follow-up|14|||
160843264|NCT00850538|580813357|FG000|Overall Study|unable/unwilling to complete MRI|13|||
160843265|NCT00850538|580813357|FG000|Overall Study|specimen missed due to scheduling error|14|||
160843266|NCT00850538|580813357|FG000|Overall Study|specimen unusable|7|||
160905703|NCT02955602|581050287|FG000|Overall Study|Adverse Event|0|||
160905704|NCT02955602|581050288|FG001|Overall Study|Adverse Event|3|||
160843267|NCT00850538|580813357|FG000|Overall Study|Withdrawal by Subject|3|||
160843268|NCT00850538|580813357|FG000|Overall Study|radiology error|2|||
160843269|NCT00850538|580813357|FG000|Overall Study|Protocol Violation|2|||
160843270|NCT01088399|580813363|FG000|Overall Study|Adverse Event|211|||
160843271|NCT01088399|580813364|FG001|Overall Study|Adverse Event|16|||
160843272|NCT01088399|580813365|FG002|Overall Study|Adverse Event|0|||
160843273|NCT01088399|580813363|FG000|Overall Study|Death|204|||
160843274|NCT01088399|580813364|FG001|Overall Study|Death|45|||
160565239|NCT01217606|579790295|FG000|Initial Treatment Phase|Protocol Violation|3|||
160565240|NCT01217606|579790296|FG001|Initial Treatment Phase|Protocol Violation|2|||
160565241|NCT01217606|579790295|FG000|Initial Treatment Phase|Personal Reasons|0|||
160565242|NCT01217606|579790296|FG001|Initial Treatment Phase|Personal Reasons|2|||
160843275|NCT01088399|580813365|FG002|Overall Study|Death|0|||
160843276|NCT01088399|580813363|FG000|Overall Study|Lack of Efficacy|298|||
160843277|NCT01088399|580813364|FG001|Overall Study|Lack of Efficacy|7|||
160843278|NCT01088399|580813365|FG002|Overall Study|Lack of Efficacy|5|||
160843279|NCT01088399|580813363|FG000|Overall Study|Lost to Follow-up|1070|||
160843280|NCT01088399|580813364|FG001|Overall Study|Lost to Follow-up|278|||
160843281|NCT01088399|580813365|FG002|Overall Study|Lost to Follow-up|58|||
160843282|NCT01088399|580813363|FG000|Overall Study|Physician Decision|531|||
160843283|NCT01088399|580813364|FG001|Overall Study|Physician Decision|88|||
160843284|NCT01088399|580813365|FG002|Overall Study|Physician Decision|16|||
160843285|NCT01088399|580813363|FG000|Overall Study|Withdrawal by Subject|544|||
160843286|NCT01088399|580813364|FG001|Overall Study|Withdrawal by Subject|195|||
160843287|NCT01088399|580813365|FG002|Overall Study|Withdrawal by Subject|33|||
160843288|NCT01088399|580813363|FG000|Overall Study|Change to or start of somatropin therapy|234|||
160843289|NCT01088399|580813364|FG001|Overall Study|Change to or start of somatropin therapy|17|||
160843290|NCT01088399|580813365|FG002|Overall Study|Change to or start of somatropin therapy|12|||
160843291|NCT01088399|580813363|FG000|Overall Study|Sponsor decision|1573|||
160843292|NCT01088399|580813364|FG001|Overall Study|Sponsor decision|298|||
160843293|NCT01088399|580813365|FG002|Overall Study|Sponsor decision|7|||
160843294|NCT01088399|580813363|FG000|Overall Study|Protocol Violation|10|||
160843295|NCT01088399|580813364|FG001|Overall Study|Protocol Violation|1|||
160843296|NCT01088399|580813365|FG002|Overall Study|Protocol Violation|0|||
160843297|NCT01088399|580813363|FG000|Overall Study|Enrollment criteria not met|48|||
160843298|NCT01088399|580813364|FG001|Overall Study|Enrollment criteria not met|119|||
160843299|NCT01088399|580813365|FG002|Overall Study|Enrollment criteria not met|70|||
160843300|NCT01088399|580813363|FG000|Overall Study|Study summary visit not completed|2398|||
160843301|NCT01088399|580813364|FG001|Overall Study|Study summary visit not completed|283|||
160843302|NCT01088399|580813365|FG002|Overall Study|Study summary visit not completed|80|||
160843303|NCT03193736|580813366|FG000|Overall Study|Death|2|||
160843304|NCT03193736|580813366|FG000|Overall Study|Withdrawal by Subject|1|||
160843305|NCT03193736|580813366|FG000|Overall Study|Lost to Follow-up|1|||
160843306|NCT03193736|580813366|FG000|Overall Study|implant not received|1|||
160843307|NCT00852241|580813367|FG000|Overall Study|Physician Decision|18|||
160843308|NCT00534976|580813370|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
160843309|NCT00534976|580813371|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
160843310|NCT00534976|580813370|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
160843311|NCT00534976|580813371|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
160843312|NCT00534976|580813370|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
160843313|NCT00534976|580813371|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
160843314|NCT00269633|580813374|FG000|Overall Study|Withdrawal by Subject|1|||
160843315|NCT00269633|580813375|FG001|Overall Study|Withdrawal by Subject|0|||
160843316|NCT04506502|580815437|FG000|Overall Study|Withdrawal by Subject|1|||
160843317|NCT04506502|580815437|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
160843318|NCT01449006|580815438|FG000|Overall Study|Lost to Follow-up|1|||
160843319|NCT01449006|580815439|FG001|Overall Study|Lost to Follow-up|0|||
160843320|NCT01449006|580815438|FG000|Overall Study|Withdrawal by Subject|1|||
160843321|NCT01449006|580815439|FG001|Overall Study|Withdrawal by Subject|0|||
160843322|NCT01449006|580815438|FG000|Overall Study|Protocol Violation|1|||
160843323|NCT01449006|580815439|FG001|Overall Study|Protocol Violation|0|||
160565243|NCT01217606|579790295|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
160843324|NCT04720417|580815444|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
160843325|NCT03574779|580815445|FG000|Overall Study|Screening failure|13|||
160843326|NCT03574779|580815446|FG001|Overall Study|Screening failure|83|||
160843327|NCT02783599|580815447|FG000|Overall Study|Progressive disease|23|||
160843328|NCT02783599|580815447|FG000|Overall Study|Surgical Resection|10|||
160843329|NCT02783599|580815447|FG000|Overall Study|Adverse Event|4|||
160843330|NCT02783599|580815447|FG000|Overall Study|Physician Decision|2|||
160843331|NCT02783599|580815447|FG000|Overall Study|Death|1|||
160843332|NCT03755882|580815453|FG000|Period 1|Protocol Violation|1|||
160843333|NCT03755882|580815454|FG001|Period 1|Protocol Violation|0|||
160843334|NCT03755882|580815453|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
160843335|NCT03755882|580815454|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
160843336|NCT01687101|580815455|FG000|Overall Study|Lost to Follow-up|7|||
160843337|NCT02003534|580815458|FG000|Overall Study|Lost to Follow-up|47|||
160843338|NCT02206035|580815459|FG000|Overall Study|Physician Decision|10|||
160843339|NCT02206035|580815460|FG001|Overall Study|Physician Decision|0|||
160843340|NCT02206035|580815461|FG002|Overall Study|Physician Decision|175|||
160843341|NCT01934010|580815462|FG000|Overall Study|Adverse Event|1|||
160843342|NCT01934010|580815463|FG001|Overall Study|Adverse Event|1|||
160843343|NCT01934010|580815464|FG002|Overall Study|Adverse Event|0|||
160843344|NCT01934010|580815462|FG000|Overall Study|Withdrawal by Subject|15|||
160843345|NCT01934010|580815463|FG001|Overall Study|Withdrawal by Subject|6|||
160843346|NCT01934010|580815464|FG002|Overall Study|Withdrawal by Subject|2|||
160843347|NCT01934010|580815462|FG000|Overall Study|Lost to Follow-up|7|||
160843348|NCT01934010|580815463|FG001|Overall Study|Lost to Follow-up|4|||
160843349|NCT01934010|580815464|FG002|Overall Study|Lost to Follow-up|0|||
160843350|NCT00377858|580815465|FG000|Overall Study|Withdrawal by Subject|12|||
160843351|NCT00377858|580815466|FG001|Overall Study|Withdrawal by Subject|11|||
160843352|NCT00377858|580815465|FG000|Overall Study|Lost to Follow-up|6|||
160843353|NCT00377858|580815466|FG001|Overall Study|Lost to Follow-up|1|||
160843354|NCT00377858|580815465|FG000|Overall Study|Physician Decision|5|||
160843355|NCT00377858|580815466|FG001|Overall Study|Physician Decision|5|||
160843356|NCT00377858|580815465|FG000|Overall Study|Protocol Violation|3|||
160843357|NCT00377858|580815466|FG001|Overall Study|Protocol Violation|4|||
160843358|NCT00377858|580815465|FG000|Overall Study|Adverse Event|2|||
160843359|NCT00377858|580815466|FG001|Overall Study|Adverse Event|1|||
160843360|NCT00377858|580815465|FG000|Overall Study|Entry Criteria Not Met|2|||
160843361|NCT00377858|580815466|FG001|Overall Study|Entry Criteria Not Met|0|||
160843362|NCT00377858|580815465|FG000|Overall Study|Sponsor Decision|1|||
160843363|NCT00377858|580815466|FG001|Overall Study|Sponsor Decision|2|||
160843364|NCT00377858|580815465|FG000|Overall Study|Death|0|||
160843365|NCT00377858|580815466|FG001|Overall Study|Death|3|||
160843366|NCT03534141|580815467|FG000|Overall Study|Enrolled in other clinical trial|1|||
160843367|NCT03534141|580815468|FG001|Overall Study|Enrolled in other clinical trial|0|||
160843368|NCT03534141|580815467|FG000|Overall Study|Liver transplant aborted after randomization|0|||
160843369|NCT03534141|580815468|FG001|Overall Study|Liver transplant aborted after randomization|2|||
160843370|NCT03534141|580815467|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
160843371|NCT03534141|580815468|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
160843374|NCT03785405|580815471|FG000|Overall Study|Adverse Event|16|||
160843375|NCT03785405|580815472|FG001|Overall Study|Adverse Event|1|||
160843376|NCT03785405|580815471|FG000|Overall Study|Death|6|||
160843377|NCT03785405|580815472|FG001|Overall Study|Death|4|||
160843378|NCT03785405|580815471|FG000|Overall Study|Guardian decision|4|||
160843379|NCT03785405|580815472|FG001|Overall Study|Guardian decision|1|||
160843380|NCT03785405|580815471|FG000|Overall Study|Lost to Follow-up|1|||
160843381|NCT03785405|580815472|FG001|Overall Study|Lost to Follow-up|0|||
160843382|NCT03785405|580815471|FG000|Overall Study|Physician Decision|8|||
160843383|NCT03785405|580815472|FG001|Overall Study|Physician Decision|5|||
160843384|NCT03785405|580815471|FG000|Overall Study|Participant decision|2|||
160843385|NCT03785405|580815472|FG001|Overall Study|Participant decision|0|||
160843386|NCT03785405|580815471|FG000|Overall Study|Other|1|||
160843387|NCT03785405|580815472|FG001|Overall Study|Other|0|||
160843388|NCT03785405|580815471|FG000|Overall Study|No treatment was received|0|||
160843389|NCT03785405|580815472|FG001|Overall Study|No treatment was received|1|||
160843390|NCT06041919|580815478|FG000|Overall Study|Lost to Follow-up|1|||
160843391|NCT06041919|580815479|FG001|Overall Study|Lost to Follow-up|0|||
160843392|NCT06041919|580815480|FG002|Overall Study|Lost to Follow-up|0|||
160843393|NCT06041919|580815481|FG003|Overall Study|Lost to Follow-up|0|||
160843394|NCT06041919|580815482|FG004|Overall Study|Lost to Follow-up|0|||
160843395|NCT06041919|580815478|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
160843396|NCT06041919|580815479|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
160905705|NCT02955602|581050289|FG002|Overall Study|Adverse Event|0|||
160843397|NCT06041919|580815480|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
160843398|NCT06041919|580815481|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
160843399|NCT06041919|580815482|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
160843400|NCT01147055|580815483|FG000|First Intervention Period|Lost to Follow-up|1|||
160843401|NCT01147055|580815484|FG001|First Intervention Period|Lost to Follow-up|0|||
160843402|NCT03724890|580815485|FG000|Overall Study|Death|2|||
160843403|NCT03724890|580815486|FG001|Overall Study|Death|6|||
160843404|NCT03724890|580815487|FG002|Overall Study|Death|3|||
160843405|NCT03724890|580815488|FG003|Overall Study|Death|5|||
160843406|NCT03724890|580815489|FG004|Overall Study|Death|2|||
160843407|NCT03724890|580815490|FG005|Overall Study|Death|0|||
160843408|NCT03724890|580815491|FG006|Overall Study|Death|2|||
160843409|NCT03724890|580815492|FG007|Overall Study|Death|3|||
160843410|NCT03724890|580815493|FG008|Overall Study|Death|4|||
160843411|NCT03724890|580815494|FG009|Overall Study|Death|2|||
160843412|NCT03724890|580815495|FG010|Overall Study|Death|2|||
160905706|NCT02955602|581050287|FG000|Overall Study|Withdrawal of informed consent|1|||
160843413|NCT03724890|580815485|FG000|Overall Study|Lost to Follow-up|0|||
160843414|NCT03724890|580815486|FG001|Overall Study|Lost to Follow-up|3|||
160843415|NCT03724890|580815487|FG002|Overall Study|Lost to Follow-up|0|||
160843416|NCT03724890|580815488|FG003|Overall Study|Lost to Follow-up|1|||
160843417|NCT03724890|580815489|FG004|Overall Study|Lost to Follow-up|2|||
160843418|NCT03724890|580815490|FG005|Overall Study|Lost to Follow-up|2|||
160843419|NCT03724890|580815491|FG006|Overall Study|Lost to Follow-up|1|||
160843420|NCT03724890|580815492|FG007|Overall Study|Lost to Follow-up|0|||
160843421|NCT03724890|580815493|FG008|Overall Study|Lost to Follow-up|2|||
160843422|NCT03724890|580815494|FG009|Overall Study|Lost to Follow-up|0|||
160843423|NCT03724890|580815495|FG010|Overall Study|Lost to Follow-up|0|||
160843424|NCT03724890|580815485|FG000|Overall Study|Withdrawal by Subject|1|||
160843425|NCT03724890|580815486|FG001|Overall Study|Withdrawal by Subject|2|||
160843426|NCT03724890|580815487|FG002|Overall Study|Withdrawal by Subject|1|||
160992154|NCT00477412|581359989|FG000|Overall Study|Second Malignancy|0|||
160843427|NCT03724890|580815488|FG003|Overall Study|Withdrawal by Subject|0|||
160843428|NCT03724890|580815489|FG004|Overall Study|Withdrawal by Subject|0|||
160843429|NCT03724890|580815490|FG005|Overall Study|Withdrawal by Subject|1|||
160843430|NCT03724890|580815491|FG006|Overall Study|Withdrawal by Subject|0|||
160843431|NCT03724890|580815492|FG007|Overall Study|Withdrawal by Subject|0|||
160843432|NCT03724890|580815493|FG008|Overall Study|Withdrawal by Subject|2|||
160843433|NCT03724890|580815494|FG009|Overall Study|Withdrawal by Subject|2|||
160843434|NCT03724890|580815495|FG010|Overall Study|Withdrawal by Subject|1|||
160843435|NCT03724890|580815485|FG000|Overall Study|Other|1|||
160843436|NCT03724890|580815486|FG001|Overall Study|Other|0|||
160843437|NCT03724890|580815487|FG002|Overall Study|Other|0|||
160843438|NCT03724890|580815488|FG003|Overall Study|Other|0|||
160843439|NCT03724890|580815489|FG004|Overall Study|Other|0|||
160843440|NCT03724890|580815490|FG005|Overall Study|Other|0|||
160843441|NCT03724890|580815491|FG006|Overall Study|Other|0|||
160843442|NCT03724890|580815492|FG007|Overall Study|Other|1|||
160843443|NCT03724890|580815493|FG008|Overall Study|Other|1|||
160843444|NCT03724890|580815494|FG009|Overall Study|Other|0|||
160843445|NCT03724890|580815495|FG010|Overall Study|Other|2|||
160843446|NCT02123823|580815497|FG000|Overall Study|Lack of Efficacy|0|||
160843447|NCT02123823|580815498|FG001|Overall Study|Lack of Efficacy|2|||
160843448|NCT02123823|580815499|FG002|Overall Study|Lack of Efficacy|8|||
160843449|NCT02123823|580815500|FG003|Overall Study|Lack of Efficacy|10|||
160843450|NCT02123823|580815497|FG000|Overall Study|Progressive disease|3|||
160843451|NCT02123823|580815498|FG001|Overall Study|Progressive disease|19|||
160843452|NCT02123823|580815499|FG002|Overall Study|Progressive disease|52|||
160843453|NCT02123823|580815500|FG003|Overall Study|Progressive disease|53|||
160992155|NCT00477412|581359990|FG001|Overall Study|Second Malignancy|0|||
160992156|NCT00477412|581359991|FG002|Overall Study|Second Malignancy|0|||
160992157|NCT00477412|581359992|FG003|Overall Study|Second Malignancy|1|||
160992158|NCT00477412|581359989|FG000|Overall Study|Adverse Event|1|||
160992159|NCT00477412|581359990|FG001|Overall Study|Adverse Event|0|||
160992160|NCT00477412|581359991|FG002|Overall Study|Adverse Event|1|||
160992161|NCT00477412|581359992|FG003|Overall Study|Adverse Event|0|||
160992162|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
160992163|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
160992164|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
160992165|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
160992166|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
160992167|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
160992168|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
160992169|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
160843454|NCT02123823|580815497|FG000|Overall Study|Withdrawal by Subject|0|||
160843455|NCT02123823|580815498|FG001|Overall Study|Withdrawal by Subject|0|||
160992170|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Death|1|||
160992171|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Death|0|||
160992172|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
160992173|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
160992174|NCT01080131|581359993|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
160647716|NCT05002569|580092810|FG001|Follow Up|Death|69|||
160647717|NCT05002569|580092809|FG000|Follow Up|Lost to Follow-up|3|||
160992175|NCT01080131|581359994|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
160843456|NCT02123823|580815499|FG002|Overall Study|Withdrawal by Subject|7|||
160843457|NCT02123823|580815500|FG003|Overall Study|Withdrawal by Subject|2|||
160843458|NCT02123823|580815497|FG000|Overall Study|Adverse Event|0|||
160843459|NCT02123823|580815498|FG001|Overall Study|Adverse Event|0|||
160843460|NCT02123823|580815499|FG002|Overall Study|Adverse Event|3|||
160843461|NCT02123823|580815500|FG003|Overall Study|Adverse Event|5|||
160843462|NCT01635855|580815535|FG000|Overall Study|Withdrawal by Subject|4|||
160843463|NCT01844778|580815538|FG000|Overall Study|Protocol deviation|0|||
160843464|NCT01844778|580815539|FG001|Overall Study|Protocol deviation|1|||
160843465|NCT01844778|580815540|FG002|Overall Study|Protocol deviation|2|||
160843466|NCT01844778|580815538|FG000|Overall Study|Withdrawal by Subject|2|||
160843467|NCT01844778|580815539|FG001|Overall Study|Withdrawal by Subject|0|||
160843468|NCT01844778|580815540|FG002|Overall Study|Withdrawal by Subject|0|||
160843469|NCT01844778|580815538|FG000|Overall Study|Adverse Event|0|||
160843470|NCT01844778|580815539|FG001|Overall Study|Adverse Event|2|||
160843471|NCT01844778|580815540|FG002|Overall Study|Adverse Event|2|||
160843472|NCT00095173|580815541|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
160843473|NCT00095173|580815542|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
160843474|NCT00095173|580815543|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
160843475|NCT00095173|580815544|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
160843476|NCT00095173|580815545|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
160843477|NCT00095173|580815546|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
160843478|NCT00095173|580815541|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
160843479|NCT00095173|580815542|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
160843480|NCT00095173|580815543|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
160843481|NCT00095173|580815544|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
160843482|NCT00095173|580815545|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
160843483|NCT00095173|580815546|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
160843484|NCT00095173|580815541|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
160843485|NCT00095173|580815542|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
160843486|NCT00095173|580815543|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
160843487|NCT00095173|580815544|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
160843488|NCT00095173|580815545|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
160843489|NCT00095173|580815546|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
160843490|NCT00095173|580815541|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
160843491|NCT00095173|580815542|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
160843492|NCT00095173|580815543|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
160843493|NCT00095173|580815544|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
160843494|NCT00095173|580815545|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
160843495|NCT00095173|580815546|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
160843496|NCT00095173|580815541|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
160843497|NCT00095173|580815542|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
160843498|NCT00095173|580815543|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
160843499|NCT00095173|580815544|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
160843500|NCT00095173|580815545|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
160843501|NCT00095173|580815546|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
160843502|NCT00095173|580815541|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
160843503|NCT00095173|580815542|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
160843504|NCT00095173|580815543|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
160843505|NCT00095173|580815544|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
160843506|NCT00095173|580815545|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
160843507|NCT00095173|580815546|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
160843508|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Death|0|||
160843509|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Death|0|||
160843510|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Death|0|||
160843511|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Death|0|||
160843512|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Death|0|||
160843513|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Death|1|||
160843514|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
160843515|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
160843516|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
160843517|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
160843518|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
160843519|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
160843520|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
160843521|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
160843522|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
160843523|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
160843524|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
160843525|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
160843526|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
160843527|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
160843528|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
160843529|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
160565244|NCT01217606|579790296|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
160565245|NCT01217606|579790295|FG000|Initial Treatment Phase|Adverse Event|10|||
160565246|NCT01217606|579790296|FG001|Initial Treatment Phase|Adverse Event|6|||
160565247|NCT01217606|579790295|FG000|9-Month Masked Extension|Adverse Event|3|||
160565248|NCT01217606|579790296|FG001|9-Month Masked Extension|Adverse Event|6|||
160565249|NCT01217606|579790295|FG000|9-Month Masked Extension|Other Reasons|4|||
160565250|NCT01217606|579790296|FG001|9-Month Masked Extension|Other Reasons|4|||
160565251|NCT01217606|579790295|FG000|9-Month Masked Extension|Personal Reasons|2|||
160565252|NCT01217606|579790296|FG001|9-Month Masked Extension|Personal Reasons|1|||
160565253|NCT01217606|579790295|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
160565254|NCT01217606|579790296|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
160565255|NCT01217606|579790295|FG000|9-Month Masked Extension|Pregnancy|1|||
160565256|NCT01217606|579790296|FG001|9-Month Masked Extension|Pregnancy|0|||
160565257|NCT01217606|579790295|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
160565258|NCT01217606|579790296|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
160565259|NCT02432807|579790300|FG000|Overall Study|Adverse Event|0|||
160565260|NCT02432807|579790301|FG001|Overall Study|Adverse Event|2|||
160565261|NCT02432807|579790300|FG000|Overall Study|Lost to Follow-up|1|||
160565262|NCT02432807|579790301|FG001|Overall Study|Lost to Follow-up|0|||
160565263|NCT02432807|579790300|FG000|Overall Study|Withdrawal by Subject|1|||
160565264|NCT02432807|579790301|FG001|Overall Study|Withdrawal by Subject|1|||
160565265|NCT02432807|579790300|FG000|Overall Study|Other|1|||
160565266|NCT02432807|579790301|FG001|Overall Study|Other|1|||
160565267|NCT02966314|579790305|FG000|Overall Study|Lost to Follow-up|1|||
160565268|NCT02966314|579790306|FG001|Overall Study|Lost to Follow-up|0|||
160565269|NCT02725788|579790309|FG000|Overall Study|Lost to Follow-up|1|||
160565270|NCT02725788|579790310|FG001|Overall Study|Lost to Follow-up|1|||
160565271|NCT02725788|579790309|FG000|Overall Study|Protocol Violation|0|||
160565272|NCT02725788|579790310|FG001|Overall Study|Protocol Violation|1|||
160565273|NCT00828464|579790311|FG000|Overall Study|Withdrawal by Subject|1|||
160565274|NCT00474240|579790312|FG000|Overall Study|Withdrawal by Subject|1|||
160565275|NCT00474240|579790313|FG001|Overall Study|Withdrawal by Subject|1|||
160565276|NCT00474240|579790314|FG002|Overall Study|Withdrawal by Subject|0|||
160565277|NCT00474240|579790315|FG003|Overall Study|Withdrawal by Subject|2|||
160565278|NCT00474240|579790316|FG004|Overall Study|Withdrawal by Subject|3|||
160565279|NCT00474240|579790317|FG005|Overall Study|Withdrawal by Subject|1|||
160565280|NCT00474240|579790312|FG000|Overall Study|Adverse Event|0|||
160565281|NCT00474240|579790313|FG001|Overall Study|Adverse Event|0|||
160565282|NCT00474240|579790314|FG002|Overall Study|Adverse Event|9|||
160565283|NCT00474240|579790315|FG003|Overall Study|Adverse Event|14|||
160565284|NCT00474240|579790316|FG004|Overall Study|Adverse Event|5|||
160565285|NCT00474240|579790317|FG005|Overall Study|Adverse Event|16|||
160565286|NCT00474240|579790312|FG000|Overall Study|Removed due to lab value|0|||
160565287|NCT00474240|579790313|FG001|Overall Study|Removed due to lab value|0|||
160565288|NCT00474240|579790314|FG002|Overall Study|Removed due to lab value|0|||
160565289|NCT00474240|579790315|FG003|Overall Study|Removed due to lab value|0|||
160565290|NCT00474240|579790316|FG004|Overall Study|Removed due to lab value|0|||
160565291|NCT00474240|579790317|FG005|Overall Study|Removed due to lab value|1|||
160565292|NCT03093155|579790319|FG000|Overall Study|Not Eligible|1|||
160565293|NCT03093155|579790320|FG001|Overall Study|Not Eligible|0|||
160565294|NCT03093155|579790319|FG000|Overall Study|Withdrawal by Subject|0|||
160843530|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
160843531|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
160843532|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
160843533|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
160843534|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
160843535|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
160843536|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
160843537|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
160843538|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
160843539|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
160565295|NCT03093155|579790320|FG001|Overall Study|Withdrawal by Subject|1|||
160565296|NCT01700829|579790321|FG000|Overall Study|Withdrawal by Subject|1|||
160565297|NCT01700829|579790322|FG001|Overall Study|Withdrawal by Subject|1|||
160565298|NCT01075178|579790323|FG000|Subject Matching|eligible but not matched|130|||
160843540|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
160565299|NCT01075178|579790324|FG001|Subject Matching|eligible but not matched|403|||
160565300|NCT01075178|579790323|FG000|Subject Chart Review|died before chart review period|0|||
160565301|NCT01075178|579790324|FG001|Subject Chart Review|died before chart review period|2|||
160843541|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
160565302|NCT01075178|579790323|FG000|Subject Chart Review|no data collected due to site closure|3|||
160565303|NCT01075178|579790324|FG001|Subject Chart Review|no data collected due to site closure|4|||
160565304|NCT01075178|579790323|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
160565305|NCT01075178|579790324|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
160565306|NCT01241786|579790325|FG000|Overall Study|Lack of Efficacy|5|||
160565307|NCT03182738|579790336|FG000|Overall Study|Lost to Follow-up|9|||
160565308|NCT03182738|579790337|FG001|Overall Study|Lost to Follow-up|3|||
160565309|NCT03182738|579790336|FG000|Overall Study|Pregnancy|0|||
160565310|NCT03182738|579790337|FG001|Overall Study|Pregnancy|1|||
160565311|NCT03182738|579790336|FG000|Overall Study|Withdrawal by Subject|0|||
160565312|NCT03182738|579790337|FG001|Overall Study|Withdrawal by Subject|1|||
160565313|NCT00446030|579790338|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
160565314|NCT00446030|579790339|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
160565315|NCT00446030|579790338|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
160565316|NCT00446030|579790339|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
160565317|NCT00446030|579790338|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
160565318|NCT00446030|579790339|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
160565319|NCT00446030|579790338|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
160565320|NCT00446030|579790339|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
160565321|NCT00446030|579790338|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
160565322|NCT00446030|579790339|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
160565323|NCT00446030|579790338|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
160843542|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
160843543|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
160843544|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
160843545|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
160843546|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
160843547|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
160843548|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
160843549|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
160843550|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
160843551|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
160843552|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
160843553|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
160843554|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
160843555|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
160843556|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Other|0|||
160843557|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Other|0|||
160843558|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Other|0|||
160843559|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Other|4|||
160843560|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Other|6|||
160843561|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Other|8|||
160843562|NCT02161757|580815553|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
160843563|NCT02161757|580815554|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
160843564|NCT02161757|580815555|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
160843565|NCT02161757|580815553|FG000|Treatment Through Study Completion|Adverse Event|1|||
160843566|NCT02161757|580815554|FG001|Treatment Through Study Completion|Adverse Event|1|||
160843567|NCT02161757|580815555|FG002|Treatment Through Study Completion|Adverse Event|0|||
160843568|NCT02161757|580815553|FG000|Treatment Through Study Completion|Protocol Violation|0|||
160843569|NCT02161757|580815554|FG001|Treatment Through Study Completion|Protocol Violation|1|||
160843570|NCT02161757|580815555|FG002|Treatment Through Study Completion|Protocol Violation|2|||
160843571|NCT02161757|580815553|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
160843572|NCT02161757|580815554|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
160843573|NCT02161757|580815555|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
160843574|NCT02161757|580815553|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
160843575|NCT02161757|580815554|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
160843576|NCT02161757|580815555|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
160843577|NCT02161757|580815553|FG000|Treatment Through Study Completion|Other|20|||
160843578|NCT02161757|580815554|FG001|Treatment Through Study Completion|Other|19|||
160843579|NCT02161757|580815555|FG002|Treatment Through Study Completion|Other|12|||
160905707|NCT02955602|581050288|FG001|Overall Study|Withdrawal of informed consent|3|||
160565324|NCT00446030|579790339|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
160565325|NCT00446030|579790338|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
160905708|NCT02955602|581050289|FG002|Overall Study|Withdrawal of informed consent|2|||
160565326|NCT00446030|579790339|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
160565327|NCT00446030|579790338|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
160843580|NCT02161757|580815553|FG000|Treatment Through Study Completion|Death|2|||
160843581|NCT02161757|580815554|FG001|Treatment Through Study Completion|Death|1|||
160565328|NCT00446030|579790339|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
160565329|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
160843582|NCT02161757|580815555|FG002|Treatment Through Study Completion|Death|1|||
160905709|NCT02955602|581050287|FG000|Overall Study|Lost to Follow-up|0|||
160843583|NCT00391625|580815556|FG000|Month 14|Withdrawal by Subject|1|||
160843584|NCT00391625|580815556|FG000|Month 50|Physician Decision|1|||
160843585|NCT02106403|580815563|FG000|Follow-Up Visit 3|Other Reason|0|||
160843586|NCT02106403|580815564|FG001|Follow-Up Visit 3|Other Reason|0|||
160843587|NCT02106403|580815565|FG002|Follow-Up Visit 3|Other Reason|0|||
160843588|NCT02106403|580815566|FG003|Follow-Up Visit 3|Other Reason|0|||
160843589|NCT02106403|580815567|FG004|Follow-Up Visit 3|Other Reason|0|||
160843590|NCT02106403|580815568|FG005|Follow-Up Visit 3|Other Reason|1|||
160843591|NCT01128946|580815581|FG000|Period I|Protocol Violation|0|||
160843592|NCT01128946|580815582|FG001|Period I|Protocol Violation|1|||
160843593|NCT01128946|580815583|FG002|Period I|Protocol Violation|0|||
160843594|NCT01128946|580815584|FG003|Period I|Protocol Violation|0|||
160843595|NCT01128946|580815581|FG000|Period I|Withdrawal by Subject|0|||
160843596|NCT01128946|580815582|FG001|Period I|Withdrawal by Subject|0|||
160843597|NCT01128946|580815583|FG002|Period I|Withdrawal by Subject|1|||
160843598|NCT01128946|580815584|FG003|Period I|Withdrawal by Subject|1|||
160843599|NCT01128946|580815581|FG000|Period II|Protocol Violation|0|||
160843600|NCT01128946|580815582|FG001|Period II|Protocol Violation|1|||
160843601|NCT01128946|580815583|FG002|Period II|Protocol Violation|0|||
160843602|NCT01128946|580815584|FG003|Period II|Protocol Violation|0|||
160843603|NCT01128946|580815581|FG000|Period II|Withdrawal by Subject|0|||
160843604|NCT01128946|580815582|FG001|Period II|Withdrawal by Subject|0|||
160843605|NCT01128946|580815583|FG002|Period II|Withdrawal by Subject|0|||
160843606|NCT01128946|580815584|FG003|Period II|Withdrawal by Subject|1|||
160843607|NCT01128946|580815581|FG000|Period III|Protocol Violation|1|||
160843608|NCT01128946|580815582|FG001|Period III|Protocol Violation|0|||
160843609|NCT01128946|580815583|FG002|Period III|Protocol Violation|0|||
160843610|NCT01128946|580815584|FG003|Period III|Protocol Violation|0|||
160843611|NCT00379912|580815585|FG000|Overall Study|Lack of Efficacy|1|||
160843612|NCT00379912|580815586|FG001|Overall Study|Lack of Efficacy|0|||
160843613|NCT04698993|580815587|FG000|Overall Study|PCR results not accessible|2|||
160843614|NCT04698993|580815588|FG001|Overall Study|PCR results not accessible|7|||
160843615|NCT04698993|580815587|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
160843616|NCT04698993|580815588|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
160843617|NCT00206440|580815589|FG000|Overall Study|Protocol Violation|1|||
160843618|NCT00206440|580815590|FG001|Overall Study|Protocol Violation|2|||
160843619|NCT00206440|580815589|FG000|Overall Study|Adverse Event|4|||
160843620|NCT00206440|580815590|FG001|Overall Study|Adverse Event|2|||
160843621|NCT01371734|580815591|FG000|Overall Study|Other|2|||
160843622|NCT01371734|580815592|FG001|Overall Study|Other|1|||
160843623|NCT01371734|580815593|FG002|Overall Study|Other|2|||
160843624|NCT01371734|580815591|FG000|Overall Study|Withdrawal by Subject|3|||
160843625|NCT01371734|580815592|FG001|Overall Study|Withdrawal by Subject|4|||
160843626|NCT01371734|580815593|FG002|Overall Study|Withdrawal by Subject|9|||
160565330|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
160843627|NCT01371734|580815591|FG000|Overall Study|Lost to Follow-up|5|||
160843628|NCT01371734|580815592|FG001|Overall Study|Lost to Follow-up|3|||
160843629|NCT01371734|580815593|FG002|Overall Study|Lost to Follow-up|1|||
160843630|NCT01371734|580815591|FG000|Overall Study|Protocol Violation|3|||
160843631|NCT01371734|580815592|FG001|Overall Study|Protocol Violation|1|||
160843632|NCT01371734|580815593|FG002|Overall Study|Protocol Violation|2|||
160843633|NCT01371734|580815591|FG000|Overall Study|Adverse Event|8|||
160843634|NCT01371734|580815592|FG001|Overall Study|Adverse Event|8|||
160843635|NCT01371734|580815593|FG002|Overall Study|Adverse Event|3|||
160843636|NCT01371734|580815591|FG000|Overall Study|Lack of Efficacy|2|||
160843637|NCT01371734|580815592|FG001|Overall Study|Lack of Efficacy|2|||
160565331|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
160843638|NCT01371734|580815593|FG002|Overall Study|Lack of Efficacy|0|||
160843639|NCT01140061|580815596|FG000|Part I|Adverse Event|1|||
160843640|NCT01140061|580815597|FG001|Part I|Adverse Event|0|||
160565332|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
160565333|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
160565334|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
160843641|NCT01140061|580815598|FG002|Part I|Adverse Event|0|||
160843642|NCT01140061|580815599|FG003|Part I|Adverse Event|0|||
160565335|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
160843643|NCT01140061|580815600|FG004|Part I|Adverse Event|0|||
160843644|NCT01140061|580815601|FG005|Part I|Adverse Event|0|||
160843645|NCT01140061|580815602|FG006|Part I|Adverse Event|0|||
160843646|NCT01140061|580815603|FG007|Part I|Adverse Event|0|||
160843647|NCT01140061|580815604|FG008|Part I|Adverse Event|0|||
160843648|NCT01140061|580815605|FG009|Part I|Adverse Event|0|||
160843649|NCT01140061|580815596|FG000|Extension|Laboratory Adverse Event|0|||
160843650|NCT01140061|580815597|FG001|Extension|Laboratory Adverse Event|0|||
160843651|NCT01140061|580815598|FG002|Extension|Laboratory Adverse Event|0|||
160843652|NCT01140061|580815599|FG003|Extension|Laboratory Adverse Event|0|||
160843653|NCT01140061|580815600|FG004|Extension|Laboratory Adverse Event|0|||
160843654|NCT01140061|580815601|FG005|Extension|Laboratory Adverse Event|0|||
160843655|NCT01140061|580815602|FG006|Extension|Laboratory Adverse Event|0|||
160905710|NCT02955602|581050288|FG001|Overall Study|Lost to Follow-up|0|||
160905711|NCT02955602|581050289|FG002|Overall Study|Lost to Follow-up|1|||
160905712|NCT02955602|581050287|FG000|Overall Study|Other|0|||
160905713|NCT02955602|581050288|FG001|Overall Study|Other|1|||
160905714|NCT02955602|581050289|FG002|Overall Study|Other|3|||
160905715|NCT03000439|581050292|FG000|Open Label Part 1|Adverse Event|6|||
160905716|NCT03000439|581050293|FG001|Open Label Part 1|Adverse Event|0|||
160905717|NCT03000439|581050294|FG002|Open Label Part 1|Adverse Event|0|||
160905718|NCT03000439|581050295|FG003|Open Label Part 1|Adverse Event|0|||
160905719|NCT03000439|581050292|FG000|Open Label Part 1|Other|2|||
160905720|NCT03000439|581050293|FG001|Open Label Part 1|Other|0|||
160905721|NCT03000439|581050294|FG002|Open Label Part 1|Other|0|||
160905722|NCT03000439|581050295|FG003|Open Label Part 1|Other|0|||
160905723|NCT03000439|581050292|FG000|Open Label Part 1|Insufficient clinical response|16|||
160905724|NCT03000439|581050293|FG001|Open Label Part 1|Insufficient clinical response|0|||
160905725|NCT03000439|581050294|FG002|Open Label Part 1|Insufficient clinical response|0|||
160905726|NCT03000439|581050295|FG003|Open Label Part 1|Insufficient clinical response|0|||
160905727|NCT03000439|581050292|FG000|Open Label Part 2|Other|0|||
160905728|NCT03000439|581050293|FG001|Open Label Part 2|Other|5|||
160905729|NCT03000439|581050294|FG002|Open Label Part 2|Other|0|||
160905730|NCT03000439|581050295|FG003|Open Label Part 2|Other|0|||
160905731|NCT03000439|581050292|FG000|Open Label Part 2|Insufficient clinical response|0|||
160905732|NCT03000439|581050293|FG001|Open Label Part 2|Insufficient clinical response|12|||
160905733|NCT03000439|581050294|FG002|Open Label Part 2|Insufficient clinical response|0|||
160905734|NCT03000439|581050295|FG003|Open Label Part 2|Insufficient clinical response|0|||
160905735|NCT03000439|581050292|FG000|Double Blind Phase|Adverse Event|0|||
160905736|NCT03000439|581050293|FG001|Double Blind Phase|Adverse Event|0|||
160905737|NCT03000439|581050294|FG002|Double Blind Phase|Adverse Event|2|||
160905738|NCT03000439|581050295|FG003|Double Blind Phase|Adverse Event|1|||
160905739|NCT03000439|581050292|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
160905740|NCT03000439|581050293|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
160905741|NCT03000439|581050294|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
160905742|NCT03000439|581050295|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
160905743|NCT03000439|581050292|FG000|Double Blind Phase|Other|0|||
160905744|NCT03000439|581050293|FG001|Double Blind Phase|Other|0|||
160905745|NCT03000439|581050294|FG002|Double Blind Phase|Other|10|||
160905746|NCT03000439|581050295|FG003|Double Blind Phase|Other|11|||
160905747|NCT03000439|581050292|FG000|Double Blind Phase|Insufficient clinical response|0|||
160905748|NCT03000439|581050293|FG001|Double Blind Phase|Insufficient clinical response|0|||
160905749|NCT03000439|581050294|FG002|Double Blind Phase|Insufficient clinical response|0|||
160905750|NCT03000439|581050295|FG003|Double Blind Phase|Insufficient clinical response|2|||
160905751|NCT02501473|581050296|FG000|Overall Study|Study Terminated|2|||
160905752|NCT02501473|581050297|FG001|Overall Study|Study Terminated|3|||
160905753|NCT02501473|581050298|FG002|Overall Study|Study Terminated|7|||
160905754|NCT02501473|581050299|FG003|Overall Study|Study Terminated|9|||
160905755|NCT02501473|581050300|FG004|Overall Study|Study Terminated|2|||
160905756|NCT02501473|581050301|FG005|Overall Study|Study Terminated|10|||
160905757|NCT02501473|581050302|FG006|Overall Study|Study Terminated|1|||
160905758|NCT02501473|581050303|FG007|Overall Study|Study Terminated|0|||
160905759|NCT02501473|581050296|FG000|Overall Study|Withdrawal by Subject|0|||
160905760|NCT02501473|581050297|FG001|Overall Study|Withdrawal by Subject|0|||
160905761|NCT02501473|581050298|FG002|Overall Study|Withdrawal by Subject|3|||
160905762|NCT02501473|581050299|FG003|Overall Study|Withdrawal by Subject|3|||
160905763|NCT02501473|581050300|FG004|Overall Study|Withdrawal by Subject|2|||
160905764|NCT02501473|581050301|FG005|Overall Study|Withdrawal by Subject|2|||
160905765|NCT02501473|581050302|FG006|Overall Study|Withdrawal by Subject|0|||
160905766|NCT02501473|581050303|FG007|Overall Study|Withdrawal by Subject|0|||
160905767|NCT02501473|581050296|FG000|Overall Study|Death|0|||
160905768|NCT02501473|581050297|FG001|Overall Study|Death|0|||
160905769|NCT02501473|581050298|FG002|Overall Study|Death|1|||
160905770|NCT02501473|581050299|FG003|Overall Study|Death|1|||
160905771|NCT02501473|581050300|FG004|Overall Study|Death|0|||
160905772|NCT02501473|581050301|FG005|Overall Study|Death|1|||
160905773|NCT02501473|581050302|FG006|Overall Study|Death|0|||
160905774|NCT02501473|581050303|FG007|Overall Study|Death|0|||
160905775|NCT02501473|581050296|FG000|Overall Study|Lost to Follow-up|1|||
160905776|NCT02501473|581050297|FG001|Overall Study|Lost to Follow-up|0|||
160905777|NCT02501473|581050298|FG002|Overall Study|Lost to Follow-up|1|||
160905778|NCT02501473|581050299|FG003|Overall Study|Lost to Follow-up|0|||
160905779|NCT02501473|581050300|FG004|Overall Study|Lost to Follow-up|0|||
160905780|NCT02501473|581050301|FG005|Overall Study|Lost to Follow-up|1|||
160905781|NCT02501473|581050302|FG006|Overall Study|Lost to Follow-up|0|||
160905782|NCT02501473|581050303|FG007|Overall Study|Lost to Follow-up|0|||
160647718|NCT05002569|580092810|FG001|Follow Up|Lost to Follow-up|3|||
160905783|NCT02501473|581050296|FG000|Overall Study|Reason not specified|0|||
160905784|NCT02501473|581050297|FG001|Overall Study|Reason not specified|0|||
160905785|NCT02501473|581050298|FG002|Overall Study|Reason not specified|1|||
160905786|NCT02501473|581050299|FG003|Overall Study|Reason not specified|1|||
160905787|NCT02501473|581050300|FG004|Overall Study|Reason not specified|0|||
160905788|NCT02501473|581050301|FG005|Overall Study|Reason not specified|0|||
160843656|NCT01140061|580815603|FG007|Extension|Laboratory Adverse Event|0|||
160843657|NCT01140061|580815604|FG008|Extension|Laboratory Adverse Event|0|||
160843658|NCT01140061|580815605|FG009|Extension|Laboratory Adverse Event|1|||
160565336|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
160565337|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
160565338|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
160565339|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
160565340|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
160565341|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
160565342|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
160565343|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
160565344|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
160843659|NCT00766051|580815607|FG000|Overall Study|Withdrawal by Subject|2|||
160843660|NCT00766051|580815608|FG001|Overall Study|Withdrawal by Subject|0|||
160843661|NCT02669121|580815609|FG000|Overall Study|Adverse Event|4|||
160843662|NCT02669121|580815610|FG001|Overall Study|Adverse Event|5|||
160843663|NCT02669121|580815609|FG000|Overall Study|Lost to Follow-up|15|||
160843664|NCT02669121|580815610|FG001|Overall Study|Lost to Follow-up|27|||
160843665|NCT02669121|580815609|FG000|Overall Study|Withdrawal by Subject|132|||
160843666|NCT02669121|580815610|FG001|Overall Study|Withdrawal by Subject|140|||
160843667|NCT02669121|580815609|FG000|Overall Study|Pregnancy|0|||
160843668|NCT02669121|580815610|FG001|Overall Study|Pregnancy|1|||
160843669|NCT02669121|580815609|FG000|Overall Study|Discharged from US Military Active Service|117|||
160843670|NCT02669121|580815610|FG001|Overall Study|Discharged from US Military Active Service|91|||
160843671|NCT02669121|580815609|FG000|Overall Study|Reason not Specified|22|||
160843672|NCT02669121|580815610|FG001|Overall Study|Reason not Specified|18|||
160843673|NCT02708355|580815611|FG000|Overall Study|Adverse Event|1|||
160843674|NCT02708355|580815612|FG001|Overall Study|Adverse Event|0|||
160843675|NCT02708355|580815613|FG002|Overall Study|Adverse Event|0|||
160843676|NCT04384523|580815614|FG000|Overall Study|Lost to Follow-up|0|||
160843677|NCT04384523|580815615|FG001|Overall Study|Lost to Follow-up|0|||
160843678|NCT04384523|580815616|FG002|Overall Study|Lost to Follow-up|0|||
160843679|NCT04384523|580815617|FG003|Overall Study|Lost to Follow-up|0|||
160843680|NCT04384523|580815618|FG004|Overall Study|Lost to Follow-up|0|||
160843681|NCT04384523|580815619|FG005|Overall Study|Lost to Follow-up|1|||
160843682|NCT04384523|580815614|FG000|Overall Study|Protocol Violation|0|||
160843683|NCT04384523|580815615|FG001|Overall Study|Protocol Violation|1|||
160843684|NCT04384523|580815616|FG002|Overall Study|Protocol Violation|0|||
160843685|NCT04384523|580815617|FG003|Overall Study|Protocol Violation|0|||
160843686|NCT04384523|580815618|FG004|Overall Study|Protocol Violation|0|||
160843687|NCT04384523|580815619|FG005|Overall Study|Protocol Violation|0|||
160843688|NCT04384523|580815614|FG000|Overall Study|Withdrawal by Subject|1|||
160843689|NCT04384523|580815615|FG001|Overall Study|Withdrawal by Subject|0|||
160843690|NCT04384523|580815616|FG002|Overall Study|Withdrawal by Subject|0|||
160843691|NCT04384523|580815617|FG003|Overall Study|Withdrawal by Subject|0|||
160843692|NCT04384523|580815618|FG004|Overall Study|Withdrawal by Subject|0|||
160843693|NCT04384523|580815619|FG005|Overall Study|Withdrawal by Subject|0|||
160843694|NCT03216746|580815620|FG000|Overall Study|Lost to Follow-up|6|||
160843695|NCT03216746|580815621|FG001|Overall Study|Lost to Follow-up|8|||
160843696|NCT03216746|580815622|FG002|Overall Study|Lost to Follow-up|5|||
160843697|NCT03216746|580815623|FG003|Overall Study|Lost to Follow-up|6|||
160843698|NCT00635882|580815624|FG000|Overall Study|Protocol Violation|1|||
160843699|NCT00635882|580815625|FG001|Overall Study|Protocol Violation|0|||
160843700|NCT00635882|580815626|FG002|Overall Study|Protocol Violation|0|||
160843701|NCT00635882|580815627|FG003|Overall Study|Protocol Violation|0|||
160843702|NCT00635882|580815628|FG004|Overall Study|Protocol Violation|0|||
160905789|NCT02501473|581050302|FG006|Overall Study|Reason not specified|0|||
160843703|NCT00635882|580815629|FG005|Overall Study|Protocol Violation|0|||
160843704|NCT01320202|580815630|FG000|Overall Study|Adverse Event|5|||
160843705|NCT01320202|580815631|FG001|Overall Study|Adverse Event|5|||
160843706|NCT01320202|580815630|FG000|Overall Study|Death|5|||
160843707|NCT01320202|580815631|FG001|Overall Study|Death|3|||
160843708|NCT01320202|580815630|FG000|Overall Study|Lost to Follow-up|1|||
160843709|NCT01320202|580815631|FG001|Overall Study|Lost to Follow-up|0|||
160843710|NCT01320202|580815630|FG000|Overall Study|Physician Decision|3|||
160843711|NCT01320202|580815631|FG001|Overall Study|Physician Decision|1|||
160843712|NCT01320202|580815630|FG000|Overall Study|Protocol Violation|2|||
160843713|NCT01320202|580815631|FG001|Overall Study|Protocol Violation|1|||
160843714|NCT01320202|580815630|FG000|Overall Study|Withdrawal by Subject|10|||
160843715|NCT01320202|580815631|FG001|Overall Study|Withdrawal by Subject|3|||
160843716|NCT01320202|580815630|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
160843717|NCT01320202|580815631|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
160843718|NCT01320202|580815630|FG000|Overall Study|kidney transplant|1|||
160843719|NCT01320202|580815631|FG001|Overall Study|kidney transplant|2|||
160843720|NCT01320202|580815630|FG000|Overall Study|blood transfusion|1|||
160905790|NCT02501473|581050303|FG007|Overall Study|Reason not specified|0|||
160843721|NCT01320202|580815631|FG001|Overall Study|blood transfusion|7|||
160843722|NCT01320202|580815630|FG000|Overall Study|moved/changed dialysis|5|||
160843723|NCT01320202|580815631|FG001|Overall Study|moved/changed dialysis|2|||
160843724|NCT01320202|580815630|FG000|Overall Study|sponsor request|2|||
160843725|NCT01320202|580815631|FG001|Overall Study|sponsor request|0|||
160843726|NCT01320202|580815630|FG000|Overall Study|ineligible|3|||
160843727|NCT01320202|580815631|FG001|Overall Study|ineligible|0|||
160843728|NCT01320202|580815630|FG000|Overall Study|regained renal function|1|||
160843729|NCT01320202|580815631|FG001|Overall Study|regained renal function|0|||
160843730|NCT02006979|580815633|FG000|Overall Study|Withdrawal by Subject|1|||
160843731|NCT02006979|580815634|FG001|Overall Study|Withdrawal by Subject|1|||
160843732|NCT02006979|580815633|FG000|Overall Study|Protocol Violation|0|||
160843733|NCT02006979|580815634|FG001|Overall Study|Protocol Violation|1|||
160843734|NCT03848949|580815640|FG000|Overall Study|Lost to Follow-up|5|||
160843735|NCT03848949|580815641|FG001|Overall Study|Lost to Follow-up|7|||
160843736|NCT02697435|580815642|FG000|Overall Study|Withdrawal by Subject|1|||
160843737|NCT02697435|580815643|FG001|Overall Study|Withdrawal by Subject|0|||
160843738|NCT02697435|580815642|FG000|Overall Study|Physician Decision|0|||
160843739|NCT02697435|580815643|FG001|Overall Study|Physician Decision|4|||
160843740|NCT04230213|580815648|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
160843741|NCT04230213|580815649|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
160843742|NCT04230213|580815650|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
160843743|NCT04230213|580815648|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
160843744|NCT04230213|580815649|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
160843745|NCT04230213|580815650|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
160843746|NCT04230213|580815648|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
160843747|NCT04230213|580815649|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
160843748|NCT04230213|580815650|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
160843749|NCT04230213|580815648|FG000|TP2: Week 10 to Week 16|Other|0|||
160843750|NCT04230213|580815649|FG001|TP2: Week 10 to Week 16|Other|2|||
160843751|NCT04230213|580815650|FG002|TP2: Week 10 to Week 16|Other|1|||
160843752|NCT04230213|580815648|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
160843753|NCT04230213|580815649|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
160843754|NCT04230213|580815650|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
160843755|NCT04230213|580815648|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
160843756|NCT04230213|580815649|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
160843757|NCT04230213|580815650|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
160843758|NCT04230213|580815648|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
160843759|NCT04230213|580815649|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
160843760|NCT04230213|580815650|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
160843761|NCT04230213|580815648|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
160843762|NCT04230213|580815649|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
160843763|NCT04230213|580815650|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
160843764|NCT04230213|580815648|FG000|TP3: Week 16 to Week 22|Other|0|||
160843765|NCT04230213|580815649|FG001|TP3: Week 16 to Week 22|Other|1|||
160843766|NCT04230213|580815650|FG002|TP3: Week 16 to Week 22|Other|3|||
160843767|NCT04230213|580815648|FG000|TP4: Week 22 to Week 32|Other|0|||
160843768|NCT04230213|580815649|FG001|TP4: Week 22 to Week 32|Other|5|||
160843769|NCT04230213|580815650|FG002|TP4: Week 22 to Week 32|Other|5|||
160843770|NCT04230213|580815648|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
160992176|NCT01080131|581359993|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
160992177|NCT01080131|581359994|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
160992178|NCT01080131|581359993|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
160992179|NCT01080131|581359994|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
160992180|NCT01080131|581359993|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
160992181|NCT01080131|581359994|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
160992182|NCT01080131|581359993|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
160992183|NCT01080131|581359994|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
160843771|NCT04230213|580815649|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
160843772|NCT04230213|580815650|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
160843773|NCT04230213|580815648|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
160843774|NCT04230213|580815649|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
160843775|NCT04230213|580815650|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
160565345|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
160843776|NCT04230213|580815648|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
160843777|NCT04230213|580815649|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
160843778|NCT04230213|580815650|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
160843779|NCT04230213|580815648|FG000|Follow up: Week 32 to Week 36|Other|0|||
160843780|NCT04230213|580815649|FG001|Follow up: Week 32 to Week 36|Other|1|||
160843781|NCT04230213|580815650|FG002|Follow up: Week 32 to Week 36|Other|1|||
160843782|NCT00619307|580815660|FG000|Overall Study|Adverse Event|0|||
160843783|NCT00619307|580815661|FG001|Overall Study|Adverse Event|1|||
160843784|NCT00619307|580815660|FG000|Overall Study|Lost to Follow-up|0|||
160843785|NCT00619307|580815661|FG001|Overall Study|Lost to Follow-up|1|||
160843786|NCT00619307|580815660|FG000|Overall Study|Protocol Violation|3|||
160843787|NCT00619307|580815661|FG001|Overall Study|Protocol Violation|0|||
160843788|NCT00619307|580815660|FG000|Overall Study|Withdrew consent|1|||
160843789|NCT00619307|580815661|FG001|Overall Study|Withdrew consent|0|||
160843790|NCT00619307|580815660|FG000|Overall Study|Severe migraine|0|||
160843791|NCT00619307|580815661|FG001|Overall Study|Severe migraine|1|||
160843792|NCT00619307|580815660|FG000|Overall Study|MS attack plus steroids|0|||
160843793|NCT00619307|580815661|FG001|Overall Study|MS attack plus steroids|1|||
160843794|NCT00118430|580815670|FG000|Overall Study|Withdrawal by Subject|6|||
160843795|NCT00118430|580815671|FG001|Overall Study|Withdrawal by Subject|2|||
160843796|NCT00118430|580815672|FG002|Overall Study|Withdrawal by Subject|0|||
160843797|NCT00118430|580815670|FG000|Overall Study|Lost to Follow-up|15|||
160843798|NCT00118430|580815671|FG001|Overall Study|Lost to Follow-up|22|||
160843799|NCT00118430|580815672|FG002|Overall Study|Lost to Follow-up|28|||
160843800|NCT02147288|580815673|FG000|Overall Study|post-operative hematoma|1|||
160843801|NCT02147288|580815674|FG001|Overall Study|post-operative hematoma|1|||
160843802|NCT02147288|580815675|FG002|Overall Study|post-operative hematoma|0|||
160843803|NCT02147288|580815676|FG003|Overall Study|post-operative hematoma|0|||
160843804|NCT02147288|580815677|FG004|Overall Study|post-operative hematoma|0|||
160843805|NCT02147288|580815678|FG005|Overall Study|post-operative hematoma|0|||
160843806|NCT02147288|580815679|FG006|Overall Study|post-operative hematoma|0|||
160843807|NCT02147288|580815680|FG007|Overall Study|post-operative hematoma|0|||
160843808|NCT02147288|580815681|FG008|Overall Study|post-operative hematoma|0|||
160843809|NCT02147288|580815682|FG009|Overall Study|post-operative hematoma|0|||
160843810|NCT02147288|580815673|FG000|Overall Study|complications from concurrent hernia rep|0|||
160843811|NCT02147288|580815674|FG001|Overall Study|complications from concurrent hernia rep|1|||
160843812|NCT02147288|580815675|FG002|Overall Study|complications from concurrent hernia rep|0|||
160843813|NCT02147288|580815676|FG003|Overall Study|complications from concurrent hernia rep|0|||
160843814|NCT02147288|580815677|FG004|Overall Study|complications from concurrent hernia rep|0|||
160843815|NCT02147288|580815678|FG005|Overall Study|complications from concurrent hernia rep|0|||
160843816|NCT02147288|580815679|FG006|Overall Study|complications from concurrent hernia rep|0|||
160843817|NCT02147288|580815680|FG007|Overall Study|complications from concurrent hernia rep|0|||
160843818|NCT02147288|580815681|FG008|Overall Study|complications from concurrent hernia rep|0|||
160843819|NCT02147288|580815682|FG009|Overall Study|complications from concurrent hernia rep|0|||
160843820|NCT00861471|580815683|FG000|Overall Study|Withdrawal by Subject|1|||
160843821|NCT00861471|580815683|FG000|Overall Study|Adverse Event|2|||
160843822|NCT00861471|580815683|FG000|Overall Study|Lack of Efficacy|3|||
160843823|NCT00861471|580815683|FG000|Overall Study|treatment for lumbar laminectomy|1|||
160843824|NCT00861471|580815683|FG000|Overall Study|Physician Decision|2|||
160843825|NCT02069392|580815684|FG000|Overall Study|Withdrawal by Subject|4|||
160843826|NCT02069392|580815685|FG001|Overall Study|Withdrawal by Subject|2|||
160843827|NCT01574651|580815686|FG000|Overall Study|Lost to Follow-up|2|||
160843828|NCT01574651|580815687|FG001|Overall Study|Lost to Follow-up|4|||
160843829|NCT01574651|580815686|FG000|Overall Study|Administrative problems|0|||
160647719|NCT05002569|580092809|FG000|Follow Up|Withdrew consent|17|||
160647720|NCT05002569|580092810|FG001|Follow Up|Withdrew consent|16|||
160647721|NCT05002569|580092809|FG000|Follow Up|Other Reasons|444|||
160843830|NCT01574651|580815687|FG001|Overall Study|Administrative problems|1|||
160843831|NCT01574651|580815686|FG000|Overall Study|Death|3|||
160843832|NCT01574651|580815687|FG001|Overall Study|Death|3|||
160843833|NCT01574651|580815686|FG000|Overall Study|Patient's inability to use the device|0|||
160843834|NCT01574651|580815687|FG001|Overall Study|Patient's inability to use the device|1|||
160843835|NCT01574651|580815686|FG000|Overall Study|Adverse Event|36|||
160843836|NCT01574651|580815687|FG001|Overall Study|Adverse Event|27|||
160843837|NCT01574651|580815686|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160843838|NCT01574651|580815687|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160843839|NCT01574651|580815686|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160843840|NCT01574651|580815687|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160843841|NCT01574651|580815686|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
160843842|NCT01574651|580815687|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160843843|NCT01574651|580815686|FG000|Overall Study|Protocol Violation|3|||
160843844|NCT01574651|580815687|FG001|Overall Study|Protocol Violation|5|||
160843845|NCT01574651|580815686|FG000|Overall Study|Withdrawal by Subject|9|||
160843846|NCT01574651|580815687|FG001|Overall Study|Withdrawal by Subject|10|||
160843847|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Adverse Event|33|||
160843848|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
160843849|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
160843850|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
160843851|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Physician Decision|6|||
160843852|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
160843853|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
160843854|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
160843855|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
160843856|NCT00965419|580815688|FG000|Follow-up Phase|Adverse Event|9|||
160843857|NCT00965419|580815688|FG000|Follow-up Phase|Protocol Violation|4|||
160843858|NCT00965419|580815688|FG000|Follow-up Phase|Withdrawal by Subject|8|||
160843859|NCT00965419|580815688|FG000|Follow-up Phase|Physician Decision|4|||
160843860|NCT00965419|580815688|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
160843861|NCT00965419|580815688|FG000|Follow-up Phase|Lack of Efficacy|28|||
160843862|NCT04412707|580815689|FG000|Cycle 1|Death|0|||
160843863|NCT04412707|580815690|FG001|Cycle 1|Death|3|||
160843864|NCT04412707|580815689|FG000|Cycle 1|Disease progression|1|||
160843865|NCT04412707|580815690|FG001|Cycle 1|Disease progression|2|||
160843866|NCT04412707|580815689|FG000|Cycle 2|Death|0|||
160843867|NCT04412707|580815690|FG001|Cycle 2|Death|1|||
160843868|NCT04412707|580815689|FG000|Cycle 2|Disease progression|3|||
160843869|NCT04412707|580815690|FG001|Cycle 2|Disease progression|0|||
160843870|NCT04412707|580815689|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
160843871|NCT04412707|580815690|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
160843872|NCT04412707|580815689|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
160843873|NCT04412707|580815690|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
160843874|NCT04412707|580815689|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
160843875|NCT04412707|580815690|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
160843876|NCT04412707|580815689|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
160843877|NCT04412707|580815690|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
160843878|NCT00264537|580815691|FG000|Overall Study|Death|0|||
160843879|NCT00264537|580815692|FG001|Overall Study|Death|3|||
160843880|NCT00264537|580815693|FG002|Overall Study|Death|3|||
160843881|NCT00264537|580815694|FG003|Overall Study|Death|2|||
160843882|NCT00264537|580815691|FG000|Overall Study|Lost to Follow-up|3|||
160843883|NCT00264537|580815692|FG001|Overall Study|Lost to Follow-up|4|||
160843884|NCT00264537|580815693|FG002|Overall Study|Lost to Follow-up|7|||
160843885|NCT00264537|580815694|FG003|Overall Study|Lost to Follow-up|6|||
160843886|NCT00264537|580815691|FG000|Overall Study|Adverse Event|21|||
160843887|NCT00264537|580815692|FG001|Overall Study|Adverse Event|32|||
160843888|NCT00264537|580815693|FG002|Overall Study|Adverse Event|24|||
160843889|NCT00264537|580815694|FG003|Overall Study|Adverse Event|34|||
160843890|NCT00264537|580815691|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
160843891|NCT00264537|580815692|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
160843892|NCT00264537|580815693|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
160843893|NCT00264537|580815694|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
160843894|NCT00264537|580815691|FG000|Overall Study|Other|21|||
160843895|NCT00264537|580815692|FG001|Overall Study|Other|11|||
160843896|NCT00264537|580815693|FG002|Overall Study|Other|10|||
160843897|NCT00264537|580815694|FG003|Overall Study|Other|11|||
160843898|NCT00264537|580815691|FG000|Overall Study|Not treated|0|||
160843899|NCT00264537|580815692|FG001|Overall Study|Not treated|2|||
160843900|NCT00264537|580815693|FG002|Overall Study|Not treated|1|||
160843901|NCT00264537|580815694|FG003|Overall Study|Not treated|0|||
160843902|NCT00615017|580817877|FG000|Overall Study|Adverse Event|0|||
160843903|NCT00615017|580817878|FG001|Overall Study|Adverse Event|1|||
160843904|NCT00615017|580817879|FG002|Overall Study|Adverse Event|2|||
160843905|NCT00615017|580817880|FG003|Overall Study|Adverse Event|0|||
160843906|NCT00615017|580817881|FG004|Overall Study|Adverse Event|0|||
160843907|NCT00615017|580817882|FG005|Overall Study|Adverse Event|1|||
160843908|NCT00615017|580817877|FG000|Overall Study|Death|0|||
160843909|NCT00615017|580817878|FG001|Overall Study|Death|0|||
160843910|NCT00615017|580817879|FG002|Overall Study|Death|2|||
160843911|NCT00615017|580817880|FG003|Overall Study|Death|0|||
160843912|NCT00615017|580817881|FG004|Overall Study|Death|1|||
160843913|NCT00615017|580817882|FG005|Overall Study|Death|1|||
160905791|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
160843914|NCT00615017|580817877|FG000|Overall Study|Sepsis resolved|0|||
160843915|NCT00615017|580817878|FG001|Overall Study|Sepsis resolved|0|||
160843916|NCT00615017|580817879|FG002|Overall Study|Sepsis resolved|1|||
160843917|NCT00615017|580817880|FG003|Overall Study|Sepsis resolved|0|||
160843918|NCT00615017|580817881|FG004|Overall Study|Sepsis resolved|0|||
160843919|NCT00615017|580817882|FG005|Overall Study|Sepsis resolved|0|||
160905792|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
160843920|NCT00615017|580817877|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
160843921|NCT00615017|580817878|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
160843922|NCT00615017|580817879|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
160843923|NCT00615017|580817880|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
160843924|NCT00615017|580817881|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
160843925|NCT00615017|580817882|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
160843926|NCT00615017|580817877|FG000|Overall Study|Physician discontinued drug|0|||
160843927|NCT00615017|580817878|FG001|Overall Study|Physician discontinued drug|0|||
160843928|NCT00615017|580817879|FG002|Overall Study|Physician discontinued drug|0|||
160843929|NCT00615017|580817880|FG003|Overall Study|Physician discontinued drug|0|||
160843930|NCT00615017|580817881|FG004|Overall Study|Physician discontinued drug|0|||
160843931|NCT00615017|580817882|FG005|Overall Study|Physician discontinued drug|1|||
160843932|NCT00855959|580817883|FG000|Overall Study|Adverse Event|2|||
160843933|NCT00855959|580817883|FG000|Overall Study|Lost to Follow-up|2|||
160843934|NCT00855959|580817883|FG000|Overall Study|Withdrawal by Subject|3|||
160843935|NCT00855959|580817883|FG000|Overall Study|Pregnancy|1|||
160843936|NCT00855959|580817883|FG000|Overall Study|Incorrect enrolment|1|||
160843937|NCT04014062|580817884|FG000|Period I: Dosing|Medical Grounds|4|||
160843938|NCT04014062|580817885|FG001|Period I: Dosing|Medical Grounds|5|||
160843939|NCT04014062|580817884|FG000|Period I: Dosing|Withdrawal by Subject|3|||
160843940|NCT04014062|580817885|FG001|Period I: Dosing|Withdrawal by Subject|1|||
160843941|NCT04306510|580817886|FG000|Overall Study|Voluntarily withdrawal|1|||
160843942|NCT04306510|580817886|FG000|Overall Study|Enrolled but Not Treated|1|||
160843943|NCT03329092|580817887|FG000|Overall Study|Other|2|||
160843944|NCT03329092|580817888|FG001|Overall Study|Other|2|||
160843945|NCT03329092|580817887|FG000|Overall Study|Withdrawal by Subject|16|||
160843946|NCT03329092|580817888|FG001|Overall Study|Withdrawal by Subject|3|||
160843947|NCT03329092|580817887|FG000|Overall Study|Physician Decision|1|||
160843948|NCT03329092|580817888|FG001|Overall Study|Physician Decision|0|||
160843949|NCT03329092|580817887|FG000|Overall Study|Death|17|||
160843950|NCT03329092|580817888|FG001|Overall Study|Death|11|||
160843951|NCT03329092|580817887|FG000|Overall Study|Adverse Event|3|||
160843952|NCT03329092|580817888|FG001|Overall Study|Adverse Event|1|||
160843953|NCT03329092|580817887|FG000|Overall Study|Lost to Follow-up|1|||
160843954|NCT03329092|580817888|FG001|Overall Study|Lost to Follow-up|1|||
160843955|NCT04878211|580817889|FG000|Overall Study|Lost to Follow-up|0|||
160843956|NCT04878211|580817890|FG001|Overall Study|Lost to Follow-up|0|||
160843957|NCT04878211|580817891|FG002|Overall Study|Lost to Follow-up|0|||
160843958|NCT04878211|580817892|FG003|Overall Study|Lost to Follow-up|1|||
160843959|NCT04878211|580817893|FG004|Overall Study|Lost to Follow-up|0|||
160843960|NCT04878211|580817894|FG005|Overall Study|Lost to Follow-up|1|||
160843961|NCT04878211|580817889|FG000|Overall Study|Protocol deviation|1|||
160843962|NCT04878211|580817890|FG001|Overall Study|Protocol deviation|0|||
160843963|NCT04878211|580817891|FG002|Overall Study|Protocol deviation|0|||
160843964|NCT04878211|580817892|FG003|Overall Study|Protocol deviation|0|||
160843965|NCT04878211|580817893|FG004|Overall Study|Protocol deviation|0|||
160843966|NCT04878211|580817894|FG005|Overall Study|Protocol deviation|0|||
160843967|NCT04878211|580817889|FG000|Overall Study|Study terminated by sponsor|0|||
160843968|NCT04878211|580817890|FG001|Overall Study|Study terminated by sponsor|0|||
160843969|NCT04878211|580817891|FG002|Overall Study|Study terminated by sponsor|0|||
160843970|NCT04878211|580817892|FG003|Overall Study|Study terminated by sponsor|0|||
160843971|NCT04878211|580817893|FG004|Overall Study|Study terminated by sponsor|9|||
160843972|NCT04878211|580817894|FG005|Overall Study|Study terminated by sponsor|4|||
160843973|NCT04878211|580817889|FG000|Overall Study|Subject decision|0|||
160843974|NCT04878211|580817890|FG001|Overall Study|Subject decision|0|||
160843975|NCT04878211|580817891|FG002|Overall Study|Subject decision|0|||
160843976|NCT04878211|580817892|FG003|Overall Study|Subject decision|0|||
160843977|NCT04878211|580817893|FG004|Overall Study|Subject decision|1|||
160843978|NCT04878211|580817894|FG005|Overall Study|Subject decision|0|||
160843979|NCT00856544|580817901|FG000|Overall Study|Randomized but not treated|3|||
160843980|NCT00856544|580817902|FG001|Overall Study|Randomized but not treated|0|||
160843981|NCT00856544|580817903|FG002|Overall Study|Randomized but not treated|0|||
160843982|NCT00856544|580817904|FG003|Overall Study|Randomized but not treated|0|||
160843983|NCT00856544|580817901|FG000|Overall Study|Death|0|||
160843984|NCT00856544|580817902|FG001|Overall Study|Death|2|||
160843985|NCT00856544|580817903|FG002|Overall Study|Death|0|||
160843986|NCT00856544|580817904|FG003|Overall Study|Death|0|||
160843987|NCT00856544|580817901|FG000|Overall Study|Adverse Event|20|||
160843988|NCT00856544|580817902|FG001|Overall Study|Adverse Event|29|||
160843989|NCT00856544|580817903|FG002|Overall Study|Adverse Event|2|||
160843990|NCT00856544|580817904|FG003|Overall Study|Adverse Event|3|||
160843991|NCT00856544|580817901|FG000|Overall Study|Lack of Efficacy|16|||
160992184|NCT01080131|581359993|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
160992185|NCT01080131|581359994|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
160843992|NCT00856544|580817902|FG001|Overall Study|Lack of Efficacy|12|||
160843993|NCT00856544|580817903|FG002|Overall Study|Lack of Efficacy|3|||
160843994|NCT00856544|580817904|FG003|Overall Study|Lack of Efficacy|3|||
160843995|NCT00856544|580817901|FG000|Overall Study|Other|9|||
160843996|NCT00856544|580817902|FG001|Overall Study|Other|16|||
160843997|NCT00856544|580817903|FG002|Overall Study|Other|1|||
160843998|NCT00856544|580817904|FG003|Overall Study|Other|6|||
160843999|NCT00856544|580817901|FG000|Overall Study|Lost to Follow-up|1|||
160844000|NCT00856544|580817902|FG001|Overall Study|Lost to Follow-up|2|||
160844001|NCT00856544|580817903|FG002|Overall Study|Lost to Follow-up|2|||
160844002|NCT00856544|580817904|FG003|Overall Study|Lost to Follow-up|0|||
160844003|NCT00856544|580817901|FG000|Overall Study|Withdrawal by Subject|8|||
160844004|NCT00856544|580817902|FG001|Overall Study|Withdrawal by Subject|5|||
160844005|NCT00856544|580817903|FG002|Overall Study|Withdrawal by Subject|0|||
160844006|NCT00856544|580817904|FG003|Overall Study|Withdrawal by Subject|1|||
160844007|NCT01564732|580817905|FG000|Overall Study|Early termination by the study sponsor|6|||
160844008|NCT01564732|580817906|FG001|Overall Study|Early termination by the study sponsor|5|||
160844009|NCT00394706|580817912|FG000|Overall Study|Withdrawal by Subject|2|||
160844010|NCT00394706|580817913|FG001|Overall Study|Withdrawal by Subject|0|||
160844011|NCT00394706|580817914|FG002|Overall Study|Withdrawal by Subject|1|||
160844012|NCT00394706|580817915|FG003|Overall Study|Withdrawal by Subject|0|||
160844013|NCT00394706|580817916|FG004|Overall Study|Withdrawal by Subject|0|||
160844014|NCT00394706|580817917|FG005|Overall Study|Withdrawal by Subject|2|||
160844015|NCT00394706|580817918|FG006|Overall Study|Withdrawal by Subject|1|||
160844016|NCT00394706|580817919|FG007|Overall Study|Withdrawal by Subject|0|||
160844017|NCT00394706|580817912|FG000|Overall Study|Lost to Follow-up|2|||
160844018|NCT00394706|580817913|FG001|Overall Study|Lost to Follow-up|2|||
160844019|NCT00394706|580817914|FG002|Overall Study|Lost to Follow-up|8|||
160844020|NCT00394706|580817915|FG003|Overall Study|Lost to Follow-up|1|||
160844021|NCT00394706|580817916|FG004|Overall Study|Lost to Follow-up|2|||
160844022|NCT00394706|580817917|FG005|Overall Study|Lost to Follow-up|5|||
160844023|NCT00394706|580817918|FG006|Overall Study|Lost to Follow-up|2|||
160844024|NCT00394706|580817919|FG007|Overall Study|Lost to Follow-up|0|||
160844025|NCT03040674|580817921|FG000|Overall Study|Lost to Follow-up|225|||
160844026|NCT03040674|580817921|FG000|Overall Study|Death|23|||
160844027|NCT01746368|580817924|FG000|Overall Study|Lost to Follow-up|2|||
160844028|NCT01746368|580817925|FG001|Overall Study|Lost to Follow-up|0|||
160844029|NCT01746368|580817924|FG000|Overall Study|Withdrawal by Subject|0|||
160844030|NCT01746368|580817925|FG001|Overall Study|Withdrawal by Subject|1|||
160844031|NCT02506192|580817926|FG000|Overall Study|Withdrawal by Subject|1|||
160844032|NCT02506192|580817927|FG001|Overall Study|Withdrawal by Subject|1|||
160844033|NCT04042909|580817928|FG000|Overall Study|Withdrawal by Subject|1|||
160844034|NCT04042909|580817929|FG001|Overall Study|Withdrawal by Subject|0|||
160844035|NCT04042909|580817930|FG002|Overall Study|Withdrawal by Subject|0|||
160844036|NCT04042909|580817928|FG000|Overall Study|duplicate cases|2|||
160844037|NCT04042909|580817929|FG001|Overall Study|duplicate cases|0|||
160844038|NCT04042909|580817930|FG002|Overall Study|duplicate cases|0|||
160844039|NCT04042909|580817928|FG000|Overall Study|technical problem|0|||
160844040|NCT04042909|580817929|FG001|Overall Study|technical problem|1|||
160844041|NCT04042909|580817930|FG002|Overall Study|technical problem|0|||
160844042|NCT03705559|580817931|FG000|Overall Study|COVID Shut down|1|||
160844043|NCT02576795|580817932|FG000|Overall Study|Lost to Follow-up|0|||
160844044|NCT02576795|580817933|FG001|Overall Study|Lost to Follow-up|0|||
160844045|NCT02576795|580817934|FG002|Overall Study|Lost to Follow-up|1|||
160844046|NCT02576795|580817935|FG003|Overall Study|Lost to Follow-up|0|||
160844047|NCT02362464|580817936|FG000|Overall Study|Switched to alternative therapy|1|||
160844048|NCT02362464|580817936|FG000|Overall Study|Refused further treatment|1|||
160844049|NCT02362464|580817936|FG000|Overall Study|Physician Decision|4|||
160844050|NCT02104947|580817937|FG000|Overall Study|Withdrawal by Subject|10|||
160844051|NCT02104947|580817938|FG001|Overall Study|Withdrawal by Subject|3|||
160844052|NCT02104947|580817937|FG000|Overall Study|Lost to Follow-up|4|||
160844053|NCT02104947|580817938|FG001|Overall Study|Lost to Follow-up|4|||
160844054|NCT02104947|580817937|FG000|Overall Study|Protocol Violation|6|||
160844055|NCT02104947|580817938|FG001|Overall Study|Protocol Violation|8|||
160844056|NCT02104947|580817937|FG000|Overall Study|Adverse Event|57|||
160844057|NCT02104947|580817938|FG001|Overall Study|Adverse Event|38|||
160844058|NCT02104947|580817937|FG000|Overall Study|Other than stated above|2|||
160844059|NCT02104947|580817938|FG001|Overall Study|Other than stated above|3|||
160844060|NCT02343406|580817939|FG000|Overall Study|Progressive disease|72|||
160844061|NCT02343406|580817940|FG001|Overall Study|Progressive disease|70|||
160844062|NCT02343406|580817941|FG002|Overall Study|Progressive disease|43|||
160844063|NCT02343406|580817942|FG003|Overall Study|Progressive disease|15|||
160844064|NCT02343406|580817943|FG004|Overall Study|Progressive disease|5|||
160844065|NCT02343406|580817939|FG000|Overall Study|Adverse Event|6|||
160844066|NCT02343406|580817940|FG001|Overall Study|Adverse Event|8|||
160844067|NCT02343406|580817941|FG002|Overall Study|Adverse Event|6|||
160844068|NCT02343406|580817942|FG003|Overall Study|Adverse Event|3|||
160844069|NCT02343406|580817943|FG004|Overall Study|Adverse Event|0|||
160844070|NCT02343406|580817939|FG000|Overall Study|Withdrawal by Subject|6|||
160844071|NCT02343406|580817940|FG001|Overall Study|Withdrawal by Subject|4|||
160844072|NCT02343406|580817941|FG002|Overall Study|Withdrawal by Subject|8|||
160844073|NCT02343406|580817942|FG003|Overall Study|Withdrawal by Subject|3|||
160844074|NCT02343406|580817943|FG004|Overall Study|Withdrawal by Subject|0|||
160844075|NCT02343406|580817939|FG000|Overall Study|Death|2|||
160844076|NCT02343406|580817940|FG001|Overall Study|Death|1|||
160844077|NCT02343406|580817941|FG002|Overall Study|Death|0|||
160844078|NCT02343406|580817942|FG003|Overall Study|Death|0|||
160844079|NCT02343406|580817943|FG004|Overall Study|Death|0|||
160844080|NCT02343406|580817939|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
160905793|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
160905794|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
160905795|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905796|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905797|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905798|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905799|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905800|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905801|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905802|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
160905803|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
160905804|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
160905805|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
160905806|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905807|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905808|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905809|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905810|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905811|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905812|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905813|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
160905814|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
160905815|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
160905816|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
160905817|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905818|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905819|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905820|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905821|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905822|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905823|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905824|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905825|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160565346|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
160565347|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
160565348|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
160565349|NCT00446030|579790338|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
160565350|NCT00446030|579790339|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
160565351|NCT02886715|579790340|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160565352|NCT02886715|579790341|FG001|Overall Study|Non-Compliance With Study Drug|2|||
160565353|NCT02886715|579790342|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160565354|NCT02886715|579790340|FG000|Overall Study|Adverse Event|4|||
160565355|NCT02886715|579790341|FG001|Overall Study|Adverse Event|2|||
160565356|NCT02886715|579790342|FG002|Overall Study|Adverse Event|0|||
160565357|NCT02886715|579790340|FG000|Overall Study|Lack of Efficacy|0|||
160565358|NCT02886715|579790341|FG001|Overall Study|Lack of Efficacy|2|||
160565359|NCT02886715|579790342|FG002|Overall Study|Lack of Efficacy|1|||
160565360|NCT02886715|579790340|FG000|Overall Study|Lost to Follow-up|29|||
160565361|NCT02886715|579790341|FG001|Overall Study|Lost to Follow-up|26|||
160565362|NCT02886715|579790342|FG002|Overall Study|Lost to Follow-up|10|||
160565363|NCT02886715|579790340|FG000|Overall Study|Pregnancy|1|||
160905826|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905827|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
160905828|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905829|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160565364|NCT02886715|579790341|FG001|Overall Study|Pregnancy|1|||
160565365|NCT02886715|579790342|FG002|Overall Study|Pregnancy|1|||
160565366|NCT02886715|579790340|FG000|Overall Study|Protocol Violation|3|||
160565367|NCT02886715|579790341|FG001|Overall Study|Protocol Violation|2|||
160565368|NCT02886715|579790342|FG002|Overall Study|Protocol Violation|1|||
160565369|NCT02886715|579790340|FG000|Overall Study|Withdrawal by Subject|20|||
160565370|NCT02886715|579790341|FG001|Overall Study|Withdrawal by Subject|18|||
160565371|NCT02886715|579790342|FG002|Overall Study|Withdrawal by Subject|5|||
160565372|NCT02886715|579790340|FG000|Overall Study|missing|7|||
160565373|NCT02886715|579790341|FG001|Overall Study|missing|2|||
160565374|NCT02886715|579790342|FG002|Overall Study|missing|2|||
160565375|NCT00503399|579790343|FG000|Overall Study|Death|2|||
160565376|NCT00503399|579790344|FG001|Overall Study|Death|1|||
160565377|NCT00503399|579790343|FG000|Overall Study|Protocol Violation|1|||
160565378|NCT00503399|579790344|FG001|Overall Study|Protocol Violation|0|||
160565379|NCT00503399|579790343|FG000|Overall Study|Withdrawal by Subject|4|||
160844081|NCT02343406|580817940|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
160844082|NCT02343406|580817941|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
160844083|NCT02343406|580817942|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
160844084|NCT02343406|580817943|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
160844085|NCT02343406|580817939|FG000|Overall Study|Other primary malignancy|0|||
160844086|NCT02343406|580817940|FG001|Overall Study|Other primary malignancy|1|||
160844087|NCT02343406|580817941|FG002|Overall Study|Other primary malignancy|0|||
160844088|NCT02343406|580817942|FG003|Overall Study|Other primary malignancy|0|||
160844089|NCT02343406|580817943|FG004|Overall Study|Other primary malignancy|0|||
160844090|NCT02343406|580817939|FG000|Overall Study|Other, not specified|2|||
160844091|NCT02343406|580817940|FG001|Overall Study|Other, not specified|1|||
160844092|NCT02343406|580817941|FG002|Overall Study|Other, not specified|1|||
160844093|NCT02343406|580817942|FG003|Overall Study|Other, not specified|4|||
160844094|NCT02343406|580817943|FG004|Overall Study|Other, not specified|0|||
160844095|NCT00548145|580817944|FG000|Overall Study|Death|0|||
160844096|NCT00548145|580817945|FG001|Overall Study|Death|1|||
160844097|NCT00548145|580817944|FG000|Overall Study|Withdrawal by Subject|0|||
160844098|NCT00548145|580817945|FG001|Overall Study|Withdrawal by Subject|2|||
160844099|NCT00548145|580817944|FG000|Overall Study|Physician Decision|1|||
160844100|NCT00548145|580817945|FG001|Overall Study|Physician Decision|1|||
160844101|NCT00874848|580817946|FG000|Overall Study|Adverse Event|13|||
160844102|NCT00874848|580817947|FG001|Overall Study|Adverse Event|2|||
160844103|NCT00874848|580817946|FG000|Overall Study|Progressive neoplastic disease|38|||
160844104|NCT00874848|580817947|FG001|Overall Study|Progressive neoplastic disease|18|||
160844105|NCT00874848|580817946|FG000|Overall Study|Withdrawal by Subject|7|||
160844106|NCT00874848|580817947|FG001|Overall Study|Withdrawal by Subject|4|||
160844107|NCT00874848|580817946|FG000|Overall Study|Noncompliance|1|||
160844108|NCT00874848|580817947|FG001|Overall Study|Noncompliance|1|||
160844109|NCT00874848|580817946|FG000|Overall Study|Failure to comply with protocol|0|||
160844110|NCT00874848|580817947|FG001|Overall Study|Failure to comply with protocol|1|||
160844111|NCT00874848|580817946|FG000|Overall Study|Physician Decision|0|||
160844112|NCT00874848|580817947|FG001|Overall Study|Physician Decision|2|||
160844113|NCT03301350|580817954|FG000|Overall Study|Withdrawal by Subject|4|||
160844114|NCT03301350|580817954|FG000|Overall Study|Adverse Event|1|||
160844115|NCT03301350|580817954|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
160565380|NCT00503399|579790344|FG001|Overall Study|Withdrawal by Subject|2|||
160565381|NCT00503399|579790343|FG000|Overall Study|Adverse Event|0|||
160565382|NCT00503399|579790344|FG001|Overall Study|Adverse Event|3|||
160565383|NCT00503399|579790343|FG000|Overall Study|Lost to Follow-up|0|||
160565384|NCT00503399|579790344|FG001|Overall Study|Lost to Follow-up|2|||
160844116|NCT03301350|580817954|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
160844117|NCT03301350|580817954|FG000|Overall Study|no detail provided|1|||
160844118|NCT00621140|580817955|FG000|Overall Study|Adverse Event|4|||
160565385|NCT01676961|579790345|FG000|Overall Study|Death|3|||
160844119|NCT00621140|580817956|FG001|Overall Study|Adverse Event|5|||
160565386|NCT01676961|579790345|FG000|Overall Study|Lost to Follow-up|1|||
160565387|NCT01676961|579790345|FG000|Overall Study|Withdrawal by Subject|1|||
160565388|NCT03168867|579790346|FG000|Overall Study|Withdrawal by Subject|1|||
160565389|NCT03168867|579790347|FG001|Overall Study|Withdrawal by Subject|5|||
160565390|NCT04433117|579790348|FG000|Overall Study|Withdrawal by Subject|1|||
160565391|NCT04433117|579790349|FG001|Overall Study|Withdrawal by Subject|0|||
160565392|NCT00824421|579790351|FG000|Overall Study|Adverse Event|6|||
160565393|NCT00824421|579790352|FG001|Overall Study|Adverse Event|6|||
160565394|NCT00824421|579790353|FG002|Overall Study|Adverse Event|6|||
160565395|NCT00824421|579790351|FG000|Overall Study|Death|0|||
160565396|NCT00824421|579790352|FG001|Overall Study|Death|1|||
160565397|NCT00824421|579790353|FG002|Overall Study|Death|0|||
160565398|NCT00824421|579790351|FG000|Overall Study|Lack of Efficacy|5|||
160565399|NCT00824421|579790352|FG001|Overall Study|Lack of Efficacy|7|||
160565400|NCT00824421|579790353|FG002|Overall Study|Lack of Efficacy|4|||
160565401|NCT00824421|579790351|FG000|Overall Study|Lost to Follow-up|2|||
160565402|NCT00824421|579790352|FG001|Overall Study|Lost to Follow-up|3|||
160565403|NCT00824421|579790353|FG002|Overall Study|Lost to Follow-up|0|||
160565404|NCT00824421|579790351|FG000|Overall Study|Pregnancy|1|||
160565405|NCT00824421|579790352|FG001|Overall Study|Pregnancy|0|||
160565406|NCT00824421|579790353|FG002|Overall Study|Pregnancy|1|||
160565407|NCT00824421|579790351|FG000|Overall Study|Withdrawal by Subject|2|||
160565408|NCT00824421|579790352|FG001|Overall Study|Withdrawal by Subject|3|||
160565409|NCT00824421|579790353|FG002|Overall Study|Withdrawal by Subject|3|||
160565410|NCT00824421|579790351|FG000|Overall Study|Randomized but not Treated|1|||
160565411|NCT00824421|579790352|FG001|Overall Study|Randomized but not Treated|1|||
160565412|NCT00824421|579790353|FG002|Overall Study|Randomized but not Treated|0|||
160565413|NCT00824421|579790351|FG000|Overall Study|Other|0|||
160565414|NCT00824421|579790352|FG001|Overall Study|Other|1|||
160565415|NCT00824421|579790353|FG002|Overall Study|Other|0|||
160565416|NCT02499952|579790354|FG000|Overall Study|Lost to Follow-up|1|||
160565417|NCT02499952|579790354|FG000|Overall Study|Death|9|||
160565418|NCT02120417|579790355|FG000|Overall Study|Death|5|||
160565419|NCT02120417|579790356|FG001|Overall Study|Death|1|||
160565420|NCT02120417|579790355|FG000|Overall Study|Adverse Event|3|||
160565421|NCT02120417|579790356|FG001|Overall Study|Adverse Event|9|||
160565422|NCT02120417|579790355|FG000|Overall Study|Participant decision|4|||
160565423|NCT02120417|579790356|FG001|Overall Study|Participant decision|4|||
160565424|NCT02120417|579790355|FG000|Overall Study|Disease progression|41|||
160565425|NCT02120417|579790356|FG001|Overall Study|Disease progression|45|||
160565426|NCT02120417|579790355|FG000|Overall Study|Noncompliance with study treatment|0|||
160565427|NCT02120417|579790356|FG001|Overall Study|Noncompliance with study treatment|2|||
160647722|NCT05002569|580092810|FG001|Follow Up|Other Reasons|452|||
160844120|NCT00621140|580817955|FG000|Overall Study|Lost to Follow-up|1|||
160844121|NCT00621140|580817956|FG001|Overall Study|Lost to Follow-up|2|||
160844122|NCT00621140|580817955|FG000|Overall Study|Withdrawal by Subject|4|||
160844123|NCT00621140|580817956|FG001|Overall Study|Withdrawal by Subject|6|||
160844124|NCT00621140|580817955|FG000|Overall Study|Other incl. lack of efficacy|6|||
160844125|NCT00621140|580817956|FG001|Overall Study|Other incl. lack of efficacy|5|||
160844126|NCT00145574|580817957|FG000|Double Blind|Adverse Event|0|||
160844127|NCT00145574|580817958|FG001|Double Blind|Adverse Event|3|||
160844128|NCT00145574|580817959|FG002|Double Blind|Adverse Event|1|||
160844129|NCT00145574|580817957|FG000|Double Blind|Withdrawal by Subject|1|||
160844130|NCT00145574|580817958|FG001|Double Blind|Withdrawal by Subject|1|||
160844131|NCT00145574|580817959|FG002|Double Blind|Withdrawal by Subject|1|||
160844132|NCT00145574|580817957|FG000|Double Blind|required restricted medicine|0|||
160844133|NCT00145574|580817958|FG001|Double Blind|required restricted medicine|1|||
160992186|NCT01080131|581359993|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
160992187|NCT01080131|581359994|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
160565428|NCT02120417|579790355|FG000|Overall Study|Physician Decision|2|||
160844134|NCT00145574|580817959|FG002|Double Blind|required restricted medicine|0|||
160565429|NCT02120417|579790356|FG001|Overall Study|Physician Decision|3|||
160565430|NCT02120417|579790355|FG000|Overall Study|Other unspecified|5|||
160565431|NCT02120417|579790356|FG001|Overall Study|Other unspecified|4|||
160565432|NCT00927485|579790357|FG000|Overall Study|Adverse Event|4|||
160565433|NCT00927485|579790358|FG001|Overall Study|Adverse Event|2|||
160565434|NCT00927485|579790357|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
160844135|NCT00145574|580817957|FG000|Open Label Long-term Extension|Adverse Event|0|||
160565435|NCT00927485|579790358|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
160565436|NCT02344576|579790367|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
160565437|NCT02344576|579790368|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
160565438|NCT02344576|579790369|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
160844136|NCT00145574|580817958|FG001|Open Label Long-term Extension|Adverse Event|0|||
160844137|NCT00145574|580817959|FG002|Open Label Long-term Extension|Adverse Event|5|||
160844138|NCT00145574|580817957|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
160844139|NCT00145574|580817958|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
160844140|NCT00145574|580817959|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
160844141|NCT00145574|580817957|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
160844142|NCT00145574|580817958|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
160844143|NCT00145574|580817959|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
160844144|NCT00145574|580817957|FG000|Open Label Long-term Extension|required restricted medicine|0|||
160844145|NCT00145574|580817958|FG001|Open Label Long-term Extension|required restricted medicine|0|||
160844146|NCT00145574|580817959|FG002|Open Label Long-term Extension|required restricted medicine|1|||
160844147|NCT00958165|580817960|FG000|Overall Study|Lost to Follow-up|5|||
160844148|NCT00958165|580817960|FG000|Overall Study|Not eligible|9|||
160844149|NCT01298765|580817962|FG000|Titration Period|Adverse Event|26|||
160844150|NCT01298765|580817962|FG000|Titration Period|Death|1|||
160844151|NCT01298765|580817962|FG000|Titration Period|Lack of Efficacy|21|||
160992188|NCT02014558|581359995|FG000|Overall Study|Never Received Study Drug|0|||
160992189|NCT02014558|581359996|FG001|Overall Study|Never Received Study Drug|0|||
160992190|NCT02014558|581359997|FG002|Overall Study|Never Received Study Drug|0|||
160992191|NCT02014558|581359998|FG003|Overall Study|Never Received Study Drug|0|||
160992192|NCT02014558|581359999|FG004|Overall Study|Never Received Study Drug|1|||
160992193|NCT02014558|581360000|FG005|Overall Study|Never Received Study Drug|0|||
160992194|NCT02014558|581360001|FG006|Overall Study|Never Received Study Drug|1|||
160992195|NCT02014558|581360002|FG007|Overall Study|Never Received Study Drug|0|||
160992196|NCT02014558|581360003|FG008|Overall Study|Never Received Study Drug|2|||
160992197|NCT02014558|581360004|FG009|Overall Study|Never Received Study Drug|0|||
160992198|NCT02014558|581360005|FG010|Overall Study|Never Received Study Drug|2|||
160992199|NCT02014558|581360006|FG011|Overall Study|Never Received Study Drug|2|||
160992200|NCT02014558|581360007|FG012|Overall Study|Never Received Study Drug|0|||
160992201|NCT02014558|581359995|FG000|Overall Study|Adverse Event|0|||
160992202|NCT02014558|581359996|FG001|Overall Study|Adverse Event|0|||
160844152|NCT01298765|580817962|FG000|Titration Period|Lost to Follow-up|9|||
160844153|NCT01298765|580817962|FG000|Titration Period|Physician Decision|1|||
160844154|NCT01298765|580817962|FG000|Titration Period|Withdrawal by Subject|10|||
160844155|NCT01298765|580817962|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
160844156|NCT01298765|580817962|FG000|Long-Term Treatment Period|Adverse Event|19|||
160844157|NCT01298765|580817962|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
160844158|NCT01298765|580817962|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
160844159|NCT01298765|580817962|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
160844160|NCT01298765|580817962|FG000|Long-Term Treatment Period|Physician Decision|1|||
160844161|NCT01298765|580817962|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
160844162|NCT03565237|580817963|FG000|Overall Study|Non-compliance of Investigational Product|1|||
160844163|NCT03565237|580817963|FG000|Overall Study|Physician Decision|1|||
160844164|NCT00428389|580817964|FG000|Core Phase|Adverse Event|6|||
160844165|NCT00428389|580817965|FG001|Core Phase|Adverse Event|4|||
160844166|NCT00428389|580817964|FG000|Core Phase|Lack of Efficacy|2|||
160844167|NCT00428389|580817965|FG001|Core Phase|Lack of Efficacy|0|||
160844168|NCT00428389|580817964|FG000|Core Phase|Abnormal test procedure result(s)|0|||
160844169|NCT00428389|580817965|FG001|Core Phase|Abnormal test procedure result(s)|1|||
160844170|NCT00428389|580817964|FG000|Core Phase|Withdrawal by Subject|3|||
160992203|NCT02014558|581359997|FG002|Overall Study|Adverse Event|0|||
160992204|NCT02014558|581359998|FG003|Overall Study|Adverse Event|0|||
160992205|NCT02014558|581359999|FG004|Overall Study|Adverse Event|1|||
160992206|NCT02014558|581360000|FG005|Overall Study|Adverse Event|0|||
160992207|NCT02014558|581360001|FG006|Overall Study|Adverse Event|0|||
160992208|NCT02014558|581360002|FG007|Overall Study|Adverse Event|0|||
160844171|NCT00428389|580817965|FG001|Core Phase|Withdrawal by Subject|4|||
160844172|NCT00428389|580817964|FG000|Core Phase|Protocol deviation|0|||
160844173|NCT00428389|580817965|FG001|Core Phase|Protocol deviation|2|||
160844174|NCT00428389|580817964|FG000|Extension Phase|Adverse Event|17|||
160844175|NCT00428389|580817965|FG001|Extension Phase|Adverse Event|11|||
160844176|NCT00428389|580817964|FG000|Extension Phase|Lack of Efficacy|4|||
160844177|NCT00428389|580817965|FG001|Extension Phase|Lack of Efficacy|3|||
160844178|NCT00428389|580817964|FG000|Extension Phase|Withdrawal by Subject|6|||
160565439|NCT02344576|579790370|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
160565440|NCT02344576|579790367|FG000|1-Month Follow-Up|Death|13|||
160844179|NCT00428389|580817965|FG001|Extension Phase|Withdrawal by Subject|6|||
160844180|NCT00428389|580817964|FG000|Extension Phase|Lost to Follow-up|0|||
160844181|NCT00428389|580817965|FG001|Extension Phase|Lost to Follow-up|3|||
160844182|NCT00428389|580817964|FG000|Extension Phase|Death|1|||
160992209|NCT02014558|581360003|FG008|Overall Study|Adverse Event|2|||
160992210|NCT02014558|581360004|FG009|Overall Study|Adverse Event|2|||
160992211|NCT02014558|581360005|FG010|Overall Study|Adverse Event|5|||
160992212|NCT02014558|581360006|FG011|Overall Study|Adverse Event|21|||
160844183|NCT00428389|580817965|FG001|Extension Phase|Death|0|||
160844184|NCT00428389|580817964|FG000|Extension Phase|Protocol Violation|3|||
160844185|NCT00428389|580817965|FG001|Extension Phase|Protocol Violation|2|||
160844186|NCT00428389|580817964|FG000|Extension Phase|Administrative problems|1|||
160844187|NCT00428389|580817965|FG001|Extension Phase|Administrative problems|1|||
160844188|NCT04090242|580817966|FG000|Overall Study|Withdrawal by Subject|1|||
160844189|NCT04090242|580817967|FG001|Overall Study|Withdrawal by Subject|0|||
160844190|NCT02687581|580817968|FG000|Overall Study|Withdrawal by Subject|1|||
160844191|NCT02687581|580817969|FG001|Overall Study|Withdrawal by Subject|0|||
160844192|NCT02687581|580817970|FG002|Overall Study|Withdrawal by Subject|0|||
160844193|NCT02687581|580817971|FG003|Overall Study|Withdrawal by Subject|1|||
160844194|NCT02687581|580817968|FG000|Overall Study|Lost to Follow-up|2|||
160844195|NCT02687581|580817969|FG001|Overall Study|Lost to Follow-up|2|||
160844196|NCT02687581|580817970|FG002|Overall Study|Lost to Follow-up|0|||
160844197|NCT02687581|580817971|FG003|Overall Study|Lost to Follow-up|0|||
160844198|NCT02687581|580817968|FG000|Overall Study|the device is too small for the patient.|1|||
160844199|NCT02687581|580817969|FG001|Overall Study|the device is too small for the patient.|0|||
160844200|NCT02687581|580817970|FG002|Overall Study|the device is too small for the patient.|0|||
160844201|NCT02687581|580817971|FG003|Overall Study|the device is too small for the patient.|0|||
160844202|NCT00835341|580817972|FG000|Overall Study|Lost to Follow-up|3|||
160844203|NCT00835341|580817973|FG001|Overall Study|Lost to Follow-up|12|||
160844204|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
160844205|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
160844206|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
160844207|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
160844208|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
160992213|NCT02014558|581360007|FG012|Overall Study|Adverse Event|3|||
160992214|NCT02014558|581359995|FG000|Overall Study|Death|1|||
160992215|NCT02014558|581359996|FG001|Overall Study|Death|0|||
160992216|NCT02014558|581359997|FG002|Overall Study|Death|0|||
160992217|NCT02014558|581359998|FG003|Overall Study|Death|0|||
160992218|NCT02014558|581359999|FG004|Overall Study|Death|0|||
160992219|NCT02014558|581360000|FG005|Overall Study|Death|0|||
160992220|NCT02014558|581360001|FG006|Overall Study|Death|1|||
160565441|NCT02344576|579790368|FG001|1-Month Follow-Up|Death|8|||
160565442|NCT02344576|579790369|FG002|1-Month Follow-Up|Death|0|||
160565443|NCT02344576|579790370|FG003|1-Month Follow-Up|Death|0|||
160565444|NCT02344576|579790367|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
160565445|NCT02344576|579790368|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
160565446|NCT02344576|579790369|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
160565447|NCT02344576|579790370|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
160565448|NCT02344576|579790367|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
160844209|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
160844210|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
160844211|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
160844212|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
160844213|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Physician Decision|1|||
160844214|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Physician Decision|2|||
160565449|NCT02344576|579790368|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
160565450|NCT02344576|579790369|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
160565451|NCT02344576|579790370|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
160565452|NCT02344576|579790367|FG000|6-Month Follow-Up|Death|14|||
160565453|NCT02344576|579790368|FG001|6-Month Follow-Up|Death|14|||
160565454|NCT02344576|579790369|FG002|6-Month Follow-Up|Death|0|||
160905830|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905831|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905832|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905833|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905834|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905835|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
160905836|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
160905837|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
160905838|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
160905839|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905840|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905841|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905842|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905843|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905844|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905845|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905846|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
160992221|NCT02014558|581360002|FG007|Overall Study|Death|1|||
160992222|NCT02014558|581360003|FG008|Overall Study|Death|2|||
160992223|NCT02014558|581360004|FG009|Overall Study|Death|5|||
160992224|NCT02014558|581360005|FG010|Overall Study|Death|5|||
160844215|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Physician Decision|0|||
160844216|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Physician Decision|0|||
160844217|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Physician Decision|0|||
160844218|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Physician Decision|0|||
160844219|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Physician Decision|0|||
160844220|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Physician Decision|0|||
160992225|NCT02014558|581360006|FG011|Overall Study|Death|19|||
160992226|NCT02014558|581360007|FG012|Overall Study|Death|2|||
160992227|NCT02014558|581359995|FG000|Overall Study|Lack of Efficacy|1|||
160844221|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Physician Decision|0|||
160844222|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
160844223|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
160844224|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
160844225|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
160844226|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
160844227|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
160844228|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
160844229|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
160844230|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
160844231|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
160844232|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844233|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844234|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844235|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844236|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844237|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844238|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844239|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844240|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
160844241|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
160844242|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844243|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844244|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844245|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844246|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844247|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844248|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844249|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Other than Specified|0|||
160844250|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Other than Specified|0|||
160844251|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Other than Specified|3|||
160844252|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Other than Specified|0|||
160844253|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Other than Specified|0|||
160844254|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Other than Specified|0|||
160844255|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Other than Specified|0|||
160844256|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Other than Specified|0|||
160844257|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Other than Specified|0|||
160844258|NCT04405076|580817974|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844259|NCT04405076|580817975|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844260|NCT04405076|580817976|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844261|NCT04405076|580817977|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
160844262|NCT04405076|580817978|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
160844263|NCT04405076|580817979|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
160844264|NCT04405076|580817980|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844265|NCT04405076|580817981|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844266|NCT04405076|580817982|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844267|NCT04405076|580817974|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844268|NCT04405076|580817975|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844269|NCT04405076|580817976|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844270|NCT04405076|580817977|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160992228|NCT02014558|581359996|FG001|Overall Study|Lack of Efficacy|2|||
160992229|NCT02014558|581359997|FG002|Overall Study|Lack of Efficacy|1|||
160992230|NCT02014558|581359998|FG003|Overall Study|Lack of Efficacy|1|||
160992231|NCT02014558|581359999|FG004|Overall Study|Lack of Efficacy|0|||
160992232|NCT02014558|581360000|FG005|Overall Study|Lack of Efficacy|0|||
160565455|NCT02344576|579790370|FG003|6-Month Follow-Up|Death|0|||
160844271|NCT04405076|580817978|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
160844272|NCT04405076|580817979|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844273|NCT04405076|580817980|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844274|NCT04405076|580817981|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844275|NCT04405076|580817982|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844276|NCT04405076|580817974|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844277|NCT04405076|580817975|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844278|NCT04405076|580817976|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844279|NCT04405076|580817977|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
160844280|NCT04405076|580817978|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
160844281|NCT04405076|580817979|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
160844282|NCT04405076|580817980|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844283|NCT04405076|580817981|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844284|NCT04405076|580817982|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844285|NCT04405076|580817974|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844286|NCT04405076|580817975|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844287|NCT04405076|580817976|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844288|NCT04405076|580817977|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844289|NCT04405076|580817978|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844290|NCT04405076|580817979|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844291|NCT04405076|580817980|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844292|NCT04405076|580817981|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
160844293|NCT04405076|580817982|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
160844294|NCT04405076|580817974|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844295|NCT04405076|580817975|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844296|NCT04405076|580817976|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844297|NCT04405076|580817977|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844298|NCT04405076|580817978|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844299|NCT04405076|580817979|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844300|NCT04405076|580817980|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
160844301|NCT04405076|580817981|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844302|NCT04405076|580817982|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844303|NCT02513472|580817983|FG000|Overall Study|Radiological Disease Progression|45|||
160844304|NCT02513472|580817984|FG001|Overall Study|Radiological Disease Progression|57|||
160844305|NCT02513472|580817983|FG000|Overall Study|Clinical Disease Progression|5|||
160844306|NCT02513472|580817984|FG001|Overall Study|Clinical Disease Progression|13|||
160844307|NCT02513472|580817983|FG000|Overall Study|Adverse Event|8|||
160844308|NCT02513472|580817984|FG001|Overall Study|Adverse Event|11|||
160844309|NCT02513472|580817983|FG000|Overall Study|Withdrawal by Subject|0|||
160844310|NCT02513472|580817984|FG001|Overall Study|Withdrawal by Subject|4|||
160844311|NCT02513472|580817983|FG000|Overall Study|Subject Choice|2|||
160844312|NCT02513472|580817984|FG001|Overall Study|Subject Choice|7|||
160844313|NCT02513472|580817983|FG000|Overall Study|Treatment Completed as per Protocol|3|||
160844314|NCT02513472|580817984|FG001|Overall Study|Treatment Completed as per Protocol|3|||
160844315|NCT02513472|580817983|FG000|Overall Study|Other|3|||
160844316|NCT02513472|580817984|FG001|Overall Study|Other|6|||
160844317|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
160844318|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
160844319|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
160844320|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Death|0|||
160844321|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Death|2|||
160844322|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Death|0|||
160844323|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
160844324|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
160844325|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
160844326|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
160844327|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
160844328|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
160844329|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
160844330|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
160844331|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
160844332|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
160844333|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
160844334|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
160844335|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
160844336|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
160844337|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
160844338|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Recovery|1|||
160844339|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Recovery|0|||
160992233|NCT02014558|581360001|FG006|Overall Study|Lack of Efficacy|1|||
160565456|NCT02344576|579790367|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
160565457|NCT02344576|579790368|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
160565458|NCT02344576|579790369|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
160565459|NCT02344576|579790370|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
160565460|NCT02344576|579790367|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
160565461|NCT02344576|579790368|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
160565462|NCT02344576|579790369|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
160565463|NCT02344576|579790370|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
160565464|NCT04325503|579790372|FG000|Overall Study|Withdrawal by Subject|1|||
160565465|NCT04325503|579790372|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
160565466|NCT02337387|579790373|FG000|Overall Study|Adverse Event|0|||
160565467|NCT02337387|579790374|FG001|Overall Study|Adverse Event|1|||
160565468|NCT02337387|579790375|FG002|Overall Study|Adverse Event|0|||
160565469|NCT02337387|579790376|FG003|Overall Study|Adverse Event|0|||
160565470|NCT02337387|579790373|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
160565471|NCT02337387|579790374|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
160565472|NCT02337387|579790375|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
160565473|NCT02337387|579790376|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
160565474|NCT01243268|579790377|FG000|Overall Study|Lost to Follow-up|4|||
160565475|NCT01243268|579790377|FG000|Overall Study|Protocol Violation|51|||
160565476|NCT01243268|579790377|FG000|Overall Study|Deviation with contract date|7|||
160565477|NCT01243268|579790377|FG000|Overall Study|Duplicate subject|2|||
160565478|NCT00702143|579790378|FG000|Overall Study|Lost to Follow-up|0|||
160565479|NCT00702143|579790379|FG001|Overall Study|Lost to Follow-up|0|||
160565480|NCT00702143|579790380|FG002|Overall Study|Lost to Follow-up|1|||
160565481|NCT03871491|579790383|FG000|Overall Study|Withdrawal by Subject|14|||
160565482|NCT03871491|579790384|FG001|Overall Study|Withdrawal by Subject|14|||
160565483|NCT03871491|579790385|FG002|Overall Study|Withdrawal by Subject|14|||
160565484|NCT03871491|579790386|FG003|Overall Study|Withdrawal by Subject|14|||
160565485|NCT03871491|579790383|FG000|Overall Study|Physician Decision|0|||
160565486|NCT03871491|579790384|FG001|Overall Study|Physician Decision|0|||
160565487|NCT03871491|579790385|FG002|Overall Study|Physician Decision|1|||
160565488|NCT03871491|579790386|FG003|Overall Study|Physician Decision|1|||
160565489|NCT03871491|579790383|FG000|Overall Study|Lost to Follow-up|50|||
160565490|NCT03871491|579790384|FG001|Overall Study|Lost to Follow-up|15|||
160565491|NCT03871491|579790385|FG002|Overall Study|Lost to Follow-up|36|||
160565492|NCT03871491|579790386|FG003|Overall Study|Lost to Follow-up|11|||
160565493|NCT05202808|579790387|FG000|Overall Study|Lost to Follow-up|3|||
160905847|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
160905848|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
160905849|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
160905850|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905851|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905852|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905853|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905854|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905855|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905856|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905857|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
160905858|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
160565494|NCT05202808|579790388|FG001|Overall Study|Lost to Follow-up|1|||
160565495|NCT04996797|579790389|FG000|Overall Study|Adverse Event|0|||
160647770|NCT05245617|580092830|FG000|Overall Study|Withdrawal by Subject|1|||
160565496|NCT04996797|579790390|FG001|Overall Study|Adverse Event|2|||
160565497|NCT04996797|579790391|FG002|Overall Study|Adverse Event|0|||
160565498|NCT04996797|579790392|FG003|Overall Study|Adverse Event|1|||
160565499|NCT04996797|579790389|FG000|Overall Study|Lack of Efficacy|0|||
160992234|NCT02014558|581360002|FG007|Overall Study|Lack of Efficacy|3|||
160905859|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
160905860|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
160905861|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905862|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905863|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160647791|NCT03425331|580092836|FG000|Overall Study|Withdrawal by Subject|1|||
160647792|NCT03425331|580092836|FG000|Overall Study|Death|1|||
160647793|NCT03425331|580092836|FG000|Overall Study|Adverse Event|1|||
160647794|NCT03425331|580092836|FG000|Overall Study|Disease Progression|2|||
160647795|NCT05211336|580092837|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
160647796|NCT05211336|580092838|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
160647797|NCT05211336|580092837|FG000|Overall Study|Progressive disease|0|||
160647798|NCT05211336|580092838|FG001|Overall Study|Progressive disease|4|||
160647799|NCT05211336|580092837|FG000|Overall Study|Death due to myocardial infarction|0|||
160647800|NCT05211336|580092838|FG001|Overall Study|Death due to myocardial infarction|1|||
160647801|NCT05211336|580092837|FG000|Overall Study|Death due to unknown cause|0|||
160647802|NCT05211336|580092838|FG001|Overall Study|Death due to unknown cause|1|||
160647803|NCT05211336|580092837|FG000|Overall Study|Worsening kidney function and quality of response|0|||
160647804|NCT05211336|580092838|FG001|Overall Study|Worsening kidney function and quality of response|1|||
160647805|NCT03433274|580092841|FG000|Overall Study|Withdrawal by Subject|2|||
160647806|NCT03433274|580092841|FG000|Overall Study|Missed visit|5|||
160647807|NCT03433274|580092841|FG000|Overall Study|Death|23|||
160647808|NCT02337829|580092842|FG000|Overall Study|Death|0|||
160647809|NCT02337829|580092843|FG001|Overall Study|Death|1|||
160647810|NCT02337829|580092844|FG002|Overall Study|Death|0|||
160647811|NCT02337829|580092845|FG003|Overall Study|Death|0|||
160647812|NCT02337829|580092842|FG000|Overall Study|Study terminated by sponsor|12|||
160905864|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905865|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905866|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905867|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905868|NCT01847274|581050304|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905869|NCT01847274|581050305|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905870|NCT01847274|581050306|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905871|NCT01847274|581050307|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905872|NCT01847274|581050308|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905873|NCT01847274|581050309|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
160905874|NCT01847274|581050310|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905875|NCT01847274|581050311|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905876|NCT01847274|581050312|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905877|NCT01847274|581050313|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905878|NCT01847274|581050314|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905879|NCT01847274|581050304|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905880|NCT01847274|581050305|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905881|NCT01847274|581050306|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905882|NCT01847274|581050307|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905883|NCT01847274|581050308|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
160905884|NCT01847274|581050309|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905885|NCT01847274|581050310|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160844340|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Recovery|1|||
160844341|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
160844342|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
160844343|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
160565500|NCT04996797|579790390|FG001|Overall Study|Lack of Efficacy|2|||
160844344|NCT00195663|580817985|FG000|Open-Label Extension Period|Adverse Event|21|||
160844345|NCT00195663|580817986|FG001|Open-Label Extension Period|Adverse Event|32|||
160844346|NCT00195663|580817987|FG002|Open-Label Extension Period|Adverse Event|36|||
160565501|NCT04996797|579790391|FG002|Overall Study|Lack of Efficacy|0|||
160844347|NCT00195663|580817985|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
160844348|NCT00195663|580817986|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
160992235|NCT02014558|581360003|FG008|Overall Study|Lack of Efficacy|3|||
160565502|NCT04996797|579790392|FG003|Overall Study|Lack of Efficacy|0|||
160565503|NCT04996797|579790389|FG000|Overall Study|Prohibited Medication|0|||
160565504|NCT04996797|579790390|FG001|Overall Study|Prohibited Medication|1|||
160565505|NCT04996797|579790391|FG002|Overall Study|Prohibited Medication|0|||
160565506|NCT04996797|579790392|FG003|Overall Study|Prohibited Medication|0|||
160565507|NCT04996797|579790389|FG000|Overall Study|Ongoing|68|||
160565508|NCT04996797|579790390|FG001|Overall Study|Ongoing|60|||
160565509|NCT04996797|579790391|FG002|Overall Study|Ongoing|22|||
160565510|NCT04996797|579790392|FG003|Overall Study|Ongoing|20|||
160565511|NCT04996797|579790389|FG000|Overall Study|Withdrawal by Subject|0|||
160565512|NCT04996797|579790390|FG001|Overall Study|Withdrawal by Subject|2|||
160565513|NCT04996797|579790391|FG002|Overall Study|Withdrawal by Subject|0|||
160565514|NCT04996797|579790392|FG003|Overall Study|Withdrawal by Subject|0|||
160565515|NCT02793544|579790393|FG000|Overall Study|Death|10|||
160565516|NCT02793544|579790394|FG001|Overall Study|Death|8|||
160565517|NCT02793544|579790393|FG000|Overall Study|Lost to Follow-up|2|||
160565518|NCT02793544|579790394|FG001|Overall Study|Lost to Follow-up|0|||
160565519|NCT02793544|579790393|FG000|Overall Study|Withdrawal by Subject|1|||
160565520|NCT02793544|579790394|FG001|Overall Study|Withdrawal by Subject|0|||
160565521|NCT04091217|579790397|FG000|Overall Study|Lost to Follow-up|2|||
160565522|NCT01822561|579790398|FG000|Overall Study|Withdrawal by Subject|2|||
160565523|NCT02747004|579790399|FG000|Overall Study|Withdrawal by Subject|8|||
160565524|NCT02747004|579790400|FG001|Overall Study|Withdrawal by Subject|5|||
160565525|NCT02747004|579790401|FG002|Overall Study|Withdrawal by Subject|4|||
160565526|NCT02747004|579790399|FG000|Overall Study|Lost to Follow-up|1|||
160565527|NCT02747004|579790400|FG001|Overall Study|Lost to Follow-up|2|||
160565528|NCT02747004|579790401|FG002|Overall Study|Lost to Follow-up|2|||
160565529|NCT02747004|579790399|FG000|Overall Study|on study treatment/follow-up|48|||
160565530|NCT02747004|579790400|FG001|Overall Study|on study treatment/follow-up|42|||
160565531|NCT02747004|579790401|FG002|Overall Study|on study treatment/follow-up|41|||
160565532|NCT05087030|579790402|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
160565533|NCT05087030|579790403|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
160565534|NCT05087030|579790404|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
160565535|NCT05087030|579790405|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
160565536|NCT05087030|579790406|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
160565537|NCT05087030|579790402|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
160565538|NCT05087030|579790403|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
160565539|NCT05087030|579790404|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
160565540|NCT05087030|579790405|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
160565541|NCT05087030|579790406|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
160565542|NCT05087030|579790402|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
160565543|NCT05087030|579790403|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
160565544|NCT05087030|579790404|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
160565545|NCT05087030|579790405|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
160565546|NCT05087030|579790406|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
160565547|NCT05087030|579790402|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
160565548|NCT05087030|579790403|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
160565549|NCT05087030|579790404|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
160565550|NCT05087030|579790405|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
160565551|NCT05087030|579790406|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
160565552|NCT05087030|579790402|FG000|Main Period (Week 0 to Week 52)|Death|0|||
160565553|NCT05087030|579790403|FG001|Main Period (Week 0 to Week 52)|Death|1|||
160565554|NCT05087030|579790404|FG002|Main Period (Week 0 to Week 52)|Death|0|||
160565555|NCT05087030|579790405|FG003|Main Period (Week 0 to Week 52)|Death|0|||
160565556|NCT05087030|579790406|FG004|Main Period (Week 0 to Week 52)|Death|0|||
160565557|NCT05087030|579790402|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
160565558|NCT05087030|579790403|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
160565559|NCT05087030|579790404|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
160565560|NCT05087030|579790405|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
160565561|NCT05087030|579790406|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
160565562|NCT05087030|579790402|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
160647813|NCT02337829|580092843|FG001|Overall Study|Study terminated by sponsor|10|||
160647814|NCT02337829|580092844|FG002|Overall Study|Study terminated by sponsor|5|||
160647815|NCT02337829|580092845|FG003|Overall Study|Study terminated by sponsor|6|||
160647816|NCT02337829|580092842|FG000|Overall Study|discontinued for other reasons|6|||
160647817|NCT02337829|580092843|FG001|Overall Study|discontinued for other reasons|3|||
160647818|NCT02337829|580092844|FG002|Overall Study|discontinued for other reasons|1|||
160647819|NCT02337829|580092845|FG003|Overall Study|discontinued for other reasons|4|||
160647822|NCT00542386|580092850|FG000|Overall Study|Adverse Event|1|||
160647823|NCT00542386|580092851|FG001|Overall Study|Adverse Event|7|||
160647824|NCT00542386|580092852|FG002|Overall Study|Adverse Event|7|||
160647825|NCT00542386|580092853|FG003|Overall Study|Adverse Event|8|||
160647826|NCT00542386|580092854|FG004|Overall Study|Adverse Event|13|||
160647827|NCT00542386|580092855|FG005|Overall Study|Adverse Event|4|||
160647828|NCT00542386|580092850|FG000|Overall Study|Death|0|||
160647829|NCT00542386|580092851|FG001|Overall Study|Death|0|||
160647830|NCT00542386|580092852|FG002|Overall Study|Death|1|||
160647831|NCT00542386|580092853|FG003|Overall Study|Death|2|||
160647832|NCT00542386|580092854|FG004|Overall Study|Death|1|||
160647833|NCT00542386|580092855|FG005|Overall Study|Death|2|||
160647834|NCT00542386|580092850|FG000|Overall Study|Lack of Efficacy|32|||
160647835|NCT00542386|580092851|FG001|Overall Study|Lack of Efficacy|12|||
160647836|NCT00542386|580092852|FG002|Overall Study|Lack of Efficacy|10|||
160647837|NCT00542386|580092853|FG003|Overall Study|Lack of Efficacy|13|||
160647838|NCT00542386|580092854|FG004|Overall Study|Lack of Efficacy|7|||
160647839|NCT00542386|580092855|FG005|Overall Study|Lack of Efficacy|31|||
160647840|NCT00542386|580092850|FG000|Overall Study|Physician Decision|1|||
160647841|NCT00542386|580092851|FG001|Overall Study|Physician Decision|0|||
160647842|NCT00542386|580092852|FG002|Overall Study|Physician Decision|0|||
160647843|NCT00542386|580092853|FG003|Overall Study|Physician Decision|1|||
160647844|NCT00542386|580092854|FG004|Overall Study|Physician Decision|0|||
160647845|NCT00542386|580092855|FG005|Overall Study|Physician Decision|0|||
160647846|NCT00542386|580092850|FG000|Overall Study|Protocol Violation|0|||
160647847|NCT00542386|580092851|FG001|Overall Study|Protocol Violation|0|||
160647848|NCT00542386|580092852|FG002|Overall Study|Protocol Violation|1|||
160647849|NCT00542386|580092853|FG003|Overall Study|Protocol Violation|0|||
160647850|NCT00542386|580092854|FG004|Overall Study|Protocol Violation|0|||
160647851|NCT00542386|580092855|FG005|Overall Study|Protocol Violation|4|||
160647852|NCT00542386|580092850|FG000|Overall Study|Withdrawal by Subject|5|||
160647853|NCT00542386|580092851|FG001|Overall Study|Withdrawal by Subject|8|||
160647854|NCT00542386|580092852|FG002|Overall Study|Withdrawal by Subject|10|||
160647855|NCT00542386|580092853|FG003|Overall Study|Withdrawal by Subject|11|||
160647856|NCT00542386|580092854|FG004|Overall Study|Withdrawal by Subject|15|||
160647857|NCT00542386|580092855|FG005|Overall Study|Withdrawal by Subject|7|||
160647858|NCT00542386|580092850|FG000|Overall Study|Other Reasons|4|||
160647859|NCT00542386|580092851|FG001|Overall Study|Other Reasons|1|||
160647860|NCT00542386|580092852|FG002|Overall Study|Other Reasons|4|||
160647861|NCT00542386|580092853|FG003|Overall Study|Other Reasons|3|||
160647862|NCT00542386|580092854|FG004|Overall Study|Other Reasons|4|||
160647863|NCT00542386|580092855|FG005|Overall Study|Other Reasons|2|||
160844349|NCT00195663|580817987|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
160844350|NCT00195663|580817985|FG000|Open-Label Extension Period|Recovery|0|||
160844351|NCT00195663|580817986|FG001|Open-Label Extension Period|Recovery|2|||
160844352|NCT00195663|580817987|FG002|Open-Label Extension Period|Recovery|2|||
160844353|NCT00195663|580817985|FG000|Open-Label Extension Period|Protocol Violation|3|||
160844354|NCT00195663|580817986|FG001|Open-Label Extension Period|Protocol Violation|4|||
160844355|NCT00195663|580817987|FG002|Open-Label Extension Period|Protocol Violation|4|||
160844356|NCT00195663|580817985|FG000|Open-Label Extension Period|Death|2|||
160844357|NCT00195663|580817986|FG001|Open-Label Extension Period|Death|2|||
160844358|NCT00195663|580817987|FG002|Open-Label Extension Period|Death|2|||
160647875|NCT02227849|580092859|FG000|Overall Study|Adverse Event|4|||
160647876|NCT02227849|580092859|FG000|Overall Study|Physician Decision|1|||
160917937|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
160647877|NCT02227849|580092859|FG000|Overall Study|Withdrawal by Subject|3|||
160565563|NCT05087030|579790403|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
160565564|NCT05087030|579790404|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
160565565|NCT05087030|579790405|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
160565566|NCT05087030|579790406|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
160565567|NCT05087030|579790402|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
160565568|NCT05087030|579790403|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
160565569|NCT05087030|579790404|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
160565570|NCT05087030|579790405|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
160565571|NCT05087030|579790406|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
160565572|NCT05087030|579790402|FG000|Main Period (Week 0 to Week 52)|Other|1|||
160565573|NCT05087030|579790403|FG001|Main Period (Week 0 to Week 52)|Other|2|||
160565574|NCT05087030|579790404|FG002|Main Period (Week 0 to Week 52)|Other|0|||
160565575|NCT05087030|579790405|FG003|Main Period (Week 0 to Week 52)|Other|0|||
160565576|NCT05087030|579790406|FG004|Main Period (Week 0 to Week 52)|Other|0|||
160565577|NCT05087030|579790402|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
160565578|NCT05087030|579790403|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
160565579|NCT05087030|579790404|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
160565580|NCT05087030|579790405|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
160565581|NCT05087030|579790406|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
160565582|NCT01444300|579790407|FG000|Overall Study|Adverse Event|4|||
160565583|NCT01444300|579790408|FG001|Overall Study|Adverse Event|0|||
160565584|NCT02722044|579790409|FG000|Overall Study|Adverse Event|2|||
160565585|NCT02722044|579790409|FG000|Overall Study|Physician Decision|1|||
160565586|NCT02722044|579790409|FG000|Overall Study|Withdrawal by Subject|1|||
160565587|NCT02722044|579790409|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
160565588|NCT04885257|579790410|FG000|Overall Study|Withdrawal by Subject|1|||
160565589|NCT04885257|579790411|FG001|Overall Study|Withdrawal by Subject|0|||
160565590|NCT00818259|579790412|FG000|Part I|Withdrawal by Subject|1|||
160565591|NCT00818259|579790413|FG001|Part I|Withdrawal by Subject|0|||
160565592|NCT00818259|579790414|FG002|Part I|Withdrawal by Subject|0|||
160565593|NCT00818259|579790415|FG003|Part I|Withdrawal by Subject|0|||
160565594|NCT00818259|579790416|FG004|Part I|Withdrawal by Subject|0|||
160565595|NCT00818259|579790417|FG005|Part I|Withdrawal by Subject|0|||
160565596|NCT00818259|579790418|FG006|Part I|Withdrawal by Subject|0|||
160565597|NCT00818259|579790419|FG007|Part I|Withdrawal by Subject|0|||
160565598|NCT00818259|579790420|FG008|Part I|Withdrawal by Subject|0|||
160565599|NCT00818259|579790412|FG000|Part II|Physician Decision|0|||
160565600|NCT00818259|579790413|FG001|Part II|Physician Decision|0|||
160565601|NCT00818259|579790414|FG002|Part II|Physician Decision|1|||
160565602|NCT00818259|579790415|FG003|Part II|Physician Decision|0|||
160565603|NCT00818259|579790416|FG004|Part II|Physician Decision|0|||
160565604|NCT00818259|579790417|FG005|Part II|Physician Decision|0|||
160565605|NCT00818259|579790418|FG006|Part II|Physician Decision|0|||
160565606|NCT00818259|579790419|FG007|Part II|Physician Decision|0|||
160647988|NCT04864405|580092881|FG000|Overall Study|Withdrawal by Subject|4|||
160647989|NCT04864405|580092882|FG001|Overall Study|Withdrawal by Subject|6|||
160647990|NCT04864405|580092881|FG000|Overall Study|Did not want endocrine therapy|3|||
160647991|NCT04864405|580092882|FG001|Overall Study|Did not want endocrine therapy|5|||
160647994|NCT04029090|580092887|FG000|Overall Study|Protocol Violation|1|||
160647995|NCT04029090|580092888|FG001|Overall Study|Protocol Violation|0|||
160647996|NCT04029090|580092889|FG002|Overall Study|Protocol Violation|0|||
160647997|NCT04029090|580092887|FG000|Overall Study|Withdrawal by Subject|0|||
160647998|NCT04029090|580092888|FG001|Overall Study|Withdrawal by Subject|1|||
160647999|NCT04029090|580092889|FG002|Overall Study|Withdrawal by Subject|0|||
160648000|NCT00506441|580092890|FG000|Period 1; Open-label Period|Adverse Event|21|||
160648001|NCT00506441|580092891|FG001|Period 1; Open-label Period|Adverse Event|0|||
160648002|NCT00506441|580092890|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
160648003|NCT00506441|580092891|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
160648004|NCT00506441|580092890|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
160648005|NCT00506441|580092891|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
160648006|NCT00506441|580092890|FG000|Period 1; Open-label Period|Physician Decision|5|||
160648007|NCT00506441|580092891|FG001|Period 1; Open-label Period|Physician Decision|0|||
160648008|NCT00506441|580092890|FG000|Period 1; Open-label Period|Protocol Violation|9|||
160648009|NCT00506441|580092891|FG001|Period 1; Open-label Period|Protocol Violation|0|||
160648010|NCT00506441|580092890|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
160648011|NCT00506441|580092891|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
160648012|NCT00506441|580092890|FG000|Period 1; Open-label Period|Other Reasons|13|||
160648013|NCT00506441|580092891|FG001|Period 1; Open-label Period|Other Reasons|0|||
160648014|NCT00506441|580092890|FG000|Period 2; Double-blind Period|Adverse Event|0|||
160648015|NCT00506441|580092891|FG001|Period 2; Double-blind Period|Adverse Event|1|||
160648016|NCT00506441|580092890|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
160648017|NCT00506441|580092891|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
160565607|NCT00818259|579790420|FG008|Part II|Physician Decision|0|||
160565608|NCT00818259|579790412|FG000|Part II|Lack of Efficacy|0|||
160565609|NCT00818259|579790413|FG001|Part II|Lack of Efficacy|0|||
160565610|NCT00818259|579790414|FG002|Part II|Lack of Efficacy|0|||
160565611|NCT00818259|579790415|FG003|Part II|Lack of Efficacy|1|||
160565612|NCT00818259|579790416|FG004|Part II|Lack of Efficacy|0|||
160565613|NCT00818259|579790417|FG005|Part II|Lack of Efficacy|0|||
160565614|NCT00818259|579790418|FG006|Part II|Lack of Efficacy|0|||
160565615|NCT00818259|579790419|FG007|Part II|Lack of Efficacy|0|||
160648018|NCT00506441|580092890|FG000|Period 2; Double-blind Period|Physician Decision|1|||
160648019|NCT00506441|580092891|FG001|Period 2; Double-blind Period|Physician Decision|1|||
160565616|NCT00818259|579790420|FG008|Part II|Lack of Efficacy|0|||
160648020|NCT00506441|580092890|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
160648021|NCT00506441|580092891|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
160648022|NCT00506441|580092890|FG000|Period 2; Double-blind Period|Other Reason|1|||
160648023|NCT00506441|580092891|FG001|Period 2; Double-blind Period|Other Reason|1|||
160565617|NCT00818259|579790412|FG000|Part II|Not Treated|0|||
160565618|NCT00818259|579790413|FG001|Part II|Not Treated|0|||
160565619|NCT00818259|579790414|FG002|Part II|Not Treated|0|||
160565620|NCT00818259|579790415|FG003|Part II|Not Treated|1|||
160648048|NCT00501046|580092904|FG000|Overall Study|Adverse Event|21|||
160648049|NCT00501046|580092905|FG001|Overall Study|Adverse Event|25|||
160648050|NCT00501046|580092904|FG000|Overall Study|Death|23|||
160648051|NCT00501046|580092905|FG001|Overall Study|Death|30|||
160648052|NCT00501046|580092904|FG000|Overall Study|Lost to Follow-up|14|||
160648053|NCT00501046|580092905|FG001|Overall Study|Lost to Follow-up|13|||
160648054|NCT00501046|580092904|FG000|Overall Study|Physician Decision|7|||
160648055|NCT00501046|580092905|FG001|Overall Study|Physician Decision|2|||
160648056|NCT00501046|580092904|FG000|Overall Study|Pregnancy|0|||
160648057|NCT00501046|580092905|FG001|Overall Study|Pregnancy|3|||
160648058|NCT00501046|580092904|FG000|Overall Study|Protocol Violation|2|||
160648059|NCT00501046|580092905|FG001|Overall Study|Protocol Violation|1|||
160565621|NCT00818259|579790416|FG004|Part II|Not Treated|0|||
160648060|NCT00501046|580092904|FG000|Overall Study|Withdrawal by Subject|84|||
160648061|NCT00501046|580092905|FG001|Overall Study|Withdrawal by Subject|83|||
160648062|NCT00501046|580092904|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
160648063|NCT00501046|580092905|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
160565622|NCT00818259|579790417|FG005|Part II|Not Treated|0|||
160565623|NCT00818259|579790418|FG006|Part II|Not Treated|0|||
160565624|NCT00818259|579790419|FG007|Part II|Not Treated|0|||
160565625|NCT00818259|579790420|FG008|Part II|Not Treated|0|||
160565626|NCT00818259|579790412|FG000|Part IV|Physician Decision|0|||
160565627|NCT00818259|579790413|FG001|Part IV|Physician Decision|0|||
160565628|NCT00818259|579790414|FG002|Part IV|Physician Decision|0|||
160565629|NCT00818259|579790415|FG003|Part IV|Physician Decision|0|||
160565630|NCT00818259|579790416|FG004|Part IV|Physician Decision|0|||
160565631|NCT00818259|579790417|FG005|Part IV|Physician Decision|1|||
160648076|NCT05056727|580092910|FG000|Initiation Phase|Lost to Follow-up|1|||
160648077|NCT05056727|580092911|FG001|Initiation Phase|Lost to Follow-up|0|||
160648078|NCT05056727|580092912|FG002|Initiation Phase|Lost to Follow-up|0|||
160648079|NCT05056727|580092913|FG003|Initiation Phase|Lost to Follow-up|0|||
160648080|NCT05056727|580092910|FG000|Initiation Phase|Study-specific; Study terminated; Other|20|||
160648081|NCT05056727|580092911|FG001|Initiation Phase|Study-specific; Study terminated; Other|0|||
160565632|NCT00818259|579790418|FG006|Part IV|Physician Decision|0|||
160648082|NCT05056727|580092912|FG002|Initiation Phase|Study-specific; Study terminated; Other|0|||
160648083|NCT05056727|580092913|FG003|Initiation Phase|Study-specific; Study terminated; Other|0|||
160565633|NCT00818259|579790419|FG007|Part IV|Physician Decision|0|||
160565634|NCT00818259|579790420|FG008|Part IV|Physician Decision|0|||
160648084|NCT05056727|580092910|FG000|Initiation Phase|Withdrawal by Subject|9|||
160648085|NCT05056727|580092911|FG001|Initiation Phase|Withdrawal by Subject|0|||
160992236|NCT02014558|581360004|FG009|Overall Study|Lack of Efficacy|3|||
160565635|NCT00818259|579790412|FG000|Part V|Adverse Event|0|||
160648086|NCT05056727|580092912|FG002|Initiation Phase|Withdrawal by Subject|0|||
160648087|NCT05056727|580092913|FG003|Initiation Phase|Withdrawal by Subject|0|||
160648088|NCT05056727|580092910|FG000|Initiation Phase|Physician Decision|4|||
160648089|NCT05056727|580092911|FG001|Initiation Phase|Physician Decision|0|||
160648090|NCT05056727|580092912|FG002|Initiation Phase|Physician Decision|0|||
160648091|NCT05056727|580092913|FG003|Initiation Phase|Physician Decision|0|||
160648092|NCT05056727|580092910|FG000|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
160648093|NCT05056727|580092911|FG001|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|237|||
160648094|NCT05056727|580092912|FG002|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
160648095|NCT05056727|580092913|FG003|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
160648096|NCT05056727|580092910|FG000|Run-in Phase|Death|0|||
160648097|NCT05056727|580092911|FG001|Run-in Phase|Death|3|||
160648098|NCT05056727|580092912|FG002|Run-in Phase|Death|0|||
160648099|NCT05056727|580092913|FG003|Run-in Phase|Death|0|||
160648100|NCT05056727|580092910|FG000|Run-in Phase|Withdrawal by Subject|0|||
160648101|NCT05056727|580092911|FG001|Run-in Phase|Withdrawal by Subject|25|||
160648102|NCT05056727|580092912|FG002|Run-in Phase|Withdrawal by Subject|0|||
160648103|NCT05056727|580092913|FG003|Run-in Phase|Withdrawal by Subject|0|||
160648104|NCT05056727|580092910|FG000|Run-in Phase|Physician Decision|0|||
160648105|NCT05056727|580092911|FG001|Run-in Phase|Physician Decision|20|||
160648106|NCT05056727|580092912|FG002|Run-in Phase|Physician Decision|0|||
160648107|NCT05056727|580092913|FG003|Run-in Phase|Physician Decision|0|||
160648108|NCT05056727|580092910|FG000|Run-in Phase|Lost to Follow-up|0|||
160648109|NCT05056727|580092911|FG001|Run-in Phase|Lost to Follow-up|1|||
160648110|NCT05056727|580092912|FG002|Run-in Phase|Lost to Follow-up|0|||
160992237|NCT02014558|581360005|FG010|Overall Study|Lack of Efficacy|16|||
160992238|NCT02014558|581360006|FG011|Overall Study|Lack of Efficacy|8|||
160992239|NCT02014558|581360007|FG012|Overall Study|Lack of Efficacy|5|||
160992240|NCT02014558|581359995|FG000|Overall Study|Lost to Follow-up|0|||
160992241|NCT02014558|581359996|FG001|Overall Study|Lost to Follow-up|0|||
160992242|NCT02014558|581359997|FG002|Overall Study|Lost to Follow-up|0|||
160992243|NCT02014558|581359998|FG003|Overall Study|Lost to Follow-up|0|||
160992244|NCT02014558|581359999|FG004|Overall Study|Lost to Follow-up|0|||
160992245|NCT02014558|581360000|FG005|Overall Study|Lost to Follow-up|0|||
160992246|NCT02014558|581360001|FG006|Overall Study|Lost to Follow-up|0|||
160992247|NCT02014558|581360002|FG007|Overall Study|Lost to Follow-up|0|||
160992248|NCT02014558|581360003|FG008|Overall Study|Lost to Follow-up|0|||
160648111|NCT05056727|580092913|FG003|Run-in Phase|Lost to Follow-up|0|||
160648112|NCT05056727|580092910|FG000|Maintenance Phase|Site terminated; Study terminated; Other|0|||
160648113|NCT05056727|580092911|FG001|Maintenance Phase|Site terminated; Study terminated; Other|0|||
160992249|NCT02014558|581360004|FG009|Overall Study|Lost to Follow-up|0|||
160992250|NCT02014558|581360005|FG010|Overall Study|Lost to Follow-up|1|||
160992251|NCT02014558|581360006|FG011|Overall Study|Lost to Follow-up|0|||
160992252|NCT02014558|581360007|FG012|Overall Study|Lost to Follow-up|0|||
160992253|NCT02014558|581359995|FG000|Overall Study|Progressive Disease|1|||
160992254|NCT02014558|581359996|FG001|Overall Study|Progressive Disease|0|||
160992255|NCT02014558|581359997|FG002|Overall Study|Progressive Disease|1|||
160992256|NCT02014558|581359998|FG003|Overall Study|Progressive Disease|1|||
160992257|NCT02014558|581359999|FG004|Overall Study|Progressive Disease|1|||
160992258|NCT02014558|581360000|FG005|Overall Study|Progressive Disease|2|||
160992259|NCT02014558|581360001|FG006|Overall Study|Progressive Disease|1|||
160992260|NCT02014558|581360002|FG007|Overall Study|Progressive Disease|6|||
160992261|NCT02014558|581360003|FG008|Overall Study|Progressive Disease|5|||
160992262|NCT02014558|581360004|FG009|Overall Study|Progressive Disease|6|||
160992263|NCT02014558|581360005|FG010|Overall Study|Progressive Disease|22|||
160992264|NCT02014558|581360006|FG011|Overall Study|Progressive Disease|31|||
160992265|NCT02014558|581360007|FG012|Overall Study|Progressive Disease|6|||
160992266|NCT02014558|581359995|FG000|Overall Study|Withdrawal by Subject|0|||
160992267|NCT02014558|581359996|FG001|Overall Study|Withdrawal by Subject|0|||
160992268|NCT02014558|581359997|FG002|Overall Study|Withdrawal by Subject|0|||
160565636|NCT00818259|579790413|FG001|Part V|Adverse Event|0|||
160565637|NCT00818259|579790414|FG002|Part V|Adverse Event|0|||
160565638|NCT00818259|579790415|FG003|Part V|Adverse Event|0|||
160565639|NCT00818259|579790416|FG004|Part V|Adverse Event|0|||
160565640|NCT00818259|579790417|FG005|Part V|Adverse Event|0|||
160565641|NCT00818259|579790418|FG006|Part V|Adverse Event|0|||
160565642|NCT00818259|579790419|FG007|Part V|Adverse Event|1|||
160565643|NCT00818259|579790420|FG008|Part V|Adverse Event|0|||
160565644|NCT04640766|579790421|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
160565645|NCT00609622|579790422|FG000|Overall Study|Adverse Event|14|||
160565646|NCT00609622|579790423|FG001|Overall Study|Adverse Event|10|||
160565647|NCT00609622|579790422|FG000|Overall Study|Withdrawal by Subject|4|||
160565648|NCT00609622|579790423|FG001|Overall Study|Withdrawal by Subject|20|||
160565649|NCT00609622|579790422|FG000|Overall Study|Death|1|||
160565650|NCT00609622|579790423|FG001|Overall Study|Death|4|||
160565651|NCT00609622|579790422|FG000|Overall Study|Protocol Violation|1|||
160565652|NCT00609622|579790423|FG001|Overall Study|Protocol Violation|1|||
160565653|NCT00609622|579790422|FG000|Overall Study|Objective progression or relapse|47|||
160565654|NCT00609622|579790423|FG001|Overall Study|Objective progression or relapse|41|||
160565655|NCT00609622|579790422|FG000|Overall Study|Study terminated by sponsor|16|||
160565656|NCT00609622|579790423|FG001|Overall Study|Study terminated by sponsor|3|||
160565657|NCT00609622|579790422|FG000|Overall Study|Other|7|||
160565658|NCT00609622|579790423|FG001|Overall Study|Other|14|||
160565659|NCT00609622|579790422|FG000|Overall Study|Global deterioration of health status|6|||
160565660|NCT00609622|579790423|FG001|Overall Study|Global deterioration of health status|2|||
160565661|NCT01708057|579790426|FG000|Overall Study|Withdrawal due to study termination.|1|||
160565662|NCT01708057|579790427|FG001|Overall Study|Withdrawal due to study termination.|1|||
160565663|NCT01708057|579790428|FG002|Overall Study|Withdrawal due to study termination.|1|||
160565664|NCT01523873|579790436|FG000|Overall Study|Protocol Violation|422|||
160565665|NCT00075881|579791806|FG000|Overall Study|Lack of Efficacy|18|||
160565666|NCT00075881|579791806|FG000|Overall Study|Adverse Event|7|||
160565667|NCT00075881|579791806|FG000|Overall Study|Death|1|||
160565668|NCT00075881|579791806|FG000|Overall Study|Withdrawal by Subject|2|||
160565669|NCT00075881|579791806|FG000|Overall Study|Protocol Violation|4|||
160565670|NCT00075881|579791806|FG000|Overall Study|other complicating disease|3|||
160565671|NCT00075881|579791806|FG000|Overall Study|other|4|||
160565672|NCT00075881|579791806|FG000|Overall Study|missing data|2|||
160565673|NCT00075881|579791806|FG000|Overall Study|Ineligible|1|||
160565674|NCT00075881|579791806|FG000|Overall Study|never start protocol therapy|1|||
160565675|NCT02224664|579791807|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
160565676|NCT02224664|579791808|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
160565677|NCT02224664|579791809|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
160565678|NCT02224664|579791810|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
160565679|NCT02224664|579791811|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
160565680|NCT02224664|579791807|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
160565681|NCT02224664|579791808|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
160565682|NCT02224664|579791809|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
160565683|NCT02224664|579791810|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
160565684|NCT02224664|579791811|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
160565685|NCT02224664|579791807|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
160565686|NCT02224664|579791808|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
160565687|NCT02224664|579791809|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
160565688|NCT02224664|579791810|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
160565689|NCT02224664|579791811|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
160565690|NCT01024244|579791827|FG000|Overall Study|Adverse Event|1|||
160565691|NCT01024244|579791828|FG001|Overall Study|Adverse Event|2|||
160565692|NCT01024244|579791829|FG002|Overall Study|Adverse Event|0|||
160565693|NCT01024244|579791830|FG003|Overall Study|Adverse Event|1|||
160565694|NCT01024244|579791831|FG004|Overall Study|Adverse Event|2|||
160565695|NCT01024244|579791827|FG000|Overall Study|Entry Criteria Not Met|0|||
160565696|NCT01024244|579791828|FG001|Overall Study|Entry Criteria Not Met|1|||
160565697|NCT01024244|579791829|FG002|Overall Study|Entry Criteria Not Met|0|||
160565698|NCT01024244|579791830|FG003|Overall Study|Entry Criteria Not Met|0|||
160565699|NCT01024244|579791831|FG004|Overall Study|Entry Criteria Not Met|0|||
160565700|NCT01024244|579791827|FG000|Overall Study|Lack of Efficacy|1|||
160565701|NCT01024244|579791828|FG001|Overall Study|Lack of Efficacy|0|||
160565702|NCT01024244|579791829|FG002|Overall Study|Lack of Efficacy|0|||
160565703|NCT01024244|579791830|FG003|Overall Study|Lack of Efficacy|0|||
160565704|NCT01024244|579791831|FG004|Overall Study|Lack of Efficacy|0|||
160565705|NCT01024244|579791827|FG000|Overall Study|Protocol Violation|1|||
160565706|NCT01024244|579791828|FG001|Overall Study|Protocol Violation|0|||
160565707|NCT01024244|579791829|FG002|Overall Study|Protocol Violation|0|||
160565708|NCT01024244|579791830|FG003|Overall Study|Protocol Violation|0|||
160565709|NCT01024244|579791831|FG004|Overall Study|Protocol Violation|2|||
160565710|NCT01024244|579791827|FG000|Overall Study|Sponsor Decision|14|||
160565711|NCT01024244|579791828|FG001|Overall Study|Sponsor Decision|7|||
160648114|NCT05056727|580092912|FG002|Maintenance Phase|Site terminated; Study terminated; Other|332|||
160648115|NCT05056727|580092913|FG003|Maintenance Phase|Site terminated; Study terminated; Other|314|||
160648116|NCT05056727|580092910|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160648117|NCT05056727|580092911|FG001|Maintenance Phase|Withdrawal by Subject|0|||
160648118|NCT05056727|580092912|FG002|Maintenance Phase|Withdrawal by Subject|19|||
160648119|NCT05056727|580092913|FG003|Maintenance Phase|Withdrawal by Subject|21|||
160648120|NCT05056727|580092910|FG000|Maintenance Phase|Physician Decision|0|||
160648121|NCT05056727|580092911|FG001|Maintenance Phase|Physician Decision|0|||
160648122|NCT05056727|580092912|FG002|Maintenance Phase|Physician Decision|4|||
160648123|NCT05056727|580092913|FG003|Maintenance Phase|Physician Decision|16|||
160648124|NCT05056727|580092910|FG000|Maintenance Phase|Lost to Follow-up|0|||
160648125|NCT05056727|580092911|FG001|Maintenance Phase|Lost to Follow-up|0|||
160565712|NCT01024244|579791829|FG002|Overall Study|Sponsor Decision|14|||
160565713|NCT01024244|579791830|FG003|Overall Study|Sponsor Decision|12|||
160565714|NCT01024244|579791831|FG004|Overall Study|Sponsor Decision|10|||
160565715|NCT01024244|579791827|FG000|Overall Study|Withdrawal by Subject|0|||
160648126|NCT05056727|580092912|FG002|Maintenance Phase|Lost to Follow-up|2|||
160648127|NCT05056727|580092913|FG003|Maintenance Phase|Lost to Follow-up|2|||
160648128|NCT05056727|580092910|FG000|Maintenance Phase|Death|0|||
160648129|NCT05056727|580092911|FG001|Maintenance Phase|Death|0|||
160648130|NCT05056727|580092912|FG002|Maintenance Phase|Death|4|||
160648131|NCT05056727|580092913|FG003|Maintenance Phase|Death|2|||
160648132|NCT02622113|580092914|FG000|Overall Study|Adverse Event|4|||
160648133|NCT02622113|580092915|FG001|Overall Study|Adverse Event|4|||
160648134|NCT02622113|580092914|FG000|Overall Study|Physician Decision|0|||
160648135|NCT02622113|580092915|FG001|Overall Study|Physician Decision|1|||
160648136|NCT02622113|580092914|FG000|Overall Study|Withdrawal by Subject|0|||
160648137|NCT02622113|580092915|FG001|Overall Study|Withdrawal by Subject|2|||
160565716|NCT01024244|579791828|FG001|Overall Study|Withdrawal by Subject|1|||
160565717|NCT01024244|579791829|FG002|Overall Study|Withdrawal by Subject|0|||
160565718|NCT01024244|579791830|FG003|Overall Study|Withdrawal by Subject|0|||
160648138|NCT02622113|580092914|FG000|Overall Study|Stopping Criteria|1|||
160565719|NCT01024244|579791831|FG004|Overall Study|Withdrawal by Subject|0|||
160648139|NCT02622113|580092915|FG001|Overall Study|Stopping Criteria|3|||
160648148|NCT03289208|580092928|FG000|Overall Study|Adverse Event|1|||
160648149|NCT03289208|580092929|FG001|Overall Study|Adverse Event|0|||
160648150|NCT03289208|580092930|FG002|Overall Study|Adverse Event|0|||
160648155|NCT01840605|580094665|FG000|Overall Study|Adverse Event|0|||
160648156|NCT01840605|580094666|FG001|Overall Study|Adverse Event|1|||
160648157|NCT01840605|580094665|FG000|Overall Study|Physician Decision|2|||
160648158|NCT01840605|580094666|FG001|Overall Study|Physician Decision|1|||
160648159|NCT04969939|580094667|FG000|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
160648160|NCT04969939|580094668|FG001|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
160648161|NCT04969939|580094669|FG002|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
160648162|NCT04969939|580094670|FG003|Part 2a: Run in Period (32 Weeks)|Adverse Event|4|||
160648163|NCT04969939|580094671|FG004|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
160648164|NCT04969939|580094672|FG005|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
160648165|NCT04969939|580094673|FG006|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
160648166|NCT04969939|580094667|FG000|Part 2a: Run in Period (32 Weeks)|Other|0|||
160648167|NCT04969939|580094668|FG001|Part 2a: Run in Period (32 Weeks)|Other|0|||
160648168|NCT04969939|580094669|FG002|Part 2a: Run in Period (32 Weeks)|Other|0|||
160648169|NCT04969939|580094670|FG003|Part 2a: Run in Period (32 Weeks)|Other|5|||
160648170|NCT04969939|580094671|FG004|Part 2a: Run in Period (32 Weeks)|Other|0|||
160648171|NCT04969939|580094672|FG005|Part 2a: Run in Period (32 Weeks)|Other|0|||
160648172|NCT04969939|580094673|FG006|Part 2a: Run in Period (32 Weeks)|Other|0|||
160648173|NCT04969939|580094667|FG000|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
160648174|NCT04969939|580094668|FG001|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
160648175|NCT04969939|580094669|FG002|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
160648176|NCT04969939|580094670|FG003|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|2|||
160648177|NCT04969939|580094671|FG004|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
160648178|NCT04969939|580094672|FG005|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
160648179|NCT04969939|580094673|FG006|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
160648180|NCT04969939|580094667|FG000|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
160648181|NCT04969939|580094668|FG001|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
160648182|NCT04969939|580094669|FG002|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
160648183|NCT04969939|580094670|FG003|Part 2a: Run in Period (32 Weeks)|Pregnancy|1|||
160648184|NCT04969939|580094671|FG004|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
160648185|NCT04969939|580094672|FG005|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
160648186|NCT04969939|580094673|FG006|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
160648187|NCT04969939|580094667|FG000|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
160648188|NCT04969939|580094668|FG001|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
160648189|NCT04969939|580094669|FG002|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
160648190|NCT04969939|580094670|FG003|Part 2a: Run in Period (32 Weeks)|Protocol Violation|1|||
160648191|NCT04969939|580094671|FG004|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
160648192|NCT04969939|580094672|FG005|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
160648193|NCT04969939|580094673|FG006|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
160648194|NCT04969939|580094667|FG000|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
160648195|NCT04969939|580094668|FG001|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
160648196|NCT04969939|580094669|FG002|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
160648197|NCT04969939|580094670|FG003|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
160648198|NCT04969939|580094671|FG004|Part 2b (16 Weeks)|Withdrawal by Subject|3|||
160648199|NCT04969939|580094672|FG005|Part 2b (16 Weeks)|Withdrawal by Subject|1|||
160648200|NCT04969939|580094673|FG006|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
160844359|NCT00195663|580817985|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
160844360|NCT00195663|580817986|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
160844361|NCT00195663|580817987|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
160844362|NCT00195663|580817985|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
160844363|NCT00195663|580817986|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
160844364|NCT00195663|580817987|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
160844365|NCT00195663|580817985|FG000|Open-Label Extension Period|Administrative reasons|11|||
160844366|NCT00195663|580817986|FG001|Open-Label Extension Period|Administrative reasons|11|||
160844367|NCT00195663|580817987|FG002|Open-Label Extension Period|Administrative reasons|13|||
160565720|NCT03874234|579791836|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160844368|NCT01380834|580817988|FG000|Overall Study|Physician Decision|1|||
160565721|NCT03874234|579791837|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565722|NCT03874234|579791838|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565723|NCT03874234|579791839|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
160565724|NCT03874234|579791840|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565725|NCT03874234|579791841|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565726|NCT03874234|579791842|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565727|NCT03874234|579791843|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565728|NCT03874234|579791844|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565729|NCT03874234|579791845|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565730|NCT03874234|579791846|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565731|NCT03874234|579791847|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565732|NCT03874234|579791848|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160565733|NCT03874234|579791836|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
160565734|NCT03874234|579791837|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565735|NCT03874234|579791838|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565736|NCT03874234|579791839|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565737|NCT03874234|579791840|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565738|NCT03874234|579791841|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565739|NCT03874234|579791842|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565740|NCT03874234|579791843|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565741|NCT03874234|579791844|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565742|NCT03874234|579791845|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565743|NCT03874234|579791846|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565744|NCT03874234|579791847|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565745|NCT03874234|579791848|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160565746|NCT03874234|579791836|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565747|NCT03874234|579791837|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565748|NCT03874234|579791838|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565749|NCT03874234|579791839|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
160565750|NCT03874234|579791840|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565751|NCT03874234|579791841|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565752|NCT03874234|579791842|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565753|NCT03874234|579791843|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565754|NCT03874234|579791844|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565755|NCT03874234|579791845|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565756|NCT03874234|579791846|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565757|NCT03874234|579791847|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565758|NCT03874234|579791848|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160565759|NCT03874234|579791836|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565760|NCT03874234|579791837|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565761|NCT03874234|579791838|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565762|NCT03874234|579791839|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565763|NCT03874234|579791840|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
160565764|NCT03874234|579791841|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565765|NCT03874234|579791842|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565766|NCT03874234|579791843|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565767|NCT03874234|579791844|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565768|NCT03874234|579791845|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565769|NCT03874234|579791846|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565770|NCT03874234|579791847|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565771|NCT03874234|579791848|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
160565772|NCT03874234|579791836|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565773|NCT03874234|579791837|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565774|NCT03874234|579791838|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565775|NCT03874234|579791839|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565776|NCT03874234|579791840|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160648213|NCT03843359|580094679|FG000|Escalation Phase|Lost to Follow-up|0|||
160648214|NCT03843359|580094680|FG001|Escalation Phase|Lost to Follow-up|0|||
160648215|NCT03843359|580094681|FG002|Escalation Phase|Lost to Follow-up|0|||
160648216|NCT03843359|580094682|FG003|Escalation Phase|Lost to Follow-up|0|||
160648217|NCT03843359|580094683|FG004|Escalation Phase|Lost to Follow-up|0|||
160648218|NCT03843359|580094684|FG005|Escalation Phase|Lost to Follow-up|0|||
160648219|NCT03843359|580094685|FG006|Escalation Phase|Lost to Follow-up|0|||
160648220|NCT03843359|580094686|FG007|Escalation Phase|Lost to Follow-up|0|||
160648221|NCT03843359|580094687|FG008|Escalation Phase|Lost to Follow-up|1|||
160648222|NCT03843359|580094688|FG009|Escalation Phase|Lost to Follow-up|0|||
160648223|NCT03843359|580094689|FG010|Escalation Phase|Lost to Follow-up|0|||
160648224|NCT03843359|580094690|FG011|Escalation Phase|Lost to Follow-up|0|||
160648225|NCT03843359|580094691|FG012|Escalation Phase|Lost to Follow-up|0|||
160648226|NCT03843359|580094692|FG013|Escalation Phase|Lost to Follow-up|0|||
160648227|NCT03843359|580094693|FG014|Escalation Phase|Lost to Follow-up|0|||
160992269|NCT02014558|581359998|FG003|Overall Study|Withdrawal by Subject|0|||
160648228|NCT03843359|580094694|FG015|Escalation Phase|Lost to Follow-up|0|||
160648229|NCT03843359|580094679|FG000|Escalation Phase|Physician Decision|0|||
160648230|NCT03843359|580094680|FG001|Escalation Phase|Physician Decision|0|||
160648231|NCT03843359|580094681|FG002|Escalation Phase|Physician Decision|1|||
160648232|NCT03843359|580094682|FG003|Escalation Phase|Physician Decision|0|||
160648233|NCT03843359|580094683|FG004|Escalation Phase|Physician Decision|0|||
160648234|NCT03843359|580094684|FG005|Escalation Phase|Physician Decision|1|||
160648235|NCT03843359|580094685|FG006|Escalation Phase|Physician Decision|0|||
160648236|NCT03843359|580094686|FG007|Escalation Phase|Physician Decision|0|||
160648237|NCT03843359|580094687|FG008|Escalation Phase|Physician Decision|0|||
160648238|NCT03843359|580094688|FG009|Escalation Phase|Physician Decision|0|||
160648239|NCT03843359|580094689|FG010|Escalation Phase|Physician Decision|0|||
160648240|NCT03843359|580094690|FG011|Escalation Phase|Physician Decision|0|||
160648241|NCT03843359|580094691|FG012|Escalation Phase|Physician Decision|0|||
160648242|NCT03843359|580094692|FG013|Escalation Phase|Physician Decision|0|||
160648243|NCT03843359|580094693|FG014|Escalation Phase|Physician Decision|0|||
160648244|NCT03843359|580094694|FG015|Escalation Phase|Physician Decision|0|||
160648245|NCT03843359|580094679|FG000|Escalation Phase|Investigator site closed|0|||
160648246|NCT03843359|580094680|FG001|Escalation Phase|Investigator site closed|1|||
160648247|NCT03843359|580094681|FG002|Escalation Phase|Investigator site closed|0|||
160648248|NCT03843359|580094682|FG003|Escalation Phase|Investigator site closed|1|||
160648249|NCT03843359|580094683|FG004|Escalation Phase|Investigator site closed|1|||
160844369|NCT01380834|580817989|FG001|Overall Study|Physician Decision|0|||
160844370|NCT03214406|580817990|FG000|Overall Study|did not meet enrollment criteria|9|||
160844371|NCT03214406|580817991|FG001|Overall Study|did not meet enrollment criteria|13|||
160844372|NCT03214406|580817990|FG000|Overall Study|Withdrawal by Subject|1|||
160844373|NCT03214406|580817991|FG001|Overall Study|Withdrawal by Subject|0|||
160844374|NCT03214406|580817990|FG000|Overall Study|Lost to Follow-up|0|||
160844375|NCT03214406|580817991|FG001|Overall Study|Lost to Follow-up|2|||
160844376|NCT01098305|580817992|FG000|Overall Study|Lost to Follow-up|31|||
160648250|NCT03843359|580094684|FG005|Escalation Phase|Investigator site closed|0|||
160648251|NCT03843359|580094685|FG006|Escalation Phase|Investigator site closed|1|||
160648252|NCT03843359|580094686|FG007|Escalation Phase|Investigator site closed|0|||
160648253|NCT03843359|580094687|FG008|Escalation Phase|Investigator site closed|2|||
160648254|NCT03843359|580094688|FG009|Escalation Phase|Investigator site closed|0|||
160648255|NCT03843359|580094689|FG010|Escalation Phase|Investigator site closed|0|||
160648256|NCT03843359|580094690|FG011|Escalation Phase|Investigator site closed|0|||
160648257|NCT03843359|580094691|FG012|Escalation Phase|Investigator site closed|0|||
160648258|NCT03843359|580094692|FG013|Escalation Phase|Investigator site closed|0|||
160648259|NCT03843359|580094693|FG014|Escalation Phase|Investigator site closed|0|||
160648260|NCT03843359|580094694|FG015|Escalation Phase|Investigator site closed|0|||
160648261|NCT03843359|580094679|FG000|Escalation Phase|Ongoing at the time of analysis|0|||
160648262|NCT03843359|580094680|FG001|Escalation Phase|Ongoing at the time of analysis|0|||
160648263|NCT03843359|580094681|FG002|Escalation Phase|Ongoing at the time of analysis|0|||
160648264|NCT03843359|580094682|FG003|Escalation Phase|Ongoing at the time of analysis|0|||
160648265|NCT03843359|580094683|FG004|Escalation Phase|Ongoing at the time of analysis|0|||
160565777|NCT03874234|579791841|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565778|NCT03874234|579791842|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565779|NCT03874234|579791843|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
160565780|NCT03874234|579791844|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565781|NCT03874234|579791845|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565782|NCT03874234|579791846|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565783|NCT03874234|579791847|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565784|NCT03874234|579791848|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
160565785|NCT03874234|579791836|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160565786|NCT03874234|579791837|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160565787|NCT03874234|579791838|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160565788|NCT03874234|579791839|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160565789|NCT03874234|579791840|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
160565790|NCT03874234|579791841|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
160565791|NCT03874234|579791842|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160565792|NCT03874234|579791843|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160565793|NCT03874234|579791844|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160565794|NCT03874234|579791845|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160565795|NCT03874234|579791846|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160565796|NCT03874234|579791847|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160565797|NCT03874234|579791848|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
160648266|NCT03843359|580094684|FG005|Escalation Phase|Ongoing at the time of analysis|0|||
160648267|NCT03843359|580094685|FG006|Escalation Phase|Ongoing at the time of analysis|0|||
160648268|NCT03843359|580094686|FG007|Escalation Phase|Ongoing at the time of analysis|0|||
160648269|NCT03843359|580094687|FG008|Escalation Phase|Ongoing at the time of analysis|1|||
160648270|NCT03843359|580094688|FG009|Escalation Phase|Ongoing at the time of analysis|0|||
160648271|NCT03843359|580094689|FG010|Escalation Phase|Ongoing at the time of analysis|0|||
160565798|NCT03874234|579791836|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565799|NCT03874234|579791837|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565800|NCT03874234|579791838|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565801|NCT03874234|579791839|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565802|NCT03874234|579791840|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565803|NCT03874234|579791841|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565804|NCT03874234|579791842|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
160565805|NCT03874234|579791843|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565806|NCT03874234|579791844|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565807|NCT03874234|579791845|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565808|NCT03874234|579791846|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565809|NCT03874234|579791847|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565810|NCT03874234|579791848|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
160565811|NCT03874234|579791836|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565812|NCT03874234|579791837|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565813|NCT03874234|579791838|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565814|NCT03874234|579791839|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565815|NCT03874234|579791840|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
160565816|NCT03874234|579791841|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565817|NCT03874234|579791842|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565818|NCT03874234|579791843|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565819|NCT03874234|579791844|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160905886|NCT01847274|581050311|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905887|NCT01847274|581050312|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905888|NCT01847274|581050313|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905889|NCT01847274|581050314|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905890|NCT01847274|581050304|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905891|NCT01847274|581050305|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905892|NCT01847274|581050306|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905893|NCT01847274|581050307|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905894|NCT01847274|581050308|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905895|NCT01847274|581050309|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905896|NCT01847274|581050310|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
160905897|NCT01847274|581050311|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905898|NCT01847274|581050312|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905899|NCT01847274|581050313|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905900|NCT01847274|581050314|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905901|NCT01847274|581050304|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905902|NCT01847274|581050305|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905903|NCT01847274|581050306|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905904|NCT01847274|581050307|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905905|NCT01847274|581050308|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905906|NCT01847274|581050309|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905907|NCT01847274|581050310|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
160905908|NCT01847274|581050311|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905909|NCT01847274|581050312|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905910|NCT01847274|581050313|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905911|NCT01847274|581050314|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905912|NCT01847274|581050304|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160565820|NCT03874234|579791845|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565821|NCT03874234|579791846|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565822|NCT03874234|579791847|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565823|NCT03874234|579791848|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160565824|NCT01896232|579791854|FG000|Overall Study|Death|6|||
160565825|NCT01896232|579791855|FG001|Overall Study|Death|10|||
160565826|NCT01896232|579791854|FG000|Overall Study|Withdrawal by Subject|32|||
160565827|NCT01896232|579791855|FG001|Overall Study|Withdrawal by Subject|31|||
160565828|NCT01896232|579791854|FG000|Overall Study|Sponsor Decision|2|||
160565829|NCT01896232|579791855|FG001|Overall Study|Sponsor Decision|0|||
160565830|NCT01896232|579791854|FG000|Overall Study|Lost to Follow-up|9|||
160565831|NCT01896232|579791855|FG001|Overall Study|Lost to Follow-up|12|||
160565832|NCT00686205|579791856|FG000|Overall Study|Protocol Violation|127|||
160565833|NCT00686205|579791857|FG001|Overall Study|Protocol Violation|0|||
160905913|NCT01847274|581050305|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160565834|NCT00686205|579791856|FG000|Overall Study|Withdrawal by Subject|2|||
160565835|NCT00686205|579791857|FG001|Overall Study|Withdrawal by Subject|0|||
160565836|NCT00686205|579791856|FG000|Overall Study|Specimen handling procedure altered|5878|||
160648272|NCT03843359|580094690|FG011|Escalation Phase|Ongoing at the time of analysis|1|||
160648273|NCT03843359|580094691|FG012|Escalation Phase|Ongoing at the time of analysis|1|||
160648274|NCT03843359|580094692|FG013|Escalation Phase|Ongoing at the time of analysis|0|||
160648275|NCT03843359|580094693|FG014|Escalation Phase|Ongoing at the time of analysis|0|||
160648276|NCT03843359|580094694|FG015|Escalation Phase|Ongoing at the time of analysis|0|||
160648277|NCT03843359|580094679|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648278|NCT03843359|580094680|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648279|NCT03843359|580094681|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|7|||
160648280|NCT03843359|580094682|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160565837|NCT00686205|579791857|FG001|Overall Study|Specimen handling procedure altered|0|||
160565838|NCT00686205|579791856|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
160565839|NCT00686205|579791857|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
160565840|NCT03812510|579791862|FG000|Overall Study|Lost to Follow-up|39|||
160565841|NCT03812510|579791862|FG000|Overall Study|Withdrawal by Subject|42|||
160648281|NCT03843359|580094683|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
160648282|NCT03843359|580094684|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648283|NCT03843359|580094685|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648284|NCT03843359|580094686|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648285|NCT03843359|580094687|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648286|NCT03843359|580094688|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648287|NCT03843359|580094689|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160844377|NCT01098305|580817993|FG001|Overall Study|Lost to Follow-up|33|||
160844378|NCT04310566|580818000|FG000|Period 1|Study Termination due to COVID-19|15|||
160844379|NCT04310566|580818001|FG001|Period 1|Study Termination due to COVID-19|17|||
160844380|NCT04310566|580818000|FG000|Period 1|Protocol Violation|0|||
160844381|NCT04310566|580818001|FG001|Period 1|Protocol Violation|1|||
160844382|NCT04310566|580818000|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
160844383|NCT04310566|580818001|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
160844384|NCT04310566|580818000|FG000|Period 1|Lost to Follow-up|1|||
160844385|NCT04310566|580818001|FG001|Period 1|Lost to Follow-up|0|||
160844386|NCT04310566|580818000|FG000|Period 1|Withdrawal by Subject|0|||
160905914|NCT01847274|581050306|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905915|NCT01847274|581050307|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905916|NCT01847274|581050308|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905917|NCT01847274|581050309|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905918|NCT01847274|581050310|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
160905919|NCT01847274|581050311|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160565842|NCT03812510|579791862|FG000|Overall Study|Physician Decision|2|||
160565843|NCT03812510|579791862|FG000|Overall Study|Study Terminated by Sponsor|9|||
160565844|NCT03812510|579791862|FG000|Overall Study|Did Not Start Study Medication|55|||
160565845|NCT03812510|579791862|FG000|Overall Study|Adverse Event|5|||
160565846|NCT01128387|579791863|FG000|Overall Study|Physician Decision|0|||
160565847|NCT01128387|579791864|FG001|Overall Study|Physician Decision|1|||
160565848|NCT00858832|579791865|FG000|Overall Study|became ineligible: delivered vaginally|1|||
160565849|NCT00858832|579791866|FG001|Overall Study|became ineligible: delivered vaginally|0|||
160565850|NCT00858832|579791865|FG000|Overall Study|Adverse Event|0|||
160565851|NCT00858832|579791866|FG001|Overall Study|Adverse Event|1|||
160565852|NCT03075839|579791873|FG000|Overall Study|Lost to Follow-up|4|||
160565853|NCT05089708|579791875|FG000|Overall Study|Lost to Follow-up|9|||
160565854|NCT05089708|579791876|FG001|Overall Study|Lost to Follow-up|7|||
160565855|NCT05089708|579791875|FG000|Overall Study|Withdrawal by Subject|3|||
160565856|NCT05089708|579791876|FG001|Overall Study|Withdrawal by Subject|1|||
160565857|NCT05089708|579791875|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
160565858|NCT05089708|579791876|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
160565859|NCT05089708|579791875|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
160565860|NCT05089708|579791876|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
160565861|NCT00659438|579791877|FG000|Overall Study|Withdrawal by Subject|2|||
160565862|NCT00659438|579791878|FG001|Overall Study|Withdrawal by Subject|2|||
160565863|NCT00659438|579791877|FG000|Overall Study|Death|11|||
160565864|NCT00659438|579791878|FG001|Overall Study|Death|6|||
160844387|NCT04310566|580818001|FG001|Period 1|Withdrawal by Subject|1|||
160905920|NCT01847274|581050312|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905921|NCT01847274|581050313|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905922|NCT01847274|581050314|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160565865|NCT00659438|579791877|FG000|Overall Study|Lost to Follow-up|1|||
160565866|NCT00659438|579791878|FG001|Overall Study|Lost to Follow-up|0|||
160565867|NCT00201851|579791879|FG000|Overall Study|Lost to Follow-up|2|||
160565868|NCT00201851|579791880|FG001|Overall Study|Lost to Follow-up|1|||
160565869|NCT00201851|579791881|FG002|Overall Study|Lost to Follow-up|0|||
160565870|NCT00201851|579791879|FG000|Overall Study|Ineligible post enrollment|6|||
160565871|NCT00201851|579791880|FG001|Overall Study|Ineligible post enrollment|1|||
160565872|NCT00201851|579791881|FG002|Overall Study|Ineligible post enrollment|1|||
160565873|NCT00074958|579791882|FG000|Overall Study|Adverse Event|1|||
160565874|NCT02700451|579791883|FG000|Overall Study|Protocol Violation|2|||
160565875|NCT02700451|579791884|FG001|Overall Study|Protocol Violation|2|||
160844388|NCT04310566|580818000|FG000|Period 2|Study Termination|7|||
160844389|NCT04310566|580818001|FG001|Period 2|Study Termination|5|||
160648288|NCT03843359|580094690|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648289|NCT03843359|580094691|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648290|NCT03843359|580094692|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648291|NCT03843359|580094693|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160565876|NCT02700451|579791885|FG002|Overall Study|Protocol Violation|3|||
160565877|NCT02700451|579791883|FG000|Overall Study|Discontinued intervention|14|||
160565878|NCT02700451|579791884|FG001|Overall Study|Discontinued intervention|15|||
160565879|NCT02700451|579791885|FG002|Overall Study|Discontinued intervention|14|||
160565880|NCT02690701|579791886|FG000|Treatment Period 1|Adverse Event|2|||
160565881|NCT02690701|579791887|FG001|Treatment Period 1|Adverse Event|2|||
160565882|NCT02690701|579791886|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160565883|NCT02690701|579791887|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160565884|NCT02690701|579791886|FG000|Treatment Period 2|Adverse Event|2|||
160565885|NCT02690701|579791887|FG001|Treatment Period 2|Adverse Event|0|||
160565886|NCT02690701|579791886|FG000|Treatment Period 2|Lack of Efficacy|1|||
160565887|NCT02690701|579791887|FG001|Treatment Period 2|Lack of Efficacy|0|||
160648292|NCT03843359|580094694|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160648293|NCT03843359|580094679|FG000|Crossover|Withdrawal by Subject|0|||
160648294|NCT03843359|580094680|FG001|Crossover|Withdrawal by Subject|0|||
160648295|NCT03843359|580094681|FG002|Crossover|Withdrawal by Subject|0|||
160648296|NCT03843359|580094682|FG003|Crossover|Withdrawal by Subject|0|||
160648297|NCT03843359|580094683|FG004|Crossover|Withdrawal by Subject|0|||
160648298|NCT03843359|580094684|FG005|Crossover|Withdrawal by Subject|0|||
160648299|NCT03843359|580094685|FG006|Crossover|Withdrawal by Subject|0|||
160648300|NCT03843359|580094686|FG007|Crossover|Withdrawal by Subject|0|||
160565888|NCT02690701|579791886|FG000|Treatment Period 2|Lost to Follow-up|0|||
160565889|NCT02690701|579791887|FG001|Treatment Period 2|Lost to Follow-up|2|||
160565890|NCT02690701|579791886|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160565891|NCT02690701|579791887|FG001|Treatment Period 2|Withdrawal by Subject|2|||
160648301|NCT03843359|580094687|FG008|Crossover|Withdrawal by Subject|0|||
160648302|NCT03843359|580094688|FG009|Crossover|Withdrawal by Subject|0|||
160648303|NCT03843359|580094689|FG010|Crossover|Withdrawal by Subject|0|||
160648304|NCT03843359|580094690|FG011|Crossover|Withdrawal by Subject|0|||
160648305|NCT03843359|580094691|FG012|Crossover|Withdrawal by Subject|0|||
160648306|NCT03843359|580094692|FG013|Crossover|Withdrawal by Subject|0|||
160648307|NCT03843359|580094693|FG014|Crossover|Withdrawal by Subject|0|||
160648308|NCT03843359|580094694|FG015|Crossover|Withdrawal by Subject|1|||
160648309|NCT03843359|580094679|FG000|Crossover|Investigator site closed|0|||
160648310|NCT03843359|580094680|FG001|Crossover|Investigator site closed|0|||
160648311|NCT03843359|580094681|FG002|Crossover|Investigator site closed|0|||
160648312|NCT03843359|580094682|FG003|Crossover|Investigator site closed|0|||
160648313|NCT03843359|580094683|FG004|Crossover|Investigator site closed|0|||
160648314|NCT03843359|580094684|FG005|Crossover|Investigator site closed|0|||
160844390|NCT04677504|580818003|FG000|Overall Study|Death|51|||
160565892|NCT02690701|579791886|FG000|Treatment Period 2|Protocol Violation|0|||
160565893|NCT02690701|579791887|FG001|Treatment Period 2|Protocol Violation|1|||
160565894|NCT00404092|579791891|FG000|Overall Study|Death|1|||
160565895|NCT00404092|579791892|FG001|Overall Study|Death|0|||
160565896|NCT00404092|579791893|FG002|Overall Study|Death|0|||
160565897|NCT00404092|579791894|FG003|Overall Study|Death|0|||
160565898|NCT00404092|579791891|FG000|Overall Study|Adverse Event|0|||
160648315|NCT03843359|580094685|FG006|Crossover|Investigator site closed|0|||
160648316|NCT03843359|580094686|FG007|Crossover|Investigator site closed|0|||
160648317|NCT03843359|580094687|FG008|Crossover|Investigator site closed|0|||
160844391|NCT04677504|580818004|FG001|Overall Study|Death|49|||
160844392|NCT04677504|580818003|FG000|Overall Study|Progressive Disease|1|||
160844393|NCT04677504|580818004|FG001|Overall Study|Progressive Disease|0|||
160844394|NCT04677504|580818003|FG000|Overall Study|Symptomatic Deterioration|1|||
160844395|NCT04677504|580818004|FG001|Overall Study|Symptomatic Deterioration|0|||
160844396|NCT04677504|580818003|FG000|Overall Study|Withdrawal by Subject|2|||
160844397|NCT04677504|580818004|FG001|Overall Study|Withdrawal by Subject|5|||
160844398|NCT04677504|580818003|FG000|Overall Study|Study Terminated By Sponsor|28|||
160844399|NCT04677504|580818004|FG001|Overall Study|Study Terminated By Sponsor|24|||
160844400|NCT04677504|580818003|FG000|Overall Study|Adverse Event|0|||
160844401|NCT04677504|580818004|FG001|Overall Study|Adverse Event|1|||
160844402|NCT03182907|580818005|FG000|Overall Study|Death|3|||
160844403|NCT03182907|580818006|FG001|Overall Study|Death|0|||
160844404|NCT03182907|580818005|FG000|Overall Study|Protocol Violation|4|||
160648318|NCT03843359|580094688|FG009|Crossover|Investigator site closed|0|||
160648319|NCT03843359|580094689|FG010|Crossover|Investigator site closed|0|||
160648320|NCT03843359|580094690|FG011|Crossover|Investigator site closed|0|||
160648321|NCT03843359|580094691|FG012|Crossover|Investigator site closed|0|||
160648322|NCT03843359|580094692|FG013|Crossover|Investigator site closed|0|||
160648323|NCT03843359|580094693|FG014|Crossover|Investigator site closed|2|||
160648324|NCT03843359|580094694|FG015|Crossover|Investigator site closed|2|||
160648325|NCT03843359|580094679|FG000|Crossover|Ongoing at the time of analysis|0|||
160648326|NCT03843359|580094680|FG001|Crossover|Ongoing at the time of analysis|0|||
160648327|NCT03843359|580094681|FG002|Crossover|Ongoing at the time of analysis|0|||
160648328|NCT03843359|580094682|FG003|Crossover|Ongoing at the time of analysis|0|||
160648329|NCT03843359|580094683|FG004|Crossover|Ongoing at the time of analysis|0|||
160648330|NCT03843359|580094684|FG005|Crossover|Ongoing at the time of analysis|0|||
160648331|NCT03843359|580094685|FG006|Crossover|Ongoing at the time of analysis|0|||
160648332|NCT03843359|580094686|FG007|Crossover|Ongoing at the time of analysis|0|||
160648333|NCT03843359|580094687|FG008|Crossover|Ongoing at the time of analysis|0|||
160648334|NCT03843359|580094688|FG009|Crossover|Ongoing at the time of analysis|0|||
160648335|NCT03843359|580094689|FG010|Crossover|Ongoing at the time of analysis|0|||
160648336|NCT03843359|580094690|FG011|Crossover|Ongoing at the time of analysis|0|||
160648337|NCT03843359|580094691|FG012|Crossover|Ongoing at the time of analysis|0|||
160648338|NCT03843359|580094692|FG013|Crossover|Ongoing at the time of analysis|1|||
160648339|NCT03843359|580094693|FG014|Crossover|Ongoing at the time of analysis|0|||
160648340|NCT03843359|580094694|FG015|Crossover|Ongoing at the time of analysis|0|||
160648341|NCT05308472|580094695|FG000|Overall Study|Adverse Event|0|||
160648342|NCT05308472|580094696|FG001|Overall Study|Adverse Event|0|||
160648343|NCT05308472|580094697|FG002|Overall Study|Adverse Event|3|||
160648344|NCT03075527|580094701|FG000|Overall Study|Death|1|||
160648345|NCT03075527|580094701|FG000|Overall Study|Withdrawal by Subject|1|||
160648346|NCT03075527|580094701|FG000|Overall Study|Physician Decision|3|||
160648347|NCT03075527|580094701|FG000|Overall Study|Progression/Relapse|14|||
160648374|NCT05359003|580094711|FG000|Overall Study|Withdrawal by Subject|1|||
160648375|NCT05359003|580094712|FG001|Overall Study|Withdrawal by Subject|3|||
160648416|NCT06202521|580094722|FG000|Overall Study|Withdrawal by Subject|0|||
160648417|NCT06202521|580094723|FG001|Overall Study|Withdrawal by Subject|1|||
160648418|NCT06202521|580094724|FG002|Overall Study|Withdrawal by Subject|0|||
160648419|NCT06202521|580094725|FG003|Overall Study|Withdrawal by Subject|1|||
160648420|NCT06202521|580094722|FG000|Overall Study|Adverse Event|0|||
160648421|NCT06202521|580094723|FG001|Overall Study|Adverse Event|0|||
160648422|NCT06202521|580094724|FG002|Overall Study|Adverse Event|1|||
160648423|NCT06202521|580094725|FG003|Overall Study|Adverse Event|0|||
160565899|NCT00404092|579791892|FG001|Overall Study|Adverse Event|0|||
160565900|NCT00404092|579791893|FG002|Overall Study|Adverse Event|1|||
160565901|NCT00404092|579791894|FG003|Overall Study|Adverse Event|0|||
160565902|NCT02597062|579791895|FG000|Overall Study|Ineligible|1|||
160565903|NCT03372941|579791896|FG000|Overall Study|Lost to Follow-up|2|||
160565904|NCT03372941|579791897|FG001|Overall Study|Lost to Follow-up|4|||
160565905|NCT00741819|579791898|FG000|Overall Study|Adverse Event|3|||
160565906|NCT00741819|579791898|FG000|Overall Study|Withdrawal by Subject|3|||
160565907|NCT00741819|579791898|FG000|Overall Study|Death|1|||
160565908|NCT00741819|579791898|FG000|Overall Study|Disease progression|1|||
160565909|NCT00686543|579791901|FG000|Overall Study|Adverse Event|9|||
160565910|NCT00686543|579791902|FG001|Overall Study|Adverse Event|1|||
160565911|NCT00686543|579791903|FG002|Overall Study|Adverse Event|3|||
160565912|NCT00686543|579791904|FG003|Overall Study|Adverse Event|2|||
160565913|NCT00686543|579791901|FG000|Overall Study|Withdrawal by Subject|2|||
160565914|NCT00686543|579791902|FG001|Overall Study|Withdrawal by Subject|0|||
160565915|NCT00686543|579791903|FG002|Overall Study|Withdrawal by Subject|0|||
160565916|NCT00686543|579791904|FG003|Overall Study|Withdrawal by Subject|0|||
160565917|NCT00686543|579791901|FG000|Overall Study|Protocol Violation|3|||
160565918|NCT00686543|579791902|FG001|Overall Study|Protocol Violation|0|||
160565919|NCT00686543|579791903|FG002|Overall Study|Protocol Violation|2|||
160565920|NCT00686543|579791904|FG003|Overall Study|Protocol Violation|1|||
160565921|NCT00752986|579791905|FG000|Overall Study|Withdrawal by Subject|2|||
160565922|NCT00752986|579791906|FG001|Overall Study|Withdrawal by Subject|1|||
160844405|NCT03182907|580818006|FG001|Overall Study|Protocol Violation|0|||
160844406|NCT03182907|580818005|FG000|Overall Study|Lost to Follow-up|1|||
160844407|NCT03182907|580818006|FG001|Overall Study|Lost to Follow-up|0|||
160844408|NCT03182907|580818005|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160844409|NCT03182907|580818006|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
160844410|NCT01711645|580818009|FG000|Overall Study|Withdrawal by Subject|8|||
160844411|NCT01711645|580818009|FG000|Overall Study|Lost to Follow-up|6|||
160844412|NCT01711645|580818009|FG000|Overall Study|Physician Decision|5|||
160844413|NCT01746173|580818014|FG000|Overall Study|Disease Progression|2|||
160844414|NCT00375518|580818015|FG000|Overall Study|Withdrawal by Subject|2|||
160565923|NCT00752986|579791907|FG002|Overall Study|Withdrawal by Subject|2|||
160844415|NCT00375518|580818016|FG001|Overall Study|Withdrawal by Subject|10|||
160844416|NCT00375518|580818015|FG000|Overall Study|Patient Not Treated|6|||
160844417|NCT00375518|580818016|FG001|Overall Study|Patient Not Treated|6|||
160844418|NCT00375518|580818015|FG000|Overall Study|Death|0|||
160844419|NCT00375518|580818016|FG001|Overall Study|Death|1|||
160844420|NCT03170193|580818017|FG000|Overall Study|Withdrawal by Subject|0|||
160844421|NCT03170193|580818018|FG001|Overall Study|Withdrawal by Subject|0|||
160844422|NCT03170193|580818019|FG002|Overall Study|Withdrawal by Subject|0|||
160844423|NCT03170193|580818020|FG003|Overall Study|Withdrawal by Subject|1|||
160565924|NCT00752986|579791905|FG000|Overall Study|Protocol Violation|3|||
160565925|NCT00752986|579791906|FG001|Overall Study|Protocol Violation|0|||
160565926|NCT00752986|579791907|FG002|Overall Study|Protocol Violation|0|||
160565927|NCT00924703|579791908|FG000|Overall Study|Withdrawal by Subject|11|||
160565928|NCT00924703|579791908|FG000|Overall Study|Physician Decision|5|||
160565929|NCT00924703|579791908|FG000|Overall Study|Lost to Follow-up|3|||
160565930|NCT00924703|579791908|FG000|Overall Study|Adverse Event|2|||
160565931|NCT00924703|579791908|FG000|Overall Study|Withdrawal by Sponsor|1|||
160565932|NCT04906707|579791909|FG000|Overall Study|Withdrawal by Subject|2|||
160565933|NCT04906707|579791910|FG001|Overall Study|Withdrawal by Subject|0|||
160565934|NCT04906707|579791909|FG000|Overall Study|Withdrawal due to PI decision|1|||
160565935|NCT04906707|579791910|FG001|Overall Study|Withdrawal due to PI decision|0|||
160565936|NCT04906707|579791909|FG000|Overall Study|Lost to Follow-up|0|||
160565937|NCT04906707|579791910|FG001|Overall Study|Lost to Follow-up|1|||
160565938|NCT04429022|579791915|FG000|Overall Study|Protocol Violation|18|||
160565939|NCT04429022|579791916|FG001|Overall Study|Protocol Violation|1|||
160565940|NCT00045032|579791925|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
160565941|NCT00045032|579791926|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
160565942|NCT00045032|579791927|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
160565943|NCT00045032|579791925|FG000|Overall Study|Death|22|||
160565944|NCT00045032|579791926|FG001|Overall Study|Death|24|||
160565945|NCT00045032|579791927|FG002|Overall Study|Death|17|||
160565946|NCT00045032|579791925|FG000|Overall Study|Insufficient Therapeutic Response|542|||
160565947|NCT00045032|579791926|FG001|Overall Study|Insufficient Therapeutic Response|437|||
160565948|NCT00045032|579791927|FG002|Overall Study|Insufficient Therapeutic Response|445|||
160565949|NCT00045032|579791925|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
160565950|NCT00045032|579791926|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
160565951|NCT00045032|579791927|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
160565952|NCT00045032|579791925|FG000|Overall Study|Other Protocol Violation|2|||
160565953|NCT00045032|579791926|FG001|Overall Study|Other Protocol Violation|0|||
160565954|NCT00045032|579791927|FG002|Overall Study|Other Protocol Violation|1|||
160565955|NCT00045032|579791925|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
160565956|NCT00045032|579791926|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
160565957|NCT00045032|579791927|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
160565958|NCT00045032|579791925|FG000|Overall Study|Failure to Return|57|||
160565959|NCT00045032|579791926|FG001|Overall Study|Failure to Return|62|||
160565960|NCT00045032|579791927|FG002|Overall Study|Failure to Return|61|||
160565961|NCT00045032|579791925|FG000|Overall Study|Other|93|||
160565962|NCT00045032|579791926|FG001|Overall Study|Other|84|||
160565963|NCT00045032|579791927|FG002|Overall Study|Other|105|||
160565964|NCT02582658|579791928|FG000|Overall Study|Failure to Return|10|||
160565965|NCT02582658|579791928|FG000|Overall Study|Insufficient Virological Response|2|||
160565966|NCT02582658|579791928|FG000|Overall Study|Withdrawn Consent|1|||
160565967|NCT02582658|579791928|FG000|Overall Study|Death|1|||
160565968|NCT02582658|579791928|FG000|Overall Study|Not further specified|11|||
160565969|NCT04909463|579793119|FG000|Overall Study|Withdrawal by Subject|0|||
160565970|NCT04909463|579793120|FG001|Overall Study|Withdrawal by Subject|1|||
160565971|NCT04909463|579793121|FG002|Overall Study|Withdrawal by Subject|0|||
160565972|NCT04909463|579793122|FG003|Overall Study|Withdrawal by Subject|0|||
160565973|NCT04909463|579793119|FG000|Overall Study|Lost to Follow-up|2|||
160565974|NCT04909463|579793120|FG001|Overall Study|Lost to Follow-up|1|||
160565975|NCT04909463|579793121|FG002|Overall Study|Lost to Follow-up|1|||
160565976|NCT04909463|579793122|FG003|Overall Study|Lost to Follow-up|0|||
160565977|NCT01614457|579793128|FG000|Overall Study|Non-Compliance|1|||
160565978|NCT01614457|579793129|FG001|Overall Study|Non-Compliance|0|||
160565979|NCT01614457|579793128|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
160565980|NCT01614457|579793129|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
160565981|NCT03518840|579793130|FG000|Overall Study|Lost to Follow-up|6|||
160565982|NCT02945657|579793133|FG000|Overall Study|Adverse Event|1|||
160565983|NCT02945657|579793133|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
160565984|NCT00283387|579793138|FG000|First Intervention|Subject non-compliant|1|||
160565985|NCT00283387|579793139|FG001|First Intervention|Subject non-compliant|1|||
160565986|NCT00283387|579793138|FG000|First Intervention|Withdrawal by Subject|0|||
160565987|NCT00283387|579793139|FG001|First Intervention|Withdrawal by Subject|1|||
160565988|NCT05340504|579793144|FG000|Overall Study|Withdrawal by Subject|1|||
160565989|NCT05340504|579793145|FG001|Overall Study|Withdrawal by Subject|0|||
160565990|NCT03068715|579793154|FG000|Overall Study|No longer met inclusion criteria|1|||
160565991|NCT03068715|579793155|FG001|Overall Study|No longer met inclusion criteria|0|||
160565992|NCT00728416|579793156|FG000|Overall Study|Adverse Event|1|||
160565993|NCT00728416|579793157|FG001|Overall Study|Adverse Event|1|||
160565994|NCT00728416|579793156|FG000|Overall Study|Treatment Failure|0|||
160565995|NCT00728416|579793157|FG001|Overall Study|Treatment Failure|1|||
160565996|NCT00728416|579793156|FG000|Overall Study|Withdrawal by Subject|1|||
160565997|NCT00728416|579793157|FG001|Overall Study|Withdrawal by Subject|0|||
160565998|NCT00117312|579793158|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
160565999|NCT00117312|579793159|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
160566000|NCT00117312|579793160|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
160566001|NCT00117312|579793161|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
160566002|NCT00117312|579793158|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
160566003|NCT00117312|579793159|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
160566004|NCT00117312|579793160|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
160566005|NCT00117312|579793161|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
160566006|NCT00117312|579793158|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
160566007|NCT00117312|579793159|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
160648453|NCT02717611|580094750|FG000|Overall Study|Death|13|||
160648454|NCT02717611|580094750|FG000|Overall Study|Withdrawal by Subject|6|||
160648455|NCT02717611|580094750|FG000|Overall Study|Active, not recruiting|40|||
160648456|NCT02717611|580094750|FG000|Overall Study|Complicating disease|1|||
160566008|NCT00117312|579793160|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
160566009|NCT00117312|579793161|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
160566010|NCT00117312|579793158|FG000|Overall Study|Other|0|||
160566011|NCT00117312|579793159|FG001|Overall Study|Other|1|||
160566012|NCT00117312|579793160|FG002|Overall Study|Other|3|||
160566013|NCT00117312|579793161|FG003|Overall Study|Other|1|||
160566014|NCT00117312|579793158|FG000|Overall Study|Patient choice|0|||
160566015|NCT00117312|579793159|FG001|Overall Study|Patient choice|0|||
160566016|NCT00117312|579793160|FG002|Overall Study|Patient choice|2|||
160566017|NCT00117312|579793161|FG003|Overall Study|Patient choice|1|||
160566018|NCT00117312|579793158|FG000|Overall Study|Adverse Event|0|||
160566019|NCT00117312|579793159|FG001|Overall Study|Adverse Event|2|||
160566020|NCT00117312|579793160|FG002|Overall Study|Adverse Event|0|||
160566021|NCT00117312|579793161|FG003|Overall Study|Adverse Event|0|||
160566022|NCT00117312|579793158|FG000|Overall Study|Protocol Violation|0|||
160566023|NCT00117312|579793159|FG001|Overall Study|Protocol Violation|1|||
160566024|NCT00117312|579793160|FG002|Overall Study|Protocol Violation|3|||
160566025|NCT00117312|579793161|FG003|Overall Study|Protocol Violation|0|||
160566026|NCT00117312|579793158|FG000|Overall Study|PSA decrease <=50%|0|||
160566027|NCT00117312|579793159|FG001|Overall Study|PSA decrease <=50%|2|||
160566028|NCT00117312|579793160|FG002|Overall Study|PSA decrease <=50%|2|||
160566029|NCT00117312|579793161|FG003|Overall Study|PSA decrease <=50%|4|||
160566030|NCT00117312|579793158|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
160566031|NCT00117312|579793159|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
160992270|NCT02014558|581359999|FG004|Overall Study|Withdrawal by Subject|1|||
160992271|NCT02014558|581360000|FG005|Overall Study|Withdrawal by Subject|0|||
160992272|NCT02014558|581360001|FG006|Overall Study|Withdrawal by Subject|0|||
160992273|NCT02014558|581360002|FG007|Overall Study|Withdrawal by Subject|0|||
160992274|NCT02014558|581360003|FG008|Overall Study|Withdrawal by Subject|0|||
160992275|NCT02014558|581360004|FG009|Overall Study|Withdrawal by Subject|2|||
160992276|NCT02014558|581360005|FG010|Overall Study|Withdrawal by Subject|6|||
160992277|NCT02014558|581360006|FG011|Overall Study|Withdrawal by Subject|10|||
160992278|NCT02014558|581360007|FG012|Overall Study|Withdrawal by Subject|0|||
160992279|NCT02014558|581359995|FG000|Overall Study|Miscellaneous|2|||
160992280|NCT02014558|581359996|FG001|Overall Study|Miscellaneous|1|||
160992281|NCT02014558|581359997|FG002|Overall Study|Miscellaneous|1|||
160992282|NCT02014558|581359998|FG003|Overall Study|Miscellaneous|1|||
160992283|NCT02014558|581359999|FG004|Overall Study|Miscellaneous|0|||
160992284|NCT02014558|581360000|FG005|Overall Study|Miscellaneous|1|||
160566032|NCT00117312|579793160|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
160566033|NCT00117312|579793161|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
160566034|NCT00117312|579793158|FG000|Overall Study|Hepatic abnormality|0|||
160566035|NCT00117312|579793159|FG001|Overall Study|Hepatic abnormality|1|||
160992285|NCT02014558|581360001|FG006|Overall Study|Miscellaneous|0|||
160992286|NCT02014558|581360002|FG007|Overall Study|Miscellaneous|1|||
160992287|NCT02014558|581360003|FG008|Overall Study|Miscellaneous|1|||
160566036|NCT00117312|579793160|FG002|Overall Study|Hepatic abnormality|0|||
160566037|NCT00117312|579793161|FG003|Overall Study|Hepatic abnormality|1|||
160992288|NCT02014558|581360004|FG009|Overall Study|Miscellaneous|3|||
160992289|NCT02014558|581360005|FG010|Overall Study|Miscellaneous|12|||
160566038|NCT00117312|579793158|FG000|Overall Study|Withdrawal by Subject|0|||
160648613|NCT05182606|580094769|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|29|||
160648630|NCT02619682|580094778|FG000|Overall Study|Withdrawal by Subject|3|||
160648631|NCT02619682|580094778|FG000|Overall Study|Lack of Efficacy|8|||
160648632|NCT02619682|580094778|FG000|Overall Study|new secondary cancer|1|||
160648633|NCT02619682|580094778|FG000|Overall Study|post surgery complications|2|||
160648634|NCT01861522|580094779|FG000|Overall Study|Adverse Event|1|||
160648635|NCT01861522|580094780|FG001|Overall Study|Adverse Event|0|||
160648636|NCT01861522|580094779|FG000|Overall Study|Withdrawal by Subject|2|||
160648637|NCT01861522|580094780|FG001|Overall Study|Withdrawal by Subject|0|||
160648638|NCT00500682|580094782|FG000|Overall Study|Adverse Event|37|||
160648639|NCT00500682|580094783|FG001|Overall Study|Adverse Event|29|||
160648640|NCT00500682|580094782|FG000|Overall Study|Death|25|||
160648641|NCT00500682|580094783|FG001|Overall Study|Death|16|||
160648642|NCT00500682|580094782|FG000|Overall Study|Lost to Follow-up|11|||
160648643|NCT00500682|580094783|FG001|Overall Study|Lost to Follow-up|11|||
160648644|NCT00500682|580094782|FG000|Overall Study|Physician Decision|6|||
160648645|NCT00500682|580094783|FG001|Overall Study|Physician Decision|10|||
160648646|NCT00500682|580094782|FG000|Overall Study|Pregnancy|2|||
160648647|NCT00500682|580094783|FG001|Overall Study|Pregnancy|0|||
160648648|NCT00500682|580094782|FG000|Overall Study|Protocol Violation|1|||
160648649|NCT00500682|580094783|FG001|Overall Study|Protocol Violation|3|||
160648650|NCT00500682|580094782|FG000|Overall Study|Withdrawal by Subject|80|||
160648651|NCT00500682|580094783|FG001|Overall Study|Withdrawal by Subject|74|||
160648652|NCT00500682|580094782|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
160648653|NCT00500682|580094783|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
160648654|NCT01680159|580094784|FG000|Screening Period|Not meet criteria for dose-up period|7|||
160648655|NCT01680159|580094784|FG000|Increased Dose Period|Adverse Event|6|||
160648656|NCT01680159|580094784|FG000|Increased Dose Period|Withdrawal by Subject|2|||
160648674|NCT01995058|580094790|FG000|Overall Study|Sponsor Decision to terminate study|14|||
160648675|NCT01995058|580094791|FG001|Overall Study|Sponsor Decision to terminate study|12|||
160648676|NCT01995058|580094792|FG002|Overall Study|Sponsor Decision to terminate study|12|||
160648677|NCT01995058|580094793|FG003|Overall Study|Sponsor Decision to terminate study|10|||
160648678|NCT01995058|580094790|FG000|Overall Study|Progressive Disease|0|||
160648679|NCT01995058|580094791|FG001|Overall Study|Progressive Disease|1|||
160648680|NCT01995058|580094792|FG002|Overall Study|Progressive Disease|1|||
160648681|NCT01995058|580094793|FG003|Overall Study|Progressive Disease|1|||
160844424|NCT03170193|580818021|FG004|Overall Study|Withdrawal by Subject|0|||
160844425|NCT03170193|580818022|FG005|Overall Study|Withdrawal by Subject|0|||
160844426|NCT03170193|580818023|FG006|Overall Study|Withdrawal by Subject|0|||
160844427|NCT03170193|580818017|FG000|Overall Study|Lost to Follow-up|1|||
160844428|NCT03170193|580818018|FG001|Overall Study|Lost to Follow-up|1|||
160844429|NCT03170193|580818019|FG002|Overall Study|Lost to Follow-up|0|||
160844430|NCT03170193|580818020|FG003|Overall Study|Lost to Follow-up|0|||
160844431|NCT03170193|580818021|FG004|Overall Study|Lost to Follow-up|0|||
160844432|NCT03170193|580818022|FG005|Overall Study|Lost to Follow-up|0|||
160844433|NCT03170193|580818023|FG006|Overall Study|Lost to Follow-up|0|||
160844434|NCT02560012|580818024|FG000|Overall Study|Study Terminated|2|||
160844435|NCT03052816|580818025|FG000|Overall Study|Withdrawal by Subject|1|||
160844436|NCT03052816|580818026|FG001|Overall Study|Withdrawal by Subject|0|||
160844437|NCT03052816|580818025|FG000|Overall Study|Desired opioids|2|||
160844438|NCT03052816|580818026|FG001|Overall Study|Desired opioids|0|||
160844439|NCT02218008|580818027|FG000|Stage 1 (S1)|Adverse Event|6|||
160844440|NCT02218008|580818028|FG001|Stage 1 (S1)|Adverse Event|5|||
160844441|NCT02218008|580818029|FG002|Stage 1 (S1)|Adverse Event|11|||
160844442|NCT02218008|580818030|FG003|Stage 1 (S1)|Adverse Event|0|||
160648682|NCT01995058|580094790|FG000|Overall Study|Adverse Event|0|||
160648683|NCT01995058|580094791|FG001|Overall Study|Adverse Event|0|||
160648684|NCT01995058|580094792|FG002|Overall Study|Adverse Event|0|||
160648685|NCT01995058|580094793|FG003|Overall Study|Adverse Event|1|||
160648686|NCT01995058|580094790|FG000|Overall Study|Lack of Efficacy|0|||
160648687|NCT01995058|580094791|FG001|Overall Study|Lack of Efficacy|0|||
160648688|NCT01995058|580094792|FG002|Overall Study|Lack of Efficacy|0|||
160648689|NCT01995058|580094793|FG003|Overall Study|Lack of Efficacy|1|||
160648690|NCT01995058|580094790|FG000|Overall Study|No Treatment Given|0|||
160648691|NCT01995058|580094791|FG001|Overall Study|No Treatment Given|0|||
160648692|NCT01995058|580094792|FG002|Overall Study|No Treatment Given|0|||
160648693|NCT01995058|580094793|FG003|Overall Study|No Treatment Given|1|||
160648706|NCT03611309|580094805|FG000|Overall Study|Lost to Follow-up|16|||
160844443|NCT02218008|580818031|FG004|Stage 1 (S1)|Adverse Event|0|||
160844444|NCT02218008|580818032|FG005|Stage 1 (S1)|Adverse Event|0|||
160844445|NCT02218008|580818027|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
160844446|NCT02218008|580818028|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
160844447|NCT02218008|580818029|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
160844448|NCT02218008|580818030|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
160844449|NCT02218008|580818031|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
160844450|NCT02218008|580818032|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
160844451|NCT02218008|580818027|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
160844452|NCT02218008|580818028|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
160844453|NCT02218008|580818029|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
160844454|NCT02218008|580818030|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
160844455|NCT02218008|580818031|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
160844456|NCT02218008|580818032|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
160844457|NCT02218008|580818027|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
160844458|NCT02218008|580818028|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
160844459|NCT02218008|580818029|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
160844460|NCT02218008|580818030|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
160844461|NCT02218008|580818031|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
160844462|NCT02218008|580818032|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
160844463|NCT02218008|580818027|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
160648707|NCT03611309|580094806|FG001|Overall Study|Lost to Follow-up|8|||
160648708|NCT03611309|580094805|FG000|Overall Study|Withdrawal by Subject|5|||
160648709|NCT03611309|580094806|FG001|Overall Study|Withdrawal by Subject|5|||
160648710|NCT03611309|580094805|FG000|Overall Study|Physician Decision|0|||
160648711|NCT03611309|580094806|FG001|Overall Study|Physician Decision|2|||
160844464|NCT02218008|580818028|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
160844465|NCT02218008|580818029|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
160844466|NCT02218008|580818030|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
160844467|NCT02218008|580818031|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
160844468|NCT02218008|580818032|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
160844469|NCT02218008|580818027|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
160844470|NCT02218008|580818028|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
160844471|NCT02218008|580818029|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
160844472|NCT02218008|580818030|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
160844473|NCT02218008|580818031|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
160844474|NCT02218008|580818032|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
160844475|NCT02218008|580818027|FG000|Stage 1 (S1)|Pregnancy|0|||
160844476|NCT02218008|580818028|FG001|Stage 1 (S1)|Pregnancy|0|||
160844477|NCT02218008|580818029|FG002|Stage 1 (S1)|Pregnancy|1|||
160844478|NCT02218008|580818030|FG003|Stage 1 (S1)|Pregnancy|0|||
160844479|NCT02218008|580818031|FG004|Stage 1 (S1)|Pregnancy|0|||
160844480|NCT02218008|580818032|FG005|Stage 1 (S1)|Pregnancy|0|||
160844481|NCT02218008|580818027|FG000|Stage 1 (S1)|Protocol Violation|0|||
160844482|NCT02218008|580818028|FG001|Stage 1 (S1)|Protocol Violation|0|||
160844483|NCT02218008|580818029|FG002|Stage 1 (S1)|Protocol Violation|1|||
160844484|NCT02218008|580818030|FG003|Stage 1 (S1)|Protocol Violation|0|||
160844485|NCT02218008|580818031|FG004|Stage 1 (S1)|Protocol Violation|0|||
160844486|NCT02218008|580818032|FG005|Stage 1 (S1)|Protocol Violation|0|||
160844487|NCT02218008|580818027|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
160844488|NCT02218008|580818028|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
160844489|NCT02218008|580818029|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
160844490|NCT02218008|580818030|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
160844491|NCT02218008|580818031|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
160844492|NCT02218008|580818032|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
160844493|NCT02218008|580818027|FG000|Stage 2 (S2)|Adverse Event|0|||
160844494|NCT02218008|580818028|FG001|Stage 2 (S2)|Adverse Event|0|||
160844495|NCT02218008|580818029|FG002|Stage 2 (S2)|Adverse Event|0|||
160844496|NCT02218008|580818030|FG003|Stage 2 (S2)|Adverse Event|2|||
160844497|NCT02218008|580818031|FG004|Stage 2 (S2)|Adverse Event|3|||
160844498|NCT02218008|580818032|FG005|Stage 2 (S2)|Adverse Event|3|||
160844499|NCT02218008|580818027|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
160844500|NCT02218008|580818028|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
160844501|NCT02218008|580818029|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
160844502|NCT02218008|580818030|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
160844503|NCT02218008|580818031|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
160648725|NCT00772382|580095218|FG000|Overall Study|Adverse Event|19|||
160844504|NCT02218008|580818032|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
160844505|NCT02218008|580818027|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
160844506|NCT02218008|580818028|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
160648726|NCT00772382|580095218|FG000|Overall Study|Death|6|||
160648727|NCT00772382|580095218|FG000|Overall Study|Lack of Efficacy|4|||
160648728|NCT00772382|580095218|FG000|Overall Study|Physician Decision|5|||
160648729|NCT00772382|580095218|FG000|Overall Study|Protocol Violation|1|||
160648730|NCT00772382|580095218|FG000|Overall Study|Withdrawal by Subject|10|||
160648731|NCT00772382|580095218|FG000|Overall Study|Other Reasons|10|||
160844507|NCT02218008|580818029|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
160844508|NCT02218008|580818030|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
160844509|NCT02218008|580818031|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
160844510|NCT02218008|580818032|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
160844511|NCT02218008|580818027|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
160844512|NCT02218008|580818028|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
160844513|NCT02218008|580818029|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
160844514|NCT02218008|580818030|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
160648745|NCT04526899|580095225|FG000|Overall Study|Withdrawal by Subject|3|||
160648746|NCT04526899|580095226|FG001|Overall Study|Withdrawal by Subject|2|||
160648747|NCT04526899|580095227|FG002|Overall Study|Withdrawal by Subject|2|||
160648748|NCT04526899|580095225|FG000|Overall Study|Lost to Follow-up|3|||
160648749|NCT04526899|580095226|FG001|Overall Study|Lost to Follow-up|3|||
160648750|NCT04526899|580095227|FG002|Overall Study|Lost to Follow-up|1|||
160648751|NCT04526899|580095225|FG000|Overall Study|Investigator's decision|1|||
160648752|NCT04526899|580095226|FG001|Overall Study|Investigator's decision|0|||
160648753|NCT04526899|580095227|FG002|Overall Study|Investigator's decision|0|||
160648754|NCT04526899|580095225|FG000|Overall Study|Death|33|||
160648755|NCT04526899|580095226|FG001|Overall Study|Death|17|||
160648756|NCT04526899|580095227|FG002|Overall Study|Death|13|||
160648757|NCT04526899|580095225|FG000|Overall Study|Other|1|||
160648758|NCT04526899|580095226|FG001|Overall Study|Other|0|||
160648759|NCT04526899|580095227|FG002|Overall Study|Other|0|||
160648760|NCT04526899|580095225|FG000|Overall Study|On-Treatment|19|||
160648761|NCT04526899|580095226|FG001|Overall Study|On-Treatment|10|||
160648762|NCT04526899|580095227|FG002|Overall Study|On-Treatment|12|||
160648763|NCT04526899|580095225|FG000|Overall Study|Survival Follow-up|34|||
160648764|NCT04526899|580095226|FG001|Overall Study|Survival Follow-up|14|||
160648765|NCT04526899|580095227|FG002|Overall Study|Survival Follow-up|16|||
160648766|NCT05576012|580095232|FG000|Overall Study|Physician Decision|0|||
160648767|NCT05576012|580095233|FG001|Overall Study|Physician Decision|0|||
160648768|NCT05576012|580095234|FG002|Overall Study|Physician Decision|0|||
160648769|NCT05576012|580095235|FG003|Overall Study|Physician Decision|0|||
160648770|NCT05576012|580095236|FG004|Overall Study|Physician Decision|0|||
160648771|NCT05576012|580095237|FG005|Overall Study|Physician Decision|0|||
160648772|NCT05576012|580095238|FG006|Overall Study|Physician Decision|0|||
160648773|NCT05576012|580095239|FG007|Overall Study|Physician Decision|0|||
160648774|NCT05576012|580095240|FG008|Overall Study|Physician Decision|1|||
160648775|NCT05576012|580095241|FG009|Overall Study|Physician Decision|0|||
160648776|NCT03996005|580095724|FG000|Overall Study|Withdrawal by Subject|1|||
160648843|NCT04567615|580095731|FG000|Randomization|Participant withdrew consent|1|||
160648844|NCT04567615|580095732|FG001|Randomization|Participant withdrew consent|0|||
160648845|NCT04567615|580095733|FG002|Randomization|Participant withdrew consent|0|||
160648846|NCT04567615|580095731|FG000|Randomization|Adverse event unrelated to study drug|0|||
160648847|NCT04567615|580095732|FG001|Randomization|Adverse event unrelated to study drug|1|||
160648848|NCT04567615|580095733|FG002|Randomization|Adverse event unrelated to study drug|0|||
160992290|NCT02014558|581360006|FG011|Overall Study|Miscellaneous|11|||
160992291|NCT02014558|581360007|FG012|Overall Study|Miscellaneous|1|||
160648849|NCT04567615|580095731|FG000|Treatment Period|Participant Withdrew Consent|2|||
160648850|NCT04567615|580095732|FG001|Treatment Period|Participant Withdrew Consent|5|||
160648851|NCT04567615|580095733|FG002|Treatment Period|Participant Withdrew Consent|1|||
160648852|NCT04567615|580095731|FG000|Treatment Period|Death|1|||
160648853|NCT04567615|580095732|FG001|Treatment Period|Death|2|||
160992292|NCT01560949|581360008|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
160992293|NCT01560949|581360008|FG000|Surgery Phase|Physician Decision|3|||
160648854|NCT04567615|580095733|FG002|Treatment Period|Death|0|||
160648855|NCT04567615|580095731|FG000|Treatment Period|Lost to Follow-up|0|||
160648856|NCT04567615|580095732|FG001|Treatment Period|Lost to Follow-up|1|||
160648857|NCT04567615|580095733|FG002|Treatment Period|Lost to Follow-up|0|||
160648858|NCT04567615|580095731|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160992294|NCT02931396|581360011|FG000|Overall Study|Lost to Follow-up|3|||
160992295|NCT02931396|581360012|FG001|Overall Study|Lost to Follow-up|0|||
160648859|NCT04567615|580095732|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
160992296|NCT02931396|581360011|FG000|Overall Study|Withdrawal by Subject|2|||
160992297|NCT02931396|581360012|FG001|Overall Study|Withdrawal by Subject|0|||
160648860|NCT04567615|580095733|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160648861|NCT04567615|580095731|FG000|Treatment Period|Disease Progression|85|||
160648862|NCT04567615|580095732|FG001|Treatment Period|Disease Progression|63|||
160648863|NCT04567615|580095733|FG002|Treatment Period|Disease Progression|16|||
160648864|NCT04567615|580095731|FG000|Treatment Period|Study Drug Toxicity|3|||
160648865|NCT04567615|580095732|FG001|Treatment Period|Study Drug Toxicity|10|||
160648866|NCT04567615|580095733|FG002|Treatment Period|Study Drug Toxicity|4|||
160648867|NCT04567615|580095731|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
160648868|NCT04567615|580095732|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
160648869|NCT04567615|580095733|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
160648870|NCT04567615|580095731|FG000|Treatment Period|Other Reasons|1|||
160648871|NCT04567615|580095732|FG001|Treatment Period|Other Reasons|2|||
160648872|NCT04567615|580095733|FG002|Treatment Period|Other Reasons|0|||
160648873|NCT04567615|580095731|FG000|Treatment Period|Still On-going Treatment|21|||
160648874|NCT04567615|580095732|FG001|Treatment Period|Still On-going Treatment|22|||
160648875|NCT04567615|580095733|FG002|Treatment Period|Still On-going Treatment|2|||
160648897|NCT01022112|580095738|FG000|Overall Study|Adverse Event|1|||
160648898|NCT01022112|580095739|FG001|Overall Study|Adverse Event|2|||
160648899|NCT01022112|580095740|FG002|Overall Study|Adverse Event|0|||
160648900|NCT01022112|580095741|FG003|Overall Study|Adverse Event|1|||
160648901|NCT01022112|580095742|FG004|Overall Study|Adverse Event|0|||
160648902|NCT01022112|580095738|FG000|Overall Study|Lack of Efficacy|1|||
160648903|NCT01022112|580095739|FG001|Overall Study|Lack of Efficacy|0|||
160648904|NCT01022112|580095740|FG002|Overall Study|Lack of Efficacy|0|||
160648905|NCT01022112|580095741|FG003|Overall Study|Lack of Efficacy|0|||
160648906|NCT01022112|580095742|FG004|Overall Study|Lack of Efficacy|1|||
160648907|NCT01022112|580095738|FG000|Overall Study|Physician Decision|0|||
160648908|NCT01022112|580095739|FG001|Overall Study|Physician Decision|0|||
160648909|NCT01022112|580095740|FG002|Overall Study|Physician Decision|1|||
160648910|NCT01022112|580095741|FG003|Overall Study|Physician Decision|0|||
160648911|NCT01022112|580095742|FG004|Overall Study|Physician Decision|1|||
160648912|NCT01022112|580095738|FG000|Overall Study|Withdrawal by Subject|0|||
160648913|NCT01022112|580095739|FG001|Overall Study|Withdrawal by Subject|1|||
160648914|NCT01022112|580095740|FG002|Overall Study|Withdrawal by Subject|2|||
160648915|NCT01022112|580095741|FG003|Overall Study|Withdrawal by Subject|2|||
160648916|NCT01022112|580095742|FG004|Overall Study|Withdrawal by Subject|1|||
160648917|NCT01022112|580095738|FG000|Overall Study|Fasting plasma glucose level increased|1|||
160648918|NCT01022112|580095739|FG001|Overall Study|Fasting plasma glucose level increased|0|||
160648919|NCT01022112|580095740|FG002|Overall Study|Fasting plasma glucose level increased|0|||
160648920|NCT01022112|580095741|FG003|Overall Study|Fasting plasma glucose level increased|0|||
160648921|NCT01022112|580095742|FG004|Overall Study|Fasting plasma glucose level increased|7|||
160648930|NCT07174544|580095748|FG000|Overall Study|Lost to Follow-up|43|||
160648931|NCT07174544|580095749|FG001|Overall Study|Lost to Follow-up|15|||
160648933|NCT03419234|580095751|FG000|Overall Study|Disease progression|37|||
160648934|NCT03419234|580095752|FG001|Overall Study|Disease progression|36|||
160648935|NCT03419234|580095751|FG000|Overall Study|Adverse Event|6|||
160648936|NCT03419234|580095752|FG001|Overall Study|Adverse Event|9|||
160566039|NCT00117312|579793159|FG001|Overall Study|Withdrawal by Subject|2|||
160566040|NCT00117312|579793160|FG002|Overall Study|Withdrawal by Subject|0|||
160566041|NCT00117312|579793161|FG003|Overall Study|Withdrawal by Subject|0|||
160566042|NCT01120626|579793162|FG000|Overall Study|Withdrawal by Subject|1|||
160566043|NCT01120626|579793163|FG001|Overall Study|Withdrawal by Subject|0|||
160566044|NCT01535235|579793165|FG000|Overall Study|Adverse Event|1|||
160566045|NCT01535235|579793166|FG001|Overall Study|Adverse Event|0|||
160566046|NCT00509106|579793168|FG000|Overall Study|Adverse Event|3|||
160566047|NCT00509106|579793169|FG001|Overall Study|Adverse Event|2|||
160566048|NCT00509106|579793168|FG000|Overall Study|Noncompliance|0|||
160566049|NCT00509106|579793169|FG001|Overall Study|Noncompliance|1|||
160566050|NCT00509106|579793168|FG000|Overall Study|At the request of sponsor/investigator|1|||
160566051|NCT00509106|579793169|FG001|Overall Study|At the request of sponsor/investigator|2|||
160566052|NCT00509106|579793168|FG000|Overall Study|Withdrew consent|4|||
160566053|NCT00509106|579793169|FG001|Overall Study|Withdrew consent|8|||
160566054|NCT00509106|579793168|FG000|Overall Study|Lost to Follow-up|16|||
160566055|NCT00509106|579793169|FG001|Overall Study|Lost to Follow-up|10|||
160566056|NCT00509106|579793168|FG000|Overall Study|Other|1|||
160566057|NCT00509106|579793169|FG001|Overall Study|Other|0|||
160566058|NCT00509106|579793168|FG000|Overall Study|Death|6|||
160566059|NCT00509106|579793169|FG001|Overall Study|Death|6|||
160566060|NCT05421754|579793175|FG000|Overall Study|Technical issue with sensor|1|||
160566061|NCT01051739|579793176|FG000|Overall Study|Death|3|||
160566062|NCT01051739|579793177|FG001|Overall Study|Death|3|||
160566063|NCT01051739|579793176|FG000|Overall Study|Withdrawal by Subject|25|||
160566064|NCT01051739|579793177|FG001|Overall Study|Withdrawal by Subject|10|||
160566065|NCT03527043|579793178|FG000|Overall Study|Withdrawal by Subject|1|||
160566066|NCT03527043|579793179|FG001|Overall Study|Withdrawal by Subject|0|||
160566067|NCT00594399|579793181|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
160566068|NCT00594399|579793182|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
160566069|NCT00594399|579793183|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
160566070|NCT00594399|579793181|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
160566071|NCT00594399|579793182|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
160566072|NCT00594399|579793183|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
160566073|NCT00594399|579793181|FG000|Initial 3 Month Counseling|Personal issues|2|||
160566074|NCT00594399|579793182|FG001|Initial 3 Month Counseling|Personal issues|0|||
160566075|NCT00594399|579793183|FG002|Initial 3 Month Counseling|Personal issues|0|||
160566076|NCT00594399|579793181|FG000|Initial 3 Month Counseling|Too busy|7|||
160566077|NCT00594399|579793182|FG001|Initial 3 Month Counseling|Too busy|1|||
160566078|NCT00594399|579793183|FG002|Initial 3 Month Counseling|Too busy|0|||
160566079|NCT00594399|579793181|FG000|Initial 3 Month Counseling|Pain|2|||
160566080|NCT00594399|579793182|FG001|Initial 3 Month Counseling|Pain|0|||
160566081|NCT00594399|579793183|FG002|Initial 3 Month Counseling|Pain|0|||
160566082|NCT00594399|579793181|FG000|Initial 3 Month Counseling|Moved|1|||
160566083|NCT00594399|579793182|FG001|Initial 3 Month Counseling|Moved|0|||
160566084|NCT00594399|579793183|FG002|Initial 3 Month Counseling|Moved|0|||
160566085|NCT00594399|579793181|FG000|Initial 3 Month Counseling|Family illness|1|||
160566086|NCT00594399|579793182|FG001|Initial 3 Month Counseling|Family illness|0|||
160566087|NCT00594399|579793183|FG002|Initial 3 Month Counseling|Family illness|0|||
160566088|NCT00594399|579793181|FG000|Rerandomization Arm 1 Only|Death|2|||
160566089|NCT00594399|579793182|FG001|Rerandomization Arm 1 Only|Death|1|||
160566090|NCT00594399|579793183|FG002|Rerandomization Arm 1 Only|Death|0|||
160566091|NCT00594399|579793181|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
160566092|NCT00594399|579793182|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
160566093|NCT00594399|579793183|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
160566094|NCT03830281|579793184|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
160566095|NCT03830281|579793185|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
160566096|NCT03830281|579793184|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
160566097|NCT03830281|579793185|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
160566098|NCT03830281|579793184|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
160566099|NCT03830281|579793185|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
160566100|NCT03830281|579793184|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
160566101|NCT03830281|579793185|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
160566102|NCT03830281|579793184|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
160566103|NCT03830281|579793185|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
160566104|NCT03830281|579793184|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
160566105|NCT03830281|579793185|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
160566106|NCT03830281|579793184|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
160566107|NCT03830281|579793185|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
160566108|NCT03830281|579793184|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
160566109|NCT03830281|579793185|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
160566110|NCT03830281|579793184|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
160566111|NCT03830281|579793185|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
160566112|NCT02469246|579793186|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
160566113|NCT02469246|579793187|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
160648937|NCT03419234|580095751|FG000|Overall Study|Withdrawal by Subject|9|||
160648938|NCT03419234|580095752|FG001|Overall Study|Withdrawal by Subject|7|||
160648939|NCT03419234|580095751|FG000|Overall Study|Death|5|||
160648940|NCT03419234|580095752|FG001|Overall Study|Death|1|||
160648941|NCT03419234|580095751|FG000|Overall Study|Alternative therapy|4|||
160648942|NCT03419234|580095752|FG001|Overall Study|Alternative therapy|2|||
160648943|NCT03419234|580095751|FG000|Overall Study|PSA progression|8|||
160648944|NCT03419234|580095752|FG001|Overall Study|PSA progression|10|||
160648945|NCT03419234|580095751|FG000|Overall Study|Rising PSA and bone issues|3|||
160648946|NCT03419234|580095752|FG001|Overall Study|Rising PSA and bone issues|2|||
160648947|NCT03419234|580095751|FG000|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|10|||
160648948|NCT03419234|580095752|FG001|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|16|||
160648949|NCT03419234|580095751|FG000|Overall Study|Physician Decision|12|||
160648950|NCT03419234|580095752|FG001|Overall Study|Physician Decision|11|||
160648951|NCT03419234|580095751|FG000|Overall Study|Second malignancy|1|||
160648952|NCT03419234|580095752|FG001|Overall Study|Second malignancy|0|||
160648953|NCT03419234|580095751|FG000|Overall Study|Insurance status change/patient could not afford|2|||
160648954|NCT03419234|580095752|FG001|Overall Study|Insurance status change/patient could not afford|1|||
160648955|NCT03419234|580095751|FG000|Overall Study|Non-compliance|1|||
160648956|NCT03419234|580095752|FG001|Overall Study|Non-compliance|3|||
160648957|NCT03419234|580095751|FG000|Overall Study|Mistakenly off treatment|1|||
160648958|NCT03419234|580095752|FG001|Overall Study|Mistakenly off treatment|0|||
160648959|NCT03419234|580095751|FG000|Overall Study|Transition to hospice|1|||
160648960|NCT03419234|580095752|FG001|Overall Study|Transition to hospice|0|||
160648961|NCT03419234|580095751|FG000|Overall Study|Still on treatment|9|||
160648962|NCT03419234|580095752|FG001|Overall Study|Still on treatment|8|||
160648963|NCT03419234|580095751|FG000|Overall Study|Never received protocol therapy|2|||
160648964|NCT03419234|580095752|FG001|Overall Study|Never received protocol therapy|4|||
160648965|NCT03419234|580095751|FG000|Overall Study|Other complicating disease|0|||
160648966|NCT03419234|580095752|FG001|Overall Study|Other complicating disease|1|||
160648967|NCT03419234|580095751|FG000|Overall Study|patient switched from prednisone to another steroid|0|||
160648968|NCT03419234|580095752|FG001|Overall Study|patient switched from prednisone to another steroid|1|||
160653398|NCT02581345|580112379|FG000|Part 1: up to Week 16|Adverse Event|3|||
160653399|NCT02581345|580112380|FG001|Part 1: up to Week 16|Adverse Event|8|||
160653400|NCT02581345|580112381|FG002|Part 1: up to Week 16|Adverse Event|0|||
160653401|NCT02581345|580112382|FG003|Part 1: up to Week 16|Adverse Event|0|||
160653402|NCT02581345|580112379|FG000|Part 1: up to Week 16|Physician Decision|2|||
160653403|NCT02581345|580112380|FG001|Part 1: up to Week 16|Physician Decision|4|||
160653404|NCT02581345|580112381|FG002|Part 1: up to Week 16|Physician Decision|0|||
160653405|NCT02581345|580112382|FG003|Part 1: up to Week 16|Physician Decision|0|||
160653406|NCT02581345|580112379|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
160653407|NCT02581345|580112380|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
160653408|NCT02581345|580112381|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
160653409|NCT02581345|580112382|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
160653410|NCT02581345|580112379|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
160653411|NCT02581345|580112380|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
160653412|NCT02581345|580112381|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
160653413|NCT02581345|580112382|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
160653414|NCT02581345|580112379|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
160653415|NCT02581345|580112380|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
160653416|NCT02581345|580112381|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
160653417|NCT02581345|580112382|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
160653418|NCT02581345|580112379|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
160653419|NCT02581345|580112380|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
160653420|NCT02581345|580112381|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
160905923|NCT01847274|581050304|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160905924|NCT01847274|581050305|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160653421|NCT02581345|580112382|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
160653422|NCT02581345|580112379|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
160653423|NCT02581345|580112380|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
160653424|NCT02581345|580112381|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
160653425|NCT02581345|580112382|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
160653426|NCT02581345|580112379|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
160653427|NCT02581345|580112380|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
160653428|NCT02581345|580112381|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
160653429|NCT02581345|580112382|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
160653430|NCT02581345|580112379|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
160653431|NCT02581345|580112380|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
160653432|NCT02581345|580112381|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
160653433|NCT02581345|580112382|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
160653434|NCT02581345|580112379|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
160653435|NCT02581345|580112380|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
160992298|NCT00681811|581360015|FG000|Overall Study|Adverse Event|1|||
160992299|NCT00681811|581360016|FG001|Overall Study|Adverse Event|1|||
160992300|NCT00681811|581360015|FG000|Overall Study|Withdrawal by Subject|2|||
160992301|NCT00681811|581360016|FG001|Overall Study|Withdrawal by Subject|2|||
160992302|NCT00681811|581360015|FG000|Overall Study|Non-compliance|0|||
160992303|NCT00681811|581360016|FG001|Overall Study|Non-compliance|1|||
160992304|NCT01140347|581360023|FG000|Overall Study|Lost to Follow-up|5|||
160992305|NCT01140347|581360024|FG001|Overall Study|Lost to Follow-up|6|||
160992306|NCT01140347|581360023|FG000|Overall Study|Withdrawal by Subject|13|||
160992307|NCT01140347|581360024|FG001|Overall Study|Withdrawal by Subject|8|||
160992308|NCT00828919|581360025|FG000|Overall Study|Death|0|||
160992309|NCT00828919|581360026|FG001|Overall Study|Death|1|||
160992310|NCT00828919|581360027|FG002|Overall Study|Death|2|||
160992311|NCT00828919|581360028|FG003|Overall Study|Death|0|||
160566114|NCT02469246|579793186|FG000|Double-Blind Phase|Adverse Event|12|||
160566115|NCT02469246|579793187|FG001|Double-Blind Phase|Adverse Event|9|||
160566116|NCT02469246|579793186|FG000|Double-Blind Phase|Death|2|||
160566117|NCT02469246|579793187|FG001|Double-Blind Phase|Death|0|||
160566118|NCT02469246|579793186|FG000|Double-Blind Phase|Lack of Efficacy|2|||
160566119|NCT02469246|579793187|FG001|Double-Blind Phase|Lack of Efficacy|1|||
160566120|NCT02469246|579793186|FG000|Double-Blind Phase|Investigator's Discretion|8|||
160566121|NCT02469246|579793187|FG001|Double-Blind Phase|Investigator's Discretion|8|||
160566122|NCT02469246|579793186|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
160566123|NCT02469246|579793187|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
160566124|NCT02469246|579793186|FG000|Double-Blind Phase|Protocol Violation|1|||
160566125|NCT02469246|579793187|FG001|Double-Blind Phase|Protocol Violation|1|||
160566126|NCT02469246|579793186|FG000|Double-Blind Phase|Withdrew Consent|25|||
160566127|NCT02469246|579793187|FG001|Double-Blind Phase|Withdrew Consent|25|||
160566128|NCT02469246|579793186|FG000|Double-Blind Phase|Lost to Follow-up|9|||
160566129|NCT02469246|579793187|FG001|Double-Blind Phase|Lost to Follow-up|5|||
160566130|NCT00922935|579793191|FG000|Overall Study|Protocol Violation|0|||
160566131|NCT00922935|579793192|FG001|Overall Study|Protocol Violation|3|||
160566132|NCT00922935|579793193|FG002|Overall Study|Protocol Violation|0|||
160566133|NCT00922935|579793191|FG000|Overall Study|Physician Decision|1|||
160566134|NCT00922935|579793192|FG001|Overall Study|Physician Decision|1|||
160566135|NCT00922935|579793193|FG002|Overall Study|Physician Decision|0|||
160566136|NCT00922935|579793191|FG000|Overall Study|Lost to Follow-up|0|||
160566137|NCT00922935|579793192|FG001|Overall Study|Lost to Follow-up|1|||
160566138|NCT00922935|579793193|FG002|Overall Study|Lost to Follow-up|0|||
160566139|NCT01491945|579793194|FG000|Overall Study|Death|30|||
160566140|NCT01491945|579793194|FG000|Overall Study|Withdrwan/LTF|16|||
160566141|NCT01491945|579793194|FG000|Overall Study|Conversion|4|||
160566142|NCT01491945|579793194|FG000|Overall Study|Missed Visit|1|||
160566143|NCT02201940|579793195|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
160566144|NCT02201940|579793196|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
160566145|NCT02201940|579793195|FG000|Overall Study|Lack of Efficacy|2|||
160566146|NCT02201940|579793196|FG001|Overall Study|Lack of Efficacy|113|||
160566147|NCT02201940|579793195|FG000|Overall Study|Lost to Follow-up|5|||
160566148|NCT02201940|579793196|FG001|Overall Study|Lost to Follow-up|0|||
160566149|NCT02201940|579793195|FG000|Overall Study|Withdrew Consent|2|||
160566150|NCT02201940|579793196|FG001|Overall Study|Withdrew Consent|1|||
160566151|NCT02201940|579793195|FG000|Overall Study|Investigator's Discretion|1|||
160566152|NCT02201940|579793196|FG001|Overall Study|Investigator's Discretion|1|||
160566153|NCT02201940|579793195|FG000|Overall Study|Death|1|||
160566154|NCT02201940|579793196|FG001|Overall Study|Death|0|||
160566155|NCT02201940|579793195|FG000|Overall Study|Adverse Event|0|||
160566156|NCT02201940|579793196|FG001|Overall Study|Adverse Event|1|||
160566157|NCT01511445|579793201|FG000|Overall Study|Lost to Follow-up|3|||
160566158|NCT01511445|579793202|FG001|Overall Study|Lost to Follow-up|1|||
160566159|NCT01511445|579793201|FG000|Overall Study|Protocol Violation|1|||
160566160|NCT01511445|579793202|FG001|Overall Study|Protocol Violation|3|||
160566161|NCT01511445|579793201|FG000|Overall Study|Protocol Violation|1|||
160566162|NCT01511445|579793202|FG001|Overall Study|Protocol Violation|0|||
160566163|NCT00709202|579793203|FG000|Overall Study|Withdrawal by Subject|6|||
160566164|NCT00709202|579793204|FG001|Overall Study|Withdrawal by Subject|6|||
160566165|NCT03133767|579793205|FG000|Overall Study|Lost to Follow-up|38|||
160566166|NCT03133767|579793206|FG001|Overall Study|Lost to Follow-up|24|||
160566167|NCT03133767|579793205|FG000|Overall Study|Protocol Violation|0|||
160566168|NCT03133767|579793206|FG001|Overall Study|Protocol Violation|1|||
160566169|NCT03301857|579793207|FG000|Overall Study|Death|0|||
160566170|NCT03301857|579793208|FG001|Overall Study|Death|2|||
160566171|NCT03301857|579793207|FG000|Overall Study|Lost to Follow-up|4|||
160566172|NCT03301857|579793208|FG001|Overall Study|Lost to Follow-up|2|||
160566173|NCT03301857|579793207|FG000|Overall Study|Decision by Sponsor|6|||
160566174|NCT03301857|579793208|FG001|Overall Study|Decision by Sponsor|0|||
160566175|NCT03301857|579793207|FG000|Overall Study|Withdrawal by Subject|12|||
160566176|NCT03301857|579793208|FG001|Overall Study|Withdrawal by Subject|4|||
160566177|NCT01856114|579793222|FG000|Overall Study|Withdrawal by Subject|1|||
160566178|NCT01856114|579793223|FG001|Overall Study|Withdrawal by Subject|0|||
160992312|NCT00828919|581360029|FG004|Overall Study|Death|0|||
160648969|NCT03731182|580097034|FG000|Overall Study|Lost to Follow-up|2|||
160648970|NCT03731182|580097035|FG001|Overall Study|Lost to Follow-up|0|||
160648971|NCT03731182|580097034|FG000|Overall Study|Physician Decision|1|||
160648972|NCT03731182|580097035|FG001|Overall Study|Physician Decision|0|||
160648973|NCT03731182|580097034|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
160648974|NCT03731182|580097035|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
160648975|NCT03036579|580097042|FG000|2 Years|Lost to Follow-up|1|||
160648976|NCT03036579|580097043|FG001|2 Years|Lost to Follow-up|0|||
160648977|NCT03036579|580097042|FG000|3 Years|Lost to Follow-up|0|||
160648978|NCT03036579|580097043|FG001|3 Years|Lost to Follow-up|1|||
160648979|NCT02352337|580097044|FG000|Overall Study|Patients never treated|4|||
160648980|NCT02352337|580097045|FG001|Overall Study|Patients never treated|1|||
160648981|NCT02352337|580097046|FG002|Overall Study|Patients never treated|2|||
160648982|NCT02458638|580097049|FG000|Overall Study|Death|309|||
160648983|NCT02458638|580097049|FG000|Overall Study|End of Cohort/End of Study|67|||
160648984|NCT02458638|580097049|FG000|Overall Study|Lost to Follow-up|31|||
160648985|NCT02458638|580097049|FG000|Overall Study|Other Reasons|4|||
160648986|NCT02458638|580097049|FG000|Overall Study|Physician Decision|1|||
160648987|NCT02458638|580097049|FG000|Overall Study|Withdrawal by Subject|47|||
160648988|NCT02623959|580097061|FG000|Overall Study|Progression|0|||
160648989|NCT02623959|580097062|FG001|Overall Study|Progression|1|||
160648990|NCT00135707|580097063|FG000|Overall Study|Lost to Follow-up|94|||
160648991|NCT00135707|580097064|FG001|Overall Study|Lost to Follow-up|89|||
160648992|NCT00135707|580097063|FG000|Overall Study|Withdrawal by Subject|0|||
160648993|NCT00135707|580097064|FG001|Overall Study|Withdrawal by Subject|1|||
160648994|NCT00135707|580097063|FG000|Overall Study|Institutional review board request|1|||
160648995|NCT00135707|580097064|FG001|Overall Study|Institutional review board request|0|||
160648996|NCT00576901|580097068|FG000|Overall Study|Withdrawal by Subject|1|||
160648997|NCT00576901|580097068|FG000|Overall Study|Disease course|1|||
160648998|NCT00576901|580097068|FG000|Overall Study|Protocol Violation|1|||
160648999|NCT02398188|580097069|FG000|Overall Study|Adverse Event|2|||
160649000|NCT02398188|580097070|FG001|Overall Study|Adverse Event|3|||
160649001|NCT02398188|580097069|FG000|Overall Study|Lost to Follow-up|5|||
160649002|NCT02398188|580097070|FG001|Overall Study|Lost to Follow-up|0|||
160649003|NCT02398188|580097069|FG000|Overall Study|Non-compliance|4|||
160649004|NCT02398188|580097070|FG001|Overall Study|Non-compliance|4|||
160649005|NCT02398188|580097069|FG000|Overall Study|Protocol Violation|6|||
160649006|NCT02398188|580097070|FG001|Overall Study|Protocol Violation|10|||
160649007|NCT02398188|580097069|FG000|Overall Study|Sponsor Decision|2|||
160649008|NCT02398188|580097070|FG001|Overall Study|Sponsor Decision|1|||
160649009|NCT02398188|580097069|FG000|Overall Study|Pregnancy|1|||
160649010|NCT02398188|580097070|FG001|Overall Study|Pregnancy|0|||
160649011|NCT02398188|580097069|FG000|Overall Study|Withdrawal by Subject|7|||
160649012|NCT02398188|580097070|FG001|Overall Study|Withdrawal by Subject|16|||
160649013|NCT01259869|580097071|FG000|Overall Study|Duplicated registration|1|||
160649014|NCT00220701|580097072|FG000|Overall Study|Lost to Follow-up|5|||
160649015|NCT00220701|580097073|FG001|Overall Study|Lost to Follow-up|4|||
160649016|NCT01612000|580097075|FG000|Overall Study|Lost to Follow-up|6|||
160649017|NCT01612000|580097076|FG001|Overall Study|Lost to Follow-up|4|||
160649018|NCT01612000|580097077|FG002|Overall Study|Lost to Follow-up|4|||
160649019|NCT01612000|580097078|FG003|Overall Study|Lost to Follow-up|8|||
160649020|NCT01612000|580097075|FG000|Overall Study|Physician Decision|0|||
160649021|NCT01612000|580097076|FG001|Overall Study|Physician Decision|0|||
160649022|NCT01612000|580097077|FG002|Overall Study|Physician Decision|1|||
160649023|NCT01612000|580097078|FG003|Overall Study|Physician Decision|0|||
160649024|NCT01612000|580097075|FG000|Overall Study|Withdrawal by Subject|3|||
160649025|NCT01612000|580097076|FG001|Overall Study|Withdrawal by Subject|1|||
160649026|NCT01612000|580097077|FG002|Overall Study|Withdrawal by Subject|2|||
160649027|NCT01612000|580097078|FG003|Overall Study|Withdrawal by Subject|2|||
160649028|NCT01180244|580097081|FG000|Overall Study|Lack of Efficacy|0|||
160649029|NCT01180244|580097082|FG001|Overall Study|Lack of Efficacy|7|||
160649030|NCT01180244|580097081|FG000|Overall Study|Physician Decision|3|||
160649031|NCT01180244|580097082|FG001|Overall Study|Physician Decision|0|||
160649032|NCT01180244|580097081|FG000|Overall Study|Adverse Event|1|||
160649033|NCT01180244|580097082|FG001|Overall Study|Adverse Event|0|||
160649034|NCT01180244|580097081|FG000|Overall Study|Withdrawal by Subject|0|||
160649035|NCT01180244|580097082|FG001|Overall Study|Withdrawal by Subject|1|||
160649036|NCT01180244|580097081|FG000|Overall Study|Protocol Violation|1|||
160649037|NCT01180244|580097082|FG001|Overall Study|Protocol Violation|0|||
160649038|NCT01180244|580097081|FG000|Overall Study|Lost to Follow-up|1|||
160649039|NCT01180244|580097082|FG001|Overall Study|Lost to Follow-up|0|||
160649040|NCT00620763|580097083|FG000|Period: First Intervention|Withdrawal by Subject|0|||
160649041|NCT00620763|580097084|FG001|Period: First Intervention|Withdrawal by Subject|2|||
160649042|NCT00620763|580097083|FG000|Period: First Intervention|Protocol Violation|0|||
160649043|NCT00620763|580097084|FG001|Period: First Intervention|Protocol Violation|3|||
160649044|NCT00620763|580097083|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
160649045|NCT00620763|580097084|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
160649046|NCT01689974|580097088|FG000|Overall Study|Termination of Study|5|||
160649047|NCT01689974|580097089|FG001|Overall Study|Termination of Study|5|||
160649048|NCT00681863|580097090|FG000|Overall Study|Adverse Event|1|||
160649049|NCT00681863|580097090|FG000|Overall Study|Lost to Follow-up|2|||
160649050|NCT00681863|580097090|FG000|Overall Study|Lack of Efficacy|2|||
160649051|NCT00681863|580097090|FG000|Overall Study|Other|18|||
160649052|NCT01388647|580097093|FG000|Overall Study|Adverse Event|1|||
160844515|NCT02218008|580818031|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
160844516|NCT02218008|580818032|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
160844517|NCT02218008|580818027|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
160844518|NCT02218008|580818028|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
160844519|NCT02218008|580818029|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
160844520|NCT02218008|580818030|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
160844521|NCT02218008|580818031|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
160844522|NCT02218008|580818032|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
160844523|NCT00408434|580818033|FG000|Overall Study|Adverse Event|0|||
160844524|NCT00408434|580818034|FG001|Overall Study|Adverse Event|0|||
160844525|NCT00408434|580818035|FG002|Overall Study|Adverse Event|1|||
160844526|NCT00408434|580818036|FG003|Overall Study|Adverse Event|0|||
160844527|NCT00408434|580818037|FG004|Overall Study|Adverse Event|0|||
160905925|NCT01847274|581050306|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160992313|NCT00828919|581360025|FG000|Overall Study|Adverse Event|2|||
160649053|NCT01388647|580097094|FG001|Overall Study|Adverse Event|2|||
160649054|NCT01006707|580097095|FG000|Study Session 1|Lost to Follow-up|2|||
160649055|NCT01006707|580097096|FG001|Study Session 1|Lost to Follow-up|0|||
160649056|NCT01006707|580097097|FG002|Study Session 1|Lost to Follow-up|0|||
160649057|NCT01006707|580097095|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
160649058|NCT01006707|580097096|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
160649059|NCT01006707|580097097|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
160649060|NCT00760383|580097098|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
160649061|NCT00760383|580097099|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
160649062|NCT01842958|580097101|FG000|Overall Study|Lost to Follow-up|1|||
160649063|NCT01842958|580097102|FG001|Overall Study|Lost to Follow-up|1|||
160649064|NCT01829477|580097103|FG000|Overall Study|Study Terminated by Sponsor|15|||
160649065|NCT01829477|580097104|FG001|Overall Study|Study Terminated by Sponsor|15|||
160649066|NCT01829477|580097103|FG000|Overall Study|Withdrawal by Subject|1|||
160649067|NCT01829477|580097104|FG001|Overall Study|Withdrawal by Subject|0|||
160649068|NCT03465891|580097106|FG000|Overall Study|Withdrawal by Subject|0|||
160649069|NCT03465891|580097107|FG001|Overall Study|Withdrawal by Subject|1|||
160649070|NCT03465891|580097106|FG000|Overall Study|Disease progression|1|||
160649071|NCT03465891|580097107|FG001|Overall Study|Disease progression|0|||
160649072|NCT02737306|580097109|FG000|Overall Study|Adverse Event|3|||
160649073|NCT02737306|580097110|FG001|Overall Study|Adverse Event|0|||
160649074|NCT02737306|580097109|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
160649075|NCT02737306|580097110|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
160844528|NCT00408434|580818038|FG005|Overall Study|Adverse Event|0|||
160844529|NCT00408434|580818039|FG006|Overall Study|Adverse Event|0|||
160844530|NCT00408434|580818033|FG000|Overall Study|Progressive disease|6|||
160844531|NCT00408434|580818034|FG001|Overall Study|Progressive disease|3|||
160844532|NCT00408434|580818035|FG002|Overall Study|Progressive disease|4|||
160844533|NCT00408434|580818036|FG003|Overall Study|Progressive disease|3|||
160844534|NCT00408434|580818037|FG004|Overall Study|Progressive disease|3|||
160649076|NCT03361423|580097111|FG000|Overall Study|Withdrawal by Subject|4|||
160649077|NCT03361423|580097112|FG001|Overall Study|Withdrawal by Subject|3|||
160649078|NCT03361423|580097111|FG000|Overall Study|Did not treat|19|||
160649079|NCT03361423|580097112|FG001|Overall Study|Did not treat|18|||
160649080|NCT03361423|580097111|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
160649081|NCT03361423|580097112|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
160649082|NCT03361423|580097111|FG000|Overall Study|Missing data|4|||
160649083|NCT03361423|580097112|FG001|Overall Study|Missing data|1|||
160649084|NCT05034731|580097113|FG000|Overall Study|Screen fail|1|||
160649085|NCT05034731|580097114|FG001|Overall Study|Screen fail|1|||
160649086|NCT02087059|580097117|FG000|Overall Study|Disease Progression|1|||
160649087|NCT02087059|580097117|FG000|Overall Study|Adverse Event|5|||
160649088|NCT02087059|580097117|FG000|Overall Study|Lost to Follow-up|1|||
160649089|NCT01851590|580097119|FG000|Overall Study|Withdrawal by Subject|0|||
160649090|NCT01851590|580097120|FG001|Overall Study|Withdrawal by Subject|0|||
160649091|NCT01851590|580097121|FG002|Overall Study|Withdrawal by Subject|1|||
160649092|NCT01851590|580097119|FG000|Overall Study|Adverse Event|0|||
160649093|NCT01851590|580097120|FG001|Overall Study|Adverse Event|0|||
160844535|NCT00408434|580818038|FG005|Overall Study|Progressive disease|1|||
160844536|NCT00408434|580818039|FG006|Overall Study|Progressive disease|4|||
160844537|NCT00408434|580818033|FG000|Overall Study|Other|0|||
160566179|NCT01856114|579793222|FG000|Overall Study|Adverse Event|1|||
160566180|NCT01856114|579793223|FG001|Overall Study|Adverse Event|0|||
160566181|NCT02853760|579793224|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
160566182|NCT02853760|579793225|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
160566183|NCT02853760|579793226|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
160566184|NCT02853760|579793227|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
160566185|NCT02853760|579793228|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
160566186|NCT02853760|579793229|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
160566187|NCT01642212|579793230|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
160566188|NCT01642212|579793231|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
160566189|NCT01642212|579793232|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
160566190|NCT01642212|579793233|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
160566191|NCT01642212|579793234|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
160566192|NCT01642212|579793230|FG000|Double-blind Treatment|Other|0|||
160566193|NCT01642212|579793231|FG001|Double-blind Treatment|Other|2|||
160566194|NCT01642212|579793232|FG002|Double-blind Treatment|Other|1|||
160566195|NCT01642212|579793233|FG003|Double-blind Treatment|Other|0|||
160566196|NCT01642212|579793234|FG004|Double-blind Treatment|Other|0|||
160566197|NCT01642212|579793230|FG000|Double-blind Treatment|Non-compliance|0|||
160566198|NCT01642212|579793231|FG001|Double-blind Treatment|Non-compliance|1|||
160844538|NCT00408434|580818034|FG001|Overall Study|Other|0|||
160844539|NCT00408434|580818035|FG002|Overall Study|Other|1|||
160566199|NCT01642212|579793232|FG002|Double-blind Treatment|Non-compliance|0|||
160844540|NCT00408434|580818036|FG003|Overall Study|Other|0|||
160844541|NCT00408434|580818037|FG004|Overall Study|Other|2|||
160844542|NCT00408434|580818038|FG005|Overall Study|Other|1|||
160844543|NCT00408434|580818039|FG006|Overall Study|Other|0|||
160844544|NCT00408434|580818033|FG000|Overall Study|Terminated by Investigator|0|||
160649094|NCT01851590|580097121|FG002|Overall Study|Adverse Event|2|||
160649095|NCT01851590|580097119|FG000|Overall Study|Lack of Efficacy|0|||
160649096|NCT01851590|580097120|FG001|Overall Study|Lack of Efficacy|1|||
160844545|NCT00408434|580818034|FG001|Overall Study|Terminated by Investigator|0|||
160844546|NCT00408434|580818035|FG002|Overall Study|Terminated by Investigator|0|||
160844547|NCT00408434|580818036|FG003|Overall Study|Terminated by Investigator|0|||
160844548|NCT00408434|580818037|FG004|Overall Study|Terminated by Investigator|1|||
160566200|NCT01642212|579793233|FG003|Double-blind Treatment|Non-compliance|0|||
160844549|NCT00408434|580818038|FG005|Overall Study|Terminated by Investigator|1|||
160844550|NCT00408434|580818039|FG006|Overall Study|Terminated by Investigator|0|||
160844551|NCT03304873|580818040|FG000|Overall Study|Lost to Follow-up|1|||
160844552|NCT03304873|580818041|FG001|Overall Study|Lost to Follow-up|8|||
160844553|NCT00400569|580818042|FG000|Overall Study|Death|1|||
160649097|NCT01851590|580097121|FG002|Overall Study|Lack of Efficacy|0|||
160649098|NCT00696709|580097122|FG000|Overall Study|Withdrawal by Subject|1|||
160649099|NCT00696709|580097123|FG001|Overall Study|Withdrawal by Subject|2|||
160566201|NCT01642212|579793234|FG004|Double-blind Treatment|Non-compliance|0|||
160566202|NCT01642212|579793230|FG000|Double-blind Treatment|Adverse Event|0|||
160566203|NCT01642212|579793231|FG001|Double-blind Treatment|Adverse Event|0|||
160566204|NCT01642212|579793232|FG002|Double-blind Treatment|Adverse Event|1|||
160566205|NCT01642212|579793233|FG003|Double-blind Treatment|Adverse Event|0|||
160566206|NCT01642212|579793234|FG004|Double-blind Treatment|Adverse Event|0|||
160566207|NCT01642212|579793230|FG000|Open-label Extension|Adverse Event|0|||
160566208|NCT01642212|579793231|FG001|Open-label Extension|Adverse Event|0|||
160566209|NCT01642212|579793232|FG002|Open-label Extension|Adverse Event|0|||
160566210|NCT01642212|579793233|FG003|Open-label Extension|Adverse Event|3|||
160566211|NCT01642212|579793234|FG004|Open-label Extension|Adverse Event|0|||
160566212|NCT01642212|579793230|FG000|Open-label Extension|Sponsor Decision|0|||
160566213|NCT01642212|579793231|FG001|Open-label Extension|Sponsor Decision|0|||
160649100|NCT00696709|580097124|FG002|Overall Study|Withdrawal by Subject|1|||
160649101|NCT00696709|580097125|FG003|Overall Study|Withdrawal by Subject|4|||
160649102|NCT00696709|580097126|FG004|Overall Study|Withdrawal by Subject|3|||
160649103|NCT00696709|580097122|FG000|Overall Study|Protocol Violation|1|||
160649104|NCT00696709|580097123|FG001|Overall Study|Protocol Violation|0|||
160566214|NCT01642212|579793232|FG002|Open-label Extension|Sponsor Decision|0|||
160566215|NCT01642212|579793233|FG003|Open-label Extension|Sponsor Decision|7|||
160566216|NCT01642212|579793234|FG004|Open-label Extension|Sponsor Decision|4|||
160649105|NCT00696709|580097124|FG002|Overall Study|Protocol Violation|0|||
160566217|NCT01642212|579793230|FG000|Open-label Extension|Consent Withdrawn|0|||
160566218|NCT01642212|579793231|FG001|Open-label Extension|Consent Withdrawn|0|||
160566219|NCT01642212|579793232|FG002|Open-label Extension|Consent Withdrawn|0|||
160649106|NCT00696709|580097125|FG003|Overall Study|Protocol Violation|0|||
160649107|NCT00696709|580097126|FG004|Overall Study|Protocol Violation|0|||
160566220|NCT01642212|579793233|FG003|Open-label Extension|Consent Withdrawn|0|||
160649108|NCT00696709|580097122|FG000|Overall Study|Lost to Follow-up|1|||
160844554|NCT00620113|580818045|FG000|Overall Study|Adverse Event|3|||
160649109|NCT00696709|580097123|FG001|Overall Study|Lost to Follow-up|1|||
160649110|NCT00696709|580097124|FG002|Overall Study|Lost to Follow-up|0|||
160649111|NCT00696709|580097125|FG003|Overall Study|Lost to Follow-up|0|||
160649112|NCT00696709|580097126|FG004|Overall Study|Lost to Follow-up|0|||
160649113|NCT00696709|580097122|FG000|Overall Study|Adverse Event|0|||
160649114|NCT00696709|580097123|FG001|Overall Study|Adverse Event|0|||
160649115|NCT00696709|580097124|FG002|Overall Study|Adverse Event|0|||
160649116|NCT00696709|580097125|FG003|Overall Study|Adverse Event|1|||
160649117|NCT00696709|580097126|FG004|Overall Study|Adverse Event|0|||
160649118|NCT00310856|580097127|FG000|Overall Study|Withdrawal by Subject|2|||
160649119|NCT00310856|580097128|FG001|Overall Study|Withdrawal by Subject|2|||
160649120|NCT00310856|580097129|FG002|Overall Study|Withdrawal by Subject|2|||
160649121|NCT00310856|580097127|FG000|Overall Study|Lost to Follow-up|1|||
160649122|NCT00310856|580097128|FG001|Overall Study|Lost to Follow-up|2|||
160649123|NCT00310856|580097129|FG002|Overall Study|Lost to Follow-up|6|||
160649124|NCT00310856|580097127|FG000|Overall Study|Inappropriate enrollment|1|||
160649125|NCT00310856|580097128|FG001|Overall Study|Inappropriate enrollment|1|||
160649126|NCT00310856|580097129|FG002|Overall Study|Inappropriate enrollment|0|||
160649127|NCT00310856|580097127|FG000|Overall Study|Unable to classify|1|||
160649128|NCT00310856|580097128|FG001|Overall Study|Unable to classify|0|||
160649129|NCT00310856|580097129|FG002|Overall Study|Unable to classify|0|||
160649130|NCT01306253|580097133|FG000|Overall Study|Lost to Follow-up|1|||
160649131|NCT01306253|580097134|FG001|Overall Study|Lost to Follow-up|1|||
160649132|NCT01261325|580097135|FG000|Overall Study|Lack of Efficacy|1|||
160649133|NCT01261325|580097136|FG001|Overall Study|Lack of Efficacy|1|||
160649134|NCT01261325|580097137|FG002|Overall Study|Lack of Efficacy|0|||
160649135|NCT01261325|580097135|FG000|Overall Study|Withdrawal by Subject|2|||
160649136|NCT01261325|580097136|FG001|Overall Study|Withdrawal by Subject|2|||
160649137|NCT01261325|580097137|FG002|Overall Study|Withdrawal by Subject|4|||
160649138|NCT01261325|580097135|FG000|Overall Study|SAE, non-fatal|1|||
160649139|NCT01261325|580097136|FG001|Overall Study|SAE, non-fatal|5|||
160649140|NCT01261325|580097137|FG002|Overall Study|SAE, non-fatal|1|||
160649141|NCT01261325|580097135|FG000|Overall Study|AE, non-serious non-fatal|9|||
160649142|NCT01261325|580097136|FG001|Overall Study|AE, non-serious non-fatal|15|||
160649143|NCT01261325|580097137|FG002|Overall Study|AE, non-serious non-fatal|13|||
160649144|NCT01261325|580097135|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
160649145|NCT01261325|580097136|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160649146|NCT01261325|580097137|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160649147|NCT01261325|580097135|FG000|Overall Study|Non Compliance|2|||
160649148|NCT01261325|580097136|FG001|Overall Study|Non Compliance|0|||
160649149|NCT01261325|580097137|FG002|Overall Study|Non Compliance|0|||
160649150|NCT01261325|580097135|FG000|Overall Study|Patient Randomized by Mistake|0|||
160649151|NCT01261325|580097136|FG001|Overall Study|Patient Randomized by Mistake|1|||
160649152|NCT01261325|580097137|FG002|Overall Study|Patient Randomized by Mistake|0|||
160649153|NCT01261325|580097135|FG000|Overall Study|Erroneously Randomized|1|||
160649154|NCT01261325|580097136|FG001|Overall Study|Erroneously Randomized|0|||
160649155|NCT01261325|580097137|FG002|Overall Study|Erroneously Randomized|0|||
160649156|NCT01261325|580097135|FG000|Overall Study|Screen Failure|1|||
160844555|NCT00620113|580818046|FG001|Overall Study|Adverse Event|2|||
160844556|NCT00620113|580818047|FG002|Overall Study|Adverse Event|2|||
160649157|NCT01261325|580097136|FG001|Overall Study|Screen Failure|0|||
160649158|NCT01261325|580097137|FG002|Overall Study|Screen Failure|0|||
160649159|NCT01261325|580097135|FG000|Overall Study|Randomized in Error|0|||
160649160|NCT01261325|580097136|FG001|Overall Study|Randomized in Error|0|||
160649161|NCT01261325|580097137|FG002|Overall Study|Randomized in Error|1|||
160649162|NCT01261325|580097135|FG000|Overall Study|Protocol Violation|0|||
160649163|NCT01261325|580097136|FG001|Overall Study|Protocol Violation|3|||
160844557|NCT00620113|580818048|FG003|Overall Study|Adverse Event|1|||
160649164|NCT01261325|580097137|FG002|Overall Study|Protocol Violation|1|||
160649165|NCT01261325|580097135|FG000|Overall Study|Lost to Follow-up|0|||
160649166|NCT01261325|580097136|FG001|Overall Study|Lost to Follow-up|1|||
160649167|NCT01261325|580097137|FG002|Overall Study|Lost to Follow-up|3|||
160649168|NCT01261325|580097135|FG000|Overall Study|AE, serious fatal|0|||
160649169|NCT01261325|580097136|FG001|Overall Study|AE, serious fatal|0|||
160649170|NCT01261325|580097137|FG002|Overall Study|AE, serious fatal|2|||
160649171|NCT00543439|580097138|FG000|Period 1|Adverse Event|0|||
160649172|NCT00543439|580097139|FG001|Period 1|Adverse Event|2|||
160649173|NCT00543439|580097140|FG002|Period 1|Adverse Event|1|||
160844558|NCT00620113|580818045|FG000|Overall Study|Lack of Efficacy|2|||
160844559|NCT00620113|580818046|FG001|Overall Study|Lack of Efficacy|3|||
160844560|NCT00620113|580818047|FG002|Overall Study|Lack of Efficacy|0|||
160844561|NCT00620113|580818048|FG003|Overall Study|Lack of Efficacy|2|||
160844562|NCT00620113|580818045|FG000|Overall Study|Physician Decision|1|||
160844563|NCT00620113|580818046|FG001|Overall Study|Physician Decision|0|||
160844564|NCT00620113|580818047|FG002|Overall Study|Physician Decision|0|||
160844565|NCT00620113|580818048|FG003|Overall Study|Physician Decision|2|||
160844566|NCT00620113|580818045|FG000|Overall Study|Protocol Violation|2|||
160649174|NCT00543439|580097138|FG000|Period 1|Withdrawal by Subject|1|||
160649175|NCT00543439|580097139|FG001|Period 1|Withdrawal by Subject|1|||
160649176|NCT00543439|580097140|FG002|Period 1|Withdrawal by Subject|0|||
160649177|NCT00543439|580097138|FG000|Period 1|Physician Decision|0|||
160649178|NCT00543439|580097139|FG001|Period 1|Physician Decision|0|||
160649179|NCT00543439|580097140|FG002|Period 1|Physician Decision|1|||
160649180|NCT00543439|580097138|FG000|Period 2|Protocol Violation|1|||
160649181|NCT00543439|580097139|FG001|Period 2|Protocol Violation|0|||
160649182|NCT00543439|580097140|FG002|Period 2|Protocol Violation|1|||
160649183|NCT00543439|580097138|FG000|Period 2|Adverse Event|0|||
160649184|NCT00543439|580097139|FG001|Period 2|Adverse Event|1|||
160649185|NCT00543439|580097140|FG002|Period 2|Adverse Event|1|||
160649186|NCT01211769|580097143|FG000|Overall Study|Lost to Follow-up|7|||
160649187|NCT01211769|580097144|FG001|Overall Study|Lost to Follow-up|9|||
160649188|NCT01211769|580097145|FG002|Overall Study|Lost to Follow-up|5|||
160649189|NCT01211769|580097146|FG003|Overall Study|Lost to Follow-up|9|||
160649190|NCT01211769|580097143|FG000|Overall Study|Physician Decision|2|||
160649191|NCT01211769|580097144|FG001|Overall Study|Physician Decision|0|||
160649192|NCT01211769|580097145|FG002|Overall Study|Physician Decision|2|||
160649193|NCT01211769|580097146|FG003|Overall Study|Physician Decision|1|||
160649194|NCT01211769|580097143|FG000|Overall Study|Adverse Event|0|||
160649195|NCT01211769|580097144|FG001|Overall Study|Adverse Event|1|||
160649196|NCT01211769|580097145|FG002|Overall Study|Adverse Event|1|||
160649197|NCT01211769|580097146|FG003|Overall Study|Adverse Event|1|||
160649198|NCT01709383|580097153|FG000|Overall Study|Lost to Follow-up|1|||
160649199|NCT01709383|580097154|FG001|Overall Study|Lost to Follow-up|0|||
160649200|NCT01484028|580097155|FG000|Period 1|Lost to Follow-up|0|||
160649201|NCT01484028|580097156|FG001|Period 1|Lost to Follow-up|1|||
160992314|NCT00828919|581360026|FG001|Overall Study|Adverse Event|2|||
160649202|NCT01484028|580097157|FG002|Period 1|Lost to Follow-up|0|||
160649203|NCT01484028|580097158|FG003|Period 1|Lost to Follow-up|0|||
160649204|NCT01484028|580097155|FG000|Period 1|Non-Compliance to Protocol|0|||
160992315|NCT00828919|581360027|FG002|Overall Study|Adverse Event|2|||
160649205|NCT01484028|580097156|FG001|Period 1|Non-Compliance to Protocol|1|||
160649206|NCT01484028|580097157|FG002|Period 1|Non-Compliance to Protocol|0|||
160649207|NCT01484028|580097158|FG003|Period 1|Non-Compliance to Protocol|1|||
160649208|NCT01484028|580097155|FG000|Period 1|Lens Discomfort|0|||
160649209|NCT01484028|580097156|FG001|Period 1|Lens Discomfort|1|||
160649210|NCT01484028|580097157|FG002|Period 1|Lens Discomfort|0|||
160649211|NCT01484028|580097158|FG003|Period 1|Lens Discomfort|0|||
160649212|NCT02668302|580097161|FG000|Overall Study|Withdrawal by Subject|1|||
160649213|NCT02668302|580097162|FG001|Overall Study|Withdrawal by Subject|0|||
160649214|NCT03558997|580097163|FG000|Overall Study|Adverse Event|0|||
160566221|NCT01642212|579793234|FG004|Open-label Extension|Consent Withdrawn|2|||
160566222|NCT01642212|579793230|FG000|Open-label Extension|Lost to Follow-up|0|||
160566223|NCT01642212|579793231|FG001|Open-label Extension|Lost to Follow-up|0|||
160566224|NCT01642212|579793232|FG002|Open-label Extension|Lost to Follow-up|0|||
160566225|NCT01642212|579793233|FG003|Open-label Extension|Lost to Follow-up|0|||
160566226|NCT01642212|579793234|FG004|Open-label Extension|Lost to Follow-up|1|||
160566227|NCT01642212|579793230|FG000|Open-label Extension|Other|0|||
160566228|NCT01642212|579793231|FG001|Open-label Extension|Other|0|||
160566229|NCT01642212|579793232|FG002|Open-label Extension|Other|0|||
160566230|NCT01642212|579793233|FG003|Open-label Extension|Other|0|||
160566231|NCT01642212|579793234|FG004|Open-label Extension|Other|1|||
160649215|NCT03558997|580097164|FG001|Overall Study|Adverse Event|2|||
160649216|NCT03558997|580097165|FG002|Overall Study|Adverse Event|5|||
160649217|NCT03558997|580097166|FG003|Overall Study|Adverse Event|1|||
160649218|NCT03558997|580097163|FG000|Overall Study|Physician Decision|0|||
160649219|NCT03558997|580097164|FG001|Overall Study|Physician Decision|0|||
160649220|NCT03558997|580097165|FG002|Overall Study|Physician Decision|1|||
160649221|NCT03558997|580097166|FG003|Overall Study|Physician Decision|0|||
160649222|NCT03558997|580097163|FG000|Overall Study|Withdrawal by Subject|1|||
160649223|NCT03558997|580097164|FG001|Overall Study|Withdrawal by Subject|0|||
160649224|NCT03558997|580097165|FG002|Overall Study|Withdrawal by Subject|1|||
160649225|NCT03558997|580097166|FG003|Overall Study|Withdrawal by Subject|1|||
160649226|NCT03558997|580097163|FG000|Overall Study|Lost to Follow-up|0|||
160649227|NCT03558997|580097164|FG001|Overall Study|Lost to Follow-up|0|||
160649228|NCT03558997|580097165|FG002|Overall Study|Lost to Follow-up|1|||
160649229|NCT03558997|580097166|FG003|Overall Study|Lost to Follow-up|0|||
160649230|NCT00526890|580097170|FG000|Overall Study|Adverse Event|2|||
160649231|NCT04128696|580097171|FG000|Overall Study|Lost to Follow-up|3|||
160649232|NCT04128696|580097172|FG001|Overall Study|Lost to Follow-up|7|||
160649233|NCT04128696|580097171|FG000|Overall Study|Withdrawal by Subject|12|||
160649234|NCT04128696|580097172|FG001|Overall Study|Withdrawal by Subject|11|||
160649235|NCT04128696|580097171|FG000|Overall Study|Study Closed/Terminated|26|||
160649236|NCT04128696|580097172|FG001|Overall Study|Study Closed/Terminated|38|||
160649237|NCT04128696|580097171|FG000|Overall Study|Physician Decision|2|||
160649238|NCT04128696|580097172|FG001|Overall Study|Physician Decision|3|||
160649239|NCT03280537|580097177|FG000|Overall Study|Withdrawal by Subject|2|||
160649240|NCT03280537|580097178|FG001|Overall Study|Withdrawal by Subject|4|||
160649241|NCT01588106|580097179|FG000|Overall Study|Withdrawal by Subject|5|||
160649242|NCT01588106|580097180|FG001|Overall Study|Withdrawal by Subject|4|||
160649243|NCT03083132|580097181|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
160649244|NCT03083132|580097182|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
160649245|NCT03083132|580097181|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
160649246|NCT03083132|580097182|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
160649247|NCT03083132|580097181|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
160649248|NCT03083132|580097182|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
160649249|NCT03118739|580097183|FG000|Overall Study|Physician Decision|0|||
160649250|NCT03118739|580097184|FG001|Overall Study|Physician Decision|1|||
160649251|NCT03118739|580097183|FG000|Overall Study|Withdrawal by Subject|5|||
160649252|NCT03118739|580097184|FG001|Overall Study|Withdrawal by Subject|3|||
160649253|NCT03118739|580097183|FG000|Overall Study|Lost to Follow-up|2|||
160649254|NCT03118739|580097184|FG001|Overall Study|Lost to Follow-up|0|||
160649255|NCT02995837|580097185|FG000|Overall Study|Lost to Follow-up|9|||
160649256|NCT02995837|580097186|FG001|Overall Study|Lost to Follow-up|8|||
160649257|NCT01859702|580097187|FG000|Overall Study|Protocol deviation|3|||
160649258|NCT01859702|580097187|FG000|Overall Study|Adverse Event|2|||
160649259|NCT01893138|580097188|FG000|Double-Blind Period|Withdrawal by Subject|1|||
160649260|NCT01893138|580097189|FG001|Double-Blind Period|Withdrawal by Subject|1|||
160649261|NCT01893138|580097188|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
160649262|NCT01893138|580097189|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
160649263|NCT01893138|580097188|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
160649264|NCT01893138|580097189|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
160649265|NCT01893138|580097188|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
160649266|NCT01893138|580097189|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
160649267|NCT01893138|580097188|FG000|Open Label - Unblinded Period|Adverse Event|1|||
160905926|NCT01847274|581050307|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160566232|NCT01624142|579793235|FG000|Overall Study|Withdrawal by Subject|14|||
160566233|NCT01624142|579793236|FG001|Overall Study|Withdrawal by Subject|4|||
160649268|NCT01893138|580097189|FG001|Open Label - Unblinded Period|Adverse Event|0|||
160649269|NCT01326026|580097190|FG000|Overall Study|Adverse Event|4|||
160649270|NCT01326026|580097191|FG001|Overall Study|Adverse Event|3|||
160649271|NCT01326026|580097190|FG000|Overall Study|Withdrawal Criteria|5|||
160649272|NCT01326026|580097191|FG001|Overall Study|Withdrawal Criteria|7|||
160566234|NCT01624142|579793235|FG000|Overall Study|Death|3|||
160649273|NCT01326026|580097190|FG000|Overall Study|Other|3|||
160649274|NCT01326026|580097191|FG001|Overall Study|Other|3|||
160649275|NCT04317053|580097195|FG000|Overall Study|Withdrawn (screen failure)|4|||
160649276|NCT04317053|580097196|FG001|Overall Study|Withdrawn (screen failure)|2|||
160649277|NCT04274192|580097197|FG000|Overall Study|Protocol Violation|1|||
160649278|NCT04274192|580097198|FG001|Overall Study|Protocol Violation|0|||
160649279|NCT00289458|580097199|FG000|Overall Study|Death|1|||
160649280|NCT00289458|580097200|FG001|Overall Study|Death|0|||
160649281|NCT00289458|580097201|FG002|Overall Study|Death|0|||
160649282|NCT00289458|580097199|FG000|Overall Study|Physician Decision|3|||
160649283|NCT00289458|580097200|FG001|Overall Study|Physician Decision|4|||
160649284|NCT00289458|580097201|FG002|Overall Study|Physician Decision|2|||
160649285|NCT00289458|580097199|FG000|Overall Study|Withdrawal by Subject|2|||
160649286|NCT00289458|580097200|FG001|Overall Study|Withdrawal by Subject|2|||
160649287|NCT00289458|580097201|FG002|Overall Study|Withdrawal by Subject|4|||
160649288|NCT03329027|580098789|FG000|Overall Study|Lost to Follow-up|1|||
160649289|NCT03329027|580098790|FG001|Overall Study|Lost to Follow-up|0|||
160649290|NCT03329027|580098791|FG002|Overall Study|Lost to Follow-up|1|||
160649291|NCT03329027|580098789|FG000|Overall Study|Protocol Violation|9|||
160649292|NCT03329027|580098790|FG001|Overall Study|Protocol Violation|5|||
160649293|NCT03329027|580098791|FG002|Overall Study|Protocol Violation|7|||
160649294|NCT00101582|580098798|FG000|Overall Study|Ineligibility determined|0|||
160649295|NCT00101582|580098799|FG001|Overall Study|Ineligibility determined|1|||
160649296|NCT00101582|580098798|FG000|Overall Study|Adverse Event|1|||
160649297|NCT00101582|580098799|FG001|Overall Study|Adverse Event|4|||
160649298|NCT00101582|580098798|FG000|Overall Study|Withdrawal by Subject|6|||
160649299|NCT00101582|580098799|FG001|Overall Study|Withdrawal by Subject|4|||
160844567|NCT00620113|580818046|FG001|Overall Study|Protocol Violation|1|||
160844568|NCT00620113|580818047|FG002|Overall Study|Protocol Violation|0|||
160844569|NCT00620113|580818048|FG003|Overall Study|Protocol Violation|0|||
160844570|NCT00620113|580818045|FG000|Overall Study|Withdrawal by Subject|5|||
160844571|NCT00620113|580818046|FG001|Overall Study|Withdrawal by Subject|1|||
160844572|NCT00620113|580818047|FG002|Overall Study|Withdrawal by Subject|3|||
160844573|NCT00620113|580818048|FG003|Overall Study|Withdrawal by Subject|5|||
160844574|NCT00042991|580818051|FG000|Overall Study|Adverse Event|1|||
160844575|NCT00042991|580818052|FG001|Overall Study|Adverse Event|4|||
160844576|NCT00042991|580818053|FG002|Overall Study|Adverse Event|2|||
160844577|NCT00042991|580818054|FG003|Overall Study|Adverse Event|0|||
160844578|NCT00042991|580818055|FG004|Overall Study|Adverse Event|0|||
160844579|NCT00042991|580818056|FG005|Overall Study|Adverse Event|1|||
160844580|NCT00042991|580818057|FG006|Overall Study|Adverse Event|0|||
160844581|NCT00042991|580818051|FG000|Overall Study|Withdrawal by Subject|0|||
160844582|NCT00042991|580818052|FG001|Overall Study|Withdrawal by Subject|7|||
160844583|NCT00042991|580818053|FG002|Overall Study|Withdrawal by Subject|2|||
160844584|NCT00042991|580818054|FG003|Overall Study|Withdrawal by Subject|0|||
160844585|NCT00042991|580818055|FG004|Overall Study|Withdrawal by Subject|1|||
160844586|NCT00042991|580818056|FG005|Overall Study|Withdrawal by Subject|0|||
160844587|NCT00042991|580818057|FG006|Overall Study|Withdrawal by Subject|0|||
160844588|NCT00042991|580818051|FG000|Overall Study|Disease Progression|5|||
160844589|NCT00042991|580818052|FG001|Overall Study|Disease Progression|29|||
160844590|NCT00042991|580818053|FG002|Overall Study|Disease Progression|2|||
160844591|NCT00042991|580818054|FG003|Overall Study|Disease Progression|2|||
160844592|NCT00042991|580818055|FG004|Overall Study|Disease Progression|1|||
160844593|NCT00042991|580818056|FG005|Overall Study|Disease Progression|4|||
160649300|NCT00101582|580098798|FG000|Overall Study|Physician Decision|1|||
160649301|NCT00101582|580098799|FG001|Overall Study|Physician Decision|0|||
160649302|NCT00101582|580098798|FG000|Overall Study|Death|3|||
160649303|NCT00101582|580098799|FG001|Overall Study|Death|5|||
160649304|NCT00101582|580098798|FG000|Overall Study|Other|0|||
160649305|NCT00101582|580098799|FG001|Overall Study|Other|1|||
160649306|NCT02207621|580098800|FG000|Overall Study|Adverse Event|71|||
160649307|NCT02207621|580098801|FG001|Overall Study|Adverse Event|15|||
160649308|NCT02207621|580098802|FG002|Overall Study|Adverse Event|132|||
160649309|NCT02207621|580098800|FG000|Overall Study|Withdrawal by Subject|9|||
160649310|NCT02207621|580098801|FG001|Overall Study|Withdrawal by Subject|9|||
160649311|NCT02207621|580098802|FG002|Overall Study|Withdrawal by Subject|13|||
160649312|NCT02207621|580098800|FG000|Overall Study|Non-Compliant|3|||
160649313|NCT02207621|580098801|FG001|Overall Study|Non-Compliant|3|||
160649314|NCT02207621|580098802|FG002|Overall Study|Non-Compliant|1|||
160649315|NCT02207621|580098800|FG000|Overall Study|Lost to Follow-up|1|||
160649316|NCT02207621|580098801|FG001|Overall Study|Lost to Follow-up|0|||
160649317|NCT02207621|580098802|FG002|Overall Study|Lost to Follow-up|3|||
160649318|NCT02207621|580098800|FG000|Overall Study|Lack of Efficacy|10|||
160649319|NCT02207621|580098801|FG001|Overall Study|Lack of Efficacy|2|||
160649320|NCT02207621|580098802|FG002|Overall Study|Lack of Efficacy|4|||
160649321|NCT02207621|580098800|FG000|Overall Study|Disallowed Concurrent Medication|2|||
160649322|NCT02207621|580098801|FG001|Overall Study|Disallowed Concurrent Medication|5|||
160649323|NCT02207621|580098802|FG002|Overall Study|Disallowed Concurrent Medication|2|||
160649324|NCT02207621|580098800|FG000|Overall Study|Physician Decision|1|||
160649325|NCT02207621|580098801|FG001|Overall Study|Physician Decision|2|||
160649326|NCT02207621|580098802|FG002|Overall Study|Physician Decision|2|||
160649327|NCT02207621|580098800|FG000|Overall Study|Protocol Violation|4|||
160649328|NCT02207621|580098801|FG001|Overall Study|Protocol Violation|10|||
160649329|NCT02207621|580098802|FG002|Overall Study|Protocol Violation|6|||
160649330|NCT02207621|580098800|FG000|Overall Study|Death|2|||
160649331|NCT02207621|580098801|FG001|Overall Study|Death|0|||
160649332|NCT02207621|580098802|FG002|Overall Study|Death|0|||
160649333|NCT02207621|580098800|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
160649334|NCT02207621|580098801|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
160649335|NCT02207621|580098802|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
160649336|NCT02848599|580098803|FG000|Overall Study|Protocol Violation|7|||
160649337|NCT02848599|580098804|FG001|Overall Study|Protocol Violation|9|||
160649338|NCT04828161|580098805|FG000|Overall Study|Withdrawal by Subject|0|||
160649339|NCT04828161|580098806|FG001|Overall Study|Withdrawal by Subject|3|||
160649340|NCT04828161|580098807|FG002|Overall Study|Withdrawal by Subject|3|||
160649341|NCT04828161|580098808|FG003|Overall Study|Withdrawal by Subject|4|||
160649342|NCT04828161|580098805|FG000|Overall Study|Lost to Follow-up|1|||
160649343|NCT04828161|580098806|FG001|Overall Study|Lost to Follow-up|4|||
160649344|NCT04828161|580098807|FG002|Overall Study|Lost to Follow-up|2|||
160649345|NCT04828161|580098808|FG003|Overall Study|Lost to Follow-up|2|||
160649346|NCT04828161|580098805|FG000|Overall Study|Other|2|||
160649347|NCT04828161|580098806|FG001|Overall Study|Other|0|||
160649348|NCT04828161|580098807|FG002|Overall Study|Other|2|||
160649349|NCT04828161|580098808|FG003|Overall Study|Other|0|||
160649350|NCT04828161|580098805|FG000|Overall Study|Death|0|||
160649351|NCT04828161|580098806|FG001|Overall Study|Death|0|||
160649352|NCT04828161|580098807|FG002|Overall Study|Death|0|||
160649353|NCT04828161|580098808|FG003|Overall Study|Death|2|||
160649354|NCT02524379|580098815|FG000|Overall Study|Death|1|||
160649355|NCT01829464|580098816|FG000|Overall Study|Adverse Event|1|||
160649356|NCT01829464|580098817|FG001|Overall Study|Adverse Event|0|||
160649357|NCT01829464|580098818|FG002|Overall Study|Adverse Event|0|||
160649358|NCT01829464|580098816|FG000|Overall Study|Lost to Follow-up|0|||
160649359|NCT01829464|580098817|FG001|Overall Study|Lost to Follow-up|0|||
160649360|NCT01829464|580098818|FG002|Overall Study|Lost to Follow-up|1|||
160649361|NCT01829464|580098816|FG000|Overall Study|Withdrawal by Subject|2|||
160649362|NCT01829464|580098817|FG001|Overall Study|Withdrawal by Subject|0|||
160649363|NCT01829464|580098818|FG002|Overall Study|Withdrawal by Subject|0|||
160649364|NCT01829464|580098816|FG000|Overall Study|Study terminated by sponsor|25|||
160649365|NCT01829464|580098817|FG001|Overall Study|Study terminated by sponsor|28|||
160649366|NCT01829464|580098818|FG002|Overall Study|Study terminated by sponsor|25|||
160649367|NCT01829464|580098816|FG000|Overall Study|Lack of Efficacy|0|||
160649368|NCT01829464|580098817|FG001|Overall Study|Lack of Efficacy|1|||
160649369|NCT01829464|580098818|FG002|Overall Study|Lack of Efficacy|0|||
160649370|NCT00635778|580098823|FG000|Overall Study|Adverse Event|1|||
160649371|NCT00635778|580098824|FG001|Overall Study|Adverse Event|0|||
160649372|NCT00635778|580098825|FG002|Overall Study|Adverse Event|0|||
160649373|NCT00635778|580098826|FG003|Overall Study|Adverse Event|3|||
160649374|NCT00635778|580098827|FG004|Overall Study|Adverse Event|3|||
160649375|NCT00635778|580098828|FG005|Overall Study|Adverse Event|6|||
160649376|NCT00635778|580098829|FG006|Overall Study|Adverse Event|1|||
160649377|NCT00635778|580098823|FG000|Overall Study|Withdrawal by Subject|0|||
160649378|NCT00635778|580098824|FG001|Overall Study|Withdrawal by Subject|0|||
160649379|NCT00635778|580098825|FG002|Overall Study|Withdrawal by Subject|0|||
160649380|NCT00635778|580098826|FG003|Overall Study|Withdrawal by Subject|1|||
160649381|NCT00635778|580098827|FG004|Overall Study|Withdrawal by Subject|0|||
160649382|NCT00635778|580098828|FG005|Overall Study|Withdrawal by Subject|1|||
160649383|NCT00635778|580098829|FG006|Overall Study|Withdrawal by Subject|1|||
160649384|NCT00635778|580098823|FG000|Overall Study|Progressive disease|0|||
160649385|NCT00635778|580098824|FG001|Overall Study|Progressive disease|3|||
160649386|NCT00635778|580098825|FG002|Overall Study|Progressive disease|3|||
160649387|NCT00635778|580098826|FG003|Overall Study|Progressive disease|4|||
160649388|NCT00635778|580098827|FG004|Overall Study|Progressive disease|5|||
160649389|NCT00635778|580098828|FG005|Overall Study|Progressive disease|14|||
160649390|NCT00635778|580098829|FG006|Overall Study|Progressive disease|4|||
160649391|NCT01884025|580098830|FG000|Overall Study|Lost to Follow-up|3|||
160649392|NCT01884025|580098831|FG001|Overall Study|Lost to Follow-up|4|||
160649393|NCT03209570|580098832|FG000|Overall Study|Death|1|||
160649394|NCT03209570|580098833|FG001|Overall Study|Death|0|||
160649395|NCT03209570|580098832|FG000|Overall Study|Incomplete Data|8|||
160649396|NCT03209570|580098833|FG001|Overall Study|Incomplete Data|10|||
160649397|NCT03209570|580098832|FG000|Overall Study|Protocol Violation|1|||
160649398|NCT03209570|580098833|FG001|Overall Study|Protocol Violation|0|||
160649399|NCT03209570|580098832|FG000|Overall Study|Withdrawal by Subject|0|||
160649400|NCT03209570|580098833|FG001|Overall Study|Withdrawal by Subject|3|||
160649401|NCT00634907|580098840|FG000|Overall Study|Withdrawal by Subject|3|||
160649402|NCT00634907|580098841|FG001|Overall Study|Withdrawal by Subject|0|||
160649403|NCT00634907|580098840|FG000|Overall Study|Physician Decision|3|||
160649404|NCT00634907|580098841|FG001|Overall Study|Physician Decision|9|||
160649405|NCT00634907|580098840|FG000|Overall Study|Withdrawal by Subject|11|||
160649406|NCT00634907|580098841|FG001|Overall Study|Withdrawal by Subject|8|||
160566235|NCT01624142|579793236|FG001|Overall Study|Death|6|||
160566236|NCT01624142|579793235|FG000|Overall Study|Study Closure|12|||
160566237|NCT01624142|579793236|FG001|Overall Study|Study Closure|6|||
160566238|NCT01624142|579793235|FG000|Overall Study|Lost to Follow-up|2|||
160566239|NCT01624142|579793236|FG001|Overall Study|Lost to Follow-up|0|||
160566240|NCT01624142|579793235|FG000|Overall Study|Other|1|||
160566241|NCT01624142|579793236|FG001|Overall Study|Other|0|||
160566242|NCT00667277|579793237|FG000|Overall Study|Withdrawal by Subject|2|||
160566243|NCT01053429|579793238|FG000|Overall Study|Adverse Event|64|||
160566244|NCT01053429|579793238|FG000|Overall Study|Other|309|||
160566245|NCT01697345|579793239|FG000|Overall Study|Withdrawal by Subject|1|||
160566246|NCT01976806|579793240|FG000|Overall Study|Lost to Follow-up|1|||
160566247|NCT01976806|579793241|FG001|Overall Study|Lost to Follow-up|4|||
160566248|NCT01976806|579793240|FG000|Overall Study|Adverse Event|1|||
160566249|NCT01976806|579793241|FG001|Overall Study|Adverse Event|1|||
160566250|NCT01976806|579793240|FG000|Overall Study|Withdrawal by Subject|1|||
160566251|NCT01976806|579793241|FG001|Overall Study|Withdrawal by Subject|1|||
160566252|NCT03929250|579793242|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
160566253|NCT03929250|579793243|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
160566254|NCT04321343|579793244|FG000|Overall Study|Adverse Event|0|||
160566255|NCT04321343|579793245|FG001|Overall Study|Adverse Event|0|||
160566256|NCT04321343|579793246|FG002|Overall Study|Adverse Event|1|||
160566257|NCT04321343|579793247|FG003|Overall Study|Adverse Event|0|||
160566258|NCT04321343|579793244|FG000|Overall Study|Death|0|||
160566259|NCT04321343|579793245|FG001|Overall Study|Death|0|||
160566260|NCT04321343|579793246|FG002|Overall Study|Death|0|||
160566261|NCT04321343|579793247|FG003|Overall Study|Death|1|||
160566262|NCT04321343|579793244|FG000|Overall Study|Pregnancy|1|||
160566263|NCT04321343|579793245|FG001|Overall Study|Pregnancy|0|||
160566264|NCT04321343|579793246|FG002|Overall Study|Pregnancy|0|||
160566265|NCT04321343|579793247|FG003|Overall Study|Pregnancy|0|||
160566266|NCT04321343|579793244|FG000|Overall Study|Protocol Violation|1|||
160566267|NCT04321343|579793245|FG001|Overall Study|Protocol Violation|1|||
160566268|NCT04321343|579793246|FG002|Overall Study|Protocol Violation|1|||
160566269|NCT04321343|579793247|FG003|Overall Study|Protocol Violation|1|||
160566270|NCT04321343|579793244|FG000|Overall Study|Withdrawal by Subject|0|||
160566271|NCT04321343|579793245|FG001|Overall Study|Withdrawal by Subject|6|||
160566272|NCT04321343|579793246|FG002|Overall Study|Withdrawal by Subject|0|||
160566273|NCT04321343|579793247|FG003|Overall Study|Withdrawal by Subject|2|||
160566274|NCT04321343|579793244|FG000|Overall Study|Lost to Follow-up|2|||
160566275|NCT04321343|579793245|FG001|Overall Study|Lost to Follow-up|2|||
160566276|NCT04321343|579793246|FG002|Overall Study|Lost to Follow-up|1|||
160566277|NCT04321343|579793247|FG003|Overall Study|Lost to Follow-up|3|||
160566278|NCT03430310|579793248|FG000|Overall Study|Protocol Violation|2|||
160566279|NCT03430310|579793249|FG001|Overall Study|Protocol Violation|0|||
160566280|NCT03430310|579793248|FG000|Overall Study|Withdrawal by Subject|3|||
160566281|NCT03430310|579793249|FG001|Overall Study|Withdrawal by Subject|2|||
160566282|NCT03430310|579793248|FG000|Overall Study|COVID shutdown March 2020|0|||
160566283|NCT03430310|579793249|FG001|Overall Study|COVID shutdown March 2020|1|||
160566284|NCT03972488|579793250|FG000|Overall Study|Progressive disease|42|||
160566285|NCT03972488|579793251|FG001|Overall Study|Progressive disease|44|||
160566286|NCT03972488|579793250|FG000|Overall Study|Physician Decision|13|||
160566287|NCT03972488|579793251|FG001|Overall Study|Physician Decision|7|||
160566288|NCT03972488|579793250|FG000|Overall Study|Adverse Event|8|||
160566289|NCT03972488|579793251|FG001|Overall Study|Adverse Event|1|||
160566290|NCT03972488|579793250|FG000|Overall Study|Death|4|||
160566291|NCT03972488|579793251|FG001|Overall Study|Death|4|||
160566292|NCT03972488|579793250|FG000|Overall Study|Withdrawal by Subject|3|||
160566293|NCT03972488|579793251|FG001|Overall Study|Withdrawal by Subject|4|||
160566294|NCT03972488|579793250|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
160566295|NCT03972488|579793251|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
160566296|NCT02581995|579793252|FG000|Overall Study|Unspecified other|3|||
160649407|NCT01338636|580098848|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
160649408|NCT02385526|580098849|FG000|Overall Study|Withdrawal by Subject|0|||
160649409|NCT02385526|580098850|FG001|Overall Study|Withdrawal by Subject|2|||
160649410|NCT02385526|580098851|FG002|Overall Study|Withdrawal by Subject|0|||
160649411|NCT02385526|580098849|FG000|Overall Study|Lost to Follow-up|0|||
160649412|NCT02385526|580098850|FG001|Overall Study|Lost to Follow-up|1|||
160649413|NCT02385526|580098851|FG002|Overall Study|Lost to Follow-up|0|||
160649414|NCT02385526|580098849|FG000|Overall Study|Physician Decision|1|||
160649415|NCT02385526|580098850|FG001|Overall Study|Physician Decision|0|||
160649416|NCT02385526|580098851|FG002|Overall Study|Physician Decision|0|||
160649417|NCT02385526|580098849|FG000|Overall Study|Protocol Violation|1|||
160649418|NCT02385526|580098850|FG001|Overall Study|Protocol Violation|0|||
160649419|NCT02385526|580098851|FG002|Overall Study|Protocol Violation|0|||
160649420|NCT01595009|580098854|FG000|Core|Patients completed per protocol|85|||
160649421|NCT01595009|580098855|FG001|Core|Patients completed per protocol|44|||
160649422|NCT01595009|580098856|FG002|Core|Patients completed per protocol|0|||
160649423|NCT01595009|580098857|FG003|Core|Patients completed per protocol|0|||
160649424|NCT01595009|580098854|FG000|Core|Adverse Event|19|||
160649425|NCT01595009|580098855|FG001|Core|Adverse Event|23|||
160649426|NCT01595009|580098856|FG002|Core|Adverse Event|0|||
160649427|NCT01595009|580098857|FG003|Core|Adverse Event|0|||
160649428|NCT01595009|580098854|FG000|Core|Disease progression|14|||
160566297|NCT02581995|579793252|FG000|Overall Study|Adverse Event|6|||
160566298|NCT02581995|579793252|FG000|Overall Study|Lost to Follow-up|5|||
160566299|NCT02581995|579793252|FG000|Overall Study|Withdrawal by participant|12|||
160566300|NCT02581995|579793252|FG000|Overall Study|Physician Decision|1|||
160566301|NCT02581995|579793252|FG000|Overall Study|Death|4|||
160566302|NCT03277196|579793254|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
160566303|NCT03277196|579793254|FG000|Overall Study|Lost to Follow-up|3|||
160566304|NCT03277196|579793254|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
160566305|NCT03277196|579793254|FG000|Overall Study|Other|2|||
160566306|NCT06119191|579793255|FG000|Overall Study|Adverse Event|0|||
160566307|NCT06119191|579793256|FG001|Overall Study|Adverse Event|1|||
160566308|NCT06119191|579793255|FG000|Overall Study|Protocol Violation|1|||
160566309|NCT06119191|579793256|FG001|Overall Study|Protocol Violation|0|||
160566310|NCT04364854|579795337|FG000|Overall Study|Withdrawal by Subject|1|||
160566311|NCT04364854|579795338|FG001|Overall Study|Withdrawal by Subject|0|||
160566312|NCT04364854|579795339|FG002|Overall Study|Withdrawal by Subject|1|||
160566313|NCT04364854|579795340|FG003|Overall Study|Withdrawal by Subject|3|||
160566314|NCT04364854|579795337|FG000|Overall Study|Death|1|||
160566315|NCT04364854|579795338|FG001|Overall Study|Death|0|||
160649429|NCT01595009|580098855|FG001|Core|Disease progression|26|||
160649430|NCT01595009|580098856|FG002|Core|Disease progression|0|||
160905927|NCT01847274|581050308|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160905928|NCT01847274|581050309|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160905929|NCT01847274|581050310|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160905930|NCT01847274|581050311|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
160905931|NCT01847274|581050312|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
160905932|NCT01847274|581050313|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
160905933|NCT01847274|581050314|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
160905934|NCT01847274|581050304|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905935|NCT01847274|581050305|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905936|NCT01847274|581050306|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905937|NCT01847274|581050307|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905938|NCT01847274|581050308|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905939|NCT01847274|581050309|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905940|NCT01847274|581050310|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905941|NCT01847274|581050311|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
160905942|NCT01847274|581050312|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905943|NCT01847274|581050313|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
160905944|NCT01847274|581050314|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905945|NCT01847274|581050304|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905946|NCT01847274|581050305|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905947|NCT01847274|581050306|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905948|NCT01847274|581050307|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160992316|NCT00828919|581360028|FG003|Overall Study|Adverse Event|1|||
160992317|NCT00828919|581360029|FG004|Overall Study|Adverse Event|3|||
160566316|NCT04364854|579795339|FG002|Overall Study|Death|0|||
160566317|NCT04364854|579795340|FG003|Overall Study|Death|0|||
160649431|NCT01595009|580098857|FG003|Core|Disease progression|0|||
160649432|NCT01595009|580098854|FG000|Core|Withdrawal by Subject|4|||
160649433|NCT01595009|580098855|FG001|Core|Withdrawal by Subject|17|||
160566318|NCT04364854|579795337|FG000|Overall Study|Lost to Follow-up|0|||
160566319|NCT04364854|579795338|FG001|Overall Study|Lost to Follow-up|0|||
160566320|NCT04364854|579795339|FG002|Overall Study|Lost to Follow-up|0|||
160566321|NCT04364854|579795340|FG003|Overall Study|Lost to Follow-up|1|||
160566322|NCT03528681|579795345|FG000|Open-Label Phase|Physician Decision|2|||
160566323|NCT03528681|579795346|FG001|Open-Label Phase|Physician Decision|0|||
160566324|NCT03528681|579795347|FG002|Open-Label Phase|Physician Decision|0|||
160566325|NCT03528681|579795348|FG003|Open-Label Phase|Physician Decision|0|||
160566326|NCT03528681|579795345|FG000|Open-Label Phase|Withdrawal by Subject|8|||
160566327|NCT03528681|579795346|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160566328|NCT03528681|579795347|FG002|Open-Label Phase|Withdrawal by Subject|0|||
160566329|NCT03528681|579795348|FG003|Open-Label Phase|Withdrawal by Subject|0|||
160566330|NCT03528681|579795345|FG000|Open-Label Phase|(Not collected)|4|||
160566331|NCT03528681|579795346|FG001|Open-Label Phase|(Not collected)|0|||
160566332|NCT03528681|579795347|FG002|Open-Label Phase|(Not collected)|0|||
160566333|NCT03528681|579795348|FG003|Open-Label Phase|(Not collected)|0|||
160566334|NCT03528681|579795345|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
160566335|NCT03528681|579795346|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
160566336|NCT03528681|579795347|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
160566337|NCT03528681|579795348|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
160566338|NCT03528681|579795345|FG000|Randomized Treatment Phase|Physician Decision|0|||
160566339|NCT03528681|579795346|FG001|Randomized Treatment Phase|Physician Decision|5|||
160566340|NCT03528681|579795347|FG002|Randomized Treatment Phase|Physician Decision|1|||
160566341|NCT03528681|579795348|FG003|Randomized Treatment Phase|Physician Decision|2|||
160566342|NCT03528681|579795345|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
160566343|NCT03528681|579795346|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
160566344|NCT03528681|579795347|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
160905949|NCT01847274|581050308|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905950|NCT01847274|581050309|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905951|NCT01847274|581050310|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905952|NCT01847274|581050311|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
160905953|NCT01847274|581050312|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905954|NCT01847274|581050313|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
160905955|NCT01847274|581050314|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
160905956|NCT01847274|581050304|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905957|NCT01847274|581050305|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160566345|NCT03528681|579795348|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
160566346|NCT03528681|579795345|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
160566347|NCT03528681|579795346|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
160566348|NCT03528681|579795347|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
160566349|NCT03528681|579795348|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
160566350|NCT03528681|579795345|FG000|Randomized Treatment Phase|(Not collected)|0|||
160566351|NCT03528681|579795346|FG001|Randomized Treatment Phase|(Not collected)|4|||
160566352|NCT03528681|579795347|FG002|Randomized Treatment Phase|(Not collected)|6|||
160566353|NCT03528681|579795348|FG003|Randomized Treatment Phase|(Not collected)|5|||
160566354|NCT00374556|579795352|FG000|Overall Study|Lost to Follow-up|1|||
160566355|NCT00374556|579795353|FG001|Overall Study|Lost to Follow-up|0|||
160566356|NCT00374556|579795352|FG000|Overall Study|Removed at baseline due to medical cond|0|||
160566357|NCT00374556|579795353|FG001|Overall Study|Removed at baseline due to medical cond|1|||
160566358|NCT00473694|579795354|FG000|Overall Study|Adverse Event|0|||
160566359|NCT00473694|579795355|FG001|Overall Study|Adverse Event|1|||
160566360|NCT00473694|579795356|FG002|Overall Study|Adverse Event|0|||
160566361|NCT00473694|579795357|FG003|Overall Study|Adverse Event|0|||
160566362|NCT00473694|579795354|FG000|Overall Study|Participants did not receive treatment|11|||
160566363|NCT00473694|579795355|FG001|Overall Study|Participants did not receive treatment|3|||
160566364|NCT00473694|579795356|FG002|Overall Study|Participants did not receive treatment|5|||
160566365|NCT00473694|579795357|FG003|Overall Study|Participants did not receive treatment|6|||
160566366|NCT00473694|579795354|FG000|Overall Study|Lost to Follow-up|0|||
160566367|NCT00473694|579795355|FG001|Overall Study|Lost to Follow-up|0|||
160566368|NCT00473694|579795356|FG002|Overall Study|Lost to Follow-up|0|||
160566369|NCT00473694|579795357|FG003|Overall Study|Lost to Follow-up|1|||
160566370|NCT02468193|579795358|FG000|Overall Study|Adverse Event|4|||
160566371|NCT02468193|579795358|FG000|Overall Study|Subject/ Guardian decision|2|||
160566372|NCT00742781|579795359|FG000|Overall Study|Withdrawal by Subject|3|||
160566373|NCT01416181|579795360|FG000|Part 1|Other|10|||
160566374|NCT01416181|579795361|FG001|Part 1|Other|24|||
160566375|NCT01416181|579795360|FG000|Part 1|Death|0|||
160566376|NCT01416181|579795361|FG001|Part 1|Death|1|||
160566377|NCT01416181|579795360|FG000|Part 1|Investigator Decision|7|||
160566378|NCT01416181|579795361|FG001|Part 1|Investigator Decision|6|||
160566379|NCT01416181|579795360|FG000|Part 1|Withdrawal by Subject|74|||
160566380|NCT01416181|579795361|FG001|Part 1|Withdrawal by Subject|48|||
160649434|NCT01595009|580098856|FG002|Core|Withdrawal by Subject|0|||
160649435|NCT01595009|580098857|FG003|Core|Withdrawal by Subject|0|||
160649436|NCT01595009|580098854|FG000|Core|Death|3|||
160649437|NCT01595009|580098855|FG001|Core|Death|6|||
160649438|NCT01595009|580098856|FG002|Core|Death|0|||
160649439|NCT01595009|580098857|FG003|Core|Death|0|||
160649440|NCT01595009|580098854|FG000|Core|Lost to Follow-up|1|||
160649441|NCT01595009|580098855|FG001|Core|Lost to Follow-up|2|||
160649442|NCT01595009|580098856|FG002|Core|Lost to Follow-up|0|||
160649443|NCT01595009|580098857|FG003|Core|Lost to Follow-up|0|||
160649444|NCT01595009|580098854|FG000|Core|Protocol deviation|0|||
160649445|NCT01595009|580098855|FG001|Core|Protocol deviation|1|||
160649446|NCT01595009|580098856|FG002|Core|Protocol deviation|0|||
160649447|NCT01595009|580098857|FG003|Core|Protocol deviation|0|||
160649448|NCT01595009|580098854|FG000|Core|Administrative problems|0|||
160649449|NCT01595009|580098855|FG001|Core|Administrative problems|1|||
160649450|NCT01595009|580098856|FG002|Core|Administrative problems|0|||
160649451|NCT01595009|580098857|FG003|Core|Administrative problems|0|||
160649452|NCT01595009|580098854|FG000|Extension|Administrative problems|0|||
160649453|NCT01595009|580098855|FG001|Extension|Administrative problems|0|||
160649454|NCT01595009|580098856|FG002|Extension|Administrative problems|0|||
160649455|NCT01595009|580098857|FG003|Extension|Administrative problems|1|||
160649456|NCT01595009|580098854|FG000|Extension|Patients completed per protocol|0|||
160649457|NCT01595009|580098855|FG001|Extension|Patients completed per protocol|0|||
160649458|NCT01595009|580098856|FG002|Extension|Patients completed per protocol|0|||
160649459|NCT01595009|580098857|FG003|Extension|Patients completed per protocol|2|||
160649460|NCT01595009|580098854|FG000|Extension|Disease progression|0|||
160649461|NCT01595009|580098855|FG001|Extension|Disease progression|0|||
160649462|NCT01595009|580098856|FG002|Extension|Disease progression|4|||
160649463|NCT01595009|580098857|FG003|Extension|Disease progression|7|||
160649464|NCT01595009|580098854|FG000|Extension|Adverse Event|0|||
160649465|NCT01595009|580098855|FG001|Extension|Adverse Event|0|||
160649466|NCT01595009|580098856|FG002|Extension|Adverse Event|0|||
160649467|NCT01595009|580098857|FG003|Extension|Adverse Event|1|||
160649468|NCT00729859|580098858|FG000|Overall Study|Adverse Event|0|||
160649469|NCT00729859|580098859|FG001|Overall Study|Adverse Event|1|||
160649470|NCT00729859|580098860|FG002|Overall Study|Adverse Event|0|||
160649471|NCT00729859|580098858|FG000|Overall Study|Withdrawal by Subject|0|||
160649472|NCT00729859|580098859|FG001|Overall Study|Withdrawal by Subject|1|||
160649473|NCT00729859|580098860|FG002|Overall Study|Withdrawal by Subject|0|||
160649474|NCT01336894|580098865|FG000|Follow-up|Study terminated prematurely|2|||
160649475|NCT01336894|580098866|FG001|Follow-up|Study terminated prematurely|7|||
160649476|NCT00622908|580098867|FG000|Overall Study|Protocol Violation|1|||
160649477|NCT00622908|580098868|FG001|Overall Study|Protocol Violation|0|||
160649478|NCT00622908|580098867|FG000|Overall Study|Adverse Event|0|||
160649479|NCT00622908|580098868|FG001|Overall Study|Adverse Event|1|||
160649480|NCT00622908|580098867|FG000|Overall Study|Lack of Efficacy|1|||
160649481|NCT00622908|580098868|FG001|Overall Study|Lack of Efficacy|7|||
160649482|NCT00622908|580098867|FG000|Overall Study|Lost to Follow-up|1|||
160649483|NCT00622908|580098868|FG001|Overall Study|Lost to Follow-up|0|||
160649484|NCT00622908|580098867|FG000|Overall Study|Refusal|0|||
160649485|NCT00622908|580098868|FG001|Overall Study|Refusal|1|||
160649486|NCT00622908|580098867|FG000|Overall Study|Termination by study sponser|0|||
160649487|NCT00622908|580098868|FG001|Overall Study|Termination by study sponser|1|||
160649488|NCT03937466|580098869|FG000|Overall Study|not eligbile after the 2-week diary|9|||
160649489|NCT03937466|580098869|FG000|Overall Study|never returned their diary|6|||
160649490|NCT03937466|580098869|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
160649491|NCT03937466|580098869|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
160649492|NCT00818623|580098870|FG000|Overall Study|Adverse Event|1|||
160649493|NCT00818623|580098871|FG001|Overall Study|Adverse Event|0|||
160649494|NCT00818623|580098872|FG002|Overall Study|Adverse Event|1|||
160649495|NCT00818623|580098873|FG003|Overall Study|Adverse Event|0|||
160649496|NCT00818623|580098874|FG004|Overall Study|Adverse Event|0|||
160649497|NCT00818623|580098875|FG005|Overall Study|Adverse Event|1|||
160649498|NCT00818623|580098876|FG006|Overall Study|Adverse Event|0|||
160649499|NCT00818623|580098877|FG007|Overall Study|Adverse Event|0|||
160649500|NCT00818623|580098870|FG000|Overall Study|Bad prostate specific antigen response|0|||
160992318|NCT00828919|581360025|FG000|Overall Study|Objective progression or relapse|4|||
160649501|NCT00818623|580098871|FG001|Overall Study|Bad prostate specific antigen response|3|||
160649502|NCT00818623|580098872|FG002|Overall Study|Bad prostate specific antigen response|2|||
160649503|NCT00818623|580098873|FG003|Overall Study|Bad prostate specific antigen response|5|||
160649504|NCT00818623|580098874|FG004|Overall Study|Bad prostate specific antigen response|0|||
160649505|NCT00818623|580098875|FG005|Overall Study|Bad prostate specific antigen response|1|||
160649506|NCT00818623|580098876|FG006|Overall Study|Bad prostate specific antigen response|0|||
160649507|NCT00818623|580098877|FG007|Overall Study|Bad prostate specific antigen response|0|||
160649508|NCT00818623|580098870|FG000|Overall Study|Withdrawal by Subject|0|||
160649509|NCT00818623|580098871|FG001|Overall Study|Withdrawal by Subject|1|||
160649510|NCT00818623|580098872|FG002|Overall Study|Withdrawal by Subject|1|||
160649511|NCT00818623|580098873|FG003|Overall Study|Withdrawal by Subject|0|||
160649512|NCT00818623|580098874|FG004|Overall Study|Withdrawal by Subject|0|||
160649513|NCT00818623|580098875|FG005|Overall Study|Withdrawal by Subject|1|||
160649514|NCT00818623|580098876|FG006|Overall Study|Withdrawal by Subject|1|||
160649515|NCT00818623|580098877|FG007|Overall Study|Withdrawal by Subject|1|||
160649516|NCT00818623|580098870|FG000|Overall Study|Protocol Violation|1|||
160649517|NCT00818623|580098871|FG001|Overall Study|Protocol Violation|0|||
160649518|NCT00818623|580098872|FG002|Overall Study|Protocol Violation|0|||
160649519|NCT00818623|580098873|FG003|Overall Study|Protocol Violation|0|||
160649520|NCT00818623|580098874|FG004|Overall Study|Protocol Violation|1|||
160649521|NCT00818623|580098875|FG005|Overall Study|Protocol Violation|0|||
160649522|NCT00818623|580098876|FG006|Overall Study|Protocol Violation|1|||
160649523|NCT00818623|580098877|FG007|Overall Study|Protocol Violation|0|||
160649524|NCT00818623|580098870|FG000|Overall Study|Need of additional treatment|0|||
160649525|NCT00818623|580098871|FG001|Overall Study|Need of additional treatment|0|||
160649526|NCT00818623|580098872|FG002|Overall Study|Need of additional treatment|0|||
160649527|NCT00818623|580098873|FG003|Overall Study|Need of additional treatment|0|||
160649528|NCT00818623|580098874|FG004|Overall Study|Need of additional treatment|1|||
160649529|NCT00818623|580098875|FG005|Overall Study|Need of additional treatment|0|||
160649530|NCT00818623|580098876|FG006|Overall Study|Need of additional treatment|0|||
160649531|NCT00818623|580098877|FG007|Overall Study|Need of additional treatment|0|||
160649532|NCT00818623|580098870|FG000|Overall Study|Lack of trial drug at site|0|||
160649533|NCT00818623|580098871|FG001|Overall Study|Lack of trial drug at site|0|||
160649534|NCT00818623|580098872|FG002|Overall Study|Lack of trial drug at site|0|||
160649535|NCT00818623|580098873|FG003|Overall Study|Lack of trial drug at site|0|||
160649536|NCT00818623|580098874|FG004|Overall Study|Lack of trial drug at site|2|||
160649537|NCT00818623|580098875|FG005|Overall Study|Lack of trial drug at site|0|||
160649538|NCT00818623|580098876|FG006|Overall Study|Lack of trial drug at site|1|||
160649539|NCT00818623|580098877|FG007|Overall Study|Lack of trial drug at site|0|||
160649540|NCT00818623|580098870|FG000|Overall Study|Disease progression|0|||
160649541|NCT00818623|580098871|FG001|Overall Study|Disease progression|0|||
160649542|NCT00818623|580098872|FG002|Overall Study|Disease progression|0|||
160649543|NCT00818623|580098873|FG003|Overall Study|Disease progression|0|||
160649544|NCT00818623|580098874|FG004|Overall Study|Disease progression|0|||
160649545|NCT00818623|580098875|FG005|Overall Study|Disease progression|0|||
160649546|NCT00818623|580098876|FG006|Overall Study|Disease progression|1|||
160649547|NCT00818623|580098877|FG007|Overall Study|Disease progression|0|||
160649548|NCT00299156|580098880|FG000|Period 2 (Randomized)|Screen Failure|0|||
160649549|NCT00299156|580098881|FG001|Period 2 (Randomized)|Screen Failure|1|||
160649550|NCT00299156|580098882|FG002|Period 2 (Randomized)|Screen Failure|0|||
160649551|NCT01166568|580098888|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
160649552|NCT01166568|580098889|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
160649553|NCT01166568|580098890|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
160649554|NCT01166568|580098888|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
160649555|NCT01166568|580098889|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
160649556|NCT01166568|580098890|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
160649557|NCT01166568|580098888|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
160649558|NCT01166568|580098889|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
160649559|NCT01166568|580098890|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
160649560|NCT01725451|580098891|FG000|Period 1|Withdrawal by Subject|1|||
160649561|NCT01725451|580098892|FG001|Period 1|Withdrawal by Subject|0|||
160649562|NCT01725451|580098893|FG002|Period 1|Withdrawal by Subject|0|||
160649563|NCT01725451|580098894|FG003|Period 1|Withdrawal by Subject|0|||
160649564|NCT01725451|580098891|FG000|Washout From Period 3|Protocol Violation|0|||
160649565|NCT01725451|580098892|FG001|Washout From Period 3|Protocol Violation|0|||
160649566|NCT01725451|580098893|FG002|Washout From Period 3|Protocol Violation|1|||
160649567|NCT01725451|580098894|FG003|Washout From Period 3|Protocol Violation|0|||
160649568|NCT01725451|580098891|FG000|Washout From Period 3|Adverse Event|0|||
160649569|NCT01725451|580098892|FG001|Washout From Period 3|Adverse Event|1|||
160649570|NCT01725451|580098893|FG002|Washout From Period 3|Adverse Event|0|||
160649571|NCT01725451|580098894|FG003|Washout From Period 3|Adverse Event|0|||
160649572|NCT01725451|580098891|FG000|Period 4|Adverse Event|0|||
160649573|NCT01725451|580098892|FG001|Period 4|Adverse Event|0|||
160649574|NCT01725451|580098893|FG002|Period 4|Adverse Event|1|||
160649575|NCT01725451|580098894|FG003|Period 4|Adverse Event|0|||
160649576|NCT00358826|580098895|FG000|Core Study|Adverse Event|1|||
160649577|NCT00358826|580098896|FG001|Core Study|Adverse Event|3|||
160649578|NCT00358826|580098897|FG002|Core Study|Adverse Event|1|||
160649579|NCT00358826|580098898|FG003|Core Study|Adverse Event|1|||
160649580|NCT00358826|580098899|FG004|Core Study|Adverse Event|0|||
160649581|NCT00358826|580098900|FG005|Core Study|Adverse Event|0|||
160649582|NCT00358826|580098901|FG006|Core Study|Adverse Event|0|||
160649583|NCT00358826|580098902|FG007|Core Study|Adverse Event|0|||
160649584|NCT00358826|580098895|FG000|Core Study|Withdrawal by Subject|2|||
160649585|NCT00358826|580098896|FG001|Core Study|Withdrawal by Subject|2|||
160649586|NCT00358826|580098897|FG002|Core Study|Withdrawal by Subject|0|||
160649587|NCT00358826|580098898|FG003|Core Study|Withdrawal by Subject|0|||
160649588|NCT00358826|580098899|FG004|Core Study|Withdrawal by Subject|0|||
160649589|NCT00358826|580098900|FG005|Core Study|Withdrawal by Subject|0|||
160649590|NCT00358826|580098901|FG006|Core Study|Withdrawal by Subject|0|||
160649591|NCT00358826|580098902|FG007|Core Study|Withdrawal by Subject|0|||
160649592|NCT00358826|580098895|FG000|Core Study|Lost to Follow-up|0|||
160649593|NCT00358826|580098896|FG001|Core Study|Lost to Follow-up|0|||
160649594|NCT00358826|580098897|FG002|Core Study|Lost to Follow-up|0|||
160649595|NCT00358826|580098898|FG003|Core Study|Lost to Follow-up|1|||
160649596|NCT00358826|580098899|FG004|Core Study|Lost to Follow-up|0|||
160649597|NCT00358826|580098900|FG005|Core Study|Lost to Follow-up|0|||
160649598|NCT00358826|580098901|FG006|Core Study|Lost to Follow-up|0|||
160649599|NCT00358826|580098902|FG007|Core Study|Lost to Follow-up|0|||
160649600|NCT00358826|580098895|FG000|Core Study|Physician Decision|0|||
160649601|NCT00358826|580098896|FG001|Core Study|Physician Decision|0|||
160649602|NCT00358826|580098897|FG002|Core Study|Physician Decision|1|||
160649603|NCT00358826|580098898|FG003|Core Study|Physician Decision|0|||
160649604|NCT00358826|580098899|FG004|Core Study|Physician Decision|0|||
160649605|NCT00358826|580098900|FG005|Core Study|Physician Decision|0|||
160649606|NCT00358826|580098901|FG006|Core Study|Physician Decision|0|||
160649607|NCT00358826|580098902|FG007|Core Study|Physician Decision|0|||
160649608|NCT00358826|580098895|FG000|MDCT Substudy|Adverse Event|0|||
160649609|NCT00358826|580098896|FG001|MDCT Substudy|Adverse Event|0|||
160649610|NCT00358826|580098897|FG002|MDCT Substudy|Adverse Event|0|||
160649611|NCT00358826|580098898|FG003|MDCT Substudy|Adverse Event|0|||
160649612|NCT00358826|580098899|FG004|MDCT Substudy|Adverse Event|1|||
160649613|NCT00358826|580098900|FG005|MDCT Substudy|Adverse Event|0|||
160649614|NCT00358826|580098901|FG006|MDCT Substudy|Adverse Event|0|||
160649615|NCT00358826|580098902|FG007|MDCT Substudy|Adverse Event|0|||
160649616|NCT00358826|580098895|FG000|MDCT Substudy|Lost to Follow-up|0|||
160649617|NCT00358826|580098896|FG001|MDCT Substudy|Lost to Follow-up|0|||
160649618|NCT00358826|580098897|FG002|MDCT Substudy|Lost to Follow-up|0|||
160649619|NCT00358826|580098898|FG003|MDCT Substudy|Lost to Follow-up|0|||
160649620|NCT00358826|580098899|FG004|MDCT Substudy|Lost to Follow-up|0|||
160649621|NCT00358826|580098900|FG005|MDCT Substudy|Lost to Follow-up|1|||
160649622|NCT00358826|580098901|FG006|MDCT Substudy|Lost to Follow-up|0|||
160649623|NCT00358826|580098902|FG007|MDCT Substudy|Lost to Follow-up|0|||
160649624|NCT00358826|580098895|FG000|MDCT Substudy|Withdrawal by Subject|0|||
160649625|NCT00358826|580098896|FG001|MDCT Substudy|Withdrawal by Subject|0|||
160649626|NCT00358826|580098897|FG002|MDCT Substudy|Withdrawal by Subject|0|||
160649627|NCT00358826|580098898|FG003|MDCT Substudy|Withdrawal by Subject|0|||
160649628|NCT00358826|580098899|FG004|MDCT Substudy|Withdrawal by Subject|0|||
160649629|NCT00358826|580098900|FG005|MDCT Substudy|Withdrawal by Subject|1|||
160649630|NCT00358826|580098901|FG006|MDCT Substudy|Withdrawal by Subject|0|||
160649631|NCT00358826|580098902|FG007|MDCT Substudy|Withdrawal by Subject|0|||
160649632|NCT00903383|580098909|FG000|Overall Study|Adverse Event|1|||
160649633|NCT00903383|580098910|FG001|Overall Study|Adverse Event|2|||
160649634|NCT00903383|580098911|FG002|Overall Study|Adverse Event|3|||
160649635|NCT00903383|580098912|FG003|Overall Study|Adverse Event|1|||
160649636|NCT00903383|580098909|FG000|Overall Study|Physician Decision|1|||
160649637|NCT00903383|580098910|FG001|Overall Study|Physician Decision|2|||
160649638|NCT00903383|580098911|FG002|Overall Study|Physician Decision|0|||
160649639|NCT00903383|580098912|FG003|Overall Study|Physician Decision|0|||
160649640|NCT00903383|580098909|FG000|Overall Study|Lost to Follow-up|0|||
160649641|NCT00903383|580098910|FG001|Overall Study|Lost to Follow-up|0|||
160649642|NCT00903383|580098911|FG002|Overall Study|Lost to Follow-up|0|||
160649643|NCT00903383|580098912|FG003|Overall Study|Lost to Follow-up|1|||
160649644|NCT00903383|580098909|FG000|Overall Study|Decision of Sponsor|1|||
160649645|NCT00903383|580098910|FG001|Overall Study|Decision of Sponsor|0|||
160649646|NCT00903383|580098911|FG002|Overall Study|Decision of Sponsor|0|||
160649647|NCT00903383|580098912|FG003|Overall Study|Decision of Sponsor|0|||
160649648|NCT00903383|580098909|FG000|Overall Study|Withdrawal by Subject|4|||
160649649|NCT00903383|580098910|FG001|Overall Study|Withdrawal by Subject|1|||
160649650|NCT00903383|580098911|FG002|Overall Study|Withdrawal by Subject|0|||
160649651|NCT00903383|580098912|FG003|Overall Study|Withdrawal by Subject|2|||
160649652|NCT00903383|580098909|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
160649653|NCT00903383|580098910|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
160649654|NCT00903383|580098911|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
160649655|NCT00903383|580098912|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
160649656|NCT00903383|580098909|FG000|Overall Study|Patient Decision|0|||
160649657|NCT00903383|580098910|FG001|Overall Study|Patient Decision|0|||
160649658|NCT00903383|580098911|FG002|Overall Study|Patient Decision|0|||
160905958|NCT01847274|581050306|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160649659|NCT00903383|580098912|FG003|Overall Study|Patient Decision|1|||
160649660|NCT02015793|580098915|FG000|Overall Study|Adverse Event|3|||
160905959|NCT01847274|581050307|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160649661|NCT02015793|580098916|FG001|Overall Study|Adverse Event|3|||
160649662|NCT02015793|580098915|FG000|Overall Study|Withdrawal by Subject|1|||
160649663|NCT02015793|580098916|FG001|Overall Study|Withdrawal by Subject|1|||
160649664|NCT00320593|580098917|FG000|Overall Study|Lost to Follow-up|3|||
160649665|NCT00320593|580098918|FG001|Overall Study|Lost to Follow-up|0|||
160649666|NCT00320593|580098917|FG000|Overall Study|Moved to another state|1|||
160649667|NCT00320593|580098918|FG001|Overall Study|Moved to another state|0|||
160649668|NCT00320593|580098917|FG000|Overall Study|Withdrawal by Subject|2|||
160649669|NCT00320593|580098918|FG001|Overall Study|Withdrawal by Subject|1|||
160649670|NCT00320593|580098917|FG000|Overall Study|Withdrawal by clinical center|1|||
160649671|NCT00320593|580098918|FG001|Overall Study|Withdrawal by clinical center|0|||
160649672|NCT00283686|580098919|FG000|Overall Study|Death|1|||
160649673|NCT00283686|580098920|FG001|Overall Study|Death|1|||
160649674|NCT00283686|580098921|FG002|Overall Study|Death|1|||
160649675|NCT00283686|580098922|FG003|Overall Study|Death|0|||
160649676|NCT00283686|580098919|FG000|Overall Study|Lost to Follow-up|21|||
160649677|NCT00283686|580098920|FG001|Overall Study|Lost to Follow-up|31|||
160649678|NCT00283686|580098921|FG002|Overall Study|Lost to Follow-up|26|||
160649679|NCT00283686|580098922|FG003|Overall Study|Lost to Follow-up|20|||
160649680|NCT00283686|580098919|FG000|Overall Study|Less than full participation|7|||
160649681|NCT00283686|580098920|FG001|Overall Study|Less than full participation|9|||
160649682|NCT00283686|580098921|FG002|Overall Study|Less than full participation|6|||
160649683|NCT00283686|580098922|FG003|Overall Study|Less than full participation|12|||
160649684|NCT01076166|580098923|FG000|Overall Study|Adverse Event|3|||
160649685|NCT01076166|580098923|FG000|Overall Study|Symptoms improved/resolved|6|||
160649686|NCT00321711|580098931|FG000|Part A|Adverse Event|3|||
160649687|NCT00321711|580098932|FG001|Part A|Adverse Event|3|||
160649688|NCT00321711|580098933|FG002|Part A|Adverse Event|2|||
160649689|NCT00321711|580098934|FG003|Part A|Adverse Event|0|||
160649690|NCT00321711|580098935|FG004|Part A|Adverse Event|0|||
160649691|NCT00321711|580098931|FG000|Part A|Withdrawal by Subject|1|||
160649692|NCT00321711|580098932|FG001|Part A|Withdrawal by Subject|1|||
160649693|NCT00321711|580098933|FG002|Part A|Withdrawal by Subject|1|||
160649694|NCT00321711|580098934|FG003|Part A|Withdrawal by Subject|0|||
160649695|NCT00321711|580098935|FG004|Part A|Withdrawal by Subject|0|||
160649696|NCT00321711|580098931|FG000|Part A|Disease progression|0|||
160649697|NCT00321711|580098932|FG001|Part A|Disease progression|1|||
160649698|NCT00321711|580098933|FG002|Part A|Disease progression|0|||
160649699|NCT00321711|580098934|FG003|Part A|Disease progression|0|||
160649700|NCT00321711|580098935|FG004|Part A|Disease progression|0|||
160649701|NCT00321711|580098931|FG000|Part A|Requirement for alternative therapy|0|||
160649702|NCT00321711|580098932|FG001|Part A|Requirement for alternative therapy|2|||
160649703|NCT00321711|580098933|FG002|Part A|Requirement for alternative therapy|1|||
160649704|NCT00321711|580098934|FG003|Part A|Requirement for alternative therapy|0|||
160649705|NCT00321711|580098935|FG004|Part A|Requirement for alternative therapy|0|||
160649706|NCT00321711|580098931|FG000|Part A|Physician Decision|0|||
160649707|NCT00321711|580098932|FG001|Part A|Physician Decision|1|||
160649708|NCT00321711|580098933|FG002|Part A|Physician Decision|3|||
160649709|NCT00321711|580098934|FG003|Part A|Physician Decision|0|||
160649710|NCT00321711|580098935|FG004|Part A|Physician Decision|0|||
160649711|NCT00321711|580098931|FG000|Part A|Other|1|||
160905960|NCT01847274|581050308|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905961|NCT01847274|581050309|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905962|NCT01847274|581050310|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905963|NCT01847274|581050311|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905964|NCT01847274|581050312|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905965|NCT01847274|581050313|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
160905966|NCT01847274|581050314|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160649712|NCT00321711|580098932|FG001|Part A|Other|2|||
160649713|NCT00321711|580098933|FG002|Part A|Other|3|||
160649714|NCT00321711|580098934|FG003|Part A|Other|0|||
160649715|NCT00321711|580098935|FG004|Part A|Other|0|||
160649716|NCT00321711|580098931|FG000|Part A|Protocol deviation|0|||
160649717|NCT00321711|580098932|FG001|Part A|Protocol deviation|0|||
160649718|NCT00321711|580098933|FG002|Part A|Protocol deviation|1|||
160649719|NCT00321711|580098934|FG003|Part A|Protocol deviation|0|||
160649720|NCT00321711|580098935|FG004|Part A|Protocol deviation|0|||
160649721|NCT00321711|580098931|FG000|Part B|Noncompliance|0|||
160905967|NCT01706146|581050315|FG000|Overall Study|Withdrawal by Subject|1|||
160905968|NCT01706146|581050315|FG000|Overall Study|Adverse Event|3|||
160905969|NCT01706146|581050315|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
160649722|NCT00321711|580098932|FG001|Part B|Noncompliance|0|||
160649723|NCT00321711|580098933|FG002|Part B|Noncompliance|0|||
160649724|NCT00321711|580098934|FG003|Part B|Noncompliance|0|||
160649725|NCT00321711|580098935|FG004|Part B|Noncompliance|1|||
160649726|NCT00321711|580098931|FG000|Part B|Adverse Event|0|||
160649727|NCT00321711|580098932|FG001|Part B|Adverse Event|0|||
160649728|NCT00321711|580098933|FG002|Part B|Adverse Event|0|||
160649729|NCT00321711|580098934|FG003|Part B|Adverse Event|2|||
160649730|NCT00321711|580098935|FG004|Part B|Adverse Event|1|||
160649731|NCT00321711|580098931|FG000|Part B|Disease progression|0|||
160649732|NCT00321711|580098932|FG001|Part B|Disease progression|0|||
160649733|NCT00321711|580098933|FG002|Part B|Disease progression|0|||
160649734|NCT00321711|580098934|FG003|Part B|Disease progression|1|||
160649735|NCT00321711|580098935|FG004|Part B|Disease progression|0|||
160649736|NCT00321711|580098931|FG000|Part B|Physician Decision|0|||
160649737|NCT00321711|580098932|FG001|Part B|Physician Decision|0|||
160649738|NCT00321711|580098933|FG002|Part B|Physician Decision|0|||
160649739|NCT00321711|580098934|FG003|Part B|Physician Decision|1|||
160649740|NCT00321711|580098935|FG004|Part B|Physician Decision|2|||
160649741|NCT00321711|580098931|FG000|Part B|Death|0|||
160649742|NCT00321711|580098932|FG001|Part B|Death|0|||
160649743|NCT00321711|580098933|FG002|Part B|Death|0|||
160649744|NCT00321711|580098934|FG003|Part B|Death|2|||
160649745|NCT00321711|580098935|FG004|Part B|Death|1|||
160649746|NCT02843074|580098936|FG000|Overall Study|Withdrawal by Subject|5|||
160649747|NCT02843074|580098936|FG000|Overall Study|Progressive disease|1|||
160649748|NCT02843074|580098936|FG000|Overall Study|Physician Decision|1|||
160649749|NCT02843074|580098936|FG000|Overall Study|Lost to Follow-up|1|||
160649750|NCT02843074|580098936|FG000|Overall Study|Death|9|||
160649751|NCT01564758|580098937|FG000|Overall Study|Death|8|||
160844594|NCT00042991|580818057|FG006|Overall Study|Disease Progression|2|||
160844595|NCT00042991|580818051|FG000|Overall Study|Alternative Therapy|0|||
160844596|NCT00042991|580818052|FG001|Overall Study|Alternative Therapy|0|||
160649752|NCT01564758|580098937|FG000|Overall Study|Adverse Event|3|||
160649753|NCT01564758|580098937|FG000|Overall Study|Other|3|||
160649754|NCT01186978|580098938|FG000|Overall Study|Withdrawal by Subject|1|||
160649755|NCT01227668|580098939|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
160649756|NCT01227668|580098940|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
160649757|NCT01227668|580098939|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
160649758|NCT01227668|580098940|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
160649759|NCT01227668|580098939|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
160649760|NCT01227668|580098940|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
160649761|NCT01227668|580098939|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
160649762|NCT01227668|580098940|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
160649763|NCT01227668|580098939|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
160649764|NCT01227668|580098940|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
160649765|NCT01227668|580098939|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
160649766|NCT01227668|580098940|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
160649767|NCT01227668|580098939|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
160649768|NCT01227668|580098940|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
160649769|NCT01227668|580098939|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
160649770|NCT01227668|580098940|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
160649771|NCT01227668|580098939|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
160649772|NCT01227668|580098940|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
160649773|NCT01227668|580098939|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
160649774|NCT01227668|580098940|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
160649775|NCT01227668|580098939|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
160649776|NCT01227668|580098940|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
160649777|NCT01227668|580098939|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
160649778|NCT01227668|580098940|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
160649779|NCT03264066|580098941|FG000|Overall Study|Adverse Event|1|||
160649780|NCT03264066|580098942|FG001|Overall Study|Adverse Event|1|||
160649781|NCT03264066|580098943|FG002|Overall Study|Adverse Event|0|||
160649782|NCT03264066|580098944|FG003|Overall Study|Adverse Event|0|||
160649783|NCT03264066|580098945|FG004|Overall Study|Adverse Event|0|||
160649784|NCT03264066|580098946|FG005|Overall Study|Adverse Event|0|||
160649785|NCT03264066|580098941|FG000|Overall Study|Death|12|||
160844597|NCT00042991|580818053|FG002|Overall Study|Alternative Therapy|0|||
160844598|NCT00042991|580818054|FG003|Overall Study|Alternative Therapy|0|||
160844599|NCT00042991|580818055|FG004|Overall Study|Alternative Therapy|1|||
160844600|NCT00042991|580818056|FG005|Overall Study|Alternative Therapy|0|||
160844601|NCT00042991|580818057|FG006|Overall Study|Alternative Therapy|0|||
160844602|NCT00856297|580818058|FG000|Overall Study|Unable to classify|2|||
160844603|NCT00856297|580818059|FG001|Overall Study|Unable to classify|0|||
160844604|NCT00856297|580818060|FG002|Overall Study|Unable to classify|0|||
160844605|NCT00856297|580818061|FG003|Overall Study|Unable to classify|0|||
160844606|NCT00856297|580818062|FG004|Overall Study|Unable to classify|0|||
160844607|NCT03369236|580818065|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
160844608|NCT03369236|580818066|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
160844609|NCT03369236|580818065|FG000|Open-label Extension Period|Lack of Efficacy|2|||
160844610|NCT03369236|580818066|FG001|Open-label Extension Period|Lack of Efficacy|1|||
160844611|NCT03369236|580818065|FG000|Open-label Extension Period|Adverse Event|0|||
160844612|NCT03369236|580818066|FG001|Open-label Extension Period|Adverse Event|1|||
160844613|NCT03369236|580818065|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
160844614|NCT03369236|580818066|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
160844615|NCT02508428|580818072|FG000|Overall Study|Death|32|||
160844616|NCT02508428|580818073|FG001|Overall Study|Death|33|||
160566381|NCT01416181|579795360|FG000|Part 1|Lack of Efficacy|16|||
160844617|NCT02508428|580818072|FG000|Overall Study|Liner revised|3|||
160844618|NCT02508428|580818073|FG001|Overall Study|Liner revised|19|||
160844619|NCT02508428|580818072|FG000|Overall Study|Incomplete follow-up|17|||
160844620|NCT02508428|580818073|FG001|Overall Study|Incomplete follow-up|15|||
160844621|NCT00806988|580819613|FG000|Overall Study|Death|15|||
160844622|NCT00806988|580819614|FG001|Overall Study|Death|16|||
160844623|NCT00806988|580819613|FG000|Overall Study|Withdrawal by Subject|8|||
160844624|NCT00806988|580819614|FG001|Overall Study|Withdrawal by Subject|8|||
160844625|NCT00806988|580819613|FG000|Overall Study|Lost to Follow-up|4|||
160844626|NCT00806988|580819614|FG001|Overall Study|Lost to Follow-up|19|||
160844627|NCT04775953|580819616|FG000|Overall Study|Lost to Follow-up|6|||
160844628|NCT04775953|580819617|FG001|Overall Study|Lost to Follow-up|11|||
160844629|NCT04775953|580819616|FG000|Overall Study|Death|5|||
160844630|NCT04775953|580819617|FG001|Overall Study|Death|4|||
160844631|NCT04775953|580819616|FG000|Overall Study|Withdrawal by Subject|3|||
160844632|NCT04775953|580819617|FG001|Overall Study|Withdrawal by Subject|3|||
160844633|NCT04775953|580819616|FG000|Overall Study|Protocol Violation|2|||
160844634|NCT04775953|580819617|FG001|Overall Study|Protocol Violation|0|||
160844635|NCT04775953|580819616|FG000|Overall Study|Participant non-compliance|0|||
160844636|NCT04775953|580819617|FG001|Overall Study|Participant non-compliance|1|||
160844637|NCT01698814|580819618|FG000|Overall Study|Adverse Event|0|||
160844638|NCT01698814|580819619|FG001|Overall Study|Adverse Event|2|||
160844639|NCT01698814|580819618|FG000|Overall Study|Lost to Follow-up|0|||
160844640|NCT01698814|580819619|FG001|Overall Study|Lost to Follow-up|1|||
160844641|NCT01698814|580819618|FG000|Overall Study|Pregnancy|1|||
160844642|NCT01698814|580819619|FG001|Overall Study|Pregnancy|0|||
160844643|NCT01698814|580819618|FG000|Overall Study|Randomized in error|1|||
160844644|NCT01698814|580819619|FG001|Overall Study|Randomized in error|0|||
160844645|NCT00368641|580819622|FG000|Overall Study|Adverse Event|2|||
160844646|NCT00368641|580819623|FG001|Overall Study|Adverse Event|1|||
160844647|NCT00368641|580819622|FG000|Overall Study|Death|1|||
160844648|NCT00368641|580819623|FG001|Overall Study|Death|0|||
160844649|NCT00368641|580819622|FG000|Overall Study|Withdrawal by Subject|1|||
160844650|NCT00368641|580819623|FG001|Overall Study|Withdrawal by Subject|0|||
160566382|NCT01416181|579795361|FG001|Part 1|Lack of Efficacy|8|||
160566383|NCT01416181|579795360|FG000|Part 1|Lost to Follow-up|1|||
160566384|NCT01416181|579795361|FG001|Part 1|Lost to Follow-up|1|||
160566385|NCT01416181|579795360|FG000|Part 1|Adverse Event|15|||
160566386|NCT01416181|579795361|FG001|Part 1|Adverse Event|18|||
160566387|NCT01416181|579795360|FG000|Part 1|Ongoing in Follow-Up|14|||
160566388|NCT01416181|579795361|FG001|Part 1|Ongoing in Follow-Up|8|||
160566389|NCT01416181|579795360|FG000|Part 2|Adverse Event|11|||
160566390|NCT01416181|579795361|FG001|Part 2|Adverse Event|4|||
160566391|NCT01416181|579795360|FG000|Part 2|Other|234|||
160566392|NCT01416181|579795361|FG001|Part 2|Other|267|||
160566393|NCT01416181|579795360|FG000|Part 2|Investigator Decision|6|||
160566394|NCT01416181|579795361|FG001|Part 2|Investigator Decision|7|||
160566395|NCT01416181|579795360|FG000|Part 2|Withdrawal by Subject|14|||
160566396|NCT01416181|579795361|FG001|Part 2|Withdrawal by Subject|5|||
160566397|NCT01416181|579795360|FG000|Part 2|Lack of Efficacy|4|||
160566398|NCT01416181|579795361|FG001|Part 2|Lack of Efficacy|1|||
160566399|NCT01416181|579795360|FG000|Part 2|Lost to Follow-up|2|||
160566400|NCT01416181|579795361|FG001|Part 2|Lost to Follow-up|2|||
160566401|NCT03816995|579795364|FG000|Overall Study|Withdrawal by Subject|3|||
160566402|NCT03816995|579795365|FG001|Overall Study|Withdrawal by Subject|1|||
160566403|NCT03816995|579795364|FG000|Overall Study|Cancelled Surgery|8|||
160566404|NCT03816995|579795365|FG001|Overall Study|Cancelled Surgery|12|||
160566405|NCT03816995|579795364|FG000|Overall Study|No wound protector used|11|||
160566406|NCT03816995|579795365|FG001|Overall Study|No wound protector used|17|||
160566407|NCT03816995|579795364|FG000|Overall Study|Protocol Violation|2|||
160566408|NCT03816995|579795365|FG001|Overall Study|Protocol Violation|3|||
160566409|NCT00486902|579795366|FG000|Overall Study|Withdrawal by Subject|1|||
160566410|NCT00486902|579795367|FG001|Overall Study|Withdrawal by Subject|2|||
160566411|NCT00486902|579795366|FG000|Overall Study|decision for postpartum tubal ligation|3|||
160566412|NCT00486902|579795367|FG001|Overall Study|decision for postpartum tubal ligation|1|||
160566413|NCT00486902|579795366|FG000|Overall Study|spinal anesthetic protocal violation|1|||
160566414|NCT00486902|579795367|FG001|Overall Study|spinal anesthetic protocal violation|1|||
160566415|NCT00486902|579795366|FG000|Overall Study|Did not meet inclusion criteria|1|||
160566416|NCT00486902|579795367|FG001|Overall Study|Did not meet inclusion criteria|0|||
160566417|NCT00486902|579795366|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
160566418|NCT00486902|579795367|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
160566419|NCT00541307|579795368|FG000|Overall Study|Death|5|||
160566420|NCT00541307|579795368|FG000|Overall Study|Physician Decision|3|||
160566421|NCT00541307|579795368|FG000|Overall Study|Withdrawal by Subject|6|||
160566422|NCT00541307|579795368|FG000|Overall Study|Lost to Follow-up|4|||
160566423|NCT00541307|579795368|FG000|Overall Study|Subject returned early (outside window)|1|||
160566424|NCT00541307|579795368|FG000|Overall Study|Surgical Bypass|5|||
160566425|NCT04178590|579795369|FG000|Overall Study|Pregnancy|1|||
160844651|NCT00368641|580819622|FG000|Overall Study|Sponsor decision to terminate study|2|||
160844652|NCT00368641|580819623|FG001|Overall Study|Sponsor decision to terminate study|5|||
160566426|NCT04178590|579795369|FG000|Overall Study|Lost to Follow-up|1|||
160566427|NCT04723537|579795370|FG000|Overall Study|Withdrawal by Subject|3|||
160566428|NCT04723537|579795371|FG001|Overall Study|Withdrawal by Subject|0|||
160566429|NCT04723537|579795372|FG002|Overall Study|Withdrawal by Subject|0|||
160566430|NCT04723537|579795370|FG000|Overall Study|Physician Decision|0|||
160566431|NCT04723537|579795371|FG001|Overall Study|Physician Decision|0|||
160566432|NCT04723537|579795372|FG002|Overall Study|Physician Decision|1|||
160566433|NCT04723537|579795370|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
160566434|NCT04723537|579795371|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
160566435|NCT04723537|579795372|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
160566436|NCT01485614|579795379|FG000|Randomization|Not Treated|1|||
160566437|NCT01485614|579795380|FG001|Randomization|Not Treated|0|||
160566438|NCT01485614|579795381|FG002|Randomization|Not Treated|0|||
160566439|NCT01485614|579795382|FG003|Randomization|Not Treated|0|||
160844653|NCT01424501|580819624|FG000|Overall Study|Withdrawal by Subject|1|||
160844654|NCT01424501|580819625|FG001|Overall Study|Withdrawal by Subject|0|||
160844655|NCT01424501|580819626|FG002|Overall Study|Withdrawal by Subject|1|||
160844656|NCT01424501|580819627|FG003|Overall Study|Withdrawal by Subject|0|||
160844657|NCT01424501|580819628|FG004|Overall Study|Withdrawal by Subject|0|||
160844658|NCT01424501|580819629|FG005|Overall Study|Withdrawal by Subject|0|||
160844659|NCT01424501|580819624|FG000|Overall Study|Lost to Follow-up|0|||
160844660|NCT01424501|580819625|FG001|Overall Study|Lost to Follow-up|1|||
160844661|NCT01424501|580819626|FG002|Overall Study|Lost to Follow-up|1|||
160844662|NCT01424501|580819627|FG003|Overall Study|Lost to Follow-up|0|||
160566440|NCT01485614|579795379|FG000|Weeks 0-20|Lost to Follow-up|2|||
160566441|NCT01485614|579795380|FG001|Weeks 0-20|Lost to Follow-up|0|||
160566442|NCT01485614|579795381|FG002|Weeks 0-20|Lost to Follow-up|0|||
160566443|NCT01485614|579795382|FG003|Weeks 0-20|Lost to Follow-up|0|||
160566444|NCT01485614|579795379|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
160566445|NCT01485614|579795380|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
160566446|NCT01485614|579795381|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
160566447|NCT01485614|579795382|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
160566448|NCT01485614|579795379|FG000|Weeks 0-20|Withdrawal by Subject|3|||
160566449|NCT01485614|579795380|FG001|Weeks 0-20|Withdrawal by Subject|2|||
160566450|NCT01485614|579795381|FG002|Weeks 0-20|Withdrawal by Subject|1|||
160566451|NCT01485614|579795382|FG003|Weeks 0-20|Withdrawal by Subject|0|||
160566452|NCT01485614|579795379|FG000|Weeks 20-54|Lost to Follow-up|4|||
160566453|NCT01485614|579795380|FG001|Weeks 20-54|Lost to Follow-up|3|||
160566454|NCT01485614|579795381|FG002|Weeks 20-54|Lost to Follow-up|1|||
160844663|NCT01424501|580819628|FG004|Overall Study|Lost to Follow-up|0|||
160844664|NCT01424501|580819629|FG005|Overall Study|Lost to Follow-up|0|||
160844665|NCT01980095|580819630|FG000|Overall Study|Lost to Follow-up|6|||
160844666|NCT01980095|580819631|FG001|Overall Study|Lost to Follow-up|7|||
160844667|NCT01980095|580819630|FG000|Overall Study|Withdrawal by Subject|2|||
160844668|NCT01980095|580819631|FG001|Overall Study|Withdrawal by Subject|3|||
160844669|NCT01980095|580819630|FG000|Overall Study|Poor compliance|5|||
160844670|NCT01980095|580819631|FG001|Overall Study|Poor compliance|0|||
160844671|NCT01980095|580819630|FG000|Overall Study|Safety issue|0|||
160844672|NCT01980095|580819631|FG001|Overall Study|Safety issue|1|||
160844673|NCT01980095|580819630|FG000|Overall Study|Study drug discontinued|1|||
160844674|NCT01980095|580819631|FG001|Overall Study|Study drug discontinued|0|||
160844675|NCT01980095|580819630|FG000|Overall Study|Randomized by mistake|1|||
160844676|NCT01980095|580819631|FG001|Overall Study|Randomized by mistake|0|||
160844677|NCT03920254|580819632|FG000|Overall Study|Adverse Event|1|||
160844678|NCT03920254|580819633|FG001|Overall Study|Adverse Event|0|||
160844679|NCT03920254|580819634|FG002|Overall Study|Adverse Event|0|||
160844680|NCT03920254|580819632|FG000|Overall Study|Physician Decision|0|||
160844681|NCT03920254|580819633|FG001|Overall Study|Physician Decision|1|||
160844682|NCT03920254|580819634|FG002|Overall Study|Physician Decision|2|||
160844683|NCT03920254|580819632|FG000|Overall Study|Study Terminated By Sponsor|12|||
160844684|NCT03920254|580819633|FG001|Overall Study|Study Terminated By Sponsor|17|||
160844685|NCT03920254|580819634|FG002|Overall Study|Study Terminated By Sponsor|12|||
160844686|NCT03920254|580819632|FG000|Overall Study|Withdrawal by Subject|0|||
160844687|NCT03920254|580819633|FG001|Overall Study|Withdrawal by Subject|0|||
160844688|NCT03920254|580819634|FG002|Overall Study|Withdrawal by Subject|1|||
160844689|NCT05274269|580819635|FG000|Overall Study|Adverse Event|0|||
160844690|NCT05274269|580819636|FG001|Overall Study|Adverse Event|3|||
160844691|NCT05274269|580819635|FG000|Overall Study|Death|0|||
160844692|NCT05274269|580819636|FG001|Overall Study|Death|1|||
160566455|NCT01485614|579795382|FG003|Weeks 20-54|Lost to Follow-up|0|||
160566456|NCT01485614|579795379|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
160844693|NCT05274269|580819635|FG000|Overall Study|Other|0|||
160844694|NCT05274269|580819636|FG001|Overall Study|Other|2|||
160844695|NCT05274269|580819635|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
160566457|NCT01485614|579795380|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
160566458|NCT01485614|579795381|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
160844696|NCT05274269|580819636|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
160566459|NCT01485614|579795382|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
160566460|NCT01485614|579795379|FG000|Weeks 20-54|Withdrawal by Subject|5|||
160844697|NCT05636852|580819637|FG000|Overall Study|Withdrawal by Subject|1|||
160844698|NCT05636852|580819637|FG000|Overall Study|Other than specified|1|||
160844699|NCT00709618|580819638|FG000|Overall Study|Withdrawal by Subject|4|||
160844700|NCT00709618|580819638|FG000|Overall Study|Lost to Follow-up|1|||
160844701|NCT00709618|580819638|FG000|Overall Study|Study Closed/Terminated|25|||
160844702|NCT01415401|580819646|FG000|Overall Study|Adverse Event|5|||
160844703|NCT01415401|580819646|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
160844704|NCT01415401|580819646|FG000|Overall Study|Terminated by Sponsor|1|||
160844705|NCT01746225|580819649|FG000|Overall Study|Death|1|||
160844706|NCT01746225|580819650|FG001|Overall Study|Death|0|||
160844707|NCT01746225|580819651|FG002|Overall Study|Death|1|||
160844708|NCT01746225|580819649|FG000|Overall Study|Withdrawal by Subject|5|||
160844709|NCT01746225|580819650|FG001|Overall Study|Withdrawal by Subject|15|||
160844710|NCT01746225|580819651|FG002|Overall Study|Withdrawal by Subject|19|||
160844711|NCT01746225|580819649|FG000|Overall Study|Physician Decision|14|||
160844712|NCT01746225|580819650|FG001|Overall Study|Physician Decision|11|||
160844713|NCT01746225|580819651|FG002|Overall Study|Physician Decision|3|||
160844714|NCT01746225|580819649|FG000|Overall Study|Adverse Event|15|||
160844715|NCT01746225|580819650|FG001|Overall Study|Adverse Event|12|||
160844716|NCT01746225|580819651|FG002|Overall Study|Adverse Event|17|||
160844717|NCT01746225|580819649|FG000|Overall Study|Continuing Treatment|5|||
160844718|NCT01746225|580819650|FG001|Overall Study|Continuing Treatment|8|||
160844719|NCT01746225|580819651|FG002|Overall Study|Continuing Treatment|3|||
160844720|NCT00595478|580819652|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
160844721|NCT00595478|580819653|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
160844722|NCT00595478|580819652|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
160844723|NCT00595478|580819653|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
160844724|NCT02713828|580819656|FG000|Overall Study|Death|2|||
160844725|NCT02713828|580819657|FG001|Overall Study|Death|0|||
160844726|NCT02713828|580819656|FG000|Overall Study|Withdrawal by Subject|1|||
160844727|NCT02713828|580819657|FG001|Overall Study|Withdrawal by Subject|0|||
160566461|NCT01485614|579795380|FG001|Weeks 20-54|Withdrawal by Subject|3|||
160566462|NCT01485614|579795381|FG002|Weeks 20-54|Withdrawal by Subject|0|||
160566463|NCT01485614|579795382|FG003|Weeks 20-54|Withdrawal by Subject|0|||
160566464|NCT00733902|579795383|FG000|Overall Study|Death|0|||
160566465|NCT00733902|579795384|FG001|Overall Study|Death|0|||
160566466|NCT00733902|579795385|FG002|Overall Study|Death|0|||
160566467|NCT00733902|579795386|FG003|Overall Study|Death|1|||
160566468|NCT00733902|579795383|FG000|Overall Study|Adverse Event|3|||
160566469|NCT00733902|579795384|FG001|Overall Study|Adverse Event|4|||
160844728|NCT02713828|580819656|FG000|Overall Study|study terminated but patient allowed to|2|||
160844729|NCT02713828|580819657|FG001|Overall Study|study terminated but patient allowed to|0|||
160844730|NCT03302247|580819658|FG000|Overall Study|the study has closed prematurely|2|||
160844731|NCT03302247|580819658|FG000|Overall Study|Death|1|||
160844732|NCT02305238|580819659|FG000|Overall Study|Death|2|||
160844733|NCT02305238|580819660|FG001|Overall Study|Death|1|||
160844734|NCT02305238|580819661|FG002|Overall Study|Death|0|||
160844735|NCT02305238|580819659|FG000|Overall Study|Progressive disease|4|||
160566470|NCT00733902|579795385|FG002|Overall Study|Adverse Event|7|||
160844736|NCT02305238|580819660|FG001|Overall Study|Progressive disease|4|||
160844737|NCT02305238|580819661|FG002|Overall Study|Progressive disease|0|||
160844738|NCT02305238|580819659|FG000|Overall Study|Logistical difficulties|1|||
160844739|NCT02305238|580819660|FG001|Overall Study|Logistical difficulties|3|||
160566471|NCT00733902|579795386|FG003|Overall Study|Adverse Event|11|||
160566472|NCT00733902|579795383|FG000|Overall Study|Lack of Efficacy|56|||
160844740|NCT02305238|580819661|FG002|Overall Study|Logistical difficulties|0|||
160844741|NCT02305238|580819659|FG000|Overall Study|Protocol Violation|0|||
160844742|NCT02305238|580819660|FG001|Overall Study|Protocol Violation|3|||
160844743|NCT02305238|580819661|FG002|Overall Study|Protocol Violation|0|||
160844744|NCT02305238|580819659|FG000|Overall Study|Physician Decision|2|||
160844745|NCT02305238|580819660|FG001|Overall Study|Physician Decision|1|||
160566473|NCT00733902|579795384|FG001|Overall Study|Lack of Efficacy|21|||
160566474|NCT00733902|579795385|FG002|Overall Study|Lack of Efficacy|34|||
160566475|NCT00733902|579795386|FG003|Overall Study|Lack of Efficacy|23|||
160566476|NCT00733902|579795383|FG000|Overall Study|Protocol Violation|4|||
160566477|NCT00733902|579795384|FG001|Overall Study|Protocol Violation|6|||
160844746|NCT02305238|580819661|FG002|Overall Study|Physician Decision|0|||
160844747|NCT02305238|580819659|FG000|Overall Study|Adverse Event|4|||
160844748|NCT02305238|580819660|FG001|Overall Study|Adverse Event|2|||
160566478|NCT00733902|579795385|FG002|Overall Study|Protocol Violation|3|||
160844749|NCT02305238|580819661|FG002|Overall Study|Adverse Event|0|||
160844750|NCT02305238|580819659|FG000|Overall Study|Withdrawal by Subject|3|||
160844751|NCT02305238|580819660|FG001|Overall Study|Withdrawal by Subject|4|||
160844752|NCT02305238|580819661|FG002|Overall Study|Withdrawal by Subject|0|||
160566479|NCT00733902|579795386|FG003|Overall Study|Protocol Violation|3|||
160566480|NCT00733902|579795383|FG000|Overall Study|Withdrawal by Subject|10|||
160566481|NCT00733902|579795384|FG001|Overall Study|Withdrawal by Subject|5|||
160566482|NCT00733902|579795385|FG002|Overall Study|Withdrawal by Subject|4|||
160566483|NCT00733902|579795386|FG003|Overall Study|Withdrawal by Subject|16|||
160566484|NCT00733902|579795383|FG000|Overall Study|Entered extension study|89|||
160566485|NCT00733902|579795384|FG001|Overall Study|Entered extension study|124|||
160566486|NCT00733902|579795385|FG002|Overall Study|Entered extension study|111|||
160566487|NCT00733902|579795386|FG003|Overall Study|Entered extension study|109|||
160566488|NCT00733902|579795383|FG000|Overall Study|Randomized but not treated|2|||
160566489|NCT00733902|579795384|FG001|Overall Study|Randomized but not treated|2|||
160566490|NCT00733902|579795385|FG002|Overall Study|Randomized but not treated|2|||
160566491|NCT00733902|579795386|FG003|Overall Study|Randomized but not treated|1|||
160566492|NCT00942409|579795387|FG000|Overall Study|Lack of Efficacy|1|||
160566493|NCT00942409|579795387|FG000|Overall Study|study drug unavailable|2|||
160566494|NCT01503021|579795392|FG000|Overall Study|Adverse Event|7|||
160566495|NCT01503021|579795393|FG001|Overall Study|Adverse Event|6|||
160566496|NCT01503021|579795392|FG000|Overall Study|Death|0|||
160566497|NCT01503021|579795393|FG001|Overall Study|Death|2|||
160566498|NCT01503021|579795392|FG000|Overall Study|Lost to Follow-up|2|||
160566499|NCT01503021|579795393|FG001|Overall Study|Lost to Follow-up|0|||
160566500|NCT01503021|579795392|FG000|Overall Study|Physician Decision|3|||
160566501|NCT01503021|579795393|FG001|Overall Study|Physician Decision|0|||
160566502|NCT01503021|579795392|FG000|Overall Study|Protocol Violation|1|||
160566503|NCT01503021|579795393|FG001|Overall Study|Protocol Violation|3|||
160566504|NCT01503021|579795392|FG000|Overall Study|Withdrawal by Subject|9|||
160566505|NCT01503021|579795393|FG001|Overall Study|Withdrawal by Subject|8|||
160566506|NCT01503021|579795392|FG000|Overall Study|Moved, received transplant, etc.|5|||
160566507|NCT01503021|579795393|FG001|Overall Study|Moved, received transplant, etc.|7|||
160566508|NCT03941548|579795394|FG000|Overall Study|Adverse Event|0|||
160566509|NCT03941548|579795395|FG001|Overall Study|Adverse Event|1|||
160566510|NCT03941548|579795394|FG000|Overall Study|Lost to Follow-up|0|||
160566511|NCT03941548|579795395|FG001|Overall Study|Lost to Follow-up|1|||
160566512|NCT03941548|579795394|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
160566513|NCT03941548|579795395|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
160566514|NCT01242111|579795397|FG000|Overall Study|Adverse Event|1|||
160566515|NCT01242111|579795397|FG000|Overall Study|Withdrawal by Subject|1|||
160566516|NCT01242111|579795397|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
160566517|NCT00870688|579795398|FG000|Overall Study|Lost to Follow-up|2|||
160566518|NCT00870688|579795398|FG000|Overall Study|Death, Unrelated|1|||
160566519|NCT00870688|579795398|FG000|Overall Study|Granules in the Stools|1|||
160566520|NCT02015819|579795399|FG000|Overall Study|Rickham catheter was misaligned|0|||
160566521|NCT02015819|579795400|FG001|Overall Study|Rickham catheter was misaligned|0|||
160566522|NCT02015819|579795401|FG002|Overall Study|Rickham catheter was misaligned|0|||
160566523|NCT02015819|579795402|FG003|Overall Study|Rickham catheter was misaligned|1|||
160566524|NCT01697215|579795405|FG000|Overall Study|Physician Decision|5|||
160566525|NCT01697215|579795405|FG000|Overall Study|Malfunction|9|||
160566526|NCT01697215|579795405|FG000|Overall Study|CXR not available|9|||
160566527|NCT01929083|579795406|FG000|Intervention 1|Lost to Follow-up|2|||
160566528|NCT01929083|579795407|FG001|Intervention 1|Lost to Follow-up|0|||
160566529|NCT01929083|579795406|FG000|Intervention 1|Nonadherent to study medications|1|||
160566530|NCT01929083|579795407|FG001|Intervention 1|Nonadherent to study medications|0|||
160844753|NCT02305238|580819659|FG000|Overall Study|Randomized failure|0|||
160844754|NCT02305238|580819660|FG001|Overall Study|Randomized failure|0|||
160844755|NCT02305238|580819661|FG002|Overall Study|Randomized failure|8|||
160844756|NCT02305238|580819659|FG000|Overall Study|Required procedure failed|0|||
160844757|NCT02305238|580819660|FG001|Overall Study|Required procedure failed|1|||
160844758|NCT02305238|580819661|FG002|Overall Study|Required procedure failed|0|||
160566531|NCT01929083|579795406|FG000|Intervention 2|Adverse Event|0|||
160566532|NCT01929083|579795407|FG001|Intervention 2|Adverse Event|1|||
160566533|NCT02599402|579795408|FG000|Overall Study|Disease progression|153|||
160566534|NCT02599402|579795408|FG000|Overall Study|Study drug toxicity|201|||
160566535|NCT02599402|579795408|FG000|Overall Study|Death|26|||
160566536|NCT02599402|579795408|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
160566537|NCT02599402|579795408|FG000|Overall Study|Participant request to discontinue study treatment|13|||
160566538|NCT02599402|579795408|FG000|Overall Study|Participant withdrew consent|5|||
160566539|NCT02599402|579795408|FG000|Overall Study|Lost to Follow-up|1|||
160566540|NCT02599402|579795408|FG000|Overall Study|Maximum Clinical Benefit|7|||
160566541|NCT02599402|579795408|FG000|Overall Study|Poor/non-compliance|1|||
160566542|NCT02599402|579795408|FG000|Overall Study|Pregnancy|1|||
160649786|NCT03264066|580098942|FG001|Overall Study|Death|12|||
160844759|NCT01019369|580819662|FG000|Overall Study|Lost to Follow-up|10|||
160844760|NCT01019369|580819663|FG001|Overall Study|Lost to Follow-up|6|||
160844761|NCT01019369|580819662|FG000|Overall Study|Withdrawal by Subject|0|||
160844762|NCT01019369|580819663|FG001|Overall Study|Withdrawal by Subject|1|||
160844763|NCT00604695|580819664|FG000|Overall Study|Did not receive first bolus.|0|||
160844764|NCT00604695|580819665|FG001|Overall Study|Did not receive first bolus.|4|||
160844765|NCT00172042|580819669|FG000|Overall Study|Adverse Event|27|||
160844766|NCT00172042|580819670|FG001|Overall Study|Adverse Event|13|||
160844767|NCT00172042|580819669|FG000|Overall Study|Abnormal laboratory value(s)|5|||
160844768|NCT00172042|580819670|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160566543|NCT02599402|579795408|FG000|Overall Study|Participant no longer met study criteria|7|||
160566544|NCT02599402|579795408|FG000|Overall Study|Other Reasons|95|||
160566545|NCT00087438|579795411|FG000|Overall Study|Ineligible / No protocol treatment|4|||
160566546|NCT01486264|579795412|FG000|Overall Study|Death|1|||
160566547|NCT01486264|579795413|FG001|Overall Study|Death|1|||
160566548|NCT01486264|579795412|FG000|Overall Study|Adverse Event|3|||
160566549|NCT01486264|579795413|FG001|Overall Study|Adverse Event|3|||
160566550|NCT01486264|579795412|FG000|Overall Study|Lack of Efficacy|6|||
160566551|NCT01486264|579795413|FG001|Overall Study|Lack of Efficacy|10|||
160566552|NCT01486264|579795412|FG000|Overall Study|Withdrawal by Subject|7|||
160566553|NCT01486264|579795413|FG001|Overall Study|Withdrawal by Subject|18|||
160566554|NCT01486264|579795412|FG000|Overall Study|Physician Decision|1|||
160566555|NCT01486264|579795413|FG001|Overall Study|Physician Decision|1|||
160566556|NCT01486264|579795412|FG000|Overall Study|Protocol Violation|3|||
160566557|NCT01486264|579795413|FG001|Overall Study|Protocol Violation|0|||
160566558|NCT01486264|579795412|FG000|Overall Study|Lost to Follow-up|3|||
160566559|NCT01486264|579795413|FG001|Overall Study|Lost to Follow-up|2|||
160566560|NCT01486264|579795412|FG000|Overall Study|Other|5|||
160566561|NCT01486264|579795413|FG001|Overall Study|Other|11|||
160566562|NCT01486264|579795412|FG000|Overall Study|Not treated|0|||
160566563|NCT01486264|579795413|FG001|Overall Study|Not treated|1|||
160844769|NCT00172042|580819669|FG000|Overall Study|Abnormal test procedure(s)|0|||
160844770|NCT00172042|580819670|FG001|Overall Study|Abnormal test procedure(s)|3|||
160844771|NCT00172042|580819669|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
160844772|NCT00172042|580819670|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
160844773|NCT00172042|580819669|FG000|Overall Study|Patient no longer requires study drug|10|||
160844774|NCT00172042|580819670|FG001|Overall Study|Patient no longer requires study drug|8|||
160844775|NCT00172042|580819669|FG000|Overall Study|Protocol Violation|8|||
160844776|NCT00172042|580819670|FG001|Overall Study|Protocol Violation|7|||
160566564|NCT03584009|579795417|FG000|Overall Study|Death|25|||
160566565|NCT03584009|579795418|FG001|Overall Study|Death|18|||
160566566|NCT03584009|579795417|FG000|Overall Study|Lost to Follow-up|0|||
160566567|NCT03584009|579795418|FG001|Overall Study|Lost to Follow-up|1|||
160566568|NCT03584009|579795417|FG000|Overall Study|Physician Decision|1|||
160566569|NCT03584009|579795418|FG001|Overall Study|Physician Decision|1|||
160844777|NCT00172042|580819669|FG000|Overall Study|Withdrawal by Subject|37|||
160844778|NCT00172042|580819670|FG001|Overall Study|Withdrawal by Subject|25|||
160844779|NCT00172042|580819669|FG000|Overall Study|Lost to Follow-up|3|||
160844780|NCT00172042|580819670|FG001|Overall Study|Lost to Follow-up|5|||
160844781|NCT00172042|580819669|FG000|Overall Study|Administrative problems|13|||
160844782|NCT00172042|580819670|FG001|Overall Study|Administrative problems|10|||
160844783|NCT00172042|580819669|FG000|Overall Study|Death|42|||
160844784|NCT00172042|580819670|FG001|Overall Study|Death|42|||
160844785|NCT00384332|580819671|FG000|Overall Study|Lost to Follow-up|4|||
160844786|NCT00384332|580819672|FG001|Overall Study|Lost to Follow-up|0|||
160844787|NCT01771250|580819673|FG000|Period 1|Met exclusion criteria|1|||
160844788|NCT01771250|580819674|FG001|Period 1|Met exclusion criteria|0|||
160844789|NCT02058563|580819675|FG000|Overall Study|Lost to Follow-up|26|||
160844790|NCT02058563|580819676|FG001|Overall Study|Lost to Follow-up|22|||
160844791|NCT02058563|580819675|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
160844792|NCT02058563|580819676|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
160844793|NCT02058563|580819675|FG000|Overall Study|Consent Withdrawal|1|||
160844794|NCT02058563|580819676|FG001|Overall Study|Consent Withdrawal|1|||
160844795|NCT02058563|580819675|FG000|Overall Study|Other (patient incarcerated)|0|||
160844796|NCT02058563|580819676|FG001|Overall Study|Other (patient incarcerated)|1|||
160844797|NCT01180296|580819677|FG000|Overall Study|Protocol Violation|1|||
160844798|NCT01180296|580819678|FG001|Overall Study|Protocol Violation|2|||
160844799|NCT00166439|580819679|FG000|Overall Study|Ineligible|5|||
160844800|NCT00483938|580819680|FG000|Overall Study|Protocol Violation|0|||
160844801|NCT00483938|580819681|FG001|Overall Study|Protocol Violation|0|||
160844802|NCT00483938|580819682|FG002|Overall Study|Protocol Violation|0|||
160844803|NCT00483938|580819683|FG003|Overall Study|Protocol Violation|0|||
160844804|NCT00483938|580819684|FG004|Overall Study|Protocol Violation|0|||
160844805|NCT00483938|580819685|FG005|Overall Study|Protocol Violation|0|||
160844806|NCT00483938|580819686|FG006|Overall Study|Protocol Violation|3|||
160844807|NCT00483938|580819680|FG000|Overall Study|Withdrawal by Subject|1|||
160844808|NCT00483938|580819681|FG001|Overall Study|Withdrawal by Subject|6|||
160844809|NCT00483938|580819682|FG002|Overall Study|Withdrawal by Subject|0|||
160844810|NCT00483938|580819683|FG003|Overall Study|Withdrawal by Subject|0|||
160844811|NCT00483938|580819684|FG004|Overall Study|Withdrawal by Subject|1|||
160844812|NCT00483938|580819685|FG005|Overall Study|Withdrawal by Subject|3|||
160844813|NCT00483938|580819686|FG006|Overall Study|Withdrawal by Subject|2|||
160844814|NCT00483938|580819680|FG000|Overall Study|Lost to Follow-up|1|||
160844815|NCT00483938|580819681|FG001|Overall Study|Lost to Follow-up|2|||
160844816|NCT00483938|580819682|FG002|Overall Study|Lost to Follow-up|0|||
160844817|NCT00483938|580819683|FG003|Overall Study|Lost to Follow-up|2|||
160844818|NCT00483938|580819684|FG004|Overall Study|Lost to Follow-up|1|||
160844819|NCT00483938|580819685|FG005|Overall Study|Lost to Follow-up|1|||
160844820|NCT00483938|580819686|FG006|Overall Study|Lost to Follow-up|3|||
160844821|NCT00483938|580819680|FG000|Overall Study|Death|0|||
160844822|NCT00483938|580819681|FG001|Overall Study|Death|2|||
160844823|NCT00483938|580819682|FG002|Overall Study|Death|0|||
160844824|NCT00483938|580819683|FG003|Overall Study|Death|0|||
160844825|NCT00483938|580819684|FG004|Overall Study|Death|0|||
160844826|NCT00483938|580819685|FG005|Overall Study|Death|0|||
160844827|NCT00483938|580819686|FG006|Overall Study|Death|0|||
160844828|NCT00483938|580819680|FG000|Overall Study|Other|3|||
160992319|NCT00828919|581360026|FG001|Overall Study|Objective progression or relapse|4|||
160992320|NCT00828919|581360027|FG002|Overall Study|Objective progression or relapse|11|||
160992321|NCT00828919|581360028|FG003|Overall Study|Objective progression or relapse|0|||
160992322|NCT00828919|581360029|FG004|Overall Study|Objective progression or relapse|5|||
160992323|NCT00828919|581360025|FG000|Overall Study|No longer willing to participate in study|0|||
160992324|NCT00828919|581360026|FG001|Overall Study|No longer willing to participate in study|0|||
160992325|NCT00828919|581360027|FG002|Overall Study|No longer willing to participate in study|2|||
160992326|NCT00828919|581360028|FG003|Overall Study|No longer willing to participate in study|0|||
160992327|NCT00828919|581360029|FG004|Overall Study|No longer willing to participate in study|0|||
160844829|NCT00483938|580819681|FG001|Overall Study|Other|9|||
160844830|NCT00483938|580819682|FG002|Overall Study|Other|0|||
160566570|NCT03584009|579795417|FG000|Overall Study|Study Terminated by Sponsor|22|||
160844831|NCT00483938|580819683|FG003|Overall Study|Other|4|||
160844832|NCT00483938|580819684|FG004|Overall Study|Other|0|||
160844833|NCT00483938|580819685|FG005|Overall Study|Other|4|||
160844834|NCT00483938|580819686|FG006|Overall Study|Other|32|||
160844835|NCT00106353|580819693|FG000|Part 1|Disease progression|3|||
160992328|NCT00828919|581360025|FG000|Overall Study|Insufficient Clinical Response|0|||
160566571|NCT03584009|579795418|FG001|Overall Study|Study Terminated by Sponsor|30|||
160566572|NCT03584009|579795417|FG000|Overall Study|Withdrawal by Subject|3|||
160844836|NCT00106353|580819694|FG001|Part 1|Disease progression|4|||
160844837|NCT00106353|580819695|FG002|Part 1|Disease progression|1|||
160844838|NCT00106353|580819696|FG003|Part 1|Disease progression|3|||
160844839|NCT00106353|580819697|FG004|Part 1|Disease progression|0|||
160566573|NCT03584009|579795418|FG001|Overall Study|Withdrawal by Subject|2|||
160844840|NCT00106353|580819698|FG005|Part 1|Disease progression|0|||
160844841|NCT00106353|580819699|FG006|Part 1|Disease progression|0|||
160844842|NCT00106353|580819693|FG000|Part 1|Withdrawal by Subject|0|||
160844843|NCT00106353|580819694|FG001|Part 1|Withdrawal by Subject|0|||
160844844|NCT00106353|580819695|FG002|Part 1|Withdrawal by Subject|1|||
160844845|NCT00106353|580819696|FG003|Part 1|Withdrawal by Subject|2|||
160844846|NCT00106353|580819697|FG004|Part 1|Withdrawal by Subject|0|||
160844847|NCT00106353|580819698|FG005|Part 1|Withdrawal by Subject|0|||
160844848|NCT00106353|580819699|FG006|Part 1|Withdrawal by Subject|0|||
160844849|NCT00106353|580819693|FG000|Part 1|Symptomatic deterioration|0|||
160844850|NCT00106353|580819694|FG001|Part 1|Symptomatic deterioration|0|||
160844851|NCT00106353|580819695|FG002|Part 1|Symptomatic deterioration|1|||
160844852|NCT00106353|580819696|FG003|Part 1|Symptomatic deterioration|0|||
160844853|NCT00106353|580819697|FG004|Part 1|Symptomatic deterioration|0|||
160844854|NCT00106353|580819698|FG005|Part 1|Symptomatic deterioration|0|||
160844855|NCT00106353|580819699|FG006|Part 1|Symptomatic deterioration|0|||
160844856|NCT00106353|580819693|FG000|Part 1|Entered follow-up phase|1|||
160844857|NCT00106353|580819694|FG001|Part 1|Entered follow-up phase|1|||
160844858|NCT00106353|580819695|FG002|Part 1|Entered follow-up phase|0|||
160844859|NCT00106353|580819696|FG003|Part 1|Entered follow-up phase|1|||
160844860|NCT00106353|580819697|FG004|Part 1|Entered follow-up phase|0|||
160844861|NCT00106353|580819698|FG005|Part 1|Entered follow-up phase|0|||
160844862|NCT00106353|580819699|FG006|Part 1|Entered follow-up phase|0|||
160844863|NCT00106353|580819693|FG000|Part 1|Adverse Event|0|||
160844864|NCT00106353|580819694|FG001|Part 1|Adverse Event|0|||
160844865|NCT00106353|580819695|FG002|Part 1|Adverse Event|0|||
160844866|NCT00106353|580819696|FG003|Part 1|Adverse Event|1|||
160844867|NCT00106353|580819697|FG004|Part 1|Adverse Event|0|||
160844868|NCT00106353|580819698|FG005|Part 1|Adverse Event|0|||
160566574|NCT04112914|579795419|FG000|Overall Study|Lost to Follow-up|13|||
160844869|NCT00106353|580819699|FG006|Part 1|Adverse Event|0|||
160844870|NCT00106353|580819693|FG000|Part 2|Disease progression|0|||
160844871|NCT00106353|580819694|FG001|Part 2|Disease progression|0|||
160844872|NCT00106353|580819695|FG002|Part 2|Disease progression|0|||
160844873|NCT00106353|580819696|FG003|Part 2|Disease progression|0|||
160844874|NCT00106353|580819697|FG004|Part 2|Disease progression|8|||
160844875|NCT00106353|580819698|FG005|Part 2|Disease progression|14|||
160844876|NCT00106353|580819699|FG006|Part 2|Disease progression|13|||
160844877|NCT00106353|580819693|FG000|Part 2|Death|0|||
160844878|NCT00106353|580819694|FG001|Part 2|Death|0|||
160844879|NCT00106353|580819695|FG002|Part 2|Death|0|||
160844880|NCT00106353|580819696|FG003|Part 2|Death|0|||
160844881|NCT00106353|580819697|FG004|Part 2|Death|3|||
160844882|NCT00106353|580819698|FG005|Part 2|Death|0|||
160844883|NCT00106353|580819699|FG006|Part 2|Death|1|||
160844884|NCT00106353|580819693|FG000|Part 2|Symptomatic deterioration|0|||
160844885|NCT00106353|580819694|FG001|Part 2|Symptomatic deterioration|0|||
160844886|NCT00106353|580819695|FG002|Part 2|Symptomatic deterioration|0|||
160844887|NCT00106353|580819696|FG003|Part 2|Symptomatic deterioration|0|||
160844888|NCT00106353|580819697|FG004|Part 2|Symptomatic deterioration|3|||
160844889|NCT00106353|580819698|FG005|Part 2|Symptomatic deterioration|0|||
160844890|NCT00106353|580819699|FG006|Part 2|Symptomatic deterioration|0|||
160844891|NCT00106353|580819693|FG000|Part 2|Adverse Event|0|||
160844892|NCT00106353|580819694|FG001|Part 2|Adverse Event|0|||
160844893|NCT00106353|580819695|FG002|Part 2|Adverse Event|0|||
160844894|NCT00106353|580819696|FG003|Part 2|Adverse Event|0|||
160844895|NCT00106353|580819697|FG004|Part 2|Adverse Event|0|||
160844896|NCT00106353|580819698|FG005|Part 2|Adverse Event|2|||
160844897|NCT00106353|580819699|FG006|Part 2|Adverse Event|1|||
160844898|NCT00106353|580819693|FG000|Part 2|Other|0|||
160844899|NCT00106353|580819694|FG001|Part 2|Other|0|||
160844900|NCT00106353|580819695|FG002|Part 2|Other|0|||
160566575|NCT04112914|579795420|FG001|Overall Study|Lost to Follow-up|9|||
160844901|NCT00106353|580819696|FG003|Part 2|Other|0|||
160844902|NCT00106353|580819697|FG004|Part 2|Other|1|||
160844903|NCT00106353|580819698|FG005|Part 2|Other|1|||
160844904|NCT00106353|580819699|FG006|Part 2|Other|1|||
160844905|NCT00106353|580819693|FG000|Part 2|Withdrawal by Subject|0|||
160844906|NCT00106353|580819694|FG001|Part 2|Withdrawal by Subject|0|||
160844907|NCT00106353|580819695|FG002|Part 2|Withdrawal by Subject|0|||
160844908|NCT00106353|580819696|FG003|Part 2|Withdrawal by Subject|0|||
160844909|NCT00106353|580819697|FG004|Part 2|Withdrawal by Subject|1|||
160844910|NCT00106353|580819698|FG005|Part 2|Withdrawal by Subject|0|||
160844911|NCT00106353|580819699|FG006|Part 2|Withdrawal by Subject|0|||
160844912|NCT00106353|580819693|FG000|Part 2|Physician Decision|0|||
160844913|NCT00106353|580819694|FG001|Part 2|Physician Decision|0|||
160844914|NCT00106353|580819695|FG002|Part 2|Physician Decision|0|||
160844915|NCT00106353|580819696|FG003|Part 2|Physician Decision|0|||
160844916|NCT00106353|580819697|FG004|Part 2|Physician Decision|0|||
160844917|NCT00106353|580819698|FG005|Part 2|Physician Decision|1|||
160566576|NCT04112914|579795419|FG000|Overall Study|Withdrawal by Subject|1|||
160844918|NCT00106353|580819699|FG006|Part 2|Physician Decision|0|||
160844919|NCT04039217|580819700|FG000|Overall Study|Lost to Follow-up|1|||
160844920|NCT01278797|580819701|FG000|Period 1|Adverse Event|0|||
160844921|NCT01278797|580819702|FG001|Period 1|Adverse Event|1|||
160844922|NCT01278797|580819701|FG000|Period 1|Protocol Violation|1|||
160844923|NCT01278797|580819702|FG001|Period 1|Protocol Violation|0|||
160844924|NCT00588354|580819703|FG000|Baseline to 2 Weeks|Adverse Event|1|||
160844925|NCT00588354|580819704|FG001|Baseline to 2 Weeks|Adverse Event|0|||
160844926|NCT00588354|580819703|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
160844927|NCT00588354|580819704|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
160844928|NCT00588354|580819703|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
160844929|NCT00588354|580819704|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
160566577|NCT04112914|579795420|FG001|Overall Study|Withdrawal by Subject|0|||
160566578|NCT00768560|579795421|FG000|Intervention Set 1|Adverse Event|0|||
160566579|NCT00768560|579795422|FG001|Intervention Set 1|Adverse Event|1|||
160566580|NCT00768560|579795423|FG002|Intervention Set 1|Adverse Event|0|||
160566581|NCT00768560|579795424|FG003|Intervention Set 1|Adverse Event|0|||
160844930|NCT03364309|580819705|FG000|Induction Period|Adverse Event|4|||
160844931|NCT03364309|580819706|FG001|Induction Period|Adverse Event|0|||
160844932|NCT03364309|580819707|FG002|Induction Period|Adverse Event|1|||
160844933|NCT03364309|580819708|FG003|Induction Period|Adverse Event|0|||
160844934|NCT03364309|580819709|FG004|Induction Period|Adverse Event|0|||
160844935|NCT03364309|580819710|FG005|Induction Period|Adverse Event|0|||
160844936|NCT03364309|580819711|FG006|Induction Period|Adverse Event|0|||
160844937|NCT03364309|580819712|FG007|Induction Period|Adverse Event|0|||
160844938|NCT03364309|580819713|FG008|Induction Period|Adverse Event|0|||
160844939|NCT03364309|580819714|FG009|Induction Period|Adverse Event|0|||
160844940|NCT03364309|580819715|FG010|Induction Period|Adverse Event|0|||
160844941|NCT03364309|580819716|FG011|Induction Period|Adverse Event|0|||
160844942|NCT03364309|580819717|FG012|Induction Period|Adverse Event|0|||
160844943|NCT03364309|580819718|FG013|Induction Period|Adverse Event|0|||
160844944|NCT03364309|580819719|FG014|Induction Period|Adverse Event|0|||
160844945|NCT03364309|580819720|FG015|Induction Period|Adverse Event|0|||
160844946|NCT03364309|580819721|FG016|Induction Period|Adverse Event|0|||
160844947|NCT03364309|580819722|FG017|Induction Period|Adverse Event|0|||
160844948|NCT03364309|580819723|FG018|Induction Period|Adverse Event|0|||
160844949|NCT03364309|580819705|FG000|Induction Period|Withdrawal by Subject|1|||
160844950|NCT03364309|580819706|FG001|Induction Period|Withdrawal by Subject|3|||
160844951|NCT03364309|580819707|FG002|Induction Period|Withdrawal by Subject|0|||
160844952|NCT03364309|580819708|FG003|Induction Period|Withdrawal by Subject|0|||
160844953|NCT03364309|580819709|FG004|Induction Period|Withdrawal by Subject|0|||
160844954|NCT03364309|580819710|FG005|Induction Period|Withdrawal by Subject|0|||
160844955|NCT03364309|580819711|FG006|Induction Period|Withdrawal by Subject|0|||
160844956|NCT03364309|580819712|FG007|Induction Period|Withdrawal by Subject|0|||
160844957|NCT03364309|580819713|FG008|Induction Period|Withdrawal by Subject|0|||
160844958|NCT03364309|580819714|FG009|Induction Period|Withdrawal by Subject|0|||
160844959|NCT03364309|580819715|FG010|Induction Period|Withdrawal by Subject|0|||
160844960|NCT03364309|580819716|FG011|Induction Period|Withdrawal by Subject|0|||
160844961|NCT03364309|580819717|FG012|Induction Period|Withdrawal by Subject|0|||
160844962|NCT03364309|580819718|FG013|Induction Period|Withdrawal by Subject|0|||
160844963|NCT03364309|580819719|FG014|Induction Period|Withdrawal by Subject|0|||
160844964|NCT03364309|580819720|FG015|Induction Period|Withdrawal by Subject|0|||
160844965|NCT03364309|580819721|FG016|Induction Period|Withdrawal by Subject|0|||
160844966|NCT03364309|580819722|FG017|Induction Period|Withdrawal by Subject|0|||
160844967|NCT03364309|580819723|FG018|Induction Period|Withdrawal by Subject|0|||
160844968|NCT03364309|580819705|FG000|Induction Period|Lost to Follow-up|1|||
160844969|NCT03364309|580819706|FG001|Induction Period|Lost to Follow-up|0|||
160844970|NCT03364309|580819707|FG002|Induction Period|Lost to Follow-up|0|||
160844971|NCT03364309|580819708|FG003|Induction Period|Lost to Follow-up|0|||
160844972|NCT03364309|580819709|FG004|Induction Period|Lost to Follow-up|0|||
160844973|NCT03364309|580819710|FG005|Induction Period|Lost to Follow-up|0|||
160844974|NCT03364309|580819711|FG006|Induction Period|Lost to Follow-up|0|||
160844975|NCT03364309|580819712|FG007|Induction Period|Lost to Follow-up|0|||
160844976|NCT03364309|580819713|FG008|Induction Period|Lost to Follow-up|0|||
160566582|NCT00768560|579795425|FG004|Intervention Set 1|Adverse Event|0|||
160566583|NCT00768560|579795426|FG005|Intervention Set 1|Adverse Event|0|||
160566584|NCT02635204|579795427|FG000|Overall Study|Adverse Event|1|||
160566585|NCT02635204|579795428|FG001|Overall Study|Adverse Event|0|||
160566586|NCT02635204|579795427|FG000|Overall Study|Lost to Follow-up|1|||
160566587|NCT02635204|579795428|FG001|Overall Study|Lost to Follow-up|1|||
160844977|NCT03364309|580819714|FG009|Induction Period|Lost to Follow-up|0|||
160844978|NCT03364309|580819715|FG010|Induction Period|Lost to Follow-up|0|||
160844979|NCT03364309|580819716|FG011|Induction Period|Lost to Follow-up|0|||
160844980|NCT03364309|580819717|FG012|Induction Period|Lost to Follow-up|0|||
160844981|NCT03364309|580819718|FG013|Induction Period|Lost to Follow-up|0|||
160844982|NCT03364309|580819719|FG014|Induction Period|Lost to Follow-up|0|||
160844983|NCT03364309|580819720|FG015|Induction Period|Lost to Follow-up|0|||
160844984|NCT03364309|580819721|FG016|Induction Period|Lost to Follow-up|0|||
160905970|NCT02582983|581050317|FG000|Overall Study|Death|3|||
160566588|NCT02500550|579795429|FG000|Overall Study|Death|7|||
160566589|NCT03293680|579795434|FG000|Overall Study|Death|1|||
160566590|NCT03293680|579795434|FG000|Overall Study|Did not meet inclusion criteria|8|||
160844985|NCT03364309|580819722|FG017|Induction Period|Lost to Follow-up|0|||
160844986|NCT03364309|580819723|FG018|Induction Period|Lost to Follow-up|0|||
160905971|NCT02582983|581050317|FG000|Overall Study|Withdrawal by Subject|2|||
160905972|NCT02582983|581050317|FG000|Overall Study|Adverse Event|1|||
160905973|NCT02059395|581050318|FG000|Overall Study|Lost to Follow-up|2|||
160905974|NCT02059395|581050319|FG001|Overall Study|Lost to Follow-up|4|||
160905975|NCT05209360|581050320|FG000|Overall Study|Withdrawal by Subject|0|||
160905976|NCT05209360|581050321|FG001|Overall Study|Withdrawal by Subject|0|||
160905977|NCT05209360|581050322|FG002|Overall Study|Withdrawal by Subject|1|||
160905978|NCT05209360|581050323|FG003|Overall Study|Withdrawal by Subject|0|||
160905979|NCT05209360|581050324|FG004|Overall Study|Withdrawal by Subject|0|||
160905980|NCT05209360|581050325|FG005|Overall Study|Withdrawal by Subject|0|||
160905981|NCT02021331|581050326|FG000|Overall Study|Adverse Event|0|||
160905982|NCT02021331|581050327|FG001|Overall Study|Adverse Event|2|||
160905983|NCT02340975|581050338|FG000|Overall Study|Death|6|||
160992329|NCT00828919|581360026|FG001|Overall Study|Insufficient Clinical Response|1|||
160992330|NCT00828919|581360027|FG002|Overall Study|Insufficient Clinical Response|2|||
160992331|NCT00828919|581360028|FG003|Overall Study|Insufficient Clinical Response|0|||
160992332|NCT00828919|581360029|FG004|Overall Study|Insufficient Clinical Response|0|||
160992333|NCT00828919|581360025|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
160992334|NCT00828919|581360026|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
160992335|NCT00828919|581360027|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
160992336|NCT00828919|581360028|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
160992337|NCT00828919|581360029|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
160992338|NCT00828919|581360025|FG000|Overall Study|Other|1|||
160992339|NCT00828919|581360026|FG001|Overall Study|Other|0|||
160992340|NCT00828919|581360027|FG002|Overall Study|Other|1|||
160992341|NCT00828919|581360028|FG003|Overall Study|Other|1|||
160992342|NCT00828919|581360029|FG004|Overall Study|Other|0|||
160992343|NCT00828919|581360025|FG000|Overall Study|Lost to Follow-up|0|||
160992344|NCT00828919|581360026|FG001|Overall Study|Lost to Follow-up|1|||
160992345|NCT00828919|581360027|FG002|Overall Study|Lost to Follow-up|0|||
160992346|NCT00828919|581360028|FG003|Overall Study|Lost to Follow-up|0|||
160992347|NCT00828919|581360029|FG004|Overall Study|Lost to Follow-up|0|||
160992348|NCT01562743|581360030|FG000|Overall Study|Adverse Event|29|||
160992349|NCT01562743|581360030|FG000|Overall Study|Lack of Efficacy|3|||
160566591|NCT00636818|579795435|FG000|Overall Study|Adverse Event|1|||
160566592|NCT00636818|579795435|FG000|Overall Study|Lost to Follow-up|2|||
160566593|NCT00636818|579795435|FG000|Overall Study|Entry Criteria Exclusion|3|||
160566594|NCT00636818|579795435|FG000|Overall Study|Protocol Violation|1|||
160566595|NCT00636818|579795435|FG000|Overall Study|Withdrawal by Subject|4|||
160844987|NCT03364309|580819705|FG000|Induction Period|Physician Decision|0|||
160844988|NCT03364309|580819706|FG001|Induction Period|Physician Decision|1|||
160844989|NCT03364309|580819707|FG002|Induction Period|Physician Decision|0|||
160844990|NCT03364309|580819708|FG003|Induction Period|Physician Decision|0|||
160844991|NCT03364309|580819709|FG004|Induction Period|Physician Decision|0|||
160844992|NCT03364309|580819710|FG005|Induction Period|Physician Decision|0|||
160905984|NCT02340975|581050339|FG001|Overall Study|Death|23|||
160905985|NCT02340975|581050340|FG002|Overall Study|Death|21|||
160905986|NCT02340975|581050341|FG003|Overall Study|Death|7|||
160992350|NCT01562743|581360030|FG000|Overall Study|Withdrawal by Subject|13|||
160844993|NCT03364309|580819711|FG006|Induction Period|Physician Decision|0|||
160844994|NCT03364309|580819712|FG007|Induction Period|Physician Decision|0|||
160844995|NCT03364309|580819713|FG008|Induction Period|Physician Decision|0|||
160844996|NCT03364309|580819714|FG009|Induction Period|Physician Decision|0|||
160844997|NCT03364309|580819715|FG010|Induction Period|Physician Decision|0|||
160844998|NCT03364309|580819716|FG011|Induction Period|Physician Decision|0|||
160844999|NCT03364309|580819717|FG012|Induction Period|Physician Decision|0|||
160845000|NCT03364309|580819718|FG013|Induction Period|Physician Decision|0|||
160845001|NCT03364309|580819719|FG014|Induction Period|Physician Decision|0|||
160845002|NCT03364309|580819720|FG015|Induction Period|Physician Decision|0|||
160845003|NCT03364309|580819721|FG016|Induction Period|Physician Decision|0|||
160845004|NCT03364309|580819722|FG017|Induction Period|Physician Decision|0|||
160905987|NCT02340975|581050342|FG004|Overall Study|Death|21|||
160905988|NCT02340975|581050343|FG005|Overall Study|Death|13|||
160992351|NCT01562743|581360030|FG000|Overall Study|Protocol Violation|1|||
160992352|NCT01562743|581360030|FG000|Overall Study|Discontinuation criteria|2|||
160992353|NCT01562743|581360030|FG000|Overall Study|Lost to Follow-up|2|||
160992354|NCT01562743|581360030|FG000|Overall Study|Physician Decision|2|||
160566596|NCT05300087|579795439|FG000|Overall Study|Withdrawal by Subject|0|||
160992355|NCT05567159|581360031|FG000|Overall Study|Adverse Event|4|||
160566597|NCT05300087|579795440|FG001|Overall Study|Withdrawal by Subject|1|||
160566598|NCT03248128|579795441|FG000|Overall Study|Lost to Follow-up|1|||
160566599|NCT03248128|579795442|FG001|Overall Study|Lost to Follow-up|0|||
160566600|NCT03248128|579795441|FG000|Overall Study|Withdrawal by Subject|16|||
160566601|NCT03248128|579795442|FG001|Overall Study|Withdrawal by Subject|14|||
160905989|NCT02340975|581050338|FG000|Overall Study|Lost to Follow-up|0|||
160905990|NCT02340975|581050339|FG001|Overall Study|Lost to Follow-up|0|||
160566602|NCT03248128|579795441|FG000|Overall Study|Site Closed|4|||
160566603|NCT03248128|579795442|FG001|Overall Study|Site Closed|3|||
160566604|NCT03248128|579795441|FG000|Overall Study|Randomized, but did not receive treatment|1|||
160566605|NCT03248128|579795442|FG001|Overall Study|Randomized, but did not receive treatment|3|||
160566606|NCT01914679|579795443|FG000|Overall Study|Lack of Efficacy|1|||
160566607|NCT01914679|579795443|FG000|Overall Study|Sponsor terminated study|4|||
160566608|NCT04826900|579795446|FG000|Overall Study|Family factor|1|||
160845005|NCT03364309|580819723|FG018|Induction Period|Physician Decision|0|||
160845006|NCT03364309|580819705|FG000|Maintenance Period|Withdrawal by Subject|0|||
160845007|NCT03364309|580819706|FG001|Maintenance Period|Withdrawal by Subject|0|||
160845008|NCT03364309|580819707|FG002|Maintenance Period|Withdrawal by Subject|0|||
160845009|NCT03364309|580819708|FG003|Maintenance Period|Withdrawal by Subject|1|||
160845010|NCT03364309|580819709|FG004|Maintenance Period|Withdrawal by Subject|3|||
160845011|NCT03364309|580819710|FG005|Maintenance Period|Withdrawal by Subject|1|||
160845012|NCT03364309|580819711|FG006|Maintenance Period|Withdrawal by Subject|3|||
160845013|NCT03364309|580819712|FG007|Maintenance Period|Withdrawal by Subject|0|||
160845014|NCT03364309|580819713|FG008|Maintenance Period|Withdrawal by Subject|1|||
160845015|NCT03364309|580819714|FG009|Maintenance Period|Withdrawal by Subject|1|||
160845016|NCT03364309|580819715|FG010|Maintenance Period|Withdrawal by Subject|2|||
160845017|NCT03364309|580819716|FG011|Maintenance Period|Withdrawal by Subject|0|||
160845018|NCT03364309|580819717|FG012|Maintenance Period|Withdrawal by Subject|0|||
160845019|NCT03364309|580819718|FG013|Maintenance Period|Withdrawal by Subject|0|||
160845020|NCT03364309|580819719|FG014|Maintenance Period|Withdrawal by Subject|0|||
160845021|NCT03364309|580819720|FG015|Maintenance Period|Withdrawal by Subject|0|||
160845022|NCT03364309|580819721|FG016|Maintenance Period|Withdrawal by Subject|0|||
160845023|NCT03364309|580819722|FG017|Maintenance Period|Withdrawal by Subject|0|||
160845024|NCT03364309|580819723|FG018|Maintenance Period|Withdrawal by Subject|0|||
160845025|NCT03364309|580819705|FG000|Maintenance Period|Adverse Event|0|||
160845026|NCT03364309|580819706|FG001|Maintenance Period|Adverse Event|0|||
160845027|NCT03364309|580819707|FG002|Maintenance Period|Adverse Event|0|||
160566609|NCT04826900|579795447|FG001|Overall Study|Family factor|1|||
160566610|NCT00256295|579795449|FG000|Overall Study|Withdrawal by Subject|3|||
160566611|NCT00256295|579795449|FG000|Overall Study|Death|1|||
160566612|NCT01126580|579795450|FG000|Overall Study|Adverse Event|14|||
160566613|NCT01126580|579795451|FG001|Overall Study|Adverse Event|8|||
160566614|NCT01126580|579795452|FG002|Overall Study|Adverse Event|12|||
160566615|NCT01126580|579795450|FG000|Overall Study|Withdrawal by Subject|11|||
160566616|NCT01126580|579795451|FG001|Overall Study|Withdrawal by Subject|19|||
160566617|NCT01126580|579795452|FG002|Overall Study|Withdrawal by Subject|14|||
160566618|NCT01126580|579795450|FG000|Overall Study|Sponsor Decision|5|||
160566619|NCT01126580|579795451|FG001|Overall Study|Sponsor Decision|4|||
160566620|NCT01126580|579795452|FG002|Overall Study|Sponsor Decision|7|||
160566621|NCT01126580|579795450|FG000|Overall Study|Physician Decision|1|||
160566622|NCT01126580|579795451|FG001|Overall Study|Physician Decision|1|||
160566623|NCT01126580|579795452|FG002|Overall Study|Physician Decision|2|||
160566624|NCT01126580|579795450|FG000|Overall Study|Entry Criteria Not Met|1|||
160566625|NCT01126580|579795451|FG001|Overall Study|Entry Criteria Not Met|1|||
160566626|NCT01126580|579795452|FG002|Overall Study|Entry Criteria Not Met|2|||
160566627|NCT01126580|579795450|FG000|Overall Study|Lack of Efficacy|2|||
160566628|NCT01126580|579795451|FG001|Overall Study|Lack of Efficacy|3|||
160566629|NCT01126580|579795452|FG002|Overall Study|Lack of Efficacy|4|||
160566630|NCT01126580|579795450|FG000|Overall Study|Protocol Violation|0|||
160845028|NCT03364309|580819708|FG003|Maintenance Period|Adverse Event|0|||
160845029|NCT03364309|580819709|FG004|Maintenance Period|Adverse Event|2|||
160845030|NCT03364309|580819710|FG005|Maintenance Period|Adverse Event|0|||
160845031|NCT03364309|580819711|FG006|Maintenance Period|Adverse Event|3|||
160845032|NCT03364309|580819712|FG007|Maintenance Period|Adverse Event|0|||
160845033|NCT03364309|580819713|FG008|Maintenance Period|Adverse Event|1|||
160845034|NCT03364309|580819714|FG009|Maintenance Period|Adverse Event|0|||
160845035|NCT03364309|580819715|FG010|Maintenance Period|Adverse Event|2|||
160845036|NCT03364309|580819716|FG011|Maintenance Period|Adverse Event|0|||
160845037|NCT03364309|580819717|FG012|Maintenance Period|Adverse Event|0|||
160566631|NCT01126580|579795451|FG001|Overall Study|Protocol Violation|1|||
160845038|NCT03364309|580819718|FG013|Maintenance Period|Adverse Event|0|||
160845039|NCT03364309|580819719|FG014|Maintenance Period|Adverse Event|0|||
160845040|NCT03364309|580819720|FG015|Maintenance Period|Adverse Event|0|||
160845041|NCT03364309|580819721|FG016|Maintenance Period|Adverse Event|0|||
160845042|NCT03364309|580819722|FG017|Maintenance Period|Adverse Event|0|||
160566632|NCT01126580|579795452|FG002|Overall Study|Protocol Violation|2|||
160566633|NCT01126580|579795450|FG000|Overall Study|Lost to Follow-up|15|||
160566634|NCT01126580|579795451|FG001|Overall Study|Lost to Follow-up|13|||
160566635|NCT01126580|579795452|FG002|Overall Study|Lost to Follow-up|9|||
160566636|NCT01126580|579795450|FG000|Overall Study|Treatment Non-compliance|0|||
160566637|NCT01126580|579795451|FG001|Overall Study|Treatment Non-compliance|2|||
160566638|NCT01126580|579795452|FG002|Overall Study|Treatment Non-compliance|3|||
160566639|NCT01731002|579795462|FG000|Overall Study|Adverse Event|0|||
160845043|NCT03364309|580819723|FG018|Maintenance Period|Adverse Event|0|||
160845044|NCT03364309|580819705|FG000|Maintenance Period|Relapsed|0|||
160845045|NCT03364309|580819706|FG001|Maintenance Period|Relapsed|0|||
160845046|NCT03364309|580819707|FG002|Maintenance Period|Relapsed|0|||
160566640|NCT01731002|579795463|FG001|Overall Study|Adverse Event|2|||
160566641|NCT01731002|579795464|FG002|Overall Study|Adverse Event|2|||
160566642|NCT01731002|579795462|FG000|Overall Study|Non-Compliant|0|||
160566643|NCT01731002|579795463|FG001|Overall Study|Non-Compliant|1|||
160566644|NCT01731002|579795464|FG002|Overall Study|Non-Compliant|0|||
160566645|NCT01731002|579795462|FG000|Overall Study|Lost to Follow-up|1|||
160566646|NCT01731002|579795463|FG001|Overall Study|Lost to Follow-up|0|||
160566647|NCT01731002|579795464|FG002|Overall Study|Lost to Follow-up|0|||
160566648|NCT01731002|579795462|FG000|Overall Study|Test Agent Discontinuation|0|||
160566649|NCT01731002|579795463|FG001|Overall Study|Test Agent Discontinuation|1|||
160566650|NCT01731002|579795464|FG002|Overall Study|Test Agent Discontinuation|0|||
160566651|NCT01731002|579795462|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
160566652|NCT01731002|579795463|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
160566653|NCT01731002|579795464|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
160566654|NCT01731002|579795462|FG000|Overall Study|Elevated IOP|1|||
160566655|NCT01731002|579795463|FG001|Overall Study|Elevated IOP|0|||
160566656|NCT01731002|579795464|FG002|Overall Study|Elevated IOP|0|||
160566657|NCT01731002|579795462|FG000|Overall Study|Inappropriate use of study medications|0|||
160566658|NCT01731002|579795463|FG001|Overall Study|Inappropriate use of study medications|0|||
160566659|NCT01731002|579795464|FG002|Overall Study|Inappropriate use of study medications|1|||
160566660|NCT00947349|579795465|FG000|Triple Treatment Combination Period|Adverse Event|0|||
160566661|NCT00947349|579795466|FG001|Triple Treatment Combination Period|Adverse Event|1|||
160566662|NCT00947349|579795467|FG002|Triple Treatment Combination Period|Adverse Event|0|||
160566663|NCT00947349|579795468|FG003|Triple Treatment Combination Period|Adverse Event|0|||
160566664|NCT00947349|579795465|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
160566665|NCT00947349|579795466|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
160566666|NCT00947349|579795467|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
160566667|NCT00947349|579795468|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
160566668|NCT00947349|579795465|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
160566669|NCT00947349|579795466|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
160566670|NCT00947349|579795467|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
160566671|NCT00947349|579795468|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
160566672|NCT00947349|579795465|FG000|Overall Study Standard of Care|Other|0|||
160566673|NCT00947349|579795466|FG001|Overall Study Standard of Care|Other|0|||
160566674|NCT00947349|579795467|FG002|Overall Study Standard of Care|Other|0|||
160566675|NCT00947349|579795468|FG003|Overall Study Standard of Care|Other|1|||
160566676|NCT00538681|579795469|FG000|Overall Study|Progressive Disease|7|||
160566677|NCT00538681|579795470|FG001|Overall Study|Progressive Disease|0|||
160566678|NCT00538681|579795471|FG002|Overall Study|Progressive Disease|1|||
160566679|NCT00538681|579795472|FG003|Overall Study|Progressive Disease|0|||
160566680|NCT00538681|579795469|FG000|Overall Study|Sponsor Decision|1|||
160566681|NCT00538681|579795470|FG001|Overall Study|Sponsor Decision|3|||
160566682|NCT00538681|579795471|FG002|Overall Study|Sponsor Decision|8|||
160566683|NCT00538681|579795472|FG003|Overall Study|Sponsor Decision|9|||
160566684|NCT00538681|579795469|FG000|Overall Study|Adverse Event|1|||
160566685|NCT00538681|579795470|FG001|Overall Study|Adverse Event|1|||
160566686|NCT00538681|579795471|FG002|Overall Study|Adverse Event|1|||
160566687|NCT00538681|579795472|FG003|Overall Study|Adverse Event|0|||
160566688|NCT00538681|579795469|FG000|Overall Study|Death|0|||
160566689|NCT00538681|579795470|FG001|Overall Study|Death|0|||
160566690|NCT00538681|579795471|FG002|Overall Study|Death|1|||
160566691|NCT00538681|579795472|FG003|Overall Study|Death|1|||
160566692|NCT00538681|579795469|FG000|Overall Study|Investigator Decision|0|||
160566693|NCT00538681|579795470|FG001|Overall Study|Investigator Decision|0|||
160649787|NCT03264066|580098943|FG002|Overall Study|Death|8|||
160845047|NCT03364309|580819708|FG003|Maintenance Period|Relapsed|43|||
160845048|NCT03364309|580819709|FG004|Maintenance Period|Relapsed|7|||
160845049|NCT03364309|580819710|FG005|Maintenance Period|Relapsed|45|||
160845050|NCT03364309|580819711|FG006|Maintenance Period|Relapsed|10|||
160845051|NCT03364309|580819712|FG007|Maintenance Period|Relapsed|2|||
160845052|NCT03364309|580819713|FG008|Maintenance Period|Relapsed|0|||
160845053|NCT03364309|580819714|FG009|Maintenance Period|Relapsed|0|||
160845054|NCT03364309|580819715|FG010|Maintenance Period|Relapsed|0|||
160566694|NCT00538681|579795471|FG002|Overall Study|Investigator Decision|0|||
160566695|NCT00538681|579795472|FG003|Overall Study|Investigator Decision|1|||
160566696|NCT02382133|579795475|FG000|Overall Study|Death|22|||
160566697|NCT02382133|579795475|FG000|Overall Study|transfer out of ICU|4|||
160566698|NCT02382133|579795475|FG000|Overall Study|Physician Decision|2|||
160566699|NCT02382133|579795475|FG000|Overall Study|arterial catheter loss|4|||
160566700|NCT02382133|579795475|FG000|Overall Study|pressure injury both sites|1|||
160566701|NCT05369806|579795476|FG000|Overall Study|Lost to Follow-up|1|||
160566702|NCT00628355|579795477|FG000|Overall Study|Withdrawal by Subject|1|||
160566703|NCT00628355|579795478|FG001|Overall Study|Withdrawal by Subject|1|||
160649788|NCT03264066|580098944|FG003|Overall Study|Death|10|||
160845055|NCT03364309|580819716|FG011|Maintenance Period|Relapsed|0|||
160566704|NCT01446809|579795481|FG000|Overall Study|Adverse Event|0|||
160845056|NCT03364309|580819717|FG012|Maintenance Period|Relapsed|0|||
160845057|NCT03364309|580819718|FG013|Maintenance Period|Relapsed|0|||
160845058|NCT03364309|580819719|FG014|Maintenance Period|Relapsed|0|||
160845059|NCT03364309|580819720|FG015|Maintenance Period|Relapsed|0|||
160845060|NCT03364309|580819721|FG016|Maintenance Period|Relapsed|0|||
160845061|NCT03364309|580819722|FG017|Maintenance Period|Relapsed|0|||
160845062|NCT03364309|580819723|FG018|Maintenance Period|Relapsed|0|||
160566705|NCT01446809|579795482|FG001|Overall Study|Adverse Event|0|||
160566706|NCT01446809|579795483|FG002|Overall Study|Adverse Event|1|||
160566707|NCT01446809|579795481|FG000|Overall Study|Failure to complete study procedures|0|||
160566708|NCT01446809|579795482|FG001|Overall Study|Failure to complete study procedures|0|||
160566709|NCT01446809|579795483|FG002|Overall Study|Failure to complete study procedures|1|||
160566710|NCT04493619|579797477|FG000|Overall Study|Death|4|||
160566711|NCT04493619|579797478|FG001|Overall Study|Death|3|||
160566712|NCT04493619|579797479|FG002|Overall Study|Death|3|||
160566713|NCT04493619|579797480|FG003|Overall Study|Death|4|||
160566714|NCT04493619|579797477|FG000|Overall Study|Study discontinued early|10|||
160566715|NCT04493619|579797478|FG001|Overall Study|Study discontinued early|0|||
160566716|NCT04493619|579797479|FG002|Overall Study|Study discontinued early|4|||
160566717|NCT04493619|579797480|FG003|Overall Study|Study discontinued early|8|||
160566718|NCT04493619|579797477|FG000|Overall Study|Lost to Follow-up|0|||
160566719|NCT04493619|579797478|FG001|Overall Study|Lost to Follow-up|0|||
160566720|NCT04493619|579797479|FG002|Overall Study|Lost to Follow-up|0|||
160566721|NCT04493619|579797480|FG003|Overall Study|Lost to Follow-up|1|||
160566722|NCT02017444|579797485|FG000|Overall Study|Physician Decision|1|||
160566723|NCT02017444|579797486|FG001|Overall Study|Physician Decision|0|||
160566724|NCT02017444|579797485|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
160566725|NCT02017444|579797486|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
160566726|NCT01845025|579797491|FG000|Overall Study|Adverse Event|6|||
160566727|NCT01845025|579797492|FG001|Overall Study|Adverse Event|3|||
160566728|NCT01845025|579797491|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160566729|NCT01845025|579797492|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160566730|NCT01845025|579797491|FG000|Overall Study|Withdrawal by Subject|48|||
160566731|NCT01845025|579797492|FG001|Overall Study|Withdrawal by Subject|44|||
160566732|NCT01845025|579797491|FG000|Overall Study|Lost to Follow-up|13|||
160566733|NCT01845025|579797492|FG001|Overall Study|Lost to Follow-up|13|||
160566734|NCT01845025|579797491|FG000|Overall Study|Administrative problems|8|||
160566735|NCT01845025|579797492|FG001|Overall Study|Administrative problems|8|||
160566736|NCT01845025|579797491|FG000|Overall Study|Death|2|||
160566737|NCT01845025|579797492|FG001|Overall Study|Death|0|||
160566738|NCT01845025|579797491|FG000|Overall Study|Protocol deviation|3|||
160566739|NCT01845025|579797492|FG001|Overall Study|Protocol deviation|6|||
160566740|NCT01845025|579797491|FG000|Overall Study|Missing|1|||
160566741|NCT01845025|579797492|FG001|Overall Study|Missing|1|||
160566742|NCT00813748|579797495|FG000|Skin Test Substudy|Physician Decision|0|||
160566743|NCT00813748|579797496|FG001|Skin Test Substudy|Physician Decision|1|||
160566744|NCT01829048|579797497|FG000|Overall Study|Withdrawal by Subject|0|||
160566745|NCT01829048|579797498|FG001|Overall Study|Withdrawal by Subject|0|||
160566746|NCT01829048|579797499|FG002|Overall Study|Withdrawal by Subject|0|||
160566747|NCT01829048|579797500|FG003|Overall Study|Withdrawal by Subject|2|||
160649789|NCT03264066|580098945|FG004|Overall Study|Death|6|||
160845063|NCT03364309|580819705|FG000|Maintenance Period|Lack of Efficacy|0|||
160845064|NCT03364309|580819706|FG001|Maintenance Period|Lack of Efficacy|0|||
160845065|NCT03364309|580819707|FG002|Maintenance Period|Lack of Efficacy|0|||
160845066|NCT03364309|580819708|FG003|Maintenance Period|Lack of Efficacy|0|||
160845067|NCT03364309|580819709|FG004|Maintenance Period|Lack of Efficacy|0|||
160845068|NCT03364309|580819710|FG005|Maintenance Period|Lack of Efficacy|0|||
160845069|NCT03364309|580819711|FG006|Maintenance Period|Lack of Efficacy|0|||
160845070|NCT03364309|580819712|FG007|Maintenance Period|Lack of Efficacy|0|||
160845071|NCT03364309|580819713|FG008|Maintenance Period|Lack of Efficacy|1|||
160845072|NCT03364309|580819714|FG009|Maintenance Period|Lack of Efficacy|3|||
160845073|NCT03364309|580819715|FG010|Maintenance Period|Lack of Efficacy|2|||
160845074|NCT03364309|580819716|FG011|Maintenance Period|Lack of Efficacy|0|||
160566748|NCT01829048|579797501|FG004|Overall Study|Withdrawal by Subject|0|||
160566749|NCT00500071|579797509|FG000|Screening and Washout Phase|Protocol Violation|1|||
160566750|NCT00500071|579797509|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
160566751|NCT00500071|579797509|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
160566752|NCT00500071|579797509|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
160566753|NCT00500071|579797509|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
160566754|NCT00500071|579797509|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
160566755|NCT00500071|579797509|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
160566756|NCT00389207|579797510|FG000|Overall Study|Adverse Event|26|||
160845075|NCT03364309|580819717|FG012|Maintenance Period|Lack of Efficacy|0|||
160649790|NCT03264066|580098946|FG005|Overall Study|Death|1|||
160649791|NCT03264066|580098941|FG000|Overall Study|Lost to Follow-up|1|||
160649792|NCT03264066|580098942|FG001|Overall Study|Lost to Follow-up|0|||
160649793|NCT03264066|580098943|FG002|Overall Study|Lost to Follow-up|0|||
160649794|NCT03264066|580098944|FG003|Overall Study|Lost to Follow-up|0|||
160649795|NCT03264066|580098945|FG004|Overall Study|Lost to Follow-up|0|||
160649796|NCT03264066|580098946|FG005|Overall Study|Lost to Follow-up|0|||
160649797|NCT03264066|580098941|FG000|Overall Study|Progressive Disease|0|||
160649798|NCT03264066|580098942|FG001|Overall Study|Progressive Disease|2|||
160649799|NCT03264066|580098943|FG002|Overall Study|Progressive Disease|1|||
160649800|NCT03264066|580098944|FG003|Overall Study|Progressive Disease|0|||
160649801|NCT03264066|580098945|FG004|Overall Study|Progressive Disease|0|||
160649802|NCT03264066|580098946|FG005|Overall Study|Progressive Disease|0|||
160649803|NCT03264066|580098941|FG000|Overall Study|Study Terminated by Sponsor|5|||
160649804|NCT03264066|580098942|FG001|Overall Study|Study Terminated by Sponsor|5|||
160649805|NCT03264066|580098943|FG002|Overall Study|Study Terminated by Sponsor|8|||
160649806|NCT03264066|580098944|FG003|Overall Study|Study Terminated by Sponsor|5|||
160566757|NCT00389207|579797511|FG001|Overall Study|Adverse Event|32|||
160566758|NCT00389207|579797512|FG002|Overall Study|Adverse Event|10|||
160566759|NCT00389207|579797510|FG000|Overall Study|Protocol Violation|3|||
160566760|NCT00389207|579797511|FG001|Overall Study|Protocol Violation|1|||
160566761|NCT00389207|579797512|FG002|Overall Study|Protocol Violation|4|||
160566762|NCT00389207|579797510|FG000|Overall Study|Lost to Follow-up|12|||
160566763|NCT00389207|579797511|FG001|Overall Study|Lost to Follow-up|9|||
160566764|NCT00389207|579797512|FG002|Overall Study|Lost to Follow-up|7|||
160566765|NCT00389207|579797510|FG000|Overall Study|Withdrawal by Subject|5|||
160566766|NCT00389207|579797511|FG001|Overall Study|Withdrawal by Subject|7|||
160566767|NCT00389207|579797512|FG002|Overall Study|Withdrawal by Subject|11|||
160566768|NCT00389207|579797510|FG000|Overall Study|Other|17|||
160566769|NCT00389207|579797511|FG001|Overall Study|Other|23|||
160566770|NCT00389207|579797512|FG002|Overall Study|Other|9|||
160566771|NCT01772134|579797518|FG000|Overall Study|Adverse Event|6|||
160566772|NCT01772134|579797519|FG001|Overall Study|Adverse Event|5|||
160566773|NCT01772134|579797520|FG002|Overall Study|Adverse Event|10|||
160566774|NCT01772134|579797518|FG000|Overall Study|Withdrew Consent|3|||
160566775|NCT01772134|579797519|FG001|Overall Study|Withdrew Consent|1|||
160566776|NCT01772134|579797520|FG002|Overall Study|Withdrew Consent|5|||
160566777|NCT01772134|579797518|FG000|Overall Study|Lost to Follow-up|2|||
160566778|NCT01772134|579797519|FG001|Overall Study|Lost to Follow-up|0|||
160566779|NCT01772134|579797520|FG002|Overall Study|Lost to Follow-up|0|||
160566780|NCT01772134|579797518|FG000|Overall Study|Protocol Deviation|4|||
160566781|NCT01772134|579797519|FG001|Overall Study|Protocol Deviation|3|||
160566782|NCT01772134|579797520|FG002|Overall Study|Protocol Deviation|3|||
160566783|NCT01772134|579797518|FG000|Overall Study|Lack of Efficacy|11|||
160566784|NCT01772134|579797519|FG001|Overall Study|Lack of Efficacy|5|||
160566785|NCT01772134|579797520|FG002|Overall Study|Lack of Efficacy|3|||
160566786|NCT01772134|579797518|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
160566787|NCT01772134|579797519|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
160566788|NCT01772134|579797520|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
160566789|NCT01772134|579797518|FG000|Overall Study|Randomized Study Medication Not Received|2|||
160566790|NCT01772134|579797519|FG001|Overall Study|Randomized Study Medication Not Received|0|||
160566791|NCT01772134|579797520|FG002|Overall Study|Randomized Study Medication Not Received|1|||
160566792|NCT02604264|579797523|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
160566793|NCT02604264|579797524|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
160566794|NCT03192904|579797526|FG000|Overall Study|Physician Decision|3|||
160566795|NCT03192904|579797527|FG001|Overall Study|Physician Decision|1|||
160566796|NCT03192904|579797526|FG000|Overall Study|Lost to Follow-up|0|||
160566797|NCT03192904|579797527|FG001|Overall Study|Lost to Follow-up|1|||
160566798|NCT00424398|579797528|FG000|Overall Study|Withdrawal by Subject|2|||
160566799|NCT00424398|579797529|FG001|Overall Study|Withdrawal by Subject|1|||
160649807|NCT03264066|580098945|FG004|Overall Study|Study Terminated by Sponsor|1|||
160649808|NCT03264066|580098946|FG005|Overall Study|Study Terminated by Sponsor|2|||
160566800|NCT00424398|579797530|FG002|Overall Study|Withdrawal by Subject|0|||
160566801|NCT00424398|579797528|FG000|Overall Study|Subject met exclusion criteria|1|||
160566802|NCT00424398|579797529|FG001|Overall Study|Subject met exclusion criteria|0|||
160566803|NCT00424398|579797530|FG002|Overall Study|Subject met exclusion criteria|0|||
160566804|NCT01023789|579797531|FG000|3 - Year Visit|Death|29|||
160566805|NCT01023789|579797531|FG000|3 - Year Visit|Withdrawal of consent|1|||
160566806|NCT01023789|579797531|FG000|3 - Year Visit|Lost to Follow-up|13|||
160566807|NCT02115308|579797542|FG000|Overall Study|Safety Screening|2|||
160566808|NCT02115308|579797543|FG001|Overall Study|Safety Screening|2|||
160649809|NCT03264066|580098941|FG000|Overall Study|Withdrawal by Subject|1|||
160649810|NCT03264066|580098942|FG001|Overall Study|Withdrawal by Subject|0|||
160649811|NCT03264066|580098943|FG002|Overall Study|Withdrawal by Subject|0|||
160649812|NCT03264066|580098944|FG003|Overall Study|Withdrawal by Subject|5|||
160649813|NCT03264066|580098945|FG004|Overall Study|Withdrawal by Subject|0|||
160649814|NCT03264066|580098946|FG005|Overall Study|Withdrawal by Subject|0|||
160649815|NCT01193517|580098960|FG000|Overall Study|Early Progression|1|||
160649816|NCT01193517|580098961|FG001|Overall Study|Early Progression|0|||
160649817|NCT01193517|580098962|FG002|Overall Study|Early Progression|0|||
160649818|NCT00146770|580098963|FG000|Overall Study|Adverse Event|2|||
160649819|NCT00146770|580098964|FG001|Overall Study|Adverse Event|0|||
160649820|NCT00146770|580098963|FG000|Overall Study|Pregnancy|1|||
160649821|NCT00146770|580098964|FG001|Overall Study|Pregnancy|0|||
160649822|NCT00146770|580098963|FG000|Overall Study|Withdrawal by Subject|2|||
160649823|NCT00146770|580098964|FG001|Overall Study|Withdrawal by Subject|0|||
160566809|NCT01309737|579797544|FG000|Week 0 to 16|Death|1|||
160566810|NCT01309737|579797545|FG001|Week 0 to 16|Death|0|||
160566811|NCT01309737|579797546|FG002|Week 0 to 16|Death|1|||
160566812|NCT01309737|579797547|FG003|Week 0 to 16|Death|0|||
160566813|NCT01309737|579797548|FG004|Week 0 to 16|Death|0|||
160566814|NCT01309737|579797544|FG000|Week 0 to 16|Adverse Event|11|||
160566815|NCT01309737|579797545|FG001|Week 0 to 16|Adverse Event|10|||
160566816|NCT01309737|579797546|FG002|Week 0 to 16|Adverse Event|5|||
160566817|NCT01309737|579797547|FG003|Week 0 to 16|Adverse Event|0|||
160566818|NCT01309737|579797548|FG004|Week 0 to 16|Adverse Event|0|||
160566819|NCT01309737|579797544|FG000|Week 0 to 16|Lack of Efficacy|15|||
160566820|NCT01309737|579797545|FG001|Week 0 to 16|Lack of Efficacy|2|||
160649824|NCT02826603|580098967|FG000|Overall Study|Adverse Event|17|||
160649825|NCT02826603|580098968|FG001|Overall Study|Adverse Event|9|||
160649826|NCT02826603|580098967|FG000|Overall Study|Lack of Efficacy|4|||
160649827|NCT02826603|580098968|FG001|Overall Study|Lack of Efficacy|9|||
160649828|NCT02826603|580098967|FG000|Overall Study|Lost to Follow-up|13|||
160649829|NCT02826603|580098968|FG001|Overall Study|Lost to Follow-up|12|||
160649830|NCT02826603|580098967|FG000|Overall Study|Noncompliance with treatment|0|||
160649831|NCT02826603|580098968|FG001|Overall Study|Noncompliance with treatment|2|||
160649832|NCT02826603|580098967|FG000|Overall Study|Physician Decision|1|||
160649833|NCT02826603|580098968|FG001|Overall Study|Physician Decision|7|||
160649834|NCT02826603|580098967|FG000|Overall Study|Pregnancy|1|||
160649835|NCT02826603|580098968|FG001|Overall Study|Pregnancy|2|||
160649836|NCT02826603|580098967|FG000|Overall Study|Protocol Violation|3|||
160649837|NCT02826603|580098968|FG001|Overall Study|Protocol Violation|3|||
160649838|NCT02826603|580098967|FG000|Overall Study|Withdrawal by Subject|20|||
160649839|NCT02826603|580098968|FG001|Overall Study|Withdrawal by Subject|19|||
160649840|NCT02826603|580098967|FG000|Overall Study|Death|2|||
160649841|NCT02826603|580098968|FG001|Overall Study|Death|0|||
160649842|NCT02826603|580098967|FG000|Overall Study|New therapy for study indication|0|||
160649843|NCT02826603|580098968|FG001|Overall Study|New therapy for study indication|1|||
160649844|NCT00905489|580098969|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
160649845|NCT00905489|580098969|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
160649846|NCT00905489|580098969|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
160649847|NCT00583596|580098972|FG000|Overall Study|Lost to Follow-up|110|||
160649848|NCT00583596|580098972|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
160649849|NCT00583596|580098972|FG000|Overall Study|Death|2|||
160649850|NCT00583596|580098972|FG000|Overall Study|Withdrawal by Subject|6|||
160649851|NCT00583596|580098972|FG000|Overall Study|Lost to Follow-up|94|||
160649852|NCT00583596|580098972|FG000|Overall Study|Data not complete|1|||
160649853|NCT00583596|580098972|FG000|Overall Study|Not consented|15|||
160649854|NCT00583596|580098972|FG000|Overall Study|Outside f-up window|26|||
160649855|NCT01688037|580098975|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
160649856|NCT01688037|580098976|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
160649857|NCT01688037|580098977|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
160649858|NCT01688037|580098975|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
160649859|NCT01688037|580098976|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
160649860|NCT01688037|580098977|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
160649861|NCT01688037|580098975|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
160649862|NCT01688037|580098976|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
160649863|NCT01688037|580098977|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
160566821|NCT01309737|579797546|FG002|Week 0 to 16|Lack of Efficacy|24|||
160566822|NCT01309737|579797547|FG003|Week 0 to 16|Lack of Efficacy|0|||
160649864|NCT01688037|580098975|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
160649865|NCT01688037|580098976|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
160649866|NCT01688037|580098977|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
160649867|NCT01688037|580098975|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
160566823|NCT01309737|579797548|FG004|Week 0 to 16|Lack of Efficacy|0|||
160649868|NCT01688037|580098976|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
160566824|NCT01309737|579797544|FG000|Week 0 to 16|Lost to Follow-up|7|||
160566825|NCT01309737|579797545|FG001|Week 0 to 16|Lost to Follow-up|8|||
160566826|NCT01309737|579797546|FG002|Week 0 to 16|Lost to Follow-up|3|||
160845076|NCT03364309|580819718|FG013|Maintenance Period|Lack of Efficacy|0|||
160845077|NCT03364309|580819719|FG014|Maintenance Period|Lack of Efficacy|0|||
160845078|NCT03364309|580819720|FG015|Maintenance Period|Lack of Efficacy|0|||
160845079|NCT03364309|580819721|FG016|Maintenance Period|Lack of Efficacy|0|||
160845080|NCT03364309|580819722|FG017|Maintenance Period|Lack of Efficacy|0|||
160845081|NCT03364309|580819723|FG018|Maintenance Period|Lack of Efficacy|0|||
160845082|NCT03364309|580819705|FG000|Maintenance Period|Death|0|||
160845083|NCT03364309|580819706|FG001|Maintenance Period|Death|0|||
160845084|NCT03364309|580819707|FG002|Maintenance Period|Death|0|||
160845085|NCT03364309|580819708|FG003|Maintenance Period|Death|0|||
160566827|NCT01309737|579797547|FG003|Week 0 to 16|Lost to Follow-up|0|||
160566828|NCT01309737|579797548|FG004|Week 0 to 16|Lost to Follow-up|0|||
160566829|NCT01309737|579797544|FG000|Week 0 to 16|Withdrawal by Subject|7|||
160566830|NCT01309737|579797545|FG001|Week 0 to 16|Withdrawal by Subject|6|||
160566831|NCT01309737|579797546|FG002|Week 0 to 16|Withdrawal by Subject|7|||
160566832|NCT01309737|579797547|FG003|Week 0 to 16|Withdrawal by Subject|0|||
160566833|NCT01309737|579797548|FG004|Week 0 to 16|Withdrawal by Subject|0|||
160566834|NCT01309737|579797544|FG000|Week 0 to 16|Other|10|||
160566835|NCT01309737|579797545|FG001|Week 0 to 16|Other|14|||
160566836|NCT01309737|579797546|FG002|Week 0 to 16|Other|4|||
160566837|NCT01309737|579797547|FG003|Week 0 to 16|Other|0|||
160566838|NCT01309737|579797548|FG004|Week 0 to 16|Other|0|||
160566839|NCT01309737|579797544|FG000|Week 0 to 16|Randomized, but not treated|1|||
160566840|NCT01309737|579797545|FG001|Week 0 to 16|Randomized, but not treated|0|||
160566841|NCT01309737|579797546|FG002|Week 0 to 16|Randomized, but not treated|0|||
160566842|NCT01309737|579797547|FG003|Week 0 to 16|Randomized, but not treated|0|||
160566843|NCT01309737|579797548|FG004|Week 0 to 16|Randomized, but not treated|0|||
160566844|NCT01309737|579797544|FG000|Week 16 to 52|Death|0|||
160566845|NCT01309737|579797545|FG001|Week 16 to 52|Death|0|||
160566846|NCT01309737|579797546|FG002|Week 16 to 52|Death|0|||
160566847|NCT01309737|579797547|FG003|Week 16 to 52|Death|0|||
160566848|NCT01309737|579797548|FG004|Week 16 to 52|Death|1|||
160566849|NCT01309737|579797544|FG000|Week 16 to 52|Adverse Event|7|||
160566850|NCT01309737|579797545|FG001|Week 16 to 52|Adverse Event|7|||
160566851|NCT01309737|579797546|FG002|Week 16 to 52|Adverse Event|0|||
160566852|NCT01309737|579797547|FG003|Week 16 to 52|Adverse Event|6|||
160566853|NCT01309737|579797548|FG004|Week 16 to 52|Adverse Event|5|||
160566854|NCT01309737|579797544|FG000|Week 16 to 52|Lack of Efficacy|107|||
160566855|NCT01309737|579797545|FG001|Week 16 to 52|Lack of Efficacy|76|||
160566856|NCT01309737|579797546|FG002|Week 16 to 52|Lack of Efficacy|0|||
160566857|NCT01309737|579797547|FG003|Week 16 to 52|Lack of Efficacy|25|||
160566858|NCT01309737|579797548|FG004|Week 16 to 52|Lack of Efficacy|21|||
160566859|NCT01309737|579797544|FG000|Week 16 to 52|Lost to Follow-up|4|||
160566860|NCT01309737|579797545|FG001|Week 16 to 52|Lost to Follow-up|2|||
160566861|NCT01309737|579797546|FG002|Week 16 to 52|Lost to Follow-up|0|||
160566862|NCT01309737|579797547|FG003|Week 16 to 52|Lost to Follow-up|1|||
160566863|NCT01309737|579797548|FG004|Week 16 to 52|Lost to Follow-up|4|||
160566864|NCT01309737|579797544|FG000|Week 16 to 52|Withdrawal by Subject|5|||
160566865|NCT01309737|579797545|FG001|Week 16 to 52|Withdrawal by Subject|6|||
160566866|NCT01309737|579797546|FG002|Week 16 to 52|Withdrawal by Subject|0|||
160566867|NCT01309737|579797547|FG003|Week 16 to 52|Withdrawal by Subject|0|||
160566868|NCT01309737|579797548|FG004|Week 16 to 52|Withdrawal by Subject|2|||
160566869|NCT01309737|579797544|FG000|Week 16 to 52|Other|10|||
160566870|NCT01309737|579797545|FG001|Week 16 to 52|Other|12|||
160566871|NCT01309737|579797546|FG002|Week 16 to 52|Other|0|||
160566872|NCT01309737|579797547|FG003|Week 16 to 52|Other|2|||
160566873|NCT01309737|579797548|FG004|Week 16 to 52|Other|0|||
160566874|NCT01442181|579797556|FG000|Overall Study|patient refused surgery|1|||
160566875|NCT01442181|579797557|FG001|Overall Study|patient refused surgery|0|||
160566876|NCT01442181|579797556|FG000|Overall Study|no insurance for surgery|1|||
160566877|NCT01442181|579797557|FG001|Overall Study|no insurance for surgery|0|||
160566878|NCT01442181|579797556|FG000|Overall Study|low ejection factor|0|||
160566879|NCT01442181|579797557|FG001|Overall Study|low ejection factor|1|||
160566880|NCT01442181|579797556|FG000|Overall Study|Lost to Follow-up|1|||
160566881|NCT01442181|579797557|FG001|Overall Study|Lost to Follow-up|1|||
160845086|NCT03364309|580819709|FG004|Maintenance Period|Death|0|||
160845087|NCT03364309|580819710|FG005|Maintenance Period|Death|0|||
160845088|NCT03364309|580819711|FG006|Maintenance Period|Death|0|||
160566882|NCT01442181|579797556|FG000|Overall Study|patient in an additional study|1|||
160566883|NCT01442181|579797557|FG001|Overall Study|patient in an additional study|0|||
160566884|NCT01442181|579797556|FG000|Overall Study|atrial fibrillation not noted|0|||
160566885|NCT01442181|579797557|FG001|Overall Study|atrial fibrillation not noted|1|||
160566886|NCT00749203|579797558|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
160566887|NCT00749203|579797559|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
160566888|NCT00749203|579797558|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
160566889|NCT00749203|579797559|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
160845089|NCT03364309|580819712|FG007|Maintenance Period|Death|0|||
160566890|NCT00749203|579797558|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
160566891|NCT00749203|579797559|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
160566892|NCT00749203|579797558|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
160566893|NCT00749203|579797559|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
160566894|NCT00749203|579797558|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
160566895|NCT00749203|579797559|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
160566896|NCT00749203|579797558|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
160566897|NCT00749203|579797559|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
160566898|NCT02034123|579797560|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566899|NCT02034123|579797561|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566900|NCT02034123|579797562|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566901|NCT02034123|579797563|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566902|NCT02034123|579797564|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
160566903|NCT02034123|579797565|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160649869|NCT01688037|580098977|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
160845090|NCT03364309|580819713|FG008|Maintenance Period|Death|1|||
160845091|NCT03364309|580819714|FG009|Maintenance Period|Death|0|||
160845092|NCT03364309|580819715|FG010|Maintenance Period|Death|0|||
160845093|NCT03364309|580819716|FG011|Maintenance Period|Death|0|||
160845094|NCT03364309|580819717|FG012|Maintenance Period|Death|0|||
160845095|NCT03364309|580819718|FG013|Maintenance Period|Death|0|||
160845096|NCT03364309|580819719|FG014|Maintenance Period|Death|0|||
160845097|NCT03364309|580819720|FG015|Maintenance Period|Death|0|||
160845098|NCT03364309|580819721|FG016|Maintenance Period|Death|0|||
160845099|NCT03364309|580819722|FG017|Maintenance Period|Death|0|||
160845100|NCT03364309|580819723|FG018|Maintenance Period|Death|0|||
160845101|NCT03364309|580819705|FG000|Maintenance Period|Lost to Follow-up|0|||
160845102|NCT03364309|580819706|FG001|Maintenance Period|Lost to Follow-up|0|||
160845103|NCT03364309|580819707|FG002|Maintenance Period|Lost to Follow-up|0|||
160845104|NCT03364309|580819708|FG003|Maintenance Period|Lost to Follow-up|0|||
160845105|NCT03364309|580819709|FG004|Maintenance Period|Lost to Follow-up|0|||
160845106|NCT03364309|580819710|FG005|Maintenance Period|Lost to Follow-up|0|||
160845107|NCT03364309|580819711|FG006|Maintenance Period|Lost to Follow-up|0|||
160845108|NCT03364309|580819712|FG007|Maintenance Period|Lost to Follow-up|0|||
160845109|NCT03364309|580819713|FG008|Maintenance Period|Lost to Follow-up|1|||
160845110|NCT03364309|580819714|FG009|Maintenance Period|Lost to Follow-up|0|||
160845111|NCT03364309|580819715|FG010|Maintenance Period|Lost to Follow-up|0|||
160845112|NCT03364309|580819716|FG011|Maintenance Period|Lost to Follow-up|0|||
160845113|NCT03364309|580819717|FG012|Maintenance Period|Lost to Follow-up|0|||
160845114|NCT03364309|580819718|FG013|Maintenance Period|Lost to Follow-up|0|||
160845115|NCT03364309|580819719|FG014|Maintenance Period|Lost to Follow-up|0|||
160845116|NCT03364309|580819720|FG015|Maintenance Period|Lost to Follow-up|0|||
160845117|NCT03364309|580819721|FG016|Maintenance Period|Lost to Follow-up|0|||
160845118|NCT03364309|580819722|FG017|Maintenance Period|Lost to Follow-up|0|||
160845119|NCT03364309|580819723|FG018|Maintenance Period|Lost to Follow-up|0|||
160845120|NCT03364309|580819705|FG000|Maintenance Period|Miscellaneous|0|||
160845121|NCT03364309|580819706|FG001|Maintenance Period|Miscellaneous|0|||
160845122|NCT03364309|580819707|FG002|Maintenance Period|Miscellaneous|0|||
160845123|NCT03364309|580819708|FG003|Maintenance Period|Miscellaneous|0|||
160845124|NCT03364309|580819709|FG004|Maintenance Period|Miscellaneous|0|||
160845125|NCT03364309|580819710|FG005|Maintenance Period|Miscellaneous|0|||
160845126|NCT03364309|580819711|FG006|Maintenance Period|Miscellaneous|0|||
160845127|NCT03364309|580819712|FG007|Maintenance Period|Miscellaneous|0|||
160845128|NCT03364309|580819713|FG008|Maintenance Period|Miscellaneous|1|||
160845129|NCT03364309|580819714|FG009|Maintenance Period|Miscellaneous|0|||
160845130|NCT03364309|580819715|FG010|Maintenance Period|Miscellaneous|0|||
160845131|NCT03364309|580819716|FG011|Maintenance Period|Miscellaneous|0|||
160845132|NCT03364309|580819717|FG012|Maintenance Period|Miscellaneous|0|||
160845133|NCT03364309|580819718|FG013|Maintenance Period|Miscellaneous|0|||
160845134|NCT03364309|580819719|FG014|Maintenance Period|Miscellaneous|0|||
160845135|NCT03364309|580819720|FG015|Maintenance Period|Miscellaneous|0|||
160845136|NCT03364309|580819721|FG016|Maintenance Period|Miscellaneous|0|||
160845137|NCT03364309|580819722|FG017|Maintenance Period|Miscellaneous|0|||
160845138|NCT03364309|580819723|FG018|Maintenance Period|Miscellaneous|0|||
160845139|NCT03364309|580819705|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845140|NCT03364309|580819706|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845141|NCT03364309|580819707|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845142|NCT03364309|580819708|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160649870|NCT01688037|580098975|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
160845143|NCT03364309|580819709|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845144|NCT03364309|580819710|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845145|NCT03364309|580819711|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160566904|NCT02034123|579797566|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566905|NCT02034123|579797567|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
160566906|NCT02034123|579797568|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
160566907|NCT02034123|579797569|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566908|NCT02034123|579797570|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566909|NCT02034123|579797571|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566910|NCT02034123|579797572|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566911|NCT02034123|579797573|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566912|NCT02034123|579797574|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566913|NCT02034123|579797575|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566914|NCT02034123|579797576|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566915|NCT02034123|579797577|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
160566916|NCT02034123|579797560|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566917|NCT02034123|579797561|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566918|NCT02034123|579797562|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566919|NCT02034123|579797563|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
160566920|NCT02034123|579797564|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566921|NCT02034123|579797565|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566922|NCT02034123|579797566|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566923|NCT02034123|579797567|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566924|NCT02034123|579797568|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566925|NCT02034123|579797569|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566926|NCT02034123|579797570|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566927|NCT02034123|579797571|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566928|NCT02034123|579797572|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566929|NCT02034123|579797573|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566930|NCT02034123|579797574|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566931|NCT02034123|579797575|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566932|NCT02034123|579797576|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566933|NCT02034123|579797577|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
160566934|NCT02034123|579797560|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566935|NCT02034123|579797561|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566936|NCT02034123|579797562|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566937|NCT02034123|579797563|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566938|NCT02034123|579797564|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160992356|NCT05567159|581360031|FG000|Overall Study|Physician Decision|3|||
160566939|NCT02034123|579797565|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566940|NCT02034123|579797566|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566941|NCT02034123|579797567|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566942|NCT02034123|579797568|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
160566943|NCT02034123|579797569|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566944|NCT02034123|579797570|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566945|NCT02034123|579797571|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566946|NCT02034123|579797572|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566947|NCT02034123|579797573|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566948|NCT02034123|579797574|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566949|NCT02034123|579797575|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566950|NCT02034123|579797576|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566951|NCT02034123|579797577|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
160566952|NCT02034123|579797560|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566953|NCT02034123|579797561|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566954|NCT02034123|579797562|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566955|NCT02034123|579797563|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
160566956|NCT02034123|579797564|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
160566957|NCT02034123|579797565|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566958|NCT02034123|579797566|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566959|NCT02034123|579797567|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566960|NCT02034123|579797568|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160905991|NCT02340975|581050340|FG002|Overall Study|Lost to Follow-up|0|||
160905992|NCT02340975|581050341|FG003|Overall Study|Lost to Follow-up|0|||
160905993|NCT02340975|581050342|FG004|Overall Study|Lost to Follow-up|2|||
160905994|NCT02340975|581050343|FG005|Overall Study|Lost to Follow-up|0|||
160905995|NCT02340975|581050338|FG000|Overall Study|Withdrawal by Subject|0|||
160905996|NCT02340975|581050339|FG001|Overall Study|Withdrawal by Subject|0|||
160566961|NCT02034123|579797569|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566962|NCT02034123|579797570|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566963|NCT02034123|579797571|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566964|NCT02034123|579797572|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566965|NCT02034123|579797573|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566966|NCT02034123|579797574|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566967|NCT02034123|579797575|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566968|NCT02034123|579797576|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566969|NCT02034123|579797577|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
160566970|NCT00246259|579797578|FG000|Overall Study|Other|3|||
160566971|NCT00246259|579797579|FG001|Overall Study|Other|3|||
160566972|NCT00246259|579797578|FG000|Overall Study|Not stable by Week 18|2|||
160566973|NCT00246259|579797579|FG001|Overall Study|Not stable by Week 18|1|||
160566974|NCT00246259|579797578|FG000|Overall Study|Participant non-compliant|4|||
160566975|NCT00246259|579797579|FG001|Overall Study|Participant non-compliant|9|||
160566976|NCT00246259|579797578|FG000|Overall Study|Lack of Efficacy|2|||
160566977|NCT00246259|579797579|FG001|Overall Study|Lack of Efficacy|2|||
160566978|NCT00246259|579797578|FG000|Overall Study|Investigator withdrew participant|2|||
160566979|NCT00246259|579797579|FG001|Overall Study|Investigator withdrew participant|0|||
160566980|NCT00246259|579797578|FG000|Overall Study|Adverse Event|5|||
160566981|NCT00246259|579797579|FG001|Overall Study|Adverse Event|0|||
160566982|NCT00246259|579797578|FG000|Overall Study|Lost to Follow-up|3|||
160566983|NCT00246259|579797579|FG001|Overall Study|Lost to Follow-up|4|||
160566984|NCT00246259|579797578|FG000|Overall Study|Withdrawal by Subject|5|||
160566985|NCT00246259|579797579|FG001|Overall Study|Withdrawal by Subject|1|||
160566986|NCT00246259|579797578|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
160566987|NCT00246259|579797579|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
160566988|NCT04233424|579797580|FG000|Overall Study|Death|15|||
160566989|NCT04233424|579797581|FG001|Overall Study|Death|16|||
160566990|NCT04233424|579797580|FG000|Overall Study|Withdrawal by Subject|2|||
160566991|NCT04233424|579797581|FG001|Overall Study|Withdrawal by Subject|8|||
160566992|NCT04233424|579797580|FG000|Overall Study|Physician Decision|1|||
160566993|NCT04233424|579797581|FG001|Overall Study|Physician Decision|3|||
160566994|NCT04233424|579797580|FG000|Overall Study|Protocol Violation|3|||
160566995|NCT04233424|579797581|FG001|Overall Study|Protocol Violation|1|||
160566996|NCT04233424|579797580|FG000|Overall Study|Lost to Follow-up|1|||
160566997|NCT04233424|579797581|FG001|Overall Study|Lost to Follow-up|3|||
160845146|NCT03364309|580819712|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845147|NCT03364309|580819713|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845148|NCT03364309|580819714|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845149|NCT03364309|580819715|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845150|NCT03364309|580819716|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845151|NCT03364309|580819717|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845152|NCT03364309|580819718|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
160845153|NCT03364309|580819719|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
160845154|NCT03364309|580819720|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
160845155|NCT03364309|580819721|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845156|NCT03364309|580819722|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845157|NCT03364309|580819723|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845158|NCT03364309|580819705|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845159|NCT03364309|580819706|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845160|NCT03364309|580819707|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845161|NCT03364309|580819708|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845162|NCT03364309|580819709|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845163|NCT03364309|580819710|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845164|NCT03364309|580819711|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845165|NCT03364309|580819712|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845166|NCT03364309|580819713|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845167|NCT03364309|580819714|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845168|NCT03364309|580819715|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845169|NCT03364309|580819716|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845170|NCT03364309|580819717|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845171|NCT03364309|580819718|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845172|NCT03364309|580819719|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
160845173|NCT03364309|580819720|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
160566998|NCT04233424|579797580|FG000|Overall Study|subject refuse to visit site|2|||
160649871|NCT01688037|580098976|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
160566999|NCT04233424|579797581|FG001|Overall Study|subject refuse to visit site|0|||
160567000|NCT02698189|579797582|FG000|Overall Study|Physician Decision|3|||
160567001|NCT02698189|579797583|FG001|Overall Study|Physician Decision|0|||
160567002|NCT02698189|579797582|FG000|Overall Study|Progressive disease|0|||
160649872|NCT01688037|580098977|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
160649873|NCT01688037|580098975|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
160649874|NCT01688037|580098976|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
160649875|NCT01688037|580098977|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
160649876|NCT01688037|580098975|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
160649877|NCT01688037|580098976|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
160649878|NCT01688037|580098977|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
160649879|NCT01688037|580098975|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
160649880|NCT01688037|580098976|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
160649881|NCT01688037|580098977|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
160649882|NCT01688037|580098975|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
160649883|NCT01688037|580098976|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
160845174|NCT03364309|580819721|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845175|NCT03364309|580819722|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845176|NCT03364309|580819723|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845177|NCT03364309|580819705|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
160845178|NCT03364309|580819706|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
160845179|NCT03364309|580819707|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
160845180|NCT03364309|580819708|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
160845181|NCT03364309|580819709|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
160845182|NCT03364309|580819710|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
160845183|NCT03364309|580819711|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
160845184|NCT03364309|580819712|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
160845185|NCT03364309|580819713|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
160845186|NCT03364309|580819714|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
160845187|NCT03364309|580819715|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
160845188|NCT03364309|580819716|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
160845189|NCT03364309|580819717|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
160845190|NCT03364309|580819718|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
160845191|NCT03364309|580819719|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
160845192|NCT03364309|580819720|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
160845193|NCT03364309|580819721|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
160845194|NCT03364309|580819722|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
160845195|NCT03364309|580819723|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
160845196|NCT03364309|580819705|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845197|NCT03364309|580819706|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845198|NCT03364309|580819707|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845199|NCT03364309|580819708|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845200|NCT03364309|580819709|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845201|NCT03364309|580819710|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845202|NCT03364309|580819711|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845203|NCT03364309|580819712|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845204|NCT03364309|580819713|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845205|NCT03364309|580819714|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845206|NCT03364309|580819715|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845207|NCT03364309|580819716|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845208|NCT03364309|580819717|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845209|NCT03364309|580819718|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845210|NCT03364309|580819719|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845211|NCT03364309|580819720|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845212|NCT03364309|580819721|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
160845213|NCT03364309|580819722|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
160845214|NCT03364309|580819723|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
160845215|NCT03364309|580819705|FG000|Post-Treatment Followup Period|Adverse Event|0|||
160845216|NCT03364309|580819706|FG001|Post-Treatment Followup Period|Adverse Event|0|||
160845217|NCT03364309|580819707|FG002|Post-Treatment Followup Period|Adverse Event|0|||
160845218|NCT03364309|580819708|FG003|Post-Treatment Followup Period|Adverse Event|0|||
160845219|NCT03364309|580819709|FG004|Post-Treatment Followup Period|Adverse Event|0|||
160845220|NCT03364309|580819710|FG005|Post-Treatment Followup Period|Adverse Event|0|||
160845221|NCT03364309|580819711|FG006|Post-Treatment Followup Period|Adverse Event|0|||
160845222|NCT03364309|580819712|FG007|Post-Treatment Followup Period|Adverse Event|0|||
160845223|NCT03364309|580819713|FG008|Post-Treatment Followup Period|Adverse Event|0|||
160992357|NCT05567159|581360031|FG000|Overall Study|Protocol deviation|1|||
160992358|NCT04155424|581360033|FG000|Overall Study|Other than specified|3|||
160649884|NCT01688037|580098977|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
160649885|NCT04680052|580100409|FG000|Overall Study|Ongoing|244|||
160845224|NCT03364309|580819714|FG009|Post-Treatment Followup Period|Adverse Event|0|||
160845225|NCT03364309|580819715|FG010|Post-Treatment Followup Period|Adverse Event|0|||
160845226|NCT03364309|580819716|FG011|Post-Treatment Followup Period|Adverse Event|0|||
160992359|NCT04155424|581360033|FG000|Overall Study|Withdrawal by Subject|1|||
160567003|NCT02698189|579797583|FG001|Overall Study|Progressive disease|5|||
160567004|NCT02698189|579797582|FG000|Overall Study|Study terminated by sponsor|0|||
160567005|NCT02698189|579797583|FG001|Overall Study|Study terminated by sponsor|1|||
160567006|NCT02240706|579797584|FG000|Overall Study|Lack of Efficacy|2|||
160567007|NCT02240706|579797585|FG001|Overall Study|Lack of Efficacy|2|||
160567008|NCT02240706|579797586|FG002|Overall Study|Lack of Efficacy|2|||
160567009|NCT02240706|579797587|FG003|Overall Study|Lack of Efficacy|2|||
160567010|NCT02240706|579797588|FG004|Overall Study|Lack of Efficacy|5|||
160567011|NCT02240706|579797589|FG005|Overall Study|Lack of Efficacy|0|||
160567012|NCT02240706|579797590|FG006|Overall Study|Lack of Efficacy|0|||
160567013|NCT02240706|579797584|FG000|Overall Study|Adverse Event|1|||
160567014|NCT02240706|579797585|FG001|Overall Study|Adverse Event|0|||
160567015|NCT02240706|579797586|FG002|Overall Study|Adverse Event|1|||
160567016|NCT02240706|579797587|FG003|Overall Study|Adverse Event|0|||
160567017|NCT02240706|579797588|FG004|Overall Study|Adverse Event|2|||
160567018|NCT02240706|579797589|FG005|Overall Study|Adverse Event|0|||
160567019|NCT02240706|579797590|FG006|Overall Study|Adverse Event|0|||
160567020|NCT02240706|579797584|FG000|Overall Study|Progressive disease|0|||
160567021|NCT02240706|579797585|FG001|Overall Study|Progressive disease|0|||
160567022|NCT02240706|579797586|FG002|Overall Study|Progressive disease|0|||
160567023|NCT02240706|579797587|FG003|Overall Study|Progressive disease|0|||
160567024|NCT02240706|579797588|FG004|Overall Study|Progressive disease|1|||
160567025|NCT02240706|579797589|FG005|Overall Study|Progressive disease|0|||
160567026|NCT02240706|579797590|FG006|Overall Study|Progressive disease|0|||
160567027|NCT02240706|579797584|FG000|Overall Study|Dose limiting toxicity|0|||
160567028|NCT02240706|579797585|FG001|Overall Study|Dose limiting toxicity|0|||
160567029|NCT02240706|579797586|FG002|Overall Study|Dose limiting toxicity|0|||
160567030|NCT02240706|579797587|FG003|Overall Study|Dose limiting toxicity|0|||
160567031|NCT02240706|579797588|FG004|Overall Study|Dose limiting toxicity|1|||
160567032|NCT02240706|579797589|FG005|Overall Study|Dose limiting toxicity|0|||
160567033|NCT02240706|579797590|FG006|Overall Study|Dose limiting toxicity|0|||
160567034|NCT02240706|579797584|FG000|Overall Study|Refused to continue taking medication|0|||
160567035|NCT02240706|579797585|FG001|Overall Study|Refused to continue taking medication|1|||
160567036|NCT02240706|579797586|FG002|Overall Study|Refused to continue taking medication|3|||
160567037|NCT02240706|579797587|FG003|Overall Study|Refused to continue taking medication|1|||
160567038|NCT02240706|579797588|FG004|Overall Study|Refused to continue taking medication|2|||
160567039|NCT02240706|579797589|FG005|Overall Study|Refused to continue taking medication|0|||
160567040|NCT02240706|579797590|FG006|Overall Study|Refused to continue taking medication|0|||
160567041|NCT02240706|579797584|FG000|Overall Study|Insurance billing concerns|0|||
160567042|NCT02240706|579797585|FG001|Overall Study|Insurance billing concerns|0|||
160567043|NCT02240706|579797586|FG002|Overall Study|Insurance billing concerns|0|||
160567044|NCT02240706|579797587|FG003|Overall Study|Insurance billing concerns|1|||
160567045|NCT02240706|579797588|FG004|Overall Study|Insurance billing concerns|0|||
160567046|NCT02240706|579797589|FG005|Overall Study|Insurance billing concerns|0|||
160567047|NCT02240706|579797590|FG006|Overall Study|Insurance billing concerns|0|||
160567048|NCT00855439|579797595|FG000|Overall Study|Withdrawal by Subject|2|||
160567049|NCT00855439|579797596|FG001|Overall Study|Withdrawal by Subject|0|||
160567050|NCT00855439|579797595|FG000|Overall Study|Pregnancy|1|||
160567051|NCT00855439|579797596|FG001|Overall Study|Pregnancy|0|||
160567052|NCT05502289|579797597|FG000|Period 1|Out Of Window|1|||
160567053|NCT05502289|579797598|FG001|Period 1|Out Of Window|0|||
160567054|NCT02333227|579797606|FG000|Overall Study|Lost to Follow-up|137|||
160567055|NCT02333227|579797607|FG001|Overall Study|Lost to Follow-up|106|||
160567056|NCT02333227|579797606|FG000|Overall Study|Pregnancy Interrupted|42|||
160567057|NCT02333227|579797607|FG001|Overall Study|Pregnancy Interrupted|89|||
160567058|NCT02333227|579797606|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
160567059|NCT02333227|579797607|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
160567060|NCT01564784|579797608|FG000|Overall Study|Other|1|||
160567061|NCT01564784|579797609|FG001|Overall Study|Other|0|||
160567062|NCT01564784|579797608|FG000|Overall Study|Subject refused further follow-up|1|||
160567063|NCT01564784|579797609|FG001|Overall Study|Subject refused further follow-up|6|||
160567064|NCT01564784|579797608|FG000|Overall Study|Lost to Follow-up|1|||
160567065|NCT01564784|579797609|FG001|Overall Study|Lost to Follow-up|1|||
160567066|NCT01564784|579797608|FG000|Overall Study|Death|131|||
160845227|NCT03364309|580819717|FG012|Post-Treatment Followup Period|Adverse Event|0|||
160845228|NCT03364309|580819718|FG013|Post-Treatment Followup Period|Adverse Event|0|||
160845229|NCT03364309|580819719|FG014|Post-Treatment Followup Period|Adverse Event|0|||
160567067|NCT01564784|579797609|FG001|Overall Study|Death|126|||
160567068|NCT01076179|579797612|FG000|Overall Study|Withdrawal by Subject|1|||
160567069|NCT03459040|579797613|FG000|Overall Study|Death|8|||
160567070|NCT03459040|579797613|FG000|Overall Study|Withdrawal by Subject|1|||
160567071|NCT00986349|579797614|FG000|Overall Study|Unsuccessful implant procedure|3|||
160567072|NCT00986349|579797614|FG000|Overall Study|Adverse Event|2|||
160567073|NCT00986349|579797614|FG000|Overall Study|Physician Decision|1|||
160567074|NCT00986349|579797614|FG000|Overall Study|device migration|1|||
160567075|NCT02299934|579797615|FG000|Overall Study|Termination of study|13|||
160649886|NCT04680052|580100410|FG001|Overall Study|Ongoing|229|||
160649887|NCT04680052|580100411|FG002|Overall Study|Ongoing|39|||
160649888|NCT04680052|580100412|FG003|Overall Study|Ongoing|46|||
160649889|NCT04680052|580100409|FG000|Overall Study|Death|15|||
160649890|NCT04680052|580100410|FG001|Overall Study|Death|22|||
160649891|NCT04680052|580100411|FG002|Overall Study|Death|7|||
160649892|NCT04680052|580100412|FG003|Overall Study|Death|1|||
160649893|NCT04680052|580100409|FG000|Overall Study|Lost to Follow-up|3|||
160649894|NCT04680052|580100410|FG001|Overall Study|Lost to Follow-up|2|||
160649895|NCT04680052|580100411|FG002|Overall Study|Lost to Follow-up|0|||
160649896|NCT04680052|580100412|FG003|Overall Study|Lost to Follow-up|1|||
160649897|NCT04680052|580100409|FG000|Overall Study|Withdrawal by Subject|11|||
160649898|NCT04680052|580100410|FG001|Overall Study|Withdrawal by Subject|19|||
160649899|NCT04680052|580100411|FG002|Overall Study|Withdrawal by Subject|7|||
160649900|NCT04680052|580100412|FG003|Overall Study|Withdrawal by Subject|5|||
160649901|NCT04680052|580100409|FG000|Overall Study|Missing|0|||
160649902|NCT04680052|580100410|FG001|Overall Study|Missing|1|||
160649903|NCT04680052|580100411|FG002|Overall Study|Missing|0|||
160649904|NCT04680052|580100412|FG003|Overall Study|Missing|0|||
160649905|NCT04680052|580100409|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
160649906|NCT04680052|580100410|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
160567076|NCT01273818|579797616|FG000|Overall Study|Physician Decision|13|||
160567077|NCT01273818|579797617|FG001|Overall Study|Physician Decision|2|||
160567078|NCT01273818|579797618|FG002|Overall Study|Physician Decision|9|||
160567079|NCT03815175|579797619|FG000|Overall Study|Subject Lost to Follow-up|6|||
160567080|NCT03815175|579797619|FG000|Overall Study|Subject Withdrew Consent|48|||
160567081|NCT03815175|579797619|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
160567082|NCT03815175|579797619|FG000|Overall Study|Death|86|||
160567083|NCT03815175|579797619|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
160567084|NCT03815175|579797619|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
160567085|NCT03815175|579797619|FG000|Overall Study|Other Status Change Reason|1|||
160567086|NCT03815175|579797619|FG000|Overall Study|Missed Visit|12|||
160567087|NCT03577990|579797620|FG000|Overall Study|Lost to Follow-up|4|||
160567088|NCT03577990|579797621|FG001|Overall Study|Lost to Follow-up|6|||
160567089|NCT03577990|579797620|FG000|Overall Study|Withdrawal by Subject|4|||
160567090|NCT03577990|579797621|FG001|Overall Study|Withdrawal by Subject|7|||
160567091|NCT00488631|579797626|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
160567092|NCT00488631|579797627|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
160567093|NCT00488631|579797628|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
160567094|NCT00488631|579797629|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
160567095|NCT00488631|579797630|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
160567096|NCT00488631|579797631|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
160567097|NCT00488631|579797632|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
160567098|NCT00488631|579797633|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
160567099|NCT00488631|579797634|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
160567100|NCT00488631|579797635|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
160567101|NCT00488631|579797626|FG000|Double Blind Period (Week 0-54)|Death|0|||
160567102|NCT00488631|579797627|FG001|Double Blind Period (Week 0-54)|Death|0|||
160567103|NCT00488631|579797628|FG002|Double Blind Period (Week 0-54)|Death|0|||
160567104|NCT00488631|579797629|FG003|Double Blind Period (Week 0-54)|Death|0|||
160567105|NCT00488631|579797630|FG004|Double Blind Period (Week 0-54)|Death|0|||
160567106|NCT00488631|579797631|FG005|Double Blind Period (Week 0-54)|Death|1|||
160567107|NCT00488631|579797632|FG006|Double Blind Period (Week 0-54)|Death|0|||
160567108|NCT00488631|579797633|FG007|Double Blind Period (Week 0-54)|Death|0|||
160567109|NCT00488631|579797634|FG008|Double Blind Period (Week 0-54)|Death|0|||
160567110|NCT00488631|579797635|FG009|Double Blind Period (Week 0-54)|Death|0|||
160567111|NCT00488631|579797626|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
160567112|NCT00488631|579797627|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
160567113|NCT00488631|579797628|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
160567114|NCT00488631|579797629|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
160567115|NCT00488631|579797630|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
160567116|NCT00488631|579797631|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
160567117|NCT00488631|579797632|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
160649907|NCT04680052|580100411|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
160649908|NCT04680052|580100412|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
160649909|NCT04680052|580100409|FG000|Overall Study|Physician Decision|0|||
160649910|NCT04680052|580100410|FG001|Overall Study|Physician Decision|1|||
160567118|NCT00488631|579797633|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
160567119|NCT00488631|579797634|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
160567120|NCT00488631|579797635|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
160649911|NCT04680052|580100411|FG002|Overall Study|Physician Decision|0|||
160649912|NCT04680052|580100412|FG003|Overall Study|Physician Decision|0|||
160649913|NCT00759148|580100414|FG000|Overall Study|Adverse Event|1|||
160649914|NCT00759148|580100415|FG001|Overall Study|Adverse Event|6|||
160567121|NCT00488631|579797626|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
160567122|NCT00488631|579797627|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
160567123|NCT00488631|579797628|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
160567124|NCT00488631|579797629|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
160567125|NCT00488631|579797630|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
160567126|NCT00488631|579797631|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
160567127|NCT00488631|579797632|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
160567128|NCT00488631|579797633|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
160567129|NCT00488631|579797634|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
160567130|NCT00488631|579797635|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
160567131|NCT00488631|579797626|FG000|Double Blind Period (Week 0-54)|Other|6|||
160567132|NCT00488631|579797627|FG001|Double Blind Period (Week 0-54)|Other|12|||
160567133|NCT00488631|579797628|FG002|Double Blind Period (Week 0-54)|Other|10|||
160567134|NCT00488631|579797629|FG003|Double Blind Period (Week 0-54)|Other|11|||
160567135|NCT00488631|579797630|FG004|Double Blind Period (Week 0-54)|Other|14|||
160567136|NCT00488631|579797631|FG005|Double Blind Period (Week 0-54)|Other|34|||
160567137|NCT00488631|579797632|FG006|Double Blind Period (Week 0-54)|Other|0|||
160567138|NCT00488631|579797633|FG007|Double Blind Period (Week 0-54)|Other|0|||
160567139|NCT00488631|579797634|FG008|Double Blind Period (Week 0-54)|Other|0|||
160567140|NCT00488631|579797635|FG009|Double Blind Period (Week 0-54)|Other|0|||
160567141|NCT00488631|579797626|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
160567142|NCT00488631|579797627|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
160567143|NCT00488631|579797628|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
160567144|NCT00488631|579797629|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
160567145|NCT00488631|579797630|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
160567146|NCT00488631|579797631|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
160567147|NCT00488631|579797632|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
160567148|NCT00488631|579797633|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
160567149|NCT00488631|579797634|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
160567150|NCT00488631|579797635|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
160567151|NCT00488631|579797626|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
160567152|NCT00488631|579797627|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
160567153|NCT00488631|579797628|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
160567154|NCT00488631|579797629|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
160567155|NCT00488631|579797630|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
160567156|NCT00488631|579797631|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
160567157|NCT00488631|579797632|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
160567158|NCT00488631|579797633|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
160567159|NCT00488631|579797634|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
160567160|NCT00488631|579797635|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
160567161|NCT00488631|579797626|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
160567162|NCT00488631|579797627|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
160567163|NCT00488631|579797628|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
160567164|NCT00488631|579797629|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
160567165|NCT00488631|579797630|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
160567166|NCT00488631|579797631|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
160567167|NCT00488631|579797632|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
160567168|NCT00488631|579797633|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
160567169|NCT00488631|579797634|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
160845230|NCT03364309|580819720|FG015|Post-Treatment Followup Period|Adverse Event|0|||
160845231|NCT03364309|580819721|FG016|Post-Treatment Followup Period|Adverse Event|2|||
160845232|NCT03364309|580819722|FG017|Post-Treatment Followup Period|Adverse Event|6|||
160567170|NCT00488631|579797635|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
160845233|NCT03364309|580819723|FG018|Post-Treatment Followup Period|Adverse Event|1|||
160845234|NCT03364309|580819705|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845235|NCT03364309|580819706|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845236|NCT03364309|580819707|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845237|NCT03364309|580819708|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845238|NCT03364309|580819709|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845239|NCT03364309|580819710|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845240|NCT03364309|580819711|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845241|NCT03364309|580819712|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845242|NCT03364309|580819713|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845243|NCT03364309|580819714|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845244|NCT03364309|580819715|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845245|NCT03364309|580819716|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845246|NCT03364309|580819717|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
160567171|NCT00488631|579797626|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
160567172|NCT00488631|579797627|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
160567173|NCT00488631|579797628|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
160567174|NCT00488631|579797629|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
160567175|NCT00488631|579797630|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
160567176|NCT00488631|579797631|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
160567177|NCT00488631|579797632|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
160567178|NCT00488631|579797633|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
160567179|NCT00488631|579797634|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
160567180|NCT00488631|579797635|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
160567181|NCT00488631|579797626|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
160567182|NCT00488631|579797627|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
160567183|NCT00488631|579797628|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
160567184|NCT00488631|579797629|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
160567185|NCT00488631|579797630|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
160567186|NCT00488631|579797631|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
160567187|NCT00488631|579797632|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
160567188|NCT00488631|579797633|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
160567189|NCT00488631|579797634|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
160567190|NCT00488631|579797635|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
160567191|NCT00761215|579797636|FG000|Overall Study|Randomized but didn't receive drug|1|||
160567192|NCT00761215|579797637|FG001|Overall Study|Randomized but didn't receive drug|1|||
160567193|NCT00761215|579797638|FG002|Overall Study|Randomized but didn't receive drug|2|||
160567194|NCT00761215|579797636|FG000|Overall Study|Lost to Follow-up|6|||
160567195|NCT00761215|579797637|FG001|Overall Study|Lost to Follow-up|3|||
160567196|NCT00761215|579797638|FG002|Overall Study|Lost to Follow-up|6|||
160567197|NCT00761215|579797636|FG000|Overall Study|Withdrawal by Subject|1|||
160567198|NCT00761215|579797637|FG001|Overall Study|Withdrawal by Subject|0|||
160567199|NCT00761215|579797638|FG002|Overall Study|Withdrawal by Subject|0|||
160567200|NCT00761215|579797636|FG000|Overall Study|Bacteremia|1|||
160567201|NCT00761215|579797637|FG001|Overall Study|Bacteremia|0|||
160567202|NCT00761215|579797638|FG002|Overall Study|Bacteremia|0|||
160567203|NCT01331161|579797644|FG000|Overall Study|Physician Decision|1|||
160567204|NCT01331161|579797645|FG001|Overall Study|Physician Decision|0|||
160567205|NCT01331161|579797644|FG000|Overall Study|Lost to Follow-up|0|||
160567206|NCT01331161|579797645|FG001|Overall Study|Lost to Follow-up|1|||
160567207|NCT01331161|579797644|FG000|Overall Study|Pregnancy|0|||
160567208|NCT01331161|579797645|FG001|Overall Study|Pregnancy|1|||
160567209|NCT02770807|579797648|FG000|Overall Study|Adverse Event|3|||
160567210|NCT02770807|579797649|FG001|Overall Study|Adverse Event|3|||
160567211|NCT02770807|579797650|FG002|Overall Study|Adverse Event|1|||
160567212|NCT02770807|579797648|FG000|Overall Study|Withdrawal by Subject|7|||
160567213|NCT02770807|579797649|FG001|Overall Study|Withdrawal by Subject|3|||
160567214|NCT02770807|579797650|FG002|Overall Study|Withdrawal by Subject|4|||
160567215|NCT02770807|579797648|FG000|Overall Study|Other|0|||
160567216|NCT02770807|579797649|FG001|Overall Study|Other|1|||
160567217|NCT02770807|579797650|FG002|Overall Study|Other|0|||
160567218|NCT02770807|579797648|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
160567219|NCT02770807|579797649|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
160567220|NCT02770807|579797650|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
160567221|NCT02770807|579797648|FG000|Overall Study|Physician Decision|0|||
160567222|NCT02770807|579797649|FG001|Overall Study|Physician Decision|0|||
160567223|NCT02770807|579797650|FG002|Overall Study|Physician Decision|1|||
160567224|NCT00222105|579797653|FG000|Overall Study|Removed due to wrong diagnosis|1|||
160567225|NCT00222105|579797653|FG000|Overall Study|Withdrawal by Subject|1|||
160567226|NCT00222105|579797653|FG000|Overall Study|Adverse Event|8|||
160567227|NCT00222105|579797653|FG000|Overall Study|Treatment delays|2|||
160567228|NCT00222105|579797653|FG000|Overall Study|Death|2|||
160567229|NCT01084252|579800012|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567230|NCT01084252|579800013|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567231|NCT01084252|579800014|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160845247|NCT03364309|580819718|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
160567232|NCT01084252|579800015|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567233|NCT01084252|579800016|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567234|NCT01084252|579800017|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567235|NCT01084252|579800018|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567236|NCT01084252|579800019|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567237|NCT01084252|579800020|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567238|NCT01084252|579800021|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567239|NCT01084252|579800022|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567240|NCT01084252|579800023|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567241|NCT01084252|579800024|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
160567242|NCT01084252|579800025|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
160567243|NCT00853632|579800026|FG000|Overall Study|Death|88|||
160567244|NCT00853632|579800026|FG000|Overall Study|Withdrawal by Subject|45|||
160567245|NCT00853632|579800026|FG000|Overall Study|Lost to Follow-up|30|||
160567246|NCT00853632|579800026|FG000|Overall Study|Reoperation/Explant|17|||
160567247|NCT00853632|579800026|FG000|Overall Study|Exit with other reason|22|||
160567248|NCT02342171|579800029|FG000|Overall Study|Death|4|||
160567249|NCT02342171|579800030|FG001|Overall Study|Death|87|||
160567250|NCT02342171|579800029|FG000|Overall Study|Received favipiravir|10|||
160567251|NCT02342171|579800030|FG001|Overall Study|Received favipiravir|0|||
160567252|NCT02342171|579800029|FG000|Overall Study|Missing cycle treshold value|1|||
160567253|NCT02342171|579800030|FG001|Overall Study|Missing cycle treshold value|0|||
160567254|NCT02342171|579800029|FG000|Overall Study|Unknown outcome|0|||
160567255|NCT02342171|579800030|FG001|Overall Study|Unknown outcome|1|||
160567256|NCT02342171|579800029|FG000|Overall Study|Missing age data|0|||
160567257|NCT02342171|579800030|FG001|Overall Study|Missing age data|1|||
160567258|NCT00875420|579800031|FG000|Overall Study|Adverse Event|0|||
160567259|NCT00875420|579800032|FG001|Overall Study|Adverse Event|1|||
160567260|NCT00875420|579800033|FG002|Overall Study|Adverse Event|1|||
160567261|NCT00875420|579800034|FG003|Overall Study|Adverse Event|0|||
160567262|NCT00875420|579800035|FG004|Overall Study|Adverse Event|0|||
160567263|NCT00875420|579800031|FG000|Overall Study|Inability to complete study procedures|1|||
160567264|NCT00875420|579800032|FG001|Overall Study|Inability to complete study procedures|0|||
160845248|NCT03364309|580819719|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845249|NCT03364309|580819720|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845250|NCT03364309|580819721|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845251|NCT03364309|580819722|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
160567265|NCT00875420|579800033|FG002|Overall Study|Inability to complete study procedures|1|||
160567266|NCT00875420|579800034|FG003|Overall Study|Inability to complete study procedures|1|||
160567267|NCT00875420|579800035|FG004|Overall Study|Inability to complete study procedures|1|||
160567268|NCT00875420|579800031|FG000|Overall Study|Lost to Follow-up|1|||
160567269|NCT00875420|579800032|FG001|Overall Study|Lost to Follow-up|0|||
160567270|NCT00875420|579800033|FG002|Overall Study|Lost to Follow-up|0|||
160845252|NCT03364309|580819723|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845253|NCT03364309|580819705|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
160845254|NCT03364309|580819706|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
160845255|NCT03364309|580819707|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
160845256|NCT03364309|580819708|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
160845257|NCT03364309|580819709|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
160845258|NCT03364309|580819710|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
160845259|NCT03364309|580819711|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
160845260|NCT03364309|580819712|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
160845261|NCT03364309|580819713|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
160845262|NCT03364309|580819714|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
160845263|NCT03364309|580819715|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
160845264|NCT03364309|580819716|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
160845265|NCT03364309|580819717|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
160845266|NCT03364309|580819718|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
160845267|NCT03364309|580819719|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
160845268|NCT03364309|580819720|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
160845269|NCT03364309|580819721|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
160845270|NCT03364309|580819722|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
160845271|NCT03364309|580819723|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
160845272|NCT01371552|580819724|FG000|Part 1, First 3 Days|Inconvenience|0|||
160845273|NCT01371552|580819725|FG001|Part 1, First 3 Days|Inconvenience|0|||
160845274|NCT01371552|580819726|FG002|Part 1, First 3 Days|Inconvenience|1|||
160845275|NCT01371552|580819727|FG003|Part 1, First 3 Days|Inconvenience|0|||
160845276|NCT01371552|580819728|FG004|Part 1, First 3 Days|Inconvenience|0|||
160845277|NCT01371552|580819729|FG005|Part 1, First 3 Days|Inconvenience|0|||
160845278|NCT00167310|580819730|FG000|Overall Study|Protocol Violation|5|||
160845279|NCT00167310|580819731|FG001|Overall Study|Protocol Violation|3|||
160845280|NCT00167310|580819730|FG000|Overall Study|Withdrawal by Subject|3|||
160845281|NCT00167310|580819731|FG001|Overall Study|Withdrawal by Subject|7|||
160845282|NCT00615992|580819732|FG000|Overall Study|Protocol Violation|67|||
160567271|NCT00875420|579800034|FG003|Overall Study|Lost to Follow-up|0|||
160567272|NCT00875420|579800035|FG004|Overall Study|Lost to Follow-up|0|||
160567273|NCT00875420|579800031|FG000|Overall Study|Personal reason|0|||
160567274|NCT00875420|579800032|FG001|Overall Study|Personal reason|0|||
160845283|NCT04522141|580819734|FG000|Overall Study|Withdrawal by Subject|1|||
160845284|NCT04522141|580819735|FG001|Overall Study|Withdrawal by Subject|0|||
160845285|NCT03052049|580819736|FG000|Overall Study|Withdrawal by Subject|2|||
160845286|NCT02328027|580819737|FG000|Overall Study|Withdrawal by Subject|0|||
160845287|NCT02328027|580819738|FG001|Overall Study|Withdrawal by Subject|1|||
160649915|NCT00759148|580100414|FG000|Overall Study|Withdrawal by Subject|3|||
160649916|NCT00759148|580100415|FG001|Overall Study|Withdrawal by Subject|7|||
160649917|NCT00759148|580100414|FG000|Overall Study|Lost to Follow-up|3|||
160649918|NCT00759148|580100415|FG001|Overall Study|Lost to Follow-up|9|||
160649919|NCT00759148|580100414|FG000|Overall Study|Treatment Failure|6|||
160649920|NCT00759148|580100415|FG001|Overall Study|Treatment Failure|10|||
160649921|NCT00759148|580100414|FG000|Overall Study|Reason not given|1|||
160649922|NCT00759148|580100415|FG001|Overall Study|Reason not given|0|||
160845288|NCT03319212|580819739|FG000|Overall Study|Discontinued as moving out of local area|0|||
160845289|NCT03319212|580819740|FG001|Overall Study|Discontinued as moving out of local area|1|||
160845290|NCT03319212|580819739|FG000|Overall Study|Adverse Event|2|||
160845291|NCT03319212|580819740|FG001|Overall Study|Adverse Event|2|||
160845292|NCT03319212|580819739|FG000|Overall Study|Withdrawal by Subject|0|||
160845293|NCT03319212|580819740|FG001|Overall Study|Withdrawal by Subject|1|||
160845294|NCT03319212|580819739|FG000|Overall Study|Lost to Follow-up|0|||
160845295|NCT03319212|580819740|FG001|Overall Study|Lost to Follow-up|1|||
160845296|NCT03319212|580819739|FG000|Overall Study|Physician Decision|1|||
160845297|NCT03319212|580819740|FG001|Overall Study|Physician Decision|0|||
160845298|NCT01868477|580819741|FG000|Overall Study|Adverse Event|2|||
160845299|NCT01868477|580819742|FG001|Overall Study|Adverse Event|4|||
160845300|NCT01868477|580819741|FG000|Overall Study|Disease progression|1|||
160845301|NCT01868477|580819742|FG001|Overall Study|Disease progression|1|||
160845302|NCT01868477|580819741|FG000|Overall Study|Withdrawal by Subject|1|||
160845303|NCT01868477|580819742|FG001|Overall Study|Withdrawal by Subject|0|||
160845304|NCT02465203|580819743|FG000|Overall Study|Protocol Violation|1|||
160845305|NCT02465203|580819744|FG001|Overall Study|Protocol Violation|1|||
160845306|NCT02465203|580819745|FG002|Overall Study|Protocol Violation|1|||
160845307|NCT02465203|580819743|FG000|Overall Study|Study terminated by sponsor|50|||
160845308|NCT02465203|580819744|FG001|Overall Study|Study terminated by sponsor|34|||
160567275|NCT00875420|579800033|FG002|Overall Study|Personal reason|0|||
160567276|NCT00875420|579800034|FG003|Overall Study|Personal reason|0|||
160567277|NCT00875420|579800035|FG004|Overall Study|Personal reason|1|||
160567278|NCT00875420|579800031|FG000|Overall Study|Prohibited medication|0|||
160567279|NCT00875420|579800032|FG001|Overall Study|Prohibited medication|0|||
160567280|NCT00875420|579800033|FG002|Overall Study|Prohibited medication|0|||
160567281|NCT00875420|579800034|FG003|Overall Study|Prohibited medication|1|||
160567282|NCT00875420|579800035|FG004|Overall Study|Prohibited medication|0|||
160567283|NCT00875420|579800031|FG000|Overall Study|Sponsor decision|0|||
160567284|NCT00875420|579800032|FG001|Overall Study|Sponsor decision|1|||
160567285|NCT00875420|579800033|FG002|Overall Study|Sponsor decision|0|||
160567286|NCT00875420|579800034|FG003|Overall Study|Sponsor decision|0|||
160567287|NCT00875420|579800035|FG004|Overall Study|Sponsor decision|0|||
160567288|NCT00875420|579800031|FG000|Overall Study|Withdrawal by Subject|0|||
160567289|NCT00875420|579800032|FG001|Overall Study|Withdrawal by Subject|0|||
160567290|NCT00875420|579800033|FG002|Overall Study|Withdrawal by Subject|1|||
160567291|NCT00875420|579800034|FG003|Overall Study|Withdrawal by Subject|0|||
160567292|NCT00875420|579800035|FG004|Overall Study|Withdrawal by Subject|0|||
160567293|NCT00886821|579800036|FG000|Stage 2|Adverse Event|0|||
160567294|NCT00886821|579800037|FG001|Stage 2|Adverse Event|0|||
160567295|NCT00886821|579800038|FG002|Stage 2|Adverse Event|0|||
160567296|NCT00886821|579800039|FG003|Stage 2|Adverse Event|0|||
160567297|NCT00886821|579800040|FG004|Stage 2|Adverse Event|0|||
160567298|NCT00886821|579800041|FG005|Stage 2|Adverse Event|0|||
160567299|NCT00886821|579800042|FG006|Stage 2|Adverse Event|0|||
160567300|NCT00886821|579800043|FG007|Stage 2|Adverse Event|0|||
160567301|NCT00886821|579800044|FG008|Stage 2|Adverse Event|0|||
160567302|NCT00886821|579800045|FG009|Stage 2|Adverse Event|0|||
160567303|NCT00886821|579800046|FG010|Stage 2|Adverse Event|0|||
160567304|NCT00886821|579800047|FG011|Stage 2|Adverse Event|1|||
160567305|NCT00886821|579800048|FG012|Stage 2|Adverse Event|3|||
160567306|NCT00886821|579800049|FG013|Stage 2|Adverse Event|0|||
160845309|NCT02465203|580819745|FG002|Overall Study|Study terminated by sponsor|11|||
160845310|NCT02465203|580819743|FG000|Overall Study|New therapy for study indication|4|||
160845311|NCT02465203|580819744|FG001|Overall Study|New therapy for study indication|0|||
160567307|NCT00886821|579800036|FG000|Stage 2|Lost to Follow-up|0|||
160567308|NCT00886821|579800037|FG001|Stage 2|Lost to Follow-up|0|||
160567309|NCT00886821|579800038|FG002|Stage 2|Lost to Follow-up|0|||
160567310|NCT00886821|579800039|FG003|Stage 2|Lost to Follow-up|0|||
160567311|NCT00886821|579800040|FG004|Stage 2|Lost to Follow-up|0|||
160567312|NCT00886821|579800041|FG005|Stage 2|Lost to Follow-up|0|||
160567313|NCT00886821|579800042|FG006|Stage 2|Lost to Follow-up|0|||
160567314|NCT00886821|579800043|FG007|Stage 2|Lost to Follow-up|0|||
160567315|NCT00886821|579800044|FG008|Stage 2|Lost to Follow-up|0|||
160649923|NCT01073020|580100416|FG000|Overall Study|Withdrawal by Subject|6|||
160845312|NCT02465203|580819745|FG002|Overall Study|New therapy for study indication|0|||
160845313|NCT02465203|580819743|FG000|Overall Study|Patient/guardian decision|1|||
160567316|NCT00886821|579800045|FG009|Stage 2|Lost to Follow-up|0|||
160992360|NCT04155424|581360033|FG000|Overall Study|Adverse Event|1|||
160567317|NCT00886821|579800046|FG010|Stage 2|Lost to Follow-up|0|||
160567318|NCT00886821|579800047|FG011|Stage 2|Lost to Follow-up|0|||
160649924|NCT01073020|580100417|FG001|Overall Study|Withdrawal by Subject|4|||
160649925|NCT01073020|580100418|FG002|Overall Study|Withdrawal by Subject|1|||
160649926|NCT01073020|580100419|FG003|Overall Study|Withdrawal by Subject|2|||
160649927|NCT01073020|580100416|FG000|Overall Study|Physician Decision|1|||
160649928|NCT01073020|580100417|FG001|Overall Study|Physician Decision|0|||
160649929|NCT01073020|580100418|FG002|Overall Study|Physician Decision|2|||
160649930|NCT01073020|580100419|FG003|Overall Study|Physician Decision|0|||
160649931|NCT01073020|580100416|FG000|Overall Study|Death|0|||
160649932|NCT01073020|580100417|FG001|Overall Study|Death|1|||
160649933|NCT01073020|580100418|FG002|Overall Study|Death|0|||
160649934|NCT01073020|580100419|FG003|Overall Study|Death|0|||
160649935|NCT00094302|580100422|FG000|Overall Study|Lost to Follow-up|43|||
160845314|NCT02465203|580819744|FG001|Overall Study|Patient/guardian decision|1|||
160845315|NCT02465203|580819745|FG002|Overall Study|Patient/guardian decision|1|||
160845316|NCT04072887|580819750|FG000|Overall Study|Withdrawal by Subject|3|||
160845317|NCT04072887|580819751|FG001|Overall Study|Withdrawal by Subject|8|||
160845318|NCT04072887|580819752|FG002|Overall Study|Withdrawal by Subject|1|||
160845319|NCT04072887|580819753|FG003|Overall Study|Withdrawal by Subject|3|||
160845320|NCT04072887|580819754|FG004|Overall Study|Withdrawal by Subject|3|||
160845321|NCT04072887|580819755|FG005|Overall Study|Withdrawal by Subject|13|||
160845322|NCT04072887|580819750|FG000|Overall Study|Adverse Event|2|||
160845323|NCT04072887|580819751|FG001|Overall Study|Adverse Event|4|||
160845324|NCT04072887|580819752|FG002|Overall Study|Adverse Event|1|||
160845325|NCT04072887|580819753|FG003|Overall Study|Adverse Event|4|||
160845326|NCT04072887|580819754|FG004|Overall Study|Adverse Event|0|||
160845327|NCT04072887|580819755|FG005|Overall Study|Adverse Event|1|||
160845328|NCT04072887|580819750|FG000|Overall Study|Physician Decision|2|||
160845329|NCT04072887|580819751|FG001|Overall Study|Physician Decision|0|||
160845330|NCT04072887|580819752|FG002|Overall Study|Physician Decision|0|||
160845331|NCT04072887|580819753|FG003|Overall Study|Physician Decision|0|||
160845332|NCT04072887|580819754|FG004|Overall Study|Physician Decision|0|||
160845333|NCT04072887|580819755|FG005|Overall Study|Physician Decision|1|||
160845334|NCT04072887|580819750|FG000|Overall Study|Lost to Follow-up|1|||
160845335|NCT04072887|580819751|FG001|Overall Study|Lost to Follow-up|3|||
160845336|NCT04072887|580819752|FG002|Overall Study|Lost to Follow-up|0|||
160845337|NCT04072887|580819753|FG003|Overall Study|Lost to Follow-up|0|||
160845338|NCT04072887|580819754|FG004|Overall Study|Lost to Follow-up|0|||
160845339|NCT04072887|580819755|FG005|Overall Study|Lost to Follow-up|0|||
160845340|NCT04072887|580819750|FG000|Overall Study|Death|0|||
160845341|NCT04072887|580819751|FG001|Overall Study|Death|2|||
160845342|NCT04072887|580819752|FG002|Overall Study|Death|0|||
160845343|NCT04072887|580819753|FG003|Overall Study|Death|2|||
160845344|NCT04072887|580819754|FG004|Overall Study|Death|3|||
160845345|NCT04072887|580819755|FG005|Overall Study|Death|0|||
160845346|NCT01153724|580819758|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160649936|NCT00094302|580100423|FG001|Overall Study|Lost to Follow-up|41|||
160649937|NCT00094302|580100422|FG000|Overall Study|Physician Decision|5|||
160649938|NCT00094302|580100423|FG001|Overall Study|Physician Decision|8|||
160649939|NCT00094302|580100422|FG000|Overall Study|Withdrawal by Subject|103|||
160649940|NCT00094302|580100423|FG001|Overall Study|Withdrawal by Subject|111|||
160649941|NCT00094302|580100422|FG000|Overall Study|Death|266|||
160649942|NCT00094302|580100423|FG001|Overall Study|Death|246|||
160649943|NCT02761980|580100428|FG000|Overall Study|Adverse Event|4|||
160649944|NCT02761980|580100429|FG001|Overall Study|Adverse Event|6|||
160649945|NCT02761980|580100430|FG002|Overall Study|Adverse Event|5|||
160649946|NCT02761980|580100431|FG003|Overall Study|Adverse Event|6|||
160649947|NCT02761980|580100428|FG000|Overall Study|Withdrawal by Subject|0|||
160649948|NCT02761980|580100429|FG001|Overall Study|Withdrawal by Subject|1|||
160845347|NCT01153724|580819758|FG000|Treatment Period 2|Adverse Event|1|||
160845348|NCT01153724|580819758|FG000|Treatment Period 2|Other reason not defined above|1|||
160845349|NCT04371666|580819763|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
160845350|NCT04371666|580819764|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
160905997|NCT02340975|581050340|FG002|Overall Study|Withdrawal by Subject|3|||
160905998|NCT02340975|581050341|FG003|Overall Study|Withdrawal by Subject|3|||
160845351|NCT04371666|580819763|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
160845352|NCT04371666|580819764|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
160905999|NCT02340975|581050342|FG004|Overall Study|Withdrawal by Subject|2|||
160649949|NCT02761980|580100430|FG002|Overall Study|Withdrawal by Subject|0|||
160649950|NCT02761980|580100431|FG003|Overall Study|Withdrawal by Subject|0|||
160649951|NCT02761980|580100428|FG000|Overall Study|Other|0|||
160649952|NCT02761980|580100429|FG001|Overall Study|Other|0|||
160649953|NCT02761980|580100430|FG002|Overall Study|Other|1|||
160649954|NCT02761980|580100431|FG003|Overall Study|Other|0|||
160649955|NCT01907087|580100432|FG000|Overall Study|Withdrawal by Subject|1|||
160649956|NCT01919190|580100433|FG000|Overall Study|Intra-op findings, etc.|3|||
160845353|NCT04371666|580819763|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
160845354|NCT04371666|580819764|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
160845355|NCT04371666|580819763|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
160845356|NCT04371666|580819764|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
160845357|NCT04371666|580819763|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
160845358|NCT04371666|580819764|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
160845359|NCT04371666|580819763|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
160845360|NCT04371666|580819764|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
160845361|NCT00445770|580819765|FG000|Overall Study|Adverse Event|9|||
160992361|NCT00662909|581360034|FG000|Overall Study|Adverse Event|17|||
160992362|NCT00662909|581360035|FG001|Overall Study|Adverse Event|18|||
160992363|NCT00662909|581360036|FG002|Overall Study|Adverse Event|19|||
160992364|NCT00662909|581360034|FG000|Overall Study|Lack of Efficacy|9|||
160992365|NCT00662909|581360035|FG001|Overall Study|Lack of Efficacy|1|||
160992366|NCT00662909|581360036|FG002|Overall Study|Lack of Efficacy|5|||
160992367|NCT00662909|581360034|FG000|Overall Study|Withdrawal by Subject|29|||
160992368|NCT00662909|581360035|FG001|Overall Study|Withdrawal by Subject|22|||
160992369|NCT00662909|581360036|FG002|Overall Study|Withdrawal by Subject|16|||
160992370|NCT00662909|581360034|FG000|Overall Study|Lost to Follow-up|2|||
160992371|NCT00662909|581360035|FG001|Overall Study|Lost to Follow-up|9|||
160992372|NCT00662909|581360036|FG002|Overall Study|Lost to Follow-up|3|||
160567319|NCT00886821|579800048|FG012|Stage 2|Lost to Follow-up|2|||
160567320|NCT00886821|579800049|FG013|Stage 2|Lost to Follow-up|1|||
160567321|NCT00914628|579800050|FG000|Overall Study|Death|35|||
160567322|NCT00914628|579800051|FG001|Overall Study|Death|17|||
160567323|NCT00914628|579800050|FG000|Overall Study|Medical decision|4|||
160567324|NCT00914628|579800051|FG001|Overall Study|Medical decision|0|||
160567325|NCT00914628|579800050|FG000|Overall Study|Protocol Violation|1|||
160567326|NCT00914628|579800051|FG001|Overall Study|Protocol Violation|0|||
160567327|NCT00914628|579800050|FG000|Overall Study|Lack of Efficacy|1|||
160567328|NCT00914628|579800051|FG001|Overall Study|Lack of Efficacy|0|||
160567329|NCT00914628|579800050|FG000|Overall Study|non-randomized|1|||
160567330|NCT00914628|579800051|FG001|Overall Study|non-randomized|0|||
160567331|NCT00914628|579800050|FG000|Overall Study|Relapse|1|||
160567332|NCT00914628|579800051|FG001|Overall Study|Relapse|2|||
160567333|NCT00914628|579800050|FG000|Overall Study|Study terminated by Sponsor|14|||
160567334|NCT00914628|579800051|FG001|Overall Study|Study terminated by Sponsor|8|||
160567335|NCT00914628|579800050|FG000|Overall Study|Patients who did not receive a single dose|7|||
160567336|NCT00914628|579800051|FG001|Overall Study|Patients who did not receive a single dose|1|||
160567337|NCT03716726|579800052|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
160567338|NCT03716726|579800053|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
160567339|NCT03716726|579800052|FG000|12 Months Followup|Lost to Follow-up|10|||
160567340|NCT03716726|579800053|FG001|12 Months Followup|Lost to Follow-up|17|||
160567341|NCT02579603|579800054|FG000|Overall Study|Not treated|1|||
160567342|NCT02579603|579800055|FG001|Overall Study|Not treated|0|||
160567343|NCT02579603|579800054|FG000|Overall Study|Adverse Event|2|||
160567344|NCT02579603|579800055|FG001|Overall Study|Adverse Event|2|||
160567345|NCT02579603|579800054|FG000|Overall Study|Other than stated|1|||
160567346|NCT02579603|579800055|FG001|Overall Study|Other than stated|0|||
160567347|NCT00469079|579800056|FG000|Overall Study|Lack of Efficacy|3|||
160567348|NCT00469079|579800057|FG001|Overall Study|Lack of Efficacy|8|||
160567349|NCT00469079|579800058|FG002|Overall Study|Lack of Efficacy|5|||
160567350|NCT00469079|579800056|FG000|Overall Study|Adverse Event|1|||
160567351|NCT00469079|579800057|FG001|Overall Study|Adverse Event|3|||
160567352|NCT00469079|579800058|FG002|Overall Study|Adverse Event|2|||
160567353|NCT00469079|579800056|FG000|Overall Study|Lost to Follow-up|4|||
160567354|NCT00469079|579800057|FG001|Overall Study|Lost to Follow-up|8|||
160567355|NCT00469079|579800058|FG002|Overall Study|Lost to Follow-up|10|||
160567356|NCT00469079|579800056|FG000|Overall Study|Withdrawal by Subject|1|||
160567357|NCT00469079|579800057|FG001|Overall Study|Withdrawal by Subject|2|||
160567358|NCT00469079|579800058|FG002|Overall Study|Withdrawal by Subject|2|||
160567359|NCT00469079|579800056|FG000|Overall Study|Ineligible|0|||
160567360|NCT00469079|579800057|FG001|Overall Study|Ineligible|1|||
160567361|NCT00469079|579800058|FG002|Overall Study|Ineligible|0|||
160992373|NCT00662909|581360034|FG000|Overall Study|Protocol Violation|7|||
160567362|NCT00942162|579800059|FG000|Overall Study|Death|45|||
160992374|NCT00662909|581360035|FG001|Overall Study|Protocol Violation|4|||
160567363|NCT00942162|579800060|FG001|Overall Study|Death|35|||
160567364|NCT00942162|579800061|FG002|Overall Study|Death|0|||
160567365|NCT00942162|579800059|FG000|Overall Study|Withdrawal by Subject|7|||
160567366|NCT00942162|579800060|FG001|Overall Study|Withdrawal by Subject|2|||
160567367|NCT00942162|579800061|FG002|Overall Study|Withdrawal by Subject|0|||
160567368|NCT00942162|579800059|FG000|Overall Study|Lost to Follow-up|4|||
160992375|NCT00662909|581360036|FG002|Overall Study|Protocol Violation|5|||
160567369|NCT00942162|579800060|FG001|Overall Study|Lost to Follow-up|0|||
160567370|NCT00942162|579800061|FG002|Overall Study|Lost to Follow-up|0|||
160567371|NCT00942162|579800059|FG000|Overall Study|Other|14|||
160567372|NCT00942162|579800060|FG001|Overall Study|Other|13|||
160567373|NCT00942162|579800061|FG002|Overall Study|Other|2|||
160567374|NCT01006356|579800062|FG000|Overall Study|Adverse Event|6|||
160567375|NCT01006356|579800062|FG000|Overall Study|Physician Decision|1|||
160845362|NCT00445770|580819766|FG001|Overall Study|Adverse Event|15|||
160845363|NCT00445770|580819767|FG002|Overall Study|Adverse Event|19|||
160845364|NCT00445770|580819765|FG000|Overall Study|Lack of Efficacy|38|||
160845365|NCT00445770|580819766|FG001|Overall Study|Lack of Efficacy|13|||
160845366|NCT00445770|580819767|FG002|Overall Study|Lack of Efficacy|6|||
160845367|NCT00445770|580819765|FG000|Overall Study|Lost to Follow-up|0|||
160845368|NCT00445770|580819766|FG001|Overall Study|Lost to Follow-up|2|||
160845369|NCT00445770|580819767|FG002|Overall Study|Lost to Follow-up|0|||
160845370|NCT00445770|580819765|FG000|Overall Study|Other|6|||
160845371|NCT00445770|580819766|FG001|Overall Study|Other|5|||
160845372|NCT00445770|580819767|FG002|Overall Study|Other|6|||
160567376|NCT01006356|579800062|FG000|Overall Study|Paticipants did not cooperate|6|||
160567377|NCT01006356|579800062|FG000|Overall Study|Withdrawal by Subject|1|||
160567378|NCT01006356|579800062|FG000|Overall Study|Choice by participants|2|||
160567379|NCT01006356|579800062|FG000|Overall Study|Protocol Violation|3|||
160567380|NCT01006356|579800062|FG000|Overall Study|Other|23|||
160567381|NCT02981472|579800067|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
160567382|NCT02981472|579800068|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
160567383|NCT02981472|579800067|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
160567384|NCT02981472|579800068|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160567385|NCT02981472|579800067|FG000|Treatment Period|Adverse Event|6|||
160567386|NCT02981472|579800068|FG001|Treatment Period|Adverse Event|1|||
160567387|NCT02981472|579800067|FG000|Treatment Period|Participant withdrew consent|1|||
160567388|NCT02981472|579800068|FG001|Treatment Period|Participant withdrew consent|0|||
160567389|NCT02981472|579800067|FG000|Treatment Period|Lost to Follow-up|0|||
160567390|NCT02981472|579800068|FG001|Treatment Period|Lost to Follow-up|1|||
160567391|NCT01756157|579800071|FG000|First Intervention Period|Withdrawal by Subject|1|||
160567392|NCT01756157|579800072|FG001|First Intervention Period|Withdrawal by Subject|0|||
160567393|NCT01756157|579800071|FG000|First Intervention Period|Lost to Follow-up|0|||
160567394|NCT01756157|579800072|FG001|First Intervention Period|Lost to Follow-up|2|||
160567395|NCT02799381|579800075|FG000|Overall Study|Withdrew consent|3|||
160567396|NCT02799381|579800076|FG001|Overall Study|Withdrew consent|2|||
160567397|NCT02799381|579800075|FG000|Overall Study|Adverse Event|0|||
160567398|NCT02799381|579800076|FG001|Overall Study|Adverse Event|1|||
160845373|NCT02092025|580819768|FG000|Overall Study|Case Report Forms Uncollected|44|||
160845374|NCT02092025|580819768|FG000|Overall Study|Protocol Deviation|24|||
160845375|NCT02927938|580819769|FG000|Overall Study|Death|0|||
160845376|NCT02927938|580819770|FG001|Overall Study|Death|1|||
160845377|NCT02927938|580819771|FG002|Overall Study|Death|0|||
160845378|NCT02927938|580819772|FG003|Overall Study|Death|4|||
160845379|NCT02927938|580819769|FG000|Overall Study|Early Study Termination|1|||
160845380|NCT02927938|580819770|FG001|Overall Study|Early Study Termination|5|||
160845381|NCT02927938|580819771|FG002|Overall Study|Early Study Termination|4|||
160845382|NCT02927938|580819772|FG003|Overall Study|Early Study Termination|3|||
160845383|NCT00934128|580819773|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
160845384|NCT00934128|580819774|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
160845385|NCT00934128|580819773|FG000|First Intervention (2 Hours)|Adverse Event|4|||
160845386|NCT00934128|580819774|FG001|First Intervention (2 Hours)|Adverse Event|1|||
160845387|NCT00934128|580819773|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
160845388|NCT00934128|580819774|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
160845389|NCT00934128|580819773|FG000|Washout Period (1 Hour)|Patient preference|1|||
160845390|NCT00934128|580819774|FG001|Washout Period (1 Hour)|Patient preference|3|||
160845391|NCT00934128|580819773|FG000|Washout Period (1 Hour)|Pain|1|||
160845392|NCT00934128|580819774|FG001|Washout Period (1 Hour)|Pain|0|||
160845393|NCT00934128|580819773|FG000|Washout Period (1 Hour)|Too tired|1|||
160845394|NCT00934128|580819774|FG001|Washout Period (1 Hour)|Too tired|0|||
160845395|NCT00934128|580819773|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
160845396|NCT00934128|580819774|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
160845397|NCT00934128|580819773|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
160845398|NCT00934128|580819774|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
160906000|NCT02340975|581050343|FG005|Overall Study|Withdrawal by Subject|0|||
160567399|NCT02799381|579800075|FG000|Overall Study|Participant did not take any study drug|1|||
160567400|NCT02799381|579800076|FG001|Overall Study|Participant did not take any study drug|0|||
160567401|NCT03368859|579800079|FG000|Overall Study|Withdrew Consent|5|||
160845399|NCT02834247|580819775|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
160845400|NCT02834247|580819776|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
160845401|NCT02834247|580819777|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
160845402|NCT02834247|580819778|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
160845403|NCT02834247|580819775|FG000|Dose Escalation Phase|Death|5|||
160845404|NCT02834247|580819776|FG001|Dose Escalation Phase|Death|6|||
160845405|NCT02834247|580819777|FG002|Dose Escalation Phase|Death|5|||
160845406|NCT02834247|580819778|FG003|Dose Escalation Phase|Death|0|||
160845407|NCT02834247|580819775|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
160845408|NCT02834247|580819776|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
160845409|NCT02834247|580819777|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
160845410|NCT02834247|580819778|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
160845411|NCT02834247|580819775|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
160845412|NCT02834247|580819776|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
160845413|NCT02834247|580819777|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
160845414|NCT02834247|580819778|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160845415|NCT02834247|580819775|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
160845416|NCT02834247|580819776|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
160845417|NCT02834247|580819777|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
160845418|NCT02834247|580819778|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
160845419|NCT02834247|580819775|FG000|Dose Expansion Phase|Death|0|||
160845420|NCT02834247|580819776|FG001|Dose Expansion Phase|Death|0|||
160845421|NCT02834247|580819777|FG002|Dose Expansion Phase|Death|0|||
160845422|NCT02834247|580819778|FG003|Dose Expansion Phase|Death|8|||
160845423|NCT02834247|580819775|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
160845424|NCT02834247|580819776|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
160845425|NCT02834247|580819777|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
160845426|NCT02834247|580819778|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
160845427|NCT02834247|580819775|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
160567402|NCT03368859|579800080|FG001|Overall Study|Withdrew Consent|4|||
160567403|NCT03368859|579800079|FG000|Overall Study|Death|12|||
160567404|NCT03368859|579800080|FG001|Overall Study|Death|6|||
160567405|NCT03368859|579800079|FG000|Overall Study|Study terminated by Sponsor|18|||
160567406|NCT03368859|579800080|FG001|Overall Study|Study terminated by Sponsor|23|||
160567407|NCT03368859|579800079|FG000|Overall Study|Other|1|||
160567408|NCT03368859|579800080|FG001|Overall Study|Other|1|||
160845428|NCT02834247|580819776|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
160845429|NCT02834247|580819777|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
160845430|NCT02834247|580819778|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
160845431|NCT01807299|580819785|FG000|Overall Study|Protocol Violation|3|||
160845432|NCT01807299|580819786|FG001|Overall Study|Protocol Violation|1|||
160845433|NCT01807299|580819787|FG002|Overall Study|Protocol Violation|0|||
160845434|NCT01807299|580819788|FG003|Overall Study|Protocol Violation|2|||
160845435|NCT02476006|580819789|FG000|Overall Study|Death|4|||
160845436|NCT02476006|580819789|FG000|Overall Study|Lack of treatment efficacy|2|||
160845437|NCT02476006|580819789|FG000|Overall Study|Pregnancy|1|||
160845438|NCT02476006|580819789|FG000|Overall Study|Participant did not wish to continue|39|||
160845439|NCT02476006|580819789|FG000|Overall Study|Adverse Event|41|||
160845440|NCT02476006|580819789|FG000|Overall Study|Poor compliance to study protocol|3|||
160845441|NCT02476006|580819789|FG000|Overall Study|Sponsor decision|6|||
160845442|NCT02476006|580819789|FG000|Overall Study|Lost to Follow-up|5|||
160845443|NCT02476006|580819789|FG000|Overall Study|Physician Decision|5|||
160845444|NCT02476006|580819789|FG000|Overall Study|Study ended treatment not available|4|||
160845445|NCT02476006|580819789|FG000|Overall Study|Switched to commercial drug|4|||
160845446|NCT02476006|580819789|FG000|Overall Study|Excluded from study|1|||
160845447|NCT02476006|580819789|FG000|Overall Study|Protocol Violation|1|||
160845448|NCT02476006|580819789|FG000|Overall Study|Enrolled but not treated|4|||
160845449|NCT00811174|580819790|FG000|Overall Study|Protocol Violation|2|||
160845450|NCT00811174|580819790|FG000|Overall Study|Sponsors Decision|1|||
160845451|NCT01410890|580821119|FG000|Overall Study|Withdrawal by Subject|0|||
160845452|NCT01410890|580821120|FG001|Overall Study|Withdrawal by Subject|1|||
160845453|NCT00412893|580821121|FG000|Overall Study|Adverse Event|31|||
160845454|NCT00412893|580821122|FG001|Overall Study|Adverse Event|53|||
160845455|NCT00412893|580821121|FG000|Overall Study|Death|17|||
160845456|NCT00412893|580821122|FG001|Overall Study|Death|21|||
160567409|NCT02698410|579800081|FG000|Overall Study|Adverse Event|2|||
160567410|NCT02698410|579800081|FG000|Overall Study|Withdrawal by Subject|1|||
160567411|NCT02698410|579800081|FG000|Overall Study|Other|1|||
160567412|NCT03952130|579800082|FG000|Overall Study|Adverse Event|0|||
160567413|NCT03952130|579800083|FG001|Overall Study|Adverse Event|1|||
160567414|NCT03952130|579800082|FG000|Overall Study|Lost to Follow-up|1|||
160845457|NCT00412893|580821121|FG000|Overall Study|Insufficient Therapeutic Response|39|||
160845458|NCT00412893|580821122|FG001|Overall Study|Insufficient Therapeutic Response|23|||
160845459|NCT00412893|580821121|FG000|Overall Study|Lost to Follow-up|2|||
160845460|NCT00412893|580821122|FG001|Overall Study|Lost to Follow-up|1|||
160845461|NCT00412893|580821121|FG000|Overall Study|Violation of Selection at Entry|17|||
160845462|NCT00412893|580821122|FG001|Overall Study|Violation of Selection at Entry|10|||
160845463|NCT00412893|580821121|FG000|Overall Study|Other Protocol Violation|10|||
160845464|NCT00412893|580821122|FG001|Overall Study|Other Protocol Violation|6|||
160845465|NCT00412893|580821121|FG000|Overall Study|Did Not Cooperate|12|||
160845466|NCT00412893|580821122|FG001|Overall Study|Did Not Cooperate|9|||
160845467|NCT00412893|580821121|FG000|Overall Study|Administrative Reason|12|||
160567415|NCT03952130|579800083|FG001|Overall Study|Lost to Follow-up|0|||
160845468|NCT00412893|580821122|FG001|Overall Study|Administrative Reason|15|||
160567416|NCT03952130|579800082|FG000|Overall Study|Withdrawal by Subject|1|||
160567417|NCT03952130|579800083|FG001|Overall Study|Withdrawal by Subject|5|||
160649957|NCT01919190|580100434|FG001|Overall Study|Intra-op findings, etc.|0|||
160649958|NCT03355742|580100435|FG000|Overall Study|Lost to Follow-up|4|||
160649959|NCT03355742|580100435|FG000|Overall Study|Withdrawal by Subject|29|||
160649960|NCT03355742|580100435|FG000|Overall Study|Physician Decision|6|||
160649961|NCT03355742|580100435|FG000|Overall Study|Death|55|||
160649962|NCT03355742|580100435|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
160649963|NCT00812253|580100439|FG000|Overall Study|Withdrawal by Subject|3|||
160649964|NCT00812253|580100440|FG001|Overall Study|Withdrawal by Subject|2|||
160649965|NCT00812253|580100439|FG000|Overall Study|Protocol Violation|1|||
160649966|NCT00812253|580100440|FG001|Overall Study|Protocol Violation|1|||
160649967|NCT00812253|580100439|FG000|Overall Study|Lost to Follow-up|2|||
160649968|NCT00812253|580100440|FG001|Overall Study|Lost to Follow-up|0|||
160845469|NCT00412893|580821121|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
160845470|NCT00412893|580821122|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
160845471|NCT03951077|580821123|FG000|Overall Study|Adverse Event|1|||
160845472|NCT03951077|580821124|FG001|Overall Study|Adverse Event|0|||
160845473|NCT03951077|580821125|FG002|Overall Study|Adverse Event|0|||
160845474|NCT03951077|580821126|FG003|Overall Study|Adverse Event|0|||
160845475|NCT03951077|580821127|FG004|Overall Study|Adverse Event|0|||
160845476|NCT03951077|580821128|FG005|Overall Study|Adverse Event|0|||
160845477|NCT03951077|580821123|FG000|Overall Study|Withdrawal by Subject|3|||
160845478|NCT03951077|580821124|FG001|Overall Study|Withdrawal by Subject|3|||
160845479|NCT03951077|580821125|FG002|Overall Study|Withdrawal by Subject|0|||
160845480|NCT03951077|580821126|FG003|Overall Study|Withdrawal by Subject|3|||
160845481|NCT03951077|580821127|FG004|Overall Study|Withdrawal by Subject|3|||
160845482|NCT03951077|580821128|FG005|Overall Study|Withdrawal by Subject|2|||
160845483|NCT03951077|580821123|FG000|Overall Study|Lost to Follow-up|1|||
160845484|NCT03951077|580821124|FG001|Overall Study|Lost to Follow-up|1|||
160845485|NCT03951077|580821125|FG002|Overall Study|Lost to Follow-up|2|||
160845486|NCT03951077|580821126|FG003|Overall Study|Lost to Follow-up|3|||
160845487|NCT03951077|580821127|FG004|Overall Study|Lost to Follow-up|2|||
160845488|NCT03951077|580821128|FG005|Overall Study|Lost to Follow-up|3|||
160845489|NCT03951077|580821123|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
160845490|NCT03951077|580821124|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
160845491|NCT03951077|580821125|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
160845492|NCT03951077|580821126|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
160567418|NCT01713348|579800084|FG000|Overall Study|Withdrawal by Subject|3|||
160567419|NCT01713348|579800085|FG001|Overall Study|Withdrawal by Subject|2|||
160567420|NCT01713348|579800086|FG002|Overall Study|Withdrawal by Subject|2|||
160567421|NCT01713348|579800087|FG003|Overall Study|Withdrawal by Subject|0|||
160567422|NCT01713348|579800084|FG000|Overall Study|Lost to Follow-up|1|||
160567423|NCT01713348|579800085|FG001|Overall Study|Lost to Follow-up|0|||
160567424|NCT01713348|579800086|FG002|Overall Study|Lost to Follow-up|0|||
160567425|NCT01713348|579800087|FG003|Overall Study|Lost to Follow-up|0|||
160567426|NCT02638012|579800090|FG000|Overall Study|Lost to Follow-up|1|||
160567427|NCT00621023|579800092|FG000|Overall Study|Death|5|||
160567428|NCT00621023|579800092|FG000|Overall Study|Follow up discontinued|1|||
160567429|NCT03199911|579800099|FG000|Overall Study|Lost to Follow-up|5|||
160567430|NCT03199911|579800100|FG001|Overall Study|Lost to Follow-up|5|||
160567431|NCT03199911|579800099|FG000|Overall Study|Did not proceed with surgery|2|||
160567432|NCT03199911|579800100|FG001|Overall Study|Did not proceed with surgery|1|||
160567433|NCT02559505|579800101|FG000|Overall Study|Lost to Follow-up|23|||
160567434|NCT02559505|579800102|FG001|Overall Study|Lost to Follow-up|20|||
160567435|NCT02559505|579800101|FG000|Overall Study|Withdrawal by Subject|4|||
160567436|NCT02559505|579800102|FG001|Overall Study|Withdrawal by Subject|2|||
160567437|NCT03523585|579800103|FG000|Overall Study|Progressive Disease|174|||
160567438|NCT03523585|579800104|FG001|Overall Study|Progressive Disease|64|||
160567439|NCT03523585|579800105|FG002|Overall Study|Progressive Disease|77|||
160567440|NCT03523585|579800103|FG000|Overall Study|Adverse Event|74|||
160567441|NCT03523585|579800104|FG001|Overall Study|Adverse Event|5|||
160567442|NCT03523585|579800105|FG002|Overall Study|Adverse Event|9|||
160845493|NCT03951077|580821127|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
160845494|NCT03951077|580821128|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
160845495|NCT03951077|580821123|FG000|Overall Study|Other, Not Specified|12|||
160567443|NCT03523585|579800103|FG000|Overall Study|Withdrawal by Subject|30|||
160567444|NCT03523585|579800104|FG001|Overall Study|Withdrawal by Subject|11|||
160567445|NCT03523585|579800105|FG002|Overall Study|Withdrawal by Subject|6|||
160567446|NCT03523585|579800103|FG000|Overall Study|Clinical Progression|23|||
160649969|NCT04903288|580100441|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
160649970|NCT04903288|580100441|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
160649971|NCT04903288|580100441|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
160567447|NCT03523585|579800104|FG001|Overall Study|Clinical Progression|5|||
160567448|NCT03523585|579800105|FG002|Overall Study|Clinical Progression|10|||
160567449|NCT03523585|579800103|FG000|Overall Study|Death|4|||
160567450|NCT03523585|579800104|FG001|Overall Study|Death|0|||
160567451|NCT03523585|579800105|FG002|Overall Study|Death|1|||
160567452|NCT03523585|579800103|FG000|Overall Study|Physician Decision|2|||
160567453|NCT03523585|579800104|FG001|Overall Study|Physician Decision|1|||
160567454|NCT03523585|579800105|FG002|Overall Study|Physician Decision|0|||
160567455|NCT03523585|579800103|FG000|Overall Study|Lost to Follow-up|1|||
160567456|NCT03523585|579800104|FG001|Overall Study|Lost to Follow-up|0|||
160567457|NCT03523585|579800105|FG002|Overall Study|Lost to Follow-up|0|||
160567458|NCT03523585|579800103|FG000|Overall Study|Miscellaneous|1|||
160567459|NCT03523585|579800104|FG001|Overall Study|Miscellaneous|0|||
160567460|NCT03523585|579800105|FG002|Overall Study|Miscellaneous|0|||
160567461|NCT03523585|579800103|FG000|Overall Study|Protocol Deviation|1|||
160567462|NCT03523585|579800104|FG001|Overall Study|Protocol Deviation|0|||
160567463|NCT03523585|579800105|FG002|Overall Study|Protocol Deviation|1|||
160567464|NCT03523585|579800103|FG000|Overall Study|Randomized But Not Treated|2|||
160567465|NCT03523585|579800104|FG001|Overall Study|Randomized But Not Treated|4|||
160567466|NCT03523585|579800105|FG002|Overall Study|Randomized But Not Treated|3|||
160567467|NCT00698516|579800106|FG000|Overall Study|Study Termination|2|||
160567468|NCT00698516|579800106|FG000|Overall Study|Withdrawal by Subject|3|||
160567469|NCT05882890|579800107|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
160567470|NCT04331899|579800118|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
160567471|NCT04331899|579800119|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
160567472|NCT01062399|579800122|FG000|Overall Study|Protocol Violation|0|||
160567473|NCT01062399|579800123|FG001|Overall Study|Protocol Violation|1|||
160567474|NCT01062399|579800124|FG002|Overall Study|Protocol Violation|0|||
160567475|NCT01062399|579800125|FG003|Overall Study|Protocol Violation|6|||
160567476|NCT01062399|579800126|FG004|Overall Study|Protocol Violation|4|||
160567477|NCT02424539|579800127|FG000|Overall Study|Adverse Event|0|||
160567478|NCT02424539|579800128|FG001|Overall Study|Adverse Event|0|||
160567479|NCT02424539|579800129|FG002|Overall Study|Adverse Event|1|||
160649972|NCT04903288|580100441|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
160649973|NCT00755326|580100446|FG000|Overall Study|Lost to Follow-up|2|||
160649974|NCT00755326|580100447|FG001|Overall Study|Lost to Follow-up|3|||
160649975|NCT02173704|580100448|FG000|Overall Study|Adverse Event|1|||
160649976|NCT02173704|580100449|FG001|Overall Study|Adverse Event|0|||
160649977|NCT02173704|580100448|FG000|Overall Study|Lost to Follow-up|1|||
160649978|NCT02173704|580100449|FG001|Overall Study|Lost to Follow-up|0|||
160649979|NCT02173704|580100448|FG000|Overall Study|Other|1|||
160649980|NCT02173704|580100449|FG001|Overall Study|Other|0|||
160649981|NCT02173704|580100448|FG000|Overall Study|Protocol Violation|1|||
160649982|NCT02173704|580100449|FG001|Overall Study|Protocol Violation|0|||
160649983|NCT02173704|580100448|FG000|Overall Study|Withdrawal by Subject|9|||
160845496|NCT03951077|580821124|FG001|Overall Study|Other, Not Specified|10|||
160845497|NCT03951077|580821125|FG002|Overall Study|Other, Not Specified|10|||
160845498|NCT03951077|580821126|FG003|Overall Study|Other, Not Specified|5|||
160845499|NCT03951077|580821127|FG004|Overall Study|Other, Not Specified|9|||
160845500|NCT03951077|580821128|FG005|Overall Study|Other, Not Specified|6|||
160845501|NCT03951077|580821123|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
160567480|NCT02424539|579800127|FG000|Overall Study|Physician Decision|0|||
160567481|NCT02424539|579800128|FG001|Overall Study|Physician Decision|0|||
160567482|NCT02424539|579800129|FG002|Overall Study|Physician Decision|1|||
160567483|NCT02424539|579800127|FG000|Overall Study|Withdrawal by Subject|3|||
160567484|NCT02424539|579800128|FG001|Overall Study|Withdrawal by Subject|1|||
160567485|NCT02424539|579800129|FG002|Overall Study|Withdrawal by Subject|0|||
160567486|NCT02424539|579800127|FG000|Overall Study|Other: Reached stopping criteria|11|||
160567487|NCT02424539|579800128|FG001|Overall Study|Other: Reached stopping criteria|7|||
160567488|NCT02424539|579800129|FG002|Overall Study|Other: Reached stopping criteria|6|||
160567489|NCT03090191|579800130|FG000|Overall Study|Adverse Event|90|||
160567490|NCT03090191|579800131|FG001|Overall Study|Adverse Event|72|||
160567491|NCT03090191|579800130|FG000|Overall Study|Death|365|||
160567492|NCT03090191|579800131|FG001|Overall Study|Death|358|||
160567493|NCT03090191|579800130|FG000|Overall Study|Lost to Follow-up|382|||
160567494|NCT03090191|579800131|FG001|Overall Study|Lost to Follow-up|394|||
160567495|NCT03090191|579800130|FG000|Overall Study|Physician Decision|77|||
160567496|NCT03090191|579800131|FG001|Overall Study|Physician Decision|66|||
160567497|NCT03090191|579800130|FG000|Overall Study|Protocol Violation|43|||
160567498|NCT03090191|579800131|FG001|Overall Study|Protocol Violation|52|||
160567499|NCT03090191|579800130|FG000|Overall Study|Withdrawal by Subject|2160|||
160567500|NCT03090191|579800131|FG001|Overall Study|Withdrawal by Subject|2133|||
160567501|NCT03090191|579800130|FG000|Overall Study|Site terminated|7|||
160567502|NCT03090191|579800131|FG001|Overall Study|Site terminated|8|||
160567503|NCT03090191|579800130|FG000|Overall Study|Other|66|||
160567504|NCT03090191|579800131|FG001|Overall Study|Other|60|||
160567505|NCT03090191|579800130|FG000|Overall Study|Withdrawn before any study vaccination|43|||
160567506|NCT03090191|579800131|FG001|Overall Study|Withdrawn before any study vaccination|52|||
160567507|NCT04645797|579800134|FG000|Overall Study|Disease Progression|3|||
160567508|NCT04645797|579800135|FG001|Overall Study|Disease Progression|3|||
160567509|NCT04645797|579800136|FG002|Overall Study|Disease Progression|1|||
160567510|NCT04645797|579800137|FG003|Overall Study|Disease Progression|0|||
160567511|NCT04645797|579800138|FG004|Overall Study|Disease Progression|0|||
160567512|NCT04645797|579800139|FG005|Overall Study|Disease Progression|0|||
160567513|NCT04645797|579800140|FG006|Overall Study|Disease Progression|0|||
160567514|NCT04645797|579800134|FG000|Overall Study|Death|3|||
160567515|NCT04645797|579800135|FG001|Overall Study|Death|1|||
160567516|NCT04645797|579800136|FG002|Overall Study|Death|0|||
160567517|NCT04645797|579800137|FG003|Overall Study|Death|0|||
160567518|NCT04645797|579800138|FG004|Overall Study|Death|0|||
160567519|NCT04645797|579800139|FG005|Overall Study|Death|0|||
160567520|NCT04645797|579800140|FG006|Overall Study|Death|0|||
160567521|NCT01931865|579800143|FG000|Overall Study|Lost to Follow-up|2|||
160649984|NCT02173704|580100449|FG001|Overall Study|Withdrawal by Subject|4|||
160649985|NCT04956666|580100450|FG000|Overall Study|Adverse Event|18|||
160845502|NCT03951077|580821124|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
160567522|NCT01931865|579800143|FG000|Overall Study|Withdrawal by Subject|2|||
160567523|NCT01121406|579800144|FG000|Overall Study|Progressive disease RECIST|44|||
160567524|NCT01121406|579800145|FG001|Overall Study|Progressive disease RECIST|28|||
160567525|NCT01121406|579800144|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
160567526|NCT01121406|579800145|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
160567527|NCT01121406|579800144|FG000|Overall Study|Other AE|3|||
160567528|NCT01121406|579800145|FG001|Overall Study|Other AE|10|||
160567529|NCT01121406|579800144|FG000|Overall Study|Non-compliant with protocol|0|||
160567530|NCT01121406|579800145|FG001|Overall Study|Non-compliant with protocol|2|||
160649986|NCT04956666|580100450|FG000|Overall Study|Physician Decision|5|||
160649987|NCT02623829|580100454|FG000|Overall Study|Lost to Follow-up|1|||
160649988|NCT02623829|580100455|FG001|Overall Study|Lost to Follow-up|1|||
160649989|NCT00662025|580100456|FG000|Overall Study|Objective progression or relapse|51|||
160845503|NCT03951077|580821125|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
160649990|NCT00662025|580100456|FG000|Overall Study|Adverse Event|7|||
160649991|NCT00662025|580100456|FG000|Overall Study|Withdrawal by Subject|1|||
160649992|NCT00662025|580100456|FG000|Overall Study|Results of other clinical study|2|||
160845504|NCT03951077|580821126|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
160845505|NCT03951077|580821127|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
160649993|NCT00662025|580100456|FG000|Overall Study|Target lesion cannot be evaluated|1|||
160649994|NCT00662025|580100456|FG000|Overall Study|Domestic circumstances|1|||
160845506|NCT03951077|580821128|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
160845507|NCT03579940|580821131|FG000|Period 2|Withdrawal by Subject|0|||
160845508|NCT03579940|580821132|FG001|Period 2|Withdrawal by Subject|0|||
160845509|NCT03579940|580821133|FG002|Period 2|Withdrawal by Subject|1|||
160845510|NCT03579940|580821134|FG003|Period 2|Withdrawal by Subject|0|||
160845511|NCT03579940|580821135|FG004|Period 2|Withdrawal by Subject|0|||
160649995|NCT01333033|580100460|FG000|Overall Study|Ineligible|0|||
160649996|NCT01333033|580100461|FG001|Overall Study|Ineligible|0|||
160649997|NCT01333033|580100462|FG002|Overall Study|Ineligible|0|||
160649998|NCT01333033|580100463|FG003|Overall Study|Ineligible|0|||
160649999|NCT01333033|580100464|FG004|Overall Study|Ineligible|6|||
160650000|NCT01333033|580100465|FG005|Overall Study|Ineligible|8|||
160650001|NCT01333033|580100460|FG000|Overall Study|Withdrawal by Subject|0|||
160650002|NCT01333033|580100461|FG001|Overall Study|Withdrawal by Subject|0|||
160650003|NCT01333033|580100462|FG002|Overall Study|Withdrawal by Subject|0|||
160650004|NCT01333033|580100463|FG003|Overall Study|Withdrawal by Subject|0|||
160650005|NCT01333033|580100464|FG004|Overall Study|Withdrawal by Subject|4|||
160845512|NCT03579940|580821136|FG005|Period 2|Withdrawal by Subject|0|||
160845513|NCT03579940|580821137|FG006|Period 2|Withdrawal by Subject|0|||
160650006|NCT01333033|580100465|FG005|Overall Study|Withdrawal by Subject|2|||
160650007|NCT01333033|580100460|FG000|Overall Study|PET inevaluable|0|||
160650008|NCT01333033|580100461|FG001|Overall Study|PET inevaluable|0|||
160650009|NCT01333033|580100462|FG002|Overall Study|PET inevaluable|0|||
160650010|NCT01333033|580100463|FG003|Overall Study|PET inevaluable|0|||
160650011|NCT01333033|580100464|FG004|Overall Study|PET inevaluable|2|||
160650012|NCT01333033|580100465|FG005|Overall Study|PET inevaluable|4|||
160650013|NCT01333033|580100460|FG000|Overall Study|Adverse Event|0|||
160650014|NCT01333033|580100461|FG001|Overall Study|Adverse Event|0|||
160650015|NCT01333033|580100462|FG002|Overall Study|Adverse Event|0|||
160650016|NCT01333033|580100463|FG003|Overall Study|Adverse Event|0|||
160650017|NCT01333033|580100464|FG004|Overall Study|Adverse Event|2|||
160845514|NCT03579940|580821138|FG007|Period 2|Withdrawal by Subject|0|||
160845515|NCT03579940|580821139|FG008|Period 2|Withdrawal by Subject|0|||
160845516|NCT03579940|580821140|FG009|Period 2|Withdrawal by Subject|0|||
160845517|NCT03579940|580821141|FG010|Period 2|Withdrawal by Subject|0|||
160845518|NCT01217944|580821142|FG000|Overall Study|Protocol Violation|1|||
160845519|NCT01217944|580821143|FG001|Overall Study|Protocol Violation|1|||
160845520|NCT01217944|580821144|FG002|Overall Study|Protocol Violation|0|||
160845521|NCT01217944|580821142|FG000|Overall Study|Lost to Follow-up|3|||
160845522|NCT01217944|580821143|FG001|Overall Study|Lost to Follow-up|1|||
160845523|NCT01217944|580821144|FG002|Overall Study|Lost to Follow-up|0|||
160845524|NCT01217944|580821142|FG000|Overall Study|Withdrawal by Subject|1|||
160845525|NCT01217944|580821143|FG001|Overall Study|Withdrawal by Subject|2|||
160845526|NCT01217944|580821144|FG002|Overall Study|Withdrawal by Subject|0|||
160845527|NCT01217944|580821142|FG000|Overall Study|Lack of Efficacy|1|||
160845528|NCT01217944|580821143|FG001|Overall Study|Lack of Efficacy|0|||
160845529|NCT01217944|580821144|FG002|Overall Study|Lack of Efficacy|0|||
160845530|NCT02274792|580821145|FG000|Overall Study|Withdrawal by Subject|13|||
160845531|NCT02274792|580821145|FG000|Overall Study|Lost to Follow-up|8|||
160845532|NCT02274792|580821145|FG000|Overall Study|Protocol Specified Criteria|2|||
160845533|NCT02274792|580821145|FG000|Overall Study|Sponsor Decision|2|||
160845534|NCT02751580|580821146|FG000|Overall Study|Lost to Follow-up|4|||
160845535|NCT02751580|580821146|FG000|Overall Study|Death|2|||
160650018|NCT01333033|580100465|FG005|Overall Study|Adverse Event|1|||
160845536|NCT04343755|580821153|FG000|Overall Study|Death|11|||
160845537|NCT04343755|580821153|FG000|Overall Study|Screen Failure|1|||
160845538|NCT00108862|580821158|FG000|Overall Study|Death|31|||
160845539|NCT00108862|580821159|FG001|Overall Study|Death|37|||
160845540|NCT00108862|580821158|FG000|Overall Study|Withdrawal by Subject|10|||
160845541|NCT00108862|580821159|FG001|Overall Study|Withdrawal by Subject|6|||
160845542|NCT00108862|580821158|FG000|Overall Study|Lost to Follow-up|27|||
160650019|NCT01333033|580100460|FG000|Overall Study|Progression|0|||
160650020|NCT01333033|580100461|FG001|Overall Study|Progression|0|||
160650021|NCT01333033|580100462|FG002|Overall Study|Progression|0|||
160650022|NCT01333033|580100463|FG003|Overall Study|Progression|0|||
160650023|NCT01333033|580100464|FG004|Overall Study|Progression|0|||
160650024|NCT01333033|580100465|FG005|Overall Study|Progression|1|||
160650025|NCT01333033|580100460|FG000|Overall Study|MD Decision|0|||
160650026|NCT01333033|580100461|FG001|Overall Study|MD Decision|0|||
160650027|NCT01333033|580100462|FG002|Overall Study|MD Decision|0|||
160845543|NCT00108862|580821159|FG001|Overall Study|Lost to Follow-up|19|||
160845544|NCT04854551|580821164|FG000|Overall Study|Withdrawal by Subject|1|||
160845545|NCT04854551|580821165|FG001|Overall Study|Withdrawal by Subject|1|||
160906001|NCT02340975|581050338|FG000|Overall Study|Other|0|||
160567531|NCT01121406|579800144|FG000|Overall Study|Lost to Follow-up|0|||
160567532|NCT01121406|579800145|FG001|Overall Study|Lost to Follow-up|1|||
160567533|NCT01121406|579800144|FG000|Overall Study|Refused continuation of study med.|1|||
160845546|NCT01076036|580821168|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
160845547|NCT00687804|580821169|FG000|Core Study|Adverse Event|5|||
160845548|NCT00687804|580821170|FG001|Core Study|Adverse Event|3|||
160845549|NCT00687804|580821171|FG002|Core Study|Adverse Event|3|||
160845550|NCT00687804|580821169|FG000|Core Study|Abnormal laboratory value(s)|1|||
160845551|NCT00687804|580821170|FG001|Core Study|Abnormal laboratory value(s)|0|||
160845552|NCT00687804|580821171|FG002|Core Study|Abnormal laboratory value(s)|0|||
160845553|NCT00687804|580821169|FG000|Core Study|Lack of Efficacy|1|||
160845554|NCT00687804|580821170|FG001|Core Study|Lack of Efficacy|1|||
160845555|NCT00687804|580821171|FG002|Core Study|Lack of Efficacy|1|||
160845556|NCT00687804|580821169|FG000|Core Study|Withdrawal by Subject|4|||
160845557|NCT00687804|580821170|FG001|Core Study|Withdrawal by Subject|7|||
160845558|NCT00687804|580821171|FG002|Core Study|Withdrawal by Subject|7|||
160845559|NCT00687804|580821169|FG000|Core Study|Lost to Follow-up|0|||
160845560|NCT00687804|580821170|FG001|Core Study|Lost to Follow-up|1|||
160845561|NCT00687804|580821171|FG002|Core Study|Lost to Follow-up|0|||
160845562|NCT00687804|580821169|FG000|Core Study|Death|2|||
160845563|NCT00687804|580821170|FG001|Core Study|Death|2|||
160845564|NCT00687804|580821171|FG002|Core Study|Death|2|||
160845565|NCT00687804|580821169|FG000|Core Study|Protocol Violation|1|||
160845566|NCT00687804|580821170|FG001|Core Study|Protocol Violation|1|||
160845567|NCT00687804|580821171|FG002|Core Study|Protocol Violation|0|||
160845568|NCT00687804|580821169|FG000|Open-Label Extension Study|Adverse Event|2|||
160845569|NCT00687804|580821170|FG001|Open-Label Extension Study|Adverse Event|2|||
160845570|NCT00687804|580821171|FG002|Open-Label Extension Study|Adverse Event|2|||
160845571|NCT00687804|580821169|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
160845572|NCT00687804|580821170|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
160845573|NCT00687804|580821171|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
160845574|NCT00687804|580821169|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
160845575|NCT00687804|580821170|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
160845576|NCT00687804|580821171|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
160845577|NCT00687804|580821169|FG000|Open-Label Extension Study|Administrative problems|1|||
160845578|NCT00687804|580821170|FG001|Open-Label Extension Study|Administrative problems|1|||
160845579|NCT00687804|580821171|FG002|Open-Label Extension Study|Administrative problems|0|||
160567534|NCT01121406|579800145|FG001|Overall Study|Refused continuation of study med.|2|||
160567535|NCT01121406|579800144|FG000|Overall Study|Reason other than specified above|2|||
160845580|NCT00687804|580821169|FG000|Open-Label Extension Study|Death|2|||
160845581|NCT00687804|580821170|FG001|Open-Label Extension Study|Death|3|||
160845582|NCT00687804|580821171|FG002|Open-Label Extension Study|Death|3|||
160845583|NCT02221674|580821172|FG000|Overall Study|Lost to Follow-up|1|||
160845584|NCT02221674|580821173|FG001|Overall Study|Lost to Follow-up|0|||
160845585|NCT02221674|580821174|FG002|Overall Study|Lost to Follow-up|0|||
160845586|NCT05292131|580821175|FG000|Overall Study|Lost to Follow-up|1|||
160845587|NCT05292131|580821176|FG001|Overall Study|Lost to Follow-up|1|||
160845588|NCT05292131|580821175|FG000|Overall Study|Withdrawal by Subject|0|||
160845589|NCT05292131|580821176|FG001|Overall Study|Withdrawal by Subject|1|||
160845590|NCT02557542|580821177|FG000|Overall Study|Poor recruitment|3|||
160845591|NCT02557542|580821178|FG001|Overall Study|Poor recruitment|0|||
160845592|NCT04390880|580821179|FG000|Overall Study|Withdrawal by Subject|1|||
160845593|NCT00195091|580821180|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
160845594|NCT01345188|580821181|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
160845595|NCT01345188|580821181|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
160845596|NCT00475709|580821185|FG000|Overall Study|Did not meet eligibility criteria|8|||
160845597|NCT00475709|580821185|FG000|Overall Study|Death|41|||
160845598|NCT00475709|580821185|FG000|Overall Study|Device Explant|6|||
160845599|NCT00475709|580821185|FG000|Overall Study|Lost to Follow-up|21|||
160845600|NCT04752358|580821186|FG000|Overall Study|Death|2|||
160845601|NCT04752358|580821187|FG001|Overall Study|Death|1|||
160845602|NCT00555672|580821190|FG000|Overall Study|Death|0|||
160845603|NCT00555672|580821191|FG001|Overall Study|Death|2|||
160845604|NCT00555672|580821190|FG000|Overall Study|Adverse Event|8|||
160845605|NCT00555672|580821191|FG001|Overall Study|Adverse Event|2|||
160845606|NCT00555672|580821190|FG000|Overall Study|Objective progression or relapse|11|||
160845607|NCT00555672|580821191|FG001|Overall Study|Objective progression or relapse|5|||
160845608|NCT00555672|580821190|FG000|Overall Study|Other|3|||
160845609|NCT00555672|580821191|FG001|Overall Study|Other|1|||
160906002|NCT02340975|581050339|FG001|Overall Study|Other|4|||
160906003|NCT02340975|581050340|FG002|Overall Study|Other|0|||
160906004|NCT02340975|581050341|FG003|Overall Study|Other|2|||
160845610|NCT00555672|580821190|FG000|Overall Study|Participant refused|2|||
160845611|NCT00555672|580821191|FG001|Overall Study|Participant refused|0|||
160845612|NCT04526145|580821192|FG000|Overall Study|Withdrawal by Subject|5|||
160845613|NCT05236257|580821195|FG000|Overall Study|Ongoing with study treatment|29|||
160906005|NCT02340975|581050342|FG004|Overall Study|Other|0|||
160906006|NCT02340975|581050343|FG005|Overall Study|Other|6|||
160845614|NCT05236257|580821196|FG001|Overall Study|Ongoing with study treatment|1|||
160845615|NCT05236257|580821195|FG000|Overall Study|Discontinued study treatment|22|||
160845616|NCT05236257|580821196|FG001|Overall Study|Discontinued study treatment|41|||
160845617|NCT05870865|580821197|FG000|Randomized|Did not receive study treatment|2|||
160845618|NCT05870865|580821198|FG001|Randomized|Did not receive study treatment|4|||
160845619|NCT05870865|580821199|FG002|Randomized|Did not receive study treatment|4|||
160845620|NCT05870865|580821200|FG003|Randomized|Did not receive study treatment|3|||
160845621|NCT05870865|580821197|FG000|Treatment Period|Adverse Event|1|||
160845622|NCT05870865|580821198|FG001|Treatment Period|Adverse Event|1|||
160845623|NCT05870865|580821199|FG002|Treatment Period|Adverse Event|1|||
160845624|NCT05870865|580821200|FG003|Treatment Period|Adverse Event|1|||
160845625|NCT05870865|580821197|FG000|Treatment Period|Lost to Follow-up|0|||
160845626|NCT05870865|580821198|FG001|Treatment Period|Lost to Follow-up|1|||
160845627|NCT05870865|580821199|FG002|Treatment Period|Lost to Follow-up|2|||
160845628|NCT05870865|580821200|FG003|Treatment Period|Lost to Follow-up|0|||
160845629|NCT05870865|580821197|FG000|Treatment Period|Protocol Violation|0|||
160845630|NCT05870865|580821198|FG001|Treatment Period|Protocol Violation|0|||
160845631|NCT05870865|580821199|FG002|Treatment Period|Protocol Violation|0|||
160845632|NCT05870865|580821200|FG003|Treatment Period|Protocol Violation|1|||
160845633|NCT05870865|580821197|FG000|Treatment Period|Withdrawal by Subject|0|||
160845634|NCT05870865|580821198|FG001|Treatment Period|Withdrawal by Subject|1|||
160845635|NCT05870865|580821199|FG002|Treatment Period|Withdrawal by Subject|1|||
160845636|NCT05870865|580821200|FG003|Treatment Period|Withdrawal by Subject|1|||
160845637|NCT03828019|580821203|FG000|Overall Study|Withdrawal by Subject|3|||
160845638|NCT03828019|580821204|FG001|Overall Study|Withdrawal by Subject|8|||
160845639|NCT03828019|580821203|FG000|Overall Study|Lost to Follow-up|1|||
160845640|NCT03828019|580821204|FG001|Overall Study|Lost to Follow-up|6|||
160845641|NCT03828019|580821203|FG000|Overall Study|Incarcerated|1|||
160845642|NCT03828019|580821204|FG001|Overall Study|Incarcerated|0|||
160845643|NCT03828019|580821203|FG000|Overall Study|Adverse Event|0|||
160845644|NCT03828019|580821204|FG001|Overall Study|Adverse Event|1|||
160845645|NCT05715242|580821205|FG000|Overall Study|Lost to Follow-up|0|||
160845646|NCT05715242|580821206|FG001|Overall Study|Lost to Follow-up|0|||
160845647|NCT05715242|580821207|FG002|Overall Study|Lost to Follow-up|1|||
160845648|NCT05715242|580821208|FG003|Overall Study|Lost to Follow-up|0|||
160845649|NCT05715242|580821209|FG004|Overall Study|Lost to Follow-up|0|||
160845650|NCT05715242|580821210|FG005|Overall Study|Lost to Follow-up|1|||
160845651|NCT05715242|580821211|FG006|Overall Study|Lost to Follow-up|0|||
160845652|NCT05715242|580821212|FG007|Overall Study|Lost to Follow-up|0|||
160845653|NCT05715242|580821213|FG008|Overall Study|Lost to Follow-up|0|||
160845654|NCT05715242|580821214|FG009|Overall Study|Lost to Follow-up|0|||
160845655|NCT05715242|580821215|FG010|Overall Study|Lost to Follow-up|0|||
160845656|NCT05715242|580821216|FG011|Overall Study|Lost to Follow-up|0|||
160845657|NCT05715242|580821217|FG012|Overall Study|Lost to Follow-up|0|||
160845658|NCT05715242|580821218|FG013|Overall Study|Lost to Follow-up|0|||
160845659|NCT05715242|580821219|FG014|Overall Study|Lost to Follow-up|0|||
160845660|NCT05715242|580821220|FG015|Overall Study|Lost to Follow-up|0|||
160845661|NCT03400176|580821221|FG000|Dose Escalation|Progressive disease|1|||
160845662|NCT03400176|580821222|FG001|Dose Escalation|Progressive disease|1|||
160845663|NCT03400176|580821223|FG002|Dose Escalation|Progressive disease|0|||
160845664|NCT03400176|580821224|FG003|Dose Escalation|Progressive disease|0|||
160845665|NCT03400176|580821225|FG004|Dose Escalation|Progressive disease|1|||
160845666|NCT03400176|580821221|FG000|Dose Escalation|Patient decision|0|||
160845667|NCT03400176|580821222|FG001|Dose Escalation|Patient decision|0|||
160845668|NCT03400176|580821223|FG002|Dose Escalation|Patient decision|0|||
160845669|NCT03400176|580821224|FG003|Dose Escalation|Patient decision|0|||
160845670|NCT03400176|580821225|FG004|Dose Escalation|Patient decision|1|||
160845671|NCT03400176|580821221|FG000|Dose Expansion|Patient decision|0|||
160845672|NCT03400176|580821222|FG001|Dose Expansion|Patient decision|0|||
160845673|NCT03400176|580821223|FG002|Dose Expansion|Patient decision|0|||
160845674|NCT03400176|580821224|FG003|Dose Expansion|Patient decision|1|||
160845675|NCT03400176|580821225|FG004|Dose Expansion|Patient decision|0|||
160845676|NCT03400176|580821221|FG000|Dose Expansion|Adverse Event|0|||
160845677|NCT03400176|580821222|FG001|Dose Expansion|Adverse Event|0|||
160845678|NCT03400176|580821223|FG002|Dose Expansion|Adverse Event|0|||
160845679|NCT03400176|580821224|FG003|Dose Expansion|Adverse Event|1|||
160845680|NCT03400176|580821225|FG004|Dose Expansion|Adverse Event|0|||
160845681|NCT03400176|580821221|FG000|Dose Expansion|Physician Decision|0|||
160845682|NCT03400176|580821222|FG001|Dose Expansion|Physician Decision|0|||
160845683|NCT03400176|580821223|FG002|Dose Expansion|Physician Decision|0|||
160845684|NCT03400176|580821224|FG003|Dose Expansion|Physician Decision|1|||
160845685|NCT03400176|580821225|FG004|Dose Expansion|Physician Decision|0|||
160845686|NCT03400176|580821221|FG000|Dose Expansion|Progressive disease|0|||
160845687|NCT03400176|580821222|FG001|Dose Expansion|Progressive disease|0|||
160845688|NCT03400176|580821223|FG002|Dose Expansion|Progressive disease|1|||
160845689|NCT03400176|580821224|FG003|Dose Expansion|Progressive disease|1|||
160845690|NCT03400176|580821225|FG004|Dose Expansion|Progressive disease|0|||
160845691|NCT01090063|580821233|FG000|Screen|Screen Failed|4|||
160845692|NCT01090063|580821233|FG000|Treatment|Withdrawal by Subject|4|||
160845693|NCT00048347|580821234|FG000|Overall Study|Screen failure|2|||
160845694|NCT02863328|580821235|FG000|Overall Study|Lost to Follow-up|4|||
160845695|NCT02863328|580821236|FG001|Overall Study|Lost to Follow-up|10|||
160650028|NCT01333033|580100463|FG003|Overall Study|MD Decision|0|||
160650029|NCT01333033|580100464|FG004|Overall Study|MD Decision|0|||
160650030|NCT01333033|580100465|FG005|Overall Study|MD Decision|2|||
160650031|NCT02752776|580100480|FG000|Overall Study|Adverse Event|15|||
160650032|NCT02752776|580100481|FG001|Overall Study|Adverse Event|23|||
160650033|NCT02752776|580100482|FG002|Overall Study|Adverse Event|11|||
160650034|NCT02752776|580100480|FG000|Overall Study|Lack of Efficacy|2|||
160650035|NCT02752776|580100481|FG001|Overall Study|Lack of Efficacy|6|||
160650036|NCT02752776|580100482|FG002|Overall Study|Lack of Efficacy|14|||
160650037|NCT02752776|580100480|FG000|Overall Study|Lost to Follow-up|11|||
160650038|NCT02752776|580100481|FG001|Overall Study|Lost to Follow-up|12|||
160650039|NCT02752776|580100482|FG002|Overall Study|Lost to Follow-up|4|||
160650040|NCT02752776|580100480|FG000|Overall Study|Non-compliance with study treatment|0|||
160650041|NCT02752776|580100481|FG001|Overall Study|Non-compliance with study treatment|0|||
160650042|NCT02752776|580100482|FG002|Overall Study|Non-compliance with study treatment|1|||
160650043|NCT02752776|580100480|FG000|Overall Study|Physician Decision|2|||
160650044|NCT02752776|580100481|FG001|Overall Study|Physician Decision|6|||
160650045|NCT02752776|580100482|FG002|Overall Study|Physician Decision|2|||
160650046|NCT02752776|580100480|FG000|Overall Study|Pregnancy|1|||
160650047|NCT02752776|580100481|FG001|Overall Study|Pregnancy|6|||
160650048|NCT02752776|580100482|FG002|Overall Study|Pregnancy|3|||
160650049|NCT02752776|580100480|FG000|Overall Study|Protocol Violation|10|||
160650050|NCT02752776|580100481|FG001|Overall Study|Protocol Violation|13|||
160650051|NCT02752776|580100482|FG002|Overall Study|Protocol Violation|6|||
160650052|NCT02752776|580100480|FG000|Overall Study|Subject/guardian decision|8|||
160650053|NCT02752776|580100481|FG001|Overall Study|Subject/guardian decision|6|||
160650054|NCT02752776|580100482|FG002|Overall Study|Subject/guardian decision|4|||
160650055|NCT02752776|580100480|FG000|Overall Study|Death|0|||
160650056|NCT02752776|580100481|FG001|Overall Study|Death|0|||
160650057|NCT02752776|580100482|FG002|Overall Study|Death|1|||
160650058|NCT02752776|580100480|FG000|Overall Study|Withdrawal by Subject|3|||
160650059|NCT02752776|580100481|FG001|Overall Study|Withdrawal by Subject|4|||
160650060|NCT02752776|580100482|FG002|Overall Study|Withdrawal by Subject|2|||
160650061|NCT01816477|580100483|FG000|Overall Study|Withdrawal by Subject|13|||
160650062|NCT01816477|580100484|FG001|Overall Study|Withdrawal by Subject|1|||
160650063|NCT01816477|580100483|FG000|Overall Study|Unable to tolerate catheter placement|3|||
160650064|NCT01816477|580100484|FG001|Overall Study|Unable to tolerate catheter placement|0|||
160650065|NCT02162758|580100485|FG000|Overall Study|Study termination|0|||
160650066|NCT02162758|580100486|FG001|Overall Study|Study termination|1|||
160650067|NCT03213210|580100487|FG000|Overall Study|Lost to Follow-up|2|||
160650068|NCT03213210|580100487|FG000|Overall Study|Study termination|3|||
160650069|NCT01716754|580100488|FG000|Overall Study|Death|0|||
160650070|NCT01716754|580100489|FG001|Overall Study|Death|0|||
160650071|NCT01716754|580100490|FG002|Overall Study|Death|0|||
160845696|NCT02863328|580821235|FG000|Overall Study|Withdrawal by Subject|7|||
160845697|NCT02863328|580821236|FG001|Overall Study|Withdrawal by Subject|12|||
160845698|NCT02863328|580821235|FG000|Overall Study|Died|0|||
160845699|NCT02863328|580821236|FG001|Overall Study|Died|1|||
160845700|NCT04565951|580821239|FG000|Overall Study|Lost to Follow-up|66|||
160845701|NCT04565951|580821240|FG001|Overall Study|Lost to Follow-up|38|||
160845702|NCT04565951|580821239|FG000|Overall Study|Withdrawal by Subject|14|||
160845703|NCT04565951|580821240|FG001|Overall Study|Withdrawal by Subject|7|||
160845704|NCT04565951|580821239|FG000|Overall Study|Death|0|||
160845705|NCT04565951|580821240|FG001|Overall Study|Death|1|||
160845706|NCT00429169|580821241|FG000|Overall Study|Lost to Follow-up|0|||
160845707|NCT00429169|580821242|FG001|Overall Study|Lost to Follow-up|1|||
160845708|NCT00429169|580821241|FG000|Overall Study|Ineligibility discovered after entry|2|||
160845709|NCT00429169|580821242|FG001|Overall Study|Ineligibility discovered after entry|1|||
160845710|NCT03508609|580821246|FG000|Overall Study|Withdrawal by Subject|1|||
160845711|NCT00423449|580821247|FG000|Overall Study|Clinical Adverse Event|1|||
160845712|NCT00423449|580821248|FG001|Overall Study|Clinical Adverse Event|0|||
160845713|NCT00423449|580821249|FG002|Overall Study|Clinical Adverse Event|1|||
160650072|NCT01716754|580100491|FG003|Overall Study|Death|1|||
160650073|NCT01716754|580100488|FG000|Overall Study|Protocol deviation|0|||
160650074|NCT01716754|580100489|FG001|Overall Study|Protocol deviation|2|||
160650075|NCT01716754|580100490|FG002|Overall Study|Protocol deviation|7|||
160650076|NCT01716754|580100491|FG003|Overall Study|Protocol deviation|2|||
160650077|NCT01716754|580100488|FG000|Overall Study|Non-compliance with study treatment|0|||
160650078|NCT01716754|580100489|FG001|Overall Study|Non-compliance with study treatment|0|||
160650079|NCT01716754|580100490|FG002|Overall Study|Non-compliance with study treatment|1|||
160650080|NCT01716754|580100491|FG003|Overall Study|Non-compliance with study treatment|0|||
160650081|NCT01716754|580100488|FG000|Overall Study|Physician Decision|1|||
160650082|NCT01716754|580100489|FG001|Overall Study|Physician Decision|0|||
160650083|NCT01716754|580100490|FG002|Overall Study|Physician Decision|0|||
160567536|NCT01121406|579800145|FG001|Overall Study|Reason other than specified above|6|||
160567537|NCT01121406|579800144|FG000|Overall Study|Not treated|1|||
160567538|NCT01121406|579800145|FG001|Overall Study|Not treated|0|||
160567539|NCT03185130|579800146|FG000|Overall Study|Withdrawal by Subject|0|||
160567540|NCT03185130|579800147|FG001|Overall Study|Withdrawal by Subject|2|||
160567541|NCT03596164|579800160|FG000|Overall Study|Adverse Event|0|||
160567542|NCT03596164|579800161|FG001|Overall Study|Adverse Event|1|||
160567543|NCT03596164|579800160|FG000|Overall Study|Death|1|||
160567544|NCT03596164|579800161|FG001|Overall Study|Death|0|||
160567545|NCT02272790|579800163|FG000|Overall Study|Physician Decision|0|||
160567546|NCT02272790|579800164|FG001|Overall Study|Physician Decision|1|||
160567547|NCT02272790|579800165|FG002|Overall Study|Physician Decision|0|||
160567548|NCT02272790|579800166|FG003|Overall Study|Physician Decision|0|||
160567549|NCT02272790|579800167|FG004|Overall Study|Physician Decision|0|||
160567550|NCT02272790|579800168|FG005|Overall Study|Physician Decision|0|||
160567551|NCT04375878|579800169|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
160567552|NCT04375878|579800170|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
160567553|NCT04375878|579800171|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
160567554|NCT04375878|579800172|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
160567555|NCT04375878|579800173|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
160567556|NCT04375878|579800174|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
160567557|NCT04375878|579800169|FG000|Crossover First and Second Interventions|Adverse Event|0|||
160567558|NCT04375878|579800170|FG001|Crossover First and Second Interventions|Adverse Event|0|||
160567559|NCT04375878|579800171|FG002|Crossover First and Second Interventions|Adverse Event|1|||
160567560|NCT04375878|579800172|FG003|Crossover First and Second Interventions|Adverse Event|0|||
160567561|NCT04375878|579800173|FG004|Crossover First and Second Interventions|Adverse Event|0|||
160567562|NCT04375878|579800174|FG005|Crossover First and Second Interventions|Adverse Event|0|||
160567563|NCT04375878|579800169|FG000|Extension Phase|Withdrawal by Subject|0|||
160567564|NCT04375878|579800170|FG001|Extension Phase|Withdrawal by Subject|0|||
160567565|NCT04375878|579800171|FG002|Extension Phase|Withdrawal by Subject|0|||
160567566|NCT04375878|579800172|FG003|Extension Phase|Withdrawal by Subject|0|||
160567567|NCT04375878|579800173|FG004|Extension Phase|Withdrawal by Subject|1|||
160567568|NCT04375878|579800174|FG005|Extension Phase|Withdrawal by Subject|0|||
160567569|NCT03022461|579800175|FG000|Overall Study|Death|3|||
160567570|NCT01982630|579800176|FG000|Overall Study|Adverse Event|2|||
160567571|NCT01982630|579800177|FG001|Overall Study|Adverse Event|0|||
160567572|NCT01982630|579800178|FG002|Overall Study|Adverse Event|1|||
160567573|NCT01982630|579800179|FG003|Overall Study|Adverse Event|0|||
160567574|NCT01982630|579800180|FG004|Overall Study|Adverse Event|1|||
160567575|NCT01982630|579800181|FG005|Overall Study|Adverse Event|2|||
160567576|NCT01982630|579800182|FG006|Overall Study|Adverse Event|1|||
160567577|NCT01982630|579800183|FG007|Overall Study|Adverse Event|0|||
160567578|NCT01982630|579800176|FG000|Overall Study|Physician Decision|1|||
160567579|NCT01982630|579800177|FG001|Overall Study|Physician Decision|0|||
160567580|NCT01982630|579800178|FG002|Overall Study|Physician Decision|2|||
160906007|NCT01007812|581050344|FG000|Period 1, One Week|Lost to Follow-up|0|||
160906008|NCT01007812|581050345|FG001|Period 1, One Week|Lost to Follow-up|1|||
160906009|NCT01007812|581050344|FG000|Period 1, One Week|Discomfort|1|||
160906010|NCT01007812|581050345|FG001|Period 1, One Week|Discomfort|0|||
160906011|NCT03948581|581050346|FG000|Overall Study|Lost to Follow-up|0|||
160906012|NCT03948581|581050347|FG001|Overall Study|Lost to Follow-up|1|||
160906013|NCT01876420|581050348|FG000|Overall Study|Missed 30 day visit|1|||
160906014|NCT03173313|581050349|FG000|Overall Study|Lost to Follow-up|2|||
160906015|NCT03173313|581050350|FG001|Overall Study|Lost to Follow-up|3|||
160906016|NCT03173313|581050349|FG000|Overall Study|Withdrawal by Subject|0|||
160906017|NCT03173313|581050350|FG001|Overall Study|Withdrawal by Subject|1|||
160906018|NCT03173313|581050349|FG000|Overall Study|Death|5|||
160906019|NCT03173313|581050350|FG001|Overall Study|Death|0|||
160906020|NCT03173313|581050349|FG000|Overall Study|Physician Decision|1|||
160906021|NCT03173313|581050350|FG001|Overall Study|Physician Decision|0|||
160906022|NCT03173313|581050349|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
160906023|NCT03173313|581050350|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
160906024|NCT03173313|581050349|FG000|Overall Study|Bone Fracture|1|||
160906025|NCT03173313|581050350|FG001|Overall Study|Bone Fracture|0|||
160906026|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
160906027|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
160906028|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
160906029|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
160906030|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
160906031|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
160567581|NCT01982630|579800179|FG003|Overall Study|Physician Decision|1|||
160567582|NCT01982630|579800180|FG004|Overall Study|Physician Decision|2|||
160567583|NCT01982630|579800181|FG005|Overall Study|Physician Decision|0|||
160906032|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
160906033|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
160567584|NCT01982630|579800182|FG006|Overall Study|Physician Decision|0|||
160567585|NCT01982630|579800183|FG007|Overall Study|Physician Decision|0|||
160567586|NCT01982630|579800176|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
160567587|NCT01982630|579800177|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
160567588|NCT01982630|579800178|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
160567589|NCT01982630|579800179|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
160567590|NCT01982630|579800180|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
160845714|NCT00423449|580821250|FG003|Overall Study|Clinical Adverse Event|8|||
160845715|NCT00423449|580821251|FG004|Overall Study|Clinical Adverse Event|2|||
160845716|NCT00423449|580821247|FG000|Overall Study|Death|1|||
160845717|NCT00423449|580821248|FG001|Overall Study|Death|0|||
160845718|NCT00423449|580821249|FG002|Overall Study|Death|2|||
160845719|NCT00423449|580821250|FG003|Overall Study|Death|1|||
160567591|NCT01982630|579800181|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
160567592|NCT01982630|579800182|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
160567593|NCT01982630|579800183|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
160567594|NCT01982630|579800176|FG000|Overall Study|Withdrawal by Subject|0|||
160567595|NCT01982630|579800177|FG001|Overall Study|Withdrawal by Subject|0|||
160567596|NCT01982630|579800178|FG002|Overall Study|Withdrawal by Subject|0|||
160567597|NCT01982630|579800179|FG003|Overall Study|Withdrawal by Subject|0|||
160567598|NCT01982630|579800180|FG004|Overall Study|Withdrawal by Subject|0|||
160567599|NCT01982630|579800181|FG005|Overall Study|Withdrawal by Subject|1|||
160567600|NCT01982630|579800182|FG006|Overall Study|Withdrawal by Subject|0|||
160567601|NCT01982630|579800183|FG007|Overall Study|Withdrawal by Subject|0|||
160567602|NCT00561353|579800184|FG000|Overall Study|Subject reached a virologic endpoint|2|||
160567603|NCT00561353|579800185|FG001|Overall Study|Subject reached a virologic endpoint|1|||
160567604|NCT00561353|579800186|FG002|Overall Study|Subject reached a virologic endpoint|1|||
160567605|NCT00561353|579800187|FG003|Overall Study|Subject reached a virologic endpoint|4|||
160567606|NCT00561353|579800188|FG004|Overall Study|Subject reached a virologic endpoint|1|||
160567607|NCT00561353|579800189|FG005|Overall Study|Subject reached a virologic endpoint|3|||
160567608|NCT00561353|579800190|FG006|Overall Study|Subject reached a virologic endpoint|4|||
160567609|NCT00561353|579800191|FG007|Overall Study|Subject reached a virologic endpoint|4|||
160567610|NCT00561353|579800192|FG008|Overall Study|Subject reached a virologic endpoint|5|||
160567611|NCT00561353|579800193|FG009|Overall Study|Subject reached a virologic endpoint|0|||
160567612|NCT00561353|579800184|FG000|Overall Study|Subject ineligible to continue the trial|0|||
160567613|NCT00561353|579800185|FG001|Overall Study|Subject ineligible to continue the trial|0|||
160567614|NCT00561353|579800186|FG002|Overall Study|Subject ineligible to continue the trial|0|||
160567615|NCT00561353|579800187|FG003|Overall Study|Subject ineligible to continue the trial|0|||
160567616|NCT00561353|579800188|FG004|Overall Study|Subject ineligible to continue the trial|0|||
160567617|NCT00561353|579800189|FG005|Overall Study|Subject ineligible to continue the trial|1|||
160567618|NCT00561353|579800190|FG006|Overall Study|Subject ineligible to continue the trial|1|||
160567619|NCT00561353|579800191|FG007|Overall Study|Subject ineligible to continue the trial|0|||
160567620|NCT00561353|579800192|FG008|Overall Study|Subject ineligible to continue the trial|2|||
160567621|NCT00561353|579800193|FG009|Overall Study|Subject ineligible to continue the trial|1|||
160567622|NCT00561353|579800184|FG000|Overall Study|Other|1|||
160567623|NCT00561353|579800185|FG001|Overall Study|Other|0|||
160567624|NCT00561353|579800186|FG002|Overall Study|Other|1|||
160567625|NCT00561353|579800187|FG003|Overall Study|Other|0|||
160567626|NCT00561353|579800188|FG004|Overall Study|Other|0|||
160567627|NCT00561353|579800189|FG005|Overall Study|Other|2|||
160567628|NCT00561353|579800190|FG006|Overall Study|Other|0|||
160567629|NCT00561353|579800191|FG007|Overall Study|Other|0|||
160567630|NCT00561353|579800192|FG008|Overall Study|Other|0|||
160567631|NCT00561353|579800193|FG009|Overall Study|Other|0|||
160567632|NCT00561353|579800184|FG000|Overall Study|Adverse Event|0|||
160567633|NCT00561353|579800185|FG001|Overall Study|Adverse Event|0|||
160567634|NCT00561353|579800186|FG002|Overall Study|Adverse Event|0|||
160567635|NCT00561353|579800187|FG003|Overall Study|Adverse Event|2|||
160567636|NCT00561353|579800188|FG004|Overall Study|Adverse Event|0|||
160567637|NCT00561353|579800189|FG005|Overall Study|Adverse Event|0|||
160567638|NCT00561353|579800190|FG006|Overall Study|Adverse Event|1|||
160567639|NCT00561353|579800191|FG007|Overall Study|Adverse Event|0|||
160567640|NCT00561353|579800192|FG008|Overall Study|Adverse Event|0|||
160845720|NCT00423449|580821251|FG004|Overall Study|Death|1|||
160845721|NCT00423449|580821247|FG000|Overall Study|Progressive Disease|1|||
160845722|NCT00423449|580821248|FG001|Overall Study|Progressive Disease|3|||
160845723|NCT00423449|580821249|FG002|Overall Study|Progressive Disease|8|||
160567641|NCT00561353|579800193|FG009|Overall Study|Adverse Event|1|||
160567642|NCT00561353|579800184|FG000|Overall Study|Lost to Follow-up|2|||
160845724|NCT00423449|580821250|FG003|Overall Study|Progressive Disease|11|||
160845725|NCT00423449|580821251|FG004|Overall Study|Progressive Disease|4|||
160567643|NCT00561353|579800185|FG001|Overall Study|Lost to Follow-up|0|||
160567644|NCT00561353|579800186|FG002|Overall Study|Lost to Follow-up|1|||
160845726|NCT00423449|580821247|FG000|Overall Study|Laboratory Adverse Event|0|||
160567645|NCT00561353|579800187|FG003|Overall Study|Lost to Follow-up|0|||
160845727|NCT00423449|580821248|FG001|Overall Study|Laboratory Adverse Event|1|||
160845728|NCT00423449|580821249|FG002|Overall Study|Laboratory Adverse Event|2|||
160845729|NCT00423449|580821250|FG003|Overall Study|Laboratory Adverse Event|0|||
160845730|NCT00423449|580821251|FG004|Overall Study|Laboratory Adverse Event|0|||
160845731|NCT00423449|580821247|FG000|Overall Study|Other|0|||
160845732|NCT00423449|580821248|FG001|Overall Study|Other|0|||
160845733|NCT00423449|580821249|FG002|Overall Study|Other|0|||
160845734|NCT00423449|580821250|FG003|Overall Study|Other|1|||
160845735|NCT00423449|580821251|FG004|Overall Study|Other|0|||
160845736|NCT00423449|580821247|FG000|Overall Study|Protocol Violation|0|||
160845737|NCT00423449|580821248|FG001|Overall Study|Protocol Violation|0|||
160845738|NCT00423449|580821249|FG002|Overall Study|Protocol Violation|2|||
160845739|NCT00423449|580821250|FG003|Overall Study|Protocol Violation|1|||
160845740|NCT00423449|580821251|FG004|Overall Study|Protocol Violation|0|||
160845741|NCT00947115|580821252|FG000|Overall Study|Missed reporting interval|3|||
160845742|NCT00947115|580821253|FG001|Overall Study|Missed reporting interval|4|||
160845743|NCT00947115|580821254|FG002|Overall Study|Missed reporting interval|2|||
160845744|NCT00947115|580821252|FG000|Overall Study|Physician Decision|0|||
160845745|NCT00947115|580821253|FG001|Overall Study|Physician Decision|2|||
160845746|NCT00947115|580821254|FG002|Overall Study|Physician Decision|0|||
160845747|NCT00947115|580821252|FG000|Overall Study|Death|0|||
160845748|NCT00947115|580821253|FG001|Overall Study|Death|1|||
160845749|NCT00947115|580821254|FG002|Overall Study|Death|1|||
160845750|NCT00947115|580821252|FG000|Overall Study|Migrated from study area|2|||
160845751|NCT00947115|580821253|FG001|Overall Study|Migrated from study area|0|||
160845752|NCT00947115|580821254|FG002|Overall Study|Migrated from study area|0|||
160845753|NCT00947115|580821252|FG000|Overall Study|Withdrawal by Subject|1|||
160845754|NCT00947115|580821253|FG001|Overall Study|Withdrawal by Subject|3|||
160567646|NCT00561353|579800188|FG004|Overall Study|Lost to Follow-up|0|||
160567647|NCT00561353|579800189|FG005|Overall Study|Lost to Follow-up|0|||
160567648|NCT00561353|579800190|FG006|Overall Study|Lost to Follow-up|0|||
160567649|NCT00561353|579800191|FG007|Overall Study|Lost to Follow-up|0|||
160567650|NCT00561353|579800192|FG008|Overall Study|Lost to Follow-up|0|||
160567651|NCT00561353|579800193|FG009|Overall Study|Lost to Follow-up|0|||
160567652|NCT00561353|579800184|FG000|Overall Study|Withdrawal by Subject|0|||
160567653|NCT00561353|579800185|FG001|Overall Study|Withdrawal by Subject|2|||
160567654|NCT00561353|579800186|FG002|Overall Study|Withdrawal by Subject|0|||
160567655|NCT00561353|579800187|FG003|Overall Study|Withdrawal by Subject|0|||
160567656|NCT00561353|579800188|FG004|Overall Study|Withdrawal by Subject|0|||
160567657|NCT00561353|579800189|FG005|Overall Study|Withdrawal by Subject|0|||
160567658|NCT00561353|579800190|FG006|Overall Study|Withdrawal by Subject|0|||
160567659|NCT00561353|579800191|FG007|Overall Study|Withdrawal by Subject|0|||
160567660|NCT00561353|579800192|FG008|Overall Study|Withdrawal by Subject|0|||
160567661|NCT00561353|579800193|FG009|Overall Study|Withdrawal by Subject|0|||
160567662|NCT03934684|579800194|FG000|Overall Study|Participants continuing in study|11|||
160567663|NCT03934684|579800195|FG001|Overall Study|Participants continuing in study|4|||
160567664|NCT03934684|579800194|FG000|Overall Study|Discontinuation of carfilzomib|20|||
160567665|NCT03934684|579800195|FG001|Overall Study|Discontinuation of carfilzomib|30|||
160567666|NCT03934684|579800194|FG000|Overall Study|Death|2|||
160567667|NCT03934684|579800195|FG001|Overall Study|Death|2|||
160567668|NCT03934684|579800194|FG000|Overall Study|Lost to Follow-up|2|||
160567669|NCT03934684|579800195|FG001|Overall Study|Lost to Follow-up|5|||
160845755|NCT00947115|580821254|FG002|Overall Study|Withdrawal by Subject|4|||
160845756|NCT00947115|580821252|FG000|Overall Study|Lost to Follow-up|11|||
160845757|NCT00947115|580821253|FG001|Overall Study|Lost to Follow-up|12|||
160845758|NCT00947115|580821254|FG002|Overall Study|Lost to Follow-up|8|||
160845759|NCT03228212|580821257|FG000|Period 1|Adverse Event|1|||
160845760|NCT03228212|580821258|FG001|Period 1|Adverse Event|0|||
160845761|NCT03228212|580821257|FG000|Period 1|no longer meets eligibility criteria|0|||
160845762|NCT03228212|580821258|FG001|Period 1|no longer meets eligibility criteria|1|||
160845763|NCT03228212|580821257|FG000|Period 2|Lost to Follow-up|1|||
160845764|NCT03228212|580821258|FG001|Period 2|Lost to Follow-up|0|||
160845765|NCT00447226|580822885|FG000|12-Week Open-label Phase|Adverse Event|0|||
160845766|NCT00447226|580822886|FG001|12-Week Open-label Phase|Adverse Event|3|||
160845767|NCT00447226|580822885|FG000|12-Week Open-label Phase|Protocol Violation|0|||
160845768|NCT00447226|580822886|FG001|12-Week Open-label Phase|Protocol Violation|1|||
160845769|NCT00447226|580822885|FG000|12-Week Open-label Phase|Disease Progression|0|||
160845770|NCT00447226|580822886|FG001|12-Week Open-label Phase|Disease Progression|20|||
160845771|NCT00447226|580822885|FG000|12-Week Open-label Phase|Physician Decision|0|||
160567670|NCT03934684|579800194|FG000|Overall Study|Withdrawal by Subject|7|||
160567671|NCT03934684|579800195|FG001|Overall Study|Withdrawal by Subject|8|||
160567672|NCT01073943|579800196|FG000|Overall Study|Withdrawal by Subject|8|||
160567673|NCT01073943|579800197|FG001|Overall Study|Withdrawal by Subject|2|||
160567674|NCT01073943|579800196|FG000|Overall Study|Protocol Violation|2|||
160567675|NCT01073943|579800197|FG001|Overall Study|Protocol Violation|1|||
160567676|NCT01073943|579800196|FG000|Overall Study|Adverse Event|1|||
160845772|NCT00447226|580822886|FG001|12-Week Open-label Phase|Physician Decision|1|||
160650084|NCT01716754|580100491|FG003|Overall Study|Physician Decision|0|||
160650085|NCT01716754|580100488|FG000|Overall Study|Lost to Follow-up|1|||
160650086|NCT01716754|580100489|FG001|Overall Study|Lost to Follow-up|0|||
160650087|NCT01716754|580100490|FG002|Overall Study|Lost to Follow-up|0|||
160650088|NCT01716754|580100491|FG003|Overall Study|Lost to Follow-up|1|||
160650089|NCT01716754|580100488|FG000|Overall Study|Adverse Event|4|||
160650090|NCT01716754|580100489|FG001|Overall Study|Adverse Event|2|||
160650091|NCT01716754|580100490|FG002|Overall Study|Adverse Event|2|||
160650092|NCT01716754|580100491|FG003|Overall Study|Adverse Event|1|||
160650093|NCT01716754|580100488|FG000|Overall Study|Withdrawal by Subject|5|||
160650094|NCT01716754|580100489|FG001|Overall Study|Withdrawal by Subject|0|||
160650095|NCT01716754|580100490|FG002|Overall Study|Withdrawal by Subject|4|||
160650096|NCT01716754|580100491|FG003|Overall Study|Withdrawal by Subject|3|||
160650097|NCT02110706|580100509|FG000|Overall Study|Adverse Event|2|||
160650098|NCT02110706|580100510|FG001|Overall Study|Adverse Event|3|||
160650099|NCT02110706|580100509|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
160650100|NCT02110706|580100510|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
160650101|NCT00947427|580100512|FG000|Overall Study|Withdrawal by Subject|1|||
160650102|NCT00947427|580100513|FG001|Overall Study|Withdrawal by Subject|3|||
160650103|NCT00947427|580100512|FG000|Overall Study|Protocol Violation|0|||
160650104|NCT00947427|580100513|FG001|Overall Study|Protocol Violation|1|||
160650105|NCT01348542|580100515|FG000|Overall Study|Withdrawal by Subject|3|||
160650106|NCT01348542|580100516|FG001|Overall Study|Withdrawal by Subject|0|||
160650107|NCT02115256|580100528|FG000|Overall Study|Withdrawal by Subject|0|||
160845773|NCT00447226|580822885|FG000|Double-blind Phase|Disease Progression|4|||
160845774|NCT00447226|580822886|FG001|Double-blind Phase|Disease Progression|3|||
160845775|NCT03449758|580822894|FG000|Overall Study|Major protocol deviation|1|||
160845776|NCT03449758|580822894|FG000|Overall Study|Treatment inefficacy|5|||
160845777|NCT03449758|580822894|FG000|Overall Study|Adverse Event|9|||
160845778|NCT03449758|580822894|FG000|Overall Study|Consent withdrawal|1|||
160845779|NCT03449758|580822894|FG000|Overall Study|Other unspecified reason|3|||
160845780|NCT01478971|580822903|FG000|Standard of Care Period|Adverse Event|1|||
160845781|NCT01478971|580822903|FG000|Standard of Care Period|Withdrawal by Subject|3|||
160845782|NCT01478971|580822903|FG000|Standard of Care Period|Death|8|||
160845783|NCT01478971|580822903|FG000|Standard of Care Period|Lost to Follow-up|9|||
160845784|NCT01478971|580822903|FG000|Standard of Care Period|Other|4|||
160845785|NCT01478971|580822903|FG000|Peginesatide Treatment Period|Adverse Event|1|||
160845786|NCT01478971|580822903|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
160650108|NCT02115256|580100529|FG001|Overall Study|Withdrawal by Subject|1|||
160650109|NCT01789320|580100532|FG000|Overall Study|Re-enrolled into study|1|||
160650110|NCT01789320|580100532|FG000|Overall Study|Lost to Follow-up|1|||
160650111|NCT01533428|580100541|FG000|Overall Study|Adverse Event|0|||
160650112|NCT01533428|580100542|FG001|Overall Study|Adverse Event|1|||
160650113|NCT01533428|580100541|FG000|Overall Study|Lost to Follow-up|2|||
160650114|NCT01533428|580100542|FG001|Overall Study|Lost to Follow-up|1|||
160650115|NCT01533428|580100541|FG000|Overall Study|Withdrawal by Subject|7|||
160650116|NCT01533428|580100542|FG001|Overall Study|Withdrawal by Subject|6|||
160650117|NCT02102490|580100548|FG000|Overall Study|Death|6|||
160650118|NCT02102490|580100548|FG000|Overall Study|Lost to Follow-up|1|||
160650119|NCT00095199|580100549|FG000|Overall Study|Adverse Event|40|||
160650120|NCT00095199|580100550|FG001|Overall Study|Adverse Event|22|||
160650121|NCT00095199|580100551|FG002|Overall Study|Adverse Event|26|||
160845787|NCT01478971|580822903|FG000|Peginesatide Treatment Period|Death|4|||
160845788|NCT01478971|580822903|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
160845789|NCT01478971|580822903|FG000|Peginesatide Treatment Period|Other|4|||
160845790|NCT00584012|580822904|FG000|Overall Study|Withdrawal by Subject|1|||
160845791|NCT04404556|580822905|FG000|Intervention|Withdrawal by Subject|15|||
160906034|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
160650122|NCT00095199|580100552|FG003|Overall Study|Adverse Event|11|||
160906035|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
160906036|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
160906037|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
160906038|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
160906039|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
160906040|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
160906041|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
160906042|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
160906043|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
160906044|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
160906045|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
160650123|NCT00095199|580100549|FG000|Overall Study|Progressive disease|213|||
160650124|NCT00095199|580100550|FG001|Overall Study|Progressive disease|179|||
160650125|NCT00095199|580100551|FG002|Overall Study|Progressive disease|105|||
160650126|NCT00095199|580100552|FG003|Overall Study|Progressive disease|98|||
160650127|NCT00095199|580100549|FG000|Overall Study|Death|10|||
160845792|NCT04404556|580822906|FG001|Intervention|Withdrawal by Subject|3|||
160845793|NCT04404556|580822905|FG000|Intervention|Did not complete all intervention sessions|2|||
160845794|NCT04404556|580822906|FG001|Intervention|Did not complete all intervention sessions|1|||
160845795|NCT04404556|580822905|FG000|Post-Intervention|Missing Data|1|||
160845796|NCT04404556|580822906|FG001|Post-Intervention|Missing Data|2|||
160567677|NCT01073943|579800197|FG001|Overall Study|Adverse Event|1|||
160567678|NCT01073943|579800196|FG000|Overall Study|Lost to Follow-up|0|||
160567679|NCT01073943|579800197|FG001|Overall Study|Lost to Follow-up|2|||
160567680|NCT01073943|579800196|FG000|Overall Study|Power outage; colonoscopy not done|1|||
160567681|NCT01073943|579800197|FG001|Overall Study|Power outage; colonoscopy not done|0|||
160567682|NCT01073943|579800196|FG000|Overall Study|Subject forgot|0|||
160567683|NCT01073943|579800197|FG001|Overall Study|Subject forgot|1|||
160845797|NCT04404556|580822905|FG000|Follow-up 1|Withdrawal by Subject|5|||
160845798|NCT04404556|580822906|FG001|Follow-up 1|Withdrawal by Subject|1|||
160845799|NCT04404556|580822905|FG000|Follow-up 1|Missing Data|4|||
160845800|NCT04404556|580822906|FG001|Follow-up 1|Missing Data|7|||
160845801|NCT04404556|580822905|FG000|Follow-up 2|Withdrawal by Subject|1|||
160845802|NCT04404556|580822906|FG001|Follow-up 2|Withdrawal by Subject|1|||
160845803|NCT04404556|580822905|FG000|Follow-up 2|Missing Data|6|||
160845804|NCT04404556|580822906|FG001|Follow-up 2|Missing Data|5|||
160845805|NCT02451943|580822907|FG000|Overall Study|Withdrawal by Subject|13|||
160845806|NCT02451943|580822908|FG001|Overall Study|Withdrawal by Subject|16|||
160845807|NCT02451943|580822907|FG000|Overall Study|Lost to Follow-up|3|||
160845808|NCT02451943|580822908|FG001|Overall Study|Lost to Follow-up|4|||
160845809|NCT02451943|580822907|FG000|Overall Study|Sponsor Decision|0|||
160845810|NCT02451943|580822908|FG001|Overall Study|Sponsor Decision|4|||
160845811|NCT03937713|580822909|FG000|Overall Study|Withdrawal by Subject|3|||
160845812|NCT03937713|580822910|FG001|Overall Study|Withdrawal by Subject|6|||
160845813|NCT03937713|580822909|FG000|Overall Study|Lost to Follow-up|1|||
160845814|NCT03937713|580822910|FG001|Overall Study|Lost to Follow-up|0|||
160845815|NCT00763386|580822916|FG000|Overall Study|Adverse Event|43|||
160845816|NCT00763386|580822917|FG001|Overall Study|Adverse Event|33|||
160845817|NCT00763386|580822916|FG000|Overall Study|Death|1|||
160845818|NCT00763386|580822917|FG001|Overall Study|Death|2|||
160845819|NCT00763386|580822916|FG000|Overall Study|Lost to Follow-up|3|||
160845820|NCT00763386|580822917|FG001|Overall Study|Lost to Follow-up|3|||
160845821|NCT00763386|580822916|FG000|Overall Study|Withdrawal by Subject|0|||
160845822|NCT00763386|580822917|FG001|Overall Study|Withdrawal by Subject|1|||
160845823|NCT00763386|580822916|FG000|Overall Study|CRF missing|0|||
160567684|NCT01073943|579800196|FG000|Overall Study|Unable to return for follow-up|0|||
160567685|NCT01073943|579800197|FG001|Overall Study|Unable to return for follow-up|1|||
160567686|NCT01073943|579800196|FG000|Overall Study|Could not tolerate prep|1|||
160567687|NCT01073943|579800197|FG001|Overall Study|Could not tolerate prep|0|||
160567688|NCT05662332|579800198|FG000|Overall Study|Death|3|||
160567689|NCT05662332|579800199|FG001|Overall Study|Death|3|||
160567690|NCT05662332|579800198|FG000|Overall Study|Lost to Follow-up|3|||
160567691|NCT05662332|579800199|FG001|Overall Study|Lost to Follow-up|8|||
160567692|NCT05662332|579800198|FG000|Overall Study|Physician Decision|1|||
160567693|NCT05662332|579800199|FG001|Overall Study|Physician Decision|2|||
160567694|NCT05662332|579800198|FG000|Overall Study|Protocol Deviation|2|||
160567695|NCT05662332|579800199|FG001|Overall Study|Protocol Deviation|1|||
160567696|NCT05662332|579800198|FG000|Overall Study|Withdrawal by Subject|14|||
160567697|NCT05662332|579800199|FG001|Overall Study|Withdrawal by Subject|14|||
160567698|NCT05662332|579800198|FG000|Overall Study|Assigned Treatment by Mistake|5|||
160567699|NCT05662332|579800199|FG001|Overall Study|Assigned Treatment by Mistake|7|||
160567700|NCT05662332|579800198|FG000|Overall Study|Non-compliance with study drug|4|||
160567701|NCT05662332|579800199|FG001|Overall Study|Non-compliance with study drug|1|||
160845824|NCT00763386|580822917|FG001|Overall Study|CRF missing|1|||
160845825|NCT00763386|580822916|FG000|Overall Study|Study Prosthesis Removed|1|||
160845826|NCT00763386|580822917|FG001|Overall Study|Study Prosthesis Removed|0|||
160845827|NCT00922623|580822918|FG000|Overall Study|Other|4|||
160845828|NCT00922623|580822918|FG000|Overall Study|Lost to Follow-up|1|||
160845829|NCT02451917|580822919|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
160845830|NCT02451917|580822920|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
160845831|NCT02451917|580822919|FG000|First Intervention (24 Weeks)|Death|0|||
160845832|NCT02451917|580822920|FG001|First Intervention (24 Weeks)|Death|1|||
160906046|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
160567702|NCT05662332|579800198|FG000|Overall Study|Due to Bariatric surgery|1|||
160567703|NCT05662332|579800199|FG001|Overall Study|Due to Bariatric surgery|0|||
160567704|NCT05662332|579800198|FG000|Overall Study|Subject Moving out of State|0|||
160567705|NCT05662332|579800199|FG001|Overall Study|Subject Moving out of State|1|||
160567706|NCT05662332|579800198|FG000|Overall Study|Subject Missed the Schedule|1|||
160650128|NCT00095199|580100550|FG001|Overall Study|Death|6|||
160845833|NCT02451917|580822919|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
160845834|NCT02451917|580822920|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
160845835|NCT02871635|580822921|FG000|Overall Study|Primary lack of efficacy|4|||
160845836|NCT02871635|580822922|FG001|Overall Study|Primary lack of efficacy|4|||
160992376|NCT00662909|581360034|FG000|Overall Study|Randomized- never received study drug|1|||
160992377|NCT00662909|581360035|FG001|Overall Study|Randomized- never received study drug|0|||
160992378|NCT00662909|581360036|FG002|Overall Study|Randomized- never received study drug|0|||
160845837|NCT02871635|580822921|FG000|Overall Study|Protocol Violation|3|||
160845838|NCT02871635|580822922|FG001|Overall Study|Protocol Violation|1|||
160567707|NCT05662332|579800199|FG001|Overall Study|Subject Missed the Schedule|0|||
160567708|NCT05662332|579800198|FG000|Overall Study|The Patient Moved to Another City|1|||
160567709|NCT05662332|579800199|FG001|Overall Study|The Patient Moved to Another City|0|||
160567710|NCT01097044|579800204|FG000|Overall Study|Withdrawal by Subject|4|||
160845839|NCT02871635|580822921|FG000|Overall Study|Lost to Follow-up|1|||
160845840|NCT02871635|580822922|FG001|Overall Study|Lost to Follow-up|2|||
160845841|NCT02871635|580822921|FG000|Overall Study|Pregnancy|0|||
160845842|NCT02871635|580822922|FG001|Overall Study|Pregnancy|2|||
160845843|NCT02871635|580822921|FG000|Overall Study|Physician Decision|1|||
160845844|NCT02871635|580822922|FG001|Overall Study|Physician Decision|1|||
160845845|NCT02871635|580822921|FG000|Overall Study|Withdrawal by Subject|3|||
160845846|NCT02871635|580822922|FG001|Overall Study|Withdrawal by Subject|4|||
160845847|NCT02871635|580822921|FG000|Overall Study|Adverse Event|4|||
160845848|NCT02871635|580822922|FG001|Overall Study|Adverse Event|4|||
160567711|NCT01097044|579800205|FG001|Overall Study|Withdrawal by Subject|4|||
160567712|NCT01097044|579800204|FG000|Overall Study|Lost to Follow-up|1|||
160567713|NCT01097044|579800205|FG001|Overall Study|Lost to Follow-up|0|||
160845849|NCT02871635|580822921|FG000|Overall Study|Secondary lack of efficacy|2|||
160845850|NCT02871635|580822922|FG001|Overall Study|Secondary lack of efficacy|1|||
160845851|NCT02420379|580822923|FG000|Overall Study|Withdrawal by Subject|0|||
160845852|NCT02420379|580822924|FG001|Overall Study|Withdrawal by Subject|3|||
160845853|NCT02420379|580822923|FG000|Overall Study|Unable to complete due to schooling|0|||
160845854|NCT02420379|580822924|FG001|Overall Study|Unable to complete due to schooling|1|||
160845855|NCT02420379|580822923|FG000|Overall Study|Transitioned to commercial drug|1|||
160845856|NCT02420379|580822924|FG001|Overall Study|Transitioned to commercial drug|0|||
160845857|NCT01402817|580822925|FG000|Overall Study|Withdrawal by Subject|3|||
160845858|NCT01402817|580822925|FG000|Overall Study|Study Suspended by FDA|8|||
160845859|NCT00502671|580822926|FG000|Overall Study|Disease Progression|13|||
160845860|NCT00502671|580822926|FG000|Overall Study|Personal Reasons|22|||
160845861|NCT00502671|580822926|FG000|Overall Study|Lost to Follow-up|7|||
160845862|NCT00502671|580822926|FG000|Overall Study|Protocol Violation|16|||
160845863|NCT00502671|580822926|FG000|Overall Study|Adverse Event|19|||
160845864|NCT00681629|580822933|FG000|Overall Study|Study termination|4|||
160845865|NCT00681629|580822934|FG001|Overall Study|Study termination|2|||
160845866|NCT00681629|580822933|FG000|Overall Study|Adverse Event|1|||
160845867|NCT00681629|580822934|FG001|Overall Study|Adverse Event|0|||
160845868|NCT00086047|580822935|FG000|Overall Study|Lost to Follow-up|7|||
160845869|NCT00086047|580822936|FG001|Overall Study|Lost to Follow-up|6|||
160567714|NCT01097044|579800204|FG000|Overall Study|Withdrawal by Sponsor|0|||
160567715|NCT01097044|579800205|FG001|Overall Study|Withdrawal by Sponsor|1|||
160567716|NCT02452359|579800208|FG000|Overall Study|Adverse Event|1|||
160567717|NCT02452359|579800208|FG000|Overall Study|Lost to Follow-up|15|||
160567718|NCT02452359|579800208|FG000|Overall Study|Pregnancy|1|||
160567719|NCT02452359|579800208|FG000|Overall Study|Withdrawal by Subject|4|||
160567720|NCT03414359|579800209|FG000|Overall Study|Lack of Efficacy|1|||
160845870|NCT00086047|580822935|FG000|Overall Study|Physician Decision|0|||
160845871|NCT00086047|580822936|FG001|Overall Study|Physician Decision|1|||
160845872|NCT01395901|580822937|FG000|Overall Study|Lost to Follow-up|4|||
160845873|NCT01395901|580822938|FG001|Overall Study|Lost to Follow-up|0|||
160845874|NCT01395901|580822937|FG000|Overall Study|Randomized but not received study drug|5|||
160845875|NCT01395901|580822938|FG001|Overall Study|Randomized but not received study drug|4|||
160845876|NCT01395901|580822937|FG000|Overall Study|Adverse Event|0|||
160845877|NCT01395901|580822938|FG001|Overall Study|Adverse Event|1|||
160845878|NCT01395901|580822937|FG000|Overall Study|Withdrawal of consent|1|||
160567721|NCT03414359|579800210|FG001|Overall Study|Lack of Efficacy|1|||
160845879|NCT01395901|580822938|FG001|Overall Study|Withdrawal of consent|0|||
160845880|NCT00853151|580822943|FG000|Overall Study|Adverse Event|1|||
160845881|NCT00853151|580822944|FG001|Overall Study|Adverse Event|4|||
160845882|NCT00853151|580822945|FG002|Overall Study|Adverse Event|2|||
160845883|NCT00853151|580822946|FG003|Overall Study|Adverse Event|0|||
160845884|NCT00853151|580822943|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
160845885|NCT00853151|580822944|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160845886|NCT00853151|580822945|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160567722|NCT03414359|579800209|FG000|Overall Study|Protocol Violation|0|||
160567723|NCT03414359|579800210|FG001|Overall Study|Protocol Violation|1|||
160567724|NCT04865731|579800211|FG000|Overall Study|Physician Decision|2|||
160567725|NCT04865731|579800212|FG001|Overall Study|Physician Decision|1|||
160567726|NCT04865731|579800211|FG000|Overall Study|Adverse Event|1|||
160567727|NCT04865731|579800212|FG001|Overall Study|Adverse Event|0|||
160567728|NCT04865731|579800211|FG000|Overall Study|Withdrawal by Subject|0|||
160567729|NCT04865731|579800212|FG001|Overall Study|Withdrawal by Subject|1|||
160650129|NCT00095199|580100551|FG002|Overall Study|Death|11|||
160650130|NCT00095199|580100552|FG003|Overall Study|Death|9|||
160650131|NCT00095199|580100549|FG000|Overall Study|Withdrawal by Subject|21|||
160650132|NCT00095199|580100550|FG001|Overall Study|Withdrawal by Subject|16|||
160650133|NCT00095199|580100551|FG002|Overall Study|Withdrawal by Subject|13|||
160650134|NCT00095199|580100552|FG003|Overall Study|Withdrawal by Subject|22|||
160650135|NCT00095199|580100549|FG000|Overall Study|Protocol Violation|4|||
160650136|NCT00095199|580100550|FG001|Overall Study|Protocol Violation|4|||
160650137|NCT00095199|580100551|FG002|Overall Study|Protocol Violation|2|||
160845887|NCT00853151|580822946|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160845888|NCT00853151|580822943|FG000|Overall Study|Lost to Follow-up|2|||
160845889|NCT00853151|580822944|FG001|Overall Study|Lost to Follow-up|0|||
160845890|NCT00853151|580822945|FG002|Overall Study|Lost to Follow-up|3|||
160845891|NCT00853151|580822946|FG003|Overall Study|Lost to Follow-up|0|||
160845892|NCT00853151|580822943|FG000|Overall Study|Death|1|||
160845893|NCT00853151|580822944|FG001|Overall Study|Death|0|||
160845894|NCT00853151|580822945|FG002|Overall Study|Death|0|||
160845895|NCT00853151|580822946|FG003|Overall Study|Death|1|||
160845896|NCT00853151|580822943|FG000|Overall Study|Protocol Violation|0|||
160845897|NCT00853151|580822944|FG001|Overall Study|Protocol Violation|0|||
160845898|NCT00853151|580822945|FG002|Overall Study|Protocol Violation|0|||
160567730|NCT05738486|579802147|FG000|Overall Study|Continuing Study|194|||
160567731|NCT05738486|579802148|FG001|Overall Study|Continuing Study|196|||
160567732|NCT05738486|579802149|FG002|Overall Study|Continuing Study|193|||
160567733|NCT05738486|579802150|FG003|Overall Study|Continuing Study|191|||
160567734|NCT05738486|579802147|FG000|Overall Study|Withdrawal by Subject|8|||
160567735|NCT05738486|579802148|FG001|Overall Study|Withdrawal by Subject|5|||
160567736|NCT05738486|579802149|FG002|Overall Study|Withdrawal by Subject|7|||
160567737|NCT05738486|579802150|FG003|Overall Study|Withdrawal by Subject|13|||
160567738|NCT05738486|579802147|FG000|Overall Study|Adverse Event|4|||
160567739|NCT05738486|579802148|FG001|Overall Study|Adverse Event|6|||
160650138|NCT00095199|580100552|FG003|Overall Study|Protocol Violation|0|||
160650139|NCT00095199|580100549|FG000|Overall Study|Liver function test results elevated|0|||
160845899|NCT00853151|580822946|FG003|Overall Study|Protocol Violation|1|||
160845900|NCT00853151|580822943|FG000|Overall Study|Withdrawal by Subject|5|||
160845901|NCT00853151|580822944|FG001|Overall Study|Withdrawal by Subject|4|||
160845902|NCT00853151|580822945|FG002|Overall Study|Withdrawal by Subject|2|||
160845903|NCT00853151|580822946|FG003|Overall Study|Withdrawal by Subject|1|||
160845904|NCT00853151|580822943|FG000|Overall Study|Physician Decision|0|||
160845905|NCT00853151|580822944|FG001|Overall Study|Physician Decision|2|||
160845906|NCT00853151|580822945|FG002|Overall Study|Physician Decision|1|||
160845907|NCT00853151|580822946|FG003|Overall Study|Physician Decision|0|||
160845908|NCT00853151|580822943|FG000|Overall Study|Sponsor Decision|0|||
160845909|NCT00853151|580822944|FG001|Overall Study|Sponsor Decision|3|||
160845910|NCT00853151|580822945|FG002|Overall Study|Sponsor Decision|0|||
160845911|NCT00853151|580822946|FG003|Overall Study|Sponsor Decision|0|||
160845912|NCT01751984|580822947|FG000|Overall Study|Adverse Event|5|||
160845913|NCT01751984|580822948|FG001|Overall Study|Adverse Event|3|||
160845914|NCT01751984|580822947|FG000|Overall Study|Withdrawal by Subject|0|||
160845915|NCT01751984|580822948|FG001|Overall Study|Withdrawal by Subject|1|||
160845916|NCT01751984|580822947|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
160845917|NCT01751984|580822948|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
160845918|NCT00587158|580822949|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
160845919|NCT00587158|580822950|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
160906047|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
160906048|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
160906049|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
160906050|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
160906051|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
160906052|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
160906053|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
160906054|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
160906055|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
160906056|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
160906057|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
160906058|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
160906059|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
160906060|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
160906061|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
160906062|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
160906063|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
160906064|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
160906065|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
160906066|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
160906067|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
160906068|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
160906069|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
160906070|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
160906071|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
160906072|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
160906073|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
160906074|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
160906075|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
160906076|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
160906077|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
160906078|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
160906079|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
160906080|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
160567740|NCT05738486|579802149|FG002|Overall Study|Adverse Event|4|||
160567741|NCT05738486|579802150|FG003|Overall Study|Adverse Event|5|||
160567742|NCT05738486|579802147|FG000|Overall Study|Physician Decision|0|||
160567743|NCT05738486|579802148|FG001|Overall Study|Physician Decision|2|||
160567744|NCT05738486|579802149|FG002|Overall Study|Physician Decision|4|||
160567745|NCT05738486|579802150|FG003|Overall Study|Physician Decision|1|||
160567746|NCT05738486|579802147|FG000|Overall Study|Lost to Follow-up|1|||
160567747|NCT05738486|579802148|FG001|Overall Study|Lost to Follow-up|1|||
160567748|NCT05738486|579802149|FG002|Overall Study|Lost to Follow-up|2|||
160567749|NCT05738486|579802150|FG003|Overall Study|Lost to Follow-up|1|||
160567750|NCT05738486|579802147|FG000|Overall Study|Participant was Non-ambulatory|0|||
160567751|NCT05738486|579802148|FG001|Overall Study|Participant was Non-ambulatory|0|||
160567752|NCT05738486|579802149|FG002|Overall Study|Participant was Non-ambulatory|1|||
160567753|NCT05738486|579802150|FG003|Overall Study|Participant was Non-ambulatory|0|||
160567754|NCT05738486|579802147|FG000|Overall Study|Participant had Poor Venous Access|0|||
160567755|NCT05738486|579802148|FG001|Overall Study|Participant had Poor Venous Access|0|||
160567756|NCT05738486|579802149|FG002|Overall Study|Participant had Poor Venous Access|0|||
160567757|NCT05738486|579802150|FG003|Overall Study|Participant had Poor Venous Access|1|||
160567758|NCT05738486|579802147|FG000|Overall Study|Assigned Treatment by Mistake|0|||
160567759|NCT05738486|579802148|FG001|Overall Study|Assigned Treatment by Mistake|0|||
160567760|NCT05738486|579802149|FG002|Overall Study|Assigned Treatment by Mistake|0|||
160567761|NCT05738486|579802150|FG003|Overall Study|Assigned Treatment by Mistake|1|||
160567762|NCT05738486|579802147|FG000|Overall Study|Death|0|||
160567763|NCT05738486|579802148|FG001|Overall Study|Death|0|||
160567764|NCT05738486|579802149|FG002|Overall Study|Death|1|||
160567765|NCT05738486|579802150|FG003|Overall Study|Death|0|||
160567766|NCT05738486|579802147|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
160567767|NCT05738486|579802148|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
160567768|NCT05738486|579802149|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
160567769|NCT05738486|579802150|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
160567770|NCT03395210|579802151|FG000|Overall Study|Other|0|||
160567771|NCT03395210|579802152|FG001|Overall Study|Other|0|||
160567772|NCT03395210|579802153|FG002|Overall Study|Other|0|||
160567773|NCT03395210|579802154|FG003|Overall Study|Other|0|||
160567774|NCT03395210|579802155|FG004|Overall Study|Other|1|||
160567775|NCT03395210|579802151|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
160567776|NCT03395210|579802152|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
160650140|NCT00095199|580100550|FG001|Overall Study|Liver function test results elevated|0|||
160567777|NCT03395210|579802153|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
160567778|NCT03395210|579802154|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
160567779|NCT03395210|579802155|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
160567780|NCT03395210|579802151|FG000|Overall Study|Adverse Event|1|||
160567781|NCT03395210|579802152|FG001|Overall Study|Adverse Event|0|||
160567782|NCT03395210|579802153|FG002|Overall Study|Adverse Event|2|||
160567783|NCT03395210|579802154|FG003|Overall Study|Adverse Event|4|||
160567784|NCT03395210|579802155|FG004|Overall Study|Adverse Event|3|||
160567785|NCT03395210|579802151|FG000|Overall Study|Need of Rescue Medication|1|||
160567786|NCT03395210|579802152|FG001|Overall Study|Need of Rescue Medication|0|||
160567787|NCT03395210|579802153|FG002|Overall Study|Need of Rescue Medication|1|||
160567788|NCT03395210|579802154|FG003|Overall Study|Need of Rescue Medication|4|||
160650141|NCT00095199|580100551|FG002|Overall Study|Liver function test results elevated|1|||
160567789|NCT03395210|579802155|FG004|Overall Study|Need of Rescue Medication|0|||
160567790|NCT03395210|579802151|FG000|Overall Study|Lack of Response|0|||
160567791|NCT03395210|579802152|FG001|Overall Study|Lack of Response|0|||
160567792|NCT03395210|579802153|FG002|Overall Study|Lack of Response|0|||
160567793|NCT03395210|579802154|FG003|Overall Study|Lack of Response|5|||
160567794|NCT03395210|579802155|FG004|Overall Study|Lack of Response|5|||
160567795|NCT03395210|579802151|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
160567796|NCT03395210|579802152|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
160567797|NCT03395210|579802153|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
160567798|NCT03395210|579802154|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
160567799|NCT03395210|579802155|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
160567800|NCT03395210|579802151|FG000|Overall Study|Participant Decision|1|||
160567801|NCT03395210|579802152|FG001|Overall Study|Participant Decision|1|||
160567802|NCT03395210|579802153|FG002|Overall Study|Participant Decision|0|||
160567803|NCT03395210|579802154|FG003|Overall Study|Participant Decision|4|||
160992379|NCT00662909|581360034|FG000|Overall Study|Non-compliance with study procedures|3|||
160992380|NCT00662909|581360035|FG001|Overall Study|Non-compliance with study procedures|3|||
160992381|NCT00662909|581360036|FG002|Overall Study|Non-compliance with study procedures|2|||
160992382|NCT00662909|581360034|FG000|Overall Study|Physician Decision|1|||
160992383|NCT00662909|581360035|FG001|Overall Study|Physician Decision|1|||
160992384|NCT00662909|581360036|FG002|Overall Study|Physician Decision|2|||
160992385|NCT00662909|581360034|FG000|Overall Study|Eligibility criterion not met|0|||
160992386|NCT00662909|581360035|FG001|Overall Study|Eligibility criterion not met|1|||
160992387|NCT00662909|581360036|FG002|Overall Study|Eligibility criterion not met|1|||
160992388|NCT01510912|581361340|FG000|Overall Study|Adverse Event|99|||
160992389|NCT01510912|581361340|FG000|Overall Study|Lack of Efficacy|12|||
160992390|NCT01510912|581361340|FG000|Overall Study|Non-compliance with trial drug|23|||
160992391|NCT01510912|581361340|FG000|Overall Study|Withdrawal by Subject|49|||
160992392|NCT01510912|581361340|FG000|Overall Study|Physician Decision|1|||
160992393|NCT01510912|581361340|FG000|Overall Study|Protocol Violation|27|||
160992394|NCT01510912|581361340|FG000|Overall Study|Lost to Follow-up|26|||
160992395|NCT01510912|581361340|FG000|Overall Study|Other, including joint replacement|5|||
160992396|NCT03179787|581361341|FG000|Overall Study|Lost to Follow-up|15|||
160992397|NCT03179787|581361341|FG000|Overall Study|Case report failures|2|||
160992398|NCT03179787|581361341|FG000|Overall Study|Treatment not administered|1|||
160992399|NCT03181958|581361342|FG000|Overall Study|Lost to Follow-up|17|||
160567804|NCT03395210|579802155|FG004|Overall Study|Participant Decision|0|||
160567805|NCT03395210|579802151|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
160567806|NCT03395210|579802152|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
160567807|NCT03395210|579802153|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
160567808|NCT03395210|579802154|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
160567809|NCT03395210|579802155|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
160567810|NCT01672892|579802156|FG000|Overall Study|Protocol Violation|7|||
160567811|NCT01672892|579802157|FG001|Overall Study|Protocol Violation|3|||
160567812|NCT02874794|579802172|FG000|Overall Study|Physician Decision|3|||
160567813|NCT02874794|579802173|FG001|Overall Study|Physician Decision|2|||
160567814|NCT02874794|579802172|FG000|Overall Study|Withdrawal by Subject|2|||
160567815|NCT02874794|579802173|FG001|Overall Study|Withdrawal by Subject|8|||
160567816|NCT02874794|579802172|FG000|Overall Study|Death|2|||
160567817|NCT02874794|579802173|FG001|Overall Study|Death|1|||
160567818|NCT01473004|579802174|FG000|Overall Study|Incomplete Lobar Treatment|1|||
160567819|NCT01473004|579802175|FG001|Overall Study|Incomplete Lobar Treatment|0|||
160567820|NCT01584024|579802179|FG000|Overall Study|Lost to Follow-up|10|||
160567821|NCT01584024|579802179|FG000|Overall Study|Withdrawal by Subject|3|||
160567822|NCT00613314|579802180|FG000|Overall Study|Adverse Event|5|||
160567823|NCT00613314|579802180|FG000|Overall Study|Protocol Violation|14|||
160567824|NCT00613314|579802180|FG000|Overall Study|Lost to Follow-up|46|||
160567825|NCT00613314|579802180|FG000|Overall Study|Other reason not defined above|90|||
160845920|NCT00587158|580822949|FG000|Overall Study|Physician Decision|0|||
160845921|NCT00587158|580822950|FG001|Overall Study|Physician Decision|1|||
160845922|NCT00587158|580822949|FG000|Overall Study|Lost to Follow-up|1|||
160845923|NCT00587158|580822950|FG001|Overall Study|Lost to Follow-up|2|||
160845924|NCT00587158|580822949|FG000|Overall Study|Death|0|||
160992400|NCT03181958|581361343|FG001|Overall Study|Lost to Follow-up|21|||
160992401|NCT03181958|581361344|FG002|Overall Study|Lost to Follow-up|15|||
160992402|NCT02030028|581361345|FG000|Overall Study|Withdrawal by Subject|4|||
160567826|NCT00719810|579802181|FG000|Overall Study|Adverse Event|0|||
160567827|NCT00719810|579802182|FG001|Overall Study|Adverse Event|2|||
160567828|NCT00719810|579802183|FG002|Overall Study|Adverse Event|3|||
160567829|NCT00719810|579802181|FG000|Overall Study|Lost to Follow-up|2|||
160567830|NCT00719810|579802182|FG001|Overall Study|Lost to Follow-up|0|||
160567831|NCT00719810|579802183|FG002|Overall Study|Lost to Follow-up|3|||
160567832|NCT00719810|579802181|FG000|Overall Study|Physician Decision|0|||
160567833|NCT00719810|579802182|FG001|Overall Study|Physician Decision|1|||
160845925|NCT00587158|580822950|FG001|Overall Study|Death|1|||
160567834|NCT00719810|579802183|FG002|Overall Study|Physician Decision|0|||
160567835|NCT00719810|579802181|FG000|Overall Study|Withdrawal by Subject|1|||
160567836|NCT00719810|579802182|FG001|Overall Study|Withdrawal by Subject|1|||
160567837|NCT00719810|579802183|FG002|Overall Study|Withdrawal by Subject|2|||
160567838|NCT04893265|579802206|FG000|Overall Study|Withdrawal by Subject|2|||
160567839|NCT04893265|579802207|FG001|Overall Study|Withdrawal by Subject|5|||
160567840|NCT04893265|579802206|FG000|Overall Study|Lost to Follow-up|0|||
160567841|NCT04893265|579802207|FG001|Overall Study|Lost to Follow-up|4|||
160567842|NCT02465034|579802208|FG000|Overall Study|Withdrawal by Subject|1|||
160567843|NCT02465034|579802209|FG001|Overall Study|Withdrawal by Subject|1|||
160567844|NCT02465034|579802208|FG000|Overall Study|Screen fail|2|||
160567845|NCT02465034|579802209|FG001|Overall Study|Screen fail|0|||
160567846|NCT02465034|579802208|FG000|Overall Study|Could not be scheduled for study visit|0|||
160567847|NCT02465034|579802209|FG001|Overall Study|Could not be scheduled for study visit|5|||
160845926|NCT00587158|580822949|FG000|Overall Study|Subject did not want to take study med|0|||
160845927|NCT00587158|580822950|FG001|Overall Study|Subject did not want to take study med|1|||
160845928|NCT01136408|580822951|FG000|Overall Study|Adverse Event|4|||
160845929|NCT01136408|580822952|FG001|Overall Study|Adverse Event|8|||
160845930|NCT01136408|580822953|FG002|Overall Study|Adverse Event|4|||
160845931|NCT01136408|580822951|FG000|Overall Study|Protocol Violation|1|||
160845932|NCT01136408|580822952|FG001|Overall Study|Protocol Violation|1|||
160845933|NCT01136408|580822953|FG002|Overall Study|Protocol Violation|1|||
160845934|NCT01510158|580822954|FG000|Overall Study|Adverse Event|7|||
160845935|NCT01510158|580822955|FG001|Overall Study|Adverse Event|8|||
160845936|NCT01510158|580822956|FG002|Overall Study|Adverse Event|5|||
160845937|NCT01510158|580822954|FG000|Overall Study|Gout flare|1|||
160845938|NCT01510158|580822955|FG001|Overall Study|Gout flare|0|||
160845939|NCT01510158|580822956|FG002|Overall Study|Gout flare|0|||
160567848|NCT00573131|579802210|FG000|Overall Study|Withdrawal by Subject|10|||
160567849|NCT00573131|579802211|FG001|Overall Study|Withdrawal by Subject|8|||
160567850|NCT02401256|579802216|FG000|Overall Study|Adverse Event|5|||
160567851|NCT02401256|579802216|FG000|Overall Study|Withdrawal by Subject|12|||
160567852|NCT00893789|579802217|FG000|Overall Study|Withdrawal by Subject|3|||
160567853|NCT00893789|579802218|FG001|Overall Study|Withdrawal by Subject|1|||
160567854|NCT00893789|579802219|FG002|Overall Study|Withdrawal by Subject|3|||
160567855|NCT00893789|579802220|FG003|Overall Study|Withdrawal by Subject|1|||
160567856|NCT00893789|579802217|FG000|Overall Study|Noncompliance With Study Drug|1|||
160567857|NCT00893789|579802218|FG001|Overall Study|Noncompliance With Study Drug|0|||
160567858|NCT00893789|579802219|FG002|Overall Study|Noncompliance With Study Drug|1|||
160567859|NCT00893789|579802220|FG003|Overall Study|Noncompliance With Study Drug|2|||
160567860|NCT00893789|579802217|FG000|Overall Study|Noncompliance With Study Procedures|1|||
160567861|NCT00893789|579802218|FG001|Overall Study|Noncompliance With Study Procedures|0|||
160567862|NCT00893789|579802219|FG002|Overall Study|Noncompliance With Study Procedures|0|||
160567863|NCT00893789|579802220|FG003|Overall Study|Noncompliance With Study Procedures|0|||
160567864|NCT00893789|579802217|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
160567865|NCT00893789|579802218|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
160567866|NCT00893789|579802219|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
160567867|NCT00893789|579802220|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
160567868|NCT00893789|579802217|FG000|Overall Study|Adverse Event|0|||
160567869|NCT00893789|579802218|FG001|Overall Study|Adverse Event|2|||
160567870|NCT00893789|579802219|FG002|Overall Study|Adverse Event|1|||
160567871|NCT00893789|579802220|FG003|Overall Study|Adverse Event|5|||
160567872|NCT00893789|579802217|FG000|Overall Study|Protocol Violation|0|||
160567873|NCT00893789|579802218|FG001|Overall Study|Protocol Violation|1|||
160567874|NCT00893789|579802219|FG002|Overall Study|Protocol Violation|1|||
160567875|NCT00893789|579802220|FG003|Overall Study|Protocol Violation|4|||
160567876|NCT00893789|579802217|FG000|Overall Study|Lost to Follow-up|0|||
160567877|NCT00893789|579802218|FG001|Overall Study|Lost to Follow-up|0|||
160567878|NCT00893789|579802219|FG002|Overall Study|Lost to Follow-up|0|||
160845940|NCT01510158|580822954|FG000|Overall Study|Protocol Violation|17|||
160845941|NCT01510158|580822955|FG001|Overall Study|Protocol Violation|16|||
160992403|NCT02030028|581361345|FG000|Overall Study|lack of transportation|1|||
160567879|NCT00893789|579802220|FG003|Overall Study|Lost to Follow-up|1|||
160567880|NCT02024464|579802221|FG000|Overall Study|Discontinued|5|||
160567881|NCT02024464|579802222|FG001|Overall Study|Discontinued|4|||
160567882|NCT02024464|579802221|FG000|Overall Study|Missed Visits|1|||
160567883|NCT02024464|579802222|FG001|Overall Study|Missed Visits|0|||
160567884|NCT02024464|579802221|FG000|Overall Study|Lost to Follow-up|4|||
160567885|NCT02024464|579802222|FG001|Overall Study|Lost to Follow-up|7|||
160567886|NCT00345605|579802227|FG000|Arm 1|Adverse Event|0|||
160567887|NCT00345605|579802228|FG001|Arm 1|Adverse Event|1|||
160567888|NCT00345605|579802227|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
160845942|NCT01510158|580822956|FG002|Overall Study|Protocol Violation|24|||
160567889|NCT00345605|579802228|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
160567890|NCT01324830|579802229|FG000|Overall Study|Progressive Disease|3|||
160567891|NCT01324830|579802230|FG001|Overall Study|Progressive Disease|2|||
160567892|NCT01324830|579802231|FG002|Overall Study|Progressive Disease|3|||
160567893|NCT01324830|579802232|FG003|Overall Study|Progressive Disease|3|||
160567894|NCT01324830|579802233|FG004|Overall Study|Progressive Disease|6|||
160567895|NCT01324830|579802234|FG005|Overall Study|Progressive Disease|6|||
160567896|NCT01324830|579802235|FG006|Overall Study|Progressive Disease|3|||
160567897|NCT01324830|579802236|FG007|Overall Study|Progressive Disease|3|||
160567898|NCT01324830|579802237|FG008|Overall Study|Progressive Disease|3|||
160845943|NCT01510158|580822954|FG000|Overall Study|Sponsor terminated study.|2|||
160845944|NCT01510158|580822955|FG001|Overall Study|Sponsor terminated study.|0|||
160845945|NCT01510158|580822956|FG002|Overall Study|Sponsor terminated study.|2|||
160845946|NCT01510158|580822954|FG000|Overall Study|Lost to Follow-up|13|||
160845947|NCT01510158|580822955|FG001|Overall Study|Lost to Follow-up|16|||
160567899|NCT01324830|579802238|FG009|Overall Study|Progressive Disease|6|||
160567900|NCT01324830|579802239|FG010|Overall Study|Progressive Disease|2|||
160567901|NCT01324830|579802240|FG011|Overall Study|Progressive Disease|1|||
160567902|NCT01324830|579802241|FG012|Overall Study|Progressive Disease|1|||
160567903|NCT01324830|579802242|FG013|Overall Study|Progressive Disease|1|||
160567904|NCT01324830|579802243|FG014|Overall Study|Progressive Disease|1|||
160567905|NCT01324830|579802244|FG015|Overall Study|Progressive Disease|3|||
160567906|NCT01324830|579802245|FG016|Overall Study|Progressive Disease|2|||
160567907|NCT01324830|579802246|FG017|Overall Study|Progressive Disease|3|||
160567908|NCT01324830|579802247|FG018|Overall Study|Progressive Disease|4|||
160567909|NCT01324830|579802229|FG000|Overall Study|Dose limiting toxicity|0|||
160567910|NCT01324830|579802230|FG001|Overall Study|Dose limiting toxicity|0|||
160567911|NCT01324830|579802231|FG002|Overall Study|Dose limiting toxicity|0|||
160567912|NCT01324830|579802232|FG003|Overall Study|Dose limiting toxicity|0|||
160567913|NCT01324830|579802233|FG004|Overall Study|Dose limiting toxicity|1|||
160567914|NCT01324830|579802234|FG005|Overall Study|Dose limiting toxicity|0|||
160567915|NCT01324830|579802235|FG006|Overall Study|Dose limiting toxicity|0|||
160567916|NCT01324830|579802236|FG007|Overall Study|Dose limiting toxicity|0|||
160567917|NCT01324830|579802237|FG008|Overall Study|Dose limiting toxicity|0|||
160567918|NCT01324830|579802238|FG009|Overall Study|Dose limiting toxicity|0|||
160567919|NCT01324830|579802239|FG010|Overall Study|Dose limiting toxicity|0|||
160650142|NCT00095199|580100552|FG003|Overall Study|Liver function test results elevated|1|||
160845948|NCT01510158|580822956|FG002|Overall Study|Lost to Follow-up|9|||
160845949|NCT01510158|580822954|FG000|Overall Study|Withdrawal by Subject|10|||
160845950|NCT01510158|580822955|FG001|Overall Study|Withdrawal by Subject|13|||
160845951|NCT01510158|580822956|FG002|Overall Study|Withdrawal by Subject|10|||
160845952|NCT01510158|580822954|FG000|Overall Study|Death|1|||
160845953|NCT01510158|580822955|FG001|Overall Study|Death|0|||
160845954|NCT01510158|580822956|FG002|Overall Study|Death|0|||
160845955|NCT03078556|580822957|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
160845956|NCT03078556|580822958|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
160906081|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
160906082|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
160906083|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
160906084|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
160906085|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
160906086|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
160906087|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
160906088|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
160906089|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
160906090|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
160906091|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
160906092|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
160906093|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
160906094|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
160906095|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
160567920|NCT01324830|579802240|FG011|Overall Study|Dose limiting toxicity|0|||
160845957|NCT03078556|580822959|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
160845958|NCT03078556|580822960|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
160845959|NCT03078556|580822957|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
160567921|NCT01324830|579802241|FG012|Overall Study|Dose limiting toxicity|0|||
160567922|NCT01324830|579802242|FG013|Overall Study|Dose limiting toxicity|0|||
160567923|NCT01324830|579802243|FG014|Overall Study|Dose limiting toxicity|0|||
160567924|NCT01324830|579802244|FG015|Overall Study|Dose limiting toxicity|0|||
160567925|NCT01324830|579802245|FG016|Overall Study|Dose limiting toxicity|1|||
160567926|NCT01324830|579802246|FG017|Overall Study|Dose limiting toxicity|1|||
160845960|NCT03078556|580822958|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
160567927|NCT01324830|579802247|FG018|Overall Study|Dose limiting toxicity|1|||
160567928|NCT01324830|579802229|FG000|Overall Study|Reason not mentioned above|0|||
160567929|NCT01324830|579802230|FG001|Overall Study|Reason not mentioned above|0|||
160567930|NCT01324830|579802231|FG002|Overall Study|Reason not mentioned above|0|||
160567931|NCT01324830|579802232|FG003|Overall Study|Reason not mentioned above|0|||
160567932|NCT01324830|579802233|FG004|Overall Study|Reason not mentioned above|0|||
160567933|NCT01324830|579802234|FG005|Overall Study|Reason not mentioned above|0|||
160567934|NCT01324830|579802235|FG006|Overall Study|Reason not mentioned above|0|||
160567935|NCT01324830|579802236|FG007|Overall Study|Reason not mentioned above|0|||
160567936|NCT01324830|579802237|FG008|Overall Study|Reason not mentioned above|0|||
160567937|NCT01324830|579802238|FG009|Overall Study|Reason not mentioned above|0|||
160567938|NCT01324830|579802239|FG010|Overall Study|Reason not mentioned above|0|||
160567939|NCT01324830|579802240|FG011|Overall Study|Reason not mentioned above|0|||
160567940|NCT01324830|579802241|FG012|Overall Study|Reason not mentioned above|0|||
160567941|NCT01324830|579802242|FG013|Overall Study|Reason not mentioned above|0|||
160567942|NCT01324830|579802243|FG014|Overall Study|Reason not mentioned above|0|||
160567943|NCT01324830|579802244|FG015|Overall Study|Reason not mentioned above|0|||
160567944|NCT01324830|579802245|FG016|Overall Study|Reason not mentioned above|0|||
160567945|NCT01324830|579802246|FG017|Overall Study|Reason not mentioned above|1|||
160567946|NCT01324830|579802247|FG018|Overall Study|Reason not mentioned above|0|||
160567947|NCT01324830|579802229|FG000|Overall Study|Adverse Event, serious fatal|0|||
160567948|NCT01324830|579802230|FG001|Overall Study|Adverse Event, serious fatal|1|||
160567949|NCT01324830|579802231|FG002|Overall Study|Adverse Event, serious fatal|0|||
160567950|NCT01324830|579802232|FG003|Overall Study|Adverse Event, serious fatal|0|||
160567951|NCT01324830|579802233|FG004|Overall Study|Adverse Event, serious fatal|0|||
160567952|NCT01324830|579802234|FG005|Overall Study|Adverse Event, serious fatal|0|||
160567953|NCT01324830|579802235|FG006|Overall Study|Adverse Event, serious fatal|0|||
160567954|NCT01324830|579802236|FG007|Overall Study|Adverse Event, serious fatal|0|||
160567955|NCT01324830|579802237|FG008|Overall Study|Adverse Event, serious fatal|0|||
160567956|NCT01324830|579802238|FG009|Overall Study|Adverse Event, serious fatal|0|||
160567957|NCT01324830|579802239|FG010|Overall Study|Adverse Event, serious fatal|0|||
160567958|NCT01324830|579802240|FG011|Overall Study|Adverse Event, serious fatal|0|||
160567959|NCT01324830|579802241|FG012|Overall Study|Adverse Event, serious fatal|0|||
160567960|NCT01324830|579802242|FG013|Overall Study|Adverse Event, serious fatal|0|||
160567961|NCT01324830|579802243|FG014|Overall Study|Adverse Event, serious fatal|0|||
160567962|NCT01324830|579802244|FG015|Overall Study|Adverse Event, serious fatal|0|||
160567963|NCT01324830|579802245|FG016|Overall Study|Adverse Event, serious fatal|0|||
160567964|NCT01324830|579802246|FG017|Overall Study|Adverse Event, serious fatal|0|||
160567965|NCT01324830|579802247|FG018|Overall Study|Adverse Event, serious fatal|0|||
160567966|NCT01324830|579802229|FG000|Overall Study|Adverse Event, non-fatal|0|||
160567967|NCT01324830|579802230|FG001|Overall Study|Adverse Event, non-fatal|0|||
160567968|NCT01324830|579802231|FG002|Overall Study|Adverse Event, non-fatal|0|||
160567969|NCT01324830|579802232|FG003|Overall Study|Adverse Event, non-fatal|0|||
160567970|NCT01324830|579802233|FG004|Overall Study|Adverse Event, non-fatal|0|||
160567971|NCT01324830|579802234|FG005|Overall Study|Adverse Event, non-fatal|0|||
160567972|NCT01324830|579802235|FG006|Overall Study|Adverse Event, non-fatal|0|||
160567973|NCT01324830|579802236|FG007|Overall Study|Adverse Event, non-fatal|0|||
160567974|NCT01324830|579802237|FG008|Overall Study|Adverse Event, non-fatal|2|||
160567975|NCT01324830|579802238|FG009|Overall Study|Adverse Event, non-fatal|0|||
160567976|NCT01324830|579802239|FG010|Overall Study|Adverse Event, non-fatal|1|||
160567977|NCT01324830|579802240|FG011|Overall Study|Adverse Event, non-fatal|0|||
160567978|NCT01324830|579802241|FG012|Overall Study|Adverse Event, non-fatal|0|||
160567979|NCT01324830|579802242|FG013|Overall Study|Adverse Event, non-fatal|0|||
160845961|NCT03078556|580822959|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
160845962|NCT03078556|580822960|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
160845963|NCT03078556|580822957|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
160845964|NCT03078556|580822958|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
160845965|NCT03078556|580822959|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
160845966|NCT03078556|580822960|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
160845967|NCT03078556|580822957|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
160845968|NCT03078556|580822958|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
160567980|NCT01324830|579802243|FG014|Overall Study|Adverse Event, non-fatal|0|||
160567981|NCT01324830|579802244|FG015|Overall Study|Adverse Event, non-fatal|0|||
160567982|NCT01324830|579802245|FG016|Overall Study|Adverse Event, non-fatal|0|||
160567983|NCT01324830|579802246|FG017|Overall Study|Adverse Event, non-fatal|1|||
160567984|NCT01324830|579802247|FG018|Overall Study|Adverse Event, non-fatal|0|||
160567985|NCT01324830|579802229|FG000|Overall Study|Withdrawal by Subject|0|||
160567986|NCT01324830|579802230|FG001|Overall Study|Withdrawal by Subject|0|||
160567987|NCT01324830|579802231|FG002|Overall Study|Withdrawal by Subject|0|||
160567988|NCT01324830|579802232|FG003|Overall Study|Withdrawal by Subject|0|||
160567989|NCT01324830|579802233|FG004|Overall Study|Withdrawal by Subject|0|||
160845969|NCT03078556|580822959|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
160845970|NCT03078556|580822960|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
160845971|NCT00832416|580822967|FG000|Overall Study|Lack of Efficacy|17|||
160845972|NCT00832416|580822968|FG001|Overall Study|Lack of Efficacy|15|||
160845973|NCT00832416|580822969|FG002|Overall Study|Lack of Efficacy|13|||
160845974|NCT00832416|580822970|FG003|Overall Study|Lack of Efficacy|52|||
160845975|NCT00832416|580822967|FG000|Overall Study|Withdrawal by Subject|5|||
160845976|NCT00832416|580822968|FG001|Overall Study|Withdrawal by Subject|7|||
160845977|NCT00832416|580822969|FG002|Overall Study|Withdrawal by Subject|2|||
160845978|NCT00832416|580822970|FG003|Overall Study|Withdrawal by Subject|10|||
160845979|NCT00832416|580822967|FG000|Overall Study|Physician Decision|2|||
160845980|NCT00832416|580822968|FG001|Overall Study|Physician Decision|12|||
160845981|NCT00832416|580822969|FG002|Overall Study|Physician Decision|5|||
160845982|NCT00832416|580822970|FG003|Overall Study|Physician Decision|10|||
160845983|NCT00832416|580822967|FG000|Overall Study|Administrative|0|||
160845984|NCT00832416|580822968|FG001|Overall Study|Administrative|0|||
160845985|NCT00832416|580822969|FG002|Overall Study|Administrative|0|||
160845986|NCT00832416|580822970|FG003|Overall Study|Administrative|1|||
160845987|NCT00832416|580822967|FG000|Overall Study|Adverse Event|21|||
160845988|NCT00832416|580822968|FG001|Overall Study|Adverse Event|19|||
160845989|NCT00832416|580822969|FG002|Overall Study|Adverse Event|41|||
160845990|NCT00832416|580822970|FG003|Overall Study|Adverse Event|10|||
160845991|NCT00832416|580822967|FG000|Overall Study|Death|1|||
160845992|NCT00832416|580822968|FG001|Overall Study|Death|0|||
160845993|NCT00832416|580822969|FG002|Overall Study|Death|0|||
160845994|NCT00832416|580822970|FG003|Overall Study|Death|0|||
160845995|NCT04421482|580822977|FG000|Overall Study|Physician Decision|1|||
160845996|NCT00571038|580822980|FG000|Overall Study|Lost to Follow-up|1|||
160845997|NCT00571038|580822981|FG001|Overall Study|Lost to Follow-up|4|||
160845998|NCT00571038|580822980|FG000|Overall Study|Death|7|||
160845999|NCT00571038|580822981|FG001|Overall Study|Death|5|||
160846000|NCT00571038|580822980|FG000|Overall Study|Withdrawal by Subject|1|||
160846001|NCT00571038|580822981|FG001|Overall Study|Withdrawal by Subject|3|||
160906096|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Change of location|0|||
160906097|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Change of location|0|||
160567990|NCT01324830|579802234|FG005|Overall Study|Withdrawal by Subject|1|||
160567991|NCT01324830|579802235|FG006|Overall Study|Withdrawal by Subject|0|||
160567992|NCT01324830|579802236|FG007|Overall Study|Withdrawal by Subject|0|||
160567993|NCT01324830|579802237|FG008|Overall Study|Withdrawal by Subject|0|||
160567994|NCT01324830|579802238|FG009|Overall Study|Withdrawal by Subject|0|||
160567995|NCT01324830|579802239|FG010|Overall Study|Withdrawal by Subject|1|||
160567996|NCT01324830|579802240|FG011|Overall Study|Withdrawal by Subject|0|||
160567997|NCT01324830|579802241|FG012|Overall Study|Withdrawal by Subject|0|||
160567998|NCT01324830|579802242|FG013|Overall Study|Withdrawal by Subject|0|||
160567999|NCT01324830|579802243|FG014|Overall Study|Withdrawal by Subject|0|||
160568000|NCT01324830|579802244|FG015|Overall Study|Withdrawal by Subject|0|||
160568001|NCT01324830|579802245|FG016|Overall Study|Withdrawal by Subject|0|||
160568002|NCT01324830|579802246|FG017|Overall Study|Withdrawal by Subject|0|||
160568003|NCT01324830|579802247|FG018|Overall Study|Withdrawal by Subject|1|||
160906098|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Change of location|0|||
160568004|NCT00817414|579802248|FG000|Overall Study|Adverse Event|1|||
160568005|NCT00817414|579802249|FG001|Overall Study|Adverse Event|1|||
160568006|NCT00817414|579802250|FG002|Overall Study|Adverse Event|1|||
160568007|NCT00817414|579802251|FG003|Overall Study|Adverse Event|0|||
160568008|NCT00817414|579802252|FG004|Overall Study|Adverse Event|0|||
160571874|NCT00491530|579816848|FG002|Overall Study|Withdrawal by Subject|0|||
160571875|NCT00491530|579816846|FG000|Overall Study|Lost to Follow-up|3|||
160571876|NCT00491530|579816847|FG001|Overall Study|Lost to Follow-up|2|||
160571877|NCT00491530|579816848|FG002|Overall Study|Lost to Follow-up|2|||
160571878|NCT00491530|579816846|FG000|Overall Study|Lack of Efficacy|0|||
160571879|NCT00491530|579816847|FG001|Overall Study|Lack of Efficacy|1|||
160571880|NCT00491530|579816848|FG002|Overall Study|Lack of Efficacy|0|||
160571881|NCT00491530|579816846|FG000|Overall Study|Investigator Discretion|0|||
160571882|NCT00491530|579816847|FG001|Overall Study|Investigator Discretion|1|||
160571883|NCT00491530|579816848|FG002|Overall Study|Investigator Discretion|0|||
160571884|NCT00491530|579816846|FG000|Overall Study|Patient Request|0|||
160571885|NCT00491530|579816847|FG001|Overall Study|Patient Request|1|||
160571886|NCT00491530|579816848|FG002|Overall Study|Patient Request|0|||
160571887|NCT00491530|579816846|FG000|Overall Study|Use of Prohibited Medication|0|||
160571888|NCT00491530|579816847|FG001|Overall Study|Use of Prohibited Medication|0|||
160571889|NCT00491530|579816848|FG002|Overall Study|Use of Prohibited Medication|1|||
160571890|NCT02168946|579816852|FG000|Overall Study|Adverse Event|8|||
160571891|NCT02168946|579816853|FG001|Overall Study|Adverse Event|5|||
160571892|NCT02168946|579816852|FG000|Overall Study|Lost to Follow-up|3|||
160571893|NCT02168946|579816853|FG001|Overall Study|Lost to Follow-up|0|||
160571894|NCT02168946|579816852|FG000|Overall Study|Subject unable to come back for visits|1|||
160571895|NCT02168946|579816853|FG001|Overall Study|Subject unable to come back for visits|0|||
160846002|NCT00571038|580822980|FG000|Overall Study|Moved out of state|2|||
160846003|NCT00571038|580822981|FG001|Overall Study|Moved out of state|2|||
160846004|NCT05786508|580822982|FG000|Overall Study|Withdrawal by Subject|2|||
160846005|NCT05786508|580822983|FG001|Overall Study|Withdrawal by Subject|0|||
160846006|NCT02588261|580822986|FG000|Overall Study|Study Terminated by Sponsor|157|||
160846007|NCT02588261|580822987|FG001|Overall Study|Study Terminated by Sponsor|142|||
160846008|NCT02588261|580822986|FG000|Overall Study|Protocol Deviation|1|||
160846009|NCT02588261|580822987|FG001|Overall Study|Protocol Deviation|0|||
160846010|NCT02588261|580822986|FG000|Overall Study|Death|1|||
160846011|NCT02588261|580822987|FG001|Overall Study|Death|2|||
160846012|NCT02588261|580822986|FG000|Overall Study|Withdrawal by Subject|12|||
160846013|NCT02588261|580822987|FG001|Overall Study|Withdrawal by Subject|8|||
160846014|NCT02588261|580822986|FG000|Overall Study|Noncompliance with Study Drug|0|||
160846015|NCT02588261|580822987|FG001|Overall Study|Noncompliance with Study Drug|1|||
160846016|NCT02588261|580822986|FG000|Overall Study|Miscellaneous|5|||
160846017|NCT02588261|580822987|FG001|Overall Study|Miscellaneous|4|||
160846018|NCT02588261|580822986|FG000|Overall Study|Progressive Disease|61|||
160846019|NCT02588261|580822987|FG001|Overall Study|Progressive Disease|82|||
160846020|NCT02588261|580822986|FG000|Overall Study|Adverse Event|29|||
160846021|NCT02588261|580822987|FG001|Overall Study|Adverse Event|24|||
160846022|NCT02588261|580822986|FG000|Overall Study|Lost to Follow-up|1|||
160846023|NCT02588261|580822987|FG001|Overall Study|Lost to Follow-up|0|||
160846024|NCT02652156|580822988|FG000|Overall Study|Physician Decision|1|||
160846025|NCT02652156|580822989|FG001|Overall Study|Physician Decision|0|||
160846026|NCT02652156|580822990|FG002|Overall Study|Physician Decision|0|||
160846027|NCT03329846|580822991|FG000|Overall Study|Disease progression|4|||
160846028|NCT03329846|580822992|FG001|Overall Study|Disease progression|6|||
160846029|NCT03329846|580822991|FG000|Overall Study|Study drug toxicity|1|||
160846030|NCT03329846|580822992|FG001|Overall Study|Study drug toxicity|0|||
160846031|NCT03329846|580822991|FG000|Overall Study|Participant request to discontinue treatment|0|||
160846032|NCT03329846|580822992|FG001|Overall Study|Participant request to discontinue treatment|1|||
160568009|NCT00817414|579802248|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
160568010|NCT00817414|579802249|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
160568011|NCT00817414|579802250|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
160568012|NCT00817414|579802251|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
160568013|NCT00817414|579802252|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
160568014|NCT00817414|579802248|FG000|Overall Study|Withdrawal by Subject|1|||
160568015|NCT00817414|579802249|FG001|Overall Study|Withdrawal by Subject|1|||
160568016|NCT00817414|579802250|FG002|Overall Study|Withdrawal by Subject|0|||
160568017|NCT00817414|579802251|FG003|Overall Study|Withdrawal by Subject|0|||
160568018|NCT00817414|579802252|FG004|Overall Study|Withdrawal by Subject|0|||
160568019|NCT00817414|579802248|FG000|Overall Study|Lost to Follow-up|0|||
160568020|NCT00817414|579802249|FG001|Overall Study|Lost to Follow-up|0|||
160568021|NCT00817414|579802250|FG002|Overall Study|Lost to Follow-up|1|||
160568022|NCT00817414|579802251|FG003|Overall Study|Lost to Follow-up|1|||
160568023|NCT00817414|579802252|FG004|Overall Study|Lost to Follow-up|1|||
160568024|NCT00817414|579802248|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
160568025|NCT00817414|579802249|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
160568026|NCT00817414|579802250|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
160568027|NCT00817414|579802251|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
160568028|NCT00817414|579802252|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
160568029|NCT00817414|579802248|FG000|Overall Study|Protocol Violation|0|||
160650143|NCT00095199|580100549|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
160846033|NCT03329846|580822991|FG000|Overall Study|Participant withdrew consent|1|||
160568030|NCT00817414|579802249|FG001|Overall Study|Protocol Violation|0|||
160568031|NCT00817414|579802250|FG002|Overall Study|Protocol Violation|0|||
160568032|NCT00817414|579802251|FG003|Overall Study|Protocol Violation|0|||
160568033|NCT00817414|579802252|FG004|Overall Study|Protocol Violation|1|||
160568034|NCT01126619|579802263|FG000|Overall Study|Not eligible for the study|2|||
160846034|NCT03329846|580822992|FG001|Overall Study|Participant withdrew consent|0|||
160846035|NCT03329846|580822991|FG000|Overall Study|Other reasons|2|||
160568035|NCT01126619|579802263|FG000|Overall Study|Investigator decision|4|||
160846036|NCT03329846|580822992|FG001|Overall Study|Other reasons|2|||
160846037|NCT03066193|580822993|FG000|Overall Study|Withdrawal by Subject|1|||
160846038|NCT04034004|580822997|FG000|Overall Study|Withdrawal by Subject|1|||
160846039|NCT04034004|580822998|FG001|Overall Study|Withdrawal by Subject|2|||
160846040|NCT04034004|580822999|FG002|Overall Study|Withdrawal by Subject|2|||
160846041|NCT04034004|580823000|FG003|Overall Study|Withdrawal by Subject|3|||
160568036|NCT01126619|579802263|FG000|Overall Study|Serious adverse event|1|||
160846042|NCT04034004|580822997|FG000|Overall Study|could not find vein to administer IV|2|||
160846043|NCT04034004|580822998|FG001|Overall Study|could not find vein to administer IV|1|||
160846044|NCT04034004|580822999|FG002|Overall Study|could not find vein to administer IV|0|||
160568037|NCT01126619|579802263|FG000|Overall Study|Withdrawal by Subject|9|||
160568038|NCT01126619|579802263|FG000|Overall Study|Non-compliance|1|||
160846045|NCT04034004|580823000|FG003|Overall Study|could not find vein to administer IV|0|||
160846046|NCT04034004|580822997|FG000|Overall Study|nurse accidentally unblinded subject|0|||
160846047|NCT04034004|580822998|FG001|Overall Study|nurse accidentally unblinded subject|0|||
160846048|NCT04034004|580822999|FG002|Overall Study|nurse accidentally unblinded subject|0|||
160846049|NCT04034004|580823000|FG003|Overall Study|nurse accidentally unblinded subject|1|||
160846050|NCT01397461|580823001|FG000|Overall Study|Withdrawal by Subject|2|||
160846051|NCT01397461|580823002|FG001|Overall Study|Withdrawal by Subject|1|||
160846052|NCT01397461|580823003|FG002|Overall Study|Withdrawal by Subject|0|||
160846053|NCT01397461|580823001|FG000|Overall Study|Lost to Follow-up|0|||
160846054|NCT01397461|580823002|FG001|Overall Study|Lost to Follow-up|2|||
160846055|NCT01397461|580823003|FG002|Overall Study|Lost to Follow-up|1|||
160846056|NCT01397461|580823001|FG000|Overall Study|Lack of Efficacy|0|||
160846057|NCT01397461|580823002|FG001|Overall Study|Lack of Efficacy|3|||
160846058|NCT01397461|580823003|FG002|Overall Study|Lack of Efficacy|0|||
160846059|NCT01397461|580823001|FG000|Overall Study|Not treated|0|||
160846060|NCT01397461|580823002|FG001|Overall Study|Not treated|0|||
160846061|NCT01397461|580823003|FG002|Overall Study|Not treated|1|||
160846062|NCT03364738|580823024|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
160846063|NCT03364738|580823024|FG000|Overall Study|Withdrawal by Subject|1|||
160846064|NCT03364738|580823024|FG000|Overall Study|Adverse Event|1|||
160568039|NCT04876391|579802264|FG000|Overall Study|Withdrawal by Subject|1|||
160568040|NCT04876391|579802265|FG001|Overall Study|Withdrawal by Subject|10|||
160568041|NCT04876391|579802264|FG000|Overall Study|Lost to Follow-up|2|||
160568042|NCT04876391|579802265|FG001|Overall Study|Lost to Follow-up|4|||
160568043|NCT04876391|579802264|FG000|Overall Study|Lack of Efficacy|0|||
160568044|NCT04876391|579802265|FG001|Overall Study|Lack of Efficacy|2|||
160568045|NCT04876391|579802264|FG000|Overall Study|Adverse Event|3|||
160568046|NCT04876391|579802265|FG001|Overall Study|Adverse Event|1|||
160568047|NCT04876391|579802264|FG000|Overall Study|Patient non-compliance|0|||
160846065|NCT03245398|580823025|FG000|Overall Study|Travelled to another island|1|||
160568048|NCT04876391|579802265|FG001|Overall Study|Patient non-compliance|1|||
160568049|NCT04876391|579802264|FG000|Overall Study|Personal reasons|0|||
160568050|NCT04876391|579802265|FG001|Overall Study|Personal reasons|1|||
160568051|NCT04876391|579802264|FG000|Overall Study|Withdrawn as per protocol|2|||
160568052|NCT04876391|579802265|FG001|Overall Study|Withdrawn as per protocol|2|||
160568053|NCT00811252|579802268|FG000|Overall Study|Adverse Event|6|||
160568054|NCT00811252|579802269|FG001|Overall Study|Adverse Event|10|||
160568055|NCT00811252|579802270|FG002|Overall Study|Adverse Event|15|||
160568056|NCT00811252|579802268|FG000|Overall Study|Lack of Efficacy|7|||
160568057|NCT00811252|579802269|FG001|Overall Study|Lack of Efficacy|2|||
160568058|NCT00811252|579802270|FG002|Overall Study|Lack of Efficacy|0|||
160568059|NCT00811252|579802268|FG000|Overall Study|Protocol Violation|3|||
160568060|NCT00811252|579802269|FG001|Overall Study|Protocol Violation|3|||
160568061|NCT00811252|579802270|FG002|Overall Study|Protocol Violation|2|||
160568062|NCT00811252|579802268|FG000|Overall Study|Withdrawal of Consent|1|||
160568063|NCT00811252|579802269|FG001|Overall Study|Withdrawal of Consent|2|||
160568064|NCT00811252|579802270|FG002|Overall Study|Withdrawal of Consent|2|||
160568065|NCT00811252|579802268|FG000|Overall Study|Lost to Follow-up|0|||
160568066|NCT00811252|579802269|FG001|Overall Study|Lost to Follow-up|0|||
160568067|NCT00811252|579802270|FG002|Overall Study|Lost to Follow-up|2|||
160568068|NCT00811252|579802268|FG000|Overall Study|Administrative or Other Reasons|0|||
160650144|NCT00095199|580100550|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
160650145|NCT00095199|580100551|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
160650146|NCT00095199|580100552|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
160650147|NCT00095199|580100549|FG000|Overall Study|Physician Decision|5|||
160650148|NCT00095199|580100550|FG001|Overall Study|Physician Decision|6|||
160568069|NCT00811252|579802269|FG001|Overall Study|Administrative or Other Reasons|3|||
160846066|NCT03245398|580823026|FG001|Overall Study|Travelled to another island|0|||
160846067|NCT02735343|580823028|FG000|Overall Study|screen fail|0|||
160846068|NCT02735343|580823029|FG001|Overall Study|screen fail|2|||
160846069|NCT04531241|580823039|FG000|Period 1|Withdrawal by Subject|2|||
160846070|NCT04531241|580823040|FG001|Period 1|Withdrawal by Subject|0|||
160906099|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Change of location|1|||
160906100|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Change of location|0|||
160906101|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
160906102|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
160906103|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
160906104|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
160906105|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
160906106|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
160568070|NCT00811252|579802270|FG002|Overall Study|Administrative or Other Reasons|2|||
160568071|NCT00892437|579802272|FG000|Randomized Phase|Randomized but not treated|6|||
160568072|NCT00892437|579802273|FG001|Randomized Phase|Randomized but not treated|0|||
160568073|NCT00892437|579802272|FG000|Randomized Phase|Adverse Event|2|||
160568074|NCT00892437|579802273|FG001|Randomized Phase|Adverse Event|2|||
160568075|NCT00892437|579802272|FG000|Randomized Phase|Lost to Follow-up|1|||
160568076|NCT00892437|579802273|FG001|Randomized Phase|Lost to Follow-up|3|||
160568077|NCT00892437|579802272|FG000|Randomized Phase|Investigator's Discretion|1|||
160846071|NCT04531241|580823039|FG000|Period 1|Dispesed incorrect lens power|1|||
160846072|NCT04531241|580823040|FG001|Period 1|Dispesed incorrect lens power|0|||
160846073|NCT04531241|580823039|FG000|Period 1|Protocol Violation|1|||
160846074|NCT04531241|580823040|FG001|Period 1|Protocol Violation|0|||
160846075|NCT04531241|580823039|FG000|Period 1|No longer eligible|0|||
160846076|NCT04531241|580823040|FG001|Period 1|No longer eligible|1|||
160846077|NCT04531241|580823039|FG000|Period 1|Lens Discomfort|0|||
160568078|NCT00892437|579802273|FG001|Randomized Phase|Investigator's Discretion|0|||
160568079|NCT00892437|579802272|FG000|Randomized Phase|Withdrew Consent|1|||
160568080|NCT00892437|579802273|FG001|Randomized Phase|Withdrew Consent|0|||
160568081|NCT00892437|579802272|FG000|Open-Label Extension Phase|Adverse Event|4|||
160568082|NCT00892437|579802273|FG001|Open-Label Extension Phase|Adverse Event|2|||
160568083|NCT00892437|579802272|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
160568084|NCT00892437|579802273|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
160568085|NCT00892437|579802272|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
160568086|NCT00892437|579802273|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
160568087|NCT00892437|579802272|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
160568088|NCT00892437|579802273|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
160568089|NCT00892437|579802272|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
160568090|NCT00892437|579802273|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
160568091|NCT00504257|579802274|FG000|Overall Study|Withdrawal by Subject|2|||
160568092|NCT00504257|579802274|FG000|Overall Study|ineligible histology|2|||
160568093|NCT02286960|579802275|FG000|Overall Study|Lost to Follow-up|3|||
160568094|NCT02286960|579802276|FG001|Overall Study|Lost to Follow-up|3|||
160568095|NCT02750410|579802277|FG000|Double-Blind Treatment Period|Adverse Event|2|||
160568096|NCT02750410|579802278|FG001|Double-Blind Treatment Period|Adverse Event|2|||
160568097|NCT02750410|579802277|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160568098|NCT02750410|579802278|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160568099|NCT02750410|579802277|FG000|Open-Label Extension Period|Adverse Event|5|||
160568100|NCT02750410|579802278|FG001|Open-Label Extension Period|Adverse Event|3|||
160568101|NCT02750410|579802277|FG000|Open-Label Extension Period|Protocol Violation|0|||
160568102|NCT02750410|579802278|FG001|Open-Label Extension Period|Protocol Violation|1|||
160568103|NCT02750410|579802277|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
160568104|NCT02750410|579802278|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
160568105|NCT02504541|579802279|FG000|Overall Study|Adverse Event|4|||
160568106|NCT02504541|579802279|FG000|Overall Study|Withdrawal by Subject|4|||
160568107|NCT02504541|579802279|FG000|Overall Study|Lost to Follow-up|1|||
160568108|NCT02504541|579802279|FG000|Overall Study|Met Stopping Criteria|1|||
160568109|NCT02504541|579802279|FG000|Overall Study|Protocol Violation|2|||
160568110|NCT02504541|579802279|FG000|Overall Study|Termination by Sponsor|1|||
160568111|NCT02504541|579802279|FG000|Overall Study|Other|2|||
160568112|NCT02504541|579802279|FG000|Overall Study|Multiple|5|||
160568113|NCT03215277|579802280|FG000|Overall Study|Adverse Event|2|||
160568114|NCT03215277|579802281|FG001|Overall Study|Adverse Event|3|||
160846078|NCT04531241|580823040|FG001|Period 1|Lens Discomfort|1|||
160846079|NCT04531241|580823039|FG000|Period 2|Covid-19 Related|1|||
160846080|NCT04531241|580823040|FG001|Period 2|Covid-19 Related|1|||
160846081|NCT03983304|580823041|FG000|Overall Study|Withdrawal by Subject|5|||
160846082|NCT03983304|580823041|FG000|Overall Study|Lost to Follow-up|2|||
160846083|NCT01702246|580823042|FG000|Overall Study|Lost to Follow-up|2|||
160846084|NCT01702246|580823042|FG000|Overall Study|Withdrawal by Subject|2|||
160846085|NCT01702246|580823042|FG000|Overall Study|Physician Decision|1|||
160846086|NCT01518374|580823045|FG000|Overall Study|Withdrawal by Subject|2|||
160846087|NCT01518374|580823045|FG000|Overall Study|Protocol Violation|3|||
160846088|NCT01518374|580823045|FG000|Overall Study|Lost to Follow-up|2|||
160846089|NCT04607837|580823046|FG000|Overall Study|Adverse Event|8|||
160846090|NCT04607837|580823047|FG001|Overall Study|Adverse Event|2|||
160846091|NCT04607837|580823046|FG000|Overall Study|Withdrawal by Subject|8|||
160846092|NCT04607837|580823047|FG001|Overall Study|Withdrawal by Subject|7|||
160846093|NCT04607837|580823046|FG000|Overall Study|Physician Decision|2|||
160846094|NCT04607837|580823047|FG001|Overall Study|Physician Decision|0|||
160568115|NCT03215277|579802280|FG000|Overall Study|Death|1|||
160568116|NCT03215277|579802281|FG001|Overall Study|Death|0|||
160568117|NCT03215277|579802280|FG000|Overall Study|Lost to Follow-up|0|||
160568118|NCT03215277|579802281|FG001|Overall Study|Lost to Follow-up|1|||
160846095|NCT04607837|580823046|FG000|Overall Study|Lack of Efficacy|2|||
160846096|NCT04607837|580823047|FG001|Overall Study|Lack of Efficacy|0|||
160992404|NCT00661778|581361346|FG000|Overall Study|Disease Progression|23|||
160568119|NCT03215277|579802280|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
160568120|NCT03215277|579802281|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
160568121|NCT03427073|579802282|FG000|Overall Study|Disease Progression|1|||
160568122|NCT03427073|579802283|FG001|Overall Study|Disease Progression|1|||
160568123|NCT03427073|579802284|FG002|Overall Study|Disease Progression|1|||
160846097|NCT04607837|580823046|FG000|Overall Study|Participant terminated by sponsor|1|||
160846098|NCT04607837|580823047|FG001|Overall Study|Participant terminated by sponsor|0|||
160846099|NCT04607837|580823046|FG000|Overall Study|Disease worsening|36|||
160846100|NCT04607837|580823047|FG001|Overall Study|Disease worsening|36|||
160846101|NCT04607837|580823046|FG000|Overall Study|Other|1|||
160846102|NCT04607837|580823047|FG001|Overall Study|Other|0|||
160846103|NCT02023996|580823057|FG000|Overall Study|Protocol Violation|6|||
160846104|NCT00465452|580823058|FG000|Overall Study|Adverse Event|1|||
160846105|NCT04209205|580823062|FG000|Overall Study|Adverse Event|2|||
160568124|NCT03427073|579802285|FG003|Overall Study|Disease Progression|3|||
160568125|NCT03427073|579802286|FG004|Overall Study|Disease Progression|3|||
160568126|NCT03427073|579802287|FG005|Overall Study|Disease Progression|4|||
160568127|NCT03427073|579802288|FG006|Overall Study|Disease Progression|2|||
160568128|NCT03427073|579802289|FG007|Overall Study|Disease Progression|3|||
160568129|NCT03427073|579802282|FG000|Overall Study|Physician Decision|0|||
160568130|NCT03427073|579802283|FG001|Overall Study|Physician Decision|0|||
160568131|NCT03427073|579802284|FG002|Overall Study|Physician Decision|0|||
160568132|NCT03427073|579802285|FG003|Overall Study|Physician Decision|0|||
160568133|NCT03427073|579802286|FG004|Overall Study|Physician Decision|0|||
160568134|NCT03427073|579802287|FG005|Overall Study|Physician Decision|0|||
160568135|NCT03427073|579802288|FG006|Overall Study|Physician Decision|1|||
160568136|NCT03427073|579802289|FG007|Overall Study|Physician Decision|1|||
160568137|NCT02835495|579802292|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
160568138|NCT02835495|579802293|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
160568139|NCT02835495|579802292|FG000|Overall Study|Declined in-person follow-up visit|4|||
160568140|NCT02835495|579802293|FG001|Overall Study|Declined in-person follow-up visit|2|||
160568141|NCT02580058|579802295|FG000|Overall Study|Adverse Event|16|||
160568142|NCT02580058|579802296|FG001|Overall Study|Adverse Event|30|||
160568143|NCT02580058|579802297|FG002|Overall Study|Adverse Event|20|||
160568144|NCT02580058|579802295|FG000|Overall Study|Death|4|||
160568145|NCT02580058|579802296|FG001|Overall Study|Death|4|||
160568146|NCT02580058|579802297|FG002|Overall Study|Death|5|||
160568147|NCT02580058|579802295|FG000|Overall Study|Physician Decision|1|||
160568148|NCT02580058|579802296|FG001|Overall Study|Physician Decision|3|||
160568149|NCT02580058|579802297|FG002|Overall Study|Physician Decision|11|||
160568150|NCT02580058|579802295|FG000|Overall Study|Other|5|||
160568151|NCT02580058|579802296|FG001|Overall Study|Other|1|||
160568152|NCT02580058|579802297|FG002|Overall Study|Other|3|||
160568153|NCT02580058|579802295|FG000|Overall Study|Withdrawal by Subject|4|||
160568154|NCT02580058|579802296|FG001|Overall Study|Withdrawal by Subject|7|||
160568155|NCT02580058|579802297|FG002|Overall Study|Withdrawal by Subject|31|||
160568156|NCT02580058|579802295|FG000|Overall Study|Global Deterioration of Health Status|19|||
160568157|NCT02580058|579802296|FG001|Overall Study|Global Deterioration of Health Status|18|||
160568158|NCT02580058|579802297|FG002|Overall Study|Global Deterioration of Health Status|24|||
160650149|NCT00095199|580100551|FG002|Overall Study|Physician Decision|1|||
160650150|NCT00095199|580100552|FG003|Overall Study|Physician Decision|1|||
160650151|NCT00095199|580100549|FG000|Overall Study|Not eligible|1|||
160846106|NCT04209205|580823063|FG001|Overall Study|Adverse Event|3|||
160846107|NCT04209205|580823062|FG000|Overall Study|Lost to Follow-up|3|||
160846108|NCT04209205|580823063|FG001|Overall Study|Lost to Follow-up|1|||
160846109|NCT04209205|580823062|FG000|Overall Study|Physician Decision|1|||
160846110|NCT04209205|580823063|FG001|Overall Study|Physician Decision|1|||
160846111|NCT04209205|580823062|FG000|Overall Study|Subject decision|10|||
160846112|NCT04209205|580823063|FG001|Overall Study|Subject decision|10|||
160846113|NCT04209205|580823062|FG000|Overall Study|Progressive disease|1|||
160846114|NCT04209205|580823063|FG001|Overall Study|Progressive disease|0|||
160846115|NCT04209205|580823062|FG000|Overall Study|Protocol deviation|0|||
160846116|NCT04209205|580823063|FG001|Overall Study|Protocol deviation|1|||
160846117|NCT04209205|580823062|FG000|Overall Study|New therapy for study indication|1|||
160846118|NCT04209205|580823063|FG001|Overall Study|New therapy for study indication|0|||
160846119|NCT04209205|580823062|FG000|Overall Study|Adverse event - placebo not switched|0|||
160846120|NCT04209205|580823063|FG001|Overall Study|Adverse event - placebo not switched|1|||
160846121|NCT04209205|580823062|FG000|Overall Study|Subject decision - placebo not switched|0|||
160846122|NCT04209205|580823063|FG001|Overall Study|Subject decision - placebo not switched|5|||
160846123|NCT04209205|580823062|FG000|Overall Study|Death - placebo not switched|0|||
160846124|NCT04209205|580823063|FG001|Overall Study|Death - placebo not switched|1|||
160846125|NCT00999544|580824983|FG000|Overall Study|Withdrawal by Subject|1|||
160568159|NCT02580058|579802295|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
160568160|NCT02580058|579802296|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160568161|NCT02580058|579802297|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
160568162|NCT02580058|579802295|FG000|Overall Study|Progressive Disease|137|||
160568163|NCT02580058|579802296|FG001|Overall Study|Progressive Disease|125|||
160568164|NCT02580058|579802297|FG002|Overall Study|Progressive Disease|94|||
160568165|NCT02580058|579802295|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160650152|NCT00095199|580100550|FG001|Overall Study|Not eligible|7|||
160846126|NCT01392547|580824984|FG000|Overall Study|Adverse Event|2|||
160846127|NCT01392547|580824984|FG000|Overall Study|Non-compliance|2|||
160846128|NCT01392547|580824984|FG000|Overall Study|Withdrawal criteria|3|||
160846129|NCT01392547|580824984|FG000|Overall Study|Unclassified|1|||
160846130|NCT02936635|580824986|FG000|Overall Study|Adverse Event|43|||
160846131|NCT02936635|580824987|FG001|Overall Study|Adverse Event|25|||
160846132|NCT02936635|580824986|FG000|Overall Study|Progressive Disease|10|||
160846133|NCT02936635|580824987|FG001|Overall Study|Progressive Disease|18|||
160846134|NCT02936635|580824986|FG000|Overall Study|Sponsor Discretion|10|||
160846135|NCT02936635|580824987|FG001|Overall Study|Sponsor Discretion|16|||
160846136|NCT02936635|580824986|FG000|Overall Study|Death|9|||
160846137|NCT02936635|580824987|FG001|Overall Study|Death|15|||
160846138|NCT02936635|580824986|FG000|Overall Study|Withdrawal by Subject|8|||
160846139|NCT02936635|580824987|FG001|Overall Study|Withdrawal by Subject|15|||
160846140|NCT02936635|580824986|FG000|Overall Study|Physician Decision|2|||
160846141|NCT02936635|580824987|FG001|Overall Study|Physician Decision|9|||
160846142|NCT02936635|580824986|FG000|Overall Study|Lost to Follow-up|1|||
160846143|NCT02936635|580824987|FG001|Overall Study|Lost to Follow-up|2|||
160846144|NCT02936635|580824986|FG000|Overall Study|Protocol Violation|1|||
160846145|NCT02936635|580824987|FG001|Overall Study|Protocol Violation|0|||
160846146|NCT02936635|580824986|FG000|Overall Study|Lack of effect/Entry into other study|31|||
160846147|NCT02936635|580824987|FG001|Overall Study|Lack of effect/Entry into other study|65|||
160846148|NCT02407223|580824988|FG000|Overall Study|Adverse Event|1|||
160846149|NCT02407223|580824989|FG001|Overall Study|Adverse Event|0|||
160846150|NCT02407223|580824990|FG002|Overall Study|Adverse Event|1|||
160846151|NCT02407223|580824988|FG000|Overall Study|Lack of Efficacy|6|||
160846152|NCT02407223|580824989|FG001|Overall Study|Lack of Efficacy|6|||
160846153|NCT02407223|580824990|FG002|Overall Study|Lack of Efficacy|4|||
160846154|NCT02407223|580824988|FG000|Overall Study|Lost to Follow-up|1|||
160846155|NCT02407223|580824989|FG001|Overall Study|Lost to Follow-up|0|||
160846156|NCT02407223|580824990|FG002|Overall Study|Lost to Follow-up|2|||
160846157|NCT02407223|580824988|FG000|Overall Study|Withdrawal by Subject|2|||
160846158|NCT02407223|580824989|FG001|Overall Study|Withdrawal by Subject|4|||
160846159|NCT02407223|580824990|FG002|Overall Study|Withdrawal by Subject|4|||
160846160|NCT02407223|580824988|FG000|Overall Study|Study Terminated by Sponsor|77|||
160846161|NCT02407223|580824989|FG001|Overall Study|Study Terminated by Sponsor|80|||
160846162|NCT02407223|580824990|FG002|Overall Study|Study Terminated by Sponsor|86|||
160846163|NCT02407223|580824988|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
160846164|NCT02407223|580824989|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
160846165|NCT02407223|580824990|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
160846166|NCT02407223|580824988|FG000|Overall Study|Other|29|||
160846167|NCT02407223|580824989|FG001|Overall Study|Other|27|||
160846168|NCT02407223|580824990|FG002|Overall Study|Other|25|||
160846169|NCT00950846|580824992|FG000|Overall Study|Death|6|||
160846170|NCT00950846|580824992|FG000|Overall Study|Lost to Follow-up|3|||
160846171|NCT00950846|580824992|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
160846172|NCT04426318|580824993|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
160846173|NCT04426318|580824994|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
160846174|NCT04829916|580824995|FG000|Overall Study|Withdrawal by Subject|1|||
160846175|NCT04829916|580824996|FG001|Overall Study|Withdrawal by Subject|0|||
160846176|NCT03781778|580824998|FG000|Overall Study|Withdrawal by Subject|2|||
160846177|NCT03781778|580824999|FG001|Overall Study|Withdrawal by Subject|2|||
160846178|NCT02287467|580825000|FG000|Overall Study|Protocol Violation|12|||
160846179|NCT02287467|580825001|FG001|Overall Study|Protocol Violation|9|||
160846180|NCT01456169|580825003|FG000|Overall Study|Adverse Event|1|||
160846181|NCT01456169|580825004|FG001|Overall Study|Adverse Event|2|||
160846182|NCT01456169|580825005|FG002|Overall Study|Adverse Event|7|||
160846183|NCT01456169|580825003|FG000|Overall Study|Major Protocol Deviation|3|||
160846184|NCT01456169|580825004|FG001|Overall Study|Major Protocol Deviation|2|||
160846185|NCT01456169|580825005|FG002|Overall Study|Major Protocol Deviation|3|||
160846186|NCT01456169|580825003|FG000|Overall Study|Voluntary Withdrawal|3|||
160846187|NCT01456169|580825004|FG001|Overall Study|Voluntary Withdrawal|0|||
160846188|NCT01456169|580825005|FG002|Overall Study|Voluntary Withdrawal|2|||
160846189|NCT01456169|580825003|FG000|Overall Study|Lack of Efficacy|2|||
160846190|NCT01456169|580825004|FG001|Overall Study|Lack of Efficacy|0|||
160846191|NCT01456169|580825005|FG002|Overall Study|Lack of Efficacy|0|||
160650153|NCT00095199|580100551|FG002|Overall Study|Not eligible|0|||
160846192|NCT01456169|580825003|FG000|Overall Study|Other|1|||
160846193|NCT01456169|580825004|FG001|Overall Study|Other|1|||
160846194|NCT01456169|580825005|FG002|Overall Study|Other|0|||
160846195|NCT02292446|580825006|FG000|Overall Study|Adverse Event|12|||
160846196|NCT02292446|580825006|FG000|Overall Study|Death|1|||
160846197|NCT02292446|580825006|FG000|Overall Study|Disease progression|2|||
160846198|NCT02292446|580825006|FG000|Overall Study|Subject/guardian decision|2|||
160846199|NCT02292446|580825006|FG000|Overall Study|Withdrawal by Subject|3|||
160846200|NCT00496080|580825011|FG000|Overall Study|Lost to Follow-up|9|||
160846201|NCT00496080|580825011|FG000|Overall Study|Surgical re-intervention|7|||
160846202|NCT00496080|580825011|FG000|Overall Study|Withdrawal by Subject|5|||
160846203|NCT00496080|580825011|FG000|Overall Study|Physician Decision|6|||
160846204|NCT04098809|580825012|FG000|Overall Study|Withdrawal by Subject|1|||
160846205|NCT04098809|580825013|FG001|Overall Study|Withdrawal by Subject|3|||
160846206|NCT04098809|580825012|FG000|Overall Study|Physician Decision|2|||
160846207|NCT04098809|580825013|FG001|Overall Study|Physician Decision|1|||
160846208|NCT00570310|580825018|FG000|Overall Study|Adverse Event|1|||
160846209|NCT00570310|580825019|FG001|Overall Study|Adverse Event|2|||
160846210|NCT00570310|580825018|FG000|Overall Study|Lack of Efficacy|1|||
160846211|NCT00570310|580825019|FG001|Overall Study|Lack of Efficacy|4|||
160846212|NCT02741596|580825022|FG000|Overall Study|Adverse Event|1|||
160846213|NCT02741596|580825023|FG001|Overall Study|Adverse Event|5|||
160846214|NCT02741596|580825022|FG000|Overall Study|Lost to Follow-up|1|||
160846215|NCT02741596|580825023|FG001|Overall Study|Lost to Follow-up|1|||
160846216|NCT02741596|580825022|FG000|Overall Study|Physician Decision|2|||
160846217|NCT02741596|580825023|FG001|Overall Study|Physician Decision|1|||
160846218|NCT02741596|580825022|FG000|Overall Study|Pregnancy|3|||
160846219|NCT02741596|580825023|FG001|Overall Study|Pregnancy|1|||
160846220|NCT02741596|580825022|FG000|Overall Study|Other (Unspecified)|0|||
160846221|NCT02741596|580825023|FG001|Overall Study|Other (Unspecified)|3|||
160846222|NCT02741596|580825022|FG000|Overall Study|Subject withdrawn-Other|17|||
160846223|NCT02741596|580825023|FG001|Overall Study|Subject withdrawn-Other|4|||
160846224|NCT02741596|580825022|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
160846225|NCT02741596|580825023|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
160846226|NCT00479336|580825024|FG000|Overall Study|Adverse Event|1|||
160846227|NCT00479336|580825025|FG001|Overall Study|Adverse Event|1|||
160846228|NCT00479336|580825026|FG002|Overall Study|Adverse Event|1|||
160846229|NCT00479336|580825027|FG003|Overall Study|Adverse Event|3|||
160846230|NCT00479336|580825024|FG000|Overall Study|Lack of Efficacy|1|||
160846231|NCT00479336|580825025|FG001|Overall Study|Lack of Efficacy|0|||
160846232|NCT00479336|580825026|FG002|Overall Study|Lack of Efficacy|0|||
160846233|NCT00479336|580825027|FG003|Overall Study|Lack of Efficacy|0|||
160846234|NCT00479336|580825024|FG000|Overall Study|Protocol Violation|0|||
160846235|NCT00479336|580825025|FG001|Overall Study|Protocol Violation|1|||
160846236|NCT00479336|580825026|FG002|Overall Study|Protocol Violation|0|||
160846237|NCT00479336|580825027|FG003|Overall Study|Protocol Violation|0|||
160846238|NCT00479336|580825024|FG000|Overall Study|Withdrawal by Subject|1|||
160846239|NCT00479336|580825025|FG001|Overall Study|Withdrawal by Subject|2|||
160846240|NCT00479336|580825026|FG002|Overall Study|Withdrawal by Subject|0|||
160846241|NCT00479336|580825027|FG003|Overall Study|Withdrawal by Subject|0|||
160846242|NCT00479336|580825024|FG000|Overall Study|Physician Decision|0|||
160846243|NCT00479336|580825025|FG001|Overall Study|Physician Decision|1|||
160846244|NCT00479336|580825026|FG002|Overall Study|Physician Decision|0|||
160846245|NCT00479336|580825027|FG003|Overall Study|Physician Decision|2|||
160846246|NCT00479336|580825024|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
160846247|NCT00479336|580825025|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
160846248|NCT00479336|580825026|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
160846249|NCT00479336|580825027|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
160846250|NCT02021643|580825028|FG000|Overall Study|Enrolled but Never Treated|1|||
160846251|NCT02021643|580825029|FG001|Overall Study|Enrolled but Never Treated|0|||
160846252|NCT02021643|580825030|FG002|Overall Study|Enrolled but Never Treated|0|||
160846253|NCT02021643|580825031|FG003|Overall Study|Enrolled but Never Treated|0|||
160846254|NCT02021643|580825028|FG000|Overall Study|Adverse Event|0|||
160846255|NCT02021643|580825029|FG001|Overall Study|Adverse Event|1|||
160846256|NCT02021643|580825030|FG002|Overall Study|Adverse Event|0|||
160846257|NCT02021643|580825031|FG003|Overall Study|Adverse Event|0|||
160846258|NCT02021643|580825028|FG000|Overall Study|Death|0|||
160846259|NCT02021643|580825029|FG001|Overall Study|Death|1|||
160846260|NCT02021643|580825030|FG002|Overall Study|Death|0|||
160846261|NCT02021643|580825031|FG003|Overall Study|Death|0|||
160846262|NCT02021643|580825028|FG000|Overall Study|Investigator's Discretion|1|||
160846263|NCT02021643|580825029|FG001|Overall Study|Investigator's Discretion|0|||
160846264|NCT02021643|580825030|FG002|Overall Study|Investigator's Discretion|0|||
160846265|NCT02021643|580825031|FG003|Overall Study|Investigator's Discretion|0|||
160846266|NCT02021643|580825028|FG000|Overall Study|Lack of Efficacy|7|||
160846267|NCT02021643|580825029|FG001|Overall Study|Lack of Efficacy|6|||
160846268|NCT02021643|580825030|FG002|Overall Study|Lack of Efficacy|0|||
160846269|NCT02021643|580825031|FG003|Overall Study|Lack of Efficacy|12|||
160846270|NCT02021643|580825028|FG000|Overall Study|Lost to Follow-up|0|||
160846271|NCT02021643|580825029|FG001|Overall Study|Lost to Follow-up|1|||
160846272|NCT02021643|580825030|FG002|Overall Study|Lost to Follow-up|0|||
160650154|NCT00095199|580100552|FG003|Overall Study|Not eligible|1|||
160846273|NCT02021643|580825031|FG003|Overall Study|Lost to Follow-up|0|||
160846274|NCT02021643|580825028|FG000|Overall Study|Withdrew Consent|0|||
160846275|NCT02021643|580825029|FG001|Overall Study|Withdrew Consent|1|||
160846276|NCT02021643|580825030|FG002|Overall Study|Withdrew Consent|0|||
160846277|NCT02021643|580825031|FG003|Overall Study|Withdrew Consent|0|||
160846278|NCT02631551|580825032|FG000|Overall Study|Adverse Event|1|||
160846279|NCT02631551|580825033|FG001|Overall Study|Adverse Event|2|||
160846280|NCT02631551|580825034|FG002|Overall Study|Adverse Event|4|||
160846281|NCT02631551|580825035|FG003|Overall Study|Adverse Event|0|||
160846282|NCT02631551|580825032|FG000|Overall Study|Lack of Efficacy|0|||
160846283|NCT02631551|580825033|FG001|Overall Study|Lack of Efficacy|0|||
160846284|NCT02631551|580825034|FG002|Overall Study|Lack of Efficacy|1|||
160846285|NCT02631551|580825035|FG003|Overall Study|Lack of Efficacy|0|||
160846286|NCT02631551|580825032|FG000|Overall Study|Lost to Follow-up|1|||
160846287|NCT02631551|580825033|FG001|Overall Study|Lost to Follow-up|2|||
160846288|NCT02631551|580825034|FG002|Overall Study|Lost to Follow-up|0|||
160846289|NCT02631551|580825035|FG003|Overall Study|Lost to Follow-up|3|||
160846290|NCT02631551|580825032|FG000|Overall Study|Withdrawal by Subject|2|||
160846291|NCT02631551|580825033|FG001|Overall Study|Withdrawal by Subject|2|||
160846292|NCT02631551|580825034|FG002|Overall Study|Withdrawal by Subject|0|||
160846293|NCT02631551|580825035|FG003|Overall Study|Withdrawal by Subject|5|||
160846294|NCT02631551|580825032|FG000|Overall Study|Protocol deviation|3|||
160846295|NCT02631551|580825033|FG001|Overall Study|Protocol deviation|6|||
160846296|NCT02631551|580825034|FG002|Overall Study|Protocol deviation|3|||
160846297|NCT02631551|580825035|FG003|Overall Study|Protocol deviation|0|||
160846298|NCT02631551|580825032|FG000|Overall Study|Non-compliance with study procedures|0|||
160846299|NCT02631551|580825033|FG001|Overall Study|Non-compliance with study procedures|0|||
160846300|NCT02631551|580825034|FG002|Overall Study|Non-compliance with study procedures|1|||
160846301|NCT02631551|580825035|FG003|Overall Study|Non-compliance with study procedures|1|||
160846302|NCT02631551|580825032|FG000|Overall Study|Non-compliance with study drug|1|||
160846303|NCT02631551|580825033|FG001|Overall Study|Non-compliance with study drug|0|||
160846304|NCT02631551|580825034|FG002|Overall Study|Non-compliance with study drug|0|||
160846305|NCT02631551|580825035|FG003|Overall Study|Non-compliance with study drug|0|||
160846306|NCT02631551|580825032|FG000|Overall Study|Other, specific reasons not collected|5|||
160846307|NCT02631551|580825033|FG001|Overall Study|Other, specific reasons not collected|7|||
160846308|NCT02631551|580825034|FG002|Overall Study|Other, specific reasons not collected|2|||
160846309|NCT02631551|580825035|FG003|Overall Study|Other, specific reasons not collected|2|||
160846310|NCT04390243|580825038|FG000|Overall Study|Death|1|||
160846311|NCT04390243|580825038|FG000|Overall Study|Disease Progression|4|||
160846312|NCT04390243|580825038|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
160846313|NCT01521507|580825045|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
160846314|NCT01521507|580825046|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
160846315|NCT01521507|580825045|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
160846316|NCT01521507|580825046|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
160846317|NCT01521507|580825045|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
160846318|NCT01521507|580825046|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
160846319|NCT01521507|580825045|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
160846320|NCT01521507|580825046|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
160846321|NCT01521507|580825045|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
160846322|NCT01521507|580825046|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
160846323|NCT01521507|580825045|FG000|Stage 2: Observational Design|Physician Decision|1|||
160846324|NCT01521507|580825046|FG001|Stage 2: Observational Design|Physician Decision|0|||
160846325|NCT04317040|580825047|FG000|Overall Study|Lost to Follow-up|2|||
160846326|NCT04317040|580825048|FG001|Overall Study|Lost to Follow-up|0|||
160846327|NCT04317040|580825047|FG000|Overall Study|Death|16|||
160846328|NCT04317040|580825048|FG001|Overall Study|Death|18|||
160846329|NCT04317040|580825047|FG000|Overall Study|Withdrawal by Subject|0|||
160846330|NCT04317040|580825048|FG001|Overall Study|Withdrawal by Subject|1|||
160846331|NCT04317040|580825047|FG000|Overall Study|Incomplete assessments|0|||
160846332|NCT04317040|580825048|FG001|Overall Study|Incomplete assessments|1|||
160846333|NCT03672292|580825049|FG000|Overall Study|Adverse Event|3|||
160846334|NCT03672292|580825050|FG001|Overall Study|Adverse Event|1|||
160846335|NCT03672292|580825049|FG000|Overall Study|Physician Decision|0|||
160846336|NCT03672292|580825050|FG001|Overall Study|Physician Decision|1|||
160846337|NCT03672292|580825049|FG000|Overall Study|Withdrawal by Subject|1|||
160846338|NCT03672292|580825050|FG001|Overall Study|Withdrawal by Subject|2|||
160846339|NCT00799903|580825051|FG000|Overall Study|Investigator Site Closed|25|||
160846340|NCT00799903|580825052|FG001|Overall Study|Investigator Site Closed|23|||
160846341|NCT00799903|580825051|FG000|Overall Study|Withdrawal by Subject|179|||
160846342|NCT00799903|580825052|FG001|Overall Study|Withdrawal by Subject|175|||
160568166|NCT02580058|579802296|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160568167|NCT02580058|579802297|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160568168|NCT04283461|579802298|FG000|Overall Study|Enrolled in separate trial|0|||
160568169|NCT04283461|579802299|FG001|Overall Study|Enrolled in separate trial|0|||
160846343|NCT00799903|580825051|FG000|Overall Study|Lost to Follow-up|69|||
160846344|NCT00799903|580825052|FG001|Overall Study|Lost to Follow-up|80|||
160568170|NCT04283461|579802300|FG002|Overall Study|Enrolled in separate trial|8|||
160568171|NCT04283461|579802301|FG003|Overall Study|Enrolled in separate trial|13|||
160568172|NCT04283461|579802302|FG004|Overall Study|Enrolled in separate trial|12|||
160568173|NCT04283461|579802303|FG005|Overall Study|Enrolled in separate trial|0|||
160846345|NCT02518971|580825053|FG000|Overall Study|Lost to Follow-up|0|||
160846346|NCT02518971|580825054|FG001|Overall Study|Lost to Follow-up|1|||
160846347|NCT02518971|580825053|FG000|Overall Study|Physician Decision|6|||
160846348|NCT02518971|580825054|FG001|Overall Study|Physician Decision|6|||
160846349|NCT02518971|580825053|FG000|Overall Study|Protocol Violation|6|||
160846350|NCT02518971|580825054|FG001|Overall Study|Protocol Violation|4|||
160846351|NCT02518971|580825053|FG000|Overall Study|Withdrawal by Subject|4|||
160846352|NCT02518971|580825054|FG001|Overall Study|Withdrawal by Subject|5|||
160846353|NCT02518971|580825053|FG000|Overall Study|Side effects|1|||
160846354|NCT02518971|580825054|FG001|Overall Study|Side effects|0|||
160846355|NCT02518971|580825053|FG000|Overall Study|medication lost in mail|0|||
160846356|NCT02518971|580825054|FG001|Overall Study|medication lost in mail|1|||
160846357|NCT02518971|580825053|FG000|Overall Study|eligibility criteria no longer met|6|||
160846358|NCT02518971|580825054|FG001|Overall Study|eligibility criteria no longer met|3|||
160846359|NCT03088917|580825055|FG000|Overall Study|In care/cured elsewhere|15|||
160846360|NCT03088917|580825055|FG000|Overall Study|Refuse re-evaluation|13|||
160846361|NCT03088917|580825055|FG000|Overall Study|Contact not established|13|||
160846362|NCT03088917|580825055|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
160846363|NCT03088917|580825055|FG000|Overall Study|Moved outside study region|50|||
160846364|NCT00757237|580825056|FG000|Overall Study|Lost to Follow-up|0|||
160846365|NCT00757237|580825057|FG001|Overall Study|Lost to Follow-up|1|||
160846366|NCT00757237|580825056|FG000|Overall Study|Protocol Violation|0|||
160846367|NCT00757237|580825057|FG001|Overall Study|Protocol Violation|2|||
160846368|NCT00757237|580825056|FG000|Overall Study|Physician Decision|2|||
160846369|NCT00757237|580825057|FG001|Overall Study|Physician Decision|3|||
160846370|NCT00757237|580825056|FG000|Overall Study|Withdrawal by Subject|8|||
160846371|NCT00757237|580825057|FG001|Overall Study|Withdrawal by Subject|12|||
160846372|NCT00757237|580825056|FG000|Overall Study|Safety or Tolerability|3|||
160846373|NCT00757237|580825057|FG001|Overall Study|Safety or Tolerability|5|||
160846374|NCT00757237|580825056|FG000|Overall Study|Other|0|||
160846375|NCT00757237|580825057|FG001|Overall Study|Other|2|||
160846376|NCT05150990|580825062|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
160846377|NCT05150990|580825063|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
160846378|NCT05150990|580825062|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
160846379|NCT05150990|580825063|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
160846380|NCT05150990|580825062|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
160846381|NCT05150990|580825063|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
160846382|NCT05150990|580825062|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
160846383|NCT05150990|580825063|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
160846384|NCT05150990|580825062|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
160846385|NCT05150990|580825063|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
160846386|NCT05150990|580825062|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
160846387|NCT05150990|580825063|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
160846388|NCT05150990|580825062|FG000|Overall Study|Death (unrelated to the intervention)|1|||
160846389|NCT05150990|580825063|FG001|Overall Study|Death (unrelated to the intervention)|2|||
160846390|NCT01843023|580825064|FG000|Overall Study|Death|1|||
160846391|NCT01843023|580825065|FG001|Overall Study|Death|0|||
160846392|NCT01843023|580825064|FG000|Overall Study|Lost to Follow-up|24|||
160846393|NCT01843023|580825065|FG001|Overall Study|Lost to Follow-up|29|||
160846394|NCT01843023|580825064|FG000|Overall Study|Withdrawal by Subject|8|||
160846395|NCT01843023|580825065|FG001|Overall Study|Withdrawal by Subject|6|||
160846396|NCT04980612|580825067|FG000|Overall Study|Withdrawal by Subject|7|||
160846397|NCT04980612|580825068|FG001|Overall Study|Withdrawal by Subject|5|||
160846398|NCT01514201|580825071|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
160846399|NCT01514201|580825072|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846400|NCT01514201|580825073|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846401|NCT01514201|580825074|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846402|NCT01514201|580825071|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
160846403|NCT01514201|580825072|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
160846404|NCT01514201|580825073|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
160846405|NCT01514201|580825074|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
160846406|NCT01514201|580825071|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
160846407|NCT01514201|580825072|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
160846408|NCT01514201|580825073|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
160846409|NCT01514201|580825074|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
160846410|NCT01514201|580825071|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
160846411|NCT01514201|580825072|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
160846412|NCT01514201|580825073|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
160846413|NCT01514201|580825074|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
160846414|NCT01514201|580825071|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
160846415|NCT01514201|580825072|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
160846416|NCT01514201|580825073|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
160846417|NCT01514201|580825074|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
160846418|NCT01514201|580825071|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
160846419|NCT01514201|580825072|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
160846420|NCT01514201|580825073|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
160846421|NCT01514201|580825074|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
160846422|NCT01514201|580825071|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
160846423|NCT01514201|580825072|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
160846424|NCT01514201|580825073|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
160846425|NCT01514201|580825074|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
160846426|NCT01514201|580825071|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846427|NCT01514201|580825072|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846428|NCT01514201|580825073|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846429|NCT01514201|580825074|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
160846430|NCT01514201|580825071|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
160846431|NCT01514201|580825072|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
160846432|NCT01514201|580825073|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
160846433|NCT01514201|580825074|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
160846434|NCT01514201|580825071|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
160846435|NCT01514201|580825072|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
160846436|NCT01514201|580825073|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
160846437|NCT01514201|580825074|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
160846438|NCT01514201|580825071|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
160846439|NCT01514201|580825072|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
160846440|NCT01514201|580825073|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
160846441|NCT01514201|580825074|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
160846442|NCT01514201|580825071|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
160846443|NCT01514201|580825072|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
160846444|NCT01514201|580825073|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
160846445|NCT01514201|580825074|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
160846446|NCT00566852|580825079|FG000|Overall Study|Protocol Violation|22|||
160846447|NCT00566852|580825080|FG001|Overall Study|Protocol Violation|24|||
160846448|NCT00566852|580825079|FG000|Overall Study|Death|95|||
160846449|NCT00566852|580825080|FG001|Overall Study|Death|78|||
160846450|NCT00566852|580825079|FG000|Overall Study|Withdrawal by Subject|30|||
160846451|NCT00566852|580825080|FG001|Overall Study|Withdrawal by Subject|25|||
160846452|NCT00566852|580825079|FG000|Overall Study|Patient refusal|37|||
160846453|NCT00566852|580825080|FG001|Overall Study|Patient refusal|37|||
160846454|NCT00566852|580825079|FG000|Overall Study|Not tested due to disability|6|||
160846455|NCT00566852|580825080|FG001|Overall Study|Not tested due to disability|12|||
160846456|NCT00566852|580825079|FG000|Overall Study|Missing reason not specified|1|||
160846457|NCT00566852|580825080|FG001|Overall Study|Missing reason not specified|2|||
160846458|NCT00566852|580825079|FG000|Overall Study|Missing reason not reported|16|||
160846459|NCT00566852|580825080|FG001|Overall Study|Missing reason not reported|20|||
160846460|NCT02715609|580825084|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
160846461|NCT02715609|580825085|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
160846462|NCT02715609|580825086|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
160846463|NCT02715609|580825084|FG000|Overall Study|Withdrawal by Subject|0|||
160846464|NCT02715609|580825085|FG001|Overall Study|Withdrawal by Subject|0|||
160846465|NCT02715609|580825086|FG002|Overall Study|Withdrawal by Subject|1|||
160846466|NCT00286429|580825089|FG000|Overall Study|Adverse Event|4|||
160846467|NCT00286429|580825090|FG001|Overall Study|Adverse Event|1|||
160846468|NCT00286429|580825091|FG002|Overall Study|Adverse Event|6|||
160846469|NCT00286429|580825089|FG000|Overall Study|Lack of Efficacy|52|||
160846470|NCT00286429|580825090|FG001|Overall Study|Lack of Efficacy|27|||
160846471|NCT00286429|580825091|FG002|Overall Study|Lack of Efficacy|25|||
160846472|NCT00286429|580825089|FG000|Overall Study|Lost to Follow-up|2|||
160846473|NCT00286429|580825090|FG001|Overall Study|Lost to Follow-up|4|||
160846474|NCT00286429|580825091|FG002|Overall Study|Lost to Follow-up|3|||
160846475|NCT00286429|580825089|FG000|Overall Study|Physician Decision|10|||
160846476|NCT00286429|580825090|FG001|Overall Study|Physician Decision|7|||
160846477|NCT00286429|580825091|FG002|Overall Study|Physician Decision|7|||
160846478|NCT00286429|580825089|FG000|Overall Study|Protocol Violation|3|||
160846479|NCT00286429|580825090|FG001|Overall Study|Protocol Violation|5|||
160846480|NCT00286429|580825091|FG002|Overall Study|Protocol Violation|4|||
160846481|NCT00286429|580825089|FG000|Overall Study|Withdrawal by Subject|3|||
160846482|NCT00286429|580825090|FG001|Overall Study|Withdrawal by Subject|2|||
160846483|NCT00286429|580825091|FG002|Overall Study|Withdrawal by Subject|6|||
160846484|NCT00286429|580825089|FG000|Overall Study|Administrative Error|1|||
160846485|NCT00286429|580825090|FG001|Overall Study|Administrative Error|1|||
160846486|NCT00286429|580825091|FG002|Overall Study|Administrative Error|1|||
160846487|NCT00286429|580825089|FG000|Overall Study|Administrative Decision|0|||
160846488|NCT00286429|580825090|FG001|Overall Study|Administrative Decision|1|||
160650155|NCT00095199|580100549|FG000|Overall Study|Started Palliative Radiotherapy|1|||
160650156|NCT00095199|580100550|FG001|Overall Study|Started Palliative Radiotherapy|0|||
160650157|NCT00095199|580100551|FG002|Overall Study|Started Palliative Radiotherapy|0|||
160650158|NCT00095199|580100552|FG003|Overall Study|Started Palliative Radiotherapy|0|||
160650159|NCT00095199|580100549|FG000|Overall Study|Started radiotherapy regimen|0|||
160650160|NCT00095199|580100550|FG001|Overall Study|Started radiotherapy regimen|1|||
160846489|NCT00286429|580825091|FG002|Overall Study|Administrative Decision|0|||
160846490|NCT03197376|580825095|FG000|Primary and Booster Phase|Adverse Event|0|||
160846491|NCT03197376|580825096|FG001|Primary and Booster Phase|Adverse Event|0|||
160846492|NCT03197376|580825097|FG002|Primary and Booster Phase|Adverse Event|0|||
160846493|NCT03197376|580825098|FG003|Primary and Booster Phase|Adverse Event|1|||
160846494|NCT03197376|580825095|FG000|Primary and Booster Phase|Death|1|||
160846495|NCT03197376|580825096|FG001|Primary and Booster Phase|Death|0|||
160846496|NCT03197376|580825097|FG002|Primary and Booster Phase|Death|0|||
160846497|NCT03197376|580825098|FG003|Primary and Booster Phase|Death|2|||
160846498|NCT03197376|580825095|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
160846499|NCT03197376|580825096|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
160846500|NCT03197376|580825097|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
160846501|NCT03197376|580825098|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
160846502|NCT03197376|580825095|FG000|Primary and Booster Phase|Physician Decision|1|||
160846503|NCT03197376|580825096|FG001|Primary and Booster Phase|Physician Decision|0|||
160846504|NCT03197376|580825097|FG002|Primary and Booster Phase|Physician Decision|1|||
160846505|NCT03197376|580825098|FG003|Primary and Booster Phase|Physician Decision|3|||
160846506|NCT03197376|580825095|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
160846507|NCT03197376|580825096|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
160846508|NCT03197376|580825097|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
160846509|NCT03197376|580825098|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
160846510|NCT03197376|580825095|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
160846511|NCT03197376|580825096|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
160846512|NCT03197376|580825097|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
160846513|NCT03197376|580825098|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
160846514|NCT03197376|580825095|FG000|Primary and Booster Phase|Not vaccine related|1|||
160846515|NCT03197376|580825096|FG001|Primary and Booster Phase|Not vaccine related|2|||
160846516|NCT03197376|580825097|FG002|Primary and Booster Phase|Not vaccine related|0|||
160846517|NCT03197376|580825098|FG003|Primary and Booster Phase|Not vaccine related|6|||
160846518|NCT03197376|580825095|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
160846519|NCT03197376|580825096|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
160846520|NCT03197376|580825097|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
160846521|NCT03197376|580825098|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
160846522|NCT03197376|580825095|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
160650161|NCT00095199|580100551|FG002|Overall Study|Started radiotherapy regimen|0|||
160650162|NCT00095199|580100552|FG003|Overall Study|Started radiotherapy regimen|0|||
160650163|NCT00095199|580100549|FG000|Overall Study|Primary tumor removed in other surgery|0|||
160846523|NCT03197376|580825096|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
160846524|NCT03197376|580825097|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
160846525|NCT03197376|580825098|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
160846526|NCT03197376|580825095|FG000|Immune Persistence Phase|Not vaccine related|1|||
160846527|NCT03197376|580825096|FG001|Immune Persistence Phase|Not vaccine related|0|||
160846528|NCT03197376|580825097|FG002|Immune Persistence Phase|Not vaccine related|1|||
160846529|NCT03197376|580825098|FG003|Immune Persistence Phase|Not vaccine related|1|||
160846530|NCT00999518|580825100|FG000|Overall Study|Adverse Event|1|||
160846531|NCT00999518|580825101|FG001|Overall Study|Adverse Event|6|||
160846532|NCT00999518|580825102|FG002|Overall Study|Adverse Event|3|||
160846533|NCT00999518|580825103|FG003|Overall Study|Adverse Event|1|||
160846534|NCT00999518|580825104|FG004|Overall Study|Adverse Event|2|||
160846535|NCT00999518|580825100|FG000|Overall Study|Lack of Efficacy|2|||
160846536|NCT00999518|580825101|FG001|Overall Study|Lack of Efficacy|0|||
160846537|NCT00999518|580825102|FG002|Overall Study|Lack of Efficacy|0|||
160846538|NCT00999518|580825103|FG003|Overall Study|Lack of Efficacy|2|||
160846539|NCT00999518|580825104|FG004|Overall Study|Lack of Efficacy|2|||
160846540|NCT00999518|580825100|FG000|Overall Study|Lost to Follow-up|0|||
160846541|NCT00999518|580825101|FG001|Overall Study|Lost to Follow-up|0|||
160846542|NCT00999518|580825102|FG002|Overall Study|Lost to Follow-up|0|||
160846543|NCT00999518|580825103|FG003|Overall Study|Lost to Follow-up|4|||
160846544|NCT00999518|580825104|FG004|Overall Study|Lost to Follow-up|1|||
160846545|NCT00999518|580825100|FG000|Overall Study|Did not meet entrance criteria|0|||
160846546|NCT00999518|580825101|FG001|Overall Study|Did not meet entrance criteria|0|||
160846547|NCT00999518|580825102|FG002|Overall Study|Did not meet entrance criteria|0|||
160846548|NCT00999518|580825103|FG003|Overall Study|Did not meet entrance criteria|0|||
160846549|NCT00999518|580825104|FG004|Overall Study|Did not meet entrance criteria|1|||
160846550|NCT00999518|580825100|FG000|Overall Study|Study terminated by sponsor|10|||
160846551|NCT00999518|580825101|FG001|Overall Study|Study terminated by sponsor|6|||
160846552|NCT00999518|580825102|FG002|Overall Study|Study terminated by sponsor|5|||
160846553|NCT00999518|580825103|FG003|Overall Study|Study terminated by sponsor|5|||
160846554|NCT00999518|580825104|FG004|Overall Study|Study terminated by sponsor|9|||
160846555|NCT00999518|580825100|FG000|Overall Study|Pregnancy|0|||
160846556|NCT00999518|580825101|FG001|Overall Study|Pregnancy|0|||
160846557|NCT00999518|580825102|FG002|Overall Study|Pregnancy|1|||
160846558|NCT00999518|580825103|FG003|Overall Study|Pregnancy|0|||
160846559|NCT00999518|580825104|FG004|Overall Study|Pregnancy|0|||
160846560|NCT00999518|580825100|FG000|Overall Study|Protocol Violation|0|||
160846561|NCT00999518|580825101|FG001|Overall Study|Protocol Violation|1|||
160846562|NCT00999518|580825102|FG002|Overall Study|Protocol Violation|0|||
160846563|NCT00999518|580825103|FG003|Overall Study|Protocol Violation|0|||
160846564|NCT00999518|580825104|FG004|Overall Study|Protocol Violation|2|||
160846565|NCT00999518|580825100|FG000|Overall Study|Withdrawal by Subject|5|||
160846566|NCT00999518|580825101|FG001|Overall Study|Withdrawal by Subject|4|||
160846567|NCT00999518|580825102|FG002|Overall Study|Withdrawal by Subject|10|||
160846568|NCT00999518|580825103|FG003|Overall Study|Withdrawal by Subject|6|||
160846569|NCT00999518|580825104|FG004|Overall Study|Withdrawal by Subject|1|||
160846570|NCT00999518|580825100|FG000|Overall Study|Other|5|||
160846571|NCT00999518|580825101|FG001|Overall Study|Other|7|||
160846572|NCT00999518|580825102|FG002|Overall Study|Other|1|||
160846573|NCT00999518|580825103|FG003|Overall Study|Other|4|||
160846574|NCT00999518|580825104|FG004|Overall Study|Other|5|||
160846575|NCT00999518|580825100|FG000|Overall Study|Randomized but not Treated|1|||
160846576|NCT00999518|580825101|FG001|Overall Study|Randomized but not Treated|1|||
160846577|NCT00999518|580825102|FG002|Overall Study|Randomized but not Treated|2|||
160846578|NCT00999518|580825103|FG003|Overall Study|Randomized but not Treated|0|||
160846579|NCT00999518|580825104|FG004|Overall Study|Randomized but not Treated|1|||
160846580|NCT01811186|580825108|FG000|Overall Study|Adverse Event|54|||
160846581|NCT01811186|580825109|FG001|Overall Study|Adverse Event|38|||
160846582|NCT01811186|580825108|FG000|Overall Study|Protocol Violation|5|||
160846583|NCT01811186|580825109|FG001|Overall Study|Protocol Violation|6|||
160846584|NCT01811186|580825108|FG000|Overall Study|Withdrawal by Subject|5|||
160846585|NCT01811186|580825109|FG001|Overall Study|Withdrawal by Subject|10|||
160846586|NCT01811186|580825108|FG000|Overall Study|Lack of Efficacy|3|||
160846587|NCT01811186|580825109|FG001|Overall Study|Lack of Efficacy|6|||
160846588|NCT01811186|580825108|FG000|Overall Study|Lost to Follow-up|4|||
160846589|NCT01811186|580825109|FG001|Overall Study|Lost to Follow-up|2|||
160846590|NCT01445080|580825117|FG000|Overall Study|Adverse Event|5|||
160846591|NCT01445080|580825118|FG001|Overall Study|Adverse Event|3|||
160846592|NCT01445080|580825119|FG002|Overall Study|Adverse Event|11|||
160846593|NCT01445080|580825120|FG003|Overall Study|Adverse Event|6|||
160846594|NCT01445080|580825121|FG004|Overall Study|Adverse Event|2|||
160846595|NCT01445080|580825122|FG005|Overall Study|Adverse Event|3|||
160846596|NCT01445080|580825123|FG006|Overall Study|Adverse Event|0|||
160846597|NCT01445080|580825124|FG007|Overall Study|Adverse Event|3|||
160846598|NCT01445080|580825125|FG008|Overall Study|Adverse Event|10|||
160846599|NCT01445080|580825117|FG000|Overall Study|Physician Decision|0|||
160846600|NCT01445080|580825118|FG001|Overall Study|Physician Decision|0|||
160846601|NCT01445080|580825119|FG002|Overall Study|Physician Decision|1|||
160846602|NCT01445080|580825120|FG003|Overall Study|Physician Decision|0|||
160846603|NCT01445080|580825121|FG004|Overall Study|Physician Decision|0|||
160846604|NCT01445080|580825122|FG005|Overall Study|Physician Decision|3|||
160846605|NCT01445080|580825123|FG006|Overall Study|Physician Decision|2|||
160992405|NCT00661778|581361346|FG000|Overall Study|Adverse Event|18|||
160846606|NCT01445080|580825124|FG007|Overall Study|Physician Decision|2|||
160846607|NCT01445080|580825125|FG008|Overall Study|Physician Decision|0|||
160846608|NCT01445080|580825117|FG000|Overall Study|Withdrawal by Subject|1|||
160846609|NCT01445080|580825118|FG001|Overall Study|Withdrawal by Subject|0|||
160846610|NCT01445080|580825119|FG002|Overall Study|Withdrawal by Subject|0|||
160846611|NCT01445080|580825120|FG003|Overall Study|Withdrawal by Subject|1|||
160846612|NCT01445080|580825121|FG004|Overall Study|Withdrawal by Subject|0|||
160846613|NCT01445080|580825122|FG005|Overall Study|Withdrawal by Subject|0|||
160846614|NCT01445080|580825123|FG006|Overall Study|Withdrawal by Subject|0|||
160846615|NCT01445080|580825124|FG007|Overall Study|Withdrawal by Subject|0|||
160846616|NCT01445080|580825125|FG008|Overall Study|Withdrawal by Subject|2|||
160846617|NCT01445080|580825117|FG000|Overall Study|Ineligible/Inevaluable|1|||
160846618|NCT01445080|580825118|FG001|Overall Study|Ineligible/Inevaluable|2|||
160846619|NCT01445080|580825119|FG002|Overall Study|Ineligible/Inevaluable|0|||
160846620|NCT01445080|580825120|FG003|Overall Study|Ineligible/Inevaluable|1|||
160846621|NCT01445080|580825121|FG004|Overall Study|Ineligible/Inevaluable|2|||
160846622|NCT01445080|580825122|FG005|Overall Study|Ineligible/Inevaluable|3|||
160846623|NCT01445080|580825123|FG006|Overall Study|Ineligible/Inevaluable|0|||
160846624|NCT01445080|580825124|FG007|Overall Study|Ineligible/Inevaluable|0|||
160846625|NCT01445080|580825125|FG008|Overall Study|Ineligible/Inevaluable|6|||
160846626|NCT03887221|580825126|FG000|Overall Study|Protocol Violation|1|||
160846627|NCT03887221|580825127|FG001|Overall Study|Protocol Violation|0|||
160846628|NCT02487030|580825128|FG000|Overall Study|Lack of Efficacy|2|||
160846629|NCT02487030|580825129|FG001|Overall Study|Lack of Efficacy|4|||
160846630|NCT02487030|580825130|FG002|Overall Study|Lack of Efficacy|1|||
160846631|NCT02487030|580825131|FG003|Overall Study|Lack of Efficacy|0|||
160846632|NCT02487030|580825132|FG004|Overall Study|Lack of Efficacy|1|||
160846633|NCT02487030|580825133|FG005|Overall Study|Lack of Efficacy|0|||
160846634|NCT02487030|580825134|FG006|Overall Study|Lack of Efficacy|0|||
160846635|NCT02487030|580825128|FG000|Overall Study|Lost to Follow-up|0|||
160846636|NCT02487030|580825129|FG001|Overall Study|Lost to Follow-up|0|||
160846637|NCT02487030|580825130|FG002|Overall Study|Lost to Follow-up|1|||
160846638|NCT02487030|580825131|FG003|Overall Study|Lost to Follow-up|1|||
160846639|NCT02487030|580825132|FG004|Overall Study|Lost to Follow-up|0|||
160846640|NCT02487030|580825133|FG005|Overall Study|Lost to Follow-up|1|||
160846641|NCT02487030|580825134|FG006|Overall Study|Lost to Follow-up|0|||
160846642|NCT02487030|580825128|FG000|Overall Study|Adverse Event|0|||
160846643|NCT02487030|580825129|FG001|Overall Study|Adverse Event|0|||
160846644|NCT02487030|580825130|FG002|Overall Study|Adverse Event|0|||
160846645|NCT02487030|580825131|FG003|Overall Study|Adverse Event|1|||
160846646|NCT02487030|580825132|FG004|Overall Study|Adverse Event|0|||
160846647|NCT02487030|580825133|FG005|Overall Study|Adverse Event|0|||
160846648|NCT02487030|580825134|FG006|Overall Study|Adverse Event|0|||
160846649|NCT02487030|580825128|FG000|Overall Study|Death|0|||
160846650|NCT02487030|580825129|FG001|Overall Study|Death|0|||
160846651|NCT02487030|580825130|FG002|Overall Study|Death|0|||
160992406|NCT00661778|581361346|FG000|Overall Study|Reason not Specified|6|||
160992407|NCT00661778|581361346|FG000|Overall Study|Protocol Violation|2|||
160992408|NCT00661778|581361346|FG000|Overall Study|Withdrawal of Consent|1|||
160992409|NCT01149681|581361353|FG000|Overall Study|Withdrawal by Subject|7|||
160846652|NCT02487030|580825131|FG003|Overall Study|Death|0|||
160846653|NCT02487030|580825132|FG004|Overall Study|Death|1|||
160846654|NCT02487030|580825133|FG005|Overall Study|Death|0|||
160846655|NCT02487030|580825134|FG006|Overall Study|Death|0|||
160846656|NCT03857542|580825135|FG000|Overall Study|Adverse Event|1|||
160846657|NCT03857542|580825136|FG001|Overall Study|Adverse Event|3|||
160846658|NCT03857542|580825135|FG000|Overall Study|Withdrawal by Subject|2|||
160846659|NCT03857542|580825136|FG001|Overall Study|Withdrawal by Subject|1|||
160846660|NCT03857542|580825135|FG000|Overall Study|Lost to Follow-up|2|||
160846661|NCT03857542|580825136|FG001|Overall Study|Lost to Follow-up|1|||
160846662|NCT03857542|580825135|FG000|Overall Study|Reason not Specified|1|||
160846663|NCT03857542|580825136|FG001|Overall Study|Reason not Specified|0|||
160568174|NCT04283461|579802304|FG006|Overall Study|Enrolled in separate trial|0|||
160568175|NCT04283461|579802305|FG007|Overall Study|Enrolled in separate trial|8|||
160568176|NCT04283461|579802306|FG008|Overall Study|Enrolled in separate trial|0|||
160846664|NCT02123576|580825137|FG000|Overall Study|Adverse Event|1|||
160846665|NCT02123576|580825138|FG001|Overall Study|Adverse Event|0|||
160846666|NCT04864639|580826619|FG000|Overall Study|Death|1|||
160846667|NCT04864639|580826619|FG000|Overall Study|Lost to Follow-up|1|||
160846668|NCT00713544|580826635|FG000|Overall Study|Adverse Event|5|||
160846669|NCT00713544|580826636|FG001|Overall Study|Adverse Event|3|||
160846670|NCT00713544|580826637|FG002|Overall Study|Adverse Event|7|||
160846671|NCT00713544|580826638|FG003|Overall Study|Adverse Event|7|||
160846672|NCT00713544|580826639|FG004|Overall Study|Adverse Event|3|||
160846673|NCT00713544|580826640|FG005|Overall Study|Adverse Event|5|||
160846674|NCT00713544|580826635|FG000|Overall Study|Withdrawal by Subject|2|||
160846675|NCT00713544|580826636|FG001|Overall Study|Withdrawal by Subject|0|||
160846676|NCT00713544|580826637|FG002|Overall Study|Withdrawal by Subject|3|||
160846677|NCT00713544|580826638|FG003|Overall Study|Withdrawal by Subject|2|||
160846678|NCT00713544|580826639|FG004|Overall Study|Withdrawal by Subject|3|||
160846679|NCT00713544|580826640|FG005|Overall Study|Withdrawal by Subject|1|||
160846680|NCT00713544|580826635|FG000|Overall Study|Protocol Violation|0|||
160846681|NCT00713544|580826636|FG001|Overall Study|Protocol Violation|0|||
160846682|NCT00713544|580826637|FG002|Overall Study|Protocol Violation|0|||
160846683|NCT00713544|580826638|FG003|Overall Study|Protocol Violation|0|||
160846684|NCT00713544|580826639|FG004|Overall Study|Protocol Violation|0|||
160846685|NCT00713544|580826640|FG005|Overall Study|Protocol Violation|1|||
160846686|NCT00713544|580826635|FG000|Overall Study|Physician Decision|0|||
160846687|NCT00713544|580826636|FG001|Overall Study|Physician Decision|0|||
160846688|NCT00713544|580826637|FG002|Overall Study|Physician Decision|0|||
160846689|NCT00713544|580826638|FG003|Overall Study|Physician Decision|0|||
160846690|NCT00713544|580826639|FG004|Overall Study|Physician Decision|0|||
160846691|NCT00713544|580826640|FG005|Overall Study|Physician Decision|2|||
160846692|NCT00713544|580826635|FG000|Overall Study|Lack of Efficacy|0|||
160846693|NCT00713544|580826636|FG001|Overall Study|Lack of Efficacy|1|||
160846694|NCT00713544|580826637|FG002|Overall Study|Lack of Efficacy|0|||
160846695|NCT00713544|580826638|FG003|Overall Study|Lack of Efficacy|1|||
160846696|NCT00713544|580826639|FG004|Overall Study|Lack of Efficacy|1|||
160846697|NCT00713544|580826640|FG005|Overall Study|Lack of Efficacy|0|||
160846698|NCT00713544|580826635|FG000|Overall Study|Lost to Follow-up|0|||
160846699|NCT00713544|580826636|FG001|Overall Study|Lost to Follow-up|0|||
160846700|NCT00713544|580826637|FG002|Overall Study|Lost to Follow-up|1|||
160846701|NCT00713544|580826638|FG003|Overall Study|Lost to Follow-up|0|||
160846702|NCT00713544|580826639|FG004|Overall Study|Lost to Follow-up|0|||
160846703|NCT00713544|580826640|FG005|Overall Study|Lost to Follow-up|0|||
160846704|NCT00713544|580826635|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
160846705|NCT00713544|580826636|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
160846706|NCT00713544|580826637|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
160846707|NCT00713544|580826638|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
160846708|NCT00713544|580826639|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
160846709|NCT00713544|580826640|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
160846710|NCT00713544|580826635|FG000|Overall Study|Incorrect enrollment|0|||
160846711|NCT00713544|580826636|FG001|Overall Study|Incorrect enrollment|1|||
160846712|NCT00713544|580826637|FG002|Overall Study|Incorrect enrollment|0|||
160846713|NCT00713544|580826638|FG003|Overall Study|Incorrect enrollment|0|||
160846714|NCT00713544|580826639|FG004|Overall Study|Incorrect enrollment|0|||
160846715|NCT00713544|580826640|FG005|Overall Study|Incorrect enrollment|0|||
160846716|NCT00713544|580826635|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
160846717|NCT00713544|580826636|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
160846718|NCT00713544|580826637|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
160906107|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
160906108|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
160906109|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
160906110|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
160568177|NCT04283461|579802307|FG009|Overall Study|Enrolled in separate trial|0|||
160568178|NCT04283461|579802308|FG010|Overall Study|Enrolled in separate trial|0|||
160906111|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
160906112|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
160906113|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
160906114|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
160906115|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
160906116|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
160906117|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
160906118|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
160906119|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
160906120|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
160906121|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
160906122|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
160906123|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
160906124|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
160906125|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
160906126|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
160906127|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
160906128|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
160906129|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
160906130|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
160846719|NCT00713544|580826638|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
160846720|NCT00713544|580826639|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
160846721|NCT00713544|580826640|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
160846722|NCT00269919|580826641|FG000|Overall Study|Other|26|||
160846723|NCT00269919|580826641|FG000|Overall Study|Started but not treated|1|||
160846724|NCT00786799|580826644|FG000|Overall Study|Lost to Follow-up|1|||
160846725|NCT00786799|580826645|FG001|Overall Study|Lost to Follow-up|1|||
160846726|NCT02544503|580826646|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
160846727|NCT02544503|580826647|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
160846728|NCT02544503|580826646|FG000|Overall Study|Lost to Follow-up|9|||
160846729|NCT02544503|580826647|FG001|Overall Study|Lost to Follow-up|0|||
160846730|NCT02544503|580826646|FG000|Overall Study|Withdrawal by Subject|1|||
160846731|NCT02544503|580826647|FG001|Overall Study|Withdrawal by Subject|0|||
160846732|NCT04640311|580826648|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
160846733|NCT04640311|580826649|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846734|NCT04640311|580826650|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846735|NCT04640311|580826651|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846736|NCT04640311|580826652|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846737|NCT04640311|580826653|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846738|NCT04640311|580826654|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846739|NCT04640311|580826655|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846740|NCT04640311|580826656|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846741|NCT04640311|580826657|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846742|NCT04640311|580826658|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846743|NCT04640311|580826659|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846744|NCT04640311|580826660|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846745|NCT04640311|580826648|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846746|NCT04640311|580826649|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
160846747|NCT04640311|580826650|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846748|NCT04640311|580826651|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846749|NCT04640311|580826652|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846750|NCT04640311|580826653|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846751|NCT04640311|580826654|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846752|NCT04640311|580826655|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846753|NCT04640311|580826656|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846754|NCT04640311|580826657|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846755|NCT04640311|580826658|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846756|NCT04640311|580826659|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846757|NCT04640311|580826660|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846758|NCT04640311|580826648|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846759|NCT04640311|580826649|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
160846760|NCT04640311|580826650|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846761|NCT04640311|580826651|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846762|NCT04640311|580826652|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846763|NCT04640311|580826653|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846764|NCT04640311|580826654|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846765|NCT04640311|580826655|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846766|NCT04640311|580826656|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846767|NCT04640311|580826657|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846768|NCT04640311|580826658|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846769|NCT04640311|580826659|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846770|NCT04640311|580826660|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846771|NCT04640311|580826648|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
160846772|NCT04640311|580826649|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
160846773|NCT04640311|580826650|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
160846774|NCT04640311|580826651|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846775|NCT04640311|580826652|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846776|NCT04640311|580826653|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846777|NCT04640311|580826654|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846778|NCT04640311|580826655|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846779|NCT04640311|580826656|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846780|NCT04640311|580826657|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160906131|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Death|0|||
160992410|NCT01149681|581361353|FG000|Overall Study|Progressive disease|1|||
160568179|NCT04283461|579802309|FG011|Overall Study|Enrolled in separate trial|7|||
160568180|NCT04283461|579802310|FG012|Overall Study|Enrolled in separate trial|0|||
160568181|NCT05490771|579802311|FG000|Overall Study|Disease progression|18|||
160568182|NCT05490771|579802311|FG000|Overall Study|Adverse Event|3|||
160568183|NCT05490771|579802311|FG000|Overall Study|Other complicating disease|1|||
160846781|NCT04640311|580826658|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846782|NCT04640311|580826659|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846783|NCT04640311|580826660|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846784|NCT04640311|580826648|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846785|NCT04640311|580826649|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846786|NCT04640311|580826650|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
160846787|NCT04640311|580826651|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846788|NCT04640311|580826652|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846789|NCT04640311|580826653|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846790|NCT04640311|580826654|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846791|NCT04640311|580826655|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846792|NCT04640311|580826656|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846793|NCT04640311|580826657|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846794|NCT04640311|580826658|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846795|NCT04640311|580826659|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846796|NCT04640311|580826660|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846797|NCT04640311|580826648|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846798|NCT04640311|580826649|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846799|NCT04640311|580826650|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846800|NCT04640311|580826651|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
160846801|NCT04640311|580826652|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160568184|NCT05490771|579802311|FG000|Overall Study|Withdrawal by Subject|3|||
160568185|NCT05490771|579802311|FG000|Overall Study|Physician Decision|1|||
160906132|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Death|1|||
160906133|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Death|0|||
160906134|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Death|1|||
160906135|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Death|0|||
160906136|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Change of location|1|||
160906137|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Change of location|1|||
160906138|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Change of location|0|||
160906139|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Change of location|1|||
160906140|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Change of location|0|||
160906141|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
160906142|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
160906143|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
160906144|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
160906145|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
160906146|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
160906147|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
160906148|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
160906149|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
160906150|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
160906151|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
160906152|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
160906153|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
160906154|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
160906155|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
160906156|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
160906157|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
160906158|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
160906159|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
160906160|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
160906161|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
160906162|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
160906163|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
160906164|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
160906165|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
160906166|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
160568186|NCT05490771|579802311|FG000|Overall Study|Still on treatment|2|||
160846802|NCT04640311|580826653|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846803|NCT04640311|580826654|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
160846804|NCT04640311|580826655|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846805|NCT04640311|580826656|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846806|NCT04640311|580826657|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846807|NCT04640311|580826658|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846808|NCT04640311|580826659|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846809|NCT04640311|580826660|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846810|NCT04640311|580826648|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846811|NCT04640311|580826649|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846812|NCT04640311|580826650|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846813|NCT04640311|580826651|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846814|NCT04640311|580826652|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846815|NCT04640311|580826653|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
160846816|NCT04640311|580826654|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846817|NCT04640311|580826655|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846818|NCT04640311|580826656|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
160846819|NCT04640311|580826657|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846820|NCT04640311|580826658|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846821|NCT04640311|580826659|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846822|NCT04640311|580826660|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846823|NCT04640311|580826648|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846824|NCT04640311|580826649|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846825|NCT04640311|580826650|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846826|NCT04640311|580826651|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846827|NCT04640311|580826652|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846828|NCT04640311|580826653|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846829|NCT04640311|580826654|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
160846830|NCT04640311|580826655|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846831|NCT04640311|580826656|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846832|NCT04640311|580826657|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846833|NCT04640311|580826658|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
160846834|NCT04640311|580826659|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846835|NCT04640311|580826660|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846836|NCT04640311|580826648|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846837|NCT04640311|580826649|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846838|NCT04640311|580826650|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846839|NCT04640311|580826651|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846840|NCT04640311|580826652|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846841|NCT04640311|580826653|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846842|NCT04640311|580826654|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846843|NCT04640311|580826655|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846844|NCT04640311|580826656|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846845|NCT04640311|580826657|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846846|NCT04640311|580826658|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846847|NCT04640311|580826659|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
160846848|NCT04640311|580826660|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846849|NCT01641601|580826661|FG000|Overall Study|Study discontinued.|3|||
160846850|NCT01641601|580826662|FG001|Overall Study|Study discontinued.|5|||
160846851|NCT01799226|580826666|FG000|Overall Study|Withdrawal by Subject|1|||
160846852|NCT01799226|580826667|FG001|Overall Study|Withdrawal by Subject|0|||
160846853|NCT01799226|580826666|FG000|Overall Study|Disqualified at Day 14|1|||
160846854|NCT01799226|580826667|FG001|Overall Study|Disqualified at Day 14|0|||
160846855|NCT02178995|580826668|FG000|Double Blind|Adverse Event|0|||
160846856|NCT02178995|580826669|FG001|Double Blind|Adverse Event|0|||
160846857|NCT02178995|580826670|FG002|Double Blind|Adverse Event|0|||
160846858|NCT02178995|580826671|FG003|Double Blind|Adverse Event|0|||
160846859|NCT02178995|580826672|FG004|Double Blind|Adverse Event|0|||
160846860|NCT02178995|580826673|FG005|Double Blind|Adverse Event|1|||
160846861|NCT02178995|580826674|FG006|Double Blind|Adverse Event|0|||
160846862|NCT02178995|580826675|FG007|Double Blind|Adverse Event|1|||
160846863|NCT02178995|580826676|FG008|Double Blind|Adverse Event|1|||
160568187|NCT05490771|579802311|FG000|Overall Study|Never start protocol therapy|5|||
160846864|NCT02178995|580826668|FG000|Double Blind|Lost to Follow-up|0|||
160846865|NCT02178995|580826669|FG001|Double Blind|Lost to Follow-up|1|||
160846866|NCT02178995|580826670|FG002|Double Blind|Lost to Follow-up|0|||
160846867|NCT02178995|580826671|FG003|Double Blind|Lost to Follow-up|0|||
160992411|NCT01149681|581361353|FG000|Overall Study|Physician Decision|2|||
160992412|NCT01149681|581361353|FG000|Overall Study|adverse events nonrelated study drug|2|||
160992413|NCT01259102|581361354|FG000|Overall Study|Adverse Event|1|||
160992414|NCT01259102|581361355|FG001|Overall Study|Adverse Event|0|||
160568188|NCT05490771|579802311|FG000|Overall Study|Ineligible|2|||
160846868|NCT02178995|580826672|FG004|Double Blind|Lost to Follow-up|0|||
160568189|NCT00140855|579802322|FG000|Overall Study|Progressive disease|2|||
160568190|NCT03542682|579802323|FG000|Overall Study|COVID-19 Protocol|0|||
160568191|NCT03542682|579802324|FG001|Overall Study|COVID-19 Protocol|1|||
160568192|NCT01682044|579802331|FG000|Overall Study|Death|1|||
160568193|NCT01682044|579802331|FG000|Overall Study|Progression|3|||
160568194|NCT04090164|579802332|FG000|Overall Study|incomplete data on file|245|||
160568195|NCT04090164|579802333|FG001|Overall Study|incomplete data on file|0|||
160846869|NCT02178995|580826673|FG005|Double Blind|Lost to Follow-up|0|||
160846870|NCT02178995|580826674|FG006|Double Blind|Lost to Follow-up|0|||
160846871|NCT02178995|580826675|FG007|Double Blind|Lost to Follow-up|1|||
160846872|NCT02178995|580826676|FG008|Double Blind|Lost to Follow-up|0|||
160846873|NCT02178995|580826668|FG000|Open Label|Adverse Event|2|||
160846874|NCT02178995|580826669|FG001|Open Label|Adverse Event|0|||
160846875|NCT02178995|580826670|FG002|Open Label|Adverse Event|0|||
160846876|NCT02178995|580826671|FG003|Open Label|Adverse Event|0|||
160846877|NCT02178995|580826672|FG004|Open Label|Adverse Event|0|||
160846878|NCT02178995|580826673|FG005|Open Label|Adverse Event|0|||
160846879|NCT02178995|580826674|FG006|Open Label|Adverse Event|0|||
160568196|NCT01386385|579803831|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
160568197|NCT01386385|579803832|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
160568198|NCT01386385|579803833|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
160568199|NCT01386385|579803834|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
160568200|NCT01386385|579803835|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
160568201|NCT01386385|579803836|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
160568202|NCT01386385|579803837|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
160568203|NCT01386385|579803838|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
160568204|NCT01386385|579803831|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
160568205|NCT01386385|579803832|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
160568206|NCT01386385|579803833|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
160568207|NCT01386385|579803834|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
160568208|NCT01386385|579803835|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
160568209|NCT01386385|579803836|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
160568210|NCT01386385|579803837|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
160568211|NCT01386385|579803838|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
160568212|NCT01386385|579803831|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
160568213|NCT01386385|579803832|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
160568214|NCT01386385|579803833|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
160568215|NCT01386385|579803834|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
160568216|NCT01386385|579803835|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
160568217|NCT01386385|579803836|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
160568218|NCT01386385|579803837|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
160568219|NCT01386385|579803838|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
160568220|NCT01386385|579803831|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
160568221|NCT01386385|579803832|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
160568222|NCT01386385|579803833|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
160568223|NCT01386385|579803834|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
160568224|NCT01386385|579803835|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
160568225|NCT01386385|579803836|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
160568226|NCT01386385|579803837|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
160568227|NCT01386385|579803838|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
160568228|NCT01386385|579803831|FG000|Phase II Concurrent CRT|Adverse Event|0|||
160650164|NCT00095199|580100550|FG001|Overall Study|Primary tumor removed in other surgery|1|||
160846880|NCT02178995|580826675|FG007|Open Label|Adverse Event|0|||
160846881|NCT02178995|580826676|FG008|Open Label|Adverse Event|0|||
160846882|NCT02114606|580826678|FG000|Overall Study|Unable to swallow Cytosponge|6|||
160846883|NCT00981461|580826679|FG000|Overall Study|Lost to Follow-up|5|||
160846884|NCT00981461|580826680|FG001|Overall Study|Lost to Follow-up|2|||
160846885|NCT01388907|580826681|FG000|Overall Study|Adverse Event|2|||
160846886|NCT01388907|580826682|FG001|Overall Study|Adverse Event|0|||
160846887|NCT03361293|580826683|FG000|Overall Study|Lost to Follow-up|0|||
160992415|NCT01259102|581361356|FG002|Overall Study|Adverse Event|1|||
160846888|NCT03361293|580826684|FG001|Overall Study|Lost to Follow-up|2|||
160846889|NCT03361293|580826683|FG000|Overall Study|Withdrawal by Subject|1|||
160846890|NCT03361293|580826684|FG001|Overall Study|Withdrawal by Subject|3|||
160846891|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
160846892|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
160992416|NCT01259102|581361357|FG003|Overall Study|Adverse Event|1|||
160846893|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
160568229|NCT01386385|579803832|FG001|Phase II Concurrent CRT|Adverse Event|0|||
160568230|NCT01386385|579803833|FG002|Phase II Concurrent CRT|Adverse Event|0|||
160568231|NCT01386385|579803834|FG003|Phase II Concurrent CRT|Adverse Event|0|||
160568232|NCT01386385|579803835|FG004|Phase II Concurrent CRT|Adverse Event|0|||
160846894|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
160846895|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
160846896|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
160846897|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
160846898|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
160846899|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
160846900|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
160846901|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
160846902|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
160846903|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
160846904|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
160846905|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
160846906|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
160846907|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
160846908|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
160846909|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
160846910|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
160846911|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
160846912|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
160846913|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
160846914|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
160846915|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
160846916|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
160846917|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
160846918|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
160846919|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
160846920|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
160568233|NCT01386385|579803836|FG005|Phase II Concurrent CRT|Adverse Event|0|||
160846921|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
160568234|NCT01386385|579803837|FG006|Phase II Concurrent CRT|Adverse Event|3|||
160568235|NCT01386385|579803838|FG007|Phase II Concurrent CRT|Adverse Event|3|||
160568236|NCT01386385|579803831|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
160568237|NCT01386385|579803832|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
160568238|NCT01386385|579803833|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
160568239|NCT01386385|579803834|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
160650165|NCT00095199|580100551|FG002|Overall Study|Primary tumor removed in other surgery|0|||
160568240|NCT01386385|579803835|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
160568241|NCT01386385|579803836|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
160568242|NCT01386385|579803837|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
160568243|NCT01386385|579803838|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
160568244|NCT01386385|579803831|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
160568245|NCT01386385|579803832|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
160568246|NCT01386385|579803833|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
160568247|NCT01386385|579803834|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
160846922|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
160846923|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
160846924|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
160846925|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
160846926|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
160846927|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
160846928|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
160846929|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
160846930|NCT00483405|580826688|FG000|Overall Study|Adverse Event|8|||
160846931|NCT00483405|580826688|FG000|Overall Study|Lack of Efficacy|14|||
160846932|NCT00483405|580826688|FG000|Overall Study|Death|3|||
160846933|NCT00483405|580826688|FG000|Overall Study|Withdrawal by Subject|2|||
160846934|NCT00483405|580826688|FG000|Overall Study|Other complicating disease|1|||
160846935|NCT03010319|580826689|FG000|Overall Study|Adverse Event|15|||
160846936|NCT03010319|580826690|FG001|Overall Study|Adverse Event|9|||
160846937|NCT03010319|580826689|FG000|Overall Study|Withdrawal by Subject|1|||
160846938|NCT03010319|580826690|FG001|Overall Study|Withdrawal by Subject|6|||
160846939|NCT03010319|580826689|FG000|Overall Study|Physician Decision|2|||
160846940|NCT03010319|580826690|FG001|Overall Study|Physician Decision|4|||
160846941|NCT03010319|580826689|FG000|Overall Study|Sponsor requested withdrawal|2|||
160846942|NCT03010319|580826690|FG001|Overall Study|Sponsor requested withdrawal|2|||
160846943|NCT03010319|580826689|FG000|Overall Study|Death|1|||
160846944|NCT03010319|580826690|FG001|Overall Study|Death|0|||
160846945|NCT03010319|580826689|FG000|Overall Study|Lost to Follow-up|0|||
160846946|NCT03010319|580826690|FG001|Overall Study|Lost to Follow-up|1|||
160846947|NCT03010319|580826689|FG000|Overall Study|Other Reason|5|||
160846948|NCT03010319|580826690|FG001|Overall Study|Other Reason|7|||
160846949|NCT02128724|580826691|FG000|Overall Study|Death|1|||
160846950|NCT02128724|580826692|FG001|Overall Study|Death|0|||
160846951|NCT02128724|580826693|FG002|Overall Study|Death|0|||
160846952|NCT02128724|580826694|FG003|Overall Study|Death|0|||
160568248|NCT01386385|579803835|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
160568249|NCT01386385|579803836|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
160568250|NCT01386385|579803837|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
160568251|NCT01386385|579803838|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
160846953|NCT02128724|580826691|FG000|Overall Study|Adverse Event|0|||
160846954|NCT02128724|580826692|FG001|Overall Study|Adverse Event|1|||
160846955|NCT02128724|580826693|FG002|Overall Study|Adverse Event|0|||
160846956|NCT02128724|580826694|FG003|Overall Study|Adverse Event|0|||
160846957|NCT02128724|580826691|FG000|Overall Study|Physician Decision|0|||
160846958|NCT02128724|580826692|FG001|Overall Study|Physician Decision|0|||
160846959|NCT02128724|580826693|FG002|Overall Study|Physician Decision|0|||
160846960|NCT02128724|580826694|FG003|Overall Study|Physician Decision|2|||
160846961|NCT02128724|580826691|FG000|Overall Study|Withdrawal by Subject|0|||
160846962|NCT02128724|580826692|FG001|Overall Study|Withdrawal by Subject|0|||
160992417|NCT01259102|581361358|FG004|Overall Study|Adverse Event|0|||
160992418|NCT01259102|581361354|FG000|Overall Study|Other|0|||
160992419|NCT01259102|581361355|FG001|Overall Study|Other|0|||
160992420|NCT01259102|581361356|FG002|Overall Study|Other|1|||
160992421|NCT01259102|581361357|FG003|Overall Study|Other|1|||
160992422|NCT01259102|581361358|FG004|Overall Study|Other|1|||
160992423|NCT00817635|581361359|FG000|Overall Study|Adverse Event|1|||
160992424|NCT00817635|581361360|FG001|Overall Study|Adverse Event|0|||
160568252|NCT01386385|579803831|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
160568253|NCT01386385|579803832|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
160568254|NCT01386385|579803833|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
160568255|NCT01386385|579803834|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
160846963|NCT02128724|580826693|FG002|Overall Study|Withdrawal by Subject|0|||
160846964|NCT02128724|580826694|FG003|Overall Study|Withdrawal by Subject|1|||
160992425|NCT00817635|581361361|FG002|Overall Study|Adverse Event|0|||
160568256|NCT01386385|579803835|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
160846965|NCT01957202|580826696|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846966|NCT01957202|580826697|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
160846967|NCT01957202|580826698|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160992426|NCT00817635|581361362|FG003|Overall Study|Adverse Event|1|||
160846968|NCT01957202|580826699|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846969|NCT01957202|580826700|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846970|NCT01957202|580826701|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846971|NCT01957202|580826702|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846972|NCT01957202|580826703|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846973|NCT01957202|580826704|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846974|NCT01957202|580826705|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846975|NCT01957202|580826706|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846976|NCT01957202|580826707|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160650166|NCT00095199|580100552|FG003|Overall Study|Primary tumor removed in other surgery|0|||
160650167|NCT00095199|580100549|FG000|Overall Study|Data inadvertently lost by site|1|||
160650168|NCT00095199|580100550|FG001|Overall Study|Data inadvertently lost by site|0|||
160650169|NCT00095199|580100551|FG002|Overall Study|Data inadvertently lost by site|0|||
160650170|NCT00095199|580100552|FG003|Overall Study|Data inadvertently lost by site|0|||
160650171|NCT03896490|580100587|FG000|Overall Study|Withdrawal by Subject|1|||
160650172|NCT03896490|580100588|FG001|Overall Study|Withdrawal by Subject|1|||
160650173|NCT05440097|580101501|FG000|Overall Study|Withdrawal by Subject|154|||
160650174|NCT05440097|580101501|FG000|Overall Study|Death|2|||
160650175|NCT05440097|580101501|FG000|Overall Study|Physician Decision|2|||
160650176|NCT05440097|580101501|FG000|Overall Study|Lost to Follow-up|56|||
160650177|NCT05440097|580101501|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
160650178|NCT02081599|580101502|FG000|Period 1：Double-blind Period|Adverse Event|3|||
160650179|NCT02081599|580101503|FG001|Period 1：Double-blind Period|Adverse Event|0|||
160650180|NCT02081599|580101502|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
160650181|NCT02081599|580101503|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
160650182|NCT02081599|580101502|FG000|Period 1：Double-blind Period|Physician Decision|1|||
160650183|NCT02081599|580101503|FG001|Period 1：Double-blind Period|Physician Decision|0|||
160846977|NCT01957202|580826708|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846978|NCT01957202|580826709|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846979|NCT01957202|580826710|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846980|NCT01957202|580826711|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846981|NCT01957202|580826712|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
160846982|NCT01957202|580826713|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846983|NCT01957202|580826696|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846984|NCT01957202|580826697|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846985|NCT01957202|580826698|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846986|NCT01957202|580826699|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846987|NCT01957202|580826700|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846988|NCT01957202|580826701|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846989|NCT01957202|580826702|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846990|NCT01957202|580826703|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846991|NCT01957202|580826704|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846992|NCT01957202|580826705|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846993|NCT01957202|580826706|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846994|NCT01957202|580826707|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846995|NCT01957202|580826708|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846996|NCT01957202|580826709|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846997|NCT01957202|580826710|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846998|NCT01957202|580826711|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846999|NCT01957202|580826712|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
160847000|NCT01957202|580826713|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
160847001|NCT03594773|580826715|FG000|Overall Study|Withdrawal by Subject|3|||
160847002|NCT03594773|580826716|FG001|Overall Study|Withdrawal by Subject|2|||
160847003|NCT03594773|580826715|FG000|Overall Study|Lost to Follow-up|3|||
160847004|NCT03594773|580826716|FG001|Overall Study|Lost to Follow-up|4|||
160847005|NCT02640547|580826717|FG000|Overall Study|Failure to Return|1|||
160847006|NCT02640547|580826717|FG000|Overall Study|Withdrawal by Subject|1|||
160847007|NCT02640547|580826717|FG000|Overall Study|Death|6|||
160847008|NCT02640547|580826717|FG000|Overall Study|Miscellaneous|3|||
160847009|NCT00193206|580826718|FG000|Preoperative Therapy|Lack of Efficacy|2|||
160847010|NCT00193206|580826718|FG000|Preoperative Therapy|Adverse Event|2|||
160847011|NCT00193206|580826718|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
160847012|NCT00193206|580826718|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
160847013|NCT00193206|580826718|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
160847014|NCT00193206|580826718|FG000|Postoperative Therapy|Physician Decision|3|||
160847015|NCT00193206|580826718|FG000|Postoperative Therapy|Intercurrent Illness|2|||
160847016|NCT00193206|580826718|FG000|Postoperative Therapy|Lack of Efficacy|1|||
160847017|NCT00193206|580826718|FG000|Postoperative Therapy|Protocol Violation|1|||
160847018|NCT01200368|580826719|FG000|Infant Series|Adverse Event|2|||
160906167|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
160906168|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
160650184|NCT02081599|580101502|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
160650185|NCT02081599|580101503|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
160847019|NCT01200368|580826720|FG001|Infant Series|Adverse Event|2|||
160847020|NCT01200368|580826721|FG002|Infant Series|Adverse Event|3|||
160847021|NCT01200368|580826719|FG000|Infant Series|Withdrawal by Subject|0|||
160847022|NCT01200368|580826720|FG001|Infant Series|Withdrawal by Subject|2|||
160847023|NCT01200368|580826721|FG002|Infant Series|Withdrawal by Subject|2|||
160847024|NCT01200368|580826719|FG000|Infant Series|Did not meet entrance criteria|0|||
160847025|NCT01200368|580826720|FG001|Infant Series|Did not meet entrance criteria|1|||
160847026|NCT01200368|580826721|FG002|Infant Series|Did not meet entrance criteria|0|||
160847027|NCT01200368|580826719|FG000|Infant Series|Randomized, not vaccinated|0|||
160847028|NCT01200368|580826720|FG001|Infant Series|Randomized, not vaccinated|1|||
160847029|NCT01200368|580826721|FG002|Infant Series|Randomized, not vaccinated|1|||
160847030|NCT01200368|580826719|FG000|Infant Series|Other|1|||
160847031|NCT01200368|580826720|FG001|Infant Series|Other|0|||
160847032|NCT01200368|580826721|FG002|Infant Series|Other|0|||
160847033|NCT01200368|580826719|FG000|After Infant Series|Adverse Event|6|||
160847034|NCT01200368|580826720|FG001|After Infant Series|Adverse Event|6|||
160847035|NCT01200368|580826721|FG002|After Infant Series|Adverse Event|3|||
160847036|NCT01200368|580826719|FG000|After Infant Series|Withdrawal by Subject|10|||
160847037|NCT01200368|580826720|FG001|After Infant Series|Withdrawal by Subject|8|||
160847038|NCT01200368|580826721|FG002|After Infant Series|Withdrawal by Subject|4|||
160847039|NCT01200368|580826719|FG000|After Infant Series|Lost to Follow-up|1|||
160847040|NCT01200368|580826720|FG001|After Infant Series|Lost to Follow-up|0|||
160847041|NCT01200368|580826721|FG002|After Infant Series|Lost to Follow-up|0|||
160847042|NCT01200368|580826719|FG000|After Infant Series|Other|1|||
160847043|NCT01200368|580826720|FG001|After Infant Series|Other|2|||
160847044|NCT01200368|580826721|FG002|After Infant Series|Other|2|||
160847045|NCT01200368|580826719|FG000|Toddler Dose|Adverse Event|0|||
160847046|NCT01200368|580826720|FG001|Toddler Dose|Adverse Event|3|||
160847047|NCT01200368|580826721|FG002|Toddler Dose|Adverse Event|1|||
160847048|NCT01290757|580826723|FG000|Overall Study|Adverse Event|1|||
160847049|NCT01290757|580826724|FG001|Overall Study|Adverse Event|0|||
160847050|NCT01290757|580826723|FG000|Overall Study|Protocol Violation|1|||
160847051|NCT01290757|580826724|FG001|Overall Study|Protocol Violation|1|||
160847052|NCT01290757|580826723|FG000|Overall Study|Other|0|||
160847053|NCT01290757|580826724|FG001|Overall Study|Other|1|||
160847054|NCT00080301|580826726|FG000|Overall Study|Randomized but Never Treated|5|||
160847055|NCT00080301|580826727|FG001|Overall Study|Randomized but Never Treated|10|||
160847056|NCT00080301|580826726|FG000|Overall Study|Still on Treatment as of CSR date|0|||
160847057|NCT00080301|580826727|FG001|Overall Study|Still on Treatment as of CSR date|1|||
160847058|NCT00991939|580826728|FG000|Overall Study|Lost to Follow-up|0|||
160906169|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
160906170|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
160906171|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
160906172|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
160906173|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
160906174|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
160906175|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
160568257|NCT01386385|579803836|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
160568258|NCT01386385|579803837|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
160568259|NCT01386385|579803838|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
160568260|NCT01386385|579803831|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
160568261|NCT01386385|579803832|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
160568262|NCT01386385|579803833|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
160847059|NCT00991939|580826729|FG001|Overall Study|Lost to Follow-up|1|||
160847060|NCT00991939|580826728|FG000|Overall Study|Withdrawal by Subject|1|||
160847061|NCT00991939|580826729|FG001|Overall Study|Withdrawal by Subject|0|||
160847062|NCT00991939|580826728|FG000|Overall Study|Entire study terminated|4|||
160847063|NCT00991939|580826729|FG001|Overall Study|Entire study terminated|1|||
160847064|NCT00181766|580826739|FG000|Overall Study|Lost to Follow-up|6|||
160847065|NCT00181766|580826739|FG000|Overall Study|Adverse Event|4|||
160847066|NCT00181766|580826739|FG000|Overall Study|non-compliance|2|||
160847067|NCT01965704|580826742|FG000|Overall Study|Withdrawal by Subject|2|||
160847068|NCT01965704|580826743|FG001|Overall Study|Withdrawal by Subject|2|||
160847069|NCT01965704|580826744|FG002|Overall Study|Withdrawal by Subject|1|||
160847070|NCT01965704|580826745|FG003|Overall Study|Withdrawal by Subject|1|||
160847071|NCT01965704|580826742|FG000|Overall Study|Delivered at home|1|||
160847072|NCT01965704|580826743|FG001|Overall Study|Delivered at home|1|||
160847073|NCT01965704|580826744|FG002|Overall Study|Delivered at home|0|||
160847074|NCT01965704|580826745|FG003|Overall Study|Delivered at home|0|||
160847075|NCT01965704|580826742|FG000|Overall Study|Experienced complications|0|||
160847076|NCT01965704|580826743|FG001|Overall Study|Experienced complications|0|||
160847077|NCT01965704|580826744|FG002|Overall Study|Experienced complications|2|||
160847078|NCT01965704|580826745|FG003|Overall Study|Experienced complications|2|||
160847079|NCT01965704|580826742|FG000|Overall Study|Adverse Event|0|||
160906176|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
160847080|NCT01965704|580826743|FG001|Overall Study|Adverse Event|0|||
160847081|NCT01965704|580826744|FG002|Overall Study|Adverse Event|1|||
160847082|NCT01965704|580826745|FG003|Overall Study|Adverse Event|1|||
160847083|NCT01965704|580826742|FG000|Overall Study|Did not meet inclusion criteria|0|||
160847084|NCT01965704|580826743|FG001|Overall Study|Did not meet inclusion criteria|0|||
160847085|NCT01965704|580826744|FG002|Overall Study|Did not meet inclusion criteria|1|||
160847086|NCT01965704|580826745|FG003|Overall Study|Did not meet inclusion criteria|1|||
160847087|NCT02524171|580826749|FG000|6-month Follow-up|Lost to Follow-up|53|||
160847088|NCT02524171|580826750|FG001|6-month Follow-up|Lost to Follow-up|45|||
160847089|NCT02524171|580826749|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
160847090|NCT02524171|580826750|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
160568263|NCT01386385|579803834|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
160568264|NCT01386385|579803835|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
160847091|NCT01502228|580826751|FG000|Overall Study|Death|1|||
160847092|NCT05730387|580826752|FG000|Overall Study|Stillbirth|0|||
160847093|NCT05730387|580826753|FG001|Overall Study|Stillbirth|262|||
160847094|NCT05730387|580826752|FG000|Overall Study|Died during or after delivery|2|||
160847095|NCT05730387|580826753|FG001|Overall Study|Died during or after delivery|85|||
160847096|NCT05730387|580826752|FG000|Overall Study|Died after being admitted|0|||
160847097|NCT05730387|580826753|FG001|Overall Study|Died after being admitted|44|||
160847098|NCT05730387|580826752|FG000|Overall Study|Lost to Follow-up|69|||
160847099|NCT05730387|580826753|FG001|Overall Study|Lost to Follow-up|77|||
160847100|NCT00637416|580826759|FG000|Overall Study|Lost to Follow-up|1|||
160847101|NCT00637416|580826760|FG001|Overall Study|Lost to Follow-up|1|||
160847102|NCT00637416|580826759|FG000|Overall Study|Unable to take study drug|0|||
160847103|NCT00637416|580826760|FG001|Overall Study|Unable to take study drug|1|||
160847104|NCT04137731|580826763|FG000|Overall Study|Surgery Cancellation|1|||
160847105|NCT04137731|580826764|FG001|Overall Study|Surgery Cancellation|2|||
160847106|NCT04137731|580826763|FG000|Overall Study|Withdrawal by Subject|2|||
160847107|NCT04137731|580826764|FG001|Overall Study|Withdrawal by Subject|0|||
160847108|NCT04137731|580826763|FG000|Overall Study|Protocol Violation|0|||
160847109|NCT04137731|580826764|FG001|Overall Study|Protocol Violation|1|||
160847110|NCT02204072|580826766|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
160847111|NCT02204072|580826767|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
160847112|NCT02204072|580826768|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
160847113|NCT02204072|580826769|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
160847114|NCT02204072|580826770|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
160847115|NCT02204072|580826766|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
160847116|NCT02204072|580826767|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
160847117|NCT02204072|580826768|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
160847118|NCT02204072|580826769|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
160847119|NCT02204072|580826770|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
160847120|NCT02204072|580826766|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
160847121|NCT02204072|580826767|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
160568265|NCT01386385|579803836|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
160568266|NCT01386385|579803837|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
160568267|NCT01386385|579803838|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
160568268|NCT03746080|579803840|FG000|Overall Study|In follow up|2|||
160568269|NCT03746080|579803840|FG000|Overall Study|Death|15|||
160568270|NCT03839524|579803847|FG000|Overall Study|Adverse Event|1|||
160568271|NCT04419506|579803856|FG000|Overall Study|Adverse Event|0|||
160568272|NCT04419506|579803857|FG001|Overall Study|Adverse Event|10|||
160847122|NCT02204072|580826768|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
160847123|NCT02204072|580826769|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
160847124|NCT02204072|580826770|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
160847125|NCT02204072|580826766|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
160847126|NCT02204072|580826767|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
160847127|NCT02204072|580826768|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
160847128|NCT02204072|580826769|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
160847129|NCT02204072|580826770|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
160847130|NCT00310817|580826771|FG000|Overall Study|AE or Death|3|||
160847131|NCT00310817|580826772|FG001|Overall Study|AE or Death|1|||
160847132|NCT00310817|580826773|FG002|Overall Study|AE or Death|0|||
160847133|NCT00310817|580826774|FG003|Overall Study|AE or Death|0|||
160847134|NCT00310817|580826771|FG000|Overall Study|Withdrawal by Subject|1|||
160847135|NCT00310817|580826772|FG001|Overall Study|Withdrawal by Subject|4|||
160847136|NCT00310817|580826773|FG002|Overall Study|Withdrawal by Subject|6|||
160847137|NCT00310817|580826774|FG003|Overall Study|Withdrawal by Subject|7|||
160847138|NCT00310817|580826771|FG000|Overall Study|Lost to Follow-up|2|||
160568273|NCT04419506|579803858|FG002|Overall Study|Adverse Event|0|||
160568274|NCT04419506|579803859|FG003|Overall Study|Adverse Event|3|||
160568275|NCT04419506|579803856|FG000|Overall Study|Withdrawal by Subject|0|||
160847139|NCT00310817|580826772|FG001|Overall Study|Lost to Follow-up|1|||
160847140|NCT00310817|580826773|FG002|Overall Study|Lost to Follow-up|0|||
160847141|NCT00310817|580826774|FG003|Overall Study|Lost to Follow-up|0|||
160847142|NCT00310817|580826771|FG000|Overall Study|Inappropriate Enrollment|1|||
160847143|NCT00310817|580826772|FG001|Overall Study|Inappropriate Enrollment|0|||
160847144|NCT00310817|580826773|FG002|Overall Study|Inappropriate Enrollment|1|||
160847145|NCT00310817|580826774|FG003|Overall Study|Inappropriate Enrollment|0|||
160847146|NCT00310817|580826771|FG000|Overall Study|Protocol Violation|1|||
160847147|NCT00310817|580826772|FG001|Overall Study|Protocol Violation|1|||
160847148|NCT00310817|580826773|FG002|Overall Study|Protocol Violation|1|||
160847149|NCT00310817|580826774|FG003|Overall Study|Protocol Violation|1|||
160847150|NCT00310817|580826771|FG000|Overall Study|Unable to classify|3|||
160847151|NCT00310817|580826772|FG001|Overall Study|Unable to classify|1|||
160847152|NCT00310817|580826773|FG002|Overall Study|Unable to classify|0|||
160847153|NCT00310817|580826774|FG003|Overall Study|Unable to classify|0|||
160847154|NCT01587040|580826780|FG000|Overall Study|Protocol Violation|0|||
160847155|NCT01587040|580826781|FG001|Overall Study|Protocol Violation|0|||
160847156|NCT01587040|580826782|FG002|Overall Study|Protocol Violation|1|||
160847157|NCT01587040|580826783|FG003|Overall Study|Protocol Violation|0|||
160847158|NCT01587040|580826780|FG000|Overall Study|Adverse Event|0|||
160847159|NCT01587040|580826781|FG001|Overall Study|Adverse Event|1|||
160847160|NCT01587040|580826782|FG002|Overall Study|Adverse Event|10|||
160847161|NCT01587040|580826783|FG003|Overall Study|Adverse Event|0|||
160847162|NCT01587040|580826780|FG000|Overall Study|Disease progression|12|||
160847163|NCT01587040|580826781|FG001|Overall Study|Disease progression|1|||
160847164|NCT01587040|580826782|FG002|Overall Study|Disease progression|15|||
160847165|NCT01587040|580826783|FG003|Overall Study|Disease progression|3|||
160847166|NCT01587040|580826780|FG000|Overall Study|Other than specified|5|||
160847167|NCT01587040|580826781|FG001|Overall Study|Other than specified|1|||
160847168|NCT01587040|580826782|FG002|Overall Study|Other than specified|11|||
160847169|NCT01587040|580826783|FG003|Overall Study|Other than specified|1|||
160847172|NCT00367835|580826789|FG000|Overall Study|Adverse Event|14|||
160847173|NCT00367835|580826790|FG001|Overall Study|Adverse Event|1|||
160847174|NCT00367835|580826789|FG000|Overall Study|Protocol Violation|1|||
160847175|NCT00367835|580826790|FG001|Overall Study|Protocol Violation|7|||
160847176|NCT00367835|580826789|FG000|Overall Study|Withdrawal by Subject|7|||
160847177|NCT00367835|580826790|FG001|Overall Study|Withdrawal by Subject|6|||
160847178|NCT00367835|580826789|FG000|Overall Study|Lost to Follow-up|1|||
160847179|NCT00367835|580826790|FG001|Overall Study|Lost to Follow-up|4|||
160847180|NCT00367835|580826789|FG000|Overall Study|Lack of Efficacy|3|||
160847181|NCT00367835|580826790|FG001|Overall Study|Lack of Efficacy|12|||
160847182|NCT00367835|580826789|FG000|Overall Study|Subject in juvenile detention center|1|||
160847183|NCT00367835|580826790|FG001|Overall Study|Subject in juvenile detention center|0|||
160847184|NCT00367835|580826789|FG000|Overall Study|refused blood collection|1|||
160847185|NCT00367835|580826790|FG001|Overall Study|refused blood collection|0|||
160847186|NCT00367835|580826789|FG000|Overall Study|Did not respond to calls|1|||
160847187|NCT00367835|580826790|FG001|Overall Study|Did not respond to calls|0|||
160847188|NCT00367835|580826789|FG000|Overall Study|History of lead poisoning|0|||
160847189|NCT00367835|580826790|FG001|Overall Study|History of lead poisoning|1|||
160847190|NCT04346654|580826792|FG000|Overall Study|Adverse Event|2|||
160847191|NCT04346654|580826793|FG001|Overall Study|Adverse Event|0|||
160847192|NCT04346654|580826792|FG000|Overall Study|Non-response|1|||
160847193|NCT04346654|580826793|FG001|Overall Study|Non-response|1|||
160847194|NCT04346654|580826792|FG000|Overall Study|Withdrawal by Subject|2|||
160847195|NCT04346654|580826793|FG001|Overall Study|Withdrawal by Subject|0|||
160847196|NCT04346654|580826792|FG000|Overall Study|Lost to Follow-up|0|||
160847197|NCT04346654|580826793|FG001|Overall Study|Lost to Follow-up|1|||
160847198|NCT04346654|580826792|FG000|Overall Study|Pregnancy|0|||
160847199|NCT04346654|580826793|FG001|Overall Study|Pregnancy|1|||
160847200|NCT01525615|580828623|FG000|Overall Study|Adverse Event|11|||
160847201|NCT01525615|580828624|FG001|Overall Study|Adverse Event|7|||
160847202|NCT01525615|580828625|FG002|Overall Study|Adverse Event|5|||
160847203|NCT01525615|580828623|FG000|Overall Study|Lost to Follow-up|1|||
160847204|NCT01525615|580828624|FG001|Overall Study|Lost to Follow-up|0|||
160847205|NCT01525615|580828625|FG002|Overall Study|Lost to Follow-up|0|||
160847206|NCT01525615|580828623|FG000|Overall Study|Withdrawal by Subject|1|||
160847207|NCT01525615|580828624|FG001|Overall Study|Withdrawal by Subject|0|||
160847208|NCT01525615|580828625|FG002|Overall Study|Withdrawal by Subject|0|||
160847209|NCT01525615|580828623|FG000|Overall Study|Other reason not described above|1|||
160847210|NCT01525615|580828624|FG001|Overall Study|Other reason not described above|0|||
160847211|NCT01525615|580828625|FG002|Overall Study|Other reason not described above|1|||
160847212|NCT04050618|580828626|FG000|First Intervention|Withdrawal by Subject|2|||
160847213|NCT04050618|580828627|FG001|First Intervention|Withdrawal by Subject|0|||
160847214|NCT04050618|580828626|FG000|Second Intervention|Withdrawal by Subject|1|||
160847215|NCT04050618|580828627|FG001|Second Intervention|Withdrawal by Subject|0|||
160568276|NCT04419506|579803857|FG001|Overall Study|Withdrawal by Subject|0|||
160568277|NCT04419506|579803858|FG002|Overall Study|Withdrawal by Subject|0|||
160568278|NCT04419506|579803859|FG003|Overall Study|Withdrawal by Subject|1|||
160568279|NCT04419506|579803856|FG000|Overall Study|poor-compliance|0|||
160847216|NCT01101035|580828628|FG000|Overall Study|Adverse Event|191|||
160847217|NCT01101035|580828629|FG001|Overall Study|Adverse Event|172|||
160847218|NCT01101035|580828628|FG000|Overall Study|Major Protocol Deviation|52|||
160847219|NCT01101035|580828629|FG001|Overall Study|Major Protocol Deviation|46|||
160847220|NCT01101035|580828628|FG000|Overall Study|Lost to Follow-up|226|||
160847221|NCT01101035|580828629|FG001|Overall Study|Lost to Follow-up|223|||
160847222|NCT01101035|580828628|FG000|Overall Study|Voluntary Withdrawal|595|||
160847223|NCT01101035|580828629|FG001|Overall Study|Voluntary Withdrawal|587|||
160847224|NCT01101035|580828628|FG000|Overall Study|Reason not Specified|333|||
160847225|NCT01101035|580828629|FG001|Overall Study|Reason not Specified|363|||
160650186|NCT02081599|580101502|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
160568280|NCT04419506|579803857|FG001|Overall Study|poor-compliance|0|||
160568281|NCT04419506|579803858|FG002|Overall Study|poor-compliance|0|||
160650187|NCT02081599|580101503|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
160847226|NCT00217425|580828630|FG000|Overall Study|Never started treatment|2|||
160568282|NCT04419506|579803859|FG003|Overall Study|poor-compliance|1|||
160650188|NCT02081599|580101502|FG000|Period 1：Double-blind Period|stopping criteria|1|||
160650189|NCT02081599|580101503|FG001|Period 1：Double-blind Period|stopping criteria|0|||
160650190|NCT02081599|580101502|FG000|Period 2：Open-label Period|Adverse Event|1|||
160650191|NCT02081599|580101503|FG001|Period 2：Open-label Period|Adverse Event|0|||
160650192|NCT02081599|580101502|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
160650193|NCT02081599|580101503|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
160650194|NCT02081599|580101502|FG000|Period 2：Open-label Period|Physician Decision|1|||
160650195|NCT02081599|580101503|FG001|Period 2：Open-label Period|Physician Decision|0|||
160650196|NCT02081599|580101502|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
160650197|NCT02081599|580101503|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
160650198|NCT01767597|580101513|FG000|Overall Study|Incomplete intervention|3|||
160650199|NCT01767597|580101514|FG001|Overall Study|Incomplete intervention|1|||
160650200|NCT01767597|580101513|FG000|Overall Study|Withdrawal by Subject|1|||
160650201|NCT01767597|580101514|FG001|Overall Study|Withdrawal by Subject|0|||
160650202|NCT00836927|580101515|FG000|Overall Study|Progressive disease|2|||
160650203|NCT00836927|580101516|FG001|Overall Study|Progressive disease|0|||
160650204|NCT00836927|580101517|FG002|Overall Study|Progressive disease|0|||
160650205|NCT00836927|580101518|FG003|Overall Study|Progressive disease|1|||
160650206|NCT00836927|580101519|FG004|Overall Study|Progressive disease|1|||
160650207|NCT00836927|580101515|FG000|Overall Study|Withdrawal by Subject|1|||
160650208|NCT00836927|580101516|FG001|Overall Study|Withdrawal by Subject|0|||
160650209|NCT00836927|580101517|FG002|Overall Study|Withdrawal by Subject|0|||
160650210|NCT00836927|580101518|FG003|Overall Study|Withdrawal by Subject|0|||
160650211|NCT00836927|580101519|FG004|Overall Study|Withdrawal by Subject|0|||
160650212|NCT03093454|580101520|FG000|Overall Study|Withdrawal by Subject|1|||
160650213|NCT03093454|580101521|FG001|Overall Study|Withdrawal by Subject|1|||
160650214|NCT03093454|580101520|FG000|Overall Study|Scheduling conflict|3|||
160650215|NCT03093454|580101521|FG001|Overall Study|Scheduling conflict|1|||
160650216|NCT03093454|580101520|FG000|Overall Study|Physician Decision|2|||
160650217|NCT03093454|580101521|FG001|Overall Study|Physician Decision|1|||
160650218|NCT06041646|580101522|FG000|Overall Study|Withdrawal by Subject|1|||
160650219|NCT01000337|580101523|FG000|Overall Study|Lost to Follow-up|4|||
160650220|NCT01000337|580101524|FG001|Overall Study|Lost to Follow-up|3|||
160650221|NCT03901963|580101525|FG000|Overall Study|Lost to Follow-up|1|||
160650222|NCT03901963|580101526|FG001|Overall Study|Lost to Follow-up|1|||
160650223|NCT03901963|580101525|FG000|Overall Study|Physician Decision|1|||
160650224|NCT03901963|580101526|FG001|Overall Study|Physician Decision|2|||
160650225|NCT03901963|580101525|FG000|Overall Study|Protocol Violation|1|||
160568283|NCT04329949|579803860|FG000|Overall Study|Death|36|||
160568284|NCT04329949|579803860|FG000|Overall Study|Withdrawal by Subject|4|||
160568285|NCT04329949|579803860|FG000|Overall Study|Termination of study by sponsor|3|||
160568286|NCT01973283|579803863|FG000|Overall Study|Lost to Follow-up|4|||
160568287|NCT00886938|579803864|FG000|Overall Study|Adverse Event|1|||
160568288|NCT00886938|579803864|FG000|Overall Study|Withdrawal by Subject|1|||
160650226|NCT03901963|580101526|FG001|Overall Study|Protocol Violation|1|||
160650227|NCT03901963|580101525|FG000|Overall Study|Withdrawal by Subject|4|||
160650228|NCT03901963|580101526|FG001|Overall Study|Withdrawal by Subject|11|||
160650229|NCT03901963|580101525|FG000|Overall Study|Ongoing|84|||
160650230|NCT03901963|580101526|FG001|Overall Study|Ongoing|73|||
160650231|NCT03901963|580101525|FG000|Overall Study|Randomized but not treated|3|||
160847227|NCT00217425|580828630|FG000|Overall Study|Patient ineligible|5|||
160847228|NCT00217425|580828630|FG000|Overall Study|Lack of Efficacy|13|||
160847229|NCT00217425|580828630|FG000|Overall Study|Adverse Event|8|||
160568289|NCT00917384|579803865|FG000|Overall Study|Lost to Follow-up|4|||
160650232|NCT03901963|580101526|FG001|Overall Study|Randomized but not treated|3|||
160650233|NCT02854436|580101527|FG000|Overall Study|Adverse Event|1|||
160847230|NCT00217425|580828630|FG000|Overall Study|Withdrawal by Subject|4|||
160847231|NCT00217425|580828630|FG000|Overall Study|Other complicating disease|1|||
160847232|NCT00217425|580828630|FG000|Overall Study|Other|4|||
160847233|NCT00330759|580828632|FG000|Overall Study|Death|316|||
160847234|NCT00330759|580828633|FG001|Overall Study|Death|310|||
160847235|NCT00330759|580828632|FG000|Overall Study|Disease progression|104|||
160847236|NCT00330759|580828633|FG001|Overall Study|Disease progression|126|||
160847237|NCT00330759|580828632|FG000|Overall Study|Withdrawal by Subject|143|||
160847238|NCT00330759|580828633|FG001|Overall Study|Withdrawal by Subject|124|||
160847239|NCT00330759|580828632|FG000|Overall Study|Adverse Event|48|||
160847240|NCT00330759|580828633|FG001|Overall Study|Adverse Event|36|||
160847241|NCT00330759|580828632|FG000|Overall Study|Participant request|31|||
160847242|NCT00330759|580828633|FG001|Overall Study|Participant request|22|||
160847243|NCT00330759|580828632|FG000|Overall Study|Lost to Follow-up|16|||
160847244|NCT00330759|580828633|FG001|Overall Study|Lost to Follow-up|22|||
160847245|NCT00330759|580828632|FG000|Overall Study|Noncompliance|15|||
160847246|NCT00330759|580828633|FG001|Overall Study|Noncompliance|17|||
160847247|NCT00330759|580828632|FG000|Overall Study|Physician Decision|1|||
160847248|NCT00330759|580828633|FG001|Overall Study|Physician Decision|2|||
160847249|NCT00330759|580828632|FG000|Overall Study|Protocol deviation|0|||
160847250|NCT00330759|580828633|FG001|Overall Study|Protocol deviation|2|||
160847251|NCT00330759|580828632|FG000|Overall Study|Ineligibility determined|2|||
160847252|NCT00330759|580828633|FG001|Overall Study|Ineligibility determined|1|||
160847253|NCT00330759|580828632|FG000|Overall Study|Other|36|||
160847254|NCT00330759|580828633|FG001|Overall Study|Other|44|||
160650234|NCT02854436|580101527|FG000|Overall Study|Death|208|||
160650235|NCT02854436|580101527|FG000|Overall Study|Lost to Follow-up|5|||
160650236|NCT02854436|580101527|FG000|Overall Study|Withdrawal by Subject|24|||
160650237|NCT02854436|580101527|FG000|Overall Study|Other|45|||
160650238|NCT02854436|580101527|FG000|Overall Study|Physician Decision|6|||
160650239|NCT01700621|580101528|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
160650240|NCT01700621|580101529|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
160650241|NCT01700621|580101528|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
160650242|NCT01700621|580101529|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
160650243|NCT01700621|580101528|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
160650244|NCT01700621|580101529|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
160650245|NCT00384033|580101536|FG000|Overall Study|Adverse Event|10|||
160650246|NCT00384033|580101537|FG001|Overall Study|Adverse Event|8|||
160650247|NCT00384033|580101538|FG002|Overall Study|Adverse Event|11|||
160650248|NCT00384033|580101539|FG003|Overall Study|Adverse Event|20|||
160650249|NCT00384033|580101536|FG000|Overall Study|Failed to return|1|||
160650250|NCT00384033|580101537|FG001|Overall Study|Failed to return|3|||
160847255|NCT00671034|580828634|FG000|Overall Study|Adverse Event|5|||
160847256|NCT00671034|580828635|FG001|Overall Study|Adverse Event|7|||
160847257|NCT00671034|580828636|FG002|Overall Study|Adverse Event|1|||
160906177|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
160906178|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
160906179|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
160906180|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
160906181|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
160906182|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
160906183|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
160906184|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
160906185|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
160906186|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
160906187|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
160906188|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
160906189|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
160906190|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
160906191|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Missing|0|||
160906192|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Missing|0|||
160906193|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Missing|2|||
160906194|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Missing|0|||
160906195|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Missing|0|||
160906196|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
160906197|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
160906198|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
160650251|NCT00384033|580101538|FG002|Overall Study|Failed to return|2|||
160650252|NCT00384033|580101539|FG003|Overall Study|Failed to return|2|||
160650253|NCT00384033|580101536|FG000|Overall Study|Physician Decision|1|||
160650254|NCT00384033|580101537|FG001|Overall Study|Physician Decision|0|||
160650255|NCT00384033|580101538|FG002|Overall Study|Physician Decision|0|||
160847258|NCT00671034|580828634|FG000|Overall Study|Death|3|||
160847259|NCT00671034|580828635|FG001|Overall Study|Death|2|||
160847260|NCT00671034|580828636|FG002|Overall Study|Death|1|||
160847261|NCT00671034|580828634|FG000|Overall Study|Physician Decision|12|||
160847262|NCT00671034|580828635|FG001|Overall Study|Physician Decision|4|||
160847263|NCT00671034|580828636|FG002|Overall Study|Physician Decision|5|||
160847264|NCT00671034|580828634|FG000|Overall Study|VHR ALL feature|8|||
160847265|NCT00671034|580828635|FG001|Overall Study|VHR ALL feature|3|||
160847266|NCT00671034|580828636|FG002|Overall Study|VHR ALL feature|5|||
160847267|NCT00671034|580828634|FG000|Overall Study|Refusal|5|||
160847268|NCT00671034|580828635|FG001|Overall Study|Refusal|3|||
160847269|NCT00671034|580828636|FG002|Overall Study|Refusal|5|||
160847270|NCT00671034|580828634|FG000|Overall Study|includes Alternative therapy, etc.|6|||
160847271|NCT00671034|580828635|FG001|Overall Study|includes Alternative therapy, etc.|1|||
160847272|NCT00671034|580828636|FG002|Overall Study|includes Alternative therapy, etc.|7|||
160650256|NCT00384033|580101539|FG003|Overall Study|Physician Decision|0|||
160650257|NCT00384033|580101536|FG000|Overall Study|Lost to Follow-up|6|||
160650258|NCT00384033|580101537|FG001|Overall Study|Lost to Follow-up|12|||
160650259|NCT00384033|580101538|FG002|Overall Study|Lost to Follow-up|7|||
160650260|NCT00384033|580101539|FG003|Overall Study|Lost to Follow-up|7|||
160650261|NCT00384033|580101536|FG000|Overall Study|Other|2|||
160650262|NCT00384033|580101537|FG001|Overall Study|Other|0|||
160650263|NCT00384033|580101538|FG002|Overall Study|Other|0|||
160650264|NCT00384033|580101539|FG003|Overall Study|Other|0|||
160650265|NCT00384033|580101536|FG000|Overall Study|Protocol Violation|5|||
160650266|NCT00384033|580101537|FG001|Overall Study|Protocol Violation|0|||
160650267|NCT00384033|580101538|FG002|Overall Study|Protocol Violation|5|||
160650268|NCT00384033|580101539|FG003|Overall Study|Protocol Violation|6|||
160650269|NCT00384033|580101536|FG000|Overall Study|Withdrawal by Subject|6|||
160650270|NCT00384033|580101537|FG001|Overall Study|Withdrawal by Subject|2|||
160650271|NCT00384033|580101538|FG002|Overall Study|Withdrawal by Subject|5|||
160650272|NCT00384033|580101539|FG003|Overall Study|Withdrawal by Subject|2|||
160650273|NCT00384033|580101536|FG000|Overall Study|Lack of Efficacy|7|||
160650274|NCT00384033|580101537|FG001|Overall Study|Lack of Efficacy|3|||
160650275|NCT00384033|580101538|FG002|Overall Study|Lack of Efficacy|3|||
160650276|NCT00384033|580101539|FG003|Overall Study|Lack of Efficacy|1|||
160650277|NCT00384033|580101536|FG000|Overall Study|Randomized but not treated|3|||
160650278|NCT00384033|580101537|FG001|Overall Study|Randomized but not treated|7|||
160650279|NCT00384033|580101538|FG002|Overall Study|Randomized but not treated|10|||
160650280|NCT00384033|580101539|FG003|Overall Study|Randomized but not treated|2|||
160650281|NCT03349333|580101540|FG000|Overall Study|Progression of Disease|36|||
160650282|NCT03349333|580101540|FG000|Overall Study|Adverse Event|11|||
160650283|NCT03349333|580101540|FG000|Overall Study|Other|6|||
160650284|NCT03349333|580101540|FG000|Overall Study|Withdrawal by Subject|5|||
160650285|NCT03349333|580101540|FG000|Overall Study|Conditions interfere with participation|2|||
160650286|NCT03349333|580101540|FG000|Overall Study|Physician Decision|2|||
160650287|NCT03349333|580101540|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
160650288|NCT03349333|580101540|FG000|Overall Study|Patients in treatment less than 24 month|8|||
160650289|NCT02985151|580101541|FG000|Original Randomization|Withdrawal by Subject|0|||
160650290|NCT02985151|580101542|FG001|Original Randomization|Withdrawal by Subject|1|||
160650291|NCT02116803|580101545|FG000|Overall Study|Adverse Event|2|||
160650292|NCT02116803|580101546|FG001|Overall Study|Adverse Event|1|||
160650293|NCT02116803|580101545|FG000|Overall Study|Physician Decision|1|||
160650294|NCT02116803|580101546|FG001|Overall Study|Physician Decision|0|||
160650295|NCT02116803|580101545|FG000|Overall Study|Progressive disease|4|||
160650296|NCT02116803|580101546|FG001|Overall Study|Progressive disease|0|||
160650297|NCT02116803|580101545|FG000|Overall Study|Study terminated by sponsor|2|||
160650298|NCT02116803|580101546|FG001|Overall Study|Study terminated by sponsor|1|||
160650299|NCT02116803|580101545|FG000|Overall Study|Death|1|||
160650300|NCT02116803|580101546|FG001|Overall Study|Death|0|||
160650301|NCT00684671|580101547|FG000|Overall Study|Adverse Event|1|||
160650302|NCT00684671|580101548|FG001|Overall Study|Adverse Event|0|||
160650303|NCT00684671|580101549|FG002|Overall Study|Adverse Event|0|||
160650304|NCT00684671|580101547|FG000|Overall Study|Lost to Follow-up|1|||
160650305|NCT00684671|580101548|FG001|Overall Study|Lost to Follow-up|0|||
160650306|NCT00684671|580101549|FG002|Overall Study|Lost to Follow-up|0|||
160650307|NCT00684671|580101547|FG000|Overall Study|Alcoholic dependance|1|||
160650308|NCT00684671|580101548|FG001|Overall Study|Alcoholic dependance|0|||
160847273|NCT02380287|580828637|FG000|Overall Study|Adverse Event|0|||
160650309|NCT00684671|580101549|FG002|Overall Study|Alcoholic dependance|0|||
160847274|NCT02380287|580828638|FG001|Overall Study|Adverse Event|0|||
160847275|NCT02380287|580828639|FG002|Overall Study|Adverse Event|1|||
160650310|NCT04128007|580101550|FG000|Overall Study|Withdrawal by Subject|9|||
160650311|NCT04128007|580101551|FG001|Overall Study|Withdrawal by Subject|6|||
160650312|NCT04128007|580101550|FG000|Overall Study|Protocol Violation|1|||
160650313|NCT04128007|580101551|FG001|Overall Study|Protocol Violation|0|||
160650314|NCT04128007|580101550|FG000|Overall Study|Lost to Follow-up|8|||
160650315|NCT04128007|580101551|FG001|Overall Study|Lost to Follow-up|7|||
160650316|NCT04128007|580101550|FG000|Overall Study|Adverse Event|5|||
160650317|NCT04128007|580101551|FG001|Overall Study|Adverse Event|2|||
160847276|NCT02380287|580828640|FG003|Overall Study|Adverse Event|0|||
160847277|NCT02380287|580828641|FG004|Overall Study|Adverse Event|0|||
160847278|NCT02380287|580828642|FG005|Overall Study|Adverse Event|0|||
160847279|NCT02380287|580828643|FG006|Overall Study|Adverse Event|0|||
160847280|NCT02380287|580828644|FG007|Overall Study|Adverse Event|0|||
160847281|NCT04473963|580828645|FG000|Overall Study|Withdrawal by Subject|1|||
160847282|NCT04473963|580828646|FG001|Overall Study|Withdrawal by Subject|1|||
160847283|NCT04473963|580828647|FG002|Overall Study|Withdrawal by Subject|0|||
160847284|NCT04473963|580828645|FG000|Overall Study|Not inducible in AF|0|||
160847285|NCT04473963|580828646|FG001|Overall Study|Not inducible in AF|0|||
160847286|NCT04473963|580828647|FG002|Overall Study|Not inducible in AF|2|||
160847287|NCT04685798|580828648|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
160847288|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Technical problems|0|||
160847289|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Technical problems|0|||
160847290|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Technical problems|0|||
160847291|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Technical problems|1|||
160847292|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
160847293|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
160847294|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
160847295|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
160847296|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
160847297|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
160847298|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
160847299|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
160847300|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
160847301|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
160847302|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
160847303|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
160847304|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Death|0|||
160847305|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Death|3|||
160847306|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Death|1|||
160847307|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Death|0|||
160847308|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
160568290|NCT00917384|579803866|FG001|Overall Study|Lost to Follow-up|2|||
160568291|NCT00917384|579803865|FG000|Overall Study|Withdrawal by Subject|10|||
160568292|NCT00917384|579803866|FG001|Overall Study|Withdrawal by Subject|2|||
160568293|NCT03717922|579803867|FG000|Overall Study|Lost to Follow-up|2|||
160568294|NCT03717922|579803868|FG001|Overall Study|Lost to Follow-up|2|||
160568295|NCT01458340|579803869|FG000|Overall Study|Adverse Event|5|||
160568296|NCT01458340|579803870|FG001|Overall Study|Adverse Event|4|||
160568297|NCT01458340|579803871|FG002|Overall Study|Adverse Event|2|||
160568298|NCT01458340|579803869|FG000|Overall Study|Lost to Follow-up|3|||
160568299|NCT01458340|579803870|FG001|Overall Study|Lost to Follow-up|3|||
160568300|NCT01458340|579803871|FG002|Overall Study|Lost to Follow-up|10|||
160568301|NCT01458340|579803869|FG000|Overall Study|Miscellaneous|0|||
160568302|NCT01458340|579803870|FG001|Overall Study|Miscellaneous|1|||
160568303|NCT01458340|579803871|FG002|Overall Study|Miscellaneous|0|||
160568304|NCT01458340|579803869|FG000|Overall Study|Physician Decision|1|||
160568305|NCT01458340|579803870|FG001|Overall Study|Physician Decision|1|||
160568306|NCT01458340|579803871|FG002|Overall Study|Physician Decision|2|||
160568307|NCT01458340|579803869|FG000|Overall Study|Protocol Violation|6|||
160568308|NCT01458340|579803870|FG001|Overall Study|Protocol Violation|6|||
160568309|NCT01458340|579803871|FG002|Overall Study|Protocol Violation|5|||
160568310|NCT01458340|579803869|FG000|Overall Study|Withdrawal by Subject|12|||
160568311|NCT01458340|579803870|FG001|Overall Study|Withdrawal by Subject|6|||
160568312|NCT01458340|579803871|FG002|Overall Study|Withdrawal by Subject|4|||
160568313|NCT03126227|579803872|FG000|Overall Study|Adverse Event|43|||
160847309|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
160847310|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
160847311|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
160847312|NCT02152761|580828653|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
160906199|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
160906200|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
160906201|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
160906202|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
160906203|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
160906204|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
160906205|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
160906206|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
160906207|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
160992427|NCT00817635|581361363|FG004|Overall Study|Adverse Event|1|||
160568314|NCT03126227|579803873|FG001|Overall Study|Adverse Event|4|||
160568315|NCT03126227|579803872|FG000|Overall Study|Death|0|||
160568316|NCT03126227|579803873|FG001|Overall Study|Death|1|||
160568317|NCT03126227|579803872|FG000|Overall Study|Lost to Follow-up|0|||
160568318|NCT03126227|579803873|FG001|Overall Study|Lost to Follow-up|1|||
160847313|NCT02152761|580828654|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
160847314|NCT02152761|580828655|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
160847315|NCT02152761|580828656|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
160847316|NCT02152761|580828653|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
160847317|NCT02152761|580828654|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
160847318|NCT02152761|580828655|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
160847319|NCT02152761|580828656|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
160847320|NCT02152761|580828653|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
160847321|NCT02152761|580828654|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
160568319|NCT03126227|579803872|FG000|Overall Study|Physician Decision|2|||
160568320|NCT03126227|579803873|FG001|Overall Study|Physician Decision|0|||
160568321|NCT03126227|579803872|FG000|Overall Study|Protocol Violation|1|||
160568322|NCT03126227|579803873|FG001|Overall Study|Protocol Violation|0|||
160568323|NCT03126227|579803872|FG000|Overall Study|Withdrawal by Subject|19|||
160568324|NCT03126227|579803873|FG001|Overall Study|Withdrawal by Subject|3|||
160568325|NCT03126227|579803872|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
160568326|NCT03126227|579803873|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
160568327|NCT03126227|579803872|FG000|Overall Study|Lack of dosing compliance|2|||
160568328|NCT03126227|579803873|FG001|Overall Study|Lack of dosing compliance|0|||
160568329|NCT03126227|579803872|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
160568330|NCT03126227|579803873|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
160568331|NCT03126227|579803872|FG000|Overall Study|Scheduling conflict|1|||
160568332|NCT03126227|579803873|FG001|Overall Study|Scheduling conflict|0|||
160568333|NCT00947154|579803880|FG000|Overall Study|Lost to Follow-up|1|||
160568334|NCT00900796|579803881|FG000|Phase 1|Lacked sufficient information|4|||
160568335|NCT00900796|579803881|FG000|Phase 1|Missing information at Week 16|7|||
160568336|NCT00900796|579803881|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
160568337|NCT00900796|579803881|FG000|Phase 2|Lost to Follow-up|5|||
160568338|NCT02586805|579803885|FG000|Overall Study|Withdrawal by Subject|3|||
160568339|NCT02586805|579803886|FG001|Overall Study|Withdrawal by Subject|1|||
160568340|NCT02586805|579803887|FG002|Overall Study|Withdrawal by Subject|1|||
160568341|NCT02586805|579803888|FG003|Overall Study|Withdrawal by Subject|2|||
160568342|NCT02586805|579803885|FG000|Overall Study|Adverse Event|2|||
160568343|NCT02586805|579803886|FG001|Overall Study|Adverse Event|0|||
160568344|NCT02586805|579803887|FG002|Overall Study|Adverse Event|1|||
160568345|NCT02586805|579803888|FG003|Overall Study|Adverse Event|0|||
160568346|NCT02586805|579803885|FG000|Overall Study|Lost to Follow-up|0|||
160568347|NCT02586805|579803886|FG001|Overall Study|Lost to Follow-up|0|||
160568348|NCT02586805|579803887|FG002|Overall Study|Lost to Follow-up|1|||
160568349|NCT02586805|579803888|FG003|Overall Study|Lost to Follow-up|0|||
160568350|NCT02586805|579803885|FG000|Overall Study|Physician Decision|1|||
160568351|NCT02586805|579803886|FG001|Overall Study|Physician Decision|0|||
160568352|NCT02586805|579803887|FG002|Overall Study|Physician Decision|0|||
160568353|NCT02586805|579803888|FG003|Overall Study|Physician Decision|0|||
160568354|NCT01859403|579803889|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
160568355|NCT01859403|579803890|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
160568356|NCT01859403|579803889|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
160568357|NCT01859403|579803890|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
160568358|NCT01859403|579803889|FG000|Primary Endpoint Measure|Physician Decision|0|||
160568359|NCT01859403|579803890|FG001|Primary Endpoint Measure|Physician Decision|1|||
160568360|NCT01859403|579803889|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
160568361|NCT01859403|579803890|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
160568362|NCT01157117|579803891|FG000|Overall Study|Dosing Symptoms|0|||
160568363|NCT01157117|579803892|FG001|Overall Study|Dosing Symptoms|4|||
160568364|NCT01157117|579803893|FG002|Overall Study|Dosing Symptoms|0|||
160568365|NCT01157117|579803891|FG000|Overall Study|Withdrawal by Subject|4|||
160568366|NCT01157117|579803892|FG001|Overall Study|Withdrawal by Subject|1|||
160568367|NCT01157117|579803893|FG002|Overall Study|Withdrawal by Subject|1|||
160568368|NCT01157117|579803891|FG000|Overall Study|Lack of Efficacy|1|||
160568369|NCT01157117|579803892|FG001|Overall Study|Lack of Efficacy|1|||
160568370|NCT01157117|579803893|FG002|Overall Study|Lack of Efficacy|0|||
160568371|NCT01157117|579803891|FG000|Overall Study|Lost to Follow-up|0|||
160568372|NCT01157117|579803892|FG001|Overall Study|Lost to Follow-up|0|||
160568373|NCT01157117|579803893|FG002|Overall Study|Lost to Follow-up|1|||
160568374|NCT01157117|579803891|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
160568375|NCT01157117|579803892|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
160568376|NCT01157117|579803893|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
160568377|NCT01531725|579803895|FG000|Overall Study|Protocol Violation|5|||
160568378|NCT02317510|579803896|FG000|Overall Study|Adverse Event|0|||
160568379|NCT02317510|579803897|FG001|Overall Study|Adverse Event|1|||
160568380|NCT00472303|579803898|FG000|Titration Phase|Adverse Event|22|||
160568381|NCT00472303|579803899|FG001|Titration Phase|Adverse Event|12|||
160568382|NCT00472303|579803900|FG002|Titration Phase|Adverse Event|0|||
160847322|NCT02152761|580828655|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
160847323|NCT02152761|580828656|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
160847324|NCT02152761|580828653|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
160847325|NCT02152761|580828654|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
160847326|NCT02152761|580828655|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
160847327|NCT02152761|580828656|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
160847328|NCT01797263|580828657|FG000|Overall Study|Withdrawal by Subject|21|||
160847329|NCT01797263|580828658|FG001|Overall Study|Withdrawal by Subject|25|||
160847330|NCT01797263|580828657|FG000|Overall Study|Death|1|||
160847331|NCT01797263|580828658|FG001|Overall Study|Death|0|||
160847332|NCT01797263|580828657|FG000|Overall Study|Lost to Follow-up|15|||
160847333|NCT01797263|580828658|FG001|Overall Study|Lost to Follow-up|15|||
160847334|NCT01550757|580828659|FG000|Overall Study|Lost to Follow-up|21|||
160847335|NCT01550757|580828660|FG001|Overall Study|Lost to Follow-up|14|||
160847336|NCT01550757|580828661|FG002|Overall Study|Lost to Follow-up|42|||
160847337|NCT01550757|580828662|FG003|Overall Study|Lost to Follow-up|53|||
160847338|NCT01550757|580828659|FG000|Overall Study|Withdrawal by Subject|2|||
160847339|NCT01550757|580828660|FG001|Overall Study|Withdrawal by Subject|0|||
160847340|NCT01550757|580828661|FG002|Overall Study|Withdrawal by Subject|3|||
160847341|NCT01550757|580828662|FG003|Overall Study|Withdrawal by Subject|1|||
160847342|NCT02342223|580828663|FG000|Overall Study|Lost to Follow-up|1|||
160847343|NCT03018691|580828664|FG000|Overall Study|Adverse Event|1|||
160847344|NCT03018691|580828665|FG001|Overall Study|Adverse Event|1|||
160847345|NCT03018691|580828666|FG002|Overall Study|Adverse Event|4|||
160847346|NCT03018691|580828664|FG000|Overall Study|Lack of Efficacy|0|||
160847347|NCT03018691|580828665|FG001|Overall Study|Lack of Efficacy|0|||
160847348|NCT03018691|580828666|FG002|Overall Study|Lack of Efficacy|1|||
160847349|NCT03018691|580828664|FG000|Overall Study|Withdrawal by Subject|0|||
160847350|NCT03018691|580828665|FG001|Overall Study|Withdrawal by Subject|0|||
160847351|NCT03018691|580828666|FG002|Overall Study|Withdrawal by Subject|1|||
160847352|NCT03018691|580828664|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160847353|NCT03018691|580828665|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160847354|NCT03018691|580828666|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160847355|NCT03369418|580828667|FG000|Overall Study|Withdrawal by Subject|3|||
160847356|NCT03369418|580828668|FG001|Overall Study|Withdrawal by Subject|3|||
160847357|NCT01485094|580828669|FG000|Overall Study|Adverse Event|1|||
160847358|NCT01485094|580828670|FG001|Overall Study|Adverse Event|1|||
160847359|NCT01485094|580828671|FG002|Overall Study|Adverse Event|1|||
160847360|NCT01485094|580828669|FG000|Overall Study|Lost to Follow-up|1|||
160847361|NCT01485094|580828670|FG001|Overall Study|Lost to Follow-up|0|||
160847362|NCT01485094|580828671|FG002|Overall Study|Lost to Follow-up|0|||
160847363|NCT01485094|580828669|FG000|Overall Study|Withdrawal by Subject|1|||
160847364|NCT01485094|580828670|FG001|Overall Study|Withdrawal by Subject|1|||
160847365|NCT01485094|580828671|FG002|Overall Study|Withdrawal by Subject|0|||
160847366|NCT01426958|580828672|FG000|Overall Study|Adverse Event|2|||
160847367|NCT02859246|580828678|FG000|Overall Study|Screen fails|3|||
160847368|NCT02859246|580828678|FG000|Overall Study|Adverse Event|1|||
160847369|NCT02859246|580828678|FG000|Overall Study|Withdrawal by Subject|1|||
160847370|NCT05280717|580828679|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
160847371|NCT05280717|580828680|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
160847372|NCT05280717|580828681|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
160847373|NCT05280717|580828682|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
160847374|NCT05280717|580828683|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
160568383|NCT00472303|579803898|FG000|Titration Phase|Death|4|||
160847375|NCT05280717|580828684|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
160847376|NCT05280717|580828685|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
160847377|NCT05280717|580828679|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
160847378|NCT05280717|580828680|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160847379|NCT05280717|580828681|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160847380|NCT05280717|580828682|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160568384|NCT00472303|579803899|FG001|Titration Phase|Death|2|||
160568385|NCT00472303|579803900|FG002|Titration Phase|Death|0|||
160568386|NCT00472303|579803898|FG000|Titration Phase|Lack of Efficacy|10|||
160568387|NCT00472303|579803899|FG001|Titration Phase|Lack of Efficacy|0|||
160568388|NCT00472303|579803900|FG002|Titration Phase|Lack of Efficacy|0|||
160847381|NCT05280717|580828683|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160847382|NCT05280717|580828684|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160847383|NCT05280717|580828685|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160847384|NCT05280717|580828679|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847385|NCT05280717|580828680|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
160862052|NCT05138653|580887931|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862053|NCT05138653|580887932|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160847386|NCT05280717|580828681|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847387|NCT05280717|580828682|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847388|NCT05280717|580828683|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847389|NCT05280717|580828684|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847390|NCT05280717|580828685|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847391|NCT05280717|580828679|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847392|NCT05280717|580828680|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847393|NCT05280717|580828681|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
160568389|NCT00472303|579803898|FG000|Titration Phase|Withdrawal by Subject|16|||
160568390|NCT00472303|579803899|FG001|Titration Phase|Withdrawal by Subject|13|||
160568391|NCT00472303|579803900|FG002|Titration Phase|Withdrawal by Subject|0|||
160568392|NCT00472303|579803898|FG000|Titration Phase|Trial Medication non-compliant|4|||
160568393|NCT00472303|579803899|FG001|Titration Phase|Trial Medication non-compliant|1|||
160568394|NCT00472303|579803900|FG002|Titration Phase|Trial Medication non-compliant|0|||
160568395|NCT00472303|579803898|FG000|Titration Phase|Other|3|||
160568396|NCT00472303|579803899|FG001|Titration Phase|Other|1|||
160568397|NCT00472303|579803900|FG002|Titration Phase|Other|0|||
160568398|NCT00472303|579803898|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
160568399|NCT00472303|579803899|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
160568400|NCT00472303|579803900|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
160568401|NCT00472303|579803898|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
160568402|NCT00472303|579803899|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
160568403|NCT00472303|579803900|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
160568404|NCT00472303|579803898|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
160568405|NCT00472303|579803899|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
160568406|NCT00472303|579803900|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
160568407|NCT00472303|579803898|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
160568408|NCT00472303|579803899|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
160568409|NCT00472303|579803900|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
160568410|NCT00472303|579803898|FG000|Discontinuations After Titration Phase|Other|5|||
160568411|NCT00472303|579803899|FG001|Discontinuations After Titration Phase|Other|0|||
160568412|NCT00472303|579803900|FG002|Discontinuations After Titration Phase|Other|0|||
160568413|NCT00472303|579803898|FG000|Maintenance Phase|Adverse Event|5|||
160847394|NCT05280717|580828682|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847395|NCT05280717|580828683|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847396|NCT05280717|580828684|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847397|NCT05280717|580828685|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847398|NCT05280717|580828679|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847399|NCT05280717|580828680|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847400|NCT05280717|580828681|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847401|NCT05280717|580828682|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847402|NCT05280717|580828683|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847403|NCT05280717|580828684|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
160847404|NCT05280717|580828685|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847405|NCT05280717|580828679|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847406|NCT05280717|580828680|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847407|NCT05280717|580828681|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847408|NCT05280717|580828682|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847409|NCT05280717|580828683|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847410|NCT05280717|580828684|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
160847411|NCT05280717|580828685|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847412|NCT00740584|580828688|FG000|Overall Study|Withdrawal by Subject|1|||
160847413|NCT00855816|580828689|FG000|Overall Study|Withdrawal by Subject|22|||
160847414|NCT00855816|580828690|FG001|Overall Study|Withdrawal by Subject|15|||
160847415|NCT00855816|580828689|FG000|Overall Study|Lost to Follow-up|3|||
160847416|NCT00855816|580828690|FG001|Overall Study|Lost to Follow-up|5|||
160847417|NCT00855816|580828689|FG000|Overall Study|Death|1|||
160847418|NCT00855816|580828690|FG001|Overall Study|Death|0|||
160847419|NCT00855816|580828689|FG000|Overall Study|Became ineligible|0|||
160847420|NCT00855816|580828690|FG001|Overall Study|Became ineligible|1|||
160568414|NCT00472303|579803899|FG001|Maintenance Phase|Adverse Event|6|||
160568415|NCT00472303|579803900|FG002|Maintenance Phase|Adverse Event|6|||
160568416|NCT00472303|579803898|FG000|Maintenance Phase|Death|3|||
160568417|NCT00472303|579803899|FG001|Maintenance Phase|Death|0|||
160568418|NCT00472303|579803900|FG002|Maintenance Phase|Death|2|||
160847421|NCT03188432|580828697|FG000|Overall Study|Death|3|||
160847422|NCT03188432|580828697|FG000|Overall Study|Withdrawal by Subject|15|||
160847423|NCT03188432|580828697|FG000|Overall Study|Did not complete protocol treatment|9|||
160847424|NCT01196026|580828700|FG000|Overall Study|Withdrawal by Subject|1|||
160847425|NCT01196026|580828701|FG001|Overall Study|Withdrawal by Subject|4|||
160847426|NCT01196026|580828702|FG002|Overall Study|Withdrawal by Subject|0|||
160847427|NCT01196026|580828703|FG003|Overall Study|Withdrawal by Subject|0|||
160847428|NCT01196026|580828704|FG004|Overall Study|Withdrawal by Subject|0|||
160847429|NCT01196026|580828705|FG005|Overall Study|Withdrawal by Subject|0|||
160847430|NCT01196026|580828700|FG000|Overall Study|Lost to Follow-up|0|||
160847431|NCT01196026|580828701|FG001|Overall Study|Lost to Follow-up|3|||
160847432|NCT01196026|580828702|FG002|Overall Study|Lost to Follow-up|0|||
160847433|NCT01196026|580828703|FG003|Overall Study|Lost to Follow-up|0|||
160847434|NCT01196026|580828704|FG004|Overall Study|Lost to Follow-up|1|||
160847435|NCT01196026|580828705|FG005|Overall Study|Lost to Follow-up|0|||
160847436|NCT01196026|580828700|FG000|Overall Study|Other|0|||
160847437|NCT01196026|580828701|FG001|Overall Study|Other|1|||
160847438|NCT01196026|580828702|FG002|Overall Study|Other|0|||
160847439|NCT01196026|580828703|FG003|Overall Study|Other|0|||
160847440|NCT01196026|580828704|FG004|Overall Study|Other|0|||
160847441|NCT01196026|580828705|FG005|Overall Study|Other|0|||
160847442|NCT02868554|580828706|FG000|Overall Study|Lost to Follow-up|3|||
160847443|NCT02868554|580828707|FG001|Overall Study|Lost to Follow-up|0|||
160847444|NCT02868554|580828708|FG002|Overall Study|Lost to Follow-up|1|||
160847445|NCT05447663|580828713|FG000|Overall Study|Study terminated by Sponsor|5|||
160847446|NCT05447663|580828713|FG000|Overall Study|Death|2|||
160847447|NCT05447663|580828713|FG000|Overall Study|Withdrawal by Subject|1|||
160847448|NCT01100320|580828714|FG000|Period 1|Withdrawal by Subject|2|||
160847449|NCT01100320|580828715|FG001|Period 1|Withdrawal by Subject|4|||
160847450|NCT01100320|580828714|FG000|Period 1|Positive Drug Screen|1|||
160847451|NCT01100320|580828715|FG001|Period 1|Positive Drug Screen|1|||
160847452|NCT01100320|580828714|FG000|Period 1|Adverse Event|2|||
160847453|NCT01100320|580828715|FG001|Period 1|Adverse Event|2|||
160847454|NCT01100320|580828714|FG000|Period 2|Withdrawal by Subject|1|||
160847455|NCT01100320|580828715|FG001|Period 2|Withdrawal by Subject|1|||
160847456|NCT04181762|580828716|FG000|Overall Study|Adverse Event|1|||
160847457|NCT04181762|580828717|FG001|Overall Study|Adverse Event|3|||
160847458|NCT04181762|580828716|FG000|Overall Study|Lost to Follow-up|1|||
160847459|NCT04181762|580828717|FG001|Overall Study|Lost to Follow-up|1|||
160847460|NCT04181762|580828716|FG000|Overall Study|Physician Decision|1|||
160847461|NCT04181762|580828717|FG001|Overall Study|Physician Decision|3|||
160847462|NCT04181762|580828716|FG000|Overall Study|Pregnancy|0|||
160847463|NCT04181762|580828717|FG001|Overall Study|Pregnancy|1|||
160847464|NCT04181762|580828716|FG000|Overall Study|Lack of Efficacy|2|||
160847465|NCT04181762|580828717|FG001|Overall Study|Lack of Efficacy|2|||
160847466|NCT04181762|580828716|FG000|Overall Study|Study terminated by sponsor|95|||
160847467|NCT04181762|580828717|FG001|Overall Study|Study terminated by sponsor|97|||
160847468|NCT04181762|580828716|FG000|Overall Study|Subject decision|11|||
160847469|NCT04181762|580828717|FG001|Overall Study|Subject decision|4|||
160847470|NCT04181762|580828716|FG000|Overall Study|Death|1|||
160847471|NCT04181762|580828717|FG001|Overall Study|Death|1|||
160847472|NCT04181762|580828716|FG000|Overall Study|Protocol deviation|1|||
160847473|NCT04181762|580828717|FG001|Overall Study|Protocol deviation|0|||
160847474|NCT04181762|580828716|FG000|Overall Study|Withdrawal of informed consent|1|||
160847475|NCT04181762|580828717|FG001|Overall Study|Withdrawal of informed consent|3|||
160847476|NCT04669301|580828718|FG000|Overall Study|Lost to Follow-up|0|||
160568419|NCT00472303|579803898|FG000|Maintenance Phase|Lack of Efficacy|2|||
160568420|NCT00472303|579803899|FG001|Maintenance Phase|Lack of Efficacy|2|||
160568421|NCT00472303|579803900|FG002|Maintenance Phase|Lack of Efficacy|4|||
160568422|NCT00472303|579803898|FG000|Maintenance Phase|Withdrawal by Subject|6|||
160568423|NCT00472303|579803899|FG001|Maintenance Phase|Withdrawal by Subject|7|||
160568424|NCT00472303|579803900|FG002|Maintenance Phase|Withdrawal by Subject|3|||
160568425|NCT00472303|579803898|FG000|Maintenance Phase|Trial medication non-compliant|0|||
160847477|NCT04669301|580828719|FG001|Overall Study|Lost to Follow-up|1|||
160847478|NCT04669301|580828720|FG002|Overall Study|Lost to Follow-up|0|||
160847479|NCT04669301|580828718|FG000|Overall Study|Withdrawal by Subject|3|||
160847480|NCT04669301|580828719|FG001|Overall Study|Withdrawal by Subject|2|||
160847481|NCT04669301|580828720|FG002|Overall Study|Withdrawal by Subject|0|||
160847482|NCT02586727|580828721|FG000|Overall Study|Lost to Follow-up|1|||
160847483|NCT02586727|580828722|FG001|Overall Study|Lost to Follow-up|0|||
160847484|NCT05888181|580828723|FG000|Overall Study|Lost to Follow-up|1|||
160847485|NCT05888181|580828724|FG001|Overall Study|Lost to Follow-up|1|||
160847486|NCT05888181|580828725|FG002|Overall Study|Lost to Follow-up|0|||
160847487|NCT02534909|580828728|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
160847488|NCT02326597|580828731|FG000|Overall Study|Lost to Follow-up|42|||
160847489|NCT02326597|580828732|FG001|Overall Study|Lost to Follow-up|32|||
160847490|NCT00132808|580828733|FG000|Stratum I|Adverse Event|2|||
160847491|NCT00132808|580828734|FG001|Stratum I|Adverse Event|1|||
160847492|NCT00132808|580828735|FG002|Stratum I|Adverse Event|0|||
160847493|NCT00132808|580828733|FG000|Stratum I|Lost to Follow-up|3|||
160847494|NCT00132808|580828734|FG001|Stratum I|Lost to Follow-up|4|||
160847495|NCT00132808|580828735|FG002|Stratum I|Lost to Follow-up|1|||
160847496|NCT00132808|580828733|FG000|Stratum I|Withdrawal by Subject|4|||
160847497|NCT00132808|580828734|FG001|Stratum I|Withdrawal by Subject|7|||
160847498|NCT00132808|580828735|FG002|Stratum I|Withdrawal by Subject|3|||
160847499|NCT00132808|580828733|FG000|Stratum I|Abnormal test procedure result (s)|0|||
160847500|NCT00132808|580828734|FG001|Stratum I|Abnormal test procedure result (s)|0|||
160847501|NCT00132808|580828735|FG002|Stratum I|Abnormal test procedure result (s)|1|||
160847502|NCT00132808|580828733|FG000|Stratum II|Adverse Event|1|||
160847503|NCT00132808|580828734|FG001|Stratum II|Adverse Event|2|||
160847504|NCT00132808|580828735|FG002|Stratum II|Adverse Event|1|||
160847505|NCT00132808|580828733|FG000|Stratum II|Death|1|||
160847506|NCT00132808|580828734|FG001|Stratum II|Death|0|||
160847507|NCT00132808|580828735|FG002|Stratum II|Death|0|||
160847508|NCT00132808|580828733|FG000|Stratum II|Lost to Follow-up|2|||
160847509|NCT00132808|580828734|FG001|Stratum II|Lost to Follow-up|2|||
160847510|NCT00132808|580828735|FG002|Stratum II|Lost to Follow-up|1|||
160847511|NCT00132808|580828733|FG000|Stratum II|Protocol Violation|0|||
160847512|NCT00132808|580828734|FG001|Stratum II|Protocol Violation|2|||
160847513|NCT00132808|580828735|FG002|Stratum II|Protocol Violation|1|||
160847514|NCT00132808|580828733|FG000|Stratum II|Withdrawal by Subject|4|||
160847515|NCT00132808|580828734|FG001|Stratum II|Withdrawal by Subject|9|||
160847516|NCT00132808|580828735|FG002|Stratum II|Withdrawal by Subject|6|||
160847517|NCT00428948|580828739|FG000|Overall Study|Lost to Follow-up|15|||
160847518|NCT00428948|580828740|FG001|Overall Study|Lost to Follow-up|8|||
160847519|NCT00428948|580828739|FG000|Overall Study|Adverse Event|148|||
160847520|NCT00428948|580828740|FG001|Overall Study|Adverse Event|24|||
160847521|NCT00428948|580828739|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
160847522|NCT00428948|580828740|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
160847523|NCT00428948|580828739|FG000|Overall Study|Investigator Withdrew Subject|3|||
160847524|NCT00428948|580828740|FG001|Overall Study|Investigator Withdrew Subject|4|||
160847525|NCT00428948|580828739|FG000|Overall Study|Subject Withdrew Consent|50|||
160847526|NCT00428948|580828740|FG001|Overall Study|Subject Withdrew Consent|30|||
160847527|NCT00428948|580828739|FG000|Overall Study|Protocol Deviation|1|||
160847528|NCT00428948|580828740|FG001|Overall Study|Protocol Deviation|1|||
160847529|NCT00577824|580828741|FG000|Overall Study|Adverse Event|6|||
160847530|NCT00577824|580828742|FG001|Overall Study|Adverse Event|18|||
160847531|NCT00577824|580828743|FG002|Overall Study|Adverse Event|1|||
160847532|NCT00577824|580828741|FG000|Overall Study|Patient decision|0|||
160847533|NCT00577824|580828742|FG001|Overall Study|Patient decision|1|||
160847534|NCT00577824|580828743|FG002|Overall Study|Patient decision|1|||
160847535|NCT00577824|580828741|FG000|Overall Study|Protocol Violation|1|||
160847536|NCT00577824|580828742|FG001|Overall Study|Protocol Violation|1|||
160847537|NCT00577824|580828743|FG002|Overall Study|Protocol Violation|0|||
160847538|NCT00362648|580828744|FG000|Overall Study|Adverse Event|12|||
160847539|NCT00362648|580828745|FG001|Overall Study|Adverse Event|21|||
160847540|NCT00362648|580828746|FG002|Overall Study|Adverse Event|1|||
160847541|NCT00362648|580828747|FG003|Overall Study|Adverse Event|0|||
160847542|NCT00362648|580828744|FG000|Overall Study|Lost to Follow-up|62|||
160847543|NCT00362648|580828745|FG001|Overall Study|Lost to Follow-up|69|||
160847544|NCT00362648|580828746|FG002|Overall Study|Lost to Follow-up|4|||
160847545|NCT00362648|580828747|FG003|Overall Study|Lost to Follow-up|3|||
160847546|NCT00362648|580828744|FG000|Overall Study|Protocol Violation|4|||
160847547|NCT00362648|580828745|FG001|Overall Study|Protocol Violation|2|||
160847548|NCT00362648|580828746|FG002|Overall Study|Protocol Violation|2|||
160847549|NCT00362648|580828747|FG003|Overall Study|Protocol Violation|2|||
160847550|NCT00362648|580828744|FG000|Overall Study|Withdrawal by Subject|48|||
160847551|NCT00362648|580828745|FG001|Overall Study|Withdrawal by Subject|42|||
160906208|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
160906209|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
160906210|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
160906211|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
160906212|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
160906213|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
160906214|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
160906215|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
160906216|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
160906217|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
160650318|NCT04128007|580101550|FG000|Overall Study|Not reported|0|||
160847552|NCT00362648|580828746|FG002|Overall Study|Withdrawal by Subject|2|||
160847553|NCT00362648|580828747|FG003|Overall Study|Withdrawal by Subject|6|||
160847554|NCT04752332|580828748|FG000|Overall Study|Adverse Event|3|||
160847555|NCT04752332|580828749|FG001|Overall Study|Adverse Event|1|||
160847556|NCT04752332|580828748|FG000|Overall Study|Disease Relapse|1|||
160847557|NCT04752332|580828749|FG001|Overall Study|Disease Relapse|0|||
160847558|NCT04752332|580828748|FG000|Overall Study|Non-compliance With Study Drug|2|||
160847559|NCT04752332|580828749|FG001|Overall Study|Non-compliance With Study Drug|0|||
160847560|NCT04752332|580828748|FG000|Overall Study|Physician Decision|2|||
160847561|NCT04752332|580828749|FG001|Overall Study|Physician Decision|1|||
160847562|NCT04752332|580828748|FG000|Overall Study|Protocol Violation|1|||
160847563|NCT04752332|580828749|FG001|Overall Study|Protocol Violation|1|||
160847564|NCT04752332|580828748|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
160847565|NCT04752332|580828749|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
160847566|NCT04752332|580828748|FG000|Overall Study|Study Terminated by Sponsor|10|||
160847567|NCT04752332|580828749|FG001|Overall Study|Study Terminated by Sponsor|48|||
160847568|NCT04752332|580828748|FG000|Overall Study|Withdrawal by Subject|11|||
160847569|NCT04752332|580828749|FG001|Overall Study|Withdrawal by Subject|3|||
160847570|NCT00924443|580828750|FG000|Overall Study|Physician Decision|2|||
160847571|NCT00924443|580828750|FG000|Overall Study|Protocol Violation|1|||
160847572|NCT02978833|580828753|FG000|Overall Study|Study terminated|1|||
160847573|NCT02978833|580828754|FG001|Overall Study|Study terminated|1|||
160847574|NCT01123395|580828757|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
160847575|NCT01123395|580828758|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
160847576|NCT00186901|580828759|FG000|Overall Study|Pregnancy|6|||
160847577|NCT00186901|580828760|FG001|Overall Study|Pregnancy|3|||
160847578|NCT00186901|580828761|FG002|Overall Study|Pregnancy|0|||
160847579|NCT00186901|580828759|FG000|Overall Study|Lost to Follow-up|6|||
160847580|NCT00186901|580828760|FG001|Overall Study|Lost to Follow-up|3|||
160847581|NCT00186901|580828761|FG002|Overall Study|Lost to Follow-up|0|||
160847582|NCT00186901|580828759|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
160847583|NCT00186901|580828760|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
160847584|NCT00186901|580828761|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
160847585|NCT00186901|580828759|FG000|Overall Study|ALL relapse or second malignancy|1|||
160847586|NCT00186901|580828760|FG001|Overall Study|ALL relapse or second malignancy|2|||
160847587|NCT00186901|580828761|FG002|Overall Study|ALL relapse or second malignancy|0|||
160847588|NCT00186901|580828759|FG000|Overall Study|Withdrawal by Subject|4|||
160847589|NCT00186901|580828760|FG001|Overall Study|Withdrawal by Subject|5|||
160847590|NCT00186901|580828761|FG002|Overall Study|Withdrawal by Subject|0|||
160847591|NCT00186901|580828759|FG000|Overall Study|Open label|3|||
160847592|NCT00186901|580828760|FG001|Overall Study|Open label|2|||
160847593|NCT00186901|580828761|FG002|Overall Study|Open label|0|||
160847594|NCT00186901|580828759|FG000|Overall Study|Limited adherence to study requirements|20|||
160847595|NCT00186901|580828760|FG001|Overall Study|Limited adherence to study requirements|23|||
160847596|NCT00186901|580828761|FG002|Overall Study|Limited adherence to study requirements|0|||
160847597|NCT00186901|580828759|FG000|Overall Study|Bone Mineral Density > 0|0|||
160847598|NCT00186901|580828760|FG001|Overall Study|Bone Mineral Density > 0|0|||
160847599|NCT00186901|580828761|FG002|Overall Study|Bone Mineral Density > 0|149|||
160847600|NCT00782483|580828764|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
160847601|NCT01052077|580828765|FG000|Phase A|Lost to Follow-up|22|||
160847602|NCT01052077|580828766|FG001|Phase A|Lost to Follow-up|0|||
160847603|NCT01052077|580828767|FG002|Phase A|Lost to Follow-up|0|||
160847604|NCT01052077|580828768|FG003|Phase A|Lost to Follow-up|0|||
160847605|NCT01052077|580828765|FG000|Phase A|Adverse Event|32|||
160847606|NCT01052077|580828766|FG001|Phase A|Adverse Event|0|||
160847607|NCT01052077|580828767|FG002|Phase A|Adverse Event|0|||
160847608|NCT01052077|580828768|FG003|Phase A|Adverse Event|0|||
160847609|NCT01052077|580828765|FG000|Phase A|Met Withdrawal Criteria|26|||
160847610|NCT01052077|580828766|FG001|Phase A|Met Withdrawal Criteria|0|||
160847611|NCT01052077|580828767|FG002|Phase A|Met Withdrawal Criteria|0|||
160847612|NCT01052077|580828768|FG003|Phase A|Met Withdrawal Criteria|0|||
160847613|NCT01052077|580828765|FG000|Phase A|Physician Decision|10|||
160847614|NCT01052077|580828766|FG001|Phase A|Physician Decision|0|||
160847615|NCT01052077|580828767|FG002|Phase A|Physician Decision|0|||
160847616|NCT01052077|580828768|FG003|Phase A|Physician Decision|0|||
160847617|NCT01052077|580828765|FG000|Phase A|Withdrawal by Subject|29|||
160847618|NCT01052077|580828766|FG001|Phase A|Withdrawal by Subject|0|||
160650319|NCT04128007|580101551|FG001|Overall Study|Not reported|2|||
160650320|NCT00481247|580101554|FG000|Overall Study|Death|0|||
160650321|NCT00481247|580101555|FG001|Overall Study|Death|1|||
160650322|NCT00481247|580101554|FG000|Overall Study|Disease progression|18|||
160650323|NCT00481247|580101555|FG001|Overall Study|Disease progression|22|||
160650324|NCT00481247|580101554|FG000|Overall Study|Intolerance|42|||
160847619|NCT01052077|580828767|FG002|Phase A|Withdrawal by Subject|0|||
160847620|NCT01052077|580828768|FG003|Phase A|Withdrawal by Subject|0|||
160847621|NCT01052077|580828765|FG000|Phase A|Protocol Deviation|27|||
160847622|NCT01052077|580828766|FG001|Phase A|Protocol Deviation|0|||
160847623|NCT01052077|580828767|FG002|Phase A|Protocol Deviation|0|||
160847624|NCT01052077|580828768|FG003|Phase A|Protocol Deviation|0|||
160847625|NCT01052077|580828765|FG000|Phase B|Lost to Follow-up|0|||
160650325|NCT00481247|580101555|FG001|Overall Study|Intolerance|17|||
160650326|NCT00481247|580101554|FG000|Overall Study|Treatment failure|10|||
160847626|NCT01052077|580828766|FG001|Phase B|Lost to Follow-up|2|||
160847627|NCT01052077|580828767|FG002|Phase B|Lost to Follow-up|3|||
160847628|NCT01052077|580828768|FG003|Phase B|Lost to Follow-up|0|||
160847629|NCT01052077|580828765|FG000|Phase B|Adverse Event|0|||
160847630|NCT01052077|580828766|FG001|Phase B|Adverse Event|9|||
160650327|NCT00481247|580101555|FG001|Overall Study|Treatment failure|14|||
160650328|NCT00481247|580101554|FG000|Overall Study|AE unrelated to study drug|13|||
160650329|NCT00481247|580101555|FG001|Overall Study|AE unrelated to study drug|4|||
160650330|NCT00481247|580101554|FG000|Overall Study|Withdrawal by Subject|8|||
160650331|NCT00481247|580101555|FG001|Overall Study|Withdrawal by Subject|13|||
160650332|NCT00481247|580101554|FG000|Overall Study|Pregnancy|2|||
160650333|NCT00481247|580101555|FG001|Overall Study|Pregnancy|1|||
160650334|NCT00481247|580101554|FG000|Overall Study|Lost to Follow-up|1|||
160650335|NCT00481247|580101555|FG001|Overall Study|Lost to Follow-up|2|||
160650336|NCT00481247|580101554|FG000|Overall Study|Poor compliance/noncompliance|1|||
160650337|NCT00481247|580101555|FG001|Overall Study|Poor compliance/noncompliance|7|||
160650338|NCT00481247|580101554|FG000|Overall Study|Administrative reason by sponsor|157|||
160650339|NCT00481247|580101555|FG001|Overall Study|Administrative reason by sponsor|162|||
160650340|NCT00481247|580101554|FG000|Overall Study|Varied|6|||
160650341|NCT00481247|580101555|FG001|Overall Study|Varied|15|||
160650342|NCT00481247|580101554|FG000|Overall Study|Did not receive treatment|1|||
160650343|NCT00481247|580101555|FG001|Overall Study|Did not receive treatment|2|||
160650344|NCT04281485|580101556|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
160847631|NCT01052077|580828767|FG002|Phase B|Adverse Event|2|||
160847632|NCT01052077|580828768|FG003|Phase B|Adverse Event|0|||
160847633|NCT01052077|580828765|FG000|Phase B|Met Withdrawal Criteria|0|||
160847634|NCT01052077|580828766|FG001|Phase B|Met Withdrawal Criteria|2|||
160847635|NCT01052077|580828767|FG002|Phase B|Met Withdrawal Criteria|1|||
160847636|NCT01052077|580828768|FG003|Phase B|Met Withdrawal Criteria|0|||
160847637|NCT01052077|580828765|FG000|Phase B|Physician Decision|0|||
160847638|NCT01052077|580828766|FG001|Phase B|Physician Decision|1|||
160847639|NCT01052077|580828767|FG002|Phase B|Physician Decision|1|||
160847640|NCT01052077|580828768|FG003|Phase B|Physician Decision|0|||
160847641|NCT01052077|580828765|FG000|Phase B|Withdrawal by Subject|0|||
160847642|NCT01052077|580828766|FG001|Phase B|Withdrawal by Subject|0|||
160847643|NCT01052077|580828767|FG002|Phase B|Withdrawal by Subject|5|||
160847644|NCT01052077|580828768|FG003|Phase B|Withdrawal by Subject|0|||
160847645|NCT01052077|580828765|FG000|Phase B|Protocol Deviation|0|||
160847646|NCT01052077|580828766|FG001|Phase B|Protocol Deviation|3|||
160847647|NCT01052077|580828767|FG002|Phase B|Protocol Deviation|4|||
160847648|NCT01052077|580828768|FG003|Phase B|Protocol Deviation|0|||
160847649|NCT01052077|580828765|FG000|Phase B|Lack of Efficacy|0|||
160847650|NCT01052077|580828766|FG001|Phase B|Lack of Efficacy|1|||
160847651|NCT01052077|580828767|FG002|Phase B|Lack of Efficacy|0|||
160847652|NCT01052077|580828768|FG003|Phase B|Lack of Efficacy|0|||
160847653|NCT01052077|580828765|FG000|Phase A+|Lost to Follow-up|0|||
160847654|NCT01052077|580828766|FG001|Phase A+|Lost to Follow-up|0|||
160847655|NCT01052077|580828767|FG002|Phase A+|Lost to Follow-up|0|||
160847656|NCT01052077|580828768|FG003|Phase A+|Lost to Follow-up|8|||
160847657|NCT01052077|580828765|FG000|Phase A+|Adverse Event|0|||
160847658|NCT01052077|580828766|FG001|Phase A+|Adverse Event|0|||
160847659|NCT01052077|580828767|FG002|Phase A+|Adverse Event|0|||
160847660|NCT01052077|580828768|FG003|Phase A+|Adverse Event|4|||
160847661|NCT01052077|580828765|FG000|Phase A+|Met Withdrawal Criteria|0|||
160847662|NCT01052077|580828766|FG001|Phase A+|Met Withdrawal Criteria|0|||
160847663|NCT01052077|580828767|FG002|Phase A+|Met Withdrawal Criteria|0|||
160847664|NCT01052077|580828768|FG003|Phase A+|Met Withdrawal Criteria|2|||
160847665|NCT01052077|580828765|FG000|Phase A+|Withdrawal by Subject|0|||
160847666|NCT01052077|580828766|FG001|Phase A+|Withdrawal by Subject|0|||
160847667|NCT01052077|580828767|FG002|Phase A+|Withdrawal by Subject|0|||
160847668|NCT01052077|580828768|FG003|Phase A+|Withdrawal by Subject|7|||
160847669|NCT00003199|580828773|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
160906218|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
160906219|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
160906220|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
160906221|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
160650345|NCT04281485|580101557|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
160847670|NCT00003199|580828773|FG000|Overall Study|Lack of insurance clearance|2|||
160906222|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
160906223|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
160847671|NCT00003199|580828773|FG000|Overall Study|Screen fail|15|||
160847672|NCT00940498|580828774|FG000|Overall Study|Death|2|||
160906224|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
160650346|NCT04281485|580101556|FG000|Overall Study|Ongoing (Safety data collection)|10|||
160650347|NCT04281485|580101557|FG001|Overall Study|Ongoing (Safety data collection)|5|||
160650348|NCT04317599|580101558|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
160650349|NCT04317599|580101558|FG000|Overall Study|treatment outside standard of care|4|||
160650350|NCT03933202|580101559|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
160847673|NCT00940498|580828775|FG001|Overall Study|Death|0|||
160847674|NCT00940498|580828776|FG002|Overall Study|Death|0|||
160847675|NCT00940498|580828777|FG003|Overall Study|Death|1|||
160847676|NCT00940498|580828778|FG004|Overall Study|Death|5|||
160847677|NCT00940498|580828779|FG005|Overall Study|Death|0|||
160847678|NCT00940498|580828780|FG006|Overall Study|Death|1|||
160847679|NCT00940498|580828781|FG007|Overall Study|Death|0|||
160847680|NCT00940498|580828774|FG000|Overall Study|Lost to Follow-up|1|||
160847681|NCT00940498|580828775|FG001|Overall Study|Lost to Follow-up|1|||
160847682|NCT00940498|580828776|FG002|Overall Study|Lost to Follow-up|2|||
160847683|NCT00940498|580828777|FG003|Overall Study|Lost to Follow-up|0|||
160847684|NCT00940498|580828778|FG004|Overall Study|Lost to Follow-up|1|||
160847685|NCT00940498|580828779|FG005|Overall Study|Lost to Follow-up|0|||
160847686|NCT00940498|580828780|FG006|Overall Study|Lost to Follow-up|0|||
160847687|NCT00940498|580828781|FG007|Overall Study|Lost to Follow-up|1|||
160847688|NCT00940498|580828774|FG000|Overall Study|Disease Progression|0|||
160847689|NCT00940498|580828775|FG001|Overall Study|Disease Progression|0|||
160847690|NCT00940498|580828776|FG002|Overall Study|Disease Progression|1|||
160847691|NCT00940498|580828777|FG003|Overall Study|Disease Progression|1|||
160847692|NCT00940498|580828778|FG004|Overall Study|Disease Progression|0|||
160847693|NCT00940498|580828779|FG005|Overall Study|Disease Progression|1|||
160847694|NCT00940498|580828780|FG006|Overall Study|Disease Progression|0|||
160847695|NCT00940498|580828781|FG007|Overall Study|Disease Progression|0|||
160847696|NCT00940498|580828774|FG000|Overall Study|Physician Decision|0|||
160847697|NCT00940498|580828775|FG001|Overall Study|Physician Decision|0|||
160847698|NCT00940498|580828776|FG002|Overall Study|Physician Decision|0|||
160847699|NCT00940498|580828777|FG003|Overall Study|Physician Decision|0|||
160847700|NCT00940498|580828778|FG004|Overall Study|Physician Decision|2|||
160847701|NCT00940498|580828779|FG005|Overall Study|Physician Decision|0|||
160847702|NCT00940498|580828780|FG006|Overall Study|Physician Decision|0|||
160847703|NCT00940498|580828781|FG007|Overall Study|Physician Decision|0|||
160847704|NCT00940498|580828774|FG000|Overall Study|Not treated due to disease related pain|0|||
160847705|NCT00940498|580828775|FG001|Overall Study|Not treated due to disease related pain|0|||
160847706|NCT00940498|580828776|FG002|Overall Study|Not treated due to disease related pain|0|||
160847707|NCT00940498|580828777|FG003|Overall Study|Not treated due to disease related pain|0|||
160847708|NCT00940498|580828778|FG004|Overall Study|Not treated due to disease related pain|1|||
160847709|NCT00940498|580828779|FG005|Overall Study|Not treated due to disease related pain|0|||
160847710|NCT00940498|580828780|FG006|Overall Study|Not treated due to disease related pain|0|||
160847711|NCT00940498|580828781|FG007|Overall Study|Not treated due to disease related pain|0|||
160847712|NCT00900029|580828782|FG000|Overall Study|Lost to Follow-up|0|||
160847713|NCT00900029|580828783|FG001|Overall Study|Lost to Follow-up|2|||
160847714|NCT00900029|580828784|FG002|Overall Study|Lost to Follow-up|1|||
160847715|NCT00900029|580828785|FG003|Overall Study|Lost to Follow-up|4|||
160847716|NCT00900029|580828786|FG004|Overall Study|Lost to Follow-up|4|||
160847717|NCT00900029|580828782|FG000|Overall Study|Withdrawal by Subject|2|||
160847718|NCT00900029|580828783|FG001|Overall Study|Withdrawal by Subject|2|||
160847719|NCT00900029|580828784|FG002|Overall Study|Withdrawal by Subject|1|||
160847720|NCT00900029|580828785|FG003|Overall Study|Withdrawal by Subject|1|||
160847721|NCT00900029|580828786|FG004|Overall Study|Withdrawal by Subject|1|||
160847722|NCT00900029|580828782|FG000|Overall Study|Adverse Event|0|||
160847723|NCT00900029|580828783|FG001|Overall Study|Adverse Event|0|||
160847724|NCT00900029|580828784|FG002|Overall Study|Adverse Event|1|||
160847725|NCT00900029|580828785|FG003|Overall Study|Adverse Event|1|||
160847726|NCT00900029|580828786|FG004|Overall Study|Adverse Event|1|||
160847727|NCT00900029|580828782|FG000|Overall Study|Death|1|||
160847728|NCT00900029|580828783|FG001|Overall Study|Death|0|||
160847729|NCT00900029|580828784|FG002|Overall Study|Death|0|||
160847730|NCT00900029|580828785|FG003|Overall Study|Death|1|||
160847731|NCT00900029|580828786|FG004|Overall Study|Death|0|||
160847732|NCT02709330|580828787|FG000|Overall Study|Death|5|||
160847733|NCT02709330|580828788|FG001|Overall Study|Death|0|||
160847734|NCT02709330|580828787|FG000|Overall Study|Lost to Follow-up|2|||
160847735|NCT02709330|580828788|FG001|Overall Study|Lost to Follow-up|0|||
160847736|NCT02709330|580828787|FG000|Overall Study|Physician Decision|2|||
160847737|NCT02709330|580828788|FG001|Overall Study|Physician Decision|0|||
160847738|NCT02709330|580828787|FG000|Overall Study|Withdrawal by Subject|4|||
160847739|NCT02709330|580828788|FG001|Overall Study|Withdrawal by Subject|0|||
160847740|NCT02587819|580828791|FG000|Overall Study|Adverse Event|1|||
160847741|NCT02587819|580828791|FG000|Overall Study|Lost to Follow-up|1|||
160847742|NCT01594931|580831700|FG000|Overall Study|Adverse Event|3|||
160847743|NCT01594931|580831701|FG001|Overall Study|Adverse Event|1|||
160847744|NCT01594931|580831702|FG002|Overall Study|Adverse Event|1|||
160847745|NCT01594931|580831700|FG000|Overall Study|Withdrawal by Subject|2|||
160847746|NCT01594931|580831701|FG001|Overall Study|Withdrawal by Subject|1|||
160847747|NCT01594931|580831702|FG002|Overall Study|Withdrawal by Subject|1|||
160847748|NCT01594931|580831700|FG000|Overall Study|Lack of Efficacy|7|||
160847749|NCT01594931|580831701|FG001|Overall Study|Lack of Efficacy|2|||
160847750|NCT01594931|580831702|FG002|Overall Study|Lack of Efficacy|2|||
160847751|NCT01594931|580831700|FG000|Overall Study|Lost to Follow-up|4|||
160847752|NCT01594931|580831701|FG001|Overall Study|Lost to Follow-up|3|||
160847753|NCT01594931|580831702|FG002|Overall Study|Lost to Follow-up|3|||
160847754|NCT01594931|580831700|FG000|Overall Study|Protocol Violation|2|||
160847755|NCT01594931|580831701|FG001|Overall Study|Protocol Violation|1|||
160847756|NCT01594931|580831702|FG002|Overall Study|Protocol Violation|0|||
160847757|NCT01594931|580831700|FG000|Overall Study|No defiined|11|||
160568426|NCT00472303|579803899|FG001|Maintenance Phase|Trial medication non-compliant|0|||
160568427|NCT00472303|579803900|FG002|Maintenance Phase|Trial medication non-compliant|1|||
160568428|NCT00472303|579803898|FG000|Maintenance Phase|Resolution of pain|0|||
160568429|NCT00472303|579803899|FG001|Maintenance Phase|Resolution of pain|0|||
160847758|NCT01594931|580831701|FG001|Overall Study|No defiined|4|||
160847759|NCT01594931|580831702|FG002|Overall Study|No defiined|7|||
160847760|NCT01929226|580831707|FG000|Overall Study|Lost to Follow-up|4|||
160847761|NCT01929226|580831708|FG001|Overall Study|Lost to Follow-up|0|||
160847762|NCT01929226|580831707|FG000|Overall Study|Withdrawal by Subject|1|||
160847763|NCT01929226|580831708|FG001|Overall Study|Withdrawal by Subject|1|||
160847764|NCT00859547|580831709|FG000|Overall Study|Lost to Follow-up|1|||
160847765|NCT00859547|580831709|FG000|Overall Study|Parent withdrew consent|1|||
160847766|NCT01473732|580831712|FG000|Overall Study|Adverse Event|1|||
160847767|NCT01473732|580831713|FG001|Overall Study|Adverse Event|0|||
160847768|NCT01473732|580831712|FG000|Overall Study|Death|1|||
160847769|NCT01473732|580831713|FG001|Overall Study|Death|0|||
160847770|NCT00592904|580831734|FG000|Overall Study|Adverse Event|15|||
160847771|NCT00592904|580831735|FG001|Overall Study|Adverse Event|25|||
160847772|NCT00592904|580831736|FG002|Overall Study|Adverse Event|13|||
160847773|NCT00592904|580831737|FG003|Overall Study|Adverse Event|5|||
160847774|NCT00592904|580831734|FG000|Overall Study|Protocol Violation|1|||
160847775|NCT00592904|580831735|FG001|Overall Study|Protocol Violation|1|||
160847776|NCT00592904|580831736|FG002|Overall Study|Protocol Violation|0|||
160847777|NCT00592904|580831737|FG003|Overall Study|Protocol Violation|1|||
160847778|NCT00592904|580831734|FG000|Overall Study|Withdrawal by Subject|4|||
160847779|NCT00592904|580831735|FG001|Overall Study|Withdrawal by Subject|16|||
160847780|NCT00592904|580831736|FG002|Overall Study|Withdrawal by Subject|1|||
160847781|NCT00592904|580831737|FG003|Overall Study|Withdrawal by Subject|2|||
160847782|NCT00592904|580831734|FG000|Overall Study|Lack of Efficacy|2|||
160847783|NCT00592904|580831735|FG001|Overall Study|Lack of Efficacy|7|||
160992428|NCT00817635|581361359|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
160568430|NCT00472303|579803900|FG002|Maintenance Phase|Resolution of pain|1|||
160568431|NCT00472303|579803898|FG000|Maintenance Phase|Other|1|||
160568432|NCT00472303|579803899|FG001|Maintenance Phase|Other|1|||
160568433|NCT00472303|579803900|FG002|Maintenance Phase|Other|0|||
160847784|NCT00592904|580831736|FG002|Overall Study|Lack of Efficacy|2|||
160847785|NCT00592904|580831737|FG003|Overall Study|Lack of Efficacy|3|||
160847786|NCT00592904|580831734|FG000|Overall Study|Physician Decision|0|||
160847787|NCT00592904|580831735|FG001|Overall Study|Physician Decision|3|||
160847788|NCT00592904|580831736|FG002|Overall Study|Physician Decision|1|||
160992429|NCT00817635|581361360|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
160992430|NCT00817635|581361361|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
160992431|NCT00817635|581361362|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
160992432|NCT00817635|581361363|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
160992433|NCT00817635|581361359|FG000|Overall Study|Withdrawal by Subject|2|||
160992434|NCT00817635|581361360|FG001|Overall Study|Withdrawal by Subject|1|||
160992435|NCT00817635|581361361|FG002|Overall Study|Withdrawal by Subject|0|||
160568434|NCT01122927|579803901|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
160568435|NCT01122927|579803902|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
160568436|NCT01122927|579803901|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
160568437|NCT01122927|579803902|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
160568438|NCT01122927|579803901|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
160847789|NCT00592904|580831737|FG003|Overall Study|Physician Decision|0|||
160568439|NCT01122927|579803902|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
160847790|NCT00592904|580831734|FG000|Overall Study|Other|3|||
160568440|NCT01122927|579803901|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
160568441|NCT01122927|579803902|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
160847791|NCT00592904|580831735|FG001|Overall Study|Other|3|||
160847792|NCT00592904|580831736|FG002|Overall Study|Other|0|||
160847793|NCT00592904|580831737|FG003|Overall Study|Other|0|||
160847794|NCT00824473|580831740|FG000|Overall Study|Adverse Event|4|||
160847795|NCT00824473|580831741|FG001|Overall Study|Adverse Event|5|||
160847796|NCT00824473|580831740|FG000|Overall Study|Lack of Efficacy|2|||
160847797|NCT00824473|580831741|FG001|Overall Study|Lack of Efficacy|2|||
160847798|NCT00824473|580831740|FG000|Overall Study|Protocol Violation|2|||
160847799|NCT00824473|580831741|FG001|Overall Study|Protocol Violation|0|||
160847800|NCT00824473|580831740|FG000|Overall Study|Non-Compliance|4|||
160847801|NCT00824473|580831741|FG001|Overall Study|Non-Compliance|2|||
160847802|NCT00824473|580831740|FG000|Overall Study|Withdrawal by Subject|2|||
160847803|NCT00824473|580831741|FG001|Overall Study|Withdrawal by Subject|3|||
160847804|NCT00824473|580831740|FG000|Overall Study|Other|1|||
160847805|NCT00824473|580831741|FG001|Overall Study|Other|1|||
160847806|NCT03906071|580831742|FG000|Overall Study|Death|180|||
160847807|NCT03906071|580831743|FG001|Overall Study|Death|185|||
160847808|NCT03906071|580831742|FG000|Overall Study|Lost to Follow-up|3|||
160847809|NCT03906071|580831743|FG001|Overall Study|Lost to Follow-up|3|||
160847810|NCT03906071|580831742|FG000|Overall Study|Withdrawal by Subject|15|||
160847811|NCT03906071|580831743|FG001|Overall Study|Withdrawal by Subject|27|||
160847812|NCT03906071|580831742|FG000|Overall Study|Other|2|||
160847813|NCT03906071|580831743|FG001|Overall Study|Other|1|||
160847814|NCT01359904|580831744|FG000|Overall Study|Withdrawal by Subject|1|||
160847815|NCT01359904|580831745|FG001|Overall Study|Withdrawal by Subject|0|||
160847816|NCT01172535|580831748|FG000|Overall Study|Death|3|||
160847817|NCT01172535|580831748|FG000|Overall Study|Withdrawal by Subject|2|||
160650351|NCT03933202|580101560|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
160847818|NCT01172535|580831748|FG000|Overall Study|Lost to Follow-up|1|||
160847819|NCT01172535|580831748|FG000|Overall Study|Ineligible at study entry|1|||
160847820|NCT01172535|580831748|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
160847821|NCT01461707|580831749|FG000|Overall Study|Withdrawal by Subject|1|||
160847822|NCT01461707|580831750|FG001|Overall Study|Withdrawal by Subject|0|||
160847823|NCT00337207|580831751|FG000|Overall Study|Withdrawal by Subject|3|||
160847824|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
160847825|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
160847826|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
160847827|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
160847828|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
160906225|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
160906226|NCT01496807|581050361|FG000|Overall Study|Progressive Disease|21|||
160906227|NCT01496807|581050361|FG000|Overall Study|Participant preference/toxicity|8|||
160906228|NCT01496807|581050361|FG000|Overall Study|Change in diagnosis|1|||
160906229|NCT03330288|581050364|FG000|Overall Study|Other reason|1|||
160906230|NCT03330288|581050365|FG001|Overall Study|Other reason|1|||
160906231|NCT03330288|581050364|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
160906232|NCT03330288|581050365|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
160906233|NCT03330288|581050364|FG000|Overall Study|Adverse Event|1|||
160906234|NCT03330288|581050365|FG001|Overall Study|Adverse Event|0|||
160906235|NCT03330288|581050364|FG000|Overall Study|Withdrawal by Subject|1|||
160906236|NCT03330288|581050365|FG001|Overall Study|Withdrawal by Subject|0|||
160906237|NCT03330288|581050364|FG000|Overall Study|Lost to Follow-up|26|||
160906238|NCT03330288|581050365|FG001|Overall Study|Lost to Follow-up|7|||
160906239|NCT04447794|581050366|FG000|Overall Study|Lost to Follow-up|2|||
160906240|NCT04447794|581050367|FG001|Overall Study|Lost to Follow-up|3|||
160906241|NCT04447794|581050368|FG002|Overall Study|Lost to Follow-up|8|||
160906242|NCT04447794|581050366|FG000|Overall Study|Withdrawal by Subject|1|||
160906243|NCT04447794|581050367|FG001|Overall Study|Withdrawal by Subject|1|||
160906244|NCT04447794|581050368|FG002|Overall Study|Withdrawal by Subject|0|||
160906245|NCT00963937|581050373|FG000|Overall Study|Protocol Violation|1|||
160906246|NCT00963937|581050374|FG001|Overall Study|Protocol Violation|1|||
160906247|NCT00963937|581050375|FG002|Overall Study|Protocol Violation|0|||
160906248|NCT00963937|581050373|FG000|Overall Study|Physician Decision|18|||
160906249|NCT00963937|581050374|FG001|Overall Study|Physician Decision|10|||
160906250|NCT00963937|581050375|FG002|Overall Study|Physician Decision|4|||
160906251|NCT02106975|581050376|FG000|Overall Study|Death|25|||
160906252|NCT02106975|581050377|FG001|Overall Study|Death|39|||
160906253|NCT03546062|581050378|FG000|Overall Study|Adverse Event|6|||
160906254|NCT03546062|581050379|FG001|Overall Study|Adverse Event|5|||
160906255|NCT03546062|581050380|FG002|Overall Study|Adverse Event|8|||
160906256|NCT00181155|581050381|FG000|Overall Study|Physician Decision|1|||
160906257|NCT00181155|581050382|FG001|Overall Study|Physician Decision|0|||
160906258|NCT00181155|581050381|FG000|Overall Study|Withdrawal by Subject|1|||
160906259|NCT00181155|581050382|FG001|Overall Study|Withdrawal by Subject|0|||
160906260|NCT02572401|581050383|FG000|Overall Study|Lost to Follow-up|5|||
160906261|NCT02572401|581050384|FG001|Overall Study|Lost to Follow-up|8|||
160906262|NCT02572401|581050385|FG002|Overall Study|Lost to Follow-up|9|||
160906263|NCT02572401|581050386|FG003|Overall Study|Lost to Follow-up|9|||
160906264|NCT02572401|581050383|FG000|Overall Study|Death|0|||
160906265|NCT02572401|581050384|FG001|Overall Study|Death|0|||
160906266|NCT02572401|581050385|FG002|Overall Study|Death|0|||
160906267|NCT02572401|581050386|FG003|Overall Study|Death|1|||
160906268|NCT01768286|581050389|FG000|Overall Study|Randomized But Not Treated|0|||
160906269|NCT01768286|581050390|FG001|Overall Study|Randomized But Not Treated|0|||
160847829|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
160847830|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
160847831|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
160847832|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
160847833|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
160847834|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
160847835|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
160847836|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
160847837|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
160847838|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
160847839|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
160847840|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
160847841|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
160847842|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
160847843|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
160847844|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
160847845|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
160847846|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
160847847|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
160847848|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
160847849|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
160847850|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
160847851|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
160847852|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
160847853|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
160847854|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
160847855|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
160847856|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
160847857|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
160847858|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
160847859|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
160847860|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
160847861|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
160847862|NCT00413218|580831755|FG000|Overall Study|Randomized but didn't receive study drug|2|||
160847863|NCT00413218|580831756|FG001|Overall Study|Randomized but didn't receive study drug|8|||
160847864|NCT00413218|580831755|FG000|Overall Study|Death|57|||
160847865|NCT00413218|580831756|FG001|Overall Study|Death|56|||
160847866|NCT00413218|580831755|FG000|Overall Study|Lost to Follow-up|14|||
160847867|NCT00413218|580831756|FG001|Overall Study|Lost to Follow-up|17|||
160847868|NCT00413218|580831755|FG000|Overall Study|Admin|20|||
160992436|NCT00817635|581361362|FG003|Overall Study|Withdrawal by Subject|1|||
160571896|NCT01743027|579816861|FG000|Overall Study|Adverse Event|2|||
160571897|NCT01743027|579816862|FG001|Overall Study|Adverse Event|0|||
160571898|NCT01743027|579816863|FG002|Overall Study|Adverse Event|0|||
160571899|NCT01743027|579816864|FG003|Overall Study|Adverse Event|0|||
160571900|NCT01743027|579816861|FG000|Overall Study|Lost to Follow-up|0|||
160571901|NCT01743027|579816862|FG001|Overall Study|Lost to Follow-up|0|||
160571902|NCT01743027|579816863|FG002|Overall Study|Lost to Follow-up|2|||
160571903|NCT01743027|579816864|FG003|Overall Study|Lost to Follow-up|0|||
160847869|NCT00413218|580831756|FG001|Overall Study|Admin|14|||
160847870|NCT00413218|580831755|FG000|Overall Study|Missing|1|||
160847871|NCT00413218|580831756|FG001|Overall Study|Missing|0|||
160847872|NCT00413218|580831755|FG000|Overall Study|Withdrawal by Subject|9|||
160847873|NCT00413218|580831756|FG001|Overall Study|Withdrawal by Subject|1|||
160847874|NCT00837213|580831759|FG000|Overall Study|Lost to Follow-up|3|||
160847875|NCT00837213|580831760|FG001|Overall Study|Lost to Follow-up|2|||
160847876|NCT00837213|580831759|FG000|Overall Study|Withdrawal by Subject|2|||
160847877|NCT00837213|580831760|FG001|Overall Study|Withdrawal by Subject|2|||
160847878|NCT00837213|580831759|FG000|Overall Study|not stated|1|||
160847879|NCT00837213|580831760|FG001|Overall Study|not stated|1|||
160847880|NCT02562716|580831768|FG000|Overall Study|Adverse Event|7|||
160847881|NCT02562716|580831769|FG001|Overall Study|Adverse Event|14|||
160847882|NCT02562716|580831768|FG000|Overall Study|Withdrawal unrelated to AE|7|||
160847883|NCT02562716|580831769|FG001|Overall Study|Withdrawal unrelated to AE|1|||
160847884|NCT02562716|580831768|FG000|Overall Study|Progression|8|||
160847885|NCT02562716|580831769|FG001|Overall Study|Progression|10|||
160847886|NCT02562716|580831768|FG000|Overall Study|Death|2|||
160847887|NCT02562716|580831769|FG001|Overall Study|Death|1|||
160847888|NCT02562716|580831768|FG000|Overall Study|Not protocol specified|4|||
160847889|NCT02562716|580831769|FG001|Overall Study|Not protocol specified|2|||
160847890|NCT02753946|580831770|FG000|Overall Study|Adverse Event|7|||
160847891|NCT02753946|580831771|FG001|Overall Study|Adverse Event|6|||
160847892|NCT02753946|580831770|FG000|Overall Study|Withdrawal by Subject|6|||
160847893|NCT02753946|580831771|FG001|Overall Study|Withdrawal by Subject|1|||
160847894|NCT02753946|580831770|FG000|Overall Study|Lack of Efficacy|1|||
160847895|NCT02753946|580831771|FG001|Overall Study|Lack of Efficacy|0|||
160847896|NCT02753946|580831770|FG000|Overall Study|Physician Decision|0|||
160847897|NCT02753946|580831771|FG001|Overall Study|Physician Decision|2|||
160847898|NCT02175017|580831772|FG000|Overall Study|Did not receive the investigational product|1|||
160847899|NCT02175017|580831773|FG001|Overall Study|Did not receive the investigational product|2|||
160847900|NCT02175017|580831772|FG000|Overall Study|Withdrawal by Subject|6|||
160847901|NCT02175017|580831773|FG001|Overall Study|Withdrawal by Subject|3|||
160847902|NCT02175017|580831772|FG000|Overall Study|Met an exclusion criteria|0|||
160847903|NCT02175017|580831773|FG001|Overall Study|Met an exclusion criteria|1|||
160847904|NCT02175017|580831772|FG000|Overall Study|Adverse Event|3|||
160847905|NCT02175017|580831773|FG001|Overall Study|Adverse Event|10|||
160847906|NCT02175017|580831772|FG000|Overall Study|Disease progression|20|||
160847907|NCT02175017|580831773|FG001|Overall Study|Disease progression|27|||
160847908|NCT02175017|580831772|FG000|Overall Study|Other than above reasons|3|||
160847909|NCT02175017|580831773|FG001|Overall Study|Other than above reasons|0|||
160847910|NCT00216671|580831774|FG000|Overall Study|Adverse Event|4|||
160847911|NCT00216671|580831775|FG001|Overall Study|Adverse Event|9|||
160847912|NCT00216671|580831774|FG000|Overall Study|Pregnancy|0|||
160847913|NCT00216671|580831775|FG001|Overall Study|Pregnancy|1|||
160847914|NCT00216671|580831774|FG000|Overall Study|Withdrawal by Subject|4|||
160847915|NCT00216671|580831775|FG001|Overall Study|Withdrawal by Subject|2|||
160847916|NCT00216671|580831774|FG000|Overall Study|Refused Injections|3|||
160847917|NCT00216671|580831775|FG001|Overall Study|Refused Injections|13|||
160847918|NCT00216671|580831774|FG000|Overall Study|No Need to Continue Medication|1|||
160847919|NCT00216671|580831775|FG001|Overall Study|No Need to Continue Medication|1|||
160847920|NCT00216671|580831774|FG000|Overall Study|Insufficient Response|9|||
160847921|NCT00216671|580831775|FG001|Overall Study|Insufficient Response|4|||
160847922|NCT00216671|580831774|FG000|Overall Study|Lost to Follow-up|3|||
160847923|NCT00216671|580831775|FG001|Overall Study|Lost to Follow-up|5|||
160847924|NCT00216671|580831774|FG000|Overall Study|Non compliant|2|||
160847925|NCT00216671|580831775|FG001|Overall Study|Non compliant|2|||
160847926|NCT00216671|580831774|FG000|Overall Study|Ineligible|0|||
160847927|NCT00216671|580831775|FG001|Overall Study|Ineligible|2|||
160847928|NCT00216671|580831774|FG000|Overall Study|Physician Decision|1|||
160847929|NCT00216671|580831775|FG001|Overall Study|Physician Decision|1|||
160650352|NCT03933202|580101559|FG000|Overall Study|Participant transferred care|1|||
160650353|NCT03933202|580101560|FG001|Overall Study|Participant transferred care|0|||
160650354|NCT03933202|580101559|FG000|Overall Study|Site research department closing|1|||
160650355|NCT03933202|580101560|FG001|Overall Study|Site research department closing|0|||
160650356|NCT03933202|580101559|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
160650357|NCT03933202|580101560|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
160650358|NCT03933202|580101559|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
160650359|NCT03933202|580101560|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
160650360|NCT03933202|580101559|FG000|Overall Study|Participant changed primary neurology provider|1|||
160650361|NCT03933202|580101560|FG001|Overall Study|Participant changed primary neurology provider|0|||
160650362|NCT03933202|580101559|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
160650363|NCT03933202|580101560|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
160992437|NCT00817635|581361363|FG004|Overall Study|Withdrawal by Subject|2|||
160992438|NCT00817635|581361359|FG000|Overall Study|Lost to Follow-up|0|||
160650364|NCT03933202|580101559|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
160847930|NCT00216671|580831774|FG000|Overall Study|Protocol Violation|3|||
160847931|NCT00216671|580831775|FG001|Overall Study|Protocol Violation|5|||
160847932|NCT00216671|580831774|FG000|Overall Study|Relapse|1|||
160847933|NCT00216671|580831775|FG001|Overall Study|Relapse|0|||
160847934|NCT00216671|580831774|FG000|Overall Study|Investigator Illness|0|||
160847935|NCT00216671|580831775|FG001|Overall Study|Investigator Illness|1|||
160847936|NCT00216671|580831774|FG000|Overall Study|Patient Moved|0|||
160847937|NCT00216671|580831775|FG001|Overall Study|Patient Moved|1|||
160847938|NCT00216671|580831774|FG000|Overall Study|Ineligible, no efficacy data|2|||
160847939|NCT00216671|580831775|FG001|Overall Study|Ineligible, no efficacy data|2|||
160847940|NCT00216671|580831774|FG000|Overall Study|Insufficient Response Adverse Event|2|||
160847941|NCT00216671|580831775|FG001|Overall Study|Insufficient Response Adverse Event|1|||
160847942|NCT02714569|580831776|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
160847943|NCT02714569|580831777|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
160847944|NCT02714569|580831778|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
160847945|NCT02714569|580831779|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
160847946|NCT02714569|580831780|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
160847947|NCT02714569|580831781|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
160847948|NCT02714569|580831782|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
160847949|NCT02714569|580831783|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
160847950|NCT02714569|580831784|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
160847951|NCT02714569|580831785|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
160847952|NCT02714569|580831786|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
160847953|NCT02714569|580831776|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847954|NCT02714569|580831777|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847955|NCT02714569|580831778|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847956|NCT02714569|580831779|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
160847957|NCT02714569|580831780|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160992439|NCT00817635|581361360|FG001|Overall Study|Lost to Follow-up|1|||
160650365|NCT03933202|580101560|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
160650366|NCT03933202|580101559|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
160847958|NCT02714569|580831781|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847959|NCT02714569|580831782|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847960|NCT02714569|580831783|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847961|NCT02714569|580831784|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847962|NCT02714569|580831785|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160992440|NCT00817635|581361361|FG002|Overall Study|Lost to Follow-up|0|||
160992441|NCT00817635|581361362|FG003|Overall Study|Lost to Follow-up|1|||
160847963|NCT02714569|580831786|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847964|NCT02714569|580831776|FG000|Part A Third Intervention|Adverse Event|0|||
160847965|NCT02714569|580831777|FG001|Part A Third Intervention|Adverse Event|0|||
160847966|NCT02714569|580831778|FG002|Part A Third Intervention|Adverse Event|1|||
160847967|NCT02714569|580831779|FG003|Part A Third Intervention|Adverse Event|0|||
160847968|NCT02714569|580831780|FG004|Part A Third Intervention|Adverse Event|0|||
160847969|NCT02714569|580831781|FG005|Part A Third Intervention|Adverse Event|0|||
160847970|NCT02714569|580831782|FG006|Part A Third Intervention|Adverse Event|0|||
160847971|NCT02714569|580831783|FG007|Part A Third Intervention|Adverse Event|0|||
160847972|NCT02714569|580831784|FG008|Part A Third Intervention|Adverse Event|0|||
160847973|NCT02714569|580831785|FG009|Part A Third Intervention|Adverse Event|0|||
160847974|NCT02714569|580831786|FG010|Part A Third Intervention|Adverse Event|0|||
160847975|NCT02714569|580831776|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
160847976|NCT02714569|580831777|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847977|NCT02714569|580831778|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847978|NCT02714569|580831779|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847979|NCT02714569|580831780|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847980|NCT02714569|580831781|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
160847981|NCT02714569|580831782|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847982|NCT02714569|580831783|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847983|NCT02714569|580831784|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847984|NCT02714569|580831785|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847985|NCT02714569|580831786|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847986|NCT02714569|580831776|FG000|Part B (Overall)|Lost to Follow-up|0|||
160847987|NCT02714569|580831777|FG001|Part B (Overall)|Lost to Follow-up|0|||
160847988|NCT02714569|580831778|FG002|Part B (Overall)|Lost to Follow-up|0|||
160847989|NCT02714569|580831779|FG003|Part B (Overall)|Lost to Follow-up|0|||
160847990|NCT02714569|580831780|FG004|Part B (Overall)|Lost to Follow-up|0|||
160847991|NCT02714569|580831781|FG005|Part B (Overall)|Lost to Follow-up|0|||
160847992|NCT02714569|580831782|FG006|Part B (Overall)|Lost to Follow-up|1|||
160847993|NCT02714569|580831783|FG007|Part B (Overall)|Lost to Follow-up|0|||
160847994|NCT02714569|580831784|FG008|Part B (Overall)|Lost to Follow-up|0|||
160992442|NCT00817635|581361363|FG004|Overall Study|Lost to Follow-up|0|||
160992443|NCT00817635|581361359|FG000|Overall Study|Administrative Problems|0|||
160992444|NCT00817635|581361360|FG001|Overall Study|Administrative Problems|0|||
160992445|NCT00817635|581361361|FG002|Overall Study|Administrative Problems|0|||
160992446|NCT00817635|581361362|FG003|Overall Study|Administrative Problems|0|||
160992447|NCT00817635|581361363|FG004|Overall Study|Administrative Problems|1|||
160992448|NCT00817635|581361359|FG000|Overall Study|Protocol Violation|5|||
160992449|NCT00817635|581361360|FG001|Overall Study|Protocol Violation|1|||
160992450|NCT00817635|581361361|FG002|Overall Study|Protocol Violation|3|||
160992451|NCT00817635|581361362|FG003|Overall Study|Protocol Violation|2|||
160992452|NCT00817635|581361363|FG004|Overall Study|Protocol Violation|3|||
160992453|NCT00918957|581361365|FG000|Overall Study|Adverse Event|2|||
160992454|NCT00918957|581361366|FG001|Overall Study|Adverse Event|0|||
160992455|NCT00918957|581361365|FG000|Overall Study|Withdrawal by Subject|1|||
160992456|NCT00918957|581361366|FG001|Overall Study|Withdrawal by Subject|0|||
160992457|NCT03107611|581361367|FG000|Overall Study|Adverse Event|1|||
160992458|NCT03107611|581361368|FG001|Overall Study|Adverse Event|0|||
160992459|NCT03107611|581361369|FG002|Overall Study|Adverse Event|2|||
160992460|NCT03107611|581361367|FG000|Overall Study|Lost to Follow-up|3|||
160992461|NCT03107611|581361368|FG001|Overall Study|Lost to Follow-up|3|||
160992462|NCT03107611|581361369|FG002|Overall Study|Lost to Follow-up|3|||
160992463|NCT03107611|581361367|FG000|Overall Study|Protocol Violation|0|||
160992464|NCT03107611|581361368|FG001|Overall Study|Protocol Violation|0|||
160992465|NCT03107611|581361369|FG002|Overall Study|Protocol Violation|1|||
160992466|NCT03107611|581361367|FG000|Overall Study|Withdrawal by Subject|1|||
160992467|NCT03107611|581361368|FG001|Overall Study|Withdrawal by Subject|0|||
160992468|NCT03107611|581361369|FG002|Overall Study|Withdrawal by Subject|1|||
160992469|NCT03107611|581361367|FG000|Overall Study|Worsening signs/symptoms|2|||
160992470|NCT03107611|581361368|FG001|Overall Study|Worsening signs/symptoms|1|||
160992471|NCT03107611|581361369|FG002|Overall Study|Worsening signs/symptoms|2|||
160992472|NCT01720446|581361370|FG000|Overall Study|Lost to Follow-up|12|||
160992473|NCT01720446|581361371|FG001|Overall Study|Lost to Follow-up|6|||
160992474|NCT01720446|581361372|FG002|Overall Study|Lost to Follow-up|16|||
160847995|NCT02714569|580831785|FG009|Part B (Overall)|Lost to Follow-up|0|||
160847996|NCT02714569|580831786|FG010|Part B (Overall)|Lost to Follow-up|0|||
160992475|NCT01720446|581361373|FG003|Overall Study|Lost to Follow-up|16|||
160992476|NCT01720446|581361370|FG000|Overall Study|Withdrawal by Subject|2|||
160992477|NCT01720446|581361371|FG001|Overall Study|Withdrawal by Subject|5|||
160992478|NCT01720446|581361372|FG002|Overall Study|Withdrawal by Subject|4|||
160992479|NCT01720446|581361373|FG003|Overall Study|Withdrawal by Subject|4|||
160992480|NCT01020838|581361376|FG000|Overall Study|Death|90|||
160992481|NCT01020838|581361376|FG000|Overall Study|Adverse Event|1|||
160568442|NCT01122927|579803901|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
160568443|NCT01122927|579803902|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
160568444|NCT01122927|579803901|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
160568445|NCT01122927|579803902|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
160568446|NCT01122927|579803901|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
160568447|NCT01122927|579803902|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
160568448|NCT01122927|579803901|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
160650367|NCT03933202|580101560|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
160650368|NCT03933202|580101559|FG000|Overall Study|Missed visit|0|||
160650369|NCT03933202|580101560|FG001|Overall Study|Missed visit|1|||
160650370|NCT03933202|580101559|FG000|Overall Study|Investigator decision|4|||
160650371|NCT03933202|580101560|FG001|Overall Study|Investigator decision|0|||
160650372|NCT03933202|580101559|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
160650373|NCT03933202|580101560|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
160650374|NCT03933202|580101559|FG000|Overall Study|Withdrawal by Subject|10|||
160650375|NCT03933202|580101560|FG001|Overall Study|Withdrawal by Subject|8|||
160650376|NCT03933202|580101559|FG000|Overall Study|Death|2|||
160650377|NCT03933202|580101560|FG001|Overall Study|Death|0|||
160650378|NCT03933202|580101559|FG000|Overall Study|Progressive disease|0|||
160650379|NCT03933202|580101560|FG001|Overall Study|Progressive disease|3|||
160650380|NCT03933202|580101559|FG000|Overall Study|Protocol non-compliance|6|||
160650381|NCT03933202|580101560|FG001|Overall Study|Protocol non-compliance|3|||
160650382|NCT03933202|580101559|FG000|Overall Study|Lost to Follow-up|16|||
160650383|NCT03933202|580101560|FG001|Overall Study|Lost to Follow-up|8|||
160650384|NCT03933202|580101559|FG000|Overall Study|Adverse Event|3|||
160650385|NCT03933202|580101560|FG001|Overall Study|Adverse Event|0|||
160650386|NCT05658523|580101561|FG000|Baseline|No blood draw|1|||
160650387|NCT05658523|580101562|FG001|Baseline|No blood draw|0|||
160650388|NCT05658523|580101563|FG002|Baseline|No blood draw|0|||
160650389|NCT05658523|580101561|FG000|28 Days|Lost to Follow-up|1|||
160650390|NCT05658523|580101562|FG001|28 Days|Lost to Follow-up|0|||
160650391|NCT05658523|580101563|FG002|28 Days|Lost to Follow-up|0|||
160650392|NCT05658523|580101561|FG000|28 Days|Withdrawal by Subject|1|||
160650393|NCT05658523|580101562|FG001|28 Days|Withdrawal by Subject|1|||
160650394|NCT05658523|580101563|FG002|28 Days|Withdrawal by Subject|0|||
160650395|NCT05658523|580101561|FG000|28 Days|Visit missed|0|||
160650396|NCT05658523|580101562|FG001|28 Days|Visit missed|4|||
160650397|NCT05658523|580101563|FG002|28 Days|Visit missed|0|||
160650398|NCT05658523|580101561|FG000|6 Months|Lost to Follow-up|1|||
160650399|NCT05658523|580101562|FG001|6 Months|Lost to Follow-up|7|||
160650400|NCT05658523|580101563|FG002|6 Months|Lost to Follow-up|2|||
160650401|NCT05658523|580101561|FG000|6 Months|Withdrawal by Subject|1|||
160650402|NCT05658523|580101562|FG001|6 Months|Withdrawal by Subject|3|||
160650403|NCT05658523|580101563|FG002|6 Months|Withdrawal by Subject|4|||
160650404|NCT05658523|580101561|FG000|6 Months|Visit missed|5|||
160650405|NCT05658523|580101562|FG001|6 Months|Visit missed|7|||
160650406|NCT05658523|580101563|FG002|6 Months|Visit missed|0|||
160650407|NCT05658523|580101561|FG000|6 Months|No blood draw|0|||
160650408|NCT05658523|580101562|FG001|6 Months|No blood draw|0|||
160650409|NCT05658523|580101563|FG002|6 Months|No blood draw|1|||
160650410|NCT05658523|580101561|FG000|12 Months|Lost to Follow-up|2|||
160650411|NCT05658523|580101562|FG001|12 Months|Lost to Follow-up|6|||
160650412|NCT05658523|580101563|FG002|12 Months|Lost to Follow-up|3|||
160650413|NCT05658523|580101561|FG000|12 Months|Withdrawal by Subject|4|||
160650414|NCT05658523|580101562|FG001|12 Months|Withdrawal by Subject|4|||
160650415|NCT05658523|580101563|FG002|12 Months|Withdrawal by Subject|2|||
160650416|NCT05658523|580101561|FG000|12 Months|Visit missed|4|||
160650417|NCT05658523|580101562|FG001|12 Months|Visit missed|8|||
160650418|NCT05658523|580101563|FG002|12 Months|Visit missed|8|||
160650419|NCT05658523|580101561|FG000|18 Months|Lost to Follow-up|5|||
160650420|NCT05658523|580101562|FG001|18 Months|Lost to Follow-up|8|||
160650421|NCT05658523|580101563|FG002|18 Months|Lost to Follow-up|2|||
160650422|NCT05658523|580101561|FG000|18 Months|Withdrawal by Subject|17|||
160650423|NCT05658523|580101562|FG001|18 Months|Withdrawal by Subject|9|||
160650424|NCT05658523|580101563|FG002|18 Months|Withdrawal by Subject|16|||
160650425|NCT05658523|580101561|FG000|18 Months|Visit missed|12|||
160650426|NCT05658523|580101562|FG001|18 Months|Visit missed|14|||
160650427|NCT05658523|580101563|FG002|18 Months|Visit missed|6|||
160650428|NCT00628212|580101564|FG000|Overall Study|Adverse Event|2|||
160650429|NCT00628212|580101565|FG001|Overall Study|Adverse Event|0|||
160650430|NCT00628212|580101566|FG002|Overall Study|Adverse Event|1|||
160650431|NCT00628212|580101567|FG003|Overall Study|Adverse Event|2|||
160650432|NCT00628212|580101564|FG000|Overall Study|Physician Decision|1|||
160650433|NCT00628212|580101565|FG001|Overall Study|Physician Decision|1|||
160650434|NCT00628212|580101566|FG002|Overall Study|Physician Decision|2|||
160650435|NCT00628212|580101567|FG003|Overall Study|Physician Decision|3|||
160650436|NCT02427607|580101568|FG000|Overall Study|Withdrawal by Subject|1|||
160650437|NCT03211416|580101569|FG000|Overall Study|Adverse Event|7|||
160650438|NCT03211416|580101569|FG000|Overall Study|Lack of Efficacy|2|||
160847997|NCT02714569|580831776|FG000|Part B (Overall)|Withdrawal by Subject|0|||
160568449|NCT01122927|579803902|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
160568450|NCT01122927|579803901|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
160847998|NCT02714569|580831777|FG001|Part B (Overall)|Withdrawal by Subject|0|||
160847999|NCT02714569|580831778|FG002|Part B (Overall)|Withdrawal by Subject|0|||
160848000|NCT02714569|580831779|FG003|Part B (Overall)|Withdrawal by Subject|0|||
160848001|NCT02714569|580831780|FG004|Part B (Overall)|Withdrawal by Subject|0|||
160848002|NCT02714569|580831781|FG005|Part B (Overall)|Withdrawal by Subject|0|||
160848003|NCT02714569|580831782|FG006|Part B (Overall)|Withdrawal by Subject|0|||
160848004|NCT02714569|580831783|FG007|Part B (Overall)|Withdrawal by Subject|1|||
160848005|NCT02714569|580831784|FG008|Part B (Overall)|Withdrawal by Subject|0|||
160848006|NCT02714569|580831785|FG009|Part B (Overall)|Withdrawal by Subject|1|||
160848007|NCT02714569|580831786|FG010|Part B (Overall)|Withdrawal by Subject|0|||
160848008|NCT02714569|580831776|FG000|Part B (Overall)|Adverse Event|0|||
160848009|NCT02714569|580831777|FG001|Part B (Overall)|Adverse Event|0|||
160848010|NCT02714569|580831778|FG002|Part B (Overall)|Adverse Event|0|||
160848011|NCT02714569|580831779|FG003|Part B (Overall)|Adverse Event|0|||
160848012|NCT02714569|580831780|FG004|Part B (Overall)|Adverse Event|0|||
160848013|NCT02714569|580831781|FG005|Part B (Overall)|Adverse Event|0|||
160848014|NCT02714569|580831782|FG006|Part B (Overall)|Adverse Event|0|||
160848015|NCT02714569|580831783|FG007|Part B (Overall)|Adverse Event|0|||
160848016|NCT02714569|580831784|FG008|Part B (Overall)|Adverse Event|0|||
160848017|NCT02714569|580831785|FG009|Part B (Overall)|Adverse Event|1|||
160848018|NCT02714569|580831786|FG010|Part B (Overall)|Adverse Event|0|||
160568451|NCT01122927|579803902|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
160568452|NCT01122927|579803901|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
160568453|NCT01122927|579803902|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
160568454|NCT01122927|579803901|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
160568455|NCT01122927|579803902|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
160568456|NCT01122927|579803901|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
160568457|NCT01122927|579803902|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
160568458|NCT01244737|579803910|FG000|Overall Study|Physician Decision|2|||
160568459|NCT01244737|579803911|FG001|Overall Study|Physician Decision|18|||
160568460|NCT01244737|579803912|FG002|Overall Study|Physician Decision|5|||
160568461|NCT01244737|579803910|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
160568462|NCT01244737|579803911|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
160568463|NCT01244737|579803912|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
160568464|NCT01244737|579803910|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
160568465|NCT01244737|579803911|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
160568466|NCT01244737|579803912|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
160568467|NCT01244737|579803910|FG000|Overall Study|MIB immunopathology results not available|3|||
160568468|NCT01244737|579803911|FG001|Overall Study|MIB immunopathology results not available|2|||
160568469|NCT01244737|579803912|FG002|Overall Study|MIB immunopathology results not available|0|||
160568470|NCT01244737|579803910|FG000|Overall Study|PET data failure|0|||
160568471|NCT01244737|579803911|FG001|Overall Study|PET data failure|1|||
160568472|NCT01244737|579803912|FG002|Overall Study|PET data failure|0|||
160568473|NCT01244737|579803910|FG000|Overall Study|Withdrawal by Subject|0|||
160568474|NCT01244737|579803911|FG001|Overall Study|Withdrawal by Subject|0|||
160568475|NCT01244737|579803912|FG002|Overall Study|Withdrawal by Subject|1|||
160568476|NCT00356915|579803918|FG000|Overall Study|Non compliance|1|||
160568477|NCT00356915|579803919|FG001|Overall Study|Non compliance|2|||
160568478|NCT00356915|579803920|FG002|Overall Study|Non compliance|1|||
160568479|NCT00356915|579803918|FG000|Overall Study|Protocol Violation|2|||
160568480|NCT00356915|579803919|FG001|Overall Study|Protocol Violation|3|||
160848019|NCT04915729|580831787|FG000|Overall Study|Lost to Follow-up|20|||
160848020|NCT04915729|580831788|FG001|Overall Study|Lost to Follow-up|10|||
160848021|NCT04915729|580831787|FG000|Overall Study|Withdrawal by Subject|12|||
160848022|NCT04915729|580831788|FG001|Overall Study|Withdrawal by Subject|5|||
160848023|NCT04915729|580831787|FG000|Overall Study|Death|34|||
160848024|NCT04915729|580831788|FG001|Overall Study|Death|44|||
160848025|NCT04915729|580831787|FG000|Overall Study|not treated|3|||
160848026|NCT04915729|580831788|FG001|Overall Study|not treated|6|||
160906270|NCT01768286|581050391|FG002|Overall Study|Randomized But Not Treated|1|||
160906271|NCT01768286|581050392|FG003|Overall Study|Randomized But Not Treated|0|||
160906272|NCT01768286|581050389|FG000|Overall Study|Lack of Efficacy|7|||
160906273|NCT01768286|581050390|FG001|Overall Study|Lack of Efficacy|4|||
160906274|NCT01768286|581050391|FG002|Overall Study|Lack of Efficacy|0|||
160848027|NCT04915729|580831787|FG000|Overall Study|Investigator removed subject|1|||
160848028|NCT04915729|580831788|FG001|Overall Study|Investigator removed subject|2|||
160848029|NCT04915729|580831787|FG000|Overall Study|questionnaire result not evaluated|1|||
160848030|NCT04915729|580831788|FG001|Overall Study|questionnaire result not evaluated|0|||
160848031|NCT04915729|580831787|FG000|Overall Study|refuse of hospital visit|1|||
160848032|NCT04915729|580831788|FG001|Overall Study|refuse of hospital visit|3|||
160848033|NCT04915729|580831787|FG000|Overall Study|Subject withdrew|1|||
160848034|NCT04915729|580831788|FG001|Overall Study|Subject withdrew|0|||
160848035|NCT04961541|580831789|FG000|Overall Study|Adverse Event|0|||
160848036|NCT04961541|580831790|FG001|Overall Study|Adverse Event|0|||
160848037|NCT04961541|580831791|FG002|Overall Study|Adverse Event|0|||
160848038|NCT04961541|580831792|FG003|Overall Study|Adverse Event|0|||
160848039|NCT04961541|580831793|FG004|Overall Study|Adverse Event|0|||
160848040|NCT04961541|580831794|FG005|Overall Study|Adverse Event|1|||
160848041|NCT04961541|580831795|FG006|Overall Study|Adverse Event|0|||
160848042|NCT04961541|580831796|FG007|Overall Study|Adverse Event|0|||
160848043|NCT04961541|580831797|FG008|Overall Study|Adverse Event|0|||
160848044|NCT04961541|580831798|FG009|Overall Study|Adverse Event|0|||
160848045|NCT04961541|580831799|FG010|Overall Study|Adverse Event|0|||
160848046|NCT04961541|580831800|FG011|Overall Study|Adverse Event|0|||
160848047|NCT04961541|580831801|FG012|Overall Study|Adverse Event|0|||
160848048|NCT04961541|580831802|FG013|Overall Study|Adverse Event|0|||
160848049|NCT04961541|580831789|FG000|Overall Study|Lost to Follow-up|0|||
160848050|NCT04961541|580831790|FG001|Overall Study|Lost to Follow-up|0|||
160848051|NCT04961541|580831791|FG002|Overall Study|Lost to Follow-up|3|||
160848052|NCT04961541|580831792|FG003|Overall Study|Lost to Follow-up|0|||
160848053|NCT04961541|580831793|FG004|Overall Study|Lost to Follow-up|0|||
160848054|NCT04961541|580831794|FG005|Overall Study|Lost to Follow-up|0|||
160848055|NCT04961541|580831795|FG006|Overall Study|Lost to Follow-up|1|||
160848056|NCT04961541|580831796|FG007|Overall Study|Lost to Follow-up|1|||
160848057|NCT04961541|580831797|FG008|Overall Study|Lost to Follow-up|0|||
160848058|NCT04961541|580831798|FG009|Overall Study|Lost to Follow-up|1|||
160848059|NCT04961541|580831799|FG010|Overall Study|Lost to Follow-up|0|||
160848060|NCT04961541|580831800|FG011|Overall Study|Lost to Follow-up|0|||
160848061|NCT04961541|580831801|FG012|Overall Study|Lost to Follow-up|1|||
160848062|NCT04961541|580831802|FG013|Overall Study|Lost to Follow-up|0|||
160848063|NCT04961541|580831789|FG000|Overall Study|Withdrawal by Subject|0|||
160848064|NCT04961541|580831790|FG001|Overall Study|Withdrawal by Subject|0|||
160848065|NCT04961541|580831791|FG002|Overall Study|Withdrawal by Subject|1|||
160848066|NCT04961541|580831792|FG003|Overall Study|Withdrawal by Subject|1|||
160848067|NCT04961541|580831793|FG004|Overall Study|Withdrawal by Subject|0|||
160848068|NCT04961541|580831794|FG005|Overall Study|Withdrawal by Subject|0|||
160848069|NCT04961541|580831795|FG006|Overall Study|Withdrawal by Subject|0|||
160848070|NCT04961541|580831796|FG007|Overall Study|Withdrawal by Subject|0|||
160848071|NCT04961541|580831797|FG008|Overall Study|Withdrawal by Subject|0|||
160848072|NCT04961541|580831798|FG009|Overall Study|Withdrawal by Subject|1|||
160848073|NCT04961541|580831799|FG010|Overall Study|Withdrawal by Subject|0|||
160848074|NCT04961541|580831800|FG011|Overall Study|Withdrawal by Subject|0|||
160848075|NCT04961541|580831801|FG012|Overall Study|Withdrawal by Subject|0|||
160848076|NCT04961541|580831802|FG013|Overall Study|Withdrawal by Subject|0|||
160848077|NCT01684202|580831803|FG000|Dose-escalation Period|Adverse Event|0|||
160848078|NCT01684202|580831804|FG001|Dose-escalation Period|Adverse Event|1|||
160848079|NCT01684202|580831805|FG002|Dose-escalation Period|Adverse Event|0|||
160848080|NCT01684202|580831806|FG003|Dose-escalation Period|Adverse Event|0|||
160848081|NCT01684202|580831803|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
160848082|NCT01684202|580831804|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
160848083|NCT01684202|580831805|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
160848084|NCT01684202|580831806|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
160848085|NCT01684202|580831803|FG000|Maintenance Period|Adverse Event|1|||
160848086|NCT01684202|580831804|FG001|Maintenance Period|Adverse Event|1|||
160848087|NCT01684202|580831805|FG002|Maintenance Period|Adverse Event|1|||
160848088|NCT01684202|580831806|FG003|Maintenance Period|Adverse Event|1|||
160848089|NCT01684202|580831803|FG000|Maintenance Period|Physician Decision|0|||
160848090|NCT01684202|580831804|FG001|Maintenance Period|Physician Decision|1|||
160848091|NCT01684202|580831805|FG002|Maintenance Period|Physician Decision|0|||
160848092|NCT01684202|580831806|FG003|Maintenance Period|Physician Decision|0|||
160848093|NCT01684202|580831803|FG000|Maintenance Period|Withdrawal by Subject|0|||
160848094|NCT01684202|580831804|FG001|Maintenance Period|Withdrawal by Subject|1|||
160848095|NCT01684202|580831805|FG002|Maintenance Period|Withdrawal by Subject|0|||
160848096|NCT01684202|580831806|FG003|Maintenance Period|Withdrawal by Subject|0|||
160848097|NCT00191308|580831807|FG000|Overall Study|Adverse Event|1|||
160848098|NCT00466921|580831808|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
160848099|NCT00466921|580831808|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
160848100|NCT00466921|580831808|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
160848101|NCT00466921|580831808|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
160848102|NCT00466921|580831808|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
160848103|NCT00466921|580831808|FG000|Follow up for a Minimum of 1 Year|Death|6|||
160848104|NCT00779025|580831809|FG000|Overall Study|Withdrawal by Subject|1|||
160848105|NCT03305770|580831810|FG000|Overall Study|Physician Decision - prior to dispense|0|||
160848106|NCT03305770|580831811|FG001|Overall Study|Physician Decision - prior to dispense|1|||
160848107|NCT03305770|580831810|FG000|Overall Study|Subject moved|1|||
160848108|NCT03305770|580831811|FG001|Overall Study|Subject moved|0|||
160848109|NCT03539601|580831812|FG000|Overall Study|Withdraw by parent/guardian|1|||
160848110|NCT03539601|580831813|FG001|Overall Study|Withdraw by parent/guardian|0|||
160848111|NCT03539601|580831814|FG002|Overall Study|Withdraw by parent/guardian|1|||
160848112|NCT03539601|580831815|FG003|Overall Study|Withdraw by parent/guardian|0|||
160848113|NCT03539601|580831812|FG000|Overall Study|Adverse Event|0|||
160848114|NCT03539601|580831813|FG001|Overall Study|Adverse Event|2|||
160848115|NCT03539601|580831814|FG002|Overall Study|Adverse Event|0|||
160848116|NCT03539601|580831815|FG003|Overall Study|Adverse Event|0|||
160848117|NCT03539601|580831812|FG000|Overall Study|Lost to Follow-up|2|||
160848118|NCT03539601|580831813|FG001|Overall Study|Lost to Follow-up|4|||
160848119|NCT03539601|580831814|FG002|Overall Study|Lost to Follow-up|5|||
160848120|NCT03539601|580831815|FG003|Overall Study|Lost to Follow-up|0|||
160848121|NCT03539601|580831812|FG000|Overall Study|Withdrawal by Subject|2|||
160848122|NCT03539601|580831813|FG001|Overall Study|Withdrawal by Subject|0|||
160848123|NCT03539601|580831814|FG002|Overall Study|Withdrawal by Subject|0|||
160848124|NCT03539601|580831815|FG003|Overall Study|Withdrawal by Subject|1|||
160848125|NCT03539601|580831812|FG000|Overall Study|Randomized but not treated|1|||
160848126|NCT03539601|580831813|FG001|Overall Study|Randomized but not treated|1|||
160848127|NCT03539601|580831814|FG002|Overall Study|Randomized but not treated|0|||
160848128|NCT03539601|580831815|FG003|Overall Study|Randomized but not treated|0|||
160568481|NCT00356915|579803920|FG002|Overall Study|Protocol Violation|2|||
160568482|NCT00356915|579803918|FG000|Overall Study|Withdrawal by Subject|14|||
160568483|NCT00356915|579803919|FG001|Overall Study|Withdrawal by Subject|14|||
160568484|NCT00356915|579803920|FG002|Overall Study|Withdrawal by Subject|10|||
160568485|NCT00356915|579803918|FG000|Overall Study|Lack of Efficacy|0|||
160568486|NCT00356915|579803919|FG001|Overall Study|Lack of Efficacy|0|||
160568487|NCT00356915|579803920|FG002|Overall Study|Lack of Efficacy|3|||
160848129|NCT03710642|580831816|FG000|Overall Study|Adverse Event|5|||
160848130|NCT03710642|580831817|FG001|Overall Study|Adverse Event|1|||
160848131|NCT03710642|580831816|FG000|Overall Study|non-site physician recommendation|1|||
160848132|NCT03710642|580831817|FG001|Overall Study|non-site physician recommendation|0|||
160568488|NCT00356915|579803918|FG000|Overall Study|Lost to Follow-up|27|||
160568489|NCT00356915|579803919|FG001|Overall Study|Lost to Follow-up|34|||
160848133|NCT03710642|580831816|FG000|Overall Study|Participant unwilling or unable to participate|1|||
160848134|NCT03710642|580831817|FG001|Overall Study|Participant unwilling or unable to participate|1|||
160568490|NCT00356915|579803920|FG002|Overall Study|Lost to Follow-up|14|||
160568491|NCT00356915|579803918|FG000|Overall Study|Administrative Decision|0|||
160568492|NCT00356915|579803919|FG001|Overall Study|Administrative Decision|0|||
160568493|NCT00356915|579803920|FG002|Overall Study|Administrative Decision|1|||
160568494|NCT00356915|579803918|FG000|Overall Study|Physician Decision|0|||
160848135|NCT03710642|580831816|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
160568495|NCT00356915|579803919|FG001|Overall Study|Physician Decision|2|||
160568496|NCT00356915|579803920|FG002|Overall Study|Physician Decision|0|||
160568497|NCT00356915|579803918|FG000|Overall Study|Adverse Event|21|||
160848136|NCT03710642|580831817|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
160848137|NCT03710642|580831816|FG000|Overall Study|NA-no code provided|1|||
160848138|NCT03710642|580831817|FG001|Overall Study|NA-no code provided|0|||
160848139|NCT03710642|580831816|FG000|Overall Study|Withdrawal by Subject|1|||
160848140|NCT03710642|580831817|FG001|Overall Study|Withdrawal by Subject|0|||
160848141|NCT00226811|580831818|FG000|Overall Study|Death|8|||
160848142|NCT00226811|580831818|FG000|Overall Study|Adverse Event|11|||
160848143|NCT00226811|580831818|FG000|Overall Study|Lack of Efficacy|55|||
160848144|NCT00226811|580831818|FG000|Overall Study|Withdrawal by Subject|2|||
160848145|NCT01633541|580831822|FG000|Overall Study|Death|1|||
160848146|NCT01633541|580831823|FG001|Overall Study|Death|0|||
160848147|NCT01010971|580831824|FG000|Overall Study|Adverse Event|2|||
160848148|NCT01010971|580831825|FG001|Overall Study|Adverse Event|4|||
160848149|NCT01010971|580831826|FG002|Overall Study|Adverse Event|3|||
160848150|NCT01010971|580831824|FG000|Overall Study|Withdrawal by Subject|0|||
160848151|NCT01010971|580831825|FG001|Overall Study|Withdrawal by Subject|2|||
160848152|NCT01010971|580831826|FG002|Overall Study|Withdrawal by Subject|5|||
160848153|NCT01010971|580831824|FG000|Overall Study|Lost to Follow-up|0|||
160848154|NCT01010971|580831825|FG001|Overall Study|Lost to Follow-up|2|||
160848155|NCT01010971|580831826|FG002|Overall Study|Lost to Follow-up|3|||
160848156|NCT01010971|580831824|FG000|Overall Study|Other|1|||
160848157|NCT01010971|580831825|FG001|Overall Study|Other|0|||
160848158|NCT01010971|580831826|FG002|Overall Study|Other|2|||
160848159|NCT00773513|580831828|FG000|Overall Study|Renal Transplant|254|||
160848160|NCT00773513|580831829|FG001|Overall Study|Renal Transplant|263|||
160848161|NCT00773513|580831828|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
160848162|NCT00773513|580831829|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
160848163|NCT00773513|580831828|FG000|Overall Study|Withdrew Consent|68|||
160848164|NCT00773513|580831829|FG001|Overall Study|Withdrew Consent|69|||
160848165|NCT00773513|580831828|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
160848166|NCT00773513|580831829|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
160848167|NCT00773513|580831828|FG000|Overall Study|Failure to Return|22|||
160848168|NCT00773513|580831829|FG001|Overall Study|Failure to Return|8|||
160848169|NCT00773513|580831828|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160848170|NCT00773513|580831829|FG001|Overall Study|Insufficient Therapeutic Response|18|||
160848171|NCT00773513|580831828|FG000|Overall Study|Reason Not Specified|159|||
160848172|NCT00773513|580831829|FG001|Overall Study|Reason Not Specified|126|||
160848173|NCT00773513|580831828|FG000|Overall Study|Death|531|||
160848174|NCT00773513|580831829|FG001|Overall Study|Death|545|||
160848175|NCT00700713|580831830|FG000|Overall Study|Protocol Violation|1|||
160848176|NCT00700713|580831831|FG001|Overall Study|Protocol Violation|0|||
160848177|NCT00700713|580831832|FG002|Overall Study|Protocol Violation|1|||
160848178|NCT00700713|580831830|FG000|Overall Study|Withdrawal by Subject|0|||
160848179|NCT00700713|580831831|FG001|Overall Study|Withdrawal by Subject|0|||
160848180|NCT00700713|580831832|FG002|Overall Study|Withdrawal by Subject|1|||
160848181|NCT02330055|580831834|FG000|Overall Study|technical issues|2|||
160848182|NCT02330055|580831835|FG001|Overall Study|technical issues|0|||
160848183|NCT02330055|580831834|FG000|Overall Study|participant forgot to wear device|5|||
160848184|NCT02330055|580831835|FG001|Overall Study|participant forgot to wear device|5|||
160848185|NCT02330055|580831834|FG000|Overall Study|data for less than 60 minutes|3|||
160848186|NCT02330055|580831835|FG001|Overall Study|data for less than 60 minutes|3|||
160848187|NCT02330055|580831834|FG000|Overall Study|participant did not sleep|0|||
160848188|NCT02330055|580831835|FG001|Overall Study|participant did not sleep|1|||
160848189|NCT05729568|580831837|FG000|Overall Study|Still on Study|52|||
160848190|NCT05729568|580831838|FG001|Overall Study|Still on Study|26|||
160568498|NCT00356915|579803919|FG001|Overall Study|Adverse Event|31|||
160568499|NCT00356915|579803920|FG002|Overall Study|Adverse Event|8|||
160568500|NCT00356915|579803918|FG000|Overall Study|Miscellaneous reasons|11|||
160568501|NCT00356915|579803919|FG001|Overall Study|Miscellaneous reasons|8|||
160848191|NCT05729568|580831837|FG000|Overall Study|Randomized but Never Treated|3|||
160848192|NCT05729568|580831838|FG001|Overall Study|Randomized but Never Treated|0|||
160848193|NCT05729568|580831837|FG000|Overall Study|Adverse Event|0|||
160848194|NCT05729568|580831838|FG001|Overall Study|Adverse Event|1|||
160848195|NCT05729568|580831837|FG000|Overall Study|Investigator's Discretion|1|||
160848196|NCT05729568|580831838|FG001|Overall Study|Investigator's Discretion|0|||
160848197|NCT00550953|580831839|FG000|Overall Study|Adverse Event|4|||
160568502|NCT00356915|579803920|FG002|Overall Study|Miscellaneous reasons|3|||
160848198|NCT00550953|580831840|FG001|Overall Study|Adverse Event|3|||
160848199|NCT00550953|580831839|FG000|Overall Study|Not able to visit the site|2|||
160848200|NCT00550953|580831840|FG001|Overall Study|Not able to visit the site|3|||
160848201|NCT02728089|580831841|FG000|Overall Study|Physician Decision|2|||
160848202|NCT02728089|580831841|FG000|Overall Study|Withdrawal by Subject|1|||
160568503|NCT02371629|579803929|FG000|Overall Study|Patient decision|14|||
160568504|NCT02371629|579803930|FG001|Overall Study|Patient decision|10|||
160568505|NCT02371629|579803929|FG000|Overall Study|Adverse Event|8|||
160568506|NCT02371629|579803930|FG001|Overall Study|Adverse Event|8|||
160568507|NCT02371629|579803929|FG000|Overall Study|Physician Decision|2|||
160568508|NCT02371629|579803930|FG001|Overall Study|Physician Decision|3|||
160568509|NCT02371629|579803929|FG000|Overall Study|Death|1|||
160568510|NCT02371629|579803930|FG001|Overall Study|Death|1|||
160848203|NCT01221350|580831842|FG000|Overall Study|Discontinued intervention (GERD)|1|||
160848204|NCT01221350|580831843|FG001|Overall Study|Discontinued intervention (GERD)|0|||
160848205|NCT01221350|580831842|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
160848206|NCT01221350|580831843|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
160848207|NCT01221350|580831842|FG000|Overall Study|Withdrawal by Subject|4|||
160848208|NCT01221350|580831843|FG001|Overall Study|Withdrawal by Subject|2|||
160848209|NCT04739436|580831846|FG000|Overall Study|Lost to Follow-up|21|||
160848210|NCT04739436|580831847|FG001|Overall Study|Lost to Follow-up|23|||
160848211|NCT04739436|580831846|FG000|Overall Study|Withdrawal by Subject|4|||
160848212|NCT04739436|580831847|FG001|Overall Study|Withdrawal by Subject|6|||
160848213|NCT04739436|580831846|FG000|Overall Study|not randomized properly|1|||
160848214|NCT04739436|580831847|FG001|Overall Study|not randomized properly|0|||
160848215|NCT02915978|580831851|FG000|Overall Study|Adverse Event|2|||
160848216|NCT02915978|580831852|FG001|Overall Study|Adverse Event|1|||
160848217|NCT02915978|580831853|FG002|Overall Study|Adverse Event|0|||
160848218|NCT02119663|580831858|FG000|Overall Study|Disease progression|26|||
160848219|NCT02119663|580831859|FG001|Overall Study|Disease progression|27|||
160848220|NCT02119663|580831858|FG000|Overall Study|Adverse Event|5|||
160848221|NCT02119663|580831859|FG001|Overall Study|Adverse Event|5|||
160848222|NCT02119663|580831858|FG000|Overall Study|Death|3|||
160848223|NCT02119663|580831859|FG001|Overall Study|Death|2|||
160848224|NCT02119663|580831858|FG000|Overall Study|Physician Decision|1|||
160848225|NCT02119663|580831859|FG001|Overall Study|Physician Decision|2|||
160848226|NCT02119663|580831858|FG000|Overall Study|Other unspecified|2|||
160848227|NCT02119663|580831859|FG001|Overall Study|Other unspecified|0|||
160848228|NCT02119663|580831858|FG000|Overall Study|Subject decision|0|||
160848229|NCT02119663|580831859|FG001|Overall Study|Subject decision|1|||
160848230|NCT02119663|580831858|FG000|Overall Study|Study Terminated by the Sponsor|3|||
160848231|NCT02119663|580831859|FG001|Overall Study|Study Terminated by the Sponsor|4|||
160848232|NCT01248949|580831860|FG000|Overall Study|Lost to Follow-up|2|||
160848233|NCT01248949|580831861|FG001|Overall Study|Lost to Follow-up|2|||
160848234|NCT01248949|580831862|FG002|Overall Study|Lost to Follow-up|2|||
160848235|NCT01248949|580831863|FG003|Overall Study|Lost to Follow-up|1|||
160848236|NCT01248949|580831864|FG004|Overall Study|Lost to Follow-up|0|||
160848237|NCT01248949|580831860|FG000|Overall Study|Withdrawal by Subject|5|||
160848238|NCT01248949|580831861|FG001|Overall Study|Withdrawal by Subject|3|||
160848239|NCT01248949|580831862|FG002|Overall Study|Withdrawal by Subject|11|||
160848240|NCT01248949|580831863|FG003|Overall Study|Withdrawal by Subject|3|||
160848241|NCT01248949|580831864|FG004|Overall Study|Withdrawal by Subject|1|||
160848242|NCT01248949|580831860|FG000|Overall Study|Death|22|||
160848243|NCT01248949|580831861|FG001|Overall Study|Death|7|||
160848244|NCT01248949|580831862|FG002|Overall Study|Death|21|||
160848245|NCT01248949|580831863|FG003|Overall Study|Death|6|||
160848246|NCT01248949|580831864|FG004|Overall Study|Death|2|||
160848247|NCT01248949|580831860|FG000|Overall Study|Alternative Therapy|1|||
160848248|NCT01248949|580831861|FG001|Overall Study|Alternative Therapy|0|||
160848249|NCT01248949|580831862|FG002|Overall Study|Alternative Therapy|0|||
160848250|NCT01248949|580831863|FG003|Overall Study|Alternative Therapy|0|||
160848251|NCT01248949|580831864|FG004|Overall Study|Alternative Therapy|0|||
160568511|NCT02371629|579803929|FG000|Overall Study|Noncompliance with study treatment|1|||
160568512|NCT02371629|579803930|FG001|Overall Study|Noncompliance with study treatment|0|||
160568513|NCT02371629|579803929|FG000|Overall Study|Lack of Efficacy|0|||
160848252|NCT01248949|580831860|FG000|Overall Study|Alternative Therapy.|1|||
160848253|NCT01248949|580831861|FG001|Overall Study|Alternative Therapy.|0|||
160848254|NCT01248949|580831862|FG002|Overall Study|Alternative Therapy.|0|||
160848255|NCT01248949|580831863|FG003|Overall Study|Alternative Therapy.|0|||
160848256|NCT01248949|580831864|FG004|Overall Study|Alternative Therapy.|0|||
160848257|NCT01248949|580831860|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
160848258|NCT01248949|580831861|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
160848259|NCT01248949|580831862|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
160848260|NCT01248949|580831863|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
160848261|NCT01248949|580831864|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
160848262|NCT01248949|580831860|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
160848263|NCT01248949|580831861|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
160848264|NCT01248949|580831862|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
160848265|NCT01248949|580831863|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
160848266|NCT01248949|580831864|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
160848267|NCT01248949|580831860|FG000|Overall Study|Participant Went To Hospice|0|||
160848268|NCT01248949|580831861|FG001|Overall Study|Participant Went To Hospice|0|||
160848269|NCT01248949|580831862|FG002|Overall Study|Participant Went To Hospice|1|||
160848270|NCT01248949|580831863|FG003|Overall Study|Participant Went To Hospice|0|||
160848271|NCT01248949|580831864|FG004|Overall Study|Participant Went To Hospice|0|||
160848272|NCT01248949|580831860|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
160848273|NCT01248949|580831861|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
160848274|NCT01248949|580831862|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
160848275|NCT01248949|580831863|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
160848276|NCT01248949|580831864|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
160848277|NCT01248949|580831860|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
160848278|NCT01248949|580831861|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
160848279|NCT01248949|580831862|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
160848280|NCT01248949|580831863|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
160848281|NCT01248949|580831864|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
160848282|NCT01248949|580831860|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
160848283|NCT01248949|580831861|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
160848284|NCT01248949|580831862|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
160848285|NCT01248949|580831863|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
160848286|NCT01248949|580831864|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
160848287|NCT01248949|580831860|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
160848288|NCT01248949|580831861|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
160848289|NCT01248949|580831862|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
160848290|NCT01248949|580831863|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
160848291|NCT01248949|580831864|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
160848292|NCT03245775|580831867|FG000|Overall Study|Lost to Follow-up|25|||
160848293|NCT03245775|580831868|FG001|Overall Study|Lost to Follow-up|26|||
160848294|NCT03245775|580831869|FG002|Overall Study|Lost to Follow-up|16|||
160848295|NCT03245775|580831870|FG003|Overall Study|Lost to Follow-up|16|||
160906275|NCT01768286|581050392|FG003|Overall Study|Lack of Efficacy|1|||
160906276|NCT01768286|581050389|FG000|Overall Study|Withdrew Consent|0|||
160906277|NCT01768286|581050390|FG001|Overall Study|Withdrew Consent|0|||
160906278|NCT01768286|581050391|FG002|Overall Study|Withdrew Consent|1|||
160906279|NCT01768286|581050392|FG003|Overall Study|Withdrew Consent|0|||
160906280|NCT03344796|581050393|FG000|Overall Study|Lost to Follow-up|0|||
160906281|NCT03344796|581050394|FG001|Overall Study|Lost to Follow-up|0|||
160906282|NCT03344796|581050395|FG002|Overall Study|Lost to Follow-up|0|||
160906283|NCT03344796|581050396|FG003|Overall Study|Lost to Follow-up|0|||
160906284|NCT03344796|581050397|FG004|Overall Study|Lost to Follow-up|0|||
160906285|NCT03344796|581050398|FG005|Overall Study|Lost to Follow-up|2|||
160906286|NCT04066023|581050400|FG000|Overall Study|Adverse Event|0|||
160906287|NCT04066023|581050401|FG001|Overall Study|Adverse Event|0|||
160906288|NCT04066023|581050402|FG002|Overall Study|Adverse Event|1|||
160906289|NCT04066023|581050400|FG000|Overall Study|Sponsor decision|3|||
160906290|NCT04066023|581050401|FG001|Overall Study|Sponsor decision|6|||
160906291|NCT04066023|581050402|FG002|Overall Study|Sponsor decision|2|||
160906292|NCT04066023|581050400|FG000|Overall Study|Physician Decision|0|||
160906293|NCT04066023|581050401|FG001|Overall Study|Physician Decision|0|||
160906294|NCT04066023|581050402|FG002|Overall Study|Physician Decision|1|||
160906295|NCT04066023|581050400|FG000|Overall Study|Lost to Follow-up|0|||
160906296|NCT04066023|581050401|FG001|Overall Study|Lost to Follow-up|1|||
160906297|NCT04066023|581050402|FG002|Overall Study|Lost to Follow-up|1|||
160906298|NCT04066023|581050400|FG000|Overall Study|Noncompliance|0|||
160906299|NCT04066023|581050401|FG001|Overall Study|Noncompliance|1|||
160906300|NCT04066023|581050402|FG002|Overall Study|Noncompliance|1|||
160906301|NCT03338010|581050404|FG000|Overall Study|Withdrawal by Subject|14|||
160906302|NCT03338010|581050405|FG001|Overall Study|Withdrawal by Subject|8|||
160906303|NCT03338010|581050404|FG000|Overall Study|Lost to Follow-up|4|||
160906304|NCT03338010|581050405|FG001|Overall Study|Lost to Follow-up|2|||
160650439|NCT03211416|580101569|FG000|Overall Study|Physician Decision|1|||
160906305|NCT03338010|581050404|FG000|Overall Study|Adverse Event|3|||
160906306|NCT03338010|581050405|FG001|Overall Study|Adverse Event|2|||
160906307|NCT03338010|581050404|FG000|Overall Study|Physician Decision|2|||
160906308|NCT03338010|581050405|FG001|Overall Study|Physician Decision|2|||
160848296|NCT01099397|580831872|FG000|Overall Study|Lost to Follow-up|4|||
160906309|NCT03338010|581050404|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160906310|NCT03338010|581050405|FG001|Overall Study|Non-Compliance with Study Drug|3|||
160906311|NCT03338010|581050404|FG000|Overall Study|Protocol Violation|0|||
160906312|NCT03338010|581050405|FG001|Overall Study|Protocol Violation|1|||
160848297|NCT01099397|580831872|FG000|Overall Study|Protocol Violation|4|||
160848298|NCT01099397|580831872|FG000|Overall Study|Withdrawal by Subject|5|||
160848299|NCT02363959|580831873|FG000|Overall Study|Medical instability|1|||
160848300|NCT02363959|580831874|FG001|Overall Study|Medical instability|0|||
160848301|NCT00950248|580831877|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
160848302|NCT00950248|580831878|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
160848303|NCT00950248|580831879|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
160848304|NCT00950248|580831877|FG000|Year 1: Baseline|worsening of symptoms|2|||
160848305|NCT00950248|580831878|FG001|Year 1: Baseline|worsening of symptoms|0|||
160848306|NCT00950248|580831879|FG002|Year 1: Baseline|worsening of symptoms|0|||
160848307|NCT00950248|580831877|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
160848308|NCT00950248|580831878|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
160848309|NCT00950248|580831879|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
160848310|NCT00950248|580831877|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
160848311|NCT00950248|580831878|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
160848312|NCT00950248|580831879|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
160848313|NCT00950248|580831877|FG000|Year 2&3 Treatment Randomization|Death|0|||
160848314|NCT00950248|580831878|FG001|Year 2&3 Treatment Randomization|Death|0|||
160848315|NCT00950248|580831879|FG002|Year 2&3 Treatment Randomization|Death|1|||
160848316|NCT00950248|580831877|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
160848317|NCT00950248|580831878|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
160848318|NCT00950248|580831879|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
160848319|NCT00650845|580831884|FG000|Overall Study|Withdrawal by Subject|5|||
160848320|NCT00650845|580831885|FG001|Overall Study|Withdrawal by Subject|0|||
160848321|NCT00650845|580831884|FG000|Overall Study|Protocol Violation|0|||
160848322|NCT00650845|580831885|FG001|Overall Study|Protocol Violation|13|||
160848323|NCT01900652|580831886|FG000|Overall Study|Progressive Disease|1|||
160848324|NCT01900652|580831887|FG001|Overall Study|Progressive Disease|0|||
160848325|NCT01900652|580831886|FG000|Overall Study|Consent withdrawn by subject|1|||
160848326|NCT01900652|580831887|FG001|Overall Study|Consent withdrawn by subject|1|||
160848327|NCT01900652|580831886|FG000|Overall Study|Death|3|||
160848328|NCT01900652|580831887|FG001|Overall Study|Death|0|||
160848329|NCT01900652|580831886|FG000|Overall Study|Adverse Event|2|||
160848330|NCT01900652|580831887|FG001|Overall Study|Adverse Event|1|||
160848331|NCT01900652|580831886|FG000|Overall Study|Physician Decision|1|||
160848332|NCT01900652|580831887|FG001|Overall Study|Physician Decision|1|||
160848333|NCT01479868|580833701|FG000|Overall Study|Adverse Event|1|||
160848334|NCT01479868|580833701|FG000|Overall Study|Lost to Follow-up|4|||
160848335|NCT01479868|580833701|FG000|Overall Study|Protocol Violation|1|||
160848336|NCT01479868|580833701|FG000|Overall Study|Withdrawal by Subject|1|||
160848337|NCT01479868|580833701|FG000|Overall Study|Sponsor's Decision|1|||
160848338|NCT01479868|580833701|FG000|Overall Study|Initiation of new HCV Therapy|1|||
160848339|NCT01618669|580833702|FG000|Overall Study|Lost to Follow-up|1|||
160848340|NCT01618669|580833703|FG001|Overall Study|Lost to Follow-up|1|||
160848341|NCT01618669|580833702|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
160848342|NCT01618669|580833703|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
160848343|NCT01618669|580833702|FG000|Overall Study|Adverse Event|16|||
160848344|NCT01618669|580833703|FG001|Overall Study|Adverse Event|7|||
160848345|NCT01618669|580833702|FG000|Overall Study|Protocol Violation|5|||
160848346|NCT01618669|580833703|FG001|Overall Study|Protocol Violation|3|||
160848347|NCT01618669|580833702|FG000|Overall Study|Withdrawal by Subject|9|||
160848348|NCT01618669|580833703|FG001|Overall Study|Withdrawal by Subject|9|||
160848349|NCT01618669|580833702|FG000|Overall Study|Miscellaneous Reason|0|||
160848350|NCT01618669|580833703|FG001|Overall Study|Miscellaneous Reason|1|||
160848351|NCT01508169|580833707|FG000|Overall Study|Adverse Event|1|||
160848352|NCT01508169|580833708|FG001|Overall Study|Adverse Event|0|||
160848353|NCT01508169|580833707|FG000|Overall Study|Withdrawal by Subject|1|||
160848354|NCT01508169|580833708|FG001|Overall Study|Withdrawal by Subject|0|||
160848355|NCT01508169|580833707|FG000|Overall Study|Lost to Follow-up|1|||
160848356|NCT01508169|580833708|FG001|Overall Study|Lost to Follow-up|2|||
160906313|NCT00293033|581050410|FG000|Open-label Titration Period|Adverse Event|10|||
160906314|NCT00293033|581050410|FG000|Open-label Titration Period|Death|3|||
160848357|NCT03600740|580833713|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
160906315|NCT00293033|581050410|FG000|Open-label Titration Period|Lack of Efficacy|5|||
160906316|NCT00293033|581050410|FG000|Open-label Titration Period|Protocol Violation|2|||
160906317|NCT00293033|581050410|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
160906318|NCT00293033|581050410|FG000|Open-label Titration Period|Noncompliance and other|27|||
160906319|NCT00293033|581050410|FG000|Double-blind Treatment Period|Adverse Event|3|||
160848358|NCT02336230|580833718|FG000|Overall Study|Adverse Event|1|||
160848359|NCT02336230|580833718|FG000|Overall Study|Withdrawal of consent|1|||
160848360|NCT02336230|580833718|FG000|Overall Study|Death|9|||
160848361|NCT02336230|580833718|FG000|Overall Study|Dose not received due to shipping delay|1|||
160848362|NCT02336230|580833718|FG000|Overall Study|Discontinuation of MSC infusion|1|||
160848363|NCT01620086|580833723|FG000|Overall Study|Withdrawal by Subject|3|||
160906320|NCT00293033|581050410|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
160848364|NCT01620086|580833724|FG001|Overall Study|Withdrawal by Subject|3|||
160848365|NCT01620086|580833725|FG002|Overall Study|Withdrawal by Subject|0|||
160848366|NCT01620086|580833723|FG000|Overall Study|failed study criteria|1|||
160848367|NCT01620086|580833724|FG001|Overall Study|failed study criteria|4|||
160848368|NCT01620086|580833725|FG002|Overall Study|failed study criteria|0|||
160848369|NCT01620086|580833723|FG000|Overall Study|Physician Decision|1|||
160848370|NCT01620086|580833724|FG001|Overall Study|Physician Decision|0|||
160848371|NCT01620086|580833725|FG002|Overall Study|Physician Decision|0|||
160848372|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Progressive disease|50|||
160848373|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Progressive disease|110|||
160848374|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Progressive disease|0|||
160848375|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Progressive disease|0|||
160848376|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
160848377|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
160848378|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160848379|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160848380|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Adverse Event|7|||
160848381|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Adverse Event|7|||
160848382|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Adverse Event|0|||
160848383|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Adverse Event|0|||
160848384|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Other|1|||
160848385|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Other|3|||
160848386|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Other|0|||
160848387|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Other|0|||
160848388|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Physician Decision|6|||
160848389|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Physician Decision|3|||
160848390|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Physician Decision|0|||
160848391|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Physician Decision|0|||
160848392|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Death|1|||
160848393|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Death|1|||
160848394|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Death|0|||
160848395|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Death|0|||
160848396|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
160848397|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
160848398|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
160848399|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
160848400|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
160906321|NCT00293033|581050410|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
160906322|NCT00293033|581050410|FG000|Double-blind Treatment Period|Noncompliance|4|||
160906323|NCT00629707|581050411|FG000|Overall Study|Withdrawal by Subject|0|||
160906324|NCT00629707|581050412|FG001|Overall Study|Withdrawal by Subject|1|||
160906325|NCT00629707|581050411|FG000|Overall Study|Physician Decision|0|||
160906326|NCT00629707|581050412|FG001|Overall Study|Physician Decision|1|||
160906327|NCT00453063|581050413|FG000|Overall Study|Adverse Event|1|||
160906328|NCT00453063|581050414|FG001|Overall Study|Adverse Event|2|||
160906329|NCT00453063|581050413|FG000|Overall Study|Withdrawal by Subject|1|||
160906330|NCT00453063|581050414|FG001|Overall Study|Withdrawal by Subject|1|||
160906331|NCT00453063|581050413|FG000|Overall Study|Protocol Violation|1|||
160906332|NCT00453063|581050414|FG001|Overall Study|Protocol Violation|0|||
160906333|NCT00365508|581050415|FG000|Overall Study|Lost to Follow-up|139|||
160906334|NCT00365508|581050416|FG001|Overall Study|Lost to Follow-up|154|||
160906335|NCT04094883|581050417|FG000|Overall Study|Withdrawal by Subject|1|||
160906336|NCT00837811|581050419|FG000|Overall Study|Adverse Event|4|||
160906337|NCT00837811|581050420|FG001|Overall Study|Adverse Event|6|||
160906338|NCT00837811|581050421|FG002|Overall Study|Adverse Event|0|||
160906339|NCT00837811|581050419|FG000|Overall Study|Death|1|||
160906340|NCT00837811|581050420|FG001|Overall Study|Death|1|||
160906341|NCT00837811|581050421|FG002|Overall Study|Death|0|||
160906342|NCT00837811|581050419|FG000|Overall Study|Lack of Efficacy|0|||
160906343|NCT00837811|581050420|FG001|Overall Study|Lack of Efficacy|11|||
160906344|NCT00837811|581050421|FG002|Overall Study|Lack of Efficacy|0|||
160906345|NCT00837811|581050419|FG000|Overall Study|Lost to Follow-up|1|||
160906346|NCT00837811|581050420|FG001|Overall Study|Lost to Follow-up|3|||
160906347|NCT00837811|581050421|FG002|Overall Study|Lost to Follow-up|0|||
160848401|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
160848402|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
160568514|NCT02371629|579803930|FG001|Overall Study|Lack of Efficacy|2|||
160568515|NCT02371629|579803929|FG000|Overall Study|Protocol deviation|0|||
160568516|NCT02371629|579803930|FG001|Overall Study|Protocol deviation|1|||
160906348|NCT00837811|581050419|FG000|Overall Study|Physician Decision|0|||
160906349|NCT00837811|581050420|FG001|Overall Study|Physician Decision|2|||
160906350|NCT00837811|581050421|FG002|Overall Study|Physician Decision|1|||
160906351|NCT00837811|581050419|FG000|Overall Study|Withdrawal by Subject|1|||
160906352|NCT00837811|581050420|FG001|Overall Study|Withdrawal by Subject|9|||
160848403|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
160848404|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
160848405|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
160848406|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
160848407|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
160848408|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
160848409|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
160848410|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
160848411|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
160848412|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Other|0|||
160848413|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Other|0|||
160848414|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Other|4|||
160848415|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Other|7|||
160848416|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
160848417|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
160848418|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
160848419|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
160848420|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Death|0|||
160848421|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Death|0|||
160848422|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Death|2|||
160848423|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Death|7|||
160848424|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
160848425|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
160848426|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
160848427|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
160848428|NCT00580723|580833735|FG000|Overall Study|Did not want to participate in extension|3|||
160848429|NCT00580723|580833735|FG000|Overall Study|Lost to Follow-up|5|||
160848430|NCT00684996|580833736|FG000|Overall Study|Adverse Event|1|||
160906353|NCT00837811|581050421|FG002|Overall Study|Withdrawal by Subject|0|||
160906354|NCT00837811|581050419|FG000|Overall Study|Sponsor Decision|0|||
160906355|NCT00837811|581050420|FG001|Overall Study|Sponsor Decision|2|||
160650440|NCT03199274|580101570|FG000|Overall Study|Withdrawal by Subject|4|||
160650441|NCT03199274|580101571|FG001|Overall Study|Withdrawal by Subject|0|||
160650442|NCT03199274|580101570|FG000|Overall Study|Lost to Follow-up|0|||
160650443|NCT03199274|580101571|FG001|Overall Study|Lost to Follow-up|1|||
160650444|NCT03199274|580101570|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
160650445|NCT03199274|580101571|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
160650446|NCT00656019|580101574|FG000|Overall Study|Not Eligible|10|||
160650447|NCT00656019|580101575|FG001|Overall Study|Not Eligible|0|||
160650448|NCT00656019|580101576|FG002|Overall Study|Not Eligible|0|||
160650449|NCT00656019|580101577|FG003|Overall Study|Not Eligible|0|||
160650450|NCT00656019|580101574|FG000|Overall Study|Withdrawal by Subject|2|||
160650451|NCT00656019|580101575|FG001|Overall Study|Withdrawal by Subject|0|||
160650452|NCT00656019|580101576|FG002|Overall Study|Withdrawal by Subject|0|||
160650453|NCT00656019|580101577|FG003|Overall Study|Withdrawal by Subject|0|||
160650454|NCT00656019|580101574|FG000|Overall Study|Lost to Follow-up|2|||
160650455|NCT00656019|580101575|FG001|Overall Study|Lost to Follow-up|1|||
160650456|NCT00656019|580101576|FG002|Overall Study|Lost to Follow-up|0|||
160650457|NCT00656019|580101577|FG003|Overall Study|Lost to Follow-up|0|||
160650458|NCT00859469|580101580|FG000|Overall Study|Adverse Event|2|||
160650459|NCT00859469|580101580|FG000|Overall Study|Lack of Efficacy|9|||
160650460|NCT00859469|580101580|FG000|Overall Study|Withdrawal by Subject|1|||
160906356|NCT00837811|581050421|FG002|Overall Study|Sponsor Decision|0|||
160906357|NCT04731363|581050427|FG000|Overall Study|Could not obtain samples|0|||
160906358|NCT04731363|581050428|FG001|Overall Study|Could not obtain samples|1|||
160906359|NCT04731363|581050429|FG002|Overall Study|Could not obtain samples|0|||
160906360|NCT04731363|581050430|FG003|Overall Study|Could not obtain samples|0|||
160906361|NCT04731363|581050427|FG000|Overall Study|Physician Decision|0|||
160906362|NCT04731363|581050428|FG001|Overall Study|Physician Decision|1|||
160906363|NCT04731363|581050429|FG002|Overall Study|Physician Decision|0|||
160906364|NCT04731363|581050430|FG003|Overall Study|Physician Decision|0|||
160906365|NCT00307294|581052158|FG000|Overall Study|Withdrawal by Subject|1|||
160906366|NCT03311724|581052159|FG000|Overall Study|Physician Decision|0|||
160650461|NCT00859469|580101580|FG000|Overall Study|Death|16|||
160650462|NCT04071769|580101581|FG000|Overall Study|Lost to Follow-up|3|||
160650463|NCT04071769|580101581|FG000|Overall Study|Physician Decision|2|||
160650464|NCT04071769|580101581|FG000|Overall Study|Withdrawal by Subject|8|||
160650465|NCT00669955|580101582|FG000|Overall Study|Adverse Event|3|||
160650466|NCT00669955|580101583|FG001|Overall Study|Adverse Event|5|||
160650467|NCT00669955|580101582|FG000|Overall Study|Death|0|||
160906367|NCT03311724|581052160|FG001|Overall Study|Physician Decision|0|||
160650468|NCT00669955|580101583|FG001|Overall Study|Death|1|||
160848431|NCT00684996|580833736|FG000|Overall Study|Refusal unrelated to adverse event|1|||
160848432|NCT00684996|580833736|FG000|Overall Study|Progression/relapse|2|||
160848433|NCT00684996|580833736|FG000|Overall Study|Other reasons not protocol specified|1|||
160848434|NCT00556998|580833737|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
160848435|NCT00556998|580833737|FG000|Voriconazole Intravenous (IV)|Other|4|||
160848436|NCT00556998|580833737|FG000|Voriconazole Oral|Adverse Event|1|||
160848437|NCT00556998|580833737|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
160848438|NCT02519439|580833740|FG000|Overall Study|Study Termination|19|||
160848439|NCT02519439|580833740|FG000|Overall Study|Withdrawal by Subject|1|||
160848440|NCT02519439|580833740|FG000|Overall Study|Adverse Event|1|||
160848441|NCT03030417|580833747|FG000|Dose Expansion|Disease progression before treatment|0|||
160848442|NCT03030417|580833748|FG001|Dose Expansion|Disease progression before treatment|0|||
160848443|NCT03030417|580833749|FG002|Dose Expansion|Disease progression before treatment|0|||
160848444|NCT03030417|580833750|FG003|Dose Expansion|Disease progression before treatment|0|||
160848445|NCT03030417|580833751|FG004|Dose Expansion|Disease progression before treatment|0|||
160848446|NCT03030417|580833752|FG005|Dose Expansion|Disease progression before treatment|0|||
160848447|NCT03030417|580833753|FG006|Dose Expansion|Disease progression before treatment|0|||
160848448|NCT03030417|580833754|FG007|Dose Expansion|Disease progression before treatment|0|||
160848449|NCT03030417|580833755|FG008|Dose Expansion|Disease progression before treatment|0|||
160848450|NCT03030417|580833756|FG009|Dose Expansion|Disease progression before treatment|0|||
160848451|NCT03030417|580833757|FG010|Dose Expansion|Disease progression before treatment|0|||
160848452|NCT03030417|580833758|FG011|Dose Expansion|Disease progression before treatment|0|||
160848453|NCT03030417|580833759|FG012|Dose Expansion|Disease progression before treatment|1|||
160848454|NCT01078441|580833760|FG000|Overall Study|Withdrawal by Subject|1|||
160848455|NCT01970306|580833764|FG000|Overall Study|Not eligible|3|||
160848456|NCT01970306|580833764|FG000|Overall Study|Not able to be treated|9|||
160848457|NCT02741635|580833765|FG000|Overall Study|Withdrawal by Subject|1|||
160848458|NCT01427933|580833766|FG000|Overall Study|Withdrawal by Subject|5|||
160848459|NCT01427933|580833767|FG001|Overall Study|Withdrawal by Subject|8|||
160848460|NCT01427933|580833766|FG000|Overall Study|Lost to Follow-up|1|||
160848461|NCT01427933|580833767|FG001|Overall Study|Lost to Follow-up|5|||
160848462|NCT01427933|580833766|FG000|Overall Study|Other|1|||
160848463|NCT01427933|580833767|FG001|Overall Study|Other|0|||
160848464|NCT01427933|580833766|FG000|Overall Study|Investigator's Decision|1|||
160848465|NCT01427933|580833767|FG001|Overall Study|Investigator's Decision|0|||
160848466|NCT03472326|580833768|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
160848467|NCT03472326|580833769|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
160906368|NCT03311724|581052161|FG002|Overall Study|Physician Decision|0|||
160906369|NCT03311724|581052162|FG003|Overall Study|Physician Decision|1|||
160906370|NCT03311724|581052159|FG000|Overall Study|Protocol Violation|1|||
160906371|NCT03311724|581052160|FG001|Overall Study|Protocol Violation|0|||
160650469|NCT00669955|580101582|FG000|Overall Study|Withdrawal by Subject|2|||
160906372|NCT03311724|581052161|FG002|Overall Study|Protocol Violation|1|||
160906373|NCT03311724|581052162|FG003|Overall Study|Protocol Violation|0|||
160906374|NCT03311724|581052159|FG000|Overall Study|Withdrawal by Subject|1|||
160906375|NCT03311724|581052160|FG001|Overall Study|Withdrawal by Subject|1|||
160906376|NCT03311724|581052161|FG002|Overall Study|Withdrawal by Subject|0|||
160906377|NCT03311724|581052162|FG003|Overall Study|Withdrawal by Subject|0|||
160906378|NCT03311724|581052159|FG000|Overall Study|Lost to Follow-up|1|||
160906379|NCT03311724|581052160|FG001|Overall Study|Lost to Follow-up|0|||
160906380|NCT03311724|581052161|FG002|Overall Study|Lost to Follow-up|0|||
160906381|NCT03311724|581052162|FG003|Overall Study|Lost to Follow-up|0|||
160906382|NCT03311724|581052159|FG000|Overall Study|Sponsor Decision|0|||
160906383|NCT03311724|581052160|FG001|Overall Study|Sponsor Decision|0|||
160906384|NCT03311724|581052161|FG002|Overall Study|Sponsor Decision|1|||
160906385|NCT03311724|581052162|FG003|Overall Study|Sponsor Decision|0|||
160906386|NCT01581931|581052167|FG000|Washout|Adverse Event|0|||
160848468|NCT03472326|580833770|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
160848469|NCT03472326|580833771|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
160848470|NCT03472326|580833768|FG000|Part 2: Combination Therapy|Pregnancy|0|||
160848471|NCT03472326|580833769|FG001|Part 2: Combination Therapy|Pregnancy|0|||
160848472|NCT03472326|580833770|FG002|Part 2: Combination Therapy|Pregnancy|0|||
160848473|NCT03472326|580833771|FG003|Part 2: Combination Therapy|Pregnancy|1|||
160848474|NCT03386721|580833772|FG000|Overall Study|Death|12|||
160906387|NCT01581931|581052168|FG001|Washout|Adverse Event|1|||
160906388|NCT00395304|581052175|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160848475|NCT03386721|580833773|FG001|Overall Study|Death|21|||
160848476|NCT03386721|580833774|FG002|Overall Study|Death|2|||
160848477|NCT03386721|580833775|FG003|Overall Study|Death|5|||
160906389|NCT00395304|581052176|FG001|Treatment Period 1|Withdrawal by Subject|3|||
160848478|NCT03386721|580833776|FG004|Overall Study|Death|1|||
160848479|NCT03386721|580833777|FG005|Overall Study|Death|12|||
160848480|NCT03386721|580833778|FG006|Overall Study|Death|1|||
160906390|NCT00395304|581052177|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160906391|NCT00395304|581052178|FG003|Treatment Period 1|Withdrawal by Subject|2|||
160848481|NCT03386721|580833779|FG007|Overall Study|Death|1|||
160848482|NCT03386721|580833780|FG008|Overall Study|Death|12|||
160848483|NCT03386721|580833781|FG009|Overall Study|Death|20|||
160848484|NCT03386721|580833782|FG010|Overall Study|Death|21|||
160848485|NCT03386721|580833783|FG011|Overall Study|Death|21|||
160848486|NCT03386721|580833784|FG012|Overall Study|Death|14|||
160848487|NCT03386721|580833785|FG013|Overall Study|Death|2|||
160848488|NCT03386721|580833786|FG014|Overall Study|Death|1|||
160848489|NCT03386721|580833772|FG000|Overall Study|Lost to Follow-up|1|||
160848490|NCT03386721|580833773|FG001|Overall Study|Lost to Follow-up|3|||
160848491|NCT03386721|580833774|FG002|Overall Study|Lost to Follow-up|0|||
160848492|NCT03386721|580833775|FG003|Overall Study|Lost to Follow-up|0|||
160848493|NCT03386721|580833776|FG004|Overall Study|Lost to Follow-up|0|||
160848494|NCT03386721|580833777|FG005|Overall Study|Lost to Follow-up|2|||
160848495|NCT03386721|580833778|FG006|Overall Study|Lost to Follow-up|1|||
160848496|NCT03386721|580833779|FG007|Overall Study|Lost to Follow-up|0|||
160848497|NCT03386721|580833780|FG008|Overall Study|Lost to Follow-up|1|||
160848498|NCT03386721|580833781|FG009|Overall Study|Lost to Follow-up|2|||
160848499|NCT03386721|580833782|FG010|Overall Study|Lost to Follow-up|1|||
160848500|NCT03386721|580833783|FG011|Overall Study|Lost to Follow-up|0|||
160848501|NCT03386721|580833784|FG012|Overall Study|Lost to Follow-up|0|||
160848502|NCT03386721|580833785|FG013|Overall Study|Lost to Follow-up|0|||
160848503|NCT03386721|580833786|FG014|Overall Study|Lost to Follow-up|0|||
160848504|NCT03386721|580833772|FG000|Overall Study|Reason not specified|3|||
160848505|NCT03386721|580833773|FG001|Overall Study|Reason not specified|0|||
160848506|NCT03386721|580833774|FG002|Overall Study|Reason not specified|0|||
160848507|NCT03386721|580833775|FG003|Overall Study|Reason not specified|0|||
160848508|NCT03386721|580833776|FG004|Overall Study|Reason not specified|0|||
160848509|NCT03386721|580833777|FG005|Overall Study|Reason not specified|3|||
160848510|NCT03386721|580833778|FG006|Overall Study|Reason not specified|1|||
160848511|NCT03386721|580833779|FG007|Overall Study|Reason not specified|0|||
160848512|NCT03386721|580833780|FG008|Overall Study|Reason not specified|0|||
160848513|NCT03386721|580833781|FG009|Overall Study|Reason not specified|1|||
160848514|NCT03386721|580833782|FG010|Overall Study|Reason not specified|2|||
160848515|NCT03386721|580833783|FG011|Overall Study|Reason not specified|6|||
160848516|NCT03386721|580833784|FG012|Overall Study|Reason not specified|1|||
160848517|NCT03386721|580833785|FG013|Overall Study|Reason not specified|0|||
160848518|NCT03386721|580833786|FG014|Overall Study|Reason not specified|0|||
160848519|NCT03386721|580833772|FG000|Overall Study|Progressive Disease|0|||
160848520|NCT03386721|580833773|FG001|Overall Study|Progressive Disease|0|||
160848521|NCT03386721|580833774|FG002|Overall Study|Progressive Disease|1|||
160848522|NCT03386721|580833775|FG003|Overall Study|Progressive Disease|0|||
160848523|NCT03386721|580833776|FG004|Overall Study|Progressive Disease|0|||
160848524|NCT03386721|580833777|FG005|Overall Study|Progressive Disease|1|||
160848525|NCT03386721|580833778|FG006|Overall Study|Progressive Disease|0|||
160848526|NCT03386721|580833779|FG007|Overall Study|Progressive Disease|0|||
160848527|NCT03386721|580833780|FG008|Overall Study|Progressive Disease|2|||
160848528|NCT03386721|580833781|FG009|Overall Study|Progressive Disease|1|||
160848529|NCT03386721|580833782|FG010|Overall Study|Progressive Disease|1|||
160848530|NCT03386721|580833783|FG011|Overall Study|Progressive Disease|0|||
160848531|NCT03386721|580833784|FG012|Overall Study|Progressive Disease|1|||
160848532|NCT03386721|580833785|FG013|Overall Study|Progressive Disease|0|||
160848533|NCT03386721|580833786|FG014|Overall Study|Progressive Disease|0|||
160848534|NCT03386721|580833772|FG000|Overall Study|Site Terminated by Sponsor|5|||
160848535|NCT03386721|580833773|FG001|Overall Study|Site Terminated by Sponsor|5|||
160848536|NCT03386721|580833774|FG002|Overall Study|Site Terminated by Sponsor|0|||
160848537|NCT03386721|580833775|FG003|Overall Study|Site Terminated by Sponsor|0|||
160848538|NCT03386721|580833776|FG004|Overall Study|Site Terminated by Sponsor|1|||
160848539|NCT03386721|580833777|FG005|Overall Study|Site Terminated by Sponsor|3|||
160848540|NCT03386721|580833778|FG006|Overall Study|Site Terminated by Sponsor|0|||
160848541|NCT03386721|580833779|FG007|Overall Study|Site Terminated by Sponsor|1|||
160848542|NCT03386721|580833780|FG008|Overall Study|Site Terminated by Sponsor|4|||
160848543|NCT03386721|580833781|FG009|Overall Study|Site Terminated by Sponsor|5|||
160848544|NCT03386721|580833782|FG010|Overall Study|Site Terminated by Sponsor|3|||
160650470|NCT00669955|580101583|FG001|Overall Study|Withdrawal by Subject|3|||
160848545|NCT03386721|580833783|FG011|Overall Study|Site Terminated by Sponsor|11|||
160848546|NCT03386721|580833784|FG012|Overall Study|Site Terminated by Sponsor|6|||
160848547|NCT03386721|580833785|FG013|Overall Study|Site Terminated by Sponsor|0|||
160848548|NCT03386721|580833786|FG014|Overall Study|Site Terminated by Sponsor|0|||
160848549|NCT03386721|580833772|FG000|Overall Study|Symptomatic Deterioration|0|||
160848550|NCT03386721|580833773|FG001|Overall Study|Symptomatic Deterioration|0|||
160906392|NCT00395304|581052179|FG004|Treatment Period 1|Withdrawal by Subject|1|||
160906393|NCT00395304|581052180|FG005|Treatment Period 1|Withdrawal by Subject|1|||
160906394|NCT00395304|581052175|FG000|Treatment Period 1|Lost to Follow-up|1|||
160848551|NCT03386721|580833774|FG002|Overall Study|Symptomatic Deterioration|0|||
160848552|NCT03386721|580833775|FG003|Overall Study|Symptomatic Deterioration|0|||
160848553|NCT03386721|580833776|FG004|Overall Study|Symptomatic Deterioration|0|||
160848554|NCT03386721|580833777|FG005|Overall Study|Symptomatic Deterioration|0|||
160848555|NCT03386721|580833778|FG006|Overall Study|Symptomatic Deterioration|0|||
160848556|NCT03386721|580833779|FG007|Overall Study|Symptomatic Deterioration|0|||
160848557|NCT03386721|580833780|FG008|Overall Study|Symptomatic Deterioration|1|||
160848558|NCT03386721|580833781|FG009|Overall Study|Symptomatic Deterioration|0|||
160848559|NCT03386721|580833782|FG010|Overall Study|Symptomatic Deterioration|0|||
160848560|NCT03386721|580833783|FG011|Overall Study|Symptomatic Deterioration|1|||
160848561|NCT03386721|580833784|FG012|Overall Study|Symptomatic Deterioration|0|||
160848562|NCT03386721|580833785|FG013|Overall Study|Symptomatic Deterioration|0|||
160848563|NCT03386721|580833786|FG014|Overall Study|Symptomatic Deterioration|0|||
160848564|NCT03386721|580833772|FG000|Overall Study|Withdrawal by Subject|1|||
160848565|NCT03386721|580833773|FG001|Overall Study|Withdrawal by Subject|2|||
160848566|NCT03386721|580833774|FG002|Overall Study|Withdrawal by Subject|0|||
160848567|NCT03386721|580833775|FG003|Overall Study|Withdrawal by Subject|0|||
160848568|NCT03386721|580833776|FG004|Overall Study|Withdrawal by Subject|0|||
160848569|NCT03386721|580833777|FG005|Overall Study|Withdrawal by Subject|0|||
160848570|NCT03386721|580833778|FG006|Overall Study|Withdrawal by Subject|0|||
160848571|NCT03386721|580833779|FG007|Overall Study|Withdrawal by Subject|0|||
160848572|NCT03386721|580833780|FG008|Overall Study|Withdrawal by Subject|2|||
160848573|NCT03386721|580833781|FG009|Overall Study|Withdrawal by Subject|1|||
160848574|NCT03386721|580833782|FG010|Overall Study|Withdrawal by Subject|3|||
160848575|NCT03386721|580833783|FG011|Overall Study|Withdrawal by Subject|2|||
160848576|NCT03386721|580833784|FG012|Overall Study|Withdrawal by Subject|3|||
160848577|NCT03386721|580833785|FG013|Overall Study|Withdrawal by Subject|0|||
160848578|NCT03386721|580833786|FG014|Overall Study|Withdrawal by Subject|0|||
160848579|NCT03359174|580833789|FG000|Overall Study|Adverse Event|1|||
160848580|NCT02680665|580833790|FG000|Overall Study|No visit after the first prescription|5|||
160848581|NCT02905266|580833791|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
160848582|NCT02905266|580833792|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
160848583|NCT02905266|580833791|FG000|Treatment Phase Part 1|Disease Progression|6|||
160848584|NCT02905266|580833792|FG001|Treatment Phase Part 1|Disease Progression|7|||
160848585|NCT02905266|580833791|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
160848586|NCT02905266|580833792|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
160848587|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
160848588|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
160848589|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
160848590|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
160848591|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
160848592|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
160848593|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Death|0|||
160848594|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Death|1|||
160848595|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
160848596|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
160848597|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
160848598|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
160848599|NCT02905266|580833791|FG000|Maintenance Phase Part 2|Disease Progression|9|||
160848600|NCT02905266|580833792|FG001|Maintenance Phase Part 2|Disease Progression|2|||
160848601|NCT02905266|580833791|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
160848602|NCT02905266|580833792|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
160848603|NCT02905266|580833791|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
160848604|NCT02905266|580833792|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
160848605|NCT00596752|580833795|FG000|Overall Study|Other Reason|44|||
160848606|NCT00596752|580833796|FG001|Overall Study|Other Reason|49|||
160848607|NCT00596752|580833795|FG000|Overall Study|Adverse Event|34|||
160848608|NCT00596752|580833796|FG001|Overall Study|Adverse Event|34|||
160848609|NCT00596752|580833795|FG000|Overall Study|Lost to Follow-up|22|||
160848610|NCT00596752|580833796|FG001|Overall Study|Lost to Follow-up|38|||
160848611|NCT00596752|580833795|FG000|Overall Study|Withdrawal by Subject|12|||
160848612|NCT00596752|580833796|FG001|Overall Study|Withdrawal by Subject|9|||
160848613|NCT00596752|580833795|FG000|Overall Study|Unsatisfactory Compliance|9|||
160848614|NCT00596752|580833796|FG001|Overall Study|Unsatisfactory Compliance|6|||
160848615|NCT00596752|580833795|FG000|Overall Study|Lack of Efficacy|4|||
160848616|NCT00596752|580833796|FG001|Overall Study|Lack of Efficacy|7|||
160848617|NCT00596752|580833795|FG000|Overall Study|Protocol Violation|1|||
160848618|NCT00596752|580833796|FG001|Overall Study|Protocol Violation|0|||
160848619|NCT04445662|580833799|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
160848620|NCT04445662|580833800|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
160848621|NCT04445662|580833799|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
160848622|NCT04445662|580833800|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
160848623|NCT04445662|580833799|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
160848624|NCT04445662|580833800|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
160848625|NCT04445662|580833799|FG000|Post-treatment (12-24 weeks)|Death|1|||
160848626|NCT04445662|580833800|FG001|Post-treatment (12-24 weeks)|Death|0|||
160848627|NCT02451124|580833811|FG000|Overall Study|Withdrawal by Subject|1|||
160848628|NCT01870726|580833812|FG000|Overall Study|Withdrawal of informed consent|0|||
160848629|NCT01870726|580833813|FG001|Overall Study|Withdrawal of informed consent|0|||
160848630|NCT01870726|580833814|FG002|Overall Study|Withdrawal of informed consent|0|||
160848631|NCT01870726|580833815|FG003|Overall Study|Withdrawal of informed consent|1|||
160848632|NCT01870726|580833816|FG004|Overall Study|Withdrawal of informed consent|0|||
160848633|NCT01870726|580833817|FG005|Overall Study|Withdrawal of informed consent|0|||
160848634|NCT01870726|580833818|FG006|Overall Study|Withdrawal of informed consent|0|||
160848635|NCT01870726|580833812|FG000|Overall Study|Withdrawal by Subject|0|||
160848636|NCT01870726|580833813|FG001|Overall Study|Withdrawal by Subject|1|||
160848637|NCT01870726|580833814|FG002|Overall Study|Withdrawal by Subject|0|||
160848638|NCT01870726|580833815|FG003|Overall Study|Withdrawal by Subject|0|||
160848639|NCT01870726|580833816|FG004|Overall Study|Withdrawal by Subject|0|||
160848640|NCT01870726|580833817|FG005|Overall Study|Withdrawal by Subject|0|||
160848641|NCT01870726|580833818|FG006|Overall Study|Withdrawal by Subject|0|||
160848642|NCT01870726|580833812|FG000|Overall Study|Adverse Event|0|||
160848643|NCT01870726|580833813|FG001|Overall Study|Adverse Event|0|||
160848644|NCT01870726|580833814|FG002|Overall Study|Adverse Event|0|||
160848645|NCT01870726|580833815|FG003|Overall Study|Adverse Event|0|||
160848646|NCT01870726|580833816|FG004|Overall Study|Adverse Event|1|||
160848647|NCT01870726|580833817|FG005|Overall Study|Adverse Event|1|||
160848648|NCT01870726|580833818|FG006|Overall Study|Adverse Event|0|||
160848649|NCT01870726|580833812|FG000|Overall Study|Progressive disease|5|||
160848650|NCT01870726|580833813|FG001|Overall Study|Progressive disease|5|||
160848651|NCT01870726|580833814|FG002|Overall Study|Progressive disease|4|||
160848652|NCT01870726|580833815|FG003|Overall Study|Progressive disease|5|||
160848653|NCT01870726|580833816|FG004|Overall Study|Progressive disease|6|||
160848654|NCT01870726|580833817|FG005|Overall Study|Progressive disease|4|||
160848655|NCT01870726|580833818|FG006|Overall Study|Progressive disease|10|||
160848656|NCT00103740|580833821|FG000|Period 1 - Core|Adverse Event|1|||
160848657|NCT00103740|580833822|FG001|Period 1 - Core|Adverse Event|0|||
160848658|NCT00103740|580833821|FG000|Period 1 - Core|Protocol Violation|3|||
160848659|NCT00103740|580833822|FG001|Period 1 - Core|Protocol Violation|2|||
160848660|NCT00103740|580833821|FG000|Period 1 - Core|Patient withdrew consent|3|||
160848661|NCT00103740|580833822|FG001|Period 1 - Core|Patient withdrew consent|2|||
160848662|NCT00103740|580833821|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
160848663|NCT00103740|580833822|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
160848664|NCT00103740|580833821|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
160848665|NCT00103740|580833822|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
160848666|NCT00103740|580833821|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
160848667|NCT00103740|580833822|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
160848668|NCT00103740|580833821|FG000|Period 2 - Extended Observation Period|Death|6|||
160848669|NCT00103740|580833822|FG001|Period 2 - Extended Observation Period|Death|2|||
160568517|NCT03486314|579803931|FG000|Part A|Adverse Event|1|||
160568518|NCT03486314|579803932|FG001|Part A|Adverse Event|0|||
160568519|NCT03486314|579803933|FG002|Part A|Adverse Event|0|||
160568520|NCT03486314|579803931|FG000|Part A|Symptomatic Deterioration|2|||
160568521|NCT03486314|579803932|FG001|Part A|Symptomatic Deterioration|0|||
160568522|NCT03486314|579803933|FG002|Part A|Symptomatic Deterioration|0|||
160568523|NCT01364467|579803940|FG000|Overall Study|Lost to Follow-up|1|||
160568524|NCT01364467|579803941|FG001|Overall Study|Lost to Follow-up|2|||
160568525|NCT03228186|579803942|FG000|Overall Study|Patient never started treatment|1|||
160568526|NCT01634243|579803943|FG000|Overall Study|Adverse Event|5|||
160568527|NCT01634243|579803944|FG001|Overall Study|Adverse Event|5|||
160568528|NCT01634243|579803943|FG000|Overall Study|Lack of Efficacy|1|||
160568529|NCT01634243|579803944|FG001|Overall Study|Lack of Efficacy|0|||
160568530|NCT00258154|579803945|FG000|Overall Study|Adverse Event|1|||
160568531|NCT00258154|579803946|FG001|Overall Study|Adverse Event|0|||
160568532|NCT00258154|579803945|FG000|Overall Study|Lost to Follow-up|0|||
160568533|NCT00258154|579803946|FG001|Overall Study|Lost to Follow-up|1|||
160568534|NCT00258154|579803945|FG000|Overall Study|Protocol Violation|2|||
160568535|NCT00258154|579803946|FG001|Overall Study|Protocol Violation|1|||
160568536|NCT00258154|579803945|FG000|Overall Study|Withdrawal by Subject|3|||
160568537|NCT00258154|579803946|FG001|Overall Study|Withdrawal by Subject|4|||
160568538|NCT00258154|579803945|FG000|Overall Study|Patient Moved|3|||
160568539|NCT00258154|579803946|FG001|Overall Study|Patient Moved|1|||
160568540|NCT05139030|579803947|FG000|Overall Study|Withdrawal by Subject|1|||
160568541|NCT05139030|579803948|FG001|Overall Study|Withdrawal by Subject|3|||
160568542|NCT05139030|579803947|FG000|Overall Study|Adverse Event|0|||
160568543|NCT05139030|579803948|FG001|Overall Study|Adverse Event|1|||
160568544|NCT05139030|579803947|FG000|Overall Study|Failure to meet continuation criteria|0|||
160568545|NCT05139030|579803948|FG001|Overall Study|Failure to meet continuation criteria|1|||
160568546|NCT02502864|579803953|FG000|Overall Study|Withdrawal by Subject|1|||
160848670|NCT00103740|580833821|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
160848671|NCT00103740|580833822|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
160848672|NCT03691571|580833823|FG000|Overall Study|Withdrawal by Subject|9|||
160848673|NCT03691571|580833824|FG001|Overall Study|Withdrawal by Subject|2|||
160848674|NCT01463306|580833825|FG000|Overall Study|Adverse Event|6|||
160848675|NCT01463306|580833826|FG001|Overall Study|Adverse Event|9|||
160848676|NCT01463306|580833827|FG002|Overall Study|Adverse Event|3|||
160848677|NCT01463306|580833825|FG000|Overall Study|Death|3|||
160848678|NCT01463306|580833826|FG001|Overall Study|Death|3|||
160848679|NCT01463306|580833827|FG002|Overall Study|Death|0|||
160848680|NCT01463306|580833825|FG000|Overall Study|Lack of Efficacy|22|||
160848681|NCT01463306|580833826|FG001|Overall Study|Lack of Efficacy|16|||
160848682|NCT01463306|580833827|FG002|Overall Study|Lack of Efficacy|1|||
160848683|NCT01463306|580833825|FG000|Overall Study|Lost to Follow-up|5|||
160848684|NCT01463306|580833826|FG001|Overall Study|Lost to Follow-up|2|||
160848685|NCT01463306|580833827|FG002|Overall Study|Lost to Follow-up|0|||
160848686|NCT01463306|580833825|FG000|Overall Study|Protocol Violation|4|||
160848687|NCT01463306|580833826|FG001|Overall Study|Protocol Violation|0|||
160848688|NCT01463306|580833827|FG002|Overall Study|Protocol Violation|0|||
160848689|NCT01463306|580833825|FG000|Overall Study|Withdrawal by Subject|19|||
160848690|NCT01463306|580833826|FG001|Overall Study|Withdrawal by Subject|9|||
160848691|NCT01463306|580833827|FG002|Overall Study|Withdrawal by Subject|1|||
160848692|NCT01463306|580833825|FG000|Overall Study|Other|26|||
160848693|NCT01463306|580833826|FG001|Overall Study|Other|13|||
160848694|NCT01463306|580833827|FG002|Overall Study|Other|0|||
160906395|NCT00395304|581052176|FG001|Treatment Period 1|Lost to Follow-up|0|||
160906396|NCT00395304|581052177|FG002|Treatment Period 1|Lost to Follow-up|0|||
160906397|NCT00395304|581052178|FG003|Treatment Period 1|Lost to Follow-up|1|||
160906398|NCT00395304|581052179|FG004|Treatment Period 1|Lost to Follow-up|0|||
160906399|NCT00395304|581052180|FG005|Treatment Period 1|Lost to Follow-up|1|||
160906400|NCT00395304|581052175|FG000|Treatment Period 1|Physician Decision|0|||
160906401|NCT00395304|581052176|FG001|Treatment Period 1|Physician Decision|1|||
160906402|NCT00395304|581052177|FG002|Treatment Period 1|Physician Decision|0|||
160906403|NCT00395304|581052178|FG003|Treatment Period 1|Physician Decision|0|||
160906404|NCT00395304|581052179|FG004|Treatment Period 1|Physician Decision|0|||
160906405|NCT00395304|581052180|FG005|Treatment Period 1|Physician Decision|0|||
160906406|NCT00395304|581052175|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160906407|NCT00395304|581052176|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160906408|NCT00395304|581052177|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160906409|NCT00395304|581052178|FG003|Treatment Period 2|Withdrawal by Subject|1|||
160906410|NCT00395304|581052179|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160906411|NCT00395304|581052180|FG005|Treatment Period 2|Withdrawal by Subject|2|||
160906412|NCT00395304|581052175|FG000|Treatment Period 2|Lost to Follow-up|0|||
160906413|NCT00395304|581052176|FG001|Treatment Period 2|Lost to Follow-up|3|||
160906414|NCT00395304|581052177|FG002|Treatment Period 2|Lost to Follow-up|0|||
160906415|NCT00395304|581052178|FG003|Treatment Period 2|Lost to Follow-up|0|||
160906416|NCT00395304|581052179|FG004|Treatment Period 2|Lost to Follow-up|0|||
160906417|NCT00395304|581052180|FG005|Treatment Period 2|Lost to Follow-up|0|||
160906418|NCT00395304|581052175|FG000|Treatment Period 2|Physician Decision|0|||
160906419|NCT00395304|581052176|FG001|Treatment Period 2|Physician Decision|0|||
160906420|NCT00395304|581052177|FG002|Treatment Period 2|Physician Decision|1|||
160906421|NCT00395304|581052178|FG003|Treatment Period 2|Physician Decision|0|||
160906422|NCT00395304|581052179|FG004|Treatment Period 2|Physician Decision|0|||
160906423|NCT00395304|581052180|FG005|Treatment Period 2|Physician Decision|0|||
160906424|NCT00395304|581052175|FG000|Treatment Period 2|Other|0|||
160906425|NCT00395304|581052176|FG001|Treatment Period 2|Other|1|||
160906426|NCT00395304|581052177|FG002|Treatment Period 2|Other|0|||
160568547|NCT00613626|579803957|FG000|Overall Study|Ineligible|0|||
160848695|NCT01463306|580833825|FG000|Overall Study|Approval expiry at site|1|||
160848696|NCT01463306|580833826|FG001|Overall Study|Approval expiry at site|0|||
160848697|NCT01463306|580833827|FG002|Overall Study|Approval expiry at site|0|||
160848698|NCT00250276|580833832|FG000|Overall Study|Serious Adverse Event|0|||
160848699|NCT00250276|580833833|FG001|Overall Study|Serious Adverse Event|0|||
160848700|NCT00250276|580833834|FG002|Overall Study|Serious Adverse Event|1|||
160848701|NCT00250276|580833835|FG003|Overall Study|Serious Adverse Event|0|||
160848702|NCT00250276|580833832|FG000|Overall Study|Non-serious Adverse Event|2|||
160848703|NCT00250276|580833833|FG001|Overall Study|Non-serious Adverse Event|0|||
160848704|NCT00250276|580833834|FG002|Overall Study|Non-serious Adverse Event|0|||
160848705|NCT00250276|580833835|FG003|Overall Study|Non-serious Adverse Event|2|||
160848706|NCT00250276|580833832|FG000|Overall Study|Protocol Violation|0|||
160848707|NCT00250276|580833833|FG001|Overall Study|Protocol Violation|1|||
160848708|NCT00250276|580833834|FG002|Overall Study|Protocol Violation|0|||
160848709|NCT00250276|580833835|FG003|Overall Study|Protocol Violation|0|||
160848710|NCT00250276|580833832|FG000|Overall Study|Withdrawal by Subject|1|||
160848711|NCT00250276|580833833|FG001|Overall Study|Withdrawal by Subject|2|||
160848712|NCT00250276|580833834|FG002|Overall Study|Withdrawal by Subject|3|||
160848713|NCT00250276|580833835|FG003|Overall Study|Withdrawal by Subject|2|||
160848714|NCT00250276|580833832|FG000|Overall Study|Migrated/moved from study area|3|||
160848715|NCT00250276|580833833|FG001|Overall Study|Migrated/moved from study area|0|||
160848716|NCT00250276|580833834|FG002|Overall Study|Migrated/moved from study area|2|||
160848717|NCT00250276|580833835|FG003|Overall Study|Migrated/moved from study area|7|||
160848718|NCT00250276|580833832|FG000|Overall Study|Lost to Follow-up|11|||
160848719|NCT00250276|580833833|FG001|Overall Study|Lost to Follow-up|18|||
160848720|NCT00250276|580833834|FG002|Overall Study|Lost to Follow-up|13|||
160848721|NCT00250276|580833835|FG003|Overall Study|Lost to Follow-up|8|||
160848722|NCT00555217|580833836|FG000|Overall Study|Withdrawal by Subject|35|||
160848723|NCT00555217|580833837|FG001|Overall Study|Withdrawal by Subject|31|||
160848724|NCT00555217|580833836|FG000|Overall Study|Lost to Follow-up|19|||
160848725|NCT00555217|580833837|FG001|Overall Study|Lost to Follow-up|20|||
160848726|NCT00555217|580833836|FG000|Overall Study|close out sites|21|||
160848727|NCT00555217|580833837|FG001|Overall Study|close out sites|17|||
160848728|NCT01546688|580833838|FG000|Overall Study|Adverse Event|0|||
160848729|NCT01546688|580833839|FG001|Overall Study|Adverse Event|4|||
160848730|NCT01546688|580833838|FG000|Overall Study|Withdrawal by Subject|2|||
160848731|NCT01546688|580833839|FG001|Overall Study|Withdrawal by Subject|1|||
160848732|NCT01546688|580833838|FG000|Overall Study|Lack of Efficacy|1|||
160848733|NCT01546688|580833839|FG001|Overall Study|Lack of Efficacy|0|||
160848734|NCT03543137|580833840|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
160848735|NCT03543137|580833841|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
160848736|NCT03543137|580833840|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
160848737|NCT03543137|580833841|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
160848738|NCT03543137|580833840|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
160848739|NCT03543137|580833841|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
160848740|NCT01045694|580833847|FG000|Overall Study|Withdrawal by Subject|2|||
160848741|NCT01657292|580833848|FG000|Overall Study|Adverse Event|6|||
160848742|NCT01657292|580833848|FG000|Overall Study|Withdrawal by Subject|2|||
160848743|NCT01657292|580833848|FG000|Overall Study|Violation of eligibility criteria|1|||
160848744|NCT01657292|580833848|FG000|Overall Study|Change of therapy|1|||
160848745|NCT03761810|580833849|FG000|Overall Study|Adverse Event|12|||
160848746|NCT03761810|580833850|FG001|Overall Study|Adverse Event|0|||
160848747|NCT03761810|580833849|FG000|Overall Study|Lost to Follow-up|15|||
160848748|NCT03761810|580833850|FG001|Overall Study|Lost to Follow-up|7|||
160848749|NCT03761810|580833849|FG000|Overall Study|Pregnancy|1|||
160848750|NCT03761810|580833850|FG001|Overall Study|Pregnancy|0|||
160848751|NCT03761810|580833849|FG000|Overall Study|Withdrawal by Subject|14|||
160848752|NCT03761810|580833850|FG001|Overall Study|Withdrawal by Subject|5|||
160848753|NCT03761810|580833849|FG000|Overall Study|Physician Decision|1|||
160848754|NCT03761810|580833850|FG001|Overall Study|Physician Decision|0|||
160848755|NCT03761810|580833849|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
160848756|NCT03761810|580833850|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160848757|NCT03761810|580833849|FG000|Overall Study|Other Than Specified|1|||
160848758|NCT03761810|580833850|FG001|Overall Study|Other Than Specified|0|||
160848759|NCT03566082|580833851|FG000|Overall Study|Death|7|||
160848760|NCT03566082|580833851|FG000|Overall Study|Failures (revision required)|2|||
160848761|NCT03566082|580833851|FG000|Overall Study|Lost to Follow-up|8|||
160848762|NCT00983385|580833852|FG000|Observation Period|Not eligible to be dosed|20|||
160848763|NCT00983385|580833852|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
160848764|NCT02663622|580833853|FG000|Overall Study|Death|3|||
160848765|NCT02663622|580833854|FG001|Overall Study|Death|1|||
160848766|NCT02663622|580833855|FG002|Overall Study|Death|1|||
160848767|NCT02663622|580833856|FG003|Overall Study|Death|8|||
160650471|NCT00669955|580101582|FG000|Overall Study|Lost to Follow-up|5|||
160848768|NCT02663622|580833853|FG000|Overall Study|Protocol Violation|0|||
160848769|NCT02663622|580833854|FG001|Overall Study|Protocol Violation|0|||
160848770|NCT02663622|580833855|FG002|Overall Study|Protocol Violation|0|||
160848771|NCT02663622|580833856|FG003|Overall Study|Protocol Violation|1|||
160848772|NCT00930930|580833858|FG000|Overall Study|Death|1|||
160848773|NCT00930930|580833859|FG001|Overall Study|Death|0|||
160848774|NCT00930930|580833858|FG000|Overall Study|Physician Decision|1|||
160848775|NCT00930930|580833859|FG001|Overall Study|Physician Decision|0|||
160848776|NCT00930930|580833858|FG000|Overall Study|Adverse Event|13|||
160848777|NCT00930930|580833859|FG001|Overall Study|Adverse Event|3|||
160848778|NCT00930930|580833858|FG000|Overall Study|Withdrawal by Subject|3|||
160848779|NCT00930930|580833859|FG001|Overall Study|Withdrawal by Subject|1|||
160848780|NCT00930930|580833858|FG000|Overall Study|Disease progression|2|||
160848781|NCT00930930|580833859|FG001|Overall Study|Disease progression|3|||
160848782|NCT00930930|580833858|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
160848783|NCT00930930|580833859|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
160848784|NCT00930930|580833858|FG000|Overall Study|patients not compliant|1|||
160848785|NCT00930930|580833859|FG001|Overall Study|patients not compliant|1|||
160848786|NCT00511238|580833860|FG000|Overall Study|Adverse Event|13|||
160650472|NCT00669955|580101583|FG001|Overall Study|Lost to Follow-up|7|||
160650473|NCT00669955|580101582|FG000|Overall Study|Protocol Violation|2|||
160650474|NCT00669955|580101583|FG001|Overall Study|Protocol Violation|7|||
160650475|NCT00669955|580101582|FG000|Overall Study|Investigator Sponsor Judgement|0|||
160650476|NCT00669955|580101583|FG001|Overall Study|Investigator Sponsor Judgement|1|||
160650477|NCT00669955|580101582|FG000|Overall Study|not compliant with study drug/visit|2|||
160650478|NCT00669955|580101583|FG001|Overall Study|not compliant with study drug/visit|3|||
160650479|NCT01890707|580101584|FG000|Overall Study|Lost to Follow-up|1|||
160650480|NCT01890707|580101585|FG001|Overall Study|Lost to Follow-up|1|||
160650481|NCT00385541|580101588|FG000|Overall Study|severe pain, clinician requested unblind|0|||
160650482|NCT00385541|580101589|FG001|Overall Study|severe pain, clinician requested unblind|1|||
160650483|NCT00929708|580101590|FG000|Overall Study|Protocol Violation|2|||
160650484|NCT00929708|580101591|FG001|Overall Study|Protocol Violation|1|||
160650485|NCT00929708|580101592|FG002|Overall Study|Protocol Violation|1|||
160650486|NCT00929708|580101593|FG003|Overall Study|Protocol Violation|1|||
160650487|NCT00929708|580101594|FG004|Overall Study|Protocol Violation|1|||
160650488|NCT00929708|580101590|FG000|Overall Study|Withdrawal by Subject|2|||
160650489|NCT00929708|580101591|FG001|Overall Study|Withdrawal by Subject|0|||
160650490|NCT00929708|580101592|FG002|Overall Study|Withdrawal by Subject|0|||
160650491|NCT00929708|580101593|FG003|Overall Study|Withdrawal by Subject|2|||
160650492|NCT00929708|580101594|FG004|Overall Study|Withdrawal by Subject|1|||
160650493|NCT00929708|580101590|FG000|Overall Study|Adverse Event|0|||
160650494|NCT00929708|580101591|FG001|Overall Study|Adverse Event|0|||
160650495|NCT00929708|580101592|FG002|Overall Study|Adverse Event|0|||
160650496|NCT00929708|580101593|FG003|Overall Study|Adverse Event|0|||
160650497|NCT00929708|580101594|FG004|Overall Study|Adverse Event|3|||
160650498|NCT00929708|580101590|FG000|Overall Study|Physician Decision|0|||
160650499|NCT00929708|580101591|FG001|Overall Study|Physician Decision|2|||
160650500|NCT00929708|580101592|FG002|Overall Study|Physician Decision|2|||
160650501|NCT00929708|580101593|FG003|Overall Study|Physician Decision|2|||
160650502|NCT00929708|580101594|FG004|Overall Study|Physician Decision|1|||
160650503|NCT00929708|580101590|FG000|Overall Study|Lost to Follow-up|0|||
160650504|NCT00929708|580101591|FG001|Overall Study|Lost to Follow-up|0|||
160650505|NCT00929708|580101592|FG002|Overall Study|Lost to Follow-up|0|||
160650506|NCT00929708|580101593|FG003|Overall Study|Lost to Follow-up|1|||
160650507|NCT00929708|580101594|FG004|Overall Study|Lost to Follow-up|0|||
160650508|NCT03495869|580101595|FG000|Overall Study|Lost to Follow-up|4|||
160650509|NCT03495869|580101596|FG001|Overall Study|Lost to Follow-up|17|||
160650510|NCT03495869|580101597|FG002|Overall Study|Lost to Follow-up|8|||
160650511|NCT03495869|580101598|FG003|Overall Study|Lost to Follow-up|14|||
160650512|NCT03495869|580101595|FG000|Overall Study|Withdrawal by Subject|0|||
160650513|NCT03495869|580101596|FG001|Overall Study|Withdrawal by Subject|3|||
160650514|NCT03495869|580101597|FG002|Overall Study|Withdrawal by Subject|0|||
160650515|NCT03495869|580101598|FG003|Overall Study|Withdrawal by Subject|3|||
160650516|NCT03495869|580101595|FG000|Overall Study|Dropped from study|0|||
160650517|NCT03495869|580101596|FG001|Overall Study|Dropped from study|7|||
160650518|NCT03495869|580101597|FG002|Overall Study|Dropped from study|2|||
160848787|NCT00511238|580833861|FG001|Overall Study|Adverse Event|33|||
160848788|NCT00511238|580833860|FG000|Overall Study|Withdrawal by Subject|2|||
160848789|NCT00511238|580833861|FG001|Overall Study|Withdrawal by Subject|22|||
160650519|NCT03495869|580101598|FG003|Overall Study|Dropped from study|4|||
160650520|NCT02154529|580101599|FG000|Overall Study|Death|1|||
160650521|NCT02154529|580101600|FG001|Overall Study|Death|1|||
160650522|NCT02154529|580101601|FG002|Overall Study|Death|5|||
160848790|NCT00511238|580833860|FG000|Overall Study|Progressive Disease|23|||
160848791|NCT00511238|580833861|FG001|Overall Study|Progressive Disease|157|||
160650523|NCT02154529|580101602|FG003|Overall Study|Death|1|||
160650524|NCT02154529|580101599|FG000|Overall Study|Termination of study by sponsor|2|||
160650525|NCT02154529|580101600|FG001|Overall Study|Termination of study by sponsor|2|||
160650526|NCT02154529|580101601|FG002|Overall Study|Termination of study by sponsor|3|||
160650527|NCT02154529|580101602|FG003|Overall Study|Termination of study by sponsor|1|||
160650528|NCT02154529|580101599|FG000|Overall Study|Lost to Follow-up|1|||
160650529|NCT02154529|580101600|FG001|Overall Study|Lost to Follow-up|0|||
160848792|NCT00511238|580833860|FG000|Overall Study|various reasons|4|||
160848793|NCT00511238|580833861|FG001|Overall Study|various reasons|14|||
160848794|NCT00163020|580833862|FG000|Overall Study|Lost to Follow-up|0|||
160848795|NCT00163020|580833863|FG001|Overall Study|Lost to Follow-up|2|||
160848796|NCT03790111|580835599|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
160848797|NCT00997035|580835603|FG000|3-week Followup Visit|Lost to Follow-up|9|||
160848798|NCT00997035|580835604|FG001|3-week Followup Visit|Lost to Follow-up|6|||
160848799|NCT00997035|580835603|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
160848800|NCT00997035|580835604|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
160848801|NCT02471014|580835605|FG000|Overall Study|Lost to Follow-up|2|||
160848802|NCT02471014|580835606|FG001|Overall Study|Lost to Follow-up|2|||
160848803|NCT00936702|580835609|FG000|Overall Study|Disease progression|34|||
160848804|NCT00936702|580835609|FG000|Overall Study|Adverse Event|8|||
160848805|NCT00936702|580835609|FG000|Overall Study|Withdrawal by Subject|2|||
160848806|NCT00936702|580835609|FG000|Overall Study|Alternative Treatment|1|||
160848807|NCT00936702|580835609|FG000|Overall Study|Other|1|||
160848808|NCT00354679|580835610|FG000|Overall Study|Patient Not Treated|1|||
160848809|NCT03456076|580835611|FG000|Overall Study|Withdrawal by Subject|5|||
160848810|NCT03456076|580835612|FG001|Overall Study|Withdrawal by Subject|9|||
160848811|NCT03456076|580835611|FG000|Overall Study|Protocol deviation|0|||
160848812|NCT03456076|580835612|FG001|Overall Study|Protocol deviation|1|||
160848813|NCT03456076|580835611|FG000|Overall Study|Lost to Follow-up|0|||
160848814|NCT03456076|580835612|FG001|Overall Study|Lost to Follow-up|1|||
160848815|NCT03456076|580835611|FG000|Overall Study|Death|2|||
160848816|NCT03456076|580835612|FG001|Overall Study|Death|5|||
160906427|NCT00395304|581052178|FG003|Treatment Period 2|Other|0|||
160906428|NCT00395304|581052179|FG004|Treatment Period 2|Other|0|||
160906429|NCT00395304|581052180|FG005|Treatment Period 2|Other|0|||
160906430|NCT00395304|581052175|FG000|Treatment Period 3|Withdrawal by Subject|0|||
160906431|NCT00395304|581052176|FG001|Treatment Period 3|Withdrawal by Subject|0|||
160906432|NCT00395304|581052177|FG002|Treatment Period 3|Withdrawal by Subject|0|||
160906433|NCT00395304|581052178|FG003|Treatment Period 3|Withdrawal by Subject|1|||
160906434|NCT00395304|581052179|FG004|Treatment Period 3|Withdrawal by Subject|0|||
160906435|NCT00395304|581052180|FG005|Treatment Period 3|Withdrawal by Subject|1|||
160906436|NCT00395304|581052175|FG000|Treatment Period 3|Lost to Follow-up|1|||
160906437|NCT00395304|581052176|FG001|Treatment Period 3|Lost to Follow-up|1|||
160906438|NCT00395304|581052177|FG002|Treatment Period 3|Lost to Follow-up|0|||
160906439|NCT00395304|581052178|FG003|Treatment Period 3|Lost to Follow-up|0|||
160906440|NCT00395304|581052179|FG004|Treatment Period 3|Lost to Follow-up|0|||
160906441|NCT00395304|581052180|FG005|Treatment Period 3|Lost to Follow-up|0|||
160906442|NCT00395304|581052175|FG000|Treatment Period 3|Physician Decision|0|||
160906443|NCT00395304|581052176|FG001|Treatment Period 3|Physician Decision|1|||
160906444|NCT00395304|581052177|FG002|Treatment Period 3|Physician Decision|0|||
160906445|NCT00395304|581052178|FG003|Treatment Period 3|Physician Decision|0|||
160906446|NCT00395304|581052179|FG004|Treatment Period 3|Physician Decision|0|||
160906447|NCT00395304|581052180|FG005|Treatment Period 3|Physician Decision|0|||
160906448|NCT00395304|581052175|FG000|Treatment Period 3|Other|0|||
160906449|NCT00395304|581052176|FG001|Treatment Period 3|Other|0|||
160906450|NCT00395304|581052177|FG002|Treatment Period 3|Other|0|||
160906451|NCT00395304|581052178|FG003|Treatment Period 3|Other|1|||
160906452|NCT00395304|581052179|FG004|Treatment Period 3|Other|0|||
160906453|NCT00395304|581052180|FG005|Treatment Period 3|Other|0|||
160906454|NCT00980057|581052185|FG000|Overall Study|Death|13|||
160906455|NCT00980057|581052186|FG001|Overall Study|Death|3|||
160906456|NCT00980057|581052185|FG000|Overall Study|Adverse Event|0|||
160906457|NCT00980057|581052186|FG001|Overall Study|Adverse Event|1|||
160906458|NCT00980057|581052185|FG000|Overall Study|Physician Decision|4|||
160906459|NCT00980057|581052186|FG001|Overall Study|Physician Decision|0|||
160906460|NCT00980057|581052185|FG000|Overall Study|Lost to Follow-up|1|||
160906461|NCT00980057|581052186|FG001|Overall Study|Lost to Follow-up|0|||
160906462|NCT00980057|581052185|FG000|Overall Study|Withdrawal by Subject|1|||
160906463|NCT00980057|581052186|FG001|Overall Study|Withdrawal by Subject|1|||
160906464|NCT00691015|581052190|FG000|Overall Study|Refused further treatment|1|||
160906465|NCT03766581|581052195|FG000|Randomization|Other reasons|2|||
160906466|NCT03766581|581052196|FG001|Randomization|Other reasons|1|||
160848817|NCT03456076|580835611|FG000|Overall Study|Study ongoing|123|||
160848818|NCT03456076|580835612|FG001|Overall Study|Study ongoing|111|||
160848819|NCT03187132|580835615|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
160906467|NCT03766581|581052197|FG002|Randomization|Other reasons|0|||
160906468|NCT03766581|581052198|FG003|Randomization|Other reasons|1|||
160906469|NCT03766581|581052199|FG004|Randomization|Other reasons|0|||
160848820|NCT03187132|580835616|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
160848821|NCT03187132|580835615|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
160848822|NCT03187132|580835616|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
160906470|NCT03766581|581052200|FG005|Randomization|Other reasons|0|||
160906471|NCT03766581|581052201|FG006|Randomization|Other reasons|0|||
160906472|NCT03766581|581052202|FG007|Randomization|Other reasons|0|||
160906473|NCT03766581|581052195|FG000|Randomization|Participant no longer meets study criteria|5|||
160848823|NCT03187132|580835615|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
160848824|NCT03187132|580835616|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
160848825|NCT03187132|580835615|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
160848826|NCT03187132|580835616|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
160848827|NCT03187132|580835615|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
160848828|NCT03187132|580835616|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
160848829|NCT03187132|580835615|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
160848830|NCT03187132|580835616|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
160848831|NCT03187132|580835615|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
160848832|NCT03187132|580835616|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
160848833|NCT03187132|580835615|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
160848834|NCT03187132|580835616|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
160848835|NCT03187132|580835615|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
160848836|NCT03187132|580835616|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
160848837|NCT03187132|580835615|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
160848838|NCT03187132|580835616|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
160848839|NCT03187132|580835615|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
160848840|NCT03187132|580835616|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
160848841|NCT02045095|580835617|FG000|Overall Study|Other|0|||
160848842|NCT02045095|580835618|FG001|Overall Study|Other|0|||
160848843|NCT02045095|580835619|FG002|Overall Study|Other|1|||
160848844|NCT02045095|580835620|FG003|Overall Study|Other|0|||
160848845|NCT02045095|580835621|FG004|Overall Study|Other|0|||
160848846|NCT02045095|580835622|FG005|Overall Study|Other|2|||
160848847|NCT02045095|580835623|FG006|Overall Study|Other|0|||
160848848|NCT02045095|580835617|FG000|Overall Study|Progressive Disease|3|||
160848849|NCT02045095|580835618|FG001|Overall Study|Progressive Disease|3|||
160848850|NCT02045095|580835619|FG002|Overall Study|Progressive Disease|2|||
160848851|NCT02045095|580835620|FG003|Overall Study|Progressive Disease|4|||
160848852|NCT02045095|580835621|FG004|Overall Study|Progressive Disease|2|||
160848853|NCT02045095|580835622|FG005|Overall Study|Progressive Disease|4|||
160848854|NCT02045095|580835623|FG006|Overall Study|Progressive Disease|1|||
160848855|NCT02045095|580835617|FG000|Overall Study|Withdrawal by Subject|0|||
160848856|NCT02045095|580835618|FG001|Overall Study|Withdrawal by Subject|0|||
160848857|NCT02045095|580835619|FG002|Overall Study|Withdrawal by Subject|0|||
160848858|NCT02045095|580835620|FG003|Overall Study|Withdrawal by Subject|0|||
160848859|NCT02045095|580835621|FG004|Overall Study|Withdrawal by Subject|3|||
160848860|NCT02045095|580835622|FG005|Overall Study|Withdrawal by Subject|0|||
160848861|NCT02045095|580835623|FG006|Overall Study|Withdrawal by Subject|0|||
160848862|NCT02045095|580835617|FG000|Overall Study|Adverse Event|0|||
160848863|NCT02045095|580835618|FG001|Overall Study|Adverse Event|1|||
160848864|NCT02045095|580835619|FG002|Overall Study|Adverse Event|1|||
160848865|NCT02045095|580835620|FG003|Overall Study|Adverse Event|0|||
160848866|NCT02045095|580835621|FG004|Overall Study|Adverse Event|0|||
160848867|NCT02045095|580835622|FG005|Overall Study|Adverse Event|2|||
160848868|NCT02045095|580835623|FG006|Overall Study|Adverse Event|0|||
160848869|NCT02525588|580835624|FG000|Overall Study|Death|3|||
160848870|NCT02525588|580835625|FG001|Overall Study|Death|1|||
160848871|NCT02525588|580835624|FG000|Overall Study|Lost to Follow-up|2|||
160848872|NCT02525588|580835625|FG001|Overall Study|Lost to Follow-up|0|||
160848873|NCT02525588|580835624|FG000|Overall Study|Withdrawal by Subject|1|||
160848874|NCT02525588|580835625|FG001|Overall Study|Withdrawal by Subject|1|||
160848875|NCT02525588|580835624|FG000|Overall Study|Adverse Event|0|||
160848876|NCT02525588|580835625|FG001|Overall Study|Adverse Event|1|||
160848877|NCT01450761|580835629|FG000|Randomization|Subject no longer meets study criteria|1|||
160848878|NCT01450761|580835630|FG001|Randomization|Subject no longer meets study criteria|2|||
160848879|NCT01450761|580835629|FG000|Randomization|Withdrawal by Subject|2|||
160848880|NCT01450761|580835630|FG001|Randomization|Withdrawal by Subject|0|||
160848881|NCT01450761|580835629|FG000|Randomization|Disease progression|0|||
160848882|NCT01450761|580835630|FG001|Randomization|Disease progression|2|||
160848883|NCT01450761|580835629|FG000|Randomization|Adverse Event unrelated to study drug|1|||
160848884|NCT01450761|580835630|FG001|Randomization|Adverse Event unrelated to study drug|0|||
160848885|NCT01450761|580835629|FG000|Randomization|Other|0|||
160848886|NCT01450761|580835630|FG001|Randomization|Other|1|||
160848887|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Disease progression|33|||
160848888|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Disease progression|32|||
160848889|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
160906474|NCT03766581|581052196|FG001|Randomization|Participant no longer meets study criteria|3|||
160848890|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
160848891|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
160848892|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
160848893|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
160848894|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
160848895|NCT01450761|580835629|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
160848896|NCT01450761|580835630|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
160848897|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Death|3|||
160848898|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Death|3|||
160848899|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Other|2|||
160848900|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Other|2|||
160848901|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
160848902|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
160848903|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
160848904|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
160848905|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
160848906|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
160848907|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
160848908|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
160848909|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
160848910|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
160848911|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
160848912|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
160848913|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Death|5|||
160848914|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Death|6|||
160848915|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
160848916|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
160848917|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
160848918|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
160848919|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
160848920|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
160848921|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
160848922|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
160848923|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
160848924|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
160848925|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
160848926|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
160848927|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
160848928|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
160848929|NCT03801174|580835631|FG000|Overall Study|Withdrawal by Subject|14|||
160848930|NCT03801174|580835632|FG001|Overall Study|Withdrawal by Subject|15|||
160848931|NCT03801174|580835631|FG000|Overall Study|Death|1|||
160848932|NCT03801174|580835632|FG001|Overall Study|Death|0|||
160848933|NCT03801174|580835631|FG000|Overall Study|Pregnancy|2|||
160848934|NCT03801174|580835632|FG001|Overall Study|Pregnancy|2|||
160848935|NCT03801174|580835631|FG000|Overall Study|Lost to Follow-up|19|||
160848936|NCT03801174|580835632|FG001|Overall Study|Lost to Follow-up|10|||
160848937|NCT03801174|580835631|FG000|Overall Study|Other|4|||
160848938|NCT03801174|580835632|FG001|Overall Study|Other|3|||
160848939|NCT03801174|580835631|FG000|Overall Study|Lack of Efficacy|4|||
160848940|NCT03801174|580835632|FG001|Overall Study|Lack of Efficacy|0|||
160848941|NCT03801174|580835631|FG000|Overall Study|Unwilling to complete activities|5|||
160848942|NCT03801174|580835632|FG001|Overall Study|Unwilling to complete activities|6|||
160848943|NCT03801174|580835631|FG000|Overall Study|Moved out of area|3|||
160848944|NCT03801174|580835632|FG001|Overall Study|Moved out of area|0|||
160848945|NCT04435366|580835633|FG000|Year 1 (12 Months)|Adverse Event|3|||
160848946|NCT04435366|580835634|FG001|Year 1 (12 Months)|Adverse Event|0|||
160848947|NCT04435366|580835635|FG002|Year 1 (12 Months)|Adverse Event|2|||
160848948|NCT04435366|580835633|FG000|Year 1 (12 Months)|Death|2|||
160848949|NCT04435366|580835634|FG001|Year 1 (12 Months)|Death|0|||
160848950|NCT04435366|580835635|FG002|Year 1 (12 Months)|Death|1|||
160848951|NCT04435366|580835633|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
160848952|NCT04435366|580835634|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
160848953|NCT04435366|580835635|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
160848954|NCT04435366|580835633|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
160848955|NCT04435366|580835634|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
160848956|NCT04435366|580835635|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
160848957|NCT04435366|580835633|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
160848958|NCT04435366|580835634|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
160848959|NCT04435366|580835635|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
160848960|NCT04435366|580835633|FG000|Year 1 (12 Months)|Not treated|0|||
160848961|NCT04435366|580835634|FG001|Year 1 (12 Months)|Not treated|0|||
160848962|NCT04435366|580835635|FG002|Year 1 (12 Months)|Not treated|1|||
160848963|NCT04435366|580835633|FG000|Year 2 (12 Months)|Death|1|||
160848964|NCT04435366|580835634|FG001|Year 2 (12 Months)|Death|4|||
160568548|NCT00613626|579803958|FG001|Overall Study|Ineligible|1|||
160906475|NCT03766581|581052197|FG002|Randomization|Participant no longer meets study criteria|4|||
160906476|NCT03766581|581052198|FG003|Randomization|Participant no longer meets study criteria|0|||
160906477|NCT03766581|581052199|FG004|Randomization|Participant no longer meets study criteria|2|||
160906478|NCT03766581|581052200|FG005|Randomization|Participant no longer meets study criteria|3|||
160906479|NCT03766581|581052201|FG006|Randomization|Participant no longer meets study criteria|0|||
160906480|NCT03766581|581052202|FG007|Randomization|Participant no longer meets study criteria|1|||
160906481|NCT03766581|581052195|FG000|Randomization|Participant request to discontinue study treatment|1|||
160906482|NCT03766581|581052196|FG001|Randomization|Participant request to discontinue study treatment|0|||
160906483|NCT03766581|581052197|FG002|Randomization|Participant request to discontinue study treatment|0|||
160906484|NCT03766581|581052198|FG003|Randomization|Participant request to discontinue study treatment|0|||
160906485|NCT03766581|581052199|FG004|Randomization|Participant request to discontinue study treatment|1|||
160906486|NCT03766581|581052200|FG005|Randomization|Participant request to discontinue study treatment|2|||
160906487|NCT03766581|581052201|FG006|Randomization|Participant request to discontinue study treatment|0|||
160906488|NCT03766581|581052202|FG007|Randomization|Participant request to discontinue study treatment|0|||
160906489|NCT03766581|581052195|FG000|Randomization|Participant withdrew consent|1|||
160906490|NCT03766581|581052196|FG001|Randomization|Participant withdrew consent|0|||
160906491|NCT03766581|581052197|FG002|Randomization|Participant withdrew consent|1|||
160906492|NCT03766581|581052198|FG003|Randomization|Participant withdrew consent|2|||
160906493|NCT03766581|581052199|FG004|Randomization|Participant withdrew consent|1|||
160906494|NCT03766581|581052200|FG005|Randomization|Participant withdrew consent|1|||
160906495|NCT03766581|581052201|FG006|Randomization|Participant withdrew consent|0|||
160906496|NCT03766581|581052202|FG007|Randomization|Participant withdrew consent|0|||
160906497|NCT03766581|581052195|FG000|Treatment|Adverse Event|82|||
160906498|NCT03766581|581052196|FG001|Treatment|Adverse Event|44|||
160906499|NCT03766581|581052197|FG002|Treatment|Adverse Event|47|||
160906500|NCT03766581|581052198|FG003|Treatment|Adverse Event|46|||
160906501|NCT03766581|581052199|FG004|Treatment|Adverse Event|50|||
160906502|NCT03766581|581052200|FG005|Treatment|Adverse Event|77|||
160906503|NCT03766581|581052201|FG006|Treatment|Adverse Event|5|||
160906504|NCT03766581|581052202|FG007|Treatment|Adverse Event|2|||
160906505|NCT03766581|581052195|FG000|Treatment|Participant request to discontinue treatment|34|||
160906506|NCT03766581|581052196|FG001|Treatment|Participant request to discontinue treatment|6|||
160906507|NCT03766581|581052197|FG002|Treatment|Participant request to discontinue treatment|10|||
160906508|NCT03766581|581052198|FG003|Treatment|Participant request to discontinue treatment|10|||
160906509|NCT03766581|581052199|FG004|Treatment|Participant request to discontinue treatment|14|||
160906510|NCT03766581|581052200|FG005|Treatment|Participant request to discontinue treatment|15|||
160906511|NCT03766581|581052201|FG006|Treatment|Participant request to discontinue treatment|0|||
160906512|NCT03766581|581052202|FG007|Treatment|Participant request to discontinue treatment|1|||
160906513|NCT03766581|581052195|FG000|Treatment|Participant withdrew consent|11|||
160906514|NCT03766581|581052196|FG001|Treatment|Participant withdrew consent|4|||
160906515|NCT03766581|581052197|FG002|Treatment|Participant withdrew consent|5|||
160906516|NCT03766581|581052198|FG003|Treatment|Participant withdrew consent|5|||
160906517|NCT03766581|581052199|FG004|Treatment|Participant withdrew consent|4|||
160906518|NCT03766581|581052200|FG005|Treatment|Participant withdrew consent|4|||
160906519|NCT03766581|581052201|FG006|Treatment|Participant withdrew consent|0|||
160906520|NCT03766581|581052202|FG007|Treatment|Participant withdrew consent|0|||
160906521|NCT03766581|581052195|FG000|Treatment|Death|1|||
160906522|NCT03766581|581052196|FG001|Treatment|Death|0|||
160906523|NCT03766581|581052197|FG002|Treatment|Death|0|||
160906524|NCT03766581|581052198|FG003|Treatment|Death|0|||
160906525|NCT03766581|581052199|FG004|Treatment|Death|0|||
160906526|NCT03766581|581052200|FG005|Treatment|Death|0|||
160568549|NCT00613626|579803959|FG002|Overall Study|Ineligible|0|||
160848965|NCT04435366|580835635|FG002|Year 2 (12 Months)|Death|6|||
160848966|NCT04435366|580835633|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
160848967|NCT04435366|580835634|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
160848968|NCT04435366|580835635|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
160848969|NCT04435366|580835633|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
160848970|NCT04435366|580835634|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
160848971|NCT04435366|580835635|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
160848972|NCT04435366|580835633|FG000|Year 2 (12 Months)|Adverse Event|2|||
160906527|NCT03766581|581052201|FG006|Treatment|Death|0|||
160848973|NCT04435366|580835634|FG001|Year 2 (12 Months)|Adverse Event|1|||
160848974|NCT04435366|580835635|FG002|Year 2 (12 Months)|Adverse Event|6|||
160848975|NCT05963022|580835640|FG000|Overall Study|Adverse Event|0|||
160848976|NCT05963022|580835641|FG001|Overall Study|Adverse Event|1|||
160848977|NCT05963022|580835642|FG002|Overall Study|Adverse Event|1|||
160848978|NCT05963022|580835643|FG003|Overall Study|Adverse Event|0|||
160848979|NCT05963022|580835640|FG000|Overall Study|Protocol Violation|0|||
160848980|NCT05963022|580835641|FG001|Overall Study|Protocol Violation|3|||
160848981|NCT05963022|580835642|FG002|Overall Study|Protocol Violation|0|||
160848982|NCT05963022|580835643|FG003|Overall Study|Protocol Violation|0|||
160848983|NCT05963022|580835640|FG000|Overall Study|Pregnancy|0|||
160848984|NCT05963022|580835641|FG001|Overall Study|Pregnancy|1|||
160848985|NCT05963022|580835642|FG002|Overall Study|Pregnancy|1|||
160848986|NCT05963022|580835643|FG003|Overall Study|Pregnancy|1|||
160848987|NCT05963022|580835640|FG000|Overall Study|Withdrawal by Subject|0|||
160848988|NCT05963022|580835641|FG001|Overall Study|Withdrawal by Subject|0|||
160848989|NCT05963022|580835642|FG002|Overall Study|Withdrawal by Subject|2|||
160848990|NCT05963022|580835643|FG003|Overall Study|Withdrawal by Subject|1|||
160848991|NCT05963022|580835640|FG000|Overall Study|Lost to Follow-up|0|||
160848992|NCT05963022|580835641|FG001|Overall Study|Lost to Follow-up|0|||
160848993|NCT05963022|580835642|FG002|Overall Study|Lost to Follow-up|0|||
160848994|NCT05963022|580835643|FG003|Overall Study|Lost to Follow-up|1|||
160848995|NCT05963022|580835640|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
160848996|NCT05963022|580835641|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
160848997|NCT05963022|580835642|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
160848998|NCT05963022|580835643|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
160848999|NCT02478463|580835648|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
160849000|NCT02478463|580835648|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
160849001|NCT02478463|580835648|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
160849002|NCT01177007|580835650|FG000|Overall Study|Lost to Follow-up|2|||
160849003|NCT01177007|580835650|FG000|Overall Study|Death|4|||
160849004|NCT01177007|580835650|FG000|Overall Study|Entered hospice care|5|||
160849005|NCT01177007|580835650|FG000|Overall Study|Required additional Y90 treatment|6|||
160849006|NCT01177007|580835650|FG000|Overall Study|Change in treatment modality|21|||
160849007|NCT01702558|580835652|FG000|Overall Study|Withdrawal by Subject|0|||
160992482|NCT01020838|581361376|FG000|Overall Study|Withdrawal by Subject|9|||
160992483|NCT01020838|581361376|FG000|Overall Study|Lost to Follow-up|6|||
160992484|NCT01020838|581361376|FG000|Overall Study|Most common: Study ended by sponsor|77|||
160992485|NCT02993471|581361377|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
160992486|NCT02993471|581361377|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
160992487|NCT01908634|581361379|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
160849008|NCT01702558|580835653|FG001|Overall Study|Withdrawal by Subject|0|||
160849009|NCT01702558|580835654|FG002|Overall Study|Withdrawal by Subject|0|||
160849010|NCT01702558|580835655|FG003|Overall Study|Withdrawal by Subject|12|||
160906528|NCT03766581|581052202|FG007|Treatment|Death|0|||
160906529|NCT03766581|581052195|FG000|Treatment|Lost to Follow-up|1|||
160906530|NCT03766581|581052196|FG001|Treatment|Lost to Follow-up|0|||
160906531|NCT03766581|581052197|FG002|Treatment|Lost to Follow-up|0|||
160906532|NCT03766581|581052198|FG003|Treatment|Lost to Follow-up|1|||
160906533|NCT03766581|581052199|FG004|Treatment|Lost to Follow-up|0|||
160906534|NCT03766581|581052200|FG005|Treatment|Lost to Follow-up|0|||
160906535|NCT03766581|581052201|FG006|Treatment|Lost to Follow-up|0|||
160906536|NCT03766581|581052202|FG007|Treatment|Lost to Follow-up|0|||
160992488|NCT01908634|581361379|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
160849011|NCT01702558|580835656|FG004|Overall Study|Withdrawal by Subject|4|||
160849012|NCT01702558|580835652|FG000|Overall Study|Lost to Follow-up|0|||
160849013|NCT01702558|580835653|FG001|Overall Study|Lost to Follow-up|0|||
160849014|NCT01702558|580835654|FG002|Overall Study|Lost to Follow-up|0|||
160906537|NCT03766581|581052195|FG000|Treatment|Poor/Non compliance|2|||
160849015|NCT01702558|580835655|FG003|Overall Study|Lost to Follow-up|3|||
160849016|NCT01702558|580835656|FG004|Overall Study|Lost to Follow-up|0|||
160849017|NCT01702558|580835652|FG000|Overall Study|Death|4|||
160849018|NCT01702558|580835653|FG001|Overall Study|Death|3|||
160849019|NCT01702558|580835654|FG002|Overall Study|Death|3|||
160906538|NCT03766581|581052196|FG001|Treatment|Poor/Non compliance|2|||
160906539|NCT03766581|581052197|FG002|Treatment|Poor/Non compliance|1|||
160906540|NCT03766581|581052198|FG003|Treatment|Poor/Non compliance|1|||
160849020|NCT01702558|580835655|FG003|Overall Study|Death|16|||
160849021|NCT01702558|580835656|FG004|Overall Study|Death|20|||
160849022|NCT01702558|580835652|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
160849023|NCT01702558|580835653|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
160849024|NCT01702558|580835654|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
160849025|NCT01702558|580835655|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
160849026|NCT01702558|580835656|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
160849027|NCT01702558|580835652|FG000|Overall Study|Study Terminated by Sponsor|0|||
160849028|NCT01702558|580835653|FG001|Overall Study|Study Terminated by Sponsor|1|||
160849029|NCT01702558|580835654|FG002|Overall Study|Study Terminated by Sponsor|0|||
160849030|NCT01702558|580835655|FG003|Overall Study|Study Terminated by Sponsor|0|||
160849031|NCT01702558|580835656|FG004|Overall Study|Study Terminated by Sponsor|1|||
160849032|NCT01702558|580835652|FG000|Overall Study|Other|0|||
160849033|NCT01702558|580835653|FG001|Overall Study|Other|0|||
160849034|NCT01702558|580835654|FG002|Overall Study|Other|0|||
160849035|NCT01702558|580835655|FG003|Overall Study|Other|16|||
160849036|NCT01702558|580835656|FG004|Overall Study|Other|17|||
160849037|NCT03259087|580835662|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
160849038|NCT03259087|580835663|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
160849039|NCT03259087|580835664|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
160849040|NCT03259087|580835665|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
160849041|NCT03259087|580835666|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
160849042|NCT03259087|580835662|FG000|Period 2 of Part 2|Adverse Event|0|||
160849043|NCT03259087|580835663|FG001|Period 2 of Part 2|Adverse Event|0|||
160849044|NCT03259087|580835664|FG002|Period 2 of Part 2|Adverse Event|0|||
160849045|NCT03259087|580835665|FG003|Period 2 of Part 2|Adverse Event|0|||
160849046|NCT03259087|580835666|FG004|Period 2 of Part 2|Adverse Event|1|||
160849047|NCT04524858|580835667|FG000|Overall Study|Adverse Event|1|||
160849048|NCT03571204|580835668|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
160849049|NCT03571204|580835669|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
160849050|NCT03571204|580835670|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
160849051|NCT03571204|580835668|FG000|Overall Study|Physician Decision|0|||
160849052|NCT03571204|580835669|FG001|Overall Study|Physician Decision|1|||
160849053|NCT03571204|580835670|FG002|Overall Study|Physician Decision|0|||
160849054|NCT02396212|580835671|FG000|Overall Study|Adverse Event|1|||
160849055|NCT02396212|580835671|FG000|Overall Study|Lack of Efficacy|2|||
160849056|NCT01623115|580835672|FG000|Overall Study|Randomized but not treated|0|||
160849057|NCT01623115|580835673|FG001|Overall Study|Randomized but not treated|1|||
160849058|NCT01623115|580835672|FG000|Overall Study|Physician Decision|1|||
160849059|NCT01623115|580835673|FG001|Overall Study|Physician Decision|0|||
160849060|NCT01623115|580835672|FG000|Overall Study|Participants moved|1|||
160849061|NCT01623115|580835673|FG001|Overall Study|Participants moved|5|||
160849062|NCT01623115|580835672|FG000|Overall Study|Adverse Event|10|||
160849063|NCT01623115|580835673|FG001|Overall Study|Adverse Event|13|||
160849064|NCT01623115|580835672|FG000|Overall Study|Poor compliance to protocol|4|||
160849065|NCT01623115|580835673|FG001|Overall Study|Poor compliance to protocol|10|||
160849066|NCT01623115|580835672|FG000|Overall Study|Consent withdrawn by participant|2|||
160849067|NCT01623115|580835673|FG001|Overall Study|Consent withdrawn by participant|6|||
160650530|NCT02154529|580101601|FG002|Overall Study|Lost to Follow-up|0|||
160849068|NCT01623115|580835672|FG000|Overall Study|Related to study drug administration|0|||
160849069|NCT01623115|580835673|FG001|Overall Study|Related to study drug administration|2|||
160849070|NCT01623115|580835672|FG000|Overall Study|Last visit outside protocol visit window|14|||
160849071|NCT01623115|580835673|FG001|Overall Study|Last visit outside protocol visit window|26|||
160849072|NCT01623115|580835672|FG000|Overall Study|Site closure|1|||
160849073|NCT01623115|580835673|FG001|Overall Study|Site closure|7|||
160849074|NCT01623115|580835672|FG000|Overall Study|Death|0|||
160849075|NCT01623115|580835673|FG001|Overall Study|Death|4|||
160849076|NCT01623115|580835672|FG000|Overall Study|Other than specified above|0|||
160849077|NCT01623115|580835673|FG001|Overall Study|Other than specified above|3|||
160849078|NCT04950465|580835674|FG000|Overall Study|Lost to Follow-up|1|||
160849079|NCT04950465|580835675|FG001|Overall Study|Lost to Follow-up|0|||
160849080|NCT04950465|580835676|FG002|Overall Study|Lost to Follow-up|0|||
160849081|NCT02721875|580835681|FG000|Overall Study|Progressive disease/relapse|1|||
160849082|NCT02721875|580835682|FG001|Overall Study|Progressive disease/relapse|0|||
160849083|NCT02888106|580835683|FG000|Overall Study|Withdrawal by Subject|1|||
160849084|NCT02888106|580835684|FG001|Overall Study|Withdrawal by Subject|2|||
160849085|NCT02888106|580835685|FG002|Overall Study|Withdrawal by Subject|0|||
160849086|NCT02888106|580835686|FG003|Overall Study|Withdrawal by Subject|1|||
160849087|NCT02888106|580835687|FG004|Overall Study|Withdrawal by Subject|0|||
160849088|NCT02888106|580835688|FG005|Overall Study|Withdrawal by Subject|0|||
160849089|NCT02888106|580835683|FG000|Overall Study|Lost to Follow-up|1|||
160849090|NCT02888106|580835684|FG001|Overall Study|Lost to Follow-up|0|||
160849091|NCT02888106|580835685|FG002|Overall Study|Lost to Follow-up|0|||
160849092|NCT02888106|580835686|FG003|Overall Study|Lost to Follow-up|1|||
160849093|NCT02888106|580835687|FG004|Overall Study|Lost to Follow-up|0|||
160849094|NCT02888106|580835688|FG005|Overall Study|Lost to Follow-up|1|||
160849095|NCT02888106|580835683|FG000|Overall Study|Adverse Event|2|||
160849096|NCT02888106|580835684|FG001|Overall Study|Adverse Event|0|||
160849097|NCT02888106|580835685|FG002|Overall Study|Adverse Event|0|||
160849098|NCT02888106|580835686|FG003|Overall Study|Adverse Event|0|||
160849099|NCT02888106|580835687|FG004|Overall Study|Adverse Event|0|||
160849100|NCT02888106|580835688|FG005|Overall Study|Adverse Event|0|||
160849101|NCT02888106|580835683|FG000|Overall Study|Withdrawal of consent|0|||
160849102|NCT02888106|580835684|FG001|Overall Study|Withdrawal of consent|0|||
160849103|NCT02888106|580835685|FG002|Overall Study|Withdrawal of consent|0|||
160849104|NCT02888106|580835686|FG003|Overall Study|Withdrawal of consent|0|||
160849105|NCT02888106|580835687|FG004|Overall Study|Withdrawal of consent|1|||
160849106|NCT02888106|580835688|FG005|Overall Study|Withdrawal of consent|0|||
160849107|NCT02888106|580835683|FG000|Overall Study|Pregnancy|1|||
160849108|NCT02888106|580835684|FG001|Overall Study|Pregnancy|0|||
160849109|NCT02888106|580835685|FG002|Overall Study|Pregnancy|0|||
160849110|NCT02888106|580835686|FG003|Overall Study|Pregnancy|0|||
160849111|NCT02888106|580835687|FG004|Overall Study|Pregnancy|0|||
160849112|NCT02888106|580835688|FG005|Overall Study|Pregnancy|0|||
160849113|NCT01425801|580835694|FG000|Period 1|Withdrawal by Subject|0|||
160849114|NCT01425801|580835695|FG001|Period 1|Withdrawal by Subject|0|||
160849115|NCT01425801|580835696|FG002|Period 1|Withdrawal by Subject|0|||
160849116|NCT01425801|580835697|FG003|Period 1|Withdrawal by Subject|0|||
160849117|NCT01425801|580835698|FG004|Period 1|Withdrawal by Subject|1|||
160849118|NCT01425801|580835699|FG005|Period 1|Withdrawal by Subject|0|||
160849119|NCT01425801|580835694|FG000|Period 2|Withdrawal by Subject|0|||
160849120|NCT01425801|580835695|FG001|Period 2|Withdrawal by Subject|0|||
160849121|NCT01425801|580835696|FG002|Period 2|Withdrawal by Subject|0|||
160849122|NCT01425801|580835697|FG003|Period 2|Withdrawal by Subject|0|||
160849123|NCT01425801|580835698|FG004|Period 2|Withdrawal by Subject|1|||
160849124|NCT01425801|580835699|FG005|Period 2|Withdrawal by Subject|0|||
160849125|NCT01425801|580835694|FG000|Period 3|Stability criteria not fullfilled|0|||
160849126|NCT01425801|580835695|FG001|Period 3|Stability criteria not fullfilled|0|||
160849127|NCT01425801|580835696|FG002|Period 3|Stability criteria not fullfilled|1|||
160849128|NCT01425801|580835697|FG003|Period 3|Stability criteria not fullfilled|0|||
160849129|NCT01425801|580835698|FG004|Period 3|Stability criteria not fullfilled|0|||
160849130|NCT01425801|580835699|FG005|Period 3|Stability criteria not fullfilled|0|||
160849131|NCT01425801|580835694|FG000|Period 4|Not able to maintain visit schedule|0|||
160849132|NCT01425801|580835695|FG001|Period 4|Not able to maintain visit schedule|0|||
160849133|NCT01425801|580835696|FG002|Period 4|Not able to maintain visit schedule|1|||
160849134|NCT01425801|580835697|FG003|Period 4|Not able to maintain visit schedule|0|||
160849135|NCT01425801|580835698|FG004|Period 4|Not able to maintain visit schedule|0|||
160849136|NCT01425801|580835699|FG005|Period 4|Not able to maintain visit schedule|0|||
160849137|NCT03066596|580835700|FG000|Overall Study|Withdrawal by Subject|4|||
160849138|NCT03066596|580835701|FG001|Overall Study|Withdrawal by Subject|2|||
160849139|NCT03066596|580835700|FG000|Overall Study|Lost to Follow-up|14|||
160849140|NCT03066596|580835701|FG001|Overall Study|Lost to Follow-up|10|||
160849141|NCT03797586|580835702|FG000|Overall Study|Lost to Follow-up|3|||
160849142|NCT03797586|580835703|FG001|Overall Study|Lost to Follow-up|6|||
160849143|NCT03797586|580835702|FG000|Overall Study|Death|1|||
160849144|NCT03797586|580835703|FG001|Overall Study|Death|1|||
160849145|NCT03797586|580835702|FG000|Overall Study|Adverse Event|0|||
160849146|NCT03797586|580835703|FG001|Overall Study|Adverse Event|2|||
160906541|NCT03766581|581052199|FG004|Treatment|Poor/Non compliance|1|||
160906542|NCT03766581|581052200|FG005|Treatment|Poor/Non compliance|1|||
160906543|NCT03766581|581052201|FG006|Treatment|Poor/Non compliance|0|||
160906544|NCT03766581|581052202|FG007|Treatment|Poor/Non compliance|0|||
160906545|NCT03766581|581052195|FG000|Treatment|Participant no longer meets study criteria|9|||
160906546|NCT03766581|581052196|FG001|Treatment|Participant no longer meets study criteria|1|||
160906547|NCT03766581|581052197|FG002|Treatment|Participant no longer meets study criteria|5|||
160906548|NCT03766581|581052198|FG003|Treatment|Participant no longer meets study criteria|4|||
160906549|NCT03766581|581052199|FG004|Treatment|Participant no longer meets study criteria|4|||
160849147|NCT02959437|580835704|FG000|Overall Study|Death|33|||
160849148|NCT02959437|580835705|FG001|Overall Study|Death|3|||
160849149|NCT02959437|580835706|FG002|Overall Study|Death|0|||
160849150|NCT02959437|580835707|FG003|Overall Study|Death|0|||
160849151|NCT02959437|580835704|FG000|Overall Study|Lost to Follow-up|3|||
160849152|NCT02959437|580835705|FG001|Overall Study|Lost to Follow-up|1|||
160849153|NCT02959437|580835706|FG002|Overall Study|Lost to Follow-up|0|||
160849154|NCT02959437|580835707|FG003|Overall Study|Lost to Follow-up|0|||
160849155|NCT02959437|580835704|FG000|Overall Study|Withdrawal by Subject|11|||
160849156|NCT02959437|580835705|FG001|Overall Study|Withdrawal by Subject|3|||
160849157|NCT02959437|580835706|FG002|Overall Study|Withdrawal by Subject|0|||
160906550|NCT03766581|581052200|FG005|Treatment|Participant no longer meets study criteria|4|||
160849158|NCT02959437|580835707|FG003|Overall Study|Withdrawal by Subject|0|||
160849159|NCT02959437|580835704|FG000|Overall Study|Progressive Disease|9|||
160849160|NCT02959437|580835705|FG001|Overall Study|Progressive Disease|1|||
160849161|NCT02959437|580835706|FG002|Overall Study|Progressive Disease|0|||
160849162|NCT02959437|580835707|FG003|Overall Study|Progressive Disease|0|||
160906551|NCT03766581|581052201|FG006|Treatment|Participant no longer meets study criteria|2|||
160849163|NCT02959437|580835704|FG000|Overall Study|Study Terminated by Sponsor|4|||
160849164|NCT02959437|580835705|FG001|Overall Study|Study Terminated by Sponsor|0|||
160849165|NCT02959437|580835706|FG002|Overall Study|Study Terminated by Sponsor|0|||
160849166|NCT02959437|580835707|FG003|Overall Study|Study Terminated by Sponsor|0|||
160849167|NCT02959437|580835704|FG000|Overall Study|Other Unspecified|2|||
160849168|NCT02959437|580835705|FG001|Overall Study|Other Unspecified|0|||
160849169|NCT02959437|580835706|FG002|Overall Study|Other Unspecified|0|||
160849170|NCT02959437|580835707|FG003|Overall Study|Other Unspecified|0|||
160849171|NCT02864901|580835708|FG000|Overall Study|Withdrawal by Subject|1|||
160849172|NCT02864901|580835709|FG001|Overall Study|Withdrawal by Subject|0|||
160849173|NCT01219985|580835714|FG000|Overall Study|Physician Decision|20|||
160849174|NCT01369784|580835715|FG000|Overall Study|Protocol Violation|12|||
160849175|NCT04797780|580835718|FG000|Overall Study|Lost to Follow-up|1|||
160849176|NCT04797780|580835719|FG001|Overall Study|Lost to Follow-up|1|||
160849177|NCT04797780|580835718|FG000|Overall Study|Withdrawal by Subject|14|||
160849178|NCT04797780|580835719|FG001|Overall Study|Withdrawal by Subject|9|||
160849179|NCT04797780|580835718|FG000|Overall Study|Death|49|||
160849180|NCT04797780|580835719|FG001|Overall Study|Death|20|||
160849181|NCT02940496|580835720|FG000|Overall Study|Adverse Event|1|||
160849182|NCT02940496|580835721|FG001|Overall Study|Adverse Event|0|||
160849183|NCT02940496|580835720|FG000|Overall Study|Death|2|||
160849184|NCT02940496|580835721|FG001|Overall Study|Death|0|||
160849185|NCT02940496|580835720|FG000|Overall Study|Hospice Care|1|||
160849186|NCT02940496|580835721|FG001|Overall Study|Hospice Care|0|||
160849187|NCT02940496|580835720|FG000|Overall Study|No MRE Done|1|||
160849188|NCT02940496|580835721|FG001|Overall Study|No MRE Done|0|||
160849189|NCT02940496|580835720|FG000|Overall Study|MRE Failure|1|||
160849190|NCT02940496|580835721|FG001|Overall Study|MRE Failure|0|||
160849191|NCT05973006|580835722|FG000|Overall Study|Early termination|3|||
160849192|NCT05973006|580835723|FG001|Overall Study|Early termination|9|||
160849193|NCT05167825|580835724|FG000|Overall Study|Ongoing|3|||
160849194|NCT01807598|580835725|FG000|Overall Study|Withdrawal by Subject|4|||
160849195|NCT01807598|580835725|FG000|Overall Study|Adverse Event|1|||
160849196|NCT01807598|580835725|FG000|Overall Study|Other Physician Decision|1|||
160849197|NCT04089761|580835728|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
160849198|NCT04089761|580835728|FG000|"Run In Phase"|Lost to Follow-up|1|||
160849199|NCT04089761|580835728|FG000|"Treatment Phase"|No evaluable data|5|||
160849200|NCT04089761|580835728|FG000|"Treatment Phase"|Lost to Follow-up|1|||
160849201|NCT03622814|580835729|FG000|Overall Study|Lost to Follow-up|8|||
160849202|NCT03622814|580835730|FG001|Overall Study|Lost to Follow-up|14|||
160906552|NCT03766581|581052202|FG007|Treatment|Participant no longer meets study criteria|0|||
160906553|NCT03766581|581052195|FG000|Treatment|Other reasons|13|||
160906554|NCT03766581|581052196|FG001|Treatment|Other reasons|8|||
160906555|NCT03766581|581052197|FG002|Treatment|Other reasons|3|||
160906556|NCT03766581|581052198|FG003|Treatment|Other reasons|7|||
160906557|NCT03766581|581052199|FG004|Treatment|Other reasons|3|||
160906558|NCT03766581|581052200|FG005|Treatment|Other reasons|3|||
160906559|NCT03766581|581052201|FG006|Treatment|Other reasons|0|||
160849203|NCT04417361|580835731|FG000|Overall Study|Withdrawal by Subject|1|||
160849204|NCT04417361|580835732|FG001|Overall Study|Withdrawal by Subject|0|||
160849205|NCT04417361|580835731|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
160849206|NCT04417361|580835732|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
160849207|NCT00165672|580835733|FG000|Overall Study|Adverse Event|0|||
160849208|NCT00165672|580835734|FG001|Overall Study|Adverse Event|1|||
160849209|NCT03868943|580835735|FG000|Overall Study|Adverse Event|1|||
160849210|NCT04896593|580835738|FG000|Overall Study|Withdrawal by Subject|2|||
160849211|NCT04896593|580835738|FG000|Overall Study|Lost to Follow-up|1|||
160849212|NCT04896593|580835738|FG000|Overall Study|Did not complete onboarding|2|||
160849213|NCT00892775|580835739|FG000|Overall Study|Protocol Violation|1|||
160849214|NCT00892775|580835740|FG001|Overall Study|Protocol Violation|0|||
160849215|NCT00892775|580835739|FG000|Overall Study|Subject difficulties with blood drawing|1|||
160849216|NCT00892775|580835740|FG001|Overall Study|Subject difficulties with blood drawing|0|||
160906560|NCT03766581|581052202|FG007|Treatment|Other reasons|0|||
160849217|NCT00892775|580835739|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
160849218|NCT00892775|580835740|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
160849219|NCT00892775|580835739|FG000|Overall Study|Migrated/ moved from study area|1|||
160849220|NCT00892775|580835740|FG001|Overall Study|Migrated/ moved from study area|0|||
160849221|NCT00892775|580835739|FG000|Overall Study|Withdrawal by Subject|0|||
160849222|NCT00892775|580835740|FG001|Overall Study|Withdrawal by Subject|1|||
160849223|NCT00892775|580835739|FG000|Overall Study|Lost to Follow-up|1|||
160849224|NCT00892775|580835740|FG001|Overall Study|Lost to Follow-up|0|||
160849225|NCT00869518|580835743|FG000|Overall Study|Lost to Follow-up|1|||
160849226|NCT00869518|580835744|FG001|Overall Study|Lost to Follow-up|1|||
160849227|NCT04178720|580835745|FG000|Overall Study|Withdrawal by Subject|2|||
160849228|NCT04178720|580835746|FG001|Overall Study|Withdrawal by Subject|0|||
160906561|NCT03716024|581052203|FG000|Overall Study|Randomized, not Treated|7|||
160906562|NCT03716024|581052204|FG001|Overall Study|Randomized, not Treated|8|||
160906563|NCT03716024|581052203|FG000|Overall Study|Adverse Event|1|||
160849229|NCT04178720|580835745|FG000|Overall Study|Relocation|0|||
160849230|NCT04178720|580835746|FG001|Overall Study|Relocation|1|||
160849231|NCT03922620|580835747|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
160849232|NCT03922620|580835748|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
160849233|NCT01633788|580837733|FG000|Overall Study|Adverse Event|1|||
160849234|NCT01633788|580837734|FG001|Overall Study|Adverse Event|3|||
160849235|NCT01633788|580837735|FG002|Overall Study|Adverse Event|3|||
160849236|NCT01633788|580837736|FG003|Overall Study|Adverse Event|3|||
160849237|NCT01633788|580837733|FG000|Overall Study|Lost to Follow-up|2|||
160849238|NCT01633788|580837734|FG001|Overall Study|Lost to Follow-up|2|||
160849239|NCT01633788|580837735|FG002|Overall Study|Lost to Follow-up|2|||
160849240|NCT01633788|580837736|FG003|Overall Study|Lost to Follow-up|0|||
160849241|NCT01633788|580837733|FG000|Overall Study|Personal Reasons|3|||
160849242|NCT01633788|580837734|FG001|Overall Study|Personal Reasons|1|||
160849243|NCT01633788|580837735|FG002|Overall Study|Personal Reasons|1|||
160849244|NCT01633788|580837736|FG003|Overall Study|Personal Reasons|3|||
160849245|NCT01633788|580837733|FG000|Overall Study|Protocol Violation|1|||
160849246|NCT01633788|580837734|FG001|Overall Study|Protocol Violation|0|||
160849247|NCT01633788|580837735|FG002|Overall Study|Protocol Violation|1|||
160849248|NCT01633788|580837736|FG003|Overall Study|Protocol Violation|0|||
160849249|NCT01633788|580837733|FG000|Overall Study|Other Reasons|0|||
160849250|NCT01633788|580837734|FG001|Overall Study|Other Reasons|2|||
160849251|NCT01633788|580837735|FG002|Overall Study|Other Reasons|3|||
160849252|NCT01633788|580837736|FG003|Overall Study|Other Reasons|7|||
160849253|NCT01389882|580837741|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
160849254|NCT01389882|580837742|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
160849255|NCT01389882|580837741|FG000|Overall Study|Withdrawal by Subject|0|||
160849256|NCT01389882|580837742|FG001|Overall Study|Withdrawal by Subject|1|||
160849257|NCT03811340|580837743|FG000|Overall Study|subjects did not complete the survey.|90|||
160849258|NCT01045967|580837744|FG000|Second Intervention|Protocol Violation|0|||
160849259|NCT01045967|580837745|FG001|Second Intervention|Protocol Violation|1|||
160849260|NCT00985673|580837746|FG000|Overall Study|Lost to Follow-up|6|||
160849261|NCT00985673|580837747|FG001|Overall Study|Lost to Follow-up|7|||
160849262|NCT00985673|580837748|FG002|Overall Study|Lost to Follow-up|6|||
160849263|NCT00985673|580837749|FG003|Overall Study|Lost to Follow-up|10|||
160849264|NCT00985673|580837750|FG004|Overall Study|Lost to Follow-up|5|||
160849265|NCT00985673|580837751|FG005|Overall Study|Lost to Follow-up|3|||
160849266|NCT00985673|580837746|FG000|Overall Study|Withdrawal by Subject|0|||
160849267|NCT00985673|580837747|FG001|Overall Study|Withdrawal by Subject|4|||
160849268|NCT00985673|580837748|FG002|Overall Study|Withdrawal by Subject|5|||
160849269|NCT00985673|580837749|FG003|Overall Study|Withdrawal by Subject|2|||
160992489|NCT04176458|581361380|FG000|Overall Study|Covid 19|4|||
160992490|NCT00891618|581361381|FG000|Overall Study|Withdrawal by Subject|1|||
160992491|NCT02145182|581361382|FG000|Overall Study|Adverse Event|4|||
160992492|NCT02145182|581361383|FG001|Overall Study|Adverse Event|1|||
160992493|NCT02145182|581361382|FG000|Overall Study|Death|7|||
160992494|NCT02145182|581361383|FG001|Overall Study|Death|7|||
160992495|NCT02145182|581361382|FG000|Overall Study|Lost to Follow-up|2|||
160849270|NCT00985673|580837750|FG004|Overall Study|Withdrawal by Subject|2|||
160849271|NCT00985673|580837751|FG005|Overall Study|Withdrawal by Subject|3|||
160849272|NCT00985673|580837746|FG000|Overall Study|Other|1|||
160849273|NCT00985673|580837747|FG001|Overall Study|Other|0|||
160849274|NCT00985673|580837748|FG002|Overall Study|Other|1|||
160849275|NCT00985673|580837749|FG003|Overall Study|Other|0|||
160849276|NCT00985673|580837750|FG004|Overall Study|Other|1|||
160849277|NCT00985673|580837751|FG005|Overall Study|Other|0|||
160849278|NCT02252146|580837752|FG000|Overall Study|Lack of Efficacy|4|||
160849279|NCT02252146|580837752|FG000|Overall Study|Entered hospice care|1|||
160849280|NCT02252146|580837752|FG000|Overall Study|Inability to travel to study site|1|||
160849281|NCT00531284|580837753|FG000|Overall Study|Progressive Disease|1|||
160849282|NCT00531284|580837754|FG001|Overall Study|Progressive Disease|3|||
160992496|NCT02145182|581361383|FG001|Overall Study|Lost to Follow-up|2|||
160992497|NCT02145182|581361382|FG000|Overall Study|Pre-transplant Withdrawal|0|||
160992498|NCT02145182|581361383|FG001|Overall Study|Pre-transplant Withdrawal|2|||
160992499|NCT02145182|581361382|FG000|Overall Study|Withdrawal by Subject|5|||
160849283|NCT00531284|580837755|FG002|Overall Study|Progressive Disease|5|||
160849284|NCT00531284|580837756|FG003|Overall Study|Progressive Disease|42|||
160849285|NCT00531284|580837757|FG004|Overall Study|Progressive Disease|4|||
160849286|NCT00531284|580837758|FG005|Overall Study|Progressive Disease|4|||
160849287|NCT00531284|580837759|FG006|Overall Study|Progressive Disease|3|||
160849288|NCT00531284|580837760|FG007|Overall Study|Progressive Disease|8|||
160849289|NCT00531284|580837761|FG008|Overall Study|Progressive Disease|6|||
160849290|NCT00531284|580837762|FG009|Overall Study|Progressive Disease|3|||
160992500|NCT02145182|581361383|FG001|Overall Study|Withdrawal by Subject|4|||
160992501|NCT03999554|581361385|FG000|Overall Study|Lost to Follow-up|4|||
160992502|NCT03999554|581361386|FG001|Overall Study|Lost to Follow-up|5|||
160849291|NCT00531284|580837763|FG010|Overall Study|Progressive Disease|3|||
160849292|NCT00531284|580837764|FG011|Overall Study|Progressive Disease|14|||
160849293|NCT00531284|580837765|FG012|Overall Study|Progressive Disease|2|||
160906564|NCT03716024|581052204|FG001|Overall Study|Adverse Event|2|||
160906565|NCT03716024|581052203|FG000|Overall Study|Treatment Failure|1|||
160906566|NCT03716024|581052204|FG001|Overall Study|Treatment Failure|0|||
160906567|NCT03716024|581052203|FG000|Overall Study|Lost to Follow-up|2|||
160906568|NCT03716024|581052204|FG001|Overall Study|Lost to Follow-up|6|||
160906569|NCT03716024|581052203|FG000|Overall Study|Withdrawal by Subject|0|||
160906570|NCT03716024|581052204|FG001|Overall Study|Withdrawal by Subject|1|||
160906571|NCT03716024|581052203|FG000|Overall Study|Missing Reason|0|||
160906572|NCT03716024|581052204|FG001|Overall Study|Missing Reason|1|||
160906573|NCT01651039|581052206|FG000|Overall Study|Non-evaluables|5|||
160906574|NCT01651039|581052206|FG000|Overall Study|Physician Decision|2|||
160906575|NCT01651039|581052206|FG000|Overall Study|Withdrawal by Subject|1|||
160906576|NCT01651039|581052206|FG000|Overall Study|Progressive Disease|22|||
160906577|NCT03600818|581052208|FG000|Overall Study|Adverse Event|4|||
160906578|NCT03600818|581052209|FG001|Overall Study|Adverse Event|7|||
160906579|NCT03600818|581052208|FG000|Overall Study|Lack of Efficacy|9|||
160849294|NCT00531284|580837766|FG013|Overall Study|Progressive Disease|1|||
160849295|NCT00531284|580837767|FG014|Overall Study|Progressive Disease|2|||
160849296|NCT00531284|580837768|FG015|Overall Study|Progressive Disease|11|||
160849297|NCT00531284|580837769|FG016|Overall Study|Progressive Disease|5|||
160849298|NCT00531284|580837753|FG000|Overall Study|Adverse Event|0|||
160849299|NCT00531284|580837754|FG001|Overall Study|Adverse Event|1|||
160849300|NCT00531284|580837755|FG002|Overall Study|Adverse Event|1|||
160849301|NCT00531284|580837756|FG003|Overall Study|Adverse Event|7|||
160849302|NCT00531284|580837757|FG004|Overall Study|Adverse Event|0|||
160849303|NCT00531284|580837758|FG005|Overall Study|Adverse Event|2|||
160849304|NCT00531284|580837759|FG006|Overall Study|Adverse Event|3|||
160849305|NCT00531284|580837760|FG007|Overall Study|Adverse Event|2|||
160849306|NCT00531284|580837761|FG008|Overall Study|Adverse Event|3|||
160849307|NCT00531284|580837762|FG009|Overall Study|Adverse Event|0|||
160849308|NCT00531284|580837763|FG010|Overall Study|Adverse Event|0|||
160849309|NCT00531284|580837764|FG011|Overall Study|Adverse Event|5|||
160849310|NCT00531284|580837765|FG012|Overall Study|Adverse Event|0|||
160849311|NCT00531284|580837766|FG013|Overall Study|Adverse Event|1|||
160849312|NCT00531284|580837767|FG014|Overall Study|Adverse Event|1|||
160849313|NCT00531284|580837768|FG015|Overall Study|Adverse Event|0|||
160849314|NCT00531284|580837769|FG016|Overall Study|Adverse Event|2|||
160849315|NCT00531284|580837753|FG000|Overall Study|Withdrawal by Subject|1|||
160849316|NCT00531284|580837754|FG001|Overall Study|Withdrawal by Subject|0|||
160849317|NCT00531284|580837755|FG002|Overall Study|Withdrawal by Subject|0|||
160849318|NCT00531284|580837756|FG003|Overall Study|Withdrawal by Subject|4|||
160849319|NCT00531284|580837757|FG004|Overall Study|Withdrawal by Subject|0|||
160849320|NCT00531284|580837758|FG005|Overall Study|Withdrawal by Subject|0|||
160849321|NCT00531284|580837759|FG006|Overall Study|Withdrawal by Subject|0|||
160849322|NCT00531284|580837760|FG007|Overall Study|Withdrawal by Subject|0|||
160849323|NCT00531284|580837761|FG008|Overall Study|Withdrawal by Subject|0|||
160849324|NCT00531284|580837762|FG009|Overall Study|Withdrawal by Subject|0|||
160849325|NCT00531284|580837763|FG010|Overall Study|Withdrawal by Subject|0|||
160849326|NCT00531284|580837764|FG011|Overall Study|Withdrawal by Subject|3|||
160849327|NCT00531284|580837765|FG012|Overall Study|Withdrawal by Subject|0|||
160849328|NCT00531284|580837766|FG013|Overall Study|Withdrawal by Subject|1|||
160849329|NCT00531284|580837767|FG014|Overall Study|Withdrawal by Subject|0|||
160849330|NCT00531284|580837768|FG015|Overall Study|Withdrawal by Subject|1|||
160849331|NCT00531284|580837769|FG016|Overall Study|Withdrawal by Subject|1|||
160849332|NCT00531284|580837753|FG000|Overall Study|Other|1|||
160849333|NCT00531284|580837754|FG001|Overall Study|Other|0|||
160849334|NCT00531284|580837755|FG002|Overall Study|Other|0|||
160849335|NCT00531284|580837756|FG003|Overall Study|Other|10|||
160849336|NCT00531284|580837757|FG004|Overall Study|Other|2|||
160849337|NCT00531284|580837758|FG005|Overall Study|Other|1|||
160849338|NCT00531284|580837759|FG006|Overall Study|Other|0|||
160849339|NCT00531284|580837760|FG007|Overall Study|Other|0|||
160849340|NCT00531284|580837761|FG008|Overall Study|Other|2|||
160849341|NCT00531284|580837762|FG009|Overall Study|Other|1|||
160849342|NCT00531284|580837763|FG010|Overall Study|Other|0|||
160849343|NCT00531284|580837764|FG011|Overall Study|Other|2|||
160849344|NCT00531284|580837765|FG012|Overall Study|Other|0|||
160849345|NCT00531284|580837766|FG013|Overall Study|Other|0|||
160849346|NCT00531284|580837767|FG014|Overall Study|Other|1|||
160849347|NCT00531284|580837768|FG015|Overall Study|Other|0|||
160849348|NCT00531284|580837769|FG016|Overall Study|Other|0|||
160849349|NCT03057496|580837770|FG000|Overall Study|Withdrawal by Subject|8|||
160849350|NCT03057496|580837770|FG000|Overall Study|Lost to Follow-up|5|||
160849351|NCT03057496|580837770|FG000|Overall Study|Did not use device during home trial|3|||
160849352|NCT03057496|580837770|FG000|Overall Study|Device failure|2|||
160849353|NCT00280917|580837771|FG000|Overall Study|Adverse Event|1|||
160906580|NCT03600818|581052209|FG001|Overall Study|Lack of Efficacy|4|||
160906581|NCT03600818|581052208|FG000|Overall Study|Withdrawal by Subject|4|||
160906582|NCT03600818|581052209|FG001|Overall Study|Withdrawal by Subject|3|||
160906583|NCT03600818|581052208|FG000|Overall Study|Other-unspecified|5|||
160849354|NCT00280917|580837772|FG001|Overall Study|Adverse Event|1|||
160849355|NCT00280917|580837773|FG002|Overall Study|Adverse Event|4|||
160849356|NCT00280917|580837774|FG003|Overall Study|Adverse Event|1|||
160849357|NCT00280917|580837771|FG000|Overall Study|Change Therapy|1|||
160849358|NCT00280917|580837772|FG001|Overall Study|Change Therapy|2|||
160849359|NCT00280917|580837773|FG002|Overall Study|Change Therapy|0|||
160849360|NCT00280917|580837774|FG003|Overall Study|Change Therapy|0|||
160849361|NCT00280917|580837771|FG000|Overall Study|Withdrawal by Subject|0|||
160849362|NCT00280917|580837772|FG001|Overall Study|Withdrawal by Subject|2|||
160849363|NCT00280917|580837773|FG002|Overall Study|Withdrawal by Subject|0|||
160568550|NCT00816036|579803960|FG000|Overall Study|Death|47|||
160568551|NCT00816036|579803961|FG001|Overall Study|Death|28|||
160849364|NCT00280917|580837774|FG003|Overall Study|Withdrawal by Subject|1|||
160849365|NCT00280917|580837771|FG000|Overall Study|Noncompliance|0|||
160849366|NCT00280917|580837772|FG001|Overall Study|Noncompliance|1|||
160849367|NCT00280917|580837773|FG002|Overall Study|Noncompliance|2|||
160849368|NCT00280917|580837774|FG003|Overall Study|Noncompliance|0|||
160849369|NCT03310723|580837779|FG000|Overall Study|Withdrawal by Subject|0|||
160849370|NCT03310723|580837780|FG001|Overall Study|Withdrawal by Subject|1|||
160849371|NCT03310723|580837779|FG000|Overall Study|Protocol Violation|0|||
160849372|NCT03310723|580837780|FG001|Overall Study|Protocol Violation|2|||
160568552|NCT00816036|579803960|FG000|Overall Study|Lost to Follow-up|75|||
160568553|NCT00816036|579803961|FG001|Overall Study|Lost to Follow-up|57|||
160568554|NCT00816036|579803960|FG000|Overall Study|Withdrawal by Subject|54|||
160568555|NCT00816036|579803961|FG001|Overall Study|Withdrawal by Subject|23|||
160849373|NCT02098746|580837781|FG000|Overall Study|Changes of Investigator|2|||
160849374|NCT02098746|580837781|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160849375|NCT02098746|580837781|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
160849376|NCT02098746|580837781|FG000|Overall Study|Data Not Available After Treatment|1|||
160849377|NCT01508312|580837784|FG000|Overall Study|Lost to Follow-up|1|||
160849378|NCT01508312|580837785|FG001|Overall Study|Lost to Follow-up|0|||
160849379|NCT01508312|580837786|FG002|Overall Study|Lost to Follow-up|0|||
160849380|NCT01508312|580837787|FG003|Overall Study|Lost to Follow-up|0|||
160849381|NCT01508312|580837784|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
160849382|NCT01508312|580837785|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
160849383|NCT01508312|580837786|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
160849384|NCT01508312|580837787|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
160849385|NCT01508312|580837784|FG000|Overall Study|Adverse Event|0|||
160849386|NCT01508312|580837785|FG001|Overall Study|Adverse Event|0|||
160849387|NCT01508312|580837786|FG002|Overall Study|Adverse Event|2|||
160849388|NCT01508312|580837787|FG003|Overall Study|Adverse Event|0|||
160849389|NCT01508312|580837784|FG000|Overall Study|Lack of Efficacy|0|||
160849390|NCT01508312|580837785|FG001|Overall Study|Lack of Efficacy|0|||
160849391|NCT01508312|580837786|FG002|Overall Study|Lack of Efficacy|1|||
160849392|NCT01508312|580837787|FG003|Overall Study|Lack of Efficacy|0|||
160568556|NCT01299025|579803962|FG000|Overall Study|Withdrawal by Subject|2|||
160568557|NCT01299025|579803963|FG001|Overall Study|Withdrawal by Subject|1|||
160568558|NCT01299025|579803962|FG000|Overall Study|Lost to Follow-up|1|||
160568559|NCT01299025|579803963|FG001|Overall Study|Lost to Follow-up|0|||
160568560|NCT01624194|579803964|FG000|Overall Study|Lost to Follow-up|1|||
160568561|NCT01624194|579803965|FG001|Overall Study|Lost to Follow-up|0|||
160568562|NCT01624194|579803964|FG000|Overall Study|Withdrawal by Subject|1|||
160568563|NCT01624194|579803965|FG001|Overall Study|Withdrawal by Subject|0|||
160568564|NCT03212261|579803966|FG000|Overall Study|Became ineligible d/t tech|2|||
160568565|NCT03212261|579803966|FG000|Overall Study|Tech Trouble- No first study visit|1|||
160568566|NCT03212261|579803966|FG000|Overall Study|Lost to Follow-up|7|||
160568567|NCT03212261|579803966|FG000|Overall Study|Family Emergency|1|||
160568568|NCT03212261|579803966|FG000|Overall Study|Too busy/ No time|5|||
160568569|NCT05480514|579803967|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
160568570|NCT05480514|579803968|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
160568571|NCT05480514|579803967|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
160849393|NCT01508312|580837784|FG000|Overall Study|Withdrawal by Subject|0|||
160849394|NCT01508312|580837785|FG001|Overall Study|Withdrawal by Subject|0|||
160849395|NCT01508312|580837786|FG002|Overall Study|Withdrawal by Subject|1|||
160849396|NCT01508312|580837787|FG003|Overall Study|Withdrawal by Subject|0|||
160849397|NCT02222558|580837788|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
160849398|NCT02222558|580837789|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
160849399|NCT02222558|580837790|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
160849400|NCT02222558|580837791|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
160849401|NCT02222558|580837792|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
160849402|NCT02222558|580837793|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
160568572|NCT05480514|579803968|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
160568573|NCT05480514|579803967|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160568574|NCT05480514|579803968|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
160568575|NCT05480514|579803967|FG000|Period 1|Covid-19 Related|1|||
160568576|NCT05480514|579803968|FG001|Period 1|Covid-19 Related|0|||
160568577|NCT05480514|579803967|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
160568578|NCT05480514|579803968|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
160568579|NCT02296840|579803975|FG000|Overall Study|Adverse Event|1|||
160568580|NCT02296840|579803976|FG001|Overall Study|Adverse Event|1|||
160568581|NCT02296840|579803975|FG000|Overall Study|Protocol Violation|2|||
160568582|NCT02296840|579803976|FG001|Overall Study|Protocol Violation|1|||
160568583|NCT02296840|579803975|FG000|Overall Study|Lost to Follow-up|6|||
160568584|NCT02296840|579803976|FG001|Overall Study|Lost to Follow-up|17|||
160568585|NCT02485717|579803977|FG000|Overall Study|Lost to Follow-up|6|||
160568586|NCT02485717|579803978|FG001|Overall Study|Lost to Follow-up|0|||
160568587|NCT02485717|579803979|FG002|Overall Study|Lost to Follow-up|0|||
160568588|NCT02485717|579803977|FG000|Overall Study|Withdrawal by Subject|0|||
160568589|NCT02485717|579803978|FG001|Overall Study|Withdrawal by Subject|0|||
160568590|NCT02485717|579803979|FG002|Overall Study|Withdrawal by Subject|1|||
160568591|NCT02485717|579803977|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
160568592|NCT02485717|579803978|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
160568593|NCT02485717|579803979|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
160568594|NCT02485717|579803977|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
160568595|NCT02485717|579803978|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
160568596|NCT02485717|579803979|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
160568597|NCT02827877|579803980|FG000|Overall Study|Withdrawal by Subject|1|||
160568598|NCT00814710|579803983|FG000|Overall Study|Adverse Event|1|||
160568599|NCT00814710|579803984|FG001|Overall Study|Adverse Event|0|||
160568600|NCT00814710|579803983|FG000|Overall Study|Lost to Follow-up|7|||
160568601|NCT00814710|579803984|FG001|Overall Study|Lost to Follow-up|3|||
160568602|NCT01450540|579803985|FG000|Overall Study|Withdrawal by Subject|19|||
160568603|NCT01450540|579803986|FG001|Overall Study|Withdrawal by Subject|13|||
160568604|NCT01450540|579803985|FG000|Overall Study|protocol deviation|3|||
160568605|NCT01450540|579803986|FG001|Overall Study|protocol deviation|23|||
160568606|NCT00840463|579803992|FG000|Overall Study|Adverse Event|1|||
160568607|NCT00840463|579803993|FG001|Overall Study|Adverse Event|0|||
160568608|NCT03439345|579805555|FG000|Overall Study|Lost to Follow-up|0|||
160568609|NCT03439345|579805556|FG001|Overall Study|Lost to Follow-up|1|||
160568610|NCT03439345|579805555|FG000|Overall Study|Consent withdrawn|0|||
160568611|NCT03439345|579805556|FG001|Overall Study|Consent withdrawn|1|||
160568612|NCT02128490|579805557|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
160849403|NCT02222558|580837788|FG000|Period 3|Withdrawal by Subject|0|||
160849404|NCT02222558|580837789|FG001|Period 3|Withdrawal by Subject|0|||
160849405|NCT02222558|580837790|FG002|Period 3|Withdrawal by Subject|0|||
160849406|NCT02222558|580837791|FG003|Period 3|Withdrawal by Subject|0|||
160849407|NCT02222558|580837792|FG004|Period 3|Withdrawal by Subject|0|||
160849408|NCT02222558|580837793|FG005|Period 3|Withdrawal by Subject|1|||
160849409|NCT02322281|580837796|FG000|Overall Study|Progressive Disease|42|||
160849410|NCT02322281|580837797|FG001|Overall Study|Progressive Disease|14|||
160849411|NCT02322281|580837798|FG002|Overall Study|Progressive Disease|49|||
160849412|NCT02322281|580837796|FG000|Overall Study|Adverse Event|3|||
160849413|NCT02322281|580837797|FG001|Overall Study|Adverse Event|4|||
160849414|NCT02322281|580837798|FG002|Overall Study|Adverse Event|6|||
160849415|NCT02322281|580837796|FG000|Overall Study|Death|3|||
160849416|NCT02322281|580837797|FG001|Overall Study|Death|3|||
160849417|NCT02322281|580837798|FG002|Overall Study|Death|3|||
160849418|NCT02322281|580837796|FG000|Overall Study|Withdrawal by Subject|1|||
160849419|NCT02322281|580837797|FG001|Overall Study|Withdrawal by Subject|1|||
160849420|NCT02322281|580837798|FG002|Overall Study|Withdrawal by Subject|6|||
160849421|NCT02322281|580837796|FG000|Overall Study|Physician Decision|2|||
160906584|NCT03600818|581052209|FG001|Overall Study|Other-unspecified|3|||
160906585|NCT03600818|581052208|FG000|Overall Study|Randomized and not treated|0|||
160906586|NCT03600818|581052209|FG001|Overall Study|Randomized and not treated|1|||
160906587|NCT04377620|581052212|FG000|Overall Study|Death|42|||
160906588|NCT04377620|581052213|FG001|Overall Study|Death|48|||
160906589|NCT04377620|581052214|FG002|Overall Study|Death|36|||
160906590|NCT04377620|581052212|FG000|Overall Study|Withdrawal by Subject|0|||
160568613|NCT02128490|579805558|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
160568614|NCT02128490|579805559|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
160568615|NCT02128490|579805560|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
160568616|NCT02128490|579805561|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
160650531|NCT02154529|580101602|FG003|Overall Study|Lost to Follow-up|0|||
160650532|NCT02146430|580102491|FG000|Overall Study|Protocol Violation|5|||
160568617|NCT02128490|579805557|FG000|Overall Study|Major Protocol Deviation|1|||
160568618|NCT02128490|579805558|FG001|Overall Study|Major Protocol Deviation|2|||
160568619|NCT02128490|579805559|FG002|Overall Study|Major Protocol Deviation|0|||
160650533|NCT02146430|580102492|FG001|Overall Study|Protocol Violation|4|||
160849422|NCT02322281|580837797|FG001|Overall Study|Physician Decision|0|||
160849423|NCT02322281|580837798|FG002|Overall Study|Physician Decision|5|||
160849424|NCT02322281|580837796|FG000|Overall Study|Study Terminated by Sponsor|2|||
160906591|NCT04377620|581052213|FG001|Overall Study|Withdrawal by Subject|2|||
160906592|NCT04377620|581052214|FG002|Overall Study|Withdrawal by Subject|0|||
160849425|NCT02322281|580837797|FG001|Overall Study|Study Terminated by Sponsor|0|||
160849426|NCT02322281|580837798|FG002|Overall Study|Study Terminated by Sponsor|0|||
160849427|NCT02322281|580837796|FG000|Overall Study|Missing|0|||
160849428|NCT02322281|580837797|FG001|Overall Study|Missing|0|||
160849429|NCT02322281|580837798|FG002|Overall Study|Missing|1|||
160849430|NCT02322281|580837796|FG000|Overall Study|Miscellaneous|0|||
160849431|NCT02322281|580837797|FG001|Overall Study|Miscellaneous|0|||
160849432|NCT02322281|580837798|FG002|Overall Study|Miscellaneous|4|||
160849433|NCT02532465|580837799|FG000|Overall Study|Protocol Violation|1|||
160849434|NCT02532465|580837800|FG001|Overall Study|Protocol Violation|0|||
160849435|NCT02532465|580837799|FG000|Overall Study|Lack of Efficacy|0|||
160568620|NCT02128490|579805560|FG003|Overall Study|Major Protocol Deviation|2|||
160568621|NCT02128490|579805561|FG004|Overall Study|Major Protocol Deviation|2|||
160568622|NCT02128490|579805557|FG000|Overall Study|Lost to Follow-up|0|||
160568623|NCT02128490|579805558|FG001|Overall Study|Lost to Follow-up|0|||
160568624|NCT02128490|579805559|FG002|Overall Study|Lost to Follow-up|1|||
160568625|NCT02128490|579805560|FG003|Overall Study|Lost to Follow-up|1|||
160568626|NCT02128490|579805561|FG004|Overall Study|Lost to Follow-up|1|||
160568627|NCT02128490|579805557|FG000|Overall Study|Voluntary Withdrawal|3|||
160568628|NCT02128490|579805558|FG001|Overall Study|Voluntary Withdrawal|3|||
160568629|NCT02128490|579805559|FG002|Overall Study|Voluntary Withdrawal|1|||
160849436|NCT02532465|580837800|FG001|Overall Study|Lack of Efficacy|1|||
160849437|NCT00466440|580837805|FG000|Overall Study|Adverse Event|0|||
160849438|NCT00466440|580837806|FG001|Overall Study|Adverse Event|3|||
160849439|NCT00466440|580837807|FG002|Overall Study|Adverse Event|1|||
160849440|NCT00466440|580837805|FG000|Overall Study|Death|1|||
160849441|NCT00466440|580837806|FG001|Overall Study|Death|1|||
160849442|NCT00466440|580837807|FG002|Overall Study|Death|0|||
160849443|NCT00466440|580837805|FG000|Overall Study|Progressive disease|13|||
160849444|NCT00466440|580837806|FG001|Overall Study|Progressive disease|5|||
160568630|NCT02128490|579805560|FG003|Overall Study|Voluntary Withdrawal|1|||
160568631|NCT02128490|579805561|FG004|Overall Study|Voluntary Withdrawal|2|||
160568632|NCT02128490|579805557|FG000|Overall Study|Lack of Efficacy|0|||
160568633|NCT02128490|579805558|FG001|Overall Study|Lack of Efficacy|1|||
160568634|NCT02128490|579805559|FG002|Overall Study|Lack of Efficacy|0|||
160849445|NCT00466440|580837807|FG002|Overall Study|Progressive disease|4|||
160849446|NCT00466440|580837805|FG000|Overall Study|Lost to Follow-up|0|||
160568635|NCT02128490|579805560|FG003|Overall Study|Lack of Efficacy|0|||
160568636|NCT02128490|579805561|FG004|Overall Study|Lack of Efficacy|0|||
160568637|NCT02128490|579805557|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
160568638|NCT02128490|579805558|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
160568639|NCT02128490|579805559|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
160568640|NCT02128490|579805560|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
160568641|NCT02128490|579805561|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
160568642|NCT02128490|579805557|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160568643|NCT02128490|579805558|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160568644|NCT02128490|579805559|FG002|Overall Study|Other Miscellaneous Reasons|2|||
160568645|NCT02128490|579805560|FG003|Overall Study|Other Miscellaneous Reasons|1|||
160568646|NCT02128490|579805561|FG004|Overall Study|Other Miscellaneous Reasons|1|||
160568647|NCT02243176|579805562|FG000|Overall Study|Other reason|1|||
160568648|NCT02243176|579805563|FG001|Overall Study|Other reason|2|||
160568649|NCT02243176|579805562|FG000|Overall Study|protocol specified withdrawal critera|1|||
160849447|NCT00466440|580837806|FG001|Overall Study|Lost to Follow-up|1|||
160849448|NCT00466440|580837807|FG002|Overall Study|Lost to Follow-up|0|||
160849449|NCT00466440|580837805|FG000|Overall Study|Physician Decision|0|||
160849450|NCT00466440|580837806|FG001|Overall Study|Physician Decision|1|||
160849451|NCT00466440|580837807|FG002|Overall Study|Physician Decision|2|||
160849452|NCT00466440|580837805|FG000|Overall Study|Protocol entry criteria not met|0|||
160849453|NCT00466440|580837806|FG001|Overall Study|Protocol entry criteria not met|0|||
160849454|NCT00466440|580837807|FG002|Overall Study|Protocol entry criteria not met|4|||
160849455|NCT00466440|580837805|FG000|Overall Study|Withdrawal by Subject|0|||
160568650|NCT02243176|579805563|FG001|Overall Study|protocol specified withdrawal critera|3|||
160568651|NCT02243176|579805562|FG000|Overall Study|Protocol Violation|2|||
160568652|NCT02243176|579805563|FG001|Overall Study|Protocol Violation|1|||
160568653|NCT02243176|579805562|FG000|Overall Study|Withdrawal by Subject|8|||
160568654|NCT02243176|579805563|FG001|Overall Study|Withdrawal by Subject|7|||
160849456|NCT00466440|580837806|FG001|Overall Study|Withdrawal by Subject|1|||
160849457|NCT00466440|580837807|FG002|Overall Study|Withdrawal by Subject|0|||
160849458|NCT00466440|580837805|FG000|Overall Study|Sponsor decision|0|||
160568655|NCT02243176|579805562|FG000|Overall Study|Adverse Event|2|||
160568656|NCT02243176|579805563|FG001|Overall Study|Adverse Event|2|||
160568657|NCT03311126|579805565|FG000|Induction|Death|1|||
160568658|NCT03311126|579805565|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
160849459|NCT00466440|580837806|FG001|Overall Study|Sponsor decision|0|||
160849460|NCT00466440|580837807|FG002|Overall Study|Sponsor decision|1|||
160849461|NCT03191630|580837811|FG000|Overall Study|Lost to Follow-up|7|||
160849462|NCT03191630|580837812|FG001|Overall Study|Lost to Follow-up|7|||
160849463|NCT00714415|580837823|FG000|Overall Study|Lack of Efficacy|1|||
160849464|NCT00714415|580837824|FG001|Overall Study|Lack of Efficacy|0|||
160849465|NCT00714415|580837823|FG000|Overall Study|Death|1|||
160849466|NCT00714415|580837824|FG001|Overall Study|Death|0|||
160849467|NCT01818596|580837831|FG000|Overall Study|Enrolled but Not Treated|4|||
160849468|NCT01818596|580837832|FG001|Overall Study|Enrolled but Not Treated|0|||
160849469|NCT01818596|580837831|FG000|Overall Study|Adverse Event|7|||
160849470|NCT01818596|580837832|FG001|Overall Study|Adverse Event|0|||
160849471|NCT01818596|580837831|FG000|Overall Study|Death|3|||
160849472|NCT01818596|580837832|FG001|Overall Study|Death|0|||
160849473|NCT01818596|580837831|FG000|Overall Study|Investigator's Discretion|4|||
160849474|NCT01818596|580837832|FG001|Overall Study|Investigator's Discretion|0|||
160568659|NCT03113500|579805566|FG000|Overall Study|Withdrawal by Subject|1|||
160568660|NCT02517515|579805569|FG000|Overall Study|Adverse Event|0|||
160568661|NCT02517515|579805570|FG001|Overall Study|Adverse Event|1|||
160568662|NCT02517515|579805569|FG000|Overall Study|Withdrew Consent|0|||
160849475|NCT01818596|580837831|FG000|Overall Study|Protocol Violation|1|||
160849476|NCT01818596|580837832|FG001|Overall Study|Protocol Violation|0|||
160568663|NCT02517515|579805570|FG001|Overall Study|Withdrew Consent|1|||
160568664|NCT02517515|579805569|FG000|Overall Study|Lost to Follow-up|1|||
160568665|NCT02517515|579805570|FG001|Overall Study|Lost to Follow-up|0|||
160568666|NCT02517515|579805569|FG000|Overall Study|Other|1|||
160906593|NCT04930965|581052215|FG000|Overall Study|Lost to Follow-up|7|||
160906594|NCT04930965|581052216|FG001|Overall Study|Lost to Follow-up|5|||
160906595|NCT01488370|581052217|FG000|Overall Study|Protocol Violation|0|||
160906596|NCT01488370|581052218|FG001|Overall Study|Protocol Violation|1|||
160906597|NCT01488370|581052219|FG002|Overall Study|Protocol Violation|1|||
160906598|NCT04189081|581052221|FG000|Overall Study|Lost to Follow-up|1|||
160906599|NCT04189081|581052222|FG001|Overall Study|Lost to Follow-up|0|||
160906600|NCT04189081|581052223|FG002|Overall Study|Lost to Follow-up|0|||
160906601|NCT04189081|581052221|FG000|Overall Study|Withdrawal by Subject|0|||
160906602|NCT04189081|581052222|FG001|Overall Study|Withdrawal by Subject|0|||
160906603|NCT04189081|581052223|FG002|Overall Study|Withdrawal by Subject|1|||
160906604|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
160906605|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
160906606|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
160906607|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
160906608|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
160906609|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
160906610|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
160906611|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
160906612|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
160906613|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
160906614|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
160906615|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
160906616|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
160906617|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
160906618|NCT00044083|581052224|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
160906619|NCT00044083|581052225|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
160906620|NCT00044083|581052224|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
160906621|NCT00044083|581052225|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
160906622|NCT00044083|581052224|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
160906623|NCT00044083|581052225|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
160906624|NCT00444912|581052229|FG000|Overall Study|Death|1|||
160906625|NCT00444912|581052230|FG001|Overall Study|Death|2|||
160906626|NCT00444912|581052229|FG000|Overall Study|Lost to Follow-up|1|||
160906627|NCT00444912|581052230|FG001|Overall Study|Lost to Follow-up|0|||
160906628|NCT00444912|581052229|FG000|Overall Study|Participant Failed Mobilization|1|||
160906629|NCT00444912|581052230|FG001|Overall Study|Participant Failed Mobilization|0|||
160906630|NCT03758066|581052231|FG000|Overall Study|Lost to Follow-up|14|||
160906631|NCT03570697|581052240|FG000|Overall Study|Lost to Follow-up|0|||
160906632|NCT03570697|581052241|FG001|Overall Study|Lost to Follow-up|1|||
160906633|NCT03570697|581052240|FG000|Overall Study|Death|2|||
160906634|NCT03570697|581052241|FG001|Overall Study|Death|0|||
160906635|NCT03570697|581052240|FG000|Overall Study|Withdrawal by Subject|4|||
160906636|NCT03570697|581052241|FG001|Overall Study|Withdrawal by Subject|2|||
160906637|NCT01849783|581052242|FG000|Overall Study|Adverse Event|5|||
160906638|NCT01849783|581052242|FG000|Overall Study|Death|2|||
160906639|NCT01849783|581052242|FG000|Overall Study|Physician Decision|1|||
160568667|NCT02517515|579805570|FG001|Overall Study|Other|0|||
160906640|NCT01849783|581052242|FG000|Overall Study|Withdrawal by Subject|1|||
160906641|NCT01849783|581052242|FG000|Overall Study|Unable to comply|2|||
160906642|NCT01849783|581052242|FG000|Overall Study|Disease progression|11|||
160568668|NCT06400238|579805571|FG000|Overall Study|Started Protocol Therapy|2|||
160849477|NCT01818596|580837831|FG000|Overall Study|Withdrew Consent|5|||
160849478|NCT01818596|580837832|FG001|Overall Study|Withdrew Consent|0|||
160849479|NCT01818596|580837831|FG000|Overall Study|Lost to Follow-up|7|||
160568669|NCT06400238|579805571|FG000|Overall Study|Adverse Event|1|||
160568670|NCT06400238|579805571|FG000|Overall Study|Death|1|||
160568671|NCT06400238|579805571|FG000|Overall Study|Disease Progression|27|||
160568672|NCT06400238|579805571|FG000|Overall Study|Withdrawal by Subject|2|||
160568673|NCT06400238|579805571|FG000|Overall Study|Physician Decision|2|||
160568674|NCT02037919|579805572|FG000|Overall Study|Lost to Follow-up|30|||
160568675|NCT02037919|579805573|FG001|Overall Study|Lost to Follow-up|45|||
160568676|NCT01021007|579805576|FG000|Overall Study|Lost to Follow-up|1|||
160568677|NCT01021007|579805577|FG001|Overall Study|Lost to Follow-up|1|||
160568678|NCT01021007|579805576|FG000|Overall Study|Adverse Event|1|||
160568679|NCT01021007|579805577|FG001|Overall Study|Adverse Event|3|||
160568680|NCT01575548|579805578|FG000|Overall Study|Adverse Event|15|||
160568681|NCT01575548|579805579|FG001|Overall Study|Adverse Event|2|||
160568682|NCT01575548|579805578|FG000|Overall Study|Disease progression|12|||
160568683|NCT01575548|579805579|FG001|Overall Study|Disease progression|25|||
160568684|NCT01575548|579805578|FG000|Overall Study|Death|1|||
160568685|NCT01575548|579805579|FG001|Overall Study|Death|0|||
160568686|NCT01575548|579805578|FG000|Overall Study|Other complicating disease|1|||
160568687|NCT01575548|579805579|FG001|Overall Study|Other complicating disease|0|||
160568688|NCT01575548|579805578|FG000|Overall Study|Withdrawal by Subject|7|||
160568689|NCT01575548|579805579|FG001|Overall Study|Withdrawal by Subject|3|||
160568690|NCT01575548|579805578|FG000|Overall Study|Noncompliance|1|||
160568691|NCT01575548|579805579|FG001|Overall Study|Noncompliance|0|||
160568692|NCT01575548|579805578|FG000|Overall Study|Anticipated surgery|0|||
160568693|NCT01575548|579805579|FG001|Overall Study|Anticipated surgery|1|||
160568694|NCT01575548|579805578|FG000|Overall Study|Never started protocol therapy|3|||
160568695|NCT01575548|579805579|FG001|Overall Study|Never started protocol therapy|2|||
160568696|NCT03872180|579805580|FG000|Overall Study|Adverse Event|4|||
160568697|NCT03872180|579805580|FG000|Overall Study|Lack of Efficacy|2|||
160568698|NCT03293030|579805581|FG000|Overall Study|Withdrawal by Subject|3|||
160568699|NCT01193335|579805586|FG000|After Infant Series|Lost to Follow-up|1|||
160568700|NCT01193335|579805587|FG001|After Infant Series|Lost to Follow-up|2|||
160568701|NCT01193335|579805586|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
160568702|NCT01193335|579805587|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
160568703|NCT01193335|579805586|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
160568704|NCT01193335|579805587|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
160568705|NCT01193335|579805586|FG000|1-Year Follow-up|Lost to Follow-up|4|||
160568706|NCT01193335|579805587|FG001|1-Year Follow-up|Lost to Follow-up|0|||
160568707|NCT01193335|579805586|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
160568708|NCT01193335|579805587|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
160568709|NCT01193335|579805586|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
160568710|NCT01193335|579805587|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
160568711|NCT01985321|579805589|FG000|Overall Study|Protocol Violation|4|||
160568712|NCT01985321|579805590|FG001|Overall Study|Protocol Violation|3|||
160568713|NCT01985321|579805589|FG000|Overall Study|Withdrawal by Subject|1|||
160568714|NCT01985321|579805590|FG001|Overall Study|Withdrawal by Subject|0|||
160568715|NCT01985321|579805589|FG000|Overall Study|Lost to Follow-up|5|||
160568716|NCT01985321|579805590|FG001|Overall Study|Lost to Follow-up|2|||
160568717|NCT01985321|579805589|FG000|Overall Study|Subject treated wrong type of sore|1|||
160568718|NCT01985321|579805590|FG001|Overall Study|Subject treated wrong type of sore|0|||
160568719|NCT00498173|579805591|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
160568720|NCT00498173|579805592|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
160568721|NCT00498173|579805593|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
160568722|NCT00542828|579805594|FG000|Overall Study|Physician Decision|1|||
160568723|NCT00542828|579805594|FG000|Overall Study|Need for Prohibited Treatment|3|||
160568724|NCT00542828|579805594|FG000|Overall Study|Study Prematurely Discontinued|7|||
160568725|NCT00542828|579805594|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
160568726|NCT00095303|579805595|FG000|Main Study|Lost to Follow-up|91|||
160568727|NCT00095303|579805596|FG001|Main Study|Lost to Follow-up|87|||
160568728|NCT00095303|579805595|FG000|Follow Up Study|Lost to Follow-up|59|||
160568729|NCT00095303|579805596|FG001|Follow Up Study|Lost to Follow-up|58|||
160906643|NCT01042678|581052248|FG000|Overall Study|Physician Decision|1|||
160906644|NCT01042678|581052249|FG001|Overall Study|Physician Decision|0|||
160906645|NCT01042678|581052250|FG002|Overall Study|Physician Decision|0|||
160906646|NCT01042678|581052251|FG003|Overall Study|Physician Decision|0|||
160906647|NCT01042678|581052252|FG004|Overall Study|Physician Decision|0|||
160906648|NCT01042678|581052253|FG005|Overall Study|Physician Decision|0|||
160568730|NCT03953118|579805599|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
160568731|NCT03953118|579805600|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
160568732|NCT00004980|579805603|FG000|Overall Study|Withdrawal by Subject|1|||
160906649|NCT02197520|581052261|FG000|Period 1|Withdrawal by Subject|1|||
160906650|NCT02197520|581052262|FG001|Period 1|Withdrawal by Subject|0|||
160568733|NCT00004980|579805604|FG001|Overall Study|Withdrawal by Subject|0|||
160568734|NCT00004980|579805603|FG000|Overall Study|memory difficulties|1|||
160568735|NCT00004980|579805604|FG001|Overall Study|memory difficulties|1|||
160568736|NCT00004980|579805603|FG000|Overall Study|Physician Decision|0|||
160568737|NCT00004980|579805604|FG001|Overall Study|Physician Decision|1|||
160568738|NCT00820040|579805611|FG000|Overall Study|Death|1|||
160568739|NCT00820040|579805611|FG000|Overall Study|Sponsor terminated study|1|||
160568740|NCT00820040|579805611|FG000|Overall Study|Screen failure|1|||
160568741|NCT01259466|579805614|FG000|Overall Study|Withdrawal by Subject|1|||
160568742|NCT01259466|579805615|FG001|Overall Study|Withdrawal by Subject|9|||
160568743|NCT00184054|579805616|FG000|Overall Study|Adverse Event|1|||
160568744|NCT00519532|579805617|FG000|Overall Study|Adverse Event|11|||
160568745|NCT00519532|579805617|FG000|Overall Study|Withdrawal by Subject|5|||
160568746|NCT00519532|579805617|FG000|Overall Study|Lost to Follow-up|2|||
160568747|NCT03885284|579805618|FG000|Overall Study|Disease Progression|1|||
160568748|NCT03885284|579805619|FG001|Overall Study|Disease Progression|3|||
160568749|NCT03885284|579805618|FG000|Overall Study|Physician Decision|0|||
160849480|NCT01818596|580837832|FG001|Overall Study|Lost to Follow-up|0|||
160849481|NCT02073682|580837843|FG000|Overall Study|Low Creatinine Clearance|1|||
160849482|NCT02073682|580837844|FG001|Overall Study|Low Creatinine Clearance|2|||
160849483|NCT02073682|580837843|FG000|Overall Study|Death|86|||
160849484|NCT02073682|580837844|FG001|Overall Study|Death|100|||
160849485|NCT02073682|580837843|FG000|Overall Study|Cancer Cured|10|||
160849486|NCT02073682|580837844|FG001|Overall Study|Cancer Cured|15|||
160849487|NCT02073682|580837843|FG000|Overall Study|ID: Patient Noncompliance|1|||
160849488|NCT02073682|580837844|FG001|Overall Study|ID: Patient Noncompliance|2|||
160849489|NCT02073682|580837843|FG000|Overall Study|ID: Palliative Treatment Only|10|||
160849490|NCT02073682|580837844|FG001|Overall Study|ID: Palliative Treatment Only|7|||
160849491|NCT02073682|580837843|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
160849492|NCT02073682|580837844|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
160849493|NCT02073682|580837843|FG000|Overall Study|Platelet Count <50,000/mL|1|||
160849494|NCT02073682|580837844|FG001|Overall Study|Platelet Count <50,000/mL|2|||
160849495|NCT02073682|580837843|FG000|Overall Study|Surgery/Medical Procedure|3|||
160849496|NCT02073682|580837844|FG001|Overall Study|Surgery/Medical Procedure|1|||
160849497|NCT02073682|580837843|FG000|Overall Study|Withdrawal by Subject|6|||
160849498|NCT02073682|580837844|FG001|Overall Study|Withdrawal by Subject|8|||
160849499|NCT02073682|580837843|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
160849500|NCT02073682|580837844|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
160849501|NCT02073682|580837843|FG000|Overall Study|Cancer Progression|53|||
160849502|NCT02073682|580837844|FG001|Overall Study|Cancer Progression|33|||
160568750|NCT03885284|579805619|FG001|Overall Study|Physician Decision|1|||
160568751|NCT00002850|579805622|FG000|Overall Study|Death|4|||
160568752|NCT00002850|579805623|FG001|Overall Study|Death|1|||
160568753|NCT00002850|579805624|FG002|Overall Study|Death|3|||
160568754|NCT00002850|579805622|FG000|Overall Study|Protocol Violation|1|||
160568755|NCT00002850|579805623|FG001|Overall Study|Protocol Violation|0|||
160568756|NCT00002850|579805624|FG002|Overall Study|Protocol Violation|1|||
160568757|NCT00002850|579805622|FG000|Overall Study|Withdrawal by Subject|0|||
160568758|NCT00002850|579805623|FG001|Overall Study|Withdrawal by Subject|1|||
160568759|NCT00002850|579805624|FG002|Overall Study|Withdrawal by Subject|0|||
160568760|NCT02932267|579805625|FG000|Overall Study|Withdrawal by Subject|3|||
160568761|NCT02932267|579805625|FG000|Overall Study|Lost to Follow-up|4|||
160568762|NCT02932267|579805625|FG000|Overall Study|Pregnancy|1|||
160568763|NCT01687673|579805628|FG000|Overall Study|Physician Decision|1|||
160568764|NCT02234622|579805629|FG000|Overall Study|Withdrawal by Subject|16|||
160568765|NCT02234622|579805630|FG001|Overall Study|Withdrawal by Subject|22|||
160568766|NCT02234622|579805629|FG000|Overall Study|Lost to Follow-up|27|||
160568767|NCT02234622|579805630|FG001|Overall Study|Lost to Follow-up|14|||
160568768|NCT03476239|579805631|FG000|Overall Study|Withdrawal by Subject|10|||
160568769|NCT03476239|579805631|FG000|Overall Study|Death|80|||
160568770|NCT03476239|579805631|FG000|Overall Study|Lost to Follow-up|8|||
160568771|NCT00618956|579805632|FG000|Overall Study|Adverse Event|10|||
160568772|NCT00618956|579805633|FG001|Overall Study|Adverse Event|34|||
160568773|NCT00618956|579805632|FG000|Overall Study|Lack of Efficacy|2|||
160568774|NCT00618956|579805633|FG001|Overall Study|Lack of Efficacy|1|||
160568775|NCT00618956|579805632|FG000|Overall Study|Withdrawal by Subject|5|||
160568776|NCT00618956|579805633|FG001|Overall Study|Withdrawal by Subject|7|||
160568777|NCT00618956|579805632|FG000|Overall Study|Lost to Follow-up|4|||
160568778|NCT00618956|579805633|FG001|Overall Study|Lost to Follow-up|5|||
160568779|NCT00618956|579805632|FG000|Overall Study|Protocol Violation|2|||
160568780|NCT00618956|579805633|FG001|Overall Study|Protocol Violation|2|||
160568781|NCT00618956|579805632|FG000|Overall Study|did not meet criteria, non-compliance|2|||
160568782|NCT00618956|579805633|FG001|Overall Study|did not meet criteria, non-compliance|1|||
160568783|NCT03598777|579805634|FG000|Overall Study|Study Terminated by Sponsor|3|||
160568784|NCT03598777|579805635|FG001|Overall Study|Study Terminated by Sponsor|0|||
160571904|NCT01743027|579816861|FG000|Overall Study|Progressive Disease|1|||
160849503|NCT02073682|580837843|FG000|Overall Study|Protocol Violation|1|||
160849504|NCT02073682|580837844|FG001|Overall Study|Protocol Violation|0|||
160849505|NCT02073682|580837843|FG000|Overall Study|Adverse Event|79|||
160849506|NCT02073682|580837844|FG001|Overall Study|Adverse Event|62|||
160849507|NCT02073682|580837843|FG000|Overall Study|No reason provided|11|||
160568785|NCT03598777|579805636|FG002|Overall Study|Study Terminated by Sponsor|0|||
160568786|NCT03598777|579805637|FG003|Overall Study|Study Terminated by Sponsor|0|||
160568787|NCT03598777|579805638|FG004|Overall Study|Study Terminated by Sponsor|15|||
160568788|NCT03598777|579805634|FG000|Overall Study|Withdrawal by Subject|1|||
160568789|NCT03598777|579805635|FG001|Overall Study|Withdrawal by Subject|1|||
160568790|NCT03598777|579805636|FG002|Overall Study|Withdrawal by Subject|0|||
160568791|NCT03598777|579805637|FG003|Overall Study|Withdrawal by Subject|0|||
160568792|NCT03598777|579805638|FG004|Overall Study|Withdrawal by Subject|0|||
160568793|NCT03598777|579805634|FG000|Overall Study|Adverse Event|1|||
160568794|NCT03598777|579805635|FG001|Overall Study|Adverse Event|0|||
160568795|NCT03598777|579805636|FG002|Overall Study|Adverse Event|0|||
160568796|NCT03598777|579805637|FG003|Overall Study|Adverse Event|0|||
160849508|NCT02073682|580837844|FG001|Overall Study|No reason provided|9|||
160849509|NCT02073682|580837843|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
160849510|NCT02073682|580837844|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
160849511|NCT02073682|580837843|FG000|Overall Study|Lost to Follow-up|1|||
160849512|NCT02073682|580837844|FG001|Overall Study|Lost to Follow-up|1|||
160849513|NCT02073682|580837843|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
160849514|NCT02073682|580837844|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
160849515|NCT04112810|580837850|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
160849516|NCT01687296|580837851|FG000|Overall Study|Lack of Efficacy|1|||
160849517|NCT01687296|580837852|FG001|Overall Study|Lack of Efficacy|1|||
160849518|NCT01687296|580837851|FG000|Overall Study|Protocol Violation|0|||
160849519|NCT01687296|580837852|FG001|Overall Study|Protocol Violation|1|||
160849520|NCT01687296|580837851|FG000|Overall Study|Withdrawal by Subject|6|||
160849521|NCT01687296|580837852|FG001|Overall Study|Withdrawal by Subject|3|||
160849522|NCT04497116|580837854|FG000|Overall Study|Lost to Follow-up|1|||
160849523|NCT04497116|580837855|FG001|Overall Study|Lost to Follow-up|0|||
160849524|NCT04497116|580837856|FG002|Overall Study|Lost to Follow-up|0|||
160849525|NCT04497116|580837857|FG003|Overall Study|Lost to Follow-up|0|||
160849526|NCT04497116|580837858|FG004|Overall Study|Lost to Follow-up|0|||
160849527|NCT04497116|580837859|FG005|Overall Study|Lost to Follow-up|0|||
160849528|NCT04497116|580837860|FG006|Overall Study|Lost to Follow-up|0|||
160849529|NCT04497116|580837861|FG007|Overall Study|Lost to Follow-up|3|||
160849530|NCT04497116|580837862|FG008|Overall Study|Lost to Follow-up|3|||
160849531|NCT04497116|580837863|FG009|Overall Study|Lost to Follow-up|0|||
160849532|NCT04497116|580837864|FG010|Overall Study|Lost to Follow-up|0|||
160849533|NCT04497116|580837865|FG011|Overall Study|Lost to Follow-up|0|||
160849534|NCT04497116|580837866|FG012|Overall Study|Lost to Follow-up|0|||
160849535|NCT04497116|580837867|FG013|Overall Study|Lost to Follow-up|0|||
160849536|NCT04497116|580837868|FG014|Overall Study|Lost to Follow-up|0|||
160849537|NCT04497116|580837869|FG015|Overall Study|Lost to Follow-up|0|||
160849538|NCT04497116|580837870|FG016|Overall Study|Lost to Follow-up|0|||
160849539|NCT04497116|580837871|FG017|Overall Study|Lost to Follow-up|0|||
160849540|NCT04497116|580837872|FG018|Overall Study|Lost to Follow-up|0|||
160849541|NCT04497116|580837873|FG019|Overall Study|Lost to Follow-up|0|||
160849542|NCT04497116|580837874|FG020|Overall Study|Lost to Follow-up|0|||
160849543|NCT04497116|580837875|FG021|Overall Study|Lost to Follow-up|0|||
160849544|NCT04497116|580837876|FG022|Overall Study|Lost to Follow-up|1|||
160849545|NCT04497116|580837877|FG023|Overall Study|Lost to Follow-up|0|||
160849546|NCT04497116|580837878|FG024|Overall Study|Lost to Follow-up|0|||
160849547|NCT04497116|580837854|FG000|Overall Study|Sponsor decision to terminate study|0|||
160849548|NCT04497116|580837855|FG001|Overall Study|Sponsor decision to terminate study|0|||
160849549|NCT04497116|580837856|FG002|Overall Study|Sponsor decision to terminate study|0|||
160849550|NCT04497116|580837857|FG003|Overall Study|Sponsor decision to terminate study|0|||
160849551|NCT04497116|580837858|FG004|Overall Study|Sponsor decision to terminate study|0|||
160849552|NCT04497116|580837859|FG005|Overall Study|Sponsor decision to terminate study|0|||
160849553|NCT04497116|580837860|FG006|Overall Study|Sponsor decision to terminate study|1|||
160849554|NCT04497116|580837861|FG007|Overall Study|Sponsor decision to terminate study|0|||
160849555|NCT04497116|580837862|FG008|Overall Study|Sponsor decision to terminate study|0|||
160568797|NCT03598777|579805638|FG004|Overall Study|Adverse Event|0|||
160568798|NCT03598777|579805634|FG000|Overall Study|Lost to Follow-up|1|||
160568799|NCT03598777|579805635|FG001|Overall Study|Lost to Follow-up|0|||
160568800|NCT03598777|579805636|FG002|Overall Study|Lost to Follow-up|0|||
160568801|NCT03598777|579805637|FG003|Overall Study|Lost to Follow-up|0|||
160849556|NCT04497116|580837863|FG009|Overall Study|Sponsor decision to terminate study|1|||
160849557|NCT04497116|580837864|FG010|Overall Study|Sponsor decision to terminate study|0|||
160849558|NCT04497116|580837865|FG011|Overall Study|Sponsor decision to terminate study|0|||
160849559|NCT04497116|580837866|FG012|Overall Study|Sponsor decision to terminate study|0|||
160849560|NCT04497116|580837867|FG013|Overall Study|Sponsor decision to terminate study|0|||
160849561|NCT04497116|580837868|FG014|Overall Study|Sponsor decision to terminate study|0|||
160849562|NCT04497116|580837869|FG015|Overall Study|Sponsor decision to terminate study|0|||
160849563|NCT04497116|580837870|FG016|Overall Study|Sponsor decision to terminate study|0|||
160568802|NCT03598777|579805638|FG004|Overall Study|Lost to Follow-up|0|||
160568803|NCT02006576|579805639|FG000|Overall Study|Withdrawal by Subject|4|||
160568804|NCT02006576|579805640|FG001|Overall Study|Withdrawal by Subject|6|||
160849564|NCT04497116|580837871|FG017|Overall Study|Sponsor decision to terminate study|0|||
160568805|NCT02006576|579805641|FG002|Overall Study|Withdrawal by Subject|2|||
160568806|NCT02006576|579805639|FG000|Overall Study|Death|0|||
160849565|NCT04497116|580837872|FG018|Overall Study|Sponsor decision to terminate study|0|||
160849566|NCT04497116|580837873|FG019|Overall Study|Sponsor decision to terminate study|1|||
160568807|NCT02006576|579805640|FG001|Overall Study|Death|0|||
160568808|NCT02006576|579805641|FG002|Overall Study|Death|1|||
160568809|NCT02006576|579805639|FG000|Overall Study|Lost to Follow-up|1|||
160568810|NCT02006576|579805640|FG001|Overall Study|Lost to Follow-up|0|||
160568811|NCT02006576|579805641|FG002|Overall Study|Lost to Follow-up|1|||
160568812|NCT02006576|579805639|FG000|Overall Study|Screen Failure, too sick, other|13|||
160568813|NCT02006576|579805640|FG001|Overall Study|Screen Failure, too sick, other|1|||
160568814|NCT02006576|579805641|FG002|Overall Study|Screen Failure, too sick, other|13|||
160568815|NCT00785577|579805642|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
160568816|NCT00785577|579805643|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
160568817|NCT00785577|579805644|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
160568818|NCT00785577|579805645|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
160568819|NCT00785577|579805646|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
160568820|NCT00785577|579805642|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
160568821|NCT00785577|579805643|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
160568822|NCT00785577|579805644|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
160568823|NCT00785577|579805645|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
160568824|NCT00785577|579805646|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
160568825|NCT00785577|579805642|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
160849567|NCT04497116|580837874|FG020|Overall Study|Sponsor decision to terminate study|0|||
160849568|NCT04497116|580837875|FG021|Overall Study|Sponsor decision to terminate study|0|||
160849569|NCT04497116|580837876|FG022|Overall Study|Sponsor decision to terminate study|0|||
160568826|NCT00785577|579805643|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
160568827|NCT00785577|579805644|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
160568828|NCT00785577|579805645|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
160849570|NCT04497116|580837877|FG023|Overall Study|Sponsor decision to terminate study|0|||
160568829|NCT00785577|579805646|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
160849571|NCT04497116|580837878|FG024|Overall Study|Sponsor decision to terminate study|0|||
160849572|NCT04497116|580837854|FG000|Overall Study|Death|4|||
160849573|NCT04497116|580837855|FG001|Overall Study|Death|5|||
160849574|NCT04497116|580837856|FG002|Overall Study|Death|2|||
160849575|NCT04497116|580837857|FG003|Overall Study|Death|2|||
160849576|NCT04497116|580837858|FG004|Overall Study|Death|1|||
160849577|NCT04497116|580837859|FG005|Overall Study|Death|1|||
160849578|NCT04497116|580837860|FG006|Overall Study|Death|3|||
160849579|NCT04497116|580837861|FG007|Overall Study|Death|10|||
160849580|NCT04497116|580837862|FG008|Overall Study|Death|37|||
160849581|NCT04497116|580837863|FG009|Overall Study|Death|17|||
160849582|NCT04497116|580837864|FG010|Overall Study|Death|2|||
160849583|NCT04497116|580837865|FG011|Overall Study|Death|1|||
160849584|NCT04497116|580837866|FG012|Overall Study|Death|1|||
160849585|NCT04497116|580837867|FG013|Overall Study|Death|3|||
160849586|NCT04497116|580837868|FG014|Overall Study|Death|18|||
160849587|NCT04497116|580837869|FG015|Overall Study|Death|3|||
160849588|NCT04497116|580837870|FG016|Overall Study|Death|2|||
160849589|NCT04497116|580837871|FG017|Overall Study|Death|1|||
160849590|NCT04497116|580837872|FG018|Overall Study|Death|4|||
160849591|NCT04497116|580837873|FG019|Overall Study|Death|17|||
160849592|NCT04497116|580837874|FG020|Overall Study|Death|1|||
160849593|NCT04497116|580837875|FG021|Overall Study|Death|0|||
160849594|NCT04497116|580837876|FG022|Overall Study|Death|3|||
160849595|NCT04497116|580837877|FG023|Overall Study|Death|5|||
160849596|NCT04497116|580837878|FG024|Overall Study|Death|4|||
160906651|NCT02197520|581052261|FG000|Period 2|Adverse Event|0|||
160906652|NCT02197520|581052262|FG001|Period 2|Adverse Event|2|||
160568830|NCT00785577|579805642|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
160568831|NCT00785577|579805643|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
160568832|NCT00785577|579805644|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
160568833|NCT00785577|579805645|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
160568834|NCT00785577|579805646|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
160849597|NCT04497116|580837854|FG000|Overall Study|Withdrawal by Subject|1|||
160849598|NCT04497116|580837855|FG001|Overall Study|Withdrawal by Subject|0|||
160849599|NCT04497116|580837856|FG002|Overall Study|Withdrawal by Subject|1|||
160849600|NCT04497116|580837857|FG003|Overall Study|Withdrawal by Subject|0|||
160849601|NCT04497116|580837858|FG004|Overall Study|Withdrawal by Subject|0|||
160906653|NCT02197520|581052261|FG000|Period 2|Withdrawal by Subject|1|||
160568835|NCT00785577|579805642|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
160568836|NCT00785577|579805643|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
160571905|NCT01743027|579816862|FG001|Overall Study|Progressive Disease|4|||
160849602|NCT04497116|580837859|FG005|Overall Study|Withdrawal by Subject|0|||
160849603|NCT04497116|580837860|FG006|Overall Study|Withdrawal by Subject|0|||
160849604|NCT04497116|580837861|FG007|Overall Study|Withdrawal by Subject|7|||
160849605|NCT04497116|580837862|FG008|Overall Study|Withdrawal by Subject|14|||
160906654|NCT02197520|581052262|FG001|Period 2|Withdrawal by Subject|0|||
160849606|NCT04497116|580837863|FG009|Overall Study|Withdrawal by Subject|3|||
160849607|NCT04497116|580837864|FG010|Overall Study|Withdrawal by Subject|3|||
160849608|NCT04497116|580837865|FG011|Overall Study|Withdrawal by Subject|0|||
160849609|NCT04497116|580837866|FG012|Overall Study|Withdrawal by Subject|1|||
160849610|NCT04497116|580837867|FG013|Overall Study|Withdrawal by Subject|0|||
160849611|NCT04497116|580837868|FG014|Overall Study|Withdrawal by Subject|7|||
160849612|NCT04497116|580837869|FG015|Overall Study|Withdrawal by Subject|1|||
160849613|NCT04497116|580837870|FG016|Overall Study|Withdrawal by Subject|3|||
160849614|NCT04497116|580837871|FG017|Overall Study|Withdrawal by Subject|1|||
160849615|NCT04497116|580837872|FG018|Overall Study|Withdrawal by Subject|1|||
160849616|NCT04497116|580837873|FG019|Overall Study|Withdrawal by Subject|5|||
160568837|NCT00785577|579805644|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
160568838|NCT00785577|579805645|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
160568839|NCT00785577|579805646|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
160568840|NCT00785577|579805642|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
160568841|NCT00785577|579805643|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
160568842|NCT00785577|579805644|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
160568843|NCT00785577|579805645|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
160568844|NCT00785577|579805646|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
160568845|NCT00785577|579805642|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
160568846|NCT00785577|579805643|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
160568847|NCT00785577|579805644|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
160568848|NCT00785577|579805645|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
160568849|NCT00785577|579805646|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
160568850|NCT00785577|579805642|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
160568851|NCT00785577|579805643|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
160568852|NCT00785577|579805644|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
160568853|NCT00785577|579805645|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
160568854|NCT00785577|579805646|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
160568855|NCT00785577|579805642|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
160568856|NCT00785577|579805643|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
160568857|NCT00785577|579805644|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
160568858|NCT00785577|579805645|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
160568859|NCT00785577|579805646|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
160568860|NCT00785577|579805642|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
160568861|NCT00785577|579805643|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
160568862|NCT00785577|579805644|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
160568863|NCT00785577|579805645|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
160849617|NCT04497116|580837874|FG020|Overall Study|Withdrawal by Subject|2|||
160849618|NCT04497116|580837875|FG021|Overall Study|Withdrawal by Subject|2|||
160849619|NCT04497116|580837876|FG022|Overall Study|Withdrawal by Subject|2|||
160849620|NCT04497116|580837877|FG023|Overall Study|Withdrawal by Subject|4|||
160849621|NCT04497116|580837878|FG024|Overall Study|Withdrawal by Subject|3|||
160849622|NCT04497116|580837854|FG000|Overall Study|Physician Decision|0|||
160849623|NCT04497116|580837855|FG001|Overall Study|Physician Decision|0|||
160568864|NCT00785577|579805646|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
160568865|NCT01650805|579805649|FG000|Overall Study|Withdrawal by Subject|1|||
160568866|NCT01650805|579805650|FG001|Overall Study|Withdrawal by Subject|0|||
160568867|NCT01887210|579805653|FG000|Overall Study|Withdrawal by Subject|1|||
160568868|NCT01887210|579805654|FG001|Overall Study|Withdrawal by Subject|3|||
160568869|NCT01887210|579805653|FG000|Overall Study|Lost to Follow-up|0|||
160568870|NCT01887210|579805654|FG001|Overall Study|Lost to Follow-up|1|||
160568871|NCT02515669|579805661|FG000|228 Week Open-Label Phase|Other|0|||
160568872|NCT02515669|579805662|FG001|228 Week Open-Label Phase|Other|0|||
160568873|NCT02515669|579805663|FG002|228 Week Open-Label Phase|Other|1|||
160568874|NCT02515669|579805664|FG003|228 Week Open-Label Phase|Other|4|||
160568875|NCT02515669|579805661|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
160568876|NCT02515669|579805662|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
160650534|NCT02146430|580102493|FG002|Overall Study|Protocol Violation|8|||
160849624|NCT04497116|580837856|FG002|Overall Study|Physician Decision|0|||
160849625|NCT04497116|580837857|FG003|Overall Study|Physician Decision|0|||
160849626|NCT04497116|580837858|FG004|Overall Study|Physician Decision|0|||
160849627|NCT04497116|580837859|FG005|Overall Study|Physician Decision|0|||
160849628|NCT04497116|580837860|FG006|Overall Study|Physician Decision|0|||
160849629|NCT04497116|580837861|FG007|Overall Study|Physician Decision|0|||
160849630|NCT04497116|580837862|FG008|Overall Study|Physician Decision|0|||
160849631|NCT04497116|580837863|FG009|Overall Study|Physician Decision|0|||
160568877|NCT02515669|579805663|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
160849632|NCT04497116|580837864|FG010|Overall Study|Physician Decision|0|||
160849633|NCT04497116|580837865|FG011|Overall Study|Physician Decision|0|||
160849634|NCT04497116|580837866|FG012|Overall Study|Physician Decision|0|||
160849635|NCT04497116|580837867|FG013|Overall Study|Physician Decision|0|||
160849636|NCT04497116|580837868|FG014|Overall Study|Physician Decision|0|||
160849637|NCT04497116|580837869|FG015|Overall Study|Physician Decision|0|||
160849638|NCT04497116|580837870|FG016|Overall Study|Physician Decision|0|||
160849639|NCT04497116|580837871|FG017|Overall Study|Physician Decision|0|||
160849640|NCT04497116|580837872|FG018|Overall Study|Physician Decision|0|||
160849641|NCT04497116|580837873|FG019|Overall Study|Physician Decision|0|||
160849642|NCT04497116|580837874|FG020|Overall Study|Physician Decision|0|||
160849643|NCT04497116|580837875|FG021|Overall Study|Physician Decision|0|||
160849644|NCT04497116|580837876|FG022|Overall Study|Physician Decision|0|||
160849645|NCT04497116|580837877|FG023|Overall Study|Physician Decision|1|||
160849646|NCT04497116|580837878|FG024|Overall Study|Physician Decision|0|||
160849647|NCT04497116|580837854|FG000|Overall Study|Clinical Progression Related|0|||
160849648|NCT04497116|580837855|FG001|Overall Study|Clinical Progression Related|0|||
160849649|NCT04497116|580837856|FG002|Overall Study|Clinical Progression Related|0|||
160849650|NCT04497116|580837857|FG003|Overall Study|Clinical Progression Related|0|||
160849651|NCT04497116|580837858|FG004|Overall Study|Clinical Progression Related|0|||
160849652|NCT04497116|580837859|FG005|Overall Study|Clinical Progression Related|0|||
160849653|NCT04497116|580837860|FG006|Overall Study|Clinical Progression Related|0|||
160849654|NCT04497116|580837861|FG007|Overall Study|Clinical Progression Related|0|||
160849655|NCT04497116|580837862|FG008|Overall Study|Clinical Progression Related|0|||
160849656|NCT04497116|580837863|FG009|Overall Study|Clinical Progression Related|1|||
160849657|NCT04497116|580837864|FG010|Overall Study|Clinical Progression Related|0|||
160849658|NCT04497116|580837865|FG011|Overall Study|Clinical Progression Related|0|||
160849659|NCT04497116|580837866|FG012|Overall Study|Clinical Progression Related|0|||
160849660|NCT04497116|580837867|FG013|Overall Study|Clinical Progression Related|0|||
160849661|NCT04497116|580837868|FG014|Overall Study|Clinical Progression Related|0|||
160849662|NCT04497116|580837869|FG015|Overall Study|Clinical Progression Related|0|||
160849663|NCT04497116|580837870|FG016|Overall Study|Clinical Progression Related|0|||
160849664|NCT04497116|580837871|FG017|Overall Study|Clinical Progression Related|0|||
160849665|NCT04497116|580837872|FG018|Overall Study|Clinical Progression Related|0|||
160568878|NCT02515669|579805664|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
160568879|NCT02515669|579805661|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
160568880|NCT02515669|579805662|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
160568881|NCT02515669|579805663|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
160568882|NCT02515669|579805664|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
160568883|NCT02515669|579805661|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
160568884|NCT02515669|579805662|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
160568885|NCT02515669|579805663|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
160568886|NCT02515669|579805664|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
160568887|NCT02515669|579805661|FG000|228 Week Open-Label Phase|Missing|0|||
160568888|NCT02515669|579805662|FG001|228 Week Open-Label Phase|Missing|2|||
160568889|NCT02515669|579805663|FG002|228 Week Open-Label Phase|Missing|2|||
160568890|NCT02515669|579805664|FG003|228 Week Open-Label Phase|Missing|2|||
160568891|NCT00957372|579805665|FG000|PART I|Lost to Follow-up|0|||
160568892|NCT00957372|579805666|FG001|PART I|Lost to Follow-up|0|||
160568893|NCT00957372|579805667|FG002|PART I|Lost to Follow-up|1|||
160849666|NCT04497116|580837873|FG019|Overall Study|Clinical Progression Related|0|||
160849667|NCT04497116|580837874|FG020|Overall Study|Clinical Progression Related|0|||
160849668|NCT04497116|580837875|FG021|Overall Study|Clinical Progression Related|0|||
160849669|NCT04497116|580837876|FG022|Overall Study|Clinical Progression Related|0|||
160849670|NCT04497116|580837877|FG023|Overall Study|Clinical Progression Related|0|||
160849671|NCT04497116|580837878|FG024|Overall Study|Clinical Progression Related|0|||
160849672|NCT02698826|580837879|FG000|Overall Study|Death|13|||
160849673|NCT02698826|580837879|FG000|Overall Study|Adverse Event|1|||
160849674|NCT02915263|580837882|FG000|Overall Study|Covid|3|||
160849675|NCT02915263|580837883|FG001|Overall Study|Covid|2|||
160849676|NCT01358825|580837884|FG000|Overall Study|Blood sample not drawn|0|||
160849677|NCT01358825|580837885|FG001|Overall Study|Blood sample not drawn|1|||
160849678|NCT01788566|580837888|FG000|Overall Study|Death|4|||
160849679|NCT01788566|580837888|FG000|Overall Study|Adverse Event|1|||
160849680|NCT01788566|580837888|FG000|Overall Study|Clinical Progressive Disease|3|||
160568894|NCT00957372|579805668|FG003|PART I|Lost to Follow-up|0|||
160849681|NCT00857285|580837891|FG000|Overall Study|Adverse Event|4|||
160849682|NCT00857285|580837892|FG001|Overall Study|Adverse Event|2|||
160849683|NCT00857285|580837891|FG000|Overall Study|Lack of Efficacy|0|||
160849684|NCT00857285|580837892|FG001|Overall Study|Lack of Efficacy|2|||
160849685|NCT00857285|580837891|FG000|Overall Study|Protocol Violation|3|||
160849686|NCT00857285|580837892|FG001|Overall Study|Protocol Violation|1|||
160849687|NCT00857285|580837891|FG000|Overall Study|Withdrawal by Subject|4|||
160849688|NCT00857285|580837892|FG001|Overall Study|Withdrawal by Subject|0|||
160849689|NCT00857285|580837891|FG000|Overall Study|Randomization criteria not met|1|||
160849690|NCT00857285|580837892|FG001|Overall Study|Randomization criteria not met|1|||
160849691|NCT01539759|580837893|FG000|Overall Study|Lost to Follow-up|6|||
160849692|NCT01539759|580837894|FG001|Overall Study|Lost to Follow-up|8|||
160849693|NCT01076959|580837895|FG000|Overall Study|Adverse Event|767|||
160849694|NCT01076959|580837895|FG000|Overall Study|Lack of Efficacy|849|||
160849695|NCT01076959|580837895|FG000|Overall Study|Non-compliance|274|||
160849696|NCT01076959|580837895|FG000|Overall Study|Lost to Follow-up|241|||
160849697|NCT01076959|580837895|FG000|Overall Study|Other|119|||
160849698|NCT02491983|580837896|FG000|Overall Study|Physician Decision|1|||
160849699|NCT02491983|580837897|FG001|Overall Study|Physician Decision|0|||
160849700|NCT02491983|580837896|FG000|Overall Study|Not meet selection criteria|1|||
160568895|NCT00957372|579805665|FG000|PART II|Withdrawal by Subject|0|||
160568896|NCT00957372|579805666|FG001|PART II|Withdrawal by Subject|0|||
160568897|NCT00957372|579805667|FG002|PART II|Withdrawal by Subject|0|||
160568898|NCT00957372|579805668|FG003|PART II|Withdrawal by Subject|8|||
160568899|NCT00957372|579805665|FG000|PART II|Physician Decision|0|||
160568900|NCT00957372|579805666|FG001|PART II|Physician Decision|0|||
160568901|NCT00957372|579805667|FG002|PART II|Physician Decision|0|||
160568902|NCT00957372|579805668|FG003|PART II|Physician Decision|1|||
160568903|NCT00957372|579805665|FG000|PART II|Pregnancy|0|||
160568904|NCT00957372|579805666|FG001|PART II|Pregnancy|0|||
160568905|NCT00957372|579805667|FG002|PART II|Pregnancy|0|||
160568906|NCT00957372|579805668|FG003|PART II|Pregnancy|1|||
160568907|NCT00957372|579805665|FG000|PART II|Not Know|0|||
160568908|NCT00957372|579805666|FG001|PART II|Not Know|0|||
160568909|NCT00957372|579805667|FG002|PART II|Not Know|0|||
160568910|NCT00957372|579805668|FG003|PART II|Not Know|20|||
160568911|NCT00957372|579805665|FG000|PART II|Adverse Event|0|||
160568912|NCT00957372|579805666|FG001|PART II|Adverse Event|0|||
160568913|NCT00957372|579805667|FG002|PART II|Adverse Event|0|||
160568914|NCT00957372|579805668|FG003|PART II|Adverse Event|10|||
160568915|NCT00957372|579805665|FG000|PART II|Patient non-compliance|0|||
160568916|NCT00957372|579805666|FG001|PART II|Patient non-compliance|0|||
160568917|NCT00957372|579805667|FG002|PART II|Patient non-compliance|0|||
160568918|NCT00957372|579805668|FG003|PART II|Patient non-compliance|4|||
160568919|NCT03750838|579805671|FG000|Overall Study|Lost to Follow-up|10|||
160568920|NCT03750838|579805672|FG001|Overall Study|Lost to Follow-up|6|||
160568921|NCT01444391|579805673|FG000|Overall Study|Death|1|||
160568922|NCT00630032|579805676|FG000|Overall Study|Death|55|||
160568923|NCT00630032|579805677|FG001|Overall Study|Death|49|||
160568924|NCT00630032|579805676|FG000|Overall Study|Withdrawal by Subject|3|||
160568925|NCT00630032|579805677|FG001|Overall Study|Withdrawal by Subject|2|||
160568926|NCT00630032|579805676|FG000|Overall Study|Lost to Follow-up|18|||
160568927|NCT00630032|579805677|FG001|Overall Study|Lost to Follow-up|31|||
160568928|NCT00630032|579805676|FG000|Overall Study|Protocol Violation|1|||
160568929|NCT00630032|579805677|FG001|Overall Study|Protocol Violation|0|||
160568930|NCT00630032|579805676|FG000|Overall Study|Patient has moved|1|||
160568931|NCT00630032|579805677|FG001|Overall Study|Patient has moved|1|||
160568932|NCT00630032|579805676|FG000|Overall Study|Disease progression|1|||
160568933|NCT00630032|579805677|FG001|Overall Study|Disease progression|1|||
160568934|NCT00630032|579805676|FG000|Overall Study|End of monitoring in US centers|11|||
160568935|NCT00630032|579805677|FG001|Overall Study|End of monitoring in US centers|11|||
160568936|NCT02332915|579805678|FG000|Overall Study|Moved out of region|3|||
160568937|NCT02332915|579805679|FG001|Overall Study|Moved out of region|0|||
160568938|NCT02332915|579805678|FG000|Overall Study|Unrelated illness|1|||
160568939|NCT02332915|579805679|FG001|Overall Study|Unrelated illness|1|||
160568940|NCT02332915|579805678|FG000|Overall Study|Travel distance prohibitive|0|||
160568941|NCT02332915|579805679|FG001|Overall Study|Travel distance prohibitive|1|||
160568942|NCT02332915|579805678|FG000|Overall Study|did not meet inclusion criteria|2|||
160568943|NCT02332915|579805679|FG001|Overall Study|did not meet inclusion criteria|4|||
160568944|NCT04070378|579805683|FG000|Overall Study|Withdrawal by Subject|2|||
160568945|NCT04070378|579805683|FG000|Overall Study|Screen Failure|6|||
160849701|NCT02491983|580837897|FG001|Overall Study|Not meet selection criteria|0|||
160568946|NCT04070378|579805683|FG000|Overall Study|Physician Decision|1|||
160568947|NCT04070378|579805683|FG000|Overall Study|Adverse Event|1|||
160568948|NCT01901328|579805684|FG000|Overall Study|Lost to Follow-up|1|||
160568949|NCT01901328|579805685|FG001|Overall Study|Lost to Follow-up|0|||
160568950|NCT01901328|579805684|FG000|Overall Study|Physician Decision|0|||
160568951|NCT01901328|579805685|FG001|Overall Study|Physician Decision|1|||
160568952|NCT01901328|579805684|FG000|Overall Study|Protocol Violation|1|||
160568953|NCT01901328|579805685|FG001|Overall Study|Protocol Violation|1|||
160568954|NCT01901328|579805684|FG000|Overall Study|Study Terminated by Sponsor|19|||
160568955|NCT01901328|579805685|FG001|Overall Study|Study Terminated by Sponsor|16|||
160568956|NCT01901328|579805684|FG000|Overall Study|Withdrawal by Subject|1|||
160568957|NCT01901328|579805685|FG001|Overall Study|Withdrawal by Subject|2|||
160849702|NCT02491983|580837896|FG000|Overall Study|Withdrawal by Subject|0|||
160906655|NCT00913497|581052263|FG000|Overall Study|Adverse Event|1|||
160568958|NCT01901328|579805684|FG000|Overall Study|Lack of Efficacy|0|||
160568959|NCT01901328|579805685|FG001|Overall Study|Lack of Efficacy|1|||
160568960|NCT02462889|579805686|FG000|Overall Study|Withdrawal by Subject|2|||
160849703|NCT02491983|580837897|FG001|Overall Study|Withdrawal by Subject|1|||
160849704|NCT04378270|580837899|FG000|Overall Study|Lack of Efficacy|1|||
160849705|NCT04378270|580837899|FG000|Overall Study|Withdrawal by Subject|1|||
160849706|NCT04378270|580837899|FG000|Overall Study|Screen Failure|1|||
160849707|NCT04378270|580837899|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
160849708|NCT01132313|580837900|FG000|Overall Study|Lack of Efficacy|1|||
160849709|NCT01132313|580837901|FG001|Overall Study|Lack of Efficacy|0|||
160849710|NCT01132313|580837902|FG002|Overall Study|Lack of Efficacy|0|||
160849711|NCT01132313|580837903|FG003|Overall Study|Lack of Efficacy|0|||
160849712|NCT01132313|580837904|FG004|Overall Study|Lack of Efficacy|0|||
160849713|NCT01132313|580837905|FG005|Overall Study|Lack of Efficacy|0|||
160849714|NCT01132313|580837906|FG006|Overall Study|Lack of Efficacy|0|||
160849715|NCT01132313|580837907|FG007|Overall Study|Lack of Efficacy|3|||
160849716|NCT01132313|580837908|FG008|Overall Study|Lack of Efficacy|14|||
160849717|NCT01132313|580837909|FG009|Overall Study|Lack of Efficacy|16|||
160849718|NCT01132313|580837910|FG010|Overall Study|Lack of Efficacy|0|||
160849719|NCT01132313|580837911|FG011|Overall Study|Lack of Efficacy|0|||
160849720|NCT01132313|580837900|FG000|Overall Study|Not treated|2|||
160849721|NCT01132313|580837901|FG001|Overall Study|Not treated|0|||
160849722|NCT01132313|580837902|FG002|Overall Study|Not treated|0|||
160849723|NCT01132313|580837903|FG003|Overall Study|Not treated|0|||
160849724|NCT01132313|580837904|FG004|Overall Study|Not treated|2|||
160849725|NCT01132313|580837905|FG005|Overall Study|Not treated|1|||
160849726|NCT01132313|580837906|FG006|Overall Study|Not treated|3|||
160849727|NCT01132313|580837907|FG007|Overall Study|Not treated|0|||
160849728|NCT01132313|580837908|FG008|Overall Study|Not treated|0|||
160849729|NCT01132313|580837909|FG009|Overall Study|Not treated|0|||
160849730|NCT01132313|580837910|FG010|Overall Study|Not treated|0|||
160849731|NCT01132313|580837911|FG011|Overall Study|Not treated|0|||
160849732|NCT01132313|580837900|FG000|Overall Study|Adverse Event|0|||
160849733|NCT01132313|580837901|FG001|Overall Study|Adverse Event|0|||
160849734|NCT01132313|580837902|FG002|Overall Study|Adverse Event|4|||
160849735|NCT01132313|580837903|FG003|Overall Study|Adverse Event|10|||
160849736|NCT01132313|580837904|FG004|Overall Study|Adverse Event|19|||
160849737|NCT01132313|580837905|FG005|Overall Study|Adverse Event|6|||
160568961|NCT02462889|579805687|FG001|Overall Study|Withdrawal by Subject|6|||
160849738|NCT01132313|580837906|FG006|Overall Study|Adverse Event|5|||
160849739|NCT01132313|580837907|FG007|Overall Study|Adverse Event|3|||
160849740|NCT01132313|580837908|FG008|Overall Study|Adverse Event|7|||
160849741|NCT01132313|580837909|FG009|Overall Study|Adverse Event|2|||
160849742|NCT01132313|580837910|FG010|Overall Study|Adverse Event|0|||
160849743|NCT01132313|580837911|FG011|Overall Study|Adverse Event|0|||
160849744|NCT01132313|580837900|FG000|Overall Study|Protocol Violation|0|||
160849745|NCT01132313|580837901|FG001|Overall Study|Protocol Violation|0|||
160849746|NCT01132313|580837902|FG002|Overall Study|Protocol Violation|0|||
160849747|NCT01132313|580837903|FG003|Overall Study|Protocol Violation|1|||
160849748|NCT01132313|580837904|FG004|Overall Study|Protocol Violation|0|||
160849749|NCT01132313|580837905|FG005|Overall Study|Protocol Violation|0|||
160849750|NCT01132313|580837906|FG006|Overall Study|Protocol Violation|0|||
160849751|NCT01132313|580837907|FG007|Overall Study|Protocol Violation|0|||
160849752|NCT01132313|580837908|FG008|Overall Study|Protocol Violation|0|||
160849753|NCT01132313|580837909|FG009|Overall Study|Protocol Violation|0|||
160849754|NCT01132313|580837910|FG010|Overall Study|Protocol Violation|0|||
160849755|NCT01132313|580837911|FG011|Overall Study|Protocol Violation|0|||
160849756|NCT01132313|580837900|FG000|Overall Study|Lost to Follow-up|0|||
160849757|NCT01132313|580837901|FG001|Overall Study|Lost to Follow-up|0|||
160849758|NCT01132313|580837902|FG002|Overall Study|Lost to Follow-up|1|||
160849759|NCT01132313|580837903|FG003|Overall Study|Lost to Follow-up|0|||
160849760|NCT01132313|580837904|FG004|Overall Study|Lost to Follow-up|0|||
160849761|NCT01132313|580837905|FG005|Overall Study|Lost to Follow-up|0|||
160849762|NCT01132313|580837906|FG006|Overall Study|Lost to Follow-up|0|||
160849763|NCT01132313|580837907|FG007|Overall Study|Lost to Follow-up|1|||
160849764|NCT01132313|580837908|FG008|Overall Study|Lost to Follow-up|0|||
160849765|NCT01132313|580837909|FG009|Overall Study|Lost to Follow-up|0|||
160849766|NCT01132313|580837910|FG010|Overall Study|Lost to Follow-up|0|||
160849767|NCT01132313|580837911|FG011|Overall Study|Lost to Follow-up|0|||
160849768|NCT01132313|580837900|FG000|Overall Study|Withdrawal by Subject|0|||
160849769|NCT01132313|580837901|FG001|Overall Study|Withdrawal by Subject|0|||
160849770|NCT01132313|580837902|FG002|Overall Study|Withdrawal by Subject|3|||
160849771|NCT01132313|580837903|FG003|Overall Study|Withdrawal by Subject|3|||
160849772|NCT01132313|580837904|FG004|Overall Study|Withdrawal by Subject|6|||
160849773|NCT01132313|580837905|FG005|Overall Study|Withdrawal by Subject|0|||
160849774|NCT01132313|580837906|FG006|Overall Study|Withdrawal by Subject|1|||
160849775|NCT01132313|580837907|FG007|Overall Study|Withdrawal by Subject|0|||
160849776|NCT01132313|580837908|FG008|Overall Study|Withdrawal by Subject|0|||
160849777|NCT01132313|580837909|FG009|Overall Study|Withdrawal by Subject|2|||
160849778|NCT01132313|580837910|FG010|Overall Study|Withdrawal by Subject|0|||
160849779|NCT01132313|580837911|FG011|Overall Study|Withdrawal by Subject|0|||
160849780|NCT01132313|580837900|FG000|Overall Study|Lack of antiviral response|0|||
160568962|NCT02462889|579805686|FG000|Overall Study|Death|1|||
160849781|NCT01132313|580837901|FG001|Overall Study|Lack of antiviral response|0|||
160849782|NCT01132313|580837902|FG002|Overall Study|Lack of antiviral response|12|||
160849783|NCT01132313|580837903|FG003|Overall Study|Lack of antiviral response|18|||
160849784|NCT01132313|580837904|FG004|Overall Study|Lack of antiviral response|18|||
160849785|NCT01132313|580837905|FG005|Overall Study|Lack of antiviral response|18|||
160849786|NCT01132313|580837906|FG006|Overall Study|Lack of antiviral response|21|||
160849787|NCT01132313|580837907|FG007|Overall Study|Lack of antiviral response|0|||
160849788|NCT01132313|580837908|FG008|Overall Study|Lack of antiviral response|0|||
160849789|NCT01132313|580837909|FG009|Overall Study|Lack of antiviral response|0|||
160849790|NCT01132313|580837910|FG010|Overall Study|Lack of antiviral response|1|||
160849791|NCT01132313|580837911|FG011|Overall Study|Lack of antiviral response|0|||
160849792|NCT01132313|580837900|FG000|Overall Study|Other reason not defined above|0|||
160849793|NCT01132313|580837901|FG001|Overall Study|Other reason not defined above|0|||
160849794|NCT01132313|580837902|FG002|Overall Study|Other reason not defined above|0|||
160849795|NCT01132313|580837903|FG003|Overall Study|Other reason not defined above|0|||
160849796|NCT01132313|580837904|FG004|Overall Study|Other reason not defined above|0|||
160849797|NCT01132313|580837905|FG005|Overall Study|Other reason not defined above|0|||
160849798|NCT01132313|580837906|FG006|Overall Study|Other reason not defined above|0|||
160849799|NCT01132313|580837907|FG007|Overall Study|Other reason not defined above|1|||
160849800|NCT01132313|580837908|FG008|Overall Study|Other reason not defined above|0|||
160849801|NCT01132313|580837909|FG009|Overall Study|Other reason not defined above|0|||
160849802|NCT01132313|580837910|FG010|Overall Study|Other reason not defined above|0|||
160849803|NCT01132313|580837911|FG011|Overall Study|Other reason not defined above|0|||
160849804|NCT03201419|580837914|FG000|Overall Study|Adverse Event|3|||
160849805|NCT03201419|580837915|FG001|Overall Study|Adverse Event|1|||
160849806|NCT03201419|580837916|FG002|Overall Study|Adverse Event|0|||
160849807|NCT03201419|580837917|FG003|Overall Study|Adverse Event|0|||
160849808|NCT03201419|580837918|FG004|Overall Study|Adverse Event|1|||
160849809|NCT03201419|580837919|FG005|Overall Study|Adverse Event|1|||
160849810|NCT03201419|580837920|FG006|Overall Study|Adverse Event|5|||
160849811|NCT03201419|580837921|FG007|Overall Study|Adverse Event|0|||
160849812|NCT03201419|580837922|FG008|Overall Study|Adverse Event|0|||
160849813|NCT03201419|580837914|FG000|Overall Study|Lost to Follow-up|1|||
160849814|NCT03201419|580837915|FG001|Overall Study|Lost to Follow-up|0|||
160849815|NCT03201419|580837916|FG002|Overall Study|Lost to Follow-up|0|||
160849816|NCT03201419|580837917|FG003|Overall Study|Lost to Follow-up|0|||
160849817|NCT03201419|580837918|FG004|Overall Study|Lost to Follow-up|0|||
160849818|NCT03201419|580837919|FG005|Overall Study|Lost to Follow-up|0|||
160849819|NCT03201419|580837920|FG006|Overall Study|Lost to Follow-up|0|||
160849820|NCT03201419|580837921|FG007|Overall Study|Lost to Follow-up|0|||
160849821|NCT03201419|580837922|FG008|Overall Study|Lost to Follow-up|0|||
160849822|NCT03201419|580837914|FG000|Overall Study|Protocol Deviation|0|||
160849823|NCT03201419|580837915|FG001|Overall Study|Protocol Deviation|0|||
160849824|NCT03201419|580837916|FG002|Overall Study|Protocol Deviation|0|||
160849825|NCT03201419|580837917|FG003|Overall Study|Protocol Deviation|0|||
160849826|NCT03201419|580837918|FG004|Overall Study|Protocol Deviation|0|||
160849827|NCT03201419|580837919|FG005|Overall Study|Protocol Deviation|0|||
160849828|NCT03201419|580837920|FG006|Overall Study|Protocol Deviation|1|||
160849829|NCT03201419|580837921|FG007|Overall Study|Protocol Deviation|0|||
160849830|NCT03201419|580837922|FG008|Overall Study|Protocol Deviation|0|||
160849831|NCT03201419|580837914|FG000|Overall Study|Withdrawal by Subject|4|||
160568963|NCT02462889|579805687|FG001|Overall Study|Death|5|||
160568964|NCT03232073|579805688|FG000|Overall Study|Death|1|||
160568965|NCT03232073|579805689|FG001|Overall Study|Death|0|||
160849832|NCT03201419|580837915|FG001|Overall Study|Withdrawal by Subject|2|||
160849833|NCT03201419|580837916|FG002|Overall Study|Withdrawal by Subject|1|||
160849834|NCT03201419|580837917|FG003|Overall Study|Withdrawal by Subject|0|||
160849835|NCT03201419|580837918|FG004|Overall Study|Withdrawal by Subject|0|||
160849836|NCT03201419|580837919|FG005|Overall Study|Withdrawal by Subject|0|||
160849837|NCT03201419|580837920|FG006|Overall Study|Withdrawal by Subject|0|||
160849838|NCT03201419|580837921|FG007|Overall Study|Withdrawal by Subject|1|||
160849839|NCT03201419|580837922|FG008|Overall Study|Withdrawal by Subject|2|||
160849840|NCT03201419|580837914|FG000|Overall Study|Other|0|||
160849841|NCT03201419|580837915|FG001|Overall Study|Other|0|||
160849842|NCT03201419|580837916|FG002|Overall Study|Other|1|||
160849843|NCT03201419|580837917|FG003|Overall Study|Other|0|||
160849844|NCT03201419|580837918|FG004|Overall Study|Other|0|||
160568966|NCT03232073|579805688|FG000|Overall Study|Adverse Event|7|||
160849845|NCT03201419|580837919|FG005|Overall Study|Other|0|||
160849846|NCT03201419|580837920|FG006|Overall Study|Other|0|||
160849847|NCT03201419|580837921|FG007|Overall Study|Other|0|||
160849848|NCT03201419|580837922|FG008|Overall Study|Other|0|||
160849849|NCT04965688|580837928|FG000|Overall Study|Withdrawal by Subject|2|||
160849850|NCT00369577|580837929|FG000|Overall Study|Withdrawal by Subject|0|||
160849851|NCT00369577|580837930|FG001|Overall Study|Withdrawal by Subject|0|||
160849852|NCT00369577|580837931|FG002|Overall Study|Withdrawal by Subject|1|||
160849853|NCT00699660|580837932|FG000|Overall Study|Lost to Follow-up|4|||
160849854|NCT00699660|580837933|FG001|Overall Study|Lost to Follow-up|2|||
160849855|NCT00699660|580837932|FG000|Overall Study|missing reports and recording failures|10|||
160849856|NCT00699660|580837933|FG001|Overall Study|missing reports and recording failures|6|||
160849857|NCT03915470|580837934|FG000|Overall Study|Death|3|||
160849858|NCT03915470|580837935|FG001|Overall Study|Death|1|||
160849859|NCT03915470|580837934|FG000|Overall Study|Adverse Event|1|||
160849860|NCT03915470|580837935|FG001|Overall Study|Adverse Event|0|||
160849861|NCT03915470|580837934|FG000|Overall Study|Physician Decision|1|||
160849862|NCT03915470|580837935|FG001|Overall Study|Physician Decision|0|||
160849863|NCT03915470|580837934|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
160849864|NCT03915470|580837935|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
160849865|NCT03160898|580837936|FG000|Overall Study|Adverse Event|4|||
160849866|NCT03160898|580837937|FG001|Overall Study|Adverse Event|8|||
160849867|NCT03160898|580837938|FG002|Overall Study|Adverse Event|7|||
160849868|NCT03160898|580837939|FG003|Overall Study|Adverse Event|10|||
160849869|NCT03160898|580837936|FG000|Overall Study|Death|1|||
160849870|NCT03160898|580837937|FG001|Overall Study|Death|0|||
160849871|NCT03160898|580837938|FG002|Overall Study|Death|0|||
160849872|NCT03160898|580837939|FG003|Overall Study|Death|1|||
160849873|NCT03160898|580837936|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
160849874|NCT03160898|580837937|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
160849875|NCT03160898|580837938|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
160849876|NCT03160898|580837939|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
160849877|NCT03160898|580837936|FG000|Overall Study|Lost to Follow-up|1|||
160849878|NCT03160898|580837937|FG001|Overall Study|Lost to Follow-up|1|||
160849879|NCT03160898|580837938|FG002|Overall Study|Lost to Follow-up|1|||
160849880|NCT03160898|580837939|FG003|Overall Study|Lost to Follow-up|2|||
160849881|NCT03160898|580837936|FG000|Overall Study|Physician Decision|1|||
160849882|NCT03160898|580837937|FG001|Overall Study|Physician Decision|0|||
160849883|NCT03160898|580837938|FG002|Overall Study|Physician Decision|0|||
160849884|NCT03160898|580837939|FG003|Overall Study|Physician Decision|1|||
160849885|NCT03160898|580837936|FG000|Overall Study|Progressive Disease|4|||
160849886|NCT03160898|580837937|FG001|Overall Study|Progressive Disease|1|||
160849887|NCT03160898|580837938|FG002|Overall Study|Progressive Disease|2|||
160849888|NCT03160898|580837939|FG003|Overall Study|Progressive Disease|1|||
160849889|NCT03160898|580837936|FG000|Overall Study|Protocol Violation|1|||
160849890|NCT03160898|580837937|FG001|Overall Study|Protocol Violation|0|||
160849891|NCT03160898|580837938|FG002|Overall Study|Protocol Violation|2|||
160849892|NCT03160898|580837939|FG003|Overall Study|Protocol Violation|0|||
160849893|NCT03160898|580837936|FG000|Overall Study|Sponsor Discretion|2|||
160849894|NCT03160898|580837937|FG001|Overall Study|Sponsor Discretion|0|||
160849895|NCT03160898|580837938|FG002|Overall Study|Sponsor Discretion|0|||
160849896|NCT03160898|580837939|FG003|Overall Study|Sponsor Discretion|0|||
160849897|NCT03160898|580837936|FG000|Overall Study|Withdrawal by Subject|1|||
160849898|NCT03160898|580837937|FG001|Overall Study|Withdrawal by Subject|3|||
160849899|NCT03160898|580837938|FG002|Overall Study|Withdrawal by Subject|2|||
160849900|NCT03160898|580837939|FG003|Overall Study|Withdrawal by Subject|1|||
160849901|NCT03160898|580837936|FG000|Overall Study|Other|2|||
160849902|NCT03160898|580837937|FG001|Overall Study|Other|0|||
160849903|NCT03160898|580837938|FG002|Overall Study|Other|2|||
160849904|NCT03160898|580837939|FG003|Overall Study|Other|2|||
160849905|NCT03405818|580837942|FG000|Overall Study|Withdrawal by Subject|4|||
160568967|NCT03232073|579805689|FG001|Overall Study|Adverse Event|12|||
160568968|NCT03232073|579805688|FG000|Overall Study|Lost to Follow-up|6|||
160568969|NCT03232073|579805689|FG001|Overall Study|Lost to Follow-up|6|||
160568970|NCT03232073|579805688|FG000|Overall Study|Lack of Efficacy|10|||
160849906|NCT03405818|580837942|FG000|Overall Study|Lost to Follow-up|4|||
160849907|NCT00434109|580837943|FG000|Overall Study|Physician Decision|9|||
160849908|NCT00434109|580837943|FG000|Overall Study|Adverse Event|5|||
160849909|NCT00434109|580837943|FG000|Overall Study|Protocol Violation|1|||
160849910|NCT00434109|580837943|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
160849911|NCT04186871|580837944|FG000|Overall Study|Lack of Efficacy|0|||
160849912|NCT04186871|580837945|FG001|Overall Study|Lack of Efficacy|1|||
160849913|NCT04186871|580837946|FG002|Overall Study|Lack of Efficacy|0|||
160849914|NCT04186871|580837947|FG003|Overall Study|Lack of Efficacy|0|||
160849915|NCT04186871|580837948|FG004|Overall Study|Lack of Efficacy|1|||
160849916|NCT04186871|580837949|FG005|Overall Study|Lack of Efficacy|1|||
160849917|NCT04186871|580837944|FG000|Overall Study|Adverse Event|1|||
160849918|NCT04186871|580837945|FG001|Overall Study|Adverse Event|1|||
160849919|NCT04186871|580837946|FG002|Overall Study|Adverse Event|0|||
160849920|NCT04186871|580837947|FG003|Overall Study|Adverse Event|0|||
160849921|NCT04186871|580837948|FG004|Overall Study|Adverse Event|0|||
160849922|NCT04186871|580837949|FG005|Overall Study|Adverse Event|2|||
160849923|NCT04186871|580837944|FG000|Overall Study|Study terminated by sponsor|1|||
160849924|NCT04186871|580837945|FG001|Overall Study|Study terminated by sponsor|2|||
160849925|NCT04186871|580837946|FG002|Overall Study|Study terminated by sponsor|0|||
160849926|NCT04186871|580837947|FG003|Overall Study|Study terminated by sponsor|1|||
160849927|NCT04186871|580837948|FG004|Overall Study|Study terminated by sponsor|0|||
160849928|NCT04186871|580837949|FG005|Overall Study|Study terminated by sponsor|0|||
160849929|NCT04186871|580837944|FG000|Overall Study|Other reasons|0|||
160849930|NCT04186871|580837945|FG001|Overall Study|Other reasons|0|||
160849931|NCT04186871|580837946|FG002|Overall Study|Other reasons|0|||
160568971|NCT03232073|579805689|FG001|Overall Study|Lack of Efficacy|8|||
160568972|NCT03232073|579805688|FG000|Overall Study|Physician Decision|9|||
160568973|NCT03232073|579805689|FG001|Overall Study|Physician Decision|2|||
160568974|NCT03232073|579805688|FG000|Overall Study|Withdrawal by Subject|54|||
160568975|NCT03232073|579805689|FG001|Overall Study|Withdrawal by Subject|39|||
160568976|NCT02032875|579805690|FG000|Treatment Period|Adverse Event|1|||
160568977|NCT02032875|579805691|FG001|Treatment Period|Adverse Event|0|||
160568978|NCT02032875|579805690|FG000|Treatment Period|Liver transplant, No extension needed|0|||
160568979|NCT02032875|579805691|FG001|Treatment Period|Liver transplant, No extension needed|1|||
160568980|NCT02032875|579805690|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
160849932|NCT04186871|580837947|FG003|Overall Study|Other reasons|0|||
160849933|NCT04186871|580837948|FG004|Overall Study|Other reasons|0|||
160849934|NCT04186871|580837949|FG005|Overall Study|Other reasons|1|||
160849935|NCT04186871|580837944|FG000|Overall Study|Withdrawal by Subject|0|||
160849936|NCT04186871|580837945|FG001|Overall Study|Withdrawal by Subject|0|||
160849937|NCT04186871|580837946|FG002|Overall Study|Withdrawal by Subject|0|||
160849938|NCT04186871|580837947|FG003|Overall Study|Withdrawal by Subject|0|||
160849939|NCT04186871|580837948|FG004|Overall Study|Withdrawal by Subject|0|||
160849940|NCT04186871|580837949|FG005|Overall Study|Withdrawal by Subject|1|||
160849941|NCT04186871|580837944|FG000|Overall Study|Lost to Follow-up|0|||
160849942|NCT04186871|580837945|FG001|Overall Study|Lost to Follow-up|0|||
160849943|NCT04186871|580837946|FG002|Overall Study|Lost to Follow-up|0|||
160849944|NCT04186871|580837947|FG003|Overall Study|Lost to Follow-up|0|||
160849945|NCT04186871|580837948|FG004|Overall Study|Lost to Follow-up|0|||
160849946|NCT04186871|580837949|FG005|Overall Study|Lost to Follow-up|1|||
160849947|NCT01467505|580839455|FG000|Overall Study|Adverse Event|1|||
160849948|NCT01467505|580839456|FG001|Overall Study|Adverse Event|0|||
160849949|NCT01467505|580839455|FG000|Overall Study|Withdrawal by Subject|4|||
160849950|NCT01467505|580839456|FG001|Overall Study|Withdrawal by Subject|0|||
160849951|NCT01467505|580839455|FG000|Overall Study|Study Terminated by Sponsor|28|||
160849952|NCT01467505|580839456|FG001|Overall Study|Study Terminated by Sponsor|3|||
160849953|NCT00227721|580839457|FG000|Overall Study|On study, but never treated.|1|||
160849954|NCT00984256|580839461|FG000|Overall Study|Withdrawal by Subject|0|||
160849955|NCT00984256|580839462|FG001|Overall Study|Withdrawal by Subject|1|||
160849956|NCT03529110|580839468|FG000|Overall Study|Progressive Disease|66|||
160849957|NCT03529110|580839469|FG001|Overall Study|Progressive Disease|158|||
160849958|NCT03529110|580839468|FG000|Overall Study|Clinical Progression|4|||
160849959|NCT03529110|580839469|FG001|Overall Study|Clinical Progression|12|||
160849960|NCT03529110|580839468|FG000|Overall Study|Adverse Event|35|||
160849961|NCT03529110|580839469|FG001|Overall Study|Adverse Event|17|||
160849962|NCT03529110|580839468|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
160849963|NCT03529110|580839469|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
160849964|NCT03529110|580839468|FG000|Overall Study|Lack of Efficacy|3|||
160849965|NCT03529110|580839469|FG001|Overall Study|Lack of Efficacy|3|||
160849966|NCT03529110|580839468|FG000|Overall Study|Physician Decision|2|||
160849967|NCT03529110|580839469|FG001|Overall Study|Physician Decision|8|||
160849968|NCT03529110|580839468|FG000|Overall Study|Miscellaneous|2|||
160849969|NCT03529110|580839469|FG001|Overall Study|Miscellaneous|5|||
160849970|NCT03493945|580839470|FG000|Phase I Dose Escalation|Ineligible|0|||
160849971|NCT03493945|580839471|FG001|Phase I Dose Escalation|Ineligible|0|||
160849972|NCT03493945|580839472|FG002|Phase I Dose Escalation|Ineligible|1|||
160568981|NCT02032875|579805691|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
160568982|NCT02032875|579805690|FG000|Follow-up Period|Death|0|||
160568983|NCT02032875|579805691|FG001|Follow-up Period|Death|1|||
160568984|NCT02032875|579805690|FG000|Follow-up Period|Virologic Relapse|3|||
160849973|NCT03493945|580839473|FG003|Phase I Dose Escalation|Ineligible|0|||
160849974|NCT03493945|580839474|FG004|Phase I Dose Escalation|Ineligible|0|||
160906656|NCT00913497|581052263|FG000|Overall Study|Withdrawal by Subject|2|||
160906657|NCT01306942|581052264|FG000|Phase I|Adverse Event|2|||
160906658|NCT01306942|581052265|FG001|Phase I|Adverse Event|2|||
160906659|NCT01306942|581052266|FG002|Phase I|Adverse Event|0|||
160906660|NCT01306942|581052267|FG003|Phase I|Adverse Event|0|||
160906661|NCT01306942|581052264|FG000|Phase I|Physician Decision|3|||
160568985|NCT02032875|579805691|FG001|Follow-up Period|Virologic Relapse|10|||
160906662|NCT01306942|581052265|FG001|Phase I|Physician Decision|1|||
160568986|NCT03191786|579805696|FG000|Overall Study|Death|236|||
160568987|NCT03191786|579805697|FG001|Overall Study|Death|127|||
160849975|NCT03493945|580839475|FG005|Phase I Dose Escalation|Ineligible|0|||
160849976|NCT03493945|580839476|FG006|Phase I Dose Escalation|Ineligible|0|||
160849977|NCT03493945|580839470|FG000|Phase I Dose Escalation|New therapy|0|||
160849978|NCT03493945|580839471|FG001|Phase I Dose Escalation|New therapy|1|||
160849979|NCT03493945|580839472|FG002|Phase I Dose Escalation|New therapy|0|||
160849980|NCT03493945|580839473|FG003|Phase I Dose Escalation|New therapy|0|||
160849981|NCT03493945|580839474|FG004|Phase I Dose Escalation|New therapy|0|||
160849982|NCT03493945|580839475|FG005|Phase I Dose Escalation|New therapy|0|||
160849983|NCT03493945|580839476|FG006|Phase I Dose Escalation|New therapy|0|||
160568988|NCT03191786|579805696|FG000|Overall Study|Lost to Follow-up|9|||
160568989|NCT03191786|579805697|FG001|Overall Study|Lost to Follow-up|3|||
160849984|NCT03493945|580839470|FG000|Phase II Dose Expansion|Refused further treatment|0|||
160849985|NCT03493945|580839471|FG001|Phase II Dose Expansion|Refused further treatment|0|||
160849986|NCT03493945|580839472|FG002|Phase II Dose Expansion|Refused further treatment|0|||
160568990|NCT03191786|579805696|FG000|Overall Study|Physician Decision|1|||
160568991|NCT03191786|579805697|FG001|Overall Study|Physician Decision|0|||
160849987|NCT03493945|580839473|FG003|Phase II Dose Expansion|Refused further treatment|0|||
160849988|NCT03493945|580839474|FG004|Phase II Dose Expansion|Refused further treatment|1|||
160849989|NCT03493945|580839475|FG005|Phase II Dose Expansion|Refused further treatment|1|||
160849990|NCT03493945|580839476|FG006|Phase II Dose Expansion|Refused further treatment|0|||
160849991|NCT03493945|580839470|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849992|NCT03493945|580839471|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849993|NCT03493945|580839472|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849994|NCT03493945|580839473|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
160849995|NCT03493945|580839474|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849996|NCT03493945|580839475|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849997|NCT03493945|580839476|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849998|NCT05104450|580839477|FG000|Overall Study|Death|1|||
160849999|NCT05104450|580839478|FG001|Overall Study|Death|2|||
160850000|NCT05104450|580839477|FG000|Overall Study|Withdrawal by Subject|3|||
160850001|NCT05104450|580839478|FG001|Overall Study|Withdrawal by Subject|1|||
160906663|NCT01306942|581052266|FG002|Phase I|Physician Decision|0|||
160906664|NCT01306942|581052267|FG003|Phase I|Physician Decision|0|||
160906665|NCT01306942|581052264|FG000|Phase II|Adverse Event|0|||
160850002|NCT01584232|580839479|FG000|Overall Study|Adverse Event|3|||
160568992|NCT03191786|579805696|FG000|Overall Study|Moved to Post Trial Access Program|30|||
160568993|NCT03191786|579805697|FG001|Overall Study|Moved to Post Trial Access Program|5|||
160568994|NCT03191786|579805696|FG000|Overall Study|Withdrawal by Subject|26|||
160568995|NCT03191786|579805697|FG001|Overall Study|Withdrawal by Subject|16|||
160568996|NCT05847881|579805698|FG000|Overall Study|Principal Investigator Decision|8|||
160568997|NCT05847881|579805698|FG000|Overall Study|Withdrawal by Subject|2|||
160568998|NCT05405166|579806922|FG000|Overall Study|Death|49|||
160568999|NCT05405166|579806923|FG001|Overall Study|Death|50|||
160569000|NCT05405166|579806922|FG000|Overall Study|Withdrawal by Subject|10|||
160569001|NCT05405166|579806923|FG001|Overall Study|Withdrawal by Subject|3|||
160569002|NCT05405166|579806922|FG000|Overall Study|Ongoing at the time of PCD|209|||
160569003|NCT05405166|579806923|FG001|Overall Study|Ongoing at the time of PCD|210|||
160569004|NCT01348919|579806924|FG000|Overall Study|Adverse Event|3|||
160569005|NCT01348919|579806925|FG001|Overall Study|Adverse Event|1|||
160569006|NCT01348919|579806926|FG002|Overall Study|Adverse Event|0|||
160569007|NCT01348919|579806924|FG000|Overall Study|Withdrawal by Subject|0|||
160569008|NCT01348919|579806925|FG001|Overall Study|Withdrawal by Subject|1|||
160569009|NCT01348919|579806926|FG002|Overall Study|Withdrawal by Subject|0|||
160569010|NCT01348919|579806924|FG000|Overall Study|Disease progression|0|||
160569011|NCT01348919|579806925|FG001|Overall Study|Disease progression|1|||
160569012|NCT01348919|579806926|FG002|Overall Study|Disease progression|1|||
160906666|NCT01306942|581052265|FG001|Phase II|Adverse Event|0|||
160906667|NCT01306942|581052266|FG002|Phase II|Adverse Event|0|||
160906668|NCT01306942|581052267|FG003|Phase II|Adverse Event|6|||
160906669|NCT01306942|581052264|FG000|Phase II|Physician Decision|2|||
160906670|NCT01306942|581052265|FG001|Phase II|Physician Decision|0|||
160906671|NCT01306942|581052266|FG002|Phase II|Physician Decision|0|||
160906672|NCT01306942|581052267|FG003|Phase II|Physician Decision|5|||
160906673|NCT01306942|581052264|FG000|Phase II|Withdrawal by Subject|0|||
160906674|NCT01306942|581052265|FG001|Phase II|Withdrawal by Subject|0|||
160906675|NCT01306942|581052266|FG002|Phase II|Withdrawal by Subject|0|||
160906676|NCT01306942|581052267|FG003|Phase II|Withdrawal by Subject|2|||
160906677|NCT01306942|581052264|FG000|Phase II|Death|0|||
160906678|NCT01306942|581052265|FG001|Phase II|Death|0|||
160906679|NCT01306942|581052266|FG002|Phase II|Death|0|||
160906680|NCT01306942|581052267|FG003|Phase II|Death|1|||
160906681|NCT01306942|581052264|FG000|Phase II|Not finished treatment|0|||
160906682|NCT01306942|581052265|FG001|Phase II|Not finished treatment|0|||
160569013|NCT01009463|579806932|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
160569014|NCT01009463|579806933|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
160569015|NCT01009463|579806934|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
160906683|NCT01306942|581052266|FG002|Phase II|Not finished treatment|0|||
160906684|NCT01306942|581052267|FG003|Phase II|Not finished treatment|1|||
160906685|NCT01306942|581052264|FG000|Phase II|Protocol Violation|0|||
160906686|NCT01306942|581052265|FG001|Phase II|Protocol Violation|0|||
160906687|NCT01306942|581052266|FG002|Phase II|Protocol Violation|0|||
160906688|NCT01306942|581052267|FG003|Phase II|Protocol Violation|1|||
160992503|NCT03999554|581361387|FG002|Overall Study|Lost to Follow-up|4|||
160569016|NCT01009463|579806935|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
160569017|NCT01009463|579806936|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
160569018|NCT01009463|579806932|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
160906689|NCT03190915|581052268|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
160569019|NCT01009463|579806933|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
160569020|NCT01009463|579806934|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
160569021|NCT01009463|579806935|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
160569022|NCT01009463|579806936|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
160569023|NCT01009463|579806932|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
160569024|NCT01009463|579806933|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160569025|NCT01009463|579806934|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160569026|NCT01009463|579806935|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160569027|NCT01009463|579806936|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160569028|NCT01009463|579806932|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
160569029|NCT01009463|579806933|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
160569030|NCT01009463|579806934|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
160569031|NCT01009463|579806935|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
160569032|NCT01009463|579806936|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
160569033|NCT01009463|579806932|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
160569034|NCT01009463|579806933|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
160569035|NCT01009463|579806934|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
160569036|NCT01009463|579806935|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
160569037|NCT01009463|579806936|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
160569038|NCT01009463|579806932|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
160569039|NCT01009463|579806933|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
160569040|NCT01009463|579806934|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
160569041|NCT01009463|579806935|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
160569042|NCT01009463|579806936|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
160569043|NCT01009463|579806932|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
160569044|NCT01009463|579806933|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
160569045|NCT01009463|579806934|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
160569046|NCT01009463|579806935|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
160569047|NCT01009463|579806936|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
160569048|NCT01009463|579806932|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
160569049|NCT01009463|579806933|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
160569050|NCT01009463|579806934|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
160569051|NCT01009463|579806935|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
160850003|NCT01584232|580839480|FG001|Overall Study|Adverse Event|1|||
160850004|NCT01584232|580839479|FG000|Overall Study|Withdrawal by Subject|2|||
160850005|NCT01584232|580839480|FG001|Overall Study|Withdrawal by Subject|1|||
160850006|NCT01584232|580839479|FG000|Overall Study|Physician Decision|2|||
160850007|NCT01584232|580839480|FG001|Overall Study|Physician Decision|1|||
160850008|NCT01584232|580839479|FG000|Overall Study|Lost to Follow-up|1|||
160569052|NCT01009463|579806936|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
160569053|NCT01009463|579806932|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
160569054|NCT01009463|579806933|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
160569055|NCT01009463|579806934|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
160569056|NCT01009463|579806935|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
160569057|NCT01009463|579806936|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
160569058|NCT01009463|579806932|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
160569059|NCT01009463|579806933|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
160569060|NCT01009463|579806934|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
160569061|NCT01009463|579806935|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
160569062|NCT01009463|579806936|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
160569063|NCT01009463|579806932|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
160569064|NCT01009463|579806933|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
160569065|NCT01009463|579806934|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
160569066|NCT01009463|579806935|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
160569067|NCT01009463|579806936|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
160569068|NCT01009463|579806932|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160569069|NCT01009463|579806933|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
160569070|NCT01009463|579806934|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
160569071|NCT01009463|579806935|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
160569072|NCT01009463|579806936|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
160569073|NCT01009463|579806932|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
160850009|NCT01584232|580839480|FG001|Overall Study|Lost to Follow-up|0|||
160850010|NCT01307319|580839481|FG000|Overall Study|Adverse Event|2|||
160850011|NCT01307319|580839482|FG001|Overall Study|Adverse Event|2|||
160850012|NCT01307319|580839483|FG002|Overall Study|Adverse Event|1|||
160850013|NCT01307319|580839481|FG000|Overall Study|Lost to Follow-up|1|||
160569074|NCT01009463|579806933|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
160569075|NCT01009463|579806934|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
160569076|NCT01009463|579806935|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
160569077|NCT01009463|579806936|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
160569078|NCT04430348|579806937|FG000|Overall Study|Death|3|||
160569079|NCT04430348|579806938|FG001|Overall Study|Death|2|||
160569080|NCT04430348|579806939|FG002|Overall Study|Death|2|||
160569081|NCT04430348|579806940|FG003|Overall Study|Death|2|||
160569082|NCT04430348|579806941|FG004|Overall Study|Death|2|||
160569083|NCT04430348|579806942|FG005|Overall Study|Death|3|||
160569084|NCT04430348|579806937|FG000|Overall Study|Lost to Follow-up|0|||
160569085|NCT04430348|579806938|FG001|Overall Study|Lost to Follow-up|0|||
160569086|NCT04430348|579806939|FG002|Overall Study|Lost to Follow-up|0|||
160569087|NCT04430348|579806940|FG003|Overall Study|Lost to Follow-up|1|||
160850014|NCT01307319|580839482|FG001|Overall Study|Lost to Follow-up|0|||
160850015|NCT01307319|580839483|FG002|Overall Study|Lost to Follow-up|1|||
160850016|NCT01307319|580839481|FG000|Overall Study|Protocol Violation|1|||
160850017|NCT01307319|580839482|FG001|Overall Study|Protocol Violation|1|||
160850018|NCT01307319|580839483|FG002|Overall Study|Protocol Violation|0|||
160850019|NCT01307319|580839481|FG000|Overall Study|Withdrawal by Subject|0|||
160850020|NCT01307319|580839482|FG001|Overall Study|Withdrawal by Subject|1|||
160850021|NCT01307319|580839483|FG002|Overall Study|Withdrawal by Subject|2|||
160850022|NCT01307319|580839481|FG000|Overall Study|Other|0|||
160850023|NCT01307319|580839482|FG001|Overall Study|Other|4|||
160850024|NCT01307319|580839483|FG002|Overall Study|Other|3|||
160850025|NCT02735239|580839485|FG000|Overall Study|Adverse Event|0|||
160850026|NCT02735239|580839486|FG001|Overall Study|Adverse Event|0|||
160850027|NCT02735239|580839487|FG002|Overall Study|Adverse Event|4|||
160850028|NCT02735239|580839488|FG003|Overall Study|Adverse Event|0|||
160850029|NCT02735239|580839489|FG004|Overall Study|Adverse Event|0|||
160850030|NCT02735239|580839490|FG005|Overall Study|Adverse Event|0|||
160850031|NCT02735239|580839485|FG000|Overall Study|Death|1|||
160850032|NCT02735239|580839486|FG001|Overall Study|Death|1|||
160850033|NCT02735239|580839487|FG002|Overall Study|Death|0|||
160850034|NCT02735239|580839488|FG003|Overall Study|Death|0|||
160850035|NCT02735239|580839489|FG004|Overall Study|Death|0|||
160850036|NCT02735239|580839490|FG005|Overall Study|Death|0|||
160850037|NCT02735239|580839485|FG000|Overall Study|Physician Decision|0|||
160850038|NCT02735239|580839486|FG001|Overall Study|Physician Decision|0|||
160850039|NCT02735239|580839487|FG002|Overall Study|Physician Decision|1|||
160850040|NCT02735239|580839488|FG003|Overall Study|Physician Decision|0|||
160850041|NCT02735239|580839489|FG004|Overall Study|Physician Decision|0|||
160850042|NCT02735239|580839490|FG005|Overall Study|Physician Decision|0|||
160850043|NCT02735239|580839485|FG000|Overall Study|Progressive disease|3|||
160850044|NCT02735239|580839486|FG001|Overall Study|Progressive disease|1|||
160850045|NCT02735239|580839487|FG002|Overall Study|Progressive disease|3|||
160850046|NCT02735239|580839488|FG003|Overall Study|Progressive disease|0|||
160850047|NCT02735239|580839489|FG004|Overall Study|Progressive disease|0|||
160850048|NCT02735239|580839490|FG005|Overall Study|Progressive disease|2|||
160850049|NCT02735239|580839485|FG000|Overall Study|Withdrawal by Subject|0|||
160850050|NCT02735239|580839486|FG001|Overall Study|Withdrawal by Subject|1|||
160850051|NCT02735239|580839487|FG002|Overall Study|Withdrawal by Subject|0|||
160850052|NCT02735239|580839488|FG003|Overall Study|Withdrawal by Subject|0|||
160850053|NCT02735239|580839489|FG004|Overall Study|Withdrawal by Subject|0|||
160850054|NCT02735239|580839490|FG005|Overall Study|Withdrawal by Subject|0|||
160850055|NCT02152631|580839496|FG000|Overall Study|Adverse Event|32|||
160850056|NCT02152631|580839497|FG001|Overall Study|Adverse Event|4|||
160850057|NCT02152631|580839496|FG000|Overall Study|Withdrawal by Subject|13|||
160850058|NCT02152631|580839497|FG001|Overall Study|Withdrawal by Subject|16|||
160850059|NCT02152631|580839496|FG000|Overall Study|Noncompliance with study drug|1|||
160850060|NCT02152631|580839497|FG001|Overall Study|Noncompliance with study drug|0|||
160850061|NCT02152631|580839496|FG000|Overall Study|Physician Decision|1|||
160850062|NCT02152631|580839497|FG001|Overall Study|Physician Decision|2|||
160850063|NCT02152631|580839496|FG000|Overall Study|Lost to Follow-up|0|||
160850064|NCT02152631|580839497|FG001|Overall Study|Lost to Follow-up|1|||
160850065|NCT02152631|580839496|FG000|Overall Study|On Treatment|19|||
160850066|NCT02152631|580839497|FG001|Overall Study|On Treatment|3|||
160850067|NCT00404651|580839503|FG000|Overall Study|Serious Adverse Event|0|||
160850068|NCT00404651|580839504|FG001|Overall Study|Serious Adverse Event|0|||
160850069|NCT00404651|580839505|FG002|Overall Study|Serious Adverse Event|2|||
160569088|NCT04430348|579806941|FG004|Overall Study|Lost to Follow-up|0|||
160850070|NCT00404651|580839506|FG003|Overall Study|Serious Adverse Event|0|||
160850071|NCT00404651|580839503|FG000|Overall Study|Protocol Violation|10|||
160650535|NCT02146430|580102494|FG003|Overall Study|Protocol Violation|6|||
160650536|NCT02146430|580102491|FG000|Overall Study|Lack of Efficacy|13|||
160650537|NCT02146430|580102492|FG001|Overall Study|Lack of Efficacy|11|||
160850072|NCT00404651|580839504|FG001|Overall Study|Protocol Violation|5|||
160850073|NCT00404651|580839505|FG002|Overall Study|Protocol Violation|14|||
160850074|NCT00404651|580839506|FG003|Overall Study|Protocol Violation|5|||
160850075|NCT00404651|580839503|FG000|Overall Study|Lost to Follow-up|15|||
160850076|NCT00404651|580839504|FG001|Overall Study|Lost to Follow-up|11|||
160850077|NCT00404651|580839505|FG002|Overall Study|Lost to Follow-up|13|||
160850078|NCT00404651|580839506|FG003|Overall Study|Lost to Follow-up|10|||
160850079|NCT00404651|580839503|FG000|Overall Study|Withdrawal by Subject|14|||
160850080|NCT00404651|580839504|FG001|Overall Study|Withdrawal by Subject|12|||
160850081|NCT00404651|580839505|FG002|Overall Study|Withdrawal by Subject|16|||
160850082|NCT00404651|580839506|FG003|Overall Study|Withdrawal by Subject|6|||
160850083|NCT01121146|580839515|FG000|Overall Study|Death|17|||
160850084|NCT01121146|580839516|FG001|Overall Study|Death|15|||
160850085|NCT01121146|580839515|FG000|Overall Study|Adverse Event|2|||
160850086|NCT01121146|580839516|FG001|Overall Study|Adverse Event|11|||
160850087|NCT01121146|580839515|FG000|Overall Study|Lost to Follow-up|7|||
160850088|NCT01121146|580839516|FG001|Overall Study|Lost to Follow-up|16|||
160850089|NCT03922581|580839525|FG000|Overall Study|Lost to Follow-up|20|||
160850090|NCT03922581|580839526|FG001|Overall Study|Lost to Follow-up|9|||
160850091|NCT03922581|580839525|FG000|Overall Study|Physician Decision|1|||
160850092|NCT03922581|580839526|FG001|Overall Study|Physician Decision|1|||
160850093|NCT03922581|580839525|FG000|Overall Study|Withdrawal by Subject|1|||
160850094|NCT03922581|580839526|FG001|Overall Study|Withdrawal by Subject|0|||
160850095|NCT00764699|580839529|FG000|Overall Study|PI left and study terminated|3|||
160850096|NCT02223715|580839535|FG000|Overall Study|Death|31|||
160850097|NCT02223715|580839535|FG000|Overall Study|Lost to Follow-up|73|||
160850098|NCT01745367|580839536|FG000|Overall Study|Death|1|||
160850099|NCT01745367|580839537|FG001|Overall Study|Death|0|||
160850100|NCT01745367|580839536|FG000|Overall Study|Withdrawal by Subject|1|||
160850101|NCT01745367|580839537|FG001|Overall Study|Withdrawal by Subject|2|||
160850102|NCT01745367|580839536|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
160850103|NCT01745367|580839537|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
160850104|NCT01745367|580839536|FG000|Overall Study|Other Reasons Unspecified|0|||
160850105|NCT01745367|580839537|FG001|Overall Study|Other Reasons Unspecified|2|||
160850106|NCT00965081|580839539|FG000|Overall Study|Adverse Event|14|||
160850107|NCT00965081|580839540|FG001|Overall Study|Adverse Event|9|||
160850108|NCT00965081|580839539|FG000|Overall Study|Lack of Efficacy|2|||
160850109|NCT00965081|580839540|FG001|Overall Study|Lack of Efficacy|5|||
160850110|NCT00965081|580839539|FG000|Overall Study|Lost to Follow-up|4|||
160850111|NCT00965081|580839540|FG001|Overall Study|Lost to Follow-up|5|||
160850112|NCT00965081|580839539|FG000|Overall Study|Physician Decision|2|||
160850113|NCT00965081|580839540|FG001|Overall Study|Physician Decision|0|||
160850114|NCT00965081|580839539|FG000|Overall Study|Protocol Violation|2|||
160850115|NCT00965081|580839540|FG001|Overall Study|Protocol Violation|5|||
160850116|NCT00965081|580839539|FG000|Overall Study|Sponsor Decision|1|||
160850117|NCT00965081|580839540|FG001|Overall Study|Sponsor Decision|0|||
160850118|NCT00965081|580839539|FG000|Overall Study|Withdrawal by Subject|4|||
160850119|NCT00965081|580839540|FG001|Overall Study|Withdrawal by Subject|7|||
160850120|NCT00965081|580839539|FG000|Overall Study|Switched to Rescue Arm|5|||
160850121|NCT00965081|580839540|FG001|Overall Study|Switched to Rescue Arm|12|||
160850122|NCT01020786|580839543|FG000|Induction Period|Entry Criteria Not Met|2|||
160850123|NCT01020786|580839543|FG000|Induction Period|Adverse Event|10|||
160850124|NCT01020786|580839543|FG000|Induction Period|Progressive Disease|31|||
160850125|NCT01020786|580839543|FG000|Induction Period|Investigator Decision|3|||
160850126|NCT01020786|580839543|FG000|Induction Period|Withdrawal by Subject|3|||
160850127|NCT01020786|580839543|FG000|Maintenance Period|Adverse Event|8|||
160850128|NCT01020786|580839543|FG000|Maintenance Period|Progressive Disease|43|||
160850129|NCT01020786|580839543|FG000|Maintenance Period|Withdrawal by Subject|8|||
160850130|NCT01020786|580839543|FG000|Maintenance Period|Sponsor Decision|1|||
160850131|NCT02292719|580839546|FG000|Overall Study|Withdrawal by Subject|0|||
160850132|NCT02292719|580839547|FG001|Overall Study|Withdrawal by Subject|0|||
160850133|NCT02292719|580839548|FG002|Overall Study|Withdrawal by Subject|0|||
160850134|NCT02292719|580839549|FG003|Overall Study|Withdrawal by Subject|1|||
160850135|NCT02292719|580839550|FG004|Overall Study|Withdrawal by Subject|1|||
160850136|NCT02292719|580839551|FG005|Overall Study|Withdrawal by Subject|0|||
160850137|NCT02292719|580839546|FG000|Overall Study|Subject enrolled in new study.|0|||
160850138|NCT02292719|580839547|FG001|Overall Study|Subject enrolled in new study.|0|||
160850139|NCT02292719|580839548|FG002|Overall Study|Subject enrolled in new study.|1|||
160850140|NCT02292719|580839549|FG003|Overall Study|Subject enrolled in new study.|0|||
160850141|NCT02292719|580839550|FG004|Overall Study|Subject enrolled in new study.|0|||
160850142|NCT02292719|580839551|FG005|Overall Study|Subject enrolled in new study.|0|||
160850143|NCT04170543|580839557|FG000|Overall Study|Death|1|||
160850144|NCT04170543|580839558|FG001|Overall Study|Death|1|||
160850145|NCT04170543|580839559|FG002|Overall Study|Death|1|||
160850146|NCT04170543|580839560|FG003|Overall Study|Death|1|||
160850147|NCT04170543|580839561|FG004|Overall Study|Death|1|||
160850148|NCT04170543|580839557|FG000|Overall Study|Lost to Follow-up|3|||
160850149|NCT04170543|580839558|FG001|Overall Study|Lost to Follow-up|3|||
160850150|NCT04170543|580839559|FG002|Overall Study|Lost to Follow-up|0|||
160850151|NCT04170543|580839560|FG003|Overall Study|Lost to Follow-up|3|||
160850152|NCT04170543|580839561|FG004|Overall Study|Lost to Follow-up|1|||
160850153|NCT04170543|580839557|FG000|Overall Study|Withdrawal by Subject|13|||
160850154|NCT04170543|580839558|FG001|Overall Study|Withdrawal by Subject|6|||
160850155|NCT04170543|580839559|FG002|Overall Study|Withdrawal by Subject|5|||
160850156|NCT04170543|580839560|FG003|Overall Study|Withdrawal by Subject|4|||
160850157|NCT04170543|580839561|FG004|Overall Study|Withdrawal by Subject|9|||
160850158|NCT04170543|580839557|FG000|Overall Study|Not able to transition to phase 2b|8|||
160850159|NCT04170543|580839558|FG001|Overall Study|Not able to transition to phase 2b|0|||
160850160|NCT04170543|580839559|FG002|Overall Study|Not able to transition to phase 2b|10|||
160850161|NCT04170543|580839560|FG003|Overall Study|Not able to transition to phase 2b|0|||
160850162|NCT04170543|580839561|FG004|Overall Study|Not able to transition to phase 2b|6|||
160850163|NCT04170543|580839557|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
160850164|NCT04170543|580839558|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
160850165|NCT04170543|580839559|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
160850166|NCT04170543|580839560|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
160850167|NCT04170543|580839561|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
160850168|NCT04170543|580839557|FG000|Overall Study|Not Treated|0|||
160850169|NCT04170543|580839558|FG001|Overall Study|Not Treated|0|||
160850170|NCT04170543|580839559|FG002|Overall Study|Not Treated|0|||
160850171|NCT04170543|580839560|FG003|Overall Study|Not Treated|0|||
160850172|NCT04170543|580839561|FG004|Overall Study|Not Treated|2|||
160850173|NCT04170543|580839557|FG000|Overall Study|(CRF)|16|||
160850174|NCT04170543|580839558|FG001|Overall Study|(CRF)|15|||
160850175|NCT04170543|580839559|FG002|Overall Study|(CRF)|12|||
160850176|NCT04170543|580839560|FG003|Overall Study|(CRF)|17|||
160850177|NCT04170543|580839561|FG004|Overall Study|(CRF)|17|||
160850178|NCT04170543|580839557|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
160850179|NCT04170543|580839558|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
160850180|NCT04170543|580839559|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
160850181|NCT04170543|580839560|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
160850182|NCT04170543|580839561|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
160850183|NCT00770601|580839562|FG000|Overall Study|Withdrawal by Subject|1|||
160850184|NCT04628780|580839563|FG000|Overall Study|Death|0|||
160850185|NCT04628780|580839564|FG001|Overall Study|Death|1|||
160850186|NCT04628780|580839565|FG002|Overall Study|Death|0|||
160850187|NCT04628780|580839566|FG003|Overall Study|Death|0|||
160850188|NCT04628780|580839567|FG004|Overall Study|Death|1|||
160850189|NCT04628780|580839568|FG005|Overall Study|Death|0|||
160850190|NCT04628780|580839563|FG000|Overall Study|Physician Decision|2|||
160850191|NCT04628780|580839564|FG001|Overall Study|Physician Decision|0|||
160850192|NCT04628780|580839565|FG002|Overall Study|Physician Decision|0|||
160850193|NCT04628780|580839566|FG003|Overall Study|Physician Decision|0|||
160850194|NCT04628780|580839567|FG004|Overall Study|Physician Decision|2|||
160850195|NCT04628780|580839568|FG005|Overall Study|Physician Decision|0|||
160992504|NCT03999554|581361388|FG003|Overall Study|Lost to Follow-up|5|||
160992505|NCT03999554|581361389|FG004|Overall Study|Lost to Follow-up|8|||
160850196|NCT04628780|580839563|FG000|Overall Study|Progressive disease|2|||
160850197|NCT04628780|580839564|FG001|Overall Study|Progressive disease|2|||
160850198|NCT04628780|580839565|FG002|Overall Study|Progressive disease|2|||
160992506|NCT03999554|581361385|FG000|Overall Study|Protocol Violation|0|||
160850199|NCT04628780|580839566|FG003|Overall Study|Progressive disease|3|||
160850200|NCT04628780|580839567|FG004|Overall Study|Progressive disease|9|||
160850201|NCT04628780|580839568|FG005|Overall Study|Progressive disease|4|||
160850202|NCT04628780|580839563|FG000|Overall Study|Withdrawal by Subject|0|||
160850203|NCT04628780|580839564|FG001|Overall Study|Withdrawal by Subject|1|||
160850204|NCT04628780|580839565|FG002|Overall Study|Withdrawal by Subject|2|||
160850205|NCT04628780|580839566|FG003|Overall Study|Withdrawal by Subject|0|||
160850206|NCT04628780|580839567|FG004|Overall Study|Withdrawal by Subject|3|||
160850207|NCT04628780|580839568|FG005|Overall Study|Withdrawal by Subject|1|||
160850208|NCT04628780|580839563|FG000|Overall Study|Global deterioration of health status|0|||
160850209|NCT04628780|580839564|FG001|Overall Study|Global deterioration of health status|0|||
160850210|NCT04628780|580839565|FG002|Overall Study|Global deterioration of health status|0|||
160850211|NCT04628780|580839566|FG003|Overall Study|Global deterioration of health status|0|||
160850212|NCT04628780|580839567|FG004|Overall Study|Global deterioration of health status|1|||
160850213|NCT04628780|580839568|FG005|Overall Study|Global deterioration of health status|1|||
160850214|NCT01987102|580839573|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
160850215|NCT01987102|580839574|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
160850216|NCT01987102|580839573|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
160850217|NCT01987102|580839574|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
160850218|NCT01987102|580839573|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
160850219|NCT01987102|580839574|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
160850220|NCT01987102|580839573|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
160850221|NCT01987102|580839574|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
160850222|NCT01987102|580839573|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
160850223|NCT01987102|580839574|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
160850224|NCT01987102|580839573|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
160850225|NCT01987102|580839574|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
160850226|NCT01327599|580839575|FG000|Overall Study|Adverse Event|1|||
160850227|NCT01327599|580839575|FG000|Overall Study|Could Not Attend Visit|1|||
160850228|NCT01327599|580839575|FG000|Overall Study|Withdrawal of Consent|1|||
160850229|NCT01236521|580839576|FG000|Overall Study|Withdrawal by Subject|12|||
160850230|NCT01236521|580839577|FG001|Overall Study|Withdrawal by Subject|17|||
160850231|NCT01236521|580839576|FG000|Overall Study|Death|2|||
160850232|NCT01236521|580839577|FG001|Overall Study|Death|1|||
160850233|NCT01236521|580839576|FG000|Overall Study|Lost to Follow-up|9|||
160850234|NCT01236521|580839577|FG001|Overall Study|Lost to Follow-up|7|||
160850235|NCT04661150|580839583|FG000|Overall Study|Ongoing in study|19|||
160850236|NCT04661150|580839584|FG001|Overall Study|Ongoing in study|20|||
160850237|NCT04661150|580839583|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
160850238|NCT04661150|580839584|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
160850239|NCT04661150|580839583|FG000|Overall Study|Death|2|||
160850240|NCT04661150|580839584|FG001|Overall Study|Death|0|||
160850241|NCT05864586|580839585|FG000|Overall Study|Ineligible|4|||
160850242|NCT05864586|580839586|FG001|Overall Study|Ineligible|12|||
160850243|NCT05864586|580839585|FG000|Overall Study|Pregnancy|0|||
160850244|NCT05864586|580839586|FG001|Overall Study|Pregnancy|1|||
160850245|NCT05864586|580839585|FG000|Overall Study|Withdrawal by Subject|0|||
160850246|NCT05864586|580839586|FG001|Overall Study|Withdrawal by Subject|1|||
160850247|NCT03635424|580839587|FG000|Overall Study|Adverse Event|1|||
160850248|NCT03635424|580839587|FG000|Overall Study|Death|1|||
160850249|NCT03635424|580839587|FG000|Overall Study|Device not implanted|1|||
160850250|NCT02701283|580839588|FG000|Overall Study|Death|25|||
160850251|NCT02701283|580839589|FG001|Overall Study|Death|29|||
160850252|NCT02701283|580839590|FG002|Overall Study|Death|19|||
160850253|NCT02701283|580839588|FG000|Overall Study|Lost to Follow-up|3|||
160850254|NCT02701283|580839589|FG001|Overall Study|Lost to Follow-up|8|||
160850255|NCT02701283|580839590|FG002|Overall Study|Lost to Follow-up|1|||
160850256|NCT02701283|580839588|FG000|Overall Study|Withdrawal by Subject|12|||
160850257|NCT02701283|580839589|FG001|Overall Study|Withdrawal by Subject|41|||
160850258|NCT02701283|580839590|FG002|Overall Study|Withdrawal by Subject|1|||
160850259|NCT02701283|580839588|FG000|Overall Study|Missed 2-year visit|22|||
160850260|NCT02701283|580839589|FG001|Overall Study|Missed 2-year visit|27|||
160850261|NCT02701283|580839590|FG002|Overall Study|Missed 2-year visit|0|||
160850262|NCT02701283|580839588|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
160850263|NCT02701283|580839589|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
160850264|NCT02701283|580839590|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
160850265|NCT04544956|580839591|FG000|Overall Study|Withdrawal by Subject|1|||
160850266|NCT04266795|580839592|FG000|Overall Study|Adverse Event|10|||
160850267|NCT04266795|580839593|FG001|Overall Study|Adverse Event|19|||
160850268|NCT04266795|580839592|FG000|Overall Study|Death|7|||
160850269|NCT04266795|580839593|FG001|Overall Study|Death|8|||
160850270|NCT04266795|580839592|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
160850271|NCT04266795|580839593|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
160850272|NCT04266795|580839592|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
160850273|NCT04266795|580839593|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160850274|NCT04266795|580839592|FG000|Overall Study|Progressive Disease|12|||
160850275|NCT04266795|580839593|FG001|Overall Study|Progressive Disease|9|||
160850276|NCT04266795|580839592|FG000|Overall Study|Withdrawal by Patient|5|||
160850277|NCT04266795|580839593|FG001|Overall Study|Withdrawal by Patient|6|||
160906690|NCT03190915|581052268|FG000|Overall Study|Progressive Disease|3|||
160906691|NCT03988088|581052272|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
160906692|NCT03988088|581052273|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
160906693|NCT03988088|581052274|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
160906694|NCT03988088|581052275|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
160850278|NCT04266795|580839592|FG000|Overall Study|Disease Relapse|3|||
160850279|NCT04266795|580839593|FG001|Overall Study|Disease Relapse|6|||
160850280|NCT04266795|580839592|FG000|Overall Study|Reason not Specified|12|||
160850281|NCT04266795|580839593|FG001|Overall Study|Reason not Specified|10|||
160850282|NCT04266795|580839592|FG000|Overall Study|Participants Ongoing on Treatment|25|||
160850283|NCT04266795|580839593|FG001|Overall Study|Participants Ongoing on Treatment|23|||
160906695|NCT03988088|581052272|FG000|Open-Label Addendum|Lost to Follow-up|0|||
160906696|NCT03988088|581052273|FG001|Open-Label Addendum|Lost to Follow-up|0|||
160650538|NCT02146430|580102493|FG002|Overall Study|Lack of Efficacy|8|||
160850284|NCT00549445|580839599|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
160850285|NCT00549445|580839600|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
160850286|NCT03932760|580839601|FG000|Overall Study|Became Ineligible|2|||
160850287|NCT03932760|580839602|FG001|Overall Study|Became Ineligible|5|||
160850288|NCT03932760|580839601|FG000|Overall Study|Withdrawal by Subject|6|||
160850289|NCT03932760|580839602|FG001|Overall Study|Withdrawal by Subject|6|||
160850290|NCT04725500|580839603|FG000|Screening|Screen Failure|26|||
160850291|NCT04725500|580839603|FG000|Screening|Withdrawal by Subject|1|||
160906697|NCT03988088|581052274|FG002|Open-Label Addendum|Lost to Follow-up|1|||
160650539|NCT02146430|580102494|FG003|Overall Study|Lack of Efficacy|5|||
160850292|NCT04725500|580839603|FG000|2 Week Take Home|Screen Fail|5|||
160850293|NCT04618744|580839606|FG000|Overall Study|Adverse Event|0|||
160850294|NCT04618744|580839607|FG001|Overall Study|Adverse Event|1|||
160992507|NCT03999554|581361386|FG001|Overall Study|Protocol Violation|0|||
160850295|NCT04618744|580839606|FG000|Overall Study|Withdrawal by Subject|0|||
160850296|NCT04618744|580839607|FG001|Overall Study|Withdrawal by Subject|1|||
160850297|NCT03553758|580841422|FG000|Overall Study|Lost to Follow-up|1|||
160850298|NCT02807623|580841423|FG000|Overall Study|Lost to Follow-up|23|||
160850299|NCT02807623|580841424|FG001|Overall Study|Lost to Follow-up|18|||
160850300|NCT02807623|580841425|FG002|Overall Study|Lost to Follow-up|22|||
160850301|NCT02807623|580841423|FG000|Overall Study|Drug intolerance|0|||
160850302|NCT02807623|580841424|FG001|Overall Study|Drug intolerance|1|||
160850303|NCT02807623|580841425|FG002|Overall Study|Drug intolerance|0|||
160850304|NCT02807623|580841423|FG000|Overall Study|incomplete blood draw|0|||
160850305|NCT02807623|580841424|FG001|Overall Study|incomplete blood draw|2|||
160850306|NCT02807623|580841425|FG002|Overall Study|incomplete blood draw|1|||
160850307|NCT02614729|580841426|FG000|Overall Study|Withdrawal by Subject|1|||
160850308|NCT02614729|580841427|FG001|Overall Study|Withdrawal by Subject|0|||
160850309|NCT04002960|580841432|FG000|Overall Study|Withdrawn prior to Completion|2|||
160850310|NCT00383786|580841435|FG000|Overall Study|Protocol Violation|2|||
160850311|NCT00383786|580841436|FG001|Overall Study|Protocol Violation|6|||
160850312|NCT00383786|580841435|FG000|Overall Study|Withdrawal by Subject|2|||
160850313|NCT00383786|580841436|FG001|Overall Study|Withdrawal by Subject|5|||
160850314|NCT00383786|580841435|FG000|Overall Study|Physician Decision|0|||
160850315|NCT00383786|580841436|FG001|Overall Study|Physician Decision|1|||
160850316|NCT02219464|580841440|FG000|Overall Study|Withdrawal by Subject|1|||
160850317|NCT02219464|580841441|FG001|Overall Study|Withdrawal by Subject|0|||
160850318|NCT02219464|580841440|FG000|Overall Study|case cancelled|1|||
160850319|NCT02219464|580841441|FG001|Overall Study|case cancelled|0|||
160850320|NCT02219464|580841440|FG000|Overall Study|catheter malfunction|1|||
160850321|NCT02219464|580841441|FG001|Overall Study|catheter malfunction|0|||
160850322|NCT02544321|580841442|FG000|Overall Study|Withdrawal by Subject|1|||
160850323|NCT02544321|580841443|FG001|Overall Study|Withdrawal by Subject|2|||
160850324|NCT02544321|580841442|FG000|Overall Study|Adverse Event|1|||
160850325|NCT02544321|580841443|FG001|Overall Study|Adverse Event|1|||
160850326|NCT02544321|580841442|FG000|Overall Study|Protocol Violation|0|||
160850327|NCT02544321|580841443|FG001|Overall Study|Protocol Violation|1|||
160850328|NCT00527735|580841445|FG000|Overall Study|Disease progression|47|||
160850329|NCT00527735|580841446|FG001|Overall Study|Disease progression|61|||
160850330|NCT00527735|580841447|FG002|Overall Study|Disease progression|53|||
160850331|NCT00527735|580841445|FG000|Overall Study|Death|23|||
160850332|NCT00527735|580841446|FG001|Overall Study|Death|13|||
160850333|NCT00527735|580841447|FG002|Overall Study|Death|15|||
160850334|NCT00527735|580841445|FG000|Overall Study|Completed treatment in treatment phase|14|||
160850335|NCT00527735|580841446|FG001|Overall Study|Completed treatment in treatment phase|13|||
160850336|NCT00527735|580841447|FG002|Overall Study|Completed treatment in treatment phase|18|||
160850337|NCT00527735|580841445|FG000|Overall Study|Adverse Event|10|||
160850338|NCT00527735|580841446|FG001|Overall Study|Adverse Event|6|||
160850339|NCT00527735|580841447|FG002|Overall Study|Adverse Event|7|||
160850340|NCT00527735|580841445|FG000|Overall Study|Not identified|5|||
160850341|NCT00527735|580841446|FG001|Overall Study|Not identified|5|||
160850342|NCT00527735|580841447|FG002|Overall Study|Not identified|5|||
160850343|NCT00527735|580841445|FG000|Overall Study|Withdrawal by Subject|5|||
160850344|NCT00527735|580841446|FG001|Overall Study|Withdrawal by Subject|4|||
160850345|NCT00527735|580841447|FG002|Overall Study|Withdrawal by Subject|3|||
160850346|NCT00527735|580841445|FG000|Overall Study|No longer met study criteria|2|||
160850347|NCT00527735|580841446|FG001|Overall Study|No longer met study criteria|2|||
160850348|NCT00527735|580841447|FG002|Overall Study|No longer met study criteria|1|||
160850349|NCT00527735|580841445|FG000|Overall Study|Lost to Follow-up|0|||
160850350|NCT00527735|580841446|FG001|Overall Study|Lost to Follow-up|0|||
160850351|NCT00527735|580841447|FG002|Overall Study|Lost to Follow-up|3|||
160850352|NCT00527735|580841445|FG000|Overall Study|Poor compliance or noncompliance|0|||
160850353|NCT00527735|580841446|FG001|Overall Study|Poor compliance or noncompliance|1|||
160850354|NCT00527735|580841447|FG002|Overall Study|Poor compliance or noncompliance|1|||
160850355|NCT00527735|580841445|FG000|Overall Study|Completed treatment during maintenance|2|||
160850356|NCT00527735|580841446|FG001|Overall Study|Completed treatment during maintenance|2|||
160850357|NCT00527735|580841447|FG002|Overall Study|Completed treatment during maintenance|1|||
160850358|NCT01080807|580841448|FG000|Overall Study|Adverse Event|9|||
160850359|NCT01080807|580841449|FG001|Overall Study|Adverse Event|1|||
160850360|NCT01080807|580841448|FG000|Overall Study|Lack of Efficacy|0|||
160850361|NCT01080807|580841449|FG001|Overall Study|Lack of Efficacy|1|||
160850362|NCT01080807|580841448|FG000|Overall Study|Withdrawal by Subject|7|||
160850363|NCT01080807|580841449|FG001|Overall Study|Withdrawal by Subject|2|||
160850364|NCT01080807|580841448|FG000|Overall Study|Protocol Violation|7|||
160850365|NCT01080807|580841449|FG001|Overall Study|Protocol Violation|6|||
160850366|NCT01080807|580841448|FG000|Overall Study|Lost to Follow-up|6|||
160850367|NCT01080807|580841449|FG001|Overall Study|Lost to Follow-up|4|||
160850368|NCT01080807|580841448|FG000|Overall Study|Noncompliance with drug administration|1|||
160850369|NCT01080807|580841449|FG001|Overall Study|Noncompliance with drug administration|1|||
160850370|NCT01080807|580841448|FG000|Overall Study|Noncompliance to study procedures|1|||
160850371|NCT01080807|580841449|FG001|Overall Study|Noncompliance to study procedures|1|||
160850372|NCT01080807|580841448|FG000|Overall Study|Began working day shift|0|||
160850373|NCT01080807|580841449|FG001|Overall Study|Began working day shift|2|||
160850374|NCT01080807|580841448|FG000|Overall Study|Laid off or terminated from job|1|||
160850375|NCT01080807|580841449|FG001|Overall Study|Laid off or terminated from job|2|||
160850376|NCT01080807|580841448|FG000|Overall Study|Stopped working consistent night shifts|0|||
160850377|NCT01080807|580841449|FG001|Overall Study|Stopped working consistent night shifts|1|||
160850378|NCT01080807|580841448|FG000|Overall Study|Work schedule changing|1|||
160850379|NCT01080807|580841449|FG001|Overall Study|Work schedule changing|1|||
160850380|NCT01080807|580841448|FG000|Overall Study|Work schedule and travel|0|||
160850381|NCT01080807|580841449|FG001|Overall Study|Work schedule and travel|1|||
160850382|NCT01080807|580841448|FG000|Overall Study|Switched to first shift|1|||
160850383|NCT01080807|580841449|FG001|Overall Study|Switched to first shift|0|||
160850384|NCT01080807|580841448|FG000|Overall Study|Moved away without notifying center|1|||
160850385|NCT01080807|580841449|FG001|Overall Study|Moved away without notifying center|0|||
160850386|NCT02107703|580841456|FG000|Overall Study|Withdrawal by Subject|46|||
160850387|NCT02107703|580841457|FG001|Overall Study|Withdrawal by Subject|21|||
160850388|NCT02107703|580841456|FG000|Overall Study|Lost to Follow-up|20|||
160850389|NCT02107703|580841457|FG001|Overall Study|Lost to Follow-up|9|||
160850390|NCT02107703|580841456|FG000|Overall Study|On study treatment/follow up|48|||
160850391|NCT02107703|580841457|FG001|Overall Study|On study treatment/follow up|5|||
160850392|NCT02366312|580841458|FG000|Overall Study|Lost to Follow-up|0|||
160850393|NCT02366312|580841459|FG001|Overall Study|Lost to Follow-up|1|||
160850394|NCT01879683|580841466|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
160850395|NCT01338818|580841474|FG000|Overall Study|Adverse Event|8|||
160850396|NCT01338818|580841474|FG000|Overall Study|Lack of Efficacy|5|||
160850397|NCT01338818|580841474|FG000|Overall Study|no longer require study drug|1|||
160850398|NCT01338818|580841474|FG000|Overall Study|Withdrawal by Subject|11|||
160850399|NCT01338818|580841474|FG000|Overall Study|Lost to Follow-up|4|||
160850400|NCT01338818|580841474|FG000|Overall Study|Administrative problems|3|||
160850401|NCT01338818|580841474|FG000|Overall Study|Protocol Deviation|4|||
160850402|NCT05202418|580841475|FG000|Overall Study|Withdrawal by Subject|2|||
160850403|NCT05202418|580841476|FG001|Overall Study|Withdrawal by Subject|1|||
160850404|NCT05202418|580841475|FG000|Overall Study|Lost to Follow-up|1|||
160850405|NCT05202418|580841476|FG001|Overall Study|Lost to Follow-up|1|||
160850406|NCT03901144|580841481|FG000|Overall Study|Lost to Follow-up|1|||
160850407|NCT03901144|580841482|FG001|Overall Study|Lost to Follow-up|1|||
160850408|NCT03901144|580841483|FG002|Overall Study|Lost to Follow-up|1|||
160850409|NCT03901144|580841484|FG003|Overall Study|Lost to Follow-up|1|||
160850410|NCT02021565|580841485|FG000|Baseline Through Intervention|Death|0|||
160850411|NCT02021565|580841486|FG001|Baseline Through Intervention|Death|1|||
160850412|NCT02021565|580841485|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
160850413|NCT02021565|580841486|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
160850414|NCT02021565|580841485|FG000|Baseline Through Intervention|Protocol Violation|0|||
160850415|NCT02021565|580841486|FG001|Baseline Through Intervention|Protocol Violation|7|||
160850416|NCT02021565|580841485|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
160850417|NCT02021565|580841486|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
160850418|NCT02021565|580841485|FG000|3-month Follow-up|Death|3|||
160850419|NCT02021565|580841486|FG001|3-month Follow-up|Death|0|||
160850420|NCT02021565|580841485|FG000|3-month Follow-up|Withdrawal by Subject|4|||
160850421|NCT02021565|580841486|FG001|3-month Follow-up|Withdrawal by Subject|0|||
160850422|NCT02021565|580841485|FG000|3-month Follow-up|Protocol Violation|3|||
160850423|NCT02021565|580841486|FG001|3-month Follow-up|Protocol Violation|2|||
160850424|NCT03575403|580841487|FG000|Overall Study|Adverse Event|1|||
160850425|NCT03575403|580841488|FG001|Overall Study|Adverse Event|0|||
160850426|NCT03575403|580841489|FG002|Overall Study|Adverse Event|0|||
160850427|NCT03575403|580841487|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
160850428|NCT03575403|580841488|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
160850429|NCT03575403|580841489|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
160850430|NCT01332994|580841491|FG000|Overall Study|Adverse Event|34|||
160850431|NCT01332994|580841491|FG000|Overall Study|Death|1|||
160850432|NCT01332994|580841491|FG000|Overall Study|Lack of Efficacy|1|||
160850433|NCT01332994|580841491|FG000|Overall Study|Lost to Follow-up|4|||
160850434|NCT01332994|580841491|FG000|Overall Study|Protocol Violation|6|||
160850435|NCT01332994|580841491|FG000|Overall Study|Withdrawal by Subject|15|||
160850436|NCT01332994|580841491|FG000|Overall Study|Administrative Problem|2|||
160850437|NCT01332994|580841491|FG000|Overall Study|Other|8|||
160850438|NCT00279916|580841492|FG000|Overall Study|Withdrawal by Subject|4|||
160850439|NCT00279916|580841493|FG001|Overall Study|Withdrawal by Subject|3|||
160850440|NCT00279916|580841492|FG000|Overall Study|Lost to Follow-up|3|||
160850441|NCT00279916|580841493|FG001|Overall Study|Lost to Follow-up|2|||
160850442|NCT00731679|580841497|FG000|Overall Study|Adverse Event|7|||
160850443|NCT00731679|580841498|FG001|Overall Study|Adverse Event|8|||
160850444|NCT00731679|580841497|FG000|Overall Study|Withdrawal by Subject|8|||
160850445|NCT00731679|580841498|FG001|Overall Study|Withdrawal by Subject|8|||
160850446|NCT00731679|580841497|FG000|Overall Study|Lost to Follow-up|7|||
160850447|NCT00731679|580841498|FG001|Overall Study|Lost to Follow-up|8|||
160850448|NCT00731679|580841497|FG000|Overall Study|Noncompliance|0|||
160850449|NCT00731679|580841498|FG001|Overall Study|Noncompliance|1|||
160850450|NCT00731679|580841497|FG000|Overall Study|Pregnancy|0|||
160850451|NCT00731679|580841498|FG001|Overall Study|Pregnancy|1|||
160850452|NCT02488005|580841499|FG000|Overall Study|Lost to Follow-up|2|||
160850453|NCT03384940|580841506|FG000|Overall Study|Progressive disease|36|||
160850454|NCT03384940|580841507|FG001|Overall Study|Progressive disease|11|||
160850455|NCT03384940|580841508|FG002|Overall Study|Progressive disease|13|||
160850456|NCT03384940|580841506|FG000|Overall Study|Clinical progression|4|||
160850457|NCT03384940|580841507|FG001|Overall Study|Clinical progression|0|||
160850458|NCT03384940|580841508|FG002|Overall Study|Clinical progression|3|||
160850459|NCT03384940|580841506|FG000|Overall Study|Adverse Event|7|||
160850460|NCT03384940|580841507|FG001|Overall Study|Adverse Event|1|||
160850461|NCT03384940|580841508|FG002|Overall Study|Adverse Event|1|||
160850462|NCT03384940|580841506|FG000|Overall Study|Withdrawal by Subject|3|||
160850463|NCT03384940|580841507|FG001|Overall Study|Withdrawal by Subject|1|||
160850464|NCT03384940|580841508|FG002|Overall Study|Withdrawal by Subject|0|||
160850465|NCT03384940|580841506|FG000|Overall Study|Physician Decision|1|||
160850466|NCT03384940|580841507|FG001|Overall Study|Physician Decision|1|||
160850467|NCT03384940|580841508|FG002|Overall Study|Physician Decision|0|||
160850468|NCT03384940|580841506|FG000|Overall Study|Death|2|||
160850469|NCT03384940|580841507|FG001|Overall Study|Death|1|||
160850470|NCT03384940|580841508|FG002|Overall Study|Death|0|||
160850471|NCT03384940|580841506|FG000|Overall Study|Other|0|||
160850472|NCT03384940|580841507|FG001|Overall Study|Other|0|||
160850473|NCT03384940|580841508|FG002|Overall Study|Other|1|||
160850474|NCT03089580|580841511|FG000|Overall Study|Lost to Follow-up|2|||
160850475|NCT03087513|580841512|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
160850476|NCT03269994|580841513|FG000|Overall Study|Withdrawal by Subject|4|||
160850477|NCT03269994|580841514|FG001|Overall Study|Withdrawal by Subject|5|||
160850478|NCT03269994|580841513|FG000|Overall Study|Unresectable at surgery|39|||
160850479|NCT03269994|580841514|FG001|Overall Study|Unresectable at surgery|58|||
160850480|NCT03269994|580841513|FG000|Overall Study|Patient canceled surgery|5|||
160850481|NCT03269994|580841514|FG001|Overall Study|Patient canceled surgery|14|||
160850482|NCT03269994|580841513|FG000|Overall Study|Preoperative progression|14|||
160850483|NCT03269994|580841514|FG001|Overall Study|Preoperative progression|9|||
160850484|NCT03269994|580841513|FG000|Overall Study|Preoperative infection|10|||
160850485|NCT03269994|580841514|FG001|Overall Study|Preoperative infection|4|||
160850486|NCT03269994|580841513|FG000|Overall Study|Kidney insufficiency|1|||
160850487|NCT03269994|580841514|FG001|Overall Study|Kidney insufficiency|0|||
160850488|NCT03269994|580841513|FG000|Overall Study|Drug allergy|0|||
160850489|NCT03269994|580841514|FG001|Overall Study|Drug allergy|2|||
160850490|NCT03269994|580841513|FG000|Overall Study|Operation changed to different resection|9|||
160850491|NCT03269994|580841514|FG001|Overall Study|Operation changed to different resection|0|||
160850492|NCT03269994|580841513|FG000|Overall Study|Preoperative steroid|0|||
160850493|NCT03269994|580841514|FG001|Overall Study|Preoperative steroid|3|||
160850494|NCT03269994|580841513|FG000|Overall Study|Accrual Closed|2|||
160850495|NCT03269994|580841514|FG001|Overall Study|Accrual Closed|0|||
160850496|NCT03269994|580841513|FG000|Overall Study|Operation changed to different resection|0|||
160850497|NCT03269994|580841514|FG001|Overall Study|Operation changed to different resection|10|||
160850498|NCT04303559|580841515|FG000|Overall Study|Study closed due to poor enrollment.|1|||
160850499|NCT01288989|580841518|FG000|Overall Study|Death|0|||
160850500|NCT01288989|580841519|FG001|Overall Study|Death|0|||
160850501|NCT01288989|580841520|FG002|Overall Study|Death|0|||
160850502|NCT01288989|580841521|FG003|Overall Study|Death|1|||
160850503|NCT01288989|580841522|FG004|Overall Study|Death|0|||
160850504|NCT01288989|580841518|FG000|Overall Study|Dose limiting toxicity|1|||
160850505|NCT01288989|580841519|FG001|Overall Study|Dose limiting toxicity|0|||
160850506|NCT01288989|580841520|FG002|Overall Study|Dose limiting toxicity|0|||
160850507|NCT01288989|580841521|FG003|Overall Study|Dose limiting toxicity|0|||
160850508|NCT01288989|580841522|FG004|Overall Study|Dose limiting toxicity|0|||
160850509|NCT01288989|580841518|FG000|Overall Study|Adverse Event|0|||
160850510|NCT01288989|580841519|FG001|Overall Study|Adverse Event|0|||
160850511|NCT01288989|580841520|FG002|Overall Study|Adverse Event|0|||
160850512|NCT01288989|580841521|FG003|Overall Study|Adverse Event|0|||
160850513|NCT01288989|580841522|FG004|Overall Study|Adverse Event|2|||
160850514|NCT01288989|580841518|FG000|Overall Study|Physician Decision|0|||
160850515|NCT01288989|580841519|FG001|Overall Study|Physician Decision|0|||
160850516|NCT01288989|580841520|FG002|Overall Study|Physician Decision|0|||
160850517|NCT01288989|580841521|FG003|Overall Study|Physician Decision|0|||
160850518|NCT01288989|580841522|FG004|Overall Study|Physician Decision|1|||
160850519|NCT01288989|580841518|FG000|Overall Study|Withdrawal by Subject|0|||
160906698|NCT03988088|581052275|FG003|Open-Label Addendum|Lost to Follow-up|0|||
160906699|NCT00622401|581052276|FG000|Overall Study|Disease progression prior to treatment|3|||
160906700|NCT00622401|581052277|FG001|Overall Study|Disease progression prior to treatment|2|||
160906701|NCT00622401|581052278|FG002|Overall Study|Disease progression prior to treatment|0|||
160850520|NCT01288989|580841519|FG001|Overall Study|Withdrawal by Subject|0|||
160850521|NCT01288989|580841520|FG002|Overall Study|Withdrawal by Subject|0|||
160850522|NCT01288989|580841521|FG003|Overall Study|Withdrawal by Subject|0|||
160850523|NCT01288989|580841522|FG004|Overall Study|Withdrawal by Subject|3|||
160850524|NCT01156714|580841523|FG000|Overall Study|Withdrawal by Subject|9|||
160850525|NCT01156714|580841524|FG001|Overall Study|Withdrawal by Subject|4|||
160850526|NCT01156714|580841525|FG002|Overall Study|Withdrawal by Subject|3|||
160850527|NCT05907395|580841530|FG000|Period 1|No longer met eligibility criteria|0|||
160850528|NCT05907395|580841531|FG001|Period 1|No longer met eligibility criteria|1|||
160850529|NCT05907395|580841532|FG002|Period 1|No longer met eligibility criteria|0|||
160850530|NCT05907395|580841533|FG003|Period 1|No longer met eligibility criteria|0|||
160850531|NCT05907395|580841534|FG004|Period 1|No longer met eligibility criteria|0|||
160850532|NCT05907395|580841535|FG005|Period 1|No longer met eligibility criteria|1|||
160850533|NCT05907395|580841536|FG006|Period 1|No longer met eligibility criteria|1|||
160850534|NCT05907395|580841537|FG007|Period 1|No longer met eligibility criteria|0|||
160850535|NCT05907395|580841538|FG008|Period 1|No longer met eligibility criteria|0|||
160850536|NCT05907395|580841539|FG009|Period 1|No longer met eligibility criteria|0|||
160850537|NCT05907395|580841540|FG010|Period 1|No longer met eligibility criteria|0|||
160850538|NCT05907395|580841541|FG011|Period 1|No longer met eligibility criteria|0|||
160850539|NCT05907395|580841530|FG000|Period 2|Adverse Event|0|||
160850540|NCT05907395|580841531|FG001|Period 2|Adverse Event|0|||
160850541|NCT05907395|580841532|FG002|Period 2|Adverse Event|0|||
160850542|NCT05907395|580841533|FG003|Period 2|Adverse Event|1|||
160850543|NCT05907395|580841534|FG004|Period 2|Adverse Event|0|||
160850544|NCT05907395|580841535|FG005|Period 2|Adverse Event|0|||
160850545|NCT05907395|580841536|FG006|Period 2|Adverse Event|0|||
160850546|NCT05907395|580841537|FG007|Period 2|Adverse Event|1|||
160850547|NCT05907395|580841538|FG008|Period 2|Adverse Event|0|||
160850548|NCT05907395|580841539|FG009|Period 2|Adverse Event|0|||
160850549|NCT05907395|580841540|FG010|Period 2|Adverse Event|0|||
160850550|NCT05907395|580841541|FG011|Period 2|Adverse Event|0|||
160850551|NCT05907395|580841530|FG000|Period 2|Personal reason|0|||
160850552|NCT05907395|580841531|FG001|Period 2|Personal reason|0|||
160850553|NCT05907395|580841532|FG002|Period 2|Personal reason|0|||
160850554|NCT05907395|580841533|FG003|Period 2|Personal reason|0|||
160850555|NCT05907395|580841534|FG004|Period 2|Personal reason|0|||
160850556|NCT05907395|580841535|FG005|Period 2|Personal reason|0|||
160850557|NCT05907395|580841536|FG006|Period 2|Personal reason|0|||
160850558|NCT05907395|580841537|FG007|Period 2|Personal reason|0|||
160850559|NCT05907395|580841538|FG008|Period 2|Personal reason|0|||
160850560|NCT05907395|580841539|FG009|Period 2|Personal reason|1|||
160850561|NCT05907395|580841540|FG010|Period 2|Personal reason|0|||
160850562|NCT05907395|580841541|FG011|Period 2|Personal reason|0|||
160850563|NCT05907395|580841530|FG000|Period 3|Adverse Event|0|||
160850564|NCT05907395|580841531|FG001|Period 3|Adverse Event|0|||
160850565|NCT05907395|580841532|FG002|Period 3|Adverse Event|0|||
160850566|NCT05907395|580841533|FG003|Period 3|Adverse Event|0|||
160850567|NCT05907395|580841534|FG004|Period 3|Adverse Event|1|||
160850568|NCT05907395|580841535|FG005|Period 3|Adverse Event|0|||
160850569|NCT05907395|580841536|FG006|Period 3|Adverse Event|0|||
160850570|NCT05907395|580841537|FG007|Period 3|Adverse Event|0|||
160850571|NCT05907395|580841538|FG008|Period 3|Adverse Event|0|||
160850572|NCT05907395|580841539|FG009|Period 3|Adverse Event|0|||
160850573|NCT05907395|580841540|FG010|Period 3|Adverse Event|0|||
160850574|NCT05907395|580841541|FG011|Period 3|Adverse Event|0|||
160850575|NCT03043872|580841542|FG000|Overall Study|Withdrawal by Subject|6|||
160850576|NCT03043872|580841543|FG001|Overall Study|Withdrawal by Subject|6|||
160850577|NCT03043872|580841544|FG002|Overall Study|Withdrawal by Subject|15|||
160850578|NCT03043872|580841542|FG000|Overall Study|Lost to Follow-up|2|||
160850579|NCT03043872|580841543|FG001|Overall Study|Lost to Follow-up|1|||
160850580|NCT03043872|580841544|FG002|Overall Study|Lost to Follow-up|1|||
160850581|NCT03043872|580841542|FG000|Overall Study|Death|270|||
160850582|NCT03043872|580841543|FG001|Overall Study|Death|269|||
160850583|NCT03043872|580841544|FG002|Overall Study|Death|296|||
160850584|NCT02777827|580841545|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
160850585|NCT02777827|580841546|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
160906702|NCT01546883|581052282|FG000|Overall Study|Withdrawal by Subject|3|||
160850586|NCT02777827|580841547|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
160850587|NCT02777827|580841548|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
160850588|NCT02777827|580841549|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
160850589|NCT02777827|580841550|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
160850590|NCT04551066|580841551|FG000|Overall Study|Death|5|||
160850591|NCT04551066|580841552|FG001|Overall Study|Death|3|||
160850592|NCT04551066|580841551|FG000|Overall Study|Lost to Follow-up|1|||
160850593|NCT04551066|580841552|FG001|Overall Study|Lost to Follow-up|0|||
160850594|NCT04551066|580841551|FG000|Overall Study|Sponsor Decision|104|||
160850595|NCT04551066|580841552|FG001|Overall Study|Sponsor Decision|117|||
160850596|NCT04551066|580841551|FG000|Overall Study|Withdrawal by Subject|8|||
160850597|NCT04551066|580841552|FG001|Overall Study|Withdrawal by Subject|2|||
160850598|NCT04551066|580841551|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
160850599|NCT04551066|580841552|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
160850600|NCT04551066|580841551|FG000|Overall Study|Adverse Event|2|||
160850601|NCT04551066|580841552|FG001|Overall Study|Adverse Event|0|||
160850602|NCT04551066|580841551|FG000|Overall Study|Physician Decision|2|||
160850603|NCT04551066|580841552|FG001|Overall Study|Physician Decision|0|||
160850604|NCT04551066|580841551|FG000|Overall Study|Protocol Violation|1|||
160850605|NCT04551066|580841552|FG001|Overall Study|Protocol Violation|0|||
160850606|NCT04551066|580841551|FG000|Overall Study|Lack of Efficacy|0|||
160850607|NCT04551066|580841552|FG001|Overall Study|Lack of Efficacy|1|||
160850608|NCT04551066|580841551|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
160850609|NCT04551066|580841552|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
160850610|NCT04491136|580841553|FG000|Overall Study|Patient withdraw informed consent|9|||
160850611|NCT04491136|580841553|FG000|Overall Study|Adverse Event|2|||
160850612|NCT04491136|580841553|FG000|Overall Study|Death|3|||
160850613|NCT04491136|580841553|FG000|Overall Study|Lost to Follow-up|3|||
160850614|NCT04491136|580841553|FG000|Overall Study|Physician Decision|45|||
160850615|NCT04491136|580841553|FG000|Overall Study|sponsor terminated the study early|16|||
160850616|NCT04491136|580841553|FG000|Overall Study|Patient/guardian's decision|1|||
160850617|NCT00398320|580841554|FG000|Overall Study|Death|1|||
160850618|NCT00398320|580841554|FG000|Overall Study|Adverse Event|4|||
160850619|NCT00398320|580841554|FG000|Overall Study|Physician Decision|1|||
160850620|NCT00064792|580841555|FG000|Overall Study|Withdrawal by Subject|2|||
160850621|NCT00064792|580841556|FG001|Overall Study|Withdrawal by Subject|0|||
160850622|NCT00064792|580841555|FG000|Overall Study|Adverse Event|3|||
160850623|NCT00064792|580841556|FG001|Overall Study|Adverse Event|0|||
160850624|NCT00319254|580841561|FG000|Overall Study|Withdrawal by Subject|4|||
160850625|NCT00319254|580841561|FG000|Overall Study|Death|46|||
160850626|NCT00319254|580841561|FG000|Overall Study|Lost to Follow-up|2|||
160850627|NCT00319254|580841561|FG000|Overall Study|Enrolled, Not Treated|2|||
160850628|NCT01712204|580841565|FG000|Overall Study|Adverse Event|3|||
160850629|NCT01712204|580841566|FG001|Overall Study|Adverse Event|1|||
160850630|NCT01712204|580841565|FG000|Overall Study|Withdrawal by Subject|3|||
160850631|NCT01712204|580841566|FG001|Overall Study|Withdrawal by Subject|3|||
160850632|NCT01712204|580841565|FG000|Overall Study|Lost to Follow-up|1|||
160850633|NCT01712204|580841566|FG001|Overall Study|Lost to Follow-up|0|||
160850634|NCT01712204|580841565|FG000|Overall Study|Protocol Violation|1|||
160850635|NCT01712204|580841566|FG001|Overall Study|Protocol Violation|1|||
160850636|NCT02452424|580841567|FG000|Overall Study|Death|2|||
160850637|NCT02452424|580841568|FG001|Overall Study|Death|2|||
160850638|NCT02452424|580841569|FG002|Overall Study|Death|2|||
160850639|NCT02452424|580841570|FG003|Overall Study|Death|6|||
160850640|NCT02452424|580841571|FG004|Overall Study|Death|2|||
160850641|NCT02452424|580841572|FG005|Overall Study|Death|0|||
160850642|NCT02452424|580841573|FG006|Overall Study|Death|5|||
160850643|NCT02452424|580841574|FG007|Overall Study|Death|1|||
160850644|NCT02452424|580841575|FG008|Overall Study|Death|3|||
160850645|NCT02452424|580841576|FG009|Overall Study|Death|1|||
160850646|NCT02452424|580841577|FG010|Overall Study|Death|0|||
160850647|NCT02452424|580841567|FG000|Overall Study|Lost to Follow-up|0|||
160850648|NCT02452424|580841568|FG001|Overall Study|Lost to Follow-up|1|||
160850649|NCT02452424|580841569|FG002|Overall Study|Lost to Follow-up|1|||
160850650|NCT02452424|580841570|FG003|Overall Study|Lost to Follow-up|0|||
160850651|NCT02452424|580841571|FG004|Overall Study|Lost to Follow-up|0|||
160850652|NCT02452424|580841572|FG005|Overall Study|Lost to Follow-up|0|||
160850653|NCT02452424|580841573|FG006|Overall Study|Lost to Follow-up|0|||
160850654|NCT02452424|580841574|FG007|Overall Study|Lost to Follow-up|0|||
160850655|NCT02452424|580841575|FG008|Overall Study|Lost to Follow-up|0|||
160850656|NCT02452424|580841576|FG009|Overall Study|Lost to Follow-up|0|||
160850657|NCT02452424|580841577|FG010|Overall Study|Lost to Follow-up|0|||
160850658|NCT02452424|580841567|FG000|Overall Study|Withdrawal by Subject|0|||
160850659|NCT02452424|580841568|FG001|Overall Study|Withdrawal by Subject|0|||
160850660|NCT02452424|580841569|FG002|Overall Study|Withdrawal by Subject|3|||
160850661|NCT02452424|580841570|FG003|Overall Study|Withdrawal by Subject|2|||
160850662|NCT02452424|580841571|FG004|Overall Study|Withdrawal by Subject|0|||
160850663|NCT02452424|580841572|FG005|Overall Study|Withdrawal by Subject|0|||
160850664|NCT02452424|580841573|FG006|Overall Study|Withdrawal by Subject|1|||
160850665|NCT02452424|580841574|FG007|Overall Study|Withdrawal by Subject|0|||
160850666|NCT02452424|580841575|FG008|Overall Study|Withdrawal by Subject|1|||
160850667|NCT02452424|580841576|FG009|Overall Study|Withdrawal by Subject|1|||
160850668|NCT02452424|580841577|FG010|Overall Study|Withdrawal by Subject|0|||
160850669|NCT02452424|580841567|FG000|Overall Study|Other|0|||
160850670|NCT02452424|580841568|FG001|Overall Study|Other|0|||
160850671|NCT02452424|580841569|FG002|Overall Study|Other|1|||
160850672|NCT02452424|580841570|FG003|Overall Study|Other|0|||
160850673|NCT02452424|580841571|FG004|Overall Study|Other|0|||
160850674|NCT02452424|580841572|FG005|Overall Study|Other|1|||
160850675|NCT02452424|580841573|FG006|Overall Study|Other|4|||
160850676|NCT02452424|580841574|FG007|Overall Study|Other|3|||
160850677|NCT02452424|580841575|FG008|Overall Study|Other|0|||
160850678|NCT02452424|580841576|FG009|Overall Study|Other|0|||
160850679|NCT02452424|580841577|FG010|Overall Study|Other|1|||
160850680|NCT02452424|580841567|FG000|Overall Study|Progressive disease (per RECIST)|0|||
160850681|NCT02452424|580841568|FG001|Overall Study|Progressive disease (per RECIST)|0|||
160850682|NCT02452424|580841569|FG002|Overall Study|Progressive disease (per RECIST)|0|||
160850683|NCT02452424|580841570|FG003|Overall Study|Progressive disease (per RECIST)|0|||
160850684|NCT02452424|580841571|FG004|Overall Study|Progressive disease (per RECIST)|0|||
160850685|NCT02452424|580841572|FG005|Overall Study|Progressive disease (per RECIST)|0|||
160850686|NCT02452424|580841573|FG006|Overall Study|Progressive disease (per RECIST)|0|||
160850687|NCT02452424|580841574|FG007|Overall Study|Progressive disease (per RECIST)|0|||
160850688|NCT02452424|580841575|FG008|Overall Study|Progressive disease (per RECIST)|2|||
160850689|NCT02452424|580841576|FG009|Overall Study|Progressive disease (per RECIST)|0|||
160850690|NCT02452424|580841577|FG010|Overall Study|Progressive disease (per RECIST)|0|||
160850691|NCT02452424|580841567|FG000|Overall Study|Adverse Event|0|||
160850692|NCT02452424|580841568|FG001|Overall Study|Adverse Event|0|||
160850693|NCT02452424|580841569|FG002|Overall Study|Adverse Event|0|||
160850694|NCT02452424|580841570|FG003|Overall Study|Adverse Event|0|||
160850695|NCT02452424|580841571|FG004|Overall Study|Adverse Event|0|||
160850696|NCT02452424|580841572|FG005|Overall Study|Adverse Event|0|||
160850697|NCT02452424|580841573|FG006|Overall Study|Adverse Event|0|||
160850698|NCT02452424|580841574|FG007|Overall Study|Adverse Event|0|||
160850699|NCT02452424|580841575|FG008|Overall Study|Adverse Event|0|||
160850700|NCT02452424|580841576|FG009|Overall Study|Adverse Event|0|||
160850701|NCT02452424|580841577|FG010|Overall Study|Adverse Event|1|||
160850702|NCT01059318|580841578|FG000|Core Study (26 Week)|Adverse Event|3|||
160850703|NCT01059318|580841578|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
160850704|NCT01059318|580841578|FG000|Extension (36 Week)|Adverse Event|3|||
160850705|NCT03790917|580841579|FG000|Overall Study|Death|1|||
160850706|NCT01150097|580841583|FG000|Months 24 to 36 Post-transplantation|Death|2|||
160850707|NCT01150097|580841584|FG001|Months 24 to 36 Post-transplantation|Death|0|||
160850708|NCT01150097|580841585|FG002|Months 24 to 36 Post-transplantation|Death|0|||
160850709|NCT01150097|580841583|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
160850710|NCT01150097|580841584|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
160850711|NCT01150097|580841585|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
160850712|NCT01150097|580841583|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
160850713|NCT01150097|580841584|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
160850714|NCT01150097|580841585|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
160850715|NCT01150097|580841583|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
160850716|NCT01150097|580841584|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
160906703|NCT01546883|581052282|FG000|Overall Study|Adverse Event|4|||
160906704|NCT01546883|581052282|FG000|Overall Study|Lost to Follow-up|2|||
160906705|NCT01546883|581052282|FG000|Overall Study|early closure of study|2|||
160906706|NCT01546883|581052282|FG000|Overall Study|other unrelated illness|1|||
160906707|NCT02243696|581052283|FG000|Overall Study|Death|282|||
160906708|NCT02243696|581052283|FG000|Overall Study|Withdrawal by Subject|79|||
160906709|NCT02243696|581052283|FG000|Overall Study|Lost to Follow-up|57|||
160906710|NCT02243696|581052283|FG000|Overall Study|Subject No Longer has Study System|42|||
160906711|NCT02243696|581052283|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
160906712|NCT02243696|581052283|FG000|Overall Study|Study Terminated for EP PASSION|961|||
160992508|NCT03999554|581361387|FG002|Overall Study|Protocol Violation|5|||
160850717|NCT01150097|580841585|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
160850718|NCT01150097|580841583|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
160850719|NCT01150097|580841584|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
160850720|NCT01150097|580841585|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
160850721|NCT01150097|580841583|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
160850722|NCT01150097|580841584|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
160906713|NCT00622284|581052284|FG000|Overall Study|Lack of Efficacy|45|||
160906714|NCT00622284|581052285|FG001|Overall Study|Lack of Efficacy|15|||
160850723|NCT01150097|580841585|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
160850724|NCT01150097|580841583|FG000|Months 24 to 48 Post-transplantation|Death|2|||
160850725|NCT01150097|580841584|FG001|Months 24 to 48 Post-transplantation|Death|0|||
160850726|NCT01150097|580841585|FG002|Months 24 to 48 Post-transplantation|Death|0|||
160850727|NCT01408459|580841586|FG000|Overall Study|Withdrawal by Subject|1|||
160850728|NCT01408459|580841587|FG001|Overall Study|Withdrawal by Subject|1|||
160850729|NCT00992459|580841588|FG000|Overall Study|Withdrawal by Subject|0|||
160850730|NCT00992459|580841589|FG001|Overall Study|Withdrawal by Subject|1|||
160850731|NCT00992459|580841588|FG000|Overall Study|Adverse Event|1|||
160850732|NCT00992459|580841589|FG001|Overall Study|Adverse Event|0|||
160850733|NCT00543387|580841594|FG000|Panel 1 + Panel 2|Adverse Event|0|||
160850734|NCT00543387|580841595|FG001|Panel 1 + Panel 2|Adverse Event|1|||
160850735|NCT00543387|580841596|FG002|Panel 1 + Panel 2|Adverse Event|0|||
160850736|NCT00543387|580841597|FG003|Panel 1 + Panel 2|Adverse Event|0|||
160850737|NCT00543387|580841598|FG004|Panel 1 + Panel 2|Adverse Event|0|||
160850738|NCT00543387|580841599|FG005|Panel 1 + Panel 2|Adverse Event|0|||
160850739|NCT00543387|580841600|FG006|Panel 1 + Panel 2|Adverse Event|0|||
160850740|NCT00543387|580841601|FG007|Panel 1 + Panel 2|Adverse Event|1|||
160850741|NCT00543387|580841602|FG008|Panel 1 + Panel 2|Adverse Event|1|||
160850742|NCT00543387|580841603|FG009|Panel 1 + Panel 2|Adverse Event|0|||
160850743|NCT00543387|580841604|FG010|Panel 1 + Panel 2|Adverse Event|0|||
160850744|NCT00543387|580841594|FG000|Panel 1 + Panel 2|Physician Decision|0|||
160850745|NCT00543387|580841595|FG001|Panel 1 + Panel 2|Physician Decision|0|||
160850746|NCT00543387|580841596|FG002|Panel 1 + Panel 2|Physician Decision|1|||
160850747|NCT00543387|580841597|FG003|Panel 1 + Panel 2|Physician Decision|0|||
160850748|NCT00543387|580841598|FG004|Panel 1 + Panel 2|Physician Decision|0|||
160850749|NCT00543387|580841599|FG005|Panel 1 + Panel 2|Physician Decision|0|||
160850750|NCT00543387|580841600|FG006|Panel 1 + Panel 2|Physician Decision|0|||
160850751|NCT00543387|580841601|FG007|Panel 1 + Panel 2|Physician Decision|1|||
160850752|NCT00543387|580841602|FG008|Panel 1 + Panel 2|Physician Decision|0|||
160850753|NCT00543387|580841603|FG009|Panel 1 + Panel 2|Physician Decision|0|||
160850754|NCT00543387|580841604|FG010|Panel 1 + Panel 2|Physician Decision|0|||
160850755|NCT00543387|580841594|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
160850756|NCT00543387|580841595|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
160850757|NCT00543387|580841596|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
160850758|NCT00543387|580841597|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
160850759|NCT00543387|580841598|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
160850760|NCT00543387|580841599|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
160850761|NCT00543387|580841600|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
160850762|NCT00543387|580841601|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
160850763|NCT00543387|580841602|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
160850764|NCT00543387|580841603|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
160850765|NCT00543387|580841604|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
160850766|NCT00543387|580841594|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850767|NCT00543387|580841595|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850768|NCT00543387|580841596|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850769|NCT00543387|580841597|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850770|NCT00543387|580841598|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850771|NCT00543387|580841599|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850772|NCT00543387|580841600|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
160850773|NCT00543387|580841601|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850774|NCT00543387|580841602|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850775|NCT00543387|580841603|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850776|NCT00543387|580841604|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850777|NCT00543387|580841594|FG000|Crossover Participants|Progressive Disease|0|||
160850778|NCT00543387|580841595|FG001|Crossover Participants|Progressive Disease|0|||
160850779|NCT00543387|580841596|FG002|Crossover Participants|Progressive Disease|0|||
160850780|NCT00543387|580841597|FG003|Crossover Participants|Progressive Disease|0|||
160850781|NCT00543387|580841598|FG004|Crossover Participants|Progressive Disease|0|||
160850782|NCT00543387|580841599|FG005|Crossover Participants|Progressive Disease|0|||
160850783|NCT00543387|580841600|FG006|Crossover Participants|Progressive Disease|0|||
160850784|NCT00543387|580841601|FG007|Crossover Participants|Progressive Disease|0|||
160850785|NCT00543387|580841602|FG008|Crossover Participants|Progressive Disease|0|||
160850786|NCT00543387|580841603|FG009|Crossover Participants|Progressive Disease|1|||
160850787|NCT00543387|580841604|FG010|Crossover Participants|Progressive Disease|2|||
160850788|NCT00543387|580841594|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
160850789|NCT00543387|580841595|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
160850790|NCT00543387|580841596|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
160850791|NCT00543387|580841597|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
160850792|NCT00543387|580841598|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
160850793|NCT00543387|580841599|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
160850794|NCT00543387|580841600|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
160992509|NCT03999554|581361388|FG003|Overall Study|Protocol Violation|0|||
160850795|NCT00543387|580841601|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
160850796|NCT00543387|580841602|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
160850797|NCT00543387|580841603|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
160850798|NCT00543387|580841604|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
160850799|NCT01223183|580841610|FG000|Imaging Day 1|Physician Decision|0|||
160850800|NCT01223183|580841611|FG001|Imaging Day 1|Physician Decision|1|||
160850801|NCT01223183|580841610|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
160850802|NCT01223183|580841611|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
160850803|NCT01223183|580841610|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
160850804|NCT01223183|580841611|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
160850805|NCT03772665|580841612|FG000|Overall Study|Protocol Violation|1|||
160850806|NCT03772665|580841613|FG001|Overall Study|Protocol Violation|0|||
160850807|NCT02719171|580843585|FG000|Overall Study|Adverse Event|1|||
160850808|NCT02719171|580843586|FG001|Overall Study|Adverse Event|2|||
160850809|NCT02719171|580843587|FG002|Overall Study|Adverse Event|0|||
160850810|NCT02719171|580843588|FG003|Overall Study|Adverse Event|0|||
160850811|NCT02719171|580843589|FG004|Overall Study|Adverse Event|2|||
160850812|NCT02719171|580843585|FG000|Overall Study|Lost to Follow-up|0|||
160850813|NCT02719171|580843586|FG001|Overall Study|Lost to Follow-up|0|||
160850814|NCT02719171|580843587|FG002|Overall Study|Lost to Follow-up|1|||
160850815|NCT02719171|580843588|FG003|Overall Study|Lost to Follow-up|0|||
160850816|NCT02719171|580843589|FG004|Overall Study|Lost to Follow-up|0|||
160850817|NCT02719171|580843585|FG000|Overall Study|Subject Withdrawal|0|||
160850818|NCT02719171|580843586|FG001|Overall Study|Subject Withdrawal|2|||
160850819|NCT02719171|580843587|FG002|Overall Study|Subject Withdrawal|2|||
160850820|NCT02719171|580843588|FG003|Overall Study|Subject Withdrawal|1|||
160850821|NCT02719171|580843589|FG004|Overall Study|Subject Withdrawal|0|||
160850822|NCT02719171|580843585|FG000|Overall Study|Other|0|||
160850823|NCT02719171|580843586|FG001|Overall Study|Other|0|||
160850824|NCT02719171|580843587|FG002|Overall Study|Other|0|||
160850825|NCT02719171|580843588|FG003|Overall Study|Other|1|||
160850826|NCT02719171|580843589|FG004|Overall Study|Other|0|||
160850827|NCT02539797|580843593|FG000|Overall Study|Lost to Follow-up|0|||
160850828|NCT02539797|580843594|FG001|Overall Study|Lost to Follow-up|1|||
160850829|NCT02539797|580843595|FG002|Overall Study|Lost to Follow-up|0|||
160850830|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
160850831|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
160850832|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
160850833|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
160850834|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
160850835|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
160850836|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
160850837|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
160850838|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
160850839|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
160850840|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
160850841|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
160850842|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
160850843|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
160850844|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
160850845|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
160850846|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
160850847|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
160850848|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
160850849|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
160850850|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
160850851|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
160850852|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
160850853|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
160850854|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
160850855|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
160850856|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
160850857|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
160850858|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
160850859|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
160906715|NCT00622284|581052284|FG000|Overall Study|Adverse Event|61|||
160906716|NCT00622284|581052285|FG001|Overall Study|Adverse Event|90|||
160906717|NCT00622284|581052284|FG000|Overall Study|Protocol Violation|12|||
160906718|NCT00622284|581052285|FG001|Overall Study|Protocol Violation|5|||
160906719|NCT00622284|581052284|FG000|Overall Study|Lost to Follow-up|11|||
160906720|NCT00622284|581052285|FG001|Overall Study|Lost to Follow-up|13|||
160850860|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
160850861|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
160850862|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
160850863|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
160850864|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
160850865|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
160850866|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
160850867|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
160850868|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
160850869|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
160850870|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
160850871|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
160850872|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
160850873|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
160850874|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
160850875|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160850876|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160850877|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
160850878|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160850879|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160850880|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
160850881|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
160850882|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
160850883|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
160850884|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
160850885|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
160850886|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
160850887|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
160850888|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
160850889|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
160850890|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
160850891|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
160850892|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
160850893|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
160850894|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
160850895|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
160850896|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
160850897|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
160850898|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
160850899|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
160850900|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
160906721|NCT00622284|581052284|FG000|Overall Study|Withdrawal by Subject|27|||
160906722|NCT00622284|581052285|FG001|Overall Study|Withdrawal by Subject|24|||
160906723|NCT00622284|581052284|FG000|Overall Study|Other reason (not specified)|33|||
160906724|NCT00622284|581052285|FG001|Overall Study|Other reason (not specified)|24|||
160906725|NCT02935842|581052286|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
160906726|NCT02935842|581052287|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
160906727|NCT02935842|581052288|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
160906728|NCT02935842|581052289|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
160906729|NCT02935842|581052286|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
160906730|NCT02935842|581052287|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
160906731|NCT02935842|581052288|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
160906732|NCT02935842|581052289|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
160906733|NCT02935842|581052286|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
160906734|NCT02935842|581052287|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
160906735|NCT02935842|581052288|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
160906736|NCT02935842|581052289|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
160906737|NCT02935842|581052286|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
160906738|NCT02935842|581052287|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
160906739|NCT02935842|581052288|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
160906740|NCT02935842|581052289|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
160906741|NCT02935842|581052286|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
160906742|NCT02935842|581052287|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
160906743|NCT02935842|581052288|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
160850901|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
160850902|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
160850903|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
160850904|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
160850905|NCT02831764|580843596|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160850906|NCT02831764|580843597|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160850907|NCT02831764|580843598|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160850908|NCT02831764|580843599|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160850909|NCT02831764|580843600|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
160850910|NCT02831764|580843596|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160850911|NCT02831764|580843597|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160850912|NCT02831764|580843598|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160850913|NCT02831764|580843599|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160850914|NCT02831764|580843600|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
160850915|NCT02831764|580843596|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160850916|NCT02831764|580843597|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160850917|NCT02831764|580843598|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160850918|NCT02831764|580843599|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160850919|NCT02831764|580843600|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
160850920|NCT02831764|580843596|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160850921|NCT02831764|580843597|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160850922|NCT02831764|580843598|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160850923|NCT02831764|580843599|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160850924|NCT02831764|580843600|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
160850925|NCT02796677|580843606|FG000|Overall Study|Adverse Event|11|||
160850926|NCT02796677|580843607|FG001|Overall Study|Adverse Event|22|||
160850927|NCT02796677|580843608|FG002|Overall Study|Adverse Event|14|||
160850928|NCT02796677|580843609|FG003|Overall Study|Adverse Event|14|||
160850929|NCT02796677|580843606|FG000|Overall Study|Protocol Violation|7|||
160850930|NCT02796677|580843607|FG001|Overall Study|Protocol Violation|5|||
160850931|NCT02796677|580843608|FG002|Overall Study|Protocol Violation|4|||
160850932|NCT02796677|580843609|FG003|Overall Study|Protocol Violation|8|||
160850933|NCT02796677|580843606|FG000|Overall Study|Lost to Follow-up|1|||
160850934|NCT02796677|580843607|FG001|Overall Study|Lost to Follow-up|5|||
160850935|NCT02796677|580843608|FG002|Overall Study|Lost to Follow-up|2|||
160850936|NCT02796677|580843609|FG003|Overall Study|Lost to Follow-up|2|||
160850937|NCT02796677|580843606|FG000|Overall Study|Lack of Efficacy|7|||
160850938|NCT02796677|580843607|FG001|Overall Study|Lack of Efficacy|9|||
160850939|NCT02796677|580843608|FG002|Overall Study|Lack of Efficacy|14|||
160850940|NCT02796677|580843609|FG003|Overall Study|Lack of Efficacy|20|||
160850941|NCT02796677|580843606|FG000|Overall Study|Withdrawal by Subject|4|||
160850942|NCT02796677|580843607|FG001|Overall Study|Withdrawal by Subject|14|||
160850943|NCT02796677|580843608|FG002|Overall Study|Withdrawal by Subject|6|||
160850944|NCT02796677|580843609|FG003|Overall Study|Withdrawal by Subject|7|||
160850945|NCT02796677|580843606|FG000|Overall Study|Progressive disease|6|||
160850946|NCT02796677|580843607|FG001|Overall Study|Progressive disease|15|||
160850947|NCT02796677|580843608|FG002|Overall Study|Progressive disease|13|||
160850948|NCT02796677|580843609|FG003|Overall Study|Progressive disease|18|||
160850949|NCT02796677|580843606|FG000|Overall Study|Reason not mentioned|2|||
160850950|NCT02796677|580843607|FG001|Overall Study|Reason not mentioned|3|||
160850951|NCT02796677|580843608|FG002|Overall Study|Reason not mentioned|0|||
160850952|NCT02796677|580843609|FG003|Overall Study|Reason not mentioned|5|||
160850953|NCT00961181|580843610|FG000|Overall Study|Death|2|||
160850954|NCT00961181|580843610|FG000|Overall Study|Withdrawal by Subject|2|||
160850955|NCT00961181|580843610|FG000|Overall Study|Lost to Follow-up|1|||
160850956|NCT01777308|580843613|FG000|Overall Study|Withdrawal by Subject|5|||
160850957|NCT01777308|580843614|FG001|Overall Study|Withdrawal by Subject|1|||
160906744|NCT02935842|581052289|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
160906745|NCT00915278|581052292|FG000|Overall Study|Death|1|||
160906746|NCT00915278|581052293|FG001|Overall Study|Death|0|||
160850958|NCT01777308|580843613|FG000|Overall Study|Migrated/moved from study area|1|||
160850959|NCT01777308|580843614|FG001|Overall Study|Migrated/moved from study area|0|||
160850960|NCT01777308|580843613|FG000|Overall Study|Lost to Follow-up|7|||
160850961|NCT01777308|580843614|FG001|Overall Study|Lost to Follow-up|2|||
160906747|NCT00915278|581052294|FG002|Overall Study|Death|0|||
160906748|NCT00915278|581052295|FG003|Overall Study|Death|0|||
160906749|NCT00915278|581052296|FG004|Overall Study|Death|0|||
160906750|NCT00915278|581052297|FG005|Overall Study|Death|0|||
160906751|NCT00915278|581052292|FG000|Overall Study|Lost to Follow-up|0|||
160906752|NCT00915278|581052293|FG001|Overall Study|Lost to Follow-up|1|||
160906753|NCT00915278|581052294|FG002|Overall Study|Lost to Follow-up|0|||
160906754|NCT00915278|581052295|FG003|Overall Study|Lost to Follow-up|0|||
160906755|NCT00915278|581052296|FG004|Overall Study|Lost to Follow-up|0|||
160850962|NCT01777308|580843613|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
160850963|NCT01777308|580843614|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
160850964|NCT03212326|580843616|FG000|Overall Study|Physician Decision|4|||
160850965|NCT01517750|580843628|FG000|Overall Study|Lost to Follow-up|1|||
160850966|NCT01517750|580843629|FG001|Overall Study|Lost to Follow-up|2|||
160850967|NCT01517750|580843630|FG002|Overall Study|Lost to Follow-up|4|||
160850968|NCT01517750|580843631|FG003|Overall Study|Lost to Follow-up|1|||
160850969|NCT01855412|580843632|FG000|Overall Study|Death|77|||
160850970|NCT01855412|580843633|FG001|Overall Study|Death|123|||
160850971|NCT01855412|580843634|FG002|Overall Study|Death|30|||
160850972|NCT01855412|580843632|FG000|Overall Study|Lost to Follow-up|28|||
160850973|NCT01855412|580843633|FG001|Overall Study|Lost to Follow-up|46|||
160850974|NCT01855412|580843634|FG002|Overall Study|Lost to Follow-up|15|||
160850975|NCT01855412|580843632|FG000|Overall Study|Withdrawal by Subject|77|||
160850976|NCT01855412|580843633|FG001|Overall Study|Withdrawal by Subject|123|||
160850977|NCT01855412|580843634|FG002|Overall Study|Withdrawal by Subject|24|||
160906756|NCT00915278|581052297|FG005|Overall Study|Lost to Follow-up|0|||
160906757|NCT00915278|581052292|FG000|Overall Study|Withdrawal by Subject|0|||
160906758|NCT00915278|581052293|FG001|Overall Study|Withdrawal by Subject|1|||
160850978|NCT01855412|580843632|FG000|Overall Study|Physician Decision|25|||
160850979|NCT01855412|580843633|FG001|Overall Study|Physician Decision|31|||
160850980|NCT01855412|580843634|FG002|Overall Study|Physician Decision|3|||
160850981|NCT01855412|580843632|FG000|Overall Study|Site Closure|4|||
160850982|NCT01855412|580843633|FG001|Overall Study|Site Closure|18|||
160850983|NCT01855412|580843634|FG002|Overall Study|Site Closure|1|||
160850984|NCT01855412|580843632|FG000|Overall Study|Reason not Specified|1|||
160850985|NCT01855412|580843633|FG001|Overall Study|Reason not Specified|2|||
160850986|NCT01855412|580843634|FG002|Overall Study|Reason not Specified|3|||
160850987|NCT03347123|580843637|FG000|Overall Study|Death|1|||
160850988|NCT03347123|580843638|FG001|Overall Study|Death|2|||
160850989|NCT03347123|580843639|FG002|Overall Study|Death|0|||
160850990|NCT03347123|580843640|FG003|Overall Study|Death|0|||
160850991|NCT03347123|580843641|FG004|Overall Study|Death|0|||
160850992|NCT03347123|580843642|FG005|Overall Study|Death|0|||
160850993|NCT03347123|580843643|FG006|Overall Study|Death|0|||
160850994|NCT03347123|580843637|FG000|Overall Study|Withdrawal by Subject|1|||
160850995|NCT03347123|580843638|FG001|Overall Study|Withdrawal by Subject|0|||
160850996|NCT03347123|580843639|FG002|Overall Study|Withdrawal by Subject|0|||
160906759|NCT00915278|581052294|FG002|Overall Study|Withdrawal by Subject|0|||
160906760|NCT00915278|581052295|FG003|Overall Study|Withdrawal by Subject|0|||
160906761|NCT00915278|581052296|FG004|Overall Study|Withdrawal by Subject|1|||
160906762|NCT00915278|581052297|FG005|Overall Study|Withdrawal by Subject|4|||
160906763|NCT00915278|581052292|FG000|Overall Study|Adverse Event|4|||
160906764|NCT00915278|581052293|FG001|Overall Study|Adverse Event|1|||
160906765|NCT00915278|581052294|FG002|Overall Study|Adverse Event|0|||
160906766|NCT00915278|581052295|FG003|Overall Study|Adverse Event|0|||
160906767|NCT00915278|581052296|FG004|Overall Study|Adverse Event|0|||
160906768|NCT00915278|581052297|FG005|Overall Study|Adverse Event|0|||
160906769|NCT00915278|581052292|FG000|Overall Study|Progressive disease/clinical progression|0|||
160906770|NCT00915278|581052293|FG001|Overall Study|Progressive disease/clinical progression|0|||
160906771|NCT00915278|581052294|FG002|Overall Study|Progressive disease/clinical progression|0|||
160906772|NCT00915278|581052295|FG003|Overall Study|Progressive disease/clinical progression|3|||
160906773|NCT00915278|581052296|FG004|Overall Study|Progressive disease/clinical progression|1|||
160906774|NCT00915278|581052297|FG005|Overall Study|Progressive disease/clinical progression|2|||
160906775|NCT00915278|581052292|FG000|Overall Study|Infusion related AEs|0|||
160906776|NCT00915278|581052293|FG001|Overall Study|Infusion related AEs|0|||
160906777|NCT00915278|581052294|FG002|Overall Study|Infusion related AEs|0|||
160906778|NCT00915278|581052295|FG003|Overall Study|Infusion related AEs|0|||
160906779|NCT00915278|581052296|FG004|Overall Study|Infusion related AEs|0|||
160850997|NCT03347123|580843640|FG003|Overall Study|Withdrawal by Subject|0|||
160569089|NCT04430348|579806942|FG005|Overall Study|Lost to Follow-up|0|||
160569090|NCT04430348|579806937|FG000|Overall Study|Adverse Event|0|||
160569091|NCT04430348|579806938|FG001|Overall Study|Adverse Event|0|||
160569092|NCT04430348|579806939|FG002|Overall Study|Adverse Event|0|||
160850998|NCT03347123|580843641|FG004|Overall Study|Withdrawal by Subject|0|||
160850999|NCT03347123|580843642|FG005|Overall Study|Withdrawal by Subject|0|||
160851000|NCT03347123|580843643|FG006|Overall Study|Withdrawal by Subject|0|||
160851001|NCT03347123|580843637|FG000|Overall Study|Reason not Specified|3|||
160906780|NCT00915278|581052297|FG005|Overall Study|Infusion related AEs|2|||
160906781|NCT00915278|581052292|FG000|Overall Study|Admission to hospice|0|||
160906782|NCT00915278|581052293|FG001|Overall Study|Admission to hospice|0|||
160851002|NCT03347123|580843638|FG001|Overall Study|Reason not Specified|4|||
160851003|NCT03347123|580843639|FG002|Overall Study|Reason not Specified|0|||
160851004|NCT03347123|580843640|FG003|Overall Study|Reason not Specified|0|||
160851005|NCT03347123|580843641|FG004|Overall Study|Reason not Specified|0|||
160851006|NCT03347123|580843642|FG005|Overall Study|Reason not Specified|0|||
160851007|NCT03347123|580843643|FG006|Overall Study|Reason not Specified|0|||
160569093|NCT04430348|579806940|FG003|Overall Study|Adverse Event|0|||
160569094|NCT04430348|579806941|FG004|Overall Study|Adverse Event|0|||
160569095|NCT04430348|579806942|FG005|Overall Study|Adverse Event|1|||
160569096|NCT04430348|579806937|FG000|Overall Study|Withdrawal by Subject|0|||
160851008|NCT01276639|580843649|FG000|Week 0 to 16|Death|1|||
160851009|NCT01276639|580843650|FG001|Week 0 to 16|Death|0|||
160851010|NCT01276639|580843651|FG002|Week 0 to 16|Death|0|||
160851011|NCT01276639|580843652|FG003|Week 0 to 16|Death|0|||
160851012|NCT01276639|580843653|FG004|Week 0 to 16|Death|0|||
160851013|NCT01276639|580843649|FG000|Week 0 to 16|Adverse Event|11|||
160569097|NCT04430348|579806938|FG001|Overall Study|Withdrawal by Subject|1|||
160851014|NCT01276639|580843650|FG001|Week 0 to 16|Adverse Event|8|||
160851015|NCT01276639|580843651|FG002|Week 0 to 16|Adverse Event|11|||
160851016|NCT01276639|580843652|FG003|Week 0 to 16|Adverse Event|0|||
160851017|NCT01276639|580843653|FG004|Week 0 to 16|Adverse Event|0|||
160851018|NCT01276639|580843649|FG000|Week 0 to 16|Lack of Efficacy|20|||
160851019|NCT01276639|580843650|FG001|Week 0 to 16|Lack of Efficacy|15|||
160851020|NCT01276639|580843651|FG002|Week 0 to 16|Lack of Efficacy|25|||
160851021|NCT01276639|580843652|FG003|Week 0 to 16|Lack of Efficacy|0|||
160851022|NCT01276639|580843653|FG004|Week 0 to 16|Lack of Efficacy|0|||
160851023|NCT01276639|580843649|FG000|Week 0 to 16|Lost to Follow-up|3|||
160851024|NCT01276639|580843650|FG001|Week 0 to 16|Lost to Follow-up|5|||
160851025|NCT01276639|580843651|FG002|Week 0 to 16|Lost to Follow-up|3|||
160851026|NCT01276639|580843652|FG003|Week 0 to 16|Lost to Follow-up|0|||
160851027|NCT01276639|580843653|FG004|Week 0 to 16|Lost to Follow-up|0|||
160851028|NCT01276639|580843649|FG000|Week 0 to 16|Withdrawal by Subject|8|||
160851029|NCT01276639|580843650|FG001|Week 0 to 16|Withdrawal by Subject|5|||
160851030|NCT01276639|580843651|FG002|Week 0 to 16|Withdrawal by Subject|4|||
160851031|NCT01276639|580843652|FG003|Week 0 to 16|Withdrawal by Subject|0|||
160851032|NCT01276639|580843653|FG004|Week 0 to 16|Withdrawal by Subject|0|||
160851033|NCT01276639|580843649|FG000|Week 0 to 16|Other|7|||
160851034|NCT01276639|580843650|FG001|Week 0 to 16|Other|7|||
160851035|NCT01276639|580843651|FG002|Week 0 to 16|Other|2|||
160851036|NCT01276639|580843652|FG003|Week 0 to 16|Other|0|||
160851037|NCT01276639|580843653|FG004|Week 0 to 16|Other|0|||
160851038|NCT01276639|580843649|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
160851039|NCT01276639|580843650|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
160851040|NCT01276639|580843651|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
160851041|NCT01276639|580843652|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
160851042|NCT01276639|580843653|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
160851043|NCT01276639|580843649|FG000|Week 16 to 52|Death|1|||
160851044|NCT01276639|580843650|FG001|Week 16 to 52|Death|0|||
160851045|NCT01276639|580843651|FG002|Week 16 to 52|Death|0|||
160851046|NCT01276639|580843652|FG003|Week 16 to 52|Death|0|||
160851047|NCT01276639|580843653|FG004|Week 16 to 52|Death|0|||
160851048|NCT01276639|580843649|FG000|Week 16 to 52|Adverse Event|10|||
160851049|NCT01276639|580843650|FG001|Week 16 to 52|Adverse Event|13|||
160851050|NCT01276639|580843651|FG002|Week 16 to 52|Adverse Event|0|||
160851051|NCT01276639|580843652|FG003|Week 16 to 52|Adverse Event|1|||
160851052|NCT01276639|580843653|FG004|Week 16 to 52|Adverse Event|3|||
160851053|NCT01276639|580843649|FG000|Week 16 to 52|Lack of Efficacy|99|||
160851054|NCT01276639|580843650|FG001|Week 16 to 52|Lack of Efficacy|71|||
160851055|NCT01276639|580843651|FG002|Week 16 to 52|Lack of Efficacy|0|||
160851056|NCT01276639|580843652|FG003|Week 16 to 52|Lack of Efficacy|14|||
160851057|NCT01276639|580843653|FG004|Week 16 to 52|Lack of Efficacy|13|||
160851058|NCT01276639|580843649|FG000|Week 16 to 52|Lost to Follow-up|3|||
160851059|NCT01276639|580843650|FG001|Week 16 to 52|Lost to Follow-up|1|||
160851060|NCT01276639|580843651|FG002|Week 16 to 52|Lost to Follow-up|0|||
160851061|NCT01276639|580843652|FG003|Week 16 to 52|Lost to Follow-up|0|||
160851062|NCT01276639|580843653|FG004|Week 16 to 52|Lost to Follow-up|1|||
160851063|NCT01276639|580843649|FG000|Week 16 to 52|Withdrawal by Subject|4|||
160851064|NCT01276639|580843650|FG001|Week 16 to 52|Withdrawal by Subject|4|||
160851065|NCT01276639|580843651|FG002|Week 16 to 52|Withdrawal by Subject|0|||
160851066|NCT01276639|580843652|FG003|Week 16 to 52|Withdrawal by Subject|0|||
160851067|NCT01276639|580843653|FG004|Week 16 to 52|Withdrawal by Subject|1|||
160851068|NCT01276639|580843649|FG000|Week 16 to 52|Other|10|||
160851069|NCT01276639|580843650|FG001|Week 16 to 52|Other|12|||
160851070|NCT01276639|580843651|FG002|Week 16 to 52|Other|0|||
160851071|NCT01276639|580843652|FG003|Week 16 to 52|Other|1|||
160851072|NCT01276639|580843653|FG004|Week 16 to 52|Other|3|||
160851073|NCT01132807|580843658|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
160851074|NCT01132807|580843659|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
160851075|NCT01132807|580843660|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
160851076|NCT01132807|580843658|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
160851077|NCT01132807|580843659|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
160851078|NCT01132807|580843660|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
160569098|NCT04430348|579806939|FG002|Overall Study|Withdrawal by Subject|0|||
160851079|NCT01380769|580843661|FG000|Overall Study|Withdrawal by Subject|7|||
160851080|NCT01380769|580843662|FG001|Overall Study|Withdrawal by Subject|11|||
160851081|NCT01380769|580843661|FG000|Overall Study|Physician Decision|1|||
160851082|NCT01380769|580843662|FG001|Overall Study|Physician Decision|1|||
160851083|NCT01380769|580843661|FG000|Overall Study|Adverse Event|1|||
160851084|NCT01380769|580843662|FG001|Overall Study|Adverse Event|1|||
160851085|NCT01380769|580843661|FG000|Overall Study|Protocol Violation|0|||
160851086|NCT01380769|580843662|FG001|Overall Study|Protocol Violation|1|||
160851087|NCT03654690|580843664|FG000|Overall Study|Withdrawal by Subject|1|||
160851088|NCT03654690|580843665|FG001|Overall Study|Withdrawal by Subject|0|||
160851089|NCT03654690|580843666|FG002|Overall Study|Withdrawal by Subject|0|||
160851090|NCT00742183|580843669|FG000|Overall Study|Adverse Event|2|||
160851091|NCT00742183|580843670|FG001|Overall Study|Adverse Event|2|||
160851092|NCT00742183|580843669|FG000|Overall Study|Death|1|||
160851093|NCT00742183|580843670|FG001|Overall Study|Death|0|||
160851094|NCT00742183|580843669|FG000|Overall Study|Physician Decision|0|||
160851095|NCT00742183|580843670|FG001|Overall Study|Physician Decision|2|||
160851096|NCT00742183|580843669|FG000|Overall Study|Lost to Follow-up|4|||
160851097|NCT00742183|580843670|FG001|Overall Study|Lost to Follow-up|4|||
160851098|NCT00742183|580843669|FG000|Overall Study|Required skin-graft|1|||
160851099|NCT00742183|580843670|FG001|Overall Study|Required skin-graft|1|||
160851100|NCT00742183|580843669|FG000|Overall Study|Withdrawal by Subject|1|||
160851101|NCT00742183|580843670|FG001|Overall Study|Withdrawal by Subject|0|||
160851102|NCT00742183|580843669|FG000|Overall Study|Lack of Efficacy|0|||
160851103|NCT00742183|580843670|FG001|Overall Study|Lack of Efficacy|3|||
160851104|NCT01176058|580843682|FG000|Overall Study|Adverse Event|1|||
160851105|NCT01176058|580843683|FG001|Overall Study|Adverse Event|0|||
160851106|NCT01176058|580843682|FG000|Overall Study|Insufficient clinical response|2|||
160851107|NCT01176058|580843683|FG001|Overall Study|Insufficient clinical response|2|||
160851108|NCT01176058|580843682|FG000|Overall Study|Insufficient mycological response|0|||
160851109|NCT01176058|580843683|FG001|Overall Study|Insufficient mycological response|1|||
160851110|NCT01176058|580843682|FG000|Overall Study|Withdrawal by Subject|1|||
160851111|NCT01176058|580843683|FG001|Overall Study|Withdrawal by Subject|0|||
160851112|NCT00256724|580843686|FG000|Overall Study|Physician Decision|2|||
160851113|NCT00256724|580843687|FG001|Overall Study|Physician Decision|5|||
160851114|NCT00256724|580843686|FG000|Overall Study|Protocol Violation|3|||
160851115|NCT00256724|580843687|FG001|Overall Study|Protocol Violation|3|||
160851116|NCT01217463|580843688|FG000|Overall Study|Adverse Event|8|||
160851117|NCT01217463|580843689|FG001|Overall Study|Adverse Event|5|||
160851118|NCT01217463|580843688|FG000|Overall Study|Physician Decision|0|||
160851119|NCT01217463|580843689|FG001|Overall Study|Physician Decision|1|||
160851120|NCT01217463|580843688|FG000|Overall Study|Withdrawal by Subject|3|||
160851121|NCT01217463|580843689|FG001|Overall Study|Withdrawal by Subject|0|||
160851122|NCT01217463|580843688|FG000|Overall Study|Surgery on the Target Limb|0|||
160851123|NCT01217463|580843689|FG001|Overall Study|Surgery on the Target Limb|1|||
160851124|NCT01217463|580843688|FG000|Overall Study|Patient Non-compliant|1|||
160851125|NCT01217463|580843689|FG001|Overall Study|Patient Non-compliant|0|||
160851126|NCT01217463|580843688|FG000|Overall Study|Other|1|||
160851127|NCT01217463|580843689|FG001|Overall Study|Other|1|||
160851128|NCT01569841|580843690|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
160851129|NCT01569841|580843691|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
160851130|NCT05114473|580843694|FG000|Overall Study|Lost to Follow-up|2|||
160851131|NCT05114473|580843695|FG001|Overall Study|Lost to Follow-up|2|||
160851132|NCT05114473|580843696|FG002|Overall Study|Lost to Follow-up|0|||
160851133|NCT00782717|580843698|FG000|Overall Study|Adverse Event|2|||
160851134|NCT00782717|580843699|FG001|Overall Study|Adverse Event|5|||
160851135|NCT00782717|580843698|FG000|Overall Study|Patient decision unrelated to AE|6|||
160851136|NCT00782717|580843699|FG001|Overall Study|Patient decision unrelated to AE|3|||
160851137|NCT00782717|580843698|FG000|Overall Study|Noncompliance|2|||
160851138|NCT00782717|580843699|FG001|Overall Study|Noncompliance|1|||
160906783|NCT00915278|581052294|FG002|Overall Study|Admission to hospice|1|||
160906784|NCT00915278|581052295|FG003|Overall Study|Admission to hospice|0|||
160906785|NCT00915278|581052296|FG004|Overall Study|Admission to hospice|0|||
160906786|NCT00915278|581052297|FG005|Overall Study|Admission to hospice|0|||
160906787|NCT02412618|581052298|FG000|Overall Study|Withdrawal by Subject|1|||
160906788|NCT02412618|581052299|FG001|Overall Study|Withdrawal by Subject|1|||
160851139|NCT00782717|580843698|FG000|Overall Study|Treatment failure|3|||
160851140|NCT00782717|580843699|FG001|Overall Study|Treatment failure|14|||
160851141|NCT00782717|580843698|FG000|Overall Study|Enrollment close prior to surgery|1|||
160851142|NCT00782717|580843699|FG001|Overall Study|Enrollment close prior to surgery|0|||
160851143|NCT00782717|580843698|FG000|Overall Study|Did not meet entrance criteria|1|||
160851144|NCT00782717|580843699|FG001|Overall Study|Did not meet entrance criteria|3|||
160851145|NCT00782717|580843698|FG000|Overall Study|Exited in error|0|||
160906789|NCT02412618|581052298|FG000|Overall Study|Expulsion|1|||
160906790|NCT02412618|581052299|FG001|Overall Study|Expulsion|1|||
160851146|NCT00782717|580843699|FG001|Overall Study|Exited in error|2|||
160851147|NCT02446717|580843700|FG000|Overall Study|Adverse Event|0|||
160851148|NCT02446717|580843701|FG001|Overall Study|Adverse Event|0|||
160851149|NCT02446717|580843702|FG002|Overall Study|Adverse Event|1|||
160851150|NCT02446717|580843703|FG003|Overall Study|Adverse Event|0|||
160851151|NCT02446717|580843704|FG004|Overall Study|Adverse Event|0|||
160851152|NCT02446717|580843700|FG000|Overall Study|Lost to Follow-up|0|||
160851153|NCT02446717|580843701|FG001|Overall Study|Lost to Follow-up|1|||
160851154|NCT02446717|580843702|FG002|Overall Study|Lost to Follow-up|1|||
160851155|NCT02446717|580843703|FG003|Overall Study|Lost to Follow-up|0|||
160851156|NCT02446717|580843704|FG004|Overall Study|Lost to Follow-up|1|||
160851157|NCT02446717|580843700|FG000|Overall Study|Withdrew consent|0|||
160851158|NCT02446717|580843701|FG001|Overall Study|Withdrew consent|0|||
160851159|NCT02446717|580843702|FG002|Overall Study|Withdrew consent|0|||
160851160|NCT02446717|580843703|FG003|Overall Study|Withdrew consent|1|||
160851161|NCT02446717|580843704|FG004|Overall Study|Withdrew consent|0|||
160851162|NCT00650767|580843713|FG000|Overall Study|Adverse Event|0|||
160851163|NCT00650767|580843714|FG001|Overall Study|Adverse Event|3|||
160851164|NCT00650767|580843715|FG002|Overall Study|Adverse Event|10|||
160851165|NCT00650767|580843716|FG003|Overall Study|Adverse Event|8|||
160851166|NCT00650767|580843713|FG000|Overall Study|Death|1|||
160851167|NCT00650767|580843714|FG001|Overall Study|Death|0|||
160851168|NCT00650767|580843715|FG002|Overall Study|Death|0|||
160851169|NCT00650767|580843716|FG003|Overall Study|Death|0|||
160851170|NCT00650767|580843713|FG000|Overall Study|Withdrawal by Subject|2|||
160851171|NCT00650767|580843714|FG001|Overall Study|Withdrawal by Subject|4|||
160851172|NCT00650767|580843715|FG002|Overall Study|Withdrawal by Subject|3|||
160851173|NCT00650767|580843716|FG003|Overall Study|Withdrawal by Subject|3|||
160851174|NCT00650767|580843713|FG000|Overall Study|Lost to Follow-up|1|||
160851175|NCT00650767|580843714|FG001|Overall Study|Lost to Follow-up|1|||
160851176|NCT00650767|580843715|FG002|Overall Study|Lost to Follow-up|1|||
160851177|NCT00650767|580843716|FG003|Overall Study|Lost to Follow-up|0|||
160851178|NCT00650767|580843713|FG000|Overall Study|Other|1|||
160851179|NCT00650767|580843714|FG001|Overall Study|Other|1|||
160851180|NCT00650767|580843715|FG002|Overall Study|Other|0|||
160851181|NCT00650767|580843716|FG003|Overall Study|Other|0|||
160851182|NCT03649074|580843717|FG000|Overall Study|Lost to Follow-up|2|||
160851183|NCT03649074|580843718|FG001|Overall Study|Lost to Follow-up|1|||
160851184|NCT03649074|580843717|FG000|Overall Study|Adverse Event|1|||
160851185|NCT03649074|580843718|FG001|Overall Study|Adverse Event|0|||
160851186|NCT03649074|580843717|FG000|Overall Study|Physician Decision|1|||
160851187|NCT03649074|580843718|FG001|Overall Study|Physician Decision|0|||
160851188|NCT03649074|580843717|FG000|Overall Study|Withdrawal by Subject|0|||
160851189|NCT03649074|580843718|FG001|Overall Study|Withdrawal by Subject|2|||
160851190|NCT03649074|580843717|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
160851191|NCT03649074|580843718|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
160851192|NCT03649074|580843717|FG000|Overall Study|Other|1|||
160851193|NCT03649074|580843718|FG001|Overall Study|Other|0|||
160851194|NCT03775486|580843719|FG000|Initial Therapy Phase|Other reason provided|0|||
160851195|NCT03775486|580843720|FG001|Initial Therapy Phase|Other reason provided|15|||
160851196|NCT03775486|580843719|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
160851197|NCT03775486|580843720|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
160851198|NCT03775486|580843719|FG000|Initial Therapy Phase|Protocol Violation|0|||
160851199|NCT03775486|580843720|FG001|Initial Therapy Phase|Protocol Violation|2|||
160851200|NCT03775486|580843719|FG000|Initial Therapy Phase|Adverse Event|0|||
160851201|NCT03775486|580843720|FG001|Initial Therapy Phase|Adverse Event|34|||
160851202|NCT03775486|580843719|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
160851203|NCT03775486|580843720|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
160851204|NCT03775486|580843719|FG000|Maintenance Phase|Withdrawal by Subject|13|||
160851205|NCT03775486|580843720|FG001|Maintenance Phase|Withdrawal by Subject|12|||
160851206|NCT03775486|580843719|FG000|Maintenance Phase|Death|44|||
160851207|NCT03775486|580843720|FG001|Maintenance Phase|Death|45|||
160851208|NCT00801216|580843721|FG000|Overall Study|Screening Failure|2|||
160851209|NCT05214768|580843722|FG000|Induction Period|Withdrawal by Subject|1|||
160851210|NCT05214768|580843723|FG001|Induction Period|Withdrawal by Subject|0|||
160851211|NCT05214768|580843724|FG002|Induction Period|Withdrawal by Subject|0|||
160650540|NCT02146430|580102491|FG000|Overall Study|Adverse Event|20|||
160851212|NCT05214768|580843725|FG003|Induction Period|Withdrawal by Subject|0|||
160851213|NCT05214768|580843726|FG004|Induction Period|Withdrawal by Subject|0|||
160851214|NCT05214768|580843727|FG005|Induction Period|Withdrawal by Subject|0|||
160851215|NCT05214768|580843722|FG000|Induction Period|Physician Decision|1|||
160851216|NCT05214768|580843723|FG001|Induction Period|Physician Decision|0|||
160851217|NCT05214768|580843724|FG002|Induction Period|Physician Decision|0|||
160851218|NCT05214768|580843725|FG003|Induction Period|Physician Decision|0|||
160851219|NCT05214768|580843726|FG004|Induction Period|Physician Decision|0|||
160851220|NCT05214768|580843727|FG005|Induction Period|Physician Decision|0|||
160851221|NCT05214768|580843722|FG000|Maintenance Period|Other Reasons|0|||
160851222|NCT05214768|580843723|FG001|Maintenance Period|Other Reasons|0|||
160851223|NCT05214768|580843724|FG002|Maintenance Period|Other Reasons|1|||
160851224|NCT05214768|580843725|FG003|Maintenance Period|Other Reasons|1|||
160851225|NCT05214768|580843726|FG004|Maintenance Period|Other Reasons|0|||
160851226|NCT05214768|580843727|FG005|Maintenance Period|Other Reasons|0|||
160851227|NCT05214768|580843722|FG000|Maintenance Period|Withdrawal by Subject|0|||
160851228|NCT05214768|580843723|FG001|Maintenance Period|Withdrawal by Subject|0|||
160851229|NCT05214768|580843724|FG002|Maintenance Period|Withdrawal by Subject|0|||
160851230|NCT05214768|580843725|FG003|Maintenance Period|Withdrawal by Subject|1|||
160851231|NCT05214768|580843726|FG004|Maintenance Period|Withdrawal by Subject|0|||
160851232|NCT05214768|580843727|FG005|Maintenance Period|Withdrawal by Subject|0|||
160851233|NCT05214768|580843722|FG000|Maintenance Period|Lack of Efficacy|0|||
160851234|NCT05214768|580843723|FG001|Maintenance Period|Lack of Efficacy|0|||
160851235|NCT05214768|580843724|FG002|Maintenance Period|Lack of Efficacy|1|||
160851236|NCT05214768|580843725|FG003|Maintenance Period|Lack of Efficacy|0|||
160851237|NCT05214768|580843726|FG004|Maintenance Period|Lack of Efficacy|1|||
160851238|NCT05214768|580843727|FG005|Maintenance Period|Lack of Efficacy|0|||
160851239|NCT05214768|580843722|FG000|Open Label Extension Period|Physician Decision|0|||
160851240|NCT05214768|580843723|FG001|Open Label Extension Period|Physician Decision|0|||
160851241|NCT05214768|580843724|FG002|Open Label Extension Period|Physician Decision|0|||
160851242|NCT05214768|580843725|FG003|Open Label Extension Period|Physician Decision|0|||
160851243|NCT05214768|580843726|FG004|Open Label Extension Period|Physician Decision|0|||
160851244|NCT05214768|580843727|FG005|Open Label Extension Period|Physician Decision|1|||
160851245|NCT05214768|580843722|FG000|Open Label Extension Period|Lack of Efficacy|0|||
160851246|NCT05214768|580843723|FG001|Open Label Extension Period|Lack of Efficacy|0|||
160851247|NCT05214768|580843724|FG002|Open Label Extension Period|Lack of Efficacy|0|||
160851248|NCT05214768|580843725|FG003|Open Label Extension Period|Lack of Efficacy|0|||
160851249|NCT05214768|580843726|FG004|Open Label Extension Period|Lack of Efficacy|0|||
160851250|NCT05214768|580843727|FG005|Open Label Extension Period|Lack of Efficacy|1|||
160851251|NCT05214768|580843722|FG000|Open Label Extension Period|Ongoing Study|0|||
160851252|NCT05214768|580843723|FG001|Open Label Extension Period|Ongoing Study|0|||
160851253|NCT05214768|580843724|FG002|Open Label Extension Period|Ongoing Study|0|||
160851254|NCT05214768|580843725|FG003|Open Label Extension Period|Ongoing Study|0|||
160851255|NCT05214768|580843726|FG004|Open Label Extension Period|Ongoing Study|0|||
160851256|NCT05214768|580843727|FG005|Open Label Extension Period|Ongoing Study|42|||
160851257|NCT05481359|580843728|FG000|Overall Study|Lost to Follow-up|3|||
160851258|NCT05481359|580843728|FG000|Overall Study|Withdrawal by Subject|1|||
160851259|NCT00291486|580843734|FG000|Overall Study|Adverse Event|0|||
160851260|NCT00291486|580843735|FG001|Overall Study|Adverse Event|3|||
160851261|NCT00291486|580843736|FG002|Overall Study|Adverse Event|0|||
160851262|NCT00291486|580843737|FG003|Overall Study|Adverse Event|1|||
160851263|NCT00291486|580843738|FG004|Overall Study|Adverse Event|0|||
160851264|NCT00291486|580843734|FG000|Overall Study|Withdrawal by Subject|0|||
160851265|NCT00291486|580843735|FG001|Overall Study|Withdrawal by Subject|0|||
160851266|NCT00291486|580843736|FG002|Overall Study|Withdrawal by Subject|0|||
160851267|NCT00291486|580843737|FG003|Overall Study|Withdrawal by Subject|0|||
160851268|NCT00291486|580843738|FG004|Overall Study|Withdrawal by Subject|1|||
160851269|NCT00291486|580843734|FG000|Overall Study|Disease progression|1|||
160851270|NCT00291486|580843735|FG001|Overall Study|Disease progression|0|||
160851271|NCT00291486|580843736|FG002|Overall Study|Disease progression|1|||
160851272|NCT00291486|580843737|FG003|Overall Study|Disease progression|0|||
160851273|NCT00291486|580843738|FG004|Overall Study|Disease progression|0|||
160851274|NCT01232868|580844811|FG000|Overall Study|Lost to Follow-up|2|||
160851275|NCT01232868|580844812|FG001|Overall Study|Lost to Follow-up|4|||
160851276|NCT04481243|580844813|FG000|Overall Study|Withdrawal by Subject|4|||
160851277|NCT01131507|580844816|FG000|Overall Study|Adverse Event|1|||
160851278|NCT01131507|580844816|FG000|Overall Study|Lost to Follow-up|1|||
160851279|NCT01131507|580844816|FG000|Overall Study|Withdrawal by Subject|1|||
160851280|NCT00346216|580844820|FG000|Overall Study|Other|181|||
160906791|NCT00923156|581052302|FG000|Overall Study|Adverse Event|0|||
160906792|NCT00923156|581052303|FG001|Overall Study|Adverse Event|2|||
160906793|NCT00923156|581052304|FG002|Overall Study|Adverse Event|1|||
160906794|NCT00923156|581052302|FG000|Overall Study|Abnormal laboratory values|0|||
160906795|NCT00923156|581052303|FG001|Overall Study|Abnormal laboratory values|0|||
160906796|NCT00923156|581052304|FG002|Overall Study|Abnormal laboratory values|1|||
160906797|NCT00923156|581052302|FG000|Overall Study|Withdrawal by Subject|0|||
160906798|NCT00923156|581052303|FG001|Overall Study|Withdrawal by Subject|1|||
160906799|NCT00923156|581052304|FG002|Overall Study|Withdrawal by Subject|0|||
160906800|NCT00923156|581052302|FG000|Overall Study|Death|0|||
160851281|NCT00346216|580844821|FG001|Overall Study|Other|231|||
160851282|NCT00346216|580844822|FG002|Overall Study|Other|205|||
160851283|NCT00346216|580844820|FG000|Overall Study|No longer willing to participate|600|||
160851284|NCT00346216|580844821|FG001|Overall Study|No longer willing to participate|606|||
160851285|NCT00346216|580844822|FG002|Overall Study|No longer willing to participate|585|||
160851286|NCT00346216|580844820|FG000|Overall Study|Withdrawal by Subject|661|||
160851287|NCT00346216|580844821|FG001|Overall Study|Withdrawal by Subject|692|||
160851288|NCT00346216|580844822|FG002|Overall Study|Withdrawal by Subject|651|||
160851289|NCT00346216|580844820|FG000|Overall Study|Lost to Follow-up|611|||
160906801|NCT00923156|581052303|FG001|Overall Study|Death|1|||
160851290|NCT00346216|580844821|FG001|Overall Study|Lost to Follow-up|588|||
160851291|NCT00346216|580844822|FG002|Overall Study|Lost to Follow-up|542|||
160851292|NCT00346216|580844820|FG000|Overall Study|Physician Decision|80|||
160851293|NCT00346216|580844821|FG001|Overall Study|Physician Decision|76|||
160851294|NCT00346216|580844822|FG002|Overall Study|Physician Decision|59|||
160851295|NCT00346216|580844820|FG000|Overall Study|Does not meet entrance criteria|13|||
160851296|NCT00346216|580844821|FG001|Overall Study|Does not meet entrance criteria|10|||
160851297|NCT00346216|580844822|FG002|Overall Study|Does not meet entrance criteria|8|||
160851298|NCT00346216|580844820|FG000|Overall Study|Death|189|||
160851299|NCT00346216|580844821|FG001|Overall Study|Death|192|||
160851300|NCT00346216|580844822|FG002|Overall Study|Death|228|||
160851301|NCT00346216|580844820|FG000|Overall Study|Study terminated by sponsor|11|||
160851302|NCT00346216|580844821|FG001|Overall Study|Study terminated by sponsor|4|||
160851303|NCT00346216|580844822|FG002|Overall Study|Study terminated by sponsor|8|||
160851304|NCT00346216|580844820|FG000|Overall Study|Missing Subject Summary Status|62|||
160851305|NCT00346216|580844821|FG001|Overall Study|Missing Subject Summary Status|61|||
160851306|NCT00346216|580844822|FG002|Overall Study|Missing Subject Summary Status|62|||
160851307|NCT03431441|580844823|FG000|Overall Study|Withdrawal by Subject|2|||
160851308|NCT03431441|580844823|FG000|Overall Study|Adverse Event|2|||
160851309|NCT03431441|580844823|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
160851310|NCT05030350|580844827|FG000|Overall Study|Adverse Event|13|||
160851311|NCT05030350|580844827|FG000|Overall Study|Lack of Efficacy|8|||
160851312|NCT05030350|580844827|FG000|Overall Study|Lost to Follow-up|35|||
160851313|NCT05030350|580844827|FG000|Overall Study|Pregnancy|2|||
160851314|NCT05030350|580844827|FG000|Overall Study|Protocol Violation|2|||
160851315|NCT05030350|580844827|FG000|Overall Study|Withdrawal by Subject|60|||
160851316|NCT05030350|580844827|FG000|Overall Study|Study terminated by sponsor|349|||
160851317|NCT05030350|580844827|FG000|Overall Study|Positive Drug Screen|4|||
160851318|NCT05030350|580844827|FG000|Overall Study|Other|8|||
160851319|NCT03985761|580844831|FG000|Overall Study|Withdrawal by Subject|2|||
160851320|NCT03985761|580844832|FG001|Overall Study|Withdrawal by Subject|3|||
160851321|NCT01858363|580844838|FG000|Overall Study|Death|35|||
160851322|NCT01858363|580844839|FG001|Overall Study|Death|9|||
160851323|NCT01858363|580844838|FG000|Overall Study|Withdrawal by Subject|28|||
160851324|NCT01858363|580844839|FG001|Overall Study|Withdrawal by Subject|14|||
160851325|NCT01858363|580844838|FG000|Overall Study|Lost to Follow-up|13|||
160851326|NCT01858363|580844839|FG001|Overall Study|Lost to Follow-up|3|||
160851327|NCT01859923|580844840|FG000|Overall Study|Adverse Event|0|||
160851328|NCT01859923|580844841|FG001|Overall Study|Adverse Event|0|||
160851329|NCT01859923|580844842|FG002|Overall Study|Adverse Event|1|||
160851330|NCT01859923|580844843|FG003|Overall Study|Adverse Event|1|||
160851331|NCT00764361|580844849|FG000|Overall Study|Withdrawal by Subject|2|||
160851332|NCT00764361|580844850|FG001|Overall Study|Withdrawal by Subject|3|||
160851333|NCT00764361|580844849|FG000|Overall Study|Adverse Event|0|||
160851334|NCT00764361|580844850|FG001|Overall Study|Adverse Event|1|||
160851335|NCT02090426|580844851|FG000|Overall Study|Lost to Follow-up|12|||
160851336|NCT02090426|580844852|FG001|Overall Study|Lost to Follow-up|6|||
160851337|NCT01141712|580844856|FG000|Overall Study|Disease progression|3|||
160851338|NCT01308736|580844863|FG000|Overall Study|Did not attend a single session|6|||
160851339|NCT01308736|580844864|FG001|Overall Study|Did not attend a single session|5|||
160851340|NCT03634085|580844865|FG000|Overall Study|Adverse Event|1|||
160851341|NCT03634085|580844866|FG001|Overall Study|Adverse Event|0|||
160851342|NCT03634085|580844865|FG000|Overall Study|Withdrawal by Subject|0|||
160851343|NCT03634085|580844866|FG001|Overall Study|Withdrawal by Subject|2|||
160851344|NCT01054456|580844873|FG000|Overall Study|Other|1|||
160851345|NCT04701333|580844874|FG000|Overall Study|Lost to Follow-up|3|||
160851346|NCT04701333|580844875|FG001|Overall Study|Lost to Follow-up|7|||
160851347|NCT04701333|580844874|FG000|Overall Study|Withdrawal by Subject|0|||
160851348|NCT04701333|580844875|FG001|Overall Study|Withdrawal by Subject|1|||
160851349|NCT01012258|580844876|FG000|Overall Study|Death|14|||
160851350|NCT01012258|580844876|FG000|Overall Study|Lost to Follow-up|1|||
160851351|NCT01012258|580844876|FG000|Overall Study|Adverse Event|1|||
160851352|NCT01012258|580844876|FG000|Overall Study|Progressive Disease (PD)|18|||
160851353|NCT01012258|580844876|FG000|Overall Study|Symptomatic Deterioration|1|||
160906802|NCT00923156|581052304|FG002|Overall Study|Death|0|||
160851354|NCT01012258|580844876|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
160851355|NCT01012258|580844876|FG000|Overall Study|Another Tumor Discovered|1|||
160851356|NCT01012258|580844876|FG000|Overall Study|Ongoing|29|||
160851357|NCT01292187|580844877|FG000|Overall Study|Adverse Event|10|||
160851358|NCT01292187|580844878|FG001|Overall Study|Adverse Event|5|||
160851359|NCT01292187|580844877|FG000|Overall Study|Withdrawal by Subject|6|||
160851360|NCT01292187|580844878|FG001|Overall Study|Withdrawal by Subject|5|||
160851361|NCT01292187|580844877|FG000|Overall Study|All other reasons|1|||
160851362|NCT01292187|580844878|FG001|Overall Study|All other reasons|3|||
160851363|NCT01814527|580844880|FG000|Overall Study|RTP greater than 30 days|6|||
160851364|NCT01814527|580844881|FG001|Overall Study|RTP greater than 30 days|1|||
160851365|NCT00687401|580844882|FG000|Overall Study|Protocol Violation|7|||
160851366|NCT00687401|580844882|FG000|Overall Study|Adverse Event|6|||
160851367|NCT00687401|580844882|FG000|Overall Study|Lack of Efficacy|6|||
160851368|NCT00687401|580844882|FG000|Overall Study|Withdrawal by Subject|4|||
160851369|NCT00687401|580844882|FG000|Overall Study|Did not return for visit|3|||
160851370|NCT00687401|580844882|FG000|Overall Study|For reasons different from those above|4|||
160851371|NCT02366195|580844883|FG000|Overall Study|Protocol-specified criteria|3|||
160851372|NCT02366195|580844883|FG000|Overall Study|Withdrawal by Subject|9|||
160851373|NCT02366195|580844883|FG000|Overall Study|Lost to Follow-up|1|||
160851374|NCT02366195|580844883|FG000|Overall Study|Death|41|||
160851375|NCT00113841|580844884|FG000|Overall Study|Disease progression|0|||
160851376|NCT00113841|580844885|FG001|Overall Study|Disease progression|2|||
160851377|NCT00113841|580844884|FG000|Overall Study|Non-compliant|1|||
160851378|NCT00113841|580844885|FG001|Overall Study|Non-compliant|0|||
160851379|NCT02520726|580844886|FG000|Overall Study|Lost to Follow-up|3|||
160851380|NCT02520726|580844887|FG001|Overall Study|Lost to Follow-up|2|||
160851381|NCT00721396|580844888|FG000|Overall Study|Adverse Event|4|||
160851382|NCT00721396|580844889|FG001|Overall Study|Adverse Event|7|||
160851383|NCT00721396|580844890|FG002|Overall Study|Adverse Event|2|||
160851384|NCT00721396|580844891|FG003|Overall Study|Adverse Event|0|||
160851385|NCT00721396|580844888|FG000|Overall Study|Withdrawal by Subject|12|||
160851386|NCT00721396|580844889|FG001|Overall Study|Withdrawal by Subject|15|||
160851387|NCT00721396|580844890|FG002|Overall Study|Withdrawal by Subject|3|||
160851388|NCT00721396|580844891|FG003|Overall Study|Withdrawal by Subject|7|||
160851389|NCT00721396|580844888|FG000|Overall Study|Lost to Follow-up|7|||
160851390|NCT00721396|580844889|FG001|Overall Study|Lost to Follow-up|9|||
160851391|NCT00721396|580844890|FG002|Overall Study|Lost to Follow-up|3|||
160851392|NCT00721396|580844891|FG003|Overall Study|Lost to Follow-up|3|||
160851393|NCT00721396|580844888|FG000|Overall Study|Protocol Violation|4|||
160851394|NCT00721396|580844889|FG001|Overall Study|Protocol Violation|3|||
160851395|NCT00721396|580844890|FG002|Overall Study|Protocol Violation|1|||
160851396|NCT00721396|580844891|FG003|Overall Study|Protocol Violation|0|||
160851397|NCT00721396|580844888|FG000|Overall Study|Inappropriate enrollment|0|||
160851398|NCT00721396|580844889|FG001|Overall Study|Inappropriate enrollment|2|||
160851399|NCT00721396|580844890|FG002|Overall Study|Inappropriate enrollment|0|||
160851400|NCT00721396|580844891|FG003|Overall Study|Inappropriate enrollment|0|||
160851401|NCT00721396|580844888|FG000|Overall Study|Administrative reason|3|||
160851402|NCT00721396|580844889|FG001|Overall Study|Administrative reason|0|||
160851403|NCT00721396|580844890|FG002|Overall Study|Administrative reason|1|||
160851404|NCT00721396|580844891|FG003|Overall Study|Administrative reason|0|||
160851405|NCT00148759|580844892|FG000|Overall Study|Withdrawal by Subject|1|||
160851406|NCT00148759|580844893|FG001|Overall Study|Withdrawal by Subject|1|||
160851407|NCT00148759|580844892|FG000|Overall Study|Lost to Follow-up|1|||
160851408|NCT00148759|580844893|FG001|Overall Study|Lost to Follow-up|0|||
160851409|NCT00430716|580844895|FG000|Double Blind Phase|Death|1|||
160851410|NCT00430716|580844896|FG001|Double Blind Phase|Death|0|||
160851411|NCT00430716|580844897|FG002|Double Blind Phase|Death|0|||
160851412|NCT00430716|580844895|FG000|Double Blind Phase|No longer willing to participate|2|||
160851413|NCT00430716|580844896|FG001|Double Blind Phase|No longer willing to participate|1|||
160851414|NCT00430716|580844897|FG002|Double Blind Phase|No longer willing to participate|1|||
160851415|NCT00430716|580844895|FG000|Double Blind Phase|Other|0|||
160851416|NCT00430716|580844896|FG001|Double Blind Phase|Other|2|||
160851417|NCT00430716|580844897|FG002|Double Blind Phase|Other|0|||
160851418|NCT00430716|580844895|FG000|Double Blind Phase|Study terminated by sponsor|1|||
160851419|NCT00430716|580844896|FG001|Double Blind Phase|Study terminated by sponsor|1|||
160851420|NCT00430716|580844897|FG002|Double Blind Phase|Study terminated by sponsor|2|||
160851421|NCT00430716|580844895|FG000|Double Blind Phase|Adverse Event|1|||
160851422|NCT00430716|580844896|FG001|Double Blind Phase|Adverse Event|1|||
160851423|NCT00430716|580844897|FG002|Double Blind Phase|Adverse Event|3|||
160851424|NCT00430716|580844895|FG000|Double Blind Phase|Not treated|1|||
160851425|NCT00430716|580844896|FG001|Double Blind Phase|Not treated|0|||
160851426|NCT00430716|580844897|FG002|Double Blind Phase|Not treated|0|||
160851427|NCT00430716|580844895|FG000|Open Label Phase|Lost to Follow-up|1|||
160851428|NCT00430716|580844896|FG001|Open Label Phase|Lost to Follow-up|0|||
160851429|NCT00430716|580844897|FG002|Open Label Phase|Lost to Follow-up|1|||
160851430|NCT00430716|580844895|FG000|Open Label Phase|No longer willing to participate|0|||
160906803|NCT00923156|581052302|FG000|Overall Study|Lack of Efficacy|0|||
160851431|NCT00430716|580844896|FG001|Open Label Phase|No longer willing to participate|1|||
160851432|NCT00430716|580844897|FG002|Open Label Phase|No longer willing to participate|1|||
160851433|NCT00430716|580844895|FG000|Open Label Phase|Other|3|||
160851434|NCT00430716|580844896|FG001|Open Label Phase|Other|1|||
160851435|NCT00430716|580844897|FG002|Open Label Phase|Other|1|||
160851436|NCT00430716|580844895|FG000|Open Label Phase|Protocol Violation|1|||
160851437|NCT00430716|580844896|FG001|Open Label Phase|Protocol Violation|0|||
160851438|NCT00430716|580844897|FG002|Open Label Phase|Protocol Violation|0|||
160851439|NCT00430716|580844895|FG000|Open Label Phase|Study terminated by sponsor|4|||
160851440|NCT00430716|580844896|FG001|Open Label Phase|Study terminated by sponsor|5|||
160851441|NCT00430716|580844897|FG002|Open Label Phase|Study terminated by sponsor|4|||
160851442|NCT03948334|580844898|FG000|Overall Study|Adverse Event|1|||
160851443|NCT03948334|580844899|FG001|Overall Study|Adverse Event|4|||
160851444|NCT03948334|580844898|FG000|Overall Study|Lack of Efficacy|2|||
160851445|NCT03948334|580844899|FG001|Overall Study|Lack of Efficacy|0|||
160851446|NCT03948334|580844898|FG000|Overall Study|Lost to Follow-up|1|||
160851447|NCT03948334|580844899|FG001|Overall Study|Lost to Follow-up|0|||
160851448|NCT03948334|580844898|FG000|Overall Study|Physician Decision|1|||
160851449|NCT03948334|580844899|FG001|Overall Study|Physician Decision|0|||
160851450|NCT03948334|580844898|FG000|Overall Study|Pregnancy|0|||
160851451|NCT03948334|580844899|FG001|Overall Study|Pregnancy|1|||
160851452|NCT03948334|580844898|FG000|Overall Study|Protocol Deviation|1|||
160851453|NCT03948334|580844899|FG001|Overall Study|Protocol Deviation|0|||
160851454|NCT03948334|580844898|FG000|Overall Study|Study terminated by Sponsor|50|||
160851455|NCT03948334|580844899|FG001|Overall Study|Study terminated by Sponsor|51|||
160851456|NCT03948334|580844898|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
160851457|NCT03948334|580844899|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
160851458|NCT00154297|580844902|FG000|Overall Study|Death|5|||
160851459|NCT00154297|580844903|FG001|Overall Study|Death|2|||
160851460|NCT00154297|580844902|FG000|Overall Study|Withdrawal by Subject|0|||
160851461|NCT00154297|580844903|FG001|Overall Study|Withdrawal by Subject|5|||
160851462|NCT00154297|580844902|FG000|Overall Study|Lost to Follow-up|3|||
160851463|NCT00154297|580844903|FG001|Overall Study|Lost to Follow-up|0|||
160851464|NCT04332107|580844904|FG000|Day 3|Lost to Follow-up|23|||
160851465|NCT04332107|580844905|FG001|Day 3|Lost to Follow-up|14|||
160851466|NCT04332107|580844904|FG000|Day 3|Missing outcome data|3|||
160851467|NCT04332107|580844905|FG001|Day 3|Missing outcome data|6|||
160851468|NCT04332107|580844904|FG000|Day 14|Lost to Follow-up|13|||
160851469|NCT04332107|580844905|FG001|Day 14|Lost to Follow-up|4|||
160851470|NCT04332107|580844904|FG000|Day 14|Missing outcome data|4|||
160851471|NCT04332107|580844905|FG001|Day 14|Missing outcome data|4|||
160851472|NCT04332107|580844904|FG000|Day 21|Lost to Follow-up|10|||
160851473|NCT04332107|580844905|FG001|Day 21|Lost to Follow-up|2|||
160851474|NCT03116685|580844908|FG000|Overall Study|Physician Decision|0|||
160851475|NCT03116685|580844909|FG001|Overall Study|Physician Decision|1|||
160851476|NCT06235905|580844911|FG000|Overall Study|Adverse Event|1|||
160851477|NCT06235905|580844911|FG000|Overall Study|Non-compliant with protocol procedures|1|||
160851478|NCT01505374|580844915|FG000|Overall Study|Lost to Follow-up|1|||
160851479|NCT01505374|580844916|FG001|Overall Study|Lost to Follow-up|0|||
160851480|NCT00176462|580844919|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
160851481|NCT00176462|580844920|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
160851482|NCT00176462|580844919|FG000|Induction (4 Weeks)|Death|1|||
160851483|NCT00176462|580844920|FG001|Induction (4 Weeks)|Death|2|||
160851484|NCT00176462|580844919|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
160851485|NCT00176462|580844920|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
160851486|NCT00176462|580844919|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
160851487|NCT00176462|580844920|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
160851488|NCT00176462|580844919|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
160851489|NCT00176462|580844920|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
160851490|NCT00176462|580844919|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
160851491|NCT00176462|580844920|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
160851492|NCT00176462|580844919|FG000|Consolidation (12 Weeks)|Not documented|0|||
160851493|NCT00176462|580844920|FG001|Consolidation (12 Weeks)|Not documented|1|||
160851494|NCT00176462|580844919|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
160851495|NCT00176462|580844920|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
160851496|NCT00176462|580844919|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
160851497|NCT00176462|580844920|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
160851498|NCT00320515|580844925|FG000|Overall Study|Death|33|||
160851499|NCT00320515|580844925|FG000|Overall Study|Lost to Follow-up|6|||
160851500|NCT00320515|580844925|FG000|Overall Study|Physician Decision|2|||
160851501|NCT00320515|580844925|FG000|Overall Study|Withdrawal by Subject|8|||
160851502|NCT01114828|580844926|FG000|Overall Study|Adverse Event|1|||
160851503|NCT01114828|580844927|FG001|Overall Study|Adverse Event|1|||
160851504|NCT01114828|580844926|FG000|Overall Study|Lack of Efficacy|0|||
160851505|NCT01114828|580844927|FG001|Overall Study|Lack of Efficacy|2|||
160851506|NCT01114828|580844926|FG000|Overall Study|Protocol Violation|2|||
160851507|NCT01114828|580844927|FG001|Overall Study|Protocol Violation|0|||
160851508|NCT01114828|580844926|FG000|Overall Study|Withdrawal by Subject|0|||
160851509|NCT01114828|580844927|FG001|Overall Study|Withdrawal by Subject|1|||
160851510|NCT00794950|580844928|FG000|BCG Induction|Withdrawal by Subject|2|||
160851511|NCT00794950|580844928|FG000|BCG Induction|ineligible|3|||
160851512|NCT00794950|580844928|FG000|BCG Induction|noncompliant w. BCG|1|||
160851513|NCT00794950|580844928|FG000|BCG Induction|Adverse Event|1|||
160851514|NCT00794950|580844928|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
160851515|NCT00794950|580844928|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
160851516|NCT00794950|580844928|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
160851517|NCT00794950|580844928|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
160851518|NCT02485704|580844929|FG000|Overall Study|Lost to Follow-up|4|||
160851519|NCT02485704|580844930|FG001|Overall Study|Lost to Follow-up|5|||
160851520|NCT02485704|580844929|FG000|Overall Study|Withdrawal by Subject|0|||
160851521|NCT02485704|580844930|FG001|Overall Study|Withdrawal by Subject|3|||
160851522|NCT02485704|580844929|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
160851523|NCT02485704|580844930|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
160851524|NCT00851786|580844933|FG000|Overall Study|Withdrawal by Subject|0|||
160851525|NCT00851786|580844934|FG001|Overall Study|Withdrawal by Subject|1|||
160851526|NCT00851786|580844933|FG000|Overall Study|Protocol Violation|0|||
160851527|NCT00851786|580844934|FG001|Overall Study|Protocol Violation|1|||
160851528|NCT00851786|580844933|FG000|Overall Study|Lost to Follow-up|1|||
160851529|NCT00851786|580844934|FG001|Overall Study|Lost to Follow-up|0|||
160851530|NCT00851786|580844933|FG000|Overall Study|Incarceration|1|||
160851531|NCT00851786|580844934|FG001|Overall Study|Incarceration|0|||
160851532|NCT00851786|580844933|FG000|Overall Study|Site Closure|1|||
160851533|NCT00851786|580844934|FG001|Overall Study|Site Closure|0|||
160851534|NCT00851786|580844933|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
160851535|NCT00851786|580844934|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
160851536|NCT04177212|580844938|FG000|Overall Study|Withdrawal by Subject|9|||
160851537|NCT04177212|580844939|FG001|Overall Study|Withdrawal by Subject|7|||
160851538|NCT04177212|580844938|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
160851539|NCT04177212|580844939|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
160851540|NCT04177212|580844938|FG000|Overall Study|Physician Decision|1|||
160851541|NCT04177212|580844939|FG001|Overall Study|Physician Decision|0|||
160851542|NCT04177212|580844938|FG000|Overall Study|Lost to Follow-up|0|||
160851543|NCT04177212|580844939|FG001|Overall Study|Lost to Follow-up|3|||
160851544|NCT04177212|580844938|FG000|Overall Study|Adverse Event|0|||
160851545|NCT04177212|580844939|FG001|Overall Study|Adverse Event|1|||
160851546|NCT04177212|580844938|FG000|Overall Study|Other|1|||
160851547|NCT04177212|580844939|FG001|Overall Study|Other|2|||
160851548|NCT01792115|580844940|FG000|Overall Study|Lost to Follow-up|0|||
160851549|NCT01792115|580844941|FG001|Overall Study|Lost to Follow-up|1|||
160851550|NCT01792115|580844942|FG002|Overall Study|Lost to Follow-up|0|||
160851551|NCT01279681|580844943|FG000|Overall Study|Disease Progression|9|||
160851552|NCT01279681|580844944|FG001|Overall Study|Disease Progression|6|||
160851553|NCT01279681|580844943|FG000|Overall Study|Withdrawal by Subject|3|||
160851554|NCT01279681|580844944|FG001|Overall Study|Withdrawal by Subject|4|||
160851555|NCT01279681|580844943|FG000|Overall Study|Adverse Event|2|||
160851556|NCT01279681|580844944|FG001|Overall Study|Adverse Event|3|||
160851557|NCT01279681|580844943|FG000|Overall Study|Death|0|||
160851558|NCT01279681|580844944|FG001|Overall Study|Death|1|||
160851559|NCT01279681|580844943|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
160851560|NCT01279681|580844944|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
160851561|NCT01279681|580844943|FG000|Overall Study|Physician Decision|1|||
160851562|NCT01279681|580844944|FG001|Overall Study|Physician Decision|0|||
160851563|NCT01279681|580844943|FG000|Overall Study|Other Reason|0|||
160851564|NCT01279681|580844944|FG001|Overall Study|Other Reason|2|||
160851565|NCT01943591|580844945|FG000|Overall Study|Lost to Follow-up|3|||
160851566|NCT01943591|580844946|FG001|Overall Study|Lost to Follow-up|4|||
160851567|NCT01943591|580844945|FG000|Overall Study|Death|2|||
160851568|NCT01943591|580844946|FG001|Overall Study|Death|7|||
160851569|NCT02711137|580846274|FG000|Overall Study|Death|1|||
160851570|NCT02711137|580846275|FG001|Overall Study|Death|4|||
160851571|NCT02711137|580846276|FG002|Overall Study|Death|5|||
160851572|NCT02711137|580846277|FG003|Overall Study|Death|5|||
160851573|NCT02711137|580846278|FG004|Overall Study|Death|3|||
160851574|NCT02711137|580846279|FG005|Overall Study|Death|1|||
160851575|NCT02711137|580846280|FG006|Overall Study|Death|61|||
160851576|NCT02711137|580846281|FG007|Overall Study|Death|3|||
160851577|NCT02711137|580846282|FG008|Overall Study|Death|0|||
160851578|NCT02711137|580846283|FG009|Overall Study|Death|1|||
160851579|NCT02711137|580846284|FG010|Overall Study|Death|1|||
160851580|NCT02711137|580846285|FG011|Overall Study|Death|1|||
160851581|NCT02711137|580846286|FG012|Overall Study|Death|0|||
160851582|NCT02711137|580846287|FG013|Overall Study|Death|0|||
160851583|NCT02711137|580846288|FG014|Overall Study|Death|0|||
160851584|NCT02711137|580846274|FG000|Overall Study|Study Terminated by Sponsor|0|||
160851585|NCT02711137|580846275|FG001|Overall Study|Study Terminated by Sponsor|0|||
160851586|NCT02711137|580846276|FG002|Overall Study|Study Terminated by Sponsor|1|||
160851587|NCT02711137|580846277|FG003|Overall Study|Study Terminated by Sponsor|0|||
160851588|NCT02711137|580846278|FG004|Overall Study|Study Terminated by Sponsor|0|||
160851589|NCT02711137|580846279|FG005|Overall Study|Study Terminated by Sponsor|0|||
160851590|NCT02711137|580846280|FG006|Overall Study|Study Terminated by Sponsor|1|||
160851591|NCT02711137|580846281|FG007|Overall Study|Study Terminated by Sponsor|0|||
160851592|NCT02711137|580846282|FG008|Overall Study|Study Terminated by Sponsor|0|||
160650541|NCT02146430|580102492|FG001|Overall Study|Adverse Event|40|||
160851593|NCT02711137|580846283|FG009|Overall Study|Study Terminated by Sponsor|0|||
160851594|NCT02711137|580846284|FG010|Overall Study|Study Terminated by Sponsor|0|||
160851595|NCT02711137|580846285|FG011|Overall Study|Study Terminated by Sponsor|0|||
160851596|NCT02711137|580846286|FG012|Overall Study|Study Terminated by Sponsor|0|||
160851597|NCT02711137|580846287|FG013|Overall Study|Study Terminated by Sponsor|0|||
160851598|NCT02711137|580846288|FG014|Overall Study|Study Terminated by Sponsor|0|||
160851599|NCT02711137|580846274|FG000|Overall Study|Physician Decision|1|||
160851600|NCT02711137|580846275|FG001|Overall Study|Physician Decision|0|||
160851601|NCT02711137|580846276|FG002|Overall Study|Physician Decision|2|||
160851602|NCT02711137|580846277|FG003|Overall Study|Physician Decision|1|||
160851603|NCT02711137|580846278|FG004|Overall Study|Physician Decision|1|||
160851604|NCT02711137|580846279|FG005|Overall Study|Physician Decision|0|||
160851605|NCT02711137|580846280|FG006|Overall Study|Physician Decision|12|||
160650542|NCT02146430|580102493|FG002|Overall Study|Adverse Event|32|||
160650543|NCT02146430|580102494|FG003|Overall Study|Adverse Event|49|||
160650544|NCT02146430|580102491|FG000|Overall Study|Reason missing or not reported|2|||
160650545|NCT02146430|580102492|FG001|Overall Study|Reason missing or not reported|3|||
160650546|NCT02146430|580102493|FG002|Overall Study|Reason missing or not reported|4|||
160650547|NCT02146430|580102494|FG003|Overall Study|Reason missing or not reported|5|||
160650548|NCT02146430|580102491|FG000|Overall Study|Withdrawal by Subject|27|||
160650549|NCT02146430|580102492|FG001|Overall Study|Withdrawal by Subject|29|||
160650550|NCT02146430|580102493|FG002|Overall Study|Withdrawal by Subject|30|||
160650551|NCT02146430|580102494|FG003|Overall Study|Withdrawal by Subject|34|||
160650552|NCT03312530|580102495|FG000|Overall Study|Death|5|||
160650553|NCT03312530|580102496|FG001|Overall Study|Death|5|||
160650554|NCT03312530|580102497|FG002|Overall Study|Death|4|||
160650555|NCT03312530|580102498|FG003|Overall Study|Death|10|||
160650556|NCT03312530|580102499|FG004|Overall Study|Death|8|||
160650557|NCT03312530|580102495|FG000|Overall Study|Lost to Follow-up|0|||
160650558|NCT03312530|580102496|FG001|Overall Study|Lost to Follow-up|0|||
160650559|NCT03312530|580102497|FG002|Overall Study|Lost to Follow-up|0|||
160650560|NCT03312530|580102498|FG003|Overall Study|Lost to Follow-up|1|||
160650561|NCT03312530|580102499|FG004|Overall Study|Lost to Follow-up|0|||
160650562|NCT03312530|580102495|FG000|Overall Study|Participant in another sponsor study.|0|||
160650563|NCT03312530|580102496|FG001|Overall Study|Participant in another sponsor study.|0|||
160650564|NCT03312530|580102497|FG002|Overall Study|Participant in another sponsor study.|0|||
160650565|NCT03312530|580102498|FG003|Overall Study|Participant in another sponsor study.|1|||
160650566|NCT03312530|580102499|FG004|Overall Study|Participant in another sponsor study.|0|||
160650567|NCT03312530|580102495|FG000|Overall Study|Study terminated by sponsor|1|||
160650568|NCT03312530|580102496|FG001|Overall Study|Study terminated by sponsor|0|||
160650569|NCT03312530|580102497|FG002|Overall Study|Study terminated by sponsor|2|||
160650570|NCT03312530|580102498|FG003|Overall Study|Study terminated by sponsor|3|||
160650571|NCT03312530|580102499|FG004|Overall Study|Study terminated by sponsor|7|||
160650572|NCT03312530|580102495|FG000|Overall Study|Withdrawal by Subject|0|||
160650573|NCT03312530|580102496|FG001|Overall Study|Withdrawal by Subject|1|||
160650574|NCT03312530|580102497|FG002|Overall Study|Withdrawal by Subject|0|||
160650575|NCT03312530|580102498|FG003|Overall Study|Withdrawal by Subject|0|||
160650576|NCT03312530|580102499|FG004|Overall Study|Withdrawal by Subject|0|||
160650577|NCT03312530|580102495|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
160650578|NCT03312530|580102496|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
160650579|NCT03312530|580102497|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
160650580|NCT03312530|580102498|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
160650581|NCT03312530|580102499|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
160650582|NCT03093324|580102500|FG000|Overall Study|Adverse Event|4|||
160650583|NCT03093324|580102501|FG001|Overall Study|Adverse Event|15|||
160650584|NCT03093324|580102500|FG000|Overall Study|Lost to Follow-up|1|||
160650585|NCT03093324|580102501|FG001|Overall Study|Lost to Follow-up|0|||
160650586|NCT03093324|580102500|FG000|Overall Study|Protocol Deviation|2|||
160650587|NCT03093324|580102501|FG001|Overall Study|Protocol Deviation|2|||
160650588|NCT03093324|580102500|FG000|Overall Study|Withdrawal by Subject|2|||
160650589|NCT03093324|580102501|FG001|Overall Study|Withdrawal by Subject|2|||
160650590|NCT05342753|580102502|FG000|Overall Study|Withdrawal by Subject|6|||
160650591|NCT05342753|580102502|FG000|Overall Study|Lost to Follow-up|1|||
160650592|NCT00614055|580102505|FG000|Overall Study|Adverse Event|1|||
160650593|NCT00614055|580102506|FG001|Overall Study|Adverse Event|0|||
160650594|NCT00614055|580102507|FG002|Overall Study|Adverse Event|0|||
160650595|NCT00614055|580102505|FG000|Overall Study|Protocol Violation|2|||
160650596|NCT00614055|580102506|FG001|Overall Study|Protocol Violation|2|||
160650597|NCT00614055|580102507|FG002|Overall Study|Protocol Violation|1|||
160851606|NCT02711137|580846281|FG007|Overall Study|Physician Decision|2|||
160650598|NCT00614055|580102505|FG000|Overall Study|Lack of Efficacy|0|||
160650599|NCT00614055|580102506|FG001|Overall Study|Lack of Efficacy|0|||
160650600|NCT00614055|580102507|FG002|Overall Study|Lack of Efficacy|2|||
160650601|NCT00614055|580102505|FG000|Overall Study|Unclassified|1|||
160650602|NCT00614055|580102506|FG001|Overall Study|Unclassified|4|||
160851607|NCT02711137|580846282|FG008|Overall Study|Physician Decision|1|||
160851608|NCT02711137|580846283|FG009|Overall Study|Physician Decision|1|||
160851609|NCT02711137|580846284|FG010|Overall Study|Physician Decision|3|||
160906804|NCT00923156|581052303|FG001|Overall Study|Lack of Efficacy|0|||
160906805|NCT00923156|581052304|FG002|Overall Study|Lack of Efficacy|1|||
160650603|NCT00614055|580102507|FG002|Overall Study|Unclassified|2|||
160851610|NCT02711137|580846285|FG011|Overall Study|Physician Decision|2|||
160851611|NCT02711137|580846286|FG012|Overall Study|Physician Decision|1|||
160851612|NCT02711137|580846287|FG013|Overall Study|Physician Decision|1|||
160851613|NCT02711137|580846288|FG014|Overall Study|Physician Decision|2|||
160851614|NCT02711137|580846274|FG000|Overall Study|Other|0|||
160851615|NCT02711137|580846275|FG001|Overall Study|Other|1|||
160851616|NCT02711137|580846276|FG002|Overall Study|Other|0|||
160851617|NCT02711137|580846277|FG003|Overall Study|Other|0|||
160851618|NCT02711137|580846278|FG004|Overall Study|Other|0|||
160851619|NCT02711137|580846279|FG005|Overall Study|Other|0|||
160851620|NCT02711137|580846280|FG006|Overall Study|Other|3|||
160851621|NCT02711137|580846281|FG007|Overall Study|Other|0|||
160851622|NCT02711137|580846282|FG008|Overall Study|Other|0|||
160851623|NCT02711137|580846283|FG009|Overall Study|Other|0|||
160851624|NCT02711137|580846284|FG010|Overall Study|Other|0|||
160851625|NCT02711137|580846285|FG011|Overall Study|Other|0|||
160851626|NCT02711137|580846286|FG012|Overall Study|Other|0|||
160851627|NCT02711137|580846287|FG013|Overall Study|Other|0|||
160851628|NCT02711137|580846288|FG014|Overall Study|Other|1|||
160851629|NCT02711137|580846274|FG000|Overall Study|Withdrawal by Subject|1|||
160851630|NCT02711137|580846275|FG001|Overall Study|Withdrawal by Subject|0|||
160851631|NCT02711137|580846276|FG002|Overall Study|Withdrawal by Subject|0|||
160851632|NCT02711137|580846277|FG003|Overall Study|Withdrawal by Subject|1|||
160851633|NCT02711137|580846278|FG004|Overall Study|Withdrawal by Subject|1|||
160851634|NCT02711137|580846279|FG005|Overall Study|Withdrawal by Subject|0|||
160851635|NCT02711137|580846280|FG006|Overall Study|Withdrawal by Subject|7|||
160851636|NCT02711137|580846281|FG007|Overall Study|Withdrawal by Subject|0|||
160851637|NCT02711137|580846282|FG008|Overall Study|Withdrawal by Subject|0|||
160851638|NCT02711137|580846283|FG009|Overall Study|Withdrawal by Subject|0|||
160851639|NCT02711137|580846284|FG010|Overall Study|Withdrawal by Subject|0|||
160851640|NCT02711137|580846285|FG011|Overall Study|Withdrawal by Subject|0|||
160851641|NCT02711137|580846286|FG012|Overall Study|Withdrawal by Subject|0|||
160851642|NCT02711137|580846287|FG013|Overall Study|Withdrawal by Subject|1|||
160851643|NCT02711137|580846288|FG014|Overall Study|Withdrawal by Subject|0|||
160650604|NCT04583579|580102510|FG000|Overall Study|Lost to Follow-up|4|||
160650605|NCT02006706|580102512|FG000|Overall Study|Lost to Follow-up|1|||
160650606|NCT05590585|580102513|FG000|Overall Study|Lost to Follow-up|3|||
160650607|NCT05590585|580102513|FG000|Overall Study|Withdrawal by Subject|1|||
160650608|NCT01673009|580102514|FG000|Overall Study|Physician Decision|5|||
160650609|NCT01673009|580102514|FG000|Overall Study|Withdrawal by Subject|8|||
160650610|NCT04161144|580102515|FG000|Overall Study|Withdrawal by Subject|0|||
160650611|NCT04161144|580102516|FG001|Overall Study|Withdrawal by Subject|1|||
160650612|NCT04161144|580102515|FG000|Overall Study|Protocol Violation|1|||
160650613|NCT04161144|580102516|FG001|Overall Study|Protocol Violation|0|||
160650614|NCT04700449|580102520|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
160650615|NCT04700449|580102521|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
160650616|NCT04700449|580102522|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
160650617|NCT04700449|580102523|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
160650618|NCT04700449|580102520|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
160851644|NCT02711137|580846274|FG000|Overall Study|Lost to Follow-up|1|||
160851645|NCT02711137|580846275|FG001|Overall Study|Lost to Follow-up|0|||
160906806|NCT01201850|581052307|FG000|Overall Study|Tumor progression|4|||
160906807|NCT03137537|581052308|FG000|Overall Study|Adverse Event|0|||
160906808|NCT03137537|581052309|FG001|Overall Study|Adverse Event|1|||
160906809|NCT01552694|581052310|FG000|Overall Study|Lost to Follow-up|0|||
160906810|NCT01552694|581052311|FG001|Overall Study|Lost to Follow-up|1|||
160906811|NCT01552694|581052310|FG000|Overall Study|Protocol Violation|0|||
160906812|NCT01552694|581052311|FG001|Overall Study|Protocol Violation|1|||
160906813|NCT00191139|581052312|FG000|Overall Study|Adverse Event|2|||
160906814|NCT00191139|581052313|FG001|Overall Study|Adverse Event|6|||
160906815|NCT00191139|581052312|FG000|Overall Study|Death|2|||
160906816|NCT00191139|581052313|FG001|Overall Study|Death|0|||
160992510|NCT03999554|581361389|FG004|Overall Study|Protocol Violation|0|||
160650619|NCT04700449|580102521|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
160650620|NCT04700449|580102522|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
160650621|NCT04700449|580102523|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
160650622|NCT04700449|580102520|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
160851646|NCT02711137|580846276|FG002|Overall Study|Lost to Follow-up|0|||
160851647|NCT02711137|580846277|FG003|Overall Study|Lost to Follow-up|0|||
160851648|NCT02711137|580846278|FG004|Overall Study|Lost to Follow-up|0|||
160851649|NCT02711137|580846279|FG005|Overall Study|Lost to Follow-up|0|||
160851650|NCT02711137|580846280|FG006|Overall Study|Lost to Follow-up|2|||
160851651|NCT02711137|580846281|FG007|Overall Study|Lost to Follow-up|0|||
160851652|NCT02711137|580846282|FG008|Overall Study|Lost to Follow-up|0|||
160851653|NCT02711137|580846283|FG009|Overall Study|Lost to Follow-up|0|||
160851654|NCT02711137|580846284|FG010|Overall Study|Lost to Follow-up|0|||
160851655|NCT02711137|580846285|FG011|Overall Study|Lost to Follow-up|0|||
160851656|NCT02711137|580846286|FG012|Overall Study|Lost to Follow-up|0|||
160851657|NCT02711137|580846287|FG013|Overall Study|Lost to Follow-up|0|||
160906817|NCT00191139|581052312|FG000|Overall Study|Withdrawal by Subject|0|||
160851658|NCT02711137|580846288|FG014|Overall Study|Lost to Follow-up|0|||
160851659|NCT01285401|580846289|FG000|Overall Study|Prematurely withdrawn from the study|17|||
160851660|NCT01285401|580846290|FG001|Overall Study|Prematurely withdrawn from the study|29|||
160851661|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
160851662|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
160851663|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Death|1|||
160851664|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Death|2|||
160851665|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
160851666|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
160851667|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
160851668|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
160851669|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
160851670|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
160851671|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
160851672|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
160851673|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
160851674|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
160851675|NCT01794000|580846297|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
160851676|NCT01794000|580846298|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
160851677|NCT00796666|580846299|FG000|Overall Study|Death|2|||
160851678|NCT00796666|580846300|FG001|Overall Study|Death|4|||
160851679|NCT00796666|580846299|FG000|Overall Study|Withdrawal by Subject|2|||
160851680|NCT00796666|580846300|FG001|Overall Study|Withdrawal by Subject|0|||
160851681|NCT00796666|580846299|FG000|Overall Study|Adverse Event|7|||
160851682|NCT00796666|580846300|FG001|Overall Study|Adverse Event|5|||
160851683|NCT00796666|580846299|FG000|Overall Study|Protocol Violation|1|||
160851684|NCT00796666|580846300|FG001|Overall Study|Protocol Violation|0|||
160851685|NCT00796666|580846299|FG000|Overall Study|Other|1|||
160851686|NCT00796666|580846300|FG001|Overall Study|Other|0|||
160851687|NCT00796666|580846299|FG000|Overall Study|Terminated by sponsor|53|||
160851688|NCT00796666|580846300|FG001|Overall Study|Terminated by sponsor|55|||
160851689|NCT00796666|580846299|FG000|Overall Study|Randomized and not treated|1|||
160851690|NCT00796666|580846300|FG001|Overall Study|Randomized and not treated|0|||
160851691|NCT01367834|580846301|FG000|Overall Study|Withdrawal by Subject|2|||
160851692|NCT01367834|580846302|FG001|Overall Study|Withdrawal by Subject|2|||
160851693|NCT01367834|580846301|FG000|Overall Study|Study was ended.|0|||
160851694|NCT01367834|580846302|FG001|Overall Study|Study was ended.|1|||
160851695|NCT00255190|580846303|FG000|Overall Study|Adverse Event|17|||
160851696|NCT00255190|580846304|FG001|Overall Study|Adverse Event|36|||
160851697|NCT00255190|580846303|FG000|Overall Study|Protocol Violation|2|||
160851698|NCT00255190|580846304|FG001|Overall Study|Protocol Violation|2|||
160851699|NCT00255190|580846303|FG000|Overall Study|Lost to Follow-up|10|||
160851700|NCT00255190|580846304|FG001|Overall Study|Lost to Follow-up|27|||
160851701|NCT00255190|580846303|FG000|Overall Study|Withdrew Consent|17|||
160851702|NCT00255190|580846304|FG001|Overall Study|Withdrew Consent|48|||
160851703|NCT00255190|580846303|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
160851704|NCT00255190|580846304|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
160851705|NCT00255190|580846303|FG000|Overall Study|Erosive esophagitis not healed|0|||
160851706|NCT00255190|580846304|FG001|Overall Study|Erosive esophagitis not healed|20|||
160851707|NCT00255190|580846303|FG000|Overall Study|Various|4|||
160851708|NCT00255190|580846304|FG001|Overall Study|Various|23|||
160851709|NCT00628030|580846305|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
160851710|NCT00628030|580846306|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
160851711|NCT00628030|580846305|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
160851712|NCT00628030|580846306|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
160851713|NCT00628030|580846305|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
160851714|NCT00628030|580846306|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
160851715|NCT01156480|580846307|FG000|Overall Study|change in diagnosis|0|||
160851716|NCT01156480|580846308|FG001|Overall Study|change in diagnosis|1|||
160851717|NCT04537793|580846309|FG000|Part B (24 Weeks)|Adverse Event|0|||
160851718|NCT04537793|580846310|FG001|Part B (24 Weeks)|Adverse Event|1|||
160851719|NCT05470387|580846311|FG000|Overall Study|Protocol Violation|0|||
160851720|NCT05470387|580846312|FG001|Overall Study|Protocol Violation|3|||
160851721|NCT01255423|580846313|FG000|Overall Study|Abnormal Laboratory value|3|||
160851722|NCT01255423|580846314|FG001|Overall Study|Abnormal Laboratory value|2|||
160851723|NCT01255423|580846313|FG000|Overall Study|Use of prohibited medications|0|||
160851724|NCT01255423|580846314|FG001|Overall Study|Use of prohibited medications|1|||
160851725|NCT00988598|580846315|FG000|Overall Study|Withdrawal by Subject|2|||
160851726|NCT00988598|580846316|FG001|Overall Study|Withdrawal by Subject|0|||
160851727|NCT03367858|580846317|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
160851728|NCT03367858|580846318|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
160851729|NCT03367858|580846317|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
160851730|NCT03367858|580846318|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
160851731|NCT03367858|580846317|FG000|3 Month Follow Up|Lost to Follow-up|8|||
160851732|NCT03367858|580846318|FG001|3 Month Follow Up|Lost to Follow-up|3|||
160851733|NCT03367858|580846317|FG000|3 Month Follow Up|Moved out of study area|2|||
160851734|NCT03367858|580846318|FG001|3 Month Follow Up|Moved out of study area|6|||
160851735|NCT03367858|580846317|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
160851736|NCT03367858|580846318|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
160650623|NCT04700449|580102521|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
160650624|NCT04700449|580102522|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
160650625|NCT04700449|580102523|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
160650626|NCT04700449|580102520|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
160650627|NCT04700449|580102521|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
160650628|NCT04700449|580102522|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
160650629|NCT04700449|580102523|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
160650630|NCT04700449|580102520|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
160650631|NCT04700449|580102521|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
160851737|NCT03367858|580846317|FG000|3 Month Follow Up|MRI contraindication|2|||
160851738|NCT03367858|580846318|FG001|3 Month Follow Up|MRI contraindication|1|||
160851739|NCT03367858|580846317|FG000|3 Month Follow Up|Incarcerated|0|||
160851740|NCT03367858|580846318|FG001|3 Month Follow Up|Incarcerated|1|||
160851741|NCT03367858|580846317|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
160851742|NCT03367858|580846318|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
160851743|NCT03367858|580846317|FG000|6 Month Follow Up|Lost to Follow-up|5|||
160851744|NCT03367858|580846318|FG001|6 Month Follow Up|Lost to Follow-up|2|||
160851745|NCT03367858|580846317|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
160851746|NCT03367858|580846318|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
160851747|NCT03367858|580846317|FG000|12 Month Follow Up|Lost to Follow-up|3|||
160851748|NCT03367858|580846318|FG001|12 Month Follow Up|Lost to Follow-up|3|||
160650632|NCT04700449|580102522|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
160650633|NCT04700449|580102523|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
160650634|NCT04700449|580102520|FG000|Stage 1: Double-Blind Period|Other|0|||
160650635|NCT04700449|580102521|FG001|Stage 1: Double-Blind Period|Other|0|||
160650636|NCT04700449|580102522|FG002|Stage 1: Double-Blind Period|Other|1|||
160650637|NCT04700449|580102523|FG003|Stage 1: Double-Blind Period|Other|0|||
160650638|NCT04700449|580102520|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
160650639|NCT04700449|580102521|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
160650640|NCT04700449|580102522|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
160650641|NCT04700449|580102523|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
160650642|NCT04700449|580102520|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
160650643|NCT04700449|580102521|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
160650644|NCT04700449|580102522|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
160650645|NCT04700449|580102523|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
160650646|NCT04700449|580102520|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
160650647|NCT04700449|580102521|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
160650648|NCT04700449|580102522|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
160650649|NCT04700449|580102523|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
160650650|NCT04700449|580102520|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
160650651|NCT04700449|580102521|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
160650652|NCT04700449|580102522|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
160851749|NCT03367858|580846317|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
160851750|NCT03367858|580846318|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
160851751|NCT00057863|580846341|FG000|Overall Study|Death|1|||
160650653|NCT04700449|580102523|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
160650654|NCT04700449|580102520|FG000|Stage 2 Sub-study 1|Other|1|||
160851752|NCT00057863|580846341|FG000|Overall Study|Withdrawal by Subject|2|||
160851753|NCT02079038|580846343|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
160851754|NCT02079038|580846344|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
160851755|NCT02079038|580846343|FG000|Modified Intent to Treat Population|Death|1|||
160851756|NCT02079038|580846344|FG001|Modified Intent to Treat Population|Death|0|||
160851757|NCT02079038|580846343|FG000|Completed 6 Months|Lost to Follow-up|2|||
160851758|NCT02079038|580846344|FG001|Completed 6 Months|Lost to Follow-up|1|||
160851759|NCT03480152|580846345|FG000|Phase I|Signed consent. Died before treatment.|1|||
160906818|NCT00191139|581052313|FG001|Overall Study|Withdrawal by Subject|3|||
160906819|NCT00191139|581052312|FG000|Overall Study|Disease Progression|0|||
160906820|NCT00191139|581052313|FG001|Overall Study|Disease Progression|1|||
160906821|NCT00191139|581052312|FG000|Overall Study|Other|1|||
160650655|NCT04700449|580102521|FG001|Stage 2 Sub-study 1|Other|2|||
160650656|NCT04700449|580102522|FG002|Stage 2 Sub-study 1|Other|0|||
160650657|NCT04700449|580102523|FG003|Stage 2 Sub-study 1|Other|0|||
160650658|NCT04700449|580102520|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
160851760|NCT03480152|580846346|FG001|Phase I|Signed consent. Died before treatment.|0|||
160851761|NCT03480152|580846347|FG002|Phase I|Signed consent. Died before treatment.|0|||
160650659|NCT04700449|580102521|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
160650660|NCT04700449|580102522|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
160650661|NCT04700449|580102523|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
160851762|NCT04276233|580846348|FG000|Overall Study|Adverse Event|1|||
160851763|NCT04276233|580846348|FG000|Overall Study|Lost to Follow-up|3|||
160851764|NCT04276233|580846348|FG000|Overall Study|Physician Decision|4|||
160851765|NCT04276233|580846348|FG000|Overall Study|Withdrawal by Subject|2|||
160851766|NCT01946139|580846349|FG000|Overall Study|Withdrawal by Subject|8|||
160851767|NCT01946139|580846349|FG000|Overall Study|ineligible|8|||
160851768|NCT01946139|580846349|FG000|Overall Study|Specimens not available|4|||
160851769|NCT00101686|580846356|FG000|Overall Study|Progressive Disease|37|||
160851770|NCT00101686|580846357|FG001|Overall Study|Progressive Disease|28|||
160851771|NCT00101686|580846358|FG002|Overall Study|Progressive Disease|37|||
160851772|NCT00101686|580846359|FG003|Overall Study|Progressive Disease|38|||
160851773|NCT00101686|580846360|FG004|Overall Study|Progressive Disease|28|||
160851774|NCT00101686|580846361|FG005|Overall Study|Progressive Disease|25|||
160851775|NCT00101686|580846362|FG006|Overall Study|Progressive Disease|5|||
160851776|NCT00101686|580846363|FG007|Overall Study|Progressive Disease|7|||
160851777|NCT00101686|580846364|FG008|Overall Study|Progressive Disease|10|||
160851778|NCT00101686|580846365|FG009|Overall Study|Progressive Disease|8|||
160851779|NCT00101686|580846356|FG000|Overall Study|initiation other anti-cancer treatment|4|||
160851780|NCT00101686|580846357|FG001|Overall Study|initiation other anti-cancer treatment|3|||
160851781|NCT00101686|580846358|FG002|Overall Study|initiation other anti-cancer treatment|4|||
160851782|NCT00101686|580846359|FG003|Overall Study|initiation other anti-cancer treatment|3|||
160851783|NCT00101686|580846360|FG004|Overall Study|initiation other anti-cancer treatment|1|||
160851784|NCT00101686|580846361|FG005|Overall Study|initiation other anti-cancer treatment|1|||
160851785|NCT00101686|580846362|FG006|Overall Study|initiation other anti-cancer treatment|2|||
160851786|NCT00101686|580846363|FG007|Overall Study|initiation other anti-cancer treatment|2|||
160851787|NCT00101686|580846364|FG008|Overall Study|initiation other anti-cancer treatment|3|||
160851788|NCT00101686|580846365|FG009|Overall Study|initiation other anti-cancer treatment|3|||
160851789|NCT00101686|580846356|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
160851790|NCT00101686|580846357|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
160851791|NCT00101686|580846358|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
160851792|NCT00101686|580846359|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
160851793|NCT00101686|580846360|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
160851794|NCT00101686|580846361|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
160851795|NCT00101686|580846362|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
160851796|NCT00101686|580846363|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
160851797|NCT00101686|580846364|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
160851798|NCT00101686|580846365|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
160851799|NCT00101686|580846356|FG000|Overall Study|unacceptable toxicity|3|||
160851800|NCT00101686|580846357|FG001|Overall Study|unacceptable toxicity|9|||
160851801|NCT00101686|580846358|FG002|Overall Study|unacceptable toxicity|10|||
160851802|NCT00101686|580846359|FG003|Overall Study|unacceptable toxicity|6|||
160851803|NCT00101686|580846360|FG004|Overall Study|unacceptable toxicity|16|||
160851804|NCT00101686|580846361|FG005|Overall Study|unacceptable toxicity|10|||
160851805|NCT00101686|580846362|FG006|Overall Study|unacceptable toxicity|4|||
160851806|NCT00101686|580846363|FG007|Overall Study|unacceptable toxicity|2|||
160851807|NCT00101686|580846364|FG008|Overall Study|unacceptable toxicity|1|||
160851808|NCT00101686|580846365|FG009|Overall Study|unacceptable toxicity|4|||
160851809|NCT00101686|580846356|FG000|Overall Study|Randomized but did not receive treament|1|||
160851810|NCT00101686|580846357|FG001|Overall Study|Randomized but did not receive treament|6|||
160851811|NCT00101686|580846358|FG002|Overall Study|Randomized but did not receive treament|2|||
160851812|NCT00101686|580846359|FG003|Overall Study|Randomized but did not receive treament|2|||
160851813|NCT00101686|580846360|FG004|Overall Study|Randomized but did not receive treament|2|||
160851814|NCT00101686|580846361|FG005|Overall Study|Randomized but did not receive treament|2|||
160851815|NCT00101686|580846362|FG006|Overall Study|Randomized but did not receive treament|0|||
160851816|NCT00101686|580846363|FG007|Overall Study|Randomized but did not receive treament|1|||
160851817|NCT00101686|580846364|FG008|Overall Study|Randomized but did not receive treament|0|||
160851818|NCT00101686|580846365|FG009|Overall Study|Randomized but did not receive treament|1|||
160851819|NCT00101686|580846356|FG000|Overall Study|intercurrent non-cancer related illness|0|||
160851820|NCT00101686|580846357|FG001|Overall Study|intercurrent non-cancer related illness|0|||
160851821|NCT00101686|580846358|FG002|Overall Study|intercurrent non-cancer related illness|2|||
160650662|NCT04700449|580102520|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
160650663|NCT04700449|580102521|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
160650664|NCT04700449|580102522|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
160650665|NCT04700449|580102523|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
160851822|NCT00101686|580846359|FG003|Overall Study|intercurrent non-cancer related illness|0|||
160851823|NCT00101686|580846360|FG004|Overall Study|intercurrent non-cancer related illness|1|||
160851824|NCT00101686|580846361|FG005|Overall Study|intercurrent non-cancer related illness|3|||
160851825|NCT00101686|580846362|FG006|Overall Study|intercurrent non-cancer related illness|1|||
160851826|NCT00101686|580846363|FG007|Overall Study|intercurrent non-cancer related illness|0|||
160851827|NCT00101686|580846364|FG008|Overall Study|intercurrent non-cancer related illness|1|||
160851828|NCT00101686|580846365|FG009|Overall Study|intercurrent non-cancer related illness|1|||
160851829|NCT00101686|580846356|FG000|Overall Study|Physician Decision|10|||
160851830|NCT00101686|580846357|FG001|Overall Study|Physician Decision|13|||
160851831|NCT00101686|580846358|FG002|Overall Study|Physician Decision|6|||
160851832|NCT00101686|580846359|FG003|Overall Study|Physician Decision|7|||
160851833|NCT00101686|580846360|FG004|Overall Study|Physician Decision|8|||
160851834|NCT00101686|580846361|FG005|Overall Study|Physician Decision|9|||
160851835|NCT00101686|580846362|FG006|Overall Study|Physician Decision|5|||
160851836|NCT00101686|580846363|FG007|Overall Study|Physician Decision|5|||
160851837|NCT00101686|580846364|FG008|Overall Study|Physician Decision|1|||
160851838|NCT00101686|580846365|FG009|Overall Study|Physician Decision|1|||
160851839|NCT00101686|580846356|FG000|Overall Study|Other|1|||
160851840|NCT00101686|580846357|FG001|Overall Study|Other|4|||
160851841|NCT00101686|580846358|FG002|Overall Study|Other|1|||
160851842|NCT00101686|580846359|FG003|Overall Study|Other|6|||
160851843|NCT00101686|580846360|FG004|Overall Study|Other|2|||
160851844|NCT00101686|580846361|FG005|Overall Study|Other|12|||
160851845|NCT00101686|580846362|FG006|Overall Study|Other|1|||
160851846|NCT00101686|580846363|FG007|Overall Study|Other|5|||
160851847|NCT00101686|580846364|FG008|Overall Study|Other|3|||
160851848|NCT00101686|580846365|FG009|Overall Study|Other|3|||
160851849|NCT00101686|580846356|FG000|Overall Study|Withdrawal by Subject|9|||
160851850|NCT00101686|580846357|FG001|Overall Study|Withdrawal by Subject|8|||
160851851|NCT00101686|580846358|FG002|Overall Study|Withdrawal by Subject|6|||
160851852|NCT00101686|580846359|FG003|Overall Study|Withdrawal by Subject|8|||
160851853|NCT00101686|580846360|FG004|Overall Study|Withdrawal by Subject|8|||
160851854|NCT00101686|580846361|FG005|Overall Study|Withdrawal by Subject|7|||
160851855|NCT00101686|580846362|FG006|Overall Study|Withdrawal by Subject|7|||
160851856|NCT00101686|580846363|FG007|Overall Study|Withdrawal by Subject|7|||
160851857|NCT00101686|580846364|FG008|Overall Study|Withdrawal by Subject|8|||
160851858|NCT00101686|580846365|FG009|Overall Study|Withdrawal by Subject|9|||
160851859|NCT00296816|580846366|FG000|Overall Study|Disease Progression|37|||
160851860|NCT00296816|580846366|FG000|Overall Study|Adverse Event|18|||
160851861|NCT00296816|580846366|FG000|Overall Study|Investigator/Participant request|5|||
160851862|NCT00296816|580846366|FG000|Overall Study|Non-compliance|1|||
160851863|NCT00296816|580846366|FG000|Overall Study|Missing for end of treatment|4|||
160851864|NCT00296816|580846366|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
160851865|NCT00296816|580846366|FG000|Overall Study|Poor performance status|1|||
160851866|NCT00296816|580846366|FG000|Overall Study|Relocation to Florida|1|||
160851867|NCT00296816|580846366|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
160851868|NCT00296816|580846366|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
160851869|NCT00296816|580846366|FG000|Overall Study|Neuropathy/patient preference|1|||
160851870|NCT00296816|580846366|FG000|Overall Study|Proteinuria|1|||
160851871|NCT00296816|580846366|FG000|Overall Study|ineligibility due to radiation treatment|1|||
160851872|NCT00985465|580846367|FG000|Overall Study|Withdrawal by Subject|1|||
160851873|NCT00985465|580846368|FG001|Overall Study|Withdrawal by Subject|2|||
160851874|NCT00985465|580846367|FG000|Overall Study|Considered to be part of the other group|0|||
160851875|NCT00985465|580846368|FG001|Overall Study|Considered to be part of the other group|1|||
160851876|NCT01454596|580846373|FG000|Overall Study|Death|0|||
160851877|NCT01454596|580846374|FG001|Overall Study|Death|0|||
160851878|NCT01454596|580846375|FG002|Overall Study|Death|0|||
160851879|NCT01454596|580846376|FG003|Overall Study|Death|0|||
160851880|NCT01454596|580846377|FG004|Overall Study|Death|0|||
160851881|NCT01454596|580846378|FG005|Overall Study|Death|0|||
160851882|NCT01454596|580846379|FG006|Overall Study|Death|0|||
160851883|NCT01454596|580846380|FG007|Overall Study|Death|0|||
160851884|NCT01454596|580846381|FG008|Overall Study|Death|0|||
160851885|NCT01454596|580846382|FG009|Overall Study|Death|1|||
160851886|NCT01454596|580846383|FG010|Overall Study|Death|1|||
160851887|NCT01454596|580846384|FG011|Overall Study|Death|0|||
160851888|NCT02800863|580846390|FG000|Overall Study|Adverse Event|14|||
160851889|NCT02800863|580846390|FG000|Overall Study|Another Device Implanted|1|||
160906822|NCT00191139|581052313|FG001|Overall Study|Other|2|||
160906823|NCT02465515|581052316|FG000|Overall Study|Investigator site closed|4|||
160906824|NCT02465515|581052317|FG001|Overall Study|Investigator site closed|5|||
160906825|NCT02465515|581052316|FG000|Overall Study|Withdrawal by Subject|74|||
160906826|NCT02465515|581052317|FG001|Overall Study|Withdrawal by Subject|43|||
160906827|NCT02465515|581052316|FG000|Overall Study|Physician Decision|8|||
160906828|NCT02465515|581052317|FG001|Overall Study|Physician Decision|12|||
160906829|NCT02465515|581052316|FG000|Overall Study|Lost to Follow-up|68|||
160851890|NCT02800863|580846390|FG000|Overall Study|Device Explanted|1|||
160906830|NCT02465515|581052317|FG001|Overall Study|Lost to Follow-up|51|||
160906831|NCT00816595|581052318|FG000|Overall Study|Withdrawal by Subject|2|||
160906832|NCT00816595|581052319|FG001|Overall Study|Withdrawal by Subject|0|||
160851891|NCT02800863|580846390|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
160851892|NCT02800863|580846390|FG000|Overall Study|Health Issues|1|||
160851893|NCT02800863|580846390|FG000|Overall Study|Insurance Denial|8|||
160851894|NCT02800863|580846390|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
160851895|NCT02800863|580846390|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
160851896|NCT02800863|580846390|FG000|Overall Study|Screen Failure|1|||
160851897|NCT02800863|580846390|FG000|Overall Study|Sponsor Request|6|||
160851898|NCT02800863|580846390|FG000|Overall Study|Death|3|||
160851899|NCT02800863|580846390|FG000|Overall Study|Subject Implant at Another Facility|1|||
160851900|NCT02800863|580846390|FG000|Overall Study|Lost to Follow-up|26|||
160851901|NCT02800863|580846390|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
160851902|NCT02800863|580846390|FG000|Overall Study|Subject and/or Family Request|64|||
160851903|NCT02800863|580846390|FG000|Overall Study|Trial Failure|81|||
160851904|NCT02800863|580846390|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
160851905|NCT00717249|580846391|FG000|Overall Study|Lens Discomfort|4|||
160851906|NCT00717249|580846392|FG001|Overall Study|Lens Discomfort|1|||
160851907|NCT00717249|580846391|FG000|Overall Study|Unsatisfactory visual Response|0|||
160851908|NCT00717249|580846392|FG001|Overall Study|Unsatisfactory visual Response|2|||
160851909|NCT00717249|580846391|FG000|Overall Study|Adverse Event|4|||
160851910|NCT00717249|580846392|FG001|Overall Study|Adverse Event|2|||
160851911|NCT00717249|580846391|FG000|Overall Study|Lost to Follow-up|2|||
160851912|NCT00717249|580846392|FG001|Overall Study|Lost to Follow-up|0|||
160851913|NCT00717249|580846391|FG000|Overall Study|Withdrawal by Subject|1|||
160851914|NCT00717249|580846392|FG001|Overall Study|Withdrawal by Subject|2|||
160851915|NCT00717249|580846391|FG000|Overall Study|Pregnancy|6|||
160851916|NCT00717249|580846392|FG001|Overall Study|Pregnancy|3|||
160851917|NCT00717249|580846391|FG000|Overall Study|Protocol Violation|0|||
160851918|NCT00717249|580846392|FG001|Overall Study|Protocol Violation|2|||
160851919|NCT00717249|580846391|FG000|Overall Study|Subject became Ineligible|1|||
160851920|NCT00717249|580846392|FG001|Overall Study|Subject became Ineligible|1|||
160851921|NCT00717249|580846391|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
160851922|NCT00717249|580846392|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
160851923|NCT00717249|580846391|FG000|Overall Study|Gastric Surgery|0|||
160851924|NCT00717249|580846392|FG001|Overall Study|Gastric Surgery|1|||
160851925|NCT00717249|580846391|FG000|Overall Study|Diagnosed with Diabetes|1|||
160851926|NCT00717249|580846392|FG001|Overall Study|Diagnosed with Diabetes|0|||
160851927|NCT00717249|580846391|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
160851928|NCT00717249|580846392|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
160851929|NCT00717249|580846391|FG000|Overall Study|Subject relocated|1|||
160851930|NCT00717249|580846392|FG001|Overall Study|Subject relocated|0|||
160851931|NCT00717249|580846391|FG000|Overall Study|Headaches|1|||
160851932|NCT00717249|580846392|FG001|Overall Study|Headaches|0|||
160851933|NCT01808196|580846396|FG000|Overall Study|Lost to Follow-up|1|||
160851934|NCT03370718|580846397|FG000|Overall Study|Withdrawal by Subject|1|||
160851935|NCT01670721|580846398|FG000|Overall Study|Participant's decision|15|||
160851936|NCT01670721|580846398|FG000|Overall Study|Other than specified above|38|||
160851937|NCT00479713|580846401|FG000|Overall Study|Adverse Event|8|||
160851938|NCT00479713|580846402|FG001|Overall Study|Adverse Event|6|||
160851939|NCT00479713|580846401|FG000|Overall Study|Death|1|||
160851940|NCT00479713|580846402|FG001|Overall Study|Death|0|||
160851941|NCT00479713|580846401|FG000|Overall Study|Lost to Follow-up|0|||
160851942|NCT00479713|580846402|FG001|Overall Study|Lost to Follow-up|1|||
160851943|NCT00479713|580846401|FG000|Overall Study|Protocol Violation|0|||
160851944|NCT00479713|580846402|FG001|Overall Study|Protocol Violation|1|||
160851945|NCT00479713|580846401|FG000|Overall Study|Withdrawal by Subject|4|||
160851946|NCT00479713|580846402|FG001|Overall Study|Withdrawal by Subject|1|||
160851947|NCT00141102|580846405|FG000|Overall Study|Adverse Event|233|||
160851948|NCT00141102|580846406|FG001|Overall Study|Adverse Event|305|||
160851949|NCT00141102|580846405|FG000|Overall Study|Laboratory Abnormality|9|||
160851950|NCT00141102|580846406|FG001|Overall Study|Laboratory Abnormality|33|||
160851951|NCT00141102|580846405|FG000|Overall Study|Lack of Efficacy|21|||
160851952|NCT00141102|580846406|FG001|Overall Study|Lack of Efficacy|26|||
160851953|NCT00141102|580846405|FG000|Overall Study|Lost to Follow-up|29|||
160851954|NCT00141102|580846406|FG001|Overall Study|Lost to Follow-up|32|||
160851955|NCT00141102|580846405|FG000|Overall Study|Other|87|||
160851956|NCT00141102|580846406|FG001|Overall Study|Other|76|||
160851957|NCT00141102|580846405|FG000|Overall Study|Withdrawal by Subject|112|||
160851958|NCT00141102|580846406|FG001|Overall Study|Withdrawal by Subject|142|||
160650666|NCT04700449|580102520|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
160851959|NCT00141102|580846405|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
160851960|NCT00141102|580846406|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
160851961|NCT00141102|580846405|FG000|Overall Study|Death|2|||
160851962|NCT00141102|580846406|FG001|Overall Study|Death|2|||
160851963|NCT05477485|580846407|FG000|Overall Study|Lost to Follow-up|0|||
160851964|NCT05477485|580846408|FG001|Overall Study|Lost to Follow-up|4|||
160851965|NCT03061201|580846409|FG000|Overall Study|Participants Terminated at Month 36|0|||
160906833|NCT00481078|581052323|FG000|Overall Study|Progression of disease|11|||
160906834|NCT00481078|581052324|FG001|Overall Study|Progression of disease|11|||
160906835|NCT00481078|581052323|FG000|Overall Study|Adverse Event|15|||
160851966|NCT03061201|580846410|FG001|Overall Study|Participants Terminated at Month 36|1|||
160851967|NCT03061201|580846411|FG002|Overall Study|Participants Terminated at Month 36|0|||
160851968|NCT03061201|580846412|FG003|Overall Study|Participants Terminated at Month 36|1|||
160851969|NCT03061201|580846409|FG000|Overall Study|Lost to Follow-up|1|||
160851970|NCT03061201|580846410|FG001|Overall Study|Lost to Follow-up|0|||
160851971|NCT03061201|580846411|FG002|Overall Study|Lost to Follow-up|0|||
160851972|NCT03061201|580846412|FG003|Overall Study|Lost to Follow-up|0|||
160851973|NCT01572480|580846413|FG000|Participants Enrolled|Withdrawal by Subject|1|||
160851974|NCT01572480|580846413|FG000|Drug Administration|Discontinued drug/Off Study|1|||
160851975|NCT01572480|580846413|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
160851976|NCT01572480|580846413|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
160851977|NCT05081219|580846414|FG000|Overall Study|Withdrawal by Subject|4|||
160851978|NCT05081219|580846415|FG001|Overall Study|Withdrawal by Subject|0|||
160851979|NCT05081219|580846416|FG002|Overall Study|Withdrawal by Subject|0|||
160851980|NCT05081219|580846417|FG003|Overall Study|Withdrawal by Subject|1|||
160851981|NCT03446313|580846418|FG000|Overall Study|Lost to Follow-up|1|||
160851982|NCT03446313|580846419|FG001|Overall Study|Lost to Follow-up|2|||
160851983|NCT03446313|580846418|FG000|Overall Study|Failed primary screening|3|||
160851984|NCT03446313|580846419|FG001|Overall Study|Failed primary screening|0|||
160851985|NCT03446313|580846418|FG000|Overall Study|Diagnosed with terminal cancer|1|||
160851986|NCT03446313|580846419|FG001|Overall Study|Diagnosed with terminal cancer|0|||
160851987|NCT03446313|580846418|FG000|Overall Study|Excluded from analysis|1|||
160851988|NCT03446313|580846419|FG001|Overall Study|Excluded from analysis|1|||
160851989|NCT05274958|580846420|FG000|Overall Study|Only completed 1 set of PROMs|22|||
160851990|NCT05274958|580846421|FG001|Overall Study|Only completed 1 set of PROMs|35|||
160851991|NCT00866814|580846422|FG000|Overall Study|Lost to Follow-up|12|||
160851992|NCT00866814|580846422|FG000|Overall Study|Adverse Event|2|||
160851993|NCT00866814|580846422|FG000|Overall Study|Physician Decision|1|||
160851994|NCT00866814|580846422|FG000|Overall Study|Death|1|||
160851995|NCT00866814|580846422|FG000|Overall Study|No longer wished to participate|1|||
160851996|NCT00866814|580846422|FG000|Overall Study|Unable to meet follow-up requirements|2|||
160851997|NCT00866814|580846422|FG000|Overall Study|Moved to area without study site|1|||
160851998|NCT02679287|580846427|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
160851999|NCT02679287|580846428|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
160852000|NCT02679287|580846427|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
160852001|NCT02679287|580846428|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
160852002|NCT02679287|580846427|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
160852003|NCT02679287|580846428|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
160852004|NCT02679287|580846427|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
160852005|NCT02679287|580846428|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
160852006|NCT02679287|580846427|FG000|Period 2|Work/Scheduling Conflict|1|||
160852007|NCT02679287|580846428|FG001|Period 2|Work/Scheduling Conflict|0|||
160852008|NCT02679287|580846427|FG000|Period 2|Disliked Mobile System|2|||
160852009|NCT02679287|580846428|FG001|Period 2|Disliked Mobile System|0|||
160852010|NCT02679287|580846427|FG000|Period 3|Work/Scheduling Conflict|0|||
160852011|NCT02679287|580846428|FG001|Period 3|Work/Scheduling Conflict|1|||
160852012|NCT01790594|580848683|FG000|Overall Study|Death|1|||
160852013|NCT01790594|580848684|FG001|Overall Study|Death|0|||
160852014|NCT01790594|580848685|FG002|Overall Study|Death|0|||
160852015|NCT01790594|580848683|FG000|Overall Study|Physician Decision|2|||
160852016|NCT01790594|580848684|FG001|Overall Study|Physician Decision|1|||
160852017|NCT01790594|580848685|FG002|Overall Study|Physician Decision|0|||
160852018|NCT01790594|580848683|FG000|Overall Study|Withdrawal by Subject|2|||
160852019|NCT01790594|580848684|FG001|Overall Study|Withdrawal by Subject|0|||
160852020|NCT01790594|580848685|FG002|Overall Study|Withdrawal by Subject|0|||
160852021|NCT01790594|580848683|FG000|Overall Study|Transplant was not done|0|||
160852022|NCT01790594|580848684|FG001|Overall Study|Transplant was not done|0|||
160852023|NCT01790594|580848685|FG002|Overall Study|Transplant was not done|3|||
160852024|NCT01790594|580848683|FG000|Overall Study|Terminated prior to week 76|0|||
160852025|NCT01790594|580848684|FG001|Overall Study|Terminated prior to week 76|2|||
160852026|NCT01790594|580848685|FG002|Overall Study|Terminated prior to week 76|0|||
160852027|NCT03956550|580848686|FG000|Overall Study|Sponsor decision|65|||
160852028|NCT03956550|580848687|FG001|Overall Study|Sponsor decision|66|||
160852029|NCT03956550|580848688|FG002|Overall Study|Sponsor decision|64|||
160852030|NCT03956550|580848686|FG000|Overall Study|Adverse Event|0|||
160852031|NCT03956550|580848687|FG001|Overall Study|Adverse Event|1|||
160852032|NCT03956550|580848688|FG002|Overall Study|Adverse Event|0|||
160852033|NCT03956550|580848686|FG000|Overall Study|Withdrawal by Subject|5|||
160852034|NCT03956550|580848687|FG001|Overall Study|Withdrawal by Subject|5|||
160852035|NCT03956550|580848688|FG002|Overall Study|Withdrawal by Subject|6|||
160852036|NCT03400852|580848689|FG000|Blinded Treatment Period|Physician Decision|0|||
160852037|NCT03400852|580848690|FG001|Blinded Treatment Period|Physician Decision|1|||
160852038|NCT03400852|580848691|FG002|Blinded Treatment Period|Physician Decision|0|||
160852039|NCT03400852|580848689|FG000|Blinded Treatment Period|Adverse Event|1|||
160852040|NCT03400852|580848690|FG001|Blinded Treatment Period|Adverse Event|1|||
160852041|NCT03400852|580848691|FG002|Blinded Treatment Period|Adverse Event|0|||
160852042|NCT03400852|580848689|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
160852043|NCT03400852|580848690|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
160906836|NCT00481078|581052324|FG001|Overall Study|Adverse Event|3|||
160852044|NCT03400852|580848691|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
160852045|NCT03400852|580848689|FG000|Open Label Period|Physician Decision|0|||
160852046|NCT03400852|580848690|FG001|Open Label Period|Physician Decision|0|||
160852047|NCT03400852|580848691|FG002|Open Label Period|Physician Decision|1|||
160852048|NCT03400852|580848689|FG000|Open Label Period|Study terminated by sponsor|0|||
160852049|NCT03400852|580848690|FG001|Open Label Period|Study terminated by sponsor|0|||
160852050|NCT03400852|580848691|FG002|Open Label Period|Study terminated by sponsor|21|||
160852051|NCT00248495|580848692|FG000|Overall Study|Withdrawal by Subject|1|||
160852052|NCT03719131|580848694|FG000|Overall Study|Death|1|||
160852053|NCT03719131|580848695|FG001|Overall Study|Death|2|||
160852054|NCT04244253|580848696|FG000|Overall Study|Adverse Event|2|||
160852055|NCT04244253|580848697|FG001|Overall Study|Adverse Event|2|||
160852056|NCT04244253|580848698|FG002|Overall Study|Adverse Event|4|||
160852057|NCT04244253|580848696|FG000|Overall Study|Protocol Violation|1|||
160852058|NCT04244253|580848697|FG001|Overall Study|Protocol Violation|2|||
160852059|NCT04244253|580848698|FG002|Overall Study|Protocol Violation|1|||
160852060|NCT04244253|580848696|FG000|Overall Study|Withdrawal by Subject|0|||
160852061|NCT04244253|580848697|FG001|Overall Study|Withdrawal by Subject|1|||
160852062|NCT04244253|580848698|FG002|Overall Study|Withdrawal by Subject|6|||
160852063|NCT04244253|580848696|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160852064|NCT04244253|580848697|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160852065|NCT04244253|580848698|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160852066|NCT01544920|580848699|FG000|Overall Study|Adverse Event|0|||
160852067|NCT01544920|580848700|FG001|Overall Study|Adverse Event|3|||
160852068|NCT01544920|580848699|FG000|Overall Study|Death|0|||
160852069|NCT01544920|580848700|FG001|Overall Study|Death|1|||
160852070|NCT01544920|580848699|FG000|Overall Study|Lost to Follow-up|11|||
160852071|NCT01544920|580848700|FG001|Overall Study|Lost to Follow-up|12|||
160852072|NCT01544920|580848699|FG000|Overall Study|Protocol Violation|0|||
160852073|NCT01544920|580848700|FG001|Overall Study|Protocol Violation|2|||
160852074|NCT01544920|580848699|FG000|Overall Study|Physician Decision|4|||
160852075|NCT01544920|580848700|FG001|Overall Study|Physician Decision|1|||
160852076|NCT01544920|580848699|FG000|Overall Study|Withdrawal by Subject|4|||
160852077|NCT01544920|580848700|FG001|Overall Study|Withdrawal by Subject|4|||
160852078|NCT02420093|580848701|FG000|Overall Study|Withdrawal by Subject|1|||
160852079|NCT02420093|580848702|FG001|Overall Study|Withdrawal by Subject|1|||
160852080|NCT03244917|580848706|FG000|Overall Study|Lost to Follow-up|2|||
160852081|NCT03244917|580848707|FG001|Overall Study|Lost to Follow-up|2|||
160650667|NCT04700449|580102521|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
160650668|NCT04700449|580102522|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
160650669|NCT04700449|580102523|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
160650670|NCT04700449|580102520|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
160650671|NCT04700449|580102521|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
160650672|NCT04700449|580102522|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
160650673|NCT04700449|580102523|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
160650674|NCT04700449|580102520|FG000|Stage 2 Sub-study 2|Other|0|||
160650675|NCT04700449|580102521|FG001|Stage 2 Sub-study 2|Other|0|||
160650676|NCT04700449|580102522|FG002|Stage 2 Sub-study 2|Other|0|||
160650677|NCT04700449|580102523|FG003|Stage 2 Sub-study 2|Other|5|||
160650678|NCT00356200|580102524|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
160650679|NCT00356200|580102525|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
160650680|NCT00356200|580102524|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
160650681|NCT00356200|580102525|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
160650682|NCT02909673|580102526|FG000|Overall Study|Did not meet inclusion criteria|129|||
160650683|NCT02909673|580102527|FG001|Overall Study|Did not meet inclusion criteria|29|||
160852082|NCT03001557|580848709|FG000|Core Phase|Randomized but not treated|0|||
160852083|NCT03001557|580848710|FG001|Core Phase|Randomized but not treated|0|||
160852084|NCT03001557|580848711|FG002|Core Phase|Randomized but not treated|1|||
160852085|NCT03001557|580848712|FG003|Core Phase|Randomized but not treated|0|||
160852086|NCT03001557|580848713|FG004|Core Phase|Randomized but not treated|0|||
160852087|NCT03001557|580848714|FG005|Core Phase|Randomized but not treated|0|||
160852088|NCT03001557|580848715|FG006|Core Phase|Randomized but not treated|0|||
160852089|NCT03001557|580848716|FG007|Core Phase|Randomized but not treated|0|||
160852090|NCT03001557|580848709|FG000|Extension Phase|Adverse Event|0|||
160852091|NCT03001557|580848710|FG001|Extension Phase|Adverse Event|0|||
160650684|NCT02909673|580102526|FG000|Overall Study|Surveys lost by scanner|95|||
160650685|NCT02909673|580102527|FG001|Overall Study|Surveys lost by scanner|2|||
160650686|NCT02909673|580102526|FG000|Overall Study|Tracking info missing|0|||
160650687|NCT02909673|580102527|FG001|Overall Study|Tracking info missing|5|||
160852092|NCT03001557|580848711|FG002|Extension Phase|Adverse Event|0|||
160852093|NCT03001557|580848712|FG003|Extension Phase|Adverse Event|0|||
160852094|NCT03001557|580848713|FG004|Extension Phase|Adverse Event|0|||
160852095|NCT03001557|580848714|FG005|Extension Phase|Adverse Event|2|||
160852096|NCT03001557|580848715|FG006|Extension Phase|Adverse Event|0|||
160852097|NCT03001557|580848716|FG007|Extension Phase|Adverse Event|0|||
160852098|NCT03001557|580848709|FG000|Extension Phase|Withdrawal by Subject|0|||
160852099|NCT03001557|580848710|FG001|Extension Phase|Withdrawal by Subject|0|||
160852100|NCT03001557|580848711|FG002|Extension Phase|Withdrawal by Subject|0|||
160852101|NCT03001557|580848712|FG003|Extension Phase|Withdrawal by Subject|0|||
160852102|NCT03001557|580848713|FG004|Extension Phase|Withdrawal by Subject|0|||
160852103|NCT03001557|580848714|FG005|Extension Phase|Withdrawal by Subject|1|||
160852104|NCT03001557|580848715|FG006|Extension Phase|Withdrawal by Subject|5|||
160852105|NCT03001557|580848716|FG007|Extension Phase|Withdrawal by Subject|2|||
160852106|NCT03001557|580848709|FG000|Extension Phase|Lost to Follow-up|0|||
160852107|NCT03001557|580848710|FG001|Extension Phase|Lost to Follow-up|0|||
160852108|NCT03001557|580848711|FG002|Extension Phase|Lost to Follow-up|0|||
160852109|NCT03001557|580848712|FG003|Extension Phase|Lost to Follow-up|0|||
160852110|NCT03001557|580848713|FG004|Extension Phase|Lost to Follow-up|0|||
160852111|NCT03001557|580848714|FG005|Extension Phase|Lost to Follow-up|0|||
160852112|NCT03001557|580848715|FG006|Extension Phase|Lost to Follow-up|2|||
160852113|NCT03001557|580848716|FG007|Extension Phase|Lost to Follow-up|1|||
160852114|NCT03001557|580848709|FG000|Extension Phase|Administrative Reason|0|||
160852115|NCT03001557|580848710|FG001|Extension Phase|Administrative Reason|0|||
160852116|NCT03001557|580848711|FG002|Extension Phase|Administrative Reason|0|||
160852117|NCT03001557|580848712|FG003|Extension Phase|Administrative Reason|0|||
160852118|NCT03001557|580848713|FG004|Extension Phase|Administrative Reason|0|||
160852119|NCT03001557|580848714|FG005|Extension Phase|Administrative Reason|1|||
160852120|NCT03001557|580848715|FG006|Extension Phase|Administrative Reason|3|||
160852121|NCT03001557|580848716|FG007|Extension Phase|Administrative Reason|3|||
160852122|NCT03001557|580848709|FG000|Extension Phase|Loss of caregiver|0|||
160852123|NCT03001557|580848710|FG001|Extension Phase|Loss of caregiver|0|||
160852124|NCT03001557|580848711|FG002|Extension Phase|Loss of caregiver|0|||
160852125|NCT03001557|580848712|FG003|Extension Phase|Loss of caregiver|0|||
160852126|NCT03001557|580848713|FG004|Extension Phase|Loss of caregiver|0|||
160852127|NCT03001557|580848714|FG005|Extension Phase|Loss of caregiver|0|||
160852128|NCT03001557|580848715|FG006|Extension Phase|Loss of caregiver|1|||
160852129|NCT03001557|580848716|FG007|Extension Phase|Loss of caregiver|0|||
160852130|NCT03001557|580848709|FG000|Extension Phase|Others|0|||
160852131|NCT03001557|580848710|FG001|Extension Phase|Others|0|||
160852132|NCT03001557|580848711|FG002|Extension Phase|Others|0|||
160852133|NCT03001557|580848712|FG003|Extension Phase|Others|0|||
160852134|NCT03001557|580848713|FG004|Extension Phase|Others|0|||
160852135|NCT03001557|580848714|FG005|Extension Phase|Others|1|||
160852136|NCT03001557|580848715|FG006|Extension Phase|Others|3|||
160852137|NCT03001557|580848716|FG007|Extension Phase|Others|0|||
160852138|NCT01272232|580848717|FG000|Weeks 0-56|Adverse Event|39|||
160852139|NCT01272232|580848718|FG001|Weeks 0-56|Adverse Event|18|||
160852140|NCT01272232|580848719|FG002|Weeks 0-56|Adverse Event|7|||
160852141|NCT01272232|580848717|FG000|Weeks 0-56|Lack of Efficacy|0|||
160852142|NCT01272232|580848718|FG001|Weeks 0-56|Lack of Efficacy|0|||
160852143|NCT01272232|580848719|FG002|Weeks 0-56|Lack of Efficacy|3|||
160852144|NCT01272232|580848717|FG000|Weeks 0-56|Protocol Violation|12|||
160852145|NCT01272232|580848718|FG001|Weeks 0-56|Protocol Violation|8|||
160852146|NCT01272232|580848719|FG002|Weeks 0-56|Protocol Violation|13|||
160852147|NCT01272232|580848717|FG000|Weeks 0-56|Withdrawal criteria|32|||
160852148|NCT01272232|580848718|FG001|Weeks 0-56|Withdrawal criteria|14|||
160852149|NCT01272232|580848719|FG002|Weeks 0-56|Withdrawal criteria|37|||
160852150|NCT01272232|580848717|FG000|Weeks 0-56|Unclassified|16|||
160852151|NCT01272232|580848718|FG001|Weeks 0-56|Unclassified|7|||
160852152|NCT01272232|580848719|FG002|Weeks 0-56|Unclassified|12|||
160852153|NCT01272232|580848717|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
160852154|NCT01272232|580848718|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
160852155|NCT01272232|580848719|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
160852156|NCT01272232|580848717|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
160852157|NCT01272232|580848718|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
160852158|NCT01272232|580848719|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
160852159|NCT01272232|580848717|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
160852160|NCT01272232|580848718|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
160852161|NCT01272232|580848719|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
160852162|NCT01272232|580848717|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
160852163|NCT01272232|580848718|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
160852164|NCT01272232|580848719|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
160992511|NCT03999554|581361385|FG000|Overall Study|Pregnancy|0|||
160852165|NCT01272232|580848717|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
160852166|NCT01272232|580848718|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
160852167|NCT01272232|580848719|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
160852168|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
160852169|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
160852170|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
160852171|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852172|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852173|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852174|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852175|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852176|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852177|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852178|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852179|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852180|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
160852181|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852182|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852183|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852184|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
160852185|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852186|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852187|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
160852188|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
160852189|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
160852190|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
160852191|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852192|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
160852193|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852194|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852195|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
160852196|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852197|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
160852198|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
160852199|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
160852200|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
160852201|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
160852202|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
160852203|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
160852204|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
160852205|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
160852206|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
160852207|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
160852208|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
160852209|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
160852210|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
160852211|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
160852212|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
160852213|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
160852214|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852215|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852216|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
160852217|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852218|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852219|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852220|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852221|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852222|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852223|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
160852224|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852225|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852226|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852227|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852228|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852229|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852230|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852231|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852232|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852233|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852234|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852235|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852236|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852237|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852238|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852239|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852240|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852241|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852242|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852243|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852244|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852245|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852246|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
160852247|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852248|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852249|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852250|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852251|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852252|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852253|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
160852254|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852255|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852256|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852257|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852258|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852259|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852260|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852261|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852262|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852263|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852264|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852265|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852266|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852267|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852268|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852269|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
160852270|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
160852271|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852272|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
160852273|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
160650688|NCT02540356|580102528|FG000|Overall Study|Terminated due to disease progression|1|||
160650689|NCT02540356|580102529|FG001|Overall Study|Terminated due to disease progression|0|||
160650690|NCT03500484|580102530|FG000|Overall Study|Adverse Event|2|||
160650691|NCT03500484|580102531|FG001|Overall Study|Adverse Event|0|||
160650692|NCT03500484|580102530|FG000|Overall Study|Physician Decision|1|||
160650693|NCT03500484|580102531|FG001|Overall Study|Physician Decision|0|||
160650694|NCT03500484|580102530|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
160650695|NCT03500484|580102531|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
160650696|NCT00998881|580102534|FG000|Overall Study|Adverse Event|2|||
160650697|NCT00998881|580102535|FG001|Overall Study|Adverse Event|2|||
160650698|NCT00998881|580102534|FG000|Overall Study|Lack of Efficacy|1|||
160852274|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
160852275|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
160852276|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
160852277|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
160852278|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
160852279|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
160852280|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
160852281|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
160906837|NCT00481078|581052323|FG000|Overall Study|Death|5|||
160906838|NCT00481078|581052324|FG001|Overall Study|Death|3|||
160906839|NCT00481078|581052323|FG000|Overall Study|Intercurrent illness|1|||
160906840|NCT00481078|581052324|FG001|Overall Study|Intercurrent illness|0|||
160906841|NCT00481078|581052323|FG000|Overall Study|Withdrawal by Subject|7|||
160906842|NCT00481078|581052324|FG001|Overall Study|Withdrawal by Subject|1|||
160906843|NCT00481078|581052323|FG000|Overall Study|Information not available|1|||
160906844|NCT00481078|581052324|FG001|Overall Study|Information not available|0|||
160906845|NCT00481078|581052323|FG000|Overall Study|Received other treatment|2|||
160906846|NCT00481078|581052324|FG001|Overall Study|Received other treatment|1|||
160906847|NCT00481078|581052323|FG000|Overall Study|Brain metastasis|0|||
160906848|NCT00481078|581052324|FG001|Overall Study|Brain metastasis|1|||
160906849|NCT00228384|581052325|FG000|Overall Study|Death|9|||
160906850|NCT00228384|581052326|FG001|Overall Study|Death|3|||
160650699|NCT00998881|580102535|FG001|Overall Study|Lack of Efficacy|0|||
160650700|NCT00998881|580102534|FG000|Overall Study|Physician Decision|3|||
160650701|NCT00998881|580102535|FG001|Overall Study|Physician Decision|0|||
160650702|NCT00998881|580102534|FG000|Overall Study|Withdrawal by Subject|1|||
160906851|NCT00228384|581052325|FG000|Overall Study|Lost to Follow-up|6|||
160906852|NCT00228384|581052326|FG001|Overall Study|Lost to Follow-up|10|||
160992512|NCT03999554|581361386|FG001|Overall Study|Pregnancy|0|||
160852282|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
160852283|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
160852284|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
160852285|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
160852286|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
160852287|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
160852288|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852289|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852290|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852291|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852292|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
160852293|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
160852294|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
160852295|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
160852296|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852297|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
160852298|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852299|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852300|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
160852301|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852302|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
160852303|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852304|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852305|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852306|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
160852307|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852308|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852309|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852310|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852311|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852312|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852313|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852314|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852315|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852316|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852317|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852318|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852319|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852320|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852321|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852322|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
160852323|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
160852324|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852325|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
160852326|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852327|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
160852328|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852329|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852330|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852331|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
160852332|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852333|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852334|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852335|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852336|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
160852337|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852338|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852339|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852340|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852341|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852342|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160650703|NCT00998881|580102535|FG001|Overall Study|Withdrawal by Subject|0|||
160650704|NCT00998881|580102534|FG000|Overall Study|Personal matter|1|||
160650705|NCT00998881|580102535|FG001|Overall Study|Personal matter|0|||
160650706|NCT02649231|580102538|FG000|Overall Study|Adverse Event|0|||
160650707|NCT02649231|580102539|FG001|Overall Study|Adverse Event|0|||
160852343|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
160852344|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852345|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852346|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852347|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852348|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852349|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852350|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852351|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852352|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852353|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852354|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852355|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852356|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852357|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852358|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852359|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852360|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
160852361|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852362|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852363|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852364|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852365|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852366|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852367|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852368|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852369|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852370|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852371|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852372|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852373|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852374|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852375|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
160852376|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852377|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
160852378|NCT02159066|580848735|FG000|Part I|Adverse Event|7|||
160852379|NCT02159066|580848736|FG001|Part I|Adverse Event|5|||
160852380|NCT02159066|580848737|FG002|Part I|Adverse Event|0|||
160852381|NCT02159066|580848738|FG003|Part I|Adverse Event|0|||
160852382|NCT02159066|580848739|FG004|Part I|Adverse Event|0|||
160852383|NCT02159066|580848740|FG005|Part I|Adverse Event|0|||
160852384|NCT02159066|580848735|FG000|Part I|Death|11|||
160852385|NCT02159066|580848736|FG001|Part I|Death|9|||
160852386|NCT02159066|580848737|FG002|Part I|Death|0|||
160852387|NCT02159066|580848738|FG003|Part I|Death|0|||
160852388|NCT02159066|580848739|FG004|Part I|Death|0|||
160852389|NCT02159066|580848740|FG005|Part I|Death|0|||
160852390|NCT02159066|580848735|FG000|Part I|Progressive Disease|37|||
160852391|NCT02159066|580848736|FG001|Part I|Progressive Disease|46|||
160852392|NCT02159066|580848737|FG002|Part I|Progressive Disease|0|||
160852393|NCT02159066|580848738|FG003|Part I|Progressive Disease|0|||
160852394|NCT02159066|580848739|FG004|Part I|Progressive Disease|0|||
160852395|NCT02159066|580848740|FG005|Part I|Progressive Disease|0|||
160852396|NCT02159066|580848735|FG000|Part I|New Therapy for Study Indication|5|||
160852397|NCT02159066|580848736|FG001|Part I|New Therapy for Study Indication|4|||
160852398|NCT02159066|580848737|FG002|Part I|New Therapy for Study Indication|0|||
160852399|NCT02159066|580848738|FG003|Part I|New Therapy for Study Indication|0|||
160852400|NCT02159066|580848739|FG004|Part I|New Therapy for Study Indication|0|||
160852401|NCT02159066|580848740|FG005|Part I|New Therapy for Study Indication|0|||
160852402|NCT02159066|580848735|FG000|Part I|Termination of participants from the study|3|||
160852403|NCT02159066|580848736|FG001|Part I|Termination of participants from the study|3|||
160852404|NCT02159066|580848737|FG002|Part I|Termination of participants from the study|0|||
160852405|NCT02159066|580848738|FG003|Part I|Termination of participants from the study|0|||
160852406|NCT02159066|580848739|FG004|Part I|Termination of participants from the study|0|||
160852407|NCT02159066|580848740|FG005|Part I|Termination of participants from the study|0|||
160852408|NCT02159066|580848735|FG000|Part I|Physician Decision|2|||
160852409|NCT02159066|580848736|FG001|Part I|Physician Decision|9|||
160852410|NCT02159066|580848737|FG002|Part I|Physician Decision|0|||
160569099|NCT04430348|579806940|FG003|Overall Study|Withdrawal by Subject|0|||
160569100|NCT04430348|579806941|FG004|Overall Study|Withdrawal by Subject|0|||
160852411|NCT02159066|580848738|FG003|Part I|Physician Decision|0|||
160852412|NCT02159066|580848739|FG004|Part I|Physician Decision|0|||
160852413|NCT02159066|580848740|FG005|Part I|Physician Decision|0|||
160852414|NCT02159066|580848735|FG000|Part I|Participant/Guardian Decision|9|||
160852415|NCT02159066|580848736|FG001|Part I|Participant/Guardian Decision|3|||
160852416|NCT02159066|580848737|FG002|Part I|Participant/Guardian Decision|0|||
160852417|NCT02159066|580848738|FG003|Part I|Participant/Guardian Decision|0|||
160852418|NCT02159066|580848739|FG004|Part I|Participant/Guardian Decision|0|||
160852419|NCT02159066|580848740|FG005|Part I|Participant/Guardian Decision|0|||
160852420|NCT02159066|580848735|FG000|Part I|Missing Data|1|||
160852421|NCT02159066|580848736|FG001|Part I|Missing Data|0|||
160852422|NCT02159066|580848737|FG002|Part I|Missing Data|0|||
160852423|NCT02159066|580848738|FG003|Part I|Missing Data|0|||
160852424|NCT02159066|580848739|FG004|Part I|Missing Data|0|||
160852425|NCT02159066|580848740|FG005|Part I|Missing Data|0|||
160852426|NCT02159066|580848735|FG000|Part II|Adverse Event|0|||
160852427|NCT02159066|580848736|FG001|Part II|Adverse Event|0|||
160852428|NCT02159066|580848737|FG002|Part II|Adverse Event|1|||
160852429|NCT02159066|580848738|FG003|Part II|Adverse Event|0|||
160852430|NCT02159066|580848739|FG004|Part II|Adverse Event|1|||
160852431|NCT02159066|580848740|FG005|Part II|Adverse Event|1|||
160852432|NCT02159066|580848735|FG000|Part II|Death|0|||
160852433|NCT02159066|580848736|FG001|Part II|Death|0|||
160852434|NCT02159066|580848737|FG002|Part II|Death|1|||
160852435|NCT02159066|580848738|FG003|Part II|Death|0|||
160852436|NCT02159066|580848739|FG004|Part II|Death|2|||
160852437|NCT02159066|580848740|FG005|Part II|Death|1|||
160852438|NCT02159066|580848735|FG000|Part II|Progressive Disease|0|||
160852439|NCT02159066|580848736|FG001|Part II|Progressive Disease|0|||
160852440|NCT02159066|580848737|FG002|Part II|Progressive Disease|35|||
160852441|NCT02159066|580848738|FG003|Part II|Progressive Disease|1|||
160852442|NCT02159066|580848739|FG004|Part II|Progressive Disease|7|||
160852443|NCT02159066|580848740|FG005|Part II|Progressive Disease|4|||
160852444|NCT02159066|580848735|FG000|Part II|New Therapy for Study Indication|0|||
160852445|NCT02159066|580848736|FG001|Part II|New Therapy for Study Indication|0|||
160852446|NCT02159066|580848737|FG002|Part II|New Therapy for Study Indication|0|||
160852447|NCT02159066|580848738|FG003|Part II|New Therapy for Study Indication|0|||
160852448|NCT02159066|580848739|FG004|Part II|New Therapy for Study Indication|1|||
160852449|NCT02159066|580848740|FG005|Part II|New Therapy for Study Indication|0|||
160852450|NCT02159066|580848735|FG000|Part II|Physician Decision|0|||
160852451|NCT02159066|580848736|FG001|Part II|Physician Decision|0|||
160852452|NCT02159066|580848737|FG002|Part II|Physician Decision|1|||
160852453|NCT02159066|580848738|FG003|Part II|Physician Decision|0|||
160852454|NCT02159066|580848739|FG004|Part II|Physician Decision|0|||
160852455|NCT02159066|580848740|FG005|Part II|Physician Decision|0|||
160852456|NCT02159066|580848735|FG000|Part II|Participant/Guardian Decision|0|||
160852457|NCT02159066|580848736|FG001|Part II|Participant/Guardian Decision|0|||
160852458|NCT02159066|580848737|FG002|Part II|Participant/Guardian Decision|0|||
160852459|NCT02159066|580848738|FG003|Part II|Participant/Guardian Decision|0|||
160852460|NCT02159066|580848739|FG004|Part II|Participant/Guardian Decision|2|||
160852461|NCT02159066|580848740|FG005|Part II|Participant/Guardian Decision|0|||
160852462|NCT02748863|580848741|FG000|Treatment Period 1|Adverse Event|0|||
160852463|NCT02748863|580848742|FG001|Treatment Period 1|Adverse Event|1|||
160852464|NCT02748863|580848743|FG002|Treatment Period 1|Adverse Event|0|||
160852465|NCT02748863|580848744|FG003|Treatment Period 1|Adverse Event|0|||
160852466|NCT02748863|580848745|FG004|Treatment Period 1|Adverse Event|0|||
160852467|NCT02748863|580848741|FG000|Treatment Period 1|Lack of Efficacy|0|||
160852468|NCT02748863|580848742|FG001|Treatment Period 1|Lack of Efficacy|0|||
160852469|NCT02748863|580848743|FG002|Treatment Period 1|Lack of Efficacy|1|||
160852470|NCT02748863|580848744|FG003|Treatment Period 1|Lack of Efficacy|0|||
160852471|NCT02748863|580848745|FG004|Treatment Period 1|Lack of Efficacy|0|||
160852472|NCT02748863|580848741|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160852473|NCT02748863|580848742|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160852474|NCT02748863|580848743|FG002|Treatment Period 1|Withdrawal by Subject|1|||
160852475|NCT02748863|580848744|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160852476|NCT02748863|580848745|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160852477|NCT02748863|580848741|FG000|Treatment Period 2|Lost to Follow-up|2|||
160852478|NCT02748863|580848742|FG001|Treatment Period 2|Lost to Follow-up|0|||
160852479|NCT02748863|580848743|FG002|Treatment Period 2|Lost to Follow-up|0|||
160852480|NCT02748863|580848744|FG003|Treatment Period 2|Lost to Follow-up|0|||
160852481|NCT02748863|580848745|FG004|Treatment Period 2|Lost to Follow-up|0|||
160852482|NCT02748863|580848741|FG000|Treatment Period 2|Adverse Event|3|||
160852483|NCT02748863|580848742|FG001|Treatment Period 2|Adverse Event|2|||
160852484|NCT02748863|580848743|FG002|Treatment Period 2|Adverse Event|0|||
160852485|NCT02748863|580848744|FG003|Treatment Period 2|Adverse Event|2|||
160852486|NCT02748863|580848745|FG004|Treatment Period 2|Adverse Event|0|||
160852487|NCT02748863|580848741|FG000|Treatment Period 2|Lack of Efficacy|0|||
160852488|NCT02748863|580848742|FG001|Treatment Period 2|Lack of Efficacy|1|||
160852489|NCT02748863|580848743|FG002|Treatment Period 2|Lack of Efficacy|0|||
160852490|NCT02748863|580848744|FG003|Treatment Period 2|Lack of Efficacy|0|||
160852491|NCT02748863|580848745|FG004|Treatment Period 2|Lack of Efficacy|0|||
160852492|NCT02748863|580848741|FG000|Treatment Period 2|Pregnancy|0|||
160852493|NCT02748863|580848742|FG001|Treatment Period 2|Pregnancy|0|||
160852494|NCT02748863|580848743|FG002|Treatment Period 2|Pregnancy|0|||
160852495|NCT02748863|580848744|FG003|Treatment Period 2|Pregnancy|0|||
160852496|NCT02748863|580848745|FG004|Treatment Period 2|Pregnancy|1|||
160852497|NCT01135134|580848747|FG000|Overall Study|Adverse Event|1|||
160852498|NCT01135134|580848748|FG001|Overall Study|Adverse Event|1|||
160852499|NCT01135134|580848747|FG000|Overall Study|Did not meet protocol eligibility|1|||
160852500|NCT01135134|580848748|FG001|Overall Study|Did not meet protocol eligibility|0|||
160852501|NCT02576639|580848749|FG000|Overall Study|Withdrawal by Subject|1|||
160852502|NCT02576639|580848750|FG001|Overall Study|Withdrawal by Subject|2|||
160852503|NCT02576639|580848751|FG002|Overall Study|Withdrawal by Subject|1|||
160852504|NCT02576639|580848752|FG003|Overall Study|Withdrawal by Subject|0|||
160852505|NCT02576639|580848753|FG004|Overall Study|Withdrawal by Subject|1|||
160852506|NCT02576639|580848749|FG000|Overall Study|Adverse Event|1|||
160852507|NCT02576639|580848750|FG001|Overall Study|Adverse Event|0|||
160852508|NCT02576639|580848751|FG002|Overall Study|Adverse Event|1|||
160852509|NCT02576639|580848752|FG003|Overall Study|Adverse Event|1|||
160852510|NCT02576639|580848753|FG004|Overall Study|Adverse Event|2|||
160852511|NCT02576639|580848749|FG000|Overall Study|Physician Decision|0|||
160852512|NCT02576639|580848750|FG001|Overall Study|Physician Decision|0|||
160852513|NCT02576639|580848751|FG002|Overall Study|Physician Decision|0|||
160852514|NCT02576639|580848752|FG003|Overall Study|Physician Decision|0|||
160852515|NCT02576639|580848753|FG004|Overall Study|Physician Decision|1|||
160852516|NCT01329978|580848759|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
160852517|NCT01329978|580848760|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
160852518|NCT01329978|580848761|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
160852519|NCT01329978|580848762|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
160852520|NCT01329978|580848763|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
160852521|NCT01329978|580848759|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
160852522|NCT01329978|580848760|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
160852523|NCT01329978|580848761|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
160852524|NCT01329978|580848762|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
160852525|NCT01329978|580848763|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
160852526|NCT01329978|580848759|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
160852527|NCT01329978|580848760|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
160852528|NCT01329978|580848761|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
160852529|NCT01329978|580848762|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
160852530|NCT01329978|580848763|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
160852531|NCT01329978|580848759|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
160852532|NCT01329978|580848760|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
160852533|NCT01329978|580848761|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
160852534|NCT01329978|580848762|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
160852535|NCT01329978|580848763|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
160852536|NCT01329978|580848759|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
160852537|NCT01329978|580848760|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
160852538|NCT01329978|580848761|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
160852539|NCT01329978|580848762|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
160852540|NCT01329978|580848763|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
160852541|NCT01329978|580848759|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
160852542|NCT01329978|580848760|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
160852543|NCT01329978|580848761|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
160852544|NCT01329978|580848762|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
160852545|NCT01329978|580848763|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
160852546|NCT01329978|580848759|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
160852547|NCT01329978|580848760|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
160852548|NCT01329978|580848761|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
160852549|NCT01329978|580848762|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
160852550|NCT01329978|580848763|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
160852551|NCT01188772|580848767|FG000|Overall Study|Randomized but Not Treated|0|||
160852552|NCT01188772|580848768|FG001|Overall Study|Randomized but Not Treated|1|||
160852553|NCT01188772|580848769|FG002|Overall Study|Randomized but Not Treated|0|||
160852554|NCT01188772|580848770|FG003|Overall Study|Randomized but Not Treated|0|||
160852555|NCT01188772|580848767|FG000|Overall Study|Adverse Event|0|||
160852556|NCT01188772|580848768|FG001|Overall Study|Adverse Event|1|||
160852557|NCT01188772|580848769|FG002|Overall Study|Adverse Event|2|||
160852558|NCT01188772|580848770|FG003|Overall Study|Adverse Event|0|||
160852559|NCT01188772|580848767|FG000|Overall Study|Lost to Follow-up|4|||
160852560|NCT01188772|580848768|FG001|Overall Study|Lost to Follow-up|1|||
160852561|NCT01188772|580848769|FG002|Overall Study|Lost to Follow-up|1|||
160852562|NCT01188772|580848770|FG003|Overall Study|Lost to Follow-up|1|||
160852563|NCT01188772|580848767|FG000|Overall Study|Non-responder|0|||
160852564|NCT01188772|580848768|FG001|Overall Study|Non-responder|0|||
160852565|NCT01188772|580848769|FG002|Overall Study|Non-responder|3|||
160852566|NCT01188772|580848770|FG003|Overall Study|Non-responder|0|||
160852567|NCT01188772|580848767|FG000|Overall Study|Physician Decision|0|||
160852568|NCT01188772|580848768|FG001|Overall Study|Physician Decision|0|||
160852569|NCT01188772|580848769|FG002|Overall Study|Physician Decision|1|||
160852570|NCT01188772|580848770|FG003|Overall Study|Physician Decision|0|||
160852571|NCT01188772|580848767|FG000|Overall Study|Terminated by Sponsor|0|||
160852572|NCT01188772|580848768|FG001|Overall Study|Terminated by Sponsor|0|||
160852573|NCT01188772|580848769|FG002|Overall Study|Terminated by Sponsor|1|||
160852574|NCT01188772|580848770|FG003|Overall Study|Terminated by Sponsor|0|||
160852575|NCT01188772|580848767|FG000|Overall Study|Treatment Failure|0|||
160852576|NCT01188772|580848768|FG001|Overall Study|Treatment Failure|0|||
160852577|NCT01188772|580848769|FG002|Overall Study|Treatment Failure|1|||
160852578|NCT01188772|580848770|FG003|Overall Study|Treatment Failure|0|||
160852579|NCT01188772|580848767|FG000|Overall Study|Virologic Failure|1|||
160852580|NCT01188772|580848768|FG001|Overall Study|Virologic Failure|0|||
160852581|NCT01188772|580848769|FG002|Overall Study|Virologic Failure|0|||
160852582|NCT01188772|580848770|FG003|Overall Study|Virologic Failure|0|||
160852583|NCT01188772|580848767|FG000|Overall Study|Withdrawal by Subject|0|||
160852584|NCT01188772|580848768|FG001|Overall Study|Withdrawal by Subject|0|||
160852585|NCT01188772|580848769|FG002|Overall Study|Withdrawal by Subject|2|||
160852586|NCT01188772|580848770|FG003|Overall Study|Withdrawal by Subject|0|||
160852587|NCT03081884|580848774|FG000|Overall Study|deferred prostate cancer treatment|1|||
160852588|NCT03081884|580848774|FG000|Overall Study|metastasis managed with systemic therapy|3|||
160852589|NCT02294058|580848775|FG000|Overall Study|Adverse Event|16|||
160852590|NCT02294058|580848776|FG001|Overall Study|Adverse Event|7|||
160852591|NCT02294058|580848777|FG002|Overall Study|Adverse Event|13|||
160852592|NCT02294058|580848775|FG000|Overall Study|Lack of Efficacy|3|||
160852593|NCT02294058|580848776|FG001|Overall Study|Lack of Efficacy|3|||
160852594|NCT02294058|580848777|FG002|Overall Study|Lack of Efficacy|0|||
160852595|NCT02294058|580848775|FG000|Overall Study|Lost to Follow-up|1|||
160852596|NCT02294058|580848776|FG001|Overall Study|Lost to Follow-up|0|||
160852597|NCT02294058|580848777|FG002|Overall Study|Lost to Follow-up|2|||
160852598|NCT02294058|580848775|FG000|Overall Study|Withdrawal by Subject|10|||
160852599|NCT02294058|580848776|FG001|Overall Study|Withdrawal by Subject|14|||
160852600|NCT02294058|580848777|FG002|Overall Study|Withdrawal by Subject|13|||
160852601|NCT02294058|580848775|FG000|Overall Study|Physician Decision|2|||
160852602|NCT02294058|580848776|FG001|Overall Study|Physician Decision|1|||
160852603|NCT02294058|580848777|FG002|Overall Study|Physician Decision|0|||
160852604|NCT02294058|580848775|FG000|Overall Study|Miscellaneous|4|||
160852605|NCT02294058|580848776|FG001|Overall Study|Miscellaneous|1|||
160906853|NCT00228384|581052325|FG000|Overall Study|Surgical Intervention (bypass)|5|||
160906854|NCT00228384|581052326|FG001|Overall Study|Surgical Intervention (bypass)|5|||
160906855|NCT00228384|581052325|FG000|Overall Study|Withdrawal by Subject|9|||
160852606|NCT02294058|580848777|FG002|Overall Study|Miscellaneous|1|||
160852607|NCT01894607|580848779|FG000|Overall Study|Ineligible|1|||
160906856|NCT00228384|581052326|FG001|Overall Study|Withdrawal by Subject|10|||
160852608|NCT01787461|580848792|FG000|Overall Study|Adverse Event|4|||
160852609|NCT01787461|580848793|FG001|Overall Study|Adverse Event|3|||
160852610|NCT01787461|580848792|FG000|Overall Study|Lost to Follow-up|3|||
160906857|NCT00228384|581052325|FG000|Overall Study|Physician Decision|0|||
160906858|NCT00228384|581052326|FG001|Overall Study|Physician Decision|1|||
160906859|NCT01918774|581053908|FG000|Overall Study|Lost prior to first CBTw session|4|||
160906860|NCT01918774|581053908|FG000|Overall Study|Lost to Follow-up|1|||
160906861|NCT00717197|581053912|FG000|Overall Study|Unable to purchase study drug|5|||
160906862|NCT00717197|581053912|FG000|Overall Study|Tumor Progression|1|||
160906863|NCT00717197|581053912|FG000|Overall Study|Physician Decision|1|||
160906864|NCT01898806|581053915|FG000|Overall Study|Withdrawal by Subject|2|||
160906865|NCT01898806|581053915|FG000|Overall Study|Physician Decision|1|||
160906866|NCT01648101|581053916|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
160906867|NCT01648101|581053917|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
160906868|NCT01648101|581053918|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
160906869|NCT01648101|581053916|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
160906870|NCT01648101|581053917|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
160852611|NCT01787461|580848793|FG001|Overall Study|Lost to Follow-up|2|||
160852612|NCT01787461|580848792|FG000|Overall Study|No longer met eligibility criteria|1|||
160852613|NCT01787461|580848793|FG001|Overall Study|No longer met eligibility criteria|0|||
160852614|NCT01787461|580848792|FG000|Overall Study|Withdrawal by Subject|3|||
160852615|NCT01787461|580848793|FG001|Overall Study|Withdrawal by Subject|4|||
160906871|NCT01648101|581053918|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
160906872|NCT01648101|581053916|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
160906873|NCT01648101|581053917|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
160852616|NCT01787461|580848792|FG000|Overall Study|Protocol Violation|3|||
160992513|NCT03999554|581361387|FG002|Overall Study|Pregnancy|1|||
160852617|NCT01787461|580848793|FG001|Overall Study|Protocol Violation|0|||
160906874|NCT01648101|581053918|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
160852618|NCT00152503|580848794|FG000|Overall Study|Adverse Event|4|||
160852619|NCT03259555|580848795|FG000|Overall Study|Adverse Event|6|||
160852620|NCT03259555|580848796|FG001|Overall Study|Adverse Event|4|||
160852621|NCT03259555|580848795|FG000|Overall Study|Lack of Efficacy|6|||
160852622|NCT03259555|580848796|FG001|Overall Study|Lack of Efficacy|4|||
160852623|NCT03259555|580848795|FG000|Overall Study|Lost to Follow-up|0|||
160852624|NCT03259555|580848796|FG001|Overall Study|Lost to Follow-up|2|||
160852625|NCT03259555|580848795|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160852626|NCT03259555|580848796|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160852627|NCT03259555|580848795|FG000|Overall Study|Progressive Disease|0|||
160852628|NCT03259555|580848796|FG001|Overall Study|Progressive Disease|2|||
160852629|NCT03259555|580848795|FG000|Overall Study|Withdrawal by Subject|19|||
160852630|NCT03259555|580848796|FG001|Overall Study|Withdrawal by Subject|16|||
160852631|NCT03259555|580848795|FG000|Overall Study|Physician Decision|1|||
160852632|NCT03259555|580848796|FG001|Overall Study|Physician Decision|2|||
160852633|NCT03259555|580848795|FG000|Overall Study|Other|1|||
160852634|NCT03259555|580848796|FG001|Overall Study|Other|0|||
160852635|NCT03957551|580848797|FG000|Overall Study|Adverse Event|2|||
160852636|NCT03957551|580848798|FG001|Overall Study|Adverse Event|2|||
160852637|NCT03957551|580848799|FG002|Overall Study|Adverse Event|6|||
160852638|NCT03957551|580848797|FG000|Overall Study|Physician Decision|1|||
160852639|NCT03957551|580848798|FG001|Overall Study|Physician Decision|0|||
160852640|NCT03957551|580848799|FG002|Overall Study|Physician Decision|2|||
160852641|NCT03957551|580848797|FG000|Overall Study|Withdrawal by Subject|1|||
160852642|NCT03957551|580848798|FG001|Overall Study|Withdrawal by Subject|0|||
160852643|NCT03957551|580848799|FG002|Overall Study|Withdrawal by Subject|2|||
160852644|NCT03957551|580848797|FG000|Overall Study|Disease progression|1|||
160852645|NCT03957551|580848798|FG001|Overall Study|Disease progression|0|||
160852646|NCT03957551|580848799|FG002|Overall Study|Disease progression|8|||
160852647|NCT00607087|580848800|FG000|Overall Study|Withdrawal by Subject|9|||
160852648|NCT00607087|580848801|FG001|Overall Study|Withdrawal by Subject|4|||
160852649|NCT00607087|580848802|FG002|Overall Study|Withdrawal by Subject|4|||
160852650|NCT00607087|580848800|FG000|Overall Study|Adverse Event|3|||
160852651|NCT00607087|580848801|FG001|Overall Study|Adverse Event|2|||
160852652|NCT00607087|580848802|FG002|Overall Study|Adverse Event|3|||
160852653|NCT00607087|580848800|FG000|Overall Study|Other reason|1|||
160852654|NCT00607087|580848801|FG001|Overall Study|Other reason|5|||
160852655|NCT00607087|580848802|FG002|Overall Study|Other reason|2|||
160852656|NCT00607087|580848800|FG000|Overall Study|Poor compliance to protocol|1|||
160852657|NCT00607087|580848801|FG001|Overall Study|Poor compliance to protocol|0|||
160852658|NCT00607087|580848802|FG002|Overall Study|Poor compliance to protocol|1|||
160852659|NCT00607087|580848800|FG000|Overall Study|Lost to Follow-up|1|||
160852660|NCT00607087|580848801|FG001|Overall Study|Lost to Follow-up|0|||
160852661|NCT00607087|580848802|FG002|Overall Study|Lost to Follow-up|0|||
160852662|NCT00607087|580848800|FG000|Period 1|Withdrawal by Subject|7|||
160852663|NCT00607087|580848801|FG001|Period 1|Withdrawal by Subject|2|||
160852664|NCT00607087|580848802|FG002|Period 1|Withdrawal by Subject|3|||
160852665|NCT00607087|580848800|FG000|Period 1|Adverse Event|3|||
160852666|NCT00607087|580848801|FG001|Period 1|Adverse Event|0|||
160852667|NCT00607087|580848802|FG002|Period 1|Adverse Event|0|||
160852668|NCT00607087|580848800|FG000|Period 1|Poor compliance to protocol|1|||
160852669|NCT00607087|580848801|FG001|Period 1|Poor compliance to protocol|0|||
160852670|NCT00607087|580848802|FG002|Period 1|Poor compliance to protocol|0|||
160852671|NCT00607087|580848800|FG000|Period 1|Lost to Follow-up|1|||
160852672|NCT00607087|580848801|FG001|Period 1|Lost to Follow-up|0|||
160852673|NCT00607087|580848802|FG002|Period 1|Lost to Follow-up|0|||
160852674|NCT00607087|580848800|FG000|Period 1|Other reason|0|||
160852675|NCT00607087|580848801|FG001|Period 1|Other reason|4|||
160852676|NCT00607087|580848802|FG002|Period 1|Other reason|2|||
160852677|NCT00607087|580848800|FG000|Period 2|Withdrawal by Subject|0|||
160852678|NCT00607087|580848801|FG001|Period 2|Withdrawal by Subject|1|||
160852679|NCT00607087|580848802|FG002|Period 2|Withdrawal by Subject|1|||
160852680|NCT00607087|580848800|FG000|Period 2|Other reason|1|||
160852681|NCT00607087|580848801|FG001|Period 2|Other reason|1|||
160852682|NCT00607087|580848802|FG002|Period 2|Other reason|0|||
160852683|NCT00607087|580848800|FG000|Period 2|Adverse Event|0|||
160852684|NCT00607087|580848801|FG001|Period 2|Adverse Event|1|||
160852685|NCT00607087|580848802|FG002|Period 2|Adverse Event|3|||
160852686|NCT00607087|580848800|FG000|Period 2|Poor compliance to protocol|0|||
160852687|NCT00607087|580848801|FG001|Period 2|Poor compliance to protocol|0|||
160852688|NCT00607087|580848802|FG002|Period 2|Poor compliance to protocol|1|||
160852689|NCT00607087|580848800|FG000|Period 3|Withdrawal by Subject|2|||
160852690|NCT00607087|580848801|FG001|Period 3|Withdrawal by Subject|1|||
160992514|NCT03999554|581361388|FG003|Overall Study|Pregnancy|0|||
160852691|NCT00607087|580848802|FG002|Period 3|Withdrawal by Subject|0|||
160852692|NCT00607087|580848800|FG000|Period 3|Adverse Event|0|||
160852693|NCT00607087|580848801|FG001|Period 3|Adverse Event|1|||
160852694|NCT00607087|580848802|FG002|Period 3|Adverse Event|0|||
160852695|NCT02717494|580848805|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
160852696|NCT02717494|580848806|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
160992515|NCT03999554|581361389|FG004|Overall Study|Pregnancy|0|||
160852697|NCT02717494|580848807|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
160852698|NCT02717494|580848805|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
160852699|NCT02717494|580848806|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
160852700|NCT02717494|580848807|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
160852701|NCT02717494|580848805|FG000|First Intervention (Step 1)|Death|0|||
160852702|NCT02717494|580848806|FG001|First Intervention (Step 1)|Death|0|||
160852703|NCT02717494|580848807|FG002|First Intervention (Step 1)|Death|1|||
160852704|NCT02717494|580848805|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
160852705|NCT02717494|580848806|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
160852706|NCT02717494|580848807|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
160852707|NCT01774799|580848813|FG000|Overall Study|Lost to Follow-up|1|||
160852708|NCT01774799|580848814|FG001|Overall Study|Lost to Follow-up|1|||
160852709|NCT01774799|580848815|FG002|Overall Study|Lost to Follow-up|0|||
160852710|NCT01774799|580848816|FG003|Overall Study|Lost to Follow-up|0|||
160852711|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
160852712|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
160852713|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
160852714|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
160852715|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
160852716|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
160852717|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
160852718|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
160852719|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
160852720|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
160852721|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
160852722|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
160852723|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
160852724|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
160852725|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
160852726|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
160852727|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
160852728|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
160852729|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
160852730|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
160852731|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
160852732|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
160852733|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
160852734|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
160852735|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
160852736|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
160852737|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
160852738|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
160852739|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
160852740|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
160852741|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
160852742|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
160852743|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
160852744|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
160852745|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
160852746|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
160852747|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
160852748|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
160852749|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
160852750|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
160852751|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
160852752|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
160852753|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
160852754|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
160852755|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
160852756|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
160852757|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
160852758|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
160852759|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
160852760|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
160852761|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
160852762|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
160852763|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
160852764|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
160852765|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
160852766|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
160852767|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
160852768|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
160852769|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
160852770|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
160852771|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
160852772|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
160852773|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
160852774|NCT04393493|580848822|FG000|First 4 Days of Intervention|Early improvement|5|||
160852775|NCT04393493|580848823|FG001|First 4 Days of Intervention|Early improvement|7|||
160852776|NCT02910466|580848824|FG000|Overall Study|Adverse Event|1|||
160852777|NCT02910466|580848824|FG000|Overall Study|Withdrawal by Subject|3|||
160852778|NCT02910466|580848824|FG000|Overall Study|Lost to Follow-up|5|||
160852779|NCT02910466|580848824|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
160852780|NCT02910466|580848824|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
160852781|NCT01125800|580848826|FG000|Phase I|Protocol Violation|0|||
160852782|NCT01125800|580848827|FG001|Phase I|Protocol Violation|3|||
160852783|NCT01125800|580848828|FG002|Phase I|Protocol Violation|1|||
160852784|NCT01125800|580848829|FG003|Phase I|Protocol Violation|1|||
160852785|NCT01125800|580848830|FG004|Phase I|Protocol Violation|0|||
160852786|NCT01125800|580848826|FG000|Phase I|Adverse Event|2|||
160852787|NCT01125800|580848827|FG001|Phase I|Adverse Event|2|||
160852788|NCT01125800|580848828|FG002|Phase I|Adverse Event|1|||
160852789|NCT01125800|580848829|FG003|Phase I|Adverse Event|7|||
160852790|NCT01125800|580848830|FG004|Phase I|Adverse Event|0|||
160852791|NCT01125800|580848826|FG000|Phase I|Administrative problems|1|||
160852792|NCT01125800|580848827|FG001|Phase I|Administrative problems|0|||
160852793|NCT01125800|580848828|FG002|Phase I|Administrative problems|0|||
160852794|NCT01125800|580848829|FG003|Phase I|Administrative problems|0|||
160852795|NCT01125800|580848830|FG004|Phase I|Administrative problems|0|||
160852796|NCT01125800|580848826|FG000|Phase I|Withdrawal by Subject|0|||
160852797|NCT01125800|580848827|FG001|Phase I|Withdrawal by Subject|0|||
160852798|NCT01125800|580848828|FG002|Phase I|Withdrawal by Subject|1|||
160852799|NCT01125800|580848829|FG003|Phase I|Withdrawal by Subject|0|||
160852800|NCT01125800|580848830|FG004|Phase I|Withdrawal by Subject|0|||
160852801|NCT01125800|580848826|FG000|Phase I|Disease progression|5|||
160852802|NCT01125800|580848827|FG001|Phase I|Disease progression|4|||
160852803|NCT01125800|580848828|FG002|Phase I|Disease progression|1|||
160852804|NCT01125800|580848829|FG003|Phase I|Disease progression|3|||
160852805|NCT01125800|580848830|FG004|Phase I|Disease progression|0|||
160852806|NCT01125800|580848826|FG000|Phase II|Protocol Violation|0|||
160852807|NCT01125800|580848827|FG001|Phase II|Protocol Violation|0|||
160852808|NCT01125800|580848828|FG002|Phase II|Protocol Violation|0|||
160852809|NCT01125800|580848829|FG003|Phase II|Protocol Violation|0|||
160852810|NCT01125800|580848830|FG004|Phase II|Protocol Violation|1|||
160852811|NCT01125800|580848826|FG000|Phase II|Adverse Event|0|||
160852812|NCT01125800|580848827|FG001|Phase II|Adverse Event|0|||
160852813|NCT01125800|580848828|FG002|Phase II|Adverse Event|0|||
160852814|NCT01125800|580848829|FG003|Phase II|Adverse Event|0|||
160852815|NCT01125800|580848830|FG004|Phase II|Adverse Event|2|||
160852816|NCT01125800|580848826|FG000|Phase II|Disease progression|0|||
160569101|NCT04430348|579806942|FG005|Overall Study|Withdrawal by Subject|1|||
160569102|NCT04430348|579806937|FG000|Overall Study|Study Terminated by Sponsor|0|||
160569103|NCT04430348|579806938|FG001|Overall Study|Study Terminated by Sponsor|0|||
160569104|NCT04430348|579806939|FG002|Overall Study|Study Terminated by Sponsor|2|||
160569105|NCT04430348|579806940|FG003|Overall Study|Study Terminated by Sponsor|0|||
160569106|NCT04430348|579806941|FG004|Overall Study|Study Terminated by Sponsor|1|||
160569107|NCT04430348|579806942|FG005|Overall Study|Study Terminated by Sponsor|1|||
160569108|NCT05408858|579806943|FG000|Overall Study|no longer met eligibility criteria|1|||
160569109|NCT04899271|579806947|FG000|Overall Study|Lost to Follow-up|1|||
160569110|NCT04899271|579806948|FG001|Overall Study|Lost to Follow-up|0|||
160569111|NCT04899271|579806947|FG000|Overall Study|Subject request/consent withdrawal|2|||
160569112|NCT04899271|579806948|FG001|Overall Study|Subject request/consent withdrawal|0|||
160569113|NCT00881205|579806951|FG000|Overall Study|Adverse Event|8|||
160569114|NCT00881205|579806952|FG001|Overall Study|Adverse Event|3|||
160569115|NCT00881205|579806951|FG000|Overall Study|Withdrawal by Subject|1|||
160569116|NCT00881205|579806952|FG001|Overall Study|Withdrawal by Subject|2|||
160569117|NCT00881205|579806951|FG000|Overall Study|Lost to Follow-up|0|||
160569118|NCT00881205|579806952|FG001|Overall Study|Lost to Follow-up|1|||
160569119|NCT00881205|579806951|FG000|Overall Study|Administrative problems|1|||
160569120|NCT00881205|579806952|FG001|Overall Study|Administrative problems|1|||
160569121|NCT00881205|579806951|FG000|Overall Study|Condition no longer requires drug|1|||
160569122|NCT00881205|579806952|FG001|Overall Study|Condition no longer requires drug|0|||
160569123|NCT02318602|579806954|FG000|Overall Study|Adverse Event|0|||
160569124|NCT02318602|579806955|FG001|Overall Study|Adverse Event|1|||
160569125|NCT02318602|579806956|FG002|Overall Study|Adverse Event|1|||
160852817|NCT01125800|580848827|FG001|Phase II|Disease progression|0|||
160852818|NCT01125800|580848828|FG002|Phase II|Disease progression|0|||
160852819|NCT01125800|580848829|FG003|Phase II|Disease progression|1|||
160852820|NCT01125800|580848830|FG004|Phase II|Disease progression|8|||
160852821|NCT05051579|580848834|FG000|Overall Study|Withdrawal by Subject|3|||
160852822|NCT05051579|580848835|FG001|Overall Study|Withdrawal by Subject|5|||
160992516|NCT03999554|581361385|FG000|Overall Study|Withdrawal by Subject|2|||
160852823|NCT05051579|580848836|FG002|Overall Study|Withdrawal by Subject|2|||
160852824|NCT05051579|580848837|FG003|Overall Study|Withdrawal by Subject|1|||
160852825|NCT05051579|580848838|FG004|Overall Study|Withdrawal by Subject|4|||
160852826|NCT05051579|580848839|FG005|Overall Study|Withdrawal by Subject|0|||
160852827|NCT05051579|580848840|FG006|Overall Study|Withdrawal by Subject|4|||
160852828|NCT05051579|580848834|FG000|Overall Study|Lost to Follow-up|1|||
160852829|NCT05051579|580848835|FG001|Overall Study|Lost to Follow-up|0|||
160852830|NCT05051579|580848836|FG002|Overall Study|Lost to Follow-up|0|||
160852831|NCT05051579|580848837|FG003|Overall Study|Lost to Follow-up|0|||
160852832|NCT05051579|580848838|FG004|Overall Study|Lost to Follow-up|1|||
160852833|NCT05051579|580848839|FG005|Overall Study|Lost to Follow-up|0|||
160852834|NCT05051579|580848840|FG006|Overall Study|Lost to Follow-up|1|||
160852835|NCT05051579|580848834|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852836|NCT05051579|580848835|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852837|NCT05051579|580848836|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852838|NCT05051579|580848837|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852839|NCT05051579|580848838|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852840|NCT05051579|580848839|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852841|NCT05051579|580848840|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
160852842|NCT05051579|580848834|FG000|Overall Study|Adverse Event|2|||
160852843|NCT05051579|580848835|FG001|Overall Study|Adverse Event|1|||
160852844|NCT05051579|580848836|FG002|Overall Study|Adverse Event|0|||
160852845|NCT05051579|580848837|FG003|Overall Study|Adverse Event|4|||
160852846|NCT05051579|580848838|FG004|Overall Study|Adverse Event|1|||
160852847|NCT05051579|580848839|FG005|Overall Study|Adverse Event|2|||
160852848|NCT05051579|580848840|FG006|Overall Study|Adverse Event|0|||
160852849|NCT05051579|580848834|FG000|Overall Study|Inadvertent Enrollment|0|||
160852850|NCT05051579|580848835|FG001|Overall Study|Inadvertent Enrollment|0|||
160852851|NCT05051579|580848836|FG002|Overall Study|Inadvertent Enrollment|0|||
160852852|NCT05051579|580848837|FG003|Overall Study|Inadvertent Enrollment|0|||
160852853|NCT05051579|580848838|FG004|Overall Study|Inadvertent Enrollment|0|||
160852854|NCT05051579|580848839|FG005|Overall Study|Inadvertent Enrollment|0|||
160852855|NCT05051579|580848840|FG006|Overall Study|Inadvertent Enrollment|1|||
160852856|NCT05051579|580848834|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852857|NCT05051579|580848835|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
160852858|NCT05051579|580848836|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852859|NCT05051579|580848837|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852860|NCT05051579|580848838|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852861|NCT05051579|580848839|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852862|NCT05051579|580848840|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852863|NCT05051579|580848834|FG000|Overall Study|Sponsor Decision|0|||
160852864|NCT05051579|580848835|FG001|Overall Study|Sponsor Decision|0|||
160852865|NCT05051579|580848836|FG002|Overall Study|Sponsor Decision|0|||
160852866|NCT05051579|580848837|FG003|Overall Study|Sponsor Decision|0|||
160852867|NCT05051579|580848838|FG004|Overall Study|Sponsor Decision|1|||
160852868|NCT05051579|580848839|FG005|Overall Study|Sponsor Decision|0|||
160852869|NCT05051579|580848840|FG006|Overall Study|Sponsor Decision|0|||
160852870|NCT05051579|580848834|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852871|NCT05051579|580848835|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852872|NCT05051579|580848836|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852873|NCT05051579|580848837|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852874|NCT05051579|580848838|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
160852875|NCT05051579|580848839|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852876|NCT05051579|580848840|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852877|NCT06172348|580848845|FG000|Treatment Period 2|Adverse Event|0|||
160852878|NCT06172348|580848846|FG001|Treatment Period 2|Adverse Event|0|||
160852879|NCT06172348|580848847|FG002|Treatment Period 2|Adverse Event|1|||
160852880|NCT06172348|580848848|FG003|Treatment Period 2|Adverse Event|0|||
160852881|NCT06172348|580848849|FG004|Treatment Period 2|Adverse Event|0|||
160852882|NCT06172348|580848850|FG005|Treatment Period 2|Adverse Event|0|||
160992517|NCT03999554|581361386|FG001|Overall Study|Withdrawal by Subject|2|||
160992518|NCT03999554|581361387|FG002|Overall Study|Withdrawal by Subject|2|||
160852883|NCT03799341|580848851|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
160852884|NCT03799341|580848852|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
160852885|NCT03799341|580848853|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
160852886|NCT03799341|580848851|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
160852887|NCT03799341|580848852|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
160852888|NCT03799341|580848853|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
160852889|NCT03799341|580848851|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
160852890|NCT03799341|580848852|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
160852891|NCT03799341|580848853|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
160852892|NCT03799341|580848851|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
160852893|NCT03799341|580848852|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
160852894|NCT03799341|580848853|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
160852895|NCT03799341|580848851|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
160852896|NCT03799341|580848852|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
160852897|NCT03799341|580848853|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
160852898|NCT03799341|580848851|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
160852899|NCT03799341|580848852|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
160852900|NCT03799341|580848853|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
160852901|NCT04539938|580848854|FG000|Overall Study|Death|30|||
160852902|NCT04539938|580848854|FG000|Overall Study|Withdrawal by Subject|4|||
160852903|NCT04037891|580848855|FG000|Open-label Period|Withdrawal by Subject|1|||
160852904|NCT04037891|580848856|FG001|Open-label Period|Withdrawal by Subject|0|||
160906875|NCT01648101|581053916|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
160906876|NCT01648101|581053917|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
160906877|NCT01648101|581053918|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
160906878|NCT01648101|581053916|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
160906879|NCT01648101|581053917|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
160906880|NCT01648101|581053918|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
160906881|NCT01648101|581053916|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
160906882|NCT01648101|581053917|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
160906883|NCT01648101|581053918|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
160906884|NCT01648101|581053916|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
160569126|NCT02318602|579806954|FG000|Overall Study|Withdrawal by Subject|0|||
160569127|NCT02318602|579806955|FG001|Overall Study|Withdrawal by Subject|3|||
160569128|NCT02318602|579806956|FG002|Overall Study|Withdrawal by Subject|0|||
160906885|NCT01648101|581053917|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
160906886|NCT01648101|581053918|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
160906887|NCT01648101|581053916|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
160906888|NCT01648101|581053917|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
160906889|NCT01648101|581053918|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
160906890|NCT01648101|581053916|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
160906891|NCT01648101|581053917|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
160906892|NCT01648101|581053918|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
160906893|NCT01648101|581053916|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
160906894|NCT01648101|581053917|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
160906895|NCT01648101|581053918|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
160906896|NCT01648101|581053916|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
160906897|NCT01648101|581053917|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
160906898|NCT01648101|581053918|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
160906899|NCT03003390|581053919|FG000|Overall Study|Physician Decision|2|||
160906900|NCT03003390|581053920|FG001|Overall Study|Physician Decision|0|||
160906901|NCT03003390|581053919|FG000|Overall Study|Parent refused intervention|2|||
160906902|NCT03003390|581053920|FG001|Overall Study|Parent refused intervention|0|||
160906903|NCT01970397|581053926|FG000|Overall Study|Adverse Event|0|||
160906904|NCT01970397|581053927|FG001|Overall Study|Adverse Event|1|||
160906905|NCT01970397|581053926|FG000|Overall Study|Lost to Follow-up|0|||
160906906|NCT01970397|581053927|FG001|Overall Study|Lost to Follow-up|1|||
160906907|NCT01970397|581053926|FG000|Overall Study|Personal Reasons|1|||
160906908|NCT01970397|581053927|FG001|Overall Study|Personal Reasons|2|||
160906909|NCT01970397|581053926|FG000|Overall Study|Protocol Violation|1|||
160906910|NCT01970397|581053927|FG001|Overall Study|Protocol Violation|1|||
160906911|NCT01389817|581053928|FG000|Overall Study|Physician Decision|1|||
160906912|NCT01389817|581053929|FG001|Overall Study|Physician Decision|0|||
160906913|NCT01389817|581053928|FG000|Overall Study|Lost to Follow-up|1|||
160906914|NCT01389817|581053929|FG001|Overall Study|Lost to Follow-up|0|||
160906915|NCT01389817|581053928|FG000|Overall Study|Withdrawal by Subject|2|||
160569129|NCT02318602|579806954|FG000|Overall Study|Death|1|||
160906916|NCT01389817|581053929|FG001|Overall Study|Withdrawal by Subject|0|||
160569130|NCT02318602|579806955|FG001|Overall Study|Death|0|||
160569131|NCT02318602|579806956|FG002|Overall Study|Death|0|||
160852905|NCT04037891|580848857|FG002|Open-label Period|Withdrawal by Subject|0|||
160852906|NCT04037891|580848855|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
160906917|NCT01749137|581053930|FG000|Overall Study|Adverse Event|4|||
160852907|NCT04037891|580848856|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
160852908|NCT04037891|580848857|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
160852909|NCT00990106|580848858|FG000|Overall Study|"too busy to continue"|1|||
160852910|NCT00990106|580848859|FG001|Overall Study|"too busy to continue"|2|||
160852911|NCT00990106|580848858|FG000|Overall Study|Lost to Follow-up|1|||
160852912|NCT00990106|580848859|FG001|Overall Study|Lost to Follow-up|3|||
160852913|NCT00990106|580848858|FG000|Overall Study|Withdrawal by Subject|2|||
160852914|NCT00990106|580848859|FG001|Overall Study|Withdrawal by Subject|1|||
160852915|NCT00990106|580848858|FG000|Overall Study|opted for open label prazosin|1|||
160852916|NCT00990106|580848859|FG001|Overall Study|opted for open label prazosin|1|||
160852917|NCT00990106|580848858|FG000|Overall Study|relocation/deployment|4|||
160852918|NCT00990106|580848859|FG001|Overall Study|relocation/deployment|1|||
160852919|NCT00990106|580848858|FG000|Overall Study|started exclusionary medication|0|||
160852920|NCT00990106|580848859|FG001|Overall Study|started exclusionary medication|1|||
160852921|NCT00990106|580848858|FG000|Overall Study|planned major surgery|0|||
160852922|NCT00990106|580848859|FG001|Overall Study|planned major surgery|1|||
160852923|NCT00990106|580848858|FG000|Overall Study|scheduling conflicts|0|||
160852924|NCT00990106|580848859|FG001|Overall Study|scheduling conflicts|2|||
160852925|NCT04194944|580848860|FG000|Overall Study|Lost to Follow-up|3|||
160852926|NCT04194944|580848861|FG001|Overall Study|Lost to Follow-up|0|||
160852927|NCT04194944|580848860|FG000|Overall Study|Withdrawal by Subject|2|||
160852928|NCT04194944|580848861|FG001|Overall Study|Withdrawal by Subject|2|||
160852929|NCT04194944|580848860|FG000|Overall Study|On Treatment|93|||
160852930|NCT04194944|580848861|FG001|Overall Study|On Treatment|30|||
160852931|NCT00348673|580848864|FG000|Stage 1|Randomized but not Treated|0|||
160852932|NCT00348673|580848865|FG001|Stage 1|Randomized but not Treated|0|||
160852933|NCT00348673|580848866|FG002|Stage 1|Randomized but not Treated|1|||
160852934|NCT00348673|580848867|FG003|Stage 1|Randomized but not Treated|0|||
160852935|NCT00348673|580848868|FG004|Stage 1|Randomized but not Treated|0|||
160852936|NCT00348673|580848869|FG005|Stage 1|Randomized but not Treated|0|||
160852937|NCT00348673|580848870|FG006|Stage 1|Randomized but not Treated|0|||
160852938|NCT00348673|580848871|FG007|Stage 1|Randomized but not Treated|0|||
160852939|NCT00348673|580848872|FG008|Stage 1|Randomized but not Treated|0|||
160852940|NCT03798717|580851185|FG000|Overall Study|Failed Screening|0|||
160852941|NCT03798717|580851186|FG001|Overall Study|Failed Screening|0|||
160852942|NCT03798717|580851187|FG002|Overall Study|Failed Screening|0|||
160852943|NCT03798717|580851188|FG003|Overall Study|Failed Screening|0|||
160852944|NCT03798717|580851189|FG004|Overall Study|Failed Screening|0|||
160852945|NCT03798717|580851190|FG005|Overall Study|Failed Screening|1|||
160852946|NCT03798717|580851185|FG000|Overall Study|Physician Decision|1|||
160852947|NCT03798717|580851186|FG001|Overall Study|Physician Decision|0|||
160852948|NCT03798717|580851187|FG002|Overall Study|Physician Decision|1|||
160852949|NCT03798717|580851188|FG003|Overall Study|Physician Decision|0|||
160852950|NCT03798717|580851189|FG004|Overall Study|Physician Decision|0|||
160852951|NCT03798717|580851190|FG005|Overall Study|Physician Decision|0|||
160650708|NCT02649231|580102540|FG002|Overall Study|Adverse Event|0|||
160650709|NCT02649231|580102541|FG003|Overall Study|Adverse Event|1|||
160852952|NCT03798717|580851185|FG000|Overall Study|Withdrawal by Subject|0|||
160852953|NCT03798717|580851186|FG001|Overall Study|Withdrawal by Subject|0|||
160852954|NCT03798717|580851187|FG002|Overall Study|Withdrawal by Subject|0|||
160906918|NCT01749137|581053931|FG001|Overall Study|Adverse Event|4|||
160906919|NCT01749137|581053930|FG000|Overall Study|Lost to Follow-up|2|||
160906920|NCT01749137|581053931|FG001|Overall Study|Lost to Follow-up|3|||
160906921|NCT01749137|581053930|FG000|Overall Study|Physician Decision|1|||
160852955|NCT03798717|580851188|FG003|Overall Study|Withdrawal by Subject|1|||
160852956|NCT03798717|580851189|FG004|Overall Study|Withdrawal by Subject|0|||
160906922|NCT01749137|581053931|FG001|Overall Study|Physician Decision|0|||
160906923|NCT01749137|581053930|FG000|Overall Study|Withdrawal by Subject|8|||
160852957|NCT03798717|580851190|FG005|Overall Study|Withdrawal by Subject|0|||
160852958|NCT03798717|580851185|FG000|Overall Study|Lost to Follow-up|1|||
160852959|NCT03798717|580851186|FG001|Overall Study|Lost to Follow-up|0|||
160852960|NCT03798717|580851187|FG002|Overall Study|Lost to Follow-up|0|||
160852961|NCT03798717|580851188|FG003|Overall Study|Lost to Follow-up|1|||
160852962|NCT03798717|580851189|FG004|Overall Study|Lost to Follow-up|0|||
160852963|NCT03798717|580851190|FG005|Overall Study|Lost to Follow-up|0|||
160852964|NCT03798717|580851185|FG000|Overall Study|Adverse Event|0|||
160852965|NCT03798717|580851186|FG001|Overall Study|Adverse Event|1|||
160852966|NCT03798717|580851187|FG002|Overall Study|Adverse Event|0|||
160852967|NCT03798717|580851188|FG003|Overall Study|Adverse Event|0|||
160852968|NCT03798717|580851189|FG004|Overall Study|Adverse Event|0|||
160852969|NCT03798717|580851190|FG005|Overall Study|Adverse Event|0|||
160852970|NCT03798717|580851185|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
160852971|NCT03798717|580851186|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
160852972|NCT03798717|580851187|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
160852973|NCT03798717|580851188|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
160650710|NCT02649231|580102538|FG000|Overall Study|Lost to Follow-up|2|||
160650711|NCT02649231|580102539|FG001|Overall Study|Lost to Follow-up|1|||
160650712|NCT02649231|580102540|FG002|Overall Study|Lost to Follow-up|1|||
160852974|NCT03798717|580851189|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
160852975|NCT03798717|580851190|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
160852976|NCT00445549|580851191|FG000|Overall Study|progressive disease|12|||
160852977|NCT03858049|580851194|FG000|Overall Study|Adverse Event|16|||
160852978|NCT03858049|580851195|FG001|Overall Study|Adverse Event|9|||
160852979|NCT03858049|580851194|FG000|Overall Study|Other|1|||
160852980|NCT03858049|580851195|FG001|Overall Study|Other|1|||
160852981|NCT01600326|580851196|FG000|Overall Study|Lost to Follow-up|1|||
160852982|NCT01600326|580851197|FG001|Overall Study|Lost to Follow-up|1|||
160852983|NCT02079740|580851198|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
160852984|NCT02079740|580851199|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
160852985|NCT02079740|580851200|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
160852986|NCT02079740|580851201|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
160852987|NCT02079740|580851202|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
160852988|NCT02079740|580851203|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
160852989|NCT02079740|580851204|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
160852990|NCT02079740|580851205|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
160852991|NCT02079740|580851206|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
160852992|NCT02079740|580851207|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
160852993|NCT02079740|580851208|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
160852994|NCT02079740|580851209|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
160852995|NCT02079740|580851210|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
160852996|NCT02079740|580851198|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
160852997|NCT02079740|580851199|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
160852998|NCT02079740|580851200|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
160852999|NCT02079740|580851201|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
160853000|NCT02079740|580851202|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
160853001|NCT02079740|580851203|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
160906924|NCT01749137|581053931|FG001|Overall Study|Withdrawal by Subject|4|||
160853002|NCT02079740|580851204|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
160853003|NCT02079740|580851205|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
160853004|NCT02079740|580851206|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
160906925|NCT04980040|581053933|FG000|Overall Study|Violated the Inclusion Criteria|260|||
160906926|NCT04980040|581053933|FG000|Overall Study|Violated the Administration & Dosage|225|||
160906927|NCT04980040|581053933|FG000|Overall Study|Lost to Safety-Follow-up|4|||
160906928|NCT04980040|581053933|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
160906929|NCT01408485|581053934|FG000|Overall Study|Withdrawal by Subject|21|||
160906930|NCT01397084|581053935|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
160906931|NCT01397084|581053935|FG000|Overall Study|Protocol Violation|2|||
160906932|NCT01397084|581053935|FG000|Overall Study|Adverse Event|2|||
160906933|NCT01397084|581053935|FG000|Overall Study|Withdrawal by Subject|1|||
160906934|NCT01397084|581053935|FG000|Overall Study|Lost to Follow-up|1|||
160906935|NCT01397084|581053935|FG000|Overall Study|Used other proton pump inhibitor|1|||
160906936|NCT04160195|581053936|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
160906937|NCT04160195|581053937|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
160906938|NCT01342796|581053938|FG000|Overall Study|Withdrawal by Subject|2|||
160906939|NCT01342796|581053939|FG001|Overall Study|Withdrawal by Subject|0|||
160906940|NCT01342796|581053938|FG000|Overall Study|Lost to Follow-up|0|||
160906941|NCT01342796|581053939|FG001|Overall Study|Lost to Follow-up|3|||
160853005|NCT02079740|580851207|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
160853006|NCT02079740|580851208|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
160853007|NCT02079740|580851209|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
160853008|NCT02079740|580851210|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
160906942|NCT01342796|581053938|FG000|Overall Study|Inappropriate enrollment|1|||
160906943|NCT01342796|581053939|FG001|Overall Study|Inappropriate enrollment|0|||
160906944|NCT03130257|581053940|FG000|Overall Study|Withdrawal by Subject|1|||
160853009|NCT02079740|580851198|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853010|NCT02079740|580851199|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853011|NCT02079740|580851200|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853012|NCT02079740|580851201|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853013|NCT02079740|580851202|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853014|NCT02079740|580851203|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853015|NCT02079740|580851204|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853016|NCT02079740|580851205|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
160853017|NCT02079740|580851206|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853018|NCT02079740|580851207|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853019|NCT02079740|580851208|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853020|NCT02079740|580851209|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853021|NCT02079740|580851210|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853022|NCT02079740|580851198|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853023|NCT02079740|580851199|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853024|NCT02079740|580851200|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853025|NCT02079740|580851201|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853026|NCT02079740|580851202|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853027|NCT02079740|580851203|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853028|NCT02079740|580851204|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853029|NCT02079740|580851205|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
160853030|NCT02079740|580851206|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853031|NCT02079740|580851207|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853032|NCT02079740|580851208|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853033|NCT02079740|580851209|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853034|NCT02079740|580851210|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853035|NCT02079740|580851198|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853036|NCT02079740|580851199|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853037|NCT02079740|580851200|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853038|NCT02079740|580851201|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853039|NCT02079740|580851202|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853040|NCT02079740|580851203|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853041|NCT02079740|580851204|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853042|NCT02079740|580851205|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853043|NCT02079740|580851206|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853044|NCT02079740|580851207|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
160853045|NCT02079740|580851208|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853046|NCT02079740|580851209|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
160853047|NCT02079740|580851210|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
160853048|NCT04617782|580851211|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
160853049|NCT04617782|580851211|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
160853050|NCT04617782|580851211|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
160853051|NCT04617782|580851211|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
160853052|NCT04617782|580851211|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
160853053|NCT04617782|580851211|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
160853054|NCT01405768|580851224|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
160853055|NCT01405768|580851225|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
160853056|NCT04388111|580851228|FG000|Overall Study|Lost to Follow-up|5|||
160853057|NCT04388111|580851229|FG001|Overall Study|Lost to Follow-up|3|||
160853058|NCT04388111|580851228|FG000|Overall Study|Adverse Event|1|||
160853059|NCT04388111|580851229|FG001|Overall Study|Adverse Event|1|||
160853060|NCT04388111|580851228|FG000|Overall Study|Protocol Violation|2|||
160853061|NCT04388111|580851229|FG001|Overall Study|Protocol Violation|4|||
160853062|NCT04388111|580851228|FG000|Overall Study|Withdrawal by Subject|1|||
160853063|NCT04388111|580851229|FG001|Overall Study|Withdrawal by Subject|0|||
160853064|NCT01474317|580851237|FG000|Overall Study|Adverse Event|1|||
160853065|NCT01474317|580851237|FG000|Overall Study|Subject ineligible for study|1|||
160853066|NCT00387881|580851238|FG000|Overall Study|Lost to Follow-up|23|||
160853067|NCT00387881|580851239|FG001|Overall Study|Lost to Follow-up|23|||
160853068|NCT00387881|580851238|FG000|Overall Study|Protocol Violation|2|||
160853069|NCT00387881|580851239|FG001|Overall Study|Protocol Violation|12|||
160853070|NCT00387881|580851238|FG000|Overall Study|Withdrawal by Subject|15|||
160853071|NCT00387881|580851239|FG001|Overall Study|Withdrawal by Subject|18|||
160853072|NCT00387881|580851238|FG000|Overall Study|Sponsor terminated Study|0|||
160853073|NCT00387881|580851239|FG001|Overall Study|Sponsor terminated Study|1|||
160853074|NCT00387881|580851238|FG000|Overall Study|Not eligible|6|||
160853075|NCT00387881|580851239|FG001|Overall Study|Not eligible|7|||
160853076|NCT00387881|580851238|FG000|Overall Study|No opportunity to treat headache|32|||
160906945|NCT03130257|581053941|FG001|Overall Study|Withdrawal by Subject|0|||
160650713|NCT02649231|580102541|FG003|Overall Study|Lost to Follow-up|0|||
160650714|NCT02649231|580102538|FG000|Overall Study|Withdrawal by Subject|0|||
160650715|NCT02649231|580102539|FG001|Overall Study|Withdrawal by Subject|1|||
160650716|NCT02649231|580102540|FG002|Overall Study|Withdrawal by Subject|0|||
160650717|NCT02649231|580102541|FG003|Overall Study|Withdrawal by Subject|1|||
160650718|NCT02649231|580102538|FG000|Overall Study|Protocol Violation|2|||
160650719|NCT02649231|580102539|FG001|Overall Study|Protocol Violation|1|||
160650720|NCT02649231|580102540|FG002|Overall Study|Protocol Violation|1|||
160650721|NCT02649231|580102541|FG003|Overall Study|Protocol Violation|0|||
160650722|NCT02970669|580102542|FG000|Double-blind Period|Adverse Event|4|||
160650723|NCT02970669|580102543|FG001|Double-blind Period|Adverse Event|0|||
160650724|NCT02970669|580102542|FG000|Double-blind Period|Death|1|||
160650725|NCT02970669|580102543|FG001|Double-blind Period|Death|0|||
160650726|NCT02970669|580102542|FG000|Double-blind Period|Study terminated by sponsor|1|||
160650727|NCT02970669|580102543|FG001|Double-blind Period|Study terminated by sponsor|2|||
160650728|NCT02970669|580102542|FG000|Double-blind Period|Physician Decision|0|||
160650729|NCT02970669|580102543|FG001|Double-blind Period|Physician Decision|2|||
160650730|NCT02970669|580102542|FG000|Double-blind Period|Withdrawal by Subject|2|||
160650731|NCT02970669|580102543|FG001|Double-blind Period|Withdrawal by Subject|2|||
160650732|NCT02970669|580102542|FG000|Open-label Period|Withdrawal by Subject|2|||
160650733|NCT02970669|580102543|FG001|Open-label Period|Withdrawal by Subject|2|||
160650734|NCT02970669|580102542|FG000|Open-label Period|Adverse Event|1|||
160650735|NCT02970669|580102543|FG001|Open-label Period|Adverse Event|0|||
160650736|NCT02970669|580102542|FG000|Open-label Period|Physician Decision|1|||
160650737|NCT02970669|580102543|FG001|Open-label Period|Physician Decision|0|||
160650738|NCT00876733|580102546|FG000|Overall Study|Adverse Event|34|||
160650739|NCT00876733|580102547|FG001|Overall Study|Adverse Event|20|||
160650740|NCT00876733|580102548|FG002|Overall Study|Adverse Event|10|||
160650741|NCT00876733|580102549|FG003|Overall Study|Adverse Event|3|||
160650742|NCT00876733|580102546|FG000|Overall Study|Lack of Efficacy|17|||
160650743|NCT00876733|580102547|FG001|Overall Study|Lack of Efficacy|9|||
160650744|NCT00876733|580102548|FG002|Overall Study|Lack of Efficacy|10|||
160650745|NCT00876733|580102549|FG003|Overall Study|Lack of Efficacy|1|||
160650746|NCT00876733|580102546|FG000|Overall Study|Lost to Follow-up|26|||
160650747|NCT00876733|580102547|FG001|Overall Study|Lost to Follow-up|10|||
160650748|NCT00876733|580102548|FG002|Overall Study|Lost to Follow-up|3|||
160650749|NCT00876733|580102549|FG003|Overall Study|Lost to Follow-up|2|||
160650750|NCT00876733|580102546|FG000|Overall Study|Data not available|14|||
160650751|NCT00876733|580102547|FG001|Overall Study|Data not available|3|||
160650752|NCT00876733|580102548|FG002|Overall Study|Data not available|7|||
160650753|NCT00876733|580102549|FG003|Overall Study|Data not available|1|||
160650754|NCT02611752|580102550|FG000|Overall Study|Adverse Event|0|||
160650755|NCT02611752|580102551|FG001|Overall Study|Adverse Event|1|||
160650756|NCT03212170|580102556|FG000|Overall Study|Withdrawal by Subject|1|||
160650757|NCT00467584|580102557|FG000|Overall Study|Withdrawal by Subject|4|||
160650758|NCT00467584|580102558|FG001|Overall Study|Withdrawal by Subject|5|||
160650759|NCT00467584|580102559|FG002|Overall Study|Withdrawal by Subject|1|||
160650760|NCT02482571|580102560|FG000|Overall Study|Adverse Event|1|||
160650761|NCT02482571|580102560|FG000|Overall Study|Scanner or Respiract failure|3|||
160650762|NCT02482571|580102560|FG000|Overall Study|Withdrawal by Subject|4|||
160650763|NCT05550532|580102564|FG000|Overall Study|Withdrawal by Subject|8|||
160650764|NCT05550532|580102565|FG001|Overall Study|Withdrawal by Subject|3|||
160853077|NCT00387881|580851239|FG001|Overall Study|No opportunity to treat headache|34|||
160853078|NCT00387881|580851238|FG000|Overall Study|Not otherwise specified|11|||
160853079|NCT00387881|580851239|FG001|Overall Study|Not otherwise specified|7|||
160853080|NCT00453154|580851242|FG000|Double BIind Maintenance|Adverse Event|0|||
160853081|NCT00453154|580851243|FG001|Double BIind Maintenance|Adverse Event|0|||
160853082|NCT00453154|580851244|FG002|Double BIind Maintenance|Adverse Event|3|||
160853083|NCT00453154|580851245|FG003|Double BIind Maintenance|Adverse Event|12|||
160853084|NCT00453154|580851242|FG000|Double BIind Maintenance|Death|0|||
160853085|NCT00453154|580851243|FG001|Double BIind Maintenance|Death|0|||
160853086|NCT00453154|580851244|FG002|Double BIind Maintenance|Death|2|||
160853087|NCT00453154|580851245|FG003|Double BIind Maintenance|Death|1|||
160853088|NCT00453154|580851242|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
160853089|NCT00453154|580851243|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
160650765|NCT05550532|580102564|FG000|Overall Study|Adverse Event|2|||
160650766|NCT05550532|580102565|FG001|Overall Study|Adverse Event|3|||
160650767|NCT05550532|580102564|FG000|Overall Study|Lost to Follow-up|4|||
160650768|NCT05550532|580102565|FG001|Overall Study|Lost to Follow-up|0|||
160650769|NCT05550532|580102564|FG000|Overall Study|Other|0|||
160650770|NCT05550532|580102565|FG001|Overall Study|Other|4|||
160650771|NCT03626857|580102569|FG000|Overall Study|Adverse Event|9|||
160650772|NCT03626857|580102570|FG001|Overall Study|Adverse Event|7|||
160650773|NCT03626857|580102569|FG000|Overall Study|Lost to Follow-up|8|||
160650774|NCT03626857|580102570|FG001|Overall Study|Lost to Follow-up|8|||
160650775|NCT03626857|580102569|FG000|Overall Study|Withdrawal by Subject|2|||
160650776|NCT03626857|580102570|FG001|Overall Study|Withdrawal by Subject|2|||
160906946|NCT03130257|581053942|FG002|Overall Study|Withdrawal by Subject|2|||
160906947|NCT01751867|581053943|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
160906948|NCT01751867|581053944|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
160906949|NCT01751867|581053943|FG000|Overall Study|Diease Progression|4|||
160906950|NCT01751867|581053944|FG001|Overall Study|Diease Progression|18|||
160906951|NCT01751867|581053943|FG000|Overall Study|Adverse Event|8|||
160906952|NCT01751867|581053944|FG001|Overall Study|Adverse Event|15|||
160906953|NCT01751867|581053943|FG000|Overall Study|Poor Compliance|0|||
160906954|NCT01751867|581053944|FG001|Overall Study|Poor Compliance|5|||
160906955|NCT01751867|581053943|FG000|Overall Study|Withdrawal by Subject|3|||
160906956|NCT01751867|581053944|FG001|Overall Study|Withdrawal by Subject|1|||
160906957|NCT01751867|581053943|FG000|Overall Study|Physician Decision|4|||
160906958|NCT01751867|581053944|FG001|Overall Study|Physician Decision|7|||
160906959|NCT01751867|581053943|FG000|Overall Study|Protocol Violation|0|||
160906960|NCT01751867|581053944|FG001|Overall Study|Protocol Violation|2|||
160906961|NCT01751867|581053943|FG000|Overall Study|Death|0|||
160906962|NCT01751867|581053944|FG001|Overall Study|Death|5|||
160906963|NCT01751867|581053943|FG000|Overall Study|Other|11|||
160906964|NCT01751867|581053944|FG001|Overall Study|Other|37|||
160906965|NCT01751867|581053943|FG000|Overall Study|Randomized but not treated.|2|||
160906966|NCT01751867|581053944|FG001|Overall Study|Randomized but not treated.|1|||
160906967|NCT01508650|581053945|FG000|Overall Study|Lost to Follow-up|0|||
160906968|NCT01508650|581053946|FG001|Overall Study|Lost to Follow-up|3|||
160906969|NCT02064894|581053947|FG000|Overall Study|Withdrawal by Subject|43|||
160906970|NCT02064894|581053948|FG001|Overall Study|Withdrawal by Subject|102|||
160906971|NCT02064894|581053949|FG002|Overall Study|Withdrawal by Subject|115|||
160906972|NCT01976338|581053950|FG000|Overall Study|Physician Decision|0|||
160906973|NCT01976338|581053951|FG001|Overall Study|Physician Decision|1|||
160906974|NCT01976338|581053950|FG000|Overall Study|Lost to Follow-up|3|||
160906975|NCT01976338|581053951|FG001|Overall Study|Lost to Follow-up|0|||
160906976|NCT01976338|581053950|FG000|Overall Study|Withdrawal by Subject|5|||
160906977|NCT01976338|581053951|FG001|Overall Study|Withdrawal by Subject|2|||
160906978|NCT01976338|581053950|FG000|Overall Study|Adverse Event|5|||
160906979|NCT01976338|581053951|FG001|Overall Study|Adverse Event|1|||
160906980|NCT05988619|581053952|FG000|Overall Study|Lost to Follow-up|1|||
160906981|NCT05988619|581053953|FG001|Overall Study|Lost to Follow-up|4|||
160906982|NCT05988619|581053952|FG000|Overall Study|Withdrawal by Subject|2|||
160906983|NCT05988619|581053953|FG001|Overall Study|Withdrawal by Subject|9|||
160853090|NCT00453154|580851244|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
160853091|NCT00453154|580851245|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
160853092|NCT00453154|580851242|FG000|Double BIind Maintenance|Progression|0|||
160853093|NCT00453154|580851243|FG001|Double BIind Maintenance|Progression|0|||
160853094|NCT00453154|580851244|FG002|Double BIind Maintenance|Progression|29|||
160853095|NCT00453154|580851245|FG003|Double BIind Maintenance|Progression|26|||
160853096|NCT00453154|580851242|FG000|Double BIind Maintenance|Medical Issues|0|||
160853097|NCT00453154|580851243|FG001|Double BIind Maintenance|Medical Issues|0|||
160853098|NCT00453154|580851244|FG002|Double BIind Maintenance|Medical Issues|3|||
160853099|NCT00453154|580851245|FG003|Double BIind Maintenance|Medical Issues|1|||
160853100|NCT00453154|580851242|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
160853101|NCT00453154|580851243|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
160853102|NCT00453154|580851244|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
160853103|NCT00453154|580851245|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
160853104|NCT03629886|580851247|FG000|Overall Study|Migrated / moved from the study area|0|||
160853105|NCT03629886|580851248|FG001|Overall Study|Migrated / moved from the study area|55|||
160853106|NCT03629886|580851247|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
160853107|NCT03629886|580851248|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
160853108|NCT03629886|580851247|FG000|Overall Study|Study vaccine not administrated|0|||
160853109|NCT03629886|580851248|FG001|Overall Study|Study vaccine not administrated|3|||
160853110|NCT03629886|580851247|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
160853111|NCT03629886|580851248|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
160853112|NCT03629886|580851247|FG000|Overall Study|Refused vaccination step of the study|0|||
160853113|NCT03629886|580851248|FG001|Overall Study|Refused vaccination step of the study|44|||
160853114|NCT05473026|580851250|FG000|Overall Study|Lost to Follow-up|5|||
160906984|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Death|0|||
160906985|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Death|0|||
160906986|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Death|0|||
160906987|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Death|0|||
160906988|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Death|1|||
160906989|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Death|0|||
160906990|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Death|0|||
160906991|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Death|0|||
160569132|NCT02318602|579806954|FG000|Overall Study|Guardian decision to withdraw|0|||
160853115|NCT05473026|580851251|FG001|Overall Study|Lost to Follow-up|2|||
160853116|NCT02038153|580851252|FG000|Overall Study|Withdrawal by Subject|1|||
160853117|NCT03683173|580851253|FG000|Completed Follow-up|Unavailable|235|||
160853118|NCT03683173|580851254|FG001|Completed Follow-up|Unavailable|217|||
160853119|NCT03683173|580851253|FG000|Completed Follow-up|Refused|69|||
160853120|NCT03683173|580851254|FG001|Completed Follow-up|Refused|59|||
160853121|NCT03683173|580851253|FG000|Completed Follow-up|Disconnected phone|65|||
160853122|NCT03683173|580851254|FG001|Completed Follow-up|Disconnected phone|95|||
160853123|NCT03683173|580851253|FG000|Completed Follow-up|Health issue/deceased|10|||
160853124|NCT03683173|580851254|FG001|Completed Follow-up|Health issue/deceased|4|||
160853125|NCT03683173|580851253|FG000|Completed Follow-up|Moved away|8|||
160853126|NCT03683173|580851254|FG001|Completed Follow-up|Moved away|1|||
160853127|NCT02647281|580851255|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853128|NCT02647281|580851256|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853129|NCT02647281|580851257|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853130|NCT02647281|580851258|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853131|NCT02647281|580851259|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853132|NCT02647281|580851260|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853133|NCT02647281|580851261|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853134|NCT02647281|580851262|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853135|NCT02647281|580851263|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
160853136|NCT01050634|580851264|FG000|Overall Study|Enrolled, but Not Treated|56|||
160853137|NCT01050634|580851264|FG000|Overall Study|Death|2|||
160853138|NCT01050634|580851264|FG000|Overall Study|Adverse Event|42|||
160853139|NCT01050634|580851264|FG000|Overall Study|Lost to Follow-up|2|||
160853140|NCT01050634|580851264|FG000|Overall Study|Other|21|||
160853141|NCT01050634|580851264|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
160853142|NCT00496015|580851265|FG000|Overall Study|Other|1|||
160853143|NCT00496015|580851266|FG001|Overall Study|Other|0|||
160906992|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
160906993|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
160906994|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
160906995|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
160906996|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
160906997|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
160906998|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
160906999|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
160907000|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
160907001|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
160907002|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
160907003|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
160907004|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
160907005|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
160907006|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
160907007|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
160907008|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
160907009|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
160569133|NCT02318602|579806955|FG001|Overall Study|Guardian decision to withdraw|0|||
160569134|NCT02318602|579806956|FG002|Overall Study|Guardian decision to withdraw|1|||
160569135|NCT00693706|579806957|FG000|Overall Study|Protocol Violation|0|||
160569136|NCT00693706|579806958|FG001|Overall Study|Protocol Violation|1|||
160569137|NCT02498652|579806961|FG000|Overall Study|Protocol Violation|0|||
160569138|NCT02498652|579806962|FG001|Overall Study|Protocol Violation|1|||
160569139|NCT01733329|579806963|FG000|Overall Study|Protocol Violation|1|||
160569140|NCT01733329|579806964|FG001|Overall Study|Protocol Violation|1|||
160569141|NCT01733329|579806963|FG000|Overall Study|Uterine artery injury|1|||
160569142|NCT01733329|579806964|FG001|Overall Study|Uterine artery injury|0|||
160569143|NCT00730236|579806965|FG000|Overall Study|Adverse Event|4|||
160569144|NCT00730236|579806965|FG000|Overall Study|Withdrawal by Subject|1|||
160569145|NCT00730236|579806965|FG000|Overall Study|Non-compliance|1|||
160569146|NCT04334148|579806971|FG000|Overall Study|positive nasal swab at baseline|0|||
160569147|NCT04334148|579806972|FG001|Overall Study|positive nasal swab at baseline|1|||
160569148|NCT05370157|579806973|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
160569149|NCT05370157|579806974|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
160569150|NCT05370157|579806973|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
160571906|NCT01743027|579816863|FG002|Overall Study|Progressive Disease|3|||
160853144|NCT00496015|580851267|FG002|Overall Study|Other|0|||
160853145|NCT00496015|580851268|FG003|Overall Study|Other|1|||
160853146|NCT00496015|580851269|FG004|Overall Study|Other|0|||
160907010|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
160853147|NCT02730728|580851272|FG000|Overall Study|Withdrawal by Subject|0|||
160853148|NCT02730728|580851273|FG001|Overall Study|Withdrawal by Subject|1|||
160853149|NCT02730728|580851274|FG002|Overall Study|Withdrawal by Subject|0|||
160853150|NCT02730728|580851272|FG000|Overall Study|Lack of Efficacy|0|||
160853151|NCT02730728|580851273|FG001|Overall Study|Lack of Efficacy|1|||
160853152|NCT02730728|580851274|FG002|Overall Study|Lack of Efficacy|1|||
160853153|NCT03360682|580851293|FG000|Overall Study|Adverse Event|3|||
160853154|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853155|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853156|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853157|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
160853158|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853159|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853160|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853161|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853162|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853163|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853164|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
160853165|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
160853166|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
160853167|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
160853168|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
160853169|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
160853170|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
160853171|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
160853172|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
160853173|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
160853174|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
160853175|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
160853176|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
160853177|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
160853178|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
160853179|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
160853180|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
160853181|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
160853182|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
160853183|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
160853184|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
160853185|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853186|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
160853187|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853188|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
160853189|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
160853190|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853191|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853192|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853193|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853194|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
160853195|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853196|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
160853197|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853198|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
160853199|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853200|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853201|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853202|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853203|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853204|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
160853205|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853206|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853207|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853208|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
160853209|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
160853210|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853211|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853212|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853213|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853214|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853215|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853216|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
160853217|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853218|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853219|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853220|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853221|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853222|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853223|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853224|NCT02365649|580851303|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853225|NCT02365649|580851304|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853226|NCT02365649|580851305|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853227|NCT02365649|580851306|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853228|NCT02365649|580851307|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853229|NCT02365649|580851308|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853230|NCT02365649|580851309|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
160853231|NCT02365649|580851310|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853232|NCT02365649|580851311|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853233|NCT02365649|580851312|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853234|NCT02365649|580851303|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853235|NCT02365649|580851304|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853236|NCT02365649|580851305|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853237|NCT02365649|580851306|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853238|NCT02365649|580851307|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853239|NCT02365649|580851308|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853240|NCT02365649|580851309|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
160853241|NCT02365649|580851310|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853242|NCT02365649|580851311|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
160853243|NCT02365649|580851312|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
160853244|NCT02365649|580851303|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853245|NCT02365649|580851304|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853246|NCT02365649|580851305|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853247|NCT02365649|580851306|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853248|NCT02365649|580851307|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853249|NCT02365649|580851308|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853250|NCT02365649|580851309|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
160853251|NCT02365649|580851310|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
160907011|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
160907012|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
160907013|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
160907014|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
160907015|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
160907016|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
160907017|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
160907018|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
160907019|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
160907020|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
160907021|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
160907022|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
160907023|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
160907024|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
160907025|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
160907026|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
160907027|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
160907028|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
160907029|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
160907030|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
160907031|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
160907032|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
160907033|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
160907034|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
160907035|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
160907036|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
160853252|NCT02365649|580851311|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
160853253|NCT02365649|580851312|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
160853254|NCT02365649|580851303|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853255|NCT02365649|580851304|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853256|NCT02365649|580851305|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853257|NCT02365649|580851306|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853258|NCT02365649|580851307|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853259|NCT02365649|580851308|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853260|NCT02365649|580851309|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
160853261|NCT02365649|580851310|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853262|NCT02365649|580851311|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
160853263|NCT02365649|580851312|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
160853264|NCT02365649|580851303|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853265|NCT02365649|580851304|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853266|NCT02365649|580851305|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853267|NCT02365649|580851306|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853268|NCT02365649|580851307|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853269|NCT02365649|580851308|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853270|NCT02365649|580851309|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
160853271|NCT02365649|580851310|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853272|NCT02365649|580851311|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
160853273|NCT02365649|580851312|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853274|NCT01433172|580851325|FG000|Overall Study|Withdrawal by Subject|0|||
160853275|NCT01433172|580851326|FG001|Overall Study|Withdrawal by Subject|1|||
160853276|NCT01433172|580851327|FG002|Overall Study|Withdrawal by Subject|0|||
160853277|NCT01433172|580851325|FG000|Overall Study|Disease Progression|0|||
160853278|NCT01433172|580851326|FG001|Overall Study|Disease Progression|0|||
160853279|NCT01433172|580851327|FG002|Overall Study|Disease Progression|1|||
160853280|NCT01433172|580851325|FG000|Overall Study|Death|0|||
160853281|NCT01433172|580851326|FG001|Overall Study|Death|2|||
160853282|NCT01433172|580851327|FG002|Overall Study|Death|0|||
160853283|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
160853284|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
160853285|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
160853286|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
160853287|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
160853288|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
160853289|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Death|7|||
160853290|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Death|5|||
160853291|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Death|6|||
160853292|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
160853293|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
160853294|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
160853295|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
160853296|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
160853297|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
160853298|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Other|1|||
160853299|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Other|0|||
160853300|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Other|0|||
160853301|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
160853302|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
160853303|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
160853304|NCT00104650|580851328|FG000|Follow-up Period|Physician Decision|1|||
160853305|NCT00104650|580851329|FG001|Follow-up Period|Physician Decision|1|||
160853306|NCT00104650|580851330|FG002|Follow-up Period|Physician Decision|0|||
160853307|NCT00104650|580851328|FG000|Follow-up Period|Adverse Event|1|||
160853308|NCT00104650|580851329|FG001|Follow-up Period|Adverse Event|0|||
160853309|NCT00104650|580851330|FG002|Follow-up Period|Adverse Event|1|||
160853310|NCT00104650|580851328|FG000|Follow-up Period|Withdrawal by Subject|0|||
160853311|NCT00104650|580851329|FG001|Follow-up Period|Withdrawal by Subject|3|||
160853312|NCT00104650|580851330|FG002|Follow-up Period|Withdrawal by Subject|3|||
160853313|NCT00104650|580851328|FG000|Follow-up Period|Death|6|||
160853314|NCT00104650|580851329|FG001|Follow-up Period|Death|6|||
160853315|NCT00104650|580851330|FG002|Follow-up Period|Death|4|||
160853316|NCT00104650|580851328|FG000|Follow-up Period|Disease progression|3|||
160853317|NCT00104650|580851329|FG001|Follow-up Period|Disease progression|1|||
160569151|NCT05370157|579806974|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
160907037|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
160907038|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
160569152|NCT01508676|579806975|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
160853318|NCT00104650|580851330|FG002|Follow-up Period|Disease progression|0|||
160853319|NCT00104650|580851328|FG000|Follow-up Period|Lost to Follow-up|0|||
160853320|NCT00104650|580851329|FG001|Follow-up Period|Lost to Follow-up|1|||
160853321|NCT00104650|580851330|FG002|Follow-up Period|Lost to Follow-up|2|||
160853322|NCT00104650|580851328|FG000|Follow-up Period|Other|0|||
160853323|NCT00104650|580851329|FG001|Follow-up Period|Other|1|||
160853324|NCT00104650|580851330|FG002|Follow-up Period|Other|0|||
160853325|NCT01391663|580851331|FG000|Overall Study|Withdrawal by Subject|0|||
160853326|NCT01391663|580851332|FG001|Overall Study|Withdrawal by Subject|0|||
160853327|NCT01391663|580851333|FG002|Overall Study|Withdrawal by Subject|1|||
160853328|NCT01391663|580851334|FG003|Overall Study|Withdrawal by Subject|0|||
160853329|NCT03515824|580851335|FG000|Overall Study|Death|3|||
160853330|NCT03515824|580851336|FG001|Overall Study|Death|2|||
160853331|NCT03515824|580851337|FG002|Overall Study|Death|6|||
160853332|NCT03515824|580851338|FG003|Overall Study|Death|0|||
160853333|NCT03515824|580851335|FG000|Overall Study|Lost to Follow-up|0|||
160853334|NCT03515824|580851336|FG001|Overall Study|Lost to Follow-up|1|||
160853335|NCT03515824|580851337|FG002|Overall Study|Lost to Follow-up|1|||
160853336|NCT03515824|580851338|FG003|Overall Study|Lost to Follow-up|0|||
160853337|NCT03515824|580851335|FG000|Overall Study|Study terminated by sponsor|0|||
160853338|NCT03515824|580851336|FG001|Overall Study|Study terminated by sponsor|1|||
160853339|NCT03515824|580851337|FG002|Overall Study|Study terminated by sponsor|6|||
160853340|NCT03515824|580851338|FG003|Overall Study|Study terminated by sponsor|0|||
160853341|NCT03515824|580851335|FG000|Overall Study|Status not recorded|0|||
160853342|NCT03515824|580851336|FG001|Overall Study|Status not recorded|0|||
160853343|NCT03515824|580851337|FG002|Overall Study|Status not recorded|2|||
160853344|NCT03515824|580851338|FG003|Overall Study|Status not recorded|0|||
160853345|NCT00920855|580851339|FG000|Overall Study|Adverse Event|1|||
160853346|NCT00920855|580851340|FG001|Overall Study|Adverse Event|1|||
160853347|NCT00920855|580851341|FG002|Overall Study|Adverse Event|4|||
160853348|NCT00920855|580851339|FG000|Overall Study|Withdrawal by Subject|2|||
160853349|NCT00920855|580851340|FG001|Overall Study|Withdrawal by Subject|1|||
160853350|NCT00920855|580851341|FG002|Overall Study|Withdrawal by Subject|6|||
160853351|NCT00920855|580851339|FG000|Overall Study|Disease progression|2|||
160853352|NCT00920855|580851340|FG001|Overall Study|Disease progression|1|||
160853353|NCT00920855|580851341|FG002|Overall Study|Disease progression|10|||
160853354|NCT00920855|580851339|FG000|Overall Study|Noncompliance to study medication|0|||
160853355|NCT00920855|580851340|FG001|Overall Study|Noncompliance to study medication|0|||
160853356|NCT00920855|580851341|FG002|Overall Study|Noncompliance to study medication|1|||
160853357|NCT00920855|580851339|FG000|Overall Study|Response plateau; started maintenance|0|||
160853358|NCT00920855|580851340|FG001|Overall Study|Response plateau; started maintenance|0|||
160853359|NCT00920855|580851341|FG002|Overall Study|Response plateau; started maintenance|1|||
160853360|NCT00539994|580851342|FG000|Overall Study|Lost to Follow-up|2|||
160853361|NCT00539994|580851343|FG001|Overall Study|Lost to Follow-up|1|||
160853362|NCT00539994|580851344|FG002|Overall Study|Lost to Follow-up|0|||
160853363|NCT00539994|580851342|FG000|Overall Study|Withdrawal by Subject|1|||
160853364|NCT00539994|580851343|FG001|Overall Study|Withdrawal by Subject|0|||
160853365|NCT00539994|580851344|FG002|Overall Study|Withdrawal by Subject|1|||
160853366|NCT00539994|580851342|FG000|Overall Study|Physician Decision|0|||
160853367|NCT00539994|580851343|FG001|Overall Study|Physician Decision|0|||
160853368|NCT00539994|580851344|FG002|Overall Study|Physician Decision|1|||
160853369|NCT03084796|580851345|FG000|Overall Study|Adverse Event|4|||
160853370|NCT03084796|580851346|FG001|Overall Study|Adverse Event|5|||
160853371|NCT03084796|580851347|FG002|Overall Study|Adverse Event|6|||
160853372|NCT03084796|580851348|FG003|Overall Study|Adverse Event|2|||
160853373|NCT03084796|580851349|FG004|Overall Study|Adverse Event|3|||
160853374|NCT03084796|580851350|FG005|Overall Study|Adverse Event|5|||
160853375|NCT03084796|580851345|FG000|Overall Study|Withdrawal by Subject|3|||
160853376|NCT03084796|580851346|FG001|Overall Study|Withdrawal by Subject|5|||
160853377|NCT03084796|580851347|FG002|Overall Study|Withdrawal by Subject|2|||
160853378|NCT03084796|580851348|FG003|Overall Study|Withdrawal by Subject|1|||
160853379|NCT03084796|580851349|FG004|Overall Study|Withdrawal by Subject|3|||
160569153|NCT01508676|579806976|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
160569154|NCT01508676|579806975|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
160853380|NCT03084796|580851350|FG005|Overall Study|Withdrawal by Subject|0|||
160853381|NCT03084796|580851345|FG000|Overall Study|Protocol Violation|0|||
160853382|NCT03084796|580851346|FG001|Overall Study|Protocol Violation|0|||
160853383|NCT03084796|580851347|FG002|Overall Study|Protocol Violation|1|||
160853384|NCT03084796|580851348|FG003|Overall Study|Protocol Violation|0|||
160992519|NCT03999554|581361388|FG003|Overall Study|Withdrawal by Subject|1|||
160853385|NCT03084796|580851349|FG004|Overall Study|Protocol Violation|1|||
160853386|NCT03084796|580851350|FG005|Overall Study|Protocol Violation|1|||
160853387|NCT03084796|580851345|FG000|Overall Study|Lack of Efficacy|0|||
160853388|NCT03084796|580851346|FG001|Overall Study|Lack of Efficacy|0|||
160853389|NCT03084796|580851347|FG002|Overall Study|Lack of Efficacy|1|||
160853390|NCT03084796|580851348|FG003|Overall Study|Lack of Efficacy|0|||
160853391|NCT03084796|580851349|FG004|Overall Study|Lack of Efficacy|1|||
160853392|NCT03084796|580851350|FG005|Overall Study|Lack of Efficacy|0|||
160853393|NCT03084796|580851345|FG000|Overall Study|Lost to Follow-up|0|||
160853394|NCT03084796|580851346|FG001|Overall Study|Lost to Follow-up|0|||
160853395|NCT03084796|580851347|FG002|Overall Study|Lost to Follow-up|1|||
160853396|NCT03084796|580851348|FG003|Overall Study|Lost to Follow-up|1|||
160853397|NCT03084796|580851349|FG004|Overall Study|Lost to Follow-up|3|||
160853398|NCT03084796|580851350|FG005|Overall Study|Lost to Follow-up|1|||
160853399|NCT03084796|580851345|FG000|Overall Study|Randomization error|0|||
160853400|NCT03084796|580851346|FG001|Overall Study|Randomization error|0|||
160853401|NCT03084796|580851347|FG002|Overall Study|Randomization error|1|||
160853402|NCT03084796|580851348|FG003|Overall Study|Randomization error|0|||
160853403|NCT03084796|580851349|FG004|Overall Study|Randomization error|0|||
160853404|NCT03084796|580851350|FG005|Overall Study|Randomization error|0|||
160853405|NCT05470985|580851351|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
160853406|NCT05470985|580851352|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
160853407|NCT05470985|580851351|FG000|Double Blind Treatment Period|Physician Decision|0|||
160853408|NCT05470985|580851352|FG001|Double Blind Treatment Period|Physician Decision|1|||
160853409|NCT05470985|580851351|FG000|Long Term Extension|Adverse Event|0|||
160907039|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
160907040|NCT00726232|581053954|FG000|Expansion Phase|Death|0|||
160907041|NCT00726232|581053955|FG001|Expansion Phase|Death|0|||
160907042|NCT00726232|581053956|FG002|Expansion Phase|Death|0|||
160907043|NCT00726232|581053957|FG003|Expansion Phase|Death|0|||
160907044|NCT00726232|581053958|FG004|Expansion Phase|Death|0|||
160907045|NCT00726232|581053959|FG005|Expansion Phase|Death|0|||
160907046|NCT00726232|581053960|FG006|Expansion Phase|Death|0|||
160907047|NCT00726232|581053961|FG007|Expansion Phase|Death|1|||
160907048|NCT00726232|581053954|FG000|Expansion Phase|Adverse Event|0|||
160907049|NCT00726232|581053955|FG001|Expansion Phase|Adverse Event|0|||
160907050|NCT00726232|581053956|FG002|Expansion Phase|Adverse Event|0|||
160907051|NCT00726232|581053957|FG003|Expansion Phase|Adverse Event|0|||
160907052|NCT00726232|581053958|FG004|Expansion Phase|Adverse Event|0|||
160907053|NCT00726232|581053959|FG005|Expansion Phase|Adverse Event|0|||
160907054|NCT00726232|581053960|FG006|Expansion Phase|Adverse Event|6|||
160907055|NCT00726232|581053961|FG007|Expansion Phase|Adverse Event|11|||
160907056|NCT00726232|581053954|FG000|Expansion Phase|Withdrawal by Subject|0|||
160907057|NCT00726232|581053955|FG001|Expansion Phase|Withdrawal by Subject|0|||
160907058|NCT00726232|581053956|FG002|Expansion Phase|Withdrawal by Subject|0|||
160907059|NCT00726232|581053957|FG003|Expansion Phase|Withdrawal by Subject|0|||
160907060|NCT00726232|581053958|FG004|Expansion Phase|Withdrawal by Subject|0|||
160907061|NCT00726232|581053959|FG005|Expansion Phase|Withdrawal by Subject|0|||
160907062|NCT00726232|581053960|FG006|Expansion Phase|Withdrawal by Subject|2|||
160907063|NCT00726232|581053961|FG007|Expansion Phase|Withdrawal by Subject|3|||
160907064|NCT00726232|581053954|FG000|Expansion Phase|Disease progression|0|||
160907065|NCT00726232|581053955|FG001|Expansion Phase|Disease progression|0|||
160907066|NCT00726232|581053956|FG002|Expansion Phase|Disease progression|0|||
160907067|NCT00726232|581053957|FG003|Expansion Phase|Disease progression|0|||
160907068|NCT00726232|581053958|FG004|Expansion Phase|Disease progression|0|||
160907069|NCT00726232|581053959|FG005|Expansion Phase|Disease progression|0|||
160907070|NCT00726232|581053960|FG006|Expansion Phase|Disease progression|4|||
160907071|NCT00726232|581053961|FG007|Expansion Phase|Disease progression|0|||
160907072|NCT00726232|581053954|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
160907073|NCT00726232|581053955|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
160853410|NCT05470985|580851352|FG001|Long Term Extension|Adverse Event|1|||
160907074|NCT00726232|581053956|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
160907075|NCT00726232|581053957|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
160907076|NCT00726232|581053958|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
160907077|NCT00726232|581053959|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
160907078|NCT00726232|581053960|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
160907079|NCT00726232|581053961|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
160907080|NCT00726232|581053954|FG000|Expansion Phase|Per Investigator: lack of response|0|||
160907081|NCT00726232|581053955|FG001|Expansion Phase|Per Investigator: lack of response|0|||
160853411|NCT05470985|580851351|FG000|Long Term Extension|Study terminated by sponsor|2|||
160853412|NCT05470985|580851352|FG001|Long Term Extension|Study terminated by sponsor|0|||
160853413|NCT02741245|580851360|FG000|Overall Study|Adverse Event|0|||
160853414|NCT02741245|580851361|FG001|Overall Study|Adverse Event|0|||
160853415|NCT02741245|580851362|FG002|Overall Study|Adverse Event|0|||
160853416|NCT02741245|580851363|FG003|Overall Study|Adverse Event|2|||
160853417|NCT02741245|580851364|FG004|Overall Study|Adverse Event|2|||
160853418|NCT02741245|580851360|FG000|Overall Study|Protocol Violation|0|||
160853419|NCT02741245|580851361|FG001|Overall Study|Protocol Violation|1|||
160853420|NCT02741245|580851362|FG002|Overall Study|Protocol Violation|0|||
160853421|NCT02741245|580851363|FG003|Overall Study|Protocol Violation|1|||
160853422|NCT02741245|580851364|FG004|Overall Study|Protocol Violation|0|||
160853423|NCT02741245|580851360|FG000|Overall Study|Withdrawal by Subject|0|||
160853424|NCT02741245|580851361|FG001|Overall Study|Withdrawal by Subject|0|||
160853425|NCT02741245|580851362|FG002|Overall Study|Withdrawal by Subject|0|||
160853426|NCT02741245|580851363|FG003|Overall Study|Withdrawal by Subject|1|||
160853427|NCT02741245|580851364|FG004|Overall Study|Withdrawal by Subject|0|||
160853428|NCT01116648|580851367|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
160853429|NCT01116648|580851368|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
160853430|NCT01116648|580851369|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
160853431|NCT01116648|580851370|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
160853432|NCT01116648|580851371|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
160853433|NCT01116648|580851372|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
160853434|NCT01116648|580851373|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
160853435|NCT01116648|580851374|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
160853436|NCT01116648|580851375|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
160853437|NCT01116648|580851376|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
160853438|NCT01116648|580851377|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
160853439|NCT01116648|580851378|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
160853440|NCT01116648|580851379|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
160853441|NCT01116648|580851380|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
160853442|NCT01116648|580851381|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
160853443|NCT01519323|580853209|FG000|Overall Study|Death|3|||
160853444|NCT01519323|580853210|FG001|Overall Study|Death|2|||
160853445|NCT01519323|580853209|FG000|Overall Study|Study terminated by sponsor|0|||
160853446|NCT01519323|580853210|FG001|Overall Study|Study terminated by sponsor|1|||
160853447|NCT03096834|580853227|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
160853448|NCT03096834|580853228|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
160853449|NCT03096834|580853229|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
160853450|NCT03096834|580853230|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
160853451|NCT03096834|580853227|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
160853452|NCT03096834|580853228|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
160853453|NCT03096834|580853229|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
160853454|NCT03096834|580853230|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
160853455|NCT03096834|580853227|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
160853456|NCT03096834|580853228|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
160853457|NCT03096834|580853229|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
160853458|NCT03096834|580853230|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
160853459|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
160853460|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
160853461|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
160853462|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
160853463|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
160853464|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
160853465|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
160650777|NCT03626857|580102569|FG000|Overall Study|Protocol Violation|1|||
160650778|NCT03626857|580102570|FG001|Overall Study|Protocol Violation|3|||
160650779|NCT01301833|580102571|FG000|Overall Study|Adverse Event|7|||
160650780|NCT01301833|580102572|FG001|Overall Study|Adverse Event|5|||
160650781|NCT01301833|580102573|FG002|Overall Study|Adverse Event|5|||
160650782|NCT01301833|580102574|FG003|Overall Study|Adverse Event|5|||
160650783|NCT01301833|580102571|FG000|Overall Study|Lack of Efficacy|1|||
160650784|NCT01301833|580102572|FG001|Overall Study|Lack of Efficacy|1|||
160650785|NCT01301833|580102573|FG002|Overall Study|Lack of Efficacy|0|||
160650786|NCT01301833|580102574|FG003|Overall Study|Lack of Efficacy|0|||
160650787|NCT01301833|580102571|FG000|Overall Study|Physician Decision|3|||
160650788|NCT01301833|580102572|FG001|Overall Study|Physician Decision|1|||
160650789|NCT01301833|580102573|FG002|Overall Study|Physician Decision|1|||
160650790|NCT01301833|580102574|FG003|Overall Study|Physician Decision|0|||
160853466|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
160853467|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
160853468|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
160853469|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
160853470|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
160650791|NCT01301833|580102571|FG000|Overall Study|Withdrawal by Subject|3|||
160853471|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
160853472|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
160853473|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
160853474|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
160853475|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
160853476|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
160853477|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
160853478|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
160853479|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
160853480|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
160853481|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
160853482|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
160853483|NCT03096834|580853227|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
160853484|NCT03096834|580853228|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
160853485|NCT03096834|580853229|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
160853486|NCT03096834|580853230|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
160853487|NCT03096834|580853227|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
160853488|NCT03096834|580853228|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
160853489|NCT03096834|580853229|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
160853490|NCT03096834|580853230|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
160853491|NCT03096834|580853227|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
160853492|NCT03096834|580853228|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
160853493|NCT03096834|580853229|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
160853494|NCT03096834|580853230|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
160853495|NCT02313766|580853235|FG000|Overall Study|surgery cancelled|1|||
160853496|NCT02313766|580853236|FG001|Overall Study|surgery cancelled|0|||
160853497|NCT02313766|580853237|FG002|Overall Study|surgery cancelled|0|||
160853498|NCT02313766|580853235|FG000|Overall Study|Lost to Follow-up|0|||
160853499|NCT02313766|580853236|FG001|Overall Study|Lost to Follow-up|2|||
160853500|NCT02313766|580853237|FG002|Overall Study|Lost to Follow-up|0|||
160853501|NCT02313766|580853235|FG000|Overall Study|Adverse Event|0|||
160853502|NCT02313766|580853236|FG001|Overall Study|Adverse Event|1|||
160853503|NCT02313766|580853237|FG002|Overall Study|Adverse Event|0|||
160853504|NCT01005251|580853238|FG000|Overall Study|Withdrawal by Subject|2|||
160853505|NCT01005251|580853239|FG001|Overall Study|Withdrawal by Subject|5|||
160853506|NCT01005251|580853240|FG002|Overall Study|Withdrawal by Subject|3|||
160853507|NCT01005251|580853241|FG003|Overall Study|Withdrawal by Subject|4|||
160853508|NCT01005251|580853242|FG004|Overall Study|Withdrawal by Subject|9|||
160853509|NCT01005251|580853238|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
160853510|NCT01005251|580853239|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160853511|NCT01005251|580853240|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
160853512|NCT01005251|580853241|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
160853513|NCT01005251|580853242|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
160853514|NCT01005251|580853238|FG000|Overall Study|Adverse Event|2|||
160853515|NCT01005251|580853239|FG001|Overall Study|Adverse Event|6|||
160853516|NCT01005251|580853240|FG002|Overall Study|Adverse Event|8|||
160853517|NCT01005251|580853241|FG003|Overall Study|Adverse Event|5|||
160853518|NCT01005251|580853242|FG004|Overall Study|Adverse Event|4|||
160853519|NCT01005251|580853238|FG000|Overall Study|Protocol Violation|1|||
160853520|NCT01005251|580853239|FG001|Overall Study|Protocol Violation|0|||
160853521|NCT01005251|580853240|FG002|Overall Study|Protocol Violation|0|||
160853522|NCT01005251|580853241|FG003|Overall Study|Protocol Violation|0|||
160853523|NCT01005251|580853242|FG004|Overall Study|Protocol Violation|2|||
160853524|NCT01005251|580853238|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
160853525|NCT01005251|580853239|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
160853526|NCT01005251|580853240|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
160853527|NCT01005251|580853241|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
160853528|NCT01005251|580853242|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
160907082|NCT00726232|581053956|FG002|Expansion Phase|Per Investigator: lack of response|0|||
160907083|NCT00726232|581053957|FG003|Expansion Phase|Per Investigator: lack of response|0|||
160907084|NCT00726232|581053958|FG004|Expansion Phase|Per Investigator: lack of response|0|||
160907085|NCT00726232|581053959|FG005|Expansion Phase|Per Investigator: lack of response|0|||
160907086|NCT00726232|581053960|FG006|Expansion Phase|Per Investigator: lack of response|1|||
160907087|NCT00726232|581053961|FG007|Expansion Phase|Per Investigator: lack of response|7|||
160853529|NCT01005251|580853238|FG000|Overall Study|Lost to Follow-up|1|||
160853530|NCT01005251|580853239|FG001|Overall Study|Lost to Follow-up|4|||
160853531|NCT01005251|580853240|FG002|Overall Study|Lost to Follow-up|2|||
160853532|NCT01005251|580853241|FG003|Overall Study|Lost to Follow-up|0|||
160853533|NCT01005251|580853242|FG004|Overall Study|Lost to Follow-up|0|||
160853534|NCT01005251|580853238|FG000|Overall Study|Physician Decision|0|||
160853535|NCT01005251|580853239|FG001|Overall Study|Physician Decision|0|||
160853536|NCT01005251|580853240|FG002|Overall Study|Physician Decision|0|||
160853537|NCT01005251|580853241|FG003|Overall Study|Physician Decision|0|||
160853538|NCT01005251|580853242|FG004|Overall Study|Physician Decision|2|||
160853539|NCT01005251|580853238|FG000|Overall Study|Patient moved|1|||
160853540|NCT01005251|580853239|FG001|Overall Study|Patient moved|0|||
160853541|NCT01005251|580853240|FG002|Overall Study|Patient moved|0|||
160853542|NCT01005251|580853241|FG003|Overall Study|Patient moved|0|||
160907088|NCT00726232|581053954|FG000|Expansion Phase|Unspecified reason|0|||
160907089|NCT00726232|581053955|FG001|Expansion Phase|Unspecified reason|0|||
160907090|NCT00726232|581053956|FG002|Expansion Phase|Unspecified reason|0|||
160907091|NCT00726232|581053957|FG003|Expansion Phase|Unspecified reason|0|||
160907092|NCT00726232|581053958|FG004|Expansion Phase|Unspecified reason|0|||
160907093|NCT00726232|581053959|FG005|Expansion Phase|Unspecified reason|0|||
160907094|NCT00726232|581053960|FG006|Expansion Phase|Unspecified reason|1|||
160907095|NCT00726232|581053961|FG007|Expansion Phase|Unspecified reason|0|||
160907096|NCT02864498|581053962|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
160907097|NCT02864498|581053963|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
160907098|NCT02864498|581053964|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
160907099|NCT02864498|581053962|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
160907100|NCT02864498|581053963|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
160907101|NCT02864498|581053964|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
160907102|NCT02864498|581053962|FG000|Overall Study|Investigator Discretion|0|||
160907103|NCT02864498|581053963|FG001|Overall Study|Investigator Discretion|2|||
160907104|NCT02864498|581053964|FG002|Overall Study|Investigator Discretion|1|||
160907105|NCT02864498|581053962|FG000|Overall Study|Lost to Follow-up|8|||
160907106|NCT02864498|581053963|FG001|Overall Study|Lost to Follow-up|6|||
160907107|NCT02864498|581053964|FG002|Overall Study|Lost to Follow-up|3|||
160907108|NCT02864498|581053962|FG000|Overall Study|Lack of Efficacy|5|||
160853543|NCT01005251|580853242|FG004|Overall Study|Patient moved|0|||
160853544|NCT01005251|580853238|FG000|Overall Study|Wrong drug dispensed|0|||
160853545|NCT01005251|580853239|FG001|Overall Study|Wrong drug dispensed|1|||
160853546|NCT01005251|580853240|FG002|Overall Study|Wrong drug dispensed|0|||
160853547|NCT01005251|580853241|FG003|Overall Study|Wrong drug dispensed|0|||
160853548|NCT01005251|580853242|FG004|Overall Study|Wrong drug dispensed|0|||
160853549|NCT01005251|580853238|FG000|Overall Study|Randomized in error|0|||
160853550|NCT01005251|580853239|FG001|Overall Study|Randomized in error|0|||
160853551|NCT01005251|580853240|FG002|Overall Study|Randomized in error|1|||
160853552|NCT01005251|580853241|FG003|Overall Study|Randomized in error|1|||
160853553|NCT01005251|580853242|FG004|Overall Study|Randomized in error|0|||
160853554|NCT01005251|580853238|FG000|Overall Study|Lack of Efficacy|0|||
160853555|NCT01005251|580853239|FG001|Overall Study|Lack of Efficacy|0|||
160853556|NCT01005251|580853240|FG002|Overall Study|Lack of Efficacy|1|||
160853557|NCT01005251|580853241|FG003|Overall Study|Lack of Efficacy|1|||
160853558|NCT01005251|580853242|FG004|Overall Study|Lack of Efficacy|0|||
160853559|NCT02193776|580853243|FG000|Overall Study|Consent withdrawn|1|||
160853560|NCT02193776|580853244|FG001|Overall Study|Consent withdrawn|0|||
160853561|NCT02193776|580853245|FG002|Overall Study|Consent withdrawn|0|||
160853562|NCT02193776|580853246|FG003|Overall Study|Consent withdrawn|0|||
160853563|NCT02193776|580853243|FG000|Overall Study|Failure to comply with protocol|0|||
160853564|NCT02193776|580853244|FG001|Overall Study|Failure to comply with protocol|1|||
160853565|NCT02193776|580853245|FG002|Overall Study|Failure to comply with protocol|0|||
160853566|NCT02193776|580853246|FG003|Overall Study|Failure to comply with protocol|0|||
160853567|NCT02193776|580853243|FG000|Overall Study|Investigator/Sponsor decision|1|||
160853568|NCT02193776|580853244|FG001|Overall Study|Investigator/Sponsor decision|1|||
160853569|NCT02193776|580853245|FG002|Overall Study|Investigator/Sponsor decision|0|||
160853570|NCT02193776|580853246|FG003|Overall Study|Investigator/Sponsor decision|0|||
160853571|NCT02193776|580853243|FG000|Overall Study|Death|1|||
160853572|NCT02193776|580853244|FG001|Overall Study|Death|0|||
160853573|NCT02193776|580853245|FG002|Overall Study|Death|0|||
160907109|NCT02864498|581053963|FG001|Overall Study|Lack of Efficacy|3|||
160907110|NCT02864498|581053964|FG002|Overall Study|Lack of Efficacy|3|||
160907111|NCT02864498|581053962|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
160907112|NCT02864498|581053963|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
160853574|NCT02193776|580853246|FG003|Overall Study|Death|0|||
160853575|NCT02193776|580853243|FG000|Overall Study|Adverse event/Specific toxicity|5|||
160853576|NCT02193776|580853244|FG001|Overall Study|Adverse event/Specific toxicity|5|||
160853577|NCT02193776|580853245|FG002|Overall Study|Adverse event/Specific toxicity|2|||
160853578|NCT02193776|580853246|FG003|Overall Study|Adverse event/Specific toxicity|2|||
160853579|NCT01702844|580853247|FG000|Overall Study|Adverse Event|9|||
160853580|NCT01702844|580853247|FG000|Overall Study|Death|1|||
160907113|NCT02864498|581053964|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
160907114|NCT02864498|581053962|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
160853581|NCT01702844|580853247|FG000|Overall Study|Withdrawal by Subject|3|||
160853582|NCT01702844|580853247|FG000|Overall Study|Physician Decision|6|||
160853583|NCT02995980|580853248|FG000|Overall Study|Lost to Follow-up|14|||
160853584|NCT01169103|580853249|FG000|Overall Study|Lost to Follow-up|3|||
160853585|NCT01169103|580853250|FG001|Overall Study|Lost to Follow-up|3|||
160853586|NCT01169103|580853249|FG000|Overall Study|Withdrawal by Subject|3|||
160853587|NCT01169103|580853250|FG001|Overall Study|Withdrawal by Subject|1|||
160853588|NCT06039579|580853251|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853589|NCT06039579|580853252|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853590|NCT06039579|580853253|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853591|NCT06039579|580853254|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853592|NCT06039579|580853255|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853593|NCT06039579|580853256|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853594|NCT06039579|580853257|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853595|NCT06039579|580853258|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
160853596|NCT00981149|580853264|FG000|Overall Study|Lost to Follow-up|1|||
160853597|NCT00981149|580853265|FG001|Overall Study|Lost to Follow-up|2|||
160853598|NCT00981149|580853264|FG000|Overall Study|Withdrawal by Subject|1|||
160853599|NCT00981149|580853265|FG001|Overall Study|Withdrawal by Subject|1|||
160853600|NCT02634333|580853271|FG000|Overall Study|Completed out of Window|3|||
160853601|NCT02634333|580853272|FG001|Overall Study|Completed out of Window|2|||
160853602|NCT02634333|580853271|FG000|Overall Study|Missed Visit|5|||
160853603|NCT02634333|580853272|FG001|Overall Study|Missed Visit|2|||
160853604|NCT02634333|580853271|FG000|Overall Study|Lost to Follow-up|12|||
160853605|NCT02634333|580853272|FG001|Overall Study|Lost to Follow-up|7|||
160853606|NCT02634333|580853271|FG000|Overall Study|Withdrawal by Subject|9|||
160853607|NCT02634333|580853272|FG001|Overall Study|Withdrawal by Subject|13|||
160853608|NCT02634333|580853271|FG000|Overall Study|Death|11|||
160853609|NCT02634333|580853272|FG001|Overall Study|Death|8|||
160853610|NCT00657046|580853275|FG000|Overall Study|Adverse Event|1|||
160853611|NCT00657046|580853276|FG001|Overall Study|Adverse Event|1|||
160853612|NCT00657046|580853277|FG002|Overall Study|Adverse Event|0|||
160853613|NCT00657046|580853275|FG000|Overall Study|Protocol Violation|2|||
160853614|NCT00657046|580853276|FG001|Overall Study|Protocol Violation|2|||
160853615|NCT00657046|580853277|FG002|Overall Study|Protocol Violation|0|||
160853616|NCT00657046|580853275|FG000|Overall Study|Withdrawal by Subject|1|||
160853617|NCT00657046|580853276|FG001|Overall Study|Withdrawal by Subject|0|||
160853618|NCT00657046|580853277|FG002|Overall Study|Withdrawal by Subject|0|||
160853619|NCT00657046|580853275|FG000|Overall Study|Death|0|||
160853620|NCT00657046|580853276|FG001|Overall Study|Death|0|||
160853621|NCT00657046|580853277|FG002|Overall Study|Death|1|||
160853622|NCT00657046|580853275|FG000|Overall Study|Surgery|0|||
160853623|NCT00657046|580853276|FG001|Overall Study|Surgery|0|||
160853624|NCT00657046|580853277|FG002|Overall Study|Surgery|1|||
160853625|NCT03827655|580853278|FG000|Overall Study|Death|0|||
160853626|NCT03827655|580853279|FG001|Overall Study|Death|0|||
160853627|NCT03827655|580853280|FG002|Overall Study|Death|0|||
160853628|NCT03827655|580853281|FG003|Overall Study|Death|0|||
160853629|NCT03827655|580853282|FG004|Overall Study|Death|1|||
160853630|NCT03827655|580853278|FG000|Overall Study|Protocol Deviation|1|||
160853631|NCT03827655|580853279|FG001|Overall Study|Protocol Deviation|0|||
160853632|NCT03827655|580853280|FG002|Overall Study|Protocol Deviation|1|||
160853633|NCT03827655|580853281|FG003|Overall Study|Protocol Deviation|1|||
160853634|NCT03827655|580853282|FG004|Overall Study|Protocol Deviation|0|||
160853635|NCT03827655|580853278|FG000|Overall Study|Withdrawal by Subject|3|||
160853636|NCT03827655|580853279|FG001|Overall Study|Withdrawal by Subject|2|||
160853637|NCT03827655|580853280|FG002|Overall Study|Withdrawal by Subject|2|||
160853638|NCT03827655|580853281|FG003|Overall Study|Withdrawal by Subject|0|||
160853639|NCT03827655|580853282|FG004|Overall Study|Withdrawal by Subject|1|||
160853640|NCT03827655|580853278|FG000|Overall Study|Reason not Specified|3|||
160853641|NCT03827655|580853279|FG001|Overall Study|Reason not Specified|1|||
160853642|NCT03827655|580853280|FG002|Overall Study|Reason not Specified|1|||
160853643|NCT03827655|580853281|FG003|Overall Study|Reason not Specified|1|||
160853644|NCT03827655|580853282|FG004|Overall Study|Reason not Specified|1|||
160853645|NCT03935126|580853285|FG000|Overall Study|Study termination by sponsor|3|||
160853646|NCT01092728|580853286|FG000|Overall Study|Withdrawal by Subject|2|||
160853647|NCT01092728|580853287|FG001|Overall Study|Withdrawal by Subject|0|||
160853648|NCT01092728|580853286|FG000|Overall Study|Adverse Event|0|||
160853649|NCT01092728|580853287|FG001|Overall Study|Adverse Event|1|||
160853650|NCT01092728|580853286|FG000|Overall Study|Disease Progression|1|||
160853651|NCT01092728|580853287|FG001|Overall Study|Disease Progression|13|||
160853652|NCT01092728|580853286|FG000|Overall Study|Prohibited Concomitant Medications|1|||
160853653|NCT01092728|580853287|FG001|Overall Study|Prohibited Concomitant Medications|0|||
160853654|NCT02336607|580853288|FG000|Overall Study|Physician Decision|1|||
160853655|NCT02336607|580853289|FG001|Overall Study|Physician Decision|4|||
160853656|NCT02336607|580853290|FG002|Overall Study|Physician Decision|3|||
160853657|NCT02336607|580853291|FG003|Overall Study|Physician Decision|15|||
160853658|NCT02336607|580853288|FG000|Overall Study|Lack of Efficacy|1|||
160853659|NCT02336607|580853289|FG001|Overall Study|Lack of Efficacy|0|||
160853660|NCT02336607|580853290|FG002|Overall Study|Lack of Efficacy|0|||
160853661|NCT02336607|580853291|FG003|Overall Study|Lack of Efficacy|2|||
160853662|NCT02336607|580853288|FG000|Overall Study|Lost to Follow-up|2|||
160853663|NCT02336607|580853289|FG001|Overall Study|Lost to Follow-up|1|||
160853664|NCT02336607|580853290|FG002|Overall Study|Lost to Follow-up|0|||
160853665|NCT02336607|580853291|FG003|Overall Study|Lost to Follow-up|21|||
160853666|NCT02336607|580853288|FG000|Overall Study|Protocol Violation|0|||
160650792|NCT01301833|580102572|FG001|Overall Study|Withdrawal by Subject|1|||
160650793|NCT01301833|580102573|FG002|Overall Study|Withdrawal by Subject|1|||
160853667|NCT02336607|580853289|FG001|Overall Study|Protocol Violation|1|||
160853668|NCT02336607|580853290|FG002|Overall Study|Protocol Violation|1|||
160853669|NCT02336607|580853291|FG003|Overall Study|Protocol Violation|3|||
160853670|NCT02336607|580853288|FG000|Overall Study|Adverse Event|0|||
160853671|NCT02336607|580853289|FG001|Overall Study|Adverse Event|2|||
160853672|NCT02336607|580853290|FG002|Overall Study|Adverse Event|2|||
160853673|NCT02336607|580853291|FG003|Overall Study|Adverse Event|26|||
160853674|NCT02336607|580853288|FG000|Overall Study|Withdrawal by Subject|0|||
160853675|NCT02336607|580853289|FG001|Overall Study|Withdrawal by Subject|2|||
160853676|NCT02336607|580853290|FG002|Overall Study|Withdrawal by Subject|0|||
160853677|NCT02336607|580853291|FG003|Overall Study|Withdrawal by Subject|20|||
160853678|NCT02552966|580853292|FG000|Overall Study|Lost to Follow-up|2|||
160853679|NCT02552966|580853292|FG000|Overall Study|Withdrawal by Subject|3|||
160853680|NCT01506271|580853304|FG000|Overall Study|Progressive disease|0|||
160853681|NCT01506271|580853305|FG001|Overall Study|Progressive disease|1|||
160853682|NCT01506271|580853306|FG002|Overall Study|Progressive disease|0|||
160853683|NCT01506271|580853304|FG000|Overall Study|Protocol Violation|3|||
160853684|NCT01506271|580853305|FG001|Overall Study|Protocol Violation|1|||
160907115|NCT02864498|581053963|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
160907116|NCT02864498|581053964|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
160907117|NCT02864498|581053962|FG000|Overall Study|Subject moved out of the country.|0|||
160907118|NCT02864498|581053963|FG001|Overall Study|Subject moved out of the country.|0|||
160907119|NCT02864498|581053964|FG002|Overall Study|Subject moved out of the country.|1|||
160907120|NCT00705484|581053967|FG000|Overall Study|Adverse Event|28|||
160907121|NCT00705484|581053968|FG001|Overall Study|Adverse Event|27|||
160907122|NCT00705484|581053967|FG000|Overall Study|Lost to Follow-up|169|||
160907123|NCT00705484|581053968|FG001|Overall Study|Lost to Follow-up|250|||
160907124|NCT00705484|581053967|FG000|Overall Study|Withdrawal by Subject|96|||
160907125|NCT00705484|581053968|FG001|Overall Study|Withdrawal by Subject|72|||
160907126|NCT00705484|581053967|FG000|Overall Study|Administrative|89|||
160907127|NCT00705484|581053968|FG001|Overall Study|Administrative|59|||
160907128|NCT02197247|581053969|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
160907129|NCT02197247|581053969|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
160907130|NCT02197247|581053969|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
160907131|NCT02197247|581053969|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
160907132|NCT02197247|581053969|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
160907133|NCT02197247|581053969|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
160907134|NCT02197247|581053969|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
160907135|NCT02197247|581053969|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
160907136|NCT01606007|581053970|FG000|Overall Study|Reason 'Other' in the protocol|0|||
160853685|NCT01506271|580853306|FG002|Overall Study|Protocol Violation|0|||
160853686|NCT01506271|580853304|FG000|Overall Study|Death|0|||
160853687|NCT01506271|580853305|FG001|Overall Study|Death|1|||
160853688|NCT01506271|580853306|FG002|Overall Study|Death|0|||
160454067|NCT02038777|579394025|FG003|Overall Study|Started Chemotherapy|0|||
160853689|NCT01506271|580853304|FG000|Overall Study|Adverse Event|0|||
160853690|NCT01506271|580853305|FG001|Overall Study|Adverse Event|2|||
160853691|NCT01506271|580853306|FG002|Overall Study|Adverse Event|0|||
160853692|NCT01506271|580853304|FG000|Overall Study|Insufficient supply of study drug|1|||
160853693|NCT01506271|580853305|FG001|Overall Study|Insufficient supply of study drug|0|||
160853694|NCT01506271|580853306|FG002|Overall Study|Insufficient supply of study drug|0|||
160853695|NCT01506271|580853304|FG000|Overall Study|Withdrawal by Subject|0|||
160853696|NCT01506271|580853305|FG001|Overall Study|Withdrawal by Subject|1|||
160853697|NCT01506271|580853306|FG002|Overall Study|Withdrawal by Subject|1|||
160853698|NCT01506271|580853304|FG000|Overall Study|Lost to Follow-up|0|||
160853699|NCT01506271|580853305|FG001|Overall Study|Lost to Follow-up|1|||
160853700|NCT01506271|580853306|FG002|Overall Study|Lost to Follow-up|2|||
160853701|NCT00689390|580853307|FG000|Overall Study|Adverse Event|19|||
160853702|NCT00689390|580853308|FG001|Overall Study|Adverse Event|0|||
160853703|NCT00689390|580853307|FG000|Overall Study|Lost to Follow-up|179|||
160853704|NCT00689390|580853308|FG001|Overall Study|Lost to Follow-up|7|||
160853705|NCT00689390|580853307|FG000|Overall Study|Withdrawal by Subject|117|||
160853706|NCT00689390|580853308|FG001|Overall Study|Withdrawal by Subject|3|||
160853707|NCT00689390|580853307|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
160853708|NCT00689390|580853308|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
160853709|NCT00689390|580853307|FG000|Overall Study|Non-Compliance With Protocol|21|||
160853710|NCT00689390|580853308|FG001|Overall Study|Non-Compliance With Protocol|0|||
160853711|NCT00689390|580853307|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
160853712|NCT00689390|580853308|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
160853713|NCT00689390|580853307|FG000|Overall Study|Administrative|37|||
160853714|NCT00689390|580853308|FG001|Overall Study|Administrative|0|||
160853715|NCT03318549|580853309|FG000|Overall Study|Withdrawal by Subject|5|||
160853716|NCT03318549|580853310|FG001|Overall Study|Withdrawal by Subject|19|||
160853717|NCT03318549|580853311|FG002|Overall Study|Withdrawal by Subject|2|||
160853718|NCT03318549|580853312|FG003|Overall Study|Withdrawal by Subject|0|||
160853719|NCT03318549|580853313|FG004|Overall Study|Withdrawal by Subject|0|||
160853720|NCT03318549|580853314|FG005|Overall Study|Withdrawal by Subject|0|||
160853721|NCT03318549|580853315|FG006|Overall Study|Withdrawal by Subject|0|||
160853722|NCT03318549|580853309|FG000|Overall Study|Physician Decision|0|||
160853723|NCT03318549|580853310|FG001|Overall Study|Physician Decision|4|||
160853724|NCT03318549|580853311|FG002|Overall Study|Physician Decision|1|||
160853725|NCT03318549|580853312|FG003|Overall Study|Physician Decision|0|||
160853726|NCT03318549|580853313|FG004|Overall Study|Physician Decision|0|||
160853727|NCT03318549|580853314|FG005|Overall Study|Physician Decision|0|||
160853728|NCT03318549|580853315|FG006|Overall Study|Physician Decision|0|||
160853729|NCT03318549|580853309|FG000|Overall Study|Lost to Follow-up|0|||
160853730|NCT03318549|580853310|FG001|Overall Study|Lost to Follow-up|3|||
160853731|NCT03318549|580853311|FG002|Overall Study|Lost to Follow-up|3|||
160853732|NCT03318549|580853312|FG003|Overall Study|Lost to Follow-up|0|||
160853733|NCT03318549|580853313|FG004|Overall Study|Lost to Follow-up|0|||
160853734|NCT03318549|580853314|FG005|Overall Study|Lost to Follow-up|0|||
160853735|NCT03318549|580853315|FG006|Overall Study|Lost to Follow-up|0|||
160853736|NCT00510835|580853317|FG000|Overall Study|Withdrawal by Subject|6|||
160853737|NCT00510835|580853318|FG001|Overall Study|Withdrawal by Subject|2|||
160853738|NCT00510835|580853319|FG002|Overall Study|Withdrawal by Subject|2|||
160853739|NCT01917747|580853320|FG000|Overall Study|Withdrawal by Subject|1|||
160853740|NCT01917747|580853321|FG001|Overall Study|Withdrawal by Subject|2|||
160853741|NCT01917747|580853320|FG000|Overall Study|Lost to Follow-up|18|||
160853742|NCT01917747|580853321|FG001|Overall Study|Lost to Follow-up|9|||
160853743|NCT03064490|580853323|FG000|Overall Study|Physician Decision|5|||
160853744|NCT05579977|580853328|FG000|Treatment Phase|Other|0|||
160853745|NCT05579977|580853329|FG001|Treatment Phase|Other|0|||
160853746|NCT05579977|580853330|FG002|Treatment Phase|Other|0|||
160853747|NCT05579977|580853331|FG003|Treatment Phase|Other|2|||
160853748|NCT05579977|580853332|FG004|Treatment Phase|Other|1|||
160853749|NCT05579977|580853333|FG005|Treatment Phase|Other|2|||
160853750|NCT05579977|580853334|FG006|Treatment Phase|Other|1|||
160853751|NCT05579977|580853335|FG007|Treatment Phase|Other|2|||
160853752|NCT05579977|580853336|FG008|Treatment Phase|Other|2|||
160853753|NCT05579977|580853337|FG009|Treatment Phase|Other|1|||
160853754|NCT05579977|580853338|FG010|Treatment Phase|Other|0|||
160853755|NCT05579977|580853339|FG011|Treatment Phase|Other|0|||
160853756|NCT05579977|580853340|FG012|Treatment Phase|Other|3|||
160853757|NCT05579977|580853328|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
160853758|NCT05579977|580853329|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
160853759|NCT05579977|580853330|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
160853760|NCT05579977|580853331|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
160853761|NCT05579977|580853332|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
160853762|NCT05579977|580853333|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
160853763|NCT05579977|580853334|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
160853764|NCT05579977|580853335|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
160853765|NCT05579977|580853336|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
160650794|NCT01301833|580102574|FG003|Overall Study|Withdrawal by Subject|2|||
160650795|NCT01301833|580102571|FG000|Overall Study|Personal matter|1|||
160650796|NCT01301833|580102572|FG001|Overall Study|Personal matter|0|||
160650797|NCT01301833|580102573|FG002|Overall Study|Personal matter|0|||
160650798|NCT01301833|580102574|FG003|Overall Study|Personal matter|0|||
160650799|NCT04820842|580104329|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
160650800|NCT04820842|580104330|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
160650801|NCT04820842|580104331|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
160650802|NCT04820842|580104332|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
160650803|NCT04820842|580104333|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
160650804|NCT04820842|580104334|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
160650805|NCT04820842|580104335|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
160650806|NCT04820842|580104329|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
160650807|NCT04820842|580104330|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
160650808|NCT04820842|580104331|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
160650809|NCT04820842|580104332|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
160650810|NCT04820842|580104333|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
160853766|NCT05579977|580853337|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
160853767|NCT05579977|580853338|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
160853768|NCT05579977|580853339|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
160853769|NCT05579977|580853340|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
160853770|NCT05579977|580853328|FG000|Treatment Phase|Withdrawal by Subject|2|||
160853771|NCT05579977|580853329|FG001|Treatment Phase|Withdrawal by Subject|0|||
160853772|NCT05579977|580853330|FG002|Treatment Phase|Withdrawal by Subject|0|||
160853773|NCT05579977|580853331|FG003|Treatment Phase|Withdrawal by Subject|1|||
160853774|NCT05579977|580853332|FG004|Treatment Phase|Withdrawal by Subject|2|||
160853775|NCT05579977|580853333|FG005|Treatment Phase|Withdrawal by Subject|0|||
160853776|NCT05579977|580853334|FG006|Treatment Phase|Withdrawal by Subject|1|||
160853777|NCT05579977|580853335|FG007|Treatment Phase|Withdrawal by Subject|8|||
160853778|NCT05579977|580853336|FG008|Treatment Phase|Withdrawal by Subject|3|||
160853779|NCT05579977|580853337|FG009|Treatment Phase|Withdrawal by Subject|3|||
160853780|NCT05579977|580853338|FG010|Treatment Phase|Withdrawal by Subject|5|||
160853781|NCT05579977|580853339|FG011|Treatment Phase|Withdrawal by Subject|1|||
160853782|NCT05579977|580853340|FG012|Treatment Phase|Withdrawal by Subject|3|||
160853783|NCT05579977|580853328|FG000|Treatment Phase|Study terminated by sponsor|70|||
160853784|NCT05579977|580853329|FG001|Treatment Phase|Study terminated by sponsor|70|||
160853785|NCT05579977|580853330|FG002|Treatment Phase|Study terminated by sponsor|61|||
160853786|NCT05579977|580853331|FG003|Treatment Phase|Study terminated by sponsor|59|||
160853787|NCT05579977|580853332|FG004|Treatment Phase|Study terminated by sponsor|63|||
160853788|NCT05579977|580853333|FG005|Treatment Phase|Study terminated by sponsor|53|||
160853789|NCT05579977|580853334|FG006|Treatment Phase|Study terminated by sponsor|66|||
160853790|NCT05579977|580853335|FG007|Treatment Phase|Study terminated by sponsor|48|||
160853791|NCT05579977|580853336|FG008|Treatment Phase|Study terminated by sponsor|47|||
160853792|NCT05579977|580853337|FG009|Treatment Phase|Study terminated by sponsor|37|||
160853793|NCT05579977|580853338|FG010|Treatment Phase|Study terminated by sponsor|44|||
160853794|NCT05579977|580853339|FG011|Treatment Phase|Study terminated by sponsor|36|||
160853795|NCT05579977|580853340|FG012|Treatment Phase|Study terminated by sponsor|32|||
160853796|NCT05579977|580853328|FG000|Treatment Phase|Pregnancy|0|||
160853797|NCT05579977|580853329|FG001|Treatment Phase|Pregnancy|0|||
160853798|NCT05579977|580853330|FG002|Treatment Phase|Pregnancy|0|||
160853799|NCT05579977|580853331|FG003|Treatment Phase|Pregnancy|0|||
160853800|NCT05579977|580853332|FG004|Treatment Phase|Pregnancy|0|||
160853801|NCT05579977|580853333|FG005|Treatment Phase|Pregnancy|0|||
160853802|NCT05579977|580853334|FG006|Treatment Phase|Pregnancy|0|||
160853803|NCT05579977|580853335|FG007|Treatment Phase|Pregnancy|0|||
160853804|NCT05579977|580853336|FG008|Treatment Phase|Pregnancy|0|||
160853805|NCT05579977|580853337|FG009|Treatment Phase|Pregnancy|1|||
160853806|NCT05579977|580853338|FG010|Treatment Phase|Pregnancy|0|||
160853807|NCT05579977|580853339|FG011|Treatment Phase|Pregnancy|0|||
160853808|NCT05579977|580853340|FG012|Treatment Phase|Pregnancy|0|||
160853809|NCT05579977|580853328|FG000|Treatment Phase|Physician Decision|0|||
160853810|NCT05579977|580853329|FG001|Treatment Phase|Physician Decision|0|||
160853811|NCT05579977|580853330|FG002|Treatment Phase|Physician Decision|0|||
160853812|NCT05579977|580853331|FG003|Treatment Phase|Physician Decision|0|||
160853813|NCT05579977|580853332|FG004|Treatment Phase|Physician Decision|0|||
160853814|NCT05579977|580853333|FG005|Treatment Phase|Physician Decision|0|||
160853815|NCT05579977|580853334|FG006|Treatment Phase|Physician Decision|0|||
160853816|NCT05579977|580853335|FG007|Treatment Phase|Physician Decision|0|||
160853817|NCT05579977|580853336|FG008|Treatment Phase|Physician Decision|0|||
160853818|NCT05579977|580853337|FG009|Treatment Phase|Physician Decision|0|||
160853819|NCT05579977|580853338|FG010|Treatment Phase|Physician Decision|0|||
160853820|NCT05579977|580853339|FG011|Treatment Phase|Physician Decision|1|||
160853821|NCT05579977|580853340|FG012|Treatment Phase|Physician Decision|0|||
160853822|NCT05579977|580853328|FG000|Treatment Phase|Lost to Follow-up|0|||
160853823|NCT05579977|580853329|FG001|Treatment Phase|Lost to Follow-up|0|||
160853824|NCT05579977|580853330|FG002|Treatment Phase|Lost to Follow-up|0|||
160853825|NCT05579977|580853331|FG003|Treatment Phase|Lost to Follow-up|1|||
160853826|NCT05579977|580853332|FG004|Treatment Phase|Lost to Follow-up|1|||
160853827|NCT05579977|580853333|FG005|Treatment Phase|Lost to Follow-up|1|||
160853828|NCT05579977|580853334|FG006|Treatment Phase|Lost to Follow-up|0|||
160853829|NCT05579977|580853335|FG007|Treatment Phase|Lost to Follow-up|1|||
160853830|NCT05579977|580853336|FG008|Treatment Phase|Lost to Follow-up|2|||
160853831|NCT05579977|580853337|FG009|Treatment Phase|Lost to Follow-up|2|||
160853832|NCT05579977|580853338|FG010|Treatment Phase|Lost to Follow-up|1|||
160853833|NCT05579977|580853339|FG011|Treatment Phase|Lost to Follow-up|4|||
160853834|NCT05579977|580853340|FG012|Treatment Phase|Lost to Follow-up|3|||
160853835|NCT05579977|580853328|FG000|Treatment Phase|Death|1|||
160853836|NCT05579977|580853329|FG001|Treatment Phase|Death|0|||
160853837|NCT05579977|580853330|FG002|Treatment Phase|Death|0|||
160853838|NCT05579977|580853331|FG003|Treatment Phase|Death|0|||
160853839|NCT05579977|580853332|FG004|Treatment Phase|Death|0|||
160853840|NCT05579977|580853333|FG005|Treatment Phase|Death|0|||
160853841|NCT05579977|580853334|FG006|Treatment Phase|Death|0|||
160853842|NCT05579977|580853335|FG007|Treatment Phase|Death|0|||
160853843|NCT05579977|580853336|FG008|Treatment Phase|Death|0|||
160853844|NCT05579977|580853337|FG009|Treatment Phase|Death|0|||
160853845|NCT05579977|580853338|FG010|Treatment Phase|Death|0|||
160853846|NCT05579977|580853339|FG011|Treatment Phase|Death|0|||
160853847|NCT05579977|580853340|FG012|Treatment Phase|Death|0|||
160853848|NCT05579977|580853328|FG000|Treatment Phase|Adverse Event|0|||
160853849|NCT05579977|580853329|FG001|Treatment Phase|Adverse Event|3|||
160853850|NCT05579977|580853330|FG002|Treatment Phase|Adverse Event|11|||
160853851|NCT05579977|580853331|FG003|Treatment Phase|Adverse Event|10|||
160853852|NCT05579977|580853332|FG004|Treatment Phase|Adverse Event|5|||
160853853|NCT05579977|580853333|FG005|Treatment Phase|Adverse Event|17|||
160853854|NCT05579977|580853334|FG006|Treatment Phase|Adverse Event|5|||
160853855|NCT05579977|580853335|FG007|Treatment Phase|Adverse Event|5|||
160853856|NCT05579977|580853336|FG008|Treatment Phase|Adverse Event|12|||
160853857|NCT05579977|580853337|FG009|Treatment Phase|Adverse Event|20|||
160853858|NCT05579977|580853338|FG010|Treatment Phase|Adverse Event|15|||
160853859|NCT05579977|580853339|FG011|Treatment Phase|Adverse Event|24|||
160853860|NCT05579977|580853340|FG012|Treatment Phase|Adverse Event|23|||
160853861|NCT05579977|580853328|FG000|Treatment Phase|Randomized not treated|0|||
160853862|NCT05579977|580853329|FG001|Treatment Phase|Randomized not treated|0|||
160853863|NCT05579977|580853330|FG002|Treatment Phase|Randomized not treated|0|||
160853864|NCT05579977|580853331|FG003|Treatment Phase|Randomized not treated|0|||
160853865|NCT05579977|580853332|FG004|Treatment Phase|Randomized not treated|1|||
160853866|NCT05579977|580853333|FG005|Treatment Phase|Randomized not treated|0|||
160853867|NCT05579977|580853334|FG006|Treatment Phase|Randomized not treated|0|||
160853868|NCT05579977|580853335|FG007|Treatment Phase|Randomized not treated|0|||
160853869|NCT05579977|580853336|FG008|Treatment Phase|Randomized not treated|0|||
160853870|NCT05579977|580853337|FG009|Treatment Phase|Randomized not treated|0|||
160853871|NCT05579977|580853338|FG010|Treatment Phase|Randomized not treated|0|||
160853872|NCT05579977|580853339|FG011|Treatment Phase|Randomized not treated|0|||
160853873|NCT05579977|580853340|FG012|Treatment Phase|Randomized not treated|0|||
160853874|NCT05579977|580853328|FG000|Follow up|Death|1|||
160853875|NCT05579977|580853329|FG001|Follow up|Death|0|||
160853876|NCT05579977|580853330|FG002|Follow up|Death|0|||
160853877|NCT05579977|580853331|FG003|Follow up|Death|0|||
160853878|NCT05579977|580853332|FG004|Follow up|Death|0|||
160853879|NCT05579977|580853333|FG005|Follow up|Death|0|||
160853880|NCT05579977|580853334|FG006|Follow up|Death|0|||
160853881|NCT05579977|580853335|FG007|Follow up|Death|0|||
160853882|NCT05579977|580853336|FG008|Follow up|Death|0|||
160853883|NCT05579977|580853337|FG009|Follow up|Death|0|||
160853884|NCT05579977|580853338|FG010|Follow up|Death|0|||
160853885|NCT05579977|580853339|FG011|Follow up|Death|0|||
160853886|NCT05579977|580853340|FG012|Follow up|Death|0|||
160853887|NCT05579977|580853328|FG000|Follow up|Lost to Follow-up|0|||
160853888|NCT05579977|580853329|FG001|Follow up|Lost to Follow-up|0|||
160853889|NCT05579977|580853330|FG002|Follow up|Lost to Follow-up|0|||
160853890|NCT05579977|580853331|FG003|Follow up|Lost to Follow-up|1|||
160853891|NCT05579977|580853332|FG004|Follow up|Lost to Follow-up|1|||
160853892|NCT05579977|580853333|FG005|Follow up|Lost to Follow-up|2|||
160853893|NCT05579977|580853334|FG006|Follow up|Lost to Follow-up|1|||
160853894|NCT05579977|580853335|FG007|Follow up|Lost to Follow-up|1|||
160853895|NCT05579977|580853336|FG008|Follow up|Lost to Follow-up|3|||
160853896|NCT05579977|580853337|FG009|Follow up|Lost to Follow-up|2|||
160853897|NCT05579977|580853338|FG010|Follow up|Lost to Follow-up|2|||
160853898|NCT05579977|580853339|FG011|Follow up|Lost to Follow-up|4|||
160853899|NCT05579977|580853340|FG012|Follow up|Lost to Follow-up|4|||
160853900|NCT05579977|580853328|FG000|Follow up|Withdrawal by Subject|2|||
160853901|NCT05579977|580853329|FG001|Follow up|Withdrawal by Subject|0|||
160853902|NCT05579977|580853330|FG002|Follow up|Withdrawal by Subject|0|||
160853903|NCT05579977|580853331|FG003|Follow up|Withdrawal by Subject|0|||
160853904|NCT05579977|580853332|FG004|Follow up|Withdrawal by Subject|1|||
160853905|NCT05579977|580853333|FG005|Follow up|Withdrawal by Subject|0|||
160853906|NCT05579977|580853334|FG006|Follow up|Withdrawal by Subject|1|||
160853907|NCT05579977|580853335|FG007|Follow up|Withdrawal by Subject|4|||
160853908|NCT05579977|580853336|FG008|Follow up|Withdrawal by Subject|2|||
160853909|NCT05579977|580853337|FG009|Follow up|Withdrawal by Subject|3|||
160853910|NCT05579977|580853338|FG010|Follow up|Withdrawal by Subject|3|||
160853911|NCT05579977|580853339|FG011|Follow up|Withdrawal by Subject|1|||
160853912|NCT05579977|580853340|FG012|Follow up|Withdrawal by Subject|3|||
160853913|NCT01611194|580853344|FG000|Overall Study|Lost to Follow-up|0|||
160853914|NCT01611194|580853345|FG001|Overall Study|Lost to Follow-up|1|||
160853915|NCT01611194|580853344|FG000|Overall Study|Withdrawal by Subject|0|||
160853916|NCT01611194|580853345|FG001|Overall Study|Withdrawal by Subject|1|||
160853917|NCT01611194|580853344|FG000|Overall Study|drug use|0|||
160853918|NCT01611194|580853345|FG001|Overall Study|drug use|1|||
160853919|NCT00452790|580853346|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
160853920|NCT00452790|580853347|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
160853921|NCT00452790|580853346|FG000|Infant Series|Parent/legal guardian request|8|||
160853922|NCT00452790|580853347|FG001|Infant Series|Parent/legal guardian request|6|||
160853923|NCT00452790|580853346|FG000|Infant Series|Failed to return|4|||
160853924|NCT00452790|580853347|FG001|Infant Series|Failed to return|1|||
160853925|NCT00452790|580853346|FG000|Infant Series|Protocol Violation|1|||
160853926|NCT00452790|580853347|FG001|Infant Series|Protocol Violation|3|||
160853927|NCT00452790|580853346|FG000|Infant Series|Lost to Follow-up|2|||
160853928|NCT00452790|580853347|FG001|Infant Series|Lost to Follow-up|2|||
160853929|NCT00452790|580853346|FG000|Infant Series|Adverse Event|1|||
160853930|NCT00452790|580853347|FG001|Infant Series|Adverse Event|2|||
160853931|NCT00452790|580853346|FG000|Infant Series|Other reasons|1|||
160992520|NCT03999554|581361389|FG004|Overall Study|Withdrawal by Subject|1|||
160992521|NCT03999554|581361385|FG000|Overall Study|failure to comply with protocol requirements|0|||
160992522|NCT03999554|581361386|FG001|Overall Study|failure to comply with protocol requirements|0|||
160992523|NCT03999554|581361387|FG002|Overall Study|failure to comply with protocol requirements|0|||
160992524|NCT03999554|581361388|FG003|Overall Study|failure to comply with protocol requirements|1|||
160992525|NCT03999554|581361389|FG004|Overall Study|failure to comply with protocol requirements|0|||
160992526|NCT02082158|581361390|FG000|Overall Study|Withdrawal by Subject|0|||
160992527|NCT02082158|581361391|FG001|Overall Study|Withdrawal by Subject|0|||
160992528|NCT02082158|581361392|FG002|Overall Study|Withdrawal by Subject|0|||
160992529|NCT02082158|581361393|FG003|Overall Study|Withdrawal by Subject|0|||
160992530|NCT02082158|581361394|FG004|Overall Study|Withdrawal by Subject|1|||
160992531|NCT02082158|581361395|FG005|Overall Study|Withdrawal by Subject|0|||
160992532|NCT02082158|581361390|FG000|Overall Study|Failed Fit-testing|8|||
160992533|NCT02082158|581361391|FG001|Overall Study|Failed Fit-testing|8|||
160992534|NCT02082158|581361392|FG002|Overall Study|Failed Fit-testing|14|||
160992535|NCT02082158|581361393|FG003|Overall Study|Failed Fit-testing|4|||
160992536|NCT02082158|581361394|FG004|Overall Study|Failed Fit-testing|3|||
160992537|NCT02082158|581361395|FG005|Overall Study|Failed Fit-testing|7|||
160992538|NCT01466881|581361398|FG000|Overall Study|Ineligible|5|||
160992539|NCT01466881|581361398|FG000|Overall Study|Adverse Event|6|||
160992540|NCT01466881|581361398|FG000|Overall Study|Progression/relapse|20|||
160992541|NCT01466881|581361398|FG000|Overall Study|Death|4|||
160992542|NCT01466881|581361398|FG000|Overall Study|Other reason not protocol specified|5|||
160992543|NCT00742274|581361399|FG000|Overall Study|Death|1|||
160992544|NCT00742274|581361400|FG001|Overall Study|Death|0|||
160992545|NCT00742274|581361399|FG000|Overall Study|Withdrawal by Subject|1|||
160992546|NCT00742274|581361400|FG001|Overall Study|Withdrawal by Subject|2|||
160992547|NCT00742274|581361399|FG000|Overall Study|Removed for medical reasons|1|||
160992548|NCT00742274|581361400|FG001|Overall Study|Removed for medical reasons|1|||
160992549|NCT01101165|581361401|FG000|Period 1|Adverse Event|1|||
160992550|NCT01101165|581361402|FG001|Period 1|Adverse Event|2|||
160992551|NCT01101165|581361401|FG000|Period 1|Withdrawal by Subject|0|||
160992552|NCT01101165|581361402|FG001|Period 1|Withdrawal by Subject|2|||
160992553|NCT01101165|581361401|FG000|Period 1|Positive Drug Screen|0|||
160992554|NCT01101165|581361402|FG001|Period 1|Positive Drug Screen|1|||
160992555|NCT01101165|581361401|FG000|Period 1|Lost to Follow-up|1|||
160992556|NCT01101165|581361402|FG001|Period 1|Lost to Follow-up|0|||
160992557|NCT01101165|581361401|FG000|Period 2|Withdrawal by Subject|3|||
160992558|NCT01101165|581361402|FG001|Period 2|Withdrawal by Subject|1|||
160853932|NCT00452790|580853347|FG001|Infant Series|Other reasons|2|||
160853933|NCT00452790|580853346|FG000|Infant Series|Investigator request|0|||
160992559|NCT01101165|581361401|FG000|Period 2|Adverse Event|1|||
160992560|NCT01101165|581361402|FG001|Period 2|Adverse Event|0|||
160992561|NCT00619151|581361404|FG000|Overall Study|Study terminated prior to followup|1|||
160992562|NCT00619151|581361405|FG001|Overall Study|Study terminated prior to followup|0|||
160992563|NCT03124108|581361408|FG000|Overall Study|Adverse Event|0|||
160992564|NCT03124108|581361409|FG001|Overall Study|Adverse Event|1|||
160992565|NCT03124108|581361410|FG002|Overall Study|Adverse Event|0|||
160853934|NCT00452790|580853347|FG001|Infant Series|Investigator request|1|||
160853935|NCT00452790|580853346|FG000|Infant Series|Death|0|||
160853936|NCT00452790|580853347|FG001|Infant Series|Death|1|||
160853937|NCT00452790|580853346|FG000|After Infant Series|Investigator request|10|||
160853938|NCT00452790|580853347|FG001|After Infant Series|Investigator request|10|||
160853939|NCT00452790|580853346|FG000|After Infant Series|Adverse Event|4|||
160853940|NCT00452790|580853347|FG001|After Infant Series|Adverse Event|1|||
160853941|NCT00452790|580853346|FG000|After Infant Series|Parent/legal guardian request|1|||
160853942|NCT00452790|580853347|FG001|After Infant Series|Parent/legal guardian request|3|||
160853943|NCT00452790|580853346|FG000|After Infant Series|Lost to Follow-up|4|||
160853944|NCT00452790|580853347|FG001|After Infant Series|Lost to Follow-up|0|||
160853945|NCT00452790|580853346|FG000|After Infant Series|Failed to return|1|||
160853946|NCT00452790|580853347|FG001|After Infant Series|Failed to return|0|||
160853947|NCT00452790|580853346|FG000|After Infant Series|Other reasons|1|||
160853948|NCT00452790|580853347|FG001|After Infant Series|Other reasons|0|||
160853949|NCT00452790|580853346|FG000|Toddler Dose|Failed to return|0|||
160853950|NCT00452790|580853347|FG001|Toddler Dose|Failed to return|1|||
160853951|NCT00452790|580853346|FG000|Toddler Dose|Parent/legal guardian request|0|||
160853952|NCT00452790|580853347|FG001|Toddler Dose|Parent/legal guardian request|1|||
160853953|NCT02926638|580853362|FG000|Overall Study|Progression|2|||
160853954|NCT02926638|580853363|FG001|Overall Study|Progression|5|||
160853955|NCT02926638|580853362|FG000|Overall Study|Ineligible|1|||
160853956|NCT02926638|580853363|FG001|Overall Study|Ineligible|0|||
160853957|NCT02926638|580853362|FG000|Overall Study|Not protocol specified|1|||
160853958|NCT02926638|580853363|FG001|Overall Study|Not protocol specified|0|||
160853959|NCT01928927|580853366|FG000|Overall Study|Lost to Follow-up|1|||
160853960|NCT01928927|580853367|FG001|Overall Study|Lost to Follow-up|0|||
160853961|NCT01928927|580853366|FG000|Overall Study|Withdrawal by Subject|1|||
160853962|NCT01928927|580853367|FG001|Overall Study|Withdrawal by Subject|1|||
160853963|NCT01871519|580853372|FG000|Overall Study|Death|26|||
160853964|NCT01871519|580853372|FG000|Overall Study|Lost to Follow-up|15|||
160853965|NCT01871519|580853372|FG000|Overall Study|Withdrawal by Subject|49|||
160853966|NCT01777776|580853373|FG000|Overall Study|Adverse Event|2|||
160853967|NCT01777776|580853374|FG001|Overall Study|Adverse Event|4|||
160853968|NCT01777776|580853375|FG002|Overall Study|Adverse Event|0|||
160853969|NCT01777776|580853376|FG003|Overall Study|Adverse Event|0|||
160853970|NCT01777776|580853373|FG000|Overall Study|Disease Progression|4|||
160853971|NCT01777776|580853374|FG001|Overall Study|Disease Progression|8|||
160853972|NCT01777776|580853375|FG002|Overall Study|Disease Progression|6|||
160853973|NCT01777776|580853376|FG003|Overall Study|Disease Progression|3|||
160853974|NCT01777776|580853373|FG000|Overall Study|Withdrawal by Subject|0|||
160853975|NCT01777776|580853374|FG001|Overall Study|Withdrawal by Subject|0|||
160853976|NCT01777776|580853375|FG002|Overall Study|Withdrawal by Subject|0|||
160853977|NCT01777776|580853376|FG003|Overall Study|Withdrawal by Subject|1|||
160853978|NCT01420926|580853379|FG000|Overall Study|Adverse Event|6|||
160853979|NCT01420926|580853380|FG001|Overall Study|Adverse Event|4|||
160853980|NCT01420926|580853379|FG000|Overall Study|Death|18|||
160853981|NCT01420926|580853380|FG001|Overall Study|Death|17|||
160853982|NCT01420926|580853379|FG000|Overall Study|Withdrawal by Subject|11|||
160853983|NCT01420926|580853380|FG001|Overall Study|Withdrawal by Subject|17|||
160853984|NCT01420926|580853379|FG000|Overall Study|Non-protocol treatment|17|||
160853985|NCT01420926|580853380|FG001|Overall Study|Non-protocol treatment|20|||
160853986|NCT01420926|580853379|FG000|Overall Study|Physician Decision|8|||
160853987|NCT01420926|580853380|FG001|Overall Study|Physician Decision|5|||
160853988|NCT04564846|580854842|FG000|Overall Study|Withdrawal by Subject|2|||
160853989|NCT04564846|580854843|FG001|Overall Study|Withdrawal by Subject|1|||
160853990|NCT04564846|580854842|FG000|Overall Study|Physician Decision|0|||
160853991|NCT04564846|580854843|FG001|Overall Study|Physician Decision|1|||
160853992|NCT04564846|580854842|FG000|Overall Study|Lost to Follow-up|0|||
160853993|NCT04564846|580854843|FG001|Overall Study|Lost to Follow-up|1|||
160853994|NCT04564846|580854842|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
160853995|NCT04564846|580854843|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
160853996|NCT04564846|580854842|FG000|Overall Study|Subject non-compliance|1|||
160853997|NCT04564846|580854843|FG001|Overall Study|Subject non-compliance|0|||
160853998|NCT00179621|580854844|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
160907137|NCT01606007|581053971|FG001|Overall Study|Reason 'Other' in the protocol|1|||
160907138|NCT01606007|581053972|FG002|Overall Study|Reason 'Other' in the protocol|1|||
160907139|NCT01606007|581053970|FG000|Overall Study|Pregnancy|0|||
160907140|NCT01606007|581053971|FG001|Overall Study|Pregnancy|1|||
160907141|NCT01606007|581053972|FG002|Overall Study|Pregnancy|1|||
160907142|NCT01606007|581053970|FG000|Overall Study|Withdrawal by Subject|8|||
160907143|NCT01606007|581053971|FG001|Overall Study|Withdrawal by Subject|6|||
160907144|NCT01606007|581053972|FG002|Overall Study|Withdrawal by Subject|1|||
160853999|NCT00179621|580854845|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
160854000|NCT00179621|580854846|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
160854001|NCT00179621|580854847|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
160907145|NCT01606007|581053970|FG000|Overall Study|Adverse Event|0|||
160992566|NCT01670019|581361418|FG000|Overall Study|Adverse Event|3|||
160992567|NCT01670019|581361419|FG001|Overall Study|Adverse Event|0|||
160992568|NCT01670019|581361418|FG000|Overall Study|Withdrawal by Subject|6|||
160992569|NCT01670019|581361419|FG001|Overall Study|Withdrawal by Subject|0|||
160992570|NCT05487703|581361420|FG000|Overall Study|Other|19|||
160992571|NCT05487703|581361420|FG000|Overall Study|Participant not well|5|||
160992572|NCT05487703|581361420|FG000|Overall Study|Insurance Reasons|6|||
160992573|NCT05487703|581361420|FG000|Overall Study|Physician Decision|19|||
160992574|NCT05487703|581361420|FG000|Overall Study|Lack of Efficacy|60|||
160992575|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
160992576|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
160992577|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
160992578|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Death|3|||
160992579|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Death|0|||
160992580|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Death|0|||
160992581|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
160992582|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
160992583|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
160992584|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
160992585|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
160992586|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
160992587|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
160992588|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
160992589|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
160992590|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
160992591|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
160992592|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
160992593|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
160992594|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
160992595|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
160992596|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Other|1|||
160992597|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Other|0|||
160992598|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Other|0|||
160992599|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
160992600|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
160992601|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
160992602|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
160992603|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
160992604|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
160992605|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
160992606|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
160992607|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
160992608|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
160992609|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
160992610|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
160992611|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
160854002|NCT00179621|580854844|FG000|Double-Blind Period|Adverse Event|2|||
160854003|NCT00179621|580854845|FG001|Double-Blind Period|Adverse Event|7|||
160854004|NCT00179621|580854846|FG002|Double-Blind Period|Adverse Event|4|||
160854005|NCT00179621|580854847|FG003|Double-Blind Period|Adverse Event|0|||
160854006|NCT00179621|580854844|FG000|Double-Blind Period|Withdrawal by Subject|2|||
160854007|NCT00179621|580854845|FG001|Double-Blind Period|Withdrawal by Subject|1|||
160854008|NCT00179621|580854846|FG002|Double-Blind Period|Withdrawal by Subject|3|||
160854009|NCT00179621|580854847|FG003|Double-Blind Period|Withdrawal by Subject|0|||
160854010|NCT00179621|580854844|FG000|Double-Blind Period|Death|0|||
160854011|NCT00179621|580854845|FG001|Double-Blind Period|Death|1|||
160992612|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
160992613|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
160992614|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
160992615|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
160992616|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
160992617|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
160992618|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
160992619|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
160992620|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
160992621|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
160992622|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
160992623|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
160992624|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
160992625|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
160854012|NCT00179621|580854846|FG002|Double-Blind Period|Death|2|||
160854013|NCT00179621|580854847|FG003|Double-Blind Period|Death|0|||
160854014|NCT00179621|580854844|FG000|Double-Blind Period|Protocol Violation|1|||
160854015|NCT00179621|580854845|FG001|Double-Blind Period|Protocol Violation|0|||
160854016|NCT00179621|580854846|FG002|Double-Blind Period|Protocol Violation|0|||
160854017|NCT00179621|580854847|FG003|Double-Blind Period|Protocol Violation|0|||
160854018|NCT00179621|580854844|FG000|Double-Blind Period|Other|0|||
160854019|NCT00179621|580854845|FG001|Double-Blind Period|Other|2|||
160854020|NCT00179621|580854846|FG002|Double-Blind Period|Other|2|||
160854021|NCT00179621|580854847|FG003|Double-Blind Period|Other|0|||
160854022|NCT00179621|580854844|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
160854023|NCT00179621|580854845|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
160907146|NCT01606007|581053971|FG001|Overall Study|Adverse Event|1|||
160907147|NCT01606007|581053972|FG002|Overall Study|Adverse Event|1|||
160907148|NCT01606007|581053970|FG000|Overall Study|discontinue study treatment|0|||
160907149|NCT01606007|581053971|FG001|Overall Study|discontinue study treatment|2|||
160907150|NCT01606007|581053972|FG002|Overall Study|discontinue study treatment|1|||
160907151|NCT01606007|581053970|FG000|Overall Study|Lost to Follow-up|6|||
160907152|NCT01606007|581053971|FG001|Overall Study|Lost to Follow-up|8|||
160907153|NCT01606007|581053972|FG002|Overall Study|Lost to Follow-up|5|||
160907154|NCT01606007|581053970|FG000|Overall Study|Poor/Non-compliance|1|||
160907155|NCT01606007|581053971|FG001|Overall Study|Poor/Non-compliance|0|||
160907156|NCT01606007|581053972|FG002|Overall Study|Poor/Non-compliance|0|||
160907157|NCT00851747|581053974|FG000|Overall Study|Physician Decision|6|||
160907158|NCT00851747|581053975|FG001|Overall Study|Physician Decision|6|||
160907159|NCT00851747|581053976|FG002|Overall Study|Physician Decision|6|||
160907160|NCT02499783|581053979|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
160907161|NCT02499783|581053980|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
160907162|NCT02499783|581053981|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
160907163|NCT02499783|581053979|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
160907164|NCT02499783|581053980|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
160907165|NCT02499783|581053981|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
160907166|NCT02499783|581053979|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
160907167|NCT02499783|581053980|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
160907168|NCT02499783|581053981|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
160907169|NCT02499783|581053979|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
160907170|NCT02499783|581053980|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
160907171|NCT02499783|581053981|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
160907172|NCT02499783|581053979|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
160907173|NCT02499783|581053980|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
160907174|NCT02499783|581053981|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
160907175|NCT02499783|581053979|FG000|DB Period: Weeks 0-8|Other|1|||
160907176|NCT02499783|581053980|FG001|DB Period: Weeks 0-8|Other|1|||
160907177|NCT02499783|581053981|FG002|DB Period: Weeks 0-8|Other|0|||
160907178|NCT02499783|581053979|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
160907179|NCT02499783|581053980|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
160907180|NCT02499783|581053981|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
160907181|NCT02499783|581053979|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
160907182|NCT02499783|581053980|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
160907183|NCT02499783|581053981|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
160907184|NCT02499783|581053979|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
160907185|NCT02499783|581053980|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
160907186|NCT02499783|581053981|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
160907187|NCT02499783|581053979|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
160907188|NCT02499783|581053980|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
160907189|NCT02499783|581053981|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
160907190|NCT02228460|581053982|FG000|Overall Study|Adverse Event|1|||
160907191|NCT02228460|581053982|FG000|Overall Study|Lost to Follow-up|1|||
160907192|NCT01243892|581053983|FG000|Overall Study|Did not meet eligibility criteria|2|||
160907193|NCT01243892|581053984|FG001|Overall Study|Did not meet eligibility criteria|0|||
160907194|NCT00119106|581053985|FG000|Overall Study|HIV infected at baseline|179|||
160907195|NCT00119106|581053986|FG001|Overall Study|HIV infected at baseline|178|||
160907196|NCT01866293|581053987|FG000|Overall Study|Adverse Event|2|||
160854024|NCT00179621|580854846|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
160854025|NCT00179621|580854847|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
160854026|NCT00179621|580854844|FG000|Open-Label Period|Adverse Event|0|||
160854027|NCT00179621|580854845|FG001|Open-Label Period|Adverse Event|6|||
160854028|NCT00179621|580854846|FG002|Open-Label Period|Adverse Event|5|||
160907197|NCT01010061|581053988|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
160907198|NCT01010061|581053989|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
160907199|NCT01010061|581053988|FG000|Overall Study|Disease Progression|2|||
160907200|NCT01010061|581053989|FG001|Overall Study|Disease Progression|8|||
160907201|NCT01010061|581053988|FG000|Overall Study|Withdrew Consent|5|||
160907202|NCT01010061|581053989|FG001|Overall Study|Withdrew Consent|1|||
160907203|NCT01010061|581053988|FG000|Overall Study|Death|3|||
160992626|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
160992627|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
160992628|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
160992629|NCT03885596|581361427|FG000|Overall Study|Withdrawal by Subject|2|||
160992630|NCT03885596|581361428|FG001|Overall Study|Withdrawal by Subject|1|||
160992631|NCT03885596|581361429|FG002|Overall Study|Withdrawal by Subject|0|||
160992632|NCT03885596|581361430|FG003|Overall Study|Withdrawal by Subject|0|||
160992633|NCT00746330|581361431|FG000|Period 1|Abnormal test procedure result|0|||
160992634|NCT00746330|581361432|FG001|Period 1|Abnormal test procedure result|0|||
160992635|NCT00746330|581361433|FG002|Period 1|Abnormal test procedure result|1|||
160992636|NCT00746330|581361434|FG003|Period 1|Abnormal test procedure result|0|||
160992637|NCT01076335|581361435|FG000|Overall Study|Withdrawal by Subject|3|||
160992638|NCT01076335|581361435|FG000|Overall Study|Withdrawal without treatment|1|||
160992639|NCT00517933|581361437|FG000|Period 1|Death|2|||
160992640|NCT00517933|581361438|FG001|Period 1|Death|1|||
160992641|NCT00517933|581361437|FG000|Period 1|Adverse Event|4|||
160992642|NCT00517933|581361438|FG001|Period 1|Adverse Event|4|||
160992643|NCT00517933|581361437|FG000|Period 1|Lost to Follow-up|2|||
160992644|NCT00517933|581361438|FG001|Period 1|Lost to Follow-up|0|||
160992645|NCT00517933|581361437|FG000|Period 1|Underwent lung transplant|0|||
160992646|NCT00517933|581361438|FG001|Period 1|Underwent lung transplant|1|||
160992647|NCT00517933|581361437|FG000|Period 2|Death|2|||
160992648|NCT00517933|581361438|FG001|Period 2|Death|4|||
160992649|NCT00517933|581361437|FG000|Period 2|Adverse Event|2|||
160992650|NCT00517933|581361438|FG001|Period 2|Adverse Event|4|||
160992651|NCT00517933|581361437|FG000|Period 2|Physician Decision|1|||
160992652|NCT00517933|581361438|FG001|Period 2|Physician Decision|0|||
160992653|NCT00517933|581361437|FG000|Period 2|Withdrawal by Subject|1|||
160992654|NCT00517933|581361438|FG001|Period 2|Withdrawal by Subject|3|||
160992655|NCT00517933|581361437|FG000|Period 2|Underwent lung transplant|0|||
160992656|NCT00517933|581361438|FG001|Period 2|Underwent lung transplant|2|||
160992657|NCT00235495|581361439|FG000|Overall Study|Death|52|||
160992658|NCT00235495|581361440|FG001|Overall Study|Death|42|||
160992659|NCT00235495|581361439|FG000|Overall Study|Withdrawal by Subject|5|||
160992660|NCT00235495|581361440|FG001|Overall Study|Withdrawal by Subject|3|||
160992661|NCT00235495|581361439|FG000|Overall Study|Lost to Follow-up|11|||
160992662|NCT00235495|581361440|FG001|Overall Study|Lost to Follow-up|13|||
160992663|NCT00235495|581361439|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
160992664|NCT00235495|581361440|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
160992665|NCT01268566|581361445|FG000|Overall Study|Lost to Follow-up|1|||
160992666|NCT01268566|581361445|FG000|Overall Study|Withdrawal by Subject|12|||
160992667|NCT01268566|581361445|FG000|Overall Study|Death|30|||
160992668|NCT05460663|581361452|FG000|Overall Study|Withdrawal by Subject|2|||
160992669|NCT05460663|581361453|FG001|Overall Study|Withdrawal by Subject|5|||
160992670|NCT03068468|581363110|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
160992671|NCT03068468|581363111|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
160992672|NCT03068468|581363112|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
160992673|NCT03068468|581363113|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
160992674|NCT03068468|581363110|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
160992675|NCT03068468|581363111|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
160992676|NCT03068468|581363112|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
160992677|NCT03068468|581363113|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
160992678|NCT03068468|581363110|FG000|Placebo-Controlled Period|Adverse Event|16|||
160992679|NCT03068468|581363111|FG001|Placebo-Controlled Period|Adverse Event|21|||
160992680|NCT03068468|581363112|FG002|Placebo-Controlled Period|Adverse Event|0|||
160992681|NCT03068468|581363113|FG003|Placebo-Controlled Period|Adverse Event|0|||
160992682|NCT03068468|581363110|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
160992683|NCT03068468|581363111|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
160992684|NCT03068468|581363112|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
160992685|NCT03068468|581363113|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
160992686|NCT03068468|581363110|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
160992687|NCT03068468|581363111|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
160992688|NCT03068468|581363112|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160992689|NCT03068468|581363113|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160992690|NCT03068468|581363110|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
160992691|NCT03068468|581363111|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
160992692|NCT03068468|581363112|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
160992693|NCT03068468|581363113|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
160992694|NCT03068468|581363110|FG000|Placebo-Controlled Period|Death|0|||
160992695|NCT03068468|581363111|FG001|Placebo-Controlled Period|Death|1|||
160992696|NCT03068468|581363112|FG002|Placebo-Controlled Period|Death|0|||
160992697|NCT03068468|581363113|FG003|Placebo-Controlled Period|Death|0|||
160907204|NCT01010061|581053989|FG001|Overall Study|Death|6|||
160907205|NCT01010061|581053988|FG000|Overall Study|Administrative/Other|0|||
160907206|NCT01010061|581053989|FG001|Overall Study|Administrative/Other|1|||
160907207|NCT01010061|581053988|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
160907208|NCT01010061|581053989|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
160907209|NCT01010061|581053988|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160854029|NCT00179621|580854847|FG003|Open-Label Period|Adverse Event|6|||
160854030|NCT00179621|580854844|FG000|Open-Label Period|Withdrawal by Subject|0|||
160854031|NCT00179621|580854845|FG001|Open-Label Period|Withdrawal by Subject|2|||
160854032|NCT00179621|580854846|FG002|Open-Label Period|Withdrawal by Subject|2|||
160854033|NCT00179621|580854847|FG003|Open-Label Period|Withdrawal by Subject|2|||
160854034|NCT00179621|580854844|FG000|Open-Label Period|Death|0|||
160854035|NCT00179621|580854845|FG001|Open-Label Period|Death|0|||
160854036|NCT00179621|580854846|FG002|Open-Label Period|Death|1|||
160854037|NCT00179621|580854847|FG003|Open-Label Period|Death|2|||
160854038|NCT00179621|580854844|FG000|Open-Label Period|Other|0|||
160854039|NCT00179621|580854845|FG001|Open-Label Period|Other|1|||
160854040|NCT00179621|580854846|FG002|Open-Label Period|Other|1|||
160854041|NCT00179621|580854847|FG003|Open-Label Period|Other|2|||
160854042|NCT00865345|580854849|FG000|Overall Study|Withdrawal by Subject|2|||
160854043|NCT03737123|580854850|FG000|Study Treatment|Adverse Event|2|||
160854044|NCT03737123|580854851|FG001|Study Treatment|Adverse Event|0|||
160854045|NCT03737123|580854850|FG000|Study Treatment|Disease Progression|2|||
160854046|NCT03737123|580854851|FG001|Study Treatment|Disease Progression|0|||
160854047|NCT03737123|580854850|FG000|Study Treatment|Withdrawal by Subject|2|||
160854048|NCT03737123|580854851|FG001|Study Treatment|Withdrawal by Subject|0|||
160854049|NCT03737123|580854850|FG000|Follow up|Death|1|||
160854050|NCT03737123|580854851|FG001|Follow up|Death|0|||
160854051|NCT03737123|580854850|FG000|Follow up|Withdrawal by Subject|1|||
160854052|NCT03737123|580854851|FG001|Follow up|Withdrawal by Subject|0|||
160854053|NCT03737123|580854850|FG000|Follow up|Termination of study|4|||
160854054|NCT03737123|580854851|FG001|Follow up|Termination of study|0|||
160854055|NCT00383552|580854852|FG000|Overall Study|Adverse Event|7|||
160854056|NCT00383552|580854853|FG001|Overall Study|Adverse Event|6|||
160854057|NCT00383552|580854854|FG002|Overall Study|Adverse Event|9|||
160854058|NCT00383552|580854855|FG003|Overall Study|Adverse Event|6|||
160854059|NCT00383552|580854852|FG000|Overall Study|Lack of Efficacy|4|||
160854060|NCT00383552|580854853|FG001|Overall Study|Lack of Efficacy|13|||
160854061|NCT00383552|580854854|FG002|Overall Study|Lack of Efficacy|29|||
160854062|NCT00383552|580854855|FG003|Overall Study|Lack of Efficacy|42|||
160854063|NCT00383552|580854852|FG000|Overall Study|Lost to Follow-up|0|||
160854064|NCT00383552|580854853|FG001|Overall Study|Lost to Follow-up|1|||
160854065|NCT00383552|580854854|FG002|Overall Study|Lost to Follow-up|5|||
160854066|NCT00383552|580854855|FG003|Overall Study|Lost to Follow-up|1|||
160854067|NCT00383552|580854852|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
160854068|NCT00383552|580854853|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
160854069|NCT00383552|580854854|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
160854070|NCT00383552|580854855|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
160854071|NCT00383552|580854852|FG000|Overall Study|Did not wish to continue (related)|1|||
160854072|NCT00383552|580854853|FG001|Overall Study|Did not wish to continue (related)|0|||
160854073|NCT00383552|580854854|FG002|Overall Study|Did not wish to continue (related)|2|||
160854074|NCT00383552|580854855|FG003|Overall Study|Did not wish to continue (related)|3|||
160854075|NCT00383552|580854852|FG000|Overall Study|Noncompliance with the protocol|11|||
160854076|NCT00383552|580854853|FG001|Overall Study|Noncompliance with the protocol|6|||
160854077|NCT00383552|580854854|FG002|Overall Study|Noncompliance with the protocol|8|||
160854078|NCT00383552|580854855|FG003|Overall Study|Noncompliance with the protocol|10|||
160854079|NCT00383552|580854852|FG000|Overall Study|Did not meet protocol eligibility|8|||
160854080|NCT00383552|580854853|FG001|Overall Study|Did not meet protocol eligibility|6|||
160854081|NCT00383552|580854854|FG002|Overall Study|Did not meet protocol eligibility|2|||
160854082|NCT00383552|580854855|FG003|Overall Study|Did not meet protocol eligibility|3|||
160854083|NCT00383552|580854852|FG000|Overall Study|Administrative|1|||
160854084|NCT00383552|580854853|FG001|Overall Study|Administrative|0|||
160653436|NCT02581345|580112381|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
160854085|NCT00383552|580854854|FG002|Overall Study|Administrative|1|||
160854086|NCT00383552|580854855|FG003|Overall Study|Administrative|1|||
160854087|NCT00966654|580854856|FG000|Overall Study|Study was terminated,PI left institution|12|||
160854088|NCT00762359|580854859|FG000|Overall Study|Adverse Event|20|||
160854089|NCT00762359|580854860|FG001|Overall Study|Adverse Event|23|||
160854090|NCT00762359|580854859|FG000|Overall Study|Protocol Violation|21|||
160907210|NCT01010061|581053989|FG001|Overall Study|Insufficient Therapeutic Response|5|||
160854091|NCT00762359|580854860|FG001|Overall Study|Protocol Violation|13|||
160854092|NCT00762359|580854859|FG000|Overall Study|Withdrawal by Subject|13|||
160854093|NCT00762359|580854860|FG001|Overall Study|Withdrawal by Subject|10|||
160854094|NCT00762359|580854859|FG000|Overall Study|Lack of Efficacy|0|||
160854095|NCT00762359|580854860|FG001|Overall Study|Lack of Efficacy|4|||
160854096|NCT00762359|580854859|FG000|Overall Study|Institution closed|2|||
160907211|NCT01010061|581053988|FG000|Overall Study|Violation of Selection Criteria|0|||
160854097|NCT00762359|580854860|FG001|Overall Study|Institution closed|3|||
160854098|NCT00762359|580854859|FG000|Overall Study|Physician Decision|2|||
160854099|NCT00762359|580854860|FG001|Overall Study|Physician Decision|3|||
160854100|NCT00762359|580854859|FG000|Overall Study|Removal|0|||
160854101|NCT00762359|580854860|FG001|Overall Study|Removal|1|||
160854102|NCT00762359|580854859|FG000|Overall Study|Withdrew consent|1|||
160854103|NCT00762359|580854860|FG001|Overall Study|Withdrew consent|0|||
160854104|NCT00882440|580854861|FG000|Overall Study|Adverse Event|2|||
160854105|NCT00882440|580854862|FG001|Overall Study|Adverse Event|2|||
160854106|NCT00882440|580854863|FG002|Overall Study|Adverse Event|2|||
160854107|NCT00882440|580854864|FG003|Overall Study|Adverse Event|1|||
160854108|NCT00882440|580854865|FG004|Overall Study|Adverse Event|1|||
160854109|NCT00882440|580854866|FG005|Overall Study|Adverse Event|4|||
160854110|NCT00882440|580854867|FG006|Overall Study|Adverse Event|2|||
160854111|NCT00882440|580854861|FG000|Overall Study|Lack of Efficacy|3|||
160854112|NCT00882440|580854862|FG001|Overall Study|Lack of Efficacy|5|||
160854113|NCT00882440|580854863|FG002|Overall Study|Lack of Efficacy|2|||
160854114|NCT00882440|580854864|FG003|Overall Study|Lack of Efficacy|0|||
160854115|NCT00882440|580854865|FG004|Overall Study|Lack of Efficacy|0|||
160854116|NCT00882440|580854866|FG005|Overall Study|Lack of Efficacy|3|||
160854117|NCT00882440|580854867|FG006|Overall Study|Lack of Efficacy|0|||
160854118|NCT00882440|580854861|FG000|Overall Study|Lost to Follow-up|2|||
160854119|NCT00882440|580854862|FG001|Overall Study|Lost to Follow-up|0|||
160854120|NCT00882440|580854863|FG002|Overall Study|Lost to Follow-up|1|||
160854121|NCT00882440|580854864|FG003|Overall Study|Lost to Follow-up|1|||
160854122|NCT00882440|580854865|FG004|Overall Study|Lost to Follow-up|1|||
160854123|NCT00882440|580854866|FG005|Overall Study|Lost to Follow-up|0|||
160650811|NCT04820842|580104334|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
160854124|NCT00882440|580854867|FG006|Overall Study|Lost to Follow-up|1|||
160854125|NCT00882440|580854861|FG000|Overall Study|Protocol Violation|0|||
160854126|NCT00882440|580854862|FG001|Overall Study|Protocol Violation|0|||
160854127|NCT00882440|580854863|FG002|Overall Study|Protocol Violation|1|||
160854128|NCT00882440|580854864|FG003|Overall Study|Protocol Violation|1|||
160854129|NCT00882440|580854865|FG004|Overall Study|Protocol Violation|1|||
160854130|NCT00882440|580854866|FG005|Overall Study|Protocol Violation|0|||
160854131|NCT00882440|580854867|FG006|Overall Study|Protocol Violation|0|||
160854132|NCT00882440|580854861|FG000|Overall Study|Withdrawal by Subject|2|||
160854133|NCT00882440|580854862|FG001|Overall Study|Withdrawal by Subject|1|||
160854134|NCT00882440|580854863|FG002|Overall Study|Withdrawal by Subject|1|||
160854135|NCT00882440|580854864|FG003|Overall Study|Withdrawal by Subject|0|||
160854136|NCT00882440|580854865|FG004|Overall Study|Withdrawal by Subject|6|||
160854137|NCT00882440|580854866|FG005|Overall Study|Withdrawal by Subject|0|||
160854138|NCT00882440|580854867|FG006|Overall Study|Withdrawal by Subject|1|||
160854139|NCT00882440|580854861|FG000|Overall Study|Patient Uncooperative|2|||
160854140|NCT00882440|580854862|FG001|Overall Study|Patient Uncooperative|0|||
160854141|NCT00882440|580854863|FG002|Overall Study|Patient Uncooperative|0|||
160854142|NCT00882440|580854864|FG003|Overall Study|Patient Uncooperative|0|||
160854143|NCT00882440|580854865|FG004|Overall Study|Patient Uncooperative|1|||
160854144|NCT00882440|580854866|FG005|Overall Study|Patient Uncooperative|0|||
160854145|NCT00882440|580854867|FG006|Overall Study|Patient Uncooperative|0|||
160854146|NCT05482308|580854871|FG000|Overall Study|Withdrawal by Subject|1|||
160854147|NCT05482308|580854872|FG001|Overall Study|Withdrawal by Subject|0|||
160854148|NCT05482308|580854871|FG000|Overall Study|No longer meets eligibility criteria|0|||
160854149|NCT05482308|580854872|FG001|Overall Study|No longer meets eligibility criteria|1|||
160854150|NCT03016312|580854873|FG000|Overall Study|discontinued before the treatment started|0|||
160854151|NCT03016312|580854874|FG001|Overall Study|discontinued before the treatment started|1|||
160854152|NCT03016312|580854873|FG000|Overall Study|Withdrawal by Subject|37|||
160854153|NCT03016312|580854874|FG001|Overall Study|Withdrawal by Subject|44|||
160854154|NCT03016312|580854873|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
160854155|NCT03016312|580854874|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
160854156|NCT03016312|580854873|FG000|Overall Study|Physician Decision|1|||
160854157|NCT03016312|580854874|FG001|Overall Study|Physician Decision|3|||
160854158|NCT03016312|580854873|FG000|Overall Study|Lost to Follow-up|12|||
160854159|NCT03016312|580854874|FG001|Overall Study|Lost to Follow-up|12|||
160854160|NCT03016312|580854873|FG000|Overall Study|Death|210|||
160854161|NCT03016312|580854874|FG001|Overall Study|Death|184|||
160854162|NCT03016312|580854873|FG000|Overall Study|loss to contact|1|||
160854163|NCT03016312|580854874|FG001|Overall Study|loss to contact|0|||
160854164|NCT03016312|580854873|FG000|Overall Study|started a new cancer therapy|1|||
160854165|NCT03016312|580854874|FG001|Overall Study|started a new cancer therapy|0|||
160854166|NCT01631435|580854877|FG000|Overall Study|Adverse Event|2|||
160854167|NCT01631435|580854877|FG000|Overall Study|Withdrawal by Subject|2|||
160854168|NCT01631435|580854877|FG000|Overall Study|incomplete study procedure|5|||
160854169|NCT01421017|580854878|FG000|Overall Study|Withdrawal by Subject|2|||
160854170|NCT01421017|580854879|FG001|Overall Study|Withdrawal by Subject|0|||
160854171|NCT01421017|580854880|FG002|Overall Study|Withdrawal by Subject|0|||
160992698|NCT03068468|581363110|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
160992699|NCT03068468|581363111|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
160992700|NCT03068468|581363112|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
160992701|NCT03068468|581363113|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
160992702|NCT03068468|581363110|FG000|Open-Label Extension Period|Adverse Event|0|||
160992703|NCT03068468|581363111|FG001|Open-Label Extension Period|Adverse Event|0|||
160992704|NCT03068468|581363112|FG002|Open-Label Extension Period|Adverse Event|13|||
160992705|NCT03068468|581363113|FG003|Open-Label Extension Period|Adverse Event|17|||
160992706|NCT03068468|581363110|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
160992707|NCT03068468|581363111|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
160992708|NCT03068468|581363112|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
160992709|NCT03068468|581363113|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
160992710|NCT03068468|581363110|FG000|Open-Label Extension Period|Death|0|||
160992711|NCT03068468|581363111|FG001|Open-Label Extension Period|Death|0|||
160992712|NCT03068468|581363112|FG002|Open-Label Extension Period|Death|0|||
160992713|NCT03068468|581363113|FG003|Open-Label Extension Period|Death|1|||
160992714|NCT03068468|581363110|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
160992715|NCT03068468|581363111|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
160992716|NCT03068468|581363112|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
160992717|NCT03068468|581363113|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
160854172|NCT01421017|580854878|FG000|Overall Study|POD|0|||
160854173|NCT01421017|580854879|FG001|Overall Study|POD|6|||
160854174|NCT01421017|580854880|FG002|Overall Study|POD|3|||
160854175|NCT00416624|580854883|FG000|Overall Study|Withdrawal by Subject|1|||
160854176|NCT00416624|580854884|FG001|Overall Study|Withdrawal by Subject|6|||
160854177|NCT00416624|580854885|FG002|Overall Study|Withdrawal by Subject|4|||
160854178|NCT00416624|580854886|FG003|Overall Study|Withdrawal by Subject|9|||
160854179|NCT00416624|580854883|FG000|Overall Study|Death|4|||
160854180|NCT00416624|580854884|FG001|Overall Study|Death|7|||
160854181|NCT00416624|580854885|FG002|Overall Study|Death|7|||
160854182|NCT00416624|580854886|FG003|Overall Study|Death|1|||
160854183|NCT00416624|580854883|FG000|Overall Study|Adverse Event|8|||
160854184|NCT00416624|580854884|FG001|Overall Study|Adverse Event|3|||
160854185|NCT00416624|580854885|FG002|Overall Study|Adverse Event|2|||
160854186|NCT00416624|580854886|FG003|Overall Study|Adverse Event|2|||
160854187|NCT00416624|580854883|FG000|Overall Study|Other|8|||
160854188|NCT00416624|580854884|FG001|Overall Study|Other|11|||
160907212|NCT01010061|581053989|FG001|Overall Study|Violation of Selection Criteria|1|||
160907213|NCT01010061|581053988|FG000|Overall Study|Did Not Receive Treatment|2|||
160907214|NCT01010061|581053989|FG001|Overall Study|Did Not Receive Treatment|2|||
160907215|NCT03066804|581053990|FG000|Overall Study|Physician Decision|0|||
160907216|NCT03066804|581053991|FG001|Overall Study|Physician Decision|4|||
160907217|NCT03066804|581053990|FG000|Overall Study|Death|23|||
160907218|NCT03066804|581053991|FG001|Overall Study|Death|17|||
160907219|NCT03066804|581053990|FG000|Overall Study|Withdrawal by Subject|19|||
160907220|NCT03066804|581053991|FG001|Overall Study|Withdrawal by Subject|25|||
160907221|NCT03066804|581053990|FG000|Overall Study|Lost to Follow-up|2|||
160907222|NCT03066804|581053991|FG001|Overall Study|Lost to Follow-up|0|||
160907223|NCT03066804|581053990|FG000|Overall Study|Adverse Event|2|||
160907224|NCT03066804|581053991|FG001|Overall Study|Adverse Event|3|||
160907225|NCT03066804|581053990|FG000|Overall Study|Technical problems|5|||
160907226|NCT03066804|581053991|FG001|Overall Study|Technical problems|1|||
160907227|NCT03470441|581053996|FG000|Overall Study|Death|0|||
160907228|NCT03470441|581053997|FG001|Overall Study|Death|1|||
160907229|NCT03470441|581053998|FG002|Overall Study|Death|1|||
160907230|NCT03470441|581053999|FG003|Overall Study|Death|0|||
160907231|NCT03470441|581053996|FG000|Overall Study|Adverse Event|0|||
160907232|NCT03470441|581053997|FG001|Overall Study|Adverse Event|0|||
160907233|NCT03470441|581053998|FG002|Overall Study|Adverse Event|0|||
160907234|NCT03470441|581053999|FG003|Overall Study|Adverse Event|1|||
160907235|NCT03470441|581053996|FG000|Overall Study|Withdrawal by Subject|1|||
160907236|NCT03470441|581053997|FG001|Overall Study|Withdrawal by Subject|4|||
160907237|NCT03470441|581053998|FG002|Overall Study|Withdrawal by Subject|1|||
160907238|NCT03470441|581053999|FG003|Overall Study|Withdrawal by Subject|3|||
160854189|NCT00416624|580854885|FG002|Overall Study|Other|5|||
160854190|NCT00416624|580854886|FG003|Overall Study|Other|5|||
160854191|NCT00416624|580854883|FG000|Overall Study|Cancel|1|||
160854192|NCT00416624|580854884|FG001|Overall Study|Cancel|0|||
160854193|NCT00416624|580854885|FG002|Overall Study|Cancel|0|||
160854194|NCT00416624|580854886|FG003|Overall Study|Cancel|0|||
160854195|NCT01458639|580854893|FG000|Overall Study|Physician Decision|4|||
160854196|NCT01458639|580854893|FG000|Overall Study|Equipment issue|1|||
160907239|NCT03982368|581054000|FG000|Overall Study|Adverse Event|6|||
160907240|NCT03982368|581054001|FG001|Overall Study|Adverse Event|4|||
160907241|NCT03982368|581054002|FG002|Overall Study|Adverse Event|3|||
160907242|NCT03982368|581054000|FG000|Overall Study|Lost to Follow-up|2|||
160907243|NCT03982368|581054001|FG001|Overall Study|Lost to Follow-up|1|||
160907244|NCT03982368|581054002|FG002|Overall Study|Lost to Follow-up|0|||
160907245|NCT03982368|581054000|FG000|Overall Study|Withdrawal by Subject|1|||
160650812|NCT04820842|580104335|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
160650813|NCT04820842|580104329|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
160907246|NCT03982368|581054001|FG001|Overall Study|Withdrawal by Subject|2|||
160907247|NCT03982368|581054002|FG002|Overall Study|Withdrawal by Subject|0|||
160907248|NCT03982368|581054000|FG000|Overall Study|unknow|4|||
160907249|NCT03982368|581054001|FG001|Overall Study|unknow|0|||
160907250|NCT03982368|581054002|FG002|Overall Study|unknow|2|||
160907251|NCT00518284|581054003|FG000|Overall Study|Adverse Event|0|||
160907252|NCT00518284|581054004|FG001|Overall Study|Adverse Event|1|||
160907253|NCT00518284|581054005|FG002|Overall Study|Adverse Event|0|||
160907254|NCT00518284|581054006|FG003|Overall Study|Adverse Event|0|||
160907255|NCT00518284|581054003|FG000|Overall Study|Study Termination|0|||
160907256|NCT00518284|581054004|FG001|Overall Study|Study Termination|2|||
160907257|NCT00518284|581054005|FG002|Overall Study|Study Termination|1|||
160907258|NCT00518284|581054006|FG003|Overall Study|Study Termination|2|||
160907259|NCT02571777|581054008|FG000|Overall Study|Subject/guardian decision|34|||
160907260|NCT02571777|581054009|FG001|Overall Study|Subject/guardian decision|26|||
160907261|NCT02571777|581054010|FG002|Overall Study|Subject/guardian decision|26|||
160907262|NCT02571777|581054011|FG003|Overall Study|Subject/guardian decision|25|||
160907263|NCT02571777|581054012|FG004|Overall Study|Subject/guardian decision|27|||
160907264|NCT02571777|581054008|FG000|Overall Study|Protocol Deviation|2|||
160907265|NCT02571777|581054009|FG001|Overall Study|Protocol Deviation|3|||
160907266|NCT02571777|581054010|FG002|Overall Study|Protocol Deviation|4|||
160907267|NCT02571777|581054011|FG003|Overall Study|Protocol Deviation|8|||
160907268|NCT02571777|581054012|FG004|Overall Study|Protocol Deviation|4|||
160907269|NCT02571777|581054008|FG000|Overall Study|Death|1|||
160907270|NCT02571777|581054009|FG001|Overall Study|Death|1|||
160907271|NCT02571777|581054010|FG002|Overall Study|Death|4|||
160907272|NCT02571777|581054011|FG003|Overall Study|Death|0|||
160907273|NCT02571777|581054012|FG004|Overall Study|Death|0|||
160907274|NCT02571777|581054008|FG000|Overall Study|Lost to Follow-up|1|||
160907275|NCT02571777|581054009|FG001|Overall Study|Lost to Follow-up|1|||
160907276|NCT02571777|581054010|FG002|Overall Study|Lost to Follow-up|2|||
160907277|NCT02571777|581054011|FG003|Overall Study|Lost to Follow-up|0|||
160907278|NCT02571777|581054012|FG004|Overall Study|Lost to Follow-up|1|||
160907279|NCT02571777|581054008|FG000|Overall Study|Physician Decision|1|||
160907280|NCT02571777|581054009|FG001|Overall Study|Physician Decision|7|||
160907281|NCT02571777|581054010|FG002|Overall Study|Physician Decision|5|||
160907282|NCT02571777|581054011|FG003|Overall Study|Physician Decision|2|||
160907283|NCT02571777|581054012|FG004|Overall Study|Physician Decision|4|||
160907284|NCT02571777|581054008|FG000|Overall Study|Pregnancy|0|||
160907285|NCT02571777|581054009|FG001|Overall Study|Pregnancy|0|||
160907286|NCT02571777|581054010|FG002|Overall Study|Pregnancy|0|||
160907287|NCT02571777|581054011|FG003|Overall Study|Pregnancy|2|||
160907288|NCT02571777|581054012|FG004|Overall Study|Pregnancy|0|||
160907289|NCT03706079|581054013|FG000|Predecessor Study|Death|0|||
160907290|NCT03706079|581054014|FG001|Predecessor Study|Death|2|||
160907291|NCT03706079|581054015|FG002|Predecessor Study|Death|0|||
160907292|NCT03706079|581054016|FG003|Predecessor Study|Death|1|||
160907293|NCT03706079|581054017|FG004|Predecessor Study|Death|0|||
160907294|NCT03706079|581054018|FG005|Predecessor Study|Death|0|||
160907295|NCT03706079|581054013|FG000|Predecessor Study|Lost to Follow-up|5|||
160907296|NCT03706079|581054014|FG001|Predecessor Study|Lost to Follow-up|2|||
160907297|NCT03706079|581054015|FG002|Predecessor Study|Lost to Follow-up|0|||
160907298|NCT03706079|581054016|FG003|Predecessor Study|Lost to Follow-up|0|||
160907299|NCT03706079|581054017|FG004|Predecessor Study|Lost to Follow-up|1|||
160907300|NCT03706079|581054018|FG005|Predecessor Study|Lost to Follow-up|0|||
160907301|NCT03706079|581054013|FG000|Predecessor Study|Withdrawal by Subject|8|||
160907302|NCT03706079|581054014|FG001|Predecessor Study|Withdrawal by Subject|15|||
160907303|NCT03706079|581054015|FG002|Predecessor Study|Withdrawal by Subject|0|||
160907304|NCT03706079|581054016|FG003|Predecessor Study|Withdrawal by Subject|5|||
160907305|NCT03706079|581054017|FG004|Predecessor Study|Withdrawal by Subject|2|||
160907306|NCT03706079|581054018|FG005|Predecessor Study|Withdrawal by Subject|0|||
160907307|NCT03706079|581054013|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
160907308|NCT03706079|581054014|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
160907309|NCT03706079|581054015|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
160907310|NCT03706079|581054016|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
160907311|NCT03706079|581054017|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
160907312|NCT03706079|581054018|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
160907313|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
160907314|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
160907315|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
160907316|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
160992718|NCT03068468|581363110|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
160992719|NCT03068468|581363111|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
160992720|NCT03068468|581363112|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
160992721|NCT03068468|581363113|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
160992722|NCT03068468|581363110|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
160992723|NCT03068468|581363111|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
160854197|NCT01458639|580854893|FG000|Overall Study|Inability to obtain subject blood sample|1|||
160854198|NCT04245111|580854894|FG000|Overall Study|Lost to Follow-up|5|||
160854199|NCT04245111|580854895|FG001|Overall Study|Lost to Follow-up|1|||
160854200|NCT04245111|580854896|FG002|Overall Study|Lost to Follow-up|1|||
160854201|NCT02792231|580854897|FG000|Overall Study|Patient/guardian decision|32|||
160854202|NCT02792231|580854898|FG001|Overall Study|Patient/guardian decision|42|||
160854203|NCT02792231|580854897|FG000|Overall Study|Adverse Event|15|||
160854204|NCT02792231|580854898|FG001|Overall Study|Adverse Event|11|||
160854205|NCT02792231|580854897|FG000|Overall Study|Physician Decision|14|||
160854206|NCT02792231|580854898|FG001|Overall Study|Physician Decision|12|||
160854207|NCT02792231|580854897|FG000|Overall Study|Lack of Efficacy|7|||
160854208|NCT02792231|580854898|FG001|Overall Study|Lack of Efficacy|9|||
160854209|NCT02792231|580854897|FG000|Overall Study|Lost to Follow-up|9|||
160854210|NCT02792231|580854898|FG001|Overall Study|Lost to Follow-up|5|||
160854211|NCT02792231|580854897|FG000|Overall Study|Pregnancy|1|||
160854212|NCT02792231|580854898|FG001|Overall Study|Pregnancy|3|||
160854213|NCT02792231|580854897|FG000|Overall Study|Non-compliance with study treatment|2|||
160854214|NCT02792231|580854898|FG001|Overall Study|Non-compliance with study treatment|1|||
160854215|NCT02792231|580854897|FG000|Overall Study|Protocol deviation|2|||
160854216|NCT02792231|580854898|FG001|Overall Study|Protocol deviation|0|||
160854217|NCT02792231|580854897|FG000|Overall Study|Technical problems|0|||
160854218|NCT02792231|580854898|FG001|Overall Study|Technical problems|1|||
160854219|NCT03309878|580854899|FG000|Overall Study|Adverse Event|1|||
160854220|NCT03309878|580854900|FG001|Overall Study|Adverse Event|0|||
160854221|NCT03309878|580854901|FG002|Overall Study|Adverse Event|0|||
160854222|NCT03309878|580854902|FG003|Overall Study|Adverse Event|0|||
160854223|NCT03309878|580854899|FG000|Overall Study|Did not maintain eligibility|2|||
160854224|NCT03309878|580854900|FG001|Overall Study|Did not maintain eligibility|1|||
160854225|NCT03309878|580854901|FG002|Overall Study|Did not maintain eligibility|0|||
160854226|NCT03309878|580854902|FG003|Overall Study|Did not maintain eligibility|0|||
160854227|NCT03309878|580854899|FG000|Overall Study|Withdrawal by Subject|0|||
160854228|NCT03309878|580854900|FG001|Overall Study|Withdrawal by Subject|1|||
160854229|NCT03309878|580854901|FG002|Overall Study|Withdrawal by Subject|0|||
160854230|NCT03309878|580854902|FG003|Overall Study|Withdrawal by Subject|0|||
160854231|NCT01755234|580854903|FG000|Overall Study|Lost to Follow-up|11|||
160854232|NCT01755234|580854904|FG001|Overall Study|Lost to Follow-up|6|||
160854233|NCT01755234|580854903|FG000|Overall Study|Change in surgical case|2|||
160854234|NCT01755234|580854904|FG001|Overall Study|Change in surgical case|1|||
160854235|NCT01755234|580854903|FG000|Overall Study|case cancelled|1|||
160854236|NCT01755234|580854904|FG001|Overall Study|case cancelled|0|||
160854237|NCT01755234|580854903|FG000|Overall Study|Withdrawal by Subject|0|||
160854238|NCT01755234|580854904|FG001|Overall Study|Withdrawal by Subject|1|||
160854239|NCT01755234|580854903|FG000|Overall Study|unblinded|1|||
160854240|NCT01755234|580854904|FG001|Overall Study|unblinded|0|||
160854241|NCT01884077|580854905|FG000|Overall Study|screen fail|0|||
160854242|NCT01884077|580854906|FG001|Overall Study|screen fail|2|||
160854243|NCT01884077|580854905|FG000|Overall Study|canceled surgery|2|||
160854244|NCT01884077|580854906|FG001|Overall Study|canceled surgery|0|||
160854245|NCT01884077|580854905|FG000|Overall Study|Lost to Follow-up|0|||
160854246|NCT01884077|580854906|FG001|Overall Study|Lost to Follow-up|4|||
160854247|NCT01884077|580854905|FG000|Overall Study|study closed|6|||
160854248|NCT01884077|580854906|FG001|Overall Study|study closed|4|||
160854249|NCT03812380|580854907|FG000|Overall Study|Protocol Violation|3|||
160854250|NCT03812380|580854908|FG001|Overall Study|Protocol Violation|3|||
160854251|NCT03812380|580854907|FG000|Overall Study|Withdrawal by Subject|5|||
160992724|NCT03068468|581363112|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
160854252|NCT03812380|580854908|FG001|Overall Study|Withdrawal by Subject|4|||
160992725|NCT03068468|581363113|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
160854253|NCT03812380|580854907|FG000|Overall Study|Early termination of study|14|||
160854254|NCT03812380|580854908|FG001|Overall Study|Early termination of study|14|||
160854255|NCT02836652|580854909|FG000|Overall Study|Death|3|||
160854256|NCT02836652|580854910|FG001|Overall Study|Death|3|||
160854257|NCT02836652|580854909|FG000|Overall Study|Transplant/Explant|3|||
160854258|NCT02836652|580854910|FG001|Overall Study|Transplant/Explant|4|||
160854259|NCT02836652|580854909|FG000|Overall Study|Withdrawn|9|||
160854260|NCT02836652|580854910|FG001|Overall Study|Withdrawn|9|||
160854261|NCT02836652|580854909|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
160854262|NCT02836652|580854910|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
160854263|NCT01220167|580854911|FG000|Period 3|Urine positive for substance abuse|0|||
160854264|NCT01220167|580854912|FG001|Period 3|Urine positive for substance abuse|1|||
160854265|NCT01220167|580854913|FG002|Period 3|Urine positive for substance abuse|0|||
160854266|NCT01008943|580854914|FG000|Overall Study|Withdrawal by Subject|1|||
160854267|NCT00861705|580854915|FG000|Overall Study|Never Began Treatment|7|||
160854268|NCT00861705|580854916|FG001|Overall Study|Never Began Treatment|3|||
160854269|NCT00861705|580854917|FG002|Overall Study|Never Began Treatment|0|||
160854270|NCT00861705|580854918|FG003|Overall Study|Never Began Treatment|1|||
160854271|NCT02611479|580854919|FG000|Baseline Enrollment|Exited study|13|||
160854272|NCT02611479|580854919|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
160854273|NCT02611479|580854919|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
160854274|NCT02611479|580854919|FG000|Data Cleaning|No baseline function or pain metrics|2|||
160854275|NCT00743249|580854920|FG000|Overall Study|Adverse Event|0|||
160907317|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
160907318|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
160907319|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
160907320|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
160907321|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
160907322|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
160907323|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
160907324|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
160907325|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
160907326|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
160907327|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
160907328|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
160907329|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
160907330|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
160907331|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
160907332|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
160907333|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
160907334|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
160907335|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
160907336|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
160907337|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
160907338|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
160907339|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
160907340|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
160907341|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
160907342|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
160907343|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Death|8|||
160907344|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Death|2|||
160907345|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Death|2|||
160907346|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Death|1|||
160907347|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Death|0|||
160907348|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Death|0|||
160907349|NCT00329238|581054019|FG000|Overall Study|Adverse Event|147|||
160907350|NCT00329238|581054020|FG001|Overall Study|Adverse Event|129|||
160907351|NCT00329238|581054019|FG000|Overall Study|Protocol Violation|23|||
160907352|NCT00329238|581054020|FG001|Overall Study|Protocol Violation|34|||
160907353|NCT00329238|581054019|FG000|Overall Study|Lost to Follow-up|2|||
160907354|NCT00329238|581054020|FG001|Overall Study|Lost to Follow-up|6|||
160907355|NCT00329238|581054019|FG000|Overall Study|Withdrawal by Subject|64|||
160907356|NCT00329238|581054020|FG001|Overall Study|Withdrawal by Subject|58|||
160907357|NCT00329238|581054019|FG000|Overall Study|Other reason (not specified)|40|||
160907358|NCT00329238|581054020|FG001|Overall Study|Other reason (not specified)|54|||
160907359|NCT00801632|581054021|FG000|Overall Study|Re-transplant|1|||
160907360|NCT05393895|581054025|FG000|Overall Study|Adverse Event|2|||
160907361|NCT05393895|581054026|FG001|Overall Study|Adverse Event|3|||
160907362|NCT05393895|581054025|FG000|Overall Study|Lost to Follow-up|4|||
160907363|NCT05393895|581054026|FG001|Overall Study|Lost to Follow-up|3|||
160907364|NCT05393895|581054025|FG000|Overall Study|Protocol Violation|1|||
160907365|NCT05393895|581054026|FG001|Overall Study|Protocol Violation|0|||
160907366|NCT05393895|581054025|FG000|Overall Study|Withdrawal by Subject|1|||
160907367|NCT05393895|581054026|FG001|Overall Study|Withdrawal by Subject|4|||
160907368|NCT01203098|581054035|FG000|Overall Study|Adverse Event|3|||
160907369|NCT01203098|581054036|FG001|Overall Study|Adverse Event|1|||
160907370|NCT01203098|581054037|FG002|Overall Study|Adverse Event|7|||
160907371|NCT01203098|581054035|FG000|Overall Study|Lost to Follow-up|0|||
160907372|NCT01203098|581054036|FG001|Overall Study|Lost to Follow-up|0|||
160907373|NCT01203098|581054037|FG002|Overall Study|Lost to Follow-up|1|||
160907374|NCT01203098|581054035|FG000|Overall Study|Physician Decision|2|||
160854276|NCT00743249|580854921|FG001|Overall Study|Adverse Event|4|||
160854277|NCT00743249|580854920|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
160992726|NCT03068468|581363110|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
160992727|NCT03068468|581363111|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
160992728|NCT03068468|581363112|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
160854278|NCT00743249|580854921|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
160854279|NCT00743249|580854920|FG000|Overall Study|Unsuccessful insertion of stent|2|||
160854280|NCT00743249|580854921|FG001|Overall Study|Unsuccessful insertion of stent|1|||
160854281|NCT02314052|580854924|FG000|Cycle One|Adverse Event|0|||
160854282|NCT02314052|580854925|FG001|Cycle One|Adverse Event|0|||
160854283|NCT02314052|580854926|FG002|Cycle One|Adverse Event|0|||
160854284|NCT02314052|580854927|FG003|Cycle One|Adverse Event|1|||
160854285|NCT02314052|580854928|FG004|Cycle One|Adverse Event|0|||
160854286|NCT02314052|580854929|FG005|Cycle One|Adverse Event|0|||
160854287|NCT01960140|580854931|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
160854288|NCT00686777|580854935|FG000|Overall Study|Adverse Event|2|||
160854289|NCT00686777|580854935|FG000|Overall Study|Pregnancy|1|||
160854290|NCT00686777|580854935|FG000|Overall Study|Withdrawal by Subject|2|||
160854291|NCT00686777|580854935|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
160854292|NCT00686777|580854935|FG000|Overall Study|No Visit|1|||
160854293|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
160854294|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
160854295|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Disease progression|75|||
160854296|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Disease progression|59|||
160854297|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Adverse Event|16|||
160854298|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Adverse Event|16|||
160854299|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Death|2|||
160854300|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Death|3|||
160854301|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
160854302|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
160854303|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Other|3|||
160854304|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Other|0|||
160854305|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Adverse Event|2|||
160854306|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Adverse Event|3|||
160854307|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Death|1|||
160854308|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Death|3|||
160854309|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
160854310|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
160854311|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
160854312|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
160854313|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Disease progression|103|||
160854314|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Disease progression|122|||
160854315|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Other|3|||
160854316|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Other|0|||
160854317|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
160854318|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
160854319|NCT00883779|580854936|FG000|Off-study Phase|Death|185|||
160854320|NCT00883779|580854937|FG001|Off-study Phase|Death|174|||
160854321|NCT00883779|580854936|FG000|Off-study Phase|Refused treatment|1|||
160854322|NCT00883779|580854937|FG001|Off-study Phase|Refused treatment|1|||
160854323|NCT00883779|580854936|FG000|Off-study Phase|Failure to return|5|||
160854324|NCT00883779|580854937|FG001|Off-study Phase|Failure to return|6|||
160854325|NCT00883779|580854936|FG000|Off-study Phase|Other|18|||
160854326|NCT00883779|580854937|FG001|Off-study Phase|Other|21|||
160854327|NCT00499681|580854938|FG000|Overall Study|toxicity|0|||
160854328|NCT00499681|580854939|FG001|Overall Study|toxicity|1|||
160854329|NCT00499681|580854938|FG000|Overall Study|disease progression|0|||
160854330|NCT00499681|580854939|FG001|Overall Study|disease progression|1|||
160854331|NCT00739401|580854940|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
160854332|NCT00739401|580854940|FG000|Overall Study|Death|3|||
160854333|NCT00739401|580854940|FG000|Overall Study|Withdrawal by Subject|4|||
160854334|NCT01239381|580854941|FG000|Overall Study|Protocol Violation|1|||
160854335|NCT01239381|580854941|FG000|Overall Study|Withdrawal by Subject|1|||
160854336|NCT06237049|580854942|FG000|Overall Study|Death|0|||
160854337|NCT06237049|580854943|FG001|Overall Study|Death|0|||
160854338|NCT06237049|580854944|FG002|Overall Study|Death|0|||
160854339|NCT06237049|580854945|FG003|Overall Study|Death|1|||
160854340|NCT06237049|580854942|FG000|Overall Study|Lost to Follow-up|11|||
160854341|NCT06237049|580854943|FG001|Overall Study|Lost to Follow-up|5|||
160854342|NCT06237049|580854944|FG002|Overall Study|Lost to Follow-up|8|||
160854343|NCT06237049|580854945|FG003|Overall Study|Lost to Follow-up|8|||
160854344|NCT06237049|580854942|FG000|Overall Study|Protocol Violation|0|||
160854345|NCT06237049|580854943|FG001|Overall Study|Protocol Violation|1|||
160854346|NCT06237049|580854944|FG002|Overall Study|Protocol Violation|0|||
160854347|NCT06237049|580854945|FG003|Overall Study|Protocol Violation|1|||
160854348|NCT06237049|580854942|FG000|Overall Study|Withdrawal by Subject|4|||
160854349|NCT06237049|580854943|FG001|Overall Study|Withdrawal by Subject|2|||
160854350|NCT06237049|580854944|FG002|Overall Study|Withdrawal by Subject|1|||
160854351|NCT06237049|580854945|FG003|Overall Study|Withdrawal by Subject|0|||
160854352|NCT03748823|580854946|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
160854353|NCT03748823|580854947|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
160854354|NCT03748823|580854946|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
160854355|NCT03748823|580854947|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
160907375|NCT01203098|581054036|FG001|Overall Study|Physician Decision|2|||
160907376|NCT01203098|581054037|FG002|Overall Study|Physician Decision|0|||
160907377|NCT01203098|581054035|FG000|Overall Study|Withdrawal by Subject|1|||
160907378|NCT01203098|581054036|FG001|Overall Study|Withdrawal by Subject|1|||
160907379|NCT01203098|581054037|FG002|Overall Study|Withdrawal by Subject|3|||
160907380|NCT03095612|581054042|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907381|NCT03095612|581054043|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
160907382|NCT03095612|581054044|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907383|NCT03095612|581054045|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907384|NCT03095612|581054046|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907385|NCT03095612|581054047|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907386|NCT03095612|581054048|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907387|NCT00621582|581054049|FG000|Overall Study|Adverse Event|7|||
160907388|NCT00621582|581054049|FG000|Overall Study|Protocol Violation|57|||
160907389|NCT00621582|581054049|FG000|Overall Study|Lost to Follow-up|24|||
160907390|NCT00621582|581054049|FG000|Overall Study|issues not identified by investigators|18|||
160907391|NCT03617185|581054050|FG000|Baseline|Lost to Follow-up|0|||
160907392|NCT03617185|581054051|FG001|Baseline|Lost to Follow-up|2|||
160907393|NCT03617185|581054052|FG002|Baseline|Lost to Follow-up|1|||
160907394|NCT03617185|581054053|FG003|Baseline|Lost to Follow-up|1|||
160907395|NCT03617185|581054050|FG000|Baseline|Withdrawal by Subject|0|||
160907396|NCT03617185|581054051|FG001|Baseline|Withdrawal by Subject|1|||
160907397|NCT03617185|581054052|FG002|Baseline|Withdrawal by Subject|0|||
160907398|NCT03617185|581054053|FG003|Baseline|Withdrawal by Subject|1|||
160907399|NCT03617185|581054050|FG000|Baseline|Driving Distance/Travel|0|||
160907400|NCT03617185|581054051|FG001|Baseline|Driving Distance/Travel|0|||
160907401|NCT03617185|581054052|FG002|Baseline|Driving Distance/Travel|2|||
160907402|NCT03617185|581054053|FG003|Baseline|Driving Distance/Travel|0|||
160907403|NCT03617185|581054050|FG000|Baseline|Family Obligations|0|||
160907404|NCT03617185|581054051|FG001|Baseline|Family Obligations|0|||
160907405|NCT03617185|581054052|FG002|Baseline|Family Obligations|0|||
160907406|NCT03617185|581054053|FG003|Baseline|Family Obligations|1|||
160907407|NCT03617185|581054050|FG000|3 Months|Lost to Follow-up|4|||
160907408|NCT03617185|581054051|FG001|3 Months|Lost to Follow-up|1|||
160907409|NCT03617185|581054052|FG002|3 Months|Lost to Follow-up|0|||
160907410|NCT03617185|581054053|FG003|3 Months|Lost to Follow-up|2|||
160907411|NCT03617185|581054050|FG000|3 Months|Withdrawal by Subject|1|||
160907412|NCT03617185|581054051|FG001|3 Months|Withdrawal by Subject|3|||
160907413|NCT03617185|581054052|FG002|3 Months|Withdrawal by Subject|0|||
160907414|NCT03617185|581054053|FG003|3 Months|Withdrawal by Subject|0|||
160907415|NCT03617185|581054050|FG000|3 Months|Driving Distance/Travel|1|||
160907416|NCT03617185|581054051|FG001|3 Months|Driving Distance/Travel|0|||
160907417|NCT03617185|581054052|FG002|3 Months|Driving Distance/Travel|0|||
160907418|NCT03617185|581054053|FG003|3 Months|Driving Distance/Travel|0|||
160907419|NCT03617185|581054050|FG000|3 Months|Family Obligations|0|||
160907420|NCT03617185|581054051|FG001|3 Months|Family Obligations|0|||
160907421|NCT03617185|581054052|FG002|3 Months|Family Obligations|0|||
160907422|NCT03617185|581054053|FG003|3 Months|Family Obligations|1|||
160907423|NCT03617185|581054050|FG000|12 Months|Lost to Follow-up|3|||
160907424|NCT03617185|581054051|FG001|12 Months|Lost to Follow-up|1|||
160907425|NCT03617185|581054052|FG002|12 Months|Lost to Follow-up|3|||
160907426|NCT03617185|581054053|FG003|12 Months|Lost to Follow-up|0|||
160907427|NCT03617185|581054050|FG000|12 Months|Withdrawal by Subject|0|||
160907428|NCT03617185|581054051|FG001|12 Months|Withdrawal by Subject|0|||
160907429|NCT03617185|581054052|FG002|12 Months|Withdrawal by Subject|0|||
160907430|NCT03617185|581054053|FG003|12 Months|Withdrawal by Subject|1|||
160907431|NCT03617185|581054050|FG000|12 Months|Driving Distance/Travel|0|||
160907432|NCT03617185|581054051|FG001|12 Months|Driving Distance/Travel|0|||
160907433|NCT03617185|581054052|FG002|12 Months|Driving Distance/Travel|1|||
160907434|NCT03617185|581054053|FG003|12 Months|Driving Distance/Travel|0|||
160907435|NCT01387932|581054055|FG000|Randomized and Treated|Physician Decision|3|||
160854356|NCT03748823|580854946|FG000|Extension Period|Withdrawal by Subject|9|||
160907436|NCT01387932|581054056|FG001|Randomized and Treated|Physician Decision|2|||
160907437|NCT01387932|581054055|FG000|Randomized and Treated|Withdrawal by Subject|4|||
160907438|NCT01387932|581054056|FG001|Randomized and Treated|Withdrawal by Subject|2|||
160907439|NCT01387932|581054055|FG000|Survival Follow-up|Liver Transplant|24|||
160650814|NCT04820842|580104330|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
160992729|NCT03068468|581363113|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
160992730|NCT03068468|581363110|FG000|Open-Label Extension Period|Reason not Specified|0|||
160992731|NCT03068468|581363111|FG001|Open-Label Extension Period|Reason not Specified|0|||
160992732|NCT03068468|581363112|FG002|Open-Label Extension Period|Reason not Specified|1|||
160992733|NCT03068468|581363113|FG003|Open-Label Extension Period|Reason not Specified|4|||
160992734|NCT03895034|581363115|FG000|Overall Study|Lost to Follow-up|2|||
160992735|NCT01118377|581363116|FG000|Overall Study|Did Not Receive Study Medication|1|||
160907440|NCT01387932|581054056|FG001|Survival Follow-up|Liver Transplant|28|||
160907441|NCT01387932|581054055|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
160907442|NCT01387932|581054056|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
160907443|NCT01387932|581054055|FG000|Survival Follow-up|Withdrawal by Subject|2|||
160907444|NCT01387932|581054056|FG001|Survival Follow-up|Withdrawal by Subject|4|||
160907445|NCT01387932|581054055|FG000|Survival Follow-up|Lost to Follow-up|6|||
160907446|NCT01387932|581054056|FG001|Survival Follow-up|Lost to Follow-up|5|||
160992736|NCT01118377|581363116|FG000|Overall Study|Death|38|||
160992737|NCT01118377|581363116|FG000|Overall Study|Failure to Return|3|||
160992738|NCT00739102|581363121|FG000|Overall Study|Death|5|||
160992739|NCT00739102|581363121|FG000|Overall Study|Withdrawal by Subject|10|||
160992740|NCT01331824|581363125|FG000|Overall Study|Adverse Event|2|||
160992741|NCT01331824|581363125|FG000|Overall Study|Death|1|||
160992742|NCT01331824|581363125|FG000|Overall Study|Disease Progression|9|||
160992743|NCT01331824|581363125|FG000|Overall Study|Withdrawal by Subject|1|||
160992744|NCT01091454|581363126|FG000|Overall Study|Ineligible|1|||
160992745|NCT02715258|581363130|FG000|Overall Study|Withdrawal by Subject|6|||
160992746|NCT02715258|581363131|FG001|Overall Study|Withdrawal by Subject|1|||
160992747|NCT02715258|581363130|FG000|Overall Study|Lost to Follow-up|7|||
160992748|NCT02715258|581363131|FG001|Overall Study|Lost to Follow-up|1|||
160992749|NCT02715258|581363130|FG000|Overall Study|Terminated by Sponsor|0|||
160992750|NCT02715258|581363131|FG001|Overall Study|Terminated by Sponsor|1|||
160992751|NCT02715258|581363130|FG000|Overall Study|Death|0|||
160992752|NCT02715258|581363131|FG001|Overall Study|Death|1|||
160992753|NCT02715258|581363130|FG000|Overall Study|Subject non-compliant|1|||
160992754|NCT02715258|581363131|FG001|Overall Study|Subject non-compliant|1|||
160992755|NCT02715258|581363130|FG000|Overall Study|GCP violation|2|||
160992756|NCT02715258|581363131|FG001|Overall Study|GCP violation|1|||
160992757|NCT02236559|581363141|FG000|Overall Study|Met Exclusion|3|||
160992758|NCT02236559|581363142|FG001|Overall Study|Met Exclusion|6|||
160992759|NCT02236559|581363141|FG000|Overall Study|Did not Meet Inclusion|3|||
160992760|NCT02236559|581363142|FG001|Overall Study|Did not Meet Inclusion|3|||
160992761|NCT02236559|581363141|FG000|Overall Study|Subject Did Not Consent|4|||
160992762|NCT02236559|581363142|FG001|Overall Study|Subject Did Not Consent|2|||
160992763|NCT02236559|581363141|FG000|Overall Study|Physician Decision|1|||
160992764|NCT02236559|581363142|FG001|Overall Study|Physician Decision|1|||
160992765|NCT02236559|581363141|FG000|Overall Study|Withdrawal by Subject|1|||
160992766|NCT02236559|581363142|FG001|Overall Study|Withdrawal by Subject|0|||
160992767|NCT02263508|581363144|FG000|Overall Study|Withdrawal by Subject|1|||
160650815|NCT04820842|580104331|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
160992768|NCT02263508|581363145|FG001|Overall Study|Withdrawal by Subject|23|||
160907447|NCT01964430|581054057|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
160907448|NCT01964430|581054058|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
160907449|NCT01964430|581054057|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
160907450|NCT01964430|581054058|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
160992769|NCT02263508|581363146|FG002|Overall Study|Withdrawal by Subject|17|||
160992770|NCT02263508|581363144|FG000|Overall Study|Sponsor Decision|12|||
160992771|NCT02263508|581363145|FG001|Overall Study|Sponsor Decision|165|||
160992772|NCT02263508|581363146|FG002|Overall Study|Sponsor Decision|182|||
160992773|NCT02263508|581363144|FG000|Overall Study|Lost to Follow-up|2|||
160992774|NCT02263508|581363145|FG001|Overall Study|Lost to Follow-up|7|||
160992775|NCT02263508|581363146|FG002|Overall Study|Lost to Follow-up|7|||
160992776|NCT02263508|581363144|FG000|Overall Study|Death|6|||
160992777|NCT02263508|581363145|FG001|Overall Study|Death|151|||
160992778|NCT02263508|581363146|FG002|Overall Study|Death|140|||
160992779|NCT01280591|581363147|FG000|Overall Study|Withdrawal by Subject|0|||
160992780|NCT01280591|581363148|FG001|Overall Study|Withdrawal by Subject|0|||
160992781|NCT01280591|581363149|FG002|Overall Study|Withdrawal by Subject|0|||
160992782|NCT01280591|581363150|FG003|Overall Study|Withdrawal by Subject|2|||
160992783|NCT01280591|581363147|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
160992784|NCT01280591|581363148|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
160992785|NCT01280591|581363149|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
160992786|NCT01280591|581363150|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
160992787|NCT01117480|581363151|FG000|Overall Study|Protocol Violation|8|||
160992788|NCT01117480|581363151|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
160992789|NCT02955069|581363152|FG000|Overall Study|Adverse Event|7|||
160992790|NCT02955069|581363153|FG001|Overall Study|Adverse Event|2|||
160992791|NCT02955069|581363152|FG000|Overall Study|Death|7|||
160992792|NCT02955069|581363153|FG001|Overall Study|Death|3|||
160992793|NCT02955069|581363152|FG000|Overall Study|Physician Decision|10|||
160992794|NCT02955069|581363153|FG001|Overall Study|Physician Decision|2|||
160992795|NCT02955069|581363152|FG000|Overall Study|Progressive disease|64|||
160992796|NCT02955069|581363153|FG001|Overall Study|Progressive disease|13|||
160992797|NCT02955069|581363152|FG000|Overall Study|Study terminated by sponsor|4|||
160992798|NCT02955069|581363153|FG001|Overall Study|Study terminated by sponsor|0|||
160992799|NCT02955069|581363152|FG000|Overall Study|Subject/Guardian decision|3|||
160992800|NCT02955069|581363153|FG001|Overall Study|Subject/Guardian decision|1|||
160992801|NCT03721016|581363154|FG000|Overall Study|Adverse Event|0|||
160992802|NCT03721016|581363155|FG001|Overall Study|Adverse Event|1|||
160992803|NCT03721016|581363156|FG002|Overall Study|Adverse Event|1|||
160992804|NCT03721016|581363154|FG000|Overall Study|Withdrawal by Subject|8|||
160992805|NCT03721016|581363155|FG001|Overall Study|Withdrawal by Subject|16|||
160992806|NCT03721016|581363156|FG002|Overall Study|Withdrawal by Subject|13|||
160992807|NCT03721016|581363154|FG000|Overall Study|Lost to Follow-up|4|||
160992808|NCT03721016|581363155|FG001|Overall Study|Lost to Follow-up|6|||
160992809|NCT03721016|581363156|FG002|Overall Study|Lost to Follow-up|5|||
160992810|NCT03721016|581363154|FG000|Overall Study|Physician Decision|0|||
160992811|NCT03721016|581363155|FG001|Overall Study|Physician Decision|1|||
160992812|NCT03721016|581363156|FG002|Overall Study|Physician Decision|2|||
160992813|NCT03721016|581363154|FG000|Overall Study|Protocol Violation|0|||
160992814|NCT03721016|581363155|FG001|Overall Study|Protocol Violation|1|||
160992815|NCT03721016|581363156|FG002|Overall Study|Protocol Violation|0|||
160992816|NCT03721016|581363154|FG000|Overall Study|Site terminated by sponsor|3|||
160992817|NCT03721016|581363155|FG001|Overall Study|Site terminated by sponsor|7|||
160992818|NCT03721016|581363156|FG002|Overall Study|Site terminated by sponsor|6|||
160992819|NCT03721016|581363154|FG000|Overall Study|Subject exited early due to COVID-19|1|||
160992820|NCT03721016|581363155|FG001|Overall Study|Subject exited early due to COVID-19|0|||
160992821|NCT03721016|581363156|FG002|Overall Study|Subject exited early due to COVID-19|0|||
160992822|NCT04148937|581363157|FG000|Overall Study|Withdrawal by Subject|0|||
160992823|NCT04148937|581363158|FG001|Overall Study|Withdrawal by Subject|0|||
160992824|NCT04148937|581363159|FG002|Overall Study|Withdrawal by Subject|0|||
160992825|NCT04148937|581363160|FG003|Overall Study|Withdrawal by Subject|1|||
160650816|NCT04820842|580104332|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
160650817|NCT04820842|580104333|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
160992826|NCT04148937|581363161|FG004|Overall Study|Withdrawal by Subject|0|||
160992827|NCT04148937|581363162|FG005|Overall Study|Withdrawal by Subject|1|||
160992828|NCT04148937|581363163|FG006|Overall Study|Withdrawal by Subject|1|||
160992829|NCT04148937|581363164|FG007|Overall Study|Withdrawal by Subject|0|||
160992830|NCT04148937|581363157|FG000|Overall Study|Lost to Follow-up|0|||
160992831|NCT04148937|581363158|FG001|Overall Study|Lost to Follow-up|0|||
160992832|NCT04148937|581363159|FG002|Overall Study|Lost to Follow-up|1|||
160992833|NCT04148937|581363160|FG003|Overall Study|Lost to Follow-up|0|||
160992834|NCT04148937|581363161|FG004|Overall Study|Lost to Follow-up|0|||
160992835|NCT04148937|581363162|FG005|Overall Study|Lost to Follow-up|2|||
160992836|NCT04148937|581363163|FG006|Overall Study|Lost to Follow-up|0|||
160992837|NCT04148937|581363164|FG007|Overall Study|Lost to Follow-up|0|||
160992838|NCT03357341|581363165|FG000|Overall Study|Withdrawal by Subject|3|||
160992839|NCT03357341|581363166|FG001|Overall Study|Withdrawal by Subject|6|||
160992840|NCT03357341|581363165|FG000|Overall Study|Lost to Follow-up|4|||
160992841|NCT03357341|581363166|FG001|Overall Study|Lost to Follow-up|5|||
160992842|NCT03357341|581363165|FG000|Overall Study|Death|0|||
160992843|NCT03357341|581363166|FG001|Overall Study|Death|1|||
160992844|NCT00686517|581363167|FG000|Treatment|Serious Adverse Event|1|||
160992845|NCT00686517|581363168|FG001|Treatment|Serious Adverse Event|2|||
160992846|NCT00686517|581363169|FG002|Treatment|Serious Adverse Event|1|||
160992847|NCT00686517|581363167|FG000|Treatment|Adverse Event|2|||
160992848|NCT00686517|581363168|FG001|Treatment|Adverse Event|0|||
160992849|NCT00686517|581363169|FG002|Treatment|Adverse Event|0|||
160992850|NCT00686517|581363167|FG000|Treatment|Poor Protocol Compliance|1|||
160992851|NCT00686517|581363168|FG001|Treatment|Poor Protocol Compliance|0|||
160992852|NCT00686517|581363169|FG002|Treatment|Poor Protocol Compliance|0|||
160992853|NCT00686517|581363167|FG000|Treatment|Protocol Violation|2|||
160992854|NCT00686517|581363168|FG001|Treatment|Protocol Violation|1|||
160992855|NCT00686517|581363169|FG002|Treatment|Protocol Violation|0|||
160992856|NCT01803646|581363170|FG000|Overall Study|Protocol Violation|1|||
160992857|NCT01803646|581363171|FG001|Overall Study|Protocol Violation|0|||
160992858|NCT01803646|581363170|FG000|Overall Study|Adverse Event|1|||
160992859|NCT01803646|581363171|FG001|Overall Study|Adverse Event|1|||
160992860|NCT01803646|581363170|FG000|Overall Study|Withdrawal by Subject|9|||
160992861|NCT01803646|581363171|FG001|Overall Study|Withdrawal by Subject|6|||
160992862|NCT01803646|581363170|FG000|Overall Study|Randomization error|1|||
160992863|NCT01803646|581363171|FG001|Overall Study|Randomization error|2|||
160992864|NCT01803646|581363170|FG000|Overall Study|Lost to Follow-up|5|||
160992865|NCT01803646|581363171|FG001|Overall Study|Lost to Follow-up|1|||
160992866|NCT01167426|581363172|FG000|Overall Study|Lost to Follow-up|6|||
160992867|NCT01167426|581363172|FG000|Overall Study|Protocol Violation|1|||
160992868|NCT01167426|581363172|FG000|Overall Study|Withdrawal by Subject|2|||
160992869|NCT01167426|581363172|FG000|Overall Study|Sponsor Decision|1|||
160992870|NCT01072357|581363175|FG000|Overall Study|Lost to Follow-up|0|||
160992871|NCT01072357|581363176|FG001|Overall Study|Lost to Follow-up|1|||
160992872|NCT01876511|581363177|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
160992873|NCT01876511|581363178|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
160992874|NCT01876511|581363179|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
160992875|NCT01876511|581363177|FG000|Overall Study|Death (unrelated)|3|||
160992876|NCT01876511|581363178|FG001|Overall Study|Death (unrelated)|0|||
160992877|NCT01876511|581363179|FG002|Overall Study|Death (unrelated)|2|||
160992878|NCT01876511|581363177|FG000|Overall Study|Drug-related Toxicity|5|||
160992879|NCT01876511|581363178|FG001|Overall Study|Drug-related Toxicity|1|||
160992880|NCT01876511|581363179|FG002|Overall Study|Drug-related Toxicity|6|||
160992881|NCT01876511|581363177|FG000|Overall Study|Patient Decision|3|||
160992882|NCT01876511|581363178|FG001|Overall Study|Patient Decision|0|||
160992883|NCT01876511|581363179|FG002|Overall Study|Patient Decision|6|||
160992884|NCT01876511|581363177|FG000|Overall Study|Physician Decision|1|||
160992885|NCT01876511|581363178|FG001|Overall Study|Physician Decision|0|||
160992886|NCT01876511|581363179|FG002|Overall Study|Physician Decision|1|||
160992887|NCT02131324|581363180|FG000|Overall Study|Withdrawal by Subject|1|||
160992888|NCT02131324|581363181|FG001|Overall Study|Withdrawal by Subject|2|||
160992889|NCT02131324|581363180|FG000|Overall Study|Lost to Follow-up|1|||
160992890|NCT02131324|581363181|FG001|Overall Study|Lost to Follow-up|1|||
160992891|NCT05790408|581363182|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
160992892|NCT01048788|581363183|FG000|Overall Study|Adverse Event|5|||
160992893|NCT01048788|581363184|FG001|Overall Study|Adverse Event|1|||
160992894|NCT01048788|581363185|FG002|Overall Study|Adverse Event|1|||
160992895|NCT01048788|581363183|FG000|Overall Study|Lack of Efficacy|0|||
160992896|NCT01048788|581363184|FG001|Overall Study|Lack of Efficacy|0|||
160992897|NCT01048788|581363185|FG002|Overall Study|Lack of Efficacy|1|||
160992898|NCT01048788|581363183|FG000|Overall Study|Withdrawal by Subject|0|||
160992899|NCT01048788|581363184|FG001|Overall Study|Withdrawal by Subject|1|||
160992900|NCT01048788|581363185|FG002|Overall Study|Withdrawal by Subject|0|||
160992901|NCT01233050|581363186|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
160992902|NCT01233050|581363187|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
160992903|NCT04582877|581363192|FG000|Overall Study|Did not use device measurement|5|||
160992904|NCT04582877|581363192|FG000|Overall Study|No fractional flow reserve test results|2|||
160992905|NCT04582877|581363192|FG000|Overall Study|Protocol Violation|1|||
160992906|NCT03095508|581363203|FG000|Overall Study|Adverse Event|0|||
160992907|NCT03095508|581363204|FG001|Overall Study|Adverse Event|1|||
160992908|NCT00335556|581363205|FG000|Overall Study|Death|0|||
160992909|NCT00335556|581363206|FG001|Overall Study|Death|5|||
160992910|NCT00335556|581363207|FG002|Overall Study|Death|0|||
160992911|NCT00335556|581363208|FG003|Overall Study|Death|0|||
160992912|NCT00335556|581363209|FG004|Overall Study|Death|1|||
160992913|NCT00335556|581363210|FG005|Overall Study|Death|0|||
160992914|NCT00335556|581363205|FG000|Overall Study|Lack of Efficacy|0|||
160992915|NCT00335556|581363206|FG001|Overall Study|Lack of Efficacy|19|||
160992916|NCT00335556|581363207|FG002|Overall Study|Lack of Efficacy|3|||
160992917|NCT00335556|581363208|FG003|Overall Study|Lack of Efficacy|3|||
160992918|NCT00335556|581363209|FG004|Overall Study|Lack of Efficacy|0|||
160854357|NCT03748823|580854947|FG001|Extension Period|Withdrawal by Subject|12|||
160854358|NCT03748823|580854946|FG000|Extension Period|Death|2|||
160854359|NCT03748823|580854947|FG001|Extension Period|Death|2|||
160854360|NCT03748823|580854946|FG000|Extension Period|Other than Specified|0|||
160854361|NCT03748823|580854947|FG001|Extension Period|Other than Specified|1|||
160854362|NCT03748823|580854946|FG000|Extension Period|Protocol Violation|1|||
160854363|NCT03748823|580854947|FG001|Extension Period|Protocol Violation|0|||
160854364|NCT03748823|580854946|FG000|Extension Period|Lost to Follow-up|0|||
160854365|NCT03748823|580854947|FG001|Extension Period|Lost to Follow-up|1|||
160854366|NCT03748823|580854946|FG000|Extension Period|Lack of Efficacy|0|||
160854367|NCT03748823|580854947|FG001|Extension Period|Lack of Efficacy|1|||
160854368|NCT03748823|580854946|FG000|Extension Period|Physician Decision|1|||
160854369|NCT03748823|580854947|FG001|Extension Period|Physician Decision|2|||
160854370|NCT04678115|580854948|FG000|Overall Study|Lost to Follow-up|1|||
160854371|NCT04678115|580854949|FG001|Overall Study|Lost to Follow-up|0|||
160854372|NCT00890825|580854950|FG000|Overall Study|Withdrawal by Subject|1|||
160854373|NCT00890825|580854951|FG001|Overall Study|Withdrawal by Subject|0|||
160854374|NCT00890825|580854950|FG000|Overall Study|Alive at data cut off (DCO)|13|||
160854375|NCT00890825|580854951|FG001|Overall Study|Alive at data cut off (DCO)|14|||
160854376|NCT01363700|580854952|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
160854377|NCT01363700|580854953|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
160854378|NCT01363700|580854954|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
160854379|NCT01363700|580854955|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
160854380|NCT01363700|580854956|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
160854381|NCT03649217|580854957|FG000|Overall Study|subject had severe ataxia not initially found|1|||
160854382|NCT03649217|580854957|FG000|Overall Study|subject had cognitive issues not initially found|1|||
160854383|NCT01721161|580854958|FG000|Overall Study|Adverse Event|2|||
160854384|NCT01721161|580854959|FG001|Overall Study|Adverse Event|3|||
160854385|NCT01721161|580854958|FG000|Overall Study|Lost to Follow-up|1|||
160854386|NCT01721161|580854959|FG001|Overall Study|Lost to Follow-up|2|||
160854387|NCT01721161|580854958|FG000|Overall Study|Withdrawal by Subject|1|||
160854388|NCT01721161|580854959|FG001|Overall Study|Withdrawal by Subject|1|||
160854389|NCT01721161|580854958|FG000|Overall Study|Other|0|||
160854390|NCT01721161|580854959|FG001|Overall Study|Other|1|||
160854391|NCT01091675|580854962|FG000|Overall Study|Adverse Event|7|||
160854392|NCT01091675|580854962|FG000|Overall Study|Lack of Efficacy|27|||
160854393|NCT00614380|580854965|FG000|Overall Study|Adverse Event|14|||
160854394|NCT00614380|580854966|FG001|Overall Study|Adverse Event|4|||
160854395|NCT00614380|580854967|FG002|Overall Study|Adverse Event|0|||
160854396|NCT00614380|580854968|FG003|Overall Study|Adverse Event|0|||
160854397|NCT00614380|580854965|FG000|Overall Study|Lost to Follow-up|6|||
160854398|NCT00614380|580854966|FG001|Overall Study|Lost to Follow-up|1|||
160854399|NCT00614380|580854967|FG002|Overall Study|Lost to Follow-up|0|||
160854400|NCT00614380|580854968|FG003|Overall Study|Lost to Follow-up|0|||
160854401|NCT00614380|580854965|FG000|Overall Study|Non compliant with the protocol|12|||
160854402|NCT00614380|580854966|FG001|Overall Study|Non compliant with the protocol|2|||
160854403|NCT00614380|580854967|FG002|Overall Study|Non compliant with the protocol|1|||
160854404|NCT00614380|580854968|FG003|Overall Study|Non compliant with the protocol|2|||
160854405|NCT00614380|580854965|FG000|Overall Study|Consent withdrawn|3|||
160854406|NCT00614380|580854966|FG001|Overall Study|Consent withdrawn|1|||
160854407|NCT00614380|580854967|FG002|Overall Study|Consent withdrawn|0|||
160854408|NCT00614380|580854968|FG003|Overall Study|Consent withdrawn|0|||
160854409|NCT04908397|580854973|FG000|Overall Study|Withdrawal by Subject|2|||
160854410|NCT00462306|580854974|FG000|Overall Study|insufficient data|0|||
160854411|NCT00462306|580854975|FG001|Overall Study|insufficient data|13|||
160854412|NCT02360228|580854976|FG000|Overall Study|Withdrawal by Subject|1|||
160854413|NCT02360228|580854977|FG001|Overall Study|Withdrawal by Subject|0|||
160854414|NCT02360228|580854978|FG002|Overall Study|Withdrawal by Subject|0|||
160854415|NCT02360228|580854976|FG000|Overall Study|Self-discontinued medication|0|||
160854416|NCT02360228|580854977|FG001|Overall Study|Self-discontinued medication|1|||
160854417|NCT02360228|580854978|FG002|Overall Study|Self-discontinued medication|0|||
160907451|NCT01964430|581054057|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
160907452|NCT01964430|581054058|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
160907453|NCT01964430|581054057|FG000|Treatment Period|Adverse Event|71|||
160854418|NCT02360228|580854976|FG000|Overall Study|Unstable symptoms during screening|0|||
160854419|NCT02360228|580854977|FG001|Overall Study|Unstable symptoms during screening|0|||
160854420|NCT02360228|580854978|FG002|Overall Study|Unstable symptoms during screening|1|||
160854421|NCT02464410|580854979|FG000|Overall Study|Death|3|||
160854422|NCT02464410|580854980|FG001|Overall Study|Death|4|||
160854423|NCT02464410|580854979|FG000|Overall Study|Lost to Follow-up|7|||
160854424|NCT02464410|580854980|FG001|Overall Study|Lost to Follow-up|9|||
160854425|NCT02464410|580854979|FG000|Overall Study|Withdrawal by Subject|12|||
160854426|NCT02464410|580854980|FG001|Overall Study|Withdrawal by Subject|3|||
160854427|NCT01063153|580854981|FG000|Overall Study|Found Ineligible During Screening|2|||
160854428|NCT01063153|580854982|FG001|Overall Study|Found Ineligible During Screening|0|||
160854429|NCT01063153|580854981|FG000|Overall Study|Lost to Follow-up|0|||
160992919|NCT00335556|581363210|FG005|Overall Study|Lack of Efficacy|1|||
160992920|NCT00335556|581363205|FG000|Overall Study|Physician Decision|0|||
160992921|NCT00335556|581363206|FG001|Overall Study|Physician Decision|6|||
160992922|NCT00335556|581363207|FG002|Overall Study|Physician Decision|2|||
160992923|NCT00335556|581363208|FG003|Overall Study|Physician Decision|1|||
160992924|NCT00335556|581363209|FG004|Overall Study|Physician Decision|0|||
160992925|NCT00335556|581363210|FG005|Overall Study|Physician Decision|0|||
160992926|NCT00335556|581363205|FG000|Overall Study|Ineligible|2|||
160992927|NCT00335556|581363206|FG001|Overall Study|Ineligible|0|||
160992928|NCT00335556|581363207|FG002|Overall Study|Ineligible|0|||
160992929|NCT00335556|581363208|FG003|Overall Study|Ineligible|0|||
160992930|NCT00335556|581363209|FG004|Overall Study|Ineligible|0|||
160992931|NCT00335556|581363210|FG005|Overall Study|Ineligible|0|||
160992932|NCT00335556|581363205|FG000|Overall Study|Refusal of further protocol therapy|0|||
160992933|NCT00335556|581363206|FG001|Overall Study|Refusal of further protocol therapy|4|||
160992934|NCT00335556|581363207|FG002|Overall Study|Refusal of further protocol therapy|0|||
160992935|NCT00335556|581363208|FG003|Overall Study|Refusal of further protocol therapy|1|||
160992936|NCT00335556|581363209|FG004|Overall Study|Refusal of further protocol therapy|0|||
160992937|NCT00335556|581363210|FG005|Overall Study|Refusal of further protocol therapy|0|||
160992938|NCT01878890|581363218|FG000|Overall Study|Protocol Violation|0|||
160992939|NCT01878890|581363219|FG001|Overall Study|Protocol Violation|1|||
160992940|NCT01878890|581363220|FG002|Overall Study|Protocol Violation|0|||
160992941|NCT01878890|581363221|FG003|Overall Study|Protocol Violation|0|||
160992942|NCT01710514|581363223|FG000|Overall Study|Adverse Event|6|||
160992943|NCT01710514|581363224|FG001|Overall Study|Adverse Event|7|||
160992944|NCT01710514|581363223|FG000|Overall Study|Withdrawal by Subject|1|||
160854430|NCT01063153|580854982|FG001|Overall Study|Lost to Follow-up|7|||
160854431|NCT01063153|580854981|FG000|Overall Study|Withdrawal by Subject|0|||
160854432|NCT01063153|580854982|FG001|Overall Study|Withdrawal by Subject|1|||
160854433|NCT01063153|580854981|FG000|Overall Study|Physician Decision|0|||
160854434|NCT01063153|580854982|FG001|Overall Study|Physician Decision|4|||
160854435|NCT00350844|580854983|FG000|Overall Study|Lost to Follow-up|1|||
160854436|NCT01838694|580856540|FG000|Overall Study|Adverse Event|0|||
160854437|NCT01838694|580856541|FG001|Overall Study|Adverse Event|1|||
160854438|NCT01535807|580856542|FG000|Overall Study|Withdrawal by Subject|1|||
160854439|NCT01535807|580856543|FG001|Overall Study|Withdrawal by Subject|1|||
160854440|NCT01535807|580856542|FG000|Overall Study|Data collection error|1|||
160854441|NCT01535807|580856543|FG001|Overall Study|Data collection error|1|||
160854442|NCT01329263|580856544|FG000|Overall Study|Lost to Follow-up|4|||
160854443|NCT01329263|580856545|FG001|Overall Study|Lost to Follow-up|21|||
160854444|NCT01329263|580856544|FG000|Overall Study|Withdrawal by Subject|1|||
160854445|NCT01329263|580856545|FG001|Overall Study|Withdrawal by Subject|2|||
160854446|NCT02123134|580856547|FG000|Overall Study|Withdrawal of consent|3|||
160854447|NCT02123134|580856548|FG001|Overall Study|Withdrawal of consent|2|||
160854448|NCT02123134|580856547|FG000|Overall Study|Administrative decision|0|||
160992945|NCT01710514|581363224|FG001|Overall Study|Withdrawal by Subject|0|||
160992946|NCT03404843|581363227|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
160992947|NCT03404843|581363228|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
160992948|NCT04044664|581363229|FG000|Stage 1|Adverse Event|3|||
160992949|NCT04044664|581363230|FG001|Stage 1|Adverse Event|3|||
160992950|NCT04044664|581363231|FG002|Stage 1|Adverse Event|1|||
160992951|NCT04044664|581363229|FG000|Stage 1|Lost to Follow-up|3|||
160854449|NCT02123134|580856548|FG001|Overall Study|Administrative decision|1|||
160854450|NCT00657540|580856549|FG000|Overall Study|Lost to Follow-up|1|||
160992952|NCT04044664|581363230|FG001|Stage 1|Lost to Follow-up|2|||
160992953|NCT04044664|581363231|FG002|Stage 1|Lost to Follow-up|2|||
160992954|NCT04044664|581363229|FG000|Stage 1|Withdrawal by Subject|9|||
160992955|NCT04044664|581363230|FG001|Stage 1|Withdrawal by Subject|1|||
160992956|NCT04044664|581363231|FG002|Stage 1|Withdrawal by Subject|0|||
160992957|NCT04044664|581363229|FG000|Stage 1|noncompliance, personal reason|2|||
160854451|NCT00657540|580856550|FG001|Overall Study|Lost to Follow-up|4|||
160854452|NCT00141453|580856551|FG000|Overall Study|Protocol Violation|6|||
160992958|NCT04044664|581363230|FG001|Stage 1|noncompliance, personal reason|0|||
160992959|NCT04044664|581363231|FG002|Stage 1|noncompliance, personal reason|0|||
160650818|NCT04820842|580104334|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
160854453|NCT00141453|580856552|FG001|Overall Study|Protocol Violation|5|||
160854454|NCT02043938|580856553|FG000|Overall Study|Withdrawal by Subject|7|||
160854455|NCT02043938|580856553|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
160854456|NCT02043938|580856553|FG000|Overall Study|No show by subject|1|||
160854457|NCT02043938|580856553|FG000|Overall Study|Investigator decision|1|||
160854458|NCT02656017|580856556|FG000|Overall Study|Study burden|3|||
160992960|NCT04044664|581363229|FG000|Stage 1|randomization error|0|||
160992961|NCT04044664|581363230|FG001|Stage 1|randomization error|1|||
160992962|NCT04044664|581363231|FG002|Stage 1|randomization error|0|||
160992963|NCT04044664|581363229|FG000|Stage 2|Adverse Event|2|||
160992964|NCT04044664|581363230|FG001|Stage 2|Adverse Event|0|||
160992965|NCT04044664|581363231|FG002|Stage 2|Adverse Event|0|||
160992966|NCT04044664|581363229|FG000|Stage 2|Lost to Follow-up|3|||
160992967|NCT04044664|581363230|FG001|Stage 2|Lost to Follow-up|2|||
160854459|NCT02656017|580856557|FG001|Overall Study|Study burden|3|||
160992968|NCT04044664|581363231|FG002|Stage 2|Lost to Follow-up|1|||
160992969|NCT04044664|581363229|FG000|Stage 2|Withdrawal by Subject|3|||
160992970|NCT04044664|581363230|FG001|Stage 2|Withdrawal by Subject|0|||
160992971|NCT04044664|581363231|FG002|Stage 2|Withdrawal by Subject|0|||
160992972|NCT04044664|581363229|FG000|Stage 2|protocol deviation|1|||
160992973|NCT04044664|581363230|FG001|Stage 2|protocol deviation|0|||
160992974|NCT04044664|581363231|FG002|Stage 2|protocol deviation|0|||
160992975|NCT00001575|581363235|FG000|Overall Study|Screening failures-Ph I portion|22|||
160992976|NCT00001575|581363235|FG000|Overall Study|Withdrawn/deaths|23|||
160992977|NCT00831792|581363238|FG000|Overall Study|Not Eligible|3|||
160992978|NCT00831792|581363238|FG000|Overall Study|Adverse Event|1|||
160992979|NCT00831792|581363238|FG000|Overall Study|Death|1|||
160992980|NCT00831792|581363238|FG000|Overall Study|Lack of Efficacy|1|||
160992981|NCT03736785|581363239|FG000|Overall Study|Adverse Event|1|||
160992982|NCT03736785|581363240|FG001|Overall Study|Adverse Event|1|||
160992983|NCT03736785|581363241|FG002|Overall Study|Adverse Event|1|||
160992984|NCT03736785|581363239|FG000|Overall Study|Death|1|||
160992985|NCT03736785|581363240|FG001|Overall Study|Death|0|||
160992986|NCT03736785|581363241|FG002|Overall Study|Death|1|||
160992987|NCT03736785|581363239|FG000|Overall Study|Lost to Follow-up|0|||
160992988|NCT03736785|581363240|FG001|Overall Study|Lost to Follow-up|2|||
160992989|NCT03736785|581363241|FG002|Overall Study|Lost to Follow-up|3|||
160992990|NCT03736785|581363239|FG000|Overall Study|Non compliance with study drug|1|||
160992991|NCT03736785|581363240|FG001|Overall Study|Non compliance with study drug|1|||
160992992|NCT03736785|581363241|FG002|Overall Study|Non compliance with study drug|0|||
160992993|NCT03736785|581363239|FG000|Overall Study|Physician Decision|0|||
160854460|NCT02656017|580856556|FG000|Overall Study|Adverse Event|2|||
160992994|NCT03736785|581363240|FG001|Overall Study|Physician Decision|1|||
160992995|NCT03736785|581363241|FG002|Overall Study|Physician Decision|1|||
160992996|NCT03736785|581363239|FG000|Overall Study|Protocol Violation|1|||
160992997|NCT03736785|581363240|FG001|Overall Study|Protocol Violation|4|||
160992998|NCT03736785|581363241|FG002|Overall Study|Protocol Violation|3|||
160992999|NCT03736785|581363239|FG000|Overall Study|Sponsor Decision|1|||
160993000|NCT03736785|581363240|FG001|Overall Study|Sponsor Decision|0|||
160993001|NCT03736785|581363241|FG002|Overall Study|Sponsor Decision|0|||
160993002|NCT03736785|581363239|FG000|Overall Study|Unknown/Missing data|3|||
160993003|NCT03736785|581363240|FG001|Overall Study|Unknown/Missing data|2|||
160993004|NCT03736785|581363241|FG002|Overall Study|Unknown/Missing data|1|||
160993005|NCT03736785|581363239|FG000|Overall Study|Withdrawal by Subject|9|||
160993006|NCT03736785|581363240|FG001|Overall Study|Withdrawal by Subject|6|||
160993007|NCT03736785|581363241|FG002|Overall Study|Withdrawal by Subject|4|||
160993008|NCT02974010|581363243|FG000|Overall Study|Lost to Follow-up|3|||
160993009|NCT02974010|581363244|FG001|Overall Study|Lost to Follow-up|1|||
160993010|NCT02974010|581363245|FG002|Overall Study|Lost to Follow-up|0|||
160993011|NCT02974010|581363246|FG003|Overall Study|Lost to Follow-up|0|||
160993012|NCT02974010|581363243|FG000|Overall Study|Withdrawal by Subject|2|||
160993013|NCT02974010|581363244|FG001|Overall Study|Withdrawal by Subject|1|||
160993014|NCT02974010|581363245|FG002|Overall Study|Withdrawal by Subject|0|||
160993015|NCT02974010|581363246|FG003|Overall Study|Withdrawal by Subject|0|||
160993016|NCT02974010|581363243|FG000|Overall Study|Adverse Event|0|||
160993017|NCT02974010|581363244|FG001|Overall Study|Adverse Event|1|||
160993018|NCT02974010|581363245|FG002|Overall Study|Adverse Event|0|||
160993019|NCT02974010|581363246|FG003|Overall Study|Adverse Event|0|||
160993020|NCT02974010|581363243|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
160993021|NCT02974010|581363244|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
160993022|NCT02974010|581363245|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
160993023|NCT02974010|581363246|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
160993024|NCT02974010|581363243|FG000|Overall Study|Lack of Efficacy|0|||
160993025|NCT02974010|581363244|FG001|Overall Study|Lack of Efficacy|0|||
160993026|NCT02974010|581363245|FG002|Overall Study|Lack of Efficacy|1|||
160993027|NCT02974010|581363246|FG003|Overall Study|Lack of Efficacy|0|||
160993028|NCT03256344|581363249|FG000|Overall Study|Death|6|||
160993029|NCT03256344|581363250|FG001|Overall Study|Death|22|||
160993030|NCT03256344|581363249|FG000|Overall Study|Withdrawal by Subject|3|||
160993031|NCT03256344|581363250|FG001|Overall Study|Withdrawal by Subject|3|||
160854461|NCT02656017|580856557|FG001|Overall Study|Adverse Event|1|||
160993032|NCT03256344|581363249|FG000|Overall Study|Sponsor Decision|1|||
160854462|NCT02656017|580856556|FG000|Overall Study|Unable/unwilling to take study medication|2|||
160993033|NCT03256344|581363250|FG001|Overall Study|Sponsor Decision|0|||
160993034|NCT00880906|581363251|FG000|Overall Study|Lost to Follow-up|0|||
160993035|NCT00880906|581363252|FG001|Overall Study|Lost to Follow-up|1|||
160993036|NCT00880906|581363251|FG000|Overall Study|Did not meet criteria following patholog|12|||
160993037|NCT00880906|581363252|FG001|Overall Study|Did not meet criteria following patholog|6|||
160993038|NCT01664104|581363253|FG000|Overall Study|Adverse Event|6|||
160993039|NCT01664104|581363253|FG000|Overall Study|Lack of Efficacy|2|||
160993040|NCT01664104|581363253|FG000|Overall Study|Withdrawal by Subject|1|||
160854463|NCT02656017|580856557|FG001|Overall Study|Unable/unwilling to take study medication|1|||
160854464|NCT02656017|580856556|FG000|Overall Study|Began Tolvaptan|1|||
160854465|NCT02656017|580856557|FG001|Overall Study|Began Tolvaptan|1|||
160854466|NCT02656017|580856556|FG000|Overall Study|Withdrawal by Subject|1|||
160854467|NCT02656017|580856557|FG001|Overall Study|Withdrawal by Subject|0|||
160854468|NCT02349633|580856561|FG000|Overall Study|Death|0|||
160854469|NCT02349633|580856562|FG001|Overall Study|Death|1|||
160854470|NCT02349633|580856563|FG002|Overall Study|Death|0|||
160854471|NCT02349633|580856564|FG003|Overall Study|Death|0|||
160854472|NCT02349633|580856565|FG004|Overall Study|Death|0|||
160854473|NCT02349633|580856566|FG005|Overall Study|Death|1|||
160854474|NCT02349633|580856567|FG006|Overall Study|Death|1|||
160854475|NCT02349633|580856568|FG007|Overall Study|Death|1|||
160854476|NCT02349633|580856569|FG008|Overall Study|Death|0|||
160854477|NCT02349633|580856570|FG009|Overall Study|Death|1|||
160854478|NCT02349633|580856571|FG010|Overall Study|Death|0|||
160854479|NCT02349633|580856572|FG011|Overall Study|Death|0|||
160854480|NCT02349633|580856573|FG012|Overall Study|Death|0|||
160854481|NCT02349633|580856574|FG013|Overall Study|Death|0|||
160854482|NCT02349633|580856561|FG000|Overall Study|Withdrawal by Subject|0|||
160854483|NCT02349633|580856562|FG001|Overall Study|Withdrawal by Subject|0|||
160854484|NCT02349633|580856563|FG002|Overall Study|Withdrawal by Subject|0|||
160854485|NCT02349633|580856564|FG003|Overall Study|Withdrawal by Subject|1|||
160854486|NCT02349633|580856565|FG004|Overall Study|Withdrawal by Subject|0|||
160854487|NCT02349633|580856566|FG005|Overall Study|Withdrawal by Subject|0|||
160854488|NCT02349633|580856567|FG006|Overall Study|Withdrawal by Subject|0|||
160854489|NCT02349633|580856568|FG007|Overall Study|Withdrawal by Subject|2|||
160854490|NCT02349633|580856569|FG008|Overall Study|Withdrawal by Subject|2|||
160854491|NCT02349633|580856570|FG009|Overall Study|Withdrawal by Subject|1|||
160854492|NCT02349633|580856571|FG010|Overall Study|Withdrawal by Subject|0|||
160854493|NCT02349633|580856572|FG011|Overall Study|Withdrawal by Subject|0|||
160854494|NCT02349633|580856573|FG012|Overall Study|Withdrawal by Subject|0|||
160854495|NCT02349633|580856574|FG013|Overall Study|Withdrawal by Subject|0|||
160854496|NCT02349633|580856561|FG000|Overall Study|Withdrawal of informed consent|0|||
160854497|NCT02349633|580856562|FG001|Overall Study|Withdrawal of informed consent|0|||
160854498|NCT02349633|580856563|FG002|Overall Study|Withdrawal of informed consent|0|||
160854499|NCT02349633|580856564|FG003|Overall Study|Withdrawal of informed consent|1|||
160854500|NCT02349633|580856565|FG004|Overall Study|Withdrawal of informed consent|1|||
160854501|NCT02349633|580856566|FG005|Overall Study|Withdrawal of informed consent|0|||
160854502|NCT02349633|580856567|FG006|Overall Study|Withdrawal of informed consent|0|||
160854503|NCT02349633|580856568|FG007|Overall Study|Withdrawal of informed consent|3|||
160854504|NCT02349633|580856569|FG008|Overall Study|Withdrawal of informed consent|0|||
160854505|NCT02349633|580856570|FG009|Overall Study|Withdrawal of informed consent|0|||
160854506|NCT02349633|580856571|FG010|Overall Study|Withdrawal of informed consent|0|||
160854507|NCT02349633|580856572|FG011|Overall Study|Withdrawal of informed consent|0|||
160854508|NCT02349633|580856573|FG012|Overall Study|Withdrawal of informed consent|0|||
160854509|NCT02349633|580856574|FG013|Overall Study|Withdrawal of informed consent|0|||
160854510|NCT02349633|580856561|FG000|Overall Study|Transition to compassionate use|0|||
160854511|NCT02349633|580856562|FG001|Overall Study|Transition to compassionate use|0|||
160854512|NCT02349633|580856563|FG002|Overall Study|Transition to compassionate use|0|||
160854513|NCT02349633|580856564|FG003|Overall Study|Transition to compassionate use|0|||
160854514|NCT02349633|580856565|FG004|Overall Study|Transition to compassionate use|1|||
160854515|NCT02349633|580856566|FG005|Overall Study|Transition to compassionate use|0|||
160854516|NCT02349633|580856567|FG006|Overall Study|Transition to compassionate use|0|||
160854517|NCT02349633|580856568|FG007|Overall Study|Transition to compassionate use|3|||
160854518|NCT02349633|580856569|FG008|Overall Study|Transition to compassionate use|0|||
160854519|NCT02349633|580856570|FG009|Overall Study|Transition to compassionate use|1|||
160907454|NCT01964430|581054058|FG001|Treatment Period|Adverse Event|37|||
160907455|NCT01964430|581054057|FG000|Treatment Period|Withdrawal by Subject|36|||
160907456|NCT01964430|581054058|FG001|Treatment Period|Withdrawal by Subject|27|||
160907457|NCT01964430|581054057|FG000|Treatment Period|Death|1|||
160907458|NCT01964430|581054058|FG001|Treatment Period|Death|3|||
160907459|NCT01964430|581054057|FG000|Treatment Period|Protocol Deviation|0|||
160907460|NCT01964430|581054058|FG001|Treatment Period|Protocol Deviation|1|||
160854520|NCT02349633|580856571|FG010|Overall Study|Transition to compassionate use|0|||
160854521|NCT02349633|580856572|FG011|Overall Study|Transition to compassionate use|0|||
160854522|NCT02349633|580856573|FG012|Overall Study|Transition to compassionate use|0|||
160854523|NCT02349633|580856574|FG013|Overall Study|Transition to compassionate use|0|||
160854524|NCT02349633|580856561|FG000|Overall Study|Early termination of survival follow-up|0|||
160854525|NCT02349633|580856562|FG001|Overall Study|Early termination of survival follow-up|0|||
160854526|NCT02349633|580856563|FG002|Overall Study|Early termination of survival follow-up|0|||
160854527|NCT02349633|580856564|FG003|Overall Study|Early termination of survival follow-up|0|||
160907461|NCT01964430|581054057|FG000|Treatment Period|Physician Decision|5|||
160907462|NCT01964430|581054058|FG001|Treatment Period|Physician Decision|4|||
160907463|NCT01964430|581054057|FG000|Treatment Period|Disease Relapse|28|||
160993041|NCT01664104|581363253|FG000|Overall Study|Lost to Follow-up|4|||
160993042|NCT01664104|581363253|FG000|Overall Study|Other|1|||
160993043|NCT01664104|581363253|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
160993044|NCT03586167|581363255|FG000|Overall Study|Other|1|||
160993045|NCT03586167|581363256|FG001|Overall Study|Other|0|||
160993046|NCT04163458|581363259|FG000|Overall Study|Protocol Deviation|7|||
160993047|NCT04163458|581363260|FG001|Overall Study|Protocol Deviation|13|||
160993048|NCT04163458|581363259|FG000|Overall Study|Adverse Event|5|||
160993049|NCT04163458|581363260|FG001|Overall Study|Adverse Event|8|||
160993050|NCT04163458|581363259|FG000|Overall Study|Due to COVID-19 pandemic|4|||
160854528|NCT02349633|580856565|FG004|Overall Study|Early termination of survival follow-up|0|||
160854529|NCT02349633|580856566|FG005|Overall Study|Early termination of survival follow-up|0|||
160854530|NCT02349633|580856567|FG006|Overall Study|Early termination of survival follow-up|0|||
160854531|NCT02349633|580856568|FG007|Overall Study|Early termination of survival follow-up|4|||
160854532|NCT02349633|580856569|FG008|Overall Study|Early termination of survival follow-up|0|||
160993051|NCT04163458|581363260|FG001|Overall Study|Due to COVID-19 pandemic|2|||
160993052|NCT04163458|581363259|FG000|Overall Study|Participant withdrew consent|2|||
160993053|NCT04163458|581363260|FG001|Overall Study|Participant withdrew consent|3|||
160854533|NCT02349633|580856570|FG009|Overall Study|Early termination of survival follow-up|0|||
160854534|NCT02349633|580856571|FG010|Overall Study|Early termination of survival follow-up|0|||
160854535|NCT02349633|580856572|FG011|Overall Study|Early termination of survival follow-up|0|||
160854536|NCT02349633|580856573|FG012|Overall Study|Early termination of survival follow-up|0|||
160854537|NCT02349633|580856574|FG013|Overall Study|Early termination of survival follow-up|0|||
160854538|NCT02349633|580856561|FG000|Overall Study|Termination by sponsor|0|||
160854539|NCT02349633|580856562|FG001|Overall Study|Termination by sponsor|0|||
160854540|NCT02349633|580856563|FG002|Overall Study|Termination by sponsor|0|||
160854541|NCT02349633|580856564|FG003|Overall Study|Termination by sponsor|0|||
160854542|NCT02349633|580856565|FG004|Overall Study|Termination by sponsor|0|||
160854543|NCT02349633|580856566|FG005|Overall Study|Termination by sponsor|0|||
160854544|NCT02349633|580856567|FG006|Overall Study|Termination by sponsor|0|||
160854545|NCT02349633|580856568|FG007|Overall Study|Termination by sponsor|1|||
160854546|NCT02349633|580856569|FG008|Overall Study|Termination by sponsor|0|||
160907464|NCT01964430|581054058|FG001|Treatment Period|Disease Relapse|38|||
160907465|NCT01964430|581054057|FG000|Treatment Period|Other reasons|1|||
160907466|NCT01964430|581054058|FG001|Treatment Period|Other reasons|3|||
160907467|NCT02591290|581054059|FG000|Overall Study|Withdrawal by Subject|2|||
160907468|NCT02571075|581054062|FG000|Overall Study|Lost to Follow-up|20|||
160907469|NCT02571075|581054063|FG001|Overall Study|Lost to Follow-up|24|||
160993054|NCT04163458|581363259|FG000|Overall Study|Randomization failure|2|||
160993055|NCT04163458|581363260|FG001|Overall Study|Randomization failure|2|||
160993056|NCT04163458|581363259|FG000|Overall Study|Other|4|||
160993057|NCT04163458|581363260|FG001|Overall Study|Other|2|||
160993058|NCT03852433|581363266|FG000|Overall Study|Withdrawal of consent|5|||
160993059|NCT03852433|581363267|FG001|Overall Study|Withdrawal of consent|8|||
160993060|NCT03852433|581363268|FG002|Overall Study|Withdrawal of consent|1|||
160993061|NCT03852433|581363269|FG003|Overall Study|Withdrawal of consent|1|||
160993062|NCT03852433|581363266|FG000|Overall Study|Adverse Event|1|||
160993063|NCT03852433|581363267|FG001|Overall Study|Adverse Event|1|||
160993064|NCT03852433|581363268|FG002|Overall Study|Adverse Event|1|||
160993065|NCT03852433|581363269|FG003|Overall Study|Adverse Event|1|||
160993066|NCT03852433|581363266|FG000|Overall Study|Lost to Follow-up|0|||
160993067|NCT03852433|581363267|FG001|Overall Study|Lost to Follow-up|1|||
160993068|NCT03852433|581363268|FG002|Overall Study|Lost to Follow-up|0|||
160993069|NCT03852433|581363269|FG003|Overall Study|Lost to Follow-up|1|||
160993070|NCT03852433|581363266|FG000|Overall Study|Pregnancy|0|||
160907470|NCT01606800|581056273|FG000|Overall Study|Adverse Event|3|||
160907471|NCT01606800|581056274|FG001|Overall Study|Adverse Event|1|||
160907472|NCT01606800|581056273|FG000|Overall Study|Participant withdrew consent|0|||
160907473|NCT01606800|581056274|FG001|Overall Study|Participant withdrew consent|1|||
160907474|NCT01606800|581056273|FG000|Overall Study|Missing completion status|2|||
160993071|NCT03852433|581363267|FG001|Overall Study|Pregnancy|1|||
160993072|NCT03852433|581363268|FG002|Overall Study|Pregnancy|1|||
160993073|NCT03852433|581363269|FG003|Overall Study|Pregnancy|0|||
160993074|NCT03852433|581363266|FG000|Overall Study|Protocol Violation|0|||
160993075|NCT03852433|581363267|FG001|Overall Study|Protocol Violation|0|||
160993076|NCT03852433|581363268|FG002|Overall Study|Protocol Violation|1|||
160993077|NCT03852433|581363269|FG003|Overall Study|Protocol Violation|1|||
160993078|NCT03852433|581363266|FG000|Overall Study|Death|0|||
160907475|NCT01606800|581056274|FG001|Overall Study|Missing completion status|0|||
160907476|NCT02370160|581056277|FG000|Overall Study|Death|3|||
160907477|NCT02370160|581056278|FG001|Overall Study|Death|4|||
160907478|NCT02370160|581056279|FG002|Overall Study|Death|1|||
160993079|NCT03852433|581363267|FG001|Overall Study|Death|0|||
160993080|NCT03852433|581363268|FG002|Overall Study|Death|1|||
160993081|NCT03852433|581363269|FG003|Overall Study|Death|0|||
160993082|NCT03852433|581363266|FG000|Overall Study|Lack of Efficacy|0|||
160993083|NCT03852433|581363267|FG001|Overall Study|Lack of Efficacy|1|||
160993084|NCT03852433|581363268|FG002|Overall Study|Lack of Efficacy|0|||
160854547|NCT02349633|580856570|FG009|Overall Study|Termination by sponsor|2|||
160854548|NCT02349633|580856571|FG010|Overall Study|Termination by sponsor|0|||
160854549|NCT02349633|580856572|FG011|Overall Study|Termination by sponsor|0|||
160854550|NCT02349633|580856573|FG012|Overall Study|Termination by sponsor|0|||
160854551|NCT02349633|580856574|FG013|Overall Study|Termination by sponsor|0|||
160854552|NCT02349633|580856561|FG000|Overall Study|Other|0|||
160854553|NCT02349633|580856562|FG001|Overall Study|Other|0|||
160854554|NCT02349633|580856563|FG002|Overall Study|Other|0|||
160854555|NCT02349633|580856564|FG003|Overall Study|Other|0|||
160854556|NCT02349633|580856565|FG004|Overall Study|Other|0|||
160854557|NCT02349633|580856566|FG005|Overall Study|Other|0|||
160854558|NCT02349633|580856567|FG006|Overall Study|Other|0|||
160854559|NCT02349633|580856568|FG007|Overall Study|Other|2|||
160854560|NCT02349633|580856569|FG008|Overall Study|Other|0|||
160854561|NCT02349633|580856570|FG009|Overall Study|Other|0|||
160854562|NCT02349633|580856571|FG010|Overall Study|Other|0|||
160854563|NCT02349633|580856572|FG011|Overall Study|Other|0|||
160854564|NCT02349633|580856573|FG012|Overall Study|Other|0|||
160854565|NCT02349633|580856574|FG013|Overall Study|Other|0|||
160854566|NCT00667628|580856575|FG000|Overall Study|Lost to Follow-up|1|||
160854567|NCT00667628|580856576|FG001|Overall Study|Lost to Follow-up|0|||
160854568|NCT00667628|580856575|FG000|Overall Study|Death|6|||
160854569|NCT00667628|580856576|FG001|Overall Study|Death|6|||
160854570|NCT00667628|580856575|FG000|Overall Study|Investigator Considers in Best Interest|1|||
160854571|NCT00667628|580856576|FG001|Overall Study|Investigator Considers in Best Interest|0|||
160854572|NCT00667628|580856575|FG000|Overall Study|Sponsor Terminated Study|17|||
160854573|NCT00667628|580856576|FG001|Overall Study|Sponsor Terminated Study|21|||
160854574|NCT05789745|580856577|FG000|Overall Study|Withdrawal by Subject|0|||
160854575|NCT05789745|580856578|FG001|Overall Study|Withdrawal by Subject|0|||
160854576|NCT05789745|580856579|FG002|Overall Study|Withdrawal by Subject|0|||
160854577|NCT05789745|580856580|FG003|Overall Study|Withdrawal by Subject|0|||
160854578|NCT05789745|580856581|FG004|Overall Study|Withdrawal by Subject|1|||
160854579|NCT04663321|580856582|FG000|Overall Study|Study terminated by Sponsor|2|||
160854580|NCT04663321|580856583|FG001|Overall Study|Study terminated by Sponsor|1|||
160854581|NCT04663321|580856584|FG002|Overall Study|Study terminated by Sponsor|2|||
160854582|NCT04663321|580856582|FG000|Overall Study|Withdrawal by Subject|10|||
160854583|NCT04663321|580856583|FG001|Overall Study|Withdrawal by Subject|3|||
160854584|NCT04663321|580856584|FG002|Overall Study|Withdrawal by Subject|2|||
160854585|NCT04663321|580856582|FG000|Overall Study|Not provided|0|||
160854586|NCT04663321|580856583|FG001|Overall Study|Not provided|0|||
160854587|NCT04663321|580856584|FG002|Overall Study|Not provided|1|||
160854588|NCT00622505|580856585|FG000|Overall Study|Adverse Event|9|||
160854589|NCT00622505|580856586|FG001|Overall Study|Adverse Event|7|||
160854590|NCT00622505|580856585|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
160854591|NCT00622505|580856586|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
160854592|NCT00622505|580856585|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
160854593|NCT00622505|580856586|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
160854594|NCT00622505|580856585|FG000|Overall Study|Withdrawal by Subject|12|||
160854595|NCT00622505|580856586|FG001|Overall Study|Withdrawal by Subject|5|||
160854596|NCT00622505|580856585|FG000|Overall Study|Administrative Problems|2|||
160854597|NCT00622505|580856586|FG001|Overall Study|Administrative Problems|4|||
160854598|NCT00622505|580856585|FG000|Overall Study|Death|2|||
160854599|NCT00622505|580856586|FG001|Overall Study|Death|2|||
160854600|NCT00619515|580856587|FG000|Overall Study|Study Termination by IRB|73|||
160854601|NCT03294590|580856590|FG000|Overall Study|Lost to Follow-up|105|||
160854602|NCT03294590|580856591|FG001|Overall Study|Lost to Follow-up|107|||
160854603|NCT01962441|580856594|FG000|Randomized Period|Randomized but Never Treated|4|||
160854604|NCT01962441|580856595|FG001|Randomized Period|Randomized but Never Treated|2|||
160854605|NCT01962441|580856596|FG002|Randomized Period|Randomized but Never Treated|3|||
160854606|NCT01962441|580856594|FG000|Randomized Period|Lost to Follow-up|2|||
160854607|NCT01962441|580856595|FG001|Randomized Period|Lost to Follow-up|4|||
160854608|NCT01962441|580856596|FG002|Randomized Period|Lost to Follow-up|4|||
160854609|NCT01962441|580856594|FG000|Randomized Period|Withdrew Consent|3|||
160854610|NCT01962441|580856595|FG001|Randomized Period|Withdrew Consent|3|||
160854611|NCT01962441|580856596|FG002|Randomized Period|Withdrew Consent|2|||
160907479|NCT04487730|581056280|FG000|Overall Study|Withdrawal by Subject|3|||
160907480|NCT04487730|581056281|FG001|Overall Study|Withdrawal by Subject|1|||
160907481|NCT04487730|581056280|FG000|Overall Study|Lost to Follow-up|0|||
160854612|NCT01962441|580856594|FG000|Randomized Period|Adverse Event|1|||
160854613|NCT01962441|580856595|FG001|Randomized Period|Adverse Event|1|||
160854614|NCT01962441|580856596|FG002|Randomized Period|Adverse Event|0|||
160854615|NCT01962441|580856594|FG000|Randomized Period|Death|0|||
160854616|NCT01962441|580856595|FG001|Randomized Period|Death|0|||
160854617|NCT01962441|580856596|FG002|Randomized Period|Death|2|||
160854618|NCT01962441|580856594|FG000|Randomized Period|Protocol Violation|0|||
160854619|NCT01962441|580856595|FG001|Randomized Period|Protocol Violation|1|||
160854620|NCT01962441|580856596|FG002|Randomized Period|Protocol Violation|0|||
160854621|NCT01962441|580856594|FG000|Retreatment Substudy|Lack of Efficacy|1|||
160854622|NCT01962441|580856595|FG001|Retreatment Substudy|Lack of Efficacy|0|||
160854623|NCT01962441|580856596|FG002|Retreatment Substudy|Lack of Efficacy|0|||
160854624|NCT01962441|580856594|FG000|Retreatment Substudy|Lost to Follow-up|1|||
160854625|NCT01962441|580856595|FG001|Retreatment Substudy|Lost to Follow-up|0|||
160854626|NCT01962441|580856596|FG002|Retreatment Substudy|Lost to Follow-up|0|||
160854627|NCT04862065|580856597|FG000|Screening|Protocol Violation|54|||
160854628|NCT04862065|580856598|FG001|Screening|Protocol Violation|0|||
160854629|NCT04862065|580856599|FG002|Screening|Protocol Violation|0|||
160854630|NCT04862065|580856597|FG000|Screening|Insufficient Sample|1|||
160854631|NCT04862065|580856598|FG001|Screening|Insufficient Sample|0|||
160854632|NCT04862065|580856599|FG002|Screening|Insufficient Sample|0|||
160854633|NCT04862065|580856597|FG000|Follow-Up|Lost to Follow-up|3|||
160854634|NCT04862065|580856598|FG001|Follow-Up|Lost to Follow-up|0|||
160854635|NCT04862065|580856599|FG002|Follow-Up|Lost to Follow-up|0|||
160854636|NCT01453140|580856600|FG000|Overall Study|Adverse Event|3|||
160854637|NCT00474955|580856602|FG000|Overall Study|Adverse Event|2|||
160907482|NCT04487730|581056281|FG001|Overall Study|Lost to Follow-up|1|||
160907483|NCT04487730|581056280|FG000|Overall Study|Physician Decision|0|||
160907484|NCT04487730|581056281|FG001|Overall Study|Physician Decision|1|||
160907485|NCT00907777|581056282|FG000|Overall Study|Withdrawal by Subject|0|||
160907486|NCT00907777|581056283|FG001|Overall Study|Withdrawal by Subject|1|||
160907487|NCT02871297|581056284|FG000|Overall Study|Adverse Event|34|||
160907488|NCT02871297|581056284|FG000|Overall Study|Lack of Efficacy|10|||
160907489|NCT02871297|581056284|FG000|Overall Study|Non-compliance with study drug|15|||
160907490|NCT02871297|581056284|FG000|Overall Study|Protocol Violation|3|||
160907491|NCT02871297|581056284|FG000|Overall Study|Withdrawal by Subject|20|||
160907492|NCT02871297|581056284|FG000|Overall Study|Lost to Follow-up|13|||
160907493|NCT02871297|581056284|FG000|Overall Study|Rolled over to 13546A|2|||
160907494|NCT02871297|581056284|FG000|Overall Study|Other than specified|39|||
160907495|NCT04115839|581056285|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
160907496|NCT04115839|581056286|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
160907497|NCT04115839|581056287|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
160907498|NCT04115839|581056288|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
160907499|NCT04115839|581056289|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
160907500|NCT04115839|581056290|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
160907501|NCT04115839|581056291|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
160907502|NCT04115839|581056285|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
160907503|NCT04115839|581056286|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
160907504|NCT04115839|581056287|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
160907505|NCT04115839|581056288|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
160907506|NCT04115839|581056289|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
160907507|NCT04115839|581056290|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
160907508|NCT04115839|581056291|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
160907509|NCT04115839|581056285|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
160907510|NCT04115839|581056286|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907511|NCT04115839|581056287|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907512|NCT04115839|581056288|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907513|NCT04115839|581056289|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907514|NCT04115839|581056290|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907515|NCT04115839|581056291|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907516|NCT04115839|581056285|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160907517|NCT04115839|581056286|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160907518|NCT04115839|581056287|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
160907519|NCT04115839|581056288|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160907520|NCT04115839|581056289|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160907521|NCT04115839|581056290|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160907522|NCT04115839|581056291|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160854638|NCT00474955|580856602|FG000|Overall Study|Drug unavailability|1|||
160854639|NCT00474955|580856602|FG000|Overall Study|Personal reasons|5|||
160854640|NCT02422498|580856603|FG000|Overall Study|Inevaluable|4|||
160907523|NCT04115839|581056285|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
160907524|NCT04115839|581056286|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
160907525|NCT04115839|581056287|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
160854641|NCT02653326|580856604|FG000|Overall Study|Lost to Follow-up|10|||
160854642|NCT02653326|580856605|FG001|Overall Study|Lost to Follow-up|7|||
160854643|NCT01620060|580856607|FG000|Overall Study|Adverse Event|9|||
160854644|NCT01620060|580856607|FG000|Overall Study|Protocol Violation|1|||
160907526|NCT04115839|581056288|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
160650819|NCT04820842|580104335|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
160854645|NCT01620060|580856607|FG000|Overall Study|Withdrawal by Subject|1|||
160854646|NCT01620060|580856607|FG000|Overall Study|Did not comply with Study Produre|1|||
160854647|NCT01620060|580856607|FG000|Overall Study|Family emergency|1|||
160854648|NCT01620060|580856607|FG000|Overall Study|Per Sponsor Decision|2|||
160854649|NCT03452540|580856608|FG000|Overall Study|Adverse Event|1|||
160854650|NCT03452540|580856608|FG000|Overall Study|Withdrawal by Subject|1|||
160854651|NCT03452540|580856608|FG000|Overall Study|Other SAE and AE|2|||
160854652|NCT04664153|580856609|FG000|Overall Study|Lack of Efficacy|0|||
160854653|NCT04664153|580856610|FG001|Overall Study|Lack of Efficacy|0|||
160854654|NCT04664153|580856611|FG002|Overall Study|Lack of Efficacy|1|||
160854655|NCT04664153|580856612|FG003|Overall Study|Lack of Efficacy|0|||
160854656|NCT04664153|580856609|FG000|Overall Study|Physician Decision|0|||
160854657|NCT04664153|580856610|FG001|Overall Study|Physician Decision|0|||
160854658|NCT04664153|580856611|FG002|Overall Study|Physician Decision|1|||
160854659|NCT04664153|580856612|FG003|Overall Study|Physician Decision|0|||
160854660|NCT04664153|580856609|FG000|Overall Study|Withdrawal by Subject|3|||
160854661|NCT04664153|580856610|FG001|Overall Study|Withdrawal by Subject|2|||
160854662|NCT04664153|580856611|FG002|Overall Study|Withdrawal by Subject|1|||
160854663|NCT04664153|580856612|FG003|Overall Study|Withdrawal by Subject|2|||
160854664|NCT04664153|580856609|FG000|Overall Study|Other|0|||
160854665|NCT04664153|580856610|FG001|Overall Study|Other|1|||
160907527|NCT04115839|581056289|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
160907528|NCT04115839|581056290|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
160907529|NCT04115839|581056291|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
160907530|NCT04115839|581056285|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
160907531|NCT04115839|581056286|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
160907532|NCT04115839|581056287|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
160907533|NCT04115839|581056288|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
160907534|NCT04115839|581056289|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
160907535|NCT04115839|581056290|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
160907536|NCT04115839|581056291|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
160907537|NCT02966028|581056292|FG000|Overall Study|Adverse Event|7|||
160907538|NCT02966028|581056293|FG001|Overall Study|Adverse Event|13|||
160907539|NCT02966028|581056294|FG002|Overall Study|Adverse Event|10|||
160907540|NCT02966028|581056292|FG000|Overall Study|Physician Decision|1|||
160907541|NCT02966028|581056293|FG001|Overall Study|Physician Decision|0|||
160907542|NCT02966028|581056294|FG002|Overall Study|Physician Decision|2|||
160907543|NCT02966028|581056292|FG000|Overall Study|Withdrawal by Subject|7|||
160907544|NCT02966028|581056293|FG001|Overall Study|Withdrawal by Subject|5|||
160907545|NCT02966028|581056294|FG002|Overall Study|Withdrawal by Subject|5|||
160907546|NCT02966028|581056292|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
160907547|NCT02966028|581056293|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
160907548|NCT02966028|581056294|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
160907549|NCT01396148|581056295|FG000|Overall Study|Patient Decision|1|||
160907550|NCT00224042|581056304|FG000|Overall Study|Adverse Event|2|||
160907551|NCT00224042|581056305|FG001|Overall Study|Adverse Event|1|||
160907552|NCT00224042|581056304|FG000|Overall Study|Protocol Violation|0|||
160907553|NCT00224042|581056305|FG001|Overall Study|Protocol Violation|1|||
160907554|NCT00224042|581056304|FG000|Overall Study|Physician Decision|0|||
160907555|NCT00224042|581056305|FG001|Overall Study|Physician Decision|1|||
160907556|NCT00224042|581056304|FG000|Overall Study|Did not meet lab incusion criteria|2|||
160907557|NCT00224042|581056305|FG001|Overall Study|Did not meet lab incusion criteria|3|||
160907558|NCT00224042|581056304|FG000|Overall Study|Other|2|||
160907559|NCT00224042|581056305|FG001|Overall Study|Other|0|||
160907560|NCT00840450|581056306|FG000|Overall Study|Adverse Event|1|||
160907561|NCT00840450|581056306|FG000|Overall Study|Lack of Efficacy|2|||
160907562|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
160907563|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
160907564|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907565|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907566|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907567|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907568|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907569|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907570|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
160907571|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
160907572|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160907573|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160907574|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160907575|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160907576|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160907577|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160854666|NCT04664153|580856611|FG002|Overall Study|Other|0|||
160907578|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
160854667|NCT04664153|580856612|FG003|Overall Study|Other|0|||
160993085|NCT03852433|581363269|FG003|Overall Study|Lack of Efficacy|0|||
160993086|NCT03852433|581363266|FG000|Overall Study|Non-compliance with study drug|0|||
160993087|NCT03852433|581363267|FG001|Overall Study|Non-compliance with study drug|0|||
160993088|NCT03852433|581363268|FG002|Overall Study|Non-compliance with study drug|0|||
160993089|NCT03852433|581363269|FG003|Overall Study|Non-compliance with study drug|1|||
160993090|NCT03852433|581363266|FG000|Overall Study|Physician Decision|1|||
160993091|NCT03852433|581363267|FG001|Overall Study|Physician Decision|0|||
160993092|NCT03852433|581363268|FG002|Overall Study|Physician Decision|0|||
160993093|NCT03852433|581363269|FG003|Overall Study|Physician Decision|0|||
160993094|NCT03852433|581363266|FG000|Overall Study|Randomized but never treated|1|||
160993095|NCT03852433|581363267|FG001|Overall Study|Randomized but never treated|0|||
160993096|NCT03852433|581363268|FG002|Overall Study|Randomized but never treated|0|||
160993097|NCT03852433|581363269|FG003|Overall Study|Randomized but never treated|0|||
160993098|NCT05273801|581363284|FG000|Overall Study|Physician Decision|1|||
160993099|NCT04159506|581363285|FG000|Overall Study|Lost to Follow-up|2|||
160993100|NCT04159506|581363286|FG001|Overall Study|Lost to Follow-up|5|||
160993101|NCT02449044|581363287|FG000|Overall Study|Lost to Follow-up|2|||
160854668|NCT04664153|580856609|FG000|Overall Study|Adverse Event|4|||
160854669|NCT04664153|580856610|FG001|Overall Study|Adverse Event|0|||
160854670|NCT04664153|580856611|FG002|Overall Study|Adverse Event|1|||
160854671|NCT04664153|580856612|FG003|Overall Study|Adverse Event|0|||
160854672|NCT00231777|580856614|FG000|Overall Study|Lost to Follow-up|3|||
160854673|NCT00231777|580856615|FG001|Overall Study|Lost to Follow-up|0|||
160854674|NCT00231777|580856614|FG000|Overall Study|Other|3|||
160854675|NCT00231777|580856615|FG001|Overall Study|Other|2|||
160854676|NCT00524485|580856616|FG000|Overall Study|Withdrawal by Subject|5|||
160854677|NCT01600885|580856617|FG000|First Period|Adverse Event|1|||
160854678|NCT01600885|580856618|FG001|First Period|Adverse Event|1|||
160854679|NCT01600885|580856617|FG000|First Period|moved out of area|1|||
160854680|NCT01600885|580856618|FG001|First Period|moved out of area|0|||
160854681|NCT00642356|580856626|FG000|Overall Study|Adverse Event|1|||
160854682|NCT00642356|580856627|FG001|Overall Study|Adverse Event|0|||
160854683|NCT00642356|580856626|FG000|Overall Study|Protocol Violation|0|||
160854684|NCT00642356|580856627|FG001|Overall Study|Protocol Violation|3|||
160854685|NCT00642356|580856626|FG000|Overall Study|Lack of Efficacy|1|||
160854686|NCT00642356|580856627|FG001|Overall Study|Lack of Efficacy|0|||
160854687|NCT01009060|580856636|FG000|Overall Study|Adverse Event|1|||
160854688|NCT01009060|580856637|FG001|Overall Study|Adverse Event|2|||
160854689|NCT01009060|580856636|FG000|Overall Study|Protocol Violation|0|||
160854690|NCT01009060|580856637|FG001|Overall Study|Protocol Violation|1|||
160854691|NCT01009060|580856636|FG000|Overall Study|Lost to Follow-up|1|||
160854692|NCT01009060|580856637|FG001|Overall Study|Lost to Follow-up|0|||
160854693|NCT01009060|580856636|FG000|Overall Study|Physician Decision|1|||
160854694|NCT01009060|580856637|FG001|Overall Study|Physician Decision|1|||
160854695|NCT01009060|580856636|FG000|Overall Study|Withdrawal by Subject|1|||
160854696|NCT01009060|580856637|FG001|Overall Study|Withdrawal by Subject|1|||
160854697|NCT00005906|580856638|FG000|Overall Study|Lack of Efficacy|3|||
160854698|NCT04551989|580856639|FG000|Overall Study|Adverse Event|4|||
160854699|NCT04551989|580856639|FG000|Overall Study|Protocol Violation|3|||
160854700|NCT04551989|580856639|FG000|Overall Study|Lost to Follow-up|1|||
160854701|NCT04551989|580856639|FG000|Overall Study|Physician Decision|3|||
160854702|NCT04201431|580856640|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
160854703|NCT04201431|580856641|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
160854704|NCT04201431|580856642|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
160854705|NCT00088530|580856647|FG000|Overall Study|Progressive/Relapsed Disease|28|||
160854706|NCT00088530|580856648|FG001|Overall Study|Progressive/Relapsed Disease|39|||
160854707|NCT00088530|580856647|FG000|Overall Study|Adverse Event|15|||
160854708|NCT00088530|580856648|FG001|Overall Study|Adverse Event|9|||
160854709|NCT00088530|580856647|FG000|Overall Study|Withdrawal by Subject|2|||
160854710|NCT00088530|580856648|FG001|Overall Study|Withdrawal by Subject|5|||
160854711|NCT00088530|580856647|FG000|Overall Study|Lost to Follow-up|2|||
160854712|NCT00088530|580856648|FG001|Overall Study|Lost to Follow-up|0|||
160854713|NCT00088530|580856647|FG000|Overall Study|Physician Decision|2|||
160854714|NCT00088530|580856648|FG001|Overall Study|Physician Decision|0|||
160854715|NCT00088530|580856647|FG000|Overall Study|Sponsor decision|0|||
160854716|NCT00088530|580856648|FG001|Overall Study|Sponsor decision|1|||
160854717|NCT00088530|580856647|FG000|Overall Study|Patient never treated|1|||
160993102|NCT02449044|581363287|FG000|Overall Study|Withdrawal by Subject|13|||
160993103|NCT02449044|581363287|FG000|Overall Study|Adverse Event|30|||
160993104|NCT02449044|581363287|FG000|Overall Study|Met Withdrawal Criteria|7|||
160993105|NCT02449044|581363287|FG000|Overall Study|Physician Decision|9|||
160993106|NCT02449044|581363287|FG000|Overall Study|Sponsor Discontinued Trial|3|||
160993107|NCT04257058|581365277|FG000|Overall Study|Lost to Follow-up|31|||
160993108|NCT03227757|581365278|FG000|Overall Study|Death|25|||
160653437|NCT02581345|580112382|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
160854718|NCT00088530|580856648|FG001|Overall Study|Patient never treated|0|||
160854719|NCT00300755|580856649|FG000|Overall Study|Adverse Event|1|||
160854720|NCT00300755|580856650|FG001|Overall Study|Adverse Event|2|||
160854721|NCT00300755|580856651|FG002|Overall Study|Adverse Event|1|||
160854722|NCT00300755|580856649|FG000|Overall Study|Withdrawal by Subject|0|||
160854723|NCT00300755|580856650|FG001|Overall Study|Withdrawal by Subject|2|||
160854724|NCT00300755|580856651|FG002|Overall Study|Withdrawal by Subject|0|||
160854725|NCT00300755|580856649|FG000|Overall Study|Protocol Violation|0|||
160854726|NCT00300755|580856650|FG001|Overall Study|Protocol Violation|0|||
160854727|NCT00300755|580856651|FG002|Overall Study|Protocol Violation|1|||
160854728|NCT04571944|580856652|FG000|Overall Study|Death|1|||
160854729|NCT04571944|580856653|FG001|Overall Study|Death|0|||
160854730|NCT04571944|580856652|FG000|Overall Study|Withdrawal by Subject|3|||
160854731|NCT04571944|580856653|FG001|Overall Study|Withdrawal by Subject|0|||
160854732|NCT04571944|580856652|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
160653438|NCT02581345|580112379|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
160854733|NCT04571944|580856653|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
160854734|NCT02694744|580856659|FG000|Overall Study|Adverse Event|2|||
160854735|NCT02694744|580856660|FG001|Overall Study|Adverse Event|1|||
160854736|NCT02694744|580856659|FG000|Overall Study|Withdrawal by Subject|2|||
160854737|NCT02694744|580856660|FG001|Overall Study|Withdrawal by Subject|1|||
160854738|NCT02694744|580856659|FG000|Overall Study|Physician Decision|1|||
160854739|NCT02694744|580856660|FG001|Overall Study|Physician Decision|2|||
160854740|NCT02694744|580856659|FG000|Overall Study|Lost to Follow-up|1|||
160854741|NCT02694744|580856660|FG001|Overall Study|Lost to Follow-up|0|||
160854742|NCT02694744|580856659|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
160854743|NCT02694744|580856660|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
160854744|NCT00667888|580856661|FG000|Overall Study|Death|1|||
160854745|NCT00667888|580856662|FG001|Overall Study|Death|1|||
160854746|NCT00667888|580856661|FG000|Overall Study|Withdrawal by Subject|6|||
160854747|NCT00667888|580856662|FG001|Overall Study|Withdrawal by Subject|3|||
160854748|NCT00667888|580856661|FG000|Overall Study|Proceed with other treatment|3|||
160854749|NCT00667888|580856662|FG001|Overall Study|Proceed with other treatment|3|||
160854750|NCT00667888|580856661|FG000|Overall Study|Ineligible after SIM|0|||
160854751|NCT00667888|580856662|FG001|Overall Study|Ineligible after SIM|2|||
160854752|NCT01945021|580856663|FG000|Overall Study|Adverse Event|1|||
160854753|NCT01945021|580856663|FG000|Overall Study|Withdrawal of consent|12|||
160854754|NCT01945021|580856663|FG000|Overall Study|Lost to Follow-up|5|||
160854755|NCT01945021|580856663|FG000|Overall Study|Death|65|||
160854756|NCT04575155|580856664|FG000|2 Month|Withdrawal by Subject|1|||
160854757|NCT04575155|580856665|FG001|2 Month|Withdrawal by Subject|1|||
160854758|NCT04575155|580856664|FG000|2 Month|Lost to Follow-up|5|||
160854759|NCT04575155|580856665|FG001|2 Month|Lost to Follow-up|3|||
160854760|NCT04575155|580856664|FG000|2 Month|Ineligible|1|||
160854761|NCT04575155|580856665|FG001|2 Month|Ineligible|0|||
160854762|NCT02920892|580856667|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
160854763|NCT02920892|580856668|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
160854764|NCT02920892|580856669|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
160854765|NCT02920892|580856667|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
160854766|NCT02920892|580856668|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
160854767|NCT02920892|580856669|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
160854768|NCT02920892|580856667|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
160854769|NCT02920892|580856668|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
160854770|NCT02920892|580856669|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
160854771|NCT02920892|580856667|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
160854772|NCT02920892|580856668|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
160854773|NCT02920892|580856669|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
160854774|NCT02920892|580856667|FG000|Placebo-Controlled Period|Physician Decision|0|||
160854775|NCT02920892|580856668|FG001|Placebo-Controlled Period|Physician Decision|0|||
160854776|NCT02920892|580856669|FG002|Placebo-Controlled Period|Physician Decision|1|||
160854777|NCT02920892|580856667|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
160854778|NCT02920892|580856668|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
160854779|NCT02920892|580856669|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
160854780|NCT02920892|580856667|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160854781|NCT02920892|580856668|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
160854782|NCT02920892|580856669|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
160854783|NCT02920892|580856667|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
160907579|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
160907580|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160907581|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160907582|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160653439|NCT02581345|580112380|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
160854784|NCT02920892|580856668|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
160854785|NCT02920892|580856669|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
160854786|NCT01216202|580856670|FG000|Overall Study|Withdrawal by Subject|8|||
160854787|NCT01216202|580856671|FG001|Overall Study|Withdrawal by Subject|0|||
160854788|NCT01216202|580856670|FG000|Overall Study|Death|0|||
160854789|NCT01216202|580856671|FG001|Overall Study|Death|2|||
160854790|NCT01216202|580856670|FG000|Overall Study|Lost to Follow-up|14|||
160854791|NCT01216202|580856671|FG001|Overall Study|Lost to Follow-up|0|||
160854792|NCT00360412|580856676|FG000|Overall Study|Adverse Event|37|||
160854793|NCT00360412|580856677|FG001|Overall Study|Adverse Event|65|||
160854794|NCT00360412|580856676|FG000|Overall Study|Protocol Violation|2|||
160854795|NCT00360412|580856677|FG001|Overall Study|Protocol Violation|5|||
160854796|NCT00360412|580856676|FG000|Overall Study|Patient withdrew consent|27|||
160854797|NCT00360412|580856677|FG001|Overall Study|Patient withdrew consent|52|||
160854798|NCT00360412|580856676|FG000|Overall Study|Lack of therapeutic efficacy|46|||
160854799|NCT00360412|580856677|FG001|Overall Study|Lack of therapeutic efficacy|61|||
160854800|NCT00360412|580856676|FG000|Overall Study|Physician Decision|2|||
160854801|NCT00360412|580856677|FG001|Overall Study|Physician Decision|4|||
160854802|NCT00360412|580856676|FG000|Overall Study|Other|5|||
160854803|NCT00360412|580856677|FG001|Overall Study|Other|6|||
160854804|NCT00360412|580856676|FG000|Overall Study|Study termination by Sponsor|214|||
160854805|NCT00360412|580856677|FG001|Overall Study|Study termination by Sponsor|469|||
160854806|NCT03863509|580856678|FG000|Overall Study|COVID-19 shutdown period|0|||
160854807|NCT03863509|580856679|FG001|Overall Study|COVID-19 shutdown period|4|||
160854808|NCT03863509|580856680|FG002|Overall Study|COVID-19 shutdown period|0|||
160854809|NCT03863509|580856678|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
160854810|NCT03863509|580856679|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
160854811|NCT03863509|580856680|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
160854812|NCT03863509|580856678|FG000|Overall Study|Lost to Follow-up|8|||
160854813|NCT03863509|580856679|FG001|Overall Study|Lost to Follow-up|0|||
160854814|NCT03863509|580856680|FG002|Overall Study|Lost to Follow-up|2|||
160854815|NCT03863509|580856678|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
160854816|NCT03863509|580856679|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
160854817|NCT03863509|580856680|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
160854818|NCT03863509|580856678|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
160854819|NCT03863509|580856679|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
160854820|NCT03863509|580856680|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
160854821|NCT03861273|580856681|FG000|Screening Phase (3 Weeks)|Other|1|||
160854822|NCT03861273|580856681|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
160854823|NCT03861273|580856681|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
160854824|NCT03861273|580856681|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
160854825|NCT03861273|580856681|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
160854826|NCT00191334|580856684|FG000|Overall Study|Adverse Event|4|||
160854827|NCT00191334|580856684|FG000|Overall Study|Disease Progression or Relapse|8|||
160854828|NCT00191334|580856684|FG000|Overall Study|Physician Decision|1|||
160854829|NCT00191334|580856684|FG000|Overall Study|Withdrawal by Subject|4|||
160854830|NCT02775916|580856686|FG000|Overall Study|Adverse Event|1|||
160854831|NCT02775916|580856687|FG001|Overall Study|Adverse Event|0|||
160854832|NCT02775916|580856686|FG000|Overall Study|Subject/Guardian Decision|2|||
160854833|NCT02775916|580856687|FG001|Overall Study|Subject/Guardian Decision|0|||
160854834|NCT00770653|580857773|FG000|Overall Study|Adverse Event|13|||
160854835|NCT00770653|580857774|FG001|Overall Study|Adverse Event|5|||
160854836|NCT00770653|580857773|FG000|Overall Study|Protocol Violation|8|||
160854837|NCT00770653|580857774|FG001|Overall Study|Protocol Violation|6|||
160854838|NCT00770653|580857773|FG000|Overall Study|Withdrawal by Subject|4|||
160854839|NCT00770653|580857774|FG001|Overall Study|Withdrawal by Subject|7|||
160854840|NCT00770653|580857773|FG000|Overall Study|Lack of Compliance|1|||
160854841|NCT00770653|580857774|FG001|Overall Study|Lack of Compliance|4|||
160854842|NCT00770653|580857773|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
160854843|NCT00770653|580857774|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
160854844|NCT00770653|580857773|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
160854845|NCT00770653|580857774|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
160854846|NCT00770653|580857773|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
160854847|NCT00770653|580857774|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
160854848|NCT00770653|580857773|FG000|Overall Study|Lost to Follow-up|1|||
160854849|NCT00770653|580857774|FG001|Overall Study|Lost to Follow-up|2|||
160854850|NCT00770653|580857773|FG000|Overall Study|Physician Decision|1|||
160854851|NCT00770653|580857774|FG001|Overall Study|Physician Decision|0|||
160854852|NCT01908426|580857777|FG000|Overall Study|Adverse Event|98|||
160854853|NCT01908426|580857778|FG001|Overall Study|Adverse Event|11|||
160854854|NCT01908426|580857777|FG000|Overall Study|Clinical Deterioration|72|||
160993109|NCT03227757|581365278|FG000|Overall Study|Withdrawal|10|||
160854855|NCT01908426|580857778|FG001|Overall Study|Clinical Deterioration|38|||
160854856|NCT01908426|580857777|FG000|Overall Study|Lack of Efficacy|3|||
160854857|NCT01908426|580857778|FG001|Overall Study|Lack of Efficacy|0|||
160854858|NCT01908426|580857777|FG000|Overall Study|Lost to Follow-up|0|||
160854859|NCT01908426|580857778|FG001|Overall Study|Lost to Follow-up|1|||
160854860|NCT01908426|580857777|FG000|Overall Study|Physician Decision|3|||
160854861|NCT01908426|580857778|FG001|Overall Study|Physician Decision|3|||
160854862|NCT01908426|580857777|FG000|Overall Study|Withdrawal by Subject|11|||
160854863|NCT01908426|580857778|FG001|Overall Study|Withdrawal by Subject|6|||
160854864|NCT01908426|580857777|FG000|Overall Study|Progressive Disease|206|||
160854865|NCT01908426|580857778|FG001|Overall Study|Progressive Disease|152|||
160854866|NCT01908426|580857777|FG000|Overall Study|Protocol Violation|1|||
160854867|NCT01908426|580857778|FG001|Overall Study|Protocol Violation|0|||
160854868|NCT01908426|580857777|FG000|Overall Study|No Study Treatment Given|3|||
160854869|NCT01908426|580857778|FG001|Overall Study|No Study Treatment Given|0|||
160854870|NCT02973100|580857786|FG000|Overall Study|Adverse Event|1|||
160854871|NCT02973100|580857787|FG001|Overall Study|Adverse Event|2|||
160854872|NCT02973100|580857788|FG002|Overall Study|Adverse Event|1|||
160854873|NCT02973100|580857789|FG003|Overall Study|Adverse Event|2|||
160854874|NCT02973100|580857786|FG000|Overall Study|Lost to Follow-up|3|||
160854875|NCT02973100|580857787|FG001|Overall Study|Lost to Follow-up|1|||
160854876|NCT02973100|580857788|FG002|Overall Study|Lost to Follow-up|1|||
160854877|NCT02973100|580857789|FG003|Overall Study|Lost to Follow-up|0|||
160854878|NCT02973100|580857786|FG000|Overall Study|Withdrawal by Subject|3|||
160854879|NCT02973100|580857787|FG001|Overall Study|Withdrawal by Subject|5|||
160854880|NCT02973100|580857788|FG002|Overall Study|Withdrawal by Subject|1|||
160854881|NCT02973100|580857789|FG003|Overall Study|Withdrawal by Subject|4|||
160854882|NCT02973100|580857786|FG000|Overall Study|Notification of change in address|0|||
160854883|NCT02973100|580857787|FG001|Overall Study|Notification of change in address|0|||
160854884|NCT02973100|580857788|FG002|Overall Study|Notification of change in address|0|||
160854885|NCT02973100|580857789|FG003|Overall Study|Notification of change in address|1|||
160854886|NCT02973100|580857786|FG000|Overall Study|Failed to attend Safety followup period|0|||
160854887|NCT02973100|580857787|FG001|Overall Study|Failed to attend Safety followup period|0|||
160854888|NCT02973100|580857788|FG002|Overall Study|Failed to attend Safety followup period|1|||
160854889|NCT02973100|580857789|FG003|Overall Study|Failed to attend Safety followup period|0|||
160854890|NCT02426580|580857790|FG000|Overall Study|Death|2|||
160854891|NCT02426580|580857791|FG001|Overall Study|Death|2|||
160854892|NCT02426580|580857790|FG000|Overall Study|Lost to Follow-up|0|||
160854893|NCT02426580|580857791|FG001|Overall Study|Lost to Follow-up|9|||
160854894|NCT02426580|580857790|FG000|Overall Study|transfer to hemodialysis|5|||
160854895|NCT02426580|580857791|FG001|Overall Study|transfer to hemodialysis|5|||
160854896|NCT02426580|580857790|FG000|Overall Study|Kidney transplant|3|||
160854897|NCT02426580|580857791|FG001|Overall Study|Kidney transplant|0|||
160854898|NCT02426580|580857790|FG000|Overall Study|Allergic to egg white|1|||
160854899|NCT02426580|580857791|FG001|Overall Study|Allergic to egg white|0|||
160854900|NCT04456504|580857794|FG000|Overall Study|Lost to Follow-up|2|||
160854901|NCT01342913|580857795|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
160854902|NCT01342913|580857796|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160854903|NCT01342913|580857797|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160854904|NCT01342913|580857795|FG000|2-week Run-in Period|Physician Decision|6|||
160854905|NCT01342913|580857796|FG001|2-week Run-in Period|Physician Decision|0|||
160854906|NCT01342913|580857797|FG002|2-week Run-in Period|Physician Decision|0|||
160854907|NCT01342913|580857795|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
160854908|NCT01342913|580857796|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
160854909|NCT01342913|580857797|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
160854910|NCT01342913|580857795|FG000|2-week Run-in Period|Adverse Event|2|||
160854911|NCT01342913|580857796|FG001|2-week Run-in Period|Adverse Event|0|||
160854912|NCT01342913|580857797|FG002|2-week Run-in Period|Adverse Event|0|||
160907583|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160907584|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160907585|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160907586|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160907587|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
160907588|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160854913|NCT01342913|580857795|FG000|2-week Run-in Period|Protocol Violation|5|||
160907589|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160993110|NCT03227757|581365278|FG000|Overall Study|Missed visits|1|||
160854914|NCT01342913|580857796|FG001|2-week Run-in Period|Protocol Violation|0|||
160854915|NCT01342913|580857797|FG002|2-week Run-in Period|Protocol Violation|0|||
160854916|NCT01342913|580857795|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
160854917|NCT01342913|580857796|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
160854918|NCT01342913|580857797|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
160854919|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160854920|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Adverse Event|3|||
160993111|NCT03227757|581365278|FG000|Overall Study|Lost to Follow-up|2|||
160993112|NCT01144468|581365281|FG000|Overall Study|Lost to Follow-up|4|||
160993113|NCT01144468|581365282|FG001|Overall Study|Lost to Follow-up|7|||
160993114|NCT01144468|581365281|FG000|Overall Study|Adverse Event|3|||
160993115|NCT01144468|581365282|FG001|Overall Study|Adverse Event|2|||
160993116|NCT01144468|581365281|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
160993117|NCT01144468|581365282|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
160993118|NCT02960659|581365283|FG000|Overall Study|Withdrawal by Subject|1|||
160993119|NCT02960659|581365284|FG001|Overall Study|Withdrawal by Subject|0|||
160993120|NCT02960659|581365283|FG000|Overall Study|Poor compliance|0|||
160993121|NCT02960659|581365284|FG001|Overall Study|Poor compliance|1|||
160993122|NCT04199728|581365290|FG000|Overall Study|Adverse Event|1|||
160993123|NCT04199728|581365291|FG001|Overall Study|Adverse Event|0|||
160993124|NCT04199728|581365290|FG000|Overall Study|Withdrawal by Subject|8|||
160993125|NCT04199728|581365291|FG001|Overall Study|Withdrawal by Subject|3|||
160993126|NCT04199728|581365290|FG000|Overall Study|Screen fail after consent|0|||
160993127|NCT04199728|581365291|FG001|Overall Study|Screen fail after consent|1|||
160993128|NCT04199728|581365290|FG000|Overall Study|Early withdraw criteria met|0|||
160993129|NCT04199728|581365291|FG001|Overall Study|Early withdraw criteria met|1|||
160993130|NCT04199728|581365290|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
160993131|NCT04199728|581365291|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
160993132|NCT01875250|581365294|FG000|Overall Study|Adverse Event|2|||
160993133|NCT01875250|581365295|FG001|Overall Study|Adverse Event|0|||
160993134|NCT04057196|581365299|FG000|Overall Study|Withdrawal by Subject|3|||
160993135|NCT04057196|581365299|FG000|Overall Study|Death|3|||
160993136|NCT03140176|581365303|FG000|Overall Study|Reason missing|23|||
160993137|NCT03140176|581365303|FG000|Overall Study|Death|33|||
160993138|NCT03140176|581365303|FG000|Overall Study|Disease progression|1|||
160993139|NCT03140176|581365303|FG000|Overall Study|Physician Decision|1|||
160993140|NCT03140176|581365303|FG000|Overall Study|Withdrawal by Subject|1|||
160993141|NCT03140176|581365303|FG000|Overall Study|Lost to Follow-up|15|||
160993142|NCT01268891|581365313|FG000|Overall Study|Adverse Event|3|||
160993143|NCT01268891|581365314|FG001|Overall Study|Adverse Event|7|||
160993144|NCT01268891|581365313|FG000|Overall Study|Lack of Efficacy|1|||
160907590|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160907591|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160907592|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160907593|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160907594|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
160907595|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
160907596|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907597|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907598|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907599|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907600|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907601|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907602|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
160907603|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907604|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907605|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907606|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907607|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907608|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907609|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907610|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
160907611|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
160907612|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907613|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907614|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907615|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907616|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907617|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907618|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
160907619|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
160907620|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907621|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907622|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907623|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907624|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907625|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907626|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907627|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907628|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
160907629|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907630|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907631|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907632|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907633|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
160907634|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907635|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907636|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
160907637|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907638|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907639|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907640|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907641|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
160907642|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907643|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907644|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
160907645|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907646|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907647|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907648|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907649|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
160907650|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160907651|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160907652|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
160907653|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160907654|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160854921|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Adverse Event|6|||
160854922|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
160854923|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
160854924|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
160854925|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
160854926|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
160854927|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
160854928|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160854929|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
160854930|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
160854931|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Physician Decision|0|||
160854932|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Physician Decision|2|||
160854933|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Physician Decision|0|||
160854934|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160854935|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
160854936|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
160854937|NCT02869633|580857801|FG000|Overall Study|Death|2|||
160854938|NCT02869633|580857802|FG001|Overall Study|Death|1|||
160854939|NCT02869633|580857801|FG000|Overall Study|Patient refused follow-up|1|||
160854940|NCT02869633|580857802|FG001|Overall Study|Patient refused follow-up|0|||
160907655|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160907656|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160907657|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
160907658|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907659|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907660|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
160907661|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907662|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907663|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907664|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907665|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907666|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907667|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907668|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
160907669|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907670|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907671|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907672|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907673|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
160907674|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907675|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907676|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907677|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907678|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907679|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907680|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907681|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
160907682|NCT03095066|581056307|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907683|NCT03095066|581056308|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907684|NCT03095066|581056309|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907685|NCT03095066|581056310|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907686|NCT03095066|581056311|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907687|NCT03095066|581056312|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
160907688|NCT03095066|581056313|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907689|NCT03095066|581056314|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907690|NCT03095066|581056307|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907691|NCT03095066|581056308|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907692|NCT03095066|581056309|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907693|NCT03095066|581056310|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907694|NCT03095066|581056311|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
160907695|NCT03095066|581056312|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907696|NCT03095066|581056313|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
160907697|NCT03095066|581056314|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907698|NCT03095066|581056307|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160907699|NCT03095066|581056308|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160907700|NCT03095066|581056309|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160907701|NCT03095066|581056310|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160907702|NCT03095066|581056311|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
160907703|NCT03095066|581056312|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160854941|NCT02869633|580857801|FG000|Overall Study|Provider discretion|1|||
160854942|NCT02869633|580857802|FG001|Overall Study|Provider discretion|0|||
160854943|NCT02869633|580857801|FG000|Overall Study|Investigator decision|1|||
160993145|NCT01268891|581365314|FG001|Overall Study|Lack of Efficacy|0|||
160854944|NCT02869633|580857802|FG001|Overall Study|Investigator decision|0|||
160854945|NCT02869633|580857801|FG000|Overall Study|Lost to Follow-up|0|||
160854946|NCT02869633|580857802|FG001|Overall Study|Lost to Follow-up|1|||
160854947|NCT02869633|580857801|FG000|Overall Study|Not eligible|6|||
160854948|NCT02869633|580857802|FG001|Overall Study|Not eligible|1|||
160854949|NCT02869633|580857801|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
160854950|NCT02869633|580857802|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
160854951|NCT02869633|580857801|FG000|Overall Study|Withdrawal by Subject|0|||
160854952|NCT02869633|580857802|FG001|Overall Study|Withdrawal by Subject|1|||
160854953|NCT03287791|580857804|FG000|Overall Study|Insufficient Therapeutic Response|0|||
160854954|NCT03287791|580857805|FG001|Overall Study|Insufficient Therapeutic Response|0|||
160854955|NCT03287791|580857806|FG002|Overall Study|Insufficient Therapeutic Response|1|||
160854956|NCT03287791|580857804|FG000|Overall Study|Adverse Event|0|||
160993146|NCT01268891|581365313|FG000|Overall Study|Withdrawal of Consent|3|||
160993147|NCT01268891|581365314|FG001|Overall Study|Withdrawal of Consent|1|||
160993148|NCT01268891|581365313|FG000|Overall Study|Administrative or other reason(s)|1|||
160993149|NCT01268891|581365314|FG001|Overall Study|Administrative or other reason(s)|0|||
160993150|NCT00991276|581365316|FG000|First Intervention Period|Adverse Event|0|||
160993151|NCT00991276|581365317|FG001|First Intervention Period|Adverse Event|1|||
160993152|NCT00991276|581365318|FG002|First Intervention Period|Adverse Event|0|||
160993153|NCT00991276|581365319|FG003|First Intervention Period|Adverse Event|1|||
160993154|NCT00991276|581365320|FG004|First Intervention Period|Adverse Event|0|||
160993155|NCT00991276|581365321|FG005|First Intervention Period|Adverse Event|0|||
160993156|NCT00991276|581365316|FG000|First Intervention Period|Protocol Violation|0|||
160993157|NCT00991276|581365317|FG001|First Intervention Period|Protocol Violation|0|||
160993158|NCT00991276|581365318|FG002|First Intervention Period|Protocol Violation|0|||
160993159|NCT00991276|581365319|FG003|First Intervention Period|Protocol Violation|0|||
160993160|NCT00991276|581365320|FG004|First Intervention Period|Protocol Violation|2|||
160993161|NCT00991276|581365321|FG005|First Intervention Period|Protocol Violation|0|||
160993162|NCT00991276|581365316|FG000|First Intervention Period|Insufficient clinical response|0|||
160993163|NCT00991276|581365317|FG001|First Intervention Period|Insufficient clinical response|0|||
160993164|NCT00991276|581365318|FG002|First Intervention Period|Insufficient clinical response|0|||
160993165|NCT00991276|581365319|FG003|First Intervention Period|Insufficient clinical response|0|||
160993166|NCT00991276|581365320|FG004|First Intervention Period|Insufficient clinical response|1|||
160993167|NCT00991276|581365321|FG005|First Intervention Period|Insufficient clinical response|0|||
160993168|NCT00991276|581365316|FG000|First Intervention Period|Other|0|||
160993169|NCT00991276|581365317|FG001|First Intervention Period|Other|0|||
160993170|NCT00991276|581365318|FG002|First Intervention Period|Other|0|||
160993171|NCT00991276|581365319|FG003|First Intervention Period|Other|1|||
160993172|NCT00991276|581365320|FG004|First Intervention Period|Other|1|||
160993173|NCT00991276|581365321|FG005|First Intervention Period|Other|0|||
160993174|NCT00991276|581365316|FG000|First Intervention Period|Withdrawal by Subject|0|||
160993175|NCT00991276|581365317|FG001|First Intervention Period|Withdrawal by Subject|1|||
160993176|NCT00991276|581365318|FG002|First Intervention Period|Withdrawal by Subject|0|||
160993177|NCT00991276|581365319|FG003|First Intervention Period|Withdrawal by Subject|1|||
160993178|NCT00991276|581365320|FG004|First Intervention Period|Withdrawal by Subject|0|||
160993179|NCT00991276|581365321|FG005|First Intervention Period|Withdrawal by Subject|1|||
160993180|NCT00991276|581365316|FG000|First Intervention Period|Lost to Follow-up|0|||
160993181|NCT00991276|581365317|FG001|First Intervention Period|Lost to Follow-up|1|||
160993182|NCT00991276|581365318|FG002|First Intervention Period|Lost to Follow-up|0|||
160993183|NCT00991276|581365319|FG003|First Intervention Period|Lost to Follow-up|1|||
160993184|NCT00991276|581365320|FG004|First Intervention Period|Lost to Follow-up|0|||
160993185|NCT00991276|581365321|FG005|First Intervention Period|Lost to Follow-up|0|||
160993186|NCT00991276|581365316|FG000|Second Intervention Period|Adverse Event|0|||
160854957|NCT03287791|580857805|FG001|Overall Study|Adverse Event|4|||
160854958|NCT03287791|580857806|FG002|Overall Study|Adverse Event|3|||
160993187|NCT00991276|581365317|FG001|Second Intervention Period|Adverse Event|2|||
160993188|NCT00991276|581365318|FG002|Second Intervention Period|Adverse Event|0|||
160993189|NCT00991276|581365319|FG003|Second Intervention Period|Adverse Event|1|||
160993190|NCT00991276|581365320|FG004|Second Intervention Period|Adverse Event|1|||
160650820|NCT04820842|580104329|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
160854959|NCT03287791|580857804|FG000|Overall Study|Withdrawal by Subject|12|||
160854960|NCT03287791|580857805|FG001|Overall Study|Withdrawal by Subject|12|||
160854961|NCT03287791|580857806|FG002|Overall Study|Withdrawal by Subject|17|||
160993191|NCT00991276|581365321|FG005|Second Intervention Period|Adverse Event|0|||
160993192|NCT00991276|581365316|FG000|Second Intervention Period|Protocol Violation|1|||
160993193|NCT00991276|581365317|FG001|Second Intervention Period|Protocol Violation|0|||
160993194|NCT00991276|581365318|FG002|Second Intervention Period|Protocol Violation|0|||
160854962|NCT03287791|580857804|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
160854963|NCT03287791|580857805|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
160993195|NCT00991276|581365319|FG003|Second Intervention Period|Protocol Violation|0|||
160993196|NCT00991276|581365320|FG004|Second Intervention Period|Protocol Violation|0|||
160993197|NCT00991276|581365321|FG005|Second Intervention Period|Protocol Violation|0|||
160993198|NCT00991276|581365316|FG000|Second Intervention Period|Other|0|||
160993199|NCT00991276|581365317|FG001|Second Intervention Period|Other|0|||
160993200|NCT00991276|581365318|FG002|Second Intervention Period|Other|0|||
160993201|NCT00991276|581365319|FG003|Second Intervention Period|Other|1|||
160993202|NCT00991276|581365320|FG004|Second Intervention Period|Other|0|||
160993203|NCT00991276|581365321|FG005|Second Intervention Period|Other|1|||
160993204|NCT00991276|581365316|FG000|Third Intervention Period|Protocol Violation|1|||
160993205|NCT00991276|581365317|FG001|Third Intervention Period|Protocol Violation|0|||
160993206|NCT00991276|581365318|FG002|Third Intervention Period|Protocol Violation|0|||
160993207|NCT00991276|581365319|FG003|Third Intervention Period|Protocol Violation|0|||
160993208|NCT00991276|581365320|FG004|Third Intervention Period|Protocol Violation|0|||
160993209|NCT00991276|581365321|FG005|Third Intervention Period|Protocol Violation|0|||
160569155|NCT01508676|579806976|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
160569156|NCT01508676|579806975|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
160569157|NCT01508676|579806976|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
160569158|NCT01508676|579806975|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
160569159|NCT01508676|579806976|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
160569160|NCT01508676|579806975|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
160854964|NCT03287791|580857806|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
160854965|NCT03287791|580857804|FG000|Overall Study|Lost to Follow-up|8|||
160854966|NCT03287791|580857805|FG001|Overall Study|Lost to Follow-up|14|||
160854967|NCT03287791|580857806|FG002|Overall Study|Lost to Follow-up|11|||
160854968|NCT03287791|580857804|FG000|Overall Study|Protocol Violation|7|||
160854969|NCT03287791|580857805|FG001|Overall Study|Protocol Violation|2|||
160854970|NCT03287791|580857806|FG002|Overall Study|Protocol Violation|1|||
160854971|NCT03287791|580857804|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
160854972|NCT03287791|580857805|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
160854973|NCT03287791|580857806|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
160854974|NCT03287791|580857804|FG000|Overall Study|Too much time between 2 visits|0|||
160854975|NCT03287791|580857805|FG001|Overall Study|Too much time between 2 visits|1|||
160854976|NCT03287791|580857806|FG002|Overall Study|Too much time between 2 visits|0|||
160854977|NCT03287791|580857804|FG000|Overall Study|Non-compliance|0|||
160854978|NCT03287791|580857805|FG001|Overall Study|Non-compliance|1|||
160854979|NCT03287791|580857806|FG002|Overall Study|Non-compliance|0|||
160854980|NCT03287791|580857804|FG000|Overall Study|Did not meet inclusion criteria|1|||
160854981|NCT03287791|580857805|FG001|Overall Study|Did not meet inclusion criteria|0|||
160854982|NCT03287791|580857806|FG002|Overall Study|Did not meet inclusion criteria|0|||
160854983|NCT01381016|580857808|FG000|Overall Study|Lost to Follow-up|1|||
160854984|NCT01381016|580857809|FG001|Overall Study|Lost to Follow-up|1|||
160854985|NCT01381016|580857808|FG000|Overall Study|Screen Failure|2|||
160854986|NCT01381016|580857809|FG001|Overall Study|Screen Failure|2|||
160854987|NCT01381016|580857808|FG000|Overall Study|Withdrawal by Subject|0|||
160854988|NCT01381016|580857809|FG001|Overall Study|Withdrawal by Subject|1|||
160854989|NCT01381016|580857808|FG000|Overall Study|Physician Decision|0|||
160854990|NCT01381016|580857809|FG001|Overall Study|Physician Decision|2|||
160854991|NCT03598036|580857815|FG000|Overall Study|Withdrawal by Subject|1|||
160854992|NCT03598036|580857816|FG001|Overall Study|Withdrawal by Subject|0|||
160854993|NCT02891174|580857817|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
160854994|NCT02891174|580857818|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
160854995|NCT02891174|580857817|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
160854996|NCT02891174|580857818|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
160854997|NCT02891174|580857817|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
160854998|NCT02891174|580857818|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
160854999|NCT02891174|580857817|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
160855000|NCT02891174|580857818|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
160855001|NCT02891174|580857817|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
160855002|NCT02891174|580857818|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
160855003|NCT02891174|580857817|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
160855004|NCT02891174|580857818|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
160855005|NCT02891174|580857817|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
160855006|NCT02891174|580857818|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
160855007|NCT04319198|580857821|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
160855008|NCT04319198|580857822|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
160855009|NCT04319198|580857823|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
160569161|NCT01508676|579806976|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
160993210|NCT00991276|581365316|FG000|Third Intervention Period|Other|0|||
160993211|NCT00991276|581365317|FG001|Third Intervention Period|Other|0|||
160993212|NCT00991276|581365318|FG002|Third Intervention Period|Other|0|||
160993213|NCT00991276|581365319|FG003|Third Intervention Period|Other|0|||
160993214|NCT00991276|581365320|FG004|Third Intervention Period|Other|0|||
160993215|NCT00991276|581365321|FG005|Third Intervention Period|Other|1|||
160993216|NCT00991276|581365316|FG000|Third Intervention Period|Adverse Event|0|||
160993217|NCT00991276|581365317|FG001|Third Intervention Period|Adverse Event|0|||
160993218|NCT00991276|581365318|FG002|Third Intervention Period|Adverse Event|1|||
160993219|NCT00991276|581365319|FG003|Third Intervention Period|Adverse Event|0|||
160993220|NCT00991276|581365320|FG004|Third Intervention Period|Adverse Event|0|||
160993221|NCT00991276|581365321|FG005|Third Intervention Period|Adverse Event|0|||
160993222|NCT00991276|581365316|FG000|Third Intervention Period|Withdrawal by Subject|0|||
160993223|NCT00991276|581365317|FG001|Third Intervention Period|Withdrawal by Subject|0|||
160993224|NCT00991276|581365318|FG002|Third Intervention Period|Withdrawal by Subject|0|||
160993225|NCT00991276|581365319|FG003|Third Intervention Period|Withdrawal by Subject|1|||
160993226|NCT00991276|581365320|FG004|Third Intervention Period|Withdrawal by Subject|0|||
160993227|NCT00991276|581365321|FG005|Third Intervention Period|Withdrawal by Subject|0|||
160993228|NCT02001623|581365322|FG000|Overall Study|Disease Progression|2|||
160993229|NCT02001623|581365323|FG001|Overall Study|Disease Progression|2|||
160993230|NCT02001623|581365324|FG002|Overall Study|Disease Progression|3|||
160993231|NCT02001623|581365325|FG003|Overall Study|Disease Progression|2|||
160993232|NCT02001623|581365326|FG004|Overall Study|Disease Progression|3|||
160993233|NCT02001623|581365327|FG005|Overall Study|Disease Progression|2|||
160993234|NCT02001623|581365328|FG006|Overall Study|Disease Progression|3|||
160993235|NCT02001623|581365329|FG007|Overall Study|Disease Progression|3|||
160993236|NCT02001623|581365330|FG008|Overall Study|Disease Progression|7|||
160993237|NCT02001623|581365331|FG009|Overall Study|Disease Progression|40|||
160993238|NCT02001623|581365332|FG010|Overall Study|Disease Progression|5|||
160993239|NCT02001623|581365333|FG011|Overall Study|Disease Progression|9|||
160993240|NCT02001623|581365334|FG012|Overall Study|Disease Progression|9|||
160993241|NCT02001623|581365335|FG013|Overall Study|Disease Progression|20|||
160993242|NCT02001623|581365336|FG014|Overall Study|Disease Progression|9|||
160993243|NCT02001623|581365322|FG000|Overall Study|Physician Decision|0|||
160993244|NCT02001623|581365323|FG001|Overall Study|Physician Decision|0|||
160993245|NCT02001623|581365324|FG002|Overall Study|Physician Decision|0|||
160993246|NCT02001623|581365325|FG003|Overall Study|Physician Decision|0|||
160993247|NCT02001623|581365326|FG004|Overall Study|Physician Decision|0|||
160993248|NCT02001623|581365327|FG005|Overall Study|Physician Decision|0|||
160993249|NCT02001623|581365328|FG006|Overall Study|Physician Decision|0|||
160993250|NCT02001623|581365329|FG007|Overall Study|Physician Decision|0|||
160993251|NCT02001623|581365330|FG008|Overall Study|Physician Decision|3|||
160993252|NCT02001623|581365331|FG009|Overall Study|Physician Decision|2|||
160993253|NCT02001623|581365332|FG010|Overall Study|Physician Decision|3|||
160993254|NCT02001623|581365333|FG011|Overall Study|Physician Decision|3|||
160993255|NCT02001623|581365334|FG012|Overall Study|Physician Decision|1|||
160993256|NCT02001623|581365335|FG013|Overall Study|Physician Decision|2|||
160993257|NCT02001623|581365336|FG014|Overall Study|Physician Decision|1|||
160993258|NCT02001623|581365322|FG000|Overall Study|Death|0|||
160993259|NCT02001623|581365323|FG001|Overall Study|Death|1|||
160993260|NCT02001623|581365324|FG002|Overall Study|Death|0|||
160993261|NCT02001623|581365325|FG003|Overall Study|Death|0|||
160993262|NCT02001623|581365326|FG004|Overall Study|Death|0|||
160993263|NCT02001623|581365327|FG005|Overall Study|Death|0|||
160993264|NCT02001623|581365328|FG006|Overall Study|Death|0|||
160993265|NCT02001623|581365329|FG007|Overall Study|Death|0|||
160855010|NCT04319198|580857821|FG000|Overall Study|Death|0|||
160855011|NCT04319198|580857822|FG001|Overall Study|Death|3|||
160855012|NCT04319198|580857823|FG002|Overall Study|Death|3|||
160855013|NCT04319198|580857821|FG000|Overall Study|Reason Not Specified|0|||
160993266|NCT02001623|581365330|FG008|Overall Study|Death|0|||
160993267|NCT02001623|581365331|FG009|Overall Study|Death|0|||
160993268|NCT02001623|581365332|FG010|Overall Study|Death|0|||
160993269|NCT02001623|581365333|FG011|Overall Study|Death|0|||
160993270|NCT02001623|581365334|FG012|Overall Study|Death|0|||
160993271|NCT02001623|581365335|FG013|Overall Study|Death|0|||
160993272|NCT02001623|581365336|FG014|Overall Study|Death|0|||
160993273|NCT02001623|581365322|FG000|Overall Study|Adverse Event|0|||
160993274|NCT02001623|581365323|FG001|Overall Study|Adverse Event|0|||
160993275|NCT02001623|581365324|FG002|Overall Study|Adverse Event|0|||
160993276|NCT02001623|581365325|FG003|Overall Study|Adverse Event|0|||
160993277|NCT02001623|581365326|FG004|Overall Study|Adverse Event|0|||
160993278|NCT02001623|581365327|FG005|Overall Study|Adverse Event|1|||
160993279|NCT02001623|581365328|FG006|Overall Study|Adverse Event|0|||
160993280|NCT02001623|581365329|FG007|Overall Study|Adverse Event|3|||
160993281|NCT02001623|581365330|FG008|Overall Study|Adverse Event|4|||
160993282|NCT02001623|581365331|FG009|Overall Study|Adverse Event|6|||
160855014|NCT04319198|580857822|FG001|Overall Study|Reason Not Specified|2|||
160993283|NCT02001623|581365332|FG010|Overall Study|Adverse Event|4|||
160993284|NCT02001623|581365333|FG011|Overall Study|Adverse Event|0|||
160855015|NCT04319198|580857823|FG002|Overall Study|Reason Not Specified|4|||
160569162|NCT06129487|579806977|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
160569163|NCT06129487|579806978|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
160569164|NCT03772327|579806979|FG000|Overall Study|Lost to Follow-up|3|||
160569165|NCT03772327|579806980|FG001|Overall Study|Lost to Follow-up|4|||
160569166|NCT03772327|579806979|FG000|Overall Study|Withdrawal by Subject|2|||
160569167|NCT03772327|579806980|FG001|Overall Study|Withdrawal by Subject|3|||
160569168|NCT04689828|579806981|FG000|Overall Study|Subject decision|5|||
160855016|NCT04319198|580857821|FG000|Overall Study|Withdrawal of Consent|0|||
160855017|NCT04319198|580857822|FG001|Overall Study|Withdrawal of Consent|0|||
160569169|NCT04689828|579806982|FG001|Overall Study|Subject decision|5|||
160855018|NCT04319198|580857823|FG002|Overall Study|Withdrawal of Consent|5|||
160855019|NCT04319198|580857821|FG000|Overall Study|Site Terminated by Sponsor|0|||
160855020|NCT04319198|580857822|FG001|Overall Study|Site Terminated by Sponsor|1|||
160855021|NCT04319198|580857823|FG002|Overall Study|Site Terminated by Sponsor|0|||
160855022|NCT04607668|580857828|FG000|Overall Study|Death|49|||
160855023|NCT04607668|580857829|FG001|Overall Study|Death|26|||
160855024|NCT04607668|580857828|FG000|Overall Study|Lost to Follow-up|3|||
160855025|NCT04607668|580857829|FG001|Overall Study|Lost to Follow-up|4|||
160855026|NCT04607668|580857828|FG000|Overall Study|Study terminated by Sponsor|92|||
160855027|NCT04607668|580857829|FG001|Overall Study|Study terminated by Sponsor|114|||
160855028|NCT04607668|580857828|FG000|Overall Study|Withdrawal by Subject|12|||
160855029|NCT04607668|580857829|FG001|Overall Study|Withdrawal by Subject|11|||
160855030|NCT04607668|580857828|FG000|Overall Study|Other, unspecified|8|||
160855031|NCT04607668|580857829|FG001|Overall Study|Other, unspecified|7|||
160855032|NCT02250326|580857830|FG000|Treatment|Death|1|||
160855033|NCT02250326|580857831|FG001|Treatment|Death|13|||
160855034|NCT02250326|580857832|FG002|Treatment|Death|2|||
160855035|NCT02250326|580857830|FG000|Treatment|Adverse Event|8|||
160855036|NCT02250326|580857831|FG001|Treatment|Adverse Event|8|||
160855037|NCT02250326|580857832|FG002|Treatment|Adverse Event|9|||
160855038|NCT02250326|580857830|FG000|Treatment|Progressive Disease|42|||
160855039|NCT02250326|580857831|FG001|Treatment|Progressive Disease|40|||
160855040|NCT02250326|580857832|FG002|Treatment|Progressive Disease|47|||
160855041|NCT02250326|580857830|FG000|Treatment|Symptomatic Deterioration|9|||
160855042|NCT02250326|580857831|FG001|Treatment|Symptomatic Deterioration|4|||
160855043|NCT02250326|580857832|FG002|Treatment|Symptomatic Deterioration|10|||
160855044|NCT02250326|580857830|FG000|Treatment|Withdrawal by Subject|11|||
160855045|NCT02250326|580857831|FG001|Treatment|Withdrawal by Subject|6|||
160855046|NCT02250326|580857832|FG002|Treatment|Withdrawal by Subject|4|||
160855047|NCT02250326|580857830|FG000|Treatment|Other reasons|8|||
160855048|NCT02250326|580857831|FG001|Treatment|Other reasons|7|||
160855049|NCT02250326|580857832|FG002|Treatment|Other reasons|7|||
160855050|NCT02250326|580857830|FG000|Extension Period|Progressive Disease|0|||
160855051|NCT02250326|580857831|FG001|Extension Period|Progressive Disease|2|||
160855052|NCT02250326|580857832|FG002|Extension Period|Progressive Disease|0|||
160855053|NCT02250326|580857830|FG000|Extension Period|Withdrawal by Subject|0|||
160855054|NCT02250326|580857831|FG001|Extension Period|Withdrawal by Subject|1|||
160855055|NCT02250326|580857832|FG002|Extension Period|Withdrawal by Subject|0|||
160855056|NCT02250326|580857830|FG000|Extension Period|Withdrawal by investigator|0|||
160855057|NCT02250326|580857831|FG001|Extension Period|Withdrawal by investigator|1|||
160855058|NCT02250326|580857832|FG002|Extension Period|Withdrawal by investigator|0|||
160855059|NCT01693029|580857833|FG000|Overall Study|Withdrawal by Subject|15|||
160855060|NCT01693029|580857834|FG001|Overall Study|Withdrawal by Subject|22|||
160855061|NCT01693029|580857833|FG000|Overall Study|Kidney transplantation|7|||
160855062|NCT01693029|580857834|FG001|Overall Study|Kidney transplantation|7|||
160855063|NCT01693029|580857833|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
160855064|NCT01693029|580857834|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
160855065|NCT01693029|580857833|FG000|Overall Study|Protocol Violation|6|||
160855066|NCT01693029|580857834|FG001|Overall Study|Protocol Violation|7|||
160855067|NCT01693029|580857833|FG000|Overall Study|Change in dialysis modality|2|||
160855068|NCT01693029|580857834|FG001|Overall Study|Change in dialysis modality|1|||
160855069|NCT01693029|580857833|FG000|Overall Study|Physician Decision|0|||
160855070|NCT01693029|580857834|FG001|Overall Study|Physician Decision|2|||
160855071|NCT01693029|580857833|FG000|Overall Study|Lost to Follow-up|0|||
160855072|NCT01693029|580857834|FG001|Overall Study|Lost to Follow-up|1|||
160855073|NCT01693029|580857833|FG000|Overall Study|Adverse Event|1|||
160569170|NCT04689828|579806981|FG000|Overall Study|Adverse Event|12|||
160855074|NCT01693029|580857834|FG001|Overall Study|Adverse Event|6|||
160855075|NCT01693029|580857833|FG000|Overall Study|Death|5|||
160855076|NCT01693029|580857834|FG001|Overall Study|Death|8|||
160855077|NCT01693029|580857833|FG000|Overall Study|Non-compliance|2|||
160855078|NCT01693029|580857834|FG001|Overall Study|Non-compliance|1|||
160855079|NCT05801991|580857835|FG000|Overall Study|Lost to Follow-up|1|||
160855080|NCT05801991|580857836|FG001|Overall Study|Lost to Follow-up|0|||
160855081|NCT04235140|580857837|FG000|Overall Study|Adverse Event|2|||
160855082|NCT04235140|580857837|FG000|Overall Study|Lost to Follow-up|1|||
160855083|NCT04235140|580857837|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
160855084|NCT04235140|580857837|FG000|Overall Study|Commercial drug is available for participants|7|||
160569171|NCT04689828|579806982|FG001|Overall Study|Adverse Event|12|||
160569172|NCT04689828|579806981|FG000|Overall Study|Physician Decision|24|||
160569173|NCT04689828|579806982|FG001|Overall Study|Physician Decision|32|||
160855085|NCT01451723|580857839|FG000|Overall Study|study halted|6|||
160855086|NCT01451723|580857840|FG001|Overall Study|study halted|5|||
160855087|NCT02210000|580857841|FG000|Overall Study|Study Terminated|11|||
160855088|NCT02210000|580857842|FG001|Overall Study|Study Terminated|12|||
160855089|NCT02210000|580857841|FG000|Overall Study|Withdrawal by Subject|7|||
160855090|NCT02210000|580857842|FG001|Overall Study|Withdrawal by Subject|1|||
160855091|NCT02210000|580857841|FG000|Overall Study|Adverse Event|1|||
160855092|NCT02210000|580857842|FG001|Overall Study|Adverse Event|5|||
160855093|NCT02210000|580857841|FG000|Overall Study|Lost to Follow-up|0|||
160855094|NCT02210000|580857842|FG001|Overall Study|Lost to Follow-up|2|||
160855095|NCT02210000|580857841|FG000|Overall Study|Physician Decision|0|||
160855096|NCT02210000|580857842|FG001|Overall Study|Physician Decision|1|||
160855097|NCT00833040|580857843|FG000|Overall Study|Adverse Event|0|||
160855098|NCT00833040|580857844|FG001|Overall Study|Adverse Event|0|||
160855099|NCT00833040|580857845|FG002|Overall Study|Adverse Event|0|||
160855100|NCT00833040|580857846|FG003|Overall Study|Adverse Event|0|||
160855101|NCT00833040|580857847|FG004|Overall Study|Adverse Event|0|||
160855102|NCT00833040|580857848|FG005|Overall Study|Adverse Event|1|||
160855103|NCT00962208|580857853|FG000|Overall Study|Could not achieve good vision|9|||
160855104|NCT00962208|580857854|FG001|Overall Study|Could not achieve good vision|0|||
160855105|NCT00962208|580857853|FG000|Overall Study|Contraindicated to continue study|5|||
160855106|NCT00962208|580857854|FG001|Overall Study|Contraindicated to continue study|1|||
160855107|NCT00962208|580857853|FG000|Overall Study|Lost to Follow-up|0|||
160855108|NCT00962208|580857854|FG001|Overall Study|Lost to Follow-up|9|||
160855109|NCT01731912|580857855|FG000|Overall Study|noncompliance|2|||
160855110|NCT00443040|580857858|FG000|Overall Study|Withdrawal by Subject|1|||
160855111|NCT00443040|580857859|FG001|Overall Study|Withdrawal by Subject|0|||
160855112|NCT00443040|580857860|FG002|Overall Study|Withdrawal by Subject|0|||
160855113|NCT00443040|580857858|FG000|Overall Study|Converted to an open laparotomy|3|||
160855114|NCT00443040|580857859|FG001|Overall Study|Converted to an open laparotomy|0|||
160855115|NCT00443040|580857860|FG002|Overall Study|Converted to an open laparotomy|1|||
160855116|NCT00718510|580857863|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
160855117|NCT00718510|580857864|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
160855118|NCT00718510|580857863|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
160855119|NCT00718510|580857864|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
160855120|NCT00423657|580857865|FG000|Overall Study|Withdrew consent|10|||
160855121|NCT00423657|580857866|FG001|Overall Study|Withdrew consent|8|||
160855122|NCT00423657|580857865|FG000|Overall Study|Non-compliance|0|||
160855123|NCT00423657|580857866|FG001|Overall Study|Non-compliance|1|||
160855124|NCT00423657|580857865|FG000|Overall Study|Other|15|||
160855125|NCT00423657|580857866|FG001|Overall Study|Other|16|||
160855126|NCT00423657|580857865|FG000|Overall Study|Request of sponsor/investigator|1|||
160855127|NCT00423657|580857866|FG001|Overall Study|Request of sponsor/investigator|0|||
160855128|NCT02269124|580857868|FG000|Overall Study|Lost to Follow-up|1|||
160855129|NCT02269124|580857869|FG001|Overall Study|Lost to Follow-up|0|||
160855130|NCT02269124|580857868|FG000|Overall Study|Withdrawal by Subject|0|||
160855131|NCT02269124|580857869|FG001|Overall Study|Withdrawal by Subject|2|||
160855132|NCT01045460|580857872|FG000|Overall Study|Physician Decision|3|||
160855133|NCT01045460|580857873|FG001|Overall Study|Physician Decision|2|||
160855134|NCT01045460|580857872|FG000|Overall Study|Lost to Follow-up|0|||
160855135|NCT01045460|580857873|FG001|Overall Study|Lost to Follow-up|1|||
160855136|NCT01045460|580857872|FG000|Overall Study|Lack of Efficacy|3|||
160855137|NCT01045460|580857873|FG001|Overall Study|Lack of Efficacy|0|||
160855138|NCT00097500|580857874|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
160855139|NCT00097500|580857875|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
160855140|NCT00097500|580857874|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
160855141|NCT00097500|580857875|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
160855142|NCT00097500|580857874|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
160855143|NCT00097500|580857875|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
160855144|NCT00097500|580857874|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
160855145|NCT00097500|580857875|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
160855146|NCT00097500|580857874|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
160855147|NCT00097500|580857875|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
160855148|NCT00097500|580857874|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
160855149|NCT00097500|580857875|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
160855150|NCT00097500|580857874|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
160855151|NCT00097500|580857875|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
160855152|NCT02163902|580857878|FG000|Overall Study|Subject's Request|3|||
160855153|NCT02163902|580857879|FG001|Overall Study|Subject's Request|4|||
160855154|NCT02163902|580857878|FG000|Overall Study|Lost to Follow-up|6|||
160855155|NCT02163902|580857879|FG001|Overall Study|Lost to Follow-up|7|||
160855156|NCT02163902|580857878|FG000|Overall Study|Administrative Decision|2|||
160569174|NCT04689828|579806981|FG000|Overall Study|Progressive disease|54|||
160569175|NCT04689828|579806982|FG001|Overall Study|Progressive disease|173|||
160569176|NCT04689828|579806981|FG000|Overall Study|Death|0|||
160569177|NCT04689828|579806982|FG001|Overall Study|Death|1|||
160569178|NCT04689828|579806981|FG000|Overall Study|Lost to Follow-up|1|||
160569179|NCT04689828|579806982|FG001|Overall Study|Lost to Follow-up|0|||
160569180|NCT04689828|579806981|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
160569181|NCT04689828|579806982|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
160569182|NCT04689828|579806981|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
160569183|NCT04689828|579806982|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
160855157|NCT02163902|580857879|FG001|Overall Study|Administrative Decision|2|||
160855158|NCT00844376|580857883|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
160855159|NCT00844376|580857884|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
160855160|NCT01300234|580857885|FG000|Overall Study|Adverse Event|1|||
160855161|NCT01300234|580857886|FG001|Overall Study|Adverse Event|1|||
160855162|NCT01300234|580857885|FG000|Overall Study|Protocol Violation|2|||
160855163|NCT01300234|580857886|FG001|Overall Study|Protocol Violation|3|||
160855164|NCT01300234|580857885|FG000|Overall Study|Withdrawal by Subject|5|||
160855165|NCT01300234|580857886|FG001|Overall Study|Withdrawal by Subject|9|||
160855166|NCT01300234|580857885|FG000|Overall Study|Lost to Follow-up|14|||
160855167|NCT01300234|580857886|FG001|Overall Study|Lost to Follow-up|12|||
160855168|NCT01300234|580857885|FG000|Overall Study|Pregnancy|2|||
160855169|NCT01300234|580857886|FG001|Overall Study|Pregnancy|1|||
160855170|NCT01300234|580857885|FG000|Overall Study|Participant reached stopping critera|2|||
160855171|NCT01300234|580857886|FG001|Overall Study|Participant reached stopping critera|0|||
160855172|NCT01300234|580857885|FG000|Overall Study|Participant stopped medication|1|||
160855173|NCT01300234|580857886|FG001|Overall Study|Participant stopped medication|1|||
160855174|NCT01300234|580857885|FG000|Overall Study|Participant refused return to hospital|1|||
160855175|NCT01300234|580857886|FG001|Overall Study|Participant refused return to hospital|0|||
160855176|NCT03253679|580857887|FG000|Overall Study|Screen Failure|1|||
160855177|NCT04816214|580857888|FG000|Overall Study|Progressive Disease|4|||
160855178|NCT04816214|580857889|FG001|Overall Study|Progressive Disease|0|||
160855179|NCT04816214|580857890|FG002|Overall Study|Progressive Disease|0|||
160855180|NCT04816214|580857888|FG000|Overall Study|Death|1|||
160855181|NCT04816214|580857889|FG001|Overall Study|Death|0|||
160855182|NCT04816214|580857890|FG002|Overall Study|Death|0|||
160855183|NCT04816214|580857888|FG000|Overall Study|Study Terminated by Sponsor|1|||
160855184|NCT04816214|580857889|FG001|Overall Study|Study Terminated by Sponsor|0|||
160855185|NCT04816214|580857890|FG002|Overall Study|Study Terminated by Sponsor|0|||
160855186|NCT04879628|580857891|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
160855187|NCT04879628|580857892|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
160855188|NCT04879628|580857893|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
160855189|NCT04879628|580857894|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
160855190|NCT04879628|580857891|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
160855191|NCT04879628|580857892|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
160855192|NCT04879628|580857893|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
160855193|NCT04879628|580857894|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
160855194|NCT04879628|580857891|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
160855195|NCT04879628|580857892|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
160855196|NCT04879628|580857893|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
160855197|NCT04879628|580857894|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
160855198|NCT04879628|580857891|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
160855199|NCT04879628|580857892|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
160855200|NCT04879628|580857893|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
160855201|NCT04879628|580857894|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
160855202|NCT00948064|580859248|FG000|Phase I|No treatment received|1|||
160855203|NCT00948064|580859249|FG001|Phase I|No treatment received|0|||
160855204|NCT00948064|580859250|FG002|Phase I|No treatment received|0|||
160855205|NCT00948064|580859248|FG000|Phase II|Physician Decision|0|||
160855206|NCT00948064|580859249|FG001|Phase II|Physician Decision|0|||
160855207|NCT00948064|580859250|FG002|Phase II|Physician Decision|1|||
160855208|NCT00948064|580859248|FG000|Phase II|Withdrawal by Subject|0|||
160855209|NCT00948064|580859249|FG001|Phase II|Withdrawal by Subject|1|||
160907704|NCT03095066|581056313|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160907705|NCT03095066|581056314|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
160907706|NCT03095066|581056307|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160907707|NCT03095066|581056308|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160569184|NCT04689828|579806981|FG000|Overall Study|Participants not treated|7|||
160855210|NCT00948064|580859250|FG002|Phase II|Withdrawal by Subject|0|||
160855211|NCT03409796|580859264|FG000|Overall Study|Adverse Event|2|||
160569185|NCT04689828|579806982|FG001|Overall Study|Participants not treated|2|||
160569186|NCT00195351|579806989|FG000|Overall Study|Lost to Follow-up|9|||
160569187|NCT00195351|579806990|FG001|Overall Study|Lost to Follow-up|9|||
160569188|NCT00195351|579806989|FG000|Overall Study|Withdrawal by Subject|6|||
160569189|NCT00195351|579806990|FG001|Overall Study|Withdrawal by Subject|3|||
160569190|NCT00195351|579806989|FG000|Overall Study|Protocol Deviation|3|||
160569191|NCT00195351|579806990|FG001|Overall Study|Protocol Deviation|2|||
160569192|NCT00195351|579806989|FG000|Overall Study|Death|3|||
160569193|NCT00195351|579806990|FG001|Overall Study|Death|1|||
160569194|NCT00195351|579806989|FG000|Overall Study|Lack of Efficacy|0|||
160569195|NCT00195351|579806990|FG001|Overall Study|Lack of Efficacy|1|||
160569196|NCT04332419|579806993|FG000|Overall Study|Withdrawal by Subject|1|||
160855212|NCT03409796|580859265|FG001|Overall Study|Adverse Event|0|||
160855213|NCT03409796|580859264|FG000|Overall Study|Other|0|||
160855214|NCT03409796|580859265|FG001|Overall Study|Other|1|||
160855215|NCT00740220|580859266|FG000|Overall Study|screen failures (non-COPD patients)|9|||
160855216|NCT04416204|580859279|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
160855217|NCT04416204|580859280|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
160855218|NCT04416204|580859281|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
160855219|NCT04416204|580859282|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
160855220|NCT01959503|580859283|FG000|Overall Study|Death|2|||
160855221|NCT01959503|580859284|FG001|Overall Study|Death|1|||
160855222|NCT01959503|580859283|FG000|Overall Study|Randomized but not treated|1|||
160855223|NCT01959503|580859284|FG001|Overall Study|Randomized but not treated|1|||
160855224|NCT01419236|580859285|FG000|Overall Study|Adverse Event|1|||
160855225|NCT01419236|580859286|FG001|Overall Study|Adverse Event|0|||
160855226|NCT01419236|580859285|FG000|Overall Study|Lack of Efficacy|0|||
160855227|NCT01419236|580859286|FG001|Overall Study|Lack of Efficacy|1|||
160855228|NCT01419236|580859285|FG000|Overall Study|Lost to Follow-up|1|||
160855229|NCT01419236|580859286|FG001|Overall Study|Lost to Follow-up|0|||
160855230|NCT01419236|580859285|FG000|Overall Study|Physician Decision|1|||
160855231|NCT01419236|580859286|FG001|Overall Study|Physician Decision|0|||
160855232|NCT01419236|580859285|FG000|Overall Study|Withdrawal by Subject|1|||
160855233|NCT01419236|580859286|FG001|Overall Study|Withdrawal by Subject|4|||
160855234|NCT01419236|580859285|FG000|Overall Study|Entry Criteria Not Met|1|||
160855235|NCT01419236|580859286|FG001|Overall Study|Entry Criteria Not Met|0|||
160855236|NCT01393158|580859288|FG000|Overall Study|Adverse Event|1|||
160855237|NCT01393158|580859289|FG001|Overall Study|Adverse Event|0|||
160855238|NCT02173769|580859291|FG000|Overall Study|Protocol Violation|4|||
160855239|NCT04233801|580859292|FG000|Overall Study|Other than listed|0|||
160855240|NCT04233801|580859293|FG001|Overall Study|Other than listed|0|||
160855241|NCT04233801|580859294|FG002|Overall Study|Other than listed|1|||
160855242|NCT04233801|580859292|FG000|Overall Study|Withdrawal by Subject|0|||
160855243|NCT04233801|580859293|FG001|Overall Study|Withdrawal by Subject|2|||
160855244|NCT04233801|580859294|FG002|Overall Study|Withdrawal by Subject|3|||
160855245|NCT00683878|580859307|FG000|Overall Study|Lack of Efficacy|3|||
160855246|NCT00683878|580859308|FG001|Overall Study|Lack of Efficacy|0|||
160855247|NCT00683878|580859309|FG002|Overall Study|Lack of Efficacy|1|||
160855248|NCT00683878|580859307|FG000|Overall Study|Adverse Event|4|||
160855249|NCT00683878|580859308|FG001|Overall Study|Adverse Event|3|||
160855250|NCT00683878|580859309|FG002|Overall Study|Adverse Event|3|||
160855251|NCT00683878|580859307|FG000|Overall Study|Withdrawal by Subject|9|||
160855252|NCT00683878|580859308|FG001|Overall Study|Withdrawal by Subject|8|||
160855253|NCT00683878|580859309|FG002|Overall Study|Withdrawal by Subject|6|||
160855254|NCT00683878|580859307|FG000|Overall Study|Death|0|||
160855255|NCT00683878|580859308|FG001|Overall Study|Death|1|||
160855256|NCT00683878|580859309|FG002|Overall Study|Death|0|||
160855257|NCT00683878|580859307|FG000|Overall Study|Lost to Follow-up|4|||
160855258|NCT00683878|580859308|FG001|Overall Study|Lost to Follow-up|2|||
160855259|NCT00683878|580859309|FG002|Overall Study|Lost to Follow-up|4|||
160855260|NCT00683878|580859307|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
160569197|NCT02493751|579806994|FG000|Overall Study|Withdrawal by Subject|2|||
160855261|NCT00683878|580859308|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
160569198|NCT02493751|579806995|FG001|Overall Study|Withdrawal by Subject|8|||
160569199|NCT02493751|579806994|FG000|Overall Study|Death|6|||
160855262|NCT00683878|580859309|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
160855263|NCT04024891|580859310|FG000|Overall Study|Pregnancy|0|||
160855264|NCT04024891|580859311|FG001|Overall Study|Pregnancy|1|||
160855265|NCT03010527|580859325|FG000|Overall Study|Death|0|||
160855266|NCT03010527|580859326|FG001|Overall Study|Death|0|||
160855267|NCT03010527|580859327|FG002|Overall Study|Death|1|||
160855268|NCT03010527|580859325|FG000|Overall Study|Adverse Event|0|||
160855269|NCT03010527|580859326|FG001|Overall Study|Adverse Event|4|||
160855270|NCT03010527|580859327|FG002|Overall Study|Adverse Event|2|||
160855271|NCT03010527|580859325|FG000|Overall Study|Protocol Violation|0|||
160855272|NCT03010527|580859326|FG001|Overall Study|Protocol Violation|1|||
160855273|NCT03010527|580859327|FG002|Overall Study|Protocol Violation|0|||
160855274|NCT03010527|580859325|FG000|Overall Study|Lost to Follow-up|0|||
160855275|NCT03010527|580859326|FG001|Overall Study|Lost to Follow-up|2|||
160855276|NCT03010527|580859327|FG002|Overall Study|Lost to Follow-up|1|||
160855277|NCT03010527|580859325|FG000|Overall Study|Withdrawal by Subject|0|||
160855278|NCT03010527|580859326|FG001|Overall Study|Withdrawal by Subject|3|||
160855279|NCT03010527|580859327|FG002|Overall Study|Withdrawal by Subject|4|||
160855280|NCT03010527|580859325|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
160855281|NCT03010527|580859326|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
160855282|NCT03010527|580859327|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
160855283|NCT03010527|580859325|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
160855284|NCT03010527|580859326|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
160855285|NCT03010527|580859327|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
160855286|NCT03010527|580859325|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
160855287|NCT03010527|580859326|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
160855288|NCT03010527|580859327|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
160855289|NCT02469623|580859328|FG000|Overall Study|Not consented for long-term follow-up|4|||
160855290|NCT02469623|580859328|FG000|Overall Study|Lost to Follow-up|4|||
160855291|NCT02469623|580859328|FG000|Overall Study|Withdrawal by Subject|2|||
160855292|NCT02469623|580859328|FG000|Overall Study|Death|3|||
160855293|NCT04073186|580859329|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
160855294|NCT04073186|580859329|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
160855295|NCT04073186|580859329|FG000|First Wearing Cycle|Protocol Violation|1|||
160855296|NCT04073186|580859329|FG000|First Wearing Cycle|Lens Discomfort|2|||
160855297|NCT04073186|580859329|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
160855298|NCT04073186|580859329|FG000|Second Wearing Cycle|Adverse Event|1|||
160855299|NCT01096316|580859330|FG000|Overall Study|Lost to Follow-up|15|||
160855300|NCT01096316|580859331|FG001|Overall Study|Lost to Follow-up|9|||
160855301|NCT00473434|580859332|FG000|Overall Study|Physician Decision|3|||
160907708|NCT03095066|581056309|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160907709|NCT03095066|581056310|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160907710|NCT03095066|581056311|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
160569200|NCT02493751|579806995|FG001|Overall Study|Death|13|||
160569201|NCT02493751|579806994|FG000|Overall Study|Lost to Follow-up|2|||
160569202|NCT02493751|579806995|FG001|Overall Study|Lost to Follow-up|3|||
160569203|NCT02493751|579806994|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
160569204|NCT02493751|579806995|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
160907711|NCT03095066|581056312|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160907712|NCT03095066|581056313|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160907713|NCT03095066|581056314|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
160907714|NCT03095066|581056307|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907715|NCT03095066|581056308|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907716|NCT03095066|581056309|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907717|NCT03095066|581056310|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
160907718|NCT03095066|581056311|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907719|NCT03095066|581056312|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
160907720|NCT03095066|581056313|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907721|NCT03095066|581056314|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907722|NCT00160693|581056315|FG000|Overall Study|Adverse Event|97|||
160907723|NCT00160693|581056315|FG000|Overall Study|Lack of Efficacy|30|||
160907724|NCT00160693|581056315|FG000|Overall Study|Protocol Violation|24|||
160907725|NCT00160693|581056315|FG000|Overall Study|Lost to Follow-up|15|||
160907726|NCT00160693|581056315|FG000|Overall Study|Withdrawal by Subject|54|||
160907727|NCT00160693|581056315|FG000|Overall Study|Study terminated by sponsor|15|||
160907728|NCT03052725|581056316|FG000|Overall Study|Adverse Event|2|||
160907729|NCT03052725|581056317|FG001|Overall Study|Adverse Event|0|||
160907730|NCT03052725|581056316|FG000|Overall Study|Withdrawal by Subject|3|||
160907731|NCT03052725|581056317|FG001|Overall Study|Withdrawal by Subject|4|||
160569205|NCT01824602|579806997|FG000|Overall Study|Withdrawal by Subject|0|||
160569206|NCT01824602|579806998|FG001|Overall Study|Withdrawal by Subject|0|||
160855302|NCT00473434|580859332|FG000|Overall Study|Withdrawal by Subject|9|||
160855303|NCT00473434|580859332|FG000|Overall Study|Compliance|3|||
160907732|NCT03052725|581056316|FG000|Overall Study|Pregnancy|0|||
160855304|NCT00473434|580859332|FG000|Overall Study|Lack of Efficacy|3|||
160855305|NCT00473434|580859332|FG000|Overall Study|Adverse Event|3|||
160855306|NCT00473434|580859332|FG000|Overall Study|Patient was selling medication to others|1|||
160907733|NCT03052725|581056317|FG001|Overall Study|Pregnancy|1|||
160907734|NCT03052725|581056316|FG000|Overall Study|Site closure|0|||
160907735|NCT03052725|581056317|FG001|Overall Study|Site closure|1|||
160855307|NCT00473434|580859332|FG000|Overall Study|Safety evaluation|1|||
160855308|NCT00473434|580859332|FG000|Overall Study|Reason not specified|6|||
160855309|NCT00473434|580859332|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
160855310|NCT00473434|580859332|FG000|Overall Study|Switching to trial medication|1|||
160855311|NCT00473434|580859332|FG000|Overall Study|No longer required|1|||
160855312|NCT06418152|580859334|FG000|Overall Study|Frequent DBS setting changes|1|||
160855313|NCT06418152|580859334|FG000|Overall Study|Withdrawal by Subject|2|||
160855314|NCT02529852|580859337|FG000|Overall Study|Withdrawal by Subject|2|||
160855315|NCT02055898|580859338|FG000|First Intervention (5 Days)|Physician Decision|2|||
160855316|NCT02055898|580859339|FG001|First Intervention (5 Days)|Physician Decision|0|||
160855317|NCT02055898|580859338|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
160855318|NCT02055898|580859339|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
160855319|NCT02201524|580859341|FG000|Overall Study|Adverse Event|0|||
160855320|NCT02201524|580859342|FG001|Overall Study|Adverse Event|2|||
160855321|NCT02201524|580859343|FG002|Overall Study|Adverse Event|1|||
160855322|NCT02201524|580859344|FG003|Overall Study|Adverse Event|0|||
160855323|NCT02201524|580859341|FG000|Overall Study|Insufficient clinical response|1|||
160855324|NCT02201524|580859342|FG001|Overall Study|Insufficient clinical response|0|||
160855325|NCT02201524|580859343|FG002|Overall Study|Insufficient clinical response|0|||
160855326|NCT02201524|580859344|FG003|Overall Study|Insufficient clinical response|0|||
160855327|NCT02201524|580859341|FG000|Overall Study|Lost to Follow-up|0|||
160855328|NCT02201524|580859342|FG001|Overall Study|Lost to Follow-up|0|||
160855329|NCT02201524|580859343|FG002|Overall Study|Lost to Follow-up|2|||
160855330|NCT02201524|580859344|FG003|Overall Study|Lost to Follow-up|0|||
160855331|NCT02201524|580859341|FG000|Overall Study|No longer meets eligibility criteria|0|||
160855332|NCT02201524|580859342|FG001|Overall Study|No longer meets eligibility criteria|0|||
160855333|NCT02201524|580859343|FG002|Overall Study|No longer meets eligibility criteria|0|||
160855334|NCT02201524|580859344|FG003|Overall Study|No longer meets eligibility criteria|2|||
160855335|NCT02201524|580859341|FG000|Overall Study|Protocol Violation|0|||
160855336|NCT02201524|580859342|FG001|Overall Study|Protocol Violation|0|||
160855337|NCT02201524|580859343|FG002|Overall Study|Protocol Violation|0|||
160855338|NCT02201524|580859344|FG003|Overall Study|Protocol Violation|1|||
160855339|NCT02201524|580859341|FG000|Overall Study|Withdrawal by Subject|0|||
160855340|NCT02201524|580859342|FG001|Overall Study|Withdrawal by Subject|0|||
160855341|NCT02201524|580859343|FG002|Overall Study|Withdrawal by Subject|1|||
160855342|NCT02201524|580859344|FG003|Overall Study|Withdrawal by Subject|1|||
160855343|NCT02201524|580859341|FG000|Overall Study|Other|1|||
160855344|NCT02201524|580859342|FG001|Overall Study|Other|1|||
160855345|NCT02201524|580859343|FG002|Overall Study|Other|0|||
160855346|NCT02201524|580859344|FG003|Overall Study|Other|0|||
160855347|NCT03206216|580859349|FG000|Overall Study|Withdrawal by Subject|0|||
160855348|NCT03206216|580859350|FG001|Overall Study|Withdrawal by Subject|1|||
160855349|NCT01553084|580859356|FG000|Overall Study|Withdrawal by Subject|15|||
160855350|NCT01553084|580859357|FG001|Overall Study|Withdrawal by Subject|13|||
160855351|NCT01553084|580859358|FG002|Overall Study|Withdrawal by Subject|35|||
160855352|NCT03119259|580859360|FG000|Overall Study|Withdrawn as no longer eligible|1|||
160855353|NCT03119259|580859361|FG001|Overall Study|Withdrawn as no longer eligible|0|||
160855354|NCT03119259|580859360|FG000|Overall Study|Withdrawal by Subject|4|||
160855355|NCT03119259|580859361|FG001|Overall Study|Withdrawal by Subject|2|||
160855356|NCT03119259|580859360|FG000|Overall Study|Lost to Follow-up|0|||
160855357|NCT03119259|580859361|FG001|Overall Study|Lost to Follow-up|1|||
160855358|NCT00539981|580859368|FG000|Overall Study|Adverse events (AE)|3|||
160855359|NCT00539981|580859369|FG001|Overall Study|Adverse events (AE)|3|||
160855360|NCT00539981|580859368|FG000|Overall Study|Lost to Follow-up|260|||
160855361|NCT00539981|580859369|FG001|Overall Study|Lost to Follow-up|251|||
160855362|NCT00539981|580859368|FG000|Overall Study|Withdrew consent|22|||
160855363|NCT00539981|580859369|FG001|Overall Study|Withdrew consent|14|||
160855364|NCT00539981|580859368|FG000|Overall Study|Death|1|||
160855365|NCT00539981|580859369|FG001|Overall Study|Death|1|||
160855366|NCT00539981|580859368|FG000|Overall Study|Other reason-unspecified|9|||
160855367|NCT00539981|580859369|FG001|Overall Study|Other reason-unspecified|13|||
160855368|NCT01759420|580859370|FG000|Overall Study|Screen failure|5|||
160855369|NCT01759420|580859370|FG000|Overall Study|Inaccurate EKG machine readings|1|||
160855370|NCT01129622|580859371|FG000|Overall Study|Withdrawal by Subject|2|||
160855371|NCT02051764|580859372|FG000|Overall Study|Study terminated by sponsor|0|||
160855372|NCT02051764|580859373|FG001|Overall Study|Study terminated by sponsor|7|||
160907736|NCT03052725|581056316|FG000|Overall Study|Study terminated by sponsor|143|||
160907737|NCT03052725|581056317|FG001|Overall Study|Study terminated by sponsor|144|||
160907738|NCT01471171|581056320|FG000|Treatment Period 1|Adverse Event|4|||
160907739|NCT01471171|581056321|FG001|Treatment Period 1|Adverse Event|1|||
160569207|NCT01824602|579806999|FG002|Overall Study|Withdrawal by Subject|1|||
160855373|NCT00591006|580859374|FG000|Overall Study|Withdrawal by Subject|0|||
160855374|NCT00591006|580859375|FG001|Overall Study|Withdrawal by Subject|0|||
160855375|NCT00591006|580859376|FG002|Overall Study|Withdrawal by Subject|0|||
160855376|NCT00591006|580859377|FG003|Overall Study|Withdrawal by Subject|0|||
160855377|NCT00591006|580859378|FG004|Overall Study|Withdrawal by Subject|0|||
160855378|NCT00591006|580859379|FG005|Overall Study|Withdrawal by Subject|0|||
160855379|NCT00591006|580859380|FG006|Overall Study|Withdrawal by Subject|0|||
160855380|NCT00591006|580859381|FG007|Overall Study|Withdrawal by Subject|0|||
160855381|NCT00591006|580859382|FG008|Overall Study|Withdrawal by Subject|0|||
160855382|NCT00591006|580859383|FG009|Overall Study|Withdrawal by Subject|0|||
160855383|NCT00591006|580859384|FG010|Overall Study|Withdrawal by Subject|0|||
160855384|NCT00591006|580859385|FG011|Overall Study|Withdrawal by Subject|0|||
160855385|NCT00591006|580859386|FG012|Overall Study|Withdrawal by Subject|0|||
160855386|NCT00591006|580859387|FG013|Overall Study|Withdrawal by Subject|0|||
160855387|NCT00591006|580859388|FG014|Overall Study|Withdrawal by Subject|0|||
160855388|NCT00591006|580859389|FG015|Overall Study|Withdrawal by Subject|1|||
160855389|NCT00591006|580859390|FG016|Overall Study|Withdrawal by Subject|0|||
160855390|NCT00591006|580859391|FG017|Overall Study|Withdrawal by Subject|0|||
160855391|NCT00591006|580859392|FG018|Overall Study|Withdrawal by Subject|0|||
160855392|NCT00591006|580859393|FG019|Overall Study|Withdrawal by Subject|0|||
160855393|NCT00591006|580859394|FG020|Overall Study|Withdrawal by Subject|0|||
160855394|NCT00591006|580859395|FG021|Overall Study|Withdrawal by Subject|0|||
160855395|NCT00591006|580859396|FG022|Overall Study|Withdrawal by Subject|0|||
160855396|NCT00591006|580859397|FG023|Overall Study|Withdrawal by Subject|1|||
160855397|NCT00591006|580859374|FG000|Overall Study|Adverse Event|0|||
160855398|NCT00591006|580859375|FG001|Overall Study|Adverse Event|0|||
160855399|NCT00591006|580859376|FG002|Overall Study|Adverse Event|0|||
160855400|NCT00591006|580859377|FG003|Overall Study|Adverse Event|0|||
160855401|NCT00591006|580859378|FG004|Overall Study|Adverse Event|0|||
160855402|NCT00591006|580859379|FG005|Overall Study|Adverse Event|0|||
160907740|NCT01471171|581056320|FG000|Treatment Period 2|Adverse Event|1|||
160907741|NCT01471171|581056321|FG001|Treatment Period 2|Adverse Event|0|||
160907742|NCT03851705|581056322|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
160907743|NCT03851705|581056323|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
160907744|NCT03851705|581056324|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
160907745|NCT03851705|581056325|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
160907746|NCT03851705|581056322|FG000|Part 1: Double-Blind Period|Other reason|1|||
160907747|NCT03851705|581056323|FG001|Part 1: Double-Blind Period|Other reason|0|||
160907748|NCT03851705|581056324|FG002|Part 1: Double-Blind Period|Other reason|0|||
160907749|NCT03851705|581056325|FG003|Part 1: Double-Blind Period|Other reason|0|||
160907750|NCT03851705|581056322|FG000|Part 2: Open-Label Period|Other reason|0|||
160907751|NCT03851705|581056323|FG001|Part 2: Open-Label Period|Other reason|0|||
160907752|NCT03851705|581056324|FG002|Part 2: Open-Label Period|Other reason|0|||
160907753|NCT03851705|581056325|FG003|Part 2: Open-Label Period|Other reason|1|||
160907754|NCT03851705|581056322|FG000|Part 2: Open-Label Period|Death|0|||
160907755|NCT03851705|581056323|FG001|Part 2: Open-Label Period|Death|0|||
160907756|NCT03851705|581056324|FG002|Part 2: Open-Label Period|Death|3|||
160907757|NCT03851705|581056325|FG003|Part 2: Open-Label Period|Death|0|||
160907758|NCT03851705|581056322|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
160907759|NCT03851705|581056323|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
160907760|NCT03851705|581056324|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
160907761|NCT03851705|581056325|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
160907762|NCT03208244|581056329|FG000|Overall Study|Death|1|||
160907763|NCT04431453|581056330|FG000|Overall Study|Withdrew Consent|0|||
160907764|NCT04431453|581056331|FG001|Overall Study|Withdrew Consent|1|||
160907765|NCT04431453|581056332|FG002|Overall Study|Withdrew Consent|0|||
160907766|NCT04431453|581056333|FG003|Overall Study|Withdrew Consent|2|||
160907767|NCT04431453|581056334|FG004|Overall Study|Withdrew Consent|0|||
160907768|NCT04431453|581056335|FG005|Overall Study|Withdrew Consent|0|||
160907769|NCT04431453|581056336|FG006|Overall Study|Withdrew Consent|0|||
160907770|NCT04431453|581056337|FG007|Overall Study|Withdrew Consent|0|||
160907771|NCT04431453|581056330|FG000|Overall Study|Death|1|||
160907772|NCT04431453|581056331|FG001|Overall Study|Death|0|||
160907773|NCT04431453|581056332|FG002|Overall Study|Death|0|||
160907774|NCT04431453|581056333|FG003|Overall Study|Death|0|||
160907775|NCT04431453|581056334|FG004|Overall Study|Death|0|||
160907776|NCT04431453|581056335|FG005|Overall Study|Death|0|||
160907777|NCT04431453|581056336|FG006|Overall Study|Death|0|||
160907778|NCT04431453|581056337|FG007|Overall Study|Death|1|||
160907779|NCT04431453|581056330|FG000|Overall Study|Lost to Follow-up|0|||
160907780|NCT04431453|581056331|FG001|Overall Study|Lost to Follow-up|0|||
160907781|NCT04431453|581056332|FG002|Overall Study|Lost to Follow-up|1|||
160907782|NCT04431453|581056333|FG003|Overall Study|Lost to Follow-up|1|||
160907783|NCT04431453|581056334|FG004|Overall Study|Lost to Follow-up|0|||
160907784|NCT04431453|581056335|FG005|Overall Study|Lost to Follow-up|0|||
160907785|NCT04431453|581056336|FG006|Overall Study|Lost to Follow-up|0|||
160907786|NCT04431453|581056337|FG007|Overall Study|Lost to Follow-up|0|||
160907787|NCT04431453|581056330|FG000|Overall Study|Enrolled but Never Treated|0|||
160855403|NCT00591006|580859380|FG006|Overall Study|Adverse Event|0|||
160855404|NCT00591006|580859381|FG007|Overall Study|Adverse Event|0|||
160855405|NCT00591006|580859382|FG008|Overall Study|Adverse Event|0|||
160855406|NCT00591006|580859383|FG009|Overall Study|Adverse Event|0|||
160855407|NCT00591006|580859384|FG010|Overall Study|Adverse Event|0|||
160907788|NCT04431453|581056331|FG001|Overall Study|Enrolled but Never Treated|0|||
160993285|NCT02001623|581365334|FG012|Overall Study|Adverse Event|3|||
160993286|NCT02001623|581365335|FG013|Overall Study|Adverse Event|5|||
160993287|NCT02001623|581365336|FG014|Overall Study|Adverse Event|6|||
160993288|NCT02001623|581365322|FG000|Overall Study|Other - Miscellaneous|0|||
160993289|NCT02001623|581365323|FG001|Overall Study|Other - Miscellaneous|0|||
160993290|NCT02001623|581365324|FG002|Overall Study|Other - Miscellaneous|0|||
160993291|NCT02001623|581365325|FG003|Overall Study|Other - Miscellaneous|0|||
160993292|NCT02001623|581365326|FG004|Overall Study|Other - Miscellaneous|0|||
160993293|NCT02001623|581365327|FG005|Overall Study|Other - Miscellaneous|0|||
160993294|NCT02001623|581365328|FG006|Overall Study|Other - Miscellaneous|0|||
160993295|NCT02001623|581365329|FG007|Overall Study|Other - Miscellaneous|0|||
160993296|NCT02001623|581365330|FG008|Overall Study|Other - Miscellaneous|0|||
160993297|NCT02001623|581365331|FG009|Overall Study|Other - Miscellaneous|1|||
160993298|NCT02001623|581365332|FG010|Overall Study|Other - Miscellaneous|0|||
160993299|NCT02001623|581365333|FG011|Overall Study|Other - Miscellaneous|0|||
160993300|NCT02001623|581365334|FG012|Overall Study|Other - Miscellaneous|0|||
160993301|NCT02001623|581365335|FG013|Overall Study|Other - Miscellaneous|1|||
160993302|NCT02001623|581365336|FG014|Overall Study|Other - Miscellaneous|0|||
160993303|NCT02001623|581365322|FG000|Overall Study|Withdrawal by Subject|1|||
160993304|NCT02001623|581365323|FG001|Overall Study|Withdrawal by Subject|0|||
160993305|NCT02001623|581365324|FG002|Overall Study|Withdrawal by Subject|0|||
160993306|NCT02001623|581365325|FG003|Overall Study|Withdrawal by Subject|0|||
160993307|NCT02001623|581365326|FG004|Overall Study|Withdrawal by Subject|0|||
160993308|NCT02001623|581365327|FG005|Overall Study|Withdrawal by Subject|0|||
160993309|NCT02001623|581365328|FG006|Overall Study|Withdrawal by Subject|0|||
160993310|NCT02001623|581365329|FG007|Overall Study|Withdrawal by Subject|0|||
160993311|NCT02001623|581365330|FG008|Overall Study|Withdrawal by Subject|1|||
160993312|NCT02001623|581365331|FG009|Overall Study|Withdrawal by Subject|3|||
160993313|NCT02001623|581365332|FG010|Overall Study|Withdrawal by Subject|2|||
160993314|NCT02001623|581365333|FG011|Overall Study|Withdrawal by Subject|2|||
160993315|NCT02001623|581365334|FG012|Overall Study|Withdrawal by Subject|1|||
160993316|NCT02001623|581365335|FG013|Overall Study|Withdrawal by Subject|5|||
160993317|NCT02001623|581365336|FG014|Overall Study|Withdrawal by Subject|2|||
160993318|NCT02001623|581365322|FG000|Overall Study|Lost to Follow-up|0|||
160993319|NCT02001623|581365323|FG001|Overall Study|Lost to Follow-up|0|||
160993320|NCT02001623|581365324|FG002|Overall Study|Lost to Follow-up|0|||
160993321|NCT02001623|581365325|FG003|Overall Study|Lost to Follow-up|0|||
160993322|NCT02001623|581365326|FG004|Overall Study|Lost to Follow-up|0|||
160993323|NCT02001623|581365327|FG005|Overall Study|Lost to Follow-up|0|||
160993324|NCT02001623|581365328|FG006|Overall Study|Lost to Follow-up|0|||
160993325|NCT02001623|581365329|FG007|Overall Study|Lost to Follow-up|0|||
160993326|NCT02001623|581365330|FG008|Overall Study|Lost to Follow-up|0|||
160855408|NCT00591006|580859385|FG011|Overall Study|Adverse Event|0|||
160855409|NCT00591006|580859386|FG012|Overall Study|Adverse Event|0|||
160855410|NCT00591006|580859387|FG013|Overall Study|Adverse Event|0|||
160569208|NCT01824602|579807000|FG003|Overall Study|Withdrawal by Subject|2|||
160569209|NCT01824602|579806997|FG000|Overall Study|Patient non-compliance|0|||
160569210|NCT01824602|579806998|FG001|Overall Study|Patient non-compliance|0|||
160855411|NCT00591006|580859388|FG014|Overall Study|Adverse Event|0|||
160855412|NCT00591006|580859389|FG015|Overall Study|Adverse Event|0|||
160855413|NCT00591006|580859390|FG016|Overall Study|Adverse Event|0|||
160855414|NCT00591006|580859391|FG017|Overall Study|Adverse Event|0|||
160855415|NCT00591006|580859392|FG018|Overall Study|Adverse Event|0|||
160855416|NCT00591006|580859393|FG019|Overall Study|Adverse Event|0|||
160855417|NCT00591006|580859394|FG020|Overall Study|Adverse Event|0|||
160855418|NCT00591006|580859395|FG021|Overall Study|Adverse Event|0|||
160855419|NCT00591006|580859396|FG022|Overall Study|Adverse Event|1|||
160855420|NCT00591006|580859397|FG023|Overall Study|Adverse Event|0|||
160855421|NCT01384734|580859399|FG000|Overall Study|Adverse Event|0|||
160855422|NCT01384734|580859400|FG001|Overall Study|Adverse Event|3|||
160569211|NCT01824602|579806999|FG002|Overall Study|Patient non-compliance|1|||
160569212|NCT01824602|579807000|FG003|Overall Study|Patient non-compliance|0|||
160569213|NCT01824602|579806997|FG000|Overall Study|Adverse Event|1|||
160569214|NCT01824602|579806998|FG001|Overall Study|Adverse Event|0|||
160993327|NCT02001623|581365331|FG009|Overall Study|Lost to Follow-up|1|||
160993328|NCT02001623|581365332|FG010|Overall Study|Lost to Follow-up|0|||
160993329|NCT02001623|581365333|FG011|Overall Study|Lost to Follow-up|0|||
160993330|NCT02001623|581365334|FG012|Overall Study|Lost to Follow-up|0|||
160993331|NCT02001623|581365335|FG013|Overall Study|Lost to Follow-up|0|||
160993332|NCT02001623|581365336|FG014|Overall Study|Lost to Follow-up|0|||
160993333|NCT02001623|581365322|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
160993334|NCT02001623|581365323|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
160993335|NCT02001623|581365324|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
160855423|NCT01384734|580859401|FG002|Overall Study|Adverse Event|0|||
160855424|NCT01384734|580859402|FG003|Overall Study|Adverse Event|2|||
160993336|NCT02001623|581365325|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
160993337|NCT02001623|581365326|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
160855425|NCT01384734|580859403|FG004|Overall Study|Adverse Event|7|||
160855426|NCT01384734|580859399|FG000|Overall Study|Death|1|||
160855427|NCT01384734|580859400|FG001|Overall Study|Death|0|||
160855428|NCT01384734|580859401|FG002|Overall Study|Death|1|||
160855429|NCT01384734|580859402|FG003|Overall Study|Death|0|||
160855430|NCT01384734|580859403|FG004|Overall Study|Death|0|||
160855431|NCT01384734|580859399|FG000|Overall Study|Continuation criteria not met|0|||
160855432|NCT01384734|580859400|FG001|Overall Study|Continuation criteria not met|0|||
160855433|NCT01384734|580859401|FG002|Overall Study|Continuation criteria not met|1|||
160855434|NCT01384734|580859402|FG003|Overall Study|Continuation criteria not met|1|||
160855435|NCT01384734|580859403|FG004|Overall Study|Continuation criteria not met|0|||
160855436|NCT01384734|580859399|FG000|Overall Study|Lack of Efficacy|3|||
160855437|NCT01384734|580859400|FG001|Overall Study|Lack of Efficacy|7|||
160855438|NCT01384734|580859401|FG002|Overall Study|Lack of Efficacy|4|||
160855439|NCT01384734|580859402|FG003|Overall Study|Lack of Efficacy|4|||
160855440|NCT01384734|580859403|FG004|Overall Study|Lack of Efficacy|2|||
160855441|NCT01384734|580859399|FG000|Overall Study|Lost to Follow-up|5|||
160855442|NCT01384734|580859400|FG001|Overall Study|Lost to Follow-up|3|||
160855443|NCT01384734|580859401|FG002|Overall Study|Lost to Follow-up|3|||
160855444|NCT01384734|580859402|FG003|Overall Study|Lost to Follow-up|8|||
160855445|NCT01384734|580859403|FG004|Overall Study|Lost to Follow-up|5|||
160855446|NCT01384734|580859399|FG000|Overall Study|Non-compliance with study drug|1|||
160855447|NCT01384734|580859400|FG001|Overall Study|Non-compliance with study drug|2|||
160855448|NCT01384734|580859401|FG002|Overall Study|Non-compliance with study drug|6|||
160855449|NCT01384734|580859402|FG003|Overall Study|Non-compliance with study drug|0|||
160855450|NCT01384734|580859403|FG004|Overall Study|Non-compliance with study drug|2|||
160855451|NCT01384734|580859399|FG000|Overall Study|Pregnancy|0|||
160855452|NCT01384734|580859400|FG001|Overall Study|Pregnancy|1|||
160907789|NCT04431453|581056332|FG002|Overall Study|Enrolled but Never Treated|0|||
160907790|NCT04431453|581056333|FG003|Overall Study|Enrolled but Never Treated|0|||
160907791|NCT04431453|581056334|FG004|Overall Study|Enrolled but Never Treated|1|||
160907792|NCT04431453|581056335|FG005|Overall Study|Enrolled but Never Treated|0|||
160907793|NCT04431453|581056336|FG006|Overall Study|Enrolled but Never Treated|0|||
160907794|NCT04431453|581056337|FG007|Overall Study|Enrolled but Never Treated|0|||
160907795|NCT03385564|581056338|FG000|Overall Study|Adverse Event|0|||
160907796|NCT03385564|581056339|FG001|Overall Study|Adverse Event|0|||
160907797|NCT03385564|581056340|FG002|Overall Study|Adverse Event|3|||
160907798|NCT03385564|581056341|FG003|Overall Study|Adverse Event|3|||
160907799|NCT03385564|581056338|FG000|Overall Study|Other than listed|0|||
160907800|NCT03385564|581056339|FG001|Overall Study|Other than listed|0|||
160907801|NCT03385564|581056340|FG002|Overall Study|Other than listed|0|||
160907802|NCT03385564|581056341|FG003|Overall Study|Other than listed|5|||
160907803|NCT03385564|581056338|FG000|Overall Study|Withdrawal by Subject|0|||
160907804|NCT03385564|581056339|FG001|Overall Study|Withdrawal by Subject|1|||
160907805|NCT03385564|581056340|FG002|Overall Study|Withdrawal by Subject|1|||
160907806|NCT03385564|581056341|FG003|Overall Study|Withdrawal by Subject|0|||
160907807|NCT03385564|581056338|FG000|Overall Study|Lack of Efficacy|0|||
160907808|NCT03385564|581056339|FG001|Overall Study|Lack of Efficacy|0|||
160907809|NCT03385564|581056340|FG002|Overall Study|Lack of Efficacy|0|||
160907810|NCT03385564|581056341|FG003|Overall Study|Lack of Efficacy|1|||
160907811|NCT03385564|581056338|FG000|Overall Study|Death|0|||
160907812|NCT03385564|581056339|FG001|Overall Study|Death|0|||
160907813|NCT03385564|581056340|FG002|Overall Study|Death|1|||
160907814|NCT03385564|581056341|FG003|Overall Study|Death|0|||
160907815|NCT02021773|581056357|FG000|Overall Study|Adverse Event|1|||
160907816|NCT02021773|581056358|FG001|Overall Study|Adverse Event|4|||
160855453|NCT01384734|580859401|FG002|Overall Study|Pregnancy|0|||
160907817|NCT02021773|581056359|FG002|Overall Study|Adverse Event|3|||
160907818|NCT02021773|581056357|FG000|Overall Study|Lack of Efficacy|2|||
160907819|NCT02021773|581056358|FG001|Overall Study|Lack of Efficacy|2|||
160907820|NCT02021773|581056359|FG002|Overall Study|Lack of Efficacy|2|||
160907821|NCT02021773|581056357|FG000|Overall Study|Protocol Violation|2|||
160907822|NCT02021773|581056358|FG001|Overall Study|Protocol Violation|3|||
160907823|NCT02021773|581056359|FG002|Overall Study|Protocol Violation|1|||
160907824|NCT02021773|581056357|FG000|Overall Study|Withdrawal by Subject|3|||
160907825|NCT02021773|581056358|FG001|Overall Study|Withdrawal by Subject|4|||
160907826|NCT02021773|581056359|FG002|Overall Study|Withdrawal by Subject|5|||
160907827|NCT02021773|581056357|FG000|Overall Study|Lost to Follow-up|1|||
160907828|NCT02021773|581056358|FG001|Overall Study|Lost to Follow-up|3|||
160907829|NCT02021773|581056359|FG002|Overall Study|Lost to Follow-up|0|||
160907830|NCT02021773|581056357|FG000|Overall Study|Reason not specified|3|||
160653440|NCT02581345|580112381|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
160855454|NCT01384734|580859402|FG003|Overall Study|Pregnancy|0|||
160855455|NCT01384734|580859403|FG004|Overall Study|Pregnancy|1|||
160855456|NCT01384734|580859399|FG000|Overall Study|Sponsor terminated|0|||
160855457|NCT01384734|580859400|FG001|Overall Study|Sponsor terminated|0|||
160855458|NCT01384734|580859401|FG002|Overall Study|Sponsor terminated|0|||
160855459|NCT01384734|580859402|FG003|Overall Study|Sponsor terminated|0|||
160855460|NCT01384734|580859403|FG004|Overall Study|Sponsor terminated|1|||
160855461|NCT01384734|580859399|FG000|Overall Study|Withdrawal by Subject|5|||
160855462|NCT01384734|580859400|FG001|Overall Study|Withdrawal by Subject|5|||
160855463|NCT01384734|580859401|FG002|Overall Study|Withdrawal by Subject|6|||
160855464|NCT01384734|580859402|FG003|Overall Study|Withdrawal by Subject|7|||
160855465|NCT01384734|580859403|FG004|Overall Study|Withdrawal by Subject|9|||
160855466|NCT01384734|580859399|FG000|Overall Study|Investigator relocating|0|||
160855467|NCT01384734|580859400|FG001|Overall Study|Investigator relocating|2|||
160855468|NCT01384734|580859401|FG002|Overall Study|Investigator relocating|0|||
160855469|NCT01384734|580859402|FG003|Overall Study|Investigator relocating|3|||
160855470|NCT01384734|580859403|FG004|Overall Study|Investigator relocating|1|||
160855471|NCT01384734|580859399|FG000|Overall Study|Unable to come back for visit|1|||
160855472|NCT01384734|580859400|FG001|Overall Study|Unable to come back for visit|0|||
160855473|NCT01384734|580859401|FG002|Overall Study|Unable to come back for visit|1|||
160855474|NCT01384734|580859402|FG003|Overall Study|Unable to come back for visit|1|||
160855475|NCT01384734|580859403|FG004|Overall Study|Unable to come back for visit|0|||
160855476|NCT01384734|580859399|FG000|Overall Study|Prison|0|||
160855477|NCT01384734|580859400|FG001|Overall Study|Prison|0|||
160855478|NCT01384734|580859401|FG002|Overall Study|Prison|1|||
160855479|NCT01384734|580859402|FG003|Overall Study|Prison|0|||
160855480|NCT01384734|580859403|FG004|Overall Study|Prison|0|||
160855481|NCT01384734|580859399|FG000|Overall Study|As per Exclusion criteria|0|||
160855482|NCT01384734|580859400|FG001|Overall Study|As per Exclusion criteria|1|||
160855483|NCT01384734|580859401|FG002|Overall Study|As per Exclusion criteria|0|||
160855484|NCT01384734|580859402|FG003|Overall Study|As per Exclusion criteria|0|||
160855485|NCT01384734|580859403|FG004|Overall Study|As per Exclusion criteria|0|||
160855486|NCT01384734|580859399|FG000|Overall Study|Missed End of treatment visit|0|||
160855487|NCT01384734|580859400|FG001|Overall Study|Missed End of treatment visit|0|||
160855488|NCT01384734|580859401|FG002|Overall Study|Missed End of treatment visit|0|||
160907831|NCT02021773|581056358|FG001|Overall Study|Reason not specified|0|||
160907832|NCT02021773|581056359|FG002|Overall Study|Reason not specified|0|||
160907833|NCT01253408|581056364|FG000|Overall Study|Adverse Event|0|||
160907834|NCT01253408|581056365|FG001|Overall Study|Adverse Event|1|||
160907835|NCT01253408|581056366|FG002|Overall Study|Adverse Event|0|||
160907836|NCT03408483|581056367|FG000|Overall Study|Physician Decision|3|||
160907837|NCT03408483|581056368|FG001|Overall Study|Physician Decision|3|||
160907838|NCT03408483|581056367|FG000|Overall Study|Lost to Follow-up|3|||
160907839|NCT03408483|581056368|FG001|Overall Study|Lost to Follow-up|0|||
160907840|NCT00478231|581056369|FG000|Overall Study|Death|7|||
160907841|NCT00478231|581056369|FG000|Overall Study|Lack of Efficacy|47|||
160907842|NCT00478231|581056369|FG000|Overall Study|Lost to Follow-up|7|||
160907843|NCT00478231|581056369|FG000|Overall Study|Withdrawal by Subject|6|||
160907844|NCT00478231|581056369|FG000|Overall Study|Other|9|||
160907845|NCT00478231|581056369|FG000|Overall Study|Adverse Event|5|||
160907846|NCT00478231|581056369|FG000|Overall Study|Randomized, not treated|3|||
160907847|NCT01702961|581056370|FG000|Overall Study|Additional treatment|3|||
160907848|NCT01702961|581056370|FG000|Overall Study|Progressive disease|5|||
160907849|NCT01702961|581056370|FG000|Overall Study|Relapse|20|||
160907850|NCT01702961|581056370|FG000|Overall Study|Death|6|||
160907851|NCT01702961|581056370|FG000|Overall Study|Lost to Follow-up|2|||
160907852|NCT01702961|581056370|FG000|Overall Study|Ongoing|11|||
160907853|NCT03724032|581056371|FG000|Overall Study|Physician Decision|1|||
160907854|NCT03724032|581056372|FG001|Overall Study|Physician Decision|0|||
160907855|NCT03724032|581056373|FG002|Overall Study|Physician Decision|0|||
160907856|NCT03724032|581056371|FG000|Overall Study|Protocol Violation|2|||
160907857|NCT03724032|581056372|FG001|Overall Study|Protocol Violation|2|||
160907858|NCT03724032|581056373|FG002|Overall Study|Protocol Violation|1|||
160907859|NCT00751933|581056374|FG000|Overall Study|Withdrawal by Subject|0|||
160907860|NCT00751933|581056375|FG001|Overall Study|Withdrawal by Subject|1|||
160907861|NCT00751933|581056376|FG002|Overall Study|Withdrawal by Subject|0|||
160907862|NCT00751933|581056377|FG003|Overall Study|Withdrawal by Subject|0|||
160907863|NCT00751933|581056374|FG000|Overall Study|Physician Decision|0|||
160907864|NCT00751933|581056375|FG001|Overall Study|Physician Decision|0|||
160907865|NCT00751933|581056376|FG002|Overall Study|Physician Decision|1|||
160907866|NCT00751933|581056377|FG003|Overall Study|Physician Decision|1|||
160907867|NCT01817530|581056379|FG000|Overall Study|Exclusionary Medication Received|0|||
160569215|NCT01824602|579806999|FG002|Overall Study|Adverse Event|2|||
160855489|NCT01384734|580859402|FG003|Overall Study|Missed End of treatment visit|1|||
160907868|NCT01817530|581056380|FG001|Overall Study|Exclusionary Medication Received|0|||
160907869|NCT01817530|581056381|FG002|Overall Study|Exclusionary Medication Received|0|||
160907870|NCT01817530|581056382|FG003|Overall Study|Exclusionary Medication Received|0|||
160907871|NCT01817530|581056383|FG004|Overall Study|Exclusionary Medication Received|1|||
160907872|NCT01817530|581056384|FG005|Overall Study|Exclusionary Medication Received|0|||
160569216|NCT01824602|579807000|FG003|Overall Study|Adverse Event|2|||
160569217|NCT01824602|579806997|FG000|Overall Study|Treatment failure|0|||
160907873|NCT01817530|581056385|FG006|Overall Study|Exclusionary Medication Received|0|||
160907874|NCT01817530|581056386|FG007|Overall Study|Exclusionary Medication Received|0|||
160907875|NCT01817530|581056379|FG000|Overall Study|Adverse Event|6|||
160855490|NCT01384734|580859403|FG004|Overall Study|Missed End of treatment visit|0|||
160855491|NCT01384734|580859399|FG000|Overall Study|Adhesion problem|0|||
160855492|NCT01384734|580859400|FG001|Overall Study|Adhesion problem|0|||
160855493|NCT01384734|580859401|FG002|Overall Study|Adhesion problem|0|||
160855494|NCT01384734|580859402|FG003|Overall Study|Adhesion problem|1|||
160855495|NCT01384734|580859403|FG004|Overall Study|Adhesion problem|0|||
160855496|NCT01384734|580859399|FG000|Overall Study|Early termination|0|||
160855497|NCT01384734|580859400|FG001|Overall Study|Early termination|0|||
160855498|NCT01384734|580859401|FG002|Overall Study|Early termination|0|||
160855499|NCT01384734|580859402|FG003|Overall Study|Early termination|0|||
160855500|NCT01384734|580859403|FG004|Overall Study|Early termination|1|||
160855501|NCT01384734|580859399|FG000|Overall Study|Physician Decision|1|||
160855502|NCT01384734|580859400|FG001|Overall Study|Physician Decision|0|||
160855503|NCT01384734|580859401|FG002|Overall Study|Physician Decision|0|||
160855504|NCT01384734|580859402|FG003|Overall Study|Physician Decision|0|||
160855505|NCT01384734|580859403|FG004|Overall Study|Physician Decision|0|||
160855506|NCT03071263|580859404|FG000|Overall Study|Adverse Event|1|||
160855507|NCT03071263|580859405|FG001|Overall Study|Adverse Event|3|||
160855508|NCT03071263|580859404|FG000|Overall Study|Withdrawal by Subject|1|||
160855509|NCT03071263|580859405|FG001|Overall Study|Withdrawal by Subject|3|||
160855510|NCT03071263|580859404|FG000|Overall Study|Physician Decision|1|||
160855511|NCT03071263|580859405|FG001|Overall Study|Physician Decision|0|||
160855512|NCT03071263|580859404|FG000|Overall Study|Participant moved to another city|0|||
160855513|NCT03071263|580859405|FG001|Overall Study|Participant moved to another city|1|||
160855514|NCT00647296|580859410|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
160855515|NCT00647296|580859411|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
160855516|NCT00647296|580859412|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
160855517|NCT00647296|580859413|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
160855518|NCT00647296|580859410|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
160855519|NCT00647296|580859411|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
160855520|NCT00647296|580859412|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
160855521|NCT00647296|580859413|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
160855522|NCT00647296|580859410|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
160855523|NCT00647296|580859411|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
160855524|NCT00647296|580859412|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
160855525|NCT00647296|580859413|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
160855526|NCT00647296|580859410|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
160855527|NCT00647296|580859411|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
160855528|NCT00647296|580859412|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
160855529|NCT00647296|580859413|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
160855530|NCT00647296|580859410|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
160855531|NCT00647296|580859411|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
160855532|NCT00647296|580859412|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
160855533|NCT00647296|580859413|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
160855534|NCT00647296|580859410|FG000|Part 2: 4-week Placebo Washout|Death|3|||
160855535|NCT00647296|580859411|FG001|Part 2: 4-week Placebo Washout|Death|0|||
160855536|NCT00647296|580859412|FG002|Part 2: 4-week Placebo Washout|Death|0|||
160855537|NCT00647296|580859413|FG003|Part 2: 4-week Placebo Washout|Death|0|||
160907876|NCT01817530|581056380|FG001|Overall Study|Adverse Event|3|||
160907877|NCT01817530|581056381|FG002|Overall Study|Adverse Event|2|||
160907878|NCT01817530|581056382|FG003|Overall Study|Adverse Event|5|||
160907879|NCT01817530|581056383|FG004|Overall Study|Adverse Event|0|||
160907880|NCT01817530|581056384|FG005|Overall Study|Adverse Event|10|||
160907881|NCT01817530|581056385|FG006|Overall Study|Adverse Event|5|||
160907882|NCT01817530|581056386|FG007|Overall Study|Adverse Event|8|||
160907883|NCT01817530|581056379|FG000|Overall Study|Subject Noncompliant|3|||
160907884|NCT01817530|581056380|FG001|Overall Study|Subject Noncompliant|1|||
160907885|NCT01817530|581056381|FG002|Overall Study|Subject Noncompliant|0|||
160907886|NCT01817530|581056382|FG003|Overall Study|Subject Noncompliant|4|||
160907887|NCT01817530|581056383|FG004|Overall Study|Subject Noncompliant|0|||
160907888|NCT01817530|581056384|FG005|Overall Study|Subject Noncompliant|1|||
160993338|NCT02001623|581365327|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
160653441|NCT02581345|580112382|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
160855538|NCT00647296|580859410|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
160855539|NCT00647296|580859411|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
160855540|NCT00647296|580859412|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
160855541|NCT00647296|580859413|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
160855542|NCT00647296|580859410|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
160907889|NCT01817530|581056385|FG006|Overall Study|Subject Noncompliant|1|||
160907890|NCT01817530|581056386|FG007|Overall Study|Subject Noncompliant|1|||
160907891|NCT01817530|581056379|FG000|Overall Study|Lack of Efficacy|1|||
160907892|NCT01817530|581056380|FG001|Overall Study|Lack of Efficacy|0|||
160907893|NCT01817530|581056381|FG002|Overall Study|Lack of Efficacy|0|||
160907894|NCT01817530|581056382|FG003|Overall Study|Lack of Efficacy|0|||
160907895|NCT01817530|581056383|FG004|Overall Study|Lack of Efficacy|0|||
160907896|NCT01817530|581056384|FG005|Overall Study|Lack of Efficacy|1|||
160907897|NCT01817530|581056385|FG006|Overall Study|Lack of Efficacy|0|||
160907898|NCT01817530|581056386|FG007|Overall Study|Lack of Efficacy|1|||
160907899|NCT01817530|581056379|FG000|Overall Study|Pregnancy|0|||
160907900|NCT01817530|581056380|FG001|Overall Study|Pregnancy|0|||
160907901|NCT01817530|581056381|FG002|Overall Study|Pregnancy|0|||
160907902|NCT01817530|581056382|FG003|Overall Study|Pregnancy|0|||
160907903|NCT01817530|581056383|FG004|Overall Study|Pregnancy|0|||
160907904|NCT01817530|581056384|FG005|Overall Study|Pregnancy|1|||
160907905|NCT01817530|581056385|FG006|Overall Study|Pregnancy|0|||
160907906|NCT01817530|581056386|FG007|Overall Study|Pregnancy|0|||
160907907|NCT01817530|581056379|FG000|Overall Study|Other|0|||
160907908|NCT01817530|581056380|FG001|Overall Study|Other|1|||
160907909|NCT01817530|581056381|FG002|Overall Study|Other|0|||
160907910|NCT01817530|581056382|FG003|Overall Study|Other|0|||
160907911|NCT01817530|581056383|FG004|Overall Study|Other|1|||
160907912|NCT01817530|581056384|FG005|Overall Study|Other|0|||
160907913|NCT01817530|581056385|FG006|Overall Study|Other|5|||
160907914|NCT01817530|581056386|FG007|Overall Study|Other|0|||
160907915|NCT01817530|581056379|FG000|Overall Study|Surgery or Invasive Intervention|1|||
160907916|NCT01817530|581056380|FG001|Overall Study|Surgery or Invasive Intervention|0|||
160907917|NCT01817530|581056381|FG002|Overall Study|Surgery or Invasive Intervention|0|||
160907918|NCT01817530|581056382|FG003|Overall Study|Surgery or Invasive Intervention|0|||
160907919|NCT01817530|581056383|FG004|Overall Study|Surgery or Invasive Intervention|1|||
160907920|NCT01817530|581056384|FG005|Overall Study|Surgery or Invasive Intervention|1|||
160907921|NCT01817530|581056385|FG006|Overall Study|Surgery or Invasive Intervention|1|||
160907922|NCT01817530|581056386|FG007|Overall Study|Surgery or Invasive Intervention|0|||
160907923|NCT01817530|581056379|FG000|Overall Study|Consent Withdrawn by Subject|3|||
160907924|NCT01817530|581056380|FG001|Overall Study|Consent Withdrawn by Subject|4|||
160907925|NCT01817530|581056381|FG002|Overall Study|Consent Withdrawn by Subject|7|||
160907926|NCT01817530|581056382|FG003|Overall Study|Consent Withdrawn by Subject|3|||
160907927|NCT01817530|581056383|FG004|Overall Study|Consent Withdrawn by Subject|5|||
160907928|NCT01817530|581056384|FG005|Overall Study|Consent Withdrawn by Subject|3|||
160907929|NCT01817530|581056385|FG006|Overall Study|Consent Withdrawn by Subject|3|||
160907930|NCT01817530|581056386|FG007|Overall Study|Consent Withdrawn by Subject|10|||
160907931|NCT01817530|581056379|FG000|Overall Study|Lost to Follow-up|1|||
160907932|NCT01817530|581056380|FG001|Overall Study|Lost to Follow-up|4|||
160907933|NCT01817530|581056381|FG002|Overall Study|Lost to Follow-up|2|||
160907934|NCT01817530|581056382|FG003|Overall Study|Lost to Follow-up|1|||
160907935|NCT01817530|581056383|FG004|Overall Study|Lost to Follow-up|3|||
160907936|NCT01817530|581056384|FG005|Overall Study|Lost to Follow-up|2|||
160907937|NCT01817530|581056385|FG006|Overall Study|Lost to Follow-up|8|||
160907938|NCT01817530|581056386|FG007|Overall Study|Lost to Follow-up|4|||
160907939|NCT00566995|581056387|FG000|Overall Study|Toxicity|4|||
160907940|NCT00566995|581056387|FG000|Overall Study|Withdrew consent|3|||
160907941|NCT02657369|581056388|FG000|Overall Study|Death|27|||
160907942|NCT02657369|581056388|FG000|Overall Study|Study terminated by sponsor|7|||
160907943|NCT00361569|581056389|FG000|Overall Study|Protocol Violation|3|||
160907944|NCT00361569|581056390|FG001|Overall Study|Protocol Violation|2|||
160907945|NCT00361569|581056391|FG002|Overall Study|Protocol Violation|4|||
160907946|NCT00361569|581056392|FG003|Overall Study|Protocol Violation|2|||
160907947|NCT00361569|581056389|FG000|Overall Study|Withdrawal by Subject|2|||
160907948|NCT00361569|581056390|FG001|Overall Study|Withdrawal by Subject|1|||
160907949|NCT00361569|581056391|FG002|Overall Study|Withdrawal by Subject|9|||
160907950|NCT00361569|581056392|FG003|Overall Study|Withdrawal by Subject|14|||
160907951|NCT00361569|581056389|FG000|Overall Study|Adverse Event|3|||
160907952|NCT00361569|581056390|FG001|Overall Study|Adverse Event|5|||
160907953|NCT00361569|581056391|FG002|Overall Study|Adverse Event|2|||
160569218|NCT01824602|579806998|FG001|Overall Study|Treatment failure|0|||
160569219|NCT01824602|579806999|FG002|Overall Study|Treatment failure|0|||
160569220|NCT01824602|579807000|FG003|Overall Study|Treatment failure|1|||
160569221|NCT00104871|579807001|FG000|Overall Study|Not evaluable|1|||
160569222|NCT02192359|579807004|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
160907954|NCT00361569|581056392|FG003|Overall Study|Adverse Event|2|||
160907955|NCT00361569|581056389|FG000|Overall Study|Lost to Follow-up|2|||
160907956|NCT00361569|581056390|FG001|Overall Study|Lost to Follow-up|3|||
160907957|NCT00361569|581056391|FG002|Overall Study|Lost to Follow-up|3|||
160907958|NCT00361569|581056392|FG003|Overall Study|Lost to Follow-up|2|||
160907959|NCT00361569|581056389|FG000|Overall Study|Not specified by investigator|2|||
160907960|NCT00361569|581056390|FG001|Overall Study|Not specified by investigator|0|||
160907961|NCT00361569|581056391|FG002|Overall Study|Not specified by investigator|0|||
160907962|NCT00361569|581056392|FG003|Overall Study|Not specified by investigator|1|||
160907963|NCT04875195|581056393|FG000|Overall Study|Death|9|||
160855543|NCT00647296|580859411|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
160855544|NCT00647296|580859412|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
160855545|NCT00647296|580859413|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
160855546|NCT00647296|580859410|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
160855547|NCT00647296|580859411|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
160855548|NCT00647296|580859412|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
160855549|NCT00647296|580859413|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
160855550|NCT00647296|580859410|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
160855551|NCT00647296|580859411|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
160855552|NCT00647296|580859412|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
160855553|NCT00647296|580859413|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
160855554|NCT00647296|580859410|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
160855555|NCT00647296|580859411|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
160855556|NCT00647296|580859412|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
160855557|NCT00647296|580859413|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
160855558|NCT02922725|580859414|FG000|Overall Study|Withdrawal by Subject|1|||
160855559|NCT02922725|580859415|FG001|Overall Study|Withdrawal by Subject|0|||
160855560|NCT02922725|580859416|FG002|Overall Study|Withdrawal by Subject|0|||
160855561|NCT00871871|580859417|FG000|Part I|Adverse Event|0|||
160855562|NCT00871871|580859418|FG001|Part I|Adverse Event|2|||
160855563|NCT00871871|580859419|FG002|Part I|Adverse Event|0|||
160855564|NCT00871871|580859420|FG003|Part I|Adverse Event|0|||
160855565|NCT00871871|580859417|FG000|Part I|Withdrawal by Subject|3|||
160855566|NCT00871871|580859418|FG001|Part I|Withdrawal by Subject|0|||
160855567|NCT00871871|580859419|FG002|Part I|Withdrawal by Subject|0|||
160855568|NCT00871871|580859420|FG003|Part I|Withdrawal by Subject|0|||
160855569|NCT00871871|580859417|FG000|Part I|Laboratory abnormality|0|||
160855570|NCT00871871|580859418|FG001|Part I|Laboratory abnormality|1|||
160855571|NCT00871871|580859419|FG002|Part I|Laboratory abnormality|0|||
160855572|NCT00871871|580859420|FG003|Part I|Laboratory abnormality|0|||
160855573|NCT00871871|580859417|FG000|Part II|Lack of Efficacy|0|||
160855574|NCT00871871|580859418|FG001|Part II|Lack of Efficacy|0|||
160855575|NCT00871871|580859419|FG002|Part II|Lack of Efficacy|1|||
160855576|NCT00871871|580859420|FG003|Part II|Lack of Efficacy|0|||
160855577|NCT00871871|580859417|FG000|Part II|Withdrawal by Subject|0|||
160855578|NCT00871871|580859418|FG001|Part II|Withdrawal by Subject|0|||
160855579|NCT00871871|580859419|FG002|Part II|Withdrawal by Subject|2|||
160855580|NCT00871871|580859420|FG003|Part II|Withdrawal by Subject|1|||
160855581|NCT00871871|580859417|FG000|Part II|Adverse Event|0|||
160855582|NCT00871871|580859418|FG001|Part II|Adverse Event|0|||
160855583|NCT00871871|580859419|FG002|Part II|Adverse Event|1|||
160855584|NCT00871871|580859420|FG003|Part II|Adverse Event|2|||
160855585|NCT00871871|580859417|FG000|Part II|Protocol Violation|0|||
160855586|NCT00871871|580859418|FG001|Part II|Protocol Violation|0|||
160855587|NCT00871871|580859419|FG002|Part II|Protocol Violation|0|||
160855588|NCT00871871|580859420|FG003|Part II|Protocol Violation|1|||
160855589|NCT04612725|580859421|FG000|Overall Study|Adverse Event|1|||
160855590|NCT04612725|580859422|FG001|Overall Study|Adverse Event|3|||
160855591|NCT04612725|580859423|FG002|Overall Study|Adverse Event|1|||
160855592|NCT04612725|580859424|FG003|Overall Study|Adverse Event|0|||
160855593|NCT04612725|580859425|FG004|Overall Study|Adverse Event|1|||
160855594|NCT04612725|580859421|FG000|Overall Study|Lost to Follow-up|0|||
160855595|NCT04612725|580859422|FG001|Overall Study|Lost to Follow-up|1|||
160855596|NCT04612725|580859423|FG002|Overall Study|Lost to Follow-up|0|||
160855597|NCT04612725|580859424|FG003|Overall Study|Lost to Follow-up|0|||
160855598|NCT04612725|580859425|FG004|Overall Study|Lost to Follow-up|0|||
160855599|NCT04612725|580859421|FG000|Overall Study|Physician Decision|2|||
160855600|NCT04612725|580859422|FG001|Overall Study|Physician Decision|0|||
160855601|NCT04612725|580859423|FG002|Overall Study|Physician Decision|0|||
160855602|NCT04612725|580859424|FG003|Overall Study|Physician Decision|0|||
160855603|NCT04612725|580859425|FG004|Overall Study|Physician Decision|0|||
160855604|NCT04612725|580859421|FG000|Overall Study|Study terminated by sponsor|3|||
160855605|NCT04612725|580859422|FG001|Overall Study|Study terminated by sponsor|1|||
160855606|NCT04612725|580859423|FG002|Overall Study|Study terminated by sponsor|2|||
160855607|NCT04612725|580859424|FG003|Overall Study|Study terminated by sponsor|4|||
160855608|NCT04612725|580859425|FG004|Overall Study|Study terminated by sponsor|5|||
160855609|NCT04612725|580859421|FG000|Overall Study|Withdrawal by Subject|8|||
160855610|NCT04612725|580859422|FG001|Overall Study|Withdrawal by Subject|3|||
160855611|NCT04612725|580859423|FG002|Overall Study|Withdrawal by Subject|5|||
160855612|NCT04612725|580859424|FG003|Overall Study|Withdrawal by Subject|1|||
160855613|NCT04612725|580859425|FG004|Overall Study|Withdrawal by Subject|9|||
160855614|NCT04612725|580859421|FG000|Overall Study|Other|0|||
160855615|NCT04612725|580859422|FG001|Overall Study|Other|0|||
160855616|NCT04612725|580859423|FG002|Overall Study|Other|0|||
160855617|NCT04612725|580859424|FG003|Overall Study|Other|0|||
160855618|NCT04612725|580859425|FG004|Overall Study|Other|1|||
160855619|NCT03069352|580859426|FG000|Overall Study|Ongoing|12|||
160855620|NCT03069352|580859427|FG001|Overall Study|Ongoing|40|||
160855621|NCT02621424|580859428|FG000|Overall Study|Withdrawal by Subject|1|||
160855622|NCT02621424|580859429|FG001|Overall Study|Withdrawal by Subject|2|||
160855623|NCT05148234|580859431|FG000|Phase I|Ineligible|0|||
160855624|NCT05148234|580859432|FG001|Phase I|Ineligible|0|||
160855625|NCT05148234|580859433|FG002|Phase I|Ineligible|0|||
160855626|NCT05148234|580859434|FG003|Phase I|Ineligible|0|||
160855627|NCT05148234|580859435|FG004|Phase I|Ineligible|0|||
160855628|NCT05148234|580859436|FG005|Phase I|Ineligible|0|||
160855629|NCT05148234|580859437|FG006|Phase I|Ineligible|0|||
160855630|NCT05148234|580859438|FG007|Phase I|Ineligible|1|||
160855631|NCT05148234|580859431|FG000|Phase I|Company closed the trial.|0|||
160855632|NCT05148234|580859432|FG001|Phase I|Company closed the trial.|1|||
160855633|NCT05148234|580859433|FG002|Phase I|Company closed the trial.|0|||
160855634|NCT05148234|580859434|FG003|Phase I|Company closed the trial.|0|||
160855635|NCT05148234|580859435|FG004|Phase I|Company closed the trial.|0|||
160855636|NCT05148234|580859436|FG005|Phase I|Company closed the trial.|0|||
160855637|NCT05148234|580859437|FG006|Phase I|Company closed the trial.|0|||
160855638|NCT05148234|580859438|FG007|Phase I|Company closed the trial.|0|||
160855639|NCT04750642|580859439|FG000|Overall Study|Adverse Event|1|||
160571907|NCT01743027|579816864|FG003|Overall Study|Progressive Disease|0|||
160855640|NCT04750642|580859440|FG001|Overall Study|Adverse Event|0|||
160855641|NCT04750642|580859439|FG000|Overall Study|Withdrawal by Subject|0|||
160855642|NCT04750642|580859440|FG001|Overall Study|Withdrawal by Subject|1|||
160855643|NCT04750642|580859439|FG000|Overall Study|Protocol Violation|0|||
160855644|NCT04750642|580859440|FG001|Overall Study|Protocol Violation|1|||
160855645|NCT00308139|580862337|FG000|Overall Study|Adverse Event|20|||
160855646|NCT00308139|580862338|FG001|Overall Study|Adverse Event|14|||
160855647|NCT00308139|580862337|FG000|Overall Study|Lost to Follow-up|13|||
160855648|NCT00308139|580862338|FG001|Overall Study|Lost to Follow-up|8|||
160855649|NCT00308139|580862337|FG000|Overall Study|Protocol Violation|3|||
160855650|NCT00308139|580862338|FG001|Overall Study|Protocol Violation|2|||
160855651|NCT00308139|580862337|FG000|Overall Study|Withdrawal of Consent|40|||
160855652|NCT00308139|580862338|FG001|Overall Study|Withdrawal of Consent|42|||
160855653|NCT00308139|580862337|FG000|Overall Study|Investigator Decision|11|||
160855654|NCT00308139|580862338|FG001|Overall Study|Investigator Decision|10|||
160855655|NCT00308139|580862337|FG000|Overall Study|Loss of Glucose Control|5|||
160855656|NCT00308139|580862338|FG001|Overall Study|Loss of Glucose Control|7|||
160855657|NCT00308139|580862337|FG000|Overall Study|Administrative|1|||
160855658|NCT00308139|580862338|FG001|Overall Study|Administrative|4|||
160855659|NCT00308139|580862337|FG000|Overall Study|Other|1|||
160855660|NCT00308139|580862338|FG001|Overall Study|Other|0|||
160855661|NCT00791388|580862343|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
160855662|NCT00791388|580862344|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
160855663|NCT00791388|580862345|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
160855664|NCT00791388|580862346|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
160855665|NCT00791388|580862347|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
160855666|NCT00791388|580862343|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
160855667|NCT00791388|580862344|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
160855668|NCT00791388|580862345|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
160855669|NCT00791388|580862346|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
160855670|NCT00791388|580862347|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
160855671|NCT00791388|580862343|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
160855672|NCT00791388|580862344|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
160855673|NCT00791388|580862345|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
160855674|NCT00791388|580862346|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
160855675|NCT00791388|580862347|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
160855676|NCT00435409|580862356|FG000|Overall Study|Protocol Violation|1|||
160855677|NCT00435409|580862357|FG001|Overall Study|Protocol Violation|2|||
160855678|NCT00435409|580862358|FG002|Overall Study|Protocol Violation|0|||
160855679|NCT00435409|580862356|FG000|Overall Study|Lost to Follow-up|1|||
160855680|NCT00435409|580862357|FG001|Overall Study|Lost to Follow-up|2|||
160855681|NCT00435409|580862358|FG002|Overall Study|Lost to Follow-up|0|||
160855682|NCT00435409|580862356|FG000|Overall Study|Death|8|||
160855683|NCT00435409|580862357|FG001|Overall Study|Death|6|||
160855684|NCT00435409|580862358|FG002|Overall Study|Death|6|||
160855685|NCT00435409|580862356|FG000|Overall Study|Objective progression or relapse|158|||
160855686|NCT00435409|580862357|FG001|Overall Study|Objective progression or relapse|93|||
160855687|NCT00435409|580862358|FG002|Overall Study|Objective progression or relapse|58|||
160855688|NCT00435409|580862356|FG000|Overall Study|Global deterioration of health status|0|||
160855689|NCT00435409|580862357|FG001|Overall Study|Global deterioration of health status|0|||
160855690|NCT00435409|580862358|FG002|Overall Study|Global deterioration of health status|4|||
160855691|NCT00435409|580862356|FG000|Overall Study|Withdrawal by Subject|8|||
160855692|NCT00435409|580862357|FG001|Overall Study|Withdrawal by Subject|7|||
160855693|NCT00435409|580862358|FG002|Overall Study|Withdrawal by Subject|1|||
160855694|NCT00435409|580862356|FG000|Overall Study|Other|45|||
160855695|NCT00435409|580862357|FG001|Overall Study|Other|30|||
160855696|NCT00435409|580862358|FG002|Overall Study|Other|1|||
160855697|NCT00435409|580862356|FG000|Overall Study|Adverse Event|0|||
160855698|NCT00435409|580862357|FG001|Overall Study|Adverse Event|0|||
160855699|NCT00435409|580862358|FG002|Overall Study|Adverse Event|8|||
160855700|NCT00435409|580862356|FG000|Overall Study|Sponsor decision|0|||
160855701|NCT00435409|580862357|FG001|Overall Study|Sponsor decision|3|||
160855702|NCT00435409|580862358|FG002|Overall Study|Sponsor decision|0|||
160855703|NCT04750824|580862359|FG000|Overall Study|Toxicity/intolerability|3|||
160855704|NCT04750824|580862360|FG001|Overall Study|Toxicity/intolerability|1|||
160855705|NCT04750824|580862359|FG000|Overall Study|Death|1|||
160855706|NCT04750824|580862360|FG001|Overall Study|Death|3|||
160855707|NCT04750824|580862359|FG000|Overall Study|Scheduled duration of therapy complete|1|||
160855708|NCT04750824|580862360|FG001|Overall Study|Scheduled duration of therapy complete|9|||
160855709|NCT04750824|580862359|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
160855710|NCT04750824|580862360|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
160855711|NCT05196828|580862361|FG000|Overall Study|Withdrawal by Subject|2|||
160855712|NCT05196828|580862362|FG001|Overall Study|Withdrawal by Subject|0|||
160855713|NCT05196828|580862361|FG000|Overall Study|Lost to Follow-up|0|||
160855714|NCT05196828|580862362|FG001|Overall Study|Lost to Follow-up|4|||
160855715|NCT05196828|580862361|FG000|Overall Study|Adverse Event|1|||
160855716|NCT05196828|580862362|FG001|Overall Study|Adverse Event|0|||
160855717|NCT02763644|580862363|FG000|Overall Study|Patient/guardian decision|1|||
160855718|NCT02763644|580862364|FG001|Overall Study|Patient/guardian decision|0|||
160855719|NCT02763644|580862363|FG000|Overall Study|Death|1|||
160855720|NCT02763644|580862364|FG001|Overall Study|Death|1|||
160855721|NCT02763644|580862363|FG000|Overall Study|Adverse Event|1|||
160855722|NCT02763644|580862364|FG001|Overall Study|Adverse Event|1|||
160855723|NCT02356159|580862365|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
160855724|NCT02356159|580862366|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
160855725|NCT02356159|580862367|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
160855726|NCT02356159|580862368|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
160855727|NCT02356159|580862369|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
160855728|NCT02356159|580862370|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
160855729|NCT03192176|580862371|FG000|Overall Study|Adverse Event|1|||
160855730|NCT03192176|580862372|FG001|Overall Study|Adverse Event|0|||
160855731|NCT03192176|580862373|FG002|Overall Study|Adverse Event|4|||
160855732|NCT03192176|580862374|FG003|Overall Study|Adverse Event|5|||
160855733|NCT03192176|580862375|FG004|Overall Study|Adverse Event|3|||
160855734|NCT03192176|580862376|FG005|Overall Study|Adverse Event|2|||
160855735|NCT03192176|580862377|FG006|Overall Study|Adverse Event|3|||
160855736|NCT03192176|580862378|FG007|Overall Study|Adverse Event|3|||
160855737|NCT03192176|580862371|FG000|Overall Study|Lost to Follow-up|0|||
160855738|NCT03192176|580862372|FG001|Overall Study|Lost to Follow-up|0|||
160855739|NCT03192176|580862373|FG002|Overall Study|Lost to Follow-up|1|||
160855740|NCT03192176|580862374|FG003|Overall Study|Lost to Follow-up|2|||
160855741|NCT03192176|580862375|FG004|Overall Study|Lost to Follow-up|3|||
160855742|NCT03192176|580862376|FG005|Overall Study|Lost to Follow-up|1|||
160855743|NCT03192176|580862377|FG006|Overall Study|Lost to Follow-up|1|||
160855744|NCT03192176|580862378|FG007|Overall Study|Lost to Follow-up|1|||
160855745|NCT03192176|580862371|FG000|Overall Study|Physician Decision|1|||
160855746|NCT03192176|580862372|FG001|Overall Study|Physician Decision|0|||
160855747|NCT03192176|580862373|FG002|Overall Study|Physician Decision|0|||
160855748|NCT03192176|580862374|FG003|Overall Study|Physician Decision|0|||
160855749|NCT03192176|580862375|FG004|Overall Study|Physician Decision|0|||
160855750|NCT03192176|580862376|FG005|Overall Study|Physician Decision|2|||
160855751|NCT03192176|580862377|FG006|Overall Study|Physician Decision|1|||
160855752|NCT03192176|580862378|FG007|Overall Study|Physician Decision|0|||
160855753|NCT03192176|580862371|FG000|Overall Study|Protocol Deviation|1|||
160855754|NCT03192176|580862372|FG001|Overall Study|Protocol Deviation|1|||
160855755|NCT03192176|580862373|FG002|Overall Study|Protocol Deviation|0|||
160855756|NCT03192176|580862374|FG003|Overall Study|Protocol Deviation|0|||
160855757|NCT03192176|580862375|FG004|Overall Study|Protocol Deviation|2|||
160855758|NCT03192176|580862376|FG005|Overall Study|Protocol Deviation|0|||
160855759|NCT03192176|580862377|FG006|Overall Study|Protocol Deviation|0|||
160855760|NCT03192176|580862378|FG007|Overall Study|Protocol Deviation|0|||
160855761|NCT03192176|580862371|FG000|Overall Study|Withdrawal by Subject|3|||
160855762|NCT03192176|580862372|FG001|Overall Study|Withdrawal by Subject|4|||
160855763|NCT03192176|580862373|FG002|Overall Study|Withdrawal by Subject|0|||
160855764|NCT03192176|580862374|FG003|Overall Study|Withdrawal by Subject|4|||
160855765|NCT03192176|580862375|FG004|Overall Study|Withdrawal by Subject|3|||
160855766|NCT03192176|580862376|FG005|Overall Study|Withdrawal by Subject|4|||
160855767|NCT03192176|580862377|FG006|Overall Study|Withdrawal by Subject|4|||
160855768|NCT03192176|580862378|FG007|Overall Study|Withdrawal by Subject|2|||
160855769|NCT03192176|580862371|FG000|Overall Study|Miscellaneous|1|||
160855770|NCT03192176|580862372|FG001|Overall Study|Miscellaneous|0|||
160855771|NCT03192176|580862373|FG002|Overall Study|Miscellaneous|1|||
160855772|NCT03192176|580862374|FG003|Overall Study|Miscellaneous|1|||
160855773|NCT03192176|580862375|FG004|Overall Study|Miscellaneous|1|||
160855774|NCT03192176|580862376|FG005|Overall Study|Miscellaneous|2|||
160855775|NCT03192176|580862377|FG006|Overall Study|Miscellaneous|0|||
160855776|NCT03192176|580862378|FG007|Overall Study|Miscellaneous|1|||
160855777|NCT00836589|580862383|FG000|Overall Study|Lost to Follow-up|246|||
160855778|NCT00836589|580862383|FG000|Overall Study|Death|429|||
160855779|NCT00836589|580862383|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
160855780|NCT00117637|580862384|FG000|First Intervention (Period 1)|Adverse Event|11|||
160855781|NCT00117637|580862385|FG001|First Intervention (Period 1)|Adverse Event|16|||
160855782|NCT00117637|580862384|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
160855783|NCT00117637|580862385|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
160855784|NCT00117637|580862384|FG000|First Intervention (Period 1)|Protocol Violation|1|||
160855785|NCT00117637|580862385|FG001|First Intervention (Period 1)|Protocol Violation|0|||
160855786|NCT00117637|580862384|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
160855787|NCT00117637|580862385|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
160855788|NCT00117637|580862384|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
160855789|NCT00117637|580862385|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
160855790|NCT00117637|580862384|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
160855791|NCT00117637|580862385|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
160855792|NCT00117637|580862384|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
160855793|NCT00117637|580862385|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
160855794|NCT00117637|580862384|FG000|First Intervention (Period 1)|reason not reported|0|||
160855795|NCT00117637|580862385|FG001|First Intervention (Period 1)|reason not reported|1|||
160855796|NCT00117637|580862384|FG000|Second Intervention (Period 2)|Adverse Event|0|||
160855797|NCT00117637|580862385|FG001|Second Intervention (Period 2)|Adverse Event|9|||
160855798|NCT00117637|580862384|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
160855799|NCT00117637|580862385|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
160855800|NCT00117637|580862384|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
160855801|NCT00117637|580862385|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
160855802|NCT00117637|580862384|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
160855803|NCT00117637|580862385|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
160855804|NCT00117637|580862384|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
160855805|NCT00117637|580862385|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
160855806|NCT00117637|580862384|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
160855807|NCT00117637|580862385|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
160855808|NCT00117637|580862384|FG000|Second Intervention (Period 2)|reason not reported|1|||
160855809|NCT00117637|580862385|FG001|Second Intervention (Period 2)|reason not reported|0|||
160855810|NCT02914639|580862388|FG000|Overall Study|Withdrawal by Subject|0|||
160855811|NCT02914639|580862389|FG001|Overall Study|Withdrawal by Subject|2|||
160855812|NCT01582061|580862390|FG000|Overall Study|Lack of Efficacy|3|||
160855813|NCT01582061|580862391|FG001|Overall Study|Lack of Efficacy|23|||
160855814|NCT01582061|580862390|FG000|Overall Study|Adverse Event|12|||
160855815|NCT01582061|580862391|FG001|Overall Study|Adverse Event|8|||
160855816|NCT01582061|580862390|FG000|Overall Study|Withdrawal by Subject|10|||
160855817|NCT01582061|580862391|FG001|Overall Study|Withdrawal by Subject|4|||
160855818|NCT01582061|580862390|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160855819|NCT01582061|580862391|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160855820|NCT01582061|580862390|FG000|Overall Study|Death|0|||
160855821|NCT01582061|580862391|FG001|Overall Study|Death|1|||
160855822|NCT01582061|580862390|FG000|Overall Study|condition no longer requires study drug|1|||
160855823|NCT01582061|580862391|FG001|Overall Study|condition no longer requires study drug|0|||
160855824|NCT01582061|580862390|FG000|Overall Study|Lost to Follow-up|1|||
160907964|NCT04875195|581056394|FG001|Overall Study|Death|3|||
160855825|NCT01582061|580862391|FG001|Overall Study|Lost to Follow-up|0|||
160855826|NCT00436332|580862395|FG000|Overall Study|Adverse Event|9|||
160855827|NCT00436332|580862395|FG000|Overall Study|Withdrawal by Subject|2|||
160855828|NCT00436332|580862395|FG000|Overall Study|Progression|59|||
160855829|NCT00436332|580862395|FG000|Overall Study|Death|2|||
160855830|NCT00436332|580862395|FG000|Overall Study|Not Protocol Specified|6|||
160855831|NCT00436332|580862395|FG000|Overall Study|Ineligible|2|||
160855832|NCT00436332|580862395|FG000|Overall Study|Never Received Treatment|3|||
160855833|NCT00062439|580862396|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
160855834|NCT00062439|580862396|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
160855835|NCT00062439|580862396|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
160855836|NCT00062439|580862396|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
160855837|NCT00062439|580862396|FG000|Post Chemoradiation Assessment|Death|1|||
160855838|NCT00062439|580862396|FG000|Post Chemoradiation Assessment|Disease progression|2|||
160855839|NCT00062439|580862396|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
160855840|NCT00062439|580862396|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
160855841|NCT00062439|580862396|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
160855842|NCT00062439|580862396|FG000|Surgery|Physician Decision|4|||
160855843|NCT00062439|580862396|FG000|Surgery|Death|1|||
160855844|NCT00062439|580862396|FG000|Surgery|Adverse Event|2|||
160855845|NCT00062439|580862396|FG000|Consolidation Chemotherapy|Adverse Event|2|||
160855846|NCT01924845|580862397|FG000|Overall Study|Adverse Event|3|||
160855847|NCT01924845|580862397|FG000|Overall Study|Withdrawal by Subject|2|||
160855848|NCT01924845|580862397|FG000|Overall Study|Protocol Violation|1|||
160855849|NCT03780452|580862398|FG000|Overall Study|Screening failure|2|||
160855850|NCT02388269|580862399|FG000|Overall Study|Adverse Event|2|||
160855851|NCT02388269|580862400|FG001|Overall Study|Adverse Event|0|||
160855852|NCT02388269|580862401|FG002|Overall Study|Adverse Event|0|||
160855853|NCT02388269|580862399|FG000|Overall Study|Withdrawal by Subject|1|||
160855854|NCT02388269|580862400|FG001|Overall Study|Withdrawal by Subject|2|||
160855855|NCT02388269|580862401|FG002|Overall Study|Withdrawal by Subject|0|||
160855856|NCT02388269|580862399|FG000|Overall Study|less than 50% stimulations|1|||
160855857|NCT02388269|580862400|FG001|Overall Study|less than 50% stimulations|0|||
160855858|NCT02388269|580862401|FG002|Overall Study|less than 50% stimulations|0|||
160855859|NCT02388269|580862399|FG000|Overall Study|no diary data|3|||
160855860|NCT02388269|580862400|FG001|Overall Study|no diary data|0|||
160855861|NCT02388269|580862401|FG002|Overall Study|no diary data|0|||
160855862|NCT02388269|580862399|FG000|Overall Study|Protocol Violation|2|||
160855863|NCT02388269|580862400|FG001|Overall Study|Protocol Violation|0|||
160855864|NCT02388269|580862401|FG002|Overall Study|Protocol Violation|0|||
160855865|NCT02388269|580862399|FG000|Overall Study|Screen Failure|0|||
160855866|NCT02388269|580862400|FG001|Overall Study|Screen Failure|0|||
160855867|NCT02388269|580862401|FG002|Overall Study|Screen Failure|10|||
160855868|NCT00265564|580862404|FG000|Overall Study|Lost to Follow-up|5|||
160855869|NCT00265564|580862405|FG001|Overall Study|Lost to Follow-up|7|||
160855870|NCT00265564|580862404|FG000|Overall Study|met exclusion criteria|5|||
160855871|NCT00265564|580862405|FG001|Overall Study|met exclusion criteria|2|||
160855872|NCT04698343|580862406|FG000|Overall Study|Withdrawal by Subject|6|||
160855873|NCT04698343|580862406|FG000|Overall Study|Physician Decision|2|||
160855874|NCT04698343|580862406|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
160855875|NCT04698343|580862406|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
160855876|NCT04698343|580862406|FG000|Overall Study|Personal reasons|3|||
160855877|NCT04698343|580862406|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
160855878|NCT00325897|580862410|FG000|Overall Study|Lost to Follow-up|12|||
160855879|NCT00325897|580862411|FG001|Overall Study|Lost to Follow-up|13|||
160855880|NCT03915717|580862414|FG000|Overall Study|EchoMark Not Implanted|6|||
160855881|NCT04079296|580862415|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
160855882|NCT04079296|580862416|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
160855883|NCT04079296|580862417|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
160855884|NCT04079296|580862418|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
160855885|NCT04079296|580862419|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
160855886|NCT04079296|580862415|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
160855887|NCT04079296|580862416|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
160855888|NCT04079296|580862417|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
160855889|NCT04079296|580862418|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
160855890|NCT04079296|580862419|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
160855891|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
160855892|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
160855893|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
160855894|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
160855895|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
160855896|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
160855897|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
160855898|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
160855899|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
160855900|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
160855901|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
160855902|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
160855903|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
160855904|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
160855905|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
160855906|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
160855907|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
160855908|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
160855909|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
160855910|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
160855911|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
160855912|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
160855913|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
160855914|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
160855915|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
160855916|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Death|0|||
160855917|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Death|0|||
160855918|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Death|0|||
160855919|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Death|1|||
160855920|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Death|0|||
160855921|NCT00467740|580862420|FG000|Overall Study|Adverse Event|0|||
160855922|NCT00467740|580862421|FG001|Overall Study|Adverse Event|0|||
160855923|NCT00467740|580862422|FG002|Overall Study|Adverse Event|1|||
160855924|NCT00467740|580862423|FG003|Overall Study|Adverse Event|0|||
160855925|NCT00467740|580862424|FG004|Overall Study|Adverse Event|0|||
160855926|NCT00467740|580862420|FG000|Overall Study|Protocol Violation|0|||
160855927|NCT00467740|580862421|FG001|Overall Study|Protocol Violation|0|||
160855928|NCT00467740|580862422|FG002|Overall Study|Protocol Violation|1|||
160855929|NCT00467740|580862423|FG003|Overall Study|Protocol Violation|0|||
160855930|NCT00467740|580862424|FG004|Overall Study|Protocol Violation|0|||
160855931|NCT00467740|580862420|FG000|Overall Study|Lost to Follow-up|0|||
160855932|NCT00467740|580862421|FG001|Overall Study|Lost to Follow-up|1|||
160855933|NCT00467740|580862422|FG002|Overall Study|Lost to Follow-up|0|||
160855934|NCT00467740|580862423|FG003|Overall Study|Lost to Follow-up|0|||
160855935|NCT00467740|580862424|FG004|Overall Study|Lost to Follow-up|0|||
160855936|NCT00467740|580862420|FG000|Overall Study|Withdrawal by Subject|1|||
160855937|NCT00467740|580862421|FG001|Overall Study|Withdrawal by Subject|1|||
160855938|NCT00467740|580862422|FG002|Overall Study|Withdrawal by Subject|0|||
160855939|NCT00467740|580862423|FG003|Overall Study|Withdrawal by Subject|1|||
160855940|NCT00467740|580862424|FG004|Overall Study|Withdrawal by Subject|0|||
160855941|NCT00467740|580862420|FG000|Overall Study|Lack of Efficacy|0|||
160855942|NCT00467740|580862421|FG001|Overall Study|Lack of Efficacy|1|||
160855943|NCT00467740|580862422|FG002|Overall Study|Lack of Efficacy|0|||
160855944|NCT00467740|580862423|FG003|Overall Study|Lack of Efficacy|0|||
160855945|NCT00467740|580862424|FG004|Overall Study|Lack of Efficacy|0|||
160855946|NCT02903160|580862425|FG000|Overall Study|Adverse Event|2|||
160855947|NCT02903160|580862425|FG000|Overall Study|Death|1|||
160855948|NCT02903160|580862425|FG000|Overall Study|Lost to Follow-up|2|||
160855949|NCT02903160|580862425|FG000|Overall Study|Withdrawal by Subject|1|||
160855950|NCT02903160|580862425|FG000|Overall Study|Medical Insurance Barriers|1|||
160855951|NCT01664910|580862428|FG000|Overall Study|Adverse Event|0|||
160855952|NCT01664910|580862429|FG001|Overall Study|Adverse Event|0|||
160855953|NCT01664910|580862430|FG002|Overall Study|Adverse Event|1|||
160855954|NCT02525471|580862431|FG000|Overall Study|Screen Failure|6|||
160855955|NCT02525471|580862431|FG000|Overall Study|Withdrawal by Subject|4|||
160855956|NCT02525471|580862431|FG000|Overall Study|Death|1|||
160855957|NCT02240485|580862432|FG000|3 Months Post-admission|Lost to Follow-up|1|||
160855958|NCT02240485|580862433|FG001|3 Months Post-admission|Lost to Follow-up|5|||
160855959|NCT02240485|580862432|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
160855960|NCT02240485|580862433|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
160855961|NCT02240485|580862432|FG000|9 Months Post-admission|Lost to Follow-up|3|||
160855962|NCT02240485|580862433|FG001|9 Months Post-admission|Lost to Follow-up|1|||
160855963|NCT02240485|580862432|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
160855964|NCT02240485|580862433|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
160855965|NCT02240485|580862432|FG000|18 Months Post-admission|Lost to Follow-up|1|||
160855966|NCT02240485|580862433|FG001|18 Months Post-admission|Lost to Follow-up|1|||
160855967|NCT02240485|580862432|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
160855968|NCT02240485|580862433|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
160855969|NCT00867165|580862437|FG000|Overall Study|Adverse Event|3|||
160855970|NCT00867165|580862438|FG001|Overall Study|Adverse Event|0|||
160855971|NCT00867165|580862437|FG000|Overall Study|Withdrawal by Subject|1|||
160855972|NCT00867165|580862438|FG001|Overall Study|Withdrawal by Subject|0|||
160855973|NCT03275740|580862439|FG000|Overall Study|Adverse Event|0|||
160855974|NCT03275740|580862440|FG001|Overall Study|Adverse Event|0|||
160855975|NCT03275740|580862441|FG002|Overall Study|Adverse Event|0|||
160855976|NCT03275740|580862442|FG003|Overall Study|Adverse Event|0|||
160855977|NCT03275740|580862443|FG004|Overall Study|Adverse Event|1|||
160855978|NCT03275740|580862444|FG005|Overall Study|Adverse Event|0|||
160855979|NCT03275740|580862445|FG006|Overall Study|Adverse Event|0|||
160855980|NCT03275740|580862446|FG007|Overall Study|Adverse Event|0|||
160855981|NCT03275740|580862447|FG008|Overall Study|Adverse Event|0|||
160855982|NCT03275740|580862448|FG009|Overall Study|Adverse Event|0|||
160855983|NCT03275740|580862449|FG010|Overall Study|Adverse Event|0|||
160855984|NCT03275740|580862450|FG011|Overall Study|Adverse Event|0|||
160650821|NCT04820842|580104330|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
160650822|NCT04820842|580104331|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
160650823|NCT04820842|580104332|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
160650824|NCT04820842|580104333|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
160650825|NCT04820842|580104334|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
160650826|NCT04820842|580104335|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
160650827|NCT01296932|580104336|FG000|Overall Study|Dose limiting toxicity|0|||
160650828|NCT01296932|580104337|FG001|Overall Study|Dose limiting toxicity|0|||
160855985|NCT03275740|580862439|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855986|NCT03275740|580862440|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855987|NCT03275740|580862441|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855988|NCT03275740|580862442|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855989|NCT03275740|580862443|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855990|NCT03275740|580862444|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
160650829|NCT01296932|580104338|FG002|Overall Study|Dose limiting toxicity|0|||
160650830|NCT01296932|580104339|FG003|Overall Study|Dose limiting toxicity|0|||
160650831|NCT01296932|580104340|FG004|Overall Study|Dose limiting toxicity|0|||
160650832|NCT01296932|580104341|FG005|Overall Study|Dose limiting toxicity|0|||
160650833|NCT01296932|580104342|FG006|Overall Study|Dose limiting toxicity|1|||
160855991|NCT03275740|580862445|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855992|NCT03275740|580862446|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855993|NCT03275740|580862447|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855994|NCT03275740|580862448|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855995|NCT03275740|580862449|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855996|NCT03275740|580862450|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855997|NCT03275740|580862439|FG000|Overall Study|Withdrawal by Subject|0|||
160855998|NCT03275740|580862440|FG001|Overall Study|Withdrawal by Subject|0|||
160855999|NCT03275740|580862441|FG002|Overall Study|Withdrawal by Subject|0|||
160856000|NCT03275740|580862442|FG003|Overall Study|Withdrawal by Subject|0|||
160856001|NCT03275740|580862443|FG004|Overall Study|Withdrawal by Subject|0|||
160856002|NCT03275740|580862444|FG005|Overall Study|Withdrawal by Subject|0|||
160856003|NCT03275740|580862445|FG006|Overall Study|Withdrawal by Subject|0|||
160856004|NCT03275740|580862446|FG007|Overall Study|Withdrawal by Subject|0|||
160856005|NCT03275740|580862447|FG008|Overall Study|Withdrawal by Subject|1|||
160856006|NCT03275740|580862448|FG009|Overall Study|Withdrawal by Subject|1|||
160856007|NCT03275740|580862449|FG010|Overall Study|Withdrawal by Subject|0|||
160856008|NCT03275740|580862450|FG011|Overall Study|Withdrawal by Subject|0|||
160856009|NCT00988884|580862451|FG000|Overall Study|Adverse Event|0|||
160856010|NCT00988884|580862452|FG001|Overall Study|Adverse Event|1|||
160856011|NCT00988884|580862451|FG000|Overall Study|Lost to Follow-up|20|||
160856012|NCT00988884|580862452|FG001|Overall Study|Lost to Follow-up|16|||
160856013|NCT00988884|580862451|FG000|Overall Study|Protocol Violation|0|||
160856014|NCT00988884|580862452|FG001|Overall Study|Protocol Violation|1|||
160856015|NCT00988884|580862451|FG000|Overall Study|Withdrawal by Subject|15|||
160856016|NCT00988884|580862452|FG001|Overall Study|Withdrawal by Subject|18|||
160907965|NCT04875195|581056393|FG000|Overall Study|Withdrawal by Subject|2|||
160907966|NCT04875195|581056394|FG001|Overall Study|Withdrawal by Subject|1|||
160907967|NCT04875195|581056393|FG000|Overall Study|Ongoing in study|49|||
160650834|NCT01296932|580104343|FG007|Overall Study|Dose limiting toxicity|0|||
160907968|NCT04875195|581056394|FG001|Overall Study|Ongoing in study|2|||
160856023|NCT04621448|580862457|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
160856024|NCT04621448|580862458|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
160856025|NCT04621448|580862459|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
160856026|NCT04621448|580862460|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
160907969|NCT02339584|581056395|FG000|Overall Study|Adverse Event|11|||
160856027|NCT04621448|580862457|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
160856028|NCT04621448|580862458|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
160856029|NCT04621448|580862459|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
160856030|NCT04621448|580862460|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
160856031|NCT04621448|580862457|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
160856032|NCT04621448|580862458|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
160856033|NCT04621448|580862459|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
160856034|NCT04621448|580862460|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
160856035|NCT04621448|580862457|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
160856036|NCT04621448|580862458|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
160856037|NCT04621448|580862459|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
160856038|NCT04621448|580862460|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
160856039|NCT00549640|580862461|FG000|Overall Study|Withdrawal by Subject|6|||
160856040|NCT00549640|580862462|FG001|Overall Study|Withdrawal by Subject|12|||
160856041|NCT00549640|580862461|FG000|Overall Study|Adverse Event|5|||
160856042|NCT00549640|580862462|FG001|Overall Study|Adverse Event|0|||
160856043|NCT00549640|580862461|FG000|Overall Study|Lost to Follow-up|7|||
160856044|NCT00549640|580862462|FG001|Overall Study|Lost to Follow-up|4|||
160856045|NCT03550378|580862469|FG000|Overall Study|Death|0|||
160856046|NCT03550378|580862470|FG001|Overall Study|Death|1|||
160856047|NCT04486235|580862471|FG000|Overall Study|Pregnancy|1|||
160856048|NCT04486235|580862472|FG001|Overall Study|Pregnancy|0|||
160856049|NCT04486235|580862471|FG000|Overall Study|Lost to Follow-up|1|||
160856050|NCT04486235|580862472|FG001|Overall Study|Lost to Follow-up|0|||
160569223|NCT02192359|579807005|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
160569224|NCT02192359|579807006|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
160569225|NCT02192359|579807007|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
160569226|NCT02192359|579807004|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
160569227|NCT02192359|579807005|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
160569228|NCT02192359|579807006|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
160569229|NCT02192359|579807007|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
160569230|NCT02192359|579807004|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
160569231|NCT02192359|579807005|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
160569232|NCT02192359|579807006|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
160569233|NCT02192359|579807007|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
160856051|NCT00626275|580862473|FG000|Part A - Treatment Period 1|Adverse Event|1|||
160856052|NCT00626275|580862474|FG001|Part A - Treatment Period 1|Adverse Event|0|||
160856053|NCT00626275|580862475|FG002|Part A - Treatment Period 1|Adverse Event|0|||
160856054|NCT00626275|580862476|FG003|Part A - Treatment Period 1|Adverse Event|0|||
160856055|NCT00626275|580862477|FG004|Part A - Treatment Period 1|Adverse Event|0|||
160856056|NCT00626275|580862478|FG005|Part A - Treatment Period 1|Adverse Event|0|||
160856057|NCT00626275|580862479|FG006|Part A - Treatment Period 1|Adverse Event|0|||
160856058|NCT00626275|580862480|FG007|Part A - Treatment Period 1|Adverse Event|0|||
160856059|NCT00626275|580862473|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856060|NCT00626275|580862474|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856061|NCT00626275|580862475|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
160856062|NCT00626275|580862476|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856063|NCT00626275|580862477|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856064|NCT00626275|580862478|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856065|NCT00626275|580862479|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856066|NCT00626275|580862480|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160907970|NCT02339584|581056396|FG001|Overall Study|Adverse Event|7|||
160907971|NCT02339584|581056395|FG000|Overall Study|Lack of Efficacy|0|||
160907972|NCT02339584|581056396|FG001|Overall Study|Lack of Efficacy|1|||
160907973|NCT02339584|581056395|FG000|Overall Study|Physician Decision|1|||
160907974|NCT02339584|581056396|FG001|Overall Study|Physician Decision|2|||
160907975|NCT02339584|581056395|FG000|Overall Study|Protocol Violation|1|||
160907976|NCT02339584|581056396|FG001|Overall Study|Protocol Violation|1|||
160907977|NCT02339584|581056395|FG000|Overall Study|Withdrawal by Subject|2|||
160856067|NCT00626275|580862473|FG000|Part B|Lost to Follow-up|0|||
160856068|NCT00626275|580862474|FG001|Part B|Lost to Follow-up|0|||
160856069|NCT00626275|580862475|FG002|Part B|Lost to Follow-up|0|||
160856070|NCT00626275|580862476|FG003|Part B|Lost to Follow-up|0|||
160856071|NCT00626275|580862477|FG004|Part B|Lost to Follow-up|0|||
160856072|NCT00626275|580862478|FG005|Part B|Lost to Follow-up|0|||
160856073|NCT00626275|580862479|FG006|Part B|Lost to Follow-up|1|||
160856074|NCT00626275|580862480|FG007|Part B|Lost to Follow-up|0|||
160856075|NCT00626275|580862473|FG000|Part B|Withdrawal by Subject|0|||
160856076|NCT00626275|580862474|FG001|Part B|Withdrawal by Subject|0|||
160856077|NCT00626275|580862475|FG002|Part B|Withdrawal by Subject|0|||
160856078|NCT00626275|580862476|FG003|Part B|Withdrawal by Subject|0|||
160907978|NCT02339584|581056396|FG001|Overall Study|Withdrawal by Subject|4|||
160907979|NCT00826943|581056397|FG000|Overall Study|Withdrawal by Subject|0|||
160856079|NCT00626275|580862477|FG004|Part B|Withdrawal by Subject|0|||
160856080|NCT00626275|580862478|FG005|Part B|Withdrawal by Subject|0|||
160856081|NCT00626275|580862479|FG006|Part B|Withdrawal by Subject|0|||
160856082|NCT00626275|580862480|FG007|Part B|Withdrawal by Subject|1|||
160856083|NCT04590014|580862481|FG000|Overall Study|Withdrawal by Subject|1|||
160856084|NCT04590014|580862482|FG001|Overall Study|Withdrawal by Subject|0|||
160856085|NCT00468299|580862483|FG000|Overall Study|Withdrawal by Subject|0|||
160856086|NCT00468299|580862484|FG001|Overall Study|Withdrawal by Subject|1|||
160856087|NCT04999839|580862485|FG000|Overall Study|Adverse Event|1|||
160856088|NCT04999839|580862486|FG001|Overall Study|Adverse Event|1|||
160856089|NCT04999839|580862487|FG002|Overall Study|Adverse Event|1|||
160856090|NCT04999839|580862488|FG003|Overall Study|Adverse Event|1|||
160856091|NCT04999839|580862489|FG004|Overall Study|Adverse Event|1|||
160856092|NCT04999839|580862485|FG000|Overall Study|Lost to Follow-up|2|||
160856093|NCT04999839|580862486|FG001|Overall Study|Lost to Follow-up|0|||
160856094|NCT04999839|580862487|FG002|Overall Study|Lost to Follow-up|2|||
160856095|NCT04999839|580862488|FG003|Overall Study|Lost to Follow-up|4|||
160856096|NCT04999839|580862489|FG004|Overall Study|Lost to Follow-up|1|||
160856097|NCT04999839|580862485|FG000|Overall Study|Withdrawal by Subject|6|||
160856098|NCT04999839|580862486|FG001|Overall Study|Withdrawal by Subject|5|||
160856099|NCT04999839|580862487|FG002|Overall Study|Withdrawal by Subject|3|||
160856100|NCT04999839|580862488|FG003|Overall Study|Withdrawal by Subject|2|||
160856101|NCT04999839|580862489|FG004|Overall Study|Withdrawal by Subject|2|||
160856102|NCT04999839|580862485|FG000|Overall Study|Lack of Efficacy|0|||
160856103|NCT04999839|580862486|FG001|Overall Study|Lack of Efficacy|1|||
160856104|NCT04999839|580862487|FG002|Overall Study|Lack of Efficacy|0|||
160856105|NCT04999839|580862488|FG003|Overall Study|Lack of Efficacy|0|||
160856106|NCT04999839|580862489|FG004|Overall Study|Lack of Efficacy|0|||
160856107|NCT04999839|580862485|FG000|Overall Study|Physician Decision|0|||
160856108|NCT04999839|580862486|FG001|Overall Study|Physician Decision|0|||
160856109|NCT04999839|580862487|FG002|Overall Study|Physician Decision|0|||
160856110|NCT04999839|580862488|FG003|Overall Study|Physician Decision|0|||
160856111|NCT04999839|580862489|FG004|Overall Study|Physician Decision|1|||
160856112|NCT04999839|580862485|FG000|Overall Study|Sponsor request|0|||
160856113|NCT04999839|580862486|FG001|Overall Study|Sponsor request|1|||
160856114|NCT04999839|580862487|FG002|Overall Study|Sponsor request|0|||
160856115|NCT04999839|580862488|FG003|Overall Study|Sponsor request|0|||
160856116|NCT04999839|580862489|FG004|Overall Study|Sponsor request|0|||
160856117|NCT04999839|580862485|FG000|Overall Study|Other|0|||
160856118|NCT04999839|580862486|FG001|Overall Study|Other|0|||
160856119|NCT04999839|580862487|FG002|Overall Study|Other|1|||
160856120|NCT04999839|580862488|FG003|Overall Study|Other|0|||
160856121|NCT04999839|580862489|FG004|Overall Study|Other|0|||
160856122|NCT01362348|580862490|FG000|Overall Study|Protocol-defined stopping criteria|9|||
160856123|NCT01362348|580862490|FG000|Overall Study|Study closed/terminated|5|||
160907980|NCT00826943|581056398|FG001|Overall Study|Withdrawal by Subject|0|||
160907981|NCT00826943|581056399|FG002|Overall Study|Withdrawal by Subject|0|||
160907982|NCT00826943|581056400|FG003|Overall Study|Withdrawal by Subject|0|||
160907983|NCT00826943|581056401|FG004|Overall Study|Withdrawal by Subject|1|||
160907984|NCT00826943|581056402|FG005|Overall Study|Withdrawal by Subject|0|||
160907985|NCT00074152|581056403|FG000|Overall Study|Death|21|||
160907986|NCT00074152|581056404|FG001|Overall Study|Death|9|||
160907987|NCT00074152|581056403|FG000|Overall Study|Lack of Efficacy|34|||
160907988|NCT00074152|581056404|FG001|Overall Study|Lack of Efficacy|24|||
160907989|NCT03715530|581056405|FG000|Overall Study|Lost to Follow-up|3|||
160907990|NCT03715530|581056406|FG001|Overall Study|Lost to Follow-up|1|||
160907991|NCT03715530|581056407|FG002|Overall Study|Lost to Follow-up|2|||
160907992|NCT01594762|581056408|FG000|Overall Study|Withdrawal by Subject|1|||
160907993|NCT01594762|581056409|FG001|Overall Study|Withdrawal by Subject|0|||
160907994|NCT01594762|581056408|FG000|Overall Study|Lost to Follow-up|10|||
160907995|NCT01594762|581056409|FG001|Overall Study|Lost to Follow-up|10|||
160856124|NCT00399516|580862491|FG000|Overall Study|Lost to Follow-up|2|||
160569234|NCT03914300|579807013|FG000|Overall Study|Adverse Event|1|||
160856125|NCT03546621|580862492|FG000|Overall Study|Withdrawal by Subject|0|||
160907996|NCT01785069|581056413|FG000|Overall Study|Implanted with nonstudy device|1|||
160907997|NCT01785069|581056414|FG001|Overall Study|Implanted with nonstudy device|2|||
160569235|NCT00457639|579807019|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
160569236|NCT00457639|579807020|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
160569237|NCT00457639|579807019|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
160569238|NCT00457639|579807020|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
160569239|NCT00457639|579807019|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
160856126|NCT03546621|580862493|FG001|Overall Study|Withdrawal by Subject|1|||
160856127|NCT03546621|580862494|FG002|Overall Study|Withdrawal by Subject|2|||
160856128|NCT03546621|580862495|FG003|Overall Study|Withdrawal by Subject|1|||
160856129|NCT03546621|580862492|FG000|Overall Study|Lost to Follow-up|0|||
160907998|NCT01785069|581056415|FG002|Overall Study|Implanted with nonstudy device|1|||
160907999|NCT01785069|581056416|FG003|Overall Study|Implanted with nonstudy device|0|||
160908000|NCT01785069|581056413|FG000|Overall Study|Death|0|||
160908001|NCT01785069|581056414|FG001|Overall Study|Death|0|||
160908002|NCT01785069|581056415|FG002|Overall Study|Death|2|||
160908003|NCT01785069|581056416|FG003|Overall Study|Death|0|||
160908004|NCT01785069|581056413|FG000|Overall Study|Subject choice|2|||
160908005|NCT01785069|581056414|FG001|Overall Study|Subject choice|2|||
160908006|NCT01785069|581056415|FG002|Overall Study|Subject choice|0|||
160908007|NCT01785069|581056416|FG003|Overall Study|Subject choice|1|||
160908008|NCT01785069|581056413|FG000|Overall Study|Lost to Follow-up|1|||
160908009|NCT01785069|581056414|FG001|Overall Study|Lost to Follow-up|2|||
160908010|NCT01785069|581056415|FG002|Overall Study|Lost to Follow-up|4|||
160908011|NCT01785069|581056416|FG003|Overall Study|Lost to Follow-up|1|||
160908012|NCT01785069|581056413|FG000|Overall Study|Reason not Specified|1|||
160908013|NCT01785069|581056414|FG001|Overall Study|Reason not Specified|2|||
160908014|NCT01785069|581056415|FG002|Overall Study|Reason not Specified|1|||
160908015|NCT01785069|581056416|FG003|Overall Study|Reason not Specified|4|||
160908016|NCT01785069|581056413|FG000|Overall Study|Not evaluable|7|||
160908017|NCT01785069|581056414|FG001|Overall Study|Not evaluable|4|||
160908018|NCT01785069|581056415|FG002|Overall Study|Not evaluable|5|||
160908019|NCT01785069|581056416|FG003|Overall Study|Not evaluable|8|||
160908020|NCT03338998|581056417|FG000|Treatment Period|Withdrawal by Subject|1|||
160908021|NCT03338998|581056418|FG001|Treatment Period|Withdrawal by Subject|1|||
160908022|NCT03338998|581056417|FG000|Treatment Period|Adverse Event|0|||
160908023|NCT03338998|581056418|FG001|Treatment Period|Adverse Event|2|||
160908024|NCT03338998|581056417|FG000|Treatment Period|Protocol deviation|1|||
160908025|NCT03338998|581056418|FG001|Treatment Period|Protocol deviation|0|||
160908026|NCT03338998|581056417|FG000|Treatment Period|Physician Decision|2|||
160908027|NCT03338998|581056418|FG001|Treatment Period|Physician Decision|0|||
160908028|NCT03338998|581056417|FG000|Treatment Period|Subject failed swallow test|4|||
160908029|NCT03338998|581056418|FG001|Treatment Period|Subject failed swallow test|0|||
160908030|NCT03338998|581056417|FG000|Safety Follow-Up Period|Adverse Event|0|||
160908031|NCT03338998|581056418|FG001|Safety Follow-Up Period|Adverse Event|1|||
160908032|NCT03338998|581056417|FG000|Safety Follow-Up Period|Protocol deviation|1|||
160908033|NCT03338998|581056418|FG001|Safety Follow-Up Period|Protocol deviation|0|||
160908034|NCT03338998|581056417|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
160908035|NCT03338998|581056418|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
160908036|NCT03288129|581056421|FG000|Overall Study|Adverse Event|10|||
160908037|NCT03288129|581056421|FG000|Overall Study|Lost to Follow-up|3|||
160908038|NCT03288129|581056421|FG000|Overall Study|Withdrawal by Subject|3|||
160908039|NCT03288129|581056421|FG000|Overall Study|Withdrawal of consent/assent|1|||
160993339|NCT02001623|581365328|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
160993340|NCT02001623|581365329|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
160993341|NCT02001623|581365330|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
160856130|NCT03546621|580862493|FG001|Overall Study|Lost to Follow-up|1|||
160856131|NCT03546621|580862494|FG002|Overall Study|Lost to Follow-up|0|||
160856132|NCT03546621|580862495|FG003|Overall Study|Lost to Follow-up|0|||
160856133|NCT03546621|580862492|FG000|Overall Study|Adverse Event|0|||
160856134|NCT03546621|580862493|FG001|Overall Study|Adverse Event|1|||
160856135|NCT03546621|580862494|FG002|Overall Study|Adverse Event|0|||
160856136|NCT03546621|580862495|FG003|Overall Study|Adverse Event|1|||
160856137|NCT03546621|580862492|FG000|Overall Study|Progressive disease|0|||
160856138|NCT03546621|580862493|FG001|Overall Study|Progressive disease|0|||
160856139|NCT03546621|580862494|FG002|Overall Study|Progressive disease|0|||
160856140|NCT03546621|580862495|FG003|Overall Study|Progressive disease|1|||
160856141|NCT00660192|580862496|FG000|Overall Study|Lost to Follow-up|2|||
160856142|NCT00660192|580862497|FG001|Overall Study|Lost to Follow-up|3|||
160856143|NCT00377520|580862498|FG000|Overall Study|Ineligible (Prior radiation)|1|||
160856144|NCT00982735|580862499|FG000|Overall Study|Lost to Follow-up|6|||
160856145|NCT00982735|580862499|FG000|Overall Study|Patient ineligible for trial|224|||
160569240|NCT00457639|579807020|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
160569241|NCT02117687|579807023|FG000|Overall Study|Lost to Follow-up|0|||
160856146|NCT00651924|580862502|FG000|Overall Study|Withdrawal by PI|0|||
160908040|NCT03288129|581056421|FG000|Overall Study|Other|5|||
160908041|NCT01744197|581056424|FG000|Overall Study|Received 1 patch|2|||
160908042|NCT01744197|581056425|FG001|Overall Study|Received 1 patch|1|||
160569242|NCT02117687|579807024|FG001|Overall Study|Lost to Follow-up|1|||
160856147|NCT00651924|580862503|FG001|Overall Study|Withdrawal by PI|2|||
160856148|NCT00651924|580862502|FG000|Overall Study|Withdrawal by Subject|0|||
160856149|NCT00651924|580862503|FG001|Overall Study|Withdrawal by Subject|5|||
160908043|NCT01744197|581056424|FG000|Overall Study|No patch received|2|||
160908044|NCT01744197|581056425|FG001|Overall Study|No patch received|2|||
160908045|NCT04706091|581056426|FG000|Treatment 2|Withdrawal by Subject|1|||
160569243|NCT02117687|579807023|FG000|Overall Study|Adverse Event|0|||
160856150|NCT00758771|580862504|FG000|Overall Study|Withdrawal by Subject|1|||
160856151|NCT00758771|580862505|FG001|Overall Study|Withdrawal by Subject|1|||
160856152|NCT00758771|580862504|FG000|Overall Study|Did not meet eligibility criteria|2|||
160856153|NCT00758771|580862505|FG001|Overall Study|Did not meet eligibility criteria|4|||
160856154|NCT00960063|580862506|FG000|Overall Study|Adverse Event|1|||
160856155|NCT00960063|580862507|FG001|Overall Study|Adverse Event|0|||
160856156|NCT00960063|580862508|FG002|Overall Study|Adverse Event|0|||
160856157|NCT00960063|580862506|FG000|Overall Study|Progression of Disease|0|||
160856158|NCT00960063|580862507|FG001|Overall Study|Progression of Disease|0|||
160856159|NCT00960063|580862508|FG002|Overall Study|Progression of Disease|3|||
160856160|NCT02898454|580862515|FG000|Overall Study|Adverse Event|4|||
160856161|NCT02898454|580862516|FG001|Overall Study|Adverse Event|1|||
160856162|NCT02898454|580862517|FG002|Overall Study|Adverse Event|2|||
160856163|NCT02898454|580862515|FG000|Overall Study|Protocol Violation|1|||
160856164|NCT02898454|580862516|FG001|Overall Study|Protocol Violation|0|||
160856165|NCT02898454|580862517|FG002|Overall Study|Protocol Violation|1|||
160856166|NCT02898454|580862515|FG000|Overall Study|Lack of Efficacy|4|||
160856167|NCT02898454|580862516|FG001|Overall Study|Lack of Efficacy|1|||
160856168|NCT02898454|580862517|FG002|Overall Study|Lack of Efficacy|0|||
160856169|NCT02898454|580862515|FG000|Overall Study|Withdrawal by Subject|6|||
160993342|NCT02001623|581365331|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
160993343|NCT02001623|581365332|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
160856170|NCT02898454|580862516|FG001|Overall Study|Withdrawal by Subject|3|||
160856171|NCT02898454|580862517|FG002|Overall Study|Withdrawal by Subject|3|||
160856172|NCT02898454|580862515|FG000|Overall Study|Lost to Follow-up|1|||
160856173|NCT02898454|580862516|FG001|Overall Study|Lost to Follow-up|0|||
160856174|NCT02898454|580862517|FG002|Overall Study|Lost to Follow-up|0|||
160856175|NCT02898454|580862515|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
160856176|NCT02898454|580862516|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
160856177|NCT02898454|580862517|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
160856178|NCT02343263|580862518|FG000|Overall Study|Physician Decision|5|||
160856179|NCT02343263|580862519|FG001|Overall Study|Physician Decision|3|||
160856180|NCT02343263|580862520|FG002|Overall Study|Physician Decision|1|||
160856181|NCT03040141|580862521|FG000|Overall Study|Death|1|||
160856182|NCT03040141|580862522|FG001|Overall Study|Death|2|||
160856183|NCT03040141|580862523|FG002|Overall Study|Death|3|||
160856184|NCT03040141|580862521|FG000|Overall Study|Withdrawal by Subject|3|||
160856185|NCT03040141|580862522|FG001|Overall Study|Withdrawal by Subject|1|||
160856186|NCT03040141|580862523|FG002|Overall Study|Withdrawal by Subject|1|||
160856187|NCT03040141|580862521|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
160856188|NCT03040141|580862522|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
160856189|NCT03040141|580862523|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
160856190|NCT03040141|580862521|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
160856191|NCT03040141|580862522|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
160856192|NCT03040141|580862523|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
160856193|NCT01400698|580862525|FG000|Overall Study|Lost to Follow-up|2|||
160856194|NCT01400698|580862526|FG001|Overall Study|Lost to Follow-up|5|||
160856195|NCT01400698|580862527|FG002|Overall Study|Lost to Follow-up|2|||
160856196|NCT01400698|580862528|FG003|Overall Study|Lost to Follow-up|1|||
160856197|NCT01400698|580862529|FG004|Overall Study|Lost to Follow-up|4|||
160856198|NCT01400698|580862530|FG005|Overall Study|Lost to Follow-up|3|||
160856199|NCT01400698|580862525|FG000|Overall Study|Withdrawal by Subject|8|||
160856200|NCT01400698|580862526|FG001|Overall Study|Withdrawal by Subject|2|||
160856201|NCT01400698|580862527|FG002|Overall Study|Withdrawal by Subject|0|||
160856202|NCT01400698|580862528|FG003|Overall Study|Withdrawal by Subject|4|||
160856203|NCT01400698|580862529|FG004|Overall Study|Withdrawal by Subject|1|||
160856204|NCT01400698|580862530|FG005|Overall Study|Withdrawal by Subject|3|||
160856205|NCT01400698|580862525|FG000|Overall Study|Protocol Violation|0|||
160856206|NCT01400698|580862526|FG001|Overall Study|Protocol Violation|1|||
160993344|NCT02001623|581365333|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
160993345|NCT02001623|581365334|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
160993346|NCT02001623|581365335|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
160993347|NCT02001623|581365336|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
160993348|NCT02001623|581365322|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
160856207|NCT01400698|580862527|FG002|Overall Study|Protocol Violation|0|||
160856208|NCT01400698|580862528|FG003|Overall Study|Protocol Violation|0|||
160856209|NCT01400698|580862529|FG004|Overall Study|Protocol Violation|1|||
160856210|NCT01400698|580862530|FG005|Overall Study|Protocol Violation|0|||
160856211|NCT01400698|580862525|FG000|Overall Study|Non-compliance|0|||
160856212|NCT01400698|580862526|FG001|Overall Study|Non-compliance|1|||
160856213|NCT01400698|580862527|FG002|Overall Study|Non-compliance|0|||
160856214|NCT01400698|580862528|FG003|Overall Study|Non-compliance|1|||
160856215|NCT01400698|580862529|FG004|Overall Study|Non-compliance|0|||
160856216|NCT01400698|580862530|FG005|Overall Study|Non-compliance|0|||
160856217|NCT01400698|580862525|FG000|Overall Study|Adverse Event|1|||
160993349|NCT02001623|581365323|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
160856218|NCT01400698|580862526|FG001|Overall Study|Adverse Event|0|||
160856219|NCT01400698|580862527|FG002|Overall Study|Adverse Event|0|||
160856220|NCT01400698|580862528|FG003|Overall Study|Adverse Event|0|||
160856221|NCT01400698|580862529|FG004|Overall Study|Adverse Event|0|||
160856222|NCT01400698|580862530|FG005|Overall Study|Adverse Event|0|||
160856223|NCT01400698|580862525|FG000|Overall Study|Other|4|||
160856224|NCT01400698|580862526|FG001|Overall Study|Other|2|||
160856225|NCT01400698|580862527|FG002|Overall Study|Other|0|||
160856226|NCT01400698|580862528|FG003|Overall Study|Other|2|||
160856227|NCT01400698|580862529|FG004|Overall Study|Other|1|||
160856228|NCT01400698|580862530|FG005|Overall Study|Other|0|||
160856229|NCT01650194|580862531|FG000|Overall Study|Progressive Disease (PD)|35|||
160856230|NCT01650194|580862531|FG000|Overall Study|Withdrawal by Subject|2|||
160856231|NCT01650194|580862531|FG000|Overall Study|Miscellaneous|10|||
160856232|NCT00633477|580864637|FG000|Overall Study|Death|1|||
160856233|NCT00633477|580864638|FG001|Overall Study|Death|0|||
160856234|NCT00633477|580864637|FG000|Overall Study|Randomized but not treated|1|||
160856235|NCT00633477|580864638|FG001|Overall Study|Randomized but not treated|0|||
160856236|NCT04906499|580864640|FG000|Overall Study|Lack of time|1|||
160856237|NCT00644423|580864641|FG000|Overall Study|Lost to Follow-up|1|||
160856238|NCT00644423|580864642|FG001|Overall Study|Lost to Follow-up|1|||
160856239|NCT03346434|580864643|FG000|Overall Study|Randomized in Error|0|||
160856240|NCT03346434|580864644|FG001|Overall Study|Randomized in Error|0|||
160856241|NCT03346434|580864645|FG002|Overall Study|Randomized in Error|0|||
160856242|NCT03346434|580864646|FG003|Overall Study|Randomized in Error|0|||
160856243|NCT03346434|580864647|FG004|Overall Study|Randomized in Error|1|||
160856244|NCT03346434|580864648|FG005|Overall Study|Randomized in Error|0|||
160856245|NCT03346434|580864643|FG000|Overall Study|Withdrawal by Subject|0|||
160856246|NCT03346434|580864644|FG001|Overall Study|Withdrawal by Subject|0|||
160856247|NCT03346434|580864645|FG002|Overall Study|Withdrawal by Subject|1|||
160856248|NCT03346434|580864646|FG003|Overall Study|Withdrawal by Subject|0|||
160856249|NCT03346434|580864647|FG004|Overall Study|Withdrawal by Subject|1|||
160856250|NCT03346434|580864648|FG005|Overall Study|Withdrawal by Subject|0|||
160856251|NCT03346434|580864643|FG000|Overall Study|Lost to Follow-up|0|||
160856252|NCT03346434|580864644|FG001|Overall Study|Lost to Follow-up|0|||
160856253|NCT03346434|580864645|FG002|Overall Study|Lost to Follow-up|0|||
160856254|NCT03346434|580864646|FG003|Overall Study|Lost to Follow-up|0|||
160856255|NCT03346434|580864647|FG004|Overall Study|Lost to Follow-up|1|||
160856256|NCT03346434|580864648|FG005|Overall Study|Lost to Follow-up|1|||
160856257|NCT03346434|580864643|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
160856258|NCT03346434|580864644|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
160856259|NCT03346434|580864645|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
160856260|NCT03346434|580864646|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
160856261|NCT03346434|580864647|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
160856262|NCT03346434|580864648|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
160856263|NCT03525444|580864649|FG000|Overall Study|Adverse Event|0|||
160856264|NCT03525444|580864650|FG001|Overall Study|Adverse Event|1|||
160856265|NCT03525444|580864649|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
160856266|NCT03525444|580864650|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
160856267|NCT03525444|580864649|FG000|Overall Study|Other|0|||
160856268|NCT03525444|580864650|FG001|Overall Study|Other|1|||
160856269|NCT00262860|580864652|FG000|Overall Study|Adverse Event|2|||
160993350|NCT02001623|581365324|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
160993351|NCT02001623|581365325|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
160993352|NCT02001623|581365326|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
160993353|NCT02001623|581365327|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
160569244|NCT02117687|579807024|FG001|Overall Study|Adverse Event|2|||
160856270|NCT02741128|580864653|FG000|Overall Study|Protocol Violation|4|||
160856271|NCT02741128|580864654|FG001|Overall Study|Protocol Violation|1|||
160856272|NCT02741128|580864653|FG000|Overall Study|Withdrawal by Subject|2|||
160856273|NCT02741128|580864654|FG001|Overall Study|Withdrawal by Subject|0|||
160856274|NCT02741128|580864653|FG000|Overall Study|Lost to Follow-up|1|||
160993354|NCT02001623|581365328|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
160993355|NCT02001623|581365329|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
160569245|NCT02117687|579807023|FG000|Overall Study|Other Reasons|1|||
160569246|NCT02117687|579807024|FG001|Overall Study|Other Reasons|1|||
160856275|NCT02741128|580864654|FG001|Overall Study|Lost to Follow-up|0|||
160856276|NCT02081677|580864655|FG000|Overall Study|Adverse Event|0|||
160856277|NCT02081677|580864656|FG001|Overall Study|Adverse Event|0|||
160856278|NCT02081677|580864657|FG002|Overall Study|Adverse Event|1|||
160856279|NCT02081677|580864658|FG003|Overall Study|Adverse Event|0|||
160856280|NCT02081677|580864655|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160856281|NCT02081677|580864656|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160856282|NCT02081677|580864657|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
160856283|NCT02081677|580864658|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
160993356|NCT02001623|581365330|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
160993357|NCT02001623|581365331|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
160993358|NCT02001623|581365332|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
160856284|NCT02081677|580864655|FG000|Overall Study|Not comfortable with lens care system|1|||
160856285|NCT02081677|580864656|FG001|Overall Study|Not comfortable with lens care system|0|||
160856286|NCT02081677|580864657|FG002|Overall Study|Not comfortable with lens care system|0|||
160856287|NCT02081677|580864658|FG003|Overall Study|Not comfortable with lens care system|0|||
160856288|NCT02081677|580864655|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
160856289|NCT02081677|580864656|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
160856290|NCT02081677|580864657|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
160856291|NCT02081677|580864658|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
160856292|NCT01419769|580864659|FG000|Overall Study|Did not receive the AXIOS stent|3|||
160856293|NCT01419769|580864659|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
160856294|NCT00878501|580864668|FG000|Overall Study|Adverse Event|11|||
160856295|NCT00878501|580864669|FG001|Overall Study|Adverse Event|3|||
160856296|NCT00878501|580864670|FG002|Overall Study|Adverse Event|3|||
160856297|NCT00878501|580864668|FG000|Overall Study|Lack of Efficacy|2|||
160856298|NCT00878501|580864669|FG001|Overall Study|Lack of Efficacy|1|||
160856299|NCT00878501|580864670|FG002|Overall Study|Lack of Efficacy|0|||
160856300|NCT00878501|580864668|FG000|Overall Study|Withdrawal by Subject|2|||
160856301|NCT00878501|580864669|FG001|Overall Study|Withdrawal by Subject|1|||
160856302|NCT00878501|580864670|FG002|Overall Study|Withdrawal by Subject|2|||
160856303|NCT00878501|580864668|FG000|Overall Study|Protocol Violation|0|||
160856304|NCT00878501|580864669|FG001|Overall Study|Protocol Violation|0|||
160856305|NCT00878501|580864670|FG002|Overall Study|Protocol Violation|1|||
160856306|NCT00878501|580864668|FG000|Overall Study|Incorrect enrolment|1|||
160856307|NCT00878501|580864669|FG001|Overall Study|Incorrect enrolment|2|||
160856308|NCT00878501|580864670|FG002|Overall Study|Incorrect enrolment|0|||
160856309|NCT00878501|580864668|FG000|Overall Study|Intake of prohibited concom. medication|0|||
160856310|NCT00878501|580864669|FG001|Overall Study|Intake of prohibited concom. medication|0|||
160856311|NCT00878501|580864670|FG002|Overall Study|Intake of prohibited concom. medication|1|||
160856312|NCT00878501|580864668|FG000|Overall Study|Mis-randomisation of patient|1|||
160856313|NCT00878501|580864669|FG001|Overall Study|Mis-randomisation of patient|0|||
160856314|NCT00878501|580864670|FG002|Overall Study|Mis-randomisation of patient|0|||
160856315|NCT00878501|580864668|FG000|Overall Study|Administrative|0|||
160856316|NCT00878501|580864669|FG001|Overall Study|Administrative|0|||
160856317|NCT00878501|580864670|FG002|Overall Study|Administrative|1|||
160856318|NCT03224130|580864673|FG000|Overall Study|consent issue|0|||
160856319|NCT03224130|580864674|FG001|Overall Study|consent issue|1|||
160856320|NCT01690052|580864675|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
160856321|NCT01690052|580864676|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
160856322|NCT01453049|580864677|FG000|Overall Study|Protocol Violation|2|||
160856323|NCT01453049|580864678|FG001|Overall Study|Protocol Violation|5|||
160856324|NCT01453049|580864677|FG000|Overall Study|Lost to Follow-up|2|||
160856325|NCT01453049|580864678|FG001|Overall Study|Lost to Follow-up|1|||
160856326|NCT01453049|580864677|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
160856327|NCT01453049|580864678|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
160856328|NCT01453049|580864677|FG000|Overall Study|Withdrawal by Subject|1|||
160856329|NCT01453049|580864678|FG001|Overall Study|Withdrawal by Subject|0|||
160856330|NCT01453049|580864677|FG000|Overall Study|Randomized in Error|1|||
160856331|NCT01453049|580864678|FG001|Overall Study|Randomized in Error|0|||
160856332|NCT02421172|580864679|FG000|Period 1|Adverse Event|1|||
160856333|NCT02421172|580864680|FG001|Period 1|Adverse Event|0|||
160856334|NCT02421172|580864681|FG002|Period 1|Adverse Event|0|||
160856335|NCT02421172|580864682|FG003|Period 1|Adverse Event|0|||
160856336|NCT02421172|580864683|FG004|Period 1|Adverse Event|0|||
160856337|NCT02421172|580864679|FG000|Period 1|Lost to Follow-up|3|||
160856338|NCT02421172|580864680|FG001|Period 1|Lost to Follow-up|1|||
160856339|NCT02421172|580864681|FG002|Period 1|Lost to Follow-up|0|||
160856340|NCT02421172|580864682|FG003|Period 1|Lost to Follow-up|0|||
160856341|NCT02421172|580864683|FG004|Period 1|Lost to Follow-up|0|||
160856342|NCT02421172|580864679|FG000|Period 1|Patient/guardian decision|0|||
160856343|NCT02421172|580864680|FG001|Period 1|Patient/guardian decision|1|||
160856344|NCT02421172|580864681|FG002|Period 1|Patient/guardian decision|0|||
160856345|NCT02421172|580864682|FG003|Period 1|Patient/guardian decision|0|||
160908046|NCT04706091|581056427|FG001|Treatment 2|Withdrawal by Subject|0|||
160908047|NCT03329573|581056428|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
160569247|NCT04358458|579807038|FG000|Overall Study|Death|1|||
160569248|NCT04358458|579807039|FG001|Overall Study|Death|1|||
160569249|NCT04358458|579807040|FG002|Overall Study|Death|3|||
160569250|NCT04358458|579807041|FG003|Overall Study|Death|8|||
160569251|NCT04358458|579807042|FG004|Overall Study|Death|1|||
160908048|NCT03329573|581056429|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
160569252|NCT04358458|579807043|FG005|Overall Study|Death|6|||
160569253|NCT04358458|579807044|FG006|Overall Study|Death|2|||
160569254|NCT04358458|579807045|FG007|Overall Study|Death|3|||
160569255|NCT04358458|579807038|FG000|Overall Study|Lost to Follow-up|0|||
160569256|NCT04358458|579807039|FG001|Overall Study|Lost to Follow-up|0|||
160569257|NCT04358458|579807040|FG002|Overall Study|Lost to Follow-up|0|||
160569258|NCT04358458|579807041|FG003|Overall Study|Lost to Follow-up|0|||
160569259|NCT04358458|579807042|FG004|Overall Study|Lost to Follow-up|0|||
160856346|NCT02421172|580864683|FG004|Period 1|Patient/guardian decision|0|||
160569260|NCT04358458|579807043|FG005|Overall Study|Lost to Follow-up|0|||
160569261|NCT04358458|579807044|FG006|Overall Study|Lost to Follow-up|0|||
160569262|NCT04358458|579807045|FG007|Overall Study|Lost to Follow-up|1|||
160569263|NCT04358458|579807038|FG000|Overall Study|Site is closing study participation|0|||
160569264|NCT04358458|579807039|FG001|Overall Study|Site is closing study participation|0|||
160569265|NCT04358458|579807040|FG002|Overall Study|Site is closing study participation|0|||
160569266|NCT04358458|579807041|FG003|Overall Study|Site is closing study participation|1|||
160569267|NCT04358458|579807042|FG004|Overall Study|Site is closing study participation|0|||
160569268|NCT04358458|579807043|FG005|Overall Study|Site is closing study participation|0|||
160569269|NCT04358458|579807044|FG006|Overall Study|Site is closing study participation|0|||
160569270|NCT04358458|579807045|FG007|Overall Study|Site is closing study participation|0|||
160569271|NCT04358458|579807038|FG000|Overall Study|Sponsor request|2|||
160569272|NCT04358458|579807039|FG001|Overall Study|Sponsor request|3|||
160856347|NCT02421172|580864679|FG000|Period 2|Adverse Event|0|||
160856348|NCT02421172|580864680|FG001|Period 2|Adverse Event|0|||
160856349|NCT02421172|580864681|FG002|Period 2|Adverse Event|4|||
160856350|NCT02421172|580864682|FG003|Period 2|Adverse Event|0|||
160856351|NCT02421172|580864683|FG004|Period 2|Adverse Event|0|||
160856352|NCT02421172|580864679|FG000|Period 2|Lost to Follow-up|0|||
160856353|NCT02421172|580864680|FG001|Period 2|Lost to Follow-up|0|||
160856354|NCT02421172|580864681|FG002|Period 2|Lost to Follow-up|0|||
160856355|NCT02421172|580864682|FG003|Period 2|Lost to Follow-up|1|||
160856356|NCT02421172|580864683|FG004|Period 2|Lost to Follow-up|0|||
160856357|NCT02421172|580864679|FG000|Period 2|Patient/guardian decision|0|||
160856358|NCT02421172|580864680|FG001|Period 2|Patient/guardian decision|0|||
160856359|NCT02421172|580864681|FG002|Period 2|Patient/guardian decision|3|||
160856360|NCT02421172|580864682|FG003|Period 2|Patient/guardian decision|2|||
160856361|NCT02421172|580864683|FG004|Period 2|Patient/guardian decision|1|||
160856362|NCT00928486|580864684|FG000|Overall Study|Adverse Event|2|||
160856363|NCT00928486|580864684|FG000|Overall Study|Disease Progression|7|||
160856364|NCT00928486|580864684|FG000|Overall Study|Withdrawal by Subject|1|||
160856365|NCT03095651|580864685|FG000|Overall Study|Lost to Follow-up|1|||
160856366|NCT03095651|580864686|FG001|Overall Study|Lost to Follow-up|1|||
160856367|NCT03095651|580864687|FG002|Overall Study|Lost to Follow-up|0|||
160856368|NCT03095651|580864688|FG003|Overall Study|Lost to Follow-up|1|||
160856369|NCT03095651|580864689|FG004|Overall Study|Lost to Follow-up|0|||
160856370|NCT03095651|580864690|FG005|Overall Study|Lost to Follow-up|0|||
160856371|NCT03095651|580864691|FG006|Overall Study|Lost to Follow-up|0|||
160856372|NCT03095651|580864692|FG007|Overall Study|Lost to Follow-up|0|||
160856373|NCT03095651|580864685|FG000|Overall Study|Withdrawal by Subject|0|||
160856374|NCT03095651|580864686|FG001|Overall Study|Withdrawal by Subject|0|||
160856375|NCT03095651|580864687|FG002|Overall Study|Withdrawal by Subject|0|||
160856376|NCT03095651|580864688|FG003|Overall Study|Withdrawal by Subject|0|||
160856377|NCT03095651|580864689|FG004|Overall Study|Withdrawal by Subject|0|||
160856378|NCT03095651|580864690|FG005|Overall Study|Withdrawal by Subject|1|||
160856379|NCT03095651|580864691|FG006|Overall Study|Withdrawal by Subject|0|||
160856380|NCT03095651|580864692|FG007|Overall Study|Withdrawal by Subject|0|||
160856381|NCT04124939|580864693|FG000|Overall Study|Lost to Follow-up|1|||
160856382|NCT04124939|580864694|FG001|Overall Study|Lost to Follow-up|3|||
160856383|NCT03489863|580864700|FG000|Overall Study|Withdrawal by Subject|0|||
160856384|NCT03489863|580864701|FG001|Overall Study|Withdrawal by Subject|1|||
160856385|NCT01751061|580864702|FG000|Overall Study|Death|1|||
160856386|NCT01751061|580864703|FG001|Overall Study|Death|0|||
160856387|NCT01751061|580864702|FG000|Overall Study|patient death|5|||
160856388|NCT01751061|580864703|FG001|Overall Study|patient death|0|||
160856389|NCT01751061|580864702|FG000|Overall Study|Lost to Follow-up|40|||
160856390|NCT01751061|580864703|FG001|Overall Study|Lost to Follow-up|25|||
160856391|NCT01751061|580864702|FG000|Overall Study|patient regained decisional capacity|4|||
160856392|NCT01751061|580864703|FG001|Overall Study|patient regained decisional capacity|8|||
160856393|NCT01751061|580864702|FG000|Overall Study|Withdrawal by Subject|4|||
160856394|NCT01751061|580864703|FG001|Overall Study|Withdrawal by Subject|1|||
160856395|NCT01751061|580864702|FG000|Overall Study|Physician Decision|2|||
160856396|NCT01751061|580864703|FG001|Overall Study|Physician Decision|0|||
160856397|NCT00768989|580864706|FG000|Prior to Week 24|Withdrawal by Subject|1|||
160856398|NCT00768989|580864707|FG001|Prior to Week 24|Withdrawal by Subject|0|||
160569273|NCT04358458|579807040|FG002|Overall Study|Sponsor request|3|||
160569274|NCT04358458|579807041|FG003|Overall Study|Sponsor request|0|||
160856399|NCT00768989|580864706|FG000|Prior to Week 24|Adverse Event|3|||
160856400|NCT00768989|580864707|FG001|Prior to Week 24|Adverse Event|0|||
160856401|NCT00768989|580864706|FG000|Prior to Week 24|Lost to Follow-up|0|||
160856402|NCT00768989|580864707|FG001|Prior to Week 24|Lost to Follow-up|1|||
160856403|NCT00768989|580864706|FG000|Prior to Week 24|Protocol Violation|0|||
160856404|NCT00768989|580864707|FG001|Prior to Week 24|Protocol Violation|2|||
160856405|NCT00768989|580864706|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
160856406|NCT00768989|580864707|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
160856407|NCT00768989|580864706|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
160856408|NCT00768989|580864707|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
160856409|NCT00768989|580864706|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
160856410|NCT00768989|580864707|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
160856411|NCT00768989|580864706|FG000|On or After Week 36|Lack of Efficacy|1|||
160856412|NCT00768989|580864707|FG001|On or After Week 36|Lack of Efficacy|0|||
160856413|NCT00768989|580864706|FG000|On or After Week 36|Adverse Event|0|||
160856414|NCT00768989|580864707|FG001|On or After Week 36|Adverse Event|1|||
160856415|NCT00768989|580864706|FG000|On or After Week 36|Lost to Follow-up|1|||
160856416|NCT00768989|580864707|FG001|On or After Week 36|Lost to Follow-up|0|||
160856417|NCT00768989|580864706|FG000|On or After Week 36|Poor Compliance|1|||
160856418|NCT00768989|580864707|FG001|On or After Week 36|Poor Compliance|0|||
160856419|NCT00768989|580864706|FG000|On or After Week 36|Protocol Violation|1|||
160856420|NCT00768989|580864707|FG001|On or After Week 36|Protocol Violation|0|||
160856421|NCT00768989|580864706|FG000|On or After Week 36|Did not attend termination visit|2|||
160856422|NCT00768989|580864707|FG001|On or After Week 36|Did not attend termination visit|0|||
160856423|NCT00768989|580864706|FG000|On or After Week 36|Sponsor Termination|45|||
160856424|NCT00768989|580864707|FG001|On or After Week 36|Sponsor Termination|26|||
160856425|NCT02153086|580864708|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
160856426|NCT02153086|580864708|FG000|Overall Study|Other|2|||
160856427|NCT01194830|580864709|FG000|Overall Study|Adverse Event|3|||
160856428|NCT01194830|580864710|FG001|Overall Study|Adverse Event|2|||
160856429|NCT01194830|580864709|FG000|Overall Study|Protocol Violation|5|||
160856430|NCT01194830|580864710|FG001|Overall Study|Protocol Violation|4|||
160856431|NCT01194830|580864709|FG000|Overall Study|Lost to Follow-up|9|||
160856432|NCT01194830|580864710|FG001|Overall Study|Lost to Follow-up|7|||
160856433|NCT01194830|580864709|FG000|Overall Study|Withdrawal by Subject|2|||
160856434|NCT01194830|580864710|FG001|Overall Study|Withdrawal by Subject|1|||
160856435|NCT01194830|580864709|FG000|Overall Study|Lack of Efficacy|1|||
160856436|NCT01194830|580864710|FG001|Overall Study|Lack of Efficacy|1|||
160856437|NCT01194830|580864709|FG000|Overall Study|Non-compliance issues|4|||
160856438|NCT01194830|580864710|FG001|Overall Study|Non-compliance issues|4|||
160856439|NCT01194830|580864709|FG000|Overall Study|Other Reason|12|||
160856440|NCT01194830|580864710|FG001|Overall Study|Other Reason|8|||
160856441|NCT03115359|580864711|FG000|Overall Study|Withdrawal by Subject|29|||
160856442|NCT03115359|580864712|FG001|Overall Study|Withdrawal by Subject|39|||
160856443|NCT03115359|580864711|FG000|Overall Study|Scheduling conflict|25|||
160856444|NCT03115359|580864712|FG001|Overall Study|Scheduling conflict|23|||
160856445|NCT03115359|580864711|FG000|Overall Study|Personal reasons including health|12|||
160856446|NCT03115359|580864712|FG001|Overall Study|Personal reasons including health|9|||
160856447|NCT03115359|580864711|FG000|Overall Study|Transportation barriers|3|||
160856448|NCT03115359|580864712|FG001|Overall Study|Transportation barriers|0|||
160856449|NCT03115359|580864711|FG000|Overall Study|No longer interested|5|||
160856450|NCT03115359|580864712|FG001|Overall Study|No longer interested|4|||
160856451|NCT03115359|580864711|FG000|Overall Study|No reason provided|45|||
160856452|NCT03115359|580864712|FG001|Overall Study|No reason provided|47|||
160856453|NCT01815918|580864713|FG000|Overall Study|Patient samples not analyzable|3|||
160856454|NCT01815918|580864714|FG001|Overall Study|Patient samples not analyzable|4|||
160856455|NCT01815918|580864713|FG000|Overall Study|Lack of Efficacy|15|||
160856456|NCT01815918|580864714|FG001|Overall Study|Lack of Efficacy|15|||
160856457|NCT02412306|580864717|FG000|Overall Study|Lost to Follow-up|0|||
160856458|NCT02412306|580864718|FG001|Overall Study|Lost to Follow-up|1|||
160856459|NCT02412306|580864719|FG002|Overall Study|Lost to Follow-up|0|||
160856460|NCT02412306|580864720|FG003|Overall Study|Lost to Follow-up|0|||
160908049|NCT03329573|581056430|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
160908050|NCT03329573|581056431|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
160908051|NCT03329573|581056428|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
160908052|NCT03329573|581056429|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
160856461|NCT02412306|580864721|FG004|Overall Study|Lost to Follow-up|0|||
160908053|NCT03329573|581056430|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160908054|NCT03329573|581056431|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160908055|NCT03329573|581056428|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
160908056|NCT03329573|581056429|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
160908057|NCT03329573|581056430|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
160908058|NCT03329573|581056431|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
160908059|NCT03329573|581056428|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
160908060|NCT03329573|581056429|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
160856462|NCT02412306|580864717|FG000|Overall Study|Withdrawal by Subject|0|||
160856463|NCT02412306|580864718|FG001|Overall Study|Withdrawal by Subject|0|||
160856464|NCT02412306|580864719|FG002|Overall Study|Withdrawal by Subject|1|||
160856465|NCT02412306|580864720|FG003|Overall Study|Withdrawal by Subject|0|||
160856466|NCT02412306|580864721|FG004|Overall Study|Withdrawal by Subject|0|||
160856467|NCT02412306|580864717|FG000|Overall Study|Death|5|||
160856468|NCT02412306|580864718|FG001|Overall Study|Death|7|||
160856469|NCT02412306|580864719|FG002|Overall Study|Death|15|||
160856470|NCT02412306|580864720|FG003|Overall Study|Death|0|||
160856471|NCT02412306|580864721|FG004|Overall Study|Death|2|||
160856472|NCT00866177|580864724|FG000|Overall Study|Withdrawal by Subject|1|||
160856473|NCT00866177|580864724|FG000|Overall Study|Not Treated|151|||
160856474|NCT05635461|580864725|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
160856475|NCT05635461|580864726|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
160856476|NCT05635461|580864727|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
160856477|NCT05635461|580864728|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
160856478|NCT05635461|580864729|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
160856479|NCT05635461|580864730|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
160856480|NCT05635461|580864725|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
160856481|NCT05635461|580864726|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
160856482|NCT05635461|580864727|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
160856483|NCT05635461|580864728|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
160856484|NCT05635461|580864729|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
160856485|NCT05635461|580864730|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
160856486|NCT05635461|580864725|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
160856487|NCT05635461|580864726|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
160856488|NCT05635461|580864727|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
160856489|NCT05635461|580864728|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
160856490|NCT05635461|580864729|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
160856491|NCT05635461|580864730|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
160856492|NCT03661723|580864731|FG000|Overall Study|Disease Progression|4|||
160856493|NCT03661723|580864732|FG001|Overall Study|Disease Progression|24|||
160856494|NCT03661723|580864733|FG002|Overall Study|Disease Progression|4|||
160856495|NCT03661723|580864734|FG003|Overall Study|Disease Progression|19|||
160856496|NCT03661723|580864731|FG000|Overall Study|Withdrawal by Subject|1|||
160856497|NCT03661723|580864732|FG001|Overall Study|Withdrawal by Subject|0|||
160856498|NCT03661723|580864733|FG002|Overall Study|Withdrawal by Subject|2|||
160856499|NCT03661723|580864734|FG003|Overall Study|Withdrawal by Subject|4|||
160856500|NCT03661723|580864731|FG000|Overall Study|Physician Decision|1|||
160856501|NCT03661723|580864732|FG001|Overall Study|Physician Decision|0|||
160856502|NCT03661723|580864733|FG002|Overall Study|Physician Decision|0|||
160856503|NCT03661723|580864734|FG003|Overall Study|Physician Decision|0|||
160856504|NCT03661723|580864731|FG000|Overall Study|Clinical Deterioration|0|||
160856505|NCT03661723|580864732|FG001|Overall Study|Clinical Deterioration|0|||
160856506|NCT03661723|580864733|FG002|Overall Study|Clinical Deterioration|0|||
160856507|NCT03661723|580864734|FG003|Overall Study|Clinical Deterioration|1|||
160856508|NCT00807911|580864739|FG000|Overall Study|Withdrawal by Subject|12|||
160856509|NCT00807911|580864740|FG001|Overall Study|Withdrawal by Subject|10|||
160856510|NCT00807911|580864739|FG000|Overall Study|Ineligible|0|||
160856511|NCT00807911|580864740|FG001|Overall Study|Ineligible|4|||
160856512|NCT02648204|580864745|FG000|Overall Study|Withdrawal by Subject|12|||
160856513|NCT02648204|580864746|FG001|Overall Study|Withdrawal by Subject|8|||
160856514|NCT02648204|580864747|FG002|Overall Study|Withdrawal by Subject|2|||
160856515|NCT02648204|580864748|FG003|Overall Study|Withdrawal by Subject|6|||
160856516|NCT02648204|580864745|FG000|Overall Study|Lost to Follow-up|5|||
160856517|NCT02648204|580864746|FG001|Overall Study|Lost to Follow-up|8|||
160856518|NCT02648204|580864747|FG002|Overall Study|Lost to Follow-up|4|||
160856519|NCT02648204|580864748|FG003|Overall Study|Lost to Follow-up|6|||
160856520|NCT02648204|580864745|FG000|Overall Study|Missing follow-up information|4|||
160856521|NCT02648204|580864746|FG001|Overall Study|Missing follow-up information|4|||
160856522|NCT02648204|580864747|FG002|Overall Study|Missing follow-up information|4|||
160856523|NCT02648204|580864748|FG003|Overall Study|Missing follow-up information|2|||
160856524|NCT02648204|580864745|FG000|Overall Study|Death|1|||
160856525|NCT02648204|580864746|FG001|Overall Study|Death|1|||
160856526|NCT02648204|580864747|FG002|Overall Study|Death|2|||
160856527|NCT02648204|580864748|FG003|Overall Study|Death|2|||
160856528|NCT02648204|580864745|FG000|Overall Study|Adverse Event|0|||
160856529|NCT02648204|580864746|FG001|Overall Study|Adverse Event|0|||
160856530|NCT02648204|580864747|FG002|Overall Study|Adverse Event|1|||
160856531|NCT02648204|580864748|FG003|Overall Study|Adverse Event|0|||
160856532|NCT03532542|580864749|FG000|Overall Study|Death|1|||
160856533|NCT03532542|580864750|FG001|Overall Study|Death|0|||
160856534|NCT03532542|580864749|FG000|Overall Study|Study Terminated by Sponsor|41|||
160856535|NCT03532542|580864750|FG001|Overall Study|Study Terminated by Sponsor|65|||
160856536|NCT03532542|580864749|FG000|Overall Study|Withdrawal by Subject|6|||
160856537|NCT03532542|580864750|FG001|Overall Study|Withdrawal by Subject|5|||
160856538|NCT00614575|580864751|FG000|Overall Study|Adverse Event|106|||
160856539|NCT00614575|580864751|FG000|Overall Study|Lost to Follow-up|55|||
160856540|NCT00614575|580864751|FG000|Overall Study|Lack of Efficacy|14|||
160856541|NCT00614575|580864751|FG000|Overall Study|Withdrawal by Subject|6|||
160856542|NCT00614575|580864751|FG000|Overall Study|Death|3|||
160856543|NCT00614575|580864751|FG000|Overall Study|Physician Decision|2|||
160856544|NCT00614575|580864751|FG000|Overall Study|No data were collected.|18|||
160856545|NCT00614575|580864751|FG000|Overall Study|Irregularly enrolled patients|23|||
160856546|NCT00614575|580864751|FG000|Overall Study|No treatment|1|||
160908061|NCT03329573|581056430|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
160908062|NCT03329573|581056431|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
160908063|NCT02777333|581056434|FG000|Overall Study|Withdrawal by Subject|0|||
160908064|NCT02777333|581056435|FG001|Overall Study|Withdrawal by Subject|1|||
160908065|NCT02777333|581056434|FG000|Overall Study|Lost to Follow-up|0|||
160908066|NCT02777333|581056435|FG001|Overall Study|Lost to Follow-up|1|||
160908067|NCT05695209|581056445|FG000|3-months|Withdrawal by Subject|2|||
160908068|NCT05695209|581056446|FG001|3-months|Withdrawal by Subject|0|||
160856547|NCT00189540|580864752|FG000|Overall Study|Withdrawal by Subject|3|||
160856548|NCT00189540|580864753|FG001|Overall Study|Withdrawal by Subject|0|||
160856549|NCT00189540|580864752|FG000|Overall Study|Death|4|||
160856550|NCT00189540|580864753|FG001|Overall Study|Death|1|||
160856551|NCT00472108|580864754|FG000|Overall Study|Lost to Follow-up|0|||
160856552|NCT00472108|580864755|FG001|Overall Study|Lost to Follow-up|1|||
160856553|NCT03882021|580864756|FG000|Enrollment|Procedure aborted/cancelled|2|||
160856554|NCT03882021|580864756|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
160856555|NCT03882021|580864756|FG000|Enrollment to 3-Month|Death|1|||
160856556|NCT03882021|580864756|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
160856557|NCT03882021|580864756|FG000|Enrollment to 3-Month|Missed Visit|4|||
160908069|NCT05695209|581056445|FG000|3-months|Unable to contact for 3-month data collection|0|||
160856558|NCT03882021|580864756|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
160856559|NCT03882021|580864756|FG000|6-Month to 12-Month Visit|Death|1|||
160856560|NCT03882021|580864756|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
160856561|NCT00286442|580864757|FG000|Overall Study|Hyperglycemic Rescue|19|||
160856562|NCT00286442|580864758|FG001|Overall Study|Hyperglycemic Rescue|17|||
160856563|NCT00286442|580864759|FG002|Overall Study|Hyperglycemic Rescue|25|||
160856564|NCT00286442|580864757|FG000|Overall Study|Adverse Event|7|||
160856565|NCT00286442|580864758|FG001|Overall Study|Adverse Event|6|||
160856566|NCT00286442|580864759|FG002|Overall Study|Adverse Event|1|||
160856567|NCT00286442|580864757|FG000|Overall Study|Protocol Violation|2|||
160856568|NCT00286442|580864758|FG001|Overall Study|Protocol Violation|4|||
160856569|NCT00286442|580864759|FG002|Overall Study|Protocol Violation|2|||
160856570|NCT00286442|580864757|FG000|Overall Study|Lost to Follow-up|5|||
160908070|NCT05695209|581056446|FG001|3-months|Unable to contact for 3-month data collection|1|||
160908071|NCT05695209|581056445|FG000|6-months|Lost to Follow-up|1|||
160908072|NCT05695209|581056446|FG001|6-months|Lost to Follow-up|1|||
160908073|NCT04698187|581056452|FG000|Overall Study|Withdrawal by Subject|7|||
160908074|NCT04698187|581056452|FG000|Overall Study|Death|21|||
160908075|NCT04698187|581056452|FG000|Overall Study|Sponsor Decision|15|||
160908076|NCT04698187|581056452|FG000|Overall Study|In-transit Disease|1|||
160908077|NCT03069378|581056453|FG000|Overall Study|Withdrawal by Subject|1|||
160908078|NCT02993146|581056454|FG000|Overall Study|Withdrawal by Subject|0|||
160993359|NCT02001623|581365333|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
160993360|NCT02001623|581365334|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
160856571|NCT00286442|580864758|FG001|Overall Study|Lost to Follow-up|2|||
160856572|NCT00286442|580864759|FG002|Overall Study|Lost to Follow-up|1|||
160856573|NCT00286442|580864757|FG000|Overall Study|Physician Decision|1|||
160856574|NCT00286442|580864758|FG001|Overall Study|Physician Decision|1|||
160856575|NCT00286442|580864759|FG002|Overall Study|Physician Decision|1|||
160856576|NCT00286442|580864757|FG000|Overall Study|Administrative Error|1|||
160856577|NCT00286442|580864758|FG001|Overall Study|Administrative Error|1|||
160856578|NCT00286442|580864759|FG002|Overall Study|Administrative Error|0|||
160856579|NCT00286442|580864757|FG000|Overall Study|Withdrawal by Subject|2|||
160856580|NCT00286442|580864758|FG001|Overall Study|Withdrawal by Subject|14|||
160856581|NCT00286442|580864759|FG002|Overall Study|Withdrawal by Subject|2|||
160908079|NCT02993146|581056455|FG001|Overall Study|Withdrawal by Subject|0|||
160993361|NCT02001623|581365335|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
160993362|NCT02001623|581365336|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
160993363|NCT01063036|581365339|FG000|Participants Treated With Study Drug|Adverse Event|1|||
160993364|NCT01063036|581365339|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
160993365|NCT01063036|581365339|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
160856582|NCT03582215|580864762|FG000|Overall Study|Adverse Event|1|||
160856583|NCT03582215|580864763|FG001|Overall Study|Adverse Event|0|||
160856584|NCT03582215|580864764|FG002|Overall Study|Adverse Event|0|||
160856585|NCT03582215|580864765|FG003|Overall Study|Adverse Event|0|||
160856586|NCT03582215|580864766|FG004|Overall Study|Adverse Event|0|||
160908080|NCT02993146|581056456|FG002|Overall Study|Withdrawal by Subject|1|||
160908081|NCT02993146|581056457|FG003|Overall Study|Withdrawal by Subject|1|||
160856587|NCT03582215|580864767|FG005|Overall Study|Adverse Event|0|||
160856588|NCT03582215|580864768|FG006|Overall Study|Adverse Event|2|||
160856589|NCT03582215|580864769|FG007|Overall Study|Adverse Event|2|||
160856590|NCT02174731|580864770|FG000|Overall Study|Participant decision|67|||
160856591|NCT02174731|580864771|FG001|Overall Study|Participant decision|64|||
160856592|NCT02174731|580864770|FG000|Overall Study|Incorrect enrolment before randomization|0|||
160856593|NCT02174731|580864771|FG001|Overall Study|Incorrect enrolment before randomization|1|||
160856594|NCT02174731|580864770|FG000|Overall Study|Missing|2|||
160856595|NCT02174731|580864771|FG001|Overall Study|Missing|0|||
160856596|NCT00079040|580864772|FG000|Overall Study|Withdrew before treatment|1|||
160856597|NCT00079040|580864772|FG000|Overall Study|Ineligible|1|||
160856598|NCT01046565|580864790|FG000|Overall Study|Adverse Event|2|||
160856599|NCT01046565|580864790|FG000|Overall Study|Withdrawal by Subject|7|||
160856600|NCT03740048|580864791|FG000|Overall Study|Withdrawal by Subject|1|||
160856601|NCT03740048|580864792|FG001|Overall Study|Withdrawal by Subject|1|||
160856602|NCT03740048|580864791|FG000|Overall Study|Death|1|||
160856603|NCT03740048|580864792|FG001|Overall Study|Death|6|||
160856604|NCT03740048|580864791|FG000|Overall Study|Switched to thrice-weekly HD|2|||
160856605|NCT03740048|580864792|FG001|Overall Study|Switched to thrice-weekly HD|0|||
160856606|NCT03740048|580864791|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
160856607|NCT03740048|580864792|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
160856608|NCT03740048|580864791|FG000|Overall Study|Lost to Follow-up|0|||
160856609|NCT03740048|580864792|FG001|Overall Study|Lost to Follow-up|1|||
160856610|NCT03740048|580864791|FG000|Overall Study|Non-compliance with HD|0|||
160856611|NCT03740048|580864792|FG001|Overall Study|Non-compliance with HD|1|||
160856612|NCT03261336|580864793|FG000|Overall Study|Adverse Event|1|||
160856613|NCT01069484|580864794|FG000|Overall Study|Death-in-near-family|1|||
160856614|NCT01069484|580864795|FG001|Overall Study|Death-in-near-family|0|||
160856615|NCT01069484|580864794|FG000|Overall Study|No specific reason|8|||
160856616|NCT01069484|580864795|FG001|Overall Study|No specific reason|2|||
160856617|NCT01069484|580864794|FG000|Overall Study|Illness mother or child|3|||
160856618|NCT01069484|580864795|FG001|Overall Study|Illness mother or child|1|||
160856619|NCT00292942|580864796|FG000|Overall Study|Withdrawal by Subject|0|||
160856620|NCT00292942|580864797|FG001|Overall Study|Withdrawal by Subject|0|||
160856621|NCT00292942|580864798|FG002|Overall Study|Withdrawal by Subject|1|||
160856622|NCT00292942|580864799|FG003|Overall Study|Withdrawal by Subject|0|||
160856623|NCT00292942|580864796|FG000|Overall Study|Adverse Event|0|||
160856624|NCT00292942|580864797|FG001|Overall Study|Adverse Event|0|||
160856625|NCT00292942|580864798|FG002|Overall Study|Adverse Event|0|||
160856626|NCT00292942|580864799|FG003|Overall Study|Adverse Event|1|||
160856627|NCT00644358|580864800|FG000|Overall Study|Adverse Event|124|||
160856628|NCT00644358|580864800|FG000|Overall Study|Lost to Follow-up|105|||
160856629|NCT00644358|580864800|FG000|Overall Study|Consent Withdrawal|64|||
160856630|NCT00644358|580864800|FG000|Overall Study|Lack of Effectiveness|39|||
160908082|NCT01397708|581056458|FG000|Overall Study|Withdrawal by Subject|0|||
160569275|NCT04358458|579807042|FG004|Overall Study|Sponsor request|2|||
160569276|NCT04358458|579807043|FG005|Overall Study|Sponsor request|3|||
160569277|NCT04358458|579807044|FG006|Overall Study|Sponsor request|1|||
160569278|NCT04358458|579807045|FG007|Overall Study|Sponsor request|1|||
160569279|NCT04358458|579807038|FG000|Overall Study|Withdrawal by Subject|0|||
160569280|NCT04358458|579807039|FG001|Overall Study|Withdrawal by Subject|0|||
160569281|NCT04358458|579807040|FG002|Overall Study|Withdrawal by Subject|1|||
160569282|NCT04358458|579807041|FG003|Overall Study|Withdrawal by Subject|1|||
160569283|NCT04358458|579807042|FG004|Overall Study|Withdrawal by Subject|0|||
160569284|NCT04358458|579807043|FG005|Overall Study|Withdrawal by Subject|1|||
160569285|NCT04358458|579807044|FG006|Overall Study|Withdrawal by Subject|0|||
160569286|NCT04358458|579807045|FG007|Overall Study|Withdrawal by Subject|1|||
160569287|NCT05781542|579809087|FG000|Overall Study|Lost to Follow-up|1|||
160569288|NCT05781542|579809088|FG001|Overall Study|Lost to Follow-up|0|||
160856631|NCT00644358|580864800|FG000|Overall Study|Protocol Violation|5|||
160569289|NCT05781542|579809089|FG002|Overall Study|Lost to Follow-up|1|||
160569290|NCT01843374|579809094|FG000|Overall Study|Death|155|||
160856632|NCT00644358|580864800|FG000|Overall Study|Noncompliance|14|||
160856633|NCT00644358|580864800|FG000|Overall Study|Other Unspecified|11|||
160856634|NCT01290523|580864803|FG000|Overall Study|Death|3|||
160856635|NCT04158583|580864804|FG000|Overall Study|Withdrawal by Subject|1|||
160856636|NCT04158583|580864805|FG001|Overall Study|Withdrawal by Subject|1|||
160856637|NCT04158583|580864806|FG002|Overall Study|Withdrawal by Subject|0|||
160856638|NCT04158583|580864807|FG003|Overall Study|Withdrawal by Subject|0|||
160650835|NCT01296932|580104344|FG008|Overall Study|Dose limiting toxicity|1|||
160650836|NCT01296932|580104336|FG000|Overall Study|Progressive disease|2|||
160650837|NCT01296932|580104337|FG001|Overall Study|Progressive disease|0|||
160650838|NCT01296932|580104338|FG002|Overall Study|Progressive disease|1|||
160650839|NCT01296932|580104339|FG003|Overall Study|Progressive disease|1|||
160650840|NCT01296932|580104340|FG004|Overall Study|Progressive disease|2|||
160650841|NCT01296932|580104341|FG005|Overall Study|Progressive disease|3|||
160650842|NCT01296932|580104342|FG006|Overall Study|Progressive disease|1|||
160650843|NCT01296932|580104343|FG007|Overall Study|Progressive disease|0|||
160650844|NCT01296932|580104344|FG008|Overall Study|Progressive disease|0|||
160650845|NCT01296932|580104336|FG000|Overall Study|Withdrawal by Subject|0|||
160650846|NCT01296932|580104337|FG001|Overall Study|Withdrawal by Subject|0|||
160650847|NCT01296932|580104338|FG002|Overall Study|Withdrawal by Subject|1|||
160650848|NCT01296932|580104339|FG003|Overall Study|Withdrawal by Subject|1|||
160650849|NCT01296932|580104340|FG004|Overall Study|Withdrawal by Subject|0|||
160650850|NCT01296932|580104341|FG005|Overall Study|Withdrawal by Subject|0|||
160650851|NCT01296932|580104342|FG006|Overall Study|Withdrawal by Subject|3|||
160650852|NCT01296932|580104343|FG007|Overall Study|Withdrawal by Subject|0|||
160650853|NCT01296932|580104344|FG008|Overall Study|Withdrawal by Subject|0|||
160650854|NCT01296932|580104336|FG000|Overall Study|Adverse Event|1|||
160650855|NCT01296932|580104337|FG001|Overall Study|Adverse Event|1|||
160650856|NCT01296932|580104338|FG002|Overall Study|Adverse Event|1|||
160650857|NCT01296932|580104339|FG003|Overall Study|Adverse Event|2|||
160650858|NCT01296932|580104340|FG004|Overall Study|Adverse Event|1|||
160650859|NCT01296932|580104341|FG005|Overall Study|Adverse Event|0|||
160650860|NCT01296932|580104342|FG006|Overall Study|Adverse Event|0|||
160650861|NCT01296932|580104343|FG007|Overall Study|Adverse Event|0|||
160650862|NCT01296932|580104344|FG008|Overall Study|Adverse Event|1|||
160650863|NCT01296932|580104336|FG000|Overall Study|Investigator decision|0|||
160650864|NCT01296932|580104337|FG001|Overall Study|Investigator decision|1|||
160650865|NCT01296932|580104338|FG002|Overall Study|Investigator decision|0|||
160650866|NCT01296932|580104339|FG003|Overall Study|Investigator decision|1|||
160650867|NCT01296932|580104340|FG004|Overall Study|Investigator decision|0|||
160650868|NCT01296932|580104341|FG005|Overall Study|Investigator decision|0|||
160650869|NCT01296932|580104342|FG006|Overall Study|Investigator decision|1|||
160650870|NCT01296932|580104343|FG007|Overall Study|Investigator decision|0|||
160650871|NCT01296932|580104344|FG008|Overall Study|Investigator decision|1|||
160650872|NCT01296932|580104336|FG000|Overall Study|No clinical benefit anymore|0|||
160650873|NCT01296932|580104337|FG001|Overall Study|No clinical benefit anymore|1|||
160650874|NCT01296932|580104338|FG002|Overall Study|No clinical benefit anymore|0|||
160650875|NCT01296932|580104339|FG003|Overall Study|No clinical benefit anymore|0|||
160650876|NCT01296932|580104340|FG004|Overall Study|No clinical benefit anymore|0|||
160650877|NCT01296932|580104341|FG005|Overall Study|No clinical benefit anymore|0|||
160650878|NCT01296932|580104342|FG006|Overall Study|No clinical benefit anymore|0|||
160650879|NCT01296932|580104343|FG007|Overall Study|No clinical benefit anymore|0|||
160650880|NCT01296932|580104344|FG008|Overall Study|No clinical benefit anymore|0|||
160650881|NCT01296932|580104336|FG000|Overall Study|Physician Decision|0|||
160650882|NCT01296932|580104337|FG001|Overall Study|Physician Decision|0|||
160650883|NCT01296932|580104338|FG002|Overall Study|Physician Decision|1|||
160650884|NCT01296932|580104339|FG003|Overall Study|Physician Decision|0|||
160650885|NCT01296932|580104340|FG004|Overall Study|Physician Decision|0|||
160650886|NCT01296932|580104341|FG005|Overall Study|Physician Decision|0|||
160650887|NCT01296932|580104342|FG006|Overall Study|Physician Decision|0|||
160650888|NCT01296932|580104343|FG007|Overall Study|Physician Decision|0|||
160650889|NCT01296932|580104344|FG008|Overall Study|Physician Decision|0|||
160650890|NCT01296932|580104336|FG000|Overall Study|IV problems, administration not possible|0|||
160650891|NCT01296932|580104337|FG001|Overall Study|IV problems, administration not possible|0|||
160650892|NCT01296932|580104338|FG002|Overall Study|IV problems, administration not possible|1|||
160650893|NCT01296932|580104339|FG003|Overall Study|IV problems, administration not possible|0|||
160650894|NCT01296932|580104340|FG004|Overall Study|IV problems, administration not possible|0|||
160650895|NCT01296932|580104341|FG005|Overall Study|IV problems, administration not possible|0|||
160650896|NCT01296932|580104342|FG006|Overall Study|IV problems, administration not possible|0|||
160650897|NCT01296932|580104343|FG007|Overall Study|IV problems, administration not possible|0|||
160650898|NCT01296932|580104344|FG008|Overall Study|IV problems, administration not possible|0|||
160650899|NCT01296932|580104336|FG000|Overall Study|per protocol|0|||
160650900|NCT01296932|580104337|FG001|Overall Study|per protocol|0|||
160650901|NCT01296932|580104338|FG002|Overall Study|per protocol|1|||
160650902|NCT01296932|580104339|FG003|Overall Study|per protocol|1|||
160650903|NCT01296932|580104340|FG004|Overall Study|per protocol|0|||
160650904|NCT01296932|580104341|FG005|Overall Study|per protocol|0|||
160650905|NCT01296932|580104342|FG006|Overall Study|per protocol|0|||
160650906|NCT01296932|580104343|FG007|Overall Study|per protocol|0|||
160650907|NCT01296932|580104344|FG008|Overall Study|per protocol|0|||
160650908|NCT01296932|580104336|FG000|Overall Study|Low benefit and too many side effects|0|||
160650909|NCT01296932|580104337|FG001|Overall Study|Low benefit and too many side effects|0|||
160650910|NCT01296932|580104338|FG002|Overall Study|Low benefit and too many side effects|0|||
160650911|NCT01296932|580104339|FG003|Overall Study|Low benefit and too many side effects|0|||
160650912|NCT01296932|580104340|FG004|Overall Study|Low benefit and too many side effects|0|||
160650913|NCT01296932|580104341|FG005|Overall Study|Low benefit and too many side effects|0|||
160650914|NCT01296932|580104342|FG006|Overall Study|Low benefit and too many side effects|0|||
160650915|NCT01296932|580104343|FG007|Overall Study|Low benefit and too many side effects|1|||
160650916|NCT01296932|580104344|FG008|Overall Study|Low benefit and too many side effects|0|||
160650917|NCT01296932|580104336|FG000|Overall Study|No adequate treatment response|0|||
160650918|NCT01296932|580104337|FG001|Overall Study|No adequate treatment response|0|||
160650919|NCT01296932|580104338|FG002|Overall Study|No adequate treatment response|0|||
160650920|NCT01296932|580104339|FG003|Overall Study|No adequate treatment response|0|||
160650921|NCT01296932|580104340|FG004|Overall Study|No adequate treatment response|0|||
160650922|NCT01296932|580104341|FG005|Overall Study|No adequate treatment response|0|||
160650923|NCT01296932|580104342|FG006|Overall Study|No adequate treatment response|0|||
160650924|NCT01296932|580104343|FG007|Overall Study|No adequate treatment response|1|||
160650925|NCT01296932|580104344|FG008|Overall Study|No adequate treatment response|0|||
160650926|NCT01296932|580104336|FG000|Overall Study|Dosage already reduced, AE still present|0|||
160650927|NCT01296932|580104337|FG001|Overall Study|Dosage already reduced, AE still present|0|||
160650928|NCT01296932|580104338|FG002|Overall Study|Dosage already reduced, AE still present|0|||
160650929|NCT01296932|580104339|FG003|Overall Study|Dosage already reduced, AE still present|0|||
160650930|NCT01296932|580104340|FG004|Overall Study|Dosage already reduced, AE still present|0|||
160650931|NCT01296932|580104341|FG005|Overall Study|Dosage already reduced, AE still present|0|||
160650932|NCT01296932|580104342|FG006|Overall Study|Dosage already reduced, AE still present|0|||
160650933|NCT01296932|580104343|FG007|Overall Study|Dosage already reduced, AE still present|0|||
160650934|NCT01296932|580104344|FG008|Overall Study|Dosage already reduced, AE still present|1|||
160650935|NCT02489318|580104345|FG000|Randomized|Withdrawal by Subject|0|||
160650936|NCT02489318|580104346|FG001|Randomized|Withdrawal by Subject|1|||
160650937|NCT02489318|580104345|FG000|Treated|Adverse Event|19|||
160650938|NCT02489318|580104346|FG001|Treated|Adverse Event|62|||
160650939|NCT02489318|580104345|FG000|Treated|Death|13|||
160650940|NCT02489318|580104346|FG001|Treated|Death|11|||
160650941|NCT02489318|580104345|FG000|Treated|Physician Decision|4|||
160650942|NCT02489318|580104346|FG001|Treated|Physician Decision|6|||
160650943|NCT02489318|580104345|FG000|Treated|Protocol Violation|1|||
160650944|NCT02489318|580104346|FG001|Treated|Protocol Violation|2|||
160650945|NCT02489318|580104345|FG000|Treated|Withdrawal by Subject|37|||
160650946|NCT02489318|580104346|FG001|Treated|Withdrawal by Subject|36|||
160650947|NCT02489318|580104345|FG000|Treated|Other: Progressive Disease|245|||
160650948|NCT02489318|580104346|FG001|Treated|Other: Progressive Disease|138|||
160650949|NCT02489318|580104345|FG000|Treated|Other|0|||
160650950|NCT02489318|580104346|FG001|Treated|Other|2|||
160650951|NCT02489318|580104345|FG000|Treated|Ongoing|0|||
160650952|NCT02489318|580104346|FG001|Treated|Ongoing|267|||
160650953|NCT02637557|580104352|FG000|Overall Study|Adverse Event|3|||
160650954|NCT02637557|580104353|FG001|Overall Study|Adverse Event|1|||
160650955|NCT02637557|580104354|FG002|Overall Study|Adverse Event|3|||
160650956|NCT02637557|580104355|FG003|Overall Study|Adverse Event|3|||
160650957|NCT02637557|580104352|FG000|Overall Study|Lost to Follow-up|1|||
160650958|NCT02637557|580104353|FG001|Overall Study|Lost to Follow-up|1|||
160650959|NCT02637557|580104354|FG002|Overall Study|Lost to Follow-up|0|||
160650960|NCT02637557|580104355|FG003|Overall Study|Lost to Follow-up|1|||
160650961|NCT02637557|580104352|FG000|Overall Study|Physician Decision|1|||
160650962|NCT02637557|580104353|FG001|Overall Study|Physician Decision|0|||
160650963|NCT02637557|580104354|FG002|Overall Study|Physician Decision|0|||
160650964|NCT02637557|580104355|FG003|Overall Study|Physician Decision|0|||
160650965|NCT02637557|580104352|FG000|Overall Study|Protocol Violation|2|||
160650966|NCT02637557|580104353|FG001|Overall Study|Protocol Violation|0|||
160650967|NCT02637557|580104354|FG002|Overall Study|Protocol Violation|2|||
160650968|NCT02637557|580104355|FG003|Overall Study|Protocol Violation|1|||
160650969|NCT02637557|580104352|FG000|Overall Study|Withdrawal by Subject|1|||
160650970|NCT02637557|580104353|FG001|Overall Study|Withdrawal by Subject|3|||
160650971|NCT02637557|580104354|FG002|Overall Study|Withdrawal by Subject|4|||
160650972|NCT02637557|580104355|FG003|Overall Study|Withdrawal by Subject|2|||
160650973|NCT05218655|580104356|FG000|Overall Study|Adverse Event|6|||
160650974|NCT05218655|580104356|FG000|Overall Study|Sponsor's decision|85|||
160650975|NCT05218655|580104356|FG000|Overall Study|Death|1|||
160650976|NCT05218655|580104356|FG000|Overall Study|Lost to Follow-up|3|||
160650977|NCT05218655|580104356|FG000|Overall Study|Withdrawal by Subject|3|||
160650978|NCT05218655|580104356|FG000|Overall Study|Other than specified|3|||
160650979|NCT02918162|580104359|FG000|Overall Study|Withdrawal by Subject|1|||
160650980|NCT02918162|580104359|FG000|Overall Study|Omental Disease|1|||
160650981|NCT02227862|580104360|FG000|Overall Study|Protocol Violation|7|||
160650982|NCT02227862|580104361|FG001|Overall Study|Protocol Violation|9|||
160650983|NCT02227862|580104360|FG000|Overall Study|Other|0|||
160650984|NCT02227862|580104361|FG001|Overall Study|Other|2|||
160650985|NCT02227862|580104360|FG000|Overall Study|Adverse Event|4|||
160650986|NCT02227862|580104361|FG001|Overall Study|Adverse Event|3|||
160856639|NCT04158583|580864808|FG004|Overall Study|Withdrawal by Subject|1|||
160856640|NCT04158583|580864809|FG005|Overall Study|Withdrawal by Subject|0|||
160856641|NCT04158583|580864810|FG006|Overall Study|Withdrawal by Subject|0|||
160856642|NCT04158583|580864811|FG007|Overall Study|Withdrawal by Subject|0|||
160856643|NCT04158583|580864812|FG008|Overall Study|Withdrawal by Subject|2|||
160856644|NCT04158583|580864813|FG009|Overall Study|Withdrawal by Subject|0|||
160856645|NCT04158583|580864804|FG000|Overall Study|Study Terminated by Sponsor|0|||
160856646|NCT04158583|580864805|FG001|Overall Study|Study Terminated by Sponsor|0|||
160856647|NCT04158583|580864806|FG002|Overall Study|Study Terminated by Sponsor|0|||
160856648|NCT04158583|580864807|FG003|Overall Study|Study Terminated by Sponsor|1|||
160856649|NCT04158583|580864808|FG004|Overall Study|Study Terminated by Sponsor|0|||
160856650|NCT04158583|580864809|FG005|Overall Study|Study Terminated by Sponsor|0|||
160856651|NCT04158583|580864810|FG006|Overall Study|Study Terminated by Sponsor|0|||
160856652|NCT04158583|580864811|FG007|Overall Study|Study Terminated by Sponsor|0|||
160856653|NCT04158583|580864812|FG008|Overall Study|Study Terminated by Sponsor|0|||
160856654|NCT04158583|580864813|FG009|Overall Study|Study Terminated by Sponsor|0|||
160856655|NCT04158583|580864804|FG000|Overall Study|Progressive Disease|1|||
160856656|NCT04158583|580864805|FG001|Overall Study|Progressive Disease|0|||
160856657|NCT04158583|580864806|FG002|Overall Study|Progressive Disease|3|||
160856658|NCT04158583|580864807|FG003|Overall Study|Progressive Disease|5|||
160856659|NCT04158583|580864808|FG004|Overall Study|Progressive Disease|0|||
160856660|NCT04158583|580864809|FG005|Overall Study|Progressive Disease|1|||
160856661|NCT04158583|580864810|FG006|Overall Study|Progressive Disease|6|||
160856662|NCT04158583|580864811|FG007|Overall Study|Progressive Disease|2|||
160856663|NCT04158583|580864812|FG008|Overall Study|Progressive Disease|1|||
160856664|NCT04158583|580864813|FG009|Overall Study|Progressive Disease|2|||
160856665|NCT04158583|580864804|FG000|Overall Study|Lost to Follow-up|0|||
160856666|NCT04158583|580864805|FG001|Overall Study|Lost to Follow-up|0|||
160908083|NCT01397708|581056459|FG001|Overall Study|Withdrawal by Subject|0|||
160908084|NCT01397708|581056460|FG002|Overall Study|Withdrawal by Subject|1|||
160908085|NCT01397708|581056461|FG003|Overall Study|Withdrawal by Subject|0|||
160908086|NCT01397708|581056462|FG004|Overall Study|Withdrawal by Subject|0|||
160908087|NCT01397708|581056463|FG005|Overall Study|Withdrawal by Subject|0|||
160908088|NCT01397708|581056464|FG006|Overall Study|Withdrawal by Subject|0|||
160908089|NCT01397708|581056465|FG007|Overall Study|Withdrawal by Subject|1|||
160908090|NCT01397708|581056458|FG000|Overall Study|Death|0|||
160908091|NCT01397708|581056459|FG001|Overall Study|Death|0|||
160908092|NCT01397708|581056460|FG002|Overall Study|Death|1|||
160856667|NCT04158583|580864806|FG002|Overall Study|Lost to Follow-up|1|||
160856668|NCT04158583|580864807|FG003|Overall Study|Lost to Follow-up|1|||
160856669|NCT04158583|580864808|FG004|Overall Study|Lost to Follow-up|1|||
160856670|NCT04158583|580864809|FG005|Overall Study|Lost to Follow-up|0|||
160856671|NCT04158583|580864810|FG006|Overall Study|Lost to Follow-up|0|||
160856672|NCT04158583|580864811|FG007|Overall Study|Lost to Follow-up|0|||
160856673|NCT04158583|580864812|FG008|Overall Study|Lost to Follow-up|0|||
160856674|NCT04158583|580864813|FG009|Overall Study|Lost to Follow-up|0|||
160856675|NCT04158583|580864804|FG000|Overall Study|Due To Patient Status|0|||
160856676|NCT04158583|580864805|FG001|Overall Study|Due To Patient Status|0|||
160856677|NCT04158583|580864806|FG002|Overall Study|Due To Patient Status|0|||
160569291|NCT01843374|579809095|FG001|Overall Study|Death|313|||
160454068|NCT02038777|579394026|FG004|Overall Study|Started Chemotherapy|0|||
160569292|NCT01843374|579809094|FG000|Overall Study|Withdrawal by Subject|14|||
160569293|NCT01843374|579809095|FG001|Overall Study|Withdrawal by Subject|20|||
160569294|NCT01843374|579809094|FG000|Overall Study|Withdrawing due to Other reason|20|||
160569295|NCT01843374|579809095|FG001|Overall Study|Withdrawing due to Other reason|46|||
160569296|NCT01826214|579809096|FG000|Overall Study|Adverse Event|7|||
160569297|NCT01826214|579809097|FG001|Overall Study|Adverse Event|6|||
160569298|NCT01826214|579809096|FG000|Overall Study|Death|3|||
160569299|NCT01826214|579809097|FG001|Overall Study|Death|1|||
160569300|NCT01826214|579809096|FG000|Overall Study|Lost to Follow-up|1|||
160569301|NCT01826214|579809097|FG001|Overall Study|Lost to Follow-up|0|||
160569302|NCT01826214|579809096|FG000|Overall Study|Physician Decision|0|||
160569303|NCT01826214|579809097|FG001|Overall Study|Physician Decision|2|||
160569304|NCT01826214|579809096|FG000|Overall Study|Progressive disease|22|||
160569305|NCT01826214|579809097|FG001|Overall Study|Progressive disease|21|||
160569306|NCT01826214|579809096|FG000|Overall Study|Study terminated by Sponsor|0|||
160856678|NCT04158583|580864807|FG003|Overall Study|Due To Patient Status|0|||
160856679|NCT04158583|580864808|FG004|Overall Study|Due To Patient Status|0|||
160856680|NCT04158583|580864809|FG005|Overall Study|Due To Patient Status|0|||
160856681|NCT04158583|580864810|FG006|Overall Study|Due To Patient Status|0|||
160856682|NCT04158583|580864811|FG007|Overall Study|Due To Patient Status|0|||
160856683|NCT04158583|580864812|FG008|Overall Study|Due To Patient Status|1|||
160856684|NCT04158583|580864813|FG009|Overall Study|Due To Patient Status|0|||
160908093|NCT01397708|581056461|FG003|Overall Study|Death|1|||
160908094|NCT01397708|581056462|FG004|Overall Study|Death|0|||
160569307|NCT01826214|579809097|FG001|Overall Study|Study terminated by Sponsor|1|||
160571908|NCT01743027|579816861|FG000|Overall Study|Protocol Violation|1|||
160908095|NCT01397708|581056463|FG005|Overall Study|Death|0|||
160908096|NCT01397708|581056464|FG006|Overall Study|Death|0|||
160908097|NCT01397708|581056465|FG007|Overall Study|Death|0|||
160908098|NCT01397708|581056458|FG000|Overall Study|Lost to Follow-up|0|||
160908099|NCT01397708|581056459|FG001|Overall Study|Lost to Follow-up|0|||
160908100|NCT01397708|581056460|FG002|Overall Study|Lost to Follow-up|0|||
160908101|NCT01397708|581056461|FG003|Overall Study|Lost to Follow-up|0|||
160908102|NCT01397708|581056462|FG004|Overall Study|Lost to Follow-up|1|||
160908103|NCT01397708|581056463|FG005|Overall Study|Lost to Follow-up|0|||
160908104|NCT01397708|581056464|FG006|Overall Study|Lost to Follow-up|0|||
160908105|NCT01397708|581056465|FG007|Overall Study|Lost to Follow-up|0|||
160908106|NCT01397708|581056458|FG000|Overall Study|Other|0|||
160908107|NCT01397708|581056459|FG001|Overall Study|Other|0|||
160908108|NCT01397708|581056460|FG002|Overall Study|Other|0|||
160908109|NCT01397708|581056461|FG003|Overall Study|Other|0|||
160908110|NCT01397708|581056462|FG004|Overall Study|Other|0|||
160908111|NCT01397708|581056463|FG005|Overall Study|Other|0|||
160908112|NCT01397708|581056464|FG006|Overall Study|Other|1|||
160908113|NCT01397708|581056465|FG007|Overall Study|Other|0|||
160908114|NCT04362072|581056466|FG000|Treatment|Adverse Event|1|||
160908115|NCT04362072|581056466|FG000|Treatment|Death|9|||
160908116|NCT04362072|581056466|FG000|Treatment|Physician Decision|2|||
160908117|NCT04362072|581056466|FG000|Treatment|Progressive disease|27|||
160908118|NCT04362072|581056466|FG000|Treatment|Withdrawal by Subject|4|||
160908119|NCT04362072|581056466|FG000|Treatment|Global deterioration of health status|1|||
160908120|NCT04362072|581056466|FG000|Treatment|Switched to commercial Lorlatinib|13|||
160856685|NCT04158583|580864804|FG000|Overall Study|Death|3|||
160856686|NCT04158583|580864805|FG001|Overall Study|Death|4|||
160856687|NCT04158583|580864806|FG002|Overall Study|Death|2|||
160856688|NCT04158583|580864807|FG003|Overall Study|Death|2|||
160856689|NCT04158583|580864808|FG004|Overall Study|Death|4|||
160856690|NCT04158583|580864809|FG005|Overall Study|Death|3|||
160856691|NCT04158583|580864810|FG006|Overall Study|Death|5|||
160856692|NCT04158583|580864811|FG007|Overall Study|Death|2|||
160856693|NCT04158583|580864812|FG008|Overall Study|Death|0|||
160856694|NCT04158583|580864813|FG009|Overall Study|Death|1|||
160856695|NCT04158583|580864804|FG000|Overall Study|Clinical Progression Disease|0|||
160856696|NCT04158583|580864805|FG001|Overall Study|Clinical Progression Disease|0|||
160856697|NCT04158583|580864806|FG002|Overall Study|Clinical Progression Disease|0|||
160856698|NCT04158583|580864807|FG003|Overall Study|Clinical Progression Disease|1|||
160856699|NCT04158583|580864808|FG004|Overall Study|Clinical Progression Disease|0|||
160856700|NCT04158583|580864809|FG005|Overall Study|Clinical Progression Disease|0|||
160856701|NCT04158583|580864810|FG006|Overall Study|Clinical Progression Disease|0|||
160856702|NCT04158583|580864811|FG007|Overall Study|Clinical Progression Disease|0|||
160856703|NCT04158583|580864812|FG008|Overall Study|Clinical Progression Disease|0|||
160856704|NCT04158583|580864813|FG009|Overall Study|Clinical Progression Disease|0|||
160856705|NCT04158583|580864804|FG000|Overall Study|Clinical Progression|0|||
160856706|NCT04158583|580864805|FG001|Overall Study|Clinical Progression|0|||
160856707|NCT04158583|580864806|FG002|Overall Study|Clinical Progression|0|||
160856708|NCT04158583|580864807|FG003|Overall Study|Clinical Progression|0|||
160856709|NCT04158583|580864808|FG004|Overall Study|Clinical Progression|1|||
160856710|NCT04158583|580864809|FG005|Overall Study|Clinical Progression|0|||
160856711|NCT04158583|580864810|FG006|Overall Study|Clinical Progression|2|||
160856712|NCT04158583|580864811|FG007|Overall Study|Clinical Progression|0|||
160856713|NCT04158583|580864812|FG008|Overall Study|Clinical Progression|0|||
160856714|NCT04158583|580864813|FG009|Overall Study|Clinical Progression|0|||
160856715|NCT04158583|580864804|FG000|Overall Study|Clinical Deterioration|0|||
160856716|NCT04158583|580864805|FG001|Overall Study|Clinical Deterioration|0|||
160856717|NCT04158583|580864806|FG002|Overall Study|Clinical Deterioration|0|||
160856718|NCT04158583|580864807|FG003|Overall Study|Clinical Deterioration|1|||
160856719|NCT04158583|580864808|FG004|Overall Study|Clinical Deterioration|0|||
160856720|NCT04158583|580864809|FG005|Overall Study|Clinical Deterioration|0|||
160856721|NCT04158583|580864810|FG006|Overall Study|Clinical Deterioration|0|||
160856722|NCT04158583|580864811|FG007|Overall Study|Clinical Deterioration|0|||
160856723|NCT04158583|580864812|FG008|Overall Study|Clinical Deterioration|0|||
160856724|NCT04158583|580864813|FG009|Overall Study|Clinical Deterioration|1|||
160856725|NCT01602224|580866487|FG000|Overall Study|Adverse Event|0|||
160856726|NCT01602224|580866488|FG001|Overall Study|Adverse Event|1|||
160856727|NCT01602224|580866489|FG002|Overall Study|Adverse Event|0|||
160856728|NCT01602224|580866487|FG000|Overall Study|Investigator Decison|1|||
160856729|NCT01602224|580866488|FG001|Overall Study|Investigator Decison|0|||
160856730|NCT01602224|580866489|FG002|Overall Study|Investigator Decison|0|||
160856731|NCT01602224|580866487|FG000|Overall Study|Lost to Follow-up|0|||
160856732|NCT01602224|580866488|FG001|Overall Study|Lost to Follow-up|0|||
160856733|NCT01602224|580866489|FG002|Overall Study|Lost to Follow-up|1|||
160856734|NCT01602224|580866487|FG000|Overall Study|Protocol Violation|0|||
160856735|NCT01602224|580866488|FG001|Overall Study|Protocol Violation|1|||
160856736|NCT01602224|580866489|FG002|Overall Study|Protocol Violation|0|||
160856737|NCT01602224|580866487|FG000|Overall Study|Sponsor Decision|2|||
160856738|NCT01602224|580866488|FG001|Overall Study|Sponsor Decision|3|||
160856739|NCT01602224|580866489|FG002|Overall Study|Sponsor Decision|2|||
160856740|NCT01602224|580866487|FG000|Overall Study|Withdrawal by Subject|5|||
160856741|NCT01602224|580866488|FG001|Overall Study|Withdrawal by Subject|3|||
160856742|NCT01602224|580866489|FG002|Overall Study|Withdrawal by Subject|3|||
160856743|NCT01352117|580866490|FG000|Overall Study|Death|15|||
160856744|NCT01352117|580866491|FG001|Overall Study|Death|16|||
160650987|NCT02227862|580104360|FG000|Overall Study|Withdrawal by Subject|7|||
160856745|NCT01352117|580866490|FG000|Overall Study|Withdrawal by Subject|1|||
160856746|NCT01352117|580866491|FG001|Overall Study|Withdrawal by Subject|0|||
160856747|NCT01352117|580866490|FG000|Overall Study|Lost to Follow-up|2|||
160856748|NCT01352117|580866491|FG001|Overall Study|Lost to Follow-up|7|||
160856749|NCT01352117|580866490|FG000|Overall Study|Non-adherent to study requirements|1|||
160856750|NCT01352117|580866491|FG001|Overall Study|Non-adherent to study requirements|1|||
160856751|NCT01352117|580866490|FG000|Overall Study|Did not initiate study treatment|1|||
160856752|NCT01352117|580866491|FG001|Overall Study|Did not initiate study treatment|0|||
160856753|NCT01352117|580866490|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
160856754|NCT01352117|580866491|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
160856755|NCT01317472|580866500|FG000|Overall Study|Withdrawal by Subject|1|||
160856756|NCT01317472|580866501|FG001|Overall Study|Withdrawal by Subject|0|||
160856757|NCT01317472|580866500|FG000|Overall Study|Unrelated hospitalization|1|||
160856758|NCT01317472|580866501|FG001|Overall Study|Unrelated hospitalization|0|||
160856759|NCT03585660|580866510|FG000|Overall Study|operator error|1|||
160856760|NCT03585660|580866510|FG000|Overall Study|technical error|2|||
160856761|NCT03585660|580866510|FG000|Overall Study|hip prosthesis|2|||
160856762|NCT03585660|580866510|FG000|Overall Study|did not undergo biopsy|8|||
160856763|NCT03585660|580866510|FG000|Overall Study|scanner problem|2|||
160856764|NCT04349891|580866515|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
160856765|NCT04349891|580866516|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
160856766|NCT04349891|580866515|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
160856767|NCT04349891|580866516|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
160856768|NCT04349891|580866515|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
160856769|NCT04349891|580866516|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
160856770|NCT04349891|580866515|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
160569308|NCT01826214|579809096|FG000|Overall Study|Subject/guardian decision|2|||
160569309|NCT01826214|579809097|FG001|Overall Study|Subject/guardian decision|3|||
160569310|NCT00955110|579809098|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
160569311|NCT00955110|579809098|FG000|Treatment Phase|Adverse Event|2|||
160569312|NCT00955110|579809098|FG000|Treatment Phase|Administrative reasons|2|||
160569313|NCT00955110|579809098|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
160569314|NCT00955110|579809098|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
160569315|NCT03704051|579809103|FG000|Overall Study|Withdrawal by Subject|4|||
160569316|NCT03704051|579809104|FG001|Overall Study|Withdrawal by Subject|0|||
160908121|NCT04362072|581056466|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
160908122|NCT04362072|581056466|FG000|Treatment|Other|3|||
160908123|NCT04362072|581056466|FG000|Follow up|Death|2|||
160908124|NCT04362072|581056466|FG000|Follow up|Other|2|||
160908125|NCT04524689|581056467|FG000|Overall Study|Withdrawal by Subject|1|||
160908126|NCT04524689|581056468|FG001|Overall Study|Withdrawal by Subject|1|||
160993366|NCT01063036|581365339|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
160993367|NCT01063036|581365339|FG000|Participants Treated With Study Drug|Pregnancy|1|||
160569317|NCT03167619|579809113|FG000|Overall Study|Death|11|||
160569318|NCT03167619|579809114|FG001|Overall Study|Death|8|||
160569319|NCT03167619|579809113|FG000|Overall Study|Withdrawal by Subject|1|||
160569320|NCT03167619|579809114|FG001|Overall Study|Withdrawal by Subject|2|||
160908127|NCT04524689|581056469|FG002|Overall Study|Withdrawal by Subject|0|||
160908128|NCT04524689|581056470|FG003|Overall Study|Withdrawal by Subject|0|||
160908129|NCT04524689|581056471|FG004|Overall Study|Withdrawal by Subject|2|||
160908130|NCT04524689|581056472|FG005|Overall Study|Withdrawal by Subject|0|||
160908131|NCT04524689|581056467|FG000|Overall Study|Study terminated by Sponsor|6|||
160908132|NCT04524689|581056468|FG001|Overall Study|Study terminated by Sponsor|0|||
160908133|NCT04524689|581056469|FG002|Overall Study|Study terminated by Sponsor|1|||
160908134|NCT04524689|581056470|FG003|Overall Study|Study terminated by Sponsor|0|||
160908135|NCT04524689|581056471|FG004|Overall Study|Study terminated by Sponsor|4|||
160908136|NCT04524689|581056472|FG005|Overall Study|Study terminated by Sponsor|0|||
160908137|NCT04524689|581056467|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
160908138|NCT04524689|581056468|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
160908139|NCT04524689|581056469|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
160908140|NCT04524689|581056470|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
160908141|NCT04524689|581056471|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
160908142|NCT04524689|581056472|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
160908143|NCT01133522|581056473|FG000|Overall Study|Withdrawal by Subject|0|||
160908144|NCT01133522|581056474|FG001|Overall Study|Withdrawal by Subject|1|||
160908145|NCT01133522|581056475|FG002|Overall Study|Withdrawal by Subject|0|||
160908146|NCT01133522|581056476|FG003|Overall Study|Withdrawal by Subject|1|||
160908147|NCT01133522|581056477|FG004|Overall Study|Withdrawal by Subject|0|||
160908148|NCT01133522|581056478|FG005|Overall Study|Withdrawal by Subject|0|||
160908149|NCT01133522|581056479|FG006|Overall Study|Withdrawal by Subject|0|||
160908150|NCT01133522|581056480|FG007|Overall Study|Withdrawal by Subject|0|||
160569321|NCT03167619|579809113|FG000|Overall Study|Physician Decision|0|||
160569322|NCT03167619|579809114|FG001|Overall Study|Physician Decision|1|||
160908151|NCT01133522|581056481|FG008|Overall Study|Withdrawal by Subject|0|||
160908152|NCT01133522|581056482|FG009|Overall Study|Withdrawal by Subject|0|||
160908153|NCT01133522|581056473|FG000|Overall Study|Physician Decision|0|||
160908154|NCT01133522|581056474|FG001|Overall Study|Physician Decision|0|||
160993368|NCT01063036|581365339|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
160569323|NCT01981187|579809118|FG000|Overall Study|Participant/guardian decision|2|||
160856771|NCT04349891|580866516|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
160856772|NCT01018030|580866519|FG000|Overall Study|Adverse Event|10|||
160908155|NCT01133522|581056475|FG002|Overall Study|Physician Decision|0|||
160908156|NCT01133522|581056476|FG003|Overall Study|Physician Decision|0|||
160908157|NCT01133522|581056477|FG004|Overall Study|Physician Decision|1|||
160650988|NCT02227862|580104361|FG001|Overall Study|Withdrawal by Subject|6|||
160650989|NCT02227862|580104360|FG000|Overall Study|Lost to Follow-up|1|||
160650990|NCT02227862|580104361|FG001|Overall Study|Lost to Follow-up|2|||
160650991|NCT05014204|580104364|FG000|Overall Study|Withdrawal by Subject|1|||
160650992|NCT05014204|580104364|FG000|Overall Study|Physician Decision|1|||
160650993|NCT02035137|580104365|FG000|Overall Study|Physician Decision|0|||
160650994|NCT02035137|580104366|FG001|Overall Study|Physician Decision|0|||
160650995|NCT02035137|580104367|FG002|Overall Study|Physician Decision|1|||
160650996|NCT02035137|580104365|FG000|Overall Study|Withdrawal by Subject|0|||
160650997|NCT02035137|580104366|FG001|Overall Study|Withdrawal by Subject|1|||
160650998|NCT02035137|580104367|FG002|Overall Study|Withdrawal by Subject|2|||
160650999|NCT02035137|580104365|FG000|Overall Study|Ineligible|0|||
160651000|NCT02035137|580104366|FG001|Overall Study|Ineligible|1|||
160651001|NCT02035137|580104367|FG002|Overall Study|Ineligible|2|||
160651002|NCT02035137|580104365|FG000|Overall Study|Disease progression prior to treatment start|2|||
160651003|NCT02035137|580104366|FG001|Overall Study|Disease progression prior to treatment start|0|||
160651004|NCT02035137|580104367|FG002|Overall Study|Disease progression prior to treatment start|0|||
160651005|NCT00783796|580104368|FG000|Overall Study|Did not receive any stent|4|||
160651006|NCT00783796|580104368|FG000|Overall Study|Received non-XIENCE V stent|1|||
160651007|NCT00783796|580104368|FG000|Overall Study|Received commercial XIENCE V stent|1|||
160651008|NCT01215942|580104372|FG000|Treatment Period|Adverse Event|15|||
160651009|NCT01215942|580104373|FG001|Treatment Period|Adverse Event|26|||
160651010|NCT01215942|580104372|FG000|Treatment Period|Death|2|||
160651011|NCT01215942|580104373|FG001|Treatment Period|Death|4|||
160651012|NCT01215942|580104372|FG000|Treatment Period|Lack of Efficacy|23|||
160651013|NCT01215942|580104373|FG001|Treatment Period|Lack of Efficacy|62|||
160651014|NCT01215942|580104372|FG000|Treatment Period|Lost to Follow-up|3|||
160651015|NCT01215942|580104373|FG001|Treatment Period|Lost to Follow-up|4|||
160651016|NCT01215942|580104372|FG000|Treatment Period|Withdrawal by Subject|17|||
160651017|NCT01215942|580104373|FG001|Treatment Period|Withdrawal by Subject|40|||
160651018|NCT01215942|580104372|FG000|Treatment Period|Physician Decision|5|||
160651019|NCT01215942|580104373|FG001|Treatment Period|Physician Decision|5|||
160651020|NCT01215942|580104372|FG000|Treatment Period|Protocol Violation|0|||
160651021|NCT01215942|580104373|FG001|Treatment Period|Protocol Violation|1|||
160651022|NCT01215942|580104372|FG000|Treatment Period|Sponsor Decision|349|||
160651023|NCT01215942|580104373|FG001|Treatment Period|Sponsor Decision|530|||
160651024|NCT01215942|580104372|FG000|Post-Treatment Follow-Up Period|Death|0|||
160651025|NCT01215942|580104373|FG001|Post-Treatment Follow-Up Period|Death|1|||
160651026|NCT01215942|580104372|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
160651027|NCT01215942|580104373|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
160651028|NCT01215942|580104372|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
160651029|NCT01215942|580104373|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
160651030|NCT01215942|580104372|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
160651031|NCT01215942|580104373|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
160651032|NCT01215942|580104372|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
160651033|NCT01215942|580104373|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
160651034|NCT03305055|580104374|FG000|Overall Study|Withdrawal by Subject|0|||
160651035|NCT03305055|580104375|FG001|Overall Study|Withdrawal by Subject|1|||
160651036|NCT03305055|580104374|FG000|Overall Study|Adverse Event|1|||
160651037|NCT03305055|580104375|FG001|Overall Study|Adverse Event|1|||
160651038|NCT00113490|580104376|FG000|Overall Study|Withdrawal by Subject|1|||
160651039|NCT00113490|580104377|FG001|Overall Study|Withdrawal by Subject|3|||
160651040|NCT00113490|580104376|FG000|Overall Study|Lost to Follow-up|1|||
160651041|NCT00113490|580104377|FG001|Overall Study|Lost to Follow-up|0|||
160651042|NCT00819247|580104378|FG000|Overall Study|Adverse Event|0|||
160856773|NCT01018030|580866520|FG001|Overall Study|Adverse Event|5|||
160856774|NCT01018030|580866521|FG002|Overall Study|Adverse Event|5|||
160856775|NCT01018030|580866519|FG000|Overall Study|Withdrawal by Subject|2|||
160856776|NCT01018030|580866520|FG001|Overall Study|Withdrawal by Subject|2|||
160856777|NCT01018030|580866521|FG002|Overall Study|Withdrawal by Subject|4|||
160856778|NCT01018030|580866519|FG000|Overall Study|Lost to Follow-up|2|||
160856779|NCT01018030|580866520|FG001|Overall Study|Lost to Follow-up|0|||
160856780|NCT01018030|580866521|FG002|Overall Study|Lost to Follow-up|3|||
160856781|NCT01018030|580866519|FG000|Overall Study|Protocol Violation|2|||
160856782|NCT01018030|580866520|FG001|Overall Study|Protocol Violation|1|||
160908158|NCT01133522|581056478|FG005|Overall Study|Physician Decision|0|||
160651043|NCT00819247|580104379|FG001|Overall Study|Adverse Event|5|||
160651044|NCT00819247|580104380|FG002|Overall Study|Adverse Event|3|||
160856783|NCT01018030|580866521|FG002|Overall Study|Protocol Violation|0|||
160651045|NCT00819247|580104378|FG000|Overall Study|Insufficient testosterone response|5|||
160651046|NCT00819247|580104379|FG001|Overall Study|Insufficient testosterone response|8|||
160651047|NCT00819247|580104380|FG002|Overall Study|Insufficient testosterone response|10|||
160651048|NCT00819247|580104378|FG000|Overall Study|Withdrawal by Subject|1|||
160651049|NCT00819247|580104379|FG001|Overall Study|Withdrawal by Subject|0|||
160856784|NCT01018030|580866519|FG000|Overall Study|Physician Decision|1|||
160856785|NCT01018030|580866520|FG001|Overall Study|Physician Decision|0|||
160993369|NCT01063036|581365339|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
160993370|NCT01063036|581365339|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
160993371|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
160993372|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
160993373|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
160993374|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
160993375|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Adverse Event|198|||
160993376|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Adverse Event|0|||
160993377|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Adverse Event|0|||
160993378|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Adverse Event|0|||
160993379|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Death|62|||
160993380|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Death|0|||
160993381|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Death|0|||
160993382|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Death|0|||
160993383|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
160993384|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
160993385|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
160993386|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
160993387|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Complicating disease|13|||
160993388|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Complicating disease|0|||
160993389|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Complicating disease|0|||
160993390|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Complicating disease|0|||
160993391|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
160993392|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
160993393|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
160993394|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
160993395|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
160993396|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
160993397|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
160993398|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
160993399|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Non-compliance|4|||
160993400|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Non-compliance|0|||
160993401|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Non-compliance|0|||
160993402|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Non-compliance|0|||
160993403|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Pain|4|||
160993404|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Pain|0|||
160993405|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Pain|0|||
160993406|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Pain|0|||
160993407|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
160993408|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
160993409|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
160993410|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
160993411|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Hospice care|1|||
160993412|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Hospice care|0|||
160993413|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Hospice care|0|||
160993414|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Hospice care|0|||
160993415|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Physician Decision|1|||
160993416|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Physician Decision|0|||
160993417|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Physician Decision|0|||
160993418|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Physician Decision|0|||
160993419|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
160993420|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
160993421|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
160993422|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
160993423|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
160993424|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
160993425|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
160993426|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
160993427|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
160993428|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
160993429|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
160993430|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
160569324|NCT01981187|579809118|FG000|Overall Study|Physician Decision|1|||
160569325|NCT01981187|579809118|FG000|Overall Study|Disease progression|2|||
160993431|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Death|0|||
160993432|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Death|8|||
160993433|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Death|2|||
160993434|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Death|13|||
160993435|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
160993436|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
160993437|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
160856786|NCT01018030|580866521|FG002|Overall Study|Physician Decision|1|||
160856787|NCT01018030|580866519|FG000|Overall Study|Lack of Efficacy|1|||
160856788|NCT01018030|580866520|FG001|Overall Study|Lack of Efficacy|0|||
160856789|NCT01018030|580866521|FG002|Overall Study|Lack of Efficacy|0|||
160856790|NCT01018030|580866519|FG000|Overall Study|Did Not Receive Study Drug|1|||
160856791|NCT01018030|580866520|FG001|Overall Study|Did Not Receive Study Drug|3|||
160856792|NCT01018030|580866521|FG002|Overall Study|Did Not Receive Study Drug|0|||
160856793|NCT02399215|580866532|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
160569326|NCT01981187|579809118|FG000|Overall Study|Adverse Event|7|||
160569327|NCT02082184|579809120|FG000|Overall Study|Adverse Event|1|||
160569328|NCT02082184|579809121|FG001|Overall Study|Adverse Event|0|||
160569329|NCT02082184|579809120|FG000|Overall Study|Medical diagnosis|1|||
160569330|NCT02082184|579809121|FG001|Overall Study|Medical diagnosis|2|||
160856794|NCT02399215|580866532|FG000|Overall Study|Withdrawal by Subject|1|||
160993438|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
160993439|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
160993440|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
160993441|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
160993442|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
160993443|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
160993444|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
160993445|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
160993446|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
160993447|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
160993448|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
160993449|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
160993450|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
160993451|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
160993452|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
160993453|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
160993454|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
160993455|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
160993456|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
160993457|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
160993458|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
160993459|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
160993460|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
160993461|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
160993462|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
160993463|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
160993464|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
160993465|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
160993466|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
160993467|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
160993468|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
160993469|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
160993470|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
160993471|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
160993472|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
160993473|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
160993474|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
160993475|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Pain|0|||
160993476|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Pain|0|||
160993477|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Pain|0|||
160993478|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Pain|1|||
160993479|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
160993480|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
160993481|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
160993482|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
160993483|NCT04381494|581365344|FG000|Overall Study|Early termination of trial|19|||
160993484|NCT04381494|581365344|FG000|Overall Study|Investigator's discretion|1|||
160993485|NCT04381494|581365344|FG000|Overall Study|Withdrawal by Subject|9|||
160993486|NCT04381494|581365344|FG000|Overall Study|NSCLC disease progression|4|||
160569331|NCT02082184|579809120|FG000|Overall Study|Device associated symptoms|5|||
160569332|NCT02082184|579809121|FG001|Overall Study|Device associated symptoms|0|||
160569333|NCT02082184|579809120|FG000|Overall Study|Withdrawal by Subject|3|||
160856795|NCT01903356|580866535|FG000|Overall Study|Lost to Follow-up|7|||
160856796|NCT01903356|580866535|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
160856797|NCT01903356|580866535|FG000|Overall Study|Violated the dosage and administration|3|||
160993487|NCT04381494|581365344|FG000|Overall Study|Device-Related Adverse Event|2|||
160993488|NCT01977612|581365345|FG000|Overall Study|Lost to Follow-up|1|||
160993489|NCT01977612|581365346|FG001|Overall Study|Lost to Follow-up|1|||
160993490|NCT04310579|581365347|FG000|Overall Study|Adverse Event|0|||
160993491|NCT04310579|581365348|FG001|Overall Study|Adverse Event|0|||
160993492|NCT04310579|581365349|FG002|Overall Study|Adverse Event|0|||
160993493|NCT04310579|581365350|FG003|Overall Study|Adverse Event|0|||
160993494|NCT04310579|581365351|FG004|Overall Study|Adverse Event|0|||
160993495|NCT04310579|581365352|FG005|Overall Study|Adverse Event|0|||
160993496|NCT04310579|581365353|FG006|Overall Study|Adverse Event|2|||
160993497|NCT04310579|581365354|FG007|Overall Study|Adverse Event|0|||
160993498|NCT04310579|581365355|FG008|Overall Study|Adverse Event|1|||
160993499|NCT04310579|581365356|FG009|Overall Study|Adverse Event|1|||
160993500|NCT04310579|581365357|FG010|Overall Study|Adverse Event|0|||
160993501|NCT04310579|581365347|FG000|Overall Study|Withdrawal by Subject|0|||
160993502|NCT04310579|581365348|FG001|Overall Study|Withdrawal by Subject|0|||
160993503|NCT04310579|581365349|FG002|Overall Study|Withdrawal by Subject|0|||
160993504|NCT04310579|581365350|FG003|Overall Study|Withdrawal by Subject|0|||
160993505|NCT04310579|581365351|FG004|Overall Study|Withdrawal by Subject|0|||
160993506|NCT04310579|581365352|FG005|Overall Study|Withdrawal by Subject|1|||
160993507|NCT04310579|581365353|FG006|Overall Study|Withdrawal by Subject|0|||
160993508|NCT04310579|581365354|FG007|Overall Study|Withdrawal by Subject|0|||
160993509|NCT04310579|581365355|FG008|Overall Study|Withdrawal by Subject|0|||
160993510|NCT04310579|581365356|FG009|Overall Study|Withdrawal by Subject|0|||
160993511|NCT04310579|581365357|FG010|Overall Study|Withdrawal by Subject|0|||
160993512|NCT04310579|581365347|FG000|Overall Study|Positive COVID-19 test|0|||
160993513|NCT04310579|581365348|FG001|Overall Study|Positive COVID-19 test|0|||
160993514|NCT04310579|581365349|FG002|Overall Study|Positive COVID-19 test|0|||
160993515|NCT04310579|581365350|FG003|Overall Study|Positive COVID-19 test|0|||
160993516|NCT04310579|581365351|FG004|Overall Study|Positive COVID-19 test|0|||
160993517|NCT04310579|581365352|FG005|Overall Study|Positive COVID-19 test|0|||
160993518|NCT04310579|581365353|FG006|Overall Study|Positive COVID-19 test|0|||
160993519|NCT04310579|581365354|FG007|Overall Study|Positive COVID-19 test|0|||
160993520|NCT04310579|581365355|FG008|Overall Study|Positive COVID-19 test|0|||
160993521|NCT04310579|581365356|FG009|Overall Study|Positive COVID-19 test|0|||
160993522|NCT04310579|581365357|FG010|Overall Study|Positive COVID-19 test|1|||
160993523|NCT04012853|581365358|FG000|Overall Study|Withdrawal by Subject|1|||
160993524|NCT04012853|581365359|FG001|Overall Study|Withdrawal by Subject|1|||
160993525|NCT04012853|581365358|FG000|Overall Study|Protocol Violation|1|||
160993526|NCT04012853|581365359|FG001|Overall Study|Protocol Violation|0|||
160993527|NCT04012853|581365358|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
160993528|NCT04012853|581365359|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
160993529|NCT04304534|581365360|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
160993530|NCT04304534|581365361|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
160993531|NCT04304534|581365362|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
160993532|NCT04304534|581365363|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
160993533|NCT04304534|581365360|FG000|Overall Study|Non-Compliance with study drug|0|||
160993534|NCT04304534|581365361|FG001|Overall Study|Non-Compliance with study drug|1|||
160993535|NCT04304534|581365362|FG002|Overall Study|Non-Compliance with study drug|1|||
160993536|NCT04304534|581365363|FG003|Overall Study|Non-Compliance with study drug|1|||
160993537|NCT04304534|581365360|FG000|Overall Study|Lost to Follow-up|0|||
160993538|NCT04304534|581365361|FG001|Overall Study|Lost to Follow-up|1|||
160993539|NCT04304534|581365362|FG002|Overall Study|Lost to Follow-up|2|||
160993540|NCT04304534|581365363|FG003|Overall Study|Lost to Follow-up|3|||
160993541|NCT04304534|581365360|FG000|Overall Study|Unspecific|4|||
160993542|NCT04304534|581365361|FG001|Overall Study|Unspecific|2|||
160993543|NCT04304534|581365362|FG002|Overall Study|Unspecific|2|||
160993544|NCT04304534|581365363|FG003|Overall Study|Unspecific|2|||
160993545|NCT04304534|581365360|FG000|Overall Study|Technical Problems|2|||
160993546|NCT04304534|581365361|FG001|Overall Study|Technical Problems|2|||
160993547|NCT04304534|581365362|FG002|Overall Study|Technical Problems|3|||
160993548|NCT04304534|581365363|FG003|Overall Study|Technical Problems|4|||
160993549|NCT04304534|581365360|FG000|Overall Study|Death|7|||
160993550|NCT04304534|581365361|FG001|Overall Study|Death|2|||
160993551|NCT04304534|581365362|FG002|Overall Study|Death|4|||
160993552|NCT04304534|581365363|FG003|Overall Study|Death|3|||
160993553|NCT04304534|581365360|FG000|Overall Study|Withdrawal by Subject|7|||
160993554|NCT04304534|581365361|FG001|Overall Study|Withdrawal by Subject|2|||
160993555|NCT04304534|581365362|FG002|Overall Study|Withdrawal by Subject|7|||
160993556|NCT04304534|581365363|FG003|Overall Study|Withdrawal by Subject|4|||
160993557|NCT04304534|581365360|FG000|Overall Study|Physician Decision|4|||
160993558|NCT04304534|581365361|FG001|Overall Study|Physician Decision|9|||
160993559|NCT04304534|581365362|FG002|Overall Study|Physician Decision|9|||
160993560|NCT04304534|581365363|FG003|Overall Study|Physician Decision|5|||
160993561|NCT04304534|581365360|FG000|Overall Study|Subject Decision|34|||
160993562|NCT04304534|581365361|FG001|Overall Study|Subject Decision|25|||
160993563|NCT04304534|581365362|FG002|Overall Study|Subject Decision|25|||
160993564|NCT04304534|581365363|FG003|Overall Study|Subject Decision|26|||
160993565|NCT04304534|581365360|FG000|Overall Study|Adverse Event|35|||
160651050|NCT00819247|580104380|FG002|Overall Study|Withdrawal by Subject|0|||
160651051|NCT00819247|580104378|FG000|Overall Study|Protocol Violation|1|||
160651052|NCT00819247|580104379|FG001|Overall Study|Protocol Violation|0|||
160651053|NCT00819247|580104380|FG002|Overall Study|Protocol Violation|1|||
160651054|NCT00819247|580104378|FG000|Overall Study|Mistakenly withdrawn|0|||
160651055|NCT00819247|580104379|FG001|Overall Study|Mistakenly withdrawn|1|||
160856798|NCT00713609|580866536|FG000|Overall Study|Adverse Event|2|||
160856799|NCT00713609|580866537|FG001|Overall Study|Adverse Event|0|||
160856800|NCT00713609|580866538|FG002|Overall Study|Adverse Event|2|||
160856801|NCT00713609|580866539|FG003|Overall Study|Adverse Event|2|||
160856802|NCT00713609|580866540|FG004|Overall Study|Adverse Event|3|||
160651056|NCT00819247|580104380|FG002|Overall Study|Mistakenly withdrawn|0|||
160651057|NCT00819247|580104378|FG000|Overall Study|Bad prostate-specific antigen response|3|||
160651058|NCT00819247|580104379|FG001|Overall Study|Bad prostate-specific antigen response|2|||
160651059|NCT00819247|580104380|FG002|Overall Study|Bad prostate-specific antigen response|0|||
160651060|NCT00819247|580104378|FG000|Overall Study|Other|1|||
160651061|NCT00819247|580104379|FG001|Overall Study|Other|0|||
160856803|NCT00713609|580866541|FG005|Overall Study|Adverse Event|1|||
160993566|NCT04304534|581365361|FG001|Overall Study|Adverse Event|40|||
160651062|NCT00819247|580104380|FG002|Overall Study|Other|0|||
160651063|NCT04471935|580104381|FG000|Overall Study|Withdrawal by Subject|1|||
160856804|NCT00713609|580866536|FG000|Overall Study|Lost to Follow-up|5|||
160993567|NCT04304534|581365362|FG002|Overall Study|Adverse Event|39|||
160993568|NCT04304534|581365363|FG003|Overall Study|Adverse Event|44|||
160993569|NCT01695317|581365364|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
160993570|NCT01695317|581365365|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
160993571|NCT01695317|581365364|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
160993572|NCT01695317|581365365|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
160993573|NCT00003656|581365366|FG000|Overall Study|Adverse Event|0|||
160993574|NCT00003656|581365367|FG001|Overall Study|Adverse Event|1|||
160993575|NCT03055767|581365368|FG000|Open-Label Period|Lost to Follow-up|0|||
160993576|NCT03055767|581365369|FG001|Open-Label Period|Lost to Follow-up|0|||
160993577|NCT03055767|581365370|FG002|Open-Label Period|Lost to Follow-up|2|||
160993578|NCT03055767|581365371|FG003|Open-Label Period|Lost to Follow-up|0|||
160993579|NCT03055767|581365368|FG000|Open-Label Period|Withdrawal by Subject|0|||
160993580|NCT03055767|581365369|FG001|Open-Label Period|Withdrawal by Subject|0|||
160993581|NCT03055767|581365370|FG002|Open-Label Period|Withdrawal by Subject|0|||
160993582|NCT03055767|581365371|FG003|Open-Label Period|Withdrawal by Subject|1|||
160993583|NCT02759731|581365374|FG000|Overall Study|Did not complete treatment.|8|||
160993584|NCT00957229|581365380|FG000|Study Start|Adverse Event|0|||
160993585|NCT00957229|581365381|FG001|Study Start|Adverse Event|3|||
160993586|NCT00957229|581365380|FG000|Study Start|Disease Progression|1|||
160993587|NCT00957229|581365381|FG001|Study Start|Disease Progression|0|||
160993588|NCT00957229|581365380|FG000|Reallocated to or Continued Vismodegib|Death|1|||
160993589|NCT00957229|581365381|FG001|Reallocated to or Continued Vismodegib|Death|1|||
160993590|NCT00957229|581365380|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
160993591|NCT00957229|581365381|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
160993592|NCT00763282|581365382|FG000|Overall Study|Withdrawal by Subject|6|||
160993593|NCT00763282|581365383|FG001|Overall Study|Withdrawal by Subject|5|||
160993594|NCT00763282|581365382|FG000|Overall Study|Death|4|||
160993595|NCT00763282|581365383|FG001|Overall Study|Death|3|||
160993596|NCT00763282|581365382|FG000|Overall Study|Lost to Follow-up|22|||
160993597|NCT00763282|581365383|FG001|Overall Study|Lost to Follow-up|26|||
160993598|NCT04580303|581365384|FG000|Overall Study|Adverse Event|0|||
160993599|NCT04580303|581365385|FG001|Overall Study|Adverse Event|1|||
160993600|NCT04580303|581365386|FG002|Overall Study|Adverse Event|0|||
160993601|NCT04580303|581365387|FG003|Overall Study|Adverse Event|0|||
160993602|NCT04580303|581365384|FG000|Overall Study|Withdrawal by Subject|0|||
160993603|NCT04580303|581365385|FG001|Overall Study|Withdrawal by Subject|0|||
160993604|NCT04580303|581365386|FG002|Overall Study|Withdrawal by Subject|1|||
160993605|NCT04580303|581365387|FG003|Overall Study|Withdrawal by Subject|0|||
160993606|NCT01833065|581365389|FG000|Overall Study|Adverse Event|6|||
160993607|NCT01833065|581365390|FG001|Overall Study|Adverse Event|1|||
160993608|NCT01833065|581365391|FG002|Overall Study|Adverse Event|0|||
160993609|NCT01833065|581365392|FG003|Overall Study|Adverse Event|2|||
160993610|NCT01833065|581365393|FG004|Overall Study|Adverse Event|3|||
160993611|NCT01833065|581365389|FG000|Overall Study|Protocol Violation|1|||
160993612|NCT01833065|581365390|FG001|Overall Study|Protocol Violation|0|||
160651064|NCT04471935|580104381|FG000|Overall Study|Deemed ineligible to participate|1|||
160651065|NCT01399736|580104382|FG000|Overall Study|Withdrawal by Subject|4|||
160651066|NCT01399736|580104383|FG001|Overall Study|Withdrawal by Subject|2|||
160651067|NCT01399736|580104382|FG000|Overall Study|Lost to Follow-up|0|||
160651068|NCT01399736|580104383|FG001|Overall Study|Lost to Follow-up|2|||
160993613|NCT01833065|581365391|FG002|Overall Study|Protocol Violation|0|||
160993614|NCT01833065|581365392|FG003|Overall Study|Protocol Violation|0|||
160993615|NCT01833065|581365393|FG004|Overall Study|Protocol Violation|2|||
160993616|NCT01833065|581365389|FG000|Overall Study|Lost to Follow-up|1|||
160993617|NCT01833065|581365390|FG001|Overall Study|Lost to Follow-up|0|||
160856805|NCT00713609|580866537|FG001|Overall Study|Lost to Follow-up|7|||
160856806|NCT00713609|580866538|FG002|Overall Study|Lost to Follow-up|5|||
160856807|NCT00713609|580866539|FG003|Overall Study|Lost to Follow-up|5|||
160856808|NCT00713609|580866540|FG004|Overall Study|Lost to Follow-up|7|||
160856809|NCT00713609|580866541|FG005|Overall Study|Lost to Follow-up|0|||
160856810|NCT00713609|580866536|FG000|Overall Study|Lack of Efficacy|1|||
160856811|NCT00713609|580866537|FG001|Overall Study|Lack of Efficacy|3|||
160856812|NCT00713609|580866538|FG002|Overall Study|Lack of Efficacy|0|||
160856813|NCT00713609|580866539|FG003|Overall Study|Lack of Efficacy|0|||
160856814|NCT00713609|580866540|FG004|Overall Study|Lack of Efficacy|1|||
160856815|NCT00713609|580866541|FG005|Overall Study|Lack of Efficacy|0|||
160908159|NCT01133522|581056479|FG006|Overall Study|Physician Decision|0|||
160908160|NCT01133522|581056480|FG007|Overall Study|Physician Decision|0|||
160908161|NCT01133522|581056481|FG008|Overall Study|Physician Decision|0|||
160908162|NCT01133522|581056482|FG009|Overall Study|Physician Decision|0|||
160908163|NCT04997304|581056483|FG000|Overall Study|Lost to Follow-up|11|||
160908164|NCT04997304|581056483|FG000|Overall Study|Death|1|||
160908165|NCT04997304|581056483|FG000|Overall Study|Withdrawal by Subject|14|||
160908166|NCT03291808|581058029|FG000|Overall Study|Lost to Follow-up|6|||
160908167|NCT03291808|581058029|FG000|Overall Study|Research burden|4|||
160908168|NCT00638378|581058030|FG000|Overall Study|Death|2|||
160908169|NCT00638378|581058030|FG000|Overall Study|Adverse Event|1|||
160908170|NCT00638378|581058030|FG000|Overall Study|Disease progression|15|||
160908171|NCT00638378|581058030|FG000|Overall Study|Physician Decision|4|||
160908172|NCT03364023|581058033|FG000|Overall Study|Lost to Follow-up|3|||
160908173|NCT03364023|581058033|FG000|Overall Study|Death|14|||
160908174|NCT03797014|581058034|FG000|Overall Study|Withdrawal by Subject|1|||
160908175|NCT03797014|581058034|FG000|Overall Study|Lost to Follow-up|1|||
160908176|NCT03797014|581058034|FG000|Overall Study|Protocol Violation|1|||
160908177|NCT03305575|581058039|FG000|Overall Study|Physician Decision|1|||
160908178|NCT03305575|581058040|FG001|Overall Study|Physician Decision|0|||
160908179|NCT00105469|581058041|FG000|Overall Study|Adverse Event|9|||
160908180|NCT00105469|581058042|FG001|Overall Study|Adverse Event|8|||
160908181|NCT00105469|581058041|FG000|Overall Study|Protocol Violation|4|||
160908182|NCT00105469|581058042|FG001|Overall Study|Protocol Violation|0|||
160908183|NCT00105469|581058041|FG000|Overall Study|Withdrawal by Subject|2|||
160908184|NCT00105469|581058042|FG001|Overall Study|Withdrawal by Subject|3|||
160908185|NCT00105469|581058041|FG000|Overall Study|Lost to Follow-up|1|||
160908186|NCT00105469|581058042|FG001|Overall Study|Lost to Follow-up|0|||
160908187|NCT00105469|581058041|FG000|Overall Study|Lack of Efficacy|2|||
160908188|NCT00105469|581058042|FG001|Overall Study|Lack of Efficacy|0|||
160993618|NCT01833065|581365391|FG002|Overall Study|Lost to Follow-up|0|||
160993619|NCT01833065|581365392|FG003|Overall Study|Lost to Follow-up|0|||
160993620|NCT01833065|581365393|FG004|Overall Study|Lost to Follow-up|3|||
160993621|NCT01833065|581365389|FG000|Overall Study|Withdrawal by Subject|6|||
160993622|NCT01833065|581365390|FG001|Overall Study|Withdrawal by Subject|2|||
160569334|NCT02082184|579809121|FG001|Overall Study|Withdrawal by Subject|2|||
160569335|NCT02082184|579809120|FG000|Overall Study|Protocol Violation|0|||
160569336|NCT02082184|579809121|FG001|Overall Study|Protocol Violation|6|||
160569337|NCT02082184|579809120|FG000|Overall Study|Lost to Follow-up|0|||
160569338|NCT02082184|579809121|FG001|Overall Study|Lost to Follow-up|2|||
160569339|NCT02082184|579809120|FG000|Overall Study|Subject non-compliance|0|||
160569340|NCT02082184|579809121|FG001|Overall Study|Subject non-compliance|1|||
160569341|NCT01362322|579809124|FG000|Overall Study|Withdrawal by Subject|3|||
160569342|NCT01362322|579809125|FG001|Overall Study|Withdrawal by Subject|1|||
160569343|NCT01362322|579809124|FG000|Overall Study|Lost to Follow-up|2|||
160569344|NCT01362322|579809125|FG001|Overall Study|Lost to Follow-up|6|||
160569345|NCT01943539|579809126|FG000|Overall Study|Non-compliance with at-home intervention|4|||
160569346|NCT01943539|579809127|FG001|Overall Study|Non-compliance with at-home intervention|0|||
160569347|NCT02413398|579809130|FG000|Overall Study|Lost to Follow-up|2|||
160651069|NCT02795104|580104384|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
160856816|NCT00713609|580866536|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
160856817|NCT00713609|580866537|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
160908189|NCT00105469|581058041|FG000|Overall Study|Other Reason|4|||
160908190|NCT00105469|581058042|FG001|Overall Study|Other Reason|0|||
160908191|NCT02820753|581058054|FG000|2 Month|Withdrawal by Subject|3|||
160908192|NCT02820753|581058055|FG001|2 Month|Withdrawal by Subject|3|||
160908193|NCT02820753|581058054|FG000|2 Month|Lost to Follow-up|24|||
160993623|NCT01833065|581365391|FG002|Overall Study|Withdrawal by Subject|4|||
160993624|NCT01833065|581365392|FG003|Overall Study|Withdrawal by Subject|3|||
160569348|NCT02413398|579809131|FG001|Overall Study|Lost to Follow-up|4|||
160569349|NCT02413398|579809130|FG000|Overall Study|Withdrawal by Subject|1|||
160569350|NCT02413398|579809131|FG001|Overall Study|Withdrawal by Subject|1|||
160569351|NCT02413398|579809130|FG000|Overall Study|Other Eligibility criteria|1|||
160569352|NCT02413398|579809131|FG001|Overall Study|Other Eligibility criteria|2|||
160569353|NCT00537940|579809134|FG000|Overall Study|Adverse Event|20|||
160569354|NCT00537940|579809135|FG001|Overall Study|Adverse Event|19|||
160908194|NCT02820753|581058055|FG001|2 Month|Lost to Follow-up|26|||
160993625|NCT01833065|581365393|FG004|Overall Study|Withdrawal by Subject|11|||
160993626|NCT01833065|581365389|FG000|Overall Study|Subject's substantial non-compliance|0|||
160993627|NCT01833065|581365390|FG001|Overall Study|Subject's substantial non-compliance|1|||
160993628|NCT01833065|581365391|FG002|Overall Study|Subject's substantial non-compliance|0|||
160993629|NCT01833065|581365392|FG003|Overall Study|Subject's substantial non-compliance|0|||
160993630|NCT01833065|581365393|FG004|Overall Study|Subject's substantial non-compliance|0|||
160993631|NCT01833065|581365389|FG000|Overall Study|Trial terminated by sponsor|8|||
160993632|NCT01833065|581365390|FG001|Overall Study|Trial terminated by sponsor|8|||
160993633|NCT01833065|581365391|FG002|Overall Study|Trial terminated by sponsor|7|||
160993634|NCT01833065|581365392|FG003|Overall Study|Trial terminated by sponsor|3|||
160993635|NCT01833065|581365393|FG004|Overall Study|Trial terminated by sponsor|13|||
160993636|NCT01833065|581365389|FG000|Overall Study|Others|2|||
160993637|NCT01833065|581365390|FG001|Overall Study|Others|1|||
160993638|NCT01833065|581365391|FG002|Overall Study|Others|1|||
160993639|NCT01833065|581365392|FG003|Overall Study|Others|1|||
160993640|NCT01833065|581365393|FG004|Overall Study|Others|4|||
160993641|NCT01456936|581365397|FG000|Overall Study|Other reason|41|||
160993642|NCT01456936|581365398|FG001|Overall Study|Other reason|30|||
160993643|NCT01456936|581365399|FG002|Overall Study|Other reason|36|||
160993644|NCT01456936|581365400|FG003|Overall Study|Other reason|33|||
160993645|NCT01456936|581365397|FG000|Overall Study|No longer meets eligibility criteria|4|||
160993646|NCT01456936|581365398|FG001|Overall Study|No longer meets eligibility criteria|8|||
160993647|NCT01456936|581365399|FG002|Overall Study|No longer meets eligibility criteria|6|||
160993648|NCT01456936|581365400|FG003|Overall Study|No longer meets eligibility criteria|5|||
160993649|NCT01456936|581365397|FG000|Overall Study|Protocol Violation|4|||
160993650|NCT01456936|581365398|FG001|Overall Study|Protocol Violation|2|||
160993651|NCT01456936|581365399|FG002|Overall Study|Protocol Violation|5|||
160993652|NCT01456936|581365400|FG003|Overall Study|Protocol Violation|5|||
160993653|NCT01456936|581365397|FG000|Overall Study|Pregnancy|1|||
160993654|NCT01456936|581365398|FG001|Overall Study|Pregnancy|0|||
160993655|NCT01456936|581365399|FG002|Overall Study|Pregnancy|0|||
160993656|NCT01456936|581365400|FG003|Overall Study|Pregnancy|1|||
160993657|NCT01456936|581365397|FG000|Overall Study|Insufficient clinical response|4|||
160993658|NCT01456936|581365398|FG001|Overall Study|Insufficient clinical response|4|||
160993659|NCT01456936|581365399|FG002|Overall Study|Insufficient clinical response|14|||
160993660|NCT01456936|581365400|FG003|Overall Study|Insufficient clinical response|13|||
160993661|NCT01456936|581365397|FG000|Overall Study|No longer willing to participate|195|||
160993662|NCT01456936|581365398|FG001|Overall Study|No longer willing to participate|218|||
160993663|NCT01456936|581365399|FG002|Overall Study|No longer willing to participate|224|||
160993664|NCT01456936|581365400|FG003|Overall Study|No longer willing to participate|248|||
160993665|NCT01456936|581365397|FG000|Overall Study|Lost to Follow-up|135|||
160993666|NCT01456936|581365398|FG001|Overall Study|Lost to Follow-up|126|||
160993667|NCT01456936|581365399|FG002|Overall Study|Lost to Follow-up|144|||
160993668|NCT01456936|581365400|FG003|Overall Study|Lost to Follow-up|127|||
160993669|NCT01456936|581365397|FG000|Overall Study|Medication error|0|||
160993670|NCT01456936|581365398|FG001|Overall Study|Medication error|1|||
160993671|NCT01456936|581365399|FG002|Overall Study|Medication error|0|||
160993672|NCT01456936|581365400|FG003|Overall Study|Medication error|1|||
160993673|NCT01456936|581365397|FG000|Overall Study|Adverse event (study drug)|25|||
160993674|NCT01456936|581365398|FG001|Overall Study|Adverse event (study drug)|21|||
160569355|NCT00537940|579809134|FG000|Overall Study|Lack of Efficacy|8|||
160569356|NCT00537940|579809135|FG001|Overall Study|Lack of Efficacy|16|||
160569357|NCT00537940|579809134|FG000|Overall Study|Lost to Follow-up|23|||
160569358|NCT00537940|579809135|FG001|Overall Study|Lost to Follow-up|29|||
160569359|NCT00537940|579809134|FG000|Overall Study|Withdrawal by Subject|113|||
160569360|NCT00537940|579809135|FG001|Overall Study|Withdrawal by Subject|95|||
160569361|NCT00537940|579809134|FG000|Overall Study|Protocol Violation|6|||
160569362|NCT00537940|579809135|FG001|Overall Study|Protocol Violation|4|||
160569363|NCT00537940|579809134|FG000|Overall Study|Pregnancy|1|||
160569364|NCT00537940|579809135|FG001|Overall Study|Pregnancy|1|||
160569365|NCT00537940|579809134|FG000|Overall Study|Study terminated by sponsor|2|||
160569366|NCT00537940|579809135|FG001|Overall Study|Study terminated by sponsor|3|||
160569367|NCT00537940|579809134|FG000|Overall Study|Other|10|||
160569368|NCT00537940|579809135|FG001|Overall Study|Other|12|||
160993675|NCT01456936|581365399|FG002|Overall Study|Adverse event (study drug)|26|||
160993676|NCT01456936|581365400|FG003|Overall Study|Adverse event (study drug)|17|||
160993677|NCT01456936|581365397|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
160993678|NCT01456936|581365398|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
160993679|NCT01456936|581365399|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
160569369|NCT03715465|579809139|FG000|Overall Study|Withdrawal by Subject|1|||
160569370|NCT03715465|579809140|FG001|Overall Study|Withdrawal by Subject|2|||
160569371|NCT00430781|579809141|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
160569372|NCT00430781|579809142|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
160569373|NCT00430781|579809143|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
160651070|NCT02795104|580104385|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
160651071|NCT02795104|580104386|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
160651072|NCT02795104|580104384|FG000|Overall Study|Withdrawal by Subject|0|||
160651073|NCT02795104|580104385|FG001|Overall Study|Withdrawal by Subject|2|||
160651074|NCT02795104|580104386|FG002|Overall Study|Withdrawal by Subject|0|||
160651075|NCT02795104|580104384|FG000|Overall Study|Lost to Follow-up|0|||
160651076|NCT02795104|580104385|FG001|Overall Study|Lost to Follow-up|0|||
160651077|NCT02795104|580104386|FG002|Overall Study|Lost to Follow-up|1|||
160651078|NCT00948675|580104387|FG000|Overall Study|Lost to Follow-up|1|||
160651079|NCT00948675|580104388|FG001|Overall Study|Lost to Follow-up|0|||
160651080|NCT01654380|580104389|FG000|Part B, Period 1|Physician Decision|0|||
160651081|NCT01654380|580104390|FG001|Part B, Period 1|Physician Decision|0|||
160651082|NCT01654380|580104391|FG002|Part B, Period 1|Physician Decision|1|||
160993680|NCT01456936|581365400|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
160993681|NCT01456936|581365397|FG000|Overall Study|Death|0|||
160993682|NCT01456936|581365398|FG001|Overall Study|Death|3|||
160993683|NCT01456936|581365399|FG002|Overall Study|Death|1|||
160993684|NCT01456936|581365400|FG003|Overall Study|Death|3|||
160993685|NCT01456936|581365397|FG000|Overall Study|Randomized but not treated|21|||
160993686|NCT01456936|581365398|FG001|Overall Study|Randomized but not treated|28|||
160993687|NCT01456936|581365399|FG002|Overall Study|Randomized but not treated|16|||
160993688|NCT01456936|581365400|FG003|Overall Study|Randomized but not treated|21|||
160993689|NCT00906698|581365401|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
160993690|NCT00906698|581365402|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
160993691|NCT00906698|581365403|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
160993692|NCT00906698|581365404|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
160993693|NCT00906698|581365405|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
160993694|NCT00906698|581365406|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
160993695|NCT00906698|581365401|FG000|Overall Study|Adverse Event|0|||
160993696|NCT00906698|581365402|FG001|Overall Study|Adverse Event|0|||
160993697|NCT00906698|581365403|FG002|Overall Study|Adverse Event|2|||
160993698|NCT00906698|581365404|FG003|Overall Study|Adverse Event|0|||
160993699|NCT00906698|581365405|FG004|Overall Study|Adverse Event|4|||
160993700|NCT00906698|581365406|FG005|Overall Study|Adverse Event|1|||
160993701|NCT00906698|581365401|FG000|Overall Study|Disease progression|3|||
160993702|NCT00906698|581365402|FG001|Overall Study|Disease progression|12|||
160993703|NCT00906698|581365403|FG002|Overall Study|Disease progression|4|||
160993704|NCT00906698|581365404|FG003|Overall Study|Disease progression|4|||
160993705|NCT00906698|581365405|FG004|Overall Study|Disease progression|12|||
160993706|NCT00906698|581365406|FG005|Overall Study|Disease progression|4|||
160993707|NCT00906698|581365401|FG000|Overall Study|Withdrawal by Subject|0|||
160993708|NCT00906698|581365402|FG001|Overall Study|Withdrawal by Subject|0|||
160993709|NCT00906698|581365403|FG002|Overall Study|Withdrawal by Subject|0|||
160993710|NCT00906698|581365404|FG003|Overall Study|Withdrawal by Subject|0|||
160993711|NCT00906698|581365405|FG004|Overall Study|Withdrawal by Subject|1|||
160993712|NCT00906698|581365406|FG005|Overall Study|Withdrawal by Subject|0|||
160993713|NCT00906698|581365401|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
160993714|NCT00906698|581365402|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
160993715|NCT00906698|581365403|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
160993716|NCT00906698|581365404|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
160993717|NCT00906698|581365405|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
160993718|NCT00906698|581365406|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
160993719|NCT01250002|581365407|FG000|Overall Study|Change to open surgical procedure|4|||
160993720|NCT01250002|581365408|FG001|Overall Study|Change to open surgical procedure|3|||
160993721|NCT02317705|581365409|FG000|Overall Study|Withdrawal by Subject|3|||
160993722|NCT02317705|581365409|FG000|Overall Study|Physician Decision|1|||
160856818|NCT00713609|580866538|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
160856819|NCT00713609|580866539|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
160856820|NCT00713609|580866540|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
160856821|NCT00713609|580866541|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
160856822|NCT00713609|580866536|FG000|Overall Study|Withdrawal by Subject|6|||
160856823|NCT00713609|580866537|FG001|Overall Study|Withdrawal by Subject|1|||
160856824|NCT00713609|580866538|FG002|Overall Study|Withdrawal by Subject|5|||
160856825|NCT00713609|580866539|FG003|Overall Study|Withdrawal by Subject|1|||
160993723|NCT02317705|581365409|FG000|Overall Study|Drug not usable|1|||
160993724|NCT01599325|581365410|FG000|Primary Parent Phase|Adverse Event|5|||
160993725|NCT01599325|581365410|FG000|Primary Parent Phase|Disease Progression|7|||
160993726|NCT01599325|581365410|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
160993727|NCT01599325|581365410|FG000|Primary Parent Phase|Death|13|||
160993728|NCT01599325|581365410|FG000|Primary Parent Phase|Protocol Violation|1|||
160993729|NCT01599325|581365410|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
160993730|NCT01599325|581365410|FG000|Primary Parent Phase|Other|2|||
160651083|NCT01654380|580104392|FG003|Part B, Period 1|Physician Decision|0|||
160651084|NCT03335371|580104393|FG000|Overall Study|Lost to Follow-up|0|||
160993731|NCT01599325|581365410|FG000|Extension Phase|Study Closure|1|||
160856826|NCT00713609|580866540|FG004|Overall Study|Withdrawal by Subject|5|||
160856827|NCT00713609|580866541|FG005|Overall Study|Withdrawal by Subject|7|||
160856828|NCT00713609|580866536|FG000|Overall Study|Protocol Violation|6|||
160856829|NCT00713609|580866537|FG001|Overall Study|Protocol Violation|3|||
160856830|NCT00713609|580866538|FG002|Overall Study|Protocol Violation|1|||
160569374|NCT00430781|579809141|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
160569375|NCT00430781|579809142|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
160569376|NCT00430781|579809143|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
160569377|NCT00430781|579809141|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
160569378|NCT00430781|579809142|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
160569379|NCT00430781|579809143|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
160569380|NCT00430781|579809141|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
160569381|NCT00430781|579809142|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
160569382|NCT00430781|579809143|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
160569383|NCT00430781|579809141|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
160569384|NCT00430781|579809142|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
160569385|NCT00430781|579809143|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
160569386|NCT00430781|579809141|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
160569387|NCT00430781|579809142|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
160569388|NCT00430781|579809143|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
160569389|NCT00430781|579809141|FG000|Interim Analysis; 11 February 2008|Death|0|||
160569390|NCT00430781|579809142|FG001|Interim Analysis; 11 February 2008|Death|1|||
160569391|NCT00430781|579809143|FG002|Interim Analysis; 11 February 2008|Death|0|||
160569392|NCT00430781|579809141|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
160569393|NCT00430781|579809142|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
160569394|NCT00430781|579809143|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
160569395|NCT00430781|579809141|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
160569396|NCT00430781|579809142|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
160569397|NCT00430781|579809143|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
160569398|NCT00430781|579809141|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
160569399|NCT00430781|579809142|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
160569400|NCT00430781|579809143|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
160569401|NCT00430781|579809141|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
160569402|NCT00430781|579809142|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
160569403|NCT00430781|579809143|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
160569404|NCT00430781|579809141|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
160569405|NCT00430781|579809142|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
160569406|NCT00430781|579809143|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
160569407|NCT00430781|579809141|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
160569408|NCT00430781|579809142|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
160569409|NCT00430781|579809143|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
160569410|NCT00430781|579809141|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
160569411|NCT00430781|579809142|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
160569412|NCT00430781|579809143|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
160569413|NCT00430781|579809141|FG000|Final Analysis; 31 July 2008|Other|0|||
160569414|NCT00430781|579809142|FG001|Final Analysis; 31 July 2008|Other|1|||
160569415|NCT00430781|579809143|FG002|Final Analysis; 31 July 2008|Other|0|||
160569416|NCT00430781|579809141|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
160569417|NCT00430781|579809142|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
160651085|NCT03335371|580104394|FG001|Overall Study|Lost to Follow-up|0|||
160651086|NCT03335371|580104395|FG002|Overall Study|Lost to Follow-up|0|||
160651087|NCT03335371|580104396|FG003|Overall Study|Lost to Follow-up|0|||
160651088|NCT03335371|580104397|FG004|Overall Study|Lost to Follow-up|1|||
160856831|NCT00713609|580866539|FG003|Overall Study|Protocol Violation|1|||
160856832|NCT00713609|580866540|FG004|Overall Study|Protocol Violation|2|||
160856833|NCT00713609|580866541|FG005|Overall Study|Protocol Violation|0|||
160856834|NCT01791244|580866545|FG000|Overall Study|Adverse Event|5|||
160856835|NCT01791244|580866546|FG001|Overall Study|Adverse Event|7|||
160856836|NCT01791244|580866545|FG000|Overall Study|Insufficient clinical response|10|||
160856837|NCT01791244|580866546|FG001|Overall Study|Insufficient clinical response|10|||
160856838|NCT01791244|580866545|FG000|Overall Study|Laboratory Abnormality|0|||
160856839|NCT01791244|580866546|FG001|Overall Study|Laboratory Abnormality|1|||
160856840|NCT02358473|580866548|FG000|Overall Study|Disease Progession|6|||
160856841|NCT02358473|580866548|FG000|Overall Study|Adverse Event|3|||
160856842|NCT02358473|580866548|FG000|Overall Study|Withdrawal by Subject|2|||
160856843|NCT02358473|580866548|FG000|Overall Study|Physician Decision|2|||
160908195|NCT02820753|581058054|FG000|2 Month|Stopped per NIH Hold|51|||
160569418|NCT00430781|579809143|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
160569419|NCT00430781|579809141|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
160569420|NCT00430781|579809142|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
160569421|NCT00430781|579809143|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
160651089|NCT03335371|580104393|FG000|Overall Study|Withdrawal by Subject|0|||
160651090|NCT03335371|580104394|FG001|Overall Study|Withdrawal by Subject|0|||
160651091|NCT03335371|580104395|FG002|Overall Study|Withdrawal by Subject|0|||
160651092|NCT03335371|580104396|FG003|Overall Study|Withdrawal by Subject|0|||
160651093|NCT03335371|580104397|FG004|Overall Study|Withdrawal by Subject|1|||
160651094|NCT03335371|580104393|FG000|Overall Study|Randomization Error|0|||
160651095|NCT03335371|580104394|FG001|Overall Study|Randomization Error|0|||
160651096|NCT03335371|580104395|FG002|Overall Study|Randomization Error|1|||
160651097|NCT03335371|580104396|FG003|Overall Study|Randomization Error|0|||
160651098|NCT03335371|580104397|FG004|Overall Study|Randomization Error|0|||
160651099|NCT05845645|580104399|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651100|NCT05845645|580104400|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651101|NCT05845645|580104401|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
160651102|NCT05845645|580104402|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651103|NCT05845645|580104403|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651104|NCT05845645|580104404|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651105|NCT05845645|580104405|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651106|NCT05845645|580104406|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651107|NCT05845645|580104407|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651108|NCT05845645|580104408|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651109|NCT05845645|580104409|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651110|NCT05845645|580104410|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
160651111|NCT05845645|580104399|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651112|NCT05845645|580104400|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651113|NCT05845645|580104401|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651114|NCT05845645|580104402|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651115|NCT05845645|580104403|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651116|NCT05845645|580104404|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651117|NCT05845645|580104405|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651118|NCT05845645|580104406|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651119|NCT05845645|580104407|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651120|NCT05845645|580104408|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
160651121|NCT05845645|580104409|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651122|NCT05845645|580104410|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
160651123|NCT03521999|580104418|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
160651124|NCT03521999|580104419|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
160651125|NCT03521999|580104418|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
160651126|NCT03521999|580104419|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
160651127|NCT03521999|580104418|FG000|Completed 3 Month Follow up|Death|0|||
160651128|NCT03521999|580104419|FG001|Completed 3 Month Follow up|Death|1|||
160651129|NCT03521999|580104418|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
160651130|NCT03521999|580104419|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
160651131|NCT03495986|580104420|FG000|Overall Study|Physician Decision|1|||
160651132|NCT03495986|580104421|FG001|Overall Study|Physician Decision|0|||
160651133|NCT03495986|580104420|FG000|Overall Study|Withdrawal by Subject|1|||
160651134|NCT03495986|580104421|FG001|Overall Study|Withdrawal by Subject|1|||
160651135|NCT03495986|580104420|FG000|Overall Study|Withdrawal by Subject|1|||
160651136|NCT03495986|580104421|FG001|Overall Study|Withdrawal by Subject|0|||
160651137|NCT04182204|580104422|FG000|Safety Run-in|Lost to Follow-up|1|||
160651138|NCT04182204|580104423|FG001|Safety Run-in|Lost to Follow-up|0|||
160651139|NCT04182204|580104424|FG002|Safety Run-in|Lost to Follow-up|0|||
160651140|NCT04182204|580104422|FG000|Safety Run-in|Withdrawal by Subject|2|||
160651141|NCT04182204|580104423|FG001|Safety Run-in|Withdrawal by Subject|0|||
160651142|NCT04182204|580104424|FG002|Safety Run-in|Withdrawal by Subject|0|||
160651143|NCT04182204|580104422|FG000|Safety Run-in|Death|7|||
160651144|NCT04182204|580104423|FG001|Safety Run-in|Death|0|||
160651145|NCT04182204|580104424|FG002|Safety Run-in|Death|0|||
160651146|NCT04182204|580104422|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
160651147|NCT04182204|580104423|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
160651148|NCT04182204|580104424|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
160651149|NCT04182204|580104422|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
160651150|NCT04182204|580104423|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
160651151|NCT04182204|580104424|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
160651152|NCT04182204|580104422|FG000|Randomized Controlled Trial|Death|0|||
160651153|NCT04182204|580104423|FG001|Randomized Controlled Trial|Death|83|||
160856844|NCT00703014|580866551|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
160856845|NCT00703014|580866552|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
160856846|NCT00703014|580866553|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
160908196|NCT02820753|581058055|FG001|2 Month|Stopped per NIH Hold|13|||
160651154|NCT04182204|580104424|FG002|Randomized Controlled Trial|Death|66|||
160651155|NCT05476679|580104425|FG000|Overall Study|Withdrawal by Subject|0|||
160651156|NCT05476679|580104426|FG001|Overall Study|Withdrawal by Subject|0|||
160651157|NCT05476679|580104427|FG002|Overall Study|Withdrawal by Subject|0|||
160651158|NCT05476679|580104428|FG003|Overall Study|Withdrawal by Subject|1|||
160651159|NCT05476679|580104429|FG004|Overall Study|Withdrawal by Subject|0|||
160651160|NCT05476679|580104425|FG000|Overall Study|Lost to Follow-up|0|||
160651161|NCT05476679|580104426|FG001|Overall Study|Lost to Follow-up|0|||
160651162|NCT05476679|580104427|FG002|Overall Study|Lost to Follow-up|0|||
160651163|NCT05476679|580104428|FG003|Overall Study|Lost to Follow-up|1|||
160651164|NCT05476679|580104429|FG004|Overall Study|Lost to Follow-up|0|||
160651165|NCT01214330|580104430|FG000|Overall Study|Withdrawal by Subject|2|||
160651166|NCT01214330|580104430|FG000|Overall Study|Withdrawal by Subject|2|||
160651167|NCT00249821|580104431|FG000|Overall Study|Technical problem|0|||
160651168|NCT00249821|580104432|FG001|Overall Study|Technical problem|1|||
160651169|NCT00686036|580104433|FG000|Overall Study|Adverse Event|3|||
160651170|NCT00686036|580104434|FG001|Overall Study|Adverse Event|0|||
160651171|NCT00686036|580104433|FG000|Overall Study|Withdrawal by Subject|3|||
160651172|NCT00686036|580104434|FG001|Overall Study|Withdrawal by Subject|1|||
160651173|NCT00686036|580104433|FG000|Overall Study|Study terminated by AstraZeneca|2|||
160651174|NCT00686036|580104434|FG001|Overall Study|Study terminated by AstraZeneca|1|||
160651175|NCT00686036|580104433|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
160651176|NCT00686036|580104434|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
160651177|NCT00686036|580104433|FG000|Overall Study|Other reasons not identified|0|||
160651178|NCT00686036|580104434|FG001|Overall Study|Other reasons not identified|4|||
160651179|NCT01411995|580104435|FG000|Overall Study|Failed IUD insertion|0|||
160651180|NCT01411995|580104436|FG001|Overall Study|Failed IUD insertion|1|||
160651181|NCT01937364|580104437|FG000|Overall Study|Adverse Event|2|||
160651182|NCT01937364|580104438|FG001|Overall Study|Adverse Event|1|||
160651183|NCT01498484|580104442|FG000|Overall Study|Death|6|||
160651184|NCT01498484|580104443|FG001|Overall Study|Death|3|||
160651185|NCT01498484|580104444|FG002|Overall Study|Death|1|||
160651186|NCT01498484|580104445|FG003|Overall Study|Death|1|||
160651187|NCT01498484|580104446|FG004|Overall Study|Death|0|||
160651188|NCT01498484|580104447|FG005|Overall Study|Death|0|||
160651189|NCT01498484|580104448|FG006|Overall Study|Death|10|||
160651190|NCT01498484|580104449|FG007|Overall Study|Death|1|||
160651191|NCT01498484|580104450|FG008|Overall Study|Death|0|||
160651192|NCT01498484|580104442|FG000|Overall Study|Physician Decision|3|||
160651193|NCT01498484|580104443|FG001|Overall Study|Physician Decision|2|||
160651194|NCT01498484|580104444|FG002|Overall Study|Physician Decision|1|||
160651195|NCT01498484|580104445|FG003|Overall Study|Physician Decision|1|||
160651196|NCT01498484|580104446|FG004|Overall Study|Physician Decision|0|||
160651197|NCT01498484|580104447|FG005|Overall Study|Physician Decision|0|||
160651198|NCT01498484|580104448|FG006|Overall Study|Physician Decision|8|||
160651199|NCT01498484|580104449|FG007|Overall Study|Physician Decision|13|||
160651200|NCT01498484|580104450|FG008|Overall Study|Physician Decision|1|||
160651201|NCT01498484|580104442|FG000|Overall Study|Adverse Event|0|||
160651202|NCT01498484|580104443|FG001|Overall Study|Adverse Event|0|||
160651203|NCT01498484|580104444|FG002|Overall Study|Adverse Event|0|||
160651204|NCT01498484|580104445|FG003|Overall Study|Adverse Event|0|||
160651205|NCT01498484|580104446|FG004|Overall Study|Adverse Event|0|||
160651206|NCT01498484|580104447|FG005|Overall Study|Adverse Event|1|||
160651207|NCT01498484|580104448|FG006|Overall Study|Adverse Event|0|||
160651208|NCT01498484|580104449|FG007|Overall Study|Adverse Event|0|||
160651209|NCT01498484|580104450|FG008|Overall Study|Adverse Event|0|||
160651210|NCT01498484|580104442|FG000|Overall Study|Withdrawal by Subject|0|||
160651211|NCT01498484|580104443|FG001|Overall Study|Withdrawal by Subject|0|||
160651212|NCT01498484|580104444|FG002|Overall Study|Withdrawal by Subject|0|||
160651213|NCT01498484|580104445|FG003|Overall Study|Withdrawal by Subject|1|||
160651214|NCT01498484|580104446|FG004|Overall Study|Withdrawal by Subject|0|||
160651215|NCT01498484|580104447|FG005|Overall Study|Withdrawal by Subject|0|||
160651216|NCT01498484|580104448|FG006|Overall Study|Withdrawal by Subject|1|||
160651217|NCT01498484|580104449|FG007|Overall Study|Withdrawal by Subject|0|||
160651218|NCT01498484|580104450|FG008|Overall Study|Withdrawal by Subject|0|||
160651219|NCT01498484|580104442|FG000|Overall Study|Other|5|||
160856847|NCT00703014|580866554|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
160856848|NCT00703014|580866551|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
160856849|NCT00703014|580866552|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
160651220|NCT01498484|580104443|FG001|Overall Study|Other|2|||
160651221|NCT01498484|580104444|FG002|Overall Study|Other|0|||
160651222|NCT01498484|580104445|FG003|Overall Study|Other|0|||
160651223|NCT01498484|580104446|FG004|Overall Study|Other|1|||
160862054|NCT05138653|580887933|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160651224|NCT01498484|580104447|FG005|Overall Study|Other|0|||
160651225|NCT01498484|580104448|FG006|Overall Study|Other|3|||
160651226|NCT01498484|580104449|FG007|Overall Study|Other|0|||
160651227|NCT01498484|580104450|FG008|Overall Study|Other|1|||
160651228|NCT01199601|580104451|FG000|Overall Study|Lost to Follow-up|47|||
160651229|NCT01199601|580104452|FG001|Overall Study|Lost to Follow-up|66|||
160651230|NCT01199601|580104451|FG000|Overall Study|Withdrawal by Subject|15|||
160651231|NCT01199601|580104452|FG001|Overall Study|Withdrawal by Subject|3|||
160651232|NCT01199601|580104451|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
160651233|NCT01199601|580104452|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
160651234|NCT00278512|580104453|FG000|Overall Study|Death|1|||
160651235|NCT00278512|580104454|FG001|Overall Study|Death|0|||
160651236|NCT01620177|580104455|FG000|Overall Study|Failure at Screening Visit|43|||
160651237|NCT01620177|580104455|FG000|Overall Study|Withdrawal by Subject|26|||
160651238|NCT01620177|580104455|FG000|Overall Study|Lost to Follow-up|7|||
160651239|NCT01620177|580104455|FG000|Overall Study|Physician Decision|2|||
160651240|NCT01620177|580104455|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
160651241|NCT00423800|580104456|FG000|Overall Study|Protocol Violation|0|||
160651242|NCT00423800|580104457|FG001|Overall Study|Protocol Violation|1|||
160651243|NCT00814320|580104458|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
160651244|NCT00814320|580104459|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
160651245|NCT00814320|580104458|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
160651246|NCT00814320|580104459|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
160651247|NCT00814320|580104458|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
160651248|NCT00814320|580104459|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
160651249|NCT00814320|580104458|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
160651250|NCT00814320|580104459|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
160651251|NCT00814320|580104458|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
160651252|NCT00814320|580104459|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
160651253|NCT00814320|580104458|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
160651254|NCT00814320|580104459|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
160651255|NCT00814320|580104458|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
160651256|NCT00814320|580104459|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
160651257|NCT00814320|580104458|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
160651258|NCT00814320|580104459|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
160651259|NCT00814320|580104458|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
160651260|NCT00814320|580104459|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
160651261|NCT00814320|580104458|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
160651262|NCT00814320|580104459|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
160651263|NCT00619385|580104460|FG000|Overall Study|Adverse Event|0|||
160651264|NCT00619385|580104461|FG001|Overall Study|Adverse Event|0|||
160651265|NCT00619385|580104462|FG002|Overall Study|Adverse Event|3|||
160651266|NCT00619385|580104460|FG000|Overall Study|Other|1|||
160651267|NCT00619385|580104461|FG001|Overall Study|Other|2|||
160651268|NCT00619385|580104462|FG002|Overall Study|Other|1|||
160651269|NCT02041702|580104467|FG000|Overall Study|Lost to Follow-up|1|||
160651270|NCT02041702|580104468|FG001|Overall Study|Lost to Follow-up|6|||
160651271|NCT02041702|580104467|FG000|Overall Study|Death|4|||
160651272|NCT02041702|580104468|FG001|Overall Study|Death|0|||
160651273|NCT02041702|580104467|FG000|Overall Study|Withdrawal by Subject|4|||
160651274|NCT02041702|580104468|FG001|Overall Study|Withdrawal by Subject|3|||
160651275|NCT02041702|580104467|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
160651276|NCT02041702|580104468|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
160651277|NCT02041702|580104467|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
160651278|NCT02041702|580104468|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
160651279|NCT00203307|580104469|FG000|First Intervention|Adverse Event|2|||
160651280|NCT00203307|580104470|FG001|First Intervention|Adverse Event|0|||
160651281|NCT03730103|580104471|FG000|Overall Study|Did not meet inclusion criteria|0|||
160651282|NCT03730103|580104472|FG001|Overall Study|Did not meet inclusion criteria|5|||
160651283|NCT02789111|580104473|FG000|Overall Study|Withdrawal by Subject|1|||
160651284|NCT02789111|580104474|FG001|Overall Study|Withdrawal by Subject|4|||
160651285|NCT01488578|580104475|FG000|Overall Study|Protocol Violation|1836|||
160908197|NCT02820753|581058054|FG000|6 Month|Withdrawal by Subject|2|||
160908198|NCT02820753|581058055|FG001|6 Month|Withdrawal by Subject|2|||
160908199|NCT02820753|581058054|FG000|6 Month|Lost to Follow-up|20|||
160908200|NCT02820753|581058055|FG001|6 Month|Lost to Follow-up|27|||
160651286|NCT02308111|580104476|FG000|Overall Study|Adverse Event|31|||
160651287|NCT02308111|580104477|FG001|Overall Study|Adverse Event|19|||
160651288|NCT02308111|580104476|FG000|Overall Study|Death|9|||
160651289|NCT02308111|580104477|FG001|Overall Study|Death|6|||
160651290|NCT02308111|580104476|FG000|Overall Study|Lost to Follow-up|2|||
160651291|NCT02308111|580104477|FG001|Overall Study|Lost to Follow-up|7|||
160651292|NCT02308111|580104476|FG000|Overall Study|Physician Decision|6|||
160651293|NCT02308111|580104477|FG001|Overall Study|Physician Decision|17|||
160908201|NCT02820753|581058054|FG000|6 Month|Stopped per NIH Hold|81|||
160908202|NCT02820753|581058055|FG001|6 Month|Stopped per NIH Hold|81|||
160651294|NCT02308111|580104476|FG000|Overall Study|Protocol Violation|0|||
160651295|NCT02308111|580104477|FG001|Overall Study|Protocol Violation|1|||
160651296|NCT02308111|580104476|FG000|Overall Study|Withdrawal by Subject|28|||
160908203|NCT02820753|581058054|FG000|6 Month|Death|0|||
160908204|NCT02820753|581058055|FG001|6 Month|Death|1|||
160908205|NCT00790023|581058056|FG000|Overall Study|Adverse Event|2|||
160908206|NCT00790023|581058057|FG001|Overall Study|Adverse Event|1|||
160908207|NCT00790023|581058058|FG002|Overall Study|Adverse Event|4|||
160908208|NCT00790023|581058056|FG000|Overall Study|Protocol Violation|2|||
160908209|NCT00790023|581058057|FG001|Overall Study|Protocol Violation|4|||
160908210|NCT00790023|581058058|FG002|Overall Study|Protocol Violation|2|||
160908211|NCT00790023|581058056|FG000|Overall Study|Withdrawal by Subject|2|||
160908212|NCT00790023|581058057|FG001|Overall Study|Withdrawal by Subject|0|||
160908213|NCT00790023|581058058|FG002|Overall Study|Withdrawal by Subject|6|||
160908214|NCT00790023|581058056|FG000|Overall Study|Lost to Follow-up|0|||
160908215|NCT00790023|581058057|FG001|Overall Study|Lost to Follow-up|0|||
160908216|NCT00790023|581058058|FG002|Overall Study|Lost to Follow-up|1|||
160908217|NCT00790023|581058056|FG000|Overall Study|Other|5|||
160908218|NCT00790023|581058057|FG001|Overall Study|Other|5|||
160908219|NCT00790023|581058058|FG002|Overall Study|Other|8|||
160908220|NCT02468414|581058059|FG000|Overall Study|Early Study Termination by Sponsor|1|||
160908221|NCT02468414|581058060|FG001|Overall Study|Early Study Termination by Sponsor|0|||
160908222|NCT02468414|581058059|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
160908223|NCT02468414|581058060|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
160908224|NCT02468414|581058059|FG000|Overall Study|Screen Failure|1|||
160908225|NCT02468414|581058060|FG001|Overall Study|Screen Failure|0|||
160908226|NCT01338792|581058061|FG000|Overall Study|Adverse Event|2|||
160908227|NCT01338792|581058061|FG000|Overall Study|Death|1|||
160908228|NCT01338792|581058061|FG000|Overall Study|Withdrawal by Subject|1|||
160908229|NCT01652703|581058062|FG000|Overall Study|Withdrawal by Subject|0|||
160908230|NCT01652703|581058063|FG001|Overall Study|Withdrawal by Subject|1|||
160908231|NCT01652703|581058064|FG002|Overall Study|Withdrawal by Subject|3|||
160908232|NCT01652703|581058065|FG003|Overall Study|Withdrawal by Subject|1|||
160908233|NCT01652703|581058066|FG004|Overall Study|Withdrawal by Subject|0|||
160908234|NCT01652703|581058067|FG005|Overall Study|Withdrawal by Subject|1|||
160908235|NCT01652703|581058062|FG000|Overall Study|Other|0|||
160908236|NCT01652703|581058063|FG001|Overall Study|Other|0|||
160908237|NCT01652703|581058064|FG002|Overall Study|Other|0|||
160908238|NCT01652703|581058065|FG003|Overall Study|Other|1|||
160908239|NCT01652703|581058066|FG004|Overall Study|Other|1|||
160908240|NCT01652703|581058067|FG005|Overall Study|Other|1|||
160908241|NCT00062374|581058068|FG000|Overall Study|Not treated|12|||
160908242|NCT02151591|581058069|FG000|Overall Study|Lost to Follow-up|6|||
160908243|NCT02151591|581058070|FG001|Overall Study|Lost to Follow-up|3|||
160908244|NCT05035550|581058076|FG000|Overall Study|Withdrawal by Subject|3|||
160908245|NCT05035550|581058077|FG001|Overall Study|Withdrawal by Subject|0|||
160908246|NCT00617123|581058080|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
160908247|NCT00617123|581058081|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
160908248|NCT00617123|581058080|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
160908249|NCT00617123|581058081|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
160908250|NCT00617123|581058080|FG000|Referral Screening Period|Adverse Event|0|||
160908251|NCT00617123|581058081|FG001|Referral Screening Period|Adverse Event|1|||
160908252|NCT00617123|581058080|FG000|Study Treatment Period|Withdrawal by Subject|8|||
160908253|NCT00617123|581058081|FG001|Study Treatment Period|Withdrawal by Subject|12|||
160908254|NCT00617123|581058080|FG000|Study Treatment Period|Adverse Event|7|||
160908255|NCT00617123|581058081|FG001|Study Treatment Period|Adverse Event|3|||
160908256|NCT00617123|581058080|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
160908257|NCT00617123|581058081|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
160908258|NCT00617123|581058080|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
160908259|NCT00617123|581058081|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
160908260|NCT00777608|581058083|FG000|Overall Study|Lost to Follow-up|1|||
160908261|NCT00777608|581058084|FG001|Overall Study|Lost to Follow-up|1|||
160908262|NCT00777608|581058083|FG000|Overall Study|Withdrawal by Subject|1|||
160908263|NCT00777608|581058084|FG001|Overall Study|Withdrawal by Subject|3|||
160908264|NCT00777608|581058083|FG000|Overall Study|Protocol Violation|1|||
160908265|NCT00777608|581058084|FG001|Overall Study|Protocol Violation|0|||
160908266|NCT00777608|581058083|FG000|Overall Study|Investigator Decision|1|||
160908267|NCT00777608|581058084|FG001|Overall Study|Investigator Decision|2|||
160993732|NCT01599325|581365410|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
160993733|NCT01599325|581365410|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
160993734|NCT01599325|581365410|FG000|Extension Phase|Disease Progression|1|||
160993735|NCT01599325|581365410|FG000|Extension Phase|Withdrawal by Subject|8|||
160993736|NCT02365298|581365413|FG000|Period 2|incorrect Rx dispensed|1|||
160993737|NCT02365298|581365414|FG001|Period 2|incorrect Rx dispensed|0|||
160993738|NCT02365298|581365413|FG000|Period 2|Discontinued at request of Sponsor|1|||
160993739|NCT02365298|581365414|FG001|Period 2|Discontinued at request of Sponsor|0|||
160908268|NCT04213079|581058085|FG000|Overall Study|Lost to Follow-up|0|||
160908269|NCT04213079|581058086|FG001|Overall Study|Lost to Follow-up|2|||
160908270|NCT00520936|581058088|FG000|Overall Study|Physician Decision|0|||
160908271|NCT00520936|581058089|FG001|Overall Study|Physician Decision|2|||
160908272|NCT00520936|581058090|FG002|Overall Study|Physician Decision|1|||
160993740|NCT02365298|581365413|FG000|Period 2|Test Article longer available|0|||
160993741|NCT02365298|581365414|FG001|Period 2|Test Article longer available|1|||
160993742|NCT02365298|581365413|FG000|Period 2|Protocol Violation|0|||
160993743|NCT02365298|581365414|FG001|Period 2|Protocol Violation|1|||
160993744|NCT02846415|581365419|FG000|Overall Study|Lost to Follow-up|2|||
160993745|NCT02846415|581365420|FG001|Overall Study|Lost to Follow-up|0|||
160993746|NCT02846415|581365419|FG000|Overall Study|Withdrawal by Subject|1|||
160993747|NCT02846415|581365420|FG001|Overall Study|Withdrawal by Subject|1|||
160993748|NCT00567164|581365421|FG000|Overall Study|Withdrawal by Subject|171|||
160993749|NCT00567164|581365422|FG001|Overall Study|Withdrawal by Subject|21|||
160993750|NCT00567164|581365423|FG002|Overall Study|Withdrawal by Subject|17|||
160993751|NCT00567164|581365421|FG000|Overall Study|Protocol Violation|23|||
160993752|NCT00567164|581365422|FG001|Overall Study|Protocol Violation|4|||
160993753|NCT00567164|581365423|FG002|Overall Study|Protocol Violation|2|||
160993754|NCT00567164|581365421|FG000|Overall Study|Adverse Event|92|||
160993755|NCT00567164|581365422|FG001|Overall Study|Adverse Event|13|||
160993756|NCT00567164|581365423|FG002|Overall Study|Adverse Event|9|||
160993757|NCT00567164|581365421|FG000|Overall Study|Death|0|||
160993758|NCT00567164|581365422|FG001|Overall Study|Death|0|||
160993759|NCT00567164|581365423|FG002|Overall Study|Death|1|||
160993760|NCT00567164|581365421|FG000|Overall Study|Lost to Follow-up|202|||
160993761|NCT00567164|581365422|FG001|Overall Study|Lost to Follow-up|23|||
160993762|NCT00567164|581365423|FG002|Overall Study|Lost to Follow-up|21|||
160993763|NCT00567164|581365421|FG000|Overall Study|Pregnancy|20|||
160993764|NCT00567164|581365422|FG001|Overall Study|Pregnancy|4|||
160993765|NCT00567164|581365423|FG002|Overall Study|Pregnancy|6|||
160993766|NCT00567164|581365421|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
160993767|NCT00567164|581365422|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
160993768|NCT00567164|581365423|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
160993769|NCT00567164|581365421|FG000|Overall Study|Missing|1|||
160993770|NCT00567164|581365422|FG001|Overall Study|Missing|0|||
160993771|NCT00567164|581365423|FG002|Overall Study|Missing|0|||
160993772|NCT03381274|581365430|FG000|Overall Study|Death|2|||
160993773|NCT03381274|581365431|FG001|Overall Study|Death|9|||
160993774|NCT03381274|581365432|FG002|Overall Study|Death|3|||
160993775|NCT03381274|581365433|FG003|Overall Study|Death|2|||
160993776|NCT03381274|581365434|FG004|Overall Study|Death|3|||
160993777|NCT03381274|581365430|FG000|Overall Study|Lost to Follow-up|0|||
160993778|NCT03381274|581365431|FG001|Overall Study|Lost to Follow-up|0|||
160993779|NCT03381274|581365432|FG002|Overall Study|Lost to Follow-up|0|||
160993780|NCT03381274|581365433|FG003|Overall Study|Lost to Follow-up|1|||
160993781|NCT03381274|581365434|FG004|Overall Study|Lost to Follow-up|0|||
160993782|NCT03381274|581365430|FG000|Overall Study|Withdrawal by Subject|2|||
160993783|NCT03381274|581365431|FG001|Overall Study|Withdrawal by Subject|1|||
160993784|NCT03381274|581365432|FG002|Overall Study|Withdrawal by Subject|3|||
160993785|NCT03381274|581365433|FG003|Overall Study|Withdrawal by Subject|1|||
160993786|NCT03381274|581365434|FG004|Overall Study|Withdrawal by Subject|0|||
160993787|NCT03381274|581365430|FG000|Overall Study|Other|1|||
160993788|NCT03381274|581365431|FG001|Overall Study|Other|11|||
160993789|NCT03381274|581365432|FG002|Overall Study|Other|0|||
160993790|NCT03381274|581365433|FG003|Overall Study|Other|2|||
160993791|NCT03381274|581365434|FG004|Overall Study|Other|2|||
160993792|NCT02081391|581365435|FG000|12-hour Treatment|Withdrawal by Subject|3|||
160993793|NCT02081391|581365436|FG001|12-hour Treatment|Withdrawal by Subject|2|||
160993794|NCT02081391|581365437|FG002|12-hour Treatment|Withdrawal by Subject|0|||
160993795|NCT02081391|581365438|FG003|12-hour Treatment|Withdrawal by Subject|0|||
160993796|NCT02081391|581365435|FG000|12-hour Treatment|Physician Decision|4|||
160993797|NCT02081391|581365436|FG001|12-hour Treatment|Physician Decision|1|||
160993798|NCT02081391|581365437|FG002|12-hour Treatment|Physician Decision|0|||
160993799|NCT02081391|581365438|FG003|12-hour Treatment|Physician Decision|0|||
160993800|NCT02081391|581365435|FG000|12-hour Treatment|Lack of Efficacy|3|||
160993801|NCT02081391|581365436|FG001|12-hour Treatment|Lack of Efficacy|0|||
160993802|NCT02081391|581365437|FG002|12-hour Treatment|Lack of Efficacy|0|||
160993803|NCT02081391|581365438|FG003|12-hour Treatment|Lack of Efficacy|0|||
160993804|NCT02081391|581365435|FG000|12-hour Treatment|Adverse Event|4|||
160569422|NCT00430781|579809141|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
160993805|NCT02081391|581365436|FG001|12-hour Treatment|Adverse Event|2|||
160993806|NCT02081391|581365437|FG002|12-hour Treatment|Adverse Event|0|||
160993807|NCT02081391|581365438|FG003|12-hour Treatment|Adverse Event|0|||
160993808|NCT02081391|581365435|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
160993809|NCT02081391|581365436|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
160993810|NCT02081391|581365437|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
160993811|NCT02081391|581365438|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
160993812|NCT02081391|581365435|FG000|12-hour Treatment|Further reasons|2|||
160993813|NCT02081391|581365436|FG001|12-hour Treatment|Further reasons|1|||
160993814|NCT02081391|581365437|FG002|12-hour Treatment|Further reasons|0|||
160993815|NCT02081391|581365438|FG003|12-hour Treatment|Further reasons|0|||
160993816|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
160993817|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
160651297|NCT02308111|580104477|FG001|Overall Study|Withdrawal by Subject|38|||
160651298|NCT02308111|580104476|FG000|Overall Study|Study Terminated by Sponsor|72|||
160651299|NCT02308111|580104477|FG001|Overall Study|Study Terminated by Sponsor|61|||
160651300|NCT02308111|580104476|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
160651301|NCT02308111|580104477|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
160651302|NCT02308111|580104476|FG000|Overall Study|Site Closure|3|||
160651303|NCT02308111|580104477|FG001|Overall Study|Site Closure|3|||
160651304|NCT02308111|580104476|FG000|Overall Study|Non-compliance with Study Drug|3|||
160651305|NCT02308111|580104477|FG001|Overall Study|Non-compliance with Study Drug|1|||
160651306|NCT02308111|580104476|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
160651307|NCT02308111|580104477|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
160651308|NCT02308111|580104476|FG000|Overall Study|Liver Transplant|3|||
160651309|NCT02308111|580104477|FG001|Overall Study|Liver Transplant|3|||
160651310|NCT02308111|580104476|FG000|Overall Study|Liver Transplant Waitlist|2|||
160651311|NCT02308111|580104477|FG001|Overall Study|Liver Transplant Waitlist|2|||
160651312|NCT02308111|580104476|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
160651313|NCT02308111|580104477|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
160651314|NCT03271528|580104478|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
160651315|NCT03271528|580104479|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
160651316|NCT03271528|580104478|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
160651317|NCT03271528|580104479|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
160651318|NCT03271528|580104478|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
160651319|NCT03271528|580104479|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
160651320|NCT03271528|580104478|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
160651321|NCT03271528|580104479|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
160651322|NCT03271528|580104478|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
160651323|NCT03271528|580104479|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
160651324|NCT03271528|580104478|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
160651325|NCT03271528|580104479|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
160651326|NCT03271528|580104478|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
160651327|NCT03271528|580104479|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
160651328|NCT00717756|580104481|FG000|Overall Study|Withdrawal by Subject|1|||
160651329|NCT01364870|580104486|FG000|Overall Study|Withdrawal by Subject|13|||
160651330|NCT01364870|580104487|FG001|Overall Study|Withdrawal by Subject|24|||
160651331|NCT01364870|580104488|FG002|Overall Study|Withdrawal by Subject|10|||
160651332|NCT01364870|580104486|FG000|Overall Study|Adverse Event|8|||
160651333|NCT01364870|580104487|FG001|Overall Study|Adverse Event|6|||
160651334|NCT01364870|580104488|FG002|Overall Study|Adverse Event|4|||
160651335|NCT01364870|580104486|FG000|Overall Study|Protocol Violation|1|||
160651336|NCT01364870|580104487|FG001|Overall Study|Protocol Violation|0|||
160651337|NCT01364870|580104488|FG002|Overall Study|Protocol Violation|0|||
160651338|NCT01873859|580104489|FG000|Overall Study|Withdrawal by Subject|0|||
160651339|NCT01873859|580104490|FG001|Overall Study|Withdrawal by Subject|4|||
160651340|NCT01309919|580104491|FG000|Overall Study|Did not receive a postpartum IUD|17|||
160651341|NCT01309919|580104492|FG001|Overall Study|Did not receive a postpartum IUD|48|||
160651342|NCT01691508|580106075|FG000|Overall Study|Adverse Event|3|||
160651343|NCT01691508|580106076|FG001|Overall Study|Adverse Event|3|||
160651344|NCT01691508|580106075|FG000|Overall Study|Withdrawal by Subject|1|||
160651345|NCT01691508|580106076|FG001|Overall Study|Withdrawal by Subject|0|||
160651346|NCT02228382|580106079|FG000|Overall Study|Death|5|||
160651347|NCT02228382|580106080|FG001|Overall Study|Death|7|||
160651348|NCT02228382|580106081|FG002|Overall Study|Death|5|||
160651349|NCT02228382|580106082|FG003|Overall Study|Death|0|||
160651350|NCT02228382|580106083|FG004|Overall Study|Death|2|||
160651351|NCT02228382|580106079|FG000|Overall Study|Participant refused further follow-up|0|||
160651352|NCT02228382|580106080|FG001|Overall Study|Participant refused further follow-up|0|||
160651353|NCT02228382|580106081|FG002|Overall Study|Participant refused further follow-up|1|||
160651354|NCT02228382|580106082|FG003|Overall Study|Participant refused further follow-up|0|||
160651355|NCT02228382|580106083|FG004|Overall Study|Participant refused further follow-up|0|||
160651356|NCT02228382|580106079|FG000|Overall Study|Study terminated by sponsor|3|||
160651357|NCT02228382|580106080|FG001|Overall Study|Study terminated by sponsor|5|||
160651358|NCT02228382|580106081|FG002|Overall Study|Study terminated by sponsor|7|||
160651359|NCT02228382|580106082|FG003|Overall Study|Study terminated by sponsor|0|||
160856850|NCT00703014|580866553|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
160651360|NCT02228382|580106083|FG004|Overall Study|Study terminated by sponsor|0|||
160651361|NCT02228382|580106079|FG000|Overall Study|Lost to Follow-up|0|||
160651362|NCT02228382|580106080|FG001|Overall Study|Lost to Follow-up|0|||
160651363|NCT02228382|580106081|FG002|Overall Study|Lost to Follow-up|3|||
160856851|NCT00703014|580866554|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
160856852|NCT04949191|580866555|FG000|Overall Study|Non-compliance with Study Drug|1|||
160908273|NCT00520936|581058091|FG003|Overall Study|Physician Decision|0|||
160908274|NCT00520936|581058092|FG004|Overall Study|Physician Decision|0|||
160908275|NCT00520936|581058093|FG005|Overall Study|Physician Decision|0|||
160908276|NCT00520936|581058094|FG006|Overall Study|Physician Decision|0|||
160908277|NCT00520936|581058095|FG007|Overall Study|Physician Decision|0|||
160908278|NCT00520936|581058088|FG000|Overall Study|Withdrawal by Subject|0|||
160908279|NCT00520936|581058089|FG001|Overall Study|Withdrawal by Subject|0|||
160908280|NCT00520936|581058090|FG002|Overall Study|Withdrawal by Subject|0|||
160908281|NCT00520936|581058091|FG003|Overall Study|Withdrawal by Subject|0|||
160908282|NCT00520936|581058092|FG004|Overall Study|Withdrawal by Subject|0|||
160908283|NCT00520936|581058093|FG005|Overall Study|Withdrawal by Subject|0|||
160908284|NCT00520936|581058094|FG006|Overall Study|Withdrawal by Subject|0|||
160908285|NCT00520936|581058095|FG007|Overall Study|Withdrawal by Subject|1|||
160908286|NCT00520936|581058088|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
160908287|NCT00520936|581058089|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
160908288|NCT00520936|581058090|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
160908289|NCT00520936|581058091|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
160908290|NCT00520936|581058092|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
160908291|NCT00520936|581058093|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
160908292|NCT00520936|581058094|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
160908293|NCT00520936|581058095|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
160908294|NCT00520936|581058088|FG000|Overall Study|Death|0|||
160908295|NCT00520936|581058089|FG001|Overall Study|Death|0|||
160908296|NCT00520936|581058090|FG002|Overall Study|Death|0|||
160908297|NCT00520936|581058091|FG003|Overall Study|Death|0|||
160908298|NCT00520936|581058092|FG004|Overall Study|Death|0|||
160908299|NCT00520936|581058093|FG005|Overall Study|Death|0|||
160908300|NCT00520936|581058094|FG006|Overall Study|Death|1|||
160908301|NCT00520936|581058095|FG007|Overall Study|Death|0|||
160908302|NCT00520936|581058088|FG000|Overall Study|Protocol Violation|0|||
160908303|NCT00520936|581058089|FG001|Overall Study|Protocol Violation|1|||
160908304|NCT00520936|581058090|FG002|Overall Study|Protocol Violation|1|||
160908305|NCT00520936|581058091|FG003|Overall Study|Protocol Violation|0|||
160908306|NCT00520936|581058092|FG004|Overall Study|Protocol Violation|1|||
160908307|NCT00520936|581058093|FG005|Overall Study|Protocol Violation|0|||
160908308|NCT00520936|581058094|FG006|Overall Study|Protocol Violation|1|||
160908309|NCT00520936|581058095|FG007|Overall Study|Protocol Violation|0|||
160908310|NCT01061177|581058099|FG000|Overall Study|Adverse Event|117|||
160908311|NCT01061177|581058099|FG000|Overall Study|Withdrawal by Subject|27|||
160908312|NCT01061177|581058099|FG000|Overall Study|Disease progression|17|||
160908313|NCT01061177|581058099|FG000|Overall Study|Protocol Violation|11|||
160908314|NCT01061177|581058099|FG000|Overall Study|Lost to Follow-up|9|||
160908315|NCT01061177|581058099|FG000|Overall Study|New cancer therapy|9|||
160908316|NCT01061177|581058099|FG000|Overall Study|Abnormal laboratory values|6|||
160908317|NCT01061177|581058099|FG000|Overall Study|Abnormal test procedure results|4|||
160908318|NCT01061177|581058099|FG000|Overall Study|Administratie problems|4|||
160908319|NCT01061177|581058099|FG000|Overall Study|Death|4|||
160908320|NCT03616600|581058100|FG000|Overall Study|Withdrawal by Subject|1|||
160908321|NCT03616600|581058101|FG001|Overall Study|Withdrawal by Subject|0|||
160908322|NCT03984994|581058102|FG000|Overall Study|Withdrawal by Subject|2|||
160908323|NCT03984994|581058103|FG001|Overall Study|Withdrawal by Subject|1|||
160908324|NCT03010176|581058105|FG000|Overall Study|Death|21|||
160908325|NCT03010176|581058106|FG001|Overall Study|Death|35|||
160908326|NCT03010176|581058107|FG002|Overall Study|Death|19|||
160908327|NCT03010176|581058108|FG003|Overall Study|Death|19|||
160908328|NCT03010176|581058109|FG004|Overall Study|Death|14|||
160908329|NCT03010176|581058110|FG005|Overall Study|Death|0|||
160908330|NCT03010176|581058105|FG000|Overall Study|Lost to Follow-up|0|||
160908331|NCT03010176|581058106|FG001|Overall Study|Lost to Follow-up|0|||
160908332|NCT03010176|581058107|FG002|Overall Study|Lost to Follow-up|0|||
160908333|NCT03010176|581058108|FG003|Overall Study|Lost to Follow-up|0|||
160908334|NCT03010176|581058109|FG004|Overall Study|Lost to Follow-up|1|||
160908335|NCT03010176|581058110|FG005|Overall Study|Lost to Follow-up|0|||
160908336|NCT03010176|581058105|FG000|Overall Study|Physician Decision|0|||
160908337|NCT03010176|581058106|FG001|Overall Study|Physician Decision|4|||
160908338|NCT03010176|581058107|FG002|Overall Study|Physician Decision|0|||
160908339|NCT03010176|581058108|FG003|Overall Study|Physician Decision|1|||
160908340|NCT03010176|581058109|FG004|Overall Study|Physician Decision|0|||
160908341|NCT03010176|581058110|FG005|Overall Study|Physician Decision|0|||
160908342|NCT03010176|581058105|FG000|Overall Study|Sponsor Decision|0|||
160908343|NCT03010176|581058106|FG001|Overall Study|Sponsor Decision|4|||
160908344|NCT03010176|581058107|FG002|Overall Study|Sponsor Decision|4|||
160993818|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
160908345|NCT03010176|581058108|FG003|Overall Study|Sponsor Decision|1|||
160908346|NCT03010176|581058109|FG004|Overall Study|Sponsor Decision|6|||
160908347|NCT03010176|581058110|FG005|Overall Study|Sponsor Decision|0|||
160908348|NCT03010176|581058105|FG000|Overall Study|Withdrawal by Subject|11|||
160908349|NCT03010176|581058106|FG001|Overall Study|Withdrawal by Subject|9|||
160908350|NCT03010176|581058107|FG002|Overall Study|Withdrawal by Subject|3|||
160651364|NCT02228382|580106082|FG003|Overall Study|Lost to Follow-up|1|||
160651365|NCT02228382|580106083|FG004|Overall Study|Lost to Follow-up|0|||
160651366|NCT02228382|580106079|FG000|Overall Study|Withdrawal by Subject|0|||
160651367|NCT02228382|580106080|FG001|Overall Study|Withdrawal by Subject|3|||
160651368|NCT02228382|580106081|FG002|Overall Study|Withdrawal by Subject|2|||
160651369|NCT02228382|580106082|FG003|Overall Study|Withdrawal by Subject|1|||
160651370|NCT02228382|580106083|FG004|Overall Study|Withdrawal by Subject|0|||
160651371|NCT02228382|580106079|FG000|Overall Study|Other|2|||
160651372|NCT02228382|580106080|FG001|Overall Study|Other|3|||
160651373|NCT02228382|580106081|FG002|Overall Study|Other|3|||
160651374|NCT02228382|580106082|FG003|Overall Study|Other|0|||
160651375|NCT02228382|580106083|FG004|Overall Study|Other|0|||
160651376|NCT02396381|580106084|FG000|Overall Study|Adverse Event|3|||
160651377|NCT02396381|580106085|FG001|Overall Study|Adverse Event|2|||
160651378|NCT02396381|580106084|FG000|Overall Study|Withdrawal by Subject|33|||
160651379|NCT02396381|580106085|FG001|Overall Study|Withdrawal by Subject|24|||
160651380|NCT02396381|580106084|FG000|Overall Study|Lost to Follow-up|49|||
160651381|NCT02396381|580106085|FG001|Overall Study|Lost to Follow-up|31|||
160651382|NCT02396381|580106084|FG000|Overall Study|Protocol Violation|1|||
160651383|NCT02396381|580106085|FG001|Overall Study|Protocol Violation|0|||
160651384|NCT02396381|580106084|FG000|Overall Study|Site terminated by sponsor|7|||
160651385|NCT02396381|580106085|FG001|Overall Study|Site terminated by sponsor|8|||
160651386|NCT02396381|580106084|FG000|Overall Study|Physician Decision|5|||
160651387|NCT02396381|580106085|FG001|Overall Study|Physician Decision|5|||
160651388|NCT02396381|580106084|FG000|Overall Study|Pregnancy|2|||
160651389|NCT02396381|580106085|FG001|Overall Study|Pregnancy|0|||
160651390|NCT02396381|580106084|FG000|Overall Study|Non-compliance with study procedures|1|||
160993819|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
160993820|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
160993821|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
160993822|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
160993823|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
160993824|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
160993825|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
160993826|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
160993827|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
160993828|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
160993829|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
160993830|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
160993831|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
160993832|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
160993833|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
160993834|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
160993835|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
160993836|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
160993837|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
160993838|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
160993839|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
160993840|NCT01458275|581365439|FG000|Overall Study|Adverse Event|3|||
160993841|NCT01458275|581365440|FG001|Overall Study|Adverse Event|4|||
160993842|NCT01458275|581365441|FG002|Overall Study|Adverse Event|1|||
160993843|NCT01458275|581365439|FG000|Overall Study|Lost to Follow-up|3|||
160993844|NCT01458275|581365440|FG001|Overall Study|Lost to Follow-up|2|||
160993845|NCT01458275|581365441|FG002|Overall Study|Lost to Follow-up|5|||
160993846|NCT01458275|581365439|FG000|Overall Study|Protocol Violation|5|||
160993847|NCT01458275|581365440|FG001|Overall Study|Protocol Violation|5|||
160993848|NCT01458275|581365441|FG002|Overall Study|Protocol Violation|2|||
160993849|NCT01458275|581365439|FG000|Overall Study|Withdrawal by Subject|3|||
160993850|NCT01458275|581365440|FG001|Overall Study|Withdrawal by Subject|2|||
160993851|NCT01458275|581365441|FG002|Overall Study|Withdrawal by Subject|1|||
160651391|NCT02396381|580106085|FG001|Overall Study|Non-compliance with study procedures|0|||
160651392|NCT02396381|580106084|FG000|Overall Study|Moved out of town/state|1|||
160651393|NCT02396381|580106085|FG001|Overall Study|Moved out of town/state|3|||
160651394|NCT02396381|580106084|FG000|Overall Study|Could not complete visit|1|||
160651395|NCT02396381|580106085|FG001|Overall Study|Could not complete visit|0|||
160651396|NCT02396381|580106084|FG000|Overall Study|Possible conflict of interest|1|||
160651397|NCT02396381|580106085|FG001|Overall Study|Possible conflict of interest|0|||
160993852|NCT00751036|581365443|FG000|Overall Study|Disease Progression|28|||
160993853|NCT00751036|581365444|FG001|Overall Study|Disease Progression|29|||
160651398|NCT02396381|580106084|FG000|Overall Study|Randomization/Screening Error|3|||
160651399|NCT02396381|580106085|FG001|Overall Study|Randomization/Screening Error|1|||
160651400|NCT00395226|580106086|FG000|Overall Study|Adverse Event|4|||
160651401|NCT00395226|580106087|FG001|Overall Study|Adverse Event|3|||
160651402|NCT00395226|580106086|FG000|Overall Study|Withdrawal by Subject|0|||
160651403|NCT00395226|580106087|FG001|Overall Study|Withdrawal by Subject|1|||
160651404|NCT00395226|580106086|FG000|Overall Study|Lost to Follow-up|0|||
160651405|NCT00395226|580106087|FG001|Overall Study|Lost to Follow-up|1|||
160651406|NCT02655237|580106090|FG000|Overall Study|Adverse Event|10|||
160651407|NCT02655237|580106091|FG001|Overall Study|Adverse Event|7|||
160651408|NCT02655237|580106090|FG000|Overall Study|Protocol Deviation|2|||
160651409|NCT02655237|580106091|FG001|Overall Study|Protocol Deviation|0|||
160651410|NCT02655237|580106090|FG000|Overall Study|Withdrawal by Participant|1|||
160651411|NCT02655237|580106091|FG001|Overall Study|Withdrawal by Participant|2|||
160651412|NCT02655237|580106090|FG000|Overall Study|Lack of Efficacy|0|||
160651413|NCT02655237|580106091|FG001|Overall Study|Lack of Efficacy|1|||
160651414|NCT02655237|580106090|FG000|Overall Study|Recovery Leading to Surgery|2|||
160651415|NCT02655237|580106091|FG001|Overall Study|Recovery Leading to Surgery|1|||
160651416|NCT02655237|580106090|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
160651417|NCT02655237|580106091|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
160651418|NCT02655237|580106090|FG000|Overall Study|Randomized but Not Treated|1|||
160651419|NCT02655237|580106091|FG001|Overall Study|Randomized but Not Treated|0|||
160651420|NCT03679741|580106092|FG000|Period 1|No longer meet eligibility criteria|1|||
160651421|NCT03679741|580106093|FG001|Period 1|No longer meet eligibility criteria|0|||
160651422|NCT03679741|580106092|FG000|Period 1|Lost to Follow-up|0|||
160651423|NCT03679741|580106093|FG001|Period 1|Lost to Follow-up|1|||
160651424|NCT03679741|580106092|FG000|Period 1|Adverse Event|1|||
160651425|NCT03679741|580106093|FG001|Period 1|Adverse Event|1|||
160651426|NCT03679741|580106092|FG000|Period 1|Withdrawal by Subject|0|||
160651427|NCT03679741|580106093|FG001|Period 1|Withdrawal by Subject|1|||
160651428|NCT03679741|580106092|FG000|Period 2|Adverse Event|2|||
160651429|NCT03679741|580106093|FG001|Period 2|Adverse Event|1|||
160651430|NCT03679741|580106092|FG000|Period 2|Withdrawal by Subject|1|||
160651431|NCT03679741|580106093|FG001|Period 2|Withdrawal by Subject|1|||
160651432|NCT04652453|580106099|FG000|Overall Study|Death|8|||
160651433|NCT04652453|580106100|FG001|Overall Study|Death|2|||
160651434|NCT04652453|580106101|FG002|Overall Study|Death|0|||
160651435|NCT04652453|580106099|FG000|Overall Study|Hospice|5|||
160651436|NCT04652453|580106100|FG001|Overall Study|Hospice|5|||
160651437|NCT04652453|580106101|FG002|Overall Study|Hospice|0|||
160651438|NCT04652453|580106099|FG000|Overall Study|Withdrawal by Subject|2|||
160651439|NCT04652453|580106100|FG001|Overall Study|Withdrawal by Subject|0|||
160651440|NCT04652453|580106101|FG002|Overall Study|Withdrawal by Subject|0|||
160651441|NCT04543136|580106102|FG000|Overall Study|Withdrawal by Subject|0|||
160651442|NCT04543136|580106103|FG001|Overall Study|Withdrawal by Subject|1|||
160651443|NCT04543136|580106104|FG002|Overall Study|Withdrawal by Subject|0|||
160651444|NCT04543136|580106105|FG003|Overall Study|Withdrawal by Subject|1|||
160651445|NCT04543136|580106106|FG004|Overall Study|Withdrawal by Subject|0|||
160651446|NCT04543136|580106107|FG005|Overall Study|Withdrawal by Subject|0|||
160651447|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
160651448|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
160651449|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
160651450|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
160651451|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
160651452|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
160651453|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
160651454|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
160651455|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
160651456|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
160651457|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
160651458|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
160651459|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
160651460|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
160651461|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160651462|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160651463|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160856853|NCT04949191|580866556|FG001|Overall Study|Non-compliance with Study Drug|0|||
160651464|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160651465|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160651466|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
160651467|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
160651468|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160651469|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160651470|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160993854|NCT00751036|581365443|FG000|Overall Study|Adverse Event|6|||
160993855|NCT00751036|581365444|FG001|Overall Study|Adverse Event|4|||
160569423|NCT00430781|579809142|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
160569424|NCT00430781|579809143|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
160569425|NCT00430781|579809141|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
160569426|NCT00430781|579809142|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
160569427|NCT00430781|579809143|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
160569428|NCT00430781|579809141|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
160569429|NCT00430781|579809142|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
160569430|NCT00430781|579809143|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
160569431|NCT00430781|579809141|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
160569432|NCT00430781|579809142|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
160569433|NCT00430781|579809143|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
160569434|NCT00430781|579809141|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
160569435|NCT00430781|579809142|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
160569436|NCT00430781|579809143|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
160569437|NCT02158533|579809146|FG000|Stage 1|Adverse Event|6|||
160569438|NCT02158533|579809147|FG001|Stage 1|Adverse Event|4|||
160569439|NCT02158533|579809148|FG002|Stage 1|Adverse Event|7|||
160569440|NCT02158533|579809149|FG003|Stage 1|Adverse Event|0|||
160569441|NCT02158533|579809150|FG004|Stage 1|Adverse Event|0|||
160569442|NCT02158533|579809151|FG005|Stage 1|Adverse Event|0|||
160569443|NCT02158533|579809146|FG000|Stage 1|Withdrawal by Subject|3|||
160569444|NCT02158533|579809147|FG001|Stage 1|Withdrawal by Subject|2|||
160569445|NCT02158533|579809148|FG002|Stage 1|Withdrawal by Subject|1|||
160569446|NCT02158533|579809149|FG003|Stage 1|Withdrawal by Subject|0|||
160569447|NCT02158533|579809150|FG004|Stage 1|Withdrawal by Subject|0|||
160569448|NCT02158533|579809151|FG005|Stage 1|Withdrawal by Subject|0|||
160569449|NCT02158533|579809146|FG000|Stage 1|Lack of Efficacy|1|||
160569450|NCT02158533|579809147|FG001|Stage 1|Lack of Efficacy|0|||
160569451|NCT02158533|579809148|FG002|Stage 1|Lack of Efficacy|0|||
160569452|NCT02158533|579809149|FG003|Stage 1|Lack of Efficacy|0|||
160569453|NCT02158533|579809150|FG004|Stage 1|Lack of Efficacy|0|||
160569454|NCT02158533|579809151|FG005|Stage 1|Lack of Efficacy|0|||
160569455|NCT02158533|579809146|FG000|Stage 1|Lost to Follow-up|3|||
160569456|NCT02158533|579809147|FG001|Stage 1|Lost to Follow-up|1|||
160569457|NCT02158533|579809148|FG002|Stage 1|Lost to Follow-up|0|||
160569458|NCT02158533|579809149|FG003|Stage 1|Lost to Follow-up|0|||
160569459|NCT02158533|579809150|FG004|Stage 1|Lost to Follow-up|0|||
160569460|NCT02158533|579809151|FG005|Stage 1|Lost to Follow-up|0|||
160569461|NCT02158533|579809146|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
160569462|NCT02158533|579809147|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
160569463|NCT02158533|579809148|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
160569464|NCT02158533|579809149|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
160569465|NCT02158533|579809150|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
160569466|NCT02158533|579809151|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
160569467|NCT02158533|579809146|FG000|Stage 1|Non-compliance with study visits|1|||
160569468|NCT02158533|579809147|FG001|Stage 1|Non-compliance with study visits|0|||
160569469|NCT02158533|579809148|FG002|Stage 1|Non-compliance with study visits|0|||
160569470|NCT02158533|579809149|FG003|Stage 1|Non-compliance with study visits|0|||
160569471|NCT02158533|579809150|FG004|Stage 1|Non-compliance with study visits|0|||
160569472|NCT02158533|579809151|FG005|Stage 1|Non-compliance with study visits|0|||
160569473|NCT02158533|579809146|FG000|Stage 2|Adverse Event|0|||
160569474|NCT02158533|579809147|FG001|Stage 2|Adverse Event|0|||
160569475|NCT02158533|579809148|FG002|Stage 2|Adverse Event|0|||
160569476|NCT02158533|579809149|FG003|Stage 2|Adverse Event|0|||
160569477|NCT02158533|579809150|FG004|Stage 2|Adverse Event|0|||
160569478|NCT02158533|579809151|FG005|Stage 2|Adverse Event|1|||
160569479|NCT02158533|579809146|FG000|Stage 2|Lack of Efficacy|0|||
160569480|NCT02158533|579809147|FG001|Stage 2|Lack of Efficacy|0|||
160569481|NCT02158533|579809148|FG002|Stage 2|Lack of Efficacy|0|||
160569482|NCT02158533|579809149|FG003|Stage 2|Lack of Efficacy|0|||
160569483|NCT02158533|579809150|FG004|Stage 2|Lack of Efficacy|1|||
160569484|NCT02158533|579809151|FG005|Stage 2|Lack of Efficacy|0|||
160569485|NCT02158533|579809146|FG000|Stage 2|Lost to Follow-up|0|||
160569486|NCT02158533|579809147|FG001|Stage 2|Lost to Follow-up|0|||
160569487|NCT02158533|579809148|FG002|Stage 2|Lost to Follow-up|0|||
160569488|NCT02158533|579809149|FG003|Stage 2|Lost to Follow-up|1|||
160569489|NCT02158533|579809150|FG004|Stage 2|Lost to Follow-up|1|||
160569490|NCT02158533|579809151|FG005|Stage 2|Lost to Follow-up|2|||
160569491|NCT02158533|579809146|FG000|Stage 2|Withdrawal by Subject|0|||
160569492|NCT02158533|579809147|FG001|Stage 2|Withdrawal by Subject|0|||
160569493|NCT02158533|579809148|FG002|Stage 2|Withdrawal by Subject|0|||
160569494|NCT02158533|579809149|FG003|Stage 2|Withdrawal by Subject|0|||
160569495|NCT02158533|579809150|FG004|Stage 2|Withdrawal by Subject|1|||
160651471|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160651472|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160651473|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160651474|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
160651475|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
160651476|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651477|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651478|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651479|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651480|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651481|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
160651482|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651483|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651484|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651485|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651486|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651487|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651488|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
160651489|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651490|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651491|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651492|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651493|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651494|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
160651495|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
160651496|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651497|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651498|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651499|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651500|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651501|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651502|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
160651503|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651504|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651505|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651506|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651507|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651508|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651509|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
160651510|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651511|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651512|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651513|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651514|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651515|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651516|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
160651517|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
160651518|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
160651519|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
160651520|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
160651521|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
160651522|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
160651523|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
160651524|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
160651525|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
160651526|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
160651527|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
160651528|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
160651529|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
160651530|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
160651531|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160856854|NCT04949191|580866557|FG002|Overall Study|Non-compliance with Study Drug|0|||
160856855|NCT04949191|580866558|FG003|Overall Study|Non-compliance with Study Drug|0|||
160856856|NCT04949191|580866555|FG000|Overall Study|Progressive Disease|0|||
160856857|NCT04949191|580866556|FG001|Overall Study|Progressive Disease|1|||
160856858|NCT04949191|580866557|FG002|Overall Study|Progressive Disease|0|||
160856859|NCT04949191|580866558|FG003|Overall Study|Progressive Disease|0|||
160651532|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
160651533|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651534|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651535|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651536|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
160651537|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651538|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651539|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651540|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651541|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651542|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651543|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651544|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
160651545|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
160651546|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651547|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651548|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651549|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651550|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
160651551|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651552|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651553|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651554|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651555|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651556|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651557|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651558|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
160651559|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
160651560|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
160651561|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
160651562|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
160651563|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
160651564|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
160651565|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
160651566|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
160651567|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
160651568|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
160651569|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
160651570|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
160651571|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
160651572|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
160651573|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651574|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651575|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651576|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651577|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651578|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651579|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651580|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
160651581|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
160651582|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651583|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651584|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651585|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651586|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
160651587|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651588|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651589|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651590|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651591|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651592|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651593|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651594|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651595|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
160856860|NCT04949191|580866555|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
160569496|NCT02158533|579809151|FG005|Stage 2|Withdrawal by Subject|2|||
160569497|NCT02158533|579809146|FG000|Stage 2|Physician Decision|0|||
160569498|NCT02158533|579809147|FG001|Stage 2|Physician Decision|0|||
160569499|NCT02158533|579809148|FG002|Stage 2|Physician Decision|0|||
160569500|NCT02158533|579809149|FG003|Stage 2|Physician Decision|0|||
160569501|NCT02158533|579809150|FG004|Stage 2|Physician Decision|1|||
160569502|NCT02158533|579809151|FG005|Stage 2|Physician Decision|0|||
160569503|NCT02158533|579809146|FG000|Stage 2|Pregnancy|0|||
160569504|NCT02158533|579809147|FG001|Stage 2|Pregnancy|0|||
160569505|NCT02158533|579809148|FG002|Stage 2|Pregnancy|0|||
160569506|NCT02158533|579809149|FG003|Stage 2|Pregnancy|1|||
160569507|NCT02158533|579809150|FG004|Stage 2|Pregnancy|0|||
160569508|NCT02158533|579809151|FG005|Stage 2|Pregnancy|0|||
160569509|NCT02158533|579809146|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
160569510|NCT02158533|579809147|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
160569511|NCT02158533|579809148|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
160569512|NCT02158533|579809149|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
160569513|NCT02158533|579809150|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
160569514|NCT02158533|579809151|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
160569515|NCT02158533|579809146|FG000|Stage 2|Non-adherence with study visits|0|||
160569516|NCT02158533|579809147|FG001|Stage 2|Non-adherence with study visits|0|||
160569517|NCT02158533|579809148|FG002|Stage 2|Non-adherence with study visits|0|||
160569518|NCT02158533|579809149|FG003|Stage 2|Non-adherence with study visits|0|||
160569519|NCT02158533|579809150|FG004|Stage 2|Non-adherence with study visits|0|||
160569520|NCT02158533|579809151|FG005|Stage 2|Non-adherence with study visits|1|||
160569521|NCT00384956|579809154|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
160569522|NCT01389128|579809161|FG000|Overall Study|Fetal distress|1|||
160569523|NCT01389128|579809162|FG001|Overall Study|Fetal distress|0|||
160569524|NCT01389128|579809161|FG000|Overall Study|Cervix dilation stop|1|||
160569525|NCT01389128|579809162|FG001|Overall Study|Cervix dilation stop|2|||
160569526|NCT01389128|579809161|FG000|Overall Study|Rapid labor evolution|3|||
160569527|NCT01389128|579809162|FG001|Overall Study|Rapid labor evolution|2|||
160569528|NCT01389128|579809161|FG000|Overall Study|Intolerance to procedure|0|||
160569529|NCT01389128|579809162|FG001|Overall Study|Intolerance to procedure|2|||
160569530|NCT01451515|579809163|FG000|Overall Study|Death|0|||
160569531|NCT01451515|579809164|FG001|Overall Study|Death|1|||
160569532|NCT01451515|579809165|FG002|Overall Study|Death|0|||
160569533|NCT01451515|579809163|FG000|Overall Study|Withdrawal by Subject|0|||
160569534|NCT01451515|579809164|FG001|Overall Study|Withdrawal by Subject|1|||
160569535|NCT01451515|579809165|FG002|Overall Study|Withdrawal by Subject|0|||
160569536|NCT01451515|579809163|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
160569537|NCT01451515|579809164|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
160569538|NCT01451515|579809165|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
160569539|NCT01451515|579809163|FG000|Overall Study|Relapse (except CNS)|1|||
160569540|NCT01451515|579809164|FG001|Overall Study|Relapse (except CNS)|1|||
160569541|NCT01451515|579809165|FG002|Overall Study|Relapse (except CNS)|0|||
160569542|NCT00174941|579809169|FG000|Overall Study|Adverse Event|1|||
160569543|NCT00174941|579809170|FG001|Overall Study|Adverse Event|10|||
160569544|NCT00174941|579809171|FG002|Overall Study|Adverse Event|2|||
160569545|NCT00174941|579809172|FG003|Overall Study|Adverse Event|13|||
160569546|NCT00174941|579809169|FG000|Overall Study|Protocol Violation|0|||
160569547|NCT00174941|579809170|FG001|Overall Study|Protocol Violation|1|||
160569548|NCT00174941|579809171|FG002|Overall Study|Protocol Violation|0|||
160569549|NCT00174941|579809172|FG003|Overall Study|Protocol Violation|1|||
160569550|NCT00174941|579809169|FG000|Overall Study|Lost to Follow-up|0|||
160569551|NCT00174941|579809170|FG001|Overall Study|Lost to Follow-up|3|||
160569552|NCT00174941|579809171|FG002|Overall Study|Lost to Follow-up|2|||
160569553|NCT00174941|579809172|FG003|Overall Study|Lost to Follow-up|5|||
160569554|NCT00174941|579809169|FG000|Overall Study|Personal Reason(s)|0|||
160569555|NCT00174941|579809170|FG001|Overall Study|Personal Reason(s)|14|||
160569556|NCT00174941|579809171|FG002|Overall Study|Personal Reason(s)|8|||
160569557|NCT00174941|579809172|FG003|Overall Study|Personal Reason(s)|22|||
160569558|NCT00174941|579809169|FG000|Overall Study|Gout Flare|0|||
160569559|NCT00174941|579809170|FG001|Overall Study|Gout Flare|4|||
160569560|NCT00174941|579809171|FG002|Overall Study|Gout Flare|4|||
160569561|NCT00174941|579809172|FG003|Overall Study|Gout Flare|8|||
160569562|NCT00174941|579809169|FG000|Overall Study|Reason Not Specified|1|||
160569563|NCT00174941|579809170|FG001|Overall Study|Reason Not Specified|6|||
160569564|NCT00174941|579809171|FG002|Overall Study|Reason Not Specified|2|||
160569565|NCT00174941|579809172|FG003|Overall Study|Reason Not Specified|9|||
160569566|NCT03230097|579809177|FG000|Overall Study|Adverse Event|2|||
160569567|NCT03230097|579809178|FG001|Overall Study|Adverse Event|1|||
160569568|NCT03230097|579809177|FG000|Overall Study|non-compliance|0|||
160569569|NCT03230097|579809178|FG001|Overall Study|non-compliance|1|||
160569570|NCT03230097|579809177|FG000|Overall Study|Lost to Follow-up|2|||
160569571|NCT03230097|579809178|FG001|Overall Study|Lost to Follow-up|4|||
160569572|NCT03230097|579809177|FG000|Overall Study|Withdrawal by Subject|7|||
160569573|NCT03230097|579809178|FG001|Overall Study|Withdrawal by Subject|3|||
160993856|NCT00751036|581365443|FG000|Overall Study|Administrative Problems|3|||
160993857|NCT00751036|581365444|FG001|Overall Study|Administrative Problems|4|||
160993858|NCT00751036|581365443|FG000|Overall Study|Withdrawal by Subject|5|||
160993859|NCT00751036|581365444|FG001|Overall Study|Withdrawal by Subject|2|||
160993860|NCT00751036|581365443|FG000|Overall Study|Death|3|||
160993861|NCT00751036|581365444|FG001|Overall Study|Death|3|||
160993862|NCT00751036|581365443|FG000|Overall Study|Lost to Follow-up|0|||
160993863|NCT00751036|581365444|FG001|Overall Study|Lost to Follow-up|1|||
160993864|NCT00751036|581365443|FG000|Overall Study|Protocol Violation|1|||
160993865|NCT00751036|581365444|FG001|Overall Study|Protocol Violation|0|||
160993866|NCT00751036|581365443|FG000|Overall Study|Missing end of Treatment Page|2|||
160993867|NCT00751036|581365444|FG001|Overall Study|Missing end of Treatment Page|3|||
160993868|NCT05570006|581367282|FG000|Overall Study|Lost to Follow-up|2|||
160993869|NCT05570006|581367282|FG000|Overall Study|Withdrawal by Subject|5|||
160993870|NCT05570006|581367282|FG000|Overall Study|Other than Specified|5|||
160993871|NCT00149630|581367287|FG000|Overall Study|Incarceration|2|||
160993872|NCT00149630|581367288|FG001|Overall Study|Incarceration|0|||
160993873|NCT00149630|581367287|FG000|Overall Study|Treatment Programs|4|||
160993874|NCT00149630|581367288|FG001|Overall Study|Treatment Programs|5|||
160993875|NCT00149630|581367287|FG000|Overall Study|Adverse Event|2|||
160993876|NCT00149630|581367288|FG001|Overall Study|Adverse Event|0|||
160993877|NCT00109967|581367304|FG000|Overall Study|Cancel Prior to Treatment|2|||
160993878|NCT00109967|581367305|FG001|Overall Study|Cancel Prior to Treatment|0|||
160993879|NCT00109967|581367304|FG000|Overall Study|Adverse Event|12|||
160993880|NCT00109967|581367305|FG001|Overall Study|Adverse Event|1|||
160993881|NCT00109967|581367304|FG000|Overall Study|Withdrawal by Subject|5|||
160993882|NCT00109967|581367305|FG001|Overall Study|Withdrawal by Subject|0|||
160993883|NCT00109967|581367304|FG000|Overall Study|Physician Decision|1|||
160993884|NCT00109967|581367305|FG001|Overall Study|Physician Decision|3|||
160993885|NCT00109967|581367304|FG000|Overall Study|Death|0|||
160993886|NCT00109967|581367305|FG001|Overall Study|Death|2|||
160993887|NCT00943605|581367313|FG000|Overall Study|Study termination|30|||
160993888|NCT00943605|581367314|FG001|Overall Study|Study termination|30|||
160993889|NCT02232178|581367315|FG000|Overall Study|Lost to Follow-up|0|||
160993890|NCT02232178|581367316|FG001|Overall Study|Lost to Follow-up|1|||
160993891|NCT02232178|581367317|FG002|Overall Study|Lost to Follow-up|0|||
160993892|NCT02232178|581367315|FG000|Overall Study|ineligibility|0|||
160993893|NCT02232178|581367316|FG001|Overall Study|ineligibility|0|||
160993894|NCT02232178|581367317|FG002|Overall Study|ineligibility|1|||
160993895|NCT02232178|581367315|FG000|Overall Study|surgical complication|1|||
160993896|NCT02232178|581367316|FG001|Overall Study|surgical complication|0|||
160993897|NCT02232178|581367317|FG002|Overall Study|surgical complication|0|||
160569574|NCT03230097|579809177|FG000|Overall Study|Trial termination|4|||
160569575|NCT03230097|579809178|FG001|Overall Study|Trial termination|5|||
160569576|NCT03230097|579809177|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
160569577|NCT03230097|579809178|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
160569578|NCT03230097|579809177|FG000|Overall Study|outcome event|0|||
160569579|NCT03230097|579809178|FG001|Overall Study|outcome event|1|||
160569580|NCT00635102|579809191|FG000|Overall Study|Withdrawal by Subject|7|||
160569581|NCT00635102|579809192|FG001|Overall Study|Withdrawal by Subject|8|||
160569582|NCT00440401|579809194|FG000|Overall Study|Adverse Event|2|||
160569583|NCT00440401|579809195|FG001|Overall Study|Adverse Event|1|||
160569584|NCT00440401|579809194|FG000|Overall Study|Other|2|||
160569585|NCT00440401|579809195|FG001|Overall Study|Other|5|||
160569586|NCT01925703|579809196|FG000|Overall Study|Physician Decision|1|||
160569587|NCT01925703|579809196|FG000|Overall Study|Lost to Follow-up|2|||
160569588|NCT01925703|579809196|FG000|Overall Study|Discharge prior to full iron repletion|1|||
160569589|NCT01938625|579809197|FG000|Overall Study|Withdrawal by Subject|0|||
160569590|NCT01938625|579809198|FG001|Overall Study|Withdrawal by Subject|1|||
160569591|NCT01938625|579809197|FG000|Overall Study|Adverse Event|0|||
160569592|NCT01938625|579809198|FG001|Overall Study|Adverse Event|1|||
160569593|NCT01937312|579809199|FG000|Overall Study|Adverse Event|10|||
160569594|NCT01937312|579809200|FG001|Overall Study|Adverse Event|1|||
160569595|NCT01937312|579809199|FG000|Overall Study|Lack of Efficacy|0|||
160993898|NCT01956669|581367320|FG000|Overall Study|Disease Progression|12|||
160993899|NCT01956669|581367321|FG001|Overall Study|Disease Progression|7|||
160454069|NCT02038777|579394027|FG005|Overall Study|Started Chemotherapy|0|||
160856861|NCT04949191|580866556|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
160569596|NCT01937312|579809200|FG001|Overall Study|Lack of Efficacy|1|||
160569597|NCT01937312|579809199|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
160569598|NCT01937312|579809200|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
160569599|NCT00091793|579809201|FG000|Overall Study|Adverse Event|1|||
160569600|NCT00091793|579809202|FG001|Overall Study|Adverse Event|2|||
160993900|NCT01956669|581367322|FG002|Overall Study|Disease Progression|7|||
160993901|NCT01956669|581367323|FG003|Overall Study|Disease Progression|8|||
160993902|NCT01956669|581367324|FG004|Overall Study|Disease Progression|4|||
160993903|NCT01956669|581367325|FG005|Overall Study|Disease Progression|3|||
160993904|NCT01956669|581367326|FG006|Overall Study|Disease Progression|5|||
160993905|NCT01956669|581367320|FG000|Overall Study|Adverse Event|0|||
160651596|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651597|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651598|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651599|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651600|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
160651601|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651602|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651603|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651604|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
160651605|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651606|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651607|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651608|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651609|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651610|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651611|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651612|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651613|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651614|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
160651615|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651616|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651617|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651618|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651619|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651620|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651621|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651622|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
160651623|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
160651624|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651625|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651626|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651627|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651628|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
160651629|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651630|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651631|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651632|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651633|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651634|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651635|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651636|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
160651637|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651638|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651639|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651640|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651641|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651642|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
160651643|NCT04033445|580106109|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651644|NCT04033445|580106110|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651645|NCT04033445|580106111|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651646|NCT04033445|580106112|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651647|NCT04033445|580106113|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651648|NCT04033445|580106114|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651649|NCT04033445|580106115|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651650|NCT04033445|580106116|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
160651651|NCT04033445|580106117|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651652|NCT04033445|580106118|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651653|NCT04033445|580106119|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651654|NCT04033445|580106120|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651655|NCT04033445|580106121|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160993906|NCT01956669|581367321|FG001|Overall Study|Adverse Event|2|||
160651656|NCT04033445|580106122|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
160651657|NCT04033445|580106109|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
160993907|NCT01956669|581367322|FG002|Overall Study|Adverse Event|2|||
160651658|NCT04033445|580106110|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
160651659|NCT04033445|580106111|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
160651660|NCT04033445|580106112|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
160651661|NCT04033445|580106113|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
160651662|NCT04033445|580106114|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
160651663|NCT04033445|580106115|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
160856862|NCT04949191|580866557|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
160993908|NCT01956669|581367323|FG003|Overall Study|Adverse Event|1|||
160856863|NCT04949191|580866558|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
160856864|NCT04949191|580866555|FG000|Overall Study|Sponsor Terminated Study|0|||
160856865|NCT04949191|580866556|FG001|Overall Study|Sponsor Terminated Study|0|||
160856866|NCT04949191|580866557|FG002|Overall Study|Sponsor Terminated Study|1|||
160856867|NCT04949191|580866558|FG003|Overall Study|Sponsor Terminated Study|1|||
160856868|NCT00730158|580866559|FG000|Overall Study|Withdrawal by Subject|1|||
160908351|NCT03010176|581058108|FG003|Overall Study|Withdrawal by Subject|0|||
160908352|NCT03010176|581058109|FG004|Overall Study|Withdrawal by Subject|4|||
160908353|NCT03010176|581058110|FG005|Overall Study|Withdrawal by Subject|0|||
160908354|NCT04220866|581058111|FG000|Overall Study|Death|4|||
160908355|NCT04220866|581058112|FG001|Overall Study|Death|5|||
160908356|NCT04220866|581058111|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
160908357|NCT04220866|581058112|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
160908358|NCT04220866|581058111|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
160908359|NCT04220866|581058112|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
160908360|NCT04220866|581058111|FG000|Overall Study|Withdrawal by Subject|0|||
160908361|NCT04220866|581058112|FG001|Overall Study|Withdrawal by Subject|1|||
160908362|NCT00709761|581058113|FG000|Overall Study|Withdrawal by Subject|8|||
160908363|NCT00709761|581058113|FG000|Overall Study|study closed/terminated|17|||
160908364|NCT00709761|581058113|FG000|Overall Study|Lost to Follow-up|2|||
160908365|NCT03478930|581058114|FG000|Overall Study|Adverse Event|0|||
160908366|NCT03478930|581058115|FG001|Overall Study|Adverse Event|1|||
160908367|NCT03478930|581058114|FG000|Overall Study|Lack of Efficacy|3|||
160908368|NCT03478930|581058115|FG001|Overall Study|Lack of Efficacy|3|||
160908369|NCT03478930|581058114|FG000|Overall Study|Withdrawal by Subject|6|||
160908370|NCT03478930|581058115|FG001|Overall Study|Withdrawal by Subject|5|||
160908371|NCT01812174|581058116|FG000|Overall Study|Death|1|||
160908372|NCT01812174|581058117|FG001|Overall Study|Death|0|||
160908373|NCT01812174|581058116|FG000|Overall Study|Protocol Violation|2|||
160908374|NCT01812174|581058117|FG001|Overall Study|Protocol Violation|0|||
160908375|NCT00553644|581058120|FG000|Overall Study|Adverse Event|17|||
160908376|NCT00553644|581058120|FG000|Overall Study|Withdrawal by Subject|4|||
160908377|NCT00553644|581058120|FG000|Overall Study|Physician Decision|1|||
160908378|NCT00553644|581058120|FG000|Overall Study|Alternative therapy|6|||
160908379|NCT00730132|581058125|FG000|Overall Study|Protocol Violation|154|||
160908380|NCT00730132|581058125|FG000|Overall Study|Death|1|||
160908381|NCT00370032|581058126|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
160908382|NCT00370032|581058127|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
160908383|NCT00370032|581058126|FG000|Washout Period|Withdrawal by Subject|0|||
160908384|NCT00370032|581058127|FG001|Washout Period|Withdrawal by Subject|1|||
160908385|NCT00370032|581058126|FG000|Washout Period|Lost to Follow-up|0|||
160908386|NCT00370032|581058127|FG001|Washout Period|Lost to Follow-up|1|||
160908387|NCT00370032|581058126|FG000|Washout Period|Adverse Event|1|||
160908388|NCT00370032|581058127|FG001|Washout Period|Adverse Event|0|||
160908389|NCT00370032|581058126|FG000|Follow-up Period|Withdrawal by Subject|1|||
160908390|NCT00370032|581058127|FG001|Follow-up Period|Withdrawal by Subject|0|||
160908391|NCT05469178|581058128|FG000|Overall Study|Death|1|||
160908392|NCT05469178|581058129|FG001|Overall Study|Death|1|||
160908393|NCT05469178|581058130|FG002|Overall Study|Death|3|||
160908394|NCT05469178|581058131|FG003|Overall Study|Death|6|||
160908395|NCT05469178|581058128|FG000|Overall Study|Lack of Efficacy|2|||
160908396|NCT05469178|581058129|FG001|Overall Study|Lack of Efficacy|2|||
160908397|NCT05469178|581058130|FG002|Overall Study|Lack of Efficacy|1|||
160908398|NCT05469178|581058131|FG003|Overall Study|Lack of Efficacy|10|||
160908399|NCT00968513|581058132|FG000|Overall Study|Death|4|||
160908400|NCT00968513|581058133|FG001|Overall Study|Death|10|||
160908401|NCT00968513|581058134|FG002|Overall Study|Death|15|||
160908402|NCT05466682|581058137|FG000|Overall Study|Withdrawal by Subject|0|||
160908403|NCT05466682|581058138|FG001|Overall Study|Withdrawal by Subject|2|||
160908404|NCT05466682|581058137|FG000|Overall Study|Lost to Follow-up|2|||
160908405|NCT05466682|581058138|FG001|Overall Study|Lost to Follow-up|1|||
160856869|NCT00730158|580866560|FG001|Overall Study|Withdrawal by Subject|1|||
160908406|NCT02405780|581058150|FG000|Period I|Adverse Event|8|||
160908407|NCT02405780|581058151|FG001|Period I|Adverse Event|0|||
160908408|NCT02405780|581058152|FG002|Period I|Adverse Event|3|||
160651664|NCT04033445|580106116|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
160651665|NCT04033445|580106117|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
160651666|NCT04033445|580106118|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
160651667|NCT04033445|580106119|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
160651668|NCT04033445|580106120|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
160651669|NCT04033445|580106121|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
160651670|NCT04033445|580106122|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
160651671|NCT04033445|580106109|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
160651672|NCT04033445|580106110|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
160651673|NCT04033445|580106111|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
160651674|NCT04033445|580106112|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
160651675|NCT04033445|580106113|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
160651676|NCT04033445|580106114|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
160651677|NCT04033445|580106115|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
160651678|NCT04033445|580106116|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
160651679|NCT04033445|580106117|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
160651680|NCT04033445|580106118|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
160651681|NCT04033445|580106119|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
160651682|NCT04033445|580106120|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
160651683|NCT04033445|580106121|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
160651684|NCT04033445|580106122|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
160651685|NCT04033445|580106109|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651686|NCT04033445|580106110|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651687|NCT04033445|580106111|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651688|NCT04033445|580106112|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651689|NCT04033445|580106113|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651690|NCT04033445|580106114|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651691|NCT04033445|580106115|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651692|NCT04033445|580106116|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651693|NCT04033445|580106117|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651694|NCT04033445|580106118|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651695|NCT04033445|580106119|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
160651696|NCT04033445|580106120|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
160651697|NCT04033445|580106121|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
160651698|NCT04033445|580106122|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
160651699|NCT04033445|580106109|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
160651700|NCT04033445|580106110|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
160651701|NCT04033445|580106111|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
160651702|NCT04033445|580106112|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
160651703|NCT04033445|580106113|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
160651704|NCT04033445|580106114|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
160651705|NCT04033445|580106115|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
160651706|NCT04033445|580106116|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
160651707|NCT04033445|580106117|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
160651708|NCT04033445|580106118|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
160651709|NCT04033445|580106119|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
160651710|NCT04033445|580106120|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
160651711|NCT04033445|580106121|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
160651712|NCT04033445|580106122|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
160651713|NCT04033445|580106109|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
160651714|NCT04033445|580106110|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
160651715|NCT04033445|580106111|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
160856870|NCT03535974|580866562|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
160856871|NCT03535974|580866563|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
160856872|NCT03535974|580866564|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
160856873|NCT03535974|580866562|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
160856874|NCT03535974|580866563|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
160856875|NCT03535974|580866564|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
160856876|NCT04059549|580866565|FG000|Overall Study|Withdrawal by Subject|2|||
160856877|NCT04059549|580866566|FG001|Overall Study|Withdrawal by Subject|0|||
160856878|NCT02678351|580866567|FG000|Overall Study|Withdrawal by Subject|1|||
160856879|NCT02913482|580866568|FG000|Overall Study|Death|0|||
160856880|NCT02913482|580866569|FG001|Overall Study|Death|2|||
160856881|NCT02913482|580866570|FG002|Overall Study|Death|2|||
160856882|NCT02913482|580866568|FG000|Overall Study|Progressive Disease|1|||
160856883|NCT02913482|580866569|FG001|Overall Study|Progressive Disease|1|||
160908409|NCT02405780|581058153|FG003|Period I|Adverse Event|7|||
160908410|NCT02405780|581058150|FG000|Period I|Medical reasons|1|||
160908411|NCT02405780|581058151|FG001|Period I|Medical reasons|1|||
160908412|NCT02405780|581058152|FG002|Period I|Medical reasons|0|||
160908413|NCT02405780|581058153|FG003|Period I|Medical reasons|1|||
160908414|NCT02405780|581058150|FG000|Period I|Screening Failure|1|||
160908415|NCT02405780|581058151|FG001|Period I|Screening Failure|0|||
160908416|NCT02405780|581058152|FG002|Period I|Screening Failure|1|||
160908417|NCT02405780|581058153|FG003|Period I|Screening Failure|0|||
160908418|NCT02405780|581058150|FG000|Period I|Withdrawal by Subject|9|||
160908419|NCT02405780|581058151|FG001|Period I|Withdrawal by Subject|1|||
160908420|NCT02405780|581058152|FG002|Period I|Withdrawal by Subject|3|||
160908421|NCT02405780|581058153|FG003|Period I|Withdrawal by Subject|4|||
160908422|NCT02405780|581058150|FG000|Period I|Non-compliance with study procedures|8|||
160908423|NCT02405780|581058151|FG001|Period I|Non-compliance with study procedures|6|||
160908424|NCT02405780|581058152|FG002|Period I|Non-compliance with study procedures|8|||
160908425|NCT02405780|581058153|FG003|Period I|Non-compliance with study procedures|11|||
160908426|NCT02405780|581058150|FG000|Period II|Adverse Event|3|||
160908427|NCT02405780|581058151|FG001|Period II|Adverse Event|5|||
160908428|NCT02405780|581058152|FG002|Period II|Adverse Event|4|||
160908429|NCT02405780|581058153|FG003|Period II|Adverse Event|11|||
160908430|NCT02405780|581058150|FG000|Period II|Medical reason|0|||
160908431|NCT02405780|581058151|FG001|Period II|Medical reason|1|||
160908432|NCT02405780|581058152|FG002|Period II|Medical reason|0|||
160908433|NCT02405780|581058153|FG003|Period II|Medical reason|0|||
160908434|NCT02405780|581058150|FG000|Period II|Pregnancy|0|||
160908435|NCT02405780|581058151|FG001|Period II|Pregnancy|0|||
160908436|NCT02405780|581058152|FG002|Period II|Pregnancy|1|||
160908437|NCT02405780|581058153|FG003|Period II|Pregnancy|0|||
160908438|NCT02405780|581058150|FG000|Period II|Withdrawal by Subject|7|||
160908439|NCT02405780|581058151|FG001|Period II|Withdrawal by Subject|4|||
160908440|NCT02405780|581058152|FG002|Period II|Withdrawal by Subject|0|||
160908441|NCT02405780|581058153|FG003|Period II|Withdrawal by Subject|3|||
160908442|NCT02405780|581058150|FG000|Period II|Non-compliance with study procedures|5|||
160908443|NCT02405780|581058151|FG001|Period II|Non-compliance with study procedures|2|||
160908444|NCT02405780|581058152|FG002|Period II|Non-compliance with study procedures|7|||
160908445|NCT02405780|581058153|FG003|Period II|Non-compliance with study procedures|4|||
160908446|NCT01654536|581058154|FG000|Overall Study|Lost to Follow-up|5|||
160908447|NCT01654536|581058155|FG001|Overall Study|Lost to Follow-up|5|||
160908448|NCT01654536|581058154|FG000|Overall Study|Physician Decision|12|||
160908449|NCT01654536|581058155|FG001|Overall Study|Physician Decision|8|||
160908450|NCT01654536|581058154|FG000|Overall Study|Withdrawal by Subject|27|||
160993909|NCT01956669|581367324|FG004|Overall Study|Adverse Event|0|||
160856884|NCT02913482|580866570|FG002|Overall Study|Progressive Disease|1|||
160856885|NCT02913482|580866568|FG000|Overall Study|Reason not specified|0|||
160856886|NCT02913482|580866569|FG001|Overall Study|Reason not specified|0|||
160856887|NCT02913482|580866570|FG002|Overall Study|Reason not specified|1|||
160856888|NCT02913482|580866568|FG000|Overall Study|Withdrawal by Subject|0|||
160856889|NCT02913482|580866569|FG001|Overall Study|Withdrawal by Subject|1|||
160856890|NCT02913482|580866570|FG002|Overall Study|Withdrawal by Subject|1|||
160856891|NCT01919229|580866571|FG000|Overall Study|Subject/guardian decision|0|||
160856892|NCT01919229|580866572|FG001|Overall Study|Subject/guardian decision|0|||
160856893|NCT01919229|580866573|FG002|Overall Study|Subject/guardian decision|1|||
160856894|NCT01011673|580866574|FG000|Randomized|Secondary headache|2|||
160856895|NCT01011673|580866575|FG001|Randomized|Secondary headache|1|||
160856896|NCT01011673|580866574|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
160856897|NCT01011673|580866575|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
160856898|NCT04716426|580866580|FG000|Overall Study|Vaccination|1|||
160856899|NCT04716426|580866581|FG001|Overall Study|Vaccination|1|||
160856900|NCT04716426|580866580|FG000|Overall Study|Contamination|1|||
160908451|NCT01654536|581058155|FG001|Overall Study|Withdrawal by Subject|25|||
160908452|NCT00668707|581058156|FG000|Overall Study|Cancer Recurrence|58|||
160571909|NCT01743027|579816862|FG001|Overall Study|Protocol Violation|1|||
160908453|NCT00668707|581058157|FG001|Overall Study|Cancer Recurrence|58|||
160908454|NCT00668707|581058156|FG000|Overall Study|Withdrawal by Subject|117|||
160908455|NCT00668707|581058157|FG001|Overall Study|Withdrawal by Subject|100|||
160908456|NCT00668707|581058156|FG000|Overall Study|Lost to Follow-up|3|||
160908457|NCT00668707|581058157|FG001|Overall Study|Lost to Follow-up|6|||
160908458|NCT00668707|581058156|FG000|Overall Study|Protocol Violation|10|||
160908459|NCT00668707|581058157|FG001|Overall Study|Protocol Violation|12|||
160908460|NCT00668707|581058156|FG000|Overall Study|Death|11|||
160908461|NCT00668707|581058157|FG001|Overall Study|Death|4|||
160908462|NCT03846804|581058164|FG000|Overall Study|Refused blood draw|1|||
160856901|NCT04716426|580866581|FG001|Overall Study|Contamination|0|||
160856902|NCT01650558|580866582|FG000|Overall Study|Migration out of study area|61|||
160856903|NCT01650558|580866583|FG001|Overall Study|Migration out of study area|71|||
160908463|NCT03846804|581058164|FG000|Overall Study|Protocol Violation|1|||
160908464|NCT02784431|581058165|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
160908465|NCT02784431|581058165|FG000|Overall Study|Early Study Termination|19|||
160908466|NCT02605824|581058166|FG000|Overall Study|Physician Decision|1|||
160908467|NCT02605824|581058167|FG001|Overall Study|Physician Decision|0|||
160908468|NCT01273597|581058170|FG000|Overall Study|Adverse Event|5|||
160856904|NCT01650558|580866584|FG002|Overall Study|Migration out of study area|56|||
160856905|NCT01650558|580866582|FG000|Overall Study|Lost to Follow-up|10|||
160856906|NCT01650558|580866583|FG001|Overall Study|Lost to Follow-up|13|||
160856907|NCT01650558|580866584|FG002|Overall Study|Lost to Follow-up|6|||
160856908|NCT01650558|580866582|FG000|Overall Study|Death|10|||
160856909|NCT01650558|580866583|FG001|Overall Study|Death|6|||
160856910|NCT01650558|580866584|FG002|Overall Study|Death|8|||
160856911|NCT01650558|580866582|FG000|Overall Study|Withdrawal by Subject|1|||
160856912|NCT01650558|580866583|FG001|Overall Study|Withdrawal by Subject|1|||
160856913|NCT01650558|580866584|FG002|Overall Study|Withdrawal by Subject|3|||
160856914|NCT01650558|580866582|FG000|Overall Study|Non-compliant participant|1|||
160856915|NCT01650558|580866583|FG001|Overall Study|Non-compliant participant|0|||
160856916|NCT01650558|580866584|FG002|Overall Study|Non-compliant participant|2|||
160856917|NCT01650558|580866582|FG000|Overall Study|Physician Decision|0|||
160856918|NCT01650558|580866583|FG001|Overall Study|Physician Decision|1|||
160856919|NCT01650558|580866584|FG002|Overall Study|Physician Decision|0|||
160908469|NCT01273597|581058170|FG000|Overall Study|Underwent Kidney Transplantation|2|||
160908470|NCT01273597|581058170|FG000|Overall Study|Reason Not Reported|1|||
160908471|NCT03547583|581058171|FG000|Overall Study|Adverse Event|16|||
160908472|NCT03547583|581058172|FG001|Overall Study|Adverse Event|11|||
160908473|NCT03547583|581058173|FG002|Overall Study|Adverse Event|10|||
160908474|NCT03547583|581058171|FG000|Overall Study|Death|11|||
160908475|NCT03547583|581058172|FG001|Overall Study|Death|7|||
160908476|NCT03547583|581058173|FG002|Overall Study|Death|4|||
160908477|NCT03547583|581058171|FG000|Overall Study|Lost to Follow-up|1|||
160908478|NCT03547583|581058172|FG001|Overall Study|Lost to Follow-up|0|||
160908479|NCT03547583|581058173|FG002|Overall Study|Lost to Follow-up|0|||
160908480|NCT03547583|581058171|FG000|Overall Study|Non-compliance with study drug|0|||
160908481|NCT03547583|581058172|FG001|Overall Study|Non-compliance with study drug|0|||
160908482|NCT03547583|581058173|FG002|Overall Study|Non-compliance with study drug|1|||
160856920|NCT02960217|580866585|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
160856921|NCT02960217|580866586|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
160856922|NCT02960217|580866585|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
160856923|NCT02960217|580866586|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
160856924|NCT02960217|580866585|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
160856925|NCT02960217|580866586|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
160856926|NCT02960217|580866585|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
160856927|NCT02960217|580866586|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
160856928|NCT02960217|580866585|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
160856929|NCT02960217|580866586|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
160856930|NCT02960217|580866585|FG000|Open-Label Extension Phase|Adverse Event|1|||
160856931|NCT02960217|580866586|FG001|Open-Label Extension Phase|Adverse Event|0|||
160856932|NCT02960217|580866585|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
160856933|NCT02960217|580866586|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
160856934|NCT02960217|580866585|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
160856935|NCT02960217|580866586|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
160856936|NCT02960217|580866585|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
160856937|NCT02960217|580866586|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
160856938|NCT02734693|580866587|FG000|Overall Study|Adverse Event|1|||
160856939|NCT02734693|580866588|FG001|Overall Study|Adverse Event|3|||
160856940|NCT02734693|580866589|FG002|Overall Study|Adverse Event|3|||
160856941|NCT02734693|580866587|FG000|Overall Study|Lack of Efficacy|1|||
160856942|NCT02734693|580866588|FG001|Overall Study|Lack of Efficacy|0|||
160856943|NCT02734693|580866589|FG002|Overall Study|Lack of Efficacy|0|||
160856944|NCT02734693|580866587|FG000|Overall Study|Lost to Follow-up|2|||
160856945|NCT02734693|580866588|FG001|Overall Study|Lost to Follow-up|0|||
160856946|NCT02734693|580866589|FG002|Overall Study|Lost to Follow-up|0|||
160856947|NCT02734693|580866587|FG000|Overall Study|Protocol Violation|1|||
160908483|NCT03547583|581058171|FG000|Overall Study|Physician Decision|1|||
160908484|NCT03547583|581058172|FG001|Overall Study|Physician Decision|0|||
160908485|NCT03547583|581058173|FG002|Overall Study|Physician Decision|3|||
160569601|NCT00091793|579809201|FG000|Overall Study|Withdrawal by Subject|10|||
160908486|NCT03547583|581058171|FG000|Overall Study|Protocol Violation|2|||
160569602|NCT00091793|579809202|FG001|Overall Study|Withdrawal by Subject|15|||
160569603|NCT00091793|579809201|FG000|Overall Study|Ineligibility determined|2|||
160856948|NCT02734693|580866588|FG001|Overall Study|Protocol Violation|0|||
160856949|NCT02734693|580866589|FG002|Overall Study|Protocol Violation|0|||
160856950|NCT02734693|580866587|FG000|Overall Study|Withdrawal by Subject|1|||
160908487|NCT03547583|581058172|FG001|Overall Study|Protocol Violation|1|||
160908488|NCT03547583|581058173|FG002|Overall Study|Protocol Violation|1|||
160908489|NCT03547583|581058171|FG000|Overall Study|Withdrawal by Subject|12|||
160908490|NCT03547583|581058172|FG001|Overall Study|Withdrawal by Subject|19|||
160569604|NCT00091793|579809202|FG001|Overall Study|Ineligibility determined|0|||
160856951|NCT02734693|580866588|FG001|Overall Study|Withdrawal by Subject|0|||
160856952|NCT02734693|580866589|FG002|Overall Study|Withdrawal by Subject|0|||
160856953|NCT00849940|580866599|FG000|Overall Study|Physician Decision|4|||
160856954|NCT03353675|580866603|FG000|Overall Study|Adverse Event|4|||
160856955|NCT00402168|580866604|FG000|Randomized|Lost to Follow-up|1|||
160856956|NCT00402168|580866605|FG001|Randomized|Lost to Follow-up|0|||
160856957|NCT00402168|580866604|FG000|Randomized|Withdrawal by Subject|0|||
160856958|NCT00402168|580866605|FG001|Randomized|Withdrawal by Subject|1|||
160856959|NCT00402168|580866604|FG000|Treatment (up to 12 Months)|Death|0|||
160856960|NCT00402168|580866605|FG001|Treatment (up to 12 Months)|Death|1|||
160856961|NCT00402168|580866604|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
160856962|NCT00402168|580866605|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
160856963|NCT00402168|580866604|FG000|Treatment (up to 12 Months)|non-specified|0|||
160856964|NCT00402168|580866605|FG001|Treatment (up to 12 Months)|non-specified|1|||
160856965|NCT00402168|580866604|FG000|Long Term (LT)|Adverse Event|1|||
160856966|NCT00402168|580866605|FG001|Long Term (LT)|Adverse Event|5|||
160856967|NCT00402168|580866604|FG000|Long Term (LT)|Withdrawal by Subject|4|||
160856968|NCT00402168|580866605|FG001|Long Term (LT)|Withdrawal by Subject|7|||
160856969|NCT00402168|580866604|FG000|Long Term (LT)|Pregnancy|0|||
160856970|NCT00402168|580866605|FG001|Long Term (LT)|Pregnancy|1|||
160856971|NCT00402168|580866604|FG000|Long Term (LT)|Lost to Follow-up|1|||
160856972|NCT00402168|580866605|FG001|Long Term (LT)|Lost to Follow-up|0|||
160856973|NCT00402168|580866604|FG000|Long Term (LT)|Death|4|||
160856974|NCT00402168|580866605|FG001|Long Term (LT)|Death|0|||
160856975|NCT00402168|580866604|FG000|Long Term (LT)|Lack of Efficacy|0|||
160856976|NCT00402168|580866605|FG001|Long Term (LT)|Lack of Efficacy|2|||
160856977|NCT00402168|580866604|FG000|Long Term (LT)|non-specified|1|||
160856978|NCT00402168|580866605|FG001|Long Term (LT)|non-specified|2|||
160856979|NCT00402168|580866604|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
160856980|NCT00402168|580866605|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
160856981|NCT00402168|580866604|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
160856982|NCT00402168|580866605|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
160856983|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
160856984|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
160856985|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
160856986|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
160856987|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
160856988|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
160856989|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
160856990|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
160856991|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
160856992|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
160856993|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
160856994|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
160856995|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
160856996|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
160856997|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
160856998|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
160856999|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
160857000|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
160857001|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
160857002|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
160857003|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
160857004|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
160857005|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
160857006|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
160857007|NCT00550407|580866608|FG000|26-Week Randomized Phase|Adverse Event|0|||
160857008|NCT00550407|580866609|FG001|26-Week Randomized Phase|Adverse Event|5|||
160857009|NCT00550407|580866610|FG002|26-Week Randomized Phase|Adverse Event|2|||
160857010|NCT00550407|580866608|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
160857011|NCT00550407|580866609|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
160857012|NCT00550407|580866610|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
160857013|NCT00550407|580866608|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
160857014|NCT00550407|580866609|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
160857015|NCT00550407|580866610|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
160857016|NCT00550407|580866608|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
160857017|NCT00550407|580866609|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
160857018|NCT00550407|580866610|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
160857019|NCT00584415|580866611|FG000|Overall Study|Adverse Event|7|||
160857020|NCT02370420|580866612|FG000|Overall Study|Physician Decision|3|||
160857021|NCT02370420|580866613|FG001|Overall Study|Physician Decision|3|||
160857022|NCT02370420|580866612|FG000|Overall Study|Lost to Follow-up|11|||
160857023|NCT02370420|580866613|FG001|Overall Study|Lost to Follow-up|9|||
160857024|NCT00556894|580866614|FG000|Overall Study|Adverse Event|2|||
160857025|NCT00556894|580866615|FG001|Overall Study|Adverse Event|3|||
160857026|NCT00556894|580866616|FG002|Overall Study|Adverse Event|3|||
160857027|NCT00556894|580866614|FG000|Overall Study|Death|1|||
160857028|NCT00556894|580866615|FG001|Overall Study|Death|0|||
160857029|NCT00556894|580866616|FG002|Overall Study|Death|0|||
160857030|NCT00556894|580866614|FG000|Overall Study|regulatory decision in Bulgaria|10|||
160857031|NCT00556894|580866615|FG001|Overall Study|regulatory decision in Bulgaria|14|||
160857032|NCT00556894|580866616|FG002|Overall Study|regulatory decision in Bulgaria|13|||
160857033|NCT00556894|580866614|FG000|Overall Study|Change in therapy|2|||
160857034|NCT00556894|580866615|FG001|Overall Study|Change in therapy|1|||
160857035|NCT00556894|580866616|FG002|Overall Study|Change in therapy|2|||
160857036|NCT00556894|580866614|FG000|Overall Study|Withdrawal by Subject|1|||
160857037|NCT00556894|580866615|FG001|Overall Study|Withdrawal by Subject|1|||
160857038|NCT00556894|580866616|FG002|Overall Study|Withdrawal by Subject|1|||
160857039|NCT03883581|580866617|FG000|Overall Study|Withdrawal by Subject|4|||
160857040|NCT05190120|580866621|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
160857041|NCT05190120|580866622|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
160857042|NCT05190120|580866623|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
160857043|NCT05190120|580866624|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
160857044|NCT05190120|580866621|FG000|Overall Study|Lost to Follow-up|5|||
160857045|NCT05190120|580866622|FG001|Overall Study|Lost to Follow-up|0|||
160857046|NCT05190120|580866623|FG002|Overall Study|Lost to Follow-up|2|||
160857047|NCT05190120|580866624|FG003|Overall Study|Lost to Follow-up|3|||
160857048|NCT05893862|580866627|FG000|Overall Study|Physician Decision|0|||
160857049|NCT05893862|580866628|FG001|Overall Study|Physician Decision|1|||
160857050|NCT05893862|580866629|FG002|Overall Study|Physician Decision|0|||
160857051|NCT05893862|580866630|FG003|Overall Study|Physician Decision|0|||
160857052|NCT05893862|580866631|FG004|Overall Study|Physician Decision|1|||
160857053|NCT05893862|580866632|FG005|Overall Study|Physician Decision|0|||
160857054|NCT05893862|580866627|FG000|Overall Study|Withdrawal by Subject|1|||
160857055|NCT05893862|580866628|FG001|Overall Study|Withdrawal by Subject|7|||
160857056|NCT05893862|580866629|FG002|Overall Study|Withdrawal by Subject|1|||
160857057|NCT05893862|580866630|FG003|Overall Study|Withdrawal by Subject|3|||
160857058|NCT05893862|580866631|FG004|Overall Study|Withdrawal by Subject|3|||
160857059|NCT05893862|580866632|FG005|Overall Study|Withdrawal by Subject|2|||
160857060|NCT05893862|580866627|FG000|Overall Study|Adverse Event|1|||
160857061|NCT05893862|580866628|FG001|Overall Study|Adverse Event|4|||
160857062|NCT05893862|580866629|FG002|Overall Study|Adverse Event|2|||
160857063|NCT05893862|580866630|FG003|Overall Study|Adverse Event|2|||
160857064|NCT05893862|580866631|FG004|Overall Study|Adverse Event|1|||
160857065|NCT05893862|580866632|FG005|Overall Study|Adverse Event|0|||
160857066|NCT00410956|580866633|FG000|Overall Study|Adverse Event|1|||
160857067|NCT00410956|580866633|FG000|Overall Study|Death|2|||
160857068|NCT00410956|580866633|FG000|Overall Study|Lack of Efficacy|10|||
160857069|NCT00410956|580866633|FG000|Overall Study|Physician Decision|6|||
160857070|NCT00755183|580868789|FG000|Overall Study|Adverse Event|5|||
160857071|NCT00755183|580868790|FG001|Overall Study|Adverse Event|2|||
160857072|NCT00755183|580868789|FG000|Overall Study|Protocol Violation|0|||
160857073|NCT00755183|580868790|FG001|Overall Study|Protocol Violation|1|||
160857074|NCT00755183|580868789|FG000|Overall Study|Withdrawal by Subject|0|||
160857075|NCT00755183|580868790|FG001|Overall Study|Withdrawal by Subject|2|||
160857076|NCT00755183|580868789|FG000|Overall Study|Administrative|2|||
160857077|NCT00755183|580868790|FG001|Overall Study|Administrative|1|||
160857078|NCT02587520|580868791|FG000|Overall Study|Protocol Violation|2|||
160569605|NCT00091793|579809201|FG000|Overall Study|Lost to Follow-up|7|||
160569606|NCT00091793|579809202|FG001|Overall Study|Lost to Follow-up|5|||
160569607|NCT00091793|579809201|FG000|Overall Study|Noncompliance|2|||
160569608|NCT00091793|579809202|FG001|Overall Study|Noncompliance|0|||
160569609|NCT00091793|579809201|FG000|Overall Study|Other|2|||
160569610|NCT00091793|579809202|FG001|Overall Study|Other|0|||
160569611|NCT05309083|579809204|FG000|Overall Study|Withdrawal by Subject|2|||
160569612|NCT01238120|579809205|FG000|Overall Study|Withdrawal by Subject|4|||
160569613|NCT01238120|579809206|FG001|Overall Study|Withdrawal by Subject|1|||
160569614|NCT01238120|579809207|FG002|Overall Study|Withdrawal by Subject|2|||
160569615|NCT01238120|579809208|FG003|Overall Study|Withdrawal by Subject|5|||
160569616|NCT01238120|579809205|FG000|Overall Study|Lost to Follow-up|2|||
160569617|NCT01238120|579809206|FG001|Overall Study|Lost to Follow-up|0|||
160569618|NCT01238120|579809207|FG002|Overall Study|Lost to Follow-up|1|||
160569619|NCT01238120|579809208|FG003|Overall Study|Lost to Follow-up|1|||
160569620|NCT01238120|579809205|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
160569621|NCT01238120|579809206|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
160569622|NCT01238120|579809207|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
160569623|NCT01238120|579809208|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
160857079|NCT02587520|580868792|FG001|Overall Study|Protocol Violation|0|||
160651716|NCT04033445|580106112|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
160651717|NCT04033445|580106113|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
160569624|NCT01184989|579809212|FG000|Overall Study|Adverse Event|11|||
160569625|NCT01184989|579809212|FG000|Overall Study|Withdrawal by Subject|1|||
160569626|NCT00465569|579809213|FG000|Overall Study|persistent eczema during dose escalation|1|||
160569627|NCT00465569|579809214|FG001|Overall Study|persistent eczema during dose escalation|0|||
160569628|NCT00482001|579809216|FG000|Overall Study|Protocol Violation|1|||
160569629|NCT00482001|579809217|FG001|Overall Study|Protocol Violation|1|||
160569630|NCT02388776|579809218|FG000|Overall Study|Death|1|||
160651718|NCT04033445|580106114|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
160651719|NCT04033445|580106115|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
160651720|NCT04033445|580106116|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
160651721|NCT04033445|580106117|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
160651722|NCT04033445|580106118|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
160651723|NCT04033445|580106119|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
160651724|NCT04033445|580106120|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
160651725|NCT04033445|580106121|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
160651726|NCT04033445|580106122|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
160651727|NCT04033445|580106109|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651728|NCT04033445|580106110|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651729|NCT04033445|580106111|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651730|NCT04033445|580106112|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651731|NCT04033445|580106113|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651732|NCT04033445|580106114|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651733|NCT04033445|580106115|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651734|NCT04033445|580106116|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651735|NCT04033445|580106117|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651736|NCT04033445|580106118|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160569631|NCT02388776|579809218|FG000|Overall Study|Lost to Follow-up|1|||
160569632|NCT04786210|579809219|FG000|Overall Study|Lost to Follow-up|2|||
160569633|NCT04786210|579809219|FG000|Overall Study|Withdrawal by Subject|4|||
160569634|NCT03826914|579809220|FG000|Overall Study|Withdrawal by Subject|1|||
160569635|NCT03826914|579809221|FG001|Overall Study|Withdrawal by Subject|1|||
160857080|NCT02587520|580868793|FG002|Overall Study|Protocol Violation|0|||
160857081|NCT02587520|580868794|FG003|Overall Study|Protocol Violation|2|||
160857082|NCT02587520|580868795|FG004|Overall Study|Protocol Violation|0|||
160857083|NCT02587520|580868796|FG005|Overall Study|Protocol Violation|1|||
160569636|NCT04246047|579809223|FG000|Overall Study|Death|50|||
160569637|NCT04246047|579809224|FG001|Overall Study|Death|77|||
160569638|NCT04246047|579809223|FG000|Overall Study|Lost to Follow-up|1|||
160569639|NCT04246047|579809224|FG001|Overall Study|Lost to Follow-up|3|||
160569640|NCT04246047|579809223|FG000|Overall Study|Physician Decision|4|||
160857084|NCT02587520|580868797|FG006|Overall Study|Protocol Violation|1|||
160857085|NCT02587520|580868798|FG007|Overall Study|Protocol Violation|1|||
160857086|NCT02587520|580868799|FG008|Overall Study|Protocol Violation|3|||
160857087|NCT02587520|580868800|FG009|Overall Study|Protocol Violation|3|||
160857088|NCT02587520|580868801|FG010|Overall Study|Protocol Violation|1|||
160857089|NCT02587520|580868802|FG011|Overall Study|Protocol Violation|2|||
160857090|NCT02587520|580868803|FG012|Overall Study|Protocol Violation|0|||
160857091|NCT02587520|580868804|FG013|Overall Study|Protocol Violation|0|||
160857092|NCT02587520|580868805|FG014|Overall Study|Protocol Violation|0|||
160857093|NCT02587520|580868806|FG015|Overall Study|Protocol Violation|0|||
160857094|NCT02587520|580868807|FG016|Overall Study|Protocol Violation|0|||
160857095|NCT02587520|580868808|FG017|Overall Study|Protocol Violation|0|||
160857096|NCT02587520|580868791|FG000|Overall Study|Adverse Event|0|||
160857097|NCT02587520|580868792|FG001|Overall Study|Adverse Event|0|||
160857098|NCT02587520|580868793|FG002|Overall Study|Adverse Event|0|||
160857099|NCT02587520|580868794|FG003|Overall Study|Adverse Event|0|||
160857100|NCT02587520|580868795|FG004|Overall Study|Adverse Event|0|||
160857101|NCT02587520|580868796|FG005|Overall Study|Adverse Event|0|||
160857102|NCT02587520|580868797|FG006|Overall Study|Adverse Event|0|||
160857103|NCT02587520|580868798|FG007|Overall Study|Adverse Event|0|||
160857104|NCT02587520|580868799|FG008|Overall Study|Adverse Event|0|||
160857105|NCT02587520|580868800|FG009|Overall Study|Adverse Event|0|||
160857106|NCT02587520|580868801|FG010|Overall Study|Adverse Event|0|||
160857107|NCT02587520|580868802|FG011|Overall Study|Adverse Event|1|||
160857108|NCT02587520|580868803|FG012|Overall Study|Adverse Event|0|||
160857109|NCT02587520|580868804|FG013|Overall Study|Adverse Event|0|||
160857110|NCT02587520|580868805|FG014|Overall Study|Adverse Event|0|||
160857111|NCT02587520|580868806|FG015|Overall Study|Adverse Event|0|||
160857112|NCT02587520|580868807|FG016|Overall Study|Adverse Event|0|||
160857113|NCT02587520|580868808|FG017|Overall Study|Adverse Event|0|||
160857114|NCT02587520|580868791|FG000|Overall Study|Withdrawal by Subject|0|||
160569641|NCT04246047|579809224|FG001|Overall Study|Physician Decision|10|||
160569642|NCT04246047|579809223|FG000|Overall Study|Withdrawal by Subject|19|||
160993910|NCT01956669|581367325|FG005|Overall Study|Adverse Event|0|||
160993911|NCT01956669|581367326|FG006|Overall Study|Adverse Event|0|||
160993912|NCT01956669|581367320|FG000|Overall Study|Physician Decision|0|||
160993913|NCT01956669|581367321|FG001|Overall Study|Physician Decision|2|||
160993914|NCT01956669|581367322|FG002|Overall Study|Physician Decision|0|||
160993915|NCT01956669|581367323|FG003|Overall Study|Physician Decision|0|||
160993916|NCT01956669|581367324|FG004|Overall Study|Physician Decision|0|||
160993917|NCT01956669|581367325|FG005|Overall Study|Physician Decision|1|||
160993918|NCT01956669|581367326|FG006|Overall Study|Physician Decision|0|||
160993919|NCT01956669|581367320|FG000|Overall Study|Withdrawal by Subject|0|||
160993920|NCT01956669|581367321|FG001|Overall Study|Withdrawal by Subject|0|||
160993921|NCT01956669|581367322|FG002|Overall Study|Withdrawal by Subject|1|||
160993922|NCT01956669|581367323|FG003|Overall Study|Withdrawal by Subject|1|||
160993923|NCT01956669|581367324|FG004|Overall Study|Withdrawal by Subject|0|||
160993924|NCT01956669|581367325|FG005|Overall Study|Withdrawal by Subject|0|||
160993925|NCT01956669|581367326|FG006|Overall Study|Withdrawal by Subject|1|||
160993926|NCT01570751|581367327|FG000|Period A (16 Weeks)|Protocol Violation|1|||
160993927|NCT01570751|581367328|FG001|Period A (16 Weeks)|Protocol Violation|1|||
160993928|NCT01570751|581367327|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
160993929|NCT01570751|581367328|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
160993930|NCT01570751|581367327|FG000|Period A (16 Weeks)|Unclassified|2|||
160993931|NCT01570751|581367328|FG001|Period A (16 Weeks)|Unclassified|3|||
160993932|NCT01570751|581367327|FG000|Period B (16 Weeks)|Adverse Event|1|||
160993933|NCT01570751|581367328|FG001|Period B (16 Weeks)|Adverse Event|0|||
160993934|NCT01570751|581367327|FG000|Period B (16 Weeks)|Protocol Violation|0|||
160993935|NCT01570751|581367328|FG001|Period B (16 Weeks)|Protocol Violation|1|||
160993936|NCT01131494|581367333|FG000|Overall Study|Withdrawal by Subject|2|||
160993937|NCT05419557|581367334|FG000|Overall Study|Lost to Follow-up|11|||
160993938|NCT05419557|581367335|FG001|Overall Study|Lost to Follow-up|4|||
160993939|NCT01196988|581367337|FG000|Overall Study|Adverse Event|1|||
160993940|NCT01196988|581367338|FG001|Overall Study|Adverse Event|2|||
160993941|NCT01196988|581367339|FG002|Overall Study|Adverse Event|0|||
160993942|NCT01196988|581367340|FG003|Overall Study|Adverse Event|0|||
160993943|NCT01196988|581367337|FG000|Overall Study|Withdrawal by Subject|5|||
160993944|NCT01196988|581367338|FG001|Overall Study|Withdrawal by Subject|1|||
160993945|NCT01196988|581367339|FG002|Overall Study|Withdrawal by Subject|4|||
160993946|NCT01196988|581367340|FG003|Overall Study|Withdrawal by Subject|0|||
160993947|NCT01196988|581367337|FG000|Overall Study|Lost to Follow-up|16|||
160993948|NCT01196988|581367338|FG001|Overall Study|Lost to Follow-up|29|||
160993949|NCT01196988|581367339|FG002|Overall Study|Lost to Follow-up|21|||
160993950|NCT01196988|581367340|FG003|Overall Study|Lost to Follow-up|1|||
160993951|NCT01196988|581367337|FG000|Overall Study|Other|2|||
160993952|NCT01196988|581367338|FG001|Overall Study|Other|0|||
160993953|NCT01196988|581367339|FG002|Overall Study|Other|0|||
160993954|NCT01196988|581367340|FG003|Overall Study|Other|0|||
160993955|NCT02281318|581367342|FG000|Overall Study|Adverse Event|2|||
160993956|NCT02281318|581367343|FG001|Overall Study|Adverse Event|2|||
160993957|NCT02281318|581367342|FG000|Overall Study|Lack of Efficacy|2|||
160993958|NCT02281318|581367343|FG001|Overall Study|Lack of Efficacy|0|||
160993959|NCT02281318|581367342|FG000|Overall Study|Lost to Follow-up|2|||
160993960|NCT02281318|581367343|FG001|Overall Study|Lost to Follow-up|1|||
160993961|NCT02281318|581367342|FG000|Overall Study|Physician Decision|2|||
160993962|NCT02281318|581367343|FG001|Overall Study|Physician Decision|0|||
160993963|NCT02281318|581367342|FG000|Overall Study|Withdrawal by Subject|6|||
160993964|NCT02281318|581367343|FG001|Overall Study|Withdrawal by Subject|2|||
160993965|NCT05257798|581367344|FG000|Follow-up Phase|Lost to Follow-up|1|||
160993966|NCT05257798|581367345|FG001|Follow-up Phase|Lost to Follow-up|0|||
160993967|NCT00703911|581367346|FG000|Overall Study|Death|1|||
160993968|NCT00703911|581367346|FG000|Overall Study|Physician Decision|6|||
160993969|NCT00703911|581367346|FG000|Overall Study|Lost to Follow-up|1|||
160993970|NCT00703911|581367346|FG000|Overall Study|Withdrawal by Subject|2|||
160993971|NCT01064817|581367347|FG000|Study Completion|Physician Decision|1|||
160993972|NCT01064817|581367348|FG001|Study Completion|Physician Decision|0|||
160993973|NCT01064817|581367347|FG000|Study Completion|Withdrawal by Subject|1|||
160993974|NCT01064817|581367348|FG001|Study Completion|Withdrawal by Subject|0|||
160993975|NCT03102710|581367349|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
160993976|NCT03102710|581367350|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
160993977|NCT03102710|581367351|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
160569643|NCT04246047|579809224|FG001|Overall Study|Withdrawal by Subject|26|||
160569644|NCT04246047|579809223|FG000|Overall Study|Ongoing|169|||
160993978|NCT03102710|581367349|FG000|Overall Study|Technical issues during final MRI scan|0|||
160993979|NCT03102710|581367350|FG001|Overall Study|Technical issues during final MRI scan|1|||
160569645|NCT04246047|579809224|FG001|Overall Study|Ongoing|135|||
160993980|NCT03102710|581367351|FG002|Overall Study|Technical issues during final MRI scan|0|||
160993981|NCT03102710|581367349|FG000|Overall Study|Nausea during MRI scan|0|||
160993982|NCT03102710|581367350|FG001|Overall Study|Nausea during MRI scan|1|||
160651737|NCT04033445|580106119|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651738|NCT04033445|580106120|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651739|NCT04033445|580106121|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
160651740|NCT04033445|580106122|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
160651741|NCT04033445|580106109|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
160651742|NCT04033445|580106110|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
160651743|NCT04033445|580106111|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
160651744|NCT04033445|580106112|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
160651745|NCT04033445|580106113|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
160651746|NCT04033445|580106114|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
160651747|NCT04033445|580106115|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
160651748|NCT04033445|580106116|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
160651749|NCT04033445|580106117|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
160651750|NCT04033445|580106118|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
160993983|NCT03102710|581367351|FG002|Overall Study|Nausea during MRI scan|0|||
160993984|NCT03102710|581367349|FG000|Overall Study|Subject unable to attend final session|0|||
160993985|NCT03102710|581367350|FG001|Overall Study|Subject unable to attend final session|1|||
160993986|NCT03102710|581367351|FG002|Overall Study|Subject unable to attend final session|0|||
160993987|NCT01368406|581367352|FG000|Overall Study|Lost to Follow-up|8|||
160993988|NCT01368406|581367353|FG001|Overall Study|Lost to Follow-up|4|||
160993989|NCT01368406|581367352|FG000|Overall Study|Withdrawal by Subject|8|||
160651751|NCT04033445|580106119|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
160857115|NCT02587520|580868792|FG001|Overall Study|Withdrawal by Subject|0|||
160857116|NCT02587520|580868793|FG002|Overall Study|Withdrawal by Subject|1|||
160857117|NCT02587520|580868794|FG003|Overall Study|Withdrawal by Subject|1|||
160857118|NCT02587520|580868795|FG004|Overall Study|Withdrawal by Subject|0|||
160857119|NCT02587520|580868796|FG005|Overall Study|Withdrawal by Subject|1|||
160857120|NCT02587520|580868797|FG006|Overall Study|Withdrawal by Subject|1|||
160857121|NCT02587520|580868798|FG007|Overall Study|Withdrawal by Subject|0|||
160857122|NCT02587520|580868799|FG008|Overall Study|Withdrawal by Subject|0|||
160857123|NCT02587520|580868800|FG009|Overall Study|Withdrawal by Subject|0|||
160857124|NCT02587520|580868801|FG010|Overall Study|Withdrawal by Subject|0|||
160857125|NCT02587520|580868802|FG011|Overall Study|Withdrawal by Subject|0|||
160857126|NCT02587520|580868803|FG012|Overall Study|Withdrawal by Subject|0|||
160857127|NCT02587520|580868804|FG013|Overall Study|Withdrawal by Subject|1|||
160857128|NCT02587520|580868805|FG014|Overall Study|Withdrawal by Subject|0|||
160857129|NCT02587520|580868806|FG015|Overall Study|Withdrawal by Subject|0|||
160857130|NCT02587520|580868807|FG016|Overall Study|Withdrawal by Subject|0|||
160857131|NCT02587520|580868808|FG017|Overall Study|Withdrawal by Subject|0|||
160857132|NCT02587520|580868791|FG000|Overall Study|Lost to Follow-up|0|||
160857133|NCT02587520|580868792|FG001|Overall Study|Lost to Follow-up|2|||
160908491|NCT03547583|581058173|FG002|Overall Study|Withdrawal by Subject|10|||
160908492|NCT03547583|581058171|FG000|Overall Study|Other|2|||
160908493|NCT03547583|581058172|FG001|Overall Study|Other|2|||
160908494|NCT03547583|581058173|FG002|Overall Study|Other|3|||
160908495|NCT01949506|581058179|FG000|Overall Study|Physician Decision|1|||
160908496|NCT01446289|581058180|FG000|Overall Study|Withdrawal by Subject|1|||
160908497|NCT01446289|581058181|FG001|Overall Study|Withdrawal by Subject|0|||
160908498|NCT01446289|581058182|FG002|Overall Study|Withdrawal by Subject|1|||
160908499|NCT01446289|581058183|FG003|Overall Study|Withdrawal by Subject|0|||
160908500|NCT02513394|581058189|FG000|Overall Study|Withdrawal by Subject|11|||
160908501|NCT02513394|581058190|FG001|Overall Study|Withdrawal by Subject|23|||
160908502|NCT02513394|581058189|FG000|Overall Study|Ineligible|1|||
160908503|NCT02513394|581058190|FG001|Overall Study|Ineligible|0|||
160908504|NCT00612690|581059932|FG000|Overall Study|Lost to Follow-up|72|||
160908505|NCT00612690|581059933|FG001|Overall Study|Lost to Follow-up|98|||
160908506|NCT00612690|581059932|FG000|Overall Study|Withdrawal by Subject|32|||
160908507|NCT00612690|581059933|FG001|Overall Study|Withdrawal by Subject|20|||
160908508|NCT00612690|581059932|FG000|Overall Study|Withdrawal by Site|11|||
160908509|NCT00612690|581059933|FG001|Overall Study|Withdrawal by Site|0|||
160908510|NCT01664533|581059934|FG000|Overall Study|Death|42|||
160908511|NCT01664533|581059934|FG000|Overall Study|Lost to Follow-up|3|||
160908512|NCT01664533|581059934|FG000|Overall Study|Study termination|9|||
160993990|NCT01368406|581367353|FG001|Overall Study|Withdrawal by Subject|4|||
160993991|NCT01368406|581367352|FG000|Overall Study|relapse of the disease|3|||
160857134|NCT02587520|580868793|FG002|Overall Study|Lost to Follow-up|0|||
160857135|NCT02587520|580868794|FG003|Overall Study|Lost to Follow-up|2|||
160857136|NCT02587520|580868795|FG004|Overall Study|Lost to Follow-up|0|||
160857137|NCT02587520|580868796|FG005|Overall Study|Lost to Follow-up|1|||
160908513|NCT01664533|581059934|FG000|Overall Study|Protocol Violation|3|||
160908514|NCT00844831|581059936|FG000|Overall Study|Withdrawal by Subject|4|||
160908515|NCT00844831|581059936|FG000|Overall Study|Adverse Event|1|||
160908516|NCT00844831|581059936|FG000|Overall Study|Physician Decision|1|||
160908517|NCT05255068|581059937|FG000|Overall Study|Lost to Follow-up|0|||
160908518|NCT05255068|581059938|FG001|Overall Study|Lost to Follow-up|1|||
160908519|NCT03156543|581059940|FG000|Overall Study|Withdrawal by Subject|1|||
160908520|NCT03156543|581059941|FG001|Overall Study|Withdrawal by Subject|0|||
160908521|NCT02891850|581059942|FG000|Overall Study|Adverse Event|3|||
160908522|NCT02891850|581059943|FG001|Overall Study|Adverse Event|0|||
160908523|NCT02891850|581059942|FG000|Overall Study|Death|0|||
160908524|NCT02891850|581059943|FG001|Overall Study|Death|4|||
160908525|NCT02891850|581059942|FG000|Overall Study|Physician Decision|1|||
160908526|NCT02891850|581059943|FG001|Overall Study|Physician Decision|0|||
160908527|NCT02891850|581059942|FG000|Overall Study|Pregnancy|1|||
160908528|NCT02891850|581059943|FG001|Overall Study|Pregnancy|0|||
160908529|NCT02891850|581059942|FG000|Overall Study|Withdrawal by Subject|2|||
160908530|NCT02891850|581059943|FG001|Overall Study|Withdrawal by Subject|3|||
160908531|NCT02397278|581059944|FG000|Overall Study|Withdrawal by Subject|0|||
160908532|NCT02397278|581059945|FG001|Overall Study|Withdrawal by Subject|2|||
160908533|NCT02397278|581059944|FG000|Overall Study|Deemed ineligible following surgery|1|||
160908534|NCT02397278|581059945|FG001|Overall Study|Deemed ineligible following surgery|1|||
160908535|NCT00573469|581059946|FG000|Overall Study|Adverse Event|1|||
160908536|NCT00573469|581059947|FG001|Overall Study|Adverse Event|1|||
160908537|NCT00573469|581059948|FG002|Overall Study|Adverse Event|1|||
160908538|NCT00573469|581059946|FG000|Overall Study|Withdrawal by Subject|0|||
160908539|NCT00573469|581059947|FG001|Overall Study|Withdrawal by Subject|2|||
160908540|NCT00573469|581059948|FG002|Overall Study|Withdrawal by Subject|0|||
160908541|NCT00573469|581059946|FG000|Overall Study|Other|5|||
160908542|NCT00573469|581059947|FG001|Overall Study|Other|1|||
160908543|NCT00573469|581059948|FG002|Overall Study|Other|3|||
160908544|NCT00004978|581059949|FG000|Overall Study|Death|107|||
160908545|NCT00004978|581059950|FG001|Overall Study|Death|116|||
160908546|NCT00004978|581059949|FG000|Overall Study|Lost to Follow-up|101|||
160908547|NCT00004978|581059950|FG001|Overall Study|Lost to Follow-up|108|||
160908548|NCT00004978|581059949|FG000|Overall Study|Withdrawal by Subject|17|||
160908549|NCT00004978|581059950|FG001|Overall Study|Withdrawal by Subject|26|||
160908550|NCT00004978|581059949|FG000|Overall Study|site closure - not in analysis cohort|19|||
160908551|NCT00004978|581059950|FG001|Overall Study|site closure - not in analysis cohort|20|||
160908552|NCT02155608|581059957|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
160908553|NCT02155608|581059958|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
160908554|NCT02155608|581059957|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
160908555|NCT02155608|581059958|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
160908556|NCT03555591|581059959|FG000|Overall Study|Protocol Violation|77|||
160908557|NCT01532414|581059962|FG000|Overall Study|Lost to Follow-up|3|||
160908558|NCT01532414|581059963|FG001|Overall Study|Lost to Follow-up|0|||
160908559|NCT01532414|581059964|FG002|Overall Study|Lost to Follow-up|1|||
160908560|NCT01532414|581059962|FG000|Overall Study|Withdrawal by Subject|3|||
160908561|NCT01532414|581059963|FG001|Overall Study|Withdrawal by Subject|0|||
160908562|NCT01532414|581059964|FG002|Overall Study|Withdrawal by Subject|0|||
160908563|NCT01532414|581059962|FG000|Overall Study|No V6 semen sample|0|||
160908564|NCT01532414|581059963|FG001|Overall Study|No V6 semen sample|1|||
160908565|NCT01532414|581059964|FG002|Overall Study|No V6 semen sample|0|||
160908566|NCT01532414|581059962|FG000|Overall Study|Adverse Event|0|||
160908567|NCT01532414|581059963|FG001|Overall Study|Adverse Event|1|||
160908568|NCT01532414|581059964|FG002|Overall Study|Adverse Event|1|||
160908569|NCT01532414|581059962|FG000|Overall Study|Unable to complete 24 hour PK|0|||
160908570|NCT01532414|581059963|FG001|Overall Study|Unable to complete 24 hour PK|0|||
160908571|NCT01532414|581059964|FG002|Overall Study|Unable to complete 24 hour PK|1|||
160908572|NCT01532414|581059962|FG000|Overall Study|Withdrawn by sponsor|1|||
160908573|NCT01532414|581059963|FG001|Overall Study|Withdrawn by sponsor|0|||
160908574|NCT01532414|581059964|FG002|Overall Study|Withdrawn by sponsor|0|||
160908575|NCT00684593|581059965|FG000|Overall Study|Adverse Event|0|||
160908576|NCT00684593|581059966|FG001|Overall Study|Adverse Event|2|||
160908577|NCT02380677|581059974|FG000|Overall Study|Adverse Event|0|||
160908578|NCT02380677|581059975|FG001|Overall Study|Adverse Event|0|||
160908579|NCT02380677|581059976|FG002|Overall Study|Adverse Event|0|||
160908580|NCT02380677|581059977|FG003|Overall Study|Adverse Event|1|||
160908581|NCT02380677|581059978|FG004|Overall Study|Adverse Event|1|||
160908582|NCT02380677|581059979|FG005|Overall Study|Adverse Event|4|||
160908583|NCT02380677|581059980|FG006|Overall Study|Adverse Event|2|||
160908584|NCT02380677|581059981|FG007|Overall Study|Adverse Event|2|||
160908585|NCT02380677|581059982|FG008|Overall Study|Adverse Event|2|||
160908586|NCT02380677|581059983|FG009|Overall Study|Adverse Event|1|||
160908587|NCT02380677|581059984|FG010|Overall Study|Adverse Event|2|||
160908588|NCT02380677|581059985|FG011|Overall Study|Adverse Event|1|||
160908589|NCT02380677|581059974|FG000|Overall Study|Physician Decision|1|||
160908590|NCT02380677|581059975|FG001|Overall Study|Physician Decision|0|||
160908591|NCT02380677|581059976|FG002|Overall Study|Physician Decision|1|||
160908592|NCT02380677|581059977|FG003|Overall Study|Physician Decision|1|||
160908593|NCT02380677|581059978|FG004|Overall Study|Physician Decision|0|||
160908594|NCT02380677|581059979|FG005|Overall Study|Physician Decision|0|||
160908595|NCT02380677|581059980|FG006|Overall Study|Physician Decision|0|||
160857138|NCT02587520|580868797|FG006|Overall Study|Lost to Follow-up|1|||
160857139|NCT02587520|580868798|FG007|Overall Study|Lost to Follow-up|1|||
160857140|NCT02587520|580868799|FG008|Overall Study|Lost to Follow-up|0|||
160857141|NCT02587520|580868800|FG009|Overall Study|Lost to Follow-up|2|||
160857142|NCT02587520|580868801|FG010|Overall Study|Lost to Follow-up|2|||
160857143|NCT02587520|580868802|FG011|Overall Study|Lost to Follow-up|1|||
160857144|NCT02587520|580868803|FG012|Overall Study|Lost to Follow-up|0|||
160857145|NCT02587520|580868804|FG013|Overall Study|Lost to Follow-up|0|||
160857146|NCT02587520|580868805|FG014|Overall Study|Lost to Follow-up|0|||
160857147|NCT02587520|580868806|FG015|Overall Study|Lost to Follow-up|0|||
160857148|NCT02587520|580868807|FG016|Overall Study|Lost to Follow-up|0|||
160857149|NCT02587520|580868808|FG017|Overall Study|Lost to Follow-up|0|||
160857150|NCT00672555|580868809|FG000|Overall Study|Lost to Follow-up|4|||
160857151|NCT00672555|580868809|FG000|Overall Study|Did not want to answer questionnaire|2|||
160857152|NCT04516746|580868812|FG000|Overall Study|Randomized but not Treated|51|||
160857153|NCT04516746|580868813|FG001|Overall Study|Randomized but not Treated|19|||
160857154|NCT04516746|580868812|FG000|Overall Study|Adverse Event|0|||
160857155|NCT04516746|580868813|FG001|Overall Study|Adverse Event|1|||
160857156|NCT04516746|580868812|FG000|Overall Study|Death|62|||
160857157|NCT04516746|580868813|FG001|Overall Study|Death|32|||
160857158|NCT04516746|580868812|FG000|Overall Study|Lost to Follow-up|3431|||
160857159|NCT04516746|580868813|FG001|Overall Study|Lost to Follow-up|1831|||
160857160|NCT04516746|580868812|FG000|Overall Study|Withdrawal by Subject|1946|||
160857161|NCT04516746|580868813|FG001|Overall Study|Withdrawal by Subject|1696|||
160857162|NCT04516746|580868812|FG000|Overall Study|Physician Decision|10|||
160857163|NCT04516746|580868813|FG001|Overall Study|Physician Decision|8|||
160857164|NCT04516746|580868812|FG000|Overall Study|Other|35|||
160857165|NCT04516746|580868813|FG001|Overall Study|Other|16|||
160857166|NCT00446849|580868815|FG000|Acute Phase|Lack of Efficacy|64|||
160857167|NCT00446849|580868815|FG000|Acute Phase|Protocol Violation|10|||
160857168|NCT00446849|580868815|FG000|Acute Phase|Consent withdrawn|4|||
160857169|NCT00446849|580868815|FG000|Acute Phase|Lost to Follow-up|2|||
160857170|NCT00446849|580868815|FG000|Acute Phase|Physician Decision|1|||
160857171|NCT00446849|580868815|FG000|Acute Phase|noncompliance|1|||
160857172|NCT00446849|580868815|FG000|Maintenance Phase|Lack of Efficacy|40|||
160857173|NCT00446849|580868815|FG000|Maintenance Phase|Protocol Violation|7|||
160857174|NCT00446849|580868815|FG000|Maintenance Phase|Adverse Event|6|||
160857175|NCT00446849|580868815|FG000|Maintenance Phase|Consent withdrawn|5|||
160857176|NCT00446849|580868815|FG000|Maintenance Phase|Lost to Follow-up|3|||
160857177|NCT00446849|580868815|FG000|Maintenance Phase|Pregnancy|1|||
160857178|NCT00446849|580868815|FG000|Maintenance Phase|noncompliance|2|||
160857179|NCT00446849|580868815|FG000|Maintenance Phase|prohibited medication use|2|||
160857180|NCT00446849|580868815|FG000|Maintenance Phase|antibiotic use|1|||
160857181|NCT00446849|580868815|FG000|Maintenance Phase|study closure|1|||
160857182|NCT00446849|580868815|FG000|Maintenance Phase|hydrocodone use|1|||
160857183|NCT00446849|580868815|FG000|Maintenance Phase|concomitant medication use|1|||
160857184|NCT05546476|580868816|FG000|Period 1: Part A|Adverse Event|2|||
160857185|NCT05546476|580868817|FG001|Period 1: Part A|Adverse Event|0|||
160857186|NCT05546476|580868818|FG002|Period 1: Part A|Adverse Event|0|||
160651752|NCT04033445|580106120|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
160857187|NCT05546476|580868819|FG003|Period 1: Part A|Adverse Event|1|||
160857188|NCT05546476|580868816|FG000|Period 1: Part A|Death|4|||
160857189|NCT05546476|580868817|FG001|Period 1: Part A|Death|4|||
160857190|NCT05546476|580868818|FG002|Period 1: Part A|Death|5|||
160857191|NCT05546476|580868819|FG003|Period 1: Part A|Death|6|||
160857192|NCT05546476|580868816|FG000|Period 1: Part A|Lack of Efficacy|0|||
160857193|NCT05546476|580868817|FG001|Period 1: Part A|Lack of Efficacy|0|||
160857194|NCT05546476|580868818|FG002|Period 1: Part A|Lack of Efficacy|0|||
160908596|NCT02380677|581059981|FG007|Overall Study|Physician Decision|0|||
160908597|NCT02380677|581059982|FG008|Overall Study|Physician Decision|0|||
160908598|NCT02380677|581059983|FG009|Overall Study|Physician Decision|0|||
160908599|NCT02380677|581059984|FG010|Overall Study|Physician Decision|0|||
160908600|NCT02380677|581059985|FG011|Overall Study|Physician Decision|0|||
160908601|NCT02380677|581059974|FG000|Overall Study|Lack of Efficacy|0|||
160908602|NCT02380677|581059975|FG001|Overall Study|Lack of Efficacy|1|||
160908603|NCT02380677|581059976|FG002|Overall Study|Lack of Efficacy|2|||
160908604|NCT02380677|581059977|FG003|Overall Study|Lack of Efficacy|0|||
160908605|NCT02380677|581059978|FG004|Overall Study|Lack of Efficacy|4|||
160857195|NCT05546476|580868819|FG003|Period 1: Part A|Lack of Efficacy|1|||
160857196|NCT05546476|580868816|FG000|Period 1: Part A|Lost to Follow-up|0|||
160908606|NCT02380677|581059979|FG005|Overall Study|Lack of Efficacy|1|||
160908607|NCT02380677|581059980|FG006|Overall Study|Lack of Efficacy|1|||
160908608|NCT02380677|581059981|FG007|Overall Study|Lack of Efficacy|2|||
160857197|NCT05546476|580868817|FG001|Period 1: Part A|Lost to Follow-up|0|||
160857198|NCT05546476|580868818|FG002|Period 1: Part A|Lost to Follow-up|0|||
160857199|NCT05546476|580868819|FG003|Period 1: Part A|Lost to Follow-up|1|||
160857200|NCT05546476|580868816|FG000|Period 1: Part A|Physician Decision|1|||
160857201|NCT05546476|580868817|FG001|Period 1: Part A|Physician Decision|0|||
160857202|NCT05546476|580868818|FG002|Period 1: Part A|Physician Decision|0|||
160857203|NCT05546476|580868819|FG003|Period 1: Part A|Physician Decision|0|||
160908609|NCT02380677|581059982|FG008|Overall Study|Lack of Efficacy|2|||
160908610|NCT02380677|581059983|FG009|Overall Study|Lack of Efficacy|0|||
160857204|NCT05546476|580868816|FG000|Period 1: Part A|Progressive disease|3|||
160857205|NCT05546476|580868817|FG001|Period 1: Part A|Progressive disease|5|||
160857206|NCT05546476|580868818|FG002|Period 1: Part A|Progressive disease|0|||
160857207|NCT05546476|580868819|FG003|Period 1: Part A|Progressive disease|1|||
160857208|NCT05546476|580868816|FG000|Period 1: Part A|Withdrawal by Subject|1|||
160857209|NCT05546476|580868817|FG001|Period 1: Part A|Withdrawal by Subject|1|||
160857210|NCT05546476|580868818|FG002|Period 1: Part A|Withdrawal by Subject|1|||
160857211|NCT05546476|580868819|FG003|Period 1: Part A|Withdrawal by Subject|2|||
160857212|NCT05546476|580868816|FG000|Period 1: Part A|Global deterioration of health status|2|||
160857213|NCT05546476|580868817|FG001|Period 1: Part A|Global deterioration of health status|2|||
160857214|NCT05546476|580868818|FG002|Period 1: Part A|Global deterioration of health status|1|||
160857215|NCT05546476|580868819|FG003|Period 1: Part A|Global deterioration of health status|4|||
160908611|NCT02380677|581059984|FG010|Overall Study|Lack of Efficacy|2|||
160908612|NCT02380677|581059985|FG011|Overall Study|Lack of Efficacy|1|||
160908613|NCT02380677|581059974|FG000|Overall Study|Withdrawal by Subject|0|||
160908614|NCT02380677|581059975|FG001|Overall Study|Withdrawal by Subject|0|||
160908615|NCT02380677|581059976|FG002|Overall Study|Withdrawal by Subject|0|||
160908616|NCT02380677|581059977|FG003|Overall Study|Withdrawal by Subject|0|||
160908617|NCT02380677|581059978|FG004|Overall Study|Withdrawal by Subject|0|||
160908618|NCT02380677|581059979|FG005|Overall Study|Withdrawal by Subject|0|||
160908619|NCT02380677|581059980|FG006|Overall Study|Withdrawal by Subject|0|||
160908620|NCT02380677|581059981|FG007|Overall Study|Withdrawal by Subject|0|||
160908621|NCT02380677|581059982|FG008|Overall Study|Withdrawal by Subject|0|||
160908622|NCT02380677|581059983|FG009|Overall Study|Withdrawal by Subject|1|||
160908623|NCT02380677|581059984|FG010|Overall Study|Withdrawal by Subject|0|||
160908624|NCT02380677|581059985|FG011|Overall Study|Withdrawal by Subject|3|||
160908625|NCT02380677|581059974|FG000|Overall Study|Other|0|||
160908626|NCT02380677|581059975|FG001|Overall Study|Other|0|||
160569646|NCT00587223|579809232|FG000|Overall Study|Adverse Event|1|||
160569647|NCT03519178|579809233|FG000|PF-06873600 Treatment|Adverse Event|0|||
160571910|NCT01743027|579816863|FG002|Overall Study|Protocol Violation|1|||
160908627|NCT02380677|581059976|FG002|Overall Study|Other|0|||
160857216|NCT05546476|580868816|FG000|Period 1: Part A|Other: Unspecified|0|||
160857217|NCT05546476|580868817|FG001|Period 1: Part A|Other: Unspecified|2|||
160857218|NCT05546476|580868818|FG002|Period 1: Part A|Other: Unspecified|0|||
160857219|NCT05546476|580868819|FG003|Period 1: Part A|Other: Unspecified|0|||
160857220|NCT05546476|580868816|FG000|Period 2: Part B|Ongoing|26|||
160857221|NCT05546476|580868817|FG001|Period 2: Part B|Ongoing|27|||
160857222|NCT05546476|580868818|FG002|Period 2: Part B|Ongoing|35|||
160857223|NCT05546476|580868819|FG003|Period 2: Part B|Ongoing|29|||
160857224|NCT03760029|580868827|FG000|Overall Study|Death|1|||
160857225|NCT03760029|580868828|FG001|Overall Study|Death|0|||
160857226|NCT03760029|580868829|FG002|Overall Study|Death|0|||
160857227|NCT03760029|580868827|FG000|Overall Study|Lost to Follow-up|0|||
160857228|NCT03760029|580868828|FG001|Overall Study|Lost to Follow-up|2|||
160857229|NCT03760029|580868829|FG002|Overall Study|Lost to Follow-up|1|||
160857230|NCT03760029|580868827|FG000|Overall Study|Withdrawal by Subject|1|||
160857231|NCT03760029|580868828|FG001|Overall Study|Withdrawal by Subject|4|||
160857232|NCT03760029|580868829|FG002|Overall Study|Withdrawal by Subject|1|||
160857233|NCT03760029|580868827|FG000|Overall Study|Withdrawal by parent/guardian|4|||
160857234|NCT03760029|580868828|FG001|Overall Study|Withdrawal by parent/guardian|4|||
160857235|NCT03760029|580868829|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160569648|NCT03519178|579809234|FG001|PF-06873600 Treatment|Adverse Event|0|||
160569649|NCT03519178|579809235|FG002|PF-06873600 Treatment|Adverse Event|0|||
160569650|NCT03519178|579809236|FG003|PF-06873600 Treatment|Adverse Event|0|||
160569651|NCT03519178|579809237|FG004|PF-06873600 Treatment|Adverse Event|0|||
160569652|NCT03519178|579809238|FG005|PF-06873600 Treatment|Adverse Event|0|||
160569653|NCT03519178|579809239|FG006|PF-06873600 Treatment|Adverse Event|0|||
160569654|NCT03519178|579809240|FG007|PF-06873600 Treatment|Adverse Event|2|||
160569655|NCT03519178|579809241|FG008|PF-06873600 Treatment|Adverse Event|1|||
160569656|NCT03519178|579809242|FG009|PF-06873600 Treatment|Adverse Event|0|||
160569657|NCT03519178|579809243|FG010|PF-06873600 Treatment|Adverse Event|0|||
160569658|NCT03519178|579809244|FG011|PF-06873600 Treatment|Adverse Event|0|||
160569659|NCT03519178|579809245|FG012|PF-06873600 Treatment|Adverse Event|1|||
160569660|NCT03519178|579809246|FG013|PF-06873600 Treatment|Adverse Event|3|||
160569661|NCT03519178|579809247|FG014|PF-06873600 Treatment|Adverse Event|2|||
160569662|NCT03519178|579809233|FG000|PF-06873600 Treatment|Death|0|||
160569663|NCT03519178|579809234|FG001|PF-06873600 Treatment|Death|0|||
160569664|NCT03519178|579809235|FG002|PF-06873600 Treatment|Death|0|||
160569665|NCT03519178|579809236|FG003|PF-06873600 Treatment|Death|0|||
160569666|NCT03519178|579809237|FG004|PF-06873600 Treatment|Death|0|||
160569667|NCT03519178|579809238|FG005|PF-06873600 Treatment|Death|0|||
160569668|NCT03519178|579809239|FG006|PF-06873600 Treatment|Death|0|||
160569669|NCT03519178|579809240|FG007|PF-06873600 Treatment|Death|0|||
160569670|NCT03519178|579809241|FG008|PF-06873600 Treatment|Death|1|||
160569671|NCT03519178|579809242|FG009|PF-06873600 Treatment|Death|1|||
160569672|NCT03519178|579809243|FG010|PF-06873600 Treatment|Death|0|||
160569673|NCT03519178|579809244|FG011|PF-06873600 Treatment|Death|0|||
160569674|NCT03519178|579809245|FG012|PF-06873600 Treatment|Death|0|||
160569675|NCT03519178|579809246|FG013|PF-06873600 Treatment|Death|0|||
160569676|NCT03519178|579809247|FG014|PF-06873600 Treatment|Death|1|||
160569677|NCT03519178|579809233|FG000|PF-06873600 Treatment|Physician Decision|0|||
160569678|NCT03519178|579809234|FG001|PF-06873600 Treatment|Physician Decision|0|||
160569679|NCT03519178|579809235|FG002|PF-06873600 Treatment|Physician Decision|0|||
160569680|NCT03519178|579809236|FG003|PF-06873600 Treatment|Physician Decision|0|||
160569681|NCT03519178|579809237|FG004|PF-06873600 Treatment|Physician Decision|0|||
160569682|NCT03519178|579809238|FG005|PF-06873600 Treatment|Physician Decision|0|||
160569683|NCT03519178|579809239|FG006|PF-06873600 Treatment|Physician Decision|0|||
160569684|NCT03519178|579809240|FG007|PF-06873600 Treatment|Physician Decision|1|||
160569685|NCT03519178|579809241|FG008|PF-06873600 Treatment|Physician Decision|0|||
160569686|NCT03519178|579809242|FG009|PF-06873600 Treatment|Physician Decision|0|||
160569687|NCT03519178|579809243|FG010|PF-06873600 Treatment|Physician Decision|1|||
160569688|NCT03519178|579809244|FG011|PF-06873600 Treatment|Physician Decision|0|||
160569689|NCT03519178|579809245|FG012|PF-06873600 Treatment|Physician Decision|0|||
160569690|NCT03519178|579809246|FG013|PF-06873600 Treatment|Physician Decision|4|||
160569691|NCT03519178|579809247|FG014|PF-06873600 Treatment|Physician Decision|1|||
160569692|NCT03519178|579809233|FG000|PF-06873600 Treatment|Progressive disease|1|||
160569693|NCT03519178|579809234|FG001|PF-06873600 Treatment|Progressive disease|1|||
160569694|NCT03519178|579809235|FG002|PF-06873600 Treatment|Progressive disease|1|||
160569695|NCT03519178|579809236|FG003|PF-06873600 Treatment|Progressive disease|1|||
160569696|NCT03519178|579809237|FG004|PF-06873600 Treatment|Progressive disease|6|||
160569697|NCT03519178|579809238|FG005|PF-06873600 Treatment|Progressive disease|7|||
160569698|NCT03519178|579809239|FG006|PF-06873600 Treatment|Progressive disease|3|||
160857236|NCT03760029|580868827|FG000|Overall Study|Other|2|||
160857237|NCT03760029|580868828|FG001|Overall Study|Other|1|||
160569699|NCT03519178|579809240|FG007|PF-06873600 Treatment|Progressive disease|7|||
160569700|NCT03519178|579809241|FG008|PF-06873600 Treatment|Progressive disease|3|||
160569701|NCT03519178|579809242|FG009|PF-06873600 Treatment|Progressive disease|5|||
160569702|NCT03519178|579809243|FG010|PF-06873600 Treatment|Progressive disease|4|||
160857238|NCT03760029|580868829|FG002|Overall Study|Other|0|||
160857239|NCT04890652|580868835|FG000|Overall Study|Withdrawal by Subject|2|||
160857240|NCT00772538|580868843|FG000|Overall Study|Adverse Event|6|||
160857241|NCT00772538|580868844|FG001|Overall Study|Adverse Event|6|||
160857242|NCT00772538|580868843|FG000|Overall Study|Protocol Violation|3|||
160857243|NCT00772538|580868844|FG001|Overall Study|Protocol Violation|3|||
160857244|NCT00772538|580868843|FG000|Overall Study|Lost to Follow-up|1|||
160857245|NCT00772538|580868844|FG001|Overall Study|Lost to Follow-up|1|||
160857246|NCT00772538|580868843|FG000|Overall Study|Withdrawal by Subject|3|||
160857247|NCT00772538|580868844|FG001|Overall Study|Withdrawal by Subject|8|||
160857248|NCT00772538|580868843|FG000|Overall Study|Lack of Efficacy|0|||
160857249|NCT00772538|580868844|FG001|Overall Study|Lack of Efficacy|1|||
160857250|NCT00772538|580868843|FG000|Overall Study|Other|7|||
160857251|NCT00772538|580868844|FG001|Overall Study|Other|7|||
160569703|NCT03519178|579809244|FG011|PF-06873600 Treatment|Progressive disease|3|||
160569704|NCT03519178|579809245|FG012|PF-06873600 Treatment|Progressive disease|4|||
160569705|NCT03519178|579809246|FG013|PF-06873600 Treatment|Progressive disease|28|||
160569706|NCT03519178|579809247|FG014|PF-06873600 Treatment|Progressive disease|8|||
160569707|NCT03519178|579809233|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
160569708|NCT03519178|579809234|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
160569709|NCT03519178|579809235|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
160569710|NCT03519178|579809236|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
160569711|NCT03519178|579809237|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
160569712|NCT03519178|579809238|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
160569713|NCT03519178|579809239|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
160569714|NCT03519178|579809240|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
160569715|NCT03519178|579809241|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
160569716|NCT03519178|579809242|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
160569717|NCT03519178|579809243|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
160569718|NCT03519178|579809244|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
160569719|NCT03519178|579809245|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
160569720|NCT03519178|579809246|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
160569721|NCT03519178|579809247|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
160569722|NCT03519178|579809233|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
160569723|NCT03519178|579809234|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
160569724|NCT03519178|579809235|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
160569725|NCT03519178|579809236|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
160569726|NCT03519178|579809237|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
160569727|NCT03519178|579809238|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
160569728|NCT03519178|579809239|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
160569729|NCT03519178|579809240|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
160569730|NCT03519178|579809241|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
160569731|NCT03519178|579809242|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
160569732|NCT03519178|579809243|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
160569733|NCT03519178|579809244|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
160569734|NCT03519178|579809245|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
160569735|NCT03519178|579809246|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
160569736|NCT03519178|579809247|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
160857252|NCT01089504|580868845|FG000|Overall Study|Lost to Follow-up|1|||
160857253|NCT01089504|580868846|FG001|Overall Study|Lost to Follow-up|1|||
160857254|NCT01089504|580868845|FG000|Overall Study|Withdrawal by Subject|2|||
160857255|NCT01089504|580868846|FG001|Overall Study|Withdrawal by Subject|0|||
160857256|NCT00001832|580868847|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
160857257|NCT00001832|580868848|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
160857258|NCT00001832|580868849|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
160857259|NCT00001832|580868850|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
160857260|NCT00001832|580868851|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
160857261|NCT00001832|580868852|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
160857262|NCT00001832|580868853|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
160857263|NCT00001832|580868854|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
160857264|NCT00001832|580868855|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
160857265|NCT00001832|580868856|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
160857266|NCT00001832|580868857|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
160857267|NCT00001832|580868858|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
160857268|NCT00001832|580868859|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
160857269|NCT00001832|580868860|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
160857270|NCT00001832|580868861|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
160857271|NCT00001832|580868847|FG000|Treatment Period|Death during treatment|0|||
160857272|NCT00001832|580868848|FG001|Treatment Period|Death during treatment|0|||
160857273|NCT00001832|580868849|FG002|Treatment Period|Death during treatment|0|||
160857274|NCT00001832|580868850|FG003|Treatment Period|Death during treatment|0|||
160857275|NCT00001832|580868851|FG004|Treatment Period|Death during treatment|0|||
160857276|NCT00001832|580868852|FG005|Treatment Period|Death during treatment|1|||
160857277|NCT00001832|580868853|FG006|Treatment Period|Death during treatment|0|||
160857278|NCT00001832|580868854|FG007|Treatment Period|Death during treatment|0|||
160569737|NCT03519178|579809233|FG000|PF-06873600 Treatment|Refused further treatment|0|||
160569738|NCT03519178|579809234|FG001|PF-06873600 Treatment|Refused further treatment|1|||
160569739|NCT03519178|579809235|FG002|PF-06873600 Treatment|Refused further treatment|0|||
160569740|NCT03519178|579809236|FG003|PF-06873600 Treatment|Refused further treatment|0|||
160569741|NCT03519178|579809237|FG004|PF-06873600 Treatment|Refused further treatment|1|||
160569742|NCT03519178|579809238|FG005|PF-06873600 Treatment|Refused further treatment|0|||
160569743|NCT03519178|579809239|FG006|PF-06873600 Treatment|Refused further treatment|0|||
160569744|NCT03519178|579809240|FG007|PF-06873600 Treatment|Refused further treatment|0|||
160569745|NCT03519178|579809241|FG008|PF-06873600 Treatment|Refused further treatment|0|||
160569746|NCT03519178|579809242|FG009|PF-06873600 Treatment|Refused further treatment|0|||
160569747|NCT03519178|579809243|FG010|PF-06873600 Treatment|Refused further treatment|0|||
160569748|NCT03519178|579809244|FG011|PF-06873600 Treatment|Refused further treatment|0|||
160569749|NCT03519178|579809245|FG012|PF-06873600 Treatment|Refused further treatment|0|||
160569750|NCT03519178|579809246|FG013|PF-06873600 Treatment|Refused further treatment|0|||
160569751|NCT03519178|579809247|FG014|PF-06873600 Treatment|Refused further treatment|1|||
160569752|NCT03519178|579809233|FG000|PF-06873600 Treatment|Other|0|||
160569753|NCT03519178|579809234|FG001|PF-06873600 Treatment|Other|0|||
160569754|NCT03519178|579809235|FG002|PF-06873600 Treatment|Other|0|||
160569755|NCT03519178|579809236|FG003|PF-06873600 Treatment|Other|0|||
160569756|NCT03519178|579809237|FG004|PF-06873600 Treatment|Other|0|||
160569757|NCT03519178|579809238|FG005|PF-06873600 Treatment|Other|0|||
160569758|NCT03519178|579809239|FG006|PF-06873600 Treatment|Other|0|||
160569759|NCT03519178|579809240|FG007|PF-06873600 Treatment|Other|0|||
160569760|NCT03519178|579809241|FG008|PF-06873600 Treatment|Other|1|||
160569761|NCT03519178|579809242|FG009|PF-06873600 Treatment|Other|0|||
160569762|NCT03519178|579809243|FG010|PF-06873600 Treatment|Other|0|||
160569763|NCT03519178|579809244|FG011|PF-06873600 Treatment|Other|0|||
160569764|NCT03519178|579809245|FG012|PF-06873600 Treatment|Other|0|||
160569765|NCT03519178|579809246|FG013|PF-06873600 Treatment|Other|1|||
160569766|NCT03519178|579809247|FG014|PF-06873600 Treatment|Other|3|||
160569767|NCT03519178|579809233|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
160569768|NCT03519178|579809234|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
160569769|NCT03519178|579809235|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
160569770|NCT03519178|579809236|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
160569771|NCT03519178|579809237|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
160569772|NCT03519178|579809238|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
160569773|NCT03519178|579809239|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
160569774|NCT03519178|579809240|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
160569775|NCT03519178|579809241|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
160569776|NCT03519178|579809242|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
160569777|NCT03519178|579809243|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
160569778|NCT03519178|579809244|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
160569779|NCT03519178|579809245|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
160569780|NCT03519178|579809246|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
160569781|NCT03519178|579809247|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
160569782|NCT03519178|579809233|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569783|NCT03519178|579809234|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569784|NCT03519178|579809235|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569785|NCT03519178|579809236|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569786|NCT03519178|579809237|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569787|NCT03519178|579809238|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569788|NCT03519178|579809239|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569789|NCT03519178|579809240|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569790|NCT03519178|579809241|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569791|NCT03519178|579809242|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569792|NCT03519178|579809243|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569793|NCT03519178|579809244|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569794|NCT03519178|579809245|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
160569795|NCT03519178|579809246|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
160569796|NCT03519178|579809247|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
160569797|NCT03519178|579809233|FG000|Fulvestrant. Treatment|Adverse Event|0|||
160569798|NCT03519178|579809234|FG001|Fulvestrant. Treatment|Adverse Event|0|||
160569799|NCT03519178|579809235|FG002|Fulvestrant. Treatment|Adverse Event|0|||
160857279|NCT00001832|580868855|FG008|Treatment Period|Death during treatment|0|||
160569800|NCT03519178|579809236|FG003|Fulvestrant. Treatment|Adverse Event|0|||
160569801|NCT03519178|579809237|FG004|Fulvestrant. Treatment|Adverse Event|0|||
160569802|NCT03519178|579809238|FG005|Fulvestrant. Treatment|Adverse Event|0|||
160651753|NCT04033445|580106121|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
160651754|NCT04033445|580106122|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
160651755|NCT04033445|580106109|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160651756|NCT04033445|580106110|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160651757|NCT04033445|580106111|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160651758|NCT04033445|580106112|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160651759|NCT04033445|580106113|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160857280|NCT00001832|580868856|FG009|Treatment Period|Death during treatment|0|||
160857281|NCT00001832|580868857|FG010|Treatment Period|Death during treatment|0|||
160857282|NCT00001832|580868858|FG011|Treatment Period|Death during treatment|0|||
160857283|NCT00001832|580868859|FG012|Treatment Period|Death during treatment|0|||
160651760|NCT04033445|580106114|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160651761|NCT04033445|580106115|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160651762|NCT04033445|580106116|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160651763|NCT04033445|580106117|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160651764|NCT04033445|580106118|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
160651765|NCT04033445|580106119|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160857284|NCT00001832|580868860|FG013|Treatment Period|Death during treatment|0|||
160857285|NCT00001832|580868861|FG014|Treatment Period|Death during treatment|0|||
160857286|NCT00001832|580868847|FG000|Treatment Period|Not treated|0|||
160857287|NCT00001832|580868848|FG001|Treatment Period|Not treated|0|||
160857288|NCT00001832|580868849|FG002|Treatment Period|Not treated|0|||
160857289|NCT00001832|580868850|FG003|Treatment Period|Not treated|0|||
160857290|NCT00001832|580868851|FG004|Treatment Period|Not treated|0|||
160857291|NCT00001832|580868852|FG005|Treatment Period|Not treated|0|||
160857292|NCT00001832|580868853|FG006|Treatment Period|Not treated|0|||
160857293|NCT00001832|580868854|FG007|Treatment Period|Not treated|1|||
160857294|NCT00001832|580868855|FG008|Treatment Period|Not treated|0|||
160857295|NCT00001832|580868856|FG009|Treatment Period|Not treated|0|||
160857296|NCT00001832|580868857|FG010|Treatment Period|Not treated|0|||
160857297|NCT00001832|580868858|FG011|Treatment Period|Not treated|0|||
160857298|NCT00001832|580868859|FG012|Treatment Period|Not treated|0|||
160857299|NCT00001832|580868860|FG013|Treatment Period|Not treated|0|||
160857300|NCT00001832|580868861|FG014|Treatment Period|Not treated|0|||
160651766|NCT04033445|580106120|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
160651767|NCT04033445|580106121|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
160651768|NCT04033445|580106122|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
160651769|NCT02985957|580106127|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160857301|NCT04529083|580868862|FG000|Overall Study|Withdrawal by Subject|3|||
160857302|NCT03305666|580868867|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
160857303|NCT03305666|580868868|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
160857304|NCT04196686|580868869|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
160857305|NCT04196686|580868870|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
160857306|NCT00914849|580868873|FG000|Overall Study|Withdrawal by Subject|1|||
160857307|NCT00914849|580868874|FG001|Overall Study|Withdrawal by Subject|0|||
160857308|NCT00914849|580868873|FG000|Overall Study|Not eligible|0|||
160993992|NCT01368406|581367353|FG001|Overall Study|relapse of the disease|2|||
160993993|NCT01368406|581367352|FG000|Overall Study|started working|2|||
160993994|NCT01368406|581367353|FG001|Overall Study|started working|3|||
160993995|NCT01313182|581367354|FG000|Overall Study|Protocol Violation|66|||
160993996|NCT01313182|581367355|FG001|Overall Study|Protocol Violation|92|||
160993997|NCT00464672|581367356|FG000|Overall Study|withdrawal of consent|0|||
160993998|NCT00464672|581367357|FG001|Overall Study|withdrawal of consent|0|||
160993999|NCT00464672|581367358|FG002|Overall Study|withdrawal of consent|0|||
160994000|NCT00464672|581367359|FG003|Overall Study|withdrawal of consent|1|||
160994001|NCT00464672|581367360|FG004|Overall Study|withdrawal of consent|9|||
160994002|NCT00464672|581367361|FG005|Overall Study|withdrawal of consent|4|||
160994003|NCT00464672|581367356|FG000|Overall Study|Lost to Follow-up|25|||
160994004|NCT00464672|581367357|FG001|Overall Study|Lost to Follow-up|10|||
160994005|NCT00464672|581367358|FG002|Overall Study|Lost to Follow-up|0|||
160651770|NCT02985957|580106128|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160651771|NCT02985957|580106129|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160651772|NCT02985957|580106130|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160651773|NCT02985957|580106131|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
160651774|NCT02985957|580106132|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160857309|NCT00914849|580868874|FG001|Overall Study|Not eligible|1|||
160857310|NCT01001221|580868875|FG000|Overall Study|Adverse Event|1|||
160857311|NCT01001221|580868876|FG001|Overall Study|Adverse Event|2|||
160857312|NCT01001221|580868877|FG002|Overall Study|Adverse Event|0|||
160857313|NCT01001221|580868878|FG003|Overall Study|Adverse Event|2|||
160994006|NCT00464672|581367359|FG003|Overall Study|Lost to Follow-up|0|||
160857314|NCT01001221|580868879|FG004|Overall Study|Adverse Event|0|||
160857315|NCT01001221|580868875|FG000|Overall Study|Disease progression|3|||
160857316|NCT01001221|580868876|FG001|Overall Study|Disease progression|2|||
160857317|NCT01001221|580868877|FG002|Overall Study|Disease progression|2|||
160857318|NCT01001221|580868878|FG003|Overall Study|Disease progression|4|||
160857319|NCT01001221|580868879|FG004|Overall Study|Disease progression|0|||
160994007|NCT00464672|581367360|FG004|Overall Study|Lost to Follow-up|1|||
160994008|NCT00464672|581367361|FG005|Overall Study|Lost to Follow-up|0|||
160994009|NCT00606580|581367362|FG000|Overall Study|Lost to Follow-up|1|||
160994010|NCT00606580|581367363|FG001|Overall Study|Lost to Follow-up|1|||
160994011|NCT00606580|581367364|FG002|Overall Study|Lost to Follow-up|4|||
160994012|NCT00606580|581367362|FG000|Overall Study|Clinical failures|1|||
160994013|NCT00606580|581367363|FG001|Overall Study|Clinical failures|0|||
160994014|NCT00606580|581367364|FG002|Overall Study|Clinical failures|12|||
160994015|NCT00606580|581367362|FG000|Overall Study|Withdrawal by investigator|0|||
160994016|NCT00606580|581367363|FG001|Overall Study|Withdrawal by investigator|1|||
160994017|NCT00606580|581367364|FG002|Overall Study|Withdrawal by investigator|6|||
160994018|NCT00606580|581367362|FG000|Overall Study|Withdrawal by Subject|0|||
160994019|NCT00606580|581367363|FG001|Overall Study|Withdrawal by Subject|1|||
160994020|NCT00606580|581367364|FG002|Overall Study|Withdrawal by Subject|0|||
160994021|NCT00601640|581367365|FG000|Overall Study|Withdrawal by Subject|3|||
160994022|NCT00601640|581367366|FG001|Overall Study|Withdrawal by Subject|0|||
160994023|NCT00601640|581367367|FG002|Overall Study|Withdrawal by Subject|7|||
160994024|NCT00601640|581367365|FG000|Overall Study|Death|1|||
160994025|NCT00601640|581367366|FG001|Overall Study|Death|0|||
160994026|NCT00601640|581367367|FG002|Overall Study|Death|0|||
160994027|NCT00601640|581367365|FG000|Overall Study|Adverse Event|0|||
160994028|NCT00601640|581367366|FG001|Overall Study|Adverse Event|4|||
160994029|NCT00601640|581367367|FG002|Overall Study|Adverse Event|2|||
160994030|NCT00601640|581367365|FG000|Overall Study|intercurrent illness|1|||
160994031|NCT00601640|581367366|FG001|Overall Study|intercurrent illness|0|||
160994032|NCT00601640|581367367|FG002|Overall Study|intercurrent illness|0|||
160994033|NCT00601640|581367365|FG000|Overall Study|change in eligibility status|0|||
160994034|NCT00601640|581367366|FG001|Overall Study|change in eligibility status|1|||
160994035|NCT00601640|581367367|FG002|Overall Study|change in eligibility status|1|||
160994036|NCT00015457|581367368|FG000|First Intervention|Adverse Event|0|||
160994037|NCT00015457|581367369|FG001|First Intervention|Adverse Event|2|||
160994038|NCT00015457|581367368|FG000|First Intervention|Lack of Efficacy|0|||
160994039|NCT00015457|581367369|FG001|First Intervention|Lack of Efficacy|1|||
160994040|NCT00015457|581367368|FG000|Second Intervention|Withdrawal by Subject|1|||
160994041|NCT00015457|581367369|FG001|Second Intervention|Withdrawal by Subject|0|||
160994042|NCT00543725|581367370|FG000|Overall Study|Adverse Event|18|||
160994043|NCT00543725|581367371|FG001|Overall Study|Adverse Event|27|||
160994044|NCT00543725|581367370|FG000|Overall Study|Sponsor's Decision|0|||
160994045|NCT00543725|581367371|FG001|Overall Study|Sponsor's Decision|1|||
160994046|NCT00543725|581367370|FG000|Overall Study|Subject Non-Compliant|4|||
160994047|NCT00543725|581367371|FG001|Overall Study|Subject Non-Compliant|4|||
160994048|NCT00543725|581367370|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
160994049|NCT00543725|581367371|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
160994050|NCT00543725|581367370|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
160994051|NCT00543725|581367371|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
160994052|NCT00543725|581367370|FG000|Overall Study|Protocol Violation|0|||
160994053|NCT00543725|581367371|FG001|Overall Study|Protocol Violation|1|||
160994054|NCT00543725|581367370|FG000|Overall Study|Withdrawal by Subject|4|||
160994055|NCT00543725|581367371|FG001|Overall Study|Withdrawal by Subject|13|||
160994056|NCT00543725|581367370|FG000|Overall Study|Lost to Follow-up|15|||
160994057|NCT00543725|581367371|FG001|Overall Study|Lost to Follow-up|11|||
160994058|NCT00543725|581367370|FG000|Overall Study|Other|3|||
160994059|NCT00543725|581367371|FG001|Overall Study|Other|3|||
160994060|NCT01674569|581367372|FG000|Overall Study|Adverse Event|0|||
160994061|NCT01674569|581367373|FG001|Overall Study|Adverse Event|2|||
160994062|NCT01674569|581367374|FG002|Overall Study|Adverse Event|0|||
160857320|NCT01001221|580868875|FG000|Overall Study|Other|1|||
160994063|NCT01674569|581367375|FG003|Overall Study|Adverse Event|1|||
160994064|NCT01674569|581367376|FG004|Overall Study|Adverse Event|2|||
160994065|NCT01674569|581367377|FG005|Overall Study|Adverse Event|2|||
160994066|NCT01674569|581367372|FG000|Overall Study|Protocol Violation|0|||
160857321|NCT01001221|580868876|FG001|Overall Study|Other|1|||
160857322|NCT01001221|580868877|FG002|Overall Study|Other|0|||
160857323|NCT01001221|580868878|FG003|Overall Study|Other|0|||
160857324|NCT01001221|580868879|FG004|Overall Study|Other|0|||
160994067|NCT01674569|581367373|FG001|Overall Study|Protocol Violation|1|||
160994068|NCT01674569|581367374|FG002|Overall Study|Protocol Violation|1|||
160994069|NCT01674569|581367375|FG003|Overall Study|Protocol Violation|0|||
160994070|NCT01674569|581367376|FG004|Overall Study|Protocol Violation|0|||
160994071|NCT01674569|581367377|FG005|Overall Study|Protocol Violation|0|||
160994072|NCT01674569|581367372|FG000|Overall Study|Withdrawal by Subject|0|||
160994073|NCT01674569|581367373|FG001|Overall Study|Withdrawal by Subject|0|||
160994074|NCT01674569|581367374|FG002|Overall Study|Withdrawal by Subject|1|||
160857325|NCT01001221|580868875|FG000|Overall Study|Not treated; protocol exclusion|0|||
160857326|NCT01001221|580868876|FG001|Overall Study|Not treated; protocol exclusion|0|||
160857327|NCT01001221|580868877|FG002|Overall Study|Not treated; protocol exclusion|1|||
160857328|NCT01001221|580868878|FG003|Overall Study|Not treated; protocol exclusion|0|||
160857329|NCT01001221|580868879|FG004|Overall Study|Not treated; protocol exclusion|0|||
160857330|NCT05106959|580868880|FG000|Overall Study|Lost to Follow-up|1|||
160857331|NCT03448406|580868881|FG000|Overall Study|Noncompliance of scheduled visits|1|||
160857332|NCT03448406|580868882|FG001|Overall Study|Noncompliance of scheduled visits|2|||
160857333|NCT03448406|580868881|FG000|Overall Study|Withdrawal by Subject|1|||
160857334|NCT03448406|580868882|FG001|Overall Study|Withdrawal by Subject|2|||
160857335|NCT03448406|580868881|FG000|Overall Study|Protocol Violation|1|||
160857336|NCT03448406|580868882|FG001|Overall Study|Protocol Violation|0|||
160857337|NCT03448406|580868881|FG000|Overall Study|Adverse Event|8|||
160857338|NCT03448406|580868882|FG001|Overall Study|Adverse Event|9|||
160857339|NCT01292486|580868883|FG000|Overall Study|Protocol Violation|2|||
160857340|NCT01292486|580868883|FG000|Overall Study|Did not meet screening criteria|2|||
160857341|NCT01292486|580868883|FG000|Overall Study|Adverse Event|1|||
160857342|NCT01292486|580868883|FG000|Overall Study|Physician Decision|1|||
160857343|NCT00087152|580868884|FG000|Overall Study|Ineligible|6|||
160857344|NCT04602390|580868891|FG000|Overall Study|Withdrawal by Subject|0|||
160857345|NCT04602390|580868892|FG001|Overall Study|Withdrawal by Subject|0|||
160857346|NCT04602390|580868893|FG002|Overall Study|Withdrawal by Subject|0|||
160857347|NCT04602390|580868894|FG003|Overall Study|Withdrawal by Subject|0|||
160857348|NCT04602390|580868895|FG004|Overall Study|Withdrawal by Subject|1|||
160857349|NCT04602390|580868896|FG005|Overall Study|Withdrawal by Subject|0|||
160857350|NCT04602390|580868891|FG000|Overall Study|Adverse Event|0|||
160857351|NCT04602390|580868892|FG001|Overall Study|Adverse Event|0|||
160857352|NCT04602390|580868893|FG002|Overall Study|Adverse Event|0|||
160857353|NCT04602390|580868894|FG003|Overall Study|Adverse Event|0|||
160857354|NCT04602390|580868895|FG004|Overall Study|Adverse Event|0|||
160857355|NCT04602390|580868896|FG005|Overall Study|Adverse Event|1|||
160857356|NCT02756338|580868897|FG000|Overall Study|Withdrawn by Investigator|1|||
160857357|NCT02756338|580868897|FG000|Overall Study|Device Replaced with Pacemaker|4|||
160857358|NCT01546857|580868898|FG000|Overall Study|Withdrawal by Subject|2|||
160857359|NCT01546857|580868899|FG001|Overall Study|Withdrawal by Subject|3|||
160857360|NCT02542865|580868900|FG000|Overall Study|Identified as screen failure|1|||
160857361|NCT02542865|580868901|FG001|Overall Study|Identified as screen failure|0|||
160857362|NCT02542865|580868900|FG000|Overall Study|Withdrawal by Subject|16|||
160857363|NCT02542865|580868901|FG001|Overall Study|Withdrawal by Subject|0|||
160857364|NCT01339689|580868902|FG000|Overall Study|Adverse Event|1|||
160857365|NCT01339689|580868903|FG001|Overall Study|Adverse Event|2|||
160857366|NCT01339689|580868902|FG000|Overall Study|Lost to Follow-up|9|||
160857367|NCT01339689|580868903|FG001|Overall Study|Lost to Follow-up|3|||
160857368|NCT01339689|580868902|FG000|Overall Study|Withdrawal by Subject|3|||
160857369|NCT01339689|580868903|FG001|Overall Study|Withdrawal by Subject|0|||
160857370|NCT01339689|580868902|FG000|Overall Study|Noncompliance|1|||
160857371|NCT01339689|580868903|FG001|Overall Study|Noncompliance|0|||
160857372|NCT01339689|580868902|FG000|Overall Study|Relocated out of area|0|||
160857373|NCT01339689|580868903|FG001|Overall Study|Relocated out of area|1|||
160857374|NCT01339689|580868902|FG000|Overall Study|Other|2|||
160857375|NCT01339689|580868903|FG001|Overall Study|Other|2|||
160857376|NCT01339689|580868902|FG000|Overall Study|multiple reasons|1|||
160857377|NCT01339689|580868903|FG001|Overall Study|multiple reasons|1|||
160857378|NCT00659061|580868904|FG000|Overall Study|Migration due to political unrest|21|||
160857379|NCT00659061|580868905|FG001|Overall Study|Migration due to political unrest|15|||
160857380|NCT01277744|580868914|FG000|Overall Study|Physician Decision|2|||
160857381|NCT05121766|580868917|FG000|Overall Study|Covid reinfection|3|||
160857382|NCT05121766|580868918|FG001|Overall Study|Covid reinfection|0|||
160857383|NCT05121766|580868917|FG000|Overall Study|Withdrawal by Subject|3|||
160857384|NCT05121766|580868918|FG001|Overall Study|Withdrawal by Subject|1|||
160857385|NCT05121766|580868917|FG000|Overall Study|Adverse Event|2|||
160857386|NCT05121766|580868918|FG001|Overall Study|Adverse Event|4|||
160857387|NCT05121766|580868917|FG000|Overall Study|Lost to Follow-up|0|||
160857388|NCT05121766|580868918|FG001|Overall Study|Lost to Follow-up|1|||
160857389|NCT03259230|580868919|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
160857390|NCT03259230|580868920|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
160857391|NCT01632020|580868921|FG000|Overall Study|Withdrawal by Subject|1|||
160857392|NCT01632020|580868922|FG001|Overall Study|Withdrawal by Subject|0|||
160857393|NCT01632020|580868921|FG000|Overall Study|Adverse Event|1|||
160857394|NCT01632020|580868922|FG001|Overall Study|Adverse Event|0|||
160857395|NCT05468814|580868923|FG000|Overall Study|Lost to Follow-up|5|||
160857396|NCT05468814|580868924|FG001|Overall Study|Lost to Follow-up|6|||
160857397|NCT00528957|580868929|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
160857398|NCT00528957|580868930|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
160857399|NCT00528957|580868929|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
160857400|NCT00528957|580868930|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
160857401|NCT00528957|580868929|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
160908628|NCT02380677|581059977|FG003|Overall Study|Other|1|||
160994075|NCT01674569|581367375|FG003|Overall Study|Withdrawal by Subject|0|||
160994076|NCT01674569|581367376|FG004|Overall Study|Withdrawal by Subject|0|||
160994077|NCT01674569|581367377|FG005|Overall Study|Withdrawal by Subject|0|||
160994078|NCT02595398|581367378|FG000|Overall Study|Non-compliance|1|||
160994079|NCT02595398|581367379|FG001|Overall Study|Non-compliance|0|||
160994080|NCT02595398|581367378|FG000|Overall Study|Withdrawal by Subject|2|||
160994081|NCT02595398|581367379|FG001|Overall Study|Withdrawal by Subject|1|||
160994082|NCT02595398|581367378|FG000|Overall Study|Lost to Follow-up|1|||
160994083|NCT02595398|581367379|FG001|Overall Study|Lost to Follow-up|0|||
160994084|NCT00502593|581367380|FG000|Overall Study|Withdrawn unspecified reason|1|||
160994085|NCT00502593|581367381|FG001|Overall Study|Withdrawn unspecified reason|1|||
160994086|NCT00502593|581367382|FG002|Overall Study|Withdrawn unspecified reason|3|||
160994087|NCT00502593|581367383|FG003|Overall Study|Withdrawn unspecified reason|1|||
160994088|NCT00502593|581367384|FG004|Overall Study|Withdrawn unspecified reason|2|||
160857402|NCT00528957|580868930|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
160857403|NCT00528957|580868929|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
160857404|NCT00528957|580868930|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
160857405|NCT00528957|580868929|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
160857406|NCT00528957|580868930|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
160857407|NCT00528957|580868929|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
160857408|NCT00528957|580868930|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
160857409|NCT00528957|580868929|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
160857410|NCT00528957|580868930|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
160857411|NCT00528957|580868929|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
160857412|NCT00528957|580868930|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
160857413|NCT00528957|580868929|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
160857414|NCT00528957|580868930|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
160857415|NCT00528957|580868929|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
160857416|NCT00528957|580868930|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
160857417|NCT00528957|580868929|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
160857418|NCT00528957|580868930|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
160857419|NCT00528957|580868929|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
160857420|NCT00528957|580868930|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
160857421|NCT00528957|580868929|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
160857422|NCT00528957|580868930|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
160908629|NCT02380677|581059978|FG004|Overall Study|Other|1|||
160908630|NCT02380677|581059979|FG005|Overall Study|Other|1|||
160908631|NCT02380677|581059980|FG006|Overall Study|Other|0|||
160908632|NCT02380677|581059981|FG007|Overall Study|Other|0|||
160908633|NCT02380677|581059982|FG008|Overall Study|Other|0|||
160908634|NCT02380677|581059983|FG009|Overall Study|Other|0|||
160908635|NCT02380677|581059984|FG010|Overall Study|Other|0|||
160908636|NCT02380677|581059985|FG011|Overall Study|Other|0|||
160908637|NCT02599129|581059988|FG000|Overall Study|Lack of Efficacy|2|||
160908638|NCT02599129|581059989|FG001|Overall Study|Lack of Efficacy|2|||
160908639|NCT02599129|581059988|FG000|Overall Study|Lost to Follow-up|1|||
160908640|NCT02599129|581059989|FG001|Overall Study|Lost to Follow-up|0|||
160908641|NCT02599129|581059988|FG000|Overall Study|Withdrawal by Subject|2|||
160908642|NCT02599129|581059989|FG001|Overall Study|Withdrawal by Subject|1|||
160908643|NCT00617773|581059990|FG000|Overall Study|Physician Decision|1|||
160908644|NCT00617773|581059990|FG000|Overall Study|Lack of compliance with the protocol|1|||
160908645|NCT00617773|581059990|FG000|Overall Study|Withdrawal by Subject|1|||
160908646|NCT00617773|581059990|FG000|Overall Study|Death|1|||
160908647|NCT00617773|581059990|FG000|Overall Study|Progressive disease|19|||
160908648|NCT00617773|581059990|FG000|Overall Study|Protocol Violation|1|||
160908649|NCT01029795|581059991|FG000|Overall Study|Entry Criteria Not Met|2|||
160908650|NCT01029795|581059992|FG001|Overall Study|Entry Criteria Not Met|1|||
160908651|NCT01029795|581059991|FG000|Overall Study|Physician Decision|2|||
160908652|NCT01029795|581059992|FG001|Overall Study|Physician Decision|1|||
160908653|NCT01029795|581059991|FG000|Overall Study|Sponsor Decision|11|||
160994089|NCT00502593|581367385|FG005|Overall Study|Withdrawn unspecified reason|0|||
160651775|NCT02985957|580106133|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160651776|NCT02985957|580106127|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
160857423|NCT00528957|580868929|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
160857424|NCT00528957|580868930|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
160857425|NCT00528957|580868929|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
160857426|NCT00528957|580868930|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
160857427|NCT00528957|580868929|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
160857428|NCT00528957|580868930|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
160857429|NCT00625131|580868931|FG000|Overall Study|Lost to Follow-up|3|||
160857430|NCT00625131|580868932|FG001|Overall Study|Lost to Follow-up|2|||
160857431|NCT00625131|580868933|FG002|Overall Study|Lost to Follow-up|0|||
160857432|NCT00625131|580868931|FG000|Overall Study|Withdrawal by Subject|1|||
160857433|NCT00625131|580868932|FG001|Overall Study|Withdrawal by Subject|0|||
160857434|NCT00625131|580868933|FG002|Overall Study|Withdrawal by Subject|5|||
160857435|NCT05083351|580868939|FG000|Overall Study|Adverse Event|3|||
160857436|NCT05083351|580868939|FG000|Overall Study|Did not meet data inclusion criteria|8|||
160857437|NCT05083351|580868939|FG000|Overall Study|Did not meet eligibility criteria|19|||
160857438|NCT05083351|580868939|FG000|Overall Study|Study Staff Decision|19|||
160857439|NCT01611792|580868940|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
160857440|NCT01611792|580868941|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
160857441|NCT01611792|580868940|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
160857442|NCT01611792|580868941|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
160857443|NCT03416868|580868942|FG000|Overall Study|Withdrawal by Subject|2|||
160857444|NCT03416868|580868942|FG000|Overall Study|Lost to Follow-up|1|||
160857445|NCT00960375|580868945|FG000|Overall Study|Lost to Follow-up|20|||
160857446|NCT00960375|580868946|FG001|Overall Study|Lost to Follow-up|22|||
160857447|NCT00083889|580868947|FG000|Overall Study|Adverse Event|76|||
160857448|NCT00083889|580868948|FG001|Overall Study|Adverse Event|86|||
160857449|NCT00083889|580868947|FG000|Overall Study|Protocol Violation|2|||
160857450|NCT00083889|580868948|FG001|Overall Study|Protocol Violation|2|||
160857451|NCT00083889|580868947|FG000|Overall Study|Withdrawal by Subject|22|||
160857452|NCT00083889|580868948|FG001|Overall Study|Withdrawal by Subject|24|||
160857453|NCT00083889|580868947|FG000|Overall Study|Lack of Efficacy|240|||
160857454|NCT00083889|580868948|FG001|Overall Study|Lack of Efficacy|219|||
160857455|NCT00083889|580868947|FG000|Overall Study|Decision of sponsor|32|||
160908654|NCT01029795|581059992|FG001|Overall Study|Sponsor Decision|17|||
160908655|NCT01029795|581059991|FG000|Overall Study|Withdrawal by Subject|1|||
160908656|NCT01029795|581059992|FG001|Overall Study|Withdrawal by Subject|3|||
160908657|NCT00587054|581059998|FG000|Overall Study|Patient not treated|9|||
160651777|NCT02985957|580106128|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
160651778|NCT02985957|580106129|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
160651779|NCT02985957|580106130|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
160651780|NCT02985957|580106131|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
160651781|NCT02985957|580106132|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
160651782|NCT02985957|580106133|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
160651783|NCT02985957|580106127|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
160651784|NCT02985957|580106128|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
160651785|NCT02985957|580106129|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
160651786|NCT02985957|580106130|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
160651787|NCT02985957|580106131|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
160651788|NCT02985957|580106132|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
160651789|NCT02985957|580106133|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
160651790|NCT02985957|580106127|FG000|Treatment Period|Death|0|||
160651791|NCT02985957|580106128|FG001|Treatment Period|Death|0|||
160651792|NCT02985957|580106129|FG002|Treatment Period|Death|0|||
160651793|NCT02985957|580106130|FG003|Treatment Period|Death|0|||
160651794|NCT02985957|580106131|FG004|Treatment Period|Death|1|||
160651795|NCT02985957|580106132|FG005|Treatment Period|Death|0|||
160651796|NCT02985957|580106133|FG006|Treatment Period|Death|0|||
160857456|NCT00083889|580868948|FG001|Overall Study|Decision of sponsor|4|||
160857457|NCT00083889|580868947|FG000|Overall Study|Randomized: did not take study drug|0|||
160857458|NCT00083889|580868948|FG001|Overall Study|Randomized: did not take study drug|15|||
160908658|NCT03858309|581060003|FG000|Overall Study|Withdrawal by Subject|2|||
160908659|NCT03858309|581060004|FG001|Overall Study|Withdrawal by Subject|3|||
160908660|NCT01336764|581060005|FG000|Overall Study|Withdrawal by Subject|5|||
160908661|NCT01336764|581060006|FG001|Overall Study|Withdrawal by Subject|5|||
160651797|NCT02985957|580106127|FG000|Treatment Period|Participant withdrew consent|0|||
160651798|NCT02985957|580106128|FG001|Treatment Period|Participant withdrew consent|0|||
160651799|NCT02985957|580106129|FG002|Treatment Period|Participant withdrew consent|0|||
160651800|NCT02985957|580106130|FG003|Treatment Period|Participant withdrew consent|1|||
160857459|NCT00083889|580868947|FG000|Overall Study|Completed on marketed sunitinub|3|||
160857460|NCT00083889|580868948|FG001|Overall Study|Completed on marketed sunitinub|0|||
160651801|NCT02985957|580106131|FG004|Treatment Period|Participant withdrew consent|3|||
160651802|NCT02985957|580106132|FG005|Treatment Period|Participant withdrew consent|0|||
160651803|NCT02985957|580106133|FG006|Treatment Period|Participant withdrew consent|1|||
160651804|NCT02985957|580106127|FG000|Treatment Period|Lost to Follow-up|0|||
160651805|NCT02985957|580106128|FG001|Treatment Period|Lost to Follow-up|0|||
160651806|NCT02985957|580106129|FG002|Treatment Period|Lost to Follow-up|0|||
160651807|NCT02985957|580106130|FG003|Treatment Period|Lost to Follow-up|0|||
160651808|NCT02985957|580106131|FG004|Treatment Period|Lost to Follow-up|1|||
160651809|NCT02985957|580106132|FG005|Treatment Period|Lost to Follow-up|0|||
160651810|NCT02985957|580106133|FG006|Treatment Period|Lost to Follow-up|0|||
160651811|NCT02985957|580106127|FG000|Treatment Period|Other reasons|0|||
160651812|NCT02985957|580106128|FG001|Treatment Period|Other reasons|0|||
160651813|NCT02985957|580106129|FG002|Treatment Period|Other reasons|1|||
160651814|NCT02985957|580106130|FG003|Treatment Period|Other reasons|3|||
160651815|NCT02985957|580106131|FG004|Treatment Period|Other reasons|5|||
160651816|NCT02985957|580106132|FG005|Treatment Period|Other reasons|0|||
160651817|NCT02985957|580106133|FG006|Treatment Period|Other reasons|1|||
160651818|NCT02985957|580106127|FG000|Treatment Period|Not reported|0|||
160651819|NCT02985957|580106128|FG001|Treatment Period|Not reported|2|||
160651820|NCT02985957|580106129|FG002|Treatment Period|Not reported|2|||
160651821|NCT02985957|580106130|FG003|Treatment Period|Not reported|5|||
160651822|NCT02985957|580106131|FG004|Treatment Period|Not reported|0|||
160651823|NCT02985957|580106132|FG005|Treatment Period|Not reported|0|||
160651824|NCT02985957|580106133|FG006|Treatment Period|Not reported|0|||
160651825|NCT02985957|580106127|FG000|Treatment Period|Maximum clinical benefit|0|||
160651826|NCT02985957|580106128|FG001|Treatment Period|Maximum clinical benefit|0|||
160651827|NCT02985957|580106129|FG002|Treatment Period|Maximum clinical benefit|1|||
160651828|NCT02985957|580106130|FG003|Treatment Period|Maximum clinical benefit|1|||
160651829|NCT02985957|580106131|FG004|Treatment Period|Maximum clinical benefit|0|||
160651830|NCT02985957|580106132|FG005|Treatment Period|Maximum clinical benefit|0|||
160651831|NCT02985957|580106133|FG006|Treatment Period|Maximum clinical benefit|2|||
160651832|NCT02985957|580106127|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
160651833|NCT02985957|580106128|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
160651834|NCT02985957|580106129|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
160651835|NCT02985957|580106130|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
160651836|NCT02985957|580106131|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
160651837|NCT02985957|580106132|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
160651838|NCT02985957|580106133|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
160651839|NCT02985957|580106127|FG000|Treatment Period|Study drug toxicity|1|||
160651840|NCT02985957|580106128|FG001|Treatment Period|Study drug toxicity|23|||
160651841|NCT02985957|580106129|FG002|Treatment Period|Study drug toxicity|20|||
160651842|NCT02985957|580106130|FG003|Treatment Period|Study drug toxicity|12|||
160651843|NCT02985957|580106131|FG004|Treatment Period|Study drug toxicity|20|||
160651844|NCT02985957|580106132|FG005|Treatment Period|Study drug toxicity|3|||
160651845|NCT02985957|580106133|FG006|Treatment Period|Study drug toxicity|5|||
160651846|NCT02985957|580106127|FG000|Treatment Period|Disease progression|0|||
160651847|NCT02985957|580106128|FG001|Treatment Period|Disease progression|16|||
160651848|NCT02985957|580106129|FG002|Treatment Period|Disease progression|20|||
160651849|NCT02985957|580106130|FG003|Treatment Period|Disease progression|40|||
160651850|NCT02985957|580106131|FG004|Treatment Period|Disease progression|29|||
160651851|NCT02985957|580106132|FG005|Treatment Period|Disease progression|11|||
160651852|NCT02985957|580106133|FG006|Treatment Period|Disease progression|28|||
160651853|NCT02985957|580106127|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
160651854|NCT02985957|580106128|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
160651855|NCT02985957|580106129|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
160651856|NCT02985957|580106130|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
160651857|NCT02985957|580106131|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
160651858|NCT02985957|580106132|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
160908662|NCT01051323|581060007|FG000|Overall Study|Discontinuation of treatment|103|||
160908663|NCT01051323|581060007|FG000|Overall Study|Transplantation|28|||
160908664|NCT01051323|581060007|FG000|Overall Study|Dialysis dependency|22|||
160651859|NCT02985957|580106133|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
160651860|NCT02985957|580106127|FG000|Treatment Period|Poor/Non-Compliance|0|||
160651861|NCT02985957|580106128|FG001|Treatment Period|Poor/Non-Compliance|0|||
160651862|NCT02985957|580106129|FG002|Treatment Period|Poor/Non-Compliance|0|||
160651863|NCT02985957|580106130|FG003|Treatment Period|Poor/Non-Compliance|0|||
160908665|NCT01051323|581060007|FG000|Overall Study|Withdrawal by Subject|13|||
160651864|NCT02985957|580106131|FG004|Treatment Period|Poor/Non-Compliance|1|||
160651865|NCT02985957|580106132|FG005|Treatment Period|Poor/Non-Compliance|1|||
160651866|NCT02985957|580106133|FG006|Treatment Period|Poor/Non-Compliance|0|||
160651867|NCT06331156|580106134|FG000|Overall Study|Adverse Event|1|||
160651868|NCT06331156|580106135|FG001|Overall Study|Adverse Event|0|||
160908666|NCT01051323|581060007|FG000|Overall Study|Lost to Follow-up|31|||
160908667|NCT01051323|581060007|FG000|Overall Study|Death|129|||
160908668|NCT01051323|581060007|FG000|Overall Study|Hospitalization|28|||
160908669|NCT01051323|581060007|FG000|Overall Study|Other|148|||
160908670|NCT01051323|581060007|FG000|Overall Study|Missing|37|||
160908671|NCT00555971|581060008|FG000|Overall Study|Adverse Event|1|||
160908672|NCT00555971|581060009|FG001|Overall Study|Adverse Event|1|||
160908673|NCT01626391|581060010|FG000|Overall Study|Physician Decision|1|||
160908674|NCT01626391|581060011|FG001|Overall Study|Physician Decision|0|||
160908675|NCT01626391|581060010|FG000|Overall Study|Withdrawal by Subject|1|||
160908676|NCT01626391|581060011|FG001|Overall Study|Withdrawal by Subject|0|||
160908677|NCT02573311|581060012|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
160908678|NCT02573311|581060013|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
160908679|NCT02573311|581060012|FG000|Disposition for Part 2|Physician Decision|25|||
160908680|NCT02573311|581060013|FG001|Disposition for Part 2|Physician Decision|7|||
160908681|NCT02573311|581060012|FG000|Disposition for Part 2|Adverse Event|36|||
160908682|NCT02573311|581060013|FG001|Disposition for Part 2|Adverse Event|5|||
160908683|NCT02573311|581060012|FG000|Disposition for Part 2|Lost to Follow-up|76|||
160908684|NCT02573311|581060013|FG001|Disposition for Part 2|Lost to Follow-up|7|||
160908685|NCT02573311|581060012|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
160908686|NCT02573311|581060013|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
160908687|NCT02573311|581060012|FG000|Disposition for Part 2|Investigator decision|0|||
160908688|NCT02573311|581060013|FG001|Disposition for Part 2|Investigator decision|1|||
160908689|NCT02573311|581060012|FG000|Disposition for Part 2|Other than specified above|13|||
160908690|NCT02573311|581060013|FG001|Disposition for Part 2|Other than specified above|3|||
160908691|NCT05683249|581060014|FG000|Overall Study|Adverse Event|3|||
160908692|NCT05683249|581060015|FG001|Overall Study|Adverse Event|1|||
160908693|NCT05683249|581060014|FG000|Overall Study|Lack of Efficacy|0|||
160908694|NCT05683249|581060015|FG001|Overall Study|Lack of Efficacy|2|||
160908695|NCT05683249|581060014|FG000|Overall Study|Lost to Follow-up|6|||
160908696|NCT05683249|581060015|FG001|Overall Study|Lost to Follow-up|5|||
160908697|NCT05683249|581060014|FG000|Overall Study|Non-compliance with Study Drug|2|||
160908698|NCT05683249|581060015|FG001|Overall Study|Non-compliance with Study Drug|0|||
160908699|NCT05683249|581060014|FG000|Overall Study|Protocol Violation|6|||
160908700|NCT05683249|581060015|FG001|Overall Study|Protocol Violation|3|||
160908701|NCT05683249|581060014|FG000|Overall Study|Withdrawal by Subject|9|||
160908702|NCT05683249|581060015|FG001|Overall Study|Withdrawal by Subject|8|||
160908703|NCT05683249|581060014|FG000|Overall Study|Other|0|||
160908704|NCT05683249|581060015|FG001|Overall Study|Other|2|||
160908705|NCT01328431|581060016|FG000|Baseline|Protocol Violation|0|||
160908706|NCT01328431|581060017|FG001|Baseline|Protocol Violation|2|||
160908707|NCT01328431|581060016|FG000|1 Month (1M)|Lost to Follow-up|55|||
160908708|NCT01328431|581060017|FG001|1 Month (1M)|Lost to Follow-up|58|||
160908709|NCT01328431|581060016|FG000|3 Month (3M)|Death|2|||
160908710|NCT01328431|581060017|FG001|3 Month (3M)|Death|2|||
160908711|NCT01328431|581060016|FG000|3 Month (3M)|Lost to Follow-up|75|||
160908712|NCT01328431|581060017|FG001|3 Month (3M)|Lost to Follow-up|70|||
160908713|NCT01328431|581060016|FG000|12 Month (12M)|Death|2|||
160908714|NCT01328431|581060017|FG001|12 Month (12M)|Death|6|||
160857461|NCT00083889|580868947|FG000|Overall Study|Crossover to SU011248|0|||
160857462|NCT00083889|580868948|FG001|Overall Study|Crossover to SU011248|25|||
160857463|NCT03624881|580868949|FG000|Overall Study|Screen Failure|14|||
160857464|NCT03624881|580868950|FG001|Overall Study|Screen Failure|0|||
160857465|NCT03624881|580868949|FG000|Overall Study|No Catheter Inserted|6|||
160857466|NCT03624881|580868950|FG001|Overall Study|No Catheter Inserted|1|||
160857467|NCT03624881|580868949|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
160857468|NCT03624881|580868950|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
160857469|NCT03624881|580868949|FG000|Overall Study|Death|2|||
160857470|NCT03624881|580868950|FG001|Overall Study|Death|0|||
160857471|NCT03624881|580868949|FG000|Overall Study|Lost to Follow-up|10|||
160857472|NCT03624881|580868950|FG001|Overall Study|Lost to Follow-up|4|||
160857473|NCT03624881|580868949|FG000|Overall Study|Withdrawal by Subject|12|||
160857474|NCT03624881|580868950|FG001|Overall Study|Withdrawal by Subject|1|||
160857475|NCT03473236|580868951|FG000|Overall Study|Withdrawal by Subject|0|||
160857476|NCT03473236|580868952|FG001|Overall Study|Withdrawal by Subject|0|||
160857477|NCT03473236|580868953|FG002|Overall Study|Withdrawal by Subject|0|||
160857478|NCT03473236|580868954|FG003|Overall Study|Withdrawal by Subject|0|||
160908715|NCT01328431|581060016|FG000|12 Month (12M)|Lost to Follow-up|82|||
160908716|NCT01328431|581060017|FG001|12 Month (12M)|Lost to Follow-up|91|||
160908717|NCT02801396|581060018|FG000|Period 1|Withdrawal by Subject|0|||
160908718|NCT02801396|581060019|FG001|Period 1|Withdrawal by Subject|0|||
160908719|NCT02801396|581060020|FG002|Period 1|Withdrawal by Subject|0|||
160908720|NCT02801396|581060021|FG003|Period 1|Withdrawal by Subject|0|||
160908721|NCT02801396|581060022|FG004|Period 1|Withdrawal by Subject|1|||
160908722|NCT02801396|581060023|FG005|Period 1|Withdrawal by Subject|0|||
160908723|NCT03087643|581060030|FG000|Overall Study|Withdrawal by Subject|2|||
160908724|NCT03087643|581060031|FG001|Overall Study|Withdrawal by Subject|4|||
160908725|NCT03087643|581060030|FG000|Overall Study|Death|2|||
160908726|NCT03087643|581060031|FG001|Overall Study|Death|2|||
160569803|NCT03519178|579809239|FG006|Fulvestrant. Treatment|Adverse Event|0|||
160569804|NCT03519178|579809240|FG007|Fulvestrant. Treatment|Adverse Event|0|||
160569805|NCT03519178|579809241|FG008|Fulvestrant. Treatment|Adverse Event|0|||
160569806|NCT03519178|579809242|FG009|Fulvestrant. Treatment|Adverse Event|0|||
160569807|NCT03519178|579809243|FG010|Fulvestrant. Treatment|Adverse Event|0|||
160569808|NCT03519178|579809244|FG011|Fulvestrant. Treatment|Adverse Event|0|||
160569809|NCT03519178|579809245|FG012|Fulvestrant. Treatment|Adverse Event|0|||
160569810|NCT03519178|579809246|FG013|Fulvestrant. Treatment|Adverse Event|1|||
160569811|NCT03519178|579809247|FG014|Fulvestrant. Treatment|Adverse Event|0|||
160569812|NCT03519178|579809233|FG000|Fulvestrant. Treatment|Death|0|||
160569813|NCT03519178|579809234|FG001|Fulvestrant. Treatment|Death|0|||
160569814|NCT03519178|579809235|FG002|Fulvestrant. Treatment|Death|0|||
160569815|NCT03519178|579809236|FG003|Fulvestrant. Treatment|Death|0|||
160569816|NCT03519178|579809237|FG004|Fulvestrant. Treatment|Death|0|||
160569817|NCT03519178|579809238|FG005|Fulvestrant. Treatment|Death|0|||
160569818|NCT03519178|579809239|FG006|Fulvestrant. Treatment|Death|0|||
160569819|NCT03519178|579809240|FG007|Fulvestrant. Treatment|Death|0|||
160569820|NCT03519178|579809241|FG008|Fulvestrant. Treatment|Death|0|||
160569821|NCT03519178|579809242|FG009|Fulvestrant. Treatment|Death|1|||
160569822|NCT03519178|579809243|FG010|Fulvestrant. Treatment|Death|0|||
160569823|NCT03519178|579809244|FG011|Fulvestrant. Treatment|Death|0|||
160569824|NCT03519178|579809245|FG012|Fulvestrant. Treatment|Death|0|||
160569825|NCT03519178|579809246|FG013|Fulvestrant. Treatment|Death|0|||
160569826|NCT03519178|579809247|FG014|Fulvestrant. Treatment|Death|1|||
160569827|NCT03519178|579809233|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569828|NCT03519178|579809234|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569829|NCT03519178|579809235|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569830|NCT03519178|579809236|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569831|NCT03519178|579809237|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569832|NCT03519178|579809238|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569833|NCT03519178|579809239|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569834|NCT03519178|579809240|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569835|NCT03519178|579809241|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569836|NCT03519178|579809242|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569837|NCT03519178|579809243|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569838|NCT03519178|579809244|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569839|NCT03519178|579809245|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
160908727|NCT02083783|581060032|FG000|Overall Study|Withdrawal by Subject|1|||
160908728|NCT02083783|581060033|FG001|Overall Study|Withdrawal by Subject|0|||
160908729|NCT02256631|581060036|FG000|Overall Study|Lost to Follow-up|1|||
160908730|NCT02256631|581060037|FG001|Overall Study|Lost to Follow-up|1|||
160908731|NCT02256631|581060038|FG002|Overall Study|Lost to Follow-up|0|||
160908732|NCT02256631|581060039|FG003|Overall Study|Lost to Follow-up|2|||
160908733|NCT02256631|581060040|FG004|Overall Study|Lost to Follow-up|0|||
160908734|NCT02256631|581060041|FG005|Overall Study|Lost to Follow-up|4|||
160908735|NCT02256631|581060042|FG006|Overall Study|Lost to Follow-up|1|||
160908736|NCT02256631|581060036|FG000|Overall Study|Withdrawal by Subject|0|||
160908737|NCT02256631|581060037|FG001|Overall Study|Withdrawal by Subject|0|||
160908738|NCT02256631|581060038|FG002|Overall Study|Withdrawal by Subject|0|||
160908739|NCT02256631|581060039|FG003|Overall Study|Withdrawal by Subject|1|||
160908740|NCT02256631|581060040|FG004|Overall Study|Withdrawal by Subject|1|||
160908741|NCT02256631|581060041|FG005|Overall Study|Withdrawal by Subject|0|||
160908742|NCT02256631|581060042|FG006|Overall Study|Withdrawal by Subject|1|||
160908743|NCT02256631|581060036|FG000|Overall Study|Unable to get to clinic|0|||
160908744|NCT02256631|581060037|FG001|Overall Study|Unable to get to clinic|2|||
160908745|NCT02256631|581060038|FG002|Overall Study|Unable to get to clinic|0|||
160908746|NCT02256631|581060039|FG003|Overall Study|Unable to get to clinic|1|||
160908747|NCT02256631|581060040|FG004|Overall Study|Unable to get to clinic|0|||
160908748|NCT02256631|581060041|FG005|Overall Study|Unable to get to clinic|1|||
160908749|NCT02256631|581060042|FG006|Overall Study|Unable to get to clinic|2|||
160908750|NCT01427972|581060043|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908751|NCT01427972|581060044|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908752|NCT01427972|581060045|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908753|NCT01427972|581060046|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160569840|NCT03519178|579809246|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
160569841|NCT03519178|579809247|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
160569842|NCT03519178|579809233|FG000|Fulvestrant. Treatment|Physician Decision|0|||
160569843|NCT03519178|579809234|FG001|Fulvestrant. Treatment|Physician Decision|0|||
160569844|NCT03519178|579809235|FG002|Fulvestrant. Treatment|Physician Decision|0|||
160908754|NCT01427972|581060047|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908755|NCT01427972|581060048|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908756|NCT01427972|581060049|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908757|NCT01427972|581060050|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
160569845|NCT03519178|579809236|FG003|Fulvestrant. Treatment|Physician Decision|0|||
160569846|NCT03519178|579809237|FG004|Fulvestrant. Treatment|Physician Decision|0|||
160569847|NCT03519178|579809238|FG005|Fulvestrant. Treatment|Physician Decision|0|||
160651869|NCT06331156|580106134|FG000|Overall Study|Lost to Follow-up|1|||
160908758|NCT01427972|581060051|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160569848|NCT03519178|579809239|FG006|Fulvestrant. Treatment|Physician Decision|0|||
160569849|NCT03519178|579809240|FG007|Fulvestrant. Treatment|Physician Decision|0|||
160569850|NCT03519178|579809241|FG008|Fulvestrant. Treatment|Physician Decision|0|||
160569851|NCT03519178|579809242|FG009|Fulvestrant. Treatment|Physician Decision|0|||
160569852|NCT03519178|579809243|FG010|Fulvestrant. Treatment|Physician Decision|0|||
160569853|NCT03519178|579809244|FG011|Fulvestrant. Treatment|Physician Decision|0|||
160569854|NCT03519178|579809245|FG012|Fulvestrant. Treatment|Physician Decision|0|||
160569855|NCT03519178|579809246|FG013|Fulvestrant. Treatment|Physician Decision|4|||
160569856|NCT03519178|579809247|FG014|Fulvestrant. Treatment|Physician Decision|2|||
160569857|NCT03519178|579809233|FG000|Fulvestrant. Treatment|Progressive disease|0|||
160569858|NCT03519178|579809234|FG001|Fulvestrant. Treatment|Progressive disease|0|||
160569859|NCT03519178|579809235|FG002|Fulvestrant. Treatment|Progressive disease|0|||
160569860|NCT03519178|579809236|FG003|Fulvestrant. Treatment|Progressive disease|0|||
160569861|NCT03519178|579809237|FG004|Fulvestrant. Treatment|Progressive disease|0|||
160569862|NCT03519178|579809238|FG005|Fulvestrant. Treatment|Progressive disease|0|||
160569863|NCT03519178|579809239|FG006|Fulvestrant. Treatment|Progressive disease|0|||
160569864|NCT03519178|579809240|FG007|Fulvestrant. Treatment|Progressive disease|0|||
160569865|NCT03519178|579809241|FG008|Fulvestrant. Treatment|Progressive disease|0|||
160569866|NCT03519178|579809242|FG009|Fulvestrant. Treatment|Progressive disease|5|||
160569867|NCT03519178|579809243|FG010|Fulvestrant. Treatment|Progressive disease|0|||
160569868|NCT03519178|579809244|FG011|Fulvestrant. Treatment|Progressive disease|0|||
160569869|NCT03519178|579809245|FG012|Fulvestrant. Treatment|Progressive disease|0|||
160569870|NCT03519178|579809246|FG013|Fulvestrant. Treatment|Progressive disease|30|||
160569871|NCT03519178|579809247|FG014|Fulvestrant. Treatment|Progressive disease|8|||
160569872|NCT03519178|579809233|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569873|NCT03519178|579809234|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569874|NCT03519178|579809235|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569875|NCT03519178|579809236|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569876|NCT03519178|579809237|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569877|NCT03519178|579809238|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569878|NCT03519178|579809239|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569879|NCT03519178|579809240|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569880|NCT03519178|579809241|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569881|NCT03519178|579809242|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569882|NCT03519178|579809243|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569883|NCT03519178|579809244|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569884|NCT03519178|579809245|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
160569885|NCT03519178|579809246|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
160569886|NCT03519178|579809247|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
160569887|NCT03519178|579809233|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569888|NCT03519178|579809234|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569889|NCT03519178|579809235|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569890|NCT03519178|579809236|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569891|NCT03519178|579809237|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569892|NCT03519178|579809238|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569893|NCT03519178|579809239|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569894|NCT03519178|579809240|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569895|NCT03519178|579809241|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569896|NCT03519178|579809242|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
160569897|NCT03519178|579809243|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569898|NCT03519178|579809244|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569899|NCT03519178|579809245|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
160569900|NCT03519178|579809246|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
160569901|NCT03519178|579809247|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
160569902|NCT03519178|579809233|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569903|NCT03519178|579809234|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569904|NCT03519178|579809235|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569905|NCT03519178|579809236|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569906|NCT03519178|579809237|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569907|NCT03519178|579809238|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569908|NCT03519178|579809239|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569909|NCT03519178|579809240|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569910|NCT03519178|579809241|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569911|NCT03519178|579809242|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
160569912|NCT03519178|579809243|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569913|NCT03519178|579809244|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
160651870|NCT06331156|580106135|FG001|Overall Study|Lost to Follow-up|0|||
160651871|NCT06331156|580106134|FG000|Overall Study|Migrated / Moved from the study area|4|||
160651872|NCT06331156|580106135|FG001|Overall Study|Migrated / Moved from the study area|3|||
160651873|NCT06331156|580106134|FG000|Overall Study|Other|7|||
160651874|NCT06331156|580106135|FG001|Overall Study|Other|0|||
160651875|NCT06331156|580106134|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
160651876|NCT06331156|580106135|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
160651877|NCT02978326|580106140|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
160651878|NCT02978326|580106141|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
160651879|NCT02978326|580106142|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
160651880|NCT02978326|580106140|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
160651881|NCT02978326|580106141|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
160651882|NCT02978326|580106142|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
160651883|NCT02978326|580106140|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
160651884|NCT02978326|580106141|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
160651885|NCT02978326|580106142|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
160651886|NCT02978326|580106140|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
160651887|NCT02978326|580106141|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
160651888|NCT02978326|580106142|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
160651889|NCT03748641|580106145|FG000|Overall Study|Ongoing|155|||
160651890|NCT03748641|580106146|FG001|Overall Study|Ongoing|148|||
160651891|NCT03748641|580106147|FG002|Overall Study|Ongoing|66|||
160651892|NCT03748641|580106148|FG003|Overall Study|Ongoing|79|||
160651893|NCT03748641|580106149|FG004|Overall Study|Ongoing|84|||
160651894|NCT03748641|580106145|FG000|Overall Study|Death|54|||
160651895|NCT03748641|580106146|FG001|Overall Study|Death|59|||
160651896|NCT03748641|580106147|FG002|Overall Study|Death|51|||
160651897|NCT03748641|580106148|FG003|Overall Study|Death|42|||
160651898|NCT03748641|580106149|FG004|Overall Study|Death|9|||
160651899|NCT03748641|580106145|FG000|Overall Study|Lost to Follow-up|0|||
160651900|NCT03748641|580106146|FG001|Overall Study|Lost to Follow-up|2|||
160651901|NCT03748641|580106147|FG002|Overall Study|Lost to Follow-up|1|||
160651902|NCT03748641|580106148|FG003|Overall Study|Lost to Follow-up|0|||
160651903|NCT03748641|580106149|FG004|Overall Study|Lost to Follow-up|0|||
160651904|NCT03748641|580106145|FG000|Overall Study|Withdrawal by Subject|3|||
160908759|NCT01427972|581060052|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160569914|NCT03519178|579809245|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569915|NCT03519178|579809246|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
160569916|NCT03519178|579809247|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
160569917|NCT03519178|579809233|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
160569918|NCT03519178|579809234|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
160569919|NCT03519178|579809235|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
160569920|NCT03519178|579809236|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
160569921|NCT03519178|579809237|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
160569922|NCT03519178|579809238|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
160569923|NCT03519178|579809239|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
160569924|NCT03519178|579809240|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
160569925|NCT03519178|579809241|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
160569926|NCT03519178|579809242|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
160569927|NCT03519178|579809243|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
160569928|NCT03519178|579809244|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
160569929|NCT03519178|579809245|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
160569930|NCT03519178|579809246|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
160569931|NCT03519178|579809247|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
160569932|NCT03519178|579809233|FG000|Fulvestrant. Treatment|Other|0|||
160569933|NCT03519178|579809234|FG001|Fulvestrant. Treatment|Other|0|||
160569934|NCT03519178|579809235|FG002|Fulvestrant. Treatment|Other|0|||
160569935|NCT03519178|579809236|FG003|Fulvestrant. Treatment|Other|0|||
160569936|NCT03519178|579809237|FG004|Fulvestrant. Treatment|Other|0|||
160569937|NCT03519178|579809238|FG005|Fulvestrant. Treatment|Other|0|||
160569938|NCT03519178|579809239|FG006|Fulvestrant. Treatment|Other|0|||
160569939|NCT03519178|579809240|FG007|Fulvestrant. Treatment|Other|0|||
160569940|NCT03519178|579809241|FG008|Fulvestrant. Treatment|Other|0|||
160569941|NCT03519178|579809242|FG009|Fulvestrant. Treatment|Other|0|||
160569942|NCT03519178|579809243|FG010|Fulvestrant. Treatment|Other|0|||
160651905|NCT03748641|580106146|FG001|Overall Study|Withdrawal by Subject|2|||
160651906|NCT03748641|580106147|FG002|Overall Study|Withdrawal by Subject|5|||
160651907|NCT03748641|580106148|FG003|Overall Study|Withdrawal by Subject|3|||
160651908|NCT03748641|580106149|FG004|Overall Study|Withdrawal by Subject|2|||
160651909|NCT00437281|580106150|FG000|Overall Study|Adverse Event|0|||
160651910|NCT00437281|580106151|FG001|Overall Study|Adverse Event|0|||
160651911|NCT00437281|580106152|FG002|Overall Study|Adverse Event|0|||
160651912|NCT00437281|580106153|FG003|Overall Study|Adverse Event|1|||
160651913|NCT00437281|580106154|FG004|Overall Study|Adverse Event|0|||
160651914|NCT00437281|580106155|FG005|Overall Study|Adverse Event|1|||
160651915|NCT00437281|580106156|FG006|Overall Study|Adverse Event|0|||
160651916|NCT00437281|580106157|FG007|Overall Study|Adverse Event|0|||
160651917|NCT00437281|580106158|FG008|Overall Study|Adverse Event|0|||
160651918|NCT00437281|580106159|FG009|Overall Study|Adverse Event|1|||
160651919|NCT00437281|580106160|FG010|Overall Study|Adverse Event|0|||
160651920|NCT00437281|580106161|FG011|Overall Study|Adverse Event|0|||
160651921|NCT00437281|580106162|FG012|Overall Study|Adverse Event|0|||
160651922|NCT00437281|580106163|FG013|Overall Study|Adverse Event|1|||
160651923|NCT00437281|580106164|FG014|Overall Study|Adverse Event|1|||
160651924|NCT00437281|580106165|FG015|Overall Study|Adverse Event|0|||
160651925|NCT00437281|580106166|FG016|Overall Study|Adverse Event|0|||
160651926|NCT00437281|580106167|FG017|Overall Study|Adverse Event|0|||
160651927|NCT00437281|580106168|FG018|Overall Study|Adverse Event|1|||
160651928|NCT00437281|580106169|FG019|Overall Study|Adverse Event|0|||
160651929|NCT00437281|580106150|FG000|Overall Study|Lost to Follow-up|0|||
160651930|NCT00437281|580106151|FG001|Overall Study|Lost to Follow-up|0|||
160651931|NCT00437281|580106152|FG002|Overall Study|Lost to Follow-up|0|||
160651932|NCT00437281|580106153|FG003|Overall Study|Lost to Follow-up|0|||
160651933|NCT00437281|580106154|FG004|Overall Study|Lost to Follow-up|0|||
160651934|NCT00437281|580106155|FG005|Overall Study|Lost to Follow-up|0|||
160651935|NCT00437281|580106156|FG006|Overall Study|Lost to Follow-up|0|||
160651936|NCT00437281|580106157|FG007|Overall Study|Lost to Follow-up|0|||
160651937|NCT00437281|580106158|FG008|Overall Study|Lost to Follow-up|0|||
160651938|NCT00437281|580106159|FG009|Overall Study|Lost to Follow-up|0|||
160651939|NCT00437281|580106160|FG010|Overall Study|Lost to Follow-up|0|||
160651940|NCT00437281|580106161|FG011|Overall Study|Lost to Follow-up|0|||
160651941|NCT00437281|580106162|FG012|Overall Study|Lost to Follow-up|0|||
160651942|NCT00437281|580106163|FG013|Overall Study|Lost to Follow-up|0|||
160651943|NCT00437281|580106164|FG014|Overall Study|Lost to Follow-up|0|||
160651944|NCT00437281|580106165|FG015|Overall Study|Lost to Follow-up|0|||
160651945|NCT00437281|580106166|FG016|Overall Study|Lost to Follow-up|0|||
160651946|NCT00437281|580106167|FG017|Overall Study|Lost to Follow-up|0|||
160651947|NCT00437281|580106168|FG018|Overall Study|Lost to Follow-up|0|||
160651948|NCT00437281|580106169|FG019|Overall Study|Lost to Follow-up|1|||
160651949|NCT04684524|580106170|FG000|Overall Study|Other|2|||
160651950|NCT04684524|580106171|FG001|Overall Study|Other|0|||
160651951|NCT04684524|580106170|FG000|Overall Study|Withdrawal by Subject|5|||
160651952|NCT04684524|580106171|FG001|Overall Study|Withdrawal by Subject|3|||
160651953|NCT04684524|580106170|FG000|Overall Study|Adverse Event|1|||
160651954|NCT04684524|580106171|FG001|Overall Study|Adverse Event|1|||
160651955|NCT00926289|580106172|FG000|Overall Study|Adverse Event|9|||
160651956|NCT00926289|580106173|FG001|Overall Study|Adverse Event|11|||
160651957|NCT00926289|580106172|FG000|Overall Study|Protocol Violation|8|||
160651958|NCT00926289|580106173|FG001|Overall Study|Protocol Violation|12|||
160651959|NCT00926289|580106172|FG000|Overall Study|Lost to Follow-up|3|||
160651960|NCT00926289|580106173|FG001|Overall Study|Lost to Follow-up|6|||
160651961|NCT00926289|580106172|FG000|Overall Study|Withdrawal by Subject|4|||
160651962|NCT00926289|580106173|FG001|Overall Study|Withdrawal by Subject|4|||
160651963|NCT00926289|580106172|FG000|Overall Study|Other|1|||
160651964|NCT00926289|580106173|FG001|Overall Study|Other|3|||
160651965|NCT04104646|580106174|FG000|Overall Study|Withdrawal by Subject|1|||
160651966|NCT04104646|580106175|FG001|Overall Study|Withdrawal by Subject|1|||
160651967|NCT04104646|580106174|FG000|Overall Study|Lost to Follow-up|1|||
160651968|NCT04104646|580106175|FG001|Overall Study|Lost to Follow-up|0|||
160651969|NCT04104646|580106174|FG000|Overall Study|Physician Decision|2|||
160651970|NCT04104646|580106175|FG001|Overall Study|Physician Decision|0|||
160651971|NCT00753714|580106176|FG000|Overall Study|Lack of Efficacy|21|||
160651972|NCT00753714|580106177|FG001|Overall Study|Lack of Efficacy|34|||
160651973|NCT00753714|580106176|FG000|Overall Study|Adverse Event|26|||
160651974|NCT00753714|580106177|FG001|Overall Study|Adverse Event|18|||
160651975|NCT00753714|580106176|FG000|Overall Study|Protocol Violation|1|||
160651976|NCT00753714|580106177|FG001|Overall Study|Protocol Violation|0|||
160651977|NCT00753714|580106176|FG000|Overall Study|Lost to Follow-up|0|||
160651978|NCT00753714|580106177|FG001|Overall Study|Lost to Follow-up|1|||
160651979|NCT00753714|580106176|FG000|Overall Study|Withdrawal by Subject|2|||
160651980|NCT00753714|580106177|FG001|Overall Study|Withdrawal by Subject|1|||
160651981|NCT00753714|580106176|FG000|Overall Study|Death|3|||
160651982|NCT00753714|580106177|FG001|Overall Study|Death|3|||
160651983|NCT00753714|580106176|FG000|Overall Study|Other|7|||
160651984|NCT00753714|580106177|FG001|Overall Study|Other|5|||
160651985|NCT03387098|580106178|FG000|Overall Study|progressive disease|1|||
160651986|NCT03387098|580106178|FG000|Overall Study|Withdrawal by Subject|2|||
160651987|NCT03387098|580106178|FG000|Overall Study|study terminated by sponsor|1|||
160651988|NCT02292238|580106179|FG000|Overall Study|Protocol Violation|1|||
160651989|NCT02292238|580106180|FG001|Overall Study|Protocol Violation|2|||
160651990|NCT02292238|580106179|FG000|Overall Study|Withdrawal by Subject|2|||
160651991|NCT02292238|580106180|FG001|Overall Study|Withdrawal by Subject|1|||
160651992|NCT02292238|580106179|FG000|Overall Study|Lost to Follow-up|1|||
160651993|NCT02292238|580106180|FG001|Overall Study|Lost to Follow-up|0|||
160651994|NCT02292238|580106179|FG000|Overall Study|Physician Decision|0|||
160651995|NCT02292238|580106180|FG001|Overall Study|Physician Decision|1|||
160651996|NCT01754259|580106185|FG000|Overall Study|Withdrawal by Subject|2|||
160994090|NCT00502593|581367386|FG006|Overall Study|Withdrawn unspecified reason|2|||
160994091|NCT00502593|581367387|FG007|Overall Study|Withdrawn unspecified reason|0|||
160994092|NCT00502593|581367388|FG008|Overall Study|Withdrawn unspecified reason|0|||
160994093|NCT00502593|581367389|FG009|Overall Study|Withdrawn unspecified reason|0|||
160994094|NCT00502593|581367390|FG010|Overall Study|Withdrawn unspecified reason|0|||
160994095|NCT00502593|581367391|FG011|Overall Study|Withdrawn unspecified reason|0|||
160994096|NCT00502593|581367380|FG000|Overall Study|Withdrawal by Subject|0|||
160994097|NCT00502593|581367381|FG001|Overall Study|Withdrawal by Subject|0|||
160994098|NCT00502593|581367382|FG002|Overall Study|Withdrawal by Subject|6|||
160994099|NCT00502593|581367383|FG003|Overall Study|Withdrawal by Subject|2|||
160994100|NCT00502593|581367384|FG004|Overall Study|Withdrawal by Subject|2|||
160994101|NCT00502593|581367385|FG005|Overall Study|Withdrawal by Subject|0|||
160994102|NCT00502593|581367386|FG006|Overall Study|Withdrawal by Subject|3|||
160994103|NCT00502593|581367387|FG007|Overall Study|Withdrawal by Subject|0|||
160994104|NCT00502593|581367388|FG008|Overall Study|Withdrawal by Subject|3|||
160994105|NCT00502593|581367389|FG009|Overall Study|Withdrawal by Subject|0|||
160994106|NCT00502593|581367390|FG010|Overall Study|Withdrawal by Subject|1|||
160994107|NCT00502593|581367391|FG011|Overall Study|Withdrawal by Subject|0|||
160994108|NCT00502593|581367380|FG000|Overall Study|Lost to Follow-up|2|||
160994109|NCT00502593|581367381|FG001|Overall Study|Lost to Follow-up|1|||
160994110|NCT00502593|581367382|FG002|Overall Study|Lost to Follow-up|1|||
160994111|NCT00502593|581367383|FG003|Overall Study|Lost to Follow-up|1|||
160994112|NCT00502593|581367384|FG004|Overall Study|Lost to Follow-up|0|||
160994113|NCT00502593|581367385|FG005|Overall Study|Lost to Follow-up|0|||
160994114|NCT00502593|581367386|FG006|Overall Study|Lost to Follow-up|0|||
160994115|NCT00502593|581367387|FG007|Overall Study|Lost to Follow-up|0|||
160994116|NCT00502593|581367388|FG008|Overall Study|Lost to Follow-up|3|||
160994117|NCT00502593|581367389|FG009|Overall Study|Lost to Follow-up|0|||
160994118|NCT00502593|581367390|FG010|Overall Study|Lost to Follow-up|1|||
160994119|NCT00502593|581367391|FG011|Overall Study|Lost to Follow-up|0|||
160994120|NCT03601507|581367392|FG000|Overall Study|Adverse Event|1|||
160994121|NCT02107014|581367395|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
160994122|NCT00591838|581367396|FG000|Overall Study|Withdrawal by Subject|0|||
160994123|NCT00591838|581367397|FG001|Overall Study|Withdrawal by Subject|0|||
160994124|NCT00591838|581367398|FG002|Overall Study|Withdrawal by Subject|0|||
160994125|NCT00591838|581367399|FG003|Overall Study|Withdrawal by Subject|1|||
160994126|NCT00591838|581367400|FG004|Overall Study|Withdrawal by Subject|0|||
160994127|NCT00586339|581367401|FG000|Overall Study|Withdrawal by Subject|1|||
160994128|NCT00586339|581367402|FG001|Overall Study|Withdrawal by Subject|3|||
160994129|NCT00586339|581367403|FG002|Overall Study|Withdrawal by Subject|1|||
160994130|NCT00586339|581367401|FG000|Overall Study|Migrated/moved from study area|3|||
160994131|NCT00586339|581367402|FG001|Overall Study|Migrated/moved from study area|2|||
160994132|NCT00586339|581367403|FG002|Overall Study|Migrated/moved from study area|4|||
160994133|NCT00586339|581367401|FG000|Overall Study|Lost to Follow-up|3|||
160994134|NCT00586339|581367402|FG001|Overall Study|Lost to Follow-up|2|||
160994135|NCT00586339|581367403|FG002|Overall Study|Lost to Follow-up|1|||
160994136|NCT00559949|581367404|FG000|Overall Study|Progressive Disease during cycle 1|1|||
160994137|NCT00559949|581367404|FG000|Overall Study|Adverse Event|1|||
160994138|NCT00559949|581367404|FG000|Overall Study|Withdrawal by Subject|4|||
160994139|NCT00559949|581367404|FG000|Overall Study|No disease evaluation per protocol|1|||
160994140|NCT02512042|581367405|FG000|Overall Study|Adverse Event|0|||
160994141|NCT02512042|581367406|FG001|Overall Study|Adverse Event|4|||
160994142|NCT02512042|581367405|FG000|Overall Study|Withdrawal by Subject|6|||
160994143|NCT02512042|581367406|FG001|Overall Study|Withdrawal by Subject|6|||
160994144|NCT02512042|581367405|FG000|Overall Study|Non-compliance with study drug|1|||
160994145|NCT02512042|581367406|FG001|Overall Study|Non-compliance with study drug|2|||
160994146|NCT02512042|581367405|FG000|Overall Study|Lost to Follow-up|5|||
160994147|NCT02512042|581367406|FG001|Overall Study|Lost to Follow-up|2|||
160994148|NCT02512042|581367405|FG000|Overall Study|Other|11|||
160994149|NCT02512042|581367406|FG001|Overall Study|Other|11|||
160994150|NCT01467700|581367408|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
160994151|NCT01467700|581367409|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
160994152|NCT01467700|581367410|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
160994153|NCT01467700|581367411|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
160994154|NCT01467700|581367408|FG000|Overall Study|Major Protocol Deviation|3|||
160994155|NCT01467700|581367409|FG001|Overall Study|Major Protocol Deviation|3|||
160994156|NCT01467700|581367410|FG002|Overall Study|Major Protocol Deviation|2|||
160857479|NCT03473236|580868955|FG004|Overall Study|Withdrawal by Subject|0|||
160857480|NCT03473236|580868956|FG005|Overall Study|Withdrawal by Subject|1|||
160994157|NCT01467700|581367411|FG003|Overall Study|Major Protocol Deviation|3|||
160994158|NCT01467700|581367408|FG000|Overall Study|Lost to Follow-up|6|||
160994159|NCT01467700|581367409|FG001|Overall Study|Lost to Follow-up|5|||
160994160|NCT01467700|581367410|FG002|Overall Study|Lost to Follow-up|2|||
160994161|NCT01467700|581367411|FG003|Overall Study|Lost to Follow-up|3|||
160994162|NCT01467700|581367408|FG000|Overall Study|Voluntary Withdrawal|5|||
160994163|NCT01467700|581367409|FG001|Overall Study|Voluntary Withdrawal|7|||
160651997|NCT01754259|580106186|FG001|Overall Study|Withdrawal by Subject|4|||
160651998|NCT01754259|580106185|FG000|Overall Study|Adverse Event|3|||
160651999|NCT01754259|580106186|FG001|Overall Study|Adverse Event|1|||
160652000|NCT01754259|580106185|FG000|Overall Study|Lost to Follow-up|0|||
160652001|NCT01754259|580106186|FG001|Overall Study|Lost to Follow-up|1|||
160652002|NCT02829918|580106187|FG000|Overall Study|Death|2|||
160652003|NCT02829918|580106187|FG000|Overall Study|Withdrawal by Subject|4|||
160652004|NCT02829918|580106187|FG000|Overall Study|Adverse Event|1|||
160652005|NCT02829918|580106187|FG000|Overall Study|Progression|1|||
160652006|NCT00491504|580106190|FG000|Overall Study|Adverse Event|0|||
160652007|NCT00491504|580106191|FG001|Overall Study|Adverse Event|1|||
160652008|NCT00491504|580106192|FG002|Overall Study|Adverse Event|0|||
160652009|NCT00491504|580106193|FG003|Overall Study|Adverse Event|0|||
160652010|NCT00491504|580106190|FG000|Overall Study|Withdrawal by Subject|0|||
160652011|NCT00491504|580106191|FG001|Overall Study|Withdrawal by Subject|0|||
160652012|NCT00491504|580106192|FG002|Overall Study|Withdrawal by Subject|1|||
160652013|NCT00491504|580106193|FG003|Overall Study|Withdrawal by Subject|2|||
160652014|NCT00491504|580106190|FG000|Overall Study|Protocol Violation|0|||
160652015|NCT00491504|580106191|FG001|Overall Study|Protocol Violation|0|||
160652016|NCT00491504|580106192|FG002|Overall Study|Protocol Violation|3|||
160652017|NCT00491504|580106193|FG003|Overall Study|Protocol Violation|2|||
160652018|NCT03977584|580106194|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
160652019|NCT03977584|580106195|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
160652020|NCT03977584|580106196|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
160652021|NCT02257736|580106200|FG000|Overall Study|Progressive disease|365|||
160652022|NCT02257736|580106201|FG001|Overall Study|Progressive disease|327|||
160652023|NCT02257736|580106200|FG000|Overall Study|Adverse Event|45|||
160652024|NCT02257736|580106201|FG001|Overall Study|Adverse Event|56|||
160652025|NCT02257736|580106200|FG000|Overall Study|Withdrawal by Subject|21|||
160652026|NCT02257736|580106201|FG001|Overall Study|Withdrawal by Subject|38|||
160652027|NCT02257736|580106200|FG000|Overall Study|Death|11|||
160652028|NCT02257736|580106201|FG001|Overall Study|Death|6|||
160652029|NCT02257736|580106200|FG000|Overall Study|Physician Decision|5|||
160652030|NCT02257736|580106201|FG001|Overall Study|Physician Decision|9|||
160652031|NCT02257736|580106200|FG000|Overall Study|Non-Compliance with study drug|1|||
160652032|NCT02257736|580106201|FG001|Overall Study|Non-Compliance with study drug|2|||
160652033|NCT02257736|580106200|FG000|Overall Study|Protocol Violation|1|||
160652034|NCT02257736|580106201|FG001|Overall Study|Protocol Violation|0|||
160652035|NCT02257736|580106200|FG000|Overall Study|Other|1|||
160652036|NCT02257736|580106201|FG001|Overall Study|Other|7|||
160652037|NCT02257736|580106200|FG000|Overall Study|Randomized, not treated|1|||
160652038|NCT02257736|580106201|FG001|Overall Study|Randomized, not treated|2|||
160652039|NCT00745251|580106204|FG000|Overall Study|Adverse Event|1|||
160652040|NCT00745251|580106205|FG001|Overall Study|Adverse Event|2|||
160652041|NCT00745251|580106204|FG000|Overall Study|Withdrawal by Subject|1|||
160652042|NCT00745251|580106205|FG001|Overall Study|Withdrawal by Subject|1|||
160652043|NCT03850509|580106206|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
160652044|NCT03850509|580106207|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
160652045|NCT02666430|580106208|FG000|Period 1|Lost to Follow-up|1|||
160652046|NCT02666430|580106209|FG001|Period 1|Lost to Follow-up|0|||
160652047|NCT02666430|580106208|FG000|Period 1|Adverse Event|0|||
160652048|NCT02666430|580106209|FG001|Period 1|Adverse Event|1|||
160652049|NCT02666430|580106208|FG000|Period 2|Withdrawal by Subject|1|||
160652050|NCT02666430|580106209|FG001|Period 2|Withdrawal by Subject|4|||
160652051|NCT02666430|580106208|FG000|Period 3|Lost to Follow-up|1|||
160652052|NCT02666430|580106209|FG001|Period 3|Lost to Follow-up|0|||
160652053|NCT03828461|580106210|FG000|Overall Study|Lost to Follow-up|1|||
160652054|NCT03828461|580106210|FG000|Overall Study|Withdrawal by Subject|3|||
160652055|NCT03095352|580106215|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
160652056|NCT03095352|580106216|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
160652057|NCT01618305|580106217|FG000|Overall Study|Death|0|||
160652058|NCT01618305|580106218|FG001|Overall Study|Death|1|||
160652059|NCT01618305|580106217|FG000|Overall Study|Lost to Follow-up|11|||
160652060|NCT01618305|580106218|FG001|Overall Study|Lost to Follow-up|7|||
160652061|NCT01618305|580106217|FG000|Overall Study|Protocol Violation|1|||
160652062|NCT01618305|580106218|FG001|Overall Study|Protocol Violation|0|||
160652063|NCT01618305|580106217|FG000|Overall Study|Withdrawal by Subject|3|||
160652064|NCT01618305|580106218|FG001|Overall Study|Withdrawal by Subject|2|||
160652065|NCT01565083|580106219|FG000|Overall Study|Withdrawal by Subject|6|||
160652066|NCT01565083|580106220|FG001|Overall Study|Withdrawal by Subject|4|||
160652067|NCT01565083|580106219|FG000|Overall Study|Lost to Follow-up|2|||
160652068|NCT01565083|580106220|FG001|Overall Study|Lost to Follow-up|7|||
160652069|NCT01565083|580106219|FG000|Overall Study|Death|22|||
160652070|NCT01565083|580106220|FG001|Overall Study|Death|23|||
160652071|NCT01565083|580106219|FG000|Overall Study|Other|3|||
160652072|NCT01565083|580106220|FG001|Overall Study|Other|5|||
160652073|NCT01960816|580106221|FG000|Overall Study|Lost to Follow-up|1|||
160652074|NCT01896297|580106228|FG000|Overall Study|Died in post treatment phase|1|||
160652075|NCT00003782|580106231|FG000|Overall Study|No follow up data|30|||
160652076|NCT00003782|580106232|FG001|Overall Study|No follow up data|31|||
160652077|NCT00003782|580106233|FG002|Overall Study|No follow up data|26|||
160652078|NCT02178709|580107369|FG000|Overall Study|Adverse Event|5|||
160652079|NCT02178709|580107369|FG000|Overall Study|Death|2|||
160652080|NCT02178709|580107369|FG000|Overall Study|Withdrawal by Subject|2|||
160652081|NCT02178709|580107369|FG000|Overall Study|Physician Decision|2|||
160652082|NCT02178709|580107369|FG000|Overall Study|Disease Progression|5|||
160652083|NCT01691859|580107370|FG000|Overall Study|Adverse Event|19|||
160652084|NCT01691859|580107370|FG000|Overall Study|Lack of Efficacy|11|||
160652085|NCT01691859|580107370|FG000|Overall Study|Protocol Violation|4|||
160652086|NCT01691859|580107370|FG000|Overall Study|Product commercially available|221|||
160652087|NCT01691859|580107370|FG000|Overall Study|Study closed/terminated|50|||
160652088|NCT01691859|580107370|FG000|Overall Study|Lost to Follow-up|5|||
160652089|NCT01691859|580107370|FG000|Overall Study|Physician Decision|6|||
160652090|NCT01691859|580107370|FG000|Overall Study|Withdrawal by Subject|31|||
160652091|NCT03738332|580107371|FG000|Overall Study|Withdrawal by Subject|1|||
160652092|NCT01521559|580107372|FG000|Overall Study|Adverse Event|0|||
160652093|NCT01521559|580107373|FG001|Overall Study|Adverse Event|4|||
160652094|NCT01521559|580107372|FG000|Overall Study|Death|1|||
160652095|NCT01521559|580107373|FG001|Overall Study|Death|0|||
160652096|NCT01521559|580107372|FG000|Overall Study|Withdrawal by Subject|9|||
160652097|NCT01521559|580107373|FG001|Overall Study|Withdrawal by Subject|11|||
160652098|NCT01521559|580107372|FG000|Overall Study|Lost to Follow-up|3|||
160652099|NCT01521559|580107373|FG001|Overall Study|Lost to Follow-up|1|||
160652100|NCT01521559|580107372|FG000|Overall Study|Protocol Violation|1|||
160652101|NCT01521559|580107373|FG001|Overall Study|Protocol Violation|0|||
160652102|NCT01521559|580107372|FG000|Overall Study|Other|1|||
160652103|NCT01521559|580107373|FG001|Overall Study|Other|2|||
160652104|NCT00638157|580107386|FG000|Overall Study|Adverse Event|0|||
160652105|NCT00638157|580107387|FG001|Overall Study|Adverse Event|1|||
160652106|NCT00638157|580107386|FG000|Overall Study|Clinical (symptomatic) failure|1|||
160652107|NCT00638157|580107387|FG001|Overall Study|Clinical (symptomatic) failure|1|||
160652108|NCT00638157|580107386|FG000|Overall Study|Microbiological failure|1|||
160652109|NCT00638157|580107387|FG001|Overall Study|Microbiological failure|0|||
160652110|NCT00638157|580107386|FG000|Overall Study|Lost to Follow-up|1|||
160652111|NCT00638157|580107387|FG001|Overall Study|Lost to Follow-up|0|||
160652112|NCT00638157|580107386|FG000|Overall Study|Physician Decision|1|||
160652113|NCT00638157|580107387|FG001|Overall Study|Physician Decision|0|||
160652114|NCT00638157|580107386|FG000|Overall Study|Other|1|||
160652115|NCT00638157|580107387|FG001|Overall Study|Other|2|||
160652116|NCT00638157|580107386|FG000|Overall Study|Randomized, not treated|2|||
160652117|NCT00638157|580107387|FG001|Overall Study|Randomized, not treated|0|||
160652118|NCT02365597|580107388|FG000|Overall Study|Lost to Follow-up|0|||
160652119|NCT02365597|580107389|FG001|Overall Study|Lost to Follow-up|1|||
160652120|NCT02365597|580107390|FG002|Overall Study|Lost to Follow-up|0|||
160652121|NCT02365597|580107391|FG003|Overall Study|Lost to Follow-up|1|||
160652122|NCT02365597|580107388|FG000|Overall Study|Withdrawal by Subject|1|||
160652123|NCT02365597|580107389|FG001|Overall Study|Withdrawal by Subject|8|||
160652124|NCT02365597|580107390|FG002|Overall Study|Withdrawal by Subject|5|||
160652125|NCT02365597|580107391|FG003|Overall Study|Withdrawal by Subject|1|||
160652126|NCT02365597|580107388|FG000|Overall Study|Sponsor's decision|1|||
160652127|NCT02365597|580107389|FG001|Overall Study|Sponsor's decision|3|||
160652128|NCT02365597|580107390|FG002|Overall Study|Sponsor's decision|13|||
160652129|NCT02365597|580107391|FG003|Overall Study|Sponsor's decision|0|||
160652130|NCT02365597|580107388|FG000|Overall Study|Other|0|||
160652131|NCT02365597|580107389|FG001|Overall Study|Other|4|||
160652132|NCT02365597|580107390|FG002|Overall Study|Other|0|||
160652133|NCT02365597|580107391|FG003|Overall Study|Other|0|||
160652134|NCT02365597|580107388|FG000|Overall Study|Enrolled but not treated|0|||
160652135|NCT02365597|580107389|FG001|Overall Study|Enrolled but not treated|1|||
160652136|NCT02365597|580107390|FG002|Overall Study|Enrolled but not treated|1|||
160652137|NCT02365597|580107391|FG003|Overall Study|Enrolled but not treated|0|||
160652138|NCT02365597|580107388|FG000|Overall Study|Ongoing|0|||
160652139|NCT02365597|580107389|FG001|Overall Study|Ongoing|0|||
160652140|NCT02365597|580107390|FG002|Overall Study|Ongoing|0|||
160652141|NCT02365597|580107391|FG003|Overall Study|Ongoing|17|||
160652142|NCT04309474|580107392|FG000|Overall Study|Randomized but not treated|0|||
160652143|NCT04309474|580107393|FG001|Overall Study|Randomized but not treated|2|||
160652144|NCT04309474|580107392|FG000|Overall Study|Adverse Event|4|||
160652145|NCT04309474|580107393|FG001|Overall Study|Adverse Event|1|||
160652146|NCT04309474|580107392|FG000|Overall Study|Withdrawal by Subject|6|||
160652147|NCT04309474|580107393|FG001|Overall Study|Withdrawal by Subject|9|||
160652148|NCT04309474|580107392|FG000|Overall Study|Lost to Follow-up|1|||
160652149|NCT04309474|580107393|FG001|Overall Study|Lost to Follow-up|2|||
160652150|NCT04309474|580107392|FG000|Overall Study|Not disclosed|10|||
160652151|NCT04309474|580107393|FG001|Overall Study|Not disclosed|6|||
160652152|NCT04670068|580107394|FG000|Overall Study|Progressive Disease|1|||
160652153|NCT04670068|580107395|FG001|Overall Study|Progressive Disease|1|||
160652154|NCT04670068|580107394|FG000|Overall Study|Withdrawal by Subject|1|||
160652155|NCT04670068|580107395|FG001|Overall Study|Withdrawal by Subject|0|||
160652156|NCT00601354|580107399|FG000|Overall Study|Lost to Follow-up|4|||
160652157|NCT00601354|580107400|FG001|Overall Study|Lost to Follow-up|5|||
160652158|NCT03466411|580107401|FG000|Overall Study|Lost to Follow-up|0|||
160652159|NCT03466411|580107402|FG001|Overall Study|Lost to Follow-up|1|||
160652160|NCT03466411|580107403|FG002|Overall Study|Lost to Follow-up|1|||
160652161|NCT03466411|580107404|FG003|Overall Study|Lost to Follow-up|0|||
160652162|NCT03466411|580107405|FG004|Overall Study|Lost to Follow-up|0|||
160652163|NCT03466411|580107406|FG005|Overall Study|Lost to Follow-up|0|||
160652164|NCT03466411|580107407|FG006|Overall Study|Lost to Follow-up|1|||
160652165|NCT03466411|580107408|FG007|Overall Study|Lost to Follow-up|1|||
160652166|NCT03466411|580107409|FG008|Overall Study|Lost to Follow-up|0|||
160652167|NCT03466411|580107410|FG009|Overall Study|Lost to Follow-up|1|||
160652168|NCT03466411|580107411|FG010|Overall Study|Lost to Follow-up|1|||
160652169|NCT03466411|580107412|FG011|Overall Study|Lost to Follow-up|1|||
160652170|NCT03466411|580107413|FG012|Overall Study|Lost to Follow-up|0|||
160908760|NCT01427972|581060053|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908761|NCT01427972|581060054|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908762|NCT01427972|581060043|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908763|NCT01427972|581060044|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908764|NCT01427972|581060045|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908765|NCT01427972|581060046|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160652171|NCT03466411|580107401|FG000|Overall Study|Withdrawal by Subject|14|||
160652172|NCT03466411|580107402|FG001|Overall Study|Withdrawal by Subject|7|||
160652173|NCT03466411|580107403|FG002|Overall Study|Withdrawal by Subject|8|||
160652174|NCT03466411|580107404|FG003|Overall Study|Withdrawal by Subject|4|||
160652175|NCT03466411|580107405|FG004|Overall Study|Withdrawal by Subject|6|||
160652176|NCT03466411|580107406|FG005|Overall Study|Withdrawal by Subject|3|||
160652177|NCT03466411|580107407|FG006|Overall Study|Withdrawal by Subject|6|||
160652178|NCT03466411|580107408|FG007|Overall Study|Withdrawal by Subject|9|||
160652179|NCT03466411|580107409|FG008|Overall Study|Withdrawal by Subject|6|||
160652180|NCT03466411|580107410|FG009|Overall Study|Withdrawal by Subject|11|||
160652181|NCT03466411|580107411|FG010|Overall Study|Withdrawal by Subject|14|||
160652182|NCT03466411|580107412|FG011|Overall Study|Withdrawal by Subject|12|||
160652183|NCT03466411|580107413|FG012|Overall Study|Withdrawal by Subject|7|||
160908766|NCT01427972|581060047|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908767|NCT01427972|581060048|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
160908768|NCT01427972|581060049|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908769|NCT01427972|581060050|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908770|NCT01427972|581060051|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908771|NCT01427972|581060052|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908772|NCT01427972|581060053|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908773|NCT01427972|581060054|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908774|NCT01427972|581060043|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908775|NCT01427972|581060044|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
160908776|NCT01427972|581060045|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908777|NCT01427972|581060046|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908778|NCT01427972|581060047|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908779|NCT01427972|581060048|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908780|NCT01427972|581060049|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908781|NCT01427972|581060050|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908782|NCT01427972|581060051|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908783|NCT01427972|581060052|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908784|NCT01427972|581060053|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908785|NCT01427972|581060054|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908786|NCT04528732|581060055|FG000|Overall Study|Death|1|||
160908787|NCT04528732|581060056|FG001|Overall Study|Death|0|||
160908788|NCT04528732|581060057|FG002|Overall Study|Death|1|||
160908789|NCT04528732|581060055|FG000|Overall Study|Lost to Follow-up|0|||
160908790|NCT04528732|581060056|FG001|Overall Study|Lost to Follow-up|1|||
160908791|NCT04528732|581060057|FG002|Overall Study|Lost to Follow-up|2|||
160908792|NCT04967443|581060061|FG000|Open Label Treatment|Death|1|||
160908793|NCT04967443|581060062|FG001|Open Label Treatment|Death|0|||
160908794|NCT04967443|581060063|FG002|Open Label Treatment|Death|0|||
160652184|NCT03466411|580107401|FG000|Overall Study|Other|1|||
160652185|NCT03466411|580107402|FG001|Overall Study|Other|1|||
160652186|NCT03466411|580107403|FG002|Overall Study|Other|0|||
160652187|NCT03466411|580107404|FG003|Overall Study|Other|1|||
160652188|NCT03466411|580107405|FG004|Overall Study|Other|2|||
160652189|NCT03466411|580107406|FG005|Overall Study|Other|0|||
160652190|NCT03466411|580107407|FG006|Overall Study|Other|0|||
160652191|NCT03466411|580107408|FG007|Overall Study|Other|0|||
160652192|NCT03466411|580107409|FG008|Overall Study|Other|0|||
160652193|NCT03466411|580107410|FG009|Overall Study|Other|1|||
160652194|NCT03466411|580107411|FG010|Overall Study|Other|2|||
160652195|NCT03466411|580107412|FG011|Overall Study|Other|0|||
160652196|NCT03466411|580107413|FG012|Overall Study|Other|0|||
160652197|NCT03466411|580107401|FG000|Overall Study|Randomized but not Treated|0|||
160652198|NCT03466411|580107402|FG001|Overall Study|Randomized but not Treated|0|||
160652199|NCT03466411|580107403|FG002|Overall Study|Randomized but not Treated|0|||
160652200|NCT03466411|580107404|FG003|Overall Study|Randomized but not Treated|0|||
160652201|NCT03466411|580107405|FG004|Overall Study|Randomized but not Treated|0|||
160652202|NCT03466411|580107406|FG005|Overall Study|Randomized but not Treated|0|||
160994164|NCT01467700|581367410|FG002|Overall Study|Voluntary Withdrawal|6|||
160994165|NCT01467700|581367411|FG003|Overall Study|Voluntary Withdrawal|2|||
160994166|NCT01467700|581367408|FG000|Overall Study|Study Termination|6|||
160994167|NCT01467700|581367409|FG001|Overall Study|Study Termination|5|||
160994168|NCT01467700|581367410|FG002|Overall Study|Study Termination|10|||
160994169|NCT01467700|581367411|FG003|Overall Study|Study Termination|7|||
160994170|NCT01467700|581367408|FG000|Overall Study|Pregnancy|0|||
160994171|NCT01467700|581367409|FG001|Overall Study|Pregnancy|1|||
160994172|NCT01467700|581367410|FG002|Overall Study|Pregnancy|1|||
160994173|NCT01467700|581367411|FG003|Overall Study|Pregnancy|0|||
160994174|NCT01467700|581367408|FG000|Overall Study|Lack of Efficacy|2|||
160994175|NCT01467700|581367409|FG001|Overall Study|Lack of Efficacy|0|||
160994176|NCT01467700|581367410|FG002|Overall Study|Lack of Efficacy|2|||
160994177|NCT01467700|581367411|FG003|Overall Study|Lack of Efficacy|1|||
160994178|NCT01467700|581367408|FG000|Overall Study|Reason not Specified|1|||
160994179|NCT01467700|581367409|FG001|Overall Study|Reason not Specified|3|||
160994180|NCT01467700|581367410|FG002|Overall Study|Reason not Specified|2|||
160994181|NCT01467700|581367411|FG003|Overall Study|Reason not Specified|8|||
160994182|NCT00121199|581367412|FG000|Overall Study|Adverse Event|11|||
160994183|NCT00121199|581367412|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
160994184|NCT00121199|581367412|FG000|Overall Study|Progression/Relapse|1|||
160994185|NCT00121199|581367412|FG000|Overall Study|Death|3|||
160994186|NCT00121199|581367412|FG000|Overall Study|Other - Not Protocol Specified|3|||
160994187|NCT00121199|581367412|FG000|Overall Study|Ineligible|9|||
160994188|NCT03168438|581367413|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
160994189|NCT03168438|581367414|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
160994190|NCT04109118|581367417|FG000|Overall Study|Lost to Follow-up|3|||
160994191|NCT03235349|581367420|FG000|Overall Study|Adverse Event|1|||
160994192|NCT03235349|581367420|FG000|Overall Study|Other|1|||
160994193|NCT03394027|581367421|FG000|Overall Study|Ineligible|3|||
160994194|NCT03394027|581367422|FG001|Overall Study|Ineligible|1|||
160994195|NCT03394027|581367423|FG002|Overall Study|Ineligible|3|||
160994196|NCT03394027|581367421|FG000|Overall Study|Participant declined to participate before treatment started|0|||
160994197|NCT03394027|581367422|FG001|Overall Study|Participant declined to participate before treatment started|0|||
160994198|NCT03394027|581367423|FG002|Overall Study|Participant declined to participate before treatment started|1|||
160994199|NCT05663866|581367430|FG000|Overall Study|Adverse Event|0|||
160994200|NCT05663866|581367431|FG001|Overall Study|Adverse Event|0|||
160994201|NCT05663866|581367432|FG002|Overall Study|Adverse Event|1|||
160994202|NCT05663866|581367433|FG003|Overall Study|Adverse Event|0|||
160994203|NCT05663866|581367430|FG000|Overall Study|Physician Decision|0|||
160994204|NCT05663866|581367431|FG001|Overall Study|Physician Decision|0|||
160994205|NCT05663866|581367432|FG002|Overall Study|Physician Decision|0|||
160994206|NCT05663866|581367433|FG003|Overall Study|Physician Decision|1|||
160994207|NCT05663866|581367430|FG000|Overall Study|Withdrawal by Subject|0|||
160994208|NCT05663866|581367431|FG001|Overall Study|Withdrawal by Subject|2|||
160994209|NCT05663866|581367432|FG002|Overall Study|Withdrawal by Subject|1|||
160994210|NCT05663866|581367433|FG003|Overall Study|Withdrawal by Subject|2|||
160994211|NCT05663866|581367430|FG000|Overall Study|Progressive disease|4|||
160994212|NCT05663866|581367431|FG001|Overall Study|Progressive disease|8|||
160994213|NCT05663866|581367432|FG002|Overall Study|Progressive disease|5|||
160994214|NCT05663866|581367433|FG003|Overall Study|Progressive disease|2|||
160652203|NCT03466411|580107407|FG006|Overall Study|Randomized but not Treated|1|||
160652204|NCT03466411|580107408|FG007|Overall Study|Randomized but not Treated|0|||
160652205|NCT03466411|580107409|FG008|Overall Study|Randomized but not Treated|0|||
160994215|NCT05663866|581367430|FG000|Overall Study|Other|1|||
160994216|NCT05663866|581367431|FG001|Overall Study|Other|0|||
160994217|NCT05663866|581367432|FG002|Overall Study|Other|0|||
160652206|NCT03466411|580107410|FG009|Overall Study|Randomized but not Treated|0|||
160652207|NCT03466411|580107411|FG010|Overall Study|Randomized but not Treated|0|||
160652208|NCT03466411|580107412|FG011|Overall Study|Randomized but not Treated|0|||
160994218|NCT05663866|581367433|FG003|Overall Study|Other|0|||
160994219|NCT05663866|581367430|FG000|Overall Study|Ongoing|1|||
160994220|NCT05663866|581367431|FG001|Overall Study|Ongoing|27|||
160994221|NCT05663866|581367432|FG002|Overall Study|Ongoing|6|||
160994222|NCT05663866|581367433|FG003|Overall Study|Ongoing|1|||
160994223|NCT05803720|581367434|FG000|Overall Study|Lost to Follow-up|3|||
160994224|NCT05803720|581367435|FG001|Overall Study|Lost to Follow-up|4|||
160994225|NCT05803720|581367434|FG000|Overall Study|Family leave/emergency|1|||
160994226|NCT05803720|581367435|FG001|Overall Study|Family leave/emergency|1|||
160994227|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
160994228|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
160994229|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
160994230|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
160994231|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
160994232|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
160994233|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
160994234|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
160994235|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
160994236|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
160994237|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
160994238|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
160994239|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
160994240|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
160994241|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
160994242|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
160994243|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
160994244|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
160994245|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
160994246|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
160994247|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
160994248|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160994249|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160569943|NCT03519178|579809244|FG011|Fulvestrant. Treatment|Other|0|||
160994250|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160994251|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160994252|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160994253|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160994254|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
160994255|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
160994256|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
160994257|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994258|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994259|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994260|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994261|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994262|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994263|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
160994264|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
160569944|NCT03519178|579809245|FG012|Fulvestrant. Treatment|Other|0|||
160569945|NCT03519178|579809246|FG013|Fulvestrant. Treatment|Other|1|||
160569946|NCT03519178|579809247|FG014|Fulvestrant. Treatment|Other|3|||
160569947|NCT03519178|579809233|FG000|Letrozole Treatment|Physician Decision|0|||
160569948|NCT03519178|579809234|FG001|Letrozole Treatment|Physician Decision|0|||
160569949|NCT03519178|579809235|FG002|Letrozole Treatment|Physician Decision|0|||
160569950|NCT03519178|579809236|FG003|Letrozole Treatment|Physician Decision|0|||
160569951|NCT03519178|579809237|FG004|Letrozole Treatment|Physician Decision|0|||
160569952|NCT03519178|579809238|FG005|Letrozole Treatment|Physician Decision|0|||
160569953|NCT03519178|579809239|FG006|Letrozole Treatment|Physician Decision|0|||
160569954|NCT03519178|579809240|FG007|Letrozole Treatment|Physician Decision|0|||
160569955|NCT03519178|579809241|FG008|Letrozole Treatment|Physician Decision|0|||
160569956|NCT03519178|579809242|FG009|Letrozole Treatment|Physician Decision|0|||
160569957|NCT03519178|579809243|FG010|Letrozole Treatment|Physician Decision|1|||
160569958|NCT03519178|579809244|FG011|Letrozole Treatment|Physician Decision|0|||
160569959|NCT03519178|579809245|FG012|Letrozole Treatment|Physician Decision|0|||
160569960|NCT03519178|579809246|FG013|Letrozole Treatment|Physician Decision|0|||
160569961|NCT03519178|579809247|FG014|Letrozole Treatment|Physician Decision|0|||
160569962|NCT03519178|579809233|FG000|Letrozole Treatment|Progressive disease|0|||
160569963|NCT03519178|579809234|FG001|Letrozole Treatment|Progressive disease|0|||
160569964|NCT03519178|579809235|FG002|Letrozole Treatment|Progressive disease|0|||
160569965|NCT03519178|579809236|FG003|Letrozole Treatment|Progressive disease|0|||
160569966|NCT03519178|579809237|FG004|Letrozole Treatment|Progressive disease|0|||
160569967|NCT03519178|579809238|FG005|Letrozole Treatment|Progressive disease|0|||
160569968|NCT03519178|579809239|FG006|Letrozole Treatment|Progressive disease|0|||
160569969|NCT03519178|579809240|FG007|Letrozole Treatment|Progressive disease|0|||
160994265|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
160569970|NCT03519178|579809241|FG008|Letrozole Treatment|Progressive disease|0|||
160569971|NCT03519178|579809242|FG009|Letrozole Treatment|Progressive disease|0|||
160569972|NCT03519178|579809243|FG010|Letrozole Treatment|Progressive disease|4|||
160857481|NCT03473236|580868957|FG006|Overall Study|Withdrawal by Subject|0|||
160857482|NCT03473236|580868958|FG007|Overall Study|Withdrawal by Subject|0|||
160857483|NCT03473236|580868959|FG008|Overall Study|Withdrawal by Subject|1|||
160857484|NCT03473236|580868960|FG009|Overall Study|Withdrawal by Subject|0|||
160857485|NCT04264442|580868961|FG000|Overall Study|Lack of Efficacy|6|||
160857486|NCT04264442|580868961|FG000|Overall Study|Lost to Follow-up|2|||
160857487|NCT04264442|580868961|FG000|Overall Study|Sponsor Decision|23|||
160857488|NCT04264442|580868961|FG000|Overall Study|Withdrawal by Subject|11|||
160857489|NCT04264442|580868961|FG000|Overall Study|Study Termination|5|||
160857490|NCT03062358|580868964|FG000|Overall Study|Death|269|||
160857491|NCT03062358|580868965|FG001|Overall Study|Death|145|||
160857492|NCT03062358|580868964|FG000|Overall Study|Withdrawal by Subject|2|||
160857493|NCT03062358|580868965|FG001|Overall Study|Withdrawal by Subject|1|||
160857494|NCT03062358|580868964|FG000|Overall Study|Sponsor Decision|29|||
160857495|NCT03062358|580868965|FG001|Overall Study|Sponsor Decision|7|||
160857496|NCT00880698|580868966|FG000|Overall Study|Death|0|||
160857497|NCT00880698|580868967|FG001|Overall Study|Death|0|||
160857498|NCT00880698|580868968|FG002|Overall Study|Death|1|||
160857499|NCT00880698|580868969|FG003|Overall Study|Death|2|||
160857500|NCT00880698|580868966|FG000|Overall Study|Lost to Follow-up|1|||
160857501|NCT00880698|580868967|FG001|Overall Study|Lost to Follow-up|3|||
160857502|NCT00880698|580868968|FG002|Overall Study|Lost to Follow-up|0|||
160857503|NCT00880698|580868969|FG003|Overall Study|Lost to Follow-up|1|||
160857504|NCT01766050|580870859|FG000|Overall Study|Adverse Event|1|||
160857505|NCT01766050|580870859|FG000|Overall Study|Lost to Follow-up|1|||
160857506|NCT01766050|580870859|FG000|Overall Study|Withdrawal by Subject|2|||
160857507|NCT01097668|580870860|FG000|Overall Study|Withdrawal by Subject|1|||
160857508|NCT01097668|580870861|FG001|Overall Study|Withdrawal by Subject|2|||
160857509|NCT01097668|580870860|FG000|Overall Study|Lost to Follow-up|1|||
160857510|NCT01097668|580870861|FG001|Overall Study|Lost to Follow-up|0|||
160857511|NCT00812708|580870862|FG000|Overall Study|Device could not be implanted|2|||
160908795|NCT04967443|581060064|FG003|Open Label Treatment|Death|0|||
160908796|NCT04967443|581060065|FG004|Open Label Treatment|Death|0|||
160908797|NCT04967443|581060066|FG005|Open Label Treatment|Death|0|||
160908798|NCT04967443|581060067|FG006|Open Label Treatment|Death|0|||
160908799|NCT04967443|581060068|FG007|Open Label Treatment|Death|0|||
160908800|NCT04967443|581060061|FG000|Open Label Treatment|Lost to Follow-up|0|||
160908801|NCT04967443|581060062|FG001|Open Label Treatment|Lost to Follow-up|0|||
160908802|NCT04967443|581060063|FG002|Open Label Treatment|Lost to Follow-up|1|||
160908803|NCT04967443|581060064|FG003|Open Label Treatment|Lost to Follow-up|0|||
160908804|NCT04967443|581060065|FG004|Open Label Treatment|Lost to Follow-up|0|||
160908805|NCT04967443|581060066|FG005|Open Label Treatment|Lost to Follow-up|0|||
160908806|NCT04967443|581060067|FG006|Open Label Treatment|Lost to Follow-up|0|||
160908807|NCT04967443|581060068|FG007|Open Label Treatment|Lost to Follow-up|0|||
160908808|NCT04967443|581060061|FG000|Open Label Treatment|Withdrawal by Subject|0|||
160908809|NCT04967443|581060062|FG001|Open Label Treatment|Withdrawal by Subject|1|||
160908810|NCT04967443|581060063|FG002|Open Label Treatment|Withdrawal by Subject|0|||
160908811|NCT04967443|581060064|FG003|Open Label Treatment|Withdrawal by Subject|1|||
160994266|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
160569973|NCT03519178|579809244|FG011|Letrozole Treatment|Progressive disease|0|||
160857512|NCT00812708|580870862|FG000|Overall Study|Lack of medical insurance|1|||
160857513|NCT00812708|580870862|FG000|Overall Study|Switched to another study|1|||
160857514|NCT00812708|580870862|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
160857515|NCT00812708|580870862|FG000|Overall Study|Signed consent but later withdrew|3|||
160857516|NCT01021020|580870864|FG000|Period I|Protocol Violation|1|||
160857517|NCT01021020|580870864|FG000|Period I|Withdrawal by Subject|1|||
160857518|NCT01021020|580870864|FG000|14 Day Washout Period A|Physician Decision|1|||
160857519|NCT00948246|580870865|FG000|Overall Study|Lost to Follow-up|11|||
160857520|NCT00948246|580870865|FG000|Overall Study|Adverse Event|11|||
160857521|NCT00948246|580870865|FG000|Overall Study|Death|1|||
160857522|NCT00948246|580870865|FG000|Overall Study|Withdrawal by Subject|1|||
160569974|NCT03519178|579809245|FG012|Letrozole Treatment|Progressive disease|0|||
160569975|NCT03519178|579809246|FG013|Letrozole Treatment|Progressive disease|0|||
160569976|NCT03519178|579809247|FG014|Letrozole Treatment|Progressive disease|0|||
160569977|NCT03519178|579809233|FG000|Letrozole Treatment|Global deterioration of health status|0|||
160857523|NCT01706458|580870868|FG000|Overall Study|Physician Decision|3|||
160857524|NCT01706458|580870869|FG001|Overall Study|Physician Decision|4|||
160857525|NCT03547518|580870873|FG000|Overall Study|Lost to Follow-up|2|||
160857526|NCT03547518|580870874|FG001|Overall Study|Lost to Follow-up|0|||
160857527|NCT02766023|580870876|FG000|Overall Study|Lost to Follow-up|23|||
160857528|NCT02766023|580870877|FG001|Overall Study|Lost to Follow-up|11|||
160857529|NCT02766023|580870876|FG000|Overall Study|Pregnancy|1|||
160857530|NCT02766023|580870877|FG001|Overall Study|Pregnancy|0|||
160857531|NCT02766023|580870876|FG000|Overall Study|Adverse Event|1|||
160857532|NCT02766023|580870877|FG001|Overall Study|Adverse Event|0|||
160908812|NCT04967443|581060065|FG004|Open Label Treatment|Withdrawal by Subject|0|||
160908813|NCT04967443|581060066|FG005|Open Label Treatment|Withdrawal by Subject|1|||
160857533|NCT02766023|580870876|FG000|Overall Study|Withdrawal by Subject|4|||
160857534|NCT02766023|580870877|FG001|Overall Study|Withdrawal by Subject|5|||
160857535|NCT02766023|580870876|FG000|Overall Study|Physician Decision|1|||
160857536|NCT02766023|580870877|FG001|Overall Study|Physician Decision|0|||
160857537|NCT02766023|580870876|FG000|Overall Study|Not Eligible at Enrollment|0|||
160857538|NCT02766023|580870877|FG001|Overall Study|Not Eligible at Enrollment|1|||
160857539|NCT00286468|580870878|FG000|Overall Study|Hyperglycemic Rescue|28|||
160857540|NCT00286468|580870879|FG001|Overall Study|Hyperglycemic Rescue|30|||
160857541|NCT00286468|580870880|FG002|Overall Study|Hyperglycemic Rescue|31|||
160857542|NCT00286468|580870878|FG000|Overall Study|Adverse Event|2|||
160857543|NCT00286468|580870879|FG001|Overall Study|Adverse Event|6|||
160857544|NCT00286468|580870880|FG002|Overall Study|Adverse Event|4|||
160857545|NCT00286468|580870878|FG000|Overall Study|Protocol Violation|0|||
160857546|NCT00286468|580870879|FG001|Overall Study|Protocol Violation|3|||
160857547|NCT00286468|580870880|FG002|Overall Study|Protocol Violation|1|||
160857548|NCT00286468|580870878|FG000|Overall Study|Lost to Follow-up|1|||
160857549|NCT00286468|580870879|FG001|Overall Study|Lost to Follow-up|1|||
160857550|NCT00286468|580870880|FG002|Overall Study|Lost to Follow-up|2|||
160857551|NCT00286468|580870878|FG000|Overall Study|Withdrawal by Subject|3|||
160857552|NCT00286468|580870879|FG001|Overall Study|Withdrawal by Subject|8|||
160857553|NCT00286468|580870880|FG002|Overall Study|Withdrawal by Subject|11|||
160857554|NCT00286468|580870878|FG000|Overall Study|Physician Decision|3|||
160857555|NCT00286468|580870879|FG001|Overall Study|Physician Decision|2|||
160857556|NCT00286468|580870880|FG002|Overall Study|Physician Decision|1|||
160857557|NCT02953652|580870881|FG000|Overall Study|Adverse Event|18|||
160857558|NCT02953652|580870881|FG000|Overall Study|Withdrawal by Subject|6|||
160857559|NCT02953652|580870881|FG000|Overall Study|Protocol Violation|1|||
160857560|NCT02953652|580870881|FG000|Overall Study|Disease Progression|27|||
160857561|NCT02384551|580870885|FG000|Overall Study|Lost to Follow-up|13|||
160857562|NCT02384551|580870886|FG001|Overall Study|Lost to Follow-up|14|||
160857563|NCT02384551|580870887|FG002|Overall Study|Lost to Follow-up|14|||
160857564|NCT02384551|580870888|FG003|Overall Study|Lost to Follow-up|14|||
160857565|NCT04742556|580870893|FG000|Overall Study|Withdrawal by Subject|0|||
160857566|NCT04742556|580870894|FG001|Overall Study|Withdrawal by Subject|1|||
160857567|NCT04742556|580870895|FG002|Overall Study|Withdrawal by Subject|0|||
160994267|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
160994268|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
160994269|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
160994270|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
160571911|NCT01743027|579816864|FG003|Overall Study|Protocol Violation|0|||
160571912|NCT01743027|579816861|FG000|Overall Study|Withdrawal by Subject|1|||
160571913|NCT01743027|579816862|FG001|Overall Study|Withdrawal by Subject|0|||
160571914|NCT01743027|579816863|FG002|Overall Study|Withdrawal by Subject|3|||
160571915|NCT01743027|579816864|FG003|Overall Study|Withdrawal by Subject|1|||
160571916|NCT00450866|579816865|FG000|Overall Study|Adverse Event|0|||
160571917|NCT00450866|579816866|FG001|Overall Study|Adverse Event|1|||
160571918|NCT00450866|579816865|FG000|Overall Study|Withdrawal by Subject|5|||
160571919|NCT00450866|579816866|FG001|Overall Study|Withdrawal by Subject|2|||
160571920|NCT00450866|579816865|FG000|Overall Study|Death|1|||
160571921|NCT00450866|579816866|FG001|Overall Study|Death|0|||
160571922|NCT00450866|579816865|FG000|Overall Study|Physician Decision|1|||
160571923|NCT00450866|579816866|FG001|Overall Study|Physician Decision|0|||
160571924|NCT04925570|579816869|FG000|Overall Study|Protocol Violation|24|||
160571925|NCT04925570|579816870|FG001|Overall Study|Protocol Violation|30|||
160571926|NCT04925570|579816869|FG000|Overall Study|Withdrawal by Subject|0|||
160571927|NCT04925570|579816870|FG001|Overall Study|Withdrawal by Subject|2|||
160571928|NCT03494725|579816873|FG000|Overall Study|Withdrawal by Subject|0|||
160571929|NCT03494725|579816874|FG001|Overall Study|Withdrawal by Subject|2|||
160571930|NCT03494725|579816873|FG000|Overall Study|Antibiotic use|1|||
160571931|NCT03494725|579816874|FG001|Overall Study|Antibiotic use|0|||
160571932|NCT02619253|579816875|FG000|Overall Study|Adverse Event|0|||
160571933|NCT02619253|579816876|FG001|Overall Study|Adverse Event|0|||
160571934|NCT02619253|579816877|FG002|Overall Study|Adverse Event|1|||
160571935|NCT02619253|579816878|FG003|Overall Study|Adverse Event|1|||
160571936|NCT02619253|579816879|FG004|Overall Study|Adverse Event|3|||
160571937|NCT02619253|579816875|FG000|Overall Study|Alternative Therapy|0|||
160571938|NCT02619253|579816876|FG001|Overall Study|Alternative Therapy|0|||
160571939|NCT02619253|579816877|FG002|Overall Study|Alternative Therapy|1|||
160571940|NCT02619253|579816878|FG003|Overall Study|Alternative Therapy|0|||
160571941|NCT02619253|579816879|FG004|Overall Study|Alternative Therapy|0|||
160571942|NCT02619253|579816875|FG000|Overall Study|Death|0|||
160571943|NCT02619253|579816876|FG001|Overall Study|Death|0|||
160571944|NCT02619253|579816877|FG002|Overall Study|Death|0|||
160571945|NCT02619253|579816878|FG003|Overall Study|Death|1|||
160571946|NCT02619253|579816879|FG004|Overall Study|Death|0|||
160857568|NCT04742556|580870893|FG000|Overall Study|Adverse Event|0|||
160857569|NCT04742556|580870894|FG001|Overall Study|Adverse Event|0|||
160857570|NCT04742556|580870895|FG002|Overall Study|Adverse Event|2|||
160857571|NCT04742556|580870893|FG000|Overall Study|Clinical disease progression|0|||
160857572|NCT04742556|580870894|FG001|Overall Study|Clinical disease progression|1|||
160857573|NCT04742556|580870895|FG002|Overall Study|Clinical disease progression|2|||
160857574|NCT04742556|580870893|FG000|Overall Study|Objective disease progression|3|||
160857575|NCT04742556|580870894|FG001|Overall Study|Objective disease progression|2|||
160857576|NCT04742556|580870895|FG002|Overall Study|Objective disease progression|4|||
160857577|NCT04247347|580870896|FG000|Overall Study|Withdrawal by Subject|2|||
160857578|NCT04247347|580870897|FG001|Overall Study|Withdrawal by Subject|3|||
160857579|NCT04247347|580870898|FG002|Overall Study|Withdrawal by Subject|3|||
160857580|NCT04247347|580870896|FG000|Overall Study|Lost to Follow-up|1|||
160857581|NCT04247347|580870897|FG001|Overall Study|Lost to Follow-up|1|||
160857582|NCT04247347|580870898|FG002|Overall Study|Lost to Follow-up|1|||
160857583|NCT03035032|580870899|FG000|Overall Study|Adverse Event|2|||
160857584|NCT03035032|580870899|FG000|Overall Study|Death|9|||
160857585|NCT03035032|580870899|FG000|Overall Study|Lost to Follow-up|1|||
160857586|NCT03035032|580870899|FG000|Overall Study|Progressive Disease|22|||
160857587|NCT03035032|580870899|FG000|Overall Study|Protocol Violation|2|||
160857588|NCT03035032|580870899|FG000|Overall Study|Withdrawal by Subject|2|||
160857589|NCT03035032|580870899|FG000|Overall Study|Physician Decision|5|||
160857590|NCT03562195|580870900|FG000|Overall Study|Adverse Event|0|||
160857591|NCT03562195|580870901|FG001|Overall Study|Adverse Event|6|||
160857592|NCT03562195|580870900|FG000|Overall Study|Lack of Efficacy|0|||
160857593|NCT03562195|580870901|FG001|Overall Study|Lack of Efficacy|5|||
160857594|NCT03562195|580870900|FG000|Overall Study|Protocol Violation|0|||
160857595|NCT03562195|580870901|FG001|Overall Study|Protocol Violation|1|||
160857596|NCT03562195|580870900|FG000|Overall Study|Lost to Follow-up|0|||
160857597|NCT03562195|580870901|FG001|Overall Study|Lost to Follow-up|1|||
160857598|NCT03562195|580870900|FG000|Overall Study|Physician Decision|1|||
160857599|NCT03562195|580870901|FG001|Overall Study|Physician Decision|0|||
160857600|NCT03562195|580870900|FG000|Overall Study|Withdrawal by Subject|3|||
160857601|NCT03562195|580870901|FG001|Overall Study|Withdrawal by Subject|0|||
160857602|NCT02923726|580870902|FG000|Overall Study|Death|196|||
160857603|NCT02923726|580870903|FG001|Overall Study|Death|175|||
160857604|NCT02923726|580870902|FG000|Overall Study|Withdrawal by Subject|337|||
160857605|NCT02923726|580870903|FG001|Overall Study|Withdrawal by Subject|307|||
160857606|NCT01176032|580870916|FG000|Overall Study|Adverse Event|1|||
160857607|NCT01176032|580870917|FG001|Overall Study|Adverse Event|0|||
160857608|NCT01176032|580870916|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160857609|NCT01176032|580870917|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160857610|NCT01176032|580870916|FG000|Overall Study|Protocol Violation|1|||
160857611|NCT01176032|580870917|FG001|Overall Study|Protocol Violation|0|||
160857612|NCT01176032|580870916|FG000|Overall Study|Informed consent withdrawn|3|||
160857613|NCT01176032|580870917|FG001|Overall Study|Informed consent withdrawn|0|||
160857614|NCT01176032|580870916|FG000|Overall Study|Other|1|||
160857615|NCT01176032|580870917|FG001|Overall Study|Other|0|||
160857616|NCT01469221|580870918|FG000|Double Blind Phase|Protocol Violation|1|||
160857617|NCT01469221|580870919|FG001|Double Blind Phase|Protocol Violation|0|||
160857618|NCT01469221|580870920|FG002|Double Blind Phase|Protocol Violation|0|||
160857619|NCT01469221|580870918|FG000|Double Blind Phase|Physician Decision|1|||
160857620|NCT01469221|580870919|FG001|Double Blind Phase|Physician Decision|1|||
160857621|NCT01469221|580870920|FG002|Double Blind Phase|Physician Decision|0|||
160857622|NCT01469221|580870918|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
160857623|NCT01469221|580870919|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
160857624|NCT01469221|580870920|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
160857625|NCT04038359|580870922|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
160857626|NCT04038359|580870923|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
160857627|NCT04038359|580870922|FG000|Overall Study|Death|8|||
160857628|NCT04038359|580870923|FG001|Overall Study|Death|7|||
160857629|NCT04038359|580870922|FG000|Overall Study|Lost to Follow-up|3|||
160857630|NCT04038359|580870923|FG001|Overall Study|Lost to Follow-up|0|||
160857631|NCT04038359|580870922|FG000|Overall Study|Participant Moved|1|||
160857632|NCT04038359|580870923|FG001|Overall Study|Participant Moved|0|||
160857633|NCT04038359|580870922|FG000|Overall Study|Withdrawal by Subject|4|||
160857634|NCT04038359|580870923|FG001|Overall Study|Withdrawal by Subject|3|||
160857635|NCT04038359|580870922|FG000|Overall Study|Physician Decision|3|||
160857636|NCT04038359|580870923|FG001|Overall Study|Physician Decision|2|||
160857637|NCT04038359|580870922|FG000|Overall Study|Adverse Event|0|||
160857638|NCT04038359|580870923|FG001|Overall Study|Adverse Event|2|||
160857639|NCT04038359|580870922|FG000|Overall Study|Progressive Disease|0|||
160857640|NCT04038359|580870923|FG001|Overall Study|Progressive Disease|1|||
160857641|NCT00475670|580870924|FG000|Overall Study|Death|0|||
160857642|NCT00475670|580870925|FG001|Overall Study|Death|1|||
160857643|NCT00475670|580870924|FG000|Overall Study|Lack of Efficacy|3|||
160857644|NCT00475670|580870925|FG001|Overall Study|Lack of Efficacy|34|||
160857645|NCT00475670|580870924|FG000|Overall Study|Refused treatment|0|||
160857646|NCT00475670|580870925|FG001|Overall Study|Refused treatment|2|||
160857647|NCT00475670|580870924|FG000|Overall Study|Failure to Return|0|||
160857648|NCT00475670|580870925|FG001|Overall Study|Failure to Return|1|||
160857649|NCT00475670|580870924|FG000|Overall Study|Other|0|||
160857650|NCT00475670|580870925|FG001|Overall Study|Other|3|||
160857651|NCT01168349|580870926|FG000|Overall Study|Death|157|||
160857652|NCT01168349|580870926|FG000|Overall Study|Lost to Follow-up|34|||
160857653|NCT01168349|580870926|FG000|Overall Study|Withdrawal by Subject|9|||
160857654|NCT01168349|580870926|FG000|Overall Study|Kidney transplantation|3|||
160857655|NCT01168349|580870926|FG000|Overall Study|Other|22|||
160857656|NCT01168349|580870926|FG000|Overall Study|Protocol Violation|76|||
160857657|NCT01033240|580870927|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
160857658|NCT01033240|580870928|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
160857659|NCT01033240|580870929|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
160857660|NCT01033240|580870927|FG000|Overall Study|Death|2|||
160857661|NCT01033240|580870928|FG001|Overall Study|Death|0|||
160857662|NCT01033240|580870929|FG002|Overall Study|Death|0|||
160857663|NCT01033240|580870927|FG000|Overall Study|Withdrew Consent|2|||
160857664|NCT01033240|580870928|FG001|Overall Study|Withdrew Consent|9|||
160857665|NCT01033240|580870929|FG002|Overall Study|Withdrew Consent|2|||
160857666|NCT01033240|580870927|FG000|Overall Study|Disease Progression|35|||
160857667|NCT01033240|580870928|FG001|Overall Study|Disease Progression|32|||
160857668|NCT01033240|580870929|FG002|Overall Study|Disease Progression|41|||
160857669|NCT01033240|580870927|FG000|Overall Study|Investigator Discretion|0|||
160857670|NCT01033240|580870928|FG001|Overall Study|Investigator Discretion|0|||
160857671|NCT01033240|580870929|FG002|Overall Study|Investigator Discretion|2|||
160857672|NCT01033240|580870927|FG000|Overall Study|Other|0|||
160857673|NCT01033240|580870928|FG001|Overall Study|Other|1|||
160857674|NCT01033240|580870929|FG002|Overall Study|Other|2|||
160857675|NCT00918385|580870933|FG000|Monotherapy|Adverse Event|1|||
160569978|NCT03519178|579809234|FG001|Letrozole Treatment|Global deterioration of health status|0|||
160569979|NCT03519178|579809235|FG002|Letrozole Treatment|Global deterioration of health status|0|||
160569980|NCT03519178|579809236|FG003|Letrozole Treatment|Global deterioration of health status|0|||
160569981|NCT03519178|579809237|FG004|Letrozole Treatment|Global deterioration of health status|0|||
160569982|NCT03519178|579809238|FG005|Letrozole Treatment|Global deterioration of health status|0|||
160569983|NCT03519178|579809239|FG006|Letrozole Treatment|Global deterioration of health status|0|||
160569984|NCT03519178|579809240|FG007|Letrozole Treatment|Global deterioration of health status|0|||
160569985|NCT03519178|579809241|FG008|Letrozole Treatment|Global deterioration of health status|0|||
160569986|NCT03519178|579809242|FG009|Letrozole Treatment|Global deterioration of health status|0|||
160569987|NCT03519178|579809243|FG010|Letrozole Treatment|Global deterioration of health status|2|||
160569988|NCT03519178|579809244|FG011|Letrozole Treatment|Global deterioration of health status|0|||
160569989|NCT03519178|579809245|FG012|Letrozole Treatment|Global deterioration of health status|0|||
160569990|NCT03519178|579809246|FG013|Letrozole Treatment|Global deterioration of health status|0|||
160569991|NCT03519178|579809247|FG014|Letrozole Treatment|Global deterioration of health status|0|||
160569992|NCT03519178|579809233|FG000|Follow-Up|Death|0|||
160569993|NCT03519178|579809234|FG001|Follow-Up|Death|0|||
160569994|NCT03519178|579809235|FG002|Follow-Up|Death|0|||
160569995|NCT03519178|579809236|FG003|Follow-Up|Death|0|||
160569996|NCT03519178|579809237|FG004|Follow-Up|Death|0|||
160569997|NCT03519178|579809238|FG005|Follow-Up|Death|0|||
160569998|NCT03519178|579809239|FG006|Follow-Up|Death|0|||
160569999|NCT03519178|579809240|FG007|Follow-Up|Death|0|||
160570000|NCT03519178|579809241|FG008|Follow-Up|Death|3|||
160570001|NCT03519178|579809242|FG009|Follow-Up|Death|1|||
160570002|NCT03519178|579809243|FG010|Follow-Up|Death|0|||
160570003|NCT03519178|579809244|FG011|Follow-Up|Death|0|||
160570004|NCT03519178|579809245|FG012|Follow-Up|Death|2|||
160570005|NCT03519178|579809246|FG013|Follow-Up|Death|0|||
160570006|NCT03519178|579809247|FG014|Follow-Up|Death|0|||
160570007|NCT03519178|579809233|FG000|Follow-Up|Lost to Follow-up|0|||
160570008|NCT03519178|579809234|FG001|Follow-Up|Lost to Follow-up|0|||
160570009|NCT03519178|579809235|FG002|Follow-Up|Lost to Follow-up|0|||
160570010|NCT03519178|579809236|FG003|Follow-Up|Lost to Follow-up|0|||
160570011|NCT03519178|579809237|FG004|Follow-Up|Lost to Follow-up|0|||
160570012|NCT03519178|579809238|FG005|Follow-Up|Lost to Follow-up|3|||
160570013|NCT03519178|579809239|FG006|Follow-Up|Lost to Follow-up|1|||
160570014|NCT03519178|579809240|FG007|Follow-Up|Lost to Follow-up|4|||
160570015|NCT03519178|579809241|FG008|Follow-Up|Lost to Follow-up|1|||
160570016|NCT03519178|579809242|FG009|Follow-Up|Lost to Follow-up|0|||
160570017|NCT03519178|579809243|FG010|Follow-Up|Lost to Follow-up|0|||
160570018|NCT03519178|579809244|FG011|Follow-Up|Lost to Follow-up|0|||
160652209|NCT03466411|580107413|FG012|Overall Study|Randomized but not Treated|0|||
160857676|NCT00918385|580870934|FG001|Monotherapy|Adverse Event|6|||
160857677|NCT00918385|580870933|FG000|Monotherapy|Complicating illness|1|||
160857678|NCT00918385|580870934|FG001|Monotherapy|Complicating illness|0|||
160857679|NCT00918385|580870933|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
160857680|NCT00918385|580870934|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
160857681|NCT00918385|580870933|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
160857682|NCT00918385|580870934|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
160857683|NCT00918385|580870933|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
160857684|NCT00918385|580870934|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
160857685|NCT00918385|580870933|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
160857686|NCT00918385|580870934|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
160857687|NCT01476722|580870937|FG000|Overall Study|Adverse Event|1|||
160857688|NCT02978417|580870941|FG000|Overall Study|Lost to Follow-up|2|||
160857689|NCT02978417|580870942|FG001|Overall Study|Lost to Follow-up|2|||
160857690|NCT02675907|580870945|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
160857691|NCT02675907|580870946|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
160857692|NCT02675907|580870945|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
160857693|NCT02675907|580870946|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
160857694|NCT02675907|580870945|FG000|Study Overall|Lack of Efficacy|1|||
160857695|NCT02675907|580870946|FG001|Study Overall|Lack of Efficacy|0|||
160857696|NCT02675907|580870945|FG000|Study Overall|Withdrawal by Subject|2|||
160857697|NCT02675907|580870946|FG001|Study Overall|Withdrawal by Subject|2|||
160857698|NCT02675907|580870945|FG000|Study Overall|Lost to Follow-up|0|||
160857699|NCT02675907|580870946|FG001|Study Overall|Lost to Follow-up|2|||
160857700|NCT01323582|580870947|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
160857701|NCT01323582|580870948|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
160857702|NCT01323582|580870947|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
160652210|NCT00319956|580107414|FG000|Overall Study|Death|20|||
160857703|NCT01323582|580870948|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
160857704|NCT01323582|580870947|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
160857705|NCT01323582|580870948|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
160857706|NCT00168844|580870949|FG000|Overall Study|Adverse Event|31|||
160857707|NCT00168844|580870950|FG001|Overall Study|Adverse Event|32|||
160857708|NCT00168844|580870951|FG002|Overall Study|Adverse Event|48|||
160857709|NCT00168844|580870949|FG000|Overall Study|Lost to Follow-up|4|||
160857710|NCT00168844|580870950|FG001|Overall Study|Lost to Follow-up|5|||
160857711|NCT00168844|580870951|FG002|Overall Study|Lost to Follow-up|11|||
160857712|NCT00168844|580870949|FG000|Overall Study|Withdrawal by Subject|12|||
160857713|NCT00168844|580870950|FG001|Overall Study|Withdrawal by Subject|9|||
160857714|NCT00168844|580870951|FG002|Overall Study|Withdrawal by Subject|19|||
160857715|NCT00168844|580870949|FG000|Overall Study|Protocol Violation|2|||
160857716|NCT00168844|580870950|FG001|Overall Study|Protocol Violation|2|||
160857717|NCT00168844|580870951|FG002|Overall Study|Protocol Violation|4|||
160857718|NCT00168844|580870949|FG000|Overall Study|Other|6|||
160857719|NCT00168844|580870950|FG001|Overall Study|Other|7|||
160857720|NCT00168844|580870951|FG002|Overall Study|Other|9|||
160857721|NCT00525512|580870958|FG000|Double-Blind Phase|Adverse Event|48|||
160857722|NCT00525512|580870959|FG001|Double-Blind Phase|Adverse Event|28|||
160857723|NCT00525512|580870960|FG002|Double-Blind Phase|Adverse Event|0|||
160857724|NCT00525512|580870961|FG003|Double-Blind Phase|Adverse Event|0|||
160857725|NCT00525512|580870958|FG000|Double-Blind Phase|Protocol Violation|3|||
160857726|NCT00525512|580870959|FG001|Double-Blind Phase|Protocol Violation|1|||
160857727|NCT00525512|580870960|FG002|Double-Blind Phase|Protocol Violation|0|||
160857728|NCT00525512|580870961|FG003|Double-Blind Phase|Protocol Violation|0|||
160857729|NCT00525512|580870958|FG000|Double-Blind Phase|Lost to Follow-up|3|||
160857730|NCT00525512|580870959|FG001|Double-Blind Phase|Lost to Follow-up|7|||
160857731|NCT00525512|580870960|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160857732|NCT00525512|580870961|FG003|Double-Blind Phase|Lost to Follow-up|0|||
160652211|NCT00319956|580107415|FG001|Overall Study|Death|24|||
160652212|NCT02607800|580107416|FG000|Overall Study|Lost to Follow-up|7|||
160857733|NCT00525512|580870958|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
160857734|NCT00525512|580870959|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
160857735|NCT00525512|580870960|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160857736|NCT00525512|580870961|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160857737|NCT00525512|580870958|FG000|Double-Blind Phase|Lack of Efficacy|13|||
160857738|NCT00525512|580870959|FG001|Double-Blind Phase|Lack of Efficacy|5|||
160857739|NCT00525512|580870960|FG002|Double-Blind Phase|Lack of Efficacy|0|||
160857740|NCT00525512|580870961|FG003|Double-Blind Phase|Lack of Efficacy|0|||
160652213|NCT02607800|580107417|FG001|Overall Study|Lost to Follow-up|10|||
160652214|NCT02607800|580107416|FG000|Overall Study|Withdrew Consent|2|||
160652215|NCT02607800|580107417|FG001|Overall Study|Withdrew Consent|0|||
160857741|NCT00525512|580870958|FG000|Double-Blind Phase|Other reason (not specified)|12|||
160857742|NCT00525512|580870959|FG001|Double-Blind Phase|Other reason (not specified)|13|||
160857743|NCT00525512|580870960|FG002|Double-Blind Phase|Other reason (not specified)|0|||
160857744|NCT00525512|580870961|FG003|Double-Blind Phase|Other reason (not specified)|0|||
160994271|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
160652216|NCT02607800|580107416|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
160652217|NCT02607800|580107417|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
160652218|NCT01185288|580107418|FG000|Overall Study|Adverse Event|7|||
160857745|NCT00525512|580870958|FG000|Open-Label Phase|Adverse Event|0|||
160652219|NCT01185288|580107419|FG001|Overall Study|Adverse Event|6|||
160857746|NCT00525512|580870959|FG001|Open-Label Phase|Adverse Event|0|||
160857747|NCT00525512|580870960|FG002|Open-Label Phase|Adverse Event|1|||
160857748|NCT00525512|580870961|FG003|Open-Label Phase|Adverse Event|0|||
160857749|NCT00525512|580870958|FG000|Open-Label Phase|Lost to Follow-up|0|||
160857750|NCT00525512|580870959|FG001|Open-Label Phase|Lost to Follow-up|0|||
160857751|NCT00525512|580870960|FG002|Open-Label Phase|Lost to Follow-up|1|||
160857752|NCT00525512|580870961|FG003|Open-Label Phase|Lost to Follow-up|0|||
160857753|NCT00525512|580870958|FG000|Open-Label Phase|Other reason (not specified)|0|||
160857754|NCT00525512|580870959|FG001|Open-Label Phase|Other reason (not specified)|0|||
160857755|NCT00525512|580870960|FG002|Open-Label Phase|Other reason (not specified)|4|||
160857756|NCT00525512|580870961|FG003|Open-Label Phase|Other reason (not specified)|5|||
160857757|NCT01601535|580870966|FG000|Phase 1|Adverse Event|1|||
160857758|NCT01601535|580870967|FG001|Phase 1|Adverse Event|0|||
160857759|NCT01601535|580870968|FG002|Phase 1|Adverse Event|2|||
160857760|NCT01601535|580870969|FG003|Phase 1|Adverse Event|1|||
160857761|NCT01601535|580870970|FG004|Phase 1|Adverse Event|0|||
160857762|NCT01601535|580870971|FG005|Phase 1|Adverse Event|0|||
160857763|NCT01601535|580870966|FG000|Phase 1|Withdrawal by Subject|2|||
160857764|NCT01601535|580870967|FG001|Phase 1|Withdrawal by Subject|1|||
160857765|NCT01601535|580870968|FG002|Phase 1|Withdrawal by Subject|1|||
160857766|NCT01601535|580870969|FG003|Phase 1|Withdrawal by Subject|2|||
160857767|NCT01601535|580870970|FG004|Phase 1|Withdrawal by Subject|0|||
160857768|NCT01601535|580870971|FG005|Phase 1|Withdrawal by Subject|0|||
160857769|NCT01601535|580870966|FG000|Phase 1|Progressive Disease|2|||
160857770|NCT01601535|580870967|FG001|Phase 1|Progressive Disease|3|||
160857771|NCT01601535|580870968|FG002|Phase 1|Progressive Disease|2|||
160857772|NCT01601535|580870969|FG003|Phase 1|Progressive Disease|1|||
160857773|NCT01601535|580870970|FG004|Phase 1|Progressive Disease|0|||
160857774|NCT01601535|580870971|FG005|Phase 1|Progressive Disease|0|||
160857775|NCT01601535|580870966|FG000|Phase 1|Started Another Treatment|1|||
160857776|NCT01601535|580870967|FG001|Phase 1|Started Another Treatment|2|||
160857777|NCT01601535|580870968|FG002|Phase 1|Started Another Treatment|0|||
160857778|NCT01601535|580870969|FG003|Phase 1|Started Another Treatment|0|||
160857779|NCT01601535|580870970|FG004|Phase 1|Started Another Treatment|0|||
160570019|NCT03519178|579809245|FG012|Follow-Up|Lost to Follow-up|0|||
160570020|NCT03519178|579809246|FG013|Follow-Up|Lost to Follow-up|0|||
160570021|NCT03519178|579809247|FG014|Follow-Up|Lost to Follow-up|0|||
160570022|NCT03519178|579809233|FG000|Follow-Up|Withdrawal by Subject|1|||
160570023|NCT03519178|579809234|FG001|Follow-Up|Withdrawal by Subject|2|||
160570024|NCT03519178|579809235|FG002|Follow-Up|Withdrawal by Subject|2|||
160570025|NCT03519178|579809236|FG003|Follow-Up|Withdrawal by Subject|3|||
160570026|NCT03519178|579809237|FG004|Follow-Up|Withdrawal by Subject|5|||
160570027|NCT03519178|579809238|FG005|Follow-Up|Withdrawal by Subject|1|||
160570028|NCT03519178|579809239|FG006|Follow-Up|Withdrawal by Subject|2|||
160570029|NCT03519178|579809240|FG007|Follow-Up|Withdrawal by Subject|6|||
160570030|NCT03519178|579809241|FG008|Follow-Up|Withdrawal by Subject|5|||
160570031|NCT03519178|579809242|FG009|Follow-Up|Withdrawal by Subject|2|||
160570032|NCT03519178|579809243|FG010|Follow-Up|Withdrawal by Subject|3|||
160570033|NCT03519178|579809244|FG011|Follow-Up|Withdrawal by Subject|5|||
160570034|NCT03519178|579809245|FG012|Follow-Up|Withdrawal by Subject|2|||
160570035|NCT03519178|579809246|FG013|Follow-Up|Withdrawal by Subject|0|||
160570036|NCT03519178|579809247|FG014|Follow-Up|Withdrawal by Subject|0|||
160570037|NCT03519178|579809233|FG000|Follow-Up|Other|0|||
160570038|NCT03519178|579809234|FG001|Follow-Up|Other|0|||
160570039|NCT03519178|579809235|FG002|Follow-Up|Other|0|||
160570040|NCT03519178|579809236|FG003|Follow-Up|Other|0|||
160570041|NCT03519178|579809237|FG004|Follow-Up|Other|0|||
160570042|NCT03519178|579809238|FG005|Follow-Up|Other|0|||
160570043|NCT03519178|579809239|FG006|Follow-Up|Other|0|||
160570044|NCT03519178|579809240|FG007|Follow-Up|Other|1|||
160570045|NCT03519178|579809241|FG008|Follow-Up|Other|0|||
160570046|NCT03519178|579809242|FG009|Follow-Up|Other|0|||
160570047|NCT03519178|579809243|FG010|Follow-Up|Other|0|||
160570048|NCT03519178|579809244|FG011|Follow-Up|Other|0|||
160570049|NCT03519178|579809245|FG012|Follow-Up|Other|0|||
160570050|NCT03519178|579809246|FG013|Follow-Up|Other|0|||
160652220|NCT01185288|580107418|FG000|Overall Study|Withdrawal by Subject|6|||
160857780|NCT01601535|580870971|FG005|Phase 1|Started Another Treatment|0|||
160857781|NCT01601535|580870966|FG000|Phase 2|Adverse Event|0|||
160857782|NCT01601535|580870967|FG001|Phase 2|Adverse Event|0|||
160857783|NCT01601535|580870968|FG002|Phase 2|Adverse Event|0|||
160857784|NCT01601535|580870969|FG003|Phase 2|Adverse Event|0|||
160857785|NCT01601535|580870970|FG004|Phase 2|Adverse Event|5|||
160857786|NCT01601535|580870971|FG005|Phase 2|Adverse Event|1|||
160857787|NCT01601535|580870966|FG000|Phase 2|Withdrawal by Subject|0|||
160570051|NCT03519178|579809247|FG014|Follow-Up|Other|0|||
160570052|NCT03519178|579809233|FG000|Long-term Follow-up|Death|0|||
160570053|NCT03519178|579809234|FG001|Long-term Follow-up|Death|0|||
160570054|NCT03519178|579809235|FG002|Long-term Follow-up|Death|0|||
160570055|NCT03519178|579809236|FG003|Long-term Follow-up|Death|0|||
160570056|NCT03519178|579809237|FG004|Long-term Follow-up|Death|0|||
160570057|NCT03519178|579809238|FG005|Long-term Follow-up|Death|0|||
160570058|NCT03519178|579809239|FG006|Long-term Follow-up|Death|0|||
160570059|NCT03519178|579809240|FG007|Long-term Follow-up|Death|0|||
160570060|NCT03519178|579809241|FG008|Long-term Follow-up|Death|0|||
160570061|NCT03519178|579809242|FG009|Long-term Follow-up|Death|0|||
160857788|NCT01601535|580870967|FG001|Phase 2|Withdrawal by Subject|0|||
160857789|NCT01601535|580870968|FG002|Phase 2|Withdrawal by Subject|0|||
160857790|NCT01601535|580870969|FG003|Phase 2|Withdrawal by Subject|0|||
160857791|NCT01601535|580870970|FG004|Phase 2|Withdrawal by Subject|8|||
160857792|NCT01601535|580870971|FG005|Phase 2|Withdrawal by Subject|2|||
160857793|NCT01601535|580870966|FG000|Phase 2|Progressive Disease|0|||
160857794|NCT01601535|580870967|FG001|Phase 2|Progressive Disease|0|||
160857795|NCT01601535|580870968|FG002|Phase 2|Progressive Disease|0|||
160857796|NCT01601535|580870969|FG003|Phase 2|Progressive Disease|0|||
160857797|NCT01601535|580870970|FG004|Phase 2|Progressive Disease|5|||
160857798|NCT01601535|580870971|FG005|Phase 2|Progressive Disease|7|||
160857799|NCT01601535|580870966|FG000|Phase 2|Started Another Treatment|0|||
160857800|NCT01601535|580870967|FG001|Phase 2|Started Another Treatment|0|||
160857801|NCT01601535|580870968|FG002|Phase 2|Started Another Treatment|0|||
160857802|NCT01601535|580870969|FG003|Phase 2|Started Another Treatment|0|||
160857803|NCT01601535|580870970|FG004|Phase 2|Started Another Treatment|1|||
160857804|NCT01601535|580870971|FG005|Phase 2|Started Another Treatment|2|||
160857805|NCT03600909|580870974|FG000|Overall Study|Not treated|0|||
160857806|NCT03600909|580870975|FG001|Overall Study|Not treated|3|||
160857807|NCT03600909|580870976|FG002|Overall Study|Not treated|0|||
160857808|NCT04576988|580870977|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
160857809|NCT04576988|580870978|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
160857810|NCT04576988|580870977|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
160857811|NCT04576988|580870978|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
160857812|NCT04576988|580870977|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
160857813|NCT04576988|580870978|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
160857814|NCT04576988|580870977|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
160857815|NCT04576988|580870978|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
160857816|NCT04576988|580870977|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
160857817|NCT04576988|580870978|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
160857818|NCT04576988|580870977|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
160857819|NCT04576988|580870978|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
160857820|NCT04576988|580870977|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
160857821|NCT04576988|580870978|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
160857822|NCT04576988|580870977|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
160857823|NCT04576988|580870978|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
160857824|NCT04576988|580870977|FG000|Long Term Double Blind (LTDB)|Death|2|||
160857825|NCT04576988|580870978|FG001|Long Term Double Blind (LTDB)|Death|1|||
160857826|NCT04576988|580870977|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
160857827|NCT04576988|580870978|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
160857828|NCT03309020|580870979|FG000|Overall Study|Death|1|||
160857829|NCT03309020|580870980|FG001|Overall Study|Death|0|||
160857830|NCT03309020|580870979|FG000|Overall Study|Did not undergo surgery|2|||
160857831|NCT03309020|580870980|FG001|Overall Study|Did not undergo surgery|1|||
160857832|NCT02362724|580870989|FG000|Overall Study|Withdrawal by Subject|3|||
160857833|NCT02362724|580870990|FG001|Overall Study|Withdrawal by Subject|1|||
160857834|NCT02362724|580870989|FG000|Overall Study|Adverse Event|3|||
160857835|NCT02362724|580870990|FG001|Overall Study|Adverse Event|0|||
160857836|NCT02919761|580870998|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
160857837|NCT02919761|580870999|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
160857838|NCT02919761|580871000|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
160857839|NCT02919761|580870998|FG000|Part 1: Open Label|Adverse Event|1|||
160857840|NCT02919761|580870999|FG001|Part 1: Open Label|Adverse Event|0|||
160857841|NCT02919761|580871000|FG002|Part 1: Open Label|Adverse Event|0|||
160857842|NCT02919761|580870998|FG000|Part 1: Open Label|Lost to Follow-up|1|||
160857843|NCT02919761|580870999|FG001|Part 1: Open Label|Lost to Follow-up|0|||
160994272|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
160570062|NCT03519178|579809243|FG010|Long-term Follow-up|Death|0|||
160857844|NCT02919761|580871000|FG002|Part 1: Open Label|Lost to Follow-up|0|||
160857845|NCT02919761|580870998|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
160857846|NCT02919761|580870999|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
160857847|NCT02919761|580871000|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
160857848|NCT02919761|580870998|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
160857849|NCT02919761|580870999|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
160857850|NCT02919761|580871000|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
160857851|NCT02919761|580870998|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
160857852|NCT02919761|580870999|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
160857853|NCT02919761|580871000|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
160857854|NCT02919761|580870998|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
160857855|NCT02919761|580870999|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
160857856|NCT02919761|580871000|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
160570063|NCT03519178|579809244|FG011|Long-term Follow-up|Death|0|||
160857857|NCT02919761|580870998|FG000|Part 1: Open Label|Termination by Sponsor|1|||
160857858|NCT02919761|580870999|FG001|Part 1: Open Label|Termination by Sponsor|0|||
160857859|NCT02919761|580871000|FG002|Part 1: Open Label|Termination by Sponsor|0|||
160857860|NCT02919761|580870998|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
160857861|NCT02919761|580870999|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
160857862|NCT02919761|580871000|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
160857863|NCT02919761|580870998|FG000|Part 2: Double-blind|Adverse Event|0|||
160857864|NCT02919761|580870999|FG001|Part 2: Double-blind|Adverse Event|1|||
160857865|NCT02919761|580871000|FG002|Part 2: Double-blind|Adverse Event|0|||
160857866|NCT02919761|580870998|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
160857867|NCT02919761|580870999|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
160857868|NCT02919761|580871000|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
160857869|NCT02919761|580870998|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
160857870|NCT02919761|580870999|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
160857871|NCT02919761|580871000|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
160857872|NCT02919761|580870998|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
160857873|NCT02919761|580870999|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
160857874|NCT02919761|580871000|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
160857875|NCT02919761|580870998|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
160857876|NCT02919761|580870999|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
160857877|NCT02919761|580871000|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
160857878|NCT02919761|580870998|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
160857879|NCT02919761|580870999|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
160857880|NCT02919761|580871000|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
160857881|NCT02919761|580870998|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
160857882|NCT02919761|580870999|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
160857883|NCT02919761|580871000|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
160857884|NCT03724942|580871001|FG000|Overall Study|Adverse Event|20|||
160857885|NCT03724942|580871002|FG001|Overall Study|Adverse Event|14|||
160857886|NCT03724942|580871001|FG000|Overall Study|Lack of Efficacy|0|||
160857887|NCT03724942|580871002|FG001|Overall Study|Lack of Efficacy|1|||
160857888|NCT03724942|580871001|FG000|Overall Study|Physician Decision|5|||
160857889|NCT03724942|580871002|FG001|Overall Study|Physician Decision|2|||
160857890|NCT03724942|580871001|FG000|Overall Study|Protocol Violation|1|||
160857891|NCT03724942|580871002|FG001|Overall Study|Protocol Violation|0|||
160857892|NCT03724942|580871001|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
160857893|NCT03724942|580871002|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
160857894|NCT03724942|580871001|FG000|Overall Study|Withdrawal by Legal Representative|3|||
160857895|NCT03724942|580871002|FG001|Overall Study|Withdrawal by Legal Representative|0|||
160857896|NCT02994108|580872932|FG000|Intervention Messages|Withdrawal by Subject|2|||
160857897|NCT02994108|580872933|FG001|Intervention Messages|Withdrawal by Subject|0|||
160857898|NCT02994108|580872932|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
160652221|NCT01185288|580107419|FG001|Overall Study|Withdrawal by Subject|4|||
160652222|NCT01185288|580107418|FG000|Overall Study|Lost to Follow-up|2|||
160652223|NCT01185288|580107419|FG001|Overall Study|Lost to Follow-up|5|||
160652224|NCT01185288|580107418|FG000|Overall Study|Lack of Efficacy|2|||
160652225|NCT01185288|580107419|FG001|Overall Study|Lack of Efficacy|0|||
160652226|NCT01185288|580107418|FG000|Overall Study|Investigator discretion|1|||
160652227|NCT01185288|580107419|FG001|Overall Study|Investigator discretion|0|||
160652228|NCT01185288|580107418|FG000|Overall Study|Did not meet inclusion criteria|1|||
160652229|NCT01185288|580107419|FG001|Overall Study|Did not meet inclusion criteria|0|||
160652230|NCT01185288|580107418|FG000|Overall Study|Noncompliance|0|||
160652231|NCT01185288|580107419|FG001|Overall Study|Noncompliance|1|||
160857899|NCT02994108|580872933|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
160857900|NCT02994108|580872932|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
160857901|NCT02994108|580872933|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
160857902|NCT02994108|580872932|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
160857903|NCT02994108|580872933|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
160857904|NCT00089297|580872934|FG000|Overall Study|Adverse Event|9|||
160857905|NCT00089297|580872934|FG000|Overall Study|Death|1|||
160857906|NCT00089297|580872934|FG000|Overall Study|Withdrawal by Subject|12|||
160908814|NCT04967443|581060067|FG006|Open Label Treatment|Withdrawal by Subject|2|||
160908815|NCT04967443|581060068|FG007|Open Label Treatment|Withdrawal by Subject|3|||
160908816|NCT04967443|581060061|FG000|Follow-Up|Death|1|||
160857907|NCT00089297|580872934|FG000|Overall Study|Disease progression|2|||
160857908|NCT00089297|580872934|FG000|Overall Study|Ineligible|11|||
160857909|NCT00089297|580872934|FG000|Overall Study|Secondary malignancy|1|||
160857910|NCT00089297|580872934|FG000|Overall Study|IRB approval not ready|1|||
160857911|NCT00089297|580872934|FG000|Overall Study|Non-compliance|1|||
160857912|NCT00904969|580872935|FG000|Overall Study|Lost to Follow-up|4|||
160908817|NCT04967443|581060062|FG001|Follow-Up|Death|0|||
160908818|NCT04967443|581060063|FG002|Follow-Up|Death|0|||
160652232|NCT02974153|580107420|FG000|Overall Study|Adverse Event|6|||
160652233|NCT02974153|580107421|FG001|Overall Study|Adverse Event|0|||
160652234|NCT02974153|580107422|FG002|Overall Study|Adverse Event|1|||
160652235|NCT02974153|580107420|FG000|Overall Study|Lack of Efficacy|6|||
160652236|NCT02974153|580107421|FG001|Overall Study|Lack of Efficacy|5|||
160652237|NCT02974153|580107422|FG002|Overall Study|Lack of Efficacy|10|||
160652238|NCT02974153|580107420|FG000|Overall Study|Lost to Follow-up|9|||
160652239|NCT02974153|580107421|FG001|Overall Study|Lost to Follow-up|10|||
160652240|NCT02974153|580107422|FG002|Overall Study|Lost to Follow-up|17|||
160652241|NCT02974153|580107420|FG000|Overall Study|Physician Decision|0|||
160652242|NCT02974153|580107421|FG001|Overall Study|Physician Decision|2|||
160652243|NCT02974153|580107422|FG002|Overall Study|Physician Decision|1|||
160857913|NCT00904969|580872935|FG000|Overall Study|Withdrawal by Subject|3|||
160857914|NCT00904969|580872935|FG000|Overall Study|Additional Treatments|11|||
160857915|NCT00904969|580872935|FG000|Overall Study|Case Aborted; Subject Exited|1|||
160857916|NCT01295814|580872942|FG000|Overall Study|Lack of Efficacy|0|||
160857917|NCT01295814|580872943|FG001|Overall Study|Lack of Efficacy|2|||
160857918|NCT01295814|580872942|FG000|Overall Study|Withdrawal by Subject|2|||
160857919|NCT01295814|580872943|FG001|Overall Study|Withdrawal by Subject|0|||
160857920|NCT03414983|580872944|FG000|Pre-Treatment|Other reasons|1|||
160857921|NCT03414983|580872945|FG001|Pre-Treatment|Other reasons|0|||
160908819|NCT04967443|581060064|FG003|Follow-Up|Death|0|||
160652244|NCT02974153|580107420|FG000|Overall Study|Withdrawal by Subject|9|||
160652245|NCT02974153|580107421|FG001|Overall Study|Withdrawal by Subject|16|||
160652246|NCT02974153|580107422|FG002|Overall Study|Withdrawal by Subject|11|||
160652247|NCT02974153|580107420|FG000|Overall Study|Study Burden|8|||
160652248|NCT02974153|580107421|FG001|Overall Study|Study Burden|7|||
160652249|NCT02974153|580107422|FG002|Overall Study|Study Burden|3|||
160652250|NCT02974153|580107420|FG000|Overall Study|Other|14|||
160652251|NCT02974153|580107421|FG001|Overall Study|Other|8|||
160652252|NCT02974153|580107422|FG002|Overall Study|Other|7|||
160652253|NCT01202747|580107423|FG000|Overall Study|Withdrawal by Subject|1|||
160652254|NCT01446913|580107424|FG000|Overall Study|Significant illness|1|||
160652255|NCT01446913|580107425|FG001|Overall Study|Significant illness|1|||
160652256|NCT01446913|580107426|FG002|Overall Study|Significant illness|1|||
160652257|NCT01446913|580107424|FG000|Overall Study|Withdrawal by Subject|5|||
160652258|NCT01446913|580107425|FG001|Overall Study|Withdrawal by Subject|3|||
160652259|NCT01446913|580107426|FG002|Overall Study|Withdrawal by Subject|5|||
160652260|NCT01446913|580107424|FG000|Overall Study|Physician Decision|0|||
160652261|NCT01446913|580107425|FG001|Overall Study|Physician Decision|0|||
160652262|NCT01446913|580107426|FG002|Overall Study|Physician Decision|2|||
160652263|NCT01446913|580107424|FG000|Overall Study|Lost to Follow-up|3|||
160652264|NCT01446913|580107425|FG001|Overall Study|Lost to Follow-up|5|||
160652265|NCT01446913|580107426|FG002|Overall Study|Lost to Follow-up|3|||
160652266|NCT02521948|580107427|FG000|Overall Study|Adverse Event|2|||
160652267|NCT02521948|580107427|FG000|Overall Study|Death|4|||
160652268|NCT02521948|580107427|FG000|Overall Study|Lost to Follow-up|1|||
160652269|NCT02521948|580107427|FG000|Overall Study|Did not attend one or both follow-ups|6|||
160652270|NCT04000009|580107428|FG000|Overall Study|Adverse Event|13|||
160652271|NCT04000009|580107428|FG000|Overall Study|Lack of Efficacy|7|||
160652272|NCT04000009|580107428|FG000|Overall Study|Lost to Follow-up|8|||
160652273|NCT04000009|580107428|FG000|Overall Study|Noncompliance with study drug|4|||
160652274|NCT04000009|580107428|FG000|Overall Study|Physician Decision|1|||
160652275|NCT04000009|580107428|FG000|Overall Study|Use of prohibited medication|3|||
160652276|NCT04000009|580107428|FG000|Overall Study|Pregnancy|1|||
160652277|NCT04000009|580107428|FG000|Overall Study|Withdrawal by Subject|22|||
160652278|NCT04000009|580107428|FG000|Overall Study|Study terminated by sponsor|98|||
160652279|NCT04000009|580107428|FG000|Overall Study|Not further specified|8|||
160652280|NCT00673790|580107429|FG000|Overall Study|Adverse Event|23|||
160652281|NCT00673790|580107430|FG001|Overall Study|Adverse Event|14|||
160652282|NCT00673790|580107431|FG002|Overall Study|Adverse Event|2|||
160908820|NCT04967443|581060065|FG004|Follow-Up|Death|0|||
160908821|NCT04967443|581060066|FG005|Follow-Up|Death|0|||
160908822|NCT04967443|581060067|FG006|Follow-Up|Death|0|||
160908823|NCT04967443|581060068|FG007|Follow-Up|Death|0|||
160652283|NCT00673790|580107429|FG000|Overall Study|Lack of Efficacy|2|||
160652284|NCT00673790|580107430|FG001|Overall Study|Lack of Efficacy|2|||
160652285|NCT00673790|580107431|FG002|Overall Study|Lack of Efficacy|2|||
160652286|NCT00673790|580107429|FG000|Overall Study|Protocol Violation|6|||
160652287|NCT00673790|580107430|FG001|Overall Study|Protocol Violation|9|||
160652288|NCT00673790|580107431|FG002|Overall Study|Protocol Violation|1|||
160652289|NCT00673790|580107429|FG000|Overall Study|Withdrawal by Subject|7|||
160652290|NCT00673790|580107430|FG001|Overall Study|Withdrawal by Subject|4|||
160857922|NCT03414983|580872944|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
160857923|NCT03414983|580872945|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
160908824|NCT04967443|581060061|FG000|Follow-Up|Lost to Follow-up|0|||
160652291|NCT00673790|580107431|FG002|Overall Study|Withdrawal by Subject|1|||
160652292|NCT00673790|580107429|FG000|Overall Study|Lost to Follow-up|6|||
160652293|NCT00673790|580107430|FG001|Overall Study|Lost to Follow-up|6|||
160652294|NCT00673790|580107431|FG002|Overall Study|Lost to Follow-up|5|||
160908825|NCT04967443|581060062|FG001|Follow-Up|Lost to Follow-up|0|||
160908826|NCT04967443|581060063|FG002|Follow-Up|Lost to Follow-up|1|||
160857924|NCT03414983|580872944|FG000|Pre-Treatment|Participant withdrew consent|1|||
160857925|NCT03414983|580872945|FG001|Pre-Treatment|Participant withdrew consent|3|||
160857926|NCT03414983|580872944|FG000|Treatment|Participant withdrew consent|4|||
160857927|NCT03414983|580872945|FG001|Treatment|Participant withdrew consent|3|||
160857928|NCT03414983|580872944|FG000|Treatment|Participant request to discontinue study treatment|8|||
160857929|NCT03414983|580872945|FG001|Treatment|Participant request to discontinue study treatment|10|||
160857930|NCT03414983|580872944|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
160857931|NCT03414983|580872945|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
160857932|NCT03414983|580872944|FG000|Treatment|Death|0|||
160857933|NCT03414983|580872945|FG001|Treatment|Death|1|||
160857934|NCT03414983|580872944|FG000|Treatment|Study Drug Toxicity|10|||
160857935|NCT03414983|580872945|FG001|Treatment|Study Drug Toxicity|5|||
160857936|NCT03414983|580872944|FG000|Treatment|Disease Progression|75|||
160857937|NCT03414983|580872945|FG001|Treatment|Disease Progression|29|||
160857938|NCT03414983|580872944|FG000|Treatment|Not reported|1|||
160857939|NCT03414983|580872945|FG001|Treatment|Not reported|0|||
160857940|NCT03414983|580872944|FG000|Treatment|Other reasons|3|||
160857941|NCT03414983|580872945|FG001|Treatment|Other reasons|2|||
160652295|NCT00673790|580107429|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
160857942|NCT03414983|580872944|FG000|Treatment|Poor/non-compliance|2|||
160857943|NCT03414983|580872945|FG001|Treatment|Poor/non-compliance|0|||
160857944|NCT03414983|580872944|FG000|Treatment|Maximum clinical benefit|5|||
160857945|NCT03414983|580872945|FG001|Treatment|Maximum clinical benefit|9|||
160857946|NCT03414983|580872944|FG000|Treatment|Lost to Follow-up|0|||
160857947|NCT03414983|580872945|FG001|Treatment|Lost to Follow-up|1|||
160652296|NCT00673790|580107430|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
160652297|NCT00673790|580107431|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
160652298|NCT00673790|580107429|FG000|Overall Study|Poor compliance|1|||
160857948|NCT03414983|580872944|FG000|Treatment|Administrative reasons by sponsor|1|||
160857949|NCT03414983|580872945|FG001|Treatment|Administrative reasons by sponsor|0|||
160857950|NCT04515771|580872953|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
160857951|NCT04515771|580872954|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
160857952|NCT04515771|580872953|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
160857953|NCT04515771|580872954|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
160857954|NCT04515771|580872953|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
160857955|NCT04515771|580872954|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
160857956|NCT00148317|580872958|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
160857957|NCT00148317|580872958|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
160857958|NCT00148317|580872958|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
160857959|NCT04199351|580872961|FG000|Overall Study|Decision by sponsor|0|||
160857960|NCT04199351|580872962|FG001|Overall Study|Decision by sponsor|0|||
160857961|NCT04199351|580872963|FG002|Overall Study|Decision by sponsor|0|||
160857962|NCT04199351|580872964|FG003|Overall Study|Decision by sponsor|2|||
160857963|NCT04199351|580872965|FG004|Overall Study|Decision by sponsor|0|||
160857964|NCT04199351|580872966|FG005|Overall Study|Decision by sponsor|0|||
160857965|NCT04199351|580872967|FG006|Overall Study|Decision by sponsor|0|||
160857966|NCT04199351|580872968|FG007|Overall Study|Decision by sponsor|0|||
160857967|NCT04199351|580872969|FG008|Overall Study|Decision by sponsor|0|||
160857968|NCT04199351|580872970|FG009|Overall Study|Decision by sponsor|6|||
160908827|NCT04967443|581060064|FG003|Follow-Up|Lost to Follow-up|1|||
160908828|NCT04967443|581060065|FG004|Follow-Up|Lost to Follow-up|0|||
160908829|NCT04967443|581060066|FG005|Follow-Up|Lost to Follow-up|0|||
160908830|NCT04967443|581060067|FG006|Follow-Up|Lost to Follow-up|0|||
160908831|NCT04967443|581060068|FG007|Follow-Up|Lost to Follow-up|0|||
160652299|NCT00673790|580107430|FG001|Overall Study|Poor compliance|0|||
160857969|NCT04199351|580872961|FG000|Overall Study|Lost to Follow-up|0|||
160857970|NCT04199351|580872962|FG001|Overall Study|Lost to Follow-up|0|||
160857971|NCT04199351|580872963|FG002|Overall Study|Lost to Follow-up|1|||
160857972|NCT04199351|580872964|FG003|Overall Study|Lost to Follow-up|0|||
160857973|NCT04199351|580872965|FG004|Overall Study|Lost to Follow-up|0|||
160857974|NCT04199351|580872966|FG005|Overall Study|Lost to Follow-up|1|||
160857975|NCT04199351|580872967|FG006|Overall Study|Lost to Follow-up|0|||
160857976|NCT04199351|580872968|FG007|Overall Study|Lost to Follow-up|0|||
160857977|NCT04199351|580872969|FG008|Overall Study|Lost to Follow-up|0|||
160857978|NCT04199351|580872970|FG009|Overall Study|Lost to Follow-up|0|||
160857979|NCT04199351|580872961|FG000|Overall Study|Withdrawal by Subject|0|||
160857980|NCT04199351|580872962|FG001|Overall Study|Withdrawal by Subject|1|||
160857981|NCT04199351|580872963|FG002|Overall Study|Withdrawal by Subject|0|||
160857982|NCT04199351|580872964|FG003|Overall Study|Withdrawal by Subject|0|||
160857983|NCT04199351|580872965|FG004|Overall Study|Withdrawal by Subject|1|||
160908832|NCT04967443|581060061|FG000|Follow-Up|Withdrawal by Subject|0|||
160652300|NCT00673790|580107431|FG002|Overall Study|Poor compliance|0|||
160652301|NCT00673790|580107429|FG000|Overall Study|Participated in two Nebivolol studies|0|||
160857984|NCT04199351|580872966|FG005|Overall Study|Withdrawal by Subject|4|||
160857985|NCT04199351|580872967|FG006|Overall Study|Withdrawal by Subject|2|||
160908833|NCT04967443|581060062|FG001|Follow-Up|Withdrawal by Subject|1|||
160857986|NCT04199351|580872968|FG007|Overall Study|Withdrawal by Subject|0|||
160857987|NCT04199351|580872969|FG008|Overall Study|Withdrawal by Subject|3|||
160857988|NCT04199351|580872970|FG009|Overall Study|Withdrawal by Subject|0|||
160857989|NCT03623243|580872973|FG000|Overall Study|Adverse Event|15|||
160857990|NCT03623243|580872973|FG000|Overall Study|Guardian Decision|1|||
160857991|NCT03623243|580872973|FG000|Overall Study|New Therapy for Study Indication|1|||
160857992|NCT03623243|580872973|FG000|Overall Study|Protocol Deviation|3|||
160857993|NCT03623243|580872973|FG000|Overall Study|Physician Decision|4|||
160857994|NCT03623243|580872973|FG000|Overall Study|Patient Decision|15|||
160857995|NCT03007966|580872974|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
160857996|NCT03007966|580872975|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
160857997|NCT00979901|580872979|FG000|Overall Study|Adverse Event|1|||
160857998|NCT00979901|580872980|FG001|Overall Study|Adverse Event|3|||
160857999|NCT00979901|580872981|FG002|Overall Study|Adverse Event|9|||
160858000|NCT00979901|580872982|FG003|Overall Study|Adverse Event|2|||
160858001|NCT00979901|580872979|FG000|Overall Study|Lack of Efficacy|8|||
160858002|NCT00979901|580872980|FG001|Overall Study|Lack of Efficacy|4|||
160858003|NCT00979901|580872981|FG002|Overall Study|Lack of Efficacy|9|||
160858004|NCT00979901|580872982|FG003|Overall Study|Lack of Efficacy|0|||
160858005|NCT00979901|580872979|FG000|Overall Study|Lost to Follow-up|1|||
160858006|NCT00979901|580872980|FG001|Overall Study|Lost to Follow-up|1|||
160858007|NCT00979901|580872981|FG002|Overall Study|Lost to Follow-up|2|||
160858008|NCT00979901|580872982|FG003|Overall Study|Lost to Follow-up|0|||
160858009|NCT00979901|580872979|FG000|Overall Study|Protocol Violation|2|||
160858010|NCT00979901|580872980|FG001|Overall Study|Protocol Violation|2|||
160858011|NCT00979901|580872981|FG002|Overall Study|Protocol Violation|7|||
160858012|NCT00979901|580872982|FG003|Overall Study|Protocol Violation|1|||
160858013|NCT00979901|580872979|FG000|Overall Study|Withdrawal by Subject|2|||
160858014|NCT00979901|580872980|FG001|Overall Study|Withdrawal by Subject|1|||
160858015|NCT00979901|580872981|FG002|Overall Study|Withdrawal by Subject|1|||
160858016|NCT00979901|580872982|FG003|Overall Study|Withdrawal by Subject|1|||
160858017|NCT00979901|580872979|FG000|Overall Study|Noncompliance|1|||
160858018|NCT00979901|580872980|FG001|Overall Study|Noncompliance|0|||
160858019|NCT00979901|580872981|FG002|Overall Study|Noncompliance|0|||
160858020|NCT00979901|580872982|FG003|Overall Study|Noncompliance|0|||
160858021|NCT00979901|580872979|FG000|Overall Study|out-of-state|1|||
160858022|NCT00979901|580872980|FG001|Overall Study|out-of-state|0|||
160858023|NCT00979901|580872981|FG002|Overall Study|out-of-state|0|||
160858024|NCT00979901|580872982|FG003|Overall Study|out-of-state|0|||
160858025|NCT00979901|580872979|FG000|Overall Study|vacation|1|||
160858026|NCT00979901|580872980|FG001|Overall Study|vacation|0|||
160858027|NCT00979901|580872981|FG002|Overall Study|vacation|0|||
160858028|NCT00979901|580872982|FG003|Overall Study|vacation|0|||
160858029|NCT00979901|580872979|FG000|Overall Study|elevated lab values pre-randomization|1|||
160858030|NCT00979901|580872980|FG001|Overall Study|elevated lab values pre-randomization|0|||
160858031|NCT00979901|580872981|FG002|Overall Study|elevated lab values pre-randomization|0|||
160858032|NCT00979901|580872982|FG003|Overall Study|elevated lab values pre-randomization|0|||
160858033|NCT00979901|580872979|FG000|Overall Study|Discontinued in Error|0|||
160858034|NCT00979901|580872980|FG001|Overall Study|Discontinued in Error|1|||
160858035|NCT00979901|580872981|FG002|Overall Study|Discontinued in Error|0|||
160858036|NCT00979901|580872982|FG003|Overall Study|Discontinued in Error|0|||
160858037|NCT00979901|580872979|FG000|Overall Study|Left Country|0|||
160858038|NCT00979901|580872980|FG001|Overall Study|Left Country|0|||
160858039|NCT00979901|580872981|FG002|Overall Study|Left Country|1|||
160858040|NCT00979901|580872982|FG003|Overall Study|Left Country|0|||
160858041|NCT00979901|580872979|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
160858042|NCT00979901|580872980|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
160858043|NCT00979901|580872981|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
160858044|NCT00979901|580872982|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
160858045|NCT00248625|580872983|FG000|Overall Study|Withdrawal by Subject|0|||
160858046|NCT00248625|580872984|FG001|Overall Study|Withdrawal by Subject|2|||
160858047|NCT03284710|580872989|FG000|Overall Study|Withdrawal by Subject|1|||
160858048|NCT03284710|580872990|FG001|Overall Study|Withdrawal by Subject|0|||
160858049|NCT03284710|580872991|FG002|Overall Study|Withdrawal by Subject|1|||
160858050|NCT03284710|580872992|FG003|Overall Study|Withdrawal by Subject|6|||
160858051|NCT03284710|580872989|FG000|Overall Study|Lost to Follow-up|3|||
160858052|NCT03284710|580872990|FG001|Overall Study|Lost to Follow-up|3|||
160858053|NCT03284710|580872991|FG002|Overall Study|Lost to Follow-up|1|||
160858054|NCT03284710|580872992|FG003|Overall Study|Lost to Follow-up|0|||
160858055|NCT03284710|580872989|FG000|Overall Study|Physician Decision|1|||
160858056|NCT03284710|580872990|FG001|Overall Study|Physician Decision|0|||
160858057|NCT03284710|580872991|FG002|Overall Study|Physician Decision|0|||
160858058|NCT03284710|580872992|FG003|Overall Study|Physician Decision|0|||
160858059|NCT03284710|580872989|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
160858060|NCT03284710|580872990|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
160858061|NCT03284710|580872991|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
160908834|NCT04967443|581060063|FG002|Follow-Up|Withdrawal by Subject|0|||
160858062|NCT03284710|580872992|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
160858063|NCT03284710|580872989|FG000|Overall Study|HIV Infection|0|||
160858064|NCT03284710|580872990|FG001|Overall Study|HIV Infection|2|||
160858065|NCT03284710|580872991|FG002|Overall Study|HIV Infection|2|||
160858066|NCT03284710|580872992|FG003|Overall Study|HIV Infection|1|||
160858067|NCT02814916|580872994|FG000|Overall Study|Withdrawal of consent|0|||
160858068|NCT02814916|580872995|FG001|Overall Study|Withdrawal of consent|2|||
160858069|NCT02814916|580872996|FG002|Overall Study|Withdrawal of consent|0|||
160858070|NCT02814916|580872994|FG000|Overall Study|Lost to Follow-up|0|||
160858071|NCT02814916|580872995|FG001|Overall Study|Lost to Follow-up|1|||
160858072|NCT02814916|580872996|FG002|Overall Study|Lost to Follow-up|0|||
160858073|NCT02814916|580872994|FG000|Overall Study|Other, not specified|0|||
160858074|NCT02814916|580872995|FG001|Overall Study|Other, not specified|1|||
160858075|NCT02814916|580872996|FG002|Overall Study|Other, not specified|0|||
160858076|NCT05316597|580873001|FG000|First Session|Withdrawal by Subject|0|||
160858077|NCT05316597|580873002|FG001|First Session|Withdrawal by Subject|1|||
160858078|NCT05316597|580873001|FG000|Washout Period|Lost to Follow-up|1|||
160858079|NCT05316597|580873002|FG001|Washout Period|Lost to Follow-up|2|||
160858080|NCT05316597|580873001|FG000|Washout Period|Physician Decision|1|||
160858081|NCT05316597|580873002|FG001|Washout Period|Physician Decision|1|||
160858082|NCT05316597|580873001|FG000|Washout Period|Excluded before second session|1|||
160858083|NCT05316597|580873002|FG001|Washout Period|Excluded before second session|1|||
160858084|NCT05316597|580873001|FG000|Washout Period|Withdrawal by Subject|0|||
160858085|NCT05316597|580873002|FG001|Washout Period|Withdrawal by Subject|4|||
160858086|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
160858087|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
160858088|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
160858089|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Death|9|||
160858090|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Death|0|||
160858091|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Death|0|||
160858092|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
160858093|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
160858094|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
160908835|NCT04967443|581060064|FG003|Follow-Up|Withdrawal by Subject|1|||
160908836|NCT04967443|581060065|FG004|Follow-Up|Withdrawal by Subject|0|||
160908837|NCT04967443|581060066|FG005|Follow-Up|Withdrawal by Subject|1|||
160908838|NCT04967443|581060067|FG006|Follow-Up|Withdrawal by Subject|2|||
160908839|NCT04967443|581060068|FG007|Follow-Up|Withdrawal by Subject|3|||
160908840|NCT00602797|581060069|FG000|Overall Study|Adverse Event|1|||
160908841|NCT01063868|581060070|FG000|Overall Study|Adverse Event|9|||
160908842|NCT01063868|581060071|FG001|Overall Study|Adverse Event|7|||
160908843|NCT01063868|581060070|FG000|Overall Study|Withdrawal by Subject|3|||
160908844|NCT01063868|581060071|FG001|Overall Study|Withdrawal by Subject|1|||
160908845|NCT01063868|581060070|FG000|Overall Study|Study Terminated By Sponsor|23|||
160908846|NCT01063868|581060071|FG001|Overall Study|Study Terminated By Sponsor|4|||
160908847|NCT03307967|581060072|FG000|Overall Study|Lost to Follow-up|4|||
160908848|NCT02915016|581060073|FG000|Overall Study|Lost to Follow-up|4|||
160908849|NCT02915016|581060074|FG001|Overall Study|Lost to Follow-up|2|||
160908850|NCT02915016|581060075|FG002|Overall Study|Lost to Follow-up|5|||
160858095|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
160858096|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
160858097|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
160908851|NCT02915016|581060076|FG003|Overall Study|Lost to Follow-up|3|||
160908852|NCT02915016|581060077|FG004|Overall Study|Lost to Follow-up|5|||
160908853|NCT02915016|581060078|FG005|Overall Study|Lost to Follow-up|2|||
160908854|NCT02915016|581060079|FG006|Overall Study|Lost to Follow-up|8|||
160908855|NCT02915016|581060080|FG007|Overall Study|Lost to Follow-up|2|||
160908856|NCT02915016|581060073|FG000|Overall Study|Physician Decision|0|||
160908857|NCT02915016|581060074|FG001|Overall Study|Physician Decision|0|||
160908858|NCT02915016|581060075|FG002|Overall Study|Physician Decision|1|||
160908859|NCT02915016|581060076|FG003|Overall Study|Physician Decision|0|||
160908860|NCT02915016|581060077|FG004|Overall Study|Physician Decision|0|||
160908861|NCT02915016|581060078|FG005|Overall Study|Physician Decision|1|||
160994273|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994274|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994275|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994276|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994277|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994278|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160908862|NCT02915016|581060079|FG006|Overall Study|Physician Decision|2|||
160908863|NCT02915016|581060080|FG007|Overall Study|Physician Decision|0|||
160908864|NCT02915016|581060073|FG000|Overall Study|Withdrawal by Subject|2|||
160908865|NCT02915016|581060074|FG001|Overall Study|Withdrawal by Subject|0|||
160908866|NCT02915016|581060075|FG002|Overall Study|Withdrawal by Subject|1|||
160908867|NCT02915016|581060076|FG003|Overall Study|Withdrawal by Subject|0|||
160908868|NCT02915016|581060077|FG004|Overall Study|Withdrawal by Subject|1|||
160858098|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Other|135|||
160858099|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Other|0|||
160858100|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Other|0|||
160858101|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
160858102|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
160858103|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
160858104|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
160858105|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
160858106|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
160858107|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
160858108|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
160858109|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
160858110|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Other|3|||
160858111|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Other|0|||
160908869|NCT02915016|581060078|FG005|Overall Study|Withdrawal by Subject|3|||
160908870|NCT02915016|581060079|FG006|Overall Study|Withdrawal by Subject|1|||
160858112|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Other|0|||
160908871|NCT02915016|581060080|FG007|Overall Study|Withdrawal by Subject|1|||
160908872|NCT02915016|581060073|FG000|Overall Study|Elected not to continue|0|||
160908873|NCT02915016|581060074|FG001|Overall Study|Elected not to continue|0|||
160908874|NCT02915016|581060075|FG002|Overall Study|Elected not to continue|0|||
160908875|NCT02915016|581060076|FG003|Overall Study|Elected not to continue|1|||
160908876|NCT02915016|581060077|FG004|Overall Study|Elected not to continue|0|||
160908877|NCT02915016|581060078|FG005|Overall Study|Elected not to continue|0|||
160908878|NCT02915016|581060079|FG006|Overall Study|Elected not to continue|1|||
160908879|NCT02915016|581060080|FG007|Overall Study|Elected not to continue|0|||
160908880|NCT02915016|581060073|FG000|Overall Study|HIV infection|1|||
160908881|NCT02915016|581060074|FG001|Overall Study|HIV infection|1|||
160908882|NCT02915016|581060075|FG002|Overall Study|HIV infection|1|||
160908883|NCT02915016|581060076|FG003|Overall Study|HIV infection|0|||
160908884|NCT02915016|581060077|FG004|Overall Study|HIV infection|1|||
160908885|NCT02915016|581060078|FG005|Overall Study|HIV infection|0|||
160908886|NCT02915016|581060079|FG006|Overall Study|HIV infection|0|||
160908887|NCT02915016|581060080|FG007|Overall Study|HIV infection|0|||
160908888|NCT02915016|581060073|FG000|Overall Study|Participant unable to adhere|0|||
160908889|NCT02915016|581060074|FG001|Overall Study|Participant unable to adhere|0|||
160908890|NCT02915016|581060075|FG002|Overall Study|Participant unable to adhere|0|||
160908891|NCT02915016|581060076|FG003|Overall Study|Participant unable to adhere|0|||
160908892|NCT02915016|581060077|FG004|Overall Study|Participant unable to adhere|0|||
160908893|NCT02915016|581060078|FG005|Overall Study|Participant unable to adhere|0|||
160908894|NCT02915016|581060079|FG006|Overall Study|Participant unable to adhere|0|||
160908895|NCT02915016|581060080|FG007|Overall Study|Participant unable to adhere|1|||
160908896|NCT02578316|581060081|FG000|Extension Phase|Progression of disease|6|||
160908897|NCT02166905|581060082|FG000|Overall Study|Withdrawal by Subject|1|||
160908898|NCT02166905|581060083|FG001|Overall Study|Withdrawal by Subject|0|||
160908899|NCT02166905|581060084|FG002|Overall Study|Withdrawal by Subject|0|||
160908900|NCT02166905|581060085|FG003|Overall Study|Withdrawal by Subject|0|||
160908901|NCT02617628|581060086|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
160908902|NCT02617628|581060087|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
160908903|NCT03278873|581060089|FG000|Overall Study|Withdrawal by Subject|0|||
160908904|NCT03278873|581060090|FG001|Overall Study|Withdrawal by Subject|1|||
160908905|NCT03278873|581060091|FG002|Overall Study|Withdrawal by Subject|0|||
160908906|NCT03278873|581060092|FG003|Overall Study|Withdrawal by Subject|0|||
160908907|NCT03278873|581060089|FG000|Overall Study|Sponsor's decision|0|||
160908908|NCT03278873|581060090|FG001|Overall Study|Sponsor's decision|1|||
160908909|NCT03278873|581060091|FG002|Overall Study|Sponsor's decision|0|||
160908910|NCT03278873|581060092|FG003|Overall Study|Sponsor's decision|0|||
160908911|NCT03278873|581060089|FG000|Overall Study|Early Termination|2|||
160908912|NCT03278873|581060090|FG001|Overall Study|Early Termination|6|||
160908913|NCT03278873|581060091|FG002|Overall Study|Early Termination|0|||
160908914|NCT03278873|581060092|FG003|Overall Study|Early Termination|4|||
160908915|NCT03278873|581060089|FG000|Overall Study|Lost to Follow-up|0|||
160908916|NCT03278873|581060090|FG001|Overall Study|Lost to Follow-up|0|||
160908917|NCT03278873|581060091|FG002|Overall Study|Lost to Follow-up|2|||
160908918|NCT03278873|581060092|FG003|Overall Study|Lost to Follow-up|0|||
160858113|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
160908919|NCT03278873|581060089|FG000|Overall Study|The patient decided to withdraw via email|1|||
160908920|NCT03278873|581060090|FG001|Overall Study|The patient decided to withdraw via email|0|||
160908921|NCT03278873|581060091|FG002|Overall Study|The patient decided to withdraw via email|0|||
160908922|NCT03278873|581060092|FG003|Overall Study|The patient decided to withdraw via email|0|||
160908923|NCT03278873|581060089|FG000|Overall Study|The patient was unresponsive to contact|0|||
160858114|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
160858115|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
160858116|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
160858117|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
160858118|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
160858119|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
160858120|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
160858121|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
160858122|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
160858123|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
160858124|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
160858125|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
160858126|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
160858127|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
160858128|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
160858129|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
160858130|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
160858131|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
160858132|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
160858133|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
160858134|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
160858135|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
160858136|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
160858137|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
160858138|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
160858139|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
160858140|NCT03103542|580873006|FG000|Overall Study|Physician Decision|2|||
160652302|NCT00673790|580107430|FG001|Overall Study|Participated in two Nebivolol studies|0|||
160652303|NCT00673790|580107431|FG002|Overall Study|Participated in two Nebivolol studies|1|||
160652304|NCT00673790|580107429|FG000|Overall Study|Unconfirmed pregnancy|0|||
160652305|NCT00673790|580107430|FG001|Overall Study|Unconfirmed pregnancy|1|||
160652306|NCT00673790|580107431|FG002|Overall Study|Unconfirmed pregnancy|0|||
160652307|NCT00673790|580107429|FG000|Overall Study|Randomization criteria not met|0|||
160652308|NCT00673790|580107430|FG001|Overall Study|Randomization criteria not met|1|||
160652309|NCT00673790|580107431|FG002|Overall Study|Randomization criteria not met|0|||
160858141|NCT03103542|580873006|FG000|Overall Study|Adverse Event|2|||
160858142|NCT03103542|580873006|FG000|Overall Study|Other|2|||
160858143|NCT03103542|580873006|FG000|Overall Study|Withdrawal by Subject|1|||
160858144|NCT02927301|580873008|FG000|Overall Study|Death|39|||
160858145|NCT02927301|580873008|FG000|Overall Study|Lost to Follow-up|8|||
160858146|NCT02927301|580873008|FG000|Overall Study|Physician Decision|2|||
160858147|NCT02927301|580873008|FG000|Overall Study|Withdrawal by Subject|12|||
160858148|NCT02927301|580873008|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
160858149|NCT02903771|580873009|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
160858150|NCT02903771|580873010|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
160858151|NCT02903771|580873011|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
160858152|NCT02903771|580873012|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
160858153|NCT02903771|580873013|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
160858154|NCT02903771|580873014|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
160858155|NCT02903771|580873015|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
160858156|NCT02903771|580873009|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858157|NCT02903771|580873010|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
160858158|NCT02903771|580873011|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858159|NCT02903771|580873012|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858160|NCT02903771|580873013|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858161|NCT02903771|580873014|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858162|NCT02903771|580873015|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858163|NCT02903771|580873009|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
160858164|NCT02903771|580873010|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
160908924|NCT03278873|581060090|FG001|Overall Study|The patient was unresponsive to contact|0|||
160908925|NCT03278873|581060091|FG002|Overall Study|The patient was unresponsive to contact|0|||
160908926|NCT03278873|581060092|FG003|Overall Study|The patient was unresponsive to contact|4|||
160908927|NCT03278873|581060089|FG000|Overall Study|The patient wished to participate no longer|0|||
160652310|NCT04471428|580107437|FG000|Overall Study|Withdrawal by Subject|29|||
160908928|NCT03278873|581060090|FG001|Overall Study|The patient wished to participate no longer|1|||
160908929|NCT03278873|581060091|FG002|Overall Study|The patient wished to participate no longer|0|||
160908930|NCT03278873|581060092|FG003|Overall Study|The patient wished to participate no longer|0|||
160994279|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160858165|NCT02903771|580873011|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
160858166|NCT02903771|580873012|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
160858167|NCT02903771|580873013|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
160858168|NCT02903771|580873014|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
160858169|NCT02903771|580873015|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
160858170|NCT02903771|580873009|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858171|NCT02903771|580873010|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858172|NCT02903771|580873011|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858173|NCT02903771|580873012|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858174|NCT02903771|580873013|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
160858175|NCT02903771|580873014|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858176|NCT02903771|580873015|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858177|NCT02903771|580873009|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858178|NCT02903771|580873010|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858179|NCT02903771|580873011|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858180|NCT02903771|580873012|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858181|NCT02903771|580873013|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858182|NCT02903771|580873014|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
160858183|NCT02903771|580873015|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858184|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858185|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858186|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858187|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858188|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
160858189|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858190|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858191|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858192|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858193|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858194|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858195|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
160858196|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858197|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858198|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858199|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858200|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858201|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858202|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
160858203|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858204|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858205|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858206|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858207|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858208|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858209|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
160858210|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858211|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858212|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858213|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858214|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858215|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858216|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
160858217|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858218|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858219|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160858220|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160858221|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160858222|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160858223|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
160858224|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160570064|NCT03519178|579809245|FG012|Long-term Follow-up|Death|0|||
160858225|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160858226|NCT02218372|580873016|FG000|Overall Study|Adverse Event|1|||
160858227|NCT02218372|580873017|FG001|Overall Study|Adverse Event|1|||
160858228|NCT02218372|580873016|FG000|Overall Study|Miscellaneous|2|||
160858229|NCT02218372|580873017|FG001|Overall Study|Miscellaneous|1|||
160858230|NCT02218372|580873016|FG000|Overall Study|Randomized but did not receive treatment|2|||
160858231|NCT02218372|580873017|FG001|Overall Study|Randomized but did not receive treatment|3|||
160858232|NCT02218372|580873016|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160858233|NCT02218372|580873017|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160858234|NCT03406780|580873022|FG000|Overall Study|Withdrawal by Subject|1|||
160858235|NCT03406780|580873023|FG001|Overall Study|Withdrawal by Subject|1|||
160858236|NCT03406780|580873022|FG000|Overall Study|Other|0|||
160858237|NCT03406780|580873023|FG001|Overall Study|Other|2|||
160858238|NCT02546609|580873026|FG000|Overall Study|Withdrawal by Subject|0|||
160858239|NCT02546609|580873027|FG001|Overall Study|Withdrawal by Subject|1|||
160858240|NCT02546609|580873028|FG002|Overall Study|Withdrawal by Subject|2|||
160858241|NCT02546609|580873026|FG000|Overall Study|Adverse Event|0|||
160858242|NCT02546609|580873027|FG001|Overall Study|Adverse Event|6|||
160858243|NCT02546609|580873028|FG002|Overall Study|Adverse Event|1|||
160858244|NCT02546609|580873026|FG000|Overall Study|Protocol Violation|0|||
160858245|NCT02546609|580873027|FG001|Overall Study|Protocol Violation|1|||
160858246|NCT02546609|580873028|FG002|Overall Study|Protocol Violation|1|||
160858247|NCT02546609|580873026|FG000|Overall Study|Lost to Follow-up|2|||
160858248|NCT02546609|580873027|FG001|Overall Study|Lost to Follow-up|3|||
160858249|NCT02546609|580873028|FG002|Overall Study|Lost to Follow-up|1|||
160858250|NCT02546609|580873026|FG000|Overall Study|travel or work schedule restriction|0|||
160858251|NCT02546609|580873027|FG001|Overall Study|travel or work schedule restriction|0|||
160858252|NCT02546609|580873028|FG002|Overall Study|travel or work schedule restriction|2|||
160858253|NCT02004236|580873037|FG000|Overall Study|Lack of Efficacy|0|||
160858254|NCT02004236|580873038|FG001|Overall Study|Lack of Efficacy|0|||
160858255|NCT02004236|580873039|FG002|Overall Study|Lack of Efficacy|16|||
160858256|NCT00918281|580873042|FG000|Overall Study|Physician Decision|29|||
160858257|NCT03557970|580873047|FG000|Overall Study|Study closure|1|||
160858258|NCT03557970|580873048|FG001|Overall Study|Study closure|0|||
160858259|NCT03557970|580873047|FG000|Overall Study|Physician Decision|0|||
160858260|NCT03557970|580873048|FG001|Overall Study|Physician Decision|1|||
160858261|NCT03557970|580873047|FG000|Overall Study|Death|0|||
160858262|NCT03557970|580873048|FG001|Overall Study|Death|1|||
160858263|NCT00112736|580873049|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
160858264|NCT00112736|580873050|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
160858265|NCT00004563|580873052|FG000|Overall Study|Withdrawal by Subject|20|||
160858266|NCT00004563|580873053|FG001|Overall Study|Withdrawal by Subject|16|||
160858267|NCT00004563|580873052|FG000|Overall Study|Lack of Efficacy|3|||
160858268|NCT00004563|580873053|FG001|Overall Study|Lack of Efficacy|5|||
160858269|NCT00004563|580873052|FG000|Overall Study|Death|2|||
160858270|NCT00004563|580873053|FG001|Overall Study|Death|3|||
160858271|NCT05135871|580873056|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
160858272|NCT05135871|580873057|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
160858273|NCT05135871|580873058|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
160858274|NCT05135871|580873059|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
160858275|NCT04258423|580873060|FG000|Overall Study|Study Closure|2|||
160858276|NCT04258423|580873061|FG001|Overall Study|Study Closure|2|||
160858277|NCT03980730|580873062|FG000|Overall Study|Study Terminated by Sponsor|0|||
160570065|NCT03519178|579809246|FG013|Long-term Follow-up|Death|4|||
160570066|NCT03519178|579809247|FG014|Long-term Follow-up|Death|4|||
160570067|NCT03519178|579809233|FG000|Long-term Follow-up|Lost to Follow-up|0|||
160570068|NCT03519178|579809234|FG001|Long-term Follow-up|Lost to Follow-up|0|||
160570069|NCT03519178|579809235|FG002|Long-term Follow-up|Lost to Follow-up|0|||
160570070|NCT03519178|579809236|FG003|Long-term Follow-up|Lost to Follow-up|0|||
160570071|NCT03519178|579809237|FG004|Long-term Follow-up|Lost to Follow-up|0|||
160570072|NCT03519178|579809238|FG005|Long-term Follow-up|Lost to Follow-up|0|||
160570073|NCT03519178|579809239|FG006|Long-term Follow-up|Lost to Follow-up|0|||
160570074|NCT03519178|579809240|FG007|Long-term Follow-up|Lost to Follow-up|0|||
160858278|NCT03980730|580873063|FG001|Overall Study|Study Terminated by Sponsor|3|||
160858279|NCT03980730|580873062|FG000|Overall Study|Adverse Event|2|||
160858280|NCT03980730|580873063|FG001|Overall Study|Adverse Event|0|||
160858281|NCT03980730|580873062|FG000|Overall Study|Sponsor Request|0|||
160858282|NCT03980730|580873063|FG001|Overall Study|Sponsor Request|1|||
160858283|NCT00880620|580873064|FG000|Overall Study|Adverse Event|4|||
160917938|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
160858284|NCT00880620|580873065|FG001|Overall Study|Adverse Event|5|||
160858285|NCT00880620|580873066|FG002|Overall Study|Adverse Event|15|||
160570075|NCT03519178|579809241|FG008|Long-term Follow-up|Lost to Follow-up|0|||
160570076|NCT03519178|579809242|FG009|Long-term Follow-up|Lost to Follow-up|0|||
160571947|NCT02619253|579816875|FG000|Overall Study|Disease Progression|4|||
160858286|NCT00880620|580873067|FG003|Overall Study|Adverse Event|15|||
160858287|NCT00880620|580873064|FG000|Overall Study|Death|0|||
160858288|NCT00880620|580873065|FG001|Overall Study|Death|0|||
160858289|NCT00880620|580873066|FG002|Overall Study|Death|1|||
160858290|NCT00880620|580873067|FG003|Overall Study|Death|0|||
160858291|NCT00880620|580873064|FG000|Overall Study|Lack of Efficacy|12|||
160994280|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994281|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160858292|NCT00880620|580873065|FG001|Overall Study|Lack of Efficacy|4|||
160858293|NCT00880620|580873066|FG002|Overall Study|Lack of Efficacy|0|||
160858294|NCT00880620|580873067|FG003|Overall Study|Lack of Efficacy|1|||
160858295|NCT00880620|580873064|FG000|Overall Study|Lost to Follow-up|0|||
160858296|NCT00880620|580873065|FG001|Overall Study|Lost to Follow-up|1|||
160858297|NCT00880620|580873066|FG002|Overall Study|Lost to Follow-up|1|||
160858298|NCT00880620|580873067|FG003|Overall Study|Lost to Follow-up|0|||
160858299|NCT00880620|580873064|FG000|Overall Study|Protocol Violation|0|||
160858300|NCT00880620|580873065|FG001|Overall Study|Protocol Violation|1|||
160858301|NCT00880620|580873066|FG002|Overall Study|Protocol Violation|0|||
160858302|NCT00880620|580873067|FG003|Overall Study|Protocol Violation|2|||
160858303|NCT00880620|580873064|FG000|Overall Study|Withdrawal by Subject|4|||
160858304|NCT00880620|580873065|FG001|Overall Study|Withdrawal by Subject|3|||
160858305|NCT00880620|580873066|FG002|Overall Study|Withdrawal by Subject|1|||
160858306|NCT00880620|580873067|FG003|Overall Study|Withdrawal by Subject|3|||
160858307|NCT00880620|580873064|FG000|Overall Study|Noncompliance|0|||
160858308|NCT00880620|580873065|FG001|Overall Study|Noncompliance|0|||
160858309|NCT00880620|580873066|FG002|Overall Study|Noncompliance|1|||
160858310|NCT00880620|580873067|FG003|Overall Study|Noncompliance|1|||
160858311|NCT00880620|580873064|FG000|Overall Study|Other|1|||
160858312|NCT00880620|580873065|FG001|Overall Study|Other|1|||
160858313|NCT00880620|580873066|FG002|Overall Study|Other|2|||
160858314|NCT00880620|580873067|FG003|Overall Study|Other|2|||
160858315|NCT02016781|580873081|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
160858316|NCT02016781|580873082|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
160858317|NCT02016781|580873081|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
160858318|NCT02016781|580873082|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
160858319|NCT02016781|580873081|FG000|Final Database Lock|Withdrawal by Subject|2|||
160858320|NCT02016781|580873082|FG001|Final Database Lock|Withdrawal by Subject|1|||
160858321|NCT02016781|580873081|FG000|Final Database Lock|Lost to Follow-up|11|||
160858322|NCT02016781|580873082|FG001|Final Database Lock|Lost to Follow-up|4|||
160858323|NCT02016781|580873081|FG000|Final Database Lock|Missing data|0|||
160858324|NCT02016781|580873082|FG001|Final Database Lock|Missing data|3|||
160858325|NCT00945009|580873083|FG000|Overall Study|Lack of Efficacy|10|||
160858326|NCT00945009|580873084|FG001|Overall Study|Lack of Efficacy|0|||
160908931|NCT03278873|581060089|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
160908932|NCT03278873|581060090|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
160908933|NCT03278873|581060091|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
160908934|NCT03278873|581060092|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
160908935|NCT05243641|581060093|FG000|Overall Study|Adverse Event|3|||
160908936|NCT05243641|581060094|FG001|Overall Study|Adverse Event|0|||
160908937|NCT05243641|581060095|FG002|Overall Study|Adverse Event|0|||
160908938|NCT05243641|581060096|FG003|Overall Study|Adverse Event|1|||
160908939|NCT05243641|581060097|FG004|Overall Study|Adverse Event|0|||
160908940|NCT05243641|581060098|FG005|Overall Study|Adverse Event|0|||
160908941|NCT05243641|581060093|FG000|Overall Study|Disease progression|4|||
160908942|NCT05243641|581060094|FG001|Overall Study|Disease progression|0|||
160908943|NCT05243641|581060095|FG002|Overall Study|Disease progression|0|||
160908944|NCT05243641|581060096|FG003|Overall Study|Disease progression|2|||
160908945|NCT05243641|581060097|FG004|Overall Study|Disease progression|0|||
160908946|NCT05243641|581060098|FG005|Overall Study|Disease progression|0|||
160908947|NCT04518306|581060105|FG000|Double-Blind Period|Run in failure|0|||
160858327|NCT00945009|580873085|FG002|Overall Study|Lack of Efficacy|0|||
160858328|NCT00945009|580873083|FG000|Overall Study|Physician Decision|21|||
160908948|NCT04518306|581060106|FG001|Double-Blind Period|Run in failure|0|||
160908949|NCT04518306|581060107|FG002|Double-Blind Period|Run in failure|1|||
160652311|NCT04471428|580107438|FG001|Overall Study|Withdrawal by Subject|4|||
160858329|NCT00945009|580873084|FG001|Overall Study|Physician Decision|4|||
160858330|NCT00945009|580873085|FG002|Overall Study|Physician Decision|3|||
160858331|NCT00945009|580873083|FG000|Overall Study|Protocol Violation|6|||
160858332|NCT00945009|580873084|FG001|Overall Study|Protocol Violation|1|||
160858333|NCT00945009|580873085|FG002|Overall Study|Protocol Violation|0|||
160858334|NCT00945009|580873083|FG000|Overall Study|Withdrawal by Subject|1|||
160858335|NCT00945009|580873084|FG001|Overall Study|Withdrawal by Subject|0|||
160858336|NCT00945009|580873085|FG002|Overall Study|Withdrawal by Subject|0|||
160908950|NCT04518306|581060105|FG000|Double-Blind Period|Adverse Event|0|||
160858337|NCT00945009|580873083|FG000|Overall Study|Ineligible|6|||
160858338|NCT00945009|580873084|FG001|Overall Study|Ineligible|1|||
160858339|NCT00945009|580873085|FG002|Overall Study|Ineligible|0|||
160858340|NCT00945009|580873083|FG000|Overall Study|Inevaluable|0|||
160858341|NCT00945009|580873084|FG001|Overall Study|Inevaluable|1|||
160858342|NCT00945009|580873085|FG002|Overall Study|Inevaluable|0|||
160858343|NCT00945009|580873083|FG000|Overall Study|Refusal of further protocol|1|||
160858344|NCT00945009|580873084|FG001|Overall Study|Refusal of further protocol|0|||
160908951|NCT04518306|581060106|FG001|Double-Blind Period|Adverse Event|2|||
160908952|NCT04518306|581060107|FG002|Double-Blind Period|Adverse Event|2|||
160908953|NCT04518306|581060105|FG000|Double-Blind Period|Lost to Follow-up|1|||
160908954|NCT04518306|581060106|FG001|Double-Blind Period|Lost to Follow-up|2|||
160908955|NCT04518306|581060107|FG002|Double-Blind Period|Lost to Follow-up|2|||
160908956|NCT04518306|581060105|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
160908957|NCT04518306|581060106|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
160908958|NCT04518306|581060107|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
160570077|NCT03519178|579809243|FG010|Long-term Follow-up|Lost to Follow-up|0|||
160570078|NCT03519178|579809244|FG011|Long-term Follow-up|Lost to Follow-up|0|||
160570079|NCT03519178|579809245|FG012|Long-term Follow-up|Lost to Follow-up|0|||
160570080|NCT03519178|579809246|FG013|Long-term Follow-up|Lost to Follow-up|1|||
160570081|NCT03519178|579809247|FG014|Long-term Follow-up|Lost to Follow-up|1|||
160570082|NCT03519178|579809233|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
160570083|NCT03519178|579809234|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
160570084|NCT03519178|579809235|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
160570085|NCT03519178|579809236|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
160570086|NCT03519178|579809237|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
160570087|NCT03519178|579809238|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
160570088|NCT03519178|579809239|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
160570089|NCT03519178|579809240|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
160570090|NCT03519178|579809241|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
160570091|NCT03519178|579809242|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
160570092|NCT03519178|579809243|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
160570093|NCT03519178|579809244|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
160570094|NCT03519178|579809245|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
160570095|NCT03519178|579809246|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
160570096|NCT03519178|579809247|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
160570097|NCT03519178|579809233|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
160570098|NCT03519178|579809234|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
160570099|NCT03519178|579809235|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
160570100|NCT03519178|579809236|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
160570101|NCT03519178|579809237|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
160570102|NCT03519178|579809238|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
160570103|NCT03519178|579809239|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
160570104|NCT03519178|579809240|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
160570105|NCT03519178|579809241|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
160570106|NCT03519178|579809242|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
160570107|NCT03519178|579809243|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
160570108|NCT03519178|579809244|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
160570109|NCT03519178|579809245|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
160570110|NCT03519178|579809246|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
160570111|NCT03519178|579809247|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
160570112|NCT03519178|579809233|FG000|Long-term Follow-up|Other|0|||
160570113|NCT03519178|579809234|FG001|Long-term Follow-up|Other|0|||
160570114|NCT03519178|579809235|FG002|Long-term Follow-up|Other|0|||
160570115|NCT03519178|579809236|FG003|Long-term Follow-up|Other|0|||
160570116|NCT03519178|579809237|FG004|Long-term Follow-up|Other|0|||
160570117|NCT03519178|579809238|FG005|Long-term Follow-up|Other|0|||
160570118|NCT03519178|579809239|FG006|Long-term Follow-up|Other|0|||
160570119|NCT03519178|579809240|FG007|Long-term Follow-up|Other|0|||
160570120|NCT03519178|579809241|FG008|Long-term Follow-up|Other|0|||
160858345|NCT00945009|580873085|FG002|Overall Study|Refusal of further protocol|0|||
160858346|NCT04875975|580873086|FG000|Overall Study|Adverse Event|1|||
160858347|NCT04875975|580873087|FG001|Overall Study|Adverse Event|2|||
160858348|NCT04875975|580873086|FG000|Overall Study|Lack of Efficacy|2|||
160858349|NCT04875975|580873087|FG001|Overall Study|Lack of Efficacy|2|||
160570121|NCT03519178|579809242|FG009|Long-term Follow-up|Other|0|||
160570122|NCT03519178|579809243|FG010|Long-term Follow-up|Other|0|||
160570123|NCT03519178|579809244|FG011|Long-term Follow-up|Other|0|||
160570124|NCT03519178|579809245|FG012|Long-term Follow-up|Other|0|||
160570125|NCT03519178|579809246|FG013|Long-term Follow-up|Other|0|||
160570126|NCT03519178|579809247|FG014|Long-term Follow-up|Other|1|||
160570127|NCT03519178|579809233|FG000|Long-term Follow-up|Global deterioration of health status|0|||
160570128|NCT03519178|579809234|FG001|Long-term Follow-up|Global deterioration of health status|0|||
160571948|NCT02619253|579816876|FG001|Overall Study|Disease Progression|2|||
160858350|NCT04875975|580873086|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
160858351|NCT04875975|580873087|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
160994282|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
160994283|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160858352|NCT04875975|580873086|FG000|Overall Study|Relapse With Insults|0|||
160858353|NCT04875975|580873087|FG001|Overall Study|Relapse With Insults|1|||
160858354|NCT04875975|580873086|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
160858355|NCT04875975|580873087|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
160858356|NCT04972162|580873092|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
160858357|NCT04972162|580873093|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
160858358|NCT02429830|580873094|FG000|Overall Study|Lost to Follow-up|1|||
160858359|NCT02429830|580873094|FG000|Overall Study|Device Explant|2|||
160858360|NCT00474487|580874679|FG000|Overall Study|Withdrawal by Subject|6|||
160858361|NCT00474487|580874680|FG001|Overall Study|Withdrawal by Subject|0|||
160858362|NCT00474487|580874681|FG002|Overall Study|Withdrawal by Subject|0|||
160858363|NCT00474487|580874682|FG003|Overall Study|Withdrawal by Subject|0|||
160858364|NCT00474487|580874679|FG000|Overall Study|Lost to Follow-up|20|||
160858365|NCT00474487|580874680|FG001|Overall Study|Lost to Follow-up|1|||
160858366|NCT00474487|580874681|FG002|Overall Study|Lost to Follow-up|7|||
160858367|NCT00474487|580874682|FG003|Overall Study|Lost to Follow-up|0|||
160858368|NCT00474487|580874679|FG000|Overall Study|Inappropriate enrollment|4|||
160858369|NCT00474487|580874680|FG001|Overall Study|Inappropriate enrollment|0|||
160858370|NCT00474487|580874681|FG002|Overall Study|Inappropriate enrollment|7|||
160858371|NCT00474487|580874682|FG003|Overall Study|Inappropriate enrollment|0|||
160858372|NCT00474487|580874679|FG000|Overall Study|Death|0|||
160858373|NCT00474487|580874680|FG001|Overall Study|Death|1|||
160858374|NCT00474487|580874681|FG002|Overall Study|Death|0|||
160858375|NCT00474487|580874682|FG003|Overall Study|Death|0|||
160858376|NCT03924622|580874683|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
160858377|NCT03924622|580874684|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
160858378|NCT03924622|580874685|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
160858379|NCT03924622|580874686|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
160858380|NCT03924622|580874687|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
160858381|NCT03924622|580874688|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
160858382|NCT03085095|580874689|FG000|Overall Study|Adverse Event|23|||
160858383|NCT03085095|580874690|FG001|Overall Study|Adverse Event|8|||
160858384|NCT03085095|580874689|FG000|Overall Study|Protocol Violation|0|||
160858385|NCT03085095|580874690|FG001|Overall Study|Protocol Violation|1|||
160858386|NCT03085095|580874689|FG000|Overall Study|Lost to Follow-up|2|||
160858387|NCT03085095|580874690|FG001|Overall Study|Lost to Follow-up|1|||
160858388|NCT03085095|580874689|FG000|Overall Study|Withdrawal by Subject|17|||
160858389|NCT03085095|580874690|FG001|Overall Study|Withdrawal by Subject|6|||
160858390|NCT03085095|580874689|FG000|Overall Study|Physician Decision|9|||
160858391|NCT03085095|580874690|FG001|Overall Study|Physician Decision|3|||
160858392|NCT03085095|580874689|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
160858393|NCT03085095|580874690|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
160858394|NCT03085095|580874689|FG000|Overall Study|Did not Receive Study Drug|2|||
160858395|NCT03085095|580874690|FG001|Overall Study|Did not Receive Study Drug|2|||
160858396|NCT03085095|580874689|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
160858397|NCT03085095|580874690|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
160858398|NCT05176314|580874693|FG000|Overall Study|Lost to Follow-up|2|||
160858399|NCT05176314|580874693|FG000|Overall Study|Physician Decision|1|||
160858400|NCT05176314|580874693|FG000|Overall Study|Adverse Event|1|||
160570129|NCT03519178|579809235|FG002|Long-term Follow-up|Global deterioration of health status|0|||
160858401|NCT05543265|580874695|FG000|Overall Study|Lost to Follow-up|3|||
160858402|NCT05543265|580874696|FG001|Overall Study|Lost to Follow-up|3|||
160858403|NCT05543265|580874695|FG000|Overall Study|Withdrawal by Subject|0|||
160858404|NCT05543265|580874696|FG001|Overall Study|Withdrawal by Subject|1|||
160858405|NCT02182895|580874697|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
160858406|NCT02182895|580874698|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
160858407|NCT01488045|580874708|FG000|Overall Study|Withdrawal by Subject|6|||
160858408|NCT01488045|580874709|FG001|Overall Study|Withdrawal by Subject|11|||
160858409|NCT01488045|580874708|FG000|Overall Study|Failure to present for colonoscopy|3|||
160858410|NCT01488045|580874709|FG001|Overall Study|Failure to present for colonoscopy|6|||
160858411|NCT01488045|580874708|FG000|Overall Study|Failure to report exclusion criteria|0|||
160858412|NCT01488045|580874709|FG001|Overall Study|Failure to report exclusion criteria|1|||
160858413|NCT00671658|580874711|FG000|Overall Study|Physician Decision|5|||
160570130|NCT03519178|579809236|FG003|Long-term Follow-up|Global deterioration of health status|0|||
160570131|NCT03519178|579809237|FG004|Long-term Follow-up|Global deterioration of health status|0|||
160858414|NCT03617172|580874714|FG000|Overall Study|Lost to Follow-up|1|||
160858415|NCT03617172|580874715|FG001|Overall Study|Lost to Follow-up|0|||
160858416|NCT01680341|580874716|FG000|Overall Study|Adverse Event|3|||
160858417|NCT01680341|580874717|FG001|Overall Study|Adverse Event|2|||
160570132|NCT03519178|579809238|FG005|Long-term Follow-up|Global deterioration of health status|0|||
160858418|NCT01680341|580874716|FG000|Overall Study|Unclassified|18|||
160858419|NCT01680341|580874717|FG001|Overall Study|Unclassified|15|||
160858420|NCT02587221|580874719|FG000|Overall Study|Adverse Event|3|||
160858421|NCT02587221|580874720|FG001|Overall Study|Adverse Event|3|||
160858422|NCT02587221|580874719|FG000|Overall Study|Death|33|||
160858423|NCT02587221|580874720|FG001|Overall Study|Death|34|||
160858424|NCT02587221|580874719|FG000|Overall Study|Withdrawal by Subject|66|||
160858425|NCT02587221|580874720|FG001|Overall Study|Withdrawal by Subject|61|||
160858426|NCT02587221|580874719|FG000|Overall Study|Lost to Follow-up|21|||
160858427|NCT02587221|580874720|FG001|Overall Study|Lost to Follow-up|19|||
160858428|NCT02587221|580874719|FG000|Overall Study|Protocol Violation|6|||
160858429|NCT02587221|580874720|FG001|Overall Study|Protocol Violation|5|||
160858430|NCT02587221|580874719|FG000|Overall Study|Other Reason or Unspecified|2|||
160858431|NCT02587221|580874720|FG001|Overall Study|Other Reason or Unspecified|1|||
160858432|NCT03988400|580874721|FG000|Overall Study|Adverse Event|1|||
160858433|NCT03988400|580874722|FG001|Overall Study|Adverse Event|0|||
160858434|NCT03988400|580874721|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
160858435|NCT03988400|580874722|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
160858436|NCT03988400|580874721|FG000|Overall Study|Lost to Follow-up|0|||
160858437|NCT03988400|580874722|FG001|Overall Study|Lost to Follow-up|1|||
160908959|NCT04518306|581060105|FG000|Double-Blind Period|Other|0|||
160908960|NCT04518306|581060106|FG001|Double-Blind Period|Other|2|||
160908961|NCT04518306|581060107|FG002|Double-Blind Period|Other|0|||
160908962|NCT04518306|581060105|FG000|Double-Blind Period|Missing|0|||
160908963|NCT04518306|581060106|FG001|Double-Blind Period|Missing|1|||
160908964|NCT04518306|581060107|FG002|Double-Blind Period|Missing|0|||
160908965|NCT03268954|581060111|FG000|Overall Study|Withdrawal by Subject|27|||
160908966|NCT03268954|581060112|FG001|Overall Study|Withdrawal by Subject|17|||
160908967|NCT03268954|581060111|FG000|Overall Study|Lost to Follow-up|2|||
160908968|NCT03268954|581060112|FG001|Overall Study|Lost to Follow-up|3|||
160908969|NCT03268954|581060111|FG000|Overall Study|Reason Not Specified|3|||
160908970|NCT03268954|581060112|FG001|Overall Study|Reason Not Specified|8|||
160908971|NCT05372419|581060115|FG000|Overall Study|Protocol Deviation|1|||
160908972|NCT05372419|581060115|FG000|Overall Study|Withdrawal by Subject|5|||
160908973|NCT05372419|581060115|FG000|Overall Study|Lost to Follow-up|7|||
160908974|NCT05358444|581060116|FG000|Overall Study|Withdrawal by Subject|0|||
160908975|NCT05358444|581060117|FG001|Overall Study|Withdrawal by Subject|1|||
160908976|NCT05358444|581060116|FG000|Overall Study|Lost to Follow-up|0|||
160908977|NCT05358444|581060117|FG001|Overall Study|Lost to Follow-up|3|||
160908978|NCT02801331|581060118|FG000|Overall Study|Transferred to another hospital|8|||
160908979|NCT02801331|581060119|FG001|Overall Study|Transferred to another hospital|7|||
160908980|NCT02801331|581060118|FG000|Overall Study|Withdrawal by Subject|0|||
160908981|NCT02801331|581060119|FG001|Overall Study|Withdrawal by Subject|4|||
160908982|NCT02801331|581060118|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
160908983|NCT02801331|581060119|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
160908984|NCT02443987|581060120|FG000|Overall Study|Bladder injury|1|||
160908985|NCT02443987|581060121|FG001|Overall Study|Bladder injury|1|||
160908986|NCT02443987|581060120|FG000|Overall Study|Other|0|||
160908987|NCT02443987|581060121|FG001|Overall Study|Other|1|||
160908988|NCT03820986|581060124|FG000|Overall Study|Death|201|||
160908989|NCT03820986|581060125|FG001|Overall Study|Death|175|||
160908990|NCT03820986|581060124|FG000|Overall Study|Lost to Follow-up|1|||
160908991|NCT03820986|581060125|FG001|Overall Study|Lost to Follow-up|1|||
160908992|NCT03820986|581060124|FG000|Overall Study|Physician Decision|1|||
160908993|NCT03820986|581060125|FG001|Overall Study|Physician Decision|0|||
160908994|NCT03820986|581060124|FG000|Overall Study|Sponsor Decision|122|||
160908995|NCT03820986|581060125|FG001|Overall Study|Sponsor Decision|160|||
160908996|NCT03820986|581060124|FG000|Overall Study|Withdrawal by Subject|9|||
160908997|NCT03820986|581060125|FG001|Overall Study|Withdrawal by Subject|4|||
160908998|NCT05766423|581060130|FG000|Overall Study|Withdrawal by Subject|1|||
160908999|NCT05766423|581060131|FG001|Overall Study|Withdrawal by Subject|0|||
160909000|NCT05766423|581060130|FG000|Overall Study|Consented, not scheduled|3|||
160909001|NCT05766423|581060131|FG001|Overall Study|Consented, not scheduled|5|||
160909002|NCT02601469|581061882|FG000|Overall Study|Enrolled in Error|1|||
160909003|NCT02601469|581061883|FG001|Overall Study|Enrolled in Error|0|||
160909004|NCT00056316|581061884|FG000|Overall Study|Withdrawal by Subject|2|||
160909005|NCT00056316|581061885|FG001|Overall Study|Withdrawal by Subject|2|||
160909006|NCT00056316|581061884|FG000|Overall Study|Death/NH placement of pt|1|||
160909007|NCT00056316|581061885|FG001|Overall Study|Death/NH placement of pt|1|||
160994284|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160858438|NCT04913610|580874723|FG000|Randomized Participants|Did Not Receive Treatment|0|||
160858439|NCT04913610|580874724|FG001|Randomized Participants|Did Not Receive Treatment|0|||
160909008|NCT02161731|581061886|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
160909009|NCT02161731|581061887|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
160909010|NCT02161731|581061886|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
160909011|NCT02161731|581061887|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
160909012|NCT01315678|581061892|FG000|Overall Study|Withdrawal by Subject|7|||
160858440|NCT04913610|580874725|FG002|Randomized Participants|Did Not Receive Treatment|1|||
160858441|NCT04913610|580874726|FG003|Randomized Participants|Did Not Receive Treatment|1|||
160858442|NCT04913610|580874727|FG004|Randomized Participants|Did Not Receive Treatment|0|||
160858443|NCT04913610|580874723|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
160858444|NCT04913610|580874724|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
160858445|NCT04913610|580874725|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
160858446|NCT04913610|580874726|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
160858447|NCT04913610|580874727|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
160858448|NCT03186209|580874728|FG000|Overall Study|Withdrawal by Subject|11|||
160858449|NCT03186209|580874729|FG001|Overall Study|Withdrawal by Subject|22|||
160858450|NCT03186209|580874728|FG000|Overall Study|Pregnancy|1|||
160858451|NCT03186209|580874729|FG001|Overall Study|Pregnancy|0|||
160858452|NCT03186209|580874728|FG000|Overall Study|Adverse Event|4|||
160858453|NCT03186209|580874729|FG001|Overall Study|Adverse Event|0|||
160858454|NCT03186209|580874728|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
160858455|NCT03186209|580874729|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
160858456|NCT03186209|580874728|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
160858457|NCT03186209|580874729|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
160858458|NCT03186209|580874728|FG000|Overall Study|Fail to meet randomization criteria|0|||
160858459|NCT03186209|580874729|FG001|Overall Study|Fail to meet randomization criteria|1|||
160858460|NCT03186209|580874728|FG000|Overall Study|Lost to Follow-up|0|||
160858461|NCT03186209|580874729|FG001|Overall Study|Lost to Follow-up|1|||
160858462|NCT00953667|580874732|FG000|Overall Study|Lost to Follow-up|11|||
160858463|NCT00953667|580874732|FG000|Overall Study|Physician Decision|35|||
160858464|NCT00953667|580874732|FG000|Overall Study|Withdrawal by Subject|63|||
160858465|NCT00953667|580874732|FG000|Overall Study|Adverse Event|10|||
160858466|NCT00953667|580874732|FG000|Overall Study|poor venous access,unable to draw blood|4|||
160858467|NCT00551759|580874733|FG000|Overall Study|Adverse Event|7|||
160858468|NCT00551759|580874733|FG000|Overall Study|Death|5|||
160858469|NCT00551759|580874733|FG000|Overall Study|Ineligible|1|||
160858470|NCT03521570|580874734|FG000|Overall Study|Not eligible|11|||
160858471|NCT00322881|580874736|FG000|Overall Study|Death|2|||
160858472|NCT00322881|580874736|FG000|Overall Study|Adverse Event|1|||
160858473|NCT00322881|580874736|FG000|Overall Study|Disease Progression|2|||
160858474|NCT02138890|580874743|FG000|Overall Study|Adverse Event|1|||
160858475|NCT02138890|580874744|FG001|Overall Study|Adverse Event|0|||
160858476|NCT05435339|580874745|FG000|Overall Study|Death|1|||
160858477|NCT05435339|580874746|FG001|Overall Study|Death|0|||
160858478|NCT05435339|580874747|FG002|Overall Study|Death|3|||
160858479|NCT05435339|580874748|FG003|Overall Study|Death|1|||
160858480|NCT05435339|580874749|FG004|Overall Study|Death|3|||
160858481|NCT05435339|580874750|FG005|Overall Study|Death|2|||
160858482|NCT05435339|580874751|FG006|Overall Study|Death|4|||
160858483|NCT05435339|580874752|FG007|Overall Study|Death|6|||
160858484|NCT05435339|580874745|FG000|Overall Study|Sponsor Decision|0|||
160858485|NCT05435339|580874746|FG001|Overall Study|Sponsor Decision|1|||
160858486|NCT05435339|580874747|FG002|Overall Study|Sponsor Decision|0|||
160858487|NCT05435339|580874748|FG003|Overall Study|Sponsor Decision|0|||
160858488|NCT05435339|580874749|FG004|Overall Study|Sponsor Decision|2|||
160858489|NCT05435339|580874750|FG005|Overall Study|Sponsor Decision|1|||
160858490|NCT05435339|580874751|FG006|Overall Study|Sponsor Decision|2|||
160858491|NCT05435339|580874752|FG007|Overall Study|Sponsor Decision|2|||
160858492|NCT05435339|580874745|FG000|Overall Study|Withdrawal by Subject|0|||
160858493|NCT05435339|580874746|FG001|Overall Study|Withdrawal by Subject|0|||
160858494|NCT05435339|580874747|FG002|Overall Study|Withdrawal by Subject|0|||
160858495|NCT05435339|580874748|FG003|Overall Study|Withdrawal by Subject|0|||
160858496|NCT05435339|580874749|FG004|Overall Study|Withdrawal by Subject|1|||
160909013|NCT01315678|581061893|FG001|Overall Study|Withdrawal by Subject|3|||
160909014|NCT01315678|581061892|FG000|Overall Study|Adverse Event|3|||
160909015|NCT01315678|581061893|FG001|Overall Study|Adverse Event|1|||
160909016|NCT01315678|581061892|FG000|Overall Study|Lost to Follow-up|1|||
160858497|NCT05435339|580874750|FG005|Overall Study|Withdrawal by Subject|0|||
160858498|NCT05435339|580874751|FG006|Overall Study|Withdrawal by Subject|1|||
160858499|NCT05435339|580874752|FG007|Overall Study|Withdrawal by Subject|1|||
160858500|NCT01446159|580874753|FG000|Overall Study|Withdrawal by Subject|1|||
160858501|NCT01446159|580874754|FG001|Overall Study|Withdrawal by Subject|0|||
160858502|NCT01446159|580874755|FG002|Overall Study|Withdrawal by Subject|14|||
160858503|NCT01446159|580874756|FG003|Overall Study|Withdrawal by Subject|11|||
160858504|NCT01446159|580874753|FG000|Overall Study|Lost to Follow-up|0|||
160858505|NCT01446159|580874754|FG001|Overall Study|Lost to Follow-up|0|||
160858506|NCT01446159|580874755|FG002|Overall Study|Lost to Follow-up|1|||
160858507|NCT01446159|580874756|FG003|Overall Study|Lost to Follow-up|2|||
160858508|NCT01446159|580874753|FG000|Overall Study|Death|2|||
160858509|NCT01446159|580874754|FG001|Overall Study|Death|3|||
160858510|NCT01446159|580874755|FG002|Overall Study|Death|43|||
160858511|NCT01446159|580874756|FG003|Overall Study|Death|36|||
160909017|NCT01315678|581061893|FG001|Overall Study|Lost to Follow-up|0|||
160858512|NCT01446159|580874753|FG000|Overall Study|Other|0|||
160858513|NCT01446159|580874754|FG001|Overall Study|Other|0|||
160858514|NCT01446159|580874755|FG002|Overall Study|Other|13|||
160858515|NCT01446159|580874756|FG003|Overall Study|Other|13|||
160858516|NCT00537394|580874763|FG000|First Year of Follow-up|Death|7|||
160858517|NCT00537394|580874764|FG001|First Year of Follow-up|Death|0|||
160858518|NCT00537394|580874765|FG002|First Year of Follow-up|Death|0|||
160858519|NCT00537394|580874763|FG000|First Year of Follow-up|Severe debilitation|1|||
160858520|NCT00537394|580874764|FG001|First Year of Follow-up|Severe debilitation|0|||
160858521|NCT00537394|580874765|FG002|First Year of Follow-up|Severe debilitation|1|||
160858522|NCT00537394|580874763|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
160858523|NCT00537394|580874764|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
160858524|NCT00537394|580874765|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
160858525|NCT00537394|580874763|FG000|First Year of Follow-up|Lost to Follow-up|1|||
160858526|NCT00537394|580874764|FG001|First Year of Follow-up|Lost to Follow-up|5|||
160858527|NCT00537394|580874765|FG002|First Year of Follow-up|Lost to Follow-up|1|||
160858528|NCT00537394|580874763|FG000|2nd Year of Follow-up|Death|4|||
160858529|NCT00537394|580874764|FG001|2nd Year of Follow-up|Death|1|||
160858530|NCT00537394|580874765|FG002|2nd Year of Follow-up|Death|2|||
160858531|NCT00537394|580874763|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
160858532|NCT00537394|580874764|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
160858533|NCT00537394|580874765|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
160858534|NCT00537394|580874763|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
160858535|NCT00537394|580874764|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
160858536|NCT00537394|580874765|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
160858537|NCT00537394|580874763|FG000|2nd Year of Follow-up|Clinic site closure|1|||
160858538|NCT00537394|580874764|FG001|2nd Year of Follow-up|Clinic site closure|0|||
160858539|NCT00537394|580874765|FG002|2nd Year of Follow-up|Clinic site closure|0|||
160858540|NCT01056822|580874770|FG000|Overall Study|Adverse Event|0|||
160858541|NCT01056822|580874771|FG001|Overall Study|Adverse Event|1|||
160858542|NCT01056822|580874770|FG000|Overall Study|Protocol Violation|6|||
160858543|NCT01056822|580874771|FG001|Overall Study|Protocol Violation|5|||
160858544|NCT01056822|580874770|FG000|Overall Study|Withdrawal by Subject|1|||
160858545|NCT01056822|580874771|FG001|Overall Study|Withdrawal by Subject|1|||
160858546|NCT01056822|580874770|FG000|Overall Study|Lost to Follow-up|1|||
160858547|NCT01056822|580874771|FG001|Overall Study|Lost to Follow-up|0|||
160858548|NCT01927497|580874772|FG000|Overall Study|Death|0|||
160858549|NCT01927497|580874773|FG001|Overall Study|Death|1|||
160858550|NCT01927497|580874772|FG000|Overall Study|Protocol Violation|2|||
160858551|NCT01927497|580874773|FG001|Overall Study|Protocol Violation|0|||
160858552|NCT00395746|580874774|FG000|Overall Study|Adverse Event|5|||
160858553|NCT00395746|580874775|FG001|Overall Study|Adverse Event|2|||
160858554|NCT00395746|580874776|FG002|Overall Study|Adverse Event|2|||
160858555|NCT00395746|580874774|FG000|Overall Study|Protocol Violation|0|||
160858556|NCT00395746|580874775|FG001|Overall Study|Protocol Violation|1|||
160858557|NCT00395746|580874776|FG002|Overall Study|Protocol Violation|0|||
160858558|NCT00395746|580874774|FG000|Overall Study|Lack of Efficacy|2|||
160858559|NCT00395746|580874775|FG001|Overall Study|Lack of Efficacy|0|||
160858560|NCT00395746|580874776|FG002|Overall Study|Lack of Efficacy|17|||
160858561|NCT00395746|580874774|FG000|Overall Study|Hypoglycaemia|2|||
160858562|NCT00395746|580874775|FG001|Overall Study|Hypoglycaemia|1|||
160858563|NCT00395746|580874776|FG002|Overall Study|Hypoglycaemia|0|||
160858564|NCT00395746|580874774|FG000|Overall Study|Subject decision|0|||
160858565|NCT00395746|580874775|FG001|Overall Study|Subject decision|0|||
160858566|NCT00395746|580874776|FG002|Overall Study|Subject decision|1|||
160858567|NCT00395746|580874774|FG000|Overall Study|Withdrawal of consent|0|||
160858568|NCT00395746|580874775|FG001|Overall Study|Withdrawal of consent|0|||
160858569|NCT00395746|580874776|FG002|Overall Study|Withdrawal of consent|1|||
160858570|NCT00395746|580874774|FG000|Overall Study|Difficultulty in use of device|0|||
160858571|NCT00395746|580874775|FG001|Overall Study|Difficultulty in use of device|0|||
160858572|NCT00395746|580874776|FG002|Overall Study|Difficultulty in use of device|1|||
160858573|NCT00395746|580874774|FG000|Overall Study|Unable to visit site on schedule|1|||
160858574|NCT00395746|580874775|FG001|Overall Study|Unable to visit site on schedule|0|||
160858575|NCT00395746|580874776|FG002|Overall Study|Unable to visit site on schedule|0|||
160909018|NCT01315678|581061892|FG000|Overall Study|similar reason to those listed above|3|||
160571949|NCT02619253|579816877|FG002|Overall Study|Disease Progression|8|||
160858576|NCT04528641|580874777|FG000|Overall Study|Withdrawal by Subject|0|||
160858577|NCT04528641|580874778|FG001|Overall Study|Withdrawal by Subject|0|||
160858578|NCT04528641|580874779|FG002|Overall Study|Withdrawal by Subject|0|||
160858579|NCT04528641|580874780|FG003|Overall Study|Withdrawal by Subject|1|||
160858580|NCT04528641|580874781|FG004|Overall Study|Withdrawal by Subject|0|||
160858581|NCT04528641|580874782|FG005|Overall Study|Withdrawal by Subject|1|||
160858582|NCT03914417|580874783|FG000|Overall Study|Withdrawal by Subject|2|||
160858583|NCT00517296|580874788|FG000|Overall Study|Withdrawal by Subject|1|||
160571950|NCT02619253|579816878|FG003|Overall Study|Disease Progression|9|||
160570133|NCT03519178|579809239|FG006|Long-term Follow-up|Global deterioration of health status|0|||
160570134|NCT03519178|579809240|FG007|Long-term Follow-up|Global deterioration of health status|0|||
160858584|NCT00517296|580874789|FG001|Overall Study|Withdrawal by Subject|0|||
160858585|NCT00795704|580874792|FG000|Overall Study|Withdrawal by Subject|3|||
160858586|NCT00795704|580874793|FG001|Overall Study|Withdrawal by Subject|2|||
160858587|NCT00795704|580874792|FG000|Overall Study|Adverse Event|1|||
160858588|NCT00795704|580874793|FG001|Overall Study|Adverse Event|1|||
160858589|NCT01300728|580874794|FG000|Overall Study|Withdrawal by Subject|1|||
160858590|NCT01300728|580874795|FG001|Overall Study|Withdrawal by Subject|1|||
160858591|NCT01300728|580874794|FG000|Overall Study|Physician Decision|1|||
160858592|NCT01300728|580874795|FG001|Overall Study|Physician Decision|0|||
160858593|NCT01247324|580874796|FG000|Overall Study|Death|6|||
160858594|NCT01247324|580874797|FG001|Overall Study|Death|10|||
160858595|NCT01247324|580874796|FG000|Overall Study|Physician Decision|2|||
160858596|NCT01247324|580874797|FG001|Overall Study|Physician Decision|3|||
160858597|NCT01247324|580874796|FG000|Overall Study|Non-compliance with study drug|3|||
160858598|NCT01247324|580874797|FG001|Overall Study|Non-compliance with study drug|0|||
160858599|NCT01247324|580874796|FG000|Overall Study|Lack of Efficacy|24|||
160858600|NCT01247324|580874797|FG001|Overall Study|Lack of Efficacy|14|||
160858601|NCT01247324|580874796|FG000|Overall Study|Non-compliance|3|||
160858602|NCT01247324|580874797|FG001|Overall Study|Non-compliance|2|||
160858603|NCT01247324|580874796|FG000|Overall Study|Pregnancy|5|||
160858604|NCT01247324|580874797|FG001|Overall Study|Pregnancy|10|||
160858605|NCT01247324|580874796|FG000|Overall Study|Protocol Violation|1|||
160858606|NCT01247324|580874797|FG001|Overall Study|Protocol Violation|1|||
160858607|NCT01247324|580874796|FG000|Overall Study|Reason not specified|42|||
160858608|NCT01247324|580874797|FG001|Overall Study|Reason not specified|32|||
160858609|NCT01247324|580874796|FG000|Overall Study|Consent withdrawn by participant|41|||
160858610|NCT01247324|580874797|FG001|Overall Study|Consent withdrawn by participant|56|||
160858611|NCT01247324|580874796|FG000|Overall Study|Adverse Event|49|||
160858612|NCT01247324|580874797|FG001|Overall Study|Adverse Event|35|||
160858613|NCT01247324|580874796|FG000|Overall Study|Lost to Follow-up|3|||
160858614|NCT01247324|580874797|FG001|Overall Study|Lost to Follow-up|6|||
160858615|NCT01247324|580874796|FG000|Overall Study|Study Terminated by Sponsor|4|||
160858616|NCT01247324|580874797|FG001|Overall Study|Study Terminated by Sponsor|1|||
160858617|NCT01247324|580874796|FG000|Overall Study|Missing|2|||
160858618|NCT01247324|580874797|FG001|Overall Study|Missing|1|||
160858619|NCT00506350|580874798|FG000|Overall Study|Serious Adverse Event|1|||
160858620|NCT00506350|580874799|FG001|Overall Study|Serious Adverse Event|0|||
160858621|NCT00506350|580874800|FG002|Overall Study|Serious Adverse Event|0|||
160858622|NCT00506350|580874801|FG003|Overall Study|Serious Adverse Event|0|||
160858623|NCT00506350|580874802|FG004|Overall Study|Serious Adverse Event|0|||
160858624|NCT00506350|580874803|FG005|Overall Study|Serious Adverse Event|0|||
160858625|NCT00506350|580874804|FG006|Overall Study|Serious Adverse Event|0|||
160858626|NCT00506350|580874805|FG007|Overall Study|Serious Adverse Event|0|||
160858627|NCT00506350|580874806|FG008|Overall Study|Serious Adverse Event|0|||
160858628|NCT00506350|580874798|FG000|Overall Study|Adverse Event|0|||
160858629|NCT00506350|580874799|FG001|Overall Study|Adverse Event|0|||
160858630|NCT00506350|580874800|FG002|Overall Study|Adverse Event|0|||
160858631|NCT00506350|580874801|FG003|Overall Study|Adverse Event|0|||
160858632|NCT00506350|580874802|FG004|Overall Study|Adverse Event|0|||
160858633|NCT00506350|580874803|FG005|Overall Study|Adverse Event|0|||
160858634|NCT00506350|580874804|FG006|Overall Study|Adverse Event|0|||
160858635|NCT00506350|580874805|FG007|Overall Study|Adverse Event|1|||
160858636|NCT00506350|580874806|FG008|Overall Study|Adverse Event|1|||
160858637|NCT00506350|580874798|FG000|Overall Study|Protocol Violation|0|||
160858638|NCT00506350|580874799|FG001|Overall Study|Protocol Violation|0|||
160858639|NCT00506350|580874800|FG002|Overall Study|Protocol Violation|1|||
160858640|NCT00506350|580874801|FG003|Overall Study|Protocol Violation|0|||
160858641|NCT00506350|580874802|FG004|Overall Study|Protocol Violation|0|||
160858642|NCT00506350|580874803|FG005|Overall Study|Protocol Violation|0|||
160909019|NCT01315678|581061893|FG001|Overall Study|similar reason to those listed above|2|||
160909020|NCT03633695|581061897|FG000|Overall Study|Lost to Follow-up|4|||
160858643|NCT00506350|580874804|FG006|Overall Study|Protocol Violation|1|||
160858644|NCT00506350|580874805|FG007|Overall Study|Protocol Violation|0|||
160909021|NCT03633695|581061898|FG001|Overall Study|Lost to Follow-up|5|||
160909022|NCT03633695|581061897|FG000|Overall Study|Discontinued|8|||
160909023|NCT03633695|581061898|FG001|Overall Study|Discontinued|4|||
160909024|NCT03217175|581061902|FG000|Overall Study|Physician Decision|4|||
160909025|NCT03217175|581061903|FG001|Overall Study|Physician Decision|1|||
160571951|NCT02619253|579816879|FG004|Overall Study|Disease Progression|10|||
160858645|NCT00506350|580874806|FG008|Overall Study|Protocol Violation|0|||
160858646|NCT00506350|580874798|FG000|Overall Study|Withdrawal by Subject|0|||
160858647|NCT00506350|580874799|FG001|Overall Study|Withdrawal by Subject|1|||
160858648|NCT00506350|580874800|FG002|Overall Study|Withdrawal by Subject|1|||
160858649|NCT00506350|580874801|FG003|Overall Study|Withdrawal by Subject|1|||
160909026|NCT00429273|581061904|FG000|Overall Study|Lost to Follow-up|1|||
160909027|NCT00429273|581061905|FG001|Overall Study|Lost to Follow-up|2|||
160652312|NCT04471428|580107437|FG000|Overall Study|Physician Decision|0|||
160909028|NCT00429273|581061906|FG002|Overall Study|Lost to Follow-up|2|||
160909029|NCT00429273|581061904|FG000|Overall Study|Physician Decision|6|||
160909030|NCT00429273|581061905|FG001|Overall Study|Physician Decision|5|||
160909031|NCT00429273|581061906|FG002|Overall Study|Physician Decision|5|||
160909032|NCT00429273|581061904|FG000|Overall Study|Adverse Event|1|||
160570135|NCT03519178|579809241|FG008|Long-term Follow-up|Global deterioration of health status|0|||
160909033|NCT00429273|581061905|FG001|Overall Study|Adverse Event|1|||
160909034|NCT00429273|581061906|FG002|Overall Study|Adverse Event|2|||
160909035|NCT00407797|581061910|FG000|Overall Study|Lost to Follow-up|2|||
160909036|NCT00407797|581061910|FG000|Overall Study|Adverse Event|6|||
160909037|NCT00407797|581061910|FG000|Overall Study|Other|7|||
160909038|NCT00407797|581061910|FG000|Overall Study|Withdrawal by Subject|3|||
160909039|NCT01402492|581061912|FG000|Overall Study|Withdrawal by Subject|17|||
160909040|NCT01402492|581061913|FG001|Overall Study|Withdrawal by Subject|11|||
160909041|NCT01402492|581061914|FG002|Overall Study|Withdrawal by Subject|11|||
160909042|NCT01402492|581061912|FG000|Overall Study|Adverse Event|2|||
160909043|NCT01402492|581061913|FG001|Overall Study|Adverse Event|3|||
160909044|NCT01402492|581061914|FG002|Overall Study|Adverse Event|4|||
160909045|NCT01402492|581061912|FG000|Overall Study|Physician Decision|0|||
160909046|NCT01402492|581061913|FG001|Overall Study|Physician Decision|3|||
160909047|NCT01402492|581061914|FG002|Overall Study|Physician Decision|0|||
160909048|NCT01402492|581061912|FG000|Overall Study|Incarcerated (N=3)|2|||
160909049|NCT01402492|581061913|FG001|Overall Study|Incarcerated (N=3)|0|||
160909050|NCT01402492|581061914|FG002|Overall Study|Incarcerated (N=3)|1|||
160909051|NCT00601458|581061919|FG000|Overall Study|Dosing Error|1|||
160909052|NCT00601458|581061920|FG001|Overall Study|Dosing Error|0|||
160570136|NCT03519178|579809242|FG009|Long-term Follow-up|Global deterioration of health status|0|||
160570137|NCT03519178|579809243|FG010|Long-term Follow-up|Global deterioration of health status|0|||
160570138|NCT03519178|579809244|FG011|Long-term Follow-up|Global deterioration of health status|0|||
160570139|NCT03519178|579809245|FG012|Long-term Follow-up|Global deterioration of health status|0|||
160570140|NCT03519178|579809246|FG013|Long-term Follow-up|Global deterioration of health status|1|||
160570141|NCT03519178|579809247|FG014|Long-term Follow-up|Global deterioration of health status|0|||
160570142|NCT01919411|579809253|FG000|Overall Study|Lost to Follow-up|2|||
160570143|NCT01919411|579809254|FG001|Overall Study|Lost to Follow-up|4|||
160570144|NCT01919411|579809253|FG000|Overall Study|Physician Decision|1|||
160570145|NCT01919411|579809254|FG001|Overall Study|Physician Decision|0|||
160570146|NCT01919411|579809253|FG000|Overall Study|Protocol Violation|2|||
160570147|NCT01919411|579809254|FG001|Overall Study|Protocol Violation|1|||
160570148|NCT05165394|579810416|FG000|Overall Study|Withdrawal by Subject|5|||
160570149|NCT05165394|579810417|FG001|Overall Study|Withdrawal by Subject|1|||
160570150|NCT05165394|579810416|FG000|Overall Study|Lost to Follow-up|1|||
160570151|NCT05165394|579810417|FG001|Overall Study|Lost to Follow-up|2|||
160570152|NCT05165394|579810416|FG000|Overall Study|Other Than Specified|0|||
160570153|NCT05165394|579810417|FG001|Overall Study|Other Than Specified|1|||
160570154|NCT02495077|579810418|FG000|Overall Study|Adverse Event|0|||
160570155|NCT02495077|579810419|FG001|Overall Study|Adverse Event|1|||
160570156|NCT02495077|579810420|FG002|Overall Study|Adverse Event|1|||
160570157|NCT02495077|579810421|FG003|Overall Study|Adverse Event|0|||
160570158|NCT02495077|579810418|FG000|Overall Study|Death|3|||
160570159|NCT02495077|579810419|FG001|Overall Study|Death|5|||
160570160|NCT02495077|579810420|FG002|Overall Study|Death|0|||
160570161|NCT02495077|579810421|FG003|Overall Study|Death|0|||
160570162|NCT02495077|579810418|FG000|Overall Study|Lost to Follow-up|6|||
160570163|NCT02495077|579810419|FG001|Overall Study|Lost to Follow-up|4|||
160570164|NCT02495077|579810420|FG002|Overall Study|Lost to Follow-up|0|||
160570165|NCT02495077|579810421|FG003|Overall Study|Lost to Follow-up|0|||
160570166|NCT02495077|579810418|FG000|Overall Study|Physician Decision|2|||
160570167|NCT02495077|579810419|FG001|Overall Study|Physician Decision|1|||
160570168|NCT02495077|579810420|FG002|Overall Study|Physician Decision|4|||
160570169|NCT02495077|579810421|FG003|Overall Study|Physician Decision|0|||
160570170|NCT02495077|579810418|FG000|Overall Study|Protocol Violation|0|||
160570171|NCT02495077|579810419|FG001|Overall Study|Protocol Violation|1|||
160570172|NCT02495077|579810420|FG002|Overall Study|Protocol Violation|0|||
160570173|NCT02495077|579810421|FG003|Overall Study|Protocol Violation|0|||
160570174|NCT02495077|579810418|FG000|Overall Study|Screen Failure|0|||
160570175|NCT02495077|579810419|FG001|Overall Study|Screen Failure|0|||
160570176|NCT02495077|579810420|FG002|Overall Study|Screen Failure|0|||
160570177|NCT02495077|579810421|FG003|Overall Study|Screen Failure|48|||
160570178|NCT02495077|579810418|FG000|Overall Study|Withdrawal by Subject|7|||
160570179|NCT02495077|579810419|FG001|Overall Study|Withdrawal by Subject|7|||
160570180|NCT02495077|579810420|FG002|Overall Study|Withdrawal by Subject|7|||
160909053|NCT00601458|581061921|FG002|Overall Study|Dosing Error|0|||
160909054|NCT00601458|581061919|FG000|Overall Study|Incomplete Data|0|||
160909055|NCT00601458|581061920|FG001|Overall Study|Incomplete Data|2|||
160909056|NCT00601458|581061921|FG002|Overall Study|Incomplete Data|0|||
160909057|NCT00601458|581061919|FG000|Overall Study|Protocol Violation|3|||
160909058|NCT00601458|581061920|FG001|Overall Study|Protocol Violation|2|||
160909059|NCT00601458|581061921|FG002|Overall Study|Protocol Violation|1|||
160994285|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994286|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994287|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994288|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994289|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994290|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994291|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994292|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
160994293|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994294|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994295|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994296|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994297|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994298|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994299|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
160994300|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994301|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994302|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994303|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994304|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994305|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994306|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994307|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994308|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
160994309|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994310|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994311|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994312|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994313|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994314|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994315|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994316|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994317|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
160994318|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994319|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994320|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994321|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994322|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994323|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994324|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994325|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994326|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994327|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
160994328|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
160994329|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994330|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994331|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994332|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994333|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994334|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994335|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
160994336|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
160858650|NCT00506350|580874802|FG004|Overall Study|Withdrawal by Subject|4|||
160858651|NCT00506350|580874803|FG005|Overall Study|Withdrawal by Subject|1|||
160858652|NCT00506350|580874804|FG006|Overall Study|Withdrawal by Subject|1|||
160858653|NCT00506350|580874805|FG007|Overall Study|Withdrawal by Subject|2|||
160858654|NCT00506350|580874806|FG008|Overall Study|Withdrawal by Subject|0|||
160994337|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994338|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160652313|NCT04471428|580107438|FG001|Overall Study|Physician Decision|1|||
160858655|NCT00506350|580874798|FG000|Overall Study|Lost to Follow-up|1|||
160858656|NCT00506350|580874799|FG001|Overall Study|Lost to Follow-up|1|||
160858657|NCT00506350|580874800|FG002|Overall Study|Lost to Follow-up|1|||
160858658|NCT00506350|580874801|FG003|Overall Study|Lost to Follow-up|1|||
160858659|NCT00506350|580874802|FG004|Overall Study|Lost to Follow-up|2|||
160858660|NCT00506350|580874803|FG005|Overall Study|Lost to Follow-up|1|||
160994339|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994340|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994341|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994342|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994343|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994344|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994345|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
160994346|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994347|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994348|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994349|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994350|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994351|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994352|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994353|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994354|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
160994355|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994356|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994357|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160858661|NCT00506350|580874804|FG006|Overall Study|Lost to Follow-up|0|||
160858662|NCT00506350|580874805|FG007|Overall Study|Lost to Follow-up|0|||
160858663|NCT00506350|580874806|FG008|Overall Study|Lost to Follow-up|2|||
160858664|NCT00506350|580874798|FG000|Overall Study|Medical Reason|0|||
160858665|NCT00506350|580874799|FG001|Overall Study|Medical Reason|0|||
160858666|NCT00506350|580874800|FG002|Overall Study|Medical Reason|0|||
160858667|NCT00506350|580874801|FG003|Overall Study|Medical Reason|0|||
160858668|NCT00506350|580874802|FG004|Overall Study|Medical Reason|1|||
160858669|NCT00506350|580874803|FG005|Overall Study|Medical Reason|0|||
160858670|NCT00506350|580874804|FG006|Overall Study|Medical Reason|0|||
160858671|NCT00506350|580874805|FG007|Overall Study|Medical Reason|0|||
160858672|NCT00506350|580874806|FG008|Overall Study|Medical Reason|0|||
160858673|NCT00506350|580874798|FG000|Overall Study|Other|1|||
160858674|NCT00506350|580874799|FG001|Overall Study|Other|1|||
160858675|NCT00506350|580874800|FG002|Overall Study|Other|3|||
160858676|NCT00506350|580874801|FG003|Overall Study|Other|0|||
160858677|NCT00506350|580874802|FG004|Overall Study|Other|3|||
160858678|NCT00506350|580874803|FG005|Overall Study|Other|0|||
160858679|NCT00506350|580874804|FG006|Overall Study|Other|0|||
160858680|NCT00506350|580874805|FG007|Overall Study|Other|2|||
160652314|NCT04471428|580107437|FG000|Overall Study|Reason Not Specified|0|||
160858681|NCT00506350|580874806|FG008|Overall Study|Other|2|||
160858682|NCT03474588|580874807|FG000|Overall Study|Withdrawal by Subject|4|||
160858683|NCT03474588|580874808|FG001|Overall Study|Withdrawal by Subject|3|||
160858684|NCT03474588|580874807|FG000|Overall Study|Death|0|||
160858685|NCT03474588|580874808|FG001|Overall Study|Death|1|||
160858686|NCT01607957|580874809|FG000|Overall Study|Not treated|1|||
160858687|NCT01607957|580874810|FG001|Overall Study|Not treated|1|||
160858688|NCT01607957|580874809|FG000|Overall Study|Death|367|||
160858689|NCT01607957|580874810|FG001|Overall Study|Death|211|||
160858690|NCT01607957|580874809|FG000|Overall Study|Lost to Follow-up|3|||
160858691|NCT01607957|580874810|FG001|Overall Study|Lost to Follow-up|3|||
160858692|NCT01607957|580874809|FG000|Overall Study|Participant refusal|1|||
160858693|NCT01607957|580874810|FG001|Overall Study|Participant refusal|0|||
160858694|NCT01691794|580874811|FG000|Overall Study|Poor/Non-Compliance|1|||
160858695|NCT01691794|580874812|FG001|Overall Study|Poor/Non-Compliance|4|||
160858696|NCT01691794|580874813|FG002|Overall Study|Poor/Non-Compliance|1|||
160858697|NCT01691794|580874811|FG000|Overall Study|Death|0|||
160858698|NCT01691794|580874812|FG001|Overall Study|Death|0|||
160858699|NCT01691794|580874813|FG002|Overall Study|Death|1|||
160858700|NCT01691794|580874811|FG000|Overall Study|Lack of Efficacy|0|||
160858701|NCT01691794|580874812|FG001|Overall Study|Lack of Efficacy|7|||
160858702|NCT01691794|580874813|FG002|Overall Study|Lack of Efficacy|1|||
160858703|NCT01691794|580874811|FG000|Overall Study|Participant request to discontinue|0|||
160858704|NCT01691794|580874812|FG001|Overall Study|Participant request to discontinue|1|||
160858705|NCT01691794|580874813|FG002|Overall Study|Participant request to discontinue|0|||
160858706|NCT01691794|580874811|FG000|Overall Study|Adverse Event|0|||
160858707|NCT01691794|580874812|FG001|Overall Study|Adverse Event|1|||
160858708|NCT01691794|580874813|FG002|Overall Study|Adverse Event|1|||
160909060|NCT00601458|581061919|FG000|Overall Study|Early Termination|0|||
160909061|NCT00601458|581061920|FG001|Overall Study|Early Termination|1|||
160909062|NCT00601458|581061921|FG002|Overall Study|Early Termination|1|||
160909063|NCT00518986|581061922|FG000|Overall Study|Adverse Event|12|||
160909064|NCT00518986|581061923|FG001|Overall Study|Adverse Event|7|||
160909065|NCT00518986|581061922|FG000|Overall Study|Lack of Efficacy|0|||
160909066|NCT00518986|581061923|FG001|Overall Study|Lack of Efficacy|2|||
160909067|NCT00518986|581061922|FG000|Overall Study|Lost to Follow-up|3|||
160909068|NCT00518986|581061923|FG001|Overall Study|Lost to Follow-up|2|||
160909069|NCT00518986|581061922|FG000|Overall Study|Physician Decision|0|||
160909070|NCT00518986|581061923|FG001|Overall Study|Physician Decision|3|||
160909071|NCT00518986|581061922|FG000|Overall Study|Protocol Violation|5|||
160909072|NCT00518986|581061923|FG001|Overall Study|Protocol Violation|7|||
160909073|NCT00518986|581061922|FG000|Overall Study|Withdrawal by Subject|4|||
160909074|NCT00518986|581061923|FG001|Overall Study|Withdrawal by Subject|4|||
160909075|NCT00518986|581061922|FG000|Overall Study|Non-Specific|2|||
160909076|NCT00518986|581061923|FG001|Overall Study|Non-Specific|1|||
160909077|NCT04862585|581061926|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
160909078|NCT04862585|581061927|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
160909079|NCT04862585|581061926|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
160909080|NCT04862585|581061927|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
160909081|NCT04862585|581061926|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
160909082|NCT04862585|581061927|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
160909083|NCT04862585|581061926|FG000|Overall Study|one withdrew without providing a reason|0|||
160909084|NCT04862585|581061927|FG001|Overall Study|one withdrew without providing a reason|1|||
160909085|NCT02099708|581061929|FG000|Overall Study|Data Not Available|30|||
160909086|NCT02099708|581061929|FG000|Overall Study|Lost to Follow-up|141|||
160909087|NCT02099708|581061929|FG000|Overall Study|Other|29|||
160909088|NCT05229406|581061930|FG000|Overall Study|Withdrawal by Subject|1|||
160909089|NCT05229406|581061931|FG001|Overall Study|Withdrawal by Subject|2|||
160909090|NCT01930123|581061932|FG000|Overall Study|Adverse Event|1|||
160909091|NCT01930123|581061933|FG001|Overall Study|Adverse Event|0|||
160909092|NCT01930123|581061932|FG000|Overall Study|Physician Decision|21|||
160909093|NCT01930123|581061933|FG001|Overall Study|Physician Decision|8|||
160909094|NCT01930123|581061932|FG000|Overall Study|Withdrawal by Subject|1|||
160909095|NCT01930123|581061933|FG001|Overall Study|Withdrawal by Subject|0|||
160909096|NCT03310021|581061936|FG000|Overall Study|Withdrawal by Subject|0|||
160909097|NCT03310021|581061937|FG001|Overall Study|Withdrawal by Subject|0|||
160909098|NCT03310021|581061938|FG002|Overall Study|Withdrawal by Subject|0|||
160909099|NCT03310021|581061939|FG003|Overall Study|Withdrawal by Subject|0|||
160909100|NCT03310021|581061940|FG004|Overall Study|Withdrawal by Subject|0|||
160909101|NCT03310021|581061941|FG005|Overall Study|Withdrawal by Subject|0|||
160909102|NCT03310021|581061942|FG006|Overall Study|Withdrawal by Subject|1|||
160909103|NCT03310021|581061943|FG007|Overall Study|Withdrawal by Subject|0|||
160909104|NCT03310021|581061944|FG008|Overall Study|Withdrawal by Subject|0|||
160909105|NCT03310021|581061945|FG009|Overall Study|Withdrawal by Subject|0|||
160909106|NCT03310021|581061946|FG010|Overall Study|Withdrawal by Subject|0|||
160909107|NCT03310021|581061947|FG011|Overall Study|Withdrawal by Subject|0|||
160909108|NCT03310021|581061948|FG012|Overall Study|Withdrawal by Subject|0|||
160909109|NCT03310021|581061949|FG013|Overall Study|Withdrawal by Subject|0|||
160909110|NCT03310021|581061950|FG014|Overall Study|Withdrawal by Subject|0|||
160909111|NCT03310021|581061951|FG015|Overall Study|Withdrawal by Subject|0|||
160909112|NCT03310021|581061952|FG016|Overall Study|Withdrawal by Subject|0|||
160909113|NCT03310021|581061953|FG017|Overall Study|Withdrawal by Subject|0|||
160909114|NCT03310021|581061954|FG018|Overall Study|Withdrawal by Subject|0|||
160909115|NCT03310021|581061955|FG019|Overall Study|Withdrawal by Subject|0|||
160909116|NCT03310021|581061936|FG000|Overall Study|Lost to Follow-up|0|||
160909117|NCT03310021|581061937|FG001|Overall Study|Lost to Follow-up|0|||
160909118|NCT03310021|581061938|FG002|Overall Study|Lost to Follow-up|0|||
160909119|NCT03310021|581061939|FG003|Overall Study|Lost to Follow-up|0|||
160909120|NCT03310021|581061940|FG004|Overall Study|Lost to Follow-up|0|||
160909121|NCT03310021|581061941|FG005|Overall Study|Lost to Follow-up|0|||
160909122|NCT03310021|581061942|FG006|Overall Study|Lost to Follow-up|0|||
160909123|NCT03310021|581061943|FG007|Overall Study|Lost to Follow-up|0|||
160909124|NCT03310021|581061944|FG008|Overall Study|Lost to Follow-up|0|||
160909125|NCT03310021|581061945|FG009|Overall Study|Lost to Follow-up|0|||
160909126|NCT03310021|581061946|FG010|Overall Study|Lost to Follow-up|1|||
160909127|NCT03310021|581061947|FG011|Overall Study|Lost to Follow-up|0|||
160909128|NCT03310021|581061948|FG012|Overall Study|Lost to Follow-up|0|||
160909129|NCT03310021|581061949|FG013|Overall Study|Lost to Follow-up|0|||
160909130|NCT03310021|581061950|FG014|Overall Study|Lost to Follow-up|0|||
160909131|NCT03310021|581061951|FG015|Overall Study|Lost to Follow-up|0|||
160909132|NCT03310021|581061952|FG016|Overall Study|Lost to Follow-up|0|||
160909133|NCT03310021|581061953|FG017|Overall Study|Lost to Follow-up|0|||
160909134|NCT03310021|581061954|FG018|Overall Study|Lost to Follow-up|0|||
160994358|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994359|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994360|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994361|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994362|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994363|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160909135|NCT03310021|581061955|FG019|Overall Study|Lost to Follow-up|0|||
160994364|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
160994365|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994366|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994367|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994368|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994369|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994370|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994371|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994372|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994373|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
160994374|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994375|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994376|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994377|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994378|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994379|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994380|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994381|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994382|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
160909136|NCT00702923|581061958|FG000|Overall Study|Adverse Event|1|||
160909137|NCT02002091|581061959|FG000|Screening|Lost to Follow-up|10|||
160909138|NCT02002091|581061960|FG001|Screening|Lost to Follow-up|12|||
160909139|NCT02002091|581061959|FG000|Screening|Death|3|||
160909140|NCT02002091|581061960|FG001|Screening|Death|2|||
160909141|NCT03953820|581061961|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
160909142|NCT03953820|581061962|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
160909143|NCT03953820|581061963|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
160909144|NCT03953820|581061961|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
160909145|NCT03953820|581061962|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
160909146|NCT03953820|581061963|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
160909147|NCT01233258|581061966|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
160909148|NCT01233258|581061967|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
160909149|NCT01233258|581061968|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
160909150|NCT01233258|581061969|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
160909151|NCT01233258|581061970|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
160909152|NCT01233258|581061971|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
160909153|NCT01233258|581061966|FG000|First Intervention (6 Months)|Protocol Violation|0|||
160909154|NCT01233258|581061967|FG001|First Intervention (6 Months)|Protocol Violation|0|||
160909155|NCT01233258|581061968|FG002|First Intervention (6 Months)|Protocol Violation|1|||
160909156|NCT01233258|581061969|FG003|First Intervention (6 Months)|Protocol Violation|0|||
160909157|NCT01233258|581061970|FG004|First Intervention (6 Months)|Protocol Violation|0|||
160909158|NCT01233258|581061971|FG005|First Intervention (6 Months)|Protocol Violation|0|||
160909159|NCT01233258|581061966|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
160909160|NCT01233258|581061967|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
160909161|NCT01233258|581061968|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
160909162|NCT01233258|581061969|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
160909163|NCT01233258|581061970|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
160909164|NCT01233258|581061971|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
160909165|NCT00530946|581061975|FG000|Overall Study|Adverse Event|1|||
160909166|NCT00530946|581061976|FG001|Overall Study|Adverse Event|2|||
160909167|NCT00530946|581061977|FG002|Overall Study|Adverse Event|1|||
160909168|NCT00530946|581061978|FG003|Overall Study|Adverse Event|1|||
160909169|NCT00530946|581061975|FG000|Overall Study|Protocol Violation|0|||
160909170|NCT00530946|581061976|FG001|Overall Study|Protocol Violation|0|||
160909171|NCT00530946|581061977|FG002|Overall Study|Protocol Violation|0|||
160652315|NCT04471428|580107438|FG001|Overall Study|Reason Not Specified|2|||
160909172|NCT00530946|581061978|FG003|Overall Study|Protocol Violation|1|||
160858709|NCT01691794|580874811|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
160994383|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994384|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994385|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994386|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994387|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994388|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994389|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994390|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994391|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994392|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994393|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994394|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994395|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
160994396|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994397|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994398|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
160994399|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
160994400|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994401|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994402|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994403|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994404|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994405|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994406|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994407|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994408|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994409|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
160994410|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994411|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994412|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994413|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994414|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994415|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994416|NCT03598790|581368941|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994417|NCT03598790|581368942|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994418|NCT03598790|581368943|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994419|NCT03598790|581368944|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
160994420|NCT03598790|581368945|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
160994421|NCT03598790|581368946|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
160994422|NCT03598790|581368947|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994423|NCT03598790|581368948|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994424|NCT03598790|581368949|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994425|NCT03598790|581368941|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994426|NCT03598790|581368942|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994427|NCT03598790|581368943|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994428|NCT03598790|581368944|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
160994429|NCT03598790|581368945|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994430|NCT03598790|581368946|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994431|NCT03598790|581368947|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994432|NCT03598790|581368948|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994433|NCT03598790|581368949|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994434|NCT03598790|581368941|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994435|NCT03598790|581368942|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994436|NCT03598790|581368943|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994437|NCT03598790|581368944|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
160652316|NCT04471428|580107437|FG000|Overall Study|Death|131|||
160652317|NCT04471428|580107438|FG001|Overall Study|Death|147|||
160858710|NCT01691794|580874812|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
160652318|NCT04471428|580107437|FG000|Overall Study|Lost to Follow-up|0|||
160652319|NCT04471428|580107438|FG001|Overall Study|Lost to Follow-up|3|||
160652320|NCT04471428|580107437|FG000|Overall Study|Study Terminated by Sponsor|20|||
160652321|NCT04471428|580107438|FG001|Overall Study|Study Terminated by Sponsor|29|||
160652322|NCT03504852|580107439|FG000|Overall Study|Withdrawal of informed consent|2|||
160652323|NCT03504852|580107440|FG001|Overall Study|Withdrawal of informed consent|1|||
160652324|NCT03504852|580107441|FG002|Overall Study|Withdrawal of informed consent|0|||
160652325|NCT03504852|580107439|FG000|Overall Study|Withdrawal by Subject|5|||
160858711|NCT01691794|580874813|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
160858712|NCT01691794|580874811|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
160858713|NCT01691794|580874812|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
160858714|NCT01691794|580874813|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
160858715|NCT04972786|580874814|FG000|First Intervention (1 Day)|Adverse Event|1|||
160858716|NCT04972786|580874815|FG001|First Intervention (1 Day)|Adverse Event|0|||
160858717|NCT03905096|580874816|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
160858718|NCT03905096|580874817|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
160858719|NCT00385671|580876882|FG000|Overall Study|Adverse Event|14|||
160858720|NCT00385671|580876883|FG001|Overall Study|Adverse Event|27|||
160858721|NCT00385671|580876884|FG002|Overall Study|Adverse Event|18|||
160858722|NCT00385671|580876882|FG000|Overall Study|Lack of Efficacy|5|||
160858723|NCT00385671|580876883|FG001|Overall Study|Lack of Efficacy|9|||
160858724|NCT00385671|580876884|FG002|Overall Study|Lack of Efficacy|5|||
160858725|NCT00385671|580876882|FG000|Overall Study|Lost to Follow-up|6|||
160858726|NCT00385671|580876883|FG001|Overall Study|Lost to Follow-up|6|||
160858727|NCT00385671|580876884|FG002|Overall Study|Lost to Follow-up|5|||
160858728|NCT00385671|580876882|FG000|Overall Study|Physician Decision|2|||
160858729|NCT00385671|580876883|FG001|Overall Study|Physician Decision|1|||
160858730|NCT00385671|580876884|FG002|Overall Study|Physician Decision|2|||
160858731|NCT00385671|580876882|FG000|Overall Study|Protocol Violation|5|||
160858732|NCT00385671|580876883|FG001|Overall Study|Protocol Violation|2|||
160858733|NCT00385671|580876884|FG002|Overall Study|Protocol Violation|1|||
160858734|NCT00385671|580876882|FG000|Overall Study|Sponsor Decision|2|||
160858735|NCT00385671|580876883|FG001|Overall Study|Sponsor Decision|2|||
160858736|NCT00385671|580876884|FG002|Overall Study|Sponsor Decision|1|||
160858737|NCT00385671|580876882|FG000|Overall Study|Withdrawal by Subject|4|||
160858738|NCT00385671|580876883|FG001|Overall Study|Withdrawal by Subject|4|||
160858739|NCT00385671|580876884|FG002|Overall Study|Withdrawal by Subject|4|||
160858740|NCT02608684|580876885|FG000|Overall Study|Physician Decision|2|||
160858741|NCT02608684|580876885|FG000|Overall Study|Withdrawal by Subject|1|||
160858742|NCT01775501|580876888|FG000|Overall Study|Discontinued prior to treatment|1|||
160858743|NCT03037385|580876889|FG000|Overall Study|Adverse Event|0|||
160858744|NCT03037385|580876890|FG001|Overall Study|Adverse Event|0|||
160858745|NCT03037385|580876891|FG002|Overall Study|Adverse Event|1|||
160858746|NCT03037385|580876892|FG003|Overall Study|Adverse Event|0|||
160858747|NCT03037385|580876893|FG004|Overall Study|Adverse Event|0|||
160858748|NCT03037385|580876894|FG005|Overall Study|Adverse Event|0|||
160858749|NCT03037385|580876895|FG006|Overall Study|Adverse Event|0|||
160858750|NCT03037385|580876896|FG007|Overall Study|Adverse Event|0|||
160858751|NCT03037385|580876897|FG008|Overall Study|Adverse Event|0|||
160858752|NCT03037385|580876898|FG009|Overall Study|Adverse Event|6|||
160858753|NCT03037385|580876889|FG000|Overall Study|Death|1|||
160858754|NCT03037385|580876890|FG001|Overall Study|Death|4|||
160858755|NCT03037385|580876891|FG002|Overall Study|Death|2|||
160858756|NCT03037385|580876892|FG003|Overall Study|Death|2|||
160858757|NCT03037385|580876893|FG004|Overall Study|Death|5|||
160858758|NCT03037385|580876894|FG005|Overall Study|Death|2|||
160858759|NCT03037385|580876895|FG006|Overall Study|Death|1|||
160858760|NCT03037385|580876896|FG007|Overall Study|Death|4|||
160858761|NCT03037385|580876897|FG008|Overall Study|Death|3|||
160858762|NCT03037385|580876898|FG009|Overall Study|Death|240|||
160858763|NCT03037385|580876889|FG000|Overall Study|Initiation of Another Therapy|1|||
160858764|NCT03037385|580876890|FG001|Overall Study|Initiation of Another Therapy|0|||
160858765|NCT03037385|580876891|FG002|Overall Study|Initiation of Another Therapy|0|||
160652326|NCT03504852|580107440|FG001|Overall Study|Withdrawal by Subject|5|||
160858766|NCT03037385|580876892|FG003|Overall Study|Initiation of Another Therapy|0|||
160858767|NCT03037385|580876893|FG004|Overall Study|Initiation of Another Therapy|0|||
160858768|NCT03037385|580876894|FG005|Overall Study|Initiation of Another Therapy|0|||
160858769|NCT03037385|580876895|FG006|Overall Study|Initiation of Another Therapy|0|||
160858770|NCT03037385|580876896|FG007|Overall Study|Initiation of Another Therapy|1|||
160858771|NCT03037385|580876897|FG008|Overall Study|Initiation of Another Therapy|0|||
160858772|NCT03037385|580876898|FG009|Overall Study|Initiation of Another Therapy|2|||
160858773|NCT03037385|580876889|FG000|Overall Study|Lost to Follow-up|0|||
160858774|NCT03037385|580876890|FG001|Overall Study|Lost to Follow-up|0|||
160858775|NCT03037385|580876891|FG002|Overall Study|Lost to Follow-up|0|||
160858776|NCT03037385|580876892|FG003|Overall Study|Lost to Follow-up|0|||
160858777|NCT03037385|580876893|FG004|Overall Study|Lost to Follow-up|0|||
160858778|NCT03037385|580876894|FG005|Overall Study|Lost to Follow-up|1|||
160858779|NCT03037385|580876895|FG006|Overall Study|Lost to Follow-up|0|||
160994438|NCT03598790|581368945|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994439|NCT03598790|581368946|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994440|NCT03598790|581368947|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994441|NCT03598790|581368948|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994442|NCT03598790|581368949|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994443|NCT03598790|581368941|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994444|NCT03598790|581368942|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994445|NCT03598790|581368943|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994446|NCT03598790|581368944|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
160994447|NCT03598790|581368945|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
160994448|NCT03598790|581368946|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994449|NCT03598790|581368947|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994450|NCT03598790|581368948|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994451|NCT03598790|581368949|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994452|NCT03598790|581368941|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160858780|NCT03037385|580876896|FG007|Overall Study|Lost to Follow-up|0|||
160858781|NCT03037385|580876897|FG008|Overall Study|Lost to Follow-up|0|||
160858782|NCT03037385|580876898|FG009|Overall Study|Lost to Follow-up|16|||
160858783|NCT03037385|580876889|FG000|Overall Study|Physician Decision|0|||
160858784|NCT03037385|580876890|FG001|Overall Study|Physician Decision|0|||
160858785|NCT03037385|580876891|FG002|Overall Study|Physician Decision|0|||
160858786|NCT03037385|580876892|FG003|Overall Study|Physician Decision|0|||
160858787|NCT03037385|580876893|FG004|Overall Study|Physician Decision|0|||
160858788|NCT03037385|580876894|FG005|Overall Study|Physician Decision|0|||
160858789|NCT03037385|580876895|FG006|Overall Study|Physician Decision|0|||
160858790|NCT03037385|580876896|FG007|Overall Study|Physician Decision|0|||
160858791|NCT03037385|580876897|FG008|Overall Study|Physician Decision|0|||
160858792|NCT03037385|580876898|FG009|Overall Study|Physician Decision|1|||
160858793|NCT03037385|580876889|FG000|Overall Study|Progressive Disease|0|||
160858794|NCT03037385|580876890|FG001|Overall Study|Progressive Disease|1|||
160858795|NCT03037385|580876891|FG002|Overall Study|Progressive Disease|1|||
160858796|NCT03037385|580876892|FG003|Overall Study|Progressive Disease|5|||
160858797|NCT03037385|580876893|FG004|Overall Study|Progressive Disease|2|||
160858798|NCT03037385|580876894|FG005|Overall Study|Progressive Disease|0|||
160858799|NCT03037385|580876895|FG006|Overall Study|Progressive Disease|1|||
160858800|NCT03037385|580876896|FG007|Overall Study|Progressive Disease|0|||
160858801|NCT03037385|580876897|FG008|Overall Study|Progressive Disease|0|||
160858802|NCT03037385|580876898|FG009|Overall Study|Progressive Disease|30|||
160858803|NCT03037385|580876889|FG000|Overall Study|Withdrawal by Subject|0|||
160858804|NCT03037385|580876890|FG001|Overall Study|Withdrawal by Subject|0|||
160909173|NCT00530946|581061975|FG000|Overall Study|Noncompliance|1|||
160909174|NCT00530946|581061976|FG001|Overall Study|Noncompliance|0|||
160909175|NCT00530946|581061977|FG002|Overall Study|Noncompliance|0|||
160909176|NCT00530946|581061978|FG003|Overall Study|Noncompliance|0|||
160909177|NCT01534962|581061979|FG000|Overall Study|Randomized but did not start treatment|2|||
160909178|NCT01534962|581061980|FG001|Overall Study|Randomized but did not start treatment|0|||
160909179|NCT01534962|581061981|FG002|Overall Study|Randomized but did not start treatment|0|||
160909180|NCT01534962|581061982|FG003|Overall Study|Randomized but did not start treatment|1|||
160909181|NCT01534962|581061979|FG000|Overall Study|Discontinued at AF recurrence|35|||
160909182|NCT01534962|581061980|FG001|Overall Study|Discontinued at AF recurrence|26|||
160909183|NCT01534962|581061981|FG002|Overall Study|Discontinued at AF recurrence|24|||
160909184|NCT01534962|581061982|FG003|Overall Study|Discontinued at AF recurrence|31|||
160909185|NCT00880009|581061983|FG000|Overall Study|Study terminated by sponsor|14|||
160909186|NCT00880009|581061983|FG000|Overall Study|Withdrawal by Subject|1|||
160909187|NCT00880009|581061983|FG000|Overall Study|Protocol Violation|1|||
160570181|NCT02495077|579810421|FG003|Overall Study|Withdrawal by Subject|0|||
160570182|NCT02495077|579810418|FG000|Overall Study|Covid-19 research restrictions|1|||
160570183|NCT02495077|579810419|FG001|Overall Study|Covid-19 research restrictions|0|||
160570184|NCT02495077|579810420|FG002|Overall Study|Covid-19 research restrictions|0|||
160858805|NCT03037385|580876891|FG002|Overall Study|Withdrawal by Subject|1|||
160858806|NCT03037385|580876892|FG003|Overall Study|Withdrawal by Subject|2|||
160909188|NCT04545385|581061988|FG000|Overall Study|Withdrawal by Subject|2|||
160909189|NCT04545385|581061989|FG001|Overall Study|Withdrawal by Subject|0|||
160909190|NCT04545385|581061988|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
160909191|NCT04545385|581061989|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
160858807|NCT03037385|580876893|FG004|Overall Study|Withdrawal by Subject|1|||
160858808|NCT03037385|580876894|FG005|Overall Study|Withdrawal by Subject|3|||
160909192|NCT04545385|581061988|FG000|Overall Study|Study termination|10|||
160909193|NCT04545385|581061989|FG001|Overall Study|Study termination|10|||
160909194|NCT04545385|581061988|FG000|Overall Study|Sponsor decision|2|||
160858809|NCT03037385|580876895|FG006|Overall Study|Withdrawal by Subject|0|||
160858810|NCT03037385|580876896|FG007|Overall Study|Withdrawal by Subject|0|||
160858811|NCT03037385|580876897|FG008|Overall Study|Withdrawal by Subject|0|||
160858812|NCT03037385|580876898|FG009|Overall Study|Withdrawal by Subject|52|||
160858813|NCT03037385|580876889|FG000|Overall Study|Reason Not Specified|0|||
160858814|NCT03037385|580876890|FG001|Overall Study|Reason Not Specified|1|||
160858815|NCT03037385|580876891|FG002|Overall Study|Reason Not Specified|0|||
160858816|NCT03037385|580876892|FG003|Overall Study|Reason Not Specified|4|||
160858817|NCT03037385|580876893|FG004|Overall Study|Reason Not Specified|3|||
160858818|NCT03037385|580876894|FG005|Overall Study|Reason Not Specified|6|||
160858819|NCT03037385|580876895|FG006|Overall Study|Reason Not Specified|2|||
160858820|NCT03037385|580876896|FG007|Overall Study|Reason Not Specified|0|||
160858821|NCT03037385|580876897|FG008|Overall Study|Reason Not Specified|1|||
160858822|NCT03037385|580876898|FG009|Overall Study|Reason Not Specified|181|||
160858823|NCT02318706|580876899|FG000|Double-blind Phase|Adverse Event|7|||
160858824|NCT02318706|580876900|FG001|Double-blind Phase|Adverse Event|4|||
160858825|NCT02318706|580876901|FG002|Double-blind Phase|Adverse Event|3|||
160858826|NCT02318706|580876902|FG003|Double-blind Phase|Adverse Event|10|||
160858827|NCT02318706|580876903|FG004|Double-blind Phase|Adverse Event|0|||
160858828|NCT02318706|580876899|FG000|Double-blind Phase|Lost to Follow-up|1|||
160858829|NCT02318706|580876900|FG001|Double-blind Phase|Lost to Follow-up|0|||
160858830|NCT02318706|580876901|FG002|Double-blind Phase|Lost to Follow-up|0|||
160858831|NCT02318706|580876902|FG003|Double-blind Phase|Lost to Follow-up|0|||
160858832|NCT02318706|580876903|FG004|Double-blind Phase|Lost to Follow-up|0|||
160858833|NCT02318706|580876899|FG000|Double-blind Phase|Protocol Violation|4|||
160858834|NCT02318706|580876900|FG001|Double-blind Phase|Protocol Violation|2|||
160858835|NCT02318706|580876901|FG002|Double-blind Phase|Protocol Violation|4|||
160858836|NCT02318706|580876902|FG003|Double-blind Phase|Protocol Violation|3|||
160858837|NCT02318706|580876903|FG004|Double-blind Phase|Protocol Violation|0|||
160858838|NCT02318706|580876899|FG000|Double-blind Phase|Withdrawal by Subject|9|||
160858839|NCT02318706|580876900|FG001|Double-blind Phase|Withdrawal by Subject|5|||
160858840|NCT02318706|580876901|FG002|Double-blind Phase|Withdrawal by Subject|7|||
160858841|NCT02318706|580876902|FG003|Double-blind Phase|Withdrawal by Subject|10|||
160858842|NCT02318706|580876903|FG004|Double-blind Phase|Withdrawal by Subject|0|||
160858843|NCT02318706|580876899|FG000|Double-blind Phase|Other|4|||
160858844|NCT02318706|580876900|FG001|Double-blind Phase|Other|1|||
160858845|NCT02318706|580876901|FG002|Double-blind Phase|Other|2|||
160858846|NCT02318706|580876902|FG003|Double-blind Phase|Other|1|||
160858847|NCT02318706|580876903|FG004|Double-blind Phase|Other|0|||
160858848|NCT02318706|580876899|FG000|Double-blind Phase|Death|0|||
160858849|NCT02318706|580876900|FG001|Double-blind Phase|Death|0|||
160858850|NCT02318706|580876901|FG002|Double-blind Phase|Death|2|||
160858851|NCT02318706|580876902|FG003|Double-blind Phase|Death|0|||
160858852|NCT02318706|580876903|FG004|Double-blind Phase|Death|0|||
160858853|NCT02318706|580876899|FG000|Open-label Extension Phase|Adverse Event|0|||
160858854|NCT02318706|580876900|FG001|Open-label Extension Phase|Adverse Event|0|||
160858855|NCT02318706|580876901|FG002|Open-label Extension Phase|Adverse Event|0|||
160858856|NCT02318706|580876902|FG003|Open-label Extension Phase|Adverse Event|0|||
160858857|NCT02318706|580876903|FG004|Open-label Extension Phase|Adverse Event|21|||
160858858|NCT02318706|580876899|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
160858859|NCT02318706|580876900|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
160858860|NCT02318706|580876901|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
160858861|NCT02318706|580876902|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
160858862|NCT02318706|580876903|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
160858863|NCT02318706|580876899|FG000|Open-label Extension Phase|Death|0|||
160858864|NCT02318706|580876900|FG001|Open-label Extension Phase|Death|0|||
160858865|NCT02318706|580876901|FG002|Open-label Extension Phase|Death|0|||
160858866|NCT02318706|580876902|FG003|Open-label Extension Phase|Death|0|||
160858867|NCT02318706|580876903|FG004|Open-label Extension Phase|Death|1|||
160858868|NCT02318706|580876899|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
160858869|NCT02318706|580876900|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
160858870|NCT02318706|580876901|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
160858871|NCT02318706|580876902|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
160994453|NCT03598790|581368942|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994454|NCT03598790|581368943|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994455|NCT03598790|581368944|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
160994456|NCT03598790|581368945|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160858872|NCT02318706|580876903|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
160858873|NCT04328077|580876904|FG000|Overall Study|Lost to Follow-up|0|||
160858874|NCT04328077|580876905|FG001|Overall Study|Lost to Follow-up|1|||
160858875|NCT04328077|580876906|FG002|Overall Study|Lost to Follow-up|0|||
160858876|NCT04328077|580876907|FG003|Overall Study|Lost to Follow-up|0|||
160858877|NCT04328077|580876904|FG000|Overall Study|Withdrawal by Subject|0|||
160858878|NCT04328077|580876905|FG001|Overall Study|Withdrawal by Subject|1|||
160858879|NCT04328077|580876906|FG002|Overall Study|Withdrawal by Subject|1|||
160858880|NCT04328077|580876907|FG003|Overall Study|Withdrawal by Subject|3|||
160858881|NCT01456039|580876908|FG000|Phase 1 (First Step)|Disease Progression|1|||
160858882|NCT01456039|580876909|FG001|Phase 1 (First Step)|Disease Progression|1|||
160858883|NCT01456039|580876910|FG002|Phase 1 (First Step)|Disease Progression|0|||
160858884|NCT01456039|580876908|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
160858885|NCT01456039|580876909|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
160858886|NCT01456039|580876910|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
160858887|NCT01456039|580876908|FG000|Phase 1 (First Step)|Adverse Event|0|||
160858888|NCT01456039|580876909|FG001|Phase 1 (First Step)|Adverse Event|3|||
160858889|NCT01456039|580876910|FG002|Phase 1 (First Step)|Adverse Event|0|||
160858890|NCT01456039|580876908|FG000|Phase 1 (First Step)|Other|0|||
160858891|NCT01456039|580876909|FG001|Phase 1 (First Step)|Other|1|||
160858892|NCT01456039|580876910|FG002|Phase 1 (First Step)|Other|0|||
160858893|NCT01456039|580876908|FG000|Phase 2 (Second Step)|Disease Progression|0|||
160858894|NCT01456039|580876909|FG001|Phase 2 (Second Step)|Disease Progression|0|||
160858895|NCT01456039|580876910|FG002|Phase 2 (Second Step)|Disease Progression|17|||
160858896|NCT01456039|580876908|FG000|Phase 2 (Second Step)|Adverse Event|0|||
160858897|NCT01456039|580876909|FG001|Phase 2 (Second Step)|Adverse Event|0|||
160858898|NCT01456039|580876910|FG002|Phase 2 (Second Step)|Adverse Event|10|||
160858899|NCT01456039|580876908|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
160858900|NCT01456039|580876909|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
160858901|NCT01456039|580876910|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
160858902|NCT01456039|580876908|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
160858903|NCT01456039|580876909|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
160858904|NCT01456039|580876910|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
160858905|NCT01456039|580876908|FG000|Phase 2 (Second Step)|Other|0|||
160858906|NCT01456039|580876909|FG001|Phase 2 (Second Step)|Other|0|||
160858907|NCT01456039|580876910|FG002|Phase 2 (Second Step)|Other|1|||
160858908|NCT01702311|580876914|FG000|Overall Study|Withdrawal by Subject|3|||
160909195|NCT04545385|581061989|FG001|Overall Study|Sponsor decision|2|||
160909196|NCT04545385|581061988|FG000|Overall Study|Other than specified|1|||
160909197|NCT04545385|581061989|FG001|Overall Study|Other than specified|0|||
160909198|NCT01128842|581061994|FG000|Overall Study|Adverse Event|1|||
160909199|NCT01128842|581061994|FG000|Overall Study|Disease Progression|6|||
160909200|NCT03322631|581061995|FG000|Overall Study|Withdrawal by Subject|0|||
160909201|NCT03322631|581061996|FG001|Overall Study|Withdrawal by Subject|1|||
160909202|NCT03322631|581061997|FG002|Overall Study|Withdrawal by Subject|0|||
160909203|NCT03322631|581061998|FG003|Overall Study|Withdrawal by Subject|0|||
160909204|NCT03322631|581061995|FG000|Overall Study|Adverse Event|0|||
160909205|NCT03322631|581061996|FG001|Overall Study|Adverse Event|0|||
160909206|NCT03322631|581061997|FG002|Overall Study|Adverse Event|1|||
160909207|NCT03322631|581061998|FG003|Overall Study|Adverse Event|0|||
160909208|NCT02378961|581061999|FG000|Overall Study|Lack of Efficacy|4|||
160909209|NCT02378961|581062000|FG001|Overall Study|Lack of Efficacy|2|||
160909210|NCT02378961|581062001|FG002|Overall Study|Lack of Efficacy|0|||
160909211|NCT02378961|581062002|FG003|Overall Study|Lack of Efficacy|1|||
160909212|NCT02378961|581061999|FG000|Overall Study|Death|0|||
160909213|NCT02378961|581062000|FG001|Overall Study|Death|0|||
160909214|NCT02378961|581062001|FG002|Overall Study|Death|1|||
160909215|NCT02378961|581062002|FG003|Overall Study|Death|0|||
160909216|NCT05399641|581062010|FG000|Overall Study|Adverse Event|0|||
160909217|NCT05399641|581062011|FG001|Overall Study|Adverse Event|1|||
160909218|NCT05399641|581062012|FG002|Overall Study|Adverse Event|1|||
160909219|NCT05399641|581062010|FG000|Overall Study|Lost to Follow-up|1|||
160909220|NCT05399641|581062011|FG001|Overall Study|Lost to Follow-up|2|||
160909221|NCT05399641|581062012|FG002|Overall Study|Lost to Follow-up|2|||
160909222|NCT05399641|581062010|FG000|Overall Study|Physician Decision|1|||
160909223|NCT05399641|581062011|FG001|Overall Study|Physician Decision|3|||
160909224|NCT05399641|581062012|FG002|Overall Study|Physician Decision|3|||
160909225|NCT05399641|581062010|FG000|Overall Study|Withdrawal by Subject|4|||
160909226|NCT05399641|581062011|FG001|Overall Study|Withdrawal by Subject|11|||
160909227|NCT05399641|581062012|FG002|Overall Study|Withdrawal by Subject|7|||
160909228|NCT05399641|581062010|FG000|Overall Study|Reason not defined|3|||
160909229|NCT05399641|581062011|FG001|Overall Study|Reason not defined|5|||
160909230|NCT05399641|581062012|FG002|Overall Study|Reason not defined|6|||
160909231|NCT02094677|581062013|FG000|Overall Study|Screening|3|||
160909232|NCT02094677|581062014|FG001|Overall Study|Screening|1|||
160909233|NCT01300650|581062015|FG000|Overall Study|Adverse Event|1|||
160909234|NCT04502693|581062016|FG000|Overall Study|Adverse Event|7|||
160909235|NCT04502693|581062017|FG001|Overall Study|Adverse Event|6|||
160909236|NCT04502693|581062018|FG002|Overall Study|Adverse Event|11|||
160909237|NCT04502693|581062019|FG003|Overall Study|Adverse Event|1|||
160652327|NCT03504852|580107441|FG002|Overall Study|Withdrawal by Subject|1|||
160858909|NCT01702311|580876915|FG001|Overall Study|Withdrawal by Subject|2|||
160858910|NCT01702311|580876914|FG000|Overall Study|Discharge less than 24 hours|10|||
160858911|NCT01702311|580876915|FG001|Overall Study|Discharge less than 24 hours|7|||
160858912|NCT01702311|580876914|FG000|Overall Study|Physician Decision|3|||
160858913|NCT01702311|580876915|FG001|Overall Study|Physician Decision|4|||
160909238|NCT04502693|581062016|FG000|Overall Study|Lost to Follow-up|32|||
160909239|NCT04502693|581062017|FG001|Overall Study|Lost to Follow-up|36|||
160858914|NCT04106557|580876922|FG000|Overall Study|Physician Decision|0|||
160858915|NCT04106557|580876923|FG001|Overall Study|Physician Decision|1|||
160858916|NCT04106557|580876924|FG002|Overall Study|Physician Decision|0|||
160858917|NCT04106557|580876922|FG000|Overall Study|Protocol Violation|0|||
160858918|NCT04106557|580876923|FG001|Overall Study|Protocol Violation|1|||
160858919|NCT04106557|580876924|FG002|Overall Study|Protocol Violation|0|||
160858920|NCT02326155|580876925|FG000|Overall Study|Adverse Event|21|||
160858921|NCT02326155|580876926|FG001|Overall Study|Adverse Event|5|||
160858922|NCT02326155|580876925|FG000|Overall Study|Death|3|||
160858923|NCT02326155|580876926|FG001|Overall Study|Death|0|||
160858924|NCT02326155|580876925|FG000|Overall Study|Lack of Efficacy|49|||
160858925|NCT02326155|580876926|FG001|Overall Study|Lack of Efficacy|5|||
160858926|NCT02326155|580876925|FG000|Overall Study|Lost to Follow-up|14|||
160858927|NCT02326155|580876926|FG001|Overall Study|Lost to Follow-up|3|||
160858928|NCT02326155|580876925|FG000|Overall Study|Protocol Violation|2|||
160858929|NCT02326155|580876926|FG001|Overall Study|Protocol Violation|0|||
160858930|NCT02326155|580876925|FG000|Overall Study|Withdrawal by Subject|34|||
160858931|NCT02326155|580876926|FG001|Overall Study|Withdrawal by Subject|11|||
160858932|NCT02326155|580876925|FG000|Overall Study|Disease progression|37|||
160858933|NCT02326155|580876926|FG001|Overall Study|Disease progression|4|||
160858934|NCT02326155|580876925|FG000|Overall Study|Study close|188|||
160858935|NCT02326155|580876926|FG001|Overall Study|Study close|21|||
160858936|NCT02326155|580876925|FG000|Overall Study|except for study close|46|||
160858937|NCT02326155|580876926|FG001|Overall Study|except for study close|13|||
160858938|NCT01428258|580876932|FG000|Intervention 1|Withdrawal by Subject|2|||
160858939|NCT01428258|580876933|FG001|Intervention 1|Withdrawal by Subject|0|||
160858940|NCT00419393|580876934|FG000|Overall Study|Adverse Event|5|||
160858941|NCT00419393|580876934|FG000|Overall Study|Protocol Violation|5|||
160858942|NCT00419393|580876934|FG000|Overall Study|Withdrawal by Subject|7|||
160858943|NCT00419393|580876934|FG000|Overall Study|Other: Sponsor request|3|||
160858944|NCT00419393|580876934|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
160858945|NCT00419393|580876934|FG000|Overall Study|Other: Site closure|1|||
160858946|NCT00419393|580876934|FG000|Overall Study|Other: Other health problems|1|||
160858947|NCT00419393|580876934|FG000|Overall Study|Other: Investigator decision|1|||
160858948|NCT01231984|580876939|FG000|Study Period 1|Withdrawal by Subject|0|||
160858949|NCT01231984|580876940|FG001|Study Period 1|Withdrawal by Subject|0|||
160858950|NCT01231984|580876941|FG002|Study Period 1|Withdrawal by Subject|0|||
160858951|NCT01231984|580876942|FG003|Study Period 1|Withdrawal by Subject|1|||
160858952|NCT01231984|580876939|FG000|Study Period 1|Lost to Follow-up|1|||
160858953|NCT01231984|580876940|FG001|Study Period 1|Lost to Follow-up|1|||
160858954|NCT01231984|580876941|FG002|Study Period 1|Lost to Follow-up|1|||
160858955|NCT01231984|580876942|FG003|Study Period 1|Lost to Follow-up|0|||
160858956|NCT01231984|580876939|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
160858957|NCT01231984|580876940|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
160858958|NCT01231984|580876941|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
160858959|NCT01231984|580876942|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
160858960|NCT01231984|580876939|FG000|Study Period 1|Screen Failure|0|||
160858961|NCT01231984|580876940|FG001|Study Period 1|Screen Failure|0|||
160858962|NCT01231984|580876941|FG002|Study Period 1|Screen Failure|0|||
160858963|NCT01231984|580876942|FG003|Study Period 1|Screen Failure|1|||
160858964|NCT01231984|580876939|FG000|Study Period 1|Non-compliance with study requirements|5|||
160858965|NCT01231984|580876940|FG001|Study Period 1|Non-compliance with study requirements|0|||
160858966|NCT01231984|580876941|FG002|Study Period 1|Non-compliance with study requirements|2|||
160858967|NCT01231984|580876942|FG003|Study Period 1|Non-compliance with study requirements|1|||
160858968|NCT01231984|580876939|FG000|Study Period 1|Protocol Violation|3|||
160858969|NCT01231984|580876940|FG001|Study Period 1|Protocol Violation|4|||
160858970|NCT01231984|580876941|FG002|Study Period 1|Protocol Violation|2|||
160858971|NCT01231984|580876942|FG003|Study Period 1|Protocol Violation|3|||
160858972|NCT01231984|580876939|FG000|Study Period 1|Adverse Event|1|||
160858973|NCT01231984|580876940|FG001|Study Period 1|Adverse Event|0|||
160858974|NCT01231984|580876941|FG002|Study Period 1|Adverse Event|0|||
160858975|NCT01231984|580876942|FG003|Study Period 1|Adverse Event|0|||
160858976|NCT01231984|580876939|FG000|Study Period 1|Other|0|||
160858977|NCT01231984|580876940|FG001|Study Period 1|Other|0|||
160858978|NCT01231984|580876941|FG002|Study Period 1|Other|0|||
160858979|NCT01231984|580876942|FG003|Study Period 1|Other|1|||
160858980|NCT01231984|580876939|FG000|Study Period 2|Withdrawal by Subject|1|||
160858981|NCT01231984|580876940|FG001|Study Period 2|Withdrawal by Subject|1|||
160858982|NCT01231984|580876941|FG002|Study Period 2|Withdrawal by Subject|0|||
160652328|NCT03504852|580107439|FG000|Overall Study|Lost to Follow-up|4|||
160858983|NCT01231984|580876942|FG003|Study Period 2|Withdrawal by Subject|0|||
160858984|NCT01231984|580876939|FG000|Study Period 2|Lost to Follow-up|1|||
160858985|NCT01231984|580876940|FG001|Study Period 2|Lost to Follow-up|0|||
160858986|NCT01231984|580876941|FG002|Study Period 2|Lost to Follow-up|0|||
160858987|NCT01231984|580876942|FG003|Study Period 2|Lost to Follow-up|3|||
160858988|NCT01231984|580876939|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
160858989|NCT01231984|580876940|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
160909240|NCT04502693|581062018|FG002|Overall Study|Lost to Follow-up|69|||
160858990|NCT01231984|580876941|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
160858991|NCT01231984|580876942|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
160858992|NCT02939287|580876945|FG000|Overall Study|met exclusion criteria|1|||
160858993|NCT02939287|580876946|FG001|Overall Study|met exclusion criteria|1|||
160858994|NCT02939287|580876947|FG002|Overall Study|met exclusion criteria|1|||
160858995|NCT02939287|580876945|FG000|Overall Study|Did not complete survey|2|||
160858996|NCT02939287|580876946|FG001|Overall Study|Did not complete survey|2|||
160858997|NCT02939287|580876947|FG002|Overall Study|Did not complete survey|0|||
160858998|NCT02939287|580876945|FG000|Overall Study|Withdrawal by Subject|1|||
160858999|NCT02939287|580876946|FG001|Overall Study|Withdrawal by Subject|1|||
160859000|NCT02939287|580876947|FG002|Overall Study|Withdrawal by Subject|0|||
160859001|NCT00333775|580876948|FG000|Overall Study|Death|144|||
160859002|NCT00333775|580876949|FG001|Overall Study|Death|149|||
160859003|NCT00333775|580876950|FG002|Overall Study|Death|143|||
160859004|NCT00333775|580876948|FG000|Overall Study|In Follow-up When Study Stopped|87|||
160859005|NCT00333775|580876949|FG001|Overall Study|In Follow-up When Study Stopped|92|||
160859006|NCT00333775|580876950|FG002|Overall Study|In Follow-up When Study Stopped|96|||
160859007|NCT00333775|580876948|FG000|Overall Study|Lost to Follow-up|10|||
160859008|NCT00333775|580876949|FG001|Overall Study|Lost to Follow-up|7|||
160859009|NCT00333775|580876950|FG002|Overall Study|Lost to Follow-up|8|||
160859010|NCT02476617|580876952|FG000|Overall Study|Adverse Event|1|||
160859011|NCT02476617|580876952|FG000|Overall Study|Lost to Follow-up|1|||
160859012|NCT01383928|580876953|FG000|Overall Study|Initiation of ASCT|2|||
160859013|NCT01383928|580876954|FG001|Overall Study|Initiation of ASCT|1|||
160859014|NCT01383928|580876955|FG002|Overall Study|Initiation of ASCT|18|||
160859015|NCT01383928|580876953|FG000|Overall Study|Adverse Event|1|||
160859016|NCT01383928|580876954|FG001|Overall Study|Adverse Event|2|||
160859017|NCT01383928|580876955|FG002|Overall Study|Adverse Event|8|||
160859018|NCT01383928|580876953|FG000|Overall Study|Other|1|||
160859019|NCT01383928|580876954|FG001|Overall Study|Other|3|||
160859020|NCT01383928|580876955|FG002|Overall Study|Other|4|||
160859021|NCT01383928|580876953|FG000|Overall Study|Progressive Disease|1|||
160859022|NCT01383928|580876954|FG001|Overall Study|Progressive Disease|1|||
160859023|NCT01383928|580876955|FG002|Overall Study|Progressive Disease|5|||
160859024|NCT01383928|580876953|FG000|Overall Study|Withdrawal by Subject|0|||
160859025|NCT01383928|580876954|FG001|Overall Study|Withdrawal by Subject|0|||
160859026|NCT01383928|580876955|FG002|Overall Study|Withdrawal by Subject|4|||
160859027|NCT01383928|580876953|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
160859028|NCT01383928|580876954|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
160859029|NCT01383928|580876955|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
160859030|NCT03486912|580876956|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
160859031|NCT03486912|580876957|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
160859032|NCT03486912|580876958|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
160859033|NCT03486912|580876959|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
160859034|NCT03486912|580876956|FG000|Treatment Period|Withdrawal by Subject|3|||
160859035|NCT03486912|580876957|FG001|Treatment Period|Withdrawal by Subject|3|||
160859036|NCT03486912|580876958|FG002|Treatment Period|Withdrawal by Subject|3|||
160859037|NCT03486912|580876959|FG003|Treatment Period|Withdrawal by Subject|2|||
160859038|NCT03486912|580876956|FG000|Treatment Period|Other Reasons|0|||
160859039|NCT03486912|580876957|FG001|Treatment Period|Other Reasons|2|||
160859040|NCT03486912|580876958|FG002|Treatment Period|Other Reasons|1|||
160859041|NCT03486912|580876959|FG003|Treatment Period|Other Reasons|1|||
160859042|NCT03486912|580876956|FG000|Treatment Period|Adverse Event|0|||
160859043|NCT03486912|580876957|FG001|Treatment Period|Adverse Event|1|||
160859044|NCT03486912|580876958|FG002|Treatment Period|Adverse Event|1|||
160859045|NCT03486912|580876959|FG003|Treatment Period|Adverse Event|0|||
160859046|NCT03486912|580876956|FG000|Treatment Period|Lost to Follow-up|1|||
160859047|NCT03486912|580876957|FG001|Treatment Period|Lost to Follow-up|0|||
160859048|NCT03486912|580876958|FG002|Treatment Period|Lost to Follow-up|0|||
160859049|NCT03486912|580876959|FG003|Treatment Period|Lost to Follow-up|2|||
160859050|NCT02491684|580876960|FG000|Treatment Phase|Adverse Event|2|||
160859051|NCT02491684|580876961|FG001|Treatment Phase|Adverse Event|2|||
160859052|NCT02491684|580876960|FG000|Treatment Phase|Incorrect randomisation|1|||
160859053|NCT02491684|580876961|FG001|Treatment Phase|Incorrect randomisation|0|||
160859054|NCT02491684|580876960|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
160859055|NCT02491684|580876961|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
160859056|NCT01499940|580876962|FG000|Overall Study|Study was withdrawn before completion.|9|||
160859057|NCT04739982|580876963|FG000|Overall Study|Lost to Follow-up|176|||
160859058|NCT04739982|580876964|FG001|Overall Study|Lost to Follow-up|65|||
160859059|NCT04739982|580876963|FG000|Overall Study|Withdrawal by Subject|19|||
160859060|NCT04739982|580876964|FG001|Overall Study|Withdrawal by Subject|0|||
160859061|NCT04739982|580876963|FG000|Overall Study|Protocol Violation|0|||
160859062|NCT04739982|580876964|FG001|Overall Study|Protocol Violation|5|||
160859063|NCT04914364|580876966|FG000|Overall Study|No longer eligible for study|1|||
160859064|NCT04914364|580876966|FG000|Overall Study|Lost to Follow-up|2|||
160859065|NCT01283139|580876967|FG000|Overall Study|Lost to Follow-up|5|||
160859066|NCT01283139|580876968|FG001|Overall Study|Lost to Follow-up|2|||
160859067|NCT01283139|580876969|FG002|Overall Study|Lost to Follow-up|3|||
160859068|NCT01283139|580876970|FG003|Overall Study|Lost to Follow-up|1|||
160859069|NCT01283139|580876967|FG000|Overall Study|Withdrawal by Subject|8|||
160859070|NCT01283139|580876968|FG001|Overall Study|Withdrawal by Subject|8|||
160859071|NCT01283139|580876969|FG002|Overall Study|Withdrawal by Subject|6|||
160859072|NCT01283139|580876970|FG003|Overall Study|Withdrawal by Subject|8|||
160859073|NCT01283139|580876967|FG000|Overall Study|Death|2|||
160859074|NCT01283139|580876968|FG001|Overall Study|Death|0|||
160859075|NCT01283139|580876969|FG002|Overall Study|Death|2|||
160859076|NCT01283139|580876970|FG003|Overall Study|Death|2|||
160859077|NCT01283139|580876967|FG000|Overall Study|Lack of Efficacy|1|||
160859078|NCT01283139|580876968|FG001|Overall Study|Lack of Efficacy|2|||
160859079|NCT01283139|580876969|FG002|Overall Study|Lack of Efficacy|2|||
160859080|NCT01283139|580876970|FG003|Overall Study|Lack of Efficacy|1|||
160859081|NCT01283139|580876967|FG000|Overall Study|Early termination due to AE/SAE|1|||
160859082|NCT01283139|580876968|FG001|Overall Study|Early termination due to AE/SAE|1|||
160859083|NCT01283139|580876969|FG002|Overall Study|Early termination due to AE/SAE|0|||
160859084|NCT01283139|580876970|FG003|Overall Study|Early termination due to AE/SAE|0|||
160859085|NCT01283139|580876967|FG000|Overall Study|Participant's refusal to continue|0|||
160859086|NCT01283139|580876968|FG001|Overall Study|Participant's refusal to continue|3|||
160859087|NCT01283139|580876969|FG002|Overall Study|Participant's refusal to continue|1|||
160859088|NCT01283139|580876970|FG003|Overall Study|Participant's refusal to continue|1|||
160859089|NCT01283139|580876967|FG000|Overall Study|Pregnancy|0|||
160859090|NCT01283139|580876968|FG001|Overall Study|Pregnancy|1|||
160859091|NCT01283139|580876969|FG002|Overall Study|Pregnancy|1|||
160859092|NCT01283139|580876970|FG003|Overall Study|Pregnancy|0|||
160859093|NCT01283139|580876967|FG000|Overall Study|Missed follow-up visit|0|||
160859094|NCT01283139|580876968|FG001|Overall Study|Missed follow-up visit|1|||
160859095|NCT01283139|580876969|FG002|Overall Study|Missed follow-up visit|2|||
160859096|NCT01283139|580876970|FG003|Overall Study|Missed follow-up visit|2|||
160859097|NCT01283139|580876967|FG000|Overall Study|Participant randomized in error|0|||
160859098|NCT01283139|580876968|FG001|Overall Study|Participant randomized in error|0|||
160859099|NCT01283139|580876969|FG002|Overall Study|Participant randomized in error|1|||
160859100|NCT01283139|580876970|FG003|Overall Study|Participant randomized in error|0|||
160859101|NCT01844765|580876976|FG000|Overall Study|Adverse Event|6|||
160859102|NCT01844765|580876977|FG001|Overall Study|Adverse Event|8|||
160859103|NCT01844765|580876976|FG000|Overall Study|Withdrawal by Subject|2|||
160859104|NCT01844765|580876977|FG001|Overall Study|Withdrawal by Subject|3|||
160859105|NCT01844765|580876976|FG000|Overall Study|Disease progression|1|||
160859106|NCT01844765|580876977|FG001|Overall Study|Disease progression|0|||
160859107|NCT01844765|580876976|FG000|Overall Study|Administrative problems|3|||
160859108|NCT01844765|580876977|FG001|Overall Study|Administrative problems|4|||
160859109|NCT01844765|580876976|FG000|Overall Study|Protocol deviation|2|||
160859110|NCT01844765|580876977|FG001|Overall Study|Protocol deviation|0|||
160859111|NCT01844765|580876976|FG000|Overall Study|Untreated|1|||
160859112|NCT01844765|580876977|FG001|Overall Study|Untreated|0|||
160859113|NCT02025179|580876978|FG000|Overall Study|Lost to Follow-up|0|||
160859114|NCT02025179|580876979|FG001|Overall Study|Lost to Follow-up|0|||
160859115|NCT02025179|580876980|FG002|Overall Study|Lost to Follow-up|1|||
160859116|NCT00556075|580876981|FG000|Overall Study|Lost to Follow-up|3|||
160859117|NCT00556075|580876982|FG001|Overall Study|Lost to Follow-up|0|||
160859118|NCT00556075|580876983|FG002|Overall Study|Lost to Follow-up|3|||
160859119|NCT00556075|580876981|FG000|Overall Study|Withdrawal by Subject|3|||
160859120|NCT00556075|580876982|FG001|Overall Study|Withdrawal by Subject|3|||
160859121|NCT00556075|580876983|FG002|Overall Study|Withdrawal by Subject|0|||
160859122|NCT00556075|580876981|FG000|Overall Study|Protocol Violation|1|||
160859123|NCT00556075|580876982|FG001|Overall Study|Protocol Violation|1|||
160859124|NCT00556075|580876983|FG002|Overall Study|Protocol Violation|3|||
160859125|NCT00556075|580876981|FG000|Overall Study|Not eligible|1|||
160859126|NCT00556075|580876982|FG001|Overall Study|Not eligible|1|||
160859127|NCT00556075|580876983|FG002|Overall Study|Not eligible|2|||
160859128|NCT00556075|580876981|FG000|Overall Study|Adverse Event|1|||
160859129|NCT00556075|580876982|FG001|Overall Study|Adverse Event|2|||
160859130|NCT00556075|580876983|FG002|Overall Study|Adverse Event|0|||
160859131|NCT00556075|580876981|FG000|Overall Study|Personal issues|4|||
160859132|NCT00556075|580876982|FG001|Overall Study|Personal issues|1|||
160859133|NCT00556075|580876983|FG002|Overall Study|Personal issues|0|||
160859134|NCT00556075|580876981|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
160859135|NCT00556075|580876982|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
160859136|NCT00556075|580876983|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
160859137|NCT00601835|580876984|FG000|Overall Study|Withdrawal by Subject|9|||
160859138|NCT00601835|580876985|FG001|Overall Study|Withdrawal by Subject|6|||
160859139|NCT00601835|580876984|FG000|Overall Study|Physician Decision|1|||
160859140|NCT00601835|580876985|FG001|Overall Study|Physician Decision|0|||
160859141|NCT00601835|580876984|FG000|Overall Study|Lost to Follow-up|37|||
160859142|NCT00601835|580876985|FG001|Overall Study|Lost to Follow-up|5|||
160859143|NCT00601835|580876984|FG000|Overall Study|Adverse Event|1|||
160859144|NCT00601835|580876985|FG001|Overall Study|Adverse Event|1|||
160859145|NCT00601835|580876984|FG000|Overall Study|Relocate|12|||
160859146|NCT00601835|580876985|FG001|Overall Study|Relocate|2|||
160859147|NCT03836625|580876986|FG000|Overall Study|Lost to Follow-up|9|||
160859148|NCT03836625|580876987|FG001|Overall Study|Lost to Follow-up|9|||
160859149|NCT03836625|580876986|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
160859150|NCT03836625|580876987|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
160859151|NCT03836625|580876986|FG000|Overall Study|Death|0|||
160859152|NCT03836625|580876987|FG001|Overall Study|Death|1|||
160859153|NCT03836625|580876986|FG000|Overall Study|Refused follow-up|0|||
160859154|NCT03836625|580876987|FG001|Overall Study|Refused follow-up|1|||
160859155|NCT04764162|580876990|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
160859156|NCT04764162|580876991|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
160859157|NCT03077542|580876996|FG000|Overall Study|Death|4|||
160859158|NCT03077542|580876997|FG001|Overall Study|Death|0|||
160859159|NCT03077542|580876996|FG000|Overall Study|Physician Decision|6|||
160859160|NCT03077542|580876997|FG001|Overall Study|Physician Decision|1|||
160859161|NCT03077542|580876996|FG000|Overall Study|Withdrawal by Subject|0|||
160859162|NCT03077542|580876997|FG001|Overall Study|Withdrawal by Subject|1|||
160859163|NCT00301808|580876998|FG000|Overall Study|Adverse Event|5|||
160859164|NCT00301808|580876998|FG000|Overall Study|Death|3|||
160859165|NCT00301808|580876998|FG000|Overall Study|Lack of Efficacy|4|||
160859166|NCT00844844|580876999|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
160859167|NCT00844844|580876999|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
160859168|NCT00844844|580876999|FG000|Extension Treatment Period|Adverse Event|2|||
160859169|NCT00844844|580876999|FG000|Post Treatment Period|Withdrawal by Subject|1|||
160859170|NCT04886154|580877002|FG000|Overall Study|Adverse Event|0|||
160859171|NCT04886154|580877003|FG001|Overall Study|Adverse Event|0|||
160859172|NCT04886154|580877004|FG002|Overall Study|Adverse Event|0|||
160859173|NCT04886154|580877005|FG003|Overall Study|Adverse Event|0|||
160859174|NCT04886154|580877006|FG004|Overall Study|Adverse Event|1|||
160859175|NCT04886154|580877007|FG005|Overall Study|Adverse Event|0|||
160859176|NCT04886154|580877008|FG006|Overall Study|Adverse Event|0|||
160859177|NCT04886154|580877009|FG007|Overall Study|Adverse Event|1|||
160859178|NCT04886154|580877010|FG008|Overall Study|Adverse Event|1|||
160859179|NCT04886154|580877011|FG009|Overall Study|Adverse Event|0|||
160859180|NCT04886154|580877012|FG010|Overall Study|Adverse Event|0|||
160859181|NCT04886154|580877013|FG011|Overall Study|Adverse Event|1|||
160859182|NCT04886154|580877014|FG012|Overall Study|Adverse Event|0|||
160859183|NCT04886154|580877015|FG013|Overall Study|Adverse Event|0|||
160859184|NCT04886154|580877016|FG014|Overall Study|Adverse Event|3|||
160859185|NCT04886154|580877002|FG000|Overall Study|Lost to Follow-up|1|||
160859186|NCT04886154|580877003|FG001|Overall Study|Lost to Follow-up|0|||
160859187|NCT04886154|580877004|FG002|Overall Study|Lost to Follow-up|2|||
160859188|NCT04886154|580877005|FG003|Overall Study|Lost to Follow-up|0|||
160859189|NCT04886154|580877006|FG004|Overall Study|Lost to Follow-up|17|||
160859190|NCT04886154|580877007|FG005|Overall Study|Lost to Follow-up|7|||
160859191|NCT04886154|580877008|FG006|Overall Study|Lost to Follow-up|8|||
160859192|NCT04886154|580877009|FG007|Overall Study|Lost to Follow-up|7|||
160859193|NCT04886154|580877010|FG008|Overall Study|Lost to Follow-up|8|||
160859194|NCT04886154|580877011|FG009|Overall Study|Lost to Follow-up|0|||
160859195|NCT04886154|580877012|FG010|Overall Study|Lost to Follow-up|2|||
160859196|NCT04886154|580877013|FG011|Overall Study|Lost to Follow-up|0|||
160859197|NCT04886154|580877014|FG012|Overall Study|Lost to Follow-up|0|||
160859198|NCT04886154|580877015|FG013|Overall Study|Lost to Follow-up|0|||
160859199|NCT04886154|580877016|FG014|Overall Study|Lost to Follow-up|0|||
160859200|NCT04886154|580877002|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859201|NCT04886154|580877003|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160652329|NCT03504852|580107440|FG001|Overall Study|Lost to Follow-up|1|||
160859202|NCT04886154|580877004|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859203|NCT04886154|580877005|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859204|NCT04886154|580877006|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859205|NCT04886154|580877007|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859206|NCT04886154|580877008|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
160859207|NCT04886154|580877009|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859208|NCT04886154|580877010|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859209|NCT04886154|580877011|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859210|NCT04886154|580877012|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859211|NCT04886154|580877013|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859212|NCT04886154|580877014|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859213|NCT04886154|580877015|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859214|NCT04886154|580877016|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859215|NCT04886154|580877002|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859216|NCT04886154|580877003|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859217|NCT04886154|580877004|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859218|NCT04886154|580877005|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859219|NCT04886154|580877006|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160859220|NCT04886154|580877007|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859221|NCT04886154|580877008|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
160859222|NCT04886154|580877009|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160859223|NCT04886154|580877010|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859224|NCT04886154|580877011|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859225|NCT04886154|580877012|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859226|NCT04886154|580877013|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859227|NCT04886154|580877014|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859228|NCT04886154|580877015|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859229|NCT04886154|580877016|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160859230|NCT04886154|580877002|FG000|Overall Study|Other, Not Specified|0|||
160859231|NCT04886154|580877003|FG001|Overall Study|Other, Not Specified|0|||
160859232|NCT04886154|580877004|FG002|Overall Study|Other, Not Specified|0|||
160859233|NCT04886154|580877005|FG003|Overall Study|Other, Not Specified|0|||
160859234|NCT04886154|580877006|FG004|Overall Study|Other, Not Specified|11|||
160859235|NCT04886154|580877007|FG005|Overall Study|Other, Not Specified|8|||
160859236|NCT04886154|580877008|FG006|Overall Study|Other, Not Specified|9|||
160859237|NCT04886154|580877009|FG007|Overall Study|Other, Not Specified|10|||
160859238|NCT04886154|580877010|FG008|Overall Study|Other, Not Specified|6|||
160859239|NCT04886154|580877011|FG009|Overall Study|Other, Not Specified|1|||
160859240|NCT04886154|580877012|FG010|Overall Study|Other, Not Specified|1|||
160859241|NCT04886154|580877013|FG011|Overall Study|Other, Not Specified|2|||
160859242|NCT04886154|580877014|FG012|Overall Study|Other, Not Specified|1|||
160859243|NCT04886154|580877015|FG013|Overall Study|Other, Not Specified|2|||
160859244|NCT04886154|580877016|FG014|Overall Study|Other, Not Specified|3|||
160859245|NCT03919773|580877025|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
160859246|NCT03919773|580877026|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
160859247|NCT03919773|580877025|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
160859248|NCT03919773|580877026|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
160859249|NCT04659044|580877029|FG000|Induction|Physician Decision|1|||
160859250|NCT04659044|580877029|FG000|Induction|Adverse Event|2|||
160859251|NCT04966013|580877031|FG000|Overall Study|Withdrawal by Subject|0|||
160859252|NCT04966013|580877032|FG001|Overall Study|Withdrawal by Subject|2|||
160859253|NCT04966013|580877033|FG002|Overall Study|Withdrawal by Subject|1|||
160859254|NCT04966013|580877031|FG000|Overall Study|Adverse Event|2|||
160859255|NCT04966013|580877032|FG001|Overall Study|Adverse Event|1|||
160859256|NCT04966013|580877033|FG002|Overall Study|Adverse Event|1|||
160859257|NCT02702492|580877037|FG000|Overall Study|Disease progression|3|||
160859258|NCT02702492|580877038|FG001|Overall Study|Disease progression|3|||
160859259|NCT02702492|580877039|FG002|Overall Study|Disease progression|2|||
160859260|NCT02702492|580877040|FG003|Overall Study|Disease progression|4|||
160859261|NCT02702492|580877041|FG004|Overall Study|Disease progression|4|||
160859262|NCT02702492|580877042|FG005|Overall Study|Disease progression|1|||
160859263|NCT02702492|580877043|FG006|Overall Study|Disease progression|2|||
160859264|NCT02702492|580877044|FG007|Overall Study|Disease progression|8|||
160859265|NCT02702492|580877045|FG008|Overall Study|Disease progression|5|||
160859266|NCT02702492|580877046|FG009|Overall Study|Disease progression|1|||
160909241|NCT04502693|581062019|FG003|Overall Study|Lost to Follow-up|4|||
160909242|NCT04502693|581062016|FG000|Overall Study|Protocol Violation|8|||
160909243|NCT04502693|581062017|FG001|Overall Study|Protocol Violation|8|||
160909244|NCT04502693|581062018|FG002|Overall Study|Protocol Violation|16|||
160909245|NCT04502693|581062019|FG003|Overall Study|Protocol Violation|1|||
160909246|NCT04502693|581062016|FG000|Overall Study|Withdrawal by Subject|46|||
160909247|NCT04502693|581062017|FG001|Overall Study|Withdrawal by Subject|38|||
160909248|NCT04502693|581062018|FG002|Overall Study|Withdrawal by Subject|54|||
160859267|NCT02702492|580877047|FG010|Overall Study|Disease progression|0|||
160859268|NCT02702492|580877048|FG011|Overall Study|Disease progression|3|||
160859269|NCT02702492|580877049|FG012|Overall Study|Disease progression|2|||
160859270|NCT02702492|580877037|FG000|Overall Study|Clinical progression|0|||
160859271|NCT02702492|580877038|FG001|Overall Study|Clinical progression|0|||
160859272|NCT02702492|580877039|FG002|Overall Study|Clinical progression|2|||
160859273|NCT02702492|580877040|FG003|Overall Study|Clinical progression|1|||
160859274|NCT02702492|580877041|FG004|Overall Study|Clinical progression|0|||
160859275|NCT02702492|580877042|FG005|Overall Study|Clinical progression|2|||
160859276|NCT02702492|580877043|FG006|Overall Study|Clinical progression|1|||
160859277|NCT02702492|580877044|FG007|Overall Study|Clinical progression|4|||
160859278|NCT02702492|580877045|FG008|Overall Study|Clinical progression|0|||
160859279|NCT02702492|580877046|FG009|Overall Study|Clinical progression|0|||
160859280|NCT02702492|580877047|FG010|Overall Study|Clinical progression|1|||
160859281|NCT02702492|580877048|FG011|Overall Study|Clinical progression|2|||
160859282|NCT02702492|580877049|FG012|Overall Study|Clinical progression|0|||
160859283|NCT02702492|580877037|FG000|Overall Study|Adverse Event|0|||
160859284|NCT02702492|580877038|FG001|Overall Study|Adverse Event|0|||
160859285|NCT02702492|580877039|FG002|Overall Study|Adverse Event|1|||
160859286|NCT02702492|580877040|FG003|Overall Study|Adverse Event|2|||
160859287|NCT02702492|580877041|FG004|Overall Study|Adverse Event|1|||
160859288|NCT02702492|580877042|FG005|Overall Study|Adverse Event|0|||
160859289|NCT02702492|580877043|FG006|Overall Study|Adverse Event|1|||
160859290|NCT02702492|580877044|FG007|Overall Study|Adverse Event|0|||
160859291|NCT02702492|580877045|FG008|Overall Study|Adverse Event|2|||
160859292|NCT02702492|580877046|FG009|Overall Study|Adverse Event|0|||
160859293|NCT02702492|580877047|FG010|Overall Study|Adverse Event|0|||
160859294|NCT02702492|580877048|FG011|Overall Study|Adverse Event|0|||
160859295|NCT02702492|580877049|FG012|Overall Study|Adverse Event|1|||
160859296|NCT02702492|580877037|FG000|Overall Study|Other|0|||
160859297|NCT02702492|580877038|FG001|Overall Study|Other|0|||
160859298|NCT02702492|580877039|FG002|Overall Study|Other|0|||
160859299|NCT02702492|580877040|FG003|Overall Study|Other|0|||
160859300|NCT02702492|580877041|FG004|Overall Study|Other|0|||
160859301|NCT02702492|580877042|FG005|Overall Study|Other|0|||
160859302|NCT02702492|580877043|FG006|Overall Study|Other|0|||
160859303|NCT02702492|580877044|FG007|Overall Study|Other|0|||
160859304|NCT02702492|580877045|FG008|Overall Study|Other|0|||
160859305|NCT02702492|580877046|FG009|Overall Study|Other|0|||
160859306|NCT02702492|580877047|FG010|Overall Study|Other|0|||
160859307|NCT02702492|580877048|FG011|Overall Study|Other|0|||
160859308|NCT02702492|580877049|FG012|Overall Study|Other|1|||
160859309|NCT01910298|580877050|FG000|Overall Study|Adverse Event|1|||
160859310|NCT01910298|580877051|FG001|Overall Study|Adverse Event|0|||
160859311|NCT01910298|580877050|FG000|Overall Study|Withdrawal by Subject|2|||
160859312|NCT01910298|580877051|FG001|Overall Study|Withdrawal by Subject|7|||
160859313|NCT01910298|580877050|FG000|Overall Study|Protocol Deviation|0|||
160859314|NCT01910298|580877051|FG001|Overall Study|Protocol Deviation|5|||
160859315|NCT01910298|580877050|FG000|Overall Study|Lost to Follow-up|1|||
160859316|NCT01910298|580877051|FG001|Overall Study|Lost to Follow-up|1|||
160859317|NCT01910298|580877050|FG000|Overall Study|Study Terminated by Sponsor|1|||
160859318|NCT01910298|580877051|FG001|Overall Study|Study Terminated by Sponsor|17|||
160859319|NCT01910298|580877050|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160909249|NCT04502693|581062019|FG003|Overall Study|Withdrawal by Subject|7|||
160909250|NCT04502693|581062016|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
160909251|NCT04502693|581062017|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
160909252|NCT04502693|581062018|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
160909253|NCT04502693|581062019|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160909254|NCT04502693|581062016|FG000|Overall Study|Other|1|||
160652330|NCT03504852|580107441|FG002|Overall Study|Lost to Follow-up|0|||
160652331|NCT03504852|580107439|FG000|Overall Study|New therapy for study indication|1|||
160652332|NCT03504852|580107440|FG001|Overall Study|New therapy for study indication|0|||
160652333|NCT03504852|580107441|FG002|Overall Study|New therapy for study indication|0|||
160652334|NCT03504852|580107439|FG000|Overall Study|Lack of Efficacy|1|||
160652335|NCT03504852|580107440|FG001|Overall Study|Lack of Efficacy|2|||
160652336|NCT03504852|580107441|FG002|Overall Study|Lack of Efficacy|0|||
160652337|NCT03504852|580107439|FG000|Overall Study|Death|0|||
160652338|NCT03504852|580107440|FG001|Overall Study|Death|1|||
160652339|NCT03504852|580107441|FG002|Overall Study|Death|0|||
160652340|NCT03504852|580107439|FG000|Overall Study|Adverse Event|4|||
160652341|NCT03504852|580107440|FG001|Overall Study|Adverse Event|8|||
160652342|NCT03504852|580107441|FG002|Overall Study|Adverse Event|2|||
160652343|NCT02928848|580107442|FG000|Arm 2|Withdrawal by Subject|1|||
160652344|NCT02928848|580107443|FG001|Arm 2|Withdrawal by Subject|0|||
160652345|NCT03290079|580107444|FG000|Overall Study|Death|2|||
160652346|NCT03390504|580107445|FG000|Overall Study|Lost to Follow-up|2|||
160652347|NCT03390504|580107446|FG001|Overall Study|Lost to Follow-up|4|||
160652348|NCT03390504|580107447|FG002|Overall Study|Lost to Follow-up|0|||
160652349|NCT03390504|580107448|FG003|Overall Study|Lost to Follow-up|1|||
160652350|NCT03390504|580107445|FG000|Overall Study|Withdrawal by Subject|3|||
160652351|NCT03390504|580107446|FG001|Overall Study|Withdrawal by Subject|15|||
160652352|NCT03390504|580107447|FG002|Overall Study|Withdrawal by Subject|5|||
160652353|NCT03390504|580107448|FG003|Overall Study|Withdrawal by Subject|2|||
160859320|NCT01910298|580877051|FG001|Overall Study|Other Miscellaneous Reasons|2|||
160859321|NCT00781768|580878736|FG000|Overall Study|Not transplanted.|0|||
160859322|NCT00781768|580878737|FG001|Overall Study|Not transplanted.|2|||
160859323|NCT02458313|580878740|FG000|Overall Study|Withdrawal by Subject|6|||
160859324|NCT02458313|580878741|FG001|Overall Study|Withdrawal by Subject|8|||
160859325|NCT02458313|580878740|FG000|Overall Study|Excluded for motion during MRI|1|||
160859326|NCT02458313|580878741|FG001|Overall Study|Excluded for motion during MRI|2|||
160859327|NCT00199381|580878742|FG000|Overall Study|Withdrawal by Subject|38|||
160859328|NCT00199381|580878742|FG000|Overall Study|Adverse Event|73|||
160859329|NCT00199381|580878742|FG000|Overall Study|Protocol Violation|6|||
160859330|NCT00199381|580878742|FG000|Overall Study|Lack of Efficacy|27|||
160859331|NCT00199381|580878742|FG000|Overall Study|Not including due to early termination|37|||
160652354|NCT03390504|580107445|FG000|Overall Study|Other|1|||
160859332|NCT00199381|580878742|FG000|Overall Study|Study termination by Sponsor|323|||
160652355|NCT03390504|580107446|FG001|Overall Study|Other|2|||
160652356|NCT03390504|580107447|FG002|Overall Study|Other|2|||
160652357|NCT03390504|580107448|FG003|Overall Study|Other|6|||
160652358|NCT00969332|580107449|FG000|Overall Study|Physician Decision|8|||
160652359|NCT00969332|580107449|FG000|Overall Study|Withdrawal by Subject|3|||
160652360|NCT00576199|580107450|FG000|Overall Study|Adverse Event|12|||
160652361|NCT00576199|580107450|FG000|Overall Study|Insufficient Therapeutic Response|14|||
160652362|NCT00576199|580107450|FG000|Overall Study|Refused Treatment|2|||
160652363|NCT00576199|580107450|FG000|Overall Study|Reason Unspecified|2|||
160652364|NCT00663871|580107451|FG000|Overall Study|Lost to Follow-up|5|||
160652365|NCT00663871|580107452|FG001|Overall Study|Lost to Follow-up|5|||
160652366|NCT00663871|580107451|FG000|Overall Study|Withdrawal by Subject|5|||
160652367|NCT00663871|580107452|FG001|Overall Study|Withdrawal by Subject|2|||
160652368|NCT00582309|580107453|FG000|Overall Study|Protocol Violation|0|||
160652369|NCT00582309|580107454|FG001|Overall Study|Protocol Violation|0|||
160652370|NCT00582309|580107455|FG002|Overall Study|Protocol Violation|2|||
160652371|NCT03922477|580107456|FG000|Overall Study|Death|9|||
160652372|NCT03922477|580107456|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
160652373|NCT03922477|580107456|FG000|Overall Study|Physician Decision|1|||
160652374|NCT03922477|580107456|FG000|Overall Study|Withdrawal by Subject|2|||
160652375|NCT05431686|580107460|FG000|Overall Study|unable to schedule|10|||
160652376|NCT01118728|580107475|FG000|Overall Study|Adverse Event|17|||
160652377|NCT01118728|580107475|FG000|Overall Study|Lack of Efficacy|27|||
160652378|NCT01118728|580107475|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
160652379|NCT01118728|580107475|FG000|Overall Study|Withdrawal by Subject|3|||
160652380|NCT01118728|580107475|FG000|Overall Study|Lost to Follow-up|4|||
160652381|NCT01736553|580107476|FG000|Overall Study|Death|12|||
160652382|NCT01736553|580107477|FG001|Overall Study|Death|0|||
160652383|NCT01736553|580107476|FG000|Overall Study|Withdrawal by Subject|5|||
160652384|NCT01736553|580107477|FG001|Overall Study|Withdrawal by Subject|2|||
160652385|NCT01736553|580107476|FG000|Overall Study|Lost to Follow-up|2|||
160652386|NCT01736553|580107477|FG001|Overall Study|Lost to Follow-up|2|||
160652387|NCT05328375|580108609|FG000|Overall Study|Withdrawal by Subject|0|||
160652388|NCT05328375|580108610|FG001|Overall Study|Withdrawal by Subject|1|||
160652389|NCT01893905|580108613|FG000|Overall Study|Withdrawal by Subject|1|||
160652390|NCT01893905|580108614|FG001|Overall Study|Withdrawal by Subject|0|||
160652391|NCT01893905|580108613|FG000|Overall Study|Adverse Event|9|||
160652392|NCT01893905|580108614|FG001|Overall Study|Adverse Event|3|||
160652393|NCT01893905|580108613|FG000|Overall Study|Lack of Efficacy|5|||
160652394|NCT01893905|580108614|FG001|Overall Study|Lack of Efficacy|7|||
160652395|NCT01893905|580108613|FG000|Overall Study|Lost to Follow-up|1|||
160652396|NCT01893905|580108614|FG001|Overall Study|Lost to Follow-up|0|||
160652397|NCT01893905|580108613|FG000|Overall Study|Protocol Violation|6|||
160652398|NCT01893905|580108614|FG001|Overall Study|Protocol Violation|1|||
160652399|NCT01893905|580108613|FG000|Overall Study|Lack of adherence to treatment|2|||
160652400|NCT01893905|580108614|FG001|Overall Study|Lack of adherence to treatment|0|||
160652401|NCT01893905|580108613|FG000|Overall Study|Other reason|1|||
160652402|NCT01893905|580108614|FG001|Overall Study|Other reason|3|||
160652403|NCT02192905|580108616|FG000|Overall Study|Lost to Follow-up|1|||
160652404|NCT00278200|580108617|FG000|Overall Study|Death|1|||
160652405|NCT00278200|580108618|FG001|Overall Study|Death|3|||
160652406|NCT00278200|580108617|FG000|Overall Study|Physician Decision|0|||
160652407|NCT00278200|580108618|FG001|Overall Study|Physician Decision|1|||
160652408|NCT00862979|580108621|FG000|Overall Study|Adverse Event|6|||
160652409|NCT00862979|580108622|FG001|Overall Study|Adverse Event|3|||
160652410|NCT00862979|580108621|FG000|Overall Study|Protocol Violation|0|||
160652411|NCT00862979|580108622|FG001|Overall Study|Protocol Violation|1|||
160652412|NCT00862979|580108621|FG000|Overall Study|Patient withdrew consent|2|||
160652413|NCT00862979|580108622|FG001|Overall Study|Patient withdrew consent|1|||
160652414|NCT00862979|580108621|FG000|Overall Study|Administrative problems|0|||
160652415|NCT00862979|580108622|FG001|Overall Study|Administrative problems|1|||
160652416|NCT00862979|580108621|FG000|Overall Study|Death|0|||
160652417|NCT00862979|580108622|FG001|Overall Study|Death|1|||
160652418|NCT01027143|580108626|FG000|Overall Study|Lost to Follow-up|9|||
160652419|NCT01027143|580108627|FG001|Overall Study|Lost to Follow-up|4|||
160652420|NCT00992407|580108630|FG000|Overall Study|Protocol Violation|2|||
160652421|NCT00992407|580108631|FG001|Overall Study|Protocol Violation|1|||
160652422|NCT00992407|580108630|FG000|Overall Study|Lost to Follow-up|3|||
160652423|NCT00992407|580108631|FG001|Overall Study|Lost to Follow-up|3|||
160652424|NCT00992407|580108630|FG000|Overall Study|Adverse Event|3|||
160652425|NCT00992407|580108631|FG001|Overall Study|Adverse Event|2|||
160652426|NCT00992407|580108630|FG000|Overall Study|protocol Violation & Adverse events|2|||
160652427|NCT00992407|580108631|FG001|Overall Study|protocol Violation & Adverse events|4|||
160859347|NCT00751296|580878745|FG000|Overall Study|Adverse Event|2|||
160859348|NCT01972217|580878746|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
160859349|NCT01972217|580878747|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
160859350|NCT01972217|580878748|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
160859351|NCT01972217|580878749|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
160859352|NCT01972217|580878746|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
160859353|NCT01972217|580878747|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
160859354|NCT01972217|580878748|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
160859355|NCT01972217|580878749|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
160859356|NCT01972217|580878746|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
160859357|NCT01972217|580878747|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
160859358|NCT01972217|580878748|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
160859359|NCT01972217|580878749|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
160859360|NCT01972217|580878746|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
160859361|NCT01972217|580878747|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
160859362|NCT01972217|580878748|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
160859363|NCT01972217|580878749|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
160859364|NCT01972217|580878746|FG000|Part B Double-blind, Randomised Period|Death|0|||
160859365|NCT01972217|580878747|FG001|Part B Double-blind, Randomised Period|Death|0|||
160859366|NCT01972217|580878748|FG002|Part B Double-blind, Randomised Period|Death|43|||
160859367|NCT01972217|580878749|FG003|Part B Double-blind, Randomised Period|Death|44|||
160859368|NCT01972217|580878746|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
160859369|NCT01972217|580878747|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
160859370|NCT01972217|580878748|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
160859371|NCT01972217|580878749|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
160859372|NCT01972217|580878746|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
160859373|NCT01972217|580878747|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
160859374|NCT01972217|580878748|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
160859375|NCT01972217|580878749|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
160859376|NCT01972217|580878746|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
160859377|NCT01972217|580878747|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
160859378|NCT01972217|580878748|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
160859379|NCT01972217|580878749|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
160859380|NCT01972217|580878746|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
160859381|NCT01972217|580878747|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
160859382|NCT01972217|580878748|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
160859383|NCT01972217|580878749|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
160859384|NCT00313014|580878753|FG000|Overall Study|Withdrawal by Subject|11|||
160859385|NCT00313014|580878754|FG001|Overall Study|Withdrawal by Subject|7|||
160859386|NCT00313014|580878755|FG002|Overall Study|Withdrawal by Subject|5|||
160859387|NCT00313014|580878753|FG000|Overall Study|Adverse Event|14|||
160859388|NCT00313014|580878754|FG001|Overall Study|Adverse Event|29|||
160859389|NCT00313014|580878755|FG002|Overall Study|Adverse Event|16|||
160859390|NCT00313014|580878753|FG000|Overall Study|Lost to Follow-up|7|||
160859391|NCT00313014|580878754|FG001|Overall Study|Lost to Follow-up|6|||
160859392|NCT00313014|580878755|FG002|Overall Study|Lost to Follow-up|10|||
160859393|NCT00313014|580878753|FG000|Overall Study|Administrative|9|||
160859394|NCT00313014|580878754|FG001|Overall Study|Administrative|6|||
160859395|NCT00313014|580878755|FG002|Overall Study|Administrative|14|||
160909255|NCT04502693|581062017|FG001|Overall Study|Other|0|||
160909256|NCT04502693|581062018|FG002|Overall Study|Other|1|||
160909257|NCT04502693|581062019|FG003|Overall Study|Other|1|||
160909258|NCT03943147|581062020|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
160909259|NCT03943147|581062021|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
160909260|NCT03943147|581062020|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
160859396|NCT00313014|580878753|FG000|Overall Study|Lack of Efficacy|52|||
160859397|NCT00313014|580878754|FG001|Overall Study|Lack of Efficacy|25|||
160859398|NCT00313014|580878755|FG002|Overall Study|Lack of Efficacy|16|||
160859399|NCT03714672|580878756|FG000|Overall Study|Adverse Event|0|||
160859400|NCT03714672|580878757|FG001|Overall Study|Adverse Event|0|||
160859401|NCT03714672|580878758|FG002|Overall Study|Adverse Event|3|||
160909261|NCT03943147|581062021|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
160909262|NCT03943147|581062020|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
160909263|NCT03943147|581062021|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
160909264|NCT03943147|581062020|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
160909265|NCT03943147|581062021|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
160909266|NCT03943147|581062020|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
160652428|NCT00992407|580108630|FG000|Overall Study|Other|2|||
160859402|NCT03714672|580878759|FG003|Overall Study|Adverse Event|0|||
160859403|NCT03714672|580878756|FG000|Overall Study|Physician Decision|0|||
160859404|NCT03714672|580878757|FG001|Overall Study|Physician Decision|1|||
160859405|NCT03714672|580878758|FG002|Overall Study|Physician Decision|0|||
160859406|NCT03714672|580878759|FG003|Overall Study|Physician Decision|0|||
160859407|NCT03714672|580878756|FG000|Overall Study|Other Reason|1|||
160859408|NCT03714672|580878757|FG001|Overall Study|Other Reason|2|||
160859409|NCT03714672|580878758|FG002|Overall Study|Other Reason|1|||
160859410|NCT03714672|580878759|FG003|Overall Study|Other Reason|1|||
160859411|NCT03714672|580878756|FG000|Overall Study|Lost to Follow-up|1|||
160859412|NCT03714672|580878757|FG001|Overall Study|Lost to Follow-up|1|||
160859413|NCT03714672|580878758|FG002|Overall Study|Lost to Follow-up|0|||
160859414|NCT03714672|580878759|FG003|Overall Study|Lost to Follow-up|0|||
160859415|NCT01074502|580878760|FG000|Overall Study|Withdrawal by Subject|1|||
160859416|NCT00674817|580878768|FG000|Period 1|Withdrawal by Subject|2|||
160859417|NCT00674817|580878768|FG000|Period 1|Protocol Violation|1|||
160859418|NCT00674817|580878768|FG000|Period 3|Adverse Event|1|||
160859419|NCT00674817|580878768|FG000|Period 3|Protocol Violation|1|||
160859420|NCT00674817|580878768|FG000|Period 4|Adverse Event|1|||
160859421|NCT04945733|580878771|FG000|Overall Study|Physician Decision|1|||
160859422|NCT04945733|580878772|FG001|Overall Study|Physician Decision|3|||
160859423|NCT04945733|580878773|FG002|Overall Study|Physician Decision|0|||
160859424|NCT04945733|580878771|FG000|Overall Study|Withdrawal by Subject|3|||
160859425|NCT04945733|580878772|FG001|Overall Study|Withdrawal by Subject|3|||
160859426|NCT04945733|580878773|FG002|Overall Study|Withdrawal by Subject|0|||
160859427|NCT03566511|580878780|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
160859428|NCT03566511|580878781|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
160859429|NCT00499486|580878783|FG000|Overall Study|Withdrawal by Subject|16|||
160859430|NCT03796728|580878785|FG000|Overall Study|Lost to Follow-up|8|||
160859431|NCT03796728|580878785|FG000|Overall Study|Reason not Specified|16|||
160859432|NCT05236270|580878786|FG000|Overall Study|Lost to Follow-up|3|||
160859433|NCT05236270|580878787|FG001|Overall Study|Lost to Follow-up|2|||
160859434|NCT05236270|580878788|FG002|Overall Study|Lost to Follow-up|0|||
160859435|NCT05236270|580878789|FG003|Overall Study|Lost to Follow-up|0|||
160859436|NCT05236270|580878790|FG004|Overall Study|Lost to Follow-up|2|||
160859437|NCT05236270|580878791|FG005|Overall Study|Lost to Follow-up|0|||
160859438|NCT05236270|580878792|FG006|Overall Study|Lost to Follow-up|1|||
160859439|NCT05236270|580878793|FG007|Overall Study|Lost to Follow-up|3|||
160859440|NCT01149096|580878794|FG000|Overall Study|Lost to Follow-up|0|||
160859441|NCT01149096|580878795|FG001|Overall Study|Lost to Follow-up|1|||
160859442|NCT03651765|580878797|FG000|Overall Study|Adverse Event|6|||
160859443|NCT03651765|580878797|FG000|Overall Study|Lack of Efficacy|18|||
160859444|NCT03651765|580878797|FG000|Overall Study|Lost to Follow-up|5|||
160859445|NCT03651765|580878797|FG000|Overall Study|Non-Compliance with Study Drug|4|||
160859446|NCT03651765|580878797|FG000|Overall Study|Physician Decision|6|||
160859447|NCT03651765|580878797|FG000|Overall Study|Pregnancy|1|||
160859448|NCT03651765|580878797|FG000|Overall Study|Discontinued by Sponsor|40|||
160859449|NCT03651765|580878797|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
160859450|NCT03651765|580878797|FG000|Overall Study|Withdrawal by Subject|24|||
160859451|NCT03651765|580878797|FG000|Overall Study|Miscellaneous|6|||
160859452|NCT01263769|580878800|FG000|Overall Study|Non-Compliant with treatment|1|||
160859453|NCT03267277|580878801|FG000|Overall Study|Withdrawal by Subject|1|||
160859454|NCT01346358|580878802|FG000|Overall Study|Withdrawal by Subject|1|||
160859455|NCT01346358|580878803|FG001|Overall Study|Withdrawal by Subject|0|||
160859456|NCT01346358|580878804|FG002|Overall Study|Withdrawal by Subject|1|||
160859457|NCT01346358|580878805|FG003|Overall Study|Withdrawal by Subject|1|||
160859458|NCT01346358|580878806|FG004|Overall Study|Withdrawal by Subject|0|||
160859459|NCT01346358|580878807|FG005|Overall Study|Withdrawal by Subject|2|||
160859460|NCT01346358|580878808|FG006|Overall Study|Withdrawal by Subject|1|||
160859461|NCT01346358|580878809|FG007|Overall Study|Withdrawal by Subject|1|||
160859462|NCT01346358|580878810|FG008|Overall Study|Withdrawal by Subject|1|||
160859463|NCT01346358|580878802|FG000|Overall Study|Adverse Event|1|||
160859464|NCT01346358|580878803|FG001|Overall Study|Adverse Event|0|||
160859465|NCT01346358|580878804|FG002|Overall Study|Adverse Event|0|||
160859466|NCT01346358|580878805|FG003|Overall Study|Adverse Event|0|||
160859467|NCT01346358|580878806|FG004|Overall Study|Adverse Event|1|||
160859468|NCT01346358|580878807|FG005|Overall Study|Adverse Event|0|||
160859469|NCT01346358|580878808|FG006|Overall Study|Adverse Event|0|||
160859470|NCT01346358|580878809|FG007|Overall Study|Adverse Event|0|||
160859471|NCT01346358|580878810|FG008|Overall Study|Adverse Event|1|||
160859472|NCT01346358|580878802|FG000|Overall Study|Non-Compliance|0|||
160570185|NCT02495077|579810421|FG003|Overall Study|Covid-19 research restrictions|0|||
160859473|NCT01346358|580878803|FG001|Overall Study|Non-Compliance|0|||
160859474|NCT01346358|580878804|FG002|Overall Study|Non-Compliance|0|||
160859475|NCT01346358|580878805|FG003|Overall Study|Non-Compliance|0|||
160859476|NCT01346358|580878806|FG004|Overall Study|Non-Compliance|0|||
160859477|NCT01346358|580878807|FG005|Overall Study|Non-Compliance|0|||
160859478|NCT01346358|580878808|FG006|Overall Study|Non-Compliance|0|||
160859479|NCT01346358|580878809|FG007|Overall Study|Non-Compliance|2|||
160859480|NCT01346358|580878810|FG008|Overall Study|Non-Compliance|0|||
160859481|NCT01346358|580878802|FG000|Overall Study|Physician Decision|0|||
160859482|NCT01346358|580878803|FG001|Overall Study|Physician Decision|1|||
160859483|NCT01346358|580878804|FG002|Overall Study|Physician Decision|0|||
160859484|NCT01346358|580878805|FG003|Overall Study|Physician Decision|0|||
160859485|NCT01346358|580878806|FG004|Overall Study|Physician Decision|0|||
160859486|NCT01346358|580878807|FG005|Overall Study|Physician Decision|0|||
160859487|NCT01346358|580878808|FG006|Overall Study|Physician Decision|0|||
160859488|NCT01346358|580878809|FG007|Overall Study|Physician Decision|1|||
160859489|NCT01346358|580878810|FG008|Overall Study|Physician Decision|1|||
160859490|NCT05058365|580878813|FG000|Overall Study|Migration|1|||
160859491|NCT05058365|580878814|FG001|Overall Study|Migration|1|||
160859492|NCT00702702|580878815|FG000|Overall Study|Study prematurely terminated|56|||
160859493|NCT00468169|580878816|FG000|Overall Study|Withdrawal by Subject|1|||
160859494|NCT00468169|580878817|FG001|Overall Study|Withdrawal by Subject|0|||
160859495|NCT01126749|580878822|FG000|Phase 1b|Other|0|||
160859496|NCT01126749|580878823|FG001|Phase 1b|Other|1|||
160859497|NCT01126749|580878824|FG002|Phase 1b|Other|0|||
160859498|NCT01126749|580878825|FG003|Phase 1b|Other|0|||
160859499|NCT01126749|580878822|FG000|Phase 1b|Withdrawal by Subject|0|||
160859500|NCT01126749|580878823|FG001|Phase 1b|Withdrawal by Subject|1|||
160859501|NCT01126749|580878824|FG002|Phase 1b|Withdrawal by Subject|0|||
160859502|NCT01126749|580878825|FG003|Phase 1b|Withdrawal by Subject|0|||
160859503|NCT01126749|580878822|FG000|Phase 1b|Death|3|||
160859504|NCT01126749|580878823|FG001|Phase 1b|Death|4|||
160859505|NCT01126749|580878824|FG002|Phase 1b|Death|0|||
160859506|NCT01126749|580878825|FG003|Phase 1b|Death|0|||
160859507|NCT01126749|580878822|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
160859508|NCT01126749|580878823|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
160859509|NCT01126749|580878824|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
160859510|NCT01126749|580878825|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
160859511|NCT01126749|580878822|FG000|Phase 2|Study Termination by Sponsor|0|||
160859512|NCT01126749|580878823|FG001|Phase 2|Study Termination by Sponsor|0|||
160859513|NCT01126749|580878824|FG002|Phase 2|Study Termination by Sponsor|12|||
160859514|NCT01126749|580878825|FG003|Phase 2|Study Termination by Sponsor|6|||
160859515|NCT01126749|580878822|FG000|Phase 2|Other|0|||
160859516|NCT01126749|580878823|FG001|Phase 2|Other|0|||
160859517|NCT01126749|580878824|FG002|Phase 2|Other|4|||
160859518|NCT01126749|580878825|FG003|Phase 2|Other|2|||
160859519|NCT01126749|580878822|FG000|Phase 2|Withdrawal by Subject|0|||
160859520|NCT01126749|580878823|FG001|Phase 2|Withdrawal by Subject|0|||
160859521|NCT01126749|580878824|FG002|Phase 2|Withdrawal by Subject|0|||
160859522|NCT01126749|580878825|FG003|Phase 2|Withdrawal by Subject|2|||
160859523|NCT01126749|580878822|FG000|Phase 2|Lost to Follow-up|0|||
160859524|NCT01126749|580878823|FG001|Phase 2|Lost to Follow-up|0|||
160859525|NCT01126749|580878824|FG002|Phase 2|Lost to Follow-up|0|||
160859526|NCT01126749|580878825|FG003|Phase 2|Lost to Follow-up|1|||
160859527|NCT01126749|580878822|FG000|Phase 2|Death|0|||
160859528|NCT01126749|580878823|FG001|Phase 2|Death|0|||
160859529|NCT01126749|580878824|FG002|Phase 2|Death|22|||
160859530|NCT01126749|580878825|FG003|Phase 2|Death|22|||
160570186|NCT02495077|579810418|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
160859531|NCT01126749|580878822|FG000|Phase 2|Adverse Event|0|||
160909267|NCT03943147|581062021|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
160909268|NCT03943147|581062020|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
160909269|NCT03943147|581062021|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
160909270|NCT01318993|581062022|FG000|Overall Study|Adverse Event|53|||
160909271|NCT01318993|581062022|FG000|Overall Study|Lack of Efficacy|121|||
160570187|NCT02495077|579810419|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
160570188|NCT02495077|579810420|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
160859532|NCT01126749|580878823|FG001|Phase 2|Adverse Event|0|||
160859533|NCT01126749|580878824|FG002|Phase 2|Adverse Event|0|||
160859534|NCT01126749|580878825|FG003|Phase 2|Adverse Event|1|||
160859535|NCT03668873|580878826|FG000|Overall Study|Lost to Follow-up|6|||
160859536|NCT03668873|580878827|FG001|Overall Study|Lost to Follow-up|3|||
160859537|NCT02183675|580878828|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
160859538|NCT02183675|580878829|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
160859539|NCT02183675|580878830|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
160859540|NCT02183675|580878831|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
160859541|NCT02183675|580878832|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
160859542|NCT02183675|580878833|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
160859543|NCT01521117|580878834|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
160909272|NCT01318993|581062022|FG000|Overall Study|Protocol Violation|3|||
160859544|NCT01521117|580878835|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
160859545|NCT01521117|580878834|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
160859546|NCT01521117|580878835|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
160859547|NCT01521117|580878834|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
160859548|NCT01521117|580878835|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
160859549|NCT00784563|580878838|FG000|Years 1 & 2|Withdrawal by Subject|3|||
160859550|NCT00784563|580878839|FG001|Years 1 & 2|Withdrawal by Subject|2|||
160859551|NCT00784563|580878840|FG002|Years 1 & 2|Withdrawal by Subject|0|||
160859552|NCT00784563|580878838|FG000|Years 1 & 2|Adverse Event|0|||
160859553|NCT00784563|580878839|FG001|Years 1 & 2|Adverse Event|3|||
160859554|NCT00784563|580878840|FG002|Years 1 & 2|Adverse Event|0|||
160859555|NCT00784563|580878838|FG000|Year 3|Withdrawal by Subject|0|||
160859556|NCT00784563|580878839|FG001|Year 3|Withdrawal by Subject|0|||
160859557|NCT00784563|580878840|FG002|Year 3|Withdrawal by Subject|2|||
160859558|NCT00784563|580878838|FG000|Year 3|Adverse Event|0|||
160859559|NCT00784563|580878839|FG001|Year 3|Adverse Event|0|||
160859560|NCT00784563|580878840|FG002|Year 3|Adverse Event|1|||
160859561|NCT00762164|580878841|FG000|Overall Study|Lost to Follow-up|1|||
160859562|NCT00762164|580878842|FG001|Overall Study|Lost to Follow-up|1|||
160859563|NCT00762164|580878841|FG000|Overall Study|Discontinued medication|2|||
160859564|NCT00762164|580878842|FG001|Overall Study|Discontinued medication|0|||
160859565|NCT00762164|580878841|FG000|Overall Study|Withdrawal by Subject|0|||
160859566|NCT00762164|580878842|FG001|Overall Study|Withdrawal by Subject|1|||
160859567|NCT02657889|580878847|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
160859568|NCT02657889|580878848|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
160859569|NCT02657889|580878849|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
160859570|NCT02657889|580878850|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
160859571|NCT02657889|580878847|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
160859572|NCT02657889|580878848|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
160859573|NCT02657889|580878849|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
160859574|NCT02657889|580878850|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
160859575|NCT02657889|580878847|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
160859576|NCT02657889|580878848|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
160859577|NCT02657889|580878849|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
160859578|NCT02657889|580878850|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
160859579|NCT02657889|580878847|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
160859580|NCT02657889|580878848|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
160859581|NCT02657889|580878849|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
160859582|NCT02657889|580878850|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
160859583|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
160859584|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
160859585|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
160859586|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
160859587|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
160859588|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
160859589|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
160859590|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
160859591|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
160859592|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
160859593|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
160859594|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
160859595|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
160859596|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
160859597|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
160859598|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
160859599|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
160859600|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
160859601|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
160859602|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
160859603|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
160859604|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
160909273|NCT01318993|581062022|FG000|Overall Study|Protocol based stopping criteria|6|||
160909274|NCT01318993|581062022|FG000|Overall Study|Study closed or terminated|174|||
160909275|NCT01318993|581062022|FG000|Overall Study|Lost to Follow-up|4|||
160909276|NCT01318993|581062022|FG000|Overall Study|Physician Decision|13|||
160909277|NCT01318993|581062022|FG000|Overall Study|Withdrawal by Subject|24|||
160909278|NCT03736447|581062026|FG000|Overall Study|Adverse Event|5|||
160909279|NCT03736447|581062027|FG001|Overall Study|Adverse Event|1|||
160909280|NCT03736447|581062026|FG000|Overall Study|Withdrawal by Subject|5|||
160909281|NCT03736447|581062027|FG001|Overall Study|Withdrawal by Subject|1|||
160909282|NCT03736447|581062026|FG000|Overall Study|Lost to Follow-up|1|||
160909283|NCT03736447|581062027|FG001|Overall Study|Lost to Follow-up|0|||
160909284|NCT03736447|581062026|FG000|Overall Study|Physician Decision|1|||
160909285|NCT03736447|581062027|FG001|Overall Study|Physician Decision|0|||
160909286|NCT03736447|581062026|FG000|Overall Study|Continued commitment to study treatment|3|||
160909287|NCT03736447|581062027|FG001|Overall Study|Continued commitment to study treatment|0|||
160909288|NCT03736447|581062026|FG000|Overall Study|Taste aversion to study product|0|||
160909289|NCT03736447|581062027|FG001|Overall Study|Taste aversion to study product|1|||
160909290|NCT02619175|581062029|FG000|Overall Study|Withdrawal by Subject|1|||
160909291|NCT02619175|581062030|FG001|Overall Study|Withdrawal by Subject|0|||
160909292|NCT02619175|581062029|FG000|Overall Study|foot pain|1|||
160909293|NCT02619175|581062030|FG001|Overall Study|foot pain|0|||
160909294|NCT02795832|581062034|FG000|Overall Study|Adverse Event|0|||
160909295|NCT02795832|581062035|FG001|Overall Study|Adverse Event|0|||
160994457|NCT03598790|581368946|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994458|NCT03598790|581368947|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994459|NCT03598790|581368948|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994460|NCT03598790|581368949|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994461|NCT03410992|581368951|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994462|NCT03410992|581368952|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
160994463|NCT03410992|581368953|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994464|NCT03410992|581368954|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994465|NCT03410992|581368955|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994466|NCT03410992|581368956|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994467|NCT03410992|581368957|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994468|NCT03410992|581368958|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994469|NCT03410992|581368959|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994470|NCT03410992|581368960|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994471|NCT03410992|581368961|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994472|NCT03410992|581368951|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
160994473|NCT03410992|581368952|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
160994474|NCT03410992|581368953|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994475|NCT03410992|581368954|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994476|NCT03410992|581368955|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994477|NCT03410992|581368956|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994478|NCT03410992|581368957|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994479|NCT03410992|581368958|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994480|NCT03410992|581368959|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994481|NCT03410992|581368960|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994482|NCT03410992|581368961|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994483|NCT03410992|581368951|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
160994484|NCT03410992|581368952|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
160994485|NCT03410992|581368953|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994486|NCT03410992|581368954|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994487|NCT03410992|581368955|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994488|NCT03410992|581368956|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994489|NCT03410992|581368957|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994490|NCT03410992|581368958|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994491|NCT03410992|581368959|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994492|NCT03410992|581368960|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994493|NCT03410992|581368961|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160570189|NCT02495077|579810421|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
160909296|NCT02795832|581062036|FG002|Overall Study|Adverse Event|0|||
160909297|NCT02795832|581062037|FG003|Overall Study|Adverse Event|0|||
160909298|NCT02795832|581062038|FG004|Overall Study|Adverse Event|0|||
160909299|NCT02795832|581062039|FG005|Overall Study|Adverse Event|3|||
160909300|NCT02695329|581062040|FG000|Overall Study|Adverse Event|1|||
160909301|NCT02695329|581062041|FG001|Overall Study|Adverse Event|0|||
160909302|NCT02695329|581062040|FG000|Overall Study|Poor X-ray quality for measurement|4|||
160909303|NCT02695329|581062041|FG001|Overall Study|Poor X-ray quality for measurement|5|||
160909304|NCT01382212|581062042|FG000|Overall Study|Kidney transplant|1|||
160909305|NCT01382212|581062042|FG000|Overall Study|Withdrew consent|1|||
160909306|NCT00393029|581062043|FG000|Overall Study|Not treated|0|||
160859605|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
160859606|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
160859607|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
160994494|NCT03410992|581368951|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
160994495|NCT03410992|581368952|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994496|NCT03410992|581368953|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994497|NCT03410992|581368954|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160859608|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
160859609|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
160859610|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
160859611|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
160859612|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
160859613|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
160859614|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
160859615|NCT00685165|580878851|FG000|Washout Period of 14 Days|Adverse Event|1|||
160859616|NCT00685165|580878852|FG001|Washout Period of 14 Days|Adverse Event|0|||
160859617|NCT03155724|580878854|FG000|Overall Study|Death|3|||
160859618|NCT03155724|580878854|FG000|Overall Study|Physician Decision|1|||
160859619|NCT03155724|580878854|FG000|Overall Study|Study closure|7|||
160859620|NCT00321789|580878863|FG000|Overall Study|Lost to Follow-up|4|||
160859621|NCT00321789|580878864|FG001|Overall Study|Lost to Follow-up|7|||
160859622|NCT00321789|580878863|FG000|Overall Study|Withdrawal by Subject|6|||
160859623|NCT00321789|580878864|FG001|Overall Study|Withdrawal by Subject|6|||
160994498|NCT03410992|581368955|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994499|NCT03410992|581368956|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994500|NCT03410992|581368957|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994501|NCT03410992|581368958|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994502|NCT03410992|581368959|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994503|NCT03410992|581368960|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994504|NCT03410992|581368961|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994505|NCT03410992|581368951|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
160994506|NCT03410992|581368952|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
160994507|NCT03410992|581368953|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994508|NCT03410992|581368954|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994509|NCT03410992|581368955|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994510|NCT03410992|581368956|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994511|NCT03410992|581368957|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994512|NCT03410992|581368958|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994513|NCT03410992|581368959|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994514|NCT03410992|581368960|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994515|NCT03410992|581368961|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994516|NCT03410992|581368951|FG000|Week 16 Assessment|Incorrect escapers|0|||
160859624|NCT00321789|580878863|FG000|Overall Study|Protocol Violation|5|||
160859625|NCT00321789|580878864|FG001|Overall Study|Protocol Violation|3|||
160994517|NCT03410992|581368952|FG001|Week 16 Assessment|Incorrect escapers|6|||
160859626|NCT03050801|580878865|FG000|Experiment 1|Lost to Follow-up|0|||
160859627|NCT03050801|580878866|FG001|Experiment 1|Lost to Follow-up|1|||
160859628|NCT03050801|580878867|FG002|Experiment 1|Lost to Follow-up|0|||
160859629|NCT03050801|580878868|FG003|Experiment 1|Lost to Follow-up|0|||
160859630|NCT03050801|580878869|FG004|Experiment 1|Lost to Follow-up|0|||
160859631|NCT03050801|580878870|FG005|Experiment 1|Lost to Follow-up|0|||
160859632|NCT03050801|580878865|FG000|Experiment 1|Physician Decision|0|||
160859633|NCT03050801|580878866|FG001|Experiment 1|Physician Decision|3|||
160859634|NCT03050801|580878867|FG002|Experiment 1|Physician Decision|0|||
160859635|NCT03050801|580878868|FG003|Experiment 1|Physician Decision|0|||
160859636|NCT03050801|580878869|FG004|Experiment 1|Physician Decision|0|||
160859637|NCT03050801|580878870|FG005|Experiment 1|Physician Decision|0|||
160859638|NCT03050801|580878865|FG000|Experiment 1|Change of experimental design|0|||
160859639|NCT03050801|580878866|FG001|Experiment 1|Change of experimental design|3|||
160652429|NCT00992407|580108631|FG001|Overall Study|Other|0|||
160652430|NCT00992407|580108630|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
160652431|NCT00992407|580108631|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
160652432|NCT00992407|580108630|FG000|Overall Study|Study medication not administered|17|||
160652433|NCT00992407|580108631|FG001|Overall Study|Study medication not administered|13|||
160652434|NCT02336737|580108632|FG000|Overall Study|Withdrawal by Subject|5|||
160652435|NCT02336737|580108632|FG000|Overall Study|Physician Decision|8|||
160652436|NCT00275002|580108634|FG000|Overall Study|Death|1|||
160652437|NCT00275002|580108635|FG001|Overall Study|Death|0|||
160652438|NCT00275002|580108634|FG000|Overall Study|Disease progression|21|||
160652439|NCT00275002|580108635|FG001|Overall Study|Disease progression|15|||
160652440|NCT00275002|580108634|FG000|Overall Study|Adverse Event|0|||
160652441|NCT00275002|580108635|FG001|Overall Study|Adverse Event|1|||
160652442|NCT00576381|580108640|FG000|Overall Study|Reoperation|3|||
160652443|NCT00576381|580108640|FG000|Overall Study|Adverse Event|4|||
160652444|NCT02518113|580108644|FG000|Overall Study|Adverse Event|1|||
160652445|NCT02518113|580108645|FG001|Overall Study|Adverse Event|0|||
160652446|NCT02518113|580108646|FG002|Overall Study|Adverse Event|1|||
160652447|NCT02518113|580108647|FG003|Overall Study|Adverse Event|0|||
160652448|NCT02518113|580108644|FG000|Overall Study|Death|1|||
160652449|NCT02518113|580108645|FG001|Overall Study|Death|2|||
160652450|NCT02518113|580108646|FG002|Overall Study|Death|0|||
160859640|NCT03050801|580878867|FG002|Experiment 1|Change of experimental design|0|||
160859641|NCT03050801|580878868|FG003|Experiment 1|Change of experimental design|0|||
160994518|NCT03410992|581368953|FG002|Week 16 Assessment|Incorrect escapers|0|||
160994519|NCT03410992|581368954|FG003|Week 16 Assessment|Incorrect escapers|0|||
160859642|NCT03050801|580878869|FG004|Experiment 1|Change of experimental design|0|||
160859643|NCT03050801|580878870|FG005|Experiment 1|Change of experimental design|0|||
160859644|NCT03050801|580878865|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
160994520|NCT03410992|581368955|FG004|Week 16 Assessment|Incorrect escapers|0|||
160994521|NCT03410992|581368956|FG005|Week 16 Assessment|Incorrect escapers|0|||
160994522|NCT03410992|581368957|FG006|Week 16 Assessment|Incorrect escapers|0|||
160994523|NCT03410992|581368958|FG007|Week 16 Assessment|Incorrect escapers|0|||
160859645|NCT03050801|580878866|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
160859646|NCT03050801|580878867|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
160859647|NCT03050801|580878868|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
160859648|NCT03050801|580878869|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
160859649|NCT03050801|580878870|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
160859650|NCT03050801|580878865|FG000|Experiment 2|Lost to Follow-up|0|||
160859651|NCT03050801|580878866|FG001|Experiment 2|Lost to Follow-up|0|||
160859652|NCT03050801|580878867|FG002|Experiment 2|Lost to Follow-up|0|||
160859653|NCT03050801|580878868|FG003|Experiment 2|Lost to Follow-up|1|||
160859654|NCT03050801|580878869|FG004|Experiment 2|Lost to Follow-up|1|||
160859655|NCT03050801|580878870|FG005|Experiment 2|Lost to Follow-up|0|||
160859656|NCT03050801|580878865|FG000|Experiment 2|Physician Decision|0|||
160859657|NCT03050801|580878866|FG001|Experiment 2|Physician Decision|0|||
160859658|NCT03050801|580878867|FG002|Experiment 2|Physician Decision|0|||
160859659|NCT03050801|580878868|FG003|Experiment 2|Physician Decision|0|||
160859660|NCT03050801|580878869|FG004|Experiment 2|Physician Decision|1|||
160859661|NCT03050801|580878870|FG005|Experiment 2|Physician Decision|0|||
160859662|NCT03050801|580878865|FG000|Experiment 2|Pregnancy|0|||
160859663|NCT03050801|580878866|FG001|Experiment 2|Pregnancy|0|||
160859664|NCT03050801|580878867|FG002|Experiment 2|Pregnancy|0|||
160859665|NCT03050801|580878868|FG003|Experiment 2|Pregnancy|0|||
160859666|NCT03050801|580878869|FG004|Experiment 2|Pregnancy|1|||
160859667|NCT03050801|580878870|FG005|Experiment 2|Pregnancy|0|||
160859668|NCT03050801|580878865|FG000|Experiment 2|Withdrawal by Subject|0|||
160859669|NCT03050801|580878866|FG001|Experiment 2|Withdrawal by Subject|0|||
160859670|NCT03050801|580878867|FG002|Experiment 2|Withdrawal by Subject|0|||
160859671|NCT03050801|580878868|FG003|Experiment 2|Withdrawal by Subject|1|||
160859672|NCT03050801|580878869|FG004|Experiment 2|Withdrawal by Subject|0|||
160859673|NCT03050801|580878870|FG005|Experiment 2|Withdrawal by Subject|0|||
160859674|NCT03050801|580878865|FG000|Experiment 2|Poor data quality|0|||
160859675|NCT03050801|580878866|FG001|Experiment 2|Poor data quality|0|||
160859676|NCT03050801|580878867|FG002|Experiment 2|Poor data quality|0|||
160859677|NCT03050801|580878868|FG003|Experiment 2|Poor data quality|4|||
160859678|NCT03050801|580878869|FG004|Experiment 2|Poor data quality|1|||
160859679|NCT03050801|580878870|FG005|Experiment 2|Poor data quality|0|||
160859680|NCT03050801|580878865|FG000|Experiment 2|Discomfort during stimulation|0|||
160994524|NCT03410992|581368959|FG008|Week 16 Assessment|Incorrect escapers|0|||
160652451|NCT02518113|580108647|FG003|Overall Study|Death|0|||
160652452|NCT02518113|580108644|FG000|Overall Study|Physician Decision|0|||
160652453|NCT02518113|580108645|FG001|Overall Study|Physician Decision|1|||
160652454|NCT02518113|580108646|FG002|Overall Study|Physician Decision|0|||
160652455|NCT02518113|580108647|FG003|Overall Study|Physician Decision|0|||
160652456|NCT02518113|580108644|FG000|Overall Study|Progressive Disease|1|||
160652457|NCT02518113|580108645|FG001|Overall Study|Progressive Disease|2|||
160859681|NCT03050801|580878866|FG001|Experiment 2|Discomfort during stimulation|0|||
160859682|NCT03050801|580878867|FG002|Experiment 2|Discomfort during stimulation|0|||
160859683|NCT03050801|580878868|FG003|Experiment 2|Discomfort during stimulation|0|||
160859684|NCT03050801|580878869|FG004|Experiment 2|Discomfort during stimulation|0|||
160859685|NCT03050801|580878870|FG005|Experiment 2|Discomfort during stimulation|2|||
160859686|NCT01576341|580878871|FG000|Overall Study|Withdrawal by Subject|24|||
160859687|NCT01576341|580878871|FG000|Overall Study|Adverse Event|10|||
160859688|NCT01576341|580878871|FG000|Overall Study|Death|21|||
160859689|NCT01576341|580878871|FG000|Overall Study|Physician Decision|2|||
160859690|NCT01576341|580878871|FG000|Overall Study|Lost to Follow-up|2|||
160859691|NCT01576341|580878871|FG000|Overall Study|Kidney transplantation|10|||
160859692|NCT01576341|580878871|FG000|Overall Study|Protocol Violation|12|||
160859693|NCT01576341|580878871|FG000|Overall Study|Other|12|||
160859694|NCT00617734|580878872|FG000|Overall Study|Withdrew Consent|2|||
160859695|NCT00617734|580878873|FG001|Overall Study|Withdrew Consent|0|||
160859696|NCT00617734|580878872|FG000|Overall Study|Adverse Event|4|||
160859697|NCT00617734|580878873|FG001|Overall Study|Adverse Event|1|||
160859698|NCT00617734|580878872|FG000|Overall Study|Protocol Violation|1|||
160859699|NCT00617734|580878873|FG001|Overall Study|Protocol Violation|0|||
160859700|NCT00617734|580878872|FG000|Overall Study|Found Ineligible After Randomization|1|||
160859701|NCT00617734|580878873|FG001|Overall Study|Found Ineligible After Randomization|4|||
160909307|NCT00393029|581062044|FG001|Overall Study|Not treated|1|||
160909308|NCT00039130|581062046|FG000|Overall Study|Adverse Event|11|||
160909309|NCT00039130|581062046|FG000|Overall Study|Death|9|||
160909310|NCT00039130|581062046|FG000|Overall Study|Withdrawal by Subject|3|||
160909311|NCT00039130|581062046|FG000|Overall Study|Progression|2|||
160909312|NCT00039130|581062046|FG000|Overall Study|Subsequent treatment|2|||
160909313|NCT00039130|581062046|FG000|Overall Study|Physician Decision|3|||
160909314|NCT01269463|581062047|FG000|First Intervention|Withdrawal by Subject|1|||
160909315|NCT01269463|581062048|FG001|First Intervention|Withdrawal by Subject|0|||
160909316|NCT01269463|581062047|FG000|First Intervention|Adverse Event|1|||
160909317|NCT01269463|581062048|FG001|First Intervention|Adverse Event|0|||
160909318|NCT01269463|581062047|FG000|First Intervention|Lack of Efficacy|0|||
160909319|NCT01269463|581062048|FG001|First Intervention|Lack of Efficacy|1|||
160909320|NCT01269463|581062047|FG000|First Intervention|Physician Decision|0|||
160909321|NCT01269463|581062048|FG001|First Intervention|Physician Decision|1|||
160909322|NCT00279305|581062049|FG000|Overall Study|Pregnancy|1|||
160909323|NCT00279305|581062050|FG001|Overall Study|Pregnancy|0|||
160909324|NCT00279305|581062049|FG000|Overall Study|Withdrawal by Subject|2|||
160909325|NCT00279305|581062050|FG001|Overall Study|Withdrawal by Subject|0|||
160909326|NCT00279305|581062049|FG000|Overall Study|Dificulting establishing IV|1|||
160909327|NCT00279305|581062050|FG001|Overall Study|Dificulting establishing IV|0|||
160909328|NCT00279305|581062049|FG000|Overall Study|FDA Safety Alert|4|||
160909329|NCT00279305|581062050|FG001|Overall Study|FDA Safety Alert|1|||
160909330|NCT04404361|581062052|FG000|Overall Study|Death|12|||
160909331|NCT04404361|581062053|FG001|Overall Study|Death|12|||
160909332|NCT04404361|581062052|FG000|Overall Study|Withdrawal by Subject|13|||
160909333|NCT04404361|581062053|FG001|Overall Study|Withdrawal by Subject|5|||
160909334|NCT04404361|581062052|FG000|Overall Study|Lost to Follow-up|6|||
160909335|NCT04404361|581062053|FG001|Overall Study|Lost to Follow-up|3|||
160909336|NCT04404361|581062052|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
160909337|NCT04404361|581062053|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
160909338|NCT02612727|581062055|FG000|Overall Study|Parent request|4|||
160909339|NCT02612727|581062056|FG001|Overall Study|Parent request|1|||
160909340|NCT02612727|581062055|FG000|Overall Study|Needed treatment incompatible with PT|1|||
160909341|NCT02612727|581062056|FG001|Overall Study|Needed treatment incompatible with PT|1|||
160909342|NCT02612727|581062055|FG000|Overall Study|Direct hyperbilirubinemia|0|||
160909343|NCT02612727|581062056|FG001|Overall Study|Direct hyperbilirubinemia|2|||
160909344|NCT01638546|581062067|FG000|Overall Study|Adverse Event|1|||
160909345|NCT01638546|581062068|FG001|Overall Study|Adverse Event|3|||
160909346|NCT00540514|581063909|FG000|Overall Study|Still on treatment|3|||
160909347|NCT00540514|581063910|FG001|Overall Study|Still on treatment|0|||
160909348|NCT00540514|581063909|FG000|Overall Study|Unacceptable Toxicity|61|||
160909349|NCT00540514|581063910|FG001|Overall Study|Unacceptable Toxicity|62|||
160909350|NCT00540514|581063909|FG000|Overall Study|Adverse Event|20|||
160859702|NCT00617734|580878872|FG000|Overall Study|Lost to Follow-up|0|||
160859703|NCT00617734|580878873|FG001|Overall Study|Lost to Follow-up|1|||
160859704|NCT02485691|580878874|FG000|Overall Study|Adverse Event|25|||
160859705|NCT02485691|580878875|FG001|Overall Study|Adverse Event|11|||
160859706|NCT02485691|580878874|FG000|Overall Study|Poor compliance to protocol|0|||
160909351|NCT00540514|581063910|FG001|Overall Study|Adverse Event|24|||
160909352|NCT00540514|581063909|FG000|Overall Study|Physician Decision|86|||
160909353|NCT00540514|581063910|FG001|Overall Study|Physician Decision|99|||
160909354|NCT00540514|581063909|FG000|Overall Study|Protocol Deviation|3|||
160909355|NCT00540514|581063910|FG001|Overall Study|Protocol Deviation|4|||
160909356|NCT00540514|581063909|FG000|Overall Study|Lost to Follow-up|1|||
160909357|NCT00540514|581063910|FG001|Overall Study|Lost to Follow-up|1|||
160909358|NCT00540514|581063909|FG000|Overall Study|Withdrawal by Subject|65|||
160909359|NCT00540514|581063910|FG001|Overall Study|Withdrawal by Subject|67|||
160859707|NCT02485691|580878875|FG001|Overall Study|Poor compliance to protocol|1|||
160859708|NCT02485691|580878874|FG000|Overall Study|Disease progression|57|||
160859709|NCT02485691|580878875|FG001|Overall Study|Disease progression|92|||
160859710|NCT02485691|580878874|FG000|Overall Study|Investigator's decision|23|||
160859711|NCT02485691|580878875|FG001|Overall Study|Investigator's decision|5|||
160859712|NCT02485691|580878874|FG000|Overall Study|Participant's request|13|||
160859713|NCT02485691|580878875|FG001|Overall Study|Participant's request|6|||
160859714|NCT02485691|580878874|FG000|Overall Study|Other reason|8|||
160859715|NCT02485691|580878875|FG001|Overall Study|Other reason|9|||
160859716|NCT02485691|580878874|FG000|Overall Study|Randomized and not treated|3|||
160859717|NCT02485691|580878875|FG001|Overall Study|Randomized and not treated|2|||
160859718|NCT04292535|580878876|FG000|Overall Study|Withdrawal by Subject|0|||
160859719|NCT04292535|580878877|FG001|Overall Study|Withdrawal by Subject|0|||
160859720|NCT04292535|580878878|FG002|Overall Study|Withdrawal by Subject|0|||
160859721|NCT04292535|580878879|FG003|Overall Study|Withdrawal by Subject|0|||
160859722|NCT04292535|580878880|FG004|Overall Study|Withdrawal by Subject|0|||
160859723|NCT04292535|580878881|FG005|Overall Study|Withdrawal by Subject|0|||
160859724|NCT04292535|580878882|FG006|Overall Study|Withdrawal by Subject|0|||
160859725|NCT04292535|580878883|FG007|Overall Study|Withdrawal by Subject|1|||
160859726|NCT04292535|580878884|FG008|Overall Study|Withdrawal by Subject|0|||
160859727|NCT04292535|580878885|FG009|Overall Study|Withdrawal by Subject|0|||
160859728|NCT04292535|580878886|FG010|Overall Study|Withdrawal by Subject|0|||
160859729|NCT04292535|580878887|FG011|Overall Study|Withdrawal by Subject|0|||
160859730|NCT04292535|580878888|FG012|Overall Study|Withdrawal by Subject|0|||
160859731|NCT04292535|580878889|FG013|Overall Study|Withdrawal by Subject|0|||
160859732|NCT04292535|580878876|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859733|NCT04292535|580878877|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859734|NCT04292535|580878878|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859735|NCT04292535|580878879|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859736|NCT04292535|580878880|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859737|NCT04292535|580878881|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859738|NCT04292535|580878882|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859739|NCT04292535|580878883|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
160859740|NCT04292535|580878884|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859741|NCT04292535|580878885|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859742|NCT04292535|580878886|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859743|NCT04292535|580878887|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859744|NCT04292535|580878888|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
160859745|NCT04292535|580878889|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
160859746|NCT04292535|580878876|FG000|Overall Study|Report of Dizziness|0|||
160859747|NCT04292535|580878877|FG001|Overall Study|Report of Dizziness|0|||
160859748|NCT04292535|580878878|FG002|Overall Study|Report of Dizziness|0|||
160859749|NCT04292535|580878879|FG003|Overall Study|Report of Dizziness|0|||
160859750|NCT04292535|580878880|FG004|Overall Study|Report of Dizziness|0|||
160859751|NCT04292535|580878881|FG005|Overall Study|Report of Dizziness|0|||
160859752|NCT04292535|580878882|FG006|Overall Study|Report of Dizziness|0|||
160859753|NCT04292535|580878883|FG007|Overall Study|Report of Dizziness|0|||
160859754|NCT04292535|580878884|FG008|Overall Study|Report of Dizziness|0|||
160859755|NCT04292535|580878885|FG009|Overall Study|Report of Dizziness|0|||
160859756|NCT04292535|580878886|FG010|Overall Study|Report of Dizziness|0|||
160859757|NCT04292535|580878887|FG011|Overall Study|Report of Dizziness|0|||
160859758|NCT04292535|580878888|FG012|Overall Study|Report of Dizziness|0|||
160859759|NCT04292535|580878889|FG013|Overall Study|Report of Dizziness|1|||
160859760|NCT04292535|580878876|FG000|Overall Study|Equipment Failure|0|||
160859761|NCT04292535|580878877|FG001|Overall Study|Equipment Failure|0|||
160859762|NCT04292535|580878878|FG002|Overall Study|Equipment Failure|0|||
160859763|NCT04292535|580878879|FG003|Overall Study|Equipment Failure|0|||
160859764|NCT04292535|580878880|FG004|Overall Study|Equipment Failure|0|||
160859765|NCT04292535|580878881|FG005|Overall Study|Equipment Failure|0|||
160859766|NCT04292535|580878882|FG006|Overall Study|Equipment Failure|0|||
160859767|NCT04292535|580878883|FG007|Overall Study|Equipment Failure|0|||
160859768|NCT04292535|580878884|FG008|Overall Study|Equipment Failure|0|||
160859769|NCT04292535|580878885|FG009|Overall Study|Equipment Failure|0|||
160859770|NCT04292535|580878886|FG010|Overall Study|Equipment Failure|0|||
160859771|NCT04292535|580878887|FG011|Overall Study|Equipment Failure|1|||
160859772|NCT04292535|580878888|FG012|Overall Study|Equipment Failure|0|||
160859773|NCT04292535|580878889|FG013|Overall Study|Equipment Failure|0|||
160859774|NCT01420861|580878890|FG000|Overall Study|Adverse Event|2|||
160859775|NCT01420861|580878890|FG000|Overall Study|Study terminated by Sponsor|7|||
160859776|NCT01420861|580878890|FG000|Overall Study|Screen failure|7|||
160859777|NCT01420861|580878890|FG000|Overall Study|Randomized not Treated|2|||
160859778|NCT03361137|580878891|FG000|Overall Study|Reason not specified|1|||
160859779|NCT03361137|580878892|FG001|Overall Study|Reason not specified|0|||
160859780|NCT03361137|580878893|FG002|Overall Study|Reason not specified|0|||
160859781|NCT03361137|580878894|FG003|Overall Study|Reason not specified|0|||
160859782|NCT03361137|580878895|FG004|Overall Study|Reason not specified|0|||
160859783|NCT00791934|580878896|FG000|Overall Study|Withdrawal by Subject|2|||
160859784|NCT00791934|580878896|FG000|Overall Study|Did not consent for extended follow-up|13|||
160859785|NCT03413891|580878898|FG000|Overall Study|Lost to Follow-up|2|||
160859786|NCT03413891|580878899|FG001|Overall Study|Lost to Follow-up|1|||
160859787|NCT03413891|580878898|FG000|Overall Study|Protocol Violation|0|||
160859788|NCT03413891|580878899|FG001|Overall Study|Protocol Violation|1|||
160859789|NCT04905134|580878900|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
160859790|NCT04905134|580878900|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
160859791|NCT03009058|580878901|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
160859792|NCT05556265|580878902|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
160859793|NCT05556265|580878903|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
160859794|NCT05556265|580878904|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
160859795|NCT05556265|580878905|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
160859796|NCT05556265|580878906|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
160859797|NCT05556265|580878902|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
160859798|NCT05556265|580878903|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
160859799|NCT05556265|580878904|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
160859800|NCT05556265|580878905|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
160859801|NCT05556265|580878906|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
160859802|NCT05556265|580878902|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
160859803|NCT05556265|580878903|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
160859804|NCT05556265|580878904|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
160859805|NCT05556265|580878905|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
160859806|NCT05556265|580878906|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
160859807|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
160859808|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
160859809|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
160859810|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
160859811|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
160859812|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
160859813|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
160859814|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
160859815|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
160859816|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
160859817|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
160859818|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
160859819|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
160859820|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
160859821|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
160859822|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
160859823|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
160859824|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
160859825|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
160859826|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
160859827|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
160859828|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
160859829|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
160859830|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
160859831|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
160909360|NCT00540514|581063909|FG000|Overall Study|Excluded prior to treatment|7|||
160909361|NCT00540514|581063910|FG001|Overall Study|Excluded prior to treatment|7|||
160909362|NCT00540514|581063909|FG000|Overall Study|Paclitaxel not available|0|||
160909363|NCT00540514|581063910|FG001|Overall Study|Paclitaxel not available|2|||
160909364|NCT01892293|581063921|FG000|Overall Study|Apheresed but not treated|4|||
160570190|NCT02495077|579810418|FG000|Overall Study|Incarcerated|0|||
160570191|NCT02495077|579810419|FG001|Overall Study|Incarcerated|1|||
160570192|NCT02495077|579810420|FG002|Overall Study|Incarcerated|0|||
160570193|NCT02495077|579810421|FG003|Overall Study|Incarcerated|0|||
160570194|NCT02495077|579810418|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
160570195|NCT02495077|579810419|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
160652458|NCT02518113|580108646|FG002|Overall Study|Progressive Disease|3|||
160652459|NCT02518113|580108647|FG003|Overall Study|Progressive Disease|0|||
160652460|NCT00797108|580108648|FG000|Overall Study|Adverse Event|1|||
160652461|NCT00797108|580108649|FG001|Overall Study|Adverse Event|0|||
160652462|NCT00797108|580108650|FG002|Overall Study|Adverse Event|3|||
160652463|NCT00797108|580108648|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
160859832|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
160859833|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
160652464|NCT00797108|580108649|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
160652465|NCT00797108|580108650|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
160859834|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
160859835|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
160859836|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
160859837|NCT00079417|580880553|FG000|Overall Study|Physician Decision|2|||
160652466|NCT00797108|580108648|FG000|Overall Study|Global Deterioration of Health Status|0|||
160652467|NCT00797108|580108649|FG001|Overall Study|Global Deterioration of Health Status|1|||
160652468|NCT00797108|580108650|FG002|Overall Study|Global Deterioration of Health Status|0|||
160652469|NCT00797108|580108648|FG000|Overall Study|Lack of Efficacy|1|||
160652470|NCT00797108|580108649|FG001|Overall Study|Lack of Efficacy|0|||
160652471|NCT00797108|580108650|FG002|Overall Study|Lack of Efficacy|1|||
160652472|NCT00797108|580108648|FG000|Overall Study|Other|0|||
160652473|NCT00797108|580108649|FG001|Overall Study|Other|0|||
160652474|NCT00797108|580108650|FG002|Overall Study|Other|2|||
160652475|NCT00797108|580108648|FG000|Overall Study|Randomized but not Treated|2|||
160652476|NCT00797108|580108649|FG001|Overall Study|Randomized but not Treated|0|||
160652477|NCT00797108|580108650|FG002|Overall Study|Randomized but not Treated|0|||
160652478|NCT00287118|580108651|FG000|Overall Study|Adverse Event|30|||
160652479|NCT00287118|580108651|FG000|Overall Study|Death|1|||
160652480|NCT00287118|580108651|FG000|Overall Study|Lack of Efficacy|11|||
160652481|NCT00287118|580108651|FG000|Overall Study|Lost to Follow-up|1|||
160652482|NCT00287118|580108651|FG000|Overall Study|Protocol Violation|2|||
160652483|NCT00287118|580108651|FG000|Overall Study|Other|7|||
160652484|NCT02324465|580108652|FG000|Overall Study|device failure|0|||
160652485|NCT02324465|580108653|FG001|Overall Study|device failure|1|||
160652486|NCT01631864|580108654|FG000|Overall Study|Withdrawal by Subject|0|||
160652487|NCT01631864|580108655|FG001|Overall Study|Withdrawal by Subject|1|||
160652488|NCT01631864|580108654|FG000|Overall Study|Adverse Event|2|||
160652489|NCT01631864|580108655|FG001|Overall Study|Adverse Event|3|||
160652490|NCT01031537|580108656|FG000|Overall Study|medical reasons not related to study|3|||
160652491|NCT01031537|580108656|FG000|Overall Study|Lack of Efficacy|1|||
160652492|NCT01031537|580108656|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
160652493|NCT01031537|580108656|FG000|Overall Study|moved, met exclusion criteria|10|||
160652494|NCT01031537|580108656|FG000|Overall Study|Withdrawal by Subject|5|||
160859838|NCT00079417|580880553|FG000|Overall Study|Ineligible|7|||
160859839|NCT05366738|580880554|FG000|Overall Study|Adverse Event|0|||
160859840|NCT05366738|580880555|FG001|Overall Study|Adverse Event|1|||
160859841|NCT05366738|580880556|FG002|Overall Study|Adverse Event|0|||
160859842|NCT05024032|580880557|FG000|Overall Study|Withdrawal by Subject|0|||
160859843|NCT05024032|580880558|FG001|Overall Study|Withdrawal by Subject|3|||
160859844|NCT05024032|580880559|FG002|Overall Study|Withdrawal by Subject|4|||
160859845|NCT05024032|580880557|FG000|Overall Study|Adverse Event|0|||
160859846|NCT05024032|580880558|FG001|Overall Study|Adverse Event|1|||
160859847|NCT05024032|580880559|FG002|Overall Study|Adverse Event|0|||
160859848|NCT05024032|580880557|FG000|Overall Study|Protocol Deviation|1|||
160859849|NCT05024032|580880558|FG001|Overall Study|Protocol Deviation|0|||
160859850|NCT05024032|580880559|FG002|Overall Study|Protocol Deviation|0|||
160859851|NCT00939393|580880560|FG000|Overall Study|Withdrawal by Subject|1|||
160859852|NCT00939393|580880561|FG001|Overall Study|Withdrawal by Subject|0|||
160859853|NCT00939393|580880560|FG000|Overall Study|Lost to Follow-up|3|||
160859854|NCT00939393|580880561|FG001|Overall Study|Lost to Follow-up|0|||
160859855|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
160652495|NCT01031537|580108656|FG000|Overall Study|PI removal, no longer met eligibility|12|||
160652496|NCT00386009|580108657|FG000|Overall Study|Adverse Event|0|||
160652497|NCT00386009|580108658|FG001|Overall Study|Adverse Event|2|||
160859856|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160909365|NCT03602482|581063924|FG000|Overall Study|Withdrawal by Subject|6|||
160909366|NCT03602482|581063925|FG001|Overall Study|Withdrawal by Subject|7|||
160652498|NCT00386009|580108657|FG000|Overall Study|Death|1|||
160909367|NCT03602482|581063926|FG002|Overall Study|Withdrawal by Subject|0|||
160909368|NCT03602482|581063927|FG003|Overall Study|Withdrawal by Subject|0|||
160909369|NCT03808545|581063939|FG000|Overall Study|Withdrawal by Subject|1|||
160909370|NCT03808545|581063940|FG001|Overall Study|Withdrawal by Subject|1|||
160909371|NCT00618072|581063949|FG000|Overall Study|Lost to Follow-up|2|||
160909372|NCT00618072|581063950|FG001|Overall Study|Lost to Follow-up|0|||
160909373|NCT00618072|581063951|FG002|Overall Study|Lost to Follow-up|3|||
160909374|NCT00618072|581063949|FG000|Overall Study|Physician Decision|0|||
160994525|NCT03410992|581368960|FG009|Week 16 Assessment|Incorrect escapers|0|||
160994526|NCT03410992|581368961|FG010|Week 16 Assessment|Incorrect escapers|0|||
160994527|NCT03410992|581368951|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994528|NCT03410992|581368952|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994529|NCT03410992|581368953|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160859857|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160859858|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160859859|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160859860|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160859861|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160994530|NCT03410992|581368954|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
160994531|NCT03410992|581368955|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
160994532|NCT03410992|581368956|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994533|NCT03410992|581368957|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994534|NCT03410992|581368958|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994535|NCT03410992|581368959|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994536|NCT03410992|581368960|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994537|NCT03410992|581368961|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994538|NCT03410992|581368951|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994539|NCT03410992|581368952|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994540|NCT03410992|581368953|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994541|NCT03410992|581368954|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
160994542|NCT03410992|581368955|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
160994543|NCT03410992|581368956|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
160994544|NCT03410992|581368957|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994545|NCT03410992|581368958|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994546|NCT03410992|581368959|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994547|NCT03410992|581368960|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994548|NCT03410992|581368961|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994549|NCT03410992|581368951|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994550|NCT03410992|581368952|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994551|NCT03410992|581368953|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994552|NCT03410992|581368954|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994553|NCT03410992|581368955|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994554|NCT03410992|581368956|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
160994555|NCT03410992|581368957|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994556|NCT03410992|581368958|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994557|NCT03410992|581368959|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994558|NCT03410992|581368960|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994559|NCT03410992|581368961|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994560|NCT03410992|581368951|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994561|NCT03410992|581368952|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994562|NCT03410992|581368953|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994563|NCT03410992|581368954|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
160994564|NCT03410992|581368955|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
160994565|NCT03410992|581368956|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
160994566|NCT03410992|581368957|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994567|NCT03410992|581368958|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994568|NCT03410992|581368959|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994569|NCT03410992|581368960|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994570|NCT03410992|581368961|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994571|NCT03410992|581368951|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
160859862|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
160859863|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
160859864|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
160859865|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
160859866|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
160994572|NCT03410992|581368952|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994573|NCT03410992|581368953|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994574|NCT03410992|581368954|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
160570196|NCT02495077|579810420|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
160859867|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
160570197|NCT02495077|579810421|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
160859868|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
160859869|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
160859870|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859871|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859872|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859873|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859874|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859875|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859876|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
160859877|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859878|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859879|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859880|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859881|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859882|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859883|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
160859884|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859885|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859886|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859887|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859888|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859889|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859890|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
160859891|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859892|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859893|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859894|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859895|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859896|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859897|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
160859898|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
160859899|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
160859900|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
160859901|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
160859902|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
160859903|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
160859904|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160859905|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160859906|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
160859907|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
160859908|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160859909|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
160859910|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160859911|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
160859912|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
160859913|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
160859914|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
160859915|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
160859916|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
160859917|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
160859918|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
160859919|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
160859920|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
160859921|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
160859922|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
160859923|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
160859924|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
160859925|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
160859926|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
160859927|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
160859928|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
160859929|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
160909375|NCT00618072|581063950|FG001|Overall Study|Physician Decision|1|||
160859930|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
160859931|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
160859932|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
160859933|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
160859934|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
160859935|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
160859936|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
160859937|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
160859938|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
160859939|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160859940|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
160859941|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
160859942|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160859943|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160859944|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
160859945|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
160859946|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
160859947|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
160859948|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
160859949|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
160859950|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
160859951|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
160859952|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
160859953|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
160859954|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
160859955|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
160859956|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
160859957|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
160859958|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
160859959|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
160859960|NCT00804908|580880569|FG000|Overall Study|Other|115|||
160859961|NCT00804908|580880570|FG001|Overall Study|Other|116|||
160859962|NCT00804908|580880571|FG002|Overall Study|Other|114|||
160859963|NCT01280903|580880572|FG000|Overall Study|Lost to Follow-up|23|||
160859964|NCT01280903|580880573|FG001|Overall Study|Lost to Follow-up|16|||
160859965|NCT03453164|580880574|FG000|Overall Study|Lack of Efficacy|16|||
160859966|NCT03453164|580880574|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
160859967|NCT03829228|580880575|FG000|Overall Study|Protocol Violation|1|||
160859968|NCT02177695|580880576|FG000|ITT Analysis|Ineligible|5|||
160859969|NCT02177695|580880577|FG001|ITT Analysis|Ineligible|5|||
160859970|NCT02177695|580880576|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
160859971|NCT02177695|580880577|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
160859972|NCT02177695|580880576|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
160859973|NCT02177695|580880577|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
160859974|NCT02177695|580880576|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
160859975|NCT02177695|580880577|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
160859976|NCT00744497|580880580|FG000|Overall Study|Withdrawal by Subject|21|||
160859977|NCT00744497|580880581|FG001|Overall Study|Withdrawal by Subject|18|||
160859978|NCT00744497|580880580|FG000|Overall Study|Death|11|||
160859979|NCT00744497|580880581|FG001|Overall Study|Death|9|||
160859980|NCT00744497|580880580|FG000|Overall Study|Lost to Follow-up|4|||
160859981|NCT00744497|580880581|FG001|Overall Study|Lost to Follow-up|2|||
160859982|NCT00744497|580880580|FG000|Overall Study|Poor compliance/noncompliance|9|||
160859983|NCT00744497|580880581|FG001|Overall Study|Poor compliance/noncompliance|5|||
160859984|NCT00744497|580880580|FG000|Overall Study|No longer meets study criteria|7|||
160859985|NCT00744497|580880581|FG001|Overall Study|No longer meets study criteria|3|||
160859986|NCT00744497|580880580|FG000|Overall Study|Administrative Reason By Sponsor|25|||
160859987|NCT00744497|580880581|FG001|Overall Study|Administrative Reason By Sponsor|8|||
160859988|NCT00744497|580880580|FG000|Overall Study|Disease progression|312|||
160859989|NCT00744497|580880581|FG001|Overall Study|Disease progression|219|||
160859990|NCT00744497|580880580|FG000|Overall Study|Study drug toxicity|68|||
160859991|NCT00744497|580880581|FG001|Overall Study|Study drug toxicity|141|||
160859992|NCT00744497|580880580|FG000|Overall Study|Adverse event unrelated to study drug|78|||
160859993|NCT00744497|580880581|FG001|Overall Study|Adverse event unrelated to study drug|122|||
160859994|NCT00744497|580880580|FG000|Overall Study|Patient requested to stop study drug|65|||
160859995|NCT00744497|580880581|FG001|Overall Study|Patient requested to stop study drug|80|||
160859996|NCT00744497|580880580|FG000|Overall Study|Maximum clinical benefit|141|||
160859997|NCT00744497|580880581|FG001|Overall Study|Maximum clinical benefit|142|||
160859998|NCT00744497|580880580|FG000|Overall Study|Not defined|19|||
160994575|NCT03410992|581368955|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994576|NCT03410992|581368956|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
160859999|NCT00744497|580880581|FG001|Overall Study|Not defined|13|||
160860000|NCT02443688|580880582|FG000|Overall Study|Adverse Event|2|||
160860001|NCT02443688|580880583|FG001|Overall Study|Adverse Event|3|||
160860002|NCT02443688|580880584|FG002|Overall Study|Adverse Event|2|||
160860003|NCT02443688|580880582|FG000|Overall Study|Lost to Follow-up|1|||
160860004|NCT02443688|580880583|FG001|Overall Study|Lost to Follow-up|0|||
160860005|NCT02443688|580880584|FG002|Overall Study|Lost to Follow-up|0|||
160860006|NCT02443688|580880582|FG000|Overall Study|Physician Decision|3|||
160860007|NCT02443688|580880583|FG001|Overall Study|Physician Decision|0|||
160860008|NCT02443688|580880584|FG002|Overall Study|Physician Decision|1|||
160860009|NCT02443688|580880582|FG000|Overall Study|Pregnancy|0|||
160860010|NCT02443688|580880583|FG001|Overall Study|Pregnancy|0|||
160860011|NCT02443688|580880584|FG002|Overall Study|Pregnancy|1|||
160860012|NCT02443688|580880582|FG000|Overall Study|Withdrawal by Subject|3|||
160860013|NCT02443688|580880583|FG001|Overall Study|Withdrawal by Subject|3|||
160860014|NCT02443688|580880584|FG002|Overall Study|Withdrawal by Subject|4|||
160860015|NCT02443688|580880582|FG000|Overall Study|Non-compliance with study drug|1|||
160860016|NCT02443688|580880583|FG001|Overall Study|Non-compliance with study drug|2|||
160860017|NCT02443688|580880584|FG002|Overall Study|Non-compliance with study drug|4|||
160860018|NCT02443688|580880582|FG000|Overall Study|Sponsor Request|2|||
160860019|NCT02443688|580880583|FG001|Overall Study|Sponsor Request|1|||
160860020|NCT02443688|580880584|FG002|Overall Study|Sponsor Request|0|||
160860021|NCT03459079|580880586|FG000|Overall Study|Adverse Event|4|||
160860022|NCT03459079|580880587|FG001|Overall Study|Adverse Event|2|||
160860023|NCT03459079|580880588|FG002|Overall Study|Adverse Event|0|||
160860024|NCT03459079|580880586|FG000|Overall Study|Withdrawal by Subject|2|||
160860025|NCT03459079|580880587|FG001|Overall Study|Withdrawal by Subject|2|||
160860026|NCT03459079|580880588|FG002|Overall Study|Withdrawal by Subject|0|||
160860027|NCT00726063|580880590|FG000|Overall Study|Adverse Event|9|||
160860028|NCT00726063|580880591|FG001|Overall Study|Adverse Event|7|||
160860029|NCT02007096|580880592|FG000|Overall Study|medication not available|2|||
160860030|NCT02007096|580880593|FG001|Overall Study|medication not available|0|||
160860031|NCT02007096|580880592|FG000|Overall Study|did not inject saline|0|||
160860032|NCT02007096|580880593|FG001|Overall Study|did not inject saline|3|||
160860033|NCT02007096|580880592|FG000|Overall Study|did not follow postoperative protocol|8|||
160860034|NCT02007096|580880593|FG001|Overall Study|did not follow postoperative protocol|11|||
160860035|NCT02007096|580880592|FG000|Overall Study|converted to open surgery|1|||
160860036|NCT02007096|580880593|FG001|Overall Study|converted to open surgery|1|||
160860037|NCT02007096|580880592|FG000|Overall Study|no mesh placed|0|||
160860038|NCT02007096|580880593|FG001|Overall Study|no mesh placed|1|||
160860039|NCT05660577|580880594|FG000|Overall Study|Discontinued|9|||
160994577|NCT03410992|581368957|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994578|NCT03410992|581368958|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
160994579|NCT03410992|581368959|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994580|NCT03410992|581368960|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994581|NCT03410992|581368961|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994582|NCT03410992|581368951|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994583|NCT03410992|581368952|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994584|NCT03410992|581368953|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160570198|NCT02495077|579810418|FG000|Overall Study|Timing of transplant and randomization|0|||
160570199|NCT02495077|579810419|FG001|Overall Study|Timing of transplant and randomization|0|||
160570200|NCT02495077|579810420|FG002|Overall Study|Timing of transplant and randomization|5|||
160570201|NCT02495077|579810421|FG003|Overall Study|Timing of transplant and randomization|0|||
160860040|NCT03363841|580880595|FG000|Overall Study|Adverse Event|1|||
160860041|NCT03363841|580880595|FG000|Overall Study|Withdrawal by Subject|1|||
160860042|NCT03363841|580880595|FG000|Overall Study|Death|7|||
160860043|NCT03363841|580880595|FG000|Overall Study|Physician Decision|1|||
160860044|NCT02156076|580880598|FG000|Treatment Period|no longer meets study criteria|0|||
160860045|NCT02156076|580880599|FG001|Treatment Period|no longer meets study criteria|0|||
160860046|NCT02156076|580880600|FG002|Treatment Period|no longer meets study criteria|1|||
160570202|NCT00443560|579810422|FG000|Overall Study|No intrathecal dose|58|||
160570203|NCT00443560|579810423|FG001|Overall Study|No intrathecal dose|26|||
160570204|NCT00443560|579810422|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
160860047|NCT02156076|580880601|FG003|Treatment Period|no longer meets study criteria|0|||
160860048|NCT02156076|580880598|FG000|Treatment Period|Poor/non-compliance|0|||
160570205|NCT00443560|579810423|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
160860049|NCT02156076|580880599|FG001|Treatment Period|Poor/non-compliance|1|||
160860050|NCT02156076|580880600|FG002|Treatment Period|Poor/non-compliance|0|||
160860051|NCT02156076|580880601|FG003|Treatment Period|Poor/non-compliance|0|||
160860052|NCT02156076|580880598|FG000|Treatment Period|Lost to Follow-up|0|||
160860053|NCT02156076|580880599|FG001|Treatment Period|Lost to Follow-up|0|||
160860054|NCT02156076|580880600|FG002|Treatment Period|Lost to Follow-up|0|||
160994585|NCT03410992|581368954|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994586|NCT03410992|581368955|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160860055|NCT02156076|580880601|FG003|Treatment Period|Lost to Follow-up|1|||
160860056|NCT02156076|580880598|FG000|Treatment Period|Withdrawal by Subject|0|||
160860057|NCT02156076|580880599|FG001|Treatment Period|Withdrawal by Subject|0|||
160860058|NCT02156076|580880600|FG002|Treatment Period|Withdrawal by Subject|1|||
160860059|NCT02156076|580880601|FG003|Treatment Period|Withdrawal by Subject|0|||
160860060|NCT02156076|580880598|FG000|Treatment Period|Subject request to discontinue treatment|0|||
160860061|NCT02156076|580880599|FG001|Treatment Period|Subject request to discontinue treatment|1|||
160860062|NCT02156076|580880600|FG002|Treatment Period|Subject request to discontinue treatment|0|||
160860063|NCT02156076|580880601|FG003|Treatment Period|Subject request to discontinue treatment|0|||
160860064|NCT02156076|580880598|FG000|Treatment Period|Adverse Event|0|||
160860065|NCT02156076|580880599|FG001|Treatment Period|Adverse Event|0|||
160860066|NCT02156076|580880600|FG002|Treatment Period|Adverse Event|0|||
160860067|NCT02156076|580880601|FG003|Treatment Period|Adverse Event|1|||
160860068|NCT02156076|580880598|FG000|Follow-up Period|Withdrawal by Subject|1|||
160860069|NCT02156076|580880599|FG001|Follow-up Period|Withdrawal by Subject|0|||
160860070|NCT02156076|580880600|FG002|Follow-up Period|Withdrawal by Subject|0|||
160860071|NCT02156076|580880601|FG003|Follow-up Period|Withdrawal by Subject|0|||
160860072|NCT00981656|580880610|FG000|Overall Study|Protocol Violation|1|||
160860073|NCT00981656|580880610|FG000|Overall Study|Did not start protocol treatment|2|||
160860074|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
160860075|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
160860076|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
160860077|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
160860078|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
160860079|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
160860080|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
160860081|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
160860082|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
160860083|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160860084|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
160860085|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160860086|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
160860087|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
160860088|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
160860089|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
160860090|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
160860091|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
160860092|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
160860093|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
160860094|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
160860095|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
160860096|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
160860097|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
160860098|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
160860099|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
160860100|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
160860101|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
160860102|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
160860103|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
160860104|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
160860105|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
160860106|NCT04026113|580880611|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
160860107|NCT04026113|580880612|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
160860108|NCT04026113|580880613|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
160860109|NCT04026113|580880614|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
160860110|NCT00687596|580880615|FG000|Overall Study|Adverse Event (AE)|10|||
160860111|NCT00687596|580880616|FG001|Overall Study|Adverse Event (AE)|3|||
160909376|NCT00618072|581063951|FG002|Overall Study|Physician Decision|1|||
160909377|NCT02853604|581063960|FG000|Overall Study|Withdrawal by Subject|12|||
160909378|NCT02853604|581063961|FG001|Overall Study|Withdrawal by Subject|35|||
160909379|NCT02853604|581063960|FG000|Overall Study|Lost to Follow-up|4|||
160909380|NCT02853604|581063961|FG001|Overall Study|Lost to Follow-up|8|||
160909381|NCT02853604|581063960|FG000|Overall Study|Death|1|||
160909382|NCT02853604|581063961|FG001|Overall Study|Death|5|||
160909383|NCT02853604|581063960|FG000|Overall Study|Miscellaneous|11|||
160909384|NCT02853604|581063961|FG001|Overall Study|Miscellaneous|2|||
160909385|NCT02853604|581063960|FG000|Overall Study|Progressive Disease|0|||
160909386|NCT02853604|581063961|FG001|Overall Study|Progressive Disease|2|||
160860112|NCT00687596|580880615|FG000|Overall Study|Radiological Disease Progression|6|||
160860113|NCT00687596|580880616|FG001|Overall Study|Radiological Disease Progression|2|||
160860114|NCT00687596|580880615|FG000|Overall Study|Clinical Disease Progression|1|||
160860115|NCT00687596|580880616|FG001|Overall Study|Clinical Disease Progression|3|||
160860116|NCT00687596|580880615|FG000|Overall Study|Investigator Discretion|3|||
160860117|NCT00687596|580880616|FG001|Overall Study|Investigator Discretion|1|||
160860118|NCT00687596|580880615|FG000|Overall Study|Sponsor Terminated Study|6|||
160860119|NCT00687596|580880616|FG001|Overall Study|Sponsor Terminated Study|17|||
160860120|NCT00837434|580880618|FG000|Overall Study|Physician Decision|3|||
160860121|NCT00837434|580880619|FG001|Overall Study|Physician Decision|0|||
160860122|NCT00837434|580880618|FG000|Overall Study|Lost to Follow-up|1|||
160860123|NCT00837434|580880619|FG001|Overall Study|Lost to Follow-up|1|||
160860124|NCT00837434|580880618|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
160860125|NCT00837434|580880619|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
160860126|NCT00837434|580880618|FG000|Overall Study|Noncompliant|2|||
160860127|NCT00837434|580880619|FG001|Overall Study|Noncompliant|0|||
160860128|NCT00837434|580880618|FG000|Overall Study|Baseline assessments not done in time|1|||
160860129|NCT00837434|580880619|FG001|Overall Study|Baseline assessments not done in time|0|||
160860130|NCT00837434|580880618|FG000|Overall Study|Unable to obtain study drug|1|||
160860131|NCT00837434|580880619|FG001|Overall Study|Unable to obtain study drug|0|||
160860132|NCT01527149|580880620|FG000|Overall Study|Death|2|||
160860133|NCT01709721|580880621|FG000|Open Label Phase|Withdrawal by Subject|0|||
160860134|NCT01709721|580880622|FG001|Open Label Phase|Withdrawal by Subject|0|||
160860135|NCT01709721|580880623|FG002|Open Label Phase|Withdrawal by Subject|5|||
160860136|NCT01709721|580880621|FG000|Open Label Phase|Adverse Event|0|||
160860137|NCT01709721|580880622|FG001|Open Label Phase|Adverse Event|0|||
160860138|NCT01709721|580880623|FG002|Open Label Phase|Adverse Event|8|||
160860139|NCT01709721|580880621|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
160860140|NCT01709721|580880622|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
160860141|NCT01709721|580880623|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
160860142|NCT01709721|580880621|FG000|Open Label Phase|Investigator Decision|0|||
160860143|NCT01709721|580880622|FG001|Open Label Phase|Investigator Decision|0|||
160860144|NCT01709721|580880623|FG002|Open Label Phase|Investigator Decision|1|||
160860145|NCT01709721|580880621|FG000|Open Label Phase|Sponsor Decision|0|||
160860146|NCT01709721|580880622|FG001|Open Label Phase|Sponsor Decision|0|||
160860147|NCT01709721|580880623|FG002|Open Label Phase|Sponsor Decision|2|||
160860148|NCT01709721|580880621|FG000|Open Label Phase|Protocol Violation|0|||
160860149|NCT01709721|580880622|FG001|Open Label Phase|Protocol Violation|0|||
160860150|NCT01709721|580880623|FG002|Open Label Phase|Protocol Violation|1|||
160860151|NCT01709721|580880621|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
160860152|NCT01709721|580880622|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
160860153|NCT01709721|580880623|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
160860154|NCT01709721|580880621|FG000|Open Label Phase|Inadequate Pain Control|0|||
160860155|NCT01709721|580880622|FG001|Open Label Phase|Inadequate Pain Control|0|||
160860156|NCT01709721|580880623|FG002|Open Label Phase|Inadequate Pain Control|37|||
160860157|NCT01709721|580880621|FG000|Open Label Phase|Other, Specify in text field in database|0|||
160860158|NCT01709721|580880622|FG001|Open Label Phase|Other, Specify in text field in database|0|||
160860159|NCT01709721|580880623|FG002|Open Label Phase|Other, Specify in text field in database|14|||
160860160|NCT01709721|580880621|FG000|Randomized Phase|Adverse Event|0|||
160860161|NCT01709721|580880622|FG001|Randomized Phase|Adverse Event|1|||
160860162|NCT01709721|580880623|FG002|Randomized Phase|Adverse Event|0|||
160860163|NCT01709721|580880621|FG000|Randomized Phase|Lost to Follow-up|1|||
160860164|NCT01709721|580880622|FG001|Randomized Phase|Lost to Follow-up|0|||
160860165|NCT01709721|580880623|FG002|Randomized Phase|Lost to Follow-up|0|||
160860166|NCT01709721|580880621|FG000|Randomized Phase|Inadequate Pain Control|1|||
160860167|NCT01709721|580880622|FG001|Randomized Phase|Inadequate Pain Control|2|||
160860168|NCT01709721|580880623|FG002|Randomized Phase|Inadequate Pain Control|0|||
160860169|NCT01709721|580880621|FG000|Randomized Phase|Other, Specify text field in database|1|||
160860170|NCT01709721|580880622|FG001|Randomized Phase|Other, Specify text field in database|3|||
160860171|NCT01709721|580880623|FG002|Randomized Phase|Other, Specify text field in database|0|||
160860172|NCT02230410|580880626|FG000|Overall Study|Screen Failure|3|||
160860173|NCT02558894|580880632|FG000|Overall Study|Death; any cause, entire study duration|28|||
160860174|NCT02558894|580880633|FG001|Overall Study|Death; any cause, entire study duration|31|||
160860175|NCT02558894|580880632|FG000|Overall Study|Withdrawal by Subject|2|||
160860176|NCT02558894|580880633|FG001|Overall Study|Withdrawal by Subject|1|||
160860177|NCT02558894|580880632|FG000|Overall Study|Closure of Part A|2|||
160994587|NCT03410992|581368956|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994588|NCT03410992|581368957|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160570206|NCT01702805|579810430|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
160909387|NCT02270957|581063962|FG000|Overall Study|Lack of Efficacy|2|||
160909388|NCT02270957|581063963|FG001|Overall Study|Lack of Efficacy|4|||
160909389|NCT02270957|581063962|FG000|Overall Study|Adverse Event|2|||
160909390|NCT02270957|581063963|FG001|Overall Study|Adverse Event|0|||
160570207|NCT01702805|579810431|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
160860178|NCT02558894|580880633|FG001|Overall Study|Closure of Part A|1|||
160860179|NCT02992288|580880634|FG000|Overall Study|Adverse Event|8|||
160860180|NCT02992288|580880635|FG001|Overall Study|Adverse Event|2|||
160860181|NCT02992288|580880636|FG002|Overall Study|Adverse Event|2|||
160860182|NCT02992288|580880637|FG003|Overall Study|Adverse Event|2|||
160860183|NCT02992288|580880638|FG004|Overall Study|Adverse Event|2|||
160860184|NCT02992288|580880639|FG005|Overall Study|Adverse Event|7|||
160860185|NCT02992288|580880634|FG000|Overall Study|Non-compliance with study drug|0|||
160860186|NCT02992288|580880635|FG001|Overall Study|Non-compliance with study drug|1|||
160860187|NCT02992288|580880636|FG002|Overall Study|Non-compliance with study drug|1|||
160860188|NCT02992288|580880637|FG003|Overall Study|Non-compliance with study drug|0|||
160860189|NCT02992288|580880638|FG004|Overall Study|Non-compliance with study drug|1|||
160860190|NCT02992288|580880639|FG005|Overall Study|Non-compliance with study drug|0|||
160860191|NCT02992288|580880634|FG000|Overall Study|Physician Decision|3|||
160860192|NCT02992288|580880635|FG001|Overall Study|Physician Decision|0|||
160860193|NCT02992288|580880636|FG002|Overall Study|Physician Decision|1|||
160860194|NCT02992288|580880637|FG003|Overall Study|Physician Decision|0|||
160860195|NCT02992288|580880638|FG004|Overall Study|Physician Decision|0|||
160860196|NCT02992288|580880639|FG005|Overall Study|Physician Decision|1|||
160860197|NCT02992288|580880634|FG000|Overall Study|Death|2|||
160860198|NCT02992288|580880635|FG001|Overall Study|Death|0|||
160860199|NCT02992288|580880636|FG002|Overall Study|Death|2|||
160860200|NCT02992288|580880637|FG003|Overall Study|Death|1|||
160860201|NCT02992288|580880638|FG004|Overall Study|Death|2|||
160860202|NCT02992288|580880639|FG005|Overall Study|Death|0|||
160860203|NCT02992288|580880634|FG000|Overall Study|Lost to Follow-up|0|||
160860204|NCT02992288|580880635|FG001|Overall Study|Lost to Follow-up|0|||
160860205|NCT02992288|580880636|FG002|Overall Study|Lost to Follow-up|0|||
160860206|NCT02992288|580880637|FG003|Overall Study|Lost to Follow-up|1|||
160909391|NCT01218204|581063968|FG000|Part B Washout|Adverse Event|0|||
160909392|NCT01218204|581063969|FG001|Part B Washout|Adverse Event|1|||
160909393|NCT01218204|581063970|FG002|Part B Washout|Adverse Event|0|||
160909394|NCT01218204|581063971|FG003|Part B Washout|Adverse Event|0|||
160909395|NCT01218204|581063968|FG000|Part B Washout|Lost to Follow-up|0|||
160909396|NCT01218204|581063969|FG001|Part B Washout|Lost to Follow-up|2|||
160909397|NCT01218204|581063970|FG002|Part B Washout|Lost to Follow-up|0|||
160909398|NCT01218204|581063971|FG003|Part B Washout|Lost to Follow-up|0|||
160909399|NCT01218204|581063968|FG000|Part B Washout|Physician Decision|0|||
160909400|NCT01218204|581063969|FG001|Part B Washout|Physician Decision|14|||
160909401|NCT01218204|581063970|FG002|Part B Washout|Physician Decision|0|||
160909402|NCT01218204|581063971|FG003|Part B Washout|Physician Decision|0|||
160909403|NCT01218204|581063968|FG000|Part B Washout|Withdrawal by Subject|0|||
160909404|NCT01218204|581063969|FG001|Part B Washout|Withdrawal by Subject|14|||
160909405|NCT01218204|581063970|FG002|Part B Washout|Withdrawal by Subject|0|||
160909406|NCT01218204|581063971|FG003|Part B Washout|Withdrawal by Subject|0|||
160909407|NCT01218204|581063968|FG000|Part B Washout|Reached defined stopping criteria|0|||
160909408|NCT01218204|581063969|FG001|Part B Washout|Reached defined stopping criteria|2|||
160909409|NCT01218204|581063970|FG002|Part B Washout|Reached defined stopping criteria|0|||
160909410|NCT01218204|581063971|FG003|Part B Washout|Reached defined stopping criteria|0|||
160909411|NCT01218204|581063968|FG000|Part B Washout|Did not meet continuation criteria|0|||
160909412|NCT01218204|581063969|FG001|Part B Washout|Did not meet continuation criteria|112|||
160909413|NCT01218204|581063970|FG002|Part B Washout|Did not meet continuation criteria|0|||
160909414|NCT01218204|581063971|FG003|Part B Washout|Did not meet continuation criteria|0|||
160909415|NCT01218204|581063968|FG000|Part B Run-in|Adverse Event|0|||
160909416|NCT01218204|581063969|FG001|Part B Run-in|Adverse Event|0|||
160909417|NCT01218204|581063970|FG002|Part B Run-in|Adverse Event|1|||
160909418|NCT01218204|581063971|FG003|Part B Run-in|Adverse Event|0|||
160909419|NCT01218204|581063968|FG000|Part B Run-in|Protocol Violation|0|||
160909420|NCT01218204|581063969|FG001|Part B Run-in|Protocol Violation|0|||
160909421|NCT01218204|581063970|FG002|Part B Run-in|Protocol Violation|2|||
160860207|NCT02992288|580880638|FG004|Overall Study|Lost to Follow-up|0|||
160860208|NCT02992288|580880639|FG005|Overall Study|Lost to Follow-up|0|||
160860209|NCT02992288|580880634|FG000|Overall Study|Protocol Violation|0|||
160860210|NCT02992288|580880635|FG001|Overall Study|Protocol Violation|0|||
160860211|NCT02992288|580880636|FG002|Overall Study|Protocol Violation|0|||
160860212|NCT02992288|580880637|FG003|Overall Study|Protocol Violation|0|||
160860213|NCT02992288|580880638|FG004|Overall Study|Protocol Violation|0|||
160860214|NCT02992288|580880639|FG005|Overall Study|Protocol Violation|1|||
160860215|NCT02992288|580880634|FG000|Overall Study|Withdrawal by Subject|4|||
160909422|NCT01218204|581063971|FG003|Part B Run-in|Protocol Violation|0|||
160652499|NCT00386009|580108658|FG001|Overall Study|Death|0|||
160652500|NCT00386009|580108657|FG000|Overall Study|Entry Criteria Not Met|0|||
160652501|NCT00386009|580108658|FG001|Overall Study|Entry Criteria Not Met|2|||
160652502|NCT00386009|580108657|FG000|Overall Study|Lost to Follow-up|1|||
160652503|NCT00386009|580108658|FG001|Overall Study|Lost to Follow-up|1|||
160652504|NCT00386009|580108657|FG000|Overall Study|Protocol Violation|1|||
160652505|NCT00386009|580108658|FG001|Overall Study|Protocol Violation|0|||
160652506|NCT00386009|580108657|FG000|Overall Study|Sponsor Decision|1|||
160652507|NCT00386009|580108658|FG001|Overall Study|Sponsor Decision|1|||
160652508|NCT00386009|580108657|FG000|Overall Study|Withdrawal by Subject|5|||
160652509|NCT00386009|580108658|FG001|Overall Study|Withdrawal by Subject|4|||
160652510|NCT02549495|580108662|FG000|Overall Study|Death|2|||
160652511|NCT02549495|580108662|FG000|Overall Study|Withdrawal by Subject|5|||
160652512|NCT02549495|580108662|FG000|Overall Study|Physician Decision|22|||
160652513|NCT02549495|580108662|FG000|Overall Study|Lost to Follow-up|6|||
160652514|NCT02549495|580108662|FG000|Overall Study|Protocol Violation|6|||
160652515|NCT05876091|580108665|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
160652516|NCT03402893|580108666|FG000|Overall Study|Withdrawal by Subject|1|||
160652517|NCT03462719|580108667|FG000|Overall Study|Withdrawal by Subject|4|||
160652518|NCT03462719|580108668|FG001|Overall Study|Withdrawal by Subject|3|||
160652519|NCT03462719|580108667|FG000|Overall Study|Ongoing|87|||
160652520|NCT03462719|580108668|FG001|Overall Study|Ongoing|72|||
160652521|NCT04799158|580108669|FG000|Run-In Period|Adverse Event|6|||
160652522|NCT04799158|580108670|FG001|Run-In Period|Adverse Event|0|||
160652523|NCT04799158|580108671|FG002|Run-In Period|Adverse Event|0|||
160652524|NCT04799158|580108672|FG003|Run-In Period|Adverse Event|0|||
160652525|NCT04799158|580108673|FG004|Run-In Period|Adverse Event|0|||
160652526|NCT04799158|580108669|FG000|Run-In Period|Lost to Follow-up|4|||
160652527|NCT04799158|580108670|FG001|Run-In Period|Lost to Follow-up|0|||
160652528|NCT04799158|580108671|FG002|Run-In Period|Lost to Follow-up|0|||
160652529|NCT04799158|580108672|FG003|Run-In Period|Lost to Follow-up|0|||
160652530|NCT04799158|580108673|FG004|Run-In Period|Lost to Follow-up|0|||
160652531|NCT04799158|580108669|FG000|Run-In Period|Significant Protocol Deviation|1|||
160652532|NCT04799158|580108670|FG001|Run-In Period|Significant Protocol Deviation|0|||
160652533|NCT04799158|580108671|FG002|Run-In Period|Significant Protocol Deviation|0|||
160652534|NCT04799158|580108672|FG003|Run-In Period|Significant Protocol Deviation|0|||
160652535|NCT04799158|580108673|FG004|Run-In Period|Significant Protocol Deviation|0|||
160652536|NCT04799158|580108669|FG000|Run-In Period|Withdrawal by Subject|11|||
160652537|NCT04799158|580108670|FG001|Run-In Period|Withdrawal by Subject|0|||
160652538|NCT04799158|580108671|FG002|Run-In Period|Withdrawal by Subject|0|||
160652539|NCT04799158|580108672|FG003|Run-In Period|Withdrawal by Subject|0|||
160652540|NCT04799158|580108673|FG004|Run-In Period|Withdrawal by Subject|0|||
160652541|NCT04799158|580108669|FG000|Run-In Period|Miscellaneous|3|||
160652542|NCT04799158|580108670|FG001|Run-In Period|Miscellaneous|0|||
160652543|NCT04799158|580108671|FG002|Run-In Period|Miscellaneous|0|||
160652544|NCT04799158|580108672|FG003|Run-In Period|Miscellaneous|0|||
160652545|NCT04799158|580108673|FG004|Run-In Period|Miscellaneous|0|||
160652546|NCT04799158|580108669|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
160860216|NCT02992288|580880635|FG001|Overall Study|Withdrawal by Subject|2|||
160860217|NCT02992288|580880636|FG002|Overall Study|Withdrawal by Subject|1|||
160860218|NCT02992288|580880637|FG003|Overall Study|Withdrawal by Subject|5|||
160860219|NCT02992288|580880638|FG004|Overall Study|Withdrawal by Subject|3|||
160860220|NCT02992288|580880639|FG005|Overall Study|Withdrawal by Subject|4|||
160860221|NCT00656513|580880640|FG000|Overall Study|Protocol Violation|1|||
160860222|NCT00656513|580880641|FG001|Overall Study|Protocol Violation|0|||
160909423|NCT01218204|581063968|FG000|Part B Run-in|Withdrawal by Subject|0|||
160909424|NCT01218204|581063969|FG001|Part B Run-in|Withdrawal by Subject|0|||
160909425|NCT01218204|581063970|FG002|Part B Run-in|Withdrawal by Subject|3|||
160909426|NCT01218204|581063971|FG003|Part B Run-in|Withdrawal by Subject|0|||
160652547|NCT04799158|580108670|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
160652548|NCT04799158|580108671|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
160652549|NCT04799158|580108672|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
160652550|NCT04799158|580108673|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
160652551|NCT04799158|580108669|FG000|On-Demand Treatment Period|Adverse Event|0|||
160652552|NCT04799158|580108670|FG001|On-Demand Treatment Period|Adverse Event|1|||
160652553|NCT04799158|580108671|FG002|On-Demand Treatment Period|Adverse Event|0|||
160652554|NCT04799158|580108672|FG003|On-Demand Treatment Period|Adverse Event|0|||
160652555|NCT04799158|580108673|FG004|On-Demand Treatment Period|Adverse Event|1|||
160652556|NCT04799158|580108669|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
160652557|NCT04799158|580108670|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
160652558|NCT04799158|580108671|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
160652559|NCT04799158|580108672|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
160860223|NCT00656513|580880642|FG002|Overall Study|Protocol Violation|2|||
160652560|NCT04799158|580108673|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
160860224|NCT00656513|580880640|FG000|Overall Study|Withdrawal by Subject|0|||
160860225|NCT00656513|580880641|FG001|Overall Study|Withdrawal by Subject|11|||
160860226|NCT00656513|580880642|FG002|Overall Study|Withdrawal by Subject|4|||
160860227|NCT00656513|580880640|FG000|Overall Study|Death|0|||
160860228|NCT00656513|580880641|FG001|Overall Study|Death|0|||
160860229|NCT00656513|580880642|FG002|Overall Study|Death|1|||
160860230|NCT00656513|580880640|FG000|Overall Study|Missing data|0|||
160860231|NCT00656513|580880641|FG001|Overall Study|Missing data|11|||
160860232|NCT00656513|580880642|FG002|Overall Study|Missing data|9|||
160860233|NCT00656513|580880640|FG000|Overall Study|Incomplete treatment|3|||
160860234|NCT00656513|580880641|FG001|Overall Study|Incomplete treatment|0|||
160860235|NCT00656513|580880642|FG002|Overall Study|Incomplete treatment|0|||
160860236|NCT00656513|580880640|FG000|Overall Study|Treatment completed outside of timeframe|0|||
160860237|NCT00656513|580880641|FG001|Overall Study|Treatment completed outside of timeframe|3|||
160860238|NCT00656513|580880642|FG002|Overall Study|Treatment completed outside of timeframe|1|||
160860239|NCT00656513|580880640|FG000|Overall Study|Missing baseline form|0|||
160860240|NCT00656513|580880641|FG001|Overall Study|Missing baseline form|5|||
160860241|NCT00656513|580880642|FG002|Overall Study|Missing baseline form|5|||
160860242|NCT00412984|580880651|FG000|Overall Study|Death|331|||
160860243|NCT00412984|580880652|FG001|Overall Study|Death|349|||
160860244|NCT00412984|580880651|FG000|Overall Study|Adverse Event|679|||
160860245|NCT00412984|580880652|FG001|Overall Study|Adverse Event|738|||
160860246|NCT00412984|580880651|FG000|Overall Study|Withdrawal by Subject|921|||
160860247|NCT00412984|580880652|FG001|Overall Study|Withdrawal by Subject|989|||
160860248|NCT00412984|580880651|FG000|Overall Study|Lost to Follow-up|51|||
160860249|NCT00412984|580880652|FG001|Overall Study|Lost to Follow-up|39|||
160860250|NCT00412984|580880651|FG000|Overall Study|Poor/Noncompliance|57|||
160860251|NCT00412984|580880652|FG001|Overall Study|Poor/Noncompliance|77|||
160860252|NCT00412984|580880651|FG000|Overall Study|Pregnancy|1|||
160860253|NCT00412984|580880652|FG001|Overall Study|Pregnancy|0|||
160860254|NCT00412984|580880651|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
160860255|NCT00412984|580880652|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
160860256|NCT00412984|580880651|FG000|Overall Study|Administrative Reason by Sponsor|11|||
160860257|NCT00412984|580880652|FG001|Overall Study|Administrative Reason by Sponsor|8|||
160860258|NCT00412984|580880651|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
160860259|NCT00412984|580880652|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
160860260|NCT00412984|580880651|FG000|Overall Study|Other Reason|80|||
160860261|NCT00412984|580880652|FG001|Overall Study|Other Reason|92|||
160860262|NCT00412984|580880651|FG000|Overall Study|Not Reported|11|||
160860263|NCT00412984|580880652|FG001|Overall Study|Not Reported|12|||
160860264|NCT04218240|580880653|FG000|Overall Study|Withdrawal by Subject|6|||
160860265|NCT04218240|580880654|FG001|Overall Study|Withdrawal by Subject|0|||
160909427|NCT01218204|581063968|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
160909428|NCT01218204|581063969|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
160909429|NCT01218204|581063970|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
160570208|NCT01702805|579810430|FG000|Overall Study|Incomplete Follow-up|18|||
160570209|NCT01702805|579810431|FG001|Overall Study|Incomplete Follow-up|15|||
160570210|NCT01702805|579810430|FG000|Overall Study|Vital Status Assessment Only|40|||
160570211|NCT01702805|579810431|FG001|Overall Study|Vital Status Assessment Only|39|||
160570212|NCT01702805|579810430|FG000|Overall Study|Lost to Follow-up|5|||
160570213|NCT01702805|579810431|FG001|Overall Study|Lost to Follow-up|5|||
160570214|NCT01844076|579810435|FG000|Overall Study|Adverse Event|1|||
160570215|NCT01844076|579810436|FG001|Overall Study|Adverse Event|0|||
160570216|NCT01844076|579810437|FG002|Overall Study|Adverse Event|0|||
160570217|NCT01844076|579810438|FG003|Overall Study|Adverse Event|0|||
160570218|NCT01844076|579810435|FG000|Overall Study|Withdrawal by Subject|1|||
160570219|NCT01844076|579810436|FG001|Overall Study|Withdrawal by Subject|0|||
160570220|NCT01844076|579810437|FG002|Overall Study|Withdrawal by Subject|0|||
160570221|NCT01844076|579810438|FG003|Overall Study|Withdrawal by Subject|0|||
160570222|NCT00845429|579810443|FG000|Overall Study|Protocol Violation|5|||
160570223|NCT00845429|579810444|FG001|Overall Study|Protocol Violation|4|||
160570224|NCT00845429|579810445|FG002|Overall Study|Protocol Violation|7|||
160570225|NCT00845429|579810443|FG000|Overall Study|Lost to Follow-up|7|||
160570226|NCT00845429|579810444|FG001|Overall Study|Lost to Follow-up|9|||
160570227|NCT00845429|579810445|FG002|Overall Study|Lost to Follow-up|10|||
160860266|NCT04218240|580880653|FG000|Overall Study|Lack of Efficacy|24|||
160860267|NCT04218240|580880654|FG001|Overall Study|Lack of Efficacy|19|||
160860268|NCT04218240|580880653|FG000|Overall Study|Physician Decision|0|||
160860269|NCT04218240|580880654|FG001|Overall Study|Physician Decision|1|||
160570228|NCT00845429|579810443|FG000|Overall Study|Withdrawal by Subject|2|||
160570229|NCT00845429|579810444|FG001|Overall Study|Withdrawal by Subject|2|||
160570230|NCT00845429|579810445|FG002|Overall Study|Withdrawal by Subject|2|||
160570231|NCT00845429|579810443|FG000|Overall Study|Serious adverse event|0|||
160570232|NCT00845429|579810444|FG001|Overall Study|Serious adverse event|0|||
160860270|NCT04218240|580880653|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
160860271|NCT04218240|580880654|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
160860272|NCT04097678|580880655|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
160860273|NCT04097678|580880656|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
160909430|NCT01218204|581063971|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
160994589|NCT03410992|581368958|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994590|NCT03410992|581368959|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
160994591|NCT03410992|581368960|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994592|NCT03410992|581368961|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994593|NCT05298111|581368965|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
160994594|NCT05298111|581368966|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
160994595|NCT04988295|581368969|FG000|Overall Study|Withdrawal by Subject|9|||
160994596|NCT04988295|581368970|FG001|Overall Study|Withdrawal by Subject|29|||
160994597|NCT04988295|581368971|FG002|Overall Study|Withdrawal by Subject|6|||
160994598|NCT04988295|581368972|FG003|Overall Study|Withdrawal by Subject|0|||
160994599|NCT04988295|581368969|FG000|Overall Study|Lost to Follow-up|1|||
160994600|NCT04988295|581368970|FG001|Overall Study|Lost to Follow-up|0|||
160994601|NCT04988295|581368971|FG002|Overall Study|Lost to Follow-up|0|||
160994602|NCT04988295|581368972|FG003|Overall Study|Lost to Follow-up|0|||
160994603|NCT04988295|581368969|FG000|Overall Study|Study participation ongoing|186|||
160994604|NCT04988295|581368970|FG001|Overall Study|Study participation ongoing|169|||
160994605|NCT04988295|581368971|FG002|Overall Study|Study participation ongoing|99|||
160994606|NCT04988295|581368972|FG003|Overall Study|Study participation ongoing|119|||
160994607|NCT04083976|581368977|FG000|Overall Study|Lost to Follow-up|3|||
160994608|NCT04083976|581368978|FG001|Overall Study|Lost to Follow-up|0|||
160994609|NCT04083976|581368979|FG002|Overall Study|Lost to Follow-up|0|||
160994610|NCT04083976|581368980|FG003|Overall Study|Lost to Follow-up|1|||
160994611|NCT04083976|581368977|FG000|Overall Study|Withdrawal by Subject|16|||
160994612|NCT04083976|581368978|FG001|Overall Study|Withdrawal by Subject|1|||
160994613|NCT04083976|581368979|FG002|Overall Study|Withdrawal by Subject|9|||
160994614|NCT04083976|581368980|FG003|Overall Study|Withdrawal by Subject|0|||
160994615|NCT04083976|581368977|FG000|Overall Study|Sponsor Decision|14|||
160994616|NCT04083976|581368978|FG001|Overall Study|Sponsor Decision|0|||
160994617|NCT04083976|581368979|FG002|Overall Study|Sponsor Decision|0|||
160994618|NCT04083976|581368980|FG003|Overall Study|Sponsor Decision|7|||
160994619|NCT04083976|581368977|FG000|Overall Study|Other|1|||
160994620|NCT04083976|581368978|FG001|Overall Study|Other|0|||
160994621|NCT04083976|581368979|FG002|Overall Study|Other|1|||
160994622|NCT04083976|581368980|FG003|Overall Study|Other|0|||
160994623|NCT00930813|581368982|FG000|Overall Study|Death|4|||
160994624|NCT00930813|581368983|FG001|Overall Study|Death|5|||
160994625|NCT00930813|581368982|FG000|Overall Study|Withdrawal by Subject|2|||
160994626|NCT00930813|581368983|FG001|Overall Study|Withdrawal by Subject|5|||
160994627|NCT00930813|581368982|FG000|Overall Study|Lost to Follow-up|2|||
160994628|NCT00930813|581368983|FG001|Overall Study|Lost to Follow-up|4|||
160994629|NCT01693614|581368984|FG000|Overall Study|Adverse Event|7|||
160994630|NCT01693614|581368985|FG001|Overall Study|Adverse Event|11|||
160994631|NCT01693614|581368986|FG002|Overall Study|Adverse Event|5|||
160994632|NCT01693614|581368984|FG000|Overall Study|Disease progression|11|||
160994633|NCT01693614|581368985|FG001|Overall Study|Disease progression|8|||
160994634|NCT01693614|581368986|FG002|Overall Study|Disease progression|7|||
160994635|NCT01693614|581368984|FG000|Overall Study|Protocol Violation|5|||
160994636|NCT01693614|581368985|FG001|Overall Study|Protocol Violation|2|||
160994637|NCT01693614|581368986|FG002|Overall Study|Protocol Violation|1|||
160994638|NCT01693614|581368984|FG000|Overall Study|Death|1|||
160994639|NCT01693614|581368985|FG001|Overall Study|Death|0|||
160994640|NCT01693614|581368986|FG002|Overall Study|Death|0|||
160994641|NCT01693614|581368984|FG000|Overall Study|Physician Decision|1|||
160994642|NCT01693614|581368985|FG001|Overall Study|Physician Decision|1|||
160994643|NCT01693614|581368986|FG002|Overall Study|Physician Decision|4|||
160994644|NCT01693614|581368984|FG000|Overall Study|Withdrawal by subject/guardian|0|||
160994645|NCT01693614|581368985|FG001|Overall Study|Withdrawal by subject/guardian|0|||
160994646|NCT01693614|581368986|FG002|Overall Study|Withdrawal by subject/guardian|2|||
160994647|NCT01693614|581368984|FG000|Overall Study|Withdrawal by Subject|1|||
160994648|NCT01693614|581368985|FG001|Overall Study|Withdrawal by Subject|0|||
160994649|NCT01693614|581368986|FG002|Overall Study|Withdrawal by Subject|5|||
160994650|NCT04618471|581368987|FG000|Overall Study|Screen Failure|62|||
160994651|NCT04618471|581368987|FG000|Overall Study|Withdrawal by Subject|6|||
160994652|NCT04618471|581368987|FG000|Overall Study|Physician Decision|2|||
160994653|NCT04618471|581368987|FG000|Overall Study|Lost to Follow-up|1|||
160994654|NCT04618471|581368987|FG000|Overall Study|Various other reasons|2|||
160994655|NCT04618471|581368987|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
160994656|NCT00588666|581368988|FG000|Overall Study|Adverse Event|4|||
160994657|NCT00927823|581368991|FG000|Continuous Dosing Period|Death|0|||
160994658|NCT00927823|581368992|FG001|Continuous Dosing Period|Death|0|||
160994659|NCT00927823|581368993|FG002|Continuous Dosing Period|Death|6|||
160994660|NCT00927823|581368994|FG003|Continuous Dosing Period|Death|0|||
160994661|NCT00927823|581368991|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
160994662|NCT00927823|581368992|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
160994663|NCT00927823|581368993|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
160994664|NCT00927823|581368994|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
160994665|NCT00927823|581368991|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
160994666|NCT00927823|581368992|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
160994667|NCT00927823|581368993|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
160994668|NCT00927823|581368994|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
160994669|NCT00927823|581368991|FG000|Continuous Dosing Period|Other|1|||
160994670|NCT00927823|581368992|FG001|Continuous Dosing Period|Other|2|||
160994671|NCT00927823|581368993|FG002|Continuous Dosing Period|Other|9|||
160994672|NCT00927823|581368994|FG003|Continuous Dosing Period|Other|3|||
160994673|NCT02299635|581368995|FG000|Overall Study|Adverse Event|2|||
160994674|NCT02299635|581368995|FG000|Overall Study|Death|1|||
160994675|NCT02299635|581368995|FG000|Overall Study|Global deterioration of health status|1|||
160994676|NCT02299635|581368995|FG000|Overall Study|Objective progression or relapse|10|||
160994677|NCT02299635|581368995|FG000|Overall Study|Withdrawal by Subject|2|||
160994678|NCT02299635|581368995|FG000|Overall Study|Other|3|||
160994679|NCT04889118|581368996|FG000|Overall Study|Death|49|||
160994680|NCT04889118|581368997|FG001|Overall Study|Death|47|||
160994681|NCT04889118|581368996|FG000|Overall Study|Sponsor Decision|15|||
160994682|NCT04889118|581368997|FG001|Overall Study|Sponsor Decision|20|||
160994683|NCT00828672|581368998|FG000|Study Treatment|Lost to Follow-up|1|||
160994684|NCT00828672|581368999|FG001|Study Treatment|Lost to Follow-up|0|||
160994685|NCT00828672|581368998|FG000|Study Treatment|Adverse Event|0|||
160994686|NCT00828672|581368999|FG001|Study Treatment|Adverse Event|1|||
160994687|NCT00828672|581368998|FG000|Study Treatment|Complete response, no surgery|1|||
160994688|NCT00828672|581368999|FG001|Study Treatment|Complete response, no surgery|1|||
160994689|NCT00828672|581368998|FG000|Post-surgery (<30 Days)|No central review materials|0|||
160994690|NCT00828672|581368999|FG001|Post-surgery (<30 Days)|No central review materials|1|||
160994691|NCT01744691|581369000|FG000|Overall Study|Progressive Disease|18|||
160994692|NCT01744691|581369000|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
160994693|NCT01744691|581369000|FG000|Overall Study|Withdrawal of consent for treatment|3|||
160994694|NCT01744691|581369000|FG000|Overall Study|Physician Decision|4|||
160994695|NCT02701361|581369001|FG000|Overall Study|Lost to Follow-up|5|||
160994696|NCT02701361|581369002|FG001|Overall Study|Lost to Follow-up|2|||
160994697|NCT02701361|581369003|FG002|Overall Study|Lost to Follow-up|1|||
160994698|NCT02701361|581369001|FG000|Overall Study|Withdrawal by Subject|4|||
160994699|NCT02701361|581369002|FG001|Overall Study|Withdrawal by Subject|0|||
160994700|NCT02701361|581369003|FG002|Overall Study|Withdrawal by Subject|0|||
160994701|NCT02701361|581369001|FG000|Overall Study|timed out in rehab center|0|||
160994702|NCT02701361|581369002|FG001|Overall Study|timed out in rehab center|1|||
160994703|NCT02701361|581369003|FG002|Overall Study|timed out in rehab center|0|||
160994704|NCT02701361|581369001|FG000|Overall Study|incarceration|0|||
160994705|NCT02701361|581369002|FG001|Overall Study|incarceration|0|||
160994706|NCT02701361|581369003|FG002|Overall Study|incarceration|1|||
160994707|NCT00404079|581369010|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
160994708|NCT00404079|581369011|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
160994709|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Other|4|||
160994710|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Other|0|||
160994711|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
160994712|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
160994713|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
160994714|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
160994715|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
160994716|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
160994717|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
160994718|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
160994719|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
160994720|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
160994721|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
160994722|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
160994723|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
160994724|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
160994725|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
160994726|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
160994727|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
160994728|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
160994729|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
160994730|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
160994731|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
160994732|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
160994733|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
160994734|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
160994735|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
160994736|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
160994737|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
160994738|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
160994739|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Death|1|||
160994740|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Death|6|||
160994741|NCT00580801|581369024|FG000|Overall Study|Physician Decision|1|||
160994742|NCT00580801|581369025|FG001|Overall Study|Physician Decision|0|||
160994743|NCT00580801|581369026|FG002|Overall Study|Physician Decision|0|||
160994744|NCT00580801|581369024|FG000|Overall Study|Adverse Event|2|||
160994745|NCT00580801|581369025|FG001|Overall Study|Adverse Event|0|||
160994746|NCT00580801|581369026|FG002|Overall Study|Adverse Event|0|||
160994747|NCT00580801|581369024|FG000|Overall Study|Lost to Follow-up|2|||
160994748|NCT00580801|581369025|FG001|Overall Study|Lost to Follow-up|0|||
160860274|NCT03694678|580880657|FG000|Overall Study|Withdrawal by Subject|2|||
160860275|NCT03694678|580880658|FG001|Overall Study|Withdrawal by Subject|0|||
160860276|NCT03694678|580880657|FG000|Overall Study|Lost to Follow-up|2|||
160860277|NCT03694678|580880658|FG001|Overall Study|Lost to Follow-up|3|||
160994749|NCT00580801|581369026|FG002|Overall Study|Lost to Follow-up|0|||
160994750|NCT00580801|581369024|FG000|Overall Study|Reached a virologic endpoint|0|||
160860278|NCT02435212|580880659|FG000|Core Phase|Adverse Event|8|||
160860279|NCT02435212|580880660|FG001|Core Phase|Adverse Event|5|||
160860280|NCT02435212|580880659|FG000|Core Phase|Withdrawal by Subject|3|||
160994751|NCT00580801|581369025|FG001|Overall Study|Reached a virologic endpoint|1|||
160994752|NCT00580801|581369026|FG002|Overall Study|Reached a virologic endpoint|2|||
160994753|NCT00580801|581369024|FG000|Overall Study|Participant non-compliant|0|||
160994754|NCT00580801|581369025|FG001|Overall Study|Participant non-compliant|0|||
160994755|NCT00580801|581369026|FG002|Overall Study|Participant non-compliant|1|||
160994756|NCT00580801|581369024|FG000|Overall Study|Travel|1|||
160994757|NCT00580801|581369025|FG001|Overall Study|Travel|0|||
160994758|NCT00580801|581369026|FG002|Overall Study|Travel|0|||
160994759|NCT05576051|581369027|FG000|Overall Study|Lack of Efficacy|543|||
160994760|NCT05576051|581369028|FG001|Overall Study|Lack of Efficacy|343|||
160994761|NCT05576051|581369029|FG002|Overall Study|Lack of Efficacy|108|||
160994762|NCT05576051|581369030|FG003|Overall Study|Lack of Efficacy|72|||
160994763|NCT05576051|581369031|FG004|Overall Study|Lack of Efficacy|28|||
160994764|NCT05576051|581369032|FG005|Overall Study|Lack of Efficacy|50|||
160994765|NCT05576051|581369027|FG000|Overall Study|Safety|78|||
160994766|NCT05576051|581369028|FG001|Overall Study|Safety|74|||
160994767|NCT05576051|581369029|FG002|Overall Study|Safety|16|||
160994768|NCT05576051|581369030|FG003|Overall Study|Safety|14|||
160994769|NCT05576051|581369031|FG004|Overall Study|Safety|4|||
160994770|NCT05576051|581369032|FG005|Overall Study|Safety|5|||
160994771|NCT05576051|581369027|FG000|Overall Study|Efficacy + Safety|10|||
160994772|NCT05576051|581369028|FG001|Overall Study|Efficacy + Safety|7|||
160994773|NCT05576051|581369029|FG002|Overall Study|Efficacy + Safety|3|||
160994774|NCT05576051|581369030|FG003|Overall Study|Efficacy + Safety|0|||
160994775|NCT05576051|581369031|FG004|Overall Study|Efficacy + Safety|0|||
160994776|NCT05576051|581369032|FG005|Overall Study|Efficacy + Safety|0|||
160994777|NCT05576051|581369027|FG000|Overall Study|Other|231|||
160994778|NCT05576051|581369028|FG001|Overall Study|Other|127|||
160994779|NCT05576051|581369029|FG002|Overall Study|Other|35|||
160994780|NCT05576051|581369030|FG003|Overall Study|Other|14|||
160994781|NCT05576051|581369031|FG004|Overall Study|Other|6|||
160994782|NCT05576051|581369032|FG005|Overall Study|Other|0|||
160994783|NCT04154943|581369033|FG000|Overall Study|Study Ongoing|68|||
160994784|NCT04154943|581369033|FG000|Overall Study|Lost to Follow-up|1|||
160994785|NCT04154943|581369033|FG000|Overall Study|Decision by the Investigator|1|||
160994786|NCT04154943|581369033|FG000|Overall Study|Death|5|||
160994787|NCT04154943|581369033|FG000|Overall Study|Withdrawal by Subject|4|||
160994788|NCT00544440|581369034|FG000|Overall Study|Other|1|||
160994789|NCT00544440|581369034|FG000|Overall Study|Adverse Event|1|||
160994790|NCT00544440|581369034|FG000|Overall Study|Withdrawal by Subject|2|||
160994791|NCT00544440|581369034|FG000|Overall Study|Subject Non-compliance|1|||
160994792|NCT00544440|581369034|FG000|Overall Study|Progressive Disease|47|||
160994793|NCT00544440|581369034|FG000|Overall Study|Other|5|||
160994794|NCT05650333|581369035|FG000|Treatment Period (7 Days)|Adverse Event|1|||
160994795|NCT01460342|581369036|FG000|Overall Study|Adverse Event|5|||
160994796|NCT01460342|581369037|FG001|Overall Study|Adverse Event|4|||
160860281|NCT02435212|580880660|FG001|Core Phase|Withdrawal by Subject|0|||
160860282|NCT02435212|580880659|FG000|Core Phase|Withdrawal by parent/guardian|9|||
160994797|NCT01460342|581369036|FG000|Overall Study|Lost to Follow-up|1|||
160994798|NCT01460342|581369037|FG001|Overall Study|Lost to Follow-up|2|||
160994799|NCT01460342|581369036|FG000|Overall Study|Protocol Violation|0|||
160994800|NCT01460342|581369037|FG001|Overall Study|Protocol Violation|1|||
160994801|NCT01460342|581369036|FG000|Overall Study|Withdrawal by Subject|3|||
160994802|NCT01460342|581369037|FG001|Overall Study|Withdrawal by Subject|4|||
160994803|NCT01460342|581369036|FG000|Overall Study|Physician Decision|1|||
160652561|NCT04799158|580108669|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
160860283|NCT02435212|580880660|FG001|Core Phase|Withdrawal by parent/guardian|4|||
160652562|NCT04799158|580108670|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
160860284|NCT02435212|580880659|FG000|Core Phase|Protocol Violation|1|||
160860285|NCT02435212|580880660|FG001|Core Phase|Protocol Violation|2|||
160860286|NCT02435212|580880659|FG000|Core Phase|Physician Decision|3|||
160860287|NCT02435212|580880660|FG001|Core Phase|Physician Decision|0|||
160860288|NCT02435212|580880659|FG000|Core Phase|Lost to Follow-up|0|||
160860289|NCT02435212|580880660|FG001|Core Phase|Lost to Follow-up|1|||
160860290|NCT02435212|580880659|FG000|Core Phase|Lack of Efficacy|0|||
160860291|NCT02435212|580880660|FG001|Core Phase|Lack of Efficacy|1|||
160860292|NCT02435212|580880659|FG000|Core Phase|Recovery|1|||
160860293|NCT02435212|580880660|FG001|Core Phase|Recovery|0|||
160860294|NCT02435212|580880659|FG000|Optional Extension Phase|Adverse Event|3|||
160860295|NCT02435212|580880660|FG001|Optional Extension Phase|Adverse Event|9|||
160860296|NCT02435212|580880659|FG000|Optional Extension Phase|Physician Decision|6|||
160860297|NCT02435212|580880660|FG001|Optional Extension Phase|Physician Decision|8|||
160860298|NCT02435212|580880659|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
160860299|NCT02435212|580880660|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
160860300|NCT02435212|580880659|FG000|Optional Extension Phase|Lack of Efficacy|2|||
160860301|NCT02435212|580880660|FG001|Optional Extension Phase|Lack of Efficacy|3|||
160860302|NCT02435212|580880659|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
160860303|NCT02435212|580880660|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
160860304|NCT02435212|580880659|FG000|Optional Extension Phase|Protocol Violation|0|||
160860305|NCT02435212|580880660|FG001|Optional Extension Phase|Protocol Violation|1|||
160860306|NCT02435212|580880659|FG000|Optional Extension Phase|Recovery|1|||
160860307|NCT02435212|580880660|FG001|Optional Extension Phase|Recovery|1|||
160860308|NCT02435212|580880659|FG000|Optional Extension Phase|Death|1|||
160860309|NCT02435212|580880660|FG001|Optional Extension Phase|Death|0|||
160860310|NCT02435212|580880659|FG000|Optional Extension Phase|Technical problems|2|||
160860311|NCT02435212|580880660|FG001|Optional Extension Phase|Technical problems|0|||
160860312|NCT04819945|580880661|FG000|Overall Study|Lost to Follow-up|1|||
160860313|NCT04531176|580880664|FG000|Overall Study|Study was stopped early|24|||
160860314|NCT04531176|580880665|FG001|Overall Study|Study was stopped early|26|||
160860315|NCT04531176|580880666|FG002|Overall Study|Study was stopped early|24|||
160860316|NCT00561652|580880671|FG000|Overall Study|Withdrawal by Subject|0|||
160860317|NCT00561652|580880672|FG001|Overall Study|Withdrawal by Subject|1|||
160860318|NCT00771914|580880675|FG000|Overall Study|Physician Decision|0|||
160860319|NCT00771914|580880676|FG001|Overall Study|Physician Decision|0|||
160860320|NCT00771914|580880677|FG002|Overall Study|Physician Decision|0|||
160860321|NCT00771914|580880678|FG003|Overall Study|Physician Decision|1|||
160860322|NCT00771914|580880675|FG000|Overall Study|Lost to Follow-up|0|||
160860323|NCT00771914|580880676|FG001|Overall Study|Lost to Follow-up|0|||
160860324|NCT00771914|580880677|FG002|Overall Study|Lost to Follow-up|0|||
160860325|NCT00771914|580880678|FG003|Overall Study|Lost to Follow-up|1|||
160860326|NCT01743469|580880681|FG000|Active Treatment Phase|Adverse Event|10|||
160860327|NCT01743469|580880682|FG001|Active Treatment Phase|Adverse Event|5|||
160860328|NCT01743469|580880683|FG002|Active Treatment Phase|Adverse Event|8|||
160860329|NCT01743469|580880684|FG003|Active Treatment Phase|Adverse Event|1|||
160860330|NCT01743469|580880681|FG000|Active Treatment Phase|Disease Progression|40|||
160860331|NCT01743469|580880682|FG001|Active Treatment Phase|Disease Progression|47|||
160860332|NCT01743469|580880683|FG002|Active Treatment Phase|Disease Progression|30|||
160860333|NCT01743469|580880684|FG003|Active Treatment Phase|Disease Progression|20|||
160860334|NCT01743469|580880681|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
160860335|NCT01743469|580880682|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
160860336|NCT01743469|580880683|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
160860337|NCT01743469|580880684|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
160860338|NCT01743469|580880681|FG000|Active Treatment Phase|Missing|1|||
160860339|NCT01743469|580880682|FG001|Active Treatment Phase|Missing|0|||
160860340|NCT01743469|580880683|FG002|Active Treatment Phase|Missing|0|||
160652563|NCT04799158|580108671|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
160860341|NCT01743469|580880684|FG003|Active Treatment Phase|Missing|0|||
160860342|NCT01743469|580880681|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
160860343|NCT01743469|580880682|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
160860344|NCT01743469|580880683|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
160860345|NCT01743469|580880684|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
160860346|NCT01743469|580880681|FG000|Follow-up Period - Post-Treatment|Death|43|||
160860347|NCT01743469|580880682|FG001|Follow-up Period - Post-Treatment|Death|47|||
160860348|NCT01743469|580880683|FG002|Follow-up Period - Post-Treatment|Death|22|||
160860349|NCT01743469|580880684|FG003|Follow-up Period - Post-Treatment|Death|16|||
160860350|NCT01743469|580880681|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
160860351|NCT01743469|580880682|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
160860352|NCT01743469|580880683|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
160860353|NCT01743469|580880684|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
160860354|NCT01451606|580880687|FG000|Overall Study|Withdrawal by Subject|4|||
160860355|NCT01451606|580880688|FG001|Overall Study|Withdrawal by Subject|3|||
160860356|NCT01667900|580880692|FG000|Part B|Death|0|||
160860357|NCT01667900|580880693|FG001|Part B|Death|0|||
160860358|NCT01667900|580880694|FG002|Part B|Death|0|||
160860359|NCT01667900|580880695|FG003|Part B|Death|0|||
160860360|NCT01667900|580880696|FG004|Part B|Death|0|||
160860361|NCT01667900|580880697|FG005|Part B|Death|0|||
160860362|NCT01667900|580880698|FG006|Part B|Death|0|||
160860363|NCT01667900|580880699|FG007|Part B|Death|0|||
160860364|NCT01667900|580880700|FG008|Part B|Death|0|||
160860365|NCT01667900|580880701|FG009|Part B|Death|0|||
160860366|NCT01667900|580880702|FG010|Part B|Death|0|||
160860367|NCT01667900|580880703|FG011|Part B|Death|0|||
160860368|NCT01667900|580880704|FG012|Part B|Death|0|||
160860369|NCT01667900|580880705|FG013|Part B|Death|0|||
160860370|NCT01667900|580880706|FG014|Part B|Death|0|||
160860371|NCT01667900|580880707|FG015|Part B|Death|0|||
160860372|NCT01667900|580880708|FG016|Part B|Death|1|||
160860373|NCT01667900|580880709|FG017|Part B|Death|0|||
160860374|NCT01667900|580880710|FG018|Part B|Death|0|||
160860375|NCT01667900|580880711|FG019|Part B|Death|0|||
160860376|NCT01345240|580880712|FG000|Overall Study|Adverse Event|3|||
160860377|NCT01345240|580880713|FG001|Overall Study|Adverse Event|5|||
160860378|NCT01345240|580880714|FG002|Overall Study|Adverse Event|4|||
160860379|NCT01345240|580880715|FG003|Overall Study|Adverse Event|2|||
160860380|NCT01345240|580880716|FG004|Overall Study|Adverse Event|1|||
160860381|NCT01345240|580880712|FG000|Overall Study|Lost to Follow-up|8|||
160860382|NCT01345240|580880713|FG001|Overall Study|Lost to Follow-up|9|||
160860383|NCT01345240|580880714|FG002|Overall Study|Lost to Follow-up|14|||
160860384|NCT01345240|580880715|FG003|Overall Study|Lost to Follow-up|7|||
160860385|NCT01345240|580880716|FG004|Overall Study|Lost to Follow-up|9|||
160860386|NCT00774046|580880719|FG000|Screening|Not eligible|56|||
160860387|NCT00774046|580880719|FG000|Enrollment|Desired other therapy/refused|28|||
160860388|NCT00774046|580880719|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
160860389|NCT01614249|580880720|FG000|Overall Study|Lost to Follow-up|11|||
160860390|NCT01614249|580880721|FG001|Overall Study|Lost to Follow-up|23|||
160860391|NCT05498649|580880722|FG000|Overall Study|Lost to Follow-up|1|||
160860392|NCT03094416|580880723|FG000|Run-in|Screening failure|8|||
160860393|NCT03094416|580880723|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
160860394|NCT03094416|580880723|FG000|Run-in|Withdrawal by Subject|3|||
160860395|NCT03094416|580880723|FG000|Treatment Period|Withdrawal by Subject|2|||
160860396|NCT00005780|580880725|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
160860397|NCT00374140|580880726|FG000|Overall Study|Lost to Follow-up|1|||
160860398|NCT00374140|580880726|FG000|Overall Study|Protocol Violation|1|||
160860399|NCT02651675|580880727|FG000|Overall Study|Death|0|||
160860400|NCT02651675|580880728|FG001|Overall Study|Death|0|||
160860401|NCT02651675|580880729|FG002|Overall Study|Death|1|||
160860402|NCT02246530|580880730|FG000|Overall Study|Lost to Follow-up|4|||
160860403|NCT02246530|580880731|FG001|Overall Study|Lost to Follow-up|0|||
160860404|NCT01615939|580883030|FG000|Overall Study|Lost to Follow-up|5|||
160860405|NCT01615939|580883031|FG001|Overall Study|Lost to Follow-up|0|||
160860406|NCT01586364|580883035|FG000|Overall Study|Withdrawal by Subject|40|||
160860407|NCT01586364|580883035|FG000|Overall Study|Adverse Event|37|||
160860408|NCT01586364|580883035|FG000|Overall Study|Lost to Follow-up|17|||
160860409|NCT01586364|580883035|FG000|Overall Study|Protocol Violation|16|||
160860410|NCT01586364|580883035|FG000|Overall Study|Lack of Efficacy|1|||
160860411|NCT01586364|580883035|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
160860412|NCT01586364|580883035|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
160860413|NCT01586364|580883035|FG000|Overall Study|Other-Site closure due to PI illness|1|||
160860414|NCT01586364|580883035|FG000|Overall Study|Other-PI discretion, site closing|2|||
160860415|NCT01586364|580883035|FG000|Overall Study|Other-Not specified|1|||
160860416|NCT02121535|580883036|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
160860417|NCT02121535|580883037|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
160860418|NCT02121535|580883036|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
160860419|NCT02121535|580883037|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
160860420|NCT04944992|580883038|FG000|Overall Study|Lost to Follow-up|1|||
160860421|NCT04944992|580883039|FG001|Overall Study|Lost to Follow-up|1|||
160860422|NCT04944992|580883038|FG000|Overall Study|Physician Decision|1|||
160860423|NCT04944992|580883039|FG001|Overall Study|Physician Decision|0|||
160860424|NCT04944992|580883038|FG000|Overall Study|Withdrawal by Subject|6|||
160860425|NCT04944992|580883039|FG001|Overall Study|Withdrawal by Subject|1|||
160860426|NCT02345070|580883046|FG000|Overall Study|Adverse Event|12|||
160860427|NCT02345070|580883047|FG001|Overall Study|Adverse Event|8|||
160860428|NCT02345070|580883048|FG002|Overall Study|Adverse Event|16|||
160860429|NCT02345070|580883046|FG000|Overall Study|Poor compliance to protocol|2|||
160860430|NCT02345070|580883047|FG001|Overall Study|Poor compliance to protocol|0|||
160860431|NCT02345070|580883048|FG002|Overall Study|Poor compliance to protocol|0|||
160860432|NCT02345070|580883046|FG000|Overall Study|Other than specified above|6|||
160860433|NCT02345070|580883047|FG001|Overall Study|Other than specified above|3|||
160860434|NCT02345070|580883048|FG002|Overall Study|Other than specified above|7|||
160860435|NCT03044106|580883051|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
160860436|NCT03044106|580883052|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
160860437|NCT01207414|580883053|FG000|Overall Study|Adverse Event|25|||
160860438|NCT01207414|580883054|FG001|Overall Study|Adverse Event|39|||
160860439|NCT01207414|580883053|FG000|Overall Study|Abnormal test procedure results|0|||
160860440|NCT01207414|580883054|FG001|Overall Study|Abnormal test procedure results|1|||
160860441|NCT01207414|580883053|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
160860442|NCT01207414|580883054|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
160860443|NCT01207414|580883053|FG000|Overall Study|Patient withdrew consent|14|||
160860444|NCT01207414|580883054|FG001|Overall Study|Patient withdrew consent|11|||
160860445|NCT01207414|580883053|FG000|Overall Study|Lost to Follow-up|15|||
160860446|NCT01207414|580883054|FG001|Overall Study|Lost to Follow-up|17|||
160860447|NCT01207414|580883053|FG000|Overall Study|Administrative problems|1|||
160860448|NCT01207414|580883054|FG001|Overall Study|Administrative problems|1|||
160860449|NCT01207414|580883053|FG000|Overall Study|Protocol deviation|12|||
160860450|NCT01207414|580883054|FG001|Overall Study|Protocol deviation|9|||
160860451|NCT01207414|580883053|FG000|Overall Study|Randomized in error|1|||
160860452|NCT01207414|580883054|FG001|Overall Study|Randomized in error|0|||
160860453|NCT01748292|580883055|FG000|Overall Study|Adverse Event|2|||
160994804|NCT01460342|581369037|FG001|Overall Study|Physician Decision|3|||
160994805|NCT01460342|581369036|FG000|Overall Study|Lack of Efficacy|1|||
160994806|NCT01460342|581369037|FG001|Overall Study|Lack of Efficacy|0|||
160994807|NCT03761784|581369038|FG000|Overall Study|Adverse Event|4|||
160994808|NCT03761784|581369039|FG001|Overall Study|Adverse Event|0|||
160860454|NCT01748292|580883056|FG001|Overall Study|Adverse Event|4|||
160860455|NCT01748292|580883055|FG000|Overall Study|Lost to Follow-up|0|||
160860456|NCT01748292|580883056|FG001|Overall Study|Lost to Follow-up|3|||
160860457|NCT01748292|580883055|FG000|Overall Study|Death|0|||
160860458|NCT01748292|580883056|FG001|Overall Study|Death|3|||
160994809|NCT03761784|581369038|FG000|Overall Study|Lost to Follow-up|10|||
160994810|NCT03761784|581369039|FG001|Overall Study|Lost to Follow-up|7|||
160994811|NCT03761784|581369038|FG000|Overall Study|Pregnancy|1|||
160994812|NCT03761784|581369039|FG001|Overall Study|Pregnancy|0|||
160994813|NCT03761784|581369038|FG000|Overall Study|Protocol Violation|2|||
160994814|NCT03761784|581369039|FG001|Overall Study|Protocol Violation|0|||
160994815|NCT03761784|581369038|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
160994816|NCT03761784|581369039|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
160994817|NCT03761784|581369038|FG000|Overall Study|Withdrawal by Subject|9|||
160994818|NCT03761784|581369039|FG001|Overall Study|Withdrawal by Subject|4|||
160994819|NCT03761784|581369038|FG000|Overall Study|Physician Decision|1|||
160994820|NCT03761784|581369039|FG001|Overall Study|Physician Decision|0|||
160994821|NCT03761784|581369038|FG000|Overall Study|Other Than Specified|1|||
160994822|NCT03761784|581369039|FG001|Overall Study|Other Than Specified|0|||
160994823|NCT01194258|581369042|FG000|Titration Period|Withdrawal by Subject|6|||
160570233|NCT00845429|579810445|FG002|Overall Study|Serious adverse event|1|||
160860459|NCT01748292|580883055|FG000|Overall Study|Withdrawal by Subject|0|||
160860460|NCT01748292|580883056|FG001|Overall Study|Withdrawal by Subject|2|||
160860461|NCT02057250|580883057|FG000|AID Assessment Phase|Adverse Event|3|||
160860462|NCT02057250|580883058|FG001|AID Assessment Phase|Adverse Event|2|||
160860463|NCT02057250|580883059|FG002|AID Assessment Phase|Adverse Event|6|||
160860464|NCT02057250|580883060|FG003|AID Assessment Phase|Adverse Event|1|||
160860465|NCT02057250|580883061|FG004|AID Assessment Phase|Adverse Event|0|||
160860466|NCT02057250|580883057|FG000|AID Assessment Phase|Other than specified above|1|||
160860467|NCT02057250|580883058|FG001|AID Assessment Phase|Other than specified above|1|||
160860468|NCT02057250|580883059|FG002|AID Assessment Phase|Other than specified above|1|||
160860469|NCT02057250|580883060|FG003|AID Assessment Phase|Other than specified above|1|||
160860470|NCT02057250|580883061|FG004|AID Assessment Phase|Other than specified above|0|||
160860471|NCT02057250|580883057|FG000|Extension Phase|Adverse Event|0|||
160860472|NCT02057250|580883058|FG001|Extension Phase|Adverse Event|0|||
160860473|NCT02057250|580883059|FG002|Extension Phase|Adverse Event|0|||
160860474|NCT02057250|580883060|FG003|Extension Phase|Adverse Event|0|||
160860475|NCT02057250|580883061|FG004|Extension Phase|Adverse Event|15|||
160994824|NCT01194258|581369043|FG001|Titration Period|Withdrawal by Subject|0|||
160994825|NCT01194258|581369044|FG002|Titration Period|Withdrawal by Subject|0|||
160994826|NCT01194258|581369045|FG003|Titration Period|Withdrawal by Subject|0|||
160994827|NCT01194258|581369046|FG004|Titration Period|Withdrawal by Subject|0|||
160994828|NCT01194258|581369042|FG000|Titration Period|Lost to Follow-up|2|||
160860476|NCT02057250|580883057|FG000|Extension Phase|Lack of Efficacy|0|||
160994829|NCT01194258|581369043|FG001|Titration Period|Lost to Follow-up|0|||
160994830|NCT01194258|581369044|FG002|Titration Period|Lost to Follow-up|0|||
160994831|NCT01194258|581369045|FG003|Titration Period|Lost to Follow-up|0|||
160994832|NCT01194258|581369046|FG004|Titration Period|Lost to Follow-up|0|||
160570234|NCT02111369|579810448|FG000|Overall Study|Lost to Follow-up|2|||
160860477|NCT02057250|580883058|FG001|Extension Phase|Lack of Efficacy|0|||
160860478|NCT02057250|580883059|FG002|Extension Phase|Lack of Efficacy|0|||
160860479|NCT02057250|580883060|FG003|Extension Phase|Lack of Efficacy|0|||
160860480|NCT02057250|580883061|FG004|Extension Phase|Lack of Efficacy|10|||
160860481|NCT02057250|580883057|FG000|Extension Phase|Entered in this period but not treated|0|||
160860482|NCT02057250|580883058|FG001|Extension Phase|Entered in this period but not treated|0|||
160860483|NCT02057250|580883059|FG002|Extension Phase|Entered in this period but not treated|0|||
160860484|NCT02057250|580883060|FG003|Extension Phase|Entered in this period but not treated|0|||
160860485|NCT02057250|580883061|FG004|Extension Phase|Entered in this period but not treated|4|||
160860486|NCT02057250|580883057|FG000|Extension Phase|Other than specified above|0|||
160860487|NCT02057250|580883058|FG001|Extension Phase|Other than specified above|0|||
160860488|NCT02057250|580883059|FG002|Extension Phase|Other than specified above|0|||
160860489|NCT02057250|580883060|FG003|Extension Phase|Other than specified above|0|||
160860490|NCT02057250|580883061|FG004|Extension Phase|Other than specified above|7|||
160860491|NCT03367793|580883065|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
160860492|NCT03367793|580883066|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
160860493|NCT03367793|580883067|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
160860494|NCT03367793|580883068|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
160860495|NCT03367793|580883069|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
160860496|NCT03367793|580883070|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
160860497|NCT03199976|580883071|FG000|Overall Study|Lack of Efficacy|3|||
160860498|NCT03199976|580883072|FG001|Overall Study|Lack of Efficacy|6|||
160860499|NCT03199976|580883073|FG002|Overall Study|Lack of Efficacy|13|||
160860500|NCT03199976|580883071|FG000|Overall Study|Withdrawal by Subject|1|||
160860501|NCT03199976|580883072|FG001|Overall Study|Withdrawal by Subject|0|||
160860502|NCT03199976|580883073|FG002|Overall Study|Withdrawal by Subject|0|||
160860503|NCT03199976|580883071|FG000|Overall Study|Lost to Follow-up|0|||
160860504|NCT03199976|580883072|FG001|Overall Study|Lost to Follow-up|1|||
160860505|NCT03199976|580883073|FG002|Overall Study|Lost to Follow-up|1|||
160860506|NCT00260533|580883076|FG000|Overall Study|Other|3|||
160860507|NCT00260533|580883077|FG001|Overall Study|Other|3|||
160860508|NCT01761877|580883078|FG000|Overall Study|Adverse Event|7|||
160860509|NCT01761877|580883079|FG001|Overall Study|Adverse Event|0|||
160860510|NCT01761877|580883078|FG000|Overall Study|Withdrawal by Subject|6|||
160860511|NCT01761877|580883079|FG001|Overall Study|Withdrawal by Subject|4|||
160860512|NCT01761877|580883078|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
160860513|NCT01761877|580883079|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
160860514|NCT01761877|580883078|FG000|Overall Study|Death|0|||
160860515|NCT01761877|580883079|FG001|Overall Study|Death|1|||
160860516|NCT01761877|580883078|FG000|Overall Study|MRI intolerant|1|||
160860517|NCT01761877|580883079|FG001|Overall Study|MRI intolerant|6|||
160860518|NCT00003475|580883080|FG000|Overall Study|Not evaluable|13|||
160860519|NCT03962491|580883081|FG000|Overall Study|Lost to Follow-up|4|||
160860520|NCT03962491|580883082|FG001|Overall Study|Lost to Follow-up|5|||
160860521|NCT00106704|580883089|FG000|Overall Study|Adverse Event|10|||
160860522|NCT00106704|580883090|FG001|Overall Study|Adverse Event|7|||
160860523|NCT00106704|580883089|FG000|Overall Study|Death|2|||
160860524|NCT00106704|580883090|FG001|Overall Study|Death|1|||
160860525|NCT00106704|580883089|FG000|Overall Study|Lack of Efficacy|67|||
160860526|NCT00106704|580883090|FG001|Overall Study|Lack of Efficacy|69|||
160860527|NCT00106704|580883089|FG000|Overall Study|Lost to Follow-up|7|||
160860528|NCT00106704|580883090|FG001|Overall Study|Lost to Follow-up|3|||
160860529|NCT00106704|580883089|FG000|Overall Study|Pregnancy|1|||
160860530|NCT00106704|580883090|FG001|Overall Study|Pregnancy|0|||
160860531|NCT00106704|580883089|FG000|Overall Study|Protocol Violation|4|||
160860532|NCT00106704|580883090|FG001|Overall Study|Protocol Violation|7|||
160860533|NCT00106704|580883089|FG000|Overall Study|Withdrawal by Subject|14|||
160860534|NCT00106704|580883090|FG001|Overall Study|Withdrawal by Subject|21|||
160860535|NCT00106704|580883089|FG000|Overall Study|Patient moved|1|||
160860536|NCT00106704|580883090|FG001|Overall Study|Patient moved|0|||
160860537|NCT00106704|580883089|FG000|Overall Study|Site terminated|0|||
160860538|NCT00106704|580883090|FG001|Overall Study|Site terminated|1|||
160860539|NCT00106704|580883089|FG000|Overall Study|Planned major surgery|1|||
160860540|NCT00106704|580883090|FG001|Overall Study|Planned major surgery|0|||
160860541|NCT00106704|580883089|FG000|Overall Study|Patient Received Glycemic Medication|22|||
160909431|NCT01218204|581063968|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
160909432|NCT01218204|581063969|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
160909433|NCT01218204|581063970|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
160909434|NCT01218204|581063971|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
160860542|NCT00106704|580883090|FG001|Overall Study|Patient Received Glycemic Medication|41|||
160860543|NCT00106704|580883089|FG000|Overall Study|Unable to re-enter US|1|||
160860544|NCT00106704|580883090|FG001|Overall Study|Unable to re-enter US|0|||
160860545|NCT00106704|580883089|FG000|Overall Study|Laboratory test|1|||
160860546|NCT00106704|580883090|FG001|Overall Study|Laboratory test|1|||
160909435|NCT01539538|581063982|FG000|Overall Study|Adverse Event|13|||
160860547|NCT01780506|580883091|FG000|Double-Blind Phase|Randomized but not Treated|3|||
160860548|NCT01780506|580883092|FG001|Double-Blind Phase|Randomized but not Treated|2|||
160909436|NCT01539538|581063983|FG001|Overall Study|Adverse Event|18|||
160909437|NCT01539538|581063982|FG000|Overall Study|Lack of Efficacy|13|||
160909438|NCT01539538|581063983|FG001|Overall Study|Lack of Efficacy|16|||
160909439|NCT01539538|581063982|FG000|Overall Study|Withdrawal by Subject|2|||
160909440|NCT01539538|581063983|FG001|Overall Study|Withdrawal by Subject|3|||
160909441|NCT01539538|581063982|FG000|Overall Study|PCA no longer required or PCA problem|3|||
160909442|NCT01539538|581063983|FG001|Overall Study|PCA no longer required or PCA problem|7|||
160909443|NCT03897465|581063984|FG000|Overall Study|Lost to Follow-up|2|||
160909444|NCT03897465|581063985|FG001|Overall Study|Lost to Follow-up|1|||
160909445|NCT03897465|581063984|FG000|Overall Study|Adverse Event|2|||
160909446|NCT03897465|581063985|FG001|Overall Study|Adverse Event|0|||
160909447|NCT03897465|581063984|FG000|Overall Study|complete healing by V2|1|||
160909448|NCT03897465|581063985|FG001|Overall Study|complete healing by V2|0|||
160909449|NCT03897465|581063984|FG000|Overall Study|occurence of exclusion criterion|1|||
160909450|NCT03897465|581063985|FG001|Overall Study|occurence of exclusion criterion|1|||
160909451|NCT03897465|581063984|FG000|Overall Study|Other|1|||
160909452|NCT03897465|581063985|FG001|Overall Study|Other|0|||
160909453|NCT00847379|581063986|FG000|Overall Study|Study terminated by Sponsor|59|||
160909454|NCT00847379|581063987|FG001|Overall Study|Study terminated by Sponsor|57|||
160909455|NCT00847379|581063988|FG002|Overall Study|Study terminated by Sponsor|57|||
160909456|NCT00521014|581063989|FG000|Overall Study|Inevaluable, not treated|1|||
160909457|NCT04390191|581063990|FG000|Overall Study|Withdrawal by Subject|1|||
160909458|NCT04390191|581063991|FG001|Overall Study|Withdrawal by Subject|0|||
160909459|NCT03978832|581063994|FG000|Overall Study|Adverse Event|1|||
160909460|NCT03978832|581063994|FG000|Overall Study|Lost to Follow-up|1|||
160909461|NCT03978832|581063994|FG000|Overall Study|Withdrawal by Subject|6|||
160909462|NCT03978832|581063994|FG000|Overall Study|Physician Decision|2|||
160909463|NCT03978832|581063994|FG000|Overall Study|did not pass screening criteria|44|||
160909464|NCT00003499|581063995|FG000|Overall Study|Not evaluable|8|||
160909465|NCT02042183|581064000|FG000|Overall Study|Physician Decision|7|||
160909466|NCT02042183|581064001|FG001|Overall Study|Physician Decision|2|||
160909467|NCT02042183|581064000|FG000|Overall Study|Lack of Efficacy|4|||
160909468|NCT02042183|581064001|FG001|Overall Study|Lack of Efficacy|3|||
160909469|NCT02042183|581064000|FG000|Overall Study|Non-compliance with Study Drug|2|||
160909470|NCT02042183|581064001|FG001|Overall Study|Non-compliance with Study Drug|3|||
160909471|NCT02042183|581064000|FG000|Overall Study|Adverse Event|17|||
160909472|NCT02042183|581064001|FG001|Overall Study|Adverse Event|6|||
160909473|NCT02042183|581064000|FG000|Overall Study|Other|3|||
160909474|NCT02042183|581064001|FG001|Overall Study|Other|3|||
160909475|NCT02042183|581064000|FG000|Overall Study|Withdrawal by Subject|21|||
160909476|NCT02042183|581064001|FG001|Overall Study|Withdrawal by Subject|16|||
160909477|NCT02042183|581064000|FG000|Overall Study|Site Terminated by Sponsor|2|||
160909478|NCT02042183|581064001|FG001|Overall Study|Site Terminated by Sponsor|1|||
160909479|NCT02042183|581064000|FG000|Overall Study|Lost to Follow-up|9|||
160909480|NCT02042183|581064001|FG001|Overall Study|Lost to Follow-up|2|||
160909481|NCT01256008|581064002|FG000|Overall Study|Lost to Follow-up|6|||
160909482|NCT01256008|581064003|FG001|Overall Study|Lost to Follow-up|4|||
160909483|NCT01256008|581064004|FG002|Overall Study|Lost to Follow-up|11|||
160909484|NCT01256008|581064002|FG000|Overall Study|Withdrawal by Subject|2|||
160909485|NCT01256008|581064003|FG001|Overall Study|Withdrawal by Subject|3|||
160909486|NCT01256008|581064004|FG002|Overall Study|Withdrawal by Subject|10|||
160909487|NCT00378378|581064007|FG000|Overall Study|Withdrawal by Subject|0|||
160909488|NCT00378378|581064008|FG001|Overall Study|Withdrawal by Subject|1|||
160909489|NCT00378378|581064009|FG002|Overall Study|Withdrawal by Subject|0|||
160909490|NCT00378378|581064007|FG000|Overall Study|Treatment Failure|0|||
160909491|NCT00378378|581064008|FG001|Overall Study|Treatment Failure|0|||
160909492|NCT00378378|581064009|FG002|Overall Study|Treatment Failure|1|||
160909493|NCT00378378|581064007|FG000|Overall Study|Non-compliance with protocol|0|||
160909494|NCT00378378|581064008|FG001|Overall Study|Non-compliance with protocol|0|||
160909495|NCT00378378|581064009|FG002|Overall Study|Non-compliance with protocol|1|||
160909496|NCT01854710|581064019|FG000|Overall Study|Withdrawal by Subject|2|||
160909497|NCT01854710|581064020|FG001|Overall Study|Withdrawal by Subject|1|||
160909498|NCT01854710|581064021|FG002|Overall Study|Withdrawal by Subject|0|||
160909499|NCT01854710|581064022|FG003|Overall Study|Withdrawal by Subject|0|||
160909500|NCT01854710|581064023|FG004|Overall Study|Withdrawal by Subject|0|||
160909501|NCT01854710|581064024|FG005|Overall Study|Withdrawal by Subject|0|||
160909502|NCT01854710|581064019|FG000|Overall Study|CRI procedural error|2|||
160909503|NCT01854710|581064020|FG001|Overall Study|CRI procedural error|2|||
160909504|NCT01854710|581064021|FG002|Overall Study|CRI procedural error|2|||
160909505|NCT01854710|581064022|FG003|Overall Study|CRI procedural error|2|||
160909506|NCT01854710|581064023|FG004|Overall Study|CRI procedural error|2|||
160909507|NCT01854710|581064024|FG005|Overall Study|CRI procedural error|2|||
160909508|NCT03132220|581064029|FG000|Overall Study|Lost to Follow-up|17|||
160909509|NCT03132220|581064030|FG001|Overall Study|Lost to Follow-up|8|||
160909510|NCT03132220|581064029|FG000|Overall Study|Withdrawal by Subject|1|||
160909511|NCT03132220|581064030|FG001|Overall Study|Withdrawal by Subject|4|||
160909512|NCT02296320|581064035|FG000|Overall Study|Withdrawal by Subject|4|||
160909513|NCT02296320|581064036|FG001|Overall Study|Withdrawal by Subject|0|||
160994833|NCT01194258|581369042|FG000|Titration Period|Titration failure|3|||
160994834|NCT01194258|581369043|FG001|Titration Period|Titration failure|0|||
160994835|NCT01194258|581369044|FG002|Titration Period|Titration failure|0|||
160994836|NCT01194258|581369045|FG003|Titration Period|Titration failure|0|||
160994837|NCT01194258|581369046|FG004|Titration Period|Titration failure|0|||
160994838|NCT01194258|581369042|FG000|Period 1 (12 Weeks)|Death|0|||
160994839|NCT01194258|581369043|FG001|Period 1 (12 Weeks)|Death|0|||
160994840|NCT01194258|581369044|FG002|Period 1 (12 Weeks)|Death|0|||
160994841|NCT01194258|581369045|FG003|Period 1 (12 Weeks)|Death|0|||
160994842|NCT01194258|581369046|FG004|Period 1 (12 Weeks)|Death|1|||
160994843|NCT01194258|581369042|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160994844|NCT01194258|581369043|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160994845|NCT01194258|581369044|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160994846|NCT01194258|581369045|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160994847|NCT01194258|581369046|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
160994848|NCT01194258|581369042|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
160994849|NCT01194258|581369043|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
160994850|NCT01194258|581369044|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
160994851|NCT01194258|581369045|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
160994852|NCT01194258|581369046|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
160994853|NCT01194258|581369042|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160994854|NCT01194258|581369043|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160994855|NCT01194258|581369044|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160994856|NCT01194258|581369045|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160994857|NCT01194258|581369046|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160994858|NCT02873754|581369048|FG000|Overall Study|Lost to Follow-up|5|||
160994859|NCT02873754|581369048|FG000|Overall Study|Couldn't complete study procedures|1|||
160994860|NCT01981850|581369049|FG000|Main Phase Stage 1|Death|2|||
160994861|NCT01981850|581369050|FG001|Main Phase Stage 1|Death|0|||
160994862|NCT01981850|581369051|FG002|Main Phase Stage 1|Death|0|||
160994863|NCT01981850|581369052|FG003|Main Phase Stage 1|Death|0|||
160994864|NCT01981850|581369053|FG004|Main Phase Stage 1|Death|0|||
160994865|NCT01981850|581369054|FG005|Main Phase Stage 1|Death|0|||
160994866|NCT01981850|581369055|FG006|Main Phase Stage 1|Death|0|||
160994867|NCT01981850|581369056|FG007|Main Phase Stage 1|Death|0|||
160994868|NCT01981850|581369057|FG008|Main Phase Stage 1|Death|0|||
160994869|NCT01981850|581369058|FG009|Main Phase Stage 1|Death|0|||
160994870|NCT01981850|581369049|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
160994871|NCT01981850|581369050|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994872|NCT01981850|581369051|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994873|NCT01981850|581369052|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994874|NCT01981850|581369053|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994875|NCT01981850|581369054|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994876|NCT01981850|581369055|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994877|NCT01981850|581369056|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994878|NCT01981850|581369057|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994879|NCT01981850|581369058|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994880|NCT01981850|581369049|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
160994881|NCT01981850|581369050|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
160994882|NCT01981850|581369051|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
160994883|NCT01981850|581369052|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
160994884|NCT01981850|581369053|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
160994885|NCT01981850|581369054|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
160994886|NCT01981850|581369055|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
160994887|NCT01981850|581369056|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
160994888|NCT01981850|581369057|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
160994889|NCT01981850|581369058|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
160994890|NCT01981850|581369049|FG000|Main Phase Stage 1|Various reasons|0|||
160994891|NCT01981850|581369050|FG001|Main Phase Stage 1|Various reasons|0|||
160994892|NCT01981850|581369051|FG002|Main Phase Stage 1|Various reasons|2|||
160994893|NCT01981850|581369052|FG003|Main Phase Stage 1|Various reasons|0|||
160994894|NCT01981850|581369053|FG004|Main Phase Stage 1|Various reasons|0|||
160994895|NCT01981850|581369054|FG005|Main Phase Stage 1|Various reasons|0|||
160994896|NCT01981850|581369055|FG006|Main Phase Stage 1|Various reasons|0|||
160994897|NCT01981850|581369056|FG007|Main Phase Stage 1|Various reasons|0|||
160994898|NCT01981850|581369057|FG008|Main Phase Stage 1|Various reasons|0|||
160994899|NCT01981850|581369058|FG009|Main Phase Stage 1|Various reasons|0|||
160994900|NCT01981850|581369049|FG000|Main Phase Stage 2|Adverse Event|0|||
160994901|NCT01981850|581369050|FG001|Main Phase Stage 2|Adverse Event|0|||
160994902|NCT01981850|581369051|FG002|Main Phase Stage 2|Adverse Event|0|||
160994903|NCT01981850|581369052|FG003|Main Phase Stage 2|Adverse Event|0|||
160994904|NCT01981850|581369053|FG004|Main Phase Stage 2|Adverse Event|6|||
160994905|NCT01981850|581369054|FG005|Main Phase Stage 2|Adverse Event|5|||
160994906|NCT01981850|581369055|FG006|Main Phase Stage 2|Adverse Event|7|||
160994907|NCT01981850|581369056|FG007|Main Phase Stage 2|Adverse Event|0|||
160994908|NCT01981850|581369057|FG008|Main Phase Stage 2|Adverse Event|0|||
160994909|NCT01981850|581369058|FG009|Main Phase Stage 2|Adverse Event|0|||
160994910|NCT01981850|581369049|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994911|NCT01981850|581369050|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994912|NCT01981850|581369051|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994913|NCT01981850|581369052|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994914|NCT01981850|581369053|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
160994915|NCT01981850|581369054|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
160994916|NCT01981850|581369055|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
160994917|NCT01981850|581369056|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994918|NCT01981850|581369057|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994919|NCT01981850|581369058|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994920|NCT01981850|581369049|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
160994921|NCT01981850|581369050|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
160994922|NCT01981850|581369051|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
160994923|NCT01981850|581369052|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
160994924|NCT01981850|581369053|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
160994925|NCT01981850|581369054|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
160994926|NCT01981850|581369055|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
160994927|NCT01981850|581369056|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
160994928|NCT01981850|581369057|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
160994929|NCT01981850|581369058|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
160994930|NCT01981850|581369049|FG000|Main Phase Stage 2|Various reasons|0|||
160860549|NCT01780506|580883091|FG000|Double-Blind Phase|Adverse Event|4|||
160860550|NCT01780506|580883092|FG001|Double-Blind Phase|Adverse Event|14|||
160860551|NCT01780506|580883091|FG000|Double-Blind Phase|Death|1|||
160860552|NCT01780506|580883092|FG001|Double-Blind Phase|Death|2|||
160860553|NCT01780506|580883091|FG000|Double-Blind Phase|Pregnancy|2|||
160860554|NCT01780506|580883092|FG001|Double-Blind Phase|Pregnancy|1|||
160860555|NCT01780506|580883091|FG000|Double-Blind Phase|Lack of Efficacy|1|||
160860556|NCT01780506|580883092|FG001|Double-Blind Phase|Lack of Efficacy|1|||
160860557|NCT01780506|580883091|FG000|Double-Blind Phase|Investigator's Discretion|5|||
160860558|NCT01780506|580883092|FG001|Double-Blind Phase|Investigator's Discretion|2|||
160860559|NCT01780506|580883091|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
160860560|NCT01780506|580883092|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
160860561|NCT01780506|580883091|FG000|Double-Blind Phase|Protocol Violation|4|||
160860562|NCT01780506|580883092|FG001|Double-Blind Phase|Protocol Violation|3|||
160860563|NCT01780506|580883091|FG000|Double-Blind Phase|Withdrew Consent|23|||
160860564|NCT01780506|580883092|FG001|Double-Blind Phase|Withdrew Consent|24|||
160860565|NCT01780506|580883091|FG000|Double-Blind Phase|Lost to Follow-up|23|||
160860566|NCT01780506|580883092|FG001|Double-Blind Phase|Lost to Follow-up|26|||
160860567|NCT01780506|580883091|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
160860568|NCT01780506|580883092|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
160860569|NCT01867671|580883096|FG000|Overall Study|Adverse Event|5|||
160860570|NCT01867671|580883097|FG001|Overall Study|Adverse Event|3|||
160860571|NCT01867671|580883096|FG000|Overall Study|Anaphylaxis|0|||
160860572|NCT01867671|580883097|FG001|Overall Study|Anaphylaxis|1|||
160860573|NCT01867671|580883096|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
160860574|NCT01867671|580883097|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
160860575|NCT01867671|580883096|FG000|Overall Study|Lost to Follow-up|0|||
160860576|NCT01867671|580883097|FG001|Overall Study|Lost to Follow-up|1|||
160860577|NCT01867671|580883096|FG000|Overall Study|Non-compliance with Study Drug|1|||
160860578|NCT01867671|580883097|FG001|Overall Study|Non-compliance with Study Drug|2|||
160860579|NCT01867671|580883096|FG000|Overall Study|Withdrawal by Subject|21|||
160860580|NCT01867671|580883097|FG001|Overall Study|Withdrawal by Subject|21|||
160994931|NCT01981850|581369050|FG001|Main Phase Stage 2|Various reasons|0|||
160860581|NCT04852302|580883103|FG000|Overall Study|Withdrawal by Subject|2|||
160860582|NCT04852302|580883103|FG000|Overall Study|Did not complete CALM therapy.|2|||
160860583|NCT04711850|580883104|FG000|Overall Study|Graft loss|2|||
160860584|NCT04711850|580883105|FG001|Overall Study|Graft loss|1|||
160860585|NCT04711850|580883104|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
160994932|NCT01981850|581369051|FG002|Main Phase Stage 2|Various reasons|0|||
160994933|NCT01981850|581369052|FG003|Main Phase Stage 2|Various reasons|0|||
160994934|NCT01981850|581369053|FG004|Main Phase Stage 2|Various reasons|2|||
160860586|NCT04711850|580883105|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
160860587|NCT04711850|580883104|FG000|Overall Study|Study terminated by sponsor|5|||
160994935|NCT01981850|581369054|FG005|Main Phase Stage 2|Various reasons|0|||
160860588|NCT04711850|580883105|FG001|Overall Study|Study terminated by sponsor|3|||
160860589|NCT04711850|580883104|FG000|Overall Study|Sponsor decision|0|||
160860590|NCT04711850|580883105|FG001|Overall Study|Sponsor decision|2|||
160860591|NCT05249582|580883106|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
160994936|NCT01981850|581369055|FG006|Main Phase Stage 2|Various reasons|1|||
160994937|NCT01981850|581369056|FG007|Main Phase Stage 2|Various reasons|0|||
160994938|NCT01981850|581369057|FG008|Main Phase Stage 2|Various reasons|0|||
160994939|NCT01981850|581369058|FG009|Main Phase Stage 2|Various reasons|0|||
160994940|NCT01981850|581369049|FG000|Main Phase Stage 2|Progressive Disease|0|||
160994941|NCT01981850|581369050|FG001|Main Phase Stage 2|Progressive Disease|0|||
160994942|NCT01981850|581369051|FG002|Main Phase Stage 2|Progressive Disease|0|||
160994943|NCT01981850|581369052|FG003|Main Phase Stage 2|Progressive Disease|0|||
160994944|NCT01981850|581369053|FG004|Main Phase Stage 2|Progressive Disease|0|||
160994945|NCT01981850|581369054|FG005|Main Phase Stage 2|Progressive Disease|6|||
160994946|NCT01981850|581369055|FG006|Main Phase Stage 2|Progressive Disease|6|||
160994947|NCT01981850|581369056|FG007|Main Phase Stage 2|Progressive Disease|0|||
160994948|NCT01981850|581369057|FG008|Main Phase Stage 2|Progressive Disease|0|||
160994949|NCT01981850|581369058|FG009|Main Phase Stage 2|Progressive Disease|0|||
160994950|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Adverse Event|0|||
160994951|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Adverse Event|0|||
160860592|NCT05249582|580883107|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
160860593|NCT05249582|580883106|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
160860594|NCT05249582|580883107|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
160860595|NCT05249582|580883106|FG000|Overall Study|Declined to use virtual reality headset|1|||
160860596|NCT05249582|580883107|FG001|Overall Study|Declined to use virtual reality headset|0|||
160860597|NCT02738801|580883130|FG000|Overall Study|Adverse Event|1|||
160860598|NCT02738801|580883131|FG001|Overall Study|Adverse Event|1|||
160860599|NCT02738801|580883130|FG000|Overall Study|Withdrawal by Subject|0|||
160860600|NCT02738801|580883131|FG001|Overall Study|Withdrawal by Subject|1|||
160860601|NCT03279081|580883132|FG000|Overall Study|Withdrawal by Subject|12|||
160860602|NCT03279081|580883133|FG001|Overall Study|Withdrawal by Subject|20|||
160860603|NCT03279081|580883132|FG000|Overall Study|Physician Decision|4|||
160860604|NCT03279081|580883133|FG001|Overall Study|Physician Decision|1|||
160860605|NCT03279081|580883132|FG000|Overall Study|Lost to Follow-up|8|||
160860606|NCT03279081|580883133|FG001|Overall Study|Lost to Follow-up|8|||
160860607|NCT03279081|580883132|FG000|Overall Study|Death|0|||
160860608|NCT03279081|580883133|FG001|Overall Study|Death|1|||
160860609|NCT03279081|580883132|FG000|Overall Study|Adverse Event|1|||
160860610|NCT03279081|580883133|FG001|Overall Study|Adverse Event|0|||
160860611|NCT03279081|580883132|FG000|Overall Study|Reason not Specified|14|||
160860612|NCT03279081|580883133|FG001|Overall Study|Reason not Specified|4|||
160860613|NCT02163538|580883136|FG000|Overall Study|Protocol Violation|1|||
160860614|NCT02163538|580883137|FG001|Overall Study|Protocol Violation|0|||
160860615|NCT02163538|580883136|FG000|Overall Study|Physician Decision|0|||
160860616|NCT02163538|580883137|FG001|Overall Study|Physician Decision|1|||
160860617|NCT04484961|580883140|FG000|Overall Study|Lost to Follow-up|9|||
160860618|NCT04484961|580883141|FG001|Overall Study|Lost to Follow-up|9|||
160860619|NCT00388349|580883142|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
160860620|NCT00388349|580883143|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
160860621|NCT00976274|580883145|FG000|Overall Study|Lost to Follow-up|5|||
160860622|NCT00976274|580883146|FG001|Overall Study|Lost to Follow-up|5|||
160860623|NCT00976274|580883145|FG000|Overall Study|Withdrawal by Subject|1|||
160860624|NCT00976274|580883146|FG001|Overall Study|Withdrawal by Subject|1|||
160860625|NCT00976274|580883145|FG000|Overall Study|Physician Decision|1|||
160860626|NCT00976274|580883146|FG001|Overall Study|Physician Decision|2|||
160860627|NCT02954536|580883148|FG000|Overall Study|Adverse Event|2|||
160860628|NCT02954536|580883148|FG000|Overall Study|Death|12|||
160860629|NCT02946580|580883149|FG000|Overall Study|Withdrawal by Subject|1|||
160860630|NCT02946580|580883150|FG001|Overall Study|Withdrawal by Subject|2|||
160860631|NCT02946580|580883149|FG000|Overall Study|Adverse Event|0|||
160860632|NCT02946580|580883150|FG001|Overall Study|Adverse Event|2|||
160860633|NCT02946580|580883149|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
160860634|NCT02946580|580883150|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
160860635|NCT02158442|580883151|FG000|Overall Study|Withdrawal by Subject|1|||
160860636|NCT02158442|580883152|FG001|Overall Study|Withdrawal by Subject|0|||
160860637|NCT02158442|580883151|FG000|Overall Study|Perfusion staff not available|1|||
160994952|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Adverse Event|0|||
160994953|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Adverse Event|0|||
160860638|NCT02158442|580883152|FG001|Overall Study|Perfusion staff not available|0|||
160860639|NCT02761330|580883153|FG000|Treatment Week 1|Withdrawal by Subject|0|||
160860640|NCT02761330|580883154|FG001|Treatment Week 1|Withdrawal by Subject|0|||
160860641|NCT02761330|580883155|FG002|Treatment Week 1|Withdrawal by Subject|0|||
160860642|NCT02761330|580883156|FG003|Treatment Week 1|Withdrawal by Subject|1|||
160860643|NCT02761330|580883157|FG004|Treatment Week 1|Withdrawal by Subject|0|||
160860644|NCT02761330|580883158|FG005|Treatment Week 1|Withdrawal by Subject|1|||
160860645|NCT03043313|580883163|FG000|Overall Study|Withdrawal by Subject|5|||
160860646|NCT03043313|580883164|FG001|Overall Study|Withdrawal by Subject|1|||
160860647|NCT03043313|580883165|FG002|Overall Study|Withdrawal by Subject|1|||
160994954|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Adverse Event|0|||
160860648|NCT03043313|580883163|FG000|Overall Study|Lost to Follow-up|1|||
160860649|NCT03043313|580883164|FG001|Overall Study|Lost to Follow-up|1|||
160860650|NCT03043313|580883165|FG002|Overall Study|Lost to Follow-up|0|||
160860651|NCT03043313|580883163|FG000|Overall Study|Death|28|||
160860652|NCT03043313|580883164|FG001|Overall Study|Death|26|||
160860653|NCT03043313|580883165|FG002|Overall Study|Death|17|||
160860654|NCT03043313|580883163|FG000|Overall Study|Participation terminated by sponsor|11|||
160860655|NCT03043313|580883164|FG001|Overall Study|Participation terminated by sponsor|13|||
160860656|NCT03043313|580883165|FG002|Overall Study|Participation terminated by sponsor|13|||
160860657|NCT01506596|580883166|FG000|Overall Study|ineligible pathology|1|||
160860658|NCT05712460|580883168|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860659|NCT05712460|580883169|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860660|NCT05712460|580883170|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860661|NCT05712460|580883171|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860662|NCT05712460|580883172|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860663|NCT05712460|580883173|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860664|NCT05712460|580883174|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860665|NCT05712460|580883175|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
160860666|NCT05712460|580883176|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860667|NCT05712460|580883177|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860668|NCT05712460|580883178|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860669|NCT05712460|580883179|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860670|NCT05135767|580883183|FG000|Baseline|Lost to Follow-up|1|||
160860671|NCT05135767|580883184|FG001|Baseline|Lost to Follow-up|1|||
160860672|NCT05135767|580883183|FG000|Baseline|Withdrawal by Subject|0|||
160860673|NCT05135767|580883184|FG001|Baseline|Withdrawal by Subject|2|||
160860674|NCT05135767|580883183|FG000|Active Study Phase|Lost to Follow-up|2|||
160860675|NCT05135767|580883184|FG001|Active Study Phase|Lost to Follow-up|0|||
160860676|NCT02694185|580883185|FG000|Overall Study|Withdrawal by Subject|45|||
160860677|NCT02694185|580883186|FG001|Overall Study|Withdrawal by Subject|0|||
160860678|NCT05082857|580883187|FG000|Overall Study|participants relocated and could not continue|2|||
160860679|NCT05082857|580883188|FG001|Overall Study|participants relocated and could not continue|1|||
160909514|NCT02296320|581064037|FG002|Overall Study|Withdrawal by Subject|2|||
160909515|NCT02296320|581064035|FG000|Overall Study|Death|24|||
160909516|NCT02296320|581064036|FG001|Overall Study|Death|3|||
160909517|NCT02296320|581064037|FG002|Overall Study|Death|27|||
160909518|NCT02296320|581064035|FG000|Overall Study|Lost to Follow-up|5|||
160909519|NCT02296320|581064036|FG001|Overall Study|Lost to Follow-up|2|||
160909520|NCT02296320|581064037|FG002|Overall Study|Lost to Follow-up|7|||
160909521|NCT02296320|581064035|FG000|Overall Study|Not treated|2|||
160909522|NCT02296320|581064036|FG001|Overall Study|Not treated|0|||
160909523|NCT02296320|581064037|FG002|Overall Study|Not treated|0|||
160909524|NCT02296320|581064035|FG000|Overall Study|Not - specified|0|||
160909525|NCT02296320|581064036|FG001|Overall Study|Not - specified|0|||
160909526|NCT02296320|581064037|FG002|Overall Study|Not - specified|1|||
160909527|NCT00390468|581064040|FG000|Overall Study|Protocol Violation|2|||
160909528|NCT00390468|581064040|FG000|Overall Study|Lack of Efficacy|1|||
160909529|NCT01049308|581064041|FG000|Pill Counts|Withdrawal by Subject|83|||
160909530|NCT01348165|581064042|FG000|Overall Study|Adverse Event|0|||
160909531|NCT01348165|581064043|FG001|Overall Study|Adverse Event|0|||
160909532|NCT01348165|581064044|FG002|Overall Study|Adverse Event|0|||
160909533|NCT01348165|581064045|FG003|Overall Study|Adverse Event|0|||
160909534|NCT01348165|581064046|FG004|Overall Study|Adverse Event|0|||
160909535|NCT01348165|581064047|FG005|Overall Study|Adverse Event|0|||
160909536|NCT01348165|581064048|FG006|Overall Study|Adverse Event|1|||
160909537|NCT02439138|581064053|FG000|Overall Study|Adverse Event|1|||
160909538|NCT02439138|581064053|FG000|Overall Study|PI decision to terminate the study|2|||
160909539|NCT04659161|581064054|FG000|Overall Study|Adverse Event|10|||
160909540|NCT04659161|581064055|FG001|Overall Study|Adverse Event|6|||
160860680|NCT05082857|580883187|FG000|Overall Study|Lost to Follow-up|1|||
160860681|NCT05082857|580883188|FG001|Overall Study|Lost to Follow-up|3|||
160860682|NCT04366349|580883189|FG000|Overall Study|Withdrawal by Subject|1|||
160909541|NCT04659161|581064054|FG000|Overall Study|Withdrawal by Subject|13|||
160909542|NCT04659161|581064055|FG001|Overall Study|Withdrawal by Subject|12|||
160909543|NCT04659161|581064054|FG000|Overall Study|Other|9|||
160909544|NCT04659161|581064055|FG001|Overall Study|Other|8|||
160909545|NCT01929343|581064056|FG000|Overall Study|Physician Decision|0|||
160909546|NCT01929343|581064057|FG001|Overall Study|Physician Decision|2|||
160909547|NCT01929343|581064058|FG002|Overall Study|Physician Decision|0|||
160909548|NCT01929343|581064056|FG000|Overall Study|Withdrawal by Subject|1|||
160909549|NCT01929343|581064057|FG001|Overall Study|Withdrawal by Subject|0|||
160909550|NCT01929343|581064058|FG002|Overall Study|Withdrawal by Subject|0|||
160909551|NCT02197130|581064061|FG000|Overall Study|Adverse Event|13|||
160909552|NCT02197130|581064062|FG001|Overall Study|Adverse Event|4|||
160994955|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Adverse Event|0|||
160909553|NCT02197130|581064063|FG002|Overall Study|Adverse Event|23|||
160909554|NCT02197130|581064061|FG000|Overall Study|Death|0|||
160652564|NCT04799158|580108672|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
160652565|NCT04799158|580108673|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
160652566|NCT04799158|580108669|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
160652567|NCT04799158|580108670|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
160652568|NCT04799158|580108671|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
160652569|NCT04799158|580108672|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
160652570|NCT04799158|580108673|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
160652571|NCT04799158|580108669|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
160652572|NCT04799158|580108670|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
160652573|NCT04799158|580108671|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
160652574|NCT04799158|580108672|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
160652575|NCT04799158|580108673|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
160652576|NCT04799158|580108669|FG000|On-Demand Treatment Period|Miscellaneous|0|||
160652577|NCT04799158|580108670|FG001|On-Demand Treatment Period|Miscellaneous|0|||
160652578|NCT04799158|580108671|FG002|On-Demand Treatment Period|Miscellaneous|0|||
160652579|NCT04799158|580108672|FG003|On-Demand Treatment Period|Miscellaneous|0|||
160652580|NCT04799158|580108673|FG004|On-Demand Treatment Period|Miscellaneous|1|||
160652581|NCT00679783|580108678|FG000|Overall Study|Adverse Event|0|||
160652582|NCT00679783|580108679|FG001|Overall Study|Adverse Event|0|||
160652583|NCT00679783|580108680|FG002|Overall Study|Adverse Event|0|||
160652584|NCT00679783|580108681|FG003|Overall Study|Adverse Event|3|||
160652585|NCT00679783|580108682|FG004|Overall Study|Adverse Event|0|||
160652586|NCT00679783|580108683|FG005|Overall Study|Adverse Event|0|||
160652587|NCT00679783|580108684|FG006|Overall Study|Adverse Event|1|||
160652588|NCT00679783|580108678|FG000|Overall Study|Lack of Efficacy|0|||
160652589|NCT00679783|580108679|FG001|Overall Study|Lack of Efficacy|1|||
160652590|NCT00679783|580108680|FG002|Overall Study|Lack of Efficacy|0|||
160652591|NCT00679783|580108681|FG003|Overall Study|Lack of Efficacy|2|||
160652592|NCT00679783|580108682|FG004|Overall Study|Lack of Efficacy|0|||
160652593|NCT00679783|580108683|FG005|Overall Study|Lack of Efficacy|0|||
160652594|NCT00679783|580108684|FG006|Overall Study|Lack of Efficacy|0|||
160652595|NCT00679783|580108678|FG000|Overall Study|Withdrawal by Subject|0|||
160652596|NCT00679783|580108679|FG001|Overall Study|Withdrawal by Subject|0|||
160652597|NCT00679783|580108680|FG002|Overall Study|Withdrawal by Subject|1|||
160652598|NCT00679783|580108681|FG003|Overall Study|Withdrawal by Subject|1|||
160652599|NCT00679783|580108682|FG004|Overall Study|Withdrawal by Subject|0|||
160652600|NCT00679783|580108683|FG005|Overall Study|Withdrawal by Subject|0|||
160652601|NCT00679783|580108684|FG006|Overall Study|Withdrawal by Subject|0|||
160652602|NCT00679783|580108678|FG000|Overall Study|Not Captured|0|||
160652603|NCT00679783|580108679|FG001|Overall Study|Not Captured|0|||
160652604|NCT00679783|580108680|FG002|Overall Study|Not Captured|0|||
160652605|NCT00679783|580108681|FG003|Overall Study|Not Captured|5|||
160652606|NCT00679783|580108682|FG004|Overall Study|Not Captured|0|||
160652607|NCT00679783|580108683|FG005|Overall Study|Not Captured|0|||
160652608|NCT00679783|580108684|FG006|Overall Study|Not Captured|0|||
160652609|NCT00679783|580108678|FG000|Overall Study|Ongoing at data cut-off|2|||
160652610|NCT00679783|580108679|FG001|Overall Study|Ongoing at data cut-off|2|||
160652611|NCT00679783|580108680|FG002|Overall Study|Ongoing at data cut-off|0|||
160652612|NCT00679783|580108681|FG003|Overall Study|Ongoing at data cut-off|9|||
160652613|NCT00679783|580108682|FG004|Overall Study|Ongoing at data cut-off|1|||
160652614|NCT00679783|580108683|FG005|Overall Study|Ongoing at data cut-off|0|||
160652615|NCT00679783|580108684|FG006|Overall Study|Ongoing at data cut-off|0|||
160652616|NCT01485536|580108685|FG000|Overall Study|Withdrawal by Subject|3|||
160652617|NCT01485536|580108685|FG000|Overall Study|Adverse Event|1|||
160652618|NCT02626949|580108686|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
160652619|NCT02626949|580108687|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
160652620|NCT02626949|580108686|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
160652621|NCT02626949|580108687|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
160860683|NCT04366349|580883190|FG001|Overall Study|Withdrawal by Subject|0|||
160860684|NCT04366349|580883191|FG002|Overall Study|Withdrawal by Subject|0|||
160860685|NCT04366349|580883192|FG003|Overall Study|Withdrawal by Subject|0|||
160860686|NCT04366349|580883193|FG004|Overall Study|Withdrawal by Subject|0|||
160860687|NCT04366349|580883194|FG005|Overall Study|Withdrawal by Subject|0|||
160860688|NCT03341299|580883195|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
160860689|NCT03341299|580883196|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
160860690|NCT03341299|580883197|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
160860691|NCT03341299|580883198|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
160860692|NCT01486966|580883211|FG000|Overall Study|Adverse Event|0|||
160652622|NCT02626949|580108686|FG000|Enrolled|Lost to Follow-up|7|||
160652623|NCT02626949|580108687|FG001|Enrolled|Lost to Follow-up|6|||
160652624|NCT02626949|580108686|FG000|Enrolled|Withdrawal by Subject|3|||
160652625|NCT02626949|580108687|FG001|Enrolled|Withdrawal by Subject|2|||
160860693|NCT01486966|580883212|FG001|Overall Study|Adverse Event|1|||
160860694|NCT01486966|580883211|FG000|Overall Study|Withdrawal by Subject|0|||
160860695|NCT01486966|580883212|FG001|Overall Study|Withdrawal by Subject|1|||
160860696|NCT03518086|580883215|FG000|Overall Study|Adverse Event|23|||
160860697|NCT03518086|580883216|FG001|Overall Study|Adverse Event|15|||
160860698|NCT03518086|580883217|FG002|Overall Study|Adverse Event|3|||
160860699|NCT03518086|580883218|FG003|Overall Study|Adverse Event|2|||
160860700|NCT03518086|580883215|FG000|Overall Study|Withdrawal by Subject|8|||
160860701|NCT03518086|580883216|FG001|Overall Study|Withdrawal by Subject|5|||
160994956|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Adverse Event|0|||
160994957|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Adverse Event|2|||
160994958|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Adverse Event|1|||
160994959|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Adverse Event|8|||
160994960|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994961|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994962|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994963|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994964|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994965|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994966|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994967|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
160994968|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
160860702|NCT03518086|580883217|FG002|Overall Study|Withdrawal by Subject|1|||
160860703|NCT03518086|580883218|FG003|Overall Study|Withdrawal by Subject|0|||
160860704|NCT03518086|580883215|FG000|Overall Study|Lack of Efficacy|5|||
160860705|NCT03518086|580883216|FG001|Overall Study|Lack of Efficacy|5|||
160860706|NCT03518086|580883217|FG002|Overall Study|Lack of Efficacy|0|||
160860707|NCT03518086|580883218|FG003|Overall Study|Lack of Efficacy|2|||
160860708|NCT03518086|580883215|FG000|Overall Study|Protocol Violation|1|||
160860709|NCT03518086|580883216|FG001|Overall Study|Protocol Violation|5|||
160860710|NCT03518086|580883217|FG002|Overall Study|Protocol Violation|1|||
160860711|NCT03518086|580883218|FG003|Overall Study|Protocol Violation|3|||
160860712|NCT03518086|580883215|FG000|Overall Study|Lost to Follow-up|0|||
160860713|NCT03518086|580883216|FG001|Overall Study|Lost to Follow-up|3|||
160860714|NCT03518086|580883217|FG002|Overall Study|Lost to Follow-up|0|||
160860715|NCT03518086|580883218|FG003|Overall Study|Lost to Follow-up|0|||
160909555|NCT02197130|581064062|FG001|Overall Study|Death|1|||
160909556|NCT02197130|581064063|FG002|Overall Study|Death|0|||
160909557|NCT02197130|581064061|FG000|Overall Study|Lost to Follow-up|2|||
160909558|NCT02197130|581064062|FG001|Overall Study|Lost to Follow-up|0|||
160909559|NCT02197130|581064063|FG002|Overall Study|Lost to Follow-up|1|||
160909560|NCT02197130|581064061|FG000|Overall Study|Does not meet entrance criteria|0|||
160909561|NCT02197130|581064062|FG001|Overall Study|Does not meet entrance criteria|0|||
160909562|NCT02197130|581064063|FG002|Overall Study|Does not meet entrance criteria|1|||
160909563|NCT02197130|581064061|FG000|Overall Study|Withdrawal by Subject|0|||
160909564|NCT02197130|581064062|FG001|Overall Study|Withdrawal by Subject|3|||
160909565|NCT02197130|581064063|FG002|Overall Study|Withdrawal by Subject|4|||
160909566|NCT02197130|581064061|FG000|Overall Study|Other|1|||
160909567|NCT02197130|581064062|FG001|Overall Study|Other|0|||
160909568|NCT02197130|581064063|FG002|Overall Study|Other|3|||
160909569|NCT02615145|581064064|FG000|Overall Study|Did Not Start Treatment|0|||
160909570|NCT02615145|581064065|FG001|Overall Study|Did Not Start Treatment|0|||
160909571|NCT02615145|581064066|FG002|Overall Study|Did Not Start Treatment|1|||
160909572|NCT02615145|581064067|FG003|Overall Study|Did Not Start Treatment|1|||
160909573|NCT02615145|581064064|FG000|Overall Study|Failure to Return|20|||
160909574|NCT02615145|581064065|FG001|Overall Study|Failure to Return|10|||
160909575|NCT02615145|581064066|FG002|Overall Study|Failure to Return|7|||
160909576|NCT02615145|581064067|FG003|Overall Study|Failure to Return|0|||
160909577|NCT02615145|581064064|FG000|Overall Study|Death|2|||
160909578|NCT02615145|581064065|FG001|Overall Study|Death|3|||
160909579|NCT02615145|581064066|FG002|Overall Study|Death|0|||
160909580|NCT02615145|581064067|FG003|Overall Study|Death|0|||
160994969|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
160994970|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Various reasons|0|||
160994971|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Various reasons|0|||
160994972|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Various reasons|0|||
160994973|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Various reasons|0|||
160860716|NCT03518086|580883215|FG000|Overall Study|Insufficient Diary Data|0|||
160994974|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Various reasons|0|||
160652626|NCT00601484|580108688|FG000|Overall Study|Adverse Event|0|||
160860717|NCT03518086|580883216|FG001|Overall Study|Insufficient Diary Data|2|||
160860718|NCT03518086|580883217|FG002|Overall Study|Insufficient Diary Data|0|||
160860719|NCT03518086|580883218|FG003|Overall Study|Insufficient Diary Data|0|||
160652627|NCT00601484|580108689|FG001|Overall Study|Adverse Event|1|||
160860720|NCT03518086|580883215|FG000|Overall Study|Non- compliance to Protocol|0|||
160909581|NCT02615145|581064064|FG000|Overall Study|Other, Not Specified|5|||
160909582|NCT02615145|581064065|FG001|Overall Study|Other, Not Specified|2|||
160909583|NCT02615145|581064066|FG002|Overall Study|Other, Not Specified|0|||
160909584|NCT02615145|581064067|FG003|Overall Study|Other, Not Specified|0|||
160909585|NCT00006237|581064070|FG000|Overall Study|Adverse Event|39|||
160994975|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Various reasons|0|||
160994976|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Various reasons|0|||
160994977|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Various reasons|3|||
160994978|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Various reasons|1|||
160994979|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Various reasons|3|||
160994980|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
160860721|NCT03518086|580883216|FG001|Overall Study|Non- compliance to Protocol|1|||
160860722|NCT03518086|580883217|FG002|Overall Study|Non- compliance to Protocol|0|||
160860723|NCT03518086|580883218|FG003|Overall Study|Non- compliance to Protocol|0|||
160860724|NCT03518086|580883215|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
160860725|NCT03518086|580883216|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
160860726|NCT03518086|580883217|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
160860727|NCT03518086|580883218|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
160860728|NCT03518086|580883215|FG000|Overall Study|Site Terminated by Sponsor|0|||
160860729|NCT03518086|580883216|FG001|Overall Study|Site Terminated by Sponsor|1|||
160860730|NCT03518086|580883217|FG002|Overall Study|Site Terminated by Sponsor|0|||
160860731|NCT03518086|580883218|FG003|Overall Study|Site Terminated by Sponsor|0|||
160860732|NCT03518086|580883215|FG000|Overall Study|Pregnancy|0|||
160860733|NCT03518086|580883216|FG001|Overall Study|Pregnancy|0|||
160860734|NCT03518086|580883217|FG002|Overall Study|Pregnancy|0|||
160860735|NCT03518086|580883218|FG003|Overall Study|Pregnancy|2|||
160860736|NCT02336282|580883219|FG000|Overall Study|Unrelated illness|1|||
160860737|NCT02336282|580883219|FG000|Overall Study|Uncomfortable with technology|1|||
160860738|NCT02336282|580883219|FG000|Overall Study|Lost to Follow-up|1|||
160860739|NCT02336282|580883219|FG000|Overall Study|Not enough time to complete sessions|2|||
160860740|NCT05565742|580883221|FG000|Overall Study|Withdrawal by Subject|0|||
160860741|NCT05565742|580883222|FG001|Overall Study|Withdrawal by Subject|0|||
160860742|NCT05565742|580883223|FG002|Overall Study|Withdrawal by Subject|2|||
160860743|NCT05565742|580883224|FG003|Overall Study|Withdrawal by Subject|2|||
160860744|NCT05565742|580883225|FG004|Overall Study|Withdrawal by Subject|2|||
160909586|NCT00006237|581064071|FG001|Overall Study|Adverse Event|29|||
160909587|NCT00006237|581064070|FG000|Overall Study|Death|1|||
160909588|NCT00006237|581064071|FG001|Overall Study|Death|0|||
160909589|NCT00006237|581064070|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
160909590|NCT00006237|581064071|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
160909591|NCT00006237|581064070|FG000|Overall Study|Progression/relapse|54|||
160909592|NCT00006237|581064071|FG001|Overall Study|Progression/relapse|2|||
160909593|NCT00006237|581064070|FG000|Overall Study|Not eligible|9|||
160909594|NCT00006237|581064071|FG001|Overall Study|Not eligible|20|||
160909595|NCT00006237|581064070|FG000|Overall Study|Withdrawal by Subject|0|||
160909596|NCT00006237|581064071|FG001|Overall Study|Withdrawal by Subject|1|||
160909597|NCT00006237|581064070|FG000|Overall Study|Not protocol specified|14|||
160909598|NCT00006237|581064071|FG001|Overall Study|Not protocol specified|5|||
160909599|NCT01846416|581064074|FG000|Treatment Phase|Death|2|||
160909600|NCT01846416|581064075|FG001|Treatment Phase|Death|9|||
160909601|NCT01846416|581064076|FG002|Treatment Phase|Death|1|||
160909602|NCT01846416|581064074|FG000|Treatment Phase|Withdrawal by Subject|2|||
160909603|NCT01846416|581064075|FG001|Treatment Phase|Withdrawal by Subject|4|||
160909604|NCT01846416|581064076|FG002|Treatment Phase|Withdrawal by Subject|2|||
160994981|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
160994982|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
160994983|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
160994984|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
160994985|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
160994986|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
160994987|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
160994988|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
160994989|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
160994990|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994991|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994992|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994993|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994994|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994995|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994996|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994997|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160652628|NCT00601484|580108688|FG000|Overall Study|Lost to Follow-up|4|||
160860745|NCT05565742|580883221|FG000|Overall Study|Death|1|||
160860746|NCT05565742|580883222|FG001|Overall Study|Death|0|||
160909605|NCT01846416|581064074|FG000|Treatment Phase|Other|1|||
160909606|NCT01846416|581064075|FG001|Treatment Phase|Other|5|||
160909607|NCT01846416|581064076|FG002|Treatment Phase|Other|1|||
160909608|NCT01846416|581064074|FG000|Treatment Phase|Physician Decision|1|||
160909609|NCT01846416|581064075|FG001|Treatment Phase|Physician Decision|2|||
160860747|NCT05565742|580883223|FG002|Overall Study|Death|0|||
160994998|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994999|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
160995000|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
160860748|NCT05565742|580883224|FG003|Overall Study|Death|0|||
160860749|NCT05565742|580883225|FG004|Overall Study|Death|0|||
160860750|NCT05565742|580883221|FG000|Overall Study|Participant Travelled Abroad|0|||
160860751|NCT05565742|580883222|FG001|Overall Study|Participant Travelled Abroad|0|||
160860752|NCT05565742|580883223|FG002|Overall Study|Participant Travelled Abroad|0|||
160860753|NCT05565742|580883224|FG003|Overall Study|Participant Travelled Abroad|0|||
160860754|NCT05565742|580883225|FG004|Overall Study|Participant Travelled Abroad|1|||
160860755|NCT04163341|580883226|FG000|Overall Study|Withdrawal by Subject|2|||
160860756|NCT04163341|580883227|FG001|Overall Study|Withdrawal by Subject|0|||
160860757|NCT04163341|580883226|FG000|Overall Study|Lost to Follow-up|3|||
160860758|NCT04163341|580883227|FG001|Overall Study|Lost to Follow-up|4|||
160860759|NCT00668148|580883242|FG000|Overall Study|Adverse Event|5|||
160860760|NCT00668148|580883242|FG000|Overall Study|Subject Non-compliance|1|||
160860761|NCT00668148|580883242|FG000|Overall Study|Progressive Disease Before Treatment|2|||
160860762|NCT00668148|580883242|FG000|Overall Study|Withdrawal of Consent|2|||
160860763|NCT05472090|580883244|FG000|Overall Study|Adverse Event|2|||
160860764|NCT05472090|580883245|FG001|Overall Study|Adverse Event|3|||
160860765|NCT05472090|580883244|FG000|Overall Study|Lack of Efficacy|1|||
160860766|NCT05472090|580883245|FG001|Overall Study|Lack of Efficacy|0|||
160860767|NCT05472090|580883244|FG000|Overall Study|Physician Decision|1|||
160860768|NCT05472090|580883245|FG001|Overall Study|Physician Decision|0|||
160860769|NCT05472090|580883244|FG000|Overall Study|Withdrawal by Subject|2|||
160860770|NCT05472090|580883245|FG001|Overall Study|Withdrawal by Subject|0|||
160860771|NCT05472090|580883244|FG000|Overall Study|Lost to Follow-up|0|||
160860772|NCT05472090|580883245|FG001|Overall Study|Lost to Follow-up|3|||
160860773|NCT00303069|580885098|FG000|Overall Study|Lost to Follow-up|1|||
160860774|NCT00303069|580885099|FG001|Overall Study|Lost to Follow-up|0|||
160860775|NCT00303069|580885100|FG002|Overall Study|Lost to Follow-up|0|||
160860776|NCT00303069|580885101|FG003|Overall Study|Lost to Follow-up|2|||
160860777|NCT00303069|580885098|FG000|Overall Study|subject moved|1|||
160860778|NCT00303069|580885099|FG001|Overall Study|subject moved|0|||
160860779|NCT00303069|580885100|FG002|Overall Study|subject moved|0|||
160860780|NCT00303069|580885101|FG003|Overall Study|subject moved|0|||
160860781|NCT00303069|580885098|FG000|Overall Study|Recruitment into Army Reserves|0|||
160860782|NCT00303069|580885099|FG001|Overall Study|Recruitment into Army Reserves|0|||
160860783|NCT00303069|580885100|FG002|Overall Study|Recruitment into Army Reserves|1|||
160860784|NCT00303069|580885101|FG003|Overall Study|Recruitment into Army Reserves|0|||
160860785|NCT00092417|580885102|FG000|Overall Study|Lost to Follow-up|2|||
160860786|NCT00092417|580885103|FG001|Overall Study|Lost to Follow-up|0|||
160860787|NCT00092417|580885102|FG000|Overall Study|Withdrawal by Subject|2|||
160860788|NCT00092417|580885103|FG001|Overall Study|Withdrawal by Subject|1|||
160860789|NCT00092417|580885102|FG000|Overall Study|Other|1|||
160860790|NCT00092417|580885103|FG001|Overall Study|Other|0|||
160860791|NCT00425269|580885104|FG000|Overall Study|Pregnancy|5|||
160860792|NCT00425269|580885105|FG001|Overall Study|Pregnancy|7|||
160860793|NCT00425269|580885104|FG000|Overall Study|Lost to Follow-up|9|||
160860794|NCT00425269|580885105|FG001|Overall Study|Lost to Follow-up|9|||
160995001|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995002|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995003|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995004|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
160860795|NCT00425269|580885104|FG000|Overall Study|moved or medical reason|5|||
160995005|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995006|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995007|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995008|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995009|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
160995010|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
160995011|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
160860796|NCT00425269|580885105|FG001|Overall Study|moved or medical reason|4|||
160860797|NCT01084655|580885108|FG000|Overall Study|Radiographic disease progression|3|||
160860798|NCT01084655|580885109|FG001|Overall Study|Radiographic disease progression|2|||
160860799|NCT01084655|580885110|FG002|Overall Study|Radiographic disease progression|8|||
160860800|NCT01084655|580885108|FG000|Overall Study|Withdrawal by Subject|1|||
160860801|NCT01084655|580885109|FG001|Overall Study|Withdrawal by Subject|0|||
160995012|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
160860802|NCT01084655|580885110|FG002|Overall Study|Withdrawal by Subject|4|||
160860803|NCT01084655|580885108|FG000|Overall Study|Adverse Event|2|||
160860804|NCT01084655|580885109|FG001|Overall Study|Adverse Event|1|||
160860805|NCT01084655|580885110|FG002|Overall Study|Adverse Event|2|||
160860806|NCT01084655|580885108|FG000|Overall Study|Other|0|||
160860807|NCT01084655|580885109|FG001|Overall Study|Other|3|||
160860808|NCT01084655|580885110|FG002|Overall Study|Other|2|||
160860809|NCT01084655|580885108|FG000|Overall Study|Symptomatic deterioration|0|||
160860810|NCT01084655|580885109|FG001|Overall Study|Symptomatic deterioration|0|||
160860811|NCT01084655|580885110|FG002|Overall Study|Symptomatic deterioration|2|||
160860812|NCT01084655|580885108|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
160860813|NCT01084655|580885109|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
160860814|NCT01084655|580885110|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
160860815|NCT00335777|580885111|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
160860816|NCT00335777|580885111|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
160860817|NCT00335777|580885111|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
160860818|NCT00335777|580885111|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
160860819|NCT00335777|580885111|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
160652629|NCT00601484|580108689|FG001|Overall Study|Lost to Follow-up|3|||
160652630|NCT00601484|580108688|FG000|Overall Study|Lack of Efficacy|0|||
160860820|NCT00535496|580885112|FG000|Overall Study|Lost to Follow-up|0|||
160860821|NCT00535496|580885113|FG001|Overall Study|Lost to Follow-up|1|||
160860822|NCT00535496|580885114|FG002|Overall Study|Lost to Follow-up|0|||
160860823|NCT00535496|580885115|FG003|Overall Study|Lost to Follow-up|0|||
160860824|NCT00535496|580885112|FG000|Overall Study|Not treated with sugammadex|0|||
160860825|NCT00535496|580885113|FG001|Overall Study|Not treated with sugammadex|1|||
160860826|NCT00535496|580885114|FG002|Overall Study|Not treated with sugammadex|0|||
160860827|NCT00535496|580885115|FG003|Overall Study|Not treated with sugammadex|0|||
160860828|NCT01209689|580885121|FG000|Overall Study|Insufficient Therapeutic Response|7|||
160860829|NCT01209689|580885122|FG001|Overall Study|Insufficient Therapeutic Response|2|||
160860830|NCT01209689|580885121|FG000|Overall Study|Refused Treatment|8|||
160860831|NCT01209689|580885122|FG001|Overall Study|Refused Treatment|3|||
160860832|NCT01209689|580885121|FG000|Overall Study|Adverse Event|4|||
160860833|NCT01209689|580885122|FG001|Overall Study|Adverse Event|0|||
160860834|NCT01209689|580885121|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
160860835|NCT01209689|580885122|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
160860836|NCT01209689|580885121|FG000|Overall Study|Failure to Return|3|||
160860837|NCT01209689|580885122|FG001|Overall Study|Failure to Return|0|||
160860838|NCT01209689|580885121|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
160860839|NCT01209689|580885122|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
160860840|NCT03780244|580885123|FG000|Overall Study|Lost to Follow-up|1|||
160860841|NCT03780244|580885124|FG001|Overall Study|Lost to Follow-up|0|||
160860842|NCT01083771|580885125|FG000|Overall Study|non-compliant|2|||
160860843|NCT01083771|580885125|FG000|Overall Study|Withdrawal by Subject|3|||
160860844|NCT03175367|580885128|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
160860845|NCT03175367|580885129|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
160860846|NCT03175367|580885130|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
160652631|NCT00601484|580108689|FG001|Overall Study|Lack of Efficacy|2|||
160995013|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
160995014|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
160860847|NCT03175367|580885131|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
160860848|NCT03175367|580885132|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
160860849|NCT03175367|580885133|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
160860850|NCT03175367|580885134|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
160860851|NCT03175367|580885128|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
160860852|NCT03175367|580885129|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
160860853|NCT03175367|580885130|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
160860854|NCT03175367|580885131|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
160860855|NCT03175367|580885132|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
160860856|NCT03175367|580885133|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
160860857|NCT03175367|580885134|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
160860858|NCT03175367|580885128|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
160860859|NCT03175367|580885129|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
160860860|NCT03175367|580885130|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
160860861|NCT03175367|580885131|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
160860862|NCT03175367|580885132|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
160860863|NCT03175367|580885133|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
160860864|NCT03175367|580885134|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
160995015|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
160995016|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
160995017|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
160995018|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
160995019|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
160995020|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
160995021|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
160995022|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
160995023|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
160860865|NCT03175367|580885128|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
160909610|NCT01846416|581064076|FG002|Treatment Phase|Physician Decision|0|||
160995024|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
160995025|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
160995026|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
160995027|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
160995028|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
160995029|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
160995030|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
160995031|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
160995032|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
160995033|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
160995034|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
160909611|NCT01846416|581064074|FG000|Treatment Phase|Adverse Event|3|||
160995035|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
160995036|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
160995037|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
160995038|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
160995039|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
160995040|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
160995041|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
160995042|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
160995043|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
160860866|NCT03175367|580885129|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
160860867|NCT03175367|580885130|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
160860868|NCT03175367|580885131|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
160909612|NCT01846416|581064075|FG001|Treatment Phase|Adverse Event|4|||
160909613|NCT01846416|581064076|FG002|Treatment Phase|Adverse Event|0|||
160909614|NCT01846416|581064074|FG000|Treatment Phase|Non-compliance|0|||
160909615|NCT01846416|581064075|FG001|Treatment Phase|Non-compliance|2|||
160909616|NCT01846416|581064076|FG002|Treatment Phase|Non-compliance|0|||
160909617|NCT01846416|581064074|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
160909618|NCT01846416|581064075|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
160909619|NCT01846416|581064076|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
160909620|NCT01846416|581064074|FG000|Treatment Phase|Progressive Disease|21|||
160909621|NCT01846416|581064075|FG001|Treatment Phase|Progressive Disease|63|||
160909622|NCT01846416|581064076|FG002|Treatment Phase|Progressive Disease|9|||
160909623|NCT01846416|581064074|FG000|Survival Follow-up|Death|21|||
160860869|NCT03175367|580885132|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
160860870|NCT03175367|580885133|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
160860871|NCT03175367|580885134|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
160860872|NCT03175367|580885128|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160860873|NCT03175367|580885129|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160860874|NCT03175367|580885130|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
160860875|NCT03175367|580885131|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160860876|NCT03175367|580885132|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
160860877|NCT03175367|580885133|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160860878|NCT03175367|580885134|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160860879|NCT03175367|580885128|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860880|NCT03175367|580885129|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860881|NCT03175367|580885130|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860882|NCT03175367|580885131|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860883|NCT03175367|580885132|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860884|NCT03175367|580885133|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860885|NCT03175367|580885134|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
160860886|NCT03175367|580885128|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160860887|NCT03175367|580885129|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160860888|NCT03175367|580885130|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160860889|NCT03175367|580885131|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160860890|NCT03175367|580885132|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160860891|NCT03175367|580885133|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
160860892|NCT03175367|580885134|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
160860893|NCT03182374|580885137|FG000|Overall Study|Lost to Follow-up|3|||
160860894|NCT03182374|580885138|FG001|Overall Study|Lost to Follow-up|2|||
160860895|NCT03182374|580885137|FG000|Overall Study|Lack of Efficacy|8|||
160860896|NCT03182374|580885138|FG001|Overall Study|Lack of Efficacy|14|||
160860897|NCT03182374|580885137|FG000|Overall Study|Withdrawal by Subject|1|||
160860898|NCT03182374|580885138|FG001|Overall Study|Withdrawal by Subject|1|||
160860899|NCT03182374|580885137|FG000|Overall Study|exit for non-compliance|1|||
160860900|NCT03182374|580885138|FG001|Overall Study|exit for non-compliance|1|||
160860901|NCT03182374|580885137|FG000|Overall Study|one subject was randomized but not treated|1|||
160860902|NCT03182374|580885138|FG001|Overall Study|one subject was randomized but not treated|0|||
160860903|NCT03182374|580885137|FG000|Overall Study|Other reasons|0|||
160860904|NCT03182374|580885138|FG001|Overall Study|Other reasons|3|||
160860905|NCT01462370|580885139|FG000|Overall Study|Lack of Qualifying Event|1|||
160860906|NCT01462370|580885140|FG001|Overall Study|Lack of Qualifying Event|1|||
160860907|NCT01462370|580885139|FG000|Overall Study|Physician Decision|0|||
160860908|NCT01462370|580885140|FG001|Overall Study|Physician Decision|1|||
160860909|NCT01462370|580885139|FG000|Overall Study|Withdrawal by Subject|0|||
160860910|NCT01462370|580885140|FG001|Overall Study|Withdrawal by Subject|3|||
160860911|NCT00853307|580885143|FG000|Overall Study|Adverse Event|1|||
160860912|NCT00853307|580885144|FG001|Overall Study|Adverse Event|2|||
160860913|NCT00853307|580885143|FG000|Overall Study|Withdrawal by Subject|1|||
160860914|NCT00853307|580885144|FG001|Overall Study|Withdrawal by Subject|2|||
160860915|NCT00853307|580885143|FG000|Overall Study|Reason Not Specified|0|||
160860916|NCT00853307|580885144|FG001|Overall Study|Reason Not Specified|1|||
160570235|NCT02111369|579810448|FG000|Overall Study|Withdrawal by Subject|1|||
160570236|NCT01480180|579810449|FG000|Main Phase|Withdrawal criteria|12|||
160860917|NCT00473564|580885145|FG000|Overall Study|robot surgery aborted in OR|23|||
160860918|NCT02379728|580885146|FG000|Overall Study|Lost to Follow-up|1|||
160860919|NCT02379728|580885147|FG001|Overall Study|Lost to Follow-up|0|||
160860920|NCT02379728|580885148|FG002|Overall Study|Lost to Follow-up|3|||
160860921|NCT02379728|580885149|FG003|Overall Study|Lost to Follow-up|0|||
160860922|NCT02379728|580885146|FG000|Overall Study|Withdrawal by Subject|5|||
160860923|NCT02379728|580885147|FG001|Overall Study|Withdrawal by Subject|0|||
160860924|NCT02379728|580885148|FG002|Overall Study|Withdrawal by Subject|5|||
160860925|NCT02379728|580885149|FG003|Overall Study|Withdrawal by Subject|3|||
160860926|NCT02379728|580885146|FG000|Overall Study|Protocol Violation|0|||
160860927|NCT02379728|580885147|FG001|Overall Study|Protocol Violation|0|||
160860928|NCT02379728|580885148|FG002|Overall Study|Protocol Violation|2|||
160860929|NCT02379728|580885149|FG003|Overall Study|Protocol Violation|0|||
160860930|NCT00914316|580885152|FG000|Phase 1|Physician Decision|4|||
160860931|NCT00914316|580885153|FG001|Phase 1|Physician Decision|0|||
160860932|NCT00914316|580885154|FG002|Phase 1|Physician Decision|1|||
160860933|NCT00914316|580885155|FG003|Phase 1|Physician Decision|2|||
160860934|NCT00914316|580885152|FG000|Phase 1|Withdrawal by Subject|0|||
160860935|NCT00914316|580885153|FG001|Phase 1|Withdrawal by Subject|2|||
160860936|NCT00914316|580885154|FG002|Phase 1|Withdrawal by Subject|4|||
160860937|NCT00914316|580885155|FG003|Phase 1|Withdrawal by Subject|0|||
160860938|NCT00914316|580885152|FG000|Phase 1|Adverse Event|1|||
160570237|NCT01480180|579810450|FG001|Main Phase|Withdrawal criteria|1|||
160860939|NCT00914316|580885153|FG001|Phase 1|Adverse Event|0|||
160860940|NCT00914316|580885154|FG002|Phase 1|Adverse Event|0|||
160860941|NCT00914316|580885155|FG003|Phase 1|Adverse Event|0|||
160995044|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
160995045|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
160860942|NCT00914316|580885152|FG000|Phase 2|Withdrawal by Subject|1|||
160860943|NCT00914316|580885153|FG001|Phase 2|Withdrawal by Subject|0|||
160860944|NCT00914316|580885154|FG002|Phase 2|Withdrawal by Subject|1|||
160860945|NCT00914316|580885155|FG003|Phase 2|Withdrawal by Subject|0|||
160860946|NCT01112917|580885156|FG000|Overall Study|Death|2|||
160860947|NCT01112917|580885157|FG001|Overall Study|Death|11|||
160860948|NCT01112917|580885156|FG000|Overall Study|Lost to Follow-up|1|||
160860949|NCT01112917|580885157|FG001|Overall Study|Lost to Follow-up|1|||
160860950|NCT01112917|580885156|FG000|Overall Study|Withdrawal by Subject|1|||
160860951|NCT01112917|580885157|FG001|Overall Study|Withdrawal by Subject|3|||
160860952|NCT01112917|580885156|FG000|Overall Study|Unable to Convert Filter|3|||
160860953|NCT01112917|580885157|FG001|Overall Study|Unable to Convert Filter|0|||
160860954|NCT05101122|580885158|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
160860955|NCT05101122|580885158|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
160860956|NCT05101122|580885158|FG000|AD313 80/5|Withdrawal by Subject|1|||
160860957|NCT05101122|580885158|FG000|AD313 80/10|Physician Decision|1|||
160995046|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
160995047|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
160995048|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
160995049|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
160995050|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
160995051|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
160995052|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
160860958|NCT03131219|580885159|FG000|Initial Evaluation Period|Adverse Event|2|||
160860959|NCT03131219|580885160|FG001|Initial Evaluation Period|Adverse Event|0|||
160860960|NCT03131219|580885159|FG000|Initial Evaluation Period|Protocol Violation|1|||
160860961|NCT03131219|580885160|FG001|Initial Evaluation Period|Protocol Violation|0|||
160860962|NCT03131219|580885159|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
160860963|NCT03131219|580885160|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
160860964|NCT03131219|580885159|FG000|Initial Evaluation Period|Physician Decision|1|||
160860965|NCT03131219|580885160|FG001|Initial Evaluation Period|Physician Decision|0|||
160860966|NCT03131219|580885159|FG000|Extension Period|Physician Decision|1|||
160860967|NCT03131219|580885160|FG001|Extension Period|Physician Decision|0|||
160860968|NCT00616759|580885162|FG000|Overall Study|Physician Decision|2|||
160860969|NCT00616759|580885163|FG001|Overall Study|Physician Decision|0|||
160860970|NCT00616759|580885162|FG000|Overall Study|Withdrawal by Subject|1|||
160860971|NCT00616759|580885163|FG001|Overall Study|Withdrawal by Subject|2|||
160860972|NCT02399163|580885166|FG000|Overall Study|Adverse Event|2|||
160860973|NCT02399163|580885166|FG000|Overall Study|Protocol Deviation|2|||
160860974|NCT02399163|580885166|FG000|Overall Study|Withdrawal by Participant|5|||
160860975|NCT02177123|580885172|FG000|Overall Study|Lost to Follow-up|6|||
160860976|NCT02177123|580885172|FG000|Overall Study|Withdrawal by Subject|4|||
160860977|NCT02177123|580885172|FG000|Overall Study|Adverse Event|4|||
160860978|NCT02177123|580885172|FG000|Overall Study|Physician Decision|3|||
160860979|NCT02177123|580885172|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
160860980|NCT02177123|580885172|FG000|Overall Study|Excluded for medical reasons|2|||
160860981|NCT02177123|580885172|FG000|Overall Study|Death|1|||
160860982|NCT02177123|580885172|FG000|Overall Study|Other|1|||
160860983|NCT02177123|580885172|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
160860984|NCT01391546|580885173|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
160860985|NCT01391546|580885174|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
160860986|NCT06271993|580885176|FG000|Overall Study|Not reactive to histamine|5|||
160860987|NCT06271993|580885177|FG001|Overall Study|Not reactive to histamine|5|||
160860988|NCT06271993|580885178|FG002|Overall Study|Not reactive to histamine|5|||
160860989|NCT01980017|580885187|FG000|Overall Study|Lost to Follow-up|30|||
160860990|NCT01980017|580885188|FG001|Overall Study|Lost to Follow-up|21|||
160860991|NCT01980017|580885187|FG000|Overall Study|Death|0|||
160860992|NCT01980017|580885188|FG001|Overall Study|Death|1|||
160860993|NCT01435382|580885190|FG000|Overall Study|Lost to Follow-up|1|||
160860994|NCT01435382|580885191|FG001|Overall Study|Lost to Follow-up|0|||
160860995|NCT01435382|580885192|FG002|Overall Study|Lost to Follow-up|1|||
160860996|NCT01435382|580885193|FG003|Overall Study|Lost to Follow-up|0|||
160570238|NCT01480180|579810451|FG002|Main Phase|Withdrawal criteria|0|||
160860997|NCT01435382|580885190|FG000|Overall Study|Withdrawal by Subject|0|||
160570239|NCT01480180|579810452|FG003|Main Phase|Withdrawal criteria|0|||
160570240|NCT01480180|579810453|FG004|Main Phase|Withdrawal criteria|0|||
160860998|NCT01435382|580885191|FG001|Overall Study|Withdrawal by Subject|2|||
160860999|NCT01435382|580885192|FG002|Overall Study|Withdrawal by Subject|0|||
160861000|NCT01435382|580885193|FG003|Overall Study|Withdrawal by Subject|1|||
160861001|NCT03379818|580885194|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
160861002|NCT03379818|580885195|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
160861003|NCT03379818|580885194|FG000|Overall Study|Withdrawal by Subject|2|||
160861004|NCT03379818|580885195|FG001|Overall Study|Withdrawal by Subject|3|||
160652632|NCT00601484|580108688|FG000|Overall Study|Withdrawal by Subject|1|||
160652633|NCT00601484|580108689|FG001|Overall Study|Withdrawal by Subject|1|||
160652634|NCT00601484|580108688|FG000|Overall Study|Randomized, but not treated|0|||
160652635|NCT00601484|580108689|FG001|Overall Study|Randomized, but not treated|1|||
160652636|NCT02779855|580108690|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
160652637|NCT02779855|580108691|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
160652638|NCT02779855|580108692|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
160652639|NCT00319449|580108701|FG000|Overall Study|Subject did not wish to continue|1|||
160652640|NCT00319449|580108702|FG001|Overall Study|Subject did not wish to continue|0|||
160652641|NCT00319449|580108701|FG000|Overall Study|Noncompliance with the protocol|1|||
160652642|NCT00319449|580108702|FG001|Overall Study|Noncompliance with the protocol|0|||
160652643|NCT00455533|580108703|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
160652644|NCT00455533|580108704|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
160652645|NCT00455533|580108705|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
160652646|NCT00455533|580108703|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
160652647|NCT00455533|580108704|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
160652648|NCT00455533|580108705|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
160652649|NCT00455533|580108703|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
160652650|NCT00455533|580108704|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
160652651|NCT00455533|580108705|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
160652652|NCT00455533|580108703|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
160652653|NCT00455533|580108704|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
160652654|NCT00455533|580108705|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
160652655|NCT00455533|580108703|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
160652656|NCT00455533|580108704|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
160652657|NCT00455533|580108705|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
160652658|NCT00455533|580108703|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
160652659|NCT00455533|580108704|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
160652660|NCT00455533|580108705|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
160652661|NCT00455533|580108703|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
160652662|NCT00455533|580108704|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
160652663|NCT00455533|580108705|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
160652664|NCT00455533|580108703|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
160652665|NCT00455533|580108704|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
160652666|NCT00455533|580108705|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
160652667|NCT00455533|580108703|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
160652668|NCT00455533|580108704|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
160652669|NCT00455533|580108705|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
160652670|NCT00455533|580108703|FG000|Period Two: Randomized Period|Death|0|||
160652671|NCT00455533|580108704|FG001|Period Two: Randomized Period|Death|0|||
160861005|NCT03379818|580885194|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
160861006|NCT03379818|580885195|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
160861007|NCT00910650|580885196|FG000|Overall Study|Death|2|||
160861008|NCT00423579|580885197|FG000|Overall Study|Lost to Follow-up|3|||
160861009|NCT00423579|580885198|FG001|Overall Study|Lost to Follow-up|0|||
160861010|NCT00423579|580885197|FG000|Overall Study|Protocol Violation|1|||
160861011|NCT00423579|580885198|FG001|Overall Study|Protocol Violation|3|||
160861012|NCT00423579|580885197|FG000|Overall Study|Diagnosis of diabetes|0|||
160861013|NCT00423579|580885198|FG001|Overall Study|Diagnosis of diabetes|1|||
160861014|NCT01310777|580885200|FG000|Overall Study|Adverse Event|23|||
160861015|NCT01310777|580885201|FG001|Overall Study|Adverse Event|1|||
160861016|NCT01310777|580885202|FG002|Overall Study|Adverse Event|15|||
160861017|NCT01310777|580885200|FG000|Overall Study|Lost to Follow-up|0|||
160861018|NCT01310777|580885201|FG001|Overall Study|Lost to Follow-up|4|||
160861019|NCT01310777|580885202|FG002|Overall Study|Lost to Follow-up|1|||
160861020|NCT01310777|580885200|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
160861021|NCT01310777|580885201|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
160861022|NCT01310777|580885202|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
160861023|NCT01310777|580885200|FG000|Overall Study|Inadequate Control of IOP|5|||
160652672|NCT00455533|580108705|FG002|Period Two: Randomized Period|Death|3|||
160652673|NCT00455533|580108703|FG000|Period Two: Randomized Period|Disease Progression|0|||
160861024|NCT01310777|580885201|FG001|Overall Study|Inadequate Control of IOP|7|||
160861025|NCT01310777|580885202|FG002|Overall Study|Inadequate Control of IOP|10|||
160861026|NCT01310777|580885200|FG000|Overall Study|Other|4|||
160861027|NCT01310777|580885201|FG001|Overall Study|Other|1|||
160861028|NCT01310777|580885202|FG002|Overall Study|Other|2|||
160909624|NCT01846416|581064075|FG001|Survival Follow-up|Death|62|||
160909625|NCT01846416|581064076|FG002|Survival Follow-up|Death|9|||
160909626|NCT01846416|581064074|FG000|Survival Follow-up|Lost to Follow-up|0|||
160909627|NCT01846416|581064075|FG001|Survival Follow-up|Lost to Follow-up|2|||
160909628|NCT01846416|581064076|FG002|Survival Follow-up|Lost to Follow-up|2|||
160909629|NCT01846416|581064074|FG000|Survival Follow-up|Withdrawal by Subject|2|||
160909630|NCT01846416|581064075|FG001|Survival Follow-up|Withdrawal by Subject|7|||
160909631|NCT01846416|581064076|FG002|Survival Follow-up|Withdrawal by Subject|0|||
160909632|NCT01846416|581064074|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
160909633|NCT01846416|581064075|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
160909634|NCT01846416|581064076|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
160909635|NCT01846416|581064074|FG000|Survival Follow-up|Other|3|||
160909636|NCT01846416|581064075|FG001|Survival Follow-up|Other|1|||
160909637|NCT01846416|581064076|FG002|Survival Follow-up|Other|1|||
160909638|NCT00382252|581064079|FG000|Overall Study|Death|4|||
160909639|NCT00382252|581064079|FG000|Overall Study|Protocol Violation|8|||
160909640|NCT00382252|581064079|FG000|Overall Study|Not treated by RFA|1|||
160909641|NCT00833794|581064080|FG000|Open-label Phase|Adverse Event|225|||
160909642|NCT00833794|581064081|FG001|Open-label Phase|Adverse Event|0|||
160909643|NCT00833794|581064080|FG000|Open-label Phase|Lack of Efficacy|28|||
160909644|NCT00833794|581064081|FG001|Open-label Phase|Lack of Efficacy|0|||
160909645|NCT00833794|581064080|FG000|Open-label Phase|Withdrawal by Subject|48|||
160909646|NCT00833794|581064081|FG001|Open-label Phase|Withdrawal by Subject|0|||
160909647|NCT00833794|581064080|FG000|Open-label Phase|Physician Decision|20|||
160909648|NCT00833794|581064081|FG001|Open-label Phase|Physician Decision|0|||
160909649|NCT00833794|581064080|FG000|Open-label Phase|Administrative reason|1|||
160909650|NCT00833794|581064081|FG001|Open-label Phase|Administrative reason|0|||
160909651|NCT00833794|581064080|FG000|Open-label Phase|Protocol Violation|47|||
160909652|NCT00833794|581064081|FG001|Open-label Phase|Protocol Violation|0|||
160909653|NCT00833794|581064080|FG000|Open-label Phase|Did not complete wash-out period|12|||
160909654|NCT00833794|581064081|FG001|Open-label Phase|Did not complete wash-out period|0|||
160909655|NCT00833794|581064080|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
160909656|NCT00833794|581064081|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
160909657|NCT00833794|581064080|FG000|Double-blind Phase|Adverse Event|44|||
160909658|NCT00833794|581064081|FG001|Double-blind Phase|Adverse Event|11|||
160909659|NCT00833794|581064080|FG000|Double-blind Phase|Lack of Efficacy|34|||
160909660|NCT00833794|581064081|FG001|Double-blind Phase|Lack of Efficacy|22|||
160909661|NCT00833794|581064080|FG000|Double-blind Phase|Withdrawal by Subject|23|||
160909662|NCT00833794|581064081|FG001|Double-blind Phase|Withdrawal by Subject|6|||
160909663|NCT00833794|581064080|FG000|Double-blind Phase|Physician Decision|4|||
160909664|NCT00833794|581064081|FG001|Double-blind Phase|Physician Decision|7|||
160909665|NCT00833794|581064080|FG000|Double-blind Phase|Administrative reason|1|||
160909666|NCT00833794|581064081|FG001|Double-blind Phase|Administrative reason|3|||
160909667|NCT03648983|581064086|FG000|Overall Study|Study was terminated due to PI departure|95|||
160909668|NCT01411774|581066164|FG000|Overall Study|Withdrawal by Subject|0|||
160909669|NCT01411774|581066165|FG001|Overall Study|Withdrawal by Subject|3|||
160909670|NCT03292588|581066166|FG000|Overall Study|Death|1|||
160909671|NCT03292588|581066167|FG001|Overall Study|Death|0|||
160909672|NCT03292588|581066166|FG000|Overall Study|Lost to Follow-up|12|||
160909673|NCT03292588|581066167|FG001|Overall Study|Lost to Follow-up|16|||
160909674|NCT03292588|581066166|FG000|Overall Study|Physician Decision|0|||
160861029|NCT03697252|580885203|FG000|Overall Study|Adverse Event|3|||
160861030|NCT03697252|580885204|FG001|Overall Study|Adverse Event|2|||
160861031|NCT03697252|580885203|FG000|Overall Study|Withdrawal by Subject|14|||
160861032|NCT03697252|580885204|FG001|Overall Study|Withdrawal by Subject|14|||
160861033|NCT03697252|580885203|FG000|Overall Study|Lost to Follow-up|0|||
160861034|NCT03697252|580885204|FG001|Overall Study|Lost to Follow-up|1|||
160861035|NCT03697252|580885203|FG000|Overall Study|Physician Decision|1|||
160861036|NCT03697252|580885204|FG001|Overall Study|Physician Decision|1|||
160861037|NCT03697252|580885203|FG000|Overall Study|Other|0|||
160861038|NCT03697252|580885204|FG001|Overall Study|Other|1|||
160861039|NCT00317473|580885205|FG000|Overall Study|Withdrawal by Subject|2|||
160861040|NCT00317473|580885206|FG001|Overall Study|Withdrawal by Subject|1|||
160861041|NCT00317473|580885207|FG002|Overall Study|Withdrawal by Subject|2|||
160861042|NCT00317473|580885208|FG003|Overall Study|Withdrawal by Subject|1|||
160861043|NCT00317473|580885209|FG004|Overall Study|Withdrawal by Subject|3|||
160861044|NCT00317473|580885210|FG005|Overall Study|Withdrawal by Subject|1|||
160861045|NCT00317473|580885205|FG000|Overall Study|Relocation|1|||
160861046|NCT00317473|580885206|FG001|Overall Study|Relocation|0|||
160861047|NCT00317473|580885207|FG002|Overall Study|Relocation|1|||
160861048|NCT00317473|580885208|FG003|Overall Study|Relocation|1|||
160861049|NCT00317473|580885209|FG004|Overall Study|Relocation|5|||
160861050|NCT00317473|580885210|FG005|Overall Study|Relocation|2|||
160861051|NCT00317473|580885205|FG000|Overall Study|Death|1|||
160861052|NCT00317473|580885206|FG001|Overall Study|Death|0|||
160861053|NCT00317473|580885207|FG002|Overall Study|Death|0|||
160861054|NCT00317473|580885208|FG003|Overall Study|Death|0|||
160861055|NCT00317473|580885209|FG004|Overall Study|Death|0|||
160861056|NCT00317473|580885210|FG005|Overall Study|Death|0|||
160861057|NCT00317473|580885205|FG000|Overall Study|Other|0|||
160861058|NCT00317473|580885206|FG001|Overall Study|Other|2|||
160861059|NCT00317473|580885207|FG002|Overall Study|Other|0|||
160861060|NCT00317473|580885208|FG003|Overall Study|Other|0|||
160861061|NCT00317473|580885209|FG004|Overall Study|Other|0|||
160861062|NCT00317473|580885210|FG005|Overall Study|Other|0|||
160861063|NCT03253796|580885211|FG000|Period 1: Run-In|Adverse Event|4|||
160861064|NCT03253796|580885212|FG001|Period 1: Run-In|Adverse Event|0|||
160861065|NCT03253796|580885213|FG002|Period 1: Run-In|Adverse Event|0|||
160861066|NCT03253796|580885214|FG003|Period 1: Run-In|Adverse Event|0|||
160861067|NCT03253796|580885215|FG004|Period 1: Run-In|Adverse Event|0|||
160861068|NCT03253796|580885211|FG000|Period 1: Run-In|Lack of Efficacy|1|||
160861069|NCT03253796|580885212|FG001|Period 1: Run-In|Lack of Efficacy|0|||
160861070|NCT03253796|580885213|FG002|Period 1: Run-In|Lack of Efficacy|0|||
160861071|NCT03253796|580885214|FG003|Period 1: Run-In|Lack of Efficacy|0|||
160861072|NCT03253796|580885215|FG004|Period 1: Run-In|Lack of Efficacy|0|||
160861073|NCT03253796|580885211|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
160861074|NCT03253796|580885212|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
160861075|NCT03253796|580885213|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
160861076|NCT03253796|580885214|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
160861077|NCT03253796|580885215|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
160861078|NCT03253796|580885211|FG000|Period 1: Run-In|Protocol Violation|5|||
160861079|NCT03253796|580885212|FG001|Period 1: Run-In|Protocol Violation|0|||
160861080|NCT03253796|580885213|FG002|Period 1: Run-In|Protocol Violation|0|||
160861081|NCT03253796|580885214|FG003|Period 1: Run-In|Protocol Violation|0|||
160861082|NCT03253796|580885215|FG004|Period 1: Run-In|Protocol Violation|0|||
160861083|NCT03253796|580885211|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
160861084|NCT03253796|580885212|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
160861085|NCT03253796|580885213|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
160861086|NCT03253796|580885214|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
160861087|NCT03253796|580885215|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
160861088|NCT03253796|580885211|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
160861089|NCT03253796|580885212|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
160909675|NCT03292588|581066167|FG001|Overall Study|Physician Decision|1|||
160909676|NCT03292588|581066166|FG000|Overall Study|Withdrawal by Subject|4|||
160861090|NCT03253796|580885213|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
160861091|NCT03253796|580885214|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
160861092|NCT03253796|580885215|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
160861093|NCT03253796|580885211|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
160861094|NCT03253796|580885212|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
160861095|NCT03253796|580885213|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
160861096|NCT03253796|580885214|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
160861097|NCT03253796|580885215|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
160861098|NCT03253796|580885211|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
160861099|NCT03253796|580885212|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
160861100|NCT03253796|580885213|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
160861101|NCT03253796|580885214|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
160861102|NCT03253796|580885215|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
160909677|NCT03292588|581066167|FG001|Overall Study|Withdrawal by Subject|4|||
160652674|NCT00455533|580108704|FG001|Period Two: Randomized Period|Disease Progression|1|||
160652675|NCT00455533|580108705|FG002|Period Two: Randomized Period|Disease Progression|1|||
160652676|NCT00455533|580108703|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
160861103|NCT03253796|580885211|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
160861104|NCT03253796|580885212|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
160861105|NCT03253796|580885213|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
160861106|NCT03253796|580885214|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
160861107|NCT03253796|580885215|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
160861108|NCT03253796|580885211|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
160861109|NCT03253796|580885212|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
160861110|NCT03253796|580885213|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
160861111|NCT03253796|580885214|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
160861112|NCT03253796|580885215|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
160861113|NCT03253796|580885211|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
160861114|NCT03253796|580885212|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
160861115|NCT03253796|580885213|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
160861116|NCT03253796|580885214|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
160861117|NCT03253796|580885215|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
160861118|NCT02285855|580885216|FG000|Overall Study|Withdrawal by Subject|2|||
160861119|NCT02285855|580885217|FG001|Overall Study|Withdrawal by Subject|1|||
160861120|NCT00528112|580885218|FG000|Treatment up to 3 Years|Adverse Event|313|||
160861121|NCT00528112|580885219|FG001|Treatment up to 3 Years|Adverse Event|278|||
160861122|NCT00528112|580885218|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
160861123|NCT00528112|580885219|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
160861124|NCT00528112|580885218|FG000|Treatment up to 3 Years|Protocol Violation|16|||
160861125|NCT00528112|580885219|FG001|Treatment up to 3 Years|Protocol Violation|16|||
160861126|NCT00528112|580885218|FG000|Treatment up to 3 Years|Death|0|||
160861127|NCT00528112|580885219|FG001|Treatment up to 3 Years|Death|1|||
160861128|NCT00528112|580885218|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
160861129|NCT00528112|580885219|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
160861130|NCT00528112|580885218|FG000|Treatment up to 3 Years|Pregnancy|9|||
160861131|NCT00528112|580885219|FG001|Treatment up to 3 Years|Pregnancy|10|||
160861132|NCT00528112|580885218|FG000|Treatment up to 3 Years|Other reasons|186|||
160861133|NCT00528112|580885219|FG001|Treatment up to 3 Years|Other reasons|186|||
160861134|NCT00528112|580885218|FG000|Extension Phase|Withdrawal by Subject|0|||
160861135|NCT00528112|580885219|FG001|Extension Phase|Withdrawal by Subject|3|||
160861136|NCT00528112|580885218|FG000|Extension Phase|Other reasons|0|||
160861137|NCT00528112|580885219|FG001|Extension Phase|Other reasons|100|||
160861138|NCT00528112|580885218|FG000|Extension Phase|Pregnancy|0|||
160861139|NCT00528112|580885219|FG001|Extension Phase|Pregnancy|3|||
160861140|NCT00528112|580885218|FG000|Extension Phase|Lost to Follow-up|0|||
160861141|NCT00528112|580885219|FG001|Extension Phase|Lost to Follow-up|12|||
160861142|NCT00528112|580885218|FG000|Extension Phase|Death|0|||
160861143|NCT00528112|580885219|FG001|Extension Phase|Death|1|||
160861144|NCT00528112|580885218|FG000|Extension Phase|Adverse Event|0|||
160861145|NCT00528112|580885219|FG001|Extension Phase|Adverse Event|36|||
160861146|NCT00528112|580885218|FG000|Extension Phase|Protocol Violation|0|||
160861147|NCT00528112|580885219|FG001|Extension Phase|Protocol Violation|2|||
160861148|NCT02718898|580885222|FG000|Blinded Treatment Period|Adverse Event|5|||
160861149|NCT02718898|580885223|FG001|Blinded Treatment Period|Adverse Event|1|||
160861150|NCT02718898|580885224|FG002|Blinded Treatment Period|Adverse Event|0|||
160861151|NCT02718898|580885225|FG003|Blinded Treatment Period|Adverse Event|0|||
160861152|NCT02718898|580885226|FG004|Blinded Treatment Period|Adverse Event|0|||
160861153|NCT02718898|580885227|FG005|Blinded Treatment Period|Adverse Event|0|||
160861154|NCT02718898|580885228|FG006|Blinded Treatment Period|Adverse Event|0|||
160861155|NCT02718898|580885222|FG000|Blinded Treatment Period|Physician Decision|1|||
160861156|NCT02718898|580885223|FG001|Blinded Treatment Period|Physician Decision|0|||
160652677|NCT00455533|580108704|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
160652678|NCT00455533|580108705|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
160652679|NCT00455533|580108703|FG000|Period Two: Randomized Period|Other - need reasons|0|||
160652680|NCT00455533|580108704|FG001|Period Two: Randomized Period|Other - need reasons|1|||
160861157|NCT02718898|580885224|FG002|Blinded Treatment Period|Physician Decision|0|||
160861158|NCT02718898|580885225|FG003|Blinded Treatment Period|Physician Decision|0|||
160861159|NCT02718898|580885226|FG004|Blinded Treatment Period|Physician Decision|0|||
160909678|NCT03292588|581066166|FG000|Overall Study|Move out of town|1|||
160909679|NCT03292588|581066167|FG001|Overall Study|Move out of town|0|||
160652681|NCT00455533|580108705|FG002|Period Two: Randomized Period|Other - need reasons|0|||
160861160|NCT02718898|580885227|FG005|Blinded Treatment Period|Physician Decision|0|||
160909680|NCT03292588|581066166|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
160995053|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
160995054|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
160995055|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
160995056|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
160995057|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
160995058|NCT04982575|581369062|FG000|Overall Study|Withdrawal by Subject|2|||
160995059|NCT04982575|581369063|FG001|Overall Study|Withdrawal by Subject|0|||
160995060|NCT04982575|581369064|FG002|Overall Study|Withdrawal by Subject|2|||
160995061|NCT06269367|581369067|FG000|Phase I|Unable to perform study procedures|0|||
160995062|NCT06269367|581369068|FG001|Phase I|Unable to perform study procedures|1|||
160995063|NCT06269367|581369067|FG000|Phase I|Could not continue study for personal reasons.|1|||
160995064|NCT06269367|581369068|FG001|Phase I|Could not continue study for personal reasons.|0|||
160995065|NCT02824432|581369073|FG000|Overall Study|Major Protocol Deviation|1|||
160995066|NCT02824432|581369074|FG001|Overall Study|Major Protocol Deviation|0|||
160995067|NCT01348087|581369076|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
160995068|NCT01348087|581369076|FG000|Overall Study|Administrative problems|79|||
160995069|NCT01348087|581369076|FG000|Overall Study|protocol deviation|1|||
160995070|NCT01348087|581369076|FG000|Overall Study|Lost to Follow-up|1|||
160995071|NCT01348087|581369076|FG000|Overall Study|Subject withdrew consent|7|||
160995072|NCT01348087|581369076|FG000|Overall Study|Adverse Event|25|||
160995073|NCT00117988|581369079|FG000|Overall Study|Death|3|||
160995074|NCT00117988|581369079|FG000|Overall Study|Adverse Event|1|||
160995075|NCT05824351|581369080|FG000|Overall Study|Adverse Event|6|||
160995076|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
160995077|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
160995078|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
160995079|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
160995080|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
160995081|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
160570241|NCT01480180|579810454|FG005|Main Phase|Withdrawal criteria|0|||
160570242|NCT01480180|579810449|FG000|Main Phase|Lack of Efficacy|1|||
160570243|NCT01480180|579810450|FG001|Main Phase|Lack of Efficacy|0|||
160570244|NCT01480180|579810451|FG002|Main Phase|Lack of Efficacy|0|||
160570245|NCT01480180|579810452|FG003|Main Phase|Lack of Efficacy|0|||
160570246|NCT01480180|579810453|FG004|Main Phase|Lack of Efficacy|0|||
160570247|NCT01480180|579810454|FG005|Main Phase|Lack of Efficacy|0|||
160570248|NCT01480180|579810449|FG000|Main Phase|Non-compliance|3|||
160570249|NCT01480180|579810450|FG001|Main Phase|Non-compliance|0|||
160570250|NCT01480180|579810451|FG002|Main Phase|Non-compliance|0|||
160570251|NCT01480180|579810452|FG003|Main Phase|Non-compliance|0|||
160570252|NCT01480180|579810453|FG004|Main Phase|Non-compliance|0|||
160570253|NCT01480180|579810454|FG005|Main Phase|Non-compliance|0|||
160570254|NCT01480180|579810449|FG000|Main Phase|Unclassified|3|||
160570255|NCT01480180|579810450|FG001|Main Phase|Unclassified|0|||
160570256|NCT01480180|579810451|FG002|Main Phase|Unclassified|0|||
160570257|NCT01480180|579810452|FG003|Main Phase|Unclassified|0|||
160570258|NCT01480180|579810453|FG004|Main Phase|Unclassified|0|||
160570259|NCT01480180|579810454|FG005|Main Phase|Unclassified|0|||
160570260|NCT01480180|579810449|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
160570261|NCT01480180|579810450|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
160861161|NCT02718898|580885228|FG006|Blinded Treatment Period|Physician Decision|0|||
160861162|NCT02718898|580885222|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
160861163|NCT02718898|580885223|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
160652682|NCT00455533|580108703|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
160995082|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
160861164|NCT02718898|580885224|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
160995083|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
160995084|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
160570262|NCT01480180|579810451|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
160570263|NCT01480180|579810452|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
160570264|NCT01480180|579810453|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
160570265|NCT01480180|579810454|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
160570266|NCT01480180|579810449|FG000|Extension Phase, Part 1|Unclassified|0|||
160570267|NCT01480180|579810450|FG001|Extension Phase, Part 1|Unclassified|0|||
160652683|NCT00455533|580108704|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
160652684|NCT00455533|580108705|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
160652685|NCT00455533|580108703|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
160652686|NCT00455533|580108704|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
160652687|NCT00455533|580108705|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
160652688|NCT02415959|580108706|FG000|Overall Study|Adverse Event|0|||
160652689|NCT02415959|580108707|FG001|Overall Study|Adverse Event|1|||
160652690|NCT02415959|580108708|FG002|Overall Study|Adverse Event|0|||
160652691|NCT02415959|580108709|FG003|Overall Study|Adverse Event|0|||
160652692|NCT02415959|580108710|FG004|Overall Study|Adverse Event|0|||
160652693|NCT02415959|580108706|FG000|Overall Study|Protocol Violation|0|||
160652694|NCT02415959|580108707|FG001|Overall Study|Protocol Violation|0|||
160652695|NCT02415959|580108708|FG002|Overall Study|Protocol Violation|0|||
160652696|NCT02415959|580108709|FG003|Overall Study|Protocol Violation|1|||
160652697|NCT02415959|580108710|FG004|Overall Study|Protocol Violation|0|||
160652698|NCT01497938|580108714|FG000|Overall Study|Adverse Event|0|||
160652699|NCT01497938|580108715|FG001|Overall Study|Adverse Event|1|||
160652700|NCT01497938|580108714|FG000|Overall Study|Physician Decision|0|||
160652701|NCT01497938|580108715|FG001|Overall Study|Physician Decision|1|||
160652702|NCT01497938|580108714|FG000|Overall Study|Withdrawal by Subject|4|||
160652703|NCT01497938|580108715|FG001|Overall Study|Withdrawal by Subject|0|||
160652704|NCT01497938|580108714|FG000|Overall Study|Device Violation|1|||
160652705|NCT01497938|580108715|FG001|Overall Study|Device Violation|0|||
160652706|NCT03708211|580108716|FG000|Overall Study|Progressive Disease|10|||
160652707|NCT03708211|580108717|FG001|Overall Study|Progressive Disease|7|||
160652708|NCT03708211|580108716|FG000|Overall Study|Withdrawal by Subject|0|||
160652709|NCT03708211|580108717|FG001|Overall Study|Withdrawal by Subject|1|||
160652710|NCT03708211|580108716|FG000|Overall Study|Other|2|||
160652711|NCT03708211|580108717|FG001|Overall Study|Other|0|||
160652712|NCT00365352|580108718|FG000|Overall Study|Adverse Event|6|||
160652713|NCT00365352|580108719|FG001|Overall Study|Adverse Event|7|||
160652714|NCT00365352|580108720|FG002|Overall Study|Adverse Event|8|||
160652715|NCT00365352|580108718|FG000|Overall Study|Participant Withdrew Consent|8|||
160995085|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
160995086|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
160995087|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
160995088|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
160995089|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
160995090|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
160995091|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
160995092|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
160995093|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
160995094|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
160570268|NCT01480180|579810451|FG002|Extension Phase, Part 1|Unclassified|1|||
160570269|NCT01480180|579810452|FG003|Extension Phase, Part 1|Unclassified|0|||
160570270|NCT01480180|579810453|FG004|Extension Phase, Part 1|Unclassified|0|||
160570271|NCT01480180|579810454|FG005|Extension Phase, Part 1|Unclassified|0|||
160570272|NCT01480180|579810449|FG000|Extension Phase, Part 1|Adverse Event|0|||
160570273|NCT01480180|579810450|FG001|Extension Phase, Part 1|Adverse Event|0|||
160570274|NCT01480180|579810451|FG002|Extension Phase, Part 1|Adverse Event|4|||
160570275|NCT01480180|579810452|FG003|Extension Phase, Part 1|Adverse Event|1|||
160570276|NCT01480180|579810453|FG004|Extension Phase, Part 1|Adverse Event|0|||
160570277|NCT01480180|579810454|FG005|Extension Phase, Part 1|Adverse Event|0|||
160570278|NCT01480180|579810449|FG000|Extension Phase, Part 1|Change of treatment|0|||
160570279|NCT01480180|579810450|FG001|Extension Phase, Part 1|Change of treatment|0|||
160570280|NCT01480180|579810451|FG002|Extension Phase, Part 1|Change of treatment|0|||
160652716|NCT00365352|580108719|FG001|Overall Study|Participant Withdrew Consent|3|||
160652717|NCT00365352|580108720|FG002|Overall Study|Participant Withdrew Consent|4|||
160652718|NCT00365352|580108718|FG000|Overall Study|Lack of Efficacy|3|||
160995095|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
160995096|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
160570281|NCT01480180|579810452|FG003|Extension Phase, Part 1|Change of treatment|9|||
160570282|NCT01480180|579810453|FG004|Extension Phase, Part 1|Change of treatment|0|||
160570283|NCT01480180|579810454|FG005|Extension Phase, Part 1|Change of treatment|0|||
160570284|NCT01480180|579810449|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
160570285|NCT01480180|579810450|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
160570286|NCT01480180|579810451|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
160652719|NCT00365352|580108719|FG001|Overall Study|Lack of Efficacy|0|||
160652720|NCT00365352|580108720|FG002|Overall Study|Lack of Efficacy|0|||
160652721|NCT00365352|580108718|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
160652722|NCT00365352|580108719|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
160652723|NCT00365352|580108720|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
160652724|NCT00365352|580108718|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
160995097|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
160570287|NCT01480180|579810452|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
160570288|NCT01480180|579810453|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
160570289|NCT01480180|579810454|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
160570290|NCT01480180|579810449|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
160570291|NCT01480180|579810450|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
160570292|NCT01480180|579810451|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
160570293|NCT01480180|579810452|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
160570294|NCT01480180|579810453|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
160570295|NCT01480180|579810454|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
160570296|NCT01480180|579810449|FG000|Extension Phase, Part 2|Unclassified|0|||
160570297|NCT01480180|579810450|FG001|Extension Phase, Part 2|Unclassified|0|||
160570298|NCT01480180|579810451|FG002|Extension Phase, Part 2|Unclassified|3|||
160570299|NCT01480180|579810452|FG003|Extension Phase, Part 2|Unclassified|1|||
160570300|NCT01480180|579810453|FG004|Extension Phase, Part 2|Unclassified|1|||
160570301|NCT01480180|579810454|FG005|Extension Phase, Part 2|Unclassified|0|||
160570302|NCT00519623|579810455|FG000|Overall Study|Adverse Event|1|||
160570303|NCT04222725|579810458|FG000|Overall Study|Adverse Event|0|||
160570304|NCT04222725|579810459|FG001|Overall Study|Adverse Event|1|||
160570305|NCT04222725|579810460|FG002|Overall Study|Adverse Event|0|||
160570306|NCT04222725|579810461|FG003|Overall Study|Adverse Event|0|||
160570307|NCT03819140|579810462|FG000|Overall Study|Lost to Follow-up|1|||
160570308|NCT03819140|579810463|FG001|Overall Study|Lost to Follow-up|2|||
160570309|NCT03819140|579810462|FG000|Overall Study|Withdrawal by Subject|3|||
160570310|NCT03819140|579810463|FG001|Overall Study|Withdrawal by Subject|2|||
160570311|NCT03819140|579810462|FG000|Overall Study|Adverse Event|0|||
160570312|NCT03819140|579810463|FG001|Overall Study|Adverse Event|1|||
160570313|NCT03819140|579810462|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
160570314|NCT03819140|579810463|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
160570315|NCT03819140|579810462|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
160570316|NCT03819140|579810463|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
160570317|NCT00658333|579810464|FG000|Overall Study|Adverse Event|2|||
160570318|NCT00658333|579810465|FG001|Overall Study|Adverse Event|1|||
160570319|NCT00828451|579810468|FG000|Overall Study|Death|2|||
160570320|NCT00828451|579810468|FG000|Overall Study|Lack of intravenous line|7|||
160570321|NCT00828451|579810468|FG000|Overall Study|Withdrawal by Subject|1|||
160570322|NCT00828451|579810468|FG000|Overall Study|Deterioration in clinical status|1|||
160570323|NCT03256539|579810469|FG000|Overall Study|Withdrawal by Subject|0|||
160570324|NCT03256539|579810470|FG001|Overall Study|Withdrawal by Subject|3|||
160570325|NCT03256539|579810469|FG000|Overall Study|Unexpected closure of study components|8|||
160861165|NCT02718898|580885225|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
160861166|NCT02718898|580885226|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
160861167|NCT02718898|580885227|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
160861168|NCT02718898|580885228|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
160861169|NCT02718898|580885222|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
160861170|NCT02718898|580885223|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
160861171|NCT02718898|580885224|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
160861172|NCT02718898|580885225|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
160861173|NCT02718898|580885226|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
160861174|NCT02718898|580885227|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
160861175|NCT02718898|580885228|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
160861176|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
160861177|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
160861178|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
160861179|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
160861180|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
160861181|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
160861182|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
160861183|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861184|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861185|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861186|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
160861187|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861188|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861189|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861190|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160652725|NCT00365352|580108719|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
160861191|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160570326|NCT03256539|579810470|FG001|Overall Study|Unexpected closure of study components|4|||
160570327|NCT05755438|579810473|FG000|12-week DBVC Period|Adverse Event|4|||
160570328|NCT05755438|579810474|FG001|12-week DBVC Period|Adverse Event|1|||
160570329|NCT05755438|579810473|FG000|12-week DBVC Period|Physician Decision|1|||
160861192|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
160861193|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
160861194|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160861195|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160861196|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160861197|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
160861198|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
160861199|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
160861200|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
160861201|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
160861202|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
160861203|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
160861204|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861205|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861206|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861207|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
160861208|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861209|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861210|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861211|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861212|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861213|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861214|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
160861215|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861216|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861217|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861218|NCT02718898|580885222|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
160861219|NCT02718898|580885223|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
160861220|NCT02718898|580885224|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
160861221|NCT02718898|580885225|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
160861222|NCT02718898|580885226|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
160861223|NCT02718898|580885227|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
160861224|NCT02718898|580885228|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
160861225|NCT02718898|580885222|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
160861226|NCT02718898|580885223|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
160861227|NCT02718898|580885224|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
160861228|NCT02718898|580885225|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
160861229|NCT02718898|580885226|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
160861230|NCT02718898|580885227|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
160861231|NCT02718898|580885228|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
160861232|NCT02718898|580885222|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160861233|NCT02718898|580885223|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160861234|NCT02718898|580885224|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160861235|NCT02718898|580885225|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160861236|NCT02718898|580885226|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160909681|NCT03292588|581066167|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
160909682|NCT00684307|581066168|FG000|Overall Study|Adverse Event|11|||
160909683|NCT00684307|581066169|FG001|Overall Study|Adverse Event|6|||
160909684|NCT00684307|581066170|FG002|Overall Study|Adverse Event|15|||
160909685|NCT00684307|581066171|FG003|Overall Study|Adverse Event|16|||
160909686|NCT00684307|581066172|FG004|Overall Study|Adverse Event|8|||
160909687|NCT00684307|581066168|FG000|Overall Study|Development of increasing Liver Function|0|||
160909688|NCT00684307|581066169|FG001|Overall Study|Development of increasing Liver Function|2|||
160909689|NCT00684307|581066170|FG002|Overall Study|Development of increasing Liver Function|0|||
160909690|NCT00684307|581066171|FG003|Overall Study|Development of increasing Liver Function|1|||
160909691|NCT00684307|581066172|FG004|Overall Study|Development of increasing Liver Function|0|||
160909692|NCT00684307|581066168|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
160909693|NCT00684307|581066169|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
160909694|NCT00684307|581066170|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
160909695|NCT00684307|581066171|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
160909696|NCT00684307|581066172|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
160909697|NCT00684307|581066168|FG000|Overall Study|Incorrect enrolment or randomization|4|||
160909698|NCT00684307|581066169|FG001|Overall Study|Incorrect enrolment or randomization|0|||
160909699|NCT00684307|581066170|FG002|Overall Study|Incorrect enrolment or randomization|0|||
160652726|NCT00365352|580108720|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
160861237|NCT02718898|580885227|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
160861238|NCT02718898|580885228|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
160861239|NCT00231816|580885231|FG000|Overall Study|Adverse Event|1|||
160861240|NCT00231816|580885232|FG001|Overall Study|Adverse Event|0|||
160861241|NCT00231816|580885231|FG000|Overall Study|Lost to Follow-up|8|||
160861242|NCT00231816|580885232|FG001|Overall Study|Lost to Follow-up|5|||
160861243|NCT00231816|580885231|FG000|Overall Study|Protocol Violation|2|||
160861244|NCT00231816|580885232|FG001|Overall Study|Protocol Violation|3|||
160861245|NCT00231816|580885231|FG000|Overall Study|Withdrawal by Subject|3|||
160861246|NCT00231816|580885232|FG001|Overall Study|Withdrawal by Subject|3|||
160861247|NCT00231816|580885231|FG000|Overall Study|Other|2|||
160861248|NCT00231816|580885232|FG001|Overall Study|Other|1|||
160861249|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
160861250|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
160861251|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
160861252|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
160861253|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
160861254|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
160861255|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
160861256|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
160861257|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
160861258|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
160861259|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
160861260|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
160861261|NCT01668784|580885247|FG000|Treatment Period|Disease Progression|316|||
160861262|NCT01668784|580885248|FG001|Treatment Period|Disease Progression|293|||
160861263|NCT01668784|580885247|FG000|Treatment Period|Study Drug Toxicity|46|||
160861264|NCT01668784|580885248|FG001|Treatment Period|Study Drug Toxicity|53|||
160861265|NCT01668784|580885247|FG000|Treatment Period|Death|1|||
160861266|NCT01668784|580885248|FG001|Treatment Period|Death|1|||
160861267|NCT01668784|580885247|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
160861268|NCT01668784|580885248|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
160861269|NCT01668784|580885247|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
160861270|NCT01668784|580885248|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
160861271|NCT01668784|580885247|FG000|Treatment Period|Withdrawal by Subject|5|||
160861272|NCT01668784|580885248|FG001|Treatment Period|Withdrawal by Subject|3|||
160861273|NCT01668784|580885247|FG000|Treatment Period|Maximal Clinical Benefit|3|||
160861274|NCT01668784|580885248|FG001|Treatment Period|Maximal Clinical Benefit|3|||
160861275|NCT01668784|580885247|FG000|Treatment Period|Other|2|||
160861276|NCT01668784|580885248|FG001|Treatment Period|Other|8|||
160861277|NCT01668784|580885247|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
160861278|NCT01668784|580885248|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
160861279|NCT03137992|580885249|FG000|Washout Period 1|Adverse Event|1|||
160861280|NCT03137992|580885250|FG001|Washout Period 1|Adverse Event|1|||
160861281|NCT03137992|580885251|FG002|Washout Period 1|Adverse Event|0|||
160861282|NCT03137992|580885252|FG003|Washout Period 1|Adverse Event|0|||
160861283|NCT03137992|580885253|FG004|Washout Period 1|Adverse Event|0|||
160861284|NCT03137992|580885254|FG005|Washout Period 1|Adverse Event|1|||
160861285|NCT03137992|580885249|FG000|Washout Period 1|Withdrawal by Subject|0|||
160861286|NCT03137992|580885250|FG001|Washout Period 1|Withdrawal by Subject|1|||
160861287|NCT03137992|580885251|FG002|Washout Period 1|Withdrawal by Subject|1|||
160861288|NCT03137992|580885252|FG003|Washout Period 1|Withdrawal by Subject|0|||
160861289|NCT03137992|580885253|FG004|Washout Period 1|Withdrawal by Subject|0|||
160861290|NCT03137992|580885254|FG005|Washout Period 1|Withdrawal by Subject|0|||
160861291|NCT03137992|580885249|FG000|Washout Period 1|Principal Investigator Discretion|0|||
160861292|NCT03137992|580885250|FG001|Washout Period 1|Principal Investigator Discretion|1|||
160861293|NCT03137992|580885251|FG002|Washout Period 1|Principal Investigator Discretion|0|||
160909700|NCT00684307|581066171|FG003|Overall Study|Incorrect enrolment or randomization|0|||
160909701|NCT00684307|581066172|FG004|Overall Study|Incorrect enrolment or randomization|0|||
160909702|NCT00684307|581066168|FG000|Overall Study|Interupted IP for more than 7 days|0|||
160909703|NCT00684307|581066169|FG001|Overall Study|Interupted IP for more than 7 days|4|||
160909704|NCT00684307|581066170|FG002|Overall Study|Interupted IP for more than 7 days|1|||
160909705|NCT00684307|581066171|FG003|Overall Study|Interupted IP for more than 7 days|3|||
160909706|NCT00684307|581066172|FG004|Overall Study|Interupted IP for more than 7 days|3|||
160909707|NCT00684307|581066168|FG000|Overall Study|Severe non compliance to protocol|1|||
160909708|NCT00684307|581066169|FG001|Overall Study|Severe non compliance to protocol|0|||
160652727|NCT00365352|580108718|FG000|Overall Study|Lost to Follow-up|1|||
160861294|NCT03137992|580885252|FG003|Washout Period 1|Principal Investigator Discretion|0|||
160861295|NCT03137992|580885253|FG004|Washout Period 1|Principal Investigator Discretion|0|||
160909709|NCT00684307|581066170|FG002|Overall Study|Severe non compliance to protocol|0|||
160909710|NCT00684307|581066171|FG003|Overall Study|Severe non compliance to protocol|1|||
160861296|NCT03137992|580885254|FG005|Washout Period 1|Principal Investigator Discretion|0|||
160909711|NCT00684307|581066172|FG004|Overall Study|Severe non compliance to protocol|2|||
160909712|NCT00684307|581066168|FG000|Overall Study|Participant not willing to continue|7|||
160909713|NCT00684307|581066169|FG001|Overall Study|Participant not willing to continue|10|||
160909714|NCT00684307|581066170|FG002|Overall Study|Participant not willing to continue|11|||
160909715|NCT00684307|581066171|FG003|Overall Study|Participant not willing to continue|5|||
160909716|NCT00684307|581066172|FG004|Overall Study|Participant not willing to continue|8|||
160909717|NCT00684307|581066168|FG000|Overall Study|Criteria from the CSR|0|||
160909718|NCT00684307|581066169|FG001|Overall Study|Criteria from the CSR|0|||
160909719|NCT00684307|581066170|FG002|Overall Study|Criteria from the CSR|1|||
160909720|NCT00684307|581066171|FG003|Overall Study|Criteria from the CSR|3|||
160909721|NCT00684307|581066172|FG004|Overall Study|Criteria from the CSR|3|||
160909722|NCT05526716|581066174|FG000|Overall Study|Death|1|||
160909723|NCT05526716|581066175|FG001|Overall Study|Death|2|||
160909724|NCT05526716|581066174|FG000|Overall Study|Lost to Follow-up|17|||
160909725|NCT05526716|581066175|FG001|Overall Study|Lost to Follow-up|15|||
160909726|NCT05526716|581066174|FG000|Overall Study|Physician Decision|0|||
160909727|NCT05526716|581066175|FG001|Overall Study|Physician Decision|1|||
160909728|NCT05526716|581066174|FG000|Overall Study|Randomized by mistake without study treatment|0|||
160909729|NCT05526716|581066175|FG001|Overall Study|Randomized by mistake without study treatment|1|||
160909730|NCT05526716|581066174|FG000|Overall Study|Withdrawal by Subject|12|||
160909731|NCT05526716|581066175|FG001|Overall Study|Withdrawal by Subject|12|||
160909732|NCT05526716|581066174|FG000|Overall Study|Not reported|0|||
160909733|NCT05526716|581066175|FG001|Overall Study|Not reported|2|||
160909734|NCT04932096|581066178|FG000|Overall Study|Withdrawal by Subject|1|||
160909735|NCT04932096|581066179|FG001|Overall Study|Withdrawal by Subject|1|||
160909736|NCT04932096|581066178|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
160909737|NCT04932096|581066179|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
160909738|NCT01438957|581066180|FG000|Overall Study|Physician Decision|1|||
160909739|NCT01438957|581066181|FG001|Overall Study|Physician Decision|1|||
160909740|NCT01438957|581066182|FG002|Overall Study|Physician Decision|0|||
160909741|NCT01438957|581066183|FG003|Overall Study|Physician Decision|1|||
160909742|NCT01438957|581066184|FG004|Overall Study|Physician Decision|0|||
160909743|NCT03902574|581066185|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
160909744|NCT03902574|581066186|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
160909745|NCT03902574|581066187|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
160909746|NCT00133952|581066188|FG000|Overall Study|Adverse Event|1|||
160909747|NCT00133952|581066189|FG001|Overall Study|Adverse Event|2|||
160909748|NCT00133952|581066188|FG000|Overall Study|Death|3|||
160909749|NCT00133952|581066189|FG001|Overall Study|Death|2|||
160909750|NCT00133952|581066188|FG000|Overall Study|Lost to Follow-up|9|||
160909751|NCT00133952|581066189|FG001|Overall Study|Lost to Follow-up|14|||
160909752|NCT00133952|581066188|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
160909753|NCT00133952|581066189|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
160909754|NCT00133952|581066188|FG000|Overall Study|Protocol Violation|1|||
160909755|NCT00133952|581066189|FG001|Overall Study|Protocol Violation|1|||
160909756|NCT00133952|581066188|FG000|Overall Study|Withdrawal by Subject|20|||
160909757|NCT00133952|581066189|FG001|Overall Study|Withdrawal by Subject|4|||
160909758|NCT00133952|581066188|FG000|Overall Study|Physician Decision|4|||
160909759|NCT00133952|581066189|FG001|Overall Study|Physician Decision|3|||
160909760|NCT00133952|581066188|FG000|Overall Study|Sponsor Decision|0|||
160909761|NCT00133952|581066189|FG001|Overall Study|Sponsor Decision|1|||
160909762|NCT02170298|581066194|FG000|Overall Study|Withdrawal by Subject|0|||
160909763|NCT02170298|581066195|FG001|Overall Study|Withdrawal by Subject|1|||
160909764|NCT02170298|581066194|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
160909765|NCT02170298|581066195|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
160909766|NCT05048784|581066196|FG000|Period 1|Adverse Event|3|||
160909767|NCT05048784|581066197|FG001|Period 1|Adverse Event|1|||
160909768|NCT05048784|581066198|FG002|Period 1|Adverse Event|0|||
160909769|NCT05048784|581066199|FG003|Period 1|Adverse Event|0|||
160909770|NCT05048784|581066196|FG000|Period 2|Lost to Follow-up|0|||
160909771|NCT05048784|581066197|FG001|Period 2|Lost to Follow-up|1|||
160909772|NCT05048784|581066198|FG002|Period 2|Lost to Follow-up|0|||
160909773|NCT05048784|581066199|FG003|Period 2|Lost to Follow-up|0|||
160909774|NCT00727025|581066202|FG000|Overall Study|Physician Decision|23|||
160909775|NCT02269241|581066203|FG000|Overall Study|Lost to Follow-up|269|||
160909776|NCT02269241|581066203|FG000|Overall Study|Withdrawal by Subject|155|||
160909777|NCT02269241|581066203|FG000|Overall Study|Protocol Violation|1|||
160909778|NCT02269241|581066203|FG000|Overall Study|Physician Decision|7|||
160909779|NCT02269241|581066203|FG000|Overall Study|Pregnancy|15|||
160909780|NCT02269241|581066203|FG000|Overall Study|Wish for pregnancy|5|||
160909781|NCT02269241|581066203|FG000|Overall Study|Development of an exclusion criteria|16|||
160909782|NCT02269241|581066203|FG000|Overall Study|Adverse Event|113|||
160909783|NCT02269241|581066203|FG000|Overall Study|At the specific request of the sponsor|20|||
160909784|NCT02269241|581066203|FG000|Overall Study|Several reasons not classified|53|||
160909785|NCT02269241|581066203|FG000|Overall Study|Screening failures|546|||
160909786|NCT03020160|581066204|FG000|Overall Study|Withdrawal by Subject|1|||
160570330|NCT05755438|579810474|FG001|12-week DBVC Period|Physician Decision|1|||
160570331|NCT05755438|579810473|FG000|12-week DBVC Period|Protocol Violation|4|||
160570332|NCT05755438|579810474|FG001|12-week DBVC Period|Protocol Violation|2|||
160570333|NCT05755438|579810473|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
160570334|NCT05755438|579810474|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
160570335|NCT05755438|579810473|FG000|12-week DBVC Period|Sponsor Decision|1|||
160570336|NCT05755438|579810474|FG001|12-week DBVC Period|Sponsor Decision|0|||
160570337|NCT05755438|579810473|FG000|40-week OLE Period|Adverse Event|0|||
160995098|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
160995099|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
160995100|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
160995101|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
160995102|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
160995103|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
160995104|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
160995105|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
160995106|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Other|0|||
160995107|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Other|1|||
160995108|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Other|0|||
160995109|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
160995110|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
160995111|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
160995112|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Early site closure|0|||
160995113|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Early site closure|2|||
160995114|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Early site closure|0|||
160995115|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
160995116|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
160995117|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
160995118|NCT02137850|581369081|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
160995119|NCT02137850|581369082|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
160995120|NCT02137850|581369083|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
160995121|NCT02137850|581369081|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
160995122|NCT02137850|581369082|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
160995123|NCT02137850|581369083|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
160995124|NCT02137850|581369081|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
160995125|NCT02137850|581369082|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
160995126|NCT02137850|581369083|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
160995127|NCT02137850|581369081|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
160995128|NCT02137850|581369082|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
160995129|NCT02137850|581369083|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
160995130|NCT02137850|581369081|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
160995131|NCT02137850|581369082|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
160995132|NCT02137850|581369083|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
160995133|NCT02137850|581369081|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
160995134|NCT02137850|581369082|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
160995135|NCT02137850|581369083|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
160995136|NCT02137850|581369081|FG000|Extension Phase: Prophylaxis|Other|0|||
160995137|NCT02137850|581369082|FG001|Extension Phase: Prophylaxis|Other|1|||
160995138|NCT02137850|581369083|FG002|Extension Phase: Prophylaxis|Other|0|||
160995139|NCT02137850|581369081|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
160995140|NCT02137850|581369082|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
160995141|NCT02137850|581369083|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
160995142|NCT02912260|581369084|FG000|Main Study|Lost to Follow-up|5|||
160995143|NCT02912260|581369085|FG001|Main Study|Lost to Follow-up|4|||
160995144|NCT02912260|581369084|FG000|Main Study|Withdrawal by Subject|2|||
160995145|NCT02912260|581369085|FG001|Main Study|Withdrawal by Subject|2|||
160995146|NCT02912260|581369084|FG000|Main Study|Adverse Event|3|||
160995147|NCT02912260|581369085|FG001|Main Study|Adverse Event|0|||
160995148|NCT02912260|581369084|FG000|Main Study|Physician Decision|0|||
160995149|NCT02912260|581369085|FG001|Main Study|Physician Decision|1|||
160995150|NCT02912260|581369084|FG000|Extension Study|Withdrawal by Subject|1|||
160995151|NCT02912260|581369085|FG001|Extension Study|Withdrawal by Subject|1|||
160995152|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
160995153|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
160570338|NCT05755438|579810474|FG001|40-week OLE Period|Adverse Event|2|||
160570339|NCT05755438|579810473|FG000|40-week OLE Period|Lack of Efficacy|1|||
160570340|NCT05755438|579810474|FG001|40-week OLE Period|Lack of Efficacy|1|||
160570341|NCT05755438|579810473|FG000|40-week OLE Period|Lost to Follow-up|1|||
160570342|NCT05755438|579810474|FG001|40-week OLE Period|Lost to Follow-up|0|||
160995154|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
160995155|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
160995156|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
160570343|NCT05755438|579810473|FG000|40-week OLE Period|Physician Decision|1|||
160453083|NCT04079218|579389677|FG000|Overall Study|Death|1|||
160453084|NCT04079218|579389678|FG001|Overall Study|Death|0|||
160453085|NCT04079218|579389677|FG000|Overall Study|Withdrawal by Subject|3|||
160453086|NCT04079218|579389678|FG001|Overall Study|Withdrawal by Subject|0|||
160453087|NCT04079218|579389677|FG000|Overall Study|Physician Decision|4|||
160453088|NCT04079218|579389678|FG001|Overall Study|Physician Decision|0|||
160453089|NCT04079218|579389677|FG000|Overall Study|Lost to Follow-up|0|||
160453090|NCT04079218|579389678|FG001|Overall Study|Lost to Follow-up|1|||
160453091|NCT05907174|579389684|FG000|3-Month Assessment|Withdrawal by Subject|0|||
160453092|NCT05907174|579389685|FG001|3-Month Assessment|Withdrawal by Subject|0|||
160453093|NCT05907174|579389686|FG002|3-Month Assessment|Withdrawal by Subject|0|||
160453094|NCT05907174|579389687|FG003|3-Month Assessment|Withdrawal by Subject|1|||
160453095|NCT05907174|579389684|FG000|3-Month Assessment|Lost to Follow-up|1|||
160453096|NCT05907174|579389685|FG001|3-Month Assessment|Lost to Follow-up|1|||
160453097|NCT05907174|579389686|FG002|3-Month Assessment|Lost to Follow-up|1|||
160453098|NCT05907174|579389687|FG003|3-Month Assessment|Lost to Follow-up|1|||
160453099|NCT05907174|579389684|FG000|6-Month Assessment|Death|0|||
160453100|NCT05907174|579389685|FG001|6-Month Assessment|Death|0|||
160453101|NCT05907174|579389686|FG002|6-Month Assessment|Death|3|||
160453102|NCT05907174|579389687|FG003|6-Month Assessment|Death|0|||
160570344|NCT05755438|579810474|FG001|40-week OLE Period|Physician Decision|1|||
160570345|NCT05755438|579810473|FG000|40-week OLE Period|Protocol Violation|1|||
160570346|NCT05755438|579810474|FG001|40-week OLE Period|Protocol Violation|1|||
160570347|NCT05755438|579810473|FG000|40-week OLE Period|Withdrawal by Subject|6|||
160570348|NCT05755438|579810474|FG001|40-week OLE Period|Withdrawal by Subject|6|||
160570349|NCT05755438|579810473|FG000|40-week OLE Period|Sponsor Decision|3|||
160570350|NCT05755438|579810474|FG001|40-week OLE Period|Sponsor Decision|0|||
160570351|NCT05755438|579810473|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
160570352|NCT05755438|579810474|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
160570353|NCT05755438|579810473|FG000|40-week OLE Period|Ongoing|46|||
160570354|NCT05755438|579810474|FG001|40-week OLE Period|Ongoing|58|||
160570355|NCT00624338|579810479|FG000|Overall Study|Adverse Event|14|||
160570356|NCT00624338|579810480|FG001|Overall Study|Adverse Event|14|||
160570357|NCT00624338|579810481|FG002|Overall Study|Adverse Event|18|||
160570358|NCT00624338|579810479|FG000|Overall Study|Lost to Follow-up|1|||
160570359|NCT00624338|579810480|FG001|Overall Study|Lost to Follow-up|0|||
160570360|NCT00624338|579810481|FG002|Overall Study|Lost to Follow-up|0|||
160570361|NCT00624338|579810479|FG000|Overall Study|Lack of Efficacy|11|||
160570362|NCT00624338|579810480|FG001|Overall Study|Lack of Efficacy|3|||
160570363|NCT00624338|579810481|FG002|Overall Study|Lack of Efficacy|14|||
160570364|NCT00624338|579810479|FG000|Overall Study|Protocol Violation|3|||
160570365|NCT00624338|579810480|FG001|Overall Study|Protocol Violation|3|||
160570366|NCT00624338|579810481|FG002|Overall Study|Protocol Violation|2|||
160570367|NCT00624338|579810479|FG000|Overall Study|Death|0|||
160570368|NCT00624338|579810480|FG001|Overall Study|Death|2|||
160909787|NCT03020160|581066205|FG001|Overall Study|Withdrawal by Subject|0|||
160909788|NCT00545168|581066212|FG000|Overall Study|Lost to Follow-up|5|||
160909789|NCT00545168|581066213|FG001|Overall Study|Lost to Follow-up|5|||
160909790|NCT00545168|581066214|FG002|Overall Study|Lost to Follow-up|5|||
160909791|NCT00545168|581066212|FG000|Overall Study|Withdrawal by Subject|9|||
160909792|NCT00545168|581066213|FG001|Overall Study|Withdrawal by Subject|0|||
160909793|NCT00545168|581066214|FG002|Overall Study|Withdrawal by Subject|13|||
160909794|NCT00545168|581066212|FG000|Overall Study|Protocol Violation|1|||
160909795|NCT00545168|581066213|FG001|Overall Study|Protocol Violation|0|||
160909796|NCT00545168|581066214|FG002|Overall Study|Protocol Violation|1|||
160995157|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
160453103|NCT05907174|579389684|FG000|6-Month Assessment|Withdrawal by Subject|0|||
160453104|NCT05907174|579389685|FG001|6-Month Assessment|Withdrawal by Subject|0|||
160453105|NCT05907174|579389686|FG002|6-Month Assessment|Withdrawal by Subject|1|||
160453106|NCT05907174|579389687|FG003|6-Month Assessment|Withdrawal by Subject|1|||
160909797|NCT00545168|581066212|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
160909798|NCT00545168|581066213|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
160909799|NCT00545168|581066214|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
160909800|NCT01833520|581066217|FG000|Overall Study|Lack of Efficacy|3|||
160909801|NCT01833520|581066218|FG001|Overall Study|Lack of Efficacy|3|||
160909802|NCT01833520|581066219|FG002|Overall Study|Lack of Efficacy|8|||
160453107|NCT05907174|579389684|FG000|6-Month Assessment|Lost to Follow-up|0|||
160570369|NCT00624338|579810481|FG002|Overall Study|Death|0|||
160570370|NCT00624338|579810479|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
160570371|NCT00624338|579810480|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
160453108|NCT05907174|579389685|FG001|6-Month Assessment|Lost to Follow-up|1|||
160453109|NCT05907174|579389686|FG002|6-Month Assessment|Lost to Follow-up|1|||
160453110|NCT05907174|579389687|FG003|6-Month Assessment|Lost to Follow-up|1|||
160453111|NCT04498390|579389688|FG000|Overall Study|Adverse Event|0|||
160453112|NCT04498390|579389689|FG001|Overall Study|Adverse Event|0|||
160453113|NCT04498390|579389690|FG002|Overall Study|Adverse Event|1|||
160453114|NCT04498390|579389691|FG003|Overall Study|Adverse Event|0|||
160453115|NCT04498390|579389692|FG004|Overall Study|Adverse Event|0|||
160453116|NCT04498390|579389688|FG000|Overall Study|Withdrawal by Subject|0|||
160453117|NCT04498390|579389689|FG001|Overall Study|Withdrawal by Subject|0|||
160453118|NCT04498390|579389690|FG002|Overall Study|Withdrawal by Subject|0|||
160570372|NCT00624338|579810481|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
160570373|NCT00624338|579810479|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
160909803|NCT01833520|581066220|FG003|Overall Study|Lack of Efficacy|3|||
160570374|NCT00624338|579810480|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
160909804|NCT04182763|581066230|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
160909805|NCT04182763|581066231|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
160909806|NCT04182763|581066232|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
160909807|NCT04182763|581066233|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
160909808|NCT04182763|581066234|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
160909809|NCT04182763|581066230|FG000|Double-Blind Period, initial 6 months|Death|0|||
160909810|NCT04182763|581066231|FG001|Double-Blind Period, initial 6 months|Death|1|||
160909811|NCT04182763|581066232|FG002|Double-Blind Period, initial 6 months|Death|0|||
160909812|NCT04182763|581066233|FG003|Double-Blind Period, initial 6 months|Death|0|||
160909813|NCT04182763|581066234|FG004|Double-Blind Period, initial 6 months|Death|0|||
160909814|NCT04182763|581066230|FG000|Open-Label Period, subsequent 18 months|Death|3|||
160909815|NCT04182763|581066231|FG001|Open-Label Period, subsequent 18 months|Death|2|||
160909816|NCT04182763|581066232|FG002|Open-Label Period, subsequent 18 months|Death|2|||
160909817|NCT04182763|581066233|FG003|Open-Label Period, subsequent 18 months|Death|0|||
160909818|NCT04182763|581066234|FG004|Open-Label Period, subsequent 18 months|Death|1|||
160909819|NCT04182763|581066230|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
160909820|NCT04182763|581066231|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
160909821|NCT04182763|581066232|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
160909822|NCT04182763|581066233|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
160909823|NCT04182763|581066234|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
160909824|NCT04182763|581066230|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
160909825|NCT04182763|581066231|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
160909826|NCT04182763|581066232|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
160909827|NCT04182763|581066233|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
160909828|NCT04182763|581066234|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
160909829|NCT00003479|581066238|FG000|Overall Study|Not evaluable|3|||
160909830|NCT01484197|581066251|FG000|Treatment Period 1|Adverse Event|1|||
160909831|NCT01484197|581066252|FG001|Treatment Period 1|Adverse Event|0|||
160909832|NCT01484197|581066253|FG002|Treatment Period 1|Adverse Event|0|||
160909833|NCT01484197|581066254|FG003|Treatment Period 1|Adverse Event|0|||
160909834|NCT01484197|581066251|FG000|Treatment Period 2|Subject withdrew consent|0|||
160909835|NCT01484197|581066252|FG001|Treatment Period 2|Subject withdrew consent|0|||
160909836|NCT01484197|581066253|FG002|Treatment Period 2|Subject withdrew consent|0|||
160909837|NCT01484197|581066254|FG003|Treatment Period 2|Subject withdrew consent|1|||
160909838|NCT01727297|581066255|FG000|Overall Study|Death|13|||
160909839|NCT01727297|581066256|FG001|Overall Study|Death|0|||
160909840|NCT01727297|581066255|FG000|Overall Study|Protocol Violation|1|||
160909841|NCT01727297|581066256|FG001|Overall Study|Protocol Violation|10|||
160909842|NCT01727297|581066255|FG000|Overall Study|Adverse Event|3|||
160909843|NCT01727297|581066256|FG001|Overall Study|Adverse Event|1|||
160909844|NCT01727297|581066255|FG000|Overall Study|Lost to Follow-up|11|||
160909845|NCT01727297|581066256|FG001|Overall Study|Lost to Follow-up|0|||
160909846|NCT01727297|581066255|FG000|Overall Study|Withdrawal by Subject|26|||
160909847|NCT01727297|581066256|FG001|Overall Study|Withdrawal by Subject|27|||
160909848|NCT01727297|581066255|FG000|Overall Study|Physician Decision|19|||
160909849|NCT01727297|581066256|FG001|Overall Study|Physician Decision|5|||
160453119|NCT04498390|579389691|FG003|Overall Study|Withdrawal by Subject|1|||
160570375|NCT00624338|579810481|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
160570376|NCT00624338|579810479|FG000|Overall Study|Other|15|||
160909850|NCT01727297|581066255|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
160909851|NCT01727297|581066256|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
160453120|NCT04498390|579389692|FG004|Overall Study|Withdrawal by Subject|0|||
160453121|NCT05093842|579389693|FG000|Overall Study|Pregnancy loss|1|||
160570377|NCT00624338|579810480|FG001|Overall Study|Other|5|||
160909852|NCT02244606|581066257|FG000|Overall Study|Adverse Event|0|||
160909853|NCT02244606|581066258|FG001|Overall Study|Adverse Event|1|||
160909854|NCT02244606|581066259|FG002|Overall Study|Adverse Event|1|||
160909855|NCT02244606|581066260|FG003|Overall Study|Adverse Event|0|||
160909856|NCT02244606|581066257|FG000|Overall Study|Lost to Follow-up|2|||
160909857|NCT02244606|581066258|FG001|Overall Study|Lost to Follow-up|2|||
160909858|NCT02244606|581066259|FG002|Overall Study|Lost to Follow-up|1|||
160909859|NCT02244606|581066260|FG003|Overall Study|Lost to Follow-up|0|||
160909860|NCT02244606|581066257|FG000|Overall Study|Protocol Violation|0|||
160909861|NCT02244606|581066258|FG001|Overall Study|Protocol Violation|0|||
160909862|NCT02244606|581066259|FG002|Overall Study|Protocol Violation|0|||
160909863|NCT02244606|581066260|FG003|Overall Study|Protocol Violation|1|||
160909864|NCT02244606|581066257|FG000|Overall Study|Withdrawal by Subject|1|||
160909865|NCT02244606|581066258|FG001|Overall Study|Withdrawal by Subject|1|||
160909866|NCT02244606|581066259|FG002|Overall Study|Withdrawal by Subject|0|||
160909867|NCT02244606|581066260|FG003|Overall Study|Withdrawal by Subject|0|||
160909868|NCT02244606|581066257|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
160909869|NCT02244606|581066258|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
160909870|NCT02244606|581066259|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
160909871|NCT02244606|581066260|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
160909872|NCT02321800|581066266|FG000|Overall Study|Withdrawal by Subject|3|||
160909873|NCT02321800|581066267|FG001|Overall Study|Withdrawal by Subject|3|||
160909874|NCT02321800|581066266|FG000|Overall Study|Death|1|||
160909875|NCT02321800|581066267|FG001|Overall Study|Death|0|||
160909876|NCT02321800|581066266|FG000|Overall Study|Protocol Violation|1|||
160909877|NCT02321800|581066267|FG001|Overall Study|Protocol Violation|0|||
160909878|NCT02321800|581066266|FG000|Overall Study|Lost to Follow-up|10|||
160909879|NCT02321800|581066267|FG001|Overall Study|Lost to Follow-up|4|||
160909880|NCT02321800|581066266|FG000|Overall Study|Adverse Event|2|||
160909881|NCT02321800|581066267|FG001|Overall Study|Adverse Event|3|||
160909882|NCT02321800|581066266|FG000|Overall Study|Other, Miscellaneous|3|||
160909883|NCT02321800|581066267|FG001|Overall Study|Other, Miscellaneous|1|||
160909884|NCT00982878|581066268|FG000|Overall Study|Physician Decision|1|||
160909885|NCT00642460|581066272|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
160909886|NCT00642460|581066273|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
160909887|NCT00642460|581066274|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
160909888|NCT00642460|581066275|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
160909889|NCT00642460|581066276|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
160909890|NCT00642460|581066277|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
160909891|NCT00642460|581066272|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
160909892|NCT00642460|581066273|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
160909893|NCT00642460|581066274|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
160909894|NCT00642460|581066275|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
160909895|NCT00642460|581066276|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
160909896|NCT00642460|581066277|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
160909897|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
160909898|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
160909899|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
160909900|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
160909901|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
160909902|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
160909903|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Death|0|||
160909904|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Death|1|||
160909905|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Death|0|||
160909906|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Death|2|||
160909907|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Death|0|||
160453122|NCT05093842|579389694|FG001|Overall Study|Pregnancy loss|1|||
160453123|NCT05093842|579389693|FG000|Overall Study|Lost to Follow-up|6|||
160453124|NCT05093842|579389694|FG001|Overall Study|Lost to Follow-up|0|||
160453125|NCT05093842|579389693|FG000|Overall Study|Physician Decision|0|||
160453126|NCT05093842|579389694|FG001|Overall Study|Physician Decision|1|||
160453127|NCT03910478|579389700|FG000|Overall Study|Death|13|||
160453128|NCT03910478|579389701|FG001|Overall Study|Death|6|||
160909908|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Death|0|||
160909909|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
160909910|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
160453129|NCT03910478|579389700|FG000|Overall Study|Withdrawal by Subject|23|||
160453130|NCT03910478|579389701|FG001|Overall Study|Withdrawal by Subject|2|||
160909911|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
160909912|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
160909913|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
160909914|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
160909915|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
160570378|NCT00624338|579810481|FG002|Overall Study|Other|9|||
160570379|NCT00624338|579810479|FG000|Overall Study|Randomized but not treated|2|||
160570380|NCT00624338|579810480|FG001|Overall Study|Randomized but not treated|1|||
160570381|NCT00624338|579810481|FG002|Overall Study|Randomized but not treated|3|||
160570382|NCT01548638|579810482|FG000|Overall Study|Protocol Violation|3|||
160570383|NCT01548638|579810482|FG000|Overall Study|Withdrawal by Subject|1|||
160570384|NCT01476787|579810485|FG000|Treatment|Progression|64|||
160570385|NCT01476787|579810486|FG001|Treatment|Progression|71|||
160570386|NCT01476787|579810485|FG000|Treatment|Toxicity|44|||
160570387|NCT01476787|579810486|FG001|Treatment|Toxicity|16|||
160570388|NCT01476787|579810485|FG000|Treatment|Death|0|||
160570389|NCT01476787|579810486|FG001|Treatment|Death|1|||
160570390|NCT01476787|579810485|FG000|Treatment|Withdrawal by Subject|3|||
160570391|NCT01476787|579810486|FG001|Treatment|Withdrawal by Subject|14|||
160570392|NCT01476787|579810485|FG000|Treatment|Major protocol violation|1|||
160570393|NCT01476787|579810486|FG001|Treatment|Major protocol violation|6|||
160570394|NCT01476787|579810485|FG000|Treatment|Other reasons|10|||
160570395|NCT01476787|579810486|FG001|Treatment|Other reasons|22|||
160570396|NCT01476787|579810485|FG000|Treatment|Concurrent illness|12|||
160570397|NCT01476787|579810486|FG001|Treatment|Concurrent illness|9|||
160570398|NCT01476787|579810485|FG000|Treatment|Insufficient response|15|||
160570399|NCT01476787|579810486|FG001|Treatment|Insufficient response|3|||
160570400|NCT01476787|579810485|FG000|Treatment|Voluntary treatment discontinuation|8|||
160570401|NCT01476787|579810486|FG001|Treatment|Voluntary treatment discontinuation|4|||
160570402|NCT00144300|579810497|FG000|Overall Study|Adverse Event|18|||
160570403|NCT00144300|579810498|FG001|Overall Study|Adverse Event|16|||
160570404|NCT00144300|579810497|FG000|Overall Study|Protocol Violation|1|||
160909916|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
160909917|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
160909918|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
160909919|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
160909920|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
160909921|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
160909922|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
160909923|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
160909924|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
160909925|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
160909926|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
160909927|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
160909928|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
160909929|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
160909930|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
160909931|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
160909932|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
160909933|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
160909934|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
160909935|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
160909936|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
160909937|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
160909938|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
160909939|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
160909940|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
160909941|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
160909942|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
160909943|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
160909944|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
160909945|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
160909946|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
160909947|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
160909948|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
160909949|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
160570405|NCT00144300|579810498|FG001|Overall Study|Protocol Violation|3|||
160909950|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
160570406|NCT00144300|579810497|FG000|Overall Study|Lost to Follow-up|3|||
160570407|NCT00144300|579810498|FG001|Overall Study|Lost to Follow-up|0|||
160570408|NCT00144300|579810497|FG000|Overall Study|Withdrawal by Subject|6|||
160652728|NCT00365352|580108719|FG001|Overall Study|Lost to Follow-up|1|||
160570409|NCT00144300|579810498|FG001|Overall Study|Withdrawal by Subject|6|||
160570410|NCT00144300|579810497|FG000|Overall Study|Other reason (not specified)|1|||
160570411|NCT00144300|579810498|FG001|Overall Study|Other reason (not specified)|3|||
160570412|NCT02403206|579810500|FG000|Overall Study|Lost to Follow-up|4|||
160570413|NCT02403206|579810501|FG001|Overall Study|Lost to Follow-up|3|||
160453131|NCT03910478|579389700|FG000|Overall Study|Physician Decision|5|||
160909951|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
160909952|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
160909953|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
160909954|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
160909955|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
160909956|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
160909957|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Other|0|||
160909958|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Other|0|||
160909959|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Other|0|||
160909960|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Other|0|||
160909961|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Other|2|||
160909962|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Other|2|||
160909963|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Death|0|||
160909964|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Death|0|||
160909965|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Death|0|||
160909966|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Death|0|||
160909967|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Death|0|||
160909968|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Death|3|||
160909969|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
160909970|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
160909971|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
160909972|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
160909973|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
160909974|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
160909975|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
160909976|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
160909977|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
160909978|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
160909979|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
160909980|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
160909981|NCT04605484|581066280|FG000|Overall Study|Lost to Follow-up|0|||
160909982|NCT04605484|581066281|FG001|Overall Study|Lost to Follow-up|1|||
160909983|NCT04605484|581066282|FG002|Overall Study|Lost to Follow-up|1|||
160909984|NCT04605484|581066280|FG000|Overall Study|Other|0|||
160909985|NCT04605484|581066281|FG001|Overall Study|Other|1|||
160909986|NCT04605484|581066282|FG002|Overall Study|Other|0|||
160909987|NCT04171531|581066285|FG000|Overall Study|Lost to Follow-up|4|||
160909988|NCT04171531|581066286|FG001|Overall Study|Lost to Follow-up|5|||
160909989|NCT04171531|581066285|FG000|Overall Study|Consent only through 6 months|1|||
160909990|NCT04171531|581066286|FG001|Overall Study|Consent only through 6 months|1|||
160909991|NCT04171531|581066285|FG000|Overall Study|Insurance did not cover procedure|0|||
160909992|NCT04171531|581066286|FG001|Overall Study|Insurance did not cover procedure|1|||
160909993|NCT04171531|581066285|FG000|Overall Study|Physician Decision|0|||
160909994|NCT04171531|581066286|FG001|Overall Study|Physician Decision|3|||
160909995|NCT04171531|581066285|FG000|Overall Study|Withdrawal by Subject|1|||
160909996|NCT04171531|581066286|FG001|Overall Study|Withdrawal by Subject|5|||
160909997|NCT05537883|581066287|FG000|Overall Study|revisional surgery|4|||
160909998|NCT05537883|581066288|FG001|Overall Study|revisional surgery|2|||
160995158|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Death|1|||
160995159|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Death|1|||
160995160|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Death|1|||
160995161|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Death|0|||
160995162|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Death|0|||
160995163|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Death|0|||
160995164|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
160995165|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
160995166|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
160995167|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
160995168|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
160995169|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
160453132|NCT03910478|579389701|FG001|Overall Study|Physician Decision|0|||
160453133|NCT03910478|579389700|FG000|Overall Study|Protocol Violation|1|||
160453134|NCT03910478|579389701|FG001|Overall Study|Protocol Violation|0|||
160453135|NCT03910478|579389700|FG000|Overall Study|Failure to meet continuation criteria|2|||
160453136|NCT03910478|579389701|FG001|Overall Study|Failure to meet continuation criteria|0|||
160909999|NCT05537883|581066287|FG000|Overall Study|surgeries were cancelled|0|||
160453137|NCT03910478|579389700|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
160453138|NCT03910478|579389701|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
160453139|NCT03478956|579389703|FG000|Randomized Treatment Period|Adverse Event|1|||
160453140|NCT03478956|579389704|FG001|Randomized Treatment Period|Adverse Event|0|||
160910000|NCT05537883|581066288|FG001|Overall Study|surgeries were cancelled|2|||
160910001|NCT05537883|581066287|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
160910002|NCT05537883|581066288|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
160910003|NCT03366337|581066289|FG000|Overall Study|Lost to Follow-up|1|||
160910004|NCT03366337|581066290|FG001|Overall Study|Lost to Follow-up|0|||
160910005|NCT03366337|581066291|FG002|Overall Study|Lost to Follow-up|1|||
160910006|NCT03366337|581066292|FG003|Overall Study|Lost to Follow-up|0|||
160910007|NCT03366337|581066289|FG000|Overall Study|Withdrawal by Subject|2|||
160910008|NCT03366337|581066290|FG001|Overall Study|Withdrawal by Subject|0|||
160910009|NCT03366337|581066291|FG002|Overall Study|Withdrawal by Subject|1|||
160910010|NCT03366337|581066292|FG003|Overall Study|Withdrawal by Subject|1|||
160910011|NCT05288062|581066293|FG000|Overall Study|Ineligible|0|||
160910012|NCT05288062|581066294|FG001|Overall Study|Ineligible|0|||
160910013|NCT05288062|581066295|FG002|Overall Study|Ineligible|1|||
160910014|NCT05288062|581066296|FG003|Overall Study|Ineligible|0|||
160910015|NCT05288062|581066293|FG000|Overall Study|Withdrawal by Subject|0|||
160910016|NCT05288062|581066294|FG001|Overall Study|Withdrawal by Subject|0|||
160910017|NCT05288062|581066295|FG002|Overall Study|Withdrawal by Subject|1|||
160910018|NCT05288062|581066296|FG003|Overall Study|Withdrawal by Subject|0|||
160910019|NCT00040664|581066303|FG000|Overall Study|Adverse Event|12|||
160910020|NCT00040664|581066304|FG001|Overall Study|Adverse Event|3|||
160910021|NCT00040664|581066305|FG002|Overall Study|Adverse Event|2|||
160910022|NCT00040664|581066306|FG003|Overall Study|Adverse Event|7|||
160910023|NCT00040664|581066303|FG000|Overall Study|Lack of Efficacy|9|||
160910024|NCT00040664|581066304|FG001|Overall Study|Lack of Efficacy|2|||
160910025|NCT00040664|581066305|FG002|Overall Study|Lack of Efficacy|3|||
160910026|NCT00040664|581066306|FG003|Overall Study|Lack of Efficacy|4|||
160910027|NCT00040664|581066303|FG000|Overall Study|Insufficient CD4 response|1|||
160910028|NCT00040664|581066304|FG001|Overall Study|Insufficient CD4 response|0|||
160910029|NCT00040664|581066305|FG002|Overall Study|Insufficient CD4 response|1|||
160910030|NCT00040664|581066306|FG003|Overall Study|Insufficient CD4 response|0|||
160910031|NCT00040664|581066303|FG000|Overall Study|Lost to Follow-up|4|||
160910032|NCT00040664|581066304|FG001|Overall Study|Lost to Follow-up|2|||
160910033|NCT00040664|581066305|FG002|Overall Study|Lost to Follow-up|0|||
160910034|NCT00040664|581066306|FG003|Overall Study|Lost to Follow-up|2|||
160910035|NCT00040664|581066303|FG000|Overall Study|Protocol Violation|2|||
160910036|NCT00040664|581066304|FG001|Overall Study|Protocol Violation|1|||
160910037|NCT00040664|581066305|FG002|Overall Study|Protocol Violation|0|||
160910038|NCT00040664|581066306|FG003|Overall Study|Protocol Violation|1|||
160910039|NCT00040664|581066303|FG000|Overall Study|Withdrawal by Subject|7|||
160910040|NCT00040664|581066304|FG001|Overall Study|Withdrawal by Subject|0|||
160910041|NCT00040664|581066305|FG002|Overall Study|Withdrawal by Subject|3|||
160910042|NCT00040664|581066306|FG003|Overall Study|Withdrawal by Subject|4|||
160910043|NCT00040664|581066303|FG000|Overall Study|Pregnancy|3|||
160910044|NCT00040664|581066304|FG001|Overall Study|Pregnancy|0|||
160910045|NCT00040664|581066305|FG002|Overall Study|Pregnancy|0|||
160910046|NCT00040664|581066306|FG003|Overall Study|Pregnancy|3|||
160910047|NCT00040664|581066303|FG000|Overall Study|Medication adherence/compliance problems|8|||
160910048|NCT00040664|581066304|FG001|Overall Study|Medication adherence/compliance problems|2|||
160910049|NCT00040664|581066305|FG002|Overall Study|Medication adherence/compliance problems|1|||
160910050|NCT00040664|581066306|FG003|Overall Study|Medication adherence/compliance problems|5|||
160910051|NCT00040664|581066303|FG000|Overall Study|Poor taste|2|||
160910052|NCT00040664|581066304|FG001|Overall Study|Poor taste|0|||
160910053|NCT00040664|581066305|FG002|Overall Study|Poor taste|2|||
160910054|NCT00040664|581066306|FG003|Overall Study|Poor taste|0|||
160910055|NCT00040664|581066303|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
160910056|NCT00040664|581066304|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
160910057|NCT00040664|581066305|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
160910058|NCT00040664|581066306|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
160910059|NCT00040664|581066303|FG000|Overall Study|Change of formulation|2|||
160910060|NCT00040664|581066304|FG001|Overall Study|Change of formulation|2|||
160910061|NCT00040664|581066305|FG002|Overall Study|Change of formulation|0|||
160910062|NCT00040664|581066306|FG003|Overall Study|Change of formulation|0|||
160910063|NCT00040664|581066303|FG000|Overall Study|Non-viability of oral suspension|1|||
160910064|NCT00040664|581066304|FG001|Overall Study|Non-viability of oral suspension|0|||
160910065|NCT00040664|581066305|FG002|Overall Study|Non-viability of oral suspension|1|||
160910066|NCT00040664|581066306|FG003|Overall Study|Non-viability of oral suspension|0|||
160652729|NCT00365352|580108720|FG002|Overall Study|Lost to Follow-up|0|||
160910067|NCT00729651|581066307|FG000|Overall Study|Withdrawal by Subject|5|||
160910068|NCT00729651|581066308|FG001|Overall Study|Withdrawal by Subject|6|||
160910069|NCT00729651|581066307|FG000|Overall Study|Lost to Follow-up|5|||
160910070|NCT00729651|581066308|FG001|Overall Study|Lost to Follow-up|4|||
160910071|NCT00729651|581066307|FG000|Overall Study|Protocol Violation|0|||
160910072|NCT00729651|581066308|FG001|Overall Study|Protocol Violation|1|||
160910073|NCT00729651|581066307|FG000|Overall Study|Adverse Event|7|||
160910074|NCT00729651|581066308|FG001|Overall Study|Adverse Event|3|||
160570414|NCT02403206|579810500|FG000|Overall Study|Physician Decision|2|||
160570415|NCT02403206|579810501|FG001|Overall Study|Physician Decision|0|||
160910075|NCT00729651|581066307|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
160910076|NCT00729651|581066308|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
160910077|NCT00729651|581066307|FG000|Overall Study|Subject's private reason|2|||
160910078|NCT00729651|581066308|FG001|Overall Study|Subject's private reason|0|||
160910079|NCT01874054|581066309|FG000|Overall Study|Withdrawal by Subject|3|||
160910080|NCT01874054|581066309|FG000|Overall Study|Study Termination by Sponsor|42|||
160910081|NCT01874054|581066309|FG000|Overall Study|Lost to Follow-up|5|||
160910082|NCT01874054|581066309|FG000|Overall Study|Death|5|||
160910083|NCT03334539|581066311|FG000|Overall Study|Adverse Event|3|||
160910084|NCT03334539|581066312|FG001|Overall Study|Adverse Event|5|||
160910085|NCT03334539|581066313|FG002|Overall Study|Adverse Event|0|||
160910086|NCT03334539|581066311|FG000|Overall Study|Withdrawal by Subject|0|||
160910087|NCT03334539|581066312|FG001|Overall Study|Withdrawal by Subject|1|||
160910088|NCT03334539|581066313|FG002|Overall Study|Withdrawal by Subject|1|||
160910089|NCT03334539|581066311|FG000|Overall Study|Administrative Reasons|1|||
160910090|NCT03334539|581066312|FG001|Overall Study|Administrative Reasons|0|||
160910091|NCT03334539|581066313|FG002|Overall Study|Administrative Reasons|0|||
160910092|NCT03334539|581066311|FG000|Overall Study|Hypertension Not Controlled|0|||
160910093|NCT03334539|581066312|FG001|Overall Study|Hypertension Not Controlled|1|||
160910094|NCT03334539|581066313|FG002|Overall Study|Hypertension Not Controlled|0|||
160910095|NCT00256750|581066315|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
160910096|NCT00256750|581066316|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
160910097|NCT00256750|581066317|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
160910098|NCT00256750|581066315|FG000|Transplanted Pre-Treatment|Other|2|||
160910099|NCT00256750|581066316|FG001|Transplanted Pre-Treatment|Other|0|||
160910100|NCT00256750|581066317|FG002|Transplanted Pre-Treatment|Other|0|||
160910101|NCT00256750|581066315|FG000|Transplanted Pre-Treatment|Death|1|||
160910102|NCT00256750|581066316|FG001|Transplanted Pre-Treatment|Death|0|||
160910103|NCT00256750|581066317|FG002|Transplanted Pre-Treatment|Death|0|||
160910104|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
160910105|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
160910106|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
160910107|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Death|3|||
160910108|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Death|2|||
160910109|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Death|4|||
160910110|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
160910111|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
160910112|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
160910113|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
160910114|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
160910115|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
160910116|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Other|5|||
160910117|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Other|4|||
160910118|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Other|2|||
160910119|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
160910120|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
160910121|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
160910122|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
160910123|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
160995170|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
160995171|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
160995172|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
160995173|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
160995174|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
160995175|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
160995176|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
160995177|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
160995178|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
160570416|NCT02403206|579810500|FG000|Overall Study|Withdrawal by Subject|3|||
160570417|NCT02403206|579810501|FG001|Overall Study|Withdrawal by Subject|3|||
160570418|NCT02403206|579810500|FG000|Overall Study|Reason not given|2|||
160570419|NCT02403206|579810501|FG001|Overall Study|Reason not given|4|||
160570420|NCT01877655|579810502|FG000|Overall Study|Death|57|||
160910124|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
160570421|NCT01877655|579810503|FG001|Overall Study|Death|52|||
160570422|NCT01877655|579810502|FG000|Overall Study|Withdrawal by Subject|18|||
160570423|NCT01877655|579810503|FG001|Overall Study|Withdrawal by Subject|26|||
160910125|NCT00256750|581066315|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
160910126|NCT00256750|581066316|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
160910127|NCT00256750|581066317|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
160910128|NCT00256750|581066315|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
160570424|NCT01877655|579810502|FG000|Overall Study|Physician Decision|11|||
160910129|NCT00256750|581066316|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
160910130|NCT00256750|581066317|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
160910131|NCT00256750|581066315|FG000|Post-Transplant Treated (24 Months)|Death|3|||
160910132|NCT00256750|581066316|FG001|Post-Transplant Treated (24 Months)|Death|0|||
160910133|NCT00256750|581066317|FG002|Post-Transplant Treated (24 Months)|Death|0|||
160910134|NCT00256750|581066315|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
160910135|NCT00256750|581066316|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
160910136|NCT00256750|581066317|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
160910137|NCT00256750|581066315|FG000|Post-Transplant Treated (24 Months)|Other|2|||
160910138|NCT00256750|581066316|FG001|Post-Transplant Treated (24 Months)|Other|0|||
160910139|NCT00256750|581066317|FG002|Post-Transplant Treated (24 Months)|Other|1|||
160910140|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
160910141|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
160910142|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
160910143|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
160910144|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
160910145|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
160910146|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Death|0|||
160910147|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Death|2|||
160910148|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Death|1|||
160910149|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
160910150|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
160910151|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
160570425|NCT01877655|579810503|FG001|Overall Study|Physician Decision|10|||
160570426|NCT01877655|579810502|FG000|Overall Study|Miscellaneous|4|||
160570427|NCT01877655|579810503|FG001|Overall Study|Miscellaneous|4|||
160570428|NCT01877655|579810502|FG000|Overall Study|Randomized but Never Received Drug|8|||
160570429|NCT01877655|579810503|FG001|Overall Study|Randomized but Never Received Drug|5|||
160570430|NCT00095121|579810506|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
160570431|NCT00095121|579810507|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
160570432|NCT00095121|579810506|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
160570433|NCT00095121|579810507|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
160570434|NCT03497689|579810511|FG000|Overall Study|Adverse Event|2|||
160570435|NCT03497689|579810511|FG000|Overall Study|Death|1|||
160570436|NCT03497689|579810511|FG000|Overall Study|Physician Decision|1|||
160910152|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
160910153|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
160910154|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
160910155|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
160910156|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
160910157|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
160910158|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Other|0|||
160910159|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Other|1|||
160910160|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Other|1|||
160910161|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
160910162|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
160910163|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
160910164|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
160910165|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
160910166|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
160910167|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
160570437|NCT03497689|579810511|FG000|Overall Study|Withdrawal by Subject|1|||
160570438|NCT03497689|579810511|FG000|Overall Study|Protocol Violation|2|||
160910168|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
160910169|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
160910170|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
160910171|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
160910172|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
160910173|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
160910174|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
160910175|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
160910176|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
160910177|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
160910178|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
160910179|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
160910180|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
160453141|NCT03478956|579389705|FG002|Randomized Treatment Period|Adverse Event|0|||
160570439|NCT03567187|579810512|FG000|Overall Study|Lost to Follow-up|18|||
160995179|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
160995180|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
160995181|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
160995182|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
160995183|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
160995184|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
160995185|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
160995186|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
160910181|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
160910182|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
160910183|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
160910184|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
160910185|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
160910186|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
160910187|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
160910188|NCT00558558|581066321|FG000|Overall Study|Unable to swallow|1|||
160910189|NCT00558558|581066321|FG000|Overall Study|Withdrawal by Subject|1|||
160910190|NCT00558558|581066321|FG000|Overall Study|Lack of Efficacy|4|||
160910191|NCT02549937|581066323|FG000|Overall Study|Death|0|||
160995187|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
160995188|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
160995189|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
160995190|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
160995191|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
160910192|NCT02549937|581066324|FG001|Overall Study|Death|1|||
160910193|NCT02549937|581066325|FG002|Overall Study|Death|0|||
160910194|NCT02549937|581066326|FG003|Overall Study|Death|1|||
160910195|NCT02549937|581066327|FG004|Overall Study|Death|0|||
160910196|NCT02549937|581066328|FG005|Overall Study|Death|8|||
160910197|NCT02549937|581066329|FG006|Overall Study|Death|0|||
160910198|NCT02549937|581066330|FG007|Overall Study|Death|0|||
160910199|NCT02549937|581066331|FG008|Overall Study|Death|19|||
160910200|NCT02549937|581066323|FG000|Overall Study|No follow up required|3|||
160910201|NCT02549937|581066324|FG001|Overall Study|No follow up required|6|||
160910202|NCT02549937|581066325|FG002|Overall Study|No follow up required|3|||
160910203|NCT02549937|581066326|FG003|Overall Study|No follow up required|8|||
160910204|NCT02549937|581066327|FG004|Overall Study|No follow up required|12|||
160910205|NCT02549937|581066328|FG005|Overall Study|No follow up required|21|||
160910206|NCT02549937|581066329|FG006|Overall Study|No follow up required|9|||
160910207|NCT02549937|581066330|FG007|Overall Study|No follow up required|11|||
160910208|NCT02549937|581066331|FG008|Overall Study|No follow up required|0|||
160910209|NCT02549937|581066323|FG000|Overall Study|Other|0|||
160910210|NCT02549937|581066324|FG001|Overall Study|Other|0|||
160910211|NCT02549937|581066325|FG002|Overall Study|Other|0|||
160910212|NCT02549937|581066326|FG003|Overall Study|Other|0|||
160910213|NCT02549937|581066327|FG004|Overall Study|Other|1|||
160910214|NCT02549937|581066328|FG005|Overall Study|Other|0|||
160861297|NCT03137992|580885249|FG000|Washout Period 1|COPD Exacerbation|1|||
160861298|NCT03137992|580885250|FG001|Washout Period 1|COPD Exacerbation|1|||
160861299|NCT03137992|580885251|FG002|Washout Period 1|COPD Exacerbation|1|||
160861300|NCT03137992|580885252|FG003|Washout Period 1|COPD Exacerbation|0|||
160910215|NCT02549937|581066329|FG006|Overall Study|Other|3|||
160910216|NCT02549937|581066330|FG007|Overall Study|Other|2|||
160910217|NCT02549937|581066331|FG008|Overall Study|Other|3|||
160910218|NCT02549937|581066323|FG000|Overall Study|Lost to Follow-up|0|||
160910219|NCT02549937|581066324|FG001|Overall Study|Lost to Follow-up|0|||
160910220|NCT02549937|581066325|FG002|Overall Study|Lost to Follow-up|0|||
160453142|NCT03478956|579389706|FG003|Randomized Treatment Period|Adverse Event|0|||
160861301|NCT03137992|580885253|FG004|Washout Period 1|COPD Exacerbation|1|||
160861302|NCT03137992|580885254|FG005|Washout Period 1|COPD Exacerbation|1|||
160861303|NCT03137992|580885249|FG000|Washout Period 1|Subject Noncompliance|1|||
160861304|NCT03137992|580885250|FG001|Washout Period 1|Subject Noncompliance|0|||
160861305|NCT03137992|580885251|FG002|Washout Period 1|Subject Noncompliance|0|||
160861306|NCT03137992|580885252|FG003|Washout Period 1|Subject Noncompliance|0|||
160861307|NCT03137992|580885253|FG004|Washout Period 1|Subject Noncompliance|1|||
160861308|NCT03137992|580885254|FG005|Washout Period 1|Subject Noncompliance|0|||
160861309|NCT03137992|580885249|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
160861310|NCT03137992|580885250|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
160861311|NCT03137992|580885251|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
160861312|NCT03137992|580885252|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
160861313|NCT03137992|580885253|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
160861314|NCT03137992|580885254|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
160861315|NCT03137992|580885249|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
160861316|NCT03137992|580885250|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
160910221|NCT02549937|581066326|FG003|Overall Study|Lost to Follow-up|0|||
160910222|NCT02549937|581066327|FG004|Overall Study|Lost to Follow-up|0|||
160910223|NCT02549937|581066328|FG005|Overall Study|Lost to Follow-up|0|||
160910224|NCT02549937|581066329|FG006|Overall Study|Lost to Follow-up|0|||
160910225|NCT02549937|581066330|FG007|Overall Study|Lost to Follow-up|0|||
160910226|NCT02549937|581066331|FG008|Overall Study|Lost to Follow-up|3|||
160910227|NCT02549937|581066323|FG000|Overall Study|Withdrawal by Subject|0|||
160910228|NCT02549937|581066324|FG001|Overall Study|Withdrawal by Subject|0|||
160910229|NCT02549937|581066325|FG002|Overall Study|Withdrawal by Subject|0|||
160910230|NCT02549937|581066326|FG003|Overall Study|Withdrawal by Subject|0|||
160910231|NCT02549937|581066327|FG004|Overall Study|Withdrawal by Subject|0|||
160910232|NCT02549937|581066328|FG005|Overall Study|Withdrawal by Subject|1|||
160910233|NCT02549937|581066329|FG006|Overall Study|Withdrawal by Subject|4|||
160910234|NCT02549937|581066330|FG007|Overall Study|Withdrawal by Subject|3|||
160910235|NCT02549937|581066331|FG008|Overall Study|Withdrawal by Subject|2|||
160910236|NCT02549937|581066323|FG000|Overall Study|Sponsor Decision|0|||
160910237|NCT02549937|581066324|FG001|Overall Study|Sponsor Decision|0|||
160910238|NCT02549937|581066325|FG002|Overall Study|Sponsor Decision|0|||
160910239|NCT02549937|581066326|FG003|Overall Study|Sponsor Decision|0|||
160910240|NCT02549937|581066327|FG004|Overall Study|Sponsor Decision|0|||
160910241|NCT02549937|581066328|FG005|Overall Study|Sponsor Decision|0|||
160910242|NCT02549937|581066329|FG006|Overall Study|Sponsor Decision|0|||
160910243|NCT02549937|581066330|FG007|Overall Study|Sponsor Decision|0|||
160910244|NCT02549937|581066331|FG008|Overall Study|Sponsor Decision|6|||
160910245|NCT02144012|581066332|FG000|Overall Study|Adverse Event|1|||
160910246|NCT02144012|581066333|FG001|Overall Study|Adverse Event|0|||
160910247|NCT02144012|581066332|FG000|Overall Study|Death|1|||
160910248|NCT02144012|581066333|FG001|Overall Study|Death|0|||
160910249|NCT02144012|581066332|FG000|Overall Study|Withdrawal by Subject|11|||
160910250|NCT02144012|581066333|FG001|Overall Study|Withdrawal by Subject|3|||
160910251|NCT02144012|581066332|FG000|Overall Study|Study Terminated by Sponsor|18|||
160910252|NCT02144012|581066333|FG001|Overall Study|Study Terminated by Sponsor|12|||
160910253|NCT02144012|581066332|FG000|Overall Study|Other|3|||
160910254|NCT02144012|581066333|FG001|Overall Study|Other|0|||
160910255|NCT00317356|581066334|FG000|Overall Study|Adverse Event|0|||
160910256|NCT00317356|581066335|FG001|Overall Study|Adverse Event|0|||
160910257|NCT00317356|581066336|FG002|Overall Study|Adverse Event|1|||
160910258|NCT00317356|581066337|FG003|Overall Study|Adverse Event|0|||
160910259|NCT00317356|581066334|FG000|Overall Study|Lack of Efficacy|1|||
160910260|NCT00317356|581066335|FG001|Overall Study|Lack of Efficacy|1|||
160910261|NCT00317356|581066336|FG002|Overall Study|Lack of Efficacy|0|||
160910262|NCT00317356|581066337|FG003|Overall Study|Lack of Efficacy|3|||
160910263|NCT00317356|581066334|FG000|Overall Study|Physician Decision|0|||
160910264|NCT00317356|581066335|FG001|Overall Study|Physician Decision|1|||
160910265|NCT00317356|581066336|FG002|Overall Study|Physician Decision|0|||
160910266|NCT00317356|581066337|FG003|Overall Study|Physician Decision|0|||
160910267|NCT01943292|581067861|FG000|Overall Study|Withdrawal by Subject|1|||
160910268|NCT01943292|581067862|FG001|Overall Study|Withdrawal by Subject|0|||
160910269|NCT01943292|581067863|FG002|Overall Study|Withdrawal by Subject|0|||
160910270|NCT00911820|581067864|FG000|Overall Study|RECIST progression|12|||
160910271|NCT00911820|581067865|FG001|Overall Study|RECIST progression|8|||
160910272|NCT00911820|581067864|FG000|Overall Study|Adverse Event|8|||
160910273|NCT00911820|581067865|FG001|Overall Study|Adverse Event|8|||
160910274|NCT00911820|581067864|FG000|Overall Study|Clinical Progression|7|||
160910275|NCT00911820|581067865|FG001|Overall Study|Clinical Progression|5|||
160910276|NCT00911820|581067864|FG000|Overall Study|Physician Decision|5|||
160910277|NCT00911820|581067865|FG001|Overall Study|Physician Decision|9|||
160910278|NCT00911820|581067864|FG000|Overall Study|Decline in Performance Status|4|||
160910279|NCT00911820|581067865|FG001|Overall Study|Decline in Performance Status|2|||
160910280|NCT00911820|581067864|FG000|Overall Study|Withdrawal by Subject|3|||
160910281|NCT00911820|581067865|FG001|Overall Study|Withdrawal by Subject|4|||
160910282|NCT00911820|581067864|FG000|Overall Study|Death|1|||
160910283|NCT00911820|581067865|FG001|Overall Study|Death|2|||
160910284|NCT00911820|581067864|FG000|Overall Study|Pursue surgery|1|||
160910285|NCT00911820|581067865|FG001|Overall Study|Pursue surgery|1|||
160910286|NCT00911820|581067864|FG000|Overall Study|Pursue Radiation|1|||
160910287|NCT00911820|581067865|FG001|Overall Study|Pursue Radiation|0|||
160910288|NCT00911820|581067864|FG000|Overall Study|Still on Therapy|2|||
160910289|NCT00911820|581067865|FG001|Overall Study|Still on Therapy|2|||
160910290|NCT00911820|581067864|FG000|Overall Study|Pathology Not Confirmed|1|||
160910291|NCT00911820|581067865|FG001|Overall Study|Pathology Not Confirmed|0|||
160910292|NCT00911820|581067864|FG000|Overall Study|Withdraw before Receive Treatment|0|||
160910293|NCT00911820|581067865|FG001|Overall Study|Withdraw before Receive Treatment|2|||
160910294|NCT00996216|581067866|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
160910295|NCT00996216|581067866|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
160910296|NCT00996216|581067866|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
160910297|NCT00187486|581067873|FG000|Overall Study|Protocol Violation|1|||
160910298|NCT02483520|581067874|FG000|Overall Study|Lost to Follow-up|3|||
160910299|NCT02483520|581067875|FG001|Overall Study|Lost to Follow-up|4|||
160910300|NCT02483520|581067874|FG000|Overall Study|Withdrawal by Subject|4|||
160910301|NCT02483520|581067875|FG001|Overall Study|Withdrawal by Subject|14|||
160910302|NCT02483520|581067874|FG000|Overall Study|Hospitalized|2|||
160910303|NCT02483520|581067875|FG001|Overall Study|Hospitalized|3|||
160910304|NCT02483520|581067874|FG000|Overall Study|Moved to LTC|2|||
160910305|NCT02483520|581067875|FG001|Overall Study|Moved to LTC|3|||
160910306|NCT01104493|581067882|FG000|Overall Study|Lost to Follow-up|0|||
160910307|NCT01104493|581067883|FG001|Overall Study|Lost to Follow-up|2|||
160910308|NCT03489720|581067885|FG000|Overall Study|Withdrawal by Subject|2|||
160910309|NCT03489720|581067886|FG001|Overall Study|Withdrawal by Subject|0|||
160910310|NCT02511184|581067887|FG000|Overall Study|Death|1|||
160910311|NCT02511184|581067888|FG001|Overall Study|Death|0|||
160910312|NCT02511184|581067887|FG000|Overall Study|Lost to Follow-up|0|||
160910313|NCT02511184|581067888|FG001|Overall Study|Lost to Follow-up|1|||
160910314|NCT02511184|581067887|FG000|Overall Study|Study terminated by sponsor|1|||
160910315|NCT02511184|581067888|FG001|Overall Study|Study terminated by sponsor|5|||
160910316|NCT02511184|581067887|FG000|Overall Study|Withdrawal by Subject|0|||
160910317|NCT02511184|581067888|FG001|Overall Study|Withdrawal by Subject|1|||
160910318|NCT01806545|581067889|FG000|Overall Study|Adverse Event|2|||
160910319|NCT01806545|581067890|FG001|Overall Study|Adverse Event|3|||
160910320|NCT01806545|581067889|FG000|Overall Study|Lost to Follow-up|1|||
160910321|NCT01806545|581067890|FG001|Overall Study|Lost to Follow-up|0|||
160910322|NCT01806545|581067889|FG000|Overall Study|Withdrawal by Subject|3|||
160910323|NCT01806545|581067890|FG001|Overall Study|Withdrawal by Subject|2|||
160910324|NCT00884312|581067892|FG000|Overall Study|Non-fatal Progressive Disease|0|||
160910325|NCT00884312|581067893|FG001|Overall Study|Non-fatal Progressive Disease|8|||
160910326|NCT00884312|581067892|FG000|Overall Study|Fatal Progressive Disease|0|||
160910327|NCT00884312|581067893|FG001|Overall Study|Fatal Progressive Disease|1|||
160910328|NCT00884312|581067892|FG000|Overall Study|Non-fatal Adverse Event|1|||
160910329|NCT00884312|581067893|FG001|Overall Study|Non-fatal Adverse Event|0|||
160910330|NCT00884312|581067892|FG000|Overall Study|Fatal Adverse Event|1|||
160910331|NCT00884312|581067893|FG001|Overall Study|Fatal Adverse Event|4|||
160910332|NCT00884312|581067892|FG000|Overall Study|Withdrawal by Subject|0|||
160910333|NCT00884312|581067893|FG001|Overall Study|Withdrawal by Subject|6|||
160910334|NCT00884312|581067892|FG000|Overall Study|Physician Decision|0|||
160910335|NCT00884312|581067893|FG001|Overall Study|Physician Decision|1|||
160910336|NCT00884312|581067892|FG000|Overall Study|Other|0|||
160910337|NCT00884312|581067893|FG001|Overall Study|Other|4|||
160910338|NCT00884312|581067892|FG000|Overall Study|Did Not Receive Study Drug|0|||
160910339|NCT00884312|581067893|FG001|Overall Study|Did Not Receive Study Drug|1|||
160910340|NCT03521934|581067904|FG000|Overall Study|Death|65|||
160910341|NCT03521934|581067905|FG001|Overall Study|Death|73|||
160910342|NCT03521934|581067904|FG000|Overall Study|Withdrawal by Subject|18|||
160910343|NCT03521934|581067905|FG001|Overall Study|Withdrawal by Subject|23|||
160910344|NCT03521934|581067904|FG000|Overall Study|Site Terminated by Sponsor|39|||
160910345|NCT03521934|581067905|FG001|Overall Study|Site Terminated by Sponsor|35|||
160910346|NCT03521934|581067904|FG000|Overall Study|Study Terminated by Sponsor|483|||
160910347|NCT03521934|581067905|FG001|Overall Study|Study Terminated by Sponsor|477|||
160910348|NCT03521934|581067904|FG000|Overall Study|Reason not Specified|3|||
160910349|NCT03521934|581067905|FG001|Overall Study|Reason not Specified|6|||
160910350|NCT02101060|581067906|FG000|Overall Study|Adverse Event|1|||
160910351|NCT02101060|581067907|FG001|Overall Study|Adverse Event|0|||
160910352|NCT02101060|581067906|FG000|Overall Study|Withdrawal by Subject|1|||
160910353|NCT02101060|581067907|FG001|Overall Study|Withdrawal by Subject|1|||
160910354|NCT02101060|581067906|FG000|Overall Study|Lost to Follow-up|3|||
160910355|NCT02101060|581067907|FG001|Overall Study|Lost to Follow-up|3|||
160910356|NCT00284050|581067910|FG000|Overall Study|Adverse Event|1|||
160910357|NCT00284050|581067911|FG001|Overall Study|Adverse Event|1|||
160910358|NCT00284050|581067912|FG002|Overall Study|Adverse Event|1|||
160910359|NCT00284050|581067910|FG000|Overall Study|Lack of Efficacy|0|||
160910360|NCT00284050|581067911|FG001|Overall Study|Lack of Efficacy|1|||
160910361|NCT00284050|581067912|FG002|Overall Study|Lack of Efficacy|3|||
160910362|NCT00284050|581067910|FG000|Overall Study|Protocol Violation|0|||
160910363|NCT00284050|581067911|FG001|Overall Study|Protocol Violation|1|||
160910364|NCT00284050|581067912|FG002|Overall Study|Protocol Violation|2|||
160910365|NCT00284050|581067910|FG000|Overall Study|Withdrawal by Subject|2|||
160910366|NCT00284050|581067911|FG001|Overall Study|Withdrawal by Subject|2|||
160910367|NCT00284050|581067912|FG002|Overall Study|Withdrawal by Subject|2|||
160910368|NCT00284050|581067910|FG000|Overall Study|Lost to Follow-up|1|||
160910369|NCT00284050|581067911|FG001|Overall Study|Lost to Follow-up|0|||
160910370|NCT00284050|581067912|FG002|Overall Study|Lost to Follow-up|1|||
160910371|NCT00284050|581067910|FG000|Overall Study|Death|1|||
160910372|NCT00284050|581067911|FG001|Overall Study|Death|0|||
160910373|NCT00284050|581067912|FG002|Overall Study|Death|0|||
160910374|NCT00489541|581067915|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
160910375|NCT00489541|581067916|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
160910376|NCT00489541|581067915|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
160861317|NCT03137992|580885251|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
160861318|NCT03137992|580885252|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
160910377|NCT00489541|581067916|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
160910378|NCT00489541|581067915|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
160910379|NCT00489541|581067916|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
160910380|NCT00489541|581067915|FG000|12-Month Clinical Follow-up|Death|3|||
160910381|NCT00489541|581067916|FG001|12-Month Clinical Follow-up|Death|2|||
160910382|NCT00489541|581067915|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
160910383|NCT00489541|581067916|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
160910384|NCT00489541|581067915|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
160910385|NCT00489541|581067916|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
160910386|NCT01192516|581067918|FG000|Overall Study|Lost to Follow-up|7|||
160910387|NCT01192516|581067919|FG001|Overall Study|Lost to Follow-up|10|||
160910388|NCT01192516|581067920|FG002|Overall Study|Lost to Follow-up|7|||
160910389|NCT01192516|581067918|FG000|Overall Study|Withdrawal by Subject|4|||
160910390|NCT01192516|581067919|FG001|Overall Study|Withdrawal by Subject|4|||
160910391|NCT01192516|581067920|FG002|Overall Study|Withdrawal by Subject|1|||
160910392|NCT01192516|581067918|FG000|Overall Study|started new treatment|5|||
160910393|NCT01192516|581067919|FG001|Overall Study|started new treatment|1|||
160910394|NCT01192516|581067920|FG002|Overall Study|started new treatment|0|||
160910395|NCT01192516|581067918|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
160910396|NCT01192516|581067919|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
160910397|NCT01192516|581067920|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
160910398|NCT02627144|581067928|FG000|Overall Study|Serious adverse event|32|||
160910399|NCT02627144|581067928|FG000|Overall Study|Cancer progression|171|||
160910400|NCT02627144|581067928|FG000|Overall Study|Death from cancer|20|||
160910401|NCT02627144|581067928|FG000|Overall Study|Death from other cause|8|||
160910402|NCT02627144|581067928|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
160910403|NCT02627144|581067928|FG000|Overall Study|Administrative reasons|65|||
160910404|NCT02627144|581067928|FG000|Overall Study|Lost to Follow-up|8|||
160910405|NCT02627144|581067928|FG000|Overall Study|Enrolled, not treated|6|||
160910406|NCT02627144|581067928|FG000|Overall Study|Other|17|||
160910407|NCT01697566|581067936|FG000|Overall Study|Withdrawal by Subject|0|||
160910408|NCT01697566|581067937|FG001|Overall Study|Withdrawal by Subject|0|||
160910409|NCT01697566|581067938|FG002|Overall Study|Withdrawal by Subject|1|||
160861319|NCT03137992|580885253|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
160861320|NCT03137992|580885254|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
160861321|NCT03137992|580885249|FG000|Period 2 (Visit 3)|Adverse Event|0|||
160861322|NCT03137992|580885250|FG001|Period 2 (Visit 3)|Adverse Event|1|||
160861323|NCT03137992|580885251|FG002|Period 2 (Visit 3)|Adverse Event|0|||
160861324|NCT03137992|580885252|FG003|Period 2 (Visit 3)|Adverse Event|0|||
160861325|NCT03137992|580885253|FG004|Period 2 (Visit 3)|Adverse Event|0|||
160861326|NCT03137992|580885254|FG005|Period 2 (Visit 3)|Adverse Event|0|||
160861327|NCT03137992|580885249|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
160861328|NCT03137992|580885250|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
160861329|NCT03137992|580885251|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
160861330|NCT03137992|580885252|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
160861331|NCT03137992|580885253|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
160861332|NCT03137992|580885254|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
160861333|NCT03137992|580885249|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
160861334|NCT03137992|580885250|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
160861335|NCT03137992|580885251|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
160861336|NCT03137992|580885252|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
160861337|NCT03137992|580885253|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
160861338|NCT03137992|580885254|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
160861339|NCT03137992|580885249|FG000|Washout Period 2|COPD Exacerbation|1|||
160861340|NCT03137992|580885250|FG001|Washout Period 2|COPD Exacerbation|1|||
160861341|NCT03137992|580885251|FG002|Washout Period 2|COPD Exacerbation|0|||
160861342|NCT03137992|580885252|FG003|Washout Period 2|COPD Exacerbation|0|||
160861343|NCT03137992|580885253|FG004|Washout Period 2|COPD Exacerbation|1|||
160861344|NCT03137992|580885254|FG005|Washout Period 2|COPD Exacerbation|0|||
160861345|NCT03137992|580885249|FG000|Washout Period 2|Subject Non-compliance|0|||
160861346|NCT03137992|580885250|FG001|Washout Period 2|Subject Non-compliance|1|||
160861347|NCT03137992|580885251|FG002|Washout Period 2|Subject Non-compliance|0|||
160861348|NCT03137992|580885252|FG003|Washout Period 2|Subject Non-compliance|0|||
160861349|NCT03137992|580885253|FG004|Washout Period 2|Subject Non-compliance|0|||
160861350|NCT03137992|580885254|FG005|Washout Period 2|Subject Non-compliance|0|||
160861351|NCT03137992|580885249|FG000|Washout Period 2|Adverse Event|0|||
160861352|NCT03137992|580885250|FG001|Washout Period 2|Adverse Event|0|||
160861353|NCT03137992|580885251|FG002|Washout Period 2|Adverse Event|0|||
160861354|NCT03137992|580885252|FG003|Washout Period 2|Adverse Event|1|||
160861355|NCT03137992|580885253|FG004|Washout Period 2|Adverse Event|1|||
160861356|NCT03137992|580885254|FG005|Washout Period 2|Adverse Event|0|||
160453143|NCT03478956|579389703|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
160453144|NCT03478956|579389704|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
160453145|NCT03478956|579389705|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
160453146|NCT03478956|579389706|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
160453147|NCT03478956|579389703|FG000|Open Label Extension Period|Adverse Event|0|||
160453148|NCT03478956|579389704|FG001|Open Label Extension Period|Adverse Event|0|||
160453149|NCT03478956|579389705|FG002|Open Label Extension Period|Adverse Event|4|||
160453150|NCT03478956|579389706|FG003|Open Label Extension Period|Adverse Event|0|||
160453151|NCT03478956|579389703|FG000|Open Label Extension Period|Lack of Efficacy|0|||
160453152|NCT03478956|579389704|FG001|Open Label Extension Period|Lack of Efficacy|0|||
160453153|NCT03478956|579389705|FG002|Open Label Extension Period|Lack of Efficacy|8|||
160453154|NCT03478956|579389706|FG003|Open Label Extension Period|Lack of Efficacy|0|||
160453155|NCT03478956|579389703|FG000|Open Label Extension Period|Reason Not Provided|0|||
160453156|NCT03478956|579389704|FG001|Open Label Extension Period|Reason Not Provided|0|||
160453157|NCT03478956|579389705|FG002|Open Label Extension Period|Reason Not Provided|1|||
160453158|NCT03478956|579389706|FG003|Open Label Extension Period|Reason Not Provided|0|||
160453159|NCT03478956|579389703|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
160453160|NCT03478956|579389704|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
160453161|NCT03478956|579389705|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
160453162|NCT03478956|579389706|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
160453163|NCT03478956|579389703|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
160453164|NCT03478956|579389704|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
160453165|NCT03478956|579389705|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
160453166|NCT03478956|579389706|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
160453167|NCT03478956|579389703|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
160453168|NCT03478956|579389704|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
160453169|NCT03478956|579389705|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
160995192|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
160995193|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
160995194|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
160995195|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
160995196|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
160995197|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
160995198|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
160995199|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
160995200|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
160995201|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
160453170|NCT03478956|579389706|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
160453171|NCT04800211|579389707|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
160453172|NCT04800211|579389708|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
160453173|NCT04800211|579389709|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
160453174|NCT04800211|579389707|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
160453175|NCT04800211|579389708|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
160453176|NCT04800211|579389709|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
160453177|NCT04800211|579389707|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
160453178|NCT04800211|579389708|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
160453179|NCT04800211|579389709|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
160453180|NCT04800211|579389707|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
160453181|NCT04800211|579389708|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
160453182|NCT04800211|579389709|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
160910410|NCT01697566|581067939|FG003|Overall Study|Withdrawal by Subject|1|||
160910411|NCT01697566|581067936|FG000|Overall Study|Final biopsy not obtained|0|||
160910412|NCT01697566|581067937|FG001|Overall Study|Final biopsy not obtained|0|||
160910413|NCT01697566|581067938|FG002|Overall Study|Final biopsy not obtained|1|||
160910414|NCT01697566|581067939|FG003|Overall Study|Final biopsy not obtained|0|||
160910415|NCT01447433|581067942|FG000|Overall Study|Lost to Follow-up|0|||
160910416|NCT01447433|581067943|FG001|Overall Study|Lost to Follow-up|2|||
160910417|NCT01447433|581067942|FG000|Overall Study|Withdrawal by Subject|3|||
160910418|NCT01447433|581067943|FG001|Overall Study|Withdrawal by Subject|3|||
160995202|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
160910419|NCT01447433|581067942|FG000|Overall Study|Protocol Violation|1|||
160995203|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
160995204|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
160453183|NCT04800211|579389707|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
160453184|NCT04800211|579389708|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
160453185|NCT04800211|579389709|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
160453186|NCT04800211|579389707|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
160910420|NCT01447433|581067943|FG001|Overall Study|Protocol Violation|1|||
160453187|NCT04800211|579389708|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
160910421|NCT01578187|581067944|FG000|Usability Phase|Withdrawal by Subject|1|||
160910422|NCT00496470|581067945|FG000|Overall Study|Adverse Event|8|||
160910423|NCT00496470|581067946|FG001|Overall Study|Adverse Event|10|||
160910424|NCT00496470|581067945|FG000|Overall Study|Withdrawal by Subject|5|||
160910425|NCT00496470|581067946|FG001|Overall Study|Withdrawal by Subject|12|||
160910426|NCT00496470|581067945|FG000|Overall Study|Incorrectly enrolled|13|||
160910427|NCT00496470|581067946|FG001|Overall Study|Incorrectly enrolled|5|||
160910428|NCT00496470|581067945|FG000|Overall Study|Other reason|0|||
160910429|NCT00496470|581067946|FG001|Overall Study|Other reason|2|||
160910430|NCT02516163|581067951|FG000|Overall Study|Withdrawal by Subject|1|||
160910431|NCT02516163|581067951|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
160910432|NCT02516163|581067951|FG000|Overall Study|Unfit/delay in surgery|3|||
160910433|NCT02516163|581067951|FG000|Overall Study|Use of incorrect measurement technique|5|||
160910434|NCT02516163|581067951|FG000|Overall Study|Data not recorded|2|||
160910435|NCT02516163|581067951|FG000|Overall Study|MRI contraindication exclusion|6|||
160910436|NCT01217814|581067952|FG000|Overall Study|Adverse Event|1|||
160910437|NCT01217814|581067953|FG001|Overall Study|Adverse Event|1|||
160910438|NCT01217814|581067954|FG002|Overall Study|Adverse Event|0|||
160910439|NCT01217814|581067952|FG000|Overall Study|Lack of Efficacy|0|||
160910440|NCT01217814|581067953|FG001|Overall Study|Lack of Efficacy|0|||
160910441|NCT01217814|581067954|FG002|Overall Study|Lack of Efficacy|1|||
160910442|NCT01658072|581067955|FG000|Overall Study|Protocol Violation|4|||
160910443|NCT01658072|581067956|FG001|Overall Study|Protocol Violation|2|||
160910444|NCT01709162|581067959|FG000|Overall Study|Disease progression|3|||
160910445|NCT01709162|581067960|FG001|Overall Study|Disease progression|3|||
160910446|NCT01709162|581067959|FG000|Overall Study|Study drug toxicity|2|||
160910447|NCT01709162|581067960|FG001|Overall Study|Study drug toxicity|0|||
160910448|NCT01709162|581067959|FG000|Overall Study|Administrative reason by sponsor|0|||
160910449|NCT01709162|581067960|FG001|Overall Study|Administrative reason by sponsor|1|||
160910450|NCT01709162|581067959|FG000|Overall Study|Other|1|||
160910451|NCT01709162|581067960|FG001|Overall Study|Other|0|||
160910452|NCT01709162|581067959|FG000|Overall Study|Withdrawal by Subject|0|||
160910453|NCT01709162|581067960|FG001|Overall Study|Withdrawal by Subject|1|||
160910454|NCT01637272|581067966|FG000|Overall Study|Adverse Event|6|||
160910455|NCT01637272|581067966|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160910456|NCT01637272|581067966|FG000|Overall Study|Withdrawal by Subject|3|||
160910457|NCT01637272|581067966|FG000|Overall Study|Lost to Follow-up|2|||
160910458|NCT01637272|581067966|FG000|Overall Study|completed core, did not enter ext. phase|4|||
160910459|NCT01637272|581067966|FG000|Overall Study|Administrative problems|1|||
160910460|NCT01637272|581067966|FG000|Overall Study|Protocol Violation|2|||
160910461|NCT01844518|581067967|FG000|Overall Study|Adverse Event|7|||
160910462|NCT01844518|581067968|FG001|Overall Study|Adverse Event|1|||
160910463|NCT01844518|581067967|FG000|Overall Study|Lack of Efficacy|17|||
160910464|NCT01844518|581067968|FG001|Overall Study|Lack of Efficacy|5|||
160910465|NCT01844518|581067967|FG000|Overall Study|Participant's request to discontinue|4|||
160910466|NCT01844518|581067968|FG001|Overall Study|Participant's request to discontinue|1|||
160910467|NCT01844518|581067967|FG000|Overall Study|Poor/Non-compliance|1|||
160910468|NCT01844518|581067968|FG001|Overall Study|Poor/Non-compliance|0|||
160910469|NCT01844518|581067967|FG000|Overall Study|No Longer Met Study Criteria|2|||
160910470|NCT01844518|581067968|FG001|Overall Study|No Longer Met Study Criteria|0|||
160910471|NCT01844518|581067967|FG000|Overall Study|Withdrawal by Subject|9|||
160910472|NCT01844518|581067968|FG001|Overall Study|Withdrawal by Subject|0|||
160910473|NCT01844518|581067967|FG000|Overall Study|Pregnancy|1|||
160910474|NCT01844518|581067968|FG001|Overall Study|Pregnancy|0|||
160910475|NCT01217801|581067969|FG000|Period 1|Protocol Violation|1|||
160910476|NCT01217801|581067970|FG001|Period 1|Protocol Violation|1|||
160910477|NCT01217801|581067969|FG000|Period 1|Withdrawal by Subject|0|||
160910478|NCT01217801|581067970|FG001|Period 1|Withdrawal by Subject|1|||
160910479|NCT04584645|581067971|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
160910480|NCT04584645|581067972|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
160910481|NCT03845985|581067983|FG000|Overall Study|Lost to Follow-up|2|||
160910482|NCT03845985|581067984|FG001|Overall Study|Lost to Follow-up|1|||
160910483|NCT03845985|581067983|FG000|Overall Study|Physician Decision|1|||
160910484|NCT03845985|581067984|FG001|Overall Study|Physician Decision|0|||
160910485|NCT03845985|581067983|FG000|Overall Study|Withdrawal by Subject|4|||
160910486|NCT03845985|581067984|FG001|Overall Study|Withdrawal by Subject|1|||
160910487|NCT02756013|581067985|FG000|Overall Study|Adverse Event|1|||
160995205|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
160652730|NCT00365352|580108718|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
160910488|NCT02756013|581067985|FG000|Overall Study|Hypersensitivity|1|||
160910489|NCT03926169|581067986|FG000|Period A|Adverse Event|2|||
160910490|NCT03926169|581067987|FG001|Period A|Adverse Event|2|||
160910491|NCT03926169|581067988|FG002|Period A|Adverse Event|1|||
160910492|NCT03926169|581067986|FG000|Period A|Withdrawal by Subject|2|||
160910493|NCT03926169|581067987|FG001|Period A|Withdrawal by Subject|2|||
160910494|NCT03926169|581067988|FG002|Period A|Withdrawal by Subject|2|||
160453188|NCT04800211|579389709|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
160453189|NCT04800211|579389707|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
160453190|NCT04800211|579389708|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
160861357|NCT03137992|580885249|FG000|Washout Period 2|Withdrawal by Subject|1|||
160861358|NCT03137992|580885250|FG001|Washout Period 2|Withdrawal by Subject|0|||
160861359|NCT03137992|580885251|FG002|Washout Period 2|Withdrawal by Subject|0|||
160861360|NCT03137992|580885252|FG003|Washout Period 2|Withdrawal by Subject|0|||
160861361|NCT03137992|580885253|FG004|Washout Period 2|Withdrawal by Subject|1|||
160861362|NCT03137992|580885254|FG005|Washout Period 2|Withdrawal by Subject|0|||
160861363|NCT03137992|580885249|FG000|Washout Period 2|Sponsor Decision|0|||
160861364|NCT03137992|580885250|FG001|Washout Period 2|Sponsor Decision|0|||
160861365|NCT03137992|580885251|FG002|Washout Period 2|Sponsor Decision|0|||
160861366|NCT03137992|580885252|FG003|Washout Period 2|Sponsor Decision|0|||
160861367|NCT03137992|580885253|FG004|Washout Period 2|Sponsor Decision|0|||
160861368|NCT03137992|580885254|FG005|Washout Period 2|Sponsor Decision|1|||
160861369|NCT03137992|580885249|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
160861370|NCT03137992|580885250|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
160861371|NCT03137992|580885251|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
160861372|NCT03137992|580885252|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
160861373|NCT03137992|580885253|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
160861374|NCT03137992|580885254|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
160861375|NCT03137992|580885249|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
160861376|NCT03137992|580885250|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
160861377|NCT03137992|580885251|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
160861378|NCT03137992|580885252|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
160861379|NCT03137992|580885253|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
160861380|NCT03137992|580885254|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
160861381|NCT03137992|580885249|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
160861382|NCT03137992|580885250|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
160861383|NCT03137992|580885251|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
160861384|NCT03137992|580885252|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
160861385|NCT03137992|580885253|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
160861386|NCT03137992|580885254|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
160861387|NCT03137992|580885249|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
160861388|NCT03137992|580885250|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
160861389|NCT03137992|580885251|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
160861390|NCT03137992|580885252|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
160861391|NCT03137992|580885253|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
160861392|NCT03137992|580885254|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
160861393|NCT03137992|580885249|FG000|Part 2 (Open-label Extension)|Per study team|1|||
160861394|NCT03137992|580885250|FG001|Part 2 (Open-label Extension)|Per study team|0|||
160861395|NCT03137992|580885251|FG002|Part 2 (Open-label Extension)|Per study team|0|||
160861396|NCT03137992|580885252|FG003|Part 2 (Open-label Extension)|Per study team|0|||
160861397|NCT03137992|580885253|FG004|Part 2 (Open-label Extension)|Per study team|0|||
160861398|NCT03137992|580885254|FG005|Part 2 (Open-label Extension)|Per study team|0|||
160861399|NCT03137992|580885249|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
160861400|NCT03137992|580885250|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
160861401|NCT03137992|580885251|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
160861402|NCT03137992|580885252|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
160861403|NCT03137992|580885253|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
160861404|NCT03137992|580885254|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
160861405|NCT04609319|580885255|FG000|Overall Study|Death|64|||
160861406|NCT04609319|580885256|FG001|Overall Study|Death|49|||
160861407|NCT04609319|580885257|FG002|Overall Study|Death|1|||
160861408|NCT04609319|580885255|FG000|Overall Study|Withdrawal of consent|15|||
160861409|NCT04609319|580885256|FG001|Overall Study|Withdrawal of consent|3|||
160861410|NCT04609319|580885257|FG002|Overall Study|Withdrawal of consent|0|||
160861411|NCT04609319|580885255|FG000|Overall Study|Lost to Follow-up|20|||
160861412|NCT04609319|580885256|FG001|Overall Study|Lost to Follow-up|33|||
160861413|NCT04609319|580885257|FG002|Overall Study|Lost to Follow-up|0|||
160861414|NCT04609319|580885255|FG000|Overall Study|Alive until end of follow-up|60|||
160861415|NCT04609319|580885256|FG001|Overall Study|Alive until end of follow-up|53|||
160861416|NCT04609319|580885257|FG002|Overall Study|Alive until end of follow-up|1|||
160861417|NCT03221556|580885258|FG000|Allocation|post-randomization exclusion|0|||
160861418|NCT03221556|580885259|FG001|Allocation|post-randomization exclusion|1|||
160861419|NCT03221556|580885258|FG000|Follow-Up|Withdrawal by Subject|0|||
160861420|NCT03221556|580885259|FG001|Follow-Up|Withdrawal by Subject|1|||
160861421|NCT02234843|580885260|FG000|Overall Study|Death|1|||
160861422|NCT02234843|580885261|FG001|Overall Study|Death|0|||
160861423|NCT02234843|580885262|FG002|Overall Study|Death|0|||
160453191|NCT04800211|579389709|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
160453192|NCT04800211|579389707|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
160453193|NCT04800211|579389708|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
160453194|NCT04800211|579389709|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
160453195|NCT04800211|579389707|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
160453196|NCT04800211|579389708|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
160453197|NCT04800211|579389709|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
160453198|NCT04800211|579389707|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
160453199|NCT04800211|579389708|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
160453200|NCT04800211|579389709|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
160453201|NCT04800211|579389707|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
160453202|NCT04800211|579389708|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
160453203|NCT04800211|579389709|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
160453204|NCT03734679|579389714|FG000|Overall Study|Missed Visit|1|||
160453205|NCT02823145|579389722|FG000|Enrollment|Other|1|||
160453206|NCT02823145|579389723|FG001|Enrollment|Other|0|||
160453207|NCT02823145|579389722|FG000|Treatment|Adverse Event|0|||
160453208|NCT02823145|579389723|FG001|Treatment|Adverse Event|11|||
160453209|NCT02823145|579389722|FG000|Treatment|Death|0|||
160453210|NCT02823145|579389723|FG001|Treatment|Death|3|||
160453211|NCT02823145|579389722|FG000|Treatment|Family Decision|0|||
160453212|NCT02823145|579389723|FG001|Treatment|Family Decision|1|||
160453213|NCT02823145|579389722|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
160453214|NCT02823145|579389723|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
160453215|NCT02823145|579389722|FG000|Treatment|Lack of Efficacy|0|||
160453216|NCT02823145|579389723|FG001|Treatment|Lack of Efficacy|48|||
160453217|NCT02823145|579389722|FG000|Treatment|Non-Compliance With E-Diary|0|||
160453218|NCT02823145|579389723|FG001|Treatment|Non-Compliance With E-Diary|1|||
160453219|NCT02823145|579389722|FG000|Treatment|Physician Decision|0|||
160453220|NCT02823145|579389723|FG001|Treatment|Physician Decision|2|||
160453221|NCT02823145|579389722|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
160453222|NCT02823145|579389723|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
160453223|NCT02823145|579389722|FG000|Treatment|Subject needed to take prohibited medication|0|||
160453224|NCT02823145|579389723|FG001|Treatment|Subject needed to take prohibited medication|1|||
160453225|NCT02823145|579389722|FG000|Treatment|Subject transferred to direct access programme|0|||
160453226|NCT02823145|579389723|FG001|Treatment|Subject transferred to direct access programme|1|||
160453227|NCT02823145|579389722|FG000|Treatment|Switching to commercially available drug|0|||
160453228|NCT02823145|579389723|FG001|Treatment|Switching to commercially available drug|11|||
160453229|NCT02823145|579389722|FG000|Treatment|Transitioned to commercial supply of medication|0|||
160453230|NCT02823145|579389723|FG001|Treatment|Transitioned to commercial supply of medication|1|||
160453231|NCT02823145|579389722|FG000|Treatment|Withdrawal By Caregiver|0|||
160453232|NCT02823145|579389723|FG001|Treatment|Withdrawal By Caregiver|1|||
160453233|NCT02823145|579389722|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
160453234|NCT02823145|579389723|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
160453235|NCT02823145|579389722|FG000|Treatment|Withdrawal by Subject|0|||
160453236|NCT02823145|579389723|FG001|Treatment|Withdrawal by Subject|16|||
160453237|NCT02823145|579389722|FG000|Treatment|Reason unknown|0|||
160453238|NCT02823145|579389723|FG001|Treatment|Reason unknown|1|||
160453239|NCT03748953|579392011|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
160453240|NCT03748953|579392012|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
160453241|NCT03748953|579392011|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
160453242|NCT03748953|579392012|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
160453243|NCT03748953|579392011|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
160453244|NCT03748953|579392012|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
160453245|NCT03748953|579392011|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
160453246|NCT03748953|579392012|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
160453247|NCT03748953|579392011|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
160861424|NCT02234843|580885263|FG003|Overall Study|Death|0|||
160995206|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
160995207|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
160995208|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
160995209|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
160995210|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
160995211|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
160995212|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
160995213|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
160995214|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
160453248|NCT03748953|579392012|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
160453249|NCT04676763|579392013|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
160453250|NCT04676763|579392014|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
160995215|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
160910495|NCT03926169|581067986|FG000|Period A|Lost to Follow-up|3|||
160910496|NCT03926169|581067987|FG001|Period A|Lost to Follow-up|1|||
160910497|NCT03926169|581067988|FG002|Period A|Lost to Follow-up|0|||
160910498|NCT03926169|581067986|FG000|Period A|Lack of Efficacy|0|||
160910499|NCT03926169|581067987|FG001|Period A|Lack of Efficacy|2|||
160910500|NCT03926169|581067988|FG002|Period A|Lack of Efficacy|2|||
160910501|NCT03926169|581067986|FG000|Period A|COVID-19 Infection|0|||
160910502|NCT03926169|581067987|FG001|Period A|COVID-19 Infection|1|||
160910503|NCT03926169|581067988|FG002|Period A|COVID-19 Infection|0|||
160910504|NCT03926169|581067986|FG000|Period A|COVID-19 Logistical Restrictions|0|||
160910505|NCT03926169|581067987|FG001|Period A|COVID-19 Logistical Restrictions|2|||
160910506|NCT03926169|581067988|FG002|Period A|COVID-19 Logistical Restrictions|1|||
160910507|NCT03926169|581067986|FG000|Period A|Other, Not Specified|1|||
160910508|NCT03926169|581067987|FG001|Period A|Other, Not Specified|0|||
160910509|NCT03926169|581067988|FG002|Period A|Other, Not Specified|0|||
160910510|NCT03926169|581067986|FG000|Period B|Adverse Event|3|||
160861425|NCT02234843|580885264|FG004|Overall Study|Death|0|||
160861426|NCT02234843|580885265|FG005|Overall Study|Death|0|||
160861427|NCT02234843|580885266|FG006|Overall Study|Death|0|||
160861428|NCT02234843|580885267|FG007|Overall Study|Death|0|||
160861429|NCT02234843|580885268|FG008|Overall Study|Death|0|||
160861430|NCT02234843|580885269|FG009|Overall Study|Death|0|||
160861431|NCT02234843|580885260|FG000|Overall Study|Protocol Violation|1|||
160861432|NCT02234843|580885261|FG001|Overall Study|Protocol Violation|0|||
160861433|NCT02234843|580885262|FG002|Overall Study|Protocol Violation|1|||
160861434|NCT02234843|580885263|FG003|Overall Study|Protocol Violation|0|||
160861435|NCT02234843|580885264|FG004|Overall Study|Protocol Violation|0|||
160861436|NCT02234843|580885265|FG005|Overall Study|Protocol Violation|0|||
160861437|NCT02234843|580885266|FG006|Overall Study|Protocol Violation|0|||
160861438|NCT02234843|580885267|FG007|Overall Study|Protocol Violation|0|||
160861439|NCT02234843|580885268|FG008|Overall Study|Protocol Violation|0|||
160861440|NCT02234843|580885269|FG009|Overall Study|Protocol Violation|0|||
160861441|NCT02234843|580885260|FG000|Overall Study|Efficacy outcome reached|2|||
160861442|NCT02234843|580885261|FG001|Overall Study|Efficacy outcome reached|0|||
160861443|NCT02234843|580885262|FG002|Overall Study|Efficacy outcome reached|0|||
160861444|NCT02234843|580885263|FG003|Overall Study|Efficacy outcome reached|0|||
160861445|NCT02234843|580885264|FG004|Overall Study|Efficacy outcome reached|0|||
160861446|NCT02234843|580885265|FG005|Overall Study|Efficacy outcome reached|2|||
160861447|NCT02234843|580885266|FG006|Overall Study|Efficacy outcome reached|0|||
160861448|NCT02234843|580885267|FG007|Overall Study|Efficacy outcome reached|0|||
160861449|NCT02234843|580885268|FG008|Overall Study|Efficacy outcome reached|0|||
160861450|NCT02234843|580885269|FG009|Overall Study|Efficacy outcome reached|0|||
160861451|NCT02234843|580885260|FG000|Overall Study|Patient convenience|2|||
160861452|NCT02234843|580885261|FG001|Overall Study|Patient convenience|0|||
160861453|NCT02234843|580885262|FG002|Overall Study|Patient convenience|0|||
160861454|NCT02234843|580885263|FG003|Overall Study|Patient convenience|0|||
160861455|NCT02234843|580885264|FG004|Overall Study|Patient convenience|0|||
160861456|NCT02234843|580885265|FG005|Overall Study|Patient convenience|1|||
160861457|NCT02234843|580885266|FG006|Overall Study|Patient convenience|0|||
160861458|NCT02234843|580885267|FG007|Overall Study|Patient convenience|0|||
160861459|NCT02234843|580885268|FG008|Overall Study|Patient convenience|0|||
160861460|NCT02234843|580885269|FG009|Overall Study|Patient convenience|0|||
160861461|NCT02234843|580885260|FG000|Overall Study|Withdrawal by Subject|5|||
160861462|NCT02234843|580885261|FG001|Overall Study|Withdrawal by Subject|1|||
160861463|NCT02234843|580885262|FG002|Overall Study|Withdrawal by Subject|1|||
160861464|NCT02234843|580885263|FG003|Overall Study|Withdrawal by Subject|0|||
160861465|NCT02234843|580885264|FG004|Overall Study|Withdrawal by Subject|0|||
160861466|NCT02234843|580885265|FG005|Overall Study|Withdrawal by Subject|7|||
160861467|NCT02234843|580885266|FG006|Overall Study|Withdrawal by Subject|0|||
160861468|NCT02234843|580885267|FG007|Overall Study|Withdrawal by Subject|0|||
160861469|NCT02234843|580885268|FG008|Overall Study|Withdrawal by Subject|0|||
160861470|NCT02234843|580885269|FG009|Overall Study|Withdrawal by Subject|0|||
160861471|NCT02234843|580885260|FG000|Overall Study|Recovery|1|||
160861472|NCT02234843|580885261|FG001|Overall Study|Recovery|0|||
160861473|NCT02234843|580885262|FG002|Overall Study|Recovery|0|||
160861474|NCT02234843|580885263|FG003|Overall Study|Recovery|0|||
160861475|NCT02234843|580885264|FG004|Overall Study|Recovery|0|||
160861476|NCT02234843|580885265|FG005|Overall Study|Recovery|0|||
160861477|NCT02234843|580885266|FG006|Overall Study|Recovery|0|||
160861478|NCT02234843|580885267|FG007|Overall Study|Recovery|0|||
160861479|NCT02234843|580885268|FG008|Overall Study|Recovery|0|||
160861480|NCT02234843|580885269|FG009|Overall Study|Recovery|0|||
160861481|NCT02234843|580885260|FG000|Overall Study|Other|0|||
160861482|NCT02234843|580885261|FG001|Overall Study|Other|2|||
160861483|NCT02234843|580885262|FG002|Overall Study|Other|0|||
160861484|NCT02234843|580885263|FG003|Overall Study|Other|1|||
160861485|NCT02234843|580885264|FG004|Overall Study|Other|0|||
160861486|NCT02234843|580885265|FG005|Overall Study|Other|1|||
160861487|NCT02234843|580885266|FG006|Overall Study|Other|0|||
160910511|NCT03926169|581067987|FG001|Period B|Adverse Event|1|||
160910512|NCT03926169|581067988|FG002|Period B|Adverse Event|1|||
160910513|NCT03926169|581067986|FG000|Period B|Withdrawal by Subject|1|||
160910514|NCT03926169|581067987|FG001|Period B|Withdrawal by Subject|3|||
160910515|NCT03926169|581067988|FG002|Period B|Withdrawal by Subject|0|||
160910516|NCT03926169|581067986|FG000|Period B|Lack of Efficacy|3|||
160910517|NCT03926169|581067987|FG001|Period B|Lack of Efficacy|1|||
160910518|NCT03926169|581067988|FG002|Period B|Lack of Efficacy|1|||
160910519|NCT03926169|581067986|FG000|Period B|Lost to Follow-up|1|||
160910520|NCT03926169|581067987|FG001|Period B|Lost to Follow-up|1|||
160910521|NCT03926169|581067988|FG002|Period B|Lost to Follow-up|4|||
160910522|NCT03926169|581067986|FG000|Period B|Other, Not Specified|62|||
160910523|NCT03926169|581067987|FG001|Period B|Other, Not Specified|57|||
160910524|NCT03926169|581067988|FG002|Period B|Other, Not Specified|65|||
160910525|NCT00968201|581067989|FG000|Base Study - (Period II)|Adverse Event|8|||
160910526|NCT00968201|581067990|FG001|Base Study - (Period II)|Adverse Event|0|||
160910527|NCT00968201|581067991|FG002|Base Study - (Period II)|Adverse Event|16|||
160910528|NCT00968201|581067989|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
160910529|NCT00968201|581067990|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
160910530|NCT00968201|581067991|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
160910531|NCT00968201|581067989|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
160910532|NCT00968201|581067990|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
160910533|NCT00968201|581067991|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
160910534|NCT00968201|581067989|FG000|Base Study - (Period II)|Protocol Violation|12|||
160910535|NCT00968201|581067990|FG001|Base Study - (Period II)|Protocol Violation|0|||
160910536|NCT00968201|581067991|FG002|Base Study - (Period II)|Protocol Violation|12|||
160910537|NCT00968201|581067989|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
160910538|NCT00968201|581067990|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
160910539|NCT00968201|581067991|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
160910540|NCT00968201|581067989|FG000|Base Study - (Period II)|Site Error|0|||
160910541|NCT00968201|581067990|FG001|Base Study - (Period II)|Site Error|0|||
160910542|NCT00968201|581067991|FG002|Base Study - (Period II)|Site Error|1|||
160910543|NCT00968201|581067989|FG000|Extension Study - (Period III)|Adverse Event|0|||
160910544|NCT00968201|581067990|FG001|Extension Study - (Period III)|Adverse Event|5|||
160910545|NCT00968201|581067991|FG002|Extension Study - (Period III)|Adverse Event|22|||
160910546|NCT00968201|581067989|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
160910547|NCT00968201|581067990|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
160910548|NCT00968201|581067991|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
160910549|NCT00968201|581067989|FG000|Extension Study - (Period III)|Protocol Violation|0|||
160910550|NCT00968201|581067990|FG001|Extension Study - (Period III)|Protocol Violation|17|||
160910551|NCT00968201|581067991|FG002|Extension Study - (Period III)|Protocol Violation|14|||
160910552|NCT00968201|581067989|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
160910553|NCT00968201|581067990|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
160910554|NCT00968201|581067991|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
160910555|NCT00968201|581067989|FG000|Extension Study - (Period III)|Patient Relocated|0|||
160910556|NCT00968201|581067990|FG001|Extension Study - (Period III)|Patient Relocated|1|||
160910557|NCT00968201|581067991|FG002|Extension Study - (Period III)|Patient Relocated|1|||
160910558|NCT00968201|581067989|FG000|Extension Study - (Period III)|Noncompliance|0|||
160910559|NCT00968201|581067990|FG001|Extension Study - (Period III)|Noncompliance|0|||
160910560|NCT00968201|581067991|FG002|Extension Study - (Period III)|Noncompliance|3|||
160910561|NCT00968201|581067989|FG000|Extension Study - (Period III)|Other|0|||
160910562|NCT00968201|581067990|FG001|Extension Study - (Period III)|Other|0|||
160910563|NCT00968201|581067991|FG002|Extension Study - (Period III)|Other|2|||
160910564|NCT00968201|581067989|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
160910565|NCT00968201|581067990|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
160910566|NCT00968201|581067991|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
160910567|NCT04974697|581067995|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
160910568|NCT04974697|581067995|FG000|Overall Study|Lens discomfort|1|||
160910569|NCT03706456|581067996|FG000|Overall Study|Adverse Event|1|||
160910570|NCT03706456|581067996|FG000|Overall Study|Lack of Efficacy|2|||
160910571|NCT03302234|581067997|FG000|Overall Study|Death|191|||
160910572|NCT03302234|581067998|FG001|Overall Study|Death|192|||
160910573|NCT03302234|581067997|FG000|Overall Study|Withdrawal by Subject|2|||
160910574|NCT03302234|581067998|FG001|Overall Study|Withdrawal by Subject|2|||
160910575|NCT03302234|581067997|FG000|Overall Study|Sponsor Decision|90|||
160910576|NCT03302234|581067998|FG001|Overall Study|Sponsor Decision|89|||
160910577|NCT03302234|581067997|FG000|Overall Study|Laryngeal carcinoma|0|||
160910578|NCT03302234|581067998|FG001|Overall Study|Laryngeal carcinoma|1|||
160910579|NCT03302234|581067997|FG000|Overall Study|Not Reported|1|||
160910580|NCT03302234|581067998|FG001|Overall Study|Not Reported|0|||
160910581|NCT04523220|581068000|FG000|Main Treatment Period|Physician Decision|1|||
160910582|NCT04523220|581068001|FG001|Main Treatment Period|Physician Decision|1|||
160910583|NCT04523220|581068002|FG002|Main Treatment Period|Physician Decision|0|||
160910584|NCT04523220|581068000|FG000|Main Treatment Period|Other|5|||
160910585|NCT04523220|581068001|FG001|Main Treatment Period|Other|2|||
160910586|NCT04523220|581068002|FG002|Main Treatment Period|Other|4|||
160910587|NCT04523220|581068000|FG000|Main Treatment Period|Subject Decision|5|||
160910588|NCT04523220|581068001|FG001|Main Treatment Period|Subject Decision|7|||
160910589|NCT04523220|581068002|FG002|Main Treatment Period|Subject Decision|3|||
160910590|NCT04523220|581068000|FG000|Main Treatment Period|Death|5|||
160910591|NCT04523220|581068001|FG001|Main Treatment Period|Death|11|||
160910592|NCT04523220|581068002|FG002|Main Treatment Period|Death|4|||
160910593|NCT04523220|581068000|FG000|Main Treatment Period|Adverse Event|11|||
160910594|NCT04523220|581068001|FG001|Main Treatment Period|Adverse Event|9|||
160910595|NCT04523220|581068002|FG002|Main Treatment Period|Adverse Event|9|||
160910596|NCT04523220|581068000|FG000|Main Treatment Period|Withdrawal by Subject|3|||
160910597|NCT04523220|581068001|FG001|Main Treatment Period|Withdrawal by Subject|3|||
160910598|NCT04523220|581068002|FG002|Main Treatment Period|Withdrawal by Subject|4|||
160910599|NCT04523220|581068000|FG000|Main Treatment Period|Study drug never adminstered|10|||
160910600|NCT04523220|581068001|FG001|Main Treatment Period|Study drug never adminstered|3|||
160910601|NCT04523220|581068002|FG002|Main Treatment Period|Study drug never adminstered|5|||
160910602|NCT04523220|581068000|FG000|Extension Treatment Period|Physician Decision|1|||
160910603|NCT04523220|581068001|FG001|Extension Treatment Period|Physician Decision|0|||
160910604|NCT04523220|581068002|FG002|Extension Treatment Period|Physician Decision|3|||
160910605|NCT04523220|581068000|FG000|Extension Treatment Period|Other|2|||
160910606|NCT04523220|581068001|FG001|Extension Treatment Period|Other|6|||
160910607|NCT04523220|581068002|FG002|Extension Treatment Period|Other|6|||
160910608|NCT04523220|581068000|FG000|Extension Treatment Period|Subject Decision|5|||
160910609|NCT04523220|581068001|FG001|Extension Treatment Period|Subject Decision|2|||
160910610|NCT04523220|581068002|FG002|Extension Treatment Period|Subject Decision|4|||
160910611|NCT04523220|581068000|FG000|Extension Treatment Period|Death|6|||
160910612|NCT04523220|581068001|FG001|Extension Treatment Period|Death|4|||
160910613|NCT04523220|581068002|FG002|Extension Treatment Period|Death|7|||
160910614|NCT04523220|581068000|FG000|Extension Treatment Period|Adverse Event|6|||
160910615|NCT04523220|581068001|FG001|Extension Treatment Period|Adverse Event|7|||
160910616|NCT04523220|581068002|FG002|Extension Treatment Period|Adverse Event|9|||
160910617|NCT04523220|581068000|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
160910618|NCT04523220|581068001|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
160910619|NCT04523220|581068002|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
160910620|NCT04523220|581068000|FG000|Extension Treatment Period|Study drug never administered|0|||
160910621|NCT04523220|581068001|FG001|Extension Treatment Period|Study drug never administered|1|||
160910622|NCT04523220|581068002|FG002|Extension Treatment Period|Study drug never administered|0|||
160910623|NCT04112784|581068003|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
160910624|NCT04112784|581068003|FG000|Overall Study|Screen Failures|4|||
160910625|NCT00221403|581068004|FG000|Overall Study|Protocol Violation|1|||
160910626|NCT00221403|581068005|FG001|Overall Study|Protocol Violation|0|||
160910627|NCT00221403|581068006|FG002|Overall Study|Protocol Violation|0|||
160910628|NCT00221403|581068004|FG000|Overall Study|Physician Decision|1|||
160910629|NCT00221403|581068005|FG001|Overall Study|Physician Decision|0|||
160910630|NCT00221403|581068006|FG002|Overall Study|Physician Decision|0|||
160910631|NCT00221403|581068004|FG000|Overall Study|Withdrawal by Subject|0|||
160910632|NCT00221403|581068005|FG001|Overall Study|Withdrawal by Subject|3|||
160910633|NCT00221403|581068006|FG002|Overall Study|Withdrawal by Subject|0|||
160910634|NCT00221403|581068004|FG000|Overall Study|Lack of Efficacy|0|||
160910635|NCT00221403|581068005|FG001|Overall Study|Lack of Efficacy|1|||
160910636|NCT00221403|581068006|FG002|Overall Study|Lack of Efficacy|0|||
160910637|NCT00221403|581068004|FG000|Overall Study|Adverse Event|0|||
160910638|NCT00221403|581068005|FG001|Overall Study|Adverse Event|1|||
160910639|NCT00221403|581068006|FG002|Overall Study|Adverse Event|0|||
160910640|NCT00753415|581068007|FG000|Part A|Disease progression|1|||
160910641|NCT00753415|581068008|FG001|Part A|Disease progression|0|||
160910642|NCT00753415|581068009|FG002|Part A|Disease progression|1|||
160910643|NCT00753415|581068010|FG003|Part A|Disease progression|2|||
160995216|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
160995217|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
160995218|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
160995219|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
160995220|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
160995221|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
160995222|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
160995223|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
160910644|NCT00753415|581068011|FG004|Part A|Disease progression|0|||
160910645|NCT00753415|581068012|FG005|Part A|Disease progression|0|||
160910646|NCT00753415|581068013|FG006|Part A|Disease progression|0|||
160910647|NCT00753415|581068014|FG007|Part A|Disease progression|0|||
160910648|NCT00753415|581068015|FG008|Part A|Disease progression|0|||
160910649|NCT00753415|581068016|FG009|Part A|Disease progression|0|||
160910650|NCT00753415|581068007|FG000|Part A|Withdrawal by Subject|0|||
160910651|NCT00753415|581068008|FG001|Part A|Withdrawal by Subject|0|||
160910652|NCT00753415|581068009|FG002|Part A|Withdrawal by Subject|1|||
160453251|NCT04676763|579392015|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
160453252|NCT04676763|579392013|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
160453253|NCT04676763|579392014|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
160453254|NCT04676763|579392015|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
160453255|NCT04676763|579392013|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
160453256|NCT04676763|579392014|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
160453257|NCT04676763|579392015|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
160453258|NCT04858451|579392016|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
160453259|NCT04858451|579392017|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
160453260|NCT04858451|579392018|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
160453261|NCT04858451|579392019|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
160861488|NCT02234843|580885267|FG007|Overall Study|Other|1|||
160861489|NCT02234843|580885268|FG008|Overall Study|Other|0|||
160910653|NCT00753415|581068010|FG003|Part A|Withdrawal by Subject|0|||
160910654|NCT00753415|581068011|FG004|Part A|Withdrawal by Subject|0|||
160910655|NCT00753415|581068012|FG005|Part A|Withdrawal by Subject|0|||
160910656|NCT00753415|581068013|FG006|Part A|Withdrawal by Subject|0|||
160910657|NCT00753415|581068014|FG007|Part A|Withdrawal by Subject|0|||
160910658|NCT00753415|581068015|FG008|Part A|Withdrawal by Subject|0|||
160910659|NCT00753415|581068016|FG009|Part A|Withdrawal by Subject|0|||
160910660|NCT00753415|581068007|FG000|Part B|Lost to Follow-up|0|||
160910661|NCT00753415|581068008|FG001|Part B|Lost to Follow-up|0|||
160910662|NCT00753415|581068009|FG002|Part B|Lost to Follow-up|0|||
160910663|NCT00753415|581068010|FG003|Part B|Lost to Follow-up|0|||
160910664|NCT00753415|581068011|FG004|Part B|Lost to Follow-up|0|||
160910665|NCT00753415|581068012|FG005|Part B|Lost to Follow-up|0|||
160910666|NCT00753415|581068013|FG006|Part B|Lost to Follow-up|0|||
160910667|NCT00753415|581068014|FG007|Part B|Lost to Follow-up|1|||
160910668|NCT00753415|581068015|FG008|Part B|Lost to Follow-up|1|||
160910669|NCT00753415|581068016|FG009|Part B|Lost to Follow-up|0|||
160910670|NCT00753415|581068007|FG000|Part B|Disease progression|0|||
160910671|NCT00753415|581068008|FG001|Part B|Disease progression|0|||
160910672|NCT00753415|581068009|FG002|Part B|Disease progression|0|||
160910673|NCT00753415|581068010|FG003|Part B|Disease progression|0|||
160910674|NCT00753415|581068011|FG004|Part B|Disease progression|0|||
160910675|NCT00753415|581068012|FG005|Part B|Disease progression|0|||
160910676|NCT00753415|581068013|FG006|Part B|Disease progression|0|||
160910677|NCT00753415|581068014|FG007|Part B|Disease progression|0|||
160910678|NCT00753415|581068015|FG008|Part B|Disease progression|2|||
160910679|NCT00753415|581068016|FG009|Part B|Disease progression|1|||
160910680|NCT03727347|581068020|FG000|Overall Study|Withdrawal by Subject|2|||
160910681|NCT03727347|581068020|FG000|Overall Study|Lost to Follow-up|1|||
160910682|NCT04292743|581068021|FG000|Overall Study|Physician Decision|1|||
160910683|NCT04292743|581068022|FG001|Overall Study|Physician Decision|3|||
160910684|NCT04292743|581068023|FG002|Overall Study|Physician Decision|0|||
160910685|NCT04292743|581068024|FG003|Overall Study|Physician Decision|0|||
160910686|NCT04292743|581068021|FG000|Overall Study|Withdrawal by Subject|0|||
160910687|NCT04292743|581068022|FG001|Overall Study|Withdrawal by Subject|5|||
160910688|NCT04292743|581068023|FG002|Overall Study|Withdrawal by Subject|0|||
160910689|NCT04292743|581068024|FG003|Overall Study|Withdrawal by Subject|0|||
160910690|NCT04292743|581068021|FG000|Overall Study|Death|0|||
160910691|NCT04292743|581068022|FG001|Overall Study|Death|1|||
160910692|NCT04292743|581068023|FG002|Overall Study|Death|0|||
160910693|NCT04292743|581068024|FG003|Overall Study|Death|0|||
160910694|NCT04292743|581068021|FG000|Overall Study|Progression of Disease|2|||
160910695|NCT04292743|581068022|FG001|Overall Study|Progression of Disease|5|||
160910696|NCT04292743|581068023|FG002|Overall Study|Progression of Disease|0|||
160910697|NCT04292743|581068024|FG003|Overall Study|Progression of Disease|0|||
160910698|NCT04292743|581068021|FG000|Overall Study|No Treatment per protocol|0|||
160910699|NCT04292743|581068022|FG001|Overall Study|No Treatment per protocol|2|||
160910700|NCT04292743|581068023|FG002|Overall Study|No Treatment per protocol|0|||
160861490|NCT02234843|580885269|FG009|Overall Study|Other|0|||
160910701|NCT04292743|581068024|FG003|Overall Study|No Treatment per protocol|0|||
160910702|NCT05330702|581068025|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
160910703|NCT05330702|581068026|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
160453262|NCT04858451|579392020|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
160453263|NCT04858451|579392021|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
160453264|NCT04858451|579392022|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
160861491|NCT02234843|580885260|FG000|Overall Study|Physician Decision|4|||
160910704|NCT05330702|581068027|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
160861492|NCT02234843|580885261|FG001|Overall Study|Physician Decision|1|||
160861493|NCT02234843|580885262|FG002|Overall Study|Physician Decision|0|||
160861494|NCT02234843|580885263|FG003|Overall Study|Physician Decision|1|||
160861495|NCT02234843|580885264|FG004|Overall Study|Physician Decision|0|||
160861496|NCT02234843|580885265|FG005|Overall Study|Physician Decision|0|||
160861497|NCT02234843|580885266|FG006|Overall Study|Physician Decision|0|||
160910705|NCT02881554|581068028|FG000|Overall Study|Withdrawal by Subject|2|||
160910706|NCT02881554|581068029|FG001|Overall Study|Withdrawal by Subject|0|||
160910707|NCT02674529|581070017|FG000|Overall Study|Lost to Follow-up|1|||
160910708|NCT02674529|581070018|FG001|Overall Study|Lost to Follow-up|2|||
160910709|NCT02674529|581070017|FG000|Overall Study|Withdrawal by Subject|2|||
160910710|NCT02674529|581070018|FG001|Overall Study|Withdrawal by Subject|1|||
160910711|NCT02674529|581070017|FG000|Overall Study|Physician Decision|0|||
160910712|NCT02674529|581070018|FG001|Overall Study|Physician Decision|1|||
160910713|NCT02674529|581070017|FG000|Overall Study|Protocol Violation|0|||
160910714|NCT02674529|581070018|FG001|Overall Study|Protocol Violation|1|||
160910715|NCT00963547|581070019|FG000|Overall Study|Adverse Event|0|||
160910716|NCT00963547|581070020|FG001|Overall Study|Adverse Event|1|||
160910717|NCT00963547|581070021|FG002|Overall Study|Adverse Event|0|||
160910718|NCT00963547|581070022|FG003|Overall Study|Adverse Event|1|||
160910719|NCT00963547|581070023|FG004|Overall Study|Adverse Event|0|||
160910720|NCT00963547|581070024|FG005|Overall Study|Adverse Event|0|||
160910721|NCT00963547|581070025|FG006|Overall Study|Adverse Event|0|||
160910722|NCT00963547|581070019|FG000|Overall Study|Physician Decision|1|||
160910723|NCT00963547|581070020|FG001|Overall Study|Physician Decision|1|||
160910724|NCT00963547|581070021|FG002|Overall Study|Physician Decision|0|||
160910725|NCT00963547|581070022|FG003|Overall Study|Physician Decision|0|||
160910726|NCT00963547|581070023|FG004|Overall Study|Physician Decision|0|||
160910727|NCT00963547|581070024|FG005|Overall Study|Physician Decision|0|||
160910728|NCT00963547|581070025|FG006|Overall Study|Physician Decision|0|||
160910729|NCT00963547|581070019|FG000|Overall Study|Progressive Disease|3|||
160910730|NCT00963547|581070020|FG001|Overall Study|Progressive Disease|8|||
160910731|NCT00963547|581070021|FG002|Overall Study|Progressive Disease|9|||
160910732|NCT00963547|581070022|FG003|Overall Study|Progressive Disease|5|||
160910733|NCT00963547|581070023|FG004|Overall Study|Progressive Disease|0|||
160910734|NCT00963547|581070024|FG005|Overall Study|Progressive Disease|0|||
160910735|NCT00963547|581070025|FG006|Overall Study|Progressive Disease|0|||
160910736|NCT00963547|581070019|FG000|Overall Study|Withdrawal by Subject|0|||
160910737|NCT00963547|581070020|FG001|Overall Study|Withdrawal by Subject|0|||
160910738|NCT00963547|581070021|FG002|Overall Study|Withdrawal by Subject|3|||
160910739|NCT00963547|581070022|FG003|Overall Study|Withdrawal by Subject|0|||
160910740|NCT00963547|581070023|FG004|Overall Study|Withdrawal by Subject|0|||
160910741|NCT00963547|581070024|FG005|Overall Study|Withdrawal by Subject|0|||
160910742|NCT00963547|581070025|FG006|Overall Study|Withdrawal by Subject|0|||
160910743|NCT00963547|581070019|FG000|Overall Study|Reason Unknown|0|||
160910744|NCT00963547|581070020|FG001|Overall Study|Reason Unknown|1|||
160910745|NCT00963547|581070021|FG002|Overall Study|Reason Unknown|0|||
160910746|NCT00963547|581070022|FG003|Overall Study|Reason Unknown|0|||
160910747|NCT00963547|581070023|FG004|Overall Study|Reason Unknown|0|||
160910748|NCT00963547|581070024|FG005|Overall Study|Reason Unknown|0|||
160910749|NCT00963547|581070025|FG006|Overall Study|Reason Unknown|0|||
160910750|NCT00331682|581070026|FG000|Overall Study|Adverse Event|1|||
160910751|NCT03761277|581070027|FG000|Enrollment to Implant|Screen Failure|17|||
160910752|NCT03761277|581070027|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
160910753|NCT03761277|581070027|FG000|Enrollment to Implant|Physician Decision|2|||
160910754|NCT03761277|581070027|FG000|Enrollment to Implant|Site Closure|3|||
160910755|NCT03761277|581070027|FG000|Enrollment to Implant|Sponsor Request|2|||
160910756|NCT03761277|581070027|FG000|Post-Implant to 6 Months|Adverse Event|2|||
160910757|NCT03761277|581070027|FG000|Post-Implant to 6 Months|Death|1|||
160910758|NCT03761277|581070027|FG000|Post-Implant to 6 Months|Site Closure|2|||
160910759|NCT03761277|581070027|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
160910760|NCT03761277|581070027|FG000|6 Months to 12 Months|Physician Decision|2|||
160910761|NCT03761277|581070027|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
160910762|NCT00759031|581070028|FG000|First Intervention (1 Day)|Physician Decision|1|||
160910763|NCT00759031|581070029|FG001|First Intervention (1 Day)|Physician Decision|0|||
160995224|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
160995225|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
160995226|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
160910764|NCT00759031|581070028|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
160910765|NCT00759031|581070029|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
160910766|NCT00759031|581070028|FG000|First Intervention (1 Day)|Screening failure|1|||
160910767|NCT00759031|581070029|FG001|First Intervention (1 Day)|Screening failure|0|||
160910768|NCT00543140|581070030|FG000|Overall Study|Lost to Follow-up|33|||
160995227|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
160910769|NCT00543140|581070030|FG000|Overall Study|Withdrawal by Subject|13|||
160910770|NCT00543140|581070030|FG000|Overall Study|Protocol Violation|10|||
160910771|NCT00543140|581070030|FG000|Overall Study|Insufficient weight loss|10|||
160910772|NCT00543140|581070030|FG000|Overall Study|SAE leading to explant of SAGB|3|||
160910773|NCT00543140|581070030|FG000|Overall Study|Death|1|||
160910774|NCT00543140|581070030|FG000|Overall Study|Subject moved|1|||
160910775|NCT00543140|581070030|FG000|Overall Study|Conversion to different procedure|1|||
160910776|NCT04532164|581070031|FG000|Overall Study|Adverse Event|1|||
160910777|NCT04532164|581070031|FG000|Overall Study|Protocol Violation|5|||
160910778|NCT04532164|581070031|FG000|Overall Study|Lost to Follow-up|1|||
160910779|NCT04532164|581070031|FG000|Overall Study|Found to be Ineligible|3|||
160910780|NCT04532164|581070031|FG000|Overall Study|Withdrawal by Subject|14|||
160910781|NCT01599234|581070032|FG000|Overall Study|Adverse Event|9|||
160910782|NCT01599234|581070033|FG001|Overall Study|Adverse Event|5|||
160910783|NCT01599234|581070032|FG000|Overall Study|Withdrawal by Subject|2|||
160910784|NCT01599234|581070033|FG001|Overall Study|Withdrawal by Subject|1|||
160910785|NCT01599234|581070032|FG000|Overall Study|Lost to Follow-up|1|||
160910786|NCT01599234|581070033|FG001|Overall Study|Lost to Follow-up|2|||
160910787|NCT01599234|581070032|FG000|Overall Study|Lack of Efficacy|2|||
160910788|NCT01599234|581070033|FG001|Overall Study|Lack of Efficacy|4|||
160910789|NCT01599234|581070032|FG000|Overall Study|Unable to operate spray|1|||
160910790|NCT01599234|581070033|FG001|Overall Study|Unable to operate spray|0|||
160910791|NCT01599234|581070032|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
160995228|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
160995229|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
160995230|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
160995231|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
160995232|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
160995233|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
160995234|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
160995235|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
160995236|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
160995237|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
160995238|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
160995239|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
160995240|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
160995241|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
160995242|NCT06688370|581369095|FG000|Overall Study|Discontinued the treatment|1|||
160995243|NCT06688370|581369095|FG000|Overall Study|Prohibited treatment taken|4|||
160995244|NCT02501811|581369096|FG000|Overall Study|Death|1|||
160995245|NCT02501811|581369097|FG001|Overall Study|Death|3|||
160995246|NCT02501811|581369098|FG002|Overall Study|Death|2|||
160995247|NCT02501811|581369099|FG003|Overall Study|Death|3|||
160995248|NCT02501811|581369096|FG000|Overall Study|Withdrawal by Subject|3|||
160995249|NCT02501811|581369097|FG001|Overall Study|Withdrawal by Subject|3|||
160995250|NCT02501811|581369098|FG002|Overall Study|Withdrawal by Subject|2|||
160995251|NCT02501811|581369099|FG003|Overall Study|Withdrawal by Subject|3|||
160995252|NCT02501811|581369096|FG000|Overall Study|Lost to Follow-up|0|||
160995253|NCT02501811|581369097|FG001|Overall Study|Lost to Follow-up|0|||
160995254|NCT02501811|581369098|FG002|Overall Study|Lost to Follow-up|2|||
160995255|NCT02501811|581369099|FG003|Overall Study|Lost to Follow-up|1|||
160995256|NCT04018066|581370896|FG000|Overall Study|participants started taking medications during the study period|3|||
160995257|NCT04018066|581370896|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
160995258|NCT03568318|581370897|FG000|Overall Study|Adverse Event|3|||
160995259|NCT03568318|581370898|FG001|Overall Study|Adverse Event|1|||
160995260|NCT03568318|581370899|FG002|Overall Study|Adverse Event|1|||
160910792|NCT01599234|581070033|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
160910793|NCT01599234|581070032|FG000|Overall Study|Death|1|||
160910794|NCT01599234|581070033|FG001|Overall Study|Death|0|||
160910795|NCT01599234|581070032|FG000|Overall Study|Patient would not stop driving|1|||
160995261|NCT03568318|581370900|FG003|Overall Study|Adverse Event|0|||
160995262|NCT03568318|581370901|FG004|Overall Study|Adverse Event|1|||
160995263|NCT03568318|581370902|FG005|Overall Study|Adverse Event|0|||
160995264|NCT03568318|581370897|FG000|Overall Study|Withdrawal by Subject|6|||
160995265|NCT03568318|581370898|FG001|Overall Study|Withdrawal by Subject|5|||
160995266|NCT03568318|581370899|FG002|Overall Study|Withdrawal by Subject|2|||
160995267|NCT03568318|581370900|FG003|Overall Study|Withdrawal by Subject|1|||
160995268|NCT03568318|581370901|FG004|Overall Study|Withdrawal by Subject|0|||
160995269|NCT03568318|581370902|FG005|Overall Study|Withdrawal by Subject|0|||
160995270|NCT03568318|581370897|FG000|Overall Study|Lost to Follow-up|3|||
160995271|NCT03568318|581370898|FG001|Overall Study|Lost to Follow-up|2|||
160995272|NCT03568318|581370899|FG002|Overall Study|Lost to Follow-up|2|||
160995273|NCT03568318|581370900|FG003|Overall Study|Lost to Follow-up|2|||
160995274|NCT03568318|581370901|FG004|Overall Study|Lost to Follow-up|1|||
160995275|NCT03568318|581370902|FG005|Overall Study|Lost to Follow-up|0|||
160995276|NCT03568318|581370897|FG000|Overall Study|Other|3|||
160995277|NCT03568318|581370898|FG001|Overall Study|Other|1|||
160995278|NCT03568318|581370899|FG002|Overall Study|Other|3|||
160995279|NCT03568318|581370900|FG003|Overall Study|Other|0|||
160995280|NCT03568318|581370901|FG004|Overall Study|Other|0|||
160910796|NCT01599234|581070033|FG001|Overall Study|Patient would not stop driving|0|||
160910797|NCT01599234|581070032|FG000|Overall Study|Contra-indication discovered|0|||
160910798|NCT01599234|581070033|FG001|Overall Study|Contra-indication discovered|1|||
160995281|NCT03568318|581370902|FG005|Overall Study|Other|0|||
160995282|NCT03568318|581370897|FG000|Overall Study|Ongoing at Time of Analysis|5|||
160995283|NCT03568318|581370898|FG001|Overall Study|Ongoing at Time of Analysis|3|||
160861498|NCT02234843|580885267|FG007|Overall Study|Physician Decision|1|||
160453265|NCT04858451|579392023|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
160453266|NCT04858451|579392024|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
160453267|NCT04858451|579392016|FG000|Part 2|Discontinued|0|||
160453268|NCT04858451|579392017|FG001|Part 2|Discontinued|0|||
160453269|NCT04858451|579392018|FG002|Part 2|Discontinued|0|||
160453270|NCT04858451|579392019|FG003|Part 2|Discontinued|0|||
160453271|NCT04858451|579392020|FG004|Part 2|Discontinued|0|||
160453272|NCT04858451|579392021|FG005|Part 2|Discontinued|0|||
160453273|NCT04858451|579392022|FG006|Part 2|Discontinued|0|||
160453274|NCT04858451|579392023|FG007|Part 2|Discontinued|0|||
160453275|NCT04858451|579392024|FG008|Part 2|Discontinued|63|||
160453276|NCT04119843|579392025|FG000|Overall Study|Adverse Event|3|||
160453277|NCT04119843|579392025|FG000|Overall Study|Death|1|||
160453278|NCT02998268|579392027|FG000|Overall Study|Adverse Event|0|||
160453279|NCT02998268|579392028|FG001|Overall Study|Adverse Event|2|||
160453280|NCT02998268|579392027|FG000|Overall Study|Withdrawal by Subject|0|||
160453281|NCT02998268|579392028|FG001|Overall Study|Withdrawal by Subject|1|||
160453282|NCT04225273|579392029|FG000|Overall Study|Lost to Follow-up|3|||
160453283|NCT03652389|579392030|FG000|Overall Study|Lost to Follow-up|1|||
160453284|NCT03652389|579392031|FG001|Overall Study|Lost to Follow-up|5|||
160453285|NCT03652389|579392030|FG000|Overall Study|Withdrawal by Subject|5|||
160453286|NCT03652389|579392031|FG001|Overall Study|Withdrawal by Subject|1|||
160453287|NCT03652389|579392030|FG000|Overall Study|New diagnosis|2|||
160453288|NCT03652389|579392031|FG001|Overall Study|New diagnosis|0|||
160453289|NCT04231149|579392032|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
160453290|NCT04231149|579392033|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
160453291|NCT04231149|579392034|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
160453292|NCT04231149|579392035|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
160453293|NCT04231149|579392036|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
160453294|NCT03252847|579392037|FG000|Overall Study|Withdrawal by Subject|0|||
160453295|NCT03252847|579392038|FG001|Overall Study|Withdrawal by Subject|0|||
160453296|NCT03252847|579392039|FG002|Overall Study|Withdrawal by Subject|1|||
160453297|NCT03252847|579392040|FG003|Overall Study|Withdrawal by Subject|0|||
160453298|NCT03252847|579392041|FG004|Overall Study|Withdrawal by Subject|0|||
160453299|NCT03252847|579392042|FG005|Overall Study|Withdrawal by Subject|0|||
160453300|NCT03252847|579392043|FG006|Overall Study|Withdrawal by Subject|0|||
160453301|NCT03252847|579392037|FG000|Overall Study|Other: Patient decision|0|||
160453302|NCT03252847|579392038|FG001|Overall Study|Other: Patient decision|0|||
160453303|NCT03252847|579392039|FG002|Overall Study|Other: Patient decision|0|||
160453304|NCT03252847|579392040|FG003|Overall Study|Other: Patient decision|0|||
160453305|NCT03252847|579392041|FG004|Overall Study|Other: Patient decision|1|||
160453306|NCT03252847|579392042|FG005|Overall Study|Other: Patient decision|0|||
160861499|NCT02234843|580885268|FG008|Overall Study|Physician Decision|0|||
160861500|NCT02234843|580885269|FG009|Overall Study|Physician Decision|0|||
160861501|NCT02234843|580885260|FG000|Overall Study|Adverse Event|5|||
160861502|NCT02234843|580885261|FG001|Overall Study|Adverse Event|1|||
160861503|NCT02234843|580885262|FG002|Overall Study|Adverse Event|1|||
160861504|NCT02234843|580885263|FG003|Overall Study|Adverse Event|3|||
160861505|NCT02234843|580885264|FG004|Overall Study|Adverse Event|2|||
160861506|NCT02234843|580885265|FG005|Overall Study|Adverse Event|1|||
160861507|NCT02234843|580885266|FG006|Overall Study|Adverse Event|0|||
160861508|NCT02234843|580885267|FG007|Overall Study|Adverse Event|0|||
160861509|NCT02234843|580885268|FG008|Overall Study|Adverse Event|1|||
160861510|NCT02234843|580885269|FG009|Overall Study|Adverse Event|0|||
160861511|NCT02234843|580885260|FG000|Overall Study|Non-compliance with study drug|1|||
160861512|NCT02234843|580885261|FG001|Overall Study|Non-compliance with study drug|0|||
160861513|NCT02234843|580885262|FG002|Overall Study|Non-compliance with study drug|0|||
160861514|NCT02234843|580885263|FG003|Overall Study|Non-compliance with study drug|0|||
160861515|NCT02234843|580885264|FG004|Overall Study|Non-compliance with study drug|0|||
160861516|NCT02234843|580885265|FG005|Overall Study|Non-compliance with study drug|1|||
160861517|NCT02234843|580885266|FG006|Overall Study|Non-compliance with study drug|1|||
160861518|NCT02234843|580885267|FG007|Overall Study|Non-compliance with study drug|0|||
160861519|NCT02234843|580885268|FG008|Overall Study|Non-compliance with study drug|0|||
160861520|NCT02234843|580885269|FG009|Overall Study|Non-compliance with study drug|0|||
160861521|NCT02234843|580885260|FG000|Overall Study|Lost to Follow-up|0|||
160861522|NCT02234843|580885261|FG001|Overall Study|Lost to Follow-up|1|||
160861523|NCT02234843|580885262|FG002|Overall Study|Lost to Follow-up|0|||
160861524|NCT02234843|580885263|FG003|Overall Study|Lost to Follow-up|0|||
160861525|NCT02234843|580885264|FG004|Overall Study|Lost to Follow-up|0|||
160861526|NCT02234843|580885265|FG005|Overall Study|Lost to Follow-up|0|||
160861527|NCT02234843|580885266|FG006|Overall Study|Lost to Follow-up|1|||
160861528|NCT02234843|580885267|FG007|Overall Study|Lost to Follow-up|0|||
160861529|NCT02234843|580885268|FG008|Overall Study|Lost to Follow-up|0|||
160861530|NCT02234843|580885269|FG009|Overall Study|Lost to Follow-up|0|||
160861531|NCT02331134|580885276|FG000|Overall Study|Withdrawal by Subject|1|||
160861532|NCT04825574|580885280|FG000|Overall Study|Commercial treatment became available|1|||
160861533|NCT04825574|580885280|FG000|Overall Study|Disease progression|1|||
160861534|NCT05967260|580885281|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
160570462|NCT04636177|579810517|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
160570463|NCT04636177|579810518|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
160570464|NCT04636177|579810517|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
160570465|NCT04636177|579810518|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
160570466|NCT04636177|579810517|FG000|Single-arm portion|Withdrawal by Subject|1|||
160570467|NCT04636177|579810518|FG001|Single-arm portion|Withdrawal by Subject|0|||
160570468|NCT04636177|579810517|FG000|Single-arm portion|Adverse Event|1|||
160570469|NCT04636177|579810518|FG001|Single-arm portion|Adverse Event|0|||
160570470|NCT02742649|579812104|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
160570471|NCT02742649|579812105|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
160570472|NCT02742649|579812106|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
160570473|NCT02742649|579812107|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
160910799|NCT01599234|581070032|FG000|Overall Study|Pregnancy|0|||
160910800|NCT01599234|581070033|FG001|Overall Study|Pregnancy|1|||
160910801|NCT02551731|581070035|FG000|Overall Study|Withdrawal by Subject|2|||
160910802|NCT02128113|581070036|FG000|Overall Study|Withdrawal by Subject|3|||
160910803|NCT02128113|581070037|FG001|Overall Study|Withdrawal by Subject|1|||
160910804|NCT02128113|581070038|FG002|Overall Study|Withdrawal by Subject|0|||
160910805|NCT02128113|581070036|FG000|Overall Study|Protocol Violation|0|||
160910806|NCT02128113|581070037|FG001|Overall Study|Protocol Violation|1|||
160910807|NCT02128113|581070038|FG002|Overall Study|Protocol Violation|0|||
160910808|NCT02128113|581070036|FG000|Overall Study|Surgery cancelled|0|||
160910809|NCT02128113|581070037|FG001|Overall Study|Surgery cancelled|1|||
160910810|NCT02128113|581070038|FG002|Overall Study|Surgery cancelled|0|||
160910811|NCT02128113|581070036|FG000|Overall Study|Adverse Event|0|||
160910812|NCT02128113|581070037|FG001|Overall Study|Adverse Event|0|||
160910813|NCT02128113|581070038|FG002|Overall Study|Adverse Event|1|||
160910814|NCT01750242|581070039|FG000|Overall Study|Unreadable Images|3|||
160910815|NCT03765918|581070040|FG000|Overall Study|Death|109|||
160910816|NCT03765918|581070041|FG001|Overall Study|Death|127|||
160910817|NCT03765918|581070040|FG000|Overall Study|Lost to Follow-up|2|||
160910818|NCT03765918|581070041|FG001|Overall Study|Lost to Follow-up|3|||
160910819|NCT03765918|581070040|FG000|Overall Study|Withdrawal by Subject|12|||
160910820|NCT03765918|581070041|FG001|Overall Study|Withdrawal by Subject|16|||
160910821|NCT03765918|581070040|FG000|Overall Study|Participants Ongoing|240|||
160910822|NCT03765918|581070041|FG001|Overall Study|Participants Ongoing|205|||
160910823|NCT04202965|581070042|FG000|Overall Study|Adverse Event|3|||
160910824|NCT04202965|581070042|FG000|Overall Study|Did not meet inclusion criteria|1|||
160910825|NCT02969369|581070043|FG000|Study|Adverse Event|1|||
160910826|NCT02969369|581070044|FG001|Study|Adverse Event|6|||
160570474|NCT02742649|579812108|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
160861535|NCT05967260|580885282|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
160861536|NCT00992108|580887748|FG000|Overall Study|Lost to Follow-up|0|||
160861537|NCT00992108|580887749|FG001|Overall Study|Lost to Follow-up|1|||
160861538|NCT04639245|580887750|FG000|Overall Study|Death|1|||
160861539|NCT02419001|580887753|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
160861540|NCT02419001|580887754|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
160861541|NCT02851615|580887755|FG000|Overall Study|Cognitive Issue|1|||
160861542|NCT02851615|580887756|FG001|Overall Study|Cognitive Issue|0|||
160861543|NCT02851615|580887755|FG000|Overall Study|Lost to Follow-up|0|||
160861544|NCT02851615|580887756|FG001|Overall Study|Lost to Follow-up|4|||
160861545|NCT00371150|580887758|FG000|Overall Study|Lost to Follow-up|3|||
160861546|NCT00371150|580887759|FG001|Overall Study|Lost to Follow-up|2|||
160861547|NCT02151058|580887761|FG000|Overall Study|Withdrawal by Subject|1|||
160861548|NCT02151058|580887762|FG001|Overall Study|Withdrawal by Subject|1|||
160861549|NCT02151058|580887763|FG002|Overall Study|Withdrawal by Subject|3|||
160861550|NCT02151058|580887761|FG000|Overall Study|Lost to Follow-up|1|||
160861551|NCT02151058|580887762|FG001|Overall Study|Lost to Follow-up|0|||
160861552|NCT02151058|580887763|FG002|Overall Study|Lost to Follow-up|2|||
160861553|NCT00321620|580887767|FG000|Overall Study|Death|269|||
160861554|NCT00321620|580887768|FG001|Overall Study|Death|294|||
160861555|NCT00321620|580887767|FG000|Overall Study|Withdrawal by Subject|164|||
160861556|NCT00321620|580887768|FG001|Overall Study|Withdrawal by Subject|147|||
160861557|NCT00321620|580887767|FG000|Overall Study|Disease progression|113|||
160861558|NCT00321620|580887768|FG001|Overall Study|Disease progression|117|||
160861559|NCT00321620|580887767|FG000|Overall Study|Adverse Event|43|||
160861560|NCT00321620|580887768|FG001|Overall Study|Adverse Event|56|||
160861561|NCT00321620|580887767|FG000|Overall Study|Lost to Follow-up|13|||
160861562|NCT00321620|580887768|FG001|Overall Study|Lost to Follow-up|9|||
160861563|NCT00321620|580887767|FG000|Overall Study|Physician Decision|4|||
160570475|NCT02742649|579812104|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160570476|NCT02742649|579812105|FG001|Double-Blind Treatment Period|Adverse Event|1|||
160570477|NCT02742649|579812106|FG002|Double-Blind Treatment Period|Adverse Event|0|||
160570478|NCT02742649|579812107|FG003|Double-Blind Treatment Period|Adverse Event|0|||
160570479|NCT02742649|579812108|FG004|Double-Blind Treatment Period|Adverse Event|0|||
160570480|NCT02742649|579812104|FG000|Open-Label Period|Lost to Follow-up|0|||
160570481|NCT02742649|579812105|FG001|Open-Label Period|Lost to Follow-up|0|||
160570482|NCT02742649|579812106|FG002|Open-Label Period|Lost to Follow-up|0|||
160570483|NCT02742649|579812107|FG003|Open-Label Period|Lost to Follow-up|0|||
160995284|NCT03568318|581370899|FG002|Overall Study|Ongoing at Time of Analysis|2|||
160995285|NCT03568318|581370900|FG003|Overall Study|Ongoing at Time of Analysis|1|||
160995286|NCT03568318|581370901|FG004|Overall Study|Ongoing at Time of Analysis|0|||
160995287|NCT03568318|581370902|FG005|Overall Study|Ongoing at Time of Analysis|0|||
160995288|NCT01249092|581370904|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
160995289|NCT01249092|581370904|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
160995290|NCT03518112|581370905|FG000|Overall Study|Withdrawal by Subject|1|||
160995291|NCT00420316|581370911|FG000|Overall Study|Withdrawal by Subject|0|||
160995292|NCT00420316|581370912|FG001|Overall Study|Withdrawal by Subject|1|||
160995293|NCT00420316|581370911|FG000|Overall Study|Lost to Follow-up|12|||
160995294|NCT00420316|581370912|FG001|Overall Study|Lost to Follow-up|8|||
160995295|NCT03546907|581370913|FG000|Overall Study|Lack of Efficacy|1|||
160995296|NCT03546907|581370914|FG001|Overall Study|Lack of Efficacy|1|||
160995297|NCT03546907|581370913|FG000|Overall Study|Withdrawal by Subject|8|||
160995298|NCT03546907|581370914|FG001|Overall Study|Withdrawal by Subject|9|||
160995299|NCT03546907|581370913|FG000|Overall Study|Adverse events (AEs)|7|||
160995300|NCT03546907|581370914|FG001|Overall Study|Adverse events (AEs)|10|||
160995301|NCT03546907|581370913|FG000|Overall Study|Other-unspecified|1|||
160995302|NCT03546907|581370914|FG001|Overall Study|Other-unspecified|1|||
160995303|NCT03720210|581370915|FG000|Overall Study|Lost to Follow-up|1|||
160995304|NCT04033432|581370916|FG000|Overall Study|Progressive Disease|8|||
160995305|NCT04033432|581370916|FG000|Overall Study|Adverse Event|4|||
160995306|NCT04033432|581370916|FG000|Overall Study|Death|1|||
160995307|NCT02274493|581370922|FG000|Overall Study|Withdrawal by Subject|1|||
160995308|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995309|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
160995310|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995311|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995312|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995313|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995314|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995315|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995316|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995317|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995318|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995319|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995320|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995321|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Death|0|||
160995322|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Death|0|||
160995323|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Death|0|||
160995324|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Death|1|||
160995325|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Death|0|||
160995326|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Death|0|||
160995327|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Death|0|||
160995328|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Death|0|||
160995329|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Death|0|||
160995330|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Death|0|||
160995331|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Death|0|||
160995332|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Death|0|||
160995333|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Death|0|||
160995334|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995335|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
160995336|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
160570484|NCT02742649|579812108|FG004|Open-Label Period|Lost to Follow-up|1|||
160570485|NCT01494038|579812114|FG000|Overall Study|Protocol Violation|1|||
160570486|NCT01494038|579812115|FG001|Overall Study|Protocol Violation|1|||
160570487|NCT01494038|579812114|FG000|Overall Study|Lost to Follow-up|18|||
160995337|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
160995338|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
160995339|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160570488|NCT01494038|579812115|FG001|Overall Study|Lost to Follow-up|20|||
160570489|NCT01494038|579812114|FG000|Overall Study|Withdrawal by Subject|44|||
160570490|NCT01494038|579812115|FG001|Overall Study|Withdrawal by Subject|34|||
160995340|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995341|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995342|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995343|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995344|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995345|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160570491|NCT01494038|579812114|FG000|Overall Study|Not able to get to clinic|21|||
160570492|NCT01494038|579812115|FG001|Overall Study|Not able to get to clinic|15|||
160570493|NCT01494038|579812114|FG000|Overall Study|Not willing to adhere to reqs|2|||
160995346|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995347|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995348|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
160995349|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160570494|NCT01494038|579812115|FG001|Overall Study|Not willing to adhere to reqs|9|||
160570495|NCT01494038|579812114|FG000|Overall Study|Death|2|||
160570496|NCT01494038|579812115|FG001|Overall Study|Death|4|||
160570497|NCT02138110|579812119|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
160570498|NCT02138110|579812119|FG000|Overall Scaffold Implantation|Death|3|||
160570499|NCT01059812|579812120|FG000|Overall Study|Adverse Event|9|||
160570500|NCT01059812|579812121|FG001|Overall Study|Adverse Event|5|||
160570501|NCT01059812|579812120|FG000|Overall Study|Lack of Efficacy|2|||
160995350|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995351|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995352|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995353|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995354|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995355|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995356|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995357|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995358|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995359|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995360|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995361|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995362|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
160995363|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995364|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160570502|NCT01059812|579812121|FG001|Overall Study|Lack of Efficacy|2|||
160570503|NCT01059812|579812120|FG000|Overall Study|Protocol Violation|3|||
160570504|NCT01059812|579812121|FG001|Overall Study|Protocol Violation|1|||
160570505|NCT01059812|579812120|FG000|Overall Study|Withdrawal Criteria|9|||
160570506|NCT01059812|579812121|FG001|Overall Study|Withdrawal Criteria|4|||
160570507|NCT01059812|579812120|FG000|Overall Study|Unclassified|14|||
160570508|NCT01059812|579812121|FG001|Overall Study|Unclassified|4|||
160910827|NCT02969369|581070043|FG000|Study|Lack of Efficacy|0|||
160910828|NCT02969369|581070044|FG001|Study|Lack of Efficacy|1|||
160910829|NCT02969369|581070043|FG000|Study|Lost to Follow-up|0|||
160910830|NCT02969369|581070044|FG001|Study|Lost to Follow-up|1|||
160910831|NCT02969369|581070043|FG000|Study|Withdrawal by Subject|3|||
160910832|NCT02969369|581070044|FG001|Study|Withdrawal by Subject|5|||
160910833|NCT02969369|581070043|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
160910834|NCT02969369|581070044|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
160910835|NCT02969369|581070043|FG000|Double-blind Period|Adverse Event|1|||
160910836|NCT02969369|581070044|FG001|Double-blind Period|Adverse Event|5|||
160910837|NCT02969369|581070043|FG000|Double-blind Period|Lost to Follow-up|0|||
160910838|NCT02969369|581070044|FG001|Double-blind Period|Lost to Follow-up|1|||
160910839|NCT02969369|581070043|FG000|Double-blind Period|Withdrawal by Subject|2|||
160995365|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995366|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995367|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995368|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995369|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995370|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995371|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995372|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160570509|NCT00756002|579812125|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
160910840|NCT02969369|581070044|FG001|Double-blind Period|Withdrawal by Subject|3|||
160910841|NCT02969369|581070043|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
160910842|NCT02969369|581070044|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
160570510|NCT00756002|579812126|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
160570511|NCT00756002|579812125|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160570512|NCT00756002|579812126|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
160995373|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
160910843|NCT02969369|581070043|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
160910844|NCT02969369|581070044|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
160910845|NCT02969369|581070043|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
160910846|NCT02969369|581070044|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
160910847|NCT02969369|581070043|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
160910848|NCT02969369|581070044|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
160910849|NCT01980992|581070047|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
160910850|NCT01980992|581070048|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
160910851|NCT01980992|581070047|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
160910852|NCT01980992|581070048|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
160910853|NCT01980992|581070047|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
160910854|NCT01980992|581070048|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
160910855|NCT01980992|581070047|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
160910856|NCT01980992|581070048|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
160910857|NCT01980992|581070047|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
160910858|NCT01980992|581070048|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
160910859|NCT01980992|581070047|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
160910860|NCT01980992|581070048|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
160910861|NCT00299975|581070049|FG000|Overall Study|Adverse Event|1|||
160910862|NCT00299975|581070050|FG001|Overall Study|Adverse Event|0|||
160910863|NCT00299975|581070051|FG002|Overall Study|Adverse Event|2|||
160910864|NCT00299975|581070049|FG000|Overall Study|Pregnancy|0|||
160910865|NCT00299975|581070050|FG001|Overall Study|Pregnancy|0|||
160910866|NCT00299975|581070051|FG002|Overall Study|Pregnancy|1|||
160910867|NCT00299975|581070049|FG000|Overall Study|Lack of Efficacy|1|||
160910868|NCT00299975|581070050|FG001|Overall Study|Lack of Efficacy|0|||
160910869|NCT00299975|581070051|FG002|Overall Study|Lack of Efficacy|1|||
160910870|NCT00299975|581070049|FG000|Overall Study|Lost to Follow-up|1|||
160910871|NCT00299975|581070050|FG001|Overall Study|Lost to Follow-up|0|||
160910872|NCT00299975|581070051|FG002|Overall Study|Lost to Follow-up|0|||
160910873|NCT00299975|581070049|FG000|Overall Study|Withdrawal by Subject|0|||
160910874|NCT00299975|581070050|FG001|Overall Study|Withdrawal by Subject|1|||
160910875|NCT00299975|581070051|FG002|Overall Study|Withdrawal by Subject|3|||
160910876|NCT00299975|581070049|FG000|Overall Study|Physician Decision|0|||
160910877|NCT00299975|581070050|FG001|Overall Study|Physician Decision|0|||
160910878|NCT00299975|581070051|FG002|Overall Study|Physician Decision|1|||
160910879|NCT01169493|581070055|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
160910880|NCT01169493|581070056|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
160910881|NCT01169493|581070057|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
160910882|NCT01169493|581070058|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
160910883|NCT01169493|581070059|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
160910884|NCT01169493|581070060|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
160910885|NCT01169493|581070055|FG000|Period 3 (6 Months)|Adverse Event|0|||
160910886|NCT01169493|581070056|FG001|Period 3 (6 Months)|Adverse Event|1|||
160910887|NCT01169493|581070057|FG002|Period 3 (6 Months)|Adverse Event|0|||
160910888|NCT01169493|581070058|FG003|Period 3 (6 Months)|Adverse Event|0|||
160910889|NCT01169493|581070059|FG004|Period 3 (6 Months)|Adverse Event|0|||
160910890|NCT01169493|581070060|FG005|Period 3 (6 Months)|Adverse Event|0|||
160910891|NCT01169493|581070055|FG000|Period 3 (6 Months)|Physician Decision|0|||
160910892|NCT01169493|581070056|FG001|Period 3 (6 Months)|Physician Decision|1|||
160910893|NCT01169493|581070057|FG002|Period 3 (6 Months)|Physician Decision|1|||
160910894|NCT01169493|581070058|FG003|Period 3 (6 Months)|Physician Decision|0|||
160910895|NCT01169493|581070059|FG004|Period 3 (6 Months)|Physician Decision|0|||
160910896|NCT01169493|581070060|FG005|Period 3 (6 Months)|Physician Decision|0|||
160910897|NCT05228132|581070061|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
160910898|NCT05228132|581070061|FG000|Overall Study|Adverse Event|3|||
160910899|NCT05228132|581070061|FG000|Overall Study|Lost to Follow-up|1|||
160910900|NCT05228132|581070061|FG000|Overall Study|Arteriovenous-fistula mature|1|||
160910901|NCT00211809|581070070|FG000|Overall Study|Lack of Efficacy|1|||
160910902|NCT00211809|581070070|FG000|Overall Study|Lost to Follow-up|2|||
160910903|NCT00211809|581070070|FG000|Overall Study|Pregnancy|1|||
160910904|NCT00211809|581070070|FG000|Overall Study|side effects|2|||
160910905|NCT00036270|581070072|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
160910906|NCT00036270|581070073|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
160910907|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
160652731|NCT00365352|580108719|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
160910908|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
160910909|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
160910910|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
160995374|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
160995375|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
160652732|NCT00365352|580108720|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
160453307|NCT03252847|579392043|FG006|Overall Study|Other: Patient decision|0|||
160453308|NCT01501955|579392046|FG000|Overall Study|Withdrawal by Subject|1|||
160453309|NCT01501955|579392047|FG001|Overall Study|Withdrawal by Subject|0|||
160453310|NCT01501955|579392046|FG000|Overall Study|Adverse Event|1|||
160453311|NCT01501955|579392047|FG001|Overall Study|Adverse Event|3|||
160453312|NCT04298983|579392050|FG000|Overall Study|Adverse Event|4|||
160453313|NCT04298983|579392050|FG000|Overall Study|Lack of Efficacy|3|||
160453314|NCT05477186|579392051|FG000|Overall Study|Vaccine not administered|0|||
160453315|NCT05477186|579392052|FG001|Overall Study|Vaccine not administered|2|||
160453316|NCT05477186|579392053|FG002|Overall Study|Vaccine not administered|1|||
160453317|NCT05477186|579392054|FG003|Overall Study|Vaccine not administered|0|||
160453318|NCT05477186|579392055|FG004|Overall Study|Vaccine not administered|1|||
160453319|NCT05477186|579392056|FG005|Overall Study|Vaccine not administered|0|||
160453320|NCT05477186|579392057|FG006|Overall Study|Vaccine not administered|0|||
160453321|NCT05477186|579392051|FG000|Overall Study|Withdrawal by Subject|1|||
160453322|NCT05477186|579392052|FG001|Overall Study|Withdrawal by Subject|0|||
160453323|NCT05477186|579392053|FG002|Overall Study|Withdrawal by Subject|0|||
160453324|NCT05477186|579392054|FG003|Overall Study|Withdrawal by Subject|0|||
160453325|NCT05477186|579392055|FG004|Overall Study|Withdrawal by Subject|0|||
160453326|NCT05477186|579392056|FG005|Overall Study|Withdrawal by Subject|1|||
160453327|NCT05477186|579392057|FG006|Overall Study|Withdrawal by Subject|0|||
160910911|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
160910912|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
160910913|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Other|277|||
160910914|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Other|288|||
160910915|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
160910916|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
160910917|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
160910918|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
160910919|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
160910920|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
160910921|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
160910922|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
160910923|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
160910924|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
160910925|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
160910926|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
160910927|NCT01370356|581070074|FG000|Overall Study|Death|1|||
160910928|NCT01370356|581070075|FG001|Overall Study|Death|0|||
160910929|NCT01370356|581070074|FG000|Overall Study|Lack of Efficacy|6|||
160910930|NCT01370356|581070075|FG001|Overall Study|Lack of Efficacy|28|||
160910931|NCT01370356|581070074|FG000|Overall Study|Lost to Follow-up|76|||
160910932|NCT01370356|581070075|FG001|Overall Study|Lost to Follow-up|81|||
160910933|NCT01370356|581070074|FG000|Overall Study|Withdrawal by Subject|54|||
160910934|NCT01370356|581070075|FG001|Overall Study|Withdrawal by Subject|59|||
160910935|NCT01370356|581070074|FG000|Overall Study|Reason not specified|39|||
160910936|NCT01370356|581070075|FG001|Overall Study|Reason not specified|43|||
160910937|NCT01370356|581070074|FG000|Overall Study|Protocol Violation|3|||
160910938|NCT01370356|581070075|FG001|Overall Study|Protocol Violation|3|||
160910939|NCT01370356|581070074|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
160910940|NCT01370356|581070075|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
160910941|NCT01370356|581070074|FG000|Overall Study|AE Not Related to Study Drug|1|||
160910942|NCT01370356|581070075|FG001|Overall Study|AE Not Related to Study Drug|4|||
160910943|NCT01218243|581070076|FG000|Overall Study|Lack of Efficacy|1|||
160910944|NCT01218243|581070077|FG001|Overall Study|Lack of Efficacy|1|||
160910945|NCT01218243|581070076|FG000|Overall Study|Lost to Follow-up|3|||
160910946|NCT01218243|581070077|FG001|Overall Study|Lost to Follow-up|3|||
160910947|NCT01218243|581070076|FG000|Overall Study|Protocol Violation|5|||
160910948|NCT01218243|581070077|FG001|Overall Study|Protocol Violation|10|||
160910949|NCT00799422|581070081|FG000|First Week of Wear|Lost to Follow-up|0|||
160910950|NCT00799422|581070082|FG001|First Week of Wear|Lost to Follow-up|0|||
160910951|NCT00799422|581070083|FG002|First Week of Wear|Lost to Follow-up|1|||
160910952|NCT00799422|581070084|FG003|First Week of Wear|Lost to Follow-up|0|||
160910953|NCT00799422|581070085|FG004|First Week of Wear|Lost to Follow-up|0|||
160453328|NCT05477186|579392051|FG000|Overall Study|Lost to Follow-up|1|||
160453329|NCT05477186|579392052|FG001|Overall Study|Lost to Follow-up|0|||
160453330|NCT05477186|579392053|FG002|Overall Study|Lost to Follow-up|2|||
160453331|NCT05477186|579392054|FG003|Overall Study|Lost to Follow-up|1|||
160453332|NCT05477186|579392055|FG004|Overall Study|Lost to Follow-up|1|||
160453333|NCT05477186|579392056|FG005|Overall Study|Lost to Follow-up|0|||
160453334|NCT05477186|579392057|FG006|Overall Study|Lost to Follow-up|2|||
160910954|NCT00799422|581070086|FG005|First Week of Wear|Lost to Follow-up|0|||
160910955|NCT00799422|581070081|FG000|First Week of Wear|Adverse Event|0|||
160910956|NCT00799422|581070082|FG001|First Week of Wear|Adverse Event|0|||
160910957|NCT00799422|581070083|FG002|First Week of Wear|Adverse Event|0|||
160995376|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
160995377|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
160910958|NCT00799422|581070084|FG003|First Week of Wear|Adverse Event|1|||
160910959|NCT00799422|581070085|FG004|First Week of Wear|Adverse Event|0|||
160910960|NCT00799422|581070086|FG005|First Week of Wear|Adverse Event|0|||
160910961|NCT01496612|581070088|FG000|1st Intervention|Adverse Event|1|||
160910962|NCT01496612|581070089|FG001|1st Intervention|Adverse Event|0|||
160910963|NCT01496612|581070088|FG000|1st Intervention|Withdrawal by Subject|1|||
160910964|NCT01496612|581070089|FG001|1st Intervention|Withdrawal by Subject|0|||
160910965|NCT00291577|581070090|FG000|Overall Study|Adverse Event|1|||
160910966|NCT00291577|581070090|FG000|Overall Study|Other|4|||
160910967|NCT00291577|581070090|FG000|Overall Study|Withdrawal by Subject|2|||
160910968|NCT00291577|581070090|FG000|Overall Study|Lack of Efficacy|14|||
160910969|NCT03129100|581070091|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
160910970|NCT03129100|581070092|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
160910971|NCT03129100|581070093|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
160910972|NCT03129100|581070094|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
160910973|NCT03129100|581070095|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
160910974|NCT03129100|581070096|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
160910975|NCT03129100|581070097|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
160910976|NCT03129100|581070098|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
160910977|NCT03129100|581070099|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
160910978|NCT03129100|581070100|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
160910979|NCT03129100|581070101|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
160910980|NCT03129100|581070102|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
160910981|NCT03129100|581070103|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
160910982|NCT03129100|581070104|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
160910983|NCT03129100|581070105|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
160910984|NCT03129100|581070106|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
160910985|NCT03129100|581070107|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
160910986|NCT03129100|581070108|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
160910987|NCT03129100|581070109|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
160910988|NCT03129100|581070110|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
160910989|NCT03129100|581070111|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
160910990|NCT03129100|581070112|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
160910991|NCT03129100|581070113|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
160910992|NCT03129100|581070114|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
160910993|NCT03129100|581070115|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
160910994|NCT03129100|581070116|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
160910995|NCT03129100|581070091|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
160910996|NCT03129100|581070092|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160910997|NCT03129100|581070093|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160910998|NCT03129100|581070094|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160910999|NCT03129100|581070095|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911000|NCT03129100|581070096|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911001|NCT03129100|581070097|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911002|NCT03129100|581070098|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911003|NCT03129100|581070099|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911004|NCT03129100|581070100|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911005|NCT03129100|581070101|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911006|NCT03129100|581070102|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911007|NCT03129100|581070103|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911008|NCT03129100|581070104|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911009|NCT03129100|581070105|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911010|NCT03129100|581070106|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911011|NCT03129100|581070107|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911012|NCT03129100|581070108|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911013|NCT03129100|581070109|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911014|NCT03129100|581070110|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911015|NCT03129100|581070111|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911016|NCT03129100|581070112|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911017|NCT03129100|581070113|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160995378|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995379|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160453335|NCT01919554|579392059|FG000|Overall Study|Withdrawal by Subject|0|||
160453336|NCT01919554|579392060|FG001|Overall Study|Withdrawal by Subject|0|||
160911018|NCT03129100|581070114|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160652733|NCT00462982|580108725|FG000|Overall Study|Adverse Event|1|||
160911019|NCT03129100|581070115|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911020|NCT03129100|581070116|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911021|NCT03129100|581070091|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
160453337|NCT01919554|579392061|FG002|Overall Study|Withdrawal by Subject|1|||
160911022|NCT03129100|581070092|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
160911023|NCT03129100|581070093|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911024|NCT03129100|581070094|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911025|NCT03129100|581070095|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911026|NCT03129100|581070096|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911027|NCT03129100|581070097|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911028|NCT03129100|581070098|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911029|NCT03129100|581070099|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911030|NCT03129100|581070100|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911031|NCT03129100|581070101|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911032|NCT03129100|581070102|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911033|NCT03129100|581070103|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911034|NCT03129100|581070104|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911035|NCT03129100|581070105|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911036|NCT03129100|581070106|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911037|NCT03129100|581070107|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911038|NCT03129100|581070108|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911039|NCT03129100|581070109|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911040|NCT03129100|581070110|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911041|NCT03129100|581070111|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911042|NCT03129100|581070112|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911043|NCT03129100|581070113|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911044|NCT03129100|581070114|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911045|NCT03129100|581070115|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911046|NCT03129100|581070116|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911047|NCT03129100|581070091|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
160911048|NCT03129100|581070092|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
160911049|NCT03129100|581070093|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911050|NCT03129100|581070094|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911051|NCT03129100|581070095|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911052|NCT03129100|581070096|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911053|NCT03129100|581070097|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911054|NCT03129100|581070098|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911055|NCT03129100|581070099|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911056|NCT03129100|581070100|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911057|NCT03129100|581070101|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911058|NCT03129100|581070102|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911059|NCT03129100|581070103|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911060|NCT03129100|581070104|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911061|NCT03129100|581070105|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911062|NCT03129100|581070106|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911063|NCT03129100|581070107|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911064|NCT03129100|581070108|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911065|NCT03129100|581070109|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911066|NCT03129100|581070110|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911067|NCT03129100|581070111|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911068|NCT03129100|581070112|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911069|NCT03129100|581070113|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911070|NCT03129100|581070114|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911071|NCT03129100|581070115|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911072|NCT03129100|581070116|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911073|NCT03129100|581070091|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911074|NCT03129100|581070092|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
160911075|NCT03129100|581070093|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911076|NCT03129100|581070094|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911077|NCT03129100|581070095|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911078|NCT03129100|581070096|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911079|NCT03129100|581070097|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911080|NCT03129100|581070098|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911081|NCT03129100|581070099|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911082|NCT03129100|581070100|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911083|NCT03129100|581070101|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911084|NCT03129100|581070102|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911085|NCT03129100|581070103|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911086|NCT03129100|581070104|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911087|NCT03129100|581070105|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911088|NCT03129100|581070106|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911089|NCT03129100|581070107|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911090|NCT03129100|581070108|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911091|NCT03129100|581070109|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911092|NCT03129100|581070110|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911093|NCT03129100|581070111|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911094|NCT03129100|581070112|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911095|NCT03129100|581070113|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911096|NCT03129100|581070114|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911097|NCT03129100|581070115|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911098|NCT03129100|581070116|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911099|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160995380|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160911100|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911101|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
160911102|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
160911103|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911104|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
160911105|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911106|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911107|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911108|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911109|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911110|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911111|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911112|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911113|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911114|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911115|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911116|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911117|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911118|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911119|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911120|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911121|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911122|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911123|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911124|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911125|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Death|0|||
160911126|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Death|0|||
160911127|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Death|1|||
160911128|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Death|0|||
160911129|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Death|0|||
160911130|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Death|0|||
160911131|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Death|0|||
160911132|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Death|0|||
160911133|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Death|0|||
160911134|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Death|0|||
160911135|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Death|0|||
160911136|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Death|0|||
160911137|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Death|0|||
160911138|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Death|0|||
160911139|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Death|0|||
160911140|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Death|0|||
160911141|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Death|0|||
160911142|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Death|0|||
160911143|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Death|0|||
160911144|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Death|0|||
160995381|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995382|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995383|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995384|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995385|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995386|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995387|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995388|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995389|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160911145|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Death|0|||
160911146|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Death|0|||
160570513|NCT00756002|579812125|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
160911147|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Death|0|||
160911148|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Death|0|||
160911149|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Death|0|||
160911150|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Death|0|||
160911151|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911152|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911153|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
160911154|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
160911155|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
160911156|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
160911157|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
160911158|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911159|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911160|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911161|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911162|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911163|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911164|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911165|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911166|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911167|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911168|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160652734|NCT00462982|580108725|FG000|Overall Study|Patient Not Treated|2|||
160911169|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911170|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911171|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911172|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911173|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911174|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911175|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911176|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911177|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911178|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911179|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
160911180|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911181|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911182|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911183|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911184|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911185|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911186|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911187|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911188|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911189|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911190|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911191|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911192|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911193|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911194|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911195|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911196|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911197|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911198|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911199|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911200|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911201|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911202|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911203|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911204|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911205|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
160911206|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160652735|NCT05514119|580110336|FG000|Overall Study|Ineligible due to disease progression|1|||
160652736|NCT02946385|580110337|FG000|Overall Study|Lost to Follow-up|0|||
160570514|NCT00756002|579812126|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
160570515|NCT00756002|579812125|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
160911207|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911208|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911209|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911210|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911211|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911212|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911213|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911214|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911215|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911216|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911217|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911218|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911219|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911220|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911221|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911222|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911223|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911224|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911225|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911226|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911227|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911228|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911229|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911230|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911231|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
160911232|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911233|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911234|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911235|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911236|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911237|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911238|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911239|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911240|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911241|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911242|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911243|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911244|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911245|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911246|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911247|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911248|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911249|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911250|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911251|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911252|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911253|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911254|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911255|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911256|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911257|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911258|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911259|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
160911260|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
160911261|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
160911262|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911263|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911264|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160570516|NCT00756002|579812126|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
160570517|NCT00756002|579812125|FG000|Double-Blind Treatment Period|Other|2|||
160570518|NCT00756002|579812126|FG001|Double-Blind Treatment Period|Other|2|||
160995390|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
160995391|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995392|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995393|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995394|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995395|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995396|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995397|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995398|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995399|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
160995400|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995401|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995402|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995403|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995404|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995405|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995406|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995407|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995408|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995409|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995410|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995411|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995412|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995413|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995414|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995415|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995416|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995417|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
160995418|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
160995419|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995420|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995421|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
160995422|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
160995423|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
160995424|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
160995425|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995426|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995427|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995428|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995429|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995430|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
160995431|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
160995432|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995433|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995434|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
160995435|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
160995436|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
160995437|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
160995438|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995439|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995440|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995441|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995442|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995443|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995444|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995445|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995446|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995447|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
160995448|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995449|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
160995450|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
160453338|NCT01919554|579392062|FG003|Overall Study|Withdrawal by Subject|1|||
160911265|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911266|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911267|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911268|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911269|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911270|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911271|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911272|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911273|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911274|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911275|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911276|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911277|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911278|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911279|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911280|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911281|NCT03129100|581070091|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911282|NCT03129100|581070092|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911283|NCT03129100|581070093|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911284|NCT03129100|581070094|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911285|NCT03129100|581070095|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911286|NCT03129100|581070096|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911287|NCT03129100|581070097|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911288|NCT03129100|581070098|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911289|NCT03129100|581070099|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911290|NCT03129100|581070100|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
160911291|NCT03129100|581070101|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911292|NCT03129100|581070102|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911293|NCT03129100|581070103|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911294|NCT03129100|581070104|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911295|NCT03129100|581070105|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911296|NCT03129100|581070106|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911297|NCT03129100|581070107|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911298|NCT03129100|581070108|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911299|NCT03129100|581070109|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911300|NCT03129100|581070110|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911301|NCT03129100|581070111|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911302|NCT03129100|581070112|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911303|NCT03129100|581070113|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911304|NCT03129100|581070114|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911305|NCT03129100|581070115|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911306|NCT03129100|581070116|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911307|NCT03129100|581070091|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911308|NCT03129100|581070092|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911309|NCT03129100|581070093|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911310|NCT03129100|581070094|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911311|NCT03129100|581070095|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911312|NCT03129100|581070096|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911313|NCT03129100|581070097|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911314|NCT03129100|581070098|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911315|NCT03129100|581070099|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911316|NCT03129100|581070100|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911317|NCT03129100|581070101|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911318|NCT03129100|581070102|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
160911319|NCT03129100|581070103|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911320|NCT03129100|581070104|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911321|NCT03129100|581070105|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911322|NCT03129100|581070106|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911323|NCT03129100|581070107|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911324|NCT03129100|581070108|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911325|NCT03129100|581070109|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911326|NCT03129100|581070110|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911327|NCT03129100|581070111|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911328|NCT03129100|581070112|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911329|NCT03129100|581070113|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911330|NCT03129100|581070114|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911331|NCT03129100|581070115|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911332|NCT03129100|581070116|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911333|NCT03129100|581070091|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911334|NCT03129100|581070092|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911335|NCT03129100|581070093|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911336|NCT03129100|581070094|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911337|NCT03129100|581070095|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911338|NCT03129100|581070096|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911339|NCT03129100|581070097|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911340|NCT03129100|581070098|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911341|NCT03129100|581070099|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911342|NCT03129100|581070100|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911343|NCT03129100|581070101|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911344|NCT03129100|581070102|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
160911345|NCT03129100|581070103|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
160911346|NCT03129100|581070104|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
160911347|NCT03129100|581070105|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
160911348|NCT03129100|581070106|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911349|NCT03129100|581070107|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911350|NCT03129100|581070108|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911351|NCT03129100|581070109|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911352|NCT03129100|581070110|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911353|NCT03129100|581070111|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911354|NCT03129100|581070112|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911355|NCT03129100|581070113|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911356|NCT03129100|581070114|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911357|NCT03129100|581070115|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911358|NCT03129100|581070116|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911359|NCT03129100|581070091|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911360|NCT03129100|581070092|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911361|NCT03129100|581070093|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911362|NCT03129100|581070094|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911363|NCT03129100|581070095|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911364|NCT03129100|581070096|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911365|NCT03129100|581070097|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911366|NCT03129100|581070098|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911367|NCT03129100|581070099|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911368|NCT03129100|581070100|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911369|NCT03129100|581070101|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911370|NCT03129100|581070102|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
160911371|NCT03129100|581070103|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911372|NCT03129100|581070104|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
160911373|NCT03129100|581070105|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
160911374|NCT03129100|581070106|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911375|NCT03129100|581070107|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911376|NCT03129100|581070108|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911377|NCT03129100|581070109|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911378|NCT03129100|581070110|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911379|NCT03129100|581070111|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911380|NCT03129100|581070112|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911381|NCT03129100|581070113|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911382|NCT03129100|581070114|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911383|NCT03129100|581070115|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911384|NCT03129100|581070116|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911385|NCT03129100|581070091|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911386|NCT03129100|581070092|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911387|NCT03129100|581070093|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911388|NCT03129100|581070094|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911389|NCT03129100|581070095|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911390|NCT03129100|581070096|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911391|NCT03129100|581070097|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911392|NCT03129100|581070098|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911393|NCT03129100|581070099|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911394|NCT03129100|581070100|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911395|NCT03129100|581070101|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911396|NCT03129100|581070102|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911397|NCT03129100|581070103|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911398|NCT03129100|581070104|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911399|NCT03129100|581070105|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911400|NCT03129100|581070106|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
160911401|NCT03129100|581070107|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911402|NCT03129100|581070108|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911403|NCT03129100|581070109|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911404|NCT03129100|581070110|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911405|NCT03129100|581070111|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911406|NCT03129100|581070112|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911407|NCT03129100|581070113|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911408|NCT03129100|581070114|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911409|NCT03129100|581070115|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911410|NCT03129100|581070116|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911411|NCT03129100|581070091|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911412|NCT03129100|581070092|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911413|NCT03129100|581070093|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911414|NCT03129100|581070094|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911415|NCT03129100|581070095|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911416|NCT03129100|581070096|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911417|NCT03129100|581070097|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911418|NCT03129100|581070098|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911419|NCT03129100|581070099|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911420|NCT03129100|581070100|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911421|NCT03129100|581070101|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911422|NCT03129100|581070102|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911423|NCT03129100|581070103|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
160911424|NCT03129100|581070104|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911425|NCT03129100|581070105|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
160911426|NCT03129100|581070106|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
160911427|NCT03129100|581070107|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911428|NCT03129100|581070108|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911429|NCT03129100|581070109|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911430|NCT03129100|581070110|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911431|NCT03129100|581070111|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911432|NCT03129100|581070112|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911433|NCT03129100|581070113|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911434|NCT03129100|581070114|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911435|NCT03129100|581070115|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911436|NCT03129100|581070116|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911437|NCT03129100|581070091|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911438|NCT03129100|581070092|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911439|NCT03129100|581070093|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911440|NCT03129100|581070094|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911441|NCT03129100|581070095|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911442|NCT03129100|581070096|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911443|NCT03129100|581070097|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911444|NCT03129100|581070098|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911445|NCT03129100|581070099|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911446|NCT03129100|581070100|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911447|NCT03129100|581070101|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911448|NCT03129100|581070102|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911449|NCT03129100|581070103|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911450|NCT03129100|581070104|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911451|NCT03129100|581070105|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911452|NCT03129100|581070106|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911453|NCT03129100|581070107|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160995451|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995452|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
160911454|NCT03129100|581070108|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
160911455|NCT03129100|581070109|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911456|NCT03129100|581070110|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
160911457|NCT03129100|581070111|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911458|NCT03129100|581070112|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911459|NCT03129100|581070113|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911460|NCT03129100|581070114|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911461|NCT03129100|581070115|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911462|NCT03129100|581070116|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911463|NCT03129100|581070091|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911464|NCT03129100|581070092|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911465|NCT03129100|581070093|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911466|NCT03129100|581070094|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911467|NCT03129100|581070095|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911468|NCT03129100|581070096|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911469|NCT03129100|581070097|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911470|NCT03129100|581070098|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911471|NCT03129100|581070099|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911472|NCT03129100|581070100|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911473|NCT03129100|581070101|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911474|NCT03129100|581070102|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911475|NCT03129100|581070103|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911476|NCT03129100|581070104|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911477|NCT03129100|581070105|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911478|NCT03129100|581070106|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911479|NCT03129100|581070107|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911480|NCT03129100|581070108|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911481|NCT03129100|581070109|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911482|NCT03129100|581070110|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911483|NCT03129100|581070111|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
160911484|NCT03129100|581070112|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911485|NCT03129100|581070113|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911486|NCT03129100|581070114|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911487|NCT03129100|581070115|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911488|NCT03129100|581070116|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911489|NCT03129100|581070091|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
160911490|NCT03129100|581070092|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
160911491|NCT03129100|581070093|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
160911492|NCT03129100|581070094|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
160911493|NCT03129100|581070095|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
160911494|NCT03129100|581070096|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
160911495|NCT03129100|581070097|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
160911496|NCT03129100|581070098|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
160911497|NCT03129100|581070099|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
160911498|NCT03129100|581070100|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
160911499|NCT03129100|581070101|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
160911500|NCT03129100|581070102|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
160911501|NCT03129100|581070103|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
160911502|NCT03129100|581070104|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
160911503|NCT03129100|581070105|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
160911504|NCT03129100|581070106|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
160911505|NCT03129100|581070107|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
160911506|NCT03129100|581070108|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
160911507|NCT03129100|581070109|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
160911508|NCT03129100|581070110|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
160911509|NCT03129100|581070111|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
160911510|NCT03129100|581070112|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
160911511|NCT03129100|581070113|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
160911512|NCT03129100|581070114|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
160911513|NCT03129100|581070115|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
160911514|NCT03129100|581070116|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
160911515|NCT03129100|581070091|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911516|NCT03129100|581070092|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911517|NCT03129100|581070093|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911518|NCT03129100|581070094|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911519|NCT03129100|581070095|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911520|NCT03129100|581070096|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911521|NCT03129100|581070097|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911522|NCT03129100|581070098|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911523|NCT03129100|581070099|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911524|NCT03129100|581070100|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160453339|NCT01733316|579392063|FG000|RP103 Phase|Non-compliance|1|||
160453340|NCT01733316|579392063|FG000|Long Term Extension Phase|Adverse Event|1|||
160453341|NCT01733316|579392063|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
160453342|NCT01733316|579392063|FG000|Long Term Extension Phase|Sponsor Decision|2|||
160453343|NCT04914676|579392064|FG000|Overall Study|Study termination|3|||
160453344|NCT04914676|579392065|FG001|Overall Study|Study termination|0|||
160453345|NCT03024437|579392066|FG000|Overall Study|Adverse Event|0|||
160453346|NCT03024437|579392067|FG001|Overall Study|Adverse Event|1|||
160570519|NCT04329923|579812129|FG000|Overall Study|Withdrawal by Subject|1|||
160995453|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995454|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995455|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995456|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
160995457|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995458|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
160995459|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995460|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995461|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995462|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995463|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995464|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Death|0|||
160911525|NCT03129100|581070101|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911526|NCT03129100|581070102|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911527|NCT03129100|581070103|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911528|NCT03129100|581070104|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911529|NCT03129100|581070105|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911530|NCT03129100|581070106|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911531|NCT03129100|581070107|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911532|NCT03129100|581070108|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911533|NCT03129100|581070109|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911534|NCT03129100|581070110|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911535|NCT03129100|581070111|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
160911536|NCT03129100|581070112|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911537|NCT03129100|581070113|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911538|NCT03129100|581070114|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911539|NCT03129100|581070115|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911540|NCT03129100|581070116|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911541|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
160911542|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
160911543|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
160911544|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
160911545|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
160911546|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
160995465|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Death|0|||
160995466|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Death|0|||
160995467|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Death|0|||
160995468|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Death|0|||
160995469|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Death|0|||
160995470|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Death|0|||
160995471|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Death|0|||
160995472|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Death|0|||
160911547|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
160911548|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
160911549|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
160911550|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
160911551|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
160911552|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
160911553|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
160911554|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
160911555|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
160911556|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
160911557|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
160911558|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
160911559|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
160911560|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
160995473|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Death|1|||
160995474|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Death|0|||
160453347|NCT03024437|579392068|FG002|Overall Study|Adverse Event|3|||
160995475|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Death|0|||
160995476|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Death|0|||
160995477|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160911561|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
160911562|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
160570520|NCT04329923|579812130|FG001|Overall Study|Withdrawal by Subject|4|||
160911563|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
160911564|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
160911565|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
160911566|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
160911567|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911568|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911569|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911570|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911571|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911572|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911573|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911574|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911575|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911576|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911577|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911578|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911579|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911580|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911581|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911582|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911583|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911584|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911585|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911586|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911587|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911588|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911589|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911590|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911591|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
160911592|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
160911593|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911594|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911595|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911596|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911597|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911598|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911599|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911600|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911601|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911602|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911603|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911604|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911605|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911606|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911607|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911608|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911609|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911610|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911611|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911612|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911613|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911614|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911615|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911616|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
160911617|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
160911618|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
160911619|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911620|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911621|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911622|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911623|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911624|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911625|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911626|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911627|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911628|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911629|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911630|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911631|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911632|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911633|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911634|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911635|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911636|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911637|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911638|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911639|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911640|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911641|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911642|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911643|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
160911644|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911645|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911646|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911647|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911648|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911649|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911650|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911651|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911652|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911653|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911654|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911655|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911656|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911657|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911658|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911659|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911660|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911661|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911662|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911663|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911664|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911665|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911666|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911667|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911668|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911669|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911670|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
160911671|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
160911672|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
160911673|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
160911674|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
160911675|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
160911676|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
160911677|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
160911678|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
160911679|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
160911680|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
160911681|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
160911682|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
160911683|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
160995478|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995479|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995480|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995481|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995482|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
160995483|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160453348|NCT03024437|579392069|FG003|Overall Study|Adverse Event|5|||
160911684|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
160911685|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
160911686|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
160911687|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
160453349|NCT03024437|579392070|FG004|Overall Study|Adverse Event|0|||
160911688|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
160911689|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
160911690|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
160911691|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
160911692|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
160911693|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
160911694|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
160911695|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
160911696|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
160911697|NCT03708328|581070119|FG000|Overall Study|Death|3|||
160911698|NCT03708328|581070120|FG001|Overall Study|Death|3|||
160911699|NCT03708328|581070121|FG002|Overall Study|Death|4|||
160911700|NCT03708328|581070122|FG003|Overall Study|Death|2|||
160911701|NCT03708328|581070123|FG004|Overall Study|Death|2|||
160911702|NCT03708328|581070124|FG005|Overall Study|Death|13|||
160911703|NCT03708328|581070125|FG006|Overall Study|Death|26|||
160911704|NCT03708328|581070126|FG007|Overall Study|Death|18|||
160911705|NCT03708328|581070127|FG008|Overall Study|Death|13|||
160911706|NCT03708328|581070128|FG009|Overall Study|Death|8|||
160911707|NCT03708328|581070119|FG000|Overall Study|Lost to Follow-up|0|||
160911708|NCT03708328|581070120|FG001|Overall Study|Lost to Follow-up|1|||
160911709|NCT03708328|581070121|FG002|Overall Study|Lost to Follow-up|0|||
160911710|NCT03708328|581070122|FG003|Overall Study|Lost to Follow-up|1|||
160911711|NCT03708328|581070123|FG004|Overall Study|Lost to Follow-up|0|||
160911712|NCT03708328|581070124|FG005|Overall Study|Lost to Follow-up|3|||
160911713|NCT03708328|581070125|FG006|Overall Study|Lost to Follow-up|3|||
160911714|NCT03708328|581070126|FG007|Overall Study|Lost to Follow-up|0|||
160911715|NCT03708328|581070127|FG008|Overall Study|Lost to Follow-up|0|||
160911716|NCT03708328|581070128|FG009|Overall Study|Lost to Follow-up|1|||
160911717|NCT03708328|581070119|FG000|Overall Study|Physician Decision|0|||
160911718|NCT03708328|581070120|FG001|Overall Study|Physician Decision|0|||
160911719|NCT03708328|581070121|FG002|Overall Study|Physician Decision|0|||
160911720|NCT03708328|581070122|FG003|Overall Study|Physician Decision|0|||
160911721|NCT03708328|581070123|FG004|Overall Study|Physician Decision|0|||
160911722|NCT03708328|581070124|FG005|Overall Study|Physician Decision|1|||
160911723|NCT03708328|581070125|FG006|Overall Study|Physician Decision|0|||
160911724|NCT03708328|581070126|FG007|Overall Study|Physician Decision|0|||
160911725|NCT03708328|581070127|FG008|Overall Study|Physician Decision|0|||
160911726|NCT03708328|581070128|FG009|Overall Study|Physician Decision|0|||
160911727|NCT03708328|581070119|FG000|Overall Study|Withdrawal by Subject|0|||
160911728|NCT03708328|581070120|FG001|Overall Study|Withdrawal by Subject|0|||
160911729|NCT03708328|581070121|FG002|Overall Study|Withdrawal by Subject|0|||
160911730|NCT03708328|581070122|FG003|Overall Study|Withdrawal by Subject|0|||
160911731|NCT03708328|581070123|FG004|Overall Study|Withdrawal by Subject|1|||
160911732|NCT03708328|581070124|FG005|Overall Study|Withdrawal by Subject|0|||
160911733|NCT03708328|581070125|FG006|Overall Study|Withdrawal by Subject|2|||
160911734|NCT03708328|581070126|FG007|Overall Study|Withdrawal by Subject|4|||
160911735|NCT03708328|581070127|FG008|Overall Study|Withdrawal by Subject|1|||
160911736|NCT03708328|581070128|FG009|Overall Study|Withdrawal by Subject|5|||
160911737|NCT03708328|581070119|FG000|Overall Study|Study Closed Locally|0|||
160911738|NCT03708328|581070120|FG001|Overall Study|Study Closed Locally|0|||
160911739|NCT03708328|581070121|FG002|Overall Study|Study Closed Locally|0|||
160911740|NCT03708328|581070122|FG003|Overall Study|Study Closed Locally|0|||
160911741|NCT03708328|581070123|FG004|Overall Study|Study Closed Locally|0|||
160911742|NCT03708328|581070124|FG005|Overall Study|Study Closed Locally|0|||
160911743|NCT03708328|581070125|FG006|Overall Study|Study Closed Locally|0|||
160911744|NCT03708328|581070126|FG007|Overall Study|Study Closed Locally|1|||
160995484|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995485|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995486|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
160995487|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
160911745|NCT03708328|581070127|FG008|Overall Study|Study Closed Locally|0|||
160911746|NCT03708328|581070128|FG009|Overall Study|Study Closed Locally|0|||
160911747|NCT03708328|581070119|FG000|Overall Study|Study Ended By Sponsor|0|||
160911748|NCT03708328|581070120|FG001|Overall Study|Study Ended By Sponsor|0|||
160911749|NCT03708328|581070121|FG002|Overall Study|Study Ended By Sponsor|0|||
160911750|NCT03708328|581070122|FG003|Overall Study|Study Ended By Sponsor|0|||
160911751|NCT03708328|581070123|FG004|Overall Study|Study Ended By Sponsor|0|||
160911752|NCT03708328|581070124|FG005|Overall Study|Study Ended By Sponsor|1|||
160911753|NCT03708328|581070125|FG006|Overall Study|Study Ended By Sponsor|0|||
160911754|NCT03708328|581070126|FG007|Overall Study|Study Ended By Sponsor|1|||
160995488|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160911755|NCT03708328|581070127|FG008|Overall Study|Study Ended By Sponsor|0|||
160911756|NCT03708328|581070128|FG009|Overall Study|Study Ended By Sponsor|0|||
160911757|NCT03708328|581070119|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911758|NCT03708328|581070120|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911759|NCT03708328|581070121|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911760|NCT03708328|581070122|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911761|NCT03708328|581070123|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911762|NCT03708328|581070124|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911763|NCT03708328|581070125|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911764|NCT03708328|581070126|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911765|NCT03708328|581070127|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
160911766|NCT03708328|581070128|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911767|NCT00571948|581070129|FG000|Overall Study|Lost to Follow-up|2|||
160911768|NCT00571948|581070130|FG001|Overall Study|Lost to Follow-up|0|||
160911769|NCT00571948|581070129|FG000|Overall Study|Withdrawal by Subject|1|||
160911770|NCT00571948|581070130|FG001|Overall Study|Withdrawal by Subject|2|||
160911771|NCT00571948|581070129|FG000|Overall Study|Protocol Violation|3|||
160911772|NCT00571948|581070130|FG001|Overall Study|Protocol Violation|3|||
160911773|NCT00571948|581070129|FG000|Overall Study|infant refused study meal|3|||
160911774|NCT00571948|581070130|FG001|Overall Study|infant refused study meal|4|||
160911775|NCT00571948|581070129|FG000|Overall Study|Parent were afraid of blood colection|2|||
160911776|NCT00571948|581070130|FG001|Overall Study|Parent were afraid of blood colection|5|||
160911777|NCT01845831|581070131|FG000|Inpatient Phase|Withdrawal by Subject|1|||
160911778|NCT01845831|581070132|FG001|Inpatient Phase|Withdrawal by Subject|1|||
160911779|NCT01845831|581070133|FG002|Inpatient Phase|Withdrawal by Subject|0|||
160911780|NCT01845831|581070134|FG003|Inpatient Phase|Withdrawal by Subject|0|||
160911781|NCT01845831|581070135|FG004|Inpatient Phase|Withdrawal by Subject|0|||
160911782|NCT02010775|581070137|FG000|Overall Study|Adverse Event|0|||
160911783|NCT02010775|581070138|FG001|Overall Study|Adverse Event|0|||
160911784|NCT02010775|581070139|FG002|Overall Study|Adverse Event|0|||
160911785|NCT02010775|581070140|FG003|Overall Study|Adverse Event|0|||
160911786|NCT02010775|581070141|FG004|Overall Study|Adverse Event|1|||
160911787|NCT02010775|581070137|FG000|Overall Study|Pregnancy|0|||
160911788|NCT02010775|581070138|FG001|Overall Study|Pregnancy|0|||
160911789|NCT02010775|581070139|FG002|Overall Study|Pregnancy|2|||
160911790|NCT02010775|581070140|FG003|Overall Study|Pregnancy|0|||
160911791|NCT02010775|581070141|FG004|Overall Study|Pregnancy|0|||
160911792|NCT02010775|581070137|FG000|Overall Study|Lost to Follow-up|2|||
160911793|NCT02010775|581070138|FG001|Overall Study|Lost to Follow-up|0|||
160911794|NCT02010775|581070139|FG002|Overall Study|Lost to Follow-up|0|||
160911795|NCT02010775|581070140|FG003|Overall Study|Lost to Follow-up|1|||
160911796|NCT02010775|581070141|FG004|Overall Study|Lost to Follow-up|1|||
160911797|NCT02010775|581070137|FG000|Overall Study|Personal Reasons|3|||
160911798|NCT02010775|581070138|FG001|Overall Study|Personal Reasons|3|||
160911799|NCT02010775|581070139|FG002|Overall Study|Personal Reasons|1|||
160911800|NCT02010775|581070140|FG003|Overall Study|Personal Reasons|2|||
160911801|NCT02010775|581070141|FG004|Overall Study|Personal Reasons|4|||
160911802|NCT02030041|581070143|FG000|Overall Study|Withdrawal by Subject|2|||
160911803|NCT02030041|581070144|FG001|Overall Study|Withdrawal by Subject|2|||
160911804|NCT02030041|581070145|FG002|Overall Study|Withdrawal by Subject|1|||
160911805|NCT02006719|581070146|FG000|Overall Study|Withdrawal by Subject|10|||
160911806|NCT02006719|581070147|FG001|Overall Study|Withdrawal by Subject|2|||
160911807|NCT02006719|581070146|FG000|Overall Study|Lost to Follow-up|5|||
160911808|NCT02006719|581070147|FG001|Overall Study|Lost to Follow-up|1|||
160911809|NCT02006719|581070146|FG000|Overall Study|Protocol Violation|2|||
160911810|NCT02006719|581070147|FG001|Overall Study|Protocol Violation|0|||
160911811|NCT02006719|581070146|FG000|Overall Study|Adverse Event|1|||
160911812|NCT02006719|581070147|FG001|Overall Study|Adverse Event|1|||
160911813|NCT02006719|581070146|FG000|Overall Study|Other/Unknown|0|||
160911814|NCT02006719|581070147|FG001|Overall Study|Other/Unknown|1|||
160911815|NCT00496054|581070153|FG000|Overall Study|Adverse Event|1|||
160911816|NCT00496054|581070153|FG000|Overall Study|Lost to Follow-up|7|||
160911817|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911818|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
160911819|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911820|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
160911821|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
160911822|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911823|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911824|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911825|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911826|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911827|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911828|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911829|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911830|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911831|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911832|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
160911833|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
160911834|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
160911835|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911836|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911837|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911838|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911839|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911840|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911841|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911842|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911843|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911844|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911845|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911846|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911847|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911848|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911849|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911850|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
160911851|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911852|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911853|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911854|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911855|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911856|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911857|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911858|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911859|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911860|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911861|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911862|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911863|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
160911864|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911865|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911866|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911867|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911868|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911869|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911870|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911871|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911872|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911873|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911874|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911875|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911876|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911877|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911878|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911879|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911880|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911881|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
160911882|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911883|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911884|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911885|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911886|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911887|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911888|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911889|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911890|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911891|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911892|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911893|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
160911894|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
160570521|NCT04329923|579812131|FG002|Overall Study|Withdrawal by Subject|1|||
160570522|NCT04329923|579812132|FG003|Overall Study|Withdrawal by Subject|1|||
160570523|NCT04329923|579812133|FG004|Overall Study|Withdrawal by Subject|1|||
160570524|NCT04329923|579812134|FG005|Overall Study|Withdrawal by Subject|1|||
160911895|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
160911896|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
160911897|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911898|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160570525|NCT04329923|579812129|FG000|Overall Study|early termination of study|0|||
160911899|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911900|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911901|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911902|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911903|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911904|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911905|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911906|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911907|NCT01737697|581070154|FG000|Subacute Phase|Adverse Event|0|||
160911908|NCT01737697|581070155|FG001|Subacute Phase|Adverse Event|0|||
160911909|NCT01737697|581070156|FG002|Subacute Phase|Adverse Event|0|||
160911910|NCT01737697|581070157|FG003|Subacute Phase|Adverse Event|0|||
160911911|NCT01737697|581070158|FG004|Subacute Phase|Adverse Event|0|||
160911912|NCT01737697|581070159|FG005|Subacute Phase|Adverse Event|1|||
160911913|NCT01737697|581070160|FG006|Subacute Phase|Adverse Event|1|||
160911914|NCT01737697|581070161|FG007|Subacute Phase|Adverse Event|1|||
160911915|NCT01737697|581070162|FG008|Subacute Phase|Adverse Event|1|||
160911916|NCT01737697|581070163|FG009|Subacute Phase|Adverse Event|1|||
160911917|NCT01737697|581070164|FG010|Subacute Phase|Adverse Event|4|||
160911918|NCT01737697|581070165|FG011|Subacute Phase|Adverse Event|1|||
160911919|NCT01737697|581070166|FG012|Subacute Phase|Adverse Event|1|||
160911920|NCT01737697|581070167|FG013|Subacute Phase|Adverse Event|0|||
160911921|NCT01737697|581070168|FG014|Subacute Phase|Adverse Event|0|||
160911922|NCT01737697|581070154|FG000|Subacute Phase|Withdrawal by Subject|0|||
160911923|NCT01737697|581070155|FG001|Subacute Phase|Withdrawal by Subject|0|||
160911924|NCT01737697|581070156|FG002|Subacute Phase|Withdrawal by Subject|0|||
160911925|NCT01737697|581070157|FG003|Subacute Phase|Withdrawal by Subject|0|||
160911926|NCT01737697|581070158|FG004|Subacute Phase|Withdrawal by Subject|0|||
160911927|NCT01737697|581070159|FG005|Subacute Phase|Withdrawal by Subject|1|||
160911928|NCT01737697|581070160|FG006|Subacute Phase|Withdrawal by Subject|0|||
160911929|NCT01737697|581070161|FG007|Subacute Phase|Withdrawal by Subject|2|||
160911930|NCT01737697|581070162|FG008|Subacute Phase|Withdrawal by Subject|0|||
160911931|NCT01737697|581070163|FG009|Subacute Phase|Withdrawal by Subject|1|||
160911932|NCT01737697|581070164|FG010|Subacute Phase|Withdrawal by Subject|0|||
160911933|NCT01737697|581070165|FG011|Subacute Phase|Withdrawal by Subject|1|||
160911934|NCT01737697|581070166|FG012|Subacute Phase|Withdrawal by Subject|1|||
160911935|NCT01737697|581070167|FG013|Subacute Phase|Withdrawal by Subject|1|||
160911936|NCT01737697|581070168|FG014|Subacute Phase|Withdrawal by Subject|0|||
160911937|NCT01737697|581070154|FG000|Subacute Phase|Lost to Follow-up|0|||
160911938|NCT01737697|581070155|FG001|Subacute Phase|Lost to Follow-up|0|||
160911939|NCT01737697|581070156|FG002|Subacute Phase|Lost to Follow-up|0|||
160911940|NCT01737697|581070157|FG003|Subacute Phase|Lost to Follow-up|0|||
160911941|NCT01737697|581070158|FG004|Subacute Phase|Lost to Follow-up|0|||
160911942|NCT01737697|581070159|FG005|Subacute Phase|Lost to Follow-up|0|||
160911943|NCT01737697|581070160|FG006|Subacute Phase|Lost to Follow-up|0|||
160911944|NCT01737697|581070161|FG007|Subacute Phase|Lost to Follow-up|0|||
160911945|NCT01737697|581070162|FG008|Subacute Phase|Lost to Follow-up|0|||
160911946|NCT01737697|581070163|FG009|Subacute Phase|Lost to Follow-up|0|||
160911947|NCT01737697|581070164|FG010|Subacute Phase|Lost to Follow-up|0|||
160911948|NCT01737697|581070165|FG011|Subacute Phase|Lost to Follow-up|0|||
160911949|NCT01737697|581070166|FG012|Subacute Phase|Lost to Follow-up|0|||
160911950|NCT01737697|581070167|FG013|Subacute Phase|Lost to Follow-up|0|||
160911951|NCT01737697|581070168|FG014|Subacute Phase|Lost to Follow-up|1|||
160911952|NCT01737697|581070154|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
160911953|NCT01737697|581070155|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
160911954|NCT01737697|581070156|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
160911955|NCT01737697|581070157|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
160911956|NCT01737697|581070158|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
160911957|NCT01737697|581070159|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
160911958|NCT01737697|581070160|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
160911959|NCT01737697|581070161|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
160911960|NCT01737697|581070162|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
160911961|NCT01737697|581070163|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
160911962|NCT01737697|581070164|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
160911963|NCT01737697|581070165|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
160911964|NCT01737697|581070166|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
160911965|NCT01737697|581070167|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
160911966|NCT01737697|581070168|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
160911967|NCT01737697|581070154|FG000|Subacute Phase|Protocol Violation|0|||
160911968|NCT01737697|581070155|FG001|Subacute Phase|Protocol Violation|0|||
160911969|NCT01737697|581070156|FG002|Subacute Phase|Protocol Violation|0|||
160911970|NCT01737697|581070157|FG003|Subacute Phase|Protocol Violation|0|||
160911971|NCT01737697|581070158|FG004|Subacute Phase|Protocol Violation|0|||
160911972|NCT01737697|581070159|FG005|Subacute Phase|Protocol Violation|1|||
160911973|NCT01737697|581070160|FG006|Subacute Phase|Protocol Violation|0|||
160911974|NCT01737697|581070161|FG007|Subacute Phase|Protocol Violation|0|||
160911975|NCT01737697|581070162|FG008|Subacute Phase|Protocol Violation|0|||
160911976|NCT01737697|581070163|FG009|Subacute Phase|Protocol Violation|0|||
160911977|NCT01737697|581070164|FG010|Subacute Phase|Protocol Violation|1|||
160911978|NCT01737697|581070165|FG011|Subacute Phase|Protocol Violation|0|||
160911979|NCT01737697|581070166|FG012|Subacute Phase|Protocol Violation|0|||
160911980|NCT01737697|581070167|FG013|Subacute Phase|Protocol Violation|0|||
160911981|NCT01737697|581070168|FG014|Subacute Phase|Protocol Violation|0|||
160911982|NCT01737697|581070154|FG000|Subacute Phase|Physician Decision|0|||
160911983|NCT01737697|581070155|FG001|Subacute Phase|Physician Decision|0|||
160911984|NCT01737697|581070156|FG002|Subacute Phase|Physician Decision|0|||
160911985|NCT01737697|581070157|FG003|Subacute Phase|Physician Decision|0|||
160911986|NCT01737697|581070158|FG004|Subacute Phase|Physician Decision|0|||
160911987|NCT01737697|581070159|FG005|Subacute Phase|Physician Decision|0|||
160911988|NCT01737697|581070160|FG006|Subacute Phase|Physician Decision|0|||
160911989|NCT01737697|581070161|FG007|Subacute Phase|Physician Decision|0|||
160911990|NCT01737697|581070162|FG008|Subacute Phase|Physician Decision|1|||
160911991|NCT01737697|581070163|FG009|Subacute Phase|Physician Decision|0|||
160911992|NCT01737697|581070164|FG010|Subacute Phase|Physician Decision|0|||
160911993|NCT01737697|581070165|FG011|Subacute Phase|Physician Decision|0|||
160911994|NCT01737697|581070166|FG012|Subacute Phase|Physician Decision|0|||
160911995|NCT01737697|581070167|FG013|Subacute Phase|Physician Decision|0|||
160911996|NCT01737697|581070168|FG014|Subacute Phase|Physician Decision|0|||
160911997|NCT01737697|581070154|FG000|Subacute Phase|Death|0|||
160911998|NCT01737697|581070155|FG001|Subacute Phase|Death|0|||
160911999|NCT01737697|581070156|FG002|Subacute Phase|Death|0|||
160912000|NCT01737697|581070157|FG003|Subacute Phase|Death|0|||
160912001|NCT01737697|581070158|FG004|Subacute Phase|Death|0|||
160912002|NCT01737697|581070159|FG005|Subacute Phase|Death|0|||
160912003|NCT01737697|581070160|FG006|Subacute Phase|Death|0|||
160912004|NCT01737697|581070161|FG007|Subacute Phase|Death|0|||
160912005|NCT01737697|581070162|FG008|Subacute Phase|Death|0|||
160912006|NCT01737697|581070163|FG009|Subacute Phase|Death|0|||
160912007|NCT01737697|581070164|FG010|Subacute Phase|Death|1|||
160912008|NCT01737697|581070165|FG011|Subacute Phase|Death|0|||
160912009|NCT01737697|581070166|FG012|Subacute Phase|Death|0|||
160912010|NCT01737697|581070167|FG013|Subacute Phase|Death|0|||
160912011|NCT01737697|581070168|FG014|Subacute Phase|Death|0|||
160912012|NCT02216591|581070171|FG000|Overall Study|Lost to Follow-up|0|||
160912013|NCT02216591|581070172|FG001|Overall Study|Lost to Follow-up|1|||
160912014|NCT01950741|581070175|FG000|Overall Study|Lost to Follow-up|1|||
160912015|NCT01950741|581070175|FG000|Overall Study|Death|1|||
160912016|NCT01950741|581070175|FG000|Overall Study|Withdrawal by Subject|1|||
160912017|NCT01866930|581070178|FG000|Treatment Period|Other|1|||
160912018|NCT01866930|581070179|FG001|Treatment Period|Other|0|||
160912019|NCT01866930|581070178|FG000|Treatment Period|Death|0|||
160912020|NCT01866930|581070179|FG001|Treatment Period|Death|2|||
160912021|NCT01866930|581070178|FG000|Treatment Period|Poor/non compliance|0|||
160912022|NCT01866930|581070179|FG001|Treatment Period|Poor/non compliance|2|||
160912023|NCT01866930|581070178|FG000|Treatment Period|No longer meets study criteria|0|||
160912024|NCT01866930|581070179|FG001|Treatment Period|No longer meets study criteria|1|||
160912025|NCT01866930|581070178|FG000|Treatment Period|Withdrawal by Subject|2|||
160912026|NCT01866930|581070179|FG001|Treatment Period|Withdrawal by Subject|8|||
160912027|NCT01866930|581070178|FG000|Treatment Period|Lack of Efficacy|1|||
160912028|NCT01866930|581070179|FG001|Treatment Period|Lack of Efficacy|9|||
160912029|NCT01866930|581070178|FG000|Treatment Period|Adverse Event|4|||
160912030|NCT01866930|581070179|FG001|Treatment Period|Adverse Event|12|||
160912031|NCT01866930|581070178|FG000|Treatment Period|Lost to Follow-up|1|||
160912032|NCT01866930|581070179|FG001|Treatment Period|Lost to Follow-up|1|||
160912033|NCT01866930|581070178|FG000|Follow-up Period|Lost to Follow-up|1|||
160912034|NCT01866930|581070179|FG001|Follow-up Period|Lost to Follow-up|1|||
160912035|NCT01866930|581070178|FG000|Follow-up Period|Other|1|||
160912036|NCT01866930|581070179|FG001|Follow-up Period|Other|5|||
160912037|NCT01866930|581070178|FG000|Follow-up Period|No longer required per protocol|1|||
160912038|NCT01866930|581070179|FG001|Follow-up Period|No longer required per protocol|0|||
160912039|NCT01866930|581070178|FG000|Follow-up Period|Withdrawal by Subject|3|||
160912040|NCT01866930|581070179|FG001|Follow-up Period|Withdrawal by Subject|3|||
160912041|NCT02521870|581070182|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912042|NCT02521870|581070183|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
160912043|NCT02521870|581070184|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912044|NCT02521870|581070185|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912045|NCT02521870|581070186|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912046|NCT02521870|581070187|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160453350|NCT03024437|579392066|FG000|Overall Study|Physician Decision|1|||
160912047|NCT02521870|581070188|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912048|NCT02521870|581070189|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912049|NCT02521870|581070190|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912050|NCT02521870|581070191|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912051|NCT02521870|581070192|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912052|NCT02521870|581070193|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160453351|NCT03024437|579392067|FG001|Overall Study|Physician Decision|0|||
160912053|NCT02521870|581070182|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
160912054|NCT02521870|581070183|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
160912055|NCT02521870|581070184|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
160912056|NCT02521870|581070185|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
160912057|NCT02521870|581070186|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
160912058|NCT02521870|581070187|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
160912059|NCT02521870|581070188|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
160912060|NCT02521870|581070189|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
160912061|NCT02521870|581070190|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
160912062|NCT02521870|581070191|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
160912063|NCT02521870|581070192|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
160912064|NCT02521870|581070193|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
160912065|NCT02521870|581070182|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
160912066|NCT02521870|581070183|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
160912067|NCT02521870|581070184|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
160912068|NCT02521870|581070185|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
160912069|NCT02521870|581070186|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
160912070|NCT02521870|581070187|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
160912071|NCT02521870|581070188|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
160912072|NCT02521870|581070189|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
160912073|NCT02521870|581070190|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
160912074|NCT02521870|581070191|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
160912075|NCT02521870|581070192|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
160912076|NCT02521870|581070193|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
160912077|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912078|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912079|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912080|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912081|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
160912082|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
160912083|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
160912084|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912085|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
160912086|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
160912087|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
160912088|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912089|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
160912090|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
160912091|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
160912092|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
160912093|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
160912094|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
160912095|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
160912096|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
160912097|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
160912098|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
160912099|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
160912100|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
160912101|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
160912102|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
160912103|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
160912104|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
160912105|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
160912106|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
160912107|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
160912108|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
160995489|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160912109|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
160995490|NCT05827926|581370944|FG000|Overall Study|Lost to Follow-up|1|||
160912110|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
160912111|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
160912112|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
160912113|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Death|0|||
160912114|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Death|0|||
160912115|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Death|0|||
160912116|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Death|0|||
160912117|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Death|1|||
160912118|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Death|1|||
160912119|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Death|3|||
160912120|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Death|1|||
160912121|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Death|1|||
160912122|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Death|5|||
160912123|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Death|2|||
160995491|NCT05827926|581370945|FG001|Overall Study|Lost to Follow-up|0|||
160912124|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Death|2|||
160912125|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Other|0|||
160912126|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Other|0|||
160912127|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Other|0|||
160912128|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Other|0|||
160912129|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Other|10|||
160912130|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Other|3|||
160912131|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Other|2|||
160912132|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Other|0|||
160912133|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Other|10|||
160912134|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Other|5|||
160912135|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Other|1|||
160912136|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Other|7|||
160912137|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912138|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912139|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912140|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912141|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
160912142|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912143|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912144|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912145|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912146|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912147|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912148|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912149|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912150|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912151|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912152|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912153|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
160912154|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912155|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912156|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912157|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912158|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912159|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912160|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912161|NCT00519831|581070196|FG000|Overall Study|Adverse Event|3|||
160912162|NCT00471328|581070197|FG000|Core Phase|Adverse Event|18|||
160912163|NCT00471328|581070198|FG001|Core Phase|Adverse Event|6|||
160912164|NCT00471328|581070197|FG000|Core Phase|Death|8|||
160912165|NCT00471328|581070198|FG001|Core Phase|Death|4|||
160912166|NCT00471328|581070197|FG000|Core Phase|Withdrawal by Subject|2|||
160912167|NCT00471328|581070198|FG001|Core Phase|Withdrawal by Subject|2|||
160912168|NCT00471328|581070197|FG000|Core Phase|Abnormal laboratory value|1|||
160912169|NCT00471328|581070198|FG001|Core Phase|Abnormal laboratory value|0|||
160912170|NCT00471328|581070197|FG000|Core Phase|Disease Progression|78|||
160912171|NCT00471328|581070198|FG001|Core Phase|Disease Progression|53|||
160912172|NCT00471328|581070197|FG000|Core Phase|Administrative Problem|0|||
160912173|NCT00471328|581070198|FG001|Core Phase|Administrative Problem|1|||
160912174|NCT00471328|581070197|FG000|Core Phase|Protocol Deviation|0|||
160912175|NCT00471328|581070198|FG001|Core Phase|Protocol Deviation|1|||
160912176|NCT00471328|581070197|FG000|Extension Phase|Adverse Event|3|||
160912177|NCT00471328|581070198|FG001|Extension Phase|Adverse Event|12|||
160912178|NCT00471328|581070197|FG000|Extension Phase|Withdrawal by Subject|0|||
160912179|NCT00471328|581070198|FG001|Extension Phase|Withdrawal by Subject|2|||
160912180|NCT00471328|581070197|FG000|Extension Phase|Death|1|||
160912181|NCT00471328|581070198|FG001|Extension Phase|Death|7|||
160912182|NCT00471328|581070197|FG000|Extension Phase|Protocol Deviation|3|||
160912183|NCT00471328|581070198|FG001|Extension Phase|Protocol Deviation|1|||
160912184|NCT00471328|581070197|FG000|Extension Phase|Treatment duration as per protocol|0|||
160912185|NCT00471328|581070198|FG001|Extension Phase|Treatment duration as per protocol|1|||
160912186|NCT00471328|581070197|FG000|Extension Phase|Disease Progression|32|||
160912187|NCT00471328|581070198|FG001|Extension Phase|Disease Progression|44|||
160912188|NCT00471328|581070197|FG000|Extension Phase|New cancer Therapy|1|||
160912189|NCT00471328|581070198|FG001|Extension Phase|New cancer Therapy|0|||
160912190|NCT00471328|581070197|FG000|Extension Phase|Administrative Problem|1|||
160912191|NCT00471328|581070198|FG001|Extension Phase|Administrative Problem|0|||
160912192|NCT02854631|581070199|FG000|Overall Study|Adverse Event|1|||
160912193|NCT02854631|581070200|FG001|Overall Study|Adverse Event|2|||
160912194|NCT02854631|581070199|FG000|Overall Study|Withdrew Consent|3|||
160912195|NCT02854631|581070200|FG001|Overall Study|Withdrew Consent|2|||
160912196|NCT02854631|581070199|FG000|Overall Study|Investigator's Discretion|2|||
160912197|NCT02854631|581070200|FG001|Overall Study|Investigator's Discretion|0|||
160912198|NCT02854631|581070199|FG000|Overall Study|Death|12|||
160912199|NCT02854631|581070200|FG001|Overall Study|Death|8|||
160995492|NCT05827926|581370946|FG002|Overall Study|Lost to Follow-up|0|||
160912200|NCT02854631|581070199|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
160912201|NCT02854631|581070200|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
160912202|NCT02854631|581070199|FG000|Overall Study|Protocol Violation|0|||
160912203|NCT02854631|581070200|FG001|Overall Study|Protocol Violation|1|||
160912204|NCT02854631|581070199|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
160912205|NCT02854631|581070200|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
160912206|NCT02854631|581070199|FG000|Overall Study|Lost to Follow-up|4|||
160912207|NCT02854631|581070200|FG001|Overall Study|Lost to Follow-up|2|||
160912208|NCT03930797|581070201|FG000|Overall Study|Lost to Follow-up|3|||
160912209|NCT03930797|581070202|FG001|Overall Study|Lost to Follow-up|10|||
160912210|NCT01962896|581070203|FG000|Overall Study|Lack of Efficacy|4|||
160912211|NCT00662012|581070204|FG000|Overall Study|Lost to Follow-up|85|||
160912212|NCT00662012|581070204|FG000|Overall Study|Death|1|||
160912213|NCT00662012|581070204|FG000|Overall Study|Withdrawal by Subject|1|||
160912214|NCT04342897|581070207|FG000|Overall Study|Death|7|||
160912215|NCT04342897|581070208|FG001|Overall Study|Death|4|||
160912216|NCT04342897|581070207|FG000|Overall Study|Lost to Follow-up|6|||
160912217|NCT04342897|581070208|FG001|Overall Study|Lost to Follow-up|6|||
160912218|NCT04342897|581070207|FG000|Overall Study|Withdrawal by Subject|1|||
160912219|NCT04342897|581070208|FG001|Overall Study|Withdrawal by Subject|2|||
160912220|NCT00621153|581070210|FG000|Overall Study|Safety Reason|8|||
160912221|NCT00621153|581070211|FG001|Overall Study|Safety Reason|7|||
160912222|NCT00621153|581070210|FG000|Overall Study|Adverse Event|3|||
160912223|NCT00621153|581070211|FG001|Overall Study|Adverse Event|2|||
160912224|NCT00621153|581070210|FG000|Overall Study|Lost to Follow-up|5|||
160912225|NCT00621153|581070211|FG001|Overall Study|Lost to Follow-up|1|||
160912226|NCT00621153|581070210|FG000|Overall Study|Withdrawal by Subject|4|||
160912227|NCT00621153|581070211|FG001|Overall Study|Withdrawal by Subject|5|||
160912228|NCT04212650|581070212|FG000|Overall Study|Withdrawal by Subject|1|||
160912229|NCT04212650|581070213|FG001|Overall Study|Withdrawal by Subject|0|||
160912230|NCT00598832|581070218|FG000|Overall Study|Lack of Efficacy|3|||
160912231|NCT00598832|581070219|FG001|Overall Study|Lack of Efficacy|7|||
160912232|NCT00598832|581070218|FG000|Overall Study|Adverse Event|6|||
160912233|NCT00598832|581070219|FG001|Overall Study|Adverse Event|2|||
160912234|NCT00598832|581070218|FG000|Overall Study|Withdrawal by Subject|25|||
160912235|NCT00598832|581070219|FG001|Overall Study|Withdrawal by Subject|36|||
160912236|NCT00598832|581070218|FG000|Overall Study|Protocol Violation|0|||
160912237|NCT00598832|581070219|FG001|Overall Study|Protocol Violation|2|||
160912238|NCT00598832|581070218|FG000|Overall Study|Lost to Follow-up|24|||
160912239|NCT00598832|581070219|FG001|Overall Study|Lost to Follow-up|29|||
160912240|NCT00598832|581070218|FG000|Overall Study|Pregnancy|2|||
160912241|NCT00598832|581070219|FG001|Overall Study|Pregnancy|2|||
160912242|NCT00598832|581070218|FG000|Overall Study|Physician Decision|1|||
160912243|NCT00598832|581070219|FG001|Overall Study|Physician Decision|4|||
160912244|NCT00598832|581070218|FG000|Overall Study|Non compliance|1|||
160912245|NCT00598832|581070219|FG001|Overall Study|Non compliance|0|||
160912246|NCT02142959|581070220|FG000|Overall Study|Adverse Event|1|||
160912247|NCT02142959|581070221|FG001|Overall Study|Adverse Event|0|||
160912248|NCT02142959|581070222|FG002|Overall Study|Adverse Event|0|||
160912249|NCT02142959|581070220|FG000|Overall Study|Death|0|||
160912250|NCT02142959|581070221|FG001|Overall Study|Death|1|||
160912251|NCT02142959|581070222|FG002|Overall Study|Death|0|||
160912252|NCT02142959|581070220|FG000|Overall Study|Withdrawal by Subject|3|||
160912253|NCT02142959|581070221|FG001|Overall Study|Withdrawal by Subject|1|||
160912254|NCT02142959|581070222|FG002|Overall Study|Withdrawal by Subject|3|||
160912255|NCT02142959|581070220|FG000|Overall Study|Administrative Reasons|1|||
160912256|NCT02142959|581070221|FG001|Overall Study|Administrative Reasons|0|||
160912257|NCT02142959|581070222|FG002|Overall Study|Administrative Reasons|1|||
160912258|NCT02142959|581070220|FG000|Overall Study|Missing|0|||
160912259|NCT02142959|581070221|FG001|Overall Study|Missing|1|||
160912260|NCT02142959|581070222|FG002|Overall Study|Missing|0|||
160912261|NCT02142959|581070220|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
160912262|NCT02142959|581070221|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
160912263|NCT02142959|581070222|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
160912264|NCT02142959|581070220|FG000|Overall Study|Patient didn't complete end of study visit|0|||
160912265|NCT02142959|581070221|FG001|Overall Study|Patient didn't complete end of study visit|0|||
160912266|NCT02142959|581070222|FG002|Overall Study|Patient didn't complete end of study visit|1|||
160912267|NCT01753856|581070228|FG000|Overall Study|Adverse Event|1|||
160912268|NCT01753856|581070229|FG001|Overall Study|Adverse Event|0|||
160912269|NCT01753856|581070228|FG000|Overall Study|Withdrawal by Subject|0|||
160912270|NCT01753856|581070229|FG001|Overall Study|Withdrawal by Subject|2|||
160912271|NCT01753856|581070228|FG000|Overall Study|Sponsor Decision|2|||
160912272|NCT01753856|581070229|FG001|Overall Study|Sponsor Decision|0|||
160912273|NCT05980182|581070230|FG000|Overall Study|Lost to Follow-up|10|||
160912274|NCT01852110|581072212|FG000|Overall Study|Adverse Event|12|||
160912275|NCT01852110|581072213|FG001|Overall Study|Adverse Event|5|||
160912276|NCT01852110|581072214|FG002|Overall Study|Adverse Event|0|||
160912277|NCT01852110|581072215|FG003|Overall Study|Adverse Event|0|||
160912278|NCT01852110|581072216|FG004|Overall Study|Adverse Event|0|||
160912279|NCT01852110|581072217|FG005|Overall Study|Adverse Event|0|||
160912280|NCT01852110|581072212|FG000|Overall Study|Lost to Follow-up|1|||
160912281|NCT01852110|581072213|FG001|Overall Study|Lost to Follow-up|3|||
160912282|NCT01852110|581072214|FG002|Overall Study|Lost to Follow-up|0|||
160912283|NCT01852110|581072215|FG003|Overall Study|Lost to Follow-up|0|||
160912284|NCT01852110|581072216|FG004|Overall Study|Lost to Follow-up|0|||
160912285|NCT01852110|581072217|FG005|Overall Study|Lost to Follow-up|0|||
160912286|NCT01852110|581072212|FG000|Overall Study|Non-compliance with Study Drug|2|||
160912287|NCT01852110|581072213|FG001|Overall Study|Non-compliance with Study Drug|1|||
160912288|NCT01852110|581072214|FG002|Overall Study|Non-compliance with Study Drug|0|||
160912289|NCT01852110|581072215|FG003|Overall Study|Non-compliance with Study Drug|0|||
160912290|NCT01852110|581072216|FG004|Overall Study|Non-compliance with Study Drug|0|||
160912291|NCT01852110|581072217|FG005|Overall Study|Non-compliance with Study Drug|0|||
160912292|NCT01852110|581072212|FG000|Overall Study|Physician Decision|1|||
160912293|NCT01852110|581072213|FG001|Overall Study|Physician Decision|0|||
160912294|NCT01852110|581072214|FG002|Overall Study|Physician Decision|0|||
160912295|NCT01852110|581072215|FG003|Overall Study|Physician Decision|0|||
160912296|NCT01852110|581072216|FG004|Overall Study|Physician Decision|0|||
160912297|NCT01852110|581072217|FG005|Overall Study|Physician Decision|0|||
160453352|NCT03024437|579392068|FG002|Overall Study|Physician Decision|0|||
160453353|NCT03024437|579392069|FG003|Overall Study|Physician Decision|1|||
160912298|NCT01852110|581072212|FG000|Overall Study|Protocol Violation|0|||
160912299|NCT01852110|581072213|FG001|Overall Study|Protocol Violation|1|||
160912300|NCT01852110|581072214|FG002|Overall Study|Protocol Violation|0|||
160912301|NCT01852110|581072215|FG003|Overall Study|Protocol Violation|0|||
160912302|NCT01852110|581072216|FG004|Overall Study|Protocol Violation|0|||
160912303|NCT01852110|581072217|FG005|Overall Study|Protocol Violation|0|||
160912304|NCT01852110|581072212|FG000|Overall Study|Study Terminated by Sponsor|30|||
160912305|NCT01852110|581072213|FG001|Overall Study|Study Terminated by Sponsor|32|||
160912306|NCT01852110|581072214|FG002|Overall Study|Study Terminated by Sponsor|0|||
160912307|NCT01852110|581072215|FG003|Overall Study|Study Terminated by Sponsor|0|||
160912308|NCT01852110|581072216|FG004|Overall Study|Study Terminated by Sponsor|0|||
160912309|NCT01852110|581072217|FG005|Overall Study|Study Terminated by Sponsor|0|||
160912310|NCT01852110|581072212|FG000|Overall Study|Withdrawal by Subject|4|||
160912311|NCT01852110|581072213|FG001|Overall Study|Withdrawal by Subject|4|||
160912312|NCT01852110|581072214|FG002|Overall Study|Withdrawal by Subject|0|||
160912313|NCT01852110|581072215|FG003|Overall Study|Withdrawal by Subject|0|||
160912314|NCT01852110|581072216|FG004|Overall Study|Withdrawal by Subject|0|||
160912315|NCT01852110|581072217|FG005|Overall Study|Withdrawal by Subject|0|||
160912316|NCT02961751|581072228|FG000|Overall Study|Lost to Follow-up|11|||
160912317|NCT02961751|581072228|FG000|Overall Study|Physician Decision|2|||
160912318|NCT02961751|581072228|FG000|Overall Study|Not Eligible at Enrollment|1|||
160912319|NCT02961751|581072228|FG000|Overall Study|Protocol Violation|1|||
160912320|NCT00842712|581072229|FG000|Safety Run-in Part|Adverse Event|0|||
160912321|NCT00842712|581072230|FG001|Safety Run-in Part|Adverse Event|1|||
160912322|NCT00842712|581072231|FG002|Safety Run-in Part|Adverse Event|0|||
160912323|NCT00842712|581072232|FG003|Safety Run-in Part|Adverse Event|0|||
160912324|NCT00842712|581072233|FG004|Safety Run-in Part|Adverse Event|0|||
160912325|NCT00842712|581072234|FG005|Safety Run-in Part|Adverse Event|0|||
160912326|NCT00842712|581072235|FG006|Safety Run-in Part|Adverse Event|0|||
160912327|NCT00842712|581072229|FG000|Safety Run-in Part|Progressive disease|3|||
160912328|NCT00842712|581072230|FG001|Safety Run-in Part|Progressive disease|1|||
160912329|NCT00842712|581072231|FG002|Safety Run-in Part|Progressive disease|0|||
160912330|NCT00842712|581072232|FG003|Safety Run-in Part|Progressive disease|1|||
160912331|NCT00842712|581072233|FG004|Safety Run-in Part|Progressive disease|0|||
160453354|NCT03024437|579392070|FG004|Overall Study|Physician Decision|0|||
160453355|NCT03024437|579392066|FG000|Overall Study|Disease progression, relapse|1|||
160652737|NCT02946385|580110338|FG001|Overall Study|Lost to Follow-up|0|||
160912332|NCT00842712|581072234|FG005|Safety Run-in Part|Progressive disease|0|||
160912333|NCT00842712|581072235|FG006|Safety Run-in Part|Progressive disease|0|||
160912334|NCT00842712|581072229|FG000|Randomized Part|Randomized but not treated|0|||
160912335|NCT00842712|581072230|FG001|Randomized Part|Randomized but not treated|0|||
160912336|NCT00842712|581072231|FG002|Randomized Part|Randomized but not treated|0|||
160912337|NCT00842712|581072232|FG003|Randomized Part|Randomized but not treated|0|||
160652738|NCT02946385|580110339|FG002|Overall Study|Lost to Follow-up|3|||
160912338|NCT00842712|581072233|FG004|Randomized Part|Randomized but not treated|0|||
160912339|NCT00842712|581072234|FG005|Randomized Part|Randomized but not treated|1|||
160912340|NCT00842712|581072235|FG006|Randomized Part|Randomized but not treated|4|||
160912341|NCT00842712|581072229|FG000|Randomized Part|Ongoing at cut-off date|0|||
160912342|NCT00842712|581072230|FG001|Randomized Part|Ongoing at cut-off date|0|||
160912343|NCT00842712|581072231|FG002|Randomized Part|Ongoing at cut-off date|0|||
160912344|NCT00842712|581072232|FG003|Randomized Part|Ongoing at cut-off date|0|||
160912345|NCT00842712|581072233|FG004|Randomized Part|Ongoing at cut-off date|0|||
160912346|NCT00842712|581072234|FG005|Randomized Part|Ongoing at cut-off date|0|||
160912347|NCT00842712|581072235|FG006|Randomized Part|Ongoing at cut-off date|2|||
160912348|NCT02141282|581072237|FG000|Overall Study|Adverse event, not related to progression|8|||
160912349|NCT02141282|581072238|FG001|Overall Study|Adverse event, not related to progression|1|||
160912350|NCT02141282|581072239|FG002|Overall Study|Adverse event, not related to progression|3|||
160912351|NCT02141282|581072240|FG003|Overall Study|Adverse event, not related to progression|1|||
160912352|NCT02141282|581072237|FG000|Overall Study|Adverse event, related to progression|1|||
160912353|NCT02141282|581072238|FG001|Overall Study|Adverse event, related to progression|0|||
160912354|NCT02141282|581072239|FG002|Overall Study|Adverse event, related to progression|2|||
160912355|NCT02141282|581072240|FG003|Overall Study|Adverse event, related to progression|0|||
160912356|NCT02141282|581072237|FG000|Overall Study|COVID-19 infection|1|||
160912357|NCT02141282|581072238|FG001|Overall Study|COVID-19 infection|0|||
160912358|NCT02141282|581072239|FG002|Overall Study|COVID-19 infection|0|||
160912359|NCT02141282|581072240|FG003|Overall Study|COVID-19 infection|0|||
160912360|NCT02141282|581072237|FG000|Overall Study|Lost to Follow-up|0|||
160912361|NCT02141282|581072238|FG001|Overall Study|Lost to Follow-up|0|||
160912362|NCT02141282|581072239|FG002|Overall Study|Lost to Follow-up|4|||
160912363|NCT02141282|581072240|FG003|Overall Study|Lost to Follow-up|2|||
160912364|NCT02141282|581072237|FG000|Overall Study|Other, not specified|14|||
160912365|NCT02141282|581072238|FG001|Overall Study|Other, not specified|11|||
160912366|NCT02141282|581072239|FG002|Overall Study|Other, not specified|23|||
160912367|NCT02141282|581072240|FG003|Overall Study|Other, not specified|9|||
160912368|NCT02141282|581072237|FG000|Overall Study|Progressive disease, Richter's|4|||
160912369|NCT02141282|581072238|FG001|Overall Study|Progressive disease, Richter's|1|||
160912370|NCT02141282|581072239|FG002|Overall Study|Progressive disease, Richter's|1|||
160912371|NCT02141282|581072240|FG003|Overall Study|Progressive disease, Richter's|1|||
160912372|NCT02141282|581072237|FG000|Overall Study|Progressive disease per protocol|12|||
160912373|NCT02141282|581072238|FG001|Overall Study|Progressive disease per protocol|7|||
160912374|NCT02141282|581072239|FG002|Overall Study|Progressive disease per protocol|9|||
160912375|NCT02141282|581072240|FG003|Overall Study|Progressive disease per protocol|2|||
160912376|NCT02141282|581072237|FG000|Overall Study|Stem cell transplant|1|||
160912377|NCT02141282|581072238|FG001|Overall Study|Stem cell transplant|0|||
160912378|NCT02141282|581072239|FG002|Overall Study|Stem cell transplant|1|||
160912379|NCT02141282|581072240|FG003|Overall Study|Stem cell transplant|0|||
160912380|NCT02141282|581072237|FG000|Overall Study|Study terminated by Sponsor|0|||
160912381|NCT02141282|581072238|FG001|Overall Study|Study terminated by Sponsor|1|||
160912382|NCT02141282|581072239|FG002|Overall Study|Study terminated by Sponsor|0|||
160912383|NCT02141282|581072240|FG003|Overall Study|Study terminated by Sponsor|0|||
160912384|NCT02141282|581072237|FG000|Overall Study|Subject non-compliance|0|||
160912385|NCT02141282|581072238|FG001|Overall Study|Subject non-compliance|0|||
160912386|NCT02141282|581072239|FG002|Overall Study|Subject non-compliance|1|||
160912387|NCT02141282|581072240|FG003|Overall Study|Subject non-compliance|0|||
160912388|NCT02141282|581072237|FG000|Overall Study|Withdrew consent|2|||
160912389|NCT02141282|581072238|FG001|Overall Study|Withdrew consent|0|||
160912390|NCT02141282|581072239|FG002|Overall Study|Withdrew consent|4|||
160912391|NCT02141282|581072240|FG003|Overall Study|Withdrew consent|0|||
160912392|NCT01384760|581072248|FG000|Overall Study|Lost to Follow-up|0|||
160912393|NCT01384760|581072249|FG001|Overall Study|Lost to Follow-up|6|||
160912394|NCT01384760|581072248|FG000|Overall Study|Protocol Violation|16|||
160912395|NCT01384760|581072249|FG001|Overall Study|Protocol Violation|0|||
160912396|NCT00903695|581072253|FG000|Overall Study|medical exclusion after 1st testing|1|||
160570526|NCT04329923|579812130|FG001|Overall Study|early termination of study|0|||
160570527|NCT04329923|579812131|FG002|Overall Study|early termination of study|0|||
160570528|NCT04329923|579812132|FG003|Overall Study|early termination of study|0|||
160570529|NCT04329923|579812133|FG004|Overall Study|early termination of study|1|||
160570530|NCT04329923|579812134|FG005|Overall Study|early termination of study|2|||
160570531|NCT04329923|579812129|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
160570532|NCT04329923|579812130|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
160570533|NCT04329923|579812131|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
160570534|NCT04329923|579812132|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
160570535|NCT04329923|579812133|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
160570536|NCT04329923|579812134|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
160570537|NCT03334214|579812135|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
160570538|NCT03334214|579812136|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
160570539|NCT03334214|579812135|FG000|Overall Study|Withdrawal by Subject|0|||
160570540|NCT03334214|579812136|FG001|Overall Study|Withdrawal by Subject|1|||
160570541|NCT03334214|579812135|FG000|Overall Study|Other|1|||
160570542|NCT03334214|579812136|FG001|Overall Study|Other|0|||
160912397|NCT00903695|581072254|FG001|Overall Study|medical exclusion after 1st testing|0|||
160912398|NCT00903695|581072253|FG000|Overall Study|lung cancer|1|||
160912399|NCT00903695|581072254|FG001|Overall Study|lung cancer|0|||
160912400|NCT01549860|581072255|FG000|Overall Study|Withdrawal by Subject|1|||
160912401|NCT01549860|581072256|FG001|Overall Study|Withdrawal by Subject|0|||
160912402|NCT01549860|581072255|FG000|Overall Study|Physician Decision|1|||
160912403|NCT01549860|581072256|FG001|Overall Study|Physician Decision|1|||
160912404|NCT01366521|581072258|FG000|Overall Study|Adverse Event|1|||
160912405|NCT01366521|581072259|FG001|Overall Study|Adverse Event|0|||
160912406|NCT01366521|581072260|FG002|Overall Study|Adverse Event|0|||
160912407|NCT01366521|581072261|FG003|Overall Study|Adverse Event|0|||
160912408|NCT01366521|581072258|FG000|Overall Study|Protocol Violation|0|||
160912409|NCT01366521|581072259|FG001|Overall Study|Protocol Violation|0|||
160912410|NCT01366521|581072260|FG002|Overall Study|Protocol Violation|1|||
160912411|NCT01366521|581072261|FG003|Overall Study|Protocol Violation|0|||
160912412|NCT01366521|581072258|FG000|Overall Study|Physician Decision|0|||
160912413|NCT01366521|581072259|FG001|Overall Study|Physician Decision|0|||
160912414|NCT01366521|581072260|FG002|Overall Study|Physician Decision|1|||
160912415|NCT01366521|581072261|FG003|Overall Study|Physician Decision|0|||
160912416|NCT01366521|581072258|FG000|Overall Study|Withdrawal by Subject|0|||
160912417|NCT01366521|581072259|FG001|Overall Study|Withdrawal by Subject|1|||
160912418|NCT01366521|581072260|FG002|Overall Study|Withdrawal by Subject|0|||
160912419|NCT01366521|581072261|FG003|Overall Study|Withdrawal by Subject|0|||
160912420|NCT02430311|581072262|FG000|Part A|Adverse Event|0|||
160912421|NCT02430311|581072263|FG001|Part A|Adverse Event|1|||
160912422|NCT02430311|581072262|FG000|Part A|Withdrawal by Subject|1|||
160912423|NCT02430311|581072263|FG001|Part A|Withdrawal by Subject|0|||
160912424|NCT02430311|581072262|FG000|Part B|Meet study-specific withdrawal criteria|6|||
160912425|NCT02430311|581072263|FG001|Part B|Meet study-specific withdrawal criteria|6|||
160912426|NCT02430311|581072262|FG000|Part B|Withdrawal by Subject|2|||
160912427|NCT02430311|581072263|FG001|Part B|Withdrawal by Subject|2|||
160912428|NCT02430311|581072262|FG000|Part B|Adverse Event|1|||
160912429|NCT02430311|581072263|FG001|Part B|Adverse Event|0|||
160912430|NCT02430311|581072262|FG000|Part B|Death|1|||
160912431|NCT02430311|581072263|FG001|Part B|Death|0|||
160912432|NCT00578812|581072264|FG000|Overall Study|Not treated|6|||
160912433|NCT00578812|581072265|FG001|Overall Study|Not treated|7|||
160912434|NCT02041286|581072284|FG000|Overall Study|Adverse Event|1|||
160912435|NCT00085631|581072293|FG000|Overall Study|Missing Data|4|||
160912436|NCT00085631|581072294|FG001|Overall Study|Missing Data|11|||
160912437|NCT00085631|581072295|FG002|Overall Study|Missing Data|7|||
160912438|NCT00411645|581072296|FG000|Overall Study|Consent Withdrawn|13|||
160912439|NCT00411645|581072297|FG001|Overall Study|Consent Withdrawn|22|||
160912440|NCT00411645|581072296|FG000|Overall Study|Death|56|||
160912441|NCT00411645|581072297|FG001|Overall Study|Death|135|||
160912442|NCT00411645|581072296|FG000|Overall Study|Investigator/Sponsor Decision|10|||
160912443|NCT00411645|581072297|FG001|Overall Study|Investigator/Sponsor Decision|7|||
160912444|NCT00411645|581072296|FG000|Overall Study|Lost to Follow-up|2|||
160912445|NCT00411645|581072297|FG001|Overall Study|Lost to Follow-up|0|||
160912446|NCT01349790|581072298|FG000|Overall Study|Investigator Judgement|3|||
160912447|NCT01349790|581072298|FG000|Overall Study|Death|2|||
160912448|NCT01349790|581072298|FG000|Overall Study|Withdrawal by Patient|2|||
160912449|NCT01349790|581072298|FG000|Overall Study|Adverse Event|1|||
160912450|NCT01349790|581072298|FG000|Overall Study|Lost to Follow-up|1|||
160912451|NCT01513473|581072299|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
160912452|NCT01513473|581072300|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
160912453|NCT01513473|581072299|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
160912454|NCT01513473|581072300|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
160912455|NCT01513473|581072299|FG000|Main Trial (26 Weeks)|Unclassified|0|||
160912456|NCT01513473|581072300|FG001|Main Trial (26 Weeks)|Unclassified|2|||
160912457|NCT01513473|581072299|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
160912458|NCT01513473|581072300|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
160912459|NCT01513473|581072299|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
160912460|NCT01513473|581072300|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
160912461|NCT03462082|581072301|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160912462|NCT03462082|581072302|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160912463|NCT03462082|581072303|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160912464|NCT03462082|581072304|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160912465|NCT03462082|581072305|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160453356|NCT03024437|579392067|FG001|Overall Study|Disease progression, relapse|0|||
160570543|NCT01588197|579812144|FG000|Overall Study|Lack of Efficacy|0|||
160570544|NCT01588197|579812145|FG001|Overall Study|Lack of Efficacy|1|||
160570545|NCT01588197|579812144|FG000|Overall Study|No MRI|1|||
160570546|NCT01588197|579812145|FG001|Overall Study|No MRI|0|||
160912466|NCT03462082|581072306|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160912467|NCT03462082|581072307|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
160912468|NCT03462082|581072308|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
160912469|NCT00166114|581072311|FG000|Overall Study|Protocol Violation|2|||
160912470|NCT00166114|581072312|FG001|Overall Study|Protocol Violation|1|||
160912471|NCT00166114|581072311|FG000|Overall Study|Withdrawal by Subject|10|||
160912472|NCT00166114|581072312|FG001|Overall Study|Withdrawal by Subject|4|||
160912473|NCT00166114|581072311|FG000|Overall Study|Adverse Event|2|||
160912474|NCT00166114|581072312|FG001|Overall Study|Adverse Event|1|||
160912475|NCT00743340|581072317|FG000|Overall Study|Study medication non-compliance|1|||
160912476|NCT00743340|581072317|FG000|Overall Study|Lost to Follow-up|1|||
160912477|NCT00743340|581072317|FG000|Overall Study|Withdrawal from the Study|5|||
160912478|NCT00743340|581072317|FG000|Overall Study|Protocol Violation|1|||
160912479|NCT00743340|581072317|FG000|Overall Study|Virologic failure|8|||
160912480|NCT00743340|581072317|FG000|Overall Study|Pregnancy|1|||
160912481|NCT00743340|581072317|FG000|Overall Study|Rolled over to other Gilead Study|23|||
160912482|NCT00743340|581072317|FG000|Overall Study|Participant Relocated|1|||
160453357|NCT03024437|579392068|FG002|Overall Study|Disease progression, relapse|0|||
160912483|NCT02708121|581072318|FG000|Overall Study|Withdrawn by Study Team|1|||
160912484|NCT02708121|581072319|FG001|Overall Study|Withdrawn by Study Team|1|||
160912485|NCT02708121|581072318|FG000|Overall Study|Withdrawal by Subject|0|||
160912486|NCT02708121|581072319|FG001|Overall Study|Withdrawal by Subject|4|||
160912487|NCT00127660|581072322|FG000|Overall Study|Protocol Violation|3|||
160912488|NCT00127660|581072323|FG001|Overall Study|Protocol Violation|3|||
160912489|NCT00127660|581072324|FG002|Overall Study|Protocol Violation|5|||
160912490|NCT00127660|581072325|FG003|Overall Study|Protocol Violation|0|||
160912491|NCT01987505|581072326|FG000|Overall Study|Other|9|||
160912492|NCT01987505|581072326|FG000|Overall Study|Withdrawal by Subject|2|||
160912493|NCT01987505|581072326|FG000|Overall Study|Other Reason|2|||
160912494|NCT01987505|581072326|FG000|Overall Study|Lost to Follow-up|15|||
160912495|NCT01987505|581072326|FG000|Overall Study|Investigator Decision|2|||
160912496|NCT01987505|581072326|FG000|Overall Study|Death|4|||
160912497|NCT01425281|581072327|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
160912498|NCT01425281|581072328|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
160912499|NCT01425281|581072327|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
160912500|NCT01425281|581072328|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
160912501|NCT01425281|581072327|FG000|At 180-day Clinical Follow-up|Death|0|||
160912502|NCT01425281|581072328|FG001|At 180-day Clinical Follow-up|Death|1|||
160912503|NCT01425281|581072327|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
160912504|NCT01425281|581072328|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
160912505|NCT01425281|581072327|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
160912506|NCT01425281|581072328|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
160912507|NCT01425281|581072327|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
160912508|NCT01425281|581072328|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
160912509|NCT01425281|581072327|FG000|At 2-year Clinical Follow-up|Death|2|||
160912510|NCT01425281|581072328|FG001|At 2-year Clinical Follow-up|Death|0|||
160912511|NCT01425281|581072327|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
160912512|NCT01425281|581072328|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
160912513|NCT01425281|581072327|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
160912514|NCT01425281|581072328|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
160912515|NCT01425281|581072327|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
160912516|NCT01425281|581072328|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
160912517|NCT01425281|581072327|FG000|At 3-year Clinical Follow-up|Death|2|||
160912518|NCT01425281|581072328|FG001|At 3-year Clinical Follow-up|Death|3|||
160912519|NCT01425281|581072327|FG000|At 4-year Clinical Follow-up|Death|7|||
160912520|NCT01425281|581072328|FG001|At 4-year Clinical Follow-up|Death|3|||
160912521|NCT01425281|581072327|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
160912522|NCT01425281|581072328|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
160912523|NCT01425281|581072327|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
160912524|NCT01425281|581072328|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
160912525|NCT01425281|581072327|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
160912526|NCT01425281|581072328|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
160912527|NCT01425281|581072327|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
160912528|NCT01425281|581072328|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
160912529|NCT01425281|581072327|FG000|At 5-year Clinical Follow-up|Death|2|||
160912530|NCT01425281|581072328|FG001|At 5-year Clinical Follow-up|Death|0|||
160912531|NCT01425281|581072327|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
160912532|NCT01425281|581072328|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
160912533|NCT01425281|581072327|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
160912534|NCT01425281|581072328|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
160453358|NCT03024437|579392069|FG003|Overall Study|Disease progression, relapse|3|||
160912535|NCT01425281|581072327|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
160912536|NCT01425281|581072328|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
160912537|NCT01749514|581072329|FG000|Overall Study|Lost to Follow-up|0|||
160912538|NCT01749514|581072330|FG001|Overall Study|Lost to Follow-up|0|||
160912539|NCT01749514|581072331|FG002|Overall Study|Lost to Follow-up|0|||
160912540|NCT01749514|581072332|FG003|Overall Study|Lost to Follow-up|0|||
160912541|NCT01749514|581072333|FG004|Overall Study|Lost to Follow-up|0|||
160912542|NCT01749514|581072334|FG005|Overall Study|Lost to Follow-up|0|||
160912543|NCT01749514|581072335|FG006|Overall Study|Lost to Follow-up|0|||
160912544|NCT01749514|581072336|FG007|Overall Study|Lost to Follow-up|1|||
160912545|NCT01749514|581072329|FG000|Overall Study|Withdrawal by Subject|0|||
160912546|NCT01749514|581072330|FG001|Overall Study|Withdrawal by Subject|0|||
160912547|NCT01749514|581072331|FG002|Overall Study|Withdrawal by Subject|0|||
160912548|NCT01749514|581072332|FG003|Overall Study|Withdrawal by Subject|0|||
160912549|NCT01749514|581072333|FG004|Overall Study|Withdrawal by Subject|0|||
160912550|NCT01749514|581072334|FG005|Overall Study|Withdrawal by Subject|1|||
160453359|NCT03024437|579392070|FG004|Overall Study|Disease progression, relapse|0|||
160453360|NCT03024437|579392066|FG000|Overall Study|Disease progression, refractory disease|4|||
160453361|NCT03024437|579392067|FG001|Overall Study|Disease progression, refractory disease|4|||
160453362|NCT03024437|579392068|FG002|Overall Study|Disease progression, refractory disease|2|||
160453363|NCT03024437|579392069|FG003|Overall Study|Disease progression, refractory disease|2|||
160453364|NCT03024437|579392070|FG004|Overall Study|Disease progression, refractory disease|1|||
160453365|NCT03024437|579392066|FG000|Overall Study|Newly diagnosed cancer|0|||
160453366|NCT03024437|579392067|FG001|Overall Study|Newly diagnosed cancer|0|||
160453367|NCT03024437|579392068|FG002|Overall Study|Newly diagnosed cancer|0|||
160453368|NCT03024437|579392069|FG003|Overall Study|Newly diagnosed cancer|1|||
160453369|NCT03024437|579392070|FG004|Overall Study|Newly diagnosed cancer|0|||
160453370|NCT03024437|579392066|FG000|Overall Study|Moved out of state|0|||
160453371|NCT03024437|579392067|FG001|Overall Study|Moved out of state|1|||
160453372|NCT03024437|579392068|FG002|Overall Study|Moved out of state|0|||
160453373|NCT03024437|579392069|FG003|Overall Study|Moved out of state|0|||
160453374|NCT03024437|579392070|FG004|Overall Study|Moved out of state|0|||
160453375|NCT03024437|579392066|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
160453376|NCT03024437|579392067|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
160453377|NCT03024437|579392068|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
160453378|NCT03024437|579392069|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
160453379|NCT03024437|579392070|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
160453380|NCT02606422|579392071|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
160453381|NCT02606422|579392072|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
160453382|NCT02606422|579392071|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
160453383|NCT02606422|579392072|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
160453384|NCT02606422|579392071|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
160453385|NCT02606422|579392072|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
160453386|NCT02606422|579392071|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
160453387|NCT02606422|579392072|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
160453388|NCT04625465|579392073|FG000|Overall Study|Lost to Follow-up|2|||
160453389|NCT04625465|579392074|FG001|Overall Study|Lost to Follow-up|2|||
160453390|NCT04625465|579392075|FG002|Overall Study|Lost to Follow-up|1|||
160453391|NCT04625465|579392076|FG003|Overall Study|Lost to Follow-up|0|||
160453392|NCT04625465|579392077|FG004|Overall Study|Lost to Follow-up|0|||
160453393|NCT04625465|579392078|FG005|Overall Study|Lost to Follow-up|2|||
160453394|NCT04625465|579392079|FG006|Overall Study|Lost to Follow-up|0|||
160453395|NCT04625465|579392080|FG007|Overall Study|Lost to Follow-up|0|||
160453396|NCT04625465|579392073|FG000|Overall Study|Death|1|||
160453397|NCT04625465|579392074|FG001|Overall Study|Death|0|||
160453398|NCT04625465|579392075|FG002|Overall Study|Death|0|||
160453399|NCT04625465|579392076|FG003|Overall Study|Death|0|||
160453400|NCT04625465|579392077|FG004|Overall Study|Death|0|||
160453401|NCT04625465|579392078|FG005|Overall Study|Death|0|||
160453402|NCT04625465|579392079|FG006|Overall Study|Death|0|||
160453403|NCT04625465|579392080|FG007|Overall Study|Death|0|||
160453404|NCT04625465|579392073|FG000|Overall Study|Withdrawal by Subject|1|||
160453405|NCT04625465|579392074|FG001|Overall Study|Withdrawal by Subject|0|||
160453406|NCT04625465|579392075|FG002|Overall Study|Withdrawal by Subject|4|||
160453407|NCT04625465|579392076|FG003|Overall Study|Withdrawal by Subject|4|||
160453408|NCT04625465|579392077|FG004|Overall Study|Withdrawal by Subject|4|||
160453409|NCT04625465|579392078|FG005|Overall Study|Withdrawal by Subject|0|||
160912551|NCT01749514|581072335|FG006|Overall Study|Withdrawal by Subject|0|||
160912552|NCT01749514|581072336|FG007|Overall Study|Withdrawal by Subject|1|||
160912553|NCT01749514|581072329|FG000|Overall Study|Not Reported|0|||
160912554|NCT01749514|581072330|FG001|Overall Study|Not Reported|0|||
160912555|NCT01749514|581072331|FG002|Overall Study|Not Reported|0|||
160912556|NCT01749514|581072332|FG003|Overall Study|Not Reported|0|||
160912557|NCT01749514|581072333|FG004|Overall Study|Not Reported|0|||
160912558|NCT01749514|581072334|FG005|Overall Study|Not Reported|0|||
160912559|NCT01749514|581072335|FG006|Overall Study|Not Reported|0|||
160912560|NCT01749514|581072336|FG007|Overall Study|Not Reported|5|||
160912561|NCT02509156|581072337|FG000|Randomized Phase|Death|1|||
160912562|NCT02509156|581072338|FG001|Randomized Phase|Death|0|||
160652739|NCT02946385|580110340|FG003|Overall Study|Lost to Follow-up|0|||
160912563|NCT02509156|581072337|FG000|Randomized Phase|Withdrawal by Subject|1|||
160912564|NCT02509156|581072338|FG001|Randomized Phase|Withdrawal by Subject|1|||
160453410|NCT04625465|579392079|FG006|Overall Study|Withdrawal by Subject|0|||
160453411|NCT04625465|579392080|FG007|Overall Study|Withdrawal by Subject|0|||
160453412|NCT05566639|579392084|FG000|Overall Study|Adverse Event|1|||
160453413|NCT05566639|579392085|FG001|Overall Study|Adverse Event|1|||
160453414|NCT05566639|579392084|FG000|Overall Study|Serious Adverse Event|1|||
160912565|NCT05131646|581072339|FG000|Overall Study|Withdrawal by Subject|1|||
160912566|NCT05131646|581072340|FG001|Overall Study|Withdrawal by Subject|0|||
160912567|NCT05131646|581072341|FG002|Overall Study|Withdrawal by Subject|0|||
160912568|NCT03266107|581072342|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
160912569|NCT03266107|581072342|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
160912570|NCT03266107|581072342|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
160912571|NCT03266107|581072342|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
160912572|NCT02548650|581072345|FG000|Triple Therapy|Adverse Event|1|||
160912573|NCT02548650|581072346|FG001|Triple Therapy|Adverse Event|0|||
160912574|NCT02548650|581072345|FG000|Triple Therapy|Withdrawal by Subject|0|||
160912575|NCT02548650|581072346|FG001|Triple Therapy|Withdrawal by Subject|4|||
160912576|NCT02548650|581072345|FG000|Double Therapy|Adverse Event|1|||
160912577|NCT02548650|581072346|FG001|Double Therapy|Adverse Event|1|||
160912578|NCT02548650|581072345|FG000|Double Therapy|Withdrawal by Subject|0|||
160912579|NCT02548650|581072346|FG001|Double Therapy|Withdrawal by Subject|1|||
160912580|NCT01191801|581072347|FG000|Overall Study|Death|36|||
160912581|NCT01191801|581072348|FG001|Overall Study|Death|12|||
160912582|NCT01191801|581072347|FG000|Overall Study|Lack of Efficacy|176|||
160912583|NCT01191801|581072348|FG001|Overall Study|Lack of Efficacy|258|||
160912584|NCT01191801|581072347|FG000|Overall Study|Adverse Event|9|||
160912585|NCT01191801|581072348|FG001|Overall Study|Adverse Event|8|||
160912586|NCT01191801|581072347|FG000|Overall Study|Protocol Violation|2|||
160912587|NCT01191801|581072348|FG001|Overall Study|Protocol Violation|4|||
160912588|NCT01191801|581072347|FG000|Overall Study|Physician Decision|47|||
160912589|NCT01191801|581072348|FG001|Overall Study|Physician Decision|24|||
160912590|NCT01191801|581072347|FG000|Overall Study|Withdrawal by Subject|1|||
160912591|NCT01191801|581072348|FG001|Overall Study|Withdrawal by Subject|4|||
160912592|NCT01191801|581072347|FG000|Overall Study|Not Provided|45|||
160912593|NCT01191801|581072348|FG001|Overall Study|Not Provided|27|||
160912594|NCT00299104|581072349|FG000|Treatment Period|Adverse Event|14|||
160912595|NCT00299104|581072350|FG001|Treatment Period|Adverse Event|9|||
160912596|NCT00299104|581072351|FG002|Treatment Period|Adverse Event|7|||
160912597|NCT00299104|581072349|FG000|Treatment Period|Death|1|||
160912598|NCT00299104|581072350|FG001|Treatment Period|Death|1|||
160912599|NCT00299104|581072351|FG002|Treatment Period|Death|1|||
160912600|NCT00299104|581072349|FG000|Treatment Period|Insufficient therapeutic response|34|||
160912601|NCT00299104|581072350|FG001|Treatment Period|Insufficient therapeutic response|13|||
160912602|NCT00299104|581072351|FG002|Treatment Period|Insufficient therapeutic response|8|||
160912603|NCT00299104|581072349|FG000|Treatment Period|Failure to return|9|||
160912604|NCT00299104|581072350|FG001|Treatment Period|Failure to return|8|||
160912605|NCT00299104|581072351|FG002|Treatment Period|Failure to return|8|||
160912606|NCT00299104|581072349|FG000|Treatment Period|Violation of selection criteria|1|||
160912607|NCT00299104|581072350|FG001|Treatment Period|Violation of selection criteria|2|||
160912608|NCT00299104|581072351|FG002|Treatment Period|Violation of selection criteria|0|||
160912609|NCT00299104|581072349|FG000|Treatment Period|Protocol Violation|1|||
160912610|NCT00299104|581072350|FG001|Treatment Period|Protocol Violation|1|||
160912611|NCT00299104|581072351|FG002|Treatment Period|Protocol Violation|0|||
160912612|NCT00299104|581072349|FG000|Treatment Period|Refused treatment|9|||
160912613|NCT00299104|581072350|FG001|Treatment Period|Refused treatment|2|||
160912614|NCT00299104|581072351|FG002|Treatment Period|Refused treatment|2|||
160912615|NCT00299104|581072349|FG000|Treatment Period|Withdrew consent|14|||
160912616|NCT00299104|581072350|FG001|Treatment Period|Withdrew consent|19|||
160912617|NCT00299104|581072351|FG002|Treatment Period|Withdrew consent|9|||
160912618|NCT00299104|581072349|FG000|Treatment Period|Administrative reasons|106|||
160912619|NCT00299104|581072350|FG001|Treatment Period|Administrative reasons|120|||
160912620|NCT00299104|581072351|FG002|Treatment Period|Administrative reasons|137|||
160912621|NCT00299104|581072349|FG000|Safety Follow-Up (SFU) Period|Death|3|||
160912622|NCT00299104|581072350|FG001|Safety Follow-Up (SFU) Period|Death|2|||
160912623|NCT00299104|581072351|FG002|Safety Follow-Up (SFU) Period|Death|1|||
160912624|NCT00299104|581072349|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
160912625|NCT00299104|581072350|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
160912626|NCT00299104|581072351|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
160912627|NCT00299104|581072349|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
160912628|NCT00299104|581072350|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
160912629|NCT00299104|581072351|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
160912630|NCT00299104|581072349|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
160912631|NCT00299104|581072350|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
160912632|NCT00299104|581072351|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
160912633|NCT00299104|581072349|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
160912634|NCT00299104|581072350|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
160912635|NCT00299104|581072351|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
160912636|NCT00299104|581072349|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
160912637|NCT00299104|581072350|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
160912638|NCT00299104|581072351|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
160912639|NCT00299104|581072349|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
160912640|NCT00299104|581072350|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
160995493|NCT05827926|581370947|FG003|Overall Study|Lost to Follow-up|0|||
160995494|NCT05827926|581370948|FG004|Overall Study|Lost to Follow-up|0|||
160995495|NCT05827926|581370949|FG005|Overall Study|Lost to Follow-up|1|||
160995496|NCT05827926|581370950|FG006|Overall Study|Lost to Follow-up|0|||
160995497|NCT05827926|581370951|FG007|Overall Study|Lost to Follow-up|0|||
160995498|NCT05827926|581370952|FG008|Overall Study|Lost to Follow-up|0|||
160995499|NCT05827926|581370953|FG009|Overall Study|Lost to Follow-up|0|||
160912641|NCT00299104|581072351|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
160912642|NCT00299104|581072349|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
160912643|NCT00299104|581072350|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
160912644|NCT00299104|581072351|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
160912645|NCT00814164|581072355|FG000|Overall Study|Progression|7|||
160912646|NCT00814164|581072355|FG000|Overall Study|not stated|7|||
160912647|NCT00814164|581072355|FG000|Overall Study|Death|5|||
160912648|NCT01053221|581072356|FG000|Overall Study|The study was closed prematurely|5|||
160912649|NCT01053221|581072357|FG001|Overall Study|The study was closed prematurely|9|||
160912650|NCT01417234|581072358|FG000|Overall Study|Subject non-compliant|3|||
160912651|NCT01537393|581072359|FG000|Overall Study|Exclude prior to study|32|||
160995500|NCT05827926|581370954|FG010|Overall Study|Lost to Follow-up|0|||
160995501|NCT05827926|581370955|FG011|Overall Study|Lost to Follow-up|0|||
160995502|NCT05827926|581370956|FG012|Overall Study|Lost to Follow-up|1|||
160995503|NCT05827926|581370957|FG013|Overall Study|Lost to Follow-up|1|||
160912652|NCT01537393|581072360|FG001|Overall Study|Exclude prior to study|44|||
160912653|NCT01537393|581072359|FG000|Overall Study|Death|20|||
160912654|NCT01537393|581072360|FG001|Overall Study|Death|32|||
160912655|NCT01537393|581072359|FG000|Overall Study|Withdrawal by Subject|18|||
160912656|NCT01537393|581072360|FG001|Overall Study|Withdrawal by Subject|17|||
160912657|NCT01537393|581072359|FG000|Overall Study|Lost to Follow-up|53|||
160912658|NCT01537393|581072360|FG001|Overall Study|Lost to Follow-up|48|||
160912659|NCT01537393|581072359|FG000|Overall Study|Failure - Regrafted|28|||
160912660|NCT01537393|581072360|FG001|Overall Study|Failure - Regrafted|43|||
160912661|NCT01537393|581072359|FG000|Overall Study|Failure - Not regrafted|2|||
160912662|NCT01537393|581072360|FG001|Overall Study|Failure - Not regrafted|6|||
160912663|NCT01537393|581072359|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
160912664|NCT01537393|581072360|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
160912665|NCT00459953|581072361|FG000|Overall Study|not analyzed-household member in study|1|||
160995504|NCT05827926|581370958|FG014|Overall Study|Lost to Follow-up|0|||
160995505|NCT05827926|581370959|FG015|Overall Study|Lost to Follow-up|1|||
160995506|NCT05827926|581370960|FG016|Overall Study|Lost to Follow-up|2|||
160995507|NCT05827926|581370961|FG017|Overall Study|Lost to Follow-up|0|||
160995508|NCT05827926|581370962|FG018|Overall Study|Lost to Follow-up|0|||
160995509|NCT05827926|581370963|FG019|Overall Study|Lost to Follow-up|0|||
160995510|NCT05827926|581370964|FG020|Overall Study|Lost to Follow-up|1|||
160995511|NCT05827926|581370965|FG021|Overall Study|Lost to Follow-up|2|||
160995512|NCT05827926|581370966|FG022|Overall Study|Lost to Follow-up|1|||
160995513|NCT05827926|581370967|FG023|Overall Study|Lost to Follow-up|1|||
160995514|NCT05827926|581370968|FG024|Overall Study|Lost to Follow-up|2|||
160995515|NCT05827926|581370969|FG025|Overall Study|Lost to Follow-up|1|||
160995516|NCT05827926|581370970|FG026|Overall Study|Lost to Follow-up|4|||
160995517|NCT05827926|581370971|FG027|Overall Study|Lost to Follow-up|1|||
160995518|NCT05827926|581370972|FG028|Overall Study|Lost to Follow-up|2|||
160995519|NCT05827926|581370973|FG029|Overall Study|Lost to Follow-up|1|||
160995520|NCT05827926|581370974|FG030|Overall Study|Lost to Follow-up|5|||
160995521|NCT05827926|581370975|FG031|Overall Study|Lost to Follow-up|0|||
160995522|NCT05827926|581370976|FG032|Overall Study|Lost to Follow-up|3|||
160995523|NCT05827926|581370977|FG033|Overall Study|Lost to Follow-up|2|||
160995524|NCT05827926|581370978|FG034|Overall Study|Lost to Follow-up|1|||
160995525|NCT05827926|581370979|FG035|Overall Study|Lost to Follow-up|3|||
160570547|NCT02088034|579812159|FG000|Overall Study|Lost to Follow-up|1|||
160570548|NCT02088034|579812160|FG001|Overall Study|Lost to Follow-up|1|||
160570549|NCT02088034|579812161|FG002|Overall Study|Lost to Follow-up|0|||
160570550|NCT02088034|579812159|FG000|Overall Study|Pregnancy|2|||
160995526|NCT05827926|581370980|FG036|Overall Study|Lost to Follow-up|4|||
160995527|NCT05827926|581370944|FG000|Overall Study|Withdrawal by Subject|1|||
160570551|NCT02088034|579812160|FG001|Overall Study|Pregnancy|1|||
160570552|NCT02088034|579812161|FG002|Overall Study|Pregnancy|2|||
160570553|NCT00308620|579812164|FG000|Overall Study|Death|1|||
160912666|NCT00459953|581072362|FG001|Overall Study|not analyzed-household member in study|1|||
160912667|NCT01197560|581072365|FG000|Overall Study|Adverse Event|6|||
160912668|NCT01197560|581072366|FG001|Overall Study|Adverse Event|8|||
160912669|NCT01197560|581072365|FG000|Overall Study|Death|3|||
160912670|NCT01197560|581072366|FG001|Overall Study|Death|5|||
160912671|NCT01197560|581072365|FG000|Overall Study|Withdrawal by Subject|1|||
160912672|NCT01197560|581072366|FG001|Overall Study|Withdrawal by Subject|1|||
160912673|NCT01197560|581072365|FG000|Overall Study|Disease progression|40|||
160995528|NCT05827926|581370945|FG001|Overall Study|Withdrawal by Subject|0|||
160995529|NCT05827926|581370946|FG002|Overall Study|Withdrawal by Subject|1|||
160995530|NCT05827926|581370947|FG003|Overall Study|Withdrawal by Subject|1|||
160912674|NCT01197560|581072366|FG001|Overall Study|Disease progression|35|||
160912675|NCT01197560|581072365|FG000|Overall Study|Miscellaneous|4|||
160912676|NCT01197560|581072366|FG001|Overall Study|Miscellaneous|3|||
160912677|NCT01197560|581072365|FG000|Overall Study|Missing|0|||
160912678|NCT01197560|581072366|FG001|Overall Study|Missing|1|||
160912679|NCT00211510|581072369|FG000|Overall Study|Physician Decision|3|||
160912680|NCT00211510|581072370|FG001|Overall Study|Physician Decision|1|||
160912681|NCT00211510|581072369|FG000|Overall Study|Withdrawal by Subject|3|||
160912682|NCT00211510|581072370|FG001|Overall Study|Withdrawal by Subject|1|||
160912683|NCT01487200|581072371|FG000|Overall Study|Withdrawal by Subject|0|||
160912684|NCT01487200|581072372|FG001|Overall Study|Withdrawal by Subject|1|||
160912685|NCT01487200|581072373|FG002|Overall Study|Withdrawal by Subject|0|||
160912686|NCT01487200|581072374|FG003|Overall Study|Withdrawal by Subject|0|||
160912687|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
160912688|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
160912689|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
160912690|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912691|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912692|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912693|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912694|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160995531|NCT05827926|581370948|FG004|Overall Study|Withdrawal by Subject|0|||
160995532|NCT05827926|581370949|FG005|Overall Study|Withdrawal by Subject|0|||
160995533|NCT05827926|581370950|FG006|Overall Study|Withdrawal by Subject|0|||
160912695|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912696|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912697|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912698|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
160912699|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912700|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
160912701|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912702|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912703|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912704|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912705|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912706|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912707|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912708|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912709|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
160912710|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
160912711|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
160912712|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912713|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912714|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912715|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912716|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912717|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912718|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912719|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912720|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
160912721|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
160912722|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912723|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912724|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912725|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912726|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912727|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912728|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912729|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912730|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912731|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
160995534|NCT05827926|581370951|FG007|Overall Study|Withdrawal by Subject|0|||
160995535|NCT05827926|581370952|FG008|Overall Study|Withdrawal by Subject|0|||
160995536|NCT05827926|581370953|FG009|Overall Study|Withdrawal by Subject|0|||
160995537|NCT05827926|581370954|FG010|Overall Study|Withdrawal by Subject|0|||
160995538|NCT05827926|581370955|FG011|Overall Study|Withdrawal by Subject|0|||
160995539|NCT05827926|581370956|FG012|Overall Study|Withdrawal by Subject|1|||
160912732|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
160912733|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
160912734|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912735|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912736|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912737|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912738|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912739|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912740|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912741|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912742|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912743|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
160912744|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
160912745|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912746|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912747|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912748|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912749|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912750|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912751|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912752|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912753|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912754|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
160912755|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912756|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912757|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912758|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912759|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912760|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912761|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912762|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912763|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912764|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912765|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912766|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912767|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912768|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
160912769|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
160912770|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912771|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912772|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912773|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912774|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912775|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912776|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912777|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912778|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912779|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912780|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
160912781|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912782|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912783|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912784|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912785|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912786|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912787|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912788|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160570554|NCT00308620|579812165|FG001|Overall Study|Death|1|||
160570555|NCT00308620|579812166|FG002|Overall Study|Death|0|||
160570556|NCT00308620|579812164|FG000|Overall Study|Lost to Follow-up|0|||
160570557|NCT00308620|579812165|FG001|Overall Study|Lost to Follow-up|0|||
160570558|NCT00308620|579812166|FG002|Overall Study|Lost to Follow-up|1|||
160570559|NCT02424149|579812168|FG000|Overall Study|surgery cancelled|2|||
160570560|NCT02424149|579812169|FG001|Overall Study|surgery cancelled|0|||
160570561|NCT02424149|579812168|FG000|Overall Study|Withdrawal by Subject|0|||
160570562|NCT02424149|579812169|FG001|Overall Study|Withdrawal by Subject|1|||
160570563|NCT01025336|579812170|FG000|Overall Study|Protocol Violation|0|||
160570564|NCT01025336|579812171|FG001|Overall Study|Protocol Violation|0|||
160570565|NCT01025336|579812172|FG002|Overall Study|Protocol Violation|0|||
160453415|NCT05566639|579392085|FG001|Overall Study|Serious Adverse Event|3|||
160453416|NCT05566639|579392084|FG000|Overall Study|Death|44|||
160453417|NCT05566639|579392085|FG001|Overall Study|Death|45|||
160453418|NCT05566639|579392084|FG000|Overall Study|Lost to Follow-up|467|||
160453419|NCT05566639|579392085|FG001|Overall Study|Lost to Follow-up|461|||
160453420|NCT05566639|579392084|FG000|Overall Study|Physician Decision|45|||
160453421|NCT05566639|579392085|FG001|Overall Study|Physician Decision|44|||
160453422|NCT05566639|579392084|FG000|Overall Study|Protocol Deviation|4|||
160453423|NCT05566639|579392085|FG001|Overall Study|Protocol Deviation|4|||
160453424|NCT05566639|579392084|FG000|Overall Study|Withdrawal by Subject|277|||
160453425|NCT05566639|579392085|FG001|Overall Study|Withdrawal by Subject|271|||
160453426|NCT05566639|579392084|FG000|Overall Study|Other Than Specified|52|||
160453427|NCT05566639|579392085|FG001|Overall Study|Other Than Specified|64|||
160453428|NCT04054193|579392093|FG000|Cycle 1|Physician Decision|1|||
160453429|NCT04054193|579392093|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
160453430|NCT04054193|579392093|FG000|Cycle 1|Allocated but not treated|3|||
160453431|NCT04054193|579392093|FG000|Cycles 2-3|Physician Decision|2|||
160453432|NCT04054193|579392093|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
160453433|NCT04054193|579392093|FG000|Cycles 2-3|Various reasons|17|||
160453434|NCT02966873|579392094|FG000|Overall Study|Lost to Follow-up|16|||
160453435|NCT02966873|579392095|FG001|Overall Study|Lost to Follow-up|15|||
160861564|NCT00321620|580887768|FG001|Overall Study|Physician Decision|1|||
160861565|NCT00321620|580887767|FG000|Overall Study|Noncompliance|14|||
160861566|NCT00321620|580887768|FG001|Overall Study|Noncompliance|7|||
160861567|NCT00321620|580887767|FG000|Overall Study|Protocol deviation|4|||
160861568|NCT00321620|580887768|FG001|Overall Study|Protocol deviation|3|||
160912789|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
160912790|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
160912791|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
160912792|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912793|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912794|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912795|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912796|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912797|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912798|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912799|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912800|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
160912801|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
160912802|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
160912803|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912804|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912805|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912806|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912807|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912808|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912809|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912810|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912811|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
160912812|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912813|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
160912814|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912815|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912816|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912817|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912818|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912819|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912820|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912821|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912822|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
160912823|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912824|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912825|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912826|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912827|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
160861569|NCT00321620|580887767|FG000|Overall Study|Ineligibility determined|2|||
160861570|NCT00321620|580887768|FG001|Overall Study|Ineligibility determined|3|||
160861571|NCT00321620|580887767|FG000|Overall Study|Participant request|75|||
160861572|NCT00321620|580887768|FG001|Overall Study|Participant request|52|||
160861573|NCT00321620|580887767|FG000|Overall Study|Other|42|||
160861574|NCT00321620|580887768|FG001|Overall Study|Other|33|||
160995540|NCT05827926|581370957|FG013|Overall Study|Withdrawal by Subject|1|||
160995541|NCT05827926|581370958|FG014|Overall Study|Withdrawal by Subject|1|||
160995542|NCT05827926|581370959|FG015|Overall Study|Withdrawal by Subject|2|||
160995543|NCT05827926|581370960|FG016|Overall Study|Withdrawal by Subject|1|||
160995544|NCT05827926|581370961|FG017|Overall Study|Withdrawal by Subject|1|||
160995545|NCT05827926|581370962|FG018|Overall Study|Withdrawal by Subject|0|||
160995546|NCT05827926|581370963|FG019|Overall Study|Withdrawal by Subject|0|||
160995547|NCT05827926|581370964|FG020|Overall Study|Withdrawal by Subject|1|||
160995548|NCT05827926|581370965|FG021|Overall Study|Withdrawal by Subject|0|||
160995549|NCT05827926|581370966|FG022|Overall Study|Withdrawal by Subject|0|||
160995550|NCT05827926|581370967|FG023|Overall Study|Withdrawal by Subject|2|||
160995551|NCT05827926|581370968|FG024|Overall Study|Withdrawal by Subject|1|||
160995552|NCT05827926|581370969|FG025|Overall Study|Withdrawal by Subject|0|||
160995553|NCT05827926|581370970|FG026|Overall Study|Withdrawal by Subject|0|||
160995554|NCT05827926|581370971|FG027|Overall Study|Withdrawal by Subject|1|||
160995555|NCT05827926|581370972|FG028|Overall Study|Withdrawal by Subject|0|||
160995556|NCT05827926|581370973|FG029|Overall Study|Withdrawal by Subject|0|||
160995557|NCT05827926|581370974|FG030|Overall Study|Withdrawal by Subject|0|||
160995558|NCT05827926|581370975|FG031|Overall Study|Withdrawal by Subject|2|||
160995559|NCT05827926|581370976|FG032|Overall Study|Withdrawal by Subject|0|||
160995560|NCT05827926|581370977|FG033|Overall Study|Withdrawal by Subject|0|||
160995561|NCT05827926|581370978|FG034|Overall Study|Withdrawal by Subject|0|||
160995562|NCT05827926|581370979|FG035|Overall Study|Withdrawal by Subject|0|||
160995563|NCT05827926|581370980|FG036|Overall Study|Withdrawal by Subject|1|||
160995564|NCT05827926|581370944|FG000|Overall Study|Other Than Specified|0|||
160995565|NCT05827926|581370945|FG001|Overall Study|Other Than Specified|0|||
160912828|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912829|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912830|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912831|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912832|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912833|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912834|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912835|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912836|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
160912837|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
160912838|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
160912839|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
160912840|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912841|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912842|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912843|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912844|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912845|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912846|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912847|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912848|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
160912849|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912850|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912851|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912852|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912853|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912854|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912855|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912856|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912857|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912858|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
160912859|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
160912860|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
160912861|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
160912862|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912863|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912864|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160995566|NCT05827926|581370946|FG002|Overall Study|Other Than Specified|0|||
160995567|NCT05827926|581370947|FG003|Overall Study|Other Than Specified|1|||
160995568|NCT05827926|581370948|FG004|Overall Study|Other Than Specified|0|||
160995569|NCT05827926|581370949|FG005|Overall Study|Other Than Specified|0|||
160995570|NCT05827926|581370950|FG006|Overall Study|Other Than Specified|1|||
160912865|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160995571|NCT05827926|581370951|FG007|Overall Study|Other Than Specified|0|||
160912866|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912867|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912868|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912869|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
160912870|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
160912871|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912872|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
160912873|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912874|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912875|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912876|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912877|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912878|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912879|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912880|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
160912881|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
160912882|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
160912883|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
160912884|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912885|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912886|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912887|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912888|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912889|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912890|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912891|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912892|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
160912893|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
160912894|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912895|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912896|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912897|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912898|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912899|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912900|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912901|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912902|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912903|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912904|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
160912905|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912906|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912907|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912908|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912909|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912910|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912911|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912912|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912913|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912914|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
160912915|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912916|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912917|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912918|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912919|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912920|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912921|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912922|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912923|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912924|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
160912925|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912926|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912927|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912928|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912929|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912930|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912931|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912932|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912933|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912934|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912935|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912936|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912937|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
160912938|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912939|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
160912940|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912941|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912942|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912943|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912944|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912945|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912946|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912947|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912948|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
160912949|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912950|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
160912951|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912952|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912953|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912954|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912955|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912956|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912957|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912958|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160861575|NCT03337477|580887769|FG000|Overall Study|not categorized into the listed ones|11|||
160861576|NCT03337477|580887770|FG001|Overall Study|not categorized into the listed ones|9|||
160861577|NCT03337477|580887769|FG000|Overall Study|Withdrawal by Subject|0|||
160912959|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
160912960|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912961|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
160912962|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912963|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912964|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160995572|NCT05827926|581370952|FG008|Overall Study|Other Than Specified|0|||
160861578|NCT03337477|580887770|FG001|Overall Study|Withdrawal by Subject|1|||
160861579|NCT03337477|580887769|FG000|Overall Study|Death|0|||
160453452|NCT03235544|579392099|FG000|Overall Study|Death|11|||
160453453|NCT03235544|579392100|FG001|Overall Study|Death|31|||
160453454|NCT03235544|579392101|FG002|Overall Study|Death|19|||
160861580|NCT03337477|580887770|FG001|Overall Study|Death|1|||
160861581|NCT03337477|580887769|FG000|Overall Study|Lost to Follow-up|0|||
160861582|NCT03337477|580887770|FG001|Overall Study|Lost to Follow-up|2|||
160861583|NCT03304626|580887771|FG000|Overall Study|Adverse Event|1|||
160861584|NCT03304626|580887772|FG001|Overall Study|Adverse Event|0|||
160861585|NCT03304626|580887771|FG000|Overall Study|Lack of Efficacy|1|||
160861586|NCT03304626|580887772|FG001|Overall Study|Lack of Efficacy|1|||
160861587|NCT01747876|580887774|FG000|Overall Study|Adverse Event|1|||
160861588|NCT01747876|580887775|FG001|Overall Study|Adverse Event|0|||
160861589|NCT01747876|580887776|FG002|Overall Study|Adverse Event|2|||
160861590|NCT01747876|580887774|FG000|Overall Study|Withdrawal by Subject|0|||
160861591|NCT01747876|580887775|FG001|Overall Study|Withdrawal by Subject|1|||
160861592|NCT01747876|580887776|FG002|Overall Study|Withdrawal by Subject|1|||
160861593|NCT01747876|580887774|FG000|Overall Study|Disease progression|4|||
160861594|NCT01747876|580887775|FG001|Overall Study|Disease progression|13|||
160861595|NCT01747876|580887776|FG002|Overall Study|Disease progression|8|||
160861596|NCT01747876|580887774|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
160861597|NCT01747876|580887775|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
160861598|NCT01747876|580887776|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
160861599|NCT03198715|580887779|FG000|Overall Study|Death|0|||
160861600|NCT03198715|580887780|FG001|Overall Study|Death|0|||
160861601|NCT03198715|580887781|FG002|Overall Study|Death|1|||
160861602|NCT03198715|580887782|FG003|Overall Study|Death|0|||
160861603|NCT03198715|580887783|FG004|Overall Study|Death|2|||
160912965|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912966|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912967|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912968|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912969|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912970|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
160912971|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912972|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
160912973|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
160912974|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
160912975|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
160912976|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
160912977|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
160912978|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
160912979|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
160912980|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
160912981|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
160912982|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
160912983|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
160912984|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
160912985|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
160912986|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
160912987|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
160912988|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
160912989|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
160912990|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
160912991|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
160912992|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
160912993|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
160912994|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
160912995|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160912996|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160912997|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160912998|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160912999|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913000|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913001|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913002|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913003|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913004|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913005|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
160913006|NCT04051008|581072390|FG000|Overall Study|Withdrawal by Subject|2|||
160913007|NCT04051008|581072391|FG001|Overall Study|Withdrawal by Subject|0|||
160913008|NCT04051008|581072392|FG002|Overall Study|Withdrawal by Subject|1|||
160913009|NCT02862171|581072393|FG000|Overall Study|Death|1|||
160913010|NCT02862171|581072393|FG000|Overall Study|Lost to Follow-up|13|||
160913011|NCT02862171|581072393|FG000|Overall Study|Withdrawal by Subject|57|||
160913012|NCT02862171|581072393|FG000|Overall Study|Non-compliance|4|||
160913013|NCT02862171|581072393|FG000|Overall Study|HIV-1 seroconversion|18|||
160913014|NCT02700815|581074335|FG000|Overall Study|Adverse Event|0|||
160913015|NCT02700815|581074336|FG001|Overall Study|Adverse Event|6|||
160913016|NCT02700815|581074337|FG002|Overall Study|Adverse Event|2|||
160913017|NCT02700815|581074338|FG003|Overall Study|Adverse Event|3|||
160913018|NCT02700815|581074335|FG000|Overall Study|Lack of Efficacy|0|||
160913019|NCT02700815|581074336|FG001|Overall Study|Lack of Efficacy|0|||
160913020|NCT02700815|581074337|FG002|Overall Study|Lack of Efficacy|1|||
160913021|NCT02700815|581074338|FG003|Overall Study|Lack of Efficacy|2|||
160913022|NCT02700815|581074335|FG000|Overall Study|Lost to Follow-up|1|||
160913023|NCT02700815|581074336|FG001|Overall Study|Lost to Follow-up|0|||
160913024|NCT02700815|581074337|FG002|Overall Study|Lost to Follow-up|0|||
160913025|NCT02700815|581074338|FG003|Overall Study|Lost to Follow-up|1|||
160913026|NCT02700815|581074335|FG000|Overall Study|Refusal to continue medication|0|||
160913027|NCT02700815|581074336|FG001|Overall Study|Refusal to continue medication|1|||
160913028|NCT02700815|581074337|FG002|Overall Study|Refusal to continue medication|0|||
160913029|NCT02700815|581074338|FG003|Overall Study|Refusal to continue medication|1|||
160913030|NCT02700815|581074335|FG000|Overall Study|Withdrawal by Subject|0|||
160913031|NCT02700815|581074336|FG001|Overall Study|Withdrawal by Subject|0|||
160913032|NCT02700815|581074337|FG002|Overall Study|Withdrawal by Subject|1|||
160913033|NCT02700815|581074338|FG003|Overall Study|Withdrawal by Subject|0|||
160913034|NCT04023526|581074339|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
160913035|NCT04023526|581074340|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
160913036|NCT04023526|581074339|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
160913037|NCT04023526|581074340|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
160913038|NCT01955733|581074344|FG000|Period 1|Lost to Follow-up|1|||
160913039|NCT01955733|581074345|FG001|Period 1|Lost to Follow-up|0|||
160913040|NCT01955733|581074346|FG002|Period 1|Lost to Follow-up|0|||
160913041|NCT01955733|581074344|FG000|Period 2|Adverse Event|1|||
160913042|NCT01955733|581074345|FG001|Period 2|Adverse Event|0|||
160913043|NCT01955733|581074346|FG002|Period 2|Adverse Event|0|||
160913044|NCT01955733|581074344|FG000|Period 2|Physician Decision|0|||
160913045|NCT01955733|581074345|FG001|Period 2|Physician Decision|0|||
160913046|NCT01955733|581074346|FG002|Period 2|Physician Decision|1|||
160913047|NCT01955733|581074344|FG000|Period 2|Withdrawal by Subject|1|||
160913048|NCT01955733|581074345|FG001|Period 2|Withdrawal by Subject|3|||
160913049|NCT01955733|581074346|FG002|Period 2|Withdrawal by Subject|2|||
160913050|NCT01955733|581074344|FG000|Period 2|Study terminated by sponsor|8|||
160913051|NCT01955733|581074345|FG001|Period 2|Study terminated by sponsor|14|||
160913052|NCT01955733|581074346|FG002|Period 2|Study terminated by sponsor|16|||
160913053|NCT01955733|581074344|FG000|Period 2|Lost to Follow-up|2|||
160913054|NCT01955733|581074345|FG001|Period 2|Lost to Follow-up|0|||
160913055|NCT01955733|581074346|FG002|Period 2|Lost to Follow-up|0|||
160913056|NCT01955733|581074344|FG000|Period 2|Other not defined above|0|||
160913057|NCT01955733|581074345|FG001|Period 2|Other not defined above|2|||
160913058|NCT01955733|581074346|FG002|Period 2|Other not defined above|2|||
160913059|NCT02239978|581074349|FG000|Overall Study|Withdrawal by Subject|2|||
160913060|NCT02239978|581074350|FG001|Overall Study|Withdrawal by Subject|0|||
160913061|NCT02324569|581074361|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
160913062|NCT02324569|581074362|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
160913063|NCT02324569|581074361|FG000|Overall Study|Voluntary Withdrawal|3|||
160913064|NCT02324569|581074362|FG001|Overall Study|Voluntary Withdrawal|6|||
160913065|NCT02324569|581074361|FG000|Overall Study|Lack of Efficacy|2|||
160913066|NCT02324569|581074362|FG001|Overall Study|Lack of Efficacy|3|||
160913067|NCT02324569|581074361|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
160913068|NCT02324569|581074362|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
160913069|NCT02324569|581074361|FG000|Overall Study|Inconvenient Schedule|2|||
160913070|NCT02324569|581074362|FG001|Overall Study|Inconvenient Schedule|0|||
160913071|NCT00793403|581074371|FG000|Overall Study|Other|73|||
160913072|NCT00309387|581074375|FG000|Overall Study|Death|72|||
160913073|NCT00309387|581074376|FG001|Overall Study|Death|73|||
160913074|NCT00309387|581074375|FG000|Overall Study|Lost to Follow-up|70|||
160913075|NCT00309387|581074376|FG001|Overall Study|Lost to Follow-up|86|||
160913076|NCT02899988|581074378|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
160913077|NCT02899988|581074379|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
160913078|NCT02899988|581074380|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913079|NCT02899988|581074381|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913080|NCT02899988|581074382|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913081|NCT02899988|581074383|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913082|NCT02899988|581074384|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913083|NCT02899988|581074385|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913084|NCT02899988|581074386|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913085|NCT02899988|581074387|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913086|NCT02899988|581074388|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913087|NCT02899988|581074378|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
160913088|NCT02899988|581074379|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
160913089|NCT02899988|581074380|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
160913090|NCT02899988|581074381|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
160913091|NCT02899988|581074382|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
160913092|NCT02899988|581074383|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
160913093|NCT02899988|581074384|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
160913094|NCT02899988|581074385|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
160913095|NCT02899988|581074386|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
160913096|NCT02899988|581074387|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
160913097|NCT02899988|581074388|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
160913098|NCT02899988|581074378|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
160913099|NCT02899988|581074379|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
160913100|NCT02899988|581074380|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
160652740|NCT02946385|580110341|FG004|Overall Study|Lost to Follow-up|2|||
160913101|NCT02899988|581074381|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
160913102|NCT02899988|581074382|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
160913103|NCT02899988|581074383|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
160913104|NCT02899988|581074384|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
160913105|NCT02899988|581074385|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
160913106|NCT02899988|581074386|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
160913107|NCT02899988|581074387|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
160913108|NCT02899988|581074388|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
160913109|NCT02899988|581074378|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
160913110|NCT02899988|581074379|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
160913111|NCT02899988|581074380|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
160995573|NCT05827926|581370953|FG009|Overall Study|Other Than Specified|0|||
160913112|NCT02899988|581074381|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
160913113|NCT02899988|581074382|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
160913114|NCT02899988|581074383|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
160913115|NCT02899988|581074384|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
160913116|NCT02899988|581074385|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
160913117|NCT02899988|581074386|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
160913118|NCT02899988|581074387|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
160913119|NCT02899988|581074388|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
160913120|NCT02899988|581074378|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913121|NCT02899988|581074379|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913122|NCT02899988|581074380|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913123|NCT02899988|581074381|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913124|NCT02899988|581074382|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913125|NCT02899988|581074383|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
160913126|NCT02899988|581074384|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913127|NCT02899988|581074385|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
160913128|NCT02899988|581074386|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913129|NCT02899988|581074387|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913130|NCT02899988|581074388|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913131|NCT02899988|581074378|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913132|NCT02899988|581074379|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913133|NCT02899988|581074380|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913134|NCT02899988|581074381|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913135|NCT02899988|581074382|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
160913136|NCT02899988|581074383|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913137|NCT02899988|581074384|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
160913138|NCT02899988|581074385|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
160913139|NCT02899988|581074386|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
160913140|NCT02899988|581074387|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913141|NCT02899988|581074388|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
160913142|NCT04492618|581074389|FG000|Overall Study|Withdrawal by Subject|1|||
160913143|NCT00856284|581074391|FG000|Overall Study|Hyperglycemic rescue|231|||
160913144|NCT00856284|581074392|FG001|Overall Study|Hyperglycemic rescue|201|||
160913145|NCT00856284|581074393|FG002|Overall Study|Hyperglycemic rescue|235|||
160913146|NCT00856284|581074391|FG000|Overall Study|Adverse Event|60|||
160913147|NCT00856284|581074392|FG001|Overall Study|Adverse Event|74|||
160913148|NCT00856284|581074393|FG002|Overall Study|Adverse Event|82|||
160913149|NCT00856284|581074391|FG000|Overall Study|Major protocol deviation|24|||
160913150|NCT00856284|581074392|FG001|Overall Study|Major protocol deviation|16|||
160913151|NCT00856284|581074393|FG002|Overall Study|Major protocol deviation|15|||
160652741|NCT02946385|580110342|FG005|Overall Study|Lost to Follow-up|1|||
160913152|NCT00856284|581074391|FG000|Overall Study|Lost to Follow-up|20|||
160913153|NCT00856284|581074392|FG001|Overall Study|Lost to Follow-up|22|||
160913154|NCT00856284|581074393|FG002|Overall Study|Lost to Follow-up|28|||
160913155|NCT00856284|581074391|FG000|Overall Study|Voluntary withdrawal|48|||
160913156|NCT00856284|581074392|FG001|Overall Study|Voluntary withdrawal|52|||
160913157|NCT00856284|581074393|FG002|Overall Study|Voluntary withdrawal|62|||
160913158|NCT00856284|581074391|FG000|Overall Study|Pregnancy|1|||
160913159|NCT00856284|581074392|FG001|Overall Study|Pregnancy|2|||
160913160|NCT00856284|581074393|FG002|Overall Study|Pregnancy|0|||
160913161|NCT00856284|581074391|FG000|Overall Study|Investigator discretion|9|||
160913162|NCT00856284|581074392|FG001|Overall Study|Investigator discretion|8|||
160913163|NCT00856284|581074393|FG002|Overall Study|Investigator discretion|10|||
160913164|NCT00856284|581074391|FG000|Overall Study|Other|15|||
160913165|NCT00856284|581074392|FG001|Overall Study|Other|17|||
160913166|NCT00856284|581074393|FG002|Overall Study|Other|14|||
160913167|NCT00856284|581074391|FG000|Overall Study|Randomized in error|0|||
160913168|NCT00856284|581074392|FG001|Overall Study|Randomized in error|0|||
160913169|NCT00856284|581074393|FG002|Overall Study|Randomized in error|1|||
160913170|NCT02485301|581074394|FG000|Overall Study|Serious Adverse Events|2|||
160913171|NCT02485301|581074395|FG001|Overall Study|Serious Adverse Events|1|||
160913172|NCT02485301|581074394|FG000|Overall Study|Protocol Violation|0|||
160913173|NCT02485301|581074395|FG001|Overall Study|Protocol Violation|1|||
160913174|NCT02485301|581074394|FG000|Overall Study|Withdrawal by Subject|6|||
160913175|NCT02485301|581074395|FG001|Overall Study|Withdrawal by Subject|7|||
160913176|NCT02485301|581074394|FG000|Overall Study|Migrated/moved from study area|10|||
160913177|NCT02485301|581074395|FG001|Overall Study|Migrated/moved from study area|19|||
160453455|NCT03235544|579392102|FG003|Overall Study|Death|34|||
160913178|NCT02485301|581074394|FG000|Overall Study|Lost to Follow-up|17|||
160913179|NCT02485301|581074395|FG001|Overall Study|Lost to Follow-up|17|||
160913180|NCT02485301|581074394|FG000|Overall Study|Other|3|||
160913181|NCT02485301|581074395|FG001|Overall Study|Other|4|||
160913182|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160913183|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160995574|NCT05827926|581370954|FG010|Overall Study|Other Than Specified|0|||
160995575|NCT05827926|581370955|FG011|Overall Study|Other Than Specified|0|||
160995576|NCT05827926|581370956|FG012|Overall Study|Other Than Specified|0|||
160995577|NCT05827926|581370957|FG013|Overall Study|Other Than Specified|1|||
160913184|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160913185|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160913186|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160913187|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160913188|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
160913189|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913190|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913191|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913192|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913193|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913194|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913195|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
160913196|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913197|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913198|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913199|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913200|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913201|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913202|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
160913203|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913204|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913205|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913206|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913207|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913208|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913209|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
160913210|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
160913211|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
160913212|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
160913213|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
160913214|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
160913215|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
160913216|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
160913217|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
160913218|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
160913219|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
160913220|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
160913221|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
160913222|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
160913223|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
160913224|NCT01059825|581074396|FG000|Treatment Period|Lost to Follow-up|2|||
160913225|NCT01059825|581074397|FG001|Treatment Period|Lost to Follow-up|1|||
160913226|NCT01059825|581074398|FG002|Treatment Period|Lost to Follow-up|0|||
160913227|NCT01059825|581074399|FG003|Treatment Period|Lost to Follow-up|1|||
160913228|NCT01059825|581074400|FG004|Treatment Period|Lost to Follow-up|2|||
160913229|NCT01059825|581074401|FG005|Treatment Period|Lost to Follow-up|0|||
160913230|NCT01059825|581074402|FG006|Treatment Period|Lost to Follow-up|0|||
160913231|NCT01059825|581074396|FG000|Treatment Period|Withdrawal by Subject|3|||
160913232|NCT01059825|581074397|FG001|Treatment Period|Withdrawal by Subject|0|||
160913233|NCT01059825|581074398|FG002|Treatment Period|Withdrawal by Subject|1|||
160913234|NCT01059825|581074399|FG003|Treatment Period|Withdrawal by Subject|5|||
160913235|NCT01059825|581074400|FG004|Treatment Period|Withdrawal by Subject|4|||
160913236|NCT01059825|581074401|FG005|Treatment Period|Withdrawal by Subject|1|||
160913237|NCT01059825|581074402|FG006|Treatment Period|Withdrawal by Subject|0|||
160913238|NCT01059825|581074396|FG000|Treatment Period|Other reason not specified|1|||
160913239|NCT01059825|581074397|FG001|Treatment Period|Other reason not specified|2|||
160913240|NCT01059825|581074398|FG002|Treatment Period|Other reason not specified|1|||
160913241|NCT01059825|581074399|FG003|Treatment Period|Other reason not specified|2|||
160913242|NCT01059825|581074400|FG004|Treatment Period|Other reason not specified|0|||
160913243|NCT01059825|581074401|FG005|Treatment Period|Other reason not specified|0|||
160913244|NCT01059825|581074402|FG006|Treatment Period|Other reason not specified|0|||
160913245|NCT01059825|581074396|FG000|Treatment Period|Protocol Violation|0|||
160995578|NCT05827926|581370958|FG014|Overall Study|Other Than Specified|0|||
160995579|NCT05827926|581370959|FG015|Overall Study|Other Than Specified|1|||
160995580|NCT05827926|581370960|FG016|Overall Study|Other Than Specified|0|||
160570566|NCT01025336|579812173|FG003|Overall Study|Protocol Violation|2|||
160913246|NCT01059825|581074397|FG001|Treatment Period|Protocol Violation|0|||
160913247|NCT01059825|581074398|FG002|Treatment Period|Protocol Violation|1|||
160913248|NCT01059825|581074399|FG003|Treatment Period|Protocol Violation|1|||
160913249|NCT01059825|581074400|FG004|Treatment Period|Protocol Violation|1|||
160913250|NCT01059825|581074401|FG005|Treatment Period|Protocol Violation|1|||
160913251|NCT01059825|581074402|FG006|Treatment Period|Protocol Violation|0|||
160913252|NCT01059825|581074396|FG000|Treatment Period|Adverse event related to study drug|1|||
160913253|NCT01059825|581074397|FG001|Treatment Period|Adverse event related to study drug|0|||
160913254|NCT01059825|581074398|FG002|Treatment Period|Adverse event related to study drug|1|||
160913255|NCT01059825|581074399|FG003|Treatment Period|Adverse event related to study drug|1|||
160913256|NCT01059825|581074400|FG004|Treatment Period|Adverse event related to study drug|0|||
160913257|NCT01059825|581074401|FG005|Treatment Period|Adverse event related to study drug|0|||
160913258|NCT01059825|581074402|FG006|Treatment Period|Adverse event related to study drug|0|||
160913259|NCT01059825|581074396|FG000|Treatment Period|Insufficient clinical response|3|||
160913260|NCT01059825|581074397|FG001|Treatment Period|Insufficient clinical response|0|||
160913261|NCT01059825|581074398|FG002|Treatment Period|Insufficient clinical response|0|||
160913262|NCT01059825|581074399|FG003|Treatment Period|Insufficient clinical response|0|||
160913263|NCT01059825|581074400|FG004|Treatment Period|Insufficient clinical response|0|||
160913264|NCT01059825|581074401|FG005|Treatment Period|Insufficient clinical response|0|||
160913265|NCT01059825|581074402|FG006|Treatment Period|Insufficient clinical response|0|||
160913266|NCT01059825|581074396|FG000|Treatment Period|Adverse event not related to study drug|0|||
160913267|NCT01059825|581074397|FG001|Treatment Period|Adverse event not related to study drug|1|||
160913268|NCT01059825|581074398|FG002|Treatment Period|Adverse event not related to study drug|2|||
160913269|NCT01059825|581074399|FG003|Treatment Period|Adverse event not related to study drug|1|||
160913270|NCT01059825|581074400|FG004|Treatment Period|Adverse event not related to study drug|1|||
160913271|NCT01059825|581074401|FG005|Treatment Period|Adverse event not related to study drug|1|||
160913272|NCT01059825|581074402|FG006|Treatment Period|Adverse event not related to study drug|0|||
160913273|NCT03342690|581074403|FG000|Overall Study|Missing Information|9|||
160913274|NCT03342690|581074403|FG000|Overall Study|Protocol Violation|16|||
160913275|NCT03138889|581074407|FG000|Overall Study|Withdrawal by Subject|5|||
160913276|NCT03138889|581074408|FG001|Overall Study|Withdrawal by Subject|5|||
160913277|NCT03138889|581074409|FG002|Overall Study|Withdrawal by Subject|0|||
160913278|NCT03138889|581074410|FG003|Overall Study|Withdrawal by Subject|2|||
160913279|NCT03138889|581074411|FG004|Overall Study|Withdrawal by Subject|1|||
160913280|NCT03138889|581074412|FG005|Overall Study|Withdrawal by Subject|3|||
160913281|NCT03138889|581074413|FG006|Overall Study|Withdrawal by Subject|0|||
160913282|NCT03138889|581074414|FG007|Overall Study|Withdrawal by Subject|1|||
160913283|NCT02495168|581074415|FG000|Overall Study|Other than Specified|18|||
160913284|NCT02495168|581074416|FG001|Overall Study|Other than Specified|22|||
160913285|NCT02495168|581074417|FG002|Overall Study|Other than Specified|5|||
160913286|NCT02495168|581074415|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
160913287|NCT02495168|581074416|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
160913288|NCT02495168|581074417|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
160913289|NCT02495168|581074415|FG000|Overall Study|Physician Decision|1|||
160913290|NCT02495168|581074416|FG001|Overall Study|Physician Decision|1|||
160913291|NCT02495168|581074417|FG002|Overall Study|Physician Decision|0|||
160913292|NCT02495168|581074415|FG000|Overall Study|Lost to Follow-up|10|||
160913293|NCT02495168|581074416|FG001|Overall Study|Lost to Follow-up|6|||
160913294|NCT02495168|581074417|FG002|Overall Study|Lost to Follow-up|1|||
160913295|NCT02495168|581074415|FG000|Overall Study|Withdrawal by Subject|1|||
160913296|NCT02495168|581074416|FG001|Overall Study|Withdrawal by Subject|4|||
160913297|NCT02495168|581074417|FG002|Overall Study|Withdrawal by Subject|2|||
160913298|NCT02495168|581074415|FG000|Overall Study|Protocol Violation|0|||
160913299|NCT02495168|581074416|FG001|Overall Study|Protocol Violation|10|||
160913300|NCT02495168|581074417|FG002|Overall Study|Protocol Violation|1|||
160913301|NCT02495168|581074415|FG000|Overall Study|Adverse Event|4|||
160453456|NCT03235544|579392099|FG000|Overall Study|Lost to Follow-up|0|||
160453457|NCT03235544|579392100|FG001|Overall Study|Lost to Follow-up|1|||
160453458|NCT03235544|579392101|FG002|Overall Study|Lost to Follow-up|1|||
160913302|NCT02495168|581074416|FG001|Overall Study|Adverse Event|8|||
160913303|NCT02495168|581074417|FG002|Overall Study|Adverse Event|3|||
160913304|NCT02495168|581074415|FG000|Overall Study|Lack of Efficacy|0|||
160913305|NCT02495168|581074416|FG001|Overall Study|Lack of Efficacy|0|||
160913306|NCT02495168|581074417|FG002|Overall Study|Lack of Efficacy|3|||
160913307|NCT04016285|581074420|FG000|Overall Study|Did not progress to surgery|2|||
160913308|NCT04016285|581074421|FG001|Overall Study|Did not progress to surgery|5|||
160913309|NCT04016285|581074420|FG000|Overall Study|Failed to collect outcome data|5|||
160913310|NCT04016285|581074421|FG001|Overall Study|Failed to collect outcome data|3|||
160913311|NCT04166435|581074422|FG000|Overall Study|2 patients ineligible for response|2|||
160913312|NCT03042533|581074423|FG000|Overall Study|MD left program|1|||
160913313|NCT03042533|581074424|FG001|Overall Study|MD left program|4|||
160453459|NCT03235544|579392102|FG003|Overall Study|Lost to Follow-up|1|||
160570567|NCT01025336|579812174|FG004|Overall Study|Protocol Violation|0|||
160913314|NCT03042533|581074425|FG002|Overall Study|MD left program|1|||
160913315|NCT03167411|581074429|FG000|Overall Study|Adverse Event|0|||
160913316|NCT03167411|581074430|FG001|Overall Study|Adverse Event|1|||
160913317|NCT02651922|581074431|FG000|Overall Study|due to exclusion criteria|2|||
160913318|NCT01366209|581074432|FG000|Overall Study|Adverse Event|6|||
160913319|NCT01366209|581074433|FG001|Overall Study|Adverse Event|7|||
160913320|NCT01366209|581074432|FG000|Overall Study|Withdrawal by Subject|4|||
160913321|NCT01366209|581074433|FG001|Overall Study|Withdrawal by Subject|4|||
160913322|NCT01366209|581074432|FG000|Overall Study|Death|12|||
160913323|NCT01366209|581074433|FG001|Overall Study|Death|19|||
160913324|NCT01366209|581074432|FG000|Overall Study|Lung transplantation|6|||
160913325|NCT01366209|581074433|FG001|Overall Study|Lung transplantation|1|||
160913326|NCT01366209|581074432|FG000|Overall Study|Lost to Follow-up|2|||
160913327|NCT01366209|581074433|FG001|Overall Study|Lost to Follow-up|1|||
160913328|NCT01366209|581074432|FG000|Overall Study|Physician Decision|1|||
160913329|NCT01366209|581074433|FG001|Overall Study|Physician Decision|0|||
160913330|NCT01366209|581074432|FG000|Overall Study|Sponsors decision|0|||
160913331|NCT01366209|581074433|FG001|Overall Study|Sponsors decision|1|||
160913332|NCT01366209|581074432|FG000|Overall Study|Withdrew consent|4|||
160913333|NCT01366209|581074433|FG001|Overall Study|Withdrew consent|3|||
160913334|NCT00420927|581074434|FG000|Period 1|Adverse Event|19|||
160913335|NCT00420927|581074435|FG001|Period 1|Adverse Event|15|||
160913336|NCT00420927|581074436|FG002|Period 1|Adverse Event|0|||
160913337|NCT00420927|581074437|FG003|Period 1|Adverse Event|0|||
160913338|NCT00420927|581074438|FG004|Period 1|Adverse Event|0|||
160913339|NCT00420927|581074439|FG005|Period 1|Adverse Event|0|||
160913340|NCT00420927|581074440|FG006|Period 1|Adverse Event|0|||
160913341|NCT00420927|581074434|FG000|Period 1|Withdrawal by Subject|7|||
160913342|NCT00420927|581074435|FG001|Period 1|Withdrawal by Subject|12|||
160913343|NCT00420927|581074436|FG002|Period 1|Withdrawal by Subject|0|||
160913344|NCT00420927|581074437|FG003|Period 1|Withdrawal by Subject|0|||
160913345|NCT00420927|581074438|FG004|Period 1|Withdrawal by Subject|0|||
160913346|NCT00420927|581074439|FG005|Period 1|Withdrawal by Subject|0|||
160913347|NCT00420927|581074440|FG006|Period 1|Withdrawal by Subject|0|||
160913348|NCT00420927|581074434|FG000|Period 1|Lost to Follow-up|8|||
160913349|NCT00420927|581074435|FG001|Period 1|Lost to Follow-up|6|||
160913350|NCT00420927|581074436|FG002|Period 1|Lost to Follow-up|0|||
160913351|NCT00420927|581074437|FG003|Period 1|Lost to Follow-up|0|||
160913352|NCT00420927|581074438|FG004|Period 1|Lost to Follow-up|0|||
160913353|NCT00420927|581074439|FG005|Period 1|Lost to Follow-up|0|||
160913354|NCT00420927|581074440|FG006|Period 1|Lost to Follow-up|0|||
160913355|NCT00420927|581074434|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
160913356|NCT00420927|581074435|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
160913357|NCT00420927|581074436|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
160913358|NCT00420927|581074437|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
160913359|NCT00420927|581074438|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
160913360|NCT00420927|581074439|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
160913361|NCT00420927|581074440|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
160913362|NCT00420927|581074434|FG000|Period 1|Death|2|||
160913363|NCT00420927|581074435|FG001|Period 1|Death|0|||
160913364|NCT00420927|581074436|FG002|Period 1|Death|0|||
160913365|NCT00420927|581074437|FG003|Period 1|Death|0|||
160913366|NCT00420927|581074438|FG004|Period 1|Death|0|||
160913367|NCT00420927|581074439|FG005|Period 1|Death|0|||
160913368|NCT00420927|581074440|FG006|Period 1|Death|0|||
160913369|NCT00420927|581074434|FG000|Period 1|Subject moved/relocated|0|||
160913370|NCT00420927|581074435|FG001|Period 1|Subject moved/relocated|2|||
160913371|NCT00420927|581074436|FG002|Period 1|Subject moved/relocated|0|||
160913372|NCT00420927|581074437|FG003|Period 1|Subject moved/relocated|0|||
160913373|NCT00420927|581074438|FG004|Period 1|Subject moved/relocated|0|||
160913374|NCT00420927|581074439|FG005|Period 1|Subject moved/relocated|0|||
160913375|NCT00420927|581074440|FG006|Period 1|Subject moved/relocated|0|||
160913376|NCT00420927|581074434|FG000|Period 1|Noncompliant with study drug|1|||
160913377|NCT00420927|581074435|FG001|Period 1|Noncompliant with study drug|1|||
160913378|NCT00420927|581074436|FG002|Period 1|Noncompliant with study drug|0|||
160913379|NCT00420927|581074437|FG003|Period 1|Noncompliant with study drug|0|||
160913380|NCT00420927|581074438|FG004|Period 1|Noncompliant with study drug|0|||
160913381|NCT00420927|581074439|FG005|Period 1|Noncompliant with study drug|0|||
160913382|NCT00420927|581074440|FG006|Period 1|Noncompliant with study drug|0|||
160913383|NCT00420927|581074434|FG000|Period 1|Randomization error|1|||
160913384|NCT00420927|581074435|FG001|Period 1|Randomization error|0|||
160913385|NCT00420927|581074436|FG002|Period 1|Randomization error|0|||
160913386|NCT00420927|581074437|FG003|Period 1|Randomization error|0|||
160913387|NCT00420927|581074438|FG004|Period 1|Randomization error|0|||
160913388|NCT00420927|581074439|FG005|Period 1|Randomization error|0|||
160913389|NCT00420927|581074440|FG006|Period 1|Randomization error|0|||
160913390|NCT00420927|581074434|FG000|Period 1|Suspected tuberculosis/positive test|1|||
160913391|NCT00420927|581074435|FG001|Period 1|Suspected tuberculosis/positive test|1|||
160913392|NCT00420927|581074436|FG002|Period 1|Suspected tuberculosis/positive test|0|||
160913393|NCT00420927|581074437|FG003|Period 1|Suspected tuberculosis/positive test|0|||
160913394|NCT00420927|581074438|FG004|Period 1|Suspected tuberculosis/positive test|0|||
160913395|NCT00420927|581074439|FG005|Period 1|Suspected tuberculosis/positive test|0|||
160913396|NCT00420927|581074440|FG006|Period 1|Suspected tuberculosis/positive test|0|||
160913397|NCT00420927|581074434|FG000|Period 1|Study site closure|0|||
160913398|NCT00420927|581074435|FG001|Period 1|Study site closure|1|||
160913399|NCT00420927|581074436|FG002|Period 1|Study site closure|0|||
160913400|NCT00420927|581074437|FG003|Period 1|Study site closure|0|||
160913401|NCT00420927|581074438|FG004|Period 1|Study site closure|0|||
160913402|NCT00420927|581074439|FG005|Period 1|Study site closure|0|||
160913403|NCT00420927|581074440|FG006|Period 1|Study site closure|0|||
160913404|NCT00420927|581074434|FG000|Period 1|Subject received new diagnosis|0|||
160913405|NCT00420927|581074435|FG001|Period 1|Subject received new diagnosis|2|||
160913406|NCT00420927|581074436|FG002|Period 1|Subject received new diagnosis|0|||
160913407|NCT00420927|581074437|FG003|Period 1|Subject received new diagnosis|0|||
160913408|NCT00420927|581074438|FG004|Period 1|Subject received new diagnosis|0|||
160913409|NCT00420927|581074439|FG005|Period 1|Subject received new diagnosis|0|||
160913410|NCT00420927|581074440|FG006|Period 1|Subject received new diagnosis|0|||
160913411|NCT00420927|581074434|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
160913412|NCT00420927|581074435|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
160913413|NCT00420927|581074436|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
160913414|NCT00420927|581074437|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
160913415|NCT00420927|581074438|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
160913416|NCT00420927|581074439|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
160913417|NCT00420927|581074440|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
160913418|NCT00420927|581074434|FG000|Period 1|Failed to meet entry criteria|8|||
160913419|NCT00420927|581074435|FG001|Period 1|Failed to meet entry criteria|7|||
160913420|NCT00420927|581074436|FG002|Period 1|Failed to meet entry criteria|0|||
160913421|NCT00420927|581074437|FG003|Period 1|Failed to meet entry criteria|0|||
160913422|NCT00420927|581074438|FG004|Period 1|Failed to meet entry criteria|0|||
160913423|NCT00420927|581074439|FG005|Period 1|Failed to meet entry criteria|0|||
160913424|NCT00420927|581074440|FG006|Period 1|Failed to meet entry criteria|0|||
160913425|NCT00420927|581074434|FG000|Period 1|Took prohibited medication|1|||
160913426|NCT00420927|581074435|FG001|Period 1|Took prohibited medication|3|||
160913427|NCT00420927|581074436|FG002|Period 1|Took prohibited medication|0|||
160913428|NCT00420927|581074437|FG003|Period 1|Took prohibited medication|0|||
160913429|NCT00420927|581074438|FG004|Period 1|Took prohibited medication|0|||
160913430|NCT00420927|581074439|FG005|Period 1|Took prohibited medication|0|||
160913431|NCT00420927|581074440|FG006|Period 1|Took prohibited medication|0|||
160913432|NCT00420927|581074434|FG000|Period 2|Adverse Event|0|||
160913433|NCT00420927|581074435|FG001|Period 2|Adverse Event|0|||
160913434|NCT00420927|581074436|FG002|Period 2|Adverse Event|7|||
160913435|NCT00420927|581074437|FG003|Period 2|Adverse Event|3|||
160913436|NCT00420927|581074438|FG004|Period 2|Adverse Event|17|||
160913437|NCT00420927|581074439|FG005|Period 2|Adverse Event|6|||
160913438|NCT00420927|581074440|FG006|Period 2|Adverse Event|20|||
160913439|NCT00420927|581074434|FG000|Period 2|Withdrawal by Subject|0|||
160913440|NCT00420927|581074435|FG001|Period 2|Withdrawal by Subject|0|||
160913441|NCT00420927|581074436|FG002|Period 2|Withdrawal by Subject|1|||
160913442|NCT00420927|581074437|FG003|Period 2|Withdrawal by Subject|3|||
160913443|NCT00420927|581074438|FG004|Period 2|Withdrawal by Subject|11|||
160913444|NCT00420927|581074439|FG005|Period 2|Withdrawal by Subject|2|||
160913445|NCT00420927|581074440|FG006|Period 2|Withdrawal by Subject|12|||
160913446|NCT00420927|581074434|FG000|Period 2|Lost to Follow-up|0|||
160913447|NCT00420927|581074435|FG001|Period 2|Lost to Follow-up|0|||
160913448|NCT00420927|581074436|FG002|Period 2|Lost to Follow-up|2|||
160913449|NCT00420927|581074437|FG003|Period 2|Lost to Follow-up|2|||
160913450|NCT00420927|581074438|FG004|Period 2|Lost to Follow-up|6|||
160913451|NCT00420927|581074439|FG005|Period 2|Lost to Follow-up|3|||
160913452|NCT00420927|581074440|FG006|Period 2|Lost to Follow-up|9|||
160453460|NCT03235544|579392099|FG000|Overall Study|Withdrawal by Subject|0|||
160453461|NCT03235544|579392100|FG001|Overall Study|Withdrawal by Subject|3|||
160453462|NCT03235544|579392101|FG002|Overall Study|Withdrawal by Subject|1|||
160913453|NCT00420927|581074434|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
160913454|NCT00420927|581074435|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
160913455|NCT00420927|581074436|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
160913456|NCT00420927|581074437|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
160913457|NCT00420927|581074438|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
160913458|NCT00420927|581074439|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
160913459|NCT00420927|581074440|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
160913460|NCT00420927|581074434|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
160913461|NCT00420927|581074435|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
160913462|NCT00420927|581074436|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
160913463|NCT00420927|581074437|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
160913464|NCT00420927|581074438|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
160453463|NCT03235544|579392102|FG003|Overall Study|Withdrawal by Subject|5|||
160913465|NCT00420927|581074439|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
160913466|NCT00420927|581074440|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
160913467|NCT00420927|581074434|FG000|Period 2|Subject unable to find transportation|0|||
160913468|NCT00420927|581074435|FG001|Period 2|Subject unable to find transportation|0|||
160913469|NCT00420927|581074436|FG002|Period 2|Subject unable to find transportation|0|||
160913470|NCT00420927|581074437|FG003|Period 2|Subject unable to find transportation|0|||
160913471|NCT00420927|581074438|FG004|Period 2|Subject unable to find transportation|0|||
160913472|NCT00420927|581074439|FG005|Period 2|Subject unable to find transportation|0|||
160913473|NCT00420927|581074440|FG006|Period 2|Subject unable to find transportation|1|||
160913474|NCT00420927|581074434|FG000|Period 2|Physician Decision|0|||
160913475|NCT00420927|581074435|FG001|Period 2|Physician Decision|0|||
160913476|NCT00420927|581074436|FG002|Period 2|Physician Decision|0|||
160913477|NCT00420927|581074437|FG003|Period 2|Physician Decision|0|||
160913478|NCT00420927|581074438|FG004|Period 2|Physician Decision|1|||
160913479|NCT00420927|581074439|FG005|Period 2|Physician Decision|1|||
160913480|NCT00420927|581074440|FG006|Period 2|Physician Decision|0|||
160913481|NCT00420927|581074434|FG000|Period 2|Sponsor decision|0|||
160913482|NCT00420927|581074435|FG001|Period 2|Sponsor decision|0|||
160913483|NCT00420927|581074436|FG002|Period 2|Sponsor decision|1|||
160913484|NCT00420927|581074437|FG003|Period 2|Sponsor decision|0|||
160913485|NCT00420927|581074438|FG004|Period 2|Sponsor decision|0|||
160913486|NCT00420927|581074439|FG005|Period 2|Sponsor decision|0|||
160913487|NCT00420927|581074440|FG006|Period 2|Sponsor decision|1|||
160913488|NCT00420927|581074434|FG000|Period 2|Randomization error|0|||
160913489|NCT00420927|581074435|FG001|Period 2|Randomization error|0|||
160913490|NCT00420927|581074436|FG002|Period 2|Randomization error|0|||
160913491|NCT00420927|581074437|FG003|Period 2|Randomization error|0|||
160913492|NCT00420927|581074438|FG004|Period 2|Randomization error|1|||
160913493|NCT00420927|581074439|FG005|Period 2|Randomization error|1|||
160913494|NCT00420927|581074440|FG006|Period 2|Randomization error|0|||
160913495|NCT00420927|581074434|FG000|Period 2|Noncompliant with study drug|0|||
160913496|NCT00420927|581074435|FG001|Period 2|Noncompliant with study drug|0|||
160913497|NCT00420927|581074436|FG002|Period 2|Noncompliant with study drug|0|||
160913498|NCT00420927|581074437|FG003|Period 2|Noncompliant with study drug|1|||
160913499|NCT00420927|581074438|FG004|Period 2|Noncompliant with study drug|0|||
160913500|NCT00420927|581074439|FG005|Period 2|Noncompliant with study drug|0|||
160913501|NCT00420927|581074440|FG006|Period 2|Noncompliant with study drug|2|||
160913502|NCT00420927|581074434|FG000|Period 2|Methotrexate intolerance|0|||
160913503|NCT00420927|581074435|FG001|Period 2|Methotrexate intolerance|0|||
160913504|NCT00420927|581074436|FG002|Period 2|Methotrexate intolerance|0|||
160913505|NCT00420927|581074437|FG003|Period 2|Methotrexate intolerance|0|||
160913506|NCT00420927|581074438|FG004|Period 2|Methotrexate intolerance|0|||
160913507|NCT00420927|581074439|FG005|Period 2|Methotrexate intolerance|0|||
160913508|NCT00420927|581074440|FG006|Period 2|Methotrexate intolerance|1|||
160913509|NCT00420927|581074434|FG000|Period 2|Took prohibited medication|0|||
160913510|NCT00420927|581074435|FG001|Period 2|Took prohibited medication|0|||
160913511|NCT00420927|581074436|FG002|Period 2|Took prohibited medication|0|||
160913512|NCT00420927|581074437|FG003|Period 2|Took prohibited medication|0|||
160913513|NCT00420927|581074438|FG004|Period 2|Took prohibited medication|1|||
160913514|NCT00420927|581074439|FG005|Period 2|Took prohibited medication|0|||
160913515|NCT00420927|581074440|FG006|Period 2|Took prohibited medication|0|||
160913516|NCT03018704|581074441|FG000|Overall Study|Lost to Follow-up|1|||
160913517|NCT03018704|581074442|FG001|Overall Study|Lost to Follow-up|1|||
160913518|NCT00320411|581074443|FG000|Overall Study|No investigational product admin.|4|||
160913519|NCT04448171|581074446|FG000|Overall Study|Procedure Cancelled|1|||
160913520|NCT04448171|581074447|FG001|Overall Study|Procedure Cancelled|0|||
160913521|NCT04448171|581074446|FG000|Overall Study|Protocol Violation|1|||
160913522|NCT04448171|581074447|FG001|Overall Study|Protocol Violation|0|||
160913523|NCT02088047|581074448|FG000|Overall Study|Withdrawal by Subject|1|||
160913524|NCT02088047|581074449|FG001|Overall Study|Withdrawal by Subject|0|||
160913525|NCT01025752|581074450|FG000|Overall Study|Lost to Follow-up|7|||
160913526|NCT01025752|581074451|FG001|Overall Study|Lost to Follow-up|10|||
160913527|NCT01025752|581074450|FG000|Overall Study|Physician Decision|1|||
160913528|NCT01025752|581074451|FG001|Overall Study|Physician Decision|3|||
160913529|NCT00023764|581074452|FG000|Overall Study|Other|1|||
160913530|NCT00023764|581074452|FG000|Overall Study|Adverse Event|4|||
160913531|NCT00023764|581074452|FG000|Overall Study|Withdrawal by Subject|1|||
160913532|NCT00023764|581074452|FG000|Overall Study|Progression of disease|6|||
160913533|NCT00023764|581074452|FG000|Overall Study|patient received other treatment|1|||
160913534|NCT00023764|581074452|FG000|Overall Study|delay in obtaining staging images|1|||
160913535|NCT00855920|581074453|FG000|Overall Study|Protocol Violation|0|||
160913536|NCT00855920|581074454|FG001|Overall Study|Protocol Violation|0|||
160913537|NCT00855920|581074455|FG002|Overall Study|Protocol Violation|2|||
160913538|NCT00855920|581074453|FG000|Overall Study|Adverse Event|2|||
160913539|NCT00855920|581074454|FG001|Overall Study|Adverse Event|1|||
160913540|NCT00855920|581074455|FG002|Overall Study|Adverse Event|1|||
160913541|NCT00855920|581074453|FG000|Overall Study|Lack of Efficacy|2|||
160913542|NCT00855920|581074454|FG001|Overall Study|Lack of Efficacy|2|||
160913543|NCT00855920|581074455|FG002|Overall Study|Lack of Efficacy|2|||
160913544|NCT00855920|581074453|FG000|Overall Study|Withdrawal by Subject|2|||
160913545|NCT00855920|581074454|FG001|Overall Study|Withdrawal by Subject|3|||
160913546|NCT00855920|581074455|FG002|Overall Study|Withdrawal by Subject|2|||
160913547|NCT00855920|581074453|FG000|Overall Study|Lost to Follow-up|1|||
160913548|NCT00855920|581074454|FG001|Overall Study|Lost to Follow-up|0|||
160913549|NCT00855920|581074455|FG002|Overall Study|Lost to Follow-up|2|||
160913550|NCT00855920|581074453|FG000|Overall Study|Death|0|||
160913551|NCT00855920|581074454|FG001|Overall Study|Death|1|||
160913552|NCT00855920|581074455|FG002|Overall Study|Death|0|||
160913553|NCT00855920|581074453|FG000|Overall Study|Decision by the sponsor|0|||
160913554|NCT00855920|581074454|FG001|Overall Study|Decision by the sponsor|1|||
160913555|NCT00855920|581074455|FG002|Overall Study|Decision by the sponsor|1|||
160913556|NCT00855920|581074453|FG000|Overall Study|Other than specified above|1|||
160913557|NCT00855920|581074454|FG001|Overall Study|Other than specified above|1|||
160913558|NCT00855920|581074455|FG002|Overall Study|Other than specified above|1|||
160913559|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
160913560|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
160913561|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
160913562|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
160913563|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
160913564|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
160913565|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
160913566|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
160913567|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
160913568|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
160913569|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
160913570|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
160913571|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
160913572|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
160913573|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
160913574|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
160913575|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
160913576|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
160913577|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
160913578|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
160913579|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
160913580|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
160913581|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
160913582|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
160913583|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
160913584|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
160913585|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
160913586|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
160913587|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
160913588|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
160913589|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
160913590|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
160913591|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
160913592|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
160913593|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
160913594|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
160913595|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Other|0|||
160913596|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Other|1|||
160913597|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Other|0|||
160913598|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Other|0|||
160995581|NCT05827926|581370961|FG017|Overall Study|Other Than Specified|0|||
160995582|NCT05827926|581370962|FG018|Overall Study|Other Than Specified|0|||
160913599|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Other|0|||
160913600|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Other|0|||
160913601|NCT00843024|581074458|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
160913602|NCT00843024|581074459|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
160913603|NCT00843024|581074460|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
160913604|NCT00843024|581074461|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
160913605|NCT00843024|581074462|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
160913606|NCT00843024|581074463|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
160913607|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
160652742|NCT04849988|580110343|FG000|Overall Study|Lack of Efficacy|3|||
160913608|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
160995583|NCT05827926|581370963|FG019|Overall Study|Other Than Specified|0|||
160995584|NCT05827926|581370964|FG020|Overall Study|Other Than Specified|0|||
160913609|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
160913610|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
160913611|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
160913612|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
160913613|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160913614|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160913615|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160913616|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
160913617|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160913618|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
160913619|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
160913620|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
160913621|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
160913622|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
160913623|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
160913624|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
160913625|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Physician Decision|0|||
160913626|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Physician Decision|0|||
160913627|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Physician Decision|0|||
160913628|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Physician Decision|3|||
160913629|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Physician Decision|1|||
160913630|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Physician Decision|1|||
160913631|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Adverse Event|0|||
160913632|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Adverse Event|0|||
160913633|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Adverse Event|0|||
160913634|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Adverse Event|0|||
160913635|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Adverse Event|1|||
160913636|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Adverse Event|1|||
160913637|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
160913638|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
160913639|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
160913640|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
160913641|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
160913642|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
160913643|NCT01032837|581074464|FG000|Overall Study|Adverse event/internal illness|0|||
160913644|NCT01032837|581074465|FG001|Overall Study|Adverse event/internal illness|1|||
160913645|NCT01032837|581074466|FG002|Overall Study|Adverse event/internal illness|0|||
160913646|NCT01032837|581074467|FG003|Overall Study|Adverse event/internal illness|1|||
160913647|NCT01032837|581074464|FG000|Overall Study|Withdrew consent|0|||
160913648|NCT01032837|581074465|FG001|Overall Study|Withdrew consent|2|||
160913649|NCT01032837|581074466|FG002|Overall Study|Withdrew consent|0|||
160913650|NCT01032837|581074467|FG003|Overall Study|Withdrew consent|1|||
160913651|NCT01032837|581074464|FG000|Overall Study|Failed to return|0|||
160913652|NCT01032837|581074465|FG001|Overall Study|Failed to return|0|||
160913653|NCT01032837|581074466|FG002|Overall Study|Failed to return|1|||
160913654|NCT01032837|581074467|FG003|Overall Study|Failed to return|0|||
160913655|NCT01032837|581074464|FG000|Overall Study|Refused treatment|0|||
160913656|NCT01032837|581074465|FG001|Overall Study|Refused treatment|0|||
160913657|NCT01032837|581074466|FG002|Overall Study|Refused treatment|0|||
160913658|NCT01032837|581074467|FG003|Overall Study|Refused treatment|1|||
160913659|NCT05201703|581074468|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
160913660|NCT05201703|581074469|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
160913661|NCT05201703|581074468|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
160913662|NCT05201703|581074469|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
160913663|NCT00844896|581074470|FG000|Overall Study|Lost to Follow-up|12|||
160913664|NCT00844896|581074471|FG001|Overall Study|Lost to Follow-up|16|||
160913665|NCT00844896|581074470|FG000|Overall Study|Parents did not have time to complete|0|||
160913666|NCT00844896|581074471|FG001|Overall Study|Parents did not have time to complete|1|||
160913667|NCT02233647|581074472|FG000|Overall Study|Adverse Event|1|||
160913668|NCT00458211|581074473|FG000|Overall Study|Lack of Efficacy|12|||
160913669|NCT00458211|581074473|FG000|Overall Study|Withdrawal by Subject|2|||
160913670|NCT00458211|581074473|FG000|Overall Study|Protocol Violation|2|||
160913671|NCT00838578|581074477|FG000|Overall Study|Protocol Violation|2|||
160913672|NCT00357968|581074482|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
160913673|NCT00357968|581074483|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
160913674|NCT00357968|581074482|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
160913675|NCT00357968|581074483|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
160913676|NCT03919799|581074484|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
160913677|NCT03919799|581074485|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
160913678|NCT03919799|581074486|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
160913679|NCT03919799|581074487|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
160913680|NCT03919799|581074488|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
160913681|NCT03919799|581074484|FG000|DB Period (28 Weeks)|Adverse Event|1|||
160913682|NCT03919799|581074485|FG001|DB Period (28 Weeks)|Adverse Event|1|||
160913683|NCT03919799|581074486|FG002|DB Period (28 Weeks)|Adverse Event|1|||
160913684|NCT03919799|581074487|FG003|DB Period (28 Weeks)|Adverse Event|0|||
160913685|NCT03919799|581074488|FG004|DB Period (28 Weeks)|Adverse Event|0|||
160913686|NCT03919799|581074484|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
160913687|NCT03919799|581074485|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
160913688|NCT03919799|581074486|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
160913689|NCT03919799|581074487|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
160913690|NCT03919799|581074488|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
160913691|NCT03919799|581074484|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
160913692|NCT03919799|581074485|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
160913693|NCT03919799|581074486|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
160913694|NCT03919799|581074487|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
160913695|NCT03919799|581074488|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
160913696|NCT03919799|581074484|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
160913697|NCT03919799|581074485|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
160913698|NCT03919799|581074486|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
160913699|NCT03919799|581074487|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
160913700|NCT03919799|581074488|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
160913701|NCT00679302|581074490|FG000|Overall Study|Lost to Follow-up|8|||
160913702|NCT00679302|581074491|FG001|Overall Study|Lost to Follow-up|4|||
160913703|NCT03547687|581074492|FG000|Overall Study|Withdrawal by Subject|1|||
160913704|NCT03547687|581074492|FG000|Overall Study|Death|1|||
160913705|NCT00646776|581074493|FG000|Overall Study|Adverse Event|1|||
160913706|NCT00646776|581074494|FG001|Overall Study|Adverse Event|9|||
160913707|NCT00646776|581074493|FG000|Overall Study|Investigator discretion|0|||
160913708|NCT00646776|581074494|FG001|Overall Study|Investigator discretion|4|||
160913709|NCT04600921|581074495|FG000|Overall Study|Withdrawal by Subject|3|||
160913710|NCT04600921|581074496|FG001|Overall Study|Withdrawal by Subject|5|||
160913711|NCT04600921|581074495|FG000|Overall Study|Death|0|||
160913712|NCT04600921|581074496|FG001|Overall Study|Death|1|||
160913713|NCT04419714|581074497|FG000|Overall Study|Technical Fault|5|||
160913714|NCT04419714|581074497|FG000|Overall Study|Protocol Deviation|2|||
160913715|NCT04419714|581074497|FG000|Overall Study|Withdrawal by Subject|1|||
160913716|NCT05425745|581074501|FG000|Overall Study|Withdrawal of Consent|3|||
160913717|NCT05425745|581074502|FG001|Overall Study|Withdrawal of Consent|3|||
160913718|NCT05425745|581074501|FG000|Overall Study|Death|2|||
160913719|NCT05425745|581074502|FG001|Overall Study|Death|3|||
160913720|NCT05425745|581074501|FG000|Overall Study|Lost to Follow-up|1|||
160913721|NCT05425745|581074502|FG001|Overall Study|Lost to Follow-up|2|||
160913722|NCT05425745|581074501|FG000|Overall Study|Adverse Event|0|||
160913723|NCT05425745|581074502|FG001|Overall Study|Adverse Event|1|||
160913724|NCT05425745|581074501|FG000|Overall Study|Did not return for end of study visit|0|||
160913725|NCT05425745|581074502|FG001|Overall Study|Did not return for end of study visit|1|||
160913726|NCT05425745|581074501|FG000|Overall Study|End of study visit completed by phone|1|||
160913727|NCT05425745|581074502|FG001|Overall Study|End of study visit completed by phone|0|||
160913728|NCT05425745|581074501|FG000|Overall Study|Subject decision|1|||
160913729|NCT05425745|581074502|FG001|Overall Study|Subject decision|0|||
160913730|NCT00524368|581075701|FG000|Overall Study|Adverse Event|10|||
160913731|NCT00524368|581075702|FG001|Overall Study|Adverse Event|12|||
160913732|NCT00524368|581075701|FG000|Overall Study|Lost to Follow-up|9|||
160913733|NCT00524368|581075702|FG001|Overall Study|Lost to Follow-up|13|||
160913734|NCT00524368|581075701|FG000|Overall Study|Withdrawal by Subject|4|||
160913735|NCT00524368|581075702|FG001|Overall Study|Withdrawal by Subject|5|||
160453464|NCT03235544|579392099|FG000|Overall Study|Disease Progression|0|||
160453465|NCT03235544|579392100|FG001|Overall Study|Disease Progression|1|||
160453466|NCT03235544|579392101|FG002|Overall Study|Disease Progression|0|||
160453467|NCT03235544|579392102|FG003|Overall Study|Disease Progression|2|||
160453468|NCT03235544|579392099|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
160570568|NCT03794986|579812175|FG000|Overall Study|0 Sessions Attended|34|||
160913736|NCT00524368|581075701|FG000|Overall Study|Non-compliant|8|||
160913737|NCT00524368|581075702|FG001|Overall Study|Non-compliant|9|||
160913738|NCT00524368|581075701|FG000|Overall Study|Reached a Virologic Endpoint|3|||
160913739|NCT00524368|581075702|FG001|Overall Study|Reached a Virologic Endpoint|2|||
160995585|NCT05827926|581370965|FG021|Overall Study|Other Than Specified|1|||
160995586|NCT05827926|581370966|FG022|Overall Study|Other Than Specified|1|||
160913740|NCT00524368|581075701|FG000|Overall Study|Sponsor's Decision|2|||
160913741|NCT00524368|581075702|FG001|Overall Study|Sponsor's Decision|0|||
160913742|NCT00524368|581075701|FG000|Overall Study|Ineligible to Continue the study|2|||
160913743|NCT00524368|581075702|FG001|Overall Study|Ineligible to Continue the study|5|||
160913744|NCT00524368|581075701|FG000|Overall Study|Other|3|||
160913745|NCT00524368|581075702|FG001|Overall Study|Other|2|||
160995587|NCT05827926|581370967|FG023|Overall Study|Other Than Specified|0|||
160913746|NCT03010254|581075705|FG000|Overall Study|Adverse Event|0|||
160913747|NCT03010254|581075706|FG001|Overall Study|Adverse Event|1|||
160913748|NCT03010254|581075705|FG000|Overall Study|Lost to Follow-up|4|||
160913749|NCT03010254|581075706|FG001|Overall Study|Lost to Follow-up|0|||
160913750|NCT03010254|581075705|FG000|Overall Study|Withdrawal by Subject|1|||
160913751|NCT03010254|581075706|FG001|Overall Study|Withdrawal by Subject|1|||
160913752|NCT03010254|581075705|FG000|Overall Study|Other|2|||
160913753|NCT03010254|581075706|FG001|Overall Study|Other|3|||
160913754|NCT03312933|581075707|FG000|Overall Study|Protocol Violation|15|||
160913755|NCT03312933|581075707|FG000|Overall Study|Lost to Follow-up|36|||
160913756|NCT03312933|581075707|FG000|Overall Study|Withdrawal by Subject|3|||
160913757|NCT00848081|581075709|FG000|Overall Study|Adverse Event|6|||
160913758|NCT00848081|581075710|FG001|Overall Study|Adverse Event|7|||
160913759|NCT00848081|581075709|FG000|Overall Study|Protocol Violation|8|||
160913760|NCT00848081|581075710|FG001|Overall Study|Protocol Violation|5|||
160913761|NCT00848081|581075709|FG000|Overall Study|Lost to Follow-up|1|||
160913762|NCT00848081|581075710|FG001|Overall Study|Lost to Follow-up|0|||
160913763|NCT00848081|581075709|FG000|Overall Study|Physician Decision|0|||
160913764|NCT00848081|581075710|FG001|Overall Study|Physician Decision|3|||
160913765|NCT00848081|581075709|FG000|Overall Study|Withdrawal by Subject|5|||
160913766|NCT00848081|581075710|FG001|Overall Study|Withdrawal by Subject|3|||
160913767|NCT01752907|581075711|FG000|Overall Study|Withdrawal by Subject|4|||
160913768|NCT01752907|581075712|FG001|Overall Study|Withdrawal by Subject|10|||
160913769|NCT01752907|581075711|FG000|Overall Study|Lost to Follow-up|2|||
160913770|NCT01752907|581075712|FG001|Overall Study|Lost to Follow-up|1|||
160913771|NCT01752907|581075711|FG000|Overall Study|Decision by Sponsor|6|||
160913772|NCT01752907|581075712|FG001|Overall Study|Decision by Sponsor|9|||
160913773|NCT03098550|581075713|FG000|Overall Study|Disease Progression|30|||
160913774|NCT03098550|581075714|FG001|Overall Study|Disease Progression|19|||
160913775|NCT03098550|581075715|FG002|Overall Study|Disease Progression|41|||
160913776|NCT03098550|581075713|FG000|Overall Study|Study Drug Toxicity|2|||
160913777|NCT03098550|581075714|FG001|Overall Study|Study Drug Toxicity|1|||
160995588|NCT05827926|581370968|FG024|Overall Study|Other Than Specified|0|||
160995589|NCT05827926|581370969|FG025|Overall Study|Other Than Specified|1|||
160995590|NCT05827926|581370970|FG026|Overall Study|Other Than Specified|0|||
160995591|NCT05827926|581370971|FG027|Overall Study|Other Than Specified|0|||
160995592|NCT05827926|581370972|FG028|Overall Study|Other Than Specified|0|||
160995593|NCT05827926|581370973|FG029|Overall Study|Other Than Specified|0|||
160995594|NCT05827926|581370974|FG030|Overall Study|Other Than Specified|0|||
160995595|NCT05827926|581370975|FG031|Overall Study|Other Than Specified|1|||
160995596|NCT05827926|581370976|FG032|Overall Study|Other Than Specified|0|||
160995597|NCT05827926|581370977|FG033|Overall Study|Other Than Specified|0|||
160995598|NCT05827926|581370978|FG034|Overall Study|Other Than Specified|0|||
160995599|NCT05827926|581370979|FG035|Overall Study|Other Than Specified|0|||
160995600|NCT05827926|581370980|FG036|Overall Study|Other Than Specified|0|||
160995601|NCT05827926|581370944|FG000|Overall Study|Physician Decision|0|||
160995602|NCT05827926|581370945|FG001|Overall Study|Physician Decision|0|||
160995603|NCT05827926|581370946|FG002|Overall Study|Physician Decision|0|||
160995604|NCT05827926|581370947|FG003|Overall Study|Physician Decision|0|||
160995605|NCT05827926|581370948|FG004|Overall Study|Physician Decision|0|||
160995606|NCT05827926|581370949|FG005|Overall Study|Physician Decision|0|||
160995607|NCT05827926|581370950|FG006|Overall Study|Physician Decision|0|||
160995608|NCT05827926|581370951|FG007|Overall Study|Physician Decision|0|||
160995609|NCT05827926|581370952|FG008|Overall Study|Physician Decision|0|||
160995610|NCT05827926|581370953|FG009|Overall Study|Physician Decision|0|||
160995611|NCT05827926|581370954|FG010|Overall Study|Physician Decision|0|||
160453469|NCT03235544|579392100|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
160570569|NCT03794986|579812176|FG001|Overall Study|0 Sessions Attended|37|||
160570570|NCT03794986|579812175|FG000|Overall Study|Withdrawal by Subject|4|||
160570571|NCT03794986|579812176|FG001|Overall Study|Withdrawal by Subject|6|||
160995612|NCT05827926|581370955|FG011|Overall Study|Physician Decision|0|||
160995613|NCT05827926|581370956|FG012|Overall Study|Physician Decision|0|||
160995614|NCT05827926|581370957|FG013|Overall Study|Physician Decision|0|||
160995615|NCT05827926|581370958|FG014|Overall Study|Physician Decision|0|||
160995616|NCT05827926|581370959|FG015|Overall Study|Physician Decision|0|||
160913778|NCT03098550|581075715|FG002|Overall Study|Study Drug Toxicity|0|||
160913779|NCT03098550|581075713|FG000|Overall Study|Death|1|||
160913780|NCT03098550|581075714|FG001|Overall Study|Death|0|||
160913781|NCT03098550|581075715|FG002|Overall Study|Death|0|||
160913782|NCT03098550|581075713|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
160913783|NCT03098550|581075714|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
160913784|NCT03098550|581075715|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
160913785|NCT03098550|581075713|FG000|Overall Study|Administrative reason by sponsor|0|||
160995617|NCT05827926|581370960|FG016|Overall Study|Physician Decision|0|||
160995618|NCT05827926|581370961|FG017|Overall Study|Physician Decision|0|||
160995619|NCT05827926|581370962|FG018|Overall Study|Physician Decision|1|||
160995620|NCT05827926|581370963|FG019|Overall Study|Physician Decision|0|||
160995621|NCT05827926|581370964|FG020|Overall Study|Physician Decision|0|||
160995622|NCT05827926|581370965|FG021|Overall Study|Physician Decision|0|||
160913786|NCT03098550|581075714|FG001|Overall Study|Administrative reason by sponsor|0|||
160913787|NCT03098550|581075715|FG002|Overall Study|Administrative reason by sponsor|1|||
160913788|NCT03098550|581075713|FG000|Overall Study|Other reasons|2|||
160913789|NCT03098550|581075714|FG001|Overall Study|Other reasons|0|||
160913790|NCT03098550|581075715|FG002|Overall Study|Other reasons|0|||
160913791|NCT00630396|581075716|FG000|Overall Study|Death|4|||
160913792|NCT00630396|581075716|FG000|Overall Study|Lost to Follow-up|3|||
160913793|NCT00381095|581075726|FG000|Overall Study|Death|3|||
160913794|NCT00381095|581075727|FG001|Overall Study|Death|4|||
160913795|NCT00381095|581075726|FG000|Overall Study|Lack of Efficacy|2|||
160913796|NCT00381095|581075727|FG001|Overall Study|Lack of Efficacy|4|||
160913797|NCT00381095|581075726|FG000|Overall Study|Other|2|||
160913798|NCT00381095|581075727|FG001|Overall Study|Other|2|||
160913799|NCT00381095|581075726|FG000|Overall Study|Protocol Violation|1|||
160913800|NCT00381095|581075727|FG001|Overall Study|Protocol Violation|1|||
160913801|NCT00381095|581075726|FG000|Overall Study|Withdrawal by Subject|3|||
160913802|NCT00381095|581075727|FG001|Overall Study|Withdrawal by Subject|3|||
160913803|NCT00381095|581075726|FG000|Overall Study|Adverse Event|2|||
160913804|NCT00381095|581075727|FG001|Overall Study|Adverse Event|7|||
160913805|NCT03562481|581075728|FG000|First Intervention|Lost to Follow-up|1|||
160913806|NCT03562481|581075729|FG001|First Intervention|Lost to Follow-up|0|||
160913807|NCT01327885|581075734|FG000|Overall Study|Disease progression-according to RECIST|173|||
160913808|NCT01327885|581075735|FG001|Overall Study|Disease progression-according to RECIST|165|||
160913809|NCT01327885|581075734|FG000|Overall Study|Clinical progression|24|||
160913810|NCT01327885|581075735|FG001|Overall Study|Clinical progression|27|||
160913811|NCT01327885|581075734|FG000|Overall Study|Adverse Event|14|||
160913812|NCT01327885|581075735|FG001|Overall Study|Adverse Event|10|||
160913813|NCT01327885|581075734|FG000|Overall Study|Subject choice|5|||
160913814|NCT01327885|581075735|FG001|Overall Study|Subject choice|10|||
160913815|NCT01327885|581075734|FG000|Overall Study|Other|8|||
160913816|NCT01327885|581075735|FG001|Overall Study|Other|6|||
160913817|NCT01327885|581075734|FG000|Overall Study|Withdrawal of consent from study|3|||
160913818|NCT01327885|581075735|FG001|Overall Study|Withdrawal of consent from study|4|||
160913819|NCT01327885|581075734|FG000|Overall Study|Not treated|1|||
160913820|NCT01327885|581075735|FG001|Overall Study|Not treated|1|||
160913821|NCT01327885|581075734|FG000|Overall Study|Administrative decision|0|||
160913822|NCT01327885|581075735|FG001|Overall Study|Administrative decision|1|||
160913823|NCT03824912|581075741|FG000|Overall Study|Lost to Follow-up|18|||
160913824|NCT03824912|581075742|FG001|Overall Study|Lost to Follow-up|15|||
160913825|NCT03824912|581075743|FG002|Overall Study|Lost to Follow-up|8|||
160913826|NCT03824912|581075741|FG000|Overall Study|Negative Baseline Culture Result|118|||
160913827|NCT03824912|581075742|FG001|Overall Study|Negative Baseline Culture Result|112|||
160913828|NCT03824912|581075743|FG002|Overall Study|Negative Baseline Culture Result|57|||
160913829|NCT03824912|581075741|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160913830|NCT03824912|581075742|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160913831|NCT03824912|581075743|FG002|Overall Study|Non-Compliance with Study Drug|1|||
160913832|NCT03824912|581075741|FG000|Overall Study|Protocol Violation|1|||
160913833|NCT03824912|581075742|FG001|Overall Study|Protocol Violation|4|||
160913834|NCT03824912|581075743|FG002|Overall Study|Protocol Violation|1|||
160913835|NCT03824912|581075741|FG000|Overall Study|Withdrawal by Subject|3|||
160913836|NCT03824912|581075742|FG001|Overall Study|Withdrawal by Subject|2|||
160913837|NCT03824912|581075743|FG002|Overall Study|Withdrawal by Subject|1|||
160913838|NCT03824912|581075741|FG000|Overall Study|Participation in another study|0|||
160913839|NCT03824912|581075742|FG001|Overall Study|Participation in another study|1|||
160913840|NCT03824912|581075743|FG002|Overall Study|Participation in another study|0|||
160913841|NCT04271605|581075744|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
160913842|NCT00105482|581075759|FG000|Overall Study|Adverse Event|1|||
160913843|NCT00105482|581075760|FG001|Overall Study|Adverse Event|1|||
160913844|NCT00105482|581075759|FG000|Overall Study|Lost to Follow-up|26|||
160913845|NCT00105482|581075760|FG001|Overall Study|Lost to Follow-up|17|||
160913846|NCT00105482|581075759|FG000|Overall Study|Withdrawal by Subject|0|||
160913847|NCT00105482|581075760|FG001|Overall Study|Withdrawal by Subject|1|||
160913848|NCT00105482|581075759|FG000|Overall Study|Lost Interest|29|||
160570572|NCT03794986|579812175|FG000|Overall Study|Protocol Violation|1|||
160913849|NCT00105482|581075760|FG001|Overall Study|Lost Interest|32|||
160913850|NCT00105482|581075759|FG000|Overall Study|Scheduling Conflict|2|||
160913851|NCT00105482|581075760|FG001|Overall Study|Scheduling Conflict|3|||
160913852|NCT00105482|581075759|FG000|Overall Study|Withdrawn by PI|1|||
160570573|NCT03794986|579812176|FG001|Overall Study|Protocol Violation|0|||
160570574|NCT00550238|579812182|FG000|Overall Study|Adverse Event|88|||
160570575|NCT00550238|579812182|FG000|Overall Study|Death|34|||
160913853|NCT00105482|581075760|FG001|Overall Study|Withdrawn by PI|1|||
160913854|NCT02289690|581075766|FG000|Overall Study|Adverse Event Related to Progression|0|||
160913855|NCT02289690|581075767|FG001|Overall Study|Adverse Event Related to Progression|1|||
160913856|NCT02289690|581075768|FG002|Overall Study|Adverse Event Related to Progression|1|||
160913857|NCT02289690|581075769|FG003|Overall Study|Adverse Event Related to Progression|0|||
160913858|NCT02289690|581075770|FG004|Overall Study|Adverse Event Related to Progression|1|||
160913859|NCT02289690|581075771|FG005|Overall Study|Adverse Event Related to Progression|0|||
160913860|NCT02289690|581075772|FG006|Overall Study|Adverse Event Related to Progression|1|||
160913861|NCT02289690|581075773|FG007|Overall Study|Adverse Event Related to Progression|0|||
160913862|NCT02289690|581075774|FG008|Overall Study|Adverse Event Related to Progression|0|||
160913863|NCT02289690|581075775|FG009|Overall Study|Adverse Event Related to Progression|0|||
160913864|NCT02289690|581075766|FG000|Overall Study|Withdrawal by Subject|1|||
160913865|NCT02289690|581075767|FG001|Overall Study|Withdrawal by Subject|0|||
160913866|NCT02289690|581075768|FG002|Overall Study|Withdrawal by Subject|0|||
160913867|NCT02289690|581075769|FG003|Overall Study|Withdrawal by Subject|0|||
160913868|NCT02289690|581075770|FG004|Overall Study|Withdrawal by Subject|1|||
160913869|NCT02289690|581075771|FG005|Overall Study|Withdrawal by Subject|1|||
160913870|NCT02289690|581075772|FG006|Overall Study|Withdrawal by Subject|0|||
160913871|NCT02289690|581075773|FG007|Overall Study|Withdrawal by Subject|0|||
160913872|NCT02289690|581075774|FG008|Overall Study|Withdrawal by Subject|4|||
160913873|NCT02289690|581075775|FG009|Overall Study|Withdrawal by Subject|2|||
160913874|NCT02289690|581075766|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
160913875|NCT02289690|581075767|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
160913876|NCT02289690|581075768|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
160913877|NCT02289690|581075769|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
160913878|NCT02289690|581075770|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
160913879|NCT02289690|581075771|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
160913880|NCT02289690|581075772|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
160913881|NCT02289690|581075773|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
160913882|NCT02289690|581075774|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
160913883|NCT02289690|581075775|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
160913884|NCT02289690|581075766|FG000|Overall Study|Lost to Follow-up|0|||
160913885|NCT02289690|581075767|FG001|Overall Study|Lost to Follow-up|0|||
160913886|NCT02289690|581075768|FG002|Overall Study|Lost to Follow-up|0|||
160913887|NCT02289690|581075769|FG003|Overall Study|Lost to Follow-up|0|||
160913888|NCT02289690|581075770|FG004|Overall Study|Lost to Follow-up|0|||
160913889|NCT02289690|581075771|FG005|Overall Study|Lost to Follow-up|0|||
160913890|NCT02289690|581075772|FG006|Overall Study|Lost to Follow-up|0|||
160913891|NCT02289690|581075773|FG007|Overall Study|Lost to Follow-up|1|||
160913892|NCT02289690|581075774|FG008|Overall Study|Lost to Follow-up|0|||
160913893|NCT02289690|581075775|FG009|Overall Study|Lost to Follow-up|2|||
160913894|NCT02289690|581075766|FG000|Overall Study|Death|0|||
160913895|NCT02289690|581075767|FG001|Overall Study|Death|0|||
160913896|NCT02289690|581075768|FG002|Overall Study|Death|0|||
160913897|NCT02289690|581075769|FG003|Overall Study|Death|0|||
160913898|NCT02289690|581075770|FG004|Overall Study|Death|0|||
160913899|NCT02289690|581075771|FG005|Overall Study|Death|0|||
160913900|NCT02289690|581075772|FG006|Overall Study|Death|0|||
160913901|NCT02289690|581075773|FG007|Overall Study|Death|49|||
160913902|NCT02289690|581075774|FG008|Overall Study|Death|45|||
160913903|NCT02289690|581075775|FG009|Overall Study|Death|41|||
160913904|NCT02289690|581075766|FG000|Overall Study|Sponsor Discontinued Study|0|||
160913905|NCT02289690|581075767|FG001|Overall Study|Sponsor Discontinued Study|0|||
160913906|NCT02289690|581075768|FG002|Overall Study|Sponsor Discontinued Study|0|||
160913907|NCT02289690|581075769|FG003|Overall Study|Sponsor Discontinued Study|0|||
160913908|NCT02289690|581075770|FG004|Overall Study|Sponsor Discontinued Study|0|||
160913909|NCT02289690|581075771|FG005|Overall Study|Sponsor Discontinued Study|0|||
160913910|NCT02289690|581075772|FG006|Overall Study|Sponsor Discontinued Study|0|||
160913911|NCT02289690|581075773|FG007|Overall Study|Sponsor Discontinued Study|9|||
160913912|NCT02289690|581075774|FG008|Overall Study|Sponsor Discontinued Study|7|||
160913913|NCT02289690|581075775|FG009|Overall Study|Sponsor Discontinued Study|15|||
160913914|NCT02289690|581075766|FG000|Overall Study|Other|0|||
160913915|NCT02289690|581075767|FG001|Overall Study|Other|0|||
160913916|NCT02289690|581075768|FG002|Overall Study|Other|0|||
160913917|NCT02289690|581075769|FG003|Overall Study|Other|1|||
160913918|NCT02289690|581075770|FG004|Overall Study|Other|1|||
160913919|NCT02289690|581075771|FG005|Overall Study|Other|0|||
160913920|NCT02289690|581075772|FG006|Overall Study|Other|1|||
160913921|NCT02289690|581075773|FG007|Overall Study|Other|2|||
160652743|NCT04849988|580110344|FG001|Overall Study|Lack of Efficacy|4|||
160913922|NCT02289690|581075774|FG008|Overall Study|Other|3|||
160913923|NCT02289690|581075775|FG009|Overall Study|Other|1|||
160913924|NCT00644995|581075776|FG000|Overall Study|Lost to Follow-up|1|||
160913925|NCT00644995|581075777|FG001|Overall Study|Lost to Follow-up|4|||
160913926|NCT00644995|581075776|FG000|Overall Study|Refused|1|||
160913927|NCT00644995|581075777|FG001|Overall Study|Refused|0|||
160913928|NCT03247530|581075778|FG000|Overall Study|Withdrawal by caregiver|19|||
160913929|NCT03247530|581075779|FG001|Overall Study|Withdrawal by caregiver|8|||
160652744|NCT04849988|580110345|FG002|Overall Study|Lack of Efficacy|1|||
160652745|NCT04849988|580110346|FG003|Overall Study|Lack of Efficacy|4|||
160913930|NCT03247530|581075780|FG002|Overall Study|Withdrawal by caregiver|10|||
160913931|NCT03247530|581075778|FG000|Overall Study|Lost to Follow-up|3|||
160913932|NCT03247530|581075779|FG001|Overall Study|Lost to Follow-up|9|||
160913933|NCT03247530|581075780|FG002|Overall Study|Lost to Follow-up|6|||
160913934|NCT03247530|581075778|FG000|Overall Study|Adverse Event|2|||
160913935|NCT03247530|581075779|FG001|Overall Study|Adverse Event|5|||
160913936|NCT03247530|581075780|FG002|Overall Study|Adverse Event|2|||
160913937|NCT03247530|581075778|FG000|Overall Study|Failure to follow procedure|1|||
160913938|NCT03247530|581075779|FG001|Overall Study|Failure to follow procedure|1|||
160913939|NCT03247530|581075780|FG002|Overall Study|Failure to follow procedure|1|||
160913940|NCT03247530|581075778|FG000|Overall Study|Withdrawal by Subject|1|||
160913941|NCT03247530|581075779|FG001|Overall Study|Withdrawal by Subject|1|||
160913942|NCT03247530|581075780|FG002|Overall Study|Withdrawal by Subject|0|||
160913943|NCT03247530|581075778|FG000|Overall Study|Study medication misuse|0|||
160913944|NCT03247530|581075779|FG001|Overall Study|Study medication misuse|1|||
160913945|NCT03247530|581075780|FG002|Overall Study|Study medication misuse|0|||
160913946|NCT03247530|581075778|FG000|Overall Study|Other, multiple categories|1|||
160913947|NCT03247530|581075779|FG001|Overall Study|Other, multiple categories|3|||
160913948|NCT03247530|581075780|FG002|Overall Study|Other, multiple categories|1|||
160913949|NCT01587001|581075781|FG000|Overall Study|Lost to Follow-up|2|||
160913950|NCT01587001|581075782|FG001|Overall Study|Lost to Follow-up|0|||
160913951|NCT01587001|581075781|FG000|Overall Study|Insufficient samples to complete testing|4|||
160913952|NCT01587001|581075782|FG001|Overall Study|Insufficient samples to complete testing|1|||
160913953|NCT04786990|581075783|FG000|Overall Study|Withdrawal by Subject|1|||
160913954|NCT04786990|581075783|FG000|Overall Study|Adverse Event|1|||
160913955|NCT04786990|581075783|FG000|Overall Study|Lost to Follow-up|1|||
160913956|NCT04786990|581075783|FG000|Overall Study|Noncompliance|1|||
160913957|NCT04786990|581075783|FG000|Overall Study|Unable to complete site visits|1|||
160913958|NCT04786990|581075783|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
160913959|NCT02132130|581075784|FG000|Overall Study|Lost to Follow-up|0|||
160913960|NCT02132130|581075785|FG001|Overall Study|Lost to Follow-up|2|||
160913961|NCT02132130|581075786|FG002|Overall Study|Lost to Follow-up|0|||
160913962|NCT02132130|581075787|FG003|Overall Study|Lost to Follow-up|0|||
160913963|NCT02132130|581075784|FG000|Overall Study|Withdrawal by Subject|0|||
160913964|NCT02132130|581075785|FG001|Overall Study|Withdrawal by Subject|0|||
160913965|NCT02132130|581075786|FG002|Overall Study|Withdrawal by Subject|0|||
160913966|NCT02132130|581075787|FG003|Overall Study|Withdrawal by Subject|1|||
160913967|NCT04656691|581075791|FG000|Overall Study|Adverse Event|1|||
160913968|NCT00439244|581075794|FG000|Overall Study|Adverse Event|5|||
160913969|NCT00439244|581075795|FG001|Overall Study|Adverse Event|2|||
160913970|NCT00439244|581075796|FG002|Overall Study|Adverse Event|3|||
160913971|NCT00439244|581075794|FG000|Overall Study|Withdrawal by Subject|3|||
160913972|NCT00439244|581075795|FG001|Overall Study|Withdrawal by Subject|1|||
160913973|NCT00439244|581075796|FG002|Overall Study|Withdrawal by Subject|2|||
160913974|NCT00439244|581075794|FG000|Overall Study|Lost to Follow-up|2|||
160913975|NCT00439244|581075795|FG001|Overall Study|Lost to Follow-up|1|||
160913976|NCT00439244|581075796|FG002|Overall Study|Lost to Follow-up|2|||
160913977|NCT00439244|581075794|FG000|Overall Study|Death|0|||
160913978|NCT00439244|581075795|FG001|Overall Study|Death|1|||
160913979|NCT00439244|581075796|FG002|Overall Study|Death|0|||
160913980|NCT00439244|581075794|FG000|Overall Study|Protocol Violation|0|||
160913981|NCT00439244|581075795|FG001|Overall Study|Protocol Violation|1|||
160913982|NCT00439244|581075796|FG002|Overall Study|Protocol Violation|0|||
160913983|NCT00439244|581075794|FG000|Overall Study|Administrative problems|1|||
160913984|NCT00439244|581075795|FG001|Overall Study|Administrative problems|0|||
160913985|NCT00439244|581075796|FG002|Overall Study|Administrative problems|0|||
160913986|NCT02846779|581075797|FG000|Overall Study|Lost Enrollment|83|||
160913987|NCT02846779|581075798|FG001|Overall Study|Lost Enrollment|82|||
160913988|NCT02846779|581075799|FG002|Overall Study|Lost Enrollment|86|||
160913989|NCT02846779|581075797|FG000|Overall Study|Less than 31 days of follow-up|56|||
160913990|NCT02846779|581075798|FG001|Overall Study|Less than 31 days of follow-up|45|||
160913991|NCT02846779|581075799|FG002|Overall Study|Less than 31 days of follow-up|52|||
160913992|NCT00887978|581075802|FG000|Overall Study|Adverse Event|18|||
160913993|NCT00887978|581075803|FG001|Overall Study|Adverse Event|5|||
160913994|NCT00887978|581075802|FG000|Overall Study|Clinical Worsening|4|||
160913995|NCT00887978|581075803|FG001|Overall Study|Clinical Worsening|4|||
160913996|NCT00887978|581075802|FG000|Overall Study|Death|2|||
160913997|NCT00887978|581075803|FG001|Overall Study|Death|3|||
160913998|NCT00887978|581075802|FG000|Overall Study|Withdrawal by Subject|1|||
160913999|NCT00887978|581075803|FG001|Overall Study|Withdrawal by Subject|2|||
160914000|NCT00887978|581075802|FG000|Overall Study|Lost to Follow-up|0|||
160914001|NCT00887978|581075803|FG001|Overall Study|Lost to Follow-up|1|||
160914002|NCT05353985|581075806|FG000|Overall Study|Adverse Event|5|||
160914003|NCT05353985|581075807|FG001|Overall Study|Adverse Event|7|||
160453470|NCT03235544|579392101|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
160914004|NCT05353985|581075806|FG000|Overall Study|Lost to Follow-up|1|||
160914005|NCT05353985|581075807|FG001|Overall Study|Lost to Follow-up|1|||
160914006|NCT05353985|581075806|FG000|Overall Study|Protocol Violation|1|||
160914007|NCT05353985|581075807|FG001|Overall Study|Protocol Violation|0|||
160914008|NCT05353985|581075806|FG000|Overall Study|Withdrawal by Subject|13|||
160914009|NCT05353985|581075807|FG001|Overall Study|Withdrawal by Subject|17|||
160914010|NCT05353985|581075806|FG000|Overall Study|Reason Not Specified|1|||
160914011|NCT05353985|581075807|FG001|Overall Study|Reason Not Specified|0|||
160914012|NCT05353985|581075806|FG000|Overall Study|Randomized in Error & Not Treated|0|||
160914013|NCT05353985|581075807|FG001|Overall Study|Randomized in Error & Not Treated|1|||
160914014|NCT04221009|581077536|FG000|Overall Study|Withdrawal by Subject|4|||
160914015|NCT00793598|581077537|FG000|Overall Study|Patient Request|0|||
160914016|NCT00793598|581077538|FG001|Overall Study|Patient Request|1|||
160914017|NCT00793598|581077539|FG002|Overall Study|Patient Request|0|||
160914018|NCT00793598|581077540|FG003|Overall Study|Patient Request|0|||
160914019|NCT00793598|581077541|FG004|Overall Study|Patient Request|0|||
160914020|NCT00793598|581077542|FG005|Overall Study|Patient Request|0|||
160914021|NCT00793598|581077543|FG006|Overall Study|Patient Request|0|||
160914022|NCT00793598|581077544|FG007|Overall Study|Patient Request|0|||
160914023|NCT00793598|581077537|FG000|Overall Study|Protocol Violation|0|||
160914024|NCT00793598|581077538|FG001|Overall Study|Protocol Violation|0|||
160914025|NCT00793598|581077539|FG002|Overall Study|Protocol Violation|0|||
160914026|NCT00793598|581077540|FG003|Overall Study|Protocol Violation|0|||
160914027|NCT00793598|581077541|FG004|Overall Study|Protocol Violation|0|||
160914028|NCT00793598|581077542|FG005|Overall Study|Protocol Violation|0|||
160914029|NCT00793598|581077543|FG006|Overall Study|Protocol Violation|0|||
160914030|NCT00793598|581077544|FG007|Overall Study|Protocol Violation|1|||
160914031|NCT00793598|581077537|FG000|Overall Study|Subject not dosed|0|||
160914032|NCT00793598|581077538|FG001|Overall Study|Subject not dosed|0|||
160914033|NCT00793598|581077539|FG002|Overall Study|Subject not dosed|0|||
160914034|NCT00793598|581077540|FG003|Overall Study|Subject not dosed|0|||
160914035|NCT00793598|581077541|FG004|Overall Study|Subject not dosed|0|||
160914036|NCT00793598|581077542|FG005|Overall Study|Subject not dosed|1|||
160914037|NCT00793598|581077543|FG006|Overall Study|Subject not dosed|0|||
160914038|NCT00793598|581077544|FG007|Overall Study|Subject not dosed|0|||
160914039|NCT02762266|581077545|FG000|Overall Study|Physician Decision|2|||
160914040|NCT02762266|581077546|FG001|Overall Study|Physician Decision|0|||
160914041|NCT02373202|581077547|FG000|Overall Study|Adverse Event|2|||
160914042|NCT02373202|581077548|FG001|Overall Study|Adverse Event|5|||
160914043|NCT02373202|581077549|FG002|Overall Study|Adverse Event|2|||
160914044|NCT02373202|581077550|FG003|Overall Study|Adverse Event|1|||
160914045|NCT02373202|581077547|FG000|Overall Study|Lack of Efficacy|0|||
160914046|NCT02373202|581077548|FG001|Overall Study|Lack of Efficacy|0|||
160914047|NCT02373202|581077549|FG002|Overall Study|Lack of Efficacy|1|||
160914048|NCT02373202|581077550|FG003|Overall Study|Lack of Efficacy|0|||
160914049|NCT02373202|581077547|FG000|Overall Study|Other|0|||
160914050|NCT02373202|581077548|FG001|Overall Study|Other|1|||
160914051|NCT02373202|581077549|FG002|Overall Study|Other|0|||
160914052|NCT02373202|581077550|FG003|Overall Study|Other|0|||
160914053|NCT00410046|581077551|FG000|Overall Study|Adverse Event|3|||
160914054|NCT00410046|581077551|FG000|Overall Study|Withdrawal by Subject|1|||
160914055|NCT00410046|581077551|FG000|Overall Study|Lost to Follow-up|1|||
160914056|NCT01404325|581077558|FG000|Overall Study|Lost to Follow-up|1|||
160914057|NCT01404325|581077559|FG001|Overall Study|Lost to Follow-up|0|||
160914058|NCT01404325|581077558|FG000|Overall Study|Death|2|||
160914059|NCT01404325|581077559|FG001|Overall Study|Death|0|||
160914060|NCT01404325|581077558|FG000|Overall Study|Graft loss/Retransplantation|1|||
160914061|NCT01404325|581077559|FG001|Overall Study|Graft loss/Retransplantation|0|||
160914062|NCT01404325|581077558|FG000|Overall Study|non-specified reason|0|||
160914063|NCT01404325|581077559|FG001|Overall Study|non-specified reason|2|||
160914064|NCT03909295|581077564|FG000|Overall Study|Adverse Event|2|||
160914065|NCT03909295|581077564|FG000|Overall Study|Study terminated by sponsor|50|||
160914066|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
160914067|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
160914068|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
160914069|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
160914070|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
160914071|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
160914072|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
160914073|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
160914074|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
160914075|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
160914076|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|Other|1|||
160914077|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|Other|1|||
160914078|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|Other|0|||
160914079|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|Other|0|||
160914080|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|Other|0|||
160914081|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
160914082|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
160914083|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
160914084|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
160914085|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
160914086|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
160914087|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
160914088|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
160914089|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
160914090|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
160914091|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
160914092|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
160914093|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
160914094|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
160914095|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
160914096|NCT02310568|581077569|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
160914097|NCT02310568|581077570|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
160914098|NCT02310568|581077571|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
160914099|NCT02310568|581077572|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
160914100|NCT02310568|581077573|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
160914101|NCT02310568|581077569|FG000|Stage 2 (4 Weeks)|Other|0|||
160914102|NCT02310568|581077570|FG001|Stage 2 (4 Weeks)|Other|1|||
160914103|NCT02310568|581077571|FG002|Stage 2 (4 Weeks)|Other|1|||
160914104|NCT02310568|581077572|FG003|Stage 2 (4 Weeks)|Other|0|||
160914105|NCT02310568|581077573|FG004|Stage 2 (4 Weeks)|Other|0|||
160914106|NCT02310568|581077569|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
160914107|NCT02310568|581077570|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
160914108|NCT02310568|581077571|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
160914109|NCT02310568|581077572|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
160914110|NCT02310568|581077573|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
160914111|NCT02310568|581077569|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
160914112|NCT02310568|581077570|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
160914113|NCT02310568|581077571|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
160914114|NCT02310568|581077572|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
160914115|NCT02310568|581077573|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
160914116|NCT02310568|581077569|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
160914117|NCT02310568|581077570|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
160914118|NCT02310568|581077571|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
160914119|NCT02310568|581077572|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
160914120|NCT02310568|581077573|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
160995623|NCT05827926|581370966|FG022|Overall Study|Physician Decision|0|||
160995624|NCT05827926|581370967|FG023|Overall Study|Physician Decision|0|||
160995625|NCT05827926|581370968|FG024|Overall Study|Physician Decision|0|||
160995626|NCT05827926|581370969|FG025|Overall Study|Physician Decision|0|||
160995627|NCT05827926|581370970|FG026|Overall Study|Physician Decision|0|||
160995628|NCT05827926|581370971|FG027|Overall Study|Physician Decision|0|||
160995629|NCT05827926|581370972|FG028|Overall Study|Physician Decision|0|||
160995630|NCT05827926|581370973|FG029|Overall Study|Physician Decision|0|||
160995631|NCT05827926|581370974|FG030|Overall Study|Physician Decision|0|||
160995632|NCT05827926|581370975|FG031|Overall Study|Physician Decision|0|||
160995633|NCT05827926|581370976|FG032|Overall Study|Physician Decision|0|||
160995634|NCT05827926|581370977|FG033|Overall Study|Physician Decision|0|||
160995635|NCT05827926|581370978|FG034|Overall Study|Physician Decision|0|||
160995636|NCT05827926|581370979|FG035|Overall Study|Physician Decision|0|||
160995637|NCT05827926|581370980|FG036|Overall Study|Physician Decision|0|||
160995638|NCT05197049|581370981|FG000|Overall Study|Death|0|||
160995639|NCT05197049|581370982|FG001|Overall Study|Death|1|||
160995640|NCT05197049|581370983|FG002|Overall Study|Death|0|||
160995641|NCT05197049|581370981|FG000|Overall Study|Lost to Follow-up|3|||
160914121|NCT02990910|581077580|FG000|Overall Study|Lack of Efficacy|6|||
160914122|NCT02990910|581077581|FG001|Overall Study|Lack of Efficacy|10|||
160914123|NCT02989194|581077586|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
160995642|NCT05197049|581370982|FG001|Overall Study|Lost to Follow-up|1|||
160995643|NCT05197049|581370983|FG002|Overall Study|Lost to Follow-up|0|||
160995644|NCT05197049|581370981|FG000|Overall Study|Withdrawal by Subject|15|||
160570576|NCT00550238|579812182|FG000|Overall Study|Disease progression|46|||
160914124|NCT02989194|581077587|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
160914125|NCT02989194|581077588|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
160914126|NCT02989194|581077586|FG000|Overall Study|Lost to Follow-up|0|||
160914127|NCT02989194|581077587|FG001|Overall Study|Lost to Follow-up|1|||
160914128|NCT02989194|581077588|FG002|Overall Study|Lost to Follow-up|0|||
160914129|NCT02989194|581077586|FG000|Overall Study|Withdrawal by Subject|0|||
160995645|NCT05197049|581370982|FG001|Overall Study|Withdrawal by Subject|3|||
160995646|NCT05197049|581370983|FG002|Overall Study|Withdrawal by Subject|1|||
160995647|NCT05197049|581370981|FG000|Overall Study|GCP non-compliance|1|||
160570577|NCT00550238|579812182|FG000|Overall Study|Withdrawal by Subject|167|||
160914130|NCT02989194|581077587|FG001|Overall Study|Withdrawal by Subject|1|||
160914131|NCT02989194|581077588|FG002|Overall Study|Withdrawal by Subject|0|||
160995648|NCT05197049|581370982|FG001|Overall Study|GCP non-compliance|2|||
160995649|NCT05197049|581370983|FG002|Overall Study|GCP non-compliance|0|||
160995650|NCT00608907|581370986|FG000|Overall Study|Adverse Event|6|||
160995651|NCT00608907|581370987|FG001|Overall Study|Adverse Event|0|||
160995652|NCT00608907|581370988|FG002|Overall Study|Adverse Event|1|||
160995653|NCT00608907|581370986|FG000|Overall Study|Death|1|||
160995654|NCT00608907|581370987|FG001|Overall Study|Death|0|||
160995655|NCT00608907|581370988|FG002|Overall Study|Death|0|||
160995656|NCT00608907|581370986|FG000|Overall Study|Withdrawal by Subject|4|||
160914132|NCT02064868|581077590|FG000|Overall Study|Lost to Follow-up|14|||
160914133|NCT02064868|581077591|FG001|Overall Study|Lost to Follow-up|8|||
160914134|NCT02064868|581077590|FG000|Overall Study|Physician Decision|1|||
160914135|NCT02064868|581077591|FG001|Overall Study|Physician Decision|0|||
160914136|NCT02064868|581077590|FG000|Overall Study|Withdrawal by Subject|14|||
160914137|NCT02064868|581077591|FG001|Overall Study|Withdrawal by Subject|3|||
160914138|NCT02064868|581077590|FG000|Overall Study|Technical Problems or Missing|5|||
160914139|NCT02064868|581077591|FG001|Overall Study|Technical Problems or Missing|2|||
160914140|NCT00482612|581077594|FG000|In-treatment Period|No study medication administered|0|||
160914141|NCT00482612|581077595|FG001|In-treatment Period|No study medication administered|0|||
160914142|NCT00482612|581077596|FG002|In-treatment Period|No study medication administered|1|||
160914143|NCT00482612|581077597|FG003|In-treatment Period|No study medication administered|0|||
160914144|NCT00482612|581077594|FG000|Follow-up Period|Other|4|||
160914145|NCT00482612|581077595|FG001|Follow-up Period|Other|2|||
160914146|NCT00482612|581077596|FG002|Follow-up Period|Other|1|||
160914147|NCT00482612|581077597|FG003|Follow-up Period|Other|2|||
160914148|NCT00482612|581077594|FG000|Follow-up Period|Lack of compliance|0|||
160914149|NCT00482612|581077595|FG001|Follow-up Period|Lack of compliance|0|||
160914150|NCT00482612|581077596|FG002|Follow-up Period|Lack of compliance|1|||
160914151|NCT00482612|581077597|FG003|Follow-up Period|Lack of compliance|0|||
160914152|NCT00482612|581077594|FG000|Follow-up Period|Lost to Follow-up|0|||
160914153|NCT00482612|581077595|FG001|Follow-up Period|Lost to Follow-up|4|||
160914154|NCT00482612|581077596|FG002|Follow-up Period|Lost to Follow-up|2|||
160914155|NCT00482612|581077597|FG003|Follow-up Period|Lost to Follow-up|1|||
160914156|NCT00482612|581077594|FG000|Follow-up Period|Adverse Event|4|||
160914157|NCT00482612|581077595|FG001|Follow-up Period|Adverse Event|7|||
160914158|NCT00482612|581077596|FG002|Follow-up Period|Adverse Event|9|||
160914159|NCT00482612|581077597|FG003|Follow-up Period|Adverse Event|0|||
160914160|NCT00482612|581077594|FG000|Follow-up Period|Lack of Efficacy|2|||
160914161|NCT00482612|581077595|FG001|Follow-up Period|Lack of Efficacy|0|||
160914162|NCT00482612|581077596|FG002|Follow-up Period|Lack of Efficacy|1|||
160914163|NCT00482612|581077597|FG003|Follow-up Period|Lack of Efficacy|0|||
160914164|NCT00482612|581077594|FG000|Follow-up Period|Withdrawal by Subject|3|||
160914165|NCT00482612|581077595|FG001|Follow-up Period|Withdrawal by Subject|5|||
160914166|NCT00482612|581077596|FG002|Follow-up Period|Withdrawal by Subject|7|||
160914167|NCT00482612|581077597|FG003|Follow-up Period|Withdrawal by Subject|2|||
160914168|NCT00482612|581077594|FG000|Follow-up Period|Reasons not related to trial|1|||
160914169|NCT00482612|581077595|FG001|Follow-up Period|Reasons not related to trial|0|||
160914170|NCT00482612|581077596|FG002|Follow-up Period|Reasons not related to trial|1|||
160914171|NCT00482612|581077597|FG003|Follow-up Period|Reasons not related to trial|3|||
160914172|NCT00660023|581077598|FG000|Overall Study|Adverse Event|2|||
160914173|NCT00660023|581077598|FG000|Overall Study|Death|8|||
160914174|NCT00660023|581077598|FG000|Overall Study|Blood Transfusion|5|||
160914175|NCT00660023|581077598|FG000|Overall Study|Renal Transplantation|3|||
160914176|NCT00660023|581077598|FG000|Overall Study|Withdrawal by Subject|1|||
160914177|NCT00660023|581077598|FG000|Overall Study|Missed Pregnancy Test|1|||
160914178|NCT00660023|581077598|FG000|Overall Study|Other Screening Failure|9|||
160914179|NCT04180488|581077600|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
160914180|NCT04180488|581077601|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
160914181|NCT04180488|581077602|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
160914182|NCT04180488|581077603|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
160914183|NCT04180488|581077604|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
160914184|NCT04180488|581077605|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
160914185|NCT04180488|581077600|FG000|Overall Study|Withdrawal by Subject|8|||
160914186|NCT04180488|581077601|FG001|Overall Study|Withdrawal by Subject|4|||
160914187|NCT04180488|581077602|FG002|Overall Study|Withdrawal by Subject|5|||
160914188|NCT04180488|581077603|FG003|Overall Study|Withdrawal by Subject|2|||
160914189|NCT04180488|581077604|FG004|Overall Study|Withdrawal by Subject|8|||
160914190|NCT04180488|581077605|FG005|Overall Study|Withdrawal by Subject|6|||
160914191|NCT04180488|581077600|FG000|Overall Study|Adverse Event|3|||
160914192|NCT04180488|581077601|FG001|Overall Study|Adverse Event|2|||
160914193|NCT04180488|581077602|FG002|Overall Study|Adverse Event|0|||
160914194|NCT04180488|581077603|FG003|Overall Study|Adverse Event|0|||
160914195|NCT04180488|581077604|FG004|Overall Study|Adverse Event|0|||
160914196|NCT04180488|581077605|FG005|Overall Study|Adverse Event|0|||
160914197|NCT04180488|581077600|FG000|Overall Study|Poor compliance to protocol|0|||
160914198|NCT04180488|581077601|FG001|Overall Study|Poor compliance to protocol|0|||
160914199|NCT04180488|581077602|FG002|Overall Study|Poor compliance to protocol|1|||
160914200|NCT04180488|581077603|FG003|Overall Study|Poor compliance to protocol|0|||
160914201|NCT04180488|581077604|FG004|Overall Study|Poor compliance to protocol|0|||
160914202|NCT04180488|581077605|FG005|Overall Study|Poor compliance to protocol|0|||
160914203|NCT03506815|581077606|FG000|Overall Study|Adverse Event|8|||
160914204|NCT03506815|581077607|FG001|Overall Study|Adverse Event|0|||
160914205|NCT03506815|581077606|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
160995657|NCT00608907|581370987|FG001|Overall Study|Withdrawal by Subject|0|||
160995658|NCT00608907|581370988|FG002|Overall Study|Withdrawal by Subject|0|||
160995659|NCT00608907|581370986|FG000|Overall Study|Progressive Disease|1|||
160995660|NCT00608907|581370987|FG001|Overall Study|Progressive Disease|0|||
160995661|NCT00608907|581370988|FG002|Overall Study|Progressive Disease|0|||
160995662|NCT02982213|581370991|FG000|Overall Study|Did not complete follow up questionnaire|5|||
160995663|NCT02982213|581370992|FG001|Overall Study|Did not complete follow up questionnaire|1|||
160995664|NCT01549652|581370993|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
160995665|NCT01549652|581370994|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
160995666|NCT01549652|581370995|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
160995667|NCT01549652|581370996|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
160995668|NCT01549652|581370993|FG000|Overall Study|Study Drug Titration Failure|5|||
160995669|NCT01549652|581370994|FG001|Overall Study|Study Drug Titration Failure|6|||
160995670|NCT01549652|581370995|FG002|Overall Study|Study Drug Titration Failure|0|||
160995671|NCT01549652|581370996|FG003|Overall Study|Study Drug Titration Failure|0|||
160995672|NCT01549652|581370993|FG000|Overall Study|Withdrawal Effect|0|||
160995673|NCT01549652|581370994|FG001|Overall Study|Withdrawal Effect|2|||
160995674|NCT01549652|581370995|FG002|Overall Study|Withdrawal Effect|0|||
160995675|NCT01549652|581370996|FG003|Overall Study|Withdrawal Effect|0|||
160995676|NCT01549652|581370993|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
160995677|NCT01549652|581370994|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
160995678|NCT01549652|581370995|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
160995679|NCT01549652|581370996|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
160995680|NCT01549652|581370993|FG000|Overall Study|Problem with Infusion|1|||
160995681|NCT01549652|581370994|FG001|Overall Study|Problem with Infusion|0|||
160995682|NCT01549652|581370995|FG002|Overall Study|Problem with Infusion|0|||
160995683|NCT01549652|581370996|FG003|Overall Study|Problem with Infusion|0|||
160995684|NCT01549652|581370993|FG000|Overall Study|Titration Non-Compliance|1|||
160995685|NCT01549652|581370994|FG001|Overall Study|Titration Non-Compliance|3|||
160995686|NCT01549652|581370995|FG002|Overall Study|Titration Non-Compliance|4|||
160995687|NCT01549652|581370996|FG003|Overall Study|Titration Non-Compliance|5|||
160995688|NCT01549652|581370993|FG000|Overall Study|Titration Side Effects|0|||
160995689|NCT01549652|581370994|FG001|Overall Study|Titration Side Effects|0|||
160995690|NCT01549652|581370995|FG002|Overall Study|Titration Side Effects|6|||
160995691|NCT01549652|581370996|FG003|Overall Study|Titration Side Effects|3|||
160995692|NCT01549652|581370993|FG000|Overall Study|Withdrawal by Subject|0|||
160995693|NCT01549652|581370994|FG001|Overall Study|Withdrawal by Subject|0|||
160995694|NCT01549652|581370995|FG002|Overall Study|Withdrawal by Subject|5|||
160995695|NCT01549652|581370996|FG003|Overall Study|Withdrawal by Subject|3|||
160995696|NCT03247543|581370997|FG000|Overall Study|Adverse Event|3|||
160995697|NCT03247543|581370998|FG001|Overall Study|Adverse Event|6|||
160995698|NCT03247543|581370999|FG002|Overall Study|Adverse Event|4|||
160995699|NCT03247543|581370997|FG000|Overall Study|Lost to Follow-up|10|||
160995700|NCT03247543|581370998|FG001|Overall Study|Lost to Follow-up|7|||
160995701|NCT03247543|581370999|FG002|Overall Study|Lost to Follow-up|8|||
160995702|NCT03247543|581370997|FG000|Overall Study|Consent withdrawn by caregiver|2|||
160995703|NCT03247543|581370998|FG001|Overall Study|Consent withdrawn by caregiver|2|||
160995704|NCT03247543|581370999|FG002|Overall Study|Consent withdrawn by caregiver|9|||
160995705|NCT03247543|581370997|FG000|Overall Study|Withdrawal by Subject|0|||
160995706|NCT03247543|581370998|FG001|Overall Study|Withdrawal by Subject|0|||
160995707|NCT03247543|581370999|FG002|Overall Study|Withdrawal by Subject|1|||
160995708|NCT03247543|581370997|FG000|Overall Study|Failure to Follow study procedures|1|||
160995709|NCT03247543|581370998|FG001|Overall Study|Failure to Follow study procedures|3|||
160995710|NCT03247543|581370999|FG002|Overall Study|Failure to Follow study procedures|1|||
160995711|NCT03247543|581370997|FG000|Overall Study|Lack of Efficacy|1|||
160995712|NCT03247543|581370998|FG001|Overall Study|Lack of Efficacy|0|||
160995713|NCT03247543|581370999|FG002|Overall Study|Lack of Efficacy|0|||
160995714|NCT03247543|581370997|FG000|Overall Study|Non-compliance with study visits|0|||
160995715|NCT03247543|581370998|FG001|Overall Study|Non-compliance with study visits|1|||
160995716|NCT03247543|581370999|FG002|Overall Study|Non-compliance with study visits|0|||
160652746|NCT04849988|580110343|FG000|Overall Study|Other reasons|1|||
160652747|NCT04849988|580110344|FG001|Overall Study|Other reasons|2|||
160995717|NCT02059980|581371006|FG000|Overall Study|Lost to Follow-up|2|||
160995718|NCT02059980|581371007|FG001|Overall Study|Lost to Follow-up|1|||
160995719|NCT01321606|581371008|FG000|Overall Study|Lost to Follow-up|0|||
160995720|NCT01321606|581371009|FG001|Overall Study|Lost to Follow-up|0|||
160995721|NCT01321606|581371010|FG002|Overall Study|Lost to Follow-up|0|||
160995722|NCT01321606|581371011|FG003|Overall Study|Lost to Follow-up|1|||
160995723|NCT01253226|581371015|FG000|Overall Study|Adverse Event|0|||
160995724|NCT01253226|581371016|FG001|Overall Study|Adverse Event|0|||
160995725|NCT01253226|581371017|FG002|Overall Study|Adverse Event|1|||
160995726|NCT01253226|581371018|FG003|Overall Study|Adverse Event|0|||
160995727|NCT01253226|581371019|FG004|Overall Study|Adverse Event|0|||
160995728|NCT01253226|581371015|FG000|Overall Study|Death|0|||
160995729|NCT01253226|581371016|FG001|Overall Study|Death|1|||
160914206|NCT03506815|581077607|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
160914207|NCT03506815|581077606|FG000|Overall Study|Protocol Violation|1|||
160914208|NCT03506815|581077607|FG001|Overall Study|Protocol Violation|0|||
160914209|NCT03506815|581077606|FG000|Overall Study|Elective Surgery|1|||
160914210|NCT03506815|581077607|FG001|Overall Study|Elective Surgery|0|||
160914211|NCT04160091|581077608|FG000|Overall Study|Terminated by Sponsor|7|||
160914212|NCT04160091|581077609|FG001|Overall Study|Terminated by Sponsor|3|||
160914213|NCT04160091|581077610|FG002|Overall Study|Terminated by Sponsor|5|||
160914214|NCT04160091|581077611|FG003|Overall Study|Terminated by Sponsor|2|||
160914215|NCT04160091|581077608|FG000|Overall Study|Noncompliance|0|||
160914216|NCT04160091|581077609|FG001|Overall Study|Noncompliance|0|||
160914217|NCT04160091|581077610|FG002|Overall Study|Noncompliance|0|||
160914218|NCT04160091|581077611|FG003|Overall Study|Noncompliance|1|||
160914219|NCT04160091|581077608|FG000|Overall Study|Withdrawal by Subject|0|||
160914220|NCT04160091|581077609|FG001|Overall Study|Withdrawal by Subject|0|||
160914221|NCT04160091|581077610|FG002|Overall Study|Withdrawal by Subject|0|||
160914222|NCT04160091|581077611|FG003|Overall Study|Withdrawal by Subject|1|||
160914223|NCT00609492|581077616|FG000|Overall Study|Withdrawal by Subject|0|||
160914224|NCT00609492|581077617|FG001|Overall Study|Withdrawal by Subject|2|||
160914225|NCT00609492|581077618|FG002|Overall Study|Withdrawal by Subject|3|||
160914226|NCT00609492|581077616|FG000|Overall Study|Lost to Follow-up|1|||
160914227|NCT00609492|581077617|FG001|Overall Study|Lost to Follow-up|1|||
160914228|NCT00609492|581077618|FG002|Overall Study|Lost to Follow-up|4|||
160914229|NCT01224431|581077619|FG000|Overall Study|not randomized|0|||
160914230|NCT01224431|581077620|FG001|Overall Study|not randomized|4|||
160914231|NCT01224431|581077619|FG000|Overall Study|no video record|0|||
160914232|NCT01224431|581077620|FG001|Overall Study|no video record|1|||
160914233|NCT02057406|581077621|FG000|Overall Study|Physician Decision|0|||
160914234|NCT02057406|581077622|FG001|Overall Study|Physician Decision|0|||
160914235|NCT02057406|581077623|FG002|Overall Study|Physician Decision|2|||
160914236|NCT02057406|581077621|FG000|Overall Study|Withdrawal by Subject|0|||
160914237|NCT02057406|581077622|FG001|Overall Study|Withdrawal by Subject|2|||
160914238|NCT02057406|581077623|FG002|Overall Study|Withdrawal by Subject|0|||
160914239|NCT02057406|581077621|FG000|Overall Study|Lost to Follow-up|0|||
160914240|NCT02057406|581077622|FG001|Overall Study|Lost to Follow-up|0|||
160914241|NCT02057406|581077623|FG002|Overall Study|Lost to Follow-up|1|||
160914242|NCT02057406|581077621|FG000|Overall Study|Death|1|||
160914243|NCT02057406|581077622|FG001|Overall Study|Death|0|||
160914244|NCT02057406|581077623|FG002|Overall Study|Death|0|||
160914245|NCT02057406|581077621|FG000|Overall Study|Protocol Violation|0|||
160914246|NCT02057406|581077622|FG001|Overall Study|Protocol Violation|1|||
160914247|NCT02057406|581077623|FG002|Overall Study|Protocol Violation|0|||
160914248|NCT02057406|581077621|FG000|Overall Study|Patient transportation issues|0|||
160914249|NCT02057406|581077622|FG001|Overall Study|Patient transportation issues|0|||
160914250|NCT02057406|581077623|FG002|Overall Study|Patient transportation issues|1|||
160914251|NCT01401283|581077624|FG000|Overall Study|surgery cancelled|5|||
160914252|NCT01401283|581077625|FG001|Overall Study|surgery cancelled|8|||
160914253|NCT01401283|581077624|FG000|Overall Study|preoperative arrhythmia|5|||
160914254|NCT01401283|581077625|FG001|Overall Study|preoperative arrhythmia|0|||
160914255|NCT01401283|581077624|FG000|Overall Study|no central venous access|0|||
160914256|NCT01401283|581077625|FG001|Overall Study|no central venous access|1|||
160914257|NCT01401283|581077624|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
160914258|NCT01401283|581077625|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
160914259|NCT02433483|581077626|FG000|Overall Study|Unacceptable toxicity|1|||
160914260|NCT02433483|581077626|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
160914261|NCT00549302|581077635|FG000|Double-Blind|Death|2|||
160914262|NCT00549302|581077636|FG001|Double-Blind|Death|9|||
160914263|NCT00549302|581077637|FG002|Double-Blind|Death|0|||
160914264|NCT00549302|581077635|FG000|Double-Blind|Adverse Event|3|||
160914265|NCT00549302|581077636|FG001|Double-Blind|Adverse Event|16|||
160914266|NCT00549302|581077637|FG002|Double-Blind|Adverse Event|0|||
160914267|NCT00549302|581077635|FG000|Double-Blind|Withdrawal by Subject|3|||
160914268|NCT00549302|581077636|FG001|Double-Blind|Withdrawal by Subject|8|||
160914269|NCT00549302|581077637|FG002|Double-Blind|Withdrawal by Subject|0|||
160914270|NCT00549302|581077635|FG000|Double-Blind|Investigator Decision|1|||
160914271|NCT00549302|581077636|FG001|Double-Blind|Investigator Decision|5|||
160652748|NCT04849988|580110345|FG002|Overall Study|Other reasons|2|||
160914272|NCT00549302|581077637|FG002|Double-Blind|Investigator Decision|0|||
160914273|NCT00549302|581077635|FG000|Double-Blind|Sponsor Decision|0|||
160652749|NCT04849988|580110346|FG003|Overall Study|Other reasons|1|||
160914274|NCT00549302|581077636|FG001|Double-Blind|Sponsor Decision|1|||
160914275|NCT00549302|581077637|FG002|Double-Blind|Sponsor Decision|0|||
160914276|NCT00549302|581077635|FG000|Double-Blind|Lost to Follow-up|1|||
160914277|NCT00549302|581077636|FG001|Double-Blind|Lost to Follow-up|2|||
160914278|NCT00549302|581077637|FG002|Double-Blind|Lost to Follow-up|0|||
160914279|NCT00549302|581077635|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
160914280|NCT00549302|581077636|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
160995730|NCT01253226|581371017|FG002|Overall Study|Death|0|||
160652750|NCT01402908|580110351|FG000|Overall Study|Withdrawal by Subject|30|||
160914281|NCT00549302|581077637|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
160914282|NCT00549302|581077635|FG000|Double-Blind|New condition or starts new therapy|0|||
160914283|NCT00549302|581077636|FG001|Double-Blind|New condition or starts new therapy|2|||
160914284|NCT00549302|581077637|FG002|Double-Blind|New condition or starts new therapy|0|||
160914285|NCT00549302|581077635|FG000|Open-Label|Adverse Event|0|||
160914286|NCT00549302|581077636|FG001|Open-Label|Adverse Event|0|||
160914287|NCT00549302|581077637|FG002|Open-Label|Adverse Event|11|||
160914288|NCT00549302|581077635|FG000|Open-Label|Death|0|||
160914289|NCT00549302|581077636|FG001|Open-Label|Death|0|||
160914290|NCT00549302|581077637|FG002|Open-Label|Death|40|||
160914291|NCT00549302|581077635|FG000|Open-Label|Investigator Decision|0|||
160914292|NCT00549302|581077636|FG001|Open-Label|Investigator Decision|0|||
160914293|NCT00549302|581077637|FG002|Open-Label|Investigator Decision|5|||
160914294|NCT00549302|581077635|FG000|Open-Label|Lost to Follow-up|0|||
160914295|NCT00549302|581077636|FG001|Open-Label|Lost to Follow-up|0|||
160914296|NCT00549302|581077637|FG002|Open-Label|Lost to Follow-up|2|||
160914297|NCT00549302|581077635|FG000|Open-Label|Other|0|||
160914298|NCT00549302|581077636|FG001|Open-Label|Other|0|||
160914299|NCT00549302|581077637|FG002|Open-Label|Other|3|||
160914300|NCT00549302|581077635|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
160914301|NCT00549302|581077636|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
160914302|NCT00549302|581077637|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
160914303|NCT00549302|581077635|FG000|Open-Label|Withdrawal by Subject|0|||
160914304|NCT00549302|581077636|FG001|Open-Label|Withdrawal by Subject|0|||
160914305|NCT00549302|581077637|FG002|Open-Label|Withdrawal by Subject|6|||
160914306|NCT01414114|581077638|FG000|Overall Study|Adverse Event|2|||
160914307|NCT01414114|581077638|FG000|Overall Study|Withdrawal by Subject|1|||
160914308|NCT01414114|581077638|FG000|Overall Study|Other|2|||
160914309|NCT05620563|581077639|FG000|Overall Study|Adverse Event|3|||
160914310|NCT05620563|581077640|FG001|Overall Study|Adverse Event|1|||
160914311|NCT05620563|581077639|FG000|Overall Study|Lost to Follow-up|0|||
160914312|NCT05620563|581077640|FG001|Overall Study|Lost to Follow-up|2|||
160914313|NCT05620563|581077639|FG000|Overall Study|Protocol Deviation|1|||
160914314|NCT05620563|581077640|FG001|Overall Study|Protocol Deviation|2|||
160914315|NCT05620563|581077639|FG000|Overall Study|Withdrawal by Subject|3|||
160914316|NCT05620563|581077640|FG001|Overall Study|Withdrawal by Subject|3|||
160914317|NCT05620563|581077639|FG000|Overall Study|Physician Decision|0|||
160914318|NCT05620563|581077640|FG001|Overall Study|Physician Decision|1|||
160914319|NCT00865124|581077641|FG000|Overall Study|Physician Decision|2|||
160914320|NCT00865124|581077642|FG001|Overall Study|Physician Decision|1|||
160914321|NCT00865124|581077643|FG002|Overall Study|Physician Decision|0|||
160914322|NCT00865124|581077641|FG000|Overall Study|Withdrawn consent|2|||
160914323|NCT00865124|581077642|FG001|Overall Study|Withdrawn consent|0|||
160652751|NCT01402908|580110352|FG001|Overall Study|Withdrawal by Subject|17|||
160652752|NCT01402908|580110351|FG000|Overall Study|Lost to Follow-up|3|||
160914324|NCT00865124|581077643|FG002|Overall Study|Withdrawn consent|0|||
160914325|NCT02743520|581077644|FG000|Overall Study|Withdrawal by Subject|1|||
160914326|NCT02547649|581077648|FG000|Overall Study|Lost to Follow-up|3|||
160914327|NCT02547649|581077649|FG001|Overall Study|Lost to Follow-up|1|||
160914328|NCT02547649|581077650|FG002|Overall Study|Lost to Follow-up|1|||
160914329|NCT02547649|581077648|FG000|Overall Study|Not vaccinated|0|||
160914330|NCT02547649|581077649|FG001|Overall Study|Not vaccinated|0|||
160914331|NCT02547649|581077650|FG002|Overall Study|Not vaccinated|1|||
160914332|NCT02547649|581077648|FG000|Overall Study|Withdrawal by Subject|0|||
160914333|NCT02547649|581077649|FG001|Overall Study|Withdrawal by Subject|4|||
160914334|NCT02547649|581077650|FG002|Overall Study|Withdrawal by Subject|2|||
160914335|NCT03454997|581077651|FG000|Overall Study|Staff Coach - Left Oranization|1|||
160914336|NCT03454997|581077652|FG001|Overall Study|Staff Coach - Left Oranization|1|||
160914337|NCT03454997|581077651|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
160914338|NCT03454997|581077652|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
160914339|NCT03454997|581077651|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
160914340|NCT03454997|581077652|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
160914341|NCT03454997|581077651|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
160914342|NCT03454997|581077652|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
160914343|NCT03454997|581077651|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
160914344|NCT03454997|581077652|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
160914345|NCT03454997|581077651|FG000|Overall Study|Client with SMI - Left organization|0|||
160914346|NCT03454997|581077652|FG001|Overall Study|Client with SMI - Left organization|1|||
160914347|NCT03454997|581077651|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
160914348|NCT03454997|581077652|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
160914349|NCT01111149|581077657|FG000|Overall Study|Protocol Violation|1|||
160914350|NCT01111149|581077658|FG001|Overall Study|Protocol Violation|1|||
160914351|NCT01111149|581077659|FG002|Overall Study|Protocol Violation|2|||
160914352|NCT01111149|581077657|FG000|Overall Study|Withdrawal by Subject|1|||
160914353|NCT01111149|581077658|FG001|Overall Study|Withdrawal by Subject|0|||
160914354|NCT01111149|581077659|FG002|Overall Study|Withdrawal by Subject|2|||
160914355|NCT01909674|581077664|FG000|Overall Study|Withdrawal by Subject|5|||
160995731|NCT01253226|581371018|FG003|Overall Study|Death|0|||
160995732|NCT01253226|581371019|FG004|Overall Study|Death|0|||
160995733|NCT01253226|581371015|FG000|Overall Study|Physician Decision|0|||
160995734|NCT01253226|581371016|FG001|Overall Study|Physician Decision|0|||
160995735|NCT01253226|581371017|FG002|Overall Study|Physician Decision|0|||
160995736|NCT01253226|581371018|FG003|Overall Study|Physician Decision|0|||
160995737|NCT01253226|581371019|FG004|Overall Study|Physician Decision|2|||
160995738|NCT01253226|581371015|FG000|Overall Study|Withdrawal by Subject|0|||
160995739|NCT01253226|581371016|FG001|Overall Study|Withdrawal by Subject|0|||
160995740|NCT01253226|581371017|FG002|Overall Study|Withdrawal by Subject|0|||
160995741|NCT01253226|581371018|FG003|Overall Study|Withdrawal by Subject|1|||
160995742|NCT01253226|581371019|FG004|Overall Study|Withdrawal by Subject|0|||
160995743|NCT05916170|581371020|FG000|No Warning Control|Lost to Follow-up|12|||
160995744|NCT05916170|581371020|FG000|No Warning Control|Withdrawal by Subject|15|||
160995745|NCT05916170|581371020|FG000|No Warning Control|Noncompliance with protocol|1|||
160995746|NCT05916170|581371020|FG000|Health Warning Intervention|Lost to Follow-up|15|||
160995747|NCT05916170|581371020|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
160995748|NCT05916170|581371020|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
160995749|NCT04075266|581371022|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
160995750|NCT04075266|581371023|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
160995751|NCT04075266|581371022|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
160995752|NCT04075266|581371023|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
160995753|NCT01582945|581371024|FG000|Overall Study|Intolerable side-effects|1|||
160995754|NCT01582945|581371024|FG000|Overall Study|Scheduling conflicts|1|||
160995755|NCT03643211|581371025|FG000|Overall Study|Contract violation/deficiency|12|||
160995756|NCT03643211|581371025|FG000|Overall Study|Invalid registration|3|||
160995757|NCT03643211|581371025|FG000|Overall Study|No treatment information|2|||
160995758|NCT03643211|581371025|FG000|Overall Study|No adverse event information - No revisit|4|||
160995759|NCT02864992|581371030|FG000|Overall Study|still on treatment|15|||
160995760|NCT02864992|581371031|FG001|Overall Study|still on treatment|1|||
160995761|NCT02864992|581371032|FG002|Overall Study|still on treatment|33|||
160995762|NCT04948333|581371033|FG000|Overall Study|Adverse Event|6|||
160995763|NCT04948333|581371034|FG001|Overall Study|Adverse Event|4|||
160995764|NCT04948333|581371035|FG002|Overall Study|Adverse Event|0|||
160995765|NCT04948333|581371036|FG003|Overall Study|Adverse Event|2|||
160995766|NCT04948333|581371033|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
160995767|NCT04948333|581371034|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160995768|NCT04948333|581371035|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160995769|NCT04948333|581371036|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160995770|NCT04948333|581371033|FG000|Overall Study|Progressive Disease|1|||
160995771|NCT04948333|581371034|FG001|Overall Study|Progressive Disease|5|||
160995772|NCT04948333|581371035|FG002|Overall Study|Progressive Disease|0|||
160995773|NCT04948333|581371036|FG003|Overall Study|Progressive Disease|0|||
160995774|NCT04948333|581371033|FG000|Overall Study|Physician Decision|2|||
160995775|NCT04948333|581371034|FG001|Overall Study|Physician Decision|2|||
160995776|NCT04948333|581371035|FG002|Overall Study|Physician Decision|0|||
160995777|NCT04948333|581371036|FG003|Overall Study|Physician Decision|0|||
160995778|NCT04948333|581371033|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
160995779|NCT04948333|581371034|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
160995780|NCT04948333|581371035|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
160995781|NCT04948333|581371036|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
160995782|NCT04948333|581371033|FG000|Overall Study|Withdrawal by Subject|2|||
160995783|NCT04948333|581371034|FG001|Overall Study|Withdrawal by Subject|0|||
160995784|NCT04948333|581371035|FG002|Overall Study|Withdrawal by Subject|0|||
160995785|NCT04948333|581371036|FG003|Overall Study|Withdrawal by Subject|1|||
160995786|NCT04948333|581371033|FG000|Overall Study|Protocol Violation|0|||
160995787|NCT04948333|581371034|FG001|Overall Study|Protocol Violation|1|||
160995788|NCT04948333|581371035|FG002|Overall Study|Protocol Violation|0|||
160995789|NCT04948333|581371036|FG003|Overall Study|Protocol Violation|0|||
160995790|NCT04948333|581371033|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
160995791|NCT04948333|581371034|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
160995792|NCT04948333|581371035|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
160995793|NCT04948333|581371036|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
160453471|NCT03235544|579392102|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
160995794|NCT03038022|581371038|FG000|Overall Study|Withdrawal by Subject|2|||
160995795|NCT03038022|581371039|FG001|Overall Study|Withdrawal by Subject|0|||
160995796|NCT03038022|581371038|FG000|Overall Study|Adverse Event|4|||
160995797|NCT03038022|581371039|FG001|Overall Study|Adverse Event|2|||
160995798|NCT01467427|581371042|FG000|Overall Study|Withdrawal by Subject|1|||
160995799|NCT01467427|581371043|FG001|Overall Study|Withdrawal by Subject|0|||
160995800|NCT01467427|581371042|FG000|Overall Study|Not continuing in extension phase|0|||
160995801|NCT01467427|581371043|FG001|Overall Study|Not continuing in extension phase|2|||
160995802|NCT01467427|581371042|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
160914356|NCT01909674|581077665|FG001|Overall Study|Withdrawal by Subject|2|||
160914357|NCT02794883|581077666|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
160914358|NCT02794883|581077667|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
160914359|NCT02794883|581077668|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
160914360|NCT02794883|581077666|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
160914361|NCT02794883|581077667|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
160914362|NCT02794883|581077668|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
160914363|NCT02794883|581077666|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
160914364|NCT02794883|581077667|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
160914365|NCT02794883|581077668|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
160914366|NCT02794883|581077666|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
160914367|NCT02794883|581077667|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
160914368|NCT02794883|581077668|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
160914369|NCT02794883|581077666|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
160914370|NCT02794883|581077667|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
160914371|NCT02794883|581077668|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
160914372|NCT02794883|581077666|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
160914373|NCT02794883|581077667|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
160914374|NCT02794883|581077668|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
160914375|NCT02794883|581077666|FG000|Follow-up Period (up to 2 Years)|Death|12|||
160914376|NCT02794883|581077667|FG001|Follow-up Period (up to 2 Years)|Death|10|||
160914377|NCT02794883|581077668|FG002|Follow-up Period (up to 2 Years)|Death|10|||
160914378|NCT01678911|581077672|FG000|Second Intervention|Lost to Follow-up|2|||
160914379|NCT01678911|581077673|FG001|Second Intervention|Lost to Follow-up|0|||
160914380|NCT01906008|581077674|FG000|Overall Study|Lost to Follow-up|2|||
160914381|NCT01906008|581077675|FG001|Overall Study|Lost to Follow-up|0|||
160914382|NCT01906008|581077674|FG000|Overall Study|Oxaliplatin toxicity|2|||
160914383|NCT01906008|581077675|FG001|Overall Study|Oxaliplatin toxicity|0|||
160914384|NCT01906008|581077674|FG000|Overall Study|Protocol Violation|0|||
160914385|NCT01906008|581077675|FG001|Overall Study|Protocol Violation|1|||
160914386|NCT01906008|581077674|FG000|Overall Study|Withdrawal by Subject|1|||
160914387|NCT01906008|581077675|FG001|Overall Study|Withdrawal by Subject|5|||
160914388|NCT01906008|581077674|FG000|Overall Study|Did not start study med|3|||
160914389|NCT01906008|581077675|FG001|Overall Study|Did not start study med|4|||
160914390|NCT01906008|581077674|FG000|Overall Study|Oxaliplatin stops|10|||
160914391|NCT01906008|581077675|FG001|Overall Study|Oxaliplatin stops|8|||
160914392|NCT01906008|581077674|FG000|Overall Study|Hospice|1|||
160914393|NCT01906008|581077675|FG001|Overall Study|Hospice|0|||
160914394|NCT01906008|581077674|FG000|Overall Study|Physician Decision|3|||
160914395|NCT01906008|581077675|FG001|Overall Study|Physician Decision|3|||
160914396|NCT01906008|581077674|FG000|Overall Study|Lack of compliance of study med|5|||
160914397|NCT01906008|581077675|FG001|Overall Study|Lack of compliance of study med|3|||
160914398|NCT01906008|581077674|FG000|Overall Study|Adverse Event|0|||
160914399|NCT01906008|581077675|FG001|Overall Study|Adverse Event|3|||
160914400|NCT02117648|581077676|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
160914401|NCT02117648|581077676|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
160914402|NCT02117648|581077676|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
160914403|NCT02117648|581077676|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
160914404|NCT02117648|581077676|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
160914405|NCT02117648|581077676|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
160914406|NCT02117648|581077676|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
160914407|NCT02117648|581077676|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
160914408|NCT02117648|581077676|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
160914409|NCT02117648|581077676|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
160914410|NCT02117648|581077676|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
160914411|NCT05025241|581077678|FG000|Screening|Failed Screening|5|||
160914412|NCT05025241|581077678|FG000|Treatment and Follow Up|Adverse Event|3|||
160914413|NCT02670837|581077679|FG000|Overall Study|Death|2|||
160914414|NCT02670837|581077680|FG001|Overall Study|Death|0|||
160914415|NCT02670837|581077681|FG002|Overall Study|Death|0|||
160914416|NCT02220205|581077682|FG000|Overall Study|Withdrawal by Subject|1|||
160914417|NCT02220205|581077683|FG001|Overall Study|Withdrawal by Subject|0|||
160914418|NCT02266225|581077684|FG000|Overall Study|Lost to Follow-up|2|||
160914419|NCT02266225|581077684|FG000|Overall Study|Death|1|||
160914420|NCT02266225|581077684|FG000|Overall Study|Withdrawal by Subject|13|||
160914421|NCT01574326|581077685|FG000|Overall Study|Randomized but not treated|0|||
160914422|NCT01574326|581077686|FG001|Overall Study|Randomized but not treated|1|||
160914423|NCT01574326|581077685|FG000|Overall Study|Withdrawal by Participant|2|||
160914424|NCT01574326|581077686|FG001|Overall Study|Withdrawal by Participant|4|||
160914425|NCT01574326|581077685|FG000|Overall Study|Physician Decision|5|||
160914426|NCT01574326|581077686|FG001|Overall Study|Physician Decision|3|||
160914427|NCT01574326|581077685|FG000|Overall Study|Adverse Event|1|||
160914428|NCT01574326|581077686|FG001|Overall Study|Adverse Event|3|||
160914429|NCT01574326|581077685|FG000|Overall Study|Other: Mainly kidney transplant|8|||
160914430|NCT01574326|581077686|FG001|Overall Study|Other: Mainly kidney transplant|8|||
160914431|NCT00137046|581077687|FG000|Overall Study|Death|2|||
160914432|NCT00137046|581077688|FG001|Overall Study|Death|1|||
160914433|NCT00137046|581077687|FG000|Overall Study|Adverse Event|16|||
160914434|NCT00137046|581077688|FG001|Overall Study|Adverse Event|5|||
160914435|NCT00137046|581077687|FG000|Overall Study|Laboratory Abnormality|2|||
160914436|NCT00137046|581077688|FG001|Overall Study|Laboratory Abnormality|0|||
160914437|NCT00137046|581077687|FG000|Overall Study|Lack of Efficacy|13|||
160914438|NCT00137046|581077688|FG001|Overall Study|Lack of Efficacy|1|||
160914439|NCT00137046|581077687|FG000|Overall Study|Lost to Follow-up|8|||
160914440|NCT00137046|581077688|FG001|Overall Study|Lost to Follow-up|24|||
160914441|NCT00137046|581077687|FG000|Overall Study|Other|23|||
160914442|NCT00137046|581077688|FG001|Overall Study|Other|19|||
160914443|NCT00137046|581077687|FG000|Overall Study|Withdrawal by Subject|33|||
160914444|NCT00137046|581077688|FG001|Overall Study|Withdrawal by Subject|42|||
160914445|NCT00137046|581077687|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
160914446|NCT00137046|581077688|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
160914447|NCT00137046|581077687|FG000|Overall Study|Withdrew prior to study treatment|1|||
160914448|NCT00137046|581077688|FG001|Overall Study|Withdrew prior to study treatment|1|||
160914449|NCT02268084|581077693|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
160914450|NCT02268084|581077694|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
160914451|NCT02268084|581077693|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
160914452|NCT02268084|581077694|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
160914453|NCT05227027|581077695|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
160914454|NCT05227027|581077696|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
160914455|NCT06149247|581077697|FG000|Overall Study|Adverse Event|0|||
160914456|NCT06149247|581077698|FG001|Overall Study|Adverse Event|1|||
160914457|NCT00371137|581077703|FG000|Overall Study|Adverse Event|20|||
160914458|NCT00371137|581077704|FG001|Overall Study|Adverse Event|35|||
160914459|NCT00371137|581077705|FG002|Overall Study|Adverse Event|42|||
160914460|NCT00371137|581077703|FG000|Overall Study|Withdrawal by Subject|11|||
160914461|NCT00371137|581077704|FG001|Overall Study|Withdrawal by Subject|10|||
160914462|NCT00371137|581077705|FG002|Overall Study|Withdrawal by Subject|15|||
160914463|NCT00371137|581077703|FG000|Overall Study|Lost to Follow-up|6|||
160914464|NCT00371137|581077704|FG001|Overall Study|Lost to Follow-up|3|||
160914465|NCT00371137|581077705|FG002|Overall Study|Lost to Follow-up|5|||
160914466|NCT00371137|581077703|FG000|Overall Study|Lack of Efficacy|30|||
160914467|NCT00371137|581077704|FG001|Overall Study|Lack of Efficacy|12|||
160914468|NCT00371137|581077705|FG002|Overall Study|Lack of Efficacy|13|||
160914469|NCT00371137|581077703|FG000|Overall Study|Sponsor Decision|2|||
160914470|NCT00371137|581077704|FG001|Overall Study|Sponsor Decision|1|||
160914471|NCT00371137|581077705|FG002|Overall Study|Sponsor Decision|2|||
160914472|NCT00371137|581077703|FG000|Overall Study|Physician Decision|1|||
160914473|NCT00371137|581077704|FG001|Overall Study|Physician Decision|1|||
160914474|NCT00371137|581077705|FG002|Overall Study|Physician Decision|1|||
160914475|NCT00371137|581077703|FG000|Overall Study|Protocol Violation|2|||
160914476|NCT00371137|581077704|FG001|Overall Study|Protocol Violation|1|||
160914477|NCT00371137|581077705|FG002|Overall Study|Protocol Violation|1|||
160914478|NCT01756898|581077708|FG000|Overall Study|Adverse Event|7|||
160914479|NCT01756898|581077709|FG001|Overall Study|Adverse Event|1|||
160914480|NCT01756898|581077710|FG002|Overall Study|Adverse Event|0|||
160914481|NCT01756898|581077711|FG003|Overall Study|Adverse Event|0|||
160914482|NCT01756898|581077708|FG000|Overall Study|Lack of Efficacy|4|||
160914483|NCT01756898|581077709|FG001|Overall Study|Lack of Efficacy|7|||
160914484|NCT01756898|581077710|FG002|Overall Study|Lack of Efficacy|6|||
160914485|NCT01756898|581077711|FG003|Overall Study|Lack of Efficacy|6|||
160914486|NCT01756898|581077708|FG000|Overall Study|Lost to Follow-up|2|||
160914487|NCT01756898|581077709|FG001|Overall Study|Lost to Follow-up|4|||
160914488|NCT01756898|581077710|FG002|Overall Study|Lost to Follow-up|2|||
160914489|NCT01756898|581077711|FG003|Overall Study|Lost to Follow-up|3|||
160914490|NCT01756898|581077708|FG000|Overall Study|Protocol Violation|1|||
160914491|NCT01756898|581077709|FG001|Overall Study|Protocol Violation|2|||
160914492|NCT01756898|581077710|FG002|Overall Study|Protocol Violation|2|||
160914493|NCT01756898|581077711|FG003|Overall Study|Protocol Violation|1|||
160914494|NCT01756898|581077708|FG000|Overall Study|Withdrew Consent|5|||
160914495|NCT01756898|581077709|FG001|Overall Study|Withdrew Consent|3|||
160914496|NCT01756898|581077710|FG002|Overall Study|Withdrew Consent|5|||
160914497|NCT01756898|581077711|FG003|Overall Study|Withdrew Consent|6|||
160914498|NCT01756898|581077708|FG000|Overall Study|Other|0|||
160914499|NCT01756898|581077709|FG001|Overall Study|Other|2|||
160914500|NCT01756898|581077710|FG002|Overall Study|Other|2|||
160570578|NCT00550238|579812182|FG000|Overall Study|Physician Decision|31|||
160570579|NCT00550238|579812182|FG000|Overall Study|Patient noncompliance|25|||
160570580|NCT00550238|579812182|FG000|Overall Study|Lost to Follow-up|13|||
160914501|NCT01756898|581077711|FG003|Overall Study|Other|0|||
160914502|NCT01500694|581077712|FG000|Overall Study|Adverse Event|4|||
160453472|NCT03235544|579392099|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
160914503|NCT01500694|581077713|FG001|Overall Study|Adverse Event|3|||
160914504|NCT01500694|581077712|FG000|Overall Study|Protocol Violation|0|||
160914505|NCT01500694|581077713|FG001|Overall Study|Protocol Violation|1|||
160914506|NCT01500694|581077712|FG000|Overall Study|Withdrawal by Subject|23|||
160914507|NCT01500694|581077713|FG001|Overall Study|Withdrawal by Subject|14|||
160914508|NCT01500694|581077712|FG000|Overall Study|Lost to Follow-up|2|||
160914509|NCT01500694|581077713|FG001|Overall Study|Lost to Follow-up|3|||
160914510|NCT01500694|581077712|FG000|Overall Study|Lack of Efficacy|14|||
160914511|NCT01500694|581077713|FG001|Overall Study|Lack of Efficacy|5|||
160914512|NCT01500694|581077712|FG000|Overall Study|Other|9|||
160914513|NCT01500694|581077713|FG001|Overall Study|Other|3|||
160914514|NCT01963403|581079476|FG000|Overall Study|Lost to Follow-up|2|||
160914515|NCT01963403|581079477|FG001|Overall Study|Lost to Follow-up|3|||
160914516|NCT01963403|581079476|FG000|Overall Study|Implant removal|0|||
160914517|NCT01963403|581079477|FG001|Overall Study|Implant removal|1|||
160914518|NCT02743806|581079478|FG000|Overall Study|Adverse Event|9|||
160914519|NCT02743806|581079478|FG000|Overall Study|Lost to Follow-up|8|||
160914520|NCT02743806|581079478|FG000|Overall Study|Voluntary Withdrawal|54|||
160914521|NCT02743806|581079478|FG000|Overall Study|Study Termination|65|||
160914522|NCT02743806|581079478|FG000|Overall Study|Pregnancy|6|||
160914523|NCT02743806|581079478|FG000|Overall Study|No Longer Clinically Benefiting|27|||
160914524|NCT02743806|581079478|FG000|Overall Study|Reason Not Specified|12|||
160914525|NCT00267046|581079487|FG000|Overall Study|Disease progression|4|||
160914526|NCT00267046|581079488|FG001|Overall Study|Disease progression|2|||
160914527|NCT00267046|581079487|FG000|Overall Study|Chemotoxicity|2|||
160914528|NCT00267046|581079488|FG001|Overall Study|Chemotoxicity|0|||
160914529|NCT00267046|581079487|FG000|Overall Study|Open-label palifermin|2|||
160914530|NCT00267046|581079488|FG001|Overall Study|Open-label palifermin|7|||
160914531|NCT00267046|581079487|FG000|Overall Study|Surgery|3|||
160914532|NCT00267046|581079488|FG001|Overall Study|Surgery|1|||
160914533|NCT00267046|581079487|FG000|Overall Study|Withdrawal by Subject|1|||
160914534|NCT00267046|581079488|FG001|Overall Study|Withdrawal by Subject|0|||
160914535|NCT00267046|581079487|FG000|Overall Study|Radiation|0|||
160914536|NCT00267046|581079488|FG001|Overall Study|Radiation|1|||
160914537|NCT00460408|581079489|FG000|Overall Study|Adverse Event|1|||
160914538|NCT00460408|581079490|FG001|Overall Study|Adverse Event|0|||
160914539|NCT00460408|581079491|FG002|Overall Study|Adverse Event|0|||
160914540|NCT00460408|581079492|FG003|Overall Study|Adverse Event|0|||
160914541|NCT00460408|581079489|FG000|Overall Study|Death|7|||
160914542|NCT00460408|581079490|FG001|Overall Study|Death|0|||
160914543|NCT00460408|581079491|FG002|Overall Study|Death|0|||
160914544|NCT00460408|581079492|FG003|Overall Study|Death|0|||
160914545|NCT00460408|581079489|FG000|Overall Study|Lost to Follow-up|11|||
160914546|NCT00460408|581079490|FG001|Overall Study|Lost to Follow-up|0|||
160914547|NCT00460408|581079491|FG002|Overall Study|Lost to Follow-up|1|||
160914548|NCT00460408|581079492|FG003|Overall Study|Lost to Follow-up|0|||
160914549|NCT00460408|581079489|FG000|Overall Study|Withdrawal by Subject|31|||
160914550|NCT00460408|581079490|FG001|Overall Study|Withdrawal by Subject|0|||
160914551|NCT00460408|581079491|FG002|Overall Study|Withdrawal by Subject|0|||
160914552|NCT00460408|581079492|FG003|Overall Study|Withdrawal by Subject|0|||
160914553|NCT00460408|581079489|FG000|Overall Study|Insufficient clinical response|5|||
160914554|NCT00460408|581079490|FG001|Overall Study|Insufficient clinical response|1|||
160914555|NCT00460408|581079491|FG002|Overall Study|Insufficient clinical response|5|||
160914556|NCT00460408|581079492|FG003|Overall Study|Insufficient clinical response|0|||
160914557|NCT00460408|581079489|FG000|Overall Study|Other|12|||
160914558|NCT00460408|581079490|FG001|Overall Study|Other|2|||
160914559|NCT00460408|581079491|FG002|Overall Study|Other|0|||
160914560|NCT00460408|581079492|FG003|Overall Study|Other|0|||
160914561|NCT02573350|581079493|FG000|Overall Study|Lost to Follow-up|2|||
160914562|NCT02573350|581079494|FG001|Overall Study|Lost to Follow-up|1|||
160914563|NCT02573350|581079493|FG000|Overall Study|Adverse Event|3|||
160914564|NCT02573350|581079494|FG001|Overall Study|Adverse Event|4|||
160914565|NCT02573350|581079493|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
160914566|NCT02573350|581079494|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
160914567|NCT02573350|581079493|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
160914568|NCT02573350|581079494|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
160914569|NCT02573350|581079493|FG000|Overall Study|Subject withdrew consent to participate|6|||
160914570|NCT02573350|581079494|FG001|Overall Study|Subject withdrew consent to participate|1|||
160914571|NCT02573350|581079493|FG000|Overall Study|Protocol Deviation|1|||
160914572|NCT02573350|581079494|FG001|Overall Study|Protocol Deviation|1|||
160914573|NCT04326231|581079495|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
160914574|NCT03303079|581079496|FG000|Overall Study|Adverse Event|0|||
160914575|NCT03303079|581079497|FG001|Overall Study|Adverse Event|1|||
160914576|NCT03303079|581079498|FG002|Overall Study|Adverse Event|3|||
160914577|NCT03303079|581079496|FG000|Overall Study|Protocol Violation|5|||
160914578|NCT03303079|581079497|FG001|Overall Study|Protocol Violation|4|||
160914579|NCT03303079|581079498|FG002|Overall Study|Protocol Violation|7|||
160995803|NCT01467427|581371043|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
160995804|NCT01467427|581371042|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
160995805|NCT01467427|581371043|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
160995806|NCT01467427|581371042|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
160995807|NCT01467427|581371043|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
160995808|NCT01467427|581371042|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
160914580|NCT03303079|581079496|FG000|Overall Study|Withdrawal by Subject|2|||
160914581|NCT03303079|581079497|FG001|Overall Study|Withdrawal by Subject|4|||
160914582|NCT03303079|581079498|FG002|Overall Study|Withdrawal by Subject|2|||
160914583|NCT03303079|581079496|FG000|Overall Study|Other than specified|0|||
160914584|NCT03303079|581079497|FG001|Overall Study|Other than specified|2|||
160914585|NCT03303079|581079498|FG002|Overall Study|Other than specified|0|||
160914586|NCT01741701|581079505|FG000|Overall Study|Adverse Event|5|||
160914587|NCT01741701|581079506|FG001|Overall Study|Adverse Event|1|||
160914588|NCT01741701|581079505|FG000|Overall Study|Withdrawal by Subject|0|||
160914589|NCT01741701|581079506|FG001|Overall Study|Withdrawal by Subject|1|||
160914590|NCT00006903|581079512|FG000|Overall Study|Still receiving treatment|0|||
160914591|NCT00006903|581079513|FG001|Overall Study|Still receiving treatment|0|||
160914592|NCT00006903|581079514|FG002|Overall Study|Still receiving treatment|1|||
160914593|NCT00006903|581079512|FG000|Overall Study|Refused further treatment|0|||
160914594|NCT00006903|581079513|FG001|Overall Study|Refused further treatment|2|||
160914595|NCT00006903|581079514|FG002|Overall Study|Refused further treatment|1|||
160914596|NCT00006903|581079512|FG000|Overall Study|Adverse Event|0|||
160995809|NCT01467427|581371043|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
160995810|NCT04269200|581371044|FG000|Global Cohort|Death|72|||
160995811|NCT04269200|581371045|FG001|Global Cohort|Death|54|||
160995812|NCT04269200|581371046|FG002|Global Cohort|Death|49|||
160995813|NCT04269200|581371044|FG000|Global Cohort|Lost to Follow-up|0|||
160995814|NCT04269200|581371045|FG001|Global Cohort|Lost to Follow-up|0|||
160995815|NCT04269200|581371046|FG002|Global Cohort|Lost to Follow-up|2|||
160995816|NCT04269200|581371044|FG000|Global Cohort|Withdrawal by Subject|22|||
160995817|NCT04269200|581371045|FG001|Global Cohort|Withdrawal by Subject|25|||
160995818|NCT04269200|581371046|FG002|Global Cohort|Withdrawal by Subject|18|||
160995819|NCT04269200|581371044|FG000|China Cohort|Death|12|||
160995820|NCT04269200|581371045|FG001|China Cohort|Death|11|||
160995821|NCT04269200|581371046|FG002|China Cohort|Death|13|||
160995822|NCT04269200|581371044|FG000|China Cohort|Lost to Follow-up|0|||
160995823|NCT04269200|581371045|FG001|China Cohort|Lost to Follow-up|1|||
160995824|NCT04269200|581371046|FG002|China Cohort|Lost to Follow-up|1|||
160995825|NCT04269200|581371044|FG000|China Cohort|Withdrawal by Subject|2|||
160995826|NCT04269200|581371045|FG001|China Cohort|Withdrawal by Subject|2|||
160995827|NCT04269200|581371046|FG002|China Cohort|Withdrawal by Subject|4|||
160995828|NCT04181827|581371047|FG000|Overall Study|Ongoing|124|||
160995829|NCT04181827|581371048|FG001|Overall Study|Ongoing|157|||
160995830|NCT04181827|581371047|FG000|Overall Study|Death|82|||
160995831|NCT04181827|581371048|FG001|Overall Study|Death|50|||
160995832|NCT04181827|581371047|FG000|Overall Study|Lost to Follow-up|0|||
160995833|NCT04181827|581371048|FG001|Overall Study|Lost to Follow-up|1|||
160995834|NCT04181827|581371047|FG000|Overall Study|Withdrawal by Subject|5|||
160995835|NCT04181827|581371048|FG001|Overall Study|Withdrawal by Subject|0|||
160995836|NCT03887936|581371049|FG000|Overall Study|Relocation|2|||
160995837|NCT03887936|581371050|FG001|Overall Study|Relocation|2|||
160914597|NCT00006903|581079513|FG001|Overall Study|Adverse Event|0|||
160995838|NCT03887936|581371049|FG000|Overall Study|Physician Decision|0|||
160995839|NCT03887936|581371050|FG001|Overall Study|Physician Decision|1|||
160995840|NCT03887936|581371049|FG000|Overall Study|Withdrawal by Subject|0|||
160995841|NCT03887936|581371050|FG001|Overall Study|Withdrawal by Subject|1|||
160995842|NCT00539591|581371051|FG000|Overall Study|Toxicity|3|||
160995843|NCT00539591|581371052|FG001|Overall Study|Toxicity|0|||
160995844|NCT00539591|581371053|FG002|Overall Study|Toxicity|0|||
160995845|NCT00539591|581371051|FG000|Overall Study|Disease progression|2|||
160995846|NCT00539591|581371052|FG001|Overall Study|Disease progression|2|||
160995847|NCT00539591|581371053|FG002|Overall Study|Disease progression|3|||
160995848|NCT03331250|581371054|FG000|Overall Study|Withdrawal by Subject|1|||
160995849|NCT04305912|581371055|FG000|First Intervention|COVID-19 Suspension|2|||
160995850|NCT04305912|581371056|FG001|First Intervention|COVID-19 Suspension|0|||
160995851|NCT04305912|581371055|FG000|First Intervention|Withdrawal by Subject|0|||
160995852|NCT04305912|581371056|FG001|First Intervention|Withdrawal by Subject|1|||
160914598|NCT00006903|581079514|FG002|Overall Study|Adverse Event|1|||
160914599|NCT00006903|581079512|FG000|Overall Study|Death|0|||
160914600|NCT00006903|581079513|FG001|Overall Study|Death|1|||
160914601|NCT00006903|581079514|FG002|Overall Study|Death|0|||
160914602|NCT00006903|581079512|FG000|Overall Study|Patient never treated|0|||
160995853|NCT04305912|581371055|FG000|Second Intervention|Adverse Event|0|||
160995854|NCT04305912|581371056|FG001|Second Intervention|Adverse Event|1|||
160995855|NCT03563053|581371057|FG000|Overall Study|Withdrawal by Subject|17|||
160995856|NCT03563053|581371057|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
160995857|NCT03563053|581371057|FG000|Overall Study|Adverse Event|3|||
160995858|NCT03563053|581371057|FG000|Overall Study|Physician Decision|1|||
160995859|NCT03563053|581371057|FG000|Overall Study|study terminated by sponsor|71|||
160914603|NCT00006903|581079513|FG001|Overall Study|Patient never treated|0|||
160914604|NCT00006903|581079514|FG002|Overall Study|Patient never treated|1|||
160914605|NCT00006903|581079512|FG000|Overall Study|Ineligible|10|||
160914606|NCT00006903|581079513|FG001|Overall Study|Ineligible|1|||
160995860|NCT00124982|581371058|FG000|Short-term Period|Death|1|||
160995861|NCT00124982|581371059|FG001|Short-term Period|Death|1|||
160995862|NCT00124982|581371060|FG002|Short-term Period|Death|0|||
160995863|NCT00124982|581371058|FG000|Short-term Period|Adverse Event|17|||
160995864|NCT00124982|581371059|FG001|Short-term Period|Adverse Event|22|||
160995865|NCT00124982|581371060|FG002|Short-term Period|Adverse Event|0|||
160995866|NCT00124982|581371058|FG000|Short-term Period|Lack of Efficacy|32|||
160995867|NCT00124982|581371059|FG001|Short-term Period|Lack of Efficacy|73|||
160995868|NCT00124982|581371060|FG002|Short-term Period|Lack of Efficacy|0|||
160995869|NCT00124982|581371058|FG000|Short-term Period|Lost to Follow-up|8|||
160995870|NCT00124982|581371059|FG001|Short-term Period|Lost to Follow-up|5|||
160995871|NCT00124982|581371060|FG002|Short-term Period|Lost to Follow-up|0|||
160995872|NCT00124982|581371058|FG000|Short-term Period|Withdrawal of Consent|7|||
160995873|NCT00124982|581371059|FG001|Short-term Period|Withdrawal of Consent|9|||
160995874|NCT00124982|581371060|FG002|Short-term Period|Withdrawal of Consent|0|||
160995875|NCT00124982|581371058|FG000|Short-term Period|Poor/Non-compliance|3|||
160995876|NCT00124982|581371059|FG001|Short-term Period|Poor/Non-compliance|1|||
160995877|NCT00124982|581371060|FG002|Short-term Period|Poor/Non-compliance|0|||
160995878|NCT00124982|581371058|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
160995879|NCT00124982|581371059|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
160995880|NCT00124982|581371060|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
160995881|NCT00124982|581371058|FG000|Short-term Period|Participant Decision|1|||
160995882|NCT00124982|581371059|FG001|Short-term Period|Participant Decision|0|||
160914607|NCT00006903|581079514|FG002|Overall Study|Ineligible|2|||
160914608|NCT00726661|581079515|FG000|Overall Study|Lost to Follow-up|36|||
160914609|NCT00726661|581079516|FG001|Overall Study|Lost to Follow-up|11|||
160914610|NCT00726661|581079515|FG000|Overall Study|Withdrawal by Subject|17|||
160914611|NCT00726661|581079516|FG001|Overall Study|Withdrawal by Subject|13|||
160914612|NCT00726661|581079515|FG000|Overall Study|Trial terminated by sponsor|214|||
160914613|NCT00726661|581079516|FG001|Overall Study|Trial terminated by sponsor|187|||
160914614|NCT00726661|581079515|FG000|Overall Study|Death|475|||
160914615|NCT00726661|581079516|FG001|Overall Study|Death|159|||
160914616|NCT00726661|581079515|FG000|Overall Study|Physician Decision|25|||
160914617|NCT00726661|581079516|FG001|Overall Study|Physician Decision|13|||
160914618|NCT00726661|581079515|FG000|Overall Study|Other|47|||
160914619|NCT00726661|581079516|FG001|Overall Study|Other|35|||
160914620|NCT02557646|581079519|FG000|Overall Study|Adverse Event|40|||
160914621|NCT02557646|581079519|FG000|Overall Study|Death|1|||
160914622|NCT02557646|581079519|FG000|Overall Study|Lack of Efficacy|186|||
160914623|NCT02557646|581079519|FG000|Overall Study|Withdrawal by Subject|18|||
160914624|NCT02557646|581079519|FG000|Overall Study|Lost to Follow-up|17|||
160914625|NCT02557646|581079519|FG000|Overall Study|Other|14|||
160914626|NCT00660309|581079522|FG000|Overall Study|Adverse Event|2|||
160914627|NCT00660309|581079523|FG001|Overall Study|Adverse Event|0|||
160914628|NCT00660309|581079522|FG000|Overall Study|Withdrawal by Subject|0|||
160914629|NCT00660309|581079523|FG001|Overall Study|Withdrawal by Subject|3|||
160914630|NCT02532972|581079527|FG000|Overall Study|Withdrawal by Subject|1|||
160914631|NCT00110149|581079528|FG000|Overall Study|Physician Decision|3|||
160914632|NCT00748033|581079531|FG000|Overall Study|Adverse Event|0|||
160995883|NCT00124982|581371060|FG002|Short-term Period|Participant Decision|0|||
160914633|NCT00748033|581079532|FG001|Overall Study|Adverse Event|1|||
160914634|NCT01018186|581079533|FG000|2-week Run-in Period|Protocol Violation|1|||
160914635|NCT01018186|581079534|FG001|2-week Run-in Period|Protocol Violation|0|||
160914636|NCT01018186|581079535|FG002|2-week Run-in Period|Protocol Violation|0|||
160914637|NCT01018186|581079536|FG003|2-week Run-in Period|Protocol Violation|0|||
160995884|NCT00124982|581371058|FG000|Short-term Period|Participant Chose Own Doctor|0|||
160995885|NCT00124982|581371059|FG001|Short-term Period|Participant Chose Own Doctor|1|||
160995886|NCT00124982|581371060|FG002|Short-term Period|Participant Chose Own Doctor|0|||
160995887|NCT00124982|581371058|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
160995888|NCT00124982|581371059|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
160914638|NCT01018186|581079533|FG000|2-week Run-in Period|Lost to Follow-up|2|||
160914639|NCT01018186|581079534|FG001|2-week Run-in Period|Lost to Follow-up|0|||
160914640|NCT01018186|581079535|FG002|2-week Run-in Period|Lost to Follow-up|0|||
160995889|NCT00124982|581371060|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
160995890|NCT00124982|581371058|FG000|Short-term Period|Participant Had Lymphopenia|1|||
160914641|NCT01018186|581079536|FG003|2-week Run-in Period|Lost to Follow-up|0|||
160914642|NCT01018186|581079533|FG000|2-week Run-in Period|Physician Decision|3|||
160914643|NCT01018186|581079534|FG001|2-week Run-in Period|Physician Decision|0|||
160914644|NCT01018186|581079535|FG002|2-week Run-in Period|Physician Decision|0|||
160914645|NCT01018186|581079536|FG003|2-week Run-in Period|Physician Decision|0|||
160995891|NCT00124982|581371059|FG001|Short-term Period|Participant Had Lymphopenia|0|||
160914646|NCT01018186|581079533|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
160914647|NCT01018186|581079534|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
160914648|NCT01018186|581079535|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
160914649|NCT01018186|581079536|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
160914650|NCT01018186|581079533|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
160914651|NCT01018186|581079534|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
160914652|NCT01018186|581079535|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
160914653|NCT01018186|581079536|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
160914654|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
160914655|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
160914656|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
160914657|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
160914658|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
160914659|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
160914660|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
160914661|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
160914662|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
160914663|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
160914664|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
160914665|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
160914666|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
160914667|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
160914668|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
160914669|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
160914670|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
160914671|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
160914672|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
160914673|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
160914674|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
160914675|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
160914676|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
160914677|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
160914678|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160914679|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
160914680|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
160914681|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
160914682|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
160914683|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
160914684|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
160914685|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
160914686|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
160914687|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
160914688|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
160914689|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
160914690|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
160914691|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
160914692|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
160914693|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
160914694|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
160914695|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
160914696|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
160914697|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
160914698|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
160914699|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
160914700|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
160914701|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
160914702|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
160914703|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
160914704|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
160914705|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
160914706|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
160914707|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
160570581|NCT00550238|579812182|FG000|Overall Study|Sponsor decision|55|||
160570582|NCT01486238|579812188|FG000|Overall Study|Death|0|||
160914708|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
160914709|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
160914710|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
160914711|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
160914712|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
160914713|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
160914714|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
160914715|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
160914716|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
160914717|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
160914718|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
160914719|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
160914720|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
160914721|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
160914722|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
160914723|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
160914724|NCT02603419|581079537|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
160914725|NCT02603419|581079538|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
160914726|NCT02603419|581079539|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
160914727|NCT02603419|581079540|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
160914728|NCT02603419|581079541|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
160914729|NCT02603419|581079542|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
160914730|NCT02603419|581079537|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
160914731|NCT02603419|581079538|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
160914732|NCT02603419|581079539|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
160914733|NCT02603419|581079540|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
160914734|NCT02603419|581079541|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
160914735|NCT02603419|581079542|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
160914736|NCT02603419|581079537|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
160914737|NCT02603419|581079538|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
160914738|NCT02603419|581079539|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
160914739|NCT02603419|581079540|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
160914740|NCT02603419|581079541|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
160914741|NCT02603419|581079542|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
160914742|NCT03552198|581079543|FG000|Overall Study|Lost to Follow-up|42|||
160914743|NCT03552198|581079544|FG001|Overall Study|Lost to Follow-up|48|||
160914744|NCT03552198|581079545|FG002|Overall Study|Lost to Follow-up|15|||
160914745|NCT03552198|581079546|FG003|Overall Study|Lost to Follow-up|19|||
160914746|NCT03552198|581079543|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
160914747|NCT03552198|581079544|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
160914748|NCT03552198|581079545|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
160914749|NCT03552198|581079546|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
160914750|NCT03552198|581079543|FG000|Overall Study|Did not receive air alerts|1|||
160914751|NCT03552198|581079544|FG001|Overall Study|Did not receive air alerts|0|||
160914752|NCT03552198|581079545|FG002|Overall Study|Did not receive air alerts|0|||
160914753|NCT03552198|581079546|FG003|Overall Study|Did not receive air alerts|1|||
160914754|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
160914755|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
160914756|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
160914757|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
160914758|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
160914759|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
160914760|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
160914761|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
160914762|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Other|1|||
160914763|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Other|4|||
160914764|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Other|3|||
160914765|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Other|6|||
160914766|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
160914767|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
160914768|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
160914769|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
160914770|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
160914771|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
160914772|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
160914773|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
160914774|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
160914775|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
160914776|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
160914777|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
160914778|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
160914779|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
160914780|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
160914781|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
160914782|NCT01666782|581079556|FG000|Overall Study|Received 2 doses of vaccine|0|||
160914783|NCT01666782|581079557|FG001|Overall Study|Received 2 doses of vaccine|1|||
160914784|NCT01666782|581079556|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
160914785|NCT01666782|581079557|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
160914786|NCT02007109|581079560|FG000|Overall Study|Diary not returned or excluded|102|||
160914787|NCT02007109|581079560|FG000|Overall Study|Excluded - Age<7yo|9|||
160914788|NCT03572062|581079561|FG000|Overall Study|Adverse Event|0|||
160914789|NCT03572062|581079562|FG001|Overall Study|Adverse Event|0|||
160914790|NCT03572062|581079563|FG002|Overall Study|Adverse Event|0|||
160914791|NCT03572062|581079564|FG003|Overall Study|Adverse Event|0|||
160914792|NCT03572062|581079565|FG004|Overall Study|Adverse Event|0|||
160914793|NCT03572062|581079566|FG005|Overall Study|Adverse Event|0|||
160914794|NCT03572062|581079567|FG006|Overall Study|Adverse Event|0|||
160914795|NCT03572062|581079568|FG007|Overall Study|Adverse Event|0|||
160914796|NCT03572062|581079569|FG008|Overall Study|Adverse Event|1|||
160914797|NCT03572062|581079570|FG009|Overall Study|Adverse Event|3|||
160914798|NCT03572062|581079561|FG000|Overall Study|Death|0|||
160914799|NCT03572062|581079562|FG001|Overall Study|Death|0|||
160914800|NCT03572062|581079563|FG002|Overall Study|Death|0|||
160914801|NCT03572062|581079564|FG003|Overall Study|Death|0|||
160914802|NCT03572062|581079565|FG004|Overall Study|Death|0|||
160914803|NCT03572062|581079566|FG005|Overall Study|Death|1|||
160914804|NCT03572062|581079567|FG006|Overall Study|Death|0|||
160914805|NCT03572062|581079568|FG007|Overall Study|Death|0|||
160914806|NCT03572062|581079569|FG008|Overall Study|Death|0|||
160914807|NCT03572062|581079570|FG009|Overall Study|Death|0|||
160914808|NCT03572062|581079561|FG000|Overall Study|Lost to Follow-up|0|||
160914809|NCT03572062|581079562|FG001|Overall Study|Lost to Follow-up|0|||
160914810|NCT03572062|581079563|FG002|Overall Study|Lost to Follow-up|0|||
160914811|NCT03572062|581079564|FG003|Overall Study|Lost to Follow-up|0|||
160914812|NCT03572062|581079565|FG004|Overall Study|Lost to Follow-up|0|||
160914813|NCT03572062|581079566|FG005|Overall Study|Lost to Follow-up|1|||
160914814|NCT03572062|581079567|FG006|Overall Study|Lost to Follow-up|1|||
160914815|NCT03572062|581079568|FG007|Overall Study|Lost to Follow-up|0|||
160914816|NCT03572062|581079569|FG008|Overall Study|Lost to Follow-up|0|||
160914817|NCT03572062|581079570|FG009|Overall Study|Lost to Follow-up|0|||
160914818|NCT03572062|581079561|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914819|NCT03572062|581079562|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914820|NCT03572062|581079563|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914821|NCT03572062|581079564|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914822|NCT03572062|581079565|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914823|NCT03572062|581079566|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914824|NCT03572062|581079567|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914825|NCT03572062|581079568|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914826|NCT03572062|581079569|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
160914827|NCT03572062|581079570|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914828|NCT03572062|581079561|FG000|Overall Study|Study Terminated By Sponsor|0|||
160914829|NCT03572062|581079562|FG001|Overall Study|Study Terminated By Sponsor|0|||
160914830|NCT03572062|581079563|FG002|Overall Study|Study Terminated By Sponsor|0|||
160914831|NCT03572062|581079564|FG003|Overall Study|Study Terminated By Sponsor|0|||
160914832|NCT03572062|581079565|FG004|Overall Study|Study Terminated By Sponsor|0|||
160914833|NCT03572062|581079566|FG005|Overall Study|Study Terminated By Sponsor|0|||
160914834|NCT03572062|581079567|FG006|Overall Study|Study Terminated By Sponsor|0|||
160914835|NCT03572062|581079568|FG007|Overall Study|Study Terminated By Sponsor|0|||
160914836|NCT03572062|581079569|FG008|Overall Study|Study Terminated By Sponsor|29|||
160914837|NCT03572062|581079570|FG009|Overall Study|Study Terminated By Sponsor|27|||
160914838|NCT03572062|581079561|FG000|Overall Study|Physician Decision|0|||
160914839|NCT03572062|581079562|FG001|Overall Study|Physician Decision|0|||
160914840|NCT03572062|581079563|FG002|Overall Study|Physician Decision|0|||
160914841|NCT03572062|581079564|FG003|Overall Study|Physician Decision|0|||
160914842|NCT03572062|581079565|FG004|Overall Study|Physician Decision|0|||
160914843|NCT03572062|581079566|FG005|Overall Study|Physician Decision|0|||
160914844|NCT03572062|581079567|FG006|Overall Study|Physician Decision|0|||
160914845|NCT03572062|581079568|FG007|Overall Study|Physician Decision|0|||
160914846|NCT03572062|581079569|FG008|Overall Study|Physician Decision|1|||
160914847|NCT03572062|581079570|FG009|Overall Study|Physician Decision|0|||
160914848|NCT03572062|581079561|FG000|Overall Study|Withdrawal by Subject|0|||
160914849|NCT03572062|581079562|FG001|Overall Study|Withdrawal by Subject|0|||
160914850|NCT03572062|581079563|FG002|Overall Study|Withdrawal by Subject|0|||
160914851|NCT03572062|581079564|FG003|Overall Study|Withdrawal by Subject|0|||
160914852|NCT03572062|581079565|FG004|Overall Study|Withdrawal by Subject|0|||
160914853|NCT03572062|581079566|FG005|Overall Study|Withdrawal by Subject|0|||
160914854|NCT03572062|581079567|FG006|Overall Study|Withdrawal by Subject|0|||
160914855|NCT03572062|581079568|FG007|Overall Study|Withdrawal by Subject|0|||
160914856|NCT03572062|581079569|FG008|Overall Study|Withdrawal by Subject|0|||
160914857|NCT03572062|581079570|FG009|Overall Study|Withdrawal by Subject|1|||
160914858|NCT03572062|581079561|FG000|Overall Study|Randomized But Not Treated|0|||
160914859|NCT03572062|581079562|FG001|Overall Study|Randomized But Not Treated|0|||
160914860|NCT03572062|581079563|FG002|Overall Study|Randomized But Not Treated|0|||
160914861|NCT03572062|581079564|FG003|Overall Study|Randomized But Not Treated|0|||
160914862|NCT03572062|581079565|FG004|Overall Study|Randomized But Not Treated|1|||
160914863|NCT03572062|581079566|FG005|Overall Study|Randomized But Not Treated|2|||
160914864|NCT03572062|581079567|FG006|Overall Study|Randomized But Not Treated|0|||
160914865|NCT03572062|581079568|FG007|Overall Study|Randomized But Not Treated|1|||
160914866|NCT03572062|581079569|FG008|Overall Study|Randomized But Not Treated|0|||
160914867|NCT03572062|581079570|FG009|Overall Study|Randomized But Not Treated|0|||
160914868|NCT01858389|581079571|FG000|Overall Study|Death|1|||
160914869|NCT01858389|581079572|FG001|Overall Study|Death|3|||
160914870|NCT01858389|581079571|FG000|Overall Study|Study terminated by sponsor|0|||
160914871|NCT01858389|581079572|FG001|Overall Study|Study terminated by sponsor|2|||
160914872|NCT01858389|581079571|FG000|Overall Study|Withdrawal by Subject|0|||
160914873|NCT01858389|581079572|FG001|Overall Study|Withdrawal by Subject|1|||
160914874|NCT01858389|581079571|FG000|Overall Study|Progressive disease|10|||
160914875|NCT01858389|581079572|FG001|Overall Study|Progressive disease|11|||
160914876|NCT01858389|581079571|FG000|Overall Study|Other|2|||
160914877|NCT01858389|581079572|FG001|Overall Study|Other|4|||
160914878|NCT01858389|581079571|FG000|Overall Study|Adverse Event|3|||
160914879|NCT01858389|581079572|FG001|Overall Study|Adverse Event|1|||
160914880|NCT01858389|581079571|FG000|Overall Study|Did not receive treatment|0|||
160914881|NCT01858389|581079572|FG001|Overall Study|Did not receive treatment|3|||
160914882|NCT01691781|581079573|FG000|Overall Study|Withdrawal by Subject|4|||
160914883|NCT01691781|581079574|FG001|Overall Study|Withdrawal by Subject|3|||
160914884|NCT01691781|581079573|FG000|Overall Study|Physician Decision|1|||
160914885|NCT01691781|581079574|FG001|Overall Study|Physician Decision|1|||
160914886|NCT01691781|581079573|FG000|Overall Study|Protocol Violation|2|||
160914887|NCT01691781|581079574|FG001|Overall Study|Protocol Violation|2|||
160914888|NCT01691781|581079573|FG000|Overall Study|Adverse Event|0|||
160914889|NCT01691781|581079574|FG001|Overall Study|Adverse Event|1|||
160914890|NCT03978520|581079575|FG000|Overall Study|Adverse Event|2|||
160914891|NCT03978520|581079576|FG001|Overall Study|Adverse Event|5|||
160914892|NCT03978520|581079577|FG002|Overall Study|Adverse Event|3|||
160914893|NCT03978520|581079578|FG003|Overall Study|Adverse Event|5|||
160914894|NCT03978520|581079579|FG004|Overall Study|Adverse Event|6|||
160914895|NCT03978520|581079575|FG000|Overall Study|Withdrawal by Subject|10|||
160914896|NCT03978520|581079576|FG001|Overall Study|Withdrawal by Subject|4|||
160995892|NCT00124982|581371060|FG002|Short-term Period|Participant Had Lymphopenia|0|||
160995893|NCT00124982|581371058|FG000|Long-term Period|Death|0|||
160995894|NCT00124982|581371059|FG001|Long-term Period|Death|0|||
160995895|NCT00124982|581371060|FG002|Long-term Period|Death|1|||
160995896|NCT00124982|581371058|FG000|Long-term Period|Adverse Event|0|||
160995897|NCT00124982|581371059|FG001|Long-term Period|Adverse Event|0|||
160995898|NCT00124982|581371060|FG002|Long-term Period|Adverse Event|17|||
160995899|NCT00124982|581371058|FG000|Long-term Period|Lack of Efficacy|0|||
160995900|NCT00124982|581371059|FG001|Long-term Period|Lack of Efficacy|0|||
160995901|NCT00124982|581371060|FG002|Long-term Period|Lack of Efficacy|46|||
160995902|NCT00124982|581371058|FG000|Long-term Period|Lost to Follow-up|0|||
160995903|NCT00124982|581371059|FG001|Long-term Period|Lost to Follow-up|0|||
160995904|NCT00124982|581371060|FG002|Long-term Period|Lost to Follow-up|4|||
160995905|NCT00124982|581371058|FG000|Long-term Period|Withdrawal by Subject|0|||
160995906|NCT00124982|581371059|FG001|Long-term Period|Withdrawal by Subject|0|||
160995907|NCT00124982|581371060|FG002|Long-term Period|Withdrawal by Subject|16|||
160995908|NCT00124982|581371058|FG000|Long-term Period|Pregnancy|0|||
160995909|NCT00124982|581371059|FG001|Long-term Period|Pregnancy|0|||
160995910|NCT00124982|581371060|FG002|Long-term Period|Pregnancy|1|||
160914897|NCT03978520|581079577|FG002|Overall Study|Withdrawal by Subject|5|||
160914898|NCT03978520|581079578|FG003|Overall Study|Withdrawal by Subject|6|||
160914899|NCT03978520|581079579|FG004|Overall Study|Withdrawal by Subject|5|||
160914900|NCT03978520|581079575|FG000|Overall Study|Lost to Follow-up|2|||
160914901|NCT03978520|581079576|FG001|Overall Study|Lost to Follow-up|2|||
160914902|NCT03978520|581079577|FG002|Overall Study|Lost to Follow-up|2|||
160914903|NCT03978520|581079578|FG003|Overall Study|Lost to Follow-up|0|||
160914904|NCT03978520|581079579|FG004|Overall Study|Lost to Follow-up|1|||
160995911|NCT00124982|581371058|FG000|Long-term Period|Poor/Non-compliance|0|||
160995912|NCT00124982|581371059|FG001|Long-term Period|Poor/Non-compliance|0|||
160995913|NCT00124982|581371060|FG002|Long-term Period|Poor/Non-compliance|2|||
160914905|NCT03978520|581079575|FG000|Overall Study|COVID-19 infection|0|||
160914906|NCT03978520|581079576|FG001|Overall Study|COVID-19 infection|1|||
160914907|NCT03978520|581079577|FG002|Overall Study|COVID-19 infection|0|||
160914908|NCT03978520|581079578|FG003|Overall Study|COVID-19 infection|0|||
160914909|NCT03978520|581079579|FG004|Overall Study|COVID-19 infection|0|||
160914910|NCT03978520|581079575|FG000|Overall Study|Other, not specified|9|||
160914911|NCT03978520|581079576|FG001|Overall Study|Other, not specified|4|||
160914912|NCT03978520|581079577|FG002|Overall Study|Other, not specified|1|||
160914913|NCT03978520|581079578|FG003|Overall Study|Other, not specified|1|||
160914914|NCT03978520|581079579|FG004|Overall Study|Other, not specified|2|||
160914915|NCT03978520|581079575|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
160914916|NCT03978520|581079576|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
160914917|NCT03978520|581079577|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
160914918|NCT03978520|581079578|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
160914919|NCT03978520|581079579|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
160914920|NCT02837783|581079580|FG000|Overall Study|Adverse Event|1|||
160914921|NCT02837783|581079581|FG001|Overall Study|Adverse Event|0|||
160914922|NCT02837783|581079580|FG000|Overall Study|Other, Not Specified|1|||
160914923|NCT02837783|581079581|FG001|Overall Study|Other, Not Specified|2|||
160914924|NCT03200860|581079582|FG000|Overall Study|Withdrawal by Subject|1|||
160914925|NCT03200860|581079583|FG001|Overall Study|Withdrawal by Subject|0|||
160914926|NCT02634320|581079592|FG000|Overall Study|Adverse Event|2|||
160914927|NCT02634320|581079592|FG000|Overall Study|Lost to Follow-up|3|||
160914928|NCT02634320|581079592|FG000|Overall Study|Moved out of area|2|||
160914929|NCT02634320|581079592|FG000|Overall Study|Out of window for study visits|1|||
160914930|NCT02634320|581079592|FG000|Overall Study|Protocol Violation|1|||
160914931|NCT02634320|581079592|FG000|Overall Study|Withdrawal by Subject|5|||
160914932|NCT02634320|581079592|FG000|Overall Study|Lack of Efficacy|2|||
160914933|NCT02760069|581079593|FG000|Overall Study|Withdrawal by Subject|0|||
160914934|NCT02760069|581079594|FG001|Overall Study|Withdrawal by Subject|1|||
160914935|NCT02760069|581079595|FG002|Overall Study|Withdrawal by Subject|1|||
160914936|NCT00600483|581079606|FG000|Overall Study|Lost to Follow-up|26|||
160914937|NCT00600483|581079607|FG001|Overall Study|Lost to Follow-up|47|||
160914938|NCT00600483|581079606|FG000|Overall Study|Randomized but not treated|10|||
160914939|NCT00600483|581079607|FG001|Overall Study|Randomized but not treated|0|||
160914940|NCT03031678|581079613|FG000|Overall Study|Study closed prior to completion|1|||
160914941|NCT03694821|581079614|FG000|Overall Study|Study terminated|4|||
160914942|NCT03694821|581079615|FG001|Overall Study|Study terminated|8|||
160914943|NCT03694821|581079616|FG002|Overall Study|Study terminated|4|||
160914944|NCT05109442|581079621|FG000|Overall Study|Withdrawal by Subject|0|||
160914945|NCT05109442|581079622|FG001|Overall Study|Withdrawal by Subject|0|||
160914946|NCT05109442|581079623|FG002|Overall Study|Withdrawal by Subject|1|||
160914947|NCT05109442|581079624|FG003|Overall Study|Withdrawal by Subject|0|||
160914948|NCT05109442|581079625|FG004|Overall Study|Withdrawal by Subject|0|||
160914949|NCT05109442|581079626|FG005|Overall Study|Withdrawal by Subject|0|||
160914950|NCT05109442|581079621|FG000|Overall Study|Adverse Event|0|||
160914951|NCT05109442|581079622|FG001|Overall Study|Adverse Event|1|||
160914952|NCT05109442|581079623|FG002|Overall Study|Adverse Event|5|||
160914953|NCT05109442|581079624|FG003|Overall Study|Adverse Event|0|||
160914954|NCT05109442|581079625|FG004|Overall Study|Adverse Event|0|||
160914955|NCT05109442|581079626|FG005|Overall Study|Adverse Event|2|||
160914956|NCT05109442|581079621|FG000|Overall Study|Death|0|||
160914957|NCT05109442|581079622|FG001|Overall Study|Death|0|||
160914958|NCT05109442|581079623|FG002|Overall Study|Death|4|||
160914959|NCT05109442|581079624|FG003|Overall Study|Death|0|||
160914960|NCT05109442|581079625|FG004|Overall Study|Death|0|||
160914961|NCT05109442|581079626|FG005|Overall Study|Death|1|||
160914962|NCT05109442|581079621|FG000|Overall Study|Physician Decision|1|||
160914963|NCT05109442|581079622|FG001|Overall Study|Physician Decision|0|||
160914964|NCT05109442|581079623|FG002|Overall Study|Physician Decision|1|||
160914965|NCT05109442|581079624|FG003|Overall Study|Physician Decision|0|||
160914966|NCT05109442|581079625|FG004|Overall Study|Physician Decision|0|||
160914967|NCT05109442|581079626|FG005|Overall Study|Physician Decision|2|||
160914968|NCT05109442|581079621|FG000|Overall Study|Other than listed|0|||
160995914|NCT00124982|581371058|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
160995915|NCT00124982|581371059|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
160995916|NCT00124982|581371060|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
160995917|NCT00124982|581371058|FG000|Long-term Period|Neurologist Recommendation|0|||
160914969|NCT05109442|581079622|FG001|Overall Study|Other than listed|0|||
160914970|NCT05109442|581079623|FG002|Overall Study|Other than listed|9|||
160914971|NCT05109442|581079624|FG003|Overall Study|Other than listed|2|||
160914972|NCT05109442|581079625|FG004|Overall Study|Other than listed|0|||
160914973|NCT05109442|581079626|FG005|Overall Study|Other than listed|8|||
160914974|NCT05109442|581079621|FG000|Overall Study|Lack of Efficacy|3|||
160914975|NCT05109442|581079622|FG001|Overall Study|Lack of Efficacy|5|||
160914976|NCT05109442|581079623|FG002|Overall Study|Lack of Efficacy|29|||
160914977|NCT05109442|581079624|FG003|Overall Study|Lack of Efficacy|10|||
160914978|NCT05109442|581079625|FG004|Overall Study|Lack of Efficacy|11|||
160914979|NCT05109442|581079626|FG005|Overall Study|Lack of Efficacy|17|||
160914980|NCT03278613|581079636|FG000|Overall Study|Lost to Follow-up|3|||
160914981|NCT03278613|581079637|FG001|Overall Study|Lost to Follow-up|1|||
160914982|NCT01405456|581079638|FG000|Overall Study|Lost to Follow-up|2|||
160914983|NCT01405456|581079639|FG001|Overall Study|Lost to Follow-up|1|||
160914984|NCT01405456|581079638|FG000|Overall Study|Physician Decision|1|||
160914985|NCT01405456|581079639|FG001|Overall Study|Physician Decision|0|||
160914986|NCT05475236|581079641|FG000|Overall Study|Withdrawal by Subject|0|||
160914987|NCT05475236|581079642|FG001|Overall Study|Withdrawal by Subject|1|||
160914988|NCT01438424|581081724|FG000|Overall Study|Continuing treatment|29|||
160914989|NCT01438424|581081724|FG000|Overall Study|Minimal virologic response|95|||
160914990|NCT01438424|581081724|FG000|Overall Study|Not identified|55|||
160914991|NCT01438424|581081724|FG000|Overall Study|Withdrawal by Subject|104|||
160914992|NCT01438424|581081724|FG000|Overall Study|Progression of chronic hepatitis B|22|||
160914993|NCT01438424|581081724|FG000|Overall Study|Death|22|||
160914994|NCT01438424|581081724|FG000|Overall Study|Adverse Event|17|||
160914995|NCT01438424|581081724|FG000|Overall Study|Lost to Follow-up|17|||
160914996|NCT01438424|581081724|FG000|Overall Study|Abnormal laboratory test result|14|||
160914997|NCT01438424|581081724|FG000|Overall Study|Need for drug prohibited by protocol|14|||
160914998|NCT01438424|581081724|FG000|Overall Study|Pregnancy|7|||
160914999|NCT01438424|581081724|FG000|Overall Study|No longer met inclusion criteria|1|||
160915000|NCT01438424|581081724|FG000|Overall Study|Participant noncompliance|20|||
160915001|NCT02154490|581081725|FG000|Overall Study|No tissue submitted|23|||
160915002|NCT02154490|581081725|FG000|Overall Study|No biomarker results|167|||
160915003|NCT02154490|581081725|FG000|Overall Study|Not assigned to a sub-study|270|||
160915004|NCT02154490|581081725|FG000|Overall Study|Did not register to a sub-study|749|||
160915005|NCT02927080|581081726|FG000|Overall Study|Withdrawal by Subject|0|||
160915006|NCT02927080|581081727|FG001|Overall Study|Withdrawal by Subject|0|||
160915007|NCT02927080|581081728|FG002|Overall Study|Withdrawal by Subject|0|||
160915008|NCT02927080|581081729|FG003|Overall Study|Withdrawal by Subject|0|||
160915009|NCT02927080|581081730|FG004|Overall Study|Withdrawal by Subject|1|||
160915010|NCT02927080|581081731|FG005|Overall Study|Withdrawal by Subject|0|||
160915011|NCT02927080|581081732|FG006|Overall Study|Withdrawal by Subject|1|||
160915012|NCT02927080|581081733|FG007|Overall Study|Withdrawal by Subject|1|||
160915013|NCT02927080|581081734|FG008|Overall Study|Withdrawal by Subject|0|||
160915014|NCT02927080|581081735|FG009|Overall Study|Withdrawal by Subject|2|||
160915015|NCT02927080|581081726|FG000|Overall Study|Willingness to comply with protocol|0|||
160915016|NCT02927080|581081727|FG001|Overall Study|Willingness to comply with protocol|0|||
160915017|NCT02927080|581081728|FG002|Overall Study|Willingness to comply with protocol|0|||
160915018|NCT02927080|581081729|FG003|Overall Study|Willingness to comply with protocol|0|||
160915019|NCT02927080|581081730|FG004|Overall Study|Willingness to comply with protocol|0|||
160915020|NCT02927080|581081731|FG005|Overall Study|Willingness to comply with protocol|0|||
160915021|NCT02927080|581081732|FG006|Overall Study|Willingness to comply with protocol|0|||
160915022|NCT02927080|581081733|FG007|Overall Study|Willingness to comply with protocol|0|||
160915023|NCT02927080|581081734|FG008|Overall Study|Willingness to comply with protocol|0|||
160915024|NCT02927080|581081735|FG009|Overall Study|Willingness to comply with protocol|1|||
160915025|NCT02927080|581081726|FG000|Overall Study|Study terminated by Sponsor|0|||
160915026|NCT02927080|581081727|FG001|Overall Study|Study terminated by Sponsor|0|||
160915027|NCT02927080|581081728|FG002|Overall Study|Study terminated by Sponsor|0|||
160915028|NCT02927080|581081729|FG003|Overall Study|Study terminated by Sponsor|0|||
160915029|NCT02927080|581081730|FG004|Overall Study|Study terminated by Sponsor|0|||
160915030|NCT02927080|581081731|FG005|Overall Study|Study terminated by Sponsor|0|||
160915031|NCT02927080|581081732|FG006|Overall Study|Study terminated by Sponsor|6|||
160652753|NCT01402908|580110352|FG001|Overall Study|Lost to Follow-up|1|||
160915032|NCT02927080|581081733|FG007|Overall Study|Study terminated by Sponsor|7|||
160915033|NCT02927080|581081734|FG008|Overall Study|Study terminated by Sponsor|2|||
160915034|NCT02927080|581081735|FG009|Overall Study|Study terminated by Sponsor|3|||
160915035|NCT02927080|581081726|FG000|Overall Study|Adverse Event|0|||
160915036|NCT02927080|581081727|FG001|Overall Study|Adverse Event|1|||
160915037|NCT02927080|581081728|FG002|Overall Study|Adverse Event|0|||
160915038|NCT02927080|581081729|FG003|Overall Study|Adverse Event|0|||
160652754|NCT01402908|580110351|FG000|Overall Study|Physician Decision|1|||
160652755|NCT01402908|580110352|FG001|Overall Study|Physician Decision|0|||
160652756|NCT01739790|580110353|FG000|Overall Study|Early Trial Termination|2|||
160652757|NCT01739790|580110354|FG001|Overall Study|Early Trial Termination|4|||
160652758|NCT03471078|580110359|FG000|Overall Study|Withdrawal by Subject|9|||
160652759|NCT03471078|580110360|FG001|Overall Study|Withdrawal by Subject|1|||
160652760|NCT03471078|580110359|FG000|Overall Study|Adverse Event|4|||
160652761|NCT03471078|580110360|FG001|Overall Study|Adverse Event|1|||
160915039|NCT02927080|581081730|FG004|Overall Study|Adverse Event|0|||
160915040|NCT02927080|581081731|FG005|Overall Study|Adverse Event|0|||
160915041|NCT02927080|581081732|FG006|Overall Study|Adverse Event|0|||
160915042|NCT02927080|581081733|FG007|Overall Study|Adverse Event|1|||
160915043|NCT02927080|581081734|FG008|Overall Study|Adverse Event|0|||
160915044|NCT02927080|581081735|FG009|Overall Study|Adverse Event|1|||
160915045|NCT02927080|581081726|FG000|Overall Study|Other|0|||
160915046|NCT02927080|581081727|FG001|Overall Study|Other|0|||
160652762|NCT03471078|580110359|FG000|Overall Study|Physician Decision|3|||
160915047|NCT02927080|581081728|FG002|Overall Study|Other|0|||
160915048|NCT02927080|581081729|FG003|Overall Study|Other|0|||
160915049|NCT02927080|581081730|FG004|Overall Study|Other|0|||
160915050|NCT02927080|581081731|FG005|Overall Study|Other|0|||
160915051|NCT02927080|581081732|FG006|Overall Study|Other|1|||
160915052|NCT02927080|581081733|FG007|Overall Study|Other|0|||
160915053|NCT02927080|581081734|FG008|Overall Study|Other|1|||
160915054|NCT02927080|581081735|FG009|Overall Study|Other|0|||
160915055|NCT01411228|581081737|FG000|Overall Study|Lost to Follow-up|0|||
160915056|NCT01411228|581081738|FG001|Overall Study|Lost to Follow-up|0|||
160915057|NCT01411228|581081739|FG002|Overall Study|Lost to Follow-up|1|||
160915058|NCT01411228|581081737|FG000|Overall Study|Withdrawal by Subject|1|||
160915059|NCT01411228|581081738|FG001|Overall Study|Withdrawal by Subject|0|||
160915060|NCT01411228|581081739|FG002|Overall Study|Withdrawal by Subject|0|||
160915061|NCT00664742|581081740|FG000|Overall Study|Withdrawn due to adverse events|3|||
160915062|NCT00664742|581081740|FG000|Overall Study|Withdrawal by Subject|31|||
160915063|NCT00664742|581081740|FG000|Overall Study|Lost to Follow-up|92|||
160915064|NCT02670083|581081741|FG000|Overall Study|Adverse Event|16|||
160915065|NCT02670083|581081742|FG001|Overall Study|Adverse Event|13|||
160915066|NCT02670083|581081741|FG000|Overall Study|Death|4|||
160915067|NCT02670083|581081742|FG001|Overall Study|Death|6|||
160915068|NCT02670083|581081741|FG000|Overall Study|Lost to Follow-up|2|||
160915069|NCT02670083|581081742|FG001|Overall Study|Lost to Follow-up|2|||
160915070|NCT02670083|581081741|FG000|Overall Study|Multiple Reasons|9|||
160915071|NCT02670083|581081742|FG001|Overall Study|Multiple Reasons|9|||
160915072|NCT02670083|581081741|FG000|Overall Study|Physician Decision|0|||
160915073|NCT02670083|581081742|FG001|Overall Study|Physician Decision|2|||
160915074|NCT02670083|581081741|FG000|Overall Study|Study Terminated By Sponsor|257|||
160915075|NCT02670083|581081742|FG001|Overall Study|Study Terminated By Sponsor|254|||
160915076|NCT02670083|581081741|FG000|Overall Study|Symptomatic Deterioration|0|||
160915077|NCT02670083|581081742|FG001|Overall Study|Symptomatic Deterioration|2|||
160915078|NCT02670083|581081741|FG000|Overall Study|Withdrawal by Subject|32|||
160915079|NCT02670083|581081742|FG001|Overall Study|Withdrawal by Subject|31|||
160915080|NCT02670083|581081741|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160915081|NCT02670083|581081742|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160915082|NCT02825992|581081743|FG000|Overall Study|Withdrawal by Subject|4|||
160915083|NCT02825992|581081743|FG000|Overall Study|Lost to Follow-up|2|||
160915084|NCT02825992|581081743|FG000|Overall Study|Procedure terminated|2|||
160915085|NCT00418314|581081745|FG000|Overall Study|Withdrawal by Subject|1|||
160915086|NCT00418314|581081746|FG001|Overall Study|Withdrawal by Subject|2|||
160915087|NCT02692716|581081747|FG000|Overall Study|Lost to Follow-up|2|||
160915088|NCT02692716|581081748|FG001|Overall Study|Lost to Follow-up|5|||
160915089|NCT02692716|581081747|FG000|Overall Study|Withdrawal by Subject|3|||
160915090|NCT02692716|581081748|FG001|Overall Study|Withdrawal by Subject|1|||
160915091|NCT02904512|581081753|FG000|Overall Study|Withdrawal by Subject|1|||
160915092|NCT02904512|581081754|FG001|Overall Study|Withdrawal by Subject|0|||
160915093|NCT02904512|581081753|FG000|Overall Study|Transferred to ICU|1|||
160915094|NCT02904512|581081754|FG001|Overall Study|Transferred to ICU|0|||
160915095|NCT02904512|581081753|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
160915096|NCT02904512|581081754|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
160915097|NCT00589914|581081763|FG000|Overall Study|Adverse Event|19|||
160915098|NCT00589914|581081764|FG001|Overall Study|Adverse Event|10|||
160915099|NCT00589914|581081763|FG000|Overall Study|Death|2|||
160915100|NCT00589914|581081764|FG001|Overall Study|Death|0|||
160915101|NCT00589914|581081763|FG000|Overall Study|Lack of Efficacy|40|||
160915102|NCT00589914|581081764|FG001|Overall Study|Lack of Efficacy|43|||
160915103|NCT00589914|581081763|FG000|Overall Study|Lost to Follow-up|11|||
160915104|NCT00589914|581081764|FG001|Overall Study|Lost to Follow-up|18|||
160915105|NCT00589914|581081763|FG000|Overall Study|Pregnancy|1|||
160915106|NCT00589914|581081764|FG001|Overall Study|Pregnancy|0|||
160915107|NCT00589914|581081763|FG000|Overall Study|Withdrawal by Subject|55|||
160915108|NCT00589914|581081764|FG001|Overall Study|Withdrawal by Subject|49|||
160915109|NCT00589914|581081763|FG000|Overall Study|Other|22|||
160915110|NCT00589914|581081764|FG001|Overall Study|Other|17|||
160915111|NCT03585504|581081765|FG000|Overall Study|Lost to Follow-up|26|||
160915112|NCT03585504|581081766|FG001|Overall Study|Lost to Follow-up|29|||
160915113|NCT02564042|581081767|FG000|Overall Study|Adverse Event|4|||
160915114|NCT02564042|581081768|FG001|Overall Study|Adverse Event|4|||
160915115|NCT02564042|581081769|FG002|Overall Study|Adverse Event|3|||
160915116|NCT02564042|581081770|FG003|Overall Study|Adverse Event|0|||
160915117|NCT02564042|581081771|FG004|Overall Study|Adverse Event|0|||
160915118|NCT02564042|581081772|FG005|Overall Study|Adverse Event|1|||
160915119|NCT02564042|581081767|FG000|Overall Study|Lost to Follow-up|1|||
160915120|NCT02564042|581081768|FG001|Overall Study|Lost to Follow-up|1|||
160915121|NCT02564042|581081769|FG002|Overall Study|Lost to Follow-up|1|||
160915122|NCT02564042|581081770|FG003|Overall Study|Lost to Follow-up|0|||
160915123|NCT02564042|581081771|FG004|Overall Study|Lost to Follow-up|1|||
160915124|NCT02564042|581081772|FG005|Overall Study|Lost to Follow-up|1|||
160915125|NCT02564042|581081767|FG000|Overall Study|Physician Decision|1|||
160915126|NCT02564042|581081768|FG001|Overall Study|Physician Decision|0|||
160453473|NCT03235544|579392100|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
160453474|NCT03235544|579392101|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
160453475|NCT03235544|579392102|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
160453476|NCT00950742|579392103|FG000|Overall Study|Other Adverse Event|1|||
160453477|NCT00950742|579392104|FG001|Overall Study|Other Adverse Event|0|||
160453478|NCT00950742|579392103|FG000|Overall Study|Withdrawal by Subject|3|||
160453479|NCT00950742|579392104|FG001|Overall Study|Withdrawal by Subject|0|||
160453480|NCT00950742|579392103|FG000|Overall Study|Progressive Disease|6|||
160453481|NCT00950742|579392104|FG001|Overall Study|Progressive Disease|2|||
160453482|NCT00950742|579392103|FG000|Overall Study|Dose limiting toxicity|6|||
160453483|NCT00950742|579392104|FG001|Overall Study|Dose limiting toxicity|0|||
160453484|NCT05436262|579392106|FG000|Pre-Randomization|Withdrawal by Subject|1|||
160453485|NCT05436262|579392107|FG001|Pre-Randomization|Withdrawal by Subject|0|||
160453486|NCT05436262|579392108|FG002|Pre-Randomization|Withdrawal by Subject|0|||
160453487|NCT05436262|579392106|FG000|Randomization|Withdrawal by Subject|0|||
160453488|NCT05436262|579392107|FG001|Randomization|Withdrawal by Subject|1|||
160453489|NCT05436262|579392108|FG002|Randomization|Withdrawal by Subject|0|||
160453490|NCT01456949|579392109|FG000|Enrollment|PI death- incomplete data|6|||
160453491|NCT01456949|579392109|FG000|Enrollment|Death|1|||
160453492|NCT01456949|579392109|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
160453493|NCT01456949|579392109|FG000|Enrollment|Physician Decision|10|||
160453494|NCT01456949|579392109|FG000|Enrollment|Withdrawal by Subject|7|||
160453495|NCT01456949|579392109|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
160453496|NCT01456949|579392109|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
160453497|NCT01456949|579392109|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
160453498|NCT01456949|579392109|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
160453499|NCT01456949|579392109|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
160453500|NCT01456949|579392109|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
160453501|NCT01456949|579392109|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
160453502|NCT01456949|579392109|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
160453503|NCT04753697|579392110|FG000|Induction Phase|Withdrawal by Subject|12|||
160453504|NCT04753697|579392111|FG001|Induction Phase|Withdrawal by Subject|5|||
160453505|NCT04753697|579392112|FG002|Induction Phase|Withdrawal by Subject|6|||
160453506|NCT04753697|579392110|FG000|Induction Phase|Physician Decision|1|||
160453507|NCT04753697|579392111|FG001|Induction Phase|Physician Decision|0|||
160453508|NCT04753697|579392112|FG002|Induction Phase|Physician Decision|0|||
160570583|NCT01486238|579812189|FG001|Overall Study|Death|2|||
160915127|NCT02564042|581081769|FG002|Overall Study|Physician Decision|0|||
160915128|NCT02564042|581081770|FG003|Overall Study|Physician Decision|1|||
160915129|NCT02564042|581081771|FG004|Overall Study|Physician Decision|0|||
160915130|NCT02564042|581081772|FG005|Overall Study|Physician Decision|0|||
160915131|NCT02564042|581081767|FG000|Overall Study|Withdrawal by Subject|5|||
160915132|NCT02564042|581081768|FG001|Overall Study|Withdrawal by Subject|3|||
160915133|NCT02564042|581081769|FG002|Overall Study|Withdrawal by Subject|2|||
160915134|NCT02564042|581081770|FG003|Overall Study|Withdrawal by Subject|2|||
160915135|NCT02564042|581081771|FG004|Overall Study|Withdrawal by Subject|10|||
160915136|NCT02564042|581081772|FG005|Overall Study|Withdrawal by Subject|12|||
160915137|NCT01356966|581081773|FG000|Overall Study|Withdrawal by Subject|1|||
160915138|NCT01356966|581081774|FG001|Overall Study|Withdrawal by Subject|2|||
160915139|NCT01356966|581081773|FG000|Overall Study|Physician Decision|1|||
160915140|NCT01356966|581081774|FG001|Overall Study|Physician Decision|0|||
160915141|NCT00849381|581081776|FG000|Overall Study|Adverse Event|1|||
160915142|NCT00849381|581081776|FG000|Overall Study|Lost to Follow-up|129|||
160915143|NCT00849381|581081776|FG000|Overall Study|Protocol Violation|5|||
160915144|NCT00849381|581081776|FG000|Overall Study|Withdrawal by Subject|6|||
160915145|NCT00849381|581081776|FG000|Overall Study|Other|4|||
160915146|NCT02085785|581081780|FG000|Overall Study|Withdrawal by Subject|2|||
160915147|NCT02085785|581081781|FG001|Overall Study|Withdrawal by Subject|1|||
160915148|NCT02085785|581081780|FG000|Overall Study|Lost to Follow-up|0|||
160915149|NCT02085785|581081781|FG001|Overall Study|Lost to Follow-up|1|||
160915150|NCT00779467|581081782|FG000|Overall Study|Lack of Efficacy|11|||
160915151|NCT00779467|581081783|FG001|Overall Study|Lack of Efficacy|2|||
160915152|NCT00779467|581081784|FG002|Overall Study|Lack of Efficacy|6|||
160915153|NCT00779467|581081785|FG003|Overall Study|Lack of Efficacy|11|||
160915154|NCT00779467|581081782|FG000|Overall Study|failed inclusion criteria|3|||
160915155|NCT00779467|581081783|FG001|Overall Study|failed inclusion criteria|3|||
160995918|NCT00124982|581371059|FG001|Long-term Period|Neurologist Recommendation|0|||
160453509|NCT04753697|579392110|FG000|Induction Phase|Lost to Follow-up|2|||
160453510|NCT04753697|579392111|FG001|Induction Phase|Lost to Follow-up|2|||
160453511|NCT04753697|579392112|FG002|Induction Phase|Lost to Follow-up|1|||
160453512|NCT04753697|579392110|FG000|Induction Phase|Lack of Efficacy|1|||
160453513|NCT04753697|579392111|FG001|Induction Phase|Lack of Efficacy|0|||
160453514|NCT04753697|579392112|FG002|Induction Phase|Lack of Efficacy|0|||
160453515|NCT04753697|579392110|FG000|Maintenance Phase|Physician Decision|0|||
160915156|NCT00779467|581081784|FG002|Overall Study|failed inclusion criteria|1|||
160915157|NCT00779467|581081785|FG003|Overall Study|failed inclusion criteria|2|||
160915158|NCT00779467|581081782|FG000|Overall Study|missing data|1|||
160915159|NCT00779467|581081783|FG001|Overall Study|missing data|0|||
160915160|NCT00779467|581081784|FG002|Overall Study|missing data|1|||
160915161|NCT00779467|581081785|FG003|Overall Study|missing data|4|||
160915162|NCT00779467|581081782|FG000|Overall Study|technical issue|0|||
160915163|NCT00779467|581081783|FG001|Overall Study|technical issue|0|||
160915164|NCT00779467|581081784|FG002|Overall Study|technical issue|2|||
160915165|NCT00779467|581081785|FG003|Overall Study|technical issue|1|||
160915166|NCT00779467|581081782|FG000|Overall Study|unavailable research staff|0|||
160915167|NCT00779467|581081783|FG001|Overall Study|unavailable research staff|0|||
160915168|NCT00779467|581081784|FG002|Overall Study|unavailable research staff|0|||
160915169|NCT00779467|581081785|FG003|Overall Study|unavailable research staff|1|||
160915170|NCT03590041|581081786|FG000|Overall Study|Protocol Violation|4|||
160915171|NCT03590041|581081787|FG001|Overall Study|Protocol Violation|3|||
160915172|NCT03590041|581081786|FG000|Overall Study|No session data recorded|14|||
160915173|NCT03590041|581081787|FG001|Overall Study|No session data recorded|2|||
160915174|NCT02692703|581081788|FG000|Overall Study|Lost to Follow-up|1|||
160915175|NCT02692703|581081788|FG000|Overall Study|Other|1|||
160915176|NCT04118166|581081789|FG000|Overall Study|Adverse Event|1|||
160915177|NCT00103142|581081792|FG000|Overall Study|Adverse Event|1|||
160915178|NCT00103142|581081793|FG001|Overall Study|Adverse Event|0|||
160995919|NCT00124982|581371060|FG002|Long-term Period|Neurologist Recommendation|1|||
160995920|NCT01137292|581371061|FG000|Overall Study|Death|30|||
160995921|NCT01137292|581371061|FG000|Overall Study|Adverse Event|3|||
160995922|NCT01137292|581371061|FG000|Overall Study|Lack of Efficacy|13|||
160995923|NCT01137292|581371061|FG000|Overall Study|Lost to Follow-up|1|||
160995924|NCT01137292|581371061|FG000|Overall Study|Other|7|||
160995925|NCT01311713|581371062|FG000|Overall Study|Death|0|||
160995926|NCT01311713|581371063|FG001|Overall Study|Death|0|||
160995927|NCT01311713|581371064|FG002|Overall Study|Death|1|||
160995928|NCT01311713|581371065|FG003|Overall Study|Death|1|||
160995929|NCT01311713|581371066|FG004|Overall Study|Death|0|||
160995930|NCT01311713|581371067|FG005|Overall Study|Death|1|||
160995931|NCT01311713|581371068|FG006|Overall Study|Death|0|||
160995932|NCT01311713|581371062|FG000|Overall Study|Adverse Event|0|||
160995933|NCT01311713|581371063|FG001|Overall Study|Adverse Event|1|||
160995934|NCT01311713|581371064|FG002|Overall Study|Adverse Event|0|||
160995935|NCT01311713|581371065|FG003|Overall Study|Adverse Event|2|||
160995936|NCT01311713|581371066|FG004|Overall Study|Adverse Event|0|||
160995937|NCT01311713|581371067|FG005|Overall Study|Adverse Event|0|||
160995938|NCT01311713|581371068|FG006|Overall Study|Adverse Event|2|||
160915179|NCT00103142|581081792|FG000|Overall Study|Progression of disease|2|||
160915180|NCT00103142|581081793|FG001|Overall Study|Progression of disease|1|||
160915181|NCT02772081|581081794|FG000|Overall Study|Physician Decision|1|||
160915182|NCT02772081|581081795|FG001|Overall Study|Physician Decision|1|||
160915183|NCT02772081|581081794|FG000|Overall Study|Death|1|||
160915184|NCT02772081|581081795|FG001|Overall Study|Death|1|||
160915185|NCT01979016|581081803|FG000|Overall Study|Withdrawal by Subject|2|||
160915186|NCT01979016|581081804|FG001|Overall Study|Withdrawal by Subject|0|||
160915187|NCT01979016|581081803|FG000|Overall Study|Adverse Event|0|||
160915188|NCT01979016|581081804|FG001|Overall Study|Adverse Event|1|||
160915189|NCT01442493|581081805|FG000|Overall Study|withdrawn from study|3|||
160915190|NCT01442493|581081806|FG001|Overall Study|withdrawn from study|2|||
160915191|NCT00938639|581081807|FG000|Overall Study|Moved away from study area|0|||
160915192|NCT00938639|581081808|FG001|Overall Study|Moved away from study area|1|||
160915193|NCT00938639|581081807|FG000|Overall Study|Lost to Follow-up|1|||
160915194|NCT00938639|581081808|FG001|Overall Study|Lost to Follow-up|2|||
160915195|NCT00938639|581081807|FG000|Overall Study|Family issues|1|||
160915196|NCT00938639|581081808|FG001|Overall Study|Family issues|1|||
160995939|NCT01311713|581371062|FG000|Overall Study|Withdrawal by Subject|0|||
160915197|NCT00938639|581081807|FG000|Overall Study|Participant noncompliance|1|||
160915198|NCT00938639|581081808|FG001|Overall Study|Participant noncompliance|0|||
160915199|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
160915200|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
160995940|NCT01311713|581371063|FG001|Overall Study|Withdrawal by Subject|1|||
160995941|NCT01311713|581371064|FG002|Overall Study|Withdrawal by Subject|1|||
160570584|NCT01486238|579812188|FG000|Overall Study|Withdrawal by Subject|2|||
160570585|NCT01486238|579812189|FG001|Overall Study|Withdrawal by Subject|1|||
160915201|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
160915202|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
160915203|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
160915204|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
160915205|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
160915206|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
160995942|NCT01311713|581371065|FG003|Overall Study|Withdrawal by Subject|0|||
160915207|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Patient Request|1|||
160915208|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Patient Request|0|||
160995943|NCT01311713|581371066|FG004|Overall Study|Withdrawal by Subject|0|||
160915209|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
160915210|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
160995944|NCT01311713|581371067|FG005|Overall Study|Withdrawal by Subject|1|||
160995945|NCT01311713|581371068|FG006|Overall Study|Withdrawal by Subject|2|||
160915211|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Other|1|||
160915212|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Other|0|||
160915213|NCT04649060|581081813|FG000|Crossover (Arm B)|Adverse Event|0|||
160915214|NCT04649060|581081814|FG001|Crossover (Arm B)|Adverse Event|1|||
160915215|NCT04649060|581081813|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
160915216|NCT04649060|581081814|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
160915217|NCT02706691|581081815|FG000|Overall Study|Adverse Event|1|||
160915218|NCT01830972|581081821|FG000|Part II|Withdrawal by Subject|2|||
160915219|NCT01830972|581081822|FG001|Part II|Withdrawal by Subject|2|||
160915220|NCT01830972|581081821|FG000|Part III|Withdrawal by Subject|1|||
160915221|NCT01830972|581081822|FG001|Part III|Withdrawal by Subject|0|||
160915222|NCT01830972|581081821|FG000|Part III|Noncompliance|1|||
160915223|NCT01830972|581081822|FG001|Part III|Noncompliance|0|||
160915224|NCT01830972|581081821|FG000|Part IV|Withdrawal by Subject|2|||
160915225|NCT01830972|581081822|FG001|Part IV|Withdrawal by Subject|1|||
160915226|NCT01830972|581081821|FG000|Part IV|Non-Compliance|1|||
160915227|NCT01830972|581081822|FG001|Part IV|Non-Compliance|0|||
160915228|NCT00171730|581081823|FG000|Overall Study|Adverse Event|3|||
160915229|NCT00171730|581081823|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
160915230|NCT00171730|581081823|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
160995946|NCT01311713|581371062|FG000|Overall Study|Disease progression|3|||
160995947|NCT01311713|581371063|FG001|Overall Study|Disease progression|4|||
160995948|NCT01311713|581371064|FG002|Overall Study|Disease progression|3|||
160995949|NCT01311713|581371065|FG003|Overall Study|Disease progression|2|||
160995950|NCT01311713|581371066|FG004|Overall Study|Disease progression|4|||
160995951|NCT01311713|581371067|FG005|Overall Study|Disease progression|4|||
160995952|NCT01311713|581371068|FG006|Overall Study|Disease progression|5|||
160995953|NCT01311713|581371062|FG000|Overall Study|Lost to Follow-up|0|||
160995954|NCT01311713|581371063|FG001|Overall Study|Lost to Follow-up|0|||
160995955|NCT01311713|581371064|FG002|Overall Study|Lost to Follow-up|1|||
160915231|NCT00171730|581081823|FG000|Overall Study|Withdrawal by Subject|3|||
160915232|NCT01985867|581081824|FG000|Overall Study|Lost to Follow-up|3|||
160915233|NCT01985867|581081825|FG001|Overall Study|Lost to Follow-up|4|||
160915234|NCT01985867|581081824|FG000|Overall Study|Adverse Event|3|||
160915235|NCT01985867|581081825|FG001|Overall Study|Adverse Event|2|||
160915236|NCT01985867|581081824|FG000|Overall Study|Lack of Efficacy|1|||
160995956|NCT01311713|581371065|FG003|Overall Study|Lost to Follow-up|0|||
160995957|NCT01311713|581371066|FG004|Overall Study|Lost to Follow-up|0|||
160995958|NCT01311713|581371067|FG005|Overall Study|Lost to Follow-up|0|||
160995959|NCT01311713|581371068|FG006|Overall Study|Lost to Follow-up|0|||
160995960|NCT01311713|581371062|FG000|Overall Study|Stopped taking study medication|0|||
160995961|NCT01311713|581371063|FG001|Overall Study|Stopped taking study medication|0|||
160995962|NCT01311713|581371064|FG002|Overall Study|Stopped taking study medication|0|||
160995963|NCT01311713|581371065|FG003|Overall Study|Stopped taking study medication|1|||
160995964|NCT01311713|581371066|FG004|Overall Study|Stopped taking study medication|1|||
160995965|NCT01311713|581371067|FG005|Overall Study|Stopped taking study medication|0|||
160995966|NCT01311713|581371068|FG006|Overall Study|Stopped taking study medication|0|||
160995967|NCT01311713|581371062|FG000|Overall Study|Enrolled but not treated|0|||
160995968|NCT01311713|581371063|FG001|Overall Study|Enrolled but not treated|0|||
160915237|NCT01985867|581081825|FG001|Overall Study|Lack of Efficacy|0|||
160915238|NCT01829191|581081826|FG000|Overall Study|Relocation|0|||
160915239|NCT01829191|581081827|FG001|Overall Study|Relocation|1|||
160915240|NCT01829191|581081826|FG000|Overall Study|Lens discomfort|0|||
160915241|NCT01829191|581081827|FG001|Overall Study|Lens discomfort|3|||
160915242|NCT01829191|581081826|FG000|Overall Study|Lens handling difficulty|1|||
160915243|NCT01829191|581081827|FG001|Overall Study|Lens handling difficulty|4|||
160915244|NCT01829191|581081826|FG000|Overall Study|Protocol Violation|4|||
160915245|NCT01829191|581081827|FG001|Overall Study|Protocol Violation|1|||
160915246|NCT01829191|581081826|FG000|Overall Study|Withdrawal by Subject|2|||
160995969|NCT01311713|581371064|FG002|Overall Study|Enrolled but not treated|1|||
160995970|NCT01311713|581371065|FG003|Overall Study|Enrolled but not treated|0|||
160652763|NCT03471078|580110360|FG001|Overall Study|Physician Decision|2|||
160915247|NCT01829191|581081827|FG001|Overall Study|Withdrawal by Subject|3|||
160915248|NCT01829191|581081826|FG000|Overall Study|Lost to Follow-up|0|||
160915249|NCT01829191|581081827|FG001|Overall Study|Lost to Follow-up|1|||
160915250|NCT01829191|581081826|FG000|Overall Study|Subject was fit for ortho - k|0|||
160915251|NCT01829191|581081827|FG001|Overall Study|Subject was fit for ortho - k|1|||
160915252|NCT01276353|581081828|FG000|Double-blind|Adverse Event|2|||
160915253|NCT01276353|581081829|FG001|Double-blind|Adverse Event|0|||
160915254|NCT01276353|581081828|FG000|Double-blind|Withdrawal by Subject|1|||
160995971|NCT01311713|581371066|FG004|Overall Study|Enrolled but not treated|0|||
160915255|NCT01276353|581081829|FG001|Double-blind|Withdrawal by Subject|0|||
160915256|NCT01276353|581081828|FG000|Extension|Adverse Event|2|||
160995972|NCT01311713|581371067|FG005|Overall Study|Enrolled but not treated|0|||
160453516|NCT04753697|579392111|FG001|Maintenance Phase|Physician Decision|0|||
160453517|NCT04753697|579392112|FG002|Maintenance Phase|Physician Decision|1|||
160453518|NCT04753697|579392110|FG000|Maintenance Phase|Withdrawal by Subject|3|||
160453519|NCT04753697|579392111|FG001|Maintenance Phase|Withdrawal by Subject|4|||
160453520|NCT04753697|579392112|FG002|Maintenance Phase|Withdrawal by Subject|6|||
160915257|NCT01276353|581081829|FG001|Extension|Adverse Event|5|||
160915258|NCT01276353|581081828|FG000|Extension|Withdrawal by Subject|1|||
160915259|NCT01276353|581081829|FG001|Extension|Withdrawal by Subject|2|||
160915260|NCT01276353|581081828|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
160915261|NCT01276353|581081829|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
160915262|NCT01276353|581081828|FG000|Extension|Physician Decision|1|||
160915263|NCT01276353|581081829|FG001|Extension|Physician Decision|0|||
160915264|NCT01276353|581081828|FG000|Extension|Prohibited concomitant medications|0|||
160453521|NCT04753697|579392110|FG000|Maintenance Phase|Lost to Follow-up|2|||
160453522|NCT04753697|579392111|FG001|Maintenance Phase|Lost to Follow-up|2|||
160453523|NCT04753697|579392112|FG002|Maintenance Phase|Lost to Follow-up|0|||
160453524|NCT04753697|579392110|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
160453525|NCT04753697|579392111|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
160453526|NCT04753697|579392112|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
160453527|NCT04753697|579392110|FG000|Maintenance Phase|Adverse Event|0|||
160453528|NCT04753697|579392111|FG001|Maintenance Phase|Adverse Event|1|||
160453529|NCT04753697|579392112|FG002|Maintenance Phase|Adverse Event|1|||
160453530|NCT04753697|579392110|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
160453531|NCT04753697|579392111|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
160453532|NCT04753697|579392112|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
160453533|NCT04200456|579392115|FG000|Overall Study|Physician Decision|0|||
160453534|NCT04200456|579392116|FG001|Overall Study|Physician Decision|1|||
160453535|NCT04200456|579392115|FG000|Overall Study|Withdrawal by Subject|2|||
160453536|NCT04200456|579392116|FG001|Overall Study|Withdrawal by Subject|2|||
160453537|NCT04200456|579392115|FG000|Overall Study|Lack of Efficacy|1|||
160453538|NCT04200456|579392116|FG001|Overall Study|Lack of Efficacy|1|||
160453539|NCT04200456|579392115|FG000|Overall Study|Adverse event, non-fatal|0|||
160453540|NCT04200456|579392116|FG001|Overall Study|Adverse event, non-fatal|1|||
160915265|NCT01276353|581081829|FG001|Extension|Prohibited concomitant medications|1|||
160915266|NCT00553514|581081835|FG000|Overall Study|Protocol deviation|0|||
160453541|NCT04200456|579392115|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
160453542|NCT04200456|579392116|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
160453543|NCT05002088|579392117|FG000|Overall Study|Withdrawal by Subject|9|||
160453544|NCT05002088|579392118|FG001|Overall Study|Withdrawal by Subject|0|||
160453545|NCT05002088|579392117|FG000|Overall Study|Lost to Follow-up|0|||
160915267|NCT00553514|581081836|FG001|Overall Study|Protocol deviation|0|||
160915268|NCT00553514|581081837|FG002|Overall Study|Protocol deviation|0|||
160915269|NCT00553514|581081838|FG003|Overall Study|Protocol deviation|1|||
160915270|NCT00553514|581081839|FG004|Overall Study|Protocol deviation|0|||
160915271|NCT00553514|581081835|FG000|Overall Study|Lack of ovarian response|4|||
160915272|NCT00553514|581081836|FG001|Overall Study|Lack of ovarian response|5|||
160915273|NCT00553514|581081837|FG002|Overall Study|Lack of ovarian response|5|||
160915274|NCT00553514|581081838|FG003|Overall Study|Lack of ovarian response|5|||
160915275|NCT00553514|581081839|FG004|Overall Study|Lack of ovarian response|6|||
160915276|NCT00553514|581081835|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
160915277|NCT00553514|581081836|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
160915278|NCT00553514|581081837|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
160915279|NCT00553514|581081838|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
160915280|NCT00553514|581081839|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
160915281|NCT00553514|581081835|FG000|Overall Study|Risk of multiple pregnancy|0|||
160915282|NCT00553514|581081836|FG001|Overall Study|Risk of multiple pregnancy|2|||
160915283|NCT00553514|581081837|FG002|Overall Study|Risk of multiple pregnancy|0|||
160915284|NCT00553514|581081838|FG003|Overall Study|Risk of multiple pregnancy|1|||
160915285|NCT00553514|581081839|FG004|Overall Study|Risk of multiple pregnancy|0|||
160915286|NCT00553514|581081835|FG000|Overall Study|Other|1|||
160915287|NCT00553514|581081836|FG001|Overall Study|Other|1|||
160915288|NCT00553514|581081837|FG002|Overall Study|Other|0|||
160915289|NCT00553514|581081838|FG003|Overall Study|Other|0|||
160915290|NCT00553514|581081839|FG004|Overall Study|Other|1|||
160915291|NCT01465997|581081840|FG000|Overall Study|Adverse Event|12|||
160915292|NCT01465997|581081841|FG001|Overall Study|Adverse Event|22|||
160915293|NCT01465997|581081840|FG000|Overall Study|Lack of Efficacy|13|||
160915294|NCT01465997|581081841|FG001|Overall Study|Lack of Efficacy|1|||
160915295|NCT01465997|581081840|FG000|Overall Study|Protocol Violation|1|||
160915296|NCT01465997|581081841|FG001|Overall Study|Protocol Violation|4|||
160453546|NCT05002088|579392118|FG001|Overall Study|Lost to Follow-up|1|||
160453547|NCT05002088|579392117|FG000|Overall Study|Death|16|||
160453548|NCT05002088|579392118|FG001|Overall Study|Death|2|||
160453549|NCT05002088|579392117|FG000|Overall Study|Protocol Violation|25|||
160915297|NCT01465997|581081840|FG000|Overall Study|Lost to Follow-up|6|||
160453550|NCT05002088|579392118|FG001|Overall Study|Protocol Violation|7|||
160453551|NCT04770402|579392120|FG000|Overall Study|Lost to Follow-up|1|||
160453552|NCT04770402|579392121|FG001|Overall Study|Lost to Follow-up|2|||
160453553|NCT04770402|579392120|FG000|Overall Study|Non-compliance|1|||
160453554|NCT04770402|579392121|FG001|Overall Study|Non-compliance|0|||
160453555|NCT04770402|579392120|FG000|Overall Study|Withdrawal by Subject|0|||
160453556|NCT04770402|579392121|FG001|Overall Study|Withdrawal by Subject|1|||
160453557|NCT03599661|579392122|FG000|Overall Study|Lost to Follow-up|9|||
160453558|NCT05446168|579392123|FG000|Overall Study|Physician Decision|0|||
160453559|NCT05446168|579392124|FG001|Overall Study|Physician Decision|1|||
160453560|NCT01828099|579392125|FG000|Treatment Period|Adverse Event|24|||
160453561|NCT01828099|579392126|FG001|Treatment Period|Adverse Event|23|||
160453562|NCT01828099|579392125|FG000|Treatment Period|Death|10|||
160453563|NCT01828099|579392126|FG001|Treatment Period|Death|12|||
160453564|NCT01828099|579392125|FG000|Treatment Period|Lost to Follow-up|2|||
160453565|NCT01828099|579392126|FG001|Treatment Period|Lost to Follow-up|1|||
160453566|NCT01828099|579392125|FG000|Treatment Period|Non-compliance with study treatment|1|||
160453567|NCT01828099|579392126|FG001|Treatment Period|Non-compliance with study treatment|0|||
160915298|NCT01465997|581081841|FG001|Overall Study|Lost to Follow-up|9|||
160915299|NCT01465997|581081840|FG000|Overall Study|Withdrawal by Subject|32|||
160915300|NCT01465997|581081841|FG001|Overall Study|Withdrawal by Subject|35|||
160915301|NCT01465997|581081840|FG000|Overall Study|investigator's decision|1|||
160915302|NCT01465997|581081841|FG001|Overall Study|investigator's decision|1|||
160915303|NCT01465997|581081840|FG000|Overall Study|Death|0|||
160915304|NCT01465997|581081841|FG001|Overall Study|Death|1|||
160915305|NCT01465997|581081840|FG000|Overall Study|sponsor's decision|1|||
160915306|NCT01465997|581081841|FG001|Overall Study|sponsor's decision|1|||
160915307|NCT01465997|581081840|FG000|Overall Study|subject withdrew consent|1|||
160915308|NCT01465997|581081841|FG001|Overall Study|subject withdrew consent|0|||
160915309|NCT01465997|581081840|FG000|Overall Study|local lab unblinded site|1|||
160915310|NCT01465997|581081841|FG001|Overall Study|local lab unblinded site|0|||
160915311|NCT01465997|581081840|FG000|Overall Study|withdrew before follow-up|0|||
160915312|NCT01465997|581081841|FG001|Overall Study|withdrew before follow-up|13|||
160915313|NCT01465997|581081840|FG000|Overall Study|decision by site staff|0|||
160915314|NCT01465997|581081841|FG001|Overall Study|decision by site staff|1|||
160915315|NCT01465997|581081840|FG000|Overall Study|subject left participation SP0993|0|||
160915316|NCT01465997|581081841|FG001|Overall Study|subject left participation SP0993|1|||
160915317|NCT01426373|581081842|FG000|Overall Study|Adverse Event|6|||
160915318|NCT01426373|581081842|FG000|Overall Study|Lost to Follow-up|14|||
160915319|NCT01426373|581081842|FG000|Overall Study|Participant Convenience|10|||
160915320|NCT01426373|581081842|FG000|Overall Study|Miscellaneous Reasons|4|||
160915321|NCT00005937|581081850|FG000|Overall Study|Lack of Efficacy|5|||
160915322|NCT00160251|581081851|FG000|Prior to Amendment 2|Adverse Event|2|||
160915323|NCT00160251|581081852|FG001|Prior to Amendment 2|Adverse Event|1|||
160915324|NCT00160251|581081853|FG002|Prior to Amendment 2|Adverse Event|3|||
160915325|NCT00160251|581081854|FG003|Prior to Amendment 2|Adverse Event|1|||
160915326|NCT00160251|581081855|FG004|Prior to Amendment 2|Adverse Event|1|||
160915327|NCT00160251|581081856|FG005|Prior to Amendment 2|Adverse Event|1|||
160915328|NCT00160251|581081857|FG006|Prior to Amendment 2|Adverse Event|1|||
160915329|NCT00160251|581081858|FG007|Prior to Amendment 2|Adverse Event|0|||
160915330|NCT00160251|581081851|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
160915331|NCT00160251|581081852|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
160915332|NCT00160251|581081853|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
160915333|NCT00160251|581081854|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
160915334|NCT00160251|581081855|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
160915335|NCT00160251|581081856|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
160915336|NCT00160251|581081857|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
160915337|NCT00160251|581081858|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
160915338|NCT00160251|581081851|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
160915339|NCT00160251|581081852|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
160915340|NCT00160251|581081853|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
160915341|NCT00160251|581081854|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
160915342|NCT00160251|581081855|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
160915343|NCT00160251|581081856|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
160915344|NCT00160251|581081857|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
160915345|NCT00160251|581081858|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
160915346|NCT00160251|581081851|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
160915347|NCT00160251|581081852|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
160915348|NCT00160251|581081853|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
160915349|NCT00160251|581081854|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
160453568|NCT01828099|579392125|FG000|Treatment Period|Physician Decision|17|||
160453569|NCT01828099|579392126|FG001|Treatment Period|Physician Decision|16|||
160453570|NCT01828099|579392125|FG000|Treatment Period|Progressive disease|99|||
160453571|NCT01828099|579392126|FG001|Treatment Period|Progressive disease|107|||
160453572|NCT01828099|579392125|FG000|Treatment Period|Subject/guardian decision|22|||
160915350|NCT00160251|581081855|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
160915351|NCT00160251|581081856|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
160915352|NCT00160251|581081857|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
160915353|NCT00160251|581081858|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
160915354|NCT00160251|581081851|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
160915355|NCT00160251|581081852|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
160915356|NCT00160251|581081853|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
160915357|NCT00160251|581081854|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
160652764|NCT03471078|580110359|FG000|Overall Study|Death|2|||
160915358|NCT00160251|581081855|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
160915359|NCT00160251|581081856|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
160915360|NCT00160251|581081857|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
160915361|NCT00160251|581081858|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
160915362|NCT00160251|581081851|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
160915363|NCT00160251|581081852|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
160915364|NCT00160251|581081853|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
160915365|NCT00160251|581081854|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
160915366|NCT00160251|581081855|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
160915367|NCT00160251|581081856|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
160915368|NCT00160251|581081857|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
160915369|NCT00160251|581081858|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
160915370|NCT00160251|581081851|FG000|Post-amendment 2|Adverse Event|0|||
160915371|NCT00160251|581081852|FG001|Post-amendment 2|Adverse Event|0|||
160915372|NCT00160251|581081853|FG002|Post-amendment 2|Adverse Event|0|||
160915373|NCT00160251|581081854|FG003|Post-amendment 2|Adverse Event|0|||
160915374|NCT00160251|581081855|FG004|Post-amendment 2|Adverse Event|0|||
160915375|NCT00160251|581081856|FG005|Post-amendment 2|Adverse Event|0|||
160915376|NCT00160251|581081857|FG006|Post-amendment 2|Adverse Event|0|||
160915377|NCT00160251|581081858|FG007|Post-amendment 2|Adverse Event|20|||
160915378|NCT00160251|581081851|FG000|Post-amendment 2|Lack of Efficacy|0|||
160915379|NCT00160251|581081852|FG001|Post-amendment 2|Lack of Efficacy|0|||
160915380|NCT00160251|581081853|FG002|Post-amendment 2|Lack of Efficacy|0|||
160915381|NCT00160251|581081854|FG003|Post-amendment 2|Lack of Efficacy|0|||
160915382|NCT00160251|581081855|FG004|Post-amendment 2|Lack of Efficacy|0|||
160915383|NCT00160251|581081856|FG005|Post-amendment 2|Lack of Efficacy|0|||
160915384|NCT00160251|581081857|FG006|Post-amendment 2|Lack of Efficacy|0|||
160915385|NCT00160251|581081858|FG007|Post-amendment 2|Lack of Efficacy|24|||
160915386|NCT00160251|581081851|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915387|NCT00160251|581081852|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915388|NCT00160251|581081853|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915389|NCT00160251|581081854|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915390|NCT00160251|581081855|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915391|NCT00160251|581081856|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915392|NCT00160251|581081857|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915393|NCT00160251|581081858|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
160915394|NCT01288469|581081859|FG000|Overall Study|Adverse Event|4|||
160915395|NCT01288469|581081860|FG001|Overall Study|Adverse Event|1|||
160915396|NCT01288469|581081861|FG002|Overall Study|Adverse Event|1|||
160915397|NCT01288469|581081859|FG000|Overall Study|Poor compliance to protocol|0|||
160915398|NCT01288469|581081860|FG001|Overall Study|Poor compliance to protocol|1|||
160915399|NCT01288469|581081861|FG002|Overall Study|Poor compliance to protocol|0|||
160915400|NCT01288469|581081859|FG000|Overall Study|Participant Moved|1|||
160915401|NCT01288469|581081860|FG001|Overall Study|Participant Moved|0|||
160915402|NCT01288469|581081861|FG002|Overall Study|Participant Moved|0|||
160915403|NCT01288469|581081859|FG000|Overall Study|Consent withdrawn by subject|1|||
160915404|NCT01288469|581081860|FG001|Overall Study|Consent withdrawn by subject|1|||
160915405|NCT01288469|581081861|FG002|Overall Study|Consent withdrawn by subject|1|||
160915406|NCT01288469|581081859|FG000|Overall Study|Exclusion criteria finally met|1|||
160915407|NCT01288469|581081860|FG001|Overall Study|Exclusion criteria finally met|0|||
160915408|NCT01288469|581081861|FG002|Overall Study|Exclusion criteria finally met|0|||
160915409|NCT00582166|581081862|FG000|Overall Study|Death|1|||
160915410|NCT00582166|581081862|FG000|Overall Study|Ineligible pathology|1|||
160915411|NCT01606436|581081863|FG000|Overall Study|Withdrawal by Subject|0|||
160652765|NCT03471078|580110360|FG001|Overall Study|Death|0|||
160915412|NCT01606436|581081864|FG001|Overall Study|Withdrawal by Subject|0|||
160915413|NCT01606436|581081865|FG002|Overall Study|Withdrawal by Subject|1|||
160915414|NCT01606436|581081866|FG003|Overall Study|Withdrawal by Subject|1|||
160915415|NCT01606436|581081867|FG004|Overall Study|Withdrawal by Subject|1|||
160915416|NCT01606436|581081868|FG005|Overall Study|Withdrawal by Subject|0|||
160915417|NCT01606436|581081863|FG000|Overall Study|Adverse Event|0|||
160915418|NCT01606436|581081864|FG001|Overall Study|Adverse Event|0|||
160915419|NCT01606436|581081865|FG002|Overall Study|Adverse Event|1|||
160915420|NCT01606436|581081866|FG003|Overall Study|Adverse Event|0|||
160915421|NCT01606436|581081867|FG004|Overall Study|Adverse Event|0|||
160915422|NCT01606436|581081868|FG005|Overall Study|Adverse Event|0|||
160652766|NCT03471078|580110359|FG000|Overall Study|Other|3|||
160453573|NCT01828099|579392126|FG001|Treatment Period|Subject/guardian decision|26|||
160453574|NCT01828099|579392125|FG000|Treatment Period|Study terminated by Sponsor|13|||
160453575|NCT01828099|579392126|FG001|Treatment Period|Study terminated by Sponsor|1|||
160453576|NCT01828099|579392125|FG000|Treatment Period|Protocol deviation|1|||
160453577|NCT01828099|579392126|FG001|Treatment Period|Protocol deviation|0|||
160453578|NCT01828099|579392125|FG000|Treatment Period|No longer requires treatment|0|||
160453579|NCT01828099|579392126|FG001|Treatment Period|No longer requires treatment|1|||
160453580|NCT01828099|579392125|FG000|Extension-treatment Phase|Adverse Event|0|||
160453581|NCT01828099|579392126|FG001|Extension-treatment Phase|Adverse Event|17|||
160453582|NCT01828099|579392125|FG000|Extension-treatment Phase|Death|0|||
160453583|NCT01828099|579392126|FG001|Extension-treatment Phase|Death|11|||
160453584|NCT01828099|579392125|FG000|Extension-treatment Phase|Physician Decision|0|||
160453585|NCT01828099|579392126|FG001|Extension-treatment Phase|Physician Decision|5|||
160453586|NCT01828099|579392125|FG000|Extension-treatment Phase|Progressive disease|0|||
160915423|NCT01606436|581081863|FG000|Overall Study|Sponsor Decision|0|||
160915424|NCT01606436|581081864|FG001|Overall Study|Sponsor Decision|0|||
160915425|NCT01606436|581081865|FG002|Overall Study|Sponsor Decision|0|||
160915426|NCT01606436|581081866|FG003|Overall Study|Sponsor Decision|1|||
160453587|NCT01828099|579392126|FG001|Extension-treatment Phase|Progressive disease|54|||
160453588|NCT01828099|579392125|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
160453589|NCT01828099|579392126|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
160915427|NCT01606436|581081867|FG004|Overall Study|Sponsor Decision|0|||
160915428|NCT01606436|581081868|FG005|Overall Study|Sponsor Decision|0|||
160915429|NCT03334448|581081871|FG000|Washout|Personal Reason|0|||
160915430|NCT03334448|581081872|FG001|Washout|Personal Reason|1|||
160915431|NCT03334448|581081873|FG002|Washout|Personal Reason|0|||
160915432|NCT03334448|581081874|FG003|Washout|Personal Reason|0|||
160915433|NCT03334448|581081871|FG000|Washout|Protocol Violation|0|||
160915434|NCT03334448|581081872|FG001|Washout|Protocol Violation|0|||
160453590|NCT01828099|579392125|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
160915435|NCT03334448|581081873|FG002|Washout|Protocol Violation|0|||
160915436|NCT03334448|581081874|FG003|Washout|Protocol Violation|1|||
160915437|NCT02326025|581081875|FG000|Overall Study|Adverse Event|3|||
160915438|NCT02326025|581081876|FG001|Overall Study|Adverse Event|0|||
160915439|NCT02326025|581081875|FG000|Overall Study|Physician Decision|1|||
160915440|NCT02326025|581081876|FG001|Overall Study|Physician Decision|2|||
160915441|NCT02326025|581081875|FG000|Overall Study|Physician and Participant Decision|1|||
160915442|NCT02326025|581081876|FG001|Overall Study|Physician and Participant Decision|0|||
160915443|NCT02326025|581081875|FG000|Overall Study|Withdrawal by Subject|0|||
160915444|NCT02326025|581081876|FG001|Overall Study|Withdrawal by Subject|2|||
160915445|NCT02326025|581081875|FG000|Overall Study|Protocol Violation|0|||
160915446|NCT02326025|581081876|FG001|Overall Study|Protocol Violation|1|||
160915447|NCT01365910|581081877|FG000|Overall Study|Withdrawal by Subject|7|||
160915448|NCT01365910|581081877|FG000|Overall Study|disease progression|18|||
160915449|NCT01365910|581081877|FG000|Overall Study|Adverse Event|3|||
160915450|NCT01365910|581081877|FG000|Overall Study|other complicating disease|1|||
160915451|NCT01365910|581081877|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
160915452|NCT02013791|581081878|FG000|Period 1|Lost to Follow-up|0|||
160915453|NCT02013791|581081879|FG001|Period 1|Lost to Follow-up|0|||
160915454|NCT02013791|581081880|FG002|Period 1|Lost to Follow-up|0|||
160915455|NCT02013791|581081881|FG003|Period 1|Lost to Follow-up|1|||
160915456|NCT02013791|581081882|FG004|Period 1|Lost to Follow-up|0|||
160915457|NCT02013791|581081883|FG005|Period 1|Lost to Follow-up|0|||
160915458|NCT02013791|581081884|FG006|Period 1|Lost to Follow-up|1|||
160915459|NCT02013791|581081885|FG007|Period 1|Lost to Follow-up|1|||
160915460|NCT02013791|581081886|FG008|Period 1|Lost to Follow-up|0|||
160915461|NCT02013791|581081878|FG000|Period 1|Other Miscellaneous Reasons|0|||
160915462|NCT02013791|581081879|FG001|Period 1|Other Miscellaneous Reasons|2|||
160915463|NCT02013791|581081880|FG002|Period 1|Other Miscellaneous Reasons|0|||
160915464|NCT02013791|581081881|FG003|Period 1|Other Miscellaneous Reasons|0|||
160915465|NCT02013791|581081882|FG004|Period 1|Other Miscellaneous Reasons|0|||
160915466|NCT02013791|581081883|FG005|Period 1|Other Miscellaneous Reasons|0|||
160915467|NCT02013791|581081884|FG006|Period 1|Other Miscellaneous Reasons|0|||
160453591|NCT01828099|579392126|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
160453592|NCT03924635|579392129|FG000|Overall Study|Withdrawal by Subject|2|||
160453593|NCT03924635|579392130|FG001|Overall Study|Withdrawal by Subject|4|||
160453594|NCT04471246|579392131|FG000|Overall Study|Lost to Follow-up|2|||
160915468|NCT02013791|581081885|FG007|Period 1|Other Miscellaneous Reasons|0|||
160915469|NCT02013791|581081886|FG008|Period 1|Other Miscellaneous Reasons|0|||
160915470|NCT03798483|581081887|FG000|Overall Study|Lost to Follow-up|2|||
160915471|NCT02643082|581081888|FG000|Period 1|Adverse Event|1|||
160915472|NCT02643082|581081889|FG001|Period 1|Adverse Event|0|||
160915473|NCT02289417|581081890|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
160915474|NCT02289417|581081891|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915475|NCT02289417|581081892|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
160915476|NCT02289417|581081893|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915477|NCT02289417|581081894|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915478|NCT02289417|581081895|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915479|NCT02289417|581081896|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915480|NCT02289417|581081897|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915481|NCT02289417|581081898|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915482|NCT02289417|581081890|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
160915483|NCT02289417|581081891|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
160915484|NCT02289417|581081892|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
160915485|NCT02289417|581081893|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915486|NCT02289417|581081894|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915487|NCT02289417|581081895|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915488|NCT02289417|581081896|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915489|NCT02289417|581081897|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915490|NCT02289417|581081898|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915491|NCT02289417|581081890|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915492|NCT02289417|581081891|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
160915493|NCT02289417|581081892|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915494|NCT02289417|581081893|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915495|NCT02289417|581081894|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915496|NCT02289417|581081895|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915497|NCT02289417|581081896|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915498|NCT02289417|581081897|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915499|NCT02289417|581081898|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915500|NCT02289417|581081890|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
160915501|NCT02289417|581081891|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915502|NCT02289417|581081892|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915503|NCT02289417|581081893|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915504|NCT02289417|581081894|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915505|NCT02289417|581081895|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915506|NCT02289417|581081896|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915507|NCT02289417|581081897|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915508|NCT02289417|581081898|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915509|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
160915510|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
160915511|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
160915512|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
160915513|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
160915514|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
160915515|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
160915516|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
160915517|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
160915518|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915519|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915520|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
160915521|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915522|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915523|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915524|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915525|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915526|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915527|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
160915528|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
160915529|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
160915530|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
160915531|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
160915532|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
160915533|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
160915534|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
160915535|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
160915536|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160915537|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160915538|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
160915539|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160915540|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
160915541|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
160915542|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160915543|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160995973|NCT01311713|581371068|FG006|Overall Study|Enrolled but not treated|0|||
160995974|NCT01311713|581371062|FG000|Overall Study|Other than specified|0|||
160995975|NCT01311713|581371063|FG001|Overall Study|Other than specified|1|||
160995976|NCT01311713|581371064|FG002|Overall Study|Other than specified|2|||
160995977|NCT01311713|581371065|FG003|Overall Study|Other than specified|0|||
160995978|NCT01311713|581371066|FG004|Overall Study|Other than specified|0|||
160995979|NCT01311713|581371067|FG005|Overall Study|Other than specified|0|||
160995980|NCT01311713|581371068|FG006|Overall Study|Other than specified|0|||
160995981|NCT00980538|581371070|FG000|Overall Study|Lost to Follow-up|20|||
160995982|NCT00980538|581371070|FG000|Overall Study|Sponsor's Decision|4|||
160995983|NCT00980538|581371070|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
160995984|NCT00980538|581371070|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
160995985|NCT00980538|581371070|FG000|Overall Study|Switch to Commercially Available Medication|25|||
160995986|NCT00980538|581371070|FG000|Overall Study|Participant Non-Compliant|9|||
160995987|NCT00980538|581371070|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
160995988|NCT00980538|581371070|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
160995989|NCT00980538|581371070|FG000|Overall Study|Other|60|||
160995990|NCT00980538|581371070|FG000|Overall Study|Other|1|||
160995991|NCT03878446|581371071|FG000|Overall Study|Withdrawn by parent or guardian|1|||
160995992|NCT03878446|581371072|FG001|Overall Study|Withdrawn by parent or guardian|0|||
160995993|NCT03878446|581371073|FG002|Overall Study|Withdrawn by parent or guardian|0|||
160995994|NCT03878446|581371074|FG003|Overall Study|Withdrawn by parent or guardian|0|||
160995995|NCT03878446|581371075|FG004|Overall Study|Withdrawn by parent or guardian|0|||
160995996|NCT04540835|581371076|FG000|Week 1|Lost to Follow-up|1|||
160995997|NCT04540835|581371076|FG000|Week 6|Pregnancy|1|||
160995998|NCT04540835|581371076|FG000|Week 6|Lack of Efficacy|1|||
160995999|NCT04804605|581372083|FG000|Overall Study|Withdrawal by Subject|46|||
160996000|NCT04804605|581372084|FG001|Overall Study|Withdrawal by Subject|26|||
160996001|NCT04804605|581372085|FG002|Overall Study|Withdrawal by Subject|37|||
160996002|NCT04804605|581372086|FG003|Overall Study|Withdrawal by Subject|21|||
160996003|NCT04804605|581372083|FG000|Overall Study|Lost to Follow-up|47|||
160996004|NCT04804605|581372084|FG001|Overall Study|Lost to Follow-up|21|||
160996005|NCT04804605|581372085|FG002|Overall Study|Lost to Follow-up|30|||
160996006|NCT04804605|581372086|FG003|Overall Study|Lost to Follow-up|17|||
160996007|NCT04804605|581372083|FG000|Overall Study|Lack of Efficacy|28|||
160996008|NCT04804605|581372084|FG001|Overall Study|Lack of Efficacy|11|||
160996009|NCT04804605|581372085|FG002|Overall Study|Lack of Efficacy|37|||
160996010|NCT04804605|581372086|FG003|Overall Study|Lack of Efficacy|8|||
160861604|NCT03198715|580887779|FG000|Overall Study|Other|0|||
160861605|NCT03198715|580887780|FG001|Overall Study|Other|1|||
160861606|NCT03198715|580887781|FG002|Overall Study|Other|1|||
160861607|NCT03198715|580887782|FG003|Overall Study|Other|0|||
160861608|NCT03198715|580887783|FG004|Overall Study|Other|0|||
160861609|NCT04613362|580887784|FG000|3 Month Follow-up|Lost to Follow-up|1|||
160861610|NCT04613362|580887785|FG001|3 Month Follow-up|Lost to Follow-up|2|||
160861611|NCT04613362|580887784|FG000|6 Month Follow-up|Lost to Follow-up|0|||
160861612|NCT04613362|580887785|FG001|6 Month Follow-up|Lost to Follow-up|1|||
160861613|NCT04225897|580887786|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861614|NCT04225897|580887787|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
160861615|NCT04225897|580887788|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861616|NCT04225897|580887789|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861617|NCT04225897|580887790|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861618|NCT04225897|580887791|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861619|NCT04225897|580887792|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861620|NCT04225897|580887793|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861621|NCT04225897|580887794|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861622|NCT04225897|580887795|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861623|NCT04225897|580887796|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861624|NCT04225897|580887797|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861625|NCT04225897|580887786|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861626|NCT04225897|580887787|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861627|NCT04225897|580887788|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
160861628|NCT04225897|580887789|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861629|NCT04225897|580887790|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861630|NCT04225897|580887791|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861631|NCT04225897|580887792|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861632|NCT04225897|580887793|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861633|NCT04225897|580887794|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861634|NCT04225897|580887795|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160996011|NCT04804605|581372083|FG000|Overall Study|Adverse Event|10|||
160996012|NCT04804605|581372084|FG001|Overall Study|Adverse Event|10|||
160996013|NCT04804605|581372085|FG002|Overall Study|Adverse Event|10|||
160996014|NCT04804605|581372086|FG003|Overall Study|Adverse Event|7|||
160996015|NCT04804605|581372083|FG000|Overall Study|Non-compliance|8|||
160915544|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160915545|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915546|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915547|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915548|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915549|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915550|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915551|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
160996016|NCT04804605|581372084|FG001|Overall Study|Non-compliance|3|||
160996017|NCT04804605|581372085|FG002|Overall Study|Non-compliance|5|||
160996018|NCT04804605|581372086|FG003|Overall Study|Non-compliance|1|||
160996019|NCT04804605|581372083|FG000|Overall Study|Physician Decision|3|||
160996020|NCT04804605|581372084|FG001|Overall Study|Physician Decision|0|||
160996021|NCT04804605|581372085|FG002|Overall Study|Physician Decision|5|||
160996022|NCT04804605|581372086|FG003|Overall Study|Physician Decision|0|||
160996023|NCT04804605|581372083|FG000|Overall Study|Protocol Violation|1|||
160996024|NCT04804605|581372084|FG001|Overall Study|Protocol Violation|0|||
160996025|NCT04804605|581372085|FG002|Overall Study|Protocol Violation|0|||
160996026|NCT04804605|581372086|FG003|Overall Study|Protocol Violation|1|||
160996027|NCT04804605|581372083|FG000|Overall Study|Miscellaneous|7|||
160996028|NCT04804605|581372084|FG001|Overall Study|Miscellaneous|3|||
160915552|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915553|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915554|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915555|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160996029|NCT04804605|581372085|FG002|Overall Study|Miscellaneous|4|||
160915556|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915557|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
160915558|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915559|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915560|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
160915561|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915562|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915563|NCT02289417|581081890|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
160915564|NCT02289417|581081891|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
160915565|NCT02289417|581081892|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
160915566|NCT02289417|581081893|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
160915567|NCT02289417|581081894|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
160915568|NCT02289417|581081895|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
160915569|NCT02289417|581081896|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
160915570|NCT02289417|581081897|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
160915571|NCT02289417|581081898|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
160915572|NCT02289417|581081890|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915573|NCT02289417|581081891|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915574|NCT02289417|581081892|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915575|NCT02289417|581081893|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915576|NCT02289417|581081894|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915577|NCT02289417|581081895|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915578|NCT02289417|581081896|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915579|NCT02289417|581081897|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
160915580|NCT02289417|581081898|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
160915581|NCT02289417|581081890|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915582|NCT02289417|581081891|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915583|NCT02289417|581081892|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915584|NCT02289417|581081893|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915585|NCT02289417|581081894|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915586|NCT02289417|581081895|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915587|NCT02289417|581081896|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915588|NCT02289417|581081897|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
160915589|NCT02289417|581081898|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
160915590|NCT02289417|581081890|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
160915591|NCT02289417|581081891|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
160915592|NCT02289417|581081892|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
160996030|NCT04804605|581372086|FG003|Overall Study|Miscellaneous|2|||
160996031|NCT00567879|581372089|FG000|Overall Study|Adverse Event|2|||
160453595|NCT04471246|579392132|FG001|Overall Study|Lost to Follow-up|2|||
160915593|NCT02289417|581081893|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
160996032|NCT00567879|581372090|FG001|Overall Study|Adverse Event|0|||
160996033|NCT00567879|581372091|FG002|Overall Study|Adverse Event|1|||
160996034|NCT00567879|581372092|FG003|Overall Study|Adverse Event|0|||
160996035|NCT00567879|581372093|FG004|Overall Study|Adverse Event|1|||
160570586|NCT01486238|579812188|FG000|Overall Study|Lost to Follow-up|0|||
160915594|NCT02289417|581081894|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
160453596|NCT04826471|579392133|FG000|Overall Study|Lost to Follow-up|2|||
160453597|NCT04826471|579392133|FG000|Overall Study|Protocol Violation|3|||
160453598|NCT04826471|579392133|FG000|Overall Study|Withdrawal by Subject|1|||
160453599|NCT05764525|579392134|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
160453600|NCT05764525|579392135|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
160453601|NCT05764525|579392134|FG000|Overall Study|Withdrawal by Subject|4|||
160453602|NCT05764525|579392135|FG001|Overall Study|Withdrawal by Subject|8|||
160453603|NCT05764525|579392134|FG000|Overall Study|Physician Decision|1|||
160453604|NCT05764525|579392135|FG001|Overall Study|Physician Decision|0|||
160453605|NCT01275677|579392140|FG000|Overall Study|Not at risk for recurrence.|1|||
160453606|NCT01275677|579392141|FG001|Overall Study|Not at risk for recurrence.|1|||
160453607|NCT01275677|579392140|FG000|Overall Study|No follow-up|26|||
160453608|NCT01275677|579392141|FG001|Overall Study|No follow-up|37|||
160453609|NCT01275677|579392140|FG000|Overall Study|No clinical follow up.|1|||
160453610|NCT01275677|579392141|FG001|Overall Study|No clinical follow up.|4|||
160453611|NCT05170841|579392142|FG000|Single Dose Phase|Adverse Event|1|||
160453612|NCT05170841|579392143|FG001|Single Dose Phase|Adverse Event|2|||
160453613|NCT05170841|579392144|FG002|Single Dose Phase|Adverse Event|0|||
160453614|NCT05170841|579392145|FG003|Single Dose Phase|Adverse Event|2|||
160453615|NCT05170841|579392142|FG000|Multiple Dose Phase|Adverse Event|1|||
160453616|NCT05170841|579392143|FG001|Multiple Dose Phase|Adverse Event|2|||
160453617|NCT05170841|579392144|FG002|Multiple Dose Phase|Adverse Event|1|||
160453618|NCT05170841|579392145|FG003|Multiple Dose Phase|Adverse Event|4|||
160453619|NCT05170841|579392142|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
160453620|NCT05170841|579392143|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
160453621|NCT05170841|579392144|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
160453622|NCT05170841|579392145|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
160453623|NCT03088878|579392162|FG000|Overall Study|Adverse Event|0|||
160453624|NCT03088878|579392163|FG001|Overall Study|Adverse Event|0|||
160453625|NCT03088878|579392164|FG002|Overall Study|Adverse Event|0|||
160453626|NCT03088878|579392165|FG003|Overall Study|Adverse Event|0|||
160453627|NCT03088878|579392166|FG004|Overall Study|Adverse Event|4|||
160453628|NCT03088878|579392167|FG005|Overall Study|Adverse Event|2|||
160453629|NCT03088878|579392168|FG006|Overall Study|Adverse Event|1|||
160453630|NCT03088878|579392169|FG007|Overall Study|Adverse Event|0|||
160453631|NCT03088878|579392170|FG008|Overall Study|Adverse Event|0|||
160453632|NCT03088878|579392171|FG009|Overall Study|Adverse Event|0|||
160453633|NCT03088878|579392172|FG010|Overall Study|Adverse Event|0|||
160453634|NCT03088878|579392173|FG011|Overall Study|Adverse Event|0|||
160453635|NCT03088878|579392174|FG012|Overall Study|Adverse Event|5|||
160453636|NCT03088878|579392175|FG013|Overall Study|Adverse Event|3|||
160652767|NCT03471078|580110360|FG001|Overall Study|Other|2|||
160652768|NCT02688400|580110367|FG000|Overall Study|Protocol Violation|2|||
160915595|NCT02289417|581081895|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
160915596|NCT02289417|581081896|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
160915597|NCT02289417|581081897|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
160915598|NCT02289417|581081898|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
160915599|NCT02725710|581081899|FG000|Overall Study|Lost to Follow-up|1|||
160915600|NCT02725710|581081900|FG001|Overall Study|Lost to Follow-up|0|||
160915601|NCT01782222|581081901|FG000|Overall Study|Adverse Event|4|||
160915602|NCT01782222|581081902|FG001|Overall Study|Adverse Event|5|||
160915603|NCT01782222|581081903|FG002|Overall Study|Adverse Event|3|||
160915604|NCT01782222|581081901|FG000|Overall Study|Lack of Efficacy|2|||
160915605|NCT01782222|581081902|FG001|Overall Study|Lack of Efficacy|1|||
160915606|NCT01782222|581081903|FG002|Overall Study|Lack of Efficacy|0|||
160915607|NCT01782222|581081901|FG000|Overall Study|Protocol Violation|1|||
160915608|NCT01782222|581081902|FG001|Overall Study|Protocol Violation|0|||
160915609|NCT01782222|581081903|FG002|Overall Study|Protocol Violation|0|||
160915610|NCT01782222|581081901|FG000|Overall Study|Withdrawal by Subject|1|||
160915611|NCT01782222|581081902|FG001|Overall Study|Withdrawal by Subject|4|||
160996036|NCT00567879|581372094|FG005|Overall Study|Adverse Event|0|||
160453637|NCT03088878|579392162|FG000|Overall Study|Clinical Progression|0|||
160453638|NCT03088878|579392163|FG001|Overall Study|Clinical Progression|0|||
160453639|NCT03088878|579392164|FG002|Overall Study|Clinical Progression|0|||
160453640|NCT03088878|579392165|FG003|Overall Study|Clinical Progression|0|||
160453641|NCT03088878|579392166|FG004|Overall Study|Clinical Progression|2|||
160453642|NCT03088878|579392167|FG005|Overall Study|Clinical Progression|0|||
160453643|NCT03088878|579392168|FG006|Overall Study|Clinical Progression|0|||
160652769|NCT02688400|580110368|FG001|Overall Study|Protocol Violation|5|||
160915612|NCT01782222|581081903|FG002|Overall Study|Withdrawal by Subject|1|||
160915613|NCT01782222|581081901|FG000|Overall Study|Moved to other state|0|||
160915614|NCT01782222|581081902|FG001|Overall Study|Moved to other state|1|||
160915615|NCT01782222|581081903|FG002|Overall Study|Moved to other state|0|||
160915616|NCT01918085|581081904|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
160915617|NCT01918085|581081905|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
160915618|NCT00687323|581081906|FG000|Overall Study|Death|25|||
160453644|NCT03088878|579392169|FG007|Overall Study|Clinical Progression|0|||
160453645|NCT03088878|579392170|FG008|Overall Study|Clinical Progression|0|||
160453646|NCT03088878|579392171|FG009|Overall Study|Clinical Progression|0|||
160453647|NCT03088878|579392172|FG010|Overall Study|Clinical Progression|0|||
160453648|NCT03088878|579392173|FG011|Overall Study|Clinical Progression|0|||
160453649|NCT03088878|579392174|FG012|Overall Study|Clinical Progression|0|||
160453650|NCT03088878|579392175|FG013|Overall Study|Clinical Progression|0|||
160453651|NCT03088878|579392162|FG000|Overall Study|Death|0|||
160453652|NCT03088878|579392163|FG001|Overall Study|Death|0|||
160453653|NCT03088878|579392164|FG002|Overall Study|Death|0|||
160453654|NCT03088878|579392165|FG003|Overall Study|Death|0|||
160453655|NCT03088878|579392166|FG004|Overall Study|Death|2|||
160453656|NCT03088878|579392167|FG005|Overall Study|Death|0|||
160453657|NCT03088878|579392168|FG006|Overall Study|Death|0|||
160453658|NCT03088878|579392169|FG007|Overall Study|Death|0|||
160453659|NCT03088878|579392170|FG008|Overall Study|Death|0|||
160453660|NCT03088878|579392171|FG009|Overall Study|Death|0|||
160453661|NCT03088878|579392172|FG010|Overall Study|Death|0|||
160453662|NCT03088878|579392173|FG011|Overall Study|Death|1|||
160453663|NCT03088878|579392174|FG012|Overall Study|Death|0|||
160453664|NCT03088878|579392175|FG013|Overall Study|Death|0|||
160453665|NCT03088878|579392162|FG000|Overall Study|Disease Progression|1|||
160453666|NCT03088878|579392163|FG001|Overall Study|Disease Progression|2|||
160453667|NCT03088878|579392164|FG002|Overall Study|Disease Progression|3|||
160453668|NCT03088878|579392165|FG003|Overall Study|Disease Progression|0|||
160453669|NCT03088878|579392166|FG004|Overall Study|Disease Progression|3|||
160453670|NCT03088878|579392167|FG005|Overall Study|Disease Progression|0|||
160453671|NCT03088878|579392168|FG006|Overall Study|Disease Progression|0|||
160453672|NCT03088878|579392169|FG007|Overall Study|Disease Progression|0|||
160453673|NCT03088878|579392170|FG008|Overall Study|Disease Progression|0|||
160453674|NCT03088878|579392171|FG009|Overall Study|Disease Progression|0|||
160453675|NCT03088878|579392172|FG010|Overall Study|Disease Progression|0|||
160453676|NCT03088878|579392173|FG011|Overall Study|Disease Progression|0|||
160453677|NCT03088878|579392174|FG012|Overall Study|Disease Progression|1|||
160453678|NCT03088878|579392175|FG013|Overall Study|Disease Progression|1|||
160453679|NCT03088878|579392162|FG000|Overall Study|Initiation of Alternative Treatment|0|||
160453680|NCT03088878|579392163|FG001|Overall Study|Initiation of Alternative Treatment|0|||
160453681|NCT03088878|579392164|FG002|Overall Study|Initiation of Alternative Treatment|0|||
160453682|NCT03088878|579392165|FG003|Overall Study|Initiation of Alternative Treatment|1|||
160453683|NCT03088878|579392166|FG004|Overall Study|Initiation of Alternative Treatment|0|||
160453684|NCT03088878|579392167|FG005|Overall Study|Initiation of Alternative Treatment|0|||
160453685|NCT03088878|579392168|FG006|Overall Study|Initiation of Alternative Treatment|0|||
160453686|NCT03088878|579392169|FG007|Overall Study|Initiation of Alternative Treatment|1|||
160453687|NCT03088878|579392170|FG008|Overall Study|Initiation of Alternative Treatment|1|||
160453688|NCT03088878|579392171|FG009|Overall Study|Initiation of Alternative Treatment|0|||
160453689|NCT03088878|579392172|FG010|Overall Study|Initiation of Alternative Treatment|0|||
160453690|NCT03088878|579392173|FG011|Overall Study|Initiation of Alternative Treatment|0|||
160453691|NCT03088878|579392174|FG012|Overall Study|Initiation of Alternative Treatment|0|||
160453692|NCT03088878|579392175|FG013|Overall Study|Initiation of Alternative Treatment|0|||
160453693|NCT03088878|579392162|FG000|Overall Study|Withdrawal by Subject|0|||
160453694|NCT03088878|579392163|FG001|Overall Study|Withdrawal by Subject|0|||
160453695|NCT03088878|579392164|FG002|Overall Study|Withdrawal by Subject|0|||
160453696|NCT03088878|579392165|FG003|Overall Study|Withdrawal by Subject|1|||
160453697|NCT03088878|579392166|FG004|Overall Study|Withdrawal by Subject|4|||
160453698|NCT03088878|579392167|FG005|Overall Study|Withdrawal by Subject|1|||
160570587|NCT01486238|579812189|FG001|Overall Study|Lost to Follow-up|3|||
160570588|NCT01050062|579812190|FG000|Overall Study|Adverse Event|75|||
160570589|NCT01050062|579812191|FG001|Overall Study|Adverse Event|22|||
160570590|NCT01050062|579812190|FG000|Overall Study|Lost to Follow-up|83|||
160570591|NCT01050062|579812191|FG001|Overall Study|Lost to Follow-up|35|||
160453699|NCT03088878|579392168|FG006|Overall Study|Withdrawal by Subject|1|||
160453700|NCT03088878|579392169|FG007|Overall Study|Withdrawal by Subject|0|||
160453701|NCT03088878|579392170|FG008|Overall Study|Withdrawal by Subject|1|||
160453702|NCT03088878|579392171|FG009|Overall Study|Withdrawal by Subject|2|||
160453703|NCT03088878|579392172|FG010|Overall Study|Withdrawal by Subject|0|||
160453704|NCT03088878|579392173|FG011|Overall Study|Withdrawal by Subject|2|||
160453705|NCT03088878|579392174|FG012|Overall Study|Withdrawal by Subject|1|||
160453706|NCT03088878|579392175|FG013|Overall Study|Withdrawal by Subject|0|||
160453707|NCT03088878|579392162|FG000|Overall Study|Terminated by Sponsor|2|||
160453708|NCT03088878|579392163|FG001|Overall Study|Terminated by Sponsor|1|||
160453709|NCT03088878|579392164|FG002|Overall Study|Terminated by Sponsor|0|||
160453710|NCT03088878|579392165|FG003|Overall Study|Terminated by Sponsor|1|||
160453711|NCT03088878|579392166|FG004|Overall Study|Terminated by Sponsor|6|||
160453712|NCT03088878|579392167|FG005|Overall Study|Terminated by Sponsor|0|||
160453713|NCT03088878|579392168|FG006|Overall Study|Terminated by Sponsor|0|||
160453714|NCT03088878|579392169|FG007|Overall Study|Terminated by Sponsor|0|||
160453715|NCT03088878|579392170|FG008|Overall Study|Terminated by Sponsor|0|||
160996037|NCT00567879|581372089|FG000|Overall Study|Abnormal test procedure(s)|0|||
160996038|NCT00567879|581372090|FG001|Overall Study|Abnormal test procedure(s)|0|||
160996039|NCT00567879|581372091|FG002|Overall Study|Abnormal test procedure(s)|1|||
160996040|NCT00567879|581372092|FG003|Overall Study|Abnormal test procedure(s)|0|||
160996041|NCT00567879|581372093|FG004|Overall Study|Abnormal test procedure(s)|0|||
160996042|NCT00567879|581372094|FG005|Overall Study|Abnormal test procedure(s)|0|||
160996043|NCT00567879|581372089|FG000|Overall Study|Withdrawal by Subject|0|||
160996044|NCT00567879|581372090|FG001|Overall Study|Withdrawal by Subject|0|||
160996045|NCT00567879|581372091|FG002|Overall Study|Withdrawal by Subject|3|||
160996046|NCT00567879|581372092|FG003|Overall Study|Withdrawal by Subject|1|||
160996047|NCT00567879|581372093|FG004|Overall Study|Withdrawal by Subject|0|||
160996048|NCT00567879|581372094|FG005|Overall Study|Withdrawal by Subject|0|||
160996049|NCT00567879|581372089|FG000|Overall Study|New cancer therapy|0|||
160996050|NCT00567879|581372090|FG001|Overall Study|New cancer therapy|0|||
160996051|NCT00567879|581372091|FG002|Overall Study|New cancer therapy|1|||
160996052|NCT00567879|581372092|FG003|Overall Study|New cancer therapy|0|||
160996053|NCT00567879|581372093|FG004|Overall Study|New cancer therapy|0|||
160996054|NCT00567879|581372094|FG005|Overall Study|New cancer therapy|0|||
160996055|NCT00567879|581372089|FG000|Overall Study|Disease progression|5|||
160996056|NCT00567879|581372090|FG001|Overall Study|Disease progression|7|||
160996057|NCT00567879|581372091|FG002|Overall Study|Disease progression|15|||
160996058|NCT00567879|581372092|FG003|Overall Study|Disease progression|5|||
160996059|NCT00567879|581372093|FG004|Overall Study|Disease progression|11|||
160996060|NCT00567879|581372094|FG005|Overall Study|Disease progression|3|||
160996061|NCT01546155|581372097|FG000|Overall Study|could not tolerate long scan duration|3|||
160996062|NCT00151996|581372098|FG000|Overall Study|Adverse Event|3|||
160996063|NCT00151996|581372099|FG001|Overall Study|Adverse Event|2|||
160996064|NCT00151996|581372098|FG000|Overall Study|Withdrawal by Subject|1|||
160996065|NCT00151996|581372099|FG001|Overall Study|Withdrawal by Subject|1|||
160996066|NCT00151996|581372098|FG000|Overall Study|Protocol Violation|1|||
160996067|NCT00151996|581372099|FG001|Overall Study|Protocol Violation|2|||
160996068|NCT00151996|581372098|FG000|Overall Study|Sponsor's decision|0|||
160996069|NCT00151996|581372099|FG001|Overall Study|Sponsor's decision|2|||
160996070|NCT02930343|581372100|FG000|Overall Study|Lost to Follow-up|9|||
160996071|NCT02930343|581372101|FG001|Overall Study|Lost to Follow-up|7|||
160996072|NCT04588480|581372112|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
160996073|NCT04588480|581372113|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
160996074|NCT04588480|581372114|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
160996075|NCT04588480|581372112|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
160996076|NCT04588480|581372113|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
160996077|NCT04588480|581372114|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
160996078|NCT01242085|581372115|FG000|Overall Study|Withdrawal by Subject|4|||
160996079|NCT01242085|581372116|FG001|Overall Study|Withdrawal by Subject|2|||
160996080|NCT01242085|581372117|FG002|Overall Study|Withdrawal by Subject|0|||
160996081|NCT01242085|581372115|FG000|Overall Study|medically unable to have surgery|4|||
160996082|NCT01242085|581372116|FG001|Overall Study|medically unable to have surgery|5|||
160996083|NCT01242085|581372117|FG002|Overall Study|medically unable to have surgery|0|||
160996084|NCT01178762|581372118|FG000|Overall Study|Lost to Follow-up|15|||
160996085|NCT02322216|581372119|FG000|Overall Study|Adverse Event|1|||
160996086|NCT02322216|581372120|FG001|Overall Study|Adverse Event|0|||
160996087|NCT02322216|581372119|FG000|Overall Study|Withdrawal by Subject|1|||
160996088|NCT02322216|581372120|FG001|Overall Study|Withdrawal by Subject|4|||
160996089|NCT02430532|581372124|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
160996090|NCT02430532|581372125|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
160996091|NCT02430532|581372124|FG000|Overall Study|Consent Withdrawn|0|||
160996092|NCT02430532|581372125|FG001|Overall Study|Consent Withdrawn|2|||
160996093|NCT02430532|581372124|FG000|Overall Study|Adverse Event|0|||
160996094|NCT02430532|581372125|FG001|Overall Study|Adverse Event|1|||
160996095|NCT01190150|581372126|FG000|First Treatment|Withdrawal by Subject|1|||
160996096|NCT01190150|581372127|FG001|First Treatment|Withdrawal by Subject|0|||
160996097|NCT01190150|581372126|FG000|Washout|Withdrawal by Subject|0|||
160996098|NCT01190150|581372127|FG001|Washout|Withdrawal by Subject|1|||
160996099|NCT01190150|581372126|FG000|Washout|Difficulty in adherence|0|||
160996100|NCT01190150|581372127|FG001|Washout|Difficulty in adherence|1|||
160996101|NCT01726023|581372128|FG000|Overall Study|Death|1|||
160996102|NCT01726023|581372129|FG001|Overall Study|Death|1|||
160996103|NCT01726023|581372128|FG000|Overall Study|Lost to Follow-up|5|||
160996104|NCT01726023|581372129|FG001|Overall Study|Lost to Follow-up|10|||
160996105|NCT01726023|581372128|FG000|Overall Study|Other Eligibility criteria|7|||
160996106|NCT01726023|581372129|FG001|Overall Study|Other Eligibility criteria|7|||
160996107|NCT01726023|581372128|FG000|Overall Study|Withdrawal by Subject|16|||
160996108|NCT01726023|581372129|FG001|Overall Study|Withdrawal by Subject|8|||
160996109|NCT04858425|581372132|FG000|Overall Study|Adverse Event|2|||
160996110|NCT04858425|581372133|FG001|Overall Study|Adverse Event|2|||
160996111|NCT04858425|581372132|FG000|Overall Study|Withdrawal by Subject|3|||
160996112|NCT04858425|581372133|FG001|Overall Study|Withdrawal by Subject|1|||
160996113|NCT04858425|581372132|FG000|Overall Study|Lost to Follow-up|4|||
160570592|NCT01050062|579812190|FG000|Overall Study|Lack of Efficacy|22|||
160570593|NCT01050062|579812191|FG001|Overall Study|Lack of Efficacy|35|||
160570594|NCT01050062|579812190|FG000|Overall Study|Physician Decision|74|||
160915619|NCT00687323|581081906|FG000|Overall Study|Withdrawal by Subject|1|||
160915620|NCT00687323|581081906|FG000|Overall Study|Excluded from efficacy evaluations|6|||
160915621|NCT00687323|581081906|FG000|Overall Study|Screen failure|148|||
160915622|NCT03655691|581081912|FG000|Overall Study|Adverse Event|0|||
160915623|NCT03655691|581081913|FG001|Overall Study|Adverse Event|0|||
160915624|NCT03655691|581081914|FG002|Overall Study|Adverse Event|1|||
160915625|NCT03655691|581081912|FG000|Overall Study|Lost to Follow-up|1|||
160915626|NCT03655691|581081913|FG001|Overall Study|Lost to Follow-up|1|||
160915627|NCT03655691|581081914|FG002|Overall Study|Lost to Follow-up|2|||
160915628|NCT03655691|581081912|FG000|Overall Study|Protocol Violation|0|||
160915629|NCT03655691|581081913|FG001|Overall Study|Protocol Violation|1|||
160915630|NCT03655691|581081914|FG002|Overall Study|Protocol Violation|0|||
160915631|NCT03655691|581081912|FG000|Overall Study|Withdrawal by Subject|1|||
160915632|NCT03655691|581081913|FG001|Overall Study|Withdrawal by Subject|1|||
160915633|NCT03655691|581081914|FG002|Overall Study|Withdrawal by Subject|0|||
160915634|NCT04557371|581081915|FG000|Overall Study|Covid-19-related|0|||
160915635|NCT04557371|581081916|FG001|Overall Study|Covid-19-related|1|||
160915636|NCT04557371|581081917|FG002|Overall Study|Covid-19-related|0|||
160915637|NCT04557371|581081915|FG000|Overall Study|Withdrawal by Subject|0|||
160915638|NCT04557371|581081916|FG001|Overall Study|Withdrawal by Subject|1|||
160915639|NCT04557371|581081917|FG002|Overall Study|Withdrawal by Subject|0|||
160915640|NCT04557371|581081915|FG000|Overall Study|Adverse Event|1|||
160915641|NCT04557371|581081916|FG001|Overall Study|Adverse Event|0|||
160915642|NCT04557371|581081917|FG002|Overall Study|Adverse Event|0|||
160915643|NCT03918447|581081918|FG000|Overall Study|Death|1|||
160915644|NCT03918447|581081919|FG001|Overall Study|Death|0|||
160915645|NCT03918447|581081918|FG000|Overall Study|Lost to Follow-up|13|||
160915646|NCT03918447|581081919|FG001|Overall Study|Lost to Follow-up|6|||
160915647|NCT03918447|581081918|FG000|Overall Study|Withdrawal by Subject|19|||
160915648|NCT03918447|581081919|FG001|Overall Study|Withdrawal by Subject|17|||
160915649|NCT03918447|581081918|FG000|Overall Study|Study Terminated by Sponsor|195|||
160915650|NCT03918447|581081919|FG001|Overall Study|Study Terminated by Sponsor|197|||
160915651|NCT03918447|581081918|FG000|Overall Study|Reason not Specified|0|||
160915652|NCT03918447|581081919|FG001|Overall Study|Reason not Specified|1|||
160915653|NCT05355805|581081920|FG000|Overall Study|Lost to Follow-up|6|||
160915654|NCT05355805|581081921|FG001|Overall Study|Lost to Follow-up|11|||
160915655|NCT05355805|581081922|FG002|Overall Study|Lost to Follow-up|10|||
160915656|NCT05355805|581081923|FG003|Overall Study|Lost to Follow-up|6|||
160915657|NCT05355805|581081920|FG000|Overall Study|Decision by Sponsor|0|||
160915658|NCT05355805|581081921|FG001|Overall Study|Decision by Sponsor|0|||
160915659|NCT05355805|581081922|FG002|Overall Study|Decision by Sponsor|1|||
160915660|NCT05355805|581081923|FG003|Overall Study|Decision by Sponsor|0|||
160915661|NCT05355805|581081920|FG000|Overall Study|Withdrawal by Subject|7|||
160915662|NCT05355805|581081921|FG001|Overall Study|Withdrawal by Subject|14|||
160915663|NCT05355805|581081922|FG002|Overall Study|Withdrawal by Subject|15|||
160915664|NCT05355805|581081923|FG003|Overall Study|Withdrawal by Subject|13|||
160915665|NCT04232124|581083646|FG000|Overall Study|Lost to Follow-up|3|||
160915666|NCT01986855|581083649|FG000|Overall Study|Adverse Event|1|||
160915667|NCT01986855|581083650|FG001|Overall Study|Adverse Event|0|||
160915668|NCT01986855|581083651|FG002|Overall Study|Adverse Event|0|||
160915669|NCT01986855|581083649|FG000|Overall Study|Death|3|||
160915670|NCT01986855|581083650|FG001|Overall Study|Death|4|||
160915671|NCT01986855|581083651|FG002|Overall Study|Death|4|||
160915672|NCT01986855|581083649|FG000|Overall Study|Lost to Follow-up|2|||
160915673|NCT01986855|581083650|FG001|Overall Study|Lost to Follow-up|1|||
160915674|NCT01986855|581083651|FG002|Overall Study|Lost to Follow-up|0|||
160915675|NCT01986855|581083649|FG000|Overall Study|Screen Failure|0|||
160570595|NCT01050062|579812191|FG001|Overall Study|Physician Decision|9|||
160570596|NCT01050062|579812190|FG000|Overall Study|Others|17|||
160570597|NCT01050062|579812191|FG001|Overall Study|Others|11|||
160570598|NCT03894540|579812192|FG000|Overall Study|Adverse Event|0|||
160915676|NCT01986855|581083650|FG001|Overall Study|Screen Failure|1|||
160915677|NCT01986855|581083651|FG002|Overall Study|Screen Failure|0|||
160915678|NCT01986855|581083649|FG000|Overall Study|Participant Moved|0|||
160915679|NCT01986855|581083650|FG001|Overall Study|Participant Moved|0|||
160915680|NCT01986855|581083651|FG002|Overall Study|Participant Moved|2|||
160915681|NCT01986855|581083649|FG000|Overall Study|Withdrawal by Subject|7|||
160915682|NCT01986855|581083650|FG001|Overall Study|Withdrawal by Subject|8|||
160915683|NCT01986855|581083651|FG002|Overall Study|Withdrawal by Subject|5|||
160915684|NCT04317066|581083652|FG000|Overall Study|Sponsor decision|5|||
160915685|NCT04317066|581083652|FG000|Overall Study|Death|2|||
160915686|NCT02014597|581083656|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
160915687|NCT02014597|581083657|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
160915688|NCT02279173|581083659|FG000|Overall Study|Protocol-specified Criteria|67|||
160570599|NCT03894540|579812193|FG001|Overall Study|Adverse Event|0|||
160915689|NCT02279173|581083659|FG000|Overall Study|Withdrawal by Subject|20|||
160996114|NCT04858425|581372133|FG001|Overall Study|Lost to Follow-up|2|||
160996115|NCT04858425|581372132|FG000|Overall Study|Lost to Follow-up|1|||
160996116|NCT04858425|581372133|FG001|Overall Study|Lost to Follow-up|0|||
160996117|NCT03473743|581372134|FG000|Overall Study|Withdrawal by Subject|0|||
160996118|NCT03473743|581372135|FG001|Overall Study|Withdrawal by Subject|0|||
160996119|NCT03473743|581372136|FG002|Overall Study|Withdrawal by Subject|0|||
160996120|NCT03473743|581372137|FG003|Overall Study|Withdrawal by Subject|0|||
160996121|NCT03473743|581372138|FG004|Overall Study|Withdrawal by Subject|0|||
160996122|NCT03473743|581372139|FG005|Overall Study|Withdrawal by Subject|0|||
160996123|NCT03473743|581372140|FG006|Overall Study|Withdrawal by Subject|0|||
160996124|NCT03473743|581372141|FG007|Overall Study|Withdrawal by Subject|3|||
160996125|NCT03473743|581372134|FG000|Overall Study|Other|0|||
160996126|NCT03473743|581372135|FG001|Overall Study|Other|0|||
160996127|NCT03473743|581372136|FG002|Overall Study|Other|0|||
160996128|NCT03473743|581372137|FG003|Overall Study|Other|1|||
160996129|NCT03473743|581372138|FG004|Overall Study|Other|0|||
160996130|NCT03473743|581372139|FG005|Overall Study|Other|0|||
160915690|NCT02279173|581083659|FG000|Overall Study|Decision by Sponsor|4|||
160915691|NCT02279173|581083659|FG000|Overall Study|Lost to Follow-up|3|||
160915692|NCT00464087|581083661|FG000|Overall Study|No PCI per inclusion criteria|0|||
160915693|NCT00464087|581083662|FG001|Overall Study|No PCI per inclusion criteria|0|||
160996131|NCT03473743|581372140|FG006|Overall Study|Other|0|||
160915694|NCT00464087|581083663|FG002|Overall Study|No PCI per inclusion criteria|29|||
160915695|NCT01164956|581083664|FG000|Overall Study|Side Effects|1|||
160915696|NCT01164956|581083665|FG001|Overall Study|Side Effects|0|||
160915697|NCT01164956|581083666|FG002|Overall Study|Side Effects|1|||
160915698|NCT00720434|581083667|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
160915699|NCT00720434|581083668|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
160915700|NCT00720434|581083669|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
160915701|NCT00720434|581083670|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
160915702|NCT00720434|581083667|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
160915703|NCT00720434|581083668|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
160915704|NCT00720434|581083669|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
160996132|NCT03473743|581372141|FG007|Overall Study|Other|0|||
160996133|NCT03473743|581372134|FG000|Overall Study|Ongoing|0|||
160996134|NCT03473743|581372135|FG001|Overall Study|Ongoing|0|||
160996135|NCT03473743|581372136|FG002|Overall Study|Ongoing|6|||
160996136|NCT03473743|581372137|FG003|Overall Study|Ongoing|8|||
160996137|NCT03473743|581372138|FG004|Overall Study|Ongoing|1|||
160996138|NCT03473743|581372139|FG005|Overall Study|Ongoing|1|||
160996139|NCT03473743|581372140|FG006|Overall Study|Ongoing|22|||
160996140|NCT03473743|581372141|FG007|Overall Study|Ongoing|24|||
160996141|NCT03473743|581372134|FG000|Overall Study|Randomized but not treated|0|||
160996142|NCT03473743|581372135|FG001|Overall Study|Randomized but not treated|0|||
160996143|NCT03473743|581372136|FG002|Overall Study|Randomized but not treated|0|||
160996144|NCT03473743|581372137|FG003|Overall Study|Randomized but not treated|0|||
160996145|NCT03473743|581372138|FG004|Overall Study|Randomized but not treated|0|||
160996146|NCT03473743|581372139|FG005|Overall Study|Randomized but not treated|0|||
160996147|NCT03473743|581372140|FG006|Overall Study|Randomized but not treated|1|||
160996148|NCT03473743|581372141|FG007|Overall Study|Randomized but not treated|1|||
160996149|NCT04536077|581372143|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
160996150|NCT04536077|581372144|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
160996151|NCT04536077|581372143|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
160996152|NCT04536077|581372144|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
160996153|NCT03805295|581372145|FG000|Overall Study|Lost to Follow-up|17|||
160996154|NCT03805295|581372146|FG001|Overall Study|Lost to Follow-up|43|||
160996155|NCT04925752|581372147|FG000|Overall Study|Still on Study|1826|||
160996156|NCT04925752|581372148|FG001|Overall Study|Still on Study|926|||
160996157|NCT04925752|581372147|FG000|Overall Study|Withdrew Consent|128|||
160996158|NCT04925752|581372148|FG001|Overall Study|Withdrew Consent|59|||
160996159|NCT04925752|581372147|FG000|Overall Study|Lost to Follow-up|73|||
160996160|NCT04925752|581372148|FG001|Overall Study|Lost to Follow-up|47|||
160996161|NCT04925752|581372147|FG000|Overall Study|Randomized but Never Treated|12|||
160996162|NCT04925752|581372148|FG001|Overall Study|Randomized but Never Treated|9|||
160996163|NCT04925752|581372147|FG000|Overall Study|Hiv-1 Infection|6|||
160996164|NCT04925752|581372148|FG001|Overall Study|Hiv-1 Infection|7|||
160570600|NCT03894540|579812194|FG002|Overall Study|Adverse Event|0|||
160570601|NCT03894540|579812195|FG003|Overall Study|Adverse Event|0|||
160915705|NCT00720434|581083670|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
160915706|NCT00720434|581083667|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
160915707|NCT00720434|581083668|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
160915708|NCT00720434|581083669|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
160996165|NCT04925752|581372147|FG000|Overall Study|Investigator's discretion|8|||
160996166|NCT04925752|581372148|FG001|Overall Study|Investigator's discretion|5|||
160996167|NCT04925752|581372147|FG000|Overall Study|Non-compliance with Study Drug|8|||
160915709|NCT00720434|581083670|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
160915710|NCT00720434|581083667|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
160915711|NCT00720434|581083668|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
160915712|NCT00720434|581083669|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
160915713|NCT00720434|581083670|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
160915714|NCT00720434|581083667|FG000|Open-Label Period (Week 5-72)|Other|4|||
160915715|NCT00720434|581083668|FG001|Open-Label Period (Week 5-72)|Other|3|||
160570602|NCT03894540|579812196|FG004|Overall Study|Adverse Event|1|||
160570603|NCT03894540|579812197|FG005|Overall Study|Adverse Event|0|||
160570604|NCT03894540|579812192|FG000|Overall Study|Withdrawal by Subject|0|||
160915716|NCT00720434|581083669|FG002|Open-Label Period (Week 5-72)|Other|3|||
160915717|NCT00720434|581083670|FG003|Open-Label Period (Week 5-72)|Other|2|||
160915718|NCT00754624|581083671|FG000|Overall Study|Adverse Event|16|||
160915719|NCT00754624|581083671|FG000|Overall Study|Death|1|||
160915720|NCT00754624|581083671|FG000|Overall Study|Physician Decision|8|||
160915721|NCT00754624|581083671|FG000|Overall Study|Protocol Violation|1|||
160915722|NCT00754624|581083671|FG000|Overall Study|Withdrawal by Subject|28|||
160915723|NCT00754624|581083671|FG000|Overall Study|Various|12|||
160915724|NCT00754624|581083671|FG000|Overall Study|Lost to Follow-up|3|||
160915725|NCT00967798|581083672|FG000|Overall Study|Withdrawal by Subject|5|||
160915726|NCT00967798|581083673|FG001|Overall Study|Withdrawal by Subject|2|||
160915727|NCT00967798|581083672|FG000|Overall Study|Lost to Follow-up|4|||
160915728|NCT00967798|581083673|FG001|Overall Study|Lost to Follow-up|1|||
160915729|NCT02425046|581083674|FG000|Overall Study|Lost to Follow-up|52|||
160915730|NCT02425046|581083675|FG001|Overall Study|Lost to Follow-up|50|||
160915731|NCT02425046|581083676|FG002|Overall Study|Lost to Follow-up|56|||
160915732|NCT02425046|581083674|FG000|Overall Study|Withdrawal by Subject|16|||
160915733|NCT02425046|581083675|FG001|Overall Study|Withdrawal by Subject|12|||
160915734|NCT02425046|581083676|FG002|Overall Study|Withdrawal by Subject|0|||
160915735|NCT02782780|581083677|FG000|Overall Study|dropped out after randomization.|7|||
160915736|NCT02782780|581083678|FG001|Overall Study|dropped out after randomization.|5|||
160915737|NCT02782780|581083677|FG000|Overall Study|Protocol Violation|0|||
160915738|NCT02782780|581083678|FG001|Overall Study|Protocol Violation|2|||
160915739|NCT01413191|581083679|FG000|Overall Study|Lost to Follow-up|5|||
160915740|NCT01413191|581083679|FG000|Overall Study|Disease Progression|5|||
160915741|NCT01413191|581083679|FG000|Overall Study|Death|1|||
160915742|NCT03654651|581083680|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
160915743|NCT03654651|581083681|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
160915744|NCT03045328|581083682|FG000|Overall Study|Withdrawal by Subject|2|||
160915745|NCT04429061|581083690|FG000|Overall Study|Lost to Follow-up|62|||
160915746|NCT04429061|581083691|FG001|Overall Study|Lost to Follow-up|87|||
160915747|NCT04429061|581083690|FG000|Overall Study|Withdrawal by Subject|3|||
160915748|NCT04429061|581083691|FG001|Overall Study|Withdrawal by Subject|4|||
160915749|NCT02289898|581083698|FG000|Overall Study|Death|5|||
160915750|NCT02289898|581083699|FG001|Overall Study|Death|4|||
160915751|NCT02289898|581083700|FG002|Overall Study|Death|3|||
160915752|NCT02289898|581083698|FG000|Overall Study|Physician Decision|2|||
160915753|NCT02289898|581083699|FG001|Overall Study|Physician Decision|5|||
160915754|NCT02289898|581083700|FG002|Overall Study|Physician Decision|2|||
160915755|NCT02289898|581083698|FG000|Overall Study|Withdrawal by Subject|0|||
160915756|NCT02289898|581083699|FG001|Overall Study|Withdrawal by Subject|4|||
160915757|NCT02289898|581083700|FG002|Overall Study|Withdrawal by Subject|1|||
160915758|NCT02289898|581083698|FG000|Overall Study|Adverse Event|3|||
160915759|NCT02289898|581083699|FG001|Overall Study|Adverse Event|5|||
160915760|NCT02289898|581083700|FG002|Overall Study|Adverse Event|5|||
160915761|NCT02289898|581083698|FG000|Overall Study|Disease progression|34|||
160915762|NCT02289898|581083699|FG001|Overall Study|Disease progression|28|||
160915763|NCT02289898|581083700|FG002|Overall Study|Disease progression|34|||
160915764|NCT02289898|581083698|FG000|Overall Study|Use of another anticancer therapy|0|||
160915765|NCT02289898|581083699|FG001|Overall Study|Use of another anticancer therapy|0|||
160915766|NCT02289898|581083700|FG002|Overall Study|Use of another anticancer therapy|1|||
160915767|NCT02289898|581083698|FG000|Overall Study|Other|8|||
160570605|NCT03894540|579812193|FG001|Overall Study|Withdrawal by Subject|0|||
160915768|NCT02289898|581083699|FG001|Overall Study|Other|7|||
160915769|NCT02289898|581083700|FG002|Overall Study|Other|10|||
160915770|NCT00885105|581083701|FG000|Overall Study|Withdrawal by Subject|0|||
160915771|NCT00885105|581083702|FG001|Overall Study|Withdrawal by Subject|8|||
160996168|NCT04925752|581372148|FG001|Overall Study|Non-compliance with Study Drug|5|||
160915772|NCT00885105|581083701|FG000|Overall Study|Adverse Event|1|||
160915773|NCT00885105|581083702|FG001|Overall Study|Adverse Event|0|||
160915774|NCT00885105|581083701|FG000|Overall Study|Protocol Violation|0|||
160915775|NCT00885105|581083702|FG001|Overall Study|Protocol Violation|2|||
160915776|NCT03519932|581083703|FG000|First Intervention|Adverse Event|1|||
160915777|NCT03519932|581083704|FG001|First Intervention|Adverse Event|3|||
160915778|NCT02254486|581083705|FG000|Overall Study|Adverse Event|1|||
160915779|NCT02254486|581083706|FG001|Overall Study|Adverse Event|1|||
160915780|NCT02254486|581083705|FG000|Overall Study|Lack of Efficacy|1|||
160915781|NCT02254486|581083706|FG001|Overall Study|Lack of Efficacy|0|||
160996169|NCT04925752|581372147|FG000|Overall Study|Adverse Event|5|||
160996170|NCT04925752|581372148|FG001|Overall Study|Adverse Event|2|||
160996171|NCT04925752|581372147|FG000|Overall Study|Death|4|||
160996172|NCT04925752|581372148|FG001|Overall Study|Death|2|||
160996173|NCT04925752|581372147|FG000|Overall Study|Protocol Violation|1|||
160996174|NCT04925752|581372148|FG001|Overall Study|Protocol Violation|3|||
160996175|NCT04925752|581372147|FG000|Overall Study|Withdrew Assent|1|||
160996176|NCT04925752|581372148|FG001|Overall Study|Withdrew Assent|0|||
160996177|NCT01155869|581372154|FG000|Overall Study|Lost to Follow-up|3|||
160996178|NCT01155869|581372155|FG001|Overall Study|Lost to Follow-up|1|||
160996179|NCT04538664|581372157|FG000|Overall Study|Withdrawal by Subject|5|||
160996180|NCT04538664|581372158|FG001|Overall Study|Withdrawal by Subject|9|||
160996181|NCT04538664|581372157|FG000|Overall Study|Lost to Follow-up|2|||
160996182|NCT04538664|581372158|FG001|Overall Study|Lost to Follow-up|1|||
160996183|NCT04538664|581372157|FG000|Overall Study|Ongoing|106|||
160996184|NCT04538664|581372158|FG001|Overall Study|Ongoing|115|||
160996185|NCT03431350|581372161|FG000|Overall Study|ONGOING|0|||
160996186|NCT03431350|581372162|FG001|Overall Study|ONGOING|0|||
160996187|NCT03431350|581372163|FG002|Overall Study|ONGOING|2|||
160996188|NCT03431350|581372164|FG003|Overall Study|ONGOING|0|||
160996189|NCT03431350|581372165|FG004|Overall Study|ONGOING|1|||
160996190|NCT03431350|581372166|FG005|Overall Study|ONGOING|3|||
160996191|NCT03431350|581372167|FG006|Overall Study|ONGOING|0|||
160996192|NCT03431350|581372168|FG007|Overall Study|ONGOING|1|||
160996193|NCT03431350|581372169|FG008|Overall Study|ONGOING|3|||
160996194|NCT03431350|581372170|FG009|Overall Study|ONGOING|4|||
160996195|NCT03431350|581372171|FG010|Overall Study|ONGOING|2|||
160996196|NCT03431350|581372172|FG011|Overall Study|ONGOING|1|||
160996197|NCT03431350|581372161|FG000|Overall Study|Death|6|||
160996198|NCT03431350|581372162|FG001|Overall Study|Death|5|||
160996199|NCT03431350|581372163|FG002|Overall Study|Death|18|||
160996200|NCT03431350|581372164|FG003|Overall Study|Death|7|||
160996201|NCT03431350|581372165|FG004|Overall Study|Death|4|||
160996202|NCT03431350|581372166|FG005|Overall Study|Death|3|||
160996203|NCT03431350|581372167|FG006|Overall Study|Death|2|||
160996204|NCT03431350|581372168|FG007|Overall Study|Death|0|||
160996205|NCT03431350|581372169|FG008|Overall Study|Death|0|||
160453716|NCT03088878|579392171|FG009|Overall Study|Terminated by Sponsor|0|||
160453717|NCT03088878|579392172|FG010|Overall Study|Terminated by Sponsor|3|||
160453718|NCT03088878|579392173|FG011|Overall Study|Terminated by Sponsor|13|||
160996206|NCT03431350|581372170|FG009|Overall Study|Death|0|||
160996207|NCT03431350|581372171|FG010|Overall Study|Death|4|||
160453719|NCT03088878|579392174|FG012|Overall Study|Terminated by Sponsor|2|||
160453720|NCT03088878|579392175|FG013|Overall Study|Terminated by Sponsor|1|||
160996208|NCT03431350|581372172|FG011|Overall Study|Death|0|||
160996209|NCT03431350|581372161|FG000|Overall Study|Lost to Follow-up|0|||
160996210|NCT03431350|581372162|FG001|Overall Study|Lost to Follow-up|1|||
160996211|NCT03431350|581372163|FG002|Overall Study|Lost to Follow-up|0|||
160996212|NCT03431350|581372164|FG003|Overall Study|Lost to Follow-up|0|||
160996213|NCT03431350|581372165|FG004|Overall Study|Lost to Follow-up|0|||
160996214|NCT03431350|581372166|FG005|Overall Study|Lost to Follow-up|0|||
160996215|NCT03431350|581372167|FG006|Overall Study|Lost to Follow-up|0|||
160996216|NCT03431350|581372168|FG007|Overall Study|Lost to Follow-up|0|||
160996217|NCT03431350|581372169|FG008|Overall Study|Lost to Follow-up|0|||
160996218|NCT03431350|581372170|FG009|Overall Study|Lost to Follow-up|0|||
160996219|NCT03431350|581372171|FG010|Overall Study|Lost to Follow-up|0|||
160996220|NCT03431350|581372172|FG011|Overall Study|Lost to Follow-up|0|||
160996221|NCT03431350|581372161|FG000|Overall Study|Withdrawal by Subject|0|||
160996222|NCT03431350|581372162|FG001|Overall Study|Withdrawal by Subject|0|||
160996223|NCT03431350|581372163|FG002|Overall Study|Withdrawal by Subject|0|||
160996224|NCT03431350|581372164|FG003|Overall Study|Withdrawal by Subject|1|||
160996225|NCT03431350|581372165|FG004|Overall Study|Withdrawal by Subject|1|||
160996226|NCT03431350|581372166|FG005|Overall Study|Withdrawal by Subject|1|||
160996227|NCT03431350|581372167|FG006|Overall Study|Withdrawal by Subject|0|||
160996228|NCT03431350|581372168|FG007|Overall Study|Withdrawal by Subject|0|||
160996229|NCT03431350|581372169|FG008|Overall Study|Withdrawal by Subject|0|||
160996230|NCT03431350|581372170|FG009|Overall Study|Withdrawal by Subject|2|||
160453721|NCT03088878|579392162|FG000|Overall Study|Completed 2 years of Treatment|0|||
160453722|NCT03088878|579392163|FG001|Overall Study|Completed 2 years of Treatment|0|||
160453723|NCT03088878|579392164|FG002|Overall Study|Completed 2 years of Treatment|0|||
160652770|NCT02688400|580110367|FG000|Overall Study|Lack of Efficacy|7|||
160996231|NCT03431350|581372171|FG010|Overall Study|Withdrawal by Subject|0|||
160996232|NCT03431350|581372172|FG011|Overall Study|Withdrawal by Subject|1|||
160996233|NCT03431350|581372161|FG000|Overall Study|Other|0|||
160996234|NCT03431350|581372162|FG001|Overall Study|Other|0|||
160996235|NCT03431350|581372163|FG002|Overall Study|Other|1|||
160996236|NCT03431350|581372164|FG003|Overall Study|Other|3|||
160996237|NCT03431350|581372165|FG004|Overall Study|Other|2|||
160996238|NCT03431350|581372166|FG005|Overall Study|Other|2|||
160996239|NCT03431350|581372167|FG006|Overall Study|Other|4|||
160996240|NCT03431350|581372168|FG007|Overall Study|Other|0|||
160996241|NCT03431350|581372169|FG008|Overall Study|Other|14|||
160570606|NCT03894540|579812194|FG002|Overall Study|Withdrawal by Subject|0|||
160570607|NCT03894540|579812195|FG003|Overall Study|Withdrawal by Subject|0|||
160570608|NCT03894540|579812196|FG004|Overall Study|Withdrawal by Subject|1|||
160570609|NCT03894540|579812197|FG005|Overall Study|Withdrawal by Subject|0|||
160570610|NCT03894540|579812192|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
160570611|NCT03894540|579812193|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
160570612|NCT03894540|579812194|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
160570613|NCT03894540|579812195|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
160570614|NCT03894540|579812196|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
160570615|NCT03894540|579812197|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
160570616|NCT03894540|579812192|FG000|Overall Study|Progressive Disease Clinical|1|||
160570617|NCT03894540|579812193|FG001|Overall Study|Progressive Disease Clinical|1|||
160570618|NCT03894540|579812194|FG002|Overall Study|Progressive Disease Clinical|0|||
160570619|NCT03894540|579812195|FG003|Overall Study|Progressive Disease Clinical|1|||
160570620|NCT03894540|579812196|FG004|Overall Study|Progressive Disease Clinical|5|||
160570621|NCT03894540|579812197|FG005|Overall Study|Progressive Disease Clinical|1|||
160570622|NCT03894540|579812192|FG000|Overall Study|Study termination by sponsor|0|||
160570623|NCT03894540|579812193|FG001|Overall Study|Study termination by sponsor|0|||
160570624|NCT03894540|579812194|FG002|Overall Study|Study termination by sponsor|0|||
160570625|NCT03894540|579812195|FG003|Overall Study|Study termination by sponsor|0|||
160570626|NCT03894540|579812196|FG004|Overall Study|Study termination by sponsor|2|||
160652771|NCT02688400|580110368|FG001|Overall Study|Lack of Efficacy|7|||
160915782|NCT02254486|581083705|FG000|Overall Study|Lost to Follow-up|2|||
160915783|NCT02254486|581083706|FG001|Overall Study|Lost to Follow-up|4|||
160915784|NCT02254486|581083705|FG000|Overall Study|Protocol Violation|1|||
160996242|NCT03431350|581372170|FG009|Overall Study|Other|11|||
160996243|NCT03431350|581372171|FG010|Overall Study|Other|11|||
160996244|NCT03431350|581372172|FG011|Overall Study|Other|15|||
160915785|NCT02254486|581083706|FG001|Overall Study|Protocol Violation|2|||
160915786|NCT02254486|581083705|FG000|Overall Study|Withdrawal by Subject|17|||
160915787|NCT02254486|581083706|FG001|Overall Study|Withdrawal by Subject|15|||
160915788|NCT02254486|581083705|FG000|Overall Study|GFR<60mL/min|16|||
160915789|NCT02254486|581083706|FG001|Overall Study|GFR<60mL/min|21|||
160915790|NCT02254486|581083705|FG000|Overall Study|Various|12|||
160915791|NCT02254486|581083706|FG001|Overall Study|Various|12|||
160915792|NCT01350414|581083707|FG000|Overall Study|Lost to Follow-up|13|||
160915793|NCT01350414|581083707|FG000|Overall Study|Withdrawal by Subject|4|||
160915794|NCT01350414|581083707|FG000|Overall Study|Physician Decision|2|||
160915795|NCT00759954|581083715|FG000|Overall Study|Personal reason|1|||
160915796|NCT00759954|581083716|FG001|Overall Study|Personal reason|0|||
160915797|NCT00759954|581083715|FG000|Overall Study|Adverse Event|1|||
160915798|NCT00759954|581083716|FG001|Overall Study|Adverse Event|2|||
160915799|NCT00022633|581083720|FG000|Overall Study|Adverse Event|11|||
160915800|NCT00022633|581083721|FG001|Overall Study|Adverse Event|1|||
160915801|NCT00022633|581083720|FG000|Overall Study|Refusal unrelated to adverse event|1|||
160915802|NCT00022633|581083721|FG001|Overall Study|Refusal unrelated to adverse event|0|||
160915803|NCT00022633|581083720|FG000|Overall Study|Progression/relapse|9|||
160915804|NCT00022633|581083721|FG001|Overall Study|Progression/relapse|2|||
160915805|NCT00022633|581083720|FG000|Overall Study|Death|4|||
160915806|NCT00022633|581083721|FG001|Overall Study|Death|0|||
160915807|NCT00022633|581083720|FG000|Overall Study|Other - not protocol specified|3|||
160915808|NCT00022633|581083721|FG001|Overall Study|Other - not protocol specified|2|||
160915809|NCT00022633|581083720|FG000|Overall Study|Ineligible|4|||
160915810|NCT00022633|581083721|FG001|Overall Study|Ineligible|0|||
160915811|NCT00372112|581083726|FG000|Overall Study|Adverse Event|0|||
160915812|NCT00372112|581083727|FG001|Overall Study|Adverse Event|1|||
160915813|NCT00372112|581083728|FG002|Overall Study|Adverse Event|1|||
160996245|NCT04487080|581372175|FG000|Overall Study|Withdrawal by Subject|19|||
160996246|NCT04487080|581372176|FG001|Overall Study|Withdrawal by Subject|18|||
160996247|NCT04487080|581372177|FG002|Overall Study|Withdrawal by Subject|13|||
160996248|NCT04487080|581372175|FG000|Overall Study|Lost to Follow-up|3|||
160996249|NCT04487080|581372176|FG001|Overall Study|Lost to Follow-up|1|||
160996250|NCT04487080|581372177|FG002|Overall Study|Lost to Follow-up|0|||
160996251|NCT04487080|581372175|FG000|Overall Study|Ongoing|313|||
160453724|NCT03088878|579392165|FG003|Overall Study|Completed 2 years of Treatment|0|||
160915814|NCT00372112|581083729|FG003|Overall Study|Adverse Event|1|||
160915815|NCT00372112|581083726|FG000|Overall Study|Withdrawal by Subject|0|||
160915816|NCT00372112|581083727|FG001|Overall Study|Withdrawal by Subject|0|||
160453725|NCT03088878|579392166|FG004|Overall Study|Completed 2 years of Treatment|0|||
160915817|NCT00372112|581083728|FG002|Overall Study|Withdrawal by Subject|2|||
160915818|NCT00372112|581083729|FG003|Overall Study|Withdrawal by Subject|1|||
160915819|NCT00372112|581083726|FG000|Overall Study|Exacerbation|0|||
160915820|NCT00372112|581083727|FG001|Overall Study|Exacerbation|0|||
160915821|NCT00372112|581083728|FG002|Overall Study|Exacerbation|0|||
160915822|NCT00372112|581083729|FG003|Overall Study|Exacerbation|1|||
160915823|NCT00372112|581083726|FG000|Overall Study|PR >240 at Visit 3|0|||
160915824|NCT00372112|581083727|FG001|Overall Study|PR >240 at Visit 3|0|||
160915825|NCT00372112|581083728|FG002|Overall Study|PR >240 at Visit 3|0|||
160915826|NCT00372112|581083729|FG003|Overall Study|PR >240 at Visit 3|1|||
160915827|NCT00372112|581083726|FG000|Overall Study|Hepatitis B|1|||
160915828|NCT00372112|581083727|FG001|Overall Study|Hepatitis B|0|||
160915829|NCT00372112|581083728|FG002|Overall Study|Hepatitis B|0|||
160915830|NCT00372112|581083729|FG003|Overall Study|Hepatitis B|0|||
160915831|NCT00372112|581083726|FG000|Overall Study|Other-protocol violation|0|||
160915832|NCT00372112|581083727|FG001|Overall Study|Other-protocol violation|0|||
160915833|NCT00372112|581083728|FG002|Overall Study|Other-protocol violation|1|||
160915834|NCT00372112|581083729|FG003|Overall Study|Other-protocol violation|0|||
160915835|NCT02927431|581083730|FG000|Overall Study|Withdrawal by Subject|0|||
160915836|NCT02927431|581083731|FG001|Overall Study|Withdrawal by Subject|0|||
160915837|NCT02927431|581083732|FG002|Overall Study|Withdrawal by Subject|1|||
160915838|NCT02205814|581083733|FG000|Overall Study|Lost to Follow-up|0|||
160915839|NCT02205814|581083734|FG001|Overall Study|Lost to Follow-up|0|||
160915840|NCT02205814|581083735|FG002|Overall Study|Lost to Follow-up|0|||
160915841|NCT02205814|581083736|FG003|Overall Study|Lost to Follow-up|1|||
160915842|NCT02205814|581083733|FG000|Overall Study|Lack of Efficacy|1|||
160915843|NCT02205814|581083734|FG001|Overall Study|Lack of Efficacy|0|||
160915844|NCT02205814|581083735|FG002|Overall Study|Lack of Efficacy|1|||
160915845|NCT02205814|581083736|FG003|Overall Study|Lack of Efficacy|1|||
160915846|NCT02205814|581083733|FG000|Overall Study|Physician Decision|0|||
160915847|NCT02205814|581083734|FG001|Overall Study|Physician Decision|0|||
160915848|NCT02205814|581083735|FG002|Overall Study|Physician Decision|1|||
160915849|NCT02205814|581083736|FG003|Overall Study|Physician Decision|0|||
160915850|NCT02205814|581083733|FG000|Overall Study|Protocol Violation|1|||
160915851|NCT02205814|581083734|FG001|Overall Study|Protocol Violation|0|||
160915852|NCT02205814|581083735|FG002|Overall Study|Protocol Violation|0|||
160915853|NCT02205814|581083736|FG003|Overall Study|Protocol Violation|1|||
160915854|NCT02205814|581083733|FG000|Overall Study|Withdrawal by Subject|0|||
160915855|NCT02205814|581083734|FG001|Overall Study|Withdrawal by Subject|1|||
160915856|NCT02205814|581083735|FG002|Overall Study|Withdrawal by Subject|2|||
160915857|NCT02205814|581083736|FG003|Overall Study|Withdrawal by Subject|1|||
160915858|NCT02205814|581083733|FG000|Overall Study|not compliant with study procedures|0|||
160915859|NCT02205814|581083734|FG001|Overall Study|not compliant with study procedures|0|||
160915860|NCT02205814|581083735|FG002|Overall Study|not compliant with study procedures|1|||
160915861|NCT02205814|581083736|FG003|Overall Study|not compliant with study procedures|0|||
160915862|NCT02246660|581083737|FG000|Overall Study|Withdrawal by Subject|0|||
160915863|NCT02246660|581083738|FG001|Overall Study|Withdrawal by Subject|1|||
160915864|NCT02246660|581083739|FG002|Overall Study|Withdrawal by Subject|0|||
160915865|NCT02246660|581083737|FG000|Overall Study|Death|0|||
160915866|NCT02246660|581083738|FG001|Overall Study|Death|0|||
160915867|NCT02246660|581083739|FG002|Overall Study|Death|1|||
160915868|NCT04952402|581083740|FG000|Overall Study|Lost to Follow-up|1|||
160915869|NCT04952402|581083741|FG001|Overall Study|Lost to Follow-up|3|||
160996252|NCT04487080|581372176|FG001|Overall Study|Ongoing|297|||
160996253|NCT04487080|581372177|FG002|Overall Study|Ongoing|149|||
160996254|NCT01838200|581372178|FG000|Overall Study|Adverse Event|0|||
160570627|NCT03894540|579812197|FG005|Overall Study|Study termination by sponsor|0|||
160570628|NCT03000452|579812198|FG000|Treatment Period|Death|1|||
160570629|NCT03000452|579812198|FG000|Treatment Period|Progressive Disease (PD)|14|||
160570630|NCT03000452|579812198|FG000|Treatment Period|Physician Decision|1|||
160570631|NCT03000452|579812198|FG000|Treatment Period|Miscellaneous|2|||
160570632|NCT03000452|579812198|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
160570633|NCT03000452|579812198|FG000|Follow-Up Period|Death|3|||
160570634|NCT03000452|579812198|FG000|Follow-Up Period|Withdrawal by Subject|3|||
160570635|NCT00593112|579812199|FG000|Overall Study|Scan Anxiety|3|||
160570636|NCT00593112|579812200|FG001|Overall Study|Scan Anxiety|0|||
160570637|NCT00593112|579812199|FG000|Overall Study|Abnormal Scan|1|||
160570638|NCT00593112|579812200|FG001|Overall Study|Abnormal Scan|0|||
160570639|NCT00593112|579812199|FG000|Overall Study|Unreadable Scan|1|||
160570640|NCT00593112|579812200|FG001|Overall Study|Unreadable Scan|0|||
160570641|NCT00593112|579812199|FG000|Overall Study|Withdrawal by Subject|5|||
160915870|NCT04952402|581083740|FG000|Overall Study|Lack Of Venous Access|0|||
160570642|NCT00593112|579812200|FG001|Overall Study|Withdrawal by Subject|0|||
160570643|NCT03043365|579812201|FG000|Weeks 0 to Week 8|Adverse Event|1|||
160570644|NCT03043365|579812202|FG001|Weeks 0 to Week 8|Adverse Event|3|||
160915871|NCT04952402|581083741|FG001|Overall Study|Lack Of Venous Access|1|||
160915872|NCT00143403|581083742|FG000|Overall Study|Adverse Event|3|||
160915873|NCT00143403|581083743|FG001|Overall Study|Adverse Event|8|||
160915874|NCT00143403|581083742|FG000|Overall Study|Death|1|||
160915875|NCT00143403|581083743|FG001|Overall Study|Death|0|||
160915876|NCT00143403|581083742|FG000|Overall Study|Withdrawal by Subject|3|||
160915877|NCT00143403|581083743|FG001|Overall Study|Withdrawal by Subject|12|||
160915878|NCT00143403|581083742|FG000|Overall Study|Relapse|15|||
160915879|NCT00143403|581083743|FG001|Overall Study|Relapse|7|||
160996255|NCT01838200|581372179|FG001|Overall Study|Adverse Event|2|||
160570645|NCT03043365|579812201|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
160570646|NCT03043365|579812202|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
160570647|NCT03043365|579812201|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
160570648|NCT03043365|579812202|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
160570649|NCT03700892|579812204|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
160570650|NCT03700892|579812205|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
160570651|NCT03700892|579812206|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
160570652|NCT00849212|579812207|FG000|Overall Study|Lack of Efficacy|1|||
160570653|NCT00849212|579812207|FG000|Overall Study|Withdrawal by Subject|3|||
160570654|NCT00849212|579812207|FG000|Overall Study|Adverse Event|2|||
160570655|NCT00849212|579812207|FG000|Overall Study|Miscellaneous|1|||
160570656|NCT00923091|579812211|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
160570657|NCT00923091|579812212|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
160570658|NCT00923091|579812213|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
160570659|NCT00923091|579812214|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
160570660|NCT00923091|579812215|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
160570661|NCT00923091|579812216|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
160570662|NCT00923091|579812217|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
160570663|NCT00923091|579812218|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
160570664|NCT00923091|579812219|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
160570665|NCT00923091|579812220|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
160570666|NCT00923091|579812221|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
160570667|NCT00923091|579812222|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
160570668|NCT00923091|579812223|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
160570669|NCT00923091|579812211|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
160570670|NCT00923091|579812212|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
160570671|NCT00923091|579812213|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
160570672|NCT00923091|579812214|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
160570673|NCT00923091|579812215|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
160570674|NCT00923091|579812216|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
160915880|NCT00143403|581083742|FG000|Overall Study|Protocol Violation|2|||
160915881|NCT00143403|581083743|FG001|Overall Study|Protocol Violation|2|||
160915882|NCT00143403|581083742|FG000|Overall Study|specified by site|4|||
160915883|NCT00143403|581083743|FG001|Overall Study|specified by site|9|||
160915884|NCT00143403|581083742|FG000|Overall Study|Randomized Not Treated|7|||
160915885|NCT00143403|581083743|FG001|Overall Study|Randomized Not Treated|8|||
160915886|NCT00587639|581083744|FG000|Overall Study|Withdrawal by Subject|1|||
160915887|NCT01442675|581083745|FG000|Overall Study|Protocol Violation|6|||
160915888|NCT01442675|581083745|FG000|Overall Study|Lost to Follow-up|2|||
160915889|NCT01442675|581083745|FG000|Overall Study|Withdrawal by Subject|4|||
160915890|NCT01574612|581083750|FG000|Overall Study|Adverse Event|3|||
160915891|NCT01574612|581083750|FG000|Overall Study|non compliant with drug|2|||
160915892|NCT01574612|581083750|FG000|Overall Study|Withdrawal by Subject|1|||
160915893|NCT01574612|581083750|FG000|Overall Study|Lost to Follow-up|2|||
160915894|NCT02859454|581083751|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
160915895|NCT02452398|581083756|FG000|Overall Study|Adverse Event|1|||
160915896|NCT02452398|581083756|FG000|Overall Study|Lost to Follow-up|28|||
160915897|NCT02452398|581083756|FG000|Overall Study|Physician Decision|2|||
160915898|NCT02452398|581083756|FG000|Overall Study|Withdrawal by Subject|6|||
160915899|NCT02452398|581083756|FG000|Overall Study|Moved away|4|||
160915900|NCT03944954|581083757|FG000|Overall Study|Withdrawal by Subject|22|||
160915901|NCT03944954|581083758|FG001|Overall Study|Withdrawal by Subject|4|||
160915902|NCT03944954|581083757|FG000|Overall Study|Lost to Follow-up|18|||
160915903|NCT03944954|581083758|FG001|Overall Study|Lost to Follow-up|0|||
160915904|NCT03944954|581083757|FG000|Overall Study|Failed Medical Screening|7|||
160915905|NCT03944954|581083758|FG001|Overall Study|Failed Medical Screening|0|||
160915906|NCT02505867|581083759|FG000|Overall Study|Lack of Efficacy|6|||
160915907|NCT02505867|581083760|FG001|Overall Study|Lack of Efficacy|6|||
160915908|NCT01605877|581083776|FG000|Overall Study|Withdrawal by Subject|1|||
160915909|NCT02547454|581083780|FG000|Overall Study|Due to hemodialysis|53|||
160915910|NCT02547454|581083780|FG000|Overall Study|Due to transplantation|1|||
160915911|NCT02547454|581083780|FG000|Overall Study|Due to no further need to treat|4|||
160915912|NCT02547454|581083780|FG000|Overall Study|Death|38|||
160915913|NCT02547454|581083780|FG000|Overall Study|Lost to Follow-up|26|||
160915914|NCT02547454|581083780|FG000|Overall Study|Other|39|||
160915915|NCT02547454|581083780|FG000|Overall Study|No data|11|||
160915916|NCT01428453|581083783|FG000|Overall Study|Adverse Event|2|||
160915917|NCT01428453|581083784|FG001|Overall Study|Adverse Event|7|||
160915918|NCT01428453|581083783|FG000|Overall Study|Protocol Violation|1|||
160915919|NCT01428453|581083784|FG001|Overall Study|Protocol Violation|0|||
160915920|NCT01428453|581083783|FG000|Overall Study|Lost to Follow-up|0|||
160915921|NCT01428453|581083784|FG001|Overall Study|Lost to Follow-up|1|||
160915922|NCT01428453|581083783|FG000|Overall Study|Withdrawal by Subject|3|||
160996256|NCT01838200|581372178|FG000|Overall Study|Progressive disease|3|||
160996257|NCT01838200|581372179|FG001|Overall Study|Progressive disease|0|||
160996258|NCT03105336|581372180|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
160996259|NCT03105336|581372181|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
160996260|NCT03105336|581372180|FG000|Overall Study|Death|40|||
160996261|NCT03105336|581372181|FG001|Overall Study|Death|8|||
160996262|NCT03105336|581372180|FG000|Overall Study|Lost to Follow-up|13|||
160996263|NCT03105336|581372181|FG001|Overall Study|Lost to Follow-up|2|||
160996264|NCT03105336|581372180|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
160996265|NCT03105336|581372181|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
160570675|NCT00923091|579812217|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
160570676|NCT00923091|579812218|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
160570677|NCT00923091|579812219|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
160570678|NCT00923091|579812220|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
160570679|NCT00923091|579812221|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
160996266|NCT03105336|581372180|FG000|Overall Study|Reason Not Specified|3|||
160996267|NCT03105336|581372181|FG001|Overall Study|Reason Not Specified|3|||
160996268|NCT03105336|581372180|FG000|Overall Study|Investigator Decision|3|||
160996269|NCT03105336|581372181|FG001|Overall Study|Investigator Decision|0|||
160996270|NCT03451851|581372182|FG000|PCP: Week 0 -16|Adverse Event|1|||
160996271|NCT03451851|581372183|FG001|PCP: Week 0 -16|Adverse Event|0|||
160996272|NCT03451851|581372184|FG002|PCP: Week 0 -16|Adverse Event|0|||
160570680|NCT00923091|579812222|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
160570681|NCT00923091|579812223|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
160570682|NCT00923091|579812211|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
160570683|NCT00923091|579812212|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
160570684|NCT00923091|579812213|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
160570685|NCT00923091|579812214|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
160570686|NCT00923091|579812215|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
160570687|NCT00923091|579812216|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
160570688|NCT00923091|579812217|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
160570689|NCT00923091|579812218|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
160570690|NCT00923091|579812219|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
160570691|NCT00923091|579812220|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
160570692|NCT00923091|579812221|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
160570693|NCT00923091|579812222|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
160570694|NCT00923091|579812223|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
160570695|NCT00923091|579812211|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570696|NCT00923091|579812212|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570697|NCT00923091|579812213|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570698|NCT00923091|579812214|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570699|NCT00923091|579812215|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570700|NCT00923091|579812216|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
160570701|NCT00923091|579812217|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570702|NCT00923091|579812218|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570703|NCT00923091|579812219|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570704|NCT00923091|579812220|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570705|NCT00923091|579812221|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570706|NCT00923091|579812222|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570707|NCT00923091|579812223|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
160570708|NCT00923091|579812211|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
160570709|NCT00923091|579812212|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
160570710|NCT00923091|579812213|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
160570711|NCT00923091|579812214|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
160570712|NCT00923091|579812215|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
160570713|NCT00923091|579812216|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
160570714|NCT00923091|579812217|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
160570715|NCT00923091|579812218|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
160570716|NCT00923091|579812219|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
160570717|NCT00923091|579812220|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
160570718|NCT00923091|579812221|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
160570719|NCT00923091|579812222|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
160996273|NCT03451851|581372185|FG003|PCP: Week 0 -16|Adverse Event|0|||
160996274|NCT03451851|581372186|FG004|PCP: Week 0 -16|Adverse Event|0|||
160996275|NCT03451851|581372187|FG005|PCP: Week 0 -16|Adverse Event|0|||
160996276|NCT03451851|581372188|FG006|PCP: Week 0 -16|Adverse Event|1|||
160996277|NCT03451851|581372189|FG007|PCP: Week 0 -16|Adverse Event|0|||
160996278|NCT03451851|581372182|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
160570720|NCT00923091|579812223|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
160570721|NCT00923091|579812211|FG000|Period III (Single-Blind)|Adverse Event|5|||
160570722|NCT00923091|579812212|FG001|Period III (Single-Blind)|Adverse Event|0|||
160570723|NCT00923091|579812213|FG002|Period III (Single-Blind)|Adverse Event|0|||
160570724|NCT00923091|579812214|FG003|Period III (Single-Blind)|Adverse Event|0|||
160570725|NCT00923091|579812215|FG004|Period III (Single-Blind)|Adverse Event|0|||
160570726|NCT00923091|579812216|FG005|Period III (Single-Blind)|Adverse Event|0|||
160570727|NCT00923091|579812217|FG006|Period III (Single-Blind)|Adverse Event|0|||
160570728|NCT00923091|579812218|FG007|Period III (Single-Blind)|Adverse Event|0|||
160570729|NCT00923091|579812219|FG008|Period III (Single-Blind)|Adverse Event|0|||
160570730|NCT00923091|579812220|FG009|Period III (Single-Blind)|Adverse Event|0|||
160570731|NCT00923091|579812221|FG010|Period III (Single-Blind)|Adverse Event|0|||
160570732|NCT00923091|579812222|FG011|Period III (Single-Blind)|Adverse Event|0|||
160570733|NCT00923091|579812223|FG012|Period III (Single-Blind)|Adverse Event|0|||
160570734|NCT00923091|579812211|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
160570735|NCT00923091|579812212|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
160570736|NCT00923091|579812213|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
160570737|NCT00923091|579812214|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
160570738|NCT00923091|579812215|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
160570739|NCT00923091|579812216|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
160570740|NCT00923091|579812217|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
160652772|NCT02688400|580110367|FG000|Overall Study|Adverse Event|21|||
160652773|NCT02688400|580110368|FG001|Overall Study|Adverse Event|12|||
160652774|NCT02688400|580110367|FG000|Overall Study|Withdrawal by Subject|15|||
160652775|NCT02688400|580110368|FG001|Overall Study|Withdrawal by Subject|13|||
160652776|NCT02688400|580110367|FG000|Overall Study|No study medication intake|1|||
160652777|NCT02688400|580110368|FG001|Overall Study|No study medication intake|4|||
160652778|NCT02688400|580110367|FG000|Overall Study|Lost to Follow-up|0|||
160652779|NCT02688400|580110368|FG001|Overall Study|Lost to Follow-up|3|||
160652780|NCT05568225|580110373|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
160652781|NCT05568225|580110374|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
160652782|NCT05568225|580110375|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
160652783|NCT05568225|580110373|FG000|Primary Treatment Period|Physician Decision|0|||
160652784|NCT05568225|580110374|FG001|Primary Treatment Period|Physician Decision|1|||
160652785|NCT05568225|580110375|FG002|Primary Treatment Period|Physician Decision|0|||
160652786|NCT05568225|580110373|FG000|Primary Treatment Period|Disease progression|0|||
160652787|NCT05568225|580110374|FG001|Primary Treatment Period|Disease progression|1|||
160652788|NCT05568225|580110375|FG002|Primary Treatment Period|Disease progression|0|||
160652789|NCT05568225|580110373|FG000|Primary Treatment Period|Lack of Efficacy|0|||
160652790|NCT05568225|580110374|FG001|Primary Treatment Period|Lack of Efficacy|1|||
160652791|NCT05568225|580110375|FG002|Primary Treatment Period|Lack of Efficacy|0|||
160652792|NCT05568225|580110373|FG000|Primary Treatment Period|Withdrawal of conset|1|||
160652793|NCT05568225|580110374|FG001|Primary Treatment Period|Withdrawal of conset|0|||
160652794|NCT05568225|580110375|FG002|Primary Treatment Period|Withdrawal of conset|4|||
160652795|NCT05568225|580110373|FG000|Primary Treatment Period|Adverse Event|1|||
160652796|NCT05568225|580110374|FG001|Primary Treatment Period|Adverse Event|0|||
160652797|NCT05568225|580110375|FG002|Primary Treatment Period|Adverse Event|0|||
160652798|NCT05568225|580110373|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
160652799|NCT05568225|580110374|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
160652800|NCT05568225|580110375|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
160652801|NCT05568225|580110373|FG000|Extension Treatment Period|Protocol Violation|0|||
160915923|NCT01428453|581083784|FG001|Overall Study|Withdrawal by Subject|1|||
160570741|NCT00923091|579812218|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
160570742|NCT00923091|579812219|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
160915924|NCT01996709|581083785|FG000|Overall Study|Withdrawal by Subject|1|||
160915925|NCT01996709|581083786|FG001|Overall Study|Withdrawal by Subject|0|||
160915926|NCT01996709|581083785|FG000|Overall Study|Lost to Follow-up|3|||
160453726|NCT03088878|579392167|FG005|Overall Study|Completed 2 years of Treatment|0|||
160652802|NCT05568225|580110374|FG001|Extension Treatment Period|Protocol Violation|0|||
160652803|NCT05568225|580110375|FG002|Extension Treatment Period|Protocol Violation|1|||
160652804|NCT05568225|580110373|FG000|Extension Treatment Period|Lack of Efficacy|0|||
160652805|NCT05568225|580110374|FG001|Extension Treatment Period|Lack of Efficacy|0|||
160652806|NCT05568225|580110375|FG002|Extension Treatment Period|Lack of Efficacy|1|||
160652807|NCT03519256|580110386|FG000|Overall Study|Disease recurrence|4|||
160652808|NCT03519256|580110387|FG001|Overall Study|Disease recurrence|4|||
160652809|NCT03519256|580110388|FG002|Overall Study|Disease recurrence|5|||
160652810|NCT03519256|580110389|FG003|Overall Study|Disease recurrence|2|||
160652811|NCT03519256|580110386|FG000|Overall Study|Study drug toxicity|0|||
160652812|NCT03519256|580110387|FG001|Overall Study|Study drug toxicity|2|||
160652813|NCT03519256|580110388|FG002|Overall Study|Study drug toxicity|5|||
160652814|NCT03519256|580110389|FG003|Overall Study|Study drug toxicity|2|||
160915927|NCT01996709|581083786|FG001|Overall Study|Lost to Follow-up|0|||
160915928|NCT01996709|581083785|FG000|Overall Study|Subject Non-Compliant|1|||
160915929|NCT01996709|581083786|FG001|Overall Study|Subject Non-Compliant|0|||
160915930|NCT01996709|581083785|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
160915931|NCT01996709|581083786|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
160915932|NCT01482884|581083787|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
160915933|NCT01482884|581083788|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
160915934|NCT01482884|581083787|FG000|Overall Study|Protocol Violation|1|||
160915935|NCT01482884|581083788|FG001|Overall Study|Protocol Violation|0|||
160915936|NCT01482884|581083787|FG000|Overall Study|Lost to Follow-up|2|||
160915937|NCT01482884|581083788|FG001|Overall Study|Lost to Follow-up|2|||
160915938|NCT01482884|581083787|FG000|Overall Study|Lack of Efficacy|0|||
160915939|NCT01482884|581083788|FG001|Overall Study|Lack of Efficacy|1|||
160915940|NCT01482884|581083787|FG000|Overall Study|Adverse Event|2|||
160915941|NCT01482884|581083788|FG001|Overall Study|Adverse Event|1|||
160915942|NCT01482884|581083787|FG000|Overall Study|Withdrawal by Subject|8|||
160915943|NCT01482884|581083788|FG001|Overall Study|Withdrawal by Subject|13|||
160915944|NCT04102020|581083789|FG000|Overall Study|Adverse Event|1|||
160915945|NCT04102020|581083790|FG001|Overall Study|Adverse Event|0|||
160915946|NCT04102020|581083791|FG002|Overall Study|Adverse Event|0|||
160915947|NCT04102020|581083792|FG003|Overall Study|Adverse Event|1|||
160915948|NCT04102020|581083793|FG004|Overall Study|Adverse Event|0|||
160915949|NCT04102020|581083789|FG000|Overall Study|Withdrawal by Subject|0|||
160915950|NCT04102020|581083790|FG001|Overall Study|Withdrawal by Subject|1|||
160915951|NCT04102020|581083791|FG002|Overall Study|Withdrawal by Subject|1|||
160915952|NCT04102020|581083792|FG003|Overall Study|Withdrawal by Subject|1|||
160915953|NCT04102020|581083793|FG004|Overall Study|Withdrawal by Subject|1|||
160915954|NCT04102020|581083789|FG000|Overall Study|Death|1|||
160570743|NCT00923091|579812220|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
160570744|NCT00923091|579812221|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
160570745|NCT00923091|579812222|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
160570746|NCT00923091|579812223|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
160570747|NCT00923091|579812211|FG000|Period III (Single-Blind)|Protocol Violation|3|||
160570748|NCT00923091|579812212|FG001|Period III (Single-Blind)|Protocol Violation|0|||
160570749|NCT00923091|579812213|FG002|Period III (Single-Blind)|Protocol Violation|0|||
160570750|NCT00923091|579812214|FG003|Period III (Single-Blind)|Protocol Violation|0|||
160570751|NCT00923091|579812215|FG004|Period III (Single-Blind)|Protocol Violation|0|||
160570752|NCT00923091|579812216|FG005|Period III (Single-Blind)|Protocol Violation|0|||
160570753|NCT00923091|579812217|FG006|Period III (Single-Blind)|Protocol Violation|0|||
160570754|NCT00923091|579812218|FG007|Period III (Single-Blind)|Protocol Violation|0|||
160570755|NCT00923091|579812219|FG008|Period III (Single-Blind)|Protocol Violation|0|||
160570756|NCT00923091|579812220|FG009|Period III (Single-Blind)|Protocol Violation|0|||
160570757|NCT00923091|579812221|FG010|Period III (Single-Blind)|Protocol Violation|0|||
160570758|NCT00923091|579812222|FG011|Period III (Single-Blind)|Protocol Violation|0|||
160570759|NCT00923091|579812223|FG012|Period III (Single-Blind)|Protocol Violation|0|||
160570760|NCT00923091|579812211|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
160570761|NCT00923091|579812212|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
160570762|NCT00923091|579812213|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
160570763|NCT00923091|579812214|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
160570764|NCT00923091|579812215|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
160570765|NCT00923091|579812216|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
160570766|NCT00923091|579812217|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
160570767|NCT00923091|579812218|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
160570768|NCT00923091|579812219|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
160570769|NCT00923091|579812220|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
160570770|NCT00923091|579812221|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
160570771|NCT00923091|579812222|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
160570772|NCT00923091|579812223|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
160570773|NCT00923091|579812211|FG000|Period IV (Double-Blind)|Adverse Event|2|||
160570774|NCT00923091|579812212|FG001|Period IV (Double-Blind)|Adverse Event|0|||
160570775|NCT00923091|579812213|FG002|Period IV (Double-Blind)|Adverse Event|0|||
160570776|NCT00923091|579812214|FG003|Period IV (Double-Blind)|Adverse Event|0|||
160861635|NCT04225897|580887796|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861636|NCT04225897|580887797|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861637|NCT04225897|580887786|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861638|NCT04225897|580887787|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861639|NCT04225897|580887788|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
160861640|NCT04225897|580887789|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861641|NCT04225897|580887790|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861642|NCT04225897|580887791|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861643|NCT04225897|580887792|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861644|NCT04225897|580887793|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160915955|NCT04102020|581083790|FG001|Overall Study|Death|4|||
160915956|NCT04102020|581083791|FG002|Overall Study|Death|1|||
160570777|NCT00923091|579812215|FG004|Period IV (Double-Blind)|Adverse Event|0|||
160570778|NCT00923091|579812216|FG005|Period IV (Double-Blind)|Adverse Event|0|||
160570779|NCT00923091|579812217|FG006|Period IV (Double-Blind)|Adverse Event|0|||
160570780|NCT00923091|579812218|FG007|Period IV (Double-Blind)|Adverse Event|0|||
160570781|NCT00923091|579812219|FG008|Period IV (Double-Blind)|Adverse Event|0|||
160570782|NCT00923091|579812220|FG009|Period IV (Double-Blind)|Adverse Event|0|||
160570783|NCT00923091|579812221|FG010|Period IV (Double-Blind)|Adverse Event|0|||
160915957|NCT04102020|581083792|FG003|Overall Study|Death|1|||
160915958|NCT04102020|581083793|FG004|Overall Study|Death|0|||
160915959|NCT04102020|581083789|FG000|Overall Study|Physician Decision|1|||
160915960|NCT04102020|581083790|FG001|Overall Study|Physician Decision|2|||
160915961|NCT04102020|581083791|FG002|Overall Study|Physician Decision|2|||
160915962|NCT04102020|581083792|FG003|Overall Study|Physician Decision|0|||
160915963|NCT04102020|581083793|FG004|Overall Study|Physician Decision|1|||
160915964|NCT04102020|581083789|FG000|Overall Study|COVID-19 Infection|1|||
160915965|NCT04102020|581083790|FG001|Overall Study|COVID-19 Infection|0|||
160915966|NCT04102020|581083791|FG002|Overall Study|COVID-19 Infection|0|||
160915967|NCT04102020|581083792|FG003|Overall Study|COVID-19 Infection|0|||
160915968|NCT04102020|581083793|FG004|Overall Study|COVID-19 Infection|0|||
160915969|NCT04102020|581083789|FG000|Overall Study|Not disclosed|5|||
160915970|NCT04102020|581083790|FG001|Overall Study|Not disclosed|3|||
160915971|NCT04102020|581083791|FG002|Overall Study|Not disclosed|8|||
160915972|NCT04102020|581083792|FG003|Overall Study|Not disclosed|0|||
160915973|NCT04102020|581083793|FG004|Overall Study|Not disclosed|1|||
160915974|NCT04102020|581083789|FG000|Overall Study|MIssing|1|||
160915975|NCT04102020|581083790|FG001|Overall Study|MIssing|0|||
160915976|NCT04102020|581083791|FG002|Overall Study|MIssing|1|||
160915977|NCT04102020|581083792|FG003|Overall Study|MIssing|1|||
160915978|NCT04102020|581083793|FG004|Overall Study|MIssing|1|||
160915979|NCT04102020|581083789|FG000|Overall Study|Continuing in ongoing study|13|||
160915980|NCT04102020|581083790|FG001|Overall Study|Continuing in ongoing study|13|||
160915981|NCT04102020|581083791|FG002|Overall Study|Continuing in ongoing study|7|||
160915982|NCT04102020|581083792|FG003|Overall Study|Continuing in ongoing study|26|||
160915983|NCT04102020|581083793|FG004|Overall Study|Continuing in ongoing study|12|||
160915984|NCT04853225|581083794|FG000|Overall Study|Withdrawal by Subject|81|||
160915985|NCT04853225|581083795|FG001|Overall Study|Withdrawal by Subject|4|||
160915986|NCT04853225|581083796|FG002|Overall Study|Withdrawal by Subject|1|||
160915987|NCT04853225|581083794|FG000|Overall Study|Physician Decision|12|||
160915988|NCT04853225|581083795|FG001|Overall Study|Physician Decision|4|||
160915989|NCT04853225|581083796|FG002|Overall Study|Physician Decision|1|||
160915990|NCT04853225|581083794|FG000|Overall Study|Lost to Follow-up|50|||
160915991|NCT04853225|581083795|FG001|Overall Study|Lost to Follow-up|0|||
160915992|NCT04853225|581083796|FG002|Overall Study|Lost to Follow-up|0|||
160915993|NCT04853225|581083794|FG000|Overall Study|Other|102|||
160915994|NCT04853225|581083795|FG001|Overall Study|Other|11|||
160915995|NCT04853225|581083796|FG002|Overall Study|Other|5|||
160915996|NCT04853225|581083794|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
160570784|NCT00923091|579812222|FG011|Period IV (Double-Blind)|Adverse Event|0|||
160570785|NCT00923091|579812223|FG012|Period IV (Double-Blind)|Adverse Event|0|||
160570786|NCT00923091|579812211|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570787|NCT00923091|579812212|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
160570788|NCT00923091|579812213|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570789|NCT00923091|579812214|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570790|NCT00923091|579812215|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570791|NCT00923091|579812216|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570792|NCT00923091|579812217|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570793|NCT00923091|579812218|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570794|NCT00923091|579812219|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570795|NCT00923091|579812220|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570796|NCT00923091|579812221|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570797|NCT00923091|579812222|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570798|NCT00923091|579812223|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
160570799|NCT00923091|579812211|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
160570800|NCT00923091|579812212|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
160570801|NCT00923091|579812213|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
160570802|NCT00923091|579812214|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
160915997|NCT04853225|581083795|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
160915998|NCT04853225|581083796|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
160915999|NCT04853225|581083794|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
160916000|NCT04853225|581083795|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
160916001|NCT04853225|581083796|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
160916002|NCT03789318|581083797|FG000|Overall Study|Adverse Event|0|||
160916003|NCT03789318|581083798|FG001|Overall Study|Adverse Event|0|||
160570803|NCT00923091|579812215|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
160916004|NCT03789318|581083799|FG002|Overall Study|Adverse Event|1|||
160652815|NCT03519256|580110386|FG000|Overall Study|Adverse event unrelated to study drug|0|||
160652816|NCT03519256|580110387|FG001|Overall Study|Adverse event unrelated to study drug|1|||
160652817|NCT03519256|580110388|FG002|Overall Study|Adverse event unrelated to study drug|1|||
160570804|NCT00923091|579812216|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
160570805|NCT00923091|579812217|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
160570806|NCT00923091|579812218|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
160570807|NCT00923091|579812219|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
160570808|NCT00923091|579812220|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
160570809|NCT00923091|579812221|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
160570810|NCT00923091|579812222|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
160570811|NCT00923091|579812223|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
160570812|NCT00923091|579812211|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570813|NCT00923091|579812212|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570814|NCT00923091|579812213|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570815|NCT00923091|579812214|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570816|NCT00923091|579812215|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570817|NCT00923091|579812216|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570818|NCT00923091|579812217|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570819|NCT00923091|579812218|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570820|NCT00923091|579812219|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
160570821|NCT00923091|579812220|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570822|NCT00923091|579812221|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570823|NCT00923091|579812222|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
160570824|NCT00923091|579812223|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
160570825|NCT00923091|579812211|FG000|Period V (Double -Blind)|Protocol Violation|0|||
160570826|NCT00923091|579812212|FG001|Period V (Double -Blind)|Protocol Violation|0|||
160570827|NCT00923091|579812213|FG002|Period V (Double -Blind)|Protocol Violation|0|||
160570828|NCT00923091|579812214|FG003|Period V (Double -Blind)|Protocol Violation|0|||
160570829|NCT00923091|579812215|FG004|Period V (Double -Blind)|Protocol Violation|0|||
160570830|NCT00923091|579812216|FG005|Period V (Double -Blind)|Protocol Violation|0|||
160570831|NCT00923091|579812217|FG006|Period V (Double -Blind)|Protocol Violation|0|||
160570832|NCT00923091|579812218|FG007|Period V (Double -Blind)|Protocol Violation|0|||
160570833|NCT00923091|579812219|FG008|Period V (Double -Blind)|Protocol Violation|0|||
160570834|NCT00923091|579812220|FG009|Period V (Double -Blind)|Protocol Violation|0|||
160570835|NCT00923091|579812221|FG010|Period V (Double -Blind)|Protocol Violation|0|||
160570836|NCT00923091|579812222|FG011|Period V (Double -Blind)|Protocol Violation|0|||
160570837|NCT00923091|579812223|FG012|Period V (Double -Blind)|Protocol Violation|1|||
160570838|NCT00923091|579812211|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
160570839|NCT00923091|579812212|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
160570840|NCT00923091|579812213|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
160570841|NCT00923091|579812214|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
160570842|NCT00923091|579812215|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
160570843|NCT00923091|579812216|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
160570844|NCT00923091|579812217|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
160570845|NCT00923091|579812218|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
160570846|NCT00923091|579812219|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
160570847|NCT00923091|579812220|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
160570848|NCT00923091|579812221|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
160570849|NCT00923091|579812222|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
160570850|NCT00923091|579812223|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
160570851|NCT00923091|579812211|FG000|Period VI (Open-Label)|Adverse Event|17|||
160570852|NCT00923091|579812212|FG001|Period VI (Open-Label)|Adverse Event|0|||
160570853|NCT00923091|579812213|FG002|Period VI (Open-Label)|Adverse Event|4|||
160570854|NCT00923091|579812214|FG003|Period VI (Open-Label)|Adverse Event|1|||
160652818|NCT03519256|580110389|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160652819|NCT03519256|580110386|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160652820|NCT03519256|580110387|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160652821|NCT03519256|580110388|FG002|Overall Study|Participant request to discontinue study treatment|0|||
160652822|NCT03519256|580110389|FG003|Overall Study|Participant request to discontinue study treatment|2|||
160652823|NCT03519256|580110386|FG000|Overall Study|Other reasons|0|||
160652824|NCT03519256|580110387|FG001|Overall Study|Other reasons|0|||
160652825|NCT03519256|580110388|FG002|Overall Study|Other reasons|2|||
160652826|NCT03519256|580110389|FG003|Overall Study|Other reasons|0|||
160652827|NCT03519256|580110386|FG000|Overall Study|Disease progression|6|||
160652828|NCT03519256|580110387|FG001|Overall Study|Disease progression|3|||
160652829|NCT03519256|580110388|FG002|Overall Study|Disease progression|2|||
160570855|NCT00923091|579812215|FG004|Period VI (Open-Label)|Adverse Event|1|||
160570856|NCT00923091|579812216|FG005|Period VI (Open-Label)|Adverse Event|0|||
160570857|NCT00923091|579812217|FG006|Period VI (Open-Label)|Adverse Event|0|||
160652830|NCT03519256|580110389|FG003|Overall Study|Disease progression|1|||
160570858|NCT00923091|579812218|FG007|Period VI (Open-Label)|Adverse Event|0|||
160570859|NCT00923091|579812219|FG008|Period VI (Open-Label)|Adverse Event|0|||
160570860|NCT00923091|579812220|FG009|Period VI (Open-Label)|Adverse Event|0|||
160570861|NCT00923091|579812221|FG010|Period VI (Open-Label)|Adverse Event|0|||
160570862|NCT00923091|579812222|FG011|Period VI (Open-Label)|Adverse Event|0|||
160570863|NCT00923091|579812223|FG012|Period VI (Open-Label)|Adverse Event|0|||
160570864|NCT00923091|579812211|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
160570865|NCT00923091|579812212|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
160570866|NCT00923091|579812213|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
160570867|NCT00923091|579812214|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
160570868|NCT00923091|579812215|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
160570869|NCT00923091|579812216|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
160570870|NCT00923091|579812217|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
160570871|NCT00923091|579812218|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
160570872|NCT00923091|579812219|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
160570873|NCT00923091|579812220|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
160652831|NCT03519256|580110386|FG000|Overall Study|Lost to Follow-up|0|||
160652832|NCT03519256|580110387|FG001|Overall Study|Lost to Follow-up|1|||
160652833|NCT03519256|580110388|FG002|Overall Study|Lost to Follow-up|0|||
160652834|NCT03519256|580110389|FG003|Overall Study|Lost to Follow-up|0|||
160652835|NCT02207231|580110390|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
160652836|NCT02207231|580110391|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
160652837|NCT02207231|580110392|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
160652838|NCT02207231|580110393|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
160652839|NCT02207231|580110390|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
160652840|NCT02207231|580110391|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
160652841|NCT02207231|580110392|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
160652842|NCT02207231|580110393|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
160652843|NCT02207231|580110390|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
160652844|NCT02207231|580110391|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
160652845|NCT02207231|580110392|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
160652846|NCT02207231|580110393|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
160570874|NCT00923091|579812221|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
160570875|NCT00923091|579812222|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
160570876|NCT00923091|579812223|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
160570877|NCT00923091|579812211|FG000|Period VI (Open-Label)|Protocol Violation|6|||
160916005|NCT03789318|581083800|FG003|Overall Study|Adverse Event|1|||
160570878|NCT00923091|579812212|FG001|Period VI (Open-Label)|Protocol Violation|1|||
160916006|NCT03789318|581083801|FG004|Overall Study|Adverse Event|0|||
160916007|NCT03789318|581083797|FG000|Overall Study|Lost to Follow-up|0|||
160916008|NCT03789318|581083798|FG001|Overall Study|Lost to Follow-up|0|||
160916009|NCT03789318|581083799|FG002|Overall Study|Lost to Follow-up|1|||
160916010|NCT03789318|581083800|FG003|Overall Study|Lost to Follow-up|0|||
160916011|NCT03789318|581083801|FG004|Overall Study|Lost to Follow-up|0|||
160916012|NCT03789318|581083797|FG000|Overall Study|Withdrawal by Subject|0|||
160916013|NCT03789318|581083798|FG001|Overall Study|Withdrawal by Subject|0|||
160916014|NCT03789318|581083799|FG002|Overall Study|Withdrawal by Subject|1|||
160916015|NCT03789318|581083800|FG003|Overall Study|Withdrawal by Subject|0|||
160916016|NCT03789318|581083801|FG004|Overall Study|Withdrawal by Subject|0|||
160916017|NCT00477971|581083802|FG000|Overall Study|Disease progression|6|||
160916018|NCT00477971|581083803|FG001|Overall Study|Disease progression|0|||
160916019|NCT00477971|581083802|FG000|Overall Study|Withdrawal by Subject|3|||
160916020|NCT00477971|581083803|FG001|Overall Study|Withdrawal by Subject|1|||
160916021|NCT00477971|581083802|FG000|Overall Study|Adverse Event|3|||
160916022|NCT00477971|581083803|FG001|Overall Study|Adverse Event|0|||
160916023|NCT00477971|581083802|FG000|Overall Study|Death|2|||
160916024|NCT00477971|581083803|FG001|Overall Study|Death|4|||
160916025|NCT00477971|581083802|FG000|Overall Study|Alternative treatment|3|||
160916026|NCT00477971|581083803|FG001|Overall Study|Alternative treatment|1|||
160916027|NCT01774968|581083804|FG000|Overall Study|Adverse Event|4|||
160916028|NCT01774968|581083805|FG001|Overall Study|Adverse Event|4|||
160916029|NCT01774968|581083804|FG000|Overall Study|Death|0|||
160916030|NCT01774968|581083805|FG001|Overall Study|Death|1|||
160916031|NCT01774968|581083804|FG000|Overall Study|Lost to Follow-up|1|||
160916032|NCT01774968|581083805|FG001|Overall Study|Lost to Follow-up|3|||
160916033|NCT01774968|581083804|FG000|Overall Study|Physician Decision|5|||
160916034|NCT01774968|581083805|FG001|Overall Study|Physician Decision|1|||
160570879|NCT00923091|579812213|FG002|Period VI (Open-Label)|Protocol Violation|3|||
160652847|NCT02207231|580110390|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
160652848|NCT02207231|580110391|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
160916035|NCT01774968|581083804|FG000|Overall Study|Protocol Violation|14|||
160916036|NCT01774968|581083805|FG001|Overall Study|Protocol Violation|13|||
160916037|NCT01774968|581083804|FG000|Overall Study|Sponsor Decision|0|||
160916038|NCT01774968|581083805|FG001|Overall Study|Sponsor Decision|2|||
160916039|NCT01774968|581083804|FG000|Overall Study|Withdrawal by Subject|6|||
160453727|NCT03088878|579392168|FG006|Overall Study|Completed 2 years of Treatment|1|||
160453728|NCT03088878|579392169|FG007|Overall Study|Completed 2 years of Treatment|0|||
160453729|NCT03088878|579392170|FG008|Overall Study|Completed 2 years of Treatment|0|||
160453730|NCT03088878|579392171|FG009|Overall Study|Completed 2 years of Treatment|1|||
160453731|NCT03088878|579392172|FG010|Overall Study|Completed 2 years of Treatment|0|||
160453732|NCT03088878|579392173|FG011|Overall Study|Completed 2 years of Treatment|0|||
160453733|NCT03088878|579392174|FG012|Overall Study|Completed 2 years of Treatment|8|||
160453734|NCT03088878|579392175|FG013|Overall Study|Completed 2 years of Treatment|3|||
160453735|NCT03088878|579392162|FG000|Overall Study|Physician Decision|0|||
160453736|NCT03088878|579392163|FG001|Overall Study|Physician Decision|0|||
160453737|NCT03088878|579392164|FG002|Overall Study|Physician Decision|0|||
160453738|NCT03088878|579392165|FG003|Overall Study|Physician Decision|0|||
160453739|NCT03088878|579392166|FG004|Overall Study|Physician Decision|0|||
160453740|NCT03088878|579392167|FG005|Overall Study|Physician Decision|0|||
160453741|NCT03088878|579392168|FG006|Overall Study|Physician Decision|0|||
160453742|NCT03088878|579392169|FG007|Overall Study|Physician Decision|2|||
160453743|NCT03088878|579392170|FG008|Overall Study|Physician Decision|1|||
160453744|NCT03088878|579392171|FG009|Overall Study|Physician Decision|0|||
160453745|NCT03088878|579392172|FG010|Overall Study|Physician Decision|0|||
160453746|NCT03088878|579392173|FG011|Overall Study|Physician Decision|0|||
160453747|NCT03088878|579392174|FG012|Overall Study|Physician Decision|0|||
160453748|NCT03088878|579392175|FG013|Overall Study|Physician Decision|1|||
160453749|NCT03088878|579392162|FG000|Overall Study|COVID Related noncompliance|0|||
160453750|NCT03088878|579392163|FG001|Overall Study|COVID Related noncompliance|0|||
160453751|NCT03088878|579392164|FG002|Overall Study|COVID Related noncompliance|0|||
160453752|NCT03088878|579392165|FG003|Overall Study|COVID Related noncompliance|0|||
160453753|NCT03088878|579392166|FG004|Overall Study|COVID Related noncompliance|0|||
160453754|NCT03088878|579392167|FG005|Overall Study|COVID Related noncompliance|0|||
160453755|NCT03088878|579392168|FG006|Overall Study|COVID Related noncompliance|0|||
160453756|NCT03088878|579392169|FG007|Overall Study|COVID Related noncompliance|0|||
160570880|NCT00923091|579812214|FG003|Period VI (Open-Label)|Protocol Violation|1|||
160570881|NCT00923091|579812215|FG004|Period VI (Open-Label)|Protocol Violation|4|||
160570882|NCT00923091|579812216|FG005|Period VI (Open-Label)|Protocol Violation|0|||
160570883|NCT00923091|579812217|FG006|Period VI (Open-Label)|Protocol Violation|0|||
160570884|NCT00923091|579812218|FG007|Period VI (Open-Label)|Protocol Violation|0|||
160570885|NCT00923091|579812219|FG008|Period VI (Open-Label)|Protocol Violation|0|||
160570886|NCT00923091|579812220|FG009|Period VI (Open-Label)|Protocol Violation|0|||
160570887|NCT00923091|579812221|FG010|Period VI (Open-Label)|Protocol Violation|0|||
160570888|NCT00923091|579812222|FG011|Period VI (Open-Label)|Protocol Violation|0|||
160570889|NCT00923091|579812223|FG012|Period VI (Open-Label)|Protocol Violation|0|||
160570890|NCT00923091|579812211|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
160570891|NCT00923091|579812212|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
160570892|NCT00923091|579812213|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
160570893|NCT00923091|579812214|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
160570894|NCT00923091|579812215|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
160570895|NCT00923091|579812216|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
160570896|NCT00923091|579812217|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
160570897|NCT00923091|579812218|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
160570898|NCT00923091|579812219|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
160570899|NCT00923091|579812220|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
160570900|NCT00923091|579812221|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
160570901|NCT00923091|579812222|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
160570902|NCT00923091|579812223|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
160916040|NCT01774968|581083805|FG001|Overall Study|Withdrawal by Subject|11|||
160453757|NCT03088878|579392170|FG008|Overall Study|COVID Related noncompliance|0|||
160453758|NCT03088878|579392171|FG009|Overall Study|COVID Related noncompliance|0|||
160453759|NCT03088878|579392172|FG010|Overall Study|COVID Related noncompliance|0|||
160453760|NCT03088878|579392173|FG011|Overall Study|COVID Related noncompliance|0|||
160453761|NCT03088878|579392174|FG012|Overall Study|COVID Related noncompliance|0|||
160453762|NCT03088878|579392175|FG013|Overall Study|COVID Related noncompliance|1|||
160453763|NCT03088878|579392162|FG000|Overall Study|Drug or Study Noncompliance|0|||
160453764|NCT03088878|579392163|FG001|Overall Study|Drug or Study Noncompliance|0|||
160570903|NCT00923091|579812211|FG000|Period VI (Open-Label)|Other Reason|0|||
160570904|NCT00923091|579812212|FG001|Period VI (Open-Label)|Other Reason|0|||
160453765|NCT03088878|579392164|FG002|Overall Study|Drug or Study Noncompliance|0|||
160453766|NCT03088878|579392165|FG003|Overall Study|Drug or Study Noncompliance|0|||
160453767|NCT03088878|579392166|FG004|Overall Study|Drug or Study Noncompliance|0|||
160453768|NCT03088878|579392167|FG005|Overall Study|Drug or Study Noncompliance|0|||
160453769|NCT03088878|579392168|FG006|Overall Study|Drug or Study Noncompliance|0|||
160453770|NCT03088878|579392169|FG007|Overall Study|Drug or Study Noncompliance|0|||
160453771|NCT03088878|579392170|FG008|Overall Study|Drug or Study Noncompliance|0|||
160453772|NCT03088878|579392171|FG009|Overall Study|Drug or Study Noncompliance|0|||
160453773|NCT03088878|579392172|FG010|Overall Study|Drug or Study Noncompliance|0|||
160570905|NCT00923091|579812213|FG002|Period VI (Open-Label)|Other Reason|0|||
160570906|NCT00923091|579812214|FG003|Period VI (Open-Label)|Other Reason|1|||
160570907|NCT00923091|579812215|FG004|Period VI (Open-Label)|Other Reason|1|||
160570908|NCT00923091|579812216|FG005|Period VI (Open-Label)|Other Reason|0|||
160570909|NCT00923091|579812217|FG006|Period VI (Open-Label)|Other Reason|0|||
160570910|NCT00923091|579812218|FG007|Period VI (Open-Label)|Other Reason|0|||
160570911|NCT00923091|579812219|FG008|Period VI (Open-Label)|Other Reason|0|||
160570912|NCT00923091|579812220|FG009|Period VI (Open-Label)|Other Reason|0|||
160570913|NCT00923091|579812221|FG010|Period VI (Open-Label)|Other Reason|0|||
160570914|NCT00923091|579812222|FG011|Period VI (Open-Label)|Other Reason|0|||
160916041|NCT00407563|581085061|FG000|Overall Study|Patient continues on treatment|1|||
160916042|NCT01409564|581085062|FG000|Overall Study|low medication compliance|4|||
160916043|NCT01409564|581085063|FG001|Overall Study|low medication compliance|3|||
160916044|NCT01409564|581085062|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
160916045|NCT01409564|581085063|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
160916046|NCT05040386|581085064|FG000|Overall Study|Withdrawal by Subject|1|||
160916047|NCT05040386|581085065|FG001|Overall Study|Withdrawal by Subject|0|||
160916048|NCT05040386|581085066|FG002|Overall Study|Withdrawal by Subject|1|||
160916049|NCT05040386|581085067|FG003|Overall Study|Withdrawal by Subject|0|||
160916050|NCT05040386|581085064|FG000|Overall Study|Lost to Follow-up|0|||
160916051|NCT05040386|581085065|FG001|Overall Study|Lost to Follow-up|0|||
160916052|NCT05040386|581085066|FG002|Overall Study|Lost to Follow-up|1|||
160916053|NCT05040386|581085067|FG003|Overall Study|Lost to Follow-up|0|||
160916054|NCT02618434|581085070|FG000|Overall Study|Withdrawal by Subject|0|||
160916055|NCT02618434|581085071|FG001|Overall Study|Withdrawal by Subject|2|||
160916056|NCT02618434|581085072|FG002|Overall Study|Withdrawal by Subject|3|||
160916057|NCT02618434|581085070|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
160916058|NCT02618434|581085071|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
160916059|NCT02618434|581085072|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
160916060|NCT02618434|581085070|FG000|Overall Study|Lost to Follow-up|3|||
160916061|NCT02618434|581085071|FG001|Overall Study|Lost to Follow-up|1|||
160916062|NCT02618434|581085072|FG002|Overall Study|Lost to Follow-up|3|||
160916063|NCT02618434|581085070|FG000|Overall Study|Adverse Event|1|||
160916064|NCT02618434|581085071|FG001|Overall Study|Adverse Event|0|||
160570915|NCT00923091|579812223|FG012|Period VI (Open-Label)|Other Reason|0|||
160570916|NCT02117050|579812229|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
160570917|NCT02460822|579812232|FG000|Overall Study|Withdrawal by Subject|1|||
160570918|NCT00754390|579812233|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
160570919|NCT00754390|579812233|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
160570920|NCT00754390|579812233|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
160570921|NCT00754390|579812233|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
160570922|NCT00847613|579812234|FG000|Overall Study|Ongoing at cut-off date|250|||
160570923|NCT00847613|579812235|FG001|Overall Study|Ongoing at cut-off date|265|||
160570924|NCT00847613|579812236|FG002|Overall Study|Ongoing at cut-off date|64|||
160570925|NCT00847613|579812237|FG003|Overall Study|Ongoing at cut-off date|64|||
160570926|NCT00847613|579812234|FG000|Overall Study|Death|1|||
160861645|NCT04225897|580887794|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861646|NCT04225897|580887795|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861647|NCT04225897|580887796|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861648|NCT04225897|580887797|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861649|NCT04225897|580887786|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861650|NCT04225897|580887787|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861651|NCT04225897|580887788|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861652|NCT04225897|580887789|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861653|NCT04225897|580887790|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861654|NCT04225897|580887791|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861655|NCT04225897|580887792|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861656|NCT04225897|580887793|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
160861657|NCT04225897|580887794|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861658|NCT04225897|580887795|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861659|NCT04225897|580887796|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861660|NCT04225897|580887797|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861661|NCT00074711|580887799|FG000|Overall Study|Withdrawal by Subject|1|||
160861662|NCT00074711|580887800|FG001|Overall Study|Withdrawal by Subject|1|||
160861663|NCT00074711|580887799|FG000|Overall Study|Lost to Follow-up|10|||
160861664|NCT00074711|580887800|FG001|Overall Study|Lost to Follow-up|8|||
160861665|NCT00074711|580887799|FG000|Overall Study|Participant stopped study drug|4|||
160861666|NCT00074711|580887800|FG001|Overall Study|Participant stopped study drug|6|||
160861667|NCT03466658|580887801|FG000|Overall Study|Withdrawal by Subject|3|||
160861668|NCT01921205|580887802|FG000|Overall Study|Adverse Event|12|||
160861669|NCT01921205|580887803|FG001|Overall Study|Adverse Event|7|||
160861670|NCT01921205|580887802|FG000|Overall Study|Lack of Efficacy|1|||
160916065|NCT02618434|581085072|FG002|Overall Study|Adverse Event|12|||
160570927|NCT00847613|579812235|FG001|Overall Study|Death|1|||
160453774|NCT03088878|579392173|FG011|Overall Study|Drug or Study Noncompliance|0|||
160453775|NCT03088878|579392174|FG012|Overall Study|Drug or Study Noncompliance|1|||
160453776|NCT03088878|579392175|FG013|Overall Study|Drug or Study Noncompliance|0|||
160453777|NCT04032847|579392183|FG000|Overall Study|Study termination by sponsor|8|||
160453778|NCT04032847|579392184|FG001|Overall Study|Study termination by sponsor|0|||
160453779|NCT04032847|579392185|FG002|Overall Study|Study termination by sponsor|4|||
160453780|NCT04032847|579392183|FG000|Overall Study|Death|12|||
160453781|NCT04032847|579392184|FG001|Overall Study|Death|0|||
160453782|NCT04032847|579392185|FG002|Overall Study|Death|0|||
160453783|NCT04032847|579392183|FG000|Overall Study|Progressive disease|2|||
160453784|NCT04032847|579392184|FG001|Overall Study|Progressive disease|0|||
160453785|NCT04032847|579392185|FG002|Overall Study|Progressive disease|1|||
160453786|NCT03056573|579392186|FG000|Overall Study|Death|2|||
160453787|NCT03056573|579392187|FG001|Overall Study|Death|4|||
160453788|NCT03056573|579392186|FG000|Overall Study|Withdrawal by Subject|2|||
160453789|NCT03056573|579392187|FG001|Overall Study|Withdrawal by Subject|0|||
160453790|NCT03056573|579392186|FG000|Overall Study|Lost to Follow-up|1|||
160453791|NCT03056573|579392187|FG001|Overall Study|Lost to Follow-up|1|||
160453792|NCT05104463|579392188|FG000|Overall Study|Adverse Event|1|||
160453793|NCT05104463|579392189|FG001|Overall Study|Adverse Event|1|||
160453794|NCT05104463|579392188|FG000|Overall Study|Lost to Follow-up|1|||
160453795|NCT05104463|579392189|FG001|Overall Study|Lost to Follow-up|1|||
160453796|NCT05104463|579392188|FG000|Overall Study|Physician Decision|1|||
160453797|NCT05104463|579392189|FG001|Overall Study|Physician Decision|0|||
160453798|NCT05104463|579392188|FG000|Overall Study|Protocol Violation|0|||
160453799|NCT05104463|579392189|FG001|Overall Study|Protocol Violation|2|||
160453800|NCT05104463|579392188|FG000|Overall Study|Withdrawal by Subject|1|||
160453801|NCT05104463|579392189|FG001|Overall Study|Withdrawal by Subject|1|||
160453802|NCT04428203|579392190|FG000|Overall Study|Adverse Event|1|||
160453803|NCT04428203|579392191|FG001|Overall Study|Adverse Event|0|||
160453804|NCT04428203|579392192|FG002|Overall Study|Adverse Event|0|||
160453805|NCT04428203|579392190|FG000|Overall Study|Withdrawal by Subject|1|||
160453806|NCT04428203|579392191|FG001|Overall Study|Withdrawal by Subject|0|||
160453807|NCT04428203|579392192|FG002|Overall Study|Withdrawal by Subject|1|||
160453808|NCT04741776|579392193|FG000|Overall Study|Withdrawal by Subject|7|||
160453809|NCT04741776|579392194|FG001|Overall Study|Withdrawal by Subject|10|||
160453810|NCT04741776|579392195|FG002|Overall Study|Withdrawal by Subject|10|||
160453811|NCT04741776|579392196|FG003|Overall Study|Withdrawal by Subject|17|||
160453812|NCT04741776|579392193|FG000|Overall Study|Death|0|||
160453813|NCT04741776|579392194|FG001|Overall Study|Death|0|||
160453814|NCT04741776|579392195|FG002|Overall Study|Death|1|||
160453815|NCT04741776|579392196|FG003|Overall Study|Death|0|||
160453816|NCT02852655|579392212|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
160453817|NCT02852655|579392213|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
160453818|NCT02852655|579392214|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
160570928|NCT00847613|579812236|FG002|Overall Study|Death|0|||
160570929|NCT00847613|579812237|FG003|Overall Study|Death|0|||
160570930|NCT00847613|579812234|FG000|Overall Study|Adverse Event|36|||
160570931|NCT00847613|579812235|FG001|Overall Study|Adverse Event|26|||
160570932|NCT00847613|579812236|FG002|Overall Study|Adverse Event|5|||
160570933|NCT00847613|579812237|FG003|Overall Study|Adverse Event|6|||
160570934|NCT00847613|579812234|FG000|Overall Study|Lack of Efficacy|7|||
160916066|NCT02618434|581085070|FG000|Overall Study|Physician Decision|0|||
160916067|NCT02618434|581085071|FG001|Overall Study|Physician Decision|1|||
160916068|NCT02618434|581085072|FG002|Overall Study|Physician Decision|0|||
160916069|NCT02618434|581085070|FG000|Overall Study|Protocol Violation|0|||
160916070|NCT02618434|581085071|FG001|Overall Study|Protocol Violation|0|||
160916071|NCT02618434|581085072|FG002|Overall Study|Protocol Violation|1|||
160916072|NCT02618434|581085070|FG000|Overall Study|Other, Multiple categories|1|||
160916073|NCT02618434|581085071|FG001|Overall Study|Other, Multiple categories|1|||
160916074|NCT02618434|581085072|FG002|Overall Study|Other, Multiple categories|1|||
160916075|NCT04626297|581085076|FG000|Overall Study|Adverse Event|5|||
160453819|NCT02852655|579392212|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
160453820|NCT02852655|579392213|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
160570935|NCT00847613|579812235|FG001|Overall Study|Lack of Efficacy|3|||
160453821|NCT02852655|579392214|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
160453822|NCT02852655|579392212|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
160453823|NCT02852655|579392213|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
160570936|NCT00847613|579812236|FG002|Overall Study|Lack of Efficacy|3|||
160453824|NCT02852655|579392214|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
160453825|NCT02852655|579392212|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
160453826|NCT02852655|579392213|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
160454070|NCT02038777|579394028|FG006|Overall Study|Started Chemotherapy|0|||
160916076|NCT04626297|581085077|FG001|Overall Study|Adverse Event|3|||
160916077|NCT04626297|581085076|FG000|Overall Study|Lost to Follow-up|7|||
160570937|NCT00847613|579812237|FG003|Overall Study|Lack of Efficacy|1|||
160570938|NCT00847613|579812234|FG000|Overall Study|Study terminated by Sponsor|1|||
160570939|NCT00847613|579812235|FG001|Overall Study|Study terminated by Sponsor|0|||
160570940|NCT00847613|579812236|FG002|Overall Study|Study terminated by Sponsor|2|||
160570941|NCT00847613|579812237|FG003|Overall Study|Study terminated by Sponsor|1|||
160570942|NCT00847613|579812234|FG000|Overall Study|Lost to Follow-up|5|||
160570943|NCT00847613|579812235|FG001|Overall Study|Lost to Follow-up|0|||
160570944|NCT00847613|579812236|FG002|Overall Study|Lost to Follow-up|0|||
160570945|NCT00847613|579812237|FG003|Overall Study|Lost to Follow-up|3|||
160570946|NCT00847613|579812234|FG000|Overall Study|Protocol Violation|6|||
160570947|NCT00847613|579812235|FG001|Overall Study|Protocol Violation|6|||
160570948|NCT00847613|579812236|FG002|Overall Study|Protocol Violation|3|||
160570949|NCT00847613|579812237|FG003|Overall Study|Protocol Violation|1|||
160570950|NCT00847613|579812234|FG000|Overall Study|Pregnancy|1|||
160570951|NCT00847613|579812235|FG001|Overall Study|Pregnancy|1|||
160570952|NCT00847613|579812236|FG002|Overall Study|Pregnancy|0|||
160570953|NCT00847613|579812237|FG003|Overall Study|Pregnancy|0|||
160570954|NCT00847613|579812234|FG000|Overall Study|Site closure|1|||
160570955|NCT00847613|579812235|FG001|Overall Study|Site closure|0|||
160570956|NCT00847613|579812236|FG002|Overall Study|Site closure|0|||
160570957|NCT00847613|579812237|FG003|Overall Study|Site closure|1|||
160570958|NCT00847613|579812234|FG000|Overall Study|Withdrawal by Subject|8|||
160570959|NCT00847613|579812235|FG001|Overall Study|Withdrawal by Subject|11|||
160570960|NCT00847613|579812236|FG002|Overall Study|Withdrawal by Subject|2|||
160570961|NCT00847613|579812237|FG003|Overall Study|Withdrawal by Subject|2|||
160570962|NCT00847613|579812234|FG000|Overall Study|Participant moved|4|||
160570963|NCT00847613|579812235|FG001|Overall Study|Participant moved|1|||
160570964|NCT00847613|579812236|FG002|Overall Study|Participant moved|0|||
160570965|NCT00847613|579812237|FG003|Overall Study|Participant moved|0|||
160570966|NCT00847613|579812234|FG000|Overall Study|Sponsor request|0|||
160570967|NCT00847613|579812235|FG001|Overall Study|Sponsor request|1|||
160570968|NCT00847613|579812236|FG002|Overall Study|Sponsor request|0|||
160570969|NCT00847613|579812237|FG003|Overall Study|Sponsor request|0|||
160570970|NCT00847613|579812234|FG000|Overall Study|Randomized, but not treated|0|||
160570971|NCT00847613|579812235|FG001|Overall Study|Randomized, but not treated|3|||
160570972|NCT00847613|579812236|FG002|Overall Study|Randomized, but not treated|0|||
160570973|NCT00847613|579812237|FG003|Overall Study|Randomized, but not treated|0|||
160570974|NCT00847613|579812234|FG000|Overall Study|Other|1|||
160570975|NCT00847613|579812235|FG001|Overall Study|Other|1|||
160570976|NCT00847613|579812236|FG002|Overall Study|Other|2|||
160570977|NCT00847613|579812237|FG003|Overall Study|Other|0|||
160570978|NCT00971321|579812238|FG000|Up to Month 7|Withdrawal by Subject|1|||
160570979|NCT00971321|579812239|FG001|Up to Month 7|Withdrawal by Subject|0|||
160570980|NCT00971321|579812238|FG000|Up to Month 7|Migrated/moved from study area|3|||
160570981|NCT00971321|579812239|FG001|Up to Month 7|Migrated/moved from study area|2|||
160570982|NCT00971321|579812238|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
160570983|NCT00971321|579812239|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
160570984|NCT00971321|579812238|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
160570985|NCT00971321|579812239|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
160570986|NCT00971321|579812238|FG000|Up to Month 11-12|Lost to Follow-up|1|||
160570987|NCT00971321|579812239|FG001|Up to Month 11-12|Lost to Follow-up|0|||
160570988|NCT01591330|579812240|FG000|Period 1|Adverse Event|1|||
160570989|NCT01591330|579812241|FG001|Period 1|Adverse Event|0|||
160570990|NCT01591330|579812242|FG002|Period 1|Adverse Event|0|||
160570991|NCT01591330|579812243|FG003|Period 1|Adverse Event|0|||
160570992|NCT01591330|579812240|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
160570993|NCT01591330|579812241|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
160570994|NCT01591330|579812242|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
160570995|NCT01591330|579812243|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
160916078|NCT04626297|581085077|FG001|Overall Study|Lost to Follow-up|3|||
160916079|NCT04626297|581085076|FG000|Overall Study|Protocol Violation|5|||
160916080|NCT04626297|581085077|FG001|Overall Study|Protocol Violation|1|||
160916081|NCT04626297|581085076|FG000|Overall Study|Withdrawal by Subject|20|||
160916082|NCT04626297|581085077|FG001|Overall Study|Withdrawal by Subject|6|||
160916083|NCT04626297|581085076|FG000|Overall Study|Sponsor decision|2|||
160916084|NCT04626297|581085077|FG001|Overall Study|Sponsor decision|1|||
160570996|NCT01591330|579812240|FG000|Period 2|Adverse Event|1|||
160570997|NCT01591330|579812241|FG001|Period 2|Adverse Event|0|||
160570998|NCT01591330|579812242|FG002|Period 2|Adverse Event|0|||
160570999|NCT01591330|579812243|FG003|Period 2|Adverse Event|0|||
160571000|NCT02782715|579812244|FG000|Overall Study|Withdrawal by Subject|1|||
160571001|NCT02190591|579812245|FG000|Overall Study|Withdrawal by Subject|1|||
160571002|NCT02190591|579812246|FG001|Overall Study|Withdrawal by Subject|8|||
160571003|NCT02190591|579812245|FG000|Overall Study|Protocol Violation|1|||
160571004|NCT02190591|579812246|FG001|Overall Study|Protocol Violation|0|||
160571005|NCT02190591|579812245|FG000|Overall Study|did not use peanut ball as instructed|0|||
160916085|NCT02066233|581085078|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
160916086|NCT02066233|581085079|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
160453827|NCT02852655|579392214|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
160453828|NCT02852655|579392212|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
160453829|NCT02852655|579392213|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
160453830|NCT02852655|579392214|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
160453831|NCT02852655|579392212|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
160453832|NCT02852655|579392213|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
160571006|NCT02190591|579812246|FG001|Overall Study|did not use peanut ball as instructed|2|||
160571007|NCT02190591|579812245|FG000|Overall Study|face presentation so she was ineligible|0|||
160571008|NCT02190591|579812246|FG001|Overall Study|face presentation so she was ineligible|1|||
160652849|NCT02207231|580110392|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
160652850|NCT02207231|580110393|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
160652851|NCT02207231|580110390|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
160652852|NCT02207231|580110391|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
160652853|NCT02207231|580110392|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
160571009|NCT01933672|579812247|FG000|Metformin Run-in Period|Adverse Event|1|||
160571010|NCT01933672|579812248|FG001|Metformin Run-in Period|Adverse Event|0|||
160571011|NCT01933672|579812249|FG002|Metformin Run-in Period|Adverse Event|0|||
160571012|NCT01933672|579812250|FG003|Metformin Run-in Period|Adverse Event|0|||
160571013|NCT01933672|579812251|FG004|Metformin Run-in Period|Adverse Event|0|||
160571014|NCT01933672|579812252|FG005|Metformin Run-in Period|Adverse Event|0|||
160571015|NCT01933672|579812253|FG006|Metformin Run-in Period|Adverse Event|0|||
160571016|NCT01933672|579812247|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
160571017|NCT01933672|579812248|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
160571018|NCT01933672|579812249|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
160571019|NCT01933672|579812250|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
160571020|NCT01933672|579812251|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
160571021|NCT01933672|579812252|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
160571022|NCT01933672|579812253|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
160571023|NCT01933672|579812247|FG000|Metformin Run-in Period|Other|5|||
160571024|NCT01933672|579812248|FG001|Metformin Run-in Period|Other|0|||
160571025|NCT01933672|579812249|FG002|Metformin Run-in Period|Other|0|||
160571026|NCT01933672|579812250|FG003|Metformin Run-in Period|Other|0|||
160571027|NCT01933672|579812251|FG004|Metformin Run-in Period|Other|0|||
160571028|NCT01933672|579812252|FG005|Metformin Run-in Period|Other|0|||
160571029|NCT01933672|579812253|FG006|Metformin Run-in Period|Other|0|||
160571030|NCT01933672|579812247|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571031|NCT01933672|579812248|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571032|NCT01933672|579812249|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571033|NCT01933672|579812250|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571034|NCT01933672|579812251|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
160571035|NCT01933672|579812252|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571036|NCT01933672|579812253|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571037|NCT01933672|579812247|FG000|First Intervention Period (12-16 Days)|Other|0|||
160652854|NCT02207231|580110393|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
160652855|NCT02207231|580110390|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
160652856|NCT02207231|580110391|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
160652857|NCT02207231|580110392|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
160652858|NCT02207231|580110393|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
160652859|NCT02207231|580110390|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
160652860|NCT02207231|580110391|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
160652861|NCT02207231|580110392|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
160652862|NCT02207231|580110393|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
160652863|NCT02207231|580110390|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
160652864|NCT02207231|580110391|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
160652865|NCT02207231|580110392|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
160652866|NCT02207231|580110393|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
160652867|NCT02207231|580110390|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
160652868|NCT02207231|580110391|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
160652869|NCT02207231|580110392|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
160571038|NCT01933672|579812248|FG001|First Intervention Period (12-16 Days)|Other|0|||
160571039|NCT01933672|579812249|FG002|First Intervention Period (12-16 Days)|Other|1|||
160571040|NCT01933672|579812250|FG003|First Intervention Period (12-16 Days)|Other|0|||
160571041|NCT01933672|579812251|FG004|First Intervention Period (12-16 Days)|Other|0|||
160571042|NCT01933672|579812252|FG005|First Intervention Period (12-16 Days)|Other|1|||
160652870|NCT02207231|580110393|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
160916087|NCT02598076|581085080|FG000|Overall Study|Lost to Follow-up|2|||
160916088|NCT02598076|581085081|FG001|Overall Study|Lost to Follow-up|3|||
160916089|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Death|3|||
160453833|NCT02852655|579392214|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
160453834|NCT02852655|579392212|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
160571043|NCT01933672|579812253|FG006|First Intervention Period (12-16 Days)|Other|0|||
160571044|NCT01933672|579812247|FG000|Second Intervention Period (12-16 Days)|Other|0|||
160571045|NCT01933672|579812248|FG001|Second Intervention Period (12-16 Days)|Other|1|||
160571046|NCT01933672|579812249|FG002|Second Intervention Period (12-16 Days)|Other|1|||
160571047|NCT01933672|579812250|FG003|Second Intervention Period (12-16 Days)|Other|0|||
160571048|NCT01933672|579812251|FG004|Second Intervention Period (12-16 Days)|Other|0|||
160571049|NCT01933672|579812252|FG005|Second Intervention Period (12-16 Days)|Other|0|||
160571050|NCT01933672|579812253|FG006|Second Intervention Period (12-16 Days)|Other|0|||
160571051|NCT01933672|579812247|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571052|NCT01933672|579812248|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571053|NCT01933672|579812249|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571054|NCT01933672|579812250|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
160571055|NCT01933672|579812251|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571056|NCT01933672|579812252|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571057|NCT01933672|579812253|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160571058|NCT01933672|579812247|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
160571059|NCT01933672|579812248|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
160571060|NCT01933672|579812249|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
160571061|NCT01933672|579812250|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
160571062|NCT01933672|579812251|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
160571063|NCT01933672|579812252|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
160571064|NCT01933672|579812253|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
160571065|NCT01676116|579812258|FG000|Overall Study|Withdrawal criteria|2|||
160571066|NCT01676116|579812259|FG001|Overall Study|Withdrawal criteria|14|||
160571067|NCT01676116|579812258|FG000|Overall Study|Adverse Event|1|||
160571068|NCT01676116|579812259|FG001|Overall Study|Adverse Event|2|||
160571069|NCT01676116|579812258|FG000|Overall Study|Unclassified|4|||
160571070|NCT01676116|579812259|FG001|Overall Study|Unclassified|10|||
160571071|NCT01676116|579812258|FG000|Overall Study|Protocol Violation|9|||
160571072|NCT01676116|579812259|FG001|Overall Study|Protocol Violation|3|||
160571073|NCT01821677|579812260|FG000|Overall Study|Adverse Event|4|||
160571074|NCT01821677|579812261|FG001|Overall Study|Adverse Event|6|||
160571075|NCT01821677|579812262|FG002|Overall Study|Adverse Event|5|||
160571076|NCT01821677|579812260|FG000|Overall Study|Physician Decision|1|||
160571077|NCT01821677|579812261|FG001|Overall Study|Physician Decision|4|||
160996279|NCT03451851|581372183|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996280|NCT03451851|581372184|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
160996281|NCT03451851|581372185|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996282|NCT03451851|581372186|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996283|NCT03451851|581372187|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996284|NCT03451851|581372188|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996285|NCT03451851|581372189|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996286|NCT03451851|581372182|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996287|NCT03451851|581372183|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996288|NCT03451851|581372184|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
160996289|NCT03451851|581372185|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996290|NCT03451851|581372186|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996291|NCT03451851|581372187|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996292|NCT03451851|581372188|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996293|NCT03451851|581372189|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996294|NCT03451851|581372182|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160996295|NCT03451851|581372183|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160996296|NCT03451851|581372184|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160996297|NCT03451851|581372185|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160996298|NCT03451851|581372186|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
160996299|NCT03451851|581372187|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
160996300|NCT03451851|581372188|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160996301|NCT03451851|581372189|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160571078|NCT01821677|579812262|FG002|Overall Study|Physician Decision|1|||
160571079|NCT01821677|579812260|FG000|Overall Study|Non-compliance|0|||
160571080|NCT01821677|579812261|FG001|Overall Study|Non-compliance|1|||
160571081|NCT01821677|579812262|FG002|Overall Study|Non-compliance|2|||
160861671|NCT01921205|580887803|FG001|Overall Study|Lack of Efficacy|0|||
160996302|NCT03451851|581372182|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
160996303|NCT03451851|581372183|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
160571082|NCT01821677|579812260|FG000|Overall Study|Lost to Follow-up|2|||
160571083|NCT01821677|579812261|FG001|Overall Study|Lost to Follow-up|1|||
160571084|NCT01821677|579812262|FG002|Overall Study|Lost to Follow-up|3|||
160916090|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Death|3|||
160916091|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Death|0|||
160916092|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Death|0|||
160571085|NCT01821677|579812260|FG000|Overall Study|Protocol Violation|0|||
160571086|NCT01821677|579812261|FG001|Overall Study|Protocol Violation|0|||
160571087|NCT01821677|579812262|FG002|Overall Study|Protocol Violation|2|||
160916093|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
160916094|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
160916095|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
160916096|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
160916097|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
160916098|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
160916099|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
160916100|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
160916101|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
160916102|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
160916103|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
160916104|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
160916105|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
160916106|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
160916107|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
160916108|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
160916109|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
160916110|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
160916111|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
160916112|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
160916113|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
160916114|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
160916115|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
160916116|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
160916117|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Other|6|||
160916118|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Other|3|||
160916119|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Other|0|||
160916120|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Other|0|||
160916121|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
160916122|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
160916123|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
160916124|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
160916125|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Adverse Event|0|||
160916126|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Adverse Event|0|||
160916127|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Adverse Event|6|||
160916128|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Adverse Event|8|||
160916129|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Death|0|||
160916130|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Death|0|||
160916131|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Death|7|||
160916132|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Death|4|||
160916133|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
160916134|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
160916135|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
160916136|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
160916137|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
160916138|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
160916139|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
160916140|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
160916141|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
160916142|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
160916143|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
160916144|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
160916145|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
160916146|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
160916147|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
160916148|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
160916149|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Physician Decision|0|||
160916150|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Physician Decision|0|||
160916151|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Physician Decision|8|||
160916152|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Physician Decision|5|||
160916153|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Other|0|||
160916154|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Other|0|||
160571088|NCT01821677|579812260|FG000|Overall Study|Withdrawal by Subject|7|||
160571089|NCT01821677|579812261|FG001|Overall Study|Withdrawal by Subject|3|||
160571090|NCT01821677|579812262|FG002|Overall Study|Withdrawal by Subject|2|||
160571091|NCT01821677|579812260|FG000|Overall Study|Other|9|||
160571092|NCT01821677|579812261|FG001|Overall Study|Other|0|||
160571093|NCT01821677|579812262|FG002|Overall Study|Other|0|||
160571094|NCT04513158|579812263|FG000|Overall Study|Screen Failure|1|||
160571095|NCT00001259|579814358|FG000|Study 2|Adverse Event|0|||
160571096|NCT00001259|579814359|FG001|Study 2|Adverse Event|0|||
160571097|NCT00001259|579814360|FG002|Study 2|Adverse Event|0|||
160571098|NCT00001259|579814361|FG003|Study 2|Adverse Event|0|||
160571099|NCT00001259|579814362|FG004|Study 2|Adverse Event|2|||
160571100|NCT00001259|579814363|FG005|Study 2|Adverse Event|0|||
160571101|NCT00001259|579814364|FG006|Study 2|Adverse Event|0|||
160571102|NCT03705494|579814365|FG000|Overall Study|Lost to Follow-up|2|||
160571103|NCT03705494|579814366|FG001|Overall Study|Lost to Follow-up|1|||
160571104|NCT03705494|579814365|FG000|Overall Study|Withdrawal by Subject|5|||
160571105|NCT03705494|579814366|FG001|Overall Study|Withdrawal by Subject|2|||
160571106|NCT01582282|579814367|FG000|Overall Study|Adverse Event|1|||
160571107|NCT01582282|579814368|FG001|Overall Study|Adverse Event|1|||
160571108|NCT01582282|579814369|FG002|Overall Study|Adverse Event|0|||
160571109|NCT01582282|579814367|FG000|Overall Study|Lost to Follow-up|1|||
160571110|NCT01582282|579814368|FG001|Overall Study|Lost to Follow-up|0|||
160571111|NCT01582282|579814369|FG002|Overall Study|Lost to Follow-up|0|||
160571112|NCT01582282|579814367|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
160571113|NCT01582282|579814368|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
160571114|NCT01582282|579814369|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
160571115|NCT03937986|579814371|FG000|Overall Study|COVID-19 Pandemic|1|||
160571116|NCT02839746|579814372|FG000|Overall Study|Not met selection criteria|12|||
160571117|NCT02089737|579814373|FG000|Overall Study|Survey form not completed|5|||
160571118|NCT02089737|579814373|FG000|Overall Study|Not treated|1|||
160571119|NCT00744055|579814374|FG000|Overall Study|Withdrawal by Subject|6|||
160571120|NCT00744055|579814375|FG001|Overall Study|Withdrawal by Subject|9|||
160571121|NCT00744055|579814374|FG000|Overall Study|Lack of Efficacy|0|||
160571122|NCT00744055|579814375|FG001|Overall Study|Lack of Efficacy|1|||
160571123|NCT00744055|579814374|FG000|Overall Study|Physician Decision|0|||
160571124|NCT00744055|579814375|FG001|Overall Study|Physician Decision|2|||
160571125|NCT00744055|579814374|FG000|Overall Study|Protocol Violation|1|||
160571126|NCT00744055|579814375|FG001|Overall Study|Protocol Violation|1|||
160571127|NCT00744055|579814374|FG000|Overall Study|Lost to Follow-up|0|||
160571128|NCT00744055|579814375|FG001|Overall Study|Lost to Follow-up|1|||
160571129|NCT04426630|579814376|FG000|Overall Study|Death|4|||
160571130|NCT04426630|579814376|FG000|Overall Study|Lost to Follow-up|2|||
160571131|NCT01123889|579814377|FG000|Overall Study|Lost to Follow-up|3|||
160571132|NCT01123889|579814378|FG001|Overall Study|Lost to Follow-up|1|||
160571133|NCT02333331|579814379|FG000|Overall Study|Adverse Event|1|||
160571134|NCT02333331|579814380|FG001|Overall Study|Adverse Event|0|||
160571135|NCT02333331|579814381|FG002|Overall Study|Adverse Event|4|||
160571136|NCT02333331|579814382|FG003|Overall Study|Adverse Event|1|||
160571137|NCT02333331|579814379|FG000|Overall Study|Death|0|||
160571138|NCT02333331|579814380|FG001|Overall Study|Death|0|||
160571139|NCT02333331|579814381|FG002|Overall Study|Death|2|||
160571140|NCT02333331|579814382|FG003|Overall Study|Death|0|||
160571141|NCT02333331|579814379|FG000|Overall Study|Lost to Follow-up|0|||
160571142|NCT02333331|579814380|FG001|Overall Study|Lost to Follow-up|0|||
160571143|NCT02333331|579814381|FG002|Overall Study|Lost to Follow-up|1|||
160571144|NCT02333331|579814382|FG003|Overall Study|Lost to Follow-up|0|||
160571145|NCT02333331|579814379|FG000|Overall Study|Physician Decision|0|||
160571146|NCT02333331|579814380|FG001|Overall Study|Physician Decision|1|||
160916155|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Other|9|||
160916156|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Other|9|||
160916157|NCT03033394|581085092|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
160571147|NCT02333331|579814381|FG002|Overall Study|Physician Decision|0|||
160571148|NCT02333331|579814382|FG003|Overall Study|Physician Decision|0|||
160571149|NCT02333331|579814379|FG000|Overall Study|Protocol Deviation|0|||
160571150|NCT02333331|579814380|FG001|Overall Study|Protocol Deviation|3|||
160571151|NCT02333331|579814381|FG002|Overall Study|Protocol Deviation|2|||
160571152|NCT02333331|579814382|FG003|Overall Study|Protocol Deviation|1|||
160571153|NCT02333331|579814379|FG000|Overall Study|Patient/Guardian Decision|1|||
160571154|NCT02333331|579814380|FG001|Overall Study|Patient/Guardian Decision|2|||
160571155|NCT02333331|579814381|FG002|Overall Study|Patient/Guardian Decision|9|||
160571156|NCT02333331|579814382|FG003|Overall Study|Patient/Guardian Decision|1|||
160916158|NCT03033394|581085092|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
160571157|NCT00685178|579814386|FG000|Overall Study|Adverse Event|1|||
160571158|NCT00685178|579814387|FG001|Overall Study|Adverse Event|5|||
160571159|NCT00685178|579814388|FG002|Overall Study|Adverse Event|2|||
160571160|NCT00685178|579814389|FG003|Overall Study|Adverse Event|4|||
160571161|NCT00685178|579814386|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
160571162|NCT00685178|579814387|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
160571163|NCT00685178|579814388|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
160571164|NCT00685178|579814389|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
160571165|NCT00685178|579814386|FG000|Overall Study|voluntary study discharge|4|||
160571166|NCT00685178|579814387|FG001|Overall Study|voluntary study discharge|5|||
160571167|NCT00685178|579814388|FG002|Overall Study|voluntary study discharge|1|||
160571168|NCT00685178|579814389|FG003|Overall Study|voluntary study discharge|1|||
160571169|NCT00685178|579814386|FG000|Overall Study|incarcerated|1|||
160571170|NCT00685178|579814387|FG001|Overall Study|incarcerated|3|||
160571171|NCT00685178|579814388|FG002|Overall Study|incarcerated|7|||
160571172|NCT00685178|579814389|FG003|Overall Study|incarcerated|0|||
160571173|NCT00685178|579814386|FG000|Overall Study|administrative (disciplinary) discharge|0|||
160571174|NCT00685178|579814387|FG001|Overall Study|administrative (disciplinary) discharge|1|||
160571175|NCT00685178|579814388|FG002|Overall Study|administrative (disciplinary) discharge|0|||
160571176|NCT00685178|579814389|FG003|Overall Study|administrative (disciplinary) discharge|2|||
160571177|NCT00685178|579814386|FG000|Overall Study|Pregnancy|0|||
160571178|NCT00685178|579814387|FG001|Overall Study|Pregnancy|0|||
160571179|NCT00685178|579814388|FG002|Overall Study|Pregnancy|0|||
160571180|NCT00685178|579814389|FG003|Overall Study|Pregnancy|1|||
160571181|NCT00077623|579814395|FG000|Overall Study|Adverse Event|1|||
160571182|NCT00077623|579814396|FG001|Overall Study|Adverse Event|0|||
160571183|NCT00077623|579814397|FG002|Overall Study|Adverse Event|1|||
160571184|NCT00077623|579814395|FG000|Overall Study|Withdrawal by Subject|2|||
160571185|NCT00077623|579814396|FG001|Overall Study|Withdrawal by Subject|10|||
160571186|NCT00077623|579814397|FG002|Overall Study|Withdrawal by Subject|1|||
160571187|NCT00077623|579814395|FG000|Overall Study|Other-Non safety reason|18|||
160571188|NCT00077623|579814396|FG001|Overall Study|Other-Non safety reason|15|||
160571189|NCT00077623|579814397|FG002|Overall Study|Other-Non safety reason|19|||
160571190|NCT00077623|579814395|FG000|Overall Study|Insufficient therapeutic response|2|||
160571191|NCT00077623|579814396|FG001|Overall Study|Insufficient therapeutic response|0|||
160571192|NCT00077623|579814397|FG002|Overall Study|Insufficient therapeutic response|0|||
160571193|NCT00077623|579814395|FG000|Overall Study|Death|12|||
160571194|NCT00077623|579814396|FG001|Overall Study|Death|18|||
160571195|NCT00077623|579814397|FG002|Overall Study|Death|11|||
160571196|NCT00077623|579814395|FG000|Overall Study|Failure to return|1|||
160571197|NCT00077623|579814396|FG001|Overall Study|Failure to return|0|||
160571198|NCT00077623|579814397|FG002|Overall Study|Failure to return|0|||
160571199|NCT01334125|579814398|FG000|Overall Study|Lost to Follow-up|3|||
160571200|NCT01334125|579814399|FG001|Overall Study|Lost to Follow-up|3|||
160571201|NCT00882713|579814402|FG000|Overall Study|Adverse Event|2|||
160571202|NCT00882713|579814402|FG000|Overall Study|Death|3|||
160571203|NCT00882713|579814402|FG000|Overall Study|Administrative reasons|4|||
160571204|NCT00882713|579814402|FG000|Overall Study|refused treatment/withdrew consent|4|||
160571205|NCT00882713|579814402|FG000|Overall Study|Blood transfusion|2|||
160571206|NCT00882713|579814402|FG000|Overall Study|Insufficient therapeutic response|3|||
160571207|NCT00882713|579814402|FG000|Overall Study|Failure to return|2|||
160571208|NCT00882713|579814402|FG000|Overall Study|Other - Reasons|2|||
160571209|NCT00401973|579814405|FG000|Overall Study|Adverse Event|2|||
160571210|NCT00401973|579814406|FG001|Overall Study|Adverse Event|8|||
160571211|NCT00401973|579814407|FG002|Overall Study|Adverse Event|4|||
160571212|NCT00401973|579814405|FG000|Overall Study|Clinical Relapse|0|||
160571213|NCT00401973|579814406|FG001|Overall Study|Clinical Relapse|1|||
160571214|NCT00401973|579814407|FG002|Overall Study|Clinical Relapse|1|||
160571215|NCT00401973|579814405|FG000|Overall Study|Lack of Efficacy|0|||
160571216|NCT00401973|579814406|FG001|Overall Study|Lack of Efficacy|0|||
160571217|NCT00401973|579814407|FG002|Overall Study|Lack of Efficacy|3|||
160571218|NCT00401973|579814405|FG000|Overall Study|Lost to Follow-up|2|||
160571219|NCT00401973|579814406|FG001|Overall Study|Lost to Follow-up|2|||
160571220|NCT00401973|579814407|FG002|Overall Study|Lost to Follow-up|2|||
160571221|NCT00401973|579814405|FG000|Overall Study|Physician Decision|2|||
160571222|NCT00401973|579814406|FG001|Overall Study|Physician Decision|0|||
160571223|NCT00401973|579814407|FG002|Overall Study|Physician Decision|1|||
160571224|NCT00401973|579814405|FG000|Overall Study|Protocol Violation|1|||
160571225|NCT00401973|579814406|FG001|Overall Study|Protocol Violation|2|||
160571226|NCT00401973|579814407|FG002|Overall Study|Protocol Violation|3|||
160571227|NCT00401973|579814405|FG000|Overall Study|Sponsor Decision|0|||
160571228|NCT00401973|579814406|FG001|Overall Study|Sponsor Decision|1|||
160916159|NCT03033394|581085092|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
160916160|NCT03033394|581085092|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
160916161|NCT03033394|581085092|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
160916162|NCT00533845|581085097|FG000|Overall Study|Physician Decision|1|||
160916163|NCT00533845|581085098|FG001|Overall Study|Physician Decision|0|||
160916164|NCT01919723|581085099|FG000|Overall Study|Blood Samples Hemolyzed|2|||
160916165|NCT01919723|581085100|FG001|Overall Study|Blood Samples Hemolyzed|2|||
160453835|NCT02852655|579392213|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
160571229|NCT00401973|579814407|FG002|Overall Study|Sponsor Decision|0|||
160571230|NCT00401973|579814405|FG000|Overall Study|Withdrawal by Subject|4|||
160571231|NCT00401973|579814406|FG001|Overall Study|Withdrawal by Subject|12|||
160571232|NCT00401973|579814407|FG002|Overall Study|Withdrawal by Subject|9|||
160571233|NCT02760602|579814414|FG000|Overall Study|Withdrawal by Subject|1|||
160571234|NCT02760602|579814415|FG001|Overall Study|Withdrawal by Subject|0|||
160571235|NCT02760602|579814414|FG000|Overall Study|Terminated by sponsor|12|||
160571236|NCT02760602|579814415|FG001|Overall Study|Terminated by sponsor|13|||
160571237|NCT01335971|579814422|FG000|Overall Study|Withdrawal by Subject|1|||
160571238|NCT01335971|579814423|FG001|Overall Study|Withdrawal by Subject|0|||
160571239|NCT01335971|579814424|FG002|Overall Study|Withdrawal by Subject|0|||
160571240|NCT01335971|579814422|FG000|Overall Study|Did not complete bronchoscopy|1|||
160571241|NCT01335971|579814423|FG001|Overall Study|Did not complete bronchoscopy|1|||
160571242|NCT01335971|579814424|FG002|Overall Study|Did not complete bronchoscopy|1|||
160571243|NCT05299892|579814425|FG000|Overall Study|Withdrawal by Subject|2|||
160571244|NCT00149214|579814426|FG000|Overall Study|Adverse Event|12|||
160571245|NCT00149214|579814427|FG001|Overall Study|Adverse Event|9|||
160571246|NCT00149214|579814426|FG000|Overall Study|Withdrawal by Subject|4|||
160571247|NCT00149214|579814427|FG001|Overall Study|Withdrawal by Subject|1|||
160571248|NCT00149214|579814426|FG000|Overall Study|Physician Decision|3|||
160571249|NCT00149214|579814427|FG001|Overall Study|Physician Decision|3|||
160571250|NCT00149214|579814426|FG000|Overall Study|Sponsor Decision|0|||
160571251|NCT00149214|579814427|FG001|Overall Study|Sponsor Decision|1|||
160571252|NCT00149214|579814426|FG000|Overall Study|Progressive Disease|7|||
160571253|NCT00149214|579814427|FG001|Overall Study|Progressive Disease|3|||
160571254|NCT01272180|579814428|FG000|Overall Study|Adverse Event|0|||
160571255|NCT01272180|579814429|FG001|Overall Study|Adverse Event|0|||
160571256|NCT01272180|579814430|FG002|Overall Study|Adverse Event|1|||
160571257|NCT01272180|579814431|FG003|Overall Study|Adverse Event|0|||
160571258|NCT01272180|579814428|FG000|Overall Study|Withdrawal by Subject|2|||
160571259|NCT01272180|579814429|FG001|Overall Study|Withdrawal by Subject|6|||
160571260|NCT01272180|579814430|FG002|Overall Study|Withdrawal by Subject|3|||
160571261|NCT01272180|579814431|FG003|Overall Study|Withdrawal by Subject|2|||
160571262|NCT01272180|579814428|FG000|Overall Study|Lost to Follow-up|15|||
160571263|NCT01272180|579814429|FG001|Overall Study|Lost to Follow-up|14|||
160571264|NCT01272180|579814430|FG002|Overall Study|Lost to Follow-up|8|||
160571265|NCT01272180|579814431|FG003|Overall Study|Lost to Follow-up|10|||
160571266|NCT01272180|579814428|FG000|Overall Study|Inappropriate enrollment|0|||
160571267|NCT01272180|579814429|FG001|Overall Study|Inappropriate enrollment|0|||
160571268|NCT01272180|579814430|FG002|Overall Study|Inappropriate enrollment|1|||
160571269|NCT01272180|579814431|FG003|Overall Study|Inappropriate enrollment|1|||
160571270|NCT01272180|579814428|FG000|Overall Study|Protocol Violation|0|||
160571271|NCT01272180|579814429|FG001|Overall Study|Protocol Violation|1|||
160571272|NCT01272180|579814430|FG002|Overall Study|Protocol Violation|0|||
160571273|NCT01272180|579814431|FG003|Overall Study|Protocol Violation|1|||
160571274|NCT03056287|579814432|FG000|Overall Study|Withdrawal by Subject|0|||
160571275|NCT03056287|579814433|FG001|Overall Study|Withdrawal by Subject|1|||
160571276|NCT03056287|579814434|FG002|Overall Study|Withdrawal by Subject|0|||
160571277|NCT03056287|579814435|FG003|Overall Study|Withdrawal by Subject|0|||
160571278|NCT03056287|579814432|FG000|Overall Study|move out of area|0|||
160571279|NCT03056287|579814433|FG001|Overall Study|move out of area|0|||
160571280|NCT03056287|579814434|FG002|Overall Study|move out of area|1|||
160571281|NCT03056287|579814435|FG003|Overall Study|move out of area|1|||
160571282|NCT01260181|579814436|FG000|Overall Study|Decision of Investigator|1|||
160571283|NCT03351244|579814437|FG000|Overall Study|Adverse Event|7|||
160571284|NCT03351244|579814438|FG001|Overall Study|Adverse Event|11|||
160571285|NCT03351244|579814439|FG002|Overall Study|Adverse Event|12|||
160571286|NCT03351244|579814437|FG000|Overall Study|Investigator's decision|0|||
160571287|NCT03351244|579814438|FG001|Overall Study|Investigator's decision|0|||
160571288|NCT03351244|579814439|FG002|Overall Study|Investigator's decision|2|||
160571289|NCT03351244|579814437|FG000|Overall Study|System error|0|||
160571290|NCT03351244|579814438|FG001|Overall Study|System error|0|||
160571291|NCT03351244|579814439|FG002|Overall Study|System error|2|||
160571292|NCT03351244|579814437|FG000|Overall Study|COVID-19 restrictions|3|||
160571293|NCT03351244|579814438|FG001|Overall Study|COVID-19 restrictions|0|||
160571294|NCT03351244|579814439|FG002|Overall Study|COVID-19 restrictions|1|||
160652871|NCT02207231|580110390|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
160571295|NCT03351244|579814437|FG000|Overall Study|Non-compliance|2|||
160861672|NCT01921205|580887802|FG000|Overall Study|Protocol Violation|1|||
160571296|NCT03351244|579814438|FG001|Overall Study|Non-compliance|5|||
160571297|NCT03351244|579814439|FG002|Overall Study|Non-compliance|0|||
160571298|NCT03351244|579814437|FG000|Overall Study|Withdrawal by Subject|11|||
160571299|NCT03351244|579814438|FG001|Overall Study|Withdrawal by Subject|16|||
160571300|NCT03351244|579814439|FG002|Overall Study|Withdrawal by Subject|13|||
160571301|NCT03351244|579814437|FG000|Overall Study|Lost to Follow-up|2|||
160571302|NCT03351244|579814438|FG001|Overall Study|Lost to Follow-up|6|||
160571303|NCT03351244|579814439|FG002|Overall Study|Lost to Follow-up|4|||
160571304|NCT03351244|579814437|FG000|Overall Study|Protocol Violation|2|||
160571305|NCT03351244|579814438|FG001|Overall Study|Protocol Violation|2|||
160571306|NCT03351244|579814439|FG002|Overall Study|Protocol Violation|0|||
160571307|NCT00474253|579814442|FG000|Overall Study|Withdrew consent|2|||
160571308|NCT00474253|579814443|FG001|Overall Study|Withdrew consent|0|||
160571309|NCT00474253|579814442|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
160916166|NCT04294472|581085108|FG000|Overall Study|Adverse Event|0|||
160916167|NCT04294472|581085109|FG001|Overall Study|Adverse Event|1|||
160916168|NCT04294472|581085110|FG002|Overall Study|Adverse Event|1|||
160916169|NCT04294472|581085108|FG000|Overall Study|Randomized but not treated|0|||
160916170|NCT04294472|581085109|FG001|Overall Study|Randomized but not treated|1|||
160916171|NCT04294472|581085110|FG002|Overall Study|Randomized but not treated|1|||
160996304|NCT03451851|581372184|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
160996305|NCT03451851|581372185|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
160571310|NCT00474253|579814443|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
160571311|NCT00474253|579814442|FG000|Overall Study|Lost to Follow-up|1|||
160571312|NCT00474253|579814443|FG001|Overall Study|Lost to Follow-up|0|||
160571313|NCT00474253|579814442|FG000|Overall Study|Discharged prior to study completion|0|||
160571314|NCT00474253|579814443|FG001|Overall Study|Discharged prior to study completion|1|||
160571315|NCT01165229|579814444|FG000|Overall Study|Serious Adverse Event|456|||
160571316|NCT01165229|579814445|FG001|Overall Study|Serious Adverse Event|487|||
160571317|NCT01165229|579814444|FG000|Overall Study|Non-Serious Adverse Event|47|||
160571318|NCT01165229|579814445|FG001|Overall Study|Non-Serious Adverse Event|15|||
160571319|NCT01165229|579814444|FG000|Overall Study|Protocol Violation|6|||
160571320|NCT01165229|579814445|FG001|Overall Study|Protocol Violation|8|||
160571321|NCT01165229|579814444|FG000|Overall Study|Withdrawal by Subject|387|||
160571322|NCT01165229|579814445|FG001|Overall Study|Withdrawal by Subject|396|||
160571323|NCT01165229|579814444|FG000|Overall Study|Migrated/moved from study area|51|||
160571324|NCT01165229|579814445|FG001|Overall Study|Migrated/moved from study area|46|||
160571325|NCT01165229|579814444|FG000|Overall Study|Lost to Follow-up|123|||
160571326|NCT01165229|579814445|FG001|Overall Study|Lost to Follow-up|133|||
160571327|NCT01165229|579814444|FG000|Overall Study|Suspected HZ Episode|2|||
160571328|NCT01165229|579814445|FG001|Overall Study|Suspected HZ Episode|2|||
160571329|NCT01165229|579814444|FG000|Overall Study|No reason from the subject|108|||
160571330|NCT01165229|579814445|FG001|Overall Study|No reason from the subject|102|||
160571331|NCT01165229|579814444|FG000|Overall Study|Unknown completion status|0|||
160571332|NCT01165229|579814445|FG001|Overall Study|Unknown completion status|1|||
160571333|NCT01357239|579814446|FG000|Stratum: All Patients|Adverse Event|0|||
160571334|NCT01357239|579814447|FG001|Stratum: All Patients|Adverse Event|0|||
160571335|NCT01357239|579814448|FG002|Stratum: All Patients|Adverse Event|1|||
160571336|NCT01357239|579814449|FG003|Stratum: All Patients|Adverse Event|1|||
160571337|NCT01357239|579814446|FG000|Stratum: All Patients|Subject withdrew consent|0|||
160571338|NCT01357239|579814447|FG001|Stratum: All Patients|Subject withdrew consent|0|||
160571339|NCT01357239|579814448|FG002|Stratum: All Patients|Subject withdrew consent|1|||
160571340|NCT01357239|579814449|FG003|Stratum: All Patients|Subject withdrew consent|1|||
160571341|NCT01357239|579814446|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
160571342|NCT01357239|579814447|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
160571343|NCT01357239|579814448|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
160571344|NCT01357239|579814449|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
160571345|NCT01357239|579814446|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
160571346|NCT01357239|579814447|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
160571347|NCT01357239|579814448|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
160571348|NCT01357239|579814449|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
160571349|NCT01357239|579814446|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
160571350|NCT01357239|579814447|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
160571351|NCT01357239|579814448|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
160571352|NCT01357239|579814449|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
160571353|NCT03133481|579814452|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
160571354|NCT03133481|579814453|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
160571355|NCT00637728|579814457|FG000|Double-blind Phase|Adverse Event|1|||
160571356|NCT00637728|579814458|FG001|Double-blind Phase|Adverse Event|0|||
160571357|NCT00637728|579814459|FG002|Double-blind Phase|Adverse Event|0|||
160571358|NCT00637728|579814457|FG000|Double-blind Phase|Non-compliance|2|||
160571359|NCT00637728|579814458|FG001|Double-blind Phase|Non-compliance|0|||
160571360|NCT00637728|579814459|FG002|Double-blind Phase|Non-compliance|0|||
160571361|NCT00637728|579814457|FG000|Double-blind Phase|Study Discontinued|1|||
160571362|NCT00637728|579814458|FG001|Double-blind Phase|Study Discontinued|1|||
160916172|NCT00563381|581085112|FG000|Overall Study|Adverse Event|264|||
160996306|NCT03451851|581372186|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
160571363|NCT00637728|579814459|FG002|Double-blind Phase|Study Discontinued|0|||
160571364|NCT01873950|579814462|FG000|Period 5|Withdrawal by Subject|0|||
160571365|NCT01873950|579814463|FG001|Period 5|Withdrawal by Subject|0|||
160571366|NCT01873950|579814464|FG002|Period 5|Withdrawal by Subject|0|||
160571367|NCT01873950|579814465|FG003|Period 5|Withdrawal by Subject|1|||
160571368|NCT01873950|579814466|FG004|Period 5|Withdrawal by Subject|0|||
160916173|NCT00563381|581085113|FG001|Overall Study|Adverse Event|292|||
160571369|NCT02723630|579814468|FG000|Intervention Period 1|Adverse Event|1|||
160571370|NCT02723630|579814469|FG001|Intervention Period 1|Adverse Event|0|||
160571371|NCT02723630|579814470|FG002|Intervention Period 1|Adverse Event|0|||
160571372|NCT02723630|579814471|FG003|Intervention Period 1|Adverse Event|0|||
160916174|NCT00563381|581085112|FG000|Overall Study|Protocol Violation|66|||
160571373|NCT02723630|579814472|FG004|Intervention Period 1|Adverse Event|0|||
160571374|NCT02723630|579814473|FG005|Intervention Period 1|Adverse Event|0|||
160571375|NCT02723630|579814468|FG000|Intervention Period 3|consumption of restricted item|0|||
160571376|NCT02723630|579814469|FG001|Intervention Period 3|consumption of restricted item|1|||
160571377|NCT02723630|579814470|FG002|Intervention Period 3|consumption of restricted item|0|||
160571378|NCT02723630|579814471|FG003|Intervention Period 3|consumption of restricted item|0|||
160571379|NCT02723630|579814472|FG004|Intervention Period 3|consumption of restricted item|0|||
160571380|NCT02723630|579814473|FG005|Intervention Period 3|consumption of restricted item|0|||
160571381|NCT00852930|579814474|FG000|Overall Study|Withdrawal by Subject|1|||
160571382|NCT00852930|579814475|FG001|Overall Study|Withdrawal by Subject|1|||
160571383|NCT00852930|579814476|FG002|Overall Study|Withdrawal by Subject|1|||
160571384|NCT00852930|579814474|FG000|Overall Study|Physician Decision|0|||
160571385|NCT00852930|579814475|FG001|Overall Study|Physician Decision|0|||
160571386|NCT00852930|579814476|FG002|Overall Study|Physician Decision|1|||
160571387|NCT00537745|579814479|FG000|Overall Study|Did not meet eligibility criteria|2|||
160571388|NCT00537745|579814479|FG000|Overall Study|Withdrawal by Subject|2|||
160571389|NCT00537745|579814479|FG000|Overall Study|Subject unable to provide Interlock info|1|||
160571390|NCT01512368|579814480|FG000|Overall Study|Protocol Violation|3|||
160571391|NCT00328198|579814481|FG000|Treatment|Adverse Event|21|||
160571392|NCT00328198|579814481|FG000|Treatment|Death|1|||
160571393|NCT00328198|579814481|FG000|Treatment|Physician Decision|5|||
160571394|NCT00328198|579814481|FG000|Treatment|Withdrawal by Subject|5|||
160916175|NCT00563381|581085113|FG001|Overall Study|Protocol Violation|74|||
160916176|NCT00563381|581085112|FG000|Overall Study|Lost to Follow-up|7|||
160916177|NCT00563381|581085113|FG001|Overall Study|Lost to Follow-up|15|||
160453836|NCT02852655|579392214|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
160453837|NCT02852655|579392212|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
160453838|NCT02852655|579392213|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
160571395|NCT00328198|579814481|FG000|Treatment|Evidence of disease progression|2|||
160571396|NCT00328198|579814481|FG000|Treatment|Non-compliance|1|||
160571397|NCT00328198|579814481|FG000|Treatment|Confirmed complete response, MRD -|3|||
160571398|NCT00328198|579814481|FG000|Follow-up|Lost to Follow-up|4|||
160861673|NCT01921205|580887803|FG001|Overall Study|Protocol Violation|3|||
160861674|NCT01921205|580887802|FG000|Overall Study|Lost to Follow-up|1|||
160861675|NCT01921205|580887803|FG001|Overall Study|Lost to Follow-up|1|||
160861676|NCT01921205|580887802|FG000|Overall Study|Withdrawal by Subject|6|||
160861677|NCT01921205|580887803|FG001|Overall Study|Withdrawal by Subject|5|||
160861678|NCT01921205|580887802|FG000|Overall Study|Use Of Prohibited Medication|0|||
160861679|NCT01921205|580887803|FG001|Overall Study|Use Of Prohibited Medication|1|||
160861680|NCT01921205|580887802|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
160861681|NCT01921205|580887803|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
160861682|NCT01921205|580887802|FG000|Overall Study|Non Compliance Of The Parent|0|||
160861683|NCT01921205|580887803|FG001|Overall Study|Non Compliance Of The Parent|1|||
160861684|NCT01921205|580887802|FG000|Overall Study|Non Compliance Of Child|0|||
160861685|NCT01921205|580887803|FG001|Overall Study|Non Compliance Of Child|1|||
160861686|NCT03331315|580887804|FG000|Overall Study|Physician Decision|18|||
160861687|NCT03331315|580887805|FG001|Overall Study|Physician Decision|14|||
160861688|NCT00481832|580887806|FG000|Enrollment|Physician Decision|8|||
160861689|NCT00481832|580887806|FG000|Enrollment|Unable to collect enough stem cells|2|||
160861690|NCT00481832|580887806|FG000|Inter-transplant Period|Adverse Event|4|||
160861691|NCT00481832|580887806|FG000|Inter-transplant Period|Death|3|||
160861692|NCT00481832|580887806|FG000|Inter-transplant Period|Physician Decision|4|||
160861693|NCT00481832|580887806|FG000|Inter-transplant Period|Disease relapse|11|||
160861694|NCT00481832|580887806|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
160861695|NCT00456846|580887807|FG000|Overall Study|Adverse Event|2|||
160861696|NCT00456846|580887808|FG001|Overall Study|Adverse Event|15|||
160861697|NCT00456846|580887807|FG000|Overall Study|Physician Decision|11|||
160861698|NCT00456846|580887808|FG001|Overall Study|Physician Decision|6|||
160861699|NCT00456846|580887807|FG000|Overall Study|Protocol Deviation|2|||
160861700|NCT00456846|580887808|FG001|Overall Study|Protocol Deviation|0|||
160861701|NCT00456846|580887807|FG000|Overall Study|Participant Discretion|1|||
160861702|NCT00456846|580887808|FG001|Overall Study|Participant Discretion|5|||
160861703|NCT00456846|580887807|FG000|Overall Study|Other|0|||
160861704|NCT00456846|580887808|FG001|Overall Study|Other|2|||
160861705|NCT00886379|580887812|FG000|Overall Study|Transferred Schools|0|||
160861706|NCT00886379|580887813|FG001|Overall Study|Transferred Schools|0|||
160861707|NCT00886379|580887814|FG002|Overall Study|Transferred Schools|2|||
160861708|NCT00886379|580887815|FG003|Overall Study|Transferred Schools|1|||
160861709|NCT00886379|580887816|FG004|Overall Study|Transferred Schools|1|||
160861710|NCT00886379|580887812|FG000|Overall Study|Final blood draw not obtained|3|||
160861711|NCT00886379|580887813|FG001|Overall Study|Final blood draw not obtained|3|||
160861712|NCT00886379|580887814|FG002|Overall Study|Final blood draw not obtained|4|||
160861713|NCT00886379|580887815|FG003|Overall Study|Final blood draw not obtained|2|||
160861714|NCT00886379|580887816|FG004|Overall Study|Final blood draw not obtained|2|||
160571399|NCT00328198|579814481|FG000|Follow-up|Death|31|||
160571400|NCT01570491|579814482|FG000|Overall Study|Lost to Follow-up|3|||
160916178|NCT00563381|581085112|FG000|Overall Study|Withdrawal by Subject|192|||
160916179|NCT00563381|581085113|FG001|Overall Study|Withdrawal by Subject|209|||
160916180|NCT00563381|581085112|FG000|Overall Study|Lack of Efficacy|32|||
160916181|NCT00563381|581085113|FG001|Overall Study|Lack of Efficacy|24|||
160571401|NCT01570491|579814483|FG001|Overall Study|Lost to Follow-up|1|||
160571402|NCT01570491|579814482|FG000|Overall Study|treatment: not given or discontinued|2|||
160571403|NCT01570491|579814483|FG001|Overall Study|treatment: not given or discontinued|0|||
160571404|NCT02532543|579814487|FG000|Overall Study|Lost to Follow-up|0|||
160571405|NCT02532543|579814488|FG001|Overall Study|Lost to Follow-up|0|||
160571406|NCT02532543|579814489|FG002|Overall Study|Lost to Follow-up|1|||
160571407|NCT02532543|579814490|FG003|Overall Study|Lost to Follow-up|0|||
160571408|NCT02640612|579814493|FG000|Overall Study|Adverse Event|6|||
160571409|NCT02640612|579814494|FG001|Overall Study|Adverse Event|7|||
160571410|NCT02640612|579814495|FG002|Overall Study|Adverse Event|2|||
160571411|NCT02640612|579814493|FG000|Overall Study|Death|1|||
160571412|NCT02640612|579814494|FG001|Overall Study|Death|0|||
160571413|NCT02640612|579814495|FG002|Overall Study|Death|0|||
160571414|NCT02640612|579814493|FG000|Overall Study|Withdrawal by Subject|10|||
160571415|NCT02640612|579814494|FG001|Overall Study|Withdrawal by Subject|3|||
160571416|NCT02640612|579814495|FG002|Overall Study|Withdrawal by Subject|3|||
160571417|NCT02640612|579814493|FG000|Overall Study|Lost to Follow-up|4|||
160571418|NCT02640612|579814494|FG001|Overall Study|Lost to Follow-up|1|||
160571419|NCT02640612|579814495|FG002|Overall Study|Lost to Follow-up|1|||
160571420|NCT02640612|579814493|FG000|Overall Study|Protocol Violation|0|||
160571421|NCT02640612|579814494|FG001|Overall Study|Protocol Violation|2|||
160571422|NCT02640612|579814495|FG002|Overall Study|Protocol Violation|0|||
160571423|NCT02640612|579814493|FG000|Overall Study|Lack of Efficacy|1|||
160571424|NCT02640612|579814494|FG001|Overall Study|Lack of Efficacy|1|||
160571425|NCT02640612|579814495|FG002|Overall Study|Lack of Efficacy|0|||
160571426|NCT04407507|579814496|FG000|Overall Study|Withdrawal by Subject|0|||
160571427|NCT04407507|579814497|FG001|Overall Study|Withdrawal by Subject|1|||
160571428|NCT01499576|579814506|FG000|Overall Study|Physician Decision|12|||
160571429|NCT01499576|579814506|FG000|Overall Study|Withdrawal by Subject|9|||
160571430|NCT03396471|579814507|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
160571431|NCT03396471|579814507|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
160571432|NCT03396471|579814507|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
160916182|NCT00563381|581085112|FG000|Overall Study|Individual different reasons|24|||
160916183|NCT00563381|581085113|FG001|Overall Study|Individual different reasons|34|||
160916184|NCT00667368|581085114|FG000|Overall Study|Lost to Follow-up|176|||
160916185|NCT00667368|581085115|FG001|Overall Study|Lost to Follow-up|155|||
160916186|NCT00667368|581085114|FG000|Overall Study|Discontinued early|24|||
160916187|NCT00667368|581085115|FG001|Overall Study|Discontinued early|17|||
160916188|NCT02407704|581085116|FG000|Overall Study|Lost to Follow-up|0|||
160916189|NCT02407704|581085117|FG001|Overall Study|Lost to Follow-up|0|||
160916190|NCT02407704|581085118|FG002|Overall Study|Lost to Follow-up|0|||
160916191|NCT02407704|581085119|FG003|Overall Study|Lost to Follow-up|2|||
160916192|NCT02407704|581085116|FG000|Overall Study|Protocol Violation|0|||
160916193|NCT02407704|581085117|FG001|Overall Study|Protocol Violation|0|||
160916194|NCT02407704|581085118|FG002|Overall Study|Protocol Violation|0|||
160916195|NCT02407704|581085119|FG003|Overall Study|Protocol Violation|1|||
160916196|NCT02407704|581085116|FG000|Overall Study|Withdrawal by Subject|0|||
160916197|NCT02407704|581085117|FG001|Overall Study|Withdrawal by Subject|0|||
160916198|NCT02407704|581085118|FG002|Overall Study|Withdrawal by Subject|1|||
160916199|NCT02407704|581085119|FG003|Overall Study|Withdrawal by Subject|0|||
160916200|NCT01957644|581085120|FG000|Overall Study|Adverse Event|4|||
160916201|NCT01957644|581085121|FG001|Overall Study|Adverse Event|2|||
160916202|NCT01957644|581085122|FG002|Overall Study|Adverse Event|0|||
160916203|NCT01957644|581085123|FG003|Overall Study|Adverse Event|0|||
160916204|NCT01957644|581085124|FG004|Overall Study|Adverse Event|1|||
160916205|NCT01957644|581085120|FG000|Overall Study|Progressive disease / relapse|0|||
160916206|NCT01957644|581085121|FG001|Overall Study|Progressive disease / relapse|1|||
160916207|NCT01957644|581085122|FG002|Overall Study|Progressive disease / relapse|0|||
160571433|NCT03396471|579814507|FG000|Study Treatment - Up to 22 Months|Death|2|||
160571434|NCT03396471|579814507|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
160571435|NCT03396471|579814507|FG000|Follow up - Up to 2 Years|Death|9|||
160571436|NCT03396471|579814507|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
160571437|NCT03396471|579814507|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
160571438|NCT03396471|579814507|FG000|Follow up - Up to 2 Years|study terminated|1|||
160916208|NCT01957644|581085123|FG003|Overall Study|Progressive disease / relapse|1|||
160916209|NCT01957644|581085124|FG004|Overall Study|Progressive disease / relapse|0|||
160571439|NCT03396471|579814507|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
160571952|NCT02619253|579816875|FG000|Overall Study|Needed a disqualifying therapy|0|||
160916210|NCT01957644|581085120|FG000|Overall Study|Other reason|1|||
160916211|NCT01957644|581085121|FG001|Overall Study|Other reason|2|||
160453839|NCT02852655|579392214|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
160453840|NCT02852655|579392212|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
160453841|NCT02852655|579392213|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
160453842|NCT02852655|579392214|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
160453843|NCT04233216|579393938|FG000|Overall Study|Lost to Follow-up|1|||
160453844|NCT04233216|579393939|FG001|Overall Study|Lost to Follow-up|0|||
160453845|NCT04233216|579393940|FG002|Overall Study|Lost to Follow-up|2|||
160453846|NCT04233216|579393941|FG003|Overall Study|Lost to Follow-up|0|||
160453847|NCT04233216|579393938|FG000|Overall Study|Physician Decision|0|||
160453848|NCT04233216|579393939|FG001|Overall Study|Physician Decision|3|||
160453849|NCT04233216|579393940|FG002|Overall Study|Physician Decision|0|||
160453850|NCT04233216|579393941|FG003|Overall Study|Physician Decision|2|||
160453851|NCT04233216|579393938|FG000|Overall Study|Withdrawal by Subject|0|||
160453852|NCT04233216|579393939|FG001|Overall Study|Withdrawal by Subject|2|||
160453853|NCT04233216|579393940|FG002|Overall Study|Withdrawal by Subject|1|||
160453854|NCT04233216|579393941|FG003|Overall Study|Withdrawal by Subject|0|||
160453855|NCT02927236|579393944|FG000|Characterization Phase|Physician Decision|0|||
160453856|NCT02927236|579393945|FG001|Characterization Phase|Physician Decision|3|||
160453857|NCT02927236|579393946|FG002|Characterization Phase|Physician Decision|0|||
160453858|NCT02927236|579393947|FG003|Characterization Phase|Physician Decision|2|||
160652872|NCT02207231|580110391|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
160652873|NCT02207231|580110392|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
160652874|NCT02207231|580110393|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
160652875|NCT02207231|580110390|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
160652876|NCT02207231|580110391|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
160652877|NCT02207231|580110392|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
160652878|NCT02207231|580110393|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
160652879|NCT02207231|580110390|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
160652880|NCT02207231|580110391|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
160652881|NCT02207231|580110392|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
160652882|NCT02207231|580110393|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
160652883|NCT02207231|580110390|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
160652884|NCT02207231|580110391|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
160652885|NCT02207231|580110392|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
160652886|NCT02207231|580110393|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
160652887|NCT02207231|580110390|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
160652888|NCT02207231|580110391|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
160652889|NCT02207231|580110392|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
160652890|NCT02207231|580110393|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
160652891|NCT02207231|580110390|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
160652892|NCT02207231|580110391|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
160652893|NCT02207231|580110392|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
160652894|NCT02207231|580110393|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
160916212|NCT01957644|581085122|FG002|Overall Study|Other reason|1|||
160916213|NCT01957644|581085123|FG003|Overall Study|Other reason|1|||
160916214|NCT01957644|581085124|FG004|Overall Study|Other reason|0|||
160916215|NCT01957644|581085120|FG000|Overall Study|Withdrawal by Subject|1|||
160916216|NCT01957644|581085121|FG001|Overall Study|Withdrawal by Subject|0|||
160916217|NCT01957644|581085122|FG002|Overall Study|Withdrawal by Subject|0|||
160916218|NCT01957644|581085123|FG003|Overall Study|Withdrawal by Subject|0|||
160916219|NCT01957644|581085124|FG004|Overall Study|Withdrawal by Subject|0|||
160916220|NCT01957644|581085120|FG000|Overall Study|Protocol Violation|0|||
160916221|NCT01957644|581085121|FG001|Overall Study|Protocol Violation|1|||
160916222|NCT01957644|581085122|FG002|Overall Study|Protocol Violation|0|||
160916223|NCT01957644|581085123|FG003|Overall Study|Protocol Violation|0|||
160916224|NCT01957644|581085124|FG004|Overall Study|Protocol Violation|0|||
160916225|NCT04044716|581085125|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
160916226|NCT04044716|581085126|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
160916227|NCT04044716|581085127|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
160916228|NCT04044716|581085125|FG000|Overall Study|Lost to Follow-up|2|||
160916229|NCT04044716|581085126|FG001|Overall Study|Lost to Follow-up|3|||
160916230|NCT04044716|581085127|FG002|Overall Study|Lost to Follow-up|0|||
160916231|NCT01957553|581085128|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
160916232|NCT01957553|581085129|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
160916233|NCT01957553|581085128|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
160996307|NCT03451851|581372187|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
160453859|NCT02927236|579393944|FG000|Characterization Phase|Lost to Follow-up|0|||
160453860|NCT02927236|579393945|FG001|Characterization Phase|Lost to Follow-up|0|||
160453861|NCT02927236|579393946|FG002|Characterization Phase|Lost to Follow-up|0|||
160453862|NCT02927236|579393947|FG003|Characterization Phase|Lost to Follow-up|3|||
160453863|NCT02927236|579393944|FG000|Characterization Phase|Withdrawal by Subject|1|||
160652895|NCT02207231|580110390|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
160916234|NCT01957553|581085129|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
160652896|NCT02207231|580110391|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
160652897|NCT02207231|580110392|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
160652898|NCT02207231|580110393|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
160652899|NCT02207231|580110390|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
160652900|NCT02207231|580110391|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
160652901|NCT02207231|580110392|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
160652902|NCT02207231|580110393|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
160652903|NCT02207231|580110390|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
160652904|NCT02207231|580110391|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
160652905|NCT02207231|580110392|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
160652906|NCT02207231|580110393|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
160652907|NCT02207231|580110390|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
160652908|NCT02207231|580110391|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
160652909|NCT02207231|580110392|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
160652910|NCT02207231|580110393|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
160652911|NCT02207231|580110390|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
160652912|NCT02207231|580110391|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
160652913|NCT02207231|580110392|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
160652914|NCT02207231|580110393|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
160652915|NCT02207231|580110390|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
160652916|NCT02207231|580110391|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
160652917|NCT02207231|580110392|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
160652918|NCT02207231|580110393|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
160652919|NCT00421174|580110394|FG000|Overall Study|Withdrawal by Subject|0|||
160652920|NCT00421174|580110395|FG001|Overall Study|Withdrawal by Subject|1|||
160652921|NCT00421174|580110394|FG000|Overall Study|Ineligible due to infection|2|||
160652922|NCT00421174|580110395|FG001|Overall Study|Ineligible due to infection|0|||
160652923|NCT01290263|580110399|FG000|Overall Study|Adverse Event|0|||
160652924|NCT01290263|580110400|FG001|Overall Study|Adverse Event|0|||
160652925|NCT01290263|580110401|FG002|Overall Study|Adverse Event|0|||
160652926|NCT01290263|580110402|FG003|Overall Study|Adverse Event|1|||
160652927|NCT01290263|580110403|FG004|Overall Study|Adverse Event|1|||
160652928|NCT01290263|580110399|FG000|Overall Study|Lack of Efficacy|8|||
160652929|NCT01290263|580110400|FG001|Overall Study|Lack of Efficacy|2|||
160652930|NCT01290263|580110401|FG002|Overall Study|Lack of Efficacy|7|||
160652931|NCT01290263|580110402|FG003|Overall Study|Lack of Efficacy|24|||
160652932|NCT01290263|580110403|FG004|Overall Study|Lack of Efficacy|33|||
160652933|NCT01290263|580110399|FG000|Overall Study|Withdrawal by Subject|3|||
160652934|NCT01290263|580110400|FG001|Overall Study|Withdrawal by Subject|1|||
160652935|NCT01290263|580110401|FG002|Overall Study|Withdrawal by Subject|0|||
160652936|NCT01290263|580110402|FG003|Overall Study|Withdrawal by Subject|1|||
160652937|NCT01290263|580110403|FG004|Overall Study|Withdrawal by Subject|2|||
160652938|NCT01290263|580110399|FG000|Overall Study|Participant Non-Compliance|0|||
160652939|NCT01290263|580110400|FG001|Overall Study|Participant Non-Compliance|0|||
160652940|NCT01290263|580110401|FG002|Overall Study|Participant Non-Compliance|0|||
160652941|NCT01290263|580110402|FG003|Overall Study|Participant Non-Compliance|1|||
160652942|NCT01290263|580110403|FG004|Overall Study|Participant Non-Compliance|1|||
160652943|NCT02204371|580110417|FG000|Overall Study|Adverse Event|1|||
160916235|NCT01957553|581085128|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
160916236|NCT01957553|581085129|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
160916237|NCT01957553|581085128|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
160916238|NCT01957553|581085129|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
160916239|NCT01957553|581085128|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
160916240|NCT01957553|581085129|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
160916241|NCT01957553|581085128|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
160916242|NCT01957553|581085129|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
160916243|NCT01957553|581085128|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
160916244|NCT01957553|581085129|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
160916245|NCT01957553|581085128|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
160916246|NCT01957553|581085129|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
160916247|NCT01957553|581085128|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
160996308|NCT03451851|581372188|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
160652944|NCT01506947|580110418|FG000|Overall Study|Lost to Follow-up|7|||
160652945|NCT01506947|580110418|FG000|Overall Study|Adverse Event|5|||
160652946|NCT01506947|580110418|FG000|Overall Study|Death|1|||
160652947|NCT01506947|580110418|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
160652948|NCT02187042|580110421|FG000|Overall Study|Death|1|||
160652949|NCT02187042|580110422|FG001|Overall Study|Death|1|||
160652950|NCT02187042|580110421|FG000|Overall Study|Toxicity|6|||
160916248|NCT01957553|581085129|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
160571440|NCT03396471|579814507|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
160916249|NCT03235154|581085133|FG000|Overall Study|Withdrawal by Subject|1|||
160916250|NCT03235154|581085133|FG000|Overall Study|Adverse Event|1|||
160916251|NCT03235154|581085133|FG000|Overall Study|Lost to Follow-up|2|||
160916252|NCT01683383|581085138|FG000|Overall Study|Infant was not transported|1|||
160916253|NCT01683383|581085139|FG001|Overall Study|Infant was not transported|0|||
160571441|NCT01319929|579814508|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
160916254|NCT02496611|581085140|FG000|Overall Study|Lost to Follow-up|2|||
160916255|NCT02496611|581085141|FG001|Overall Study|Lost to Follow-up|1|||
160916256|NCT02496611|581085140|FG000|Overall Study|Withdrawal by Subject|5|||
160916257|NCT02496611|581085141|FG001|Overall Study|Withdrawal by Subject|2|||
160916258|NCT02850965|581085142|FG000|Overall Study|Other than listed|3|||
160916259|NCT02850965|581085143|FG001|Overall Study|Other than listed|4|||
160916260|NCT02850965|581085142|FG000|Overall Study|Protocol Violation|0|||
160916261|NCT02850965|581085143|FG001|Overall Study|Protocol Violation|2|||
160916262|NCT02850965|581085142|FG000|Overall Study|Lost to Follow-up|5|||
160916263|NCT02850965|581085143|FG001|Overall Study|Lost to Follow-up|3|||
160916264|NCT02850965|581085142|FG000|Overall Study|Lack of Efficacy|4|||
160916265|NCT02850965|581085143|FG001|Overall Study|Lack of Efficacy|8|||
160916266|NCT02850965|581085142|FG000|Overall Study|Adverse Event|3|||
160916267|NCT02850965|581085143|FG001|Overall Study|Adverse Event|2|||
160916268|NCT02850965|581085142|FG000|Overall Study|Withdrawal by Subject|3|||
160916269|NCT02850965|581085143|FG001|Overall Study|Withdrawal by Subject|4|||
160916270|NCT02850965|581085142|FG000|Overall Study|Physician Decision|0|||
160916271|NCT02850965|581085143|FG001|Overall Study|Physician Decision|1|||
160916272|NCT02850965|581085142|FG000|Overall Study|Randomized but not treated|0|||
160916273|NCT02850965|581085143|FG001|Overall Study|Randomized but not treated|1|||
160916274|NCT00536198|581085144|FG000|Overall Study|Lost to Follow-up|15|||
160916275|NCT00536198|581085145|FG001|Overall Study|Lost to Follow-up|14|||
160916276|NCT00536198|581085144|FG000|Overall Study|Withdrawal by Subject|16|||
160571442|NCT01319929|579814509|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
160571443|NCT01319929|579814508|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
160571444|NCT01319929|579814509|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
160571445|NCT01319929|579814508|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
160571446|NCT01319929|579814509|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
160571447|NCT01319929|579814508|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
160571448|NCT01319929|579814509|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
160571449|NCT01319929|579814508|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
160571450|NCT01319929|579814509|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
160571451|NCT01221233|579814510|FG000|Overall Study|Withdrawal by Subject|3|||
160571452|NCT01221233|579814511|FG001|Overall Study|Withdrawal by Subject|1|||
160571453|NCT02859415|579814513|FG000|Overall Study|Physician Decision|1|||
160571454|NCT02859415|579814514|FG001|Overall Study|Physician Decision|0|||
160571455|NCT02859415|579814513|FG000|Overall Study|Off treatment due to cardiac event|0|||
160571456|NCT02859415|579814514|FG001|Overall Study|Off treatment due to cardiac event|1|||
160652951|NCT02187042|580110422|FG001|Overall Study|Toxicity|5|||
160652952|NCT02187042|580110421|FG000|Overall Study|Participant choice|1|||
160652953|NCT02187042|580110422|FG001|Overall Study|Participant choice|0|||
160652954|NCT02187042|580110421|FG000|Overall Study|Doctor choice|1|||
160652955|NCT02187042|580110422|FG001|Overall Study|Doctor choice|0|||
160652956|NCT02187042|580110421|FG000|Overall Study|Progressive disease|4|||
160916277|NCT00536198|581085145|FG001|Overall Study|Withdrawal by Subject|12|||
160916278|NCT00536198|581085144|FG000|Overall Study|Adverse Event|2|||
160916279|NCT00536198|581085145|FG001|Overall Study|Adverse Event|2|||
160916280|NCT00536198|581085144|FG000|Overall Study|Rescue|3|||
160916281|NCT00536198|581085145|FG001|Overall Study|Rescue|9|||
160916282|NCT00536198|581085144|FG000|Overall Study|Pregnancy|1|||
160916283|NCT00536198|581085145|FG001|Overall Study|Pregnancy|1|||
160916284|NCT00536198|581085144|FG000|Overall Study|Protocol Violation|0|||
160916285|NCT00536198|581085145|FG001|Overall Study|Protocol Violation|1|||
160996309|NCT03451851|581372189|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
160571457|NCT01396525|579814515|FG000|Overall Study|Withdrawal by Subject|8|||
160571458|NCT01396525|579814515|FG000|Overall Study|Death|14|||
160652957|NCT02187042|580110422|FG001|Overall Study|Progressive disease|8|||
160652958|NCT01766921|580110425|FG000|Overall Study|Administrative Reason|5|||
160652959|NCT01766921|580110426|FG001|Overall Study|Administrative Reason|5|||
160916286|NCT00881712|581085146|FG000|Overall Study|Death|1|||
160916287|NCT00881712|581085147|FG001|Overall Study|Death|0|||
160916288|NCT00881712|581085148|FG002|Overall Study|Death|0|||
160916289|NCT00881712|581085146|FG000|Overall Study|Withdrawal by Subject|1|||
160916290|NCT00881712|581085147|FG001|Overall Study|Withdrawal by Subject|0|||
160916291|NCT00881712|581085148|FG002|Overall Study|Withdrawal by Subject|0|||
160916292|NCT00276744|581085149|FG000|PART A|Reason unknown|98|||
160916293|NCT00965718|581085160|FG000|Overall Study|Withdrawal by Subject|4|||
160916294|NCT03667924|581085161|FG000|Baseline Completed|Lost to Follow-up|0|||
160916295|NCT03667924|581085162|FG001|Baseline Completed|Lost to Follow-up|2|||
160916296|NCT03667924|581085163|FG002|Baseline Completed|Lost to Follow-up|0|||
160571459|NCT01396525|579814515|FG000|Overall Study|Lost to Follow-up|4|||
160571460|NCT03114969|579814516|FG000|Overall Study|Lost to Follow-up|0|||
160571461|NCT03114969|579814517|FG001|Overall Study|Lost to Follow-up|0|||
160571462|NCT03114969|579814518|FG002|Overall Study|Lost to Follow-up|3|||
160571463|NCT03114969|579814519|FG003|Overall Study|Lost to Follow-up|2|||
160571464|NCT03114969|579814520|FG004|Overall Study|Lost to Follow-up|0|||
160571465|NCT03114969|579814521|FG005|Overall Study|Lost to Follow-up|0|||
160571466|NCT03114969|579814522|FG006|Overall Study|Lost to Follow-up|0|||
160571467|NCT03114969|579814523|FG007|Overall Study|Lost to Follow-up|0|||
160571468|NCT03114969|579814524|FG008|Overall Study|Lost to Follow-up|0|||
160571469|NCT03114969|579814516|FG000|Overall Study|Adverse Event|0|||
160571470|NCT03114969|579814517|FG001|Overall Study|Adverse Event|0|||
160571471|NCT03114969|579814518|FG002|Overall Study|Adverse Event|1|||
160571472|NCT03114969|579814519|FG003|Overall Study|Adverse Event|0|||
160571473|NCT03114969|579814520|FG004|Overall Study|Adverse Event|0|||
160571474|NCT03114969|579814521|FG005|Overall Study|Adverse Event|1|||
160571475|NCT03114969|579814522|FG006|Overall Study|Adverse Event|1|||
160571476|NCT03114969|579814523|FG007|Overall Study|Adverse Event|0|||
160571477|NCT03114969|579814524|FG008|Overall Study|Adverse Event|2|||
160571478|NCT01662999|579814529|FG000|Period 3|Withdrawal by Subject|0|||
160571479|NCT01662999|579814530|FG001|Period 3|Withdrawal by Subject|1|||
160571480|NCT01662999|579814531|FG002|Period 3|Withdrawal by Subject|0|||
160571481|NCT01662999|579814532|FG003|Period 3|Withdrawal by Subject|0|||
160571482|NCT01662999|579814533|FG004|Period 3|Withdrawal by Subject|0|||
160571483|NCT01662999|579814534|FG005|Period 3|Withdrawal by Subject|0|||
160571484|NCT01151137|579814537|FG000|Overall Study|Death|15|||
160571485|NCT01151137|579814538|FG001|Overall Study|Death|27|||
160571486|NCT01151137|579814537|FG000|Overall Study|Lost to Follow-up|1|||
160571487|NCT01151137|579814538|FG001|Overall Study|Lost to Follow-up|1|||
160571488|NCT00072189|579814539|FG000|Overall Study|Withdrawal by Subject|1|||
160571489|NCT02973815|579814540|FG000|Post Intervention|Death|1|||
160571490|NCT02973815|579814541|FG001|Post Intervention|Death|0|||
160571491|NCT02973815|579814540|FG000|Post Intervention|Lost to Follow-up|7|||
160571492|NCT02973815|579814541|FG001|Post Intervention|Lost to Follow-up|24|||
160571493|NCT02973815|579814540|FG000|Follow-up|Lost to Follow-up|2|||
160571494|NCT02973815|579814541|FG001|Follow-up|Lost to Follow-up|0|||
160571495|NCT03478683|579814543|FG000|Overall Study|Adverse Event|5|||
160571496|NCT03478683|579814544|FG001|Overall Study|Adverse Event|3|||
160571497|NCT03478683|579814543|FG000|Overall Study|Lost to Follow-up|0|||
160571498|NCT03478683|579814544|FG001|Overall Study|Lost to Follow-up|5|||
160571499|NCT03478683|579814543|FG000|Overall Study|Physician Decision|1|||
160571500|NCT03478683|579814544|FG001|Overall Study|Physician Decision|3|||
160571501|NCT03478683|579814543|FG000|Overall Study|Withdrawal by Subject|7|||
160571502|NCT03478683|579814544|FG001|Overall Study|Withdrawal by Subject|7|||
160571503|NCT00524303|579814545|FG000|Overall Study|Lost to Follow-up|6|||
160571504|NCT00524303|579814546|FG001|Overall Study|Lost to Follow-up|0|||
160571505|NCT00524303|579814547|FG002|Overall Study|Lost to Follow-up|3|||
160571506|NCT00524303|579814545|FG000|Overall Study|Protocol Violation|0|||
160571507|NCT00524303|579814546|FG001|Overall Study|Protocol Violation|1|||
160571508|NCT00524303|579814547|FG002|Overall Study|Protocol Violation|1|||
160571509|NCT00524303|579814545|FG000|Overall Study|Withdrawal by Subject|3|||
160571510|NCT00524303|579814546|FG001|Overall Study|Withdrawal by Subject|0|||
160571511|NCT00524303|579814547|FG002|Overall Study|Withdrawal by Subject|4|||
160571512|NCT00524303|579814545|FG000|Overall Study|Death|0|||
160916297|NCT03667924|581085161|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
160916298|NCT03667924|581085162|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
160916299|NCT03667924|581085163|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
160916300|NCT03667924|581085161|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
160916301|NCT03667924|581085162|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
160916302|NCT03667924|581085163|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
160571513|NCT00524303|579814546|FG001|Overall Study|Death|2|||
160571514|NCT00524303|579814547|FG002|Overall Study|Death|3|||
160571515|NCT00524303|579814545|FG000|Overall Study|Adverse Event|1|||
160571516|NCT00524303|579814546|FG001|Overall Study|Adverse Event|2|||
160571517|NCT00524303|579814547|FG002|Overall Study|Adverse Event|3|||
160571518|NCT00524303|579814545|FG000|Overall Study|Did not Complete Study Dosing|1|||
160571519|NCT00524303|579814546|FG001|Overall Study|Did not Complete Study Dosing|0|||
160652960|NCT01766921|580110425|FG000|Overall Study|Death|1|||
160571520|NCT00524303|579814547|FG002|Overall Study|Did not Complete Study Dosing|0|||
160571521|NCT00524303|579814545|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
160571522|NCT00524303|579814546|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
160571523|NCT00524303|579814547|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
160571524|NCT00524303|579814545|FG000|Overall Study|Disease Progression|0|||
160571525|NCT00524303|579814546|FG001|Overall Study|Disease Progression|4|||
160571526|NCT00524303|579814547|FG002|Overall Study|Disease Progression|1|||
160571527|NCT00524303|579814545|FG000|Overall Study|Disease Recurrence|0|||
160571528|NCT00524303|579814546|FG001|Overall Study|Disease Recurrence|1|||
160571529|NCT00524303|579814547|FG002|Overall Study|Disease Recurrence|0|||
160571530|NCT00524303|579814545|FG000|Overall Study|Sponsor Request|0|||
160571531|NCT00524303|579814546|FG001|Overall Study|Sponsor Request|0|||
160571532|NCT00524303|579814547|FG002|Overall Study|Sponsor Request|1|||
160571533|NCT00524303|579814545|FG000|Overall Study|Physician Decision|0|||
160571534|NCT00524303|579814546|FG001|Overall Study|Physician Decision|0|||
160571535|NCT00524303|579814547|FG002|Overall Study|Physician Decision|1|||
160571536|NCT00524303|579814545|FG000|Overall Study|Completed 5 years|0|||
160571537|NCT00524303|579814546|FG001|Overall Study|Completed 5 years|0|||
160571538|NCT00524303|579814547|FG002|Overall Study|Completed 5 years|1|||
160571539|NCT01607892|579814559|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
160571540|NCT01607892|579814560|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
160571541|NCT01607892|579814561|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
160571542|NCT01607892|579814562|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
160571543|NCT01607892|579814563|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
160571544|NCT01607892|579814559|FG000|Overall Study|Death|4|||
160571545|NCT01607892|579814560|FG001|Overall Study|Death|2|||
160571546|NCT01607892|579814561|FG002|Overall Study|Death|8|||
160571547|NCT01607892|579814562|FG003|Overall Study|Death|10|||
160571548|NCT01607892|579814563|FG004|Overall Study|Death|3|||
160571549|NCT01607892|579814559|FG000|Overall Study|Investigator discretion|2|||
160571550|NCT01607892|579814560|FG001|Overall Study|Investigator discretion|4|||
160571551|NCT01607892|579814561|FG002|Overall Study|Investigator discretion|4|||
160571552|NCT01607892|579814562|FG003|Overall Study|Investigator discretion|8|||
160571553|NCT01607892|579814563|FG004|Overall Study|Investigator discretion|0|||
160571554|NCT01607892|579814559|FG000|Overall Study|Other treatments became available|1|||
160571555|NCT01607892|579814560|FG001|Overall Study|Other treatments became available|1|||
160571556|NCT01607892|579814561|FG002|Overall Study|Other treatments became available|0|||
160571557|NCT01607892|579814562|FG003|Overall Study|Other treatments became available|0|||
160571558|NCT01607892|579814563|FG004|Overall Study|Other treatments became available|2|||
160571559|NCT01607892|579814559|FG000|Overall Study|Intercurrent illness|1|||
160571560|NCT01607892|579814560|FG001|Overall Study|Intercurrent illness|0|||
160571561|NCT01607892|579814561|FG002|Overall Study|Intercurrent illness|0|||
160571562|NCT01607892|579814562|FG003|Overall Study|Intercurrent illness|3|||
160571563|NCT01607892|579814563|FG004|Overall Study|Intercurrent illness|0|||
160571564|NCT01607892|579814559|FG000|Overall Study|Non-Compliance with study procedures|0|||
160571565|NCT01607892|579814560|FG001|Overall Study|Non-Compliance with study procedures|0|||
160571566|NCT01607892|579814561|FG002|Overall Study|Non-Compliance with study procedures|1|||
160916303|NCT03667924|581085161|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
160916304|NCT03667924|581085162|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
160916305|NCT03667924|581085163|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
160916306|NCT03667924|581085161|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
160916307|NCT03667924|581085162|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
160916308|NCT03667924|581085163|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
160916309|NCT03667924|581085161|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
160916310|NCT03667924|581085162|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
160916311|NCT03667924|581085163|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
160916312|NCT03667924|581085161|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
160916313|NCT03667924|581085162|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
160916314|NCT03667924|581085163|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
160916315|NCT00126568|581085164|FG000|Overall Study|Death|2|||
160916316|NCT01244425|581085165|FG000|Overall Study|Withdrawal by Subject|2|||
160916317|NCT01244425|581085166|FG001|Overall Study|Withdrawal by Subject|2|||
160916318|NCT01244425|581085165|FG000|Overall Study|Adverse Event|1|||
160916319|NCT01244425|581085166|FG001|Overall Study|Adverse Event|1|||
160916320|NCT02167893|581085167|FG000|Overall Study|Investigator transferred|85|||
160916321|NCT02167893|581085167|FG000|Overall Study|Investigator health reasons|10|||
160916322|NCT02167893|581085167|FG000|Overall Study|Case report forms not collected|68|||
160916323|NCT04847557|581085168|FG000|Overall Study|Adverse Event|1|||
160996310|NCT03451851|581372182|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996311|NCT03451851|581372183|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996312|NCT03451851|581372184|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160571567|NCT01607892|579814562|FG003|Overall Study|Non-Compliance with study procedures|0|||
160571568|NCT01607892|579814563|FG004|Overall Study|Non-Compliance with study procedures|0|||
160571569|NCT01607892|579814559|FG000|Overall Study|Consent withdrawn by participant|9|||
160571570|NCT01607892|579814560|FG001|Overall Study|Consent withdrawn by participant|4|||
160571571|NCT01607892|579814561|FG002|Overall Study|Consent withdrawn by participant|24|||
160571572|NCT01607892|579814562|FG003|Overall Study|Consent withdrawn by participant|14|||
160571573|NCT01607892|579814563|FG004|Overall Study|Consent withdrawn by participant|4|||
160571574|NCT01607892|579814559|FG000|Overall Study|Disease progression|38|||
160916324|NCT04847557|581085169|FG001|Overall Study|Adverse Event|0|||
160916325|NCT04847557|581085168|FG000|Overall Study|Death|19|||
160916326|NCT04847557|581085169|FG001|Overall Study|Death|15|||
160916327|NCT04847557|581085168|FG000|Overall Study|Lost to Follow-up|3|||
160916328|NCT04847557|581085169|FG001|Overall Study|Lost to Follow-up|6|||
160916329|NCT04847557|581085168|FG000|Overall Study|Physician Decision|1|||
160916330|NCT04847557|581085169|FG001|Overall Study|Physician Decision|0|||
160916331|NCT04847557|581085168|FG000|Overall Study|Protocol Violation|0|||
160916332|NCT04847557|581085169|FG001|Overall Study|Protocol Violation|1|||
160916333|NCT04847557|581085168|FG000|Overall Study|Withdrawal by Subject|8|||
160916334|NCT04847557|581085169|FG001|Overall Study|Withdrawal by Subject|14|||
160916335|NCT01325584|581085170|FG000|Overall Study|Death|1|||
160916336|NCT00733408|581086665|FG000|Overall Study|Adverse Event|4|||
160916337|NCT01134783|581086666|FG000|Overall Study|Pregnancy|16|||
160916338|NCT01134783|581086667|FG001|Overall Study|Pregnancy|8|||
160916339|NCT01134783|581086666|FG000|Overall Study|Withdrawal by Subject|15|||
160916340|NCT01134783|581086667|FG001|Overall Study|Withdrawal by Subject|9|||
160916341|NCT01134783|581086666|FG000|Overall Study|Lost to Follow-up|5|||
160916342|NCT01134783|581086667|FG001|Overall Study|Lost to Follow-up|20|||
160916343|NCT00531232|581086670|FG000|Overall Study|Investigator decision|0|||
160916344|NCT00531232|581086671|FG001|Overall Study|Investigator decision|0|||
160916345|NCT00531232|581086672|FG002|Overall Study|Investigator decision|4|||
160916346|NCT00531232|581086670|FG000|Overall Study|Participants refused further treatment|0|||
160916347|NCT00531232|581086671|FG001|Overall Study|Participants refused further treatment|1|||
160916348|NCT00531232|581086672|FG002|Overall Study|Participants refused further treatment|2|||
160916349|NCT00531232|581086670|FG000|Overall Study|Adverse events (AEs)|1|||
160916350|NCT00531232|581086671|FG001|Overall Study|Adverse events (AEs)|2|||
160916351|NCT00531232|581086672|FG002|Overall Study|Adverse events (AEs)|2|||
160916352|NCT00531232|581086670|FG000|Overall Study|Treatment failure|1|||
160916353|NCT00531232|581086671|FG001|Overall Study|Treatment failure|3|||
160916354|NCT00531232|581086672|FG002|Overall Study|Treatment failure|7|||
160916355|NCT00531232|581086670|FG000|Overall Study|Disease recurrence|0|||
160916356|NCT00531232|581086671|FG001|Overall Study|Disease recurrence|0|||
160916357|NCT00531232|581086672|FG002|Overall Study|Disease recurrence|1|||
160916358|NCT00531232|581086670|FG000|Overall Study|Deceased|2|||
160916359|NCT00531232|581086671|FG001|Overall Study|Deceased|2|||
160916360|NCT00531232|581086672|FG002|Overall Study|Deceased|2|||
160916361|NCT00531232|581086670|FG000|Overall Study|Withdrawal by Subject|0|||
160916362|NCT00531232|581086671|FG001|Overall Study|Withdrawal by Subject|1|||
160916363|NCT00531232|581086672|FG002|Overall Study|Withdrawal by Subject|2|||
160916364|NCT00531232|581086670|FG000|Overall Study|Other|0|||
160916365|NCT00531232|581086671|FG001|Overall Study|Other|0|||
160916366|NCT00531232|581086672|FG002|Overall Study|Other|5|||
160916367|NCT00397982|581086673|FG000|Overall Study|Withdrawal by Subject|1|||
160916368|NCT00397982|581086673|FG000|Overall Study|Adverse Event|1|||
160916369|NCT00397982|581086673|FG000|Overall Study|noncompliance|1|||
160916370|NCT00397982|581086673|FG000|Overall Study|Unrelated health issues|1|||
160916371|NCT02345850|581086674|FG000|Overall Study|Not transplanted|10|||
160571575|NCT01607892|579814560|FG001|Overall Study|Disease progression|13|||
160571576|NCT01607892|579814561|FG002|Overall Study|Disease progression|37|||
160571577|NCT01607892|579814562|FG003|Overall Study|Disease progression|57|||
160571578|NCT01607892|579814563|FG004|Overall Study|Disease progression|9|||
160571579|NCT01607892|579814559|FG000|Overall Study|Incidence or severity of Adverse events|3|||
160571580|NCT01607892|579814560|FG001|Overall Study|Incidence or severity of Adverse events|3|||
160571581|NCT01607892|579814561|FG002|Overall Study|Incidence or severity of Adverse events|7|||
160571582|NCT01607892|579814562|FG003|Overall Study|Incidence or severity of Adverse events|2|||
160571583|NCT01607892|579814563|FG004|Overall Study|Incidence or severity of Adverse events|6|||
160571584|NCT02273973|579814566|FG000|Overall Study|Adverse Event|4|||
160916372|NCT02345850|581086675|FG001|Overall Study|Not transplanted|5|||
160916373|NCT02345850|581086676|FG002|Overall Study|Not transplanted|4|||
160916374|NCT02345850|581086674|FG000|Overall Study|Lost to Follow-up|2|||
160916375|NCT02345850|581086675|FG001|Overall Study|Lost to Follow-up|3|||
160916376|NCT02345850|581086676|FG002|Overall Study|Lost to Follow-up|2|||
160916377|NCT02345850|581086674|FG000|Overall Study|Withdrawal by Subject|1|||
160916378|NCT02345850|581086675|FG001|Overall Study|Withdrawal by Subject|0|||
160571585|NCT02273973|579814567|FG001|Overall Study|Adverse Event|0|||
160571586|NCT02273973|579814566|FG000|Overall Study|Withdrawal by Subject|2|||
160916379|NCT02345850|581086676|FG002|Overall Study|Withdrawal by Subject|0|||
160916380|NCT00463346|581086678|FG000|Overall Study|Withdrawal by Subject|3|||
160916381|NCT00463346|581086679|FG001|Overall Study|Withdrawal by Subject|3|||
160916382|NCT02392247|581086680|FG000|Overall Study|Withdrawal by Subject|1|||
160916383|NCT02392247|581086680|FG000|Overall Study|Surgery cancelled; no data|1|||
160916384|NCT03641651|581086681|FG000|Overall Study|organizational issues at one study site|1|||
160916385|NCT01991067|581086683|FG000|Overall Study|Lost to Follow-up|6|||
160916386|NCT01991067|581086684|FG001|Overall Study|Lost to Follow-up|5|||
160916387|NCT00951665|581086686|FG000|Phase 1b|Adverse Event|2|||
160571587|NCT02273973|579814567|FG001|Overall Study|Withdrawal by Subject|3|||
160916388|NCT00951665|581086687|FG001|Phase 1b|Adverse Event|1|||
160916389|NCT00951665|581086688|FG002|Phase 1b|Adverse Event|0|||
160916390|NCT00951665|581086689|FG003|Phase 1b|Adverse Event|1|||
160916391|NCT00951665|581086690|FG004|Phase 1b|Adverse Event|0|||
160916392|NCT00951665|581086691|FG005|Phase 1b|Adverse Event|0|||
160916393|NCT00951665|581086686|FG000|Phase 1b|Death|1|||
160916394|NCT00951665|581086687|FG001|Phase 1b|Death|0|||
160916395|NCT00951665|581086688|FG002|Phase 1b|Death|2|||
160916396|NCT00951665|581086689|FG003|Phase 1b|Death|0|||
160916397|NCT00951665|581086690|FG004|Phase 1b|Death|0|||
160916398|NCT00951665|581086691|FG005|Phase 1b|Death|0|||
160916399|NCT00951665|581086686|FG000|Phase 1b|Physician Decision|4|||
160916400|NCT00951665|581086687|FG001|Phase 1b|Physician Decision|0|||
160916401|NCT00951665|581086688|FG002|Phase 1b|Physician Decision|1|||
160916402|NCT00951665|581086689|FG003|Phase 1b|Physician Decision|0|||
160916403|NCT00951665|581086690|FG004|Phase 1b|Physician Decision|0|||
160916404|NCT00951665|581086691|FG005|Phase 1b|Physician Decision|0|||
160916405|NCT00951665|581086686|FG000|Phase 1b|Withdrawal by Subject|0|||
160916406|NCT00951665|581086687|FG001|Phase 1b|Withdrawal by Subject|1|||
160916407|NCT00951665|581086688|FG002|Phase 1b|Withdrawal by Subject|0|||
160916408|NCT00951665|581086689|FG003|Phase 1b|Withdrawal by Subject|0|||
160916409|NCT00951665|581086690|FG004|Phase 1b|Withdrawal by Subject|0|||
160916410|NCT00951665|581086691|FG005|Phase 1b|Withdrawal by Subject|0|||
160916411|NCT00951665|581086686|FG000|Phase 1b|Disease Progression|13|||
160916412|NCT00951665|581086687|FG001|Phase 1b|Disease Progression|2|||
160916413|NCT00951665|581086688|FG002|Phase 1b|Disease Progression|14|||
160916414|NCT00951665|581086689|FG003|Phase 1b|Disease Progression|0|||
160916415|NCT00951665|581086690|FG004|Phase 1b|Disease Progression|0|||
160916416|NCT00951665|581086691|FG005|Phase 1b|Disease Progression|0|||
160916417|NCT00951665|581086686|FG000|Phase 1b|Protocol Violation|2|||
160916418|NCT00951665|581086687|FG001|Phase 1b|Protocol Violation|0|||
160916419|NCT00951665|581086688|FG002|Phase 1b|Protocol Violation|0|||
160916420|NCT00951665|581086689|FG003|Phase 1b|Protocol Violation|0|||
160916421|NCT00951665|581086690|FG004|Phase 1b|Protocol Violation|0|||
160916422|NCT00951665|581086691|FG005|Phase 1b|Protocol Violation|0|||
160916423|NCT00951665|581086686|FG000|Phase 2a|Adverse Event|0|||
160916424|NCT00951665|581086687|FG001|Phase 2a|Adverse Event|0|||
160916425|NCT00951665|581086688|FG002|Phase 2a|Adverse Event|0|||
160916426|NCT00951665|581086689|FG003|Phase 2a|Adverse Event|0|||
160916427|NCT00951665|581086690|FG004|Phase 2a|Adverse Event|2|||
160916428|NCT00951665|581086691|FG005|Phase 2a|Adverse Event|0|||
160916429|NCT00951665|581086686|FG000|Phase 2a|Death|0|||
160916430|NCT00951665|581086687|FG001|Phase 2a|Death|0|||
160916431|NCT00951665|581086688|FG002|Phase 2a|Death|0|||
160916432|NCT00951665|581086689|FG003|Phase 2a|Death|0|||
160916433|NCT00951665|581086690|FG004|Phase 2a|Death|1|||
160916434|NCT00951665|581086691|FG005|Phase 2a|Death|1|||
160916435|NCT00951665|581086686|FG000|Phase 2a|Lost to Follow-up|0|||
160916436|NCT00951665|581086687|FG001|Phase 2a|Lost to Follow-up|0|||
160916437|NCT00951665|581086688|FG002|Phase 2a|Lost to Follow-up|0|||
160916438|NCT00951665|581086689|FG003|Phase 2a|Lost to Follow-up|0|||
160916439|NCT00951665|581086690|FG004|Phase 2a|Lost to Follow-up|1|||
160916440|NCT00951665|581086691|FG005|Phase 2a|Lost to Follow-up|0|||
160916441|NCT00951665|581086686|FG000|Phase 2a|Physician Decision|0|||
160916442|NCT00951665|581086687|FG001|Phase 2a|Physician Decision|0|||
160916443|NCT00951665|581086688|FG002|Phase 2a|Physician Decision|0|||
160916444|NCT00951665|581086689|FG003|Phase 2a|Physician Decision|0|||
160916445|NCT00951665|581086690|FG004|Phase 2a|Physician Decision|0|||
160916446|NCT00951665|581086691|FG005|Phase 2a|Physician Decision|1|||
160916447|NCT00951665|581086686|FG000|Phase 2a|Withdrawal by Subject|0|||
160916448|NCT00951665|581086687|FG001|Phase 2a|Withdrawal by Subject|0|||
160916449|NCT00951665|581086688|FG002|Phase 2a|Withdrawal by Subject|0|||
160916450|NCT00951665|581086689|FG003|Phase 2a|Withdrawal by Subject|0|||
160916451|NCT00951665|581086690|FG004|Phase 2a|Withdrawal by Subject|2|||
160916452|NCT00951665|581086691|FG005|Phase 2a|Withdrawal by Subject|0|||
160916453|NCT00951665|581086686|FG000|Phase 2a|Disease Progression|0|||
160916454|NCT00951665|581086687|FG001|Phase 2a|Disease Progression|0|||
160916455|NCT00951665|581086688|FG002|Phase 2a|Disease Progression|0|||
160916456|NCT00951665|581086689|FG003|Phase 2a|Disease Progression|0|||
160916457|NCT00951665|581086690|FG004|Phase 2a|Disease Progression|6|||
160916458|NCT00951665|581086691|FG005|Phase 2a|Disease Progression|5|||
160916459|NCT02450903|581086692|FG000|Overall Study|Adverse Event|3|||
160916460|NCT02450903|581086692|FG000|Overall Study|Progressive disease|15|||
160916461|NCT02450903|581086692|FG000|Overall Study|Switched to commercial drug|1|||
160916462|NCT02450903|581086692|FG000|Overall Study|Subject/guardian decision|1|||
160916463|NCT00592839|581086693|FG000|Overall Study|Withdrawal by Subject|1|||
160916464|NCT00592839|581086694|FG001|Overall Study|Withdrawal by Subject|1|||
160916465|NCT00592839|581086695|FG002|Overall Study|Withdrawal by Subject|3|||
160916466|NCT00592839|581086693|FG000|Overall Study|Protocol Violation|1|||
160916467|NCT00592839|581086694|FG001|Overall Study|Protocol Violation|1|||
160916468|NCT00592839|581086695|FG002|Overall Study|Protocol Violation|2|||
160916469|NCT00592839|581086693|FG000|Overall Study|Adverse Event|0|||
160916470|NCT00592839|581086694|FG001|Overall Study|Adverse Event|1|||
160916471|NCT00592839|581086695|FG002|Overall Study|Adverse Event|0|||
160916472|NCT00592839|581086693|FG000|Overall Study|Lost to Follow-up|0|||
160996313|NCT03451851|581372185|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996314|NCT03451851|581372186|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
160996315|NCT03451851|581372187|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996316|NCT03451851|581372188|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996317|NCT03451851|581372189|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996318|NCT03354390|581372190|FG000|Level 1|Death|2|||
160996319|NCT03354390|581372191|FG001|Level 1|Death|0|||
160996320|NCT03354390|581372192|FG002|Level 1|Death|0|||
160996321|NCT03354390|581372193|FG003|Level 1|Death|0|||
160996322|NCT03354390|581372190|FG000|Level 1|Physician Decision|1|||
160996323|NCT03354390|581372191|FG001|Level 1|Physician Decision|0|||
160996324|NCT03354390|581372192|FG002|Level 1|Physician Decision|0|||
160996325|NCT03354390|581372193|FG003|Level 1|Physician Decision|0|||
160996326|NCT03354390|581372190|FG000|Level 2|Physician Decision|0|||
160996327|NCT03354390|581372191|FG001|Level 2|Physician Decision|2|||
160571588|NCT02273973|579814566|FG000|Overall Study|Death|1|||
160571589|NCT02273973|579814567|FG001|Overall Study|Death|0|||
160571590|NCT02273973|579814566|FG000|Overall Study|Non-compliance|1|||
160571591|NCT02273973|579814567|FG001|Overall Study|Non-compliance|0|||
160571592|NCT02273973|579814566|FG000|Overall Study|Protocol Violation|1|||
160571593|NCT02273973|579814567|FG001|Overall Study|Protocol Violation|0|||
160571594|NCT02273973|579814566|FG000|Overall Study|Progression of disease|0|||
160916473|NCT00592839|581086694|FG001|Overall Study|Lost to Follow-up|1|||
160916474|NCT00592839|581086695|FG002|Overall Study|Lost to Follow-up|1|||
160916475|NCT03454893|581086696|FG000|Overall Study|Study Terminated by the Sponsor|5|||
160916476|NCT03454893|581086696|FG000|Overall Study|Did not pass screening|4|||
160916477|NCT04876274|581086697|FG000|Overall Study|Lost to Follow-up|9|||
160916478|NCT04876274|581086698|FG001|Overall Study|Lost to Follow-up|12|||
160916479|NCT00142584|581086699|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
160916480|NCT00142584|581086700|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
160916481|NCT00142584|581086699|FG000|Overall Study|Withdrawal by Subject|30|||
160916482|NCT00142584|581086700|FG001|Overall Study|Withdrawal by Subject|16|||
160916483|NCT00142584|581086699|FG000|Overall Study|Lost to Follow-up|22|||
160916484|NCT00142584|581086700|FG001|Overall Study|Lost to Follow-up|12|||
160916485|NCT00142584|581086699|FG000|Overall Study|Adverse Event|14|||
160916486|NCT00142584|581086700|FG001|Overall Study|Adverse Event|5|||
160916487|NCT00142584|581086699|FG000|Overall Study|Protocol Violation|4|||
160916488|NCT00142584|581086700|FG001|Overall Study|Protocol Violation|7|||
160916489|NCT00142584|581086699|FG000|Overall Study|Treatment Failure|2|||
160916490|NCT00142584|581086700|FG001|Overall Study|Treatment Failure|0|||
160916491|NCT03070782|581086701|FG000|Overall Study|Adverse Event|3|||
160916492|NCT03070782|581086702|FG001|Overall Study|Adverse Event|0|||
160916493|NCT03070782|581086703|FG002|Overall Study|Adverse Event|3|||
160916494|NCT03070782|581086704|FG003|Overall Study|Adverse Event|1|||
160916495|NCT03070782|581086705|FG004|Overall Study|Adverse Event|6|||
160916496|NCT03070782|581086706|FG005|Overall Study|Adverse Event|2|||
160916497|NCT03070782|581086701|FG000|Overall Study|Withdrawal by Subject|2|||
160916498|NCT03070782|581086702|FG001|Overall Study|Withdrawal by Subject|1|||
160916499|NCT03070782|581086703|FG002|Overall Study|Withdrawal by Subject|1|||
160916500|NCT03070782|581086704|FG003|Overall Study|Withdrawal by Subject|0|||
160916501|NCT03070782|581086705|FG004|Overall Study|Withdrawal by Subject|4|||
160916502|NCT03070782|581086706|FG005|Overall Study|Withdrawal by Subject|3|||
160916503|NCT03070782|581086701|FG000|Overall Study|Reason Not Specified|2|||
160916504|NCT03070782|581086702|FG001|Overall Study|Reason Not Specified|0|||
160916505|NCT03070782|581086703|FG002|Overall Study|Reason Not Specified|0|||
160916506|NCT03070782|581086704|FG003|Overall Study|Reason Not Specified|1|||
160916507|NCT03070782|581086705|FG004|Overall Study|Reason Not Specified|2|||
160916508|NCT03070782|581086706|FG005|Overall Study|Reason Not Specified|1|||
160916509|NCT03070782|581086701|FG000|Overall Study|Ineligibility|0|||
160916510|NCT03070782|581086702|FG001|Overall Study|Ineligibility|0|||
160996328|NCT03354390|581372192|FG002|Level 2|Physician Decision|0|||
160996329|NCT03354390|581372193|FG003|Level 2|Physician Decision|0|||
160996330|NCT03354390|581372190|FG000|Level 2|Lack of Efficacy|0|||
160996331|NCT03354390|581372191|FG001|Level 2|Lack of Efficacy|1|||
160996332|NCT03354390|581372192|FG002|Level 2|Lack of Efficacy|0|||
160996333|NCT03354390|581372193|FG003|Level 2|Lack of Efficacy|0|||
160571595|NCT02273973|579814567|FG001|Overall Study|Progression of disease|2|||
160571596|NCT02273973|579814566|FG000|Overall Study|Lost to Follow-up|0|||
160916511|NCT03070782|581086703|FG002|Overall Study|Ineligibility|0|||
160916512|NCT03070782|581086704|FG003|Overall Study|Ineligibility|1|||
160916513|NCT03070782|581086705|FG004|Overall Study|Ineligibility|0|||
160916514|NCT03070782|581086706|FG005|Overall Study|Ineligibility|1|||
160916515|NCT03070782|581086701|FG000|Overall Study|Pregnancy|0|||
160916516|NCT03070782|581086702|FG001|Overall Study|Pregnancy|0|||
160916517|NCT03070782|581086703|FG002|Overall Study|Pregnancy|0|||
160916518|NCT03070782|581086704|FG003|Overall Study|Pregnancy|1|||
160916519|NCT03070782|581086705|FG004|Overall Study|Pregnancy|0|||
160916520|NCT03070782|581086706|FG005|Overall Study|Pregnancy|0|||
160916521|NCT03070782|581086701|FG000|Overall Study|Investigator Judgement|0|||
160916522|NCT03070782|581086702|FG001|Overall Study|Investigator Judgement|0|||
160916523|NCT03070782|581086703|FG002|Overall Study|Investigator Judgement|0|||
160916524|NCT03070782|581086704|FG003|Overall Study|Investigator Judgement|1|||
160916525|NCT03070782|581086705|FG004|Overall Study|Investigator Judgement|0|||
160916526|NCT03070782|581086706|FG005|Overall Study|Investigator Judgement|0|||
160916527|NCT01083576|581086711|FG000|Overall Study|Treatment Failure|6|||
160916528|NCT01083576|581086712|FG001|Overall Study|Treatment Failure|1|||
160916529|NCT01986985|581086713|FG000|Overall Study|Withdrawal by Subject|4|||
160916530|NCT01986985|581086713|FG000|Overall Study|Scan not completed due to malfunction|3|||
160916531|NCT03527966|581086714|FG000|Overall Study|Lost to Follow-up|3|||
160916532|NCT03527966|581086715|FG001|Overall Study|Lost to Follow-up|0|||
160916533|NCT01948050|581086716|FG000|Overall Study|Withdrawal by Subject|0|||
160916534|NCT01948050|581086717|FG001|Overall Study|Withdrawal by Subject|1|||
160916535|NCT00558025|581086718|FG000|Overall Study|Adverse Event|1|||
160916536|NCT00558025|581086719|FG001|Overall Study|Adverse Event|1|||
160916537|NCT00558025|581086718|FG000|Overall Study|Withdrawal by Subject|2|||
160916538|NCT00558025|581086719|FG001|Overall Study|Withdrawal by Subject|2|||
160916539|NCT00558025|581086718|FG000|Overall Study|Protocol Violation|1|||
160916540|NCT00558025|581086719|FG001|Overall Study|Protocol Violation|0|||
160916541|NCT02288559|581086720|FG000|Overall Study|Adverse Event|1|||
160916542|NCT02288559|581086721|FG001|Overall Study|Adverse Event|1|||
160916543|NCT02288559|581086722|FG002|Overall Study|Adverse Event|5|||
160916544|NCT02288559|581086723|FG003|Overall Study|Adverse Event|0|||
160916545|NCT02288559|581086720|FG000|Overall Study|Death|0|||
160916546|NCT02288559|581086721|FG001|Overall Study|Death|0|||
160916547|NCT02288559|581086722|FG002|Overall Study|Death|1|||
160916548|NCT02288559|581086723|FG003|Overall Study|Death|0|||
160916549|NCT02288559|581086720|FG000|Overall Study|Lost to Follow-up|0|||
160916550|NCT02288559|581086721|FG001|Overall Study|Lost to Follow-up|0|||
160916551|NCT02288559|581086722|FG002|Overall Study|Lost to Follow-up|0|||
160916552|NCT02288559|581086723|FG003|Overall Study|Lost to Follow-up|1|||
160916553|NCT02288559|581086720|FG000|Overall Study|Withdrawal by Subject|0|||
160916554|NCT02288559|581086721|FG001|Overall Study|Withdrawal by Subject|0|||
160916555|NCT02288559|581086722|FG002|Overall Study|Withdrawal by Subject|2|||
160916556|NCT02288559|581086723|FG003|Overall Study|Withdrawal by Subject|1|||
160916557|NCT02288559|581086720|FG000|Overall Study|Reason Not Specified|0|||
160916558|NCT02288559|581086721|FG001|Overall Study|Reason Not Specified|0|||
160916559|NCT02288559|581086722|FG002|Overall Study|Reason Not Specified|3|||
160916560|NCT02288559|581086723|FG003|Overall Study|Reason Not Specified|0|||
160916561|NCT02005445|581086724|FG000|Overall Study|Dual study enrollment|0|||
160916562|NCT02005445|581086725|FG001|Overall Study|Dual study enrollment|1|||
160916563|NCT00449540|581086726|FG000|Pretreatment Phase|No migraine experienced|66|||
160916564|NCT00449540|581086727|FG001|Pretreatment Phase|No migraine experienced|0|||
160916565|NCT00449540|581086728|FG002|Pretreatment Phase|No migraine experienced|0|||
160916566|NCT00449540|581086726|FG000|Treatment Phase|did not experience or treat migraine|0|||
160916567|NCT00449540|581086727|FG001|Treatment Phase|did not experience or treat migraine|20|||
160916568|NCT00449540|581086728|FG002|Treatment Phase|did not experience or treat migraine|17|||
160916569|NCT00010374|581086729|FG000|Overall Study|False positive phrenic nerve test|1|||
160916570|NCT00640601|581086736|FG000|Overall Study|Adverse Event|43|||
160916571|NCT00640601|581086736|FG000|Overall Study|Withdrawal by Subject|20|||
160916572|NCT00640601|581086736|FG000|Overall Study|Protocol Violation|6|||
160916573|NCT00640601|581086736|FG000|Overall Study|Lack of Efficacy|16|||
160916574|NCT00640601|581086736|FG000|Overall Study|Lost to Follow-up|9|||
160916575|NCT00640601|581086736|FG000|Overall Study|Physician Decision|8|||
160916576|NCT00640601|581086736|FG000|Overall Study|treatment naive, combination therapy|10|||
160916577|NCT00230607|581086737|FG000|Overall Study|Other|3|||
160916578|NCT03672747|581086738|FG000|Overall Study|Lost to Follow-up|1|||
160916579|NCT03672747|581086739|FG001|Overall Study|Lost to Follow-up|1|||
160916580|NCT03672747|581086740|FG002|Overall Study|Lost to Follow-up|2|||
160916581|NCT03672747|581086741|FG003|Overall Study|Lost to Follow-up|2|||
160916582|NCT03672747|581086742|FG004|Overall Study|Lost to Follow-up|2|||
160916583|NCT03672747|581086743|FG005|Overall Study|Lost to Follow-up|1|||
160916584|NCT03198234|581086744|FG000|Overall Study|Relapse of primary disease|0|||
160916585|NCT03198234|581086745|FG001|Overall Study|Relapse of primary disease|1|||
160916586|NCT03198234|581086746|FG002|Overall Study|Relapse of primary disease|0|||
160916587|NCT00165776|581086747|FG000|Overall Study|Lack of Efficacy|0|||
160916588|NCT00165776|581086748|FG001|Overall Study|Lack of Efficacy|0|||
160916589|NCT00165776|581086749|FG002|Overall Study|Lack of Efficacy|0|||
160916590|NCT00165776|581086750|FG003|Overall Study|Lack of Efficacy|1|||
160916591|NCT00165776|581086747|FG000|Overall Study|Withdrawal by Subject|4|||
160916592|NCT00165776|581086748|FG001|Overall Study|Withdrawal by Subject|1|||
160916593|NCT00165776|581086749|FG002|Overall Study|Withdrawal by Subject|2|||
160916594|NCT00165776|581086750|FG003|Overall Study|Withdrawal by Subject|0|||
160916595|NCT00165776|581086747|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
160916596|NCT00165776|581086748|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
160916597|NCT00165776|581086749|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
160916598|NCT00165776|581086750|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
160916599|NCT03228537|581086758|FG000|Neoadjuvant|Adverse Event|2|||
160916600|NCT03228537|581086758|FG000|Neoadjuvant|Progression/Relapse|4|||
160571597|NCT02273973|579814567|FG001|Overall Study|Lost to Follow-up|1|||
160571598|NCT02273973|579814566|FG000|Overall Study|Physician Decision|0|||
160571599|NCT02273973|579814567|FG001|Overall Study|Physician Decision|1|||
160571600|NCT02273973|579814566|FG000|Overall Study|Reason not specified|0|||
160571601|NCT02273973|579814567|FG001|Overall Study|Reason not specified|1|||
160571602|NCT03022422|579814568|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
160916601|NCT03228537|581086758|FG000|Neoadjuvant|Death|1|||
160916602|NCT03228537|581086758|FG000|Surgery|Death|1|||
160916603|NCT03228537|581086758|FG000|Surgery|Other - Not Protocol Specified|2|||
160916604|NCT03228537|581086758|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
160916605|NCT03228537|581086758|FG000|Maintenance|Progression/Relapse|10|||
160916606|NCT03310775|581086765|FG000|Overall Study|Lost to Follow-up|2|||
160916607|NCT03310775|581086766|FG001|Overall Study|Lost to Follow-up|3|||
160916608|NCT03310775|581086765|FG000|Overall Study|aggravation of depression|0|||
160916609|NCT03310775|581086766|FG001|Overall Study|aggravation of depression|1|||
160916610|NCT01648205|581086767|FG000|Placebo|Pregnancy|1|||
160916611|NCT01648205|581086767|FG000|Placebo|Withdrawal by Subject|1|||
160916612|NCT01648205|581086767|FG000|Placebo|Protocol Violation|2|||
160916613|NCT01648205|581086767|FG000|Ranolazine|Death|1|||
160916614|NCT01648205|581086767|FG000|Ranolazine|Withdrawal by Subject|1|||
160916615|NCT01648205|581086767|FG000|Ranolazine|Protocol Violation|3|||
160916616|NCT02260921|581086776|FG000|Overall Study|Adverse Event|1|||
160916617|NCT02260921|581086777|FG001|Overall Study|Adverse Event|0|||
160916618|NCT02260921|581086776|FG000|Overall Study|Lost to Follow-up|4|||
160916619|NCT02260921|581086777|FG001|Overall Study|Lost to Follow-up|3|||
160916620|NCT02260921|581086776|FG000|Overall Study|Withdraw Consent|4|||
160916621|NCT02260921|581086777|FG001|Overall Study|Withdraw Consent|1|||
160916622|NCT02260921|581086776|FG000|Overall Study|Death|1|||
160916623|NCT02260921|581086777|FG001|Overall Study|Death|0|||
160916624|NCT02260921|581086776|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
160916625|NCT02260921|581086777|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
160916626|NCT00580606|581086787|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
160916627|NCT00580606|581086788|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
160916628|NCT00580606|581086787|FG000|Open Label (OL)|Withdrawal by Subject|4|||
160916629|NCT00580606|581086788|FG001|Open Label (OL)|Withdrawal by Subject|6|||
160916630|NCT00580606|581086787|FG000|Open Label (OL)|Dosing Symptoms|0|||
160916631|NCT00580606|581086788|FG001|Open Label (OL)|Dosing Symptoms|1|||
160996334|NCT03354390|581372190|FG000|Level 2|Lost to Follow-up|0|||
160996335|NCT03354390|581372191|FG001|Level 2|Lost to Follow-up|1|||
160996336|NCT03354390|581372192|FG002|Level 2|Lost to Follow-up|0|||
160996337|NCT03354390|581372193|FG003|Level 2|Lost to Follow-up|0|||
160996338|NCT03354390|581372190|FG000|Level 3|Death|0|||
160996339|NCT03354390|581372191|FG001|Level 3|Death|0|||
160996340|NCT03354390|581372192|FG002|Level 3|Death|1|||
160996341|NCT03354390|581372193|FG003|Level 3|Death|0|||
160571603|NCT03022422|579814569|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
160571604|NCT03022422|579814570|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
160571605|NCT03022422|579814571|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
160571606|NCT03022422|579814572|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
160571607|NCT03022422|579814573|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
160571608|NCT00538733|579814574|FG000|Overall Study|Adverse Event|8|||
160916632|NCT00580606|581086787|FG000|Open Label (OL)|Lost to Follow-up|0|||
160916633|NCT00580606|581086788|FG001|Open Label (OL)|Lost to Follow-up|1|||
160916634|NCT00580606|581086787|FG000|Open Label (OL)|Pregnancy|0|||
160916635|NCT00580606|581086788|FG001|Open Label (OL)|Pregnancy|1|||
160916636|NCT00580606|581086787|FG000|Open Label (OL)|Non-compliance|2|||
160916637|NCT00580606|581086788|FG001|Open Label (OL)|Non-compliance|0|||
160916638|NCT00580606|581086787|FG000|Open Label (OL)|Physician Decision|1|||
160652961|NCT01766921|580110426|FG001|Overall Study|Death|1|||
160652962|NCT01766921|580110425|FG000|Overall Study|Lost to Follow-up|1|||
160916639|NCT00580606|581086788|FG001|Open Label (OL)|Physician Decision|1|||
160916640|NCT00580606|581086787|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
160916641|NCT00580606|581086788|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
160652963|NCT01766921|580110426|FG001|Overall Study|Lost to Follow-up|3|||
160916642|NCT03358290|581086790|FG000|Overall Study|Study discontinued by Sponsor|0|||
160916643|NCT03358290|581086791|FG001|Overall Study|Study discontinued by Sponsor|1|||
160916644|NCT03358290|581086792|FG002|Overall Study|Study discontinued by Sponsor|1|||
160916645|NCT03358290|581086793|FG003|Overall Study|Study discontinued by Sponsor|0|||
160916646|NCT03358290|581086794|FG004|Overall Study|Study discontinued by Sponsor|0|||
160916647|NCT03358290|581086790|FG000|Overall Study|Adverse Event|0|||
160916648|NCT03358290|581086791|FG001|Overall Study|Adverse Event|0|||
160916649|NCT03358290|581086792|FG002|Overall Study|Adverse Event|1|||
160916650|NCT03358290|581086793|FG003|Overall Study|Adverse Event|2|||
160996342|NCT03354390|581372190|FG000|Level 3|Physician Decision|0|||
160996343|NCT03354390|581372191|FG001|Level 3|Physician Decision|0|||
160996344|NCT03354390|581372192|FG002|Level 3|Physician Decision|2|||
160571609|NCT00538733|579814574|FG000|Overall Study|Death|1|||
160453864|NCT02927236|579393945|FG001|Characterization Phase|Withdrawal by Subject|0|||
160453865|NCT02927236|579393946|FG002|Characterization Phase|Withdrawal by Subject|0|||
160453866|NCT02927236|579393947|FG003|Characterization Phase|Withdrawal by Subject|1|||
160453867|NCT02927236|579393944|FG000|Treatment Phase|Adverse Event|1|||
160453868|NCT02927236|579393945|FG001|Treatment Phase|Adverse Event|0|||
160453869|NCT02927236|579393946|FG002|Treatment Phase|Adverse Event|1|||
160453870|NCT02927236|579393947|FG003|Treatment Phase|Adverse Event|1|||
160453871|NCT02927236|579393944|FG000|Treatment Phase|Protocol Violation|3|||
160453872|NCT02927236|579393945|FG001|Treatment Phase|Protocol Violation|0|||
160453873|NCT02927236|579393946|FG002|Treatment Phase|Protocol Violation|0|||
160453874|NCT02927236|579393947|FG003|Treatment Phase|Protocol Violation|1|||
160453875|NCT02927236|579393944|FG000|Treatment Phase|Lost to Follow-up|1|||
160453876|NCT02927236|579393945|FG001|Treatment Phase|Lost to Follow-up|0|||
160453877|NCT02927236|579393946|FG002|Treatment Phase|Lost to Follow-up|0|||
160453878|NCT02927236|579393947|FG003|Treatment Phase|Lost to Follow-up|0|||
160453879|NCT02927236|579393944|FG000|Follow-up Phase|Lost to Follow-up|1|||
160453880|NCT02927236|579393945|FG001|Follow-up Phase|Lost to Follow-up|0|||
160453881|NCT02927236|579393946|FG002|Follow-up Phase|Lost to Follow-up|1|||
160453882|NCT02927236|579393947|FG003|Follow-up Phase|Lost to Follow-up|0|||
160453883|NCT05297565|579393948|FG000|Overall Study|Other Reasons|0|||
160453884|NCT05297565|579393949|FG001|Overall Study|Other Reasons|1|||
160453885|NCT05297565|579393948|FG000|Overall Study|Physician Decision|0|||
160453886|NCT05297565|579393949|FG001|Overall Study|Physician Decision|1|||
160453887|NCT05297565|579393948|FG000|Overall Study|Disease recurrence|1|||
160453888|NCT05297565|579393949|FG001|Overall Study|Disease recurrence|0|||
160453889|NCT01959607|579393950|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
160453890|NCT01959607|579393951|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
160453891|NCT01959607|579393952|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
160453892|NCT01959607|579393953|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
160453893|NCT03913442|579393954|FG000|Overall Study|Adverse Event|0|||
160453894|NCT03913442|579393955|FG001|Overall Study|Adverse Event|3|||
160453895|NCT03913442|579393954|FG000|Overall Study|Withdrawal by Subject|5|||
160453896|NCT03913442|579393955|FG001|Overall Study|Withdrawal by Subject|5|||
160453897|NCT03913442|579393954|FG000|Overall Study|Terminations|2|||
160453898|NCT03913442|579393955|FG001|Overall Study|Terminations|1|||
160453899|NCT03913442|579393954|FG000|Overall Study|Lost to Follow-up|2|||
160453900|NCT03913442|579393955|FG001|Overall Study|Lost to Follow-up|2|||
160453901|NCT02433379|579393959|FG000|Overall Study|Screen Failures|55|||
160453902|NCT02433379|579393959|FG000|Overall Study|Death|57|||
160453903|NCT02433379|579393959|FG000|Overall Study|Total Withdrawals|209|||
160652964|NCT01766921|580110425|FG000|Overall Study|Unclassified|2|||
160652965|NCT01766921|580110426|FG001|Overall Study|Unclassified|2|||
160652966|NCT01766921|580110425|FG000|Overall Study|Protocol Violation|1|||
160861715|NCT03219723|580887817|FG000|Overall Study|Case Report Forms Uncollected|6|||
160453904|NCT05299073|579393960|FG000|Overall Study|Withdrawal by Subject|0|||
160453905|NCT05299073|579393961|FG001|Overall Study|Withdrawal by Subject|0|||
160453906|NCT05299073|579393962|FG002|Overall Study|Withdrawal by Subject|1|||
160453907|NCT05299073|579393960|FG000|Overall Study|Adverse Event|0|||
160453908|NCT05299073|579393961|FG001|Overall Study|Adverse Event|1|||
160453909|NCT05299073|579393962|FG002|Overall Study|Adverse Event|0|||
160453910|NCT05299073|579393960|FG000|Overall Study|Lost to Follow-up|0|||
160861716|NCT03219723|580887817|FG000|Overall Study|Protocol Deviation|4|||
160861717|NCT04558125|580887818|FG000|Overall Study|Death|1|||
160861718|NCT03137381|580887819|FG000|Overall Study|Adverse Event|3|||
160861719|NCT03137381|580887820|FG001|Overall Study|Adverse Event|0|||
160861720|NCT03137381|580887821|FG002|Overall Study|Adverse Event|2|||
160861721|NCT03137381|580887822|FG003|Overall Study|Adverse Event|0|||
160861722|NCT03137381|580887819|FG000|Overall Study|Lost to Follow-up|2|||
160861723|NCT03137381|580887820|FG001|Overall Study|Lost to Follow-up|1|||
160861724|NCT03137381|580887821|FG002|Overall Study|Lost to Follow-up|1|||
160861725|NCT03137381|580887822|FG003|Overall Study|Lost to Follow-up|0|||
160861726|NCT03137381|580887819|FG000|Overall Study|Protocol deviation|1|||
160861727|NCT03137381|580887820|FG001|Overall Study|Protocol deviation|1|||
160861728|NCT03137381|580887821|FG002|Overall Study|Protocol deviation|0|||
160861729|NCT03137381|580887822|FG003|Overall Study|Protocol deviation|1|||
160861730|NCT03137381|580887819|FG000|Overall Study|Withdrawal by Investigator|0|||
160861731|NCT03137381|580887820|FG001|Overall Study|Withdrawal by Investigator|1|||
160861732|NCT03137381|580887821|FG002|Overall Study|Withdrawal by Investigator|1|||
160861733|NCT03137381|580887822|FG003|Overall Study|Withdrawal by Investigator|0|||
160861734|NCT03137381|580887819|FG000|Overall Study|Withdrawal by Subject|3|||
160861735|NCT03137381|580887820|FG001|Overall Study|Withdrawal by Subject|4|||
160861736|NCT03137381|580887821|FG002|Overall Study|Withdrawal by Subject|3|||
160861737|NCT03137381|580887822|FG003|Overall Study|Withdrawal by Subject|0|||
160861738|NCT03137381|580887819|FG000|Overall Study|Pregnancy|0|||
160861739|NCT03137381|580887820|FG001|Overall Study|Pregnancy|0|||
160861740|NCT03137381|580887821|FG002|Overall Study|Pregnancy|1|||
160861741|NCT03137381|580887822|FG003|Overall Study|Pregnancy|0|||
160453911|NCT05299073|579393961|FG001|Overall Study|Lost to Follow-up|1|||
160652967|NCT01766921|580110426|FG001|Overall Study|Protocol Violation|1|||
160916651|NCT03358290|581086794|FG004|Overall Study|Adverse Event|0|||
160916652|NCT03358290|581086790|FG000|Overall Study|Withdrawal by Subject|0|||
160916653|NCT03358290|581086791|FG001|Overall Study|Withdrawal by Subject|0|||
160916654|NCT03358290|581086792|FG002|Overall Study|Withdrawal by Subject|0|||
160916655|NCT03358290|581086793|FG003|Overall Study|Withdrawal by Subject|0|||
160916656|NCT03358290|581086794|FG004|Overall Study|Withdrawal by Subject|1|||
160916657|NCT02999854|581086795|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
160916658|NCT02999854|581086796|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
160916659|NCT02999854|581086795|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
160916660|NCT02999854|581086796|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
160916661|NCT02999854|581086795|FG000|Active Study Phase (up to 18 Months)|Death|7|||
160916662|NCT02999854|581086796|FG001|Active Study Phase (up to 18 Months)|Death|5|||
160916663|NCT02999854|581086795|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
160916664|NCT02999854|581086796|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
160916665|NCT02999854|581086795|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
160916666|NCT02999854|581086796|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
160916667|NCT02999854|581086795|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
160916668|NCT02999854|581086796|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
160916669|NCT02999854|581086795|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
160916670|NCT02999854|581086796|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
160916671|NCT02999854|581086795|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
160916672|NCT02999854|581086796|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
160916673|NCT00203996|581086797|FG000|Overall Study|Lost to Follow-up|0|||
160916674|NCT00203996|581086798|FG001|Overall Study|Lost to Follow-up|0|||
160916675|NCT00203996|581086799|FG002|Overall Study|Lost to Follow-up|0|||
160916676|NCT00203996|581086800|FG003|Overall Study|Lost to Follow-up|1|||
160916677|NCT00203996|581086801|FG004|Overall Study|Lost to Follow-up|0|||
160916678|NCT00203996|581086802|FG005|Overall Study|Lost to Follow-up|0|||
160916679|NCT00203996|581086803|FG006|Overall Study|Lost to Follow-up|0|||
160916680|NCT00203996|581086804|FG007|Overall Study|Lost to Follow-up|0|||
160916681|NCT00203996|581086805|FG008|Overall Study|Lost to Follow-up|0|||
160916682|NCT00203996|581086806|FG009|Overall Study|Lost to Follow-up|0|||
160916683|NCT00203996|581086797|FG000|Overall Study|Protocol Violation|0|||
160916684|NCT00203996|581086798|FG001|Overall Study|Protocol Violation|0|||
160916685|NCT00203996|581086799|FG002|Overall Study|Protocol Violation|0|||
160916686|NCT00203996|581086800|FG003|Overall Study|Protocol Violation|6|||
160916687|NCT00203996|581086801|FG004|Overall Study|Protocol Violation|1|||
160916688|NCT00203996|581086802|FG005|Overall Study|Protocol Violation|0|||
160916689|NCT00203996|581086803|FG006|Overall Study|Protocol Violation|0|||
160916690|NCT00203996|581086804|FG007|Overall Study|Protocol Violation|0|||
160916691|NCT00203996|581086805|FG008|Overall Study|Protocol Violation|0|||
160916692|NCT00203996|581086806|FG009|Overall Study|Protocol Violation|0|||
160916693|NCT00203996|581086797|FG000|Overall Study|Physician Decision|0|||
160916694|NCT00203996|581086798|FG001|Overall Study|Physician Decision|0|||
160916695|NCT00203996|581086799|FG002|Overall Study|Physician Decision|0|||
160916696|NCT00203996|581086800|FG003|Overall Study|Physician Decision|2|||
160916697|NCT00203996|581086801|FG004|Overall Study|Physician Decision|0|||
160916698|NCT00203996|581086802|FG005|Overall Study|Physician Decision|0|||
160916699|NCT00203996|581086803|FG006|Overall Study|Physician Decision|0|||
160916700|NCT00203996|581086804|FG007|Overall Study|Physician Decision|0|||
160916701|NCT00203996|581086805|FG008|Overall Study|Physician Decision|0|||
160916702|NCT00203996|581086806|FG009|Overall Study|Physician Decision|1|||
160916703|NCT00203996|581086797|FG000|Overall Study|CPAP machine malfunction|0|||
160916704|NCT00203996|581086798|FG001|Overall Study|CPAP machine malfunction|0|||
160916705|NCT00203996|581086799|FG002|Overall Study|CPAP machine malfunction|0|||
160916706|NCT00203996|581086800|FG003|Overall Study|CPAP machine malfunction|1|||
160916707|NCT00203996|581086801|FG004|Overall Study|CPAP machine malfunction|0|||
160916708|NCT00203996|581086802|FG005|Overall Study|CPAP machine malfunction|0|||
160916709|NCT00203996|581086803|FG006|Overall Study|CPAP machine malfunction|0|||
160916710|NCT00203996|581086804|FG007|Overall Study|CPAP machine malfunction|0|||
160916711|NCT00203996|581086805|FG008|Overall Study|CPAP machine malfunction|0|||
160916712|NCT00203996|581086806|FG009|Overall Study|CPAP machine malfunction|0|||
160916713|NCT00203996|581086797|FG000|Overall Study|Scheduling issue|0|||
160916714|NCT00203996|581086798|FG001|Overall Study|Scheduling issue|0|||
160916715|NCT00203996|581086799|FG002|Overall Study|Scheduling issue|0|||
160916716|NCT00203996|581086800|FG003|Overall Study|Scheduling issue|0|||
160916717|NCT00203996|581086801|FG004|Overall Study|Scheduling issue|0|||
160916718|NCT00203996|581086802|FG005|Overall Study|Scheduling issue|0|||
160916719|NCT00203996|581086803|FG006|Overall Study|Scheduling issue|0|||
160916720|NCT00203996|581086804|FG007|Overall Study|Scheduling issue|2|||
160453912|NCT05299073|579393962|FG002|Overall Study|Lost to Follow-up|0|||
160916721|NCT00203996|581086805|FG008|Overall Study|Scheduling issue|0|||
160916722|NCT00203996|581086806|FG009|Overall Study|Scheduling issue|0|||
160916723|NCT03064451|581086807|FG000|Overall Study|Lost to Follow-up|1|||
160916724|NCT03064451|581086807|FG000|Overall Study|Mapping Failure|4|||
160996345|NCT03354390|581372193|FG003|Level 3|Physician Decision|0|||
160571610|NCT00538733|579814574|FG000|Overall Study|declined to participate|2|||
160571611|NCT00538733|579814574|FG000|Overall Study|still on therapy|1|||
160571612|NCT05278104|579814577|FG000|Overall Study|Not treated|1|||
160571613|NCT05278104|579814578|FG001|Overall Study|Not treated|0|||
160571614|NCT05278104|579814577|FG000|Overall Study|Adverse Event|2|||
160571615|NCT05278104|579814578|FG001|Overall Study|Adverse Event|1|||
160571616|NCT05278104|579814577|FG000|Overall Study|Exclusion criteria not met|1|||
160571617|NCT05278104|579814578|FG001|Overall Study|Exclusion criteria not met|0|||
160571618|NCT01330381|579816761|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
160571619|NCT01330381|579816762|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
160571620|NCT01330381|579816763|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
160571621|NCT01330381|579816761|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
160571622|NCT01330381|579816762|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
160571623|NCT01330381|579816763|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
160571624|NCT01330381|579816761|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
160571625|NCT01330381|579816762|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
160571626|NCT01330381|579816763|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
160571627|NCT01330381|579816761|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
160571628|NCT01330381|579816762|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
160571629|NCT01330381|579816763|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
160571630|NCT01330381|579816761|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
160571631|NCT01330381|579816762|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
160571632|NCT01330381|579816763|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
160571633|NCT01330381|579816761|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
160571634|NCT01330381|579816762|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
160571635|NCT01330381|579816763|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
160571636|NCT01330381|579816761|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
160571637|NCT01330381|579816762|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
160571638|NCT01330381|579816763|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
160571639|NCT01330381|579816761|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
160571640|NCT01330381|579816762|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
160571641|NCT01330381|579816763|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
160571642|NCT01330381|579816761|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
160571643|NCT01330381|579816762|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
160571644|NCT01330381|579816763|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
160571645|NCT01330381|579816761|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
160571646|NCT01330381|579816762|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
160571647|NCT01330381|579816763|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
160571648|NCT02413255|579816766|FG000|Overall Study|Voluntary Withdrawal|0|||
160571649|NCT02413255|579816767|FG001|Overall Study|Voluntary Withdrawal|0|||
160571650|NCT02413255|579816768|FG002|Overall Study|Voluntary Withdrawal|0|||
160571651|NCT02413255|579816769|FG003|Overall Study|Voluntary Withdrawal|0|||
160571652|NCT02413255|579816770|FG004|Overall Study|Voluntary Withdrawal|0|||
160571653|NCT02413255|579816771|FG005|Overall Study|Voluntary Withdrawal|0|||
160571654|NCT02413255|579816772|FG006|Overall Study|Voluntary Withdrawal|0|||
160571655|NCT02413255|579816773|FG007|Overall Study|Voluntary Withdrawal|0|||
160571656|NCT02413255|579816774|FG008|Overall Study|Voluntary Withdrawal|0|||
160916725|NCT03064451|581086807|FG000|Overall Study|Exited prior to procedure|8|||
160916726|NCT03064451|581086807|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
160916727|NCT00897104|581086808|FG000|Overall Study|Lost to Follow-up|12|||
160916728|NCT00897104|581086809|FG001|Overall Study|Lost to Follow-up|17|||
160916729|NCT00897104|581086810|FG002|Overall Study|Lost to Follow-up|2|||
160916730|NCT00897104|581086808|FG000|Overall Study|Pregnancy|0|||
160916731|NCT00897104|581086809|FG001|Overall Study|Pregnancy|1|||
160916732|NCT00897104|581086810|FG002|Overall Study|Pregnancy|0|||
160916733|NCT00897104|581086808|FG000|Overall Study|Protocol Violation|0|||
160916734|NCT00897104|581086809|FG001|Overall Study|Protocol Violation|1|||
160916735|NCT00897104|581086810|FG002|Overall Study|Protocol Violation|0|||
160916736|NCT00897104|581086808|FG000|Overall Study|Withdrawal by Subject|23|||
160916737|NCT00897104|581086809|FG001|Overall Study|Withdrawal by Subject|27|||
160916738|NCT00897104|581086810|FG002|Overall Study|Withdrawal by Subject|3|||
160916739|NCT00897104|581086808|FG000|Overall Study|Abnormal Prestudy Labs|2|||
160916740|NCT00897104|581086809|FG001|Overall Study|Abnormal Prestudy Labs|0|||
160571657|NCT02413255|579816775|FG009|Overall Study|Voluntary Withdrawal|0|||
160571658|NCT02413255|579816776|FG010|Overall Study|Voluntary Withdrawal|0|||
160571659|NCT02413255|579816777|FG011|Overall Study|Voluntary Withdrawal|0|||
160916741|NCT00897104|581086810|FG002|Overall Study|Abnormal Prestudy Labs|0|||
160916742|NCT00897104|581086808|FG000|Overall Study|Abnormal Baseline ECG|2|||
160916743|NCT00897104|581086809|FG001|Overall Study|Abnormal Baseline ECG|2|||
160916744|NCT00897104|581086810|FG002|Overall Study|Abnormal Baseline ECG|0|||
160916745|NCT00897104|581086808|FG000|Overall Study|Need for Concom. Med.|0|||
160916746|NCT00897104|581086809|FG001|Overall Study|Need for Concom. Med.|1|||
160916747|NCT00897104|581086810|FG002|Overall Study|Need for Concom. Med.|1|||
160916748|NCT00897104|581086808|FG000|Overall Study|Lack of Migraine Attack|20|||
160916749|NCT00897104|581086809|FG001|Overall Study|Lack of Migraine Attack|22|||
160916750|NCT00897104|581086810|FG002|Overall Study|Lack of Migraine Attack|1|||
160916751|NCT00897104|581086808|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
160916752|NCT00897104|581086809|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
160916753|NCT00897104|581086810|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
160916754|NCT00897104|581086808|FG000|Overall Study|Other|3|||
160916755|NCT00897104|581086809|FG001|Overall Study|Other|0|||
160916756|NCT00897104|581086810|FG002|Overall Study|Other|0|||
160916757|NCT00897104|581086808|FG000|Overall Study|Protocol Violation|1|||
160916758|NCT00897104|581086809|FG001|Overall Study|Protocol Violation|0|||
160916759|NCT00897104|581086810|FG002|Overall Study|Protocol Violation|0|||
160916760|NCT00897104|581086808|FG000|Overall Study|Withdrawal by Subject|0|||
160916761|NCT00897104|581086809|FG001|Overall Study|Withdrawal by Subject|0|||
160916762|NCT00897104|581086810|FG002|Overall Study|Withdrawal by Subject|1|||
160916763|NCT00750204|581086811|FG000|Overall Study|study halted prematurely|1|||
160916764|NCT00750204|581086812|FG001|Overall Study|study halted prematurely|1|||
160916765|NCT00434330|581086813|FG000|Overall Study|Adverse Event|0|||
160916766|NCT00434330|581086814|FG001|Overall Study|Adverse Event|0|||
160916767|NCT00434330|581086815|FG002|Overall Study|Adverse Event|1|||
160916768|NCT00434330|581086816|FG003|Overall Study|Adverse Event|0|||
160916769|NCT00434330|581086817|FG004|Overall Study|Adverse Event|0|||
160916770|NCT00434330|581086818|FG005|Overall Study|Adverse Event|0|||
160916771|NCT00434330|581086813|FG000|Overall Study|Death|1|||
160916772|NCT00434330|581086814|FG001|Overall Study|Death|0|||
160916773|NCT00434330|581086815|FG002|Overall Study|Death|0|||
160916774|NCT00434330|581086816|FG003|Overall Study|Death|0|||
160916775|NCT00434330|581086817|FG004|Overall Study|Death|1|||
160916776|NCT00434330|581086818|FG005|Overall Study|Death|1|||
160916777|NCT00434330|581086813|FG000|Overall Study|Withdrawal by Subject|0|||
160916778|NCT00434330|581086814|FG001|Overall Study|Withdrawal by Subject|0|||
160916779|NCT00434330|581086815|FG002|Overall Study|Withdrawal by Subject|1|||
160916780|NCT00434330|581086816|FG003|Overall Study|Withdrawal by Subject|1|||
160916781|NCT00434330|581086817|FG004|Overall Study|Withdrawal by Subject|0|||
160916782|NCT00434330|581086818|FG005|Overall Study|Withdrawal by Subject|0|||
160916783|NCT00434330|581086813|FG000|Overall Study|Renal transplant|0|||
160916784|NCT00434330|581086814|FG001|Overall Study|Renal transplant|0|||
160916785|NCT00434330|581086815|FG002|Overall Study|Renal transplant|0|||
160916786|NCT00434330|581086816|FG003|Overall Study|Renal transplant|1|||
160916787|NCT00434330|581086817|FG004|Overall Study|Renal transplant|0|||
160916788|NCT00434330|581086818|FG005|Overall Study|Renal transplant|0|||
160916789|NCT00434330|581086813|FG000|Overall Study|Subject Not Compliant With Study|0|||
160916790|NCT00434330|581086814|FG001|Overall Study|Subject Not Compliant With Study|0|||
160916791|NCT00434330|581086815|FG002|Overall Study|Subject Not Compliant With Study|1|||
160916792|NCT00434330|581086816|FG003|Overall Study|Subject Not Compliant With Study|0|||
160916793|NCT00434330|581086817|FG004|Overall Study|Subject Not Compliant With Study|0|||
160916794|NCT00434330|581086818|FG005|Overall Study|Subject Not Compliant With Study|0|||
160916795|NCT00850564|581086821|FG000|Overall Study|Withdrawal by Subject|2|||
160916796|NCT03032705|581086822|FG000|Overall Study|Lost to Follow-up|16|||
160916797|NCT03032705|581086823|FG001|Overall Study|Lost to Follow-up|17|||
160916798|NCT03032705|581086822|FG000|Overall Study|did not quality|6|||
160916799|NCT03032705|581086823|FG001|Overall Study|did not quality|6|||
160916800|NCT01937559|581086826|FG000|Overall Study|Physician Decision|3|||
160916801|NCT01937559|581086827|FG001|Overall Study|Physician Decision|3|||
160916802|NCT01937559|581086828|FG002|Overall Study|Physician Decision|0|||
160916803|NCT01937559|581086826|FG000|Overall Study|Withdrawal by Subject|6|||
160916804|NCT01937559|581086827|FG001|Overall Study|Withdrawal by Subject|4|||
160916805|NCT01937559|581086828|FG002|Overall Study|Withdrawal by Subject|0|||
160916806|NCT01937559|581086826|FG000|Overall Study|screen fail|2|||
160916807|NCT01937559|581086827|FG001|Overall Study|screen fail|4|||
160916808|NCT01937559|581086828|FG002|Overall Study|screen fail|0|||
160916809|NCT04818840|581086829|FG000|Overall Study|Lost to Follow-up|0|||
160916810|NCT04818840|581086830|FG001|Overall Study|Lost to Follow-up|5|||
160916811|NCT04818840|581086829|FG000|Overall Study|Physician Decision|1|||
160916812|NCT04818840|581086830|FG001|Overall Study|Physician Decision|0|||
160916813|NCT04818840|581086829|FG000|Overall Study|Site Terminated by Sponsor|0|||
160916814|NCT04818840|581086830|FG001|Overall Study|Site Terminated by Sponsor|3|||
160916815|NCT04818840|581086829|FG000|Overall Study|Study Terminated by Sponsor|43|||
160916816|NCT04818840|581086830|FG001|Overall Study|Study Terminated by Sponsor|7|||
160453913|NCT03952338|579393963|FG000|Overall Study|Lost to Follow-up|11|||
160916817|NCT04818840|581086829|FG000|Overall Study|Withdrawal by Subject|0|||
160916818|NCT04818840|581086830|FG001|Overall Study|Withdrawal by Subject|1|||
160916819|NCT02329730|581089381|FG000|Overall Study|Protocol Violation|0|||
160916820|NCT02329730|581089382|FG001|Overall Study|Protocol Violation|0|||
160916821|NCT02329730|581089383|FG002|Overall Study|Protocol Violation|0|||
160916822|NCT02329730|581089384|FG003|Overall Study|Protocol Violation|0|||
160916823|NCT02329730|581089385|FG004|Overall Study|Protocol Violation|2|||
160916824|NCT02329730|581089386|FG005|Overall Study|Protocol Violation|2|||
160916825|NCT02329730|581089387|FG006|Overall Study|Protocol Violation|0|||
160916826|NCT02329730|581089388|FG007|Overall Study|Protocol Violation|0|||
160916827|NCT02329730|581089389|FG008|Overall Study|Protocol Violation|0|||
160916828|NCT02329730|581089390|FG009|Overall Study|Protocol Violation|0|||
160916829|NCT02329730|581089391|FG010|Overall Study|Protocol Violation|0|||
160916830|NCT02329730|581089392|FG011|Overall Study|Protocol Violation|0|||
160916831|NCT02329730|581089381|FG000|Overall Study|Withdrawal by Subject|0|||
160916832|NCT02329730|581089382|FG001|Overall Study|Withdrawal by Subject|0|||
160916833|NCT02329730|581089383|FG002|Overall Study|Withdrawal by Subject|0|||
160916834|NCT02329730|581089384|FG003|Overall Study|Withdrawal by Subject|0|||
160916835|NCT02329730|581089385|FG004|Overall Study|Withdrawal by Subject|1|||
160916836|NCT02329730|581089386|FG005|Overall Study|Withdrawal by Subject|0|||
160916837|NCT02329730|581089387|FG006|Overall Study|Withdrawal by Subject|1|||
160916838|NCT02329730|581089388|FG007|Overall Study|Withdrawal by Subject|1|||
160916839|NCT02329730|581089389|FG008|Overall Study|Withdrawal by Subject|1|||
160916840|NCT02329730|581089390|FG009|Overall Study|Withdrawal by Subject|1|||
160916841|NCT02329730|581089391|FG010|Overall Study|Withdrawal by Subject|0|||
160916842|NCT02329730|581089392|FG011|Overall Study|Withdrawal by Subject|0|||
160916843|NCT00224055|581089393|FG000|Overall Study|Adverse Event|9|||
160916844|NCT00224055|581089394|FG001|Overall Study|Adverse Event|3|||
160916845|NCT00224055|581089393|FG000|Overall Study|Lost to Follow-up|1|||
160916846|NCT00224055|581089394|FG001|Overall Study|Lost to Follow-up|2|||
160916847|NCT00224055|581089393|FG000|Overall Study|Protocol Violation|1|||
160916848|NCT00224055|581089394|FG001|Overall Study|Protocol Violation|1|||
160916849|NCT00224055|581089393|FG000|Overall Study|Inclusion Violation|3|||
160916850|NCT00224055|581089394|FG001|Overall Study|Inclusion Violation|6|||
160916851|NCT00224055|581089393|FG000|Overall Study|Withdrawal by Subject|0|||
160916852|NCT00224055|581089394|FG001|Overall Study|Withdrawal by Subject|2|||
160916853|NCT00224055|581089393|FG000|Overall Study|Other|1|||
160916854|NCT00224055|581089394|FG001|Overall Study|Other|0|||
160916855|NCT00127712|581089395|FG000|Overall Study|Adverse Event|3|||
160916856|NCT00127712|581089396|FG001|Overall Study|Adverse Event|0|||
160916857|NCT00127712|581089395|FG000|Overall Study|Lack of GI access to continue|2|||
160916858|NCT00127712|581089396|FG001|Overall Study|Lack of GI access to continue|0|||
160916859|NCT03055260|581089399|FG000|Overall Study|Withdrawal by Subject|1|||
160916860|NCT03055260|581089400|FG001|Overall Study|Withdrawal by Subject|0|||
160916861|NCT00799487|581089402|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
160916862|NCT00799487|581089403|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
160916863|NCT00799487|581089404|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
160916864|NCT00799487|581089402|FG000|Dose Adjustment Period|Adverse Event|2|||
160916865|NCT00799487|581089403|FG001|Dose Adjustment Period|Adverse Event|0|||
160916866|NCT00799487|581089404|FG002|Dose Adjustment Period|Adverse Event|0|||
160916867|NCT00799487|581089402|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
160916868|NCT00799487|581089403|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
160916869|NCT00799487|581089404|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
160916870|NCT00799487|581089402|FG000|Dose Adjustment Period|Investigator Discretion|2|||
160916871|NCT00799487|581089403|FG001|Dose Adjustment Period|Investigator Discretion|0|||
160916872|NCT00799487|581089404|FG002|Dose Adjustment Period|Investigator Discretion|0|||
160916873|NCT00799487|581089402|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
160916874|NCT00799487|581089403|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
160916875|NCT00799487|581089404|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
160916876|NCT00799487|581089402|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
160916877|NCT00799487|581089403|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
160916878|NCT00799487|581089404|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
160916879|NCT00799487|581089402|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
160916880|NCT00799487|581089403|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
160916881|NCT00799487|581089404|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
160916882|NCT00799487|581089402|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
160916883|NCT00799487|581089403|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
160916884|NCT00799487|581089404|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
160916885|NCT00799487|581089402|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
160916886|NCT00799487|581089403|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
160916887|NCT00799487|581089404|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
160916888|NCT00799487|581089402|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
160916889|NCT00799487|581089403|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
160916890|NCT00799487|581089404|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
160916891|NCT00799487|581089402|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
160916892|NCT00799487|581089403|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
160916893|NCT00799487|581089404|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
160916894|NCT00799487|581089402|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
160916895|NCT00799487|581089403|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
160996346|NCT03354390|581372190|FG000|Level 4|Death|0|||
160571660|NCT02413255|579816778|FG012|Overall Study|Voluntary Withdrawal|0|||
160571661|NCT02413255|579816779|FG013|Overall Study|Voluntary Withdrawal|0|||
160571662|NCT02413255|579816780|FG014|Overall Study|Voluntary Withdrawal|1|||
160571663|NCT02413255|579816781|FG015|Overall Study|Voluntary Withdrawal|0|||
160571664|NCT02413255|579816782|FG016|Overall Study|Voluntary Withdrawal|0|||
160571665|NCT05372315|579816783|FG000|Overall Study|Withdrawal by Subject|1|||
160571666|NCT05372315|579816784|FG001|Overall Study|Withdrawal by Subject|0|||
160571667|NCT00650585|579816789|FG000|Overall Study|Lost to Follow-up|505|||
160571668|NCT00650585|579816790|FG001|Overall Study|Lost to Follow-up|482|||
160571669|NCT00650585|579816789|FG000|Overall Study|No parental consent|935|||
160571670|NCT00650585|579816790|FG001|Overall Study|No parental consent|866|||
160571671|NCT00650585|579816789|FG000|Overall Study|Excluded/ruled ineligible|357|||
160571672|NCT00650585|579816790|FG001|Overall Study|Excluded/ruled ineligible|129|||
160571673|NCT01720667|579816791|FG000|Overall Study|Adverse Event|1|||
160571674|NCT01720667|579816792|FG001|Overall Study|Adverse Event|1|||
160571675|NCT01720667|579816791|FG000|Overall Study|Withdrawal by Subject|3|||
160571676|NCT01720667|579816792|FG001|Overall Study|Withdrawal by Subject|0|||
160571677|NCT03472534|579816793|FG000|Overall Study|Withdrawal by Subject|9|||
160571678|NCT03472534|579816793|FG000|Overall Study|Adverse Event|2|||
160571679|NCT02614794|579816794|FG000|Overall Study|Death|258|||
160571680|NCT02614794|579816795|FG001|Overall Study|Death|151|||
160571681|NCT02614794|579816794|FG000|Overall Study|Study closure by Sponsor|119|||
160571682|NCT02614794|579816795|FG001|Overall Study|Study closure by Sponsor|45|||
160571683|NCT02614794|579816794|FG000|Overall Study|Withdrawal by Subject|24|||
160571684|NCT02614794|579816795|FG001|Overall Study|Withdrawal by Subject|5|||
160571685|NCT02614794|579816794|FG000|Overall Study|Lost to Follow-up|7|||
160571686|NCT02614794|579816795|FG001|Overall Study|Lost to Follow-up|0|||
160916896|NCT00799487|581089404|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
160916897|NCT01463878|581089408|FG000|Overall Study|no longer met criteria for tube feed|2|||
160916898|NCT01463878|581089409|FG001|Overall Study|no longer met criteria for tube feed|2|||
160916899|NCT01084174|581089410|FG000|Overall Study|gastrointestinal symptoms|1|||
160916900|NCT01084174|581089411|FG001|Overall Study|gastrointestinal symptoms|1|||
160916901|NCT01084174|581089410|FG000|Overall Study|Eosinophilic esophagitis|0|||
160916902|NCT01084174|581089411|FG001|Overall Study|Eosinophilic esophagitis|1|||
160916903|NCT01084174|581089410|FG000|Overall Study|Anaphylaxis|0|||
160916904|NCT01084174|581089411|FG001|Overall Study|Anaphylaxis|1|||
160916905|NCT01084174|581089410|FG000|Overall Study|Participant noncompliance|0|||
160916906|NCT01084174|581089411|FG001|Overall Study|Participant noncompliance|1|||
160916907|NCT04273217|581089412|FG000|Overall Study|Lost to Follow-up|0|||
160916908|NCT04273217|581089413|FG001|Overall Study|Lost to Follow-up|0|||
160916909|NCT04273217|581089414|FG002|Overall Study|Lost to Follow-up|0|||
160916910|NCT04273217|581089415|FG003|Overall Study|Lost to Follow-up|0|||
160916911|NCT04273217|581089416|FG004|Overall Study|Lost to Follow-up|0|||
160916912|NCT04273217|581089417|FG005|Overall Study|Lost to Follow-up|1|||
160916913|NCT04273217|581089412|FG000|Overall Study|Participant non-compliance|0|||
160916914|NCT04273217|581089413|FG001|Overall Study|Participant non-compliance|0|||
160916915|NCT04273217|581089414|FG002|Overall Study|Participant non-compliance|0|||
160916916|NCT04273217|581089415|FG003|Overall Study|Participant non-compliance|0|||
160916917|NCT04273217|581089416|FG004|Overall Study|Participant non-compliance|1|||
160916918|NCT04273217|581089417|FG005|Overall Study|Participant non-compliance|0|||
160916919|NCT04273217|581089412|FG000|Overall Study|Positive urine drug screen|1|||
160916920|NCT04273217|581089413|FG001|Overall Study|Positive urine drug screen|0|||
160916921|NCT04273217|581089414|FG002|Overall Study|Positive urine drug screen|1|||
160916922|NCT04273217|581089415|FG003|Overall Study|Positive urine drug screen|0|||
160916923|NCT04273217|581089416|FG004|Overall Study|Positive urine drug screen|0|||
160916924|NCT04273217|581089417|FG005|Overall Study|Positive urine drug screen|1|||
160571687|NCT02614794|579816794|FG000|Overall Study|Physician Decision|1|||
160916925|NCT04532099|581089418|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
160916926|NCT04532099|581089419|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
160916927|NCT04532099|581089420|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
160916928|NCT02506153|581089421|FG000|Overall Study|Adverse Event|359|||
160916929|NCT02506153|581089422|FG001|Overall Study|Adverse Event|114|||
160916930|NCT02506153|581089421|FG000|Overall Study|Refused unrelated to adverse event|127|||
160916931|NCT02506153|581089422|FG001|Overall Study|Refused unrelated to adverse event|18|||
160916932|NCT02506153|581089421|FG000|Overall Study|Progression/relapse|91|||
160916933|NCT02506153|581089422|FG001|Overall Study|Progression/relapse|136|||
160916934|NCT02506153|581089421|FG000|Overall Study|Death|2|||
160571688|NCT02614794|579816795|FG001|Overall Study|Physician Decision|1|||
160916935|NCT02506153|581089422|FG001|Overall Study|Death|1|||
160916936|NCT02506153|581089421|FG000|Overall Study|Other - not protocol specified|23|||
160916937|NCT02506153|581089422|FG001|Overall Study|Other - not protocol specified|12|||
160916938|NCT03998189|581089423|FG000|Overall Study|Lack of Efficacy|0|||
160571689|NCT02614794|579816794|FG000|Overall Study|Hospital closure|1|||
160571690|NCT02614794|579816795|FG001|Overall Study|Hospital closure|0|||
160571691|NCT03237845|579816804|FG000|Overall Study|Adverse Event|0|||
160571692|NCT03237845|579816805|FG001|Overall Study|Adverse Event|1|||
160571693|NCT03237845|579816804|FG000|Overall Study|Lost to Follow-up|13|||
160916939|NCT03998189|581089424|FG001|Overall Study|Lack of Efficacy|1|||
160916940|NCT04983264|581089425|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
160916941|NCT04983264|581089426|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
160916942|NCT04983264|581089427|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
160916943|NCT04983264|581089425|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
160916944|NCT04983264|581089426|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
160571694|NCT03237845|579816805|FG001|Overall Study|Lost to Follow-up|10|||
160571695|NCT03237845|579816804|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
160571696|NCT03237845|579816805|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
160571697|NCT03237845|579816804|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
160571698|NCT03237845|579816805|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
160916945|NCT04983264|581089427|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
160916946|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
160916947|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
160916948|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
160916949|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
160916950|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
160916951|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
160916952|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
160916953|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
160916954|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
160916955|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
160916956|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
160916957|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
160916958|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
160916959|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
160916960|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
160916961|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
160916962|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
160916963|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
160916964|NCT01124422|581089428|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
160916965|NCT01124422|581089429|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
160916966|NCT01124422|581089430|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
160916967|NCT01124422|581089428|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
160916968|NCT01124422|581089429|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
160916969|NCT01124422|581089430|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
160916970|NCT01124422|581089428|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
160916971|NCT01124422|581089429|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
160916972|NCT01124422|581089430|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
160916973|NCT01124422|581089428|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
160916974|NCT01124422|581089429|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
160916975|NCT01124422|581089430|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
160916976|NCT01828281|581089431|FG000|Overall Study|Withdrawal by Subject|1|||
160916977|NCT01828281|581089432|FG001|Overall Study|Withdrawal by Subject|0|||
160916978|NCT02709785|581089439|FG000|Overall Study|Withdrawal by Subject|1|||
160916979|NCT02709785|581089440|FG001|Overall Study|Withdrawal by Subject|2|||
160916980|NCT02709785|581089441|FG002|Overall Study|Withdrawal by Subject|1|||
160916981|NCT04577118|581089444|FG000|Overall Study|Withdrawal by Subject|4|||
160916982|NCT01961323|581089445|FG000|Overall Study|Withdrawal by Subject|7|||
160916983|NCT01961323|581089445|FG000|Overall Study|Lost to Follow-up|8|||
160916984|NCT01961323|581089445|FG000|Overall Study|screen failure|34|||
160916985|NCT03315208|581089446|FG000|Overall Study|Lost to Follow-up|11|||
160916986|NCT03315208|581089447|FG001|Overall Study|Lost to Follow-up|6|||
160916987|NCT03315208|581089446|FG000|Overall Study|Withdrawal by Subject|2|||
160916988|NCT03315208|581089447|FG001|Overall Study|Withdrawal by Subject|0|||
160916989|NCT02320149|581089448|FG000|Overall Study|Adverse Event|3|||
160916990|NCT02320149|581089449|FG001|Overall Study|Adverse Event|7|||
160916991|NCT02320149|581089448|FG000|Overall Study|Withdrawal of Consent|28|||
160916992|NCT02320149|581089449|FG001|Overall Study|Withdrawal of Consent|32|||
160916993|NCT02320149|581089448|FG000|Overall Study|Lost to Follow-up|21|||
160916994|NCT02320149|581089449|FG001|Overall Study|Lost to Follow-up|34|||
160916995|NCT02320149|581089448|FG000|Overall Study|Protocol Violation|2|||
160916996|NCT02320149|581089449|FG001|Overall Study|Protocol Violation|1|||
160916997|NCT02320149|581089448|FG000|Overall Study|Noncompliance with Study Treatment|7|||
160916998|NCT02320149|581089449|FG001|Overall Study|Noncompliance with Study Treatment|2|||
160916999|NCT02320149|581089448|FG000|Overall Study|Lack of Efficacy|0|||
160917000|NCT02320149|581089449|FG001|Overall Study|Lack of Efficacy|1|||
160917001|NCT02320149|581089448|FG000|Overall Study|Other Miscellaneous Reasons|2|||
160917002|NCT02320149|581089449|FG001|Overall Study|Other Miscellaneous Reasons|3|||
160917003|NCT06133348|581089450|FG000|Overall Study|Death|3|||
160917004|NCT06133348|581089450|FG000|Overall Study|Lost to Follow-up|1|||
160917005|NCT06133348|581089450|FG000|Overall Study|Physician Decision|1|||
160917006|NCT06133348|581089450|FG000|Overall Study|Withdrawal by Subject|5|||
160917007|NCT02036294|581089451|FG000|Overall Study|Death|7|||
160917008|NCT02036294|581089452|FG001|Overall Study|Death|8|||
160917009|NCT02036294|581089451|FG000|Overall Study|Withdrawal by Subject|2|||
160917010|NCT02036294|581089452|FG001|Overall Study|Withdrawal by Subject|3|||
160917011|NCT00356369|581089453|FG000|Active Phase|Withdrawal by Subject|2|||
160917012|NCT00356369|581089454|FG001|Active Phase|Withdrawal by Subject|1|||
160917013|NCT00673465|581089457|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917014|NCT00673465|581089458|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917015|NCT00673465|581089459|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917016|NCT00673465|581089460|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917017|NCT00673465|581089461|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
160917018|NCT00673465|581089462|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
160917019|NCT00673465|581089463|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917020|NCT00673465|581089464|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917021|NCT00673465|581089465|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917022|NCT00673465|581089466|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917023|NCT00673465|581089467|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917024|NCT00673465|581089468|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917025|NCT00673465|581089457|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917026|NCT00673465|581089458|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917027|NCT00673465|581089459|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917028|NCT00673465|581089460|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917029|NCT00673465|581089461|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
160917030|NCT00673465|581089462|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917031|NCT00673465|581089463|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917032|NCT00673465|581089464|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917033|NCT00673465|581089465|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917034|NCT00673465|581089466|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917035|NCT00673465|581089467|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917036|NCT00673465|581089468|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917037|NCT01996982|581089469|FG000|Overall Study|PI/team left institution|7|||
160917038|NCT01195415|581089488|FG000|Overall Study|No repeat biopsy due to progression|2|||
160917039|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
160917040|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
160917041|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
160917042|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
160917043|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
160917044|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
160917045|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
160917046|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
160917047|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
160917048|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
160917049|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Death|2|||
160917050|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Death|1|||
160917051|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Death|4|||
160917052|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Death|0|||
160917053|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Death|0|||
160917054|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
160917055|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
160917056|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
160917057|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
160917058|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
160917059|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Other Reason|1|||
160917060|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Other Reason|3|||
160917061|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Other Reason|2|||
160917062|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Other Reason|0|||
160917063|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Other Reason|0|||
160917064|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Never treated|2|||
160917065|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Never treated|3|||
160917066|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Never treated|1|||
160917067|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Never treated|0|||
160917068|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Never treated|4|||
160917069|NCT00555321|581089493|FG000|Long-term Extension Phase|Adverse Event|2|||
160917070|NCT00555321|581089494|FG001|Long-term Extension Phase|Adverse Event|5|||
160917071|NCT00555321|581089495|FG002|Long-term Extension Phase|Adverse Event|2|||
160917072|NCT00555321|581089496|FG003|Long-term Extension Phase|Adverse Event|1|||
160917073|NCT00555321|581089497|FG004|Long-term Extension Phase|Adverse Event|0|||
160917074|NCT00555321|581089493|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
160996347|NCT03354390|581372191|FG001|Level 4|Death|0|||
160571699|NCT03237845|579816804|FG000|Overall Study|Physician Decision|1|||
160571700|NCT03237845|579816805|FG001|Overall Study|Physician Decision|2|||
160571701|NCT03237845|579816804|FG000|Overall Study|Pregnancy|1|||
160571702|NCT03237845|579816805|FG001|Overall Study|Pregnancy|0|||
160571703|NCT03237845|579816804|FG000|Overall Study|Protocol Deviation|0|||
160571704|NCT03237845|579816805|FG001|Overall Study|Protocol Deviation|1|||
160571705|NCT03237845|579816804|FG000|Overall Study|Technical Problems|8|||
160917075|NCT00555321|581089494|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
160917076|NCT00555321|581089495|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
160917077|NCT00555321|581089496|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
160917078|NCT00555321|581089497|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
160917079|NCT00555321|581089493|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
160917080|NCT00555321|581089494|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
160917081|NCT00555321|581089495|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
160917082|NCT00555321|581089496|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
160917083|NCT00555321|581089497|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
160917084|NCT00555321|581089493|FG000|Long-term Extension Phase|Death|2|||
160917085|NCT00555321|581089494|FG001|Long-term Extension Phase|Death|0|||
160917086|NCT00555321|581089495|FG002|Long-term Extension Phase|Death|0|||
160917087|NCT00555321|581089496|FG003|Long-term Extension Phase|Death|3|||
160917088|NCT00555321|581089497|FG004|Long-term Extension Phase|Death|0|||
160917089|NCT00555321|581089493|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
160917090|NCT00555321|581089494|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
160917091|NCT00555321|581089495|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
160917092|NCT00555321|581089496|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
160917093|NCT00555321|581089497|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
160917094|NCT00555321|581089493|FG000|Long-term Extension Phase|Other Reason|1|||
160917095|NCT00555321|581089494|FG001|Long-term Extension Phase|Other Reason|0|||
160917096|NCT00555321|581089495|FG002|Long-term Extension Phase|Other Reason|2|||
160917097|NCT00555321|581089496|FG003|Long-term Extension Phase|Other Reason|0|||
160917098|NCT00555321|581089497|FG004|Long-term Extension Phase|Other Reason|0|||
160917099|NCT02733367|581089498|FG000|Overall Study|Withdrawal by Subject|6|||
160917100|NCT01348347|581089499|FG000|Overall Study|Withdrawal by Subject|1|||
160917101|NCT01348347|581089500|FG001|Overall Study|Withdrawal by Subject|1|||
160917102|NCT01348347|581089501|FG002|Overall Study|Withdrawal by Subject|1|||
160917103|NCT01348347|581089499|FG000|Overall Study|Progressive disease|2|||
160917104|NCT01348347|581089500|FG001|Overall Study|Progressive disease|5|||
160917105|NCT01348347|581089501|FG002|Overall Study|Progressive disease|5|||
160917106|NCT00191789|581089505|FG000|Overall Study|Adverse Event|5|||
160917107|NCT00191789|581089505|FG000|Overall Study|Patient: Satisfactory Response|5|||
160917108|NCT00191789|581089505|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
160917109|NCT00191789|581089505|FG000|Overall Study|Withdrawal by Subject|4|||
160917110|NCT00191789|581089505|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
160917111|NCT00191789|581089505|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
160917112|NCT00191789|581089505|FG000|Overall Study|Death - Not Study-Drug Related|1|||
160917113|NCT01922089|581089506|FG000|Overall Study|Adverse Event|18|||
160917114|NCT01922089|581089507|FG001|Overall Study|Adverse Event|13|||
160917115|NCT01922089|581089506|FG000|Overall Study|Protocol Deviation|10|||
160917116|NCT01922089|581089507|FG001|Overall Study|Protocol Deviation|7|||
160917117|NCT01922089|581089506|FG000|Overall Study|Withdrawal by Subject|3|||
160917118|NCT01922089|581089507|FG001|Overall Study|Withdrawal by Subject|4|||
160917119|NCT01922089|581089506|FG000|Overall Study|administrative problems|4|||
160917120|NCT01922089|581089507|FG001|Overall Study|administrative problems|1|||
160917121|NCT01922089|581089506|FG000|Overall Study|Physician Decision|2|||
160571706|NCT03237845|579816805|FG001|Overall Study|Technical Problems|1|||
160571707|NCT03237845|579816804|FG000|Overall Study|Withdrawal by Subject|3|||
160571708|NCT03237845|579816805|FG001|Overall Study|Withdrawal by Subject|3|||
160571709|NCT03237845|579816804|FG000|Overall Study|Other Reasons|4|||
160917122|NCT01922089|581089507|FG001|Overall Study|Physician Decision|3|||
160917123|NCT01922089|581089506|FG000|Overall Study|Death|2|||
160917124|NCT01922089|581089507|FG001|Overall Study|Death|1|||
160917125|NCT01922089|581089506|FG000|Overall Study|Lost to Follow-up|0|||
160917126|NCT01922089|581089507|FG001|Overall Study|Lost to Follow-up|1|||
160917127|NCT00996307|581089509|FG000|Overall Study|Adverse Event|0|||
160571710|NCT03237845|579816805|FG001|Overall Study|Other Reasons|0|||
160917128|NCT00996307|581089510|FG001|Overall Study|Adverse Event|1|||
160917129|NCT00996307|581089511|FG002|Overall Study|Adverse Event|0|||
160917130|NCT00996307|581089512|FG003|Overall Study|Adverse Event|0|||
160917131|NCT00996307|581089509|FG000|Overall Study|Withdrawal by Subject|3|||
160571711|NCT03865407|579816806|FG000|Overall Study|Adverse Event|1|||
160917132|NCT00996307|581089510|FG001|Overall Study|Withdrawal by Subject|2|||
160917133|NCT00996307|581089511|FG002|Overall Study|Withdrawal by Subject|5|||
160571712|NCT03865407|579816807|FG001|Overall Study|Adverse Event|0|||
160571713|NCT03865407|579816806|FG000|Overall Study|Withdrawal by Subject|1|||
160917134|NCT00996307|581089512|FG003|Overall Study|Withdrawal by Subject|5|||
160917135|NCT00996307|581089509|FG000|Overall Study|Lost to Follow-up|13|||
160917136|NCT00996307|581089510|FG001|Overall Study|Lost to Follow-up|13|||
160917137|NCT00996307|581089511|FG002|Overall Study|Lost to Follow-up|7|||
160917138|NCT00996307|581089512|FG003|Overall Study|Lost to Follow-up|15|||
160917139|NCT00996307|581089509|FG000|Overall Study|Administrative reason|0|||
160917140|NCT00996307|581089510|FG001|Overall Study|Administrative reason|1|||
160917141|NCT00996307|581089511|FG002|Overall Study|Administrative reason|0|||
160917142|NCT00996307|581089512|FG003|Overall Study|Administrative reason|0|||
160917143|NCT00996307|581089509|FG000|Overall Study|Unable to classify|4|||
160571714|NCT03865407|579816807|FG001|Overall Study|Withdrawal by Subject|0|||
160571715|NCT03865407|579816806|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
160571716|NCT03865407|579816807|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
160571717|NCT01645280|579816808|FG000|Overall Study|Death|0|||
160571718|NCT01645280|579816809|FG001|Overall Study|Death|1|||
160571719|NCT01645280|579816810|FG002|Overall Study|Death|0|||
160571720|NCT01645280|579816811|FG003|Overall Study|Death|0|||
160571721|NCT01645280|579816812|FG004|Overall Study|Death|0|||
160571722|NCT01645280|579816808|FG000|Overall Study|Withdrawal by Subject|4|||
160571723|NCT01645280|579816809|FG001|Overall Study|Withdrawal by Subject|0|||
160917144|NCT00996307|581089510|FG001|Overall Study|Unable to classify|0|||
160917145|NCT00996307|581089511|FG002|Overall Study|Unable to classify|2|||
160917146|NCT00996307|581089512|FG003|Overall Study|Unable to classify|1|||
160917147|NCT02788357|581089513|FG000|Overall Study|Lost to Follow-up|3|||
160917148|NCT02788357|581089514|FG001|Overall Study|Lost to Follow-up|0|||
160917149|NCT02170051|581089515|FG000|Overall Study|Withdrawal by Subject|10|||
160917150|NCT02170051|581089516|FG001|Overall Study|Withdrawal by Subject|10|||
160917151|NCT02170051|581089515|FG000|Overall Study|Lost to Follow-up|1|||
160917152|NCT02170051|581089516|FG001|Overall Study|Lost to Follow-up|3|||
160917153|NCT01712490|581089517|FG000|Overall Study|Ongoing|601|||
160917154|NCT01712490|581089518|FG001|Overall Study|Ongoing|586|||
160917155|NCT01712490|581089517|FG000|Overall Study|Other|11|||
160917156|NCT01712490|581089518|FG001|Overall Study|Other|11|||
160917157|NCT01712490|581089517|FG000|Overall Study|Withdrawal by Subject|36|||
160917158|NCT01712490|581089518|FG001|Overall Study|Withdrawal by Subject|44|||
160917159|NCT01712490|581089517|FG000|Overall Study|Lost to Follow-up|16|||
160917160|NCT01712490|581089518|FG001|Overall Study|Lost to Follow-up|29|||
160917161|NCT01129960|581089526|FG000|Overall Study|Withdrawal by Subject|3|||
160917162|NCT01129960|581089527|FG001|Overall Study|Withdrawal by Subject|0|||
160917163|NCT01129960|581089528|FG002|Overall Study|Withdrawal by Subject|3|||
160917164|NCT01129960|581089529|FG003|Overall Study|Withdrawal by Subject|2|||
160917165|NCT01129960|581089526|FG000|Overall Study|Lack of Efficacy|1|||
160917166|NCT01129960|581089527|FG001|Overall Study|Lack of Efficacy|1|||
160917167|NCT01129960|581089528|FG002|Overall Study|Lack of Efficacy|1|||
160917168|NCT01129960|581089529|FG003|Overall Study|Lack of Efficacy|1|||
160917169|NCT01129960|581089526|FG000|Overall Study|Adverse Event|23|||
160917170|NCT01129960|581089527|FG001|Overall Study|Adverse Event|16|||
160917171|NCT01129960|581089528|FG002|Overall Study|Adverse Event|16|||
160917172|NCT01129960|581089529|FG003|Overall Study|Adverse Event|7|||
160917173|NCT01129960|581089526|FG000|Overall Study|Protocol Violation|1|||
160917174|NCT01129960|581089527|FG001|Overall Study|Protocol Violation|2|||
160917175|NCT01129960|581089528|FG002|Overall Study|Protocol Violation|3|||
160917176|NCT01129960|581089529|FG003|Overall Study|Protocol Violation|0|||
160917177|NCT01129960|581089526|FG000|Overall Study|Lost to Follow-up|0|||
160917178|NCT01129960|581089527|FG001|Overall Study|Lost to Follow-up|2|||
160917179|NCT01129960|581089528|FG002|Overall Study|Lost to Follow-up|3|||
160917180|NCT01129960|581089529|FG003|Overall Study|Lost to Follow-up|3|||
160917181|NCT01129960|581089526|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
160917182|NCT01129960|581089527|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
160917183|NCT01129960|581089528|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
160917184|NCT01129960|581089529|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
160917185|NCT01129960|581089526|FG000|Overall Study|Physician Decision|1|||
160996348|NCT03354390|581372192|FG002|Level 4|Death|0|||
160571724|NCT01645280|579816810|FG002|Overall Study|Withdrawal by Subject|2|||
160571725|NCT01645280|579816811|FG003|Overall Study|Withdrawal by Subject|4|||
160571726|NCT01645280|579816812|FG004|Overall Study|Withdrawal by Subject|5|||
160571727|NCT01645280|579816808|FG000|Overall Study|Lost to Follow-up|0|||
160917186|NCT01129960|581089527|FG001|Overall Study|Physician Decision|0|||
160917187|NCT01129960|581089528|FG002|Overall Study|Physician Decision|0|||
160917188|NCT01129960|581089529|FG003|Overall Study|Physician Decision|0|||
160917189|NCT01129960|581089526|FG000|Overall Study|Pregnancy|1|||
160917190|NCT01129960|581089527|FG001|Overall Study|Pregnancy|0|||
160571728|NCT01645280|579816809|FG001|Overall Study|Lost to Follow-up|0|||
160571729|NCT01645280|579816810|FG002|Overall Study|Lost to Follow-up|0|||
160917191|NCT01129960|581089528|FG002|Overall Study|Pregnancy|0|||
160917192|NCT01129960|581089529|FG003|Overall Study|Pregnancy|0|||
160917193|NCT02860169|581089530|FG000|Part A|Withdrawal by Subject|1|||
160917194|NCT02860169|581089530|FG000|Part A|Other (Screening failure)|6|||
160917195|NCT02860169|581089530|FG000|Part A|Other (Survey not completed)|3|||
160996349|NCT03354390|581372193|FG003|Level 4|Death|3|||
160571730|NCT01645280|579816811|FG003|Overall Study|Lost to Follow-up|2|||
160571731|NCT01645280|579816812|FG004|Overall Study|Lost to Follow-up|1|||
160571732|NCT01645280|579816808|FG000|Overall Study|Other|1|||
160571733|NCT01645280|579816809|FG001|Overall Study|Other|1|||
160571734|NCT01645280|579816810|FG002|Overall Study|Other|2|||
160571735|NCT01645280|579816811|FG003|Overall Study|Other|0|||
160571736|NCT01645280|579816812|FG004|Overall Study|Other|0|||
160571737|NCT01645280|579816808|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
160917196|NCT02860169|581089530|FG000|Part A|Other (did not completed consent)|1|||
160917197|NCT02860169|581089530|FG000|Part B|Other (Screening failure)|10|||
160917198|NCT02860169|581089530|FG000|Part B|Withdrawal by Subject|1|||
160917199|NCT02860169|581089530|FG000|Part C|Other (Screening failure)|1|||
160917200|NCT04285879|581089531|FG000|Overall Study|Lost to Follow-up|1|||
160917201|NCT04285879|581089532|FG001|Overall Study|Lost to Follow-up|8|||
160917202|NCT04285879|581089531|FG000|Overall Study|medical/surgical exclusion|16|||
160917203|NCT04285879|581089532|FG001|Overall Study|medical/surgical exclusion|0|||
160917204|NCT01835587|581089535|FG000|Overall Study|Disease Recurrence or Relapse|0|||
160917205|NCT01835587|581089536|FG001|Overall Study|Disease Recurrence or Relapse|3|||
160917206|NCT01835587|581089537|FG002|Overall Study|Disease Recurrence or Relapse|0|||
160917207|NCT01835587|581089538|FG003|Overall Study|Disease Recurrence or Relapse|3|||
160917208|NCT01835587|581089535|FG000|Overall Study|Withdrawal by Subject|2|||
160917209|NCT01835587|581089536|FG001|Overall Study|Withdrawal by Subject|0|||
160917210|NCT01835587|581089537|FG002|Overall Study|Withdrawal by Subject|0|||
160917211|NCT01835587|581089538|FG003|Overall Study|Withdrawal by Subject|3|||
160917212|NCT01835587|581089535|FG000|Overall Study|Adverse Event|0|||
160917213|NCT01835587|581089536|FG001|Overall Study|Adverse Event|0|||
160917214|NCT01835587|581089537|FG002|Overall Study|Adverse Event|2|||
160917215|NCT01835587|581089538|FG003|Overall Study|Adverse Event|2|||
160917216|NCT01835587|581089535|FG000|Overall Study|Death|0|||
160917217|NCT01835587|581089536|FG001|Overall Study|Death|0|||
160917218|NCT01835587|581089537|FG002|Overall Study|Death|0|||
160917219|NCT01835587|581089538|FG003|Overall Study|Death|1|||
160917220|NCT01835587|581089535|FG000|Overall Study|Miscellaneous|0|||
160917221|NCT01835587|581089536|FG001|Overall Study|Miscellaneous|1|||
160917222|NCT01835587|581089537|FG002|Overall Study|Miscellaneous|0|||
160917223|NCT01835587|581089538|FG003|Overall Study|Miscellaneous|0|||
160917224|NCT01782495|581089539|FG000|Overall Study|Adverse Event|0|||
160917225|NCT01782495|581089540|FG001|Overall Study|Adverse Event|0|||
160917226|NCT01782495|581089541|FG002|Overall Study|Adverse Event|0|||
160917227|NCT01782495|581089542|FG003|Overall Study|Adverse Event|0|||
160917228|NCT01782495|581089543|FG004|Overall Study|Adverse Event|0|||
160917229|NCT01782495|581089544|FG005|Overall Study|Adverse Event|0|||
160571738|NCT01645280|579816809|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
160571739|NCT01645280|579816810|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
160571740|NCT01645280|579816811|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
160571741|NCT01645280|579816812|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
160571742|NCT00546819|579816817|FG000|Overall Study|Adverse Event|2|||
160571743|NCT00546819|579816818|FG001|Overall Study|Adverse Event|3|||
160571744|NCT00546819|579816817|FG000|Overall Study|Lost to Follow-up|2|||
160571745|NCT00546819|579816818|FG001|Overall Study|Lost to Follow-up|1|||
160917230|NCT01782495|581089545|FG006|Overall Study|Adverse Event|0|||
160917231|NCT01782495|581089546|FG007|Overall Study|Adverse Event|2|||
160917232|NCT01782495|581089547|FG008|Overall Study|Adverse Event|0|||
160917233|NCT01782495|581089548|FG009|Overall Study|Adverse Event|0|||
160917234|NCT01782495|581089549|FG010|Overall Study|Adverse Event|0|||
160917235|NCT01782495|581089539|FG000|Overall Study|Withdrew Consent|0|||
160917236|NCT01782495|581089540|FG001|Overall Study|Withdrew Consent|1|||
160917237|NCT01782495|581089541|FG002|Overall Study|Withdrew Consent|0|||
160917238|NCT01782495|581089542|FG003|Overall Study|Withdrew Consent|0|||
160917239|NCT01782495|581089543|FG004|Overall Study|Withdrew Consent|0|||
160917240|NCT01782495|581089544|FG005|Overall Study|Withdrew Consent|0|||
160917241|NCT01782495|581089545|FG006|Overall Study|Withdrew Consent|0|||
160917242|NCT01782495|581089546|FG007|Overall Study|Withdrew Consent|1|||
160917243|NCT01782495|581089547|FG008|Overall Study|Withdrew Consent|0|||
160917244|NCT01782495|581089548|FG009|Overall Study|Withdrew Consent|0|||
160917245|NCT01782495|581089549|FG010|Overall Study|Withdrew Consent|0|||
160917246|NCT01927367|581089550|FG000|Overall Study|Withdrawal by Subject|7|||
160917247|NCT01927367|581089551|FG001|Overall Study|Withdrawal by Subject|4|||
160917248|NCT01927367|581089550|FG000|Overall Study|No baseline data|0|||
160917249|NCT01927367|581089551|FG001|Overall Study|No baseline data|1|||
160917250|NCT00071513|581089554|FG000|Intervention Component|Withdrawal by Subject|2|||
160917251|NCT00071513|581089555|FG001|Intervention Component|Withdrawal by Subject|3|||
160917252|NCT00071513|581089554|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
160917253|NCT00071513|581089555|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
160917254|NCT02622321|581089556|FG000|Overall Study|Withdrawal by Subject|2|||
160571746|NCT00546819|579816817|FG000|Overall Study|Withdrawal by Subject|4|||
160571747|NCT00546819|579816818|FG001|Overall Study|Withdrawal by Subject|2|||
160917255|NCT02622321|581089557|FG001|Overall Study|Withdrawal by Subject|0|||
160917256|NCT02622321|581089558|FG002|Overall Study|Withdrawal by Subject|0|||
160917257|NCT02622321|581089559|FG003|Overall Study|Withdrawal by Subject|0|||
160917258|NCT02622321|581089556|FG000|Overall Study|Death|0|||
160917259|NCT02622321|581089557|FG001|Overall Study|Death|0|||
160917260|NCT02622321|581089558|FG002|Overall Study|Death|1|||
160917261|NCT02622321|581089559|FG003|Overall Study|Death|0|||
160917262|NCT02622321|581089556|FG000|Overall Study|Physician Decision|1|||
160917263|NCT02622321|581089557|FG001|Overall Study|Physician Decision|0|||
160917264|NCT02622321|581089558|FG002|Overall Study|Physician Decision|0|||
160917265|NCT02622321|581089559|FG003|Overall Study|Physician Decision|0|||
160917266|NCT00241280|581089560|FG000|Overall Study|Adverse Event|2|||
160917267|NCT00241280|581089561|FG001|Overall Study|Adverse Event|6|||
160917268|NCT00241280|581089560|FG000|Overall Study|Discomfort|11|||
160917269|NCT00241280|581089561|FG001|Overall Study|Discomfort|16|||
160917270|NCT00241280|581089560|FG000|Overall Study|Pregnancy|1|||
160917271|NCT00241280|581089561|FG001|Overall Study|Pregnancy|5|||
160917272|NCT00241280|581089560|FG000|Overall Study|Lost to Follow-up|5|||
160917273|NCT00241280|581089561|FG001|Overall Study|Lost to Follow-up|8|||
160917274|NCT00241280|581089560|FG000|Overall Study|Withdrawal by Subject|7|||
160917275|NCT00241280|581089561|FG001|Overall Study|Withdrawal by Subject|4|||
160917276|NCT00241280|581089560|FG000|Overall Study|Protocol Violation|4|||
160917277|NCT00241280|581089561|FG001|Overall Study|Protocol Violation|10|||
160917278|NCT00241280|581089560|FG000|Overall Study|Relocation|4|||
160917279|NCT00241280|581089561|FG001|Overall Study|Relocation|4|||
160917280|NCT00241280|581089560|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
160917281|NCT00241280|581089561|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
160917282|NCT00241280|581089560|FG000|Overall Study|Unsatisfactory Visual Response|1|||
160917283|NCT00241280|581089561|FG001|Overall Study|Unsatisfactory Visual Response|1|||
160917284|NCT00241280|581089560|FG000|Overall Study|Diabetic|1|||
160917285|NCT00241280|581089561|FG001|Overall Study|Diabetic|0|||
160917286|NCT00241280|581089560|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
160917287|NCT00241280|581089561|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
160917288|NCT00241280|581089560|FG000|Overall Study|Dispensed incorrect test article|1|||
160917289|NCT00241280|581089561|FG001|Overall Study|Dispensed incorrect test article|2|||
160917290|NCT00241280|581089560|FG000|Overall Study|Unacceptable Fit|0|||
160917291|NCT00241280|581089561|FG001|Overall Study|Unacceptable Fit|1|||
160917292|NCT00241280|581089560|FG000|Overall Study|Scheduling Conflict|0|||
160917293|NCT00241280|581089561|FG001|Overall Study|Scheduling Conflict|2|||
160917294|NCT00241280|581089560|FG000|Overall Study|History of Ocular Surgery|0|||
160917295|NCT00241280|581089561|FG001|Overall Study|History of Ocular Surgery|1|||
160917296|NCT00241280|581089560|FG000|Overall Study|Coating on Lens|1|||
160917297|NCT00241280|581089561|FG001|Overall Study|Coating on Lens|0|||
160917298|NCT00241280|581089560|FG000|Overall Study|Excessive Dryness|0|||
160917299|NCT00241280|581089561|FG001|Overall Study|Excessive Dryness|1|||
160917300|NCT01958008|581089562|FG000|Overall Study|Worsening of disease under study|0|||
160917301|NCT01958008|581089563|FG001|Overall Study|Worsening of disease under study|0|||
160917302|NCT01958008|581089564|FG002|Overall Study|Worsening of disease under study|1|||
160917303|NCT01958008|581089565|FG003|Overall Study|Worsening of disease under study|0|||
160917304|NCT01958008|581089562|FG000|Overall Study|Other adverse event|1|||
160917305|NCT01958008|581089563|FG001|Overall Study|Other adverse event|0|||
160917306|NCT01958008|581089564|FG002|Overall Study|Other adverse event|0|||
160917307|NCT01958008|581089565|FG003|Overall Study|Other adverse event|0|||
160917308|NCT01634360|581089566|FG000|Overall Study|Adverse Event|10|||
160917309|NCT01634360|581089567|FG001|Overall Study|Adverse Event|34|||
160917310|NCT01634360|581089566|FG000|Overall Study|subject withdrew consent|13|||
160917311|NCT01634360|581089567|FG001|Overall Study|subject withdrew consent|23|||
160917312|NCT01634360|581089566|FG000|Overall Study|Protocol Violation|1|||
160917313|NCT01634360|581089567|FG001|Overall Study|Protocol Violation|1|||
160917314|NCT01634360|581089566|FG000|Overall Study|Lack of Efficacy|4|||
160917315|NCT01634360|581089567|FG001|Overall Study|Lack of Efficacy|14|||
160917316|NCT01634360|581089566|FG000|Overall Study|Other|3|||
160917317|NCT01634360|581089567|FG001|Overall Study|Other|20|||
160917318|NCT01634360|581089566|FG000|Overall Study|Study termination by sponsor|18|||
160917319|NCT01634360|581089567|FG001|Overall Study|Study termination by sponsor|44|||
160917320|NCT01414855|581089568|FG000|Overall Study|Death|17|||
160917321|NCT01414855|581089568|FG000|Overall Study|Lost to Follow-up|5|||
160917322|NCT01414855|581089568|FG000|Overall Study|Withdrawal by Subject|7|||
160917323|NCT02743871|581089569|FG000|Overall Study|Lost to Follow-up|0|||
160917324|NCT02743871|581089570|FG001|Overall Study|Lost to Follow-up|0|||
160917325|NCT02743871|581089571|FG002|Overall Study|Lost to Follow-up|0|||
160917326|NCT02743871|581089572|FG003|Overall Study|Lost to Follow-up|1|||
160917327|NCT02743871|581089573|FG004|Overall Study|Lost to Follow-up|0|||
160917328|NCT02743871|581089574|FG005|Overall Study|Lost to Follow-up|0|||
160917329|NCT02743871|581089575|FG006|Overall Study|Lost to Follow-up|1|||
160917330|NCT02743871|581089576|FG007|Overall Study|Lost to Follow-up|0|||
160917331|NCT02743871|581089577|FG008|Overall Study|Lost to Follow-up|0|||
160917332|NCT02743871|581089578|FG009|Overall Study|Lost to Follow-up|0|||
160917333|NCT02743871|581089579|FG010|Overall Study|Lost to Follow-up|0|||
160917334|NCT02743871|581089580|FG011|Overall Study|Lost to Follow-up|2|||
160917335|NCT02743871|581089581|FG012|Overall Study|Lost to Follow-up|0|||
160917336|NCT02743871|581089582|FG013|Overall Study|Lost to Follow-up|0|||
160917337|NCT02743871|581089569|FG000|Overall Study|Withdrawal by Subject|0|||
160571748|NCT03849560|579816819|FG000|Overall Study|Withdrawal by Subject|1|||
160917338|NCT02743871|581089570|FG001|Overall Study|Withdrawal by Subject|0|||
160917339|NCT02743871|581089571|FG002|Overall Study|Withdrawal by Subject|0|||
160917340|NCT02743871|581089572|FG003|Overall Study|Withdrawal by Subject|0|||
160917341|NCT02743871|581089573|FG004|Overall Study|Withdrawal by Subject|0|||
160917342|NCT02743871|581089574|FG005|Overall Study|Withdrawal by Subject|0|||
160917343|NCT02743871|581089575|FG006|Overall Study|Withdrawal by Subject|0|||
160917344|NCT02743871|581089576|FG007|Overall Study|Withdrawal by Subject|0|||
160917345|NCT02743871|581089577|FG008|Overall Study|Withdrawal by Subject|0|||
160917346|NCT02743871|581089578|FG009|Overall Study|Withdrawal by Subject|0|||
160917347|NCT02743871|581089579|FG010|Overall Study|Withdrawal by Subject|1|||
160917348|NCT02743871|581089580|FG011|Overall Study|Withdrawal by Subject|0|||
160917349|NCT02743871|581089581|FG012|Overall Study|Withdrawal by Subject|12|||
160917350|NCT02743871|581089582|FG013|Overall Study|Withdrawal by Subject|6|||
160917351|NCT02743871|581089569|FG000|Overall Study|Adverse Event|1|||
160917352|NCT02743871|581089570|FG001|Overall Study|Adverse Event|0|||
160917353|NCT02743871|581089571|FG002|Overall Study|Adverse Event|0|||
160917354|NCT02743871|581089572|FG003|Overall Study|Adverse Event|0|||
160917355|NCT02743871|581089573|FG004|Overall Study|Adverse Event|0|||
160917356|NCT02743871|581089574|FG005|Overall Study|Adverse Event|0|||
160917357|NCT02743871|581089575|FG006|Overall Study|Adverse Event|0|||
160917358|NCT02743871|581089576|FG007|Overall Study|Adverse Event|0|||
160917359|NCT02743871|581089577|FG008|Overall Study|Adverse Event|0|||
160917360|NCT02743871|581089578|FG009|Overall Study|Adverse Event|0|||
160917361|NCT02743871|581089579|FG010|Overall Study|Adverse Event|0|||
160917362|NCT02743871|581089580|FG011|Overall Study|Adverse Event|0|||
160917363|NCT02743871|581089581|FG012|Overall Study|Adverse Event|0|||
160917364|NCT02743871|581089582|FG013|Overall Study|Adverse Event|0|||
160917365|NCT02743871|581089569|FG000|Overall Study|Other|0|||
160917366|NCT02743871|581089570|FG001|Overall Study|Other|0|||
160917367|NCT02743871|581089571|FG002|Overall Study|Other|0|||
160917368|NCT02743871|581089572|FG003|Overall Study|Other|0|||
160917369|NCT02743871|581089573|FG004|Overall Study|Other|0|||
160917370|NCT02743871|581089574|FG005|Overall Study|Other|0|||
160917371|NCT02743871|581089575|FG006|Overall Study|Other|0|||
160917372|NCT02743871|581089576|FG007|Overall Study|Other|0|||
160917373|NCT02743871|581089577|FG008|Overall Study|Other|0|||
160917374|NCT02743871|581089578|FG009|Overall Study|Other|0|||
160917375|NCT02743871|581089579|FG010|Overall Study|Other|0|||
160917376|NCT02743871|581089580|FG011|Overall Study|Other|1|||
160917377|NCT02743871|581089581|FG012|Overall Study|Other|1|||
160917378|NCT02743871|581089582|FG013|Overall Study|Other|1|||
160917379|NCT02743871|581089569|FG000|Overall Study|Protocol Violation|0|||
160917380|NCT02743871|581089570|FG001|Overall Study|Protocol Violation|0|||
160917381|NCT02743871|581089571|FG002|Overall Study|Protocol Violation|0|||
160917382|NCT02743871|581089572|FG003|Overall Study|Protocol Violation|0|||
160917383|NCT02743871|581089573|FG004|Overall Study|Protocol Violation|0|||
160917384|NCT02743871|581089574|FG005|Overall Study|Protocol Violation|0|||
160917385|NCT02743871|581089575|FG006|Overall Study|Protocol Violation|0|||
160917386|NCT02743871|581089576|FG007|Overall Study|Protocol Violation|0|||
160917387|NCT02743871|581089577|FG008|Overall Study|Protocol Violation|0|||
160917388|NCT02743871|581089578|FG009|Overall Study|Protocol Violation|0|||
160917389|NCT02743871|581089579|FG010|Overall Study|Protocol Violation|0|||
160917390|NCT02743871|581089580|FG011|Overall Study|Protocol Violation|0|||
160917391|NCT02743871|581089581|FG012|Overall Study|Protocol Violation|2|||
160917392|NCT02743871|581089582|FG013|Overall Study|Protocol Violation|0|||
160917393|NCT04779489|581091610|FG000|Overall Study|Physician Decision|1|||
160917394|NCT05126901|581091611|FG000|Overall Study|Withdrawal by Subject|1|||
160917395|NCT05126901|581091612|FG001|Overall Study|Withdrawal by Subject|1|||
160917396|NCT05126901|581091613|FG002|Overall Study|Withdrawal by Subject|4|||
160917397|NCT05126901|581091611|FG000|Overall Study|Adverse Event|0|||
160917398|NCT05126901|581091612|FG001|Overall Study|Adverse Event|0|||
160917399|NCT05126901|581091613|FG002|Overall Study|Adverse Event|1|||
160917400|NCT05126901|581091611|FG000|Overall Study|Lost to Follow-up|0|||
160917401|NCT05126901|581091612|FG001|Overall Study|Lost to Follow-up|2|||
160571749|NCT03849560|579816820|FG001|Overall Study|Withdrawal by Subject|0|||
160571750|NCT03849560|579816821|FG002|Overall Study|Withdrawal by Subject|0|||
160917402|NCT05126901|581091613|FG002|Overall Study|Lost to Follow-up|0|||
160917403|NCT00254540|581091614|FG000|Overall Study|Adverse Event|6|||
160917404|NCT00254540|581091615|FG001|Overall Study|Adverse Event|7|||
160917405|NCT00254540|581091614|FG000|Overall Study|Lack of Efficacy|13|||
160917406|NCT00254540|581091615|FG001|Overall Study|Lack of Efficacy|13|||
160917407|NCT00254540|581091614|FG000|Overall Study|Death|0|||
160917408|NCT00254540|581091615|FG001|Overall Study|Death|1|||
160917409|NCT00254540|581091614|FG000|Overall Study|Laboratory Test Abnormality|0|||
160917410|NCT00254540|581091615|FG001|Overall Study|Laboratory Test Abnormality|1|||
160917411|NCT00710710|581091616|FG000|Overall Study|Consent withdrawn|2|||
160917412|NCT00710710|581091617|FG001|Overall Study|Consent withdrawn|2|||
160652968|NCT01766921|580110425|FG000|Overall Study|Withdrawal by Subject|14|||
160652969|NCT01766921|580110426|FG001|Overall Study|Withdrawal by Subject|5|||
160652970|NCT01901055|580110429|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
160652971|NCT01901055|580110430|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
160652972|NCT01901055|580110429|FG000|Randomization But Not Titrated|Physician Decision|0|||
160652973|NCT01901055|580110430|FG001|Randomization But Not Titrated|Physician Decision|1|||
160652974|NCT01901055|580110429|FG000|Started Protocol to Week 6|Physician Decision|2|||
160652975|NCT01901055|580110430|FG001|Started Protocol to Week 6|Physician Decision|1|||
160652976|NCT01901055|580110429|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
160652977|NCT01901055|580110430|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
160652978|NCT01901055|580110429|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
160652979|NCT01901055|580110430|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
160652980|NCT01901055|580110429|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
160652981|NCT01901055|580110430|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
160652982|NCT01901055|580110429|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
160652983|NCT01901055|580110430|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
160652984|NCT01901055|580110429|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
160652985|NCT01901055|580110430|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
160652986|NCT01901055|580110429|FG000|Week 24|Withdrawal by Subject|13|||
160652987|NCT01901055|580110430|FG001|Week 24|Withdrawal by Subject|19|||
160652988|NCT01901055|580110429|FG000|Week 24|Physician Decision|1|||
160652989|NCT01901055|580110430|FG001|Week 24|Physician Decision|0|||
160652990|NCT01901055|580110429|FG000|Week 36|Withdrawal by Subject|0|||
160652991|NCT01901055|580110430|FG001|Week 36|Withdrawal by Subject|5|||
160652992|NCT03019965|580110433|FG000|Overall Study|Withdrawal by Subject|1|||
160652993|NCT03019965|580110434|FG001|Overall Study|Withdrawal by Subject|0|||
160652994|NCT03019965|580110433|FG000|Overall Study|Protocol Violation|1|||
160652995|NCT03019965|580110434|FG001|Overall Study|Protocol Violation|3|||
160652996|NCT03019965|580110433|FG000|Overall Study|viral or fungal infection|3|||
160652997|NCT03019965|580110434|FG001|Overall Study|viral or fungal infection|4|||
160652998|NCT03019965|580110433|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
160652999|NCT03019965|580110434|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
160653000|NCT03019965|580110433|FG000|Overall Study|Physician Decision|1|||
160653001|NCT03019965|580110434|FG001|Overall Study|Physician Decision|1|||
160653002|NCT01513148|580110440|FG000|Overall Study|Protocol Violation|2|||
160653003|NCT01513148|580110441|FG001|Overall Study|Protocol Violation|2|||
160653004|NCT03552757|580110442|FG000|Overall Study|Withdrawal by Subject|10|||
160653005|NCT03552757|580110443|FG001|Overall Study|Withdrawal by Subject|5|||
160653006|NCT03552757|580110444|FG002|Overall Study|Withdrawal by Subject|12|||
160653007|NCT03552757|580110442|FG000|Overall Study|Lost to Follow-up|2|||
160653008|NCT03552757|580110443|FG001|Overall Study|Lost to Follow-up|7|||
160653009|NCT03552757|580110444|FG002|Overall Study|Lost to Follow-up|7|||
160653010|NCT03552757|580110442|FG000|Overall Study|Death|1|||
160653011|NCT03552757|580110443|FG001|Overall Study|Death|1|||
160653012|NCT03552757|580110444|FG002|Overall Study|Death|1|||
160653013|NCT02192099|580110447|FG000|Overall Study|Adverse Event|1|||
160653014|NCT02192099|580110447|FG000|Overall Study|Lost to Follow-up|2|||
160653015|NCT02192099|580110447|FG000|Overall Study|Physician Decision|1|||
160653016|NCT02192099|580110447|FG000|Overall Study|Pregnancy|1|||
160653017|NCT02192099|580110447|FG000|Overall Study|Protocol Violation|8|||
160653018|NCT02192099|580110447|FG000|Overall Study|Study Terminated by Sponsor|32|||
160653019|NCT02192099|580110447|FG000|Overall Study|Withdrawal by Subject|11|||
160653020|NCT02192099|580110447|FG000|Overall Study|Miscellaneous Reasons|5|||
160653021|NCT01862328|580110452|FG000|Overall Study|Progressive Disease|3|||
160653022|NCT01862328|580110453|FG001|Overall Study|Progressive Disease|11|||
160653023|NCT01862328|580110454|FG002|Overall Study|Progressive Disease|5|||
160653024|NCT01862328|580110455|FG003|Overall Study|Progressive Disease|6|||
160653025|NCT01862328|580110456|FG004|Overall Study|Progressive Disease|7|||
160653026|NCT01862328|580110457|FG005|Overall Study|Progressive Disease|4|||
160653027|NCT01862328|580110458|FG006|Overall Study|Progressive Disease|3|||
160653028|NCT01862328|580110452|FG000|Overall Study|Adverse Event|0|||
160653029|NCT01862328|580110453|FG001|Overall Study|Adverse Event|4|||
160653030|NCT01862328|580110454|FG002|Overall Study|Adverse Event|0|||
160653031|NCT01862328|580110455|FG003|Overall Study|Adverse Event|1|||
160653032|NCT01862328|580110456|FG004|Overall Study|Adverse Event|0|||
160653033|NCT01862328|580110457|FG005|Overall Study|Adverse Event|2|||
160653034|NCT01862328|580110458|FG006|Overall Study|Adverse Event|4|||
160861742|NCT00459316|580887827|FG000|Steps 1 & 2|Other eligibility failure|1|||
160453914|NCT03952338|579393964|FG001|Overall Study|Lost to Follow-up|17|||
160653035|NCT01862328|580110452|FG000|Overall Study|Other|0|||
160653036|NCT01862328|580110453|FG001|Overall Study|Other|2|||
160653037|NCT01862328|580110454|FG002|Overall Study|Other|1|||
160653038|NCT01862328|580110455|FG003|Overall Study|Other|0|||
160653039|NCT01862328|580110456|FG004|Overall Study|Other|4|||
160653040|NCT01862328|580110457|FG005|Overall Study|Other|0|||
160917413|NCT00710710|581091616|FG000|Overall Study|Protocol Violation|0|||
160917414|NCT00710710|581091617|FG001|Overall Study|Protocol Violation|1|||
160917415|NCT00710710|581091616|FG000|Overall Study|Adverse Event|3|||
160917416|NCT00710710|581091617|FG001|Overall Study|Adverse Event|3|||
160917417|NCT00710710|581091616|FG000|Overall Study|Progressive disease|40|||
160917418|NCT00710710|581091617|FG001|Overall Study|Progressive disease|38|||
160917419|NCT01313767|581091618|FG000|Overall Study|Adverse Event|1|||
160917420|NCT01313767|581091619|FG001|Overall Study|Adverse Event|0|||
160917421|NCT01313767|581091618|FG000|Overall Study|Lost to Follow-up|1|||
160917422|NCT01313767|581091619|FG001|Overall Study|Lost to Follow-up|0|||
160917423|NCT01313767|581091618|FG000|Overall Study|Withdrawal by Subject|2|||
160917424|NCT01313767|581091619|FG001|Overall Study|Withdrawal by Subject|1|||
160917425|NCT01313767|581091618|FG000|Overall Study|Protocol Violation|3|||
160917426|NCT01313767|581091619|FG001|Overall Study|Protocol Violation|1|||
160917427|NCT01529346|581091620|FG000|Overall Study|Lost to Follow-up|2|||
160917428|NCT01529346|581091621|FG001|Overall Study|Lost to Follow-up|0|||
160917429|NCT01529346|581091622|FG002|Overall Study|Lost to Follow-up|1|||
160453915|NCT03952338|579393963|FG000|Overall Study|Withdrawal by Subject|1|||
160453916|NCT03952338|579393964|FG001|Overall Study|Withdrawal by Subject|1|||
160917430|NCT01529346|581091623|FG003|Overall Study|Lost to Follow-up|0|||
160917431|NCT01529346|581091624|FG004|Overall Study|Lost to Follow-up|0|||
160917432|NCT01529346|581091620|FG000|Overall Study|Other|0|||
160917433|NCT01529346|581091621|FG001|Overall Study|Other|1|||
160917434|NCT01529346|581091622|FG002|Overall Study|Other|1|||
160917435|NCT01529346|581091623|FG003|Overall Study|Other|0|||
160917436|NCT01529346|581091624|FG004|Overall Study|Other|0|||
160917437|NCT01287897|581091625|FG000|Overall Study|Adverse Event|5|||
160917438|NCT01287897|581091626|FG001|Overall Study|Adverse Event|3|||
160917439|NCT01287897|581091627|FG002|Overall Study|Adverse Event|6|||
160917440|NCT01287897|581091628|FG003|Overall Study|Adverse Event|4|||
160917441|NCT01287897|581091625|FG000|Overall Study|Lack of Efficacy|2|||
160917442|NCT01287897|581091626|FG001|Overall Study|Lack of Efficacy|0|||
160917443|NCT01287897|581091627|FG002|Overall Study|Lack of Efficacy|0|||
160917444|NCT01287897|581091628|FG003|Overall Study|Lack of Efficacy|0|||
160917445|NCT01287897|581091625|FG000|Overall Study|Protocol Violation|1|||
160917446|NCT01287897|581091626|FG001|Overall Study|Protocol Violation|1|||
160917447|NCT01287897|581091627|FG002|Overall Study|Protocol Violation|0|||
160917448|NCT01287897|581091628|FG003|Overall Study|Protocol Violation|1|||
160917449|NCT01287897|581091625|FG000|Overall Study|Lost to Follow-up|0|||
160917450|NCT01287897|581091626|FG001|Overall Study|Lost to Follow-up|0|||
160861743|NCT00459316|580887828|FG001|Steps 1 & 2|Other eligibility failure|1|||
160861744|NCT00459316|580887829|FG002|Steps 1 & 2|Other eligibility failure|0|||
160861745|NCT00459316|580887827|FG000|Steps 1 & 2|Death|1|||
160861746|NCT00459316|580887828|FG001|Steps 1 & 2|Death|1|||
160861747|NCT00459316|580887829|FG002|Steps 1 & 2|Death|0|||
160861748|NCT00459316|580887827|FG000|Steps 1 & 2|Not able to get to clinic|7|||
160861749|NCT00459316|580887828|FG001|Steps 1 & 2|Not able to get to clinic|4|||
160861750|NCT00459316|580887829|FG002|Steps 1 & 2|Not able to get to clinic|0|||
160861751|NCT00459316|580887827|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
160861752|NCT00459316|580887828|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
160861753|NCT00459316|580887829|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
160861754|NCT00459316|580887827|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
160861755|NCT00459316|580887828|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
160861756|NCT00459316|580887829|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
160861757|NCT00459316|580887827|FG000|Steps 1 & 2|Lost to Follow-up|5|||
160861758|NCT00459316|580887828|FG001|Steps 1 & 2|Lost to Follow-up|0|||
160861759|NCT00459316|580887829|FG002|Steps 1 & 2|Lost to Follow-up|2|||
160861760|NCT00459316|580887827|FG000|Step 3|Withdrawal by Subject|3|||
160861761|NCT00459316|580887828|FG001|Step 3|Withdrawal by Subject|0|||
160861762|NCT00459316|580887829|FG002|Step 3|Withdrawal by Subject|1|||
160861763|NCT01614886|580887830|FG000|Overall Study|Adverse Event|15|||
160861764|NCT01614886|580887831|FG001|Overall Study|Adverse Event|20|||
160861765|NCT01614886|580887830|FG000|Overall Study|Withdrawal by Subject|4|||
160861766|NCT01614886|580887831|FG001|Overall Study|Withdrawal by Subject|4|||
160861767|NCT01614886|580887830|FG000|Overall Study|Death|1|||
160861768|NCT01614886|580887831|FG001|Overall Study|Death|0|||
160861769|NCT01614886|580887830|FG000|Overall Study|Protocol deviation|0|||
160861770|NCT01614886|580887831|FG001|Overall Study|Protocol deviation|2|||
160861771|NCT04004988|580887834|FG000|Period 1|Physician Decision|2|||
160861772|NCT04004988|580887835|FG001|Period 1|Physician Decision|0|||
160861773|NCT04004988|580887834|FG000|Period 1|Withdrawal by Subject|0|||
160861774|NCT04004988|580887835|FG001|Period 1|Withdrawal by Subject|1|||
160861775|NCT04004988|580887834|FG000|Period 1|Adverse Event|1|||
160861776|NCT04004988|580887835|FG001|Period 1|Adverse Event|2|||
160861777|NCT03873116|580887836|FG000|Part 1|Study drug discontinuation due to rash|0|||
160861778|NCT03873116|580887837|FG001|Part 1|Study drug discontinuation due to rash|0|||
160861779|NCT03873116|580887838|FG002|Part 1|Study drug discontinuation due to rash|0|||
160861780|NCT03873116|580887839|FG003|Part 1|Study drug discontinuation due to rash|0|||
160861781|NCT03873116|580887840|FG004|Part 1|Study drug discontinuation due to rash|0|||
160996350|NCT03944512|581372194|FG000|Overall Study|Death|0|||
160996351|NCT03944512|581372195|FG001|Overall Study|Death|0|||
160996352|NCT03944512|581372196|FG002|Overall Study|Death|1|||
160996353|NCT03944512|581372197|FG003|Overall Study|Death|2|||
160996354|NCT03944512|581372194|FG000|Overall Study|Lost to Follow-up|0|||
160996355|NCT03944512|581372195|FG001|Overall Study|Lost to Follow-up|0|||
160996356|NCT03944512|581372196|FG002|Overall Study|Lost to Follow-up|4|||
160996357|NCT03944512|581372197|FG003|Overall Study|Lost to Follow-up|4|||
160996358|NCT03944512|581372194|FG000|Overall Study|refused follow-up|0|||
160996359|NCT03944512|581372195|FG001|Overall Study|refused follow-up|0|||
160996360|NCT03944512|581372196|FG002|Overall Study|refused follow-up|2|||
160996361|NCT03944512|581372197|FG003|Overall Study|refused follow-up|2|||
160996362|NCT02380742|581373577|FG000|Overall Study|Withdrawal by Subject|1|||
160996363|NCT02380742|581373578|FG001|Overall Study|Withdrawal by Subject|0|||
160996364|NCT01185522|581373579|FG000|Overall Study|Lack of Efficacy|28|||
160996365|NCT01185522|581373579|FG000|Overall Study|Lost to Follow-up|19|||
160996366|NCT01185522|581373579|FG000|Overall Study|Withdrawal by Subject|10|||
160917451|NCT01287897|581091627|FG002|Overall Study|Lost to Follow-up|2|||
160917452|NCT01287897|581091628|FG003|Overall Study|Lost to Follow-up|0|||
160917453|NCT01287897|581091625|FG000|Overall Study|Withdrawal by Subject|1|||
160917454|NCT01287897|581091626|FG001|Overall Study|Withdrawal by Subject|5|||
160917455|NCT01287897|581091627|FG002|Overall Study|Withdrawal by Subject|3|||
160917456|NCT01287897|581091628|FG003|Overall Study|Withdrawal by Subject|2|||
160917457|NCT01287897|581091625|FG000|Overall Study|Not consented properly|0|||
160917458|NCT01287897|581091626|FG001|Overall Study|Not consented properly|1|||
160917459|NCT01287897|581091627|FG002|Overall Study|Not consented properly|0|||
160917460|NCT01287897|581091628|FG003|Overall Study|Not consented properly|0|||
160917461|NCT01287897|581091625|FG000|Overall Study|Not meeting entrance criteria|1|||
160917462|NCT01287897|581091626|FG001|Overall Study|Not meeting entrance criteria|1|||
160917463|NCT01287897|581091627|FG002|Overall Study|Not meeting entrance criteria|0|||
160917464|NCT01287897|581091628|FG003|Overall Study|Not meeting entrance criteria|0|||
160917465|NCT01287897|581091625|FG000|Overall Study|Other|1|||
160917466|NCT01287897|581091626|FG001|Overall Study|Other|0|||
160917467|NCT01287897|581091627|FG002|Overall Study|Other|1|||
160917468|NCT01287897|581091628|FG003|Overall Study|Other|0|||
160917469|NCT00386776|581091635|FG000|Overall Study|Withdrawal by Subject|8|||
160917470|NCT02282020|581091636|FG000|Overall Study|Objective Disease Progression|128|||
160917471|NCT02282020|581091637|FG001|Overall Study|Objective Disease Progression|30|||
160917472|NCT02282020|581091636|FG000|Overall Study|Adverse Event|18|||
160917473|NCT02282020|581091637|FG001|Overall Study|Adverse Event|15|||
160917474|NCT02282020|581091636|FG000|Overall Study|Withdrawal by Subject|7|||
160917475|NCT02282020|581091637|FG001|Overall Study|Withdrawal by Subject|10|||
160917476|NCT02282020|581091636|FG000|Overall Study|Miscellaneous|5|||
160917477|NCT02282020|581091637|FG001|Overall Study|Miscellaneous|19|||
160917478|NCT02282020|581091636|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
160917479|NCT02282020|581091637|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
160917480|NCT02282020|581091636|FG000|Overall Study|Developed Discontinuation Criteria|0|||
160917481|NCT02282020|581091637|FG001|Overall Study|Developed Discontinuation Criteria|2|||
160917482|NCT02282020|581091636|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
160917483|NCT02282020|581091637|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
160917484|NCT00249444|581091638|FG000|Overall Study|Lost to Follow-up|2|||
160917485|NCT00249444|581091639|FG001|Overall Study|Lost to Follow-up|2|||
160917486|NCT00249444|581091638|FG000|Overall Study|non-compliant|9|||
160917487|NCT00249444|581091639|FG001|Overall Study|non-compliant|11|||
160917488|NCT00249444|581091638|FG000|Overall Study|Adverse Event|1|||
160917489|NCT00249444|581091639|FG001|Overall Study|Adverse Event|1|||
160917490|NCT00249444|581091638|FG000|Overall Study|life event|0|||
160917491|NCT00249444|581091639|FG001|Overall Study|life event|1|||
160996367|NCT01185522|581373579|FG000|Overall Study|Poor tolerance|39|||
160917492|NCT00232817|581091640|FG000|Overall Study|Protocol Violation|2|||
160917493|NCT00232817|581091641|FG001|Overall Study|Protocol Violation|1|||
160917494|NCT05492942|581091642|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
160917495|NCT05492942|581091643|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
160917496|NCT05492942|581091644|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
160917497|NCT05492942|581091645|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
160917498|NCT00311623|581091646|FG000|Overall Study|Physician Decision|0|||
160917499|NCT00311623|581091647|FG001|Overall Study|Physician Decision|0|||
160996368|NCT01185522|581373579|FG000|Overall Study|Other reasons|12|||
160917500|NCT00311623|581091648|FG002|Overall Study|Physician Decision|2|||
160917501|NCT03103919|581091649|FG000|Overall Study|Adverse Event|2|||
160996369|NCT01729819|581373580|FG000|Overall Study|Adverse Event|2|||
160996370|NCT01729819|581373581|FG001|Overall Study|Adverse Event|4|||
160996371|NCT01729819|581373580|FG000|Overall Study|Lack of Efficacy|1|||
160996372|NCT01729819|581373581|FG001|Overall Study|Lack of Efficacy|0|||
160996373|NCT01729819|581373580|FG000|Overall Study|Lost to Follow-up|2|||
160996374|NCT01729819|581373581|FG001|Overall Study|Lost to Follow-up|0|||
160653041|NCT01862328|580110458|FG006|Overall Study|Other|1|||
160653042|NCT01862328|580110452|FG000|Overall Study|Withdrawal by Subject|1|||
160653043|NCT01862328|580110453|FG001|Overall Study|Withdrawal by Subject|1|||
160653044|NCT01862328|580110454|FG002|Overall Study|Withdrawal by Subject|0|||
160653045|NCT01862328|580110455|FG003|Overall Study|Withdrawal by Subject|0|||
160653046|NCT01862328|580110456|FG004|Overall Study|Withdrawal by Subject|1|||
160653047|NCT01862328|580110457|FG005|Overall Study|Withdrawal by Subject|1|||
160653048|NCT01862328|580110458|FG006|Overall Study|Withdrawal by Subject|1|||
160653049|NCT01862328|580110452|FG000|Overall Study|Symptomatic Deterioration|0|||
160653050|NCT01862328|580110453|FG001|Overall Study|Symptomatic Deterioration|0|||
160653051|NCT01862328|580110454|FG002|Overall Study|Symptomatic Deterioration|0|||
160653052|NCT01862328|580110455|FG003|Overall Study|Symptomatic Deterioration|0|||
160653053|NCT01862328|580110456|FG004|Overall Study|Symptomatic Deterioration|0|||
160653054|NCT01862328|580110457|FG005|Overall Study|Symptomatic Deterioration|0|||
160653055|NCT01862328|580110458|FG006|Overall Study|Symptomatic Deterioration|1|||
160653056|NCT00936975|580110459|FG000|Overall Study|Withdrawal by Subject|1|||
160653057|NCT00936975|580110459|FG000|Overall Study|Disease progression|3|||
160653058|NCT00936975|580110459|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
160653059|NCT01656889|580110463|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
160653060|NCT01656889|580110464|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
160653061|NCT01656889|580110463|FG000|Treatment Period, 12 Weeks|Death|0|||
160653062|NCT01656889|580110464|FG001|Treatment Period, 12 Weeks|Death|1|||
160653063|NCT01656889|580110463|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
160653064|NCT01656889|580110464|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
160917502|NCT03103919|581091650|FG001|Overall Study|Adverse Event|2|||
160917503|NCT00810407|581091651|FG000|Overall Study|Protocol Violation|3|||
160917504|NCT00810407|581091651|FG000|Overall Study|No Visit After First Day of Treatment|3|||
160917505|NCT02875860|581091653|FG000|Overall Study|Withdrawal by Subject|0|||
160917506|NCT02875860|581091654|FG001|Overall Study|Withdrawal by Subject|1|||
160917507|NCT02746874|581091655|FG000|Overall Study|Withdrawal by Subject|0|||
160917508|NCT02746874|581091656|FG001|Overall Study|Withdrawal by Subject|1|||
160917509|NCT02746874|581091655|FG000|Overall Study|Surgery Date Changed|0|||
160917510|NCT02746874|581091656|FG001|Overall Study|Surgery Date Changed|2|||
160917511|NCT01881776|581091657|FG000|Overall Study|Lost to Follow-up|1|||
160917512|NCT01881776|581091658|FG001|Overall Study|Lost to Follow-up|2|||
160917513|NCT01881776|581091659|FG002|Overall Study|Lost to Follow-up|1|||
160917514|NCT01881776|581091657|FG000|Overall Study|Protocol Violation|0|||
160917515|NCT01881776|581091658|FG001|Overall Study|Protocol Violation|2|||
160917516|NCT01881776|581091659|FG002|Overall Study|Protocol Violation|1|||
160917517|NCT01156311|581091663|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
160917518|NCT01156311|581091664|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
160917519|NCT01156311|581091665|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
160453917|NCT03952338|579393963|FG000|Overall Study|Protocol Violation|1|||
160917520|NCT01156311|581091666|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
160917521|NCT01156311|581091663|FG000|2-Month Monotherapy Period|Physician Decision|0|||
160917522|NCT01156311|581091664|FG001|2-Month Monotherapy Period|Physician Decision|1|||
160917523|NCT01156311|581091665|FG002|2-Month Monotherapy Period|Physician Decision|0|||
160917524|NCT01156311|581091666|FG003|2-Month Monotherapy Period|Physician Decision|0|||
160917525|NCT01156311|581091663|FG000|2-Month Monotherapy Period|Other|1|||
160917526|NCT01156311|581091664|FG001|2-Month Monotherapy Period|Other|0|||
160917527|NCT01156311|581091665|FG002|2-Month Monotherapy Period|Other|0|||
160917528|NCT01156311|581091666|FG003|2-Month Monotherapy Period|Other|0|||
160917529|NCT01156311|581091663|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
160917530|NCT01156311|581091664|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
160917531|NCT01156311|581091665|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
160917532|NCT01156311|581091666|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
160917533|NCT01156311|581091663|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
160917534|NCT01156311|581091664|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
160917535|NCT01156311|581091665|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
160917536|NCT01156311|581091666|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
160453918|NCT03952338|579393964|FG001|Overall Study|Protocol Violation|0|||
160653065|NCT01656889|580110463|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
160653066|NCT01656889|580110464|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
160917537|NCT01156311|581091663|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
160917538|NCT01156311|581091664|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
160917539|NCT01156311|581091665|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
160917540|NCT01156311|581091666|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
160653067|NCT01656889|580110463|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
160917541|NCT01156311|581091663|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
160917542|NCT01156311|581091664|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
160653068|NCT01656889|580110464|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
160653069|NCT01656889|580110463|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
160653070|NCT01656889|580110464|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
160653071|NCT01656889|580110463|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
160453919|NCT03710603|579393965|FG000|Overall Study|Adverse Event|1|||
160453920|NCT03710603|579393966|FG001|Overall Study|Adverse Event|0|||
160861782|NCT03873116|580887841|FG005|Part 1|Study drug discontinuation due to rash|1|||
160861783|NCT03873116|580887836|FG000|Part 2|Withdrawal by Subject|0|||
160861784|NCT03873116|580887837|FG001|Part 2|Withdrawal by Subject|0|||
160861785|NCT03873116|580887838|FG002|Part 2|Withdrawal by Subject|1|||
160861786|NCT03873116|580887839|FG003|Part 2|Withdrawal by Subject|0|||
160861787|NCT03873116|580887840|FG004|Part 2|Withdrawal by Subject|0|||
160861788|NCT03873116|580887841|FG005|Part 2|Withdrawal by Subject|0|||
160861789|NCT03873116|580887836|FG000|Part 2|Lab abnormality or AE|0|||
160861790|NCT03873116|580887837|FG001|Part 2|Lab abnormality or AE|0|||
160861791|NCT03873116|580887838|FG002|Part 2|Lab abnormality or AE|0|||
160861792|NCT03873116|580887839|FG003|Part 2|Lab abnormality or AE|0|||
160861793|NCT03873116|580887840|FG004|Part 2|Lab abnormality or AE|1|||
160861794|NCT03873116|580887841|FG005|Part 2|Lab abnormality or AE|0|||
160861795|NCT03873116|580887836|FG000|Part 3|Withdrawal by Subject|0|||
160861796|NCT03873116|580887837|FG001|Part 3|Withdrawal by Subject|0|||
160861797|NCT03873116|580887838|FG002|Part 3|Withdrawal by Subject|0|||
160861798|NCT03873116|580887839|FG003|Part 3|Withdrawal by Subject|0|||
160861799|NCT03873116|580887840|FG004|Part 3|Withdrawal by Subject|1|||
160861800|NCT03873116|580887841|FG005|Part 3|Withdrawal by Subject|0|||
160861801|NCT04682366|580887842|FG000|Overall Study|Lost to Follow-up|1|||
160861802|NCT04682366|580887843|FG001|Overall Study|Lost to Follow-up|1|||
160861803|NCT03125395|580887844|FG000|Overall Study|Adverse Event|2|||
160861804|NCT03125395|580887844|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
160861805|NCT03125395|580887844|FG000|Overall Study|Physician Decision|2|||
160861806|NCT03125395|580887844|FG000|Overall Study|Commercial drug is available|5|||
160861807|NCT02531802|580887845|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
160861808|NCT02531802|580887846|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
160861809|NCT02531802|580887847|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
160861810|NCT02531802|580887848|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
160861811|NCT02531802|580887849|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
160861812|NCT02531802|580887850|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
160861813|NCT02531802|580887851|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
160861814|NCT02531802|580887852|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
160861815|NCT02531802|580887853|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
160861816|NCT02531802|580887854|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
160861817|NCT02531802|580887855|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
160861818|NCT02531802|580887856|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
160861819|NCT02531802|580887857|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
160861820|NCT02531802|580887858|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
160861821|NCT02531802|580887859|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
160861822|NCT02531802|580887860|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
160861823|NCT02531802|580887861|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
160861824|NCT02531802|580887862|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
160861825|NCT02531802|580887863|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
160861826|NCT02531802|580887864|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
160861827|NCT02531802|580887865|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
160861828|NCT02531802|580887845|FG000|Received Vaccination 2|Physician Decision|0|||
160861829|NCT02531802|580887846|FG001|Received Vaccination 2|Physician Decision|0|||
160861830|NCT02531802|580887847|FG002|Received Vaccination 2|Physician Decision|0|||
160861831|NCT02531802|580887848|FG003|Received Vaccination 2|Physician Decision|0|||
160861832|NCT02531802|580887849|FG004|Received Vaccination 2|Physician Decision|0|||
160861833|NCT02531802|580887850|FG005|Received Vaccination 2|Physician Decision|1|||
160861834|NCT02531802|580887851|FG006|Received Vaccination 2|Physician Decision|0|||
160861835|NCT02531802|580887852|FG007|Received Vaccination 2|Physician Decision|0|||
160861836|NCT02531802|580887853|FG008|Received Vaccination 2|Physician Decision|0|||
160861837|NCT02531802|580887854|FG009|Received Vaccination 2|Physician Decision|2|||
160861838|NCT02531802|580887855|FG010|Received Vaccination 2|Physician Decision|0|||
160861839|NCT02531802|580887856|FG011|Received Vaccination 2|Physician Decision|0|||
160861840|NCT02531802|580887857|FG012|Received Vaccination 2|Physician Decision|0|||
160861841|NCT02531802|580887858|FG013|Received Vaccination 2|Physician Decision|1|||
160861842|NCT02531802|580887859|FG014|Received Vaccination 2|Physician Decision|0|||
160861843|NCT02531802|580887860|FG015|Received Vaccination 2|Physician Decision|0|||
160861844|NCT02531802|580887861|FG016|Received Vaccination 2|Physician Decision|0|||
160861845|NCT02531802|580887862|FG017|Received Vaccination 2|Physician Decision|1|||
160861846|NCT02531802|580887863|FG018|Received Vaccination 2|Physician Decision|0|||
160861847|NCT02531802|580887864|FG019|Received Vaccination 2|Physician Decision|0|||
160861848|NCT02531802|580887865|FG020|Received Vaccination 2|Physician Decision|0|||
160917543|NCT01156311|581091665|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
160917544|NCT01156311|581091666|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
160917545|NCT01156311|581091663|FG000|6-month Add-on Therapy Period|Other|0|||
160917546|NCT01156311|581091664|FG001|6-month Add-on Therapy Period|Other|0|||
160917547|NCT01156311|581091665|FG002|6-month Add-on Therapy Period|Other|1|||
160917548|NCT01156311|581091666|FG003|6-month Add-on Therapy Period|Other|2|||
160917549|NCT00276159|581091667|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
160917550|NCT00333866|581091670|FG000|Overall Study|Adverse Event|23|||
160917551|NCT00333866|581091671|FG001|Overall Study|Adverse Event|37|||
160917552|NCT00333866|581091672|FG002|Overall Study|Adverse Event|38|||
160917553|NCT00333866|581091673|FG003|Overall Study|Adverse Event|47|||
160917554|NCT00333866|581091670|FG000|Overall Study|Other|3|||
160917555|NCT00333866|581091671|FG001|Overall Study|Other|2|||
160917556|NCT00333866|581091672|FG002|Overall Study|Other|2|||
160917557|NCT00333866|581091673|FG003|Overall Study|Other|2|||
160917558|NCT00333866|581091670|FG000|Overall Study|Lack of Efficacy|8|||
160917559|NCT00333866|581091671|FG001|Overall Study|Lack of Efficacy|6|||
160917560|NCT00333866|581091672|FG002|Overall Study|Lack of Efficacy|3|||
160917561|NCT00333866|581091673|FG003|Overall Study|Lack of Efficacy|5|||
160917562|NCT00333866|581091670|FG000|Overall Study|Lost to Follow-up|1|||
160917563|NCT00333866|581091671|FG001|Overall Study|Lost to Follow-up|2|||
160917564|NCT00333866|581091672|FG002|Overall Study|Lost to Follow-up|2|||
160917565|NCT00333866|581091673|FG003|Overall Study|Lost to Follow-up|2|||
160917566|NCT00333866|581091670|FG000|Overall Study|Withdrawal by Subject|8|||
160917567|NCT00333866|581091671|FG001|Overall Study|Withdrawal by Subject|14|||
160917568|NCT00333866|581091672|FG002|Overall Study|Withdrawal by Subject|4|||
160917569|NCT00333866|581091673|FG003|Overall Study|Withdrawal by Subject|9|||
160917570|NCT00333866|581091670|FG000|Overall Study|Randomized but not Treated|5|||
160917571|NCT00333866|581091671|FG001|Overall Study|Randomized but not Treated|3|||
160917572|NCT00333866|581091672|FG002|Overall Study|Randomized but not Treated|2|||
160917573|NCT00333866|581091673|FG003|Overall Study|Randomized but not Treated|1|||
160917574|NCT06073119|581091674|FG000|Overall Study|Adverse Event|1|||
160917575|NCT06073119|581091675|FG001|Overall Study|Adverse Event|3|||
160917576|NCT06073119|581091676|FG002|Overall Study|Adverse Event|0|||
160917577|NCT06073119|581091677|FG003|Overall Study|Adverse Event|0|||
160917578|NCT06073119|581091678|FG004|Overall Study|Adverse Event|1|||
160917579|NCT06073119|581091679|FG005|Overall Study|Adverse Event|0|||
160917580|NCT06073119|581091674|FG000|Overall Study|Non-compliance with study schedule|1|||
160917581|NCT06073119|581091675|FG001|Overall Study|Non-compliance with study schedule|0|||
160917582|NCT06073119|581091676|FG002|Overall Study|Non-compliance with study schedule|0|||
160917583|NCT06073119|581091677|FG003|Overall Study|Non-compliance with study schedule|0|||
160917584|NCT06073119|581091678|FG004|Overall Study|Non-compliance with study schedule|1|||
160917585|NCT06073119|581091679|FG005|Overall Study|Non-compliance with study schedule|0|||
160917586|NCT06073119|581091674|FG000|Overall Study|Withdrawal by Subject|4|||
160917587|NCT06073119|581091675|FG001|Overall Study|Withdrawal by Subject|4|||
160917588|NCT06073119|581091676|FG002|Overall Study|Withdrawal by Subject|3|||
160917589|NCT06073119|581091677|FG003|Overall Study|Withdrawal by Subject|5|||
160917590|NCT06073119|581091678|FG004|Overall Study|Withdrawal by Subject|3|||
160917591|NCT06073119|581091679|FG005|Overall Study|Withdrawal by Subject|1|||
160917592|NCT06073119|581091674|FG000|Overall Study|Other|2|||
160917593|NCT06073119|581091675|FG001|Overall Study|Other|4|||
160917594|NCT06073119|581091676|FG002|Overall Study|Other|1|||
160917595|NCT06073119|581091677|FG003|Overall Study|Other|0|||
160917596|NCT06073119|581091678|FG004|Overall Study|Other|1|||
160917597|NCT06073119|581091679|FG005|Overall Study|Other|0|||
160917598|NCT01359449|581091680|FG000|Overall Study|Lost to Follow-up|1|||
160917599|NCT01359449|581091681|FG001|Overall Study|Lost to Follow-up|0|||
160917600|NCT01359449|581091680|FG000|Overall Study|Protocol Violation|0|||
160917601|NCT01359449|581091681|FG001|Overall Study|Protocol Violation|2|||
160917602|NCT01359449|581091680|FG000|Overall Study|Withdrawal by Subject|3|||
160917603|NCT01359449|581091681|FG001|Overall Study|Withdrawal by Subject|2|||
160917604|NCT02393547|581091699|FG000|Overall Study|Adverse Event|2|||
160917605|NCT02393547|581091699|FG000|Overall Study|Withdrawal by Subject|3|||
160917606|NCT02393547|581091699|FG000|Overall Study|Lost to Follow-up|1|||
160917607|NCT00429104|581091703|FG000|Overall Study|Protocol Violation|1|||
160917608|NCT01907815|581091704|FG000|Overall Study|Withdrawal by Subject|1|||
160917609|NCT01907815|581091705|FG001|Overall Study|Withdrawal by Subject|0|||
160917610|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
160917611|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
160917612|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
160917613|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
160917614|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
160917615|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
160917616|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
160917617|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
160917618|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
160996375|NCT01729819|581373580|FG000|Overall Study|Other reason|1|||
160996376|NCT01729819|581373581|FG001|Overall Study|Other reason|0|||
160996377|NCT01729819|581373580|FG000|Overall Study|Protocol Violation|0|||
160996378|NCT01729819|581373581|FG001|Overall Study|Protocol Violation|1|||
160996379|NCT01729819|581373580|FG000|Overall Study|Withdrawal by Subject|0|||
160996380|NCT01729819|581373581|FG001|Overall Study|Withdrawal by Subject|2|||
160996381|NCT01025843|581373582|FG000|Washout 4|Withdrawal by Subject|0|||
160996382|NCT01025843|581373583|FG001|Washout 4|Withdrawal by Subject|0|||
160996383|NCT01025843|581373584|FG002|Washout 4|Withdrawal by Subject|1|||
160996384|NCT01025843|581373585|FG003|Washout 4|Withdrawal by Subject|1|||
160996385|NCT01025843|581373586|FG004|Washout 4|Withdrawal by Subject|0|||
160996386|NCT01025843|581373587|FG005|Washout 4|Withdrawal by Subject|0|||
160996387|NCT01025843|581373588|FG006|Washout 4|Withdrawal by Subject|0|||
160996388|NCT01025843|581373589|FG007|Washout 4|Withdrawal by Subject|0|||
160996389|NCT01025843|581373590|FG008|Washout 4|Withdrawal by Subject|0|||
160996390|NCT01025843|581373591|FG009|Washout 4|Withdrawal by Subject|0|||
160996391|NCT01649791|581373592|FG000|Overall Study|Disease Progression|2|||
160996392|NCT01649791|581373592|FG000|Overall Study|Adverse Event|1|||
160996393|NCT00771667|581373595|FG000|Induction Phase|Adverse Event|5|||
160996394|NCT00771667|581373596|FG001|Induction Phase|Adverse Event|2|||
160996395|NCT00771667|581373597|FG002|Induction Phase|Adverse Event|4|||
160996396|NCT00771667|581373598|FG003|Induction Phase|Adverse Event|1|||
160917619|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
160917620|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
160917621|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
160917622|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
160917623|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
160917624|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
160917625|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
160917626|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
160917627|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
160917628|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
160917629|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
160917630|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
160917631|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
160917632|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
160917633|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
160917634|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
160996397|NCT00771667|581373599|FG004|Induction Phase|Adverse Event|0|||
160996398|NCT00771667|581373600|FG005|Induction Phase|Adverse Event|0|||
160996399|NCT00771667|581373601|FG006|Induction Phase|Adverse Event|0|||
160996400|NCT00771667|581373602|FG007|Induction Phase|Adverse Event|0|||
160996401|NCT00771667|581373603|FG008|Induction Phase|Adverse Event|0|||
160996402|NCT00771667|581373604|FG009|Induction Phase|Adverse Event|0|||
160996403|NCT00771667|581373595|FG000|Induction Phase|Lack of Efficacy|9|||
160996404|NCT00771667|581373596|FG001|Induction Phase|Lack of Efficacy|2|||
160996405|NCT00771667|581373597|FG002|Induction Phase|Lack of Efficacy|4|||
160996406|NCT00771667|581373598|FG003|Induction Phase|Lack of Efficacy|3|||
160996407|NCT00771667|581373599|FG004|Induction Phase|Lack of Efficacy|0|||
160996408|NCT00771667|581373600|FG005|Induction Phase|Lack of Efficacy|0|||
160996409|NCT00771667|581373601|FG006|Induction Phase|Lack of Efficacy|0|||
160996410|NCT00771667|581373602|FG007|Induction Phase|Lack of Efficacy|0|||
160996411|NCT00771667|581373603|FG008|Induction Phase|Lack of Efficacy|0|||
160996412|NCT00771667|581373604|FG009|Induction Phase|Lack of Efficacy|0|||
160996413|NCT00771667|581373595|FG000|Induction Phase|Lost to Follow-up|1|||
160996414|NCT00771667|581373596|FG001|Induction Phase|Lost to Follow-up|0|||
160996415|NCT00771667|581373597|FG002|Induction Phase|Lost to Follow-up|1|||
160996416|NCT00771667|581373598|FG003|Induction Phase|Lost to Follow-up|0|||
160996417|NCT00771667|581373599|FG004|Induction Phase|Lost to Follow-up|0|||
160996418|NCT00771667|581373600|FG005|Induction Phase|Lost to Follow-up|0|||
160996419|NCT00771667|581373601|FG006|Induction Phase|Lost to Follow-up|0|||
160996420|NCT00771667|581373602|FG007|Induction Phase|Lost to Follow-up|0|||
160996421|NCT00771667|581373603|FG008|Induction Phase|Lost to Follow-up|0|||
160996422|NCT00771667|581373604|FG009|Induction Phase|Lost to Follow-up|0|||
160453921|NCT03710603|579393965|FG000|Overall Study|Death|44|||
160996423|NCT00771667|581373595|FG000|Induction Phase|Other|4|||
160996424|NCT00771667|581373596|FG001|Induction Phase|Other|6|||
160996425|NCT00771667|581373597|FG002|Induction Phase|Other|3|||
160453922|NCT03710603|579393966|FG001|Overall Study|Death|34|||
160917635|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
160996426|NCT00771667|581373598|FG003|Induction Phase|Other|4|||
160996427|NCT00771667|581373599|FG004|Induction Phase|Other|0|||
160996428|NCT00771667|581373600|FG005|Induction Phase|Other|0|||
160996429|NCT00771667|581373601|FG006|Induction Phase|Other|0|||
160996430|NCT00771667|581373602|FG007|Induction Phase|Other|0|||
160996431|NCT00771667|581373603|FG008|Induction Phase|Other|0|||
160453923|NCT03710603|579393965|FG000|Overall Study|Lost to Follow-up|3|||
160996432|NCT00771667|581373604|FG009|Induction Phase|Other|0|||
160996433|NCT00771667|581373595|FG000|Maintenance Phase|Adverse Event|0|||
160996434|NCT00771667|581373596|FG001|Maintenance Phase|Adverse Event|0|||
160996435|NCT00771667|581373597|FG002|Maintenance Phase|Adverse Event|0|||
160996436|NCT00771667|581373598|FG003|Maintenance Phase|Adverse Event|0|||
160996437|NCT00771667|581373599|FG004|Maintenance Phase|Adverse Event|1|||
160996438|NCT00771667|581373600|FG005|Maintenance Phase|Adverse Event|3|||
160996439|NCT00771667|581373601|FG006|Maintenance Phase|Adverse Event|5|||
160996440|NCT00771667|581373602|FG007|Maintenance Phase|Adverse Event|1|||
160996441|NCT00771667|581373603|FG008|Maintenance Phase|Adverse Event|8|||
160996442|NCT00771667|581373604|FG009|Maintenance Phase|Adverse Event|7|||
160996443|NCT00771667|581373595|FG000|Maintenance Phase|Lack of Efficacy|0|||
160996444|NCT00771667|581373596|FG001|Maintenance Phase|Lack of Efficacy|0|||
160996445|NCT00771667|581373597|FG002|Maintenance Phase|Lack of Efficacy|0|||
160996446|NCT00771667|581373598|FG003|Maintenance Phase|Lack of Efficacy|0|||
160996447|NCT00771667|581373599|FG004|Maintenance Phase|Lack of Efficacy|1|||
160996448|NCT00771667|581373600|FG005|Maintenance Phase|Lack of Efficacy|3|||
160996449|NCT00771667|581373601|FG006|Maintenance Phase|Lack of Efficacy|3|||
160996450|NCT00771667|581373602|FG007|Maintenance Phase|Lack of Efficacy|2|||
160996451|NCT00771667|581373603|FG008|Maintenance Phase|Lack of Efficacy|11|||
160996452|NCT00771667|581373604|FG009|Maintenance Phase|Lack of Efficacy|7|||
160996453|NCT00771667|581373595|FG000|Maintenance Phase|Other|0|||
160996454|NCT00771667|581373596|FG001|Maintenance Phase|Other|0|||
160996455|NCT00771667|581373597|FG002|Maintenance Phase|Other|0|||
160996456|NCT00771667|581373598|FG003|Maintenance Phase|Other|0|||
160996457|NCT00771667|581373599|FG004|Maintenance Phase|Other|0|||
160996458|NCT00771667|581373600|FG005|Maintenance Phase|Other|1|||
160996459|NCT00771667|581373601|FG006|Maintenance Phase|Other|2|||
160996460|NCT00771667|581373602|FG007|Maintenance Phase|Other|2|||
160996461|NCT00771667|581373603|FG008|Maintenance Phase|Other|3|||
160996462|NCT00771667|581373604|FG009|Maintenance Phase|Other|3|||
160996463|NCT00364286|581373605|FG000|Overall Study|Withdrawal by Subject|1|||
160996464|NCT00364286|581373605|FG000|Overall Study|Adverse Event|2|||
160996465|NCT01897233|581373606|FG000|Part B (24 Weeks)|Adverse Event|1|||
160996466|NCT01897233|581373606|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
160996467|NCT01897233|581373606|FG000|Part B (24 Weeks)|Physician Decision|1|||
160996468|NCT00628862|581373611|FG000|Overall Study|Adverse Event|6|||
160996469|NCT00628862|581373612|FG001|Overall Study|Adverse Event|8|||
160996470|NCT00628862|581373613|FG002|Overall Study|Adverse Event|10|||
160996471|NCT00628862|581373611|FG000|Overall Study|Withdrawal by Subject|4|||
160996472|NCT00628862|581373612|FG001|Overall Study|Withdrawal by Subject|6|||
160996473|NCT00628862|581373613|FG002|Overall Study|Withdrawal by Subject|11|||
160996474|NCT00628862|581373611|FG000|Overall Study|Lost to Follow-up|0|||
160996475|NCT00628862|581373612|FG001|Overall Study|Lost to Follow-up|2|||
160996476|NCT00628862|581373613|FG002|Overall Study|Lost to Follow-up|1|||
160996477|NCT00628862|581373611|FG000|Overall Study|Protocol Violation|1|||
160996478|NCT00628862|581373612|FG001|Overall Study|Protocol Violation|0|||
160996479|NCT00628862|581373613|FG002|Overall Study|Protocol Violation|0|||
160996480|NCT00628862|581373611|FG000|Overall Study|COPD Exacerbation|0|||
160996481|NCT00628862|581373612|FG001|Overall Study|COPD Exacerbation|1|||
160996482|NCT00628862|581373613|FG002|Overall Study|COPD Exacerbation|0|||
160996483|NCT02814643|581373614|FG000|Overall Study|Lost to Follow-up|0|||
160996484|NCT02814643|581373615|FG001|Overall Study|Lost to Follow-up|1|||
160996485|NCT02814643|581373614|FG000|Overall Study|Withdrawal by Subject|1|||
160996486|NCT02814643|581373615|FG001|Overall Study|Withdrawal by Subject|2|||
160917636|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
160917637|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
160917638|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
160917639|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
160917640|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
160917641|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
160917642|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
160917643|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
160917644|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
160996487|NCT01227278|581373618|FG000|Overall Study|Withdrawal by Subject|4|||
160996488|NCT01227278|581373619|FG001|Overall Study|Withdrawal by Subject|4|||
160996489|NCT01227278|581373618|FG000|Overall Study|Death|0|||
160453924|NCT03710603|579393966|FG001|Overall Study|Lost to Follow-up|5|||
160917645|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
160996490|NCT01227278|581373619|FG001|Overall Study|Death|2|||
160996491|NCT01227278|581373618|FG000|Overall Study|Other|1|||
160996492|NCT01227278|581373619|FG001|Overall Study|Other|2|||
160996493|NCT01281813|581373634|FG000|Overall Study|Adverse Event|0|||
160996494|NCT01281813|581373635|FG001|Overall Study|Adverse Event|0|||
160996495|NCT01281813|581373636|FG002|Overall Study|Adverse Event|10|||
160996496|NCT01281813|581373634|FG000|Overall Study|Lost to Follow-up|0|||
160996497|NCT01281813|581373635|FG001|Overall Study|Lost to Follow-up|0|||
160996498|NCT01281813|581373636|FG002|Overall Study|Lost to Follow-up|31|||
160996499|NCT01281813|581373634|FG000|Overall Study|Withdrawal by Subject|0|||
160653072|NCT01656889|580110464|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
160653073|NCT01656889|580110463|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
160653074|NCT01656889|580110464|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
160653075|NCT01656889|580110463|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
160653076|NCT01656889|580110464|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
160653077|NCT01656889|580110463|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
160653078|NCT01656889|580110464|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
160653079|NCT02486796|580110465|FG000|Overall Study|Withdrawal by Subject|1|||
160653080|NCT02486796|580110466|FG001|Overall Study|Withdrawal by Subject|1|||
160653081|NCT02486796|580110465|FG000|Overall Study|Physician Decision|1|||
160653082|NCT02486796|580110466|FG001|Overall Study|Physician Decision|0|||
160653083|NCT03276975|580110467|FG000|Overall Study|Withdrawal by Subject|1|||
160653084|NCT03276975|580110468|FG001|Overall Study|Withdrawal by Subject|0|||
160653085|NCT00306384|580110471|FG000|Overall Study|Adverse Event|103|||
160653086|NCT00306384|580110472|FG001|Overall Study|Adverse Event|87|||
160653087|NCT00306384|580110473|FG002|Overall Study|Adverse Event|40|||
160653088|NCT00306384|580110471|FG000|Overall Study|Major protocol deviation|43|||
160653089|NCT00306384|580110472|FG001|Overall Study|Major protocol deviation|51|||
160653090|NCT00306384|580110473|FG002|Overall Study|Major protocol deviation|18|||
160653091|NCT00306384|580110471|FG000|Overall Study|Lost to Follow-up|57|||
160653092|NCT00306384|580110472|FG001|Overall Study|Lost to Follow-up|41|||
160653093|NCT00306384|580110473|FG002|Overall Study|Lost to Follow-up|35|||
160653094|NCT00306384|580110471|FG000|Overall Study|Voluntary withdrawal|199|||
160653095|NCT00306384|580110472|FG001|Overall Study|Voluntary withdrawal|187|||
160653096|NCT00306384|580110473|FG002|Overall Study|Voluntary withdrawal|91|||
160653097|NCT00306384|580110471|FG000|Overall Study|Study termination|1|||
160653098|NCT00306384|580110472|FG001|Overall Study|Study termination|0|||
160653099|NCT00306384|580110473|FG002|Overall Study|Study termination|1|||
160653100|NCT00306384|580110471|FG000|Overall Study|Pregnancy|3|||
160653101|NCT00306384|580110472|FG001|Overall Study|Pregnancy|1|||
160653102|NCT00306384|580110473|FG002|Overall Study|Pregnancy|1|||
160653103|NCT00306384|580110471|FG000|Overall Study|Lack of Efficacy|26|||
160653104|NCT00306384|580110472|FG001|Overall Study|Lack of Efficacy|40|||
160653105|NCT00306384|580110473|FG002|Overall Study|Lack of Efficacy|38|||
160653106|NCT00306384|580110471|FG000|Overall Study|Investigator discretion|28|||
160653107|NCT00306384|580110472|FG001|Overall Study|Investigator discretion|31|||
160653108|NCT00306384|580110473|FG002|Overall Study|Investigator discretion|21|||
160653109|NCT00306384|580110471|FG000|Overall Study|Other|80|||
160653110|NCT00306384|580110472|FG001|Overall Study|Other|70|||
160653111|NCT00306384|580110473|FG002|Overall Study|Other|32|||
160996500|NCT01281813|581373635|FG001|Overall Study|Withdrawal by Subject|0|||
160996501|NCT01281813|581373636|FG002|Overall Study|Withdrawal by Subject|13|||
160996502|NCT01281813|581373634|FG000|Overall Study|Subject Non-Compliant|0|||
160996503|NCT01281813|581373635|FG001|Overall Study|Subject Non-Compliant|0|||
160996504|NCT01281813|581373636|FG002|Overall Study|Subject Non-Compliant|6|||
160996505|NCT01281813|581373634|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
160996506|NCT01281813|581373635|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
160996507|NCT01281813|581373636|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
160996508|NCT01281813|581373634|FG000|Overall Study|Sponsor's Decision|4|||
160996509|NCT01281813|581373635|FG001|Overall Study|Sponsor's Decision|3|||
160996510|NCT01281813|581373636|FG002|Overall Study|Sponsor's Decision|7|||
160996511|NCT01281813|581373634|FG000|Overall Study|Switched to Commercially Available Medication|0|||
160996512|NCT01281813|581373635|FG001|Overall Study|Switched to Commercially Available Medication|0|||
160996513|NCT01281813|581373636|FG002|Overall Study|Switched to Commercially Available Medication|26|||
160996514|NCT01281813|581373634|FG000|Overall Study|Other|0|||
160996515|NCT01281813|581373635|FG001|Overall Study|Other|1|||
160996516|NCT01281813|581373636|FG002|Overall Study|Other|39|||
160996517|NCT00558363|581373637|FG000|Overall Study|Physician Decision|18|||
160996518|NCT00558363|581373638|FG001|Overall Study|Physician Decision|4|||
160996519|NCT00558363|581373637|FG000|Overall Study|Withdrawal by Subject|11|||
160996520|NCT00558363|581373638|FG001|Overall Study|Withdrawal by Subject|4|||
160996521|NCT00558363|581373637|FG000|Overall Study|Adverse Event|5|||
160996522|NCT00558363|581373638|FG001|Overall Study|Adverse Event|5|||
160996523|NCT00558363|581373637|FG000|Overall Study|Lack of Efficacy|2|||
160996524|NCT00558363|581373638|FG001|Overall Study|Lack of Efficacy|2|||
160996525|NCT00558363|581373637|FG000|Overall Study|Protocol Violation|2|||
160996526|NCT00558363|581373638|FG001|Overall Study|Protocol Violation|1|||
160996527|NCT00558363|581373637|FG000|Overall Study|Lost to Follow-up|0|||
160653112|NCT00306384|580110471|FG000|Overall Study|Site closure|2|||
160653113|NCT00306384|580110472|FG001|Overall Study|Site closure|0|||
160653114|NCT00306384|580110473|FG002|Overall Study|Site closure|0|||
160653115|NCT02275364|580110474|FG000|Period 1|Withdrawal by Subject|1|||
160653116|NCT02275364|580110475|FG001|Period 1|Withdrawal by Subject|0|||
160653117|NCT02275364|580110474|FG000|Period 1|Other reason|1|||
160653118|NCT02275364|580110475|FG001|Period 1|Other reason|0|||
160653119|NCT03111147|580110478|FG000|Overall Study|Lost to Follow-up|2|||
160996528|NCT00558363|581373638|FG001|Overall Study|Lost to Follow-up|1|||
160653120|NCT03111147|580110479|FG001|Overall Study|Lost to Follow-up|5|||
160653121|NCT03111147|580110478|FG000|Overall Study|Withdrawal by Subject|4|||
160653122|NCT03111147|580110479|FG001|Overall Study|Withdrawal by Subject|3|||
160653123|NCT03111147|580110478|FG000|Overall Study|Protocol Violation|2|||
160653124|NCT03111147|580110479|FG001|Overall Study|Protocol Violation|1|||
160653125|NCT03111147|580110478|FG000|Overall Study|Death|1|||
160653126|NCT03111147|580110479|FG001|Overall Study|Death|1|||
160653127|NCT01463683|580110480|FG000|Overall Study|Adverse Event|2|||
160653128|NCT01463683|580110481|FG001|Overall Study|Adverse Event|0|||
160653129|NCT01463683|580110482|FG002|Overall Study|Adverse Event|0|||
160653130|NCT01463683|580110480|FG000|Overall Study|Lost to Follow-up|10|||
160653131|NCT01463683|580110481|FG001|Overall Study|Lost to Follow-up|9|||
160653132|NCT01463683|580110482|FG002|Overall Study|Lost to Follow-up|7|||
160917646|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
160917647|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
160917648|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
160917649|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
160653133|NCT01463683|580110480|FG000|Overall Study|Physician Decision|0|||
160653134|NCT01463683|580110481|FG001|Overall Study|Physician Decision|3|||
160653135|NCT01463683|580110482|FG002|Overall Study|Physician Decision|1|||
160653136|NCT01463683|580110480|FG000|Overall Study|Pregnancy|2|||
160653137|NCT01463683|580110481|FG001|Overall Study|Pregnancy|2|||
160653138|NCT01463683|580110482|FG002|Overall Study|Pregnancy|1|||
160653139|NCT01463683|580110480|FG000|Overall Study|Withdrawal by Subject|5|||
160653140|NCT01463683|580110481|FG001|Overall Study|Withdrawal by Subject|17|||
160653141|NCT01463683|580110482|FG002|Overall Study|Withdrawal by Subject|2|||
160653142|NCT03384745|580110485|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
160653143|NCT03384745|580110486|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
160653144|NCT03384745|580110487|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
160653145|NCT03384745|580110488|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
160653146|NCT03384745|580110489|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
160653147|NCT03384745|580110490|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
160653148|NCT03384745|580110485|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
160653149|NCT03384745|580110486|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
160653150|NCT03384745|580110487|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
160653151|NCT03384745|580110488|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
160653152|NCT03384745|580110489|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
160653153|NCT03384745|580110490|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
160653154|NCT03384745|580110485|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
160653155|NCT03384745|580110486|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
160653156|NCT03384745|580110487|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
160653157|NCT03384745|580110488|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
160653158|NCT03384745|580110489|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
160917650|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
160917651|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
160917652|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
160917653|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
160917654|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
160917655|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
160917656|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
160917657|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
160917658|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
160917659|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
160917660|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
160917661|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
160917662|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
160917663|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
160917664|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
160917665|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
160917666|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
160917667|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
160917668|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
160917669|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
160917670|NCT00514540|581091711|FG000|First-Line Chemo|Withdrawal by Subject|1|||
160917671|NCT00514540|581091711|FG000|First-Line Chemo|Protocol Violation|7|||
160996529|NCT00558363|581373637|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
160653159|NCT03384745|580110490|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
160917672|NCT00514540|581091711|FG000|Second-Line|Physician/Patient Decision|31|||
160996530|NCT00558363|581373638|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
160653160|NCT03384745|580110485|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
160996531|NCT00558363|581373637|FG000|Overall Study|Randomized in Error|1|||
160996532|NCT00558363|581373638|FG001|Overall Study|Randomized in Error|2|||
160996533|NCT00558363|581373637|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
160917673|NCT05185089|581091718|FG000|First Intervention (4 weeks)|Adverse Event|0|||
160917674|NCT05185089|581091719|FG001|First Intervention (4 weeks)|Adverse Event|0|||
160917675|NCT05185089|581091720|FG002|First Intervention (4 weeks)|Adverse Event|0|||
160917676|NCT05185089|581091721|FG003|First Intervention (4 weeks)|Adverse Event|1|||
160917677|NCT05185089|581091718|FG000|Second Intervention (4 weeks)|Death|0|||
160917678|NCT05185089|581091719|FG001|Second Intervention (4 weeks)|Death|1|||
160917679|NCT05185089|581091720|FG002|Second Intervention (4 weeks)|Death|0|||
160917680|NCT05185089|581091721|FG003|Second Intervention (4 weeks)|Death|0|||
160917681|NCT05185089|581091718|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
160917682|NCT05185089|581091719|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
160917683|NCT05185089|581091720|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
160917684|NCT05185089|581091721|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
160917685|NCT04997161|581091734|FG000|Overall Study|Study terminated by sponsor|3|||
160917686|NCT00752232|581091735|FG000|Overall Study|Protocol Violation|0|||
160917687|NCT00752232|581091736|FG001|Overall Study|Protocol Violation|0|||
160917688|NCT00752232|581091737|FG002|Overall Study|Protocol Violation|0|||
160917689|NCT00752232|581091738|FG003|Overall Study|Protocol Violation|0|||
160917690|NCT00752232|581091739|FG004|Overall Study|Protocol Violation|0|||
160917691|NCT00752232|581091740|FG005|Overall Study|Protocol Violation|1|||
160917692|NCT00752232|581091741|FG006|Overall Study|Protocol Violation|0|||
160917693|NCT00752232|581091735|FG000|Overall Study|Caregiver request|2|||
160917694|NCT00752232|581091736|FG001|Overall Study|Caregiver request|0|||
160917695|NCT00752232|581091737|FG002|Overall Study|Caregiver request|0|||
160917696|NCT00752232|581091738|FG003|Overall Study|Caregiver request|0|||
160917697|NCT00752232|581091739|FG004|Overall Study|Caregiver request|1|||
160917698|NCT00752232|581091740|FG005|Overall Study|Caregiver request|0|||
160917699|NCT00752232|581091741|FG006|Overall Study|Caregiver request|0|||
160917700|NCT00752232|581091735|FG000|Overall Study|Investigator request|0|||
160917701|NCT00752232|581091736|FG001|Overall Study|Investigator request|0|||
160917702|NCT00752232|581091737|FG002|Overall Study|Investigator request|0|||
160917703|NCT00752232|581091738|FG003|Overall Study|Investigator request|0|||
160917704|NCT00752232|581091739|FG004|Overall Study|Investigator request|1|||
160917705|NCT00752232|581091740|FG005|Overall Study|Investigator request|0|||
160917706|NCT00752232|581091741|FG006|Overall Study|Investigator request|0|||
160917707|NCT00752232|581091735|FG000|Overall Study|Subject request|0|||
160917708|NCT00752232|581091736|FG001|Overall Study|Subject request|0|||
160917709|NCT00752232|581091737|FG002|Overall Study|Subject request|1|||
160917710|NCT00752232|581091738|FG003|Overall Study|Subject request|0|||
160917711|NCT00752232|581091739|FG004|Overall Study|Subject request|0|||
160917712|NCT00752232|581091740|FG005|Overall Study|Subject request|0|||
160917713|NCT00752232|581091741|FG006|Overall Study|Subject request|0|||
160917714|NCT00752232|581091735|FG000|Overall Study|Group home admission|0|||
160917715|NCT00752232|581091736|FG001|Overall Study|Group home admission|0|||
160917716|NCT00752232|581091737|FG002|Overall Study|Group home admission|0|||
160917717|NCT00752232|581091738|FG003|Overall Study|Group home admission|1|||
160917718|NCT00752232|581091739|FG004|Overall Study|Group home admission|0|||
160917719|NCT00752232|581091740|FG005|Overall Study|Group home admission|0|||
160917720|NCT00752232|581091741|FG006|Overall Study|Group home admission|0|||
160917721|NCT00752232|581091735|FG000|Overall Study|Caregiver could not attend the subject|0|||
160917722|NCT00752232|581091736|FG001|Overall Study|Caregiver could not attend the subject|0|||
160917723|NCT00752232|581091737|FG002|Overall Study|Caregiver could not attend the subject|0|||
160917724|NCT00752232|581091738|FG003|Overall Study|Caregiver could not attend the subject|0|||
160917725|NCT00752232|581091739|FG004|Overall Study|Caregiver could not attend the subject|1|||
160917726|NCT00752232|581091740|FG005|Overall Study|Caregiver could not attend the subject|0|||
160917727|NCT00752232|581091741|FG006|Overall Study|Caregiver could not attend the subject|0|||
160917728|NCT04502589|581091742|FG000|Overall Study|Physician Decision|1|||
160917729|NCT04502589|581091743|FG001|Overall Study|Physician Decision|0|||
160917730|NCT02730455|581091745|FG000|Overall Study|Death|5|||
160917731|NCT02730455|581091746|FG001|Overall Study|Death|6|||
160917732|NCT02730455|581091747|FG002|Overall Study|Death|4|||
160917733|NCT02730455|581091745|FG000|Overall Study|Consent withdrawn|2|||
160917734|NCT02730455|581091746|FG001|Overall Study|Consent withdrawn|4|||
160917735|NCT02730455|581091747|FG002|Overall Study|Consent withdrawn|1|||
160996534|NCT00558363|581373638|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
160996535|NCT00868192|581373639|FG000|Overall Study|Ineligible|4|||
160996536|NCT03673124|581373641|FG000|Overall Study|Eligible with no protocol therapy|2|||
160996537|NCT02174562|581373642|FG000|Overall Study|Withdrawal by Subject|7|||
160453925|NCT03710603|579393965|FG000|Overall Study|Withdrawal by Subject|11|||
160917736|NCT02730455|581091745|FG000|Overall Study|Lost to Follow-up|3|||
160917737|NCT02730455|581091746|FG001|Overall Study|Lost to Follow-up|1|||
160917738|NCT02730455|581091747|FG002|Overall Study|Lost to Follow-up|4|||
160917739|NCT02730455|581091745|FG000|Overall Study|Other|1|||
160917740|NCT02730455|581091746|FG001|Overall Study|Other|1|||
160996538|NCT02174562|581373643|FG001|Overall Study|Withdrawal by Subject|2|||
160996539|NCT02174562|581373642|FG000|Overall Study|Death|2|||
160996540|NCT02174562|581373643|FG001|Overall Study|Death|0|||
160996541|NCT02174562|581373642|FG000|Overall Study|Lost to Follow-up|0|||
160996542|NCT02174562|581373643|FG001|Overall Study|Lost to Follow-up|3|||
160996543|NCT00798096|581373645|FG000|Overall Study|Ongoing|2|||
160996544|NCT00290732|581373649|FG000|Overall Study|Inability to instill drug intraductally.|0|||
160996545|NCT00290732|581373650|FG001|Overall Study|Inability to instill drug intraductally.|1|||
160996546|NCT00290732|581373651|FG002|Overall Study|Inability to instill drug intraductally.|1|||
160996547|NCT00290732|581373652|FG003|Overall Study|Inability to instill drug intraductally.|0|||
160996548|NCT00290732|581373653|FG004|Overall Study|Inability to instill drug intraductally.|0|||
160996549|NCT02736799|581373657|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
160996550|NCT02736799|581373658|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
160996551|NCT02736799|581373659|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
160996552|NCT02736799|581373660|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
160996553|NCT01833832|581373661|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
160996554|NCT00843193|581373662|FG000|Overall Study|Adverse Event|2|||
160996555|NCT00843193|581373663|FG001|Overall Study|Adverse Event|4|||
160996556|NCT00843193|581373662|FG000|Overall Study|Lack of Efficacy|1|||
160653161|NCT03384745|580110486|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
160653162|NCT03384745|580110487|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
160653163|NCT03384745|580110488|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
160653164|NCT03384745|580110489|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
160653165|NCT03384745|580110490|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
160653166|NCT03384745|580110485|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
160653167|NCT03384745|580110486|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
160653168|NCT03384745|580110487|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
160653169|NCT03384745|580110488|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
160996557|NCT00843193|581373663|FG001|Overall Study|Lack of Efficacy|1|||
160996558|NCT00843193|581373662|FG000|Overall Study|Protocol Violation|1|||
160996559|NCT00843193|581373663|FG001|Overall Study|Protocol Violation|2|||
160996560|NCT00843193|581373662|FG000|Overall Study|Lost to Follow-up|1|||
160996561|NCT00843193|581373663|FG001|Overall Study|Lost to Follow-up|0|||
160996562|NCT00843193|581373662|FG000|Overall Study|Physician Decision|0|||
160996563|NCT00843193|581373663|FG001|Overall Study|Physician Decision|1|||
160996564|NCT00843193|581373662|FG000|Overall Study|Withdrawal by Subject|3|||
160996565|NCT00843193|581373663|FG001|Overall Study|Withdrawal by Subject|3|||
160996566|NCT00197015|581373664|FG000|Overall Study|Adverse Event|3|||
160996567|NCT00197015|581373665|FG001|Overall Study|Adverse Event|0|||
160996568|NCT00197015|581373666|FG002|Overall Study|Adverse Event|1|||
160996569|NCT00197015|581373664|FG000|Overall Study|Protocol Violation|0|||
160996570|NCT00197015|581373665|FG001|Overall Study|Protocol Violation|3|||
160996571|NCT00197015|581373666|FG002|Overall Study|Protocol Violation|3|||
160996572|NCT00197015|581373664|FG000|Overall Study|Withdrawal by Subject|17|||
160996573|NCT00197015|581373665|FG001|Overall Study|Withdrawal by Subject|37|||
160996574|NCT00197015|581373666|FG002|Overall Study|Withdrawal by Subject|34|||
160996575|NCT00197015|581373664|FG000|Overall Study|Lost to Follow-up|28|||
160996576|NCT00197015|581373665|FG001|Overall Study|Lost to Follow-up|46|||
160996577|NCT00197015|581373666|FG002|Overall Study|Lost to Follow-up|37|||
160996578|NCT00197015|581373664|FG000|Overall Study|Other|2|||
160996579|NCT00197015|581373665|FG001|Overall Study|Other|3|||
160996580|NCT00197015|581373666|FG002|Overall Study|Other|2|||
160996581|NCT04511650|581373667|FG000|Overall Study|Lost to Follow-up|1|||
160996582|NCT04511650|581373668|FG001|Overall Study|Lost to Follow-up|0|||
160653170|NCT03384745|580110489|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
160653171|NCT03384745|580110490|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
160653172|NCT03384745|580110485|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
160653173|NCT03384745|580110486|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
160996583|NCT04511650|581373669|FG002|Overall Study|Lost to Follow-up|0|||
160996584|NCT04511650|581373667|FG000|Overall Study|Withdrawal by Subject|1|||
160996585|NCT04511650|581373668|FG001|Overall Study|Withdrawal by Subject|0|||
160996586|NCT04511650|581373669|FG002|Overall Study|Withdrawal by Subject|0|||
160653174|NCT03384745|580110487|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
160653175|NCT03384745|580110488|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
160653176|NCT03384745|580110489|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
160996587|NCT04511650|581373667|FG000|Overall Study|reason not provided|0|||
160996588|NCT04511650|581373668|FG001|Overall Study|reason not provided|0|||
160996589|NCT04511650|581373669|FG002|Overall Study|reason not provided|1|||
160996590|NCT04511650|581373667|FG000|Overall Study|Death|1|||
160996591|NCT04511650|581373668|FG001|Overall Study|Death|1|||
160996592|NCT04511650|581373669|FG002|Overall Study|Death|1|||
160996593|NCT02596035|581373673|FG000|Overall Study|Disease Progression|64|||
160996594|NCT02596035|581373674|FG001|Overall Study|Disease Progression|32|||
160996595|NCT02596035|581373675|FG002|Overall Study|Disease Progression|1|||
160653177|NCT03384745|580110490|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
160653178|NCT03384745|580110485|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
160653179|NCT03384745|580110486|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
160653180|NCT03384745|580110487|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
160653181|NCT03384745|580110488|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
160653182|NCT03384745|580110489|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
160653183|NCT03384745|580110490|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
160653184|NCT03384745|580110485|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
160653185|NCT03384745|580110486|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
160653186|NCT03384745|580110487|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
160653187|NCT03384745|580110488|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
160653188|NCT03384745|580110489|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
160653189|NCT03384745|580110490|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
160653190|NCT03384745|580110485|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
160653191|NCT03384745|580110486|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
160653192|NCT03384745|580110487|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
160653193|NCT03384745|580110488|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
160653194|NCT03384745|580110489|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
160653195|NCT03384745|580110490|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
160653196|NCT03384745|580110485|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
160653197|NCT03384745|580110486|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
160653198|NCT03384745|580110487|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
160653199|NCT03384745|580110488|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
160653200|NCT03384745|580110489|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
160653201|NCT03384745|580110490|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
160653202|NCT03384745|580110485|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
160653203|NCT03384745|580110486|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
160653204|NCT03384745|580110487|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
160653205|NCT03384745|580110488|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
160653206|NCT03384745|580110489|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
160653207|NCT03384745|580110490|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
160653208|NCT01058421|580110491|FG000|1 Month Outcomes|Death|10|||
160653209|NCT01058421|580110492|FG001|1 Month Outcomes|Death|6|||
160653210|NCT01058421|580110491|FG000|1 Month Outcomes|Lost to Follow-up|8|||
160653211|NCT01058421|580110492|FG001|1 Month Outcomes|Lost to Follow-up|7|||
160653212|NCT01058421|580110491|FG000|1 Month Outcomes|Remained in Hospital|5|||
160653213|NCT01058421|580110492|FG001|1 Month Outcomes|Remained in Hospital|12|||
160653214|NCT01058421|580110491|FG000|1 Month Outcomes|Remained in Other Facility|16|||
160653215|NCT01058421|580110492|FG001|1 Month Outcomes|Remained in Other Facility|17|||
160653216|NCT01058421|580110491|FG000|3 Month Outcomes|Death|3|||
160653217|NCT01058421|580110492|FG001|3 Month Outcomes|Death|5|||
160653218|NCT01058421|580110491|FG000|3 Month Outcomes|Lost to Follow-up|12|||
160653219|NCT01058421|580110492|FG001|3 Month Outcomes|Lost to Follow-up|11|||
160653220|NCT01058421|580110491|FG000|3 Month Outcomes|Remained in Hospital|0|||
160653221|NCT01058421|580110492|FG001|3 Month Outcomes|Remained in Hospital|2|||
160653222|NCT01058421|580110491|FG000|3 Month Outcomes|Remained in Other Facility|5|||
160653223|NCT01058421|580110492|FG001|3 Month Outcomes|Remained in Other Facility|8|||
160653224|NCT01058421|580110491|FG000|6 Month Outcomes|Death|2|||
160653225|NCT01058421|580110492|FG001|6 Month Outcomes|Death|2|||
160653226|NCT01058421|580110491|FG000|6 Month Outcomes|Lost to Follow-up|16|||
160653227|NCT01058421|580110492|FG001|6 Month Outcomes|Lost to Follow-up|21|||
160653228|NCT01058421|580110491|FG000|6 Month Outcomes|Remained in Other Facility|1|||
160653229|NCT01058421|580110492|FG001|6 Month Outcomes|Remained in Other Facility|3|||
160653230|NCT02984683|580110493|FG000|Overall Study|Adverse Event|3|||
160653231|NCT02984683|580110494|FG001|Overall Study|Adverse Event|3|||
160653232|NCT02984683|580110493|FG000|Overall Study|Withdrawal by Subject|1|||
160653233|NCT02984683|580110494|FG001|Overall Study|Withdrawal by Subject|0|||
160653234|NCT02984683|580110493|FG000|Overall Study|Disease progression|7|||
160653235|NCT02984683|580110494|FG001|Overall Study|Disease progression|9|||
160653236|NCT03131999|580110495|FG000|Overall Study|Withdrawal by Subject|0|||
160653237|NCT03131999|580110496|FG001|Overall Study|Withdrawal by Subject|1|||
160653238|NCT02260492|580110497|FG000|Overall Study|Adverse Event|6|||
160653239|NCT02260492|580110498|FG001|Overall Study|Adverse Event|1|||
160653240|NCT02260492|580110499|FG002|Overall Study|Adverse Event|2|||
160653241|NCT02260492|580110497|FG000|Overall Study|Death|0|||
160653242|NCT02260492|580110498|FG001|Overall Study|Death|1|||
160653243|NCT02260492|580110499|FG002|Overall Study|Death|0|||
160653244|NCT02260492|580110497|FG000|Overall Study|Lost to Follow-up|12|||
160653245|NCT02260492|580110498|FG001|Overall Study|Lost to Follow-up|9|||
160653246|NCT02260492|580110499|FG002|Overall Study|Lost to Follow-up|0|||
160653247|NCT02260492|580110497|FG000|Overall Study|Physician Decision|2|||
160653248|NCT02260492|580110498|FG001|Overall Study|Physician Decision|0|||
160653249|NCT02260492|580110499|FG002|Overall Study|Physician Decision|1|||
160653250|NCT02260492|580110497|FG000|Overall Study|Withdrawal by Subject|3|||
160653251|NCT02260492|580110498|FG001|Overall Study|Withdrawal by Subject|2|||
160653252|NCT02260492|580110499|FG002|Overall Study|Withdrawal by Subject|2|||
160653253|NCT04634409|580110500|FG000|Overall Study|Death|0|||
160653254|NCT04634409|580110501|FG001|Overall Study|Death|0|||
160653255|NCT04634409|580110502|FG002|Overall Study|Death|0|||
160653256|NCT04634409|580110503|FG003|Overall Study|Death|0|||
160653257|NCT04634409|580110504|FG004|Overall Study|Death|0|||
160653258|NCT04634409|580110505|FG005|Overall Study|Death|0|||
160653259|NCT04634409|580110506|FG006|Overall Study|Death|0|||
160996596|NCT02596035|581373673|FG000|Overall Study|study drug toxicity|12|||
160996597|NCT02596035|581373674|FG001|Overall Study|study drug toxicity|3|||
160996598|NCT02596035|581373675|FG002|Overall Study|study drug toxicity|0|||
160996599|NCT02596035|581373673|FG000|Overall Study|AE unrelated to study drug|5|||
160996600|NCT02596035|581373674|FG001|Overall Study|AE unrelated to study drug|2|||
160996601|NCT02596035|581373675|FG002|Overall Study|AE unrelated to study drug|0|||
160996602|NCT02596035|581373673|FG000|Overall Study|participant request to discontinue study treatment|2|||
160996603|NCT02596035|581373674|FG001|Overall Study|participant request to discontinue study treatment|0|||
160996604|NCT02596035|581373675|FG002|Overall Study|participant request to discontinue study treatment|0|||
160996605|NCT02596035|581373673|FG000|Overall Study|participant withdrew consent|2|||
160453926|NCT03710603|579393966|FG001|Overall Study|Withdrawal by Subject|10|||
160996606|NCT02596035|581373674|FG001|Overall Study|participant withdrew consent|2|||
160653260|NCT04634409|580110507|FG007|Overall Study|Death|0|||
160653261|NCT04634409|580110508|FG008|Overall Study|Death|0|||
160653262|NCT04634409|580110509|FG009|Overall Study|Death|0|||
160653263|NCT04634409|580110510|FG010|Overall Study|Death|1|||
160653264|NCT04634409|580110511|FG011|Overall Study|Death|0|||
160653265|NCT04634409|580110512|FG012|Overall Study|Death|1|||
160653266|NCT04634409|580110513|FG013|Overall Study|Death|0|||
160653267|NCT04634409|580110514|FG014|Overall Study|Death|0|||
160653268|NCT04634409|580110515|FG015|Overall Study|Death|0|||
160653269|NCT04634409|580110516|FG016|Overall Study|Death|0|||
160653270|NCT04634409|580110517|FG017|Overall Study|Death|0|||
160653271|NCT04634409|580110518|FG018|Overall Study|Death|0|||
160653272|NCT04634409|580110519|FG019|Overall Study|Death|0|||
160653273|NCT04634409|580110520|FG020|Overall Study|Death|0|||
160653274|NCT04634409|580110521|FG021|Overall Study|Death|0|||
160653275|NCT04634409|580110522|FG022|Overall Study|Death|0|||
160653276|NCT04634409|580110523|FG023|Overall Study|Death|0|||
160653277|NCT04634409|580110524|FG024|Overall Study|Death|0|||
160653278|NCT04634409|580110525|FG025|Overall Study|Death|0|||
160653279|NCT04634409|580110526|FG026|Overall Study|Death|0|||
160653280|NCT04634409|580110500|FG000|Overall Study|Adverse Event|0|||
160653281|NCT04634409|580110501|FG001|Overall Study|Adverse Event|0|||
160653282|NCT04634409|580110502|FG002|Overall Study|Adverse Event|1|||
160653283|NCT04634409|580110503|FG003|Overall Study|Adverse Event|0|||
160653284|NCT04634409|580110504|FG004|Overall Study|Adverse Event|0|||
160653285|NCT04634409|580110505|FG005|Overall Study|Adverse Event|1|||
160653286|NCT04634409|580110506|FG006|Overall Study|Adverse Event|0|||
160653287|NCT04634409|580110507|FG007|Overall Study|Adverse Event|0|||
160653288|NCT04634409|580110508|FG008|Overall Study|Adverse Event|0|||
160653289|NCT04634409|580110509|FG009|Overall Study|Adverse Event|0|||
160653290|NCT04634409|580110510|FG010|Overall Study|Adverse Event|0|||
160996607|NCT02596035|581373675|FG002|Overall Study|participant withdrew consent|0|||
160996608|NCT02596035|581373673|FG000|Overall Study|Poor/Non Comlpiance|0|||
160996609|NCT02596035|581373674|FG001|Overall Study|Poor/Non Comlpiance|1|||
160996610|NCT02596035|581373675|FG002|Overall Study|Poor/Non Comlpiance|0|||
160996611|NCT02596035|581373673|FG000|Overall Study|participant no longer meets study criteria|1|||
160996612|NCT02596035|581373674|FG001|Overall Study|participant no longer meets study criteria|0|||
160996613|NCT02596035|581373675|FG002|Overall Study|participant no longer meets study criteria|0|||
160996614|NCT02596035|581373673|FG000|Overall Study|other reasons|11|||
160996615|NCT02596035|581373674|FG001|Overall Study|other reasons|4|||
160996616|NCT02596035|581373675|FG002|Overall Study|other reasons|0|||
160996617|NCT03523962|581373679|FG000|Closed Fractures|Death|86|||
160653291|NCT04634409|580110511|FG011|Overall Study|Adverse Event|0|||
160653292|NCT04634409|580110512|FG012|Overall Study|Adverse Event|0|||
160653293|NCT04634409|580110513|FG013|Overall Study|Adverse Event|0|||
160653294|NCT04634409|580110514|FG014|Overall Study|Adverse Event|0|||
160653295|NCT04634409|580110515|FG015|Overall Study|Adverse Event|0|||
160653296|NCT04634409|580110516|FG016|Overall Study|Adverse Event|0|||
160653297|NCT04634409|580110517|FG017|Overall Study|Adverse Event|0|||
160653298|NCT04634409|580110518|FG018|Overall Study|Adverse Event|0|||
160653299|NCT04634409|580110519|FG019|Overall Study|Adverse Event|0|||
160653300|NCT04634409|580110520|FG020|Overall Study|Adverse Event|0|||
160653301|NCT04634409|580110521|FG021|Overall Study|Adverse Event|0|||
160653302|NCT04634409|580110522|FG022|Overall Study|Adverse Event|0|||
160653303|NCT04634409|580110523|FG023|Overall Study|Adverse Event|0|||
160653304|NCT04634409|580110524|FG024|Overall Study|Adverse Event|0|||
160653305|NCT04634409|580110525|FG025|Overall Study|Adverse Event|0|||
160996618|NCT03523962|581373680|FG001|Closed Fractures|Death|71|||
160996619|NCT03523962|581373681|FG002|Closed Fractures|Death|0|||
160996620|NCT03523962|581373682|FG003|Closed Fractures|Death|0|||
160996621|NCT03523962|581373679|FG000|Closed Fractures|Lost to Follow-up|62|||
160996622|NCT03523962|581373680|FG001|Closed Fractures|Lost to Follow-up|36|||
160996623|NCT03523962|581373681|FG002|Closed Fractures|Lost to Follow-up|0|||
160996624|NCT03523962|581373682|FG003|Closed Fractures|Lost to Follow-up|0|||
160996625|NCT03523962|581373679|FG000|Closed Fractures|Withdrawal by Subject|19|||
160996626|NCT03523962|581373680|FG001|Closed Fractures|Withdrawal by Subject|29|||
160996627|NCT03523962|581373681|FG002|Closed Fractures|Withdrawal by Subject|0|||
160996628|NCT03523962|581373682|FG003|Closed Fractures|Withdrawal by Subject|0|||
160996629|NCT03523962|581373679|FG000|Closed Fractures|Incarceration|1|||
160996630|NCT03523962|581373680|FG001|Closed Fractures|Incarceration|4|||
160996631|NCT03523962|581373681|FG002|Closed Fractures|Incarceration|0|||
160996632|NCT03523962|581373682|FG003|Closed Fractures|Incarceration|0|||
160996633|NCT03523962|581373679|FG000|Open Fractures|Death|0|||
160996634|NCT03523962|581373680|FG001|Open Fractures|Death|0|||
160996635|NCT03523962|581373681|FG002|Open Fractures|Death|11|||
160996636|NCT03523962|581373682|FG003|Open Fractures|Death|6|||
160996637|NCT03523962|581373679|FG000|Open Fractures|Lost to Follow-up|0|||
160996638|NCT03523962|581373680|FG001|Open Fractures|Lost to Follow-up|0|||
160996639|NCT03523962|581373681|FG002|Open Fractures|Lost to Follow-up|15|||
160996640|NCT03523962|581373682|FG003|Open Fractures|Lost to Follow-up|8|||
160996641|NCT03523962|581373679|FG000|Open Fractures|Withdrawal by Subject|0|||
160996642|NCT03523962|581373680|FG001|Open Fractures|Withdrawal by Subject|0|||
160996643|NCT03523962|581373681|FG002|Open Fractures|Withdrawal by Subject|6|||
160996644|NCT03523962|581373682|FG003|Open Fractures|Withdrawal by Subject|2|||
160996645|NCT03523962|581373679|FG000|Open Fractures|Incarceration|0|||
160996646|NCT03523962|581373680|FG001|Open Fractures|Incarceration|0|||
160996647|NCT03523962|581373681|FG002|Open Fractures|Incarceration|1|||
160996648|NCT03523962|581373682|FG003|Open Fractures|Incarceration|0|||
160996649|NCT00835380|581373683|FG000|Overall Study|Withdrawal by Subject|2|||
160996650|NCT01081145|581373684|FG000|Open-Label Phase|Lack of Efficacy|56|||
160996651|NCT01081145|581373685|FG001|Open-Label Phase|Lack of Efficacy|0|||
160996652|NCT01081145|581373684|FG000|Open-Label Phase|Response criteria not met|46|||
160996653|NCT01081145|581373685|FG001|Open-Label Phase|Response criteria not met|0|||
160996654|NCT01081145|581373684|FG000|Open-Label Phase|Adverse Event|42|||
160996655|NCT01081145|581373685|FG001|Open-Label Phase|Adverse Event|0|||
160996656|NCT01081145|581373684|FG000|Open-Label Phase|Withdrawal by Subject|41|||
160996657|NCT01081145|581373685|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160996658|NCT01081145|581373684|FG000|Open-Label Phase|Other|12|||
160996659|NCT01081145|581373685|FG001|Open-Label Phase|Other|0|||
160996660|NCT01081145|581373684|FG000|Open-Label Phase|Lost to Follow-up|11|||
160996661|NCT01081145|581373685|FG001|Open-Label Phase|Lost to Follow-up|0|||
160996662|NCT01081145|581373684|FG000|Open-Label Phase|Protocol Violation|4|||
160996663|NCT01081145|581373685|FG001|Open-Label Phase|Protocol Violation|0|||
160996664|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
160996665|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
160996666|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
160996667|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
160996668|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
160996669|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
160996670|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
160996671|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
160996672|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
160996673|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
160996674|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
160996675|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
160996676|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
160996677|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
160996678|NCT03593070|581373686|FG000|Overall Study|administrative withdrawal|1|||
160996679|NCT03593070|581373687|FG001|Overall Study|administrative withdrawal|1|||
160996680|NCT00881335|581373688|FG000|Overall Study|Lost to Follow-up|3|||
160996681|NCT00881335|581373689|FG001|Overall Study|Lost to Follow-up|2|||
160996682|NCT03681678|581373690|FG000|Overall Study|Lost to Follow-up|20|||
160996683|NCT00828945|581373693|FG000|Overall Study|Death|4|||
160996684|NCT00828945|581373693|FG000|Overall Study|Participant was missing|1|||
160996685|NCT00828945|581373693|FG000|Overall Study|Other|36|||
160996686|NCT02141074|581373696|FG000|Pre-prophylaxis|Adverse Event|3|||
160996687|NCT02141074|581373697|FG001|Pre-prophylaxis|Adverse Event|0|||
160453927|NCT00592852|579393967|FG000|Overall Study|Non-compliance|1|||
160653306|NCT04634409|580110526|FG026|Overall Study|Adverse Event|0|||
160996688|NCT02141074|581373696|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
160996689|NCT02141074|581373697|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
160996690|NCT02141074|581373696|FG000|Prophylaxis|Adverse Event|0|||
160996691|NCT02141074|581373697|FG001|Prophylaxis|Adverse Event|4|||
160996692|NCT02141074|581373696|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
160996693|NCT02141074|581373697|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
160996694|NCT02141074|581373696|FG000|Prophylaxis|Withdrawal by Subject|0|||
160996695|NCT02141074|581373697|FG001|Prophylaxis|Withdrawal by Subject|1|||
160996696|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
160996697|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
160996698|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996699|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160453928|NCT00592852|579393967|FG000|Overall Study|Adverse Event|3|||
160996700|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996701|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996702|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996703|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996704|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996705|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996706|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996707|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996708|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996709|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
160996710|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996711|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996712|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996713|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996714|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996715|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996716|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996717|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996718|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996719|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996720|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
160996721|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
160996722|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996723|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996724|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996725|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996726|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996727|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996728|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996729|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996730|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996731|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996732|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996733|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
160996734|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996735|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996736|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996737|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996738|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996739|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996740|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996741|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996742|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996743|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996744|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996745|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
160996746|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996747|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996748|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996749|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996750|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996751|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996752|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160653307|NCT04634409|580110500|FG000|Overall Study|Lost to Follow-up|3|||
160653308|NCT04634409|580110501|FG001|Overall Study|Lost to Follow-up|1|||
160653309|NCT04634409|580110502|FG002|Overall Study|Lost to Follow-up|1|||
160653310|NCT04634409|580110503|FG003|Overall Study|Lost to Follow-up|3|||
160917741|NCT02730455|581091747|FG002|Overall Study|Other|2|||
160917742|NCT02730455|581091745|FG000|Overall Study|Other|2|||
160917743|NCT02730455|581091746|FG001|Overall Study|Other|2|||
160917744|NCT02730455|581091747|FG002|Overall Study|Other|0|||
160917745|NCT05582889|581091750|FG000|Overall Study|Health event|3|||
160917746|NCT05582889|581091751|FG001|Overall Study|Health event|2|||
160917747|NCT05582889|581091750|FG000|Overall Study|Lost to Follow-up|2|||
160917748|NCT05582889|581091751|FG001|Overall Study|Lost to Follow-up|4|||
160917749|NCT00001723|581091752|FG000|Overall Study|Lack of Efficacy|6|||
160917750|NCT00001723|581091753|FG001|Overall Study|Lack of Efficacy|7|||
160917751|NCT00001723|581091752|FG000|Overall Study|Lack of family interest|4|||
160917752|NCT00001723|581091753|FG001|Overall Study|Lack of family interest|5|||
160917753|NCT00001723|581091752|FG000|Overall Study|Lost to Follow-up|2|||
160917754|NCT00001723|581091753|FG001|Overall Study|Lost to Follow-up|2|||
160917755|NCT00001723|581091752|FG000|Overall Study|medication intolerance|1|||
160917756|NCT00001723|581091753|FG001|Overall Study|medication intolerance|2|||
160917757|NCT04551092|581091754|FG000|Overall Study|Lost to Follow-up|7|||
160917758|NCT04551092|581091754|FG000|Overall Study|Withdrawal by Subject|4|||
160917759|NCT01324999|581091755|FG000|Overall Study|Adverse Event|3|||
160917760|NCT01324999|581091755|FG000|Overall Study|Withdrawal by Subject|2|||
160917761|NCT01714635|581091761|FG000|Overall Study|Discontinued|1|||
160917762|NCT01714635|581091762|FG001|Overall Study|Discontinued|0|||
160917763|NCT01714635|581091763|FG002|Overall Study|Discontinued|2|||
160917764|NCT01714635|581091761|FG000|Overall Study|Missed 6-month exam|1|||
160917765|NCT01714635|581091762|FG001|Overall Study|Missed 6-month exam|0|||
160917766|NCT01714635|581091763|FG002|Overall Study|Missed 6-month exam|0|||
160917767|NCT02848651|581091765|FG000|Overall Study|Death|85|||
160917768|NCT02848651|581091765|FG000|Overall Study|Lost to Follow-up|1|||
160917769|NCT02848651|581091765|FG000|Overall Study|Non-Compliance|1|||
160917770|NCT02848651|581091765|FG000|Overall Study|Symptomatic Deterioration|1|||
160917771|NCT02848651|581091765|FG000|Overall Study|Physician Decision|4|||
160917772|NCT02848651|581091765|FG000|Overall Study|Withdrawal by Subject|14|||
160917773|NCT00396591|581091770|FG000|Overall Study|Disease Progression|13|||
160917774|NCT00396591|581091770|FG000|Overall Study|Adverse Event|2|||
160917775|NCT00396591|581091770|FG000|Overall Study|Participant request|1|||
160917776|NCT01535053|581091773|FG000|Overall Study|Ineligible|1|||
160917777|NCT01535053|581091774|FG001|Overall Study|Ineligible|2|||
160917778|NCT00512707|581091775|FG000|Overall Study|Lost to Follow-up|5|||
160917779|NCT00512707|581091776|FG001|Overall Study|Lost to Follow-up|11|||
160917780|NCT00512707|581091775|FG000|Overall Study|Developed skin irritation|2|||
160917781|NCT00512707|581091776|FG001|Overall Study|Developed skin irritation|1|||
160917782|NCT00512707|581091775|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
160917783|NCT00512707|581091776|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
160917784|NCT00512707|581091775|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
160917785|NCT00512707|581091776|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
160917786|NCT01853826|581094094|FG000|Overall Study|Patients who switched to commercial drug|11|||
160917787|NCT01853826|581094094|FG000|Overall Study|Patient refused to continue medication|21|||
160917788|NCT01853826|581094094|FG000|Overall Study|Lost to Follow-up|2|||
160917789|NCT01853826|581094094|FG000|Overall Study|Non-compliant with protocol|4|||
160917790|NCT01853826|581094094|FG000|Overall Study|Other adverse events (AE)|62|||
160917791|NCT01853826|581094094|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
160917792|NCT01853826|581094094|FG000|Overall Study|Progressive disease|342|||
160917793|NCT01853826|581094094|FG000|Overall Study|Other than listed|13|||
160917794|NCT01853826|581094094|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
160917795|NCT03653637|581094095|FG000|Overall Study|Death|1|||
160917796|NCT03653637|581094096|FG001|Overall Study|Death|3|||
160917797|NCT03653637|581094095|FG000|Overall Study|Lost to Follow-up|29|||
160917798|NCT03653637|581094096|FG001|Overall Study|Lost to Follow-up|30|||
160917799|NCT03653637|581094095|FG000|Overall Study|Physician Decision|1|||
160917800|NCT03653637|581094096|FG001|Overall Study|Physician Decision|1|||
160917801|NCT03653637|581094095|FG000|Overall Study|Withdrawal by Subject|7|||
160917802|NCT03653637|581094096|FG001|Overall Study|Withdrawal by Subject|4|||
160917803|NCT02068443|581094107|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160917804|NCT02068443|581094108|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
160917805|NCT02068443|581094109|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
160917806|NCT02068443|581094107|FG000|Overall Study|Voluntary Withdrawal|4|||
160917807|NCT02068443|581094108|FG001|Overall Study|Voluntary Withdrawal|0|||
160917808|NCT02068443|581094109|FG002|Overall Study|Voluntary Withdrawal|1|||
160917809|NCT02068443|581094107|FG000|Overall Study|Lack of Efficacy|2|||
160917810|NCT02068443|581094108|FG001|Overall Study|Lack of Efficacy|1|||
160917811|NCT02068443|581094109|FG002|Overall Study|Lack of Efficacy|0|||
160917812|NCT02068443|581094107|FG000|Overall Study|Other Reason Not Specified|1|||
160653311|NCT04634409|580110504|FG004|Overall Study|Lost to Follow-up|1|||
160653312|NCT04634409|580110505|FG005|Overall Study|Lost to Follow-up|1|||
160653313|NCT04634409|580110506|FG006|Overall Study|Lost to Follow-up|1|||
160653314|NCT04634409|580110507|FG007|Overall Study|Lost to Follow-up|3|||
160653315|NCT04634409|580110508|FG008|Overall Study|Lost to Follow-up|3|||
160653316|NCT04634409|580110509|FG009|Overall Study|Lost to Follow-up|11|||
160653317|NCT04634409|580110510|FG010|Overall Study|Lost to Follow-up|8|||
160653318|NCT04634409|580110511|FG011|Overall Study|Lost to Follow-up|15|||
160653319|NCT04634409|580110512|FG012|Overall Study|Lost to Follow-up|3|||
160653320|NCT04634409|580110513|FG013|Overall Study|Lost to Follow-up|2|||
160653321|NCT04634409|580110514|FG014|Overall Study|Lost to Follow-up|7|||
160653322|NCT04634409|580110515|FG015|Overall Study|Lost to Follow-up|0|||
160653323|NCT04634409|580110516|FG016|Overall Study|Lost to Follow-up|0|||
160653324|NCT04634409|580110517|FG017|Overall Study|Lost to Follow-up|0|||
160653325|NCT04634409|580110518|FG018|Overall Study|Lost to Follow-up|0|||
160653326|NCT04634409|580110519|FG019|Overall Study|Lost to Follow-up|0|||
160653327|NCT04634409|580110520|FG020|Overall Study|Lost to Follow-up|0|||
160653328|NCT04634409|580110521|FG021|Overall Study|Lost to Follow-up|0|||
160653329|NCT04634409|580110522|FG022|Overall Study|Lost to Follow-up|0|||
160653330|NCT04634409|580110523|FG023|Overall Study|Lost to Follow-up|0|||
160996753|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996754|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996755|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996756|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996757|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
160996758|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996759|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996760|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996761|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996762|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996763|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996764|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996765|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996766|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996767|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996768|NCT03536884|581373698|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996769|NCT03536884|581373699|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996770|NCT03536884|581373700|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
160996771|NCT03536884|581373701|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996772|NCT03536884|581373702|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
160996773|NCT03536884|581373703|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996774|NCT03536884|581373704|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996775|NCT03536884|581373705|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996776|NCT03536884|581373706|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996777|NCT03536884|581373707|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996778|NCT03536884|581373708|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996779|NCT03536884|581373709|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996780|NCT03536884|581373698|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996781|NCT03536884|581373699|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996782|NCT03536884|581373700|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
160996783|NCT03536884|581373701|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
160996784|NCT03536884|581373702|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
160996785|NCT03536884|581373703|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996786|NCT03536884|581373704|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996787|NCT03536884|581373705|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996788|NCT03536884|581373706|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160653331|NCT04634409|580110524|FG024|Overall Study|Lost to Follow-up|0|||
160653332|NCT04634409|580110525|FG025|Overall Study|Lost to Follow-up|0|||
160653333|NCT04634409|580110526|FG026|Overall Study|Lost to Follow-up|0|||
160653334|NCT04634409|580110500|FG000|Overall Study|Withdrawal by Subject|3|||
160653335|NCT04634409|580110501|FG001|Overall Study|Withdrawal by Subject|1|||
160653336|NCT04634409|580110502|FG002|Overall Study|Withdrawal by Subject|6|||
160653337|NCT04634409|580110503|FG003|Overall Study|Withdrawal by Subject|4|||
160996789|NCT03536884|581373707|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996790|NCT03536884|581373708|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996791|NCT03536884|581373709|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996792|NCT03536884|581373698|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160653338|NCT04634409|580110504|FG004|Overall Study|Withdrawal by Subject|2|||
160653339|NCT04634409|580110505|FG005|Overall Study|Withdrawal by Subject|0|||
160653340|NCT04634409|580110506|FG006|Overall Study|Withdrawal by Subject|0|||
160861849|NCT02531802|580887845|FG000|Received Vaccination 2|Adverse Event|0|||
160653341|NCT04634409|580110507|FG007|Overall Study|Withdrawal by Subject|2|||
160653342|NCT04634409|580110508|FG008|Overall Study|Withdrawal by Subject|3|||
160653343|NCT04634409|580110509|FG009|Overall Study|Withdrawal by Subject|2|||
160653344|NCT04634409|580110510|FG010|Overall Study|Withdrawal by Subject|3|||
160653345|NCT04634409|580110511|FG011|Overall Study|Withdrawal by Subject|2|||
160653346|NCT04634409|580110512|FG012|Overall Study|Withdrawal by Subject|2|||
160653347|NCT04634409|580110513|FG013|Overall Study|Withdrawal by Subject|1|||
160653348|NCT04634409|580110514|FG014|Overall Study|Withdrawal by Subject|5|||
160653349|NCT04634409|580110515|FG015|Overall Study|Withdrawal by Subject|0|||
160996793|NCT03536884|581373699|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996794|NCT03536884|581373700|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996795|NCT03536884|581373701|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
160996796|NCT03536884|581373702|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
160996797|NCT03536884|581373703|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996798|NCT03536884|581373704|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996799|NCT03536884|581373705|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996800|NCT03536884|581373706|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996801|NCT03536884|581373707|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160653350|NCT04634409|580110516|FG016|Overall Study|Withdrawal by Subject|0|||
160653351|NCT04634409|580110517|FG017|Overall Study|Withdrawal by Subject|1|||
160917813|NCT02068443|581094108|FG001|Overall Study|Other Reason Not Specified|0|||
160917814|NCT02068443|581094109|FG002|Overall Study|Other Reason Not Specified|0|||
160917815|NCT02723084|581094111|FG000|Overall Study|Withdrawal by Subject|1|||
160917816|NCT02723084|581094112|FG001|Overall Study|Withdrawal by Subject|1|||
160917817|NCT02723084|581094111|FG000|Overall Study|Lost to Follow-up|3|||
160917818|NCT02723084|581094112|FG001|Overall Study|Lost to Follow-up|0|||
160917819|NCT04067544|581094117|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
160917820|NCT01320085|581094118|FG000|Overall Study|Disease Progression|26|||
160917821|NCT01320085|581094119|FG001|Overall Study|Disease Progression|93|||
160917822|NCT01320085|581094120|FG002|Overall Study|Disease Progression|17|||
160917823|NCT01320085|581094118|FG000|Overall Study|Adverse Event|12|||
160917824|NCT01320085|581094119|FG001|Overall Study|Adverse Event|20|||
160917825|NCT01320085|581094120|FG002|Overall Study|Adverse Event|5|||
160917826|NCT01320085|581094118|FG000|Overall Study|Withdrawal by Subject|2|||
160917827|NCT01320085|581094119|FG001|Overall Study|Withdrawal by Subject|4|||
160917828|NCT01320085|581094120|FG002|Overall Study|Withdrawal by Subject|1|||
160917829|NCT01320085|581094118|FG000|Overall Study|Protocol Deviation|1|||
160917830|NCT01320085|581094119|FG001|Overall Study|Protocol Deviation|0|||
160917831|NCT01320085|581094120|FG002|Overall Study|Protocol Deviation|1|||
160917832|NCT01320085|581094118|FG000|Overall Study|Administrative problems|0|||
160917833|NCT01320085|581094119|FG001|Overall Study|Administrative problems|0|||
160917834|NCT01320085|581094120|FG002|Overall Study|Administrative problems|1|||
160917835|NCT00225251|581094123|FG000|Overall Study|Withdrawal by Subject|1|||
160917836|NCT00225251|581094124|FG001|Overall Study|Withdrawal by Subject|1|||
160917837|NCT01702454|581094125|FG000|Overall Study|Consent withdrawal|0|||
160917838|NCT01702454|581094126|FG001|Overall Study|Consent withdrawal|1|||
160917839|NCT01702454|581094125|FG000|Overall Study|Migrated/moved from study area|0|||
160917840|NCT01702454|581094126|FG001|Overall Study|Migrated/moved from study area|1|||
160917841|NCT01702454|581094125|FG000|Overall Study|Lost to Follow-up|3|||
160917842|NCT01702454|581094126|FG001|Overall Study|Lost to Follow-up|6|||
160917843|NCT03510884|581094127|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
160917844|NCT03510884|581094128|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
160917845|NCT03510884|581094129|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
160917846|NCT03510884|581094130|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
160917847|NCT03510884|581094127|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
160917848|NCT03510884|581094128|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
160917849|NCT03510884|581094129|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
160917850|NCT03510884|581094130|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
160917851|NCT03510884|581094127|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
160917852|NCT03510884|581094128|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
160917853|NCT03510884|581094129|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
160917854|NCT03510884|581094130|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
160917855|NCT03510884|581094127|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
160917856|NCT03510884|581094128|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
160917857|NCT03510884|581094129|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
160917858|NCT03510884|581094130|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
160653352|NCT04634409|580110518|FG018|Overall Study|Withdrawal by Subject|0|||
160653353|NCT04634409|580110519|FG019|Overall Study|Withdrawal by Subject|0|||
160653354|NCT04634409|580110520|FG020|Overall Study|Withdrawal by Subject|0|||
160653442|NCT02581345|580112379|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
160653443|NCT02581345|580112380|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
160653444|NCT02581345|580112381|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
160653445|NCT02581345|580112382|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
160653446|NCT01768858|580112385|FG000|Overall Study|Lost to Follow-up|9|||
160653447|NCT01768858|580112385|FG000|Overall Study|Lack of Efficacy|8|||
160653448|NCT01768858|580112385|FG000|Overall Study|Serious Adverse Event|1|||
160653449|NCT01768858|580112385|FG000|Overall Study|Participant moved to Germany|1|||
160653450|NCT01768858|580112385|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
160653451|NCT01768858|580112385|FG000|Overall Study|Exanthema|1|||
160653452|NCT01768858|580112385|FG000|Overall Study|Withdrawal by Subject|1|||
160653453|NCT02742090|580112388|FG000|Overall Study|Adverse Event|10|||
160653454|NCT02742090|580112388|FG000|Overall Study|Death|3|||
160653455|NCT02742090|580112388|FG000|Overall Study|Disease Progression|25|||
160653456|NCT02742090|580112388|FG000|Overall Study|Investigator's Decision|1|||
160653457|NCT02742090|580112388|FG000|Overall Study|Lost to Follow-up|1|||
160653458|NCT02742090|580112388|FG000|Overall Study|Non-compliance with Study|1|||
160653459|NCT02742090|580112388|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
160653460|NCT02742090|580112388|FG000|Overall Study|Withdrawal by Subject|4|||
160653461|NCT02742090|580112388|FG000|Overall Study|Reason Not Specified|1|||
160653462|NCT00502775|580112394|FG000|Overall Study|Adverse Event|1|||
160653463|NCT00502775|580112395|FG001|Overall Study|Adverse Event|2|||
160653464|NCT00502775|580112396|FG002|Overall Study|Adverse Event|1|||
160653465|NCT00502775|580112394|FG000|Overall Study|Protocol Violation|1|||
160653466|NCT00502775|580112395|FG001|Overall Study|Protocol Violation|5|||
160653467|NCT00502775|580112396|FG002|Overall Study|Protocol Violation|2|||
160653468|NCT00502775|580112394|FG000|Overall Study|Withdrawal by Subject|1|||
160653469|NCT00502775|580112395|FG001|Overall Study|Withdrawal by Subject|1|||
160653470|NCT00502775|580112396|FG002|Overall Study|Withdrawal by Subject|2|||
160653471|NCT00502775|580112394|FG000|Overall Study|Sponsor Terminated Study|1|||
160653472|NCT00502775|580112395|FG001|Overall Study|Sponsor Terminated Study|0|||
160653473|NCT00502775|580112396|FG002|Overall Study|Sponsor Terminated Study|1|||
160653474|NCT00502775|580112394|FG000|Overall Study|Non-compliance with eDiary|4|||
160653475|NCT00502775|580112395|FG001|Overall Study|Non-compliance with eDiary|1|||
160653476|NCT00502775|580112396|FG002|Overall Study|Non-compliance with eDiary|1|||
160653477|NCT00502775|580112394|FG000|Overall Study|Subject unable to swallow capsule|1|||
160653478|NCT00502775|580112395|FG001|Overall Study|Subject unable to swallow capsule|0|||
160653479|NCT00502775|580112396|FG002|Overall Study|Subject unable to swallow capsule|1|||
160653480|NCT00502775|580112394|FG000|Overall Study|Logpad compliance <80%|1|||
160653481|NCT00502775|580112395|FG001|Overall Study|Logpad compliance <80%|0|||
160653482|NCT00502775|580112396|FG002|Overall Study|Logpad compliance <80%|0|||
160653483|NCT00502775|580112394|FG000|Overall Study|Randomized in error|0|||
160653484|NCT00502775|580112395|FG001|Overall Study|Randomized in error|1|||
160653485|NCT00502775|580112396|FG002|Overall Study|Randomized in error|1|||
160653486|NCT00502775|580112394|FG000|Overall Study|Non-compliance|0|||
160653487|NCT00502775|580112395|FG001|Overall Study|Non-compliance|2|||
160653488|NCT00502775|580112396|FG002|Overall Study|Non-compliance|2|||
160653489|NCT00502775|580112394|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
160653490|NCT00502775|580112395|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
160653491|NCT00502775|580112396|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
160653492|NCT00502775|580112394|FG000|Overall Study|Declining pollen counts|0|||
160653493|NCT00502775|580112395|FG001|Overall Study|Declining pollen counts|1|||
160653494|NCT00502775|580112396|FG002|Overall Study|Declining pollen counts|1|||
160653495|NCT00502775|580112394|FG000|Overall Study|Subject in jail|0|||
160653496|NCT00502775|580112395|FG001|Overall Study|Subject in jail|1|||
160653497|NCT00502775|580112396|FG002|Overall Study|Subject in jail|0|||
160653498|NCT00502775|580112394|FG000|Overall Study|Subject took disallowed drug|0|||
160653499|NCT00502775|580112395|FG001|Overall Study|Subject took disallowed drug|0|||
160653500|NCT00502775|580112396|FG002|Overall Study|Subject took disallowed drug|1|||
160653501|NCT02309099|580112400|FG000|Overall Study|Adverse Event|2|||
160653502|NCT02309099|580112401|FG001|Overall Study|Adverse Event|0|||
160653503|NCT02819362|580112403|FG000|Overall Study|On-site MRI could not be performed|70|||
160653504|NCT01545076|580112404|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
160653505|NCT01545076|580112405|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
160653506|NCT01545076|580112406|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
160653507|NCT01545076|580112407|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
160653508|NCT01545076|580112408|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
160653509|NCT01545076|580112404|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
160653510|NCT01545076|580112405|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
160653511|NCT01545076|580112406|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
160653512|NCT01545076|580112407|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
160653513|NCT01545076|580112408|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
160653514|NCT01545076|580112404|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
160653515|NCT01545076|580112405|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
160653516|NCT01545076|580112406|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
160653517|NCT01545076|580112407|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
160653518|NCT01545076|580112408|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
160653519|NCT01545076|580112404|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
160653520|NCT01545076|580112405|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
160653521|NCT01545076|580112406|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
160653522|NCT01545076|580112407|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
160653523|NCT01545076|580112408|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
160653524|NCT01545076|580112404|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
160653525|NCT01545076|580112405|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
160653526|NCT01545076|580112406|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
160653527|NCT01545076|580112407|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
160653528|NCT01545076|580112408|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
160653529|NCT01545076|580112404|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
160653530|NCT01545076|580112405|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
160653531|NCT01545076|580112406|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
160653532|NCT01545076|580112407|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
160653533|NCT01545076|580112408|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
160653534|NCT01545076|580112404|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
160653535|NCT01545076|580112405|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
160653536|NCT01545076|580112406|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
160653537|NCT01545076|580112407|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
160653538|NCT01545076|580112408|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
160653539|NCT01545076|580112404|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
160653540|NCT01545076|580112405|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
160653541|NCT01545076|580112406|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
160653542|NCT01545076|580112407|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
160653543|NCT01545076|580112408|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
160653544|NCT01545076|580112404|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
160653545|NCT01545076|580112405|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
160653546|NCT01545076|580112406|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
160653547|NCT01545076|580112407|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
160653548|NCT01545076|580112408|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
160653549|NCT05456529|580112409|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
160653550|NCT05456529|580112409|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
160653551|NCT05456529|580112409|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
160653552|NCT05456529|580112409|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
160653553|NCT05456529|580112409|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
160653554|NCT05456529|580112409|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
160653555|NCT05456529|580112409|FG000|44-week Long-term Safety Period|Physician Decision|2|||
160653556|NCT05456529|580112409|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
160653557|NCT05456529|580112409|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
160653558|NCT05456529|580112409|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
160653559|NCT05456529|580112409|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
160653560|NCT02710123|580112410|FG000|Overall Study|Lost to Follow-up|3|||
160653561|NCT02710123|580112411|FG001|Overall Study|Lost to Follow-up|4|||
160653562|NCT02710123|580112410|FG000|Overall Study|Withdrawal by Subject|1|||
160653563|NCT02710123|580112411|FG001|Overall Study|Withdrawal by Subject|1|||
160653564|NCT02710123|580112410|FG000|Overall Study|Illness unrelated to study intervention|1|||
160653565|NCT02710123|580112411|FG001|Overall Study|Illness unrelated to study intervention|0|||
160653566|NCT00561730|580112412|FG000|Overall Study|Adverse Event|2|||
160653567|NCT00561730|580112412|FG000|Overall Study|Handling of the drug|1|||
160653568|NCT00561730|580112412|FG000|Overall Study|Lost to Follow-up|5|||
160454071|NCT02038777|579394029|FG007|Overall Study|Started Chemotherapy|0|||
160454072|NCT02038777|579394022|FG000|Overall Study|participation terminated by sponsor|0|||
160454073|NCT02038777|579394023|FG001|Overall Study|participation terminated by sponsor|0|||
160454074|NCT02038777|579394024|FG002|Overall Study|participation terminated by sponsor|0|||
160454075|NCT02038777|579394025|FG003|Overall Study|participation terminated by sponsor|0|||
160454076|NCT02038777|579394026|FG004|Overall Study|participation terminated by sponsor|0|||
160454077|NCT02038777|579394027|FG005|Overall Study|participation terminated by sponsor|0|||
160454078|NCT02038777|579394028|FG006|Overall Study|participation terminated by sponsor|1|||
160454079|NCT02038777|579394029|FG007|Overall Study|participation terminated by sponsor|1|||
160454080|NCT04299464|579394030|FG000|Overall Study|Adverse Event|1|||
160454081|NCT04299464|579394031|FG001|Overall Study|Adverse Event|0|||
160653569|NCT00561730|580112412|FG000|Overall Study|Not specified reasons|1|||
160653570|NCT03194464|580112413|FG000|Overall Study|data not usable|2|||
160454082|NCT04299464|579394032|FG002|Overall Study|Adverse Event|2|||
160653571|NCT02750761|580112414|FG000|Overall Study|Lost to Follow-up|0|||
160653572|NCT02750761|580112415|FG001|Overall Study|Lost to Follow-up|0|||
160653573|NCT02750761|580112416|FG002|Overall Study|Lost to Follow-up|1|||
160653574|NCT02750761|580112417|FG003|Overall Study|Lost to Follow-up|0|||
160653575|NCT02750761|580112418|FG004|Overall Study|Lost to Follow-up|0|||
160653576|NCT02750761|580112419|FG005|Overall Study|Lost to Follow-up|0|||
160653577|NCT01860976|580112420|FG000|Blinded Treatment|Adverse Event|1|||
160653578|NCT01860976|580112421|FG001|Blinded Treatment|Adverse Event|3|||
160653579|NCT01860976|580112420|FG000|Blinded Treatment|Lack of Efficacy|5|||
160653580|NCT01860976|580112421|FG001|Blinded Treatment|Lack of Efficacy|12|||
160653581|NCT01860976|580112420|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
160653582|NCT01860976|580112421|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
160653583|NCT01860976|580112420|FG000|Blinded Treatment|Withdrawal by Subject|3|||
160653584|NCT01860976|580112421|FG001|Blinded Treatment|Withdrawal by Subject|5|||
160653585|NCT01860976|580112420|FG000|Blinded Treatment|Subject no longer met criteria|1|||
160653586|NCT01860976|580112421|FG001|Blinded Treatment|Subject no longer met criteria|0|||
160653587|NCT01860976|580112420|FG000|Blinded Treatment|Entered Open-Label in error|0|||
160653588|NCT01860976|580112421|FG001|Blinded Treatment|Entered Open-Label in error|1|||
160653589|NCT01860976|580112420|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
160653590|NCT01860976|580112421|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
160653591|NCT01860976|580112420|FG000|Open-Label|Adverse Event|2|||
160653592|NCT01860976|580112421|FG001|Open-Label|Adverse Event|4|||
160653593|NCT01860976|580112420|FG000|Open-Label|Lack of Efficacy|16|||
160653594|NCT01860976|580112421|FG001|Open-Label|Lack of Efficacy|8|||
160653595|NCT01860976|580112420|FG000|Open-Label|Lost to Follow-up|1|||
160653596|NCT01860976|580112421|FG001|Open-Label|Lost to Follow-up|2|||
160653597|NCT01860976|580112420|FG000|Open-Label|Subject request discontinue treatment|4|||
160653598|NCT01860976|580112421|FG001|Open-Label|Subject request discontinue treatment|3|||
160653599|NCT01860976|580112420|FG000|Open-Label|Withdrawal by Subject|4|||
160653600|NCT01860976|580112421|FG001|Open-Label|Withdrawal by Subject|1|||
160653601|NCT01860976|580112420|FG000|Open-Label|Other Reasons|1|||
160653602|NCT01860976|580112421|FG001|Open-Label|Other Reasons|1|||
160653603|NCT01860976|580112420|FG000|Long Term Extension|Adverse Event|4|||
160653604|NCT01860976|580112421|FG001|Long Term Extension|Adverse Event|0|||
160653605|NCT01860976|580112420|FG000|Long Term Extension|Lack of Efficacy|2|||
160653606|NCT01860976|580112421|FG001|Long Term Extension|Lack of Efficacy|0|||
160653607|NCT01860976|580112420|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
160653608|NCT01860976|580112421|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
160653609|NCT01860976|580112420|FG000|Long Term Extension|Lost to Follow-up|2|||
160653610|NCT01860976|580112421|FG001|Long Term Extension|Lost to Follow-up|0|||
160653611|NCT01860976|580112420|FG000|Long Term Extension|subject withdrew consent|7|||
160653612|NCT01860976|580112421|FG001|Long Term Extension|subject withdrew consent|0|||
160653613|NCT00419926|580112422|FG000|Overall Study|Withdrawal by Subject|7|||
160653614|NCT00419926|580112423|FG001|Overall Study|Withdrawal by Subject|3|||
160653615|NCT00419926|580112422|FG000|Overall Study|Administrative Problem|4|||
160653616|NCT00419926|580112423|FG001|Overall Study|Administrative Problem|4|||
160653617|NCT00419926|580112422|FG000|Overall Study|Lost to Follow-up|1|||
160653618|NCT00419926|580112423|FG001|Overall Study|Lost to Follow-up|2|||
160653619|NCT00419926|580112422|FG000|Overall Study|Death|2|||
160653620|NCT00419926|580112423|FG001|Overall Study|Death|1|||
160653621|NCT02153398|580112425|FG000|Overall Study|Withdrawal by Subject|1|||
160653622|NCT02153398|580112426|FG001|Overall Study|Withdrawal by Subject|0|||
160653623|NCT02153398|580112427|FG002|Overall Study|Withdrawal by Subject|0|||
160653624|NCT02153398|580112428|FG003|Overall Study|Withdrawal by Subject|0|||
160653625|NCT02153398|580112429|FG004|Overall Study|Withdrawal by Subject|0|||
160653626|NCT02153398|580112425|FG000|Overall Study|Adverse Event|0|||
160653627|NCT02153398|580112426|FG001|Overall Study|Adverse Event|0|||
160653628|NCT02153398|580112427|FG002|Overall Study|Adverse Event|1|||
160653629|NCT02153398|580112428|FG003|Overall Study|Adverse Event|1|||
160653630|NCT02153398|580112429|FG004|Overall Study|Adverse Event|0|||
160653631|NCT02374918|580112430|FG000|Overall Study|Protocol Violation|2|||
160653632|NCT02374918|580112431|FG001|Overall Study|Protocol Violation|0|||
160653633|NCT02374918|580112432|FG002|Overall Study|Protocol Violation|2|||
160653634|NCT02374918|580112433|FG003|Overall Study|Protocol Violation|1|||
160653635|NCT02374918|580112430|FG000|Overall Study|Withdrawal by Subject|1|||
160653636|NCT02374918|580112431|FG001|Overall Study|Withdrawal by Subject|1|||
160653637|NCT02374918|580112432|FG002|Overall Study|Withdrawal by Subject|1|||
160653638|NCT02374918|580112433|FG003|Overall Study|Withdrawal by Subject|0|||
160653639|NCT02374918|580112430|FG000|Overall Study|Lack of Efficacy|0|||
160653640|NCT02374918|580112431|FG001|Overall Study|Lack of Efficacy|0|||
160653641|NCT02374918|580112432|FG002|Overall Study|Lack of Efficacy|1|||
160653642|NCT02374918|580112433|FG003|Overall Study|Lack of Efficacy|1|||
160653643|NCT00810368|580112435|FG000|Overall Study|Lost to Follow-up|4|||
160653644|NCT00810368|580112436|FG001|Overall Study|Lost to Follow-up|2|||
160653645|NCT00810368|580112435|FG000|Overall Study|Lack of Efficacy|2|||
160653646|NCT00810368|580112436|FG001|Overall Study|Lack of Efficacy|0|||
160653647|NCT03803943|580112439|FG000|Overall Study|Withdrawal by Subject|2|||
160653648|NCT03803943|580112440|FG001|Overall Study|Withdrawal by Subject|2|||
160653649|NCT03803943|580112441|FG002|Overall Study|Withdrawal by Subject|2|||
160653650|NCT03803943|580112442|FG003|Overall Study|Withdrawal by Subject|2|||
160653651|NCT01781286|580112443|FG000|Overall Study|Lost to Follow-up|0|||
160653652|NCT01781286|580112444|FG001|Overall Study|Lost to Follow-up|0|||
160653653|NCT01781286|580112445|FG002|Overall Study|Lost to Follow-up|0|||
160653654|NCT01781286|580112446|FG003|Overall Study|Lost to Follow-up|0|||
160653655|NCT01781286|580112447|FG004|Overall Study|Lost to Follow-up|0|||
160653656|NCT01781286|580112448|FG005|Overall Study|Lost to Follow-up|1|||
160653657|NCT01781286|580112443|FG000|Overall Study|Time Constraints|2|||
160653658|NCT01781286|580112444|FG001|Overall Study|Time Constraints|0|||
160653659|NCT01781286|580112445|FG002|Overall Study|Time Constraints|2|||
160653660|NCT01781286|580112446|FG003|Overall Study|Time Constraints|0|||
160653661|NCT01781286|580112447|FG004|Overall Study|Time Constraints|0|||
160653662|NCT01781286|580112448|FG005|Overall Study|Time Constraints|0|||
160653663|NCT01781286|580112443|FG000|Overall Study|Noncompliance|0|||
160653664|NCT01781286|580112444|FG001|Overall Study|Noncompliance|0|||
160653665|NCT01781286|580112445|FG002|Overall Study|Noncompliance|0|||
160653666|NCT01781286|580112446|FG003|Overall Study|Noncompliance|1|||
160653667|NCT01781286|580112447|FG004|Overall Study|Noncompliance|0|||
160653668|NCT01781286|580112448|FG005|Overall Study|Noncompliance|0|||
160653669|NCT00995410|580112449|FG000|Overall Study|Adverse Event|51|||
160653670|NCT00995410|580112449|FG000|Overall Study|Withdrawal by Subject|7|||
160653671|NCT00995410|580112449|FG000|Overall Study|Lost to Follow-up|2|||
160653672|NCT00995410|580112449|FG000|Overall Study|Misc|28|||
160653673|NCT03594123|580112450|FG000|Overall Study|Lost to Follow-up|0|||
160653674|NCT03594123|580112451|FG001|Overall Study|Lost to Follow-up|1|||
160653675|NCT03594123|580112450|FG000|Overall Study|Adverse Event|8|||
160653676|NCT03594123|580112451|FG001|Overall Study|Adverse Event|5|||
160653677|NCT03594123|580112450|FG000|Overall Study|Site Terminated by Sponsor|4|||
160653678|NCT03594123|580112451|FG001|Overall Study|Site Terminated by Sponsor|1|||
160653679|NCT03594123|580112450|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
160653680|NCT03594123|580112451|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
160653681|NCT03594123|580112450|FG000|Overall Study|Lack of Efficacy|1|||
160653682|NCT03594123|580112451|FG001|Overall Study|Lack of Efficacy|0|||
160653683|NCT03594123|580112450|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
160653684|NCT03594123|580112451|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
160653685|NCT02483975|580112452|FG000|Overall Study|Adverse Event|0|||
160653686|NCT02483975|580112453|FG001|Overall Study|Adverse Event|1|||
160653687|NCT02483975|580112452|FG000|Overall Study|Lost to Follow-up|0|||
160653688|NCT02483975|580112453|FG001|Overall Study|Lost to Follow-up|1|||
160653689|NCT02483975|580112452|FG000|Overall Study|Physician Decision|2|||
160653690|NCT02483975|580112453|FG001|Overall Study|Physician Decision|0|||
160653691|NCT03365375|580112454|FG000|Overall Study|Withdrawal by Subject|0|||
160653692|NCT03365375|580112455|FG001|Overall Study|Withdrawal by Subject|1|||
160653693|NCT03365375|580112454|FG000|Overall Study|Lost to Follow-up|0|||
160653694|NCT03365375|580112455|FG001|Overall Study|Lost to Follow-up|4|||
160653695|NCT00818883|580112456|FG000|Overall Study|Adverse Event|28|||
160653696|NCT00818883|580112457|FG001|Overall Study|Adverse Event|19|||
160653697|NCT00818883|580112456|FG000|Overall Study|Protocol Violation|2|||
160653698|NCT00818883|580112457|FG001|Overall Study|Protocol Violation|2|||
160653699|NCT00818883|580112456|FG000|Overall Study|Lost to Follow-up|3|||
160653700|NCT00818883|580112457|FG001|Overall Study|Lost to Follow-up|2|||
160653701|NCT00818883|580112456|FG000|Overall Study|Withdrawal by Subject|16|||
160653702|NCT00818883|580112457|FG001|Overall Study|Withdrawal by Subject|14|||
160653703|NCT00818883|580112456|FG000|Overall Study|Lack of Efficacy|0|||
160653704|NCT00818883|580112457|FG001|Overall Study|Lack of Efficacy|2|||
160653705|NCT00818883|580112456|FG000|Overall Study|Other|2|||
160653706|NCT00818883|580112457|FG001|Overall Study|Other|7|||
160653707|NCT02166697|580112458|FG000|Overall Study|Protocol Violation|347|||
160653708|NCT02684578|580112460|FG000|Overall Study|Withdrawal by Subject|10|||
160653709|NCT02684578|580112461|FG001|Overall Study|Withdrawal by Subject|7|||
160653710|NCT02684578|580112460|FG000|Overall Study|Lost to Follow-up|0|||
160653711|NCT02684578|580112461|FG001|Overall Study|Lost to Follow-up|3|||
160917939|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
160917940|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
160454083|NCT04299464|579394030|FG000|Overall Study|Non-compliance with Study Drug|1|||
160653712|NCT02684578|580112460|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
160653713|NCT02684578|580112461|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
160653714|NCT02684578|580112460|FG000|Overall Study|Missing follow-up data|0|||
160653715|NCT02684578|580112461|FG001|Overall Study|Missing follow-up data|1|||
160653716|NCT01505530|580112462|FG000|Overall Study|Progressive Disease|19|||
160653717|NCT01505530|580112463|FG001|Overall Study|Progressive Disease|17|||
160653718|NCT01505530|580112464|FG002|Overall Study|Progressive Disease|18|||
160653719|NCT01505530|580112462|FG000|Overall Study|Adverse Event|1|||
160917941|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
160653720|NCT01505530|580112463|FG001|Overall Study|Adverse Event|1|||
160653721|NCT01505530|580112464|FG002|Overall Study|Adverse Event|0|||
160917942|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
160917943|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
160917944|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
160917945|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
160917946|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
160917947|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Death|4|||
160917948|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Death|1|||
160917949|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
160917950|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
160917951|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
160917952|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
160917953|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
160917954|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
160996831|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
160996832|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
160996833|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
160996834|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
160996835|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
160996836|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
160996837|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
160996838|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
160996839|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
160996840|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996841|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996842|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996843|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996844|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996845|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
160996846|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
160996847|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
160996848|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
160996849|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996850|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996851|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996852|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996853|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996854|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996855|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160571953|NCT02619253|579816876|FG001|Overall Study|Needed a disqualifying therapy|0|||
160571954|NCT02619253|579816877|FG002|Overall Study|Needed a disqualifying therapy|1|||
160571955|NCT02619253|579816878|FG003|Overall Study|Needed a disqualifying therapy|0|||
160571956|NCT02619253|579816879|FG004|Overall Study|Needed a disqualifying therapy|0|||
160571957|NCT02619253|579816875|FG000|Overall Study|Transferred to hospice|0|||
160571958|NCT02619253|579816876|FG001|Overall Study|Transferred to hospice|0|||
160571959|NCT02619253|579816877|FG002|Overall Study|Transferred to hospice|1|||
160571960|NCT02619253|579816878|FG003|Overall Study|Transferred to hospice|0|||
160571961|NCT02619253|579816879|FG004|Overall Study|Transferred to hospice|0|||
160571962|NCT02619253|579816875|FG000|Overall Study|Physician Decision|0|||
160571963|NCT02619253|579816876|FG001|Overall Study|Physician Decision|1|||
160571964|NCT02619253|579816877|FG002|Overall Study|Physician Decision|2|||
160571965|NCT02619253|579816878|FG003|Overall Study|Physician Decision|3|||
160571966|NCT02619253|579816879|FG004|Overall Study|Physician Decision|0|||
160571967|NCT02619253|579816875|FG000|Overall Study|Withdrawal by Subject|0|||
160571968|NCT02619253|579816876|FG001|Overall Study|Withdrawal by Subject|1|||
160571969|NCT02619253|579816877|FG002|Overall Study|Withdrawal by Subject|0|||
160571970|NCT02619253|579816878|FG003|Overall Study|Withdrawal by Subject|0|||
160996856|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996857|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
160996858|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996859|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
160996860|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996861|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996862|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996863|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996864|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996865|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996866|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996867|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996868|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996869|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
160996870|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996871|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
160996872|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
160653722|NCT01505530|580112462|FG000|Overall Study|Withdrawal by Subject|7|||
160653723|NCT01505530|580112463|FG001|Overall Study|Withdrawal by Subject|8|||
160653724|NCT01505530|580112464|FG002|Overall Study|Withdrawal by Subject|6|||
160653725|NCT01505530|580112462|FG000|Overall Study|Physician Decision|6|||
160653726|NCT01505530|580112463|FG001|Overall Study|Physician Decision|2|||
160653727|NCT01505530|580112464|FG002|Overall Study|Physician Decision|5|||
160653728|NCT01505530|580112462|FG000|Overall Study|Sponsor Decision|1|||
160653729|NCT01505530|580112463|FG001|Overall Study|Sponsor Decision|8|||
160653730|NCT01505530|580112464|FG002|Overall Study|Sponsor Decision|7|||
160653731|NCT01505530|580112462|FG000|Overall Study|Death|7|||
160653732|NCT01505530|580112463|FG001|Overall Study|Death|6|||
160653733|NCT01505530|580112464|FG002|Overall Study|Death|5|||
160653734|NCT01505530|580112462|FG000|Overall Study|entry criteria not met|0|||
160653735|NCT01505530|580112463|FG001|Overall Study|entry criteria not met|1|||
160653736|NCT01505530|580112464|FG002|Overall Study|entry criteria not met|0|||
160917955|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
160917956|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
160917957|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
160917958|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
160917959|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
160917960|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
160917961|NCT00293254|581094150|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
160917962|NCT00293254|581094151|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
160917963|NCT00293254|581094150|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
160917964|NCT00293254|581094151|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
160653737|NCT01153984|580112470|FG000|Overall Study|Withdrawal by Subject|1|||
160917965|NCT00293254|581094150|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
160917966|NCT00293254|581094151|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
160917967|NCT00293254|581094150|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
160917968|NCT00293254|581094151|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
160917969|NCT00293254|581094150|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
160917970|NCT00293254|581094151|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
160917971|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
160917972|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
160917973|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
160917974|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
160917975|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
160917976|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
160917977|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
160917978|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
160917979|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
160917980|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
160917981|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
160917982|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
160917983|NCT00082355|581094152|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
160917984|NCT00082355|581094152|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
160917985|NCT00082355|581094152|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
160917986|NCT00531050|581094154|FG000|Part 1: Period 1|Adverse Event|0|||
160917987|NCT00531050|581094155|FG001|Part 1: Period 1|Adverse Event|1|||
160917988|NCT00531050|581094156|FG002|Part 1: Period 1|Adverse Event|0|||
160917989|NCT00531050|581094157|FG003|Part 1: Period 1|Adverse Event|0|||
160917990|NCT00531050|581094158|FG004|Part 1: Period 1|Adverse Event|0|||
160917991|NCT00531050|581094159|FG005|Part 1: Period 1|Adverse Event|0|||
160917992|NCT00531050|581094154|FG000|Part 1: Period 1|Protocol Deviation|0|||
160917993|NCT00531050|581094155|FG001|Part 1: Period 1|Protocol Deviation|0|||
160917994|NCT00531050|581094156|FG002|Part 1: Period 1|Protocol Deviation|0|||
160917995|NCT00531050|581094157|FG003|Part 1: Period 1|Protocol Deviation|1|||
160917996|NCT00531050|581094158|FG004|Part 1: Period 1|Protocol Deviation|0|||
160917997|NCT00531050|581094159|FG005|Part 1: Period 1|Protocol Deviation|0|||
160917998|NCT00531050|581094154|FG000|Part 1: Period 3|Adverse Event|1|||
160917999|NCT00531050|581094155|FG001|Part 1: Period 3|Adverse Event|0|||
160918000|NCT00531050|581094156|FG002|Part 1: Period 3|Adverse Event|0|||
160918001|NCT00531050|581094157|FG003|Part 1: Period 3|Adverse Event|0|||
160653738|NCT01153984|580112470|FG000|Overall Study|Adverse Event|1|||
160653739|NCT00973700|580112471|FG000|Overall Study|Withdrawal by Subject|2|||
160653740|NCT00973700|580112472|FG001|Overall Study|Withdrawal by Subject|2|||
160653741|NCT00973700|580112473|FG002|Overall Study|Withdrawal by Subject|8|||
160653742|NCT00973700|580112474|FG003|Overall Study|Withdrawal by Subject|4|||
160918002|NCT00531050|581094158|FG004|Part 1: Period 3|Adverse Event|0|||
160996873|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996874|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160918003|NCT00531050|581094159|FG005|Part 1: Period 3|Adverse Event|0|||
160653743|NCT00973700|580112475|FG004|Overall Study|Withdrawal by Subject|4|||
160653744|NCT00973700|580112471|FG000|Overall Study|Lost to Follow-up|5|||
160653745|NCT00973700|580112472|FG001|Overall Study|Lost to Follow-up|0|||
160653746|NCT00973700|580112473|FG002|Overall Study|Lost to Follow-up|1|||
160653747|NCT00973700|580112474|FG003|Overall Study|Lost to Follow-up|8|||
160653748|NCT00973700|580112475|FG004|Overall Study|Lost to Follow-up|5|||
160653749|NCT00973700|580112471|FG000|Overall Study|Inappropriate enrolment|0|||
160653750|NCT00973700|580112472|FG001|Overall Study|Inappropriate enrolment|0|||
160653751|NCT00973700|580112473|FG002|Overall Study|Inappropriate enrolment|0|||
160653752|NCT00973700|580112474|FG003|Overall Study|Inappropriate enrolment|4|||
160653753|NCT00973700|580112475|FG004|Overall Study|Inappropriate enrolment|0|||
160653754|NCT00973700|580112471|FG000|Overall Study|Unable to Classify|0|||
160653755|NCT00973700|580112472|FG001|Overall Study|Unable to Classify|0|||
160653756|NCT00973700|580112473|FG002|Overall Study|Unable to Classify|1|||
160653757|NCT00973700|580112474|FG003|Overall Study|Unable to Classify|2|||
160653758|NCT00973700|580112475|FG004|Overall Study|Unable to Classify|1|||
160653759|NCT00290745|580112485|FG000|Overall Study|Withdrawal by Subject|4|||
160653760|NCT00290745|580112485|FG000|Overall Study|Physician Decision|2|||
160653761|NCT00290745|580112485|FG000|Overall Study|Surgery after 3 months for progression|3|||
160653762|NCT00290745|580112485|FG000|Overall Study|Baseline MRI not available|3|||
160653763|NCT00626925|580112488|FG000|Overall Study|Lost to Follow-up|1|||
160653764|NCT00626925|580112489|FG001|Overall Study|Lost to Follow-up|2|||
160653765|NCT00626925|580112488|FG000|Overall Study|relapse|1|||
160653766|NCT00626925|580112489|FG001|Overall Study|relapse|0|||
160653767|NCT00626925|580112488|FG000|Overall Study|Adverse effect|6|||
160653768|NCT00626925|580112489|FG001|Overall Study|Adverse effect|2|||
160653769|NCT00626925|580112488|FG000|Overall Study|Lack of Efficacy|1|||
160653770|NCT00626925|580112489|FG001|Overall Study|Lack of Efficacy|4|||
160653771|NCT00626925|580112488|FG000|Overall Study|Time constraints|3|||
160653772|NCT00626925|580112489|FG001|Overall Study|Time constraints|1|||
160653773|NCT00625807|580112492|FG000|Overall Study|schedule conflict|2|||
160653774|NCT00625807|580112493|FG001|Overall Study|schedule conflict|8|||
160653775|NCT01802879|580112494|FG000|Overall Study|Administrative problems|2|||
160653776|NCT01802879|580112494|FG000|Overall Study|Disease progression|6|||
160653777|NCT00266409|580112495|FG000|Overall Study|Lack of Efficacy|2|||
160653778|NCT00266409|580112496|FG001|Overall Study|Lack of Efficacy|6|||
160653779|NCT00266409|580112497|FG002|Overall Study|Lack of Efficacy|1|||
160653780|NCT00266409|580112498|FG003|Overall Study|Lack of Efficacy|2|||
160653781|NCT00266409|580112495|FG000|Overall Study|Adverse Event|7|||
160653782|NCT00266409|580112496|FG001|Overall Study|Adverse Event|2|||
160653783|NCT00266409|580112497|FG002|Overall Study|Adverse Event|1|||
160653784|NCT00266409|580112498|FG003|Overall Study|Adverse Event|1|||
160653785|NCT00266409|580112495|FG000|Overall Study|Lost to Follow-up|18|||
160653786|NCT00266409|580112496|FG001|Overall Study|Lost to Follow-up|21|||
160653787|NCT00266409|580112497|FG002|Overall Study|Lost to Follow-up|6|||
160653788|NCT00266409|580112498|FG003|Overall Study|Lost to Follow-up|8|||
160653789|NCT00266409|580112495|FG000|Overall Study|Withdrawal by Subject|6|||
160653790|NCT00266409|580112496|FG001|Overall Study|Withdrawal by Subject|10|||
160653791|NCT00266409|580112497|FG002|Overall Study|Withdrawal by Subject|3|||
160653792|NCT00266409|580112498|FG003|Overall Study|Withdrawal by Subject|9|||
160653793|NCT00266409|580112495|FG000|Overall Study|Protocol Violation|5|||
160653794|NCT00266409|580112496|FG001|Overall Study|Protocol Violation|3|||
160653795|NCT00266409|580112497|FG002|Overall Study|Protocol Violation|4|||
160454084|NCT04299464|579394031|FG001|Overall Study|Non-compliance with Study Drug|0|||
160454085|NCT04299464|579394032|FG002|Overall Study|Non-compliance with Study Drug|0|||
160454086|NCT04299464|579394030|FG000|Overall Study|Reason not Specified|0|||
160454087|NCT04299464|579394031|FG001|Overall Study|Reason not Specified|1|||
160454088|NCT04299464|579394032|FG002|Overall Study|Reason not Specified|3|||
160454089|NCT04299464|579394030|FG000|Overall Study|Physician Decision|0|||
160454090|NCT04299464|579394031|FG001|Overall Study|Physician Decision|1|||
160454091|NCT04299464|579394032|FG002|Overall Study|Physician Decision|1|||
160454092|NCT04299464|579394030|FG000|Overall Study|Withdrawal by Subject|0|||
160454093|NCT04299464|579394031|FG001|Overall Study|Withdrawal by Subject|2|||
160454094|NCT04299464|579394032|FG002|Overall Study|Withdrawal by Subject|1|||
160454095|NCT05293171|579394039|FG000|Washout 5 to 7 Days|Adverse Event|1|||
160454096|NCT05293171|579394040|FG001|Washout 5 to 7 Days|Adverse Event|1|||
160653796|NCT00266409|580112498|FG003|Overall Study|Protocol Violation|2|||
160653797|NCT00266409|580112495|FG000|Overall Study|Other|7|||
160653798|NCT00266409|580112496|FG001|Overall Study|Other|4|||
160653799|NCT00266409|580112497|FG002|Overall Study|Other|2|||
160653800|NCT00266409|580112498|FG003|Overall Study|Other|0|||
160454097|NCT05293171|579394041|FG002|Washout 5 to 7 Days|Adverse Event|0|||
160653801|NCT00108732|580112501|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
160653802|NCT00108732|580112501|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
160653803|NCT00108732|580112501|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
160653804|NCT00108732|580112501|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
160653805|NCT00108732|580112501|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
160653806|NCT00108732|580112501|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
160653807|NCT00108732|580112501|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
160653808|NCT01946165|580112503|FG000|Overall Study|Physician Decision|2|||
160653809|NCT01946165|580112504|FG001|Overall Study|Physician Decision|0|||
160653810|NCT01946165|580112503|FG000|Overall Study|Withdrawal by Subject|0|||
160653811|NCT01946165|580112504|FG001|Overall Study|Withdrawal by Subject|2|||
160653812|NCT01659567|580112505|FG000|Overall Study|Lack of Efficacy|22|||
160653813|NCT01659567|580112505|FG000|Overall Study|Switched to Pegferon|6|||
160653814|NCT01659567|580112505|FG000|Overall Study|Adverse Event|12|||
160653815|NCT01659567|580112505|FG000|Overall Study|Good result at early stage of treatment|5|||
160653816|NCT01659567|580112505|FG000|Overall Study|Withdrawal by Subject|64|||
160653817|NCT01659567|580112505|FG000|Overall Study|Progression of the main disease|1|||
160653818|NCT01659567|580112505|FG000|Overall Study|Other|13|||
160653819|NCT01179919|580112508|FG000|Overall Study|Protocol Violation|1|||
160653820|NCT01179919|580112508|FG000|Overall Study|Adverse Event|1|||
160653821|NCT01325207|580112514|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
160653822|NCT01325207|580112515|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
160653823|NCT01325207|580112516|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
160653824|NCT01325207|580112517|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
160653825|NCT01325207|580112518|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
160653826|NCT01325207|580112519|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
160653827|NCT01325207|580112514|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
160653828|NCT01325207|580112515|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
160653829|NCT01325207|580112516|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
160653830|NCT01325207|580112517|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
160653831|NCT01325207|580112518|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
160653832|NCT01325207|580112519|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
160653833|NCT01325207|580112514|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
160653834|NCT01325207|580112515|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
160653835|NCT01325207|580112516|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
160653836|NCT01325207|580112517|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
160653837|NCT01325207|580112518|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
160653838|NCT01325207|580112519|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
160653839|NCT01325207|580112514|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
160653840|NCT01325207|580112515|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
160653841|NCT01325207|580112516|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
160653842|NCT01325207|580112517|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
160653843|NCT01325207|580112518|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
160653844|NCT01325207|580112519|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
160653845|NCT01325207|580112514|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
160653846|NCT01325207|580112515|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
160653847|NCT01325207|580112516|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
160653848|NCT01325207|580112517|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
160653849|NCT01325207|580112518|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
160653850|NCT01325207|580112519|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
160653851|NCT01325207|580112514|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
160653852|NCT01325207|580112515|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
160653853|NCT01325207|580112516|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
160653854|NCT01325207|580112517|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
160653855|NCT01325207|580112518|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
160653856|NCT01325207|580112519|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
160653857|NCT01325207|580112514|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
160653858|NCT01325207|580112515|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
160653859|NCT01325207|580112516|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
160653860|NCT01325207|580112517|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
160653861|NCT01325207|580112518|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
160653862|NCT01325207|580112519|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
160653863|NCT00708422|580112520|FG000|Overall Study|Adverse Event|3|||
160653864|NCT00708422|580112521|FG001|Overall Study|Adverse Event|1|||
160653865|NCT00708422|580112520|FG000|Overall Study|Withdrawal by Subject|1|||
160653866|NCT00708422|580112521|FG001|Overall Study|Withdrawal by Subject|0|||
160653867|NCT01254409|580112522|FG000|Overall Study|Adverse Event|0|||
160653868|NCT01254409|580112523|FG001|Overall Study|Adverse Event|1|||
160653869|NCT01254409|580112524|FG002|Overall Study|Adverse Event|0|||
160653870|NCT01254409|580112525|FG003|Overall Study|Adverse Event|0|||
160653871|NCT01974895|580112526|FG000|Overall Study|Protocol Violation|1|||
160653872|NCT01974895|580112527|FG001|Overall Study|Protocol Violation|0|||
160653873|NCT01974895|580112526|FG000|Overall Study|Lost to Follow-up|4|||
160653874|NCT01974895|580112527|FG001|Overall Study|Lost to Follow-up|6|||
160653875|NCT01974895|580112526|FG000|Overall Study|Withdrawal by Subject|0|||
160653876|NCT01974895|580112527|FG001|Overall Study|Withdrawal by Subject|1|||
160653877|NCT01974895|580112526|FG000|Overall Study|Other (Missed Visit)|1|||
160653878|NCT01974895|580112527|FG001|Overall Study|Other (Missed Visit)|0|||
160653879|NCT01974895|580112526|FG000|Overall Study|Other (Reason unknown)|9|||
160653880|NCT01974895|580112527|FG001|Overall Study|Other (Reason unknown)|8|||
160653881|NCT00635154|580112528|FG000|Overall Study|Alternative Treatment|8|||
160653882|NCT00635154|580112528|FG000|Overall Study|Other|4|||
160653883|NCT00635154|580112528|FG000|Overall Study|Still on treatment|21|||
160653884|NCT02785913|580114208|FG000|Overall Study|Adverse Event|5|||
160653885|NCT02785913|580114208|FG000|Overall Study|Death|2|||
160653886|NCT02785913|580114208|FG000|Overall Study|Progression|18|||
160653887|NCT02785913|580114208|FG000|Overall Study|Not protocol specified|1|||
160653888|NCT01052116|580114209|FG000|Overall Study|Lost to Follow-up|11|||
160653889|NCT01052116|580114210|FG001|Overall Study|Lost to Follow-up|17|||
160653890|NCT01052116|580114209|FG000|Overall Study|Withdrawal by Subject|3|||
160653891|NCT01052116|580114210|FG001|Overall Study|Withdrawal by Subject|6|||
160653892|NCT01052116|580114209|FG000|Overall Study|Spirometry not performed|0|||
160653893|NCT01052116|580114210|FG001|Overall Study|Spirometry not performed|4|||
160653894|NCT02016300|580114213|FG000|Overall Study|Lost to Follow-up|0|||
160653895|NCT02016300|580114214|FG001|Overall Study|Lost to Follow-up|3|||
160653896|NCT05301751|580114215|FG000|Overall Study|Withdrawal by Subject|0|||
160653897|NCT05301751|580114216|FG001|Overall Study|Withdrawal by Subject|0|||
160653898|NCT05301751|580114217|FG002|Overall Study|Withdrawal by Subject|1|||
160653899|NCT05301751|580114218|FG003|Overall Study|Withdrawal by Subject|0|||
160653900|NCT06165744|580114221|FG000|Overall Study|Non device-related adverse event|1|||
160653901|NCT01546987|580114222|FG000|Overall Study|Protocol Violation|3|||
160653902|NCT01546987|580114223|FG001|Overall Study|Protocol Violation|4|||
160653903|NCT02270736|580114224|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
160653904|NCT02270736|580114225|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
160653905|NCT02270736|580114226|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
160653906|NCT02270736|580114227|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
160653907|NCT02270736|580114228|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
160653908|NCT02270736|580114224|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
160653909|NCT02270736|580114225|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
160653910|NCT02270736|580114226|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
160653911|NCT02270736|580114227|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
160653912|NCT02270736|580114228|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
160653913|NCT02270736|580114224|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
160653914|NCT02270736|580114225|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
160653915|NCT02270736|580114226|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
160653916|NCT02270736|580114227|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
160653917|NCT02270736|580114228|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
160653918|NCT02270736|580114224|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
160653919|NCT02270736|580114225|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
160653920|NCT02270736|580114226|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
160653921|NCT02270736|580114227|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
160653922|NCT02270736|580114228|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
160653923|NCT02270736|580114224|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
160653924|NCT02270736|580114225|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
160653925|NCT02270736|580114226|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
160653926|NCT02270736|580114227|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
160653927|NCT02270736|580114228|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
160653928|NCT02270736|580114224|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
160653929|NCT02270736|580114225|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
160653930|NCT02270736|580114226|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
160653931|NCT02270736|580114227|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
160653932|NCT02270736|580114228|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
160996875|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996876|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160996877|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160996878|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160996879|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160653933|NCT02270736|580114224|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
160653934|NCT02270736|580114225|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
160653935|NCT02270736|580114226|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
160653936|NCT02270736|580114227|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
160653937|NCT02270736|580114228|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
160653938|NCT02270736|580114224|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
160653939|NCT02270736|580114225|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
160653940|NCT02270736|580114226|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
160996880|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160454098|NCT05293171|579394042|FG003|Washout 5 to 7 Days|Adverse Event|0|||
160454099|NCT05293171|579394043|FG004|Washout 5 to 7 Days|Adverse Event|0|||
160454100|NCT05293171|579394044|FG005|Washout 5 to 7 Days|Adverse Event|0|||
160454101|NCT05293171|579394045|FG006|Washout 5 to 7 Days|Adverse Event|0|||
160454102|NCT05293171|579394046|FG007|Washout 5 to 7 Days|Adverse Event|0|||
160454103|NCT05293171|579394047|FG008|Washout 5 to 7 Days|Adverse Event|0|||
160454104|NCT05293171|579394048|FG009|Washout 5 to 7 Days|Adverse Event|0|||
160454105|NCT05293171|579394049|FG010|Washout 5 to 7 Days|Adverse Event|0|||
160454106|NCT05293171|579394050|FG011|Washout 5 to 7 Days|Adverse Event|0|||
160454107|NCT05293171|579394039|FG000|Washout 5 to 7 Days|Adverse Event|0|||
160454108|NCT05293171|579394040|FG001|Washout 5 to 7 Days|Adverse Event|0|||
160454109|NCT05293171|579394041|FG002|Washout 5 to 7 Days|Adverse Event|0|||
160454110|NCT05293171|579394042|FG003|Washout 5 to 7 Days|Adverse Event|0|||
160454111|NCT05293171|579394043|FG004|Washout 5 to 7 Days|Adverse Event|0|||
160454112|NCT05293171|579394044|FG005|Washout 5 to 7 Days|Adverse Event|1|||
160454113|NCT05293171|579394045|FG006|Washout 5 to 7 Days|Adverse Event|0|||
160454114|NCT05293171|579394046|FG007|Washout 5 to 7 Days|Adverse Event|0|||
160454115|NCT05293171|579394047|FG008|Washout 5 to 7 Days|Adverse Event|0|||
160454116|NCT05293171|579394048|FG009|Washout 5 to 7 Days|Adverse Event|0|||
160454117|NCT05293171|579394049|FG010|Washout 5 to 7 Days|Adverse Event|0|||
160454118|NCT05293171|579394050|FG011|Washout 5 to 7 Days|Adverse Event|0|||
160454119|NCT04066205|579394051|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
160454120|NCT04066205|579394052|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
160454121|NCT04066205|579394051|FG000|T2 Immediate Post-Intervention|did not respond|5|||
160454122|NCT04066205|579394052|FG001|T2 Immediate Post-Intervention|did not respond|3|||
160454123|NCT02052882|579394053|FG000|Overall Study|Not treated|11|||
160454124|NCT02052882|579394053|FG000|Overall Study|Protocol Violation|1|||
160454125|NCT02052882|579394053|FG000|Overall Study|Inadequate testing|1|||
160454126|NCT05123586|579394061|FG000|Overall Study|Physician Decision|1|||
160454127|NCT05123586|579394062|FG001|Overall Study|Physician Decision|1|||
160454128|NCT05123586|579394061|FG000|Overall Study|Withdrawal by Subject|0|||
160454129|NCT05123586|579394062|FG001|Overall Study|Withdrawal by Subject|3|||
160454130|NCT02733159|579394074|FG000|Overall Study|Adverse Event|1|||
160454131|NCT02733159|579394074|FG000|Overall Study|Lack of disease progression|1|||
160454132|NCT06122194|579394077|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
160454133|NCT06122194|579394078|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
160454134|NCT06122194|579394079|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
160454135|NCT06122194|579394080|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
160454136|NCT05218096|579394081|FG000|Primary Evaluation|Withdrawal by Subject|0|||
160454137|NCT05218096|579394082|FG001|Primary Evaluation|Withdrawal by Subject|0|||
160454138|NCT05218096|579394083|FG002|Primary Evaluation|Withdrawal by Subject|2|||
160454139|NCT05218096|579394084|FG003|Primary Evaluation|Withdrawal by Subject|0|||
160454140|NCT05218096|579394085|FG004|Primary Evaluation|Withdrawal by Subject|0|||
160454141|NCT05218096|579394081|FG000|Primary Evaluation|Physician Decision|1|||
160918004|NCT00531050|581094154|FG000|Part 2: Period 1|Adverse Event|0|||
160918005|NCT00531050|581094155|FG001|Part 2: Period 1|Adverse Event|0|||
160918006|NCT00531050|581094156|FG002|Part 2: Period 1|Adverse Event|0|||
160918007|NCT00531050|581094157|FG003|Part 2: Period 1|Adverse Event|0|||
160918008|NCT00531050|581094158|FG004|Part 2: Period 1|Adverse Event|0|||
160918009|NCT00531050|581094159|FG005|Part 2: Period 1|Adverse Event|1|||
160918010|NCT00531050|581094154|FG000|Part 2: Period 3|Abnormal test procedure|1|||
160918011|NCT00531050|581094155|FG001|Part 2: Period 3|Abnormal test procedure|0|||
160918012|NCT00531050|581094156|FG002|Part 2: Period 3|Abnormal test procedure|0|||
160918013|NCT00531050|581094157|FG003|Part 2: Period 3|Abnormal test procedure|0|||
160918014|NCT00531050|581094158|FG004|Part 2: Period 3|Abnormal test procedure|0|||
160918015|NCT00531050|581094159|FG005|Part 2: Period 3|Abnormal test procedure|1|||
160918016|NCT02233309|581094163|FG000|Overall Study|Physician Decision|5|||
160918017|NCT00475176|581094166|FG000|Overall Study|Adverse Event|2|||
160918018|NCT00475176|581094166|FG000|Overall Study|Withdrawal by Subject|1|||
160918019|NCT00475176|581094166|FG000|Overall Study|Protocol Violation|1|||
160918020|NCT01484873|581094167|FG000|Overall Study|Withdrawal by Subject|2|||
160918021|NCT01549392|581094168|FG000|Overall Study|Withdrawal by Subject|1|||
160918022|NCT01549392|581094169|FG001|Overall Study|Withdrawal by Subject|0|||
160454142|NCT05218096|579394082|FG001|Primary Evaluation|Physician Decision|0|||
160454143|NCT05218096|579394083|FG002|Primary Evaluation|Physician Decision|0|||
160454144|NCT05218096|579394084|FG003|Primary Evaluation|Physician Decision|0|||
160454145|NCT05218096|579394085|FG004|Primary Evaluation|Physician Decision|0|||
160520037|NCT01078454|579632967|FG001|Overall Study|Death|1|||
160520038|NCT04737187|579632968|FG000|Overall Study|Switched to marketed drug|32|||
160520039|NCT04737187|579632969|FG001|Overall Study|Switched to marketed drug|4|||
160520040|NCT04737187|579632968|FG000|Overall Study|Radiological Progressive Disease|145|||
160520041|NCT04737187|579632969|FG001|Overall Study|Radiological Progressive Disease|146|||
160520042|NCT04737187|579632968|FG000|Overall Study|Clinical Progressive Disease|20|||
160520043|NCT04737187|579632969|FG001|Overall Study|Clinical Progressive Disease|20|||
160520044|NCT04737187|579632968|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
160520045|NCT04737187|579632969|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
160454146|NCT05218096|579394081|FG000|Extended Treatment|Clinical Deterioration|1|||
160454147|NCT05218096|579394082|FG001|Extended Treatment|Clinical Deterioration|1|||
160454148|NCT05218096|579394083|FG002|Extended Treatment|Clinical Deterioration|0|||
160454149|NCT05218096|579394084|FG003|Extended Treatment|Clinical Deterioration|0|||
160454150|NCT05218096|579394085|FG004|Extended Treatment|Clinical Deterioration|0|||
160454151|NCT05218096|579394081|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
160454152|NCT05218096|579394082|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
160454153|NCT05218096|579394083|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
160454154|NCT05218096|579394084|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
160454155|NCT05218096|579394085|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
160454156|NCT05218096|579394081|FG000|Extended Treatment|Withdrawal by Subject|1|||
160454157|NCT05218096|579394082|FG001|Extended Treatment|Withdrawal by Subject|3|||
160454158|NCT05218096|579394083|FG002|Extended Treatment|Withdrawal by Subject|0|||
160454159|NCT05218096|579394084|FG003|Extended Treatment|Withdrawal by Subject|2|||
160454160|NCT05218096|579394085|FG004|Extended Treatment|Withdrawal by Subject|2|||
160454161|NCT05218096|579394081|FG000|Extended Treatment|Lack of Efficacy|3|||
160454162|NCT05218096|579394082|FG001|Extended Treatment|Lack of Efficacy|0|||
160454163|NCT05218096|579394083|FG002|Extended Treatment|Lack of Efficacy|0|||
160571971|NCT02619253|579816879|FG004|Overall Study|Withdrawal by Subject|2|||
160571972|NCT00196937|579816888|FG000|Overall Study|Serious Adverse Event|1|||
160571973|NCT00196937|579816889|FG001|Overall Study|Serious Adverse Event|0|||
160571974|NCT00196937|579816890|FG002|Overall Study|Serious Adverse Event|0|||
160571975|NCT00196937|579816888|FG000|Overall Study|Non-serious adverse event|1|||
160571976|NCT00196937|579816889|FG001|Overall Study|Non-serious adverse event|1|||
160571977|NCT00196937|579816890|FG002|Overall Study|Non-serious adverse event|1|||
160571978|NCT00196937|579816888|FG000|Overall Study|Withdrawal by Subject|0|||
160571979|NCT00196937|579816889|FG001|Overall Study|Withdrawal by Subject|0|||
160571980|NCT00196937|579816890|FG002|Overall Study|Withdrawal by Subject|2|||
160571981|NCT00196937|579816888|FG000|Overall Study|Lost to Follow-up|4|||
160571982|NCT00196937|579816889|FG001|Overall Study|Lost to Follow-up|3|||
160571983|NCT00196937|579816890|FG002|Overall Study|Lost to Follow-up|3|||
160571984|NCT00196937|579816888|FG000|Overall Study|Other|3|||
160571985|NCT00196937|579816889|FG001|Overall Study|Other|1|||
160571986|NCT00196937|579816890|FG002|Overall Study|Other|1|||
160571987|NCT03368404|579816898|FG000|Overall Study|Adverse Event|2|||
160571988|NCT03368404|579816899|FG001|Overall Study|Adverse Event|1|||
160571989|NCT03368404|579816898|FG000|Overall Study|Withdrawal by Subject|1|||
160571990|NCT03368404|579816899|FG001|Overall Study|Withdrawal by Subject|1|||
160571991|NCT04725682|579816900|FG000|Overall Study|Withdrawal by Subject|7|||
160571992|NCT04725682|579816901|FG001|Overall Study|Withdrawal by Subject|5|||
160571993|NCT04725682|579816900|FG000|Overall Study|Failed to comply with the requirements|2|||
160571994|NCT04725682|579816901|FG001|Overall Study|Failed to comply with the requirements|1|||
160571995|NCT04725682|579816900|FG000|Overall Study|Adverse Event|1|||
160571996|NCT04725682|579816901|FG001|Overall Study|Adverse Event|1|||
160571997|NCT04725682|579816900|FG000|Overall Study|Death|0|||
160571998|NCT04725682|579816901|FG001|Overall Study|Death|1|||
160571999|NCT00964795|579816902|FG000|Overall Study|Withdrawal by Subject|79|||
160572000|NCT00964795|579816902|FG000|Overall Study|Adverse Event|12|||
160572001|NCT00964795|579816902|FG000|Overall Study|Death|14|||
160572002|NCT00964795|579816902|FG000|Overall Study|Lost to Follow-up|7|||
160572003|NCT00964795|579816902|FG000|Overall Study|Termination of Study by Sponsor|169|||
160572004|NCT00964795|579816902|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
160572005|NCT00964795|579816902|FG000|Overall Study|Other|23|||
160572006|NCT02453841|579816910|FG000|Overall Study|Protocol Violation|1|||
160572007|NCT02453841|579816910|FG000|Overall Study|Unable to obtain blood samples|2|||
160572008|NCT00586690|579816911|FG000|Overall Study|Death|2|||
160572009|NCT00586690|579816912|FG001|Overall Study|Death|0|||
160454164|NCT05218096|579394084|FG003|Extended Treatment|Lack of Efficacy|0|||
160454165|NCT05218096|579394085|FG004|Extended Treatment|Lack of Efficacy|0|||
160454166|NCT05218096|579394081|FG000|Extended Treatment|Physician Decision|0|||
160454167|NCT05218096|579394082|FG001|Extended Treatment|Physician Decision|1|||
160454168|NCT05218096|579394083|FG002|Extended Treatment|Physician Decision|0|||
160454169|NCT05218096|579394084|FG003|Extended Treatment|Physician Decision|0|||
160454170|NCT05218096|579394085|FG004|Extended Treatment|Physician Decision|0|||
160454171|NCT05218096|579394081|FG000|Open-label Extension|Adverse Event|1|||
160454172|NCT05218096|579394082|FG001|Open-label Extension|Adverse Event|0|||
160454173|NCT05218096|579394083|FG002|Open-label Extension|Adverse Event|0|||
160572010|NCT00586690|579816911|FG000|Overall Study|Disease Progression|10|||
160572011|NCT00586690|579816912|FG001|Overall Study|Disease Progression|0|||
160572012|NCT00586690|579816911|FG000|Overall Study|Adverse Event|1|||
160572013|NCT00586690|579816912|FG001|Overall Study|Adverse Event|0|||
160572014|NCT00586690|579816911|FG000|Overall Study|Lack of Efficacy|2|||
160454174|NCT05218096|579394084|FG003|Open-label Extension|Adverse Event|0|||
160454175|NCT05218096|579394085|FG004|Open-label Extension|Adverse Event|1|||
160572015|NCT00586690|579816912|FG001|Overall Study|Lack of Efficacy|0|||
160572016|NCT00586690|579816911|FG000|Overall Study|Lab can't accommodate|1|||
160996881|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
160996882|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
160996883|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
160996884|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
160996885|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160996886|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160996887|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160454176|NCT05218096|579394081|FG000|Open-label Extension|Pregnancy|0|||
160572017|NCT00586690|579816912|FG001|Overall Study|Lab can't accommodate|0|||
160572018|NCT01751646|579816913|FG000|Overall Study|Lost to Follow-up|5|||
160572019|NCT01751646|579816914|FG001|Overall Study|Lost to Follow-up|1|||
160572020|NCT01751646|579816913|FG000|Overall Study|Withdrawal by Subject|0|||
160572021|NCT01751646|579816914|FG001|Overall Study|Withdrawal by Subject|4|||
160572022|NCT01751646|579816913|FG000|Overall Study|Starting hormone therapy|1|||
160572023|NCT01751646|579816914|FG001|Overall Study|Starting hormone therapy|0|||
160572024|NCT01751646|579816913|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
160572025|NCT01751646|579816914|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
160572026|NCT01751646|579816913|FG000|Overall Study|Inadvertent enrollment|1|||
160572027|NCT01751646|579816914|FG001|Overall Study|Inadvertent enrollment|1|||
160572028|NCT01751646|579816913|FG000|Overall Study|Moved out of the area|1|||
160572029|NCT01751646|579816914|FG001|Overall Study|Moved out of the area|5|||
160572030|NCT01751646|579816913|FG000|Overall Study|Inability to attend required visits|0|||
160572031|NCT01751646|579816914|FG001|Overall Study|Inability to attend required visits|1|||
160572032|NCT01751646|579816913|FG000|Overall Study|Off study due to multiple obligations|0|||
160572033|NCT01751646|579816914|FG001|Overall Study|Off study due to multiple obligations|1|||
160572034|NCT01751646|579816913|FG000|Overall Study|Fails to comply with study requirements|0|||
160572035|NCT01751646|579816914|FG001|Overall Study|Fails to comply with study requirements|1|||
160572036|NCT01751646|579816913|FG000|Overall Study|Childcare issues|1|||
160572037|NCT01751646|579816914|FG001|Overall Study|Childcare issues|1|||
160572038|NCT00857246|579816915|FG000|Induction Regimen|Adverse Event|1|||
160572039|NCT00857246|579816915|FG000|Induction Regimen|disease-related complications|1|||
160572040|NCT00857246|579816915|FG000|Induction Regimen|Withdrawal by Subject|1|||
160572041|NCT00857246|579816915|FG000|Surgery (Curative)|disease progression|6|||
160572042|NCT00857246|579816915|FG000|ChemoRT|Withdrawal by Subject|1|||
160572043|NCT00857246|579816915|FG000|ChemoRT|Adverse Event|2|||
160572044|NCT03851510|579816916|FG000|Overall Study|Screen Fail|1|||
160572045|NCT03851510|579816916|FG000|Overall Study|Adverse Event|1|||
160572046|NCT03851510|579816916|FG000|Overall Study|Withdrawal by Subject|1|||
160572047|NCT02426086|579816917|FG000|Overall Study|Death|33|||
160572048|NCT02426086|579816918|FG001|Overall Study|Death|36|||
160572049|NCT02426086|579816917|FG000|Overall Study|Lost to Follow-up|2|||
160572050|NCT02426086|579816918|FG001|Overall Study|Lost to Follow-up|0|||
160572051|NCT02426086|579816917|FG000|Overall Study|Study Terminated by Sponsor|5|||
160572052|NCT02426086|579816918|FG001|Overall Study|Study Terminated by Sponsor|14|||
160572053|NCT02426086|579816917|FG000|Overall Study|Withdrawal by Subject|8|||
160572054|NCT02426086|579816918|FG001|Overall Study|Withdrawal by Subject|9|||
160572055|NCT00970294|579816919|FG000|Overall Study|Physician Decision|4|||
160572056|NCT00970294|579816919|FG000|Overall Study|Withdrawal by Subject|1|||
160572057|NCT02104180|579816920|FG000|Overall Study|Protocol Violation|1|||
160572058|NCT02104180|579816921|FG001|Overall Study|Protocol Violation|0|||
160572059|NCT01287117|579816922|FG000|Overall Study|Adverse Event|2|||
160572060|NCT01287117|579816923|FG001|Overall Study|Adverse Event|1|||
160572061|NCT01287117|579816924|FG002|Overall Study|Adverse Event|1|||
160572062|NCT01287117|579816925|FG003|Overall Study|Adverse Event|1|||
160572063|NCT01287117|579816922|FG000|Overall Study|Lost to Follow-up|1|||
160572064|NCT01287117|579816923|FG001|Overall Study|Lost to Follow-up|1|||
160572065|NCT01287117|579816924|FG002|Overall Study|Lost to Follow-up|0|||
160572066|NCT01287117|579816925|FG003|Overall Study|Lost to Follow-up|0|||
160572067|NCT01287117|579816922|FG000|Overall Study|Physician Decision|0|||
160572068|NCT01287117|579816923|FG001|Overall Study|Physician Decision|1|||
160572069|NCT01287117|579816924|FG002|Overall Study|Physician Decision|1|||
160572070|NCT01287117|579816925|FG003|Overall Study|Physician Decision|1|||
160572071|NCT01287117|579816922|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
160572072|NCT01287117|579816923|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
160572073|NCT01287117|579816924|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
160572074|NCT01287117|579816925|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
160572075|NCT01287117|579816922|FG000|Overall Study|Disease Progression|10|||
160572076|NCT01287117|579816923|FG001|Overall Study|Disease Progression|5|||
160572077|NCT01287117|579816924|FG002|Overall Study|Disease Progression|6|||
160572078|NCT01287117|579816925|FG003|Overall Study|Disease Progression|5|||
160572079|NCT00793585|579816931|FG000|Overall Study|Adverse Event|1|||
160572080|NCT00793585|579816932|FG001|Overall Study|Adverse Event|1|||
160572081|NCT00793585|579816931|FG000|Overall Study|Protocol Violation|1|||
160572082|NCT00793585|579816932|FG001|Overall Study|Protocol Violation|2|||
160572083|NCT01769404|579816933|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
160996888|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160653941|NCT02270736|580114227|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
160572084|NCT01769404|579816934|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
160572085|NCT01769404|579816933|FG000|Treatment Period 1|Withdrawal by Subject|3|||
160572086|NCT01769404|579816934|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160572087|NCT01769404|579816933|FG000|Treatment Period 1|Sponsor decision|1|||
160572088|NCT01769404|579816934|FG001|Treatment Period 1|Sponsor decision|0|||
160572089|NCT01769404|579816933|FG000|Treatment Period 2|Sponsor decision|7|||
160572090|NCT01769404|579816934|FG001|Treatment Period 2|Sponsor decision|0|||
160572091|NCT02606877|579816949|FG000|Overall Study|Adverse Event|3|||
160572092|NCT02606877|579816950|FG001|Overall Study|Adverse Event|0|||
160572093|NCT02606877|579816949|FG000|Overall Study|Non-compliance with protocol|0|||
160572094|NCT02606877|579816950|FG001|Overall Study|Non-compliance with protocol|1|||
160572095|NCT02606877|579816949|FG000|Overall Study|Other than listed above|1|||
160572096|NCT02606877|579816950|FG001|Overall Study|Other than listed above|0|||
160572097|NCT00778999|579816951|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
160572098|NCT00778999|579816952|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
160572099|NCT00778999|579816951|FG000|Overall Study|Did not receive recFSH|14|||
160572100|NCT00778999|579816952|FG001|Overall Study|Did not receive recFSH|20|||
160572101|NCT02032524|579816953|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
160572102|NCT02032524|579816954|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
160572103|NCT02032524|579816955|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
160572104|NCT02032524|579816956|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
160572105|NCT02032524|579816957|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
160572106|NCT02032524|579816958|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
160572107|NCT02032524|579816953|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
160572108|NCT02032524|579816954|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
160572109|NCT02032524|579816955|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
160572110|NCT02032524|579816956|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
160572111|NCT02032524|579816957|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
160572112|NCT02032524|579816958|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
160572113|NCT02032524|579816953|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
160572114|NCT02032524|579816954|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
160572115|NCT02032524|579816955|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
160572116|NCT02032524|579816956|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
160572117|NCT02032524|579816957|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
160572118|NCT02032524|579816958|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
160572119|NCT02032524|579816953|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
160572120|NCT02032524|579816954|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
160572121|NCT02032524|579816955|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
160572122|NCT02032524|579816956|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
160572123|NCT02032524|579816957|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
160572124|NCT02032524|579816958|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
160572125|NCT02032524|579816953|FG000|Period 2: LTS13769 Study|Other|0|||
160572126|NCT02032524|579816954|FG001|Period 2: LTS13769 Study|Other|0|||
160572127|NCT02032524|579816955|FG002|Period 2: LTS13769 Study|Other|0|||
160572128|NCT02032524|579816956|FG003|Period 2: LTS13769 Study|Other|0|||
160572129|NCT02032524|579816957|FG004|Period 2: LTS13769 Study|Other|0|||
160572130|NCT02032524|579816958|FG005|Period 2: LTS13769 Study|Other|1|||
160572131|NCT02277444|579816965|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
160572132|NCT02277444|579816965|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
160572133|NCT02277444|579816965|FG000|Treatment Period (Week 0-52)|Other|1|||
160572134|NCT02277444|579816965|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
160572135|NCT02277444|579816965|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
160572136|NCT02277444|579816965|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
160572137|NCT02277444|579816965|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
160572138|NCT02277444|579816965|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
160572139|NCT02277444|579816965|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
160572140|NCT02031146|579818357|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
160572141|NCT02031146|579818358|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
160572142|NCT02031146|579818359|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
160572143|NCT02031146|579818360|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
160572144|NCT02031146|579818361|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
160572145|NCT02031146|579818362|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
160572146|NCT02031146|579818363|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
160572147|NCT02629393|579818367|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
160572148|NCT02629393|579818367|FG000|Overall Study|Physician Decision|1|||
160572149|NCT01040832|579818371|FG000|Overall Study|Adverse Event|4|||
160572150|NCT01040832|579818372|FG001|Overall Study|Adverse Event|5|||
160572151|NCT01040832|579818371|FG000|Overall Study|Death|4|||
160572152|NCT01040832|579818372|FG001|Overall Study|Death|6|||
160572153|NCT01040832|579818371|FG000|Overall Study|Withdrawal by Subject|2|||
160572154|NCT01040832|579818372|FG001|Overall Study|Withdrawal by Subject|3|||
160918023|NCT00227903|581094170|FG000|Overall Study|Withdrawal by Subject|2|||
160918024|NCT00227903|581094171|FG001|Overall Study|Withdrawal by Subject|5|||
160918025|NCT00227903|581094170|FG000|Overall Study|Subject moved out of area|1|||
160918026|NCT00227903|581094171|FG001|Overall Study|Subject moved out of area|2|||
160918027|NCT00227903|581094170|FG000|Overall Study|Lost to Follow-up|1|||
160918028|NCT00227903|581094171|FG001|Overall Study|Lost to Follow-up|3|||
160918029|NCT00227903|581094170|FG000|Overall Study|Miscarriage|1|||
160918030|NCT00227903|581094171|FG001|Overall Study|Miscarriage|0|||
160918031|NCT01475331|581094172|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
160918032|NCT01475331|581094173|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
160918033|NCT01475331|581094172|FG000|Overall Study|excessive main duct communication|1|||
160918034|NCT01475331|581094173|FG001|Overall Study|excessive main duct communication|1|||
160918035|NCT01475331|581094172|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
160918036|NCT01475331|581094173|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
160918037|NCT01475331|581094172|FG000|Overall Study|Sign of malignancy during the procedure|2|||
160918038|NCT01475331|581094173|FG001|Overall Study|Sign of malignancy during the procedure|0|||
160918039|NCT01475331|581094172|FG000|Overall Study|cyst found to be prohibitively small|0|||
160918040|NCT01475331|581094173|FG001|Overall Study|cyst found to be prohibitively small|1|||
160918041|NCT00462761|581094174|FG000|Overall Study|Adverse Event|6|||
160918042|NCT00462761|581094174|FG000|Overall Study|Withdrawal by Subject|9|||
160918043|NCT00462761|581094174|FG000|Overall Study|Physician Decision|5|||
160918044|NCT00462761|581094174|FG000|Overall Study|Disease progression|43|||
160918045|NCT00462761|581094174|FG000|Overall Study|Death|12|||
160918046|NCT00462761|581094174|FG000|Overall Study|Other|1|||
160918047|NCT02877082|581094175|FG000|Overall Study|Trial was closed early|5|||
160918048|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
160918049|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
160918050|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
160918051|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
160918052|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
160918053|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
160996889|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160572155|NCT01040832|579818371|FG000|Overall Study|Progressive disease|32|||
160572156|NCT01040832|579818372|FG001|Overall Study|Progressive disease|17|||
160572157|NCT01040832|579818371|FG000|Overall Study|Symptomatic deterioration|2|||
160572158|NCT01040832|579818372|FG001|Overall Study|Symptomatic deterioration|5|||
160572159|NCT01040832|579818371|FG000|Overall Study|Other|2|||
160572160|NCT01040832|579818372|FG001|Overall Study|Other|1|||
160572161|NCT00151411|579818373|FG000|Overall Study|Lost to Follow-up|15|||
160572162|NCT00151411|579818374|FG001|Overall Study|Lost to Follow-up|19|||
160572163|NCT00151411|579818373|FG000|Overall Study|Withdrawal by Subject|12|||
160572164|NCT00151411|579818374|FG001|Overall Study|Withdrawal by Subject|20|||
160572165|NCT00151411|579818373|FG000|Overall Study|Adverse Event|6|||
160572166|NCT00151411|579818374|FG001|Overall Study|Adverse Event|0|||
160572167|NCT00151411|579818373|FG000|Overall Study|Pregnancy|0|||
160572168|NCT00151411|579818374|FG001|Overall Study|Pregnancy|4|||
160572169|NCT00417612|579818375|FG000|Overall Study|Errant diagnosis|0|||
160572170|NCT00417612|579818376|FG001|Overall Study|Errant diagnosis|1|||
160572171|NCT00417612|579818375|FG000|Overall Study|Adverse Event|2|||
160572172|NCT00417612|579818376|FG001|Overall Study|Adverse Event|0|||
160572173|NCT00417612|579818375|FG000|Overall Study|Protocol Violation|0|||
160572174|NCT00417612|579818376|FG001|Overall Study|Protocol Violation|2|||
160572175|NCT00417612|579818375|FG000|Overall Study|Lost to Follow-up|1|||
160572176|NCT00417612|579818376|FG001|Overall Study|Lost to Follow-up|0|||
160572177|NCT01283581|579818379|FG000|Overall Study|Lost to Follow-up|8|||
160572178|NCT01283581|579818380|FG001|Overall Study|Lost to Follow-up|6|||
160572179|NCT01283581|579818381|FG002|Overall Study|Lost to Follow-up|8|||
160572180|NCT01283581|579818379|FG000|Overall Study|Withdrawal by Subject|2|||
160572181|NCT01283581|579818380|FG001|Overall Study|Withdrawal by Subject|5|||
160572182|NCT01283581|579818381|FG002|Overall Study|Withdrawal by Subject|2|||
160572183|NCT01283581|579818379|FG000|Overall Study|Adverse Event|1|||
160572184|NCT01283581|579818380|FG001|Overall Study|Adverse Event|1|||
160572185|NCT01283581|579818381|FG002|Overall Study|Adverse Event|4|||
160572186|NCT01283581|579818379|FG000|Overall Study|Physician Decision|0|||
160572187|NCT01283581|579818380|FG001|Overall Study|Physician Decision|1|||
160572188|NCT01283581|579818381|FG002|Overall Study|Physician Decision|2|||
160572189|NCT01283581|579818379|FG000|Overall Study|Protocol Violation|0|||
160572190|NCT01283581|579818380|FG001|Overall Study|Protocol Violation|1|||
160918054|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
160572191|NCT01283581|579818381|FG002|Overall Study|Protocol Violation|2|||
160572192|NCT01283581|579818379|FG000|Overall Study|Noncompliance|1|||
160572193|NCT01283581|579818380|FG001|Overall Study|Noncompliance|0|||
160572194|NCT01283581|579818381|FG002|Overall Study|Noncompliance|0|||
160572195|NCT01283581|579818379|FG000|Overall Study|Investigator unblinded|0|||
160572196|NCT01283581|579818380|FG001|Overall Study|Investigator unblinded|0|||
160572197|NCT01283581|579818381|FG002|Overall Study|Investigator unblinded|1|||
160572198|NCT01283581|579818379|FG000|Overall Study|"Early termination"|0|||
160572199|NCT01283581|579818380|FG001|Overall Study|"Early termination"|0|||
160572200|NCT01283581|579818381|FG002|Overall Study|"Early termination"|1|||
160918055|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
160918056|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
160454177|NCT05218096|579394082|FG001|Open-label Extension|Pregnancy|0|||
160454178|NCT05218096|579394083|FG002|Open-label Extension|Pregnancy|0|||
160572201|NCT01712438|579818382|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
160572202|NCT01712438|579818382|FG000|Overall Study|Ongoing ITI treatment|6|||
160572203|NCT01712438|579818382|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
160572204|NCT01712438|579818382|FG000|Overall Study|Prematurely Discontinued|25|||
160572205|NCT02786537|579818383|FG000|As Randomized|Adverse Event|0|||
160572206|NCT02786537|579818384|FG001|As Randomized|Adverse Event|11|||
160572207|NCT02786537|579818385|FG002|As Randomized|Adverse Event|0|||
160572208|NCT02786537|579818386|FG003|As Randomized|Adverse Event|4|||
160572209|NCT02786537|579818387|FG004|As Randomized|Adverse Event|6|||
160572210|NCT02786537|579818388|FG005|As Randomized|Adverse Event|2|||
160572211|NCT02786537|579818383|FG000|As Randomized|Lack of Efficacy|0|||
160572212|NCT02786537|579818384|FG001|As Randomized|Lack of Efficacy|0|||
160572213|NCT02786537|579818385|FG002|As Randomized|Lack of Efficacy|0|||
160572214|NCT02786537|579818386|FG003|As Randomized|Lack of Efficacy|1|||
160572215|NCT02786537|579818387|FG004|As Randomized|Lack of Efficacy|0|||
160572216|NCT02786537|579818388|FG005|As Randomized|Lack of Efficacy|0|||
160572217|NCT02786537|579818383|FG000|As Randomized|Withdrawal by Subject|1|||
160572218|NCT02786537|579818384|FG001|As Randomized|Withdrawal by Subject|2|||
160572219|NCT02786537|579818385|FG002|As Randomized|Withdrawal by Subject|0|||
160572220|NCT02786537|579818386|FG003|As Randomized|Withdrawal by Subject|1|||
160572221|NCT02786537|579818387|FG004|As Randomized|Withdrawal by Subject|1|||
160572222|NCT02786537|579818388|FG005|As Randomized|Withdrawal by Subject|0|||
160572223|NCT02786537|579818383|FG000|As Randomized|Death|0|||
160572224|NCT02786537|579818384|FG001|As Randomized|Death|2|||
160572225|NCT02786537|579818385|FG002|As Randomized|Death|0|||
160572226|NCT02786537|579818386|FG003|As Randomized|Death|3|||
160572227|NCT02786537|579818387|FG004|As Randomized|Death|1|||
160572228|NCT02786537|579818388|FG005|As Randomized|Death|0|||
160572229|NCT02786537|579818383|FG000|As Randomized|Non-compliance with study drug|1|||
160572230|NCT02786537|579818384|FG001|As Randomized|Non-compliance with study drug|11|||
160572231|NCT02786537|579818385|FG002|As Randomized|Non-compliance with study drug|0|||
160572232|NCT02786537|579818386|FG003|As Randomized|Non-compliance with study drug|1|||
160572233|NCT02786537|579818387|FG004|As Randomized|Non-compliance with study drug|0|||
160572234|NCT02786537|579818388|FG005|As Randomized|Non-compliance with study drug|1|||
160572235|NCT02786537|579818383|FG000|As Randomized|Lost to treatment follow-up|4|||
160572236|NCT02786537|579818384|FG001|As Randomized|Lost to treatment follow-up|32|||
160572237|NCT02786537|579818385|FG002|As Randomized|Lost to treatment follow-up|0|||
160572238|NCT02786537|579818386|FG003|As Randomized|Lost to treatment follow-up|24|||
160572239|NCT02786537|579818387|FG004|As Randomized|Lost to treatment follow-up|4|||
160572240|NCT02786537|579818388|FG005|As Randomized|Lost to treatment follow-up|4|||
160572241|NCT02786537|579818383|FG000|As Randomized|Incarceration|0|||
160572242|NCT02786537|579818384|FG001|As Randomized|Incarceration|1|||
160572243|NCT02786537|579818385|FG002|As Randomized|Incarceration|0|||
160572244|NCT02786537|579818386|FG003|As Randomized|Incarceration|0|||
160454179|NCT05218096|579394084|FG003|Open-label Extension|Pregnancy|0|||
160454180|NCT05218096|579394085|FG004|Open-label Extension|Pregnancy|1|||
160454181|NCT05218096|579394081|FG000|Open-label Extension|Lack of Efficacy|1|||
160454182|NCT05218096|579394082|FG001|Open-label Extension|Lack of Efficacy|2|||
160454183|NCT05218096|579394083|FG002|Open-label Extension|Lack of Efficacy|0|||
160454184|NCT05218096|579394084|FG003|Open-label Extension|Lack of Efficacy|0|||
160454185|NCT05218096|579394085|FG004|Open-label Extension|Lack of Efficacy|0|||
160454186|NCT05218096|579394081|FG000|Open-label Extension|Lost to Follow-up|1|||
160454187|NCT05218096|579394082|FG001|Open-label Extension|Lost to Follow-up|0|||
160454188|NCT05218096|579394083|FG002|Open-label Extension|Lost to Follow-up|0|||
160454189|NCT05218096|579394084|FG003|Open-label Extension|Lost to Follow-up|0|||
160454190|NCT05218096|579394085|FG004|Open-label Extension|Lost to Follow-up|0|||
160454191|NCT05218096|579394081|FG000|Open-label Extension|Death|0|||
160454192|NCT05218096|579394082|FG001|Open-label Extension|Death|0|||
160454193|NCT05218096|579394083|FG002|Open-label Extension|Death|0|||
160454194|NCT05218096|579394084|FG003|Open-label Extension|Death|1|||
160454195|NCT05218096|579394085|FG004|Open-label Extension|Death|0|||
160454196|NCT05218096|579394081|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
160454197|NCT05218096|579394082|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
160454198|NCT05218096|579394083|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
160572245|NCT02786537|579818387|FG004|As Randomized|Incarceration|0|||
160454199|NCT05218096|579394084|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
160454200|NCT05218096|579394085|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
160454201|NCT04690582|579394091|FG000|Overall Study|Withdrawal by Subject|6|||
160454202|NCT04690582|579394092|FG001|Overall Study|Withdrawal by Subject|4|||
160572246|NCT02786537|579818388|FG005|As Randomized|Incarceration|0|||
160454203|NCT05267470|579394098|FG000|Overall Study|Decision by sponsor|0|||
160454204|NCT05267470|579394099|FG001|Overall Study|Decision by sponsor|3|||
160454205|NCT05267470|579394100|FG002|Overall Study|Decision by sponsor|19|||
160454206|NCT05267470|579394101|FG003|Overall Study|Decision by sponsor|7|||
160454207|NCT05267470|579394102|FG004|Overall Study|Decision by sponsor|3|||
160454208|NCT05267470|579394098|FG000|Overall Study|Withdrawal by Subject|1|||
160454209|NCT05267470|579394099|FG001|Overall Study|Withdrawal by Subject|1|||
160454210|NCT05267470|579394100|FG002|Overall Study|Withdrawal by Subject|2|||
160454211|NCT05267470|579394101|FG003|Overall Study|Withdrawal by Subject|2|||
160454212|NCT05267470|579394102|FG004|Overall Study|Withdrawal by Subject|0|||
160454213|NCT05267470|579394098|FG000|Overall Study|Death|3|||
160454214|NCT05267470|579394099|FG001|Overall Study|Death|5|||
160454215|NCT05267470|579394100|FG002|Overall Study|Death|8|||
160454216|NCT05267470|579394101|FG003|Overall Study|Death|18|||
160454217|NCT05267470|579394102|FG004|Overall Study|Death|1|||
160454218|NCT05267470|579394098|FG000|Overall Study|Lost to Follow-up|0|||
160454219|NCT05267470|579394099|FG001|Overall Study|Lost to Follow-up|0|||
160454220|NCT05267470|579394100|FG002|Overall Study|Lost to Follow-up|0|||
160454221|NCT05267470|579394101|FG003|Overall Study|Lost to Follow-up|1|||
160454222|NCT05267470|579394102|FG004|Overall Study|Lost to Follow-up|0|||
160454223|NCT03257410|579396078|FG000|Overall Study|Adverse Event|2|||
160454224|NCT03257410|579396079|FG001|Overall Study|Adverse Event|3|||
160454225|NCT03257410|579396078|FG000|Overall Study|Protocol Violation|1|||
160454226|NCT03257410|579396079|FG001|Overall Study|Protocol Violation|2|||
160454227|NCT03257410|579396078|FG000|Overall Study|Lost to Follow-up|1|||
160454228|NCT03257410|579396079|FG001|Overall Study|Lost to Follow-up|0|||
160454229|NCT03257410|579396078|FG000|Overall Study|Withdrawal by Subject|1|||
160454230|NCT03257410|579396079|FG001|Overall Study|Withdrawal by Subject|2|||
160454231|NCT03257410|579396078|FG000|Overall Study|Physician Decision|1|||
160454232|NCT03257410|579396079|FG001|Overall Study|Physician Decision|1|||
160454233|NCT03257410|579396078|FG000|Overall Study|Renal transplantation|2|||
160454234|NCT03257410|579396079|FG001|Overall Study|Renal transplantation|0|||
160454235|NCT03257410|579396078|FG000|Overall Study|Switch to peritoneal dialysis|1|||
160454236|NCT03257410|579396079|FG001|Overall Study|Switch to peritoneal dialysis|0|||
160454237|NCT03257410|579396078|FG000|Overall Study|Death|3|||
160454238|NCT03257410|579396079|FG001|Overall Study|Death|2|||
160454239|NCT03257410|579396078|FG000|Overall Study|Change to another dialysis center|2|||
160454240|NCT03257410|579396079|FG001|Overall Study|Change to another dialysis center|2|||
160454241|NCT03257410|579396078|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
160454242|NCT03257410|579396079|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
160454243|NCT03257410|579396078|FG000|Overall Study|Miscellaneous|2|||
160454244|NCT03257410|579396079|FG001|Overall Study|Miscellaneous|2|||
160454245|NCT03257410|579396078|FG000|Overall Study|Other|0|||
160454246|NCT03257410|579396079|FG001|Overall Study|Other|1|||
160454247|NCT02598388|579396080|FG000|Overall Study|Lost to Follow-up|1|||
160454248|NCT02598388|579396081|FG001|Overall Study|Lost to Follow-up|0|||
160454249|NCT02598388|579396082|FG002|Overall Study|Lost to Follow-up|1|||
160454250|NCT02598388|579396083|FG003|Overall Study|Lost to Follow-up|0|||
160454251|NCT02598388|579396084|FG004|Overall Study|Lost to Follow-up|5|||
160454252|NCT02598388|579396085|FG005|Overall Study|Lost to Follow-up|1|||
160454253|NCT02598388|579396086|FG006|Overall Study|Lost to Follow-up|2|||
160454254|NCT02598388|579396087|FG007|Overall Study|Lost to Follow-up|1|||
160454255|NCT02598388|579396088|FG008|Overall Study|Lost to Follow-up|0|||
160454256|NCT02598388|579396089|FG009|Overall Study|Lost to Follow-up|0|||
160454257|NCT02598388|579396090|FG010|Overall Study|Lost to Follow-up|1|||
160454258|NCT02598388|579396091|FG011|Overall Study|Lost to Follow-up|0|||
160454259|NCT02598388|579396080|FG000|Overall Study|Withdrawal by Subject|0|||
160454260|NCT02598388|579396081|FG001|Overall Study|Withdrawal by Subject|0|||
160572247|NCT02786537|579818383|FG000|As Randomized|Opiate Dependency Relapse|0|||
160454261|NCT02598388|579396082|FG002|Overall Study|Withdrawal by Subject|0|||
160454262|NCT02598388|579396083|FG003|Overall Study|Withdrawal by Subject|0|||
160454263|NCT02598388|579396084|FG004|Overall Study|Withdrawal by Subject|2|||
160454264|NCT02598388|579396085|FG005|Overall Study|Withdrawal by Subject|0|||
160454265|NCT02598388|579396086|FG006|Overall Study|Withdrawal by Subject|2|||
160454266|NCT02598388|579396087|FG007|Overall Study|Withdrawal by Subject|0|||
160454267|NCT02598388|579396088|FG008|Overall Study|Withdrawal by Subject|0|||
160454268|NCT02598388|579396089|FG009|Overall Study|Withdrawal by Subject|1|||
160454269|NCT02598388|579396090|FG010|Overall Study|Withdrawal by Subject|0|||
160454270|NCT02598388|579396091|FG011|Overall Study|Withdrawal by Subject|0|||
160454271|NCT02598388|579396080|FG000|Overall Study|Other|0|||
160454272|NCT02598388|579396081|FG001|Overall Study|Other|0|||
160454273|NCT02598388|579396082|FG002|Overall Study|Other|1|||
160454274|NCT02598388|579396083|FG003|Overall Study|Other|0|||
160454275|NCT02598388|579396084|FG004|Overall Study|Other|3|||
160454276|NCT02598388|579396085|FG005|Overall Study|Other|0|||
160454277|NCT02598388|579396086|FG006|Overall Study|Other|1|||
160454278|NCT02598388|579396087|FG007|Overall Study|Other|0|||
160454279|NCT02598388|579396088|FG008|Overall Study|Other|0|||
160454280|NCT02598388|579396089|FG009|Overall Study|Other|0|||
160454281|NCT02598388|579396090|FG010|Overall Study|Other|0|||
160572248|NCT02786537|579818384|FG001|As Randomized|Opiate Dependency Relapse|1|||
160572249|NCT02786537|579818385|FG002|As Randomized|Opiate Dependency Relapse|0|||
160918057|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
160918058|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
160918059|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
160918060|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
160918061|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
160918062|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
160918063|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
160918064|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
160918065|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
160918066|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
160918067|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
160572250|NCT02786537|579818386|FG003|As Randomized|Opiate Dependency Relapse|0|||
160572251|NCT02786537|579818387|FG004|As Randomized|Opiate Dependency Relapse|0|||
160572252|NCT02786537|579818388|FG005|As Randomized|Opiate Dependency Relapse|0|||
160572253|NCT02786537|579818383|FG000|As Randomized|HCV drugs stolen from pt|0|||
160572254|NCT02786537|579818384|FG001|As Randomized|HCV drugs stolen from pt|1|||
160572255|NCT02786537|579818385|FG002|As Randomized|HCV drugs stolen from pt|0|||
160572256|NCT02786537|579818386|FG003|As Randomized|HCV drugs stolen from pt|0|||
160572257|NCT02786537|579818387|FG004|As Randomized|HCV drugs stolen from pt|0|||
160572258|NCT02786537|579818388|FG005|As Randomized|HCV drugs stolen from pt|0|||
160572259|NCT02786537|579818383|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
160572260|NCT02786537|579818384|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
160572261|NCT02786537|579818385|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
160572262|NCT02786537|579818386|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
160572263|NCT02786537|579818387|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
160572264|NCT02786537|579818388|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
160572265|NCT02786537|579818383|FG000|As Randomized|Subject lost insurance|0|||
160572266|NCT02786537|579818384|FG001|As Randomized|Subject lost insurance|0|||
160572267|NCT02786537|579818385|FG002|As Randomized|Subject lost insurance|0|||
160572268|NCT02786537|579818386|FG003|As Randomized|Subject lost insurance|1|||
160572269|NCT02786537|579818387|FG004|As Randomized|Subject lost insurance|0|||
160572270|NCT02786537|579818388|FG005|As Randomized|Subject lost insurance|0|||
160572271|NCT02786537|579818383|FG000|As Treated|Adverse Event|0|||
160572272|NCT02786537|579818384|FG001|As Treated|Adverse Event|11|||
160572273|NCT02786537|579818385|FG002|As Treated|Adverse Event|0|||
160572274|NCT02786537|579818386|FG003|As Treated|Adverse Event|4|||
160572275|NCT02786537|579818387|FG004|As Treated|Adverse Event|6|||
160572276|NCT02786537|579818388|FG005|As Treated|Adverse Event|2|||
160572277|NCT02786537|579818383|FG000|As Treated|Death|0|||
160572278|NCT02786537|579818384|FG001|As Treated|Death|2|||
160572279|NCT02786537|579818385|FG002|As Treated|Death|0|||
160572280|NCT02786537|579818386|FG003|As Treated|Death|3|||
160572281|NCT02786537|579818387|FG004|As Treated|Death|1|||
160572282|NCT02786537|579818388|FG005|As Treated|Death|0|||
160653942|NCT02270736|580114228|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
160454282|NCT02598388|579396091|FG011|Overall Study|Other|0|||
160520046|NCT04737187|579632968|FG000|Overall Study|Adverse Event|16|||
160520047|NCT04737187|579632969|FG001|Overall Study|Adverse Event|16|||
160520048|NCT04737187|579632968|FG000|Overall Study|Physician Decision|2|||
160520049|NCT04737187|579632969|FG001|Overall Study|Physician Decision|0|||
160520050|NCT04737187|579632968|FG000|Overall Study|Withdrawal by Subject|5|||
160520051|NCT04737187|579632969|FG001|Overall Study|Withdrawal by Subject|8|||
160520052|NCT05227703|579632970|FG000|Overall Study|Adverse Event|2|||
160520053|NCT05227703|579632971|FG001|Overall Study|Adverse Event|6|||
160520054|NCT05227703|579632972|FG002|Overall Study|Adverse Event|4|||
160520055|NCT05227703|579632970|FG000|Overall Study|Lack of Efficacy|4|||
160520056|NCT05227703|579632971|FG001|Overall Study|Lack of Efficacy|0|||
160520057|NCT05227703|579632972|FG002|Overall Study|Lack of Efficacy|1|||
160520058|NCT05227703|579632970|FG000|Overall Study|Physician Decision|2|||
160520059|NCT05227703|579632971|FG001|Overall Study|Physician Decision|2|||
160520060|NCT05227703|579632972|FG002|Overall Study|Physician Decision|1|||
160520061|NCT05227703|579632970|FG000|Overall Study|Protocol Violation|2|||
160520062|NCT05227703|579632971|FG001|Overall Study|Protocol Violation|1|||
160520063|NCT05227703|579632972|FG002|Overall Study|Protocol Violation|0|||
160520064|NCT05227703|579632970|FG000|Overall Study|Withdrawal by Subject|17|||
160520065|NCT05227703|579632971|FG001|Overall Study|Withdrawal by Subject|26|||
160520066|NCT05227703|579632972|FG002|Overall Study|Withdrawal by Subject|32|||
160520067|NCT05227703|579632970|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
160520068|NCT05227703|579632971|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
160520069|NCT05227703|579632972|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
160520070|NCT05227703|579632970|FG000|Overall Study|Other|1|||
160520071|NCT05227703|579632971|FG001|Overall Study|Other|1|||
160520072|NCT05227703|579632972|FG002|Overall Study|Other|0|||
160454283|NCT03668236|579396094|FG000|90-day Follow-up|Withdrawal by Subject|3|||
160454284|NCT03668236|579396095|FG001|90-day Follow-up|Withdrawal by Subject|2|||
160454285|NCT03668236|579396094|FG000|90-day Follow-up|Lost to Follow-up|3|||
160454286|NCT03668236|579396095|FG001|90-day Follow-up|Lost to Follow-up|1|||
160454287|NCT03668236|579396094|FG000|Baseline Characteristics|Lost to Follow-up|9|||
160454288|NCT03668236|579396095|FG001|Baseline Characteristics|Lost to Follow-up|5|||
160454289|NCT03668236|579396094|FG000|1-year Follow-up|Withdrawal by Subject|17|||
160454290|NCT03668236|579396095|FG001|1-year Follow-up|Withdrawal by Subject|15|||
160454291|NCT06132282|579396096|FG000|Overall Study|Lost to Follow-up|31|||
160454292|NCT04171141|579396097|FG000|Overall Study|Adverse Event|0|||
160454293|NCT04171141|579396098|FG001|Overall Study|Adverse Event|0|||
160454294|NCT04171141|579396099|FG002|Overall Study|Adverse Event|2|||
160454295|NCT04171141|579396100|FG003|Overall Study|Adverse Event|0|||
160454296|NCT04171141|579396101|FG004|Overall Study|Adverse Event|0|||
160454297|NCT04171141|579396102|FG005|Overall Study|Adverse Event|0|||
160454298|NCT04171141|579396103|FG006|Overall Study|Adverse Event|0|||
160454299|NCT04171141|579396104|FG007|Overall Study|Adverse Event|0|||
160454300|NCT04171141|579396105|FG008|Overall Study|Adverse Event|0|||
160454301|NCT04171141|579396106|FG009|Overall Study|Adverse Event|0|||
160454302|NCT04171141|579396107|FG010|Overall Study|Adverse Event|0|||
160454303|NCT04171141|579396108|FG011|Overall Study|Adverse Event|0|||
160454304|NCT04171141|579396109|FG012|Overall Study|Adverse Event|0|||
160454305|NCT04171141|579396110|FG013|Overall Study|Adverse Event|2|||
160454306|NCT04171141|579396111|FG014|Overall Study|Adverse Event|0|||
160454307|NCT04171141|579396112|FG015|Overall Study|Adverse Event|0|||
160454308|NCT04171141|579396097|FG000|Overall Study|Physician Decision|0|||
160454309|NCT04171141|579396098|FG001|Overall Study|Physician Decision|0|||
160454310|NCT04171141|579396099|FG002|Overall Study|Physician Decision|0|||
160454311|NCT04171141|579396100|FG003|Overall Study|Physician Decision|0|||
160454312|NCT04171141|579396101|FG004|Overall Study|Physician Decision|1|||
160454313|NCT04171141|579396102|FG005|Overall Study|Physician Decision|0|||
160454314|NCT04171141|579396103|FG006|Overall Study|Physician Decision|0|||
160454315|NCT04171141|579396104|FG007|Overall Study|Physician Decision|0|||
160454316|NCT04171141|579396105|FG008|Overall Study|Physician Decision|0|||
160454317|NCT04171141|579396106|FG009|Overall Study|Physician Decision|0|||
160454318|NCT04171141|579396107|FG010|Overall Study|Physician Decision|0|||
160454319|NCT04171141|579396108|FG011|Overall Study|Physician Decision|0|||
160454320|NCT04171141|579396109|FG012|Overall Study|Physician Decision|0|||
160454321|NCT04171141|579396110|FG013|Overall Study|Physician Decision|0|||
160454322|NCT04171141|579396111|FG014|Overall Study|Physician Decision|0|||
160454323|NCT04171141|579396112|FG015|Overall Study|Physician Decision|1|||
160454324|NCT04171141|579396097|FG000|Overall Study|Progressive disease|2|||
160454325|NCT04171141|579396098|FG001|Overall Study|Progressive disease|3|||
160454326|NCT04171141|579396099|FG002|Overall Study|Progressive disease|4|||
160454327|NCT04171141|579396100|FG003|Overall Study|Progressive disease|7|||
160454328|NCT04171141|579396101|FG004|Overall Study|Progressive disease|1|||
160454329|NCT04171141|579396102|FG005|Overall Study|Progressive disease|8|||
160454330|NCT04171141|579396103|FG006|Overall Study|Progressive disease|4|||
160454331|NCT04171141|579396104|FG007|Overall Study|Progressive disease|6|||
160454332|NCT04171141|579396105|FG008|Overall Study|Progressive disease|7|||
160454333|NCT04171141|579396106|FG009|Overall Study|Progressive disease|3|||
160454334|NCT04171141|579396107|FG010|Overall Study|Progressive disease|4|||
160454335|NCT04171141|579396108|FG011|Overall Study|Progressive disease|3|||
160454336|NCT04171141|579396109|FG012|Overall Study|Progressive disease|4|||
160454337|NCT04171141|579396110|FG013|Overall Study|Progressive disease|2|||
160454338|NCT04171141|579396111|FG014|Overall Study|Progressive disease|4|||
160454339|NCT04171141|579396112|FG015|Overall Study|Progressive disease|1|||
160454340|NCT04171141|579396097|FG000|Overall Study|Withdrawal by Subject|0|||
160454341|NCT04171141|579396098|FG001|Overall Study|Withdrawal by Subject|0|||
160653943|NCT02270736|580114224|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
160454342|NCT04171141|579396099|FG002|Overall Study|Withdrawal by Subject|0|||
160454343|NCT04171141|579396100|FG003|Overall Study|Withdrawal by Subject|1|||
160454344|NCT04171141|579396101|FG004|Overall Study|Withdrawal by Subject|0|||
160454345|NCT04171141|579396102|FG005|Overall Study|Withdrawal by Subject|0|||
160454346|NCT04171141|579396103|FG006|Overall Study|Withdrawal by Subject|1|||
160454347|NCT04171141|579396104|FG007|Overall Study|Withdrawal by Subject|0|||
160454348|NCT04171141|579396105|FG008|Overall Study|Withdrawal by Subject|0|||
160454349|NCT04171141|579396106|FG009|Overall Study|Withdrawal by Subject|1|||
160454350|NCT04171141|579396107|FG010|Overall Study|Withdrawal by Subject|0|||
160454351|NCT04171141|579396108|FG011|Overall Study|Withdrawal by Subject|0|||
160454352|NCT04171141|579396109|FG012|Overall Study|Withdrawal by Subject|0|||
160454353|NCT04171141|579396110|FG013|Overall Study|Withdrawal by Subject|0|||
160454354|NCT04171141|579396111|FG014|Overall Study|Withdrawal by Subject|0|||
160454355|NCT04171141|579396112|FG015|Overall Study|Withdrawal by Subject|0|||
160454356|NCT04171141|579396097|FG000|Overall Study|Global deterioration of health status|0|||
160454357|NCT04171141|579396098|FG001|Overall Study|Global deterioration of health status|0|||
160454358|NCT04171141|579396099|FG002|Overall Study|Global deterioration of health status|0|||
160454359|NCT04171141|579396100|FG003|Overall Study|Global deterioration of health status|1|||
160918068|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
160918069|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
160918070|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
160918071|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
160918072|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
160918073|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
160572283|NCT02786537|579818383|FG000|As Treated|Lack of Efficacy|0|||
160572284|NCT02786537|579818384|FG001|As Treated|Lack of Efficacy|0|||
160572285|NCT02786537|579818385|FG002|As Treated|Lack of Efficacy|0|||
160572286|NCT02786537|579818386|FG003|As Treated|Lack of Efficacy|1|||
160572287|NCT02786537|579818387|FG004|As Treated|Lack of Efficacy|0|||
160572288|NCT02786537|579818388|FG005|As Treated|Lack of Efficacy|0|||
160572289|NCT02786537|579818383|FG000|As Treated|Lost to Follow-up|4|||
160572290|NCT02786537|579818384|FG001|As Treated|Lost to Follow-up|32|||
160572291|NCT02786537|579818385|FG002|As Treated|Lost to Follow-up|0|||
160572292|NCT02786537|579818386|FG003|As Treated|Lost to Follow-up|25|||
160572293|NCT02786537|579818387|FG004|As Treated|Lost to Follow-up|4|||
160572294|NCT02786537|579818388|FG005|As Treated|Lost to Follow-up|4|||
160572295|NCT02786537|579818383|FG000|As Treated|Non-compliance with study drug|1|||
160572296|NCT02786537|579818384|FG001|As Treated|Non-compliance with study drug|11|||
160572297|NCT02786537|579818385|FG002|As Treated|Non-compliance with study drug|0|||
160572298|NCT02786537|579818386|FG003|As Treated|Non-compliance with study drug|1|||
160572299|NCT02786537|579818387|FG004|As Treated|Non-compliance with study drug|0|||
160572300|NCT02786537|579818388|FG005|As Treated|Non-compliance with study drug|1|||
160572301|NCT02786537|579818383|FG000|As Treated|Lost insurance|0|||
160572302|NCT02786537|579818384|FG001|As Treated|Lost insurance|0|||
160572303|NCT02786537|579818385|FG002|As Treated|Lost insurance|0|||
160572304|NCT02786537|579818386|FG003|As Treated|Lost insurance|1|||
160572305|NCT02786537|579818387|FG004|As Treated|Lost insurance|0|||
160572306|NCT02786537|579818388|FG005|As Treated|Lost insurance|0|||
160572307|NCT02786537|579818383|FG000|As Treated|Withdrawal by Subject|1|||
160572308|NCT02786537|579818384|FG001|As Treated|Withdrawal by Subject|2|||
160572309|NCT02786537|579818385|FG002|As Treated|Withdrawal by Subject|0|||
160572310|NCT02786537|579818386|FG003|As Treated|Withdrawal by Subject|0|||
160572311|NCT02786537|579818387|FG004|As Treated|Withdrawal by Subject|1|||
160572312|NCT02786537|579818388|FG005|As Treated|Withdrawal by Subject|0|||
160572313|NCT02786537|579818383|FG000|As Treated|Incarceration|0|||
160572314|NCT02786537|579818384|FG001|As Treated|Incarceration|1|||
160572315|NCT02786537|579818385|FG002|As Treated|Incarceration|0|||
160572316|NCT02786537|579818386|FG003|As Treated|Incarceration|0|||
160572317|NCT02786537|579818387|FG004|As Treated|Incarceration|0|||
160572318|NCT02786537|579818388|FG005|As Treated|Incarceration|0|||
160572319|NCT02786537|579818383|FG000|As Treated|Opiate dependency relapse|0|||
160572320|NCT02786537|579818384|FG001|As Treated|Opiate dependency relapse|1|||
160572321|NCT02786537|579818385|FG002|As Treated|Opiate dependency relapse|0|||
160572322|NCT02786537|579818386|FG003|As Treated|Opiate dependency relapse|0|||
160572323|NCT02786537|579818387|FG004|As Treated|Opiate dependency relapse|0|||
160572324|NCT02786537|579818388|FG005|As Treated|Opiate dependency relapse|0|||
160572325|NCT02786537|579818383|FG000|As Treated|Drugs stolen from patient|0|||
160572326|NCT02786537|579818384|FG001|As Treated|Drugs stolen from patient|1|||
160572327|NCT02786537|579818385|FG002|As Treated|Drugs stolen from patient|0|||
160572328|NCT02786537|579818386|FG003|As Treated|Drugs stolen from patient|0|||
160572329|NCT02786537|579818387|FG004|As Treated|Drugs stolen from patient|0|||
160572330|NCT02786537|579818388|FG005|As Treated|Drugs stolen from patient|0|||
160572331|NCT02786537|579818383|FG000|As Treated|Advised to stop tx after loss of meds|0|||
160572332|NCT02786537|579818384|FG001|As Treated|Advised to stop tx after loss of meds|1|||
160572333|NCT02786537|579818385|FG002|As Treated|Advised to stop tx after loss of meds|0|||
160572334|NCT02786537|579818386|FG003|As Treated|Advised to stop tx after loss of meds|0|||
160572335|NCT02786537|579818387|FG004|As Treated|Advised to stop tx after loss of meds|0|||
160572336|NCT02786537|579818388|FG005|As Treated|Advised to stop tx after loss of meds|0|||
160572337|NCT03060577|579818389|FG000|Overall Study|Withdrawal by Subject|25|||
160572338|NCT03060577|579818390|FG001|Overall Study|Withdrawal by Subject|5|||
160572339|NCT03060577|579818389|FG000|Overall Study|Physician Decision|4|||
160572340|NCT03060577|579818390|FG001|Overall Study|Physician Decision|3|||
160572341|NCT03060577|579818389|FG000|Overall Study|Lost to Follow-up|3|||
160572342|NCT03060577|579818390|FG001|Overall Study|Lost to Follow-up|0|||
160572343|NCT03060577|579818389|FG000|Overall Study|Death|7|||
160572344|NCT03060577|579818390|FG001|Overall Study|Death|1|||
160918074|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
160918075|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
160572345|NCT03060577|579818389|FG000|Overall Study|Adverse Event|9|||
160572346|NCT03060577|579818390|FG001|Overall Study|Adverse Event|1|||
160572347|NCT03060577|579818389|FG000|Overall Study|Inclusion/Exclusion|1|||
160572348|NCT03060577|579818390|FG001|Overall Study|Inclusion/Exclusion|0|||
160572349|NCT03060577|579818389|FG000|Overall Study|Other|8|||
160572350|NCT03060577|579818390|FG001|Overall Study|Other|2|||
160572351|NCT03216265|579818391|FG000|Overall Study|Adverse Event|2|||
160572352|NCT03216265|579818392|FG001|Overall Study|Adverse Event|0|||
160918076|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
160918077|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
160918078|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
160918079|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
160918080|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
160918081|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
160918082|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
160918083|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
160918084|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
160918085|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
160918086|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
160918087|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
160918088|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
160918089|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
160918090|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
160918091|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
160918092|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
160996890|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996891|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996892|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996893|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
160996894|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996895|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996896|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996897|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996898|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160454360|NCT04171141|579396101|FG004|Overall Study|Global deterioration of health status|0|||
160454361|NCT04171141|579396102|FG005|Overall Study|Global deterioration of health status|2|||
160454362|NCT04171141|579396103|FG006|Overall Study|Global deterioration of health status|1|||
160454363|NCT04171141|579396104|FG007|Overall Study|Global deterioration of health status|0|||
160454364|NCT04171141|579396105|FG008|Overall Study|Global deterioration of health status|1|||
160454365|NCT04171141|579396106|FG009|Overall Study|Global deterioration of health status|0|||
160454366|NCT04171141|579396107|FG010|Overall Study|Global deterioration of health status|0|||
160454367|NCT04171141|579396108|FG011|Overall Study|Global deterioration of health status|0|||
160454368|NCT04171141|579396109|FG012|Overall Study|Global deterioration of health status|0|||
160454369|NCT04171141|579396110|FG013|Overall Study|Global deterioration of health status|0|||
160454370|NCT04171141|579396111|FG014|Overall Study|Global deterioration of health status|1|||
160454371|NCT04171141|579396112|FG015|Overall Study|Global deterioration of health status|1|||
160454372|NCT03314454|579396113|FG000|Overall Study|Protocol Violation|1|||
160454373|NCT04499924|579396114|FG000|Overall Study|Study termination by sponsor|4|||
160454374|NCT04499924|579396115|FG001|Overall Study|Study termination by sponsor|6|||
160454375|NCT04499924|579396114|FG000|Overall Study|Withdrawal by Subject|1|||
160454376|NCT04499924|579396115|FG001|Overall Study|Withdrawal by Subject|3|||
160454377|NCT02841579|579396116|FG000|Overall Study|Death|1|||
160454378|NCT02841579|579396116|FG000|Overall Study|Adverse Event|1|||
160454379|NCT02841579|579396116|FG000|Overall Study|Lack of Efficacy|9|||
160454380|NCT03011333|579396117|FG000|Overall Study|Lost to Follow-up|0|||
160454381|NCT03011333|579396118|FG001|Overall Study|Lost to Follow-up|1|||
160454382|NCT03011333|579396119|FG002|Overall Study|Lost to Follow-up|0|||
160454383|NCT03011333|579396120|FG003|Overall Study|Lost to Follow-up|1|||
160454384|NCT03011333|579396121|FG004|Overall Study|Lost to Follow-up|4|||
160454385|NCT03011333|579396122|FG005|Overall Study|Lost to Follow-up|4|||
160454386|NCT03011333|579396123|FG006|Overall Study|Lost to Follow-up|5|||
160454387|NCT04979442|579396124|FG000|Overall Study|Death|43|||
160454388|NCT04979442|579396125|FG001|Overall Study|Death|30|||
160454389|NCT04979442|579396124|FG000|Overall Study|Withdrawal by Subject|8|||
160454390|NCT04979442|579396125|FG001|Overall Study|Withdrawal by Subject|13|||
160454391|NCT04979442|579396124|FG000|Overall Study|Physician Decision|1|||
160454392|NCT04979442|579396125|FG001|Overall Study|Physician Decision|1|||
160454393|NCT04979442|579396124|FG000|Overall Study|Lost to Follow-up|0|||
160454394|NCT04979442|579396125|FG001|Overall Study|Lost to Follow-up|2|||
160454395|NCT04979442|579396124|FG000|Overall Study|do not want to continue|0|||
160454396|NCT04979442|579396125|FG001|Overall Study|do not want to continue|1|||
160454397|NCT04005794|579396127|FG000|Overall Study|Lost to Follow-up|0|||
160454398|NCT04005794|579396128|FG001|Overall Study|Lost to Follow-up|4|||
160454399|NCT04005794|579396129|FG002|Overall Study|Lost to Follow-up|0|||
160454400|NCT00104676|579396133|FG000|Overall Study|Death|3|||
160918093|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
160918094|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
160918095|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
160918096|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
160918097|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
160918098|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
160918099|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
160918100|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
160918101|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
160918102|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
160918103|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
160918104|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
160918105|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
160918106|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
160996899|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996900|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996901|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996902|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996903|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996904|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996905|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996906|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
160996907|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996908|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996909|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996910|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996911|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996912|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996913|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996914|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160454401|NCT00104676|579396134|FG001|Overall Study|Death|2|||
160454402|NCT00104676|579396133|FG000|Overall Study|Withdrawal by Subject|0|||
160454403|NCT00104676|579396134|FG001|Overall Study|Withdrawal by Subject|2|||
160454404|NCT00104676|579396133|FG000|Overall Study|treatment interruption|4|||
160454405|NCT00104676|579396134|FG001|Overall Study|treatment interruption|10|||
160454406|NCT05622812|579396135|FG000|Overall Study|Withdrawal by Subject|1|||
160454407|NCT05622812|579396136|FG001|Overall Study|Withdrawal by Subject|4|||
160454408|NCT05622812|579396135|FG000|Overall Study|Lost to Follow-up|2|||
160454409|NCT05622812|579396136|FG001|Overall Study|Lost to Follow-up|1|||
160454410|NCT03916185|579396137|FG000|Overall Study|Lost to Follow-up|0|||
160454411|NCT03916185|579396138|FG001|Overall Study|Lost to Follow-up|1|||
160454412|NCT03916185|579396139|FG002|Overall Study|Lost to Follow-up|0|||
160454413|NCT03916185|579396140|FG003|Overall Study|Lost to Follow-up|0|||
160454414|NCT03916185|579396137|FG000|Overall Study|Moved|1|||
160454415|NCT03916185|579396138|FG001|Overall Study|Moved|0|||
160454416|NCT03916185|579396139|FG002|Overall Study|Moved|0|||
160454417|NCT03916185|579396140|FG003|Overall Study|Moved|1|||
160454418|NCT03916185|579396137|FG000|Overall Study|Not Able to Get to Clinic|1|||
160454419|NCT03916185|579396138|FG001|Overall Study|Not Able to Get to Clinic|0|||
160454420|NCT03916185|579396139|FG002|Overall Study|Not Able to Get to Clinic|0|||
160454421|NCT03916185|579396140|FG003|Overall Study|Not Able to Get to Clinic|0|||
160454422|NCT02116530|579396141|FG000|Overall Study|Withdrawal by Subject|1|||
160454423|NCT02116530|579396142|FG001|Overall Study|Withdrawal by Subject|2|||
160454424|NCT02116530|579396141|FG000|Overall Study|Adverse Event|4|||
160454425|NCT02116530|579396142|FG001|Overall Study|Adverse Event|0|||
160454426|NCT02116530|579396141|FG000|Overall Study|Physician Decision|1|||
160454427|NCT02116530|579396142|FG001|Overall Study|Physician Decision|0|||
160454428|NCT02116530|579396141|FG000|Overall Study|Lost to Follow-up|1|||
160454429|NCT02116530|579396142|FG001|Overall Study|Lost to Follow-up|0|||
160454430|NCT02116530|579396141|FG000|Overall Study|Other Medical Problems|2|||
160454431|NCT02116530|579396142|FG001|Overall Study|Other Medical Problems|2|||
160454432|NCT03766685|579396143|FG000|Overall Study|Lost to Follow-up|1|||
160454433|NCT03766685|579396144|FG001|Overall Study|Lost to Follow-up|1|||
160454434|NCT03766685|579396145|FG002|Overall Study|Lost to Follow-up|0|||
160454435|NCT03766685|579396146|FG003|Overall Study|Lost to Follow-up|0|||
160454436|NCT03766685|579396143|FG000|Overall Study|Adverse Event, not fatal|0|||
160454437|NCT03766685|579396144|FG001|Overall Study|Adverse Event, not fatal|1|||
160454438|NCT03766685|579396145|FG002|Overall Study|Adverse Event, not fatal|0|||
160454439|NCT03766685|579396146|FG003|Overall Study|Adverse Event, not fatal|1|||
160454440|NCT03766685|579396143|FG000|Overall Study|Withdrawal by Subject|0|||
160918107|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
160918108|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
160918109|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
160918110|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
160918111|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
160918112|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
160918113|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
160918114|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
160918115|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
160918116|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
160918117|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
160918118|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
160918119|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
160918120|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
160918121|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
160572353|NCT03216265|579818393|FG002|Overall Study|Adverse Event|2|||
160572354|NCT03216265|579818391|FG000|Overall Study|Lost to Follow-up|0|||
160572355|NCT03216265|579818392|FG001|Overall Study|Lost to Follow-up|1|||
160572356|NCT03216265|579818393|FG002|Overall Study|Lost to Follow-up|0|||
160572357|NCT03216265|579818391|FG000|Overall Study|Withdrawal by Subject|0|||
160572358|NCT03216265|579818392|FG001|Overall Study|Withdrawal by Subject|0|||
160572359|NCT03216265|579818393|FG002|Overall Study|Withdrawal by Subject|1|||
160572360|NCT01306058|579818394|FG000|Overall Study|Death|1|||
160572361|NCT01306058|579818394|FG000|Overall Study|Enrolled but did not get treatment|1|||
160572362|NCT02584634|579818397|FG000|Overall Study|Adverse Event|3|||
160572363|NCT02584634|579818398|FG001|Overall Study|Adverse Event|5|||
160572364|NCT02584634|579818397|FG000|Overall Study|Death|0|||
160572365|NCT02584634|579818398|FG001|Overall Study|Death|1|||
160572366|NCT02584634|579818397|FG000|Overall Study|Lost to Follow-up|0|||
160572367|NCT02584634|579818398|FG001|Overall Study|Lost to Follow-up|1|||
160572368|NCT02584634|579818397|FG000|Overall Study|Physician Decision|1|||
160572369|NCT02584634|579818398|FG001|Overall Study|Physician Decision|2|||
160572370|NCT02584634|579818397|FG000|Overall Study|Progressive disease|7|||
160572371|NCT02584634|579818398|FG001|Overall Study|Progressive disease|15|||
160572372|NCT02584634|579818397|FG000|Overall Study|Withdrawal by Subject|1|||
160572373|NCT02584634|579818398|FG001|Overall Study|Withdrawal by Subject|1|||
160572374|NCT02584634|579818397|FG000|Overall Study|Other|0|||
160572375|NCT02584634|579818398|FG001|Overall Study|Other|6|||
160572376|NCT05523362|579818399|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
160572377|NCT05523362|579818399|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
160572378|NCT05523362|579818399|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
160572379|NCT05523362|579818399|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
160572380|NCT04075604|579818401|FG000|Overall Study|Adverse Event|0|||
160572381|NCT04075604|579818402|FG001|Overall Study|Adverse Event|0|||
160572382|NCT04075604|579818403|FG002|Overall Study|Adverse Event|3|||
160572383|NCT04075604|579818401|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160572384|NCT04075604|579818402|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160572385|NCT04075604|579818403|FG002|Overall Study|Participant request to discontinue study treatment|1|||
160572386|NCT04075604|579818401|FG000|Overall Study|Participant withdrew consent|0|||
160572387|NCT04075604|579818402|FG001|Overall Study|Participant withdrew consent|0|||
160572388|NCT04075604|579818403|FG002|Overall Study|Participant withdrew consent|1|||
160572389|NCT04075604|579818401|FG000|Overall Study|Other reasons|1|||
160572390|NCT04075604|579818402|FG001|Overall Study|Other reasons|0|||
160572391|NCT04075604|579818403|FG002|Overall Study|Other reasons|0|||
160572392|NCT04075604|579818401|FG000|Overall Study|Disease progression|0|||
160572393|NCT04075604|579818402|FG001|Overall Study|Disease progression|1|||
160572394|NCT04075604|579818403|FG002|Overall Study|Disease progression|0|||
160572395|NCT04075604|579818401|FG000|Overall Study|Study drug toxicity|0|||
160572396|NCT04075604|579818402|FG001|Overall Study|Study drug toxicity|5|||
160572397|NCT04075604|579818403|FG002|Overall Study|Study drug toxicity|1|||
160572398|NCT01183858|579818404|FG000|Overall Study|Death not related to Progressive Disease|5|||
160572399|NCT01183858|579818405|FG001|Overall Study|Death not related to Progressive Disease|6|||
160572400|NCT01183858|579818404|FG000|Overall Study|Adverse Event|14|||
160572401|NCT01183858|579818405|FG001|Overall Study|Adverse Event|11|||
160572402|NCT01183858|579818404|FG000|Overall Study|Investigator's Decision|0|||
160572403|NCT01183858|579818405|FG001|Overall Study|Investigator's Decision|3|||
160572404|NCT01183858|579818404|FG000|Overall Study|Insufficient Therapeutic Response|2|||
160572405|NCT01183858|579818405|FG001|Overall Study|Insufficient Therapeutic Response|0|||
160918122|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
160918123|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
160572406|NCT01183858|579818404|FG000|Overall Study|Refused Treatment|1|||
160572407|NCT01183858|579818405|FG001|Overall Study|Refused Treatment|4|||
160572408|NCT01183858|579818404|FG000|Overall Study|Withdrew Consent|4|||
160572409|NCT01183858|579818405|FG001|Overall Study|Withdrew Consent|4|||
160918124|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
160918125|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
160918126|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
160918127|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
160918128|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
160918129|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
160918130|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
160918131|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
160918132|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
160918133|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
160918134|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
160918135|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
160572410|NCT01183858|579818404|FG000|Overall Study|Discontinued Smoking|3|||
160572411|NCT01183858|579818405|FG001|Overall Study|Discontinued Smoking|1|||
160572412|NCT01183858|579818404|FG000|Overall Study|Protocol Violation|1|||
160572413|NCT01183858|579818405|FG001|Overall Study|Protocol Violation|0|||
160572414|NCT01183858|579818404|FG000|Overall Study|Administrative/Other|6|||
160572415|NCT01183858|579818405|FG001|Overall Study|Administrative/Other|6|||
160572416|NCT01183858|579818404|FG000|Overall Study|Progressive Disease|112|||
160572417|NCT01183858|579818405|FG001|Overall Study|Progressive Disease|115|||
160572418|NCT01183858|579818404|FG000|Overall Study|Death related to Progressive Disease|4|||
160572419|NCT01183858|579818405|FG001|Overall Study|Death related to Progressive Disease|5|||
160572420|NCT01183858|579818404|FG000|Overall Study|Lost to Follow-up|1|||
160572421|NCT01183858|579818405|FG001|Overall Study|Lost to Follow-up|1|||
160572422|NCT00098345|579818406|FG000|Overall Study|Adverse Event|7|||
160572423|NCT00098345|579818406|FG000|Overall Study|Withdrawal by Subject|2|||
160572424|NCT00098345|579818406|FG000|Overall Study|progression|4|||
160572425|NCT03069690|579818409|FG000|Pregnancy Intervention|Pregnancy loss|9|||
160572426|NCT03069690|579818410|FG001|Pregnancy Intervention|Pregnancy loss|4|||
160572427|NCT03069690|579818411|FG002|Pregnancy Intervention|Pregnancy loss|0|||
160572428|NCT03069690|579818412|FG003|Pregnancy Intervention|Pregnancy loss|0|||
160572429|NCT03069690|579818413|FG004|Pregnancy Intervention|Pregnancy loss|0|||
160572430|NCT03069690|579818414|FG005|Pregnancy Intervention|Pregnancy loss|0|||
160572431|NCT03069690|579818409|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
160572432|NCT03069690|579818410|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
160572433|NCT03069690|579818411|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
160572434|NCT03069690|579818412|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
160572435|NCT03069690|579818413|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
160572436|NCT03069690|579818414|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
160572437|NCT03069690|579818409|FG000|Postpartum Intervention|Lost to Follow-up|0|||
160572438|NCT03069690|579818410|FG001|Postpartum Intervention|Lost to Follow-up|0|||
160572439|NCT03069690|579818411|FG002|Postpartum Intervention|Lost to Follow-up|5|||
160572440|NCT03069690|579818412|FG003|Postpartum Intervention|Lost to Follow-up|5|||
160572441|NCT03069690|579818413|FG004|Postpartum Intervention|Lost to Follow-up|2|||
160572442|NCT03069690|579818414|FG005|Postpartum Intervention|Lost to Follow-up|4|||
160572443|NCT00891657|579818417|FG000|Overall Study|Withdrawal by Subject|1|||
160572444|NCT00891657|579818418|FG001|Overall Study|Withdrawal by Subject|1|||
160572445|NCT03455543|579818424|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
160572446|NCT03455543|579818425|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
160572447|NCT03455543|579818426|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
160572448|NCT03455543|579818424|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
160572449|NCT03455543|579818425|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
160572450|NCT03455543|579818426|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
160572451|NCT03455543|579818424|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
160572452|NCT03455543|579818425|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
160572453|NCT03455543|579818426|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
160572454|NCT03455543|579818424|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
160572455|NCT03455543|579818425|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
160572456|NCT03455543|579818426|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
160572457|NCT03455543|579818424|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
160572458|NCT03455543|579818425|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
160572459|NCT03455543|579818426|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
160572460|NCT03455543|579818424|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
160572461|NCT03455543|579818425|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
160572462|NCT03455543|579818426|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
160572463|NCT03455543|579818424|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
160572464|NCT03455543|579818425|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
160572465|NCT03455543|579818426|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
160632808|NCT00203892|580036075|FG000|Overall Study|Death|1|||
160632809|NCT00203892|580036076|FG001|Overall Study|Death|0|||
160996915|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996916|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996917|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996918|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
160996919|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996920|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996921|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996922|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996923|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160572466|NCT03455543|579818424|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
160572467|NCT03455543|579818425|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
160572468|NCT03455543|579818426|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
160572469|NCT03455543|579818424|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
160572470|NCT03455543|579818425|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
160572471|NCT03455543|579818426|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
160572472|NCT00779038|579818427|FG000|Overall Study|Study Prematurely Terminated|13|||
160572473|NCT00234104|579818431|FG000|Overall Study|Adverse Event|4|||
160572474|NCT00234104|579818432|FG001|Overall Study|Adverse Event|0|||
160572475|NCT00234104|579818433|FG002|Overall Study|Adverse Event|3|||
160572476|NCT00234104|579818434|FG003|Overall Study|Adverse Event|5|||
160572477|NCT00234104|579818431|FG000|Overall Study|Protocol Violation|0|||
160572478|NCT00234104|579818432|FG001|Overall Study|Protocol Violation|0|||
160572479|NCT00234104|579818433|FG002|Overall Study|Protocol Violation|0|||
160572480|NCT00234104|579818434|FG003|Overall Study|Protocol Violation|1|||
160572481|NCT00234104|579818431|FG000|Overall Study|Physician Decision|0|||
160572482|NCT00234104|579818432|FG001|Overall Study|Physician Decision|1|||
160572483|NCT00234104|579818433|FG002|Overall Study|Physician Decision|2|||
160572484|NCT00234104|579818434|FG003|Overall Study|Physician Decision|2|||
160572485|NCT02052960|579818436|FG000|Overall Study|Adverse Event|19|||
160572486|NCT02052960|579818437|FG001|Overall Study|Adverse Event|17|||
160572487|NCT02052960|579818436|FG000|Overall Study|Protocol Violation|4|||
160572488|NCT02052960|579818437|FG001|Overall Study|Protocol Violation|3|||
160572489|NCT02052960|579818436|FG000|Overall Study|Withdrawal by Subject|6|||
160572490|NCT02052960|579818437|FG001|Overall Study|Withdrawal by Subject|11|||
160572491|NCT02052960|579818436|FG000|Overall Study|Other|25|||
160572492|NCT02052960|579818437|FG001|Overall Study|Other|15|||
160572493|NCT04045613|579818438|FG000|Overall Study|Adverse Event|2|||
160572494|NCT04045613|579818439|FG001|Overall Study|Adverse Event|2|||
160572495|NCT04045613|579818440|FG002|Overall Study|Adverse Event|1|||
160572496|NCT04045613|579818441|FG003|Overall Study|Adverse Event|1|||
160572497|NCT04045613|579818442|FG004|Overall Study|Adverse Event|0|||
160572498|NCT04045613|579818443|FG005|Overall Study|Adverse Event|0|||
160572499|NCT04045613|579818444|FG006|Overall Study|Adverse Event|1|||
160572500|NCT04045613|579818438|FG000|Overall Study|Withdrawal by Subject|0|||
160572501|NCT04045613|579818439|FG001|Overall Study|Withdrawal by Subject|5|||
160572502|NCT04045613|579818440|FG002|Overall Study|Withdrawal by Subject|0|||
160572503|NCT04045613|579818441|FG003|Overall Study|Withdrawal by Subject|0|||
160572504|NCT04045613|579818442|FG004|Overall Study|Withdrawal by Subject|0|||
160572505|NCT04045613|579818443|FG005|Overall Study|Withdrawal by Subject|1|||
160572506|NCT04045613|579818444|FG006|Overall Study|Withdrawal by Subject|0|||
160572507|NCT04045613|579818438|FG000|Overall Study|Physician Decision|2|||
160572508|NCT04045613|579818439|FG001|Overall Study|Physician Decision|0|||
160572509|NCT04045613|579818440|FG002|Overall Study|Physician Decision|0|||
160572510|NCT04045613|579818441|FG003|Overall Study|Physician Decision|0|||
160572511|NCT04045613|579818442|FG004|Overall Study|Physician Decision|1|||
160572512|NCT04045613|579818443|FG005|Overall Study|Physician Decision|0|||
160572513|NCT04045613|579818444|FG006|Overall Study|Physician Decision|0|||
160572514|NCT04045613|579818438|FG000|Overall Study|Death|3|||
160572515|NCT04045613|579818439|FG001|Overall Study|Death|0|||
160572516|NCT04045613|579818440|FG002|Overall Study|Death|0|||
160572517|NCT04045613|579818441|FG003|Overall Study|Death|0|||
160572518|NCT04045613|579818442|FG004|Overall Study|Death|0|||
160572519|NCT04045613|579818443|FG005|Overall Study|Death|0|||
160653944|NCT02270736|580114225|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
160454441|NCT03766685|579396144|FG001|Overall Study|Withdrawal by Subject|2|||
160572520|NCT04045613|579818444|FG006|Overall Study|Death|1|||
160572521|NCT04045613|579818438|FG000|Overall Study|Other reasons|0|||
160572522|NCT04045613|579818439|FG001|Overall Study|Other reasons|1|||
160572523|NCT04045613|579818440|FG002|Overall Study|Other reasons|0|||
160572524|NCT04045613|579818441|FG003|Overall Study|Other reasons|0|||
160572525|NCT04045613|579818442|FG004|Overall Study|Other reasons|0|||
160572526|NCT04045613|579818443|FG005|Overall Study|Other reasons|0|||
160572527|NCT04045613|579818444|FG006|Overall Study|Other reasons|1|||
160572528|NCT04045613|579818438|FG000|Overall Study|Progressive disease: Clinical progression|1|||
160572529|NCT04045613|579818439|FG001|Overall Study|Progressive disease: Clinical progression|0|||
160572530|NCT04045613|579818440|FG002|Overall Study|Progressive disease: Clinical progression|3|||
160572531|NCT04045613|579818441|FG003|Overall Study|Progressive disease: Clinical progression|1|||
160572532|NCT04045613|579818442|FG004|Overall Study|Progressive disease: Clinical progression|1|||
160572533|NCT04045613|579818443|FG005|Overall Study|Progressive disease: Clinical progression|3|||
160572534|NCT04045613|579818444|FG006|Overall Study|Progressive disease: Clinical progression|3|||
160572535|NCT04045613|579818438|FG000|Overall Study|Progressive disease: Radiological progression|24|||
160572536|NCT04045613|579818439|FG001|Overall Study|Progressive disease: Radiological progression|6|||
160572537|NCT04045613|579818440|FG002|Overall Study|Progressive disease: Radiological progression|8|||
160653945|NCT02270736|580114226|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
160653946|NCT02270736|580114227|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
160653947|NCT02270736|580114228|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
160653948|NCT00262600|580114229|FG000|Overall Study|Lost to Follow-up|17|||
160653949|NCT00262600|580114230|FG001|Overall Study|Lost to Follow-up|31|||
160653950|NCT00262600|580114231|FG002|Overall Study|Lost to Follow-up|41|||
160653951|NCT00262600|580114229|FG000|Overall Study|Withdrawal by Subject|128|||
160653952|NCT00262600|580114230|FG001|Overall Study|Withdrawal by Subject|145|||
160653953|NCT00262600|580114231|FG002|Overall Study|Withdrawal by Subject|139|||
160653954|NCT00262600|580114229|FG000|Overall Study|Not Treated|32|||
160653955|NCT00262600|580114230|FG001|Overall Study|Not Treated|17|||
160653956|NCT00262600|580114231|FG002|Overall Study|Not Treated|24|||
160653957|NCT00262600|580114229|FG000|Overall Study|Other|58|||
160918136|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
160918137|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
160918138|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Other|0|||
160918139|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Other|1|||
160918140|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Other|0|||
160918141|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Other|2|||
160918142|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Other|1|||
160918143|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Other|0|||
160918144|NCT00460031|581094186|FG000|Overall Study|Adverse Event|5|||
160918145|NCT00460031|581094186|FG000|Overall Study|Withdrawal by Subject|5|||
160918146|NCT00460031|581094186|FG000|Overall Study|Death|1|||
160918147|NCT01988103|581094191|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
160918148|NCT01988103|581094192|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
160918149|NCT01988103|581094193|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
160918150|NCT01988103|581094194|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
160918151|NCT01988103|581094195|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
160918152|NCT01988103|581094191|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
160918153|NCT01988103|581094192|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
160918154|NCT01988103|581094193|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
160918155|NCT01988103|581094194|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
160918156|NCT01988103|581094195|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
160918157|NCT01988103|581094191|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
160918158|NCT01988103|581094192|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
160572538|NCT04045613|579818441|FG003|Overall Study|Progressive disease: Radiological progression|0|||
160572539|NCT04045613|579818442|FG004|Overall Study|Progressive disease: Radiological progression|6|||
160572540|NCT04045613|579818443|FG005|Overall Study|Progressive disease: Radiological progression|6|||
160572541|NCT04045613|579818444|FG006|Overall Study|Progressive disease: Radiological progression|11|||
160572542|NCT00883753|579818448|FG000|Overall Study|Adverse Event|37|||
160572543|NCT00883753|579818448|FG000|Overall Study|Death|2|||
160572544|NCT00883753|579818448|FG000|Overall Study|Insufficient therapeutic response|16|||
160572545|NCT00883753|579818448|FG000|Overall Study|Lost to Follow-up|4|||
160572546|NCT00883753|579818448|FG000|Overall Study|Violation of selection criteria at entry|7|||
160572547|NCT00883753|579818448|FG000|Overall Study|Protocol Violation|2|||
160572548|NCT00883753|579818448|FG000|Overall Study|Refused treatment|4|||
160572549|NCT00883753|579818448|FG000|Overall Study|Withdrew consent|10|||
160572550|NCT00883753|579818448|FG000|Overall Study|Investigator's decision|17|||
160572551|NCT00883753|579818448|FG000|Overall Study|Administrative/Other|8|||
160653958|NCT00262600|580114230|FG001|Overall Study|Other|59|||
160653959|NCT00262600|580114231|FG002|Overall Study|Other|62|||
160653960|NCT05381948|580114236|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
160572552|NCT02436239|579818449|FG000|Open-Lable Treatment Period|Adverse Event|12|||
160572553|NCT02436239|579818450|FG001|Open-Lable Treatment Period|Adverse Event|3|||
160572554|NCT02436239|579818451|FG002|Open-Lable Treatment Period|Adverse Event|4|||
160572555|NCT02436239|579818452|FG003|Open-Lable Treatment Period|Adverse Event|2|||
160572556|NCT02436239|579818449|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
160572557|NCT02436239|579818450|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
160572558|NCT02436239|579818451|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
160572559|NCT02436239|579818452|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
160572560|NCT02436239|579818449|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
160653961|NCT05381948|580114237|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
160572561|NCT02436239|579818450|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
160572562|NCT02436239|579818451|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
160572563|NCT02436239|579818452|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
160572564|NCT02436239|579818449|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
160572565|NCT02436239|579818450|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
160572566|NCT02436239|579818451|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
160572567|NCT02436239|579818452|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
160572568|NCT02436239|579818449|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
160572569|NCT02436239|579818450|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
160572570|NCT02436239|579818451|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
160572571|NCT02436239|579818452|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
160572572|NCT02436239|579818449|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
160572573|NCT02436239|579818450|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
160572574|NCT02436239|579818451|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
160572575|NCT02436239|579818452|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
160572576|NCT02436239|579818449|FG000|Open-Lable Treatment Period|Other Reason|1|||
160572577|NCT02436239|579818450|FG001|Open-Lable Treatment Period|Other Reason|1|||
160572578|NCT02436239|579818451|FG002|Open-Lable Treatment Period|Other Reason|0|||
160572579|NCT02436239|579818452|FG003|Open-Lable Treatment Period|Other Reason|0|||
160572580|NCT02436239|579818449|FG000|Down-Taper Period|Withdrawal by Subject|4|||
160572581|NCT02436239|579818450|FG001|Down-Taper Period|Withdrawal by Subject|4|||
160572582|NCT02436239|579818451|FG002|Down-Taper Period|Withdrawal by Subject|1|||
160572583|NCT02436239|579818452|FG003|Down-Taper Period|Withdrawal by Subject|2|||
160572584|NCT00940342|579818453|FG000|Overall Study|Adverse Event|0|||
160572585|NCT00940342|579818454|FG001|Overall Study|Adverse Event|2|||
160572586|NCT00940342|579818455|FG002|Overall Study|Adverse Event|1|||
160572587|NCT00138151|579818456|FG000|Overall Study|Withdrawal by Subject|3|||
160572588|NCT00138151|579818456|FG000|Overall Study|Physician Decision|1|||
160572589|NCT02675517|579818457|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
160572590|NCT02675517|579818457|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
160572591|NCT03249350|579818460|FG000|Overall Study|Participant did not initiate treatment|5|||
160572592|NCT03249350|579818461|FG001|Overall Study|Participant did not initiate treatment|8|||
160572593|NCT01716169|579818463|FG000|Overall Study|Adverse Event|1|||
160572594|NCT01716169|579818463|FG000|Overall Study|Lost to Follow-up|1|||
160572595|NCT01716169|579818463|FG000|Overall Study|Withdrawal by Subject|1|||
160572596|NCT01716169|579818463|FG000|Overall Study|inconsistent dressing application|1|||
160572597|NCT00553787|579818464|FG000|Overall Study|Adverse Event|34|||
160572598|NCT00553787|579818465|FG001|Overall Study|Adverse Event|21|||
160572599|NCT00553787|579818466|FG002|Overall Study|Adverse Event|67|||
160572600|NCT00553787|579818464|FG000|Overall Study|Lost to Follow-up|132|||
160572601|NCT00553787|579818465|FG001|Overall Study|Lost to Follow-up|44|||
160572602|NCT00553787|579818466|FG002|Overall Study|Lost to Follow-up|78|||
160572603|NCT00553787|579818464|FG000|Overall Study|Withdrawal by Subject|151|||
160572604|NCT00553787|579818465|FG001|Overall Study|Withdrawal by Subject|40|||
160572605|NCT00553787|579818466|FG002|Overall Study|Withdrawal by Subject|83|||
160572606|NCT00553787|579818464|FG000|Overall Study|Lack of Efficacy|31|||
160572607|NCT00553787|579818465|FG001|Overall Study|Lack of Efficacy|1|||
160572608|NCT00553787|579818466|FG002|Overall Study|Lack of Efficacy|3|||
160572609|NCT00553787|579818464|FG000|Overall Study|Pregnancy|0|||
160572610|NCT00553787|579818465|FG001|Overall Study|Pregnancy|1|||
160572611|NCT00553787|579818466|FG002|Overall Study|Pregnancy|2|||
160572612|NCT00553787|579818464|FG000|Overall Study|non compliance|4|||
160572613|NCT00553787|579818465|FG001|Overall Study|non compliance|0|||
160572614|NCT00553787|579818466|FG002|Overall Study|non compliance|11|||
160572615|NCT00553787|579818464|FG000|Overall Study|Requirement for restricted medication|8|||
160572616|NCT00553787|579818465|FG001|Overall Study|Requirement for restricted medication|7|||
160572617|NCT00553787|579818466|FG002|Overall Study|Requirement for restricted medication|5|||
160572618|NCT00553787|579818464|FG000|Overall Study|Other|18|||
160572619|NCT00553787|579818465|FG001|Overall Study|Other|10|||
160572620|NCT00553787|579818466|FG002|Overall Study|Other|13|||
160572621|NCT01088412|579818467|FG000|Overall Study|Adverse Event|38|||
160572622|NCT01088412|579818468|FG001|Overall Study|Adverse Event|0|||
160572623|NCT01088412|579818469|FG002|Overall Study|Adverse Event|0|||
160653962|NCT05381948|580114238|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
160653963|NCT05381948|580114236|FG000|Overall Study|Adverse Event: Non-ocular|0|||
160572624|NCT01088412|579818467|FG000|Overall Study|Death|42|||
160572625|NCT01088412|579818468|FG001|Overall Study|Death|6|||
160572626|NCT01088412|579818469|FG002|Overall Study|Death|0|||
160572627|NCT01088412|579818467|FG000|Overall Study|Other Reason per Case Report Form|2089|||
160572628|NCT01088412|579818468|FG001|Overall Study|Other Reason per Case Report Form|103|||
160572629|NCT01088412|579818469|FG002|Overall Study|Other Reason per Case Report Form|9|||
160653964|NCT05381948|580114237|FG001|Overall Study|Adverse Event: Non-ocular|1|||
160918159|NCT01988103|581094193|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
160918160|NCT01988103|581094194|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
160918161|NCT01988103|581094195|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
160996924|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996925|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996926|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996927|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996928|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996929|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
160454442|NCT03766685|579396145|FG002|Overall Study|Withdrawal by Subject|0|||
160454443|NCT03766685|579396146|FG003|Overall Study|Withdrawal by Subject|0|||
160454444|NCT03766685|579396143|FG000|Overall Study|Protocol Violation|0|||
160454445|NCT03766685|579396144|FG001|Overall Study|Protocol Violation|1|||
160454446|NCT03766685|579396145|FG002|Overall Study|Protocol Violation|0|||
160454447|NCT03766685|579396146|FG003|Overall Study|Protocol Violation|0|||
160454448|NCT03766685|579396143|FG000|Overall Study|Non-compliance|0|||
160454449|NCT03766685|579396144|FG001|Overall Study|Non-compliance|2|||
160454450|NCT03766685|579396145|FG002|Overall Study|Non-compliance|0|||
160454451|NCT03766685|579396146|FG003|Overall Study|Non-compliance|0|||
160454452|NCT02844465|579396149|FG000|Overall Study|Screen Failure|36|||
160454453|NCT02844465|579396149|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
160454454|NCT02844465|579396149|FG000|Overall Study|Withdrawal by Subject|5|||
160454455|NCT02844465|579396149|FG000|Overall Study|Lost to Follow-up|1|||
160454456|NCT02844465|579396149|FG000|Overall Study|Retreatment|1|||
160454457|NCT05029622|579396150|FG000|Overall Study|Lost to Follow-up|1|||
160454458|NCT05671653|579396151|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
160454459|NCT05671653|579396152|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
160454460|NCT05671653|579396153|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
160454461|NCT05671653|579396154|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
160454462|NCT05671653|579396155|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
160454463|NCT05671653|579396156|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
160454464|NCT05671653|579396157|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
160454465|NCT05671653|579396158|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
160454466|NCT05671653|579396159|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
160454467|NCT05671653|579396160|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
160454468|NCT05671653|579396161|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
160454469|NCT05671653|579396162|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
160454470|NCT05671653|579396163|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
160454471|NCT05671653|579396151|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454472|NCT05671653|579396152|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454473|NCT05671653|579396153|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454474|NCT05671653|579396154|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454475|NCT05671653|579396155|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454476|NCT05671653|579396156|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
160454477|NCT05671653|579396157|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454478|NCT05671653|579396158|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454479|NCT05671653|579396159|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454480|NCT05671653|579396160|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454481|NCT05671653|579396161|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454482|NCT05671653|579396162|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454483|NCT05671653|579396163|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
160454484|NCT05671653|579396151|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454485|NCT05671653|579396152|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454486|NCT05671653|579396153|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454487|NCT05671653|579396154|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454488|NCT05671653|579396155|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454489|NCT05671653|579396156|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
160454490|NCT05671653|579396157|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454491|NCT05671653|579396158|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454492|NCT05671653|579396159|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454493|NCT05671653|579396160|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454494|NCT05671653|579396161|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454495|NCT05671653|579396162|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454496|NCT05671653|579396163|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
160454497|NCT05671653|579396151|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160454498|NCT05671653|579396152|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160454499|NCT05671653|579396153|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160454500|NCT05671653|579396154|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160454501|NCT05671653|579396155|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160454502|NCT05671653|579396156|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160454503|NCT05671653|579396157|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160454504|NCT05671653|579396158|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160454505|NCT05671653|579396159|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
160454506|NCT05671653|579396160|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160572630|NCT01088412|579818467|FG000|Overall Study|Withdrawal by Subject|1761|||
160996930|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996931|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996932|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996933|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996934|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996935|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996936|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996937|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996938|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996939|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996940|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996941|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996942|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996943|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996944|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
160996945|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996946|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996947|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996948|NCT03536884|581373698|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996949|NCT03536884|581373699|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996950|NCT03536884|581373700|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996951|NCT03536884|581373701|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996952|NCT03536884|581373702|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996953|NCT03536884|581373703|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996954|NCT03536884|581373704|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996955|NCT03536884|581373705|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996956|NCT03536884|581373706|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996957|NCT03536884|581373707|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
160996958|NCT03536884|581373708|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
160996959|NCT03536884|581373709|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
160996960|NCT03536884|581373698|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996961|NCT03536884|581373699|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996962|NCT03536884|581373700|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996963|NCT03536884|581373701|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996964|NCT03536884|581373702|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996965|NCT03536884|581373703|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996966|NCT03536884|581373704|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996967|NCT03536884|581373705|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996968|NCT03536884|581373706|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996969|NCT03536884|581373707|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
160996970|NCT03536884|581373708|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
160996971|NCT03536884|581373709|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
160996972|NCT03536884|581373698|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996973|NCT03536884|581373699|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996974|NCT03536884|581373700|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996975|NCT03536884|581373701|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996976|NCT03536884|581373702|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996977|NCT03536884|581373703|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996978|NCT03536884|581373704|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996979|NCT03536884|581373705|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996980|NCT03536884|581373706|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996981|NCT03536884|581373707|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996982|NCT03536884|581373708|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
160996983|NCT03536884|581373709|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996984|NCT03536884|581373698|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996985|NCT03536884|581373699|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996986|NCT03536884|581373700|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996987|NCT03536884|581373701|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996988|NCT03536884|581373702|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996989|NCT03536884|581373703|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996990|NCT03536884|581373704|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996991|NCT03536884|581373705|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996992|NCT03536884|581373706|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996993|NCT03536884|581373707|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996994|NCT03536884|581373708|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996995|NCT03536884|581373709|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
160996996|NCT03536884|581373698|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160996997|NCT03536884|581373699|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160996998|NCT03536884|581373700|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160996999|NCT03536884|581373701|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997000|NCT03536884|581373702|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997001|NCT03536884|581373703|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997002|NCT03536884|581373704|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997003|NCT03536884|581373705|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160572631|NCT01088412|579818468|FG001|Overall Study|Withdrawal by Subject|25|||
160572632|NCT01088412|579818469|FG002|Overall Study|Withdrawal by Subject|1|||
160572633|NCT01088412|579818467|FG000|Overall Study|Received Another GH Product|79|||
160572634|NCT01088412|579818468|FG001|Overall Study|Received Another GH Product|0|||
160572635|NCT01088412|579818469|FG002|Overall Study|Received Another GH Product|0|||
160572636|NCT01088412|579818467|FG000|Overall Study|Participant Moved|601|||
160572637|NCT01088412|579818468|FG001|Overall Study|Participant Moved|21|||
160572638|NCT01088412|579818469|FG002|Overall Study|Participant Moved|2|||
160572639|NCT01088412|579818467|FG000|Overall Study|Physician Decision|1041|||
160572640|NCT01088412|579818468|FG001|Overall Study|Physician Decision|8|||
160572641|NCT01088412|579818469|FG002|Overall Study|Physician Decision|4|||
160572642|NCT01088412|579818467|FG000|Overall Study|Sponsor Decision|4467|||
160572643|NCT01088412|579818468|FG001|Overall Study|Sponsor Decision|79|||
160572644|NCT01088412|579818469|FG002|Overall Study|Sponsor Decision|23|||
160572645|NCT01088412|579818467|FG000|Overall Study|Third Party Required to Change Brand|487|||
160572646|NCT01088412|579818468|FG001|Overall Study|Third Party Required to Change Brand|0|||
160572647|NCT01088412|579818469|FG002|Overall Study|Third Party Required to Change Brand|0|||
160572648|NCT01088412|579818467|FG000|Overall Study|Lost to Follow-up|3052|||
160572649|NCT01088412|579818468|FG001|Overall Study|Lost to Follow-up|130|||
160572650|NCT01088412|579818469|FG002|Overall Study|Lost to Follow-up|11|||
160572651|NCT01088412|579818467|FG000|Overall Study|Study Summary Not Completed|4360|||
160572652|NCT01088412|579818468|FG001|Overall Study|Study Summary Not Completed|64|||
160572653|NCT01088412|579818469|FG002|Overall Study|Study Summary Not Completed|22|||
160572654|NCT00793104|579818470|FG000|Overall Study|Lost to Follow-up|1|||
160572655|NCT02111811|579818471|FG000|Treatment Phase|Lost to Follow-up|22|||
160572656|NCT02111811|579818472|FG001|Treatment Phase|Lost to Follow-up|18|||
160572657|NCT02111811|579818471|FG000|Treatment Phase|Death|2|||
160572658|NCT02111811|579818472|FG001|Treatment Phase|Death|0|||
160572659|NCT02111811|579818471|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
160572660|NCT02111811|579818472|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
160572661|NCT02111811|579818471|FG000|Follow up Period (Aim 2)|Death|2|||
160572662|NCT02111811|579818472|FG001|Follow up Period (Aim 2)|Death|0|||
160572663|NCT03443024|579818475|FG000|Overall Study|Adverse Event|2|||
160572664|NCT03443024|579818476|FG001|Overall Study|Adverse Event|4|||
160572665|NCT03443024|579818477|FG002|Overall Study|Adverse Event|3|||
160572666|NCT03443024|579818478|FG003|Overall Study|Adverse Event|1|||
160572667|NCT03443024|579818475|FG000|Overall Study|Lost to Follow-up|9|||
160572668|NCT03443024|579818476|FG001|Overall Study|Lost to Follow-up|9|||
160572669|NCT03443024|579818477|FG002|Overall Study|Lost to Follow-up|7|||
160572670|NCT03443024|579818478|FG003|Overall Study|Lost to Follow-up|5|||
160572671|NCT03443024|579818475|FG000|Overall Study|Withdrawal by Subject|8|||
160572672|NCT03443024|579818476|FG001|Overall Study|Withdrawal by Subject|15|||
160572673|NCT03443024|579818477|FG002|Overall Study|Withdrawal by Subject|9|||
160572674|NCT03443024|579818478|FG003|Overall Study|Withdrawal by Subject|23|||
160572675|NCT03443024|579818475|FG000|Overall Study|Physician Decision|1|||
160572676|NCT03443024|579818476|FG001|Overall Study|Physician Decision|2|||
160572677|NCT03443024|579818477|FG002|Overall Study|Physician Decision|0|||
160572678|NCT03443024|579818478|FG003|Overall Study|Physician Decision|1|||
160997004|NCT03536884|581373706|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997005|NCT03536884|581373707|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997006|NCT03536884|581373708|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160572679|NCT03443024|579818475|FG000|Overall Study|Sponsor Decision|1|||
160572680|NCT03443024|579818476|FG001|Overall Study|Sponsor Decision|1|||
160572681|NCT03443024|579818477|FG002|Overall Study|Sponsor Decision|0|||
160572682|NCT03443024|579818478|FG003|Overall Study|Sponsor Decision|0|||
160572683|NCT03443024|579818475|FG000|Overall Study|Protocol Deviation|0|||
160572684|NCT03443024|579818476|FG001|Overall Study|Protocol Deviation|0|||
160572685|NCT03443024|579818477|FG002|Overall Study|Protocol Deviation|0|||
160572686|NCT03443024|579818478|FG003|Overall Study|Protocol Deviation|2|||
160572687|NCT00301067|579818479|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
160572688|NCT00301067|579818480|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
160997007|NCT03536884|581373709|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
160997008|NCT03722446|581373710|FG000|Overall Study|Protocol Violation|15|||
160997009|NCT03722446|581373711|FG001|Overall Study|Protocol Violation|2|||
160997010|NCT03425643|581373718|FG000|Overall Study|Withdrawal by Subject|10|||
160997011|NCT03425643|581373719|FG001|Overall Study|Withdrawal by Subject|12|||
160997012|NCT03425643|581373718|FG000|Overall Study|Lost to Follow-up|2|||
160997013|NCT03425643|581373719|FG001|Overall Study|Lost to Follow-up|0|||
160997014|NCT03425643|581373718|FG000|Overall Study|Death|109|||
160997015|NCT03425643|581373719|FG001|Overall Study|Death|141|||
160997016|NCT03425643|581373718|FG000|Overall Study|Ongoing in study|276|||
160997017|NCT03425643|581373719|FG001|Overall Study|Ongoing in study|247|||
160997018|NCT04133363|581373720|FG000|Overall Study|Lost to Follow-up|2|||
160997019|NCT04133363|581373721|FG001|Overall Study|Lost to Follow-up|1|||
160997020|NCT04133363|581373722|FG002|Overall Study|Lost to Follow-up|4|||
160997021|NCT07214922|581373729|FG000|Overall Study|Adverse Event|0|||
160997022|NCT07214922|581373730|FG001|Overall Study|Adverse Event|0|||
160997023|NCT07214922|581373731|FG002|Overall Study|Adverse Event|1|||
160997024|NCT07214922|581373732|FG003|Overall Study|Adverse Event|0|||
160997025|NCT07214922|581373729|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
160997026|NCT07214922|581373730|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
160997027|NCT07214922|581373731|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
160997028|NCT07214922|581373732|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
160454507|NCT05671653|579396161|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160454508|NCT05671653|579396162|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160454509|NCT05671653|579396163|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
160572689|NCT00301067|579818481|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
160572690|NCT00301067|579818482|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
160572691|NCT00301067|579818479|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
160572692|NCT00301067|579818480|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
160572693|NCT00301067|579818481|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
160572694|NCT00301067|579818482|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
160572695|NCT00301067|579818479|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
160454510|NCT05671653|579396151|FG000|Cohort 2 Period 2|Adverse Event|0|||
160454511|NCT05671653|579396152|FG001|Cohort 2 Period 2|Adverse Event|0|||
160454512|NCT05671653|579396153|FG002|Cohort 2 Period 2|Adverse Event|0|||
160454513|NCT05671653|579396154|FG003|Cohort 2 Period 2|Adverse Event|0|||
160454514|NCT05671653|579396155|FG004|Cohort 2 Period 2|Adverse Event|0|||
160454515|NCT05671653|579396156|FG005|Cohort 2 Period 2|Adverse Event|0|||
160454516|NCT05671653|579396157|FG006|Cohort 2 Period 2|Adverse Event|0|||
160454517|NCT05671653|579396158|FG007|Cohort 2 Period 2|Adverse Event|0|||
160454518|NCT05671653|579396159|FG008|Cohort 2 Period 2|Adverse Event|0|||
160454519|NCT05671653|579396160|FG009|Cohort 2 Period 2|Adverse Event|0|||
160454520|NCT05671653|579396161|FG010|Cohort 2 Period 2|Adverse Event|1|||
160454521|NCT05671653|579396162|FG011|Cohort 2 Period 2|Adverse Event|0|||
160454522|NCT05671653|579396163|FG012|Cohort 2 Period 2|Adverse Event|0|||
160454523|NCT05671653|579396151|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
160454524|NCT05671653|579396152|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
160454525|NCT05671653|579396153|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
160454526|NCT05671653|579396154|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
160454527|NCT05671653|579396155|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
160454528|NCT05671653|579396156|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
160454529|NCT05671653|579396157|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
160454530|NCT05671653|579396158|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
160454531|NCT05671653|579396159|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
160454532|NCT05671653|579396160|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
160454533|NCT05671653|579396161|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
160454534|NCT05671653|579396162|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
160572696|NCT00301067|579818480|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
160572697|NCT00301067|579818481|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
160572698|NCT00301067|579818482|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
160572699|NCT00301067|579818479|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
160572700|NCT00301067|579818480|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
160572701|NCT00301067|579818481|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
160572702|NCT00301067|579818482|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
160454535|NCT05671653|579396163|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
160454536|NCT05671653|579396151|FG000|Cohort 2 Period 2|Pregnancy|0|||
160572703|NCT00301067|579818479|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
160572704|NCT00301067|579818480|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
160572705|NCT00301067|579818481|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
160632810|NCT00203892|580036077|FG002|Overall Study|Death|0|||
160997029|NCT00482729|581374851|FG000|Overall Study|Adverse Event|29|||
160997030|NCT00482729|581374852|FG001|Overall Study|Adverse Event|33|||
160997031|NCT00482729|581374851|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
160997032|NCT00482729|581374852|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
160572706|NCT00301067|579818482|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
160572707|NCT00301067|579818479|FG000|Follow up Until Death|Alive at last data cut point|1|||
160572708|NCT00301067|579818480|FG001|Follow up Until Death|Alive at last data cut point|0|||
160653965|NCT05381948|580114238|FG002|Overall Study|Adverse Event: Non-ocular|0|||
160653966|NCT05381948|580114236|FG000|Overall Study|Lost to Follow-up|1|||
160653967|NCT05381948|580114237|FG001|Overall Study|Lost to Follow-up|0|||
160653968|NCT05381948|580114238|FG002|Overall Study|Lost to Follow-up|0|||
160572709|NCT00301067|579818481|FG002|Follow up Until Death|Alive at last data cut point|0|||
160572710|NCT00301067|579818482|FG003|Follow up Until Death|Alive at last data cut point|1|||
160572711|NCT00149825|579818483|FG000|Overall Study|Intolerance to medication side effects|1|||
160572712|NCT00149825|579818484|FG001|Overall Study|Intolerance to medication side effects|2|||
160572713|NCT00149825|579818483|FG000|Overall Study|Time commitments|2|||
160572714|NCT00149825|579818484|FG001|Overall Study|Time commitments|1|||
160572715|NCT00149825|579818483|FG000|Overall Study|Not liking insomnia therapy|1|||
160572716|NCT00149825|579818484|FG001|Overall Study|Not liking insomnia therapy|0|||
160572717|NCT00149825|579818483|FG000|Overall Study|Other|1|||
160572718|NCT00149825|579818484|FG001|Overall Study|Other|0|||
160572719|NCT01359982|579818485|FG000|Overall Study|Adverse Event|2|||
160572720|NCT01359982|579818486|FG001|Overall Study|Adverse Event|0|||
160572721|NCT01359982|579818487|FG002|Overall Study|Adverse Event|0|||
160572722|NCT01359982|579818488|FG003|Overall Study|Adverse Event|1|||
160572723|NCT01359982|579818489|FG004|Overall Study|Adverse Event|0|||
160572724|NCT01359982|579818490|FG005|Overall Study|Adverse Event|0|||
160572725|NCT01359982|579818485|FG000|Overall Study|Death|1|||
160572726|NCT01359982|579818486|FG001|Overall Study|Death|0|||
160572727|NCT01359982|579818487|FG002|Overall Study|Death|0|||
160653969|NCT05381948|580114236|FG000|Overall Study|Protocol Deviation|0|||
160572728|NCT01359982|579818488|FG003|Overall Study|Death|0|||
160572729|NCT01359982|579818489|FG004|Overall Study|Death|0|||
160572730|NCT01359982|579818490|FG005|Overall Study|Death|0|||
160572731|NCT05593432|579818491|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
160572732|NCT05593432|579818492|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
160572733|NCT05593432|579818493|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
160572734|NCT05593432|579818494|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
160572735|NCT05593432|579818491|FG000|16-Week OLE Period|Lack of Efficacy|0|||
160572736|NCT05593432|579818492|FG001|16-Week OLE Period|Lack of Efficacy|0|||
160572737|NCT05593432|579818493|FG002|16-Week OLE Period|Lack of Efficacy|0|||
160572738|NCT05593432|579818494|FG003|16-Week OLE Period|Lack of Efficacy|1|||
160572739|NCT05593432|579818491|FG000|16-Week OLE Period|Lost to Follow-up|0|||
160572740|NCT05593432|579818492|FG001|16-Week OLE Period|Lost to Follow-up|0|||
160572741|NCT05593432|579818493|FG002|16-Week OLE Period|Lost to Follow-up|1|||
160572742|NCT05593432|579818494|FG003|16-Week OLE Period|Lost to Follow-up|2|||
160572743|NCT05593432|579818491|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
160572744|NCT05593432|579818492|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
160572745|NCT05593432|579818493|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
160572746|NCT05593432|579818494|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
160572747|NCT00069121|579818496|FG000|Overall Study|Death|286|||
160572748|NCT00069121|579818497|FG001|Overall Study|Death|242|||
160572749|NCT00069121|579818496|FG000|Overall Study|Withdrawal by Subject|18|||
160572750|NCT00069121|579818497|FG001|Overall Study|Withdrawal by Subject|20|||
160572751|NCT00069121|579818496|FG000|Overall Study|Lost to Follow-up|63|||
160572752|NCT00069121|579818497|FG001|Overall Study|Lost to Follow-up|63|||
160572753|NCT04542291|579818501|FG000|Overall Study|Adverse Event|1|||
160572754|NCT04542291|579818501|FG000|Overall Study|Physician Decision|2|||
160572755|NCT04952389|579818503|FG000|Overall Study|Withdrawal by Subject|8|||
160572756|NCT04952389|579818504|FG001|Overall Study|Withdrawal by Subject|4|||
160572757|NCT05635838|579820092|FG000|16-Week DBVC Period|Adverse Event|2|||
160653970|NCT05381948|580114237|FG001|Overall Study|Protocol Deviation|2|||
160653971|NCT05381948|580114238|FG002|Overall Study|Protocol Deviation|0|||
160653972|NCT05381948|580114236|FG000|Overall Study|Withdrawal by Subject|1|||
160572758|NCT05635838|579820093|FG001|16-Week DBVC Period|Adverse Event|0|||
160572759|NCT05635838|579820094|FG002|16-Week DBVC Period|Adverse Event|0|||
160572760|NCT05635838|579820095|FG003|16-Week DBVC Period|Adverse Event|0|||
160572761|NCT05635838|579820092|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
160572762|NCT05635838|579820093|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
160572763|NCT05635838|579820094|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
160572764|NCT05635838|579820095|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
160572765|NCT05635838|579820092|FG000|16-Week DBVC Period|Physician Decision|0|||
160572766|NCT05635838|579820093|FG001|16-Week DBVC Period|Physician Decision|1|||
160572767|NCT05635838|579820094|FG002|16-Week DBVC Period|Physician Decision|0|||
160572768|NCT05635838|579820095|FG003|16-Week DBVC Period|Physician Decision|0|||
160572769|NCT05635838|579820092|FG000|16-Week DBVC Period|Protocol Violation|1|||
160572770|NCT05635838|579820093|FG001|16-Week DBVC Period|Protocol Violation|0|||
160572771|NCT05635838|579820094|FG002|16-Week DBVC Period|Protocol Violation|0|||
160572772|NCT05635838|579820095|FG003|16-Week DBVC Period|Protocol Violation|0|||
160572773|NCT05635838|579820092|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
160572774|NCT05635838|579820093|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
160572775|NCT05635838|579820094|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
160572776|NCT05635838|579820095|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
160572777|NCT05635838|579820092|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
160572778|NCT05635838|579820093|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
160572779|NCT05635838|579820094|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
160572780|NCT05635838|579820095|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
160572781|NCT05635838|579820092|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
160572782|NCT05635838|579820093|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
160572783|NCT05635838|579820094|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
160572784|NCT05635838|579820095|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
160572785|NCT05635838|579820092|FG000|16-Week OLE Period|Adverse Event|0|||
160572786|NCT05635838|579820093|FG001|16-Week OLE Period|Adverse Event|0|||
160572787|NCT05635838|579820094|FG002|16-Week OLE Period|Adverse Event|0|||
160572788|NCT05635838|579820095|FG003|16-Week OLE Period|Adverse Event|2|||
160572789|NCT05635838|579820092|FG000|16-Week OLE Period|Lost to Follow-up|0|||
160572790|NCT05635838|579820093|FG001|16-Week OLE Period|Lost to Follow-up|0|||
160572791|NCT05635838|579820094|FG002|16-Week OLE Period|Lost to Follow-up|1|||
160572792|NCT05635838|579820095|FG003|16-Week OLE Period|Lost to Follow-up|3|||
160572793|NCT05635838|579820092|FG000|16-Week OLE Period|Physician Decision|0|||
160572794|NCT05635838|579820093|FG001|16-Week OLE Period|Physician Decision|0|||
160572795|NCT05635838|579820094|FG002|16-Week OLE Period|Physician Decision|0|||
160572796|NCT05635838|579820095|FG003|16-Week OLE Period|Physician Decision|1|||
160572797|NCT05635838|579820092|FG000|16-Week OLE Period|Protocol Violation|0|||
160572798|NCT05635838|579820093|FG001|16-Week OLE Period|Protocol Violation|0|||
160572799|NCT05635838|579820094|FG002|16-Week OLE Period|Protocol Violation|1|||
160572800|NCT05635838|579820095|FG003|16-Week OLE Period|Protocol Violation|1|||
160572801|NCT05635838|579820092|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
160572802|NCT05635838|579820093|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
160572803|NCT05635838|579820094|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
160572804|NCT05635838|579820095|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
160572805|NCT05635838|579820092|FG000|16-Week OLE Period|Pregnancy|0|||
160572806|NCT05635838|579820093|FG001|16-Week OLE Period|Pregnancy|0|||
160572807|NCT05635838|579820094|FG002|16-Week OLE Period|Pregnancy|1|||
160572808|NCT05635838|579820095|FG003|16-Week OLE Period|Pregnancy|0|||
160572809|NCT02699515|579820102|FG000|Overall Study|Death|3|||
160572810|NCT02699515|579820103|FG001|Overall Study|Death|3|||
160572811|NCT02699515|579820104|FG002|Overall Study|Death|3|||
160572812|NCT02699515|579820105|FG003|Overall Study|Death|23|||
160572813|NCT02699515|579820106|FG004|Overall Study|Death|22|||
160572814|NCT02699515|579820107|FG005|Overall Study|Death|23|||
160572815|NCT02699515|579820108|FG006|Overall Study|Death|3|||
160572816|NCT02699515|579820109|FG007|Overall Study|Death|5|||
160572817|NCT02699515|579820102|FG000|Overall Study|Withdrawal by Subject|0|||
160572818|NCT02699515|579820103|FG001|Overall Study|Withdrawal by Subject|0|||
160572819|NCT02699515|579820104|FG002|Overall Study|Withdrawal by Subject|3|||
160572820|NCT02699515|579820105|FG003|Overall Study|Withdrawal by Subject|1|||
160572821|NCT02699515|579820106|FG004|Overall Study|Withdrawal by Subject|5|||
160572822|NCT02699515|579820107|FG005|Overall Study|Withdrawal by Subject|3|||
160572823|NCT02699515|579820108|FG006|Overall Study|Withdrawal by Subject|0|||
160572824|NCT02699515|579820109|FG007|Overall Study|Withdrawal by Subject|1|||
160572825|NCT02699515|579820102|FG000|Overall Study|Other|1|||
160572826|NCT02699515|579820103|FG001|Overall Study|Other|0|||
160572827|NCT02699515|579820104|FG002|Overall Study|Other|1|||
160572828|NCT02699515|579820105|FG003|Overall Study|Other|6|||
160572829|NCT02699515|579820106|FG004|Overall Study|Other|4|||
160572830|NCT02699515|579820107|FG005|Overall Study|Other|3|||
160572831|NCT02699515|579820108|FG006|Overall Study|Other|0|||
160997033|NCT00482729|581374851|FG000|Overall Study|Hyperglycemia Criteria|7|||
160997034|NCT00482729|581374852|FG001|Overall Study|Hyperglycemia Criteria|5|||
160997035|NCT00482729|581374851|FG000|Overall Study|Lack of Efficacy|4|||
160997036|NCT00482729|581374852|FG001|Overall Study|Lack of Efficacy|16|||
160997037|NCT00482729|581374851|FG000|Overall Study|Lost to Follow-up|86|||
160997038|NCT00482729|581374852|FG001|Overall Study|Lost to Follow-up|66|||
160572832|NCT02699515|579820109|FG007|Overall Study|Other|0|||
160572833|NCT05243550|579820110|FG000|Overall Study|Ongoing in the Study|171|||
160572834|NCT05243550|579820110|FG000|Overall Study|Withdrawal by Subject|10|||
160572835|NCT05243550|579820110|FG000|Overall Study|Lost to Follow-up|7|||
160572836|NCT05243550|579820110|FG000|Overall Study|Adverse Event|3|||
160572837|NCT05243550|579820110|FG000|Overall Study|Noncompliance|1|||
160572838|NCT05243550|579820110|FG000|Overall Study|Physician Decision|1|||
160572839|NCT05243550|579820110|FG000|Overall Study|Other Reason|4|||
160997039|NCT00482729|581374851|FG000|Overall Study|Physician Decision|10|||
160572840|NCT02452970|579820112|FG000|Overall Study|Adverse Event|1|||
160572841|NCT02100657|579820113|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
160572842|NCT02100657|579820114|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
160572843|NCT02100657|579820115|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
160572844|NCT02100657|579820113|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
160572845|NCT02100657|579820114|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
160572846|NCT02100657|579820115|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
160572847|NCT02100657|579820113|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
160572848|NCT02100657|579820114|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
160572849|NCT02100657|579820115|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
160572850|NCT02100657|579820113|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
160572851|NCT02100657|579820114|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
160454537|NCT05671653|579396152|FG001|Cohort 2 Period 2|Pregnancy|0|||
160454538|NCT05671653|579396153|FG002|Cohort 2 Period 2|Pregnancy|0|||
160454539|NCT05671653|579396154|FG003|Cohort 2 Period 2|Pregnancy|0|||
160454540|NCT05671653|579396155|FG004|Cohort 2 Period 2|Pregnancy|0|||
160454541|NCT05671653|579396156|FG005|Cohort 2 Period 2|Pregnancy|0|||
160572852|NCT02100657|579820115|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
160572853|NCT02100657|579820113|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
160572854|NCT02100657|579820114|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
160572855|NCT02100657|579820115|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
160572856|NCT02100657|579820113|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
160572857|NCT02100657|579820114|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
160572858|NCT02100657|579820115|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
160572859|NCT02100657|579820113|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
160572860|NCT02100657|579820114|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
160572861|NCT02100657|579820115|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
160997040|NCT00482729|581374852|FG001|Overall Study|Physician Decision|7|||
160454542|NCT05671653|579396157|FG006|Cohort 2 Period 2|Pregnancy|0|||
160454543|NCT05671653|579396158|FG007|Cohort 2 Period 2|Pregnancy|0|||
160454544|NCT05671653|579396159|FG008|Cohort 2 Period 2|Pregnancy|0|||
160454545|NCT05671653|579396160|FG009|Cohort 2 Period 2|Pregnancy|0|||
160454546|NCT05671653|579396161|FG010|Cohort 2 Period 2|Pregnancy|1|||
160454547|NCT05671653|579396162|FG011|Cohort 2 Period 2|Pregnancy|0|||
160454548|NCT05671653|579396163|FG012|Cohort 2 Period 2|Pregnancy|0|||
160454549|NCT05671653|579396151|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
160454550|NCT05671653|579396152|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
160454551|NCT05671653|579396153|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
160454552|NCT05671653|579396154|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
160454553|NCT05671653|579396155|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
160454554|NCT05671653|579396156|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
160454555|NCT05671653|579396157|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
160454556|NCT05671653|579396158|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
160454557|NCT05671653|579396159|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
160454558|NCT05671653|579396160|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
160454559|NCT05671653|579396161|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
160454560|NCT05671653|579396162|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
160572862|NCT02100657|579820113|FG000|Cohort 3: Dose Level 3|Death|0|||
160997041|NCT00482729|581374851|FG000|Overall Study|Pregnancy|4|||
160997042|NCT00482729|581374852|FG001|Overall Study|Pregnancy|2|||
160997043|NCT00482729|581374851|FG000|Overall Study|Protocol Violation|10|||
160997044|NCT00482729|581374852|FG001|Overall Study|Protocol Violation|18|||
160997045|NCT00482729|581374851|FG000|Overall Study|Withdrawal by Subject|67|||
160997046|NCT00482729|581374852|FG001|Overall Study|Withdrawal by Subject|69|||
160997047|NCT01090024|581374857|FG000|Period 1|Met exclusion criteria|0|||
160997048|NCT01090024|581374858|FG001|Period 1|Met exclusion criteria|0|||
160997049|NCT01090024|581374859|FG002|Period 1|Met exclusion criteria|0|||
160997050|NCT01090024|581374860|FG003|Period 1|Met exclusion criteria|0|||
160997051|NCT01090024|581374861|FG004|Period 1|Met exclusion criteria|0|||
160997052|NCT01090024|581374862|FG005|Period 1|Met exclusion criteria|0|||
160997053|NCT01090024|581374863|FG006|Period 1|Met exclusion criteria|0|||
160997054|NCT01090024|581374864|FG007|Period 1|Met exclusion criteria|0|||
160997055|NCT01090024|581374865|FG008|Period 1|Met exclusion criteria|0|||
160997056|NCT01090024|581374866|FG009|Period 1|Met exclusion criteria|0|||
160997057|NCT01090024|581374867|FG010|Period 1|Met exclusion criteria|0|||
160997058|NCT01090024|581374868|FG011|Period 1|Met exclusion criteria|0|||
160997059|NCT01090024|581374869|FG012|Period 1|Met exclusion criteria|0|||
160997060|NCT01090024|581374870|FG013|Period 1|Met exclusion criteria|0|||
160997061|NCT01090024|581374871|FG014|Period 1|Met exclusion criteria|1|||
160997062|NCT01090024|581374872|FG015|Period 1|Met exclusion criteria|0|||
160997063|NCT01090024|581374873|FG016|Period 1|Met exclusion criteria|0|||
160997064|NCT01090024|581374874|FG017|Period 1|Met exclusion criteria|0|||
160997065|NCT01090024|581374857|FG000|Period 1|Adverse Event|0|||
160997066|NCT01090024|581374858|FG001|Period 1|Adverse Event|0|||
160454561|NCT05671653|579396163|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
160572863|NCT02100657|579820114|FG001|Cohort 3: Dose Level 3|Death|0|||
160572864|NCT02100657|579820115|FG002|Cohort 3: Dose Level 3|Death|1|||
160997067|NCT01090024|581374859|FG002|Period 1|Adverse Event|0|||
160997068|NCT01090024|581374860|FG003|Period 1|Adverse Event|0|||
160997069|NCT01090024|581374861|FG004|Period 1|Adverse Event|0|||
160997070|NCT01090024|581374862|FG005|Period 1|Adverse Event|0|||
160997071|NCT01090024|581374863|FG006|Period 1|Adverse Event|0|||
160997072|NCT01090024|581374864|FG007|Period 1|Adverse Event|0|||
160997073|NCT01090024|581374865|FG008|Period 1|Adverse Event|0|||
160572865|NCT02100657|579820113|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
160572866|NCT02100657|579820114|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
160572867|NCT02100657|579820115|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
160572868|NCT02100657|579820113|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
160572869|NCT02100657|579820114|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
160572870|NCT02100657|579820115|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
160454562|NCT05671653|579396151|FG000|Cohort 2 Period 2|Other|0|||
160454563|NCT05671653|579396152|FG001|Cohort 2 Period 2|Other|0|||
160454564|NCT05671653|579396153|FG002|Cohort 2 Period 2|Other|0|||
160454565|NCT05671653|579396154|FG003|Cohort 2 Period 2|Other|0|||
160454566|NCT05671653|579396155|FG004|Cohort 2 Period 2|Other|0|||
160454567|NCT05671653|579396156|FG005|Cohort 2 Period 2|Other|0|||
160454568|NCT05671653|579396157|FG006|Cohort 2 Period 2|Other|0|||
160454569|NCT05671653|579396158|FG007|Cohort 2 Period 2|Other|0|||
160454570|NCT05671653|579396159|FG008|Cohort 2 Period 2|Other|0|||
160454571|NCT05671653|579396160|FG009|Cohort 2 Period 2|Other|0|||
160454572|NCT05671653|579396161|FG010|Cohort 2 Period 2|Other|1|||
160572871|NCT02100657|579820113|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
160572872|NCT02100657|579820114|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
160572873|NCT02100657|579820115|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
160572874|NCT02100657|579820113|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
160572875|NCT02100657|579820114|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
160572876|NCT02100657|579820115|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
160572877|NCT02100657|579820113|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
160572878|NCT02100657|579820114|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
160572879|NCT02100657|579820115|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
160572880|NCT02531035|579820116|FG000|Overall Study|Death|0|||
160572881|NCT02531035|579820117|FG001|Overall Study|Death|1|||
160572882|NCT02531035|579820116|FG000|Overall Study|Protocol Violation|1|||
160572883|NCT02531035|579820117|FG001|Overall Study|Protocol Violation|1|||
160572884|NCT02531035|579820116|FG000|Overall Study|Noncompliance with study drug|8|||
160572885|NCT02531035|579820117|FG001|Overall Study|Noncompliance with study drug|3|||
160572886|NCT02531035|579820116|FG000|Overall Study|Physician Decision|1|||
160572887|NCT02531035|579820117|FG001|Overall Study|Physician Decision|0|||
160572888|NCT02531035|579820116|FG000|Overall Study|Adverse Event|16|||
160572889|NCT02531035|579820117|FG001|Overall Study|Adverse Event|45|||
160572890|NCT02531035|579820116|FG000|Overall Study|Other|3|||
160572891|NCT02531035|579820117|FG001|Overall Study|Other|2|||
160454573|NCT05671653|579396162|FG011|Cohort 2 Period 2|Other|0|||
160454574|NCT05671653|579396163|FG012|Cohort 2 Period 2|Other|0|||
160454575|NCT05671653|579396151|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454576|NCT05671653|579396152|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454577|NCT05671653|579396153|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454578|NCT05671653|579396154|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454579|NCT05671653|579396155|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454580|NCT05671653|579396156|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454581|NCT05671653|579396157|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454582|NCT05671653|579396158|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454583|NCT05671653|579396159|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454584|NCT05671653|579396160|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454585|NCT05671653|579396161|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454586|NCT05671653|579396162|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
160454587|NCT05671653|579396163|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
160454588|NCT06232590|579396167|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
160572892|NCT02531035|579820116|FG000|Overall Study|Withdrawal by Subject|42|||
160572893|NCT02531035|579820117|FG001|Overall Study|Withdrawal by Subject|32|||
160572894|NCT02531035|579820116|FG000|Overall Study|Lost to Follow-up|8|||
160918162|NCT01988103|581094191|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
160918163|NCT01988103|581094192|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
160918164|NCT01988103|581094193|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
160918165|NCT01988103|581094194|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
160918166|NCT01988103|581094195|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
160918167|NCT01988103|581094191|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
160454589|NCT06232590|579396168|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
160918168|NCT01988103|581094192|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
160454590|NCT02460458|579396169|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
160572895|NCT02531035|579820117|FG001|Overall Study|Lost to Follow-up|10|||
160572896|NCT02531035|579820116|FG000|Overall Study|Randomized, not treated|2|||
160572897|NCT02531035|579820117|FG001|Overall Study|Randomized, not treated|1|||
160454591|NCT02460458|579396169|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
160572898|NCT01266148|579820118|FG000|Overall Study|Adverse Event|2|||
160572899|NCT01266148|579820119|FG001|Overall Study|Adverse Event|0|||
160572900|NCT01266148|579820118|FG000|Overall Study|Ongoing rejection|1|||
160653973|NCT05381948|580114237|FG001|Overall Study|Withdrawal by Subject|0|||
160918169|NCT01988103|581094193|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
160918170|NCT01988103|581094194|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
160572901|NCT01266148|579820119|FG001|Overall Study|Ongoing rejection|0|||
160572902|NCT01266148|579820118|FG000|Overall Study|2 2R rejections|1|||
160572903|NCT01266148|579820119|FG001|Overall Study|2 2R rejections|0|||
160572904|NCT01266148|579820118|FG000|Overall Study|Death|2|||
160572905|NCT01266148|579820119|FG001|Overall Study|Death|3|||
160572906|NCT01266148|579820118|FG000|Overall Study|missing mGFR value + AE|1|||
160572907|NCT01266148|579820119|FG001|Overall Study|missing mGFR value + AE|0|||
160572908|NCT01543490|579820120|FG000|Overall Study|Adverse Event|4|||
160572909|NCT01543490|579820121|FG001|Overall Study|Adverse Event|0|||
160572910|NCT01543490|579820120|FG000|Overall Study|Physician Decision|1|||
160572911|NCT01543490|579820121|FG001|Overall Study|Physician Decision|0|||
160572912|NCT01543490|579820120|FG000|Overall Study|Lack of Efficacy|3|||
160572913|NCT01543490|579820121|FG001|Overall Study|Lack of Efficacy|3|||
160572914|NCT01543490|579820120|FG000|Overall Study|Lost to Follow-up|5|||
160572915|NCT01543490|579820121|FG001|Overall Study|Lost to Follow-up|0|||
160572916|NCT01543490|579820120|FG000|Overall Study|Withdrawal by Subject|2|||
160572917|NCT01543490|579820121|FG001|Overall Study|Withdrawal by Subject|0|||
160572918|NCT01543490|579820120|FG000|Overall Study|Other-Various Administrative Reasons|1|||
160572919|NCT01543490|579820121|FG001|Overall Study|Other-Various Administrative Reasons|2|||
160572920|NCT01853228|579820124|FG000|Phase 1|Lack of Efficacy|8|||
160572921|NCT01853228|579820125|FG001|Phase 1|Lack of Efficacy|0|||
160572922|NCT01853228|579820124|FG000|Phase 1|Other|1|||
160572923|NCT01853228|579820125|FG001|Phase 1|Other|0|||
160572924|NCT01853228|579820124|FG000|Phase 2|Physician Decision|0|||
160572925|NCT01853228|579820125|FG001|Phase 2|Physician Decision|1|||
160572926|NCT01853228|579820124|FG000|Phase 2|Proceed To Transplant|0|||
160572927|NCT01853228|579820125|FG001|Phase 2|Proceed To Transplant|3|||
160572928|NCT01853228|579820124|FG000|Phase 2|Lack of Efficacy|0|||
160572929|NCT01853228|579820125|FG001|Phase 2|Lack of Efficacy|4|||
160572930|NCT01269125|579820131|FG000|Overall Study|Adverse Event|3|||
160572931|NCT01269125|579820132|FG001|Overall Study|Adverse Event|5|||
160572932|NCT01269125|579820133|FG002|Overall Study|Adverse Event|0|||
160572933|NCT01269125|579820131|FG000|Overall Study|Lost to Follow-up|4|||
160572934|NCT01269125|579820132|FG001|Overall Study|Lost to Follow-up|0|||
160572935|NCT01269125|579820133|FG002|Overall Study|Lost to Follow-up|0|||
160572936|NCT01300286|579820134|FG000|Overall Study|did not get dosed|1|||
160572937|NCT03635190|579820135|FG000|Overall Study|Lost to Follow-up|4|||
160572938|NCT03635190|579820135|FG000|Overall Study|Death|3|||
160572939|NCT03635190|579820135|FG000|Overall Study|Withdrawal by Subject|1|||
160572940|NCT03635190|579820135|FG000|Overall Study|Patient moved and did not return for follow up|1|||
160572941|NCT02767570|579820138|FG000|Overall Study|Lost to Follow-up|3|||
160572942|NCT02767570|579820139|FG001|Overall Study|Lost to Follow-up|0|||
160572943|NCT02767570|579820138|FG000|Overall Study|COVID shutdown|2|||
160572944|NCT02767570|579820139|FG001|Overall Study|COVID shutdown|5|||
160572945|NCT02767570|579820138|FG000|Overall Study|Increased pain|2|||
160572946|NCT02767570|579820139|FG001|Overall Study|Increased pain|0|||
160572947|NCT02767570|579820138|FG000|Overall Study|Withdrawal by Subject|1|||
160572948|NCT02767570|579820139|FG001|Overall Study|Withdrawal by Subject|3|||
160572949|NCT02767570|579820138|FG000|Overall Study|Unrelated medical issue|1|||
160572950|NCT02767570|579820139|FG001|Overall Study|Unrelated medical issue|1|||
160572951|NCT02767570|579820138|FG000|Overall Study|Received intra-articular injection|0|||
160572952|NCT02767570|579820139|FG001|Overall Study|Received intra-articular injection|1|||
160572953|NCT03692910|579820140|FG000|Overall Study|Lost to Follow-up|4|||
160572954|NCT03692910|579820141|FG001|Overall Study|Lost to Follow-up|0|||
160572955|NCT03692910|579820142|FG002|Overall Study|Lost to Follow-up|0|||
160572956|NCT03692910|579820140|FG000|Overall Study|Withdrawal by Subject|2|||
160572957|NCT03692910|579820141|FG001|Overall Study|Withdrawal by Subject|0|||
160572958|NCT03692910|579820142|FG002|Overall Study|Withdrawal by Subject|0|||
160572959|NCT01539837|579820143|FG000|Overall Study|reduce neutrophil level|0|||
160572960|NCT01539837|579820144|FG001|Overall Study|reduce neutrophil level|1|||
160572961|NCT01539837|579820145|FG002|Overall Study|reduce neutrophil level|1|||
160572962|NCT01539837|579820143|FG000|Overall Study|bad compliance|0|||
160572963|NCT01539837|579820144|FG001|Overall Study|bad compliance|0|||
160572964|NCT01539837|579820145|FG002|Overall Study|bad compliance|1|||
160572965|NCT00849693|579820146|FG000|Acute Treatment Phase|Adverse Event|12|||
160572966|NCT00849693|579820147|FG001|Acute Treatment Phase|Adverse Event|7|||
160572967|NCT00849693|579820148|FG002|Acute Treatment Phase|Adverse Event|6|||
160572968|NCT00849693|579820149|FG003|Acute Treatment Phase|Adverse Event|4|||
160572969|NCT00849693|579820146|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
160572970|NCT00849693|579820147|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
160572971|NCT00849693|579820148|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
160572972|NCT00849693|579820149|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
160572973|NCT00849693|579820146|FG000|Acute Treatment Phase|Protocol Violation|1|||
160572974|NCT00849693|579820147|FG001|Acute Treatment Phase|Protocol Violation|5|||
160572975|NCT00849693|579820148|FG002|Acute Treatment Phase|Protocol Violation|2|||
160572976|NCT00849693|579820149|FG003|Acute Treatment Phase|Protocol Violation|6|||
160918171|NCT01988103|581094195|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
160918172|NCT01988103|581094191|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
160918173|NCT01988103|581094192|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
160918174|NCT01988103|581094193|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
160918175|NCT01988103|581094194|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
160918176|NCT01988103|581094195|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
160918177|NCT01988103|581094191|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
160918178|NCT01988103|581094192|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
160918179|NCT01988103|581094193|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
160918180|NCT01988103|581094194|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
160918181|NCT01988103|581094195|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
160918182|NCT01946425|581094199|FG000|Overall Study|Protocol Violation|1|||
160918183|NCT01946425|581094200|FG001|Overall Study|Protocol Violation|0|||
160918184|NCT01946425|581094199|FG000|Overall Study|Withdrawal by Subject|1|||
160918185|NCT01946425|581094200|FG001|Overall Study|Withdrawal by Subject|0|||
160918186|NCT05682326|581094206|FG000|Overall Study|Withdrawal by Subject|1|||
160918187|NCT05682326|581094207|FG001|Overall Study|Withdrawal by Subject|0|||
160918188|NCT01402544|581094208|FG000|Overall Study|Withdrawal by Subject|6|||
160918189|NCT01113801|581094209|FG000|Overall Study|Adverse Event|4|||
160918190|NCT01113801|581094210|FG001|Overall Study|Adverse Event|0|||
160918191|NCT01113801|581094211|FG002|Overall Study|Adverse Event|2|||
160918192|NCT01113801|581094212|FG003|Overall Study|Adverse Event|6|||
160918193|NCT01113801|581094209|FG000|Overall Study|Death|4|||
160918194|NCT01113801|581094210|FG001|Overall Study|Death|5|||
160918195|NCT01113801|581094211|FG002|Overall Study|Death|3|||
160918196|NCT01113801|581094212|FG003|Overall Study|Death|4|||
160918197|NCT01113801|581094209|FG000|Overall Study|Protocol Violation|0|||
160918198|NCT01113801|581094210|FG001|Overall Study|Protocol Violation|1|||
160918199|NCT01113801|581094211|FG002|Overall Study|Protocol Violation|0|||
160918200|NCT01113801|581094212|FG003|Overall Study|Protocol Violation|0|||
160918201|NCT01113801|581094209|FG000|Overall Study|Withdrawal by Subject|9|||
160918202|NCT01113801|581094210|FG001|Overall Study|Withdrawal by Subject|7|||
160918203|NCT01113801|581094211|FG002|Overall Study|Withdrawal by Subject|7|||
160918204|NCT01113801|581094212|FG003|Overall Study|Withdrawal by Subject|8|||
160918205|NCT01113801|581094209|FG000|Overall Study|Physician Decision|2|||
160918206|NCT01113801|581094210|FG001|Overall Study|Physician Decision|2|||
160918207|NCT01113801|581094211|FG002|Overall Study|Physician Decision|3|||
160918208|NCT01113801|581094212|FG003|Overall Study|Physician Decision|3|||
160918209|NCT01113801|581094209|FG000|Overall Study|Sponsor Decision|15|||
160918210|NCT01113801|581094210|FG001|Overall Study|Sponsor Decision|21|||
160918211|NCT01113801|581094211|FG002|Overall Study|Sponsor Decision|20|||
160918212|NCT01113801|581094212|FG003|Overall Study|Sponsor Decision|15|||
160918213|NCT01113801|581094209|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
160918214|NCT01113801|581094210|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
160918215|NCT01113801|581094211|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
160918216|NCT01113801|581094212|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
160918217|NCT01949051|581094216|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
160918218|NCT01949051|581094217|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
160918219|NCT01949051|581094218|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
160653974|NCT05381948|580114238|FG002|Overall Study|Withdrawal by Subject|1|||
160918220|NCT01949051|581094219|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
160918221|NCT01949051|581094220|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
160918222|NCT01949051|581094221|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
160918223|NCT01949051|581094216|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
160918224|NCT01949051|581094217|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160572977|NCT00849693|579820146|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
160572978|NCT00849693|579820147|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
160572979|NCT00849693|579820148|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
160572980|NCT00849693|579820149|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
160572981|NCT00849693|579820146|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
160572982|NCT00849693|579820147|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
160572983|NCT00849693|579820148|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
160572984|NCT00849693|579820149|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
160572985|NCT00849693|579820146|FG000|Acute Treatment Phase|Physician Decision|2|||
160572986|NCT00849693|579820147|FG001|Acute Treatment Phase|Physician Decision|1|||
160572987|NCT00849693|579820148|FG002|Acute Treatment Phase|Physician Decision|2|||
160572988|NCT00849693|579820149|FG003|Acute Treatment Phase|Physician Decision|1|||
160653975|NCT05381948|580114236|FG000|Overall Study|Death|0|||
160918225|NCT01949051|581094218|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160918226|NCT01949051|581094219|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160997074|NCT01090024|581374866|FG009|Period 1|Adverse Event|1|||
160454592|NCT02460458|579396169|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
160918227|NCT01949051|581094220|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160918228|NCT01949051|581094221|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160918229|NCT01949051|581094216|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
160918230|NCT01949051|581094217|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
160918231|NCT01949051|581094218|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
160918232|NCT01949051|581094219|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
160918233|NCT01949051|581094220|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
160918234|NCT01949051|581094221|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
160653976|NCT05381948|580114237|FG001|Overall Study|Death|2|||
160653977|NCT05381948|580114238|FG002|Overall Study|Death|0|||
160653978|NCT05381948|580114236|FG000|Overall Study|Discontinued study without receiving study drug|0|||
160653979|NCT05381948|580114237|FG001|Overall Study|Discontinued study without receiving study drug|0|||
160653980|NCT05381948|580114238|FG002|Overall Study|Discontinued study without receiving study drug|1|||
160653981|NCT04471207|580114239|FG000|Overall Study|Lost to Follow-up|4|||
160653982|NCT04471207|580114240|FG001|Overall Study|Lost to Follow-up|1|||
160653983|NCT04471207|580114239|FG000|Overall Study|Medication Contraindication|0|||
160653984|NCT04471207|580114240|FG001|Overall Study|Medication Contraindication|1|||
160653985|NCT04471207|580114239|FG000|Overall Study|Loss of Interest|2|||
160653986|NCT04471207|580114240|FG001|Overall Study|Loss of Interest|1|||
160653987|NCT04471207|580114239|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
160653988|NCT04471207|580114240|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
160653989|NCT04471207|580114239|FG000|Overall Study|Scheduling Conflicts|3|||
160918235|NCT01949051|581094216|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
160918236|NCT01949051|581094217|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
160918237|NCT01949051|581094218|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
160653990|NCT04471207|580114240|FG001|Overall Study|Scheduling Conflicts|1|||
160653991|NCT04471207|580114239|FG000|Overall Study|Physician Decision|1|||
160653992|NCT04471207|580114240|FG001|Overall Study|Physician Decision|0|||
160653993|NCT04471207|580114239|FG000|Overall Study|Unwilling to Use System|0|||
160653994|NCT04471207|580114240|FG001|Overall Study|Unwilling to Use System|1|||
160653995|NCT02132247|580114241|FG000|Overall Study|Protocol Violation|1|||
160653996|NCT02132247|580114242|FG001|Overall Study|Protocol Violation|0|||
160653997|NCT00520741|580114245|FG000|Overall Study|Adverse Event|16|||
160653998|NCT00520741|580114246|FG001|Overall Study|Adverse Event|56|||
160653999|NCT00520741|580114245|FG000|Overall Study|Lack of Efficacy|11|||
160654000|NCT00520741|580114246|FG001|Overall Study|Lack of Efficacy|30|||
160654001|NCT00520741|580114245|FG000|Overall Study|Withdrawal by Subject|0|||
160654002|NCT00520741|580114246|FG001|Overall Study|Withdrawal by Subject|11|||
160654003|NCT00520741|580114245|FG000|Overall Study|Protocol Violation|2|||
160654004|NCT00520741|580114246|FG001|Overall Study|Protocol Violation|15|||
160918238|NCT01949051|581094219|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
160918239|NCT01949051|581094220|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
160918240|NCT01949051|581094221|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
160918241|NCT01949051|581094216|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
160918242|NCT01949051|581094217|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
160918243|NCT01949051|581094218|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
160918244|NCT01949051|581094219|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
160918245|NCT01949051|581094220|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
160918246|NCT01949051|581094221|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
160918247|NCT01506479|581094223|FG000|Overall Study|Lost to Follow-up|1|||
160918248|NCT01506479|581094224|FG001|Overall Study|Lost to Follow-up|2|||
160918249|NCT01506479|581094225|FG002|Overall Study|Lost to Follow-up|2|||
160918250|NCT01506479|581094223|FG000|Overall Study|Withdrawal by Subject|1|||
160918251|NCT01506479|581094224|FG001|Overall Study|Withdrawal by Subject|2|||
160918252|NCT01506479|581094225|FG002|Overall Study|Withdrawal by Subject|1|||
160918253|NCT01506479|581094223|FG000|Overall Study|Missing assessment|1|||
160918254|NCT01506479|581094224|FG001|Overall Study|Missing assessment|0|||
160918255|NCT01506479|581094225|FG002|Overall Study|Missing assessment|0|||
160918256|NCT01506479|581094223|FG000|Overall Study|Adverse Event|0|||
160918257|NCT01506479|581094224|FG001|Overall Study|Adverse Event|1|||
160918258|NCT01506479|581094225|FG002|Overall Study|Adverse Event|0|||
160918259|NCT01846507|581094226|FG000|Overall Study|Lost to Follow-up|4|||
160918260|NCT01846507|581094226|FG000|Overall Study|Protocol Violation|1|||
160654005|NCT00520741|580114245|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
160654006|NCT00520741|580114246|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
160654007|NCT00520741|580114245|FG000|Overall Study|Lost to Follow-up|4|||
160654008|NCT00520741|580114246|FG001|Overall Study|Lost to Follow-up|4|||
160918261|NCT01846507|581094226|FG000|Overall Study|Missing data|2|||
160918262|NCT01314443|581094227|FG000|Overall Study|Withdrawal by Subject|2|||
160918263|NCT01314443|581094228|FG001|Overall Study|Withdrawal by Subject|1|||
160918264|NCT01314443|581094229|FG002|Overall Study|Withdrawal by Subject|1|||
160918265|NCT01314443|581094230|FG003|Overall Study|Withdrawal by Subject|1|||
160918266|NCT01314443|581094227|FG000|Overall Study|Protocol Violation|2|||
160918267|NCT01314443|581094228|FG001|Overall Study|Protocol Violation|2|||
160918268|NCT01314443|581094229|FG002|Overall Study|Protocol Violation|1|||
160918269|NCT01314443|581094230|FG003|Overall Study|Protocol Violation|1|||
160918270|NCT04545866|581094232|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
160918271|NCT04545866|581094233|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
160918272|NCT04545866|581094232|FG000|Overall Study|Withdrawal by Physician|1|||
160918273|NCT04545866|581094233|FG001|Overall Study|Withdrawal by Physician|0|||
160918274|NCT05247866|581094234|FG000|Overall Study|Adverse Event|2|||
160918275|NCT05247866|581094234|FG000|Overall Study|Lack of Efficacy|1|||
160918276|NCT05247866|581094234|FG000|Overall Study|Protocol Violation|1|||
160918277|NCT05247866|581094234|FG000|Overall Study|Withdrawal by Subject|3|||
160918278|NCT04463719|581094239|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
160918279|NCT04463719|581094240|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
160572989|NCT00849693|579820146|FG000|Acute Treatment Phase|Sponsor decision|0|||
160572990|NCT00849693|579820147|FG001|Acute Treatment Phase|Sponsor decision|0|||
160572991|NCT00849693|579820148|FG002|Acute Treatment Phase|Sponsor decision|1|||
160572992|NCT00849693|579820149|FG003|Acute Treatment Phase|Sponsor decision|0|||
160572993|NCT00849693|579820146|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
160572994|NCT00849693|579820147|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
160572995|NCT00849693|579820148|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
160572996|NCT00849693|579820149|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
160572997|NCT00849693|579820146|FG000|Extension Phase|Adverse Event|4|||
160572998|NCT00849693|579820147|FG001|Extension Phase|Adverse Event|6|||
160572999|NCT00849693|579820148|FG002|Extension Phase|Adverse Event|3|||
160573000|NCT00849693|579820149|FG003|Extension Phase|Adverse Event|7|||
160573001|NCT00849693|579820146|FG000|Extension Phase|Lost to Follow-up|7|||
160573002|NCT00849693|579820147|FG001|Extension Phase|Lost to Follow-up|5|||
160573003|NCT00849693|579820148|FG002|Extension Phase|Lost to Follow-up|6|||
160573004|NCT00849693|579820149|FG003|Extension Phase|Lost to Follow-up|6|||
160573005|NCT00849693|579820146|FG000|Extension Phase|Protocol Violation|0|||
160573006|NCT00849693|579820147|FG001|Extension Phase|Protocol Violation|3|||
160573007|NCT00849693|579820148|FG002|Extension Phase|Protocol Violation|2|||
160573008|NCT00849693|579820149|FG003|Extension Phase|Protocol Violation|3|||
160573009|NCT00849693|579820146|FG000|Extension Phase|Withdrawal by Subject|6|||
160573010|NCT00849693|579820147|FG001|Extension Phase|Withdrawal by Subject|9|||
160573011|NCT00849693|579820148|FG002|Extension Phase|Withdrawal by Subject|10|||
160573012|NCT00849693|579820149|FG003|Extension Phase|Withdrawal by Subject|15|||
160573013|NCT00849693|579820146|FG000|Extension Phase|Parent or caregiver decision|9|||
160573014|NCT00849693|579820147|FG001|Extension Phase|Parent or caregiver decision|4|||
160573015|NCT00849693|579820148|FG002|Extension Phase|Parent or caregiver decision|10|||
160573016|NCT00849693|579820149|FG003|Extension Phase|Parent or caregiver decision|5|||
160573017|NCT00849693|579820146|FG000|Extension Phase|Physician Decision|1|||
160573018|NCT00849693|579820147|FG001|Extension Phase|Physician Decision|1|||
160573019|NCT00849693|579820148|FG002|Extension Phase|Physician Decision|2|||
160573020|NCT00849693|579820149|FG003|Extension Phase|Physician Decision|0|||
160573021|NCT00849693|579820146|FG000|Extension Phase|Sponsor decision|1|||
160573022|NCT00849693|579820147|FG001|Extension Phase|Sponsor decision|0|||
160573023|NCT00849693|579820148|FG002|Extension Phase|Sponsor decision|0|||
160573024|NCT00849693|579820149|FG003|Extension Phase|Sponsor decision|1|||
160573025|NCT00849693|579820146|FG000|Extension Phase|Lack of Efficacy|2|||
160573026|NCT00849693|579820147|FG001|Extension Phase|Lack of Efficacy|2|||
160573027|NCT00849693|579820148|FG002|Extension Phase|Lack of Efficacy|2|||
160573028|NCT00849693|579820149|FG003|Extension Phase|Lack of Efficacy|1|||
160573029|NCT01978912|579820150|FG000|Overall Study|Adverse Event|0|||
160573030|NCT01978912|579820151|FG001|Overall Study|Adverse Event|1|||
160573031|NCT01978912|579820152|FG002|Overall Study|Adverse Event|0|||
160573032|NCT01978912|579820153|FG003|Overall Study|Adverse Event|0|||
160573033|NCT01978912|579820150|FG000|Overall Study|Lost to Follow-up|1|||
160573034|NCT01978912|579820151|FG001|Overall Study|Lost to Follow-up|1|||
160573035|NCT01978912|579820152|FG002|Overall Study|Lost to Follow-up|0|||
160918280|NCT04463719|581094241|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
160918281|NCT02436356|581094242|FG000|Overall Study|Excluded by MRI Screening|0|||
160918282|NCT02436356|581094243|FG001|Overall Study|Excluded by MRI Screening|0|||
160918283|NCT02436356|581094244|FG002|Overall Study|Excluded by MRI Screening|2|||
160918284|NCT02436356|581094242|FG000|Overall Study|Lost to Follow-up|0|||
160997075|NCT01090024|581374867|FG010|Period 1|Adverse Event|0|||
160918285|NCT02436356|581094243|FG001|Overall Study|Lost to Follow-up|1|||
160918286|NCT02436356|581094244|FG002|Overall Study|Lost to Follow-up|0|||
160573036|NCT01978912|579820153|FG003|Overall Study|Lost to Follow-up|1|||
160573037|NCT01978912|579820150|FG000|Overall Study|Withdrawal by Subject|1|||
160573038|NCT01978912|579820151|FG001|Overall Study|Withdrawal by Subject|0|||
160573039|NCT01978912|579820152|FG002|Overall Study|Withdrawal by Subject|2|||
160573040|NCT01978912|579820153|FG003|Overall Study|Withdrawal by Subject|2|||
160573041|NCT01978912|579820150|FG000|Overall Study|Lumbar Surgery|1|||
160573042|NCT01978912|579820151|FG001|Overall Study|Lumbar Surgery|0|||
160573043|NCT01978912|579820152|FG002|Overall Study|Lumbar Surgery|1|||
160573044|NCT01978912|579820153|FG003|Overall Study|Lumbar Surgery|0|||
160918287|NCT02436356|581094242|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
160997076|NCT01090024|581374868|FG011|Period 1|Adverse Event|1|||
160918288|NCT02436356|581094243|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
160918289|NCT02436356|581094244|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
160918290|NCT02436356|581094242|FG000|Overall Study|Excluded due to other medical conditions|3|||
160918291|NCT02436356|581094243|FG001|Overall Study|Excluded due to other medical conditions|0|||
160918292|NCT02436356|581094244|FG002|Overall Study|Excluded due to other medical conditions|0|||
160573045|NCT01978912|579820150|FG000|Overall Study|Intradiscal Steroid Injection|0|||
160573046|NCT01978912|579820151|FG001|Overall Study|Intradiscal Steroid Injection|1|||
160573047|NCT01978912|579820152|FG002|Overall Study|Intradiscal Steroid Injection|0|||
160573048|NCT01978912|579820153|FG003|Overall Study|Intradiscal Steroid Injection|0|||
160573049|NCT00224107|579820154|FG000|Overall Study|Adverse Event|20|||
160573050|NCT00224107|579820155|FG001|Overall Study|Adverse Event|6|||
160573051|NCT00224107|579820154|FG000|Overall Study|Protocol Violation|2|||
160573052|NCT00224107|579820155|FG001|Overall Study|Protocol Violation|3|||
160573053|NCT00224107|579820154|FG000|Overall Study|Withdrawal by Subject|1|||
160573054|NCT00224107|579820155|FG001|Overall Study|Withdrawal by Subject|4|||
160573055|NCT00224107|579820154|FG000|Overall Study|Lack of Efficacy|2|||
160573056|NCT00224107|579820155|FG001|Overall Study|Lack of Efficacy|0|||
160573057|NCT00224107|579820154|FG000|Overall Study|Lost to Follow-up|4|||
160573058|NCT00224107|579820155|FG001|Overall Study|Lost to Follow-up|0|||
160573059|NCT00224107|579820154|FG000|Overall Study|Physician Decision|1|||
160573060|NCT00224107|579820155|FG001|Overall Study|Physician Decision|0|||
160573061|NCT00224107|579820154|FG000|Overall Study|Other|1|||
160573062|NCT00224107|579820155|FG001|Overall Study|Other|1|||
160573063|NCT01408537|579820156|FG000|Overall Study|Withdrawal by Subject|2|||
160918293|NCT02436356|581094242|FG000|Overall Study|Withdrawal by Subject|1|||
160918294|NCT02436356|581094243|FG001|Overall Study|Withdrawal by Subject|0|||
160918295|NCT02436356|581094244|FG002|Overall Study|Withdrawal by Subject|0|||
160918296|NCT00487747|581094247|FG000|Overall Study|Adverse Event|1|||
160918297|NCT00487747|581094247|FG000|Overall Study|Lost to Follow-up|9|||
160918298|NCT00487747|581094247|FG000|Overall Study|Lack of Efficacy|1|||
160918299|NCT04483011|581094248|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
160918300|NCT04483011|581094249|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
160918301|NCT02979522|581094261|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
160918302|NCT02979522|581094262|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
160918303|NCT02979522|581094261|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
160918304|NCT02979522|581094262|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
160918305|NCT01896531|581094263|FG000|Overall Study|Death|57|||
160918306|NCT01896531|581094264|FG001|Overall Study|Death|59|||
160918307|NCT01896531|581094263|FG000|Overall Study|Lost to Follow-up|3|||
160918308|NCT01896531|581094264|FG001|Overall Study|Lost to Follow-up|0|||
160918309|NCT01896531|581094263|FG000|Overall Study|Non-compliance|0|||
160918310|NCT01896531|581094264|FG001|Overall Study|Non-compliance|1|||
160918311|NCT01896531|581094263|FG000|Overall Study|Study Ended by Sponsor|7|||
160918312|NCT01896531|581094264|FG001|Overall Study|Study Ended by Sponsor|20|||
160918313|NCT01896531|581094263|FG000|Overall Study|Withdrawal by Subject|3|||
160918314|NCT01896531|581094264|FG001|Overall Study|Withdrawal by Subject|2|||
160918315|NCT01896531|581094263|FG000|Overall Study|Death Prior to Treatment|1|||
160918316|NCT01896531|581094264|FG001|Overall Study|Death Prior to Treatment|0|||
160918317|NCT00770289|581094265|FG000|Overall Study|Other|6|||
160918318|NCT02733991|581094266|FG000|Overall Study|Adverse Event|1|||
160918319|NCT02733991|581094267|FG001|Overall Study|Adverse Event|0|||
160918320|NCT02733991|581094266|FG000|Overall Study|Withdrawal by Subject|0|||
160918321|NCT02733991|581094267|FG001|Overall Study|Withdrawal by Subject|5|||
160918322|NCT00680745|581094270|FG000|Overall Study|Withdrawal by Subject|8|||
160918323|NCT00680745|581094271|FG001|Overall Study|Withdrawal by Subject|3|||
160918324|NCT00680745|581094272|FG002|Overall Study|Withdrawal by Subject|2|||
160918325|NCT00680745|581094273|FG003|Overall Study|Withdrawal by Subject|8|||
160918326|NCT00680745|581094270|FG000|Overall Study|Lost to Follow-up|0|||
160573064|NCT01408537|579820156|FG000|Overall Study|Protocol Violation|3|||
160573065|NCT01408537|579820156|FG000|Overall Study|Lost to Follow-up|3|||
160573066|NCT03707977|579820157|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
160573067|NCT03707977|579820158|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
160573068|NCT03707977|579820159|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
160918327|NCT00680745|581094271|FG001|Overall Study|Lost to Follow-up|1|||
160918328|NCT00680745|581094272|FG002|Overall Study|Lost to Follow-up|1|||
160997077|NCT01090024|581374869|FG012|Period 1|Adverse Event|0|||
160573069|NCT03707977|579820157|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
160573070|NCT03707977|579820158|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
160573071|NCT03707977|579820159|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
160573072|NCT02564120|579820160|FG000|Overall Study|Did not return release forms|160|||
160573073|NCT02564120|579820160|FG000|Overall Study|Death|58|||
160918329|NCT00680745|581094273|FG003|Overall Study|Lost to Follow-up|0|||
160918330|NCT00680745|581094270|FG000|Overall Study|Death|1|||
160918331|NCT00680745|581094271|FG001|Overall Study|Death|0|||
160573074|NCT02564120|579820160|FG000|Overall Study|Withdrawal by Subject|204|||
160573075|NCT02564120|579820160|FG000|Overall Study|Other medical condition|24|||
160573076|NCT03842709|579820161|FG000|Overall Study|Withdrawal by Subject|3|||
160573077|NCT03842709|579820162|FG001|Overall Study|Withdrawal by Subject|3|||
160573078|NCT03842709|579820161|FG000|Overall Study|Lost to Follow-up|1|||
160573079|NCT03842709|579820162|FG001|Overall Study|Lost to Follow-up|0|||
160573080|NCT00641147|579820163|FG000|Completed 4 Months.|Physician Decision|1|||
160573081|NCT00641147|579820164|FG001|Completed 4 Months.|Physician Decision|0|||
160573082|NCT00641147|579820163|FG000|Completed 4 Months.|Adverse Event|1|||
160573083|NCT00641147|579820164|FG001|Completed 4 Months.|Adverse Event|0|||
160573084|NCT00641147|579820163|FG000|Completed 8 Months.|Physician Decision|2|||
160573085|NCT00641147|579820164|FG001|Completed 8 Months.|Physician Decision|1|||
160573086|NCT00641147|579820163|FG000|Completed 8 Months.|non compliance|1|||
160573087|NCT00641147|579820164|FG001|Completed 8 Months.|non compliance|0|||
160573088|NCT00641147|579820163|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
160573089|NCT00641147|579820164|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
160573090|NCT00641147|579820163|FG000|Completed 12 Months.|Physician Decision|1|||
160573091|NCT00641147|579820164|FG001|Completed 12 Months.|Physician Decision|1|||
160573092|NCT00641147|579820163|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
160573093|NCT00641147|579820164|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
160573094|NCT00641147|579820163|FG000|Completed 16 Months.|Physician Decision|1|||
160573095|NCT00641147|579820164|FG001|Completed 16 Months.|Physician Decision|0|||
160573096|NCT00641147|579820163|FG000|Completed 16 Months.|Lost to Follow-up|1|||
160573097|NCT00641147|579820164|FG001|Completed 16 Months.|Lost to Follow-up|0|||
160573098|NCT00791128|579820165|FG000|Overall Study|Adverse Event|4|||
160573099|NCT00791128|579820165|FG000|Overall Study|Device migration|2|||
160573100|NCT00791128|579820165|FG000|Overall Study|non-compliance by subject|2|||
160573101|NCT00791128|579820165|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
160573102|NCT01629667|579820166|FG000|Overall Study|Lost to Follow-up|0|||
160573103|NCT01629667|579820167|FG001|Overall Study|Lost to Follow-up|1|||
160573104|NCT01629667|579820168|FG002|Overall Study|Lost to Follow-up|1|||
160573105|NCT01629667|579820166|FG000|Overall Study|Withdrawal by Subject|31|||
160573106|NCT01629667|579820167|FG001|Overall Study|Withdrawal by Subject|20|||
160573107|NCT01629667|579820168|FG002|Overall Study|Withdrawal by Subject|28|||
160573108|NCT01629667|579820166|FG000|Overall Study|Death|1|||
160573109|NCT01629667|579820167|FG001|Overall Study|Death|5|||
160573110|NCT01629667|579820168|FG002|Overall Study|Death|3|||
160573111|NCT01629667|579820166|FG000|Overall Study|Randomized, not treated|2|||
160573112|NCT01629667|579820167|FG001|Overall Study|Randomized, not treated|1|||
160573113|NCT01629667|579820168|FG002|Overall Study|Randomized, not treated|0|||
160573114|NCT01629667|579820166|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
160573115|NCT01629667|579820167|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
160573116|NCT01629667|579820168|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
160573117|NCT01629667|579820166|FG000|Overall Study|Requiring lung transplant|2|||
160573118|NCT01629667|579820167|FG001|Overall Study|Requiring lung transplant|1|||
160573119|NCT01629667|579820168|FG002|Overall Study|Requiring lung transplant|3|||
160573120|NCT01629667|579820166|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
160573121|NCT01629667|579820167|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
160573122|NCT01629667|579820168|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
160573123|NCT01629667|579820166|FG000|Overall Study|Started other medicine|1|||
160573124|NCT01629667|579820167|FG001|Overall Study|Started other medicine|0|||
160573125|NCT01629667|579820168|FG002|Overall Study|Started other medicine|1|||
160573126|NCT01629667|579820166|FG000|Overall Study|Site error in safety follow-up|0|||
160573127|NCT01629667|579820167|FG001|Overall Study|Site error in safety follow-up|0|||
160573128|NCT01629667|579820168|FG002|Overall Study|Site error in safety follow-up|1|||
160573129|NCT01629667|579820166|FG000|Overall Study|Enrolled in another clinical study|0|||
160573130|NCT01629667|579820167|FG001|Overall Study|Enrolled in another clinical study|1|||
160573131|NCT01629667|579820168|FG002|Overall Study|Enrolled in another clinical study|0|||
160573132|NCT01629667|579820166|FG000|Overall Study|Code break|1|||
160918332|NCT00680745|581094272|FG002|Overall Study|Death|1|||
160918333|NCT00680745|581094273|FG003|Overall Study|Death|0|||
160918334|NCT00680745|581094270|FG000|Overall Study|Adverse Event|5|||
160918335|NCT00680745|581094271|FG001|Overall Study|Adverse Event|3|||
160918336|NCT00680745|581094272|FG002|Overall Study|Adverse Event|3|||
160918337|NCT00680745|581094273|FG003|Overall Study|Adverse Event|3|||
160573133|NCT01629667|579820167|FG001|Overall Study|Code break|0|||
160573134|NCT01629667|579820168|FG002|Overall Study|Code break|0|||
160573135|NCT00984659|579820169|FG000|2-week Run-in Period|Adverse Event|8|||
160573136|NCT00984659|579820170|FG001|2-week Run-in Period|Adverse Event|0|||
160573137|NCT00984659|579820171|FG002|2-week Run-in Period|Adverse Event|0|||
160573138|NCT00984659|579820172|FG003|2-week Run-in Period|Adverse Event|0|||
160573139|NCT00984659|579820169|FG000|2-week Run-in Period|Protocol Violation|5|||
160573140|NCT00984659|579820170|FG001|2-week Run-in Period|Protocol Violation|0|||
160918338|NCT00680745|581094270|FG000|Overall Study|Poor/Non-compliance|0|||
160918339|NCT00680745|581094271|FG001|Overall Study|Poor/Non-compliance|3|||
160918340|NCT00680745|581094272|FG002|Overall Study|Poor/Non-compliance|0|||
160573141|NCT00984659|579820171|FG002|2-week Run-in Period|Protocol Violation|0|||
160573142|NCT00984659|579820172|FG003|2-week Run-in Period|Protocol Violation|0|||
160573143|NCT00984659|579820169|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
160573144|NCT00984659|579820170|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
160573145|NCT00984659|579820171|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
160573146|NCT00984659|579820172|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
160573147|NCT00984659|579820169|FG000|2-week Run-in Period|Lost to Follow-up|3|||
160573148|NCT00984659|579820170|FG001|2-week Run-in Period|Lost to Follow-up|0|||
160573149|NCT00984659|579820171|FG002|2-week Run-in Period|Lost to Follow-up|0|||
160573150|NCT00984659|579820172|FG003|2-week Run-in Period|Lost to Follow-up|0|||
160573151|NCT00984659|579820169|FG000|2-week Run-in Period|Physician Decision|10|||
160573152|NCT00984659|579820170|FG001|2-week Run-in Period|Physician Decision|0|||
160573153|NCT00984659|579820171|FG002|2-week Run-in Period|Physician Decision|0|||
160573154|NCT00984659|579820172|FG003|2-week Run-in Period|Physician Decision|0|||
160573155|NCT00984659|579820169|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
160573156|NCT00984659|579820170|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
160573157|NCT00984659|579820171|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
160573158|NCT00984659|579820172|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
160573159|NCT00984659|579820169|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
160573160|NCT00984659|579820170|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
160573161|NCT00984659|579820171|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
160573162|NCT00984659|579820172|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
160573163|NCT00984659|579820169|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
160573164|NCT00984659|579820170|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
160573165|NCT00984659|579820171|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
160573166|NCT00984659|579820172|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
160573167|NCT00984659|579820169|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
160573168|NCT00984659|579820170|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
160573169|NCT00984659|579820171|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
160573170|NCT00984659|579820172|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
160573171|NCT00984659|579820169|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
160573172|NCT00984659|579820170|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
160573173|NCT00984659|579820171|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
160573174|NCT00984659|579820172|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
160573175|NCT00984659|579820169|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
160573176|NCT00984659|579820170|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
160573177|NCT00984659|579820171|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
160573178|NCT00984659|579820172|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
160573179|NCT00984659|579820169|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160573180|NCT00984659|579820170|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
160573181|NCT00984659|579820171|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
160573182|NCT00984659|579820172|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
160573183|NCT02717546|579820173|FG000|Overall Study|Lost to Follow-up|12|||
160573184|NCT00909090|579820174|FG000|Overall Study|Lost to Follow-up|17|||
160573185|NCT00909090|579820175|FG001|Overall Study|Lost to Follow-up|17|||
160573186|NCT03633331|579820181|FG000|Overall Study|Withdrawal by Subject|1|||
160573187|NCT01009294|579820182|FG000|Overall Study|Study discontinued by Sponsor|6|||
160573188|NCT00949650|579820183|FG000|Overall Study|Progressive disease|188|||
160573189|NCT00949650|579820184|FG001|Overall Study|Progressive disease|19|||
160573190|NCT00949650|579820183|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
160573191|NCT00949650|579820184|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
160573192|NCT00949650|579820183|FG000|Overall Study|Other Adverse Event (AE)|28|||
160573193|NCT00949650|579820184|FG001|Overall Study|Other Adverse Event (AE)|17|||
160573194|NCT00949650|579820183|FG000|Overall Study|Protocol Violation|1|||
160573195|NCT00949650|579820184|FG001|Overall Study|Protocol Violation|4|||
160573196|NCT00949650|579820183|FG000|Overall Study|Refusal to continue medication|7|||
160573197|NCT00949650|579820184|FG001|Overall Study|Refusal to continue medication|11|||
160573198|NCT00949650|579820183|FG000|Overall Study|Not treated|1|||
160573199|NCT00949650|579820184|FG001|Overall Study|Not treated|4|||
160573200|NCT00949650|579820183|FG000|Overall Study|Other not specified above|5|||
160573201|NCT00949650|579820184|FG001|Overall Study|Other not specified above|0|||
160573202|NCT00414440|579820187|FG000|Core Period|Withdrawal by Subject|70|||
160997078|NCT01090024|581374870|FG013|Period 1|Adverse Event|0|||
160573203|NCT00414440|579820188|FG001|Core Period|Withdrawal by Subject|32|||
160573204|NCT00414440|579820187|FG000|Extension Period|Lost to Follow-up|44|||
160573205|NCT00414440|579820188|FG001|Extension Period|Lost to Follow-up|52|||
160573206|NCT00414440|579820187|FG000|Extension Period|Did not consent to continue follow up|61|||
160573207|NCT00414440|579820188|FG001|Extension Period|Did not consent to continue follow up|54|||
160573208|NCT00414440|579820187|FG000|Extension Period|Other|1|||
160573209|NCT00414440|579820188|FG001|Extension Period|Other|1|||
160573210|NCT00414440|579820187|FG000|Extension Period|Administrative|16|||
160654009|NCT00520741|580114245|FG000|Overall Study|Other reasons for premature termination|0|||
160654010|NCT00520741|580114246|FG001|Overall Study|Other reasons for premature termination|6|||
160654011|NCT03702621|580114247|FG000|Overall Study|Physician Decision|6|||
160654012|NCT03702621|580114248|FG001|Overall Study|Physician Decision|6|||
160654013|NCT03444038|580114249|FG000|Overall Study|Adverse Event|12|||
160654014|NCT03444038|580114249|FG000|Overall Study|Withdrawal by Subject|7|||
160654015|NCT03444038|580114249|FG000|Overall Study|Lost to Follow-up|1|||
160654016|NCT03444038|580114249|FG000|Overall Study|Physician Decision|2|||
160654017|NCT03444038|580114249|FG000|Overall Study|Lack of Efficacy|7|||
160654018|NCT02354586|580114251|FG000|Overall Study|Death|230|||
160654019|NCT02354586|580114251|FG000|Overall Study|Withdrawal by Subject|59|||
160654020|NCT02354586|580114251|FG000|Overall Study|Lost to Follow-up|11|||
160654021|NCT02354586|580114251|FG000|Overall Study|Sponsor decision|51|||
160654022|NCT02354586|580114251|FG000|Overall Study|Site closure|2|||
160654023|NCT02354586|580114251|FG000|Overall Study|Intercurrent illness|1|||
160654024|NCT02354586|580114251|FG000|Overall Study|Protocol Violation|3|||
160654025|NCT02354586|580114251|FG000|Overall Study|Physician Decision|13|||
160654026|NCT02354586|580114251|FG000|Overall Study|Lack of Efficacy|86|||
160654027|NCT02354586|580114251|FG000|Overall Study|Adverse Event|7|||
160654028|NCT01957488|580114252|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
160654029|NCT01957488|580114253|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
160654030|NCT01957488|580114254|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
160654031|NCT01957488|580114255|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
160654032|NCT01957488|580114256|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
160654033|NCT01957488|580114257|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
160654034|NCT01957488|580114252|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
160654035|NCT01957488|580114253|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
160654036|NCT01957488|580114254|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
160654037|NCT01957488|580114255|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
160654038|NCT01957488|580114256|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
160654039|NCT01957488|580114257|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
160654040|NCT01957488|580114252|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
160654041|NCT01957488|580114253|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
160654042|NCT01957488|580114254|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
160654043|NCT01957488|580114255|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
160654044|NCT01957488|580114256|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
160654045|NCT01957488|580114257|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
160654046|NCT01957488|580114252|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
160654047|NCT01957488|580114253|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
160654048|NCT01957488|580114254|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
160573211|NCT00414440|579820188|FG001|Extension Period|Administrative|16|||
160573212|NCT00414440|579820187|FG000|Extension Period|Death|1|||
160573213|NCT00414440|579820188|FG001|Extension Period|Death|2|||
160573214|NCT00414440|579820187|FG000|Extension Period|Withdrawal by Subject|9|||
160573215|NCT00414440|579820188|FG001|Extension Period|Withdrawal by Subject|7|||
160573216|NCT00414440|579820187|FG000|Extension Period|Not included in follow up period|18|||
160573217|NCT00414440|579820188|FG001|Extension Period|Not included in follow up period|8|||
160573218|NCT00790296|579820193|FG000|Overall Study|Did not meet study eligibility criteria|1|||
160573219|NCT00790296|579820194|FG001|Overall Study|Did not meet study eligibility criteria|1|||
160573220|NCT00790296|579820193|FG000|Overall Study|Adverse Event|0|||
160573221|NCT00790296|579820194|FG001|Overall Study|Adverse Event|1|||
160573222|NCT01753518|579820195|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
160573223|NCT01753518|579820196|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
160573224|NCT01753518|579820195|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
160573225|NCT01753518|579820196|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
160573226|NCT01753518|579820195|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
160573227|NCT01753518|579820196|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
160654049|NCT01957488|580114255|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
160654050|NCT01957488|580114256|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
160654051|NCT01957488|580114257|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
160654052|NCT01957488|580114252|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
160654053|NCT01957488|580114253|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
160654054|NCT01957488|580114254|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
160918341|NCT00680745|581094273|FG003|Overall Study|Poor/Non-compliance|0|||
160918342|NCT00680745|581094270|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
160918343|NCT00680745|581094271|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
160918344|NCT00680745|581094272|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
160573228|NCT01753518|579820195|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
160654055|NCT01957488|580114255|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
160654056|NCT01957488|580114256|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
160654057|NCT01957488|580114257|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
160654058|NCT01957488|580114252|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
160654059|NCT01957488|580114253|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
160654060|NCT01957488|580114254|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
160654061|NCT01957488|580114255|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
160654062|NCT01957488|580114256|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
160918345|NCT00680745|581094273|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
160918346|NCT00680745|581094270|FG000|Overall Study|False Treatment|0|||
160918347|NCT00680745|581094271|FG001|Overall Study|False Treatment|1|||
160918348|NCT00680745|581094272|FG002|Overall Study|False Treatment|3|||
160918349|NCT00680745|581094273|FG003|Overall Study|False Treatment|0|||
160918350|NCT02485574|581094276|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
160918351|NCT00255047|581094278|FG000|Overall Study|Serious Adverse Events|2|||
160918352|NCT00255047|581094279|FG001|Overall Study|Serious Adverse Events|1|||
160918353|NCT00255047|581094280|FG002|Overall Study|Serious Adverse Events|2|||
160918354|NCT00255047|581094281|FG003|Overall Study|Serious Adverse Events|1|||
160918355|NCT00255047|581094278|FG000|Overall Study|Adverse Event|0|||
160918356|NCT00255047|581094279|FG001|Overall Study|Adverse Event|3|||
160918357|NCT00255047|581094280|FG002|Overall Study|Adverse Event|2|||
160918358|NCT00255047|581094281|FG003|Overall Study|Adverse Event|1|||
160918359|NCT00255047|581094278|FG000|Overall Study|Protocol Violation|13|||
160918360|NCT00255047|581094279|FG001|Overall Study|Protocol Violation|13|||
160918361|NCT00255047|581094280|FG002|Overall Study|Protocol Violation|16|||
160918362|NCT00255047|581094281|FG003|Overall Study|Protocol Violation|20|||
160918363|NCT00255047|581094278|FG000|Overall Study|Lost to Follow-up|9|||
160918364|NCT00255047|581094279|FG001|Overall Study|Lost to Follow-up|8|||
160918365|NCT00255047|581094280|FG002|Overall Study|Lost to Follow-up|5|||
160918366|NCT00255047|581094281|FG003|Overall Study|Lost to Follow-up|6|||
160918367|NCT00255047|581094278|FG000|Overall Study|Withdrawal by Subject|24|||
160918368|NCT00255047|581094279|FG001|Overall Study|Withdrawal by Subject|23|||
160918369|NCT00255047|581094280|FG002|Overall Study|Withdrawal by Subject|25|||
160918370|NCT00255047|581094281|FG003|Overall Study|Withdrawal by Subject|18|||
160918371|NCT03049280|581094284|FG000|Overall Study|Physician Decision|1|||
160918372|NCT01867021|581094285|FG000|Overall Study|Adverse Event|0|||
160918373|NCT01867021|581094286|FG001|Overall Study|Adverse Event|1|||
160918374|NCT01867021|581094285|FG000|Overall Study|Not Eligible|0|||
160918375|NCT01867021|581094286|FG001|Overall Study|Not Eligible|1|||
160918376|NCT01867021|581094285|FG000|Overall Study|Death|1|||
160918377|NCT01867021|581094286|FG001|Overall Study|Death|0|||
160918378|NCT01867021|581094285|FG000|Overall Study|Lost to Follow-up|0|||
160918379|NCT01867021|581094286|FG001|Overall Study|Lost to Follow-up|2|||
160918380|NCT01867021|581094285|FG000|Overall Study|Withdrawal by Subject|1|||
160918381|NCT01867021|581094286|FG001|Overall Study|Withdrawal by Subject|6|||
160918382|NCT02480114|581094290|FG000|Overall Study|Not completing surveys|3|||
160918383|NCT02480114|581094291|FG001|Overall Study|Not completing surveys|2|||
160918384|NCT02480114|581094290|FG000|Overall Study|Withdrawal by Subject|2|||
160918385|NCT02480114|581094291|FG001|Overall Study|Withdrawal by Subject|4|||
160918386|NCT02480114|581094290|FG000|Overall Study|Disease progression|3|||
160918387|NCT02480114|581094291|FG001|Overall Study|Disease progression|0|||
160918388|NCT02480114|581094290|FG000|Overall Study|Improper completion of survey|1|||
160918389|NCT02480114|581094291|FG001|Overall Study|Improper completion of survey|1|||
160918390|NCT02480114|581094290|FG000|Overall Study|Not eligible|0|||
160918391|NCT02480114|581094291|FG001|Overall Study|Not eligible|1|||
160918392|NCT01031069|581094292|FG000|Overall Study|Serious Adverse Event|0|||
160918393|NCT01031069|581094293|FG001|Overall Study|Serious Adverse Event|1|||
160918394|NCT01031069|581094294|FG002|Overall Study|Serious Adverse Event|0|||
160918395|NCT01031069|581094295|FG003|Overall Study|Serious Adverse Event|0|||
160918396|NCT01031069|581094292|FG000|Overall Study|Withdrawal by Subject|2|||
160918397|NCT01031069|581094293|FG001|Overall Study|Withdrawal by Subject|3|||
160918398|NCT01031069|581094294|FG002|Overall Study|Withdrawal by Subject|18|||
160918399|NCT01031069|581094295|FG003|Overall Study|Withdrawal by Subject|18|||
160918400|NCT01031069|581094292|FG000|Overall Study|Migrated/moved from study area|1|||
160918401|NCT01031069|581094293|FG001|Overall Study|Migrated/moved from study area|2|||
160918402|NCT01031069|581094294|FG002|Overall Study|Migrated/moved from study area|1|||
160918403|NCT01031069|581094295|FG003|Overall Study|Migrated/moved from study area|1|||
160918404|NCT01031069|581094292|FG000|Overall Study|Lost to Follow-up|9|||
160918405|NCT01031069|581094293|FG001|Overall Study|Lost to Follow-up|5|||
160918406|NCT01031069|581094294|FG002|Overall Study|Lost to Follow-up|21|||
160918407|NCT01031069|581094295|FG003|Overall Study|Lost to Follow-up|15|||
160918408|NCT01031069|581094292|FG000|Overall Study|Other|0|||
160918409|NCT01031069|581094293|FG001|Overall Study|Other|0|||
160918410|NCT01031069|581094294|FG002|Overall Study|Other|1|||
160918411|NCT01031069|581094295|FG003|Overall Study|Other|0|||
160918412|NCT01317160|581094296|FG000|Overall Study|Incorrect inclusion|1|||
160918413|NCT01317160|581094297|FG001|Overall Study|Incorrect inclusion|1|||
160997079|NCT01090024|581374871|FG014|Period 1|Adverse Event|0|||
160654063|NCT01957488|580114257|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
160918414|NCT01317160|581094296|FG000|Overall Study|Lost to Follow-up|3|||
160918415|NCT01317160|581094297|FG001|Overall Study|Lost to Follow-up|3|||
160918416|NCT01317160|581094296|FG000|Overall Study|Withdrawal by Subject|0|||
160918417|NCT01317160|581094297|FG001|Overall Study|Withdrawal by Subject|2|||
160573229|NCT01753518|579820196|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
160573230|NCT01971476|579820197|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
160573231|NCT01971476|579820198|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
160573232|NCT01971476|579820199|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
160573233|NCT01971476|579820197|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
160573234|NCT01971476|579820198|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
160573235|NCT01971476|579820199|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
160573236|NCT01971476|579820197|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
160573237|NCT01971476|579820198|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
160573238|NCT01971476|579820199|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
160573239|NCT05121103|579820200|FG000|Overall Study|Progressive disease|2|||
160573240|NCT05121103|579820201|FG001|Overall Study|Progressive disease|1|||
160573241|NCT05121103|579820202|FG002|Overall Study|Progressive disease|6|||
160573242|NCT05121103|579820200|FG000|Overall Study|Physician Decision|2|||
160573243|NCT05121103|579820201|FG001|Overall Study|Physician Decision|1|||
160573244|NCT05121103|579820202|FG002|Overall Study|Physician Decision|0|||
160573245|NCT05121103|579820200|FG000|Overall Study|Withdrawal by Subject|0|||
160573246|NCT05121103|579820201|FG001|Overall Study|Withdrawal by Subject|1|||
160573247|NCT05121103|579820202|FG002|Overall Study|Withdrawal by Subject|0|||
160573248|NCT00514449|579820205|FG000|Overall Study|Withdrawal by Subject|1|||
160573249|NCT00514449|579820206|FG001|Overall Study|Withdrawal by Subject|2|||
160573250|NCT00514449|579820205|FG000|Overall Study|Protocol Violation|1|||
160573251|NCT00514449|579820206|FG001|Overall Study|Protocol Violation|2|||
160573252|NCT00514449|579820205|FG000|Overall Study|Lost to Follow-up|1|||
160573253|NCT00514449|579820206|FG001|Overall Study|Lost to Follow-up|0|||
160573254|NCT05897853|579820212|FG000|Overall Study|Lost to Follow-up|2|||
160573255|NCT05897853|579820213|FG001|Overall Study|Lost to Follow-up|0|||
160573256|NCT05897853|579820212|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
160573257|NCT05897853|579820213|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
160573258|NCT01450137|579820217|FG000|Up to Week 12|Adverse Event|2|||
160573259|NCT01450137|579820218|FG001|Up to Week 12|Adverse Event|1|||
160573260|NCT01450137|579820217|FG000|Up to Week 12|Withdrawal by Subject|0|||
160573261|NCT01450137|579820218|FG001|Up to Week 12|Withdrawal by Subject|2|||
160573262|NCT01450137|579820217|FG000|Week 12 to Study End|Death|0|||
160573263|NCT01450137|579820218|FG001|Week 12 to Study End|Death|1|||
160573264|NCT01450137|579820217|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
160573265|NCT01450137|579820218|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
160573266|NCT01926886|579820219|FG000|Overall Study|Administrative/other|1|||
160573267|NCT01926886|579820220|FG001|Overall Study|Administrative/other|0|||
160573268|NCT01926886|579820219|FG000|Overall Study|Adverse event/intercurrent illness|4|||
160573269|NCT01926886|579820220|FG001|Overall Study|Adverse event/intercurrent illness|0|||
160573270|NCT01926886|579820219|FG000|Overall Study|Disease progression/recurrence|4|||
160573271|NCT01926886|579820220|FG001|Overall Study|Disease progression/recurrence|0|||
160573272|NCT01926886|579820219|FG000|Overall Study|Withdrawal by Subject|15|||
160573273|NCT01926886|579820220|FG001|Overall Study|Withdrawal by Subject|0|||
160573274|NCT01926886|579820219|FG000|Overall Study|Failure to return|3|||
160573275|NCT01926886|579820220|FG001|Overall Study|Failure to return|0|||
160573276|NCT01926886|579820219|FG000|Overall Study|Recurrence of disease|1|||
160573277|NCT01926886|579820220|FG001|Overall Study|Recurrence of disease|0|||
160573278|NCT01926886|579820219|FG000|Overall Study|Progression of disease|2|||
160573279|NCT01926886|579820220|FG001|Overall Study|Progression of disease|0|||
160573280|NCT01926886|579820219|FG000|Overall Study|Death|1|||
160573281|NCT01926886|579820220|FG001|Overall Study|Death|0|||
160573282|NCT01926886|579820219|FG000|Overall Study|Did not cooperate|1|||
160573283|NCT01926886|579820220|FG001|Overall Study|Did not cooperate|0|||
160573284|NCT02609399|579820221|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
160573285|NCT02609399|579820222|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
160573286|NCT02609399|579820221|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
160573287|NCT02609399|579820222|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
160573288|NCT02609399|579820221|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
160573289|NCT02609399|579820222|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
160573290|NCT04458857|579820223|FG000|Overall Study|Adverse Event|0|||
160573291|NCT04458857|579820224|FG001|Overall Study|Adverse Event|1|||
160654064|NCT01957488|580114252|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
160654065|NCT01957488|580114253|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
160573292|NCT04458857|579820225|FG002|Overall Study|Adverse Event|0|||
160573293|NCT04458857|579820223|FG000|Overall Study|Withdrawal by Subject|2|||
160573294|NCT04458857|579820224|FG001|Overall Study|Withdrawal by Subject|0|||
160573295|NCT04458857|579820225|FG002|Overall Study|Withdrawal by Subject|0|||
160573296|NCT04458857|579820223|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160573297|NCT04458857|579820224|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160573298|NCT04458857|579820225|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160573299|NCT04458857|579820223|FG000|Overall Study|Non-compliance with study drug|0|||
160573300|NCT04458857|579820224|FG001|Overall Study|Non-compliance with study drug|1|||
160573301|NCT04458857|579820225|FG002|Overall Study|Non-compliance with study drug|0|||
160918418|NCT03578367|581094299|FG000|Overall Study|Adverse Event|0|||
160918419|NCT03578367|581094300|FG001|Overall Study|Adverse Event|3|||
160918420|NCT03578367|581094301|FG002|Overall Study|Adverse Event|0|||
160918421|NCT03578367|581094302|FG003|Overall Study|Adverse Event|5|||
160918422|NCT03578367|581094299|FG000|Overall Study|Withdrawal by Subject|2|||
160918423|NCT03578367|581094300|FG001|Overall Study|Withdrawal by Subject|2|||
160918424|NCT03578367|581094301|FG002|Overall Study|Withdrawal by Subject|1|||
160918425|NCT03578367|581094302|FG003|Overall Study|Withdrawal by Subject|3|||
160918426|NCT03578367|581094299|FG000|Overall Study|Physician Decision|0|||
160918427|NCT03578367|581094300|FG001|Overall Study|Physician Decision|0|||
160918428|NCT03578367|581094301|FG002|Overall Study|Physician Decision|14|||
160918429|NCT03578367|581094302|FG003|Overall Study|Physician Decision|0|||
160918430|NCT03578367|581094299|FG000|Overall Study|Death|1|||
160918431|NCT03578367|581094300|FG001|Overall Study|Death|0|||
160918432|NCT03578367|581094301|FG002|Overall Study|Death|0|||
160918433|NCT03578367|581094302|FG003|Overall Study|Death|0|||
160918434|NCT03578367|581094299|FG000|Overall Study|Not treated|0|||
160918435|NCT03578367|581094300|FG001|Overall Study|Not treated|0|||
160918436|NCT03578367|581094301|FG002|Overall Study|Not treated|1|||
160918437|NCT03578367|581094302|FG003|Overall Study|Not treated|0|||
160918438|NCT02734810|581095958|FG000|Overall Study|Adverse Event|1|||
160918439|NCT02734810|581095959|FG001|Overall Study|Adverse Event|0|||
160918440|NCT02734810|581095958|FG000|Overall Study|Lack of Efficacy|1|||
160918441|NCT02734810|581095959|FG001|Overall Study|Lack of Efficacy|0|||
160918442|NCT02507505|581095960|FG000|Overall Study|Withdrawal by Subject|13|||
160918443|NCT02507505|581095961|FG001|Overall Study|Withdrawal by Subject|11|||
160918444|NCT02507505|581095960|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
160918445|NCT02507505|581095961|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
160918446|NCT02507505|581095960|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
160918447|NCT02507505|581095961|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
160918448|NCT02507505|581095960|FG000|Overall Study|Death before receipt of anesthesia|0|||
160918449|NCT02507505|581095961|FG001|Overall Study|Death before receipt of anesthesia|1|||
160918450|NCT00931762|581095962|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
160918451|NCT00931762|581095962|FG000|Overall Study|Administrative Problems|5|||
160918452|NCT00931762|581095962|FG000|Overall Study|Death|1|||
160918453|NCT00931762|581095962|FG000|Overall Study|Disease Progression|3|||
160918454|NCT00931762|581095962|FG000|Overall Study|Adverse Event (s)|11|||
160918455|NCT00931762|581095962|FG000|Overall Study|Subject withdrew consent|13|||
160918456|NCT03182829|581095963|FG000|Overall Study|Protocol Violation|12|||
160918457|NCT03182829|581095964|FG001|Overall Study|Protocol Violation|12|||
160918458|NCT03182829|581095963|FG000|Overall Study|Other|4|||
160918459|NCT03182829|581095964|FG001|Overall Study|Other|3|||
160918460|NCT02664441|581095965|FG000|Randomization|Withdrawal by Subject|0|||
160918461|NCT02664441|581095966|FG001|Randomization|Withdrawal by Subject|1|||
160918462|NCT02664441|581095965|FG000|36-week Randomized Trial|Adverse Event|2|||
160918463|NCT02664441|581095966|FG001|36-week Randomized Trial|Adverse Event|0|||
160918464|NCT02664441|581095965|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
160918465|NCT02664441|581095966|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
160918466|NCT02664441|581095965|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
160918467|NCT02664441|581095966|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
160918468|NCT02664441|581095965|FG000|18-week Open Label Extension|Adverse Event|1|||
160918469|NCT02664441|581095966|FG001|18-week Open Label Extension|Adverse Event|0|||
160918470|NCT02664441|581095965|FG000|18-week Open Label Extension|Physician Decision|1|||
160918471|NCT02664441|581095966|FG001|18-week Open Label Extension|Physician Decision|0|||
160918472|NCT02664441|581095965|FG000|18-week Open Label Extension|Death|1|||
160918473|NCT02664441|581095966|FG001|18-week Open Label Extension|Death|0|||
160918474|NCT02664441|581095965|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
160918475|NCT02664441|581095966|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
160918476|NCT02259582|581095971|FG000|Overall Study|Physician Decision|0|||
160918477|NCT02259582|581095972|FG001|Overall Study|Physician Decision|1|||
160918478|NCT02259582|581095973|FG002|Overall Study|Physician Decision|0|||
160918479|NCT02259582|581095971|FG000|Overall Study|Death|0|||
160918480|NCT02259582|581095972|FG001|Overall Study|Death|0|||
160918481|NCT02259582|581095973|FG002|Overall Study|Death|1|||
160918482|NCT02259582|581095971|FG000|Overall Study|Adverse Event|1|||
160918483|NCT02259582|581095972|FG001|Overall Study|Adverse Event|0|||
160918484|NCT02259582|581095973|FG002|Overall Study|Adverse Event|1|||
160918485|NCT02259582|581095971|FG000|Overall Study|Withdrawal by Subject|0|||
160918486|NCT02259582|581095972|FG001|Overall Study|Withdrawal by Subject|0|||
160918487|NCT02259582|581095973|FG002|Overall Study|Withdrawal by Subject|1|||
160918488|NCT02259582|581095971|FG000|Overall Study|Disease progression|14|||
160918489|NCT02259582|581095972|FG001|Overall Study|Disease progression|15|||
160997080|NCT01090024|581374872|FG015|Period 1|Adverse Event|0|||
160918490|NCT02259582|581095973|FG002|Overall Study|Disease progression|17|||
160918491|NCT02259582|581095971|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
160918492|NCT02259582|581095972|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
160997081|NCT01090024|581374873|FG016|Period 1|Adverse Event|0|||
160573302|NCT04458857|579820223|FG000|Overall Study|Lost to Follow-up|4|||
160573303|NCT04458857|579820224|FG001|Overall Study|Lost to Follow-up|1|||
160573304|NCT04458857|579820225|FG002|Overall Study|Lost to Follow-up|0|||
160573305|NCT02986373|579820229|FG000|Overall Study|Adverse Event|4|||
160573306|NCT02986373|579820229|FG000|Overall Study|Lost to Follow-up|1|||
160573307|NCT02986373|579820229|FG000|Overall Study|Withdrawal by Subject|10|||
160573308|NCT02986373|579820229|FG000|Overall Study|Other|24|||
160573309|NCT04800315|579820230|FG000|Randomization|Did not receive study treatment|1|||
160573310|NCT04800315|579820231|FG001|Randomization|Did not receive study treatment|0|||
160573311|NCT04800315|579820232|FG002|Randomization|Did not receive study treatment|0|||
160573312|NCT04800315|579820233|FG003|Randomization|Did not receive study treatment|0|||
160573313|NCT04800315|579820230|FG000|Treatment Period|Adverse Event|4|||
160573314|NCT04800315|579820231|FG001|Treatment Period|Adverse Event|2|||
160573315|NCT04800315|579820232|FG002|Treatment Period|Adverse Event|1|||
160573316|NCT04800315|579820233|FG003|Treatment Period|Adverse Event|2|||
160573317|NCT04800315|579820230|FG000|Treatment Period|Lack of Efficacy|1|||
160573318|NCT04800315|579820231|FG001|Treatment Period|Lack of Efficacy|0|||
160573319|NCT04800315|579820232|FG002|Treatment Period|Lack of Efficacy|0|||
160573320|NCT04800315|579820233|FG003|Treatment Period|Lack of Efficacy|3|||
160573321|NCT04800315|579820230|FG000|Treatment Period|Lost to Follow-up|0|||
160573322|NCT04800315|579820231|FG001|Treatment Period|Lost to Follow-up|1|||
160573323|NCT04800315|579820232|FG002|Treatment Period|Lost to Follow-up|2|||
160573324|NCT04800315|579820233|FG003|Treatment Period|Lost to Follow-up|2|||
160573325|NCT04800315|579820230|FG000|Treatment Period|Withdrawal by participant|0|||
160573326|NCT04800315|579820231|FG001|Treatment Period|Withdrawal by participant|0|||
160573327|NCT04800315|579820232|FG002|Treatment Period|Withdrawal by participant|0|||
160573328|NCT04800315|579820233|FG003|Treatment Period|Withdrawal by participant|4|||
160573329|NCT04800315|579820230|FG000|Treatment Period|Other Reasons|0|||
160918493|NCT02259582|581095973|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
160918494|NCT02335489|581095974|FG000|Overall Study|Sponsor terminated study|4|||
160918495|NCT02335489|581095974|FG000|Overall Study|Lost to Follow-up|1|||
160918496|NCT02335489|581095974|FG000|Overall Study|Withdrawal by Subject|2|||
160573330|NCT04800315|579820231|FG001|Treatment Period|Other Reasons|2|||
160918497|NCT02335489|581095974|FG000|Overall Study|Physician Decision|2|||
160918498|NCT02335489|581095974|FG000|Overall Study|Lack of Efficacy|1|||
160573331|NCT04800315|579820232|FG002|Treatment Period|Other Reasons|0|||
160573332|NCT04800315|579820233|FG003|Treatment Period|Other Reasons|1|||
160573333|NCT00753922|579820234|FG000|Overall Study|Lost to Follow-up|155|||
160573334|NCT00753922|579820235|FG001|Overall Study|Lost to Follow-up|24|||
160573335|NCT00753922|579820236|FG002|Overall Study|Lost to Follow-up|28|||
160573336|NCT00753922|579820237|FG003|Overall Study|Lost to Follow-up|5|||
160573337|NCT00753922|579820234|FG000|Overall Study|Withdrawal by Subject|9|||
160573338|NCT00753922|579820235|FG001|Overall Study|Withdrawal by Subject|11|||
160573339|NCT00753922|579820236|FG002|Overall Study|Withdrawal by Subject|4|||
160573340|NCT00753922|579820237|FG003|Overall Study|Withdrawal by Subject|2|||
160573341|NCT00753922|579820234|FG000|Overall Study|Patient Non-compliance|55|||
160573342|NCT00753922|579820235|FG001|Overall Study|Patient Non-compliance|22|||
160573343|NCT00753922|579820236|FG002|Overall Study|Patient Non-compliance|14|||
160573344|NCT00753922|579820237|FG003|Overall Study|Patient Non-compliance|11|||
160573345|NCT00753922|579820234|FG000|Overall Study|Patients Not Completing Visit|11|||
160573346|NCT00753922|579820235|FG001|Overall Study|Patients Not Completing Visit|0|||
160573347|NCT00753922|579820236|FG002|Overall Study|Patients Not Completing Visit|1|||
160573348|NCT00753922|579820237|FG003|Overall Study|Patients Not Completing Visit|0|||
160573349|NCT00753922|579820234|FG000|Overall Study|Death|2|||
160918499|NCT00759863|581095977|FG000|Overall Study|Death, moved, or lost contact|20|||
160918500|NCT00759863|581095978|FG001|Overall Study|Death, moved, or lost contact|18|||
160918501|NCT00412854|581095982|FG000|Overall Study|Withdrawn due to adverse events|1|||
160918502|NCT00412854|581095983|FG001|Overall Study|Withdrawn due to adverse events|5|||
160918503|NCT00412854|581095982|FG000|Overall Study|Withdrawn for other reasons|13|||
160918504|NCT00412854|581095983|FG001|Overall Study|Withdrawn for other reasons|11|||
160918505|NCT00503308|581095984|FG000|Overall Study|Protocol Violation|2|||
160918506|NCT00503308|581095985|FG001|Overall Study|Protocol Violation|1|||
160918507|NCT03263442|581095987|FG000|Inpatient Phase|Death|1|||
160918508|NCT03263442|581095988|FG001|Inpatient Phase|Death|0|||
160573350|NCT00753922|579820235|FG001|Overall Study|Death|23|||
160918509|NCT03263442|581095987|FG000|Inpatient Phase|Withdrawal by Subject|1|||
160918510|NCT03263442|581095988|FG001|Inpatient Phase|Withdrawal by Subject|0|||
160573351|NCT00753922|579820236|FG002|Overall Study|Death|2|||
160573352|NCT00753922|579820237|FG003|Overall Study|Death|1|||
160573353|NCT00753922|579820234|FG000|Overall Study|Discontinuation Due to Explantation|14|||
160573354|NCT00753922|579820235|FG001|Overall Study|Discontinuation Due to Explantation|14|||
160573355|NCT00753922|579820236|FG002|Overall Study|Discontinuation Due to Explantation|14|||
160573356|NCT00753922|579820237|FG003|Overall Study|Discontinuation Due to Explantation|4|||
160573357|NCT02983292|579820238|FG000|Overall Study|Participant unwell & cannot travel|2|||
160573358|NCT02983292|579820238|FG000|Overall Study|Lost to Follow-up|3|||
160573359|NCT02983292|579820238|FG000|Overall Study|Participant withdrew consent|2|||
160573360|NCT02983292|579820238|FG000|Overall Study|Revision|7|||
160454593|NCT02460458|579396169|FG000|First Prospective Phase|Lost to Follow-up|84|||
160454594|NCT02460458|579396169|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
160454595|NCT01928394|579396170|FG000|Treatment Period|Disease progression|17|||
160454596|NCT01928394|579396171|FG001|Treatment Period|Disease progression|2|||
160454597|NCT01928394|579396172|FG002|Treatment Period|Disease progression|12|||
160454598|NCT01928394|579396173|FG003|Treatment Period|Disease progression|48|||
160454599|NCT01928394|579396174|FG004|Treatment Period|Disease progression|3|||
160454600|NCT01928394|579396175|FG005|Treatment Period|Disease progression|25|||
160454601|NCT01928394|579396176|FG006|Treatment Period|Disease progression|38|||
160454602|NCT01928394|579396177|FG007|Treatment Period|Disease progression|16|||
160454603|NCT01928394|579396178|FG008|Treatment Period|Disease progression|3|||
160454604|NCT01928394|579396179|FG009|Treatment Period|Disease progression|11|||
160454605|NCT01928394|579396180|FG010|Treatment Period|Disease progression|22|||
160454606|NCT01928394|579396181|FG011|Treatment Period|Disease progression|73|||
160454607|NCT01928394|579396182|FG012|Treatment Period|Disease progression|38|||
160454608|NCT01928394|579396183|FG013|Treatment Period|Disease progression|118|||
160454609|NCT01928394|579396184|FG014|Treatment Period|Disease progression|59|||
160454610|NCT01928394|579396185|FG015|Treatment Period|Disease progression|1|||
160454611|NCT01928394|579396186|FG016|Treatment Period|Disease progression|43|||
160454612|NCT01928394|579396187|FG017|Treatment Period|Disease progression|56|||
160454613|NCT01928394|579396188|FG018|Treatment Period|Disease progression|50|||
160454614|NCT01928394|579396189|FG019|Treatment Period|Disease progression|71|||
160454615|NCT01928394|579396190|FG020|Treatment Period|Disease progression|30|||
160454616|NCT01928394|579396191|FG021|Treatment Period|Disease progression|31|||
160454617|NCT01928394|579396192|FG022|Treatment Period|Disease progression|31|||
160454618|NCT01928394|579396170|FG000|Treatment Period|Study drug toxicity|1|||
160454619|NCT01928394|579396171|FG001|Treatment Period|Study drug toxicity|1|||
160454620|NCT01928394|579396172|FG002|Treatment Period|Study drug toxicity|3|||
160454621|NCT01928394|579396173|FG003|Treatment Period|Study drug toxicity|3|||
160454622|NCT01928394|579396174|FG004|Treatment Period|Study drug toxicity|0|||
160454623|NCT01928394|579396175|FG005|Treatment Period|Study drug toxicity|9|||
160454624|NCT01928394|579396176|FG006|Treatment Period|Study drug toxicity|7|||
160454625|NCT01928394|579396177|FG007|Treatment Period|Study drug toxicity|1|||
160918511|NCT03263442|581095987|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
160918512|NCT03263442|581095988|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
160918513|NCT03263442|581095987|FG000|1-month Follow-Up|Lost to Follow-up|1|||
160918514|NCT03263442|581095988|FG001|1-month Follow-Up|Lost to Follow-up|0|||
160918515|NCT03263442|581095987|FG000|3-month Follow-Up|Lost to Follow-up|1|||
160918516|NCT03263442|581095988|FG001|3-month Follow-Up|Lost to Follow-up|3|||
160918517|NCT03263442|581095987|FG000|6-month Follow-Up|Lost to Follow-up|2|||
160918518|NCT03263442|581095988|FG001|6-month Follow-Up|Lost to Follow-up|2|||
160918519|NCT02436889|581095989|FG000|Overall Study|No improvement in symptoms|1|||
160918520|NCT02436889|581095990|FG001|Overall Study|No improvement in symptoms|0|||
160918521|NCT02436889|581095989|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
160918522|NCT02436889|581095990|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
160918523|NCT00708643|581095991|FG000|Overall Study|Adverse Event|0|||
160918524|NCT00708643|581095992|FG001|Overall Study|Adverse Event|1|||
160918525|NCT01594125|581095993|FG000|Overall Study|Withdrawal by Subject|1|||
160918526|NCT01594125|581095994|FG001|Overall Study|Withdrawal by Subject|0|||
160918527|NCT01594125|581095995|FG002|Overall Study|Withdrawal by Subject|0|||
160918528|NCT01594125|581095996|FG003|Overall Study|Withdrawal by Subject|1|||
160918529|NCT01594125|581095997|FG004|Overall Study|Withdrawal by Subject|0|||
160918530|NCT01594125|581095993|FG000|Overall Study|Progressive Disease|3|||
160918531|NCT01594125|581095994|FG001|Overall Study|Progressive Disease|12|||
160918532|NCT01594125|581095995|FG002|Overall Study|Progressive Disease|3|||
160918533|NCT01594125|581095996|FG003|Overall Study|Progressive Disease|3|||
160918534|NCT01594125|581095997|FG004|Overall Study|Progressive Disease|7|||
160918535|NCT01710033|581096000|FG000|Stage 2|Adverse Event|0|||
160918536|NCT01710033|581096001|FG001|Stage 2|Adverse Event|0|||
160918537|NCT01710033|581096002|FG002|Stage 2|Adverse Event|0|||
160918538|NCT01710033|581096003|FG003|Stage 2|Adverse Event|0|||
160918539|NCT01710033|581096004|FG004|Stage 2|Adverse Event|1|||
160918540|NCT03045887|581096005|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
160918541|NCT03045887|581096006|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918542|NCT03045887|581096007|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918543|NCT03045887|581096008|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918544|NCT03045887|581096009|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918545|NCT03045887|581096010|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918546|NCT03045887|581096011|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918547|NCT03045887|581096012|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160573361|NCT02983292|579820238|FG000|Overall Study|Death|1|||
160918548|NCT03045887|581096013|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160454626|NCT01928394|579396178|FG008|Treatment Period|Study drug toxicity|0|||
160454627|NCT01928394|579396179|FG009|Treatment Period|Study drug toxicity|5|||
160454628|NCT01928394|579396180|FG010|Treatment Period|Study drug toxicity|2|||
160918549|NCT03045887|581096014|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918550|NCT03045887|581096005|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918551|NCT03045887|581096006|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160573362|NCT02983292|579820238|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
160573363|NCT02983292|579820238|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
160573364|NCT02983292|579820238|FG000|Overall Study|Participant relocation|1|||
160573365|NCT00306891|579820239|FG000|Part A|Withdrawal by Subject|1|||
160573366|NCT00306891|579820240|FG001|Part A|Withdrawal by Subject|1|||
160573367|NCT00306891|579820241|FG002|Part A|Withdrawal by Subject|0|||
160573368|NCT00306891|579820242|FG003|Part A|Withdrawal by Subject|0|||
160573369|NCT00306891|579820239|FG000|Part A|Condition under investigation worsened|2|||
160573370|NCT00306891|579820240|FG001|Part A|Condition under investigation worsened|2|||
160573371|NCT00306891|579820241|FG002|Part A|Condition under investigation worsened|0|||
160573372|NCT00306891|579820242|FG003|Part A|Condition under investigation worsened|0|||
160573373|NCT00306891|579820239|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
160573374|NCT00306891|579820240|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
160573375|NCT00306891|579820241|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
160573376|NCT00306891|579820242|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
160573377|NCT00306891|579820239|FG000|Part A|Partial bowel obstruction|1|||
160573378|NCT00306891|579820240|FG001|Part A|Partial bowel obstruction|0|||
160573379|NCT00306891|579820241|FG002|Part A|Partial bowel obstruction|0|||
160573380|NCT00306891|579820242|FG003|Part A|Partial bowel obstruction|0|||
160573381|NCT00306891|579820239|FG000|Part A|Reaccumul. of ascites following drainage|0|||
160573382|NCT00306891|579820240|FG001|Part A|Reaccumul. of ascites following drainage|1|||
160573383|NCT00306891|579820241|FG002|Part A|Reaccumul. of ascites following drainage|0|||
160573384|NCT00306891|579820242|FG003|Part A|Reaccumul. of ascites following drainage|0|||
160573385|NCT00306891|579820239|FG000|Part A|Suspicion of second malignancy|0|||
160573386|NCT00306891|579820240|FG001|Part A|Suspicion of second malignancy|1|||
160573387|NCT00306891|579820241|FG002|Part A|Suspicion of second malignancy|0|||
160573388|NCT00306891|579820242|FG003|Part A|Suspicion of second malignancy|0|||
160573389|NCT00306891|579820239|FG000|Part A|QTC interval outwith elig. criteria|1|||
160573390|NCT00306891|579820240|FG001|Part A|QTC interval outwith elig. criteria|0|||
160573391|NCT00306891|579820241|FG002|Part A|QTC interval outwith elig. criteria|0|||
160573392|NCT00306891|579820242|FG003|Part A|QTC interval outwith elig. criteria|0|||
160573393|NCT00306891|579820239|FG000|Part B|Death|0|||
160573394|NCT00306891|579820240|FG001|Part B|Death|0|||
160573395|NCT00306891|579820241|FG002|Part B|Death|1|||
160573396|NCT00306891|579820242|FG003|Part B|Death|2|||
160573397|NCT00306891|579820239|FG000|Part B|Adverse Event|0|||
160918552|NCT03045887|581096007|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918553|NCT03045887|581096008|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
160918554|NCT03045887|581096009|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918555|NCT03045887|581096010|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918556|NCT03045887|581096011|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918557|NCT03045887|581096012|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918558|NCT03045887|581096013|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918559|NCT03045887|581096014|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918560|NCT03045887|581096005|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
160918561|NCT03045887|581096006|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918562|NCT03045887|581096007|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918563|NCT03045887|581096008|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918564|NCT03045887|581096009|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918565|NCT03045887|581096010|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918566|NCT03045887|581096011|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918567|NCT03045887|581096012|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918568|NCT03045887|581096013|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918569|NCT03045887|581096014|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918570|NCT03045887|581096005|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918571|NCT03045887|581096006|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918572|NCT03045887|581096007|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
160918573|NCT03045887|581096008|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
160918574|NCT03045887|581096009|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918575|NCT03045887|581096010|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918576|NCT03045887|581096011|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160573398|NCT00306891|579820240|FG001|Part B|Adverse Event|0|||
160573399|NCT00306891|579820241|FG002|Part B|Adverse Event|5|||
160918577|NCT03045887|581096012|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918578|NCT03045887|581096013|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918579|NCT03045887|581096014|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160997082|NCT01090024|581374874|FG017|Period 1|Adverse Event|1|||
160573400|NCT00306891|579820242|FG003|Part B|Adverse Event|5|||
160573401|NCT00306891|579820239|FG000|Part B|Withdrawal by Subject|0|||
160573402|NCT00306891|579820240|FG001|Part B|Withdrawal by Subject|0|||
160918580|NCT03045887|581096005|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918581|NCT03045887|581096006|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918582|NCT03045887|581096007|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918583|NCT03045887|581096008|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
160918584|NCT03045887|581096009|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918585|NCT03045887|581096010|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918586|NCT03045887|581096011|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918587|NCT03045887|581096012|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918588|NCT03045887|581096013|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918589|NCT03045887|581096014|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918590|NCT03414424|581096015|FG000|Overall Study|Screened out after consent|0|||
160918591|NCT03414424|581096016|FG001|Overall Study|Screened out after consent|2|||
160918592|NCT03414424|581096015|FG000|Overall Study|Lost to Follow-up|0|||
160918593|NCT03414424|581096016|FG001|Overall Study|Lost to Follow-up|1|||
160918594|NCT01782859|581096017|FG000|Overall Study|Protocol Violation|6|||
160918595|NCT01782859|581096018|FG001|Overall Study|Protocol Violation|6|||
160918596|NCT01782859|581096017|FG000|Overall Study|Withdrawal by Subject|0|||
160918597|NCT01782859|581096018|FG001|Overall Study|Withdrawal by Subject|1|||
160918598|NCT03287804|581096019|FG000|Overall Study|Death|1|||
160918599|NCT03287804|581096019|FG000|Overall Study|Physician Decision|2|||
160918600|NCT03287804|581096019|FG000|Overall Study|Progressive disease|8|||
160918601|NCT02956486|581096020|FG000|Core Phase|Adverse Event|51|||
160918602|NCT02956486|581096021|FG001|Core Phase|Adverse Event|88|||
160918603|NCT02956486|581096022|FG002|Core Phase|Adverse Event|0|||
160918604|NCT02956486|581096020|FG000|Core Phase|Lost to Follow-up|8|||
160918605|NCT02956486|581096021|FG001|Core Phase|Lost to Follow-up|6|||
160918606|NCT02956486|581096022|FG002|Core Phase|Lost to Follow-up|0|||
160918607|NCT02956486|581096020|FG000|Core Phase|Inadequate therapeutic effect|4|||
160918608|NCT02956486|581096021|FG001|Core Phase|Inadequate therapeutic effect|5|||
160454629|NCT01928394|579396181|FG011|Treatment Period|Study drug toxicity|3|||
160454630|NCT01928394|579396182|FG012|Treatment Period|Study drug toxicity|7|||
160454631|NCT01928394|579396183|FG013|Treatment Period|Study drug toxicity|5|||
160454632|NCT01928394|579396184|FG014|Treatment Period|Study drug toxicity|12|||
160454633|NCT01928394|579396185|FG015|Treatment Period|Study drug toxicity|0|||
160454634|NCT01928394|579396186|FG016|Treatment Period|Study drug toxicity|3|||
160454635|NCT01928394|579396187|FG017|Treatment Period|Study drug toxicity|3|||
160454636|NCT01928394|579396188|FG018|Treatment Period|Study drug toxicity|12|||
160454637|NCT01928394|579396189|FG019|Treatment Period|Study drug toxicity|15|||
160454638|NCT01928394|579396190|FG020|Treatment Period|Study drug toxicity|4|||
160454639|NCT01928394|579396191|FG021|Treatment Period|Study drug toxicity|7|||
160454640|NCT01928394|579396192|FG022|Treatment Period|Study drug toxicity|4|||
160454641|NCT01928394|579396170|FG000|Treatment Period|AE unrelated to study drug|0|||
160454642|NCT01928394|579396171|FG001|Treatment Period|AE unrelated to study drug|0|||
160454643|NCT01928394|579396172|FG002|Treatment Period|AE unrelated to study drug|2|||
160454644|NCT01928394|579396173|FG003|Treatment Period|AE unrelated to study drug|3|||
160573403|NCT00306891|579820241|FG002|Part B|Withdrawal by Subject|3|||
160573404|NCT00306891|579820242|FG003|Part B|Withdrawal by Subject|1|||
160997083|NCT01090024|581374857|FG000|Period 1|Withdrawal by Subject|0|||
160997084|NCT01090024|581374858|FG001|Period 1|Withdrawal by Subject|0|||
160997085|NCT01090024|581374859|FG002|Period 1|Withdrawal by Subject|0|||
160997086|NCT01090024|581374860|FG003|Period 1|Withdrawal by Subject|1|||
160997087|NCT01090024|581374861|FG004|Period 1|Withdrawal by Subject|0|||
160997088|NCT01090024|581374862|FG005|Period 1|Withdrawal by Subject|0|||
160997089|NCT01090024|581374863|FG006|Period 1|Withdrawal by Subject|0|||
160997090|NCT01090024|581374864|FG007|Period 1|Withdrawal by Subject|0|||
160997091|NCT01090024|581374865|FG008|Period 1|Withdrawal by Subject|0|||
160997092|NCT01090024|581374866|FG009|Period 1|Withdrawal by Subject|0|||
160997093|NCT01090024|581374867|FG010|Period 1|Withdrawal by Subject|0|||
160997094|NCT01090024|581374868|FG011|Period 1|Withdrawal by Subject|0|||
160997095|NCT01090024|581374869|FG012|Period 1|Withdrawal by Subject|0|||
160997096|NCT01090024|581374870|FG013|Period 1|Withdrawal by Subject|0|||
160997097|NCT01090024|581374871|FG014|Period 1|Withdrawal by Subject|0|||
160997098|NCT01090024|581374872|FG015|Period 1|Withdrawal by Subject|0|||
160997099|NCT01090024|581374873|FG016|Period 1|Withdrawal by Subject|0|||
160997100|NCT01090024|581374874|FG017|Period 1|Withdrawal by Subject|0|||
160997101|NCT01090024|581374857|FG000|Period 1|Lost to Follow-up|0|||
160997102|NCT01090024|581374858|FG001|Period 1|Lost to Follow-up|1|||
160997103|NCT01090024|581374859|FG002|Period 1|Lost to Follow-up|0|||
160997104|NCT01090024|581374860|FG003|Period 1|Lost to Follow-up|0|||
160997105|NCT01090024|581374861|FG004|Period 1|Lost to Follow-up|0|||
160997106|NCT01090024|581374862|FG005|Period 1|Lost to Follow-up|0|||
160997107|NCT01090024|581374863|FG006|Period 1|Lost to Follow-up|0|||
160997108|NCT01090024|581374864|FG007|Period 1|Lost to Follow-up|0|||
160454645|NCT01928394|579396174|FG004|Treatment Period|AE unrelated to study drug|0|||
160454646|NCT01928394|579396175|FG005|Treatment Period|AE unrelated to study drug|5|||
160997109|NCT01090024|581374865|FG008|Period 1|Lost to Follow-up|0|||
160997110|NCT01090024|581374866|FG009|Period 1|Lost to Follow-up|0|||
160573405|NCT00306891|579820239|FG000|Part B|Condition under investigation worsened|0|||
160573406|NCT00306891|579820240|FG001|Part B|Condition under investigation worsened|0|||
160573407|NCT00306891|579820241|FG002|Part B|Condition under investigation worsened|2|||
160573408|NCT00306891|579820242|FG003|Part B|Condition under investigation worsened|8|||
160573409|NCT00306891|579820239|FG000|Part B|Development of study specific disc crit.|0|||
160573410|NCT00306891|579820240|FG001|Part B|Development of study specific disc crit.|0|||
160573411|NCT00306891|579820241|FG002|Part B|Development of study specific disc crit.|0|||
160573412|NCT00306891|579820242|FG003|Part B|Development of study specific disc crit.|1|||
160573413|NCT01333189|579820246|FG000|Overall Study|Time constraints|1|||
160573414|NCT01333189|579820247|FG001|Overall Study|Time constraints|0|||
160573415|NCT01333189|579820246|FG000|Overall Study|Adverse Event|1|||
160573416|NCT01333189|579820247|FG001|Overall Study|Adverse Event|0|||
160573417|NCT01333189|579820246|FG000|Overall Study|Transportation difficulties|0|||
160573418|NCT01333189|579820247|FG001|Overall Study|Transportation difficulties|1|||
160573419|NCT01333189|579820246|FG000|Overall Study|Moved from region|0|||
160573420|NCT01333189|579820247|FG001|Overall Study|Moved from region|1|||
160573421|NCT01739595|579820248|FG000|Overall Study|Adverse Event|3|||
160573422|NCT01739595|579820249|FG001|Overall Study|Adverse Event|0|||
160573423|NCT01739595|579820250|FG002|Overall Study|Adverse Event|0|||
160573424|NCT01739595|579820248|FG000|Overall Study|Lost to Follow-up|2|||
160573425|NCT01739595|579820249|FG001|Overall Study|Lost to Follow-up|0|||
160573426|NCT01739595|579820250|FG002|Overall Study|Lost to Follow-up|0|||
160573427|NCT01739595|579820248|FG000|Overall Study|Withdrawal by Subject|2|||
160573428|NCT01739595|579820249|FG001|Overall Study|Withdrawal by Subject|1|||
160573429|NCT01739595|579820250|FG002|Overall Study|Withdrawal by Subject|2|||
160573430|NCT01739595|579820248|FG000|Overall Study|Eligibility issue|3|||
160573431|NCT01739595|579820249|FG001|Overall Study|Eligibility issue|0|||
160573432|NCT01739595|579820250|FG002|Overall Study|Eligibility issue|0|||
160573433|NCT01739595|579820248|FG000|Overall Study|Protocol Violation|1|||
160573434|NCT01739595|579820249|FG001|Overall Study|Protocol Violation|0|||
160573435|NCT01739595|579820250|FG002|Overall Study|Protocol Violation|0|||
160573436|NCT01739595|579820248|FG000|Overall Study|Lab assessment|1|||
160573437|NCT01739595|579820249|FG001|Overall Study|Lab assessment|0|||
160573438|NCT01739595|579820250|FG002|Overall Study|Lab assessment|0|||
160573439|NCT01739595|579820248|FG000|Overall Study|Drug discrepancy|1|||
160573440|NCT01739595|579820249|FG001|Overall Study|Drug discrepancy|0|||
160573441|NCT01739595|579820250|FG002|Overall Study|Drug discrepancy|0|||
160573442|NCT00035815|579820251|FG000|Overall Study|Withdrawal by Subject|17|||
160573443|NCT00035815|579820252|FG001|Overall Study|Withdrawal by Subject|11|||
160573444|NCT04285723|579820255|FG000|Overall Study|Subject decision|1|||
160573445|NCT04285723|579820256|FG001|Overall Study|Subject decision|2|||
160573446|NCT04285723|579820255|FG000|Overall Study|Physician Decision|1|||
160573447|NCT04285723|579820256|FG001|Overall Study|Physician Decision|0|||
160918609|NCT02956486|581096022|FG002|Core Phase|Inadequate therapeutic effect|0|||
160918610|NCT02956486|581096020|FG000|Core Phase|Withdrawal by Subject|101|||
160918611|NCT02956486|581096021|FG001|Core Phase|Withdrawal by Subject|104|||
160918612|NCT02956486|581096022|FG002|Core Phase|Withdrawal by Subject|0|||
160918613|NCT02956486|581096020|FG000|Core Phase|Study terminated by sponsor|888|||
160918614|NCT02956486|581096021|FG001|Core Phase|Study terminated by sponsor|848|||
160918615|NCT02956486|581096022|FG002|Core Phase|Study terminated by sponsor|0|||
160918616|NCT02956486|581096020|FG000|Core Phase|Other|27|||
160918617|NCT02956486|581096021|FG001|Core Phase|Other|18|||
160918618|NCT02956486|581096022|FG002|Core Phase|Other|0|||
160918619|NCT02956486|581096020|FG000|Core Phase|Not treated|0|||
160918620|NCT02956486|581096021|FG001|Core Phase|Not treated|3|||
160918621|NCT02956486|581096022|FG002|Core Phase|Not treated|0|||
160918622|NCT02956486|581096020|FG000|Extension Phase|Adverse Event|0|||
160918623|NCT02956486|581096021|FG001|Extension Phase|Adverse Event|0|||
160918624|NCT02956486|581096022|FG002|Extension Phase|Adverse Event|2|||
160918625|NCT02956486|581096020|FG000|Extension Phase|Study terminated by sponsor|0|||
160573448|NCT04285723|579820255|FG000|Overall Study|No efficiency|1|||
160573449|NCT04285723|579820256|FG001|Overall Study|No efficiency|0|||
160573450|NCT01894516|579821558|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
160573451|NCT01894516|579821559|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
160918626|NCT02956486|581096021|FG001|Extension Phase|Study terminated by sponsor|0|||
160918627|NCT02956486|581096022|FG002|Extension Phase|Study terminated by sponsor|16|||
160654066|NCT01957488|580114254|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
160918628|NCT02956486|581096020|FG000|Extension Phase|Not Treated|0|||
160918629|NCT02956486|581096021|FG001|Extension Phase|Not Treated|0|||
160573452|NCT01894516|579821560|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
160573453|NCT01894516|579821561|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
160573454|NCT01894516|579821558|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
160573455|NCT01894516|579821559|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
160573456|NCT01894516|579821560|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
160573457|NCT01894516|579821561|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
160918630|NCT02956486|581096022|FG002|Extension Phase|Not Treated|1|||
160918631|NCT01408914|581096025|FG000|Overall Study|Could not complete tx in protocol period|5|||
160573458|NCT01894516|579821558|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
160573459|NCT01894516|579821559|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
160573460|NCT01894516|579821560|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
160573461|NCT01894516|579821561|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
160573462|NCT01894516|579821558|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
160573463|NCT01894516|579821559|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
160573464|NCT01894516|579821560|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
160573465|NCT01894516|579821561|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
160573466|NCT01894516|579821558|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
160573467|NCT01894516|579821559|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
160573468|NCT01894516|579821560|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
160573469|NCT01894516|579821561|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
160573470|NCT01894516|579821558|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
160573471|NCT01894516|579821559|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
160573472|NCT01894516|579821560|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
160573473|NCT01894516|579821561|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
160573474|NCT01894516|579821558|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
160573475|NCT01894516|579821559|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
160573476|NCT01894516|579821560|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
160573477|NCT01894516|579821561|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
160573478|NCT01894516|579821558|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
160573479|NCT01894516|579821559|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
160573480|NCT01894516|579821560|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
160573481|NCT01894516|579821561|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
160573482|NCT01486316|579821567|FG000|Overall Study|Device explanted with/without re-implant|3|||
160573483|NCT01486316|579821568|FG001|Overall Study|Device explanted with/without re-implant|2|||
160573484|NCT01486316|579821569|FG002|Overall Study|Device explanted with/without re-implant|0|||
160573485|NCT01486316|579821570|FG003|Overall Study|Device explanted with/without re-implant|2|||
160573486|NCT01486316|579821567|FG000|Overall Study|Not meeting eligibility criteria|0|||
160573487|NCT01486316|579821568|FG001|Overall Study|Not meeting eligibility criteria|0|||
160573488|NCT01486316|579821569|FG002|Overall Study|Not meeting eligibility criteria|1|||
160573489|NCT01486316|579821570|FG003|Overall Study|Not meeting eligibility criteria|0|||
160573490|NCT01486316|579821567|FG000|Overall Study|Withdrawal by Subject|1|||
160573491|NCT01486316|579821568|FG001|Overall Study|Withdrawal by Subject|0|||
160573492|NCT01486316|579821569|FG002|Overall Study|Withdrawal by Subject|3|||
160573493|NCT01486316|579821570|FG003|Overall Study|Withdrawal by Subject|0|||
160573494|NCT01486316|579821567|FG000|Overall Study|Physician Decision|0|||
160573495|NCT01486316|579821568|FG001|Overall Study|Physician Decision|0|||
160573496|NCT01486316|579821569|FG002|Overall Study|Physician Decision|1|||
160573497|NCT01486316|579821570|FG003|Overall Study|Physician Decision|0|||
160573498|NCT01486316|579821567|FG000|Overall Study|Death|0|||
160573499|NCT01486316|579821568|FG001|Overall Study|Death|1|||
160573500|NCT01486316|579821569|FG002|Overall Study|Death|0|||
160573501|NCT01486316|579821570|FG003|Overall Study|Death|0|||
160573502|NCT05094154|579821577|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
160573503|NCT05094154|579821578|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
160573504|NCT05094154|579821577|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
160573505|NCT05094154|579821578|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
160573506|NCT01240811|579821587|FG000|Overall Study|Physician Decision|0|||
160573507|NCT01240811|579821588|FG001|Overall Study|Physician Decision|1|||
160654067|NCT01957488|580114255|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
160918632|NCT01408914|581096026|FG001|Overall Study|Could not complete tx in protocol period|5|||
160918633|NCT01408914|581096027|FG002|Overall Study|Could not complete tx in protocol period|6|||
160918634|NCT01408914|581096025|FG000|Overall Study|Lost to Follow-up|4|||
160918635|NCT01408914|581096026|FG001|Overall Study|Lost to Follow-up|1|||
160918636|NCT01408914|581096027|FG002|Overall Study|Lost to Follow-up|2|||
160918637|NCT01408914|581096025|FG000|Overall Study|Physician Decision|1|||
160918638|NCT01408914|581096026|FG001|Overall Study|Physician Decision|1|||
160918639|NCT01408914|581096027|FG002|Overall Study|Physician Decision|0|||
160997111|NCT01090024|581374867|FG010|Period 1|Lost to Follow-up|0|||
160997112|NCT01090024|581374868|FG011|Period 1|Lost to Follow-up|0|||
160918640|NCT01408914|581096025|FG000|Overall Study|Withdrawal by Subject|1|||
160997113|NCT01090024|581374869|FG012|Period 1|Lost to Follow-up|0|||
160997114|NCT01090024|581374870|FG013|Period 1|Lost to Follow-up|0|||
160573508|NCT01240811|579821589|FG002|Overall Study|Physician Decision|0|||
160573509|NCT01240811|579821587|FG000|Overall Study|Withdrawal by Subject|0|||
160573510|NCT01240811|579821588|FG001|Overall Study|Withdrawal by Subject|0|||
160573511|NCT01240811|579821589|FG002|Overall Study|Withdrawal by Subject|1|||
160918641|NCT01408914|581096026|FG001|Overall Study|Withdrawal by Subject|0|||
160918642|NCT01408914|581096027|FG002|Overall Study|Withdrawal by Subject|1|||
160997115|NCT01090024|581374871|FG014|Period 1|Lost to Follow-up|0|||
160918643|NCT01408914|581096025|FG000|Overall Study|Moved out of study jurisdiction|1|||
160918644|NCT01408914|581096026|FG001|Overall Study|Moved out of study jurisdiction|1|||
160918645|NCT01408914|581096027|FG002|Overall Study|Moved out of study jurisdiction|0|||
160918646|NCT01408914|581096025|FG000|Overall Study|Late exclusion|0|||
160918647|NCT01408914|581096026|FG001|Overall Study|Late exclusion|3|||
160918648|NCT01408914|581096027|FG002|Overall Study|Late exclusion|3|||
160918649|NCT01408914|581096025|FG000|Overall Study|Change in local TB/HIV norms|0|||
160918650|NCT01408914|581096026|FG001|Overall Study|Change in local TB/HIV norms|1|||
160918651|NCT01408914|581096027|FG002|Overall Study|Change in local TB/HIV norms|1|||
160918652|NCT01585194|581096034|FG000|Overall Study|Withdrawal by Subject|1|||
160918653|NCT01585194|581096034|FG000|Overall Study|Physician Decision|2|||
160918654|NCT01585194|581096034|FG000|Overall Study|Lack of insurance|1|||
160918655|NCT00993291|581096035|FG000|Overall Study|Withdrawal by Subject|1|||
160918656|NCT00003492|581096036|FG000|Overall Study|Not evaluable|6|||
160918657|NCT04446377|581096038|FG000|Overall Study|Withdrawal by Subject|6|||
160918658|NCT04446377|581096039|FG001|Overall Study|Withdrawal by Subject|1|||
160918659|NCT04446377|581096038|FG000|Overall Study|Physician Decision|1|||
160997116|NCT01090024|581374872|FG015|Period 1|Lost to Follow-up|0|||
160997117|NCT01090024|581374873|FG016|Period 1|Lost to Follow-up|0|||
160997118|NCT01090024|581374874|FG017|Period 1|Lost to Follow-up|0|||
160997119|NCT01090024|581374857|FG000|Period 2|Lost to Follow-up|0|||
160997120|NCT01090024|581374858|FG001|Period 2|Lost to Follow-up|0|||
160997121|NCT01090024|581374859|FG002|Period 2|Lost to Follow-up|0|||
160997122|NCT01090024|581374860|FG003|Period 2|Lost to Follow-up|1|||
160997123|NCT01090024|581374861|FG004|Period 2|Lost to Follow-up|0|||
160997124|NCT01090024|581374862|FG005|Period 2|Lost to Follow-up|0|||
160997125|NCT01090024|581374863|FG006|Period 2|Lost to Follow-up|0|||
160997126|NCT01090024|581374864|FG007|Period 2|Lost to Follow-up|0|||
160997127|NCT01090024|581374865|FG008|Period 2|Lost to Follow-up|0|||
160997128|NCT01090024|581374866|FG009|Period 2|Lost to Follow-up|0|||
160997129|NCT01090024|581374867|FG010|Period 2|Lost to Follow-up|0|||
160997130|NCT01090024|581374868|FG011|Period 2|Lost to Follow-up|0|||
160997131|NCT01090024|581374869|FG012|Period 2|Lost to Follow-up|0|||
160997132|NCT01090024|581374870|FG013|Period 2|Lost to Follow-up|0|||
160997133|NCT01090024|581374871|FG014|Period 2|Lost to Follow-up|0|||
160997134|NCT01090024|581374872|FG015|Period 2|Lost to Follow-up|0|||
160997135|NCT01090024|581374873|FG016|Period 2|Lost to Follow-up|0|||
160997136|NCT01090024|581374874|FG017|Period 2|Lost to Follow-up|0|||
160997137|NCT01090024|581374857|FG000|Period 2|Adverse Event|1|||
160997138|NCT01090024|581374858|FG001|Period 2|Adverse Event|0|||
160997139|NCT01090024|581374859|FG002|Period 2|Adverse Event|0|||
160997140|NCT01090024|581374860|FG003|Period 2|Adverse Event|0|||
160997141|NCT01090024|581374861|FG004|Period 2|Adverse Event|0|||
160997142|NCT01090024|581374862|FG005|Period 2|Adverse Event|0|||
160997143|NCT01090024|581374863|FG006|Period 2|Adverse Event|0|||
160997144|NCT01090024|581374864|FG007|Period 2|Adverse Event|0|||
160997145|NCT01090024|581374865|FG008|Period 2|Adverse Event|0|||
160997146|NCT01090024|581374866|FG009|Period 2|Adverse Event|0|||
160997147|NCT01090024|581374867|FG010|Period 2|Adverse Event|0|||
160997148|NCT01090024|581374868|FG011|Period 2|Adverse Event|0|||
160997149|NCT01090024|581374869|FG012|Period 2|Adverse Event|0|||
160997150|NCT01090024|581374870|FG013|Period 2|Adverse Event|0|||
160997151|NCT01090024|581374871|FG014|Period 2|Adverse Event|0|||
160997152|NCT01090024|581374872|FG015|Period 2|Adverse Event|0|||
160997153|NCT01090024|581374873|FG016|Period 2|Adverse Event|0|||
160997154|NCT01090024|581374874|FG017|Period 2|Adverse Event|0|||
160997155|NCT01090024|581374857|FG000|Period 3|Withdrawal by Subject|0|||
160997156|NCT01090024|581374858|FG001|Period 3|Withdrawal by Subject|0|||
160997157|NCT01090024|581374859|FG002|Period 3|Withdrawal by Subject|0|||
160997158|NCT01090024|581374860|FG003|Period 3|Withdrawal by Subject|0|||
160997159|NCT01090024|581374861|FG004|Period 3|Withdrawal by Subject|0|||
160997160|NCT01090024|581374862|FG005|Period 3|Withdrawal by Subject|0|||
160997161|NCT01090024|581374863|FG006|Period 3|Withdrawal by Subject|0|||
160997162|NCT01090024|581374864|FG007|Period 3|Withdrawal by Subject|0|||
160997163|NCT01090024|581374865|FG008|Period 3|Withdrawal by Subject|0|||
160918660|NCT04446377|581096039|FG001|Overall Study|Physician Decision|1|||
160918661|NCT04446377|581096038|FG000|Overall Study|Lost to Follow-up|0|||
160918662|NCT04446377|581096039|FG001|Overall Study|Lost to Follow-up|2|||
160654068|NCT01957488|580114256|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
160997164|NCT01090024|581374866|FG009|Period 3|Withdrawal by Subject|0|||
160997165|NCT01090024|581374867|FG010|Period 3|Withdrawal by Subject|0|||
160918663|NCT04446377|581096038|FG000|Overall Study|Not eligible|0|||
160918664|NCT04446377|581096039|FG001|Overall Study|Not eligible|1|||
160918665|NCT01414075|581096047|FG000|Overall Study|Adverse Event|1|||
160997166|NCT01090024|581374868|FG011|Period 3|Withdrawal by Subject|0|||
160997167|NCT01090024|581374869|FG012|Period 3|Withdrawal by Subject|0|||
160997168|NCT01090024|581374870|FG013|Period 3|Withdrawal by Subject|0|||
160997169|NCT01090024|581374871|FG014|Period 3|Withdrawal by Subject|0|||
160997170|NCT01090024|581374872|FG015|Period 3|Withdrawal by Subject|1|||
160997171|NCT01090024|581374873|FG016|Period 3|Withdrawal by Subject|0|||
160997172|NCT01090024|581374874|FG017|Period 3|Withdrawal by Subject|0|||
160918666|NCT01414075|581096048|FG001|Overall Study|Adverse Event|0|||
160918667|NCT01414075|581096049|FG002|Overall Study|Adverse Event|1|||
160918668|NCT01414075|581096050|FG003|Overall Study|Adverse Event|0|||
160918669|NCT01414075|581096047|FG000|Overall Study|Death|1|||
160918670|NCT01414075|581096048|FG001|Overall Study|Death|0|||
160918671|NCT01414075|581096049|FG002|Overall Study|Death|0|||
160918672|NCT01414075|581096050|FG003|Overall Study|Death|1|||
160918673|NCT01414075|581096047|FG000|Overall Study|Withdrawal by Subject|0|||
160918674|NCT01414075|581096048|FG001|Overall Study|Withdrawal by Subject|0|||
160918675|NCT01414075|581096049|FG002|Overall Study|Withdrawal by Subject|0|||
160918676|NCT01414075|581096050|FG003|Overall Study|Withdrawal by Subject|1|||
160918677|NCT01414075|581096047|FG000|Overall Study|Other than specified|1|||
160918678|NCT01414075|581096048|FG001|Overall Study|Other than specified|0|||
160918679|NCT01414075|581096049|FG002|Overall Study|Other than specified|1|||
160918680|NCT01414075|581096050|FG003|Overall Study|Other than specified|0|||
160918681|NCT04903626|581096052|FG000|Overall Study|Lost to Follow-up|6|||
160918682|NCT04903626|581096052|FG000|Overall Study|Withdrawal by Subject|1|||
160918683|NCT04903626|581096052|FG000|Overall Study|Other, Not Specified|1|||
160573512|NCT04168645|579821597|FG000|Overall Study|Lost to Follow-up|23|||
160573513|NCT04168645|579821598|FG001|Overall Study|Lost to Follow-up|28|||
160573514|NCT04168645|579821599|FG002|Overall Study|Lost to Follow-up|15|||
160654069|NCT01957488|580114257|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
160654070|NCT01957488|580114252|FG000|Test Period 2 (2 Weeks)|Other|1|||
160654071|NCT01957488|580114253|FG001|Test Period 2 (2 Weeks)|Other|0|||
160654072|NCT01957488|580114254|FG002|Test Period 2 (2 Weeks)|Other|0|||
160654073|NCT01957488|580114255|FG003|Test Period 2 (2 Weeks)|Other|0|||
160654074|NCT01957488|580114256|FG004|Test Period 2 (2 Weeks)|Other|0|||
160654075|NCT01957488|580114257|FG005|Test Period 2 (2 Weeks)|Other|0|||
160654076|NCT01957488|580114252|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
160654077|NCT01957488|580114253|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
160573515|NCT04168645|579821600|FG003|Overall Study|Lost to Follow-up|12|||
160573516|NCT04168645|579821597|FG000|Overall Study|Death|1|||
160654078|NCT01957488|580114254|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
160654079|NCT01957488|580114255|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
160573517|NCT04168645|579821598|FG001|Overall Study|Death|1|||
160573518|NCT04168645|579821599|FG002|Overall Study|Death|0|||
160573519|NCT04168645|579821600|FG003|Overall Study|Death|0|||
160573520|NCT04168645|579821597|FG000|Overall Study|Withdrawal by Subject|5|||
160573521|NCT04168645|579821598|FG001|Overall Study|Withdrawal by Subject|2|||
160573522|NCT04168645|579821599|FG002|Overall Study|Withdrawal by Subject|2|||
160573523|NCT04168645|579821600|FG003|Overall Study|Withdrawal by Subject|2|||
160573524|NCT04168645|579821597|FG000|Overall Study|Administrative Withdrawal|3|||
160573525|NCT04168645|579821598|FG001|Overall Study|Administrative Withdrawal|1|||
160573526|NCT04168645|579821599|FG002|Overall Study|Administrative Withdrawal|1|||
160573527|NCT04168645|579821600|FG003|Overall Study|Administrative Withdrawal|3|||
160573528|NCT02400346|579821602|FG000|Overall Study|Adverse Event|24|||
160573529|NCT02400346|579821602|FG000|Overall Study|Lack of Efficacy|9|||
160573530|NCT02400346|579821602|FG000|Overall Study|Non-compliance with IMP|1|||
160654080|NCT01957488|580114256|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
160654081|NCT01957488|580114257|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
160654082|NCT01957488|580114252|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
160654083|NCT01957488|580114253|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
160654084|NCT01957488|580114254|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
160654085|NCT01957488|580114255|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
160654086|NCT01957488|580114256|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
160654087|NCT01957488|580114257|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
160654088|NCT01957488|580114252|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
160654089|NCT01957488|580114253|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
160654090|NCT01957488|580114254|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
160654091|NCT01957488|580114255|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
160654092|NCT01957488|580114256|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
160654093|NCT01957488|580114257|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
160918684|NCT06112756|581096055|FG000|Overall Study|Withdrawal by Subject|0|||
160918685|NCT06112756|581096056|FG001|Overall Study|Withdrawal by Subject|2|||
160573531|NCT02400346|579821602|FG000|Overall Study|Withdrawal by Subject|7|||
160573532|NCT02400346|579821602|FG000|Overall Study|Administrative or other reason(s)|2|||
160573533|NCT02400346|579821602|FG000|Overall Study|Lost to Follow-up|1|||
160573534|NCT01259492|579821608|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
160573535|NCT01259492|579821609|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
160573536|NCT01259492|579821610|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
160918686|NCT06112756|581096055|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
160918687|NCT06112756|581096056|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
160918688|NCT06112756|581096055|FG000|Overall Study|Adverse Event|2|||
160918689|NCT06112756|581096056|FG001|Overall Study|Adverse Event|2|||
160918690|NCT03060629|581096057|FG000|Overall Study|Death|4|||
160573537|NCT01259492|579821611|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
160918691|NCT03060629|581096058|FG001|Overall Study|Death|5|||
160918692|NCT03060629|581096057|FG000|Overall Study|Withdrawal by Subject|50|||
160918693|NCT03060629|581096058|FG001|Overall Study|Withdrawal by Subject|35|||
160918694|NCT03060629|581096057|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
160918695|NCT03060629|581096058|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
160918696|NCT03060629|581096057|FG000|Overall Study|Participant Relocate|15|||
160918697|NCT03060629|581096058|FG001|Overall Study|Participant Relocate|15|||
160918698|NCT03060629|581096057|FG000|Overall Study|Unable to Contact Participant|34|||
160918699|NCT03060629|581096058|FG001|Overall Study|Unable to Contact Participant|23|||
160918700|NCT03060629|581096057|FG000|Overall Study|Investigator Decision|7|||
160918701|NCT03060629|581096058|FG001|Overall Study|Investigator Decision|7|||
160918702|NCT03060629|581096057|FG000|Overall Study|Study Terminated by Sponsor|1100|||
160918703|NCT03060629|581096058|FG001|Overall Study|Study Terminated by Sponsor|1123|||
160918704|NCT03060629|581096057|FG000|Overall Study|Other|4|||
160918705|NCT03060629|581096058|FG001|Overall Study|Other|4|||
160918706|NCT01862874|581096059|FG000|Overall Study|Randomized not treated|1|||
160918707|NCT01862874|581096060|FG001|Overall Study|Randomized not treated|0|||
160918708|NCT01862874|581096059|FG000|Overall Study|Adverse Event|0|||
160918709|NCT01862874|581096060|FG001|Overall Study|Adverse Event|3|||
160918710|NCT01862874|581096059|FG000|Overall Study|Lost to Follow-up|26|||
160918711|NCT01862874|581096060|FG001|Overall Study|Lost to Follow-up|29|||
160918712|NCT01862874|581096059|FG000|Overall Study|Physician Decision|5|||
160918713|NCT01862874|581096060|FG001|Overall Study|Physician Decision|3|||
160918714|NCT01862874|581096059|FG000|Overall Study|Withdrawn by parent/guardian|1|||
160918715|NCT01862874|581096060|FG001|Overall Study|Withdrawn by parent/guardian|1|||
160918716|NCT01862874|581096059|FG000|Overall Study|Withdrawal by Subject|46|||
160918717|NCT01862874|581096060|FG001|Overall Study|Withdrawal by Subject|40|||
160918718|NCT01862874|581096059|FG000|Overall Study|Death|0|||
160918719|NCT01862874|581096060|FG001|Overall Study|Death|1|||
160918720|NCT03681405|581096061|FG000|Overall Study|Found to be ineligible after randomized|1|||
160918721|NCT03681405|581096062|FG001|Overall Study|Found to be ineligible after randomized|0|||
160918722|NCT02056340|581096064|FG000|Overall Study|Lost to Follow-up|5|||
160918723|NCT02056340|581096065|FG001|Overall Study|Lost to Follow-up|5|||
160918724|NCT02056340|581096064|FG000|Overall Study|Withdrawal by Subject|2|||
160918725|NCT02056340|581096065|FG001|Overall Study|Withdrawal by Subject|6|||
160918726|NCT04851314|581096070|FG000|Overall Study|Unable to complete research set-up procedures|0|||
160918727|NCT04851314|581096071|FG001|Overall Study|Unable to complete research set-up procedures|2|||
160918728|NCT04851314|581096070|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
160918729|NCT04851314|581096071|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
160918730|NCT00867009|581096072|FG000|Induction Period|Nonserious Adverse Event|5|||
160918731|NCT00867009|581096072|FG000|Induction Period|Serious Adverse Event|10|||
160918732|NCT00867009|581096072|FG000|Induction Period|Death due to serious adverse event|6|||
160918733|NCT00867009|581096072|FG000|Induction Period|Death due to Study Disease|4|||
160918734|NCT00867009|581096072|FG000|Induction Period|Protocol Violation|1|||
160918735|NCT00867009|581096072|FG000|Induction Period|Withdrawal by Subject|8|||
160918736|NCT00867009|581096072|FG000|Induction Period|Physician Decision|3|||
160918737|NCT00867009|581096072|FG000|Induction Period|Progressive Disease (PD)|25|||
160918738|NCT00867009|581096072|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
160918739|NCT03266094|581096075|FG000|Overall Study|Lost to Follow-up|1|||
160918740|NCT03266094|581096075|FG000|Overall Study|Withdrawal by Subject|1|||
160918741|NCT03171415|581096076|FG000|Overall Study|Lost to Follow-up|0|||
160918742|NCT03171415|581096077|FG001|Overall Study|Lost to Follow-up|0|||
160918743|NCT03171415|581096078|FG002|Overall Study|Lost to Follow-up|0|||
160918744|NCT03171415|581096079|FG003|Overall Study|Lost to Follow-up|0|||
160918745|NCT03171415|581096080|FG004|Overall Study|Lost to Follow-up|2|||
160918746|NCT04140292|581096081|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
160918747|NCT04140292|581096082|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
160918748|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
160573538|NCT01259492|579821608|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
160573539|NCT01259492|579821609|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
160573540|NCT01259492|579821610|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
160918749|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
160918750|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
160573541|NCT01259492|579821611|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
160573542|NCT01259492|579821608|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
160573543|NCT01259492|579821609|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
160573544|NCT01259492|579821610|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
160573545|NCT01259492|579821611|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
160918751|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
160918752|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
160918753|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
160918754|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
160918755|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
160918756|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
160918757|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
160918758|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
160918759|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
160918760|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
160918761|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
160918762|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
160918763|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
160918764|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
160918765|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
160918766|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
160918767|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
160918768|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
160918769|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
160918770|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
160454647|NCT01928394|579396176|FG006|Treatment Period|AE unrelated to study drug|1|||
160454648|NCT01928394|579396177|FG007|Treatment Period|AE unrelated to study drug|0|||
160454649|NCT01928394|579396178|FG008|Treatment Period|AE unrelated to study drug|0|||
160918771|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
160918772|NCT03036072|581096088|FG000|Overall Study|Death|0|||
160918773|NCT03036072|581096089|FG001|Overall Study|Death|1|||
160918774|NCT03036072|581096088|FG000|Overall Study|Withdrawal by Subject|0|||
160918775|NCT03036072|581096089|FG001|Overall Study|Withdrawal by Subject|1|||
160918776|NCT03036072|581096088|FG000|Overall Study|Physician Decision|0|||
160918777|NCT03036072|581096089|FG001|Overall Study|Physician Decision|1|||
160918778|NCT00680043|581096090|FG000|Overall Study|Withdrawal by Subject|1|||
160918779|NCT00680043|581096091|FG001|Overall Study|Withdrawal by Subject|0|||
160918780|NCT00680043|581096092|FG002|Overall Study|Withdrawal by Subject|0|||
160918781|NCT00680043|581096090|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
160918782|NCT00680043|581096091|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
160918783|NCT00680043|581096092|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
160918784|NCT00680043|581096090|FG000|Overall Study|Renal Transplant|1|||
160918785|NCT00680043|581096091|FG001|Overall Study|Renal Transplant|0|||
160918786|NCT00680043|581096092|FG002|Overall Study|Renal Transplant|4|||
160918787|NCT02484729|581096093|FG000|Overall Study|Failure of IntelliCap Error|0|||
160918788|NCT02484729|581096094|FG001|Overall Study|Failure of IntelliCap Error|0|||
160918789|NCT02484729|581096095|FG002|Overall Study|Failure of IntelliCap Error|0|||
160918790|NCT02484729|581096096|FG003|Overall Study|Failure of IntelliCap Error|0|||
160918791|NCT02484729|581096097|FG004|Overall Study|Failure of IntelliCap Error|0|||
160918792|NCT02484729|581096098|FG005|Overall Study|Failure of IntelliCap Error|0|||
160918793|NCT02484729|581096099|FG006|Overall Study|Failure of IntelliCap Error|0|||
160918794|NCT02484729|581096100|FG007|Overall Study|Failure of IntelliCap Error|0|||
160918795|NCT02484729|581096101|FG008|Overall Study|Failure of IntelliCap Error|0|||
160454650|NCT01928394|579396179|FG009|Treatment Period|AE unrelated to study drug|2|||
160918796|NCT02484729|581096102|FG009|Overall Study|Failure of IntelliCap Error|1|||
160918797|NCT00670800|581097915|FG000|Overall Study|2 controls were insulin resistant|0|||
160918798|NCT00670800|581097916|FG001|Overall Study|2 controls were insulin resistant|2|||
160918799|NCT00587561|581097917|FG000|Overall Study|Lost to Follow-up|6|||
160918800|NCT00587561|581097918|FG001|Overall Study|Lost to Follow-up|4|||
160918801|NCT05661942|581097919|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
160918802|NCT05661942|581097920|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
160918803|NCT02081690|581097932|FG000|Overall Study|Death|3|||
160918804|NCT02081690|581097932|FG000|Overall Study|Physician Decision|3|||
160918805|NCT02081690|581097932|FG000|Overall Study|Withdrawal by Subject|1|||
160918806|NCT00982488|581097934|FG000|Overall Study|Administrative reason by sponsor|81|||
160918807|NCT00982488|581097935|FG001|Overall Study|Administrative reason by sponsor|3|||
160918808|NCT00982488|581097936|FG002|Overall Study|Administrative reason by sponsor|11|||
160918809|NCT00982488|581097937|FG003|Overall Study|Administrative reason by sponsor|0|||
160918810|NCT00982488|581097938|FG004|Overall Study|Administrative reason by sponsor|0|||
160918811|NCT00982488|581097934|FG000|Overall Study|Adverse event unrelated to study drug|5|||
160918812|NCT00982488|581097935|FG001|Overall Study|Adverse event unrelated to study drug|1|||
160918813|NCT00982488|581097936|FG002|Overall Study|Adverse event unrelated to study drug|0|||
160918814|NCT00982488|581097937|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160918815|NCT00982488|581097938|FG004|Overall Study|Adverse event unrelated to study drug|0|||
160918816|NCT00982488|581097934|FG000|Overall Study|Death|11|||
160918817|NCT00982488|581097935|FG001|Overall Study|Death|0|||
160918818|NCT00982488|581097936|FG002|Overall Study|Death|2|||
160918819|NCT00982488|581097937|FG003|Overall Study|Death|0|||
160918820|NCT00982488|581097938|FG004|Overall Study|Death|0|||
160918821|NCT00982488|581097934|FG000|Overall Study|Disease progression|30|||
160918822|NCT00982488|581097935|FG001|Overall Study|Disease progression|5|||
160573546|NCT01259492|579821608|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
160573547|NCT01259492|579821609|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
160573548|NCT01259492|579821610|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
160573549|NCT01259492|579821611|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
160573550|NCT01259492|579821608|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
160573551|NCT01259492|579821609|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
160573552|NCT01259492|579821610|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
160918823|NCT00982488|581097936|FG002|Overall Study|Disease progression|10|||
160918824|NCT00982488|581097937|FG003|Overall Study|Disease progression|1|||
160918825|NCT00982488|581097938|FG004|Overall Study|Disease progression|1|||
160918826|NCT00982488|581097934|FG000|Overall Study|Lost to Follow-up|1|||
160918827|NCT00982488|581097935|FG001|Overall Study|Lost to Follow-up|0|||
160918828|NCT00982488|581097936|FG002|Overall Study|Lost to Follow-up|0|||
160918829|NCT00982488|581097937|FG003|Overall Study|Lost to Follow-up|0|||
160918830|NCT00982488|581097938|FG004|Overall Study|Lost to Follow-up|0|||
160918831|NCT00982488|581097934|FG000|Overall Study|Maximum clinical benefit|1|||
160918832|NCT00982488|581097935|FG001|Overall Study|Maximum clinical benefit|1|||
160918833|NCT00982488|581097936|FG002|Overall Study|Maximum clinical benefit|1|||
160918834|NCT00982488|581097937|FG003|Overall Study|Maximum clinical benefit|0|||
160918835|NCT00982488|581097938|FG004|Overall Study|Maximum clinical benefit|0|||
160918836|NCT00982488|581097934|FG000|Overall Study|Other|15|||
160918837|NCT00982488|581097935|FG001|Overall Study|Other|1|||
160918838|NCT00982488|581097936|FG002|Overall Study|Other|3|||
160918839|NCT00982488|581097937|FG003|Overall Study|Other|1|||
160918840|NCT00982488|581097938|FG004|Overall Study|Other|0|||
160918841|NCT00982488|581097934|FG000|Overall Study|Poor compliance/noncompliance|0|||
160918842|NCT00982488|581097935|FG001|Overall Study|Poor compliance/noncompliance|1|||
160918843|NCT00982488|581097936|FG002|Overall Study|Poor compliance/noncompliance|0|||
160918844|NCT00982488|581097937|FG003|Overall Study|Poor compliance/noncompliance|0|||
160918845|NCT00982488|581097938|FG004|Overall Study|Poor compliance/noncompliance|0|||
160918846|NCT00982488|581097934|FG000|Overall Study|Stem cell transplant|2|||
160918847|NCT00982488|581097935|FG001|Overall Study|Stem cell transplant|0|||
160918848|NCT00982488|581097936|FG002|Overall Study|Stem cell transplant|0|||
160918849|NCT00982488|581097937|FG003|Overall Study|Stem cell transplant|1|||
160918850|NCT00982488|581097938|FG004|Overall Study|Stem cell transplant|0|||
160918851|NCT00982488|581097934|FG000|Overall Study|Study drug toxicity|34|||
160918852|NCT00982488|581097935|FG001|Overall Study|Study drug toxicity|1|||
160918853|NCT00982488|581097936|FG002|Overall Study|Study drug toxicity|6|||
160918854|NCT00982488|581097937|FG003|Overall Study|Study drug toxicity|0|||
160918855|NCT00982488|581097938|FG004|Overall Study|Study drug toxicity|0|||
160918856|NCT00982488|581097934|FG000|Overall Study|Withdrawal by Subject|5|||
160918857|NCT00982488|581097935|FG001|Overall Study|Withdrawal by Subject|1|||
160918858|NCT00982488|581097936|FG002|Overall Study|Withdrawal by Subject|1|||
160918859|NCT00982488|581097937|FG003|Overall Study|Withdrawal by Subject|0|||
160918860|NCT00982488|581097938|FG004|Overall Study|Withdrawal by Subject|0|||
160918861|NCT03204981|581097939|FG000|Overall Study|Physician Decision|2|||
160918862|NCT03204981|581097939|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
160918863|NCT04203238|581097940|FG000|Overall Study|Withdrawal by Subject|1|||
160918864|NCT04203238|581097941|FG001|Overall Study|Withdrawal by Subject|1|||
160918865|NCT04203238|581097940|FG000|Overall Study|Covid-19|3|||
160918866|NCT04203238|581097941|FG001|Overall Study|Covid-19|0|||
160918867|NCT04244786|581097944|FG000|Overall Study|Adverse Event|0|||
160918868|NCT04244786|581097945|FG001|Overall Study|Adverse Event|0|||
160918869|NCT04244786|581097946|FG002|Overall Study|Adverse Event|2|||
160918870|NCT04244786|581097944|FG000|Overall Study|Withdrawal by Subject|0|||
160918871|NCT04244786|581097945|FG001|Overall Study|Withdrawal by Subject|0|||
160573553|NCT01259492|579821611|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
160573554|NCT01259492|579821608|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
160573555|NCT01259492|579821609|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
160573556|NCT01259492|579821610|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
160918872|NCT04244786|581097946|FG002|Overall Study|Withdrawal by Subject|5|||
160918873|NCT00001596|581097947|FG000|Overall Study|Death|1|||
160918874|NCT00001596|581097948|FG001|Overall Study|Death|0|||
160918875|NCT00001596|581097947|FG000|Overall Study|Withdrawal by Subject|3|||
160997173|NCT01090024|581374857|FG000|Period 3|Protocol Violation|0|||
160997174|NCT01090024|581374858|FG001|Period 3|Protocol Violation|0|||
160918876|NCT00001596|581097948|FG001|Overall Study|Withdrawal by Subject|1|||
160918877|NCT00001596|581097947|FG000|Overall Study|Study Termination|12|||
160918878|NCT00001596|581097948|FG001|Overall Study|Study Termination|9|||
160918879|NCT00001596|581097947|FG000|Overall Study|Adverse Event|1|||
160918880|NCT00001596|581097948|FG001|Overall Study|Adverse Event|0|||
160918881|NCT03274687|581097949|FG000|Overall Study|Protocol Violation|1|||
160573557|NCT01259492|579821611|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
160918882|NCT03274687|581097950|FG001|Overall Study|Protocol Violation|1|||
160918883|NCT01572909|581097953|FG000|Overall Study|Adverse Event|7|||
160918884|NCT01572909|581097954|FG001|Overall Study|Adverse Event|2|||
160918885|NCT01572909|581097953|FG000|Overall Study|Death|3|||
160997175|NCT01090024|581374859|FG002|Period 3|Protocol Violation|0|||
160918886|NCT01572909|581097954|FG001|Overall Study|Death|1|||
160918887|NCT01572909|581097953|FG000|Overall Study|Lost to Follow-up|8|||
160918888|NCT01572909|581097954|FG001|Overall Study|Lost to Follow-up|7|||
160918889|NCT01572909|581097953|FG000|Overall Study|Physician Decision|1|||
160918890|NCT01572909|581097954|FG001|Overall Study|Physician Decision|1|||
160918891|NCT01572909|581097953|FG000|Overall Study|Technical Issues|1|||
160573558|NCT01259492|579821608|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
160573559|NCT01259492|579821609|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
160573560|NCT01259492|579821610|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
160573561|NCT01259492|579821611|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
160573562|NCT01259492|579821608|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
160573563|NCT01259492|579821609|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
160573564|NCT01259492|579821610|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
160573565|NCT01259492|579821611|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
160573566|NCT01259492|579821608|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
160573567|NCT01259492|579821609|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
160573568|NCT01259492|579821610|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
160573569|NCT01259492|579821611|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
160573570|NCT01259492|579821608|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
160573571|NCT01259492|579821609|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
160573572|NCT01259492|579821610|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
160573573|NCT01259492|579821611|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
160573574|NCT01259492|579821608|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
160573575|NCT01259492|579821609|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
160573576|NCT01259492|579821610|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
160573577|NCT01259492|579821611|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
160573578|NCT01259492|579821608|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
160573579|NCT01259492|579821609|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
160573580|NCT01259492|579821610|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
160573581|NCT01259492|579821611|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
160573582|NCT01259492|579821608|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
160573583|NCT01259492|579821609|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
160573584|NCT01259492|579821610|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
160573585|NCT01259492|579821611|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
160573586|NCT01259492|579821608|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
160573587|NCT01259492|579821609|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
160573588|NCT01259492|579821610|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
160573589|NCT01259492|579821611|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
160573590|NCT01259492|579821608|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
160573591|NCT01259492|579821609|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
160654094|NCT01957488|580114252|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
160654095|NCT01957488|580114253|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
160918892|NCT01572909|581097954|FG001|Overall Study|Technical Issues|0|||
160918893|NCT01572909|581097953|FG000|Overall Study|Withdrawal by Subject|12|||
160918894|NCT01572909|581097954|FG001|Overall Study|Withdrawal by Subject|11|||
160918895|NCT01572909|581097953|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
160918896|NCT01572909|581097954|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
160918897|NCT01199289|581097955|FG000|Overall Study|Ineligibility determined|2|||
160918898|NCT01199289|581097956|FG001|Overall Study|Ineligibility determined|1|||
160918899|NCT01199289|581097957|FG002|Overall Study|Ineligibility determined|0|||
160918900|NCT01199289|581097958|FG003|Overall Study|Ineligibility determined|0|||
160918901|NCT01199289|581097955|FG000|Overall Study|Protocol Violation|1|||
160918902|NCT01199289|581097956|FG001|Overall Study|Protocol Violation|0|||
160918903|NCT01199289|581097957|FG002|Overall Study|Protocol Violation|0|||
160918904|NCT01199289|581097958|FG003|Overall Study|Protocol Violation|1|||
160918905|NCT01199289|581097955|FG000|Overall Study|Noncompliance|1|||
160918906|NCT01199289|581097956|FG001|Overall Study|Noncompliance|0|||
160918907|NCT01199289|581097957|FG002|Overall Study|Noncompliance|2|||
160918908|NCT01199289|581097958|FG003|Overall Study|Noncompliance|0|||
160918909|NCT01199289|581097955|FG000|Overall Study|Adverse Event|0|||
160918910|NCT01199289|581097956|FG001|Overall Study|Adverse Event|3|||
160654096|NCT01957488|580114254|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
160654097|NCT01957488|580114255|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
160918911|NCT01199289|581097957|FG002|Overall Study|Adverse Event|1|||
160918912|NCT01199289|581097958|FG003|Overall Study|Adverse Event|4|||
160654098|NCT01957488|580114256|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
160918913|NCT01199289|581097955|FG000|Overall Study|Full consent withdrawn|2|||
160918914|NCT01199289|581097956|FG001|Overall Study|Full consent withdrawn|2|||
160918915|NCT01199289|581097957|FG002|Overall Study|Full consent withdrawn|2|||
160918916|NCT01199289|581097958|FG003|Overall Study|Full consent withdrawn|3|||
160918917|NCT01199289|581097955|FG000|Overall Study|Administrative decision|0|||
160918918|NCT01199289|581097956|FG001|Overall Study|Administrative decision|0|||
160918919|NCT01199289|581097957|FG002|Overall Study|Administrative decision|0|||
160918920|NCT01199289|581097958|FG003|Overall Study|Administrative decision|1|||
160918921|NCT01199289|581097955|FG000|Overall Study|Lost to Follow-up|0|||
160918922|NCT01199289|581097956|FG001|Overall Study|Lost to Follow-up|0|||
160918923|NCT01199289|581097957|FG002|Overall Study|Lost to Follow-up|0|||
160918924|NCT01199289|581097958|FG003|Overall Study|Lost to Follow-up|1|||
160918925|NCT01199289|581097955|FG000|Overall Study|Protocol-specified criteria|3|||
160918926|NCT01199289|581097956|FG001|Overall Study|Protocol-specified criteria|0|||
160918927|NCT01199289|581097957|FG002|Overall Study|Protocol-specified criteria|0|||
160918928|NCT01199289|581097958|FG003|Overall Study|Protocol-specified criteria|1|||
160918929|NCT01199289|581097955|FG000|Overall Study|Pregnancy|0|||
160918930|NCT01199289|581097956|FG001|Overall Study|Pregnancy|1|||
160918931|NCT01199289|581097957|FG002|Overall Study|Pregnancy|0|||
160918932|NCT01199289|581097958|FG003|Overall Study|Pregnancy|1|||
160918933|NCT02636868|581097959|FG000|Overall Study|Death|0|||
160918934|NCT02636868|581097960|FG001|Overall Study|Death|1|||
160918935|NCT02636868|581097961|FG002|Overall Study|Death|2|||
160918936|NCT00415909|581097962|FG000|Overall Study|Withdrawal by Subject|2|||
160918937|NCT00415909|581097962|FG000|Overall Study|Death|1|||
160573592|NCT01259492|579821610|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
160573593|NCT01259492|579821611|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
160573594|NCT01259492|579821608|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
160573595|NCT01259492|579821609|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
160573596|NCT01259492|579821610|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
160573597|NCT01259492|579821611|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
160573598|NCT01259492|579821608|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
160573599|NCT01259492|579821609|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
160573600|NCT01259492|579821610|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
160573601|NCT01259492|579821611|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
160573602|NCT01259492|579821608|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
160573603|NCT01259492|579821609|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
160573604|NCT01259492|579821610|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
160573605|NCT01259492|579821611|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
160573606|NCT01259492|579821608|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
160573607|NCT01259492|579821609|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
160573608|NCT01259492|579821610|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
160573609|NCT01259492|579821611|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
160573610|NCT01259492|579821608|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
160573611|NCT01259492|579821609|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
160573612|NCT01259492|579821610|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
160573613|NCT01259492|579821611|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
160573614|NCT01981122|579821616|FG000|Overall Study|Withdrawal by Subject|0|||
160573615|NCT01981122|579821617|FG001|Overall Study|Withdrawal by Subject|2|||
160573616|NCT01981122|579821616|FG000|Overall Study|Protocol Violation|0|||
160573617|NCT01981122|579821617|FG001|Overall Study|Protocol Violation|1|||
160573618|NCT01981122|579821616|FG000|Overall Study|Lost to Follow-up|0|||
160573619|NCT01981122|579821617|FG001|Overall Study|Lost to Follow-up|1|||
160573620|NCT01981122|579821616|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
160573621|NCT01981122|579821617|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
160573622|NCT01981122|579821616|FG000|Overall Study|Death|14|||
160573623|NCT01981122|579821617|FG001|Overall Study|Death|15|||
160573624|NCT03846947|579821618|FG000|Overall Study|technical issues with imaging sequence|2|||
160573625|NCT00537823|579821625|FG000|Overall Study|Adverse Event|2|||
160573626|NCT00537823|579821626|FG001|Overall Study|Adverse Event|0|||
160573627|NCT02926573|579821628|FG000|Overall Study|Nausea|1|||
160654099|NCT01957488|580114257|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
160918938|NCT05024058|581097963|FG000|Treatment|Study terminated by sponsor|5|||
160918939|NCT05024058|581097964|FG001|Treatment|Study terminated by sponsor|6|||
160918940|NCT05024058|581097965|FG002|Treatment|Study terminated by sponsor|4|||
160918941|NCT05024058|581097966|FG003|Treatment|Study terminated by sponsor|2|||
160918942|NCT05024058|581097967|FG004|Treatment|Study terminated by sponsor|3|||
160918943|NCT05024058|581097968|FG005|Treatment|Study terminated by sponsor|3|||
160918944|NCT05024058|581097969|FG006|Treatment|Study terminated by sponsor|1|||
160918945|NCT05024058|581097970|FG007|Treatment|Study terminated by sponsor|3|||
160918946|NCT05024058|581097971|FG008|Treatment|Study terminated by sponsor|6|||
160573628|NCT02926573|579821629|FG001|Overall Study|Nausea|0|||
160573629|NCT02926573|579821628|FG000|Overall Study|Remain intubated|2|||
160573630|NCT02926573|579821629|FG001|Overall Study|Remain intubated|2|||
160573631|NCT02926573|579821628|FG000|Overall Study|Change in surgery plan|3|||
160918947|NCT05024058|581097972|FG009|Treatment|Study terminated by sponsor|6|||
160918948|NCT05024058|581097963|FG000|Follow-up|Withdrawal by Subject|1|||
160918949|NCT05024058|581097964|FG001|Follow-up|Withdrawal by Subject|0|||
160918950|NCT05024058|581097965|FG002|Follow-up|Withdrawal by Subject|1|||
160918951|NCT05024058|581097966|FG003|Follow-up|Withdrawal by Subject|0|||
160918952|NCT05024058|581097967|FG004|Follow-up|Withdrawal by Subject|0|||
160918953|NCT05024058|581097968|FG005|Follow-up|Withdrawal by Subject|0|||
160918954|NCT05024058|581097969|FG006|Follow-up|Withdrawal by Subject|0|||
160573632|NCT02926573|579821629|FG001|Overall Study|Change in surgery plan|1|||
160573633|NCT02926573|579821628|FG000|Overall Study|Change to outpatient status|5|||
160573634|NCT02926573|579821629|FG001|Overall Study|Change to outpatient status|1|||
160573635|NCT02926573|579821628|FG000|Overall Study|Withdrawal by Subject|0|||
160573636|NCT02926573|579821629|FG001|Overall Study|Withdrawal by Subject|2|||
160573637|NCT02926573|579821628|FG000|Overall Study|Return to operating room|0|||
160573638|NCT02926573|579821629|FG001|Overall Study|Return to operating room|2|||
160573639|NCT02926573|579821628|FG000|Overall Study|Delirium|0|||
160573640|NCT02926573|579821629|FG001|Overall Study|Delirium|1|||
160573641|NCT00611455|579821632|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
160573642|NCT00611455|579821633|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
160573643|NCT00611455|579821634|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160573644|NCT00611455|579821632|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
160573645|NCT00611455|579821633|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
160573646|NCT00611455|579821634|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
160573647|NCT00611455|579821632|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
160573648|NCT00611455|579821633|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
160573649|NCT00611455|579821634|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
160573650|NCT00611455|579821632|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
160573651|NCT00611455|579821633|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
160573652|NCT00611455|579821634|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160573653|NCT00611455|579821632|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
160573654|NCT00611455|579821633|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
160573655|NCT00611455|579821634|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
160573656|NCT00611455|579821632|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
160573657|NCT00611455|579821633|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
160573658|NCT00611455|579821634|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
160573659|NCT00611455|579821632|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
160573660|NCT00611455|579821633|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
160573661|NCT00611455|579821634|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
160573662|NCT00611455|579821632|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
160573663|NCT00611455|579821633|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
160573664|NCT00611455|579821634|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
160573665|NCT00611455|579821632|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
160573666|NCT00611455|579821633|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
160573667|NCT00611455|579821634|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
160573668|NCT00611455|579821632|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
160573669|NCT00611455|579821633|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
160573670|NCT00611455|579821634|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
160573671|NCT00611455|579821632|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
160573672|NCT00611455|579821633|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
160573673|NCT00611455|579821634|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
160573674|NCT00611455|579821632|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
160573675|NCT00611455|579821633|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
160573676|NCT00611455|579821634|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
160573677|NCT00611455|579821632|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
160573678|NCT00611455|579821633|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
160573679|NCT00611455|579821634|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
160573680|NCT00611455|579821632|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
160573681|NCT00611455|579821633|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
160573682|NCT00611455|579821634|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
160573683|NCT00611455|579821632|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
160573684|NCT00611455|579821633|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
160573685|NCT00611455|579821634|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
160573686|NCT00611455|579821632|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
160573687|NCT00611455|579821633|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
160573688|NCT00611455|579821634|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
160573689|NCT00611455|579821632|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
160573690|NCT00611455|579821633|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
160573691|NCT00611455|579821634|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
160573692|NCT00611455|579821632|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
160654100|NCT01957488|580114252|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
160918955|NCT05024058|581097970|FG007|Follow-up|Withdrawal by Subject|1|||
160918956|NCT05024058|581097971|FG008|Follow-up|Withdrawal by Subject|0|||
160918957|NCT05024058|581097972|FG009|Follow-up|Withdrawal by Subject|1|||
160918958|NCT00903617|581097977|FG000|Overall Study|Adverse Event|0|||
160918959|NCT00903617|581097978|FG001|Overall Study|Adverse Event|1|||
160918960|NCT00903617|581097979|FG002|Overall Study|Adverse Event|1|||
160918961|NCT00903617|581097980|FG003|Overall Study|Adverse Event|0|||
160918962|NCT00903617|581097977|FG000|Overall Study|Protocol-defined stopping criteria|0|||
160918963|NCT00903617|581097978|FG001|Overall Study|Protocol-defined stopping criteria|2|||
160918964|NCT00903617|581097979|FG002|Overall Study|Protocol-defined stopping criteria|0|||
160918965|NCT00903617|581097980|FG003|Overall Study|Protocol-defined stopping criteria|0|||
160918966|NCT00903617|581097977|FG000|Overall Study|Lost to Follow-up|2|||
160918967|NCT00903617|581097978|FG001|Overall Study|Lost to Follow-up|0|||
160918968|NCT00903617|581097979|FG002|Overall Study|Lost to Follow-up|1|||
160918969|NCT00903617|581097980|FG003|Overall Study|Lost to Follow-up|1|||
160918970|NCT00903617|581097977|FG000|Overall Study|Withdrawal by Subject|1|||
160918971|NCT00903617|581097978|FG001|Overall Study|Withdrawal by Subject|2|||
160918972|NCT00903617|581097979|FG002|Overall Study|Withdrawal by Subject|3|||
160918973|NCT00903617|581097980|FG003|Overall Study|Withdrawal by Subject|0|||
160918974|NCT01104636|581097981|FG000|Overall Study|Lack of Efficacy|43|||
160918975|NCT01104636|581097981|FG000|Overall Study|Lost to Follow-up|24|||
160918976|NCT01104636|581097981|FG000|Overall Study|Withdrawal by Subject|4|||
160918977|NCT01104636|581097981|FG000|Overall Study|Other|43|||
160918978|NCT01104636|581097981|FG000|Overall Study|Study terminated by sponsor|1|||
160918979|NCT01104636|581097981|FG000|Overall Study|Pregnancy|2|||
160918980|NCT01104636|581097981|FG000|Overall Study|Adverse Event|40|||
160918981|NCT01104636|581097981|FG000|Overall Study|Ongoing|21|||
160918982|NCT01706003|581097982|FG000|Overall Study|Withdrawal by Subject|2|||
160918983|NCT01706003|581097983|FG001|Overall Study|Withdrawal by Subject|0|||
160918984|NCT01706003|581097982|FG000|Overall Study|Not scheduled|3|||
160918985|NCT01706003|581097983|FG001|Overall Study|Not scheduled|0|||
160918986|NCT01706003|581097982|FG000|Overall Study|Lost to Follow-up|6|||
160918987|NCT01706003|581097983|FG001|Overall Study|Lost to Follow-up|4|||
160918988|NCT03316131|581097984|FG000|Treatment Period 2|Protocol deviation|1|||
160918989|NCT03316131|581097985|FG001|Treatment Period 2|Protocol deviation|0|||
160918990|NCT05608005|581097987|FG000|Overall Study|Adverse Event|2|||
160918991|NCT05608005|581097988|FG001|Overall Study|Adverse Event|1|||
160918992|NCT05608005|581097989|FG002|Overall Study|Adverse Event|3|||
160918993|NCT05608005|581097987|FG000|Overall Study|Protocol Violation|2|||
160918994|NCT05608005|581097988|FG001|Overall Study|Protocol Violation|3|||
160918995|NCT05608005|581097989|FG002|Overall Study|Protocol Violation|0|||
160918996|NCT05608005|581097987|FG000|Overall Study|Withdrawal by Subject|10|||
160918997|NCT05608005|581097988|FG001|Overall Study|Withdrawal by Subject|12|||
160918998|NCT05608005|581097989|FG002|Overall Study|Withdrawal by Subject|4|||
160918999|NCT05608005|581097987|FG000|Overall Study|Lost to Follow-up|25|||
160919000|NCT05608005|581097988|FG001|Overall Study|Lost to Follow-up|27|||
160919001|NCT05608005|581097989|FG002|Overall Study|Lost to Follow-up|15|||
160919002|NCT05608005|581097987|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
160919003|NCT05608005|581097988|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
160919004|NCT05608005|581097989|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
160919005|NCT03518073|581097990|FG000|Overall Study|Adverse Event|2|||
160919006|NCT03518073|581097991|FG001|Overall Study|Adverse Event|4|||
160919007|NCT03518073|581097992|FG002|Overall Study|Adverse Event|2|||
160919008|NCT03518073|581097990|FG000|Overall Study|Death|2|||
160919009|NCT03518073|581097991|FG001|Overall Study|Death|1|||
160919010|NCT03518073|581097992|FG002|Overall Study|Death|3|||
160919011|NCT03518073|581097990|FG000|Overall Study|Lost to Follow-up|1|||
160919012|NCT03518073|581097991|FG001|Overall Study|Lost to Follow-up|0|||
160919013|NCT03518073|581097992|FG002|Overall Study|Lost to Follow-up|1|||
160919014|NCT03518073|581097990|FG000|Overall Study|Physician Decision|5|||
160919015|NCT03518073|581097991|FG001|Overall Study|Physician Decision|0|||
160919016|NCT03518073|581097992|FG002|Overall Study|Physician Decision|2|||
160919017|NCT03518073|581097990|FG000|Overall Study|Progressive disease|1|||
160919018|NCT03518073|581097991|FG001|Overall Study|Progressive disease|1|||
160919019|NCT03518073|581097992|FG002|Overall Study|Progressive disease|1|||
160919020|NCT03518073|581097990|FG000|Overall Study|Protocol Violation|1|||
160919021|NCT03518073|581097991|FG001|Overall Study|Protocol Violation|0|||
160919022|NCT03518073|581097992|FG002|Overall Study|Protocol Violation|0|||
160919023|NCT03518073|581097990|FG000|Overall Study|Withdrawal by Subject|30|||
160919024|NCT03518073|581097991|FG001|Overall Study|Withdrawal by Subject|34|||
160919025|NCT03518073|581097992|FG002|Overall Study|Withdrawal by Subject|29|||
160919026|NCT03518073|581097990|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
160919027|NCT03518073|581097991|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
160919028|NCT03518073|581097992|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
160919029|NCT03518073|581097990|FG000|Overall Study|Covid-19|1|||
160919030|NCT03518073|581097991|FG001|Overall Study|Covid-19|2|||
160919031|NCT03518073|581097992|FG002|Overall Study|Covid-19|1|||
160919032|NCT03045081|581097993|FG000|Overall Study|Withdrawal by Subject|6|||
160919033|NCT03045081|581097994|FG001|Overall Study|Withdrawal by Subject|11|||
160573693|NCT00611455|579821633|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
160919034|NCT03804879|581097995|FG000|Overall Study|Adverse Event|3|||
160919035|NCT03804879|581097996|FG001|Overall Study|Adverse Event|0|||
160919036|NCT03804879|581097995|FG000|Overall Study|Study Terminated By Sponsor|10|||
160919037|NCT03804879|581097996|FG001|Overall Study|Study Terminated By Sponsor|12|||
160919038|NCT03804879|581097995|FG000|Overall Study|Withdrawal by Subject|3|||
160919039|NCT03804879|581097996|FG001|Overall Study|Withdrawal by Subject|1|||
160919040|NCT01034462|581097997|FG000|Overall Study|Adverse Event|7|||
160919041|NCT01034462|581097998|FG001|Overall Study|Adverse Event|17|||
160919042|NCT01034462|581097997|FG000|Overall Study|Lack of Efficacy|4|||
160919043|NCT01034462|581097998|FG001|Overall Study|Lack of Efficacy|4|||
160919044|NCT01034462|581097997|FG000|Overall Study|Protocol Violation|10|||
160919045|NCT01034462|581097998|FG001|Overall Study|Protocol Violation|7|||
160919046|NCT01034462|581097997|FG000|Overall Study|Withdrawal by Subject|9|||
160919047|NCT01034462|581097998|FG001|Overall Study|Withdrawal by Subject|8|||
160919048|NCT01034462|581097997|FG000|Overall Study|Lost to Follow-up|14|||
160919049|NCT01034462|581097998|FG001|Overall Study|Lost to Follow-up|16|||
160919050|NCT01034462|581097997|FG000|Overall Study|Other reasons|1|||
160919051|NCT01034462|581097998|FG001|Overall Study|Other reasons|2|||
160919052|NCT03635957|581097999|FG000|Run-In Period|Lost to Follow-up|1|||
160919053|NCT03635957|581097999|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
160919054|NCT01525550|581098001|FG000|Overall Study|Lost to Follow-up|8|||
160919055|NCT01525550|581098002|FG001|Overall Study|Lost to Follow-up|2|||
160919056|NCT01525550|581098001|FG000|Overall Study|Death|19|||
160919057|NCT01525550|581098002|FG001|Overall Study|Death|28|||
160919058|NCT01525550|581098001|FG000|Overall Study|Other|0|||
160919059|NCT01525550|581098002|FG001|Overall Study|Other|4|||
160919060|NCT01525550|581098001|FG000|Overall Study|Sponsor's Decision|30|||
160919061|NCT01525550|581098002|FG001|Overall Study|Sponsor's Decision|11|||
160919062|NCT01525550|581098001|FG000|Overall Study|Withdrawal by Subject|4|||
160919063|NCT01525550|581098002|FG001|Overall Study|Withdrawal by Subject|0|||
160919064|NCT00174915|581098005|FG000|Overall Study|Lost to Follow-up|19|||
160919065|NCT00174915|581098006|FG001|Overall Study|Lost to Follow-up|17|||
160919066|NCT00174915|581098007|FG002|Overall Study|Lost to Follow-up|9|||
160919067|NCT00174915|581098008|FG003|Overall Study|Lost to Follow-up|17|||
160919068|NCT00174915|581098009|FG004|Overall Study|Lost to Follow-up|10|||
160919069|NCT00174915|581098005|FG000|Overall Study|Adverse Event|18|||
160919070|NCT00174915|581098006|FG001|Overall Study|Adverse Event|16|||
160919071|NCT00174915|581098007|FG002|Overall Study|Adverse Event|11|||
160919072|NCT00174915|581098008|FG003|Overall Study|Adverse Event|18|||
160919073|NCT00174915|581098009|FG004|Overall Study|Adverse Event|5|||
160919074|NCT00174915|581098005|FG000|Overall Study|Personal Reason(s)|16|||
160919075|NCT00174915|581098006|FG001|Overall Study|Personal Reason(s)|16|||
160919076|NCT00174915|581098007|FG002|Overall Study|Personal Reason(s)|9|||
160919077|NCT00174915|581098008|FG003|Overall Study|Personal Reason(s)|9|||
160919078|NCT00174915|581098009|FG004|Overall Study|Personal Reason(s)|9|||
160919079|NCT00174915|581098005|FG000|Overall Study|Other|15|||
160919080|NCT00174915|581098006|FG001|Overall Study|Other|8|||
160919081|NCT00174915|581098007|FG002|Overall Study|Other|6|||
160919082|NCT00174915|581098008|FG003|Overall Study|Other|5|||
160919083|NCT00174915|581098009|FG004|Overall Study|Other|3|||
160919084|NCT00174915|581098005|FG000|Overall Study|Gout Flare|13|||
160919085|NCT00174915|581098006|FG001|Overall Study|Gout Flare|6|||
160919086|NCT00174915|581098007|FG002|Overall Study|Gout Flare|8|||
160997176|NCT01090024|581374860|FG003|Period 3|Protocol Violation|0|||
160997177|NCT01090024|581374861|FG004|Period 3|Protocol Violation|0|||
160997178|NCT01090024|581374862|FG005|Period 3|Protocol Violation|0|||
160573694|NCT00611455|579821634|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
160573695|NCT00611455|579821632|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
160997179|NCT01090024|581374863|FG006|Period 3|Protocol Violation|0|||
160997180|NCT01090024|581374864|FG007|Period 3|Protocol Violation|0|||
160997181|NCT01090024|581374865|FG008|Period 3|Protocol Violation|1|||
160997182|NCT01090024|581374866|FG009|Period 3|Protocol Violation|0|||
160997183|NCT01090024|581374867|FG010|Period 3|Protocol Violation|0|||
160919087|NCT00174915|581098008|FG003|Overall Study|Gout Flare|1|||
160997184|NCT01090024|581374868|FG011|Period 3|Protocol Violation|0|||
160919088|NCT00174915|581098009|FG004|Overall Study|Gout Flare|0|||
160919089|NCT00174915|581098005|FG000|Overall Study|Protocol Violation|6|||
160919090|NCT00174915|581098006|FG001|Overall Study|Protocol Violation|3|||
160919091|NCT00174915|581098007|FG002|Overall Study|Protocol Violation|3|||
160919092|NCT00174915|581098008|FG003|Overall Study|Protocol Violation|6|||
160919093|NCT00174915|581098009|FG004|Overall Study|Protocol Violation|3|||
160919094|NCT00174915|581098005|FG000|Overall Study|Therapeutic Failure|6|||
160919095|NCT00174915|581098006|FG001|Overall Study|Therapeutic Failure|3|||
160919096|NCT00174915|581098007|FG002|Overall Study|Therapeutic Failure|2|||
160919097|NCT00174915|581098008|FG003|Overall Study|Therapeutic Failure|1|||
160919098|NCT00174915|581098009|FG004|Overall Study|Therapeutic Failure|3|||
160919099|NCT03060447|581098010|FG000|Overall Study|Withdrawal by Subject|2|||
160997185|NCT01090024|581374869|FG012|Period 3|Protocol Violation|0|||
160997186|NCT01090024|581374870|FG013|Period 3|Protocol Violation|0|||
160919100|NCT03060447|581098011|FG001|Overall Study|Withdrawal by Subject|0|||
160919101|NCT00546637|581098012|FG000|Overall Study|Adverse Event|46|||
160919102|NCT00546637|581098013|FG001|Overall Study|Adverse Event|20|||
160919103|NCT00546637|581098012|FG000|Overall Study|Lack of Efficacy|5|||
160919104|NCT00546637|581098013|FG001|Overall Study|Lack of Efficacy|5|||
160919105|NCT00546637|581098012|FG000|Overall Study|Lost to Follow-up|2|||
160919106|NCT00546637|581098013|FG001|Overall Study|Lost to Follow-up|2|||
160919107|NCT00546637|581098012|FG000|Overall Study|Other|10|||
160919108|NCT00546637|581098013|FG001|Overall Study|Other|12|||
160919109|NCT00546637|581098012|FG000|Overall Study|Withdrawal by Subject|7|||
160919110|NCT00546637|581098013|FG001|Overall Study|Withdrawal by Subject|9|||
160919111|NCT00546637|581098012|FG000|Overall Study|Randomized, but not treated|3|||
160919112|NCT00546637|581098013|FG001|Overall Study|Randomized, but not treated|1|||
160919113|NCT03108027|581098021|FG000|Period 1|Subject/Guardian Decision|0|||
160919114|NCT03108027|581098022|FG001|Period 1|Subject/Guardian Decision|0|||
160919115|NCT03108027|581098023|FG002|Period 1|Subject/Guardian Decision|0|||
160919116|NCT03108027|581098024|FG003|Period 1|Subject/Guardian Decision|2|||
160919117|NCT03108027|581098025|FG004|Period 1|Subject/Guardian Decision|0|||
160919118|NCT03108027|581098026|FG005|Period 1|Subject/Guardian Decision|0|||
160919119|NCT03108027|581098021|FG000|Period 3|Adverse Event|0|||
160919120|NCT03108027|581098022|FG001|Period 3|Adverse Event|1|||
160919121|NCT03108027|581098023|FG002|Period 3|Adverse Event|0|||
160919122|NCT03108027|581098024|FG003|Period 3|Adverse Event|0|||
160919123|NCT03108027|581098025|FG004|Period 3|Adverse Event|0|||
160919124|NCT03108027|581098026|FG005|Period 3|Adverse Event|0|||
160919125|NCT02426892|581098027|FG000|Overall Study|Adverse Event|2|||
160919126|NCT02426892|581098027|FG000|Overall Study|Lack of Efficacy|17|||
160919127|NCT02426892|581098027|FG000|Overall Study|Withdrawal by Subject|1|||
160919128|NCT03178773|581098028|FG000|Overall Study|Death|0|||
160919129|NCT03178773|581098029|FG001|Overall Study|Death|1|||
160919130|NCT03178773|581098028|FG000|Overall Study|Lost to Follow-up|29|||
160919131|NCT03178773|581098029|FG001|Overall Study|Lost to Follow-up|25|||
160919132|NCT03178773|581098028|FG000|Overall Study|Withdrawal by Subject|10|||
160919133|NCT03178773|581098029|FG001|Overall Study|Withdrawal by Subject|14|||
160919134|NCT01382446|581098030|FG000|Overall Study|Withdrawal by Subject|0|||
160919135|NCT01382446|581098031|FG001|Overall Study|Withdrawal by Subject|1|||
160919136|NCT01382446|581098030|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
160919137|NCT01382446|581098031|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
160919138|NCT00003901|581098032|FG000|Overall Study|Adverse Event|1|||
160919139|NCT00003901|581098032|FG000|Overall Study|Withdrawal by Subject|1|||
160919140|NCT00003901|581098032|FG000|Overall Study|Ineligible|6|||
160919141|NCT00003901|581098032|FG000|Overall Study|CT Scan not within protocol requirement|2|||
160919142|NCT00003901|581098032|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
160919143|NCT00003901|581098032|FG000|Overall Study|Medical problems|6|||
160919144|NCT03325075|581098037|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
160919145|NCT03325075|581098038|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
160919146|NCT03325075|581098039|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
160919147|NCT03325075|581098040|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
160919148|NCT03325075|581098037|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
160919149|NCT03325075|581098038|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
160919150|NCT03325075|581098039|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
160919151|NCT03325075|581098040|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
160919152|NCT03325075|581098037|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
160454651|NCT01928394|579396180|FG010|Treatment Period|AE unrelated to study drug|0|||
160454652|NCT01928394|579396181|FG011|Treatment Period|AE unrelated to study drug|12|||
160454653|NCT01928394|579396182|FG012|Treatment Period|AE unrelated to study drug|6|||
160454654|NCT01928394|579396183|FG013|Treatment Period|AE unrelated to study drug|13|||
160454655|NCT01928394|579396184|FG014|Treatment Period|AE unrelated to study drug|6|||
160454656|NCT01928394|579396185|FG015|Treatment Period|AE unrelated to study drug|1|||
160454657|NCT01928394|579396186|FG016|Treatment Period|AE unrelated to study drug|1|||
160454658|NCT01928394|579396187|FG017|Treatment Period|AE unrelated to study drug|6|||
160454659|NCT01928394|579396188|FG018|Treatment Period|AE unrelated to study drug|3|||
160454660|NCT01928394|579396189|FG019|Treatment Period|AE unrelated to study drug|5|||
160454661|NCT01928394|579396190|FG020|Treatment Period|AE unrelated to study drug|1|||
160454662|NCT01928394|579396191|FG021|Treatment Period|AE unrelated to study drug|1|||
160454663|NCT01928394|579396192|FG022|Treatment Period|AE unrelated to study drug|0|||
160454664|NCT01928394|579396170|FG000|Treatment Period|Participant request to stop therapy|0|||
160454665|NCT01928394|579396171|FG001|Treatment Period|Participant request to stop therapy|0|||
160997187|NCT01090024|581374871|FG014|Period 3|Protocol Violation|0|||
160919153|NCT03325075|581098038|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
160919154|NCT03325075|581098039|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
160919155|NCT03325075|581098040|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
160919156|NCT00422591|581098041|FG000|Overall Study|Physician Decision|4|||
160454666|NCT01928394|579396172|FG002|Treatment Period|Participant request to stop therapy|0|||
160654101|NCT01957488|580114253|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
160654102|NCT01957488|580114254|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
160654103|NCT01957488|580114255|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
160654104|NCT01957488|580114256|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
160654105|NCT01957488|580114257|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
160654106|NCT00721409|580114258|FG000|Overall Study|Global deterioration of health status|2|||
160654107|NCT00721409|580114259|FG001|Overall Study|Global deterioration of health status|6|||
160654108|NCT00721409|580114260|FG002|Overall Study|Global deterioration of health status|3|||
160654109|NCT00721409|580114258|FG000|Overall Study|Death|0|||
160654110|NCT00721409|580114259|FG001|Overall Study|Death|1|||
160654111|NCT00721409|580114260|FG002|Overall Study|Death|0|||
160654112|NCT00721409|580114258|FG000|Overall Study|Randomized not Treated|0|||
160654113|NCT00721409|580114259|FG001|Overall Study|Randomized not Treated|1|||
160654114|NCT00721409|580114260|FG002|Overall Study|Randomized not Treated|4|||
160654115|NCT00721409|580114258|FG000|Overall Study|Reason not specified|1|||
160654116|NCT00721409|580114259|FG001|Overall Study|Reason not specified|0|||
160654117|NCT00721409|580114260|FG002|Overall Study|Reason not specified|2|||
160654118|NCT00721409|580114258|FG000|Overall Study|Adverse Event|0|||
160654119|NCT00721409|580114259|FG001|Overall Study|Adverse Event|13|||
160654120|NCT00721409|580114260|FG002|Overall Study|Adverse Event|2|||
160654121|NCT00721409|580114258|FG000|Overall Study|Lost to Follow-up|0|||
160654122|NCT00721409|580114259|FG001|Overall Study|Lost to Follow-up|0|||
160654123|NCT00721409|580114260|FG002|Overall Study|Lost to Follow-up|1|||
160919157|NCT00422591|581098041|FG000|Overall Study|Withdrawal by Subject|2|||
160919158|NCT00883116|581098044|FG000|Overall Study|Adverse event unrelated to study drug|5|||
160919159|NCT00883116|581098045|FG001|Overall Study|Adverse event unrelated to study drug|10|||
160919160|NCT00883116|581098044|FG000|Overall Study|Death|6|||
160919161|NCT00883116|581098045|FG001|Overall Study|Death|2|||
160919162|NCT00883116|581098044|FG000|Overall Study|Disease progression|130|||
160919163|NCT00883116|581098045|FG001|Overall Study|Disease progression|128|||
160919164|NCT00883116|581098044|FG000|Overall Study|Lost to Follow-up|0|||
160919165|NCT00883116|581098045|FG001|Overall Study|Lost to Follow-up|1|||
160919166|NCT00883116|581098044|FG000|Overall Study|Maximum clinical benefit|13|||
160919167|NCT00883116|581098045|FG001|Overall Study|Maximum clinical benefit|46|||
160919168|NCT00883116|581098044|FG000|Overall Study|Not identified|3|||
160919169|NCT00883116|581098045|FG001|Overall Study|Not identified|6|||
160919170|NCT00883116|581098044|FG000|Overall Study|Study drug toxicity|36|||
160919171|NCT00883116|581098045|FG001|Overall Study|Study drug toxicity|16|||
160919172|NCT00883116|581098044|FG000|Overall Study|Withdrawal by Subject|14|||
160919173|NCT00883116|581098045|FG001|Overall Study|Withdrawal by Subject|8|||
160919174|NCT00883116|581098044|FG000|Overall Study|No longer meets study criteria|2|||
160919175|NCT00883116|581098045|FG001|Overall Study|No longer meets study criteria|2|||
160919176|NCT03241342|581098048|FG000|Overall Study|Adverse Event|5|||
160919177|NCT03241342|581098049|FG001|Overall Study|Adverse Event|8|||
160919178|NCT03241342|581098050|FG002|Overall Study|Adverse Event|4|||
160919179|NCT03241342|581098048|FG000|Overall Study|Lack of Efficacy|0|||
160919180|NCT03241342|581098049|FG001|Overall Study|Lack of Efficacy|0|||
160919181|NCT03241342|581098050|FG002|Overall Study|Lack of Efficacy|1|||
160919182|NCT03241342|581098048|FG000|Overall Study|noncompliance with study drug|2|||
160919183|NCT03241342|581098049|FG001|Overall Study|noncompliance with study drug|1|||
160919184|NCT03241342|581098050|FG002|Overall Study|noncompliance with study drug|1|||
160919185|NCT03241342|581098048|FG000|Overall Study|sponsor decision|0|||
160919186|NCT03241342|581098049|FG001|Overall Study|sponsor decision|1|||
160919187|NCT03241342|581098050|FG002|Overall Study|sponsor decision|2|||
160919188|NCT03241342|581098048|FG000|Overall Study|not reported|15|||
160919189|NCT03241342|581098049|FG001|Overall Study|not reported|21|||
160919190|NCT03241342|581098050|FG002|Overall Study|not reported|19|||
160919191|NCT00541034|581098054|FG000|Overall Study|Non-Compliance|3|||
160919192|NCT00847704|581098055|FG000|Overall Study|Withdrawal by Subject|1|||
160919193|NCT05838742|581098059|FG000|Overall Study|Adverse Event|2|||
160919194|NCT05838742|581098060|FG001|Overall Study|Adverse Event|0|||
160919195|NCT05838742|581098061|FG002|Overall Study|Adverse Event|1|||
160919196|NCT05838742|581098062|FG003|Overall Study|Adverse Event|0|||
160919197|NCT05838742|581098063|FG004|Overall Study|Adverse Event|1|||
160919198|NCT05838742|581098059|FG000|Overall Study|Lost to Follow-up|1|||
160919199|NCT05838742|581098060|FG001|Overall Study|Lost to Follow-up|1|||
160919200|NCT05838742|581098061|FG002|Overall Study|Lost to Follow-up|1|||
160919201|NCT05838742|581098062|FG003|Overall Study|Lost to Follow-up|0|||
160919202|NCT05838742|581098063|FG004|Overall Study|Lost to Follow-up|0|||
160919203|NCT05838742|581098059|FG000|Overall Study|Physician Decision|0|||
160919204|NCT05838742|581098060|FG001|Overall Study|Physician Decision|0|||
160654124|NCT00721409|580114258|FG000|Overall Study|Withdrawal by Subject|1|||
160654125|NCT00721409|580114259|FG001|Overall Study|Withdrawal by Subject|6|||
160654126|NCT00721409|580114260|FG002|Overall Study|Withdrawal by Subject|5|||
160919205|NCT05838742|581098061|FG002|Overall Study|Physician Decision|0|||
160919206|NCT05838742|581098062|FG003|Overall Study|Physician Decision|0|||
160919207|NCT05838742|581098063|FG004|Overall Study|Physician Decision|1|||
160919208|NCT05838742|581098059|FG000|Overall Study|Withdrawal by Subject|8|||
160997188|NCT01090024|581374872|FG015|Period 3|Protocol Violation|0|||
160997189|NCT01090024|581374873|FG016|Period 3|Protocol Violation|0|||
160997190|NCT01090024|581374874|FG017|Period 3|Protocol Violation|0|||
160997191|NCT01090024|581374857|FG000|Period 3|Adverse Event|0|||
160997192|NCT01090024|581374858|FG001|Period 3|Adverse Event|0|||
160997193|NCT01090024|581374859|FG002|Period 3|Adverse Event|0|||
160997194|NCT01090024|581374860|FG003|Period 3|Adverse Event|0|||
160997195|NCT01090024|581374861|FG004|Period 3|Adverse Event|0|||
160997196|NCT01090024|581374862|FG005|Period 3|Adverse Event|1|||
160997197|NCT01090024|581374863|FG006|Period 3|Adverse Event|0|||
160997198|NCT01090024|581374864|FG007|Period 3|Adverse Event|0|||
160997199|NCT01090024|581374865|FG008|Period 3|Adverse Event|0|||
160997200|NCT01090024|581374866|FG009|Period 3|Adverse Event|0|||
160997201|NCT01090024|581374867|FG010|Period 3|Adverse Event|0|||
160997202|NCT01090024|581374868|FG011|Period 3|Adverse Event|0|||
160997203|NCT01090024|581374869|FG012|Period 3|Adverse Event|0|||
160997204|NCT01090024|581374870|FG013|Period 3|Adverse Event|0|||
160997205|NCT01090024|581374871|FG014|Period 3|Adverse Event|0|||
160919209|NCT05838742|581098060|FG001|Overall Study|Withdrawal by Subject|3|||
160919210|NCT05838742|581098061|FG002|Overall Study|Withdrawal by Subject|3|||
160919211|NCT05838742|581098062|FG003|Overall Study|Withdrawal by Subject|1|||
160919212|NCT05838742|581098063|FG004|Overall Study|Withdrawal by Subject|4|||
160919213|NCT05838742|581098059|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
160919214|NCT05838742|581098060|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
160919215|NCT05838742|581098061|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
160919216|NCT05838742|581098062|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
160919217|NCT05838742|581098063|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
160919218|NCT05838742|581098059|FG000|Overall Study|Lack of Efficacy|0|||
160919219|NCT05838742|581098060|FG001|Overall Study|Lack of Efficacy|0|||
160919220|NCT05838742|581098061|FG002|Overall Study|Lack of Efficacy|0|||
160919221|NCT05838742|581098062|FG003|Overall Study|Lack of Efficacy|1|||
160919222|NCT05838742|581098063|FG004|Overall Study|Lack of Efficacy|0|||
160919223|NCT05838742|581098059|FG000|Overall Study|Randomized, not treated|2|||
160919224|NCT05838742|581098060|FG001|Overall Study|Randomized, not treated|1|||
160919225|NCT05838742|581098061|FG002|Overall Study|Randomized, not treated|0|||
160919226|NCT05838742|581098062|FG003|Overall Study|Randomized, not treated|1|||
160919227|NCT05838742|581098063|FG004|Overall Study|Randomized, not treated|0|||
160919228|NCT02045797|581098064|FG000|Overall Study|Adverse Event|3|||
160919229|NCT02045797|581098065|FG001|Overall Study|Adverse Event|1|||
160919230|NCT02045797|581098066|FG002|Overall Study|Adverse Event|0|||
160919231|NCT02045797|581098064|FG000|Overall Study|Lack of Efficacy|1|||
160997206|NCT01090024|581374872|FG015|Period 3|Adverse Event|0|||
160997207|NCT01090024|581374873|FG016|Period 3|Adverse Event|0|||
160997208|NCT01090024|581374874|FG017|Period 3|Adverse Event|0|||
160997209|NCT00470626|581374876|FG000|Overall Study|Lost to Follow-up|10|||
160997210|NCT00470626|581374876|FG000|Overall Study|Withdrawal by Subject|7|||
160997211|NCT00777556|581374877|FG000|Overall Study|Inappropriate self-selection|34|||
160997212|NCT00777556|581374877|FG000|Overall Study|Dispensed but did not use product|12|||
160997213|NCT00777556|581374877|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
160997214|NCT02689349|581374878|FG000|Overall Study|Not implanted|4|||
160997215|NCT02689349|581374879|FG001|Overall Study|Not implanted|0|||
160997216|NCT02689349|581374878|FG000|Overall Study|Withdrawal by Subject|9|||
160997217|NCT02689349|581374879|FG001|Overall Study|Withdrawal by Subject|0|||
160997218|NCT00486759|581374885|FG000|Treatment|Adverse event/intercurrent illness|86|||
160997219|NCT00486759|581374886|FG001|Treatment|Adverse event/intercurrent illness|39|||
160997220|NCT00486759|581374885|FG000|Treatment|Insufficient therapeutic response|37|||
160997221|NCT00486759|581374886|FG001|Treatment|Insufficient therapeutic response|39|||
160997222|NCT00486759|581374885|FG000|Treatment|Death|17|||
160997223|NCT00486759|581374886|FG001|Treatment|Death|10|||
160997224|NCT00486759|581374885|FG000|Treatment|Withdrew consent|15|||
160997225|NCT00486759|581374886|FG001|Treatment|Withdrew consent|12|||
160997226|NCT00486759|581374885|FG000|Treatment|Administrative/reason not specified|17|||
160997227|NCT00486759|581374886|FG001|Treatment|Administrative/reason not specified|21|||
160997228|NCT00486759|581374885|FG000|Treatment|Refused treatment|10|||
160919232|NCT02045797|581098065|FG001|Overall Study|Lack of Efficacy|0|||
160997229|NCT00486759|581374886|FG001|Treatment|Refused treatment|7|||
160997230|NCT00486759|581374885|FG000|Treatment|Violation of selection criteria at entry|3|||
160919233|NCT02045797|581098066|FG002|Overall Study|Lack of Efficacy|0|||
160919234|NCT02045797|581098064|FG000|Overall Study|Lost to Follow-up|2|||
160919235|NCT02045797|581098065|FG001|Overall Study|Lost to Follow-up|3|||
160919236|NCT02045797|581098066|FG002|Overall Study|Lost to Follow-up|1|||
160919237|NCT02045797|581098064|FG000|Overall Study|Physician Decision|0|||
160919238|NCT02045797|581098065|FG001|Overall Study|Physician Decision|1|||
160919239|NCT02045797|581098066|FG002|Overall Study|Physician Decision|0|||
160919240|NCT02045797|581098064|FG000|Overall Study|Withdrawal by Subject|1|||
160997231|NCT00486759|581374886|FG001|Treatment|Violation of selection criteria at entry|3|||
160997232|NCT00486759|581374885|FG000|Treatment|Other protocol violation|1|||
160997233|NCT00486759|581374886|FG001|Treatment|Other protocol violation|5|||
160997234|NCT00486759|581374885|FG000|Treatment|Failure to return|1|||
160919241|NCT02045797|581098065|FG001|Overall Study|Withdrawal by Subject|2|||
160919242|NCT02045797|581098066|FG002|Overall Study|Withdrawal by Subject|0|||
160919243|NCT03334903|581098067|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
160919244|NCT03334903|581098068|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
160919245|NCT03334903|581098067|FG000|Overall Study|Protocol Violation|1|||
160919246|NCT03334903|581098068|FG001|Overall Study|Protocol Violation|3|||
160919247|NCT03334903|581098067|FG000|Overall Study|Surgery postponed|1|||
160919248|NCT03334903|581098068|FG001|Overall Study|Surgery postponed|0|||
160919249|NCT03334903|581098067|FG000|Overall Study|Adverse Event|1|||
160919250|NCT03334903|581098068|FG001|Overall Study|Adverse Event|1|||
160919251|NCT03334903|581098067|FG000|Overall Study|Withdrawal by Subject|0|||
160919252|NCT03334903|581098068|FG001|Overall Study|Withdrawal by Subject|1|||
160919253|NCT04405037|581098069|FG000|Overall Study|Withdrawal by Subject|1|||
160919254|NCT04405037|581098070|FG001|Overall Study|Withdrawal by Subject|0|||
160919255|NCT04405037|581098069|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
160919256|NCT04405037|581098070|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
160919257|NCT02169739|581099335|FG000|Overall Study|Lost to Follow-up|0|||
160919258|NCT02169739|581099336|FG001|Overall Study|Lost to Follow-up|4|||
160919259|NCT01244906|581099338|FG000|Overall Study|Death|2|||
160919260|NCT01244906|581099338|FG000|Overall Study|Progression of disease post treatment|6|||
160919261|NCT03480750|581099339|FG000|Overall Study|Withdrawal by Subject|0|||
160919262|NCT03480750|581099340|FG001|Overall Study|Withdrawal by Subject|1|||
160919263|NCT03480750|581099341|FG002|Overall Study|Withdrawal by Subject|0|||
160919264|NCT03480750|581099342|FG003|Overall Study|Withdrawal by Subject|0|||
160919265|NCT03480750|581099343|FG004|Overall Study|Withdrawal by Subject|0|||
160919266|NCT03480750|581099344|FG005|Overall Study|Withdrawal by Subject|0|||
160919267|NCT03480750|581099339|FG000|Overall Study|The interruption in Trientine shippment|0|||
160919268|NCT03480750|581099340|FG001|Overall Study|The interruption in Trientine shippment|0|||
160919269|NCT03480750|581099341|FG002|Overall Study|The interruption in Trientine shippment|0|||
160919270|NCT03480750|581099342|FG003|Overall Study|The interruption in Trientine shippment|0|||
160919271|NCT03480750|581099343|FG004|Overall Study|The interruption in Trientine shippment|0|||
160919272|NCT03480750|581099344|FG005|Overall Study|The interruption in Trientine shippment|1|||
160919273|NCT00723892|581099351|FG000|Overall Study|Participant not tracked|33|||
160919274|NCT00723892|581099352|FG001|Overall Study|Participant not tracked|35|||
160919275|NCT00723892|581099351|FG000|Overall Study|Virological criterion|24|||
160919276|NCT00723892|581099352|FG001|Overall Study|Virological criterion|9|||
160919277|NCT00723892|581099351|FG000|Overall Study|Withdrawal by Subject|6|||
160919278|NCT00723892|581099352|FG001|Overall Study|Withdrawal by Subject|9|||
160919279|NCT00723892|581099351|FG000|Overall Study|End planned|11|||
160919280|NCT00723892|581099352|FG001|Overall Study|End planned|7|||
160919281|NCT00723892|581099351|FG000|Overall Study|Bad tolerance|5|||
160919282|NCT00723892|581099352|FG001|Overall Study|Bad tolerance|5|||
160919283|NCT00723892|581099351|FG000|Overall Study|Multiple reasons|17|||
160919284|NCT00723892|581099352|FG001|Overall Study|Multiple reasons|12|||
160919285|NCT00723892|581099351|FG000|Overall Study|Other|6|||
160919286|NCT00723892|581099352|FG001|Overall Study|Other|3|||
160919287|NCT00723892|581099351|FG000|Overall Study|Study end|1|||
160919288|NCT00723892|581099352|FG001|Overall Study|Study end|3|||
160919289|NCT00723892|581099351|FG000|Overall Study|Weight loss|1|||
160919290|NCT00723892|581099352|FG001|Overall Study|Weight loss|3|||
160919291|NCT00723892|581099351|FG000|Overall Study|Alcohol abuse|0|||
160919292|NCT00723892|581099352|FG001|Overall Study|Alcohol abuse|1|||
160919293|NCT00723892|581099351|FG000|Overall Study|Intercurrent infection|2|||
160919294|NCT00723892|581099352|FG001|Overall Study|Intercurrent infection|0|||
160919295|NCT00723892|581099351|FG000|Overall Study|Drug addiction|1|||
160919296|NCT00723892|581099352|FG001|Overall Study|Drug addiction|0|||
160919297|NCT03683758|581099353|FG000|Overall Study|Non-study commitment conflict|1|||
160919298|NCT03683758|581099354|FG001|Overall Study|Non-study commitment conflict|3|||
160919299|NCT03683758|581099353|FG000|Overall Study|Illness preventing participation|1|||
160919300|NCT03683758|581099354|FG001|Overall Study|Illness preventing participation|0|||
160919301|NCT03683758|581099353|FG000|Overall Study|Adverse Event|1|||
160919302|NCT03683758|581099354|FG001|Overall Study|Adverse Event|0|||
160919303|NCT02411292|581099355|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
160919304|NCT02411292|581099355|FG000|Overall Study|Death|2|||
160919305|NCT02411292|581099355|FG000|Overall Study|Lost to Follow-up|3|||
160654127|NCT00721409|580114258|FG000|Overall Study|Objective progression or relapse|8|||
160919306|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
160919307|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
160919308|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
160919309|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
160654128|NCT00721409|580114259|FG001|Overall Study|Objective progression or relapse|55|||
160919310|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
160919311|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
160919312|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
160919313|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
160919314|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Other|4|||
160919315|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Other|1|||
160919316|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
160919317|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
160919318|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
160919319|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
160919320|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
160919321|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
160919322|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Death|1|||
160919323|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Death|0|||
160919324|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
160919325|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
160919326|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
160919327|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
160919328|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
160919329|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
160919330|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
160919331|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
160919332|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Other|1|||
160919333|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Other|0|||
160919334|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
160919335|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
160919336|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
160919337|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
160919338|NCT00453921|581099358|FG000|Overall Study|Withdrawal by Subject|1|||
160919339|NCT00453921|581099359|FG001|Overall Study|Withdrawal by Subject|1|||
160919340|NCT00453921|581099360|FG002|Overall Study|Withdrawal by Subject|1|||
160919341|NCT00453921|581099361|FG003|Overall Study|Withdrawal by Subject|1|||
160919342|NCT00453921|581099358|FG000|Overall Study|Lost to Follow-up|0|||
160919343|NCT00453921|581099359|FG001|Overall Study|Lost to Follow-up|0|||
160919344|NCT00453921|581099360|FG002|Overall Study|Lost to Follow-up|1|||
160919345|NCT00453921|581099361|FG003|Overall Study|Lost to Follow-up|0|||
160919346|NCT02232425|581099362|FG000|Overall Study|Lost to Follow-up|6|||
160919347|NCT02232425|581099363|FG001|Overall Study|Lost to Follow-up|2|||
160919348|NCT02232425|581099362|FG000|Overall Study|Adverse Event|2|||
160919349|NCT02232425|581099363|FG001|Overall Study|Adverse Event|0|||
160919350|NCT02232425|581099362|FG000|Overall Study|Withdrawal by Subject|5|||
160919351|NCT02232425|581099363|FG001|Overall Study|Withdrawal by Subject|6|||
160919352|NCT02232425|581099362|FG000|Overall Study|Lack of Efficacy|1|||
160919353|NCT02232425|581099363|FG001|Overall Study|Lack of Efficacy|0|||
160919354|NCT01601626|581099366|FG000|Overall Study|Death|1|||
160919355|NCT01601626|581099367|FG001|Overall Study|Death|1|||
160919356|NCT01601626|581099368|FG002|Overall Study|Death|1|||
160919357|NCT01601626|581099366|FG000|Overall Study|Lost to Follow-up|1|||
160919358|NCT01601626|581099367|FG001|Overall Study|Lost to Follow-up|2|||
160919359|NCT01601626|581099368|FG002|Overall Study|Lost to Follow-up|0|||
160919360|NCT01601626|581099366|FG000|Overall Study|Unable to Get to Clinic|0|||
160919361|NCT01601626|581099367|FG001|Overall Study|Unable to Get to Clinic|1|||
160919362|NCT01601626|581099368|FG002|Overall Study|Unable to Get to Clinic|0|||
160919363|NCT01601626|581099366|FG000|Overall Study|Withdrawal by Subject|0|||
160919364|NCT01601626|581099367|FG001|Overall Study|Withdrawal by Subject|1|||
160919365|NCT01601626|581099368|FG002|Overall Study|Withdrawal by Subject|1|||
160919366|NCT01601626|581099366|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
160919367|NCT01601626|581099367|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
160919368|NCT01601626|581099368|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
160919369|NCT00498602|581099369|FG000|Overall Study|Death|0|||
160919370|NCT00498602|581099370|FG001|Overall Study|Death|0|||
160919371|NCT00498602|581099371|FG002|Overall Study|Death|0|||
160919372|NCT00498602|581099372|FG003|Overall Study|Death|0|||
160919373|NCT00498602|581099373|FG004|Overall Study|Death|0|||
160919374|NCT00498602|581099374|FG005|Overall Study|Death|1|||
160919375|NCT00498602|581099375|FG006|Overall Study|Death|0|||
160654129|NCT00721409|580114260|FG002|Overall Study|Objective progression or relapse|62|||
160919376|NCT00498602|581099369|FG000|Overall Study|Lack of Efficacy|1|||
160919377|NCT00498602|581099370|FG001|Overall Study|Lack of Efficacy|0|||
160919378|NCT00498602|581099371|FG002|Overall Study|Lack of Efficacy|0|||
160919379|NCT00498602|581099372|FG003|Overall Study|Lack of Efficacy|0|||
160919380|NCT00498602|581099373|FG004|Overall Study|Lack of Efficacy|0|||
160919381|NCT00498602|581099374|FG005|Overall Study|Lack of Efficacy|0|||
160919382|NCT00498602|581099375|FG006|Overall Study|Lack of Efficacy|0|||
160919383|NCT00498602|581099369|FG000|Overall Study|Lost to Follow-up|0|||
160919384|NCT00498602|581099370|FG001|Overall Study|Lost to Follow-up|2|||
160919385|NCT00498602|581099371|FG002|Overall Study|Lost to Follow-up|0|||
160919386|NCT00498602|581099372|FG003|Overall Study|Lost to Follow-up|2|||
160997235|NCT00486759|581374886|FG001|Treatment|Failure to return|1|||
160654130|NCT02402166|580114261|FG000|Overall Study|Adverse Event|2|||
160654131|NCT02402166|580114261|FG000|Overall Study|Withdrawal by Subject|2|||
160654132|NCT02402166|580114261|FG000|Overall Study|Lost to Follow-up|1|||
160654133|NCT00623103|580114262|FG000|Overall Study|Adverse Event|70|||
160654134|NCT00623103|580114263|FG001|Overall Study|Adverse Event|60|||
160654135|NCT00623103|580114262|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160654136|NCT00623103|580114263|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
160654137|NCT00623103|580114262|FG000|Overall Study|Withdrawal by Subject|18|||
160654138|NCT00623103|580114263|FG001|Overall Study|Withdrawal by Subject|24|||
160654139|NCT00623103|580114262|FG000|Overall Study|Lost to Follow-up|4|||
160654140|NCT00623103|580114263|FG001|Overall Study|Lost to Follow-up|1|||
160654141|NCT00623103|580114262|FG000|Overall Study|Administrative problems|2|||
160654142|NCT00623103|580114263|FG001|Overall Study|Administrative problems|4|||
160654143|NCT00623103|580114262|FG000|Overall Study|Death|11|||
160654144|NCT00623103|580114263|FG001|Overall Study|Death|11|||
160654145|NCT00623103|580114262|FG000|Overall Study|Protocol deviation|2|||
160654146|NCT00623103|580114263|FG001|Overall Study|Protocol deviation|1|||
160654147|NCT02433678|580114268|FG000|Overall Study|Lost to Follow-up|1|||
160919387|NCT00498602|581099373|FG004|Overall Study|Lost to Follow-up|0|||
160919388|NCT00498602|581099374|FG005|Overall Study|Lost to Follow-up|0|||
160919389|NCT00498602|581099375|FG006|Overall Study|Lost to Follow-up|0|||
160919390|NCT00498602|581099369|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
160919391|NCT00498602|581099370|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
160919392|NCT00498602|581099371|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
160919393|NCT00498602|581099372|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
160919394|NCT00498602|581099373|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
160919395|NCT00498602|581099374|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
160919396|NCT00498602|581099375|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
160997236|NCT00486759|581374885|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
160997237|NCT00486759|581374886|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
160997238|NCT00486759|581374885|FG000|Safety Follow-up|Death|40|||
160997239|NCT00486759|581374886|FG001|Safety Follow-up|Death|29|||
160997240|NCT00486759|581374885|FG000|Safety Follow-up|Withdrew consent|32|||
160997241|NCT00486759|581374886|FG001|Safety Follow-up|Withdrew consent|23|||
160997242|NCT00486759|581374885|FG000|Safety Follow-up|Failure to return|9|||
160997243|NCT00486759|581374886|FG001|Safety Follow-up|Failure to return|6|||
160997244|NCT00486759|581374885|FG000|Safety Follow-up|Administrative/not specified|8|||
160997245|NCT00486759|581374886|FG001|Safety Follow-up|Administrative/not specified|6|||
160997246|NCT00486759|581374885|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
160997247|NCT00486759|581374886|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
160573696|NCT00611455|579821633|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
160573697|NCT00611455|579821634|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
160573698|NCT00611455|579821632|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
160573699|NCT00611455|579821633|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
160573700|NCT00611455|579821634|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
160573701|NCT00611455|579821632|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
160573702|NCT00611455|579821633|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
160573703|NCT00611455|579821634|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
160573704|NCT03240081|579821637|FG000|Overall Study|Withdrawal by Subject|0|||
160573705|NCT03240081|579821638|FG001|Overall Study|Withdrawal by Subject|2|||
160573706|NCT03240081|579821637|FG000|Overall Study|Lost to Follow-up|0|||
160573707|NCT03240081|579821638|FG001|Overall Study|Lost to Follow-up|1|||
160573708|NCT04601272|579821639|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
160573709|NCT04601272|579821640|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
160573710|NCT04601272|579821641|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
160573711|NCT03671369|579821644|FG000|Overall Study|Other|1|||
160573712|NCT03671369|579821644|FG000|Overall Study|Withdrawal by Subject|289|||
160573713|NCT03671369|579821644|FG000|Overall Study|Not willing to be vaccinated|1|||
160573714|NCT04382651|579821645|FG000|Overall Study|Death|26|||
160573715|NCT04382651|579821646|FG001|Overall Study|Death|23|||
160573716|NCT04382651|579821645|FG000|Overall Study|Lost to Follow-up|3|||
160573717|NCT04382651|579821646|FG001|Overall Study|Lost to Follow-up|4|||
160573718|NCT04382651|579821645|FG000|Overall Study|Withdrawal by Subject|2|||
160573719|NCT04382651|579821646|FG001|Overall Study|Withdrawal by Subject|0|||
160573720|NCT04382651|579821645|FG000|Overall Study|Physician Decision|0|||
160919397|NCT00498602|581099369|FG000|Overall Study|AE not related to Study Drug|1|||
160919398|NCT00498602|581099370|FG001|Overall Study|AE not related to Study Drug|3|||
160919399|NCT00498602|581099371|FG002|Overall Study|AE not related to Study Drug|0|||
160997248|NCT00486759|581374885|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
160654148|NCT02433678|580114269|FG001|Overall Study|Lost to Follow-up|2|||
160654149|NCT01424722|580114273|FG000|Overall Study|Sponsor terminated investigation|2258|||
160654150|NCT01618266|580114276|FG000|Overall Study|Lost to Follow-up|9|||
160919400|NCT00498602|581099372|FG003|Overall Study|AE not related to Study Drug|0|||
160919401|NCT00498602|581099373|FG004|Overall Study|AE not related to Study Drug|2|||
160919402|NCT00498602|581099374|FG005|Overall Study|AE not related to Study Drug|2|||
160919403|NCT00498602|581099375|FG006|Overall Study|AE not related to Study Drug|1|||
160919404|NCT00498602|581099369|FG000|Overall Study|Caregiver Request|2|||
160919405|NCT00498602|581099370|FG001|Overall Study|Caregiver Request|2|||
160919406|NCT00498602|581099371|FG002|Overall Study|Caregiver Request|2|||
160919407|NCT00498602|581099372|FG003|Overall Study|Caregiver Request|0|||
160919408|NCT00498602|581099373|FG004|Overall Study|Caregiver Request|1|||
160919409|NCT00498602|581099374|FG005|Overall Study|Caregiver Request|2|||
160919410|NCT00498602|581099375|FG006|Overall Study|Caregiver Request|0|||
160919411|NCT00498602|581099369|FG000|Overall Study|Investigator Request|0|||
160919412|NCT00498602|581099370|FG001|Overall Study|Investigator Request|0|||
160919413|NCT00498602|581099371|FG002|Overall Study|Investigator Request|1|||
160919414|NCT00498602|581099372|FG003|Overall Study|Investigator Request|0|||
160919415|NCT00498602|581099373|FG004|Overall Study|Investigator Request|0|||
160919416|NCT00498602|581099374|FG005|Overall Study|Investigator Request|0|||
160919417|NCT00498602|581099375|FG006|Overall Study|Investigator Request|0|||
160919418|NCT00498602|581099369|FG000|Overall Study|Subject Request|3|||
160919419|NCT00498602|581099370|FG001|Overall Study|Subject Request|0|||
160919420|NCT00498602|581099371|FG002|Overall Study|Subject Request|1|||
160919421|NCT00498602|581099372|FG003|Overall Study|Subject Request|1|||
160919422|NCT00498602|581099373|FG004|Overall Study|Subject Request|1|||
160919423|NCT00498602|581099374|FG005|Overall Study|Subject Request|4|||
160919424|NCT00498602|581099375|FG006|Overall Study|Subject Request|1|||
160919425|NCT00498602|581099369|FG000|Overall Study|Other|2|||
160919426|NCT00498602|581099370|FG001|Overall Study|Other|3|||
160919427|NCT00498602|581099371|FG002|Overall Study|Other|1|||
160919428|NCT00498602|581099372|FG003|Overall Study|Other|0|||
160919429|NCT00498602|581099373|FG004|Overall Study|Other|0|||
160919430|NCT00498602|581099374|FG005|Overall Study|Other|3|||
160919431|NCT00498602|581099375|FG006|Overall Study|Other|0|||
160919432|NCT04984993|581099376|FG000|Overall Study|Withdrawal by Subject|8|||
160919433|NCT04984993|581099377|FG001|Overall Study|Withdrawal by Subject|2|||
160573721|NCT04382651|579821646|FG001|Overall Study|Physician Decision|1|||
160573722|NCT01507545|579821648|FG000|Overall Study|Withdrawal by Subject|6|||
160573723|NCT01507545|579821649|FG001|Overall Study|Withdrawal by Subject|2|||
160573724|NCT01507545|579821648|FG000|Overall Study|Lost to Follow-up|1|||
160573725|NCT01507545|579821649|FG001|Overall Study|Lost to Follow-up|0|||
160573726|NCT01507545|579821648|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
160573727|NCT01507545|579821649|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
160573728|NCT01507545|579821648|FG000|Overall Study|Progressive disease|60|||
160573729|NCT01507545|579821649|FG001|Overall Study|Progressive disease|27|||
160573730|NCT01507545|579821648|FG000|Overall Study|Other|6|||
160573731|NCT01507545|579821649|FG001|Overall Study|Other|4|||
160573732|NCT02612077|579821651|FG000|Overall Study|Adverse Event|3|||
160573733|NCT02612077|579821651|FG000|Overall Study|Withdrawal by Subject|9|||
160573734|NCT02612077|579821651|FG000|Overall Study|Protocol Violation|28|||
160573735|NCT02612077|579821651|FG000|Overall Study|Lost to Follow-up|20|||
160919434|NCT04984993|581099376|FG000|Overall Study|Lost to Follow-up|2|||
160919435|NCT04984993|581099377|FG001|Overall Study|Lost to Follow-up|2|||
160919436|NCT04984993|581099376|FG000|Overall Study|Both patients moved to another country|4|||
160919437|NCT04984993|581099377|FG001|Overall Study|Both patients moved to another country|0|||
160919438|NCT01110707|581099378|FG000|Overall Study|Protocol Violation|0|||
160919439|NCT01110707|581099379|FG001|Overall Study|Protocol Violation|3|||
160919440|NCT03318315|581099380|FG000|Overall Study|Lost to Follow-up|3|||
160919441|NCT03318315|581099381|FG001|Overall Study|Lost to Follow-up|2|||
160919442|NCT03318315|581099382|FG002|Overall Study|Lost to Follow-up|1|||
160919443|NCT03318315|581099380|FG000|Overall Study|Protocol Violation|1|||
160919444|NCT03318315|581099381|FG001|Overall Study|Protocol Violation|1|||
160919445|NCT03318315|581099382|FG002|Overall Study|Protocol Violation|1|||
160919446|NCT03318315|581099380|FG000|Overall Study|Withdrawal by Subject|0|||
160573736|NCT02612077|579821651|FG000|Overall Study|Death|377|||
160919447|NCT03318315|581099381|FG001|Overall Study|Withdrawal by Subject|0|||
160919448|NCT03318315|581099382|FG002|Overall Study|Withdrawal by Subject|2|||
160919449|NCT00268996|581099393|FG000|Overall Study|Adverse Event|11|||
160919450|NCT00268996|581099394|FG001|Overall Study|Adverse Event|7|||
160919451|NCT00268996|581099393|FG000|Overall Study|Lost to Follow-up|3|||
160919452|NCT00268996|581099394|FG001|Overall Study|Lost to Follow-up|1|||
160573737|NCT02612077|579821651|FG000|Overall Study|Moved or Changed Medical Team|23|||
160573738|NCT02612077|579821651|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
160919453|NCT00268996|581099393|FG000|Overall Study|Withdrawal by Subject|5|||
160919454|NCT00268996|581099394|FG001|Overall Study|Withdrawal by Subject|11|||
160919455|NCT00268996|581099393|FG000|Overall Study|Non-compliance|1|||
160919456|NCT00268996|581099394|FG001|Overall Study|Non-compliance|0|||
160919457|NCT00268996|581099393|FG000|Overall Study|Other|1|||
160919458|NCT00268996|581099394|FG001|Overall Study|Other|1|||
160919459|NCT02617511|581099397|FG000|Overall Study|Withdrawal by Subject|1|||
160919460|NCT02617511|581099398|FG001|Overall Study|Withdrawal by Subject|0|||
160573739|NCT02612077|579821651|FG000|Overall Study|Disease Progression|3|||
160573740|NCT02612077|579821651|FG000|Overall Study|Unknown reason|2|||
160573741|NCT00995371|579821654|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
160573742|NCT00995371|579821655|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
160573743|NCT00206518|579821658|FG000|Overall Study|Lack of Efficacy|6|||
160573744|NCT00206518|579821659|FG001|Overall Study|Lack of Efficacy|4|||
160573745|NCT00206518|579821658|FG000|Overall Study|Adverse Event|2|||
160573746|NCT00206518|579821659|FG001|Overall Study|Adverse Event|1|||
160573747|NCT00206518|579821658|FG000|Overall Study|Physician Decision|1|||
160573748|NCT00206518|579821659|FG001|Overall Study|Physician Decision|0|||
160573749|NCT00206518|579821658|FG000|Overall Study|Protocol Violation|1|||
160573750|NCT00206518|579821659|FG001|Overall Study|Protocol Violation|1|||
160573751|NCT02335450|579821660|FG000|Overall Study|Pregnancy|1|||
160573752|NCT02613572|579821661|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
160573753|NCT02613572|579821662|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
160573754|NCT02613572|579821663|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
160573755|NCT02613572|579821661|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
160573756|NCT02613572|579821662|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
160573757|NCT02613572|579821663|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
160573758|NCT00231478|579821664|FG000|Overall Study|Protocol Violation|3|||
160573759|NCT00231478|579821665|FG001|Overall Study|Protocol Violation|2|||
160573760|NCT00231478|579821664|FG000|Overall Study|Refused Treatment|1|||
160573761|NCT00231478|579821665|FG001|Overall Study|Refused Treatment|1|||
160573762|NCT00231478|579821664|FG000|Overall Study|Withdrawal by Subject|1|||
160573763|NCT00231478|579821665|FG001|Overall Study|Withdrawal by Subject|0|||
160573764|NCT00231478|579821664|FG000|Overall Study|Adverse Event|0|||
160573765|NCT00231478|579821665|FG001|Overall Study|Adverse Event|1|||
160573766|NCT00231478|579821664|FG000|Overall Study|Administrative|3|||
160573767|NCT00231478|579821665|FG001|Overall Study|Administrative|2|||
160573768|NCT00853905|579821666|FG000|Overall Study|Lost to Follow-up|1|||
160573769|NCT00853905|579821667|FG001|Overall Study|Lost to Follow-up|3|||
160573770|NCT00853905|579821666|FG000|Overall Study|Withdrawal by Subject|0|||
160573771|NCT00853905|579821667|FG001|Overall Study|Withdrawal by Subject|1|||
160573772|NCT00853905|579821666|FG000|Overall Study|never had surgery|1|||
160573773|NCT00853905|579821667|FG001|Overall Study|never had surgery|0|||
160573774|NCT00847561|579821670|FG000|Overall Study|Withdrawal by Subject|4|||
160573775|NCT00847561|579821671|FG001|Overall Study|Withdrawal by Subject|3|||
160573776|NCT00847561|579821670|FG000|Overall Study|Unable to schedule|9|||
160573777|NCT00847561|579821671|FG001|Overall Study|Unable to schedule|1|||
160573778|NCT00393458|579821673|FG000|Overall Study|Adverse Event|35|||
160573779|NCT00393458|579821674|FG001|Overall Study|Adverse Event|24|||
160573780|NCT00393458|579821675|FG002|Overall Study|Adverse Event|40|||
160573781|NCT00393458|579821676|FG003|Overall Study|Adverse Event|35|||
160573782|NCT00393458|579821673|FG000|Overall Study|Subject withdrew consent|27|||
160573783|NCT00393458|579821674|FG001|Overall Study|Subject withdrew consent|40|||
160573784|NCT00393458|579821675|FG002|Overall Study|Subject withdrew consent|33|||
160573785|NCT00393458|579821676|FG003|Overall Study|Subject withdrew consent|50|||
160573786|NCT00393458|579821673|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
160573787|NCT00393458|579821674|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
160573788|NCT00393458|579821675|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
160573789|NCT00393458|579821676|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
160654151|NCT01618266|580114276|FG000|Overall Study|Treatment satisfaction|10|||
160654152|NCT01618266|580114276|FG000|Overall Study|Other reasons|11|||
160919461|NCT00811473|581099399|FG000|Overall Study|Adverse Event|3|||
160919462|NCT00811473|581099400|FG001|Overall Study|Adverse Event|12|||
160919463|NCT00811473|581099399|FG000|Overall Study|Lost to Follow-up|5|||
160919464|NCT00811473|581099400|FG001|Overall Study|Lost to Follow-up|1|||
160919465|NCT00811473|581099399|FG000|Overall Study|Withdrawal by Subject|2|||
160919466|NCT00811473|581099400|FG001|Overall Study|Withdrawal by Subject|4|||
160919467|NCT00811473|581099399|FG000|Overall Study|Severe non-compliance to protocol|2|||
160919468|NCT00811473|581099400|FG001|Overall Study|Severe non-compliance to protocol|4|||
160919469|NCT00811473|581099399|FG000|Overall Study|Lack of therapeutic response|4|||
160573790|NCT00393458|579821673|FG000|Overall Study|Protocol deviation|11|||
160573791|NCT00393458|579821674|FG001|Overall Study|Protocol deviation|11|||
160573792|NCT00393458|579821675|FG002|Overall Study|Protocol deviation|11|||
160573793|NCT00393458|579821676|FG003|Overall Study|Protocol deviation|10|||
160573794|NCT00393458|579821673|FG000|Overall Study|Administrative problems|7|||
160573795|NCT00393458|579821674|FG001|Overall Study|Administrative problems|8|||
160573796|NCT00393458|579821675|FG002|Overall Study|Administrative problems|5|||
160573797|NCT00393458|579821676|FG003|Overall Study|Administrative problems|2|||
160573798|NCT00393458|579821673|FG000|Overall Study|Lost to Follow-up|5|||
160573799|NCT00393458|579821674|FG001|Overall Study|Lost to Follow-up|6|||
160573800|NCT00393458|579821675|FG002|Overall Study|Lost to Follow-up|5|||
160573801|NCT00393458|579821676|FG003|Overall Study|Lost to Follow-up|3|||
160573802|NCT00393458|579821673|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160654153|NCT01618266|580114276|FG000|Overall Study|Lack of Efficacy|23|||
160919470|NCT00811473|581099400|FG001|Overall Study|Lack of therapeutic response|1|||
160919471|NCT00811473|581099399|FG000|Overall Study|Condition under investigation worsened|1|||
160919472|NCT00811473|581099400|FG001|Overall Study|Condition under investigation worsened|3|||
160919473|NCT00811473|581099399|FG000|Overall Study|Other 2|4|||
160919474|NCT00811473|581099400|FG001|Overall Study|Other 2|1|||
160919475|NCT00811473|581099399|FG000|Overall Study|Incorrect Enrollment|1|||
160919476|NCT00811473|581099400|FG001|Overall Study|Incorrect Enrollment|0|||
160919477|NCT00811473|581099399|FG000|Overall Study|Safety Reasons|1|||
160919478|NCT00811473|581099400|FG001|Overall Study|Safety Reasons|0|||
160919479|NCT01119131|581099404|FG000|Overall Study|Adverse Event|1|||
160919480|NCT01119131|581099405|FG001|Overall Study|Adverse Event|1|||
160919481|NCT01119131|581099406|FG002|Overall Study|Adverse Event|1|||
160919482|NCT01119131|581099404|FG000|Overall Study|Non-Compliance|1|||
160919483|NCT01119131|581099405|FG001|Overall Study|Non-Compliance|0|||
160919484|NCT01119131|581099406|FG002|Overall Study|Non-Compliance|4|||
160919485|NCT01119131|581099404|FG000|Overall Study|Physician Decision|0|||
160919486|NCT01119131|581099405|FG001|Overall Study|Physician Decision|0|||
160919487|NCT01119131|581099406|FG002|Overall Study|Physician Decision|1|||
160919488|NCT01187043|581099408|FG000|Overall Study|Adverse Event|0|||
160919489|NCT01187043|581099409|FG001|Overall Study|Adverse Event|0|||
160919490|NCT01187043|581099410|FG002|Overall Study|Adverse Event|0|||
160919491|NCT01187043|581099411|FG003|Overall Study|Adverse Event|0|||
160919492|NCT01187043|581099412|FG004|Overall Study|Adverse Event|1|||
160919493|NCT01187043|581099408|FG000|Overall Study|Unable to make scheduled visits|1|||
160919494|NCT01187043|581099409|FG001|Overall Study|Unable to make scheduled visits|0|||
160919495|NCT01187043|581099410|FG002|Overall Study|Unable to make scheduled visits|4|||
160919496|NCT01187043|581099411|FG003|Overall Study|Unable to make scheduled visits|0|||
160919497|NCT01187043|581099412|FG004|Overall Study|Unable to make scheduled visits|1|||
160919498|NCT00573534|581099413|FG000|Overall Study|oppositional behavior|3|||
160919499|NCT03035409|581099414|FG000|Overall Study|Adverse Event|5|||
160919500|NCT03035409|581099414|FG000|Overall Study|Death|2|||
160919501|NCT03035409|581099414|FG000|Overall Study|Withdrawal by Subject|2|||
160919502|NCT03035409|581099414|FG000|Overall Study|Non compliance|4|||
160919503|NCT03035409|581099414|FG000|Overall Study|Patient was jittery|1|||
160919504|NCT03035409|581099414|FG000|Overall Study|Did not like Questionnaire|1|||
160919505|NCT03035409|581099414|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
160919506|NCT03035409|581099414|FG000|Overall Study|Did not like taking drugs|1|||
160919507|NCT00927784|581099417|FG000|Overall Study|Death|1|||
160919508|NCT00927784|581099418|FG001|Overall Study|Death|0|||
160919509|NCT00927784|581099417|FG000|Overall Study|Withdrawal by Subject|1|||
160919510|NCT00927784|581099418|FG001|Overall Study|Withdrawal by Subject|0|||
160919511|NCT02457910|581099419|FG000|Overall Study|Withdrawal by Subject|0|||
160919512|NCT02457910|581099420|FG001|Overall Study|Withdrawal by Subject|0|||
160919513|NCT02457910|581099421|FG002|Overall Study|Withdrawal by Subject|0|||
160919514|NCT02457910|581099422|FG003|Overall Study|Withdrawal by Subject|0|||
160919515|NCT02457910|581099423|FG004|Overall Study|Withdrawal by Subject|0|||
160919516|NCT02457910|581099424|FG005|Overall Study|Withdrawal by Subject|1|||
160919517|NCT02457910|581099419|FG000|Overall Study|Adverse Event|0|||
160919518|NCT02457910|581099420|FG001|Overall Study|Adverse Event|2|||
160919519|NCT02457910|581099421|FG002|Overall Study|Adverse Event|1|||
160919520|NCT02457910|581099422|FG003|Overall Study|Adverse Event|1|||
160919521|NCT02457910|581099423|FG004|Overall Study|Adverse Event|1|||
160919522|NCT02457910|581099424|FG005|Overall Study|Adverse Event|3|||
160919523|NCT02457910|581099419|FG000|Overall Study|Disease progression|3|||
160919524|NCT02457910|581099420|FG001|Overall Study|Disease progression|3|||
160919525|NCT02457910|581099421|FG002|Overall Study|Disease progression|1|||
160919526|NCT02457910|581099422|FG003|Overall Study|Disease progression|1|||
160919527|NCT02457910|581099423|FG004|Overall Study|Disease progression|4|||
160919528|NCT02457910|581099424|FG005|Overall Study|Disease progression|6|||
160919529|NCT02457910|581099419|FG000|Overall Study|Other complicating illness|0|||
160919530|NCT02457910|581099420|FG001|Overall Study|Other complicating illness|0|||
160919531|NCT02457910|581099421|FG002|Overall Study|Other complicating illness|0|||
160919532|NCT02457910|581099422|FG003|Overall Study|Other complicating illness|0|||
160919533|NCT02457910|581099423|FG004|Overall Study|Other complicating illness|0|||
160919534|NCT02457910|581099424|FG005|Overall Study|Other complicating illness|1|||
160919535|NCT02457910|581099419|FG000|Overall Study|Death|0|||
160919536|NCT02457910|581099420|FG001|Overall Study|Death|0|||
160919537|NCT02457910|581099421|FG002|Overall Study|Death|1|||
160919538|NCT02457910|581099422|FG003|Overall Study|Death|0|||
160919539|NCT02457910|581099423|FG004|Overall Study|Death|0|||
160919540|NCT02457910|581099424|FG005|Overall Study|Death|0|||
160919541|NCT00467259|581099425|FG000|Overall Study|Adverse Event|24|||
160919542|NCT00467259|581099426|FG001|Overall Study|Adverse Event|90|||
160919543|NCT00467259|581099425|FG000|Overall Study|Protocol Violation|1|||
160919544|NCT00467259|581099426|FG001|Overall Study|Protocol Violation|7|||
160919545|NCT00467259|581099425|FG000|Overall Study|Withdrawal by Subject|34|||
160919546|NCT00467259|581099426|FG001|Overall Study|Withdrawal by Subject|108|||
160919547|NCT00467259|581099425|FG000|Overall Study|Physician Decision|0|||
160919548|NCT00467259|581099426|FG001|Overall Study|Physician Decision|2|||
160919549|NCT00467259|581099425|FG000|Overall Study|Lost to Follow-up|14|||
160919550|NCT00467259|581099426|FG001|Overall Study|Lost to Follow-up|34|||
160919551|NCT00467259|581099425|FG000|Overall Study|Site Closed|2|||
160919552|NCT00467259|581099426|FG001|Overall Study|Site Closed|1|||
160919553|NCT01339429|581099429|FG000|Overall Study|Withdrawal by Subject|1|||
160919554|NCT01339429|581099429|FG000|Overall Study|Physician Decision|3|||
160919555|NCT00459667|581099430|FG000|Overall Study|Adverse Event|9|||
160919556|NCT00459667|581099431|FG001|Overall Study|Adverse Event|12|||
160919557|NCT00459667|581099432|FG002|Overall Study|Adverse Event|8|||
160919558|NCT00459667|581099430|FG000|Overall Study|Lost to Follow-up|5|||
160919559|NCT00459667|581099431|FG001|Overall Study|Lost to Follow-up|9|||
160919560|NCT00459667|581099432|FG002|Overall Study|Lost to Follow-up|3|||
160919561|NCT00459667|581099430|FG000|Overall Study|Pregnancy|1|||
160919562|NCT00459667|581099431|FG001|Overall Study|Pregnancy|1|||
160919563|NCT00459667|581099432|FG002|Overall Study|Pregnancy|1|||
160919564|NCT00459667|581099430|FG000|Overall Study|Protocol Violation|1|||
160919565|NCT00459667|581099431|FG001|Overall Study|Protocol Violation|0|||
160919566|NCT00459667|581099432|FG002|Overall Study|Protocol Violation|0|||
160919567|NCT00459667|581099430|FG000|Overall Study|Withdrawal by Subject|3|||
160919568|NCT00459667|581099431|FG001|Overall Study|Withdrawal by Subject|5|||
160919569|NCT00459667|581099432|FG002|Overall Study|Withdrawal by Subject|5|||
160919570|NCT00459667|581099430|FG000|Overall Study|Other disease modifying treatment|1|||
160919571|NCT00459667|581099431|FG001|Overall Study|Other disease modifying treatment|2|||
160919572|NCT00459667|581099432|FG002|Overall Study|Other disease modifying treatment|1|||
160919573|NCT00459667|581099430|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
160919574|NCT00459667|581099431|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
160919575|NCT00459667|581099432|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
160919576|NCT00459667|581099430|FG000|Overall Study|No treatment administered|6|||
160919577|NCT00459667|581099431|FG001|Overall Study|No treatment administered|3|||
160919578|NCT00459667|581099432|FG002|Overall Study|No treatment administered|1|||
160919579|NCT00818662|581099434|FG000|Overall Study|Adverse Event|5|||
160919580|NCT00818662|581099435|FG001|Overall Study|Adverse Event|14|||
160919581|NCT00818662|581099436|FG002|Overall Study|Adverse Event|4|||
160919582|NCT00818662|581099437|FG003|Overall Study|Adverse Event|3|||
160919583|NCT00818662|581099434|FG000|Overall Study|Withdrawal by Subject|5|||
160919584|NCT00818662|581099435|FG001|Overall Study|Withdrawal by Subject|4|||
160919585|NCT00818662|581099436|FG002|Overall Study|Withdrawal by Subject|2|||
160919586|NCT00818662|581099437|FG003|Overall Study|Withdrawal by Subject|2|||
160919587|NCT00818662|581099434|FG000|Overall Study|Death|1|||
160919588|NCT00818662|581099435|FG001|Overall Study|Death|3|||
160919589|NCT00818662|581099436|FG002|Overall Study|Death|0|||
160919590|NCT00818662|581099437|FG003|Overall Study|Death|0|||
160919591|NCT00818662|581099434|FG000|Overall Study|Physician Decision|1|||
160919592|NCT00818662|581099435|FG001|Overall Study|Physician Decision|0|||
160919593|NCT00818662|581099436|FG002|Overall Study|Physician Decision|0|||
160919594|NCT00818662|581099437|FG003|Overall Study|Physician Decision|0|||
160919595|NCT00818662|581099434|FG000|Overall Study|Lost to Follow-up|0|||
160919596|NCT00818662|581099435|FG001|Overall Study|Lost to Follow-up|0|||
160919597|NCT00818662|581099436|FG002|Overall Study|Lost to Follow-up|0|||
160919598|NCT00818662|581099437|FG003|Overall Study|Lost to Follow-up|1|||
160919599|NCT00818662|581099434|FG000|Overall Study|Unwilling or Unable to Participate|4|||
160919600|NCT00818662|581099435|FG001|Overall Study|Unwilling or Unable to Participate|6|||
160919601|NCT00818662|581099436|FG002|Overall Study|Unwilling or Unable to Participate|2|||
160919602|NCT00818662|581099437|FG003|Overall Study|Unwilling or Unable to Participate|4|||
160919603|NCT00818662|581099434|FG000|Overall Study|Protocol Violation|1|||
160919604|NCT00818662|581099435|FG001|Overall Study|Protocol Violation|1|||
160919605|NCT00818662|581099436|FG002|Overall Study|Protocol Violation|0|||
160997249|NCT00486759|581374886|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
160997250|NCT00954707|581374887|FG000|Overall Study|Death|34|||
160997251|NCT00954707|581374887|FG000|Overall Study|Withdrawal by Subject|100|||
160997252|NCT00954707|581374887|FG000|Overall Study|Lost to Follow-up|33|||
160997253|NCT02987543|581374888|FG000|Overall Study|Ongoing study at data cut off|49|||
160997254|NCT02987543|581374889|FG001|Overall Study|Ongoing study at data cut off|21|||
160919606|NCT00818662|581099437|FG003|Overall Study|Protocol Violation|0|||
160919607|NCT00818662|581099434|FG000|Overall Study|Requires a Prohibited Medication|1|||
160919608|NCT00818662|581099435|FG001|Overall Study|Requires a Prohibited Medication|0|||
160997255|NCT02987543|581374890|FG002|Overall Study|Ongoing study at data cut off|19|||
160654154|NCT01618266|580114276|FG000|Overall Study|Protocol Violation|43|||
160654155|NCT01966042|580114277|FG000|Overall Study|Death|2|||
160997256|NCT02987543|581374891|FG003|Overall Study|Ongoing study at data cut off|12|||
160997257|NCT02987543|581374888|FG000|Overall Study|Death|88|||
160454667|NCT01928394|579396173|FG003|Treatment Period|Participant request to stop therapy|0|||
160654156|NCT03267264|580114278|FG000|Overall Study|Withdrawal by Subject|1|||
160919609|NCT00818662|581099436|FG002|Overall Study|Requires a Prohibited Medication|0|||
160919610|NCT00818662|581099437|FG003|Overall Study|Requires a Prohibited Medication|0|||
160919611|NCT00818662|581099434|FG000|Overall Study|Safety Risk|1|||
160919612|NCT00818662|581099435|FG001|Overall Study|Safety Risk|1|||
160919613|NCT00818662|581099436|FG002|Overall Study|Safety Risk|0|||
160919614|NCT00818662|581099437|FG003|Overall Study|Safety Risk|1|||
160919615|NCT00818662|581099434|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
160919616|NCT00818662|581099435|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
160919617|NCT00818662|581099436|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
160919618|NCT00818662|581099437|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
160919619|NCT00818662|581099434|FG000|Overall Study|Participant's health declined|0|||
160919620|NCT00818662|581099435|FG001|Overall Study|Participant's health declined|0|||
160919621|NCT00818662|581099436|FG002|Overall Study|Participant's health declined|0|||
160919622|NCT00818662|581099437|FG003|Overall Study|Participant's health declined|1|||
160919623|NCT00818662|581099434|FG000|Overall Study|Caregiver to pursue other treatment|0|||
160919624|NCT00818662|581099435|FG001|Overall Study|Caregiver to pursue other treatment|1|||
160919625|NCT00818662|581099436|FG002|Overall Study|Caregiver to pursue other treatment|0|||
160919626|NCT00818662|581099437|FG003|Overall Study|Caregiver to pursue other treatment|0|||
160919627|NCT00818662|581099434|FG000|Overall Study|Moving out of state|0|||
160919628|NCT00818662|581099435|FG001|Overall Study|Moving out of state|0|||
160919629|NCT00818662|581099436|FG002|Overall Study|Moving out of state|0|||
160919630|NCT00818662|581099437|FG003|Overall Study|Moving out of state|1|||
160919631|NCT00818662|581099434|FG000|Overall Study|Declined move to another study site|1|||
160919632|NCT00818662|581099435|FG001|Overall Study|Declined move to another study site|0|||
160919633|NCT00818662|581099436|FG002|Overall Study|Declined move to another study site|0|||
160919634|NCT00818662|581099437|FG003|Overall Study|Declined move to another study site|0|||
160919635|NCT00818662|581099434|FG000|Overall Study|Change in living situation|0|||
160919636|NCT00818662|581099435|FG001|Overall Study|Change in living situation|0|||
160919637|NCT00818662|581099436|FG002|Overall Study|Change in living situation|0|||
160919638|NCT00818662|581099437|FG003|Overall Study|Change in living situation|1|||
160919639|NCT00818662|581099434|FG000|Overall Study|Study partner decision|0|||
160919640|NCT00818662|581099435|FG001|Overall Study|Study partner decision|0|||
160919641|NCT00818662|581099436|FG002|Overall Study|Study partner decision|0|||
160919642|NCT00818662|581099437|FG003|Overall Study|Study partner decision|1|||
160919643|NCT00818662|581099434|FG000|Overall Study|Admitted to long term nursing care|0|||
160919644|NCT00818662|581099435|FG001|Overall Study|Admitted to long term nursing care|1|||
160919645|NCT00818662|581099436|FG002|Overall Study|Admitted to long term nursing care|0|||
160919646|NCT00818662|581099437|FG003|Overall Study|Admitted to long term nursing care|0|||
160919647|NCT00662363|581099440|FG000|Overall Study|Withdrawal by Subject|6|||
160919648|NCT00662363|581099441|FG001|Overall Study|Withdrawal by Subject|5|||
160919649|NCT00662363|581099440|FG000|Overall Study|Adverse Event|0|||
160919650|NCT00662363|581099441|FG001|Overall Study|Adverse Event|3|||
160919651|NCT00662363|581099440|FG000|Overall Study|Discharged early from rehab|4|||
160919652|NCT00662363|581099441|FG001|Overall Study|Discharged early from rehab|1|||
160919653|NCT00662363|581099440|FG000|Overall Study|Protocol Violation|1|||
160919654|NCT00662363|581099441|FG001|Overall Study|Protocol Violation|1|||
160919655|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Adverse Event|82|||
160919656|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Death|6|||
160919657|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
160919658|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
160919659|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
160919660|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
160919661|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
160919662|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Other reasons|68|||
160919663|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
160919664|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
160919665|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
160919666|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
160919667|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
160919668|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
160919669|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
160919670|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
160919671|NCT00195676|581099442|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
160919672|NCT00195676|581099442|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
160919673|NCT00195676|581099442|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
160919674|NCT00195676|581099442|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
160919675|NCT00195676|581099442|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
160573803|NCT00393458|579821674|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160573804|NCT00393458|579821675|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160573805|NCT00393458|579821676|FG003|Overall Study|Abnormal laboratory value(s)|0|||
160919676|NCT01905657|581099443|FG000|Overall Study|Adverse Event|23|||
160919677|NCT01905657|581099444|FG001|Overall Study|Adverse Event|17|||
160919678|NCT01905657|581099445|FG002|Overall Study|Adverse Event|18|||
160919679|NCT01905657|581099443|FG000|Overall Study|Clinical Progression|103|||
160919680|NCT01905657|581099444|FG001|Overall Study|Clinical Progression|78|||
160573806|NCT00393458|579821673|FG000|Overall Study|Death|1|||
160573807|NCT00393458|579821674|FG001|Overall Study|Death|1|||
160573808|NCT00393458|579821675|FG002|Overall Study|Death|5|||
160573809|NCT00393458|579821676|FG003|Overall Study|Death|5|||
160919681|NCT01905657|581099445|FG002|Overall Study|Clinical Progression|59|||
160919682|NCT01905657|581099443|FG000|Overall Study|Death|40|||
160919683|NCT01905657|581099444|FG001|Overall Study|Death|43|||
160919684|NCT01905657|581099445|FG002|Overall Study|Death|47|||
160919685|NCT01905657|581099443|FG000|Overall Study|Excluded Medication|13|||
160919686|NCT01905657|581099444|FG001|Overall Study|Excluded Medication|16|||
160919687|NCT01905657|581099445|FG002|Overall Study|Excluded Medication|9|||
160919688|NCT01905657|581099443|FG000|Overall Study|Lost to Follow-up|1|||
160919689|NCT01905657|581099444|FG001|Overall Study|Lost to Follow-up|2|||
160919690|NCT01905657|581099445|FG002|Overall Study|Lost to Follow-up|1|||
160919691|NCT01905657|581099443|FG000|Overall Study|Physician Decision|5|||
160919692|NCT01905657|581099444|FG001|Overall Study|Physician Decision|8|||
160919693|NCT01905657|581099445|FG002|Overall Study|Physician Decision|12|||
160919694|NCT01905657|581099443|FG000|Overall Study|Protocol Violation|2|||
160919695|NCT01905657|581099444|FG001|Overall Study|Protocol Violation|1|||
160919696|NCT01905657|581099445|FG002|Overall Study|Protocol Violation|1|||
160919697|NCT01905657|581099443|FG000|Overall Study|Screen Failure|0|||
160919698|NCT01905657|581099444|FG001|Overall Study|Screen Failure|1|||
160919699|NCT01905657|581099445|FG002|Overall Study|Screen Failure|0|||
160919700|NCT01905657|581099443|FG000|Overall Study|Withdrawal by Subject|15|||
160919701|NCT01905657|581099444|FG001|Overall Study|Withdrawal by Subject|21|||
160919702|NCT01905657|581099445|FG002|Overall Study|Withdrawal by Subject|53|||
160919703|NCT01905657|581099443|FG000|Overall Study|Sponsor Decision|1|||
160919704|NCT01905657|581099444|FG001|Overall Study|Sponsor Decision|0|||
160919705|NCT01905657|581099445|FG002|Overall Study|Sponsor Decision|0|||
160919706|NCT01189812|581099446|FG000|Overall Study|Withdrawal by Subject|2|||
160919707|NCT01189812|581099447|FG001|Overall Study|Withdrawal by Subject|3|||
160919708|NCT01189812|581099446|FG000|Overall Study|Adverse Event|1|||
160919709|NCT01189812|581099447|FG001|Overall Study|Adverse Event|0|||
160919710|NCT01189812|581099446|FG000|Overall Study|Out of Window|4|||
160919711|NCT01189812|581099447|FG001|Overall Study|Out of Window|3|||
160919712|NCT01189812|581099446|FG000|Overall Study|Moved out of State|1|||
160919713|NCT01189812|581099447|FG001|Overall Study|Moved out of State|2|||
160919714|NCT03761147|581099449|FG000|Overall Study|Withdrawal by Subject|6|||
160919715|NCT03761147|581099450|FG001|Overall Study|Withdrawal by Subject|1|||
160919716|NCT03761147|581099449|FG000|Overall Study|Adverse Event|1|||
160919717|NCT03761147|581099450|FG001|Overall Study|Adverse Event|3|||
160919718|NCT02744391|581099451|FG000|Overall Study|Lost to Follow-up|9|||
160919719|NCT02744391|581099451|FG000|Overall Study|Physician Decision|2|||
160919720|NCT02744391|581099451|FG000|Overall Study|Withdrawal by Subject|3|||
160919721|NCT05119569|581099452|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
160919722|NCT05119569|581099453|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
160919723|NCT05119569|581099454|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
160919724|NCT05119569|581099455|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
160919725|NCT05119569|581099452|FG000|Double Blind Treatment Phase|Adverse Event|6|||
160919726|NCT05119569|581099453|FG001|Double Blind Treatment Phase|Adverse Event|0|||
160919727|NCT05119569|581099454|FG002|Double Blind Treatment Phase|Adverse Event|0|||
160919728|NCT05119569|581099455|FG003|Double Blind Treatment Phase|Adverse Event|0|||
160919729|NCT05119569|581099452|FG000|Open Label Extension Phase|Ongoing in the study|0|||
160919730|NCT05119569|581099453|FG001|Open Label Extension Phase|Ongoing in the study|0|||
160919731|NCT05119569|581099454|FG002|Open Label Extension Phase|Ongoing in the study|65|||
160919732|NCT05119569|581099455|FG003|Open Label Extension Phase|Ongoing in the study|34|||
160919733|NCT02623439|581099456|FG000|Overall Study|Withdrawal by Subject|1|||
160919734|NCT02623439|581099456|FG000|Overall Study|Screen Failure|1|||
160919735|NCT02200445|581099460|FG000|Overall Study|Lack of Efficacy|1|||
160919736|NCT02200445|581099461|FG001|Overall Study|Lack of Efficacy|2|||
160919737|NCT02200445|581099462|FG002|Overall Study|Lack of Efficacy|2|||
160919738|NCT02200445|581099460|FG000|Overall Study|Adverse Event|0|||
160919739|NCT02200445|581099461|FG001|Overall Study|Adverse Event|2|||
160997258|NCT02987543|581374889|FG001|Overall Study|Death|54|||
160997259|NCT02987543|581374890|FG002|Overall Study|Death|67|||
160573810|NCT00393458|579821673|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160573811|NCT00393458|579821674|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160573812|NCT00393458|579821675|FG002|Overall Study|Abnormal test procedure result(s)|1|||
160919740|NCT02200445|581099462|FG002|Overall Study|Adverse Event|0|||
160919741|NCT03700671|581099463|FG000|Overall Study|Lack of Efficacy|1|||
160919742|NCT03700671|581099464|FG001|Overall Study|Lack of Efficacy|2|||
160919743|NCT03851302|581099471|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
160919744|NCT03851302|581099472|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
160919745|NCT03851302|581099473|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
160919746|NCT03851302|581099474|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
160919747|NCT03851302|581099475|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
160919748|NCT03851302|581099476|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
160919749|NCT03851302|581099471|FG000|Screening (1 Day)|Screened out|0|||
160997260|NCT02987543|581374891|FG003|Overall Study|Death|28|||
160573813|NCT00393458|579821676|FG003|Overall Study|Abnormal test procedure result(s)|2|||
160919750|NCT03851302|581099472|FG001|Screening (1 Day)|Screened out|0|||
160919751|NCT03851302|581099473|FG002|Screening (1 Day)|Screened out|1|||
160919752|NCT03851302|581099474|FG003|Screening (1 Day)|Screened out|1|||
160919753|NCT03851302|581099475|FG004|Screening (1 Day)|Screened out|0|||
160919754|NCT03851302|581099476|FG005|Screening (1 Day)|Screened out|0|||
160919755|NCT03851302|581099471|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
160919756|NCT03851302|581099472|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
160919757|NCT03851302|581099473|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
160919758|NCT03851302|581099474|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
160919759|NCT03851302|581099475|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
160919760|NCT03851302|581099476|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
160919761|NCT04434092|581099477|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
160919762|NCT04434092|581099478|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
160919763|NCT04434092|581099479|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
160919764|NCT04434092|581099477|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
160919765|NCT04434092|581099478|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
160919766|NCT04434092|581099479|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
160919767|NCT04434092|581099477|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
160919768|NCT04434092|581099478|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
160919769|NCT04434092|581099479|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
160919770|NCT04434092|581099477|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
160919771|NCT04434092|581099478|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
160919772|NCT04434092|581099479|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
160919773|NCT04434092|581099477|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
160919774|NCT04434092|581099478|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
160919775|NCT04434092|581099479|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
160919776|NCT04434092|581099477|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
160919777|NCT04434092|581099478|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
160919778|NCT04434092|581099479|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
160919779|NCT04434092|581099477|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
160919780|NCT04434092|581099478|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
160919781|NCT04434092|581099479|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
160919782|NCT03220217|581101306|FG000|Overall Study|Withdrawal by Subject|0|||
160919783|NCT03220217|581101307|FG001|Overall Study|Withdrawal by Subject|1|||
160919784|NCT03220217|581101308|FG002|Overall Study|Withdrawal by Subject|0|||
160919785|NCT03220217|581101306|FG000|Overall Study|Subject Missed Procedure|0|||
160919786|NCT03220217|581101307|FG001|Overall Study|Subject Missed Procedure|0|||
160919787|NCT03220217|581101308|FG002|Overall Study|Subject Missed Procedure|1|||
160919788|NCT00312494|581101309|FG000|Overall Study|Randomized; not treated with study drug|9|||
160919789|NCT00312494|581101310|FG001|Overall Study|Randomized; not treated with study drug|10|||
160919790|NCT00312494|581101311|FG002|Overall Study|Randomized; not treated with study drug|5|||
160919791|NCT00312494|581101309|FG000|Overall Study|Adverse Event|33|||
160919792|NCT00312494|581101310|FG001|Overall Study|Adverse Event|15|||
160919793|NCT00312494|581101311|FG002|Overall Study|Adverse Event|11|||
160919794|NCT00312494|581101309|FG000|Overall Study|Lack of Efficacy|4|||
160919795|NCT00312494|581101310|FG001|Overall Study|Lack of Efficacy|6|||
160919796|NCT00312494|581101311|FG002|Overall Study|Lack of Efficacy|8|||
160919797|NCT00312494|581101309|FG000|Overall Study|Laboratory abnormality|1|||
160919798|NCT00312494|581101310|FG001|Overall Study|Laboratory abnormality|0|||
160919799|NCT00312494|581101311|FG002|Overall Study|Laboratory abnormality|0|||
160919800|NCT00312494|581101309|FG000|Overall Study|Lost to Follow-up|8|||
160919801|NCT00312494|581101310|FG001|Overall Study|Lost to Follow-up|8|||
160919802|NCT00312494|581101311|FG002|Overall Study|Lost to Follow-up|8|||
160919803|NCT00312494|581101309|FG000|Overall Study|Withdrawal by Subject|6|||
160919804|NCT00312494|581101310|FG001|Overall Study|Withdrawal by Subject|9|||
160919805|NCT00312494|581101311|FG002|Overall Study|Withdrawal by Subject|10|||
160919806|NCT00312494|581101309|FG000|Overall Study|Other|10|||
160919807|NCT00312494|581101310|FG001|Overall Study|Other|10|||
160919808|NCT00312494|581101311|FG002|Overall Study|Other|1|||
160919809|NCT00501293|581101312|FG000|Optimization Period|Enrolled in error|1|||
160919810|NCT00501293|581101313|FG001|Optimization Period|Enrolled in error|0|||
160919811|NCT00501293|581101312|FG000|Maintenance Period|Withdrawal by Subject|14|||
160997261|NCT02987543|581374888|FG000|Overall Study|Lost to Follow-up|3|||
160573814|NCT00393458|579821673|FG000|Overall Study|Subject no longer requires study drug|0|||
160997262|NCT02987543|581374889|FG001|Overall Study|Lost to Follow-up|0|||
160573815|NCT00393458|579821674|FG001|Overall Study|Subject no longer requires study drug|1|||
160573816|NCT00393458|579821675|FG002|Overall Study|Subject no longer requires study drug|0|||
160573817|NCT00393458|579821676|FG003|Overall Study|Subject no longer requires study drug|0|||
160573818|NCT02519231|579821685|FG000|Overall Study|Lost to Follow-up|2|||
160997263|NCT02987543|581374890|FG002|Overall Study|Lost to Follow-up|1|||
160573819|NCT02519231|579821686|FG001|Overall Study|Lost to Follow-up|5|||
160919812|NCT00501293|581101313|FG001|Maintenance Period|Withdrawal by Subject|13|||
160919813|NCT00501293|581101312|FG000|Maintenance Period|Lost to Follow-up|12|||
160919814|NCT00501293|581101313|FG001|Maintenance Period|Lost to Follow-up|7|||
160919815|NCT00501293|581101312|FG000|Maintenance Period|Adverse Event|6|||
160919816|NCT00501293|581101313|FG001|Maintenance Period|Adverse Event|6|||
160919817|NCT00501293|581101312|FG000|Maintenance Period|Protocol Violation|2|||
160919818|NCT00501293|581101313|FG001|Maintenance Period|Protocol Violation|1|||
160919819|NCT00501293|581101312|FG000|Maintenance Period|Lack of Efficacy|4|||
160919820|NCT00501293|581101313|FG001|Maintenance Period|Lack of Efficacy|1|||
160919821|NCT00501293|581101312|FG000|Maintenance Period|Noncompliant with study medication|5|||
160919822|NCT00501293|581101313|FG001|Maintenance Period|Noncompliant with study medication|0|||
160919823|NCT00501293|581101312|FG000|Maintenance Period|Went into rehabilitation|1|||
160919824|NCT00501293|581101313|FG001|Maintenance Period|Went into rehabilitation|0|||
160919825|NCT00501293|581101312|FG000|Maintenance Period|Would not wear patch|1|||
160919826|NCT00501293|581101313|FG001|Maintenance Period|Would not wear patch|0|||
160919827|NCT00501293|581101312|FG000|Maintenance Period|Application site reaction|1|||
160919828|NCT00501293|581101313|FG001|Maintenance Period|Application site reaction|0|||
160919829|NCT02865187|581101321|FG000|Overall Study|Lost to Follow-up|12|||
160919830|NCT02865187|581101322|FG001|Overall Study|Lost to Follow-up|7|||
160919831|NCT02865187|581101321|FG000|Overall Study|Adverse Event|1|||
160919832|NCT02865187|581101322|FG001|Overall Study|Adverse Event|0|||
160919833|NCT04267133|581101323|FG000|Overall Study|Withdrawal by Subject|1|||
160919834|NCT04267133|581101323|FG000|Overall Study|Adverse Event|4|||
160919835|NCT02968563|581101324|FG000|Overall Study|Adverse Event|0|||
160919836|NCT02968563|581101325|FG001|Overall Study|Adverse Event|6|||
160919837|NCT02968563|581101324|FG000|Overall Study|Death|1|||
160919838|NCT02968563|581101325|FG001|Overall Study|Death|1|||
160919839|NCT02968563|581101324|FG000|Overall Study|Lost to Follow-up|0|||
160919840|NCT02968563|581101325|FG001|Overall Study|Lost to Follow-up|1|||
160919841|NCT00674661|581101326|FG000|Overall Study|Other|5|||
160919842|NCT00674661|581101327|FG001|Overall Study|Other|7|||
160919843|NCT00674661|581101326|FG000|Overall Study|Lost to Follow-up|6|||
160919844|NCT00674661|581101327|FG001|Overall Study|Lost to Follow-up|3|||
160919845|NCT00674661|581101326|FG000|Overall Study|Withdrawal by Subject|0|||
160919846|NCT00674661|581101327|FG001|Overall Study|Withdrawal by Subject|5|||
160919847|NCT03566823|581101333|FG000|Overall Study|Lack of Efficacy|0|||
160919848|NCT03566823|581101334|FG001|Overall Study|Lack of Efficacy|1|||
160919849|NCT03566823|581101335|FG002|Overall Study|Lack of Efficacy|0|||
160919850|NCT03566823|581101333|FG000|Overall Study|Withdrawal by Subject|1|||
160919851|NCT03566823|581101334|FG001|Overall Study|Withdrawal by Subject|2|||
160919852|NCT03566823|581101335|FG002|Overall Study|Withdrawal by Subject|0|||
160919853|NCT03566823|581101333|FG000|Overall Study|Adverse Event|1|||
160919854|NCT03566823|581101334|FG001|Overall Study|Adverse Event|0|||
160919855|NCT03566823|581101335|FG002|Overall Study|Adverse Event|2|||
160919856|NCT01909479|581101336|FG000|From Baseline to Week 26|Adverse Event|3|||
160919857|NCT01909479|581101337|FG001|From Baseline to Week 26|Adverse Event|2|||
160919858|NCT01909479|581101336|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
160919859|NCT01909479|581101337|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
160919860|NCT01909479|581101336|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
160919861|NCT01909479|581101337|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
160919862|NCT01909479|581101336|FG000|26 - 52 Weeks|Adverse Event|0|||
160919863|NCT01909479|581101337|FG001|26 - 52 Weeks|Adverse Event|1|||
160919864|NCT01909479|581101336|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
160997264|NCT02987543|581374891|FG003|Overall Study|Lost to Follow-up|0|||
160997265|NCT02987543|581374888|FG000|Overall Study|Screen failure|0|||
160997266|NCT02987543|581374889|FG001|Overall Study|Screen failure|0|||
160997267|NCT02987543|581374890|FG002|Overall Study|Screen failure|0|||
160997268|NCT02987543|581374891|FG003|Overall Study|Screen failure|1|||
160997269|NCT02987543|581374888|FG000|Overall Study|Withdrawal by Subject|21|||
160997270|NCT02987543|581374889|FG001|Overall Study|Withdrawal by Subject|7|||
160997271|NCT02987543|581374890|FG002|Overall Study|Withdrawal by Subject|7|||
160997272|NCT02987543|581374891|FG003|Overall Study|Withdrawal by Subject|6|||
160997273|NCT02987543|581374888|FG000|Overall Study|Study terminated by sponsor|1|||
160454668|NCT01928394|579396174|FG004|Treatment Period|Participant request to stop therapy|0|||
160454669|NCT01928394|579396175|FG005|Treatment Period|Participant request to stop therapy|3|||
160919865|NCT01909479|581101337|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
160919866|NCT01909479|581101336|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
160997274|NCT02987543|581374889|FG001|Overall Study|Study terminated by sponsor|0|||
160997275|NCT02987543|581374890|FG002|Overall Study|Study terminated by sponsor|0|||
160454670|NCT01928394|579396176|FG006|Treatment Period|Participant request to stop therapy|3|||
160919867|NCT01909479|581101337|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
160919868|NCT01909479|581101336|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
160919869|NCT01909479|581101337|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
160997276|NCT02987543|581374891|FG003|Overall Study|Study terminated by sponsor|0|||
160997277|NCT02987543|581374888|FG000|Overall Study|Investigator decision|0|||
160919870|NCT01909479|581101336|FG000|52 Weeks to End of Study|Adverse Event|2|||
160919871|NCT01909479|581101337|FG001|52 Weeks to End of Study|Adverse Event|1|||
160919872|NCT01909479|581101336|FG000|52 Weeks to End of Study|Death|0|||
160919873|NCT01909479|581101337|FG001|52 Weeks to End of Study|Death|1|||
160919874|NCT01909479|581101336|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
160919875|NCT01909479|581101337|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
160919876|NCT01909479|581101336|FG000|52 Weeks to End of Study|Protocol Violation|1|||
160919877|NCT01909479|581101337|FG001|52 Weeks to End of Study|Protocol Violation|0|||
160919878|NCT01909479|581101336|FG000|52 Weeks to End of Study|Progressive disease|1|||
160919879|NCT01909479|581101337|FG001|52 Weeks to End of Study|Progressive disease|1|||
160919880|NCT01909479|581101336|FG000|52 Weeks to End of Study|Personal reasons|2|||
160919881|NCT01909479|581101337|FG001|52 Weeks to End of Study|Personal reasons|1|||
160919882|NCT01909479|581101336|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
160919883|NCT01909479|581101337|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
160919884|NCT01909479|581101336|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
160919885|NCT01909479|581101337|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
160919886|NCT01909479|581101336|FG000|52 Weeks to End of Study|Lack of contact|1|||
160919887|NCT01909479|581101337|FG001|52 Weeks to End of Study|Lack of contact|0|||
160919888|NCT01909479|581101336|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
160919889|NCT01909479|581101337|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
160919890|NCT01909479|581101336|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
160919891|NCT01909479|581101337|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
160919892|NCT03557151|581101339|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
160919893|NCT03557151|581101340|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
160919894|NCT03557151|581101339|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
160919895|NCT03557151|581101340|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
160919896|NCT03557151|581101339|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
160919897|NCT03557151|581101340|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
160919898|NCT02810392|581101341|FG000|Overall Study|Subject too ill to continue|1|||
160919899|NCT02810392|581101342|FG001|Overall Study|Subject too ill to continue|0|||
160919900|NCT02810392|581101341|FG000|Overall Study|COVID 19 research restrictions|0|||
160919901|NCT02810392|581101342|FG001|Overall Study|COVID 19 research restrictions|1|||
160919902|NCT06079320|581101345|FG000|Follow up Phase|Lost to Follow-up|1|||
160919903|NCT06079320|581101346|FG001|Follow up Phase|Lost to Follow-up|0|||
160919904|NCT01405742|581101347|FG000|Overall Study|Lost to Follow-up|1|||
160919905|NCT01405742|581101348|FG001|Overall Study|Lost to Follow-up|0|||
160919906|NCT04900220|581101349|FG000|Overall Study|Lost to Follow-up|1|||
160919907|NCT04900220|581101350|FG001|Overall Study|Lost to Follow-up|1|||
160919908|NCT02196558|581101351|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
160919909|NCT02196558|581101352|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
160919910|NCT02196558|581101353|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
160919911|NCT02196558|581101351|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
160919912|NCT02196558|581101352|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
160919913|NCT02196558|581101353|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
160919914|NCT02196558|581101351|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
160919915|NCT02196558|581101352|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
160919916|NCT02196558|581101353|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
160919917|NCT02196558|581101351|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
160919918|NCT02196558|581101352|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
160919919|NCT02196558|581101353|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
160919920|NCT02196558|581101351|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
160919921|NCT02196558|581101352|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
160919922|NCT02196558|581101353|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
160919923|NCT03428360|581101355|FG000|Overall Study|Informed consent withdrawn|5|||
160919924|NCT03428360|581101355|FG000|Overall Study|Withdrawal by Subject|4|||
160919925|NCT03428360|581101355|FG000|Overall Study|Lost to Follow-up|5|||
160919926|NCT03428360|581101355|FG000|Overall Study|Physician Decision|2|||
160919927|NCT03428360|581101355|FG000|Overall Study|Informed consent withdrawn|5|||
160919928|NCT03428360|581101355|FG000|Overall Study|Study terminated by sponsor|10|||
160919929|NCT03428360|581101355|FG000|Overall Study|Non-compliant with study|1|||
160919930|NCT03428360|581101355|FG000|Overall Study|Non-compliant with study drug|3|||
160919931|NCT03428360|581101355|FG000|Overall Study|Death|3|||
160919932|NCT03428360|581101355|FG000|Overall Study|Adverse Event|1|||
160919933|NCT03428360|581101355|FG000|Overall Study|Not on antiepileptic drug|1|||
160919934|NCT02107482|581101359|FG000|Overall Study|inconveinence|2|||
160919935|NCT02107482|581101359|FG000|Overall Study|Lost to Follow-up|1|||
160919936|NCT02107482|581101359|FG000|Overall Study|Lack of Efficacy|1|||
160919937|NCT00576927|581101362|FG000|Clinical Assessment|Lack of Efficacy|24|||
160919938|NCT00576927|581101362|FG000|Clinical Assessment|Death|1|||
160919939|NCT00576927|581101362|FG000|Clinical Assessment|Withdrawal by Subject|10|||
160919940|NCT00576927|581101362|FG000|Clinical Assessment|Physician Decision|1|||
160919941|NCT00576927|581101362|FG000|Baseline|Physician Decision|9|||
160919942|NCT00576927|581101362|FG000|Baseline|Medication Change by PCP of subject|1|||
160919943|NCT00576927|581101362|FG000|Baseline|Withdrawal by Subject|3|||
160919944|NCT00576927|581101362|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
160919945|NCT00576927|581101362|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
160919946|NCT00576927|581101362|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
160919947|NCT00576927|581101362|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
160919948|NCT00576927|581101362|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
160919949|NCT03128892|581101363|FG000|Overall Study|Withdrawal by Subject|2|||
160919950|NCT03128892|581101363|FG000|Overall Study|Physician Decision|1|||
160919951|NCT01850524|581101365|FG000|Overall Study|Lost to Follow-up|5|||
160919952|NCT01850524|581101366|FG001|Overall Study|Lost to Follow-up|10|||
160919953|NCT01850524|581101365|FG000|Overall Study|Withdrawal by Subject|24|||
160919954|NCT01850524|581101366|FG001|Overall Study|Withdrawal by Subject|22|||
160919955|NCT01850524|581101365|FG000|Overall Study|Reason not Specified|142|||
160919956|NCT01850524|581101366|FG001|Overall Study|Reason not Specified|141|||
160919957|NCT00368355|581101367|FG000|Overall Study|Adverse Event|1|||
160919958|NCT00368355|581101368|FG001|Overall Study|Adverse Event|0|||
160919959|NCT00368355|581101367|FG000|Overall Study|Death|2|||
160919960|NCT00368355|581101368|FG001|Overall Study|Death|4|||
160919961|NCT00368355|581101367|FG000|Overall Study|Relapse|6|||
160919962|NCT00368355|581101368|FG001|Overall Study|Relapse|10|||
160919963|NCT00368355|581101367|FG000|Overall Study|Subsequent transplant|0|||
160919964|NCT00368355|581101368|FG001|Overall Study|Subsequent transplant|3|||
160919965|NCT00368355|581101367|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
160919966|NCT00368355|581101368|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
160919967|NCT03473808|581101378|FG000|Overall Study|Withdrawal by Subject|1|||
160919968|NCT02157298|581101381|FG000|Overall Study|Adverse Event|1|||
160919969|NCT02157298|581101382|FG001|Overall Study|Adverse Event|0|||
160919970|NCT02157298|581101381|FG000|Overall Study|Subject no longer meets study criteria|1|||
160919971|NCT02157298|581101382|FG001|Overall Study|Subject no longer meets study criteria|2|||
160919972|NCT02157298|581101381|FG000|Overall Study|Poor/Non-compliance|1|||
160919973|NCT02157298|581101382|FG001|Overall Study|Poor/Non-compliance|0|||
160919974|NCT02157298|581101381|FG000|Overall Study|Withdrawal by Subject|1|||
160919975|NCT02157298|581101382|FG001|Overall Study|Withdrawal by Subject|0|||
160919976|NCT04059094|581101383|FG000|Overall Study|Adverse Event|0|||
160919977|NCT04059094|581101384|FG001|Overall Study|Adverse Event|0|||
160919978|NCT04059094|581101385|FG002|Overall Study|Adverse Event|0|||
160919979|NCT04059094|581101386|FG003|Overall Study|Adverse Event|0|||
160919980|NCT04059094|581101387|FG004|Overall Study|Adverse Event|1|||
160919981|NCT04059094|581101383|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
160919982|NCT04059094|581101384|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
160919983|NCT04059094|581101385|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
160919984|NCT04059094|581101386|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
160919985|NCT04059094|581101387|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
160919986|NCT01085591|581101388|FG000|Overall Study|Adverse Event|0|||
160919987|NCT01085591|581101389|FG001|Overall Study|Adverse Event|1|||
160919988|NCT01085591|581101390|FG002|Overall Study|Adverse Event|3|||
160919989|NCT01085591|581101388|FG000|Overall Study|Physician Decision|1|||
160919990|NCT01085591|581101389|FG001|Overall Study|Physician Decision|0|||
160919991|NCT01085591|581101390|FG002|Overall Study|Physician Decision|1|||
160919992|NCT01085591|581101388|FG000|Overall Study|Withdrawal by Subject|0|||
160919993|NCT01085591|581101389|FG001|Overall Study|Withdrawal by Subject|2|||
160919994|NCT01085591|581101390|FG002|Overall Study|Withdrawal by Subject|1|||
160919995|NCT01085591|581101388|FG000|Overall Study|Lost to Follow-up|0|||
160919996|NCT01085591|581101389|FG001|Overall Study|Lost to Follow-up|1|||
160919997|NCT01085591|581101390|FG002|Overall Study|Lost to Follow-up|1|||
160919998|NCT01085591|581101388|FG000|Overall Study|Protocol Violation|1|||
160919999|NCT01085591|581101389|FG001|Overall Study|Protocol Violation|1|||
160997278|NCT02987543|581374889|FG001|Overall Study|Investigator decision|1|||
160997279|NCT02987543|581374890|FG002|Overall Study|Investigator decision|0|||
160920000|NCT01085591|581101390|FG002|Overall Study|Protocol Violation|1|||
160920001|NCT01085591|581101388|FG000|Overall Study|Other|0|||
160920002|NCT01085591|581101389|FG001|Overall Study|Other|1|||
160920003|NCT01085591|581101390|FG002|Overall Study|Other|0|||
160920004|NCT01085591|581101388|FG000|Overall Study|Not Properly Consented|1|||
160997280|NCT02987543|581374891|FG003|Overall Study|Investigator decision|0|||
160454671|NCT01928394|579396177|FG007|Treatment Period|Participant request to stop therapy|0|||
160573820|NCT02519231|579821685|FG000|Overall Study|Withdrawal by Subject|0|||
160920005|NCT01085591|581101389|FG001|Overall Study|Not Properly Consented|0|||
160920006|NCT01085591|581101390|FG002|Overall Study|Not Properly Consented|0|||
160920007|NCT03715764|581101395|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
160920008|NCT03715764|581101396|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
160920009|NCT03715764|581101395|FG000|3 Month Follow-up|Lost to Follow-up|2|||
160920010|NCT03715764|581101396|FG001|3 Month Follow-up|Lost to Follow-up|2|||
160920011|NCT03715764|581101395|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
160997281|NCT02987543|581374888|FG000|Overall Study|Disease progression|0|||
160920012|NCT03715764|581101396|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
160920013|NCT03715764|581101395|FG000|6 Month Follow-up|Lost to Follow-up|3|||
160920014|NCT03715764|581101396|FG001|6 Month Follow-up|Lost to Follow-up|0|||
160920015|NCT03715764|581101395|FG000|12 Month Follow-up|Lost to Follow-up|2|||
160920016|NCT03715764|581101396|FG001|12 Month Follow-up|Lost to Follow-up|3|||
160920017|NCT03715764|581101395|FG000|12 Month Follow-up|Pregnancy|0|||
160920018|NCT03715764|581101396|FG001|12 Month Follow-up|Pregnancy|1|||
160920019|NCT03715764|581101395|FG000|12 Month Follow-up|Surgery|2|||
160920020|NCT03715764|581101396|FG001|12 Month Follow-up|Surgery|0|||
160920021|NCT03715764|581101395|FG000|12 Month Follow-up|Wrong address|1|||
160920022|NCT03715764|581101396|FG001|12 Month Follow-up|Wrong address|0|||
160920023|NCT03715764|581101395|FG000|12 Month Follow-up|No symptoms|1|||
160920024|NCT03715764|581101396|FG001|12 Month Follow-up|No symptoms|0|||
160573821|NCT02519231|579821686|FG001|Overall Study|Withdrawal by Subject|1|||
160573822|NCT02704429|579821687|FG000|Part A: 24 Weeks|Adverse Event|3|||
160920025|NCT03715764|581101395|FG000|12 Month Follow-up|Changed primary care centre|0|||
160920026|NCT03715764|581101396|FG001|12 Month Follow-up|Changed primary care centre|1|||
160920027|NCT01013701|581101397|FG000|Overall Study|study prematurely terminated|7|||
160920028|NCT00556712|581101401|FG000|Overall Study|Adverse Event|7|||
160920029|NCT00556712|581101402|FG001|Overall Study|Adverse Event|19|||
160920030|NCT00556712|581101401|FG000|Overall Study|Death|5|||
160920031|NCT00556712|581101402|FG001|Overall Study|Death|10|||
160920032|NCT00556712|581101401|FG000|Overall Study|Progressive Disease|383|||
160920033|NCT00556712|581101402|FG001|Overall Study|Progressive Disease|320|||
160920034|NCT00556712|581101401|FG000|Overall Study|Protocol Violation|3|||
160920035|NCT00556712|581101402|FG001|Overall Study|Protocol Violation|2|||
160920036|NCT00556712|581101401|FG000|Overall Study|Refused Treatment|17|||
160920037|NCT00556712|581101402|FG001|Overall Study|Refused Treatment|16|||
160920038|NCT00556712|581101401|FG000|Overall Study|Failure to Return|2|||
160920039|NCT00556712|581101402|FG001|Overall Study|Failure to Return|3|||
160920040|NCT00556712|581101401|FG000|Overall Study|Other|2|||
160920041|NCT00556712|581101402|FG001|Overall Study|Other|2|||
160920042|NCT00556712|581101401|FG000|Overall Study|Ongoing at Data Cutoff|32|||
160920043|NCT00556712|581101402|FG001|Overall Study|Ongoing at Data Cutoff|66|||
160920044|NCT01059799|581101404|FG000|Overall Study|Adverse Event|2|||
160920045|NCT01059799|581101405|FG001|Overall Study|Adverse Event|3|||
160920046|NCT01059799|581101404|FG000|Overall Study|Lack of Efficacy|1|||
160920047|NCT01059799|581101405|FG001|Overall Study|Lack of Efficacy|0|||
160920048|NCT01059799|581101404|FG000|Overall Study|Protocol Violation|3|||
160920049|NCT01059799|581101405|FG001|Overall Study|Protocol Violation|2|||
160920050|NCT01059799|581101404|FG000|Overall Study|Withdrawal criteria|13|||
160920051|NCT01059799|581101405|FG001|Overall Study|Withdrawal criteria|2|||
160920052|NCT01059799|581101404|FG000|Overall Study|Other|12|||
160920053|NCT01059799|581101405|FG001|Overall Study|Other|3|||
160920054|NCT01361464|581101406|FG000|Overall Study|Death|1|||
160920055|NCT01361464|581101406|FG000|Overall Study|Withdrawal by Subject|2|||
160920056|NCT03021265|581101410|FG000|Overall Study|Adverse Event|29|||
160920057|NCT03021265|581101410|FG000|Overall Study|Lack of Efficacy|3|||
160920058|NCT03021265|581101410|FG000|Overall Study|Improved|17|||
160920059|NCT03021265|581101410|FG000|Overall Study|Lost to Follow-up|67|||
160920060|NCT03021265|581101410|FG000|Overall Study|No reason given|2|||
160920061|NCT03021265|581101410|FG000|Overall Study|No visit since the first visit|4|||
160920062|NCT01106898|581101411|FG000|Overall Study|Adverse Event|6|||
160920063|NCT01722071|581101412|FG000|Overall Study|Protocol Violation|1|||
160920064|NCT01722071|581101413|FG001|Overall Study|Protocol Violation|0|||
160920065|NCT01338493|581101414|FG000|Enrolled|Withdrawal by Subject|1|||
160920066|NCT01338493|581101414|FG000|Enrolled|Patient not implanted|4|||
160920067|NCT01338493|581101414|FG000|Discharge|Death|1|||
160920068|NCT01338493|581101414|FG000|Discharge|Missed visit|1|||
160920069|NCT01338493|581101414|FG000|6 Months Follow up|Lost to Follow-up|11|||
160920070|NCT01338493|581101414|FG000|6 Months Follow up|Missed visit|8|||
160920071|NCT01338493|581101414|FG000|12 Months Follow up|Lost to Follow-up|9|||
160920072|NCT01846611|581101415|FG000|Overall Study|Lost to Follow-up|4|||
160573823|NCT02704429|579821688|FG001|Part A: 24 Weeks|Adverse Event|0|||
160573824|NCT02704429|579821687|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
160573825|NCT02704429|579821688|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
160573826|NCT00447421|579821690|FG000|Overall Study|Lack of Efficacy|1|||
160573827|NCT00447421|579821690|FG000|Overall Study|Adverse Event|3|||
160920073|NCT01846611|581101416|FG001|Overall Study|Lost to Follow-up|6|||
160920074|NCT01846611|581101415|FG000|Overall Study|Withdrawal by Subject|15|||
160920075|NCT01846611|581101416|FG001|Overall Study|Withdrawal by Subject|19|||
160920076|NCT01846611|581101415|FG000|Overall Study|Other|19|||
160920077|NCT01846611|581101416|FG001|Overall Study|Other|18|||
160920078|NCT01614067|581101417|FG000|Overall Study|Pregnancy|1|||
160920079|NCT01614067|581101418|FG001|Overall Study|Pregnancy|0|||
160920080|NCT01614067|581101417|FG000|Overall Study|Physician Decision|6|||
160920081|NCT01614067|581101418|FG001|Overall Study|Physician Decision|5|||
160920082|NCT01614067|581101417|FG000|Overall Study|Withdrawal by Subject|0|||
160920083|NCT01614067|581101418|FG001|Overall Study|Withdrawal by Subject|1|||
160920084|NCT01614067|581101417|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
160920085|NCT01614067|581101418|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
160920086|NCT02289079|581101419|FG000|Overall Study|Physician Decision|2|||
160920087|NCT02289079|581101420|FG001|Overall Study|Physician Decision|0|||
160920088|NCT02289079|581101419|FG000|Overall Study|Lost to Follow-up|0|||
160573828|NCT00447421|579821690|FG000|Overall Study|Sponsor Decision|2|||
160920089|NCT02289079|581101420|FG001|Overall Study|Lost to Follow-up|1|||
160920090|NCT02671422|581101421|FG000|Overall Study|Lost to Follow-up|1|||
160920091|NCT02671422|581101421|FG000|Overall Study|Adverse Event|68|||
160920092|NCT02671422|581101421|FG000|Overall Study|Lack of Efficacy|1|||
160920093|NCT02671422|581101421|FG000|Overall Study|Lost to Follow-up|4|||
160920094|NCT02671422|581101421|FG000|Overall Study|Withdrawal by Subject|7|||
160920095|NCT02671422|581101421|FG000|Overall Study|Progressive Disease|156|||
160920096|NCT02671422|581101421|FG000|Overall Study|Worsening of Disease|4|||
160920097|NCT02671422|581101421|FG000|Overall Study|Sponsor decision|5|||
160920098|NCT02671422|581101421|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
160920099|NCT02671422|581101421|FG000|Overall Study|Not treated with Vargatef®|3|||
160920100|NCT02671422|581101421|FG000|Overall Study|Other not defined above|3|||
160920101|NCT02111850|581101422|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920102|NCT02111850|581101423|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920103|NCT02111850|581101424|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920104|NCT02111850|581101425|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920105|NCT02111850|581101426|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
160920106|NCT02111850|581101427|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920107|NCT02111850|581101428|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920108|NCT02111850|581101429|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920109|NCT02111850|581101430|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920110|NCT02111850|581101431|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920111|NCT02111850|581101432|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920112|NCT03061331|581101433|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
160920113|NCT03061331|581101434|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
160920114|NCT02625259|581101435|FG000|First Intervention (Day 1)|Other|0|||
160920115|NCT02625259|581101436|FG001|First Intervention (Day 1)|Other|0|||
160920116|NCT02625259|581101437|FG002|First Intervention (Day 1)|Other|1|||
160920117|NCT02625259|581101438|FG003|First Intervention (Day 1)|Other|0|||
160920118|NCT02625259|581101439|FG004|First Intervention (Day 1)|Other|0|||
160920119|NCT02625259|581101435|FG000|First Intervention (Day 1)|Adverse Event|2|||
160920120|NCT02625259|581101436|FG001|First Intervention (Day 1)|Adverse Event|1|||
160920121|NCT02625259|581101437|FG002|First Intervention (Day 1)|Adverse Event|0|||
160920122|NCT02625259|581101438|FG003|First Intervention (Day 1)|Adverse Event|0|||
160920123|NCT02625259|581101439|FG004|First Intervention (Day 1)|Adverse Event|0|||
160920124|NCT02625259|581101435|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
160920125|NCT02625259|581101436|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
160920126|NCT02625259|581101437|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
160920127|NCT02625259|581101438|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
160920128|NCT02625259|581101439|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
160920129|NCT01980875|581101440|FG000|Overall Study|Withdrew Consent|1|||
160920130|NCT01980875|581101441|FG001|Overall Study|Withdrew Consent|1|||
160920131|NCT01980875|581101442|FG002|Overall Study|Withdrew Consent|1|||
160920132|NCT01980875|581101440|FG000|Overall Study|Study Terminated by Sponsor|7|||
160920133|NCT01980875|581101441|FG001|Overall Study|Study Terminated by Sponsor|24|||
160920134|NCT01980875|581101442|FG002|Overall Study|Study Terminated by Sponsor|22|||
160920135|NCT01980875|581101440|FG000|Overall Study|Lost to Follow-up|0|||
160920136|NCT01980875|581101441|FG001|Overall Study|Lost to Follow-up|0|||
160573829|NCT01707147|579821691|FG000|Overall Study|Administered Trajenta prior to contract|5|||
160573830|NCT01707147|579821691|FG000|Overall Study|Patients who have not taken Trajenta|1|||
160573831|NCT01707147|579821691|FG000|Overall Study|Follow-up failure|17|||
160573832|NCT01707147|579821691|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
160573833|NCT02725177|579821692|FG000|Overall Study|Physician Decision|4|||
160573834|NCT02725177|579821692|FG000|Overall Study|Adverse Event|1|||
160920137|NCT01980875|581101442|FG002|Overall Study|Lost to Follow-up|1|||
160920138|NCT00513474|581101443|FG000|Overall Study|Death|6|||
160920139|NCT00513474|581101444|FG001|Overall Study|Death|9|||
160573835|NCT02903511|579821696|FG000|Overall Study|Withdrawal by Subject|1|||
160573836|NCT02903511|579821697|FG001|Overall Study|Withdrawal by Subject|0|||
160573837|NCT02903511|579821696|FG000|Overall Study|Lost to Follow-up|3|||
160573838|NCT02903511|579821697|FG001|Overall Study|Lost to Follow-up|2|||
160573839|NCT01089725|579821701|FG000|Overall Study|Adverse Event|1|||
160573840|NCT01089725|579821702|FG001|Overall Study|Adverse Event|1|||
160573841|NCT01089725|579821703|FG002|Overall Study|Adverse Event|0|||
160573842|NCT01089725|579821704|FG003|Overall Study|Adverse Event|0|||
160573843|NCT01089725|579821705|FG004|Overall Study|Adverse Event|2|||
160920140|NCT00513474|581101443|FG000|Overall Study|Participant Withdrew Consent|1|||
160573844|NCT01089725|579821701|FG000|Overall Study|Lack of Efficacy|4|||
160920141|NCT00513474|581101444|FG001|Overall Study|Participant Withdrew Consent|0|||
160573845|NCT01089725|579821702|FG001|Overall Study|Lack of Efficacy|3|||
160573846|NCT01089725|579821703|FG002|Overall Study|Lack of Efficacy|1|||
160920142|NCT04772755|581101445|FG000|Overall Study|Withdrawal by Subject|1|||
160920143|NCT04772755|581101446|FG001|Overall Study|Withdrawal by Subject|0|||
160920144|NCT04772755|581101445|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
160920145|NCT04772755|581101446|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
160920146|NCT04080297|581101448|FG000|Overall Study|Adverse Event|1|||
160920147|NCT04080297|581101449|FG001|Overall Study|Adverse Event|3|||
160920148|NCT04080297|581101448|FG000|Overall Study|concurrent illness|1|||
160920149|NCT04080297|581101449|FG001|Overall Study|concurrent illness|0|||
160920150|NCT04484142|581101455|FG000|Overall Study|Adverse Event|13|||
160920151|NCT04484142|581101455|FG000|Overall Study|Progressive Disease|87|||
160920152|NCT04484142|581101455|FG000|Overall Study|Clinical Progression|10|||
160920153|NCT04484142|581101455|FG000|Overall Study|Withdrawal by Subject|6|||
160920154|NCT04484142|581101455|FG000|Overall Study|Physician Decision|1|||
160920155|NCT05371509|581101456|FG000|Overall Study|Physician Decision|1|||
160920156|NCT05371509|581101457|FG001|Overall Study|Physician Decision|0|||
160920157|NCT02554812|581101458|FG000|Overall Study|Adverse Event|2|||
160920158|NCT02554812|581101459|FG001|Overall Study|Adverse Event|5|||
160920159|NCT02554812|581101460|FG002|Overall Study|Adverse Event|3|||
160920160|NCT02554812|581101461|FG003|Overall Study|Adverse Event|0|||
160920161|NCT02554812|581101462|FG004|Overall Study|Adverse Event|5|||
160920162|NCT02554812|581101463|FG005|Overall Study|Adverse Event|0|||
160920163|NCT02554812|581101464|FG006|Overall Study|Adverse Event|1|||
160920164|NCT02554812|581101465|FG007|Overall Study|Adverse Event|6|||
160920165|NCT02554812|581101466|FG008|Overall Study|Adverse Event|2|||
160920166|NCT02554812|581101467|FG009|Overall Study|Adverse Event|2|||
160920167|NCT02554812|581101468|FG010|Overall Study|Adverse Event|1|||
160920168|NCT02554812|581101469|FG011|Overall Study|Adverse Event|2|||
160920169|NCT02554812|581101470|FG012|Overall Study|Adverse Event|0|||
160920170|NCT02554812|581101471|FG013|Overall Study|Adverse Event|3|||
160920171|NCT02554812|581101472|FG014|Overall Study|Adverse Event|2|||
160920172|NCT02554812|581101473|FG015|Overall Study|Adverse Event|1|||
160920173|NCT02554812|581101474|FG016|Overall Study|Adverse Event|0|||
160920174|NCT02554812|581101475|FG017|Overall Study|Adverse Event|1|||
160920175|NCT02554812|581101476|FG018|Overall Study|Adverse Event|0|||
160920176|NCT02554812|581101477|FG019|Overall Study|Adverse Event|0|||
160920177|NCT02554812|581101478|FG020|Overall Study|Adverse Event|0|||
160920178|NCT02554812|581101479|FG021|Overall Study|Adverse Event|2|||
160920179|NCT02554812|581101480|FG022|Overall Study|Adverse Event|1|||
160920180|NCT02554812|581101481|FG023|Overall Study|Adverse Event|1|||
160920181|NCT02554812|581101482|FG024|Overall Study|Adverse Event|1|||
160920182|NCT02554812|581101483|FG025|Overall Study|Adverse Event|2|||
160920183|NCT02554812|581101484|FG026|Overall Study|Adverse Event|1|||
160920184|NCT02554812|581101458|FG000|Overall Study|Death|1|||
160920185|NCT02554812|581101459|FG001|Overall Study|Death|2|||
160920186|NCT02554812|581101460|FG002|Overall Study|Death|2|||
160920187|NCT02554812|581101461|FG003|Overall Study|Death|2|||
160920188|NCT02554812|581101462|FG004|Overall Study|Death|0|||
160920189|NCT02554812|581101463|FG005|Overall Study|Death|1|||
160920190|NCT02554812|581101464|FG006|Overall Study|Death|1|||
160920191|NCT02554812|581101465|FG007|Overall Study|Death|1|||
160920192|NCT02554812|581101466|FG008|Overall Study|Death|0|||
160920193|NCT02554812|581101467|FG009|Overall Study|Death|0|||
160920194|NCT02554812|581101468|FG010|Overall Study|Death|0|||
160920195|NCT02554812|581101469|FG011|Overall Study|Death|0|||
160920196|NCT02554812|581101470|FG012|Overall Study|Death|0|||
160920197|NCT02554812|581101471|FG013|Overall Study|Death|0|||
160573847|NCT01089725|579821704|FG003|Overall Study|Lack of Efficacy|0|||
160573848|NCT01089725|579821705|FG004|Overall Study|Lack of Efficacy|4|||
160573849|NCT01089725|579821701|FG000|Overall Study|Lost to Follow-up|2|||
160573850|NCT01089725|579821702|FG001|Overall Study|Lost to Follow-up|2|||
160573851|NCT01089725|579821703|FG002|Overall Study|Lost to Follow-up|0|||
160573852|NCT01089725|579821704|FG003|Overall Study|Lost to Follow-up|3|||
160573853|NCT01089725|579821705|FG004|Overall Study|Lost to Follow-up|0|||
160573854|NCT01089725|579821701|FG000|Overall Study|Protocol Violation|0|||
160573855|NCT01089725|579821702|FG001|Overall Study|Protocol Violation|0|||
160573856|NCT01089725|579821703|FG002|Overall Study|Protocol Violation|1|||
160573857|NCT01089725|579821704|FG003|Overall Study|Protocol Violation|1|||
160654157|NCT03267264|580114279|FG001|Overall Study|Withdrawal by Subject|0|||
160920198|NCT02554812|581101472|FG014|Overall Study|Death|1|||
160920199|NCT02554812|581101473|FG015|Overall Study|Death|1|||
160920200|NCT02554812|581101474|FG016|Overall Study|Death|1|||
160920201|NCT02554812|581101475|FG017|Overall Study|Death|0|||
160920202|NCT02554812|581101476|FG018|Overall Study|Death|1|||
160920203|NCT02554812|581101477|FG019|Overall Study|Death|2|||
160920204|NCT02554812|581101478|FG020|Overall Study|Death|0|||
160920205|NCT02554812|581101479|FG021|Overall Study|Death|1|||
160920206|NCT02554812|581101480|FG022|Overall Study|Death|1|||
160920207|NCT02554812|581101481|FG023|Overall Study|Death|0|||
160920208|NCT02554812|581101482|FG024|Overall Study|Death|0|||
160920209|NCT02554812|581101483|FG025|Overall Study|Death|0|||
160920210|NCT02554812|581101484|FG026|Overall Study|Death|0|||
160920211|NCT02554812|581101458|FG000|Overall Study|Lost to Follow-up|0|||
160920212|NCT02554812|581101459|FG001|Overall Study|Lost to Follow-up|1|||
160920213|NCT02554812|581101460|FG002|Overall Study|Lost to Follow-up|0|||
160920214|NCT02554812|581101461|FG003|Overall Study|Lost to Follow-up|0|||
160920215|NCT02554812|581101462|FG004|Overall Study|Lost to Follow-up|0|||
160920216|NCT02554812|581101463|FG005|Overall Study|Lost to Follow-up|0|||
160920217|NCT02554812|581101464|FG006|Overall Study|Lost to Follow-up|0|||
160920218|NCT02554812|581101465|FG007|Overall Study|Lost to Follow-up|0|||
160920219|NCT02554812|581101466|FG008|Overall Study|Lost to Follow-up|0|||
160920220|NCT02554812|581101467|FG009|Overall Study|Lost to Follow-up|0|||
160920221|NCT02554812|581101468|FG010|Overall Study|Lost to Follow-up|0|||
160920222|NCT02554812|581101469|FG011|Overall Study|Lost to Follow-up|0|||
160920223|NCT02554812|581101470|FG012|Overall Study|Lost to Follow-up|0|||
160920224|NCT02554812|581101471|FG013|Overall Study|Lost to Follow-up|0|||
160920225|NCT02554812|581101472|FG014|Overall Study|Lost to Follow-up|0|||
160920226|NCT02554812|581101473|FG015|Overall Study|Lost to Follow-up|0|||
160920227|NCT02554812|581101474|FG016|Overall Study|Lost to Follow-up|0|||
160920228|NCT02554812|581101475|FG017|Overall Study|Lost to Follow-up|0|||
160920229|NCT02554812|581101476|FG018|Overall Study|Lost to Follow-up|0|||
160920230|NCT02554812|581101477|FG019|Overall Study|Lost to Follow-up|0|||
160920231|NCT02554812|581101478|FG020|Overall Study|Lost to Follow-up|0|||
160920232|NCT02554812|581101479|FG021|Overall Study|Lost to Follow-up|0|||
160920233|NCT02554812|581101480|FG022|Overall Study|Lost to Follow-up|0|||
160920234|NCT02554812|581101481|FG023|Overall Study|Lost to Follow-up|0|||
160920235|NCT02554812|581101482|FG024|Overall Study|Lost to Follow-up|0|||
160920236|NCT02554812|581101483|FG025|Overall Study|Lost to Follow-up|0|||
160920237|NCT02554812|581101484|FG026|Overall Study|Lost to Follow-up|0|||
160920238|NCT02554812|581101458|FG000|Overall Study|Global deterioration of health status|4|||
160920239|NCT02554812|581101459|FG001|Overall Study|Global deterioration of health status|3|||
160920240|NCT02554812|581101460|FG002|Overall Study|Global deterioration of health status|3|||
160920241|NCT02554812|581101461|FG003|Overall Study|Global deterioration of health status|2|||
160920242|NCT02554812|581101462|FG004|Overall Study|Global deterioration of health status|5|||
160573858|NCT01089725|579821705|FG004|Overall Study|Protocol Violation|0|||
160573859|NCT01089725|579821701|FG000|Overall Study|Withdrawal by Subject|5|||
160573860|NCT01089725|579821702|FG001|Overall Study|Withdrawal by Subject|5|||
160573861|NCT01089725|579821703|FG002|Overall Study|Withdrawal by Subject|4|||
160573862|NCT01089725|579821704|FG003|Overall Study|Withdrawal by Subject|5|||
160573863|NCT01089725|579821705|FG004|Overall Study|Withdrawal by Subject|4|||
160920243|NCT02554812|581101463|FG005|Overall Study|Global deterioration of health status|0|||
160920244|NCT02554812|581101464|FG006|Overall Study|Global deterioration of health status|2|||
160920245|NCT02554812|581101465|FG007|Overall Study|Global deterioration of health status|1|||
160920246|NCT02554812|581101466|FG008|Overall Study|Global deterioration of health status|1|||
160920247|NCT02554812|581101467|FG009|Overall Study|Global deterioration of health status|1|||
160920248|NCT02554812|581101468|FG010|Overall Study|Global deterioration of health status|2|||
160920249|NCT02554812|581101469|FG011|Overall Study|Global deterioration of health status|1|||
160920250|NCT02554812|581101470|FG012|Overall Study|Global deterioration of health status|0|||
160920251|NCT02554812|581101471|FG013|Overall Study|Global deterioration of health status|0|||
160920252|NCT02554812|581101472|FG014|Overall Study|Global deterioration of health status|0|||
160920253|NCT02554812|581101473|FG015|Overall Study|Global deterioration of health status|1|||
160920254|NCT02554812|581101474|FG016|Overall Study|Global deterioration of health status|0|||
160920255|NCT02554812|581101475|FG017|Overall Study|Global deterioration of health status|0|||
160920256|NCT02554812|581101476|FG018|Overall Study|Global deterioration of health status|0|||
160920257|NCT02554812|581101477|FG019|Overall Study|Global deterioration of health status|0|||
160920258|NCT02554812|581101478|FG020|Overall Study|Global deterioration of health status|0|||
160920259|NCT02554812|581101479|FG021|Overall Study|Global deterioration of health status|0|||
160920260|NCT02554812|581101480|FG022|Overall Study|Global deterioration of health status|0|||
160920261|NCT02554812|581101481|FG023|Overall Study|Global deterioration of health status|0|||
160920262|NCT02554812|581101482|FG024|Overall Study|Global deterioration of health status|0|||
160920263|NCT02554812|581101483|FG025|Overall Study|Global deterioration of health status|0|||
160920264|NCT02554812|581101484|FG026|Overall Study|Global deterioration of health status|0|||
160920265|NCT02554812|581101458|FG000|Overall Study|Progressive disease|20|||
160920266|NCT02554812|581101459|FG001|Overall Study|Progressive disease|16|||
160920267|NCT02554812|581101460|FG002|Overall Study|Progressive disease|19|||
160920268|NCT02554812|581101461|FG003|Overall Study|Progressive disease|18|||
160920269|NCT02554812|581101462|FG004|Overall Study|Progressive disease|21|||
160920270|NCT02554812|581101463|FG005|Overall Study|Progressive disease|15|||
160920271|NCT02554812|581101464|FG006|Overall Study|Progressive disease|6|||
160920272|NCT02554812|581101465|FG007|Overall Study|Progressive disease|13|||
160920273|NCT02554812|581101466|FG008|Overall Study|Progressive disease|6|||
160920274|NCT02554812|581101467|FG009|Overall Study|Progressive disease|6|||
160573864|NCT01089725|579821701|FG000|Overall Study|Study Terminated by Sponsor|51|||
160573865|NCT01089725|579821702|FG001|Overall Study|Study Terminated by Sponsor|56|||
160920275|NCT02554812|581101468|FG010|Overall Study|Progressive disease|8|||
160573866|NCT01089725|579821703|FG002|Overall Study|Study Terminated by Sponsor|53|||
160573867|NCT01089725|579821704|FG003|Overall Study|Study Terminated by Sponsor|68|||
160573868|NCT01089725|579821705|FG004|Overall Study|Study Terminated by Sponsor|68|||
160920276|NCT02554812|581101469|FG011|Overall Study|Progressive disease|8|||
160920277|NCT02554812|581101470|FG012|Overall Study|Progressive disease|6|||
160920278|NCT02554812|581101471|FG013|Overall Study|Progressive disease|10|||
160920279|NCT02554812|581101472|FG014|Overall Study|Progressive disease|20|||
160920280|NCT02554812|581101473|FG015|Overall Study|Progressive disease|6|||
160920281|NCT02554812|581101474|FG016|Overall Study|Progressive disease|3|||
160920282|NCT02554812|581101475|FG017|Overall Study|Progressive disease|3|||
160920283|NCT02554812|581101476|FG018|Overall Study|Progressive disease|11|||
160920284|NCT02554812|581101477|FG019|Overall Study|Progressive disease|7|||
160920285|NCT02554812|581101478|FG020|Overall Study|Progressive disease|11|||
160920286|NCT02554812|581101479|FG021|Overall Study|Progressive disease|6|||
160920287|NCT02554812|581101480|FG022|Overall Study|Progressive disease|9|||
160920288|NCT02554812|581101481|FG023|Overall Study|Progressive disease|9|||
160920289|NCT02554812|581101482|FG024|Overall Study|Progressive disease|4|||
160920290|NCT02554812|581101483|FG025|Overall Study|Progressive disease|5|||
160920291|NCT02554812|581101484|FG026|Overall Study|Progressive disease|5|||
160920292|NCT02554812|581101458|FG000|Overall Study|Other|0|||
160920293|NCT02554812|581101459|FG001|Overall Study|Other|0|||
160920294|NCT02554812|581101460|FG002|Overall Study|Other|2|||
160920295|NCT02554812|581101461|FG003|Overall Study|Other|3|||
160920296|NCT02554812|581101462|FG004|Overall Study|Other|2|||
160920297|NCT02554812|581101463|FG005|Overall Study|Other|1|||
160920298|NCT02554812|581101464|FG006|Overall Study|Other|0|||
160920299|NCT02554812|581101465|FG007|Overall Study|Other|0|||
160920300|NCT02554812|581101466|FG008|Overall Study|Other|1|||
160920301|NCT02554812|581101467|FG009|Overall Study|Other|1|||
160920302|NCT02554812|581101468|FG010|Overall Study|Other|0|||
160920303|NCT02554812|581101469|FG011|Overall Study|Other|0|||
160920304|NCT02554812|581101470|FG012|Overall Study|Other|1|||
160920305|NCT02554812|581101471|FG013|Overall Study|Other|0|||
160920306|NCT02554812|581101472|FG014|Overall Study|Other|1|||
160920307|NCT02554812|581101473|FG015|Overall Study|Other|0|||
160920308|NCT02554812|581101474|FG016|Overall Study|Other|0|||
160920309|NCT02554812|581101475|FG017|Overall Study|Other|0|||
160920310|NCT02554812|581101476|FG018|Overall Study|Other|0|||
160920311|NCT02554812|581101477|FG019|Overall Study|Other|0|||
160920312|NCT02554812|581101478|FG020|Overall Study|Other|0|||
160920313|NCT02554812|581101479|FG021|Overall Study|Other|2|||
160920314|NCT02554812|581101480|FG022|Overall Study|Other|0|||
160920315|NCT02554812|581101481|FG023|Overall Study|Other|0|||
160920316|NCT02554812|581101482|FG024|Overall Study|Other|0|||
160920317|NCT02554812|581101483|FG025|Overall Study|Other|0|||
160920318|NCT02554812|581101484|FG026|Overall Study|Other|0|||
160920319|NCT02554812|581101458|FG000|Overall Study|Withdrawal by Subject|1|||
160920320|NCT02554812|581101459|FG001|Overall Study|Withdrawal by Subject|0|||
160920321|NCT02554812|581101460|FG002|Overall Study|Withdrawal by Subject|0|||
160920322|NCT02554812|581101461|FG003|Overall Study|Withdrawal by Subject|2|||
160920323|NCT02554812|581101462|FG004|Overall Study|Withdrawal by Subject|2|||
160920324|NCT02554812|581101463|FG005|Overall Study|Withdrawal by Subject|3|||
160920325|NCT02554812|581101464|FG006|Overall Study|Withdrawal by Subject|0|||
160920326|NCT02554812|581101465|FG007|Overall Study|Withdrawal by Subject|0|||
160920327|NCT02554812|581101466|FG008|Overall Study|Withdrawal by Subject|1|||
160920328|NCT02554812|581101467|FG009|Overall Study|Withdrawal by Subject|1|||
160920329|NCT02554812|581101468|FG010|Overall Study|Withdrawal by Subject|0|||
160920330|NCT02554812|581101469|FG011|Overall Study|Withdrawal by Subject|1|||
160920331|NCT02554812|581101470|FG012|Overall Study|Withdrawal by Subject|1|||
160920332|NCT02554812|581101471|FG013|Overall Study|Withdrawal by Subject|1|||
160920333|NCT02554812|581101472|FG014|Overall Study|Withdrawal by Subject|1|||
160573869|NCT01089725|579821701|FG000|Overall Study|Randomized, but not treated|0|||
160573870|NCT01089725|579821702|FG001|Overall Study|Randomized, but not treated|1|||
160573871|NCT01089725|579821703|FG002|Overall Study|Randomized, but not treated|2|||
160573872|NCT01089725|579821704|FG003|Overall Study|Randomized, but not treated|1|||
160573873|NCT01089725|579821705|FG004|Overall Study|Randomized, but not treated|2|||
160573874|NCT01089725|579821701|FG000|Overall Study|Other|3|||
160573875|NCT01089725|579821702|FG001|Overall Study|Other|0|||
160920334|NCT02554812|581101473|FG015|Overall Study|Withdrawal by Subject|1|||
160920335|NCT02554812|581101474|FG016|Overall Study|Withdrawal by Subject|3|||
160920336|NCT02554812|581101475|FG017|Overall Study|Withdrawal by Subject|1|||
160920337|NCT02554812|581101476|FG018|Overall Study|Withdrawal by Subject|0|||
160920338|NCT02554812|581101477|FG019|Overall Study|Withdrawal by Subject|2|||
160920339|NCT02554812|581101478|FG020|Overall Study|Withdrawal by Subject|0|||
160920340|NCT02554812|581101479|FG021|Overall Study|Withdrawal by Subject|1|||
160920341|NCT02554812|581101480|FG022|Overall Study|Withdrawal by Subject|0|||
160920342|NCT02554812|581101481|FG023|Overall Study|Withdrawal by Subject|1|||
160920343|NCT02554812|581101482|FG024|Overall Study|Withdrawal by Subject|0|||
160920344|NCT02554812|581101483|FG025|Overall Study|Withdrawal by Subject|0|||
160920345|NCT02554812|581101484|FG026|Overall Study|Withdrawal by Subject|1|||
160920346|NCT02554812|581101458|FG000|Overall Study|Physician Decision|1|||
160573876|NCT01089725|579821703|FG002|Overall Study|Other|0|||
160573877|NCT01089725|579821704|FG003|Overall Study|Other|1|||
160573878|NCT01089725|579821705|FG004|Overall Study|Other|0|||
160573879|NCT00375934|579823004|FG000|Overall Study|Adverse Event|1|||
160573880|NCT00375934|579823005|FG001|Overall Study|Adverse Event|1|||
160573881|NCT00375934|579823004|FG000|Overall Study|Withdrawal by Subject|2|||
160573882|NCT00375934|579823005|FG001|Overall Study|Withdrawal by Subject|2|||
160573883|NCT00375934|579823004|FG000|Overall Study|Lack of Efficacy|0|||
160573884|NCT00375934|579823005|FG001|Overall Study|Lack of Efficacy|2|||
160573885|NCT00375934|579823004|FG000|Overall Study|Physician Decision|0|||
160573886|NCT00375934|579823005|FG001|Overall Study|Physician Decision|1|||
160573887|NCT03191396|579823006|FG000|Overall Study|Lost to Follow-up|0|||
160573888|NCT03191396|579823007|FG001|Overall Study|Lost to Follow-up|3|||
160573889|NCT03191396|579823006|FG000|Overall Study|Withdrawal by Subject|3|||
160573890|NCT03191396|579823007|FG001|Overall Study|Withdrawal by Subject|2|||
160573891|NCT00893113|579823008|FG000|Overall Study|Lost to Follow-up|4|||
160573892|NCT00893113|579823009|FG001|Overall Study|Lost to Follow-up|8|||
160573893|NCT00893113|579823008|FG000|Overall Study|Early Termination|1|||
160573894|NCT00893113|579823009|FG001|Overall Study|Early Termination|1|||
160573895|NCT00893113|579823008|FG000|Overall Study|Withdrew Consent|8|||
160654158|NCT03267264|580114280|FG002|Overall Study|Withdrawal by Subject|2|||
160654159|NCT03267264|580114281|FG003|Overall Study|Withdrawal by Subject|4|||
160654160|NCT02224391|580114282|FG000|Overall Study|Lost to Follow-up|26|||
160920347|NCT02554812|581101459|FG001|Overall Study|Physician Decision|0|||
160920348|NCT02554812|581101460|FG002|Overall Study|Physician Decision|0|||
160920349|NCT02554812|581101461|FG003|Overall Study|Physician Decision|1|||
160920350|NCT02554812|581101462|FG004|Overall Study|Physician Decision|0|||
160920351|NCT02554812|581101463|FG005|Overall Study|Physician Decision|1|||
160920352|NCT02554812|581101464|FG006|Overall Study|Physician Decision|0|||
160920353|NCT02554812|581101465|FG007|Overall Study|Physician Decision|0|||
160920354|NCT02554812|581101466|FG008|Overall Study|Physician Decision|0|||
160920355|NCT02554812|581101467|FG009|Overall Study|Physician Decision|0|||
160920356|NCT02554812|581101468|FG010|Overall Study|Physician Decision|1|||
160920357|NCT02554812|581101469|FG011|Overall Study|Physician Decision|0|||
160920358|NCT02554812|581101470|FG012|Overall Study|Physician Decision|0|||
160920359|NCT02554812|581101471|FG013|Overall Study|Physician Decision|0|||
160920360|NCT02554812|581101472|FG014|Overall Study|Physician Decision|0|||
160920361|NCT02554812|581101473|FG015|Overall Study|Physician Decision|0|||
160920362|NCT02554812|581101474|FG016|Overall Study|Physician Decision|1|||
160920363|NCT02554812|581101475|FG017|Overall Study|Physician Decision|1|||
160920364|NCT02554812|581101476|FG018|Overall Study|Physician Decision|0|||
160920365|NCT02554812|581101477|FG019|Overall Study|Physician Decision|1|||
160920366|NCT02554812|581101478|FG020|Overall Study|Physician Decision|1|||
160920367|NCT02554812|581101479|FG021|Overall Study|Physician Decision|0|||
160920368|NCT02554812|581101480|FG022|Overall Study|Physician Decision|1|||
160920369|NCT02554812|581101481|FG023|Overall Study|Physician Decision|0|||
160920370|NCT02554812|581101482|FG024|Overall Study|Physician Decision|0|||
160920371|NCT02554812|581101483|FG025|Overall Study|Physician Decision|0|||
160920372|NCT02554812|581101484|FG026|Overall Study|Physician Decision|0|||
160920373|NCT02554812|581101458|FG000|Overall Study|Study terminated by sponsor|0|||
160920374|NCT02554812|581101459|FG001|Overall Study|Study terminated by sponsor|0|||
160920375|NCT02554812|581101460|FG002|Overall Study|Study terminated by sponsor|0|||
160920376|NCT02554812|581101461|FG003|Overall Study|Study terminated by sponsor|0|||
160920377|NCT02554812|581101462|FG004|Overall Study|Study terminated by sponsor|0|||
160920378|NCT02554812|581101463|FG005|Overall Study|Study terminated by sponsor|0|||
160920379|NCT02554812|581101464|FG006|Overall Study|Study terminated by sponsor|0|||
160920380|NCT02554812|581101465|FG007|Overall Study|Study terminated by sponsor|0|||
160920381|NCT02554812|581101466|FG008|Overall Study|Study terminated by sponsor|0|||
160920382|NCT02554812|581101467|FG009|Overall Study|Study terminated by sponsor|0|||
160920383|NCT02554812|581101468|FG010|Overall Study|Study terminated by sponsor|0|||
160920384|NCT02554812|581101469|FG011|Overall Study|Study terminated by sponsor|0|||
160920385|NCT02554812|581101470|FG012|Overall Study|Study terminated by sponsor|0|||
160920386|NCT02554812|581101471|FG013|Overall Study|Study terminated by sponsor|0|||
160920387|NCT02554812|581101472|FG014|Overall Study|Study terminated by sponsor|0|||
160997282|NCT02987543|581374889|FG001|Overall Study|Disease progression|0|||
160573896|NCT00893113|579823009|FG001|Overall Study|Withdrew Consent|7|||
160573897|NCT02114203|579823022|FG000|Overall Study|Adverse Event|0|||
160573898|NCT02114203|579823023|FG001|Overall Study|Adverse Event|1|||
160573899|NCT02114203|579823024|FG002|Overall Study|Adverse Event|0|||
160573900|NCT02114203|579823022|FG000|Overall Study|Withdrawal by Subject|0|||
160920388|NCT02554812|581101473|FG015|Overall Study|Study terminated by sponsor|0|||
160920389|NCT02554812|581101474|FG016|Overall Study|Study terminated by sponsor|0|||
160573901|NCT02114203|579823023|FG001|Overall Study|Withdrawal by Subject|1|||
160573902|NCT02114203|579823024|FG002|Overall Study|Withdrawal by Subject|0|||
160573903|NCT01518699|579823025|FG000|Period 2|Protocol Violation|1|||
160573904|NCT01518699|579823026|FG001|Period 2|Protocol Violation|1|||
160654161|NCT02224391|580114283|FG001|Overall Study|Lost to Follow-up|19|||
160997283|NCT02987543|581374890|FG002|Overall Study|Disease progression|0|||
160654162|NCT02224391|580114282|FG000|Overall Study|Withdrawal by Subject|6|||
160573905|NCT01518699|579823027|FG002|Period 2|Protocol Violation|0|||
160920390|NCT02554812|581101475|FG017|Overall Study|Study terminated by sponsor|0|||
160920391|NCT02554812|581101476|FG018|Overall Study|Study terminated by sponsor|0|||
160920392|NCT02554812|581101477|FG019|Overall Study|Study terminated by sponsor|0|||
160920393|NCT02554812|581101478|FG020|Overall Study|Study terminated by sponsor|0|||
160920394|NCT02554812|581101479|FG021|Overall Study|Study terminated by sponsor|0|||
160920395|NCT02554812|581101480|FG022|Overall Study|Study terminated by sponsor|0|||
160920396|NCT02554812|581101481|FG023|Overall Study|Study terminated by sponsor|0|||
160920397|NCT02554812|581101482|FG024|Overall Study|Study terminated by sponsor|1|||
160573906|NCT01518699|579823028|FG003|Period 2|Protocol Violation|0|||
160573907|NCT01518699|579823029|FG004|Period 2|Protocol Violation|0|||
160920398|NCT02554812|581101483|FG025|Overall Study|Study terminated by sponsor|0|||
160920399|NCT02554812|581101484|FG026|Overall Study|Study terminated by sponsor|0|||
160920400|NCT02554812|581101458|FG000|Overall Study|No longer meets eligibility criteria|0|||
160920401|NCT02554812|581101459|FG001|Overall Study|No longer meets eligibility criteria|1|||
160920402|NCT02554812|581101460|FG002|Overall Study|No longer meets eligibility criteria|0|||
160920403|NCT02554812|581101461|FG003|Overall Study|No longer meets eligibility criteria|0|||
160920404|NCT02554812|581101462|FG004|Overall Study|No longer meets eligibility criteria|0|||
160920405|NCT02554812|581101463|FG005|Overall Study|No longer meets eligibility criteria|0|||
160920406|NCT02554812|581101464|FG006|Overall Study|No longer meets eligibility criteria|0|||
160920407|NCT02554812|581101465|FG007|Overall Study|No longer meets eligibility criteria|0|||
160920408|NCT02554812|581101466|FG008|Overall Study|No longer meets eligibility criteria|0|||
160920409|NCT02554812|581101467|FG009|Overall Study|No longer meets eligibility criteria|0|||
160920410|NCT02554812|581101468|FG010|Overall Study|No longer meets eligibility criteria|0|||
160920411|NCT02554812|581101469|FG011|Overall Study|No longer meets eligibility criteria|0|||
160920412|NCT02554812|581101470|FG012|Overall Study|No longer meets eligibility criteria|0|||
160920413|NCT02554812|581101471|FG013|Overall Study|No longer meets eligibility criteria|0|||
160920414|NCT02554812|581101472|FG014|Overall Study|No longer meets eligibility criteria|0|||
160920415|NCT02554812|581101473|FG015|Overall Study|No longer meets eligibility criteria|0|||
160920416|NCT02554812|581101474|FG016|Overall Study|No longer meets eligibility criteria|0|||
160920417|NCT02554812|581101475|FG017|Overall Study|No longer meets eligibility criteria|0|||
160920418|NCT02554812|581101476|FG018|Overall Study|No longer meets eligibility criteria|0|||
160920419|NCT02554812|581101477|FG019|Overall Study|No longer meets eligibility criteria|0|||
160920420|NCT02554812|581101478|FG020|Overall Study|No longer meets eligibility criteria|0|||
160920421|NCT02554812|581101479|FG021|Overall Study|No longer meets eligibility criteria|0|||
160920422|NCT02554812|581101480|FG022|Overall Study|No longer meets eligibility criteria|0|||
160920423|NCT02554812|581101481|FG023|Overall Study|No longer meets eligibility criteria|0|||
160920424|NCT02554812|581101482|FG024|Overall Study|No longer meets eligibility criteria|0|||
160920425|NCT02554812|581101483|FG025|Overall Study|No longer meets eligibility criteria|0|||
160920426|NCT02554812|581101484|FG026|Overall Study|No longer meets eligibility criteria|0|||
160920427|NCT02879305|581101485|FG000|Overall Study|Investigator Site Closed|55|||
160920428|NCT02879305|581101486|FG001|Overall Study|Investigator Site Closed|57|||
160920429|NCT02879305|581101485|FG000|Overall Study|Withdrawal by Subject|44|||
160920430|NCT02879305|581101486|FG001|Overall Study|Withdrawal by Subject|42|||
160920431|NCT02879305|581101485|FG000|Overall Study|Lost to Follow-up|17|||
160920432|NCT02879305|581101486|FG001|Overall Study|Lost to Follow-up|12|||
160920433|NCT02879305|581101485|FG000|Overall Study|Other|1|||
160920434|NCT02879305|581101486|FG001|Overall Study|Other|0|||
160920435|NCT01786629|581103238|FG000|Overall Study|Lack of Efficacy|0|||
160920436|NCT01786629|581103239|FG001|Overall Study|Lack of Efficacy|4|||
160920437|NCT01786629|581103238|FG000|Overall Study|Adverse Event|0|||
160920438|NCT01786629|581103239|FG001|Overall Study|Adverse Event|1|||
160920439|NCT00180414|581103240|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
160920440|NCT00180414|581103241|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
160920441|NCT00613938|581103242|FG000|Overall Study|Withdrawal by Subject|2|||
160920442|NCT00613938|581103243|FG001|Overall Study|Withdrawal by Subject|4|||
160920443|NCT00613938|581103244|FG002|Overall Study|Withdrawal by Subject|9|||
160920444|NCT00613938|581103245|FG003|Overall Study|Withdrawal by Subject|9|||
160920445|NCT00613938|581103242|FG000|Overall Study|Adverse Event|1|||
160920446|NCT00613938|581103243|FG001|Overall Study|Adverse Event|4|||
160920447|NCT00613938|581103244|FG002|Overall Study|Adverse Event|8|||
160920448|NCT00613938|581103245|FG003|Overall Study|Adverse Event|5|||
160920449|NCT00613938|581103242|FG000|Overall Study|Lack of Efficacy|16|||
160573908|NCT01518699|579823030|FG005|Period 2|Protocol Violation|0|||
160573909|NCT01518699|579823025|FG000|Period 2|Lost to Follow-up|0|||
160920450|NCT00613938|581103243|FG001|Overall Study|Lack of Efficacy|18|||
160920451|NCT00613938|581103244|FG002|Overall Study|Lack of Efficacy|5|||
160920452|NCT00613938|581103245|FG003|Overall Study|Lack of Efficacy|9|||
160920453|NCT00613938|581103242|FG000|Overall Study|Other|1|||
160920454|NCT00613938|581103243|FG001|Overall Study|Other|2|||
160920455|NCT00613938|581103244|FG002|Overall Study|Other|1|||
160573910|NCT01518699|579823026|FG001|Period 2|Lost to Follow-up|1|||
160573911|NCT01518699|579823027|FG002|Period 2|Lost to Follow-up|0|||
160920456|NCT00613938|581103245|FG003|Overall Study|Other|3|||
160920457|NCT03025542|581103246|FG000|Overall Study|Adverse Event|0|||
160920458|NCT03025542|581103247|FG001|Overall Study|Adverse Event|2|||
160920459|NCT03025542|581103246|FG000|Overall Study|Lost to Follow-up|1|||
160920460|NCT03025542|581103247|FG001|Overall Study|Lost to Follow-up|0|||
160920461|NCT03025542|581103246|FG000|Overall Study|Withdrawal by Subject|1|||
160920462|NCT03025542|581103247|FG001|Overall Study|Withdrawal by Subject|0|||
160920463|NCT00488345|581103248|FG000|Overall Study|Adverse Event|0|||
160920464|NCT00488345|581103249|FG001|Overall Study|Adverse Event|1|||
160920465|NCT00488345|581103250|FG002|Overall Study|Adverse Event|1|||
160920466|NCT00488345|581103248|FG000|Overall Study|Unable to administer antibiotics at home|0|||
160920467|NCT00488345|581103249|FG001|Overall Study|Unable to administer antibiotics at home|1|||
160920468|NCT00488345|581103250|FG002|Overall Study|Unable to administer antibiotics at home|0|||
160920469|NCT00488345|581103248|FG000|Overall Study|Institutional Review Board review|0|||
160920470|NCT00488345|581103249|FG001|Overall Study|Institutional Review Board review|0|||
160920471|NCT00488345|581103250|FG002|Overall Study|Institutional Review Board review|1|||
160920472|NCT00488345|581103248|FG000|Overall Study|Surgical team recommendation|0|||
160920473|NCT00488345|581103249|FG001|Overall Study|Surgical team recommendation|1|||
160920474|NCT00488345|581103250|FG002|Overall Study|Surgical team recommendation|0|||
160920475|NCT00488345|581103248|FG000|Overall Study|Parent/legal guardian request|0|||
160920476|NCT00488345|581103249|FG001|Overall Study|Parent/legal guardian request|1|||
160920477|NCT00488345|581103250|FG002|Overall Study|Parent/legal guardian request|1|||
160920478|NCT04708886|581103256|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
160920479|NCT04708886|581103256|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
160920480|NCT01853046|581103257|FG000|Overall Study|Withdrawal by Subject|1|||
160920481|NCT01853046|581103258|FG001|Overall Study|Withdrawal by Subject|1|||
160920482|NCT01853046|581103257|FG000|Overall Study|Adverse Event|4|||
160920483|NCT01853046|581103258|FG001|Overall Study|Adverse Event|2|||
160920484|NCT01853046|581103257|FG000|Overall Study|Disease progression|13|||
160920485|NCT01853046|581103258|FG001|Overall Study|Disease progression|3|||
160920486|NCT03020407|581103260|FG000|Overall Study|Withdrawal by Subject|2|||
160920487|NCT03020407|581103261|FG001|Overall Study|Withdrawal by Subject|1|||
160920488|NCT03020407|581103260|FG000|Overall Study|Lost to Follow-up|2|||
160920489|NCT03020407|581103261|FG001|Overall Study|Lost to Follow-up|3|||
160920490|NCT03020407|581103260|FG000|Overall Study|Protocol Violation|0|||
160920491|NCT03020407|581103261|FG001|Overall Study|Protocol Violation|1|||
160920492|NCT01585428|581103262|FG000|Overall Study|Death during treatment|1|||
160920493|NCT01585428|581103263|FG001|Overall Study|Death during treatment|0|||
160920494|NCT00708162|581103264|FG000|Randomized Phase|Randomized but Not Treated|7|||
160920495|NCT00708162|581103265|FG001|Randomized Phase|Randomized but Not Treated|5|||
160920496|NCT00708162|581103264|FG000|Randomized Phase|Participant Noncompliance|40|||
160920497|NCT00708162|581103265|FG001|Randomized Phase|Participant Noncompliance|32|||
160920498|NCT00708162|581103264|FG000|Randomized Phase|Lost to Follow-up|34|||
160920499|NCT00708162|581103265|FG001|Randomized Phase|Lost to Follow-up|34|||
160920500|NCT00708162|581103264|FG000|Randomized Phase|Withdrew Consent|31|||
160920501|NCT00708162|581103265|FG001|Randomized Phase|Withdrew Consent|22|||
160920502|NCT00708162|581103264|FG000|Randomized Phase|Lack of Efficacy|14|||
160920503|NCT00708162|581103265|FG001|Randomized Phase|Lack of Efficacy|19|||
160920504|NCT00708162|581103264|FG000|Randomized Phase|Protocol Violation|10|||
160920505|NCT00708162|581103265|FG001|Randomized Phase|Protocol Violation|11|||
160920506|NCT00708162|581103264|FG000|Randomized Phase|Adverse Event|8|||
160997284|NCT02987543|581374891|FG003|Overall Study|Disease progression|1|||
160997285|NCT03646669|581374892|FG000|Overall Study|Withdrawal by Subject|5|||
160997286|NCT03646669|581374893|FG001|Overall Study|Withdrawal by Subject|0|||
160997287|NCT00377455|581374894|FG000|Overall Study|Withdrawal by Subject|1|||
160997288|NCT00309452|581374895|FG000|Overall Study|Withdrawal by Subject|3|||
160573912|NCT01518699|579823028|FG003|Period 2|Lost to Follow-up|0|||
160573913|NCT01518699|579823029|FG004|Period 2|Lost to Follow-up|0|||
160573914|NCT01518699|579823030|FG005|Period 2|Lost to Follow-up|0|||
160573915|NCT01518699|579823025|FG000|Period 2|Adverse Event|1|||
160920507|NCT00708162|581103265|FG001|Randomized Phase|Adverse Event|12|||
160920508|NCT00708162|581103264|FG000|Randomized Phase|Investigator's Discretion|7|||
160920509|NCT00708162|581103265|FG001|Randomized Phase|Investigator's Discretion|10|||
160920510|NCT00708162|581103264|FG000|Randomized Phase|Death|2|||
160920511|NCT00708162|581103265|FG001|Randomized Phase|Death|9|||
160920512|NCT00708162|581103264|FG000|Randomized Phase|Pregnancy|3|||
160920513|NCT00708162|581103265|FG001|Randomized Phase|Pregnancy|0|||
160573916|NCT01518699|579823026|FG001|Period 2|Adverse Event|0|||
160573917|NCT01518699|579823027|FG002|Period 2|Adverse Event|0|||
160573918|NCT01518699|579823028|FG003|Period 2|Adverse Event|0|||
160920514|NCT00708162|581103264|FG000|Open-Label Phase|Lost to Follow-up|10|||
160920515|NCT00708162|581103265|FG001|Open-Label Phase|Lost to Follow-up|8|||
160920516|NCT00708162|581103264|FG000|Open-Label Phase|Withdrew Consent|12|||
160920517|NCT00708162|581103265|FG001|Open-Label Phase|Withdrew Consent|6|||
160997289|NCT00309452|581374896|FG001|Overall Study|Withdrawal by Subject|0|||
160573919|NCT01518699|579823029|FG004|Period 2|Adverse Event|0|||
160920518|NCT00708162|581103264|FG000|Open-Label Phase|Participant Noncompliance|7|||
160573920|NCT01518699|579823030|FG005|Period 2|Adverse Event|0|||
160573921|NCT00486226|579823032|FG000|Overall Study|Death|3|||
160573922|NCT00486226|579823032|FG000|Overall Study|Adverse Event|1|||
160573923|NCT00486226|579823032|FG000|Overall Study|Withdrawal by Subject|1|||
160573924|NCT00486226|579823032|FG000|Overall Study|Lost to Follow-up|8|||
160573925|NCT00089843|579823038|FG000|Overall Study|Withdrawal by Subject|1|||
160573926|NCT00089843|579823039|FG001|Overall Study|Withdrawal by Subject|4|||
160573927|NCT00089843|579823040|FG002|Overall Study|Withdrawal by Subject|5|||
160573928|NCT00089843|579823041|FG003|Overall Study|Withdrawal by Subject|6|||
160573929|NCT00089843|579823038|FG000|Overall Study|Physician Decision|1|||
160573930|NCT00089843|579823039|FG001|Overall Study|Physician Decision|0|||
160573931|NCT00089843|579823040|FG002|Overall Study|Physician Decision|0|||
160573932|NCT00089843|579823041|FG003|Overall Study|Physician Decision|1|||
160573933|NCT01295905|579823054|FG000|Overall Study|Did not meet inclusion criteria|1|||
160573934|NCT01295905|579823055|FG001|Overall Study|Did not meet inclusion criteria|0|||
160573935|NCT01295905|579823054|FG000|Overall Study|Met exclusion criteria|1|||
160573936|NCT01295905|579823055|FG001|Overall Study|Met exclusion criteria|0|||
160573937|NCT00553059|579823057|FG000|Overall Study|Deemed ineligible|1|||
160573938|NCT00553059|579823058|FG001|Overall Study|Deemed ineligible|1|||
160573939|NCT00553059|579823057|FG000|Overall Study|Drug supply not available|0|||
160573940|NCT00553059|579823058|FG001|Overall Study|Drug supply not available|1|||
160573941|NCT01966731|579823059|FG000|Overall Study|Death|2|||
160573942|NCT01966731|579823059|FG000|Overall Study|Lost to Follow-up|1|||
160573943|NCT01966731|579823059|FG000|Overall Study|Physician Decision|2|||
160573944|NCT01966731|579823059|FG000|Overall Study|Follow up is not complete|600|||
160573945|NCT01966731|579823059|FG000|Overall Study|Screening Failure|29|||
160573946|NCT01966731|579823059|FG000|Overall Study|Found to be ineligible|1|||
160573947|NCT00592683|579823060|FG000|Overall Study|Found ineligible|0|||
160573948|NCT00592683|579823061|FG001|Overall Study|Found ineligible|1|||
160573949|NCT00592683|579823060|FG000|Overall Study|Withdrawal by Subject|1|||
160573950|NCT00592683|579823061|FG001|Overall Study|Withdrawal by Subject|0|||
160573951|NCT00592683|579823060|FG000|Overall Study|Adverse Event|0|||
160573952|NCT00592683|579823061|FG001|Overall Study|Adverse Event|2|||
160573953|NCT00592683|579823060|FG000|Overall Study|Protocol Violation|1|||
160573954|NCT00592683|579823061|FG001|Overall Study|Protocol Violation|0|||
160573955|NCT00592683|579823060|FG000|Overall Study|Study drug expired|1|||
160573956|NCT00592683|579823061|FG001|Overall Study|Study drug expired|0|||
160573957|NCT00592683|579823060|FG000|Overall Study|Other|1|||
160573958|NCT00592683|579823061|FG001|Overall Study|Other|0|||
160573959|NCT00592683|579823060|FG000|Overall Study|Lost to Follow-up|0|||
160573960|NCT00592683|579823061|FG001|Overall Study|Lost to Follow-up|1|||
160573961|NCT00201201|579823062|FG000|Overall Study|Death|0|||
160573962|NCT00201201|579823063|FG001|Overall Study|Death|2|||
160573963|NCT00201201|579823062|FG000|Overall Study|Withdrawal by Subject|5|||
160573964|NCT00201201|579823063|FG001|Overall Study|Withdrawal by Subject|5|||
160573965|NCT00545818|579823069|FG000|Overall Study|Protocol Violation|1|||
160573966|NCT00545818|579823070|FG001|Overall Study|Protocol Violation|0|||
160573967|NCT00545818|579823069|FG000|Overall Study|Adverse Event|1|||
160573968|NCT00545818|579823070|FG001|Overall Study|Adverse Event|1|||
160573969|NCT00545818|579823069|FG000|Overall Study|Lost to Follow-up|1|||
160573970|NCT00545818|579823070|FG001|Overall Study|Lost to Follow-up|6|||
160573971|NCT00670111|579823071|FG000|Enrollment to One Month|Testing Failure|0|||
160573972|NCT00670111|579823072|FG001|Enrollment to One Month|Testing Failure|0|||
160573973|NCT00670111|579823073|FG002|Enrollment to One Month|Testing Failure|13|||
160573974|NCT00670111|579823071|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
160573975|NCT00670111|579823072|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
160920519|NCT00708162|581103265|FG001|Open-Label Phase|Participant Noncompliance|7|||
160920520|NCT00708162|581103264|FG000|Open-Label Phase|Lack of Efficacy|7|||
160920521|NCT00708162|581103265|FG001|Open-Label Phase|Lack of Efficacy|4|||
160920522|NCT00708162|581103264|FG000|Open-Label Phase|Investigator's Discretion|3|||
160920523|NCT00708162|581103265|FG001|Open-Label Phase|Investigator's Discretion|2|||
160573976|NCT00670111|579823073|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
160573977|NCT00670111|579823071|FG000|Enrollment to One Month|Physician Decision|1|||
160573978|NCT00670111|579823072|FG001|Enrollment to One Month|Physician Decision|0|||
160573979|NCT00670111|579823073|FG002|Enrollment to One Month|Physician Decision|0|||
160573980|NCT02623361|579823074|FG000|Overall Study|Protocol Violation|0|||
160573981|NCT02623361|579823075|FG001|Overall Study|Protocol Violation|1|||
160573982|NCT02623361|579823074|FG000|Overall Study|Withdrawal by Subject|0|||
160573983|NCT02623361|579823075|FG001|Overall Study|Withdrawal by Subject|1|||
160573984|NCT02441803|579823077|FG000|Overall Study|Physician Decision|0|||
160573985|NCT02441803|579823078|FG001|Overall Study|Physician Decision|2|||
160920524|NCT00708162|581103264|FG000|Open-Label Phase|Death|3|||
160573986|NCT02441803|579823079|FG002|Overall Study|Physician Decision|2|||
160573987|NCT02873221|579823081|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
160573988|NCT02873221|579823082|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
160573989|NCT02873221|579823083|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
160573990|NCT02873221|579823081|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
160573991|NCT02873221|579823082|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
160573992|NCT02873221|579823083|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
160573993|NCT02873221|579823081|FG000|Treatment Period|Protocol Violation|2|||
160573994|NCT02873221|579823082|FG001|Treatment Period|Protocol Violation|5|||
160573995|NCT02873221|579823083|FG002|Treatment Period|Protocol Violation|8|||
160573996|NCT02873221|579823081|FG000|Treatment Period|Pregnancy|4|||
160573997|NCT02873221|579823082|FG001|Treatment Period|Pregnancy|6|||
160573998|NCT02873221|579823083|FG002|Treatment Period|Pregnancy|3|||
160573999|NCT02873221|579823081|FG000|Treatment Period|Lack of Qualifying Event|0|||
160574000|NCT02873221|579823082|FG001|Treatment Period|Lack of Qualifying Event|3|||
160574001|NCT02873221|579823083|FG002|Treatment Period|Lack of Qualifying Event|1|||
160574002|NCT02873221|579823081|FG000|Treatment Period|Withdrawal of Consent|52|||
160574003|NCT02873221|579823082|FG001|Treatment Period|Withdrawal of Consent|51|||
160574004|NCT02873221|579823083|FG002|Treatment Period|Withdrawal of Consent|41|||
160574005|NCT02873221|579823081|FG000|Treatment Period|Lack of Efficacy|0|||
160574006|NCT02873221|579823082|FG001|Treatment Period|Lack of Efficacy|17|||
160574007|NCT02873221|579823083|FG002|Treatment Period|Lack of Efficacy|12|||
160574008|NCT02873221|579823081|FG000|Treatment Period|Adverse Event|4|||
160574009|NCT02873221|579823082|FG001|Treatment Period|Adverse Event|9|||
160574010|NCT02873221|579823083|FG002|Treatment Period|Adverse Event|11|||
160574011|NCT02873221|579823081|FG000|Treatment Period|Lost to Follow-up|26|||
160574012|NCT02873221|579823082|FG001|Treatment Period|Lost to Follow-up|30|||
160574013|NCT02873221|579823083|FG002|Treatment Period|Lost to Follow-up|26|||
160574014|NCT02873221|579823081|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
160574015|NCT02873221|579823082|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
160574016|NCT02873221|579823083|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
160574017|NCT02873221|579823081|FG000|Safety Follow-up Period|Protocol Violation|0|||
160574018|NCT02873221|579823082|FG001|Safety Follow-up Period|Protocol Violation|0|||
160574019|NCT02873221|579823083|FG002|Safety Follow-up Period|Protocol Violation|1|||
160574020|NCT02873221|579823081|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
160574021|NCT02873221|579823082|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
160574022|NCT02873221|579823083|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
160574023|NCT02873221|579823081|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
160574024|NCT02873221|579823082|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
160574025|NCT02873221|579823083|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
160574026|NCT01325493|579823084|FG000|Overall Study|Protocol Violation|0|||
160574027|NCT01325493|579823085|FG001|Overall Study|Protocol Violation|1|||
160574028|NCT01325493|579823084|FG000|Overall Study|loss of neuromonitoring signals|0|||
160574029|NCT01325493|579823085|FG001|Overall Study|loss of neuromonitoring signals|2|||
160574030|NCT01325493|579823084|FG000|Overall Study|Allergy|1|||
160574031|NCT01325493|579823085|FG001|Overall Study|Allergy|0|||
160574032|NCT02732912|579823086|FG000|Overall Study|Discharged before night|2|||
160574033|NCT02732912|579823087|FG001|Overall Study|Discharged before night|6|||
160574034|NCT02732912|579823086|FG000|Overall Study|Incomplete completion of questionnaire|2|||
160574035|NCT02732912|579823087|FG001|Overall Study|Incomplete completion of questionnaire|3|||
160574036|NCT02732912|579823086|FG000|Overall Study|No outcome; discharged or refused|6|||
160574037|NCT02732912|579823087|FG001|Overall Study|No outcome; discharged or refused|9|||
160574038|NCT01873742|579823088|FG000|Overall Study|Lost to Follow-up|68|||
160574039|NCT01873742|579823089|FG001|Overall Study|Lost to Follow-up|76|||
160574040|NCT02498821|579823090|FG000|Overall Study|Screen failure|3|||
160574041|NCT02498821|579823091|FG001|Overall Study|Screen failure|5|||
160574042|NCT00942708|579823095|FG000|Overall Study|Withdrawal by Subject|1|||
160574043|NCT01457339|579823096|FG000|Period 3 (100 mg)|Adverse Event|0|||
160574044|NCT01457339|579823097|FG001|Period 3 (100 mg)|Adverse Event|1|||
160574045|NCT01457339|579823096|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
160574046|NCT01457339|579823097|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
160574047|NCT01457339|579823096|FG000|Period 6 (250 mg)|Family Emergency|1|||
160574048|NCT01457339|579823097|FG001|Period 6 (250 mg)|Family Emergency|0|||
160574049|NCT01457339|579823096|FG000|Period 6 (250 mg)|Personal appointment|0|||
160574050|NCT01457339|579823097|FG001|Period 6 (250 mg)|Personal appointment|1|||
160574051|NCT00673673|579823098|FG000|Overall Study|Progressive disease|27|||
160574052|NCT00673673|579823098|FG000|Overall Study|Adverse Event|4|||
160574053|NCT00673673|579823098|FG000|Overall Study|Withdrawal by Subject|3|||
160574054|NCT00673673|579823098|FG000|Overall Study|Investigators' discretion|2|||
160574055|NCT04538950|579823107|FG000|Overall Study|Pulmonary Issues|2|||
160574056|NCT04538950|579823107|FG000|Overall Study|illness|2|||
160574057|NCT05258058|579823108|FG000|Overall Study|Withdrawal by Subject|2|||
160574058|NCT04579393|579823111|FG000|Overall Study|Withdrawal by Subject|2|||
160920525|NCT00708162|581103265|FG001|Open-Label Phase|Death|1|||
160574059|NCT04579393|579823112|FG001|Overall Study|Withdrawal by Subject|2|||
160574060|NCT04579393|579823111|FG000|Overall Study|Death|1|||
160574061|NCT04579393|579823112|FG001|Overall Study|Death|3|||
160574062|NCT01282814|579823115|FG000|First Intervention|Emesis During Dosing Interval|0|||
160574063|NCT01282814|579823116|FG001|First Intervention|Emesis During Dosing Interval|3|||
160574064|NCT01282814|579823115|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
160920526|NCT00708162|581103264|FG000|Open-Label Phase|Adverse Event|1|||
160920527|NCT00708162|581103265|FG001|Open-Label Phase|Adverse Event|2|||
160920528|NCT00708162|581103264|FG000|Open-Label Phase|Other|1|||
160920529|NCT00708162|581103265|FG001|Open-Label Phase|Other|0|||
160920530|NCT02699554|581103266|FG000|Overall Study|Lost to Follow-up|9|||
160920531|NCT00788151|581103267|FG000|Overall Study|Other adverse event|0|||
160920532|NCT00788151|581103268|FG001|Overall Study|Other adverse event|2|||
160920533|NCT00788151|581103267|FG000|Overall Study|Protocol Violation|0|||
160920534|NCT00788151|581103268|FG001|Overall Study|Protocol Violation|1|||
160920535|NCT00788151|581103267|FG000|Overall Study|Withdrawal by Subject|13|||
160920536|NCT00788151|581103268|FG001|Overall Study|Withdrawal by Subject|6|||
160920537|NCT00788151|581103267|FG000|Overall Study|Enrolled but not treated|1|||
160920538|NCT00788151|581103268|FG001|Overall Study|Enrolled but not treated|1|||
160920539|NCT00503009|581103269|FG000|Overall Study|Protocol Violation|1|||
160920540|NCT00503009|581103270|FG001|Overall Study|Protocol Violation|0|||
160920541|NCT00503009|581103271|FG002|Overall Study|Protocol Violation|1|||
160920542|NCT00503009|581103269|FG000|Overall Study|Withdrawal by Subject|0|||
160920543|NCT00503009|581103270|FG001|Overall Study|Withdrawal by Subject|1|||
160920544|NCT00503009|581103271|FG002|Overall Study|Withdrawal by Subject|1|||
160920545|NCT00503009|581103269|FG000|Overall Study|Physician Decision|0|||
160920546|NCT00503009|581103270|FG001|Overall Study|Physician Decision|1|||
160920547|NCT00503009|581103271|FG002|Overall Study|Physician Decision|1|||
160920548|NCT02057198|581103272|FG000|Overall Study|Death|0|||
160920549|NCT02057198|581103273|FG001|Overall Study|Death|0|||
160920550|NCT02057198|581103274|FG002|Overall Study|Death|1|||
160920551|NCT02057198|581103272|FG000|Overall Study|Discharged early; lost to followup|0|||
160920552|NCT02057198|581103273|FG001|Overall Study|Discharged early; lost to followup|1|||
160920553|NCT02057198|581103274|FG002|Overall Study|Discharged early; lost to followup|0|||
160920554|NCT02355691|581103278|FG000|Overall Study|Loss of Research Personnel|7|||
160920555|NCT02355691|581103279|FG001|Overall Study|Loss of Research Personnel|9|||
160920556|NCT00065507|581103280|FG000|Overall Study|Death|16|||
160920557|NCT00065507|581103281|FG001|Overall Study|Death|17|||
160920558|NCT00065507|581103280|FG000|Overall Study|Adverse Event|4|||
160920559|NCT00065507|581103281|FG001|Overall Study|Adverse Event|3|||
160920560|NCT00065507|581103280|FG000|Overall Study|Lack of Efficacy|0|||
160920561|NCT00065507|581103281|FG001|Overall Study|Lack of Efficacy|6|||
160920562|NCT00065507|581103280|FG000|Overall Study|Poor/Non-compliance|3|||
160920563|NCT00065507|581103281|FG001|Overall Study|Poor/Non-compliance|2|||
160920564|NCT00065507|581103280|FG000|Overall Study|Lost to Follow-up|3|||
160920565|NCT00065507|581103281|FG001|Overall Study|Lost to Follow-up|0|||
160920566|NCT00065507|581103280|FG000|Overall Study|Subject Withdrew Consent|2|||
160920567|NCT00065507|581103281|FG001|Overall Study|Subject Withdrew Consent|1|||
160920568|NCT00065507|581103280|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
160920569|NCT00065507|581103281|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
160920570|NCT00350636|581103282|FG000|Overall Study|Adverse Event|19|||
160920571|NCT00350636|581103283|FG001|Overall Study|Adverse Event|13|||
160920572|NCT00350636|581103282|FG000|Overall Study|Protocol Violation|1|||
160920573|NCT00350636|581103283|FG001|Overall Study|Protocol Violation|3|||
160920574|NCT00350636|581103282|FG000|Overall Study|Withdrawal by Subject|13|||
160920575|NCT00350636|581103283|FG001|Overall Study|Withdrawal by Subject|17|||
160920576|NCT00350636|581103282|FG000|Overall Study|Lost to Follow-up|9|||
160920577|NCT00350636|581103283|FG001|Overall Study|Lost to Follow-up|8|||
160920578|NCT00350636|581103282|FG000|Overall Study|Physician Decision|0|||
160920579|NCT00350636|581103283|FG001|Overall Study|Physician Decision|2|||
160920580|NCT00350636|581103282|FG000|Overall Study|Other|1|||
160920581|NCT00350636|581103283|FG001|Overall Study|Other|2|||
160920582|NCT00100815|581103284|FG000|Overall Study|Progression|24|||
160920583|NCT00100815|581103284|FG000|Overall Study|Adverse Event|18|||
160920584|NCT00100815|581103284|FG000|Overall Study|Death|4|||
160920585|NCT00100815|581103284|FG000|Overall Study|Other|3|||
160920586|NCT01647282|581103290|FG000|Overall Study|Physician Decision|7|||
160920587|NCT01647282|581103291|FG001|Overall Study|Physician Decision|5|||
160920588|NCT01042236|581103292|FG000|Treatment Period 1|Adverse Event|0|||
160920589|NCT01042236|581103293|FG001|Treatment Period 1|Adverse Event|1|||
160920590|NCT01042236|581103294|FG002|Treatment Period 1|Adverse Event|0|||
160920591|NCT01042236|581103295|FG003|Treatment Period 1|Adverse Event|0|||
160920592|NCT01042236|581103296|FG004|Treatment Period 1|Adverse Event|1|||
160920593|NCT01042236|581103297|FG005|Treatment Period 1|Adverse Event|0|||
160920594|NCT01042236|581103292|FG000|Treatment Period 3|Adverse Event|0|||
160920595|NCT01042236|581103293|FG001|Treatment Period 3|Adverse Event|0|||
160920596|NCT01042236|581103294|FG002|Treatment Period 3|Adverse Event|0|||
160920597|NCT01042236|581103295|FG003|Treatment Period 3|Adverse Event|1|||
160920598|NCT01042236|581103296|FG004|Treatment Period 3|Adverse Event|0|||
160920599|NCT01042236|581103297|FG005|Treatment Period 3|Adverse Event|0|||
160920600|NCT01042236|581103292|FG000|Treatment Period 3|Protocol Violation|0|||
160920601|NCT01042236|581103293|FG001|Treatment Period 3|Protocol Violation|0|||
160920602|NCT01042236|581103294|FG002|Treatment Period 3|Protocol Violation|0|||
160920603|NCT01042236|581103295|FG003|Treatment Period 3|Protocol Violation|1|||
160920604|NCT01042236|581103296|FG004|Treatment Period 3|Protocol Violation|0|||
160920605|NCT01042236|581103297|FG005|Treatment Period 3|Protocol Violation|0|||
160574065|NCT01282814|579823116|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
160574066|NCT01524289|579823117|FG000|Overall Study|Lost to Follow-up|0|||
160574067|NCT01524289|579823118|FG001|Overall Study|Lost to Follow-up|1|||
160574068|NCT01524289|579823117|FG000|Overall Study|Physician Decision|1|||
160574069|NCT01524289|579823118|FG001|Overall Study|Physician Decision|0|||
160574070|NCT01524289|579823117|FG000|Overall Study|Protocol Violation|5|||
160574071|NCT01524289|579823118|FG001|Overall Study|Protocol Violation|1|||
160574072|NCT01524289|579823117|FG000|Overall Study|Withdrawal by Subject|11|||
160574073|NCT01524289|579823118|FG001|Overall Study|Withdrawal by Subject|7|||
160574074|NCT01524289|579823117|FG000|Overall Study|Adverse Event|12|||
160574075|NCT01524289|579823118|FG001|Overall Study|Adverse Event|5|||
160574076|NCT01524289|579823117|FG000|Overall Study|Did not take study medication|1|||
160574077|NCT01524289|579823118|FG001|Overall Study|Did not take study medication|0|||
160574078|NCT00104104|579823121|FG000|Overall Study|Adverse Event|8|||
160574079|NCT00104104|579823122|FG001|Overall Study|Adverse Event|8|||
160574080|NCT00104104|579823121|FG000|Overall Study|Abnormal laboratory value(s)|20|||
160574081|NCT00104104|579823122|FG001|Overall Study|Abnormal laboratory value(s)|14|||
160574082|NCT00104104|579823121|FG000|Overall Study|Lack of Efficacy|0|||
160574083|NCT00104104|579823122|FG001|Overall Study|Lack of Efficacy|3|||
160574084|NCT00104104|579823121|FG000|Overall Study|Condition no longer requires study drug|7|||
160574085|NCT00104104|579823122|FG001|Overall Study|Condition no longer requires study drug|4|||
160574086|NCT00104104|579823121|FG000|Overall Study|Protocol Violation|5|||
160574087|NCT00104104|579823122|FG001|Overall Study|Protocol Violation|2|||
160574088|NCT00104104|579823121|FG000|Overall Study|Withdrawal by Subject|11|||
160574089|NCT00104104|579823122|FG001|Overall Study|Withdrawal by Subject|15|||
160574090|NCT00104104|579823121|FG000|Overall Study|Lost to Follow-up|3|||
160574091|NCT00104104|579823122|FG001|Overall Study|Lost to Follow-up|7|||
160574092|NCT00104104|579823121|FG000|Overall Study|Administrative problems|12|||
160574093|NCT00104104|579823122|FG001|Overall Study|Administrative problems|13|||
160574094|NCT00104104|579823121|FG000|Overall Study|Death|9|||
160574095|NCT00104104|579823122|FG001|Overall Study|Death|6|||
160574096|NCT01326962|579823126|FG000|Overall Study|Adverse Event|1|||
160574097|NCT01326962|579823126|FG000|Overall Study|Withdrawal by Subject|1|||
160574098|NCT01326962|579823126|FG000|Overall Study|Lost to Follow-up|3|||
160574099|NCT01326962|579823126|FG000|Overall Study|Other|2|||
160574100|NCT02050048|579823127|FG000|Overall Study|Lost to Follow-up|0|||
160574101|NCT02050048|579823128|FG001|Overall Study|Lost to Follow-up|1|||
160574102|NCT02050048|579823127|FG000|Overall Study|Death|1|||
160574103|NCT02050048|579823128|FG001|Overall Study|Death|0|||
160574104|NCT02050048|579823127|FG000|Overall Study|Ineligible after ERCP|4|||
160574105|NCT02050048|579823128|FG001|Overall Study|Ineligible after ERCP|1|||
160574106|NCT03067311|579823130|FG000|Overall Study|Lost to Follow-up|1|||
160574107|NCT03067311|579823131|FG001|Overall Study|Lost to Follow-up|1|||
160574108|NCT03067311|579823130|FG000|Overall Study|Moved away|1|||
160574109|NCT03067311|579823131|FG001|Overall Study|Moved away|1|||
160574110|NCT00969618|579823132|FG000|Overall Study|Adverse Event|29|||
160574111|NCT00969618|579823132|FG000|Overall Study|Entry Criteria Not Met|3|||
160574112|NCT00969618|579823132|FG000|Overall Study|Lack of Efficacy|2|||
160574113|NCT00969618|579823132|FG000|Overall Study|Lost to Follow-up|7|||
160574114|NCT00969618|579823132|FG000|Overall Study|Physician Decision|1|||
160574115|NCT00969618|579823132|FG000|Overall Study|Protocol Violation|9|||
160574116|NCT00969618|579823132|FG000|Overall Study|Withdrawal by Subject|27|||
160920606|NCT01172847|581103300|FG000|Overall Study|Withdrawal by Subject|3|||
160920607|NCT00665353|581103305|FG000|Study Step 1|Adverse Event|1|||
160920608|NCT00665353|581103305|FG000|Study Step 1|Withdrawal by Subject|2|||
160454672|NCT01928394|579396178|FG008|Treatment Period|Participant request to stop therapy|0|||
160454673|NCT01928394|579396179|FG009|Treatment Period|Participant request to stop therapy|0|||
160454674|NCT01928394|579396180|FG010|Treatment Period|Participant request to stop therapy|3|||
160454675|NCT01928394|579396181|FG011|Treatment Period|Participant request to stop therapy|2|||
160454676|NCT01928394|579396182|FG012|Treatment Period|Participant request to stop therapy|1|||
160454677|NCT01928394|579396183|FG013|Treatment Period|Participant request to stop therapy|2|||
160454678|NCT01928394|579396184|FG014|Treatment Period|Participant request to stop therapy|4|||
160454679|NCT01928394|579396185|FG015|Treatment Period|Participant request to stop therapy|0|||
160454680|NCT01928394|579396186|FG016|Treatment Period|Participant request to stop therapy|1|||
160454681|NCT01928394|579396187|FG017|Treatment Period|Participant request to stop therapy|3|||
160454682|NCT01928394|579396188|FG018|Treatment Period|Participant request to stop therapy|1|||
160454683|NCT01928394|579396189|FG019|Treatment Period|Participant request to stop therapy|1|||
160454684|NCT01928394|579396190|FG020|Treatment Period|Participant request to stop therapy|3|||
160454685|NCT01928394|579396191|FG021|Treatment Period|Participant request to stop therapy|1|||
160454686|NCT01928394|579396192|FG022|Treatment Period|Participant request to stop therapy|3|||
160454687|NCT01928394|579396170|FG000|Treatment Period|Participant withdrew consent|0|||
160454688|NCT01928394|579396171|FG001|Treatment Period|Participant withdrew consent|0|||
160574117|NCT01318902|579823133|FG000|Overall Study|Symptomatic Deterioration|0|||
160574118|NCT01318902|579823134|FG001|Overall Study|Symptomatic Deterioration|1|||
160574119|NCT01318902|579823135|FG002|Overall Study|Symptomatic Deterioration|1|||
160574120|NCT01318902|579823136|FG003|Overall Study|Symptomatic Deterioration|2|||
160574121|NCT01318902|579823133|FG000|Overall Study|Withdrawal by Patient|0|||
160574122|NCT01318902|579823134|FG001|Overall Study|Withdrawal by Patient|1|||
160574123|NCT01318902|579823135|FG002|Overall Study|Withdrawal by Patient|0|||
160574124|NCT01318902|579823136|FG003|Overall Study|Withdrawal by Patient|3|||
160574125|NCT01318902|579823133|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
160574126|NCT01318902|579823134|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
160574127|NCT01318902|579823135|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
160574128|NCT01318902|579823136|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
160574129|NCT01318902|579823133|FG000|Overall Study|Adverse Event|0|||
160574130|NCT01318902|579823134|FG001|Overall Study|Adverse Event|1|||
160574131|NCT01318902|579823135|FG002|Overall Study|Adverse Event|0|||
160574132|NCT01318902|579823136|FG003|Overall Study|Adverse Event|0|||
160574133|NCT01318902|579823133|FG000|Overall Study|Terminated by Sponsor|0|||
160574134|NCT01318902|579823134|FG001|Overall Study|Terminated by Sponsor|0|||
160574135|NCT01318902|579823135|FG002|Overall Study|Terminated by Sponsor|1|||
160574136|NCT01318902|579823136|FG003|Overall Study|Terminated by Sponsor|0|||
160574137|NCT00500149|579824847|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
160574138|NCT00500149|579824848|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
160574139|NCT00500149|579824847|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
160574140|NCT00500149|579824848|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
160574141|NCT00500149|579824847|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
160574142|NCT00500149|579824848|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
160574143|NCT00500149|579824847|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
160574144|NCT00500149|579824848|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
160574145|NCT00500149|579824847|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
160574146|NCT00500149|579824848|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
160574147|NCT00500149|579824847|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
160574148|NCT00500149|579824848|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
160574149|NCT00500149|579824847|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
160574150|NCT00500149|579824848|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
160574151|NCT01157169|579824849|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
160574152|NCT01157169|579824850|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
160574153|NCT01157169|579824849|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
160574154|NCT01157169|579824850|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
160574155|NCT00663858|579824851|FG000|Overall Study|Adverse Event|9|||
160574156|NCT00663858|579824852|FG001|Overall Study|Adverse Event|1|||
160574157|NCT00663858|579824853|FG002|Overall Study|Adverse Event|6|||
160574158|NCT00663858|579824851|FG000|Overall Study|Lack of Efficacy|5|||
160574159|NCT00663858|579824852|FG001|Overall Study|Lack of Efficacy|1|||
160574160|NCT00663858|579824853|FG002|Overall Study|Lack of Efficacy|3|||
160574161|NCT00663858|579824851|FG000|Overall Study|Withdrawal by Subject|7|||
160574162|NCT00663858|579824852|FG001|Overall Study|Withdrawal by Subject|3|||
160574163|NCT00663858|579824853|FG002|Overall Study|Withdrawal by Subject|3|||
160574164|NCT00663858|579824851|FG000|Overall Study|Protocol Violation|5|||
160574165|NCT00663858|579824852|FG001|Overall Study|Protocol Violation|3|||
160574166|NCT00663858|579824853|FG002|Overall Study|Protocol Violation|4|||
160574167|NCT00663858|579824851|FG000|Overall Study|Other|8|||
160574168|NCT00663858|579824852|FG001|Overall Study|Other|2|||
160574169|NCT00663858|579824853|FG002|Overall Study|Other|4|||
160574170|NCT02940886|579824854|FG000|Overall Study|Adverse Event|7|||
160574171|NCT02940886|579824855|FG001|Overall Study|Adverse Event|3|||
160574172|NCT02940886|579824854|FG000|Overall Study|Protocol Violation|0|||
160574173|NCT02940886|579824855|FG001|Overall Study|Protocol Violation|2|||
160574174|NCT02940886|579824854|FG000|Overall Study|Withdrawal by Subject|28|||
160574175|NCT02940886|579824855|FG001|Overall Study|Withdrawal by Subject|20|||
160574176|NCT02940886|579824854|FG000|Overall Study|Death|1|||
160574177|NCT02940886|579824855|FG001|Overall Study|Death|0|||
160574178|NCT02940886|579824854|FG000|Overall Study|Lack of Efficacy|1|||
160574179|NCT02940886|579824855|FG001|Overall Study|Lack of Efficacy|0|||
160574180|NCT02940886|579824854|FG000|Overall Study|Lost to Follow-up|49|||
160574181|NCT02940886|579824855|FG001|Overall Study|Lost to Follow-up|21|||
160574182|NCT02940886|579824854|FG000|Overall Study|Physician Decision|9|||
160574183|NCT02940886|579824855|FG001|Overall Study|Physician Decision|4|||
160574184|NCT02940886|579824854|FG000|Overall Study|Sponsor decision|0|||
160574185|NCT02940886|579824855|FG001|Overall Study|Sponsor decision|1|||
160574186|NCT02940886|579824854|FG000|Overall Study|No treatment|7|||
160574187|NCT02940886|579824855|FG001|Overall Study|No treatment|2|||
160574188|NCT02940886|579824854|FG000|Overall Study|Enrolment error|0|||
160574189|NCT02940886|579824855|FG001|Overall Study|Enrolment error|1|||
160574190|NCT03042611|579824856|FG000|Core Phase|Withdrawal by Subject|13|||
160574191|NCT03042611|579824857|FG001|Core Phase|Withdrawal by Subject|4|||
160574192|NCT03042611|579824858|FG002|Core Phase|Withdrawal by Subject|0|||
160574193|NCT03042611|579824859|FG003|Core Phase|Withdrawal by Subject|0|||
160574194|NCT03042611|579824856|FG000|Core Phase|Death|232|||
160574195|NCT03042611|579824857|FG001|Core Phase|Death|110|||
160574196|NCT03042611|579824858|FG002|Core Phase|Death|0|||
160574197|NCT03042611|579824859|FG003|Core Phase|Death|0|||
160574198|NCT03042611|579824856|FG000|Core Phase|Lost to Follow-up|4|||
160574199|NCT03042611|579824857|FG001|Core Phase|Lost to Follow-up|7|||
160574200|NCT03042611|579824858|FG002|Core Phase|Lost to Follow-up|0|||
160574201|NCT03042611|579824859|FG003|Core Phase|Lost to Follow-up|0|||
160574202|NCT03042611|579824856|FG000|Core Phase|Physician Decision|7|||
160574203|NCT03042611|579824857|FG001|Core Phase|Physician Decision|2|||
160574204|NCT03042611|579824858|FG002|Core Phase|Physician Decision|0|||
160574205|NCT03042611|579824859|FG003|Core Phase|Physician Decision|0|||
160574206|NCT03042611|579824856|FG000|Core Phase|Study Closed|0|||
160574207|NCT03042611|579824857|FG001|Core Phase|Study Closed|1|||
160574208|NCT03042611|579824858|FG002|Core Phase|Study Closed|0|||
160574209|NCT03042611|579824859|FG003|Core Phase|Study Closed|0|||
160574210|NCT03042611|579824856|FG000|Extension Phase|Death|0|||
160574211|NCT03042611|579824857|FG001|Extension Phase|Death|0|||
160574212|NCT03042611|579824858|FG002|Extension Phase|Death|34|||
160574213|NCT03042611|579824859|FG003|Extension Phase|Death|16|||
160574214|NCT03042611|579824856|FG000|Extension Phase|Lost to Follow-up|0|||
160574215|NCT03042611|579824857|FG001|Extension Phase|Lost to Follow-up|0|||
160574216|NCT03042611|579824858|FG002|Extension Phase|Lost to Follow-up|1|||
160574217|NCT03042611|579824859|FG003|Extension Phase|Lost to Follow-up|1|||
160574218|NCT03042611|579824856|FG000|Extension Phase|Study Closed|0|||
160574219|NCT03042611|579824857|FG001|Extension Phase|Study Closed|0|||
160574220|NCT03042611|579824858|FG002|Extension Phase|Study Closed|17|||
160574221|NCT03042611|579824859|FG003|Extension Phase|Study Closed|11|||
160574222|NCT01713036|579824863|FG000|Overall Study|Death|1|||
160574223|NCT00474630|579824864|FG000|Overall Study|Adverse Event|98|||
160574224|NCT00474630|579824865|FG001|Overall Study|Adverse Event|26|||
160574225|NCT00474630|579824864|FG000|Overall Study|Lost to Follow-up|22|||
160574226|NCT00474630|579824865|FG001|Overall Study|Lost to Follow-up|15|||
160574227|NCT00474630|579824864|FG000|Overall Study|Withdrawal by Subject|21|||
160574228|NCT00474630|579824865|FG001|Overall Study|Withdrawal by Subject|15|||
160574229|NCT00474630|579824864|FG000|Overall Study|Protocol Violation|3|||
160574230|NCT00474630|579824865|FG001|Overall Study|Protocol Violation|4|||
160574231|NCT00474630|579824864|FG000|Overall Study|Lack of Efficacy|5|||
160574232|NCT00474630|579824865|FG001|Overall Study|Lack of Efficacy|6|||
160574233|NCT00474630|579824864|FG000|Overall Study|Drug noncompliance, other|11|||
160574234|NCT00474630|579824865|FG001|Overall Study|Drug noncompliance, other|4|||
160574235|NCT01650779|579824870|FG000|Overall Study|Withdrawal by Subject|1|||
160574236|NCT00915005|579824873|FG000|Overall Study|Withdrawal by Subject|4|||
160574237|NCT00915005|579824874|FG001|Overall Study|Withdrawal by Subject|4|||
160574238|NCT00915005|579824873|FG000|Overall Study|Patient preferred protons therapy|6|||
160574239|NCT00915005|579824874|FG001|Overall Study|Patient preferred protons therapy|0|||
160574240|NCT00915005|579824873|FG000|Overall Study|Insurance denial|3|||
160574241|NCT00915005|579824874|FG001|Overall Study|Insurance denial|15|||
160574242|NCT02397655|579824877|FG000|Overall Study|data not completed|1301|||
160574243|NCT01736683|579824878|FG000|Overall Study|Disease Relapse|0|||
160574244|NCT01736683|579824879|FG001|Overall Study|Disease Relapse|0|||
160574245|NCT01736683|579824880|FG002|Overall Study|Disease Relapse|2|||
160574246|NCT01736683|579824881|FG003|Overall Study|Disease Relapse|1|||
160574247|NCT01736683|579824882|FG004|Overall Study|Disease Relapse|0|||
160574248|NCT01736683|579824878|FG000|Overall Study|Adverse Event|0|||
160574249|NCT01736683|579824879|FG001|Overall Study|Adverse Event|2|||
160574250|NCT01736683|579824880|FG002|Overall Study|Adverse Event|2|||
160574251|NCT01736683|579824881|FG003|Overall Study|Adverse Event|3|||
160574252|NCT01736683|579824882|FG004|Overall Study|Adverse Event|2|||
160574253|NCT01736683|579824878|FG000|Overall Study|Withdrawal by Subject|0|||
160574254|NCT01736683|579824879|FG001|Overall Study|Withdrawal by Subject|0|||
160574255|NCT01736683|579824880|FG002|Overall Study|Withdrawal by Subject|3|||
160574256|NCT01736683|579824881|FG003|Overall Study|Withdrawal by Subject|1|||
160574257|NCT01736683|579824882|FG004|Overall Study|Withdrawal by Subject|1|||
160574258|NCT01736683|579824878|FG000|Overall Study|Lack of Therapeutic Effect|7|||
160574259|NCT01736683|579824879|FG001|Overall Study|Lack of Therapeutic Effect|4|||
160574260|NCT01736683|579824880|FG002|Overall Study|Lack of Therapeutic Effect|13|||
160574261|NCT01736683|579824881|FG003|Overall Study|Lack of Therapeutic Effect|20|||
160574262|NCT01736683|579824882|FG004|Overall Study|Lack of Therapeutic Effect|1|||
160574263|NCT01736683|579824878|FG000|Overall Study|Progressive Disease|0|||
160574264|NCT01736683|579824879|FG001|Overall Study|Progressive Disease|0|||
160654163|NCT02224391|580114283|FG001|Overall Study|Withdrawal by Subject|5|||
160574265|NCT01736683|579824880|FG002|Overall Study|Progressive Disease|0|||
160574266|NCT01736683|579824881|FG003|Overall Study|Progressive Disease|1|||
160574267|NCT01736683|579824882|FG004|Overall Study|Progressive Disease|0|||
160574268|NCT01736683|579824878|FG000|Overall Study|Other|0|||
160574269|NCT01736683|579824879|FG001|Overall Study|Other|0|||
160574270|NCT01736683|579824880|FG002|Overall Study|Other|1|||
160574271|NCT01736683|579824881|FG003|Overall Study|Other|9|||
160574272|NCT01736683|579824882|FG004|Overall Study|Other|1|||
160574273|NCT00283712|579824888|FG000|Overall Study|Death|0|||
160574274|NCT00283712|579824889|FG001|Overall Study|Death|1|||
160574275|NCT02046564|579824893|FG000|Overall Study|Adverse Event|6|||
160574276|NCT02046564|579824894|FG001|Overall Study|Adverse Event|3|||
160574277|NCT02046564|579824893|FG000|Overall Study|Physician Decision|0|||
160574278|NCT02046564|579824894|FG001|Overall Study|Physician Decision|1|||
160574279|NCT02046564|579824893|FG000|Overall Study|Protocol Violation|3|||
160574280|NCT02046564|579824894|FG001|Overall Study|Protocol Violation|1|||
160574281|NCT02046564|579824893|FG000|Overall Study|Withdrawal by Subject|4|||
160574282|NCT02046564|579824894|FG001|Overall Study|Withdrawal by Subject|10|||
160574283|NCT02046564|579824893|FG000|Overall Study|Subject met withdrawal criteria|2|||
160574284|NCT02046564|579824894|FG001|Overall Study|Subject met withdrawal criteria|5|||
160574285|NCT02747043|579824895|FG000|Overall Study|Other|1|||
160574286|NCT02747043|579824896|FG001|Overall Study|Other|1|||
160574287|NCT02747043|579824895|FG000|Overall Study|Adverse Event|3|||
160574288|NCT02747043|579824896|FG001|Overall Study|Adverse Event|1|||
160574289|NCT02747043|579824895|FG000|Overall Study|Withdrawal by Subject|1|||
160574290|NCT02747043|579824896|FG001|Overall Study|Withdrawal by Subject|1|||
160574291|NCT02747043|579824895|FG000|Overall Study|Physician Decision|1|||
160574292|NCT02747043|579824896|FG001|Overall Study|Physician Decision|1|||
160574293|NCT02747043|579824895|FG000|Overall Study|Protocol Violation|0|||
160574294|NCT02747043|579824896|FG001|Overall Study|Protocol Violation|1|||
160574295|NCT02747043|579824895|FG000|Overall Study|Disease progression|4|||
160574296|NCT02747043|579824896|FG001|Overall Study|Disease progression|0|||
160574297|NCT00907478|579824897|FG000|Overall Study|Ineligibility determined|0|||
160574298|NCT00907478|579824898|FG001|Overall Study|Ineligibility determined|0|||
160574299|NCT00907478|579824899|FG002|Overall Study|Ineligibility determined|1|||
160574300|NCT00907478|579824897|FG000|Overall Study|Noncompliance|0|||
160574301|NCT00907478|579824898|FG001|Overall Study|Noncompliance|0|||
160574302|NCT00907478|579824899|FG002|Overall Study|Noncompliance|1|||
160574303|NCT00907478|579824897|FG000|Overall Study|Adverse Event|3|||
160574304|NCT00907478|579824898|FG001|Overall Study|Adverse Event|1|||
160574305|NCT00907478|579824899|FG002|Overall Study|Adverse Event|2|||
160574306|NCT00907478|579824897|FG000|Overall Study|Withdrawal by Subject|8|||
160574307|NCT00907478|579824898|FG001|Overall Study|Withdrawal by Subject|9|||
160574308|NCT00907478|579824899|FG002|Overall Study|Withdrawal by Subject|6|||
160574309|NCT00907478|579824897|FG000|Overall Study|Requirement for alternative therapy|1|||
160574310|NCT00907478|579824898|FG001|Overall Study|Requirement for alternative therapy|2|||
160574311|NCT00907478|579824899|FG002|Overall Study|Requirement for alternative therapy|3|||
160574312|NCT00907478|579824897|FG000|Overall Study|Physician Decision|2|||
160574313|NCT00907478|579824898|FG001|Overall Study|Physician Decision|0|||
160574314|NCT00907478|579824899|FG002|Overall Study|Physician Decision|3|||
160574315|NCT00907478|579824897|FG000|Overall Study|Death|4|||
160574316|NCT00907478|579824898|FG001|Overall Study|Death|2|||
160574317|NCT00907478|579824899|FG002|Overall Study|Death|1|||
160574318|NCT00907478|579824897|FG000|Overall Study|Protocol-specified criteria|5|||
160574319|NCT00907478|579824898|FG001|Overall Study|Protocol-specified criteria|2|||
160574320|NCT00907478|579824899|FG002|Overall Study|Protocol-specified criteria|3|||
160574321|NCT00907478|579824897|FG000|Overall Study|Pregnancy|0|||
160574322|NCT00907478|579824898|FG001|Overall Study|Pregnancy|1|||
160574323|NCT00907478|579824899|FG002|Overall Study|Pregnancy|1|||
160574324|NCT00907478|579824897|FG000|Overall Study|Lost to Follow-up|1|||
160574325|NCT00907478|579824898|FG001|Overall Study|Lost to Follow-up|0|||
160574326|NCT00907478|579824899|FG002|Overall Study|Lost to Follow-up|0|||
160574327|NCT00907478|579824897|FG000|Overall Study|Other|3|||
160920609|NCT00665353|581103305|FG000|Study Step 2|Lost to Follow-up|2|||
160920610|NCT00665353|581103305|FG000|Study Step 2|Lack of Efficacy|12|||
160920611|NCT01851720|581103306|FG000|Overall Study|Lost to Follow-up|0|||
160920612|NCT01851720|581103307|FG001|Overall Study|Lost to Follow-up|1|||
160920613|NCT02132767|581103312|FG000|Overall Study|Death|3|||
160920614|NCT02132767|581103313|FG001|Overall Study|Death|2|||
160920615|NCT02132767|581103312|FG000|Overall Study|Withdrawal by Subject|10|||
160920616|NCT02132767|581103313|FG001|Overall Study|Withdrawal by Subject|9|||
160920617|NCT02132767|581103312|FG000|Overall Study|Lost to Follow-up|4|||
160920618|NCT02132767|581103313|FG001|Overall Study|Lost to Follow-up|4|||
160920619|NCT00390858|581103314|FG000|Overall Study|Adverse Event|6|||
160454689|NCT01928394|579396172|FG002|Treatment Period|Participant withdrew consent|1|||
160574328|NCT00907478|579824898|FG001|Overall Study|Other|0|||
160574329|NCT00907478|579824899|FG002|Overall Study|Other|1|||
160574330|NCT01936649|579824904|FG000|Overall Study|Withdrawal by Subject|4|||
160574331|NCT01936649|579824904|FG000|Overall Study|Physician Decision|2|||
160574332|NCT01936649|579824904|FG000|Overall Study|Protocol Violation|2|||
160574333|NCT01936649|579824904|FG000|Overall Study|Other than specified above|5|||
160574334|NCT03648476|579824912|FG000|Overall Study|Withdrawal by Subject|2|||
160574335|NCT03648476|579824913|FG001|Overall Study|Withdrawal by Subject|1|||
160920620|NCT00390858|581103315|FG001|Overall Study|Adverse Event|2|||
160920621|NCT00390858|581103314|FG000|Overall Study|Lack of Efficacy|0|||
160920622|NCT00390858|581103315|FG001|Overall Study|Lack of Efficacy|1|||
160920623|NCT00390858|581103314|FG000|Overall Study|Withdrawal by Subject|3|||
160997290|NCT02962674|581374897|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
160997291|NCT03265210|581374902|FG000|Overall Study|Withdrawal by Subject|7|||
160997292|NCT03265210|581374903|FG001|Overall Study|Withdrawal by Subject|9|||
160997293|NCT03265210|581374902|FG000|Overall Study|Lost to Follow-up|2|||
160997294|NCT03265210|581374903|FG001|Overall Study|Lost to Follow-up|0|||
160997295|NCT03265210|581374902|FG000|Overall Study|Physician Decision|2|||
160997296|NCT03265210|581374903|FG001|Overall Study|Physician Decision|0|||
160997297|NCT03265210|581374902|FG000|Overall Study|Adverse Event|1|||
160997298|NCT03265210|581374903|FG001|Overall Study|Adverse Event|0|||
160997299|NCT01883492|581374904|FG000|Overall Study|Lost to Follow-up|3|||
160997300|NCT01883492|581374905|FG001|Overall Study|Lost to Follow-up|4|||
160997301|NCT01883492|581374904|FG000|Overall Study|Surgery on contra-lateral hip|0|||
160997302|NCT01883492|581374905|FG001|Overall Study|Surgery on contra-lateral hip|1|||
160997303|NCT01883492|581374904|FG000|Overall Study|Poor X-ray quality|7|||
160997304|NCT01883492|581374905|FG001|Overall Study|Poor X-ray quality|4|||
160997305|NCT01883492|581374904|FG000|Overall Study|Withdrawal by Subject|1|||
160997306|NCT01883492|581374905|FG001|Overall Study|Withdrawal by Subject|0|||
160997307|NCT01883492|581374904|FG000|Overall Study|inappropriate implant used|1|||
160997308|NCT01883492|581374905|FG001|Overall Study|inappropriate implant used|1|||
160997309|NCT01883492|581374904|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
160997310|NCT01883492|581374905|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
160997311|NCT02488980|581374911|FG000|Overall Study|Protocol Violation|2|||
160997312|NCT02488980|581374912|FG001|Overall Study|Protocol Violation|2|||
160997313|NCT02488980|581374913|FG002|Overall Study|Protocol Violation|2|||
160997314|NCT00549848|581374917|FG000|Overall Study|Death|1|||
160997315|NCT00549848|581374918|FG001|Overall Study|Death|4|||
160997316|NCT00549848|581374919|FG002|Overall Study|Death|13|||
160997317|NCT00549848|581374917|FG000|Overall Study|Physician Decision|0|||
160997318|NCT00549848|581374918|FG001|Overall Study|Physician Decision|0|||
160997319|NCT00549848|581374919|FG002|Overall Study|Physician Decision|4|||
160997320|NCT00549848|581374917|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
160997321|NCT00549848|581374918|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
160997322|NCT00549848|581374919|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
160997323|NCT00549848|581374917|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
160997324|NCT00549848|581374918|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
160997325|NCT00549848|581374919|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
160997326|NCT00549848|581374917|FG000|Overall Study|Participant/Family Withdraw|2|||
160997327|NCT00549848|581374918|FG001|Overall Study|Participant/Family Withdraw|3|||
160997328|NCT00549848|581374919|FG002|Overall Study|Participant/Family Withdraw|5|||
160997329|NCT00549848|581374917|FG000|Overall Study|Second Malignancy|1|||
160997330|NCT00549848|581374918|FG001|Overall Study|Second Malignancy|0|||
160997331|NCT00549848|581374919|FG002|Overall Study|Second Malignancy|0|||
160997332|NCT00549848|581374917|FG000|Overall Study|Transplant|3|||
160997333|NCT00549848|581374918|FG001|Overall Study|Transplant|3|||
160997334|NCT00549848|581374919|FG002|Overall Study|Transplant|18|||
160997335|NCT00549848|581374917|FG000|Overall Study|Unacceptable Toxicity|1|||
160997336|NCT00549848|581374918|FG001|Overall Study|Unacceptable Toxicity|6|||
160997337|NCT00549848|581374919|FG002|Overall Study|Unacceptable Toxicity|6|||
160997338|NCT05193318|581374920|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
160997339|NCT05193318|581374920|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
160997340|NCT03670602|581374921|FG000|Overall Study|Lost to Follow-up|1|||
160997341|NCT03670602|581374922|FG001|Overall Study|Lost to Follow-up|0|||
160997342|NCT03670602|581374921|FG000|Overall Study|Withdrawal by Subject|0|||
160997343|NCT03670602|581374922|FG001|Overall Study|Withdrawal by Subject|3|||
160997344|NCT00957658|581374923|FG000|Overall Study|Death|1|||
160997345|NCT00957658|581374923|FG000|Overall Study|Lost to Follow-up|4|||
160997346|NCT00957658|581374923|FG000|Overall Study|Withdrawal by Subject|12|||
160997347|NCT00957658|581374923|FG000|Overall Study|Revision|1|||
160997348|NCT00957658|581374923|FG000|Overall Study|Incomplete 2 yr data|28|||
160997349|NCT00957658|581374923|FG000|Overall Study|Site termination|10|||
160997350|NCT00957658|581374923|FG000|Overall Study|unwilling/unable to return|2|||
160997351|NCT00957658|581374923|FG000|Overall Study|surgery cancelled|2|||
160997352|NCT00957658|581374923|FG000|Overall Study|Protocol Violation|5|||
160997353|NCT00975806|581374924|FG000|Overall Study|Adverse Event|2|||
160997354|NCT00975806|581374925|FG001|Overall Study|Adverse Event|1|||
160997355|NCT00975806|581374926|FG002|Overall Study|Adverse Event|2|||
160997356|NCT00975806|581374924|FG000|Overall Study|Disease Progression|1|||
160997357|NCT00975806|581374925|FG001|Overall Study|Disease Progression|5|||
160997358|NCT00975806|581374926|FG002|Overall Study|Disease Progression|1|||
160997359|NCT00975806|581374924|FG000|Overall Study|Withdrawal by Subject|1|||
160997360|NCT00975806|581374925|FG001|Overall Study|Withdrawal by Subject|0|||
160997361|NCT00975806|581374926|FG002|Overall Study|Withdrawal by Subject|0|||
160997362|NCT00975806|581374924|FG000|Overall Study|Death|0|||
160997363|NCT00975806|581374925|FG001|Overall Study|Death|1|||
160997364|NCT00975806|581374926|FG002|Overall Study|Death|0|||
160997365|NCT00975806|581374924|FG000|Overall Study|Physician decision and disease related|1|||
160654164|NCT02492958|580114284|FG000|Overall Study|Withdrawal by Subject|0|||
160654165|NCT02492958|580114285|FG001|Overall Study|Withdrawal by Subject|0|||
160654166|NCT02492958|580114286|FG002|Overall Study|Withdrawal by Subject|1|||
160654167|NCT02492958|580114287|FG003|Overall Study|Withdrawal by Subject|0|||
160654168|NCT02492958|580114284|FG000|Overall Study|Adverse Event|1|||
160654169|NCT02492958|580114285|FG001|Overall Study|Adverse Event|0|||
160654170|NCT02492958|580114286|FG002|Overall Study|Adverse Event|1|||
160654171|NCT02492958|580114287|FG003|Overall Study|Adverse Event|0|||
160654172|NCT02236130|580114295|FG000|Overall Study|Lost to Follow-up|7|||
160654173|NCT02236130|580114296|FG001|Overall Study|Lost to Follow-up|12|||
160654174|NCT01915732|580114302|FG000|Overall Study|Withdrawal by Subject|18|||
160654175|NCT01915732|580114303|FG001|Overall Study|Withdrawal by Subject|18|||
160654176|NCT01915732|580114302|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
160654177|NCT01915732|580114303|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
160920624|NCT00390858|581103315|FG001|Overall Study|Withdrawal by Subject|4|||
160920625|NCT00937157|581103316|FG000|Overall Study|Pregnancy|1|||
160454690|NCT01928394|579396173|FG003|Treatment Period|Participant withdrew consent|1|||
160454691|NCT01928394|579396174|FG004|Treatment Period|Participant withdrew consent|0|||
160574336|NCT01097616|579824920|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
160574337|NCT01097616|579824921|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
160574338|NCT01097616|579824922|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
160574339|NCT01097616|579824923|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160574340|NCT01097616|579824924|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160574341|NCT01097616|579824925|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160574342|NCT01097616|579824926|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160574343|NCT01097616|579824927|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160574344|NCT01097616|579824920|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
160574345|NCT01097616|579824921|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
160574346|NCT01097616|579824922|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
160574347|NCT01097616|579824923|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160574348|NCT01097616|579824924|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160574349|NCT01097616|579824925|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160574350|NCT01097616|579824926|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160574351|NCT01097616|579824927|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160574352|NCT01097616|579824920|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
160574353|NCT01097616|579824921|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
160574354|NCT01097616|579824922|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
160574355|NCT01097616|579824923|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160574356|NCT01097616|579824924|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160574357|NCT01097616|579824925|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160574358|NCT01097616|579824926|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160574359|NCT01097616|579824927|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160574360|NCT01097616|579824920|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
160574361|NCT01097616|579824921|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
160574362|NCT01097616|579824922|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160574363|NCT01097616|579824923|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160574364|NCT01097616|579824924|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160574365|NCT01097616|579824925|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160574366|NCT01097616|579824926|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160574367|NCT01097616|579824927|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
160574368|NCT01097616|579824920|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
160574369|NCT01097616|579824921|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
160574370|NCT01097616|579824922|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
160574371|NCT01097616|579824923|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
160574372|NCT01097616|579824924|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
160574373|NCT01097616|579824925|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
160574374|NCT01097616|579824926|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
160574375|NCT01097616|579824927|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
160574376|NCT01097616|579824920|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
160574377|NCT01097616|579824921|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
160654178|NCT01915732|580114302|FG000|Overall Study|Adverse Event|12|||
160654179|NCT01915732|580114303|FG001|Overall Study|Adverse Event|4|||
160654180|NCT01915732|580114302|FG000|Overall Study|Protocol Violation|5|||
160654181|NCT01915732|580114303|FG001|Overall Study|Protocol Violation|5|||
160654182|NCT01915732|580114302|FG000|Overall Study|Lack of Efficacy|6|||
160654183|NCT01915732|580114303|FG001|Overall Study|Lack of Efficacy|11|||
160654184|NCT01915732|580114302|FG000|Overall Study|Lost to Follow-up|22|||
160654185|NCT01915732|580114303|FG001|Overall Study|Lost to Follow-up|26|||
160920626|NCT00937157|581103316|FG000|Overall Study|Lost to Follow-up|3|||
160920627|NCT02377466|581103319|FG000|Overall Study|Other: Randomized and not treated|0|||
160574378|NCT01097616|579824922|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
160574379|NCT01097616|579824923|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
160574380|NCT01097616|579824924|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
160574381|NCT01097616|579824925|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
160574382|NCT01097616|579824926|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
160574383|NCT01097616|579824927|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
160574384|NCT01097616|579824920|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
160574385|NCT01097616|579824921|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
160920628|NCT02377466|581103320|FG001|Overall Study|Other: Randomized and not treated|2|||
160920629|NCT04210310|581103321|FG000|Overall Study|Lost to Follow-up|32|||
160920630|NCT04210310|581103322|FG001|Overall Study|Lost to Follow-up|1|||
160920631|NCT00495170|581103323|FG000|Overall Study|Lost to Follow-up|9|||
160920632|NCT00495170|581103323|FG000|Overall Study|Withdrawal by Subject|3|||
160920633|NCT00495170|581103323|FG000|Overall Study|Inappropriate staging|8|||
160920634|NCT01928329|581103324|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
160920635|NCT01928329|581103325|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
160920636|NCT01928329|581103324|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
160920637|NCT01928329|581103325|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
160920638|NCT01928329|581103324|FG000|Overall Study|Adverse Event|5|||
160920639|NCT01928329|581103325|FG001|Overall Study|Adverse Event|3|||
160920640|NCT01928329|581103324|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
160920641|NCT01928329|581103325|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
160920642|NCT01928329|581103324|FG000|Overall Study|Withdrawal by Subject|1|||
160920643|NCT01928329|581103325|FG001|Overall Study|Withdrawal by Subject|5|||
160920644|NCT01928329|581103324|FG000|Overall Study|Physician Decision|1|||
160920645|NCT01928329|581103325|FG001|Overall Study|Physician Decision|1|||
160920646|NCT00330616|581103326|FG000|Overall Study|Adverse Event|13|||
160920647|NCT00330616|581103326|FG000|Overall Study|Lack of Efficacy|1|||
160920648|NCT00330616|581103326|FG000|Overall Study|Lost to Follow-up|2|||
160920649|NCT00330616|581103326|FG000|Overall Study|Withdrawal by Subject|4|||
160920650|NCT00330616|581103326|FG000|Overall Study|Other|1|||
160920651|NCT02141997|581103331|FG000|Overall Study|Adverse Event|0|||
160920652|NCT02141997|581103332|FG001|Overall Study|Adverse Event|2|||
160920653|NCT02141997|581103333|FG002|Overall Study|Adverse Event|0|||
160920654|NCT02141997|581103334|FG003|Overall Study|Adverse Event|1|||
160920655|NCT02141997|581103331|FG000|Overall Study|Participant noncompliance|1|||
160920656|NCT02141997|581103332|FG001|Overall Study|Participant noncompliance|0|||
160920657|NCT02141997|581103333|FG002|Overall Study|Participant noncompliance|0|||
160920658|NCT02141997|581103334|FG003|Overall Study|Participant noncompliance|0|||
160920659|NCT02141997|581103331|FG000|Overall Study|Withdrew consent|1|||
160920660|NCT02141997|581103332|FG001|Overall Study|Withdrew consent|0|||
160920661|NCT02141997|581103333|FG002|Overall Study|Withdrew consent|3|||
160920662|NCT02141997|581103334|FG003|Overall Study|Withdrew consent|0|||
160920663|NCT02141997|581103331|FG000|Overall Study|Other|1|||
160920664|NCT02141997|581103332|FG001|Overall Study|Other|4|||
160920665|NCT02141997|581103333|FG002|Overall Study|Other|0|||
160920666|NCT02141997|581103334|FG003|Overall Study|Other|0|||
160920667|NCT00732615|581103342|FG000|Overall Study|Withdrawal by Subject|3|||
160920668|NCT00732615|581103343|FG001|Overall Study|Withdrawal by Subject|1|||
160920669|NCT00732615|581103342|FG000|Overall Study|Lost to Follow-up|0|||
160920670|NCT00732615|581103343|FG001|Overall Study|Lost to Follow-up|1|||
160920671|NCT00732615|581103342|FG000|Overall Study|Adverse Event|0|||
160920672|NCT00732615|581103343|FG001|Overall Study|Adverse Event|2|||
160920673|NCT00732615|581103342|FG000|Overall Study|Physician Decision|3|||
160920674|NCT00732615|581103343|FG001|Overall Study|Physician Decision|0|||
160920675|NCT00732615|581103342|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
160920676|NCT00732615|581103343|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
160920677|NCT00597766|581103344|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
160574386|NCT01097616|579824922|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160574387|NCT01097616|579824923|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160654186|NCT01915732|580114302|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
160654187|NCT01915732|580114303|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
160920678|NCT00597766|581103345|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
160920679|NCT00597766|581103346|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
160920680|NCT00597766|581103344|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
160920681|NCT00597766|581103345|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
160920682|NCT00597766|581103346|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
160920683|NCT01333059|581103347|FG000|Overall Study|Physician Decision|3|||
160920684|NCT01333059|581103348|FG001|Overall Study|Physician Decision|3|||
160920685|NCT01333059|581103347|FG000|Overall Study|Protocol Violation|3|||
160920686|NCT01333059|581103348|FG001|Overall Study|Protocol Violation|0|||
160920687|NCT00737282|581103349|FG000|Overall Study|Study prematurely terminated|175|||
160920688|NCT02763189|581103350|FG000|Overall Study|Device failure|0|||
160920689|NCT02763189|581103351|FG001|Overall Study|Device failure|2|||
160654188|NCT01915732|580114302|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
160654189|NCT01915732|580114303|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
160654190|NCT01915732|580114302|FG000|Overall Study|Drug Release Error|1|||
160654191|NCT01915732|580114303|FG001|Overall Study|Drug Release Error|0|||
160997366|NCT00975806|581374925|FG001|Overall Study|Physician decision and disease related|0|||
160997367|NCT00975806|581374926|FG002|Overall Study|Physician decision and disease related|1|||
160574388|NCT01097616|579824924|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160574389|NCT01097616|579824925|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160574390|NCT01097616|579824926|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160574391|NCT01097616|579824927|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160574392|NCT01097616|579824920|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160574393|NCT01097616|579824921|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160574394|NCT01097616|579824922|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
160574395|NCT01097616|579824923|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160574396|NCT01097616|579824924|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160574397|NCT01097616|579824925|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160574398|NCT01097616|579824926|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160574399|NCT01097616|579824927|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160574400|NCT01097616|579824920|FG000|Optional DB EXT Phase|Adverse Event|0|||
160574401|NCT01097616|579824921|FG001|Optional DB EXT Phase|Adverse Event|7|||
160574402|NCT01097616|579824922|FG002|Optional DB EXT Phase|Adverse Event|2|||
160574403|NCT01097616|579824923|FG003|Optional DB EXT Phase|Adverse Event|0|||
160574404|NCT01097616|579824924|FG004|Optional DB EXT Phase|Adverse Event|0|||
160574405|NCT01097616|579824925|FG005|Optional DB EXT Phase|Adverse Event|0|||
160574406|NCT01097616|579824926|FG006|Optional DB EXT Phase|Adverse Event|0|||
160574407|NCT01097616|579824927|FG007|Optional DB EXT Phase|Adverse Event|0|||
160574408|NCT01097616|579824920|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
160574409|NCT01097616|579824921|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
160574410|NCT01097616|579824922|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
160574411|NCT01097616|579824923|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
160574412|NCT01097616|579824924|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
160574413|NCT01097616|579824925|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
160574414|NCT01097616|579824926|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
160574415|NCT01097616|579824927|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
160574416|NCT01097616|579824920|FG000|Optional DB EXT Phase|Protocol Violation|0|||
160574417|NCT01097616|579824921|FG001|Optional DB EXT Phase|Protocol Violation|2|||
160574418|NCT01097616|579824922|FG002|Optional DB EXT Phase|Protocol Violation|3|||
160574419|NCT01097616|579824923|FG003|Optional DB EXT Phase|Protocol Violation|0|||
160574420|NCT01097616|579824924|FG004|Optional DB EXT Phase|Protocol Violation|0|||
160574421|NCT01097616|579824925|FG005|Optional DB EXT Phase|Protocol Violation|0|||
160574422|NCT01097616|579824926|FG006|Optional DB EXT Phase|Protocol Violation|0|||
160574423|NCT01097616|579824927|FG007|Optional DB EXT Phase|Protocol Violation|0|||
160574424|NCT01097616|579824920|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
160574425|NCT01097616|579824921|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
160574426|NCT01097616|579824922|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
160574427|NCT01097616|579824923|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
160574428|NCT01097616|579824924|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
160574429|NCT01097616|579824925|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
160574430|NCT01097616|579824926|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
160574431|NCT01097616|579824927|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
160574432|NCT01097616|579824920|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
160574433|NCT01097616|579824921|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
160574434|NCT01097616|579824922|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
160574435|NCT01097616|579824923|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
160574436|NCT01097616|579824924|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
160574437|NCT01097616|579824925|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
160574438|NCT01097616|579824926|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
160574439|NCT01097616|579824927|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
160574440|NCT01097616|579824920|FG000|Optional DB EXT Phase|Physician Decision|1|||
160574441|NCT01097616|579824921|FG001|Optional DB EXT Phase|Physician Decision|0|||
160574442|NCT01097616|579824922|FG002|Optional DB EXT Phase|Physician Decision|0|||
160574443|NCT01097616|579824923|FG003|Optional DB EXT Phase|Physician Decision|0|||
160574444|NCT01097616|579824924|FG004|Optional DB EXT Phase|Physician Decision|0|||
160574445|NCT01097616|579824925|FG005|Optional DB EXT Phase|Physician Decision|0|||
160574446|NCT01097616|579824926|FG006|Optional DB EXT Phase|Physician Decision|0|||
160574447|NCT01097616|579824927|FG007|Optional DB EXT Phase|Physician Decision|0|||
160574448|NCT01097616|579824920|FG000|DB RO Phase|Adverse Event|0|||
160574449|NCT01097616|579824921|FG001|DB RO Phase|Adverse Event|0|||
160574450|NCT01097616|579824922|FG002|DB RO Phase|Adverse Event|0|||
160574451|NCT01097616|579824923|FG003|DB RO Phase|Adverse Event|0|||
160654192|NCT01915732|580114302|FG000|Overall Study|Recovered|1|||
160654193|NCT01915732|580114303|FG001|Overall Study|Recovered|0|||
160654194|NCT01915732|580114302|FG000|Overall Study|Pregnancy|1|||
160997368|NCT02750709|581374927|FG000|Treatment Period 1|Adverse Event|0|||
160997369|NCT02750709|581374928|FG001|Treatment Period 1|Adverse Event|0|||
160997370|NCT02750709|581374929|FG002|Treatment Period 1|Adverse Event|0|||
160997371|NCT02750709|581374930|FG003|Treatment Period 1|Adverse Event|0|||
160997372|NCT02750709|581374931|FG004|Treatment Period 1|Adverse Event|0|||
160997373|NCT02750709|581374932|FG005|Treatment Period 1|Adverse Event|1|||
160997374|NCT01120275|581374935|FG000|Overall Study|Adverse Event|3|||
160997375|NCT01120275|581374935|FG000|Overall Study|Progression|27|||
160997376|NCT01120275|581374935|FG000|Overall Study|Ineligible|3|||
160997377|NCT01120275|581374935|FG000|Overall Study|Withdrawal by Subject|1|||
160997378|NCT01120275|581374935|FG000|Overall Study|Refusal|1|||
160997379|NCT01120275|581374935|FG000|Overall Study|Not specific|1|||
160997380|NCT00771849|581374936|FG000|Overall Study|Lost to Follow-up|1|||
160997381|NCT00771849|581374937|FG001|Overall Study|Lost to Follow-up|2|||
160997382|NCT00771849|581374936|FG000|Overall Study|Withdrawal by Subject|1|||
160997383|NCT00771849|581374937|FG001|Overall Study|Withdrawal by Subject|1|||
160997384|NCT00771849|581374936|FG000|Overall Study|Not vaccinated|0|||
160574452|NCT01097616|579824924|FG004|DB RO Phase|Adverse Event|0|||
160654195|NCT01915732|580114303|FG001|Overall Study|Pregnancy|0|||
160654196|NCT01915732|580114302|FG000|Overall Study|Poor Perceived Efficacy|1|||
160654197|NCT01915732|580114303|FG001|Overall Study|Poor Perceived Efficacy|0|||
160654198|NCT01915732|580114302|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
160654199|NCT01915732|580114303|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
160654200|NCT01915732|580114302|FG000|Overall Study|Got Well|0|||
160654201|NCT01915732|580114303|FG001|Overall Study|Got Well|1|||
160654202|NCT01915732|580114302|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
160654203|NCT01915732|580114303|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
160654204|NCT01915732|580114302|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
160654205|NCT01915732|580114303|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
160654206|NCT01915732|580114302|FG000|Overall Study|Job Transfer|0|||
160654207|NCT01915732|580114303|FG001|Overall Study|Job Transfer|1|||
160654208|NCT01915732|580114302|FG000|Overall Study|Improper Facial Procedure|0|||
160654209|NCT01915732|580114303|FG001|Overall Study|Improper Facial Procedure|1|||
160654210|NCT01915732|580114302|FG000|Overall Study|Poor Conscious Effect|0|||
160654211|NCT01915732|580114303|FG001|Overall Study|Poor Conscious Effect|1|||
160654212|NCT00698685|580114304|FG000|Overall Study|Sister withdrew as donor|1|||
160654213|NCT00698685|580114304|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
160654214|NCT00337571|580114310|FG000|Overall Study|Lack of Efficacy|3|||
160654215|NCT00337571|580114311|FG001|Overall Study|Lack of Efficacy|0|||
160654216|NCT00337571|580114312|FG002|Overall Study|Lack of Efficacy|0|||
160654217|NCT00337571|580114313|FG003|Overall Study|Lack of Efficacy|0|||
160654218|NCT00337571|580114310|FG000|Overall Study|Adverse Event|4|||
160654219|NCT00337571|580114311|FG001|Overall Study|Adverse Event|5|||
160654220|NCT00337571|580114312|FG002|Overall Study|Adverse Event|8|||
160654221|NCT00337571|580114313|FG003|Overall Study|Adverse Event|4|||
160574453|NCT01097616|579824925|FG005|DB RO Phase|Adverse Event|0|||
160574454|NCT01097616|579824926|FG006|DB RO Phase|Adverse Event|1|||
160574455|NCT01097616|579824927|FG007|DB RO Phase|Adverse Event|0|||
160574456|NCT01097616|579824920|FG000|DB RO Phase|Withdrawal by Subject|0|||
160574457|NCT01097616|579824921|FG001|DB RO Phase|Withdrawal by Subject|0|||
160574458|NCT01097616|579824922|FG002|DB RO Phase|Withdrawal by Subject|0|||
160574459|NCT01097616|579824923|FG003|DB RO Phase|Withdrawal by Subject|0|||
160574460|NCT01097616|579824924|FG004|DB RO Phase|Withdrawal by Subject|0|||
160574461|NCT01097616|579824925|FG005|DB RO Phase|Withdrawal by Subject|1|||
160574462|NCT01097616|579824926|FG006|DB RO Phase|Withdrawal by Subject|0|||
160574463|NCT01097616|579824927|FG007|DB RO Phase|Withdrawal by Subject|0|||
160574464|NCT01097616|579824920|FG000|DB RO Phase|Lost to Follow-up|0|||
160574465|NCT01097616|579824921|FG001|DB RO Phase|Lost to Follow-up|0|||
160574466|NCT01097616|579824922|FG002|DB RO Phase|Lost to Follow-up|0|||
160574467|NCT01097616|579824923|FG003|DB RO Phase|Lost to Follow-up|1|||
160574468|NCT01097616|579824924|FG004|DB RO Phase|Lost to Follow-up|1|||
160574469|NCT01097616|579824925|FG005|DB RO Phase|Lost to Follow-up|0|||
160574470|NCT01097616|579824926|FG006|DB RO Phase|Lost to Follow-up|0|||
160574471|NCT01097616|579824927|FG007|DB RO Phase|Lost to Follow-up|1|||
160574472|NCT01097616|579824920|FG000|DB RO Phase|Not Treated in RO|0|||
160574473|NCT01097616|579824921|FG001|DB RO Phase|Not Treated in RO|0|||
160654222|NCT00337571|580114310|FG000|Overall Study|Withdrawal by Subject|2|||
160654223|NCT00337571|580114311|FG001|Overall Study|Withdrawal by Subject|2|||
160654224|NCT00337571|580114312|FG002|Overall Study|Withdrawal by Subject|1|||
160654225|NCT00337571|580114313|FG003|Overall Study|Withdrawal by Subject|0|||
160574474|NCT01097616|579824922|FG002|DB RO Phase|Not Treated in RO|0|||
160654226|NCT00337571|580114310|FG000|Overall Study|Lost to Follow-up|3|||
160997385|NCT00771849|581374937|FG001|Overall Study|Not vaccinated|1|||
160997386|NCT01156116|581374938|FG000|Overall Study|Withdrawal by Subject|3|||
160574475|NCT01097616|579824923|FG003|DB RO Phase|Not Treated in RO|0|||
160574476|NCT01097616|579824924|FG004|DB RO Phase|Not Treated in RO|0|||
160574477|NCT01097616|579824925|FG005|DB RO Phase|Not Treated in RO|1|||
160654227|NCT00337571|580114311|FG001|Overall Study|Lost to Follow-up|1|||
160654228|NCT00337571|580114312|FG002|Overall Study|Lost to Follow-up|0|||
160654229|NCT00337571|580114313|FG003|Overall Study|Lost to Follow-up|1|||
160574478|NCT01097616|579824926|FG006|DB RO Phase|Not Treated in RO|0|||
160574479|NCT01097616|579824927|FG007|DB RO Phase|Not Treated in RO|0|||
160574480|NCT01342640|579824930|FG000|Overall Study|Adverse Event|3|||
160574481|NCT01342640|579824930|FG000|Overall Study|Protocol Violation|16|||
160574482|NCT01342640|579824930|FG000|Overall Study|Lost to Follow-up|21|||
160574483|NCT01342640|579824930|FG000|Overall Study|Other|1|||
160574484|NCT01749735|579824933|FG000|Overall Study|Withdrawal by Subject|1|||
160574485|NCT01749735|579824934|FG001|Overall Study|Withdrawal by Subject|0|||
160574486|NCT01208181|579824937|FG000|Part 1|Withdrawal by Subject|11|||
160574487|NCT01208181|579824938|FG001|Part 1|Withdrawal by Subject|10|||
160574488|NCT01208181|579824939|FG002|Part 1|Withdrawal by Subject|0|||
160574489|NCT01208181|579824940|FG003|Part 1|Withdrawal by Subject|0|||
160574490|NCT01208181|579824941|FG004|Part 1|Withdrawal by Subject|0|||
160574491|NCT01208181|579824937|FG000|Part 1|Technical problem|5|||
160574492|NCT01208181|579824938|FG001|Part 1|Technical problem|0|||
160574493|NCT01208181|579824939|FG002|Part 1|Technical problem|0|||
160574494|NCT01208181|579824940|FG003|Part 1|Technical problem|0|||
160574495|NCT01208181|579824941|FG004|Part 1|Technical problem|0|||
160574496|NCT01208181|579824937|FG000|Part 1|Protocol Violation|10|||
160574497|NCT01208181|579824938|FG001|Part 1|Protocol Violation|5|||
160574498|NCT01208181|579824939|FG002|Part 1|Protocol Violation|0|||
160574499|NCT01208181|579824940|FG003|Part 1|Protocol Violation|0|||
160574500|NCT01208181|579824941|FG004|Part 1|Protocol Violation|0|||
160574501|NCT01208181|579824937|FG000|Part 1|Physician Decision|4|||
160574502|NCT01208181|579824938|FG001|Part 1|Physician Decision|0|||
160574503|NCT01208181|579824939|FG002|Part 1|Physician Decision|0|||
160574504|NCT01208181|579824940|FG003|Part 1|Physician Decision|0|||
160574505|NCT01208181|579824941|FG004|Part 1|Physician Decision|0|||
160574506|NCT01208181|579824937|FG000|Part 1|Non-compliance with study drug|1|||
160574507|NCT01208181|579824938|FG001|Part 1|Non-compliance with study drug|1|||
160574508|NCT01208181|579824939|FG002|Part 1|Non-compliance with study drug|0|||
160574509|NCT01208181|579824940|FG003|Part 1|Non-compliance with study drug|0|||
160574510|NCT01208181|579824941|FG004|Part 1|Non-compliance with study drug|0|||
160574511|NCT01208181|579824937|FG000|Part 1|Lost to Follow-up|5|||
160574512|NCT01208181|579824938|FG001|Part 1|Lost to Follow-up|3|||
160574513|NCT01208181|579824939|FG002|Part 1|Lost to Follow-up|0|||
160574514|NCT01208181|579824940|FG003|Part 1|Lost to Follow-up|0|||
160574515|NCT01208181|579824941|FG004|Part 1|Lost to Follow-up|1|||
160574516|NCT01208181|579824937|FG000|Part 1|Lack of Efficacy|37|||
160574517|NCT01208181|579824938|FG001|Part 1|Lack of Efficacy|12|||
160574518|NCT01208181|579824939|FG002|Part 1|Lack of Efficacy|0|||
160574519|NCT01208181|579824940|FG003|Part 1|Lack of Efficacy|0|||
160574520|NCT01208181|579824941|FG004|Part 1|Lack of Efficacy|17|||
160574521|NCT01208181|579824937|FG000|Part 1|Adverse Event|26|||
160574522|NCT01208181|579824938|FG001|Part 1|Adverse Event|24|||
160574523|NCT01208181|579824939|FG002|Part 1|Adverse Event|0|||
160574524|NCT01208181|579824940|FG003|Part 1|Adverse Event|0|||
160654230|NCT00337571|580114310|FG000|Overall Study|Poor/noncompliance|1|||
160920690|NCT02049957|581103356|FG000|Overall Study|Progressive Disease|5|||
160920691|NCT02049957|581103357|FG001|Overall Study|Progressive Disease|4|||
160920692|NCT02049957|581103358|FG002|Overall Study|Progressive Disease|2|||
160920693|NCT02049957|581103359|FG003|Overall Study|Progressive Disease|2|||
160920694|NCT02049957|581103360|FG004|Overall Study|Progressive Disease|6|||
160920695|NCT02049957|581103361|FG005|Overall Study|Progressive Disease|35|||
160920696|NCT02049957|581103362|FG006|Overall Study|Progressive Disease|7|||
160920697|NCT02049957|581103363|FG007|Overall Study|Progressive Disease|26|||
160920698|NCT02049957|581103364|FG008|Overall Study|Progressive Disease|6|||
160920699|NCT02049957|581103356|FG000|Overall Study|Adverse Event|1|||
160920700|NCT02049957|581103357|FG001|Overall Study|Adverse Event|1|||
160920701|NCT02049957|581103358|FG002|Overall Study|Adverse Event|1|||
160920702|NCT02049957|581103359|FG003|Overall Study|Adverse Event|0|||
160920703|NCT02049957|581103360|FG004|Overall Study|Adverse Event|0|||
160920704|NCT02049957|581103361|FG005|Overall Study|Adverse Event|5|||
160920705|NCT02049957|581103362|FG006|Overall Study|Adverse Event|0|||
160920706|NCT02049957|581103363|FG007|Overall Study|Adverse Event|6|||
160574525|NCT01208181|579824941|FG004|Part 1|Adverse Event|4|||
160574526|NCT01208181|579824937|FG000|Part 2|Adverse Event|0|||
160574527|NCT01208181|579824938|FG001|Part 2|Adverse Event|0|||
160574528|NCT01208181|579824939|FG002|Part 2|Adverse Event|6|||
160574529|NCT01208181|579824940|FG003|Part 2|Adverse Event|7|||
160574530|NCT01208181|579824941|FG004|Part 2|Adverse Event|0|||
160654231|NCT00337571|580114311|FG001|Overall Study|Poor/noncompliance|1|||
160654232|NCT00337571|580114312|FG002|Overall Study|Poor/noncompliance|1|||
160920707|NCT02049957|581103364|FG008|Overall Study|Adverse Event|1|||
160920708|NCT02049957|581103356|FG000|Overall Study|Study Terminated by Sponsor|0|||
160574531|NCT01208181|579824937|FG000|Part 2|Withdrawal by Subject|0|||
160574532|NCT01208181|579824938|FG001|Part 2|Withdrawal by Subject|0|||
160574533|NCT01208181|579824939|FG002|Part 2|Withdrawal by Subject|1|||
160574534|NCT01208181|579824940|FG003|Part 2|Withdrawal by Subject|1|||
160574535|NCT01208181|579824941|FG004|Part 2|Withdrawal by Subject|0|||
160574536|NCT01208181|579824937|FG000|Part 2|Protocol Violation|0|||
160920709|NCT02049957|581103357|FG001|Overall Study|Study Terminated by Sponsor|1|||
160997387|NCT01156116|581374939|FG001|Overall Study|Withdrawal by Subject|1|||
160997388|NCT01156116|581374938|FG000|Overall Study|CPAP intolerance|2|||
160997389|NCT01156116|581374939|FG001|Overall Study|CPAP intolerance|0|||
160997390|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
160997391|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
160997392|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
160997393|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
160997394|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
160454692|NCT01928394|579396175|FG005|Treatment Period|Participant withdrew consent|1|||
160454693|NCT01928394|579396176|FG006|Treatment Period|Participant withdrew consent|0|||
160454694|NCT01928394|579396177|FG007|Treatment Period|Participant withdrew consent|1|||
160454695|NCT01928394|579396178|FG008|Treatment Period|Participant withdrew consent|0|||
160574537|NCT01208181|579824938|FG001|Part 2|Protocol Violation|0|||
160574538|NCT01208181|579824939|FG002|Part 2|Protocol Violation|1|||
160574539|NCT01208181|579824940|FG003|Part 2|Protocol Violation|0|||
160574540|NCT01208181|579824941|FG004|Part 2|Protocol Violation|0|||
160574541|NCT01208181|579824937|FG000|Part 2|Physician Decision|0|||
160574542|NCT01208181|579824938|FG001|Part 2|Physician Decision|0|||
160574543|NCT01208181|579824939|FG002|Part 2|Physician Decision|1|||
160574544|NCT01208181|579824940|FG003|Part 2|Physician Decision|2|||
160574545|NCT01208181|579824941|FG004|Part 2|Physician Decision|0|||
160574546|NCT01208181|579824937|FG000|Part 2|Non-compliance with study drug|0|||
160574547|NCT01208181|579824938|FG001|Part 2|Non-compliance with study drug|0|||
160574548|NCT01208181|579824939|FG002|Part 2|Non-compliance with study drug|1|||
160574549|NCT01208181|579824940|FG003|Part 2|Non-compliance with study drug|1|||
160574550|NCT01208181|579824941|FG004|Part 2|Non-compliance with study drug|0|||
160574551|NCT01208181|579824937|FG000|Part 2|Lost to Follow-up|0|||
160574552|NCT01208181|579824938|FG001|Part 2|Lost to Follow-up|0|||
160574553|NCT01208181|579824939|FG002|Part 2|Lost to Follow-up|1|||
160574554|NCT01208181|579824940|FG003|Part 2|Lost to Follow-up|2|||
160574555|NCT01208181|579824941|FG004|Part 2|Lost to Follow-up|0|||
160574556|NCT01208181|579824937|FG000|Part 2|Lack of Efficacy|0|||
160574557|NCT01208181|579824938|FG001|Part 2|Lack of Efficacy|0|||
160574558|NCT01208181|579824939|FG002|Part 2|Lack of Efficacy|5|||
160574559|NCT01208181|579824940|FG003|Part 2|Lack of Efficacy|7|||
160574560|NCT01208181|579824941|FG004|Part 2|Lack of Efficacy|0|||
160574561|NCT01164501|579824943|FG000|Overall Study|Not treated|2|||
160574562|NCT01164501|579824944|FG001|Overall Study|Not treated|0|||
160574563|NCT01164501|579824945|FG002|Overall Study|Not treated|1|||
160574564|NCT01164501|579824943|FG000|Overall Study|Adverse Event|18|||
160574565|NCT01164501|579824944|FG001|Overall Study|Adverse Event|4|||
160574566|NCT01164501|579824945|FG002|Overall Study|Adverse Event|21|||
160574567|NCT01164501|579824943|FG000|Overall Study|Lack of Efficacy|0|||
160574568|NCT01164501|579824944|FG001|Overall Study|Lack of Efficacy|0|||
160574569|NCT01164501|579824945|FG002|Overall Study|Lack of Efficacy|1|||
160574570|NCT01164501|579824943|FG000|Overall Study|Non compliant with protocol|1|||
160574571|NCT01164501|579824944|FG001|Overall Study|Non compliant with protocol|1|||
160574572|NCT01164501|579824945|FG002|Overall Study|Non compliant with protocol|4|||
160574573|NCT01164501|579824943|FG000|Overall Study|Lost to Follow-up|3|||
160574574|NCT01164501|579824944|FG001|Overall Study|Lost to Follow-up|0|||
160574575|NCT01164501|579824945|FG002|Overall Study|Lost to Follow-up|3|||
160574576|NCT01164501|579824943|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
160574577|NCT01164501|579824944|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
160574578|NCT01164501|579824945|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
160574579|NCT01164501|579824943|FG000|Overall Study|Other reason not defined above|9|||
160574580|NCT01164501|579824944|FG001|Overall Study|Other reason not defined above|1|||
160574581|NCT01164501|579824945|FG002|Overall Study|Other reason not defined above|4|||
160574582|NCT01845077|579824946|FG000|Washout Period|Lost to Follow-up|0|||
160574583|NCT01845077|579824947|FG001|Washout Period|Lost to Follow-up|1|||
160574584|NCT01845077|579824948|FG002|Washout Period|Lost to Follow-up|0|||
160574585|NCT01845077|579824949|FG003|Washout Period|Lost to Follow-up|1|||
160574586|NCT01845077|579824950|FG004|Washout Period|Lost to Follow-up|0|||
160574587|NCT01845077|579824951|FG005|Washout Period|Lost to Follow-up|1|||
160574588|NCT01845077|579824946|FG000|Washout Period|Adverse Event|1|||
160574589|NCT01845077|579824947|FG001|Washout Period|Adverse Event|0|||
160574590|NCT01845077|579824948|FG002|Washout Period|Adverse Event|0|||
160574591|NCT01845077|579824949|FG003|Washout Period|Adverse Event|0|||
160574592|NCT01845077|579824950|FG004|Washout Period|Adverse Event|0|||
160574593|NCT01845077|579824951|FG005|Washout Period|Adverse Event|0|||
160574594|NCT01845077|579824946|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
160574595|NCT01845077|579824947|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
160574596|NCT01845077|579824948|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
160574597|NCT01845077|579824949|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
160574598|NCT01845077|579824950|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
160574599|NCT01845077|579824951|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
160574600|NCT01845077|579824946|FG000|Washout Period|Protocol Violation|0|||
160574601|NCT01845077|579824947|FG001|Washout Period|Protocol Violation|0|||
160574602|NCT01845077|579824948|FG002|Washout Period|Protocol Violation|0|||
160574603|NCT01845077|579824949|FG003|Washout Period|Protocol Violation|1|||
160574604|NCT01845077|579824950|FG004|Washout Period|Protocol Violation|1|||
160574605|NCT01845077|579824951|FG005|Washout Period|Protocol Violation|0|||
160574606|NCT00312377|579824954|FG000|Overall Study|Death|403|||
160574607|NCT00312377|579824955|FG001|Overall Study|Death|418|||
160574608|NCT00312377|579824954|FG000|Overall Study|Withdrawal by Subject|23|||
160574609|NCT00312377|579824955|FG001|Overall Study|Withdrawal by Subject|30|||
160574610|NCT00312377|579824954|FG000|Overall Study|Lost to Follow-up|9|||
160574611|NCT00312377|579824955|FG001|Overall Study|Lost to Follow-up|12|||
160574612|NCT00312377|579824954|FG000|Overall Study|Non-compliance|0|||
160574613|NCT00312377|579824955|FG001|Overall Study|Non-compliance|2|||
160574614|NCT00312377|579824954|FG000|Overall Study|Randomised but never received treatment|6|||
160574615|NCT00312377|579824955|FG001|Overall Study|Randomised but never received treatment|6|||
160574616|NCT00312377|579824954|FG000|Overall Study|Discontinue treatment survival follow up|202|||
160574617|NCT00312377|579824955|FG001|Overall Study|Discontinue treatment survival follow up|200|||
160574618|NCT00312377|579824954|FG000|Overall Study|Site ended participation in study|1|||
160574619|NCT00312377|579824955|FG001|Overall Study|Site ended participation in study|0|||
160574620|NCT02179398|579824961|FG000|Overall Study|Lack of obligatory data|3|||
160574621|NCT02179398|579824962|FG001|Overall Study|Lack of obligatory data|3|||
160574622|NCT02179398|579824961|FG000|Overall Study|Lost to Follow-up|0|||
160574623|NCT02179398|579824962|FG001|Overall Study|Lost to Follow-up|1|||
160574624|NCT00408681|579824969|FG000|Overall Study|Lack of Efficacy|2|||
160574625|NCT00408681|579824969|FG000|Overall Study|Adverse Event|7|||
160574626|NCT01787591|579824971|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
160574627|NCT01787591|579824972|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
160574628|NCT01787591|579824973|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
160574629|NCT01787591|579824974|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
160654233|NCT00337571|580114313|FG003|Overall Study|Poor/noncompliance|1|||
160920710|NCT02049957|581103358|FG002|Overall Study|Study Terminated by Sponsor|0|||
160920711|NCT02049957|581103359|FG003|Overall Study|Study Terminated by Sponsor|0|||
160920712|NCT02049957|581103360|FG004|Overall Study|Study Terminated by Sponsor|0|||
160920713|NCT02049957|581103361|FG005|Overall Study|Study Terminated by Sponsor|0|||
160920714|NCT02049957|581103362|FG006|Overall Study|Study Terminated by Sponsor|1|||
160920715|NCT02049957|581103363|FG007|Overall Study|Study Terminated by Sponsor|0|||
160920716|NCT02049957|581103364|FG008|Overall Study|Study Terminated by Sponsor|0|||
160920717|NCT02049957|581103356|FG000|Overall Study|Withdrawal by Subject|0|||
160920718|NCT02049957|581103357|FG001|Overall Study|Withdrawal by Subject|0|||
160920719|NCT02049957|581103358|FG002|Overall Study|Withdrawal by Subject|0|||
160920720|NCT02049957|581103359|FG003|Overall Study|Withdrawal by Subject|1|||
160920721|NCT02049957|581103360|FG004|Overall Study|Withdrawal by Subject|0|||
160920722|NCT02049957|581103361|FG005|Overall Study|Withdrawal by Subject|2|||
160920723|NCT02049957|581103362|FG006|Overall Study|Withdrawal by Subject|0|||
160920724|NCT02049957|581103363|FG007|Overall Study|Withdrawal by Subject|3|||
160920725|NCT02049957|581103364|FG008|Overall Study|Withdrawal by Subject|1|||
160920726|NCT02049957|581103356|FG000|Overall Study|Physician Decision|0|||
160920727|NCT02049957|581103357|FG001|Overall Study|Physician Decision|0|||
160920728|NCT02049957|581103358|FG002|Overall Study|Physician Decision|0|||
160920729|NCT02049957|581103359|FG003|Overall Study|Physician Decision|0|||
160920730|NCT02049957|581103360|FG004|Overall Study|Physician Decision|0|||
160920731|NCT02049957|581103361|FG005|Overall Study|Physician Decision|1|||
160920732|NCT02049957|581103362|FG006|Overall Study|Physician Decision|0|||
160920733|NCT02049957|581103363|FG007|Overall Study|Physician Decision|0|||
160920734|NCT02049957|581103364|FG008|Overall Study|Physician Decision|0|||
160920735|NCT00840294|581103365|FG000|Overall Study|Withdrawal by Subject|2|||
160920736|NCT00840294|581103366|FG001|Overall Study|Withdrawal by Subject|1|||
160920737|NCT00840294|581103365|FG000|Overall Study|Protocol Violation|1|||
160920738|NCT00840294|581103366|FG001|Overall Study|Protocol Violation|3|||
160920739|NCT00840294|581103365|FG000|Overall Study|Illness|0|||
160920740|NCT00840294|581103366|FG001|Overall Study|Illness|1|||
160920741|NCT00383149|581103368|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
160920742|NCT00383149|581103368|FG000|Overall Study|Death|2|||
160920743|NCT00383149|581103368|FG000|Overall Study|Disease Progression|38|||
160920744|NCT00383149|581103368|FG000|Overall Study|Lost to Follow-up|1|||
160920745|NCT00383149|581103368|FG000|Overall Study|Other|1|||
160574630|NCT02489630|579824977|FG000|Overall Study|Oversedation|1|||
160574631|NCT02489630|579824978|FG001|Overall Study|Oversedation|1|||
160574632|NCT02489630|579824977|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
160920746|NCT00383149|581103368|FG000|Overall Study|Study Drug Toxicity|4|||
160574633|NCT02489630|579824978|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
160574634|NCT02053246|579824979|FG000|Overall Study|Withdrawal by Subject|3|||
160574635|NCT02053246|579824979|FG000|Overall Study|Physician Decision|1|||
160920747|NCT00383149|581103368|FG000|Overall Study|Request to Discontinue Treatment|4|||
160920748|NCT00383149|581103368|FG000|Overall Study|Participant Withdrew Consent|1|||
160920749|NCT02028065|581103369|FG000|Randomization Through Start Treatment|Not treated|1|||
160920750|NCT02028065|581103370|FG001|Randomization Through Start Treatment|Not treated|3|||
160997395|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
160997396|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
160997397|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
160997398|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
160997399|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
160997400|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
160997401|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
160997402|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
160997403|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
160997404|NCT02057718|581374940|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
160997405|NCT02057718|581374941|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
160997406|NCT02057718|581374940|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
160997407|NCT02057718|581374941|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
160997408|NCT02057718|581374940|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
160997409|NCT02057718|581374941|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
160997410|NCT02057718|581374940|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
160997411|NCT02057718|581374941|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
160997412|NCT00906035|581374946|FG000|Overall Study|Withdrawal by Subject|2|||
160997413|NCT00906035|581374947|FG001|Overall Study|Withdrawal by Subject|3|||
160997414|NCT00906035|581374948|FG002|Overall Study|Withdrawal by Subject|0|||
160997415|NCT01972152|581374949|FG000|First Treatment Visit|Lost to Follow-up|0|||
160997416|NCT01972152|581374950|FG001|First Treatment Visit|Lost to Follow-up|1|||
160997417|NCT01972152|581374951|FG002|First Treatment Visit|Lost to Follow-up|0|||
160997418|NCT01972152|581374952|FG003|First Treatment Visit|Lost to Follow-up|0|||
160997419|NCT01972152|581374953|FG004|First Treatment Visit|Lost to Follow-up|0|||
160997420|NCT01972152|581374954|FG005|First Treatment Visit|Lost to Follow-up|0|||
160997421|NCT01972152|581374949|FG000|Second Treatment Visit|Protocol Violation|0|||
160997422|NCT01972152|581374950|FG001|Second Treatment Visit|Protocol Violation|1|||
160997423|NCT01972152|581374951|FG002|Second Treatment Visit|Protocol Violation|0|||
160997424|NCT01972152|581374952|FG003|Second Treatment Visit|Protocol Violation|0|||
160997425|NCT01972152|581374953|FG004|Second Treatment Visit|Protocol Violation|0|||
160997426|NCT01972152|581374954|FG005|Second Treatment Visit|Protocol Violation|0|||
160997427|NCT00383188|581374955|FG000|Overall Study|Adverse Event|4|||
160997428|NCT00383188|581374956|FG001|Overall Study|Adverse Event|7|||
160997429|NCT00383188|581374957|FG002|Overall Study|Adverse Event|9|||
160997430|NCT00383188|581374958|FG003|Overall Study|Adverse Event|8|||
160997431|NCT00383188|581374959|FG004|Overall Study|Adverse Event|8|||
160997432|NCT00383188|581374955|FG000|Overall Study|Lack of Efficacy|9|||
160997433|NCT00383188|581374956|FG001|Overall Study|Lack of Efficacy|3|||
160997434|NCT00383188|581374957|FG002|Overall Study|Lack of Efficacy|3|||
160997435|NCT00383188|581374958|FG003|Overall Study|Lack of Efficacy|2|||
160997436|NCT00383188|581374959|FG004|Overall Study|Lack of Efficacy|6|||
160997437|NCT00383188|581374955|FG000|Overall Study|Other|3|||
160997438|NCT00383188|581374956|FG001|Overall Study|Other|1|||
160997439|NCT00383188|581374957|FG002|Overall Study|Other|0|||
160997440|NCT00383188|581374958|FG003|Overall Study|Other|2|||
160574636|NCT02707757|579824980|FG000|Overall Study|Protocol Violation|3|||
160574637|NCT02707757|579824981|FG001|Overall Study|Protocol Violation|2|||
160574638|NCT02707757|579824980|FG000|Overall Study|Withdrawal by Subject|2|||
160574639|NCT02707757|579824981|FG001|Overall Study|Withdrawal by Subject|0|||
160574640|NCT02707757|579824980|FG000|Overall Study|Death|0|||
160574641|NCT02707757|579824981|FG001|Overall Study|Death|1|||
160574642|NCT02707757|579824980|FG000|Overall Study|Adverse Event|6|||
160574643|NCT02707757|579824981|FG001|Overall Study|Adverse Event|4|||
160574644|NCT02707757|579824980|FG000|Overall Study|Renal transplant/elective operation|1|||
160574645|NCT02707757|579824981|FG001|Overall Study|Renal transplant/elective operation|5|||
160654234|NCT00337571|580114310|FG000|Overall Study|No longer met study criteria|1|||
160654235|NCT00337571|580114311|FG001|Overall Study|No longer met study criteria|0|||
160654236|NCT00337571|580114312|FG002|Overall Study|No longer met study criteria|0|||
160654237|NCT00337571|580114313|FG003|Overall Study|No longer met study criteria|0|||
160997441|NCT00383188|581374959|FG004|Overall Study|Other|6|||
160997442|NCT00383188|581374955|FG000|Overall Study|No longer willing to participate|1|||
160997443|NCT00383188|581374956|FG001|Overall Study|No longer willing to participate|0|||
160997444|NCT00383188|581374957|FG002|Overall Study|No longer willing to participate|1|||
160997445|NCT00383188|581374958|FG003|Overall Study|No longer willing to participate|0|||
160997446|NCT00383188|581374959|FG004|Overall Study|No longer willing to participate|2|||
160997447|NCT00383188|581374955|FG000|Overall Study|Lost to Follow-up|0|||
160997448|NCT00383188|581374956|FG001|Overall Study|Lost to Follow-up|0|||
160997449|NCT00383188|581374957|FG002|Overall Study|Lost to Follow-up|0|||
160997450|NCT00383188|581374958|FG003|Overall Study|Lost to Follow-up|0|||
160997451|NCT00383188|581374959|FG004|Overall Study|Lost to Follow-up|1|||
160574646|NCT01056523|579824982|FG000|Overall Study|Death|1|||
160574647|NCT01056523|579824983|FG001|Overall Study|Death|0|||
160574648|NCT01056523|579824984|FG002|Overall Study|Death|2|||
160574649|NCT01056523|579824985|FG003|Overall Study|Death|3|||
160574650|NCT01056523|579824986|FG004|Overall Study|Death|0|||
160574651|NCT01056523|579824987|FG005|Overall Study|Death|0|||
160574652|NCT01056523|579824988|FG006|Overall Study|Death|1|||
160574653|NCT00815308|579824989|FG000|Overall Study|Adverse Event|4|||
160574654|NCT00815308|579824989|FG000|Overall Study|Withdrawal by Subject|0|||
160574655|NCT00815308|579824989|FG000|Overall Study|Protocol Violation|6|||
160574656|NCT03429556|579824992|FG000|Overall Study|Lost to Follow-up|0|||
160574657|NCT03429556|579824993|FG001|Overall Study|Lost to Follow-up|1|||
160574658|NCT03429556|579824994|FG002|Overall Study|Lost to Follow-up|0|||
160574659|NCT03429556|579824995|FG003|Overall Study|Lost to Follow-up|0|||
160574660|NCT00377299|579824996|FG000|Overall Study|Lost to Follow-up|14|||
160574661|NCT00377299|579824997|FG001|Overall Study|Lost to Follow-up|19|||
160574662|NCT00377299|579824996|FG000|Overall Study|Adverse Event|0|||
160574663|NCT00377299|579824997|FG001|Overall Study|Adverse Event|1|||
160574664|NCT00377299|579824996|FG000|Overall Study|Withdrawal by Subject|5|||
160574665|NCT00377299|579824997|FG001|Overall Study|Withdrawal by Subject|4|||
160574666|NCT02209597|579824999|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
160574667|NCT02209597|579824999|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
160574668|NCT02209597|579824999|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
160574669|NCT02209597|579824999|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
160574670|NCT04799782|579825007|FG000|Washout|Physician Decision|2|||
160574671|NCT04799782|579825008|FG001|Washout|Physician Decision|0|||
160574672|NCT04799782|579825007|FG000|Washout|Withdrawal by Subject|0|||
160574673|NCT04799782|579825008|FG001|Washout|Withdrawal by Subject|2|||
160574674|NCT04799782|579825007|FG000|Washout|Lost to Follow-up|0|||
160574675|NCT04799782|579825008|FG001|Washout|Lost to Follow-up|1|||
160574676|NCT01589094|579825014|FG000|Overall Study|Did not receive treatment|2|||
160574677|NCT02975349|579825015|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160574678|NCT02975349|579825016|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160574679|NCT02975349|579825017|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160574680|NCT02975349|579825018|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
160574681|NCT02975349|579825019|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
160574682|NCT02975349|579825020|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160574683|NCT02975349|579825021|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160574684|NCT02975349|579825015|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
160574685|NCT02975349|579825016|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160574686|NCT02975349|579825017|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160574687|NCT02975349|579825018|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160574688|NCT02975349|579825019|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160574689|NCT02975349|579825020|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160574690|NCT02975349|579825021|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160574691|NCT02975349|579825015|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
160574692|NCT02975349|579825016|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
160574693|NCT02975349|579825017|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
160574694|NCT02975349|579825018|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
160574695|NCT02975349|579825019|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
160574696|NCT02975349|579825020|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
160574697|NCT02975349|579825021|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
160574698|NCT02975349|579825015|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
160574699|NCT02975349|579825016|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
160574700|NCT02975349|579825017|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
160574701|NCT02975349|579825018|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
160574702|NCT02975349|579825019|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
160574703|NCT02975349|579825020|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
160574704|NCT02975349|579825021|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
160574705|NCT02975349|579825015|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
160574706|NCT02975349|579825016|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
160574707|NCT02975349|579825017|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
160574708|NCT02975349|579825018|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
160574709|NCT02975349|579825019|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
160574710|NCT02975349|579825020|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
160574711|NCT02975349|579825021|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
160574712|NCT02975349|579825015|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
160574713|NCT02975349|579825016|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
160574714|NCT02975349|579825017|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
160574715|NCT02975349|579825018|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
160574716|NCT02975349|579825019|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
160920751|NCT02028065|581103371|FG002|Randomization Through Start Treatment|Not treated|3|||
160920752|NCT02028065|581103369|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
160920753|NCT02028065|581103370|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
160574717|NCT02975349|579825020|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
160574718|NCT02975349|579825021|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
160574719|NCT02975349|579825015|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
160574720|NCT02975349|579825016|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
160574721|NCT02975349|579825017|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
160574722|NCT02975349|579825018|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
160574723|NCT02975349|579825019|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
160574724|NCT02975349|579825020|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
160574725|NCT02975349|579825021|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
160574726|NCT02975349|579825015|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
160574727|NCT02975349|579825016|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
160574728|NCT02975349|579825017|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
160574729|NCT02975349|579825018|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
160574730|NCT02975349|579825019|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
160574731|NCT02975349|579825020|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
160574732|NCT02975349|579825021|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
160574733|NCT02975349|579825015|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
160574734|NCT02975349|579825016|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
160574735|NCT02975349|579825017|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
160574736|NCT02975349|579825018|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
160574737|NCT02975349|579825019|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
160574738|NCT02975349|579825020|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
160574739|NCT02975349|579825021|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
160574740|NCT02975349|579825015|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
160574741|NCT02975349|579825016|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
160574742|NCT02975349|579825017|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
160574743|NCT02975349|579825018|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
160574744|NCT02975349|579825019|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
160574745|NCT02975349|579825020|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
160574746|NCT02975349|579825021|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
160574747|NCT02975349|579825015|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
160574748|NCT02975349|579825016|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
160574749|NCT02975349|579825017|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
160574750|NCT02975349|579825018|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
160574751|NCT02975349|579825019|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
160574752|NCT02975349|579825020|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
160574753|NCT02975349|579825021|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
160574754|NCT02975349|579825015|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
160574755|NCT02975349|579825016|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
160574756|NCT02975349|579825017|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
160574757|NCT02975349|579825018|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
160574758|NCT02975349|579825019|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
160574759|NCT02975349|579825020|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
160574760|NCT02975349|579825021|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
160574761|NCT02975349|579825015|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
160574762|NCT02975349|579825016|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
160574763|NCT02975349|579825017|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
160574764|NCT02975349|579825018|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
160574765|NCT02975349|579825019|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
160574766|NCT02975349|579825020|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
160574767|NCT02975349|579825021|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
160574768|NCT02975349|579825015|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
160574769|NCT02975349|579825016|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
160574770|NCT02975349|579825017|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
160574771|NCT02975349|579825018|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
160574772|NCT02975349|579825019|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
160574773|NCT02975349|579825020|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
160574774|NCT02975349|579825021|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
160574775|NCT02975349|579825015|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
160574776|NCT02975349|579825016|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
160574777|NCT02975349|579825017|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
160574778|NCT02975349|579825018|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
160574779|NCT02975349|579825019|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
160574780|NCT02975349|579825020|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
160574781|NCT02975349|579825021|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
160997452|NCT01751724|581374962|FG000|Overall Study|extubated bef.start assigned treatment|1|||
160997453|NCT01751724|581374963|FG001|Overall Study|extubated bef.start assigned treatment|0|||
160997454|NCT01751724|581374962|FG000|Overall Study|withdrawn by parent|0|||
160997455|NCT01751724|581374963|FG001|Overall Study|withdrawn by parent|2|||
160997456|NCT03395353|581374964|FG000|Overall Study|Adverse Event|20|||
160997457|NCT03395353|581374964|FG000|Overall Study|Protocol Violation|1|||
160997458|NCT03395353|581374964|FG000|Overall Study|Lack of Efficacy|3|||
160997459|NCT03395353|581374964|FG000|Overall Study|Withdrawal by Subject|24|||
160997460|NCT03395353|581374964|FG000|Overall Study|Discontinued visit|1|||
160997461|NCT03395353|581374964|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
160997462|NCT03395353|581374964|FG000|Overall Study|Physician Decision|4|||
160997463|NCT03395353|581374964|FG000|Overall Study|Early termination of overall study|33|||
160997464|NCT03301220|581374965|FG000|Overall Study|Death|26|||
160997465|NCT03301220|581374966|FG001|Overall Study|Death|15|||
160997466|NCT03301220|581374965|FG000|Overall Study|Withdrawal by Subject|23|||
160454696|NCT01928394|579396179|FG009|Treatment Period|Participant withdrew consent|0|||
160454697|NCT01928394|579396180|FG010|Treatment Period|Participant withdrew consent|1|||
160454698|NCT01928394|579396181|FG011|Treatment Period|Participant withdrew consent|1|||
160454699|NCT01928394|579396182|FG012|Treatment Period|Participant withdrew consent|1|||
160454700|NCT01928394|579396183|FG013|Treatment Period|Participant withdrew consent|0|||
160454701|NCT01928394|579396184|FG014|Treatment Period|Participant withdrew consent|2|||
160574782|NCT00907738|579825029|FG000|Overall Study|Adverse Event|2|||
160574783|NCT00907738|579825030|FG001|Overall Study|Adverse Event|0|||
160574784|NCT00907738|579825031|FG002|Overall Study|Adverse Event|1|||
160574785|NCT00907738|579825032|FG003|Overall Study|Adverse Event|0|||
160574786|NCT00907738|579825033|FG004|Overall Study|Adverse Event|0|||
160574787|NCT00907738|579825029|FG000|Overall Study|not specified or withdrew consent|3|||
160574788|NCT00907738|579825030|FG001|Overall Study|not specified or withdrew consent|0|||
160574789|NCT00907738|579825031|FG002|Overall Study|not specified or withdrew consent|0|||
160574790|NCT00907738|579825032|FG003|Overall Study|not specified or withdrew consent|0|||
160574791|NCT00907738|579825033|FG004|Overall Study|not specified or withdrew consent|0|||
160574792|NCT00907738|579825029|FG000|Overall Study|Disease progression|8|||
160574793|NCT00907738|579825030|FG001|Overall Study|Disease progression|1|||
160574794|NCT00907738|579825031|FG002|Overall Study|Disease progression|6|||
160574795|NCT00907738|579825032|FG003|Overall Study|Disease progression|4|||
160574796|NCT00907738|579825033|FG004|Overall Study|Disease progression|2|||
160574797|NCT05363293|579825034|FG000|Overall Study|Withdrawal by Subject|1|||
160574798|NCT05363293|579825035|FG001|Overall Study|Withdrawal by Subject|0|||
160574799|NCT05363293|579825036|FG002|Overall Study|Withdrawal by Subject|0|||
160574800|NCT05363293|579825037|FG003|Overall Study|Withdrawal by Subject|0|||
160574801|NCT05363293|579825038|FG004|Overall Study|Withdrawal by Subject|0|||
160574802|NCT05363293|579825039|FG005|Overall Study|Withdrawal by Subject|0|||
160574803|NCT05363293|579825040|FG006|Overall Study|Withdrawal by Subject|0|||
160574804|NCT05363293|579825041|FG007|Overall Study|Withdrawal by Subject|0|||
160574805|NCT05363293|579825042|FG008|Overall Study|Withdrawal by Subject|0|||
160574806|NCT05363293|579825043|FG009|Overall Study|Withdrawal by Subject|0|||
160574807|NCT04773041|579825044|FG000|Overall Study|Unable to data match|1|||
160574808|NCT04773041|579825045|FG001|Overall Study|Unable to data match|0|||
160574809|NCT04773041|579825046|FG002|Overall Study|Unable to data match|0|||
160574810|NCT01988012|579827317|FG000|Overall Study|Adverse Event|5|||
160574811|NCT01988012|579827317|FG000|Overall Study|Insufficient Therapeutic Response|3|||
160574812|NCT01988012|579827317|FG000|Overall Study|Patient Withdrawal of Consent|4|||
160574813|NCT01988012|579827317|FG000|Overall Study|Lost to Follow-up|1|||
160574814|NCT01988012|579827317|FG000|Overall Study|Physician Decision|1|||
160574815|NCT01988012|579827317|FG000|Overall Study|Protocol Violation|1|||
160574816|NCT00521339|579827318|FG000|Treatment Phase|Adverse Event|2|||
160574817|NCT00521339|579827319|FG001|Treatment Phase|Adverse Event|0|||
160574818|NCT00521339|579827320|FG002|Treatment Phase|Adverse Event|0|||
160574819|NCT00521339|579827318|FG000|Treatment Phase|Intolerability to study drug|2|||
160574820|NCT00521339|579827319|FG001|Treatment Phase|Intolerability to study drug|0|||
160997467|NCT03301220|581374966|FG001|Overall Study|Withdrawal by Subject|12|||
160997468|NCT03301220|581374965|FG000|Overall Study|Lost to Follow-up|1|||
160997469|NCT03301220|581374966|FG001|Overall Study|Lost to Follow-up|1|||
160997470|NCT03301220|581374965|FG000|Overall Study|Randomized in error|1|||
160997471|NCT03301220|581374966|FG001|Overall Study|Randomized in error|1|||
160997472|NCT03301220|581374965|FG000|Overall Study|Randomized but not treated|0|||
160997473|NCT03301220|581374966|FG001|Overall Study|Randomized but not treated|1|||
160574821|NCT00521339|579827320|FG002|Treatment Phase|Intolerability to study drug|0|||
160574822|NCT00521339|579827318|FG000|Treatment Phase|Lack of Efficacy|3|||
160574823|NCT00521339|579827319|FG001|Treatment Phase|Lack of Efficacy|0|||
160654238|NCT00337571|580114310|FG000|Overall Study|High Potassium level|0|||
160997474|NCT03301220|581374965|FG000|Overall Study|Ongoing followup|145|||
160574824|NCT00521339|579827320|FG002|Treatment Phase|Lack of Efficacy|0|||
160574825|NCT00521339|579827318|FG000|Treatment Phase|Withdrawal by Subject|3|||
160574826|NCT00521339|579827319|FG001|Treatment Phase|Withdrawal by Subject|0|||
160574827|NCT00521339|579827320|FG002|Treatment Phase|Withdrawal by Subject|0|||
160997475|NCT03301220|581374966|FG001|Overall Study|Ongoing followup|163|||
160997476|NCT03301220|581374965|FG000|Overall Study|Principal Investigator and participant decision|0|||
160997477|NCT03301220|581374966|FG001|Overall Study|Principal Investigator and participant decision|1|||
160997478|NCT02685033|581374967|FG000|Overall Study|Withdrawal of Consent|0|||
160997479|NCT02685033|581374968|FG001|Overall Study|Withdrawal of Consent|1|||
160997480|NCT02685033|581374967|FG000|Overall Study|Lost to Follow-up|2|||
160997481|NCT02685033|581374968|FG001|Overall Study|Lost to Follow-up|1|||
160997482|NCT02685033|581374967|FG000|Overall Study|Adverse Event|1|||
160997483|NCT02685033|581374968|FG001|Overall Study|Adverse Event|0|||
160997484|NCT04845620|581374973|FG000|Overall Study|Withdrawal by Subject|11|||
160997485|NCT04845620|581374974|FG001|Overall Study|Withdrawal by Subject|10|||
160997486|NCT04845620|581374973|FG000|Overall Study|Adverse Event|5|||
160997487|NCT04845620|581374974|FG001|Overall Study|Adverse Event|4|||
160997488|NCT04845620|581374973|FG000|Overall Study|Lost to Follow-up|5|||
160997489|NCT04845620|581374974|FG001|Overall Study|Lost to Follow-up|4|||
160997490|NCT04845620|581374973|FG000|Overall Study|Lack of Efficacy|4|||
160997491|NCT04845620|581374974|FG001|Overall Study|Lack of Efficacy|4|||
160997492|NCT04845620|581374973|FG000|Overall Study|Physician Decision|2|||
160997493|NCT04845620|581374974|FG001|Overall Study|Physician Decision|1|||
160997494|NCT00708097|581374975|FG000|Period 1|Protocol Violation|0|||
160997495|NCT00708097|581374976|FG001|Period 1|Protocol Violation|1|||
160997496|NCT00708097|581374977|FG002|Period 1|Protocol Violation|0|||
160997497|NCT00708097|581374978|FG003|Period 1|Protocol Violation|2|||
160997498|NCT00708097|581374979|FG004|Period 1|Protocol Violation|0|||
160997499|NCT00708097|581374975|FG000|Period 1|Other Reason|0|||
160997500|NCT00708097|581374976|FG001|Period 1|Other Reason|0|||
160997501|NCT00708097|581374977|FG002|Period 1|Other Reason|0|||
160997502|NCT00708097|581374978|FG003|Period 1|Other Reason|0|||
160997503|NCT00708097|581374979|FG004|Period 1|Other Reason|1|||
160997504|NCT00708097|581374975|FG000|Period 2|Protocol Violation|0|||
160997505|NCT00708097|581374976|FG001|Period 2|Protocol Violation|1|||
160997506|NCT00708097|581374977|FG002|Period 2|Protocol Violation|1|||
160997507|NCT00708097|581374978|FG003|Period 2|Protocol Violation|1|||
160997508|NCT00708097|581374979|FG004|Period 2|Protocol Violation|0|||
160997509|NCT00603447|581374980|FG000|Overall Study|Adverse Event|0|||
160454702|NCT01928394|579396185|FG015|Treatment Period|Participant withdrew consent|0|||
160454703|NCT01928394|579396186|FG016|Treatment Period|Participant withdrew consent|2|||
160454704|NCT01928394|579396187|FG017|Treatment Period|Participant withdrew consent|1|||
160574828|NCT00521339|579827318|FG000|Treatment Phase|Lost to Follow-up|1|||
160574829|NCT00521339|579827319|FG001|Treatment Phase|Lost to Follow-up|0|||
160574830|NCT00521339|579827320|FG002|Treatment Phase|Lost to Follow-up|0|||
160574831|NCT00521339|579827318|FG000|Treatment Phase|Protocol Violation|1|||
160574832|NCT00521339|579827319|FG001|Treatment Phase|Protocol Violation|0|||
160574833|NCT00521339|579827320|FG002|Treatment Phase|Protocol Violation|0|||
160574834|NCT00521339|579827318|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
160574835|NCT00521339|579827319|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
160574836|NCT00521339|579827320|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
160920754|NCT02028065|581103371|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
160920755|NCT02028065|581103369|FG000|Treatment Through Study Completion|Physician Decision|1|||
160920756|NCT02028065|581103370|FG001|Treatment Through Study Completion|Physician Decision|0|||
160920757|NCT02028065|581103371|FG002|Treatment Through Study Completion|Physician Decision|0|||
160920758|NCT02028065|581103369|FG000|Treatment Through Study Completion|Protocol Violation|1|||
160920759|NCT02028065|581103370|FG001|Treatment Through Study Completion|Protocol Violation|4|||
160920760|NCT02028065|581103371|FG002|Treatment Through Study Completion|Protocol Violation|0|||
160920761|NCT02028065|581103369|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
160920762|NCT02028065|581103370|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
160920763|NCT02028065|581103371|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
160920764|NCT02028065|581103369|FG000|Treatment Through Study Completion|Adverse Event|3|||
160920765|NCT02028065|581103370|FG001|Treatment Through Study Completion|Adverse Event|3|||
160920766|NCT02028065|581103371|FG002|Treatment Through Study Completion|Adverse Event|5|||
160920767|NCT04868890|581103374|FG000|Overall Study|Death|2|||
160920768|NCT04868890|581103375|FG001|Overall Study|Death|1|||
160920769|NCT04868890|581103374|FG000|Overall Study|Withdrawal by Subject|1|||
160997510|NCT00603447|581374981|FG001|Overall Study|Adverse Event|1|||
160997511|NCT00603447|581374982|FG002|Overall Study|Adverse Event|1|||
160997512|NCT00603447|581374983|FG003|Overall Study|Adverse Event|2|||
160997513|NCT00603447|581374984|FG004|Overall Study|Adverse Event|1|||
160997514|NCT00603447|581374985|FG005|Overall Study|Adverse Event|2|||
160997515|NCT00603447|581374986|FG006|Overall Study|Adverse Event|10|||
160574837|NCT00521339|579827318|FG000|Treatment Extension Phase|Death|0|||
160920770|NCT04868890|581103375|FG001|Overall Study|Withdrawal by Subject|5|||
160920771|NCT02669433|581103378|FG000|Overall Study|Protocol Violation|0|||
160920772|NCT02669433|581103379|FG001|Overall Study|Protocol Violation|4|||
160920773|NCT02669433|581103380|FG002|Overall Study|Protocol Violation|1|||
160997516|NCT00603447|581374980|FG000|Overall Study|Other|0|||
160997517|NCT00603447|581374981|FG001|Overall Study|Other|0|||
160997518|NCT00603447|581374982|FG002|Overall Study|Other|1|||
160654239|NCT00337571|580114311|FG001|Overall Study|High Potassium level|0|||
160654240|NCT00337571|580114312|FG002|Overall Study|High Potassium level|0|||
160654241|NCT00337571|580114313|FG003|Overall Study|High Potassium level|1|||
160654242|NCT01890915|580114315|FG000|Overall Study|Adverse Event|1|||
160654243|NCT01890915|580114316|FG001|Overall Study|Adverse Event|0|||
160654244|NCT01890915|580114315|FG000|Overall Study|Protocol Violation|2|||
160654245|NCT01890915|580114316|FG001|Overall Study|Protocol Violation|0|||
160654246|NCT01890915|580114315|FG000|Overall Study|Equipment Malfunction|0|||
160654247|NCT01890915|580114316|FG001|Overall Study|Equipment Malfunction|1|||
160654248|NCT02114697|580114318|FG000|Overall Study|Study terminated|5|||
160654249|NCT02114697|580114319|FG001|Overall Study|Study terminated|4|||
160654250|NCT00424489|580114320|FG000|Overall Study|Death|3|||
160654251|NCT01984242|580114321|FG000|Overall Study|Death|52|||
160654252|NCT01984242|580114322|FG001|Overall Study|Death|50|||
160654253|NCT01984242|580114323|FG002|Overall Study|Death|52|||
160654254|NCT01984242|580114321|FG000|Overall Study|Withdrawal by Subject|5|||
160654255|NCT01984242|580114322|FG001|Overall Study|Withdrawal by Subject|3|||
160997519|NCT00603447|581374983|FG003|Overall Study|Other|0|||
160997520|NCT00603447|581374984|FG004|Overall Study|Other|3|||
160997521|NCT00603447|581374985|FG005|Overall Study|Other|0|||
160454705|NCT01928394|579396188|FG018|Treatment Period|Participant withdrew consent|1|||
160574838|NCT00521339|579827319|FG001|Treatment Extension Phase|Death|0|||
160574839|NCT00521339|579827320|FG002|Treatment Extension Phase|Death|1|||
160574840|NCT01058369|579827321|FG000|Overall Study|Adverse Event|1|||
160574841|NCT01058369|579827321|FG000|Overall Study|Early termination study|1|||
160574842|NCT03314519|579827322|FG000|Overall Study|Protocol Violation|3|||
160574843|NCT03314519|579827323|FG001|Overall Study|Protocol Violation|2|||
160574844|NCT01277289|579827326|FG000|Overall Study|fragile vein|1|||
160574845|NCT01277289|579827327|FG001|Overall Study|fragile vein|0|||
160574846|NCT01277289|579827326|FG000|Overall Study|Physician Decision|1|||
160574847|NCT01277289|579827327|FG001|Overall Study|Physician Decision|0|||
160574848|NCT01277289|579827326|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
160574849|NCT01277289|579827327|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
160574850|NCT01277289|579827326|FG000|Overall Study|Protocol Violation|1|||
160574851|NCT01277289|579827327|FG001|Overall Study|Protocol Violation|1|||
160574852|NCT01277289|579827326|FG000|Overall Study|Adverse Event|2|||
160574853|NCT01277289|579827327|FG001|Overall Study|Adverse Event|1|||
160574854|NCT01277289|579827326|FG000|Overall Study|consent withdrawn|1|||
160574855|NCT01277289|579827327|FG001|Overall Study|consent withdrawn|1|||
160574856|NCT01277289|579827326|FG000|Overall Study|premature closure of the study|4|||
160574857|NCT01277289|579827327|FG001|Overall Study|premature closure of the study|2|||
160574858|NCT01666444|579827328|FG000|Overall Study|Did not initiate treatment|2|||
160574859|NCT01666444|579827329|FG001|Overall Study|Did not initiate treatment|1|||
160574860|NCT00950690|579827330|FG000|Overall Study|Death|4|||
160574861|NCT00950690|579827330|FG000|Overall Study|Adverse Event|15|||
160574862|NCT00950690|579827330|FG000|Overall Study|Lack of Efficacy|22|||
160574863|NCT00950690|579827330|FG000|Overall Study|Lost to Follow-up|40|||
160574864|NCT00950690|579827330|FG000|Overall Study|Other|163|||
160574865|NCT00592358|579827331|FG000|Overall Study|Withdrawal by Subject|2|||
160574866|NCT00592358|579827331|FG000|Overall Study|Adverse Event|1|||
160574867|NCT00592358|579827331|FG000|Overall Study|Lack of Efficacy|2|||
160574868|NCT00592358|579827331|FG000|Overall Study|Inability to swallow pills|1|||
160574869|NCT00092547|579827332|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
160574870|NCT00092547|579827333|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
160574871|NCT00092547|579827334|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
160574872|NCT00092547|579827332|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
160574873|NCT00092547|579827333|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
160574874|NCT00092547|579827334|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
160574875|NCT00092547|579827332|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
160574876|NCT00092547|579827333|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
160574877|NCT00092547|579827334|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
160574878|NCT00092547|579827332|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
160574879|NCT00092547|579827333|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
160574880|NCT00092547|579827334|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
160574881|NCT00092547|579827332|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
160654256|NCT01984242|580114323|FG002|Overall Study|Withdrawal by Subject|10|||
160454706|NCT01928394|579396189|FG019|Treatment Period|Participant withdrew consent|1|||
160574882|NCT00092547|579827333|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
160574883|NCT00092547|579827334|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
160574884|NCT00092547|579827332|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
160574885|NCT00092547|579827333|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
160654257|NCT01984242|580114321|FG000|Overall Study|Physician Decision|0|||
160654258|NCT01984242|580114322|FG001|Overall Study|Physician Decision|0|||
160997522|NCT00603447|581374986|FG006|Overall Study|Other|13|||
160654259|NCT01984242|580114323|FG002|Overall Study|Physician Decision|1|||
160654260|NCT01984242|580114321|FG000|Overall Study|Lost to Follow-up|4|||
160654261|NCT01984242|580114322|FG001|Overall Study|Lost to Follow-up|0|||
160654262|NCT01984242|580114323|FG002|Overall Study|Lost to Follow-up|3|||
160654263|NCT01984242|580114321|FG000|Overall Study|Sponsor Decision|1|||
160654264|NCT01984242|580114322|FG001|Overall Study|Sponsor Decision|0|||
160654265|NCT01984242|580114323|FG002|Overall Study|Sponsor Decision|0|||
160654266|NCT01984242|580114321|FG000|Overall Study|Non-Compliance|1|||
160654267|NCT01984242|580114322|FG001|Overall Study|Non-Compliance|0|||
160654268|NCT01984242|580114323|FG002|Overall Study|Non-Compliance|0|||
160654269|NCT01984242|580114321|FG000|Overall Study|Study terminated by Sponsor|38|||
160654270|NCT01984242|580114322|FG001|Overall Study|Study terminated by Sponsor|50|||
160654271|NCT01984242|580114323|FG002|Overall Study|Study terminated by Sponsor|34|||
160654272|NCT01984242|580114321|FG000|Overall Study|Disease Progression|0|||
160654273|NCT01984242|580114322|FG001|Overall Study|Disease Progression|0|||
160654274|NCT01984242|580114323|FG002|Overall Study|Disease Progression|1|||
160654275|NCT00449150|580114324|FG000|Overall Study|Adverse Event|11|||
160654276|NCT00449150|580114325|FG001|Overall Study|Adverse Event|18|||
160654277|NCT00449150|580114326|FG002|Overall Study|Adverse Event|9|||
160654278|NCT00449150|580114324|FG000|Overall Study|Lack of Efficacy|1|||
160654279|NCT00449150|580114325|FG001|Overall Study|Lack of Efficacy|2|||
160654280|NCT00449150|580114326|FG002|Overall Study|Lack of Efficacy|2|||
160654281|NCT00449150|580114324|FG000|Overall Study|Other|16|||
160654282|NCT00449150|580114325|FG001|Overall Study|Other|13|||
160654283|NCT00449150|580114326|FG002|Overall Study|Other|14|||
160654284|NCT00449150|580114324|FG000|Overall Study|Withdrawal by Subject|17|||
160654285|NCT00449150|580114325|FG001|Overall Study|Withdrawal by Subject|18|||
160654286|NCT00449150|580114326|FG002|Overall Study|Withdrawal by Subject|21|||
160654287|NCT00449150|580114324|FG000|Overall Study|Protocol Violation|1|||
160654288|NCT00449150|580114325|FG001|Overall Study|Protocol Violation|2|||
160654289|NCT00449150|580114326|FG002|Overall Study|Protocol Violation|1|||
160654290|NCT02660242|580114331|FG000|Glucose Tabs|Lost to Follow-up|1|||
160654291|NCT02660242|580114331|FG000|Glucagon Injection|Lost to Follow-up|1|||
160654292|NCT00770510|580114333|FG000|Overall Study|Lost to Follow-up|2|||
160654293|NCT00770510|580114333|FG000|Overall Study|Pregnancy|1|||
160654294|NCT00770510|580114333|FG000|Overall Study|Withdrawal by Subject|2|||
160654295|NCT02796664|580114337|FG000|Overall Study|Withdrawal by Subject|0|||
160654296|NCT02796664|580114338|FG001|Overall Study|Withdrawal by Subject|3|||
160654297|NCT02796664|580114337|FG000|Overall Study|Noncompliance|1|||
160654298|NCT02796664|580114338|FG001|Overall Study|Noncompliance|1|||
160654299|NCT02796664|580114337|FG000|Overall Study|Death|0|||
160654300|NCT02796664|580114338|FG001|Overall Study|Death|1|||
160654301|NCT02246478|580114339|FG000|Multiple-dose Phase|Protocol Violation|1|||
160654302|NCT02246478|580114340|FG001|Multiple-dose Phase|Protocol Violation|0|||
160654303|NCT02246478|580114341|FG002|Multiple-dose Phase|Protocol Violation|0|||
160654304|NCT02246478|580114342|FG003|Multiple-dose Phase|Protocol Violation|1|||
160654305|NCT00536575|580114343|FG000|Overall Study|Withdrawal by Subject|1|||
160654306|NCT00536575|580114343|FG000|Overall Study|Death|1|||
160654307|NCT01089647|580114345|FG000|Overall Study|Lost to Follow-up|2|||
160654308|NCT01089647|580114346|FG001|Overall Study|Lost to Follow-up|2|||
160654309|NCT01089647|580114345|FG000|Overall Study|Withdrawal by Subject|2|||
160654310|NCT01089647|580114346|FG001|Overall Study|Withdrawal by Subject|1|||
160997523|NCT00603447|581374980|FG000|Overall Study|Withdrew Consent|0|||
160574886|NCT00092547|579827334|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
160574887|NCT00092547|579827332|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
160574888|NCT00092547|579827333|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
160574889|NCT00092547|579827334|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
160574890|NCT00092547|579827332|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
160574891|NCT00092547|579827333|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
160574892|NCT00092547|579827334|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
160574893|NCT00092547|579827332|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
160574894|NCT00092547|579827333|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
160574895|NCT00092547|579827334|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
160574896|NCT00092547|579827332|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
160574897|NCT00092547|579827333|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
160654311|NCT01089647|580114345|FG000|Overall Study|Adverse Event|0|||
160654312|NCT01089647|580114346|FG001|Overall Study|Adverse Event|1|||
160654313|NCT01531205|580114347|FG000|Overall Study|Did not proceed to surgery|1|||
160654314|NCT00198029|580114353|FG000|Overall Study|Withdrawal by Subject|4|||
160654315|NCT02073643|580114357|FG000|Overall Study|Lost to Follow-up|24|||
160654316|NCT02430870|580114358|FG000|Part 2|Voluntary Withdrawal|0|||
160654317|NCT02430870|580114359|FG001|Part 2|Voluntary Withdrawal|0|||
160654318|NCT02430870|580114360|FG002|Part 2|Voluntary Withdrawal|0|||
160654319|NCT02430870|580114361|FG003|Part 2|Voluntary Withdrawal|0|||
160654320|NCT02430870|580114362|FG004|Part 2|Voluntary Withdrawal|0|||
160654321|NCT02430870|580114363|FG005|Part 2|Voluntary Withdrawal|0|||
160654322|NCT02430870|580114364|FG006|Part 2|Voluntary Withdrawal|1|||
160654323|NCT02430870|580114365|FG007|Part 2|Voluntary Withdrawal|0|||
160574898|NCT00092547|579827334|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
160574899|NCT00092547|579827332|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
160574900|NCT00092547|579827333|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
160574901|NCT00092547|579827334|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
160574902|NCT00092547|579827332|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
160574903|NCT00092547|579827333|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
160574904|NCT00092547|579827334|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
160574905|NCT00092547|579827332|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
160574906|NCT00092547|579827333|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
160574907|NCT00092547|579827334|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
160574908|NCT00092547|579827332|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
160574909|NCT00092547|579827333|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
160574910|NCT00092547|579827334|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
160574911|NCT00092547|579827332|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
160574912|NCT00092547|579827333|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
160574913|NCT00092547|579827334|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
160574914|NCT00092547|579827332|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
160574915|NCT00092547|579827333|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
160574916|NCT00092547|579827334|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
160574917|NCT00092547|579827332|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
160574918|NCT00092547|579827333|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
160574919|NCT00092547|579827334|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
160574920|NCT00092547|579827332|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
160574921|NCT00092547|579827333|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
160574922|NCT00092547|579827334|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
160574923|NCT00092547|579827332|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
160574924|NCT00092547|579827333|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
160574925|NCT00092547|579827334|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
160574926|NCT00092547|579827332|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
160574927|NCT00092547|579827333|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
160574928|NCT00092547|579827334|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
160574929|NCT00092547|579827332|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
160574930|NCT00092547|579827333|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
160574931|NCT00092547|579827334|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
160574932|NCT00084682|579827335|FG000|Overall Study|Withdrawal by Subject|1|||
160574933|NCT01166659|579827336|FG000|Overall Study|Subject Decision|8|||
160574934|NCT01166659|579827336|FG000|Overall Study|Investigator Decision|2|||
160574935|NCT01166659|579827336|FG000|Overall Study|Death|1|||
160574936|NCT01166659|579827336|FG000|Overall Study|Lost to Follow-up|1|||
160574937|NCT01166659|579827336|FG000|Overall Study|Study Closed at Site|1|||
160574938|NCT00641043|579827343|FG000|Overall Study|Adverse Event|6|||
160574939|NCT00641043|579827344|FG001|Overall Study|Adverse Event|4|||
160574940|NCT00641043|579827343|FG000|Overall Study|Protocol Violation|2|||
160574941|NCT00641043|579827344|FG001|Overall Study|Protocol Violation|3|||
160574942|NCT00641043|579827343|FG000|Overall Study|Lost to Follow-up|3|||
160574943|NCT00641043|579827344|FG001|Overall Study|Lost to Follow-up|2|||
160574944|NCT00641043|579827343|FG000|Overall Study|Withdrawal by Subject|4|||
160574945|NCT00641043|579827344|FG001|Overall Study|Withdrawal by Subject|4|||
160574946|NCT00641043|579827343|FG000|Overall Study|Other incl. lack of efficacy|4|||
160574947|NCT00641043|579827344|FG001|Overall Study|Other incl. lack of efficacy|2|||
160574948|NCT02225223|579827350|FG000|Overall Study|Death|10|||
160574949|NCT02225223|579827351|FG001|Overall Study|Death|1|||
160574950|NCT02225223|579827350|FG000|Overall Study|Lost to Follow-up|5|||
160574951|NCT02225223|579827351|FG001|Overall Study|Lost to Follow-up|0|||
160574952|NCT02225223|579827350|FG000|Overall Study|Other|1|||
160574953|NCT02225223|579827351|FG001|Overall Study|Other|2|||
160574954|NCT02225223|579827350|FG000|Overall Study|Physician Decision|1|||
160574955|NCT02225223|579827351|FG001|Overall Study|Physician Decision|0|||
160574956|NCT02225223|579827350|FG000|Overall Study|Withdrawal by Subject|2|||
160574957|NCT02225223|579827351|FG001|Overall Study|Withdrawal by Subject|2|||
160574958|NCT03567291|579827353|FG000|Period I|Adverse Event|14|||
160574959|NCT03567291|579827354|FG001|Period I|Adverse Event|0|||
160574960|NCT03567291|579827355|FG002|Period I|Adverse Event|0|||
160574961|NCT03567291|579827356|FG003|Period I|Adverse Event|0|||
160574962|NCT03567291|579827353|FG000|Period I|Protocol Violation|1|||
160574963|NCT03567291|579827354|FG001|Period I|Protocol Violation|0|||
160574964|NCT03567291|579827355|FG002|Period I|Protocol Violation|0|||
160574965|NCT03567291|579827356|FG003|Period I|Protocol Violation|0|||
160574966|NCT03567291|579827353|FG000|Period I|Withdrawal by Subject|23|||
160574967|NCT03567291|579827354|FG001|Period I|Withdrawal by Subject|0|||
160574968|NCT03567291|579827355|FG002|Period I|Withdrawal by Subject|0|||
160574969|NCT03567291|579827356|FG003|Period I|Withdrawal by Subject|0|||
160654324|NCT02430870|580114358|FG000|Part 2|Other Reason Not Specified|0|||
160654325|NCT02430870|580114359|FG001|Part 2|Other Reason Not Specified|0|||
160654326|NCT02430870|580114360|FG002|Part 2|Other Reason Not Specified|0|||
160654327|NCT02430870|580114361|FG003|Part 2|Other Reason Not Specified|0|||
160654328|NCT02430870|580114362|FG004|Part 2|Other Reason Not Specified|0|||
160654329|NCT02430870|580114363|FG005|Part 2|Other Reason Not Specified|0|||
160654330|NCT02430870|580114364|FG006|Part 2|Other Reason Not Specified|0|||
160654331|NCT02430870|580114365|FG007|Part 2|Other Reason Not Specified|1|||
160654332|NCT00865709|580114366|FG000|Treatment|Adverse Event|9|||
160654333|NCT00865709|580114367|FG001|Treatment|Adverse Event|6|||
160654334|NCT00865709|580114366|FG000|Treatment|Withdrawal by Subject|10|||
160654335|NCT00865709|580114367|FG001|Treatment|Withdrawal by Subject|7|||
160654336|NCT00865709|580114366|FG000|Treatment|Physician Decision|3|||
160654337|NCT00865709|580114367|FG001|Treatment|Physician Decision|2|||
160654338|NCT00865709|580114366|FG000|Treatment|Surgery|8|||
160654339|NCT00865709|580114367|FG001|Treatment|Surgery|3|||
160654340|NCT00429923|580114368|FG000|Overall Study|Adverse Event|0|||
160654341|NCT00429923|580114369|FG001|Overall Study|Adverse Event|2|||
160654342|NCT00429923|580114370|FG002|Overall Study|Adverse Event|3|||
160654343|NCT00429923|580114368|FG000|Overall Study|Lack of Efficacy|4|||
160654344|NCT00429923|580114369|FG001|Overall Study|Lack of Efficacy|1|||
160654345|NCT00429923|580114370|FG002|Overall Study|Lack of Efficacy|33|||
160654346|NCT00429923|580114368|FG000|Overall Study|Lost to Follow-up|0|||
160654347|NCT00429923|580114369|FG001|Overall Study|Lost to Follow-up|0|||
160654348|NCT00429923|580114370|FG002|Overall Study|Lost to Follow-up|2|||
160654349|NCT00429923|580114368|FG000|Overall Study|Withdrew Consent|1|||
160654350|NCT00429923|580114369|FG001|Overall Study|Withdrew Consent|0|||
160654351|NCT00429923|580114370|FG002|Overall Study|Withdrew Consent|1|||
160654352|NCT00429923|580114368|FG000|Overall Study|Early Termination|0|||
160654353|NCT00429923|580114369|FG001|Overall Study|Early Termination|1|||
160920774|NCT02669433|581103378|FG000|Overall Study|Disease Progression|1|||
160920775|NCT02669433|581103379|FG001|Overall Study|Disease Progression|0|||
160920776|NCT02669433|581103380|FG002|Overall Study|Disease Progression|0|||
160920777|NCT02669433|581103378|FG000|Overall Study|Physician Decision|1|||
160920778|NCT02669433|581103379|FG001|Overall Study|Physician Decision|1|||
160920779|NCT02669433|581103380|FG002|Overall Study|Physician Decision|0|||
160920780|NCT02669433|581103378|FG000|Overall Study|Adverse Event|6|||
160920781|NCT02669433|581103379|FG001|Overall Study|Adverse Event|7|||
160920782|NCT02669433|581103380|FG002|Overall Study|Adverse Event|10|||
160920783|NCT02669433|581103378|FG000|Overall Study|Sponsor Termination|1|||
160920784|NCT02669433|581103379|FG001|Overall Study|Sponsor Termination|0|||
160920785|NCT02669433|581103380|FG002|Overall Study|Sponsor Termination|1|||
160920786|NCT02669433|581103378|FG000|Overall Study|Withdrawal by Subject|5|||
160920787|NCT02669433|581103379|FG001|Overall Study|Withdrawal by Subject|1|||
160920788|NCT02669433|581103380|FG002|Overall Study|Withdrawal by Subject|0|||
160920789|NCT02669433|581103378|FG000|Overall Study|Withdrawal by Caregiver|1|||
160920790|NCT02669433|581103379|FG001|Overall Study|Withdrawal by Caregiver|0|||
160920791|NCT02669433|581103380|FG002|Overall Study|Withdrawal by Caregiver|2|||
160920792|NCT02669433|581103378|FG000|Overall Study|Death|0|||
160920793|NCT02669433|581103379|FG001|Overall Study|Death|1|||
160920794|NCT02669433|581103380|FG002|Overall Study|Death|1|||
160920795|NCT01698801|581103383|FG000|Treatment Phase|Adverse Event|4|||
160920796|NCT01698801|581103383|FG000|Treatment Phase|Protocol Violation|1|||
160920797|NCT01698801|581103383|FG000|Treatment Phase|Other|4|||
160920798|NCT01698801|581103383|FG000|Treatment Phase|Withdrawal by Subject|1|||
160920799|NCT01698801|581103383|FG000|Treatment Phase|Disease progression|1|||
160920800|NCT01698801|581103383|FG000|Follow Up Phase|Withdrawal by Subject|1|||
160920801|NCT01698801|581103383|FG000|Follow Up Phase|Death|4|||
160920802|NCT00656474|581103384|FG000|Overall Study|Other Reason|1|||
160920803|NCT02062879|581103385|FG000|Overall Study|Withdrawal by Subject|4|||
160997524|NCT00603447|581374981|FG001|Overall Study|Withdrew Consent|2|||
160997525|NCT00603447|581374982|FG002|Overall Study|Withdrew Consent|0|||
160654354|NCT00429923|580114370|FG002|Overall Study|Early Termination|0|||
160654355|NCT01265784|580114371|FG000|Overall Study|Lost to Follow-up|5|||
160654356|NCT01265784|580114372|FG001|Overall Study|Lost to Follow-up|3|||
160654357|NCT01265784|580114373|FG002|Overall Study|Lost to Follow-up|2|||
160654358|NCT01265784|580114371|FG000|Overall Study|Withdrawal by Subject|0|||
160654359|NCT01265784|580114372|FG001|Overall Study|Withdrawal by Subject|5|||
160654360|NCT01265784|580114373|FG002|Overall Study|Withdrawal by Subject|0|||
160654361|NCT01265784|580114371|FG000|Overall Study|Physician Decision|1|||
160654362|NCT01265784|580114372|FG001|Overall Study|Physician Decision|0|||
160654363|NCT01265784|580114373|FG002|Overall Study|Physician Decision|1|||
160920804|NCT02062879|581103386|FG001|Overall Study|Withdrawal by Subject|1|||
160920805|NCT02998840|581103387|FG000|Overall Study|Lost to Follow-up|1|||
160920806|NCT02998840|581103388|FG001|Overall Study|Lost to Follow-up|1|||
160920807|NCT02998840|581103389|FG002|Overall Study|Lost to Follow-up|2|||
160920808|NCT02998840|581103390|FG003|Overall Study|Lost to Follow-up|3|||
160920809|NCT02998840|581103387|FG000|Overall Study|Withdrawal by Subject|1|||
160920810|NCT02998840|581103388|FG001|Overall Study|Withdrawal by Subject|1|||
160920811|NCT02998840|581103389|FG002|Overall Study|Withdrawal by Subject|0|||
160920812|NCT02998840|581103390|FG003|Overall Study|Withdrawal by Subject|1|||
160454707|NCT01928394|579396190|FG020|Treatment Period|Participant withdrew consent|0|||
160454708|NCT01928394|579396191|FG021|Treatment Period|Participant withdrew consent|2|||
160574970|NCT03567291|579827353|FG000|Period I|Lost to Follow-up|2|||
160574971|NCT03567291|579827354|FG001|Period I|Lost to Follow-up|0|||
160574972|NCT03567291|579827355|FG002|Period I|Lost to Follow-up|0|||
160574973|NCT03567291|579827356|FG003|Period I|Lost to Follow-up|0|||
160574974|NCT03567291|579827353|FG000|Period I|Terminated by sponsor|44|||
160574975|NCT03567291|579827354|FG001|Period I|Terminated by sponsor|0|||
160574976|NCT03567291|579827355|FG002|Period I|Terminated by sponsor|0|||
160574977|NCT03567291|579827356|FG003|Period I|Terminated by sponsor|0|||
160574978|NCT03567291|579827353|FG000|Period I|Missing or unknown|7|||
160574979|NCT03567291|579827354|FG001|Period I|Missing or unknown|0|||
160574980|NCT03567291|579827355|FG002|Period I|Missing or unknown|0|||
160574981|NCT03567291|579827356|FG003|Period I|Missing or unknown|0|||
160574982|NCT03567291|579827353|FG000|Period II|Adverse Event|0|||
160574983|NCT03567291|579827354|FG001|Period II|Adverse Event|1|||
160574984|NCT03567291|579827355|FG002|Period II|Adverse Event|0|||
160574985|NCT03567291|579827356|FG003|Period II|Adverse Event|0|||
160574986|NCT03567291|579827353|FG000|Period II|Missing or unknown|0|||
160574987|NCT03567291|579827354|FG001|Period II|Missing or unknown|2|||
160574988|NCT03567291|579827355|FG002|Period II|Missing or unknown|1|||
160574989|NCT03567291|579827356|FG003|Period II|Missing or unknown|0|||
160574990|NCT03567291|579827353|FG000|Period III|Adverse Event|0|||
160574991|NCT03567291|579827354|FG001|Period III|Adverse Event|0|||
160574992|NCT03567291|579827355|FG002|Period III|Adverse Event|0|||
160574993|NCT03567291|579827356|FG003|Period III|Adverse Event|4|||
160574994|NCT03567291|579827353|FG000|Period III|Withdrawal by Subject|0|||
160574995|NCT03567291|579827354|FG001|Period III|Withdrawal by Subject|0|||
160574996|NCT03567291|579827355|FG002|Period III|Withdrawal by Subject|0|||
160574997|NCT03567291|579827356|FG003|Period III|Withdrawal by Subject|4|||
160574998|NCT03567291|579827353|FG000|Period III|Lost to Follow-up|0|||
160574999|NCT03567291|579827354|FG001|Period III|Lost to Follow-up|0|||
160575000|NCT03567291|579827355|FG002|Period III|Lost to Follow-up|0|||
160575001|NCT03567291|579827356|FG003|Period III|Lost to Follow-up|1|||
160575002|NCT03567291|579827353|FG000|Period III|Terminated by sponsor|0|||
160575003|NCT03567291|579827354|FG001|Period III|Terminated by sponsor|0|||
160920813|NCT02998840|581103387|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
160920814|NCT02998840|581103388|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
160920815|NCT02998840|581103389|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
160920816|NCT02998840|581103390|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
160920817|NCT00665847|581103394|FG000|Overall Study|Adverse Event|8|||
160920818|NCT00665847|581103394|FG000|Overall Study|Withdrawal by Subject|2|||
160920819|NCT00665847|581103394|FG000|Overall Study|Subject non-compliant|8|||
160920820|NCT00665847|581103394|FG000|Overall Study|Subject reached a virologic endpoint|4|||
160920821|NCT00665847|581103394|FG000|Overall Study|Resistance to TMC125|1|||
160920822|NCT00665847|581103394|FG000|Overall Study|Subject ineligible to continue the trial|1|||
160920823|NCT00665847|581103394|FG000|Overall Study|Switch to Commercial Medication|1|||
160920824|NCT01686633|581103395|FG000|Overall Study|Lack of Efficacy|33|||
160920825|NCT01686633|581103396|FG001|Overall Study|Lack of Efficacy|13|||
160920826|NCT01686633|581103397|FG002|Overall Study|Lack of Efficacy|11|||
160920827|NCT01686633|581103395|FG000|Overall Study|Withdrawal by Subject|8|||
160920828|NCT01686633|581103396|FG001|Overall Study|Withdrawal by Subject|8|||
160920829|NCT01686633|581103397|FG002|Overall Study|Withdrawal by Subject|5|||
160920830|NCT01686633|581103395|FG000|Overall Study|Physician Decision|3|||
160920831|NCT01686633|581103396|FG001|Overall Study|Physician Decision|4|||
160920832|NCT01686633|581103397|FG002|Overall Study|Physician Decision|4|||
160920833|NCT01686633|581103395|FG000|Overall Study|Adverse Event|4|||
160920834|NCT01686633|581103396|FG001|Overall Study|Adverse Event|3|||
160920835|NCT01686633|581103397|FG002|Overall Study|Adverse Event|3|||
160920836|NCT01686633|581103395|FG000|Overall Study|Protocol Violation|2|||
160920837|NCT01686633|581103396|FG001|Overall Study|Protocol Violation|3|||
160920838|NCT01686633|581103397|FG002|Overall Study|Protocol Violation|0|||
160920839|NCT01686633|581103395|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
160920840|NCT01686633|581103396|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
160997526|NCT00603447|581374983|FG003|Overall Study|Withdrew Consent|0|||
160997527|NCT00603447|581374984|FG004|Overall Study|Withdrew Consent|1|||
160997528|NCT00603447|581374985|FG005|Overall Study|Withdrew Consent|0|||
160575004|NCT03567291|579827355|FG002|Period III|Terminated by sponsor|0|||
160575005|NCT03567291|579827356|FG003|Period III|Terminated by sponsor|68|||
160575006|NCT03567291|579827353|FG000|Period III|Missing or unknown|0|||
160575007|NCT03567291|579827354|FG001|Period III|Missing or unknown|0|||
160575008|NCT03567291|579827355|FG002|Period III|Missing or unknown|0|||
160920841|NCT01686633|581103397|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
160920842|NCT01686633|581103395|FG000|Overall Study|Lost to Follow-up|0|||
160920843|NCT01686633|581103396|FG001|Overall Study|Lost to Follow-up|1|||
160920844|NCT01686633|581103397|FG002|Overall Study|Lost to Follow-up|1|||
160920845|NCT00511667|581103402|FG000|Overall Study|Adverse Event|1|||
160920846|NCT00511667|581103403|FG001|Overall Study|Adverse Event|0|||
160997529|NCT00603447|581374986|FG006|Overall Study|Withdrew Consent|1|||
160997530|NCT00726596|581376538|FG000|Overall Study|Adverse Event|2|||
160997531|NCT00726596|581376539|FG001|Overall Study|Adverse Event|1|||
160997532|NCT00726596|581376538|FG000|Overall Study|Withdrawal by Subject|3|||
160997533|NCT00726596|581376539|FG001|Overall Study|Withdrawal by Subject|3|||
160997534|NCT02614560|581376547|FG000|Overall Study|Death|6|||
160997535|NCT02614560|581376548|FG001|Overall Study|Death|2|||
160454709|NCT01928394|579396192|FG022|Treatment Period|Participant withdrew consent|0|||
160454710|NCT01928394|579396170|FG000|Treatment Period|Poor/non-compliance|0|||
160454711|NCT01928394|579396171|FG001|Treatment Period|Poor/non-compliance|0|||
160454712|NCT01928394|579396172|FG002|Treatment Period|Poor/non-compliance|0|||
160454713|NCT01928394|579396173|FG003|Treatment Period|Poor/non-compliance|1|||
160454714|NCT01928394|579396174|FG004|Treatment Period|Poor/non-compliance|0|||
160454715|NCT01928394|579396175|FG005|Treatment Period|Poor/non-compliance|0|||
160454716|NCT01928394|579396176|FG006|Treatment Period|Poor/non-compliance|0|||
160454717|NCT01928394|579396177|FG007|Treatment Period|Poor/non-compliance|0|||
160454718|NCT01928394|579396178|FG008|Treatment Period|Poor/non-compliance|0|||
160654364|NCT01265784|580114371|FG000|Overall Study|Adverse Event|1|||
160920847|NCT00511667|581103402|FG000|Overall Study|Protocol Violation|1|||
160920848|NCT00511667|581103403|FG001|Overall Study|Protocol Violation|1|||
160920849|NCT00511667|581103402|FG000|Overall Study|Withdrawal by Subject|2|||
160920850|NCT00511667|581103403|FG001|Overall Study|Withdrawal by Subject|0|||
160920851|NCT00511667|581103402|FG000|Overall Study|Site terminated|6|||
160920852|NCT00511667|581103403|FG001|Overall Study|Site terminated|1|||
160920853|NCT00511667|581103402|FG000|Overall Study|Other|2|||
160920854|NCT00511667|581103403|FG001|Overall Study|Other|1|||
160454719|NCT01928394|579396179|FG009|Treatment Period|Poor/non-compliance|0|||
160454720|NCT01928394|579396180|FG010|Treatment Period|Poor/non-compliance|0|||
160454721|NCT01928394|579396181|FG011|Treatment Period|Poor/non-compliance|0|||
160454722|NCT01928394|579396182|FG012|Treatment Period|Poor/non-compliance|1|||
160454723|NCT01928394|579396183|FG013|Treatment Period|Poor/non-compliance|0|||
160454724|NCT01928394|579396184|FG014|Treatment Period|Poor/non-compliance|1|||
160454725|NCT01928394|579396185|FG015|Treatment Period|Poor/non-compliance|0|||
160454726|NCT01928394|579396186|FG016|Treatment Period|Poor/non-compliance|0|||
160454727|NCT01928394|579396187|FG017|Treatment Period|Poor/non-compliance|1|||
160454728|NCT01928394|579396188|FG018|Treatment Period|Poor/non-compliance|0|||
160454729|NCT01928394|579396189|FG019|Treatment Period|Poor/non-compliance|1|||
160454730|NCT01928394|579396190|FG020|Treatment Period|Poor/non-compliance|0|||
160454731|NCT01928394|579396191|FG021|Treatment Period|Poor/non-compliance|0|||
160454732|NCT01928394|579396192|FG022|Treatment Period|Poor/non-compliance|0|||
160454733|NCT01928394|579396170|FG000|Treatment Period|other reason|0|||
160454734|NCT01928394|579396171|FG001|Treatment Period|other reason|0|||
160454735|NCT01928394|579396172|FG002|Treatment Period|other reason|0|||
160454736|NCT01928394|579396173|FG003|Treatment Period|other reason|0|||
160454737|NCT01928394|579396174|FG004|Treatment Period|other reason|0|||
160454738|NCT01928394|579396175|FG005|Treatment Period|other reason|0|||
160454739|NCT01928394|579396176|FG006|Treatment Period|other reason|0|||
160454740|NCT01928394|579396177|FG007|Treatment Period|other reason|0|||
160454741|NCT01928394|579396178|FG008|Treatment Period|other reason|0|||
160454742|NCT01928394|579396179|FG009|Treatment Period|other reason|0|||
160454743|NCT01928394|579396180|FG010|Treatment Period|other reason|1|||
160454744|NCT01928394|579396181|FG011|Treatment Period|other reason|1|||
160454745|NCT01928394|579396182|FG012|Treatment Period|other reason|1|||
160454746|NCT01928394|579396183|FG013|Treatment Period|other reason|0|||
160454747|NCT01928394|579396184|FG014|Treatment Period|other reason|1|||
160454748|NCT01928394|579396185|FG015|Treatment Period|other reason|0|||
160454749|NCT01928394|579396186|FG016|Treatment Period|other reason|0|||
160454750|NCT01928394|579396187|FG017|Treatment Period|other reason|0|||
160454751|NCT01928394|579396188|FG018|Treatment Period|other reason|2|||
160454752|NCT01928394|579396189|FG019|Treatment Period|other reason|2|||
160454753|NCT01928394|579396190|FG020|Treatment Period|other reason|0|||
160454754|NCT01928394|579396191|FG021|Treatment Period|other reason|0|||
160454755|NCT01928394|579396192|FG022|Treatment Period|other reason|0|||
160454756|NCT01928394|579396170|FG000|Treatment Period|Maximum clinical benefit|0|||
160454757|NCT01928394|579396171|FG001|Treatment Period|Maximum clinical benefit|0|||
160454758|NCT01928394|579396172|FG002|Treatment Period|Maximum clinical benefit|0|||
160654365|NCT01265784|580114372|FG001|Overall Study|Adverse Event|0|||
160654366|NCT01265784|580114373|FG002|Overall Study|Adverse Event|0|||
160997536|NCT02192606|581376549|FG000|Overall Study|surgery type was changed|1|||
160997537|NCT02192606|581376550|FG001|Overall Study|surgery type was changed|1|||
160997538|NCT02192606|581376549|FG000|Overall Study|Physician Decision|1|||
160454759|NCT01928394|579396173|FG003|Treatment Period|Maximum clinical benefit|0|||
160454760|NCT01928394|579396174|FG004|Treatment Period|Maximum clinical benefit|0|||
160454761|NCT01928394|579396175|FG005|Treatment Period|Maximum clinical benefit|0|||
160454762|NCT01928394|579396176|FG006|Treatment Period|Maximum clinical benefit|0|||
160454763|NCT01928394|579396177|FG007|Treatment Period|Maximum clinical benefit|0|||
160454764|NCT01928394|579396178|FG008|Treatment Period|Maximum clinical benefit|0|||
160454765|NCT01928394|579396179|FG009|Treatment Period|Maximum clinical benefit|0|||
160575009|NCT03567291|579827356|FG003|Period III|Missing or unknown|8|||
160575010|NCT03666143|579827357|FG000|Overall Study|Death|158|||
160575011|NCT03666143|579827357|FG000|Overall Study|Sponsor Decision|31|||
160575012|NCT03666143|579827357|FG000|Overall Study|Withdrawal by Subject|11|||
160575013|NCT03666143|579827357|FG000|Overall Study|Lost to Follow-up|5|||
160575014|NCT03666143|579827357|FG000|Overall Study|Physician Decision|1|||
160575015|NCT03666143|579827357|FG000|Overall Study|Rolled into extension study|9|||
160575016|NCT03666143|579827357|FG000|Overall Study|Progressive Disease|1|||
160575017|NCT01103349|579827358|FG000|Overall Study|Adverse Event|8|||
160575018|NCT01103349|579827359|FG001|Overall Study|Adverse Event|5|||
160575019|NCT01103349|579827360|FG002|Overall Study|Adverse Event|3|||
160575020|NCT01103349|579827358|FG000|Overall Study|Consent withdrawn|1|||
160575021|NCT01103349|579827359|FG001|Overall Study|Consent withdrawn|0|||
160575022|NCT01103349|579827360|FG002|Overall Study|Consent withdrawn|0|||
160575023|NCT01103349|579827358|FG000|Overall Study|Incorrectly included in the trial|1|||
160575024|NCT01103349|579827359|FG001|Overall Study|Incorrectly included in the trial|0|||
160575025|NCT01103349|579827360|FG002|Overall Study|Incorrectly included in the trial|0|||
160575026|NCT01103349|579827358|FG000|Overall Study|Withdrawal by Subject|1|||
160575027|NCT01103349|579827359|FG001|Overall Study|Withdrawal by Subject|1|||
160575028|NCT01103349|579827360|FG002|Overall Study|Withdrawal by Subject|0|||
160575029|NCT01103349|579827358|FG000|Overall Study|did not want to take trial medication|0|||
160575030|NCT01103349|579827359|FG001|Overall Study|did not want to take trial medication|1|||
160575031|NCT01103349|579827360|FG002|Overall Study|did not want to take trial medication|0|||
160575032|NCT01103349|579827358|FG000|Overall Study|forgot to take medication|0|||
160575033|NCT01103349|579827359|FG001|Overall Study|forgot to take medication|0|||
160575034|NCT01103349|579827360|FG002|Overall Study|forgot to take medication|1|||
160575035|NCT00958568|579827366|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
160575036|NCT00958568|579827367|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
160575037|NCT00958568|579827368|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
160575038|NCT00958568|579827369|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
160575039|NCT00958568|579827366|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
160575040|NCT00958568|579827367|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
160575041|NCT00958568|579827368|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
160575042|NCT00958568|579827369|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
160575043|NCT00958568|579827366|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
160575044|NCT00958568|579827367|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
160575045|NCT00958568|579827368|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
160575046|NCT00958568|579827369|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
160575047|NCT00958568|579827366|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
160575048|NCT00958568|579827367|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
160575049|NCT00958568|579827368|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
160575050|NCT00958568|579827369|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
160575051|NCT00958568|579827366|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
160575052|NCT00958568|579827367|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
160575053|NCT00958568|579827368|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
160575054|NCT00958568|579827369|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
160575055|NCT00958568|579827366|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
160575056|NCT00958568|579827367|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
160575057|NCT00958568|579827368|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
160575058|NCT00958568|579827369|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
160575059|NCT00958568|579827366|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
160575060|NCT00958568|579827367|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
160575061|NCT00958568|579827368|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
160575062|NCT00958568|579827369|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
160575063|NCT00958568|579827366|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
160575064|NCT00958568|579827367|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
160575065|NCT00958568|579827368|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
160575066|NCT00958568|579827369|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
160575067|NCT00958568|579827366|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
160575068|NCT00958568|579827367|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
160575069|NCT00958568|579827368|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
160575070|NCT00958568|579827369|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
160575071|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
160575072|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
160575073|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
160575074|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
160575075|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
160575076|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
160632811|NCT00556166|580036079|FG000|Overall Study|Withdrawal by Subject|1|||
160997539|NCT02192606|581376550|FG001|Overall Study|Physician Decision|2|||
160997540|NCT02192606|581376549|FG000|Overall Study|3D equipment rep unable to join|0|||
160997541|NCT02192606|581376550|FG001|Overall Study|3D equipment rep unable to join|1|||
160997542|NCT00738699|581376551|FG000|Overall Study|Withdrawal by Subject|5|||
160997543|NCT00738699|581376552|FG001|Overall Study|Withdrawal by Subject|0|||
160997544|NCT00738699|581376551|FG000|Overall Study|Lost to Follow-up|1|||
160997545|NCT00738699|581376552|FG001|Overall Study|Lost to Follow-up|0|||
160997546|NCT00738699|581376551|FG000|Overall Study|Death|144|||
160997547|NCT00738699|581376552|FG001|Overall Study|Death|68|||
160997548|NCT00738699|581376551|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
160997549|NCT00738699|581376552|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
160997550|NCT00738699|581376551|FG000|Overall Study|Other|2|||
160997551|NCT00738699|581376552|FG001|Overall Study|Other|0|||
160997552|NCT03201809|581376553|FG000|Overall Study|Lost to Follow-up|2|||
160997553|NCT03201809|581376554|FG001|Overall Study|Lost to Follow-up|0|||
160997554|NCT03383887|581376555|FG000|Overall Study|Lost to Follow-up|0|||
160997555|NCT03383887|581376556|FG001|Overall Study|Lost to Follow-up|1|||
160997556|NCT00246012|581376563|FG000|Overall Study|Adverse Event|0|||
160997557|NCT00246012|581376564|FG001|Overall Study|Adverse Event|0|||
160997558|NCT00246012|581376565|FG002|Overall Study|Adverse Event|0|||
160997559|NCT00246012|581376566|FG003|Overall Study|Adverse Event|0|||
160997560|NCT00246012|581376567|FG004|Overall Study|Adverse Event|0|||
160997561|NCT00246012|581376568|FG005|Overall Study|Adverse Event|1|||
160997562|NCT00246012|581376569|FG006|Overall Study|Adverse Event|0|||
160575077|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
160575078|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
160575079|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
160575080|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
160575081|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
160575082|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
160575083|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
160575084|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
160575085|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
160575086|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
160575087|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
160575088|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
160575089|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
160575090|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
160575091|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
160575092|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
160575093|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
160575094|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
160575095|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
160575096|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
160575097|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
160575098|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
160575099|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
160575100|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
160575101|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
160575102|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
160575103|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
160575104|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
160575105|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
160575106|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
160575107|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
160575108|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
160575109|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
160575110|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
160575111|NCT00958568|579827366|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
160575112|NCT00958568|579827367|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
160575113|NCT00958568|579827368|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
160654367|NCT01265784|580114371|FG000|Overall Study|Death|3|||
160997563|NCT00246012|581376570|FG007|Overall Study|Adverse Event|0|||
160997564|NCT00246012|581376571|FG008|Overall Study|Adverse Event|2|||
160997565|NCT00246012|581376563|FG000|Overall Study|Withdrawal by Subject|0|||
160997566|NCT00246012|581376564|FG001|Overall Study|Withdrawal by Subject|0|||
160454766|NCT01928394|579396180|FG010|Treatment Period|Maximum clinical benefit|1|||
160997567|NCT00246012|581376565|FG002|Overall Study|Withdrawal by Subject|0|||
160997568|NCT00246012|581376566|FG003|Overall Study|Withdrawal by Subject|0|||
160575114|NCT00958568|579827369|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
160575115|NCT00958568|579827366|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
160575116|NCT00958568|579827367|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
160575117|NCT00958568|579827368|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
160575118|NCT00958568|579827369|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
160575119|NCT00958568|579827366|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
160575120|NCT00958568|579827367|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
160575121|NCT00958568|579827368|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
160575122|NCT00958568|579827369|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
160575123|NCT00958568|579827366|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
160575124|NCT00958568|579827367|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
160575125|NCT00958568|579827368|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
160575126|NCT00958568|579827369|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
160575127|NCT00958568|579827366|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
160575128|NCT00958568|579827367|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
160575129|NCT00958568|579827368|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
160575130|NCT00958568|579827369|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
160575131|NCT00958568|579827366|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
160575132|NCT00958568|579827367|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
160575133|NCT00958568|579827368|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
160575134|NCT00958568|579827369|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
160575135|NCT00958568|579827366|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
160575136|NCT00958568|579827367|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
160575137|NCT00958568|579827368|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
160575138|NCT00958568|579827369|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
160575139|NCT00958568|579827366|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
160575140|NCT00958568|579827367|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
160575141|NCT00958568|579827368|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
160575142|NCT00958568|579827369|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
160575143|NCT00958568|579827366|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
160575144|NCT00958568|579827367|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
160575145|NCT00958568|579827368|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
160920855|NCT01729754|581105215|FG000|Part 1|Adverse Event|2|||
160920856|NCT01729754|581105216|FG001|Part 1|Adverse Event|0|||
160920857|NCT01729754|581105217|FG002|Part 1|Adverse Event|0|||
160920858|NCT01729754|581105218|FG003|Part 1|Adverse Event|1|||
160920859|NCT01729754|581105219|FG004|Part 1|Adverse Event|0|||
160920860|NCT01729754|581105220|FG005|Part 1|Adverse Event|0|||
160920861|NCT01729754|581105221|FG006|Part 1|Adverse Event|2|||
160920862|NCT01729754|581105222|FG007|Part 1|Adverse Event|0|||
160920863|NCT01729754|581105223|FG008|Part 1|Adverse Event|0|||
160920864|NCT01729754|581105224|FG009|Part 1|Adverse Event|5|||
160920865|NCT01729754|581105215|FG000|Part 1|Lack of Efficacy|1|||
160920866|NCT01729754|581105216|FG001|Part 1|Lack of Efficacy|0|||
160920867|NCT01729754|581105217|FG002|Part 1|Lack of Efficacy|0|||
160920868|NCT01729754|581105218|FG003|Part 1|Lack of Efficacy|0|||
160920869|NCT01729754|581105219|FG004|Part 1|Lack of Efficacy|0|||
160920870|NCT01729754|581105220|FG005|Part 1|Lack of Efficacy|0|||
160920871|NCT01729754|581105221|FG006|Part 1|Lack of Efficacy|2|||
160920872|NCT01729754|581105222|FG007|Part 1|Lack of Efficacy|0|||
160920873|NCT01729754|581105223|FG008|Part 1|Lack of Efficacy|0|||
160920874|NCT01729754|581105224|FG009|Part 1|Lack of Efficacy|0|||
160920875|NCT01729754|581105215|FG000|Part 1|Lost to Follow-up|1|||
160920876|NCT01729754|581105216|FG001|Part 1|Lost to Follow-up|0|||
160920877|NCT01729754|581105217|FG002|Part 1|Lost to Follow-up|0|||
160920878|NCT01729754|581105218|FG003|Part 1|Lost to Follow-up|2|||
160920879|NCT01729754|581105219|FG004|Part 1|Lost to Follow-up|0|||
160920880|NCT01729754|581105220|FG005|Part 1|Lost to Follow-up|0|||
160920881|NCT01729754|581105221|FG006|Part 1|Lost to Follow-up|3|||
160920882|NCT01729754|581105222|FG007|Part 1|Lost to Follow-up|0|||
160920883|NCT01729754|581105223|FG008|Part 1|Lost to Follow-up|0|||
160920884|NCT01729754|581105224|FG009|Part 1|Lost to Follow-up|3|||
160920885|NCT01729754|581105215|FG000|Part 1|Non-compliance with Study Drug|1|||
160920886|NCT01729754|581105216|FG001|Part 1|Non-compliance with Study Drug|0|||
160920887|NCT01729754|581105217|FG002|Part 1|Non-compliance with Study Drug|0|||
160920888|NCT01729754|581105218|FG003|Part 1|Non-compliance with Study Drug|0|||
160920889|NCT01729754|581105219|FG004|Part 1|Non-compliance with Study Drug|0|||
160920890|NCT01729754|581105220|FG005|Part 1|Non-compliance with Study Drug|0|||
160997569|NCT00246012|581376567|FG004|Overall Study|Withdrawal by Subject|0|||
160920891|NCT01729754|581105221|FG006|Part 1|Non-compliance with Study Drug|0|||
160920892|NCT01729754|581105222|FG007|Part 1|Non-compliance with Study Drug|0|||
160920893|NCT01729754|581105223|FG008|Part 1|Non-compliance with Study Drug|0|||
160920894|NCT01729754|581105224|FG009|Part 1|Non-compliance with Study Drug|0|||
160920895|NCT01729754|581105215|FG000|Part 1|Physician Decision|0|||
160654368|NCT01265784|580114372|FG001|Overall Study|Death|0|||
160654369|NCT01265784|580114373|FG002|Overall Study|Death|0|||
160654370|NCT01265784|580114371|FG000|Overall Study|Protocol Violation|2|||
160654371|NCT01265784|580114372|FG001|Overall Study|Protocol Violation|0|||
160654372|NCT01265784|580114373|FG002|Overall Study|Protocol Violation|0|||
160654373|NCT01265784|580114371|FG000|Overall Study|Incorrectly Randomized|0|||
160654374|NCT01265784|580114372|FG001|Overall Study|Incorrectly Randomized|0|||
160654375|NCT01265784|580114373|FG002|Overall Study|Incorrectly Randomized|1|||
160654376|NCT00770315|580114380|FG000|Overall Study|Adverse Event|11|||
160654377|NCT00770315|580114381|FG001|Overall Study|Adverse Event|17|||
160654378|NCT00770315|580114382|FG002|Overall Study|Adverse Event|16|||
160654379|NCT00770315|580114383|FG003|Overall Study|Adverse Event|6|||
160654380|NCT00770315|580114380|FG000|Overall Study|Lost to Follow-up|9|||
160654381|NCT00770315|580114381|FG001|Overall Study|Lost to Follow-up|5|||
160654382|NCT00770315|580114382|FG002|Overall Study|Lost to Follow-up|10|||
160654383|NCT00770315|580114383|FG003|Overall Study|Lost to Follow-up|3|||
160654384|NCT00770315|580114380|FG000|Overall Study|Withdrawal by Subject|13|||
160654385|NCT00770315|580114381|FG001|Overall Study|Withdrawal by Subject|17|||
160654386|NCT00770315|580114382|FG002|Overall Study|Withdrawal by Subject|24|||
160654387|NCT00770315|580114383|FG003|Overall Study|Withdrawal by Subject|20|||
160654388|NCT00770315|580114380|FG000|Overall Study|Noncompliance with Protocol|7|||
160654389|NCT00770315|580114381|FG001|Overall Study|Noncompliance with Protocol|4|||
160654390|NCT00770315|580114382|FG002|Overall Study|Noncompliance with Protocol|7|||
160654391|NCT00770315|580114383|FG003|Overall Study|Noncompliance with Protocol|9|||
160654392|NCT03717064|580117019|FG000|Period 2|Adverse Event|1|||
160654393|NCT01298570|580117020|FG000|Overall Study|Disease progression, relapse during acti|64|||
160654394|NCT01298570|580117021|FG001|Overall Study|Disease progression, relapse during acti|40|||
160654395|NCT01298570|580117020|FG000|Overall Study|Adverse Event|20|||
160654396|NCT01298570|580117021|FG001|Overall Study|Adverse Event|2|||
160654397|NCT01298570|580117020|FG000|Overall Study|Withdrawal by Subject|21|||
160654398|NCT01298570|580117021|FG001|Overall Study|Withdrawal by Subject|6|||
160654399|NCT01298570|580117020|FG000|Overall Study|Treatment delay > 4 weeks|4|||
160654400|NCT01298570|580117021|FG001|Overall Study|Treatment delay > 4 weeks|5|||
160654401|NCT01298570|580117020|FG000|Overall Study|Physician Decision|4|||
160654402|NCT01298570|580117021|FG001|Overall Study|Physician Decision|2|||
160654403|NCT01298570|580117020|FG000|Overall Study|Other complicating disease|2|||
160654404|NCT01298570|580117021|FG001|Overall Study|Other complicating disease|1|||
160654405|NCT01298570|580117020|FG000|Overall Study|Surgery|2|||
160654406|NCT01298570|580117021|FG001|Overall Study|Surgery|1|||
160654407|NCT01298570|580117020|FG000|Overall Study|Symptomatic progression/deterioration|3|||
160654408|NCT01298570|580117021|FG001|Overall Study|Symptomatic progression/deterioration|2|||
160654409|NCT01298570|580117020|FG000|Overall Study|Death|0|||
160654410|NCT01298570|580117021|FG001|Overall Study|Death|1|||
160654411|NCT01298570|580117020|FG000|Overall Study|Ineligibility|0|||
160654412|NCT01298570|580117021|FG001|Overall Study|Ineligibility|1|||
160654413|NCT02841709|580117022|FG000|5th Intervention|Adverse Event|2|||
160654414|NCT02841709|580117023|FG001|5th Intervention|Adverse Event|0|||
160654415|NCT02841709|580117024|FG002|5th Intervention|Adverse Event|0|||
160920896|NCT01729754|581105216|FG001|Part 1|Physician Decision|0|||
160920897|NCT01729754|581105217|FG002|Part 1|Physician Decision|0|||
160920898|NCT01729754|581105218|FG003|Part 1|Physician Decision|0|||
160920899|NCT01729754|581105219|FG004|Part 1|Physician Decision|0|||
160920900|NCT01729754|581105220|FG005|Part 1|Physician Decision|0|||
160920901|NCT01729754|581105221|FG006|Part 1|Physician Decision|0|||
160920902|NCT01729754|581105222|FG007|Part 1|Physician Decision|0|||
160920903|NCT01729754|581105223|FG008|Part 1|Physician Decision|0|||
160920904|NCT01729754|581105224|FG009|Part 1|Physician Decision|4|||
160920905|NCT01729754|581105215|FG000|Part 1|Pregnancy|0|||
160920906|NCT01729754|581105216|FG001|Part 1|Pregnancy|0|||
160920907|NCT01729754|581105217|FG002|Part 1|Pregnancy|0|||
160920908|NCT01729754|581105218|FG003|Part 1|Pregnancy|1|||
160920909|NCT01729754|581105219|FG004|Part 1|Pregnancy|0|||
160654416|NCT02841709|580117025|FG003|5th Intervention|Adverse Event|0|||
160654417|NCT02841709|580117026|FG004|5th Intervention|Adverse Event|2|||
160654418|NCT01929109|580117027|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
160654419|NCT01929109|580117028|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
160654420|NCT01929109|580117029|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
160654421|NCT01929109|580117030|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
160654422|NCT01929109|580117031|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
160920910|NCT01729754|581105220|FG005|Part 1|Pregnancy|0|||
160920911|NCT01729754|581105221|FG006|Part 1|Pregnancy|0|||
160920912|NCT01729754|581105222|FG007|Part 1|Pregnancy|0|||
160654423|NCT00076102|580117032|FG000|Overall Study|Clinical progression|1|||
160654424|NCT00076102|580117032|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
160654425|NCT00076102|580117032|FG000|Overall Study|plexiform neurofibroma surgery|1|||
160654426|NCT00076102|580117032|FG000|Overall Study|refusal of further therapy|2|||
160654427|NCT02180711|580117034|FG000|Overall Study|Death|0|||
160920913|NCT01729754|581105223|FG008|Part 1|Pregnancy|0|||
160920914|NCT01729754|581105224|FG009|Part 1|Pregnancy|1|||
160920915|NCT01729754|581105215|FG000|Part 1|Progressive Disease|0|||
160654428|NCT02180711|580117035|FG001|Overall Study|Death|1|||
160654429|NCT02180711|580117036|FG002|Overall Study|Death|0|||
160654430|NCT02180711|580117037|FG003|Overall Study|Death|0|||
160654431|NCT02180711|580117038|FG004|Overall Study|Death|7|||
160654432|NCT02180711|580117039|FG005|Overall Study|Death|0|||
160654433|NCT02180711|580117040|FG006|Overall Study|Death|1|||
160654434|NCT02180711|580117041|FG007|Overall Study|Death|3|||
160654435|NCT02180711|580117034|FG000|Overall Study|Lost to Follow-up|0|||
160654436|NCT02180711|580117035|FG001|Overall Study|Lost to Follow-up|1|||
160654437|NCT02180711|580117036|FG002|Overall Study|Lost to Follow-up|0|||
160654438|NCT02180711|580117037|FG003|Overall Study|Lost to Follow-up|0|||
160654439|NCT02180711|580117038|FG004|Overall Study|Lost to Follow-up|1|||
160654440|NCT02180711|580117039|FG005|Overall Study|Lost to Follow-up|1|||
160654441|NCT02180711|580117040|FG006|Overall Study|Lost to Follow-up|0|||
160654442|NCT02180711|580117041|FG007|Overall Study|Lost to Follow-up|3|||
160654443|NCT02180711|580117034|FG000|Overall Study|Withdrawal by Subject|2|||
160654444|NCT02180711|580117035|FG001|Overall Study|Withdrawal by Subject|1|||
160654445|NCT02180711|580117036|FG002|Overall Study|Withdrawal by Subject|0|||
160654446|NCT02180711|580117037|FG003|Overall Study|Withdrawal by Subject|4|||
160654447|NCT02180711|580117038|FG004|Overall Study|Withdrawal by Subject|3|||
160654448|NCT02180711|580117039|FG005|Overall Study|Withdrawal by Subject|0|||
160654449|NCT02180711|580117040|FG006|Overall Study|Withdrawal by Subject|3|||
160654450|NCT02180711|580117041|FG007|Overall Study|Withdrawal by Subject|2|||
160654451|NCT02180711|580117034|FG000|Overall Study|- Disease Progression|0|||
160654452|NCT02180711|580117035|FG001|Overall Study|- Disease Progression|1|||
160654453|NCT02180711|580117036|FG002|Overall Study|- Disease Progression|0|||
160654454|NCT02180711|580117037|FG003|Overall Study|- Disease Progression|0|||
160654455|NCT02180711|580117038|FG004|Overall Study|- Disease Progression|0|||
160654456|NCT02180711|580117039|FG005|Overall Study|- Disease Progression|0|||
160654457|NCT02180711|580117040|FG006|Overall Study|- Disease Progression|0|||
160654458|NCT02180711|580117041|FG007|Overall Study|- Disease Progression|0|||
160654459|NCT02180711|580117034|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
160654460|NCT02180711|580117035|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
160654461|NCT02180711|580117036|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
160654462|NCT02180711|580117037|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
160654463|NCT02180711|580117038|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
160654464|NCT02180711|580117039|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
160654465|NCT02180711|580117040|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
160654466|NCT02180711|580117041|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
160654467|NCT02180711|580117034|FG000|Overall Study|- Study Terminated by Sponsor|2|||
160654468|NCT02180711|580117035|FG001|Overall Study|- Study Terminated by Sponsor|3|||
160654469|NCT02180711|580117036|FG002|Overall Study|- Study Terminated by Sponsor|0|||
160654470|NCT02180711|580117037|FG003|Overall Study|- Study Terminated by Sponsor|5|||
160654471|NCT02180711|580117038|FG004|Overall Study|- Study Terminated by Sponsor|32|||
160654472|NCT02180711|580117039|FG005|Overall Study|- Study Terminated by Sponsor|0|||
160654473|NCT02180711|580117040|FG006|Overall Study|- Study Terminated by Sponsor|4|||
160654474|NCT02180711|580117041|FG007|Overall Study|- Study Terminated by Sponsor|13|||
160654475|NCT02180711|580117034|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
160654476|NCT02180711|580117035|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
160575146|NCT00958568|579827369|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
160575147|NCT00958568|579827366|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
160575148|NCT00958568|579827367|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
160575149|NCT00958568|579827368|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
160575150|NCT00958568|579827369|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
160575151|NCT00972244|579827370|FG000|Overall Study|Incorrect Enrolment|1|||
160575152|NCT00972244|579827371|FG001|Overall Study|Incorrect Enrolment|0|||
160575153|NCT00972244|579827372|FG002|Overall Study|Incorrect Enrolment|0|||
160575154|NCT00972244|579827373|FG003|Overall Study|Incorrect Enrolment|0|||
160575155|NCT00972244|579827374|FG004|Overall Study|Incorrect Enrolment|0|||
160575156|NCT00972244|579827370|FG000|Overall Study|Adverse Event|0|||
160575157|NCT00972244|579827371|FG001|Overall Study|Adverse Event|1|||
160575158|NCT00972244|579827372|FG002|Overall Study|Adverse Event|1|||
160654477|NCT02180711|580117036|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
160654478|NCT02180711|580117037|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
160654479|NCT02180711|580117038|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
160454767|NCT01928394|579396181|FG011|Treatment Period|Maximum clinical benefit|1|||
160454768|NCT01928394|579396182|FG012|Treatment Period|Maximum clinical benefit|0|||
160575159|NCT00972244|579827373|FG003|Overall Study|Adverse Event|0|||
160654480|NCT02180711|580117039|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
160575160|NCT00972244|579827374|FG004|Overall Study|Adverse Event|0|||
160575161|NCT00972244|579827370|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
160654481|NCT02180711|580117040|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
160654482|NCT02180711|580117041|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
160654483|NCT02180711|580117034|FG000|Overall Study|- Other|1|||
160575162|NCT00972244|579827371|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
160575163|NCT00972244|579827372|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
160575164|NCT00972244|579827373|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
160575165|NCT00972244|579827374|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
160575166|NCT00972244|579827370|FG000|Overall Study|Withdrawal by Subject|1|||
160575167|NCT00972244|579827371|FG001|Overall Study|Withdrawal by Subject|2|||
160575168|NCT00972244|579827372|FG002|Overall Study|Withdrawal by Subject|1|||
160575169|NCT00972244|579827373|FG003|Overall Study|Withdrawal by Subject|0|||
160575170|NCT00972244|579827374|FG004|Overall Study|Withdrawal by Subject|1|||
160575171|NCT00972244|579827370|FG000|Overall Study|Safety|0|||
160575172|NCT00972244|579827371|FG001|Overall Study|Safety|0|||
160575173|NCT00972244|579827372|FG002|Overall Study|Safety|0|||
160575174|NCT00972244|579827373|FG003|Overall Study|Safety|0|||
160575175|NCT00972244|579827374|FG004|Overall Study|Safety|1|||
160575176|NCT00972244|579827370|FG000|Overall Study|Death|1|||
160575177|NCT00972244|579827371|FG001|Overall Study|Death|0|||
160575178|NCT00972244|579827372|FG002|Overall Study|Death|0|||
160575179|NCT00972244|579827373|FG003|Overall Study|Death|0|||
160575180|NCT00972244|579827374|FG004|Overall Study|Death|0|||
160575181|NCT00972244|579827370|FG000|Overall Study|Various|0|||
160575182|NCT00972244|579827371|FG001|Overall Study|Various|0|||
160575183|NCT00972244|579827372|FG002|Overall Study|Various|0|||
160575184|NCT00972244|579827373|FG003|Overall Study|Various|0|||
160575185|NCT00972244|579827374|FG004|Overall Study|Various|2|||
160575186|NCT00090285|579827375|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
160575187|NCT00090285|579827376|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
160575188|NCT00090285|579827377|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
160575189|NCT00090285|579827378|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
160575190|NCT00090285|579827379|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
160575191|NCT00090285|579827380|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
160575192|NCT00090285|579827375|FG000|Base Study Vaccination Period|Adverse Event|2|||
160575193|NCT00090285|579827376|FG001|Base Study Vaccination Period|Adverse Event|4|||
160575194|NCT00090285|579827377|FG002|Base Study Vaccination Period|Adverse Event|0|||
160920916|NCT01729754|581105216|FG001|Part 1|Progressive Disease|0|||
160920917|NCT01729754|581105217|FG002|Part 1|Progressive Disease|0|||
160920918|NCT01729754|581105218|FG003|Part 1|Progressive Disease|0|||
160920919|NCT01729754|581105219|FG004|Part 1|Progressive Disease|0|||
160920920|NCT01729754|581105220|FG005|Part 1|Progressive Disease|0|||
160920921|NCT01729754|581105221|FG006|Part 1|Progressive Disease|0|||
160920922|NCT01729754|581105222|FG007|Part 1|Progressive Disease|0|||
160920923|NCT01729754|581105223|FG008|Part 1|Progressive Disease|0|||
160920924|NCT01729754|581105224|FG009|Part 1|Progressive Disease|1|||
160920925|NCT01729754|581105215|FG000|Part 1|Protocol Violation|2|||
160920926|NCT01729754|581105216|FG001|Part 1|Protocol Violation|0|||
160920927|NCT01729754|581105217|FG002|Part 1|Protocol Violation|0|||
160920928|NCT01729754|581105218|FG003|Part 1|Protocol Violation|1|||
160920929|NCT01729754|581105219|FG004|Part 1|Protocol Violation|0|||
160920930|NCT01729754|581105220|FG005|Part 1|Protocol Violation|0|||
160920931|NCT01729754|581105221|FG006|Part 1|Protocol Violation|1|||
160920932|NCT01729754|581105222|FG007|Part 1|Protocol Violation|0|||
160920933|NCT01729754|581105223|FG008|Part 1|Protocol Violation|0|||
160920934|NCT01729754|581105224|FG009|Part 1|Protocol Violation|0|||
160920935|NCT01729754|581105215|FG000|Part 1|Withdrawal by Subject|5|||
160920936|NCT01729754|581105216|FG001|Part 1|Withdrawal by Subject|0|||
160920937|NCT01729754|581105217|FG002|Part 1|Withdrawal by Subject|0|||
160920938|NCT01729754|581105218|FG003|Part 1|Withdrawal by Subject|7|||
160920939|NCT01729754|581105219|FG004|Part 1|Withdrawal by Subject|0|||
160920940|NCT01729754|581105220|FG005|Part 1|Withdrawal by Subject|0|||
160920941|NCT01729754|581105221|FG006|Part 1|Withdrawal by Subject|5|||
160920942|NCT01729754|581105222|FG007|Part 1|Withdrawal by Subject|0|||
160920943|NCT01729754|581105223|FG008|Part 1|Withdrawal by Subject|0|||
160920944|NCT01729754|581105224|FG009|Part 1|Withdrawal by Subject|6|||
160920945|NCT01729754|581105215|FG000|Part 1|Other Protocol Specified Criteria|2|||
160575195|NCT00090285|579827378|FG003|Base Study Vaccination Period|Adverse Event|0|||
160575196|NCT00090285|579827379|FG004|Base Study Vaccination Period|Adverse Event|0|||
160575197|NCT00090285|579827380|FG005|Base Study Vaccination Period|Adverse Event|0|||
160920946|NCT01729754|581105216|FG001|Part 1|Other Protocol Specified Criteria|0|||
160920947|NCT01729754|581105217|FG002|Part 1|Other Protocol Specified Criteria|0|||
160920948|NCT01729754|581105218|FG003|Part 1|Other Protocol Specified Criteria|0|||
160920949|NCT01729754|581105219|FG004|Part 1|Other Protocol Specified Criteria|0|||
160920950|NCT01729754|581105220|FG005|Part 1|Other Protocol Specified Criteria|0|||
160920951|NCT01729754|581105221|FG006|Part 1|Other Protocol Specified Criteria|1|||
160920952|NCT01729754|581105222|FG007|Part 1|Other Protocol Specified Criteria|0|||
160920953|NCT01729754|581105223|FG008|Part 1|Other Protocol Specified Criteria|0|||
160575198|NCT00090285|579827375|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
160654484|NCT02180711|580117035|FG001|Overall Study|- Other|0|||
160920954|NCT01729754|581105224|FG009|Part 1|Other Protocol Specified Criteria|4|||
160920955|NCT01729754|581105215|FG000|Part 2|Adverse Event|2|||
160920956|NCT01729754|581105216|FG001|Part 2|Adverse Event|0|||
160920957|NCT01729754|581105217|FG002|Part 2|Adverse Event|0|||
160920958|NCT01729754|581105218|FG003|Part 2|Adverse Event|0|||
160920959|NCT01729754|581105219|FG004|Part 2|Adverse Event|0|||
160920960|NCT01729754|581105220|FG005|Part 2|Adverse Event|0|||
160920961|NCT01729754|581105221|FG006|Part 2|Adverse Event|0|||
160920962|NCT01729754|581105222|FG007|Part 2|Adverse Event|0|||
160920963|NCT01729754|581105223|FG008|Part 2|Adverse Event|1|||
160920964|NCT01729754|581105224|FG009|Part 2|Adverse Event|2|||
160920965|NCT01729754|581105215|FG000|Part 2|Lack of Efficacy|0|||
160920966|NCT01729754|581105216|FG001|Part 2|Lack of Efficacy|0|||
160920967|NCT01729754|581105217|FG002|Part 2|Lack of Efficacy|0|||
160920968|NCT01729754|581105218|FG003|Part 2|Lack of Efficacy|0|||
160920969|NCT01729754|581105219|FG004|Part 2|Lack of Efficacy|0|||
160920970|NCT01729754|581105220|FG005|Part 2|Lack of Efficacy|0|||
160920971|NCT01729754|581105221|FG006|Part 2|Lack of Efficacy|0|||
160920972|NCT01729754|581105222|FG007|Part 2|Lack of Efficacy|0|||
160920973|NCT01729754|581105223|FG008|Part 2|Lack of Efficacy|2|||
160920974|NCT01729754|581105224|FG009|Part 2|Lack of Efficacy|2|||
160920975|NCT01729754|581105215|FG000|Part 2|Lost to Follow-up|0|||
160920976|NCT01729754|581105216|FG001|Part 2|Lost to Follow-up|0|||
160920977|NCT01729754|581105217|FG002|Part 2|Lost to Follow-up|0|||
160920978|NCT01729754|581105218|FG003|Part 2|Lost to Follow-up|2|||
160920979|NCT01729754|581105219|FG004|Part 2|Lost to Follow-up|0|||
160920980|NCT01729754|581105220|FG005|Part 2|Lost to Follow-up|0|||
160920981|NCT01729754|581105221|FG006|Part 2|Lost to Follow-up|0|||
160920982|NCT01729754|581105222|FG007|Part 2|Lost to Follow-up|1|||
160920983|NCT01729754|581105223|FG008|Part 2|Lost to Follow-up|0|||
160920984|NCT01729754|581105224|FG009|Part 2|Lost to Follow-up|2|||
160920985|NCT01729754|581105215|FG000|Part 2|Non-Compliance with Study Drug|0|||
160920986|NCT01729754|581105216|FG001|Part 2|Non-Compliance with Study Drug|0|||
160920987|NCT01729754|581105217|FG002|Part 2|Non-Compliance with Study Drug|0|||
160920988|NCT01729754|581105218|FG003|Part 2|Non-Compliance with Study Drug|0|||
160920989|NCT01729754|581105219|FG004|Part 2|Non-Compliance with Study Drug|0|||
160920990|NCT01729754|581105220|FG005|Part 2|Non-Compliance with Study Drug|0|||
160920991|NCT01729754|581105221|FG006|Part 2|Non-Compliance with Study Drug|0|||
160920992|NCT01729754|581105222|FG007|Part 2|Non-Compliance with Study Drug|0|||
160920993|NCT01729754|581105223|FG008|Part 2|Non-Compliance with Study Drug|0|||
160920994|NCT01729754|581105224|FG009|Part 2|Non-Compliance with Study Drug|1|||
160920995|NCT01729754|581105215|FG000|Part 2|Pregnancy|0|||
160920996|NCT01729754|581105216|FG001|Part 2|Pregnancy|0|||
160920997|NCT01729754|581105217|FG002|Part 2|Pregnancy|0|||
160920998|NCT01729754|581105218|FG003|Part 2|Pregnancy|1|||
160920999|NCT01729754|581105219|FG004|Part 2|Pregnancy|0|||
160921000|NCT01729754|581105220|FG005|Part 2|Pregnancy|0|||
160921001|NCT01729754|581105221|FG006|Part 2|Pregnancy|0|||
160921002|NCT01729754|581105222|FG007|Part 2|Pregnancy|0|||
160921003|NCT01729754|581105223|FG008|Part 2|Pregnancy|0|||
160921004|NCT01729754|581105224|FG009|Part 2|Pregnancy|1|||
160575199|NCT00090285|579827376|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
160575200|NCT00090285|579827377|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
160575201|NCT00090285|579827378|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
160575202|NCT00090285|579827379|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
160575203|NCT00090285|579827380|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
160575204|NCT00090285|579827375|FG000|Base Study Vaccination Period|Protocol Violation|2|||
160575205|NCT00090285|579827376|FG001|Base Study Vaccination Period|Protocol Violation|3|||
160575206|NCT00090285|579827377|FG002|Base Study Vaccination Period|Protocol Violation|0|||
160575207|NCT00090285|579827378|FG003|Base Study Vaccination Period|Protocol Violation|0|||
160575208|NCT00090285|579827379|FG004|Base Study Vaccination Period|Protocol Violation|0|||
160921005|NCT01729754|581105215|FG000|Part 2|Withdrawal by Subject|3|||
160921006|NCT01729754|581105216|FG001|Part 2|Withdrawal by Subject|0|||
160575209|NCT00090285|579827380|FG005|Base Study Vaccination Period|Protocol Violation|0|||
160575210|NCT00090285|579827375|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
160575211|NCT00090285|579827376|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
160575212|NCT00090285|579827377|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
160654485|NCT02180711|580117036|FG002|Overall Study|- Other|0|||
160921007|NCT01729754|581105217|FG002|Part 2|Withdrawal by Subject|0|||
160921008|NCT01729754|581105218|FG003|Part 2|Withdrawal by Subject|2|||
160921009|NCT01729754|581105219|FG004|Part 2|Withdrawal by Subject|0|||
160921010|NCT01729754|581105220|FG005|Part 2|Withdrawal by Subject|0|||
160921011|NCT01729754|581105221|FG006|Part 2|Withdrawal by Subject|0|||
160921012|NCT01729754|581105222|FG007|Part 2|Withdrawal by Subject|1|||
160921013|NCT01729754|581105223|FG008|Part 2|Withdrawal by Subject|1|||
160921014|NCT01729754|581105224|FG009|Part 2|Withdrawal by Subject|4|||
160921015|NCT01729754|581105215|FG000|Part 2|Other Protocol Specified Criteria|1|||
160921016|NCT01729754|581105216|FG001|Part 2|Other Protocol Specified Criteria|0|||
160921017|NCT01729754|581105217|FG002|Part 2|Other Protocol Specified Criteria|0|||
160921018|NCT01729754|581105218|FG003|Part 2|Other Protocol Specified Criteria|0|||
160921019|NCT01729754|581105219|FG004|Part 2|Other Protocol Specified Criteria|0|||
160921020|NCT01729754|581105220|FG005|Part 2|Other Protocol Specified Criteria|0|||
160921021|NCT01729754|581105221|FG006|Part 2|Other Protocol Specified Criteria|0|||
160921022|NCT01729754|581105222|FG007|Part 2|Other Protocol Specified Criteria|1|||
160921023|NCT01729754|581105223|FG008|Part 2|Other Protocol Specified Criteria|0|||
160921024|NCT01729754|581105224|FG009|Part 2|Other Protocol Specified Criteria|0|||
160921025|NCT01729754|581105215|FG000|Part 3|Adverse Event|0|||
160921026|NCT01729754|581105216|FG001|Part 3|Adverse Event|0|||
160921027|NCT01729754|581105217|FG002|Part 3|Adverse Event|1|||
160921028|NCT01729754|581105218|FG003|Part 3|Adverse Event|0|||
160921029|NCT01729754|581105219|FG004|Part 3|Adverse Event|0|||
160921030|NCT01729754|581105220|FG005|Part 3|Adverse Event|5|||
160921031|NCT01729754|581105221|FG006|Part 3|Adverse Event|0|||
160997570|NCT00246012|581376568|FG005|Overall Study|Withdrawal by Subject|1|||
160997571|NCT00246012|581376569|FG006|Overall Study|Withdrawal by Subject|0|||
160997572|NCT00246012|581376570|FG007|Overall Study|Withdrawal by Subject|0|||
160997573|NCT00246012|581376571|FG008|Overall Study|Withdrawal by Subject|0|||
160997574|NCT00246012|581376563|FG000|Overall Study|Disease progression|3|||
160997575|NCT00246012|581376564|FG001|Overall Study|Disease progression|1|||
160997576|NCT00246012|581376565|FG002|Overall Study|Disease progression|2|||
160997577|NCT00246012|581376566|FG003|Overall Study|Disease progression|3|||
160997578|NCT00246012|581376567|FG004|Overall Study|Disease progression|3|||
160997579|NCT00246012|581376568|FG005|Overall Study|Disease progression|25|||
160997580|NCT00246012|581376569|FG006|Overall Study|Disease progression|30|||
160997581|NCT00246012|581376570|FG007|Overall Study|Disease progression|27|||
160997582|NCT00246012|581376571|FG008|Overall Study|Disease progression|26|||
160997583|NCT00246012|581376563|FG000|Overall Study|Other|0|||
160997584|NCT00246012|581376564|FG001|Overall Study|Other|0|||
160997585|NCT00246012|581376565|FG002|Overall Study|Other|0|||
160997586|NCT00246012|581376566|FG003|Overall Study|Other|0|||
160997587|NCT00246012|581376567|FG004|Overall Study|Other|0|||
160997588|NCT00246012|581376568|FG005|Overall Study|Other|0|||
160997589|NCT00246012|581376569|FG006|Overall Study|Other|0|||
160997590|NCT00246012|581376570|FG007|Overall Study|Other|1|||
160997591|NCT00246012|581376571|FG008|Overall Study|Other|0|||
160997592|NCT00246012|581376563|FG000|Overall Study|Randomly assigned but not treated|0|||
160997593|NCT00246012|581376564|FG001|Overall Study|Randomly assigned but not treated|0|||
160997594|NCT00246012|581376565|FG002|Overall Study|Randomly assigned but not treated|0|||
160997595|NCT00246012|581376566|FG003|Overall Study|Randomly assigned but not treated|0|||
160997596|NCT00246012|581376567|FG004|Overall Study|Randomly assigned but not treated|0|||
160997597|NCT00246012|581376568|FG005|Overall Study|Randomly assigned but not treated|1|||
160997598|NCT00246012|581376569|FG006|Overall Study|Randomly assigned but not treated|1|||
160997599|NCT00246012|581376570|FG007|Overall Study|Randomly assigned but not treated|0|||
160997600|NCT00246012|581376571|FG008|Overall Study|Randomly assigned but not treated|0|||
160997601|NCT02377362|581376572|FG000|Part A Second Treatment|Protocol Violation|0|||
160997602|NCT02377362|581376573|FG001|Part A Second Treatment|Protocol Violation|0|||
160997603|NCT02377362|581376574|FG002|Part A Second Treatment|Protocol Violation|0|||
160997604|NCT02377362|581376575|FG003|Part A Second Treatment|Protocol Violation|0|||
160997605|NCT02377362|581376576|FG004|Part A Second Treatment|Protocol Violation|1|||
160997606|NCT02377362|581376577|FG005|Part A Second Treatment|Protocol Violation|0|||
160997607|NCT02377362|581376578|FG006|Part A Second Treatment|Protocol Violation|0|||
160997608|NCT02377362|581376579|FG007|Part A Second Treatment|Protocol Violation|0|||
160997609|NCT02377362|581376580|FG008|Part A Second Treatment|Protocol Violation|0|||
160997610|NCT02377362|581376581|FG009|Part A Second Treatment|Protocol Violation|0|||
160997611|NCT02377362|581376582|FG010|Part A Second Treatment|Protocol Violation|0|||
160997612|NCT02377362|581376583|FG011|Part A Second Treatment|Protocol Violation|0|||
160997613|NCT02377362|581376584|FG012|Part A Second Treatment|Protocol Violation|0|||
160997614|NCT02377362|581376572|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997615|NCT02377362|581376573|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997616|NCT02377362|581376574|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997617|NCT02377362|581376575|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
160997618|NCT02377362|581376576|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
160997619|NCT02377362|581376577|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
160997620|NCT02377362|581376578|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
160575213|NCT00090285|579827378|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
160997621|NCT02377362|581376579|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
160575214|NCT00090285|579827379|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
160997622|NCT02377362|581376580|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997623|NCT02377362|581376581|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997624|NCT02377362|581376582|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
160921032|NCT01729754|581105222|FG007|Part 3|Adverse Event|0|||
160921033|NCT01729754|581105223|FG008|Part 3|Adverse Event|0|||
160997625|NCT02377362|581376583|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997626|NCT02377362|581376584|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997627|NCT02377362|581376572|FG000|Part B Overall|Protocol Violation|0|||
160997628|NCT02377362|581376573|FG001|Part B Overall|Protocol Violation|0|||
160921034|NCT01729754|581105224|FG009|Part 3|Adverse Event|3|||
160921035|NCT01729754|581105215|FG000|Part 3|Death|0|||
160921036|NCT01729754|581105216|FG001|Part 3|Death|0|||
160921037|NCT01729754|581105217|FG002|Part 3|Death|0|||
160921038|NCT01729754|581105218|FG003|Part 3|Death|0|||
160921039|NCT01729754|581105219|FG004|Part 3|Death|0|||
160921040|NCT01729754|581105220|FG005|Part 3|Death|2|||
160921041|NCT01729754|581105221|FG006|Part 3|Death|0|||
160921042|NCT01729754|581105222|FG007|Part 3|Death|0|||
160921043|NCT01729754|581105223|FG008|Part 3|Death|0|||
160921044|NCT01729754|581105224|FG009|Part 3|Death|0|||
160921045|NCT01729754|581105215|FG000|Part 3|Lack of Efficacy|0|||
160921046|NCT01729754|581105216|FG001|Part 3|Lack of Efficacy|0|||
160921047|NCT01729754|581105217|FG002|Part 3|Lack of Efficacy|0|||
160921048|NCT01729754|581105218|FG003|Part 3|Lack of Efficacy|0|||
160921049|NCT01729754|581105219|FG004|Part 3|Lack of Efficacy|2|||
160921050|NCT01729754|581105220|FG005|Part 3|Lack of Efficacy|0|||
160921051|NCT01729754|581105221|FG006|Part 3|Lack of Efficacy|0|||
160921052|NCT01729754|581105222|FG007|Part 3|Lack of Efficacy|0|||
160921053|NCT01729754|581105223|FG008|Part 3|Lack of Efficacy|0|||
160921054|NCT01729754|581105224|FG009|Part 3|Lack of Efficacy|4|||
160921055|NCT01729754|581105215|FG000|Part 3|Lost to Follow-up|0|||
160921056|NCT01729754|581105216|FG001|Part 3|Lost to Follow-up|1|||
160921057|NCT01729754|581105217|FG002|Part 3|Lost to Follow-up|2|||
160921058|NCT01729754|581105218|FG003|Part 3|Lost to Follow-up|0|||
160921059|NCT01729754|581105219|FG004|Part 3|Lost to Follow-up|0|||
160921060|NCT01729754|581105220|FG005|Part 3|Lost to Follow-up|3|||
160921061|NCT01729754|581105221|FG006|Part 3|Lost to Follow-up|0|||
160921062|NCT01729754|581105222|FG007|Part 3|Lost to Follow-up|0|||
160921063|NCT01729754|581105223|FG008|Part 3|Lost to Follow-up|1|||
160921064|NCT01729754|581105224|FG009|Part 3|Lost to Follow-up|0|||
160921065|NCT01729754|581105215|FG000|Part 3|Physician Decision|0|||
160921066|NCT01729754|581105216|FG001|Part 3|Physician Decision|0|||
160921067|NCT01729754|581105217|FG002|Part 3|Physician Decision|1|||
160921068|NCT01729754|581105218|FG003|Part 3|Physician Decision|0|||
160921069|NCT01729754|581105219|FG004|Part 3|Physician Decision|0|||
160921070|NCT01729754|581105220|FG005|Part 3|Physician Decision|0|||
160921071|NCT01729754|581105221|FG006|Part 3|Physician Decision|0|||
160921072|NCT01729754|581105222|FG007|Part 3|Physician Decision|0|||
160921073|NCT01729754|581105223|FG008|Part 3|Physician Decision|0|||
160921074|NCT01729754|581105224|FG009|Part 3|Physician Decision|0|||
160921075|NCT01729754|581105215|FG000|Part 3|Withdrawal by Subject|0|||
160921076|NCT01729754|581105216|FG001|Part 3|Withdrawal by Subject|4|||
160921077|NCT01729754|581105217|FG002|Part 3|Withdrawal by Subject|1|||
160921078|NCT01729754|581105218|FG003|Part 3|Withdrawal by Subject|0|||
160921079|NCT01729754|581105219|FG004|Part 3|Withdrawal by Subject|2|||
160921080|NCT01729754|581105220|FG005|Part 3|Withdrawal by Subject|1|||
160921081|NCT01729754|581105221|FG006|Part 3|Withdrawal by Subject|0|||
160921082|NCT01729754|581105222|FG007|Part 3|Withdrawal by Subject|2|||
160921083|NCT01729754|581105223|FG008|Part 3|Withdrawal by Subject|0|||
160921084|NCT01729754|581105224|FG009|Part 3|Withdrawal by Subject|0|||
160921085|NCT01729754|581105215|FG000|Part 3|Other Protocol Specified Criteria|0|||
160921086|NCT01729754|581105216|FG001|Part 3|Other Protocol Specified Criteria|0|||
160921087|NCT01729754|581105217|FG002|Part 3|Other Protocol Specified Criteria|0|||
160921088|NCT01729754|581105218|FG003|Part 3|Other Protocol Specified Criteria|0|||
160921089|NCT01729754|581105219|FG004|Part 3|Other Protocol Specified Criteria|0|||
160921090|NCT01729754|581105220|FG005|Part 3|Other Protocol Specified Criteria|2|||
160921091|NCT01729754|581105221|FG006|Part 3|Other Protocol Specified Criteria|0|||
160921092|NCT01729754|581105222|FG007|Part 3|Other Protocol Specified Criteria|1|||
160921093|NCT01729754|581105223|FG008|Part 3|Other Protocol Specified Criteria|0|||
160921094|NCT01729754|581105224|FG009|Part 3|Other Protocol Specified Criteria|0|||
160921095|NCT00936910|581105225|FG000|Overall Study|Lack of Efficacy|3|||
160921096|NCT01349803|581105227|FG000|Overall Study|Adverse Event|0|||
160921097|NCT01349803|581105228|FG001|Overall Study|Adverse Event|0|||
160921098|NCT01349803|581105229|FG002|Overall Study|Adverse Event|0|||
160921099|NCT01349803|581105230|FG003|Overall Study|Adverse Event|2|||
160921100|NCT01349803|581105227|FG000|Overall Study|Withdrawal by Subject|1|||
160921101|NCT01349803|581105228|FG001|Overall Study|Withdrawal by Subject|0|||
160921102|NCT01349803|581105229|FG002|Overall Study|Withdrawal by Subject|0|||
160921103|NCT01349803|581105230|FG003|Overall Study|Withdrawal by Subject|0|||
160921104|NCT01349803|581105227|FG000|Overall Study|Protocol-specified criteria|0|||
160921105|NCT01349803|581105228|FG001|Overall Study|Protocol-specified criteria|1|||
160921106|NCT01349803|581105229|FG002|Overall Study|Protocol-specified criteria|3|||
160921107|NCT01349803|581105230|FG003|Overall Study|Protocol-specified criteria|0|||
160921108|NCT02345811|581105231|FG000|First Intervention|Withdrawal by Subject|1|||
160921109|NCT02345811|581105232|FG001|First Intervention|Withdrawal by Subject|1|||
160921110|NCT02522286|581105233|FG000|Overall Study|Withdrawal by Subject|3|||
160921111|NCT02522286|581105234|FG001|Overall Study|Withdrawal by Subject|0|||
160921112|NCT02522286|581105235|FG002|Overall Study|Withdrawal by Subject|0|||
160921113|NCT02522286|581105236|FG003|Overall Study|Withdrawal by Subject|3|||
160921114|NCT00605813|581105238|FG000|Overall Study|Protocol Violation|25|||
160921115|NCT01163279|581105239|FG000|Overall Study|Withdrawal by Subject|2|||
160921116|NCT01163279|581105240|FG001|Overall Study|Withdrawal by Subject|0|||
160921117|NCT01870583|581105242|FG000|Overall Study|Protocol Violation|0|||
160921118|NCT01870583|581105243|FG001|Overall Study|Protocol Violation|5|||
160921119|NCT01870583|581105244|FG002|Overall Study|Protocol Violation|3|||
160921120|NCT01870583|581105242|FG000|Overall Study|Lost to Follow-up|11|||
160921121|NCT01870583|581105243|FG001|Overall Study|Lost to Follow-up|13|||
160921122|NCT01870583|581105244|FG002|Overall Study|Lost to Follow-up|5|||
160921123|NCT01394523|581105245|FG000|Overall Study|Unable to place block|1|||
160921124|NCT01394523|581105246|FG001|Overall Study|Unable to place block|0|||
160921125|NCT01394523|581105247|FG002|Overall Study|Unable to place block|0|||
160921126|NCT02389998|581105251|FG000|Overall Study|car accident|1|||
160921127|NCT02389998|581105252|FG001|Overall Study|car accident|0|||
160921128|NCT04741074|581105255|FG000|Overall Study|Withdrawal by Subject|1|||
160921129|NCT04741074|581105256|FG001|Overall Study|Withdrawal by Subject|1|||
160921130|NCT04741074|581105255|FG000|Overall Study|Study terminated prematurely|1|||
160921131|NCT04741074|581105256|FG001|Overall Study|Study terminated prematurely|0|||
160921132|NCT01770379|581105258|FG000|Overall Study|Technical issues|1|||
160921133|NCT01770379|581105259|FG001|Overall Study|Technical issues|0|||
160921134|NCT01770379|581105260|FG002|Overall Study|Technical issues|0|||
160921135|NCT01770379|581105258|FG000|Overall Study|Withdrawal by Subject|7|||
160921136|NCT01770379|581105259|FG001|Overall Study|Withdrawal by Subject|10|||
160921137|NCT01770379|581105260|FG002|Overall Study|Withdrawal by Subject|7|||
160921138|NCT01770379|581105258|FG000|Overall Study|study terminated by sponsor|22|||
160921139|NCT01770379|581105259|FG001|Overall Study|study terminated by sponsor|23|||
160921140|NCT01770379|581105260|FG002|Overall Study|study terminated by sponsor|22|||
160921141|NCT01770379|581105258|FG000|Overall Study|Protocol Violation|0|||
160921142|NCT01770379|581105259|FG001|Overall Study|Protocol Violation|1|||
160921143|NCT01770379|581105260|FG002|Overall Study|Protocol Violation|1|||
160921144|NCT01770379|581105258|FG000|Overall Study|Physician Decision|0|||
160921145|NCT01770379|581105259|FG001|Overall Study|Physician Decision|1|||
160921146|NCT01770379|581105260|FG002|Overall Study|Physician Decision|2|||
160921147|NCT01770379|581105258|FG000|Overall Study|Lost to Follow-up|0|||
160921148|NCT01770379|581105259|FG001|Overall Study|Lost to Follow-up|0|||
160921149|NCT01770379|581105260|FG002|Overall Study|Lost to Follow-up|2|||
160921150|NCT01770379|581105258|FG000|Overall Study|Lack of Efficacy|8|||
160921151|NCT01770379|581105259|FG001|Overall Study|Lack of Efficacy|6|||
160921152|NCT01770379|581105260|FG002|Overall Study|Lack of Efficacy|6|||
160921153|NCT01770379|581105258|FG000|Overall Study|Adverse Event|1|||
160921154|NCT01770379|581105259|FG001|Overall Study|Adverse Event|3|||
160921155|NCT01770379|581105260|FG002|Overall Study|Adverse Event|2|||
160921156|NCT02632552|581105261|FG000|Overall Study|Lost to Follow-up|14|||
160921157|NCT02632552|581105262|FG001|Overall Study|Lost to Follow-up|8|||
160921158|NCT02632552|581105261|FG000|Overall Study|Withdrawal by Subject|2|||
160921159|NCT02632552|581105262|FG001|Overall Study|Withdrawal by Subject|0|||
160921160|NCT02632552|581105261|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
160921161|NCT02632552|581105262|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
160921162|NCT00778700|581105269|FG000|Overall Study|Adverse Event|6|||
160921163|NCT00778700|581105270|FG001|Overall Study|Adverse Event|1|||
160921164|NCT00778700|581105271|FG002|Overall Study|Adverse Event|3|||
160921165|NCT00778700|581105272|FG003|Overall Study|Adverse Event|5|||
160921166|NCT00778700|581105269|FG000|Overall Study|Protocol Violation|1|||
160921167|NCT00778700|581105270|FG001|Overall Study|Protocol Violation|1|||
160921168|NCT00778700|581105271|FG002|Overall Study|Protocol Violation|0|||
160921169|NCT00778700|581105272|FG003|Overall Study|Protocol Violation|0|||
160921170|NCT00778700|581105269|FG000|Overall Study|Subject Withdrew Consent|6|||
160921171|NCT00778700|581105270|FG001|Overall Study|Subject Withdrew Consent|4|||
160921172|NCT00778700|581105271|FG002|Overall Study|Subject Withdrew Consent|1|||
160921173|NCT00778700|581105272|FG003|Overall Study|Subject Withdrew Consent|4|||
160921174|NCT00778700|581105269|FG000|Overall Study|Lost to Follow-up|3|||
160921175|NCT00778700|581105270|FG001|Overall Study|Lost to Follow-up|1|||
160921176|NCT00778700|581105271|FG002|Overall Study|Lost to Follow-up|0|||
160921177|NCT00778700|581105272|FG003|Overall Study|Lost to Follow-up|1|||
160921178|NCT00778700|581105269|FG000|Overall Study|Reason not Specified|2|||
160921179|NCT00778700|581105270|FG001|Overall Study|Reason not Specified|0|||
160921180|NCT00778700|581105271|FG002|Overall Study|Reason not Specified|1|||
160921181|NCT00778700|581105272|FG003|Overall Study|Reason not Specified|3|||
160921182|NCT00778700|581105269|FG000|Overall Study|Other|0|||
160921183|NCT00778700|581105270|FG001|Overall Study|Other|0|||
160921184|NCT00778700|581105271|FG002|Overall Study|Other|1|||
160921185|NCT00778700|581105272|FG003|Overall Study|Other|0|||
160921186|NCT03274440|581105275|FG000|Overall Study|Time commitment too great|1|||
160921187|NCT03274440|581105276|FG001|Overall Study|Time commitment too great|0|||
160921188|NCT03274440|581105277|FG002|Overall Study|Time commitment too great|0|||
160921189|NCT03274440|581105278|FG003|Overall Study|Time commitment too great|1|||
160921190|NCT03274440|581105279|FG004|Overall Study|Time commitment too great|0|||
160921191|NCT03274440|581105280|FG005|Overall Study|Time commitment too great|0|||
160921192|NCT00450450|581105281|FG000|Overall Study|Death|1|||
160921193|NCT00450450|581105282|FG001|Overall Study|Death|3|||
160921194|NCT00450450|581105281|FG000|Overall Study|Relapse|2|||
160921195|NCT00450450|581105282|FG001|Overall Study|Relapse|0|||
160921196|NCT00450450|581105281|FG000|Overall Study|Missing Data|2|||
160921197|NCT00450450|581105282|FG001|Overall Study|Missing Data|0|||
160921198|NCT02150954|581105285|FG000|Overall Study|Protocol Violation|1|||
160921199|NCT02150954|581105286|FG001|Overall Study|Protocol Violation|0|||
160921200|NCT02611778|581105292|FG000|Overall Study|Withdrawal by Subject|2|||
160921201|NCT02611778|581105293|FG001|Overall Study|Withdrawal by Subject|8|||
160921202|NCT02611778|581105292|FG000|Overall Study|Adverse Event|1|||
160921203|NCT02611778|581105293|FG001|Overall Study|Adverse Event|2|||
160921204|NCT02611778|581105292|FG000|Overall Study|Death|2|||
160921205|NCT02611778|581105293|FG001|Overall Study|Death|1|||
160921206|NCT02611778|581105292|FG000|Overall Study|Protocol Violation|1|||
160921207|NCT02611778|581105293|FG001|Overall Study|Protocol Violation|0|||
160921208|NCT02611778|581105292|FG000|Overall Study|Lost to Follow-up|3|||
160921209|NCT02611778|581105293|FG001|Overall Study|Lost to Follow-up|1|||
160921210|NCT02611778|581105292|FG000|Overall Study|Need for alternative treatment|1|||
160921211|NCT02611778|581105293|FG001|Overall Study|Need for alternative treatment|0|||
160921212|NCT02611778|581105292|FG000|Overall Study|Other Reason|2|||
160921213|NCT02611778|581105293|FG001|Overall Study|Other Reason|1|||
160921214|NCT02369341|581105294|FG000|Overall Study|Migrated/moved from study area|1|||
160921215|NCT02369341|581105295|FG001|Overall Study|Migrated/moved from study area|0|||
160921216|NCT04008030|581105297|FG000|Pre-Treatment|Withdrawal by Subject|0|||
160921217|NCT04008030|581105298|FG001|Pre-Treatment|Withdrawal by Subject|0|||
160921218|NCT04008030|581105299|FG002|Pre-Treatment|Withdrawal by Subject|9|||
160921219|NCT04008030|581105297|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
160921220|NCT04008030|581105298|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
160921221|NCT04008030|581105299|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
160921222|NCT04008030|581105297|FG000|Pre-Treatment|Other reasons|0|||
160921223|NCT04008030|581105298|FG001|Pre-Treatment|Other reasons|1|||
160921224|NCT04008030|581105299|FG002|Pre-Treatment|Other reasons|6|||
160921225|NCT04008030|581105297|FG000|Treatment|Withdrawal by Subject|1|||
160921226|NCT04008030|581105298|FG001|Treatment|Withdrawal by Subject|1|||
160921227|NCT04008030|581105299|FG002|Treatment|Withdrawal by Subject|1|||
160921228|NCT04008030|581105297|FG000|Treatment|Death|2|||
160921229|NCT04008030|581105298|FG001|Treatment|Death|4|||
160921230|NCT04008030|581105299|FG002|Treatment|Death|0|||
160921231|NCT04008030|581105297|FG000|Treatment|Pregnancy|0|||
160921232|NCT04008030|581105298|FG001|Treatment|Pregnancy|1|||
160921233|NCT04008030|581105299|FG002|Treatment|Pregnancy|0|||
160921234|NCT04008030|581105297|FG000|Treatment|Participant no longer meets study criteria|0|||
160921235|NCT04008030|581105298|FG001|Treatment|Participant no longer meets study criteria|1|||
160921236|NCT04008030|581105299|FG002|Treatment|Participant no longer meets study criteria|0|||
160921237|NCT04008030|581105297|FG000|Treatment|Other reasons|5|||
160921238|NCT04008030|581105298|FG001|Treatment|Other reasons|13|||
160921239|NCT04008030|581105299|FG002|Treatment|Other reasons|6|||
160921240|NCT04008030|581105297|FG000|Treatment|Disease Progression|137|||
160921241|NCT04008030|581105298|FG001|Treatment|Disease Progression|82|||
160921242|NCT04008030|581105299|FG002|Treatment|Disease Progression|85|||
160921243|NCT04008030|581105297|FG000|Treatment|Study drug toxicity|28|||
160921244|NCT04008030|581105298|FG001|Treatment|Study drug toxicity|48|||
160921245|NCT04008030|581105299|FG002|Treatment|Study drug toxicity|8|||
160921246|NCT04008030|581105297|FG000|Treatment|Adverse Event unrelated to study drug|28|||
160921247|NCT04008030|581105298|FG001|Treatment|Adverse Event unrelated to study drug|22|||
160921248|NCT04008030|581105299|FG002|Treatment|Adverse Event unrelated to study drug|6|||
160921249|NCT04008030|581105297|FG000|Treatment|Maximum Clinical Benefit|0|||
160997629|NCT02377362|581376574|FG002|Part B Overall|Protocol Violation|0|||
160997630|NCT02377362|581376575|FG003|Part B Overall|Protocol Violation|0|||
160997631|NCT02377362|581376576|FG004|Part B Overall|Protocol Violation|0|||
160997632|NCT02377362|581376577|FG005|Part B Overall|Protocol Violation|0|||
160921250|NCT04008030|581105298|FG001|Treatment|Maximum Clinical Benefit|1|||
160921251|NCT04008030|581105299|FG002|Treatment|Maximum Clinical Benefit|9|||
160921252|NCT04008030|581105297|FG000|Treatment|On-going treatment|13|||
160921253|NCT04008030|581105298|FG001|Treatment|On-going treatment|20|||
160921254|NCT04008030|581105299|FG002|Treatment|On-going treatment|0|||
160921255|NCT02574247|581105300|FG000|Overall Study|Withdrawal by Subject|1|||
160921256|NCT02574247|581105301|FG001|Overall Study|Withdrawal by Subject|0|||
160921257|NCT02574247|581105302|FG002|Overall Study|Withdrawal by Subject|0|||
160921258|NCT02574247|581105300|FG000|Overall Study|Did not meet inclusion criteria|4|||
160921259|NCT02574247|581105301|FG001|Overall Study|Did not meet inclusion criteria|3|||
160921260|NCT02574247|581105302|FG002|Overall Study|Did not meet inclusion criteria|5|||
160921261|NCT02659631|581105305|FG000|Overall Study|Lost to Follow-up|0|||
160997633|NCT02377362|581376578|FG006|Part B Overall|Protocol Violation|0|||
160575215|NCT00090285|579827380|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
160575216|NCT00090285|579827375|FG000|Base Study Vaccination Period|Uncooperative|2|||
160921262|NCT02659631|581105306|FG001|Overall Study|Lost to Follow-up|0|||
160921263|NCT02659631|581105307|FG002|Overall Study|Lost to Follow-up|2|||
160921264|NCT02659631|581105308|FG003|Overall Study|Lost to Follow-up|0|||
160921265|NCT02659631|581105309|FG004|Overall Study|Lost to Follow-up|0|||
160921266|NCT02659631|581105310|FG005|Overall Study|Lost to Follow-up|1|||
160997634|NCT02377362|581376579|FG007|Part B Overall|Protocol Violation|0|||
160997635|NCT02377362|581376580|FG008|Part B Overall|Protocol Violation|0|||
160997636|NCT02377362|581376581|FG009|Part B Overall|Protocol Violation|1|||
160997637|NCT02377362|581376582|FG010|Part B Overall|Protocol Violation|0|||
160997638|NCT02377362|581376583|FG011|Part B Overall|Protocol Violation|0|||
160997639|NCT02377362|581376584|FG012|Part B Overall|Protocol Violation|0|||
160997640|NCT02377362|581376572|FG000|Part B Overall|Adverse Event|0|||
160997641|NCT02377362|581376573|FG001|Part B Overall|Adverse Event|0|||
160997642|NCT02377362|581376574|FG002|Part B Overall|Adverse Event|0|||
160997643|NCT02377362|581376575|FG003|Part B Overall|Adverse Event|0|||
160997644|NCT02377362|581376576|FG004|Part B Overall|Adverse Event|0|||
160997645|NCT02377362|581376577|FG005|Part B Overall|Adverse Event|0|||
160997646|NCT02377362|581376578|FG006|Part B Overall|Adverse Event|1|||
160997647|NCT02377362|581376579|FG007|Part B Overall|Adverse Event|1|||
160997648|NCT02377362|581376580|FG008|Part B Overall|Adverse Event|0|||
160997649|NCT02377362|581376581|FG009|Part B Overall|Adverse Event|0|||
160997650|NCT02377362|581376582|FG010|Part B Overall|Adverse Event|0|||
160997651|NCT02377362|581376583|FG011|Part B Overall|Adverse Event|0|||
160997652|NCT02377362|581376584|FG012|Part B Overall|Adverse Event|0|||
160997653|NCT02377362|581376572|FG000|Part B Overall|Withdrawal by Subject|0|||
160997654|NCT02377362|581376573|FG001|Part B Overall|Withdrawal by Subject|0|||
160997655|NCT02377362|581376574|FG002|Part B Overall|Withdrawal by Subject|0|||
160921267|NCT02659631|581105311|FG006|Overall Study|Lost to Follow-up|0|||
160921268|NCT02659631|581105312|FG007|Overall Study|Lost to Follow-up|0|||
160575217|NCT00090285|579827376|FG001|Base Study Vaccination Period|Uncooperative|2|||
160921269|NCT02659631|581105313|FG008|Overall Study|Lost to Follow-up|0|||
160921270|NCT02659631|581105314|FG009|Overall Study|Lost to Follow-up|0|||
160921271|NCT02659631|581105305|FG000|Overall Study|Withdrawal prior to treatment|0|||
160921272|NCT02659631|581105306|FG001|Overall Study|Withdrawal prior to treatment|0|||
160921273|NCT02659631|581105307|FG002|Overall Study|Withdrawal prior to treatment|0|||
160921274|NCT02659631|581105308|FG003|Overall Study|Withdrawal prior to treatment|0|||
160921275|NCT02659631|581105309|FG004|Overall Study|Withdrawal prior to treatment|1|||
160921276|NCT02659631|581105310|FG005|Overall Study|Withdrawal prior to treatment|0|||
160921277|NCT02659631|581105311|FG006|Overall Study|Withdrawal prior to treatment|0|||
160921278|NCT02659631|581105312|FG007|Overall Study|Withdrawal prior to treatment|0|||
160921279|NCT02659631|581105313|FG008|Overall Study|Withdrawal prior to treatment|0|||
160921280|NCT02659631|581105314|FG009|Overall Study|Withdrawal prior to treatment|0|||
160921281|NCT02659631|581105305|FG000|Overall Study|Participant refused further follow-up|0|||
160921282|NCT02659631|581105306|FG001|Overall Study|Participant refused further follow-up|0|||
160921283|NCT02659631|581105307|FG002|Overall Study|Participant refused further follow-up|0|||
160921284|NCT02659631|581105308|FG003|Overall Study|Participant refused further follow-up|1|||
160921285|NCT02659631|581105309|FG004|Overall Study|Participant refused further follow-up|0|||
160921286|NCT02659631|581105310|FG005|Overall Study|Participant refused further follow-up|0|||
160921287|NCT02659631|581105311|FG006|Overall Study|Participant refused further follow-up|0|||
160921288|NCT02659631|581105312|FG007|Overall Study|Participant refused further follow-up|0|||
160921289|NCT02659631|581105313|FG008|Overall Study|Participant refused further follow-up|1|||
160921290|NCT02659631|581105314|FG009|Overall Study|Participant refused further follow-up|0|||
160921291|NCT02659631|581105305|FG000|Overall Study|Death (follow-up phase)|1|||
160921292|NCT02659631|581105306|FG001|Overall Study|Death (follow-up phase)|2|||
160921293|NCT02659631|581105307|FG002|Overall Study|Death (follow-up phase)|1|||
160921294|NCT02659631|581105308|FG003|Overall Study|Death (follow-up phase)|1|||
160921295|NCT02659631|581105309|FG004|Overall Study|Death (follow-up phase)|3|||
160921296|NCT02659631|581105310|FG005|Overall Study|Death (follow-up phase)|2|||
160921297|NCT02659631|581105311|FG006|Overall Study|Death (follow-up phase)|0|||
160997656|NCT02377362|581376575|FG003|Part B Overall|Withdrawal by Subject|0|||
160997657|NCT02377362|581376576|FG004|Part B Overall|Withdrawal by Subject|0|||
160997658|NCT02377362|581376577|FG005|Part B Overall|Withdrawal by Subject|0|||
160997659|NCT02377362|581376578|FG006|Part B Overall|Withdrawal by Subject|1|||
160997660|NCT02377362|581376579|FG007|Part B Overall|Withdrawal by Subject|0|||
160921298|NCT02659631|581105312|FG007|Overall Study|Death (follow-up phase)|3|||
160921299|NCT02659631|581105313|FG008|Overall Study|Death (follow-up phase)|1|||
160921300|NCT02659631|581105314|FG009|Overall Study|Death (follow-up phase)|0|||
160921301|NCT02659631|581105305|FG000|Overall Study|Death (treatment phase)|0|||
160921302|NCT02659631|581105306|FG001|Overall Study|Death (treatment phase)|0|||
160575218|NCT00090285|579827377|FG002|Base Study Vaccination Period|Uncooperative|0|||
160575219|NCT00090285|579827378|FG003|Base Study Vaccination Period|Uncooperative|0|||
160921303|NCT02659631|581105307|FG002|Overall Study|Death (treatment phase)|0|||
160997661|NCT02377362|581376580|FG008|Part B Overall|Withdrawal by Subject|0|||
160997662|NCT02377362|581376581|FG009|Part B Overall|Withdrawal by Subject|0|||
160997663|NCT02377362|581376582|FG010|Part B Overall|Withdrawal by Subject|0|||
160575220|NCT00090285|579827379|FG004|Base Study Vaccination Period|Uncooperative|0|||
160575221|NCT00090285|579827380|FG005|Base Study Vaccination Period|Uncooperative|0|||
160997664|NCT02377362|581376583|FG011|Part B Overall|Withdrawal by Subject|1|||
160575222|NCT00090285|579827375|FG000|Base Study Vaccination Period|Moved|20|||
160997665|NCT02377362|581376584|FG012|Part B Overall|Withdrawal by Subject|0|||
160997666|NCT01651949|581376587|FG000|Overall Study|Unknown status|4|||
160575223|NCT00090285|579827376|FG001|Base Study Vaccination Period|Moved|21|||
160575224|NCT00090285|579827377|FG002|Base Study Vaccination Period|Moved|0|||
160575225|NCT00090285|579827378|FG003|Base Study Vaccination Period|Moved|0|||
160575226|NCT00090285|579827379|FG004|Base Study Vaccination Period|Moved|0|||
160575227|NCT00090285|579827380|FG005|Base Study Vaccination Period|Moved|0|||
160921304|NCT02659631|581105308|FG003|Overall Study|Death (treatment phase)|0|||
160921305|NCT02659631|581105309|FG004|Overall Study|Death (treatment phase)|1|||
160921306|NCT02659631|581105310|FG005|Overall Study|Death (treatment phase)|0|||
160921307|NCT02659631|581105311|FG006|Overall Study|Death (treatment phase)|1|||
160921308|NCT02659631|581105312|FG007|Overall Study|Death (treatment phase)|0|||
160921309|NCT02659631|581105313|FG008|Overall Study|Death (treatment phase)|0|||
160921310|NCT02659631|581105314|FG009|Overall Study|Death (treatment phase)|0|||
160921311|NCT01496313|581105315|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
160921312|NCT01496313|581105316|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
160921313|NCT01496313|581105317|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
160921314|NCT01496313|581105318|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
160921315|NCT01496313|581105319|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
160921316|NCT01496313|581105320|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
160921317|NCT01496313|581105315|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
160921318|NCT01496313|581105316|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
160921319|NCT01496313|581105317|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
160921320|NCT01496313|581105318|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
160921321|NCT01496313|581105319|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
160921322|NCT01496313|581105320|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
160921323|NCT01496313|581105315|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
160921324|NCT01496313|581105316|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
160921325|NCT01496313|581105317|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
160921326|NCT01496313|581105318|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
160921327|NCT01496313|581105319|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
160921328|NCT01496313|581105320|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
160921329|NCT01496313|581105315|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
160921330|NCT01496313|581105316|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
160921331|NCT01496313|581105317|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
160921332|NCT01496313|581105318|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
160921333|NCT01496313|581105319|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
160921334|NCT01496313|581105320|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
160921335|NCT01496313|581105315|FG000|Randomized Period (up to 14 Months)|Other|1|||
160921336|NCT01496313|581105316|FG001|Randomized Period (up to 14 Months)|Other|2|||
160921337|NCT01496313|581105317|FG002|Randomized Period (up to 14 Months)|Other|0|||
160921338|NCT01496313|581105318|FG003|Randomized Period (up to 14 Months)|Other|0|||
160921339|NCT01496313|581105319|FG004|Randomized Period (up to 14 Months)|Other|0|||
160921340|NCT01496313|581105320|FG005|Randomized Period (up to 14 Months)|Other|0|||
160921341|NCT01496313|581105315|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
160921342|NCT01496313|581105316|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
160921343|NCT01496313|581105317|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
160921344|NCT01496313|581105318|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
160921345|NCT01496313|581105319|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
160921346|NCT01496313|581105320|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
160921347|NCT01496313|581105315|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
160921348|NCT01496313|581105316|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
160921349|NCT01496313|581105317|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
160921350|NCT01496313|581105318|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
160921351|NCT01496313|581105319|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
160921352|NCT01496313|581105320|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
160921353|NCT01496313|581105315|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
160921354|NCT01496313|581105316|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
160921355|NCT01496313|581105317|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
160921356|NCT01496313|581105318|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
160921357|NCT01496313|581105319|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
160921358|NCT01496313|581105320|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
160575228|NCT00090285|579827375|FG000|Base Study Vaccination Period|Site Terminated|1|||
160575229|NCT00090285|579827376|FG001|Base Study Vaccination Period|Site Terminated|0|||
160575230|NCT00090285|579827377|FG002|Base Study Vaccination Period|Site Terminated|0|||
160575231|NCT00090285|579827378|FG003|Base Study Vaccination Period|Site Terminated|0|||
160654486|NCT02180711|580117037|FG003|Overall Study|- Other|1|||
160921359|NCT00171223|581105325|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
160921360|NCT00171223|581105326|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
160921361|NCT00171223|581105327|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
160921362|NCT00171223|581105325|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
160921363|NCT00171223|581105326|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
160921364|NCT00171223|581105327|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
160921365|NCT00171223|581105325|FG000|Overall Study|Abnormal Procedure|1|||
160921366|NCT00171223|581105326|FG001|Overall Study|Abnormal Procedure|0|||
160921367|NCT00171223|581105327|FG002|Overall Study|Abnormal Procedure|0|||
160921368|NCT00171223|581105325|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
160921369|NCT00171223|581105326|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
160921370|NCT00171223|581105327|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
160921371|NCT00171223|581105325|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
160921372|NCT00171223|581105326|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
160921373|NCT00171223|581105327|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
160921374|NCT00171223|581105325|FG000|Overall Study|Protocol Violation|2|||
160921375|NCT00171223|581105326|FG001|Overall Study|Protocol Violation|2|||
160921376|NCT00171223|581105327|FG002|Overall Study|Protocol Violation|3|||
160921377|NCT00171223|581105325|FG000|Overall Study|Participant Withdrew Consent|12|||
160921378|NCT00171223|581105326|FG001|Overall Study|Participant Withdrew Consent|21|||
160921379|NCT00171223|581105327|FG002|Overall Study|Participant Withdrew Consent|15|||
160921380|NCT00171223|581105325|FG000|Overall Study|Lost to Follow-up|5|||
160921381|NCT00171223|581105326|FG001|Overall Study|Lost to Follow-up|2|||
160921382|NCT00171223|581105327|FG002|Overall Study|Lost to Follow-up|3|||
160921383|NCT00171223|581105325|FG000|Overall Study|Administrative Problems|4|||
160921384|NCT00171223|581105326|FG001|Overall Study|Administrative Problems|7|||
160921385|NCT00171223|581105327|FG002|Overall Study|Administrative Problems|6|||
160921386|NCT00171223|581105325|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
160921387|NCT00171223|581105326|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
160921388|NCT00171223|581105327|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
160921389|NCT00171223|581105325|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
160921390|NCT00171223|581105326|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
160921391|NCT00171223|581105327|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
160921392|NCT00451321|581105328|FG000|Overall Study|Lost to Follow-up|3|||
160921393|NCT00451321|581105329|FG001|Overall Study|Lost to Follow-up|3|||
160921394|NCT00451321|581105330|FG002|Overall Study|Lost to Follow-up|1|||
160921395|NCT00451321|581105331|FG003|Overall Study|Lost to Follow-up|3|||
160921396|NCT00451321|581105332|FG004|Overall Study|Lost to Follow-up|0|||
160921397|NCT00451321|581105333|FG005|Overall Study|Lost to Follow-up|1|||
160921398|NCT00451321|581105334|FG006|Overall Study|Lost to Follow-up|0|||
160921399|NCT00451321|581105335|FG007|Overall Study|Lost to Follow-up|0|||
160921400|NCT00451321|581105328|FG000|Overall Study|Withdrawal by Subject|3|||
160921401|NCT00451321|581105329|FG001|Overall Study|Withdrawal by Subject|1|||
160921402|NCT00451321|581105330|FG002|Overall Study|Withdrawal by Subject|0|||
160921403|NCT00451321|581105331|FG003|Overall Study|Withdrawal by Subject|4|||
160921404|NCT00451321|581105332|FG004|Overall Study|Withdrawal by Subject|0|||
160921405|NCT00451321|581105333|FG005|Overall Study|Withdrawal by Subject|0|||
160921406|NCT00451321|581105334|FG006|Overall Study|Withdrawal by Subject|0|||
160921407|NCT00451321|581105335|FG007|Overall Study|Withdrawal by Subject|0|||
160921408|NCT00451321|581105328|FG000|Overall Study|Study closed/terminated|1|||
160921409|NCT00451321|581105329|FG001|Overall Study|Study closed/terminated|1|||
160921410|NCT00451321|581105330|FG002|Overall Study|Study closed/terminated|17|||
160921411|NCT00451321|581105331|FG003|Overall Study|Study closed/terminated|5|||
160921412|NCT00451321|581105332|FG004|Overall Study|Study closed/terminated|7|||
160921413|NCT00451321|581105333|FG005|Overall Study|Study closed/terminated|7|||
160921414|NCT00451321|581105334|FG006|Overall Study|Study closed/terminated|5|||
160921415|NCT00451321|581105335|FG007|Overall Study|Study closed/terminated|3|||
160921416|NCT00451321|581105328|FG000|Overall Study|Sponsor decision to amend protocol|0|||
160921417|NCT00451321|581105329|FG001|Overall Study|Sponsor decision to amend protocol|0|||
160921418|NCT00451321|581105330|FG002|Overall Study|Sponsor decision to amend protocol|0|||
160997667|NCT01651949|581376588|FG001|Overall Study|Unknown status|4|||
160997668|NCT01651949|581376589|FG002|Overall Study|Unknown status|0|||
160997669|NCT01651949|581376587|FG000|Overall Study|Lost to Follow-up|30|||
160454769|NCT01928394|579396183|FG013|Treatment Period|Maximum clinical benefit|0|||
160454770|NCT01928394|579396184|FG014|Treatment Period|Maximum clinical benefit|1|||
160654487|NCT02180711|580117038|FG004|Overall Study|- Other|0|||
160921419|NCT00451321|581105331|FG003|Overall Study|Sponsor decision to amend protocol|0|||
160921420|NCT00451321|581105332|FG004|Overall Study|Sponsor decision to amend protocol|0|||
160921421|NCT00451321|581105333|FG005|Overall Study|Sponsor decision to amend protocol|1|||
160921422|NCT00451321|581105334|FG006|Overall Study|Sponsor decision to amend protocol|1|||
160921423|NCT00451321|581105335|FG007|Overall Study|Sponsor decision to amend protocol|3|||
160654488|NCT02180711|580117039|FG005|Overall Study|- Other|0|||
160921424|NCT02064166|581105336|FG000|Overall Study|Adverse Event|1|||
160921425|NCT02064166|581105337|FG001|Overall Study|Adverse Event|0|||
160997670|NCT01651949|581376588|FG001|Overall Study|Lost to Follow-up|56|||
160997671|NCT01651949|581376589|FG002|Overall Study|Lost to Follow-up|20|||
160997672|NCT01651949|581376587|FG000|Overall Study|Protocol Violation|0|||
160997673|NCT01651949|581376588|FG001|Overall Study|Protocol Violation|2|||
160997674|NCT01651949|581376589|FG002|Overall Study|Protocol Violation|1|||
160997675|NCT01651949|581376587|FG000|Overall Study|Physician Decision|0|||
160997676|NCT01651949|581376588|FG001|Overall Study|Physician Decision|2|||
160997677|NCT01651949|581376589|FG002|Overall Study|Physician Decision|0|||
160997678|NCT01651949|581376587|FG000|Overall Study|Adverse Event|0|||
160997679|NCT01651949|581376588|FG001|Overall Study|Adverse Event|2|||
160997680|NCT01651949|581376589|FG002|Overall Study|Adverse Event|1|||
160997681|NCT01651949|581376587|FG000|Overall Study|Screen failure|2|||
160997682|NCT01651949|581376588|FG001|Overall Study|Screen failure|2|||
160997683|NCT01651949|581376589|FG002|Overall Study|Screen failure|0|||
160997684|NCT01651949|581376587|FG000|Overall Study|Withdrawal by Subject|17|||
160997685|NCT01651949|581376588|FG001|Overall Study|Withdrawal by Subject|18|||
160997686|NCT01651949|581376589|FG002|Overall Study|Withdrawal by Subject|9|||
160997687|NCT01806714|581376590|FG000|Overall Study|No functioning phone number|200|||
160997688|NCT01806714|581376591|FG001|Overall Study|No functioning phone number|170|||
160997689|NCT02155829|581376592|FG000|Overall Study|Adverse Event|1|||
160997690|NCT02155829|581376593|FG001|Overall Study|Adverse Event|0|||
160997691|NCT02155829|581376592|FG000|Overall Study|Withdrawal by Subject|3|||
160997692|NCT02155829|581376593|FG001|Overall Study|Withdrawal by Subject|3|||
160997693|NCT02155829|581376592|FG000|Overall Study|Protocol Violation|2|||
160997694|NCT02155829|581376593|FG001|Overall Study|Protocol Violation|0|||
160997695|NCT01585038|581376594|FG000|Overall Study|Adverse Event|2|||
160997696|NCT01585038|581376595|FG001|Overall Study|Adverse Event|2|||
160997697|NCT00678795|581376596|FG000|Overall Study|Adverse Event|7|||
160997698|NCT00678795|581376597|FG001|Overall Study|Adverse Event|3|||
160997699|NCT00678795|581376596|FG000|Overall Study|Withdrawal by Subject|3|||
160997700|NCT00678795|581376597|FG001|Overall Study|Withdrawal by Subject|0|||
160997701|NCT00678795|581376596|FG000|Overall Study|Protocol Violation|0|||
160997702|NCT00678795|581376597|FG001|Overall Study|Protocol Violation|1|||
160997703|NCT00678795|581376596|FG000|Overall Study|Lost to Follow-up|0|||
160997704|NCT00678795|581376597|FG001|Overall Study|Lost to Follow-up|1|||
160921426|NCT00909389|581105343|FG000|Overall Study|Adverse Event|6|||
160921427|NCT00909389|581105343|FG000|Overall Study|Death|4|||
160921428|NCT00909389|581105343|FG000|Overall Study|Poor Compliance|16|||
160921429|NCT00909389|581105343|FG000|Overall Study|Lost to Follow-up|4|||
160921430|NCT00909389|581105343|FG000|Overall Study|No Information|103|||
160921431|NCT01166763|581105346|FG000|Overall Study|Withdrawal by Subject|3|||
160921432|NCT01528254|581105347|FG000|Overall Study|Administrative problems|96|||
160921433|NCT01528254|581105348|FG001|Overall Study|Administrative problems|94|||
160921434|NCT01528254|581105347|FG000|Overall Study|Adverse Event|28|||
160921435|NCT01528254|581105348|FG001|Overall Study|Adverse Event|44|||
160921436|NCT01528254|581105347|FG000|Overall Study|Lost to Follow-up|17|||
160921437|NCT01528254|581105348|FG001|Overall Study|Lost to Follow-up|24|||
160921438|NCT01528254|581105347|FG000|Overall Study|Death|13|||
160921439|NCT01528254|581105348|FG001|Overall Study|Death|9|||
160921440|NCT01528254|581105347|FG000|Overall Study|Protocol deviation|9|||
160921441|NCT01528254|581105348|FG001|Overall Study|Protocol deviation|19|||
160921442|NCT01528254|581105347|FG000|Overall Study|New therapy for study indication|8|||
160921443|NCT01528254|581105348|FG001|Overall Study|New therapy for study indication|6|||
160921444|NCT01528254|581105347|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
160921445|NCT01528254|581105348|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
160921446|NCT01528254|581105347|FG000|Overall Study|Withdrawal by Subject|5|||
160921447|NCT01528254|581105348|FG001|Overall Study|Withdrawal by Subject|4|||
160921448|NCT01528254|581105347|FG000|Overall Study|Abnormal laboratory value(s)|3|||
160921449|NCT01528254|581105348|FG001|Overall Study|Abnormal laboratory value(s)|7|||
160921450|NCT01528254|581105347|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160921451|NCT01528254|581105348|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160997705|NCT00678795|581376596|FG000|Overall Study|Lack of Efficacy|1|||
160997706|NCT00678795|581376597|FG001|Overall Study|Lack of Efficacy|1|||
160997707|NCT04107805|581376598|FG000|Overall Study|Adverse Event|0|||
160997708|NCT04107805|581376599|FG001|Overall Study|Adverse Event|0|||
160454771|NCT01928394|579396185|FG015|Treatment Period|Maximum clinical benefit|0|||
160997709|NCT04107805|581376600|FG002|Overall Study|Adverse Event|0|||
160997710|NCT04107805|581376601|FG003|Overall Study|Adverse Event|1|||
160997711|NCT04107805|581376602|FG004|Overall Study|Adverse Event|0|||
160921452|NCT01528254|581105347|FG000|Overall Study|No longer requires study drug|1|||
160921453|NCT01528254|581105348|FG001|Overall Study|No longer requires study drug|1|||
160921454|NCT04447755|581105349|FG000|Overall Study|Death|9|||
160921455|NCT04447755|581105350|FG001|Overall Study|Death|16|||
160997712|NCT04107805|581376603|FG005|Overall Study|Adverse Event|1|||
160454772|NCT01928394|579396186|FG016|Treatment Period|Maximum clinical benefit|0|||
160921456|NCT04447755|581105351|FG002|Overall Study|Death|8|||
160921457|NCT04447755|581105352|FG003|Overall Study|Death|9|||
160921458|NCT04447755|581105353|FG004|Overall Study|Death|8|||
160997713|NCT04107805|581376604|FG006|Overall Study|Adverse Event|0|||
160575232|NCT00090285|579827379|FG004|Base Study Vaccination Period|Site Terminated|0|||
160575233|NCT00090285|579827380|FG005|Base Study Vaccination Period|Site Terminated|0|||
160575234|NCT00090285|579827375|FG000|Base Study Vaccination Period|Other|2|||
160575235|NCT00090285|579827376|FG001|Base Study Vaccination Period|Other|2|||
160575236|NCT00090285|579827377|FG002|Base Study Vaccination Period|Other|0|||
160575237|NCT00090285|579827378|FG003|Base Study Vaccination Period|Other|0|||
160575238|NCT00090285|579827379|FG004|Base Study Vaccination Period|Other|0|||
160575239|NCT00090285|579827380|FG005|Base Study Vaccination Period|Other|0|||
160575240|NCT00090285|579827375|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
160575241|NCT00090285|579827376|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
160575242|NCT00090285|579827377|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
160575243|NCT00090285|579827378|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
160575244|NCT00090285|579827379|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
160575245|NCT00090285|579827380|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
160575246|NCT00090285|579827375|FG000|Base Study Vaccination Period|HIV positive|1|||
160575247|NCT00090285|579827376|FG001|Base Study Vaccination Period|HIV positive|1|||
160575248|NCT00090285|579827377|FG002|Base Study Vaccination Period|HIV positive|0|||
160575249|NCT00090285|579827378|FG003|Base Study Vaccination Period|HIV positive|0|||
160575250|NCT00090285|579827379|FG004|Base Study Vaccination Period|HIV positive|0|||
160575251|NCT00090285|579827380|FG005|Base Study Vaccination Period|HIV positive|0|||
160575252|NCT00090285|579827375|FG000|Base Study Follow-up Period|Adverse Event|3|||
160575253|NCT00090285|579827376|FG001|Base Study Follow-up Period|Adverse Event|10|||
160575254|NCT00090285|579827377|FG002|Base Study Follow-up Period|Adverse Event|0|||
160921459|NCT04447755|581105354|FG005|Overall Study|Death|9|||
160575255|NCT00090285|579827378|FG003|Base Study Follow-up Period|Adverse Event|0|||
160575256|NCT00090285|579827379|FG004|Base Study Follow-up Period|Adverse Event|0|||
160575257|NCT00090285|579827380|FG005|Base Study Follow-up Period|Adverse Event|0|||
160575258|NCT00090285|579827375|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
160575259|NCT00090285|579827376|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
160575260|NCT00090285|579827377|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
160575261|NCT00090285|579827378|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
160575262|NCT00090285|579827379|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
160575263|NCT00090285|579827380|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
160575264|NCT00090285|579827375|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
160575265|NCT00090285|579827376|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
160575266|NCT00090285|579827377|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
160575267|NCT00090285|579827378|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
160575268|NCT00090285|579827379|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
160575269|NCT00090285|579827380|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
160921460|NCT04447755|581105355|FG006|Overall Study|Death|55|||
160921461|NCT04447755|581105349|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160921462|NCT04447755|581105350|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160921463|NCT04447755|581105351|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160921464|NCT04447755|581105352|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160921465|NCT04447755|581105353|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
160921466|NCT04447755|581105354|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
160921467|NCT04447755|581105355|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
160921468|NCT04447755|581105349|FG000|Overall Study|Sponsor Decision|0|||
160921469|NCT04447755|581105350|FG001|Overall Study|Sponsor Decision|0|||
160575270|NCT00090285|579827375|FG000|Base Study Follow-up Period|Moved|41|||
160575271|NCT00090285|579827376|FG001|Base Study Follow-up Period|Moved|36|||
160575272|NCT00090285|579827377|FG002|Base Study Follow-up Period|Moved|0|||
160575273|NCT00090285|579827378|FG003|Base Study Follow-up Period|Moved|0|||
160575274|NCT00090285|579827379|FG004|Base Study Follow-up Period|Moved|0|||
160575275|NCT00090285|579827380|FG005|Base Study Follow-up Period|Moved|0|||
160575276|NCT00090285|579827375|FG000|Base Study Follow-up Period|Other|2|||
160575277|NCT00090285|579827376|FG001|Base Study Follow-up Period|Other|0|||
160575278|NCT00090285|579827377|FG002|Base Study Follow-up Period|Other|0|||
160575279|NCT00090285|579827378|FG003|Base Study Follow-up Period|Other|0|||
160575280|NCT00090285|579827379|FG004|Base Study Follow-up Period|Other|0|||
160575281|NCT00090285|579827380|FG005|Base Study Follow-up Period|Other|0|||
160575282|NCT00090285|579827375|FG000|Base Study Follow-up Period|Protocol Violation|1|||
160575283|NCT00090285|579827376|FG001|Base Study Follow-up Period|Protocol Violation|0|||
160575284|NCT00090285|579827377|FG002|Base Study Follow-up Period|Protocol Violation|0|||
160575285|NCT00090285|579827378|FG003|Base Study Follow-up Period|Protocol Violation|0|||
160575286|NCT00090285|579827379|FG004|Base Study Follow-up Period|Protocol Violation|0|||
160575287|NCT00090285|579827380|FG005|Base Study Follow-up Period|Protocol Violation|0|||
160575288|NCT00090285|579827375|FG000|Base Study Follow-up Period|Uncooperative|3|||
160575289|NCT00090285|579827376|FG001|Base Study Follow-up Period|Uncooperative|4|||
160654489|NCT02180711|580117040|FG006|Overall Study|- Other|0|||
160654490|NCT02180711|580117041|FG007|Overall Study|- Other|0|||
160921470|NCT04447755|581105351|FG002|Overall Study|Sponsor Decision|0|||
160921471|NCT04447755|581105352|FG003|Overall Study|Sponsor Decision|0|||
160921472|NCT04447755|581105353|FG004|Overall Study|Sponsor Decision|1|||
160997714|NCT04107805|581376605|FG007|Overall Study|Adverse Event|0|||
160575290|NCT00090285|579827377|FG002|Base Study Follow-up Period|Uncooperative|0|||
160575291|NCT00090285|579827378|FG003|Base Study Follow-up Period|Uncooperative|0|||
160575292|NCT00090285|579827379|FG004|Base Study Follow-up Period|Uncooperative|0|||
160575293|NCT00090285|579827380|FG005|Base Study Follow-up Period|Uncooperative|0|||
160575294|NCT00090285|579827375|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
160575295|NCT00090285|579827376|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
160575296|NCT00090285|579827377|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
160575297|NCT00090285|579827378|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
160575298|NCT00090285|579827379|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
160575299|NCT00090285|579827380|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
160575300|NCT00090285|579827375|FG000|Extension 1|Adverse Event|0|||
160575301|NCT00090285|579827376|FG001|Extension 1|Adverse Event|0|||
160575302|NCT00090285|579827377|FG002|Extension 1|Adverse Event|2|||
160575303|NCT00090285|579827378|FG003|Extension 1|Adverse Event|0|||
160575304|NCT00090285|579827379|FG004|Extension 1|Adverse Event|0|||
160575305|NCT00090285|579827380|FG005|Extension 1|Adverse Event|0|||
160575306|NCT00090285|579827375|FG000|Extension 1|Lost to Follow-up|0|||
160575307|NCT00090285|579827376|FG001|Extension 1|Lost to Follow-up|0|||
160575308|NCT00090285|579827377|FG002|Extension 1|Lost to Follow-up|35|||
160575309|NCT00090285|579827378|FG003|Extension 1|Lost to Follow-up|0|||
160575310|NCT00090285|579827379|FG004|Extension 1|Lost to Follow-up|0|||
160575311|NCT00090285|579827380|FG005|Extension 1|Lost to Follow-up|0|||
160575312|NCT00090285|579827375|FG000|Extension 1|Withdrawal by Subject|0|||
160575313|NCT00090285|579827376|FG001|Extension 1|Withdrawal by Subject|0|||
160575314|NCT00090285|579827377|FG002|Extension 1|Withdrawal by Subject|13|||
160575315|NCT00090285|579827378|FG003|Extension 1|Withdrawal by Subject|1|||
160575316|NCT00090285|579827379|FG004|Extension 1|Withdrawal by Subject|0|||
160575317|NCT00090285|579827380|FG005|Extension 1|Withdrawal by Subject|0|||
160575318|NCT00090285|579827375|FG000|Extension 1|Other|0|||
160575319|NCT00090285|579827376|FG001|Extension 1|Other|0|||
160575320|NCT00090285|579827377|FG002|Extension 1|Other|4|||
160575321|NCT00090285|579827378|FG003|Extension 1|Other|0|||
160575322|NCT00090285|579827379|FG004|Extension 1|Other|0|||
160575323|NCT00090285|579827380|FG005|Extension 1|Other|0|||
160575324|NCT00090285|579827375|FG000|Extension 1|Moved|0|||
160575325|NCT00090285|579827376|FG001|Extension 1|Moved|0|||
160575326|NCT00090285|579827377|FG002|Extension 1|Moved|3|||
160575327|NCT00090285|579827378|FG003|Extension 1|Moved|0|||
160575328|NCT00090285|579827379|FG004|Extension 1|Moved|0|||
160575329|NCT00090285|579827380|FG005|Extension 1|Moved|0|||
160575330|NCT00090285|579827375|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
160575331|NCT00090285|579827376|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
160575332|NCT00090285|579827377|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
160575333|NCT00090285|579827378|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
160575334|NCT00090285|579827379|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
160575335|NCT00090285|579827380|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
160575336|NCT00090285|579827375|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
160575337|NCT00090285|579827376|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
160575338|NCT00090285|579827377|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
160575339|NCT00090285|579827378|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
160575340|NCT00090285|579827379|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
160575341|NCT00090285|579827380|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
160575342|NCT00090285|579827375|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
160575343|NCT00090285|579827376|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
160575344|NCT00090285|579827377|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
160575345|NCT00090285|579827378|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
160575346|NCT00090285|579827379|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
160575347|NCT00090285|579827380|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
160575348|NCT00090285|579827375|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
160654491|NCT00444145|580117045|FG000|Overall Study|Withdrawal by Subject|2|||
160997715|NCT04107805|581376606|FG008|Overall Study|Adverse Event|1|||
160575349|NCT00090285|579827376|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
160575350|NCT00090285|579827377|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
160575351|NCT00090285|579827378|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
160575352|NCT00090285|579827379|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
160575353|NCT00090285|579827380|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
160575354|NCT00907881|579827383|FG000|Overall Study|Lost to Follow-up|59|||
160575355|NCT00907881|579827383|FG000|Overall Study|Noncompliance|5|||
160575356|NCT00907881|579827383|FG000|Overall Study|Withdrawal by Subject|5|||
160575357|NCT00907881|579827383|FG000|Overall Study|Protocol Violation|1|||
160575358|NCT00907881|579827383|FG000|Overall Study|Missing discontinuation information|15|||
160575359|NCT00589472|579827390|FG000|Overall Study|Adverse Event|1|||
160575360|NCT00117338|579827391|FG000|Overall Study|Adverse Event|0|||
160575361|NCT00117338|579827392|FG001|Overall Study|Adverse Event|1|||
160575362|NCT00117338|579827391|FG000|Overall Study|Protocol Violation|3|||
160575363|NCT00117338|579827392|FG001|Overall Study|Protocol Violation|2|||
160575364|NCT00117338|579827391|FG000|Overall Study|Withdrawal by Subject|1|||
160997716|NCT01191086|581376610|FG000|Overall Study|Adverse Event|20|||
160654492|NCT00444145|580117045|FG000|Overall Study|Lost to Follow-up|1|||
160654493|NCT00444145|580117045|FG000|Overall Study|non-compliant|11|||
160654494|NCT00444145|580117045|FG000|Overall Study|Screen Failures|5|||
160654495|NCT01619800|580117046|FG000|Overall Study|study terminated|2|||
160654496|NCT01619800|580117047|FG001|Overall Study|study terminated|0|||
160654497|NCT00414466|580117049|FG000|Overall Study|Adverse Event|0|||
160654498|NCT00414466|580117050|FG001|Overall Study|Adverse Event|0|||
160654499|NCT00414466|580117051|FG002|Overall Study|Adverse Event|1|||
160654500|NCT00414466|580117052|FG003|Overall Study|Adverse Event|1|||
160654501|NCT00414466|580117049|FG000|Overall Study|Lack of Efficacy|1|||
160654502|NCT00414466|580117050|FG001|Overall Study|Lack of Efficacy|0|||
160654503|NCT00414466|580117051|FG002|Overall Study|Lack of Efficacy|0|||
160654504|NCT00414466|580117052|FG003|Overall Study|Lack of Efficacy|0|||
160654505|NCT00414466|580117049|FG000|Overall Study|Withdrawn by Sponsor|1|||
160654506|NCT00414466|580117050|FG001|Overall Study|Withdrawn by Sponsor|0|||
160654507|NCT00414466|580117051|FG002|Overall Study|Withdrawn by Sponsor|0|||
160654508|NCT00414466|580117052|FG003|Overall Study|Withdrawn by Sponsor|0|||
160654509|NCT04526210|580117053|FG000|Overall Study|Sponsor decision|7|||
160654510|NCT04526210|580117054|FG001|Overall Study|Sponsor decision|5|||
160654511|NCT04526210|580117053|FG000|Overall Study|Withdrawal by Subject|3|||
160654512|NCT04526210|580117054|FG001|Overall Study|Withdrawal by Subject|2|||
160654513|NCT03522948|580117063|FG000|Overall Study|Lost to Follow-up|1|||
160654514|NCT00712010|580117065|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
160654515|NCT00995553|580117070|FG000|Overall Study|Withdrawal by Subject|2|||
160654516|NCT00995553|580117071|FG001|Overall Study|Withdrawal by Subject|6|||
160654517|NCT00927810|580117072|FG000|Overall Study|Withdrawal by Subject|0|||
160654518|NCT00927810|580117073|FG001|Overall Study|Withdrawal by Subject|3|||
160654519|NCT00927810|580117074|FG002|Overall Study|Withdrawal by Subject|0|||
160654520|NCT00927810|580117075|FG003|Overall Study|Withdrawal by Subject|1|||
160654521|NCT00927810|580117072|FG000|Overall Study|Lost to Follow-up|0|||
160654522|NCT00927810|580117073|FG001|Overall Study|Lost to Follow-up|2|||
160654523|NCT00927810|580117074|FG002|Overall Study|Lost to Follow-up|1|||
160654524|NCT00927810|580117075|FG003|Overall Study|Lost to Follow-up|1|||
160654525|NCT00927810|580117072|FG000|Overall Study|Death|0|||
160654526|NCT00927810|580117073|FG001|Overall Study|Death|2|||
160654527|NCT00927810|580117074|FG002|Overall Study|Death|0|||
160654528|NCT00927810|580117075|FG003|Overall Study|Death|0|||
160654529|NCT00927810|580117072|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160654530|NCT00927810|580117073|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160654531|NCT00927810|580117074|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160654532|NCT00927810|580117075|FG003|Overall Study|Abnormal laboratory value(s)|0|||
160654533|NCT02001558|580117076|FG000|Overall Study|Lost to Follow-up|8|||
160654534|NCT02001558|580117077|FG001|Overall Study|Lost to Follow-up|14|||
160654535|NCT04117607|580117078|FG000|Overall Study|Early Termination|0|||
160654536|NCT04117607|580117079|FG001|Overall Study|Early Termination|1|||
160654537|NCT04117607|580117080|FG002|Overall Study|Early Termination|0|||
160654538|NCT04117607|580117081|FG003|Overall Study|Early Termination|0|||
160654539|NCT04117607|580117082|FG004|Overall Study|Early Termination|0|||
160654540|NCT04117607|580117083|FG005|Overall Study|Early Termination|0|||
160654541|NCT04117607|580117084|FG006|Overall Study|Early Termination|1|||
160654542|NCT04117607|580117085|FG007|Overall Study|Early Termination|0|||
160654543|NCT04117607|580117086|FG008|Overall Study|Early Termination|0|||
160654544|NCT04117607|580117087|FG009|Overall Study|Early Termination|0|||
160654545|NCT04117607|580117088|FG010|Overall Study|Early Termination|0|||
160654546|NCT04117607|580117089|FG011|Overall Study|Early Termination|0|||
160654547|NCT04117607|580117090|FG012|Overall Study|Early Termination|0|||
160654548|NCT04117607|580117091|FG013|Overall Study|Early Termination|0|||
160654549|NCT01626079|580117092|FG000|Overall Study|Death|167|||
160654550|NCT01626079|580117093|FG001|Overall Study|Death|192|||
160654551|NCT01626079|580117094|FG002|Overall Study|Death|39|||
160654552|NCT01626079|580117092|FG000|Overall Study|Withdrawal by Subject|23|||
160654553|NCT01626079|580117093|FG001|Overall Study|Withdrawal by Subject|37|||
160654554|NCT01626079|580117094|FG002|Overall Study|Withdrawal by Subject|5|||
160654555|NCT01626079|580117092|FG000|Overall Study|Lost to Follow-up|7|||
160654556|NCT01626079|580117093|FG001|Overall Study|Lost to Follow-up|4|||
160654557|NCT01626079|580117094|FG002|Overall Study|Lost to Follow-up|2|||
160654558|NCT01626079|580117092|FG000|Overall Study|Missed Visits|1|||
160654559|NCT01626079|580117093|FG001|Overall Study|Missed Visits|4|||
160654560|NCT01626079|580117094|FG002|Overall Study|Missed Visits|6|||
160654561|NCT01457053|580117098|FG000|Overall Study|Unable to undergo selected treatment|1|||
160654562|NCT01457053|580117099|FG001|Overall Study|Unable to undergo selected treatment|1|||
160654563|NCT04333095|580117105|FG000|Overall Study|Protocol Violation|4|||
160654564|NCT04333095|580117106|FG001|Overall Study|Protocol Violation|0|||
160654565|NCT04333095|580117105|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
160654566|NCT04333095|580117106|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
160654567|NCT04333095|580117105|FG000|Overall Study|Mini Sternotomy|4|||
160654568|NCT04333095|580117106|FG001|Overall Study|Mini Sternotomy|5|||
160654569|NCT00984295|580117107|FG000|Overall Study|Lost to Follow-up|31|||
160575365|NCT00117338|579827392|FG001|Overall Study|Withdrawal by Subject|0|||
160575366|NCT00117338|579827391|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
160575367|NCT00117338|579827392|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
160575368|NCT00117338|579827391|FG000|Overall Study|Lack of Efficacy|0|||
160575369|NCT00117338|579827392|FG001|Overall Study|Lack of Efficacy|1|||
160454773|NCT01928394|579396187|FG017|Treatment Period|Maximum clinical benefit|1|||
160454774|NCT01928394|579396188|FG018|Treatment Period|Maximum clinical benefit|1|||
160454775|NCT01928394|579396189|FG019|Treatment Period|Maximum clinical benefit|0|||
160575370|NCT01380093|579827393|FG000|Naloxone Challenge Phase|Screen failures|21|||
160575371|NCT01380093|579827394|FG001|Naloxone Challenge Phase|Screen failures|0|||
160575372|NCT01380093|579827395|FG002|Naloxone Challenge Phase|Screen failures|0|||
160575373|NCT01380093|579827396|FG003|Naloxone Challenge Phase|Screen failures|0|||
160575374|NCT01380093|579827397|FG004|Naloxone Challenge Phase|Screen failures|0|||
160575375|NCT01380093|579827398|FG005|Naloxone Challenge Phase|Screen failures|0|||
160575376|NCT01380093|579827399|FG006|Naloxone Challenge Phase|Screen failures|0|||
160575377|NCT01380093|579827400|FG007|Naloxone Challenge Phase|Screen failures|0|||
160575378|NCT01380093|579827401|FG008|Naloxone Challenge Phase|Screen failures|0|||
160575379|NCT01380093|579827393|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
160575380|NCT01380093|579827394|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
160575381|NCT01380093|579827395|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
160575382|NCT01380093|579827396|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
160575383|NCT01380093|579827397|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
160575384|NCT01380093|579827398|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
160575385|NCT01380093|579827399|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
160575386|NCT01380093|579827400|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
160575387|NCT01380093|579827401|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
160575388|NCT01380093|579827393|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
160575389|NCT01380093|579827394|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
160575390|NCT01380093|579827395|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
160575391|NCT01380093|579827396|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
160575392|NCT01380093|579827397|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
160575393|NCT01380093|579827398|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
160575394|NCT01380093|579827399|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
160575395|NCT01380093|579827400|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
160575396|NCT01380093|579827401|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
160575397|NCT01380093|579827393|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
160575398|NCT01380093|579827394|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
160575399|NCT01380093|579827395|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
160575400|NCT01380093|579827396|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
160575401|NCT01380093|579827397|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
160575402|NCT01380093|579827398|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
160575403|NCT01380093|579827399|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
160575404|NCT01380093|579827400|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
160575405|NCT01380093|579827401|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
160575406|NCT01380093|579827393|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
160575407|NCT01380093|579827394|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
160575408|NCT01380093|579827395|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
160575409|NCT01380093|579827396|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
160575410|NCT01380093|579827397|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
160575411|NCT01380093|579827398|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
160575412|NCT01380093|579827399|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
160575413|NCT01380093|579827400|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
160575414|NCT01380093|579827401|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
160575415|NCT01380093|579827393|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
160575416|NCT01380093|579827394|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
160575417|NCT01380093|579827395|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
160575418|NCT01380093|579827396|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
160575419|NCT01380093|579827397|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
160575420|NCT01380093|579827398|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
160575421|NCT01380093|579827399|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
160575422|NCT01380093|579827400|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
160575423|NCT01380093|579827401|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
160575424|NCT01380093|579827393|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
160654570|NCT00984295|580117108|FG001|Overall Study|Lost to Follow-up|12|||
160454776|NCT01928394|579396190|FG020|Treatment Period|Maximum clinical benefit|2|||
160454777|NCT01928394|579396191|FG021|Treatment Period|Maximum clinical benefit|0|||
160454778|NCT01928394|579396192|FG022|Treatment Period|Maximum clinical benefit|0|||
160454779|NCT01928394|579396170|FG000|Treatment Period|Lost to Follow-up|0|||
160575425|NCT01380093|579827394|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
160575426|NCT01380093|579827395|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
160575427|NCT01380093|579827396|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
160575428|NCT01380093|579827397|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
160575429|NCT01380093|579827398|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
160575430|NCT01380093|579827399|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
160575431|NCT01380093|579827400|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
160575432|NCT01380093|579827401|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
160575433|NCT01380093|579827393|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
160575434|NCT01380093|579827394|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
160575435|NCT01380093|579827395|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
160575436|NCT01380093|579827396|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
160575437|NCT01380093|579827397|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
160575438|NCT01380093|579827398|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
160575439|NCT01380093|579827399|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
160575440|NCT01380093|579827400|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
160575441|NCT01380093|579827401|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
160575442|NCT01380093|579827393|FG000|Treatment Phase: Second Intervention|Other|0|||
160575443|NCT01380093|579827394|FG001|Treatment Phase: Second Intervention|Other|0|||
160575444|NCT01380093|579827395|FG002|Treatment Phase: Second Intervention|Other|0|||
160575445|NCT01380093|579827396|FG003|Treatment Phase: Second Intervention|Other|1|||
160575446|NCT01380093|579827397|FG004|Treatment Phase: Second Intervention|Other|0|||
160575447|NCT01380093|579827398|FG005|Treatment Phase: Second Intervention|Other|0|||
160575448|NCT01380093|579827399|FG006|Treatment Phase: Second Intervention|Other|0|||
160575449|NCT01380093|579827400|FG007|Treatment Phase: Second Intervention|Other|0|||
160575450|NCT01380093|579827401|FG008|Treatment Phase: Second Intervention|Other|0|||
160575451|NCT01380093|579827393|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
160575452|NCT01380093|579827394|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
160575453|NCT01380093|579827395|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
160575454|NCT01380093|579827396|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
160575455|NCT01380093|579827397|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
160575456|NCT01380093|579827398|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
160575457|NCT01380093|579827399|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
160575458|NCT01380093|579827400|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
160575459|NCT01380093|579827401|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
160575460|NCT01380093|579827393|FG000|Treatment Phase: Third Intervention|Other|0|||
160575461|NCT01380093|579827394|FG001|Treatment Phase: Third Intervention|Other|0|||
160575462|NCT01380093|579827395|FG002|Treatment Phase: Third Intervention|Other|0|||
160575463|NCT01380093|579827396|FG003|Treatment Phase: Third Intervention|Other|0|||
160575464|NCT01380093|579827397|FG004|Treatment Phase: Third Intervention|Other|0|||
160575465|NCT01380093|579827398|FG005|Treatment Phase: Third Intervention|Other|0|||
160575466|NCT01380093|579827399|FG006|Treatment Phase: Third Intervention|Other|0|||
160575467|NCT01380093|579827400|FG007|Treatment Phase: Third Intervention|Other|0|||
160575468|NCT01380093|579827401|FG008|Treatment Phase: Third Intervention|Other|1|||
160575469|NCT03952650|579827402|FG000|Overall Study|TRAVEL|0|||
160575470|NCT03952650|579827403|FG001|Overall Study|TRAVEL|4|||
160575471|NCT03952650|579827404|FG002|Overall Study|TRAVEL|0|||
160575472|NCT03952650|579827405|FG003|Overall Study|TRAVEL|4|||
160575473|NCT03952650|579827406|FG004|Overall Study|TRAVEL|0|||
160575474|NCT03952650|579827407|FG005|Overall Study|TRAVEL|3|||
160575475|NCT03952650|579827408|FG006|Overall Study|TRAVEL|2|||
160575476|NCT03952650|579827402|FG000|Overall Study|Withdrawal by Subject|0|||
160575477|NCT03952650|579827403|FG001|Overall Study|Withdrawal by Subject|2|||
160575478|NCT03952650|579827404|FG002|Overall Study|Withdrawal by Subject|0|||
160575479|NCT03952650|579827405|FG003|Overall Study|Withdrawal by Subject|3|||
160575480|NCT03952650|579827406|FG004|Overall Study|Withdrawal by Subject|0|||
160575481|NCT03952650|579827407|FG005|Overall Study|Withdrawal by Subject|1|||
160575482|NCT03952650|579827408|FG006|Overall Study|Withdrawal by Subject|1|||
160575483|NCT03952650|579827402|FG000|Overall Study|Lost to Follow-up|0|||
160575484|NCT03952650|579827403|FG001|Overall Study|Lost to Follow-up|1|||
160575485|NCT03952650|579827404|FG002|Overall Study|Lost to Follow-up|0|||
160575486|NCT03952650|579827405|FG003|Overall Study|Lost to Follow-up|0|||
160575487|NCT03952650|579827406|FG004|Overall Study|Lost to Follow-up|0|||
160575488|NCT03952650|579827407|FG005|Overall Study|Lost to Follow-up|1|||
160575489|NCT03952650|579827408|FG006|Overall Study|Lost to Follow-up|1|||
160575490|NCT03952650|579827402|FG000|Overall Study|Received wrong vaccine and travelled|0|||
160575491|NCT03952650|579827403|FG001|Overall Study|Received wrong vaccine and travelled|0|||
160575492|NCT03952650|579827404|FG002|Overall Study|Received wrong vaccine and travelled|0|||
160575493|NCT03952650|579827405|FG003|Overall Study|Received wrong vaccine and travelled|0|||
160575494|NCT03952650|579827406|FG004|Overall Study|Received wrong vaccine and travelled|0|||
160575495|NCT03952650|579827407|FG005|Overall Study|Received wrong vaccine and travelled|1|||
160575496|NCT03952650|579827408|FG006|Overall Study|Received wrong vaccine and travelled|0|||
160575497|NCT03952650|579827402|FG000|Overall Study|Unable to make study visit|0|||
160575498|NCT03952650|579827403|FG001|Overall Study|Unable to make study visit|0|||
160575499|NCT03952650|579827404|FG002|Overall Study|Unable to make study visit|0|||
160575500|NCT03952650|579827405|FG003|Overall Study|Unable to make study visit|0|||
160575501|NCT03952650|579827406|FG004|Overall Study|Unable to make study visit|0|||
160575502|NCT03952650|579827407|FG005|Overall Study|Unable to make study visit|1|||
160575503|NCT03952650|579827408|FG006|Overall Study|Unable to make study visit|0|||
160575504|NCT02927171|579827409|FG000|Overall Study|Lost to Follow-up|0|||
160575505|NCT02927171|579827410|FG001|Overall Study|Lost to Follow-up|1|||
160575506|NCT02240628|579827413|FG000|Overall Study|Physician Decision|6|||
160575507|NCT02240628|579827414|FG001|Overall Study|Physician Decision|5|||
160575508|NCT04530825|579827417|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
160575509|NCT04530825|579827418|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
160575510|NCT04530825|579827419|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
160575511|NCT04530825|579827420|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
160575512|NCT04530825|579827417|FG000|Overall Study|Did not complete follow-up|3|||
160575513|NCT04530825|579827418|FG001|Overall Study|Did not complete follow-up|0|||
160575514|NCT04530825|579827419|FG002|Overall Study|Did not complete follow-up|0|||
160575515|NCT04530825|579827420|FG003|Overall Study|Did not complete follow-up|0|||
160575516|NCT04101422|579827422|FG000|Overall Study|Ineligible|1|||
160575517|NCT04101422|579827423|FG001|Overall Study|Ineligible|0|||
160575518|NCT04101422|579827424|FG002|Overall Study|Ineligible|9|||
160575519|NCT04101422|579827425|FG003|Overall Study|Ineligible|0|||
160575520|NCT04101422|579827422|FG000|Overall Study|Withdrawal by Subject|0|||
160575521|NCT04101422|579827423|FG001|Overall Study|Withdrawal by Subject|0|||
160575522|NCT04101422|579827424|FG002|Overall Study|Withdrawal by Subject|1|||
160575523|NCT04101422|579827425|FG003|Overall Study|Withdrawal by Subject|0|||
160575524|NCT04101422|579827422|FG000|Overall Study|Not attending to the stimuli|0|||
160575525|NCT04101422|579827423|FG001|Overall Study|Not attending to the stimuli|0|||
160575526|NCT04101422|579827424|FG002|Overall Study|Not attending to the stimuli|4|||
160575527|NCT04101422|579827425|FG003|Overall Study|Not attending to the stimuli|0|||
160575528|NCT04101422|579827422|FG000|Overall Study|Did not download app|0|||
160575529|NCT04101422|579827423|FG001|Overall Study|Did not download app|0|||
160575530|NCT04101422|579827424|FG002|Overall Study|Did not download app|0|||
160575531|NCT04101422|579827425|FG003|Overall Study|Did not download app|17|||
160575532|NCT04101422|579827422|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
160575533|NCT04101422|579827423|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
160575534|NCT04101422|579827424|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
160575535|NCT04101422|579827425|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
160575536|NCT00850499|579827426|FG000|Overall Study|Adverse Event|3|||
160575537|NCT00850499|579827427|FG001|Overall Study|Adverse Event|1|||
160575538|NCT00850499|579827426|FG000|Overall Study|Lack of Efficacy|0|||
160575539|NCT00850499|579827427|FG001|Overall Study|Lack of Efficacy|1|||
160575540|NCT00552305|579827428|FG000|Overall Study|Adverse Event|43|||
160575541|NCT00552305|579827428|FG000|Overall Study|Lack of Efficacy|120|||
160575542|NCT00552305|579827428|FG000|Overall Study|Lost to Follow-up|4|||
160575543|NCT00552305|579827428|FG000|Overall Study|Protocol Violation|3|||
160575544|NCT00552305|579827428|FG000|Overall Study|Withdrawal by Subject|44|||
160575545|NCT00552305|579827428|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
160575546|NCT00552305|579827428|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
160575547|NCT00552305|579827428|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
160575548|NCT00552305|579827428|FG000|Overall Study|Unsatisfactory compliance|11|||
160575549|NCT00552305|579827428|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
160575550|NCT00552305|579827428|FG000|Overall Study|AE/Other: prohibited drug required|1|||
160575551|NCT00552305|579827428|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
160575552|NCT00552305|579827428|FG000|Overall Study|Other: Site closed|4|||
160575553|NCT00552305|579827428|FG000|Overall Study|Other: Personal problems|1|||
160575554|NCT00552305|579827428|FG000|Overall Study|Other: Unable to attend visits|1|||
160575555|NCT00552305|579827428|FG000|Overall Study|Other: Subject underwent surgery|4|||
160575556|NCT00552305|579827428|FG000|Overall Study|Other: Subject became pregnant|1|||
160575557|NCT00552305|579827428|FG000|Overall Study|Other: Health problems, not drug related|1|||
160575558|NCT00552305|579827428|FG000|Overall Study|Other: Subject moved from area|2|||
160575559|NCT00552305|579827428|FG000|Overall Study|Other: Subject incarcerated|1|||
160575560|NCT00552305|579827428|FG000|Overall Study|Other: Subject went to rehab|1|||
160575561|NCT00718861|579827429|FG000|Overall Study|Withdrawal by Subject|15|||
160575562|NCT00718861|579827430|FG001|Overall Study|Withdrawal by Subject|10|||
160575563|NCT00718861|579827429|FG000|Overall Study|Adverse Event|2|||
160575564|NCT00718861|579827430|FG001|Overall Study|Adverse Event|1|||
160575565|NCT00718861|579827429|FG000|Overall Study|Lost to Follow-up|2|||
160575566|NCT00718861|579827430|FG001|Overall Study|Lost to Follow-up|1|||
160575567|NCT00718861|579827429|FG000|Overall Study|Administrative Problems|1|||
160575568|NCT00718861|579827430|FG001|Overall Study|Administrative Problems|1|||
160575569|NCT00718861|579827429|FG000|Overall Study|Death|1|||
160575570|NCT00718861|579827430|FG001|Overall Study|Death|5|||
160575571|NCT01703819|579827431|FG000|Overall Study|Adverse Event|0|||
160575572|NCT01703819|579827432|FG001|Overall Study|Adverse Event|1|||
160575573|NCT01703819|579827431|FG000|Overall Study|Withdrawal by Subject|0|||
160575574|NCT01703819|579827432|FG001|Overall Study|Withdrawal by Subject|1|||
160575575|NCT04230486|579827439|FG000|Overall Study|Screen Failure|1|||
160575576|NCT01302041|579827440|FG000|Overall Study|Death|5|||
160575577|NCT01302041|579827440|FG000|Overall Study|Withdrawal by Subject|4|||
160575578|NCT01302041|579827440|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
160575579|NCT01302041|579827440|FG000|Overall Study|Other-Miscellaneous Reason|2|||
160575580|NCT02234583|579827445|FG000|Overall Study|Adverse Event|172|||
160575581|NCT02234583|579827446|FG001|Overall Study|Adverse Event|156|||
160575582|NCT02234583|579827445|FG000|Overall Study|Withdrawal by Subject|109|||
160575583|NCT02234583|579827446|FG001|Overall Study|Withdrawal by Subject|157|||
160575584|NCT02234583|579827445|FG000|Overall Study|Lost to Follow-up|0|||
160575585|NCT02234583|579827446|FG001|Overall Study|Lost to Follow-up|1|||
160575586|NCT02234583|579827445|FG000|Overall Study|Lack of Efficacy|58|||
160575587|NCT02234583|579827446|FG001|Overall Study|Lack of Efficacy|103|||
160575588|NCT02234583|579827445|FG000|Overall Study|Protocol Violation|35|||
160575589|NCT02234583|579827446|FG001|Overall Study|Protocol Violation|42|||
160575590|NCT02234583|579827445|FG000|Overall Study|Other|39|||
160575591|NCT02234583|579827446|FG001|Overall Study|Other|97|||
160575592|NCT01849250|579827447|FG000|Overall Study|Withdrawal by Subject|1|||
160575593|NCT01849250|579827448|FG001|Overall Study|Withdrawal by Subject|0|||
160575594|NCT01849250|579827447|FG000|Overall Study|Not Evaluable|5|||
160575595|NCT01849250|579827448|FG001|Overall Study|Not Evaluable|3|||
160575596|NCT01849250|579827447|FG000|Overall Study|Screen Failure|1|||
160575597|NCT01849250|579827448|FG001|Overall Study|Screen Failure|0|||
160575598|NCT04504032|579827451|FG000|Overall Study|Adverse Event|1|||
160575599|NCT04504032|579827452|FG001|Overall Study|Adverse Event|2|||
160575600|NCT04504032|579827451|FG000|Overall Study|Lost to Follow-up|6|||
160575601|NCT04504032|579827452|FG001|Overall Study|Lost to Follow-up|9|||
160575602|NCT04504032|579827451|FG000|Overall Study|Protocol Violation|2|||
160575603|NCT04504032|579827452|FG001|Overall Study|Protocol Violation|0|||
160575604|NCT04504032|579827451|FG000|Overall Study|Study terminated by sponsor|1|||
160575605|NCT04504032|579827452|FG001|Overall Study|Study terminated by sponsor|2|||
160575606|NCT04504032|579827451|FG000|Overall Study|Withdrawal by Subject|9|||
160575607|NCT04504032|579827452|FG001|Overall Study|Withdrawal by Subject|11|||
160575608|NCT04504032|579827451|FG000|Overall Study|Disease progression prior to dosing|15|||
160575609|NCT04504032|579827452|FG001|Overall Study|Disease progression prior to dosing|3|||
160575610|NCT04504032|579827451|FG000|Overall Study|Drug supply issues|1|||
160575611|NCT04504032|579827452|FG001|Overall Study|Drug supply issues|1|||
160575612|NCT04504032|579827451|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
160575613|NCT04504032|579827452|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
160575614|NCT00771030|579827453|FG000|Overall Study|Adverse Event|0|||
160575615|NCT00771030|579827454|FG001|Overall Study|Adverse Event|1|||
160575616|NCT00771030|579827455|FG002|Overall Study|Adverse Event|0|||
160575617|NCT00771030|579827456|FG003|Overall Study|Adverse Event|0|||
160575618|NCT00771030|579827457|FG004|Overall Study|Adverse Event|0|||
160575619|NCT00771030|579827458|FG005|Overall Study|Adverse Event|0|||
160575620|NCT00771030|579827459|FG006|Overall Study|Adverse Event|0|||
160575621|NCT04983901|579827460|FG000|Overall Study|Death|1|||
160575622|NCT04983901|579827461|FG001|Overall Study|Death|4|||
160575623|NCT04983901|579827460|FG000|Overall Study|Lost to Follow-up|3|||
160575624|NCT04983901|579827461|FG001|Overall Study|Lost to Follow-up|0|||
160575625|NCT04983901|579827460|FG000|Overall Study|Protocol Violation|1|||
160575626|NCT04983901|579827461|FG001|Overall Study|Protocol Violation|0|||
160575627|NCT04983901|579827460|FG000|Overall Study|Withdrawal by Subject|1|||
160575628|NCT04983901|579827461|FG001|Overall Study|Withdrawal by Subject|2|||
160575629|NCT01174784|579827462|FG000|Overall Study|Screen fails|4|||
160575630|NCT02285010|579827463|FG000|Overall Study|not abdominal hysterectomy|2|||
160575631|NCT02285010|579827464|FG001|Overall Study|not abdominal hysterectomy|0|||
160575632|NCT02285010|579827463|FG000|Overall Study|Not spinal anesthesia|3|||
160575633|NCT02285010|579827464|FG001|Overall Study|Not spinal anesthesia|1|||
160575634|NCT04156646|579827468|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
160575635|NCT04156646|579827469|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
160575636|NCT01096667|579827480|FG000|Overall Study|Lost to Follow-up|1|||
160575637|NCT01096667|579827481|FG001|Overall Study|Lost to Follow-up|1|||
160575638|NCT01096667|579827482|FG002|Overall Study|Lost to Follow-up|1|||
160575639|NCT01096667|579827483|FG003|Overall Study|Lost to Follow-up|0|||
160575640|NCT01096667|579827484|FG004|Overall Study|Lost to Follow-up|0|||
160575641|NCT01096667|579827480|FG000|Overall Study|Withdrawal by Subject|1|||
160575642|NCT01096667|579827481|FG001|Overall Study|Withdrawal by Subject|0|||
160575643|NCT01096667|579827482|FG002|Overall Study|Withdrawal by Subject|0|||
160575644|NCT01096667|579827483|FG003|Overall Study|Withdrawal by Subject|1|||
160575645|NCT01096667|579827484|FG004|Overall Study|Withdrawal by Subject|0|||
160575646|NCT01096667|579827480|FG000|Overall Study|Reason not available|0|||
160654571|NCT00984295|580117109|FG002|Overall Study|Lost to Follow-up|13|||
160575647|NCT01096667|579827481|FG001|Overall Study|Reason not available|1|||
160654572|NCT00984295|580117107|FG000|Overall Study|Protocol Violation|2|||
160654573|NCT00984295|580117108|FG001|Overall Study|Protocol Violation|1|||
160654574|NCT00984295|580117109|FG002|Overall Study|Protocol Violation|4|||
160654575|NCT00984295|580117107|FG000|Overall Study|Withdrawal by Subject|18|||
160654576|NCT00984295|580117108|FG001|Overall Study|Withdrawal by Subject|9|||
160654577|NCT00984295|580117109|FG002|Overall Study|Withdrawal by Subject|12|||
160654578|NCT00984295|580117107|FG000|Overall Study|CAE - discontinued test vaccine|0|||
160654579|NCT00984295|580117108|FG001|Overall Study|CAE - discontinued test vaccine|1|||
160654580|NCT00984295|580117109|FG002|Overall Study|CAE - discontinued test vaccine|3|||
160654581|NCT00984295|580117107|FG000|Overall Study|Missed one or more blood samplings|3|||
160654582|NCT00984295|580117108|FG001|Overall Study|Missed one or more blood samplings|7|||
160654583|NCT00984295|580117109|FG002|Overall Study|Missed one or more blood samplings|2|||
160654584|NCT00984295|580117107|FG000|Overall Study|Incomplete safety follow-up|11|||
160654585|NCT00984295|580117108|FG001|Overall Study|Incomplete safety follow-up|2|||
160654586|NCT00984295|580117109|FG002|Overall Study|Incomplete safety follow-up|3|||
160654587|NCT02364557|580117110|FG000|Overall Study|Protocol Violation|3|||
160654588|NCT02364557|580117111|FG001|Overall Study|Protocol Violation|1|||
160654589|NCT03740165|580117112|FG000|Overall Study|Death|232|||
160654590|NCT03740165|580117113|FG001|Overall Study|Death|242|||
160654591|NCT03740165|580117114|FG002|Overall Study|Death|229|||
160654592|NCT03740165|580117112|FG000|Overall Study|Lost to Follow-up|0|||
160654593|NCT03740165|580117113|FG001|Overall Study|Lost to Follow-up|0|||
160654594|NCT03740165|580117114|FG002|Overall Study|Lost to Follow-up|1|||
160654595|NCT03740165|580117112|FG000|Overall Study|Withdrawal by Subject|7|||
160654596|NCT03740165|580117113|FG001|Overall Study|Withdrawal by Subject|4|||
160654597|NCT03740165|580117114|FG002|Overall Study|Withdrawal by Subject|3|||
160654598|NCT03740165|580117112|FG000|Overall Study|Ongoing in Study|216|||
160654599|NCT03740165|580117113|FG001|Overall Study|Ongoing in Study|212|||
160654600|NCT03740165|580117114|FG002|Overall Study|Ongoing in Study|221|||
160654601|NCT04347239|580117115|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
160654602|NCT04347239|580117116|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
160654603|NCT04347239|580117117|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
160654604|NCT04347239|580117115|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
160654605|NCT04347239|580117116|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
160654606|NCT04347239|580117117|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
160654607|NCT03049618|580117118|FG000|Overall Study|Death|1|||
160654608|NCT03049618|580117119|FG001|Overall Study|Death|0|||
160654609|NCT03049618|580117118|FG000|Overall Study|Lack of Efficacy|1|||
160654610|NCT03049618|580117119|FG001|Overall Study|Lack of Efficacy|2|||
160654611|NCT04582539|580117120|FG000|Overall Study|Death|1|||
160654612|NCT04582539|580117121|FG001|Overall Study|Death|1|||
160654613|NCT04582539|580117122|FG002|Overall Study|Death|0|||
160654614|NCT04582539|580117123|FG003|Overall Study|Death|1|||
160654615|NCT04582539|580117124|FG004|Overall Study|Death|0|||
160654616|NCT04582539|580117120|FG000|Overall Study|Lost to Follow-up|1|||
160654617|NCT04582539|580117121|FG001|Overall Study|Lost to Follow-up|0|||
160654618|NCT04582539|580117122|FG002|Overall Study|Lost to Follow-up|0|||
160654619|NCT04582539|580117123|FG003|Overall Study|Lost to Follow-up|0|||
160654620|NCT04582539|580117124|FG004|Overall Study|Lost to Follow-up|0|||
160654621|NCT04582539|580117120|FG000|Overall Study|Study Terminated by Sponsor|1|||
160654622|NCT04582539|580117121|FG001|Overall Study|Study Terminated by Sponsor|3|||
160654623|NCT04582539|580117122|FG002|Overall Study|Study Terminated by Sponsor|2|||
160654624|NCT04582539|580117123|FG003|Overall Study|Study Terminated by Sponsor|2|||
160654625|NCT04582539|580117124|FG004|Overall Study|Study Terminated by Sponsor|3|||
160654626|NCT04582539|580117120|FG000|Overall Study|Physician Decision|0|||
160654627|NCT04582539|580117121|FG001|Overall Study|Physician Decision|1|||
160654628|NCT04582539|580117122|FG002|Overall Study|Physician Decision|0|||
160654629|NCT04582539|580117123|FG003|Overall Study|Physician Decision|0|||
160654630|NCT04582539|580117124|FG004|Overall Study|Physician Decision|0|||
160654631|NCT04582539|580117120|FG000|Overall Study|Withdrawal by Subject|1|||
160654632|NCT04582539|580117121|FG001|Overall Study|Withdrawal by Subject|0|||
160654633|NCT04582539|580117122|FG002|Overall Study|Withdrawal by Subject|2|||
160654634|NCT04582539|580117123|FG003|Overall Study|Withdrawal by Subject|1|||
160997717|NCT01191086|581376610|FG000|Overall Study|Lack of Efficacy|10|||
160654635|NCT04582539|580117124|FG004|Overall Study|Withdrawal by Subject|0|||
160654636|NCT04582539|580117120|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
160654637|NCT04582539|580117121|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
160654638|NCT04582539|580117122|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
160654639|NCT04582539|580117123|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
160654640|NCT04582539|580117124|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
160654641|NCT00788957|580117128|FG000|Part 1|Death|8|||
160654642|NCT00788957|580117129|FG001|Part 1|Death|0|||
160654643|NCT00788957|580117130|FG002|Part 1|Death|0|||
160654644|NCT00788957|580117131|FG003|Part 1|Death|0|||
160997718|NCT01191086|581376610|FG000|Overall Study|Lost to Follow-up|4|||
160997719|NCT01191086|581376610|FG000|Overall Study|Physician Decision|2|||
160997720|NCT01191086|581376610|FG000|Overall Study|Withdrawal by Subject|24|||
160997721|NCT01191086|581376610|FG000|Overall Study|Discontinuation criterion met|1|||
160997722|NCT01191086|581376610|FG000|Overall Study|Other|1|||
160997723|NCT03058991|581376618|FG000|Overall Study|Lost to Follow-up|17|||
160997724|NCT03058991|581376619|FG001|Overall Study|Lost to Follow-up|12|||
160997725|NCT03058991|581376620|FG002|Overall Study|Lost to Follow-up|12|||
160997726|NCT03058991|581376618|FG000|Overall Study|Withdrawal by Subject|1|||
160997727|NCT03058991|581376619|FG001|Overall Study|Withdrawal by Subject|0|||
160997728|NCT03058991|581376620|FG002|Overall Study|Withdrawal by Subject|0|||
160997729|NCT00130637|581376621|FG000|Overall Study|Adverse Event|2|||
160997730|NCT00130637|581376621|FG000|Overall Study|Withdrawal by Subject|1|||
160997731|NCT00139737|581376622|FG000|Overall Study|Withdrawal by Subject|190|||
160997732|NCT00139737|581376622|FG000|Overall Study|Adverse Event|58|||
160454780|NCT01928394|579396171|FG001|Treatment Period|Lost to Follow-up|0|||
160575648|NCT01096667|579827482|FG002|Overall Study|Reason not available|1|||
160575649|NCT01096667|579827483|FG003|Overall Study|Reason not available|1|||
160575650|NCT01096667|579827484|FG004|Overall Study|Reason not available|0|||
160575651|NCT01096667|579827480|FG000|Overall Study|Protocol Violation|0|||
160575652|NCT01096667|579827481|FG001|Overall Study|Protocol Violation|0|||
160575653|NCT01096667|579827482|FG002|Overall Study|Protocol Violation|0|||
160575654|NCT01096667|579827483|FG003|Overall Study|Protocol Violation|1|||
160575655|NCT01096667|579827484|FG004|Overall Study|Protocol Violation|0|||
160575656|NCT01096667|579827480|FG000|Overall Study|Not treated|1|||
160575657|NCT01096667|579827481|FG001|Overall Study|Not treated|0|||
160575658|NCT01096667|579827482|FG002|Overall Study|Not treated|0|||
160575659|NCT01096667|579827483|FG003|Overall Study|Not treated|0|||
160575660|NCT01096667|579827484|FG004|Overall Study|Not treated|0|||
160575661|NCT01001494|579827485|FG000|Overall Study|Adverse Event|8|||
160575662|NCT01001494|579827486|FG001|Overall Study|Adverse Event|4|||
160575663|NCT01001494|579827487|FG002|Overall Study|Adverse Event|6|||
160575664|NCT01001494|579827485|FG000|Overall Study|Protocol Violation|0|||
160575665|NCT01001494|579827486|FG001|Overall Study|Protocol Violation|1|||
160575666|NCT01001494|579827487|FG002|Overall Study|Protocol Violation|1|||
160575667|NCT01001494|579827485|FG000|Overall Study|Lost to Follow-up|2|||
160575668|NCT01001494|579827486|FG001|Overall Study|Lost to Follow-up|0|||
160575669|NCT01001494|579827487|FG002|Overall Study|Lost to Follow-up|1|||
160575670|NCT01001494|579827485|FG000|Overall Study|Withdrawal by Subject|9|||
160575671|NCT01001494|579827486|FG001|Overall Study|Withdrawal by Subject|7|||
160575672|NCT01001494|579827487|FG002|Overall Study|Withdrawal by Subject|17|||
160575673|NCT01001494|579827485|FG000|Overall Study|COPD exacerbation|3|||
160575674|NCT01001494|579827486|FG001|Overall Study|COPD exacerbation|4|||
160575675|NCT01001494|579827487|FG002|Overall Study|COPD exacerbation|5|||
160575676|NCT01001494|579827485|FG000|Overall Study|Lack of Efficacy|2|||
160575677|NCT01001494|579827486|FG001|Overall Study|Lack of Efficacy|0|||
160575678|NCT01001494|579827487|FG002|Overall Study|Lack of Efficacy|8|||
160575679|NCT01001494|579827485|FG000|Overall Study|Other|0|||
160575680|NCT01001494|579827486|FG001|Overall Study|Other|1|||
160575681|NCT01001494|579827487|FG002|Overall Study|Other|3|||
160575682|NCT00465738|579827488|FG000|Overall Study|Lost to Follow-up|2|||
160575683|NCT00465738|579827489|FG001|Overall Study|Lost to Follow-up|0|||
160575684|NCT00465738|579827488|FG000|Overall Study|Adverse Event|0|||
160575685|NCT00465738|579827489|FG001|Overall Study|Adverse Event|1|||
160575686|NCT00465738|579827488|FG000|Overall Study|Withdrawal by Subject|2|||
160575687|NCT00465738|579827489|FG001|Overall Study|Withdrawal by Subject|0|||
160575688|NCT00465738|579827488|FG000|Overall Study|Other|2|||
160575689|NCT00465738|579827489|FG001|Overall Study|Other|5|||
160575690|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Adverse Event|37|||
160575691|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Adverse Event|0|||
160575692|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Adverse Event|0|||
160575693|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Adverse Event|0|||
160575694|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Death|2|||
160575695|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Death|0|||
160575696|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Death|0|||
160575697|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Death|0|||
160575698|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
160575699|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
160997733|NCT00139737|581376622|FG000|Overall Study|Lack of Efficacy|40|||
160997734|NCT00139737|581376622|FG000|Overall Study|Lost to Follow-up|8|||
160997735|NCT00139737|581376622|FG000|Overall Study|Death|3|||
160997736|NCT00139737|581376622|FG000|Overall Study|Laboratory Abnormality|2|||
160997737|NCT00139737|581376622|FG000|Overall Study|Protocol Violation|18|||
160997738|NCT00139737|581376622|FG000|Overall Study|Withdrew During Screening Phase|8|||
160575700|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
160575701|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
160997739|NCT00139737|581376622|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
160997740|NCT00139737|581376622|FG000|Overall Study|Screened, Not Treated|13|||
160575702|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
160575703|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
160454781|NCT01928394|579396172|FG002|Treatment Period|Lost to Follow-up|0|||
160654645|NCT00788957|580117132|FG004|Part 1|Death|0|||
160654646|NCT00788957|580117133|FG005|Part 1|Death|0|||
160654647|NCT00788957|580117128|FG000|Part 1|Lost to Follow-up|1|||
160654648|NCT00788957|580117129|FG001|Part 1|Lost to Follow-up|0|||
160654649|NCT00788957|580117130|FG002|Part 1|Lost to Follow-up|0|||
160654650|NCT00788957|580117131|FG003|Part 1|Lost to Follow-up|0|||
160654651|NCT00788957|580117132|FG004|Part 1|Lost to Follow-up|0|||
160654652|NCT00788957|580117133|FG005|Part 1|Lost to Follow-up|0|||
160654653|NCT00788957|580117128|FG000|Part 2|Withdrawal by Subject|0|||
160654654|NCT00788957|580117129|FG001|Part 2|Withdrawal by Subject|9|||
160654655|NCT00788957|580117130|FG002|Part 2|Withdrawal by Subject|5|||
160654656|NCT00788957|580117131|FG003|Part 2|Withdrawal by Subject|3|||
160654657|NCT00788957|580117132|FG004|Part 2|Withdrawal by Subject|0|||
160654658|NCT00788957|580117133|FG005|Part 2|Withdrawal by Subject|0|||
160654659|NCT00788957|580117128|FG000|Part 2|Death|0|||
160654660|NCT00788957|580117129|FG001|Part 2|Death|32|||
160654661|NCT00788957|580117130|FG002|Part 2|Death|35|||
160654662|NCT00788957|580117131|FG003|Part 2|Death|37|||
160654663|NCT00788957|580117132|FG004|Part 2|Death|0|||
160654664|NCT00788957|580117133|FG005|Part 2|Death|0|||
160654665|NCT00788957|580117128|FG000|Part 2|Lost to Follow-up|0|||
160654666|NCT00788957|580117129|FG001|Part 2|Lost to Follow-up|0|||
160654667|NCT00788957|580117130|FG002|Part 2|Lost to Follow-up|3|||
160654668|NCT00788957|580117131|FG003|Part 2|Lost to Follow-up|0|||
160654669|NCT00788957|580117132|FG004|Part 2|Lost to Follow-up|0|||
160654670|NCT00788957|580117133|FG005|Part 2|Lost to Follow-up|0|||
160654671|NCT00788957|580117128|FG000|Part 2|On-study at time of data cut-off|0|||
160654672|NCT00788957|580117129|FG001|Part 2|On-study at time of data cut-off|1|||
160654673|NCT00788957|580117130|FG002|Part 2|On-study at time of data cut-off|1|||
160654674|NCT00788957|580117131|FG003|Part 2|On-study at time of data cut-off|1|||
160654675|NCT00788957|580117132|FG004|Part 2|On-study at time of data cut-off|0|||
160654676|NCT00788957|580117133|FG005|Part 2|On-study at time of data cut-off|0|||
160654677|NCT00788957|580117128|FG000|Part 3|Withdrawal by Subject|0|||
160654678|NCT00788957|580117129|FG001|Part 3|Withdrawal by Subject|0|||
160654679|NCT00788957|580117130|FG002|Part 3|Withdrawal by Subject|0|||
160654680|NCT00788957|580117131|FG003|Part 3|Withdrawal by Subject|0|||
160654681|NCT00788957|580117132|FG004|Part 3|Withdrawal by Subject|0|||
160654682|NCT00788957|580117133|FG005|Part 3|Withdrawal by Subject|2|||
160654683|NCT00788957|580117128|FG000|Part 3|Death|0|||
160654684|NCT00788957|580117129|FG001|Part 3|Death|0|||
160654685|NCT00788957|580117130|FG002|Part 3|Death|0|||
160654686|NCT00788957|580117131|FG003|Part 3|Death|0|||
160654687|NCT00788957|580117132|FG004|Part 3|Death|8|||
160654688|NCT00788957|580117133|FG005|Part 3|Death|8|||
160654689|NCT00788957|580117128|FG000|Part 3|On-study at time of data cut-off|0|||
160654690|NCT00788957|580117129|FG001|Part 3|On-study at time of data cut-off|0|||
160654691|NCT00788957|580117130|FG002|Part 3|On-study at time of data cut-off|0|||
160654692|NCT00788957|580117131|FG003|Part 3|On-study at time of data cut-off|0|||
160654693|NCT00788957|580117132|FG004|Part 3|On-study at time of data cut-off|1|||
160654694|NCT00788957|580117133|FG005|Part 3|On-study at time of data cut-off|0|||
160654695|NCT00662129|580117134|FG000|Overall Study|Protocol Violation|1|||
160654696|NCT00662129|580117134|FG000|Overall Study|Cancel prior to beginning treatment|1|||
160654697|NCT00662129|580117134|FG000|Overall Study|Ineligible|1|||
160654698|NCT00796510|580117147|FG000|Overall Study|Death|1|||
160654699|NCT00796510|580117148|FG001|Overall Study|Death|0|||
160654700|NCT00796510|580117147|FG000|Overall Study|Study Terminated|2|||
160654701|NCT00796510|580117148|FG001|Overall Study|Study Terminated|0|||
160654702|NCT05030753|580117149|FG000|9-week|Lost to Follow-up|10|||
160654703|NCT05030753|580117150|FG001|9-week|Lost to Follow-up|7|||
160654704|NCT05030753|580117149|FG000|9-week|Withdrawal by Subject|1|||
160654705|NCT05030753|580117150|FG001|9-week|Withdrawal by Subject|0|||
160654706|NCT05030753|580117149|FG000|9-week|Excluded from analysis due to missing covariates|2|||
160654707|NCT05030753|580117150|FG001|9-week|Excluded from analysis due to missing covariates|1|||
160654708|NCT05030753|580117149|FG000|6-month post intervention|Lost to Follow-up|5|||
160654709|NCT05030753|580117150|FG001|6-month post intervention|Lost to Follow-up|4|||
160654710|NCT05030753|580117149|FG000|6-month post intervention|Withdrawal by Subject|4|||
160654711|NCT05030753|580117150|FG001|6-month post intervention|Withdrawal by Subject|0|||
160654712|NCT05030753|580117149|FG000|18-month post intervention|Lost to Follow-up|3|||
160654713|NCT05030753|580117150|FG001|18-month post intervention|Lost to Follow-up|1|||
160654714|NCT03072459|580117155|FG000|Overall Study|Device revised/removed|1|||
160654715|NCT03072459|580117155|FG000|Overall Study|Subject not able to return|1|||
160654716|NCT00329602|580117156|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
160654717|NCT00329602|580117157|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
160654718|NCT00329602|580117158|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
160654719|NCT00329602|580117156|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
160654720|NCT00329602|580117157|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
160654721|NCT00329602|580117158|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
160454782|NCT01928394|579396173|FG003|Treatment Period|Lost to Follow-up|0|||
160654722|NCT00329602|580117156|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
160575704|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
160575705|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
160575706|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
160575707|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
160575708|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
160575709|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
160575710|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
160575711|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
160575712|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
160575713|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
160575714|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Physician Decision|4|||
160575715|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Physician Decision|0|||
160575716|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Physician Decision|0|||
160575717|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Physician Decision|0|||
160575718|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Pregnancy|1|||
160575719|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Pregnancy|0|||
160575720|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Pregnancy|0|||
160575721|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Pregnancy|0|||
160575722|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
160575723|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
160575724|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
160575725|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
160575726|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
160575727|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
160575728|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
160575729|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
160575730|NCT01855789|579827490|FG000|1) Baseline up to Week 24|Other|4|||
160575731|NCT01855789|579827491|FG001|1) Baseline up to Week 24|Other|0|||
160575732|NCT01855789|579827492|FG002|1) Baseline up to Week 24|Other|0|||
160575733|NCT01855789|579827493|FG003|1) Baseline up to Week 24|Other|0|||
160575734|NCT01855789|579827490|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
160575735|NCT01855789|579827491|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
160575736|NCT01855789|579827492|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
160575737|NCT01855789|579827493|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
160575738|NCT01855789|579827490|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
160575739|NCT01855789|579827491|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
160575740|NCT01855789|579827492|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
160575741|NCT01855789|579827493|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
160575742|NCT01855789|579827490|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
160575743|NCT01855789|579827491|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
160575744|NCT01855789|579827492|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
160575745|NCT01855789|579827493|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
160575746|NCT01855789|579827490|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
160575747|NCT01855789|579827491|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
160575748|NCT01855789|579827492|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
160575749|NCT01855789|579827493|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
160575750|NCT01855789|579827490|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
160575751|NCT01855789|579827491|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
160575752|NCT01855789|579827492|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
160575753|NCT01855789|579827493|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
160575754|NCT01855789|579827490|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
160575755|NCT01855789|579827491|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
160575756|NCT01855789|579827492|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
160575757|NCT01855789|579827493|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
160575758|NCT01855789|579827490|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
160575759|NCT01855789|579827491|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
160575760|NCT01855789|579827492|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
160575761|NCT01855789|579827493|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
160575762|NCT01855789|579827490|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
160575763|NCT01855789|579827491|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
160575764|NCT01855789|579827492|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
160575765|NCT01855789|579827493|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
160575766|NCT01855789|579827490|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
160575767|NCT01855789|579827491|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
160575768|NCT01855789|579827492|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
160575769|NCT01855789|579827493|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
160575770|NCT01855789|579827490|FG000|2) Week 24 up to End of Study|Other|0|||
160575771|NCT01855789|579827491|FG001|2) Week 24 up to End of Study|Other|0|||
160654723|NCT00329602|580117157|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
160921473|NCT04447755|581105354|FG005|Overall Study|Sponsor Decision|0|||
160575772|NCT01855789|579827492|FG002|2) Week 24 up to End of Study|Other|0|||
160575773|NCT01855789|579827493|FG003|2) Week 24 up to End of Study|Other|1|||
160575774|NCT01863758|579827494|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
160575775|NCT01863758|579827494|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
160575776|NCT02369510|579827495|FG000|Overall Study|Spilled Medication|1|||
160575777|NCT02369510|579827496|FG001|Overall Study|Spilled Medication|2|||
160575778|NCT02369510|579827497|FG002|Overall Study|Spilled Medication|1|||
160575779|NCT02369510|579827495|FG000|Overall Study|Epidural Activation|1|||
160575780|NCT02369510|579827496|FG001|Overall Study|Epidural Activation|1|||
160575781|NCT02369510|579827497|FG002|Overall Study|Epidural Activation|5|||
160575782|NCT02658656|579827500|FG000|Screening|Failed eligibility criteria|0|||
160575783|NCT02658656|579827501|FG001|Screening|Failed eligibility criteria|0|||
160575784|NCT02658656|579827502|FG002|Screening|Failed eligibility criteria|263|||
160575785|NCT02658656|579827500|FG000|Randomization|Withdrawal by Subject|8|||
160575786|NCT02658656|579827501|FG001|Randomization|Withdrawal by Subject|7|||
160575787|NCT02658656|579827502|FG002|Randomization|Withdrawal by Subject|0|||
160575788|NCT02658656|579827500|FG000|Randomization|Lost to Follow-up|1|||
160575789|NCT02658656|579827501|FG001|Randomization|Lost to Follow-up|3|||
160575790|NCT02658656|579827502|FG002|Randomization|Lost to Follow-up|0|||
160575791|NCT02658656|579827500|FG000|Randomization|Adverse Event|4|||
160575792|NCT02658656|579827501|FG001|Randomization|Adverse Event|0|||
160575793|NCT02658656|579827502|FG002|Randomization|Adverse Event|0|||
160575794|NCT02658656|579827500|FG000|Randomization|Administrative Termination|3|||
160575795|NCT02658656|579827501|FG001|Randomization|Administrative Termination|1|||
160575796|NCT02658656|579827502|FG002|Randomization|Administrative Termination|0|||
160575797|NCT02658656|579827500|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
160575798|NCT02658656|579827501|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
160575799|NCT02658656|579827502|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
160575800|NCT02658656|579827500|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
160575801|NCT02658656|579827501|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
160575802|NCT02658656|579827502|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
160575803|NCT02658656|579827500|FG000|Randomization|Not eligible for Randomization|1|||
160575804|NCT02658656|579827501|FG001|Randomization|Not eligible for Randomization|0|||
160575805|NCT02658656|579827502|FG002|Randomization|Not eligible for Randomization|0|||
160575806|NCT02658656|579827500|FG000|Randomization|Protocol Violation|1|||
160575807|NCT02658656|579827501|FG001|Randomization|Protocol Violation|0|||
160575808|NCT02658656|579827502|FG002|Randomization|Protocol Violation|0|||
160575809|NCT03270085|579829173|FG000|Overall Study|Withdrawal by Subject|1|||
160575810|NCT03270085|579829174|FG001|Overall Study|Withdrawal by Subject|0|||
160575811|NCT01912872|579829182|FG000|Overall Study|Lost to Follow-up|2|||
160575812|NCT01912872|579829183|FG001|Overall Study|Lost to Follow-up|3|||
160575813|NCT01912872|579829184|FG002|Overall Study|Lost to Follow-up|5|||
160575814|NCT01912872|579829185|FG003|Overall Study|Lost to Follow-up|5|||
160575815|NCT01912872|579829182|FG000|Overall Study|Other unspecified|3|||
160575816|NCT01912872|579829183|FG001|Overall Study|Other unspecified|1|||
160575817|NCT01912872|579829184|FG002|Overall Study|Other unspecified|3|||
160575818|NCT01912872|579829185|FG003|Overall Study|Other unspecified|0|||
160575819|NCT01912872|579829182|FG000|Overall Study|Informed consent withdrawn|0|||
160575820|NCT01912872|579829183|FG001|Overall Study|Informed consent withdrawn|0|||
160575821|NCT01912872|579829184|FG002|Overall Study|Informed consent withdrawn|1|||
160575822|NCT01912872|579829185|FG003|Overall Study|Informed consent withdrawn|1|||
160575823|NCT01912872|579829182|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
160575824|NCT01912872|579829183|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
160575825|NCT01912872|579829184|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
160575826|NCT01912872|579829185|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
160575827|NCT01912872|579829182|FG000|Overall Study|Protocol Violation|0|||
160575828|NCT01912872|579829183|FG001|Overall Study|Protocol Violation|0|||
160575829|NCT01912872|579829184|FG002|Overall Study|Protocol Violation|1|||
160575830|NCT01912872|579829185|FG003|Overall Study|Protocol Violation|0|||
160575831|NCT01912872|579829182|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160575832|NCT01912872|579829183|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160575833|NCT01912872|579829184|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160575834|NCT01912872|579829185|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
160575835|NCT01912872|579829182|FG000|Overall Study|Withdrawal of study medication|0|||
160575836|NCT01912872|579829183|FG001|Overall Study|Withdrawal of study medication|0|||
160575837|NCT01912872|579829184|FG002|Overall Study|Withdrawal of study medication|0|||
160575838|NCT01912872|579829185|FG003|Overall Study|Withdrawal of study medication|2|||
160575839|NCT01912872|579829182|FG000|Overall Study|Missing|0|||
160575840|NCT01912872|579829183|FG001|Overall Study|Missing|0|||
160575841|NCT01912872|579829184|FG002|Overall Study|Missing|0|||
160575842|NCT01912872|579829185|FG003|Overall Study|Missing|1|||
160575843|NCT04760314|579829187|FG000|Induction Period|Withdrawal by Subject|0|||
160575844|NCT04760314|579829188|FG001|Induction Period|Withdrawal by Subject|1|||
160575845|NCT04760314|579829189|FG002|Induction Period|Withdrawal by Subject|1|||
160921474|NCT04447755|581105355|FG006|Overall Study|Sponsor Decision|10|||
160921475|NCT04447755|581105349|FG000|Overall Study|Lost to Follow-up|0|||
160921476|NCT04447755|581105350|FG001|Overall Study|Lost to Follow-up|0|||
160921477|NCT04447755|581105351|FG002|Overall Study|Lost to Follow-up|0|||
160921478|NCT04447755|581105352|FG003|Overall Study|Lost to Follow-up|0|||
160921479|NCT04447755|581105353|FG004|Overall Study|Lost to Follow-up|0|||
160921480|NCT04447755|581105354|FG005|Overall Study|Lost to Follow-up|0|||
160921481|NCT04447755|581105355|FG006|Overall Study|Lost to Follow-up|1|||
160921482|NCT03721276|581105356|FG000|Overall Study|Lost to Follow-up|5|||
160921483|NCT03721276|581105357|FG001|Overall Study|Lost to Follow-up|3|||
160921484|NCT03721276|581105356|FG000|Overall Study|Adverse Event|0|||
160921485|NCT03721276|581105357|FG001|Overall Study|Adverse Event|1|||
160921486|NCT01340898|581105362|FG000|Primary Phase|Serious Adverse Events|0|||
160921487|NCT01340898|581105363|FG001|Primary Phase|Serious Adverse Events|0|||
160921488|NCT01340898|581105364|FG002|Primary Phase|Serious Adverse Events|1|||
160921489|NCT01340898|581105362|FG000|Primary Phase|Withdrawal by Subject|8|||
160921490|NCT01340898|581105363|FG001|Primary Phase|Withdrawal by Subject|7|||
160921491|NCT01340898|581105364|FG002|Primary Phase|Withdrawal by Subject|5|||
160921492|NCT01340898|581105362|FG000|Primary Phase|Migrated/moved from study area|4|||
160921493|NCT01340898|581105363|FG001|Primary Phase|Migrated/moved from study area|1|||
160921494|NCT01340898|581105364|FG002|Primary Phase|Migrated/moved from study area|0|||
160921495|NCT01340898|581105362|FG000|Primary Phase|Lost to Follow-up|4|||
160921496|NCT01340898|581105363|FG001|Primary Phase|Lost to Follow-up|1|||
160921497|NCT01340898|581105364|FG002|Primary Phase|Lost to Follow-up|0|||
160921498|NCT01340898|581105362|FG000|Booster Phase|Withdrawal by Subject|3|||
160921499|NCT01340898|581105363|FG001|Booster Phase|Withdrawal by Subject|0|||
160921500|NCT01340898|581105364|FG002|Booster Phase|Withdrawal by Subject|4|||
160921501|NCT01340898|581105362|FG000|Booster Phase|Migrated/moved from study area|3|||
160921502|NCT01340898|581105363|FG001|Booster Phase|Migrated/moved from study area|0|||
160921503|NCT01340898|581105364|FG002|Booster Phase|Migrated/moved from study area|0|||
160921504|NCT01340898|581105362|FG000|Booster Phase|Lost to Follow-up|4|||
160921505|NCT01340898|581105363|FG001|Booster Phase|Lost to Follow-up|2|||
160921506|NCT01340898|581105364|FG002|Booster Phase|Lost to Follow-up|3|||
160921507|NCT00416078|581105367|FG000|Overall Study|Death|3|||
160921508|NCT00416078|581105368|FG001|Overall Study|Death|4|||
160921509|NCT00416078|581105367|FG000|Overall Study|Withdrawal by Subject|3|||
160921510|NCT00416078|581105368|FG001|Overall Study|Withdrawal by Subject|2|||
160921511|NCT00416078|581105367|FG000|Overall Study|Physician Decision|1|||
160921512|NCT00416078|581105368|FG001|Overall Study|Physician Decision|0|||
160921513|NCT00416078|581105367|FG000|Overall Study|Lost to Follow-up|4|||
160921514|NCT00416078|581105368|FG001|Overall Study|Lost to Follow-up|2|||
160921515|NCT03564145|581105377|FG000|Overall Study|Adverse Event|4|||
160921516|NCT03564145|581105377|FG000|Overall Study|Lost to Follow-up|21|||
160921517|NCT03564145|581105377|FG000|Overall Study|Protocol Violation|2|||
160921518|NCT03564145|581105377|FG000|Overall Study|Withdrawal by Subject|48|||
160575846|NCT04760314|579829190|FG003|Induction Period|Withdrawal by Subject|0|||
160575847|NCT04760314|579829191|FG004|Induction Period|Withdrawal by Subject|0|||
160575848|NCT04760314|579829192|FG005|Induction Period|Withdrawal by Subject|0|||
160575849|NCT04760314|579829193|FG006|Induction Period|Withdrawal by Subject|0|||
160575850|NCT04760314|579829194|FG007|Induction Period|Withdrawal by Subject|0|||
160575851|NCT04760314|579829195|FG008|Induction Period|Withdrawal by Subject|0|||
160575852|NCT04760314|579829196|FG009|Induction Period|Withdrawal by Subject|0|||
160575853|NCT04760314|579829197|FG010|Induction Period|Withdrawal by Subject|0|||
160575854|NCT04760314|579829187|FG000|Induction Period|Adverse Event|0|||
160575855|NCT04760314|579829188|FG001|Induction Period|Adverse Event|0|||
160575856|NCT04760314|579829189|FG002|Induction Period|Adverse Event|2|||
160575857|NCT04760314|579829190|FG003|Induction Period|Adverse Event|0|||
160575858|NCT04760314|579829191|FG004|Induction Period|Adverse Event|0|||
160575859|NCT04760314|579829192|FG005|Induction Period|Adverse Event|0|||
160575860|NCT04760314|579829193|FG006|Induction Period|Adverse Event|0|||
160575861|NCT04760314|579829194|FG007|Induction Period|Adverse Event|0|||
160575862|NCT04760314|579829195|FG008|Induction Period|Adverse Event|0|||
160575863|NCT04760314|579829196|FG009|Induction Period|Adverse Event|0|||
160575864|NCT04760314|579829197|FG010|Induction Period|Adverse Event|0|||
160575865|NCT04760314|579829187|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
160575866|NCT04760314|579829188|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
160575867|NCT04760314|579829189|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
160921519|NCT03564145|581105377|FG000|Overall Study|Study Terminated by Sponsor|146|||
160921520|NCT03564145|581105377|FG000|Overall Study|Physician Decision|1|||
160921521|NCT03564145|581105377|FG000|Overall Study|Other Than Specified|1|||
160921522|NCT03564145|581105377|FG000|Overall Study|Pregnancy|1|||
160921523|NCT00410761|581107355|FG000|Randomized Treatment Period|Adverse Event|34|||
160921524|NCT00410761|581107356|FG001|Randomized Treatment Period|Adverse Event|3|||
160921525|NCT00410761|581107355|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
160575868|NCT04760314|579829190|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
160575869|NCT04760314|579829191|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
160921526|NCT00410761|581107356|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
160921527|NCT00410761|581107355|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
160921528|NCT00410761|581107356|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
160921529|NCT00410761|581107355|FG000|Randomized Treatment Period|Other|69|||
160921530|NCT00410761|581107356|FG001|Randomized Treatment Period|Other|21|||
160921531|NCT00410761|581107355|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
160921532|NCT00410761|581107356|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
160921533|NCT00410761|581107355|FG000|Open-Label Treatment Period|Adverse Event|13|||
160921534|NCT00410761|581107356|FG001|Open-Label Treatment Period|Adverse Event|15|||
160921535|NCT00410761|581107355|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
160921536|NCT00410761|581107356|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
160921537|NCT00410761|581107355|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
160921538|NCT00410761|581107356|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
160575870|NCT04760314|579829192|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
160575871|NCT04760314|579829193|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
160575872|NCT04760314|579829194|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
160575873|NCT04760314|579829195|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
160921539|NCT00410761|581107355|FG000|Open-Label Treatment Period|Other|18|||
160921540|NCT00410761|581107356|FG001|Open-Label Treatment Period|Other|9|||
160921541|NCT00623727|581107357|FG000|Double Blind (DB)|Adverse Event|1|||
160921542|NCT00623727|581107358|FG001|Double Blind (DB)|Adverse Event|3|||
160921543|NCT00623727|581107357|FG000|Double Blind (DB)|Physician Decision|0|||
160921544|NCT00623727|581107358|FG001|Double Blind (DB)|Physician Decision|1|||
160921545|NCT00623727|581107357|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
160921546|NCT00623727|581107358|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
160921547|NCT00623727|581107357|FG000|Double Blind (DB)|Lack of Efficacy|2|||
160921548|NCT00623727|581107358|FG001|Double Blind (DB)|Lack of Efficacy|2|||
160921549|NCT00623727|581107357|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
160921550|NCT00623727|581107358|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
160921551|NCT00623727|581107357|FG000|Double Blind (DB)|Lost to Follow-up|1|||
160921552|NCT00623727|581107358|FG001|Double Blind (DB)|Lost to Follow-up|1|||
160921553|NCT00623727|581107357|FG000|Double Blind (DB)|Protocol Violation|2|||
160921554|NCT00623727|581107358|FG001|Double Blind (DB)|Protocol Violation|2|||
160921555|NCT00623727|581107357|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
160921556|NCT00623727|581107358|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
160921557|NCT00623727|581107357|FG000|Open Label Follow-up|Study termination|0|||
160921558|NCT00623727|581107358|FG001|Open Label Follow-up|Study termination|6|||
160921559|NCT00623727|581107357|FG000|Open Label Follow-up|Participant convenience|0|||
160921560|NCT00623727|581107358|FG001|Open Label Follow-up|Participant convenience|1|||
160921561|NCT01852942|581107359|FG000|Overall Study|Physician Decision|1|||
160921562|NCT01852942|581107360|FG001|Overall Study|Physician Decision|0|||
160921563|NCT01852942|581107359|FG000|Overall Study|Death|1|||
160921564|NCT01852942|581107360|FG001|Overall Study|Death|1|||
160921565|NCT01852942|581107359|FG000|Overall Study|Withdrawal by Subject|2|||
160921566|NCT01852942|581107360|FG001|Overall Study|Withdrawal by Subject|3|||
160921567|NCT01852942|581107359|FG000|Overall Study|Lost to Follow-up|1|||
160921568|NCT01852942|581107360|FG001|Overall Study|Lost to Follow-up|2|||
160921569|NCT03745937|581107362|FG000|Overall Study|Withdrawal by Subject|0|||
160921570|NCT03745937|581107363|FG001|Overall Study|Withdrawal by Subject|0|||
160921571|NCT03745937|581107364|FG002|Overall Study|Withdrawal by Subject|0|||
160921572|NCT03745937|581107365|FG003|Overall Study|Withdrawal by Subject|1|||
160921573|NCT03745937|581107362|FG000|Overall Study|Not-specifed|0|||
160921574|NCT03745937|581107363|FG001|Overall Study|Not-specifed|1|||
160921575|NCT03745937|581107364|FG002|Overall Study|Not-specifed|0|||
160921576|NCT03745937|581107365|FG003|Overall Study|Not-specifed|1|||
160921577|NCT00696696|581107371|FG000|Overall Study|Adverse Event|5|||
160921578|NCT00696696|581107371|FG000|Overall Study|Withdrawal by Subject|8|||
160921579|NCT00696696|581107371|FG000|Overall Study|Physician Decision|2|||
160921580|NCT00696696|581107371|FG000|Overall Study|Death|3|||
160921581|NCT02642614|581107372|FG000|Overall Study|Adverse Event|1|||
160921582|NCT02642614|581107373|FG001|Overall Study|Adverse Event|1|||
160921583|NCT02642614|581107374|FG002|Overall Study|Adverse Event|2|||
160921584|NCT02642614|581107375|FG003|Overall Study|Adverse Event|2|||
160921585|NCT02642614|581107372|FG000|Overall Study|Lost to Follow-up|1|||
160921586|NCT02642614|581107373|FG001|Overall Study|Lost to Follow-up|0|||
160921587|NCT02642614|581107374|FG002|Overall Study|Lost to Follow-up|0|||
160921588|NCT02642614|581107375|FG003|Overall Study|Lost to Follow-up|0|||
160921589|NCT02642614|581107372|FG000|Overall Study|Withdrawal by Subject|1|||
160921590|NCT02642614|581107373|FG001|Overall Study|Withdrawal by Subject|1|||
160921591|NCT02642614|581107374|FG002|Overall Study|Withdrawal by Subject|0|||
160921592|NCT02642614|581107375|FG003|Overall Study|Withdrawal by Subject|0|||
160921593|NCT03227029|581107378|FG000|Overall Study|Child Wheezed (no treatment)|0|||
160921594|NCT03227029|581107379|FG001|Overall Study|Child Wheezed (no treatment)|1|||
160921595|NCT03227029|581107380|FG002|Overall Study|Child Wheezed (no treatment)|0|||
160921596|NCT03227029|581107378|FG000|Overall Study|No post RSV season visit due to COVID|3|||
160921597|NCT03227029|581107379|FG001|Overall Study|No post RSV season visit due to COVID|3|||
160997741|NCT01689519|581376623|FG000|Intent to Treat|Death|157|||
160997742|NCT01689519|581376624|FG001|Intent to Treat|Death|167|||
160575874|NCT04760314|579829196|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
160575875|NCT04760314|579829197|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
160997743|NCT01689519|581376623|FG000|Intent to Treat|Lost to Follow-up|4|||
160997744|NCT01689519|581376624|FG001|Intent to Treat|Lost to Follow-up|8|||
160997745|NCT01689519|581376623|FG000|Intent to Treat|Other|2|||
160997746|NCT01689519|581376624|FG001|Intent to Treat|Other|4|||
160575876|NCT04760314|579829187|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
160575877|NCT04760314|579829188|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
160575878|NCT04760314|579829189|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
160575879|NCT04760314|579829190|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
160575880|NCT04760314|579829191|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
160921598|NCT03227029|581107380|FG002|Overall Study|No post RSV season visit due to COVID|2|||
160921599|NCT03227029|581107378|FG000|Overall Study|Not able to get to clinic|0|||
160921600|NCT03227029|581107379|FG001|Overall Study|Not able to get to clinic|0|||
160921601|NCT03227029|581107380|FG002|Overall Study|Not able to get to clinic|1|||
160921602|NCT03227029|581107378|FG000|Overall Study|Withdrawal by Subject|1|||
160921603|NCT03227029|581107379|FG001|Overall Study|Withdrawal by Subject|0|||
160921604|NCT03227029|581107380|FG002|Overall Study|Withdrawal by Subject|0|||
160921605|NCT03227029|581107378|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
160921606|NCT03227029|581107379|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
160921607|NCT03227029|581107380|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
160921608|NCT01291173|581107381|FG000|Overall Study|Adverse Event|0|||
160921609|NCT01291173|581107382|FG001|Overall Study|Adverse Event|3|||
160921610|NCT01291173|581107383|FG002|Overall Study|Adverse Event|1|||
160921611|NCT01291173|581107384|FG003|Overall Study|Adverse Event|3|||
160921612|NCT01291173|581107381|FG000|Overall Study|Protocol Violation|7|||
160921613|NCT01291173|581107382|FG001|Overall Study|Protocol Violation|2|||
160921614|NCT01291173|581107383|FG002|Overall Study|Protocol Violation|2|||
160921615|NCT01291173|581107384|FG003|Overall Study|Protocol Violation|5|||
160921616|NCT01291173|581107381|FG000|Overall Study|Withdrawal by Subject|6|||
160921617|NCT01291173|581107382|FG001|Overall Study|Withdrawal by Subject|4|||
160921618|NCT01291173|581107383|FG002|Overall Study|Withdrawal by Subject|4|||
160921619|NCT01291173|581107384|FG003|Overall Study|Withdrawal by Subject|2|||
160921620|NCT01291173|581107381|FG000|Overall Study|Lost to Follow-up|4|||
160921621|NCT01291173|581107382|FG001|Overall Study|Lost to Follow-up|6|||
160921622|NCT01291173|581107383|FG002|Overall Study|Lost to Follow-up|3|||
160921623|NCT01291173|581107384|FG003|Overall Study|Lost to Follow-up|2|||
160921624|NCT01291173|581107381|FG000|Overall Study|Unable to meet visit schedule|0|||
160921625|NCT01291173|581107382|FG001|Overall Study|Unable to meet visit schedule|0|||
160921626|NCT01291173|581107383|FG002|Overall Study|Unable to meet visit schedule|1|||
160921627|NCT01291173|581107384|FG003|Overall Study|Unable to meet visit schedule|0|||
160921628|NCT01291173|581107381|FG000|Overall Study|Lack of compliance|0|||
160921629|NCT01291173|581107382|FG001|Overall Study|Lack of compliance|0|||
160921630|NCT01291173|581107383|FG002|Overall Study|Lack of compliance|0|||
160921631|NCT01291173|581107384|FG003|Overall Study|Lack of compliance|1|||
160921632|NCT01291173|581107381|FG000|Overall Study|Subject was unblinded|0|||
160921633|NCT01291173|581107382|FG001|Overall Study|Subject was unblinded|0|||
160921634|NCT01291173|581107383|FG002|Overall Study|Subject was unblinded|1|||
160921635|NCT01291173|581107384|FG003|Overall Study|Subject was unblinded|0|||
160921636|NCT01291173|581107381|FG000|Overall Study|Excluded therapy|0|||
160921637|NCT01291173|581107382|FG001|Overall Study|Excluded therapy|0|||
160921638|NCT01291173|581107383|FG002|Overall Study|Excluded therapy|1|||
160921639|NCT01291173|581107384|FG003|Overall Study|Excluded therapy|0|||
160921640|NCT01074450|581107390|FG000|First Intervention|Emesis in Dosing Interval|0|||
160921641|NCT01074450|581107391|FG001|First Intervention|Emesis in Dosing Interval|2|||
160921642|NCT01074450|581107390|FG000|Second Intervention|Protocol Violation|1|||
160921643|NCT01074450|581107391|FG001|Second Intervention|Protocol Violation|0|||
160921644|NCT01074450|581107390|FG000|Second Intervention|Physician Decision|0|||
160921645|NCT01074450|581107391|FG001|Second Intervention|Physician Decision|1|||
160997747|NCT01689519|581376623|FG000|Intent to Treat|Physician Decision|4|||
160997748|NCT01689519|581376624|FG001|Intent to Treat|Physician Decision|1|||
160575881|NCT04760314|579829192|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
160575882|NCT04760314|579829193|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
160575883|NCT04760314|579829194|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
160575884|NCT04760314|579829195|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
160997749|NCT01689519|581376623|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
160997750|NCT01689519|581376624|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
160997751|NCT01689519|581376623|FG000|Intent to Treat|Withdrawal by Subject|21|||
160454783|NCT01928394|579396174|FG004|Treatment Period|Lost to Follow-up|0|||
160454784|NCT01928394|579396175|FG005|Treatment Period|Lost to Follow-up|0|||
160575885|NCT04760314|579829196|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
160575886|NCT04760314|579829197|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
160575887|NCT04760314|579829187|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
160575888|NCT04760314|579829188|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
160575889|NCT04760314|579829189|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
160575890|NCT04760314|579829190|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
160575891|NCT04760314|579829191|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
160575892|NCT04760314|579829192|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
160921658|NCT02728895|581107394|FG000|Overall Study|Other|1|||
160921659|NCT02728895|581107395|FG001|Overall Study|Other|2|||
160921660|NCT02728895|581107394|FG000|Overall Study|Withdrawal by Subject|0|||
160921661|NCT02728895|581107395|FG001|Overall Study|Withdrawal by Subject|3|||
160921662|NCT04788953|581107396|FG000|Overall Study|Adverse Event|1|||
160921663|NCT04788953|581107397|FG001|Overall Study|Adverse Event|1|||
160921664|NCT04788953|581107396|FG000|Overall Study|Withdrawal by Subject|1|||
160921665|NCT04788953|581107397|FG001|Overall Study|Withdrawal by Subject|0|||
160921666|NCT04788953|581107396|FG000|Overall Study|Protocol Violation|0|||
160921667|NCT04788953|581107397|FG001|Overall Study|Protocol Violation|1|||
160921668|NCT00469092|581107398|FG000|Overall Study|Adverse Event|5|||
160921669|NCT00469092|581107399|FG001|Overall Study|Adverse Event|4|||
160921670|NCT00469092|581107398|FG000|Overall Study|Lack of Efficacy|1|||
160921671|NCT00469092|581107399|FG001|Overall Study|Lack of Efficacy|0|||
160921672|NCT00469092|581107398|FG000|Overall Study|Lost to Follow-up|1|||
160921673|NCT00469092|581107399|FG001|Overall Study|Lost to Follow-up|2|||
160921674|NCT00469092|581107398|FG000|Overall Study|Protocol Violation|3|||
160921675|NCT00469092|581107399|FG001|Overall Study|Protocol Violation|3|||
160921676|NCT00469092|581107398|FG000|Overall Study|Withdrawal by Subject|4|||
160921677|NCT00469092|581107399|FG001|Overall Study|Withdrawal by Subject|4|||
160921678|NCT00469092|581107398|FG000|Overall Study|Withdrawal Criteria|3|||
160921679|NCT00469092|581107399|FG001|Overall Study|Withdrawal Criteria|4|||
160921680|NCT00469092|581107398|FG000|Overall Study|Incorrectly Randomised|4|||
160921681|NCT00469092|581107399|FG001|Overall Study|Incorrectly Randomised|3|||
160921682|NCT00469092|581107398|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
160921683|NCT00469092|581107399|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
160921684|NCT00469092|581107398|FG000|Overall Study|Use of lipid lowering drug|1|||
160921685|NCT00469092|581107399|FG001|Overall Study|Use of lipid lowering drug|0|||
160921686|NCT00469092|581107398|FG000|Overall Study|Hypoglycaemic Episodes|1|||
160921687|NCT00469092|581107399|FG001|Overall Study|Hypoglycaemic Episodes|1|||
160921688|NCT00469092|581107398|FG000|Overall Study|Abnormal lab value|1|||
160921689|NCT00469092|581107399|FG001|Overall Study|Abnormal lab value|0|||
160921690|NCT00469092|581107398|FG000|Overall Study|Use of Corticosteroid|1|||
160921691|NCT00469092|581107399|FG001|Overall Study|Use of Corticosteroid|0|||
160921692|NCT02707991|581107408|FG000|Overall Study|Protocol Violation|1|||
160921693|NCT02707991|581107409|FG001|Overall Study|Protocol Violation|0|||
160921694|NCT02707991|581107408|FG000|Overall Study|Became ineligible|0|||
160921695|NCT02707991|581107409|FG001|Overall Study|Became ineligible|1|||
160921696|NCT02268864|581107410|FG000|Overall Study|Withdrawal by Subject|2|||
160921697|NCT02268864|581107411|FG001|Overall Study|Withdrawal by Subject|0|||
160921698|NCT02268864|581107412|FG002|Overall Study|Withdrawal by Subject|0|||
160921699|NCT02268864|581107410|FG000|Overall Study|Death|0|||
160921700|NCT02268864|581107411|FG001|Overall Study|Death|1|||
160921701|NCT02268864|581107412|FG002|Overall Study|Death|0|||
160921702|NCT05407675|581107415|FG000|Overall Study|Withdrawal by Subject|0|||
160921703|NCT05407675|581107416|FG001|Overall Study|Withdrawal by Subject|2|||
160921704|NCT05407675|581107417|FG002|Overall Study|Withdrawal by Subject|3|||
160921705|NCT05407675|581107418|FG003|Overall Study|Withdrawal by Subject|5|||
160921706|NCT05407675|581107419|FG004|Overall Study|Withdrawal by Subject|0|||
160921707|NCT05407675|581107420|FG005|Overall Study|Withdrawal by Subject|2|||
160921708|NCT05407675|581107421|FG006|Overall Study|Withdrawal by Subject|0|||
160921709|NCT05407675|581107422|FG007|Overall Study|Withdrawal by Subject|0|||
160921710|NCT05407675|581107423|FG008|Overall Study|Withdrawal by Subject|2|||
160921711|NCT05407675|581107424|FG009|Overall Study|Withdrawal by Subject|0|||
160921712|NCT05407675|581107425|FG010|Overall Study|Withdrawal by Subject|1|||
160921713|NCT05407675|581107426|FG011|Overall Study|Withdrawal by Subject|0|||
160921714|NCT05407675|581107427|FG012|Overall Study|Withdrawal by Subject|0|||
160921715|NCT05407675|581107415|FG000|Overall Study|Site terminated by sponsor|0|||
160921716|NCT05407675|581107416|FG001|Overall Study|Site terminated by sponsor|0|||
160921717|NCT05407675|581107417|FG002|Overall Study|Site terminated by sponsor|1|||
160921718|NCT05407675|581107418|FG003|Overall Study|Site terminated by sponsor|0|||
160921719|NCT05407675|581107419|FG004|Overall Study|Site terminated by sponsor|2|||
160921720|NCT05407675|581107420|FG005|Overall Study|Site terminated by sponsor|0|||
160921721|NCT05407675|581107421|FG006|Overall Study|Site terminated by sponsor|1|||
160921722|NCT05407675|581107422|FG007|Overall Study|Site terminated by sponsor|0|||
160921723|NCT05407675|581107423|FG008|Overall Study|Site terminated by sponsor|0|||
160921724|NCT05407675|581107424|FG009|Overall Study|Site terminated by sponsor|2|||
160921725|NCT05407675|581107425|FG010|Overall Study|Site terminated by sponsor|2|||
160921726|NCT05407675|581107426|FG011|Overall Study|Site terminated by sponsor|2|||
160921727|NCT05407675|581107427|FG012|Overall Study|Site terminated by sponsor|1|||
160921728|NCT05407675|581107415|FG000|Overall Study|Disease Progression|0|||
160921729|NCT05407675|581107416|FG001|Overall Study|Disease Progression|0|||
160921730|NCT05407675|581107417|FG002|Overall Study|Disease Progression|0|||
160921731|NCT05407675|581107418|FG003|Overall Study|Disease Progression|0|||
160921732|NCT05407675|581107419|FG004|Overall Study|Disease Progression|0|||
160921733|NCT05407675|581107420|FG005|Overall Study|Disease Progression|0|||
160921734|NCT05407675|581107421|FG006|Overall Study|Disease Progression|0|||
160921735|NCT05407675|581107422|FG007|Overall Study|Disease Progression|0|||
160921736|NCT05407675|581107423|FG008|Overall Study|Disease Progression|0|||
160921737|NCT05407675|581107424|FG009|Overall Study|Disease Progression|0|||
160921738|NCT05407675|581107425|FG010|Overall Study|Disease Progression|1|||
160921739|NCT05407675|581107426|FG011|Overall Study|Disease Progression|0|||
160921740|NCT05407675|581107427|FG012|Overall Study|Disease Progression|0|||
160921741|NCT05407675|581107415|FG000|Overall Study|Physician Decision|0|||
160921742|NCT05407675|581107416|FG001|Overall Study|Physician Decision|0|||
160575893|NCT04760314|579829193|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
160575894|NCT04760314|579829194|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
160921743|NCT05407675|581107417|FG002|Overall Study|Physician Decision|0|||
160921744|NCT05407675|581107418|FG003|Overall Study|Physician Decision|0|||
160921745|NCT05407675|581107419|FG004|Overall Study|Physician Decision|0|||
160921746|NCT05407675|581107420|FG005|Overall Study|Physician Decision|0|||
160921747|NCT05407675|581107421|FG006|Overall Study|Physician Decision|0|||
160921748|NCT05407675|581107422|FG007|Overall Study|Physician Decision|0|||
160921749|NCT05407675|581107423|FG008|Overall Study|Physician Decision|0|||
160921750|NCT05407675|581107424|FG009|Overall Study|Physician Decision|0|||
160921751|NCT05407675|581107425|FG010|Overall Study|Physician Decision|1|||
160921752|NCT05407675|581107426|FG011|Overall Study|Physician Decision|0|||
160921753|NCT05407675|581107427|FG012|Overall Study|Physician Decision|0|||
160921754|NCT05407675|581107415|FG000|Overall Study|Other reasons|0|||
160921755|NCT05407675|581107416|FG001|Overall Study|Other reasons|0|||
160921756|NCT05407675|581107417|FG002|Overall Study|Other reasons|0|||
160921757|NCT05407675|581107418|FG003|Overall Study|Other reasons|0|||
160575895|NCT04760314|579829195|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
160921758|NCT05407675|581107419|FG004|Overall Study|Other reasons|0|||
160921759|NCT05407675|581107420|FG005|Overall Study|Other reasons|0|||
160921760|NCT05407675|581107421|FG006|Overall Study|Other reasons|0|||
160921761|NCT05407675|581107422|FG007|Overall Study|Other reasons|0|||
160921762|NCT05407675|581107423|FG008|Overall Study|Other reasons|1|||
160921763|NCT05407675|581107424|FG009|Overall Study|Other reasons|1|||
160921764|NCT05407675|581107425|FG010|Overall Study|Other reasons|1|||
160921765|NCT05407675|581107426|FG011|Overall Study|Other reasons|1|||
160921766|NCT05407675|581107427|FG012|Overall Study|Other reasons|0|||
160921767|NCT05407675|581107415|FG000|Overall Study|Death|3|||
160921768|NCT05407675|581107416|FG001|Overall Study|Death|4|||
160921769|NCT05407675|581107417|FG002|Overall Study|Death|3|||
160921770|NCT05407675|581107418|FG003|Overall Study|Death|6|||
160921771|NCT05407675|581107419|FG004|Overall Study|Death|0|||
160921772|NCT05407675|581107420|FG005|Overall Study|Death|2|||
160921773|NCT05407675|581107421|FG006|Overall Study|Death|4|||
160997752|NCT01689519|581376624|FG001|Intent to Treat|Withdrawal by Subject|20|||
160997753|NCT01689519|581376623|FG000|Safety Population|Death|158|||
160921774|NCT05407675|581107422|FG007|Overall Study|Death|2|||
160921775|NCT05407675|581107423|FG008|Overall Study|Death|2|||
160921776|NCT05407675|581107424|FG009|Overall Study|Death|4|||
160921777|NCT05407675|581107425|FG010|Overall Study|Death|2|||
160921778|NCT05407675|581107426|FG011|Overall Study|Death|1|||
160997754|NCT01689519|581376624|FG001|Safety Population|Death|165|||
160997755|NCT01689519|581376623|FG000|Safety Population|Lost to Follow-up|4|||
160997756|NCT01689519|581376624|FG001|Safety Population|Lost to Follow-up|8|||
160575896|NCT04760314|579829196|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
160921779|NCT05407675|581107427|FG012|Overall Study|Death|0|||
160921780|NCT05407675|581107415|FG000|Overall Study|Adverse Event|0|||
160921781|NCT05407675|581107416|FG001|Overall Study|Adverse Event|0|||
160921782|NCT05407675|581107417|FG002|Overall Study|Adverse Event|0|||
160997757|NCT01689519|581376623|FG000|Safety Population|Other|2|||
160997758|NCT01689519|581376624|FG001|Safety Population|Other|4|||
160921783|NCT05407675|581107418|FG003|Overall Study|Adverse Event|0|||
160921784|NCT05407675|581107419|FG004|Overall Study|Adverse Event|1|||
160921785|NCT05407675|581107420|FG005|Overall Study|Adverse Event|0|||
160921786|NCT05407675|581107421|FG006|Overall Study|Adverse Event|0|||
160921787|NCT05407675|581107422|FG007|Overall Study|Adverse Event|0|||
160921788|NCT05407675|581107423|FG008|Overall Study|Adverse Event|0|||
160921789|NCT05407675|581107424|FG009|Overall Study|Adverse Event|0|||
160921790|NCT05407675|581107425|FG010|Overall Study|Adverse Event|0|||
160921791|NCT05407675|581107426|FG011|Overall Study|Adverse Event|1|||
160921792|NCT05407675|581107427|FG012|Overall Study|Adverse Event|0|||
160921793|NCT05407675|581107415|FG000|Overall Study|Ongoing Treatment|0|||
160921794|NCT05407675|581107416|FG001|Overall Study|Ongoing Treatment|0|||
160921795|NCT05407675|581107417|FG002|Overall Study|Ongoing Treatment|0|||
160921796|NCT05407675|581107418|FG003|Overall Study|Ongoing Treatment|0|||
160921797|NCT05407675|581107419|FG004|Overall Study|Ongoing Treatment|0|||
160921798|NCT05407675|581107420|FG005|Overall Study|Ongoing Treatment|0|||
160921799|NCT05407675|581107421|FG006|Overall Study|Ongoing Treatment|0|||
160921800|NCT05407675|581107422|FG007|Overall Study|Ongoing Treatment|0|||
160921801|NCT05407675|581107423|FG008|Overall Study|Ongoing Treatment|1|||
160921802|NCT05407675|581107424|FG009|Overall Study|Ongoing Treatment|0|||
160921803|NCT05407675|581107425|FG010|Overall Study|Ongoing Treatment|0|||
160921804|NCT05407675|581107426|FG011|Overall Study|Ongoing Treatment|0|||
160921805|NCT05407675|581107427|FG012|Overall Study|Ongoing Treatment|0|||
160921806|NCT00857220|581107428|FG000|Overall Study|Adverse Event|35|||
160921807|NCT00857220|581107428|FG000|Overall Study|Death|1|||
160921808|NCT00857220|581107428|FG000|Overall Study|Lack of Efficacy|11|||
160921809|NCT00857220|581107428|FG000|Overall Study|Lost to Follow-up|30|||
160921810|NCT00857220|581107428|FG000|Overall Study|Physician Decision|4|||
160921811|NCT00857220|581107428|FG000|Overall Study|Protocol Violation|16|||
160921812|NCT00857220|581107428|FG000|Overall Study|Withdrawal by Subject|67|||
160921813|NCT00857220|581107428|FG000|Overall Study|Clinical Hold|6|||
160921814|NCT00857220|581107428|FG000|Overall Study|Site Closed|5|||
160921815|NCT00857220|581107428|FG000|Overall Study|Miscellaneous|8|||
160921816|NCT02612428|581107429|FG000|VTL-308|Death|14|||
160921817|NCT02612428|581107430|FG001|VTL-308|Death|16|||
160921818|NCT02612428|581107429|FG000|VTL-308|Withdrawal by Subject|0|||
160921819|NCT02612428|581107430|FG001|VTL-308|Withdrawal by Subject|1|||
160921820|NCT02612428|581107429|FG000|VTL-308E|Death|9|||
160921821|NCT02612428|581107430|FG001|VTL-308E|Death|7|||
160921822|NCT02612428|581107429|FG000|VTL-308E|Lost to Follow-up|2|||
160921823|NCT02612428|581107430|FG001|VTL-308E|Lost to Follow-up|0|||
160921824|NCT00742001|581107433|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
160921825|NCT00742001|581107434|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
160921826|NCT00742001|581107435|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
160921827|NCT00137423|581107436|FG000|Overall Study|Adverse Event|7|||
160921828|NCT00137423|581107437|FG001|Overall Study|Adverse Event|9|||
160921829|NCT00137423|581107436|FG000|Overall Study|consent withdrawn|1|||
160921830|NCT00137423|581107437|FG001|Overall Study|consent withdrawn|1|||
160921831|NCT00137423|581107436|FG000|Overall Study|Lack of Efficacy|31|||
160921832|NCT00137423|581107437|FG001|Overall Study|Lack of Efficacy|33|||
160921833|NCT00137423|581107436|FG000|Overall Study|Death|0|||
160921834|NCT00137423|581107437|FG001|Overall Study|Death|1|||
160921835|NCT03187262|581107439|FG000|Induction|Lack of Efficacy|2|||
160921836|NCT03187262|581107439|FG000|Induction|Progressive Disease|4|||
160921837|NCT03187262|581107439|FG000|Consolidation|Progressive Disease|5|||
160921838|NCT01050257|581107441|FG000|Overall Study|Adverse Event|4|||
160921839|NCT01050257|581107442|FG001|Overall Study|Adverse Event|4|||
160921840|NCT01050257|581107443|FG002|Overall Study|Adverse Event|2|||
160921841|NCT01050257|581107441|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
160921842|NCT01050257|581107442|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
160921843|NCT01050257|581107443|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
160921844|NCT01050257|581107441|FG000|Overall Study|Withdrawal by Subject|0|||
160921845|NCT01050257|581107442|FG001|Overall Study|Withdrawal by Subject|3|||
160454785|NCT01928394|579396176|FG006|Treatment Period|Lost to Follow-up|0|||
160454786|NCT01928394|579396177|FG007|Treatment Period|Lost to Follow-up|0|||
160454787|NCT01928394|579396178|FG008|Treatment Period|Lost to Follow-up|0|||
160575897|NCT04760314|579829197|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
160575898|NCT04760314|579829187|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
160921846|NCT01050257|581107443|FG002|Overall Study|Withdrawal by Subject|0|||
160921847|NCT01050257|581107441|FG000|Overall Study|No reason specified|0|||
160921848|NCT01050257|581107442|FG001|Overall Study|No reason specified|0|||
160921849|NCT01050257|581107443|FG002|Overall Study|No reason specified|2|||
160921850|NCT01050257|581107441|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
160921851|NCT01050257|581107442|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
160921852|NCT01050257|581107443|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
160921853|NCT01050257|581107441|FG000|Overall Study|Violation criteria|0|||
160921854|NCT01050257|581107442|FG001|Overall Study|Violation criteria|1|||
160921855|NCT01050257|581107443|FG002|Overall Study|Violation criteria|0|||
160921856|NCT01050257|581107441|FG000|Overall Study|Failure to return|0|||
160921857|NCT01050257|581107442|FG001|Overall Study|Failure to return|2|||
160921858|NCT01050257|581107443|FG002|Overall Study|Failure to return|0|||
160921859|NCT01050257|581107441|FG000|Overall Study|Death|0|||
160921860|NCT01050257|581107442|FG001|Overall Study|Death|0|||
160921861|NCT01050257|581107443|FG002|Overall Study|Death|1|||
160575899|NCT04760314|579829188|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
160575900|NCT04760314|579829189|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
160575901|NCT04760314|579829190|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
160921862|NCT00278109|581107444|FG000|Overall Study|Adverse Event|3|||
160921863|NCT00278109|581107444|FG000|Overall Study|social circumstances|1|||
160921864|NCT02580357|581107445|FG000|Overall Study|Lost to Follow-up|2|||
160921865|NCT02580357|581107446|FG001|Overall Study|Lost to Follow-up|0|||
160921866|NCT02580357|581107447|FG002|Overall Study|Lost to Follow-up|0|||
160921867|NCT02580357|581107445|FG000|Overall Study|Protocol Violation|1|||
160921868|NCT02580357|581107446|FG001|Overall Study|Protocol Violation|0|||
160921869|NCT02580357|581107447|FG002|Overall Study|Protocol Violation|0|||
160921870|NCT04128267|581107448|FG000|Overall Study|Withdrawal by Subject|6|||
160921871|NCT04128267|581107448|FG000|Overall Study|Death|2|||
160921872|NCT04128267|581107448|FG000|Overall Study|Disease progression|1|||
160921873|NCT04128267|581107448|FG000|Overall Study|Participant had other medical issues|4|||
160921874|NCT04128267|581107448|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
160921875|NCT01705652|581107452|FG000|Overall Study|Adverse Event|1|||
160921876|NCT01705652|581107453|FG001|Overall Study|Adverse Event|0|||
160921877|NCT01705652|581107452|FG000|Overall Study|Withdrawal by Subject|1|||
160921878|NCT01705652|581107453|FG001|Overall Study|Withdrawal by Subject|2|||
160921879|NCT01705652|581107452|FG000|Overall Study|non-compliance|1|||
160921880|NCT01705652|581107453|FG001|Overall Study|non-compliance|1|||
160921881|NCT00056407|581107455|FG000|Overall Study|Adverse Event|282|||
160921882|NCT00056407|581107456|FG001|Overall Study|Adverse Event|364|||
160921883|NCT00056407|581107455|FG000|Overall Study|Withdrawal by Subject|377|||
160921884|NCT00056407|581107456|FG001|Overall Study|Withdrawal by Subject|361|||
160921885|NCT00056407|581107455|FG000|Overall Study|Lost to Follow-up|123|||
160921886|NCT00056407|581107456|FG001|Overall Study|Lost to Follow-up|113|||
160921887|NCT00056407|581107455|FG000|Overall Study|Protocol Violation|104|||
160921888|NCT00056407|581107456|FG001|Overall Study|Protocol Violation|95|||
160575902|NCT04760314|579829191|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
160575903|NCT04760314|579829192|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
160575904|NCT04760314|579829193|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
160575905|NCT04760314|579829194|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
160575906|NCT04760314|579829195|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
160575907|NCT04760314|579829196|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
160575908|NCT04760314|579829197|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
160575909|NCT04760314|579829187|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160654724|NCT00329602|580117158|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
160654725|NCT00329602|580117156|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
160654726|NCT00329602|580117157|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
160654727|NCT00329602|580117158|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
160654728|NCT00329602|580117156|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
160654729|NCT00329602|580117157|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
160654730|NCT00329602|580117158|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
160654731|NCT00329602|580117156|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
160654732|NCT00329602|580117157|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
160921889|NCT00056407|581107455|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
160921890|NCT00056407|581107456|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
160575910|NCT04760314|579829188|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160575911|NCT04760314|579829189|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160575912|NCT04760314|579829190|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160575913|NCT04760314|579829191|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160575914|NCT04760314|579829192|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160575915|NCT04760314|579829193|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160575916|NCT04760314|579829194|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
160575917|NCT04760314|579829195|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160654733|NCT00329602|580117158|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
160654734|NCT02579096|580117159|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
160654735|NCT02579096|580117160|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
160921891|NCT00056407|581107455|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
160921892|NCT00056407|581107456|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
160921893|NCT00056407|581107455|FG000|Overall Study|Missing|25|||
160921894|NCT00056407|581107456|FG001|Overall Study|Missing|34|||
160921895|NCT00616655|581107457|FG000|Overall Study|Adverse Event|10|||
160921896|NCT00616655|581107458|FG001|Overall Study|Adverse Event|7|||
160575918|NCT04760314|579829196|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
160921897|NCT00616655|581107459|FG002|Overall Study|Adverse Event|12|||
160921898|NCT00616655|581107457|FG000|Overall Study|Lack of Efficacy|5|||
160921899|NCT00616655|581107458|FG001|Overall Study|Lack of Efficacy|5|||
160921900|NCT00616655|581107459|FG002|Overall Study|Lack of Efficacy|5|||
160575919|NCT04760314|579829197|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
160921901|NCT00616655|581107457|FG000|Overall Study|Lost to Follow-up|3|||
160921902|NCT00616655|581107458|FG001|Overall Study|Lost to Follow-up|12|||
160921903|NCT00616655|581107459|FG002|Overall Study|Lost to Follow-up|10|||
160921904|NCT00616655|581107457|FG000|Overall Study|Protocol Violation|2|||
160921905|NCT00616655|581107458|FG001|Overall Study|Protocol Violation|4|||
160921906|NCT00616655|581107459|FG002|Overall Study|Protocol Violation|3|||
160921907|NCT00616655|581107457|FG000|Overall Study|Withdrawal by Subject|9|||
160921908|NCT00616655|581107458|FG001|Overall Study|Withdrawal by Subject|7|||
160921909|NCT00616655|581107459|FG002|Overall Study|Withdrawal by Subject|11|||
160921910|NCT00616655|581107457|FG000|Overall Study|Does not meet in/ex criteria|0|||
160921911|NCT00616655|581107458|FG001|Overall Study|Does not meet in/ex criteria|0|||
160921912|NCT00616655|581107459|FG002|Overall Study|Does not meet in/ex criteria|2|||
160921913|NCT00616655|581107457|FG000|Overall Study|Other|6|||
160921914|NCT00616655|581107458|FG001|Overall Study|Other|6|||
160921915|NCT00616655|581107459|FG002|Overall Study|Other|5|||
160921916|NCT00309842|581107460|FG000|Overall Study|Lost to Follow-up|1|||
160921917|NCT01026792|581107461|FG000|Overall Study|Protocol Violation|1|||
160921918|NCT02335099|581107464|FG000|Treatment|Withdrawal by Subject|1|||
160921919|NCT02335099|581107465|FG001|Treatment|Withdrawal by Subject|3|||
160921920|NCT02335099|581107464|FG000|Treatment|Lost to Follow-up|2|||
160921921|NCT02335099|581107465|FG001|Treatment|Lost to Follow-up|0|||
160921922|NCT02335099|581107464|FG000|Treatment|Death|1|||
160921923|NCT02335099|581107465|FG001|Treatment|Death|0|||
160921924|NCT02335099|581107464|FG000|Treatment|Adverse Event|1|||
160921925|NCT02335099|581107465|FG001|Treatment|Adverse Event|2|||
160921926|NCT02335099|581107464|FG000|Follow-up|Death|0|||
160921927|NCT02335099|581107465|FG001|Follow-up|Death|1|||
160921928|NCT01472081|581107466|FG000|Overall Study|Continuing treatment at time of analysis|1|||
160921929|NCT01472081|581107467|FG001|Overall Study|Continuing treatment at time of analysis|4|||
160921930|NCT01472081|581107468|FG002|Overall Study|Continuing treatment at time of analysis|1|||
160921931|NCT01472081|581107469|FG003|Overall Study|Continuing treatment at time of analysis|8|||
160921932|NCT01472081|581107470|FG004|Overall Study|Continuing treatment at time of analysis|9|||
160921933|NCT01472081|581107471|FG005|Overall Study|Continuing treatment at time of analysis|0|||
160921934|NCT01472081|581107466|FG000|Overall Study|Disease Progression|4|||
160921935|NCT01472081|581107467|FG001|Overall Study|Disease Progression|10|||
160921936|NCT01472081|581107468|FG002|Overall Study|Disease Progression|12|||
160921937|NCT01472081|581107469|FG003|Overall Study|Disease Progression|31|||
160921938|NCT01472081|581107470|FG004|Overall Study|Disease Progression|22|||
160921939|NCT01472081|581107471|FG005|Overall Study|Disease Progression|3|||
160921940|NCT01472081|581107466|FG000|Overall Study|Study drug toxicity|2|||
160654736|NCT02579096|580117159|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
160921941|NCT01472081|581107467|FG001|Overall Study|Study drug toxicity|9|||
160921942|NCT01472081|581107468|FG002|Overall Study|Study drug toxicity|4|||
160921943|NCT01472081|581107469|FG003|Overall Study|Study drug toxicity|6|||
160921944|NCT01472081|581107470|FG004|Overall Study|Study drug toxicity|13|||
160921945|NCT01472081|581107471|FG005|Overall Study|Study drug toxicity|2|||
160921946|NCT01472081|581107466|FG000|Overall Study|Death|0|||
160921947|NCT01472081|581107467|FG001|Overall Study|Death|0|||
160921948|NCT01472081|581107468|FG002|Overall Study|Death|0|||
160921949|NCT01472081|581107469|FG003|Overall Study|Death|0|||
160921950|NCT01472081|581107470|FG004|Overall Study|Death|1|||
160921951|NCT01472081|581107471|FG005|Overall Study|Death|0|||
160921952|NCT01472081|581107466|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
160921953|NCT01472081|581107467|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
160921954|NCT01472081|581107468|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
160921955|NCT01472081|581107469|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
160921956|NCT01472081|581107470|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
160921957|NCT01472081|581107471|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
160921958|NCT01472081|581107466|FG000|Overall Study|Withdrawal by Subject|0|||
160997759|NCT01689519|581376623|FG000|Safety Population|Physician Decision|4|||
160997760|NCT01689519|581376624|FG001|Safety Population|Physician Decision|1|||
160921959|NCT01472081|581107467|FG001|Overall Study|Withdrawal by Subject|0|||
160921960|NCT01472081|581107468|FG002|Overall Study|Withdrawal by Subject|0|||
160921961|NCT01472081|581107469|FG003|Overall Study|Withdrawal by Subject|0|||
160921962|NCT01472081|581107470|FG004|Overall Study|Withdrawal by Subject|0|||
160921963|NCT01472081|581107471|FG005|Overall Study|Withdrawal by Subject|1|||
160997761|NCT01689519|581376623|FG000|Safety Population|Study Terminated By Sponsor|60|||
160921964|NCT01472081|581107466|FG000|Overall Study|Poor/non-compliance|0|||
160921965|NCT01472081|581107467|FG001|Overall Study|Poor/non-compliance|0|||
160921966|NCT01472081|581107468|FG002|Overall Study|Poor/non-compliance|1|||
160921967|NCT01472081|581107469|FG003|Overall Study|Poor/non-compliance|0|||
160921968|NCT01472081|581107470|FG004|Overall Study|Poor/non-compliance|1|||
160921969|NCT01472081|581107471|FG005|Overall Study|Poor/non-compliance|0|||
160921970|NCT01472081|581107466|FG000|Overall Study|No longer meets study criteria|0|||
160921971|NCT01472081|581107467|FG001|Overall Study|No longer meets study criteria|0|||
160921972|NCT01472081|581107468|FG002|Overall Study|No longer meets study criteria|1|||
160921973|NCT01472081|581107469|FG003|Overall Study|No longer meets study criteria|0|||
160921974|NCT01472081|581107470|FG004|Overall Study|No longer meets study criteria|0|||
160921975|NCT01472081|581107471|FG005|Overall Study|No longer meets study criteria|0|||
160921976|NCT01472081|581107466|FG000|Overall Study|Subject request to discontinue treatment|0|||
160921977|NCT01472081|581107467|FG001|Overall Study|Subject request to discontinue treatment|3|||
160921978|NCT01472081|581107468|FG002|Overall Study|Subject request to discontinue treatment|1|||
160921979|NCT01472081|581107469|FG003|Overall Study|Subject request to discontinue treatment|1|||
160921980|NCT01472081|581107470|FG004|Overall Study|Subject request to discontinue treatment|0|||
160921981|NCT01472081|581107471|FG005|Overall Study|Subject request to discontinue treatment|0|||
160921982|NCT01367158|581107472|FG000|Overall Study|Withdrew consent|0|||
160921983|NCT01367158|581107473|FG001|Overall Study|Withdrew consent|2|||
160921984|NCT01367158|581107474|FG002|Overall Study|Withdrew consent|1|||
160921985|NCT01367158|581107475|FG003|Overall Study|Withdrew consent|0|||
160921986|NCT01367158|581107476|FG004|Overall Study|Withdrew consent|2|||
160921987|NCT01367158|581107477|FG005|Overall Study|Withdrew consent|0|||
160921988|NCT01367158|581107478|FG006|Overall Study|Withdrew consent|0|||
160921989|NCT01367158|581107479|FG007|Overall Study|Withdrew consent|1|||
160921990|NCT01367158|581107480|FG008|Overall Study|Withdrew consent|0|||
160921991|NCT01367158|581107481|FG009|Overall Study|Withdrew consent|0|||
160921992|NCT01367158|581107482|FG010|Overall Study|Withdrew consent|0|||
160921993|NCT01367158|581107472|FG000|Overall Study|Lost to Follow-up|0|||
160921994|NCT01367158|581107473|FG001|Overall Study|Lost to Follow-up|0|||
160921995|NCT01367158|581107474|FG002|Overall Study|Lost to Follow-up|0|||
160921996|NCT01367158|581107475|FG003|Overall Study|Lost to Follow-up|1|||
160921997|NCT01367158|581107476|FG004|Overall Study|Lost to Follow-up|0|||
160921998|NCT01367158|581107477|FG005|Overall Study|Lost to Follow-up|2|||
160921999|NCT01367158|581107478|FG006|Overall Study|Lost to Follow-up|0|||
160922000|NCT01367158|581107479|FG007|Overall Study|Lost to Follow-up|1|||
160922001|NCT01367158|581107480|FG008|Overall Study|Lost to Follow-up|0|||
160922002|NCT01367158|581107481|FG009|Overall Study|Lost to Follow-up|0|||
160922003|NCT01367158|581107482|FG010|Overall Study|Lost to Follow-up|1|||
160922004|NCT01367158|581107472|FG000|Overall Study|Protocol Violation|0|||
160575920|NCT04760314|579829187|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160575921|NCT04760314|579829188|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160575922|NCT04760314|579829189|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160922005|NCT01367158|581107473|FG001|Overall Study|Protocol Violation|1|||
160922006|NCT01367158|581107474|FG002|Overall Study|Protocol Violation|0|||
160922007|NCT01367158|581107475|FG003|Overall Study|Protocol Violation|0|||
160454788|NCT01928394|579396179|FG009|Treatment Period|Lost to Follow-up|0|||
160454789|NCT01928394|579396180|FG010|Treatment Period|Lost to Follow-up|0|||
160454790|NCT01928394|579396181|FG011|Treatment Period|Lost to Follow-up|0|||
160454791|NCT01928394|579396182|FG012|Treatment Period|Lost to Follow-up|0|||
160454792|NCT01928394|579396183|FG013|Treatment Period|Lost to Follow-up|0|||
160454793|NCT01928394|579396184|FG014|Treatment Period|Lost to Follow-up|0|||
160454794|NCT01928394|579396185|FG015|Treatment Period|Lost to Follow-up|0|||
160454795|NCT01928394|579396186|FG016|Treatment Period|Lost to Follow-up|0|||
160575923|NCT04760314|579829190|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160575924|NCT04760314|579829191|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160575925|NCT04760314|579829192|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160575926|NCT04760314|579829193|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160922008|NCT01367158|581107476|FG004|Overall Study|Protocol Violation|0|||
160922009|NCT01367158|581107477|FG005|Overall Study|Protocol Violation|0|||
160922010|NCT01367158|581107478|FG006|Overall Study|Protocol Violation|0|||
160922011|NCT01367158|581107479|FG007|Overall Study|Protocol Violation|0|||
160922012|NCT01367158|581107480|FG008|Overall Study|Protocol Violation|0|||
160922013|NCT01367158|581107481|FG009|Overall Study|Protocol Violation|0|||
160922014|NCT01367158|581107482|FG010|Overall Study|Protocol Violation|0|||
160922015|NCT01765153|581107483|FG000|Training Phase 1|Format of intervention differed|1|||
160922016|NCT01765153|581107484|FG001|Training Phase 1|Format of intervention differed|0|||
160922017|NCT01765153|581107483|FG000|Training Phase 1|Poor participation in intervention|0|||
160922018|NCT01765153|581107484|FG001|Training Phase 1|Poor participation in intervention|1|||
160922019|NCT01765153|581107483|FG000|Rest Phase 1|Withdrawal by Subject|0|||
160922020|NCT01765153|581107484|FG001|Rest Phase 1|Withdrawal by Subject|1|||
160922021|NCT01765153|581107483|FG000|Training Phase 2|Withdrawal by Subject|0|||
160922022|NCT01765153|581107484|FG001|Training Phase 2|Withdrawal by Subject|1|||
160922023|NCT01765153|581107483|FG000|Rest Phase 2|Lost to Follow-up|2|||
160922024|NCT01765153|581107484|FG001|Rest Phase 2|Lost to Follow-up|1|||
160922025|NCT04702997|581107485|FG000|Overall Study|Withdrawal by Subject|1|||
160454796|NCT01928394|579396187|FG017|Treatment Period|Lost to Follow-up|0|||
160454797|NCT01928394|579396188|FG018|Treatment Period|Lost to Follow-up|0|||
160922026|NCT04702997|581107486|FG001|Overall Study|Withdrawal by Subject|1|||
160922027|NCT03915496|581107487|FG000|Overall Study|Adverse Event|2|||
160922028|NCT03915496|581107488|FG001|Overall Study|Adverse Event|1|||
160922029|NCT03915496|581107489|FG002|Overall Study|Adverse Event|2|||
160922030|NCT02663674|581107490|FG000|Overall Study|Lost to Follow-up|5|||
160922031|NCT02663674|581107491|FG001|Overall Study|Lost to Follow-up|4|||
160922032|NCT02663674|581107490|FG000|Overall Study|Withdrawal by Subject|1|||
160575927|NCT04760314|579829194|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
160575928|NCT04760314|579829195|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
160575929|NCT04760314|579829196|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
160575930|NCT04760314|579829197|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160575931|NCT04760314|579829187|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160575932|NCT04760314|579829188|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160575933|NCT04760314|579829189|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160575934|NCT04760314|579829190|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160575935|NCT04760314|579829191|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160575936|NCT04760314|579829192|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160575937|NCT04760314|579829193|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160575938|NCT04760314|579829194|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
160575939|NCT04760314|579829195|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160575940|NCT04760314|579829196|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160575941|NCT04760314|579829197|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160575942|NCT04760314|579829187|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
160575943|NCT04760314|579829188|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
160575944|NCT04760314|579829189|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
160575945|NCT04760314|579829190|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
160575946|NCT04760314|579829191|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
160575947|NCT04760314|579829192|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
160575948|NCT04760314|579829193|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
160575949|NCT04760314|579829194|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
160575950|NCT04760314|579829195|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
160575951|NCT04760314|579829196|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
160575952|NCT04760314|579829197|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
160575953|NCT00634543|579829201|FG000|Overall Study|Other|1|||
160575954|NCT00634543|579829202|FG001|Overall Study|Other|2|||
160575955|NCT00634543|579829201|FG000|Overall Study|Protocol Violation|3|||
160575956|NCT00634543|579829202|FG001|Overall Study|Protocol Violation|3|||
160575957|NCT00634543|579829201|FG000|Overall Study|Adverse Event|11|||
160575958|NCT00634543|579829202|FG001|Overall Study|Adverse Event|11|||
160575959|NCT00634543|579829201|FG000|Overall Study|Withdrawal by Subject|4|||
160575960|NCT00634543|579829202|FG001|Overall Study|Withdrawal by Subject|4|||
160575961|NCT00634543|579829201|FG000|Overall Study|Lost to Follow-up|0|||
160575962|NCT00634543|579829202|FG001|Overall Study|Lost to Follow-up|1|||
160575963|NCT01013883|579829203|FG000|Overall Study|Lost to Follow-up|2|||
160575964|NCT01013883|579829204|FG001|Overall Study|Lost to Follow-up|2|||
160575965|NCT01371838|579829205|FG000|Overall Study|Withdrawal by Subject|27|||
160575966|NCT01371838|579829206|FG001|Overall Study|Withdrawal by Subject|33|||
160575967|NCT01371838|579829205|FG000|Overall Study|Lost to Follow-up|10|||
160575968|NCT01371838|579829206|FG001|Overall Study|Lost to Follow-up|20|||
160575969|NCT01371838|579829205|FG000|Overall Study|Death|3|||
160575970|NCT01371838|579829206|FG001|Overall Study|Death|4|||
160922033|NCT02663674|581107491|FG001|Overall Study|Withdrawal by Subject|4|||
160922034|NCT02663674|581107490|FG000|Overall Study|Physician Decision|1|||
160922035|NCT02663674|581107491|FG001|Overall Study|Physician Decision|1|||
160922036|NCT02663674|581107490|FG000|Overall Study|Other Event (Health Related)|0|||
160922037|NCT02663674|581107491|FG001|Overall Study|Other Event (Health Related)|1|||
160922038|NCT01386554|581107494|FG000|Overall Study|Lost to Follow-up|0|||
160922039|NCT01386554|581107495|FG001|Overall Study|Lost to Follow-up|0|||
160922040|NCT01386554|581107496|FG002|Overall Study|Lost to Follow-up|1|||
160922041|NCT01386554|581107494|FG000|Overall Study|Adverse Event|2|||
160922042|NCT01386554|581107495|FG001|Overall Study|Adverse Event|5|||
160922043|NCT01386554|581107496|FG002|Overall Study|Adverse Event|2|||
160922044|NCT01386554|581107494|FG000|Overall Study|Progressive disease|1|||
160922045|NCT01386554|581107495|FG001|Overall Study|Progressive disease|2|||
160922046|NCT01386554|581107496|FG002|Overall Study|Progressive disease|2|||
160922047|NCT01386554|581107494|FG000|Overall Study|Administration of live vaccines|0|||
160575971|NCT01371838|579829205|FG000|Overall Study|Protocol Violation|3|||
160575972|NCT01371838|579829206|FG001|Overall Study|Protocol Violation|0|||
160575973|NCT01371838|579829205|FG000|Overall Study|Investigator Decision|3|||
160575974|NCT01371838|579829206|FG001|Overall Study|Investigator Decision|8|||
160575975|NCT01371838|579829205|FG000|Overall Study|Last follow-up visit not conducted|2|||
160575976|NCT01371838|579829206|FG001|Overall Study|Last follow-up visit not conducted|0|||
160575977|NCT01371838|579829205|FG000|Overall Study|Lack of therapeutic response|0|||
160575978|NCT01371838|579829206|FG001|Overall Study|Lack of therapeutic response|1|||
160575979|NCT01371838|579829205|FG000|Overall Study|Surgery|1|||
160575980|NCT01371838|579829206|FG001|Overall Study|Surgery|0|||
160575981|NCT03515538|579829211|FG000|Overall Study|Lack of Efficacy|2|||
160575982|NCT03515538|579829212|FG001|Overall Study|Lack of Efficacy|0|||
160922048|NCT01386554|581107495|FG001|Overall Study|Administration of live vaccines|1|||
160922049|NCT01386554|581107496|FG002|Overall Study|Administration of live vaccines|0|||
160922050|NCT01386554|581107494|FG000|Overall Study|Investigator discretion|0|||
160997762|NCT01689519|581376624|FG001|Safety Population|Study Terminated By Sponsor|47|||
160997763|NCT01689519|581376623|FG000|Safety Population|Withdrawal by Subject|20|||
160997764|NCT01689519|581376624|FG001|Safety Population|Withdrawal by Subject|20|||
160997765|NCT00217672|581376626|FG000|Allocation|Ineligible|2|||
160997766|NCT00217672|581376627|FG001|Allocation|Ineligible|0|||
160997767|NCT00217672|581376626|FG000|Treatment|disease progression|33|||
160997768|NCT00217672|581376627|FG001|Treatment|disease progression|4|||
160997769|NCT00217672|581376626|FG000|Treatment|Adverse Event|18|||
160997770|NCT00217672|581376627|FG001|Treatment|Adverse Event|2|||
160997771|NCT00217672|581376626|FG000|Treatment|reqd treatment not permitted by protocol|6|||
160997772|NCT00217672|581376627|FG001|Treatment|reqd treatment not permitted by protocol|0|||
160997773|NCT00217672|581376626|FG000|Treatment|Physician Decision|6|||
160997774|NCT00217672|581376627|FG001|Treatment|Physician Decision|0|||
160997775|NCT00217672|581376626|FG000|Treatment|insurance issues|1|||
160997776|NCT00217672|581376627|FG001|Treatment|insurance issues|1|||
160997777|NCT00217672|581376626|FG000|Treatment|Death|2|||
160997778|NCT00217672|581376627|FG001|Treatment|Death|0|||
160997779|NCT00217672|581376626|FG000|Treatment|secondary malignancy|1|||
160997780|NCT00217672|581376627|FG001|Treatment|secondary malignancy|0|||
160997781|NCT00217672|581376626|FG000|Follow-up|Withdrawal by Subject|4|||
160997782|NCT00217672|581376627|FG001|Follow-up|Withdrawal by Subject|0|||
160997783|NCT00217672|581376626|FG000|Follow-up|Lost to Follow-up|1|||
160997784|NCT00217672|581376627|FG001|Follow-up|Lost to Follow-up|0|||
160997785|NCT01959412|581376631|FG000|Overall Study|Protocol deviation|1|||
160997786|NCT01959412|581376632|FG001|Overall Study|Protocol deviation|1|||
160997787|NCT01959412|581376633|FG002|Overall Study|Protocol deviation|0|||
160997788|NCT01959412|581376634|FG003|Overall Study|Protocol deviation|1|||
160997789|NCT01959412|581376635|FG004|Overall Study|Protocol deviation|3|||
160997790|NCT01959412|581376636|FG005|Overall Study|Protocol deviation|0|||
160997791|NCT01959412|581376631|FG000|Overall Study|Adverse Event|0|||
160997792|NCT01959412|581376632|FG001|Overall Study|Adverse Event|0|||
160997793|NCT01959412|581376633|FG002|Overall Study|Adverse Event|0|||
160997794|NCT01959412|581376634|FG003|Overall Study|Adverse Event|1|||
160922051|NCT01386554|581107495|FG001|Overall Study|Investigator discretion|0|||
160922052|NCT01386554|581107496|FG002|Overall Study|Investigator discretion|1|||
160922053|NCT01386554|581107494|FG000|Overall Study|Reason not collected|0|||
160922054|NCT01386554|581107495|FG001|Overall Study|Reason not collected|1|||
160922055|NCT01386554|581107496|FG002|Overall Study|Reason not collected|0|||
160922056|NCT00353262|581107497|FG000|Overall Study|Adverse Event|8|||
160922057|NCT00353262|581107497|FG000|Overall Study|Withdrawal by Subject|2|||
160922058|NCT00353262|581107497|FG000|Overall Study|Insufficient Therapeutic Response|13|||
160922059|NCT00353262|581107497|FG000|Overall Study|Progression|1|||
160922060|NCT00353262|581107497|FG000|Overall Study|Surgery|4|||
160922061|NCT00353262|581107497|FG000|Overall Study|Break from Chemotherapy|1|||
160922062|NCT04166513|581107498|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
160922063|NCT04166513|581107499|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
160922064|NCT04166513|581107500|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
160922065|NCT04166513|581107501|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
160922066|NCT04166513|581107498|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
160922067|NCT04166513|581107499|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
160922068|NCT04166513|581107500|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
160922069|NCT04166513|581107501|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
160922070|NCT04166513|581107498|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
160922071|NCT04166513|581107499|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
160922072|NCT04166513|581107500|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
160922073|NCT04166513|581107501|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
160922074|NCT04166513|581107498|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
160922075|NCT04166513|581107499|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
160922076|NCT04166513|581107500|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
160922077|NCT04166513|581107501|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
160922078|NCT04166513|581107498|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
160922079|NCT04166513|581107499|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
160922080|NCT04166513|581107500|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
160997795|NCT01959412|581376635|FG004|Overall Study|Adverse Event|0|||
160654737|NCT02579096|580117160|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
160997796|NCT01959412|581376636|FG005|Overall Study|Adverse Event|0|||
160997797|NCT04379713|581376640|FG000|Overall Study|Adverse Event|2|||
160997798|NCT04379713|581376641|FG001|Overall Study|Adverse Event|0|||
160997799|NCT04379713|581376640|FG000|Overall Study|Physician Decision|2|||
160997800|NCT04379713|581376641|FG001|Overall Study|Physician Decision|1|||
160997801|NCT04379713|581376640|FG000|Overall Study|Protocol Violation|11|||
160997802|NCT04379713|581376641|FG001|Overall Study|Protocol Violation|6|||
160997803|NCT04379713|581376640|FG000|Overall Study|No longer met eligibility criteria|14|||
160922081|NCT04166513|581107501|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
160922082|NCT05286307|581107502|FG000|Overall Study|Incomplete outcome assessments|2|||
160997804|NCT04379713|581376641|FG001|Overall Study|No longer met eligibility criteria|11|||
160997805|NCT04379713|581376640|FG000|Overall Study|Withdrawal by parent/guardian|36|||
160454798|NCT01928394|579396189|FG019|Treatment Period|Lost to Follow-up|0|||
160454799|NCT01928394|579396190|FG020|Treatment Period|Lost to Follow-up|0|||
160454800|NCT01928394|579396191|FG021|Treatment Period|Lost to Follow-up|0|||
160575983|NCT03515538|579829213|FG002|Overall Study|Lack of Efficacy|2|||
160922083|NCT05286307|581107503|FG001|Overall Study|Incomplete outcome assessments|1|||
160922084|NCT05286307|581107502|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
160922085|NCT05286307|581107503|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
160922086|NCT05286307|581107502|FG000|Overall Study|Lost to follow up at 6 months|25|||
160922087|NCT05286307|581107503|FG001|Overall Study|Lost to follow up at 6 months|35|||
160922088|NCT05286307|581107502|FG000|Overall Study|Study medication not available|1|||
160922089|NCT05286307|581107503|FG001|Overall Study|Study medication not available|1|||
160922090|NCT04219891|581107504|FG000|Overall Study|Lost to Follow-up|3|||
160922091|NCT04219891|581107504|FG000|Overall Study|Withdrawal by Subject|2|||
160922092|NCT03712904|581108420|FG000|Overall Study|Death|0|||
160575984|NCT03515538|579829214|FG003|Overall Study|Lack of Efficacy|0|||
160922093|NCT03712904|581108421|FG001|Overall Study|Death|1|||
160922094|NCT03712904|581108420|FG000|Overall Study|Withdrawal by Subject|0|||
160922095|NCT03712904|581108421|FG001|Overall Study|Withdrawal by Subject|1|||
160922096|NCT03712904|581108420|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
160922097|NCT03712904|581108421|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
160922098|NCT04568590|581108422|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
160922099|NCT01190254|581108425|FG000|Overall Study|Adverse Event|3|||
160922100|NCT01190254|581108426|FG001|Overall Study|Adverse Event|6|||
160922101|NCT01190254|581108427|FG002|Overall Study|Adverse Event|8|||
160922102|NCT01190254|581108425|FG000|Overall Study|Lack of Efficacy|7|||
160922103|NCT01190254|581108426|FG001|Overall Study|Lack of Efficacy|4|||
160922104|NCT01190254|581108427|FG002|Overall Study|Lack of Efficacy|5|||
160922105|NCT01190254|581108425|FG000|Overall Study|Lost to Follow-up|4|||
160922106|NCT01190254|581108426|FG001|Overall Study|Lost to Follow-up|2|||
160922107|NCT01190254|581108427|FG002|Overall Study|Lost to Follow-up|0|||
160922108|NCT01190254|581108425|FG000|Overall Study|Withdrawal by Subject|4|||
160922109|NCT01190254|581108426|FG001|Overall Study|Withdrawal by Subject|5|||
160922110|NCT01190254|581108427|FG002|Overall Study|Withdrawal by Subject|7|||
160922111|NCT01190254|581108425|FG000|Overall Study|Protocol Violation|2|||
160922112|NCT01190254|581108426|FG001|Overall Study|Protocol Violation|0|||
160922113|NCT01190254|581108427|FG002|Overall Study|Protocol Violation|2|||
160922114|NCT01190254|581108425|FG000|Overall Study|Did not meet protocol eligibility|1|||
160922115|NCT01190254|581108426|FG001|Overall Study|Did not meet protocol eligibility|0|||
160922116|NCT01190254|581108427|FG002|Overall Study|Did not meet protocol eligibility|0|||
160922117|NCT00773292|581108428|FG000|Treatment 48 Weeks|Adverse Event|1|||
160922118|NCT00773292|581108428|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
160922119|NCT01485640|581108429|FG000|Overall Study|Adverse Event|10|||
160922120|NCT01485640|581108429|FG000|Overall Study|Lack of Efficacy|2|||
160922121|NCT01485640|581108429|FG000|Overall Study|Protocol Violation|1|||
160922122|NCT01485640|581108429|FG000|Overall Study|Withdrawal by Subject|14|||
160922123|NCT01485640|581108429|FG000|Overall Study|Terminated by Sponsor|95|||
160922124|NCT00202644|581108432|FG000|Overall Study|Adverse Event|12|||
160922125|NCT00202644|581108433|FG001|Overall Study|Adverse Event|13|||
160922126|NCT00202644|581108432|FG000|Overall Study|Withdrawal by Subject|8|||
160922127|NCT00202644|581108433|FG001|Overall Study|Withdrawal by Subject|6|||
160922128|NCT00202644|581108432|FG000|Overall Study|Lack of Efficacy|6|||
160922129|NCT00202644|581108433|FG001|Overall Study|Lack of Efficacy|6|||
160922130|NCT00202644|581108432|FG000|Overall Study|Lost to Follow-up|0|||
160922131|NCT00202644|581108433|FG001|Overall Study|Lost to Follow-up|1|||
160922132|NCT00202644|581108432|FG000|Overall Study|Other|9|||
160922133|NCT00202644|581108433|FG001|Overall Study|Other|1|||
160922134|NCT03232281|581108439|FG000|Overall Study|Adverse Event|1|||
160922135|NCT03232281|581108440|FG001|Overall Study|Adverse Event|1|||
160922136|NCT03232281|581108439|FG000|Overall Study|Withdrawal by Subject|5|||
160922137|NCT03232281|581108440|FG001|Overall Study|Withdrawal by Subject|4|||
160922138|NCT03232281|581108439|FG000|Overall Study|Protocol Deviation|1|||
160922139|NCT03232281|581108440|FG001|Overall Study|Protocol Deviation|1|||
160922140|NCT01372501|581108444|FG000|Overall Study|Adverse Event|4|||
160922141|NCT01372501|581108444|FG000|Overall Study|Device migration|1|||
160922142|NCT02489344|581108445|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
160922143|NCT02489344|581108445|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
160922144|NCT02489344|581108445|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
160922145|NCT02489344|581108445|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
160922146|NCT01132482|581108446|FG000|Overall Study|Adverse Event|1|||
160922147|NCT01132482|581108447|FG001|Overall Study|Adverse Event|0|||
160922148|NCT05333900|581108448|FG000|Overall Study|Protocol Violation|0|||
160922149|NCT05333900|581108449|FG001|Overall Study|Protocol Violation|1|||
160922150|NCT05333900|581108448|FG000|Overall Study|Withdrawal by Subject|0|||
160575985|NCT03515538|579829211|FG000|Overall Study|Death|0|||
160575986|NCT03515538|579829212|FG001|Overall Study|Death|0|||
160922151|NCT05333900|581108449|FG001|Overall Study|Withdrawal by Subject|1|||
160922152|NCT05333900|581108448|FG000|Overall Study|COVID-19 Pandemic|1|||
160922153|NCT05333900|581108449|FG001|Overall Study|COVID-19 Pandemic|1|||
160922154|NCT00573755|581108450|FG000|Overall Study|Still receiving treatment|1|||
160922155|NCT00573755|581108451|FG001|Overall Study|Still receiving treatment|0|||
160922156|NCT03724812|581108452|FG000|Overall Study|Missed Visit|1|||
160922157|NCT03724812|581108452|FG000|Overall Study|Death|2|||
160922158|NCT03724812|581108452|FG000|Overall Study|Withdrawal by Subject|1|||
160922159|NCT03525574|581108456|FG000|Overall Study|Adverse Event|15|||
160922160|NCT03525574|581108457|FG001|Overall Study|Adverse Event|0|||
160922161|NCT03525574|581108456|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
160922162|NCT03525574|581108457|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
160922163|NCT03525574|581108456|FG000|Overall Study|Lost to Follow-up|4|||
160922164|NCT03525574|581108457|FG001|Overall Study|Lost to Follow-up|0|||
160922165|NCT03525574|581108456|FG000|Overall Study|Commercial drug is Available for participant|48|||
160922166|NCT03525574|581108457|FG001|Overall Study|Commercial drug is Available for participant|0|||
160922167|NCT03525574|581108456|FG000|Overall Study|Death|1|||
160922168|NCT03525574|581108457|FG001|Overall Study|Death|0|||
160922169|NCT03525574|581108456|FG000|Overall Study|Other non-compliance|2|||
160922170|NCT03525574|581108457|FG001|Overall Study|Other non-compliance|0|||
160922171|NCT03525574|581108456|FG000|Overall Study|Physician Decision|6|||
160575987|NCT03515538|579829213|FG002|Overall Study|Death|1|||
160575988|NCT03515538|579829214|FG003|Overall Study|Death|0|||
160922172|NCT03525574|581108457|FG001|Overall Study|Physician Decision|0|||
160922173|NCT03525574|581108456|FG000|Overall Study|Other|58|||
160922174|NCT03525574|581108457|FG001|Overall Study|Other|0|||
160922175|NCT03525574|581108456|FG000|Overall Study|Enrolled but never dosed|1|||
160922176|NCT03525574|581108457|FG001|Overall Study|Enrolled but never dosed|0|||
160922177|NCT03525574|581108456|FG000|Overall Study|Not enrolled in 105 study|0|||
160922178|NCT03525574|581108457|FG001|Overall Study|Not enrolled in 105 study|3|||
160922179|NCT02769247|581108463|FG000|Overall Study|Withdrawal by Subject|1|||
160922180|NCT02769247|581108464|FG001|Overall Study|Withdrawal by Subject|0|||
160922181|NCT02769247|581108465|FG002|Overall Study|Withdrawal by Subject|0|||
160922182|NCT02769247|581108466|FG003|Overall Study|Withdrawal by Subject|1|||
160922183|NCT02769247|581108463|FG000|Overall Study|Protocol Violation|0|||
160922184|NCT02769247|581108464|FG001|Overall Study|Protocol Violation|0|||
160922185|NCT02769247|581108465|FG002|Overall Study|Protocol Violation|1|||
160922186|NCT02769247|581108466|FG003|Overall Study|Protocol Violation|0|||
160922187|NCT02769247|581108463|FG000|Overall Study|Physician Decision|1|||
160922188|NCT02769247|581108464|FG001|Overall Study|Physician Decision|0|||
160922189|NCT02769247|581108465|FG002|Overall Study|Physician Decision|0|||
160922190|NCT02769247|581108466|FG003|Overall Study|Physician Decision|0|||
160922191|NCT02024867|581108467|FG000|Overall Study|Protocol Violation|3|||
160922192|NCT02024867|581108468|FG001|Overall Study|Protocol Violation|3|||
160922193|NCT02024867|581108467|FG000|Overall Study|Lost to Follow-up|6|||
160922194|NCT02024867|581108468|FG001|Overall Study|Lost to Follow-up|4|||
160922195|NCT01086540|581108471|FG000|Overall Study|Death|3|||
160922196|NCT01086540|581108472|FG001|Overall Study|Death|1|||
160922197|NCT01086540|581108471|FG000|Overall Study|Physician Decision|2|||
160922198|NCT01086540|581108472|FG001|Overall Study|Physician Decision|1|||
160922199|NCT01086540|581108471|FG000|Overall Study|Addition of new therapy for PAH|1|||
160922200|NCT01086540|581108472|FG001|Overall Study|Addition of new therapy for PAH|0|||
160922201|NCT01998737|581108473|FG000|Overall Study|Corrupted database|23|||
160922202|NCT01998737|581108474|FG001|Overall Study|Corrupted database|0|||
160922205|NCT02092662|581108477|FG000|Overall Study|Lost to Follow-up|13|||
160922206|NCT02092662|581108478|FG001|Overall Study|Lost to Follow-up|0|||
160922207|NCT02710045|581108479|FG000|Overall Study|Death|1|||
160922208|NCT02710045|581108480|FG001|Overall Study|Death|2|||
160997806|NCT04379713|581376641|FG001|Overall Study|Withdrawal by parent/guardian|15|||
160997807|NCT04379713|581376640|FG000|Overall Study|Lost to Follow-up|31|||
160922209|NCT02710045|581108481|FG002|Overall Study|Death|0|||
160922210|NCT02710045|581108479|FG000|Overall Study|Withdrawal by Subject|6|||
160922211|NCT02710045|581108480|FG001|Overall Study|Withdrawal by Subject|6|||
160922212|NCT02710045|581108481|FG002|Overall Study|Withdrawal by Subject|2|||
160922213|NCT02710045|581108479|FG000|Overall Study|Protocol Violation|1|||
160922214|NCT02710045|581108480|FG001|Overall Study|Protocol Violation|2|||
160922215|NCT02710045|581108481|FG002|Overall Study|Protocol Violation|3|||
160922216|NCT02710045|581108479|FG000|Overall Study|Lost to Follow-up|3|||
160922217|NCT02710045|581108480|FG001|Overall Study|Lost to Follow-up|6|||
160922218|NCT02710045|581108481|FG002|Overall Study|Lost to Follow-up|7|||
160922219|NCT02710045|581108479|FG000|Overall Study|Physician Decision|0|||
160922220|NCT02710045|581108480|FG001|Overall Study|Physician Decision|0|||
160922221|NCT02710045|581108481|FG002|Overall Study|Physician Decision|1|||
160922222|NCT02710045|581108479|FG000|Overall Study|Poor Attendance|0|||
160922223|NCT02710045|581108480|FG001|Overall Study|Poor Attendance|1|||
160922224|NCT02710045|581108481|FG002|Overall Study|Poor Attendance|0|||
160922225|NCT00227305|581108484|FG000|Overall Study|Adverse Event|40|||
160922226|NCT00227305|581108484|FG000|Overall Study|Withdrawal by Subject|42|||
160922227|NCT00227305|581108484|FG000|Overall Study|Lost to Follow-up|33|||
160922228|NCT00227305|581108484|FG000|Overall Study|Study specific discontinuation|13|||
160922229|NCT00227305|581108484|FG000|Overall Study|MOVED OUT OF AREA|3|||
160922230|NCT00227305|581108484|FG000|Overall Study|Lack of Efficacy|7|||
160922231|NCT00227305|581108484|FG000|Overall Study|Physician Decision|3|||
160922232|NCT00227305|581108484|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
160922233|NCT00227305|581108484|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
160922234|NCT00227305|581108484|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
160922235|NCT04339296|581108491|FG000|Overall Study|Refuse to participate after allocation|1|||
160922236|NCT04339296|581108492|FG001|Overall Study|Refuse to participate after allocation|1|||
160922237|NCT04339296|581108491|FG000|Overall Study|Withdrew after completion of baseline|2|||
160922238|NCT04339296|581108492|FG001|Overall Study|Withdrew after completion of baseline|1|||
160922239|NCT04339296|581108491|FG000|Overall Study|Lost to Follow-up|0|||
160922240|NCT04339296|581108492|FG001|Overall Study|Lost to Follow-up|4|||
160922241|NCT04339296|581108491|FG000|Overall Study|Discontinued intervention|5|||
160922242|NCT04339296|581108492|FG001|Overall Study|Discontinued intervention|3|||
160922243|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922244|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
160922245|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922246|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922247|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922248|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922249|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922250|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
160922251|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
160922252|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
160922253|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
160922254|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
160922255|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
160922256|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
160922257|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
160922258|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
160922259|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
160922260|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
160922261|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
160922262|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
160922263|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
160922264|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
160922265|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
160922266|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
160922267|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
160922268|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
160997808|NCT04379713|581376641|FG001|Overall Study|Lost to Follow-up|21|||
160997809|NCT00158054|581376642|FG000|Overall Study|Refused to continue|3|||
160575989|NCT03515538|579829211|FG000|Overall Study|Protocol Violation|0|||
160575990|NCT03515538|579829212|FG001|Overall Study|Protocol Violation|0|||
160575991|NCT03515538|579829213|FG002|Overall Study|Protocol Violation|0|||
160575992|NCT03515538|579829214|FG003|Overall Study|Protocol Violation|1|||
160575993|NCT03515538|579829211|FG000|Overall Study|Screen failure (baseline dropout)|0|||
160575994|NCT03515538|579829212|FG001|Overall Study|Screen failure (baseline dropout)|1|||
160575995|NCT03515538|579829213|FG002|Overall Study|Screen failure (baseline dropout)|0|||
160575996|NCT03515538|579829214|FG003|Overall Study|Screen failure (baseline dropout)|0|||
160575997|NCT03515538|579829211|FG000|Overall Study|Withdrawal by Subject|2|||
160575998|NCT03515538|579829212|FG001|Overall Study|Withdrawal by Subject|2|||
160575999|NCT03515538|579829213|FG002|Overall Study|Withdrawal by Subject|1|||
160576000|NCT03515538|579829214|FG003|Overall Study|Withdrawal by Subject|3|||
160576001|NCT03515538|579829211|FG000|Overall Study|Physician Decision|1|||
160576002|NCT03515538|579829212|FG001|Overall Study|Physician Decision|0|||
160576003|NCT03515538|579829213|FG002|Overall Study|Physician Decision|0|||
160576004|NCT03515538|579829214|FG003|Overall Study|Physician Decision|1|||
160922269|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
160922270|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
160922271|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
160576005|NCT02345161|579829217|FG000|Overall Study|Withdrawal by Subject|25|||
160576006|NCT02345161|579829218|FG001|Overall Study|Withdrawal by Subject|33|||
160576007|NCT02345161|579829217|FG000|Overall Study|Adverse Event|16|||
160576008|NCT02345161|579829218|FG001|Overall Study|Adverse Event|19|||
160922272|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
160922273|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
160922274|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
160922275|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
160922276|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
160922277|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
160922278|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160922279|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160922280|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160576009|NCT02345161|579829217|FG000|Overall Study|Physician Decision|4|||
160576010|NCT02345161|579829218|FG001|Overall Study|Physician Decision|4|||
160576011|NCT02345161|579829217|FG000|Overall Study|Lost to Follow-up|0|||
160576012|NCT02345161|579829218|FG001|Overall Study|Lost to Follow-up|1|||
160576013|NCT03088605|579829219|FG000|Overall Study|Withdrawal by Subject|1|||
160922281|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160922282|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160922283|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
160922284|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160922285|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
160922286|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
160922287|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
160922288|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
160922289|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
160922290|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
160922291|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
160922292|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922293|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922294|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922295|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922296|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922297|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922298|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
160922299|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
160922300|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
160922301|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
160922302|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
160922303|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
160922304|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
160922305|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
160922306|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
160922307|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
160922308|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
160922309|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
160922310|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
160922311|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
160922312|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
160922313|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
160922314|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
160922315|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
160922316|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
160922317|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
160922318|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
160922319|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
160922320|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
160922321|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
160922322|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
160922323|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
160922324|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
160576014|NCT03088605|579829220|FG001|Overall Study|Withdrawal by Subject|0|||
160922325|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
160922326|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
160922327|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
160922328|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
160922329|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
160922330|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
160922331|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
160922332|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
160922333|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
160922334|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
160922335|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
160922336|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
160922337|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
160922338|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
160922339|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
160922340|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
160922341|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922342|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922343|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
160922344|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922345|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922346|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922347|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922348|NCT03424265|581108501|FG000|Overall Study|screening failure|1|||
160922349|NCT03424265|581108502|FG001|Overall Study|screening failure|0|||
160922350|NCT03424265|581108501|FG000|Overall Study|Withdrawal by Subject|0|||
160922351|NCT03424265|581108502|FG001|Overall Study|Withdrawal by Subject|2|||
160922352|NCT00453544|581108503|FG000|Overall Study|Withdrawal by Subject|1|||
160922353|NCT00453544|581108504|FG001|Overall Study|Withdrawal by Subject|0|||
160922354|NCT00453544|581108505|FG002|Overall Study|Withdrawal by Subject|0|||
160922355|NCT00453544|581108506|FG003|Overall Study|Withdrawal by Subject|0|||
160922356|NCT00453544|581108503|FG000|Overall Study|Primary outcome measure not completed|1|||
160922357|NCT00453544|581108504|FG001|Overall Study|Primary outcome measure not completed|1|||
160922358|NCT00453544|581108505|FG002|Overall Study|Primary outcome measure not completed|0|||
160922359|NCT00453544|581108506|FG003|Overall Study|Primary outcome measure not completed|1|||
160922360|NCT01558752|581108507|FG000|Overall Study|Physician Decision|2|||
160922361|NCT01558752|581108508|FG001|Overall Study|Physician Decision|0|||
160922362|NCT01829230|581108509|FG000|Overall Study|Protocol Violation|0|||
160922363|NCT01829230|581108510|FG001|Overall Study|Protocol Violation|2|||
160922364|NCT01829230|581108509|FG000|Overall Study|Withdrawal by Subject|0|||
160922365|NCT01829230|581108510|FG001|Overall Study|Withdrawal by Subject|1|||
160922366|NCT01829230|581108509|FG000|Overall Study|Lost to Follow-up|1|||
160922367|NCT01829230|581108510|FG001|Overall Study|Lost to Follow-up|1|||
160922368|NCT00969150|581108511|FG000|Overall Study|Adverse Event|4|||
160922369|NCT00969150|581108512|FG001|Overall Study|Adverse Event|14|||
160922370|NCT00969150|581108511|FG000|Overall Study|Lack of Efficacy|1|||
160997810|NCT00158054|581376643|FG001|Overall Study|Refused to continue|0|||
160997811|NCT00158054|581376642|FG000|Overall Study|Unavailable for follow up|7|||
160997812|NCT00158054|581376643|FG001|Overall Study|Unavailable for follow up|3|||
160997813|NCT00509769|581376644|FG000|Overall Study|Progressive disease|77|||
160997814|NCT00509769|581376644|FG000|Overall Study|Adverse Event|4|||
160997815|NCT00509769|581376644|FG000|Overall Study|Patient's decision|1|||
160997816|NCT00509769|581376644|FG000|Overall Study|Physician Decision|8|||
160997817|NCT00509769|581376644|FG000|Overall Study|Use of prohibited therapies during study|1|||
160997818|NCT04567888|581376645|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
160997819|NCT04567888|581376646|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
160922371|NCT00969150|581108512|FG001|Overall Study|Lack of Efficacy|1|||
160922372|NCT00969150|581108511|FG000|Overall Study|Protocol Violation|9|||
160922373|NCT00969150|581108512|FG001|Overall Study|Protocol Violation|12|||
160922374|NCT00969150|581108511|FG000|Overall Study|Withdrawal by Subject|13|||
160922375|NCT00969150|581108512|FG001|Overall Study|Withdrawal by Subject|9|||
160922376|NCT00969150|581108511|FG000|Overall Study|Lost to Follow-up|5|||
160922377|NCT00969150|581108512|FG001|Overall Study|Lost to Follow-up|4|||
160922378|NCT00969150|581108511|FG000|Overall Study|Other reasons|1|||
160922379|NCT00969150|581108512|FG001|Overall Study|Other reasons|0|||
160997820|NCT04567888|581376645|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
160997821|NCT04567888|581376646|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
160997822|NCT04567888|581376645|FG000|Overall Study|Reported Unusual Birth Year|2|||
160997823|NCT04567888|581376646|FG001|Overall Study|Reported Unusual Birth Year|3|||
160454801|NCT01928394|579396192|FG022|Treatment Period|Lost to Follow-up|1|||
160454802|NCT01928394|579396170|FG000|Treatment Period|Death|0|||
160922380|NCT00461682|581108513|FG000|Overall Study|Protocol Violation|1|||
160997824|NCT04567888|581376645|FG000|Overall Study|Duplicate Responses|0|||
160997825|NCT04567888|581376646|FG001|Overall Study|Duplicate Responses|1|||
160454803|NCT01928394|579396171|FG001|Treatment Period|Death|0|||
160576015|NCT03554005|579829221|FG000|Overall Study|Not in participant's best interest|0|||
160576016|NCT03554005|579829222|FG001|Overall Study|Not in participant's best interest|0|||
160576017|NCT03554005|579829223|FG002|Overall Study|Not in participant's best interest|0|||
160576018|NCT03554005|579829224|FG003|Overall Study|Not in participant's best interest|0|||
160922381|NCT02759471|581108519|FG000|Overall Study|discomfort|2|||
160922382|NCT00597012|581108520|FG000|Overall Study|Death|1|||
160922383|NCT00597012|581108521|FG001|Overall Study|Death|1|||
160922384|NCT00597012|581108520|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
160922385|NCT00597012|581108521|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
160922386|NCT00597012|581108520|FG000|Overall Study|Withdrawal by Subject|7|||
160922387|NCT00597012|581108521|FG001|Overall Study|Withdrawal by Subject|4|||
160922388|NCT00597012|581108520|FG000|Overall Study|Ineligible|2|||
160922389|NCT00597012|581108521|FG001|Overall Study|Ineligible|0|||
160922390|NCT00597012|581108520|FG000|Overall Study|Lost to Follow-up|0|||
160922391|NCT00597012|581108521|FG001|Overall Study|Lost to Follow-up|2|||
160922392|NCT01103284|581108523|FG000|Overall Study|Death|2|||
160922393|NCT01103284|581108524|FG001|Overall Study|Death|0|||
160922394|NCT01103284|581108523|FG000|Overall Study|Lost to Follow-up|9|||
160922395|NCT01103284|581108524|FG001|Overall Study|Lost to Follow-up|10|||
160922396|NCT01103284|581108523|FG000|Overall Study|Pregnancy|3|||
160922397|NCT01103284|581108524|FG001|Overall Study|Pregnancy|1|||
160922398|NCT01103284|581108523|FG000|Overall Study|Protocol Violation|12|||
160922399|NCT01103284|581108524|FG001|Overall Study|Protocol Violation|5|||
160922400|NCT01103284|581108523|FG000|Overall Study|Adverse Event|0|||
160922401|NCT01103284|581108524|FG001|Overall Study|Adverse Event|5|||
160922402|NCT01103284|581108523|FG000|Overall Study|Withdrawal by Subject|14|||
160922403|NCT01103284|581108524|FG001|Overall Study|Withdrawal by Subject|18|||
160922404|NCT01103284|581108523|FG000|Overall Study|Dermal Hypersensitivity|0|||
160922405|NCT01103284|581108524|FG001|Overall Study|Dermal Hypersensitivity|1|||
160922406|NCT01103284|581108523|FG000|Overall Study|Termination by the Sponsor|0|||
160922407|NCT01103284|581108524|FG001|Overall Study|Termination by the Sponsor|1|||
160922408|NCT01103284|581108523|FG000|Overall Study|Not described|2|||
160922409|NCT01103284|581108524|FG001|Overall Study|Not described|1|||
160922410|NCT01103284|581108523|FG000|Overall Study|Missing CRF entries for study completion|0|||
160922411|NCT01103284|581108524|FG001|Overall Study|Missing CRF entries for study completion|2|||
160922412|NCT02356783|581109732|FG000|Overall Study|Lost to Follow-up|1|||
160922413|NCT02356783|581109733|FG001|Overall Study|Lost to Follow-up|3|||
160922414|NCT01462084|581109734|FG000|Overall Study|Withdrawal by Subject|1|||
160922415|NCT01462084|581109735|FG001|Overall Study|Withdrawal by Subject|0|||
160922416|NCT01462084|581109734|FG000|Overall Study|Protocol Violation|1|||
160922417|NCT01462084|581109735|FG001|Overall Study|Protocol Violation|1|||
160922418|NCT02278263|581109736|FG000|Overall Study|Protocol Violation|7|||
160922419|NCT02278263|581109737|FG001|Overall Study|Protocol Violation|0|||
160922420|NCT02278263|581109738|FG002|Overall Study|Protocol Violation|9|||
160922421|NCT00772707|581109740|FG000|Overall Study|Withdrawn|3|||
160922422|NCT01266460|581109742|FG000|Overall Study|Adverse Event|3|||
160922423|NCT01266460|581109742|FG000|Overall Study|Withdrawal by Subject|5|||
160922424|NCT01266460|581109742|FG000|Overall Study|Disease Progression|18|||
160922425|NCT01266460|581109742|FG000|Overall Study|Not otherwise specified|8|||
160922426|NCT01132547|581109743|FG000|Overall Study|Withdrawal by Subject|3|||
160922427|NCT01132547|581109744|FG001|Overall Study|Withdrawal by Subject|1|||
160922428|NCT01132547|581109743|FG000|Overall Study|Death|1|||
160922429|NCT01132547|581109744|FG001|Overall Study|Death|0|||
160922430|NCT05811234|581109745|FG000|Overall Study|Loss of Effectiveness|2|||
160922431|NCT05811234|581109745|FG000|Overall Study|Adverse Event|4|||
160576019|NCT03554005|579829225|FG004|Overall Study|Not in participant's best interest|0|||
160576020|NCT03554005|579829226|FG005|Overall Study|Not in participant's best interest|1|||
160576021|NCT03554005|579829221|FG000|Overall Study|Disease Progression|1|||
160576022|NCT03554005|579829222|FG001|Overall Study|Disease Progression|1|||
160576023|NCT03554005|579829223|FG002|Overall Study|Disease Progression|1|||
160576024|NCT03554005|579829224|FG003|Overall Study|Disease Progression|1|||
160576025|NCT03554005|579829225|FG004|Overall Study|Disease Progression|5|||
160576026|NCT03554005|579829226|FG005|Overall Study|Disease Progression|6|||
160576027|NCT03554005|579829221|FG000|Overall Study|Adverse Event|0|||
160576028|NCT03554005|579829222|FG001|Overall Study|Adverse Event|0|||
160576029|NCT03554005|579829223|FG002|Overall Study|Adverse Event|0|||
160576030|NCT03554005|579829224|FG003|Overall Study|Adverse Event|0|||
160922432|NCT05811234|581109745|FG000|Overall Study|Pregnancy|1|||
160922433|NCT05811234|581109745|FG000|Overall Study|Disease progression|1|||
160922434|NCT05811234|581109745|FG000|Overall Study|Withdrawal by Subject|4|||
160922435|NCT05811234|581109745|FG000|Overall Study|Lost to Follow-up|13|||
160922436|NCT05811234|581109745|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
160922437|NCT04499781|581109746|FG000|Overall Study|Lost to Follow-up|2|||
160922438|NCT04499781|581109747|FG001|Overall Study|Lost to Follow-up|3|||
160922439|NCT04499781|581109746|FG000|Overall Study|Withdrawal by Subject|2|||
160922440|NCT04499781|581109747|FG001|Overall Study|Withdrawal by Subject|0|||
160922441|NCT04105998|581109753|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
160997826|NCT00414648|581376647|FG000|Overall Study|Adverse Event|5|||
160654738|NCT02579096|580117159|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
160654739|NCT02579096|580117160|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
160654740|NCT02579096|580117159|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
160576031|NCT03554005|579829225|FG004|Overall Study|Adverse Event|0|||
160576032|NCT03554005|579829226|FG005|Overall Study|Adverse Event|3|||
160576033|NCT03554005|579829221|FG000|Overall Study|Physician Decision|0|||
160576034|NCT03554005|579829222|FG001|Overall Study|Physician Decision|0|||
160654741|NCT02579096|580117160|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
160654742|NCT02579096|580117159|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
160654743|NCT02579096|580117160|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
160654744|NCT02579096|580117159|FG000|Phase 2, Weeks 25 - 48|Death|2|||
160654745|NCT02579096|580117160|FG001|Phase 2, Weeks 25 - 48|Death|4|||
160654746|NCT02579096|580117159|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
160654747|NCT02579096|580117160|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
160654748|NCT02579096|580117159|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
160654749|NCT02579096|580117160|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
160654750|NCT02579096|580117159|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
160654751|NCT02579096|580117160|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
160654752|NCT02579096|580117159|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
160654753|NCT02579096|580117160|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
160922442|NCT04105998|581109754|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
160922451|NCT00613015|581109760|FG000|Overall Study|Lost to Follow-up|0|||
160922452|NCT00613015|581109761|FG001|Overall Study|Lost to Follow-up|1|||
160922453|NCT00613015|581109762|FG002|Overall Study|Lost to Follow-up|3|||
160922454|NCT00613015|581109763|FG003|Overall Study|Lost to Follow-up|3|||
160922455|NCT00613015|581109764|FG004|Overall Study|Lost to Follow-up|2|||
160922456|NCT00613015|581109765|FG005|Overall Study|Lost to Follow-up|3|||
160922457|NCT00071760|581109768|FG000|Overall Study|Adverse Event|2|||
160922458|NCT00071760|581109769|FG001|Overall Study|Adverse Event|1|||
160922459|NCT00071760|581109768|FG000|Overall Study|Lost to Follow-up|0|||
160922460|NCT00071760|581109769|FG001|Overall Study|Lost to Follow-up|3|||
160922461|NCT00071760|581109768|FG000|Overall Study|Protocol Violation|1|||
160922462|NCT00071760|581109769|FG001|Overall Study|Protocol Violation|0|||
160922463|NCT00071760|581109768|FG000|Overall Study|Withdrawal by Subject|0|||
160922464|NCT00071760|581109769|FG001|Overall Study|Withdrawal by Subject|1|||
160922465|NCT00071760|581109768|FG000|Overall Study|Insufficient Viral Load Response|1|||
160922466|NCT00071760|581109769|FG001|Overall Study|Insufficient Viral Load Response|1|||
160922467|NCT00071760|581109768|FG000|Overall Study|Lack of availability of RTV|1|||
160922468|NCT00071760|581109769|FG001|Overall Study|Lack of availability of RTV|0|||
160922469|NCT00071760|581109768|FG000|Overall Study|Physician Decision|2|||
160922470|NCT00071760|581109769|FG001|Overall Study|Physician Decision|1|||
160922471|NCT00071760|581109768|FG000|Overall Study|Relocation|0|||
160922472|NCT00071760|581109769|FG001|Overall Study|Relocation|1|||
160922473|NCT02073279|581109770|FG000|Double-blind Period|Adverse Event|1|||
160922474|NCT02073279|581109771|FG001|Double-blind Period|Adverse Event|1|||
160922475|NCT02073279|581109770|FG000|Double-blind Period|Switched to another treatment|1|||
160922476|NCT02073279|581109771|FG001|Double-blind Period|Switched to another treatment|2|||
160922477|NCT02073279|581109770|FG000|Double-blind Period|Protocol Violation|0|||
160922478|NCT02073279|581109771|FG001|Double-blind Period|Protocol Violation|1|||
160922479|NCT02073279|581109770|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
160922480|NCT02073279|581109771|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
160576035|NCT03554005|579829223|FG002|Overall Study|Physician Decision|0|||
160576036|NCT03554005|579829224|FG003|Overall Study|Physician Decision|0|||
160576037|NCT03554005|579829225|FG004|Overall Study|Physician Decision|1|||
160576038|NCT03554005|579829226|FG005|Overall Study|Physician Decision|0|||
160454804|NCT01928394|579396172|FG002|Treatment Period|Death|0|||
160576039|NCT03554005|579829221|FG000|Overall Study|Other|0|||
160576040|NCT03554005|579829222|FG001|Overall Study|Other|0|||
160654754|NCT02579096|580117159|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
160654755|NCT02579096|580117160|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
160654756|NCT02579096|580117159|FG000|Phase 3, Weeks 49 - 72|Death|3|||
160654757|NCT02579096|580117160|FG001|Phase 3, Weeks 49 - 72|Death|2|||
160922481|NCT02073279|581109770|FG000|Double-blind Period|Withdrawal by Subject|2|||
160922482|NCT02073279|581109771|FG001|Double-blind Period|Withdrawal by Subject|2|||
160922483|NCT02073279|581109770|FG000|Open-label Extension Period|Adverse Event|1|||
160922484|NCT02073279|581109771|FG001|Open-label Extension Period|Adverse Event|0|||
160997827|NCT00414648|581376648|FG001|Overall Study|Adverse Event|5|||
160576041|NCT03554005|579829223|FG002|Overall Study|Other|0|||
160576042|NCT03554005|579829224|FG003|Overall Study|Other|0|||
160922485|NCT02073279|581109770|FG000|Open-label Extension Period|Lack of Efficacy|1|||
160922486|NCT02073279|581109771|FG001|Open-label Extension Period|Lack of Efficacy|0|||
160922487|NCT02073279|581109770|FG000|Open-label Extension Period|Lost to Follow-up|0|||
160922488|NCT02073279|581109771|FG001|Open-label Extension Period|Lost to Follow-up|4|||
160922489|NCT02073279|581109770|FG000|Open-label Extension Period|Switched to another treatment|1|||
160922490|NCT02073279|581109771|FG001|Open-label Extension Period|Switched to another treatment|4|||
160922491|NCT02073279|581109770|FG000|Open-label Extension Period|Protocol Violation|0|||
160922492|NCT02073279|581109771|FG001|Open-label Extension Period|Protocol Violation|1|||
160922493|NCT02073279|581109770|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
160922494|NCT02073279|581109771|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
160922495|NCT02073279|581109770|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
160922496|NCT02073279|581109771|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
160922497|NCT01994629|581109772|FG000|Overall Study|Withdrawal by Subject|1|||
160922498|NCT01994629|581109773|FG001|Overall Study|Withdrawal by Subject|0|||
160922499|NCT01994629|581109772|FG000|Overall Study|Lost to Follow-up|0|||
160922500|NCT01994629|581109773|FG001|Overall Study|Lost to Follow-up|3|||
160922501|NCT03338062|581109776|FG000|Overall Study|Alternative Therapy|1|||
160922502|NCT03338062|581109777|FG001|Overall Study|Alternative Therapy|0|||
160922503|NCT00877383|581109780|FG000|Overall Study|Adverse Event|13|||
160922504|NCT00877383|581109781|FG001|Overall Study|Adverse Event|14|||
160922505|NCT00877383|581109780|FG000|Overall Study|Lost to Follow-up|5|||
160922506|NCT00877383|581109781|FG001|Overall Study|Lost to Follow-up|3|||
160922507|NCT00877383|581109780|FG000|Overall Study|Subject withdrew consent|3|||
160922508|NCT00877383|581109781|FG001|Overall Study|Subject withdrew consent|12|||
160922509|NCT00877383|581109780|FG000|Overall Study|Subject no longer requires study drug|2|||
160922510|NCT00877383|581109781|FG001|Overall Study|Subject no longer requires study drug|0|||
160922511|NCT00877383|581109780|FG000|Overall Study|Administrative problems|2|||
160922512|NCT00877383|581109781|FG001|Overall Study|Administrative problems|0|||
160922513|NCT00877383|581109780|FG000|Overall Study|Protocol deviation|2|||
160922514|NCT00877383|581109781|FG001|Overall Study|Protocol deviation|6|||
160922515|NCT00877383|581109780|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160922516|NCT00877383|581109781|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160922517|NCT00877383|581109780|FG000|Overall Study|Death|1|||
160922518|NCT00877383|581109781|FG001|Overall Study|Death|2|||
160922519|NCT00459108|581109782|FG000|Overall Study|Withdrawal by Subject|5|||
160922520|NCT00459108|581109782|FG000|Overall Study|Adverse Event|3|||
160922521|NCT00459108|581109782|FG000|Overall Study|Death|2|||
160922522|NCT00459108|581109782|FG000|Overall Study|Progression|1|||
160922523|NCT00391274|581109794|FG000|Overall Study|Death Due to Study Disease|55|||
160922524|NCT00391274|581109795|FG001|Overall Study|Death Due to Study Disease|45|||
160922525|NCT00391274|581109794|FG000|Overall Study|Lost to Follow-up|0|||
160922526|NCT00391274|581109795|FG001|Overall Study|Lost to Follow-up|3|||
160922527|NCT00391274|581109794|FG000|Overall Study|Physician Decision|4|||
160922528|NCT00391274|581109795|FG001|Overall Study|Physician Decision|2|||
160922529|NCT00391274|581109794|FG000|Overall Study|Withdrawal by Subject|0|||
160922530|NCT00391274|581109795|FG001|Overall Study|Withdrawal by Subject|3|||
160922531|NCT00391274|581109794|FG000|Overall Study|Death Due to Adverse Event|1|||
160922532|NCT00391274|581109795|FG001|Overall Study|Death Due to Adverse Event|3|||
160922533|NCT00391274|581109794|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
160922534|NCT00391274|581109795|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
160922535|NCT00391274|581109794|FG000|Overall Study|Death Not Study Related|0|||
160922536|NCT00391274|581109795|FG001|Overall Study|Death Not Study Related|1|||
160922537|NCT04501666|581109796|FG000|Overall Study|Physician Decision|0|||
160922538|NCT04501666|581109797|FG001|Overall Study|Physician Decision|1|||
160922539|NCT04501666|581109796|FG000|Overall Study|Adverse Event|12|||
160922540|NCT04501666|581109797|FG001|Overall Study|Adverse Event|4|||
160922541|NCT04501666|581109796|FG000|Overall Study|Subject's request|10|||
160922542|NCT04501666|581109797|FG001|Overall Study|Subject's request|6|||
160922543|NCT04501666|581109796|FG000|Overall Study|Protocol Deviation|2|||
160922544|NCT04501666|581109797|FG001|Overall Study|Protocol Deviation|1|||
160922545|NCT04501666|581109796|FG000|Overall Study|Other-- site permanently closing|0|||
160922546|NCT04501666|581109797|FG001|Overall Study|Other-- site permanently closing|1|||
160922547|NCT00642941|581109798|FG000|Overall Study|Physician Decision|3|||
160654758|NCT02579096|580117159|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
160922548|NCT00642941|581109799|FG001|Overall Study|Physician Decision|1|||
160922549|NCT00642941|581109800|FG002|Overall Study|Physician Decision|0|||
160922550|NCT00642941|581109801|FG003|Overall Study|Physician Decision|0|||
160922551|NCT00642941|581109802|FG004|Overall Study|Physician Decision|0|||
160922552|NCT00642941|581109803|FG005|Overall Study|Physician Decision|0|||
160922553|NCT00642941|581109804|FG006|Overall Study|Physician Decision|1|||
160922554|NCT00642941|581109805|FG007|Overall Study|Physician Decision|0|||
160922555|NCT00642941|581109806|FG008|Overall Study|Physician Decision|0|||
160922556|NCT00642941|581109807|FG009|Overall Study|Physician Decision|1|||
160922557|NCT00642941|581109808|FG010|Overall Study|Physician Decision|0|||
160997828|NCT00414648|581376647|FG000|Overall Study|Death|0|||
160997829|NCT00414648|581376648|FG001|Overall Study|Death|1|||
160922558|NCT00642941|581109809|FG011|Overall Study|Physician Decision|1|||
160922559|NCT00642941|581109798|FG000|Overall Study|Death|4|||
160922560|NCT00642941|581109799|FG001|Overall Study|Death|0|||
160922561|NCT00642941|581109800|FG002|Overall Study|Death|1|||
160922562|NCT00642941|581109801|FG003|Overall Study|Death|1|||
160922563|NCT00642941|581109802|FG004|Overall Study|Death|2|||
160922564|NCT00642941|581109803|FG005|Overall Study|Death|1|||
160922565|NCT00642941|581109804|FG006|Overall Study|Death|0|||
160922566|NCT00642941|581109805|FG007|Overall Study|Death|0|||
160922567|NCT00642941|581109806|FG008|Overall Study|Death|0|||
160922568|NCT00642941|581109807|FG009|Overall Study|Death|0|||
160922569|NCT00642941|581109808|FG010|Overall Study|Death|0|||
160922570|NCT00642941|581109809|FG011|Overall Study|Death|1|||
160922571|NCT00642941|581109798|FG000|Overall Study|Study closed by Sponsor|0|||
160922572|NCT00642941|581109799|FG001|Overall Study|Study closed by Sponsor|1|||
160922573|NCT00642941|581109800|FG002|Overall Study|Study closed by Sponsor|0|||
160922574|NCT00642941|581109801|FG003|Overall Study|Study closed by Sponsor|0|||
160922575|NCT00642941|581109802|FG004|Overall Study|Study closed by Sponsor|0|||
160922576|NCT00642941|581109803|FG005|Overall Study|Study closed by Sponsor|0|||
160922577|NCT00642941|581109804|FG006|Overall Study|Study closed by Sponsor|0|||
160922578|NCT00642941|581109805|FG007|Overall Study|Study closed by Sponsor|0|||
160922579|NCT00642941|581109806|FG008|Overall Study|Study closed by Sponsor|0|||
160922580|NCT00642941|581109807|FG009|Overall Study|Study closed by Sponsor|0|||
160922581|NCT00642941|581109808|FG010|Overall Study|Study closed by Sponsor|0|||
160922582|NCT00642941|581109809|FG011|Overall Study|Study closed by Sponsor|0|||
160922583|NCT00642941|581109798|FG000|Overall Study|Withdrawal by Subject|1|||
160922584|NCT00642941|581109799|FG001|Overall Study|Withdrawal by Subject|0|||
160922585|NCT00642941|581109800|FG002|Overall Study|Withdrawal by Subject|0|||
160922586|NCT00642941|581109801|FG003|Overall Study|Withdrawal by Subject|2|||
160922587|NCT00642941|581109802|FG004|Overall Study|Withdrawal by Subject|0|||
160922588|NCT00642941|581109803|FG005|Overall Study|Withdrawal by Subject|0|||
160922589|NCT00642941|581109804|FG006|Overall Study|Withdrawal by Subject|2|||
160922590|NCT00642941|581109805|FG007|Overall Study|Withdrawal by Subject|0|||
160922591|NCT00642941|581109806|FG008|Overall Study|Withdrawal by Subject|1|||
160922592|NCT00642941|581109807|FG009|Overall Study|Withdrawal by Subject|0|||
160922593|NCT00642941|581109808|FG010|Overall Study|Withdrawal by Subject|0|||
160922594|NCT00642941|581109809|FG011|Overall Study|Withdrawal by Subject|1|||
160922595|NCT00642941|581109798|FG000|Overall Study|Protocol Violation|0|||
160922596|NCT00642941|581109799|FG001|Overall Study|Protocol Violation|0|||
160922597|NCT00642941|581109800|FG002|Overall Study|Protocol Violation|0|||
160922598|NCT00642941|581109801|FG003|Overall Study|Protocol Violation|0|||
160922599|NCT00642941|581109802|FG004|Overall Study|Protocol Violation|0|||
160922600|NCT00642941|581109803|FG005|Overall Study|Protocol Violation|0|||
160922601|NCT00642941|581109804|FG006|Overall Study|Protocol Violation|1|||
160922602|NCT00642941|581109805|FG007|Overall Study|Protocol Violation|0|||
160922603|NCT00642941|581109806|FG008|Overall Study|Protocol Violation|0|||
160922604|NCT00642941|581109807|FG009|Overall Study|Protocol Violation|0|||
160922605|NCT00642941|581109808|FG010|Overall Study|Protocol Violation|0|||
160922606|NCT00642941|581109809|FG011|Overall Study|Protocol Violation|0|||
160922607|NCT00642941|581109798|FG000|Overall Study|Adverse Event|1|||
160922608|NCT00642941|581109799|FG001|Overall Study|Adverse Event|1|||
160922609|NCT00642941|581109800|FG002|Overall Study|Adverse Event|0|||
160922610|NCT00642941|581109801|FG003|Overall Study|Adverse Event|0|||
160922611|NCT00642941|581109802|FG004|Overall Study|Adverse Event|0|||
160922612|NCT00642941|581109803|FG005|Overall Study|Adverse Event|0|||
160922613|NCT00642941|581109804|FG006|Overall Study|Adverse Event|1|||
160922614|NCT00642941|581109805|FG007|Overall Study|Adverse Event|1|||
160922615|NCT00642941|581109806|FG008|Overall Study|Adverse Event|0|||
160922616|NCT00642941|581109807|FG009|Overall Study|Adverse Event|1|||
160922617|NCT00642941|581109808|FG010|Overall Study|Adverse Event|0|||
160922618|NCT00642941|581109809|FG011|Overall Study|Adverse Event|0|||
160922619|NCT00642941|581109798|FG000|Overall Study|Other|1|||
160654759|NCT02579096|580117160|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
160922620|NCT00642941|581109799|FG001|Overall Study|Other|1|||
160922621|NCT00642941|581109800|FG002|Overall Study|Other|1|||
160922622|NCT00642941|581109801|FG003|Overall Study|Other|1|||
160922623|NCT00642941|581109802|FG004|Overall Study|Other|0|||
160922624|NCT00642941|581109803|FG005|Overall Study|Other|1|||
160997830|NCT00414648|581376647|FG000|Overall Study|Lack of Efficacy|0|||
160922625|NCT00642941|581109804|FG006|Overall Study|Other|0|||
160922626|NCT00642941|581109805|FG007|Overall Study|Other|1|||
160922627|NCT00642941|581109806|FG008|Overall Study|Other|0|||
160922628|NCT00642941|581109807|FG009|Overall Study|Other|0|||
160922629|NCT00642941|581109808|FG010|Overall Study|Other|0|||
160922630|NCT00642941|581109809|FG011|Overall Study|Other|1|||
160922631|NCT00642941|581109798|FG000|Overall Study|Disease progression|60|||
160922632|NCT00642941|581109799|FG001|Overall Study|Disease progression|50|||
160922633|NCT00642941|581109800|FG002|Overall Study|Disease progression|5|||
160922634|NCT00642941|581109801|FG003|Overall Study|Disease progression|36|||
160922635|NCT00642941|581109802|FG004|Overall Study|Disease progression|23|||
160922636|NCT00642941|581109803|FG005|Overall Study|Disease progression|39|||
160997831|NCT00414648|581376648|FG001|Overall Study|Lack of Efficacy|2|||
160997832|NCT00414648|581376647|FG000|Overall Study|Withdrawal by Subject|0|||
160997833|NCT00414648|581376648|FG001|Overall Study|Withdrawal by Subject|1|||
160997834|NCT01157182|581376649|FG000|Washout of 28 Days|Adverse Event|2|||
160997835|NCT01157182|581376650|FG001|Washout of 28 Days|Adverse Event|0|||
160997836|NCT00878722|581376651|FG000|Overall Study|Progressive disease|3|||
160997837|NCT00878722|581376652|FG001|Overall Study|Progressive disease|3|||
160997838|NCT00878722|581376653|FG002|Overall Study|Progressive disease|3|||
160997839|NCT00878722|581376654|FG003|Overall Study|Progressive disease|7|||
160997840|NCT00878722|581376655|FG004|Overall Study|Progressive disease|7|||
160997841|NCT00878722|581376656|FG005|Overall Study|Progressive disease|1|||
160997842|NCT00878722|581376657|FG006|Overall Study|Progressive disease|4|||
160997843|NCT00878722|581376658|FG007|Overall Study|Progressive disease|3|||
160997844|NCT00878722|581376651|FG000|Overall Study|Death|0|||
160997845|NCT00878722|581376652|FG001|Overall Study|Death|0|||
160997846|NCT00878722|581376653|FG002|Overall Study|Death|0|||
160997847|NCT00878722|581376654|FG003|Overall Study|Death|1|||
160997848|NCT00878722|581376655|FG004|Overall Study|Death|0|||
160997849|NCT00878722|581376656|FG005|Overall Study|Death|1|||
160997850|NCT00878722|581376657|FG006|Overall Study|Death|0|||
160997851|NCT00878722|581376658|FG007|Overall Study|Death|2|||
160576043|NCT03554005|579829225|FG004|Overall Study|Other|0|||
160922637|NCT00642941|581109804|FG006|Overall Study|Disease progression|18|||
160922638|NCT00642941|581109805|FG007|Overall Study|Disease progression|12|||
160922639|NCT00642941|581109806|FG008|Overall Study|Disease progression|10|||
160922640|NCT00642941|581109807|FG009|Overall Study|Disease progression|7|||
160922641|NCT00642941|581109808|FG010|Overall Study|Disease progression|12|||
160922642|NCT00642941|581109809|FG011|Overall Study|Disease progression|7|||
160922643|NCT03051607|581109810|FG000|Overall Study|Adverse Event|66|||
160922644|NCT01505868|581109811|FG000|Overall Study|Withdrawal by Subject|1|||
160922645|NCT01505868|581109812|FG001|Overall Study|Withdrawal by Subject|0|||
160922646|NCT01505868|581109813|FG002|Overall Study|Withdrawal by Subject|0|||
160922647|NCT01505868|581109814|FG003|Overall Study|Withdrawal by Subject|0|||
160922648|NCT01505868|581109815|FG004|Overall Study|Withdrawal by Subject|0|||
160922649|NCT00894322|581109816|FG000|Overall Study|Withdrawal by Subject|1|||
160922650|NCT00894322|581109817|FG001|Overall Study|Withdrawal by Subject|0|||
160922651|NCT00894322|581109818|FG002|Overall Study|Withdrawal by Subject|0|||
160922652|NCT00553150|581109819|FG000|Overall Study|Withdrawal by Subject|0|||
160922653|NCT00553150|581109820|FG001|Overall Study|Withdrawal by Subject|0|||
160922654|NCT00553150|581109821|FG002|Overall Study|Withdrawal by Subject|0|||
160922655|NCT00553150|581109822|FG003|Overall Study|Withdrawal by Subject|2|||
160922656|NCT00553150|581109819|FG000|Overall Study|Protocol Violation|0|||
160922657|NCT00553150|581109820|FG001|Overall Study|Protocol Violation|0|||
160922658|NCT00553150|581109821|FG002|Overall Study|Protocol Violation|0|||
160922659|NCT00553150|581109822|FG003|Overall Study|Protocol Violation|1|||
160922660|NCT00553150|581109819|FG000|Overall Study|Ineligible|0|||
160922661|NCT00553150|581109820|FG001|Overall Study|Ineligible|0|||
160922662|NCT00553150|581109821|FG002|Overall Study|Ineligible|0|||
160922663|NCT00553150|581109822|FG003|Overall Study|Ineligible|1|||
160922664|NCT03251079|581109824|FG000|Overall Study|Withdrawal by Subject|1|||
160922665|NCT01387347|581109825|FG000|Overall Study|Lost to Follow-up|2|||
160922666|NCT01387347|581109826|FG001|Overall Study|Lost to Follow-up|1|||
160922667|NCT03605303|581109827|FG000|Period 1|Study Terminated|2|||
160922668|NCT03605303|581109828|FG001|Period 1|Study Terminated|1|||
160922669|NCT00399360|581109833|FG000|Overall Study|Lost to Follow-up|2|||
160922670|NCT00399360|581109834|FG001|Overall Study|Lost to Follow-up|1|||
160997852|NCT00878722|581376651|FG000|Overall Study|Adverse Event|0|||
160997853|NCT00878722|581376652|FG001|Overall Study|Adverse Event|0|||
160997854|NCT00878722|581376653|FG002|Overall Study|Adverse Event|0|||
160997855|NCT00878722|581376654|FG003|Overall Study|Adverse Event|0|||
160997856|NCT00878722|581376655|FG004|Overall Study|Adverse Event|0|||
160997857|NCT00878722|581376656|FG005|Overall Study|Adverse Event|0|||
160997858|NCT00878722|581376657|FG006|Overall Study|Adverse Event|2|||
160997859|NCT00878722|581376658|FG007|Overall Study|Adverse Event|0|||
160997860|NCT00878722|581376651|FG000|Overall Study|Withdrawal by Subject|0|||
160997861|NCT00878722|581376652|FG001|Overall Study|Withdrawal by Subject|0|||
160922671|NCT00399360|581109835|FG002|Overall Study|Lost to Follow-up|2|||
160922672|NCT00399360|581109836|FG003|Overall Study|Lost to Follow-up|4|||
160922673|NCT00399360|581109833|FG000|Overall Study|Adverse Event|0|||
160922674|NCT00399360|581109834|FG001|Overall Study|Adverse Event|0|||
160922675|NCT00399360|581109835|FG002|Overall Study|Adverse Event|1|||
160922676|NCT00399360|581109836|FG003|Overall Study|Adverse Event|0|||
160922677|NCT00399360|581109833|FG000|Overall Study|Withdrawal by Subject|0|||
160997862|NCT00878722|581376653|FG002|Overall Study|Withdrawal by Subject|0|||
160997863|NCT00878722|581376654|FG003|Overall Study|Withdrawal by Subject|0|||
160997864|NCT00878722|581376655|FG004|Overall Study|Withdrawal by Subject|0|||
160997865|NCT00878722|581376656|FG005|Overall Study|Withdrawal by Subject|0|||
160997866|NCT00878722|581376657|FG006|Overall Study|Withdrawal by Subject|0|||
160997867|NCT00878722|581376658|FG007|Overall Study|Withdrawal by Subject|2|||
160997868|NCT00878722|581376651|FG000|Overall Study|Relapse|0|||
160997869|NCT00878722|581376652|FG001|Overall Study|Relapse|0|||
160922678|NCT00399360|581109834|FG001|Overall Study|Withdrawal by Subject|2|||
160922679|NCT00399360|581109835|FG002|Overall Study|Withdrawal by Subject|0|||
160576044|NCT03554005|579829226|FG005|Overall Study|Other|1|||
160576045|NCT00631488|579829230|FG000|Overall Study|Adverse Event|1|||
160576046|NCT00631488|579829231|FG001|Overall Study|Adverse Event|0|||
160576047|NCT00631488|579829232|FG002|Overall Study|Adverse Event|0|||
160576048|NCT00631488|579829230|FG000|Overall Study|Lost to Follow-up|2|||
160576049|NCT00631488|579829231|FG001|Overall Study|Lost to Follow-up|2|||
160576050|NCT00631488|579829232|FG002|Overall Study|Lost to Follow-up|0|||
160922680|NCT00399360|581109836|FG003|Overall Study|Withdrawal by Subject|2|||
160922681|NCT02626520|581109838|FG000|Overall Study|Physician Decision|1|||
160922682|NCT02626520|581109839|FG001|Overall Study|Physician Decision|1|||
160922683|NCT02626520|581109838|FG000|Overall Study|Adverse Event|0|||
160922684|NCT02626520|581109839|FG001|Overall Study|Adverse Event|4|||
160922685|NCT02626520|581109838|FG000|Overall Study|Lack of Efficacy|0|||
160922686|NCT02626520|581109839|FG001|Overall Study|Lack of Efficacy|2|||
160922687|NCT02626520|581109838|FG000|Overall Study|Did not start protocol therapy|0|||
160922688|NCT02626520|581109839|FG001|Overall Study|Did not start protocol therapy|2|||
160922689|NCT02626520|581109838|FG000|Overall Study|Study terminated|0|||
160922690|NCT02626520|581109839|FG001|Overall Study|Study terminated|1|||
160922691|NCT00492115|581109840|FG000|Overall Study|Withdrawal by Subject|3|||
160922692|NCT00492115|581109841|FG001|Overall Study|Withdrawal by Subject|4|||
160922693|NCT01288287|581109842|FG000|Overall Study|Lost to Follow-up|8|||
160922694|NCT01288287|581109842|FG000|Overall Study|Withdrawal by Subject|4|||
160922695|NCT01288287|581109842|FG000|Overall Study|Lack of Efficacy|13|||
160922696|NCT01288287|581109842|FG000|Overall Study|Other Reason|13|||
160922697|NCT01288287|581109842|FG000|Overall Study|Unknown Reason|1|||
160922698|NCT01288287|581109842|FG000|Overall Study|Unknown Status|7|||
160922699|NCT02472795|581109847|FG000|Overall Study|Adverse Event|0|||
160922700|NCT02472795|581109848|FG001|Overall Study|Adverse Event|1|||
160922701|NCT02472795|581109849|FG002|Overall Study|Adverse Event|0|||
160922702|NCT02472795|581109850|FG003|Overall Study|Adverse Event|0|||
160922703|NCT02472795|581109851|FG004|Overall Study|Adverse Event|2|||
160922704|NCT02472795|581109847|FG000|Overall Study|Withdrawal by Subject|0|||
160922705|NCT02472795|581109848|FG001|Overall Study|Withdrawal by Subject|0|||
160922706|NCT02472795|581109849|FG002|Overall Study|Withdrawal by Subject|0|||
160922707|NCT02472795|581109850|FG003|Overall Study|Withdrawal by Subject|0|||
160922708|NCT02472795|581109851|FG004|Overall Study|Withdrawal by Subject|1|||
160922709|NCT04734652|581111990|FG000|Overall Study|Withdrawal by Subject|2|||
160922710|NCT04734652|581111991|FG001|Overall Study|Withdrawal by Subject|0|||
160922711|NCT04734652|581111990|FG000|Overall Study|Death|0|||
160922712|NCT04734652|581111991|FG001|Overall Study|Death|1|||
160922713|NCT04729127|581111993|FG000|Overall Study|Suspended/Terminated EI Services|4|||
160922714|NCT04729127|581111994|FG001|Overall Study|Suspended/Terminated EI Services|0|||
160922715|NCT04729127|581111995|FG002|Overall Study|Suspended/Terminated EI Services|4|||
160922716|NCT04729127|581111996|FG003|Overall Study|Suspended/Terminated EI Services|6|||
160922717|NCT04729127|581111997|FG004|Overall Study|Suspended/Terminated EI Services|0|||
160922718|NCT04729127|581111998|FG005|Overall Study|Suspended/Terminated EI Services|6|||
160922719|NCT04729127|581111999|FG006|Overall Study|Suspended/Terminated EI Services|2|||
160922720|NCT04729127|581112000|FG007|Overall Study|Suspended/Terminated EI Services|0|||
160922721|NCT04729127|581112001|FG008|Overall Study|Suspended/Terminated EI Services|2|||
160922722|NCT04729127|581111993|FG000|Overall Study|Withdrawal by Subject|1|||
160922723|NCT04729127|581111994|FG001|Overall Study|Withdrawal by Subject|0|||
160922724|NCT04729127|581111995|FG002|Overall Study|Withdrawal by Subject|1|||
160922725|NCT04729127|581111996|FG003|Overall Study|Withdrawal by Subject|0|||
160922726|NCT04729127|581111997|FG004|Overall Study|Withdrawal by Subject|0|||
160922727|NCT04729127|581111998|FG005|Overall Study|Withdrawal by Subject|0|||
160922728|NCT04729127|581111999|FG006|Overall Study|Withdrawal by Subject|0|||
160922729|NCT04729127|581112000|FG007|Overall Study|Withdrawal by Subject|0|||
160922730|NCT04729127|581112001|FG008|Overall Study|Withdrawal by Subject|0|||
160922731|NCT04729127|581111993|FG000|Overall Study|Switched Agency/Setting|1|||
160922732|NCT04729127|581111994|FG001|Overall Study|Switched Agency/Setting|0|||
160922733|NCT04729127|581111995|FG002|Overall Study|Switched Agency/Setting|1|||
160576051|NCT00631488|579829230|FG000|Overall Study|Physician Decision|1|||
160922734|NCT04729127|581111996|FG003|Overall Study|Switched Agency/Setting|1|||
160922735|NCT04729127|581111997|FG004|Overall Study|Switched Agency/Setting|0|||
160922736|NCT04729127|581111998|FG005|Overall Study|Switched Agency/Setting|1|||
160922737|NCT04729127|581111999|FG006|Overall Study|Switched Agency/Setting|1|||
160922738|NCT04729127|581112000|FG007|Overall Study|Switched Agency/Setting|0|||
160922739|NCT04729127|581112001|FG008|Overall Study|Switched Agency/Setting|1|||
160922740|NCT01912287|581112002|FG000|Overall Study|Ineligible|1|||
160922741|NCT01912287|581112003|FG001|Overall Study|Ineligible|0|||
160922742|NCT01912287|581112004|FG002|Overall Study|Ineligible|1|||
160576052|NCT00631488|579829231|FG001|Overall Study|Physician Decision|0|||
160576053|NCT00631488|579829232|FG002|Overall Study|Physician Decision|1|||
160922743|NCT01912287|581112002|FG000|Overall Study|No-show|0|||
160922744|NCT01912287|581112003|FG001|Overall Study|No-show|0|||
160922745|NCT01912287|581112004|FG002|Overall Study|No-show|1|||
160997870|NCT00878722|581376653|FG002|Overall Study|Relapse|0|||
160997871|NCT00878722|581376654|FG003|Overall Study|Relapse|1|||
160922746|NCT01912287|581112002|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
160922747|NCT01912287|581112003|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
160922748|NCT01912287|581112004|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
160922749|NCT01912287|581112002|FG000|Overall Study|Felt treatment no longer needed|0|||
160922750|NCT01912287|581112003|FG001|Overall Study|Felt treatment no longer needed|1|||
160922751|NCT01912287|581112004|FG002|Overall Study|Felt treatment no longer needed|0|||
160997872|NCT00878722|581376655|FG004|Overall Study|Relapse|0|||
160997873|NCT00878722|581376656|FG005|Overall Study|Relapse|0|||
160922752|NCT01912287|581112002|FG000|Overall Study|Life circumstances|4|||
160922753|NCT01912287|581112003|FG001|Overall Study|Life circumstances|2|||
160922754|NCT01912287|581112004|FG002|Overall Study|Life circumstances|0|||
160922755|NCT01912287|581112002|FG000|Overall Study|Lost Interest|1|||
160922756|NCT01912287|581112003|FG001|Overall Study|Lost Interest|0|||
160922757|NCT01912287|581112004|FG002|Overall Study|Lost Interest|0|||
160922758|NCT01912287|581112002|FG000|Overall Study|Uknown reason - subject drop out|5|||
160922759|NCT01912287|581112003|FG001|Overall Study|Uknown reason - subject drop out|7|||
160922760|NCT01912287|581112004|FG002|Overall Study|Uknown reason - subject drop out|3|||
160922761|NCT01912287|581112002|FG000|Overall Study|Missed Assesment|1|||
160922762|NCT01912287|581112003|FG001|Overall Study|Missed Assesment|1|||
160922763|NCT01912287|581112004|FG002|Overall Study|Missed Assesment|1|||
160922764|NCT01912287|581112002|FG000|Overall Study|Scheduling/change in availability|17|||
160922765|NCT01912287|581112003|FG001|Overall Study|Scheduling/change in availability|10|||
160922766|NCT01912287|581112004|FG002|Overall Study|Scheduling/change in availability|8|||
160922767|NCT02631850|581112005|FG000|Treatment Period|Lost to Follow-up|0|||
160922768|NCT02631850|581112006|FG001|Treatment Period|Lost to Follow-up|1|||
160922769|NCT02631850|581112007|FG002|Treatment Period|Lost to Follow-up|0|||
160922770|NCT02631850|581112008|FG003|Treatment Period|Lost to Follow-up|0|||
160922771|NCT02631850|581112005|FG000|Treatment Period|Protocol Violation|1|||
160922772|NCT02631850|581112006|FG001|Treatment Period|Protocol Violation|0|||
160922773|NCT02631850|581112007|FG002|Treatment Period|Protocol Violation|0|||
160922774|NCT02631850|581112008|FG003|Treatment Period|Protocol Violation|0|||
160922775|NCT02631850|581112005|FG000|Treatment Period|Withdrawal by Subject|0|||
160922776|NCT02631850|581112006|FG001|Treatment Period|Withdrawal by Subject|5|||
160922777|NCT02631850|581112007|FG002|Treatment Period|Withdrawal by Subject|2|||
160922778|NCT02631850|581112008|FG003|Treatment Period|Withdrawal by Subject|2|||
160922779|NCT02631850|581112005|FG000|Treatment Period|Adverse Event|1|||
160922780|NCT02631850|581112006|FG001|Treatment Period|Adverse Event|0|||
160922781|NCT02631850|581112007|FG002|Treatment Period|Adverse Event|2|||
160922782|NCT02631850|581112008|FG003|Treatment Period|Adverse Event|3|||
160922783|NCT02631850|581112005|FG000|Treatment Period|Family medical issue|1|||
160922784|NCT02631850|581112006|FG001|Treatment Period|Family medical issue|0|||
160922785|NCT02631850|581112007|FG002|Treatment Period|Family medical issue|0|||
160922786|NCT02631850|581112008|FG003|Treatment Period|Family medical issue|0|||
160922787|NCT02631850|581112005|FG000|6 Month Follow up|Lost to Follow-up|5|||
160922788|NCT02631850|581112006|FG001|6 Month Follow up|Lost to Follow-up|8|||
160922789|NCT02631850|581112007|FG002|6 Month Follow up|Lost to Follow-up|3|||
160922790|NCT02631850|581112008|FG003|6 Month Follow up|Lost to Follow-up|5|||
160922791|NCT02631850|581112005|FG000|6 Month Follow up|Withdrawal by Subject|1|||
160922792|NCT02631850|581112006|FG001|6 Month Follow up|Withdrawal by Subject|0|||
160922793|NCT02631850|581112007|FG002|6 Month Follow up|Withdrawal by Subject|0|||
160922794|NCT02631850|581112008|FG003|6 Month Follow up|Withdrawal by Subject|2|||
160922795|NCT02631850|581112005|FG000|6 Month Follow up|Adverse Event|1|||
160922796|NCT02631850|581112006|FG001|6 Month Follow up|Adverse Event|4|||
160922797|NCT02631850|581112007|FG002|6 Month Follow up|Adverse Event|1|||
160922798|NCT02631850|581112008|FG003|6 Month Follow up|Adverse Event|3|||
160922799|NCT02631850|581112005|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
160997874|NCT00878722|581376657|FG006|Overall Study|Relapse|0|||
160997875|NCT00878722|581376658|FG007|Overall Study|Relapse|0|||
160997876|NCT00554801|581376668|FG000|Overall Study|left area before completion|5|||
160997877|NCT00554801|581376669|FG001|Overall Study|left area before completion|0|||
160922800|NCT02631850|581112006|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
160922801|NCT02631850|581112007|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
160922802|NCT02631850|581112008|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
160922803|NCT00326950|581112010|FG000|Overall Study|Progressive Disease|1|||
160922804|NCT01514760|581112011|FG000|Overall Study|Lost to Follow-up|2|||
160922805|NCT00619801|581112032|FG000|Overall Study|Lack of Efficacy|0|||
160922806|NCT00619801|581112033|FG001|Overall Study|Lack of Efficacy|1|||
160922807|NCT00619801|581112032|FG000|Overall Study|Withdrawal by Subject|1|||
160922808|NCT00619801|581112033|FG001|Overall Study|Withdrawal by Subject|1|||
160922809|NCT00619801|581112032|FG000|Overall Study|Loss of efficacy|0|||
160922810|NCT00619801|581112033|FG001|Overall Study|Loss of efficacy|1|||
160997878|NCT00554801|581376668|FG000|Overall Study|Withdrawal by Subject|14|||
160997879|NCT00554801|581376669|FG001|Overall Study|Withdrawal by Subject|0|||
160922811|NCT04340362|581112041|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
160922812|NCT02375113|581112045|FG000|Overall Study|Undisclosed Reason(s).|1|||
160922813|NCT02375113|581112046|FG001|Overall Study|Undisclosed Reason(s).|1|||
160922814|NCT02375113|581112045|FG000|Overall Study|Poor adherence (<70%).|1|||
160922815|NCT02375113|581112046|FG001|Overall Study|Poor adherence (<70%).|0|||
160922816|NCT02375113|581112045|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
160922817|NCT02375113|581112046|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
160922818|NCT01214629|581112047|FG000|Overall Study|Progressive Disease|1|||
160922819|NCT01214629|581112048|FG001|Overall Study|Progressive Disease|1|||
160922820|NCT01214629|581112049|FG002|Overall Study|Progressive Disease|0|||
160922821|NCT01214629|581112050|FG003|Overall Study|Progressive Disease|1|||
160922822|NCT01214629|581112051|FG004|Overall Study|Progressive Disease|2|||
160922823|NCT01214629|581112052|FG005|Overall Study|Progressive Disease|3|||
160922824|NCT01214629|581112053|FG006|Overall Study|Progressive Disease|1|||
160922825|NCT01214629|581112054|FG007|Overall Study|Progressive Disease|1|||
160922826|NCT01214629|581112055|FG008|Overall Study|Progressive Disease|1|||
160922827|NCT01214629|581112056|FG009|Overall Study|Progressive Disease|5|||
160922828|NCT01214629|581112057|FG010|Overall Study|Progressive Disease|1|||
160922829|NCT01214629|581112047|FG000|Overall Study|Adverse Event|0|||
160922830|NCT01214629|581112048|FG001|Overall Study|Adverse Event|0|||
160922831|NCT01214629|581112049|FG002|Overall Study|Adverse Event|0|||
160922832|NCT01214629|581112050|FG003|Overall Study|Adverse Event|1|||
160922833|NCT01214629|581112051|FG004|Overall Study|Adverse Event|0|||
160922834|NCT01214629|581112052|FG005|Overall Study|Adverse Event|1|||
160922835|NCT01214629|581112053|FG006|Overall Study|Adverse Event|0|||
160922836|NCT01214629|581112054|FG007|Overall Study|Adverse Event|0|||
160922837|NCT01214629|581112055|FG008|Overall Study|Adverse Event|0|||
160922838|NCT01214629|581112056|FG009|Overall Study|Adverse Event|1|||
160922839|NCT01214629|581112057|FG010|Overall Study|Adverse Event|0|||
160922840|NCT01214629|581112047|FG000|Overall Study|Physician Decision|0|||
160922841|NCT01214629|581112048|FG001|Overall Study|Physician Decision|0|||
160922842|NCT01214629|581112049|FG002|Overall Study|Physician Decision|0|||
160922843|NCT01214629|581112050|FG003|Overall Study|Physician Decision|0|||
160922844|NCT01214629|581112051|FG004|Overall Study|Physician Decision|0|||
160922845|NCT01214629|581112052|FG005|Overall Study|Physician Decision|0|||
160922846|NCT01214629|581112053|FG006|Overall Study|Physician Decision|0|||
160922847|NCT01214629|581112054|FG007|Overall Study|Physician Decision|0|||
160922848|NCT01214629|581112055|FG008|Overall Study|Physician Decision|0|||
160922849|NCT01214629|581112056|FG009|Overall Study|Physician Decision|0|||
160922850|NCT01214629|581112057|FG010|Overall Study|Physician Decision|1|||
160922851|NCT01214629|581112047|FG000|Overall Study|Withdrawal by Subject|0|||
160922852|NCT01214629|581112048|FG001|Overall Study|Withdrawal by Subject|0|||
160922853|NCT01214629|581112049|FG002|Overall Study|Withdrawal by Subject|0|||
160922854|NCT01214629|581112050|FG003|Overall Study|Withdrawal by Subject|0|||
160922855|NCT01214629|581112051|FG004|Overall Study|Withdrawal by Subject|0|||
160922856|NCT01214629|581112052|FG005|Overall Study|Withdrawal by Subject|0|||
160922857|NCT01214629|581112053|FG006|Overall Study|Withdrawal by Subject|0|||
160922858|NCT01214629|581112054|FG007|Overall Study|Withdrawal by Subject|0|||
160922859|NCT01214629|581112055|FG008|Overall Study|Withdrawal by Subject|0|||
160922860|NCT01214629|581112056|FG009|Overall Study|Withdrawal by Subject|1|||
160922861|NCT01214629|581112057|FG010|Overall Study|Withdrawal by Subject|0|||
160922862|NCT04387435|581112059|FG000|Overall Study|Physician Decision|1|||
160922863|NCT03338855|581112062|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
160922864|NCT03338855|581112063|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
160922865|NCT00975481|581112071|FG000|Second Intervention Period|Adverse Event|2|||
160922866|NCT00975481|581112072|FG001|Second Intervention Period|Adverse Event|1|||
160922867|NCT00975481|581112073|FG002|Second Intervention Period|Adverse Event|0|||
160922868|NCT00975481|581112074|FG003|Second Intervention Period|Adverse Event|0|||
160922869|NCT00975481|581112075|FG004|Second Intervention Period|Adverse Event|0|||
160922870|NCT00975481|581112076|FG005|Second Intervention Period|Adverse Event|0|||
160922871|NCT00975481|581112071|FG000|Second Intervention Period|Withdrawal by Subject|0|||
160922872|NCT00975481|581112072|FG001|Second Intervention Period|Withdrawal by Subject|0|||
160922873|NCT00975481|581112073|FG002|Second Intervention Period|Withdrawal by Subject|1|||
160922874|NCT00975481|581112074|FG003|Second Intervention Period|Withdrawal by Subject|0|||
160922875|NCT00975481|581112075|FG004|Second Intervention Period|Withdrawal by Subject|0|||
160454805|NCT01928394|579396173|FG003|Treatment Period|Death|0|||
160922876|NCT00975481|581112076|FG005|Second Intervention Period|Withdrawal by Subject|0|||
160922877|NCT00975481|581112071|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
160922878|NCT00975481|581112072|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
160922879|NCT00975481|581112073|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
160922880|NCT00975481|581112074|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
160922881|NCT00975481|581112075|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
160454806|NCT01928394|579396174|FG004|Treatment Period|Death|0|||
160922882|NCT00975481|581112076|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
160922883|NCT00975481|581112071|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
160922884|NCT00975481|581112072|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
160922885|NCT00975481|581112073|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
160922886|NCT00975481|581112074|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
160922887|NCT00975481|581112075|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
160922888|NCT00975481|581112076|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
160922889|NCT02738450|581112079|FG000|Overall Study|Withdrawal by Subject|0|||
160922890|NCT02738450|581112080|FG001|Overall Study|Withdrawal by Subject|2|||
160922891|NCT02738450|581112081|FG002|Overall Study|Withdrawal by Subject|0|||
160922892|NCT03559257|581112082|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
160922893|NCT03559257|581112083|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
160922894|NCT03559257|581112082|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160922895|NCT03559257|581112083|FG001|Double Blind Treatment Period|Protocol Violation|4|||
160922896|NCT03559257|581112082|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
160922897|NCT03559257|581112083|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
160922898|NCT03559257|581112082|FG000|Double Blind Treatment Period|Adverse Event|0|||
160922899|NCT03559257|581112083|FG001|Double Blind Treatment Period|Adverse Event|1|||
160922900|NCT03559257|581112082|FG000|Double Blind Treatment Period|Screen Failure|0|||
160922901|NCT03559257|581112083|FG001|Double Blind Treatment Period|Screen Failure|1|||
160922902|NCT03559257|581112082|FG000|Open-label Treatment Period|Adverse Event|1|||
160922903|NCT03559257|581112083|FG001|Open-label Treatment Period|Adverse Event|4|||
160922904|NCT03559257|581112082|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
160922905|NCT03559257|581112083|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
160922906|NCT03559257|581112082|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
160922907|NCT03559257|581112083|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
160922908|NCT03559257|581112082|FG000|Open-label Treatment Period|Protocol Violation|2|||
160922909|NCT03559257|581112083|FG001|Open-label Treatment Period|Protocol Violation|0|||
160922910|NCT03559257|581112082|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
160922911|NCT03559257|581112083|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
160922912|NCT03559257|581112082|FG000|Open-label Treatment Period|Physician Decision|0|||
160922913|NCT03559257|581112083|FG001|Open-label Treatment Period|Physician Decision|1|||
160922914|NCT03630120|581112084|FG000|Overall Study|Disease progression|0|||
160922915|NCT03630120|581112085|FG001|Overall Study|Disease progression|1|||
160922916|NCT03630120|581112086|FG002|Overall Study|Disease progression|1|||
160922917|NCT03630120|581112087|FG003|Overall Study|Disease progression|1|||
160922918|NCT01519960|581112088|FG000|Overall Study|Withdrawal from the study|26|||
160922919|NCT01519960|581112089|FG001|Overall Study|Withdrawal from the study|22|||
160922920|NCT01519960|581112090|FG002|Overall Study|Withdrawal from the study|5|||
160922921|NCT03204305|581112099|FG000|Overall Study|Lost to Follow-up|6|||
160922922|NCT03204305|581112100|FG001|Overall Study|Lost to Follow-up|4|||
160922923|NCT03204305|581112101|FG002|Overall Study|Lost to Follow-up|0|||
160922924|NCT03204305|581112102|FG003|Overall Study|Lost to Follow-up|0|||
160922925|NCT03204305|581112099|FG000|Overall Study|Physician Decision|1|||
160922926|NCT03204305|581112100|FG001|Overall Study|Physician Decision|0|||
160922927|NCT03204305|581112101|FG002|Overall Study|Physician Decision|0|||
160922928|NCT03204305|581112102|FG003|Overall Study|Physician Decision|0|||
160922929|NCT03204305|581112099|FG000|Overall Study|failure to place arterial line|2|||
160922930|NCT03204305|581112100|FG001|Overall Study|failure to place arterial line|1|||
160922931|NCT03204305|581112101|FG002|Overall Study|failure to place arterial line|0|||
160922932|NCT03204305|581112102|FG003|Overall Study|failure to place arterial line|0|||
160922933|NCT03204305|581112099|FG000|Overall Study|Withdrawal by Subject|2|||
160922934|NCT03204305|581112100|FG001|Overall Study|Withdrawal by Subject|0|||
160922935|NCT03204305|581112101|FG002|Overall Study|Withdrawal by Subject|0|||
160922936|NCT03204305|581112102|FG003|Overall Study|Withdrawal by Subject|0|||
160922937|NCT00535223|581112109|FG000|Overall Study|Withdrawal by Subject|4|||
160922938|NCT00535223|581112110|FG001|Overall Study|Withdrawal by Subject|1|||
160922939|NCT00238121|581112116|FG000|Overall Study|Withdrawal by Subject|1|||
160922940|NCT00238121|581112117|FG001|Overall Study|Withdrawal by Subject|1|||
160922941|NCT00238121|581112116|FG000|Overall Study|Adverse Event|2|||
160922942|NCT00238121|581112117|FG001|Overall Study|Adverse Event|1|||
160922943|NCT03255382|581112118|FG000|Overall Study|Adverse Event|3|||
160922944|NCT03255382|581112119|FG001|Overall Study|Adverse Event|0|||
160922945|NCT03255382|581112118|FG000|Overall Study|Lost to Follow-up|2|||
160922946|NCT03255382|581112119|FG001|Overall Study|Lost to Follow-up|0|||
160922947|NCT03255382|581112118|FG000|Overall Study|Withdrawal by Subject|2|||
160922948|NCT03255382|581112119|FG001|Overall Study|Withdrawal by Subject|0|||
160922949|NCT03255382|581112118|FG000|Overall Study|Other|6|||
160922950|NCT03255382|581112119|FG001|Overall Study|Other|0|||
160922951|NCT01166178|581112120|FG000|Overall Study|Withdrawal by Subject|1|||
160922952|NCT01166178|581112121|FG001|Overall Study|Withdrawal by Subject|0|||
160922953|NCT01166178|581112120|FG000|Overall Study|Study was terminated|20|||
160922954|NCT01166178|581112121|FG001|Overall Study|Study was terminated|8|||
160922955|NCT04948450|581112122|FG000|Overall Study|Return home|1|||
160922956|NCT04948450|581112123|FG001|Overall Study|Return home|3|||
160922957|NCT00101907|581112126|FG000|Overall Study|Adverse Event|1|||
160922958|NCT00101907|581112127|FG001|Overall Study|Adverse Event|0|||
160922959|NCT00101907|581112128|FG002|Overall Study|Adverse Event|0|||
160576054|NCT00631488|579829230|FG000|Overall Study|Protocol Violation|0|||
160922960|NCT00101907|581112129|FG003|Overall Study|Adverse Event|0|||
160922961|NCT00101907|581112130|FG004|Overall Study|Adverse Event|0|||
160922962|NCT00101907|581112131|FG005|Overall Study|Adverse Event|0|||
160922963|NCT00101907|581112126|FG000|Overall Study|Death|0|||
160922964|NCT00101907|581112127|FG001|Overall Study|Death|1|||
160922965|NCT00101907|581112128|FG002|Overall Study|Death|0|||
160922966|NCT00101907|581112129|FG003|Overall Study|Death|0|||
160922967|NCT00101907|581112130|FG004|Overall Study|Death|3|||
160922968|NCT00101907|581112131|FG005|Overall Study|Death|0|||
160576055|NCT00631488|579829231|FG001|Overall Study|Protocol Violation|0|||
160576056|NCT00631488|579829232|FG002|Overall Study|Protocol Violation|1|||
160576057|NCT02855411|579829233|FG000|Overall Study|Study terminated by sponsor|21|||
160576058|NCT02855411|579829233|FG000|Overall Study|Does not meet entrance criteria|14|||
160576059|NCT02639182|579829234|FG000|Overall Study|Disease Progression|50|||
160576060|NCT02639182|579829235|FG001|Overall Study|Disease Progression|49|||
160576061|NCT02639182|579829234|FG000|Overall Study|Adverse Event|7|||
160576062|NCT02639182|579829235|FG001|Overall Study|Adverse Event|5|||
160576063|NCT02639182|579829234|FG000|Overall Study|Physician Decision|3|||
160922969|NCT00101907|581112126|FG000|Overall Study|Physician Decision|0|||
160922970|NCT00101907|581112127|FG001|Overall Study|Physician Decision|0|||
160922971|NCT00101907|581112128|FG002|Overall Study|Physician Decision|0|||
160922972|NCT00101907|581112129|FG003|Overall Study|Physician Decision|1|||
160922973|NCT00101907|581112130|FG004|Overall Study|Physician Decision|1|||
160922974|NCT00101907|581112131|FG005|Overall Study|Physician Decision|0|||
160922975|NCT00101907|581112126|FG000|Overall Study|Withdrawal by Subject|1|||
160922976|NCT00101907|581112127|FG001|Overall Study|Withdrawal by Subject|0|||
160922977|NCT00101907|581112128|FG002|Overall Study|Withdrawal by Subject|1|||
160922978|NCT00101907|581112129|FG003|Overall Study|Withdrawal by Subject|0|||
160922979|NCT00101907|581112130|FG004|Overall Study|Withdrawal by Subject|1|||
160922980|NCT00101907|581112131|FG005|Overall Study|Withdrawal by Subject|0|||
160922981|NCT00624052|581112132|FG000|Overall Study|Adverse Event|7|||
160922982|NCT00624052|581112133|FG001|Overall Study|Adverse Event|6|||
160922983|NCT00624052|581112134|FG002|Overall Study|Adverse Event|0|||
160922984|NCT00624052|581112135|FG003|Overall Study|Adverse Event|3|||
160922985|NCT00624052|581112132|FG000|Overall Study|Lack of Efficacy|1|||
160922986|NCT00624052|581112133|FG001|Overall Study|Lack of Efficacy|1|||
160922987|NCT00624052|581112134|FG002|Overall Study|Lack of Efficacy|0|||
160922988|NCT00624052|581112135|FG003|Overall Study|Lack of Efficacy|0|||
160922989|NCT00624052|581112132|FG000|Overall Study|Lost to Follow-up|2|||
160922990|NCT00624052|581112133|FG001|Overall Study|Lost to Follow-up|3|||
160922991|NCT00624052|581112134|FG002|Overall Study|Lost to Follow-up|1|||
160922992|NCT00624052|581112135|FG003|Overall Study|Lost to Follow-up|0|||
160922993|NCT00624052|581112132|FG000|Overall Study|Non compliant with the protocol|2|||
160922994|NCT00624052|581112133|FG001|Overall Study|Non compliant with the protocol|1|||
160922995|NCT00624052|581112134|FG002|Overall Study|Non compliant with the protocol|1|||
160922996|NCT00624052|581112135|FG003|Overall Study|Non compliant with the protocol|1|||
160922997|NCT00624052|581112132|FG000|Overall Study|Consent withdrawn|3|||
160922998|NCT00624052|581112133|FG001|Overall Study|Consent withdrawn|1|||
160922999|NCT00624052|581112134|FG002|Overall Study|Consent withdrawn|1|||
160923000|NCT00624052|581112135|FG003|Overall Study|Consent withdrawn|0|||
160923001|NCT00624052|581112132|FG000|Overall Study|Changed job/ran out if meds|0|||
160923002|NCT00624052|581112133|FG001|Overall Study|Changed job/ran out if meds|2|||
160923003|NCT00624052|581112134|FG002|Overall Study|Changed job/ran out if meds|0|||
160923004|NCT00624052|581112135|FG003|Overall Study|Changed job/ran out if meds|0|||
160923005|NCT01474876|581112141|FG000|Overall Study|Adverse Event|11|||
160923006|NCT01474876|581112142|FG001|Overall Study|Adverse Event|5|||
160923007|NCT01474876|581112143|FG002|Overall Study|Adverse Event|0|||
160923008|NCT01474876|581112141|FG000|Overall Study|Serious Adverse Event|2|||
160576064|NCT02639182|579829235|FG001|Overall Study|Physician Decision|3|||
160576065|NCT02639182|579829234|FG000|Overall Study|Withdrew Consent|5|||
160576066|NCT02639182|579829235|FG001|Overall Study|Withdrew Consent|4|||
160576067|NCT02639182|579829234|FG000|Overall Study|Lost to Follow-up|0|||
160576068|NCT02639182|579829235|FG001|Overall Study|Lost to Follow-up|1|||
160576069|NCT02639182|579829234|FG000|Overall Study|Study Closure|1|||
160923009|NCT01474876|581112142|FG001|Overall Study|Serious Adverse Event|3|||
160923010|NCT01474876|581112143|FG002|Overall Study|Serious Adverse Event|0|||
160923011|NCT01474876|581112141|FG000|Overall Study|Lost to Follow-up|5|||
160923012|NCT01474876|581112142|FG001|Overall Study|Lost to Follow-up|4|||
160923013|NCT01474876|581112143|FG002|Overall Study|Lost to Follow-up|0|||
160454807|NCT01928394|579396175|FG005|Treatment Period|Death|0|||
160576070|NCT02639182|579829235|FG001|Overall Study|Study Closure|2|||
160576071|NCT02639182|579829234|FG000|Overall Study|Sponsor Ended Study|0|||
160576072|NCT02639182|579829235|FG001|Overall Study|Sponsor Ended Study|1|||
160923014|NCT01474876|581112141|FG000|Overall Study|Investigator's decision|28|||
160923015|NCT01474876|581112142|FG001|Overall Study|Investigator's decision|6|||
160923016|NCT01474876|581112143|FG002|Overall Study|Investigator's decision|0|||
160923017|NCT01474876|581112141|FG000|Overall Study|Patient's request|19|||
160923018|NCT01474876|581112142|FG001|Overall Study|Patient's request|5|||
160923019|NCT01474876|581112143|FG002|Overall Study|Patient's request|0|||
160923020|NCT01474876|581112141|FG000|Overall Study|Investigator's decision and pt request|1|||
160923021|NCT01474876|581112142|FG001|Overall Study|Investigator's decision and pt request|0|||
160923022|NCT01474876|581112143|FG002|Overall Study|Investigator's decision and pt request|0|||
160923023|NCT02291055|581112144|FG000|Overall Study|Death|2|||
160923024|NCT02291055|581112145|FG001|Overall Study|Death|2|||
160923025|NCT02291055|581112146|FG002|Overall Study|Death|5|||
160923026|NCT02291055|581112147|FG003|Overall Study|Death|8|||
160923027|NCT02291055|581112148|FG004|Overall Study|Death|12|||
160923028|NCT02291055|581112144|FG000|Overall Study|Lost to Follow-up|0|||
160923029|NCT02291055|581112145|FG001|Overall Study|Lost to Follow-up|0|||
160923030|NCT02291055|581112146|FG002|Overall Study|Lost to Follow-up|0|||
160923031|NCT02291055|581112147|FG003|Overall Study|Lost to Follow-up|1|||
160923032|NCT02291055|581112148|FG004|Overall Study|Lost to Follow-up|2|||
160923033|NCT02291055|581112144|FG000|Overall Study|Withdrawal by Subject|3|||
160923034|NCT02291055|581112145|FG001|Overall Study|Withdrawal by Subject|1|||
160923035|NCT02291055|581112146|FG002|Overall Study|Withdrawal by Subject|1|||
160923036|NCT02291055|581112147|FG003|Overall Study|Withdrawal by Subject|5|||
160923037|NCT02291055|581112148|FG004|Overall Study|Withdrawal by Subject|10|||
160923038|NCT02291055|581112144|FG000|Overall Study|Progressive Disease|0|||
160923039|NCT02291055|581112145|FG001|Overall Study|Progressive Disease|0|||
160923040|NCT02291055|581112146|FG002|Overall Study|Progressive Disease|1|||
160923041|NCT02291055|581112147|FG003|Overall Study|Progressive Disease|4|||
160923042|NCT02291055|581112148|FG004|Overall Study|Progressive Disease|2|||
160923043|NCT02291055|581112144|FG000|Overall Study|Study Terminated by Sponsor|0|||
160923044|NCT02291055|581112145|FG001|Overall Study|Study Terminated by Sponsor|0|||
160923045|NCT02291055|581112146|FG002|Overall Study|Study Terminated by Sponsor|0|||
160576073|NCT02639182|579829234|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
160576074|NCT02639182|579829235|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
160576075|NCT02616029|579829237|FG000|Overall Study|Adverse Event|1|||
160923046|NCT02291055|581112147|FG003|Overall Study|Study Terminated by Sponsor|5|||
160923047|NCT02291055|581112148|FG004|Overall Study|Study Terminated by Sponsor|1|||
160923048|NCT02291055|581112144|FG000|Overall Study|Other|0|||
160923049|NCT02291055|581112145|FG001|Overall Study|Other|2|||
160923050|NCT02291055|581112146|FG002|Overall Study|Other|1|||
160923051|NCT02291055|581112147|FG003|Overall Study|Other|4|||
160923052|NCT02291055|581112148|FG004|Overall Study|Other|0|||
160923053|NCT01523886|581112152|FG000|Overall Study|surgery cancelled|0|||
160923054|NCT01523886|581112153|FG001|Overall Study|surgery cancelled|1|||
160923055|NCT03839212|581112157|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
160923056|NCT00679263|581112158|FG000|Visit 2/Dose 1|Adverse Event|1|||
160923057|NCT00679263|581112159|FG001|Visit 2/Dose 1|Adverse Event|0|||
160923058|NCT00679263|581112160|FG002|Visit 2/Dose 1|Adverse Event|0|||
160923059|NCT00679263|581112158|FG000|Visit 2/Dose 1|subject not compliance|1|||
160923060|NCT00679263|581112159|FG001|Visit 2/Dose 1|subject not compliance|1|||
160923061|NCT00679263|581112160|FG002|Visit 2/Dose 1|subject not compliance|0|||
160923062|NCT00733746|581112161|FG000|Overall Study|Ineligible|5|||
160923063|NCT01173718|581112164|FG000|Overall Study|Death|17|||
160923064|NCT01173718|581112164|FG000|Overall Study|Abandonment of study graft|27|||
160923065|NCT02113956|581112165|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
160923066|NCT02113956|581112166|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
160923067|NCT02113956|581112165|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
160923068|NCT02113956|581112166|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
160923069|NCT02113956|581112165|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
160923070|NCT02113956|581112166|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
160923071|NCT01499563|581112169|FG000|Overall Study|Withdrawal by Subject|10|||
160923072|NCT01499563|581112170|FG001|Overall Study|Withdrawal by Subject|11|||
160923073|NCT01499563|581112171|FG002|Overall Study|Withdrawal by Subject|7|||
160923074|NCT01499563|581112172|FG003|Overall Study|Withdrawal by Subject|8|||
160997880|NCT02104765|581376670|FG000|Overall Study|Lost to Follow-up|0|||
160997881|NCT02104765|581376671|FG001|Overall Study|Lost to Follow-up|0|||
160576076|NCT02616029|579829238|FG001|Overall Study|Adverse Event|0|||
160576077|NCT02616029|579829237|FG000|Overall Study|Death|0|||
160576078|NCT02616029|579829238|FG001|Overall Study|Death|1|||
160576079|NCT02616029|579829237|FG000|Overall Study|Protocol Violation|1|||
160576080|NCT02616029|579829238|FG001|Overall Study|Protocol Violation|0|||
160923075|NCT01499563|581112169|FG000|Overall Study|Physician Decision|2|||
160997882|NCT02104765|581376672|FG002|Overall Study|Lost to Follow-up|1|||
160923076|NCT01499563|581112170|FG001|Overall Study|Physician Decision|1|||
160923077|NCT01499563|581112171|FG002|Overall Study|Physician Decision|3|||
160923078|NCT01499563|581112172|FG003|Overall Study|Physician Decision|0|||
160923079|NCT01499563|581112169|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
160997883|NCT02104765|581376673|FG003|Overall Study|Lost to Follow-up|0|||
160454808|NCT01928394|579396176|FG006|Treatment Period|Death|0|||
160576081|NCT02616029|579829237|FG000|Overall Study|Withdrew Consent|1|||
160576082|NCT02616029|579829238|FG001|Overall Study|Withdrew Consent|0|||
160923080|NCT01499563|581112170|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
160997884|NCT02104765|581376674|FG004|Overall Study|Lost to Follow-up|0|||
160923081|NCT01499563|581112171|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
160923082|NCT01499563|581112172|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
160923083|NCT01499563|581112169|FG000|Overall Study|Adverse Event|2|||
160923084|NCT01499563|581112170|FG001|Overall Study|Adverse Event|0|||
160923085|NCT01499563|581112171|FG002|Overall Study|Adverse Event|1|||
160923086|NCT01499563|581112172|FG003|Overall Study|Adverse Event|3|||
160923087|NCT01499563|581112169|FG000|Overall Study|Lack of Efficacy|0|||
160923088|NCT01499563|581112170|FG001|Overall Study|Lack of Efficacy|1|||
160923089|NCT01499563|581112171|FG002|Overall Study|Lack of Efficacy|6|||
160923090|NCT01499563|581112172|FG003|Overall Study|Lack of Efficacy|3|||
160923091|NCT01499563|581112169|FG000|Overall Study|Other|8|||
160923092|NCT01499563|581112170|FG001|Overall Study|Other|6|||
160923093|NCT01499563|581112171|FG002|Overall Study|Other|6|||
160923094|NCT01499563|581112172|FG003|Overall Study|Other|4|||
160923095|NCT03658538|581112173|FG000|Overall Study|Death|2|||
160923096|NCT03658538|581112174|FG001|Overall Study|Death|1|||
160923097|NCT03658538|581112173|FG000|Overall Study|Cancer diagnosis|1|||
160923098|NCT03658538|581112174|FG001|Overall Study|Cancer diagnosis|0|||
160923099|NCT03658538|581112173|FG000|Overall Study|Change residence|1|||
160923100|NCT03658538|581112174|FG001|Overall Study|Change residence|2|||
160923101|NCT03658538|581112173|FG000|Overall Study|Lost to Follow-up|3|||
160923102|NCT03658538|581112174|FG001|Overall Study|Lost to Follow-up|3|||
160923103|NCT03658538|581112173|FG000|Overall Study|Unblinded|2|||
160923104|NCT03658538|581112174|FG001|Overall Study|Unblinded|3|||
160923105|NCT03658538|581112173|FG000|Overall Study|Physician Decision|0|||
160923106|NCT03658538|581112174|FG001|Overall Study|Physician Decision|1|||
160923107|NCT03658538|581112173|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
160923108|NCT03658538|581112174|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
160923109|NCT03658538|581112173|FG000|Overall Study|Evicted from home|1|||
160923110|NCT03658538|581112174|FG001|Overall Study|Evicted from home|0|||
160923111|NCT02738151|581112176|FG000|Overall Study|Randomized but not treated|4|||
160923112|NCT02738151|581112177|FG001|Overall Study|Randomized but not treated|1|||
160923113|NCT02738151|581112176|FG000|Overall Study|Adverse Event|4|||
160923114|NCT02738151|581112177|FG001|Overall Study|Adverse Event|5|||
160923115|NCT02738151|581112176|FG000|Overall Study|Hypoglycemia|0|||
160923116|NCT02738151|581112177|FG001|Overall Study|Hypoglycemia|1|||
160923117|NCT02738151|581112176|FG000|Overall Study|Poor Compliance to Protocol|4|||
160923118|NCT02738151|581112177|FG001|Overall Study|Poor Compliance to Protocol|3|||
160923119|NCT02738151|581112176|FG000|Overall Study|Other than specified above|11|||
160923120|NCT02738151|581112177|FG001|Overall Study|Other than specified above|21|||
160923121|NCT03333044|581112181|FG000|Overall Study|Pregnancy|1|||
160923122|NCT03333044|581112182|FG001|Overall Study|Pregnancy|0|||
160923123|NCT03333044|581112183|FG002|Overall Study|Pregnancy|0|||
160923124|NCT03333044|581112181|FG000|Overall Study|Lost to Follow-up|0|||
160923125|NCT03333044|581112182|FG001|Overall Study|Lost to Follow-up|14|||
160923126|NCT03333044|581112183|FG002|Overall Study|Lost to Follow-up|6|||
160923127|NCT04537234|581112187|FG000|Overall Study|Withdrawal by Subject|2|||
160923128|NCT04537234|581112188|FG001|Overall Study|Withdrawal by Subject|0|||
160923129|NCT04318080|581115329|FG000|Overall Study|Study closed by sponsor|10|||
160923130|NCT04318080|581115330|FG001|Overall Study|Study closed by sponsor|22|||
160923131|NCT04318080|581115329|FG000|Overall Study|Death|3|||
160923132|NCT04318080|581115330|FG001|Overall Study|Death|9|||
160923133|NCT04318080|581115329|FG000|Overall Study|Withdrawal by Subject|1|||
160923134|NCT04318080|581115330|FG001|Overall Study|Withdrawal by Subject|0|||
160923135|NCT04318080|581115329|FG000|Overall Study|Protocol Deviation|1|||
160923136|NCT04318080|581115330|FG001|Overall Study|Protocol Deviation|0|||
160923137|NCT06308822|581115331|FG000|Overall Study|Mutation Status Not Confirmed|17|||
160923138|NCT06308822|581115331|FG000|Overall Study|Adverse Event|1|||
160923139|NCT06308822|581115331|FG000|Overall Study|Death|5|||
160923140|NCT06308822|581115331|FG000|Overall Study|Disease progression|8|||
160923141|NCT06308822|581115331|FG000|Overall Study|Withdrawal by Subject|1|||
160923142|NCT06308822|581115331|FG000|Overall Study|Physician Decision|3|||
160576083|NCT02616029|579829237|FG000|Overall Study|Enrolled and Never Treated|1|||
160923143|NCT01536379|581115332|FG000|Overall Study|Adverse Event|1|||
160923144|NCT01536379|581115333|FG001|Overall Study|Adverse Event|2|||
160923145|NCT01536379|581115332|FG000|Overall Study|Withdrawal by Subject|1|||
160923146|NCT01536379|581115333|FG001|Overall Study|Withdrawal by Subject|1|||
160923147|NCT00939809|581115341|FG000|Overall Study|Adverse Event|2|||
160923148|NCT00939809|581115341|FG000|Overall Study|Death|1|||
160923149|NCT01921179|581115342|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
160923150|NCT01921179|581115343|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
160923151|NCT01921179|581115342|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
160923152|NCT01921179|581115343|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
160923153|NCT02603809|581115344|FG000|Overall Study|Withdrawal by Subject|4|||
160923154|NCT02603809|581115345|FG001|Overall Study|Withdrawal by Subject|1|||
160923155|NCT02603809|581115346|FG002|Overall Study|Withdrawal by Subject|2|||
160576084|NCT02616029|579829238|FG001|Overall Study|Enrolled and Never Treated|1|||
160923156|NCT02603809|581115347|FG003|Overall Study|Withdrawal by Subject|3|||
160576085|NCT00609609|579829239|FG000|Overall Study|Withdrawal by Subject|2|||
160576086|NCT00609609|579829240|FG001|Overall Study|Withdrawal by Subject|0|||
160576087|NCT00609609|579829239|FG000|Overall Study|Progression|4|||
160576088|NCT00609609|579829240|FG001|Overall Study|Progression|2|||
160576089|NCT03988751|579829241|FG000|Overall Study|Withdrawal by Subject|1|||
160576090|NCT03988751|579829242|FG001|Overall Study|Withdrawal by Subject|0|||
160576091|NCT03988751|579829241|FG000|Overall Study|Protocol Violation|0|||
160576092|NCT03988751|579829242|FG001|Overall Study|Protocol Violation|1|||
160576093|NCT00844883|579829243|FG000|Overall Study|Bridged to liver transplant|3|||
160654760|NCT02579096|580117159|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
160654761|NCT02579096|580117160|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
160654762|NCT02579096|580117159|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
160654763|NCT02579096|580117160|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
160654764|NCT02579096|580117159|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
160654765|NCT02579096|580117160|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
160654766|NCT02579096|580117159|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
160654767|NCT02579096|580117160|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
160654768|NCT02579096|580117159|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
160654769|NCT02579096|580117160|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
160654770|NCT02097121|580117165|FG000|Overall Study|Other, not specified|4|||
160654771|NCT02097121|580117166|FG001|Overall Study|Other, not specified|2|||
160923157|NCT02603809|581115348|FG004|Overall Study|Withdrawal by Subject|3|||
160923158|NCT02603809|581115349|FG005|Overall Study|Withdrawal by Subject|4|||
160923159|NCT02603809|581115344|FG000|Overall Study|Lost to Follow-up|2|||
160923160|NCT02603809|581115345|FG001|Overall Study|Lost to Follow-up|3|||
160923161|NCT02603809|581115346|FG002|Overall Study|Lost to Follow-up|1|||
160923162|NCT02603809|581115347|FG003|Overall Study|Lost to Follow-up|4|||
160923163|NCT02603809|581115348|FG004|Overall Study|Lost to Follow-up|2|||
160923164|NCT02603809|581115349|FG005|Overall Study|Lost to Follow-up|2|||
160923165|NCT02603809|581115344|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
160923166|NCT02603809|581115345|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
160923167|NCT02603809|581115346|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
160923168|NCT02603809|581115347|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
160923169|NCT02603809|581115348|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
160923170|NCT02603809|581115349|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
160923171|NCT02603809|581115344|FG000|Overall Study|Physician Decision|0|||
160923172|NCT02603809|581115345|FG001|Overall Study|Physician Decision|0|||
160923173|NCT02603809|581115346|FG002|Overall Study|Physician Decision|0|||
160923174|NCT02603809|581115347|FG003|Overall Study|Physician Decision|1|||
160923175|NCT02603809|581115348|FG004|Overall Study|Physician Decision|2|||
160923176|NCT02603809|581115349|FG005|Overall Study|Physician Decision|1|||
160923177|NCT02603809|581115344|FG000|Overall Study|Adverse Event|3|||
160923178|NCT02603809|581115345|FG001|Overall Study|Adverse Event|0|||
160923179|NCT02603809|581115346|FG002|Overall Study|Adverse Event|2|||
160923180|NCT02603809|581115347|FG003|Overall Study|Adverse Event|2|||
160923181|NCT02603809|581115348|FG004|Overall Study|Adverse Event|1|||
160923182|NCT02603809|581115349|FG005|Overall Study|Adverse Event|1|||
160923183|NCT02603809|581115344|FG000|Overall Study|Lack of Efficacy|0|||
160923184|NCT02603809|581115345|FG001|Overall Study|Lack of Efficacy|1|||
160923185|NCT02603809|581115346|FG002|Overall Study|Lack of Efficacy|0|||
160923186|NCT02603809|581115347|FG003|Overall Study|Lack of Efficacy|0|||
160923187|NCT02603809|581115348|FG004|Overall Study|Lack of Efficacy|0|||
160923188|NCT02603809|581115349|FG005|Overall Study|Lack of Efficacy|1|||
160923189|NCT00380978|581115350|FG000|Overall Study|Refused allocated intervention|0|||
160923190|NCT00380978|581115351|FG001|Overall Study|Refused allocated intervention|6|||
160923191|NCT00380978|581115350|FG000|Overall Study|Wrong study envelope|0|||
160923192|NCT00380978|581115351|FG001|Overall Study|Wrong study envelope|2|||
160923193|NCT00380978|581115350|FG000|Overall Study|Allocation prior to analgesia request|1|||
160923194|NCT00380978|581115351|FG001|Overall Study|Allocation prior to analgesia request|2|||
160923195|NCT00380978|581115350|FG000|Overall Study|Parous patient|1|||
160923196|NCT00380978|581115351|FG001|Overall Study|Parous patient|0|||
160923197|NCT04146545|581115352|FG000|Overall Study|deemed ineligible after randomization|1|||
160923198|NCT04146545|581115353|FG001|Overall Study|deemed ineligible after randomization|0|||
160923199|NCT02750592|581115354|FG000|Overall Study|Adverse Event|3|||
160576094|NCT00844883|579829243|FG000|Overall Study|Bridged to resection|1|||
160576095|NCT03065530|579829248|FG000|Overall Study|Lack of Efficacy|1|||
160923200|NCT02750592|581115354|FG000|Overall Study|Lack of Efficacy|2|||
160923201|NCT02981342|581115355|FG000|Overall Study|Adverse Event|0|||
160923202|NCT02981342|581115356|FG001|Overall Study|Adverse Event|0|||
160923203|NCT02981342|581115357|FG002|Overall Study|Adverse Event|0|||
160923204|NCT02981342|581115358|FG003|Overall Study|Adverse Event|1|||
160923205|NCT02981342|581115355|FG000|Overall Study|Death|0|||
160654772|NCT02097121|580117167|FG002|Overall Study|Other, not specified|3|||
160923206|NCT02981342|581115356|FG001|Overall Study|Death|9|||
160576096|NCT03065530|579829249|FG001|Overall Study|Lack of Efficacy|1|||
160576097|NCT03065530|579829250|FG002|Overall Study|Lack of Efficacy|0|||
160923207|NCT02981342|581115357|FG002|Overall Study|Death|9|||
160923208|NCT02981342|581115358|FG003|Overall Study|Death|4|||
160923209|NCT02981342|581115355|FG000|Overall Study|Withdrawal by Subject|0|||
160923210|NCT02981342|581115356|FG001|Overall Study|Withdrawal by Subject|0|||
160923211|NCT02981342|581115357|FG002|Overall Study|Withdrawal by Subject|3|||
160923212|NCT02981342|581115358|FG003|Overall Study|Withdrawal by Subject|1|||
160923213|NCT02981342|581115355|FG000|Overall Study|Study closed by sponsor|0|||
160923214|NCT02981342|581115356|FG001|Overall Study|Study closed by sponsor|0|||
160923215|NCT02981342|581115357|FG002|Overall Study|Study closed by sponsor|1|||
160923216|NCT02981342|581115358|FG003|Overall Study|Study closed by sponsor|1|||
160923217|NCT02981342|581115355|FG000|Overall Study|Randomized, Never Treated|0|||
160923218|NCT02981342|581115356|FG001|Overall Study|Randomized, Never Treated|1|||
160923219|NCT02981342|581115357|FG002|Overall Study|Randomized, Never Treated|0|||
160923220|NCT02981342|581115358|FG003|Overall Study|Randomized, Never Treated|7|||
160923221|NCT02981342|581115355|FG000|Overall Study|Lost to Follow-up|0|||
160923222|NCT02981342|581115356|FG001|Overall Study|Lost to Follow-up|1|||
160923223|NCT02981342|581115357|FG002|Overall Study|Lost to Follow-up|0|||
160923224|NCT02981342|581115358|FG003|Overall Study|Lost to Follow-up|0|||
160576098|NCT03065530|579829251|FG003|Overall Study|Lack of Efficacy|1|||
160576099|NCT03065530|579829248|FG000|Overall Study|Protocol Violation|1|||
160576100|NCT03065530|579829249|FG001|Overall Study|Protocol Violation|0|||
160576101|NCT03065530|579829250|FG002|Overall Study|Protocol Violation|1|||
160576102|NCT03065530|579829251|FG003|Overall Study|Protocol Violation|1|||
160576103|NCT00479466|579829254|FG000|Overall Study|Adverse Event|5|||
160576104|NCT00479466|579829255|FG001|Overall Study|Adverse Event|1|||
160923225|NCT01277523|581115361|FG000|Overall Study|Adverse Event|1|||
160923226|NCT01277523|581115362|FG001|Overall Study|Adverse Event|0|||
160576105|NCT00479466|579829256|FG002|Overall Study|Adverse Event|0|||
160576106|NCT00479466|579829257|FG003|Overall Study|Adverse Event|1|||
160576107|NCT00479466|579829258|FG004|Overall Study|Adverse Event|2|||
160576108|NCT00479466|579829259|FG005|Overall Study|Adverse Event|0|||
160576109|NCT00479466|579829254|FG000|Overall Study|Hyperglycemia|0|||
160576110|NCT00479466|579829255|FG001|Overall Study|Hyperglycemia|0|||
160576111|NCT00479466|579829256|FG002|Overall Study|Hyperglycemia|0|||
160576112|NCT00479466|579829257|FG003|Overall Study|Hyperglycemia|0|||
160576113|NCT00479466|579829258|FG004|Overall Study|Hyperglycemia|0|||
160576114|NCT00479466|579829259|FG005|Overall Study|Hyperglycemia|1|||
160576115|NCT00479466|579829254|FG000|Overall Study|Lack of Efficacy|2|||
160576116|NCT00479466|579829255|FG001|Overall Study|Lack of Efficacy|0|||
160576117|NCT00479466|579829256|FG002|Overall Study|Lack of Efficacy|1|||
160576118|NCT00479466|579829257|FG003|Overall Study|Lack of Efficacy|0|||
160576119|NCT00479466|579829258|FG004|Overall Study|Lack of Efficacy|0|||
160576120|NCT00479466|579829259|FG005|Overall Study|Lack of Efficacy|0|||
160576121|NCT00479466|579829254|FG000|Overall Study|Lost to Follow-up|0|||
160576122|NCT00479466|579829255|FG001|Overall Study|Lost to Follow-up|1|||
160576123|NCT00479466|579829256|FG002|Overall Study|Lost to Follow-up|1|||
160576124|NCT00479466|579829257|FG003|Overall Study|Lost to Follow-up|0|||
160576125|NCT00479466|579829258|FG004|Overall Study|Lost to Follow-up|2|||
160576126|NCT00479466|579829259|FG005|Overall Study|Lost to Follow-up|2|||
160576127|NCT00479466|579829254|FG000|Overall Study|Physician Decision|2|||
160576128|NCT00479466|579829255|FG001|Overall Study|Physician Decision|1|||
160576129|NCT00479466|579829256|FG002|Overall Study|Physician Decision|1|||
160576130|NCT00479466|579829257|FG003|Overall Study|Physician Decision|0|||
160576131|NCT00479466|579829258|FG004|Overall Study|Physician Decision|0|||
160576132|NCT00479466|579829259|FG005|Overall Study|Physician Decision|0|||
160576133|NCT00479466|579829254|FG000|Overall Study|Pregnancy|0|||
160576134|NCT00479466|579829255|FG001|Overall Study|Pregnancy|0|||
160576135|NCT00479466|579829256|FG002|Overall Study|Pregnancy|0|||
160576136|NCT00479466|579829257|FG003|Overall Study|Pregnancy|0|||
160576137|NCT00479466|579829258|FG004|Overall Study|Pregnancy|1|||
160576138|NCT00479466|579829259|FG005|Overall Study|Pregnancy|0|||
160576139|NCT00479466|579829254|FG000|Overall Study|Protocol Violation|1|||
160576140|NCT00479466|579829255|FG001|Overall Study|Protocol Violation|0|||
160576141|NCT00479466|579829256|FG002|Overall Study|Protocol Violation|0|||
160576142|NCT00479466|579829257|FG003|Overall Study|Protocol Violation|0|||
160576143|NCT00479466|579829258|FG004|Overall Study|Protocol Violation|0|||
160576144|NCT00479466|579829259|FG005|Overall Study|Protocol Violation|0|||
160576145|NCT00479466|579829254|FG000|Overall Study|Withdrawal by Subject|3|||
160576146|NCT00479466|579829255|FG001|Overall Study|Withdrawal by Subject|5|||
160576147|NCT00479466|579829256|FG002|Overall Study|Withdrawal by Subject|0|||
160654773|NCT02097121|580117165|FG000|Overall Study|Lack of Efficacy|2|||
160923227|NCT01277523|581115363|FG002|Overall Study|Adverse Event|0|||
160923228|NCT01277523|581115361|FG000|Overall Study|Protocol Violation|2|||
160923229|NCT01277523|581115362|FG001|Overall Study|Protocol Violation|0|||
160576148|NCT00479466|579829257|FG003|Overall Study|Withdrawal by Subject|2|||
160576149|NCT00479466|579829258|FG004|Overall Study|Withdrawal by Subject|3|||
160576150|NCT00479466|579829259|FG005|Overall Study|Withdrawal by Subject|1|||
160576151|NCT01839188|579829266|FG000|Overall Study|Withdrawal by Subject|1|||
160576152|NCT01671488|579829276|FG000|Overall Study|Withdrawal by Subject|1|||
160923230|NCT01277523|581115363|FG002|Overall Study|Protocol Violation|0|||
160654774|NCT02097121|580117166|FG001|Overall Study|Lack of Efficacy|1|||
160654775|NCT02097121|580117167|FG002|Overall Study|Lack of Efficacy|3|||
160654776|NCT02097121|580117165|FG000|Overall Study|Withdrawal by Subject|0|||
160654777|NCT02097121|580117166|FG001|Overall Study|Withdrawal by Subject|1|||
160654778|NCT02097121|580117167|FG002|Overall Study|Withdrawal by Subject|2|||
160654779|NCT02097121|580117165|FG000|Overall Study|Adverse Event|0|||
160654780|NCT02097121|580117166|FG001|Overall Study|Adverse Event|1|||
160654781|NCT02097121|580117167|FG002|Overall Study|Adverse Event|0|||
160654782|NCT02097121|580117165|FG000|Overall Study|Lost to Follow-up|1|||
160654783|NCT02097121|580117166|FG001|Overall Study|Lost to Follow-up|1|||
160654784|NCT02097121|580117167|FG002|Overall Study|Lost to Follow-up|2|||
160654785|NCT00510510|580117168|FG000|Overall Study|Adverse Event|4|||
160654786|NCT00510510|580117169|FG001|Overall Study|Adverse Event|3|||
160654787|NCT00510510|580117170|FG002|Overall Study|Adverse Event|6|||
160654788|NCT00510510|580117168|FG000|Overall Study|Lack of Efficacy|0|||
160654789|NCT00510510|580117169|FG001|Overall Study|Lack of Efficacy|1|||
160654790|NCT00510510|580117170|FG002|Overall Study|Lack of Efficacy|1|||
160654791|NCT00510510|580117168|FG000|Overall Study|Subjects no longer requires study drug|0|||
160654792|NCT00510510|580117169|FG001|Overall Study|Subjects no longer requires study drug|0|||
160654793|NCT00510510|580117170|FG002|Overall Study|Subjects no longer requires study drug|2|||
160654794|NCT00510510|580117168|FG000|Overall Study|Withdrawal by Subject|1|||
160654795|NCT00510510|580117169|FG001|Overall Study|Withdrawal by Subject|2|||
160654796|NCT00510510|580117170|FG002|Overall Study|Withdrawal by Subject|3|||
160654797|NCT00510510|580117168|FG000|Overall Study|Lost to Follow-up|0|||
160654798|NCT00510510|580117169|FG001|Overall Study|Lost to Follow-up|0|||
160654799|NCT00510510|580117170|FG002|Overall Study|Lost to Follow-up|1|||
160654800|NCT00510510|580117168|FG000|Overall Study|Protocol Violation|0|||
160654801|NCT00510510|580117169|FG001|Overall Study|Protocol Violation|3|||
160654802|NCT00510510|580117170|FG002|Overall Study|Protocol Violation|4|||
160654803|NCT03595657|580117171|FG000|Overall Study|Adverse Event|14|||
160654804|NCT03595657|580117171|FG000|Overall Study|Death|1|||
160654805|NCT03595657|580117171|FG000|Overall Study|Lack of Efficacy|40|||
160654806|NCT03595657|580117171|FG000|Overall Study|Withdrawal by Subject|10|||
160654807|NCT03595657|580117171|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
160654808|NCT03595657|580117171|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
160654809|NCT01066052|580117172|FG000|Overall Study|Enrolled But Not Treated|3|||
160654810|NCT01066052|580117173|FG001|Overall Study|Enrolled But Not Treated|0|||
160654811|NCT01200394|580117174|FG000|Overall Study|Adverse Event|0|||
160654812|NCT01200394|580117175|FG001|Overall Study|Adverse Event|14|||
160654813|NCT01200394|580117174|FG000|Overall Study|Death|1|||
160654814|NCT01200394|580117175|FG001|Overall Study|Death|0|||
160654815|NCT01200394|580117174|FG000|Overall Study|Lost to Follow-up|0|||
160654816|NCT01200394|580117175|FG001|Overall Study|Lost to Follow-up|1|||
160654817|NCT01200394|580117174|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
160654818|NCT01200394|580117175|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
160654819|NCT01200394|580117174|FG000|Overall Study|Protocol Violation|0|||
160654820|NCT01200394|580117175|FG001|Overall Study|Protocol Violation|3|||
160654821|NCT01200394|580117174|FG000|Overall Study|Withdrawal by Subject|0|||
160654822|NCT01200394|580117175|FG001|Overall Study|Withdrawal by Subject|5|||
160654823|NCT01200394|580117174|FG000|Overall Study|Other|0|||
160654824|NCT01200394|580117175|FG001|Overall Study|Other|1|||
160654825|NCT02729896|580117178|FG000|Overall Study|Death|0|||
160654826|NCT02729896|580117179|FG001|Overall Study|Death|2|||
160654827|NCT02729896|580117180|FG002|Overall Study|Death|13|||
160654828|NCT02729896|580117178|FG000|Overall Study|Lost to Follow-up|0|||
160654829|NCT02729896|580117179|FG001|Overall Study|Lost to Follow-up|2|||
160654830|NCT02729896|580117180|FG002|Overall Study|Lost to Follow-up|3|||
160654831|NCT02729896|580117178|FG000|Overall Study|Other|0|||
160654832|NCT02729896|580117179|FG001|Overall Study|Other|2|||
160654833|NCT02729896|580117180|FG002|Overall Study|Other|0|||
160654834|NCT02729896|580117178|FG000|Overall Study|Physician Decision|1|||
160654835|NCT02729896|580117179|FG001|Overall Study|Physician Decision|2|||
160654836|NCT02729896|580117180|FG002|Overall Study|Physician Decision|3|||
160654837|NCT02729896|580117178|FG000|Overall Study|Progressive Disease|0|||
160654838|NCT02729896|580117179|FG001|Overall Study|Progressive Disease|1|||
160654839|NCT02729896|580117180|FG002|Overall Study|Progressive Disease|0|||
160654840|NCT02729896|580117178|FG000|Overall Study|Withdrawal by Subject|1|||
160654841|NCT02729896|580117179|FG001|Overall Study|Withdrawal by Subject|0|||
160654842|NCT02729896|580117180|FG002|Overall Study|Withdrawal by Subject|3|||
160654843|NCT01835145|580117181|FG000|Overall Study|Ineligible prior to treatment|1|||
160654844|NCT01835145|580117182|FG001|Overall Study|Ineligible prior to treatment|0|||
160654845|NCT04094870|580117183|FG000|Overall Study|Lost to Follow-up|1|||
160654846|NCT04094870|580117184|FG001|Overall Study|Lost to Follow-up|1|||
160654847|NCT02708277|580117186|FG000|Overall Study|Lost to Follow-up|7|||
160654848|NCT02708277|580117187|FG001|Overall Study|Lost to Follow-up|4|||
160654849|NCT01592370|580117190|FG000|Overall Study|Disease Progression|62|||
160654850|NCT01592370|580117191|FG001|Overall Study|Disease Progression|16|||
160654851|NCT01592370|580117192|FG002|Overall Study|Disease Progression|52|||
160654852|NCT01592370|580117193|FG003|Overall Study|Disease Progression|3|||
160923231|NCT01277523|581115361|FG000|Overall Study|Other Reason not Defined|0|||
160923232|NCT01277523|581115362|FG001|Overall Study|Other Reason not Defined|1|||
160923233|NCT01277523|581115363|FG002|Overall Study|Other Reason not Defined|0|||
160923234|NCT00112502|581115366|FG000|Overall Study|Withdrawal by Subject|0|||
160923235|NCT00112502|581115367|FG001|Overall Study|Withdrawal by Subject|1|||
160923236|NCT00112502|581115368|FG002|Overall Study|Withdrawal by Subject|1|||
160576153|NCT01022853|579829277|FG000|Overall Study|Progressive disease|2|||
160576154|NCT01022853|579829278|FG001|Overall Study|Progressive disease|3|||
160576155|NCT01022853|579829279|FG002|Overall Study|Progressive disease|11|||
160576156|NCT01022853|579829280|FG003|Overall Study|Progressive disease|7|||
160576157|NCT01022853|579829281|FG004|Overall Study|Progressive disease|1|||
160576158|NCT01022853|579829277|FG000|Overall Study|Dose-limiting toxicity|0|||
160576159|NCT01022853|579829278|FG001|Overall Study|Dose-limiting toxicity|0|||
160576160|NCT01022853|579829279|FG002|Overall Study|Dose-limiting toxicity|0|||
160576161|NCT01022853|579829280|FG003|Overall Study|Dose-limiting toxicity|0|||
160576162|NCT01022853|579829281|FG004|Overall Study|Dose-limiting toxicity|1|||
160576163|NCT01022853|579829277|FG000|Overall Study|Withdrawal by Subject|0|||
160576164|NCT01022853|579829278|FG001|Overall Study|Withdrawal by Subject|1|||
160576165|NCT01022853|579829279|FG002|Overall Study|Withdrawal by Subject|1|||
160576166|NCT01022853|579829280|FG003|Overall Study|Withdrawal by Subject|1|||
160576167|NCT01022853|579829281|FG004|Overall Study|Withdrawal by Subject|0|||
160576168|NCT01022853|579829277|FG000|Overall Study|Other not stated above|1|||
160576169|NCT01022853|579829278|FG001|Overall Study|Other not stated above|0|||
160576170|NCT01022853|579829279|FG002|Overall Study|Other not stated above|1|||
160576171|NCT01022853|579829280|FG003|Overall Study|Other not stated above|0|||
160576172|NCT01022853|579829281|FG004|Overall Study|Other not stated above|0|||
160576173|NCT02416908|579829282|FG000|Dose Escalation Phase|Adverse Event|0|||
160576174|NCT02416908|579829283|FG001|Dose Escalation Phase|Adverse Event|0|||
160576175|NCT02416908|579829284|FG002|Dose Escalation Phase|Adverse Event|3|||
160576176|NCT02416908|579829285|FG003|Dose Escalation Phase|Adverse Event|0|||
160576177|NCT02416908|579829282|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
160576178|NCT02416908|579829283|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
160576179|NCT02416908|579829284|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
160576180|NCT02416908|579829285|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160576181|NCT00532883|579829286|FG000|Overall Study|Adverse Event|1|||
160576182|NCT00532883|579829287|FG001|Overall Study|Adverse Event|0|||
160997885|NCT02104765|581376675|FG005|Overall Study|Lost to Follow-up|0|||
160997886|NCT02104765|581376676|FG006|Overall Study|Lost to Follow-up|0|||
160997887|NCT02104765|581376670|FG000|Overall Study|Withdrawal by Subject|0|||
160997888|NCT02104765|581376671|FG001|Overall Study|Withdrawal by Subject|0|||
160997889|NCT02104765|581376672|FG002|Overall Study|Withdrawal by Subject|0|||
160997890|NCT02104765|581376673|FG003|Overall Study|Withdrawal by Subject|1|||
160997891|NCT02104765|581376674|FG004|Overall Study|Withdrawal by Subject|1|||
160997892|NCT02104765|581376675|FG005|Overall Study|Withdrawal by Subject|0|||
160997893|NCT02104765|581376676|FG006|Overall Study|Withdrawal by Subject|1|||
160997894|NCT00604721|581376677|FG000|Overall Study|Physician Decision|1|||
160997895|NCT00604721|581376677|FG000|Overall Study|Withdrawal by Subject|1|||
160997896|NCT04776213|581376680|FG000|Overall Study|Other|1|||
160997897|NCT04776213|581376680|FG000|Overall Study|Withdrawal by Subject|7|||
160997898|NCT04776213|581376680|FG000|Overall Study|Protocol Violation|1|||
160997899|NCT04776213|581376680|FG000|Overall Study|Lost to Follow-up|2|||
160997900|NCT01838551|581376682|FG000|Overall Study|Adverse Event|16|||
160997901|NCT01838551|581376682|FG000|Overall Study|Death|1|||
160997902|NCT01838551|581376682|FG000|Overall Study|Lack of Efficacy|10|||
160997903|NCT01838551|581376682|FG000|Overall Study|Physician Decision|4|||
160997904|NCT01838551|581376682|FG000|Overall Study|Withdrawal by Subject|10|||
160997905|NCT01838551|581376682|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
160997906|NCT00906282|581376683|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
160997907|NCT00906282|581376683|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
160997908|NCT00906282|581376683|FG000|Preoperative Chemotherapy|Progressive disease|6|||
160997909|NCT00906282|581376683|FG000|Preoperative Chemotherapy|Toxicity|1|||
160923237|NCT00112502|581115369|FG003|Overall Study|Withdrawal by Subject|4|||
160997910|NCT00038103|581376684|FG000|Overall Study|Adverse Event|5|||
160997911|NCT00038103|581376685|FG001|Overall Study|Adverse Event|6|||
160576183|NCT00532883|579829288|FG002|Overall Study|Adverse Event|0|||
160576184|NCT00532883|579829289|FG003|Overall Study|Adverse Event|1|||
160576185|NCT00532883|579829286|FG000|Overall Study|Lost to Follow-up|1|||
160576186|NCT00532883|579829287|FG001|Overall Study|Lost to Follow-up|1|||
160576187|NCT00532883|579829288|FG002|Overall Study|Lost to Follow-up|1|||
160576188|NCT00532883|579829289|FG003|Overall Study|Lost to Follow-up|0|||
160576189|NCT00532883|579829286|FG000|Overall Study|Withdrawal by Subject|0|||
160923238|NCT00112502|581115370|FG004|Overall Study|Withdrawal by Subject|2|||
160923239|NCT00112502|581115371|FG005|Overall Study|Withdrawal by Subject|5|||
160997912|NCT00038103|581376684|FG000|Overall Study|Lack of Efficacy|48|||
160997913|NCT00038103|581376685|FG001|Overall Study|Lack of Efficacy|41|||
160997914|NCT00038103|581376684|FG000|Overall Study|Withdrawal by Subject|0|||
160576190|NCT00532883|579829287|FG001|Overall Study|Withdrawal by Subject|1|||
160576191|NCT00532883|579829288|FG002|Overall Study|Withdrawal by Subject|1|||
160576192|NCT00532883|579829289|FG003|Overall Study|Withdrawal by Subject|0|||
160576193|NCT00532883|579829286|FG000|Overall Study|Subject was Nonadherent|0|||
160923240|NCT00112502|581115372|FG006|Overall Study|Withdrawal by Subject|3|||
160923241|NCT00112502|581115373|FG007|Overall Study|Withdrawal by Subject|7|||
160923242|NCT02608268|581115374|FG000|Overall Study|Adverse Event|0|||
160923243|NCT02608268|581115375|FG001|Overall Study|Adverse Event|0|||
160923244|NCT02608268|581115376|FG002|Overall Study|Adverse Event|1|||
160923245|NCT02608268|581115377|FG003|Overall Study|Adverse Event|0|||
160923246|NCT02608268|581115378|FG004|Overall Study|Adverse Event|0|||
160923247|NCT02608268|581115379|FG005|Overall Study|Adverse Event|0|||
160923248|NCT02608268|581115380|FG006|Overall Study|Adverse Event|0|||
160923249|NCT02608268|581115381|FG007|Overall Study|Adverse Event|0|||
160923250|NCT02608268|581115382|FG008|Overall Study|Adverse Event|0|||
160923251|NCT02608268|581115383|FG009|Overall Study|Adverse Event|0|||
160923252|NCT02608268|581115384|FG010|Overall Study|Adverse Event|0|||
160923253|NCT02608268|581115385|FG011|Overall Study|Adverse Event|0|||
160923254|NCT02608268|581115386|FG012|Overall Study|Adverse Event|2|||
160923255|NCT02608268|581115387|FG013|Overall Study|Adverse Event|0|||
160923256|NCT02608268|581115388|FG014|Overall Study|Adverse Event|0|||
160923257|NCT02608268|581115389|FG015|Overall Study|Adverse Event|0|||
160923258|NCT02608268|581115390|FG016|Overall Study|Adverse Event|0|||
160923259|NCT02608268|581115391|FG017|Overall Study|Adverse Event|0|||
160923260|NCT02608268|581115392|FG018|Overall Study|Adverse Event|0|||
160923261|NCT02608268|581115393|FG019|Overall Study|Adverse Event|0|||
160923262|NCT02608268|581115394|FG020|Overall Study|Adverse Event|1|||
160923263|NCT02608268|581115395|FG021|Overall Study|Adverse Event|1|||
160923264|NCT02608268|581115396|FG022|Overall Study|Adverse Event|0|||
160923265|NCT02608268|581115397|FG023|Overall Study|Adverse Event|0|||
160923266|NCT02608268|581115398|FG024|Overall Study|Adverse Event|1|||
160923267|NCT02608268|581115399|FG025|Overall Study|Adverse Event|0|||
160923268|NCT02608268|581115400|FG026|Overall Study|Adverse Event|0|||
160923269|NCT02608268|581115401|FG027|Overall Study|Adverse Event|0|||
160923270|NCT02608268|581115402|FG028|Overall Study|Adverse Event|1|||
160923271|NCT02608268|581115403|FG029|Overall Study|Adverse Event|0|||
160923272|NCT02608268|581115374|FG000|Overall Study|Death|1|||
160923273|NCT02608268|581115375|FG001|Overall Study|Death|0|||
160923274|NCT02608268|581115376|FG002|Overall Study|Death|0|||
160923275|NCT02608268|581115377|FG003|Overall Study|Death|0|||
160923276|NCT02608268|581115378|FG004|Overall Study|Death|0|||
160923277|NCT02608268|581115379|FG005|Overall Study|Death|0|||
160923278|NCT02608268|581115380|FG006|Overall Study|Death|0|||
160923279|NCT02608268|581115381|FG007|Overall Study|Death|0|||
160923280|NCT02608268|581115382|FG008|Overall Study|Death|1|||
160923281|NCT02608268|581115383|FG009|Overall Study|Death|1|||
160923282|NCT02608268|581115384|FG010|Overall Study|Death|0|||
160923283|NCT02608268|581115385|FG011|Overall Study|Death|0|||
160923284|NCT02608268|581115386|FG012|Overall Study|Death|0|||
160923285|NCT02608268|581115387|FG013|Overall Study|Death|0|||
160923286|NCT02608268|581115388|FG014|Overall Study|Death|0|||
160923287|NCT02608268|581115389|FG015|Overall Study|Death|1|||
160923288|NCT02608268|581115390|FG016|Overall Study|Death|0|||
160923289|NCT02608268|581115391|FG017|Overall Study|Death|1|||
160923290|NCT02608268|581115392|FG018|Overall Study|Death|0|||
160923291|NCT02608268|581115393|FG019|Overall Study|Death|1|||
160923292|NCT02608268|581115394|FG020|Overall Study|Death|1|||
160923293|NCT02608268|581115395|FG021|Overall Study|Death|0|||
160923294|NCT02608268|581115396|FG022|Overall Study|Death|0|||
160923295|NCT02608268|581115397|FG023|Overall Study|Death|0|||
160923296|NCT02608268|581115398|FG024|Overall Study|Death|1|||
160997915|NCT00038103|581376685|FG001|Overall Study|Withdrawal by Subject|3|||
160997916|NCT00038103|581376684|FG000|Overall Study|Lost to Follow-up|0|||
160923297|NCT02608268|581115399|FG025|Overall Study|Death|2|||
160923298|NCT02608268|581115400|FG026|Overall Study|Death|0|||
160923299|NCT02608268|581115401|FG027|Overall Study|Death|1|||
160576194|NCT00532883|579829287|FG001|Overall Study|Subject was Nonadherent|1|||
160923300|NCT02608268|581115402|FG028|Overall Study|Death|4|||
160997917|NCT00038103|581376685|FG001|Overall Study|Lost to Follow-up|3|||
160997918|NCT00038103|581376684|FG000|Overall Study|Protocol Violation|0|||
160923301|NCT02608268|581115403|FG029|Overall Study|Death|0|||
160923302|NCT02608268|581115374|FG000|Overall Study|Physician Decision|0|||
160923303|NCT02608268|581115375|FG001|Overall Study|Physician Decision|0|||
160923304|NCT02608268|581115376|FG002|Overall Study|Physician Decision|0|||
160923305|NCT02608268|581115377|FG003|Overall Study|Physician Decision|0|||
160923306|NCT02608268|581115378|FG004|Overall Study|Physician Decision|0|||
160923307|NCT02608268|581115379|FG005|Overall Study|Physician Decision|0|||
160923308|NCT02608268|581115380|FG006|Overall Study|Physician Decision|0|||
160923309|NCT02608268|581115381|FG007|Overall Study|Physician Decision|0|||
160923310|NCT02608268|581115382|FG008|Overall Study|Physician Decision|0|||
160923311|NCT02608268|581115383|FG009|Overall Study|Physician Decision|0|||
160923312|NCT02608268|581115384|FG010|Overall Study|Physician Decision|1|||
160997919|NCT00038103|581376685|FG001|Overall Study|Protocol Violation|2|||
160923313|NCT02608268|581115385|FG011|Overall Study|Physician Decision|0|||
160923314|NCT02608268|581115386|FG012|Overall Study|Physician Decision|0|||
160923315|NCT02608268|581115387|FG013|Overall Study|Physician Decision|1|||
160923316|NCT02608268|581115388|FG014|Overall Study|Physician Decision|0|||
160923317|NCT02608268|581115389|FG015|Overall Study|Physician Decision|0|||
160923318|NCT02608268|581115390|FG016|Overall Study|Physician Decision|0|||
160923319|NCT02608268|581115391|FG017|Overall Study|Physician Decision|0|||
160923320|NCT02608268|581115392|FG018|Overall Study|Physician Decision|0|||
160923321|NCT02608268|581115393|FG019|Overall Study|Physician Decision|0|||
160923322|NCT02608268|581115394|FG020|Overall Study|Physician Decision|0|||
160923323|NCT02608268|581115395|FG021|Overall Study|Physician Decision|0|||
160923324|NCT02608268|581115396|FG022|Overall Study|Physician Decision|1|||
160923325|NCT02608268|581115397|FG023|Overall Study|Physician Decision|1|||
160576195|NCT00532883|579829288|FG002|Overall Study|Subject was Nonadherent|1|||
160923326|NCT02608268|581115398|FG024|Overall Study|Physician Decision|1|||
160923327|NCT02608268|581115399|FG025|Overall Study|Physician Decision|0|||
160923328|NCT02608268|581115400|FG026|Overall Study|Physician Decision|0|||
160923329|NCT02608268|581115401|FG027|Overall Study|Physician Decision|2|||
160923330|NCT02608268|581115402|FG028|Overall Study|Physician Decision|1|||
160923331|NCT02608268|581115403|FG029|Overall Study|Physician Decision|1|||
160923332|NCT02608268|581115374|FG000|Overall Study|Progressive disease|12|||
160923333|NCT02608268|581115375|FG001|Overall Study|Progressive disease|8|||
160923334|NCT02608268|581115376|FG002|Overall Study|Progressive disease|13|||
160923335|NCT02608268|581115377|FG003|Overall Study|Progressive disease|5|||
160923336|NCT02608268|581115378|FG004|Overall Study|Progressive disease|2|||
160923337|NCT02608268|581115379|FG005|Overall Study|Progressive disease|4|||
160923338|NCT02608268|581115380|FG006|Overall Study|Progressive disease|6|||
160923339|NCT02608268|581115381|FG007|Overall Study|Progressive disease|2|||
160923340|NCT02608268|581115382|FG008|Overall Study|Progressive disease|5|||
160923341|NCT02608268|581115383|FG009|Overall Study|Progressive disease|6|||
160923342|NCT02608268|581115384|FG010|Overall Study|Progressive disease|5|||
160923343|NCT02608268|581115385|FG011|Overall Study|Progressive disease|5|||
160923344|NCT02608268|581115386|FG012|Overall Study|Progressive disease|4|||
160923345|NCT02608268|581115387|FG013|Overall Study|Progressive disease|11|||
160923346|NCT02608268|581115388|FG014|Overall Study|Progressive disease|6|||
160576196|NCT00532883|579829289|FG003|Overall Study|Subject was Nonadherent|0|||
160576197|NCT00532883|579829286|FG000|Overall Study|Early Study Termination|4|||
160576198|NCT00532883|579829287|FG001|Overall Study|Early Study Termination|4|||
160576199|NCT00532883|579829288|FG002|Overall Study|Early Study Termination|1|||
160576200|NCT00532883|579829289|FG003|Overall Study|Early Study Termination|4|||
160576201|NCT01214434|579829292|FG000|Overall Study|Withdrawal by Subject|1|||
160576202|NCT01214434|579829293|FG001|Overall Study|Withdrawal by Subject|0|||
160576203|NCT01214434|579829292|FG000|Overall Study|Lost to Follow-up|2|||
160576204|NCT01214434|579829293|FG001|Overall Study|Lost to Follow-up|2|||
160576205|NCT01214434|579829292|FG000|Overall Study|Site error|1|||
160576206|NCT01214434|579829293|FG001|Overall Study|Site error|0|||
160576207|NCT02075255|579829295|FG000|Overall Study|Study specific withdrawal criteria|0|||
160576208|NCT02075255|579829296|FG001|Overall Study|Study specific withdrawal criteria|1|||
160576209|NCT02075255|579829297|FG002|Overall Study|Study specific withdrawal criteria|1|||
160576210|NCT02075255|579829295|FG000|Overall Study|Withdrawal by Subject|4|||
160576211|NCT02075255|579829296|FG001|Overall Study|Withdrawal by Subject|1|||
160576212|NCT02075255|579829297|FG002|Overall Study|Withdrawal by Subject|0|||
160576213|NCT02075255|579829295|FG000|Overall Study|Lost to Follow-up|0|||
160576214|NCT02075255|579829296|FG001|Overall Study|Lost to Follow-up|0|||
160576215|NCT02075255|579829297|FG002|Overall Study|Lost to Follow-up|1|||
160654853|NCT01592370|580117194|FG004|Overall Study|Disease Progression|3|||
160654854|NCT01592370|580117195|FG005|Overall Study|Disease Progression|31|||
160654855|NCT01592370|580117196|FG006|Overall Study|Disease Progression|14|||
160654856|NCT01592370|580117190|FG000|Overall Study|Study Drug Toxicity|14|||
160923347|NCT02608268|581115389|FG015|Overall Study|Progressive disease|3|||
160923348|NCT02608268|581115390|FG016|Overall Study|Progressive disease|5|||
160923349|NCT02608268|581115391|FG017|Overall Study|Progressive disease|5|||
160923350|NCT02608268|581115392|FG018|Overall Study|Progressive disease|5|||
160923351|NCT02608268|581115393|FG019|Overall Study|Progressive disease|2|||
160923352|NCT02608268|581115394|FG020|Overall Study|Progressive disease|10|||
160923353|NCT02608268|581115395|FG021|Overall Study|Progressive disease|4|||
160997920|NCT00038103|581376684|FG000|Overall Study|Sponsor Decision|0|||
160576216|NCT02075255|579829295|FG000|Overall Study|Adverse Event|0|||
160576217|NCT02075255|579829296|FG001|Overall Study|Adverse Event|0|||
160576218|NCT02075255|579829297|FG002|Overall Study|Adverse Event|1|||
160576219|NCT02075255|579829295|FG000|Overall Study|Death|0|||
160576220|NCT02075255|579829296|FG001|Overall Study|Death|2|||
160923354|NCT02608268|581115396|FG022|Overall Study|Progressive disease|5|||
160923355|NCT02608268|581115397|FG023|Overall Study|Progressive disease|5|||
160923356|NCT02608268|581115398|FG024|Overall Study|Progressive disease|3|||
160923357|NCT02608268|581115399|FG025|Overall Study|Progressive disease|11|||
160923358|NCT02608268|581115400|FG026|Overall Study|Progressive disease|16|||
160654857|NCT01592370|580117191|FG001|Overall Study|Study Drug Toxicity|3|||
160923359|NCT02608268|581115401|FG027|Overall Study|Progressive disease|11|||
160923360|NCT02608268|581115402|FG028|Overall Study|Progressive disease|10|||
160923361|NCT02608268|581115403|FG029|Overall Study|Progressive disease|15|||
160923362|NCT02608268|581115374|FG000|Overall Study|Subject/guardian decision|1|||
160576221|NCT02075255|579829297|FG002|Overall Study|Death|0|||
160576222|NCT03792750|579829298|FG000|Overall Study|Death|3|||
160576223|NCT01651052|579829299|FG000|Overall Study|Death|21|||
160576224|NCT01651052|579829299|FG000|Overall Study|Explant|1|||
160576225|NCT01651052|579829299|FG000|Overall Study|Withdrawal by Subject|1|||
160576226|NCT01651052|579829299|FG000|Overall Study|Lost to Follow-up|3|||
160923363|NCT02608268|581115375|FG001|Overall Study|Subject/guardian decision|1|||
160923364|NCT02608268|581115376|FG002|Overall Study|Subject/guardian decision|2|||
160923365|NCT02608268|581115377|FG003|Overall Study|Subject/guardian decision|0|||
160923366|NCT02608268|581115378|FG004|Overall Study|Subject/guardian decision|0|||
160923367|NCT02608268|581115379|FG005|Overall Study|Subject/guardian decision|0|||
160923368|NCT02608268|581115380|FG006|Overall Study|Subject/guardian decision|0|||
160923369|NCT02608268|581115381|FG007|Overall Study|Subject/guardian decision|0|||
160923370|NCT02608268|581115382|FG008|Overall Study|Subject/guardian decision|2|||
160923371|NCT02608268|581115383|FG009|Overall Study|Subject/guardian decision|2|||
160923372|NCT02608268|581115384|FG010|Overall Study|Subject/guardian decision|0|||
160923373|NCT02608268|581115385|FG011|Overall Study|Subject/guardian decision|1|||
160923374|NCT02608268|581115386|FG012|Overall Study|Subject/guardian decision|0|||
160923375|NCT02608268|581115387|FG013|Overall Study|Subject/guardian decision|1|||
160923376|NCT02608268|581115388|FG014|Overall Study|Subject/guardian decision|0|||
160923377|NCT02608268|581115389|FG015|Overall Study|Subject/guardian decision|1|||
160923378|NCT02608268|581115390|FG016|Overall Study|Subject/guardian decision|0|||
160923379|NCT02608268|581115391|FG017|Overall Study|Subject/guardian decision|0|||
160923380|NCT02608268|581115392|FG018|Overall Study|Subject/guardian decision|1|||
160923381|NCT02608268|581115393|FG019|Overall Study|Subject/guardian decision|0|||
160923382|NCT02608268|581115394|FG020|Overall Study|Subject/guardian decision|0|||
160923383|NCT02608268|581115395|FG021|Overall Study|Subject/guardian decision|0|||
160923384|NCT02608268|581115396|FG022|Overall Study|Subject/guardian decision|1|||
160923385|NCT02608268|581115397|FG023|Overall Study|Subject/guardian decision|0|||
160923386|NCT02608268|581115398|FG024|Overall Study|Subject/guardian decision|0|||
160923387|NCT02608268|581115399|FG025|Overall Study|Subject/guardian decision|1|||
160923388|NCT02608268|581115400|FG026|Overall Study|Subject/guardian decision|1|||
160923389|NCT02608268|581115401|FG027|Overall Study|Subject/guardian decision|1|||
160923390|NCT02608268|581115402|FG028|Overall Study|Subject/guardian decision|1|||
160923391|NCT02608268|581115403|FG029|Overall Study|Subject/guardian decision|0|||
160923392|NCT00265343|581115404|FG000|Overall Study|Adverse Event|10|||
160923393|NCT00265343|581115405|FG001|Overall Study|Adverse Event|7|||
160923394|NCT00265343|581115404|FG000|Overall Study|Withdrawal by Subject|3|||
160923395|NCT00265343|581115405|FG001|Overall Study|Withdrawal by Subject|9|||
160923396|NCT00265343|581115404|FG000|Overall Study|Other|8|||
160923397|NCT00265343|581115405|FG001|Overall Study|Other|3|||
160923398|NCT03662542|581115409|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
160923399|NCT03662542|581115410|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923400|NCT03662542|581115411|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923401|NCT03662542|581115412|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923402|NCT03662542|581115413|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923403|NCT03662542|581115414|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923404|NCT03662542|581115415|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923405|NCT03662542|581115416|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923406|NCT03662542|581115417|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923407|NCT03662542|581115409|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923408|NCT03662542|581115410|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
160923409|NCT03662542|581115411|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923410|NCT03662542|581115412|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923411|NCT03662542|581115413|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923412|NCT03662542|581115414|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923413|NCT03662542|581115415|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923414|NCT03662542|581115416|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923415|NCT03662542|581115417|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923416|NCT03662542|581115409|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
160923417|NCT03662542|581115410|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
160923418|NCT03662542|581115411|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
160923419|NCT03662542|581115412|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
160923420|NCT03662542|581115413|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
160923421|NCT03662542|581115414|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
160923422|NCT03662542|581115415|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
160576227|NCT03503773|579829300|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
160576228|NCT03503773|579829301|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
160576229|NCT03503773|579829300|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
160923423|NCT03662542|581115416|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
160923424|NCT03662542|581115417|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
160923425|NCT03662542|581115409|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
160923426|NCT03662542|581115410|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923427|NCT03662542|581115411|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923428|NCT03662542|581115412|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923429|NCT03662542|581115413|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160576230|NCT03503773|579829301|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
160576231|NCT03503773|579829300|FG000|Overall Study|Not completing the primary ABPM|3|||
160923430|NCT03662542|581115414|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923431|NCT03662542|581115415|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923432|NCT03662542|581115416|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923433|NCT03662542|581115417|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923434|NCT03662542|581115409|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923435|NCT03662542|581115410|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923436|NCT03662542|581115411|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923437|NCT03662542|581115412|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923438|NCT03662542|581115413|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923439|NCT03662542|581115414|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
160923440|NCT03662542|581115415|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923441|NCT03662542|581115416|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923442|NCT03662542|581115417|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923443|NCT03662542|581115409|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923444|NCT03662542|581115410|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923445|NCT03662542|581115411|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923446|NCT03662542|581115412|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
160923447|NCT03662542|581115413|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
160923448|NCT03662542|581115414|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923449|NCT03662542|581115415|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923450|NCT03662542|581115416|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923451|NCT03662542|581115417|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923452|NCT03662542|581115409|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923453|NCT03662542|581115410|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923454|NCT03662542|581115411|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923455|NCT03662542|581115412|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
160923456|NCT03662542|581115413|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
160923457|NCT03662542|581115414|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
160923458|NCT03662542|581115415|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923459|NCT03662542|581115416|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923460|NCT03662542|581115417|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923461|NCT03662542|581115409|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923462|NCT03662542|581115410|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923463|NCT03662542|581115411|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923464|NCT03662542|581115412|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923465|NCT03662542|581115413|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
160923466|NCT03662542|581115414|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
160923467|NCT03662542|581115415|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923468|NCT03662542|581115416|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923469|NCT03662542|581115417|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923470|NCT03662542|581115409|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923471|NCT03662542|581115410|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923472|NCT03662542|581115411|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923473|NCT03662542|581115412|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923474|NCT03662542|581115413|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160576232|NCT03503773|579829301|FG001|Overall Study|Not completing the primary ABPM|1|||
160576233|NCT03503773|579829300|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
160576234|NCT03503773|579829301|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
160923475|NCT03662542|581115414|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
160923476|NCT03662542|581115415|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923477|NCT03662542|581115416|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923478|NCT03662542|581115417|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923479|NCT03662542|581115409|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923480|NCT03662542|581115410|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923481|NCT03662542|581115411|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923482|NCT03662542|581115412|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923483|NCT03662542|581115413|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923484|NCT03662542|581115414|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923485|NCT03662542|581115415|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923486|NCT03662542|581115416|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
160654858|NCT01592370|580117192|FG002|Overall Study|Study Drug Toxicity|0|||
160923487|NCT03662542|581115417|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923488|NCT03662542|581115409|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923489|NCT03662542|581115410|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923490|NCT03662542|581115411|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923491|NCT03662542|581115412|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923492|NCT03662542|581115413|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923493|NCT03662542|581115414|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923494|NCT03662542|581115415|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
160923495|NCT03662542|581115416|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923496|NCT03662542|581115417|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
160923497|NCT03662542|581115409|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923498|NCT03662542|581115410|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923499|NCT03662542|581115411|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923500|NCT03662542|581115412|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923501|NCT03662542|581115413|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923502|NCT03662542|581115414|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923503|NCT03662542|581115415|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
160923504|NCT03662542|581115416|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923505|NCT03662542|581115417|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
160923506|NCT03662542|581115409|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
160923507|NCT03662542|581115410|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
160576235|NCT02902809|579829305|FG000|Overall Study|Discontinuation of asthma program|28|||
160576236|NCT00532259|579829306|FG000|Overall Study|Withdrawal by Subject|2|||
160576237|NCT00532259|579829306|FG000|Overall Study|Adverse Event|1|||
160576238|NCT00532259|579829306|FG000|Overall Study|Death|1|||
160576239|NCT00532259|579829306|FG000|Overall Study|Lack of Efficacy|21|||
160576240|NCT00532259|579829306|FG000|Overall Study|Lost to Follow-up|3|||
160576241|NCT00532259|579829306|FG000|Overall Study|Physician Decision|3|||
160576242|NCT00532259|579829306|FG000|Overall Study|Protocol Violation|1|||
160576243|NCT01478347|579829307|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
160576244|NCT01478347|579829307|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
160576245|NCT01478347|579829307|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
160576246|NCT01645930|579829308|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
160576247|NCT01645930|579829308|FG000|Overall Study|Progressive Disease|12|||
160576248|NCT01645930|579829308|FG000|Overall Study|Adverse Event|4|||
160576249|NCT01645930|579829308|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
160576250|NCT01645930|579829308|FG000|Overall Study|Withdrawal by Participant|2|||
160576251|NCT01645930|579829308|FG000|Overall Study|Reason not Defined|1|||
160576252|NCT03245814|579829309|FG000|Overall Study|Lost to Follow-up|5|||
160576253|NCT03245814|579829310|FG001|Overall Study|Lost to Follow-up|8|||
160576254|NCT03245814|579829309|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
160576255|NCT03245814|579829310|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
160576256|NCT02263365|579829315|FG000|Overall Study|Physician Decision|22|||
160576257|NCT02263365|579829316|FG001|Overall Study|Physician Decision|18|||
160576258|NCT01879618|579829317|FG000|Overall Study|Does not meet entrance criteria|1|||
160576259|NCT01879618|579829317|FG000|Overall Study|Withdrawal by Subject|1|||
160576260|NCT01879618|579829317|FG000|Overall Study|Surgery;changed schedule; not available|8|||
160576261|NCT01879618|579829317|FG000|Overall Study|Protocol Violation|6|||
160576262|NCT01879618|579829317|FG000|Overall Study|Adverse Event|5|||
160576263|NCT00394914|579829318|FG000|Treatment Period|Adverse Event|0|||
160576264|NCT00394914|579829319|FG001|Treatment Period|Adverse Event|3|||
160576265|NCT00394914|579829320|FG002|Treatment Period|Adverse Event|1|||
160576266|NCT00394914|579829318|FG000|Treatment Period|Lost to Follow-up|0|||
160576267|NCT00394914|579829319|FG001|Treatment Period|Lost to Follow-up|1|||
160576268|NCT00394914|579829320|FG002|Treatment Period|Lost to Follow-up|0|||
160576269|NCT00394914|579829318|FG000|Treatment Period|Withdrawal by Subject|0|||
160576270|NCT00394914|579829319|FG001|Treatment Period|Withdrawal by Subject|2|||
160576271|NCT00394914|579829320|FG002|Treatment Period|Withdrawal by Subject|2|||
160576272|NCT00394914|579829318|FG000|Treatment Period|Noncompliance with protocol|0|||
160576273|NCT00394914|579829319|FG001|Treatment Period|Noncompliance with protocol|3|||
160923508|NCT03662542|581115411|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
160923509|NCT03662542|581115412|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
160923510|NCT03662542|581115413|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
160923511|NCT03662542|581115414|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
160923512|NCT03662542|581115415|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
160576274|NCT00394914|579829320|FG002|Treatment Period|Noncompliance with protocol|2|||
160576275|NCT00394914|579829318|FG000|Treatment Period|Did not meet protocol eligibility|0|||
160576276|NCT00394914|579829319|FG001|Treatment Period|Did not meet protocol eligibility|1|||
160576277|NCT00394914|579829320|FG002|Treatment Period|Did not meet protocol eligibility|1|||
160576278|NCT01004146|579829326|FG000|Overall Study|Withdrawal by Subject|4|||
160576279|NCT01004146|579829327|FG001|Overall Study|Withdrawal by Subject|5|||
160576280|NCT00710034|579830687|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
160923513|NCT03662542|581115416|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
160923514|NCT03662542|581115417|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
160923515|NCT01217060|581115418|FG000|Overall Study|Withdrawal by Subject|1|||
160923516|NCT04762680|581115427|FG000|Phase 2|Adverse Event|0|||
160923517|NCT04762680|581115428|FG001|Phase 2|Adverse Event|1|||
160923518|NCT04762680|581115429|FG002|Phase 2|Adverse Event|0|||
160923519|NCT04762680|581115430|FG003|Phase 2|Adverse Event|0|||
160923520|NCT04762680|581115431|FG004|Phase 2|Adverse Event|0|||
160923521|NCT04762680|581115432|FG005|Phase 2|Adverse Event|0|||
160923522|NCT04762680|581115433|FG006|Phase 2|Adverse Event|0|||
160923523|NCT04762680|581115434|FG007|Phase 2|Adverse Event|0|||
160923524|NCT04762680|581115435|FG008|Phase 2|Adverse Event|0|||
160923525|NCT04762680|581115436|FG009|Phase 2|Adverse Event|0|||
160923526|NCT04762680|581115437|FG010|Phase 2|Adverse Event|0|||
160923527|NCT04762680|581115438|FG011|Phase 2|Adverse Event|0|||
160923528|NCT04762680|581115439|FG012|Phase 2|Adverse Event|0|||
160923529|NCT04762680|581115440|FG013|Phase 2|Adverse Event|0|||
160923530|NCT04762680|581115441|FG014|Phase 2|Adverse Event|0|||
160923531|NCT04762680|581115442|FG015|Phase 2|Adverse Event|0|||
160923532|NCT04762680|581115443|FG016|Phase 2|Adverse Event|0|||
160923533|NCT04762680|581115444|FG017|Phase 2|Adverse Event|0|||
160923534|NCT04762680|581115445|FG018|Phase 2|Adverse Event|0|||
160923535|NCT04762680|581115446|FG019|Phase 2|Adverse Event|0|||
160923536|NCT04762680|581115447|FG020|Phase 2|Adverse Event|0|||
160923537|NCT04762680|581115448|FG021|Phase 2|Adverse Event|0|||
160923538|NCT04762680|581115427|FG000|Phase 2|Protocol Violation|5|||
160923539|NCT04762680|581115428|FG001|Phase 2|Protocol Violation|5|||
160923540|NCT04762680|581115429|FG002|Phase 2|Protocol Violation|1|||
160923541|NCT04762680|581115430|FG003|Phase 2|Protocol Violation|0|||
160923542|NCT04762680|581115431|FG004|Phase 2|Protocol Violation|0|||
160923543|NCT04762680|581115432|FG005|Phase 2|Protocol Violation|0|||
160923544|NCT04762680|581115433|FG006|Phase 2|Protocol Violation|0|||
160923545|NCT04762680|581115434|FG007|Phase 2|Protocol Violation|0|||
160923546|NCT04762680|581115435|FG008|Phase 2|Protocol Violation|0|||
160923547|NCT04762680|581115436|FG009|Phase 2|Protocol Violation|0|||
160923548|NCT04762680|581115437|FG010|Phase 2|Protocol Violation|0|||
160923549|NCT04762680|581115438|FG011|Phase 2|Protocol Violation|0|||
160576281|NCT00710034|579830688|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
160576282|NCT00710034|579830687|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
160576283|NCT00710034|579830688|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
160576284|NCT00710034|579830687|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
160576285|NCT00710034|579830688|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
160576286|NCT00710034|579830687|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
160576287|NCT00710034|579830688|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
160576288|NCT00710034|579830687|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
160576289|NCT00710034|579830688|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
160576290|NCT00710034|579830687|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
160576291|NCT00710034|579830688|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
160576292|NCT00710034|579830687|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
160576293|NCT00710034|579830688|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
160576294|NCT00710034|579830687|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
160576295|NCT00710034|579830688|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
160576296|NCT00710034|579830687|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
160576297|NCT00710034|579830688|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
160576298|NCT00710034|579830687|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
160576299|NCT00710034|579830688|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
160576300|NCT00710034|579830687|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
160576301|NCT00710034|579830688|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
160576302|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
160576303|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
160576304|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
160576305|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
160923550|NCT04762680|581115439|FG012|Phase 2|Protocol Violation|0|||
160923551|NCT04762680|581115440|FG013|Phase 2|Protocol Violation|0|||
160923552|NCT04762680|581115441|FG014|Phase 2|Protocol Violation|0|||
160923553|NCT04762680|581115442|FG015|Phase 2|Protocol Violation|0|||
160923554|NCT04762680|581115443|FG016|Phase 2|Protocol Violation|0|||
160923555|NCT04762680|581115444|FG017|Phase 2|Protocol Violation|0|||
160923556|NCT04762680|581115445|FG018|Phase 2|Protocol Violation|0|||
160923557|NCT04762680|581115446|FG019|Phase 2|Protocol Violation|0|||
160654859|NCT01592370|580117193|FG003|Overall Study|Study Drug Toxicity|0|||
160923558|NCT04762680|581115447|FG020|Phase 2|Protocol Violation|0|||
160923559|NCT04762680|581115448|FG021|Phase 2|Protocol Violation|0|||
160923560|NCT04762680|581115427|FG000|Phase 2|Withdrawal by Subject|23|||
160923561|NCT04762680|581115428|FG001|Phase 2|Withdrawal by Subject|21|||
160923562|NCT04762680|581115429|FG002|Phase 2|Withdrawal by Subject|28|||
160923563|NCT04762680|581115430|FG003|Phase 2|Withdrawal by Subject|0|||
160923564|NCT04762680|581115431|FG004|Phase 2|Withdrawal by Subject|0|||
160923565|NCT04762680|581115432|FG005|Phase 2|Withdrawal by Subject|0|||
160923566|NCT04762680|581115433|FG006|Phase 2|Withdrawal by Subject|0|||
160923567|NCT04762680|581115434|FG007|Phase 2|Withdrawal by Subject|0|||
160923568|NCT04762680|581115435|FG008|Phase 2|Withdrawal by Subject|0|||
160923569|NCT04762680|581115436|FG009|Phase 2|Withdrawal by Subject|0|||
160923570|NCT04762680|581115437|FG010|Phase 2|Withdrawal by Subject|0|||
160923571|NCT04762680|581115438|FG011|Phase 2|Withdrawal by Subject|0|||
160923572|NCT04762680|581115439|FG012|Phase 2|Withdrawal by Subject|0|||
160923573|NCT04762680|581115440|FG013|Phase 2|Withdrawal by Subject|0|||
160923574|NCT04762680|581115441|FG014|Phase 2|Withdrawal by Subject|0|||
160923575|NCT04762680|581115442|FG015|Phase 2|Withdrawal by Subject|0|||
160923576|NCT04762680|581115443|FG016|Phase 2|Withdrawal by Subject|0|||
160923577|NCT04762680|581115444|FG017|Phase 2|Withdrawal by Subject|0|||
160923578|NCT04762680|581115445|FG018|Phase 2|Withdrawal by Subject|0|||
160923579|NCT04762680|581115446|FG019|Phase 2|Withdrawal by Subject|0|||
160923580|NCT04762680|581115447|FG020|Phase 2|Withdrawal by Subject|0|||
160923581|NCT04762680|581115448|FG021|Phase 2|Withdrawal by Subject|0|||
160923582|NCT04762680|581115427|FG000|Phase 2|Lost to Follow-up|14|||
160923583|NCT04762680|581115428|FG001|Phase 2|Lost to Follow-up|8|||
160923584|NCT04762680|581115429|FG002|Phase 2|Lost to Follow-up|9|||
160923585|NCT04762680|581115430|FG003|Phase 2|Lost to Follow-up|0|||
160923586|NCT04762680|581115431|FG004|Phase 2|Lost to Follow-up|0|||
160454809|NCT01928394|579396177|FG007|Treatment Period|Death|0|||
160576306|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Death|8|||
160923587|NCT04762680|581115432|FG005|Phase 2|Lost to Follow-up|0|||
160923588|NCT04762680|581115433|FG006|Phase 2|Lost to Follow-up|0|||
160923589|NCT04762680|581115434|FG007|Phase 2|Lost to Follow-up|0|||
160923590|NCT04762680|581115435|FG008|Phase 2|Lost to Follow-up|0|||
160923591|NCT04762680|581115436|FG009|Phase 2|Lost to Follow-up|0|||
160923592|NCT04762680|581115437|FG010|Phase 2|Lost to Follow-up|0|||
160923593|NCT04762680|581115438|FG011|Phase 2|Lost to Follow-up|0|||
160576307|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Death|3|||
160576308|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
160576309|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
160576310|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
160576311|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
160576312|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
160576313|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
160576314|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
160576315|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
160576316|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
160576317|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
160576318|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
160576319|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
160576320|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
160576321|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
160576322|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
160576323|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
160576324|NCT00494871|579830689|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
160576325|NCT00494871|579830690|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
160576326|NCT00494871|579830689|FG000|Follow-up (FU) Period|Adverse Event|1|||
160576327|NCT00494871|579830690|FG001|Follow-up (FU) Period|Adverse Event|1|||
160654860|NCT01592370|580117194|FG004|Overall Study|Study Drug Toxicity|0|||
160654861|NCT01592370|580117195|FG005|Overall Study|Study Drug Toxicity|0|||
160654862|NCT01592370|580117196|FG006|Overall Study|Study Drug Toxicity|1|||
160654863|NCT01592370|580117190|FG000|Overall Study|AE unrelated to study drug|4|||
160654864|NCT01592370|580117191|FG001|Overall Study|AE unrelated to study drug|3|||
160654865|NCT01592370|580117192|FG002|Overall Study|AE unrelated to study drug|0|||
160654866|NCT01592370|580117193|FG003|Overall Study|AE unrelated to study drug|0|||
160923594|NCT04762680|581115439|FG012|Phase 2|Lost to Follow-up|0|||
160923595|NCT04762680|581115440|FG013|Phase 2|Lost to Follow-up|0|||
160923596|NCT04762680|581115441|FG014|Phase 2|Lost to Follow-up|0|||
160923597|NCT04762680|581115442|FG015|Phase 2|Lost to Follow-up|0|||
160923598|NCT04762680|581115443|FG016|Phase 2|Lost to Follow-up|0|||
160923599|NCT04762680|581115444|FG017|Phase 2|Lost to Follow-up|0|||
160923600|NCT04762680|581115445|FG018|Phase 2|Lost to Follow-up|0|||
160923601|NCT04762680|581115446|FG019|Phase 2|Lost to Follow-up|0|||
160923602|NCT04762680|581115447|FG020|Phase 2|Lost to Follow-up|0|||
160923603|NCT04762680|581115448|FG021|Phase 2|Lost to Follow-up|0|||
160923604|NCT04762680|581115427|FG000|Phase 3|Adverse Event|0|||
160923605|NCT04762680|581115428|FG001|Phase 3|Adverse Event|0|||
160923606|NCT04762680|581115429|FG002|Phase 3|Adverse Event|0|||
160923607|NCT04762680|581115430|FG003|Phase 3|Adverse Event|1|||
160923608|NCT04762680|581115431|FG004|Phase 3|Adverse Event|0|||
160923609|NCT04762680|581115432|FG005|Phase 3|Adverse Event|0|||
160923610|NCT04762680|581115433|FG006|Phase 3|Adverse Event|0|||
160923611|NCT04762680|581115434|FG007|Phase 3|Adverse Event|0|||
160923612|NCT04762680|581115435|FG008|Phase 3|Adverse Event|0|||
160923613|NCT04762680|581115436|FG009|Phase 3|Adverse Event|0|||
160923614|NCT04762680|581115437|FG010|Phase 3|Adverse Event|0|||
160923615|NCT04762680|581115438|FG011|Phase 3|Adverse Event|0|||
160923616|NCT04762680|581115439|FG012|Phase 3|Adverse Event|0|||
160923617|NCT04762680|581115440|FG013|Phase 3|Adverse Event|0|||
160923618|NCT04762680|581115441|FG014|Phase 3|Adverse Event|0|||
160923619|NCT04762680|581115442|FG015|Phase 3|Adverse Event|0|||
160923620|NCT04762680|581115443|FG016|Phase 3|Adverse Event|0|||
160923621|NCT04762680|581115444|FG017|Phase 3|Adverse Event|3|||
160923622|NCT04762680|581115445|FG018|Phase 3|Adverse Event|0|||
160923623|NCT04762680|581115446|FG019|Phase 3|Adverse Event|0|||
160923624|NCT04762680|581115447|FG020|Phase 3|Adverse Event|0|||
160923625|NCT04762680|581115448|FG021|Phase 3|Adverse Event|0|||
160923626|NCT04762680|581115427|FG000|Phase 3|Protocol Violation|0|||
160923627|NCT04762680|581115428|FG001|Phase 3|Protocol Violation|0|||
160923628|NCT04762680|581115429|FG002|Phase 3|Protocol Violation|0|||
160923629|NCT04762680|581115430|FG003|Phase 3|Protocol Violation|4|||
160923630|NCT04762680|581115431|FG004|Phase 3|Protocol Violation|1|||
160923631|NCT04762680|581115432|FG005|Phase 3|Protocol Violation|5|||
160923632|NCT04762680|581115433|FG006|Phase 3|Protocol Violation|1|||
160923633|NCT04762680|581115434|FG007|Phase 3|Protocol Violation|0|||
160923634|NCT04762680|581115435|FG008|Phase 3|Protocol Violation|0|||
160923635|NCT04762680|581115436|FG009|Phase 3|Protocol Violation|0|||
160923636|NCT04762680|581115437|FG010|Phase 3|Protocol Violation|0|||
160923637|NCT04762680|581115438|FG011|Phase 3|Protocol Violation|2|||
160923638|NCT04762680|581115439|FG012|Phase 3|Protocol Violation|3|||
160923639|NCT04762680|581115440|FG013|Phase 3|Protocol Violation|0|||
160923640|NCT04762680|581115441|FG014|Phase 3|Protocol Violation|0|||
160923641|NCT04762680|581115442|FG015|Phase 3|Protocol Violation|1|||
160576328|NCT00494871|579830689|FG000|Follow-up (FU) Period|Death|13|||
160576329|NCT00494871|579830690|FG001|Follow-up (FU) Period|Death|12|||
160576330|NCT00494871|579830689|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
160576331|NCT00494871|579830690|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
160576332|NCT00494871|579830689|FG000|Follow-up (FU) Period|Physician Decision|0|||
160576333|NCT00494871|579830690|FG001|Follow-up (FU) Period|Physician Decision|1|||
160576334|NCT00494871|579830689|FG000|Follow-up (FU) Period|Protocol Violation|1|||
160576335|NCT00494871|579830690|FG001|Follow-up (FU) Period|Protocol Violation|0|||
160576336|NCT00494871|579830689|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
160576337|NCT00494871|579830690|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
160576338|NCT00494871|579830689|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
160576339|NCT00494871|579830690|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
160576340|NCT03825042|579830691|FG000|Overall Study|Adverse Event|1|||
160576341|NCT03825042|579830692|FG001|Overall Study|Adverse Event|0|||
160576342|NCT03825042|579830691|FG000|Overall Study|Withdrawal by Subject|1|||
160576343|NCT03825042|579830692|FG001|Overall Study|Withdrawal by Subject|0|||
160576344|NCT01158534|579830694|FG000|Overall Study|Withdrawal by Subject|1|||
160576345|NCT01158534|579830694|FG000|Overall Study|Death|1|||
160576346|NCT01158534|579830694|FG000|Overall Study|Other|1|||
160576347|NCT04003155|579830695|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
160576348|NCT04003155|579830696|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
160576349|NCT04003155|579830697|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
160576350|NCT04003155|579830698|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
160576351|NCT04003155|579830699|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
160576352|NCT04003155|579830695|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
160576353|NCT04003155|579830696|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
160576354|NCT04003155|579830697|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
160576355|NCT04003155|579830698|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
160576356|NCT04003155|579830699|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
160576357|NCT04003155|579830695|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
160576358|NCT04003155|579830696|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
160576359|NCT04003155|579830697|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
160576360|NCT04003155|579830698|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
160576361|NCT04003155|579830699|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
160576362|NCT04003155|579830695|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
160576363|NCT04003155|579830696|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
160576364|NCT04003155|579830697|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
160576365|NCT04003155|579830698|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
160576366|NCT04003155|579830699|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
160576367|NCT04003155|579830695|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
160576368|NCT04003155|579830696|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
160576369|NCT04003155|579830697|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
160576370|NCT04003155|579830698|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
160923642|NCT04762680|581115443|FG016|Phase 3|Protocol Violation|0|||
160923643|NCT04762680|581115444|FG017|Phase 3|Protocol Violation|10|||
160923644|NCT04762680|581115445|FG018|Phase 3|Protocol Violation|0|||
160923645|NCT04762680|581115446|FG019|Phase 3|Protocol Violation|0|||
160923646|NCT04762680|581115447|FG020|Phase 3|Protocol Violation|0|||
160923647|NCT04762680|581115448|FG021|Phase 3|Protocol Violation|0|||
160923648|NCT04762680|581115427|FG000|Phase 3|Withdrawal by Subject|0|||
160923649|NCT04762680|581115428|FG001|Phase 3|Withdrawal by Subject|0|||
160923650|NCT04762680|581115429|FG002|Phase 3|Withdrawal by Subject|0|||
160923651|NCT04762680|581115430|FG003|Phase 3|Withdrawal by Subject|13|||
160923652|NCT04762680|581115431|FG004|Phase 3|Withdrawal by Subject|17|||
160923653|NCT04762680|581115432|FG005|Phase 3|Withdrawal by Subject|12|||
160923654|NCT04762680|581115433|FG006|Phase 3|Withdrawal by Subject|8|||
160923655|NCT04762680|581115434|FG007|Phase 3|Withdrawal by Subject|3|||
160923656|NCT04762680|581115435|FG008|Phase 3|Withdrawal by Subject|2|||
160923657|NCT04762680|581115436|FG009|Phase 3|Withdrawal by Subject|4|||
160923658|NCT04762680|581115437|FG010|Phase 3|Withdrawal by Subject|3|||
160923659|NCT04762680|581115438|FG011|Phase 3|Withdrawal by Subject|1|||
160923660|NCT04762680|581115439|FG012|Phase 3|Withdrawal by Subject|3|||
160923661|NCT04762680|581115440|FG013|Phase 3|Withdrawal by Subject|2|||
160923662|NCT04762680|581115441|FG014|Phase 3|Withdrawal by Subject|1|||
160923663|NCT04762680|581115442|FG015|Phase 3|Withdrawal by Subject|4|||
160923664|NCT04762680|581115443|FG016|Phase 3|Withdrawal by Subject|6|||
160923665|NCT04762680|581115444|FG017|Phase 3|Withdrawal by Subject|32|||
160923666|NCT04762680|581115445|FG018|Phase 3|Withdrawal by Subject|0|||
160923667|NCT04762680|581115446|FG019|Phase 3|Withdrawal by Subject|0|||
160923668|NCT04762680|581115447|FG020|Phase 3|Withdrawal by Subject|0|||
160923669|NCT04762680|581115448|FG021|Phase 3|Withdrawal by Subject|0|||
160923670|NCT04762680|581115427|FG000|Phase 3|Lost to Follow-up|0|||
160923671|NCT04762680|581115428|FG001|Phase 3|Lost to Follow-up|0|||
160923672|NCT04762680|581115429|FG002|Phase 3|Lost to Follow-up|0|||
160923673|NCT04762680|581115430|FG003|Phase 3|Lost to Follow-up|9|||
160923674|NCT04762680|581115431|FG004|Phase 3|Lost to Follow-up|22|||
160923675|NCT04762680|581115432|FG005|Phase 3|Lost to Follow-up|24|||
160923676|NCT04762680|581115433|FG006|Phase 3|Lost to Follow-up|2|||
160923677|NCT04762680|581115434|FG007|Phase 3|Lost to Follow-up|4|||
160923678|NCT04762680|581115435|FG008|Phase 3|Lost to Follow-up|6|||
160576371|NCT04003155|579830699|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
160576372|NCT04003155|579830695|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
160576373|NCT04003155|579830696|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
160576374|NCT04003155|579830697|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
160576375|NCT04003155|579830698|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
160576376|NCT04003155|579830699|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
160576377|NCT04003155|579830695|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
160576378|NCT04003155|579830696|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
160576379|NCT04003155|579830697|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
160576380|NCT04003155|579830698|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
160576381|NCT04003155|579830699|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
160576382|NCT04003155|579830695|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
160576383|NCT04003155|579830696|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
160576384|NCT04003155|579830697|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
160576385|NCT04003155|579830698|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
160576386|NCT04003155|579830699|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
160576387|NCT04003155|579830695|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
160576388|NCT04003155|579830696|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
160576389|NCT04003155|579830697|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
160576390|NCT04003155|579830698|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
160576391|NCT04003155|579830699|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
160576392|NCT03238248|579830708|FG000|Overall Study|Death|5|||
160576393|NCT03238248|579830708|FG000|Overall Study|Withdrawal by Subject|7|||
160576394|NCT03238248|579830708|FG000|Overall Study|Participant proceeding to transplant|10|||
160576395|NCT03238248|579830708|FG000|Overall Study|Lack of Efficacy|4|||
160576396|NCT03238248|579830708|FG000|Overall Study|Physician Decision|3|||
160576397|NCT03238248|579830708|FG000|Overall Study|Transitioning to another study|1|||
160576398|NCT03238248|579830708|FG000|Overall Study|No longer benefiting|1|||
160576399|NCT03238248|579830708|FG000|Overall Study|Other complicating disease|1|||
160576400|NCT03238248|579830708|FG000|Overall Study|Adverse Event|5|||
160576401|NCT03238248|579830708|FG000|Overall Study|Disease progression|26|||
160576402|NCT03238248|579830708|FG000|Overall Study|N/A participant is still on treatment|1|||
160576403|NCT03238248|579830708|FG000|Overall Study|Decline in condition|1|||
160576404|NCT03238248|579830708|FG000|Overall Study|Alternative therapy|2|||
160576405|NCT02241512|579830715|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
160923679|NCT04762680|581115436|FG009|Phase 3|Lost to Follow-up|4|||
160923680|NCT04762680|581115437|FG010|Phase 3|Lost to Follow-up|3|||
160923681|NCT04762680|581115438|FG011|Phase 3|Lost to Follow-up|0|||
160923682|NCT04762680|581115439|FG012|Phase 3|Lost to Follow-up|5|||
160923683|NCT04762680|581115440|FG013|Phase 3|Lost to Follow-up|4|||
160923684|NCT04762680|581115441|FG014|Phase 3|Lost to Follow-up|6|||
160923685|NCT04762680|581115442|FG015|Phase 3|Lost to Follow-up|1|||
160923686|NCT04762680|581115443|FG016|Phase 3|Lost to Follow-up|1|||
160923687|NCT04762680|581115444|FG017|Phase 3|Lost to Follow-up|66|||
160923688|NCT04762680|581115445|FG018|Phase 3|Lost to Follow-up|0|||
160923689|NCT04762680|581115446|FG019|Phase 3|Lost to Follow-up|0|||
160923690|NCT04762680|581115447|FG020|Phase 3|Lost to Follow-up|0|||
160923691|NCT04762680|581115448|FG021|Phase 3|Lost to Follow-up|0|||
160923692|NCT04762680|581115427|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923693|NCT04762680|581115428|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923694|NCT04762680|581115429|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923695|NCT04762680|581115430|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923696|NCT04762680|581115431|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923697|NCT04762680|581115432|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923698|NCT04762680|581115433|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923699|NCT04762680|581115434|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923700|NCT04762680|581115435|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923701|NCT04762680|581115436|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923702|NCT04762680|581115437|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923703|NCT04762680|581115438|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923704|NCT04762680|581115439|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923705|NCT04762680|581115440|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923706|NCT04762680|581115441|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160576406|NCT02241512|579830716|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
160576407|NCT04275310|579830717|FG000|Overall Study|Non-randomized due to running out of funding|4|||
160576408|NCT04275310|579830718|FG001|Overall Study|Non-randomized due to running out of funding|0|||
160576409|NCT02546856|579830721|FG000|4 Months Evaluation|Death|2|||
160576410|NCT02546856|579830722|FG001|4 Months Evaluation|Death|3|||
160923707|NCT04762680|581115442|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923708|NCT04762680|581115443|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923709|NCT04762680|581115444|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923710|NCT04762680|581115445|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923711|NCT04762680|581115446|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923712|NCT04762680|581115447|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923713|NCT04762680|581115448|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
160923714|NCT04762680|581115427|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923715|NCT04762680|581115428|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923716|NCT04762680|581115429|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923717|NCT04762680|581115430|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923718|NCT04762680|581115431|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923719|NCT04762680|581115432|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
160576411|NCT02546856|579830721|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
160923720|NCT04762680|581115433|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923721|NCT04762680|581115434|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923722|NCT04762680|581115435|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923723|NCT04762680|581115436|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
160576412|NCT02546856|579830722|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
160576413|NCT02546856|579830721|FG000|4 Months Evaluation|Lost to Follow-up|3|||
160576414|NCT02546856|579830722|FG001|4 Months Evaluation|Lost to Follow-up|3|||
160997921|NCT00038103|581376685|FG001|Overall Study|Sponsor Decision|1|||
160576415|NCT02546856|579830721|FG000|4 Months Evaluation|Physician Decision|3|||
160576416|NCT02546856|579830722|FG001|4 Months Evaluation|Physician Decision|0|||
160576417|NCT02546856|579830721|FG000|4 Months Evaluation|Working or living abroad|5|||
160576418|NCT02546856|579830722|FG001|4 Months Evaluation|Working or living abroad|1|||
160576419|NCT02546856|579830721|FG000|4 Months Evaluation|reasons not due to titration|4|||
160576420|NCT02546856|579830722|FG001|4 Months Evaluation|reasons not due to titration|1|||
160576421|NCT02546856|579830721|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
160576422|NCT02546856|579830722|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
160576423|NCT02546856|579830721|FG000|6 Months Evaluation|Death|1|||
160576424|NCT02546856|579830722|FG001|6 Months Evaluation|Death|1|||
160576425|NCT02546856|579830721|FG000|6 Months Evaluation|Lost to Follow-up|1|||
160576426|NCT02546856|579830722|FG001|6 Months Evaluation|Lost to Follow-up|1|||
160576427|NCT02546856|579830721|FG000|6 Months Evaluation|Working or living abroad|6|||
160576428|NCT02546856|579830722|FG001|6 Months Evaluation|Working or living abroad|4|||
160576429|NCT02546856|579830721|FG000|6 Months Evaluation|reasons not due to titration|0|||
160576430|NCT02546856|579830722|FG001|6 Months Evaluation|reasons not due to titration|1|||
160576431|NCT00130208|579830725|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
160576432|NCT00130208|579830726|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
160576433|NCT00130208|579830725|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
160576434|NCT00130208|579830726|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
160576435|NCT00130208|579830725|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
160576436|NCT00130208|579830726|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
160923724|NCT04762680|581115437|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923725|NCT04762680|581115438|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923726|NCT04762680|581115439|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923727|NCT04762680|581115440|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923728|NCT04762680|581115441|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923729|NCT04762680|581115442|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923730|NCT04762680|581115443|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923731|NCT04762680|581115444|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923732|NCT04762680|581115445|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923733|NCT04762680|581115446|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
160923734|NCT04762680|581115447|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923735|NCT04762680|581115448|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923736|NCT03388138|581115449|FG000|Overall Study|Protocol Violation|1|||
160923737|NCT03388138|581115450|FG001|Overall Study|Protocol Violation|0|||
160923738|NCT01528072|581115451|FG000|Overall Study|Withdrawal by Subject|5|||
160923739|NCT01528072|581115451|FG000|Overall Study|Physician Decision|1|||
160923740|NCT01528072|581115451|FG000|Overall Study|Determined not eligible by AEAC|1|||
160923741|NCT01528072|581115451|FG000|Overall Study|Missed Visit|2|||
160923742|NCT01528072|581115451|FG000|Overall Study|Lost to Follow-up|5|||
160923743|NCT01528072|581115451|FG000|Overall Study|Explanted|2|||
160923744|NCT01528072|581115451|FG000|Overall Study|Site Closure|4|||
160923745|NCT01528072|581115451|FG000|Overall Study|Death|2|||
160923746|NCT01528072|581115451|FG000|Overall Study|Early Termination of Study|52|||
160923747|NCT02436759|581115458|FG000|Overall Study|Adverse Event|3|||
160923748|NCT02436759|581115459|FG001|Overall Study|Adverse Event|0|||
160923749|NCT02436759|581115458|FG000|Overall Study|Protocol Violation|1|||
160923750|NCT02436759|581115459|FG001|Overall Study|Protocol Violation|0|||
160923751|NCT02436759|581115458|FG000|Overall Study|Withdrawal by Subject|0|||
160923752|NCT02436759|581115459|FG001|Overall Study|Withdrawal by Subject|1|||
160923753|NCT04014075|581115460|FG000|Overall Study|Progressive Disease|53|||
160923754|NCT04014075|581115460|FG000|Overall Study|Adverse Event|15|||
160923755|NCT04014075|581115460|FG000|Overall Study|Clinical Progression|4|||
160923756|NCT04014075|581115460|FG000|Overall Study|Death|2|||
160923757|NCT04014075|581115460|FG000|Overall Study|Withdrawal by Subject|2|||
160923758|NCT04014075|581115460|FG000|Overall Study|Miscellaneous|2|||
160923759|NCT04014075|581115460|FG000|Overall Study|Physician Decision|1|||
160923760|NCT02584504|581115463|FG000|Double-blind Treatment|Participant withdrew consent|0|||
160923761|NCT02584504|581115464|FG001|Double-blind Treatment|Participant withdrew consent|0|||
160923762|NCT02584504|581115465|FG002|Double-blind Treatment|Participant withdrew consent|1|||
160923763|NCT02584504|581115463|FG000|Double-blind Treatment|Adverse Event|0|||
160923764|NCT02584504|581115464|FG001|Double-blind Treatment|Adverse Event|1|||
160923765|NCT02584504|581115465|FG002|Double-blind Treatment|Adverse Event|0|||
160923766|NCT02584504|581115463|FG000|Double-blind Treatment|Family Matter|0|||
160923767|NCT02584504|581115464|FG001|Double-blind Treatment|Family Matter|1|||
160923768|NCT02584504|581115465|FG002|Double-blind Treatment|Family Matter|0|||
160923769|NCT02584504|581115463|FG000|Open-label Treatment|Participant withdrew consent|0|||
160923770|NCT02584504|581115464|FG001|Open-label Treatment|Participant withdrew consent|0|||
160923771|NCT02584504|581115465|FG002|Open-label Treatment|Participant withdrew consent|4|||
160923772|NCT02584504|581115463|FG000|Open-label Treatment|Adverse Event|2|||
160923773|NCT02584504|581115464|FG001|Open-label Treatment|Adverse Event|2|||
160576437|NCT00130208|579830725|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
160576438|NCT00130208|579830726|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
160576439|NCT00130208|579830725|FG000|Maintenance Period (26 Weeks)|Other|1|||
160576440|NCT00130208|579830726|FG001|Maintenance Period (26 Weeks)|Other|1|||
160576441|NCT00130208|579830725|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
160576442|NCT00130208|579830726|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
160576443|NCT00130208|579830725|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
160576444|NCT00130208|579830726|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
160576445|NCT00130208|579830725|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
160576446|NCT00130208|579830726|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
160576447|NCT00130208|579830725|FG000|Washout Period (8 Weeks)|Other|1|||
160576448|NCT00130208|579830726|FG001|Washout Period (8 Weeks)|Other|1|||
160576449|NCT04655586|579830729|FG000|Overall Study|Physician Decision|1|||
160576450|NCT04655586|579830730|FG001|Overall Study|Physician Decision|3|||
160576451|NCT04655586|579830731|FG002|Overall Study|Physician Decision|4|||
160576452|NCT04655586|579830729|FG000|Overall Study|Withdrawal by Subject|1|||
160576453|NCT04655586|579830730|FG001|Overall Study|Withdrawal by Subject|3|||
160576454|NCT04655586|579830731|FG002|Overall Study|Withdrawal by Subject|1|||
160576455|NCT01372878|579830733|FG000|Overall Study|Withdrawal by Subject|63|||
160576456|NCT01372878|579830733|FG000|Overall Study|Protocol Violation|17|||
160576457|NCT01372878|579830733|FG000|Overall Study|incomplete study procedure|104|||
160576458|NCT00546351|579830734|FG000|Overall Study|Adverse Event|76|||
160923774|NCT02584504|581115465|FG002|Open-label Treatment|Adverse Event|3|||
160923775|NCT02584504|581115463|FG000|Open-label Treatment|Physician Decision|0|||
160923776|NCT02584504|581115464|FG001|Open-label Treatment|Physician Decision|1|||
160923777|NCT02584504|581115465|FG002|Open-label Treatment|Physician Decision|0|||
160923778|NCT02584504|581115463|FG000|Open-label Treatment|Entered but not treated|0|||
160923779|NCT02584504|581115464|FG001|Open-label Treatment|Entered but not treated|1|||
160923780|NCT02584504|581115465|FG002|Open-label Treatment|Entered but not treated|1|||
160923781|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Death|3|||
160923782|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Death|2|||
160923783|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Death|4|||
160923784|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Death|3|||
160923785|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Death|0|||
160923786|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Death|0|||
160923787|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
160923788|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
160923789|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
160923790|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
160923791|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
160923792|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
160923793|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
160923794|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
160923795|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
160923796|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
160923797|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
160923798|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
160923799|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
160923800|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
160923801|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
160923802|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
160923803|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
160923804|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
160923805|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
160923806|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
160923807|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
160923808|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
160923809|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
160923810|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
160923811|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
160923812|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
160923813|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
160923814|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
160923815|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
160923816|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
160923817|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
160923818|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
160923819|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
160923820|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
160923821|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
160923822|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
160923823|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
160923824|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
160923825|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
160923826|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
160923827|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
160923828|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
160923829|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
160576459|NCT00546351|579830734|FG000|Overall Study|Lack of Efficacy|15|||
160576460|NCT00546351|579830734|FG000|Overall Study|Withdrawal by Subject|109|||
160923830|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
160923831|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
160923832|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
160923833|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
160923834|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
160923835|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
160923836|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
160923837|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
160923838|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
160923839|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
160923840|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
160923841|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
160923842|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
160923843|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
160576461|NCT00546351|579830734|FG000|Overall Study|Lost to Follow-up|9|||
160923844|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
160923845|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
160923846|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
160923847|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
160923848|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
160923849|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
160923850|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
160923851|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
160923852|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
160923853|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
160923854|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
160923855|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
160923856|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
160923857|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
160923858|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
160923859|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
160923860|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
160923861|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
160923862|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
160923863|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
160923864|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
160923865|NCT00413192|581115472|FG000|Overall Study|Disease progression|26|||
160923866|NCT00413192|581115473|FG001|Overall Study|Disease progression|31|||
160923867|NCT00413192|581115474|FG002|Overall Study|Disease progression|16|||
160923868|NCT00413192|581115475|FG003|Overall Study|Disease progression|25|||
160923869|NCT00413192|581115472|FG000|Overall Study|Toxicity|3|||
160923870|NCT00413192|581115473|FG001|Overall Study|Toxicity|2|||
160923871|NCT00413192|581115474|FG002|Overall Study|Toxicity|2|||
160923872|NCT00413192|581115475|FG003|Overall Study|Toxicity|2|||
160923873|NCT00413192|581115472|FG000|Overall Study|Withdrawal by Subject|3|||
160923874|NCT00413192|581115473|FG001|Overall Study|Withdrawal by Subject|5|||
160923875|NCT00413192|581115474|FG002|Overall Study|Withdrawal by Subject|0|||
160923876|NCT00413192|581115475|FG003|Overall Study|Withdrawal by Subject|1|||
160923877|NCT00413192|581115472|FG000|Overall Study|Intercurrent illness|0|||
160923878|NCT00413192|581115473|FG001|Overall Study|Intercurrent illness|0|||
160923879|NCT00413192|581115474|FG002|Overall Study|Intercurrent illness|0|||
160923880|NCT00413192|581115475|FG003|Overall Study|Intercurrent illness|1|||
160923881|NCT00413192|581115472|FG000|Overall Study|Intercurrent death|0|||
160923882|NCT00413192|581115473|FG001|Overall Study|Intercurrent death|1|||
160923883|NCT00413192|581115474|FG002|Overall Study|Intercurrent death|0|||
160923884|NCT00413192|581115475|FG003|Overall Study|Intercurrent death|0|||
160923885|NCT00413192|581115472|FG000|Overall Study|Other|5|||
160923886|NCT00413192|581115473|FG001|Overall Study|Other|1|||
160923887|NCT00413192|581115474|FG002|Overall Study|Other|1|||
160923888|NCT00413192|581115475|FG003|Overall Study|Other|2|||
160923889|NCT00413192|581115472|FG000|Overall Study|Not treated|0|||
160923890|NCT00413192|581115473|FG001|Overall Study|Not treated|0|||
160923891|NCT00413192|581115474|FG002|Overall Study|Not treated|0|||
160923892|NCT00413192|581115475|FG003|Overall Study|Not treated|1|||
160923893|NCT01998633|581115476|FG000|Overall Study|Death|1|||
160923894|NCT03814746|581115477|FG000|Overall Study|Participant decision|9|||
160923895|NCT03814746|581115478|FG001|Overall Study|Participant decision|6|||
160923896|NCT03814746|581115479|FG002|Overall Study|Participant decision|15|||
160923897|NCT03814746|581115477|FG000|Overall Study|Physician Decision|2|||
160923898|NCT03814746|581115478|FG001|Overall Study|Physician Decision|2|||
160923899|NCT03814746|581115479|FG002|Overall Study|Physician Decision|4|||
160923900|NCT03814746|581115477|FG000|Overall Study|Death|2|||
160923901|NCT03814746|581115478|FG001|Overall Study|Death|2|||
160923902|NCT03814746|581115479|FG002|Overall Study|Death|2|||
160923903|NCT03814746|581115477|FG000|Overall Study|Adverse Event|2|||
160923904|NCT03814746|581115478|FG001|Overall Study|Adverse Event|2|||
160923905|NCT03814746|581115479|FG002|Overall Study|Adverse Event|1|||
160923906|NCT03814746|581115477|FG000|Overall Study|Lost to Follow-up|2|||
160923907|NCT03814746|581115478|FG001|Overall Study|Lost to Follow-up|1|||
160576462|NCT00546351|579830734|FG000|Overall Study|Protocol Deviation|1|||
160923908|NCT03814746|581115479|FG002|Overall Study|Lost to Follow-up|2|||
160923909|NCT03814746|581115477|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160923910|NCT03814746|581115478|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160923911|NCT03814746|581115479|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
160923912|NCT03814746|581115477|FG000|Overall Study|Pregnancy|0|||
160923913|NCT03814746|581115478|FG001|Overall Study|Pregnancy|1|||
160923914|NCT03814746|581115479|FG002|Overall Study|Pregnancy|1|||
160923915|NCT03814746|581115477|FG000|Overall Study|Protocol Violation|1|||
160923916|NCT03814746|581115478|FG001|Overall Study|Protocol Violation|0|||
160923917|NCT03814746|581115479|FG002|Overall Study|Protocol Violation|0|||
160923918|NCT03992781|581115480|FG000|Overall Study|Lost to Follow-up|5|||
160923919|NCT03992781|581115480|FG000|Overall Study|Adverse Event|1|||
160923920|NCT03992781|581115480|FG000|Overall Study|Lack of Efficacy|5|||
160923921|NCT01996826|581115481|FG000|Overall Study|Lost to Follow-up|6|||
160923922|NCT01996826|581115482|FG001|Overall Study|Lost to Follow-up|2|||
160923923|NCT01996826|581115481|FG000|Overall Study|Physician Decision|1|||
160923924|NCT01996826|581115482|FG001|Overall Study|Physician Decision|1|||
160923925|NCT00695396|581115483|FG000|Overall Study|Study Closed Prematurely|5|||
160923926|NCT00695396|581115484|FG001|Overall Study|Study Closed Prematurely|6|||
160923927|NCT00695396|581115485|FG002|Overall Study|Study Closed Prematurely|8|||
160923928|NCT00695396|581115483|FG000|Overall Study|Withdrawal by Subject|2|||
160923929|NCT00695396|581115484|FG001|Overall Study|Withdrawal by Subject|2|||
160923930|NCT00695396|581115485|FG002|Overall Study|Withdrawal by Subject|0|||
160923931|NCT00518323|581115487|FG000|Overall Study|Lack of Efficacy|14|||
160923932|NCT00518323|581115488|FG001|Overall Study|Lack of Efficacy|2|||
160923933|NCT00518323|581115489|FG002|Overall Study|Lack of Efficacy|4|||
160923934|NCT00518323|581115490|FG003|Overall Study|Lack of Efficacy|20|||
160923935|NCT00518323|581115487|FG000|Overall Study|Withdrawal by Subject|1|||
160923936|NCT00518323|581115488|FG001|Overall Study|Withdrawal by Subject|2|||
160923937|NCT00518323|581115489|FG002|Overall Study|Withdrawal by Subject|4|||
160923938|NCT00518323|581115490|FG003|Overall Study|Withdrawal by Subject|2|||
160923939|NCT00518323|581115487|FG000|Overall Study|Lost to Follow-up|0|||
160923940|NCT00518323|581115488|FG001|Overall Study|Lost to Follow-up|2|||
160923941|NCT00518323|581115489|FG002|Overall Study|Lost to Follow-up|1|||
160923942|NCT00518323|581115490|FG003|Overall Study|Lost to Follow-up|3|||
160923943|NCT00518323|581115487|FG000|Overall Study|Adverse Event|1|||
160923944|NCT00518323|581115488|FG001|Overall Study|Adverse Event|1|||
160923945|NCT00518323|581115489|FG002|Overall Study|Adverse Event|1|||
160923946|NCT00518323|581115490|FG003|Overall Study|Adverse Event|0|||
160923947|NCT00518323|581115487|FG000|Overall Study|Prohibited medication and others|3|||
160923948|NCT00518323|581115488|FG001|Overall Study|Prohibited medication and others|1|||
160923949|NCT00518323|581115489|FG002|Overall Study|Prohibited medication and others|1|||
160923950|NCT00518323|581115490|FG003|Overall Study|Prohibited medication and others|0|||
160923951|NCT03164928|581115492|FG000|Overall Study|Lost to Follow-up|1|||
160923952|NCT03164928|581115493|FG001|Overall Study|Lost to Follow-up|0|||
160923953|NCT01275833|581115496|FG000|Overall Study|Study terminated|1|||
160923954|NCT01275833|581115497|FG001|Overall Study|Study terminated|1|||
160923955|NCT02118012|581115499|FG000|Overall Study|Adverse Event|0|||
160923956|NCT02118012|581115500|FG001|Overall Study|Adverse Event|1|||
160923957|NCT02118012|581115499|FG000|Overall Study|Physician Decision|0|||
160923958|NCT02118012|581115500|FG001|Overall Study|Physician Decision|1|||
160923959|NCT00536107|581115501|FG000|Overall Study|Death|5|||
160923960|NCT00536107|581115502|FG001|Overall Study|Death|1|||
160923961|NCT00536107|581115501|FG000|Overall Study|Incorrect enrolment|1|||
160923962|NCT00536107|581115502|FG001|Overall Study|Incorrect enrolment|0|||
160923963|NCT00536107|581115501|FG000|Overall Study|Withdrawal by Subject|0|||
160923964|NCT00536107|581115502|FG001|Overall Study|Withdrawal by Subject|1|||
160923965|NCT00536107|581115501|FG000|Overall Study|Study Termination|2|||
160923966|NCT00536107|581115502|FG001|Overall Study|Study Termination|4|||
160923967|NCT03329690|581115503|FG000|Overall Study|Progressive disease per RECIST|85|||
160923968|NCT03329690|581115504|FG001|Overall Study|Progressive disease per RECIST|44|||
160923969|NCT03329690|581115505|FG002|Overall Study|Progressive disease per RECIST|6|||
160923970|NCT03329690|581115506|FG003|Overall Study|Progressive disease per RECIST|16|||
160923971|NCT03329690|581115507|FG004|Overall Study|Progressive disease per RECIST|20|||
160923972|NCT03329690|581115503|FG000|Overall Study|Clinical progression|7|||
160923973|NCT03329690|581115504|FG001|Overall Study|Clinical progression|4|||
160923974|NCT03329690|581115505|FG002|Overall Study|Clinical progression|1|||
160923975|NCT03329690|581115506|FG003|Overall Study|Clinical progression|1|||
160923976|NCT03329690|581115507|FG004|Overall Study|Clinical progression|1|||
160923977|NCT03329690|581115503|FG000|Overall Study|Adverse Event|22|||
160923978|NCT03329690|581115504|FG001|Overall Study|Adverse Event|4|||
160923979|NCT03329690|581115505|FG002|Overall Study|Adverse Event|0|||
160923980|NCT03329690|581115506|FG003|Overall Study|Adverse Event|1|||
160923981|NCT03329690|581115507|FG004|Overall Study|Adverse Event|2|||
160923982|NCT03329690|581115503|FG000|Overall Study|Death|2|||
160923983|NCT03329690|581115504|FG001|Overall Study|Death|0|||
160923984|NCT03329690|581115505|FG002|Overall Study|Death|0|||
160923985|NCT03329690|581115506|FG003|Overall Study|Death|1|||
160997922|NCT00038103|581376684|FG000|Overall Study|Randomized/never treated|2|||
160923986|NCT03329690|581115507|FG004|Overall Study|Death|0|||
160923987|NCT03329690|581115503|FG000|Overall Study|Withdrawal by Subject|2|||
160923988|NCT03329690|581115504|FG001|Overall Study|Withdrawal by Subject|3|||
160923989|NCT03329690|581115505|FG002|Overall Study|Withdrawal by Subject|0|||
160923990|NCT03329690|581115506|FG003|Overall Study|Withdrawal by Subject|1|||
160923991|NCT03329690|581115507|FG004|Overall Study|Withdrawal by Subject|0|||
160923992|NCT03329690|581115503|FG000|Overall Study|Physician Decision|1|||
160923993|NCT03329690|581115504|FG001|Overall Study|Physician Decision|0|||
160923994|NCT03329690|581115505|FG002|Overall Study|Physician Decision|0|||
160923995|NCT03329690|581115506|FG003|Overall Study|Physician Decision|0|||
160923996|NCT03329690|581115507|FG004|Overall Study|Physician Decision|1|||
160923997|NCT03329690|581115503|FG000|Overall Study|Miscellaneous|6|||
160923998|NCT03329690|581115504|FG001|Overall Study|Miscellaneous|0|||
160923999|NCT03329690|581115505|FG002|Overall Study|Miscellaneous|0|||
160924000|NCT03329690|581115506|FG003|Overall Study|Miscellaneous|0|||
160924001|NCT03329690|581115507|FG004|Overall Study|Miscellaneous|0|||
160924002|NCT03329690|581115503|FG000|Overall Study|Did not receive treatment|1|||
160924003|NCT03329690|581115504|FG001|Overall Study|Did not receive treatment|0|||
160924004|NCT03329690|581115505|FG002|Overall Study|Did not receive treatment|0|||
160924005|NCT03329690|581115506|FG003|Overall Study|Did not receive treatment|1|||
160924006|NCT03329690|581115507|FG004|Overall Study|Did not receive treatment|0|||
160924007|NCT00099437|581115510|FG000|Overall Study|Lost to Follow-up|30|||
160924008|NCT00099437|581115511|FG001|Overall Study|Lost to Follow-up|33|||
160924009|NCT00099437|581115510|FG000|Overall Study|Death|293|||
160924010|NCT00099437|581115511|FG001|Overall Study|Death|261|||
160924011|NCT00099437|581115510|FG000|Overall Study|Withdrawal by Subject|6|||
160924012|NCT00099437|581115511|FG001|Overall Study|Withdrawal by Subject|10|||
160924013|NCT00099437|581115510|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
160924014|NCT00099437|581115511|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
160924015|NCT00450333|581115512|FG000|Overall Study|Study terminated|47|||
160924016|NCT00450333|581115513|FG001|Overall Study|Study terminated|54|||
160924017|NCT00450333|581115514|FG002|Overall Study|Study terminated|16|||
160924018|NCT00450333|581115515|FG003|Overall Study|Study terminated|21|||
160924019|NCT00450333|581115512|FG000|Overall Study|Adverse Event|1|||
160924020|NCT00450333|581115513|FG001|Overall Study|Adverse Event|7|||
160924021|NCT00450333|581115514|FG002|Overall Study|Adverse Event|2|||
160924022|NCT00450333|581115515|FG003|Overall Study|Adverse Event|2|||
160924023|NCT00450333|581115512|FG000|Overall Study|Protocol Violation|1|||
160924024|NCT00450333|581115513|FG001|Overall Study|Protocol Violation|0|||
160924025|NCT00450333|581115514|FG002|Overall Study|Protocol Violation|1|||
160924026|NCT00450333|581115515|FG003|Overall Study|Protocol Violation|0|||
160924027|NCT00450333|581115512|FG000|Overall Study|Withdrawal by Subject|1|||
160924028|NCT00450333|581115513|FG001|Overall Study|Withdrawal by Subject|0|||
160924029|NCT00450333|581115514|FG002|Overall Study|Withdrawal by Subject|3|||
160924030|NCT00450333|581115515|FG003|Overall Study|Withdrawal by Subject|0|||
160924031|NCT00450333|581115512|FG000|Overall Study|Kidney transplant|1|||
160924032|NCT00450333|581115513|FG001|Overall Study|Kidney transplant|0|||
160924033|NCT00450333|581115514|FG002|Overall Study|Kidney transplant|1|||
160924034|NCT00450333|581115515|FG003|Overall Study|Kidney transplant|3|||
160924035|NCT00450333|581115512|FG000|Overall Study|Death|3|||
160924036|NCT00450333|581115513|FG001|Overall Study|Death|2|||
160924037|NCT00450333|581115514|FG002|Overall Study|Death|2|||
160924038|NCT00450333|581115515|FG003|Overall Study|Death|2|||
160924039|NCT03855280|581115522|FG000|Treatment Phase|Adverse Event|1|||
160924040|NCT03855280|581115522|FG000|Treatment Phase|Withdrawal by Subject|1|||
160924041|NCT03855280|581115522|FG000|Continuation Phase|Protocol Violation|1|||
160924042|NCT03855280|581115522|FG000|Continuation Phase|Adverse Event|1|||
160924043|NCT03855280|581115522|FG000|Continuation Phase|Sponsor Concluded Study|1|||
160924044|NCT01165554|581115524|FG000|Overall Study|Withdrawal by Subject|23|||
160924045|NCT02951156|581115525|FG000|Overall Study|Death|3|||
160924046|NCT02951156|581115526|FG001|Overall Study|Death|8|||
160924047|NCT02951156|581115527|FG002|Overall Study|Death|5|||
160924048|NCT02951156|581115525|FG000|Overall Study|Progressive disease|1|||
160924049|NCT02951156|581115526|FG001|Overall Study|Progressive disease|0|||
160924050|NCT02951156|581115527|FG002|Overall Study|Progressive disease|1|||
160924051|NCT02951156|581115525|FG000|Overall Study|Withdrawal by Subject|0|||
160924052|NCT02951156|581115526|FG001|Overall Study|Withdrawal by Subject|0|||
160924053|NCT02951156|581115527|FG002|Overall Study|Withdrawal by Subject|1|||
160924054|NCT02951156|581115525|FG000|Overall Study|Study terminated by sponsor|0|||
160924055|NCT02951156|581115526|FG001|Overall Study|Study terminated by sponsor|0|||
160924056|NCT02951156|581115527|FG002|Overall Study|Study terminated by sponsor|1|||
160924057|NCT02951156|581115525|FG000|Overall Study|Other|5|||
160924058|NCT02951156|581115526|FG001|Overall Study|Other|1|||
160924059|NCT02951156|581115527|FG002|Overall Study|Other|2|||
160924060|NCT01603459|581115528|FG000|Overall Study|Adverse Event|5|||
160924061|NCT01603459|581115528|FG000|Overall Study|Withdrawal by Subject|5|||
160924062|NCT01603459|581115528|FG000|Overall Study|Lost to Follow-up|3|||
160997923|NCT00038103|581376685|FG001|Overall Study|Randomized/never treated|0|||
160997924|NCT01144182|581376686|FG000|Overall Study|Death|5|||
160576463|NCT00546351|579830734|FG000|Overall Study|Unsatisfactory compliance|9|||
160924063|NCT01603459|581115528|FG000|Overall Study|Predefined discontinuation criteria|3|||
160924064|NCT01603459|581115528|FG000|Overall Study|Non-compliance|1|||
160924065|NCT01603459|581115528|FG000|Overall Study|Administrative reason|1|||
160924066|NCT02953314|581115532|FG000|Overall Study|Adverse Event|0|||
160924067|NCT02953314|581115533|FG001|Overall Study|Adverse Event|1|||
160924068|NCT02953314|581115532|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
160924069|NCT02953314|581115533|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
160924070|NCT02515045|581115539|FG000|Overall Study|Adverse Event|0|||
160924071|NCT02515045|581115540|FG001|Overall Study|Adverse Event|3|||
160924072|NCT02515045|581115541|FG002|Overall Study|Adverse Event|3|||
160924073|NCT02515045|581115539|FG000|Overall Study|Lost to Follow-up|0|||
160924074|NCT02515045|581115540|FG001|Overall Study|Lost to Follow-up|1|||
160924075|NCT02515045|581115541|FG002|Overall Study|Lost to Follow-up|1|||
160924076|NCT02221284|581115542|FG000|Overall Study|Case Report Forms Uncollected|56|||
160924077|NCT02221284|581115542|FG000|Overall Study|Protocol Deviation|5|||
160924078|NCT01239368|581116946|FG000|Overall Study|Principal investigator discretion|1|||
160924079|NCT01239368|581116947|FG001|Overall Study|Principal investigator discretion|0|||
160924080|NCT01239368|581116948|FG002|Overall Study|Principal investigator discretion|0|||
160924081|NCT01239368|581116949|FG003|Overall Study|Principal investigator discretion|0|||
160924082|NCT01239368|581116950|FG004|Overall Study|Principal investigator discretion|1|||
160924083|NCT01239368|581116951|FG005|Overall Study|Principal investigator discretion|2|||
160924084|NCT01239368|581116952|FG006|Overall Study|Principal investigator discretion|0|||
160924085|NCT01239368|581116953|FG007|Overall Study|Principal investigator discretion|0|||
160924086|NCT01239368|581116954|FG008|Overall Study|Principal investigator discretion|0|||
160924087|NCT01239368|581116955|FG009|Overall Study|Principal investigator discretion|1|||
160924088|NCT01239368|581116946|FG000|Overall Study|Disease progression on study|1|||
160924089|NCT01239368|581116947|FG001|Overall Study|Disease progression on study|1|||
160924090|NCT01239368|581116948|FG002|Overall Study|Disease progression on study|1|||
160924091|NCT01239368|581116949|FG003|Overall Study|Disease progression on study|1|||
160924092|NCT01239368|581116950|FG004|Overall Study|Disease progression on study|4|||
160924093|NCT01239368|581116951|FG005|Overall Study|Disease progression on study|2|||
160924094|NCT01239368|581116952|FG006|Overall Study|Disease progression on study|5|||
160924095|NCT01239368|581116953|FG007|Overall Study|Disease progression on study|0|||
160924096|NCT01239368|581116954|FG008|Overall Study|Disease progression on study|0|||
160924097|NCT01239368|581116955|FG009|Overall Study|Disease progression on study|2|||
160924098|NCT01239368|581116946|FG000|Overall Study|Refused further treatment|0|||
160924099|NCT01239368|581116947|FG001|Overall Study|Refused further treatment|0|||
160924100|NCT01239368|581116948|FG002|Overall Study|Refused further treatment|0|||
160924101|NCT01239368|581116949|FG003|Overall Study|Refused further treatment|0|||
160924102|NCT01239368|581116950|FG004|Overall Study|Refused further treatment|0|||
160924103|NCT01239368|581116951|FG005|Overall Study|Refused further treatment|0|||
160924104|NCT01239368|581116952|FG006|Overall Study|Refused further treatment|0|||
160924105|NCT01239368|581116953|FG007|Overall Study|Refused further treatment|0|||
160924106|NCT01239368|581116954|FG008|Overall Study|Refused further treatment|0|||
160924107|NCT01239368|581116955|FG009|Overall Study|Refused further treatment|1|||
160924108|NCT01239368|581116946|FG000|Overall Study|Death|0|||
160924109|NCT01239368|581116947|FG001|Overall Study|Death|0|||
160924110|NCT01239368|581116948|FG002|Overall Study|Death|0|||
160924111|NCT01239368|581116949|FG003|Overall Study|Death|0|||
160924112|NCT01239368|581116950|FG004|Overall Study|Death|0|||
160924113|NCT01239368|581116951|FG005|Overall Study|Death|0|||
160924114|NCT01239368|581116952|FG006|Overall Study|Death|1|||
160924115|NCT01239368|581116953|FG007|Overall Study|Death|0|||
160924116|NCT01239368|581116954|FG008|Overall Study|Death|0|||
160924117|NCT01239368|581116955|FG009|Overall Study|Death|0|||
160576464|NCT00546351|579830734|FG000|Overall Study|Other reasons for premature termination|17|||
160576465|NCT04734873|579830735|FG000|Overall Study|Lost to Follow-up|1|||
160924118|NCT04709575|581116956|FG000|Overall Study|Withdrawal by Subject|6|||
160924119|NCT04709575|581116957|FG001|Overall Study|Withdrawal by Subject|2|||
160924120|NCT04709575|581116956|FG000|Overall Study|Lost to Follow-up|2|||
160924121|NCT04709575|581116957|FG001|Overall Study|Lost to Follow-up|2|||
160924122|NCT04709575|581116956|FG000|Overall Study|Adverse Event|1|||
160924123|NCT04709575|581116957|FG001|Overall Study|Adverse Event|0|||
160924124|NCT04709575|581116956|FG000|Overall Study|Protocol Violation|1|||
160924125|NCT04709575|581116957|FG001|Overall Study|Protocol Violation|1|||
160924126|NCT03181399|581116959|FG000|6 Months on Treatment|Protocol non-compliance|7|||
160924127|NCT03181399|581116959|FG000|6 Months on Treatment|Adverse Event|4|||
160924128|NCT03181399|581116959|FG000|6 Months on Treatment|Tried alternative treatment|2|||
160924129|NCT03181399|581116959|FG000|6 Months on Treatment|Lost to Follow-up|2|||
160924130|NCT03181399|581116959|FG000|6 Months on Treatment|Personal reasons|1|||
160924131|NCT03181399|581116959|FG000|3 Months Off-treatment|Parent unable to travel|1|||
160576466|NCT04734873|579830736|FG001|Overall Study|Lost to Follow-up|3|||
160576467|NCT04734873|579830737|FG002|Overall Study|Lost to Follow-up|2|||
160576468|NCT04734873|579830735|FG000|Overall Study|Randomized but not dosed|1|||
160576469|NCT04734873|579830736|FG001|Overall Study|Randomized but not dosed|0|||
160924132|NCT02926924|581116960|FG000|Overall Study|withdrawal - reason unknown|0|||
160576470|NCT04734873|579830737|FG002|Overall Study|Randomized but not dosed|1|||
160576471|NCT02345434|579830740|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
160924133|NCT02926924|581116961|FG001|Overall Study|withdrawal - reason unknown|1|||
160924134|NCT01254227|581116965|FG000|Overall Study|Withdrawal by Subject|6|||
160924135|NCT01254227|581116965|FG000|Overall Study|Lost to Follow-up|6|||
160924136|NCT01254227|581116965|FG000|Overall Study|Adverse Event|5|||
160924137|NCT01254227|581116965|FG000|Overall Study|Abnormal test procedure result|5|||
160924138|NCT01254227|581116965|FG000|Overall Study|Administrative problems|2|||
160924139|NCT01254227|581116965|FG000|Overall Study|Death|1|||
160924140|NCT01254227|581116965|FG000|Overall Study|Protocol deviation|1|||
160924141|NCT03970733|581116966|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
160997925|NCT01144182|581376687|FG001|Overall Study|Death|6|||
160924142|NCT03970733|581116967|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
160924143|NCT03970733|581116968|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
160924144|NCT03970733|581116969|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
160924145|NCT03970733|581116970|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
160924146|NCT03970733|581116966|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
160924147|NCT03970733|581116967|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
160924148|NCT03970733|581116968|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
160924149|NCT03970733|581116969|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
160924150|NCT03970733|581116970|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
160924151|NCT03970733|581116966|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
160924152|NCT03970733|581116967|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
160924153|NCT03970733|581116968|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
160924154|NCT03970733|581116969|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
160924155|NCT03970733|581116970|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
160924156|NCT03970733|581116966|FG000|Main Study Phase (18 Months)|Other|1|||
160924157|NCT03970733|581116967|FG001|Main Study Phase (18 Months)|Other|1|||
160924158|NCT03970733|581116968|FG002|Main Study Phase (18 Months)|Other|0|||
160924159|NCT03970733|581116969|FG003|Main Study Phase (18 Months)|Other|0|||
160924160|NCT03970733|581116970|FG004|Main Study Phase (18 Months)|Other|0|||
160924161|NCT03970733|581116966|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
160924162|NCT03970733|581116967|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
160924163|NCT03970733|581116968|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
160924164|NCT03970733|581116969|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
160924165|NCT03970733|581116970|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
160924166|NCT02082210|581116974|FG000|Overall Study|Death|0|||
160924167|NCT02082210|581116975|FG001|Overall Study|Death|0|||
160924168|NCT02082210|581116976|FG002|Overall Study|Death|1|||
160924169|NCT02082210|581116977|FG003|Overall Study|Death|1|||
160924170|NCT02082210|581116978|FG004|Overall Study|Death|1|||
160924171|NCT02082210|581116979|FG005|Overall Study|Death|0|||
160924172|NCT02082210|581116974|FG000|Overall Study|Withdrawal by Subject|0|||
160924173|NCT02082210|581116975|FG001|Overall Study|Withdrawal by Subject|0|||
160924174|NCT02082210|581116976|FG002|Overall Study|Withdrawal by Subject|0|||
160924175|NCT02082210|581116977|FG003|Overall Study|Withdrawal by Subject|1|||
160924176|NCT02082210|581116978|FG004|Overall Study|Withdrawal by Subject|2|||
160924177|NCT02082210|581116979|FG005|Overall Study|Withdrawal by Subject|2|||
160924178|NCT02082210|581116974|FG000|Overall Study|Clinical Progression|0|||
160924179|NCT02082210|581116975|FG001|Overall Study|Clinical Progression|0|||
160924180|NCT02082210|581116976|FG002|Overall Study|Clinical Progression|0|||
160924181|NCT02082210|581116977|FG003|Overall Study|Clinical Progression|1|||
160924182|NCT02082210|581116978|FG004|Overall Study|Clinical Progression|0|||
160924183|NCT02082210|581116979|FG005|Overall Study|Clinical Progression|0|||
160924184|NCT02082210|581116974|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
160924185|NCT02082210|581116975|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
160924186|NCT02082210|581116976|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
160924187|NCT02082210|581116977|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
160924188|NCT02082210|581116978|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
160924189|NCT02082210|581116979|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
160924190|NCT02082210|581116974|FG000|Overall Study|Physician Decision|0|||
160924191|NCT02082210|581116975|FG001|Overall Study|Physician Decision|0|||
160924192|NCT02082210|581116976|FG002|Overall Study|Physician Decision|1|||
160924193|NCT02082210|581116977|FG003|Overall Study|Physician Decision|1|||
160576472|NCT02345434|579830741|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
160576473|NCT02805907|579830747|FG000|Overall Study|Lost to Follow-up|3|||
160576474|NCT02805907|579830748|FG001|Overall Study|Lost to Follow-up|3|||
160576475|NCT03799718|579830758|FG000|Overall Study|Adverse Event|2|||
160576476|NCT00425438|579830759|FG000|Overall Study|Termination by Sponsor|25|||
160576477|NCT00425438|579830760|FG001|Overall Study|Termination by Sponsor|27|||
160576478|NCT02795767|579830763|FG000|Overall Study|Received Commercial Emicizumab|1|||
160576479|NCT02795767|579830764|FG001|Overall Study|Received Commercial Emicizumab|0|||
160576480|NCT02795767|579830765|FG002|Overall Study|Received Commercial Emicizumab|0|||
160576481|NCT04983940|579830766|FG000|Overall Study|Lost to Follow-up|14|||
160576482|NCT04983940|579830766|FG000|Overall Study|Lack of Efficacy|2|||
160576483|NCT01748760|579830772|FG000|Overall Study|Withdrawal by Subject|1|||
160576484|NCT01748760|579830773|FG001|Overall Study|Withdrawal by Subject|1|||
160576485|NCT01748760|579830772|FG000|Overall Study|Lost to Follow-up|5|||
160576486|NCT01748760|579830773|FG001|Overall Study|Lost to Follow-up|1|||
160576487|NCT00734929|579830779|FG000|Overall Study|Lost to Follow-up|1|||
160576488|NCT00734929|579830780|FG001|Overall Study|Lost to Follow-up|2|||
160924194|NCT02082210|581116978|FG004|Overall Study|Physician Decision|0|||
160924195|NCT02082210|581116979|FG005|Overall Study|Physician Decision|0|||
160924196|NCT01859494|581116988|FG000|Overall Study|Adverse Event|1|||
160924197|NCT01290666|581116994|FG000|Overall Study|Lost to Follow-up|11|||
160924198|NCT01290666|581116994|FG000|Overall Study|Withdrawal by Subject|23|||
160924199|NCT01290666|581116994|FG000|Overall Study|Early Termination of Study|4|||
160924200|NCT05089682|581116997|FG000|Overall Study|Withdrawal by Subject|2|||
160924201|NCT00483379|581116999|FG000|Treatment Period|Adverse Event|1|||
160924202|NCT00483379|581117000|FG001|Treatment Period|Adverse Event|0|||
160924203|NCT00483379|581116999|FG000|Treatment Period|Withdrawal by Subject|1|||
160924204|NCT00483379|581117000|FG001|Treatment Period|Withdrawal by Subject|0|||
160924205|NCT00371254|581117002|FG000|Overall Study|Disease progression|13|||
160924206|NCT00371254|581117003|FG001|Overall Study|Disease progression|13|||
160924207|NCT00371254|581117002|FG000|Overall Study|Study drug toxicity|3|||
160924208|NCT00371254|581117003|FG001|Overall Study|Study drug toxicity|5|||
160924209|NCT00371254|581117002|FG000|Overall Study|Subject request|5|||
160924210|NCT00371254|581117003|FG001|Overall Study|Subject request|0|||
160924211|NCT00371254|581117002|FG000|Overall Study|Investigator Decision|2|||
160924212|NCT00371254|581117003|FG001|Overall Study|Investigator Decision|0|||
160924213|NCT00371254|581117002|FG000|Overall Study|Adverse event unrelated to study drug|0|||
160924214|NCT00371254|581117003|FG001|Overall Study|Adverse event unrelated to study drug|1|||
160924215|NCT00371254|581117002|FG000|Overall Study|Lost to Follow-up|0|||
160924216|NCT00371254|581117003|FG001|Overall Study|Lost to Follow-up|1|||
160924217|NCT00371254|581117002|FG000|Overall Study|Withdrawal by Subject|0|||
160924218|NCT00371254|581117003|FG001|Overall Study|Withdrawal by Subject|1|||
160576489|NCT00734929|579830779|FG000|Overall Study|No intervention/ screen fail|5|||
160576490|NCT00734929|579830780|FG001|Overall Study|No intervention/ screen fail|3|||
160924219|NCT01817725|581117004|FG000|Overall Study|Withdrawal by Subject|1|||
160924220|NCT02418468|581117006|FG000|Overall Study|Adverse Event|1|||
160924221|NCT02418468|581117007|FG001|Overall Study|Adverse Event|0|||
160924222|NCT02418468|581117006|FG000|Overall Study|Withdrawal of informed consent|1|||
160924223|NCT02418468|581117007|FG001|Overall Study|Withdrawal of informed consent|1|||
160924224|NCT02337907|581117008|FG000|Overall Study|Other than listed|1|||
160924225|NCT02337907|581117009|FG001|Overall Study|Other than listed|0|||
160924226|NCT02337907|581117010|FG002|Overall Study|Other than listed|0|||
160924227|NCT02337907|581117011|FG003|Overall Study|Other than listed|1|||
160924228|NCT02337907|581117012|FG004|Overall Study|Other than listed|1|||
160924229|NCT02337907|581117013|FG005|Overall Study|Other than listed|0|||
160924230|NCT02337907|581117008|FG000|Overall Study|Withdrawal by Subject|2|||
160576491|NCT02961764|579830781|FG000|Overall Study|Protocol Violation|0|||
160576492|NCT02961764|579830782|FG001|Overall Study|Protocol Violation|1|||
160576493|NCT02961764|579830781|FG000|Overall Study|Death|2|||
160576494|NCT02961764|579830782|FG001|Overall Study|Death|0|||
160924231|NCT02337907|581117009|FG001|Overall Study|Withdrawal by Subject|3|||
160924232|NCT02337907|581117010|FG002|Overall Study|Withdrawal by Subject|0|||
160924233|NCT02337907|581117011|FG003|Overall Study|Withdrawal by Subject|2|||
160924234|NCT02337907|581117012|FG004|Overall Study|Withdrawal by Subject|5|||
160924235|NCT02337907|581117013|FG005|Overall Study|Withdrawal by Subject|0|||
160924236|NCT02337907|581117008|FG000|Overall Study|Lost to Follow-up|0|||
160924237|NCT02337907|581117009|FG001|Overall Study|Lost to Follow-up|0|||
160924238|NCT02337907|581117010|FG002|Overall Study|Lost to Follow-up|0|||
160924239|NCT02337907|581117011|FG003|Overall Study|Lost to Follow-up|0|||
160924240|NCT02337907|581117012|FG004|Overall Study|Lost to Follow-up|0|||
160924241|NCT02337907|581117013|FG005|Overall Study|Lost to Follow-up|1|||
160924242|NCT02337907|581117008|FG000|Overall Study|Adverse Event|1|||
160924243|NCT02337907|581117009|FG001|Overall Study|Adverse Event|1|||
160924244|NCT02337907|581117010|FG002|Overall Study|Adverse Event|1|||
160924245|NCT02337907|581117011|FG003|Overall Study|Adverse Event|1|||
160924246|NCT02337907|581117012|FG004|Overall Study|Adverse Event|4|||
160924247|NCT02337907|581117013|FG005|Overall Study|Adverse Event|0|||
160924248|NCT00909779|581117014|FG000|Overall Study|Adverse Event|53|||
160924249|NCT00909779|581117015|FG001|Overall Study|Adverse Event|55|||
160924250|NCT00909779|581117014|FG000|Overall Study|Lack of Efficacy|7|||
160924251|NCT00909779|581117015|FG001|Overall Study|Lack of Efficacy|4|||
160924252|NCT00909779|581117014|FG000|Overall Study|Lost to Follow-up|19|||
160924253|NCT00909779|581117015|FG001|Overall Study|Lost to Follow-up|15|||
160924254|NCT00909779|581117014|FG000|Overall Study|Physician Decision|8|||
160924255|NCT00909779|581117015|FG001|Overall Study|Physician Decision|2|||
160924256|NCT00909779|581117014|FG000|Overall Study|Protocol Violation|2|||
160454810|NCT01928394|579396178|FG008|Treatment Period|Death|0|||
160924257|NCT00909779|581117015|FG001|Overall Study|Protocol Violation|5|||
160924258|NCT00909779|581117014|FG000|Overall Study|Withdrawal by Subject|116|||
160924259|NCT00909779|581117015|FG001|Overall Study|Withdrawal by Subject|80|||
160924260|NCT00909779|581117014|FG000|Overall Study|Site Ceasing Operation|2|||
160924261|NCT00909779|581117015|FG001|Overall Study|Site Ceasing Operation|2|||
160924262|NCT00909779|581117014|FG000|Overall Study|Medical Monitor Decision|1|||
160454811|NCT01928394|579396179|FG009|Treatment Period|Death|0|||
160924263|NCT00909779|581117015|FG001|Overall Study|Medical Monitor Decision|0|||
160576495|NCT02961764|579830781|FG000|Overall Study|Lost to Follow-up|35|||
160924264|NCT00909779|581117014|FG000|Overall Study|Noncompliance|1|||
160924265|NCT00909779|581117015|FG001|Overall Study|Noncompliance|1|||
160454812|NCT01928394|579396180|FG010|Treatment Period|Death|0|||
160924266|NCT00909779|581117014|FG000|Overall Study|Randomized in error|1|||
160576496|NCT02961764|579830782|FG001|Overall Study|Lost to Follow-up|24|||
160576497|NCT02961764|579830781|FG000|Overall Study|Withdrawal by Subject|2|||
160576498|NCT02961764|579830782|FG001|Overall Study|Withdrawal by Subject|0|||
160924267|NCT00909779|581117015|FG001|Overall Study|Randomized in error|1|||
160924268|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
160924269|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
160924270|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
160924271|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
160924272|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
160924273|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
160924274|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
160924275|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
160924276|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
160924277|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
160924278|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
160924279|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
160924280|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
160924281|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
160924282|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
160924283|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Other|0|||
160924284|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Other|2|||
160924285|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Other|1|||
160924286|NCT00561080|581117021|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
160924287|NCT00561080|581117022|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
160924288|NCT00561080|581117023|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
160924289|NCT00561080|581117021|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
160924290|NCT00561080|581117022|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
160924291|NCT00561080|581117023|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
160924292|NCT00561080|581117021|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
160924293|NCT00561080|581117022|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
160924294|NCT00561080|581117023|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
160924295|NCT00561080|581117021|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
160924296|NCT00561080|581117022|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
160924297|NCT00561080|581117023|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
160924298|NCT00423150|581117024|FG000|Overall Study|Adverse Event|11|||
160924299|NCT00423150|581117024|FG000|Overall Study|Progression of disease being studied|69|||
160924300|NCT00423150|581117024|FG000|Overall Study|Withdrawal by Subject|1|||
160924301|NCT00423150|581117024|FG000|Overall Study|Non-compliance with protocol|1|||
160924302|NCT00423150|581117024|FG000|Overall Study|Administrative|4|||
160924303|NCT01092182|581117025|FG000|Overall Study|Death|0|||
160924304|NCT01092182|581117026|FG001|Overall Study|Death|5|||
160924305|NCT01092182|581117027|FG002|Overall Study|Death|3|||
160924306|NCT01092182|581117025|FG000|Overall Study|participant safety|1|||
160924307|NCT01092182|581117026|FG001|Overall Study|participant safety|2|||
160924308|NCT01092182|581117027|FG002|Overall Study|participant safety|0|||
160924309|NCT01092182|581117025|FG000|Overall Study|Physician Decision|0|||
160924310|NCT01092182|581117026|FG001|Overall Study|Physician Decision|6|||
160924311|NCT01092182|581117027|FG002|Overall Study|Physician Decision|0|||
160924312|NCT01092182|581117025|FG000|Overall Study|Did not meet criteria|0|||
160924313|NCT01092182|581117026|FG001|Overall Study|Did not meet criteria|0|||
160924314|NCT01092182|581117027|FG002|Overall Study|Did not meet criteria|25|||
160924315|NCT01092182|581117025|FG000|Overall Study|Non-compliance|0|||
160924316|NCT01092182|581117026|FG001|Overall Study|Non-compliance|3|||
160924317|NCT01092182|581117027|FG002|Overall Study|Non-compliance|0|||
160924318|NCT01092182|581117025|FG000|Overall Study|Participant refused follow-up|0|||
160924319|NCT01092182|581117026|FG001|Overall Study|Participant refused follow-up|2|||
160924320|NCT01092182|581117027|FG002|Overall Study|Participant refused follow-up|0|||
160924321|NCT01641692|581117028|FG000|Treatment Period 1|Adverse Event|1|||
160576499|NCT01903434|579830790|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
160576500|NCT01903434|579830791|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
160576501|NCT01903434|579830790|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
160924322|NCT01641692|581117029|FG001|Treatment Period 1|Adverse Event|0|||
160924323|NCT01641692|581117030|FG002|Treatment Period 1|Adverse Event|0|||
160924324|NCT01641692|581117031|FG003|Treatment Period 1|Adverse Event|0|||
160924325|NCT01641692|581117032|FG004|Treatment Period 1|Adverse Event|0|||
160924326|NCT01641692|581117033|FG005|Treatment Period 1|Adverse Event|0|||
160924327|NCT01641692|581117034|FG006|Treatment Period 1|Adverse Event|0|||
160924328|NCT01641692|581117035|FG007|Treatment Period 1|Adverse Event|0|||
160924329|NCT01641692|581117028|FG000|Treatment Period 1|Lack of Efficacy|0|||
160924330|NCT01641692|581117029|FG001|Treatment Period 1|Lack of Efficacy|0|||
160924331|NCT01641692|581117030|FG002|Treatment Period 1|Lack of Efficacy|0|||
160924332|NCT01641692|581117031|FG003|Treatment Period 1|Lack of Efficacy|0|||
160924333|NCT01641692|581117032|FG004|Treatment Period 1|Lack of Efficacy|0|||
160924334|NCT01641692|581117033|FG005|Treatment Period 1|Lack of Efficacy|0|||
160924335|NCT01641692|581117034|FG006|Treatment Period 1|Lack of Efficacy|0|||
160924336|NCT01641692|581117035|FG007|Treatment Period 1|Lack of Efficacy|1|||
160924337|NCT01641692|581117028|FG000|Treatment Period 1|Protocol Violation|1|||
160924338|NCT01641692|581117029|FG001|Treatment Period 1|Protocol Violation|0|||
160924339|NCT01641692|581117030|FG002|Treatment Period 1|Protocol Violation|0|||
160924340|NCT01641692|581117031|FG003|Treatment Period 1|Protocol Violation|0|||
160924341|NCT01641692|581117032|FG004|Treatment Period 1|Protocol Violation|2|||
160924342|NCT01641692|581117033|FG005|Treatment Period 1|Protocol Violation|0|||
160924343|NCT01641692|581117034|FG006|Treatment Period 1|Protocol Violation|0|||
160924344|NCT01641692|581117035|FG007|Treatment Period 1|Protocol Violation|0|||
160924345|NCT01641692|581117028|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924346|NCT01641692|581117029|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924347|NCT01641692|581117030|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924348|NCT01641692|581117031|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924349|NCT01641692|581117032|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
160924350|NCT01641692|581117033|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924351|NCT01641692|581117034|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924352|NCT01641692|581117035|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
160924353|NCT01641692|581117028|FG000|Treatment Period 1|Lost to Follow-up|0|||
160924354|NCT01641692|581117029|FG001|Treatment Period 1|Lost to Follow-up|0|||
160924355|NCT01641692|581117030|FG002|Treatment Period 1|Lost to Follow-up|1|||
160924356|NCT01641692|581117031|FG003|Treatment Period 1|Lost to Follow-up|0|||
160924357|NCT01641692|581117032|FG004|Treatment Period 1|Lost to Follow-up|0|||
160924358|NCT01641692|581117033|FG005|Treatment Period 1|Lost to Follow-up|0|||
160924359|NCT01641692|581117034|FG006|Treatment Period 1|Lost to Follow-up|0|||
160924360|NCT01641692|581117035|FG007|Treatment Period 1|Lost to Follow-up|0|||
160924361|NCT01641692|581117028|FG000|Treatment Period 1|Physician Decision|0|||
160924362|NCT01641692|581117029|FG001|Treatment Period 1|Physician Decision|0|||
160924363|NCT01641692|581117030|FG002|Treatment Period 1|Physician Decision|0|||
160924364|NCT01641692|581117031|FG003|Treatment Period 1|Physician Decision|0|||
160997926|NCT01144182|581376686|FG000|Overall Study|Withdrawal by Subject|3|||
160997927|NCT01144182|581376687|FG001|Overall Study|Withdrawal by Subject|6|||
160454813|NCT01928394|579396181|FG011|Treatment Period|Death|0|||
160576502|NCT01903434|579830791|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
160576503|NCT02160977|579830792|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
160576504|NCT02160977|579830793|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
160576505|NCT02160977|579830792|FG000|Three Months After Surgery|Lost to Follow-up|0|||
160576506|NCT02160977|579830793|FG001|Three Months After Surgery|Lost to Follow-up|2|||
160576507|NCT02160977|579830792|FG000|Six Months After Surgery|Lost to Follow-up|2|||
160576508|NCT02160977|579830793|FG001|Six Months After Surgery|Lost to Follow-up|1|||
160576509|NCT01663740|579830794|FG000|Overall Study|Lost to Follow-up|1|||
160576510|NCT01663740|579830795|FG001|Overall Study|Lost to Follow-up|4|||
160576511|NCT01663740|579830794|FG000|Overall Study|Other|9|||
160576512|NCT01663740|579830795|FG001|Overall Study|Other|2|||
160576513|NCT01663740|579830794|FG000|Overall Study|Inclusion/Exclusion not met|1|||
160576514|NCT01663740|579830795|FG001|Overall Study|Inclusion/Exclusion not met|0|||
160576515|NCT01663740|579830794|FG000|Overall Study|Death|0|||
160576516|NCT01663740|579830795|FG001|Overall Study|Death|1|||
160576517|NCT01663740|579830794|FG000|Overall Study|Withdrawal by Subject|2|||
160576518|NCT01663740|579830795|FG001|Overall Study|Withdrawal by Subject|1|||
160576519|NCT01663740|579830794|FG000|Overall Study|No end of study status|3|||
160576520|NCT01663740|579830795|FG001|Overall Study|No end of study status|0|||
160576521|NCT02112448|579830796|FG000|Overall Study|lab values precluding use of ketorolac|2|||
160576522|NCT02112448|579830797|FG001|Overall Study|lab values precluding use of ketorolac|2|||
160576523|NCT02112448|579830796|FG000|Overall Study|Protocol Violation|1|||
160576524|NCT02112448|579830797|FG001|Overall Study|Protocol Violation|2|||
160576525|NCT02112448|579830796|FG000|Overall Study|Physician Decision|4|||
160576526|NCT02112448|579830797|FG001|Overall Study|Physician Decision|6|||
160576527|NCT02112448|579830796|FG000|Overall Study|required heparin so could not use ketoro|1|||
160576528|NCT02112448|579830797|FG001|Overall Study|required heparin so could not use ketoro|0|||
160576529|NCT05270694|579832276|FG000|Overall Study|Death|1|||
160576530|NCT05270694|579832276|FG000|Overall Study|Medical issues impacted ability to participate|2|||
160576531|NCT05270694|579832276|FG000|Overall Study|Lost to Follow-up|3|||
160576532|NCT05270694|579832276|FG000|Overall Study|Withdrawal by Subject|3|||
160576533|NCT04267562|579832279|FG000|Assessed for Eligibility|Screen Failure|64|||
160576534|NCT04267562|579832279|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
160576535|NCT04267562|579832279|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
160576536|NCT04267562|579832279|FG000|Assessed for Eligibility|Site closure|6|||
160576537|NCT04267562|579832279|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
160576538|NCT04267562|579832279|FG000|Assessed for Eligibility|Physician Decision|1|||
160576539|NCT04267562|579832279|FG000|Month 24|Elective hysterectomy|1|||
160576540|NCT04267562|579832279|FG000|Month 24|Lost to Follow-up|1|||
160576541|NCT04267562|579832279|FG000|Month 36|Elective hysterectomy|2|||
160924365|NCT01641692|581117032|FG004|Treatment Period 1|Physician Decision|1|||
160924366|NCT01641692|581117033|FG005|Treatment Period 1|Physician Decision|0|||
160924367|NCT01641692|581117034|FG006|Treatment Period 1|Physician Decision|0|||
160924368|NCT01641692|581117035|FG007|Treatment Period 1|Physician Decision|0|||
160924369|NCT01641692|581117028|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160924370|NCT01641692|581117029|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160924371|NCT01641692|581117030|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160924372|NCT01641692|581117031|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160924373|NCT01641692|581117032|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160924374|NCT01641692|581117033|FG005|Treatment Period 1|Withdrawal by Subject|2|||
160924375|NCT01641692|581117034|FG006|Treatment Period 1|Withdrawal by Subject|0|||
160924376|NCT01641692|581117035|FG007|Treatment Period 1|Withdrawal by Subject|1|||
160924377|NCT01641692|581117028|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
160924378|NCT01641692|581117029|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924379|NCT01641692|581117030|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924380|NCT01641692|581117031|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924381|NCT01641692|581117032|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924382|NCT01641692|581117033|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924383|NCT01641692|581117034|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924384|NCT01641692|581117035|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924385|NCT01641692|581117028|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924386|NCT01641692|581117029|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924387|NCT01641692|581117030|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924388|NCT01641692|581117031|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924389|NCT01641692|581117032|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924390|NCT01641692|581117033|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924391|NCT01641692|581117034|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
160924392|NCT01641692|581117035|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924393|NCT01641692|581117028|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
160924394|NCT01641692|581117029|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924395|NCT01641692|581117030|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
160924396|NCT01641692|581117031|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
160924397|NCT01641692|581117032|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
160924398|NCT01641692|581117033|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924399|NCT01641692|581117034|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924400|NCT01641692|581117035|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
160924401|NCT01641692|581117028|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160924402|NCT01641692|581117029|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160924403|NCT01641692|581117030|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160924404|NCT01641692|581117031|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160924405|NCT01641692|581117032|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160924406|NCT01641692|581117033|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160924407|NCT01641692|581117034|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160924408|NCT01641692|581117035|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160924409|NCT01641692|581117028|FG000|Treatment Period 2|Lack of Efficacy|1|||
160924410|NCT01641692|581117029|FG001|Treatment Period 2|Lack of Efficacy|0|||
160924411|NCT01641692|581117030|FG002|Treatment Period 2|Lack of Efficacy|0|||
160924412|NCT01641692|581117031|FG003|Treatment Period 2|Lack of Efficacy|0|||
160924413|NCT01641692|581117032|FG004|Treatment Period 2|Lack of Efficacy|0|||
160924414|NCT01641692|581117033|FG005|Treatment Period 2|Lack of Efficacy|0|||
160924415|NCT01641692|581117034|FG006|Treatment Period 2|Lack of Efficacy|0|||
160924416|NCT01641692|581117035|FG007|Treatment Period 2|Lack of Efficacy|0|||
160924417|NCT01641692|581117028|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
160924418|NCT01641692|581117029|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924419|NCT01641692|581117030|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924420|NCT01641692|581117031|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924421|NCT01641692|581117032|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924422|NCT01641692|581117033|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160576542|NCT04267562|579832279|FG000|Month 36|Lost to Follow-up|3|||
160576543|NCT00128206|579832286|FG000|Overall Study|Lost to Follow-up|137|||
160576544|NCT00128206|579832287|FG001|Overall Study|Lost to Follow-up|118|||
160576545|NCT00128206|579832286|FG000|Overall Study|Adverse Event|0|||
160576546|NCT00128206|579832287|FG001|Overall Study|Adverse Event|2|||
160576547|NCT03032068|579832296|FG000|Overall Study|Adverse Event|1|||
160576548|NCT01597622|579832297|FG000|Overall Study|Adverse Event|7|||
160576549|NCT01597622|579832297|FG000|Overall Study|Lack of Efficacy|3|||
160654867|NCT01592370|580117194|FG004|Overall Study|AE unrelated to study drug|0|||
160924423|NCT01641692|581117034|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924424|NCT01641692|581117035|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160576550|NCT01597622|579832297|FG000|Overall Study|Protocol Violation|1|||
160924425|NCT01641692|581117028|FG000|Treatment Period 2|Lost to Follow-up|0|||
160924426|NCT01641692|581117029|FG001|Treatment Period 2|Lost to Follow-up|0|||
160924427|NCT01641692|581117030|FG002|Treatment Period 2|Lost to Follow-up|0|||
160924428|NCT01641692|581117031|FG003|Treatment Period 2|Lost to Follow-up|0|||
160924429|NCT01641692|581117032|FG004|Treatment Period 2|Lost to Follow-up|0|||
160924430|NCT01641692|581117033|FG005|Treatment Period 2|Lost to Follow-up|1|||
160924431|NCT01641692|581117034|FG006|Treatment Period 2|Lost to Follow-up|0|||
160924432|NCT01641692|581117035|FG007|Treatment Period 2|Lost to Follow-up|0|||
160924433|NCT01641692|581117028|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160924434|NCT01641692|581117029|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160924435|NCT01641692|581117030|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160924436|NCT01641692|581117031|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160924437|NCT01641692|581117032|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160924438|NCT01641692|581117033|FG005|Treatment Period 2|Withdrawal by Subject|1|||
160924439|NCT01641692|581117034|FG006|Treatment Period 2|Withdrawal by Subject|0|||
160924440|NCT01641692|581117035|FG007|Treatment Period 2|Withdrawal by Subject|1|||
160924441|NCT01641692|581117028|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924442|NCT01641692|581117029|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924443|NCT01641692|581117030|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924444|NCT01641692|581117031|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924445|NCT01641692|581117032|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
160924446|NCT01641692|581117033|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924447|NCT01641692|581117034|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
160924448|NCT01641692|581117035|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924449|NCT01641692|581117028|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160924450|NCT01641692|581117029|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160924451|NCT01641692|581117030|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
160924452|NCT01641692|581117031|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160924453|NCT01641692|581117032|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160924454|NCT01641692|581117033|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
160924455|NCT01641692|581117034|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160924456|NCT01641692|581117035|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
160924457|NCT01641692|581117028|FG000|Treatment Period 3|Adverse Event|0|||
160924458|NCT01641692|581117029|FG001|Treatment Period 3|Adverse Event|0|||
160924459|NCT01641692|581117030|FG002|Treatment Period 3|Adverse Event|0|||
160576551|NCT01597622|579832297|FG000|Overall Study|Lost to Follow-up|1|||
160576552|NCT01597622|579832297|FG000|Overall Study|Investigator Discretion|5|||
160576553|NCT01597622|579832297|FG000|Overall Study|Withdrawal by Subject|20|||
160576554|NCT01597622|579832297|FG000|Overall Study|Death|1|||
160576555|NCT00408421|579832298|FG000|Treatment Initial Randomization|Adverse Event|5|||
160576556|NCT00408421|579832299|FG001|Treatment Initial Randomization|Adverse Event|9|||
160576557|NCT00408421|579832300|FG002|Treatment Initial Randomization|Adverse Event|0|||
160576558|NCT00408421|579832298|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
160576559|NCT00408421|579832299|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
160576560|NCT00408421|579832300|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
160576561|NCT00408421|579832298|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
160576562|NCT00408421|579832299|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
160576563|NCT00408421|579832300|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
160576564|NCT00408421|579832298|FG000|Treatment Initial Randomization|Physician Decision|1|||
160576565|NCT00408421|579832299|FG001|Treatment Initial Randomization|Physician Decision|0|||
160576566|NCT00408421|579832300|FG002|Treatment Initial Randomization|Physician Decision|0|||
160576567|NCT00408421|579832298|FG000|Treatment Initial Randomization|Protocol Violation|0|||
160576568|NCT00408421|579832299|FG001|Treatment Initial Randomization|Protocol Violation|1|||
160576569|NCT00408421|579832300|FG002|Treatment Initial Randomization|Protocol Violation|0|||
160576570|NCT00408421|579832298|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
160576571|NCT00408421|579832299|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
160576572|NCT00408421|579832300|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
160576573|NCT00408421|579832298|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
160576574|NCT00408421|579832299|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
160576575|NCT00408421|579832300|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
160576576|NCT00408421|579832298|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
160576577|NCT00408421|579832299|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
160576578|NCT00408421|579832300|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
160576579|NCT00408421|579832298|FG000|Treatment Re-Randomization|Adverse Event|2|||
160924460|NCT01641692|581117031|FG003|Treatment Period 3|Adverse Event|0|||
160576580|NCT00408421|579832299|FG001|Treatment Re-Randomization|Adverse Event|2|||
160924461|NCT01641692|581117032|FG004|Treatment Period 3|Adverse Event|0|||
160924462|NCT01641692|581117033|FG005|Treatment Period 3|Adverse Event|0|||
160924463|NCT01641692|581117034|FG006|Treatment Period 3|Adverse Event|1|||
160924464|NCT01641692|581117035|FG007|Treatment Period 3|Adverse Event|0|||
160924465|NCT01641692|581117028|FG000|Treatment Period 3|Protocol Violation|0|||
160924466|NCT01641692|581117029|FG001|Treatment Period 3|Protocol Violation|0|||
160924467|NCT01641692|581117030|FG002|Treatment Period 3|Protocol Violation|1|||
160924468|NCT01641692|581117031|FG003|Treatment Period 3|Protocol Violation|0|||
160924469|NCT01641692|581117032|FG004|Treatment Period 3|Protocol Violation|0|||
160924470|NCT01641692|581117033|FG005|Treatment Period 3|Protocol Violation|0|||
160924471|NCT01641692|581117034|FG006|Treatment Period 3|Protocol Violation|0|||
160924472|NCT01641692|581117035|FG007|Treatment Period 3|Protocol Violation|0|||
160924473|NCT01641692|581117028|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924474|NCT01641692|581117029|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924475|NCT01641692|581117030|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924476|NCT01641692|581117031|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924477|NCT01641692|581117032|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924478|NCT01641692|581117033|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924479|NCT01641692|581117034|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
160924480|NCT01641692|581117035|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924481|NCT01641692|581117028|FG000|Treatment Period 3|Lost to Follow-up|0|||
160924482|NCT01641692|581117029|FG001|Treatment Period 3|Lost to Follow-up|1|||
160924483|NCT01641692|581117030|FG002|Treatment Period 3|Lost to Follow-up|0|||
160924484|NCT01641692|581117031|FG003|Treatment Period 3|Lost to Follow-up|0|||
160924485|NCT01641692|581117032|FG004|Treatment Period 3|Lost to Follow-up|0|||
160924486|NCT01641692|581117033|FG005|Treatment Period 3|Lost to Follow-up|0|||
160924487|NCT01641692|581117034|FG006|Treatment Period 3|Lost to Follow-up|0|||
160924488|NCT01641692|581117035|FG007|Treatment Period 3|Lost to Follow-up|0|||
160924489|NCT01641692|581117028|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924490|NCT01641692|581117029|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924491|NCT01641692|581117030|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924492|NCT01641692|581117031|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924493|NCT01641692|581117032|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924494|NCT01641692|581117033|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
160924495|NCT01641692|581117034|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924496|NCT01641692|581117035|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924497|NCT01641692|581117028|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
160924498|NCT01641692|581117029|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
160924499|NCT01641692|581117030|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
160924500|NCT01641692|581117031|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
160924501|NCT01641692|581117032|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
160924502|NCT01641692|581117033|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
160924503|NCT01641692|581117034|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
160924504|NCT01641692|581117035|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
160924505|NCT02295995|581117037|FG000|Overall Study|Lost to Follow-up|5|||
160924506|NCT02295995|581117038|FG001|Overall Study|Lost to Follow-up|1|||
160924507|NCT03649711|581117039|FG000|Overall Study|Adverse Event|0|||
160924508|NCT03649711|581117040|FG001|Overall Study|Adverse Event|1|||
160924509|NCT03649711|581117041|FG002|Overall Study|Adverse Event|0|||
160924510|NCT03649711|581117039|FG000|Overall Study|Kidney Transplant|1|||
160576581|NCT00408421|579832300|FG002|Treatment Re-Randomization|Adverse Event|4|||
160576582|NCT00408421|579832298|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
160576583|NCT00408421|579832299|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
160576584|NCT00408421|579832300|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
160576585|NCT00408421|579832298|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
160576586|NCT00408421|579832299|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
160576587|NCT00408421|579832300|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
160576588|NCT00408421|579832298|FG000|Treatment Re-Randomization|Physician Decision|1|||
160576589|NCT00408421|579832299|FG001|Treatment Re-Randomization|Physician Decision|3|||
160576590|NCT00408421|579832300|FG002|Treatment Re-Randomization|Physician Decision|0|||
160576591|NCT00408421|579832298|FG000|Treatment Re-Randomization|Protocol Violation|1|||
160576592|NCT00408421|579832299|FG001|Treatment Re-Randomization|Protocol Violation|1|||
160576593|NCT00408421|579832300|FG002|Treatment Re-Randomization|Protocol Violation|0|||
160576594|NCT00408421|579832298|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
160576595|NCT00408421|579832299|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
160576596|NCT00408421|579832300|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
160576597|NCT03009539|579832303|FG000|Overall Study|Lost to Follow-up|132|||
160576598|NCT03009539|579832304|FG001|Overall Study|Lost to Follow-up|113|||
160576599|NCT03009539|579832305|FG002|Overall Study|Lost to Follow-up|132|||
160576600|NCT03009539|579832306|FG003|Overall Study|Lost to Follow-up|113|||
160576601|NCT04543955|579832307|FG000|Overall Study|Company cancelled study|1|||
160576602|NCT04543955|579832308|FG001|Overall Study|Company cancelled study|0|||
160576603|NCT03918642|579832309|FG000|Overall Study|Lost to Follow-up|12|||
160924511|NCT03649711|581117040|FG001|Overall Study|Kidney Transplant|0|||
160654868|NCT01592370|580117195|FG005|Overall Study|AE unrelated to study drug|0|||
160924512|NCT03649711|581117041|FG002|Overall Study|Kidney Transplant|0|||
160924513|NCT04007094|581117046|FG000|Overall Study|Lost to Follow-up|1|||
160924514|NCT04007094|581117047|FG001|Overall Study|Lost to Follow-up|1|||
160924515|NCT02921776|581117052|FG000|Overall Study|patient deterioration, fatigue|2|||
160924516|NCT02921776|581117053|FG001|Overall Study|patient deterioration, fatigue|6|||
160924517|NCT02921776|581117054|FG002|Overall Study|patient deterioration, fatigue|0|||
160924518|NCT02921776|581117055|FG003|Overall Study|patient deterioration, fatigue|0|||
160924519|NCT02921776|581117056|FG004|Overall Study|patient deterioration, fatigue|0|||
160924520|NCT02921776|581117057|FG005|Overall Study|patient deterioration, fatigue|0|||
160924521|NCT02921776|581117058|FG006|Overall Study|patient deterioration, fatigue|0|||
160924522|NCT02921776|581117059|FG007|Overall Study|patient deterioration, fatigue|0|||
160924523|NCT02921776|581117052|FG000|Overall Study|Withdrawal by Subject|0|||
160924524|NCT02921776|581117053|FG001|Overall Study|Withdrawal by Subject|2|||
160924525|NCT02921776|581117054|FG002|Overall Study|Withdrawal by Subject|0|||
160924526|NCT02921776|581117055|FG003|Overall Study|Withdrawal by Subject|1|||
160924527|NCT02921776|581117056|FG004|Overall Study|Withdrawal by Subject|1|||
160924528|NCT02921776|581117057|FG005|Overall Study|Withdrawal by Subject|0|||
160924529|NCT02921776|581117058|FG006|Overall Study|Withdrawal by Subject|8|||
160924530|NCT02921776|581117059|FG007|Overall Study|Withdrawal by Subject|1|||
160924531|NCT02921776|581117052|FG000|Overall Study|Death|0|||
160924532|NCT02921776|581117053|FG001|Overall Study|Death|0|||
160924533|NCT02921776|581117054|FG002|Overall Study|Death|0|||
160924534|NCT02921776|581117055|FG003|Overall Study|Death|2|||
160924535|NCT02921776|581117056|FG004|Overall Study|Death|0|||
160924536|NCT02921776|581117057|FG005|Overall Study|Death|0|||
160924537|NCT02921776|581117058|FG006|Overall Study|Death|0|||
160924538|NCT02921776|581117059|FG007|Overall Study|Death|0|||
160924539|NCT02921776|581117052|FG000|Overall Study|extubation or early discharge|0|||
160924540|NCT02921776|581117053|FG001|Overall Study|extubation or early discharge|0|||
160924541|NCT02921776|581117054|FG002|Overall Study|extubation or early discharge|0|||
160924542|NCT02921776|581117055|FG003|Overall Study|extubation or early discharge|5|||
160924543|NCT02921776|581117056|FG004|Overall Study|extubation or early discharge|5|||
160924544|NCT02921776|581117057|FG005|Overall Study|extubation or early discharge|0|||
160924545|NCT02921776|581117058|FG006|Overall Study|extubation or early discharge|0|||
160924546|NCT02921776|581117059|FG007|Overall Study|extubation or early discharge|0|||
160924547|NCT02921776|581117052|FG000|Overall Study|Lost to Follow-up|0|||
160924548|NCT02921776|581117053|FG001|Overall Study|Lost to Follow-up|0|||
160924549|NCT02921776|581117054|FG002|Overall Study|Lost to Follow-up|0|||
160924550|NCT02921776|581117055|FG003|Overall Study|Lost to Follow-up|0|||
160924551|NCT02921776|581117056|FG004|Overall Study|Lost to Follow-up|0|||
160924552|NCT02921776|581117057|FG005|Overall Study|Lost to Follow-up|2|||
160924553|NCT02921776|581117058|FG006|Overall Study|Lost to Follow-up|3|||
160924554|NCT02921776|581117059|FG007|Overall Study|Lost to Follow-up|6|||
160924555|NCT04350788|581117068|FG000|Overall Study|Lost to Follow-up|6|||
160924556|NCT04350788|581117069|FG001|Overall Study|Lost to Follow-up|2|||
160924557|NCT04350788|581117068|FG000|Overall Study|Withdrawal by Subject|2|||
160924558|NCT04350788|581117069|FG001|Overall Study|Withdrawal by Subject|4|||
160924559|NCT04350788|581117068|FG000|Overall Study|Protocol Violation|4|||
160924560|NCT04350788|581117069|FG001|Overall Study|Protocol Violation|0|||
160924561|NCT01581307|581117070|FG000|Overall Study|Withdrawal by Subject|1|||
160924562|NCT00378209|581117071|FG000|Overall Study|Progressive disease|11|||
160924563|NCT00378209|581117071|FG000|Overall Study|Adverse Event|3|||
160924564|NCT00378209|581117071|FG000|Overall Study|Initiation of non-protocol therapy|3|||
160924565|NCT00378209|581117071|FG000|Overall Study|Physician Decision|3|||
160924566|NCT00378209|581117071|FG000|Overall Study|Death|1|||
160924567|NCT00378209|581117071|FG000|Overall Study|Treatment delay|1|||
160924568|NCT02070744|581117072|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
160924569|NCT02070744|581117073|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
160924570|NCT02070744|581117074|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
160924571|NCT02070744|581117075|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
160924572|NCT02070744|581117076|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
160924573|NCT02070744|581117072|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
160924574|NCT02070744|581117073|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
160924575|NCT02070744|581117074|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
160997928|NCT01144182|581376686|FG000|Overall Study|Lost to Follow-up|9|||
160576604|NCT03918642|579832310|FG001|Overall Study|Lost to Follow-up|10|||
160576605|NCT03268746|579832313|FG000|Overall Study|Withdrawal by Subject|1|||
160576606|NCT02385123|579832319|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
160576607|NCT04498910|579832320|FG000|Overall Study|Lost to Follow-up|0|||
160576608|NCT04498910|579832321|FG001|Overall Study|Lost to Follow-up|1|||
160576609|NCT04498910|579832320|FG000|Overall Study|Withdrawal by Subject|2|||
160576610|NCT04498910|579832321|FG001|Overall Study|Withdrawal by Subject|1|||
160576611|NCT04498910|579832320|FG000|Overall Study|Adverse Event|1|||
160576612|NCT04498910|579832321|FG001|Overall Study|Adverse Event|0|||
160576613|NCT02145156|579832325|FG000|Overall Study|No match to vaccination records|60|||
160997929|NCT01144182|581376687|FG001|Overall Study|Lost to Follow-up|9|||
160924576|NCT02070744|581117075|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
160924577|NCT02070744|581117076|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
160924578|NCT02070744|581117072|FG000|OLE Phase (48 Weeks)|Other|0|||
160924579|NCT02070744|581117073|FG001|OLE Phase (48 Weeks)|Other|0|||
160924580|NCT02070744|581117074|FG002|OLE Phase (48 Weeks)|Other|0|||
160924581|NCT02070744|581117075|FG003|OLE Phase (48 Weeks)|Other|0|||
160924582|NCT02070744|581117076|FG004|OLE Phase (48 Weeks)|Other|1|||
160924583|NCT07114198|581117080|FG000|Overall Study|Protocol Violation|1|||
160924584|NCT07114198|581117081|FG001|Overall Study|Protocol Violation|1|||
160924585|NCT04439253|581118998|FG000|Overall Study|Adverse Event|1|||
160924586|NCT04439253|581118998|FG000|Overall Study|Disease progression|2|||
160924587|NCT04439253|581118998|FG000|Overall Study|Complicating disease|1|||
160924588|NCT00858442|581118999|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
160924589|NCT00858442|581119000|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
160924590|NCT02155738|581119003|FG000|Overall Study|Missing critical information|1|||
160924591|NCT02155738|581119004|FG001|Overall Study|Missing critical information|0|||
160924592|NCT02155738|581119005|FG002|Overall Study|Missing critical information|0|||
160924593|NCT02155738|581119006|FG003|Overall Study|Missing critical information|1|||
160924594|NCT02016625|581119007|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
160924595|NCT02016625|581119008|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
160924596|NCT02016625|581119007|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
160924597|NCT02016625|581119008|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
160924598|NCT02016625|581119007|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
160924599|NCT02016625|581119008|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
160924600|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
160924601|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
160924602|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
160924603|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
160924604|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
160924605|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
160924606|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
160924607|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
160924608|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
160924609|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
160924610|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
160924611|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
160924612|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
160924613|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
160924614|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
160924615|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
160924616|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
160924617|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
160924618|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
160924619|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
160924620|NCT00887354|581119011|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
160924621|NCT00887354|581119012|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
160924622|NCT00887354|581119011|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
160924623|NCT00887354|581119012|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
160924624|NCT00887354|581119011|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
160924625|NCT00887354|581119012|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
160924626|NCT00887354|581119011|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
160924627|NCT00887354|581119012|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
160924628|NCT00887354|581119011|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
160924629|NCT00887354|581119012|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
160924630|NCT01466348|581119013|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
160924631|NCT01466348|581119014|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
160924632|NCT02189473|581119019|FG000|Overall Study|Death|22|||
160924633|NCT02189473|581119020|FG001|Overall Study|Death|23|||
160924634|NCT02189473|581119019|FG000|Overall Study|Lost to Follow-up|1|||
160924635|NCT02189473|581119020|FG001|Overall Study|Lost to Follow-up|2|||
160924636|NCT02784821|581119021|FG000|Overall Study|Death|0|||
160924637|NCT02784821|581119022|FG001|Overall Study|Death|5|||
160924638|NCT02784821|581119023|FG002|Overall Study|Death|4|||
160924639|NCT02784821|581119024|FG003|Overall Study|Death|5|||
160924640|NCT01139450|581119025|FG000|Overall Study|Withdrawal by Subject|7|||
160924641|NCT01139450|581119026|FG001|Overall Study|Withdrawal by Subject|10|||
160924642|NCT01139450|581119027|FG002|Overall Study|Withdrawal by Subject|13|||
160924643|NCT01139450|581119025|FG000|Overall Study|Lack of Efficacy|3|||
160924644|NCT01139450|581119026|FG001|Overall Study|Lack of Efficacy|1|||
160924645|NCT01139450|581119027|FG002|Overall Study|Lack of Efficacy|8|||
160924646|NCT01139450|581119025|FG000|Overall Study|Protocol Violation|6|||
160924647|NCT01139450|581119026|FG001|Overall Study|Protocol Violation|5|||
160924648|NCT01139450|581119027|FG002|Overall Study|Protocol Violation|2|||
160924649|NCT01139450|581119025|FG000|Overall Study|Lost to Follow-up|9|||
160924650|NCT01139450|581119026|FG001|Overall Study|Lost to Follow-up|7|||
160924651|NCT01139450|581119027|FG002|Overall Study|Lost to Follow-up|11|||
160924652|NCT01139450|581119025|FG000|Overall Study|Administrative|0|||
160924653|NCT01139450|581119026|FG001|Overall Study|Administrative|0|||
160924654|NCT01139450|581119027|FG002|Overall Study|Administrative|1|||
160924655|NCT01139450|581119025|FG000|Overall Study|Adverse Event|2|||
160924656|NCT01139450|581119026|FG001|Overall Study|Adverse Event|2|||
160924657|NCT01139450|581119027|FG002|Overall Study|Adverse Event|3|||
160924658|NCT02794103|581119028|FG000|Overall Study|Loss to follow up due to high sedation|3|||
160924659|NCT02535741|581119033|FG000|Overall Study|Adverse Event|3|||
160924660|NCT02535741|581119033|FG000|Overall Study|Withdrawal by Subject|9|||
160924661|NCT02535741|581119033|FG000|Overall Study|Lost to Follow-up|10|||
160924662|NCT02535741|581119033|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
160924663|NCT02535741|581119033|FG000|Overall Study|Missing data|6|||
160924664|NCT01652664|581119039|FG000|Overall Study|Treatment Failure|5|||
160924665|NCT01652664|581119040|FG001|Overall Study|Treatment Failure|1|||
160924666|NCT01652664|581119039|FG000|Overall Study|Inadequate IOP control|1|||
160576614|NCT02145156|579832326|FG001|Overall Study|No match to vaccination records|52|||
160924667|NCT01652664|581119040|FG001|Overall Study|Inadequate IOP control|0|||
160924668|NCT00297037|581119041|FG000|Overall Study|Withdrawal by Subject|2|||
160924669|NCT00297037|581119042|FG001|Overall Study|Withdrawal by Subject|0|||
160924670|NCT00491387|581119047|FG000|Overall Study|study terminated|20|||
160924671|NCT00949325|581119054|FG000|Overall Study|Adverse Event|0|||
160924672|NCT00949325|581119055|FG001|Overall Study|Adverse Event|2|||
160924673|NCT00949325|581119056|FG002|Overall Study|Adverse Event|0|||
160924674|NCT02809677|581119057|FG000|Overall Study|Withdrawal by Subject|8|||
160924675|NCT05172544|581119062|FG000|Overall Study|Withdrawal by Subject|1|||
160924676|NCT05172544|581119063|FG001|Overall Study|Withdrawal by Subject|0|||
160924677|NCT05172544|581119064|FG002|Overall Study|Withdrawal by Subject|0|||
160924678|NCT05172544|581119062|FG000|Overall Study|Physician Decision|0|||
160924679|NCT05172544|581119063|FG001|Overall Study|Physician Decision|0|||
160924680|NCT05172544|581119064|FG002|Overall Study|Physician Decision|1|||
160924681|NCT03311659|581119069|FG000|Overall Study|Protocol Violation|1|||
160924682|NCT04327388|581119072|FG000|Overall Study|Adverse Event|17|||
160924683|NCT04327388|581119073|FG001|Overall Study|Adverse Event|18|||
160924684|NCT04327388|581119074|FG002|Overall Study|Adverse Event|9|||
160924685|NCT04327388|581119072|FG000|Overall Study|Other|1|||
160924686|NCT04327388|581119073|FG001|Overall Study|Other|2|||
160924687|NCT04327388|581119074|FG002|Overall Study|Other|0|||
160924688|NCT04327388|581119072|FG000|Overall Study|Randomized and not treated|2|||
160924689|NCT04327388|581119073|FG001|Overall Study|Randomized and not treated|0|||
160924690|NCT04327388|581119074|FG002|Overall Study|Randomized and not treated|2|||
160924691|NCT04829318|581119075|FG000|Overall Study|Adverse Event|6|||
160924692|NCT04829318|581119075|FG000|Overall Study|Death|1|||
160924693|NCT04829318|581119075|FG000|Overall Study|Lost to Follow-up|1|||
160576615|NCT02145156|579832327|FG002|Overall Study|No match to vaccination records|41|||
160576616|NCT02064439|579832328|FG000|Overall Study|Adverse Event|51|||
160576617|NCT02064439|579832329|FG001|Overall Study|Adverse Event|47|||
160576618|NCT02064439|579832330|FG002|Overall Study|Adverse Event|46|||
160576619|NCT02064439|579832328|FG000|Overall Study|Death|0|||
160576620|NCT02064439|579832329|FG001|Overall Study|Death|2|||
160576621|NCT02064439|579832330|FG002|Overall Study|Death|3|||
160576622|NCT02064439|579832328|FG000|Overall Study|Withdrawal by Subject|29|||
160576623|NCT02064439|579832329|FG001|Overall Study|Withdrawal by Subject|18|||
160576624|NCT02064439|579832330|FG002|Overall Study|Withdrawal by Subject|26|||
160576625|NCT02064439|579832328|FG000|Overall Study|Protocol Violation|3|||
160576626|NCT02064439|579832329|FG001|Overall Study|Protocol Violation|5|||
160576627|NCT02064439|579832330|FG002|Overall Study|Protocol Violation|3|||
160576628|NCT02064439|579832328|FG000|Overall Study|Lost to Follow-up|1|||
160576629|NCT02064439|579832329|FG001|Overall Study|Lost to Follow-up|3|||
160576630|NCT02064439|579832330|FG002|Overall Study|Lost to Follow-up|4|||
160576631|NCT02064439|579832328|FG000|Overall Study|Non-compliance with study medication|21|||
160576632|NCT02064439|579832329|FG001|Overall Study|Non-compliance with study medication|19|||
160576633|NCT02064439|579832330|FG002|Overall Study|Non-compliance with study medication|23|||
160576634|NCT02064439|579832328|FG000|Overall Study|Physician Decision|0|||
160576635|NCT02064439|579832329|FG001|Overall Study|Physician Decision|1|||
160576636|NCT02064439|579832330|FG002|Overall Study|Physician Decision|1|||
160576637|NCT02064439|579832328|FG000|Overall Study|Logistical difficulties|6|||
160576638|NCT02064439|579832329|FG001|Overall Study|Logistical difficulties|5|||
160576639|NCT02064439|579832330|FG002|Overall Study|Logistical difficulties|2|||
160576640|NCT02064439|579832328|FG000|Overall Study|Efficacy outcome reached|18|||
160576641|NCT02064439|579832329|FG001|Overall Study|Efficacy outcome reached|16|||
160576642|NCT02064439|579832330|FG002|Overall Study|Efficacy outcome reached|57|||
160924694|NCT04829318|581119075|FG000|Overall Study|Physician Decision|1|||
160924695|NCT04829318|581119075|FG000|Overall Study|Withdrawal by Subject|19|||
160924696|NCT04829318|581119075|FG000|Overall Study|Site terminated by sponsor|1|||
160924697|NCT04829318|581119075|FG000|Overall Study|Sponsor decision|5|||
160924698|NCT04829318|581119075|FG000|Overall Study|Other|1|||
160924699|NCT00728130|581119076|FG000|Overall Study|Withdrawal by Subject|1|||
160924700|NCT00728130|581119076|FG000|Overall Study|Paperwork not completed in time|1|||
160924701|NCT00728130|581119076|FG000|Overall Study|Physician Decision|1|||
160924702|NCT04053023|581119079|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
160924703|NCT04053023|581119080|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
160924704|NCT03447990|581119081|FG000|Overall Study|Withdrawal by Subject|0|||
160576643|NCT02064439|579832328|FG000|Overall Study|Safety outcome reached|12|||
160576644|NCT02064439|579832329|FG001|Overall Study|Safety outcome reached|20|||
160576645|NCT02064439|579832330|FG002|Overall Study|Safety outcome reached|10|||
160576646|NCT02064439|579832328|FG000|Overall Study|Other|2|||
160924705|NCT03447990|581119082|FG001|Overall Study|Withdrawal by Subject|0|||
160924706|NCT03447990|581119083|FG002|Overall Study|Withdrawal by Subject|0|||
160924707|NCT03447990|581119084|FG003|Overall Study|Withdrawal by Subject|0|||
160924708|NCT03447990|581119085|FG004|Overall Study|Withdrawal by Subject|0|||
160924709|NCT03447990|581119086|FG005|Overall Study|Withdrawal by Subject|0|||
160576647|NCT02064439|579832329|FG001|Overall Study|Other|2|||
160576648|NCT02064439|579832330|FG002|Overall Study|Other|7|||
160576649|NCT02433288|579832331|FG000|Overall Study|Severe non-compliance to protocol|13|||
160576650|NCT02433288|579832332|FG001|Overall Study|Severe non-compliance to protocol|7|||
160576651|NCT02433288|579832331|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
160576652|NCT02433288|579832332|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
160576653|NCT02433288|579832331|FG000|Overall Study|Withdrawal by Subject|101|||
160576654|NCT02433288|579832332|FG001|Overall Study|Withdrawal by Subject|99|||
160576655|NCT02433288|579832331|FG000|Overall Study|Lost to Follow-up|2|||
160576656|NCT02433288|579832332|FG001|Overall Study|Lost to Follow-up|14|||
160576657|NCT02433288|579832331|FG000|Overall Study|Death|0|||
160576658|NCT02433288|579832332|FG001|Overall Study|Death|3|||
160576659|NCT00858702|579832335|FG000|Overall Study|Lack of Efficacy|1|||
160576660|NCT00858702|579832336|FG001|Overall Study|Lack of Efficacy|0|||
160576661|NCT00858702|579832335|FG000|Overall Study|Protocol Violation|1|||
160576662|NCT00858702|579832336|FG001|Overall Study|Protocol Violation|1|||
160576663|NCT00858702|579832335|FG000|Overall Study|Other|2|||
160576664|NCT00858702|579832336|FG001|Overall Study|Other|1|||
160576665|NCT00858702|579832335|FG000|Overall Study|Withdrawal by Subject|1|||
160576666|NCT00858702|579832336|FG001|Overall Study|Withdrawal by Subject|0|||
160576667|NCT00367640|579832337|FG000|Overall Study|Adverse Event|3|||
160576668|NCT00367640|579832338|FG001|Overall Study|Adverse Event|6|||
160576669|NCT00367640|579832339|FG002|Overall Study|Adverse Event|8|||
160576670|NCT00367640|579832340|FG003|Overall Study|Adverse Event|0|||
160576671|NCT00367640|579832337|FG000|Overall Study|Withdrawal by Subject|8|||
160576672|NCT00367640|579832338|FG001|Overall Study|Withdrawal by Subject|11|||
160576673|NCT00367640|579832339|FG002|Overall Study|Withdrawal by Subject|8|||
160576674|NCT00367640|579832340|FG003|Overall Study|Withdrawal by Subject|6|||
160576675|NCT00367640|579832337|FG000|Overall Study|Any other reason not above-mentioned|7|||
160576676|NCT00367640|579832338|FG001|Overall Study|Any other reason not above-mentioned|5|||
160576677|NCT00367640|579832339|FG002|Overall Study|Any other reason not above-mentioned|3|||
160576678|NCT00367640|579832340|FG003|Overall Study|Any other reason not above-mentioned|4|||
160576679|NCT02417233|579832341|FG000|Overall Study|Death|4|||
160576680|NCT02417233|579832342|FG001|Overall Study|Death|10|||
160576681|NCT02417233|579832343|FG002|Overall Study|Death|14|||
160576682|NCT02417233|579832341|FG000|Overall Study|Lost to Follow-up|27|||
160576683|NCT02417233|579832342|FG001|Overall Study|Lost to Follow-up|39|||
160576684|NCT02417233|579832343|FG002|Overall Study|Lost to Follow-up|34|||
160576685|NCT02417233|579832341|FG000|Overall Study|Protocol Violation|2|||
160576686|NCT02417233|579832342|FG001|Overall Study|Protocol Violation|0|||
160576687|NCT02417233|579832343|FG002|Overall Study|Protocol Violation|2|||
160576688|NCT02417233|579832341|FG000|Overall Study|Withdrawal by Subject|2|||
160576689|NCT02417233|579832342|FG001|Overall Study|Withdrawal by Subject|1|||
160576690|NCT02417233|579832343|FG002|Overall Study|Withdrawal by Subject|8|||
160576691|NCT02417233|579832341|FG000|Overall Study|Relocation out of study area|1|||
160576692|NCT02417233|579832342|FG001|Overall Study|Relocation out of study area|0|||
160576693|NCT02417233|579832343|FG002|Overall Study|Relocation out of study area|1|||
160576694|NCT02417233|579832341|FG000|Overall Study|Mentally unstable|0|||
160576695|NCT02417233|579832342|FG001|Overall Study|Mentally unstable|1|||
160576696|NCT02417233|579832343|FG002|Overall Study|Mentally unstable|0|||
160576697|NCT01063751|579832344|FG000|Overall Study|Censored from analyses|42|||
160576698|NCT01063751|579832344|FG000|Overall Study|Withdrawal by Subject|34|||
160576699|NCT01063751|579832344|FG000|Overall Study|Lost to Follow-up|30|||
160576700|NCT01063751|579832344|FG000|Overall Study|Death|13|||
160576701|NCT01063751|579832344|FG000|Overall Study|Sponsored Terminated Study|60|||
160576702|NCT01063751|579832344|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
160576703|NCT01063751|579832344|FG000|Overall Study|Investigator site closed|10|||
160576704|NCT01063751|579832344|FG000|Overall Study|Revision|6|||
160576705|NCT01063751|579832344|FG000|Overall Study|Physician Decision|4|||
160924710|NCT03447990|581119087|FG006|Overall Study|Withdrawal by Subject|1|||
160924711|NCT03755414|581119089|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
160924712|NCT03755414|581119090|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
160924713|NCT03755414|581119091|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
160924714|NCT03755414|581119089|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
160924715|NCT03755414|581119090|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
160924716|NCT03755414|581119091|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
160924717|NCT03755414|581119089|FG000|Overall Study|Non-compliance|0|||
160924718|NCT03755414|581119090|FG001|Overall Study|Non-compliance|1|||
160924719|NCT03755414|581119091|FG002|Overall Study|Non-compliance|0|||
160924720|NCT02153112|581119092|FG000|Overall Study|Adverse Event|0|||
160924721|NCT02153112|581119093|FG001|Overall Study|Adverse Event|0|||
160924722|NCT02153112|581119094|FG002|Overall Study|Adverse Event|1|||
160924723|NCT02153112|581119095|FG003|Overall Study|Adverse Event|0|||
160924724|NCT02153112|581119096|FG004|Overall Study|Adverse Event|0|||
160924725|NCT02153112|581119097|FG005|Overall Study|Adverse Event|0|||
160924726|NCT02153112|581119098|FG006|Overall Study|Adverse Event|0|||
160924727|NCT02153112|581119099|FG007|Overall Study|Adverse Event|0|||
160924728|NCT02153112|581119100|FG008|Overall Study|Adverse Event|0|||
160654869|NCT01592370|580117196|FG006|Overall Study|AE unrelated to study drug|1|||
160654870|NCT01592370|580117190|FG000|Overall Study|Request to discontinue study treatment|5|||
160654871|NCT01592370|580117191|FG001|Overall Study|Request to discontinue study treatment|0|||
160654872|NCT01592370|580117192|FG002|Overall Study|Request to discontinue study treatment|2|||
160654873|NCT01592370|580117193|FG003|Overall Study|Request to discontinue study treatment|0|||
160654874|NCT01592370|580117194|FG004|Overall Study|Request to discontinue study treatment|1|||
160654875|NCT01592370|580117195|FG005|Overall Study|Request to discontinue study treatment|2|||
160654876|NCT01592370|580117196|FG006|Overall Study|Request to discontinue study treatment|0|||
160654877|NCT01592370|580117190|FG000|Overall Study|Withdrew consent|1|||
160654878|NCT01592370|580117191|FG001|Overall Study|Withdrew consent|2|||
160924729|NCT02153112|581119101|FG009|Overall Study|Adverse Event|0|||
160924730|NCT02153112|581119092|FG000|Overall Study|Lost to Follow-up|1|||
160924731|NCT02153112|581119093|FG001|Overall Study|Lost to Follow-up|1|||
160924732|NCT02153112|581119094|FG002|Overall Study|Lost to Follow-up|0|||
160924733|NCT02153112|581119095|FG003|Overall Study|Lost to Follow-up|0|||
160924734|NCT02153112|581119096|FG004|Overall Study|Lost to Follow-up|2|||
160924735|NCT02153112|581119097|FG005|Overall Study|Lost to Follow-up|1|||
160924736|NCT02153112|581119098|FG006|Overall Study|Lost to Follow-up|1|||
160924737|NCT02153112|581119099|FG007|Overall Study|Lost to Follow-up|0|||
160924738|NCT02153112|581119100|FG008|Overall Study|Lost to Follow-up|1|||
160924739|NCT02153112|581119101|FG009|Overall Study|Lost to Follow-up|1|||
160924740|NCT02153112|581119092|FG000|Overall Study|Withdrawal by Subject|3|||
160997930|NCT03254394|581376697|FG000|Overall Study|Withdrawal by Subject|0|||
160997931|NCT03254394|581376698|FG001|Overall Study|Withdrawal by Subject|2|||
160576706|NCT03408873|579832345|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
160576707|NCT03408873|579832345|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
160576708|NCT03408873|579832345|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
160576709|NCT03408873|579832345|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
160576710|NCT03408873|579832345|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
160576711|NCT03408873|579832345|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
160576712|NCT01469013|579832350|FG000|Part A (Treatment Period)|Adverse Event|1|||
160576713|NCT01469013|579832351|FG001|Part A (Treatment Period)|Adverse Event|0|||
160576714|NCT01469013|579832352|FG002|Part A (Treatment Period)|Adverse Event|0|||
160576715|NCT01469013|579832353|FG003|Part A (Treatment Period)|Adverse Event|0|||
160576716|NCT01469013|579832354|FG004|Part A (Treatment Period)|Adverse Event|1|||
160576717|NCT01469013|579832355|FG005|Part A (Treatment Period)|Adverse Event|0|||
160576718|NCT01469013|579832356|FG006|Part A (Treatment Period)|Adverse Event|0|||
160576719|NCT01469013|579832357|FG007|Part A (Treatment Period)|Adverse Event|0|||
160576720|NCT01469013|579832358|FG008|Part A (Treatment Period)|Adverse Event|0|||
160576721|NCT01469013|579832359|FG009|Part A (Treatment Period)|Adverse Event|0|||
160576722|NCT01469013|579832360|FG010|Part A (Treatment Period)|Adverse Event|0|||
160576723|NCT01469013|579832361|FG011|Part A (Treatment Period)|Adverse Event|0|||
160924741|NCT02153112|581119093|FG001|Overall Study|Withdrawal by Subject|1|||
160924742|NCT02153112|581119094|FG002|Overall Study|Withdrawal by Subject|2|||
160924743|NCT02153112|581119095|FG003|Overall Study|Withdrawal by Subject|2|||
160924744|NCT02153112|581119096|FG004|Overall Study|Withdrawal by Subject|1|||
160997932|NCT02163915|581376699|FG000|Overall Study|Withdrawal by Subject|2|||
160576724|NCT01469013|579832362|FG012|Part A (Treatment Period)|Adverse Event|0|||
160576725|NCT01469013|579832350|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576726|NCT01469013|579832351|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576727|NCT01469013|579832352|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
160997933|NCT02163915|581376700|FG001|Overall Study|Withdrawal by Subject|0|||
160997934|NCT02163915|581376701|FG002|Overall Study|Withdrawal by Subject|2|||
160654879|NCT01592370|580117192|FG002|Overall Study|Withdrew consent|1|||
160654880|NCT01592370|580117193|FG003|Overall Study|Withdrew consent|1|||
160654881|NCT01592370|580117194|FG004|Overall Study|Withdrew consent|0|||
160654882|NCT01592370|580117195|FG005|Overall Study|Withdrew consent|0|||
160654883|NCT01592370|580117196|FG006|Overall Study|Withdrew consent|0|||
160654884|NCT01592370|580117190|FG000|Overall Study|Maximum clinical benefit|11|||
160654885|NCT01592370|580117191|FG001|Overall Study|Maximum clinical benefit|1|||
160654886|NCT01592370|580117192|FG002|Overall Study|Maximum clinical benefit|7|||
160654887|NCT01592370|580117193|FG003|Overall Study|Maximum clinical benefit|1|||
160654888|NCT01592370|580117194|FG004|Overall Study|Maximum clinical benefit|0|||
160654889|NCT01592370|580117195|FG005|Overall Study|Maximum clinical benefit|0|||
160654890|NCT01592370|580117196|FG006|Overall Study|Maximum clinical benefit|0|||
160654891|NCT01592370|580117190|FG000|Overall Study|No longer meets study criteria|1|||
160654892|NCT01592370|580117191|FG001|Overall Study|No longer meets study criteria|0|||
160654893|NCT01592370|580117192|FG002|Overall Study|No longer meets study criteria|0|||
160654894|NCT01592370|580117193|FG003|Overall Study|No longer meets study criteria|0|||
160654895|NCT01592370|580117194|FG004|Overall Study|No longer meets study criteria|0|||
160654896|NCT01592370|580117195|FG005|Overall Study|No longer meets study criteria|0|||
160654897|NCT01592370|580117196|FG006|Overall Study|No longer meets study criteria|0|||
160654898|NCT01592370|580117190|FG000|Overall Study|Other Reasons|6|||
160654899|NCT01592370|580117191|FG001|Overall Study|Other Reasons|0|||
160654900|NCT01592370|580117192|FG002|Overall Study|Other Reasons|10|||
160654901|NCT01592370|580117193|FG003|Overall Study|Other Reasons|0|||
160654902|NCT01592370|580117194|FG004|Overall Study|Other Reasons|0|||
160654903|NCT01592370|580117195|FG005|Overall Study|Other Reasons|1|||
160654904|NCT01592370|580117196|FG006|Overall Study|Other Reasons|0|||
160654905|NCT01592370|580117190|FG000|Overall Study|Not Treated|0|||
160654906|NCT01592370|580117191|FG001|Overall Study|Not Treated|0|||
160654907|NCT01592370|580117192|FG002|Overall Study|Not Treated|0|||
160654908|NCT01592370|580117193|FG003|Overall Study|Not Treated|0|||
160654909|NCT01592370|580117194|FG004|Overall Study|Not Treated|2|||
160654910|NCT01592370|580117195|FG005|Overall Study|Not Treated|2|||
160654911|NCT01592370|580117196|FG006|Overall Study|Not Treated|0|||
160654912|NCT02742181|580117197|FG000|Overall Study|Physician Decision|1|||
160654913|NCT02742181|580117198|FG001|Overall Study|Physician Decision|0|||
160654914|NCT02739984|580117199|FG000|Overall Study|Sponsor Decision|1|||
160654915|NCT02739984|580117200|FG001|Overall Study|Sponsor Decision|0|||
160654916|NCT02739984|580117199|FG000|Overall Study|Withdrawal by Subject|1|||
160654917|NCT02739984|580117200|FG001|Overall Study|Withdrawal by Subject|1|||
160654918|NCT02739984|580117199|FG000|Overall Study|Death|0|||
160654919|NCT02739984|580117200|FG001|Overall Study|Death|1|||
160654920|NCT02739984|580117199|FG000|Overall Study|Lost to Follow-up|3|||
160654921|NCT02739984|580117200|FG001|Overall Study|Lost to Follow-up|0|||
160654922|NCT01048333|580117205|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
160654923|NCT01048333|580117206|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
160654924|NCT01048333|580117207|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
160654925|NCT01048333|580117208|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
160654926|NCT01048333|580117209|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
160654927|NCT01048333|580117210|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
160654928|NCT00996736|580117212|FG000|Overall Study|Death|1|||
160654929|NCT00996736|580117213|FG001|Overall Study|Death|1|||
160654930|NCT00996736|580117212|FG000|Overall Study|Lost to Follow-up|15|||
160654931|NCT00996736|580117213|FG001|Overall Study|Lost to Follow-up|14|||
160654932|NCT00996736|580117212|FG000|Overall Study|Visit not within 3-month window|5|||
160654933|NCT00996736|580117213|FG001|Overall Study|Visit not within 3-month window|3|||
160654934|NCT02346201|580117214|FG000|Overall Study|Adverse Event|3|||
160654935|NCT02346201|580117215|FG001|Overall Study|Adverse Event|2|||
160654936|NCT02346201|580117214|FG000|Overall Study|Lost to Follow-up|1|||
160654937|NCT02346201|580117215|FG001|Overall Study|Lost to Follow-up|0|||
160997935|NCT02163915|581376702|FG003|Overall Study|Withdrawal by Subject|2|||
160997936|NCT02163915|581376703|FG004|Overall Study|Withdrawal by Subject|2|||
160997937|NCT02163915|581376699|FG000|Overall Study|Study termination|1|||
160654938|NCT02346201|580117214|FG000|Overall Study|Withdrawal by Subject|6|||
160654939|NCT02346201|580117215|FG001|Overall Study|Withdrawal by Subject|3|||
160654940|NCT02346201|580117214|FG000|Overall Study|Unavailable for future follow-up|0|||
160654941|NCT02346201|580117215|FG001|Overall Study|Unavailable for future follow-up|1|||
160997938|NCT02163915|581376700|FG001|Overall Study|Study termination|0|||
160654942|NCT02346201|580117214|FG000|Overall Study|Physician Decision|0|||
160654943|NCT02346201|580117215|FG001|Overall Study|Physician Decision|1|||
160654944|NCT02346201|580117214|FG000|Overall Study|Missed final visit|0|||
160654945|NCT02346201|580117215|FG001|Overall Study|Missed final visit|2|||
160654946|NCT00409578|580117216|FG000|Overall Study|Adverse Event|27|||
160654947|NCT00409578|580117217|FG001|Overall Study|Adverse Event|37|||
160654948|NCT00409578|580117218|FG002|Overall Study|Adverse Event|25|||
160654949|NCT00409578|580117219|FG003|Overall Study|Adverse Event|33|||
160654950|NCT00409578|580117216|FG000|Overall Study|Abnormal laboratory value(s)|2|||
160654951|NCT00409578|580117217|FG001|Overall Study|Abnormal laboratory value(s)|2|||
160654952|NCT00409578|580117218|FG002|Overall Study|Abnormal laboratory value(s)|2|||
160654953|NCT00409578|580117219|FG003|Overall Study|Abnormal laboratory value(s)|4|||
160997939|NCT02163915|581376701|FG002|Overall Study|Study termination|0|||
160924745|NCT02153112|581119097|FG005|Overall Study|Withdrawal by Subject|1|||
160924746|NCT02153112|581119098|FG006|Overall Study|Withdrawal by Subject|7|||
160924747|NCT02153112|581119099|FG007|Overall Study|Withdrawal by Subject|2|||
160924748|NCT02153112|581119100|FG008|Overall Study|Withdrawal by Subject|13|||
160924749|NCT02153112|581119101|FG009|Overall Study|Withdrawal by Subject|12|||
160924750|NCT02153112|581119092|FG000|Overall Study|Reason not Specified|0|||
160924751|NCT02153112|581119093|FG001|Overall Study|Reason not Specified|0|||
160924752|NCT02153112|581119094|FG002|Overall Study|Reason not Specified|0|||
160924753|NCT02153112|581119095|FG003|Overall Study|Reason not Specified|0|||
160924754|NCT02153112|581119096|FG004|Overall Study|Reason not Specified|0|||
160924755|NCT02153112|581119097|FG005|Overall Study|Reason not Specified|0|||
160924756|NCT02153112|581119098|FG006|Overall Study|Reason not Specified|0|||
160924757|NCT02153112|581119099|FG007|Overall Study|Reason not Specified|0|||
160924758|NCT02153112|581119100|FG008|Overall Study|Reason not Specified|1|||
160924759|NCT02153112|581119101|FG009|Overall Study|Reason not Specified|1|||
160924760|NCT05104567|581119102|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924761|NCT05104567|581119103|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
160924762|NCT05104567|581119104|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924763|NCT05104567|581119105|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924764|NCT05104567|581119106|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924765|NCT05104567|581119107|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924766|NCT05104567|581119108|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924767|NCT05104567|581119102|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
160924768|NCT05104567|581119103|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
160924769|NCT05104567|581119104|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
160924770|NCT05104567|581119105|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
160924771|NCT05104567|581119106|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
160924772|NCT05104567|581119107|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
160997940|NCT02163915|581376702|FG003|Overall Study|Study termination|0|||
160997941|NCT02163915|581376703|FG004|Overall Study|Study termination|2|||
160997942|NCT02163915|581376699|FG000|Overall Study|Physician Decision|0|||
160997943|NCT02163915|581376700|FG001|Overall Study|Physician Decision|0|||
160997944|NCT02163915|581376701|FG002|Overall Study|Physician Decision|0|||
160997945|NCT02163915|581376702|FG003|Overall Study|Physician Decision|1|||
160997946|NCT02163915|581376703|FG004|Overall Study|Physician Decision|0|||
160997947|NCT02013037|581376707|FG000|Overall Study|Death|6|||
160997948|NCT02013037|581376707|FG000|Overall Study|Withdrawal by Subject|1|||
160997949|NCT02013037|581376707|FG000|Overall Study|Awaiting Transplantation|7|||
160576728|NCT01469013|579832353|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576729|NCT01469013|579832354|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576730|NCT01469013|579832355|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576731|NCT01469013|579832356|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576732|NCT01469013|579832357|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576733|NCT01469013|579832358|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576734|NCT01469013|579832359|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576735|NCT01469013|579832360|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576736|NCT01469013|579832361|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576737|NCT01469013|579832362|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
160576738|NCT01469013|579832350|FG000|Part B (Extension Period)|Adverse Event|0|||
160576739|NCT01469013|579832351|FG001|Part B (Extension Period)|Adverse Event|0|||
160576740|NCT01469013|579832352|FG002|Part B (Extension Period)|Adverse Event|0|||
160576741|NCT01469013|579832353|FG003|Part B (Extension Period)|Adverse Event|0|||
160576742|NCT01469013|579832354|FG004|Part B (Extension Period)|Adverse Event|0|||
160576743|NCT01469013|579832355|FG005|Part B (Extension Period)|Adverse Event|2|||
160576744|NCT01469013|579832356|FG006|Part B (Extension Period)|Adverse Event|5|||
160576745|NCT01469013|579832357|FG007|Part B (Extension Period)|Adverse Event|5|||
160576746|NCT01469013|579832358|FG008|Part B (Extension Period)|Adverse Event|3|||
160576747|NCT01469013|579832359|FG009|Part B (Extension Period)|Adverse Event|3|||
160576748|NCT01469013|579832360|FG010|Part B (Extension Period)|Adverse Event|1|||
160654954|NCT00409578|580117216|FG000|Overall Study|Lack of Efficacy|0|||
160654955|NCT00409578|580117217|FG001|Overall Study|Lack of Efficacy|0|||
160924773|NCT05104567|581119108|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
160924774|NCT05104567|581119102|FG000|Overall Study|Progressive disease|3|||
160924775|NCT05104567|581119103|FG001|Overall Study|Progressive disease|13|||
160924776|NCT05104567|581119104|FG002|Overall Study|Progressive disease|13|||
160924777|NCT05104567|581119105|FG003|Overall Study|Progressive disease|17|||
160997950|NCT02013037|581376707|FG000|Overall Study|Transplanted without DSA|2|||
160576749|NCT01469013|579832361|FG011|Part B (Extension Period)|Adverse Event|6|||
160576750|NCT01469013|579832362|FG012|Part B (Extension Period)|Adverse Event|3|||
160997951|NCT00798265|581376708|FG000|Overall Study|Lost to Follow-up|1|||
160997952|NCT00798265|581376709|FG001|Overall Study|Lost to Follow-up|10|||
160654956|NCT00409578|580117218|FG002|Overall Study|Lack of Efficacy|0|||
160576751|NCT01469013|579832350|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
160576752|NCT01469013|579832351|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
160576753|NCT01469013|579832352|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
160576754|NCT01469013|579832353|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
160576755|NCT01469013|579832354|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
160576756|NCT01469013|579832355|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
160576757|NCT01469013|579832356|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
160576758|NCT01469013|579832357|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
160924778|NCT05104567|581119106|FG004|Overall Study|Progressive disease|17|||
160924779|NCT05104567|581119107|FG005|Overall Study|Progressive disease|28|||
160924780|NCT05104567|581119108|FG006|Overall Study|Progressive disease|24|||
160924781|NCT05104567|581119102|FG000|Overall Study|Withdrawal by Subject|1|||
160924782|NCT05104567|581119103|FG001|Overall Study|Withdrawal by Subject|1|||
160576759|NCT01469013|579832358|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
160576760|NCT01469013|579832359|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
160576761|NCT01469013|579832360|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
160576762|NCT01469013|579832361|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
160576763|NCT01469013|579832362|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
160576764|NCT05232097|579832363|FG000|Overall Study|Physician Decision|1|||
160576765|NCT01327339|579832366|FG000|Overall Study|Protocol Violation|8|||
160576766|NCT00871858|579832367|FG000|Overall Study|Protocol Violation|3|||
160576767|NCT00871858|579832368|FG001|Overall Study|Protocol Violation|4|||
160576768|NCT00871858|579832367|FG000|Overall Study|Adverse Event|1|||
160576769|NCT00871858|579832368|FG001|Overall Study|Adverse Event|1|||
160576770|NCT00871858|579832367|FG000|Overall Study|Withdrawal by Subject|1|||
160576771|NCT00871858|579832368|FG001|Overall Study|Withdrawal by Subject|1|||
160576772|NCT00871858|579832367|FG000|Overall Study|Lost to Follow-up|0|||
160576773|NCT00871858|579832368|FG001|Overall Study|Lost to Follow-up|1|||
160576774|NCT01188798|579832371|FG000|Overall Study|Death|0|||
160576775|NCT01188798|579832372|FG001|Overall Study|Death|1|||
160576776|NCT01188798|579832371|FG000|Overall Study|Required additional transplant|1|||
160576777|NCT01188798|579832372|FG001|Overall Study|Required additional transplant|1|||
160576778|NCT01188798|579832371|FG000|Overall Study|Protocol closure|1|||
160576779|NCT01188798|579832372|FG001|Overall Study|Protocol closure|1|||
160576780|NCT00700752|579832378|FG000|First Intervention|Withdrawal by Subject|0|||
160576781|NCT00700752|579832379|FG001|First Intervention|Withdrawal by Subject|2|||
160576782|NCT03964415|579832380|FG000|Overall Study|Sponsor's decision|1563|||
160576783|NCT03964415|579832381|FG001|Overall Study|Sponsor's decision|1528|||
160576784|NCT03964415|579832380|FG000|Overall Study|Lost to Follow-up|139|||
160576785|NCT03964415|579832381|FG001|Overall Study|Lost to Follow-up|146|||
160576786|NCT03964415|579832380|FG000|Overall Study|Withdrawal by Subject|68|||
160576787|NCT03964415|579832381|FG001|Overall Study|Withdrawal by Subject|72|||
160576788|NCT03964415|579832380|FG000|Overall Study|Physician Decision|34|||
160576789|NCT03964415|579832381|FG001|Overall Study|Physician Decision|48|||
160576790|NCT03964415|579832380|FG000|Overall Study|Adverse Event|3|||
160576791|NCT03964415|579832381|FG001|Overall Study|Adverse Event|0|||
160576792|NCT03964415|579832380|FG000|Overall Study|Death|4|||
160576793|NCT03964415|579832381|FG001|Overall Study|Death|6|||
160576794|NCT03964415|579832380|FG000|Overall Study|Protocol Violation|1|||
160576795|NCT03964415|579832381|FG001|Overall Study|Protocol Violation|4|||
160576796|NCT03964415|579832380|FG000|Overall Study|Other|35|||
160576797|NCT03964415|579832381|FG001|Overall Study|Other|38|||
160924783|NCT05104567|581119104|FG002|Overall Study|Withdrawal by Subject|2|||
160924784|NCT05104567|581119105|FG003|Overall Study|Withdrawal by Subject|0|||
160924785|NCT05104567|581119106|FG004|Overall Study|Withdrawal by Subject|0|||
160924786|NCT05104567|581119107|FG005|Overall Study|Withdrawal by Subject|0|||
160924787|NCT05104567|581119108|FG006|Overall Study|Withdrawal by Subject|0|||
160924788|NCT05104567|581119102|FG000|Overall Study|Other|1|||
160924789|NCT05104567|581119103|FG001|Overall Study|Other|1|||
160924790|NCT05104567|581119104|FG002|Overall Study|Other|1|||
160924791|NCT05104567|581119105|FG003|Overall Study|Other|0|||
160924792|NCT05104567|581119106|FG004|Overall Study|Other|0|||
160924793|NCT05104567|581119107|FG005|Overall Study|Other|0|||
160924794|NCT05104567|581119108|FG006|Overall Study|Other|0|||
160924795|NCT01464346|581119109|FG000|Overall Study|Withdrawal by Subject|0|||
160576798|NCT03964415|579832380|FG000|Overall Study|Randomized but not treated|6|||
160576799|NCT03964415|579832381|FG001|Overall Study|Randomized but not treated|7|||
160576800|NCT01097330|579832387|FG000|Overall Study|Study terminated early|7|||
160576801|NCT01097330|579832388|FG001|Overall Study|Study terminated early|5|||
160576802|NCT01734993|579832389|FG000|Overall Study|Adverse Event|1|||
160576803|NCT01734993|579832389|FG000|Overall Study|Lack of Efficacy|1|||
160576804|NCT00510692|579832390|FG000|Overall Study|Adverse Event|1|||
160576805|NCT00510692|579832391|FG001|Overall Study|Adverse Event|3|||
160576806|NCT00510692|579832390|FG000|Overall Study|Withdrawal by Subject|1|||
160576807|NCT00510692|579832391|FG001|Overall Study|Withdrawal by Subject|0|||
160576808|NCT00945191|579832392|FG000|Overall Study|Did not achieve a complete response|18|||
160924796|NCT01464346|581119110|FG001|Overall Study|Withdrawal by Subject|0|||
160924797|NCT01464346|581119111|FG002|Overall Study|Withdrawal by Subject|1|||
160924798|NCT03999892|581119112|FG000|Overall Study|Lost to Follow-up|1|||
160924799|NCT01848756|581119113|FG000|Overall Study|Adverse Event|1|||
160924800|NCT01848756|581119113|FG000|Overall Study|Withdrawal by Subject|1|||
160924801|NCT01848756|581119113|FG000|Overall Study|Enrolled in Error|1|||
160924802|NCT01286012|581119114|FG000|Overall Study|Adverse Event|3|||
160924803|NCT01286012|581119115|FG001|Overall Study|Adverse Event|3|||
160924804|NCT01286012|581119114|FG000|Overall Study|Death|2|||
160924805|NCT01286012|581119115|FG001|Overall Study|Death|3|||
160924806|NCT01286012|581119114|FG000|Overall Study|Protocol Violation|1|||
160924807|NCT01286012|581119115|FG001|Overall Study|Protocol Violation|1|||
160924808|NCT01286012|581119114|FG000|Overall Study|Withdrawal by Subject|4|||
160924809|NCT01286012|581119115|FG001|Overall Study|Withdrawal by Subject|4|||
160924810|NCT01286012|581119114|FG000|Overall Study|Physician Decision|2|||
160924811|NCT01286012|581119115|FG001|Overall Study|Physician Decision|0|||
160924812|NCT01286012|581119114|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
160924813|NCT01286012|581119115|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
160924814|NCT04056195|581119119|FG000|Overall Study|Adverse Event|1|||
160924815|NCT04056195|581119120|FG001|Overall Study|Adverse Event|0|||
160924816|NCT04056195|581119121|FG002|Overall Study|Adverse Event|0|||
160924817|NCT04056195|581119119|FG000|Overall Study|Withdrawal by Subject|0|||
160924818|NCT04056195|581119120|FG001|Overall Study|Withdrawal by Subject|1|||
160924819|NCT04056195|581119121|FG002|Overall Study|Withdrawal by Subject|1|||
160924820|NCT04056195|581119119|FG000|Overall Study|Physician Decision|1|||
160924821|NCT04056195|581119120|FG001|Overall Study|Physician Decision|1|||
160924822|NCT04056195|581119121|FG002|Overall Study|Physician Decision|1|||
160924823|NCT01498458|581119122|FG000|Overall Study|Adverse Event|4|||
160924824|NCT01498458|581119122|FG000|Overall Study|Physician Decision|3|||
160924825|NCT02406651|581119123|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
160924826|NCT02226003|581119127|FG000|Overall Study|Lost to Follow-up|2|||
160924827|NCT02226003|581119128|FG001|Overall Study|Lost to Follow-up|1|||
160924828|NCT02226003|581119129|FG002|Overall Study|Lost to Follow-up|3|||
160924829|NCT02226003|581119127|FG000|Overall Study|Withdrawal by Subject|0|||
160924830|NCT02226003|581119128|FG001|Overall Study|Withdrawal by Subject|0|||
160924831|NCT02226003|581119129|FG002|Overall Study|Withdrawal by Subject|3|||
160924832|NCT00718328|581119130|FG000|Overall Study|Lost to Follow-up|1|||
160924833|NCT00718328|581119131|FG001|Overall Study|Lost to Follow-up|0|||
160924834|NCT02865915|581119132|FG000|Overall Study|Pregnancy|1|||
160924835|NCT02865915|581119133|FG001|Overall Study|Pregnancy|0|||
160924836|NCT02865915|581119132|FG000|Overall Study|Withdrawal by Subject|1|||
160924837|NCT02865915|581119133|FG001|Overall Study|Withdrawal by Subject|1|||
160924838|NCT02865915|581119132|FG000|Overall Study|Adverse Event|0|||
160924839|NCT02865915|581119133|FG001|Overall Study|Adverse Event|4|||
160924840|NCT02865915|581119132|FG000|Overall Study|Lost to Follow-up|0|||
160924841|NCT02865915|581119133|FG001|Overall Study|Lost to Follow-up|1|||
160924842|NCT02865915|581119132|FG000|Overall Study|Protocol Violation|0|||
160924843|NCT02865915|581119133|FG001|Overall Study|Protocol Violation|1|||
160924844|NCT02865915|581119132|FG000|Overall Study|Study terminated by sponsor|23|||
160924845|NCT02865915|581119133|FG001|Overall Study|Study terminated by sponsor|18|||
160924846|NCT02865915|581119132|FG000|Overall Study|Dosing group discontinued|0|||
160924847|NCT02865915|581119133|FG001|Overall Study|Dosing group discontinued|5|||
160924848|NCT00663052|581119136|FG000|Overall Study|Adverse Event|6|||
160924849|NCT00663052|581119137|FG001|Overall Study|Adverse Event|3|||
160924850|NCT00663052|581119136|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
160924851|NCT00663052|581119137|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
160924852|NCT00663052|581119136|FG000|Overall Study|Protocol Violation|1|||
160924853|NCT00663052|581119137|FG001|Overall Study|Protocol Violation|0|||
160924854|NCT00663052|581119136|FG000|Overall Study|Withdrawal by Subject|2|||
160924855|NCT00663052|581119137|FG001|Overall Study|Withdrawal by Subject|5|||
160924856|NCT00663052|581119136|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
160924857|NCT00663052|581119137|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
160924858|NCT00663052|581119136|FG000|Overall Study|Other|0|||
160924859|NCT00663052|581119137|FG001|Overall Study|Other|1|||
160924860|NCT05760300|581119146|FG000|Overall Study|Adverse Event|0|||
160924861|NCT05760300|581119147|FG001|Overall Study|Adverse Event|0|||
160924862|NCT05760300|581119148|FG002|Overall Study|Adverse Event|1|||
160924863|NCT05760300|581119149|FG003|Overall Study|Adverse Event|0|||
160924864|NCT05760300|581119146|FG000|Overall Study|Participant Decision|1|||
160924865|NCT05760300|581119147|FG001|Overall Study|Participant Decision|0|||
160924866|NCT05760300|581119148|FG002|Overall Study|Participant Decision|0|||
160924867|NCT05760300|581119149|FG003|Overall Study|Participant Decision|0|||
160924868|NCT03279692|581119150|FG000|Overall Study|Withdrawal by Subject|1|||
160924869|NCT02446990|581119153|FG000|Overall Study|Death|485|||
160924870|NCT02446990|581119154|FG001|Overall Study|Death|458|||
160924871|NCT02446990|581119153|FG000|Overall Study|Lost to Follow-up|3|||
160924872|NCT02446990|581119154|FG001|Overall Study|Lost to Follow-up|1|||
160924873|NCT02446990|581119153|FG000|Overall Study|Physician Decision|1|||
160924874|NCT02446990|581119154|FG001|Overall Study|Physician Decision|0|||
160924875|NCT02446990|581119153|FG000|Overall Study|Withdrawal by Subject|231|||
160576809|NCT00945191|579832392|FG000|Overall Study|Participant relocated to another state|1|||
160576810|NCT00945191|579832392|FG000|Overall Study|Disease progression|3|||
160576811|NCT00945191|579832392|FG000|Overall Study|Serious adverse event or adverse event|1|||
160576812|NCT00945191|579832392|FG000|Overall Study|Investigator's discretion|1|||
160576813|NCT02116972|579832393|FG000|Overall Study|Adverse Event|4|||
160924876|NCT02446990|581119154|FG001|Overall Study|Withdrawal by Subject|199|||
160924877|NCT01064401|581119155|FG000|Overall Study|Adverse Event|47|||
160924878|NCT01064401|581119156|FG001|Overall Study|Adverse Event|56|||
160924879|NCT01064401|581119155|FG000|Overall Study|Lack of Efficacy|46|||
160924880|NCT01064401|581119156|FG001|Overall Study|Lack of Efficacy|23|||
160924881|NCT01064401|581119155|FG000|Overall Study|Lost to Follow-up|12|||
160924882|NCT01064401|581119156|FG001|Overall Study|Lost to Follow-up|9|||
160924883|NCT01064401|581119155|FG000|Overall Study|Consent Withdrawn|98|||
160924884|NCT01064401|581119156|FG001|Overall Study|Consent Withdrawn|80|||
160924885|NCT01064401|581119155|FG000|Overall Study|Investigator Decision|4|||
160924886|NCT01064401|581119156|FG001|Overall Study|Investigator Decision|6|||
160924887|NCT01064401|581119155|FG000|Overall Study|Death|4|||
160924888|NCT01064401|581119156|FG001|Overall Study|Death|0|||
160924889|NCT01064401|581119155|FG000|Overall Study|Pregnancy|4|||
160924890|NCT01064401|581119156|FG001|Overall Study|Pregnancy|7|||
160924891|NCT01064401|581119155|FG000|Overall Study|Noncompliance|7|||
160924892|NCT01064401|581119156|FG001|Overall Study|Noncompliance|8|||
160924893|NCT01064401|581119155|FG000|Overall Study|Site Closure|4|||
160924894|NCT01064401|581119156|FG001|Overall Study|Site Closure|5|||
160576814|NCT02116972|579832394|FG001|Overall Study|Adverse Event|4|||
160576815|NCT02116972|579832395|FG002|Overall Study|Adverse Event|1|||
160576816|NCT02116972|579832393|FG000|Overall Study|Withdrawal by Subject|1|||
160576817|NCT02116972|579832394|FG001|Overall Study|Withdrawal by Subject|1|||
160576818|NCT02116972|579832395|FG002|Overall Study|Withdrawal by Subject|5|||
160576819|NCT02116972|579832393|FG000|Overall Study|Protocol Violation|1|||
160924895|NCT01064401|581119155|FG000|Overall Study|Other|2|||
160924896|NCT01064401|581119156|FG001|Overall Study|Other|1|||
160924897|NCT03158051|581119157|FG000|Overall Study|Lost to Follow-up|41|||
160924898|NCT03158051|581119158|FG001|Overall Study|Lost to Follow-up|47|||
160924899|NCT03158051|581119157|FG000|Overall Study|Physician Decision|6|||
160924900|NCT03158051|581119158|FG001|Overall Study|Physician Decision|7|||
160924901|NCT03158051|581119157|FG000|Overall Study|Withdrawal by Subject|24|||
160924902|NCT03158051|581119158|FG001|Overall Study|Withdrawal by Subject|15|||
160576820|NCT02116972|579832394|FG001|Overall Study|Protocol Violation|0|||
160576821|NCT02116972|579832395|FG002|Overall Study|Protocol Violation|1|||
160576822|NCT02116972|579832393|FG000|Overall Study|Lost to Follow-up|4|||
160576823|NCT02116972|579832394|FG001|Overall Study|Lost to Follow-up|3|||
160576824|NCT02116972|579832395|FG002|Overall Study|Lost to Follow-up|1|||
160576825|NCT02116972|579832393|FG000|Overall Study|Lack of Efficacy|6|||
160576826|NCT02116972|579832394|FG001|Overall Study|Lack of Efficacy|6|||
160576827|NCT02116972|579832395|FG002|Overall Study|Lack of Efficacy|5|||
160576828|NCT02116972|579832393|FG000|Overall Study|scheduling conflicts and relocation|3|||
160576829|NCT02116972|579832394|FG001|Overall Study|scheduling conflicts and relocation|3|||
160576830|NCT02116972|579832395|FG002|Overall Study|scheduling conflicts and relocation|6|||
160576831|NCT00784784|579832396|FG000|Overall Study|Withdrawal by Subject|2|||
160576832|NCT00784784|579832397|FG001|Overall Study|Withdrawal by Subject|2|||
160576833|NCT00872898|579832398|FG000|Part Two - Double Blind|Adverse Event|4|||
160576834|NCT00872898|579832399|FG001|Part Two - Double Blind|Adverse Event|3|||
160576835|NCT00872898|579832398|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
160576836|NCT00872898|579832399|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
160576837|NCT00872898|579832398|FG000|Part Two - Double Blind|Protocol Violation|1|||
160576838|NCT00872898|579832399|FG001|Part Two - Double Blind|Protocol Violation|0|||
160576839|NCT00872898|579832398|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
160576840|NCT00872898|579832399|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
160576841|NCT00872898|579832398|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
160576842|NCT00872898|579832399|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
160576843|NCT00872898|579832398|FG000|Part Two - Double Blind|Other reasons|2|||
160576844|NCT00872898|579832399|FG001|Part Two - Double Blind|Other reasons|0|||
160576845|NCT00863928|579832402|FG000|Overall Study|Protocol Violation|26|||
160654957|NCT00409578|580117219|FG003|Overall Study|Lack of Efficacy|2|||
160924903|NCT03158051|581119157|FG000|Overall Study|Death|0|||
160576846|NCT00863928|579832403|FG001|Overall Study|Protocol Violation|0|||
160576847|NCT00863928|579832402|FG000|Overall Study|Withdrawal by Subject|3|||
160576848|NCT00863928|579832403|FG001|Overall Study|Withdrawal by Subject|0|||
160576849|NCT00863928|579832402|FG000|Overall Study|surgery cancellation|4|||
160576850|NCT00863928|579832403|FG001|Overall Study|surgery cancellation|0|||
160576851|NCT00863928|579832402|FG000|Overall Study|medication allergy|3|||
160654958|NCT00409578|580117216|FG000|Overall Study|Subject no longer requires study drug|0|||
160924904|NCT03158051|581119158|FG001|Overall Study|Death|1|||
160924905|NCT02005250|581119159|FG000|Overall Study|Lost to Follow-up|15|||
160924906|NCT02005250|581119160|FG001|Overall Study|Lost to Follow-up|5|||
160924907|NCT02588833|581119161|FG000|Part 1|Withdrawal by Subject|1|||
160924908|NCT02588833|581119162|FG001|Part 1|Withdrawal by Subject|0|||
160576852|NCT00863928|579832403|FG001|Overall Study|medication allergy|0|||
160576853|NCT01797432|579832404|FG000|Overall Study|Lost to Follow-up|1|||
160576854|NCT01797432|579832404|FG000|Overall Study|Adverse Event|1|||
160576855|NCT01797432|579832404|FG000|Overall Study|Withdrawal by Subject|1|||
160576856|NCT01797432|579832404|FG000|Overall Study|lived too far from study site|1|||
160924909|NCT02588833|581119161|FG000|Part 2A|Physician Decision|0|||
160924910|NCT02588833|581119162|FG001|Part 2A|Physician Decision|1|||
160924911|NCT02588833|581119161|FG000|Part 2A|Withdrawal by Subject|0|||
160924912|NCT02588833|581119162|FG001|Part 2A|Withdrawal by Subject|1|||
160924913|NCT02588833|581119161|FG000|Part 2B|Adverse Event|0|||
160924914|NCT02588833|581119162|FG001|Part 2B|Adverse Event|1|||
160924915|NCT02588833|581119161|FG000|Part 2C|Adverse Event|0|||
160924916|NCT02588833|581119162|FG001|Part 2C|Adverse Event|1|||
160924917|NCT02588833|581119161|FG000|Part 2C|Withdrawal by Subject|0|||
160924918|NCT02588833|581119162|FG001|Part 2C|Withdrawal by Subject|1|||
160924919|NCT02588833|581119161|FG000|Part 3 (Safety Follow-up)|Other|0|||
160924920|NCT02588833|581119162|FG001|Part 3 (Safety Follow-up)|Other|2|||
160924921|NCT02967692|581121043|FG000|Overall Study|Progressive disease|3|||
160924922|NCT02967692|581121044|FG001|Overall Study|Progressive disease|15|||
160924923|NCT02967692|581121045|FG002|Overall Study|Progressive disease|114|||
160924924|NCT02967692|581121046|FG003|Overall Study|Progressive disease|151|||
160924925|NCT02967692|581121043|FG000|Overall Study|Subject/guardian decision|1|||
160924926|NCT02967692|581121044|FG001|Overall Study|Subject/guardian decision|1|||
160924927|NCT02967692|581121045|FG002|Overall Study|Subject/guardian decision|14|||
160924928|NCT02967692|581121046|FG003|Overall Study|Subject/guardian decision|22|||
160924929|NCT02967692|581121043|FG000|Overall Study|Death|0|||
160924930|NCT02967692|581121044|FG001|Overall Study|Death|1|||
160924931|NCT02967692|581121045|FG002|Overall Study|Death|13|||
160924932|NCT02967692|581121046|FG003|Overall Study|Death|13|||
160924933|NCT02967692|581121043|FG000|Overall Study|Protocol deviation|1|||
160924934|NCT02967692|581121044|FG001|Overall Study|Protocol deviation|0|||
160924935|NCT02967692|581121045|FG002|Overall Study|Protocol deviation|1|||
160924936|NCT02967692|581121046|FG003|Overall Study|Protocol deviation|1|||
160924937|NCT02967692|581121043|FG000|Overall Study|Lost to Follow-up|0|||
160924938|NCT02967692|581121044|FG001|Overall Study|Lost to Follow-up|0|||
160924939|NCT02967692|581121045|FG002|Overall Study|Lost to Follow-up|1|||
160924940|NCT02967692|581121046|FG003|Overall Study|Lost to Follow-up|0|||
160924941|NCT02967692|581121043|FG000|Overall Study|Physician Decision|0|||
160924942|NCT02967692|581121044|FG001|Overall Study|Physician Decision|0|||
160924943|NCT02967692|581121045|FG002|Overall Study|Physician Decision|22|||
160924944|NCT02967692|581121046|FG003|Overall Study|Physician Decision|13|||
160924945|NCT02967692|581121043|FG000|Overall Study|Adverse Event|2|||
160924946|NCT02967692|581121044|FG001|Overall Study|Adverse Event|9|||
160924947|NCT02967692|581121045|FG002|Overall Study|Adverse Event|60|||
160924948|NCT02967692|581121046|FG003|Overall Study|Adverse Event|28|||
160924949|NCT02967692|581121043|FG000|Overall Study|Study terminated by sponsor|2|||
160924950|NCT02967692|581121044|FG001|Overall Study|Study terminated by sponsor|1|||
160924951|NCT02967692|581121045|FG002|Overall Study|Study terminated by sponsor|42|||
160924952|NCT02967692|581121046|FG003|Overall Study|Study terminated by sponsor|37|||
160576857|NCT02792777|579832405|FG000|Overall Study|Withdrawal by Subject|2|||
160576858|NCT02792777|579832406|FG001|Overall Study|Withdrawal by Subject|0|||
160576859|NCT02792777|579832405|FG000|Overall Study|Recording malfunction|2|||
160576860|NCT02792777|579832406|FG001|Overall Study|Recording malfunction|0|||
160576861|NCT02792777|579832405|FG000|Overall Study|Later determined to be ineligible|2|||
160924953|NCT04447417|581121047|FG000|Overall Study|Withdrawal by Subject|1|||
160924954|NCT04447417|581121048|FG001|Overall Study|Withdrawal by Subject|0|||
160924955|NCT04447417|581121047|FG000|Overall Study|Failure to meet inclusion criteria|1|||
160576862|NCT02792777|579832406|FG001|Overall Study|Later determined to be ineligible|0|||
160576863|NCT02792777|579832405|FG000|Overall Study|Participant interviewed twice|1|||
160576864|NCT02792777|579832406|FG001|Overall Study|Participant interviewed twice|0|||
160576865|NCT02795156|579832407|FG000|Overall Study|Progressive Disease|22|||
160576866|NCT02795156|579832408|FG001|Overall Study|Progressive Disease|7|||
160576867|NCT02795156|579832409|FG002|Overall Study|Progressive Disease|34|||
160924956|NCT04447417|581121048|FG001|Overall Study|Failure to meet inclusion criteria|0|||
160924957|NCT04447417|581121047|FG000|Overall Study|Lost to Follow-up|1|||
160924958|NCT04447417|581121048|FG001|Overall Study|Lost to Follow-up|0|||
160924959|NCT00702403|581121049|FG000|From Consent to Engraftment|Progressive leukemia|6|||
160924960|NCT00702403|581121049|FG000|From Consent to Engraftment|Critically ill|2|||
160924961|NCT00702403|581121049|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
160924962|NCT00702403|581121049|FG000|From Consent to Engraftment|Myocardial infarction|1|||
160924963|NCT00702403|581121049|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
160924964|NCT00702403|581121049|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
160576868|NCT02795156|579832410|FG003|Overall Study|Progressive Disease|7|||
160576869|NCT02795156|579832407|FG000|Overall Study|Adverse Event|13|||
160576870|NCT02795156|579832408|FG001|Overall Study|Adverse Event|2|||
160576871|NCT02795156|579832409|FG002|Overall Study|Adverse Event|3|||
160576872|NCT02795156|579832410|FG003|Overall Study|Adverse Event|2|||
160924965|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
160924966|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
160924967|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Non-compliance|2|||
160924968|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
160924969|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
160924970|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Suicide|1|||
160924971|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
160924972|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
160924973|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
160924974|NCT00066066|581121053|FG000|Overall Study|Lost to Follow-up|6|||
160924975|NCT00066066|581121054|FG001|Overall Study|Lost to Follow-up|4|||
160924976|NCT00066066|581121055|FG002|Overall Study|Lost to Follow-up|7|||
160924977|NCT00066066|581121056|FG003|Overall Study|Lost to Follow-up|4|||
160924978|NCT00066066|581121057|FG004|Overall Study|Lost to Follow-up|3|||
160924979|NCT00066066|581121058|FG005|Overall Study|Lost to Follow-up|5|||
160924980|NCT00192504|581121067|FG000|Overall Study|Lost to Follow-up|1|||
160924981|NCT00192504|581121068|FG001|Overall Study|Lost to Follow-up|0|||
160924982|NCT00192504|581121069|FG002|Overall Study|Lost to Follow-up|0|||
160924983|NCT00192504|581121070|FG003|Overall Study|Lost to Follow-up|0|||
160924984|NCT00192504|581121067|FG000|Overall Study|Dosing window missed|0|||
160924985|NCT00192504|581121068|FG001|Overall Study|Dosing window missed|0|||
160924986|NCT00192504|581121069|FG002|Overall Study|Dosing window missed|1|||
160924987|NCT00192504|581121070|FG003|Overall Study|Dosing window missed|0|||
160924988|NCT03989440|581121071|FG000|Overall Study|COVID-19 travel restrictions|0|||
160924989|NCT03989440|581121072|FG001|Overall Study|COVID-19 travel restrictions|0|||
160997953|NCT00798265|581376708|FG000|Overall Study|Study closing|7|||
160576873|NCT02795156|579832407|FG000|Overall Study|Death|1|||
160576874|NCT02795156|579832408|FG001|Overall Study|Death|1|||
160576875|NCT02795156|579832409|FG002|Overall Study|Death|1|||
160576876|NCT02795156|579832410|FG003|Overall Study|Death|0|||
160576877|NCT02795156|579832407|FG000|Overall Study|Physician Decision|1|||
160576878|NCT02795156|579832408|FG001|Overall Study|Physician Decision|0|||
160576879|NCT02795156|579832409|FG002|Overall Study|Physician Decision|1|||
160576880|NCT02795156|579832410|FG003|Overall Study|Physician Decision|0|||
160576881|NCT02795156|579832407|FG000|Overall Study|Withdrawal by Subject|2|||
160576882|NCT02795156|579832408|FG001|Overall Study|Withdrawal by Subject|0|||
160576883|NCT02795156|579832409|FG002|Overall Study|Withdrawal by Subject|3|||
160576884|NCT02795156|579832410|FG003|Overall Study|Withdrawal by Subject|0|||
160576885|NCT03176966|579832417|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
160576886|NCT03176966|579832418|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
160576887|NCT03176966|579832417|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
160576888|NCT03176966|579832418|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
160576889|NCT03176966|579832417|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
160576890|NCT03176966|579832418|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
160576891|NCT03176966|579832417|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
160576892|NCT03176966|579832418|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
160576893|NCT03176966|579832417|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
160576894|NCT03176966|579832418|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
160576895|NCT03176966|579832417|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
160576896|NCT03176966|579832418|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
160576897|NCT03176966|579832417|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
160576898|NCT03176966|579832418|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
160576899|NCT01507246|579832419|FG000|Overall Study|Required different surgical procedures|2|||
160576900|NCT01507246|579832420|FG001|Overall Study|Required different surgical procedures|1|||
160576901|NCT03103750|579832421|FG000|Overall Study|Adverse Event|1|||
160576902|NCT03103750|579832422|FG001|Overall Study|Adverse Event|0|||
160576903|NCT03103750|579832421|FG000|Overall Study|Lost to Follow-up|1|||
160576904|NCT03103750|579832422|FG001|Overall Study|Lost to Follow-up|0|||
160576905|NCT03103750|579832421|FG000|Overall Study|PET Equipment Related|2|||
160576906|NCT03103750|579832422|FG001|Overall Study|PET Equipment Related|2|||
160576907|NCT03575468|579832426|FG000|Overall Study|Withdrawal by Subject|3|||
160576908|NCT03575468|579832427|FG001|Overall Study|Withdrawal by Subject|0|||
160997954|NCT00798265|581376709|FG001|Overall Study|Study closing|6|||
160997955|NCT00798265|581376708|FG000|Overall Study|Withdrawal by Subject|0|||
160997956|NCT00798265|581376709|FG001|Overall Study|Withdrawal by Subject|1|||
160997957|NCT00798265|581376708|FG000|Overall Study|Screen failure|0|||
160997958|NCT00798265|581376709|FG001|Overall Study|Screen failure|1|||
160576909|NCT03575468|579832426|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
160576910|NCT03575468|579832427|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
160654959|NCT00409578|580117217|FG001|Overall Study|Subject no longer requires study drug|0|||
160576911|NCT03575468|579832426|FG000|Overall Study|Lost to Follow-up|13|||
160576912|NCT03575468|579832427|FG001|Overall Study|Lost to Follow-up|17|||
160576913|NCT00404768|579832428|FG000|Part A and B|Withdrawn due to labor progression|1|||
160576914|NCT00404768|579832429|FG001|Part A and B|Withdrawn due to labor progression|0|||
160576915|NCT00404768|579832430|FG002|Part A and B|Withdrawn due to labor progression|0|||
160924990|NCT03989440|581121073|FG002|Overall Study|COVID-19 travel restrictions|1|||
160924991|NCT03989440|581121074|FG003|Overall Study|COVID-19 travel restrictions|0|||
160924992|NCT03989440|581121075|FG004|Overall Study|COVID-19 travel restrictions|0|||
160924993|NCT03989440|581121076|FG005|Overall Study|COVID-19 travel restrictions|0|||
160924994|NCT03989440|581121071|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
160924995|NCT03989440|581121072|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
160924996|NCT03989440|581121073|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
160924997|NCT03989440|581121074|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
160924998|NCT03989440|581121075|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
160924999|NCT03989440|581121076|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
160925000|NCT01955161|581121077|FG000|Overall Study|Withdrawal before treatment|2|||
160925001|NCT01955161|581121078|FG001|Overall Study|Withdrawal before treatment|0|||
160925002|NCT01955161|581121079|FG002|Overall Study|Withdrawal before treatment|1|||
160925003|NCT01955161|581121077|FG000|Overall Study|Adverse Event|10|||
160925004|NCT01955161|581121078|FG001|Overall Study|Adverse Event|14|||
160925005|NCT01955161|581121079|FG002|Overall Study|Adverse Event|15|||
160925006|NCT01955161|581121077|FG000|Overall Study|Death|1|||
160925007|NCT01955161|581121078|FG001|Overall Study|Death|1|||
160925008|NCT01955161|581121079|FG002|Overall Study|Death|3|||
160925009|NCT01955161|581121077|FG000|Overall Study|Withdrawal by Subject|9|||
160925010|NCT01955161|581121078|FG001|Overall Study|Withdrawal by Subject|8|||
160925011|NCT01955161|581121079|FG002|Overall Study|Withdrawal by Subject|12|||
160925012|NCT01955161|581121077|FG000|Overall Study|Protocol Violation|2|||
160925013|NCT01955161|581121078|FG001|Overall Study|Protocol Violation|0|||
160925014|NCT01955161|581121079|FG002|Overall Study|Protocol Violation|0|||
160925015|NCT01955161|581121077|FG000|Overall Study|Other reason: physician decision|0|||
160576916|NCT00404768|579832431|FG003|Part A and B|Withdrawn due to labor progression|0|||
160925016|NCT01955161|581121078|FG001|Overall Study|Other reason: physician decision|1|||
160925017|NCT01955161|581121079|FG002|Overall Study|Other reason: physician decision|1|||
160925018|NCT01955161|581121077|FG000|Overall Study|Other reason: disallowed medication|1|||
160925019|NCT01955161|581121078|FG001|Overall Study|Other reason: disallowed medication|0|||
160925020|NCT01955161|581121079|FG002|Overall Study|Other reason: disallowed medication|1|||
160925021|NCT01955161|581121077|FG000|Overall Study|Other reason: caregiver unavailable|1|||
160925022|NCT01955161|581121078|FG001|Overall Study|Other reason: caregiver unavailable|0|||
160925023|NCT01955161|581121079|FG002|Overall Study|Other reason: caregiver unavailable|0|||
160925024|NCT01955161|581121077|FG000|Overall Study|Other reason: moved to nursing home|0|||
160925025|NCT01955161|581121078|FG001|Overall Study|Other reason: moved to nursing home|1|||
160925026|NCT01955161|581121079|FG002|Overall Study|Other reason: moved to nursing home|0|||
160925027|NCT01955161|581121077|FG000|Overall Study|Other reason: insufficient compliance|0|||
160925028|NCT01955161|581121078|FG001|Overall Study|Other reason: insufficient compliance|0|||
160925029|NCT01955161|581121079|FG002|Overall Study|Other reason: insufficient compliance|1|||
160925030|NCT01955161|581121077|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
160925031|NCT01955161|581121078|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
160576917|NCT00404768|579832428|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
160576918|NCT00404768|579832429|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
160576919|NCT00404768|579832430|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
160576920|NCT00404768|579832431|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
160576921|NCT00404768|579832428|FG000|Part C|Adverse Event|0|||
160576922|NCT00404768|579832429|FG001|Part C|Adverse Event|0|||
160576923|NCT00404768|579832430|FG002|Part C|Adverse Event|0|||
160576924|NCT00404768|579832431|FG003|Part C|Adverse Event|3|||
160576925|NCT00404768|579832428|FG000|Part C|Lost to Follow-up|0|||
160576926|NCT00404768|579832429|FG001|Part C|Lost to Follow-up|0|||
160576927|NCT00404768|579832430|FG002|Part C|Lost to Follow-up|3|||
160576928|NCT00404768|579832431|FG003|Part C|Lost to Follow-up|1|||
160576929|NCT00404768|579832428|FG000|Part C|Withdrawal by Subject|0|||
160576930|NCT00404768|579832429|FG001|Part C|Withdrawal by Subject|0|||
160576931|NCT00404768|579832430|FG002|Part C|Withdrawal by Subject|2|||
160576932|NCT00404768|579832431|FG003|Part C|Withdrawal by Subject|1|||
160576933|NCT00404768|579832428|FG000|Part C|Early withdrawal from study medication|0|||
160576934|NCT00404768|579832429|FG001|Part C|Early withdrawal from study medication|0|||
160576935|NCT00404768|579832430|FG002|Part C|Early withdrawal from study medication|1|||
160576936|NCT00404768|579832431|FG003|Part C|Early withdrawal from study medication|0|||
160925032|NCT01955161|581121079|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
160925033|NCT01955161|581121077|FG000|Overall Study|Other reason: patient's will|0|||
160997959|NCT00589667|581378495|FG000|Overall Study|Adverse Event|2|||
160576937|NCT00404768|579832428|FG000|Part C|Participant did not respond to therapy|0|||
160576938|NCT00404768|579832429|FG001|Part C|Participant did not respond to therapy|0|||
160654960|NCT00409578|580117218|FG002|Overall Study|Subject no longer requires study drug|0|||
160576939|NCT00404768|579832430|FG002|Part C|Participant did not respond to therapy|1|||
160576940|NCT00404768|579832431|FG003|Part C|Participant did not respond to therapy|1|||
160576941|NCT00404768|579832428|FG000|Part C|Physician withdrew the study medication|0|||
160654961|NCT00409578|580117219|FG003|Overall Study|Subject no longer requires study drug|1|||
160654962|NCT00409578|580117216|FG000|Overall Study|Withdrawal by Subject|8|||
160654963|NCT00409578|580117217|FG001|Overall Study|Withdrawal by Subject|15|||
160654964|NCT00409578|580117218|FG002|Overall Study|Withdrawal by Subject|16|||
160654965|NCT00409578|580117219|FG003|Overall Study|Withdrawal by Subject|17|||
160654966|NCT00409578|580117216|FG000|Overall Study|Lost to Follow-up|2|||
160654967|NCT00409578|580117217|FG001|Overall Study|Lost to Follow-up|0|||
160654968|NCT00409578|580117218|FG002|Overall Study|Lost to Follow-up|2|||
160654969|NCT00409578|580117219|FG003|Overall Study|Lost to Follow-up|2|||
160654970|NCT00409578|580117216|FG000|Overall Study|Administrative problems|8|||
160654971|NCT00409578|580117217|FG001|Overall Study|Administrative problems|9|||
160654972|NCT00409578|580117218|FG002|Overall Study|Administrative problems|2|||
160654973|NCT00409578|580117219|FG003|Overall Study|Administrative problems|4|||
160654974|NCT00409578|580117216|FG000|Overall Study|Death|2|||
160654975|NCT00409578|580117217|FG001|Overall Study|Death|4|||
160654976|NCT00409578|580117218|FG002|Overall Study|Death|4|||
160654977|NCT00409578|580117219|FG003|Overall Study|Death|2|||
160654978|NCT00409578|580117216|FG000|Overall Study|Protocol Violation|3|||
160654979|NCT00409578|580117217|FG001|Overall Study|Protocol Violation|2|||
160654980|NCT00409578|580117218|FG002|Overall Study|Protocol Violation|3|||
160654981|NCT00409578|580117219|FG003|Overall Study|Protocol Violation|1|||
160654982|NCT00409578|580117216|FG000|Overall Study|Missing|0|||
160654983|NCT00409578|580117217|FG001|Overall Study|Missing|1|||
160654984|NCT00409578|580117218|FG002|Overall Study|Missing|0|||
160654985|NCT00409578|580117219|FG003|Overall Study|Missing|1|||
160654986|NCT02109133|580117222|FG000|Overall Study|Lost to Follow-up|1|||
160654987|NCT02109133|580117223|FG001|Overall Study|Lost to Follow-up|0|||
160654988|NCT05200858|580117224|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
160654989|NCT05200858|580117225|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
160654990|NCT05200858|580117226|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
160654991|NCT05200858|580117227|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
160654992|NCT02448771|580117228|FG000|Overall Study|Disease Progression|30|||
160654993|NCT02448771|580117228|FG000|Overall Study|Unacceptable Toxicity|1|||
160654994|NCT02448771|580117228|FG000|Overall Study|Physician Decision|3|||
160654995|NCT02448771|580117228|FG000|Overall Study|Started new therapy|2|||
160654996|NCT01781637|580118623|FG000|Overall Study|Adverse Event|1|||
160654997|NCT01781637|580118624|FG001|Overall Study|Adverse Event|0|||
160654998|NCT01781637|580118623|FG000|Overall Study|Lack of Efficacy|2|||
160654999|NCT01781637|580118624|FG001|Overall Study|Lack of Efficacy|6|||
160655000|NCT01781637|580118623|FG000|Overall Study|Withdrawal by Subject|1|||
160655001|NCT01781637|580118624|FG001|Overall Study|Withdrawal by Subject|0|||
160655002|NCT02637232|580118625|FG000|Overall Study|Lost to Follow-up|42|||
160655003|NCT02637232|580118625|FG000|Overall Study|Adverse Event|11|||
160655004|NCT02637232|580118625|FG000|Overall Study|patient 's decision|2|||
160655005|NCT00090857|580118627|FG000|Overall Study|Lost to Follow-up|0|||
160655006|NCT00090857|580118628|FG001|Overall Study|Lost to Follow-up|1|||
160655007|NCT00090857|580118627|FG000|Overall Study|Withdrawal by Subject|2|||
160655008|NCT00090857|580118628|FG001|Overall Study|Withdrawal by Subject|0|||
160655009|NCT00090857|580118627|FG000|Overall Study|Adverse Event|2|||
160655010|NCT00090857|580118628|FG001|Overall Study|Adverse Event|2|||
160576942|NCT00404768|579832429|FG001|Part C|Physician withdrew the study medication|0|||
160576943|NCT00404768|579832430|FG002|Part C|Physician withdrew the study medication|1|||
160576944|NCT00404768|579832431|FG003|Part C|Physician withdrew the study medication|0|||
160576945|NCT00404768|579832428|FG000|Part C|Participant delivered baby|0|||
160576946|NCT00404768|579832429|FG001|Part C|Participant delivered baby|0|||
160576947|NCT00404768|579832430|FG002|Part C|Participant delivered baby|0|||
160576948|NCT00404768|579832431|FG003|Part C|Participant delivered baby|1|||
160576949|NCT00404768|579832428|FG000|Part C|Unsatisfactory uterine response to IP|0|||
160576950|NCT00404768|579832429|FG001|Part C|Unsatisfactory uterine response to IP|0|||
160576951|NCT00404768|579832430|FG002|Part C|Unsatisfactory uterine response to IP|0|||
160576952|NCT00404768|579832431|FG003|Part C|Unsatisfactory uterine response to IP|1|||
160576953|NCT00404768|579832428|FG000|Part C|Active labor|0|||
160655011|NCT05097326|580118629|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
160576954|NCT00404768|579832429|FG001|Part C|Active labor|0|||
160576955|NCT00404768|579832430|FG002|Part C|Active labor|0|||
160655012|NCT05097326|580118630|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
160655013|NCT03480425|580118632|FG000|Overall Study|Force transducer technical failure|1|||
160655014|NCT01244126|580118633|FG000|Overall Study|Protocol Violation|3|||
160655015|NCT01244126|580118634|FG001|Overall Study|Protocol Violation|3|||
160655016|NCT01244126|580118635|FG002|Overall Study|Protocol Violation|9|||
160655017|NCT00863746|580118649|FG000|Treatment|Not treated|4|||
160655018|NCT00863746|580118650|FG001|Treatment|Not treated|2|||
160655019|NCT00863746|580118649|FG000|Treatment|Adverse Event|41|||
160576956|NCT00404768|579832431|FG003|Part C|Active labor|1|||
160655020|NCT00863746|580118650|FG001|Treatment|Adverse Event|16|||
160576957|NCT00404768|579832428|FG000|Part C|Lack of Efficacy|0|||
160655021|NCT00863746|580118649|FG000|Treatment|non-compliant with study medication|4|||
160655022|NCT00863746|580118650|FG001|Treatment|non-compliant with study medication|0|||
160655023|NCT00863746|580118649|FG000|Treatment|Consent withdrawn|15|||
160655024|NCT00863746|580118650|FG001|Treatment|Consent withdrawn|14|||
160655025|NCT00863746|580118649|FG000|Treatment|Lost to Follow-up|1|||
160655026|NCT00863746|580118650|FG001|Treatment|Lost to Follow-up|0|||
160655027|NCT00863746|580118649|FG000|Treatment|Protocol Violation|5|||
160655028|NCT00863746|580118650|FG001|Treatment|Protocol Violation|3|||
160655029|NCT00863746|580118649|FG000|Treatment|Other|1|||
160655030|NCT00863746|580118650|FG001|Treatment|Other|0|||
160655031|NCT00863746|580118649|FG000|Survival Follow up|Death|244|||
160655032|NCT00863746|580118650|FG001|Survival Follow up|Death|271|||
160655033|NCT00863746|580118649|FG000|Survival Follow up|Lost to Follow-up|2|||
160655034|NCT00863746|580118650|FG001|Survival Follow up|Lost to Follow-up|1|||
160655035|NCT00863746|580118649|FG000|Survival Follow up|Consent Withdrawn|7|||
160655036|NCT00863746|580118650|FG001|Survival Follow up|Consent Withdrawn|8|||
160655037|NCT03292653|580118651|FG000|Overall Study|Adverse Event|0|||
160655038|NCT03292653|580118652|FG001|Overall Study|Adverse Event|0|||
160655039|NCT03292653|580118653|FG002|Overall Study|Adverse Event|1|||
160655040|NCT03292653|580118651|FG000|Overall Study|Did not Receive Treatment|1|||
160655041|NCT03292653|580118652|FG001|Overall Study|Did not Receive Treatment|0|||
160655042|NCT03292653|580118653|FG002|Overall Study|Did not Receive Treatment|0|||
160655043|NCT04373434|580118658|FG000|Overall Study|Lost to Follow-up|37|||
160655044|NCT04373434|580118659|FG001|Overall Study|Lost to Follow-up|32|||
160655045|NCT04373434|580118658|FG000|Overall Study|Refused at 9 months|1|||
160655046|NCT04373434|580118659|FG001|Overall Study|Refused at 9 months|2|||
160655047|NCT04373434|580118658|FG000|Overall Study|Refused at 4 months|7|||
160655048|NCT04373434|580118659|FG001|Overall Study|Refused at 4 months|3|||
160655049|NCT04373434|580118658|FG000|Overall Study|Excluded|2|||
160655050|NCT04373434|580118659|FG001|Overall Study|Excluded|0|||
160655051|NCT00527423|580118660|FG000|Overall Study|Protocol Violation|1|||
160655052|NCT00527423|580118660|FG000|Overall Study|Adverse Event|5|||
160655053|NCT00527423|580118660|FG000|Overall Study|Physician Decision|4|||
160655054|NCT00527423|580118660|FG000|Overall Study|Withdrawal by Subject|10|||
160655055|NCT00527423|580118660|FG000|Overall Study|Lost to Follow-up|4|||
160655056|NCT00527423|580118660|FG000|Overall Study|OTHER|4|||
160655057|NCT00527423|580118660|FG000|Overall Study|Death|9|||
160655058|NCT02446132|580118663|FG000|Overall Study|Adverse Event|10|||
160655059|NCT02446132|580118664|FG001|Overall Study|Adverse Event|27|||
160655060|NCT02446132|580118665|FG002|Overall Study|Adverse Event|27|||
160655061|NCT02446132|580118663|FG000|Overall Study|Death|2|||
160655062|NCT02446132|580118664|FG001|Overall Study|Death|13|||
160655063|NCT02446132|580118665|FG002|Overall Study|Death|10|||
160655064|NCT02446132|580118663|FG000|Overall Study|Lack of Efficacy|1|||
160655065|NCT02446132|580118664|FG001|Overall Study|Lack of Efficacy|10|||
160655066|NCT02446132|580118665|FG002|Overall Study|Lack of Efficacy|6|||
160655067|NCT02446132|580118663|FG000|Overall Study|Lost to Follow-up|2|||
160655068|NCT02446132|580118664|FG001|Overall Study|Lost to Follow-up|4|||
160655069|NCT02446132|580118665|FG002|Overall Study|Lost to Follow-up|5|||
160655070|NCT02446132|580118663|FG000|Overall Study|Non-compliance With Study Drug|2|||
160655071|NCT02446132|580118664|FG001|Overall Study|Non-compliance With Study Drug|2|||
160655072|NCT02446132|580118665|FG002|Overall Study|Non-compliance With Study Drug|3|||
160655073|NCT02446132|580118663|FG000|Overall Study|Physician Decision|1|||
160655074|NCT02446132|580118664|FG001|Overall Study|Physician Decision|8|||
160655075|NCT02446132|580118665|FG002|Overall Study|Physician Decision|13|||
160655076|NCT02446132|580118663|FG000|Overall Study|Protocol Deviation|0|||
160655077|NCT02446132|580118664|FG001|Overall Study|Protocol Deviation|0|||
160655078|NCT02446132|580118665|FG002|Overall Study|Protocol Deviation|1|||
160655079|NCT02446132|580118663|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
160655080|NCT02446132|580118664|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
160655081|NCT02446132|580118665|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
160655082|NCT02446132|580118663|FG000|Overall Study|Study Terminated by Sponsor|4|||
160655083|NCT02446132|580118664|FG001|Overall Study|Study Terminated by Sponsor|35|||
160655084|NCT02446132|580118665|FG002|Overall Study|Study Terminated by Sponsor|58|||
160655085|NCT02446132|580118663|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
160655086|NCT02446132|580118664|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
160655087|NCT02446132|580118665|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
160655088|NCT02446132|580118663|FG000|Overall Study|Withdrawal by Subject|11|||
160655089|NCT02446132|580118664|FG001|Overall Study|Withdrawal by Subject|29|||
160655090|NCT02446132|580118665|FG002|Overall Study|Withdrawal by Subject|25|||
160655091|NCT02446132|580118663|FG000|Overall Study|Reason not Specified|4|||
160655092|NCT02446132|580118664|FG001|Overall Study|Reason not Specified|16|||
160655093|NCT02446132|580118665|FG002|Overall Study|Reason not Specified|10|||
160655094|NCT02446132|580118663|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
160655095|NCT02446132|580118664|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
160655096|NCT02446132|580118665|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
160655097|NCT00436007|580118669|FG000|Overall Study|Withdrawal by Subject|5|||
160655098|NCT00436007|580118670|FG001|Overall Study|Withdrawal by Subject|3|||
160655099|NCT00436007|580118671|FG002|Overall Study|Withdrawal by Subject|4|||
160655100|NCT00436007|580118669|FG000|Overall Study|Lost to Follow-up|14|||
160655101|NCT00436007|580118670|FG001|Overall Study|Lost to Follow-up|10|||
160576958|NCT00404768|579832429|FG001|Part C|Lack of Efficacy|0|||
160925034|NCT01955161|581121078|FG001|Overall Study|Other reason: patient's will|0|||
160925035|NCT01955161|581121079|FG002|Overall Study|Other reason: patient's will|1|||
160925036|NCT04608500|581121080|FG000|Overall Study|Adverse Event|2|||
160925037|NCT04608500|581121081|FG001|Overall Study|Adverse Event|0|||
160925038|NCT04608500|581121080|FG000|Overall Study|Lost to Follow-up|15|||
160925039|NCT04608500|581121081|FG001|Overall Study|Lost to Follow-up|9|||
160925040|NCT04608500|581121080|FG000|Overall Study|Participant request|11|||
160925041|NCT04608500|581121081|FG001|Overall Study|Participant request|7|||
160925042|NCT04608500|581121080|FG000|Overall Study|Protocol Violation|1|||
160925043|NCT04608500|581121081|FG001|Overall Study|Protocol Violation|0|||
160925044|NCT04608500|581121080|FG000|Overall Study|Other|6|||
160576959|NCT00404768|579832430|FG002|Part C|Lack of Efficacy|0|||
160576960|NCT00404768|579832431|FG003|Part C|Lack of Efficacy|2|||
160576961|NCT00404768|579832428|FG000|Part C|Treatment failure|0|||
160576962|NCT00404768|579832429|FG001|Part C|Treatment failure|0|||
160576963|NCT00404768|579832430|FG002|Part C|Treatment failure|0|||
160576964|NCT00404768|579832431|FG003|Part C|Treatment failure|1|||
160576965|NCT00404768|579832428|FG000|Part C|Investigator discretion|0|||
160576966|NCT00404768|579832429|FG001|Part C|Investigator discretion|0|||
160576967|NCT00404768|579832430|FG002|Part C|Investigator discretion|0|||
160576968|NCT00404768|579832431|FG003|Part C|Investigator discretion|1|||
160576969|NCT00404768|579832428|FG000|Part C|Researcher suspended study medication|0|||
160576970|NCT00404768|579832429|FG001|Part C|Researcher suspended study medication|0|||
160576971|NCT00404768|579832430|FG002|Part C|Researcher suspended study medication|0|||
160576972|NCT00404768|579832431|FG003|Part C|Researcher suspended study medication|1|||
160576973|NCT01522651|579832434|FG000|Overall Study|Adverse Event|3|||
160576974|NCT01522651|579832435|FG001|Overall Study|Adverse Event|4|||
160576975|NCT01522651|579832436|FG002|Overall Study|Adverse Event|4|||
160576976|NCT01522651|579832437|FG003|Overall Study|Adverse Event|5|||
160576977|NCT01522651|579832438|FG004|Overall Study|Adverse Event|4|||
160576978|NCT01522651|579832434|FG000|Overall Study|Cardioversion|1|||
160576979|NCT01522651|579832435|FG001|Overall Study|Cardioversion|0|||
160576980|NCT01522651|579832436|FG002|Overall Study|Cardioversion|0|||
160576981|NCT01522651|579832437|FG003|Overall Study|Cardioversion|0|||
160576982|NCT01522651|579832438|FG004|Overall Study|Cardioversion|0|||
160576983|NCT01522651|579832434|FG000|Overall Study|Device Malfunction|0|||
160576984|NCT01522651|579832435|FG001|Overall Study|Device Malfunction|1|||
160576985|NCT01522651|579832436|FG002|Overall Study|Device Malfunction|0|||
160576986|NCT01522651|579832437|FG003|Overall Study|Device Malfunction|0|||
160576987|NCT01522651|579832438|FG004|Overall Study|Device Malfunction|0|||
160576988|NCT01522651|579832434|FG000|Overall Study|Investigator's Discretion|0|||
160576989|NCT01522651|579832435|FG001|Overall Study|Investigator's Discretion|1|||
160576990|NCT01522651|579832436|FG002|Overall Study|Investigator's Discretion|0|||
160576991|NCT01522651|579832437|FG003|Overall Study|Investigator's Discretion|0|||
160925045|NCT04608500|581121081|FG001|Overall Study|Other|2|||
160925046|NCT00542919|581121082|FG000|Overall Study|Adverse Event|1|||
160925047|NCT00542919|581121083|FG001|Overall Study|Adverse Event|5|||
160925048|NCT00542919|581121084|FG002|Overall Study|Adverse Event|1|||
160925049|NCT00542919|581121082|FG000|Overall Study|Withdrawal by Subject|1|||
160925050|NCT00542919|581121083|FG001|Overall Study|Withdrawal by Subject|0|||
160925051|NCT00542919|581121084|FG002|Overall Study|Withdrawal by Subject|3|||
160925052|NCT00542919|581121082|FG000|Overall Study|Physician Decision|2|||
160925053|NCT00542919|581121083|FG001|Overall Study|Physician Decision|2|||
160925054|NCT00542919|581121084|FG002|Overall Study|Physician Decision|1|||
160576992|NCT01522651|579832438|FG004|Overall Study|Investigator's Discretion|0|||
160576993|NCT01522651|579832434|FG000|Overall Study|Protocol Violation|3|||
160576994|NCT01522651|579832435|FG001|Overall Study|Protocol Violation|0|||
160576995|NCT01522651|579832436|FG002|Overall Study|Protocol Violation|0|||
160576996|NCT01522651|579832437|FG003|Overall Study|Protocol Violation|0|||
160576997|NCT01522651|579832438|FG004|Overall Study|Protocol Violation|0|||
160576998|NCT01522651|579832434|FG000|Overall Study|Reason Not Specified|0|||
160576999|NCT01522651|579832435|FG001|Overall Study|Reason Not Specified|0|||
160577000|NCT01522651|579832436|FG002|Overall Study|Reason Not Specified|0|||
160577001|NCT01522651|579832437|FG003|Overall Study|Reason Not Specified|1|||
160577002|NCT01522651|579832438|FG004|Overall Study|Reason Not Specified|0|||
160577003|NCT01522651|579832434|FG000|Overall Study|Participant Non-Compliance|1|||
160577004|NCT01522651|579832435|FG001|Overall Study|Participant Non-Compliance|0|||
160577005|NCT01522651|579832436|FG002|Overall Study|Participant Non-Compliance|0|||
160577006|NCT01522651|579832437|FG003|Overall Study|Participant Non-Compliance|0|||
160577007|NCT01522651|579832438|FG004|Overall Study|Participant Non-Compliance|0|||
160577008|NCT01522651|579832434|FG000|Overall Study|Withdrew Consent|1|||
160577009|NCT01522651|579832435|FG001|Overall Study|Withdrew Consent|1|||
160577010|NCT01522651|579832436|FG002|Overall Study|Withdrew Consent|0|||
160577011|NCT01522651|579832437|FG003|Overall Study|Withdrew Consent|1|||
160925055|NCT00542919|581121082|FG000|Overall Study|Sponsor Decision|1|||
160925056|NCT00542919|581121083|FG001|Overall Study|Sponsor Decision|0|||
160925057|NCT00542919|581121084|FG002|Overall Study|Sponsor Decision|0|||
160925058|NCT00542919|581121082|FG000|Overall Study|Lost to Follow-up|2|||
160577012|NCT01522651|579832438|FG004|Overall Study|Withdrew Consent|1|||
160577013|NCT01522651|579832434|FG000|Overall Study|Randomized but Never Treated|0|||
160577014|NCT01522651|579832435|FG001|Overall Study|Randomized but Never Treated|1|||
160577015|NCT01522651|579832436|FG002|Overall Study|Randomized but Never Treated|0|||
160577016|NCT01522651|579832437|FG003|Overall Study|Randomized but Never Treated|1|||
160577017|NCT01522651|579832438|FG004|Overall Study|Randomized but Never Treated|1|||
160577018|NCT01118143|579832439|FG000|Overall Study|Withdrawal by Subject|2|||
160577019|NCT01118143|579832440|FG001|Overall Study|Withdrawal by Subject|5|||
160577020|NCT03625986|579834419|FG000|Randomization Period|Lost to Follow-up|7|||
160577021|NCT03625986|579834420|FG001|Randomization Period|Lost to Follow-up|12|||
160577022|NCT03625986|579834419|FG000|Randomization Period|Withdrawal by Subject|10|||
160577023|NCT03625986|579834420|FG001|Randomization Period|Withdrawal by Subject|6|||
160577024|NCT01115569|579834425|FG000|Conversion/Titration Phase|Adverse Event|59|||
160577025|NCT01115569|579834426|FG001|Conversion/Titration Phase|Adverse Event|0|||
160655102|NCT00436007|580118671|FG002|Overall Study|Lost to Follow-up|13|||
160577026|NCT01115569|579834425|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
160577027|NCT01115569|579834426|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
160655103|NCT00436007|580118669|FG000|Overall Study|Physician Decision|0|||
160655104|NCT00436007|580118670|FG001|Overall Study|Physician Decision|0|||
160655105|NCT00436007|580118671|FG002|Overall Study|Physician Decision|2|||
160655106|NCT00436007|580118669|FG000|Overall Study|Death|0|||
160655107|NCT00436007|580118670|FG001|Overall Study|Death|1|||
160655108|NCT00436007|580118671|FG002|Overall Study|Death|3|||
160655109|NCT00436007|580118669|FG000|Overall Study|Other|0|||
160655110|NCT00436007|580118670|FG001|Overall Study|Other|0|||
160655111|NCT00436007|580118671|FG002|Overall Study|Other|1|||
160655112|NCT01439165|580118673|FG000|Overall Study|Protocol Violation|3|||
160655113|NCT01439165|580118674|FG001|Overall Study|Protocol Violation|0|||
160655114|NCT01439165|580118673|FG000|Overall Study|Lost to Follow-up|11|||
160655115|NCT01439165|580118674|FG001|Overall Study|Lost to Follow-up|1|||
160655116|NCT01439165|580118673|FG000|Overall Study|Withdrawal by Subject|7|||
160655117|NCT01439165|580118674|FG001|Overall Study|Withdrawal by Subject|1|||
160655118|NCT03331042|580118675|FG000|Overall Study|Protocol Violation|1|||
160655119|NCT03331042|580118676|FG001|Overall Study|Protocol Violation|0|||
160655120|NCT03331042|580118677|FG002|Overall Study|Protocol Violation|0|||
160655121|NCT03331042|580118678|FG003|Overall Study|Protocol Violation|0|||
160655122|NCT03331042|580118675|FG000|Overall Study|Physician Decision|0|||
160655123|NCT03331042|580118676|FG001|Overall Study|Physician Decision|0|||
160655124|NCT03331042|580118677|FG002|Overall Study|Physician Decision|1|||
160655125|NCT03331042|580118678|FG003|Overall Study|Physician Decision|0|||
160655126|NCT03331042|580118675|FG000|Overall Study|Lost to Follow-up|0|||
160655127|NCT03331042|580118676|FG001|Overall Study|Lost to Follow-up|0|||
160655128|NCT03331042|580118677|FG002|Overall Study|Lost to Follow-up|0|||
160655129|NCT03331042|580118678|FG003|Overall Study|Lost to Follow-up|1|||
160655130|NCT02720510|580118682|FG000|Overall Study|Study Terminated by the sponsor|2|||
160655131|NCT02720510|580118683|FG001|Overall Study|Study Terminated by the sponsor|0|||
160655132|NCT02720510|580118682|FG000|Overall Study|Adverse Event|0|||
160655133|NCT02720510|580118683|FG001|Overall Study|Adverse Event|1|||
160655134|NCT02720510|580118682|FG000|Overall Study|Physician Decision|1|||
160655135|NCT02720510|580118683|FG001|Overall Study|Physician Decision|2|||
160655136|NCT02460159|580118684|FG000|Overall Study|Adverse Event|4|||
160655137|NCT02460159|580118685|FG001|Overall Study|Adverse Event|1|||
160655138|NCT02460159|580118684|FG000|Overall Study|Withdrawal by Subject|2|||
160655139|NCT02460159|580118685|FG001|Overall Study|Withdrawal by Subject|0|||
160655140|NCT03499964|580118686|FG000|Overall Study|Lack of Efficacy|6|||
160655141|NCT03499964|580118687|FG001|Overall Study|Lack of Efficacy|26|||
160655142|NCT03499964|580118686|FG000|Overall Study|Adverse Event|1|||
160655143|NCT03499964|580118687|FG001|Overall Study|Adverse Event|0|||
160655144|NCT03499964|580118686|FG000|Overall Study|Death|1|||
160655145|NCT03499964|580118687|FG001|Overall Study|Death|0|||
160655146|NCT03499964|580118686|FG000|Overall Study|Withdrawal by Subject|2|||
160655147|NCT03499964|580118687|FG001|Overall Study|Withdrawal by Subject|1|||
160655148|NCT03499964|580118686|FG000|Overall Study|Lost to Follow-up|1|||
160655149|NCT03499964|580118687|FG001|Overall Study|Lost to Follow-up|0|||
160655150|NCT02465567|580118691|FG000|Overall Study|Adverse Event|118|||
160655151|NCT02465567|580118692|FG001|Overall Study|Adverse Event|113|||
160655152|NCT02465567|580118693|FG002|Overall Study|Adverse Event|147|||
160655153|NCT02465567|580118694|FG003|Overall Study|Adverse Event|138|||
160655154|NCT02465567|580118691|FG000|Overall Study|Lack of Efficacy|103|||
160655155|NCT02465567|580118692|FG001|Overall Study|Lack of Efficacy|102|||
160655156|NCT02465567|580118693|FG002|Overall Study|Lack of Efficacy|171|||
160655157|NCT02465567|580118694|FG003|Overall Study|Lack of Efficacy|135|||
160577028|NCT01115569|579834425|FG000|Conversion/Titration Phase|Physician Decision|5|||
160577029|NCT01115569|579834426|FG001|Conversion/Titration Phase|Physician Decision|0|||
160655158|NCT02465567|580118691|FG000|Overall Study|Withdrawal by Subject|104|||
160655159|NCT02465567|580118692|FG001|Overall Study|Withdrawal by Subject|94|||
160655160|NCT02465567|580118693|FG002|Overall Study|Withdrawal by Subject|123|||
160655161|NCT02465567|580118694|FG003|Overall Study|Withdrawal by Subject|130|||
160655162|NCT02465567|580118691|FG000|Overall Study|Physician Decision|23|||
160655163|NCT02465567|580118692|FG001|Overall Study|Physician Decision|33|||
160655164|NCT02465567|580118693|FG002|Overall Study|Physician Decision|38|||
160655165|NCT02465567|580118694|FG003|Overall Study|Physician Decision|28|||
160655166|NCT02465567|580118691|FG000|Overall Study|Major Protocol Deviation|24|||
160655167|NCT02465567|580118692|FG001|Overall Study|Major Protocol Deviation|26|||
160655168|NCT02465567|580118693|FG002|Overall Study|Major Protocol Deviation|22|||
160655169|NCT02465567|580118694|FG003|Overall Study|Major Protocol Deviation|25|||
160655170|NCT02465567|580118691|FG000|Overall Study|Lost to Follow-up|25|||
160655171|NCT02465567|580118692|FG001|Overall Study|Lost to Follow-up|21|||
160655172|NCT02465567|580118693|FG002|Overall Study|Lost to Follow-up|19|||
160655173|NCT02465567|580118694|FG003|Overall Study|Lost to Follow-up|15|||
160655174|NCT02465567|580118691|FG000|Overall Study|Protocol Specified Criteria|20|||
160655175|NCT02465567|580118692|FG001|Overall Study|Protocol Specified Criteria|10|||
160655176|NCT02465567|580118693|FG002|Overall Study|Protocol Specified Criteria|9|||
160655177|NCT02465567|580118694|FG003|Overall Study|Protocol Specified Criteria|12|||
160655178|NCT02465567|580118691|FG000|Overall Study|Administrative Reasons|12|||
160655179|NCT02465567|580118692|FG001|Overall Study|Administrative Reasons|9|||
160655180|NCT02465567|580118693|FG002|Overall Study|Administrative Reasons|11|||
160655181|NCT02465567|580118694|FG003|Overall Study|Administrative Reasons|5|||
160655182|NCT02465567|580118691|FG000|Overall Study|Randomized but not treated|1|||
160655183|NCT02465567|580118692|FG001|Overall Study|Randomized but not treated|5|||
160655184|NCT02465567|580118693|FG002|Overall Study|Randomized but not treated|4|||
160655185|NCT02465567|580118694|FG003|Overall Study|Randomized but not treated|5|||
160655186|NCT02465567|580118691|FG000|Overall Study|enrolled in >1 studies|18|||
160655187|NCT02465567|580118692|FG001|Overall Study|enrolled in >1 studies|11|||
160655188|NCT02465567|580118693|FG002|Overall Study|enrolled in >1 studies|19|||
160655189|NCT02465567|580118694|FG003|Overall Study|enrolled in >1 studies|15|||
160655190|NCT02465567|580118691|FG000|Overall Study|missing PI Signature|1|||
160655191|NCT02465567|580118692|FG001|Overall Study|missing PI Signature|0|||
160925059|NCT00542919|581121083|FG001|Overall Study|Lost to Follow-up|0|||
160925060|NCT00542919|581121084|FG002|Overall Study|Lost to Follow-up|1|||
160925061|NCT05123222|581121096|FG000|Overall Study|Lost to Follow-up|2|||
160925062|NCT05123222|581121097|FG001|Overall Study|Lost to Follow-up|0|||
160577030|NCT01115569|579834425|FG000|Conversion/Titration Phase|Protocol Violation|68|||
160577031|NCT01115569|579834426|FG001|Conversion/Titration Phase|Protocol Violation|0|||
160577032|NCT01115569|579834425|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
160577033|NCT01115569|579834426|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
160577034|NCT01115569|579834425|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
160577035|NCT01115569|579834426|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
160577036|NCT01115569|579834425|FG000|Maintenance Phase|Adverse Event|0|||
160577037|NCT01115569|579834426|FG001|Maintenance Phase|Adverse Event|43|||
160577038|NCT01115569|579834425|FG000|Maintenance Phase|Lost to Follow-up|0|||
160577039|NCT01115569|579834426|FG001|Maintenance Phase|Lost to Follow-up|8|||
160577040|NCT01115569|579834425|FG000|Maintenance Phase|Physician Decision|0|||
160577041|NCT01115569|579834426|FG001|Maintenance Phase|Physician Decision|3|||
160577042|NCT01115569|579834425|FG000|Maintenance Phase|Protocol Violation|0|||
160577043|NCT01115569|579834426|FG001|Maintenance Phase|Protocol Violation|9|||
160577044|NCT01115569|579834425|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160577045|NCT01115569|579834426|FG001|Maintenance Phase|Withdrawal by Subject|27|||
160577046|NCT01115569|579834425|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
160577047|NCT01115569|579834426|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
160577048|NCT01115569|579834425|FG000|Maintenance Phase|Administrative|0|||
160577049|NCT01115569|579834426|FG001|Maintenance Phase|Administrative|1|||
160577050|NCT01614769|579834427|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
160577051|NCT01614769|579834428|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
160577052|NCT01614769|579834429|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
160577053|NCT01614769|579834430|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
160655192|NCT02465567|580118693|FG002|Overall Study|missing PI Signature|0|||
160655193|NCT02465567|580118694|FG003|Overall Study|missing PI Signature|0|||
160655194|NCT00950807|580118696|FG000|Treatment Period 1|Lack of Efficacy|1|||
160655195|NCT00950807|580118697|FG001|Treatment Period 1|Lack of Efficacy|0|||
160655196|NCT00950807|580118698|FG002|Treatment Period 1|Lack of Efficacy|0|||
160655197|NCT00950807|580118699|FG003|Treatment Period 1|Lack of Efficacy|0|||
160655198|NCT00950807|580118700|FG004|Treatment Period 1|Lack of Efficacy|0|||
160655199|NCT00950807|580118701|FG005|Treatment Period 1|Lack of Efficacy|1|||
160655200|NCT00950807|580118702|FG006|Treatment Period 1|Lack of Efficacy|0|||
160655201|NCT00950807|580118703|FG007|Treatment Period 1|Lack of Efficacy|0|||
160655202|NCT00950807|580118704|FG008|Treatment Period 1|Lack of Efficacy|0|||
160655203|NCT00950807|580118705|FG009|Treatment Period 1|Lack of Efficacy|0|||
160577054|NCT01614769|579834431|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
160577055|NCT01614769|579834432|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
160577056|NCT01614769|579834427|FG000|Period 1|Protocol Violation|0|||
160577057|NCT01614769|579834428|FG001|Period 1|Protocol Violation|0|||
160655204|NCT00950807|580118696|FG000|Treatment Period 1|Protocol Violation|1|||
160577058|NCT01614769|579834429|FG002|Period 1|Protocol Violation|0|||
160577059|NCT01614769|579834430|FG003|Period 1|Protocol Violation|1|||
160577060|NCT01614769|579834431|FG004|Period 1|Protocol Violation|0|||
160577061|NCT01614769|579834432|FG005|Period 1|Protocol Violation|0|||
160577062|NCT01614769|579834427|FG000|Period 1|Withdrawal by Subject|1|||
160577063|NCT01614769|579834428|FG001|Period 1|Withdrawal by Subject|0|||
160577064|NCT01614769|579834429|FG002|Period 1|Withdrawal by Subject|0|||
160577065|NCT01614769|579834430|FG003|Period 1|Withdrawal by Subject|0|||
160577066|NCT01614769|579834431|FG004|Period 1|Withdrawal by Subject|0|||
160577067|NCT01614769|579834432|FG005|Period 1|Withdrawal by Subject|0|||
160577068|NCT01614769|579834427|FG000|Period 3|Withdrawal by Subject|0|||
160577069|NCT01614769|579834428|FG001|Period 3|Withdrawal by Subject|0|||
160577070|NCT01614769|579834429|FG002|Period 3|Withdrawal by Subject|1|||
160577071|NCT01614769|579834430|FG003|Period 3|Withdrawal by Subject|0|||
160577072|NCT01614769|579834431|FG004|Period 3|Withdrawal by Subject|0|||
160577073|NCT01614769|579834432|FG005|Period 3|Withdrawal by Subject|0|||
160577074|NCT03242928|579834434|FG000|Overall Study|Adverse Event|2|||
160577075|NCT03242928|579834435|FG001|Overall Study|Adverse Event|1|||
160577076|NCT03242928|579834434|FG000|Overall Study|Lost to Follow-up|2|||
160577077|NCT03242928|579834435|FG001|Overall Study|Lost to Follow-up|0|||
160577078|NCT03242928|579834434|FG000|Overall Study|Physician Decision|0|||
160577079|NCT03242928|579834435|FG001|Overall Study|Physician Decision|1|||
160577080|NCT03242928|579834434|FG000|Overall Study|Withdrawal by Subject|5|||
160577081|NCT03242928|579834435|FG001|Overall Study|Withdrawal by Subject|3|||
160577082|NCT00960440|579834436|FG000|Overall Study|Death|0|||
160577083|NCT00960440|579834437|FG001|Overall Study|Death|0|||
160577084|NCT00960440|579834438|FG002|Overall Study|Death|0|||
160577085|NCT00960440|579834439|FG003|Overall Study|Death|1|||
160577086|NCT00960440|579834436|FG000|Overall Study|Adverse Event|12|||
160577087|NCT00960440|579834437|FG001|Overall Study|Adverse Event|12|||
160577088|NCT00960440|579834438|FG002|Overall Study|Adverse Event|4|||
160577089|NCT00960440|579834439|FG003|Overall Study|Adverse Event|4|||
160577090|NCT00960440|579834436|FG000|Overall Study|Lack of Efficacy|2|||
160577091|NCT00960440|579834437|FG001|Overall Study|Lack of Efficacy|5|||
160577092|NCT00960440|579834438|FG002|Overall Study|Lack of Efficacy|3|||
160577093|NCT00960440|579834439|FG003|Overall Study|Lack of Efficacy|8|||
160577094|NCT00960440|579834436|FG000|Overall Study|Protocol Violation|2|||
160577095|NCT00960440|579834437|FG001|Overall Study|Protocol Violation|8|||
160577096|NCT00960440|579834438|FG002|Overall Study|Protocol Violation|3|||
160577097|NCT00960440|579834439|FG003|Overall Study|Protocol Violation|4|||
160577098|NCT00960440|579834436|FG000|Overall Study|Withdrawal by Subject|9|||
160577099|NCT00960440|579834437|FG001|Overall Study|Withdrawal by Subject|5|||
160577100|NCT00960440|579834438|FG002|Overall Study|Withdrawal by Subject|2|||
160577101|NCT00960440|579834439|FG003|Overall Study|Withdrawal by Subject|1|||
160577102|NCT00960440|579834436|FG000|Overall Study|Other|1|||
160577103|NCT00960440|579834437|FG001|Overall Study|Other|1|||
160577104|NCT00960440|579834438|FG002|Overall Study|Other|1|||
160577105|NCT00960440|579834439|FG003|Overall Study|Other|0|||
160577106|NCT03504774|579834443|FG000|Overall Study|Adverse Event|2|||
160577107|NCT03504774|579834444|FG001|Overall Study|Adverse Event|0|||
160577108|NCT03504774|579834443|FG000|Overall Study|Lost to Follow-up|0|||
160577109|NCT03504774|579834444|FG001|Overall Study|Lost to Follow-up|1|||
160577110|NCT03504774|579834443|FG000|Overall Study|Protocol Violation|11|||
160577111|NCT03504774|579834444|FG001|Overall Study|Protocol Violation|3|||
160577112|NCT03504774|579834443|FG000|Overall Study|failed wk 52 DBPCFC|1|||
160577113|NCT03504774|579834444|FG001|Overall Study|failed wk 52 DBPCFC|0|||
160577114|NCT00625365|579834445|FG000|Overall Study|Withdrawal by Subject|1|||
160577115|NCT00625365|579834445|FG000|Overall Study|No IV access|5|||
160577116|NCT00625365|579834445|FG000|Overall Study|VSD|1|||
160577117|NCT01781429|579834446|FG000|Overall Study|Death|0|||
160577118|NCT01781429|579834447|FG001|Overall Study|Death|0|||
160577119|NCT01781429|579834448|FG002|Overall Study|Death|0|||
160577120|NCT01781429|579834449|FG003|Overall Study|Death|0|||
160577121|NCT01781429|579834450|FG004|Overall Study|Death|0|||
160577122|NCT01781429|579834451|FG005|Overall Study|Death|0|||
160577123|NCT01781429|579834452|FG006|Overall Study|Death|0|||
160577124|NCT01781429|579834453|FG007|Overall Study|Death|0|||
160577125|NCT01781429|579834454|FG008|Overall Study|Death|0|||
160577126|NCT01781429|579834455|FG009|Overall Study|Death|1|||
160577127|NCT01781429|579834456|FG010|Overall Study|Death|0|||
160577128|NCT01781429|579834457|FG011|Overall Study|Death|0|||
160577129|NCT01781429|579834458|FG012|Overall Study|Death|1|||
160577130|NCT01781429|579834459|FG013|Overall Study|Death|0|||
160577131|NCT01781429|579834460|FG014|Overall Study|Death|1|||
160577132|NCT01781429|579834461|FG015|Overall Study|Death|0|||
160577133|NCT01781429|579834446|FG000|Overall Study|Withdrawal by Subject|0|||
160577134|NCT01781429|579834447|FG001|Overall Study|Withdrawal by Subject|0|||
160577135|NCT01781429|579834448|FG002|Overall Study|Withdrawal by Subject|0|||
160577136|NCT01781429|579834449|FG003|Overall Study|Withdrawal by Subject|0|||
160577137|NCT01781429|579834450|FG004|Overall Study|Withdrawal by Subject|0|||
160577138|NCT01781429|579834451|FG005|Overall Study|Withdrawal by Subject|0|||
160577139|NCT01781429|579834452|FG006|Overall Study|Withdrawal by Subject|0|||
160577140|NCT01781429|579834453|FG007|Overall Study|Withdrawal by Subject|0|||
160925063|NCT05123222|581121098|FG002|Overall Study|Lost to Follow-up|0|||
160925064|NCT05123222|581121099|FG003|Overall Study|Lost to Follow-up|0|||
160925065|NCT05123222|581121096|FG000|Overall Study|Protocol Violation|0|||
160925066|NCT05123222|581121097|FG001|Overall Study|Protocol Violation|0|||
160925067|NCT05123222|581121098|FG002|Overall Study|Protocol Violation|1|||
160925068|NCT05123222|581121099|FG003|Overall Study|Protocol Violation|0|||
160925069|NCT02385266|581121100|FG000|Overall Study|Withdrawal by Subject|1|||
160925070|NCT02385266|581121101|FG001|Overall Study|Withdrawal by Subject|3|||
160925071|NCT00914810|581121102|FG000|Overall Study|Withdrawal by Subject|1|||
160925072|NCT00914810|581121103|FG001|Overall Study|Withdrawal by Subject|0|||
160925073|NCT00914810|581121102|FG000|Overall Study|Relocated out of state|1|||
160925074|NCT00914810|581121103|FG001|Overall Study|Relocated out of state|0|||
160925075|NCT00914810|581121102|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
160925076|NCT00914810|581121103|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
160925077|NCT03020823|581121106|FG000|Overall Study|Physician Decision|4|||
160925078|NCT03020823|581121106|FG000|Overall Study|Lack of Efficacy|4|||
160925079|NCT03020823|581121106|FG000|Overall Study|Adverse Event|2|||
160925080|NCT03739112|581121107|FG000|Overall Study|Adverse Event|2|||
160925081|NCT03739112|581121108|FG001|Overall Study|Adverse Event|2|||
160925082|NCT03739112|581121107|FG000|Overall Study|Withdrawal by Subject|38|||
160925083|NCT03739112|581121108|FG001|Overall Study|Withdrawal by Subject|19|||
160925084|NCT03739112|581121107|FG000|Overall Study|Lost to Follow-up|31|||
160925085|NCT03739112|581121108|FG001|Overall Study|Lost to Follow-up|33|||
160925086|NCT03739112|581121107|FG000|Overall Study|Protocol Deviation|12|||
160925087|NCT03739112|581121108|FG001|Overall Study|Protocol Deviation|9|||
160925088|NCT03739112|581121107|FG000|Overall Study|Physician Decision|1|||
160925089|NCT03739112|581121108|FG001|Overall Study|Physician Decision|0|||
160925090|NCT03739112|581121107|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
160925091|NCT03739112|581121108|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
160925092|NCT03739112|581121107|FG000|Overall Study|Site went on hold|65|||
160925093|NCT03739112|581121108|FG001|Overall Study|Site went on hold|67|||
160925094|NCT03739112|581121107|FG000|Overall Study|Other than specified|8|||
160925095|NCT03739112|581121108|FG001|Overall Study|Other than specified|5|||
160925096|NCT03739112|581121107|FG000|Overall Study|Randomized but not vaccinated|31|||
160925097|NCT03739112|581121108|FG001|Overall Study|Randomized but not vaccinated|25|||
160925098|NCT00588822|581121110|FG000|Overall Study|progression of disease|8|||
160925099|NCT01727141|581121112|FG000|Overall Study|Physician Decision|0|||
160925100|NCT01727141|581121113|FG001|Overall Study|Physician Decision|1|||
160925101|NCT01727141|581121114|FG002|Overall Study|Physician Decision|0|||
160925102|NCT01727141|581121115|FG003|Overall Study|Physician Decision|2|||
160925103|NCT01727141|581121112|FG000|Overall Study|Lost to Follow-up|0|||
160925104|NCT01727141|581121113|FG001|Overall Study|Lost to Follow-up|2|||
160925105|NCT01727141|581121114|FG002|Overall Study|Lost to Follow-up|0|||
160925106|NCT01727141|581121115|FG003|Overall Study|Lost to Follow-up|0|||
160925107|NCT01727141|581121112|FG000|Overall Study|Death|0|||
160925108|NCT01727141|581121113|FG001|Overall Study|Death|1|||
160925109|NCT01727141|581121114|FG002|Overall Study|Death|1|||
160925110|NCT01727141|581121115|FG003|Overall Study|Death|1|||
160925111|NCT01727141|581121112|FG000|Overall Study|Protocol deviation|1|||
160925112|NCT01727141|581121113|FG001|Overall Study|Protocol deviation|1|||
160925113|NCT01727141|581121114|FG002|Overall Study|Protocol deviation|0|||
160925114|NCT01727141|581121115|FG003|Overall Study|Protocol deviation|1|||
160925115|NCT01727141|581121112|FG000|Overall Study|Withdrawal by Subject|4|||
160925116|NCT01727141|581121113|FG001|Overall Study|Withdrawal by Subject|4|||
160925117|NCT01727141|581121114|FG002|Overall Study|Withdrawal by Subject|2|||
160925118|NCT01727141|581121115|FG003|Overall Study|Withdrawal by Subject|11|||
160925119|NCT02529137|581121118|FG000|Overall Study|Discontinuation for different reasons|8|||
160925120|NCT02731729|581121121|FG000|Overall Study|Death|2|||
160925121|NCT02731729|581121122|FG001|Overall Study|Death|2|||
160925122|NCT02731729|581121121|FG000|Overall Study|Study terminated by Sponsor|6|||
160925123|NCT02731729|581121122|FG001|Overall Study|Study terminated by Sponsor|6|||
160925124|NCT02731729|581121121|FG000|Overall Study|Withdrawal by Subject|1|||
160925125|NCT02731729|581121122|FG001|Overall Study|Withdrawal by Subject|0|||
160925126|NCT01344447|581121123|FG000|Overall Study|Adverse Event|1|||
160925127|NCT01344447|581121123|FG000|Overall Study|Protocol Violation|1|||
160925128|NCT01344447|581121123|FG000|Overall Study|Withdrawal by Subject|1|||
160925129|NCT01344447|581121123|FG000|Overall Study|The contrast was not seen|1|||
160997960|NCT00589667|581378495|FG000|Overall Study|Withdrawal by Subject|1|||
160925130|NCT01344447|581121123|FG000|Overall Study|Physician Decision|1|||
160925131|NCT01344447|581121123|FG000|Overall Study|MRA unsuccessful|1|||
160925132|NCT01344447|581121123|FG000|Overall Study|Bolus tracking failed|1|||
160925133|NCT01344447|581121123|FG000|Overall Study|Error of power injector|1|||
160925134|NCT01660711|581121124|FG000|Overall Study|Adverse Event|7|||
160925135|NCT01660711|581121124|FG000|Overall Study|Withdrawal by Subject|1|||
160925136|NCT00952341|581121126|FG000|Cycle 1|Adverse Event|4|||
160925137|NCT00952341|581121127|FG001|Cycle 1|Adverse Event|1|||
160925138|NCT00952341|581121126|FG000|Cycle 1|Withdrawal by Subject|3|||
160925139|NCT00952341|581121127|FG001|Cycle 1|Withdrawal by Subject|8|||
160925140|NCT00952341|581121126|FG000|Cycle 1|Protocol Violation|2|||
160925141|NCT00952341|581121127|FG001|Cycle 1|Protocol Violation|1|||
160925142|NCT00952341|581121126|FG000|Cycle 1|Lost to Follow-up|11|||
160925143|NCT00952341|581121127|FG001|Cycle 1|Lost to Follow-up|2|||
160925144|NCT00952341|581121126|FG000|Cycle 1|Physician Decision|0|||
160925145|NCT00952341|581121127|FG001|Cycle 1|Physician Decision|1|||
160925146|NCT00952341|581121126|FG000|Cycle 2|Withdrawal by Subject|1|||
160925147|NCT00952341|581121127|FG001|Cycle 2|Withdrawal by Subject|1|||
160925148|NCT00952341|581121126|FG000|Cycle 2|Protocol Violation|1|||
160925149|NCT00952341|581121127|FG001|Cycle 2|Protocol Violation|0|||
160925150|NCT00952341|581121126|FG000|Cycle 2|Lost to Follow-up|6|||
160925151|NCT00952341|581121127|FG001|Cycle 2|Lost to Follow-up|9|||
160925152|NCT00952341|581121126|FG000|Cycle 2|Physician Decision|1|||
160925153|NCT00952341|581121127|FG001|Cycle 2|Physician Decision|1|||
160925154|NCT00952341|581121126|FG000|Cycle 2|Progressive Disease|0|||
160925155|NCT00952341|581121127|FG001|Cycle 2|Progressive Disease|1|||
160925156|NCT02066467|581121132|FG000|Overall Study|Did not undergo implant procedure|24|||
160925157|NCT02066467|581121132|FG000|Overall Study|Attempted to implant withoput success|43|||
160925158|NCT02066467|581121132|FG000|Overall Study|Consent ineligible|1|||
160925159|NCT02066467|581121132|FG000|Overall Study|Death|54|||
160925160|NCT02066467|581121132|FG000|Overall Study|Lost to Follow-up|51|||
160925161|NCT02066467|581121132|FG000|Overall Study|Adverse Event|20|||
160925162|NCT02066467|581121132|FG000|Overall Study|Withdrawal by Subject|16|||
160925163|NCT02066467|581121132|FG000|Overall Study|Physician Decision|2|||
160925164|NCT02066467|581121132|FG000|Overall Study|Not defined|4|||
160577141|NCT01781429|579834454|FG008|Overall Study|Withdrawal by Subject|1|||
160577142|NCT01781429|579834455|FG009|Overall Study|Withdrawal by Subject|3|||
160577143|NCT01781429|579834456|FG010|Overall Study|Withdrawal by Subject|1|||
160577144|NCT01781429|579834457|FG011|Overall Study|Withdrawal by Subject|1|||
160577145|NCT01781429|579834458|FG012|Overall Study|Withdrawal by Subject|5|||
160577146|NCT01781429|579834459|FG013|Overall Study|Withdrawal by Subject|2|||
160577147|NCT01781429|579834460|FG014|Overall Study|Withdrawal by Subject|3|||
160577148|NCT01781429|579834461|FG015|Overall Study|Withdrawal by Subject|0|||
160577149|NCT01781429|579834446|FG000|Overall Study|Disease Progression|1|||
160577150|NCT01781429|579834447|FG001|Overall Study|Disease Progression|0|||
160577151|NCT01781429|579834448|FG002|Overall Study|Disease Progression|1|||
160577152|NCT01781429|579834449|FG003|Overall Study|Disease Progression|1|||
160577153|NCT01781429|579834450|FG004|Overall Study|Disease Progression|1|||
160577154|NCT01781429|579834451|FG005|Overall Study|Disease Progression|4|||
160577155|NCT01781429|579834452|FG006|Overall Study|Disease Progression|7|||
160925165|NCT02914769|581121133|FG000|Overall Study|Protocol Violation|3|||
160925166|NCT02914769|581121134|FG001|Overall Study|Protocol Violation|2|||
160925167|NCT02914769|581121133|FG000|Overall Study|Withdrawal by Subject|0|||
160577156|NCT01781429|579834453|FG007|Overall Study|Disease Progression|4|||
160577157|NCT01781429|579834454|FG008|Overall Study|Disease Progression|6|||
160577158|NCT01781429|579834455|FG009|Overall Study|Disease Progression|15|||
160577159|NCT01781429|579834456|FG010|Overall Study|Disease Progression|15|||
160577160|NCT01781429|579834457|FG011|Overall Study|Disease Progression|15|||
160925168|NCT02914769|581121134|FG001|Overall Study|Withdrawal by Subject|1|||
160925169|NCT01592344|581121135|FG000|Overall Study|Adverse Event|1|||
160925170|NCT01592344|581121136|FG001|Overall Study|Adverse Event|1|||
160925171|NCT01592344|581121135|FG000|Overall Study|Lack of Efficacy|1|||
160925172|NCT01592344|581121136|FG001|Overall Study|Lack of Efficacy|0|||
160925173|NCT01592344|581121135|FG000|Overall Study|not available at primary outcome visit|2|||
160925174|NCT01592344|581121136|FG001|Overall Study|not available at primary outcome visit|4|||
160925175|NCT02738333|581121137|FG000|Overall Study|Death|1|||
160925176|NCT02738333|581121138|FG001|Overall Study|Death|0|||
160925177|NCT02738333|581121139|FG002|Overall Study|Death|0|||
160925178|NCT02738333|581121137|FG000|Overall Study|Lost to Follow-up|1|||
160925179|NCT02738333|581121138|FG001|Overall Study|Lost to Follow-up|0|||
160577161|NCT01781429|579834458|FG012|Overall Study|Disease Progression|15|||
160577162|NCT01781429|579834459|FG013|Overall Study|Disease Progression|4|||
160577163|NCT01781429|579834460|FG014|Overall Study|Disease Progression|11|||
160577164|NCT01781429|579834461|FG015|Overall Study|Disease Progression|0|||
160577165|NCT01781429|579834446|FG000|Overall Study|Unacceptable Toxicity|0|||
160577166|NCT01781429|579834447|FG001|Overall Study|Unacceptable Toxicity|0|||
160925180|NCT02738333|581121139|FG002|Overall Study|Lost to Follow-up|0|||
160925181|NCT04519645|581121140|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
160577167|NCT01781429|579834448|FG002|Overall Study|Unacceptable Toxicity|0|||
160577168|NCT01781429|579834449|FG003|Overall Study|Unacceptable Toxicity|0|||
160925182|NCT04519645|581121141|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
160925183|NCT04519645|581121142|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
160925184|NCT04519645|581121140|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
160925185|NCT04519645|581121141|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
160925186|NCT04519645|581121142|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
160925187|NCT04519645|581121140|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
160925188|NCT04519645|581121141|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
160925189|NCT04519645|581121142|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
160925190|NCT04519645|581121140|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
160925191|NCT04519645|581121141|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
160925192|NCT04519645|581121142|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
160925193|NCT01679002|581121143|FG000|Overall Study|Adverse Event|1|||
160925194|NCT01679002|581121144|FG001|Overall Study|Adverse Event|1|||
160925195|NCT01679002|581121145|FG002|Overall Study|Adverse Event|0|||
160925196|NCT00730912|581121148|FG000|Overall Study|Discontinued|0|||
160925197|NCT00730912|581121149|FG001|Overall Study|Discontinued|0|||
160925198|NCT00730912|581121150|FG002|Overall Study|Discontinued|1|||
160925199|NCT02205333|581121154|FG000|Overall Study|Death|5|||
160925200|NCT02205333|581121155|FG001|Overall Study|Death|6|||
160925201|NCT02205333|581121156|FG002|Overall Study|Death|2|||
160925202|NCT02205333|581121157|FG003|Overall Study|Death|6|||
160925203|NCT02205333|581121158|FG004|Overall Study|Death|5|||
160925204|NCT02205333|581121159|FG005|Overall Study|Death|3|||
160925205|NCT02205333|581121160|FG006|Overall Study|Death|3|||
160925206|NCT02205333|581121161|FG007|Overall Study|Death|2|||
160925207|NCT02205333|581121162|FG008|Overall Study|Death|0|||
160925208|NCT02205333|581121154|FG000|Overall Study|Withdrawal by Subject|1|||
160925209|NCT02205333|581121155|FG001|Overall Study|Withdrawal by Subject|0|||
160925210|NCT02205333|581121156|FG002|Overall Study|Withdrawal by Subject|0|||
160925211|NCT02205333|581121157|FG003|Overall Study|Withdrawal by Subject|1|||
160577169|NCT01781429|579834450|FG004|Overall Study|Unacceptable Toxicity|0|||
160577170|NCT01781429|579834451|FG005|Overall Study|Unacceptable Toxicity|0|||
160577171|NCT01781429|579834452|FG006|Overall Study|Unacceptable Toxicity|0|||
160577172|NCT01781429|579834453|FG007|Overall Study|Unacceptable Toxicity|0|||
160577173|NCT01781429|579834454|FG008|Overall Study|Unacceptable Toxicity|0|||
160925212|NCT02205333|581121158|FG004|Overall Study|Withdrawal by Subject|0|||
160925213|NCT02205333|581121159|FG005|Overall Study|Withdrawal by Subject|0|||
160925214|NCT02205333|581121160|FG006|Overall Study|Withdrawal by Subject|2|||
160925215|NCT02205333|581121161|FG007|Overall Study|Withdrawal by Subject|0|||
160925216|NCT02205333|581121162|FG008|Overall Study|Withdrawal by Subject|0|||
160925217|NCT01176266|581121163|FG000|Overall Study|Death|6|||
160925218|NCT01176266|581121163|FG000|Overall Study|Withdrawal by Subject|3|||
160925219|NCT01179477|581121164|FG000|Overall Study|Death|542|||
160925220|NCT01179477|581121164|FG000|Overall Study|Unsuccessful implant|80|||
160925221|NCT01179477|581121164|FG000|Overall Study|Non-death withdrawal|438|||
160577174|NCT01781429|579834455|FG009|Overall Study|Unacceptable Toxicity|0|||
160655205|NCT00950807|580118697|FG001|Treatment Period 1|Protocol Violation|0|||
160655206|NCT00950807|580118698|FG002|Treatment Period 1|Protocol Violation|0|||
160925222|NCT01179477|581121164|FG000|Overall Study|Did not complete final visit|27|||
160925223|NCT00455429|581121166|FG000|Overall Study|Study Terminated by Sponsor|0|||
160925224|NCT00455429|581121167|FG001|Overall Study|Study Terminated by Sponsor|0|||
160577175|NCT01781429|579834456|FG010|Overall Study|Unacceptable Toxicity|0|||
160655207|NCT00950807|580118699|FG003|Treatment Period 1|Protocol Violation|0|||
160577176|NCT01781429|579834457|FG011|Overall Study|Unacceptable Toxicity|2|||
160577177|NCT01781429|579834458|FG012|Overall Study|Unacceptable Toxicity|0|||
160655208|NCT00950807|580118700|FG004|Treatment Period 1|Protocol Violation|0|||
160577178|NCT01781429|579834459|FG013|Overall Study|Unacceptable Toxicity|0|||
160577179|NCT01781429|579834460|FG014|Overall Study|Unacceptable Toxicity|0|||
160577180|NCT01781429|579834461|FG015|Overall Study|Unacceptable Toxicity|0|||
160577181|NCT01781429|579834446|FG000|Overall Study|Patient Condition Changed|0|||
160577182|NCT01781429|579834447|FG001|Overall Study|Patient Condition Changed|0|||
160577183|NCT01781429|579834448|FG002|Overall Study|Patient Condition Changed|0|||
160577184|NCT01781429|579834449|FG003|Overall Study|Patient Condition Changed|0|||
160577185|NCT01781429|579834450|FG004|Overall Study|Patient Condition Changed|0|||
160577186|NCT01781429|579834451|FG005|Overall Study|Patient Condition Changed|0|||
160577187|NCT01781429|579834452|FG006|Overall Study|Patient Condition Changed|0|||
160655209|NCT00950807|580118701|FG005|Treatment Period 1|Protocol Violation|0|||
160655210|NCT00950807|580118702|FG006|Treatment Period 1|Protocol Violation|0|||
160655211|NCT00950807|580118703|FG007|Treatment Period 1|Protocol Violation|0|||
160655212|NCT00950807|580118704|FG008|Treatment Period 1|Protocol Violation|0|||
160655213|NCT00950807|580118705|FG009|Treatment Period 1|Protocol Violation|0|||
160655214|NCT00950807|580118696|FG000|Treatment Period 1|Lost to Follow-up|0|||
160655215|NCT00950807|580118697|FG001|Treatment Period 1|Lost to Follow-up|0|||
160925225|NCT00455429|581121168|FG002|Overall Study|Study Terminated by Sponsor|0|||
160925226|NCT00455429|581121169|FG003|Overall Study|Study Terminated by Sponsor|3|||
160925227|NCT00455429|581121166|FG000|Overall Study|Lost to Follow-up|1|||
160577188|NCT01781429|579834453|FG007|Overall Study|Patient Condition Changed|0|||
160577189|NCT01781429|579834454|FG008|Overall Study|Patient Condition Changed|0|||
160655216|NCT00950807|580118698|FG002|Treatment Period 1|Lost to Follow-up|1|||
160925228|NCT00455429|581121167|FG001|Overall Study|Lost to Follow-up|0|||
160925229|NCT00455429|581121168|FG002|Overall Study|Lost to Follow-up|0|||
160925230|NCT00455429|581121169|FG003|Overall Study|Lost to Follow-up|3|||
160925231|NCT00455429|581121166|FG000|Overall Study|Withdrawal by Subject|0|||
160925232|NCT00455429|581121167|FG001|Overall Study|Withdrawal by Subject|1|||
160655217|NCT00950807|580118699|FG003|Treatment Period 1|Lost to Follow-up|0|||
160655218|NCT00950807|580118700|FG004|Treatment Period 1|Lost to Follow-up|0|||
160655219|NCT00950807|580118701|FG005|Treatment Period 1|Lost to Follow-up|0|||
160655220|NCT00950807|580118702|FG006|Treatment Period 1|Lost to Follow-up|0|||
160655221|NCT00950807|580118703|FG007|Treatment Period 1|Lost to Follow-up|0|||
160655222|NCT00950807|580118704|FG008|Treatment Period 1|Lost to Follow-up|0|||
160655223|NCT00950807|580118705|FG009|Treatment Period 1|Lost to Follow-up|0|||
160655224|NCT00950807|580118696|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160655225|NCT00950807|580118697|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160655226|NCT00950807|580118698|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160655227|NCT00950807|580118699|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160655228|NCT00950807|580118700|FG004|Treatment Period 1|Withdrawal by Subject|1|||
160925233|NCT00455429|581121168|FG002|Overall Study|Withdrawal by Subject|1|||
160925234|NCT00455429|581121169|FG003|Overall Study|Withdrawal by Subject|0|||
160925235|NCT00455429|581121166|FG000|Overall Study|Lack of Efficacy|0|||
160925236|NCT00455429|581121167|FG001|Overall Study|Lack of Efficacy|1|||
160925237|NCT00455429|581121168|FG002|Overall Study|Lack of Efficacy|0|||
160925238|NCT00455429|581121169|FG003|Overall Study|Lack of Efficacy|1|||
160655229|NCT00950807|580118701|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160655230|NCT00950807|580118702|FG006|Treatment Period 1|Withdrawal by Subject|0|||
160655231|NCT00950807|580118703|FG007|Treatment Period 1|Withdrawal by Subject|0|||
160655232|NCT00950807|580118704|FG008|Treatment Period 1|Withdrawal by Subject|1|||
160655233|NCT00950807|580118705|FG009|Treatment Period 1|Withdrawal by Subject|0|||
160655234|NCT00950807|580118696|FG000|Treatment Period 1|Adverse Event|0|||
160655235|NCT00950807|580118697|FG001|Treatment Period 1|Adverse Event|0|||
160655236|NCT00950807|580118698|FG002|Treatment Period 1|Adverse Event|0|||
160655237|NCT00950807|580118699|FG003|Treatment Period 1|Adverse Event|0|||
160655238|NCT00950807|580118700|FG004|Treatment Period 1|Adverse Event|0|||
160925239|NCT00455429|581121166|FG000|Overall Study|Adverse Event|0|||
160925240|NCT00455429|581121167|FG001|Overall Study|Adverse Event|1|||
160925241|NCT00455429|581121168|FG002|Overall Study|Adverse Event|0|||
160925242|NCT00455429|581121169|FG003|Overall Study|Adverse Event|3|||
160925243|NCT00455429|581121166|FG000|Overall Study|Randomly assigned but not treated|0|||
160925244|NCT00455429|581121167|FG001|Overall Study|Randomly assigned but not treated|0|||
160925245|NCT00455429|581121168|FG002|Overall Study|Randomly assigned but not treated|0|||
160925246|NCT00455429|581121169|FG003|Overall Study|Randomly assigned but not treated|2|||
160925247|NCT00455429|581121166|FG000|Overall Study|Personal Reason|1|||
160925248|NCT00455429|581121167|FG001|Overall Study|Personal Reason|0|||
160925249|NCT00455429|581121168|FG002|Overall Study|Personal Reason|0|||
160925250|NCT00455429|581121169|FG003|Overall Study|Personal Reason|0|||
160925251|NCT00455429|581121166|FG000|Overall Study|Non-compliance|0|||
160925252|NCT00455429|581121167|FG001|Overall Study|Non-compliance|0|||
160925253|NCT00455429|581121168|FG002|Overall Study|Non-compliance|0|||
160925254|NCT00455429|581121169|FG003|Overall Study|Non-compliance|1|||
160925255|NCT00455429|581121166|FG000|Overall Study|Other|0|||
160925256|NCT00455429|581121167|FG001|Overall Study|Other|2|||
160925257|NCT00455429|581121168|FG002|Overall Study|Other|0|||
160925258|NCT00455429|581121169|FG003|Overall Study|Other|1|||
160925259|NCT04351087|581121170|FG000|Overall Study|Lost to Follow-up|7|||
160925260|NCT04351087|581121171|FG001|Overall Study|Lost to Follow-up|3|||
160925261|NCT04351087|581121170|FG000|Overall Study|Withdrawal by Subject|3|||
160925262|NCT04351087|581121171|FG001|Overall Study|Withdrawal by Subject|4|||
160925263|NCT04351087|581121170|FG000|Overall Study|Lack of Efficacy|3|||
160925264|NCT04351087|581121171|FG001|Overall Study|Lack of Efficacy|2|||
160925265|NCT03519347|581121172|FG000|Interventional Crossover Period 1|Death|0|||
160925266|NCT03519347|581121173|FG001|Interventional Crossover Period 1|Death|0|||
160655239|NCT00950807|580118701|FG005|Treatment Period 1|Adverse Event|1|||
160655240|NCT00950807|580118702|FG006|Treatment Period 1|Adverse Event|0|||
160655241|NCT00950807|580118703|FG007|Treatment Period 1|Adverse Event|0|||
160655242|NCT00950807|580118704|FG008|Treatment Period 1|Adverse Event|0|||
160655243|NCT00950807|580118705|FG009|Treatment Period 1|Adverse Event|0|||
160655244|NCT00950807|580118696|FG000|Washout Period 1|Lack of Efficacy|0|||
160655245|NCT00950807|580118697|FG001|Washout Period 1|Lack of Efficacy|0|||
160655246|NCT00950807|580118698|FG002|Washout Period 1|Lack of Efficacy|0|||
160925267|NCT03519347|581121174|FG002|Interventional Crossover Period 1|Death|0|||
160655247|NCT00950807|580118699|FG003|Washout Period 1|Lack of Efficacy|0|||
160655248|NCT00950807|580118700|FG004|Washout Period 1|Lack of Efficacy|0|||
160655249|NCT00950807|580118701|FG005|Washout Period 1|Lack of Efficacy|0|||
160655250|NCT00950807|580118702|FG006|Washout Period 1|Lack of Efficacy|1|||
160655251|NCT00950807|580118703|FG007|Washout Period 1|Lack of Efficacy|0|||
160925268|NCT03519347|581121175|FG003|Interventional Crossover Period 1|Death|1|||
160925269|NCT01412021|581121176|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
160925270|NCT01412021|581121176|FG000|Overall Study|Treatment Prior to Approval|3|||
160925271|NCT01412021|581121176|FG000|Overall Study|Transferred to Other Hospital|9|||
160925272|NCT00484939|581121179|FG000|Overall Study|Death|9|||
160925273|NCT00484939|581121180|FG001|Overall Study|Death|13|||
160925274|NCT00484939|581121179|FG000|Overall Study|Adverse Event|22|||
160925275|NCT00484939|581121180|FG001|Overall Study|Adverse Event|12|||
160925276|NCT00484939|581121179|FG000|Overall Study|Patient Withdrew Consent|19|||
160925277|NCT00484939|581121180|FG001|Overall Study|Patient Withdrew Consent|10|||
160925278|NCT00484939|581121179|FG000|Overall Study|Protocol Violation|3|||
160925279|NCT00484939|581121180|FG001|Overall Study|Protocol Violation|3|||
160925280|NCT00484939|581121179|FG000|Overall Study|Lost to Follow-up|0|||
160925281|NCT00484939|581121180|FG001|Overall Study|Lost to Follow-up|3|||
160925282|NCT00484939|581121179|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
160925283|NCT00484939|581121180|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
160925284|NCT00484939|581121179|FG000|Overall Study|Disease progression|67|||
160925285|NCT00484939|581121180|FG001|Overall Study|Disease progression|88|||
160925286|NCT00484939|581121179|FG000|Overall Study|Screen Failure|2|||
160925287|NCT00484939|581121180|FG001|Overall Study|Screen Failure|2|||
160925288|NCT00484939|581121179|FG000|Overall Study|Reason Not Specified|11|||
160925289|NCT00484939|581121180|FG001|Overall Study|Reason Not Specified|6|||
160925290|NCT01522365|581121181|FG000|Overall Study|Withdrawal by Subject|1|||
160925291|NCT01522365|581121182|FG001|Overall Study|Withdrawal by Subject|1|||
160925292|NCT01522365|581121181|FG000|Overall Study|Lost to Follow-up|1|||
160925293|NCT01522365|581121182|FG001|Overall Study|Lost to Follow-up|1|||
160925294|NCT02466555|581121185|FG000|Overall Study|Lost to Follow-up|2|||
160925295|NCT01120756|581121186|FG000|Overall Study|Withdrawal by Subject|1|||
160925296|NCT01120756|581121187|FG001|Overall Study|Withdrawal by Subject|1|||
160925297|NCT00698581|581121188|FG000|Overall Study|Lack of Efficacy|23|||
160925298|NCT00698581|581121189|FG001|Overall Study|Lack of Efficacy|11|||
160925299|NCT00698581|581121188|FG000|Overall Study|Withdrawal by Subject|6|||
160925300|NCT00698581|581121189|FG001|Overall Study|Withdrawal by Subject|0|||
160925301|NCT00698581|581121188|FG000|Overall Study|Other reason|9|||
160925302|NCT00698581|581121189|FG001|Overall Study|Other reason|1|||
160925303|NCT00698581|581121188|FG000|Overall Study|SAE, non-fatal|1|||
160925304|NCT00698581|581121189|FG001|Overall Study|SAE, non-fatal|0|||
160925305|NCT00698581|581121188|FG000|Overall Study|AE, non-serious non-fatal|4|||
160925306|NCT00698581|581121189|FG001|Overall Study|AE, non-serious non-fatal|0|||
160925307|NCT00698581|581121188|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160925308|NCT00698581|581121189|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
160925309|NCT00698581|581121188|FG000|Overall Study|AE of unknown type|1|||
160925310|NCT00698581|581121189|FG001|Overall Study|AE of unknown type|0|||
160925311|NCT03760146|581121190|FG000|Overall Study|Adverse Event|11|||
160925312|NCT03760146|581121191|FG001|Overall Study|Adverse Event|8|||
160925313|NCT03760146|581121192|FG002|Overall Study|Adverse Event|0|||
160925314|NCT03760146|581121193|FG003|Overall Study|Adverse Event|0|||
160925315|NCT03760146|581121194|FG004|Overall Study|Adverse Event|0|||
160925316|NCT03760146|581121195|FG005|Overall Study|Adverse Event|0|||
160925317|NCT03760146|581121190|FG000|Overall Study|Death|1|||
160925318|NCT03760146|581121191|FG001|Overall Study|Death|0|||
160925319|NCT03760146|581121192|FG002|Overall Study|Death|0|||
160925320|NCT03760146|581121193|FG003|Overall Study|Death|0|||
160925321|NCT03760146|581121194|FG004|Overall Study|Death|0|||
160925322|NCT03760146|581121195|FG005|Overall Study|Death|0|||
160925323|NCT03760146|581121190|FG000|Overall Study|Lost to Follow-up|41|||
160925324|NCT03760146|581121191|FG001|Overall Study|Lost to Follow-up|28|||
160925325|NCT03760146|581121192|FG002|Overall Study|Lost to Follow-up|9|||
160925326|NCT03760146|581121193|FG003|Overall Study|Lost to Follow-up|2|||
160925327|NCT03760146|581121194|FG004|Overall Study|Lost to Follow-up|14|||
160925328|NCT03760146|581121195|FG005|Overall Study|Lost to Follow-up|8|||
160925329|NCT03760146|581121190|FG000|Overall Study|No longer met eligibility criteria|3|||
160925330|NCT03760146|581121191|FG001|Overall Study|No longer met eligibility criteria|9|||
160925331|NCT03760146|581121192|FG002|Overall Study|No longer met eligibility criteria|0|||
160925332|NCT03760146|581121193|FG003|Overall Study|No longer met eligibility criteria|0|||
160925333|NCT03760146|581121194|FG004|Overall Study|No longer met eligibility criteria|1|||
160925334|NCT03760146|581121195|FG005|Overall Study|No longer met eligibility criteria|0|||
160925335|NCT03760146|581121190|FG000|Overall Study|Protocol Violation|21|||
160925336|NCT03760146|581121191|FG001|Overall Study|Protocol Violation|13|||
160925337|NCT03760146|581121192|FG002|Overall Study|Protocol Violation|1|||
160925338|NCT03760146|581121193|FG003|Overall Study|Protocol Violation|0|||
160577190|NCT01781429|579834455|FG009|Overall Study|Patient Condition Changed|4|||
160925339|NCT03760146|581121194|FG004|Overall Study|Protocol Violation|1|||
160925340|NCT03760146|581121195|FG005|Overall Study|Protocol Violation|0|||
160925341|NCT03760146|581121190|FG000|Overall Study|Withdrawal by Subject|19|||
160925342|NCT03760146|581121191|FG001|Overall Study|Withdrawal by Subject|20|||
160925343|NCT03760146|581121192|FG002|Overall Study|Withdrawal by Subject|1|||
160925344|NCT03760146|581121193|FG003|Overall Study|Withdrawal by Subject|0|||
160925345|NCT03760146|581121194|FG004|Overall Study|Withdrawal by Subject|1|||
160925346|NCT03760146|581121195|FG005|Overall Study|Withdrawal by Subject|0|||
160925347|NCT00449644|581121196|FG000|Overall Study|Adverse Event|0|||
160925348|NCT00449644|581121197|FG001|Overall Study|Adverse Event|0|||
160925349|NCT00449644|581121198|FG002|Overall Study|Adverse Event|3|||
160925350|NCT00449644|581121199|FG003|Overall Study|Adverse Event|5|||
160925351|NCT00449644|581121196|FG000|Overall Study|Death|1|||
160925352|NCT00449644|581121197|FG001|Overall Study|Death|0|||
160454814|NCT01928394|579396182|FG012|Treatment Period|Death|0|||
160454815|NCT01928394|579396183|FG013|Treatment Period|Death|1|||
160454816|NCT01928394|579396184|FG014|Treatment Period|Death|2|||
160454817|NCT01928394|579396185|FG015|Treatment Period|Death|0|||
160454818|NCT01928394|579396186|FG016|Treatment Period|Death|0|||
160454819|NCT01928394|579396187|FG017|Treatment Period|Death|0|||
160454820|NCT01928394|579396188|FG018|Treatment Period|Death|0|||
160454821|NCT01928394|579396189|FG019|Treatment Period|Death|0|||
160454822|NCT01928394|579396190|FG020|Treatment Period|Death|0|||
160454823|NCT01928394|579396191|FG021|Treatment Period|Death|0|||
160454824|NCT01928394|579396192|FG022|Treatment Period|Death|0|||
160454825|NCT01928394|579396170|FG000|Follow-up Period|Participant withdrew consent|3|||
160454826|NCT01928394|579396171|FG001|Follow-up Period|Participant withdrew consent|0|||
160925353|NCT00449644|581121198|FG002|Overall Study|Death|6|||
160577191|NCT01781429|579834456|FG010|Overall Study|Patient Condition Changed|0|||
160577192|NCT01781429|579834457|FG011|Overall Study|Patient Condition Changed|1|||
160577193|NCT01781429|579834458|FG012|Overall Study|Patient Condition Changed|0|||
160577194|NCT01781429|579834459|FG013|Overall Study|Patient Condition Changed|1|||
160925354|NCT00449644|581121199|FG003|Overall Study|Death|1|||
160925355|NCT00449644|581121196|FG000|Overall Study|Lost to Follow-up|1|||
160925356|NCT00449644|581121197|FG001|Overall Study|Lost to Follow-up|1|||
160925357|NCT00449644|581121198|FG002|Overall Study|Lost to Follow-up|5|||
160925358|NCT00449644|581121199|FG003|Overall Study|Lost to Follow-up|3|||
160925359|NCT00449644|581121196|FG000|Overall Study|Pregnancy|0|||
160925360|NCT00449644|581121197|FG001|Overall Study|Pregnancy|0|||
160925361|NCT00449644|581121198|FG002|Overall Study|Pregnancy|3|||
160925362|NCT00449644|581121199|FG003|Overall Study|Pregnancy|2|||
160925363|NCT00449644|581121196|FG000|Overall Study|Protocol Violation|4|||
160925364|NCT00449644|581121197|FG001|Overall Study|Protocol Violation|4|||
160925365|NCT00449644|581121198|FG002|Overall Study|Protocol Violation|3|||
160925366|NCT00449644|581121199|FG003|Overall Study|Protocol Violation|7|||
160925367|NCT00449644|581121196|FG000|Overall Study|Withdrawal by Subject|3|||
160925368|NCT00449644|581121197|FG001|Overall Study|Withdrawal by Subject|4|||
160925369|NCT00449644|581121198|FG002|Overall Study|Withdrawal by Subject|6|||
160925370|NCT00449644|581121199|FG003|Overall Study|Withdrawal by Subject|7|||
160925371|NCT00449644|581121196|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
160925372|NCT00449644|581121197|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
160925373|NCT00449644|581121198|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
160925374|NCT00449644|581121199|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
160925375|NCT00449644|581121196|FG000|Overall Study|Other|1|||
160925376|NCT00449644|581121197|FG001|Overall Study|Other|4|||
160925377|NCT00449644|581121198|FG002|Overall Study|Other|1|||
160925378|NCT00449644|581121199|FG003|Overall Study|Other|0|||
160925379|NCT00449644|581121196|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
160925380|NCT00449644|581121197|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
160925381|NCT00449644|581121198|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
160925382|NCT00449644|581121199|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
160925383|NCT00529542|581121200|FG000|Overall Study|Withdrawal by Subject|1|||
160925384|NCT00529542|581121201|FG001|Overall Study|Withdrawal by Subject|0|||
160925385|NCT00529542|581121200|FG000|Overall Study|Lost to Follow-up|0|||
160925386|NCT00529542|581121201|FG001|Overall Study|Lost to Follow-up|1|||
160925387|NCT01721330|581121212|FG000|Overall Study|Withdrawal by Subject|0|||
160925388|NCT01721330|581121213|FG001|Overall Study|Withdrawal by Subject|1|||
160925389|NCT00581776|581122836|FG000|Overall Study|Disease progression or no response|3|||
160925390|NCT02357901|581122837|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
160925391|NCT02357901|581122838|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
160925392|NCT02357901|581122839|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
160925393|NCT02357901|581122840|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
160925394|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
160925395|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
160997961|NCT03538041|581378498|FG000|12-Week Treatment Period|Adverse Event|1|||
160454827|NCT01928394|579396172|FG002|Follow-up Period|Participant withdrew consent|1|||
160454828|NCT01928394|579396173|FG003|Follow-up Period|Participant withdrew consent|4|||
160454829|NCT01928394|579396174|FG004|Follow-up Period|Participant withdrew consent|0|||
160454830|NCT01928394|579396175|FG005|Follow-up Period|Participant withdrew consent|2|||
160577195|NCT01781429|579834460|FG014|Overall Study|Patient Condition Changed|0|||
160577196|NCT01781429|579834461|FG015|Overall Study|Patient Condition Changed|0|||
160577197|NCT01781429|579834446|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
160925396|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
160925397|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
160925398|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
160925399|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
160925400|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
160925401|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
160925402|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
160577198|NCT01781429|579834447|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
160577199|NCT01781429|579834448|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
160577200|NCT01781429|579834449|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
160925403|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
160925404|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
160925405|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
160925406|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
160925407|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
160925408|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
160925409|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
160925410|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
160925411|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
160925412|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
160925413|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
160925414|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
160925415|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
160925416|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
160925417|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
160925418|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
160925419|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
160925420|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
160925421|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
160925422|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
160925423|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
160925424|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
160925425|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
160925426|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
160925427|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
160925428|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
160925429|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
160925430|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
160925431|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
160925432|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
160925433|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
160925434|NCT02759120|581122843|FG000|Overall Study|Death|34|||
160925435|NCT02759120|581122844|FG001|Overall Study|Death|36|||
160925436|NCT02759120|581122843|FG000|Overall Study|Lost to Follow-up|4|||
160925437|NCT02759120|581122844|FG001|Overall Study|Lost to Follow-up|7|||
160925438|NCT02759120|581122843|FG000|Overall Study|Physician Decision|3|||
160925439|NCT02759120|581122844|FG001|Overall Study|Physician Decision|0|||
160925440|NCT02759120|581122843|FG000|Overall Study|Withdrawal by Subject|28|||
160925441|NCT02759120|581122844|FG001|Overall Study|Withdrawal by Subject|15|||
160925442|NCT02759120|581122843|FG000|Overall Study|Moved out of area|3|||
160925443|NCT02759120|581122844|FG001|Overall Study|Moved out of area|4|||
160925444|NCT02759120|581122843|FG000|Overall Study|Lung transplant|3|||
160925445|NCT02759120|581122844|FG001|Overall Study|Lung transplant|5|||
160925446|NCT02759120|581122843|FG000|Overall Study|Other reason not completed|10|||
160925447|NCT02759120|581122844|FG001|Overall Study|Other reason not completed|12|||
160925448|NCT04461015|581122848|FG000|Overall Study|IV access lost during the study|0|||
160925449|NCT04461015|581122849|FG001|Overall Study|IV access lost during the study|1|||
160925450|NCT04461015|581122848|FG000|Overall Study|Withdrawal by Subject|0|||
160925451|NCT04461015|581122849|FG001|Overall Study|Withdrawal by Subject|1|||
160925452|NCT02063854|581122857|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
160925453|NCT02063854|581122858|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
160925454|NCT02063854|581122859|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
160925455|NCT02063854|581122860|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
160925456|NCT02063854|581122861|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
160925457|NCT02063854|581122862|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
160925458|NCT02063854|581122863|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
160925459|NCT02063854|581122857|FG000|Overall Study|Major Protocol Deviation|0|||
160925460|NCT02063854|581122858|FG001|Overall Study|Major Protocol Deviation|0|||
160925461|NCT02063854|581122859|FG002|Overall Study|Major Protocol Deviation|3|||
160925462|NCT02063854|581122860|FG003|Overall Study|Major Protocol Deviation|0|||
160925463|NCT02063854|581122861|FG004|Overall Study|Major Protocol Deviation|0|||
160577201|NCT01781429|579834450|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
160577202|NCT01781429|579834451|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
160925464|NCT02063854|581122862|FG005|Overall Study|Major Protocol Deviation|0|||
160925465|NCT02063854|581122863|FG006|Overall Study|Major Protocol Deviation|0|||
160925466|NCT02063854|581122857|FG000|Overall Study|Voluntary Withdrawal|2|||
160925467|NCT02063854|581122858|FG001|Overall Study|Voluntary Withdrawal|0|||
160925468|NCT02063854|581122859|FG002|Overall Study|Voluntary Withdrawal|8|||
160925469|NCT02063854|581122860|FG003|Overall Study|Voluntary Withdrawal|1|||
160925470|NCT02063854|581122861|FG004|Overall Study|Voluntary Withdrawal|3|||
160925471|NCT02063854|581122862|FG005|Overall Study|Voluntary Withdrawal|6|||
160925472|NCT02063854|581122863|FG006|Overall Study|Voluntary Withdrawal|1|||
160925473|NCT02063854|581122857|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
160925474|NCT02063854|581122858|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
160925475|NCT02063854|581122859|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
160925476|NCT02063854|581122860|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
160925477|NCT02063854|581122861|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
160925478|NCT02063854|581122862|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
160925479|NCT02063854|581122863|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
160925480|NCT02063854|581122857|FG000|Overall Study|Reason Not Specified|1|||
160925481|NCT02063854|581122858|FG001|Overall Study|Reason Not Specified|0|||
160925482|NCT02063854|581122859|FG002|Overall Study|Reason Not Specified|0|||
160925483|NCT02063854|581122860|FG003|Overall Study|Reason Not Specified|0|||
160454831|NCT01928394|579396176|FG006|Follow-up Period|Participant withdrew consent|5|||
160925484|NCT02063854|581122861|FG004|Overall Study|Reason Not Specified|0|||
160925485|NCT02063854|581122862|FG005|Overall Study|Reason Not Specified|0|||
160925486|NCT02063854|581122863|FG006|Overall Study|Reason Not Specified|0|||
160925487|NCT02063854|581122857|FG000|Overall Study|Did Not Receive Study Drug|0|||
160925488|NCT02063854|581122858|FG001|Overall Study|Did Not Receive Study Drug|0|||
160925489|NCT02063854|581122859|FG002|Overall Study|Did Not Receive Study Drug|0|||
160925490|NCT02063854|581122860|FG003|Overall Study|Did Not Receive Study Drug|0|||
160925491|NCT02063854|581122861|FG004|Overall Study|Did Not Receive Study Drug|0|||
160925492|NCT02063854|581122862|FG005|Overall Study|Did Not Receive Study Drug|1|||
160925493|NCT02063854|581122863|FG006|Overall Study|Did Not Receive Study Drug|0|||
160925494|NCT01413360|581122868|FG000|Overall Study|Lost to Follow-up|2|||
160925495|NCT01413360|581122868|FG000|Overall Study|Adverse Event|1|||
160925496|NCT02246673|581122872|FG000|Overall Study|Sponsor Decision|1|||
160925497|NCT02246673|581122873|FG001|Overall Study|Sponsor Decision|0|||
160925498|NCT02246673|581122874|FG002|Overall Study|Sponsor Decision|0|||
160925499|NCT02246673|581122875|FG003|Overall Study|Sponsor Decision|0|||
160925500|NCT02246673|581122876|FG004|Overall Study|Sponsor Decision|0|||
160925501|NCT02246673|581122872|FG000|Overall Study|Withdrawal by Subject|0|||
160925502|NCT02246673|581122873|FG001|Overall Study|Withdrawal by Subject|0|||
160925503|NCT02246673|581122874|FG002|Overall Study|Withdrawal by Subject|0|||
160925504|NCT02246673|581122875|FG003|Overall Study|Withdrawal by Subject|0|||
160925505|NCT02246673|581122876|FG004|Overall Study|Withdrawal by Subject|1|||
160925506|NCT02246673|581122872|FG000|Overall Study|Lost to Follow-up|0|||
160925507|NCT02246673|581122873|FG001|Overall Study|Lost to Follow-up|0|||
160454832|NCT01928394|579396177|FG007|Follow-up Period|Participant withdrew consent|1|||
160925508|NCT02246673|581122874|FG002|Overall Study|Lost to Follow-up|0|||
160925509|NCT02246673|581122875|FG003|Overall Study|Lost to Follow-up|1|||
160925510|NCT02246673|581122876|FG004|Overall Study|Lost to Follow-up|0|||
160925511|NCT02246673|581122872|FG000|Overall Study|Protocol Violation|0|||
160925512|NCT02246673|581122873|FG001|Overall Study|Protocol Violation|0|||
160925513|NCT02246673|581122874|FG002|Overall Study|Protocol Violation|0|||
160925514|NCT02246673|581122875|FG003|Overall Study|Protocol Violation|1|||
160925515|NCT02246673|581122876|FG004|Overall Study|Protocol Violation|0|||
160925516|NCT05413369|581122877|FG000|Overall Study|Adverse Event|1|||
160454833|NCT01928394|579396178|FG008|Follow-up Period|Participant withdrew consent|0|||
160454834|NCT01928394|579396179|FG009|Follow-up Period|Participant withdrew consent|0|||
160454835|NCT01928394|579396180|FG010|Follow-up Period|Participant withdrew consent|5|||
160577203|NCT01781429|579834452|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
160577204|NCT01781429|579834453|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
160577205|NCT01781429|579834454|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
160577206|NCT01781429|579834455|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
160577207|NCT01781429|579834456|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
160577208|NCT01781429|579834457|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
160925517|NCT05413369|581122878|FG001|Overall Study|Adverse Event|1|||
160925518|NCT05413369|581122877|FG000|Overall Study|Withdrawal by Subject|13|||
160925519|NCT05413369|581122878|FG001|Overall Study|Withdrawal by Subject|4|||
160925520|NCT05413369|581122877|FG000|Overall Study|Non-compliance with study schedule|2|||
160454836|NCT01928394|579396181|FG011|Follow-up Period|Participant withdrew consent|8|||
160454837|NCT01928394|579396182|FG012|Follow-up Period|Participant withdrew consent|2|||
160454838|NCT01928394|579396183|FG013|Follow-up Period|Participant withdrew consent|12|||
160925521|NCT05413369|581122878|FG001|Overall Study|Non-compliance with study schedule|1|||
160925522|NCT05413369|581122877|FG000|Overall Study|Other|1|||
160925523|NCT05413369|581122878|FG001|Overall Study|Other|1|||
160925524|NCT05517382|581122891|FG000|Overall Study|Lost to Follow-up|0|||
160925525|NCT05517382|581122892|FG001|Overall Study|Lost to Follow-up|1|||
160925526|NCT00271947|581122895|FG000|Overall Study|Lost to Follow-up|1|||
160925527|NCT00651755|581122896|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
160925528|NCT00651755|581122897|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
160925529|NCT00651755|581122896|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
160925530|NCT00651755|581122897|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
160925531|NCT03642717|581122898|FG000|Overall Study|Lost to Follow-up|2|||
160925532|NCT03642717|581122898|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
160925533|NCT03642717|581122898|FG000|Overall Study|Taken study drug prior to contract date|3|||
160925534|NCT00946712|581122901|FG000|Overall Study|Adverse Event|118|||
160925535|NCT00946712|581122902|FG001|Overall Study|Adverse Event|124|||
160925536|NCT00946712|581122901|FG000|Overall Study|Disease progression|308|||
160925537|NCT00946712|581122902|FG001|Overall Study|Disease progression|404|||
160925538|NCT00946712|581122901|FG000|Overall Study|Death|21|||
160925539|NCT00946712|581122902|FG001|Overall Study|Death|22|||
160925540|NCT00946712|581122901|FG000|Overall Study|No treatment given|25|||
160925541|NCT00946712|581122902|FG001|Overall Study|No treatment given|29|||
160925542|NCT00946712|581122901|FG000|Overall Study|Other reasons|61|||
160925543|NCT00946712|581122902|FG001|Overall Study|Other reasons|73|||
160925544|NCT00946712|581122901|FG000|Overall Study|On Treatment|0|||
160925545|NCT00946712|581122902|FG001|Overall Study|On Treatment|4|||
160925546|NCT00946712|581122901|FG000|Overall Study|Ineligible|14|||
160925547|NCT00946712|581122902|FG001|Overall Study|Ineligible|6|||
160925548|NCT00302458|581122903|FG000|Overall Study|Lost to Follow-up|1|||
160925549|NCT00302458|581122903|FG000|Overall Study|Ineligible after screening|1|||
160925550|NCT00302458|581122903|FG000|Overall Study|Withdrawal by Subject|1|||
160925551|NCT00853723|581122905|FG000|Overall Study|Adverse Event|3|||
160925552|NCT00853723|581122906|FG001|Overall Study|Adverse Event|4|||
160925553|NCT00853723|581122907|FG002|Overall Study|Adverse Event|1|||
160925554|NCT00853723|581122905|FG000|Overall Study|Withdrawal by Subject|2|||
160925555|NCT00853723|581122906|FG001|Overall Study|Withdrawal by Subject|1|||
160925556|NCT00853723|581122907|FG002|Overall Study|Withdrawal by Subject|0|||
160925557|NCT00853723|581122905|FG000|Overall Study|Protocol Violation|1|||
160925558|NCT00853723|581122906|FG001|Overall Study|Protocol Violation|2|||
160925559|NCT00853723|581122907|FG002|Overall Study|Protocol Violation|1|||
160925560|NCT04248933|581122908|FG000|Overall Study|Lost to Follow-up|9|||
160925561|NCT04248933|581122908|FG000|Overall Study|Withdrawal by Subject|2|||
160925562|NCT02642432|581122911|FG000|Overall Study|Adverse Event|2|||
160925563|NCT02642432|581122911|FG000|Overall Study|Withdrew Consent|1|||
160925564|NCT02642432|581122911|FG000|Overall Study|Lost to Follow-up|2|||
160577209|NCT01781429|579834458|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
160577210|NCT01781429|579834459|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
160577211|NCT01781429|579834460|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
160925565|NCT02642432|581122911|FG000|Overall Study|Other|3|||
160925566|NCT02447081|581122912|FG000|Overall Study|Death|161|||
160925567|NCT02447081|581122912|FG000|Overall Study|Lost to Follow-up|36|||
160925568|NCT02447081|581122912|FG000|Overall Study|Visit not completed|17|||
160925569|NCT02447081|581122912|FG000|Overall Study|unsuccessful implant procedure|10|||
160925570|NCT05778786|581122913|FG000|Period 1|COVID-19 Related|3|||
160925571|NCT05778786|581122914|FG001|Period 1|COVID-19 Related|3|||
160925572|NCT05778786|581122913|FG000|Period 1|Withdrew Consent during Study|1|||
160925573|NCT05778786|581122914|FG001|Period 1|Withdrew Consent during Study|0|||
160925574|NCT05778786|581122913|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
160925575|NCT05778786|581122914|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
160925576|NCT05778786|581122913|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
160925577|NCT05778786|581122914|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
160925578|NCT02075658|581122917|FG000|Overall Study|Physician Decision|2|||
160925579|NCT02075658|581122918|FG001|Overall Study|Physician Decision|2|||
160454839|NCT01928394|579396184|FG014|Follow-up Period|Participant withdrew consent|7|||
160454840|NCT01928394|579396185|FG015|Follow-up Period|Participant withdrew consent|0|||
160454841|NCT01928394|579396186|FG016|Follow-up Period|Participant withdrew consent|5|||
160454842|NCT01928394|579396187|FG017|Follow-up Period|Participant withdrew consent|3|||
160454843|NCT01928394|579396188|FG018|Follow-up Period|Participant withdrew consent|2|||
160577212|NCT01781429|579834461|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
160925588|NCT05198843|581122922|FG000|Overall Study|Lack of Efficacy|1|||
160925589|NCT03188094|581122923|FG000|Overall Study|Screen failure|1|||
160925590|NCT03188094|581122924|FG001|Overall Study|Screen failure|0|||
160925591|NCT03188094|581122925|FG002|Overall Study|Screen failure|0|||
160925592|NCT03188094|581122923|FG000|Overall Study|Pregnancy|3|||
160925593|NCT03188094|581122924|FG001|Overall Study|Pregnancy|0|||
160925594|NCT03188094|581122925|FG002|Overall Study|Pregnancy|0|||
160925595|NCT03188094|581122923|FG000|Overall Study|Ineligible|1|||
160925596|NCT03188094|581122924|FG001|Overall Study|Ineligible|0|||
160925597|NCT03188094|581122925|FG002|Overall Study|Ineligible|0|||
160925598|NCT03188094|581122923|FG000|Overall Study|Lost to Follow-up|0|||
160925599|NCT03188094|581122924|FG001|Overall Study|Lost to Follow-up|0|||
160925600|NCT03188094|581122925|FG002|Overall Study|Lost to Follow-up|17|||
160925601|NCT02946047|581122926|FG000|Overall Study|Adverse Event|1|||
160925602|NCT02946047|581122927|FG001|Overall Study|Adverse Event|0|||
160925603|NCT02946047|581122928|FG002|Overall Study|Adverse Event|0|||
160925604|NCT02946047|581122929|FG003|Overall Study|Adverse Event|0|||
160925605|NCT03615105|581122930|FG000|Overall Study|Protocol Violation|1|||
160925606|NCT03615105|581122931|FG001|Overall Study|Protocol Violation|0|||
160925607|NCT03615105|581122932|FG002|Overall Study|Protocol Violation|0|||
160925608|NCT03615105|581122930|FG000|Overall Study|Death|0|||
160925609|NCT03615105|581122931|FG001|Overall Study|Death|2|||
160925610|NCT03615105|581122932|FG002|Overall Study|Death|0|||
160925611|NCT01894581|581122933|FG000|Overall Study|Withdrawal by Subject|2|||
160925612|NCT01894581|581122934|FG001|Overall Study|Withdrawal by Subject|3|||
160925613|NCT01894581|581122933|FG000|Overall Study|Screen Failure|3|||
160925614|NCT01894581|581122934|FG001|Overall Study|Screen Failure|4|||
160925615|NCT03795298|581122935|FG000|Overall Study|Death|34|||
160925616|NCT03795298|581122936|FG001|Overall Study|Death|29|||
160925617|NCT03795298|581122935|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
160925618|NCT03795298|581122936|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
160925619|NCT03795298|581122935|FG000|Overall Study|Lost to Follow-up|28|||
160925620|NCT03795298|581122936|FG001|Overall Study|Lost to Follow-up|17|||
160925621|NCT03795298|581122935|FG000|Overall Study|Physician Decision|5|||
160925622|NCT03795298|581122936|FG001|Overall Study|Physician Decision|4|||
160925623|NCT03795298|581122935|FG000|Overall Study|Withdrawal by Subject|43|||
160925624|NCT03795298|581122936|FG001|Overall Study|Withdrawal by Subject|28|||
160925625|NCT03795298|581122935|FG000|Overall Study|Reason not reported|7|||
160925626|NCT03795298|581122936|FG001|Overall Study|Reason not reported|9|||
160925627|NCT01252940|581122937|FG000|Main Study Phase|Randomized but not treated|4|||
160925628|NCT01252940|581122938|FG001|Main Study Phase|Randomized but not treated|2|||
160925629|NCT01252940|581122937|FG000|Main Study Phase|Adverse Event|3|||
160925630|NCT01252940|581122938|FG001|Main Study Phase|Adverse Event|1|||
160925631|NCT01252940|581122937|FG000|Main Study Phase|Lack of Efficacy|1|||
160925632|NCT01252940|581122938|FG001|Main Study Phase|Lack of Efficacy|0|||
160925633|NCT01252940|581122937|FG000|Main Study Phase|Lost to Follow-up|6|||
160925634|NCT01252940|581122938|FG001|Main Study Phase|Lost to Follow-up|1|||
160925635|NCT01252940|581122937|FG000|Main Study Phase|Physician Decision|1|||
160577213|NCT01781429|579834446|FG000|Overall Study|Enrolled, but not treated|0|||
160577214|NCT01781429|579834447|FG001|Overall Study|Enrolled, but not treated|0|||
160577215|NCT01781429|579834448|FG002|Overall Study|Enrolled, but not treated|0|||
160577216|NCT01781429|579834449|FG003|Overall Study|Enrolled, but not treated|0|||
160577217|NCT01781429|579834450|FG004|Overall Study|Enrolled, but not treated|0|||
160577218|NCT01781429|579834451|FG005|Overall Study|Enrolled, but not treated|0|||
160577219|NCT01781429|579834452|FG006|Overall Study|Enrolled, but not treated|0|||
160577220|NCT01781429|579834453|FG007|Overall Study|Enrolled, but not treated|0|||
160577221|NCT01781429|579834454|FG008|Overall Study|Enrolled, but not treated|0|||
160577222|NCT01781429|579834455|FG009|Overall Study|Enrolled, but not treated|0|||
160577223|NCT01781429|579834456|FG010|Overall Study|Enrolled, but not treated|1|||
160577224|NCT01781429|579834457|FG011|Overall Study|Enrolled, but not treated|0|||
160577225|NCT01781429|579834458|FG012|Overall Study|Enrolled, but not treated|0|||
160577226|NCT01781429|579834459|FG013|Overall Study|Enrolled, but not treated|0|||
160577227|NCT01781429|579834460|FG014|Overall Study|Enrolled, but not treated|0|||
160577228|NCT01781429|579834461|FG015|Overall Study|Enrolled, but not treated|0|||
160577229|NCT01703286|579834463|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
160577230|NCT01703286|579834464|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
160577231|NCT01703286|579834465|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
160577232|NCT01703286|579834466|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
160577233|NCT01703286|579834467|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
160577234|NCT01703286|579834468|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
160577235|NCT01703286|579834463|FG000|Period 2 Including Washout|Adverse Event|0|||
160577236|NCT01703286|579834464|FG001|Period 2 Including Washout|Adverse Event|0|||
160577237|NCT01703286|579834465|FG002|Period 2 Including Washout|Adverse Event|0|||
160577238|NCT01703286|579834466|FG003|Period 2 Including Washout|Adverse Event|1|||
160577239|NCT01703286|579834467|FG004|Period 2 Including Washout|Adverse Event|0|||
160577240|NCT01703286|579834468|FG005|Period 2 Including Washout|Adverse Event|0|||
160925636|NCT01252940|581122938|FG001|Main Study Phase|Physician Decision|0|||
160925637|NCT01252940|581122937|FG000|Main Study Phase|Protocol Violation|4|||
160925638|NCT01252940|581122938|FG001|Main Study Phase|Protocol Violation|2|||
160925639|NCT01252940|581122937|FG000|Main Study Phase|Withdrawal by Subject|6|||
160925640|NCT01252940|581122938|FG001|Main Study Phase|Withdrawal by Subject|5|||
160925641|NCT01252940|581122937|FG000|Main Study Phase|Subject Non-compliance|1|||
160925642|NCT01252940|581122938|FG001|Main Study Phase|Subject Non-compliance|1|||
160925643|NCT01252940|581122937|FG000|Extension Phase|Adverse Event|2|||
160925644|NCT01252940|581122938|FG001|Extension Phase|Adverse Event|1|||
160925645|NCT01252940|581122937|FG000|Extension Phase|Lack of Efficacy|1|||
160577241|NCT00931892|579834469|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
160577242|NCT00931892|579834470|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
160577243|NCT02207530|579834473|FG000|Overall Study|Worsening condition under investigation|78|||
160577244|NCT02207530|579834473|FG000|Overall Study|Patient decision to stop study treatment|5|||
160577245|NCT02207530|579834473|FG000|Overall Study|Adverse Event|8|||
160577246|NCT06094296|579834476|FG000|Overall Study|Progressive Disease|1|||
160577247|NCT06094296|579834477|FG001|Overall Study|Progressive Disease|0|||
160577248|NCT06094296|579834478|FG002|Overall Study|Progressive Disease|0|||
160577249|NCT06094296|579834479|FG003|Overall Study|Progressive Disease|0|||
160577250|NCT00986258|579834480|FG000|Observation Period|Not eligible to be dosed|11|||
160577251|NCT00986258|579834480|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
160655252|NCT00950807|580118704|FG008|Washout Period 1|Lack of Efficacy|0|||
160925646|NCT01252940|581122938|FG001|Extension Phase|Lack of Efficacy|0|||
160925647|NCT01252940|581122937|FG000|Extension Phase|Lost to Follow-up|5|||
160925648|NCT01252940|581122938|FG001|Extension Phase|Lost to Follow-up|0|||
160925649|NCT01252940|581122937|FG000|Extension Phase|Physician Decision|0|||
160655253|NCT00950807|580118705|FG009|Washout Period 1|Lack of Efficacy|0|||
160655254|NCT00950807|580118696|FG000|Washout Period 1|Withdrawal by Subject|0|||
160655255|NCT00950807|580118697|FG001|Washout Period 1|Withdrawal by Subject|0|||
160655256|NCT00950807|580118698|FG002|Washout Period 1|Withdrawal by Subject|0|||
160655257|NCT00950807|580118699|FG003|Washout Period 1|Withdrawal by Subject|0|||
160655258|NCT00950807|580118700|FG004|Washout Period 1|Withdrawal by Subject|0|||
160655259|NCT00950807|580118701|FG005|Washout Period 1|Withdrawal by Subject|0|||
160655260|NCT00950807|580118702|FG006|Washout Period 1|Withdrawal by Subject|0|||
160655261|NCT00950807|580118703|FG007|Washout Period 1|Withdrawal by Subject|0|||
160655262|NCT00950807|580118704|FG008|Washout Period 1|Withdrawal by Subject|1|||
160655263|NCT00950807|580118705|FG009|Washout Period 1|Withdrawal by Subject|0|||
160655264|NCT00950807|580118696|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
160655265|NCT00950807|580118697|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
160655266|NCT00950807|580118698|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
160655267|NCT00950807|580118699|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
160655268|NCT00950807|580118700|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
160655269|NCT00950807|580118701|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
160655270|NCT00950807|580118702|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
160655271|NCT00950807|580118703|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
160655272|NCT00950807|580118704|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
160655273|NCT00950807|580118705|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
160655274|NCT00950807|580118696|FG000|Washout Period 1|Adverse Event|2|||
160655275|NCT00950807|580118697|FG001|Washout Period 1|Adverse Event|0|||
160655276|NCT00950807|580118698|FG002|Washout Period 1|Adverse Event|0|||
160655277|NCT00950807|580118699|FG003|Washout Period 1|Adverse Event|1|||
160655278|NCT00950807|580118700|FG004|Washout Period 1|Adverse Event|1|||
160655279|NCT00950807|580118701|FG005|Washout Period 1|Adverse Event|0|||
160655280|NCT00950807|580118702|FG006|Washout Period 1|Adverse Event|0|||
160925650|NCT01252940|581122938|FG001|Extension Phase|Physician Decision|1|||
160925651|NCT01252940|581122937|FG000|Extension Phase|Subject Non-compliance|1|||
160925652|NCT01252940|581122938|FG001|Extension Phase|Subject Non-compliance|0|||
160925653|NCT01252940|581122937|FG000|Extension Phase|Withdrawal by Subject|1|||
160925654|NCT01252940|581122938|FG001|Extension Phase|Withdrawal by Subject|1|||
160925655|NCT04199117|581122939|FG000|Overall Study|Withdrawal by Subject|3|||
160925656|NCT04199117|581122940|FG001|Overall Study|Withdrawal by Subject|0|||
160925657|NCT04199117|581122941|FG002|Overall Study|Withdrawal by Subject|0|||
160925658|NCT04199117|581122942|FG003|Overall Study|Withdrawal by Subject|1|||
160925659|NCT04199117|581122943|FG004|Overall Study|Withdrawal by Subject|1|||
160925660|NCT04199117|581122944|FG005|Overall Study|Withdrawal by Subject|0|||
160925661|NCT04199117|581122945|FG006|Overall Study|Withdrawal by Subject|0|||
160655281|NCT00950807|580118703|FG007|Washout Period 1|Adverse Event|0|||
160655282|NCT00950807|580118704|FG008|Washout Period 1|Adverse Event|0|||
160655283|NCT00950807|580118705|FG009|Washout Period 1|Adverse Event|0|||
160655284|NCT00950807|580118696|FG000|Treatment Period 2|Lack of Efficacy|1|||
160577252|NCT00986258|579834480|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
160577253|NCT00986258|579834480|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
160577254|NCT00986258|579834480|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
160655285|NCT00950807|580118697|FG001|Treatment Period 2|Lack of Efficacy|0|||
160655286|NCT00950807|580118698|FG002|Treatment Period 2|Lack of Efficacy|0|||
160655287|NCT00950807|580118699|FG003|Treatment Period 2|Lack of Efficacy|0|||
160655288|NCT00950807|580118700|FG004|Treatment Period 2|Lack of Efficacy|0|||
160655289|NCT00950807|580118701|FG005|Treatment Period 2|Lack of Efficacy|0|||
160655290|NCT00950807|580118702|FG006|Treatment Period 2|Lack of Efficacy|0|||
160925662|NCT04199117|581122946|FG007|Overall Study|Withdrawal by Subject|2|||
160925663|NCT04199117|581122947|FG008|Overall Study|Withdrawal by Subject|0|||
160925664|NCT04199117|581122948|FG009|Overall Study|Withdrawal by Subject|0|||
160925665|NCT04199117|581122949|FG010|Overall Study|Withdrawal by Subject|1|||
160925666|NCT04199117|581122950|FG011|Overall Study|Withdrawal by Subject|1|||
160925667|NCT04199117|581122951|FG012|Overall Study|Withdrawal by Subject|2|||
160925668|NCT04199117|581122952|FG013|Overall Study|Withdrawal by Subject|1|||
160925669|NCT04199117|581122953|FG014|Overall Study|Withdrawal by Subject|1|||
160925670|NCT04199117|581122954|FG015|Overall Study|Withdrawal by Subject|1|||
160925671|NCT04199117|581122939|FG000|Overall Study|Death|1|||
160925672|NCT04199117|581122940|FG001|Overall Study|Death|1|||
160925673|NCT04199117|581122941|FG002|Overall Study|Death|0|||
160925674|NCT04199117|581122942|FG003|Overall Study|Death|0|||
160925675|NCT04199117|581122943|FG004|Overall Study|Death|0|||
160925676|NCT04199117|581122944|FG005|Overall Study|Death|0|||
160925677|NCT04199117|581122945|FG006|Overall Study|Death|0|||
160925678|NCT04199117|581122946|FG007|Overall Study|Death|0|||
160925679|NCT04199117|581122947|FG008|Overall Study|Death|0|||
160577255|NCT00986258|579834480|FG000|Titration and Optimal Dose Period|Other|1|||
160577256|NCT00986258|579834480|FG000|Maintenance Period|Adverse Event|5|||
160577257|NCT00986258|579834480|FG000|Maintenance Period|Lack of Efficacy|2|||
160577258|NCT00986258|579834480|FG000|Maintenance Period|Withdrawal by Subject|2|||
160577259|NCT03332667|579834481|FG000|Overall Study|Adverse Event|0|||
160577260|NCT03332667|579834482|FG001|Overall Study|Adverse Event|0|||
160577261|NCT03332667|579834483|FG002|Overall Study|Adverse Event|2|||
160577262|NCT03332667|579834484|FG003|Overall Study|Adverse Event|1|||
160577263|NCT03332667|579834481|FG000|Overall Study|Withdrawal by Subject|2|||
160577264|NCT03332667|579834482|FG001|Overall Study|Withdrawal by Subject|1|||
160577265|NCT03332667|579834483|FG002|Overall Study|Withdrawal by Subject|5|||
160577266|NCT03332667|579834484|FG003|Overall Study|Withdrawal by Subject|1|||
160577267|NCT03332667|579834481|FG000|Overall Study|Disease Progression or Relapse|2|||
160577268|NCT03332667|579834482|FG001|Overall Study|Disease Progression or Relapse|1|||
160577269|NCT03332667|579834483|FG002|Overall Study|Disease Progression or Relapse|3|||
160577270|NCT03332667|579834484|FG003|Overall Study|Disease Progression or Relapse|0|||
160577271|NCT03332667|579834481|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
160577272|NCT03332667|579834482|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
160577273|NCT03332667|579834483|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
160577274|NCT03332667|579834484|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
160577275|NCT03332667|579834481|FG000|Overall Study|No Treatment Received|0|||
160577276|NCT03332667|579834482|FG001|Overall Study|No Treatment Received|0|||
160577277|NCT03332667|579834483|FG002|Overall Study|No Treatment Received|1|||
160577278|NCT03332667|579834484|FG003|Overall Study|No Treatment Received|0|||
160577279|NCT04964063|579834485|FG000|Overall Study|Adverse Event|4|||
160577280|NCT04964063|579834485|FG000|Overall Study|Lost to Follow-up|47|||
160577281|NCT04964063|579834485|FG000|Overall Study|Withdrawal by Subject|5|||
160577282|NCT04964063|579834485|FG000|Overall Study|Baseline Tasks Expired|41|||
160577283|NCT04964063|579834485|FG000|Overall Study|Participant withdrawn in error|1|||
160577284|NCT01035606|579834486|FG000|Overall Study|change in health, job demands,family|3|||
160577285|NCT01035606|579834487|FG001|Overall Study|change in health, job demands,family|3|||
160577286|NCT01035606|579834488|FG002|Overall Study|change in health, job demands,family|4|||
160577287|NCT01070303|579834489|FG000|Overall Study|Adverse Event|39|||
160577288|NCT01070303|579834489|FG000|Overall Study|Withdrawal by Subject|20|||
160577289|NCT01070303|579834489|FG000|Overall Study|Lost to Follow-up|9|||
160577290|NCT01070303|579834489|FG000|Overall Study|Protocol Violation|0|||
160577291|NCT01070303|579834489|FG000|Overall Study|Lack of Efficacy|2|||
160577292|NCT01070303|579834489|FG000|Overall Study|Administrative Reason|1|||
160577293|NCT01070303|579834489|FG000|Overall Study|Other|18|||
160577294|NCT01809262|579834490|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
160577295|NCT01809262|579834491|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
160577296|NCT01809262|579834492|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
160577297|NCT01809262|579834493|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
160577298|NCT01809262|579834494|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
160577299|NCT01809262|579834495|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
160577300|NCT01809262|579834496|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
160577301|NCT01809262|579834497|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
160577302|NCT01809262|579834498|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
160577303|NCT01809262|579834499|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
160577304|NCT01809262|579834490|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
160577305|NCT01809262|579834491|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
160577306|NCT01809262|579834492|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
160577307|NCT01809262|579834493|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
160577308|NCT01809262|579834494|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
160577309|NCT01809262|579834495|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
160577310|NCT01809262|579834496|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
160577311|NCT01809262|579834497|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
160577312|NCT01809262|579834498|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
160925680|NCT04199117|581122948|FG009|Overall Study|Death|0|||
160925681|NCT04199117|581122949|FG010|Overall Study|Death|0|||
160925682|NCT04199117|581122950|FG011|Overall Study|Death|1|||
160925683|NCT04199117|581122951|FG012|Overall Study|Death|0|||
160655291|NCT00950807|580118703|FG007|Treatment Period 2|Lack of Efficacy|0|||
160655292|NCT00950807|580118704|FG008|Treatment Period 2|Lack of Efficacy|0|||
160655293|NCT00950807|580118705|FG009|Treatment Period 2|Lack of Efficacy|0|||
160655294|NCT00950807|580118696|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160655295|NCT00950807|580118697|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160655296|NCT00950807|580118698|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160655297|NCT00950807|580118699|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160655298|NCT00950807|580118700|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160655299|NCT00950807|580118701|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160655300|NCT00950807|580118702|FG006|Treatment Period 2|Withdrawal by Subject|1|||
160655301|NCT00950807|580118703|FG007|Treatment Period 2|Withdrawal by Subject|2|||
160655302|NCT00950807|580118704|FG008|Treatment Period 2|Withdrawal by Subject|0|||
160655303|NCT00950807|580118705|FG009|Treatment Period 2|Withdrawal by Subject|0|||
160655304|NCT00950807|580118696|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
160655305|NCT00950807|580118697|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160655306|NCT00950807|580118698|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160655307|NCT00950807|580118699|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160655308|NCT00950807|580118700|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160997962|NCT03538041|581378499|FG001|12-Week Treatment Period|Adverse Event|1|||
160997963|NCT03538041|581378498|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
160997964|NCT03538041|581378499|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
160997965|NCT03538041|581378498|FG000|Treatment Extension Period|Adverse Event|4|||
160997966|NCT03538041|581378499|FG001|Treatment Extension Period|Adverse Event|1|||
160997967|NCT03538041|581378498|FG000|Treatment Extension Period|Physician Decision|1|||
160997968|NCT03538041|581378499|FG001|Treatment Extension Period|Physician Decision|1|||
160997969|NCT03538041|581378498|FG000|Treatment Extension Period|Lack of Efficacy|1|||
160997970|NCT03538041|581378499|FG001|Treatment Extension Period|Lack of Efficacy|4|||
160997971|NCT03538041|581378498|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
160997972|NCT03538041|581378499|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
160997973|NCT03538041|581378498|FG000|Treatment Extension Period|Death|0|||
160997974|NCT03538041|581378499|FG001|Treatment Extension Period|Death|1|||
160997975|NCT01049503|581378500|FG000|Overall Study|Lost to Follow-up|11|||
160997976|NCT01049503|581378501|FG001|Overall Study|Lost to Follow-up|12|||
160997977|NCT01049503|581378502|FG002|Overall Study|Lost to Follow-up|24|||
160997978|NCT01049503|581378503|FG003|Overall Study|Lost to Follow-up|26|||
160997979|NCT01049503|581378504|FG004|Overall Study|Lost to Follow-up|27|||
160997980|NCT01049503|581378505|FG005|Overall Study|Lost to Follow-up|8|||
160997981|NCT00970307|581378506|FG000|Overall Study|Serious Adverse Event|1|||
160997982|NCT00970307|581378507|FG001|Overall Study|Serious Adverse Event|0|||
160997983|NCT00970307|581378508|FG002|Overall Study|Serious Adverse Event|0|||
160997984|NCT00970307|581378506|FG000|Overall Study|Withdrawal by Subject|2|||
160997985|NCT00970307|581378507|FG001|Overall Study|Withdrawal by Subject|3|||
160997986|NCT00970307|581378508|FG002|Overall Study|Withdrawal by Subject|2|||
160997987|NCT05174013|581378517|FG000|Overall Study|Lost to Follow-up|0|||
160997988|NCT05174013|581378518|FG001|Overall Study|Lost to Follow-up|0|||
160997989|NCT05174013|581378519|FG002|Overall Study|Lost to Follow-up|0|||
160997990|NCT05174013|581378520|FG003|Overall Study|Lost to Follow-up|1|||
160997991|NCT05174013|581378521|FG004|Overall Study|Lost to Follow-up|0|||
160997992|NCT05174013|581378522|FG005|Overall Study|Lost to Follow-up|0|||
160997993|NCT05174013|581378517|FG000|Overall Study|Withdrawal by Subject|0|||
160997994|NCT05174013|581378518|FG001|Overall Study|Withdrawal by Subject|0|||
160997995|NCT05174013|581378519|FG002|Overall Study|Withdrawal by Subject|1|||
160997996|NCT05174013|581378520|FG003|Overall Study|Withdrawal by Subject|0|||
160997997|NCT05174013|581378521|FG004|Overall Study|Withdrawal by Subject|0|||
160997998|NCT05174013|581378522|FG005|Overall Study|Withdrawal by Subject|0|||
160997999|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
160998000|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
160998001|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
160998002|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
160998003|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
160998004|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
160998005|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
160998006|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
160998007|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
160998008|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
160998009|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
160998010|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
160655309|NCT00950807|580118701|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160998011|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
160998012|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
160998013|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
160655310|NCT00950807|580118702|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160655311|NCT00950807|580118703|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160925684|NCT04199117|581122952|FG013|Overall Study|Death|1|||
160925685|NCT04199117|581122953|FG014|Overall Study|Death|0|||
160925686|NCT04199117|581122954|FG015|Overall Study|Death|0|||
160925687|NCT04199117|581122939|FG000|Overall Study|Withdrawal by PI|0|||
160925688|NCT04199117|581122940|FG001|Overall Study|Withdrawal by PI|0|||
160925689|NCT04199117|581122941|FG002|Overall Study|Withdrawal by PI|0|||
160925690|NCT04199117|581122942|FG003|Overall Study|Withdrawal by PI|0|||
160925691|NCT04199117|581122943|FG004|Overall Study|Withdrawal by PI|0|||
160925692|NCT04199117|581122944|FG005|Overall Study|Withdrawal by PI|0|||
160925693|NCT04199117|581122945|FG006|Overall Study|Withdrawal by PI|0|||
160925694|NCT04199117|581122946|FG007|Overall Study|Withdrawal by PI|0|||
160925695|NCT04199117|581122947|FG008|Overall Study|Withdrawal by PI|0|||
160925696|NCT04199117|581122948|FG009|Overall Study|Withdrawal by PI|0|||
160925697|NCT04199117|581122949|FG010|Overall Study|Withdrawal by PI|0|||
160925698|NCT04199117|581122950|FG011|Overall Study|Withdrawal by PI|0|||
160925699|NCT04199117|581122951|FG012|Overall Study|Withdrawal by PI|1|||
160925700|NCT04199117|581122952|FG013|Overall Study|Withdrawal by PI|0|||
160925701|NCT04199117|581122953|FG014|Overall Study|Withdrawal by PI|0|||
160925702|NCT04199117|581122954|FG015|Overall Study|Withdrawal by PI|0|||
160925703|NCT04383743|581122955|FG000|Overall Study|Withdrawal by Subject|1|||
160925704|NCT04383743|581122955|FG000|Overall Study|Adverse Event|1|||
160925705|NCT04814433|581122958|FG000|Overall Study|Survey not returned|4|||
160925706|NCT04814433|581122959|FG001|Overall Study|Survey not returned|8|||
160925707|NCT04814433|581122960|FG002|Overall Study|Survey not returned|4|||
160925708|NCT04814433|581122961|FG003|Overall Study|Survey not returned|5|||
160925709|NCT03482791|581122966|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
160925710|NCT03482791|581122967|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
160925711|NCT00296374|581122969|FG000|Overall Study|Adverse Event|14|||
160925712|NCT00296374|581122970|FG001|Overall Study|Adverse Event|10|||
160925713|NCT00296374|581122971|FG002|Overall Study|Adverse Event|7|||
160925714|NCT00296374|581122969|FG000|Overall Study|Withdrawal by Subject|3|||
160925715|NCT00296374|581122970|FG001|Overall Study|Withdrawal by Subject|5|||
160925716|NCT00296374|581122971|FG002|Overall Study|Withdrawal by Subject|11|||
160925717|NCT00296374|581122969|FG000|Overall Study|Incorrect enrollment|3|||
160925718|NCT00296374|581122970|FG001|Overall Study|Incorrect enrollment|3|||
160925719|NCT00296374|581122971|FG002|Overall Study|Incorrect enrollment|4|||
160925720|NCT00296374|581122969|FG000|Overall Study|Protocol Violation|1|||
160925721|NCT00296374|581122970|FG001|Overall Study|Protocol Violation|2|||
160925722|NCT00296374|581122971|FG002|Overall Study|Protocol Violation|3|||
160925723|NCT00296374|581122969|FG000|Overall Study|Lost to Follow-up|3|||
160925724|NCT00296374|581122970|FG001|Overall Study|Lost to Follow-up|1|||
160925725|NCT00296374|581122971|FG002|Overall Study|Lost to Follow-up|1|||
160925726|NCT00296374|581122969|FG000|Overall Study|Relocated to another state|1|||
160925727|NCT00296374|581122970|FG001|Overall Study|Relocated to another state|0|||
160925728|NCT00296374|581122971|FG002|Overall Study|Relocated to another state|0|||
160925729|NCT00296374|581122969|FG000|Overall Study|Stopped drug before end of study visit|0|||
160925730|NCT00296374|581122970|FG001|Overall Study|Stopped drug before end of study visit|1|||
160925731|NCT00296374|581122971|FG002|Overall Study|Stopped drug before end of study visit|0|||
160925732|NCT00296374|581122969|FG000|Overall Study|Nephrologist introduced ACE|0|||
160925733|NCT00296374|581122970|FG001|Overall Study|Nephrologist introduced ACE|1|||
160925734|NCT00296374|581122971|FG002|Overall Study|Nephrologist introduced ACE|0|||
160925735|NCT00296374|581122969|FG000|Overall Study|Pregnancy|0|||
160925736|NCT00296374|581122970|FG001|Overall Study|Pregnancy|0|||
160925737|NCT00296374|581122971|FG002|Overall Study|Pregnancy|2|||
160925738|NCT00296374|581122969|FG000|Overall Study|Other|0|||
160925739|NCT00296374|581122970|FG001|Overall Study|Other|0|||
160925740|NCT00296374|581122971|FG002|Overall Study|Other|1|||
160925741|NCT01816893|581122972|FG000|Washout Period|Withdrawal by Subject|2|||
160925742|NCT01816893|581122973|FG001|Washout Period|Withdrawal by Subject|0|||
160577313|NCT01809262|579834499|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
160925743|NCT04782856|581124501|FG000|Overall Study|Withdrawal by Subject|0|||
160925744|NCT04782856|581124502|FG001|Overall Study|Withdrawal by Subject|1|||
160925745|NCT01030523|581124503|FG000|Initial Study (5 Years)|Death|1|||
160925746|NCT01030523|581124504|FG001|Initial Study (5 Years)|Death|0|||
160577314|NCT00859898|579834501|FG000|Overall Study|Lack of Efficacy|0|||
160577315|NCT00859898|579834502|FG001|Overall Study|Lack of Efficacy|1|||
160577316|NCT00859898|579834503|FG002|Overall Study|Lack of Efficacy|1|||
160577317|NCT00859898|579834501|FG000|Overall Study|Adverse Event|4|||
160577318|NCT00859898|579834502|FG001|Overall Study|Adverse Event|9|||
160577319|NCT00859898|579834503|FG002|Overall Study|Adverse Event|8|||
160925747|NCT01030523|581124503|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
160925748|NCT01030523|581124504|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
160925749|NCT01030523|581124503|FG000|Initial Study (5 Years)|Implant failure|1|||
160925750|NCT01030523|581124504|FG001|Initial Study (5 Years)|Implant failure|0|||
160925751|NCT01030523|581124503|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
160925752|NCT01030523|581124504|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
160925753|NCT01030523|581124503|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
160925754|NCT01030523|581124504|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
160925755|NCT01030523|581124503|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
160925756|NCT01030523|581124504|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
160925757|NCT00798369|581124507|FG000|Overall Study|Subject withdrew consent|0|||
160925758|NCT00798369|581124508|FG001|Overall Study|Subject withdrew consent|0|||
160925759|NCT00798369|581124509|FG002|Overall Study|Subject withdrew consent|1|||
160925760|NCT00798369|581124510|FG003|Overall Study|Subject withdrew consent|1|||
160925761|NCT00798369|581124511|FG004|Overall Study|Subject withdrew consent|0|||
160925762|NCT00798369|581124512|FG005|Overall Study|Subject withdrew consent|2|||
160925763|NCT00798369|581124507|FG000|Overall Study|Lost to Follow-up|1|||
160925764|NCT00798369|581124508|FG001|Overall Study|Lost to Follow-up|1|||
160925765|NCT00798369|581124509|FG002|Overall Study|Lost to Follow-up|1|||
160925766|NCT00798369|581124510|FG003|Overall Study|Lost to Follow-up|0|||
160925767|NCT00798369|581124511|FG004|Overall Study|Lost to Follow-up|1|||
160925768|NCT00798369|581124512|FG005|Overall Study|Lost to Follow-up|0|||
160925769|NCT00798369|581124507|FG000|Overall Study|Adminstrative problems|0|||
160925770|NCT00798369|581124508|FG001|Overall Study|Adminstrative problems|0|||
160925771|NCT00798369|581124509|FG002|Overall Study|Adminstrative problems|0|||
160925772|NCT00798369|581124510|FG003|Overall Study|Adminstrative problems|0|||
160925773|NCT00798369|581124511|FG004|Overall Study|Adminstrative problems|0|||
160925774|NCT00798369|581124512|FG005|Overall Study|Adminstrative problems|1|||
160925775|NCT04475588|581124513|FG000|Overall Study|Adverse Event|2|||
160925776|NCT04475588|581124514|FG001|Overall Study|Adverse Event|0|||
160925777|NCT01327300|581124515|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
160925778|NCT01327300|581124516|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
160925779|NCT01063764|581124517|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
160925780|NCT01063764|581124517|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
160925781|NCT01063764|581124517|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
160925782|NCT01063764|581124517|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
160925783|NCT01063764|581124517|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
160925784|NCT01063764|581124517|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
160925785|NCT01063764|581124517|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
160925786|NCT00697515|581124518|FG000|Dose Optimization Period|Adverse Event|4|||
160925787|NCT00697515|581124519|FG001|Dose Optimization Period|Adverse Event|0|||
160925788|NCT00697515|581124518|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
160925789|NCT00697515|581124519|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
160925790|NCT00697515|581124518|FG000|Dose Optimization Period|Lost to Follow-up|2|||
160925791|NCT00697515|581124519|FG001|Dose Optimization Period|Lost to Follow-up|0|||
160925792|NCT00697515|581124518|FG000|Dose Optimization Period|sponsor request|2|||
160925793|NCT00697515|581124519|FG001|Dose Optimization Period|sponsor request|0|||
160925794|NCT00697515|581124518|FG000|Dose Optimization Period|called to active duty|1|||
160925795|NCT00697515|581124519|FG001|Dose Optimization Period|called to active duty|0|||
160925796|NCT00697515|581124518|FG000|Dose Optimization Period|elevated QTc|1|||
160454844|NCT01928394|579396189|FG019|Follow-up Period|Participant withdrew consent|7|||
160454845|NCT01928394|579396190|FG020|Follow-up Period|Participant withdrew consent|4|||
160454846|NCT01928394|579396191|FG021|Follow-up Period|Participant withdrew consent|6|||
160454847|NCT01928394|579396192|FG022|Follow-up Period|Participant withdrew consent|2|||
160454848|NCT01928394|579396170|FG000|Follow-up Period|Death|0|||
160454849|NCT01928394|579396171|FG001|Follow-up Period|Death|0|||
160454850|NCT01928394|579396172|FG002|Follow-up Period|Death|2|||
160925797|NCT00697515|581124519|FG001|Dose Optimization Period|elevated QTc|0|||
160925798|NCT00697515|581124518|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
160925799|NCT00697515|581124519|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
160925800|NCT00697515|581124518|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
160925801|NCT00697515|581124519|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
160925802|NCT00697515|581124518|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
160925803|NCT00697515|581124519|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
160925804|NCT00697515|581124518|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
160925805|NCT00697515|581124519|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
160925806|NCT02603432|581124520|FG000|Overall Study|Adverse Event|1|||
160925807|NCT02603432|581124521|FG001|Overall Study|Adverse Event|0|||
160925808|NCT02603432|581124520|FG000|Overall Study|Death|221|||
160925809|NCT02603432|581124521|FG001|Overall Study|Death|242|||
160925810|NCT02603432|581124520|FG000|Overall Study|Lost to Follow-up|3|||
160925811|NCT02603432|581124521|FG001|Overall Study|Lost to Follow-up|9|||
160925812|NCT02603432|581124520|FG000|Overall Study|Progressive Disease|7|||
160925813|NCT02603432|581124521|FG001|Overall Study|Progressive Disease|5|||
160925814|NCT02603432|581124520|FG000|Overall Study|Withdrawal by Subject|12|||
160925815|NCT02603432|581124521|FG001|Overall Study|Withdrawal by Subject|18|||
160925816|NCT02603432|581124520|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
160925817|NCT02603432|581124521|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160925818|NCT02603432|581124520|FG000|Overall Study|Study terminated by sponsor|74|||
160454851|NCT01928394|579396173|FG003|Follow-up Period|Death|6|||
160454852|NCT01928394|579396174|FG004|Follow-up Period|Death|0|||
160998014|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
160998015|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
160998016|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
160998017|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
160925819|NCT02603432|581124521|FG001|Overall Study|Study terminated by sponsor|75|||
160925820|NCT02603432|581124520|FG000|Overall Study|Other|13|||
160925821|NCT02603432|581124521|FG001|Overall Study|Other|0|||
160925822|NCT00666757|581124522|FG000|Overall Study|Lost to Follow-up|39|||
160925823|NCT00666757|581124523|FG001|Overall Study|Lost to Follow-up|35|||
160925824|NCT00666757|581124522|FG000|Overall Study|Protocol Violation|23|||
160925825|NCT00666757|581124523|FG001|Overall Study|Protocol Violation|24|||
160925826|NCT00666757|581124522|FG000|Overall Study|Adverse Event|22|||
160925827|NCT00666757|581124523|FG001|Overall Study|Adverse Event|12|||
160925828|NCT00666757|581124522|FG000|Overall Study|Withdrawal by Subject|13|||
160925829|NCT00666757|581124523|FG001|Overall Study|Withdrawal by Subject|17|||
160925830|NCT00666757|581124522|FG000|Overall Study|Lack of Efficacy|3|||
160925831|NCT00666757|581124523|FG001|Overall Study|Lack of Efficacy|6|||
160925832|NCT00666757|581124522|FG000|Overall Study|Physician Decision|0|||
160925833|NCT00666757|581124523|FG001|Overall Study|Physician Decision|2|||
160925834|NCT00666757|581124522|FG000|Overall Study|Sponsor decision|0|||
160925835|NCT00666757|581124523|FG001|Overall Study|Sponsor decision|1|||
160925836|NCT05954052|581124524|FG000|Overall Study|Adverse Event|1|||
160925837|NCT01957462|581124525|FG000|Test Period 1|Withdrawal by Subject|1|||
160925838|NCT01957462|581124526|FG001|Test Period 1|Withdrawal by Subject|0|||
160925839|NCT01957462|581124525|FG000|Test Period 1|Adverse Event|1|||
160925840|NCT01957462|581124526|FG001|Test Period 1|Adverse Event|0|||
160925841|NCT03102918|581124527|FG000|Overall Study|Protocol Violation|1|||
160925842|NCT03102918|581124528|FG001|Overall Study|Protocol Violation|0|||
160925843|NCT04765358|581124531|FG000|Overall Study|Withdrawal by Subject|1|||
160925844|NCT03446040|581124532|FG000|Overall Study|Disease progression|3|||
160925845|NCT03446040|581124533|FG001|Overall Study|Disease progression|3|||
160925846|NCT03446040|581124534|FG002|Overall Study|Disease progression|3|||
160925847|NCT03446040|581124535|FG003|Overall Study|Disease progression|4|||
160925848|NCT03446040|581124536|FG004|Overall Study|Disease progression|4|||
160925849|NCT03446040|581124537|FG005|Overall Study|Disease progression|6|||
160925850|NCT03446040|581124538|FG006|Overall Study|Disease progression|3|||
160925851|NCT03446040|581124539|FG007|Overall Study|Disease progression|4|||
160925852|NCT03446040|581124540|FG008|Overall Study|Disease progression|2|||
160925853|NCT03446040|581124541|FG009|Overall Study|Disease progression|4|||
160925854|NCT03446040|581124542|FG010|Overall Study|Disease progression|9|||
160925855|NCT03446040|581124543|FG011|Overall Study|Disease progression|3|||
160925856|NCT03446040|581124544|FG012|Overall Study|Disease progression|7|||
160925857|NCT03446040|581124545|FG013|Overall Study|Disease progression|7|||
160925858|NCT03446040|581124532|FG000|Overall Study|Study drug toxicity|0|||
160925859|NCT03446040|581124533|FG001|Overall Study|Study drug toxicity|0|||
160925860|NCT03446040|581124534|FG002|Overall Study|Study drug toxicity|0|||
160925861|NCT03446040|581124535|FG003|Overall Study|Study drug toxicity|0|||
160925862|NCT03446040|581124536|FG004|Overall Study|Study drug toxicity|0|||
160925863|NCT03446040|581124537|FG005|Overall Study|Study drug toxicity|0|||
160925864|NCT03446040|581124538|FG006|Overall Study|Study drug toxicity|0|||
160925865|NCT03446040|581124539|FG007|Overall Study|Study drug toxicity|0|||
160925866|NCT03446040|581124540|FG008|Overall Study|Study drug toxicity|1|||
160925867|NCT03446040|581124541|FG009|Overall Study|Study drug toxicity|0|||
160998018|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
160998019|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
160998020|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
160998021|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
160998022|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
160454853|NCT01928394|579396175|FG005|Follow-up Period|Death|6|||
160577320|NCT00859898|579834501|FG000|Overall Study|Withdrawal by Subject|11|||
160577321|NCT00859898|579834502|FG001|Overall Study|Withdrawal by Subject|8|||
160577322|NCT00859898|579834503|FG002|Overall Study|Withdrawal by Subject|11|||
160998023|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
160998024|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
160998025|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
160577323|NCT00859898|579834501|FG000|Overall Study|Death|0|||
160925868|NCT03446040|581124542|FG010|Overall Study|Study drug toxicity|0|||
160925869|NCT03446040|581124543|FG011|Overall Study|Study drug toxicity|0|||
160925870|NCT03446040|581124544|FG012|Overall Study|Study drug toxicity|0|||
160925871|NCT03446040|581124545|FG013|Overall Study|Study drug toxicity|0|||
160925872|NCT03446040|581124532|FG000|Overall Study|Adverse Event|0|||
160925873|NCT03446040|581124533|FG001|Overall Study|Adverse Event|0|||
160925874|NCT03446040|581124534|FG002|Overall Study|Adverse Event|0|||
160925875|NCT03446040|581124535|FG003|Overall Study|Adverse Event|0|||
160454854|NCT01928394|579396176|FG006|Follow-up Period|Death|6|||
160925876|NCT03446040|581124536|FG004|Overall Study|Adverse Event|0|||
160925877|NCT03446040|581124537|FG005|Overall Study|Adverse Event|2|||
160925878|NCT03446040|581124538|FG006|Overall Study|Adverse Event|0|||
160925879|NCT03446040|581124539|FG007|Overall Study|Adverse Event|0|||
160925880|NCT03446040|581124540|FG008|Overall Study|Adverse Event|1|||
160925881|NCT03446040|581124541|FG009|Overall Study|Adverse Event|0|||
160925882|NCT03446040|581124542|FG010|Overall Study|Adverse Event|0|||
160925883|NCT03446040|581124543|FG011|Overall Study|Adverse Event|0|||
160925884|NCT03446040|581124544|FG012|Overall Study|Adverse Event|0|||
160925885|NCT03446040|581124545|FG013|Overall Study|Adverse Event|0|||
160925886|NCT03446040|581124532|FG000|Overall Study|Death|0|||
160925887|NCT03446040|581124533|FG001|Overall Study|Death|0|||
160925888|NCT03446040|581124534|FG002|Overall Study|Death|0|||
160925889|NCT03446040|581124535|FG003|Overall Study|Death|0|||
160925890|NCT03446040|581124536|FG004|Overall Study|Death|0|||
160925891|NCT03446040|581124537|FG005|Overall Study|Death|0|||
160925892|NCT03446040|581124538|FG006|Overall Study|Death|0|||
160925893|NCT03446040|581124539|FG007|Overall Study|Death|0|||
160925894|NCT03446040|581124540|FG008|Overall Study|Death|0|||
160925895|NCT03446040|581124541|FG009|Overall Study|Death|0|||
160925896|NCT03446040|581124542|FG010|Overall Study|Death|1|||
160925897|NCT03446040|581124543|FG011|Overall Study|Death|0|||
160925898|NCT03446040|581124544|FG012|Overall Study|Death|0|||
160925899|NCT03446040|581124545|FG013|Overall Study|Death|2|||
160925900|NCT03446040|581124532|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
160925901|NCT03446040|581124533|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
160925902|NCT03446040|581124534|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
160925903|NCT03446040|581124535|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
160925904|NCT03446040|581124536|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
160925905|NCT03446040|581124537|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
160925906|NCT03446040|581124538|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
160925907|NCT03446040|581124539|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
160925908|NCT03446040|581124540|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
160925909|NCT03446040|581124541|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
160925910|NCT03446040|581124542|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
160925911|NCT03446040|581124543|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
160925912|NCT03446040|581124544|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
160925913|NCT03446040|581124545|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
160925914|NCT03446040|581124532|FG000|Overall Study|Participant withdrew consent|0|||
160925915|NCT03446040|581124533|FG001|Overall Study|Participant withdrew consent|0|||
160925916|NCT03446040|581124534|FG002|Overall Study|Participant withdrew consent|0|||
160925917|NCT03446040|581124535|FG003|Overall Study|Participant withdrew consent|0|||
160925918|NCT03446040|581124536|FG004|Overall Study|Participant withdrew consent|0|||
160925919|NCT03446040|581124537|FG005|Overall Study|Participant withdrew consent|1|||
160925920|NCT03446040|581124538|FG006|Overall Study|Participant withdrew consent|0|||
160925921|NCT03446040|581124539|FG007|Overall Study|Participant withdrew consent|1|||
160925922|NCT03446040|581124540|FG008|Overall Study|Participant withdrew consent|0|||
160925923|NCT03446040|581124541|FG009|Overall Study|Participant withdrew consent|0|||
160925924|NCT03446040|581124542|FG010|Overall Study|Participant withdrew consent|0|||
160925925|NCT03446040|581124543|FG011|Overall Study|Participant withdrew consent|0|||
160925926|NCT03446040|581124544|FG012|Overall Study|Participant withdrew consent|0|||
160925927|NCT03446040|581124545|FG013|Overall Study|Participant withdrew consent|0|||
160925928|NCT03446040|581124532|FG000|Overall Study|Not reported|0|||
160925929|NCT03446040|581124533|FG001|Overall Study|Not reported|0|||
160925930|NCT03446040|581124534|FG002|Overall Study|Not reported|1|||
160925931|NCT03446040|581124535|FG003|Overall Study|Not reported|0|||
160925932|NCT03446040|581124536|FG004|Overall Study|Not reported|0|||
160925933|NCT03446040|581124537|FG005|Overall Study|Not reported|0|||
160925934|NCT03446040|581124538|FG006|Overall Study|Not reported|0|||
160925935|NCT03446040|581124539|FG007|Overall Study|Not reported|0|||
160925936|NCT03446040|581124540|FG008|Overall Study|Not reported|0|||
160925937|NCT03446040|581124541|FG009|Overall Study|Not reported|0|||
160925938|NCT03446040|581124542|FG010|Overall Study|Not reported|0|||
160925939|NCT03446040|581124543|FG011|Overall Study|Not reported|0|||
160925940|NCT03446040|581124544|FG012|Overall Study|Not reported|0|||
160925941|NCT03446040|581124545|FG013|Overall Study|Not reported|0|||
160925942|NCT00605475|581124546|FG000|Overall Study|Abnormal Laboratory Values|0|||
160925943|NCT00605475|581124547|FG001|Overall Study|Abnormal Laboratory Values|0|||
160925944|NCT00605475|581124548|FG002|Overall Study|Abnormal Laboratory Values|0|||
160925945|NCT00605475|581124549|FG003|Overall Study|Abnormal Laboratory Values|0|||
160925946|NCT00605475|581124550|FG004|Overall Study|Abnormal Laboratory Values|0|||
160925947|NCT00605475|581124551|FG005|Overall Study|Abnormal Laboratory Values|0|||
160925948|NCT00605475|581124552|FG006|Overall Study|Abnormal Laboratory Values|0|||
160925949|NCT00605475|581124553|FG007|Overall Study|Abnormal Laboratory Values|0|||
160925950|NCT00605475|581124554|FG008|Overall Study|Abnormal Laboratory Values|1|||
160925951|NCT00605475|581124555|FG009|Overall Study|Abnormal Laboratory Values|0|||
160925952|NCT00605475|581124546|FG000|Overall Study|Administrative problems|0|||
160925953|NCT00605475|581124547|FG001|Overall Study|Administrative problems|0|||
160925954|NCT00605475|581124548|FG002|Overall Study|Administrative problems|0|||
160925955|NCT00605475|581124549|FG003|Overall Study|Administrative problems|0|||
160925956|NCT00605475|581124550|FG004|Overall Study|Administrative problems|0|||
160925957|NCT00605475|581124551|FG005|Overall Study|Administrative problems|0|||
160925958|NCT00605475|581124552|FG006|Overall Study|Administrative problems|1|||
160925959|NCT00605475|581124553|FG007|Overall Study|Administrative problems|0|||
160925960|NCT00605475|581124554|FG008|Overall Study|Administrative problems|0|||
160925961|NCT00605475|581124555|FG009|Overall Study|Administrative problems|0|||
160925962|NCT00605475|581124546|FG000|Overall Study|Lost to Follow-up|0|||
160925963|NCT00605475|581124547|FG001|Overall Study|Lost to Follow-up|0|||
160925964|NCT00605475|581124548|FG002|Overall Study|Lost to Follow-up|0|||
160925965|NCT00605475|581124549|FG003|Overall Study|Lost to Follow-up|0|||
160925966|NCT00605475|581124550|FG004|Overall Study|Lost to Follow-up|0|||
160925967|NCT00605475|581124551|FG005|Overall Study|Lost to Follow-up|0|||
160925968|NCT00605475|581124552|FG006|Overall Study|Lost to Follow-up|0|||
160925969|NCT00605475|581124553|FG007|Overall Study|Lost to Follow-up|0|||
160925970|NCT00605475|581124554|FG008|Overall Study|Lost to Follow-up|1|||
160925971|NCT00605475|581124555|FG009|Overall Study|Lost to Follow-up|1|||
160925972|NCT00605475|581124546|FG000|Overall Study|Protocol Violation|0|||
160925973|NCT00605475|581124547|FG001|Overall Study|Protocol Violation|0|||
160925974|NCT00605475|581124548|FG002|Overall Study|Protocol Violation|0|||
160925975|NCT00605475|581124549|FG003|Overall Study|Protocol Violation|0|||
160925976|NCT00605475|581124550|FG004|Overall Study|Protocol Violation|1|||
160925977|NCT00605475|581124551|FG005|Overall Study|Protocol Violation|0|||
160925978|NCT00605475|581124552|FG006|Overall Study|Protocol Violation|0|||
160925979|NCT00605475|581124553|FG007|Overall Study|Protocol Violation|0|||
160925980|NCT00605475|581124554|FG008|Overall Study|Protocol Violation|0|||
160925981|NCT00605475|581124555|FG009|Overall Study|Protocol Violation|0|||
160925982|NCT00605475|581124546|FG000|Overall Study|Withdrawal by Subject|0|||
160925983|NCT00605475|581124547|FG001|Overall Study|Withdrawal by Subject|0|||
160925984|NCT00605475|581124548|FG002|Overall Study|Withdrawal by Subject|0|||
160925985|NCT00605475|581124549|FG003|Overall Study|Withdrawal by Subject|0|||
160925986|NCT00605475|581124550|FG004|Overall Study|Withdrawal by Subject|0|||
160925987|NCT00605475|581124551|FG005|Overall Study|Withdrawal by Subject|2|||
160925988|NCT00605475|581124552|FG006|Overall Study|Withdrawal by Subject|0|||
160925989|NCT00605475|581124553|FG007|Overall Study|Withdrawal by Subject|0|||
160925990|NCT00605475|581124554|FG008|Overall Study|Withdrawal by Subject|0|||
160925991|NCT00605475|581124555|FG009|Overall Study|Withdrawal by Subject|1|||
160925992|NCT00464568|581124556|FG000|Overall Study|Adverse Event|2|||
160925993|NCT03538158|581124558|FG000|Overall Study|Lost to Follow-up|13|||
160925994|NCT03538158|581124559|FG001|Overall Study|Lost to Follow-up|7|||
160925995|NCT03538158|581124558|FG000|Overall Study|Withdrawal by Subject|2|||
160925996|NCT03538158|581124559|FG001|Overall Study|Withdrawal by Subject|1|||
160925997|NCT02419742|581124562|FG000|Overall Study|Adverse Event|2|||
160925998|NCT02419742|581124563|FG001|Overall Study|Adverse Event|0|||
160925999|NCT02419742|581124562|FG000|Overall Study|Disease Progression|0|||
160926000|NCT02419742|581124563|FG001|Overall Study|Disease Progression|1|||
160926001|NCT02419742|581124562|FG000|Overall Study|Withdrew Consent|2|||
160926002|NCT02419742|581124563|FG001|Overall Study|Withdrew Consent|1|||
160926003|NCT02419742|581124562|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
160926004|NCT02419742|581124563|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
160926005|NCT04649164|581124566|FG000|Overall Study|Withdrawal by Subject|1|||
160926006|NCT04649164|581124567|FG001|Overall Study|Withdrawal by Subject|1|||
160926007|NCT04649164|581124568|FG002|Overall Study|Withdrawal by Subject|2|||
160926008|NCT04649164|581124566|FG000|Overall Study|Participant's care recipient expired|0|||
160926009|NCT04649164|581124567|FG001|Overall Study|Participant's care recipient expired|0|||
160926010|NCT04649164|581124568|FG002|Overall Study|Participant's care recipient expired|2|||
160926011|NCT04356963|581124575|FG000|First Session|Withdrawal by Subject|1|||
160926012|NCT04356963|581124575|FG000|Second Session|Withdrawal by Subject|3|||
160926013|NCT04356963|581124575|FG000|Second Session|Lost to Follow-up|1|||
160577324|NCT00859898|579834502|FG001|Overall Study|Death|0|||
160577325|NCT00859898|579834503|FG002|Overall Study|Death|1|||
160577326|NCT00859898|579834501|FG000|Overall Study|Lost to Follow-up|10|||
160577327|NCT00859898|579834502|FG001|Overall Study|Lost to Follow-up|11|||
160926014|NCT04356963|581124575|FG000|Third Session|Lost to Follow-up|6|||
160926015|NCT04356963|581124575|FG000|Third Session|Withdrawal by Subject|1|||
160926016|NCT02410954|581124580|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
160926017|NCT02410954|581124581|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
160926018|NCT02410954|581124580|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
160926019|NCT02410954|581124581|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
160926020|NCT00791518|581124583|FG000|Overall Study|Protocol Violation|93|||
160926021|NCT02488681|581124584|FG000|Overall Study|Implant unsuccessful|7|||
160926022|NCT00720057|581124585|FG000|Overall Study|Lost to Follow-up|0|||
160577328|NCT00859898|579834503|FG002|Overall Study|Lost to Follow-up|5|||
160926023|NCT00720057|581124586|FG001|Overall Study|Lost to Follow-up|2|||
160926024|NCT00720057|581124585|FG000|Overall Study|Protocol Violation|1|||
160926025|NCT00720057|581124586|FG001|Overall Study|Protocol Violation|0|||
160926026|NCT00720057|581124585|FG000|Overall Study|Withdrawal by Subject|0|||
160926027|NCT00720057|581124586|FG001|Overall Study|Withdrawal by Subject|1|||
160926028|NCT00271609|581124598|FG000|Overall Study|Adverse Event|11|||
160926029|NCT00271609|581124599|FG001|Overall Study|Adverse Event|3|||
160926030|NCT00271609|581124598|FG000|Overall Study|Withdrawal by Subject|2|||
160926031|NCT00271609|581124599|FG001|Overall Study|Withdrawal by Subject|0|||
160926032|NCT03341533|581124600|FG000|Overall Study|Withdrawal by Subject|1|||
160926033|NCT03341533|581124601|FG001|Overall Study|Withdrawal by Subject|1|||
160926034|NCT03341533|581124600|FG000|Overall Study|Not eligible after randomization|2|||
160926035|NCT03341533|581124601|FG001|Overall Study|Not eligible after randomization|1|||
160926036|NCT00643682|581124602|FG000|Overall Study|did not keep appointment|522|||
160926037|NCT00643682|581124603|FG001|Overall Study|did not keep appointment|509|||
160926038|NCT03886220|581124607|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
160926039|NCT03886220|581124608|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
160926040|NCT03886220|581124607|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
160926041|NCT03886220|581124608|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160926042|NCT03886220|581124607|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
160926043|NCT03886220|581124608|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
160926044|NCT01675128|581124613|FG000|Overall Study|Disease progression on study|1|||
160926045|NCT01675128|581124614|FG001|Overall Study|Disease progression on study|1|||
160926046|NCT01675128|581124615|FG002|Overall Study|Disease progression on study|1|||
160926047|NCT01675128|581124613|FG000|Overall Study|Refused further treatment|1|||
160926048|NCT01675128|581124614|FG001|Overall Study|Refused further treatment|0|||
160926049|NCT01675128|581124615|FG002|Overall Study|Refused further treatment|0|||
160926050|NCT01675128|581124613|FG000|Overall Study|Pulmonary complication; off study|0|||
160926051|NCT01675128|581124614|FG001|Overall Study|Pulmonary complication; off study|1|||
160926052|NCT01675128|581124615|FG002|Overall Study|Pulmonary complication; off study|0|||
160926053|NCT03526458|581124619|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
160926054|NCT03526458|581124620|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
160926055|NCT03526458|581124619|FG000|Overall Study|Stone passed, surgery cancelled|2|||
160926056|NCT03526458|581124620|FG001|Overall Study|Stone passed, surgery cancelled|1|||
160926057|NCT03526458|581124619|FG000|Overall Study|Withdrawal by Subject|1|||
160926058|NCT03526458|581124620|FG001|Overall Study|Withdrawal by Subject|0|||
160926059|NCT03526458|581124619|FG000|Overall Study|Physician Decision|2|||
160926060|NCT03526458|581124620|FG001|Overall Study|Physician Decision|1|||
160926061|NCT03526458|581124619|FG000|Overall Study|Lack of equipment|1|||
160926062|NCT03526458|581124620|FG001|Overall Study|Lack of equipment|1|||
160926063|NCT01782664|581124621|FG000|Overall Study|Adverse Event|2|||
160926064|NCT01782664|581124622|FG001|Overall Study|Adverse Event|2|||
160926065|NCT01782664|581124623|FG002|Overall Study|Adverse Event|2|||
160926066|NCT01782664|581124624|FG003|Overall Study|Adverse Event|2|||
160926067|NCT01782664|581124625|FG004|Overall Study|Adverse Event|0|||
160926068|NCT01782664|581124626|FG005|Overall Study|Adverse Event|0|||
160926069|NCT01782664|581124621|FG000|Overall Study|Lack of Efficacy|2|||
160926070|NCT01782664|581124622|FG001|Overall Study|Lack of Efficacy|0|||
160926071|NCT01782664|581124623|FG002|Overall Study|Lack of Efficacy|2|||
160926072|NCT01782664|581124624|FG003|Overall Study|Lack of Efficacy|2|||
160926073|NCT01782664|581124625|FG004|Overall Study|Lack of Efficacy|0|||
160926074|NCT01782664|581124626|FG005|Overall Study|Lack of Efficacy|0|||
160926075|NCT01782664|581124621|FG000|Overall Study|Protocol Violation|0|||
160926076|NCT01782664|581124622|FG001|Overall Study|Protocol Violation|1|||
160926077|NCT01782664|581124623|FG002|Overall Study|Protocol Violation|0|||
160926078|NCT01782664|581124624|FG003|Overall Study|Protocol Violation|1|||
160926079|NCT01782664|581124625|FG004|Overall Study|Protocol Violation|0|||
160926080|NCT01782664|581124626|FG005|Overall Study|Protocol Violation|0|||
160926081|NCT01782664|581124621|FG000|Overall Study|Withdrawal by Subject|2|||
160926082|NCT01782664|581124622|FG001|Overall Study|Withdrawal by Subject|2|||
160926083|NCT01782664|581124623|FG002|Overall Study|Withdrawal by Subject|0|||
160926084|NCT01782664|581124624|FG003|Overall Study|Withdrawal by Subject|0|||
160926085|NCT01782664|581124625|FG004|Overall Study|Withdrawal by Subject|0|||
160655312|NCT00950807|580118704|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160926086|NCT01782664|581124626|FG005|Overall Study|Withdrawal by Subject|0|||
160926087|NCT04404855|581124627|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
160926088|NCT04404855|581124628|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
160926089|NCT00735878|581124629|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
160926090|NCT00735878|581124630|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
160926091|NCT00735878|581124631|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
160926092|NCT04170348|581124634|FG000|Overall Study|Lost to Follow-up|2|||
160655313|NCT00950807|580118705|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160926093|NCT04170348|581124635|FG001|Overall Study|Lost to Follow-up|2|||
160454855|NCT01928394|579396177|FG007|Follow-up Period|Death|2|||
160454856|NCT01928394|579396178|FG008|Follow-up Period|Death|1|||
160454857|NCT01928394|579396179|FG009|Follow-up Period|Death|2|||
160454858|NCT01928394|579396180|FG010|Follow-up Period|Death|4|||
160926094|NCT04170348|581124634|FG000|Overall Study|Withdrawal by Subject|1|||
160926095|NCT04170348|581124635|FG001|Overall Study|Withdrawal by Subject|5|||
160926096|NCT04170348|581124634|FG000|Overall Study|Non-adherence|1|||
160926097|NCT04170348|581124635|FG001|Overall Study|Non-adherence|1|||
160926098|NCT04170348|581124634|FG000|Overall Study|Adverse Event|1|||
160926099|NCT04170348|581124635|FG001|Overall Study|Adverse Event|0|||
160926100|NCT01082965|581124641|FG000|Overall Study|Protocol Violation|0|||
160926101|NCT01082965|581124642|FG001|Overall Study|Protocol Violation|1|||
160926102|NCT01082965|581124641|FG000|Overall Study|Other|1|||
160926103|NCT01082965|581124642|FG001|Overall Study|Other|1|||
160926104|NCT02587065|581124643|FG000|Overall Study|Adverse Event|14|||
160926105|NCT02587065|581124643|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
160926106|NCT02587065|581124643|FG000|Overall Study|Non-adherence to the Protocol|3|||
160926107|NCT02587065|581124643|FG000|Overall Study|Discontinuation of Study Medication|2|||
160926108|NCT02587065|581124643|FG000|Overall Study|Reason not Specified|3|||
160926109|NCT01559012|581124644|FG000|Overall Study|Withdrawal by Subject|0|||
160926110|NCT01559012|581124645|FG001|Overall Study|Withdrawal by Subject|1|||
160926111|NCT00445965|581124646|FG000|Overall Study|Adverse Event|2|||
160926112|NCT00445965|581124646|FG000|Overall Study|Physician Decision|1|||
160926113|NCT00445965|581124646|FG000|Overall Study|Enrolled but not treated|1|||
160926114|NCT00445965|581124646|FG000|Overall Study|Removed due to progressive disease|29|||
160926115|NCT02867709|581124647|FG000|Treatment Period|Adverse Event|1|||
160926116|NCT02867709|581124648|FG001|Treatment Period|Adverse Event|1|||
160926117|NCT02867709|581124649|FG002|Treatment Period|Adverse Event|2|||
160926118|NCT02867709|581124647|FG000|Treatment Period|Withdrawal of Consent|7|||
160926119|NCT02867709|581124648|FG001|Treatment Period|Withdrawal of Consent|9|||
160926120|NCT02867709|581124649|FG002|Treatment Period|Withdrawal of Consent|8|||
160926121|NCT02867709|581124647|FG000|Treatment Period|Lost to Follow-up|17|||
160926122|NCT02867709|581124648|FG001|Treatment Period|Lost to Follow-up|20|||
160926123|NCT02867709|581124649|FG002|Treatment Period|Lost to Follow-up|20|||
160926124|NCT02867709|581124647|FG000|Treatment Period|Lack of Qualifying Event|42|||
160926125|NCT02867709|581124648|FG001|Treatment Period|Lack of Qualifying Event|55|||
160926126|NCT02867709|581124649|FG002|Treatment Period|Lack of Qualifying Event|42|||
160926127|NCT02867709|581124647|FG000|Treatment Period|Protocol Violation|3|||
160926128|NCT02867709|581124648|FG001|Treatment Period|Protocol Violation|2|||
160926129|NCT02867709|581124649|FG002|Treatment Period|Protocol Violation|3|||
160926130|NCT02867709|581124647|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
160926131|NCT02867709|581124648|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
160926132|NCT02867709|581124649|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
160926133|NCT02867709|581124647|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
160926134|NCT02867709|581124648|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
160926135|NCT02867709|581124649|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
160926136|NCT02867709|581124647|FG000|Safety Follow-up Period|Pregnancy|0|||
160926137|NCT02867709|581124648|FG001|Safety Follow-up Period|Pregnancy|1|||
160926138|NCT02867709|581124649|FG002|Safety Follow-up Period|Pregnancy|0|||
160926139|NCT02867709|581124647|FG000|Safety Follow-up Period|Protocol Violation|0|||
160926140|NCT02867709|581124648|FG001|Safety Follow-up Period|Protocol Violation|1|||
160926141|NCT02867709|581124649|FG002|Safety Follow-up Period|Protocol Violation|1|||
160926142|NCT05041322|581124652|FG000|Baseline|Withdrawal by Subject|1|||
160926143|NCT05041322|581124653|FG001|Baseline|Withdrawal by Subject|0|||
160926144|NCT05041322|581124652|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
160926145|NCT05041322|581124653|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
160926146|NCT05041322|581124652|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
160454859|NCT01928394|579396181|FG011|Follow-up Period|Death|12|||
160577329|NCT00859898|579834501|FG000|Overall Study|poor/non-compliance|2|||
160926147|NCT05041322|581124653|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
160926148|NCT03313804|581124654|FG000|Treatment|Death|5|||
160926149|NCT03313804|581124654|FG000|Treatment|still on treatment|2|||
160926150|NCT03313804|581124654|FG000|Follow Up|still on follow up|3|||
160577330|NCT00859898|579834502|FG001|Overall Study|poor/non-compliance|0|||
160577331|NCT00859898|579834503|FG002|Overall Study|poor/non-compliance|0|||
160926151|NCT01502423|581124655|FG000|Overall Study|Withdrawal by Subject|0|||
160926152|NCT01502423|581124656|FG001|Overall Study|Withdrawal by Subject|1|||
160926153|NCT00699972|581126385|FG000|Overall Study|Adverse Event|7|||
160926154|NCT00699972|581126386|FG001|Overall Study|Adverse Event|9|||
160926155|NCT00699972|581126387|FG002|Overall Study|Adverse Event|24|||
160926156|NCT00699972|581126385|FG000|Overall Study|Lost to Follow-up|0|||
160926157|NCT00699972|581126386|FG001|Overall Study|Lost to Follow-up|2|||
160926158|NCT00699972|581126387|FG002|Overall Study|Lost to Follow-up|0|||
160454860|NCT01928394|579396182|FG012|Follow-up Period|Death|11|||
160454861|NCT01928394|579396183|FG013|Follow-up Period|Death|25|||
160926159|NCT00699972|581126385|FG000|Overall Study|Withdrawal by Subject|3|||
160926160|NCT00699972|581126386|FG001|Overall Study|Withdrawal by Subject|7|||
160926161|NCT00699972|581126387|FG002|Overall Study|Withdrawal by Subject|4|||
160655314|NCT00950807|580118696|FG000|Treatment Period 2|Adverse Event|0|||
160926162|NCT00699972|581126385|FG000|Overall Study|Lack of Efficacy|2|||
160926163|NCT00699972|581126386|FG001|Overall Study|Lack of Efficacy|0|||
160926164|NCT00699972|581126387|FG002|Overall Study|Lack of Efficacy|2|||
160926165|NCT00699972|581126385|FG000|Overall Study|Administrative/Other|3|||
160926166|NCT00699972|581126386|FG001|Overall Study|Administrative/Other|1|||
160926167|NCT00699972|581126387|FG002|Overall Study|Administrative/Other|4|||
160926168|NCT00699972|581126385|FG000|Overall Study|Randomized, Not Treated|1|||
160926169|NCT00699972|581126386|FG001|Overall Study|Randomized, Not Treated|0|||
160926170|NCT00699972|581126387|FG002|Overall Study|Randomized, Not Treated|1|||
160926171|NCT01545817|581126388|FG000|Pazopanib|Disease progression|51|||
160926172|NCT01545817|581126389|FG001|Pazopanib|Disease progression|0|||
160926173|NCT01545817|581126388|FG000|Pazopanib|Adverse Event|19|||
160926174|NCT01545817|581126389|FG001|Pazopanib|Adverse Event|0|||
160926175|NCT01545817|581126388|FG000|Pazopanib|Other reason|4|||
160926176|NCT01545817|581126389|FG001|Pazopanib|Other reason|0|||
160926177|NCT01545817|581126388|FG000|Everolimus|Other reason|0|||
160926178|NCT01545817|581126389|FG001|Everolimus|Other reason|7|||
160926179|NCT01545817|581126388|FG000|Everolimus|Disease progression|0|||
160926180|NCT01545817|581126389|FG001|Everolimus|Disease progression|25|||
160926181|NCT01545817|581126388|FG000|Everolimus|Adverse Event|0|||
160926182|NCT01545817|581126389|FG001|Everolimus|Adverse Event|6|||
160926183|NCT03971695|581126393|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926184|NCT03971695|581126394|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926185|NCT03971695|581126395|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926186|NCT03971695|581126396|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
160926187|NCT03971695|581126397|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
160926188|NCT03971695|581126398|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926189|NCT03971695|581126399|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926190|NCT03971695|581126400|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926191|NCT03971695|581126401|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
160926192|NCT03971695|581126402|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926193|NCT03971695|581126403|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
160926194|NCT03971695|581126404|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
160926195|NCT03971695|581126405|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
160926196|NCT00156533|581126406|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
160926197|NCT00156533|581126407|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
160926198|NCT00156533|581126408|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
160926199|NCT00156533|581126409|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
160926200|NCT00156533|581126406|FG000|Overall Study|Withdrawal by Subject|1|||
160926201|NCT00156533|581126407|FG001|Overall Study|Withdrawal by Subject|0|||
160926202|NCT00156533|581126408|FG002|Overall Study|Withdrawal by Subject|0|||
160926203|NCT00156533|581126409|FG003|Overall Study|Withdrawal by Subject|1|||
160926204|NCT00156533|581126406|FG000|Overall Study|Failed Screening|1|||
160926205|NCT00156533|581126407|FG001|Overall Study|Failed Screening|0|||
160926206|NCT00156533|581126408|FG002|Overall Study|Failed Screening|1|||
160926207|NCT00156533|581126409|FG003|Overall Study|Failed Screening|1|||
160926208|NCT01881230|581126410|FG000|Overall Study|Death|2|||
160926209|NCT01881230|581126411|FG001|Overall Study|Death|0|||
160926210|NCT01881230|581126412|FG002|Overall Study|Death|1|||
160926211|NCT01881230|581126410|FG000|Overall Study|Adverse Event|9|||
160926212|NCT01881230|581126411|FG001|Overall Study|Adverse Event|13|||
160926213|NCT01881230|581126412|FG002|Overall Study|Adverse Event|12|||
160926214|NCT01881230|581126410|FG000|Overall Study|Progressive Disease|31|||
160926215|NCT01881230|581126411|FG001|Overall Study|Progressive Disease|35|||
160454862|NCT01928394|579396184|FG014|Follow-up Period|Death|18|||
160454863|NCT01928394|579396185|FG015|Follow-up Period|Death|0|||
160454864|NCT01928394|579396186|FG016|Follow-up Period|Death|6|||
160454865|NCT01928394|579396187|FG017|Follow-up Period|Death|5|||
160454866|NCT01928394|579396188|FG018|Follow-up Period|Death|13|||
160454867|NCT01928394|579396189|FG019|Follow-up Period|Death|13|||
160655315|NCT00950807|580118697|FG001|Treatment Period 2|Adverse Event|1|||
160655316|NCT00950807|580118698|FG002|Treatment Period 2|Adverse Event|0|||
160454868|NCT01928394|579396190|FG020|Follow-up Period|Death|5|||
160655317|NCT00950807|580118699|FG003|Treatment Period 2|Adverse Event|1|||
160926216|NCT01881230|581126412|FG002|Overall Study|Progressive Disease|36|||
160926217|NCT01881230|581126410|FG000|Overall Study|Symptomatic Deterioration|3|||
160926218|NCT01881230|581126411|FG001|Overall Study|Symptomatic Deterioration|3|||
160926219|NCT01881230|581126412|FG002|Overall Study|Symptomatic Deterioration|1|||
160926220|NCT01881230|581126410|FG000|Overall Study|Withdrawal by Subject|6|||
160926221|NCT01881230|581126411|FG001|Overall Study|Withdrawal by Subject|4|||
160454869|NCT01928394|579396191|FG021|Follow-up Period|Death|3|||
160454870|NCT01928394|579396192|FG022|Follow-up Period|Death|2|||
160655318|NCT00950807|580118700|FG004|Treatment Period 2|Adverse Event|0|||
160926222|NCT01881230|581126412|FG002|Overall Study|Withdrawal by Subject|6|||
160926223|NCT01881230|581126410|FG000|Overall Study|Physician Decision|4|||
160926224|NCT01881230|581126411|FG001|Overall Study|Physician Decision|3|||
160926225|NCT01881230|581126412|FG002|Overall Study|Physician Decision|6|||
160926226|NCT01881230|581126410|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160926227|NCT01881230|581126411|FG001|Overall Study|Non-Compliance with Study Drug|2|||
160926228|NCT01881230|581126412|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160926229|NCT01881230|581126410|FG000|Overall Study|Given Commercially Available Drug|0|||
160926230|NCT01881230|581126411|FG001|Overall Study|Given Commercially Available Drug|0|||
160926231|NCT01881230|581126412|FG002|Overall Study|Given Commercially Available Drug|2|||
160926232|NCT01881230|581126410|FG000|Overall Study|Protocol Violation|1|||
160926233|NCT01881230|581126411|FG001|Overall Study|Protocol Violation|1|||
160926234|NCT01881230|581126412|FG002|Overall Study|Protocol Violation|0|||
160926235|NCT01881230|581126410|FG000|Overall Study|Miscellaneous|3|||
160926236|NCT01881230|581126411|FG001|Overall Study|Miscellaneous|3|||
160926237|NCT01881230|581126412|FG002|Overall Study|Miscellaneous|0|||
160926238|NCT01881230|581126410|FG000|Overall Study|Untreated: Other|0|||
160926239|NCT01881230|581126411|FG001|Overall Study|Untreated: Other|0|||
160926240|NCT01881230|581126412|FG002|Overall Study|Untreated: Other|1|||
160926241|NCT01881230|581126410|FG000|Overall Study|Untreated: Death|0|||
160926242|NCT01881230|581126411|FG001|Overall Study|Untreated: Death|0|||
160926243|NCT01881230|581126412|FG002|Overall Study|Untreated: Death|1|||
160926244|NCT01881230|581126410|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
160926245|NCT01881230|581126411|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
160926246|NCT01881230|581126412|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
160926247|NCT02747420|581126413|FG000|Overall Study|Lost to Follow-up|4|||
160926248|NCT02747420|581126414|FG001|Overall Study|Lost to Follow-up|2|||
160926249|NCT02747420|581126413|FG000|Overall Study|Withdrawal by Subject|3|||
160926250|NCT02747420|581126414|FG001|Overall Study|Withdrawal by Subject|2|||
160926251|NCT05129488|581126415|FG000|Overall Study|Protocol Violation|3|||
160926252|NCT00706641|581126420|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
160926253|NCT00706641|581126420|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
160926254|NCT00706641|581126420|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
160926255|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
160926256|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
160926257|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
160926258|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
160926259|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
160926260|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
160926261|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
160926262|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
160926263|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
160926264|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
160926265|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
160926266|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
160926267|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
160926268|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
160926269|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
160926270|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
160926271|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
160926272|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
160926273|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
160926274|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
160926275|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
160926276|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
160926277|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
160998026|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
160998027|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
160998028|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
160454871|NCT01928394|579396170|FG000|Follow-up Period|other reason|0|||
160577332|NCT00859898|579834501|FG000|Overall Study|No longer meets criteria|0|||
160926278|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
160926279|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
160926280|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
160926281|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
160926282|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
160926283|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
160926284|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
160926285|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
160926286|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
160926287|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
160926288|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
160926289|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
160926290|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
160926291|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
160926292|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
160926293|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
160926294|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
160926295|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
160926296|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
160926297|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
160926298|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
160926299|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
160926300|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
160926301|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
160926302|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
160926303|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
160926304|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
160926305|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
160926306|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
160926307|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
160926308|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
160926309|NCT00922766|581126426|FG000|Overall Study|Death|3|||
160926310|NCT00922766|581126426|FG000|Overall Study|Withdrawal by Subject|2|||
160926311|NCT00922766|581126426|FG000|Overall Study|Other|1|||
160926312|NCT00922766|581126426|FG000|Overall Study|Adverse Event|1|||
160926313|NCT01231581|581126430|FG000|Overall Study|Lost to Follow-up|2|||
160926314|NCT01231581|581126431|FG001|Overall Study|Lost to Follow-up|2|||
160926315|NCT01231581|581126430|FG000|Overall Study|Withdrawal by Subject|6|||
160926316|NCT01231581|581126431|FG001|Overall Study|Withdrawal by Subject|9|||
160926317|NCT01231581|581126430|FG000|Overall Study|Study Closed/Terminated|6|||
160926318|NCT01231581|581126431|FG001|Overall Study|Study Closed/Terminated|5|||
160926319|NCT01231581|581126430|FG000|Overall Study|Death|65|||
160926320|NCT01231581|581126431|FG001|Overall Study|Death|64|||
160926321|NCT01231581|581126430|FG000|Overall Study|Ongoing|1|||
160926322|NCT01231581|581126431|FG001|Overall Study|Ongoing|0|||
160926323|NCT01723163|581126434|FG000|Treatment Phase|Withdrawal by Subject|14|||
160926324|NCT01723163|581126435|FG001|Treatment Phase|Withdrawal by Subject|6|||
160926325|NCT01723163|581126434|FG000|Treatment Phase|Withdrawal by PI|5|||
160926326|NCT01723163|581126435|FG001|Treatment Phase|Withdrawal by PI|1|||
160926327|NCT01723163|581126434|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
160926328|NCT01723163|581126435|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
160926329|NCT01723163|581126434|FG000|3-Month Follow-up|Unable to Contact|12|||
160926330|NCT01723163|581126435|FG001|3-Month Follow-up|Unable to Contact|19|||
160926331|NCT01723163|581126434|FG000|6-Month Follow-up|Death|1|||
160926332|NCT01723163|581126435|FG001|6-Month Follow-up|Death|0|||
160926333|NCT01723163|581126434|FG000|6-Month Follow-up|Unable to Contact|17|||
160926334|NCT01723163|581126435|FG001|6-Month Follow-up|Unable to Contact|15|||
160926335|NCT01723163|581126434|FG000|12-Month Follow-up|Death|1|||
160926336|NCT01723163|581126435|FG001|12-Month Follow-up|Death|0|||
160926337|NCT01723163|581126434|FG000|12-Month Follow-up|Unable to Contact|23|||
160577333|NCT00859898|579834502|FG001|Overall Study|No longer meets criteria|1|||
160577334|NCT00859898|579834503|FG002|Overall Study|No longer meets criteria|0|||
160577335|NCT00859898|579834501|FG000|Overall Study|non-specified|1|||
160577336|NCT00859898|579834502|FG001|Overall Study|non-specified|1|||
160577337|NCT00859898|579834503|FG002|Overall Study|non-specified|1|||
160577338|NCT03215264|579834504|FG000|Dose Level 2|Adverse Event|0|||
160577339|NCT03215264|579834505|FG001|Dose Level 2|Adverse Event|1|||
160577340|NCT03215264|579834506|FG002|Dose Level 2|Adverse Event|0|||
160577341|NCT03215264|579834504|FG000|Dose Level 3|Withdrawal by Subject|0|||
160577342|NCT03215264|579834505|FG001|Dose Level 3|Withdrawal by Subject|0|||
160577343|NCT03215264|579834506|FG002|Dose Level 3|Withdrawal by Subject|1|||
160926338|NCT01723163|581126435|FG001|12-Month Follow-up|Unable to Contact|28|||
160926339|NCT02510794|581126436|FG000|Overall Study|Adverse Event|0|||
160926340|NCT02510794|581126437|FG001|Overall Study|Adverse Event|1|||
160926341|NCT02510794|581126438|FG002|Overall Study|Adverse Event|0|||
160926342|NCT02510794|581126439|FG003|Overall Study|Adverse Event|0|||
160577344|NCT01740440|579834510|FG000|Overall Study|Lost to Follow-up|3|||
160926343|NCT02510794|581126436|FG000|Overall Study|Death|1|||
160926344|NCT02510794|581126437|FG001|Overall Study|Death|2|||
160926345|NCT02510794|581126438|FG002|Overall Study|Death|1|||
160926346|NCT02510794|581126439|FG003|Overall Study|Death|1|||
160926347|NCT02510794|581126436|FG000|Overall Study|Lack of Efficacy|3|||
160926348|NCT02510794|581126437|FG001|Overall Study|Lack of Efficacy|1|||
160926349|NCT02510794|581126438|FG002|Overall Study|Lack of Efficacy|1|||
160577345|NCT01264965|579834513|FG000|Overall Study|Withdrawal by Subject|10|||
160577346|NCT01172288|579834515|FG000|Overall Study|Adverse Event|1|||
160577347|NCT01172288|579834516|FG001|Overall Study|Adverse Event|0|||
160577348|NCT01172288|579834515|FG000|Overall Study|Protocol Violation|0|||
160577349|NCT01172288|579834516|FG001|Overall Study|Protocol Violation|1|||
160577350|NCT03662334|579834519|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
160577351|NCT03662334|579834520|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
160577352|NCT00723840|579834523|FG000|Overall Study|Lost to Follow-up|2|||
160577353|NCT00723840|579834523|FG000|Overall Study|Failure to return|18|||
160577354|NCT00723840|579834523|FG000|Overall Study|Withdrawal by Subject|55|||
160577355|NCT00723840|579834523|FG000|Overall Study|Serious Adverse Events|3|||
160926350|NCT02510794|581126439|FG003|Overall Study|Lack of Efficacy|0|||
160926351|NCT02510794|581126436|FG000|Overall Study|Participant moved out of the area|0|||
160926352|NCT02510794|581126437|FG001|Overall Study|Participant moved out of the area|0|||
160926353|NCT02510794|581126438|FG002|Overall Study|Participant moved out of the area|0|||
160926354|NCT02510794|581126439|FG003|Overall Study|Participant moved out of the area|1|||
160926355|NCT02510794|581126436|FG000|Overall Study|Physician Decision|3|||
160926356|NCT02510794|581126437|FG001|Overall Study|Physician Decision|0|||
160926357|NCT02510794|581126438|FG002|Overall Study|Physician Decision|0|||
160926358|NCT02510794|581126439|FG003|Overall Study|Physician Decision|0|||
160926359|NCT02510794|581126436|FG000|Overall Study|Protocol Violation|0|||
160926360|NCT02510794|581126437|FG001|Overall Study|Protocol Violation|0|||
160926361|NCT02510794|581126438|FG002|Overall Study|Protocol Violation|1|||
160926362|NCT02510794|581126439|FG003|Overall Study|Protocol Violation|0|||
160926363|NCT02510794|581126436|FG000|Overall Study|Withdrawal by Subject|1|||
160926364|NCT02510794|581126437|FG001|Overall Study|Withdrawal by Subject|2|||
160926365|NCT02510794|581126438|FG002|Overall Study|Withdrawal by Subject|4|||
160926366|NCT02510794|581126439|FG003|Overall Study|Withdrawal by Subject|3|||
160926367|NCT01649375|581126440|FG000|Up to Week 16|Adverse Event|2|||
160926368|NCT01649375|581126441|FG001|Up to Week 16|Adverse Event|5|||
160926369|NCT01649375|581126442|FG002|Up to Week 16|Adverse Event|4|||
160926370|NCT01649375|581126443|FG003|Up to Week 16|Adverse Event|0|||
160926371|NCT01649375|581126444|FG004|Up to Week 16|Adverse Event|0|||
160926372|NCT01649375|581126440|FG000|Up to Week 16|Lack of Efficacy|0|||
160926373|NCT01649375|581126441|FG001|Up to Week 16|Lack of Efficacy|0|||
160926374|NCT01649375|581126442|FG002|Up to Week 16|Lack of Efficacy|1|||
160926375|NCT01649375|581126443|FG003|Up to Week 16|Lack of Efficacy|0|||
160926376|NCT01649375|581126444|FG004|Up to Week 16|Lack of Efficacy|0|||
160926377|NCT01649375|581126440|FG000|Up to Week 16|Physician Decision|0|||
160926378|NCT01649375|581126441|FG001|Up to Week 16|Physician Decision|0|||
160926379|NCT01649375|581126442|FG002|Up to Week 16|Physician Decision|1|||
160454872|NCT01928394|579396171|FG001|Follow-up Period|other reason|0|||
160454873|NCT01928394|579396172|FG002|Follow-up Period|other reason|0|||
160454874|NCT01928394|579396173|FG003|Follow-up Period|other reason|0|||
160926380|NCT01649375|581126443|FG003|Up to Week 16|Physician Decision|0|||
160926381|NCT01649375|581126444|FG004|Up to Week 16|Physician Decision|0|||
160926382|NCT01649375|581126440|FG000|Up to Week 16|Withdrawal by Subject|2|||
160926383|NCT01649375|581126441|FG001|Up to Week 16|Withdrawal by Subject|1|||
160926384|NCT01649375|581126442|FG002|Up to Week 16|Withdrawal by Subject|2|||
160926385|NCT01649375|581126443|FG003|Up to Week 16|Withdrawal by Subject|0|||
160926386|NCT01649375|581126444|FG004|Up to Week 16|Withdrawal by Subject|0|||
160926387|NCT01649375|581126440|FG000|Up to Week 16|Death|1|||
160926388|NCT01649375|581126441|FG001|Up to Week 16|Death|0|||
160926389|NCT01649375|581126442|FG002|Up to Week 16|Death|0|||
160926390|NCT01649375|581126443|FG003|Up to Week 16|Death|0|||
160926391|NCT01649375|581126444|FG004|Up to Week 16|Death|0|||
160454875|NCT01928394|579396174|FG004|Follow-up Period|other reason|0|||
160454876|NCT01928394|579396175|FG005|Follow-up Period|other reason|0|||
160926392|NCT01649375|581126440|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
160454877|NCT01928394|579396176|FG006|Follow-up Period|other reason|1|||
160454878|NCT01928394|579396177|FG007|Follow-up Period|other reason|3|||
160454879|NCT01928394|579396178|FG008|Follow-up Period|other reason|0|||
160926393|NCT01649375|581126441|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
160926394|NCT01649375|581126442|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
160926395|NCT01649375|581126443|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
160926396|NCT01649375|581126444|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
160454880|NCT01928394|579396179|FG009|Follow-up Period|other reason|0|||
160926397|NCT01649375|581126440|FG000|Week 16 up to Week 260|Non-compliance|0|||
160926398|NCT01649375|581126441|FG001|Week 16 up to Week 260|Non-compliance|1|||
160926399|NCT01649375|581126442|FG002|Week 16 up to Week 260|Non-compliance|0|||
160926400|NCT01649375|581126443|FG003|Week 16 up to Week 260|Non-compliance|1|||
160926401|NCT01649375|581126444|FG004|Week 16 up to Week 260|Non-compliance|0|||
160926402|NCT01649375|581126440|FG000|Week 16 up to Week 260|Physician Decision|0|||
160926403|NCT01649375|581126441|FG001|Week 16 up to Week 260|Physician Decision|2|||
160926404|NCT01649375|581126442|FG002|Week 16 up to Week 260|Physician Decision|0|||
160454881|NCT01928394|579396180|FG010|Follow-up Period|other reason|2|||
160454882|NCT01928394|579396181|FG011|Follow-up Period|other reason|1|||
160454883|NCT01928394|579396182|FG012|Follow-up Period|other reason|0|||
160926405|NCT01649375|581126443|FG003|Week 16 up to Week 260|Physician Decision|0|||
160926406|NCT01649375|581126444|FG004|Week 16 up to Week 260|Physician Decision|0|||
160926407|NCT01649375|581126440|FG000|Week 16 up to Week 260|Technical issues|0|||
160926408|NCT01649375|581126441|FG001|Week 16 up to Week 260|Technical issues|1|||
160926409|NCT01649375|581126442|FG002|Week 16 up to Week 260|Technical issues|0|||
160926410|NCT01649375|581126443|FG003|Week 16 up to Week 260|Technical issues|1|||
160926411|NCT01649375|581126444|FG004|Week 16 up to Week 260|Technical issues|0|||
160926412|NCT01649375|581126440|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
160926413|NCT01649375|581126441|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
160926414|NCT01649375|581126442|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
160926415|NCT01649375|581126443|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
160926416|NCT01649375|581126444|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
160926417|NCT01649375|581126440|FG000|Week 16 up to Week 260|Death|1|||
160926418|NCT01649375|581126441|FG001|Week 16 up to Week 260|Death|1|||
160926419|NCT01649375|581126442|FG002|Week 16 up to Week 260|Death|0|||
160926420|NCT01649375|581126443|FG003|Week 16 up to Week 260|Death|0|||
160926421|NCT01649375|581126444|FG004|Week 16 up to Week 260|Death|0|||
160926422|NCT01649375|581126440|FG000|Week 16 up to Week 260|Adverse Event|5|||
160926423|NCT01649375|581126441|FG001|Week 16 up to Week 260|Adverse Event|2|||
160926424|NCT01649375|581126442|FG002|Week 16 up to Week 260|Adverse Event|0|||
160926425|NCT01649375|581126443|FG003|Week 16 up to Week 260|Adverse Event|3|||
160926426|NCT01649375|581126444|FG004|Week 16 up to Week 260|Adverse Event|2|||
160926427|NCT01856790|581126445|FG000|Closed Loop Control|Withdrawal by Subject|2|||
160926428|NCT01856790|581126445|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
160926429|NCT04091646|581126448|FG000|Overall Study|Adverse Event|2|||
160926430|NCT04091646|581126449|FG001|Overall Study|Adverse Event|1|||
160926431|NCT04091646|581126448|FG000|Overall Study|Lost to Follow-up|6|||
160926432|NCT04091646|581126449|FG001|Overall Study|Lost to Follow-up|2|||
160926433|NCT04091646|581126448|FG000|Overall Study|Protocol Violation|0|||
160926434|NCT04091646|581126449|FG001|Overall Study|Protocol Violation|1|||
160926435|NCT04091646|581126448|FG000|Overall Study|Withdrawal by Subject|4|||
160926436|NCT04091646|581126449|FG001|Overall Study|Withdrawal by Subject|1|||
160926437|NCT04091646|581126448|FG000|Overall Study|Participant Incarcerated|1|||
160926438|NCT04091646|581126449|FG001|Overall Study|Participant Incarcerated|0|||
160926439|NCT01921829|581126450|FG000|Overall Study|Withdrawal by Subject|0|||
160926440|NCT01921829|581126451|FG001|Overall Study|Withdrawal by Subject|1|||
160926441|NCT01316276|581126454|FG000|Overall Study|Death|1|||
160926442|NCT01316276|581126454|FG000|Overall Study|Adverse Event|19|||
160926443|NCT01316276|581126454|FG000|Overall Study|Withdrawal of consent|24|||
160926444|NCT01316276|581126454|FG000|Overall Study|Lost to Follow-up|1|||
160926445|NCT01316276|581126454|FG000|Overall Study|Other|22|||
160926446|NCT02255981|581126459|FG000|Overall Study|Lost to Follow-up|3|||
160926447|NCT02255981|581126459|FG000|Overall Study|Withdrawal by Subject|1|||
160926448|NCT01454570|581126470|FG000|Overall Study|Withdrawal by Subject|2|||
160926449|NCT01454570|581126470|FG000|Overall Study|Screen Failure|7|||
160926450|NCT00885755|581126471|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
160926451|NCT00885755|581126472|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
160926452|NCT00885755|581126473|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
160926453|NCT00885755|581126471|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
160926454|NCT00885755|581126472|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
160926455|NCT00885755|581126473|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
160926456|NCT00885755|581126471|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
160926457|NCT00885755|581126472|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
160926458|NCT00885755|581126473|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
160926459|NCT00885755|581126471|FG000|Part I: Trastuzumab+Taxane|Death|0|||
160926460|NCT00885755|581126472|FG001|Part I: Trastuzumab+Taxane|Death|0|||
160926461|NCT00885755|581126473|FG002|Part I: Trastuzumab+Taxane|Death|1|||
160926462|NCT00885755|581126471|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
160926463|NCT00885755|581126472|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
160926464|NCT00885755|581126473|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
160926465|NCT00325754|581126474|FG000|Overall Study|Adverse Event|4|||
160926466|NCT00325754|581126475|FG001|Overall Study|Adverse Event|1|||
160926467|NCT01852812|581126479|FG000|Overall Study|Adverse Event|0|||
160926468|NCT01852812|581126480|FG001|Overall Study|Adverse Event|0|||
160926469|NCT01852812|581126481|FG002|Overall Study|Adverse Event|1|||
160926470|NCT01852812|581126479|FG000|Overall Study|Non-compliance With Study Drug|0|||
160926471|NCT01852812|581126480|FG001|Overall Study|Non-compliance With Study Drug|1|||
160926472|NCT01852812|581126481|FG002|Overall Study|Non-compliance With Study Drug|0|||
160926473|NCT02625090|581126486|FG000|Overall Study|Participant wants to be pregnant|2|||
160926474|NCT02625090|581126486|FG000|Overall Study|For the Promoter|1|||
160926475|NCT02625090|581126486|FG000|Overall Study|Sponsor's Decision|9|||
160926476|NCT02625090|581126486|FG000|Overall Study|Somnolence|1|||
160926477|NCT02625090|581126486|FG000|Overall Study|Study terminated by Sponsor|7|||
160926478|NCT02625090|581126486|FG000|Overall Study|Negative Benefit/Risk|1|||
160926479|NCT02625090|581126486|FG000|Overall Study|Protocol Deviation|2|||
160926480|NCT02625090|581126486|FG000|Overall Study|Lack of Efficacy|16|||
160655319|NCT00950807|580118701|FG005|Treatment Period 2|Adverse Event|1|||
160655320|NCT00950807|580118702|FG006|Treatment Period 2|Adverse Event|0|||
160926481|NCT02625090|581126486|FG000|Overall Study|Adverse Event|3|||
160926482|NCT03168464|581126487|FG000|Overall Study|Death|9|||
160926483|NCT03168464|581126487|FG000|Overall Study|Progression of disease|6|||
160926484|NCT02250443|581126488|FG000|Overall Study|Administrative problems|7|||
160926485|NCT02250443|581126488|FG000|Overall Study|Adverse Event|3|||
160926486|NCT01549964|581126489|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
160926487|NCT01549964|581126490|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
160926488|NCT01549964|581126491|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
160926489|NCT01549964|581126492|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
160926490|NCT01549964|581126489|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
160926491|NCT01549964|581126490|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
160926492|NCT01549964|581126491|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
160926493|NCT01549964|581126492|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
160926494|NCT01549964|581126489|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
160926495|NCT01549964|581126490|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
160926496|NCT01549964|581126491|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
160926497|NCT01549964|581126492|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
160926498|NCT01549964|581126489|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
160926499|NCT01549964|581126490|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
160926500|NCT01549964|581126491|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
160926501|NCT01549964|581126492|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
160926502|NCT01549964|581126489|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
160926503|NCT01549964|581126490|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
160926504|NCT01549964|581126491|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
160926505|NCT01549964|581126492|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
160926506|NCT01549964|581126489|FG000|24-Week Treatment Period|Other|1|||
160926507|NCT01549964|581126490|FG001|24-Week Treatment Period|Other|0|||
160926508|NCT01549964|581126491|FG002|24-Week Treatment Period|Other|1|||
160926509|NCT01549964|581126492|FG003|24-Week Treatment Period|Other|0|||
160926510|NCT01549964|581126489|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
160926511|NCT01549964|581126490|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
160926512|NCT01549964|581126491|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
160926513|NCT01549964|581126492|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
160926514|NCT01549964|581126489|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
160926515|NCT01549964|581126490|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
160926516|NCT01549964|581126491|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
160926517|NCT01549964|581126492|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
160926518|NCT01549964|581126489|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
160926519|NCT01549964|581126490|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
160926520|NCT01549964|581126491|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
160926521|NCT01549964|581126492|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
160926522|NCT01549964|581126489|FG000|80-Week Extension Period|Pregnancy|0|||
160926523|NCT01549964|581126490|FG001|80-Week Extension Period|Pregnancy|0|||
160926524|NCT01549964|581126491|FG002|80-Week Extension Period|Pregnancy|1|||
160926525|NCT01549964|581126492|FG003|80-Week Extension Period|Pregnancy|0|||
160926526|NCT01549964|581126489|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
160926527|NCT01549964|581126490|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
160926528|NCT01549964|581126491|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
160926529|NCT01549964|581126492|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
160926530|NCT01549964|581126489|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
160926531|NCT01549964|581126490|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
160926532|NCT01549964|581126491|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
160926533|NCT01549964|581126492|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
160926534|NCT01549964|581126489|FG000|80-Week Extension Period|Lost to Follow-up|1|||
160926535|NCT01549964|581126490|FG001|80-Week Extension Period|Lost to Follow-up|0|||
160926536|NCT01549964|581126491|FG002|80-Week Extension Period|Lost to Follow-up|2|||
160926537|NCT01549964|581126492|FG003|80-Week Extension Period|Lost to Follow-up|1|||
160926538|NCT01549964|581126489|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
160926539|NCT01549964|581126490|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
160655321|NCT00950807|580118703|FG007|Treatment Period 2|Adverse Event|1|||
160926540|NCT01549964|581126491|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
160655322|NCT00950807|580118704|FG008|Treatment Period 2|Adverse Event|0|||
160655323|NCT00950807|580118705|FG009|Treatment Period 2|Adverse Event|0|||
160655324|NCT00950807|580118696|FG000|Washout Period 2|Lack of Efficacy|1|||
160926541|NCT01549964|581126492|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
160926542|NCT00634088|581126495|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
160926543|NCT00634088|581126496|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
160655325|NCT00950807|580118697|FG001|Washout Period 2|Lack of Efficacy|0|||
160926544|NCT00634088|581126497|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
160926545|NCT00634088|581126498|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
160926546|NCT00634088|581126495|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
160926547|NCT00634088|581126496|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
160926548|NCT00634088|581126497|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
160926549|NCT00634088|581126498|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
160926550|NCT00634088|581126495|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
160926551|NCT00634088|581126496|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
160926552|NCT00634088|581126497|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
160926553|NCT00634088|581126498|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
160926554|NCT00634088|581126495|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
160926555|NCT00634088|581126496|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
160926556|NCT00634088|581126497|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
160926557|NCT00634088|581126498|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
160926558|NCT00634088|581126495|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
160926559|NCT00634088|581126496|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
160926560|NCT00634088|581126497|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
160926561|NCT00634088|581126498|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
160926562|NCT00634088|581126495|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
160926563|NCT00634088|581126496|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
160926564|NCT00634088|581126497|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
160926565|NCT00634088|581126498|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
160926566|NCT02290821|581126499|FG000|Overall Study|Withdrawal by Subject|1|||
160926567|NCT02290821|581126500|FG001|Overall Study|Withdrawal by Subject|1|||
160926568|NCT02290821|581126499|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
160926569|NCT02290821|581126500|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
160926570|NCT02290821|581126499|FG000|Overall Study|Lost to Follow-up|3|||
160926571|NCT02290821|581126500|FG001|Overall Study|Lost to Follow-up|2|||
160926572|NCT02438722|581126505|FG000|Overall Study|Adverse Event|12|||
160926573|NCT02438722|581126506|FG001|Overall Study|Adverse Event|9|||
160926574|NCT02438722|581126505|FG000|Overall Study|Refusal unrelated to AE|2|||
160926575|NCT02438722|581126506|FG001|Overall Study|Refusal unrelated to AE|5|||
160926576|NCT02438722|581126505|FG000|Overall Study|Disease progression/relapse|46|||
160926577|NCT02438722|581126506|FG001|Overall Study|Disease progression/relapse|51|||
160926578|NCT02438722|581126505|FG000|Overall Study|Death|0|||
160926579|NCT02438722|581126506|FG001|Overall Study|Death|3|||
160926580|NCT02438722|581126505|FG000|Overall Study|Physician Decision|2|||
160926581|NCT02438722|581126506|FG001|Overall Study|Physician Decision|2|||
160926582|NCT02438722|581126505|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
160926583|NCT02438722|581126506|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
160926584|NCT02438722|581126505|FG000|Overall Study|Withdrawal by Subject|0|||
160926585|NCT02438722|581126506|FG001|Overall Study|Withdrawal by Subject|1|||
160926586|NCT02438722|581126505|FG000|Overall Study|On protocol treatment|15|||
160926587|NCT02438722|581126506|FG001|Overall Study|On protocol treatment|14|||
160926588|NCT02438722|581126505|FG000|Overall Study|Did not receive protocol treatment|5|||
160926589|NCT02438722|581126506|FG001|Overall Study|Did not receive protocol treatment|0|||
160926590|NCT03343483|581126507|FG000|Overall Study|Death|0|||
160926591|NCT03343483|581126508|FG001|Overall Study|Death|3|||
160926592|NCT03343483|581126507|FG000|Overall Study|Lost to Follow-up|9|||
160926593|NCT03343483|581126508|FG001|Overall Study|Lost to Follow-up|13|||
160926594|NCT03343483|581126507|FG000|Overall Study|Withdrawal by Subject|8|||
160926595|NCT03343483|581126508|FG001|Overall Study|Withdrawal by Subject|17|||
160926596|NCT01488097|581126511|FG000|Overall Study|Lost to Follow-up|1|||
160926597|NCT01577758|581126512|FG000|Dose Escalation Phase|Adverse Event|0|||
160926598|NCT01577758|581126513|FG001|Dose Escalation Phase|Adverse Event|0|||
160926599|NCT01577758|581126514|FG002|Dose Escalation Phase|Adverse Event|0|||
160926600|NCT01577758|581126515|FG003|Dose Escalation Phase|Adverse Event|0|||
160926601|NCT01577758|581126516|FG004|Dose Escalation Phase|Adverse Event|0|||
160926602|NCT01577758|581126517|FG005|Dose Escalation Phase|Adverse Event|2|||
160926603|NCT01577758|581126518|FG006|Dose Escalation Phase|Adverse Event|1|||
160926604|NCT01577758|581126519|FG007|Dose Escalation Phase|Adverse Event|0|||
160926605|NCT01577758|581126512|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
160926606|NCT01577758|581126513|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
160926607|NCT01577758|581126514|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
160655326|NCT00950807|580118698|FG002|Washout Period 2|Lack of Efficacy|0|||
160655327|NCT00950807|580118699|FG003|Washout Period 2|Lack of Efficacy|0|||
160926608|NCT01577758|581126515|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
160926609|NCT01577758|581126516|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
160926610|NCT01577758|581126517|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
160926611|NCT01577758|581126518|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
160926612|NCT01577758|581126519|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
160926613|NCT01577758|581126512|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
160655328|NCT00950807|580118700|FG004|Washout Period 2|Lack of Efficacy|0|||
160926614|NCT01577758|581126513|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
160926615|NCT01577758|581126514|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
160926616|NCT01577758|581126515|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160926617|NCT01577758|581126516|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
160926618|NCT01577758|581126517|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
160926619|NCT01577758|581126518|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
160926620|NCT01577758|581126519|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
160926621|NCT01577758|581126512|FG000|Dose Escalation Phase|Progression Disease|2|||
160926622|NCT01577758|581126513|FG001|Dose Escalation Phase|Progression Disease|2|||
160926623|NCT01577758|581126514|FG002|Dose Escalation Phase|Progression Disease|1|||
160926624|NCT01577758|581126515|FG003|Dose Escalation Phase|Progression Disease|2|||
160926625|NCT01577758|581126516|FG004|Dose Escalation Phase|Progression Disease|5|||
160926626|NCT01577758|581126517|FG005|Dose Escalation Phase|Progression Disease|0|||
160926627|NCT01577758|581126518|FG006|Dose Escalation Phase|Progression Disease|0|||
160926628|NCT01577758|581126519|FG007|Dose Escalation Phase|Progression Disease|0|||
160926629|NCT01577758|581126512|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926630|NCT01577758|581126513|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926631|NCT01577758|581126514|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926632|NCT01577758|581126515|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926633|NCT01577758|581126516|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926634|NCT01577758|581126517|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926635|NCT01577758|581126518|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926636|NCT01577758|581126519|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
160926637|NCT01577758|581126512|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926638|NCT01577758|581126513|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926639|NCT01577758|581126514|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926640|NCT01577758|581126515|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926641|NCT01577758|581126516|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926642|NCT01577758|581126517|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926643|NCT01577758|581126518|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926644|NCT01577758|581126519|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
160926645|NCT01577758|581126512|FG000|mCRC Expansion Phase|Progression Disease|0|||
160926646|NCT01577758|581126513|FG001|mCRC Expansion Phase|Progression Disease|0|||
160926647|NCT01577758|581126514|FG002|mCRC Expansion Phase|Progression Disease|0|||
160926648|NCT01577758|581126515|FG003|mCRC Expansion Phase|Progression Disease|0|||
160926649|NCT01577758|581126516|FG004|mCRC Expansion Phase|Progression Disease|0|||
160926650|NCT01577758|581126517|FG005|mCRC Expansion Phase|Progression Disease|0|||
160926651|NCT01577758|581126518|FG006|mCRC Expansion Phase|Progression Disease|0|||
160926652|NCT01577758|581126519|FG007|mCRC Expansion Phase|Progression Disease|19|||
160926653|NCT04969224|581126524|FG000|Overall Study|Adverse Event|1|||
160926654|NCT04969224|581126524|FG000|Overall Study|Enrolled but never dosed|1|||
160926655|NCT03165110|581126528|FG000|Overall Study|Anroid phone software incompatibility|1|||
160926656|NCT05533632|581126529|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
160926657|NCT05533632|581126529|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
160926658|NCT05533632|581126529|FG000|Overall Study|Lost to Follow-up|1|||
160926659|NCT05533632|581126529|FG000|Overall Study|Withdrawal by Subject|4|||
160926660|NCT05533632|581126529|FG000|Overall Study|Adverse Event|4|||
160926661|NCT02726074|581126530|FG000|Overall Study|Withdrawal by Subject|4|||
160926662|NCT02726074|581126530|FG000|Overall Study|Adverse Event|14|||
160926663|NCT02726074|581126530|FG000|Overall Study|Protocol Violation|3|||
160926664|NCT02726074|581126530|FG000|Overall Study|Lost to Follow-up|2|||
160926665|NCT02726074|581126530|FG000|Overall Study|Others|3|||
160926666|NCT00579826|581126531|FG000|Overall Study|Withdrawal by Subject|5|||
160926667|NCT00579826|581126532|FG001|Overall Study|Withdrawal by Subject|3|||
160926668|NCT04191382|581126533|FG000|Overall Study|Withdrawal by Subject|1|||
160926669|NCT04191382|581126534|FG001|Overall Study|Withdrawal by Subject|0|||
160926670|NCT04191382|581126535|FG002|Overall Study|Withdrawal by Subject|0|||
160926671|NCT00454987|581126538|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
160926672|NCT00454987|581126539|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
160926673|NCT00454987|581126540|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
160926674|NCT00454987|581126538|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
160926675|NCT00454987|581126539|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
160926676|NCT00454987|581126540|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
160926677|NCT00454987|581126538|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
160926678|NCT00454987|581126539|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
160926679|NCT00454987|581126540|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
160926680|NCT03054870|581126542|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
160998029|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
160998030|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
160998031|NCT00241644|581378523|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
160998032|NCT00241644|581378524|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
160577356|NCT00723840|579834523|FG000|Overall Study|Other Medical Event|2|||
160926681|NCT03054870|581126542|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
160926682|NCT02009046|581126543|FG000|Overall Study|Lost to Follow-up|256|||
160926683|NCT02009046|581126544|FG001|Overall Study|Lost to Follow-up|206|||
160926684|NCT00973479|581126548|FG000|Overall Study|Lost to Follow-up|0|||
160926685|NCT00973479|581126549|FG001|Overall Study|Lost to Follow-up|3|||
160926686|NCT00973479|581126548|FG000|Overall Study|Death|2|||
160926687|NCT00973479|581126549|FG001|Overall Study|Death|2|||
160926688|NCT00973479|581126548|FG000|Overall Study|Withdrawal by Subject|15|||
160926689|NCT00973479|581126549|FG001|Overall Study|Withdrawal by Subject|16|||
160577357|NCT00723840|579834523|FG000|Overall Study|Unspecified reason|2|||
160577358|NCT03303339|579834524|FG000|Overall Study|Death|2|||
160926690|NCT00973479|581126548|FG000|Overall Study|Lack of Efficacy|5|||
160577359|NCT03303339|579834525|FG001|Overall Study|Death|2|||
160577360|NCT03303339|579834526|FG002|Overall Study|Death|2|||
160577361|NCT03303339|579834527|FG003|Overall Study|Death|1|||
160577362|NCT03303339|579834528|FG004|Overall Study|Death|4|||
160577363|NCT03303339|579834529|FG005|Overall Study|Death|2|||
160577364|NCT03303339|579834530|FG006|Overall Study|Death|2|||
160577365|NCT03303339|579834531|FG007|Overall Study|Death|2|||
160577366|NCT03303339|579834532|FG008|Overall Study|Death|3|||
160577367|NCT03303339|579834533|FG009|Overall Study|Death|3|||
160577368|NCT03303339|579834534|FG010|Overall Study|Death|4|||
160577369|NCT03303339|579834535|FG011|Overall Study|Death|24|||
160577370|NCT03303339|579834524|FG000|Overall Study|Study Terminated by Sponsor|0|||
160577371|NCT03303339|579834525|FG001|Overall Study|Study Terminated by Sponsor|0|||
160577372|NCT03303339|579834526|FG002|Overall Study|Study Terminated by Sponsor|0|||
160577373|NCT03303339|579834527|FG003|Overall Study|Study Terminated by Sponsor|0|||
160577374|NCT03303339|579834528|FG004|Overall Study|Study Terminated by Sponsor|0|||
160577375|NCT03303339|579834529|FG005|Overall Study|Study Terminated by Sponsor|0|||
160577376|NCT03303339|579834530|FG006|Overall Study|Study Terminated by Sponsor|0|||
160577377|NCT03303339|579834531|FG007|Overall Study|Study Terminated by Sponsor|0|||
160577378|NCT03303339|579834532|FG008|Overall Study|Study Terminated by Sponsor|1|||
160577379|NCT03303339|579834533|FG009|Overall Study|Study Terminated by Sponsor|0|||
160577380|NCT03303339|579834534|FG010|Overall Study|Study Terminated by Sponsor|1|||
160577381|NCT03303339|579834535|FG011|Overall Study|Study Terminated by Sponsor|1|||
160577382|NCT03303339|579834524|FG000|Overall Study|Withdrawal by Subject|1|||
160577383|NCT03303339|579834525|FG001|Overall Study|Withdrawal by Subject|0|||
160577384|NCT03303339|579834526|FG002|Overall Study|Withdrawal by Subject|0|||
160577385|NCT03303339|579834527|FG003|Overall Study|Withdrawal by Subject|0|||
160577386|NCT03303339|579834528|FG004|Overall Study|Withdrawal by Subject|0|||
160577387|NCT03303339|579834529|FG005|Overall Study|Withdrawal by Subject|1|||
160577388|NCT03303339|579834530|FG006|Overall Study|Withdrawal by Subject|1|||
160577389|NCT03303339|579834531|FG007|Overall Study|Withdrawal by Subject|0|||
160577390|NCT03303339|579834532|FG008|Overall Study|Withdrawal by Subject|0|||
160577391|NCT03303339|579834533|FG009|Overall Study|Withdrawal by Subject|0|||
160577392|NCT03303339|579834534|FG010|Overall Study|Withdrawal by Subject|0|||
160577393|NCT03303339|579834535|FG011|Overall Study|Withdrawal by Subject|2|||
160577394|NCT03303339|579834524|FG000|Overall Study|Physician Decision|0|||
160577395|NCT03303339|579834525|FG001|Overall Study|Physician Decision|0|||
160577396|NCT03303339|579834526|FG002|Overall Study|Physician Decision|0|||
160577397|NCT03303339|579834527|FG003|Overall Study|Physician Decision|0|||
160577398|NCT03303339|579834528|FG004|Overall Study|Physician Decision|1|||
160577399|NCT03303339|579834529|FG005|Overall Study|Physician Decision|0|||
160577400|NCT03303339|579834530|FG006|Overall Study|Physician Decision|0|||
160577401|NCT03303339|579834531|FG007|Overall Study|Physician Decision|0|||
160577402|NCT03303339|579834532|FG008|Overall Study|Physician Decision|0|||
160577403|NCT03303339|579834533|FG009|Overall Study|Physician Decision|0|||
160577404|NCT03303339|579834534|FG010|Overall Study|Physician Decision|0|||
160577405|NCT03303339|579834535|FG011|Overall Study|Physician Decision|0|||
160577406|NCT03303339|579834524|FG000|Overall Study|Safety/Non-compliance|0|||
160577407|NCT03303339|579834525|FG001|Overall Study|Safety/Non-compliance|0|||
160577408|NCT03303339|579834526|FG002|Overall Study|Safety/Non-compliance|0|||
160577409|NCT03303339|579834527|FG003|Overall Study|Safety/Non-compliance|0|||
160577410|NCT03303339|579834528|FG004|Overall Study|Safety/Non-compliance|0|||
160577411|NCT03303339|579834529|FG005|Overall Study|Safety/Non-compliance|0|||
160577412|NCT03303339|579834530|FG006|Overall Study|Safety/Non-compliance|0|||
160577413|NCT03303339|579834531|FG007|Overall Study|Safety/Non-compliance|0|||
160577414|NCT03303339|579834532|FG008|Overall Study|Safety/Non-compliance|0|||
160577415|NCT03303339|579834533|FG009|Overall Study|Safety/Non-compliance|0|||
160577416|NCT03303339|579834534|FG010|Overall Study|Safety/Non-compliance|0|||
160577417|NCT03303339|579834535|FG011|Overall Study|Safety/Non-compliance|1|||
160577418|NCT01426386|579834536|FG000|Overall Study|Adverse Event|0|||
160577419|NCT01426386|579834537|FG001|Overall Study|Adverse Event|1|||
160577420|NCT01426386|579834538|FG002|Overall Study|Adverse Event|0|||
160577421|NCT01426386|579834539|FG003|Overall Study|Adverse Event|0|||
160577422|NCT01426386|579834540|FG004|Overall Study|Adverse Event|0|||
160577423|NCT01426386|579834541|FG005|Overall Study|Adverse Event|0|||
160577424|NCT01426386|579834536|FG000|Overall Study|Did not attend scheduled visit|1|||
160577425|NCT01426386|579834537|FG001|Overall Study|Did not attend scheduled visit|4|||
160655329|NCT00950807|580118701|FG005|Washout Period 2|Lack of Efficacy|0|||
160655330|NCT00950807|580118702|FG006|Washout Period 2|Lack of Efficacy|0|||
160655331|NCT00950807|580118703|FG007|Washout Period 2|Lack of Efficacy|0|||
160577426|NCT01426386|579834538|FG002|Overall Study|Did not attend scheduled visit|0|||
160655332|NCT00950807|580118704|FG008|Washout Period 2|Lack of Efficacy|0|||
160655333|NCT00950807|580118705|FG009|Washout Period 2|Lack of Efficacy|0|||
160655334|NCT00950807|580118696|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
160655335|NCT00950807|580118697|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
160655336|NCT00950807|580118698|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
160655337|NCT00950807|580118699|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
160655338|NCT00950807|580118700|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
160655339|NCT00950807|580118701|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
160655340|NCT00950807|580118702|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
160655341|NCT00950807|580118703|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
160655342|NCT00950807|580118704|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
160655343|NCT00950807|580118705|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
160655344|NCT00950807|580118696|FG000|Washout Period 2|Adverse Event|3|||
160655345|NCT00950807|580118697|FG001|Washout Period 2|Adverse Event|0|||
160655346|NCT00950807|580118698|FG002|Washout Period 2|Adverse Event|0|||
160655347|NCT00950807|580118699|FG003|Washout Period 2|Adverse Event|1|||
160655348|NCT00950807|580118700|FG004|Washout Period 2|Adverse Event|0|||
160655349|NCT00950807|580118701|FG005|Washout Period 2|Adverse Event|0|||
160655350|NCT00950807|580118702|FG006|Washout Period 2|Adverse Event|0|||
160655351|NCT00950807|580118703|FG007|Washout Period 2|Adverse Event|0|||
160655352|NCT00950807|580118704|FG008|Washout Period 2|Adverse Event|0|||
160655353|NCT00950807|580118705|FG009|Washout Period 2|Adverse Event|0|||
160655354|NCT00950807|580118696|FG000|Treatment Period 3|Withdrawal by Subject|0|||
160655355|NCT00950807|580118697|FG001|Treatment Period 3|Withdrawal by Subject|0|||
160655356|NCT00950807|580118698|FG002|Treatment Period 3|Withdrawal by Subject|0|||
160655357|NCT00950807|580118699|FG003|Treatment Period 3|Withdrawal by Subject|0|||
160655358|NCT00950807|580118700|FG004|Treatment Period 3|Withdrawal by Subject|0|||
160655359|NCT00950807|580118701|FG005|Treatment Period 3|Withdrawal by Subject|0|||
160655360|NCT00950807|580118702|FG006|Treatment Period 3|Withdrawal by Subject|0|||
160998033|NCT00241644|581378525|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
160577427|NCT01426386|579834539|FG003|Overall Study|Did not attend scheduled visit|0|||
160577428|NCT01426386|579834540|FG004|Overall Study|Did not attend scheduled visit|2|||
160577429|NCT01426386|579834541|FG005|Overall Study|Did not attend scheduled visit|1|||
160577430|NCT01426386|579834536|FG000|Overall Study|Poor response|2|||
160577431|NCT01426386|579834537|FG001|Overall Study|Poor response|1|||
160577432|NCT01426386|579834538|FG002|Overall Study|Poor response|2|||
160577433|NCT01426386|579834539|FG003|Overall Study|Poor response|0|||
160577434|NCT01426386|579834540|FG004|Overall Study|Poor response|1|||
160577435|NCT01426386|579834541|FG005|Overall Study|Poor response|0|||
160577436|NCT01426386|579834536|FG000|Overall Study|Personal reasons|0|||
160577437|NCT01426386|579834537|FG001|Overall Study|Personal reasons|0|||
160577438|NCT01426386|579834538|FG002|Overall Study|Personal reasons|0|||
160577439|NCT01426386|579834539|FG003|Overall Study|Personal reasons|0|||
160577440|NCT01426386|579834540|FG004|Overall Study|Personal reasons|1|||
160577441|NCT01426386|579834541|FG005|Overall Study|Personal reasons|0|||
160577442|NCT02522377|579834543|FG000|Overall Study|Withdrawal by Subject|1|||
160577443|NCT02522377|579834544|FG001|Overall Study|Withdrawal by Subject|0|||
160577444|NCT02522377|579834543|FG000|Overall Study|Remission Achieved|3|||
160577445|NCT02522377|579834544|FG001|Overall Study|Remission Achieved|0|||
160577446|NCT01158950|579834545|FG000|1st Intervention (1 Day)|Physician Decision|1|||
160577447|NCT01158950|579834546|FG001|1st Intervention (1 Day)|Physician Decision|2|||
160577448|NCT02137772|579834553|FG000|Overall Study|Adverse Event|6|||
160577449|NCT02137772|579834554|FG001|Overall Study|Adverse Event|3|||
160577450|NCT02137772|579834553|FG000|Overall Study|Death|71|||
160577451|NCT02137772|579834554|FG001|Overall Study|Death|44|||
160577452|NCT02137772|579834553|FG000|Overall Study|Lost to Follow-up|8|||
160577453|NCT02137772|579834554|FG001|Overall Study|Lost to Follow-up|4|||
160577454|NCT02137772|579834553|FG000|Overall Study|Physician Decision|15|||
160577455|NCT02137772|579834554|FG001|Overall Study|Physician Decision|5|||
160577456|NCT02137772|579834553|FG000|Overall Study|Withdrawal by Subject|28|||
160577457|NCT02137772|579834554|FG001|Overall Study|Withdrawal by Subject|17|||
160577458|NCT02137772|579834553|FG000|Overall Study|Non-compliance with study drug|1|||
160577459|NCT02137772|579834554|FG001|Overall Study|Non-compliance with study drug|0|||
160577460|NCT02137772|579834553|FG000|Overall Study|Not treated|3|||
160577461|NCT02137772|579834554|FG001|Overall Study|Not treated|2|||
160577462|NCT01844700|579834555|FG000|Overall Study|Lack of Efficacy|1|||
160577463|NCT01844700|579834556|FG001|Overall Study|Lack of Efficacy|0|||
160577464|NCT01844700|579834555|FG000|Overall Study|refused medication switch|1|||
160655361|NCT00950807|580118703|FG007|Treatment Period 3|Withdrawal by Subject|0|||
160655362|NCT00950807|580118704|FG008|Treatment Period 3|Withdrawal by Subject|0|||
160655363|NCT00950807|580118705|FG009|Treatment Period 3|Withdrawal by Subject|1|||
160454884|NCT01928394|579396183|FG013|Follow-up Period|other reason|1|||
160454885|NCT01928394|579396184|FG014|Follow-up Period|other reason|4|||
160454886|NCT01928394|579396185|FG015|Follow-up Period|other reason|0|||
160577465|NCT01844700|579834556|FG001|Overall Study|refused medication switch|0|||
160577466|NCT01844700|579834555|FG000|Overall Study|Withdrawal by Subject|1|||
160577467|NCT01844700|579834556|FG001|Overall Study|Withdrawal by Subject|0|||
160577468|NCT01844700|579834555|FG000|Overall Study|stopped taking meds|0|||
160577469|NCT01844700|579834556|FG001|Overall Study|stopped taking meds|1|||
160577470|NCT03290300|579834557|FG000|Overall Study|Lost to Follow-up|3|||
160577471|NCT02124798|579834558|FG000|Overall Study|Adverse Event|3|||
160577472|NCT02124798|579834558|FG000|Overall Study|Lost to Follow-up|1|||
160577473|NCT00638846|579834559|FG000|Overall Study|Adverse Event|0|||
160577474|NCT00638846|579834560|FG001|Overall Study|Adverse Event|1|||
160577475|NCT00638846|579834559|FG000|Overall Study|Lost to Follow-up|3|||
160577476|NCT00638846|579834560|FG001|Overall Study|Lost to Follow-up|2|||
160577477|NCT00638846|579834559|FG000|Overall Study|lens issue|1|||
160577478|NCT00638846|579834560|FG001|Overall Study|lens issue|3|||
160577479|NCT02746679|579834568|FG000|Overall Study|Lost to Follow-up|4|||
160577480|NCT02746679|579834569|FG001|Overall Study|Lost to Follow-up|6|||
160577481|NCT01520922|579834570|FG000|Treatment Phase|Physician Decision|2|||
160577482|NCT01520922|579834571|FG001|Treatment Phase|Physician Decision|1|||
160577483|NCT01520922|579834570|FG000|Treatment Phase|Progression|0|||
160577484|NCT01520922|579834571|FG001|Treatment Phase|Progression|2|||
160577485|NCT01520922|579834570|FG000|Treatment Phase|Adverse Event|3|||
160577486|NCT01520922|579834571|FG001|Treatment Phase|Adverse Event|5|||
160577487|NCT01520922|579834570|FG000|Follow up|Lost to Follow-up|0|||
160577488|NCT01520922|579834571|FG001|Follow up|Lost to Follow-up|1|||
160577489|NCT01520922|579834570|FG000|Survival Follow-up|Withdrawal by Subject|1|||
160577490|NCT01520922|579834571|FG001|Survival Follow-up|Withdrawal by Subject|0|||
160577491|NCT01696877|579834572|FG000|Overall Study|Adverse Event|0|||
160577492|NCT01696877|579834573|FG001|Overall Study|Adverse Event|1|||
160577493|NCT01422304|579834576|FG000|Overall Study|Adverse Event|0|||
160577494|NCT01422304|579834577|FG001|Overall Study|Adverse Event|1|||
160577495|NCT01422304|579834576|FG000|Overall Study|Lost to Follow-up|14|||
160577496|NCT01422304|579834577|FG001|Overall Study|Lost to Follow-up|20|||
160577497|NCT01422304|579834576|FG000|Overall Study|Never Entered Follow-up|2|||
160577498|NCT01422304|579834577|FG001|Overall Study|Never Entered Follow-up|1|||
160577499|NCT01422304|579834576|FG000|Overall Study|Protocol Violation|1|||
160577500|NCT01422304|579834577|FG001|Overall Study|Protocol Violation|0|||
160577501|NCT01422304|579834576|FG000|Overall Study|Withdrawal by Subject|4|||
160577502|NCT01422304|579834577|FG001|Overall Study|Withdrawal by Subject|2|||
160577503|NCT01422304|579834576|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
160577504|NCT01422304|579834577|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
160577505|NCT01422304|579834576|FG000|Overall Study|Not Treated|3|||
160577506|NCT01422304|579834577|FG001|Overall Study|Not Treated|11|||
160577507|NCT00469014|579834582|FG000|Initial Phase Randomization|Disease Progression|0|||
160577508|NCT00469014|579834583|FG001|Initial Phase Randomization|Disease Progression|1|||
160577509|NCT00469014|579834584|FG002|Initial Phase Randomization|Disease Progression|1|||
160577510|NCT00469014|579834585|FG003|Initial Phase Randomization|Disease Progression|0|||
160577511|NCT00469014|579834582|FG000|Initial Phase Randomization|No Response|1|||
160577512|NCT00469014|579834583|FG001|Initial Phase Randomization|No Response|0|||
160577513|NCT00469014|579834584|FG002|Initial Phase Randomization|No Response|0|||
160577514|NCT00469014|579834585|FG003|Initial Phase Randomization|No Response|1|||
160577515|NCT00469014|579834582|FG000|Adaptive Randomization|Not Evaluable|1|||
160577516|NCT00469014|579834583|FG001|Adaptive Randomization|Not Evaluable|0|||
160577517|NCT00469014|579834584|FG002|Adaptive Randomization|Not Evaluable|0|||
160577518|NCT00469014|579834585|FG003|Adaptive Randomization|Not Evaluable|1|||
160577519|NCT00469014|579834582|FG000|Adaptive Randomization|No Response|0|||
160577520|NCT00469014|579834583|FG001|Adaptive Randomization|No Response|1|||
160577521|NCT00469014|579834584|FG002|Adaptive Randomization|No Response|0|||
160454887|NCT01928394|579396186|FG016|Follow-up Period|other reason|2|||
160577522|NCT00469014|579834585|FG003|Adaptive Randomization|No Response|0|||
160577523|NCT00469014|579834582|FG000|Adaptive Randomization|Death|0|||
160577524|NCT00469014|579834583|FG001|Adaptive Randomization|Death|0|||
160577525|NCT00469014|579834584|FG002|Adaptive Randomization|Death|1|||
160577526|NCT00469014|579834585|FG003|Adaptive Randomization|Death|0|||
160577527|NCT03461289|579834587|FG000|Overall Study|Death|1|||
160577528|NCT00564629|579834590|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
160577529|NCT00564629|579834591|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
160577530|NCT03241173|579834592|FG000|Overall Study|Death|3|||
160577531|NCT03241173|579834593|FG001|Overall Study|Death|2|||
160577532|NCT03241173|579834594|FG002|Overall Study|Death|4|||
160577533|NCT03241173|579834595|FG003|Overall Study|Death|4|||
160577534|NCT03241173|579834596|FG004|Overall Study|Death|2|||
160577535|NCT03241173|579834597|FG005|Overall Study|Death|2|||
160577536|NCT03241173|579834598|FG006|Overall Study|Death|3|||
160577537|NCT03241173|579834599|FG007|Overall Study|Death|1|||
160577538|NCT03241173|579834600|FG008|Overall Study|Death|0|||
160454888|NCT01928394|579396187|FG017|Follow-up Period|other reason|0|||
160655364|NCT00950807|580118696|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
160655365|NCT00950807|580118697|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160655366|NCT00950807|580118698|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160655367|NCT00950807|580118699|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160655368|NCT00950807|580118700|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160655369|NCT00950807|580118701|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160655370|NCT00950807|580118702|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160655371|NCT00950807|580118703|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
160655372|NCT00950807|580118704|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160655373|NCT00950807|580118705|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160655374|NCT00950807|580118696|FG000|Treatment Period 3|Adverse Event|0|||
160655375|NCT00950807|580118697|FG001|Treatment Period 3|Adverse Event|0|||
160655376|NCT00950807|580118698|FG002|Treatment Period 3|Adverse Event|0|||
160655377|NCT00950807|580118699|FG003|Treatment Period 3|Adverse Event|0|||
160655378|NCT00950807|580118700|FG004|Treatment Period 3|Adverse Event|0|||
160655379|NCT00950807|580118701|FG005|Treatment Period 3|Adverse Event|0|||
160655380|NCT00950807|580118702|FG006|Treatment Period 3|Adverse Event|1|||
160655381|NCT00950807|580118703|FG007|Treatment Period 3|Adverse Event|0|||
160655382|NCT00950807|580118704|FG008|Treatment Period 3|Adverse Event|0|||
160655383|NCT00950807|580118705|FG009|Treatment Period 3|Adverse Event|0|||
160655384|NCT00337077|580118706|FG000|Overall Study|Progressive disease|25|||
160655385|NCT00337077|580118707|FG001|Overall Study|Progressive disease|37|||
160655386|NCT00337077|580118708|FG002|Overall Study|Progressive disease|19|||
160655387|NCT00337077|580118706|FG000|Overall Study|Adverse Event|7|||
160655388|NCT00337077|580118707|FG001|Overall Study|Adverse Event|7|||
160655389|NCT00337077|580118708|FG002|Overall Study|Adverse Event|1|||
160655390|NCT00337077|580118706|FG000|Overall Study|Death|0|||
160655391|NCT00337077|580118707|FG001|Overall Study|Death|1|||
160655392|NCT00337077|580118708|FG002|Overall Study|Death|0|||
160655393|NCT00337077|580118706|FG000|Overall Study|Withdrawal by Subject|7|||
160655394|NCT00337077|580118707|FG001|Overall Study|Withdrawal by Subject|2|||
160655395|NCT00337077|580118708|FG002|Overall Study|Withdrawal by Subject|2|||
160655396|NCT00337077|580118706|FG000|Overall Study|Alternative therapy|1|||
160655397|NCT00337077|580118707|FG001|Overall Study|Alternative therapy|0|||
160655398|NCT00337077|580118708|FG002|Overall Study|Alternative therapy|0|||
160655399|NCT00337077|580118706|FG000|Overall Study|Physician Decision|1|||
160655400|NCT00337077|580118707|FG001|Overall Study|Physician Decision|4|||
160655401|NCT00337077|580118708|FG002|Overall Study|Physician Decision|2|||
160655402|NCT00337077|580118706|FG000|Overall Study|Never started treatment|1|||
160655403|NCT00337077|580118707|FG001|Overall Study|Never started treatment|1|||
160655404|NCT00337077|580118708|FG002|Overall Study|Never started treatment|0|||
160655405|NCT00337077|580118706|FG000|Overall Study|Ineligible|1|||
160655406|NCT00337077|580118707|FG001|Overall Study|Ineligible|1|||
160655407|NCT00337077|580118708|FG002|Overall Study|Ineligible|1|||
160655408|NCT01492400|580118712|FG000|Overall Study|Miscellaneous Reasons|2|||
160655409|NCT01492400|580118713|FG001|Overall Study|Miscellaneous Reasons|3|||
160655410|NCT01492400|580118712|FG000|Overall Study|Personal Reasons|0|||
160655411|NCT01492400|580118713|FG001|Overall Study|Personal Reasons|5|||
160655412|NCT01492400|580118712|FG000|Overall Study|Lost to Follow-up|3|||
160655413|NCT01492400|580118713|FG001|Overall Study|Lost to Follow-up|1|||
160655414|NCT01492400|580118712|FG000|Overall Study|Pregnancy|0|||
160655415|NCT01492400|580118713|FG001|Overall Study|Pregnancy|1|||
160655416|NCT01492400|580118712|FG000|Overall Study|Lack of Efficacy|1|||
160655417|NCT01492400|580118713|FG001|Overall Study|Lack of Efficacy|1|||
160655418|NCT01492400|580118712|FG000|Overall Study|Adverse Event|10|||
160655419|NCT01492400|580118713|FG001|Overall Study|Adverse Event|5|||
160655420|NCT00659607|580118714|FG000|Overall Study|No blood pressure recorded|147|||
160655421|NCT00659607|580118714|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
160655422|NCT00659607|580118714|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
160655423|NCT00659607|580118714|FG000|Overall Study|No recorded efficacy data|15|||
160655424|NCT00659607|580118714|FG000|Overall Study|Inconsistent BP measuring date|2|||
160655425|NCT02568384|580118720|FG000|Overall Study|Mobile devices incompatible with App|2|||
160655426|NCT03184441|580118721|FG000|Overall Study|Withdrawal by Subject|1|||
160655427|NCT00264810|580118722|FG000|Baseline|Withdrawal by Subject|10|||
160655428|NCT00264810|580118723|FG001|Baseline|Withdrawal by Subject|10|||
160655429|NCT00264810|580118722|FG000|Baseline|Physician Decision|7|||
160655430|NCT00264810|580118723|FG001|Baseline|Physician Decision|8|||
160655431|NCT00264810|580118722|FG000|Baseline|Subject Compliance Failure|3|||
160655432|NCT00264810|580118723|FG001|Baseline|Subject Compliance Failure|3|||
160655433|NCT00264810|580118722|FG000|Baseline|Insufficient Seizure Frequency|2|||
160655434|NCT00264810|580118723|FG001|Baseline|Insufficient Seizure Frequency|2|||
160655435|NCT00264810|580118722|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
160655436|NCT00264810|580118723|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
160655437|NCT00264810|580118722|FG000|Baseline|Other|0|||
160655438|NCT00264810|580118723|FG001|Baseline|Other|1|||
160655439|NCT00264810|580118722|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
160655440|NCT00264810|580118723|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
160577539|NCT03241173|579834601|FG009|Overall Study|Death|5|||
160577540|NCT03241173|579834602|FG010|Overall Study|Death|4|||
160577541|NCT03241173|579834603|FG011|Overall Study|Death|3|||
160577542|NCT03241173|579834604|FG012|Overall Study|Death|0|||
160577543|NCT03241173|579834605|FG013|Overall Study|Death|0|||
160577544|NCT03241173|579834606|FG014|Overall Study|Death|0|||
160577545|NCT03241173|579834592|FG000|Overall Study|Withdrawal by Subject|0|||
160577546|NCT03241173|579834593|FG001|Overall Study|Withdrawal by Subject|0|||
160577547|NCT03241173|579834594|FG002|Overall Study|Withdrawal by Subject|1|||
160577548|NCT03241173|579834595|FG003|Overall Study|Withdrawal by Subject|0|||
160577549|NCT03241173|579834596|FG004|Overall Study|Withdrawal by Subject|0|||
160577550|NCT03241173|579834597|FG005|Overall Study|Withdrawal by Subject|1|||
160577551|NCT03241173|579834598|FG006|Overall Study|Withdrawal by Subject|0|||
160577552|NCT03241173|579834599|FG007|Overall Study|Withdrawal by Subject|0|||
160577553|NCT03241173|579834600|FG008|Overall Study|Withdrawal by Subject|0|||
160577554|NCT03241173|579834601|FG009|Overall Study|Withdrawal by Subject|0|||
160577555|NCT03241173|579834602|FG010|Overall Study|Withdrawal by Subject|0|||
160577556|NCT03241173|579834603|FG011|Overall Study|Withdrawal by Subject|0|||
160577557|NCT03241173|579834604|FG012|Overall Study|Withdrawal by Subject|0|||
160577558|NCT03241173|579834605|FG013|Overall Study|Withdrawal by Subject|0|||
160577559|NCT03241173|579834606|FG014|Overall Study|Withdrawal by Subject|0|||
160577560|NCT03241173|579834592|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
160577561|NCT03241173|579834593|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
160577562|NCT03241173|579834594|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
160577563|NCT03241173|579834595|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
160577564|NCT03241173|579834596|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
160577565|NCT03241173|579834597|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
160577566|NCT03241173|579834598|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
160577567|NCT03241173|579834599|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
160577568|NCT03241173|579834600|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
160577569|NCT03241173|579834601|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
160577570|NCT03241173|579834602|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
160577571|NCT03241173|579834603|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
160577572|NCT03241173|579834604|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
160577573|NCT03241173|579834605|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
160577574|NCT03241173|579834606|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
160577575|NCT03241173|579834592|FG000|Overall Study|Lost to Follow-up|0|||
160577576|NCT03241173|579834593|FG001|Overall Study|Lost to Follow-up|0|||
160577577|NCT03241173|579834594|FG002|Overall Study|Lost to Follow-up|0|||
160577578|NCT03241173|579834595|FG003|Overall Study|Lost to Follow-up|0|||
160577579|NCT03241173|579834596|FG004|Overall Study|Lost to Follow-up|1|||
160577580|NCT03241173|579834597|FG005|Overall Study|Lost to Follow-up|0|||
160577581|NCT03241173|579834598|FG006|Overall Study|Lost to Follow-up|0|||
160577582|NCT03241173|579834599|FG007|Overall Study|Lost to Follow-up|0|||
160577583|NCT03241173|579834600|FG008|Overall Study|Lost to Follow-up|0|||
160577584|NCT03241173|579834601|FG009|Overall Study|Lost to Follow-up|1|||
160577585|NCT03241173|579834602|FG010|Overall Study|Lost to Follow-up|0|||
160577586|NCT03241173|579834603|FG011|Overall Study|Lost to Follow-up|0|||
160577587|NCT03241173|579834604|FG012|Overall Study|Lost to Follow-up|0|||
160577588|NCT03241173|579834605|FG013|Overall Study|Lost to Follow-up|0|||
160577589|NCT03241173|579834606|FG014|Overall Study|Lost to Follow-up|0|||
160577590|NCT00515463|579834607|FG000|Overall Study|Physician Decision|4|||
160577591|NCT00515463|579834608|FG001|Overall Study|Physician Decision|2|||
160577592|NCT00515463|579834607|FG000|Overall Study|Adverse Event|1|||
160577593|NCT00515463|579834608|FG001|Overall Study|Adverse Event|2|||
160577594|NCT00515463|579834607|FG000|Overall Study|Withdrawal by Subject|3|||
160577595|NCT00515463|579834608|FG001|Overall Study|Withdrawal by Subject|4|||
160577596|NCT00515463|579834607|FG000|Overall Study|Lost to Follow-up|6|||
160577597|NCT00515463|579834608|FG001|Overall Study|Lost to Follow-up|5|||
160577598|NCT00515463|579834607|FG000|Overall Study|Other|0|||
160577599|NCT00515463|579834608|FG001|Overall Study|Other|1|||
160577600|NCT01519427|579834609|FG000|Overall Study|disease progression|2|||
160577601|NCT00633139|579834619|FG000|Overall Study|Non compliance|0|||
160577602|NCT00633139|579834620|FG001|Overall Study|Non compliance|0|||
160577603|NCT00633139|579834621|FG002|Overall Study|Non compliance|1|||
160577604|NCT00633139|579834619|FG000|Overall Study|Withdrawal by Subject|0|||
160577605|NCT00633139|579834620|FG001|Overall Study|Withdrawal by Subject|1|||
160577606|NCT00633139|579834621|FG002|Overall Study|Withdrawal by Subject|0|||
160577607|NCT02269319|579834622|FG000|Overall Study|Lost to Follow-up|4|||
160577608|NCT02269319|579834623|FG001|Overall Study|Lost to Follow-up|3|||
160577609|NCT02269319|579834622|FG000|Overall Study|Adverse Event|0|||
160577610|NCT02269319|579834623|FG001|Overall Study|Adverse Event|1|||
160577611|NCT02269319|579834622|FG000|Overall Study|Instructions not followed|1|||
160655441|NCT00264810|580118722|FG000|Stimulation Optimization Period|Death|0|||
160655442|NCT00264810|580118723|FG001|Stimulation Optimization Period|Death|1|||
160655443|NCT00264810|580118722|FG000|Blinded Evaluation Period|Explant due to infection|1|||
160655444|NCT00264810|580118723|FG001|Blinded Evaluation Period|Explant due to infection|1|||
160655445|NCT00264810|580118722|FG000|Open Label Evaluation Period|Explant due to infection|1|||
160655446|NCT00264810|580118723|FG001|Open Label Evaluation Period|Explant due to infection|1|||
160655447|NCT00264810|580118722|FG000|Open Label Evaluation Period|Death|3|||
160655448|NCT00264810|580118723|FG001|Open Label Evaluation Period|Death|2|||
160655449|NCT00264810|580118722|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
160655450|NCT00264810|580118723|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
160655451|NCT02994056|580118724|FG000|Overall Study|Death|8|||
160655452|NCT02994056|580118724|FG000|Overall Study|Withdrew Consent|1|||
160655453|NCT02199509|580118727|FG000|Overall Study|Suicidal Ideation|0|||
160655454|NCT02199509|580118728|FG001|Overall Study|Suicidal Ideation|1|||
160655455|NCT02199509|580118727|FG000|Overall Study|Misunderstood titration schedule|1|||
160655456|NCT02199509|580118728|FG001|Overall Study|Misunderstood titration schedule|0|||
160655457|NCT01346410|580118730|FG000|Overall Study|Death|1|||
160655458|NCT00979628|580118731|FG000|Overall Study|received regimen < 24 hours|7|||
160655459|NCT00979628|580118732|FG001|Overall Study|received regimen < 24 hours|6|||
160577612|NCT02269319|579834623|FG001|Overall Study|Instructions not followed|0|||
160632812|NCT00244881|580036080|FG000|Overall Study|Withdrawal by Subject|3|||
160632813|NCT04101721|580036083|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
160632814|NCT04101721|580036084|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
160632815|NCT04101721|580036083|FG000|Overall Study|Death|0|||
160632816|NCT04101721|580036084|FG001|Overall Study|Death|1|||
160655460|NCT00979628|580118733|FG002|Overall Study|received regimen < 24 hours|5|||
160655461|NCT00979628|580118731|FG000|Overall Study|received steroids|1|||
160655462|NCT00979628|580118732|FG001|Overall Study|received steroids|1|||
160655463|NCT00979628|580118733|FG002|Overall Study|received steroids|0|||
160655464|NCT00979628|580118731|FG000|Overall Study|transferred to ICU|1|||
160655465|NCT00979628|580118732|FG001|Overall Study|transferred to ICU|2|||
160655466|NCT00979628|580118733|FG002|Overall Study|transferred to ICU|1|||
160655467|NCT05905783|580118734|FG000|Overall Study|Lost to Follow-up|12|||
160655468|NCT05905783|580118735|FG001|Overall Study|Lost to Follow-up|18|||
160655469|NCT05905783|580118734|FG000|Overall Study|Withdrawal by Subject|29|||
160655470|NCT05905783|580118735|FG001|Overall Study|Withdrawal by Subject|37|||
160655471|NCT05905783|580118734|FG000|Overall Study|Decision by sponsor|69|||
160655472|NCT05905783|580118735|FG001|Overall Study|Decision by sponsor|65|||
160655473|NCT00911859|580118736|FG000|Treatment Period|Adverse Event|3|||
160655474|NCT00911859|580118737|FG001|Treatment Period|Adverse Event|3|||
160655475|NCT00911859|580118738|FG002|Treatment Period|Adverse Event|7|||
160655476|NCT00911859|580118736|FG000|Treatment Period|Death|1|||
160655477|NCT00911859|580118737|FG001|Treatment Period|Death|3|||
160655478|NCT00911859|580118738|FG002|Treatment Period|Death|5|||
160655479|NCT00911859|580118736|FG000|Treatment Period|Lack of Efficacy|1|||
160655480|NCT00911859|580118737|FG001|Treatment Period|Lack of Efficacy|7|||
160655481|NCT00911859|580118738|FG002|Treatment Period|Lack of Efficacy|5|||
160655482|NCT00911859|580118736|FG000|Treatment Period|Physician Decision|3|||
160655483|NCT00911859|580118737|FG001|Treatment Period|Physician Decision|3|||
160655484|NCT00911859|580118738|FG002|Treatment Period|Physician Decision|3|||
160655485|NCT00911859|580118736|FG000|Treatment Period|Withdrawal by Subject|0|||
160655486|NCT00911859|580118737|FG001|Treatment Period|Withdrawal by Subject|4|||
160655487|NCT00911859|580118738|FG002|Treatment Period|Withdrawal by Subject|5|||
160655488|NCT00911859|580118736|FG000|Treatment Period|Did not receive study treatment|0|||
160655489|NCT00911859|580118737|FG001|Treatment Period|Did not receive study treatment|1|||
160655490|NCT00911859|580118738|FG002|Treatment Period|Did not receive study treatment|0|||
160655491|NCT00911859|580118736|FG000|Maintainance Period|Lack of Efficacy|0|||
160655492|NCT00911859|580118737|FG001|Maintainance Period|Lack of Efficacy|0|||
160655493|NCT00911859|580118738|FG002|Maintainance Period|Lack of Efficacy|9|||
160655494|NCT00911859|580118736|FG000|Maintainance Period|Physician Decision|0|||
160655495|NCT00911859|580118737|FG001|Maintainance Period|Physician Decision|0|||
160655496|NCT00911859|580118738|FG002|Maintainance Period|Physician Decision|9|||
160655497|NCT00911859|580118736|FG000|Maintainance Period|Withdrawal by Subject|0|||
160655498|NCT00911859|580118737|FG001|Maintainance Period|Withdrawal by Subject|0|||
160632817|NCT04101721|580036083|FG000|Overall Study|Lost to Follow-up|0|||
160655499|NCT00911859|580118738|FG002|Maintainance Period|Withdrawal by Subject|3|||
160655500|NCT00911859|580118736|FG000|Follow-up Period|Death|5|||
160655501|NCT00911859|580118737|FG001|Follow-up Period|Death|8|||
160655502|NCT00911859|580118738|FG002|Follow-up Period|Death|10|||
160655503|NCT00911859|580118736|FG000|Follow-up Period|Lost to Follow-up|1|||
160655504|NCT00911859|580118737|FG001|Follow-up Period|Lost to Follow-up|1|||
160632818|NCT04101721|580036084|FG001|Overall Study|Lost to Follow-up|3|||
160655505|NCT00911859|580118738|FG002|Follow-up Period|Lost to Follow-up|0|||
160655506|NCT00911859|580118736|FG000|Follow-up Period|Withdrawal by Subject|0|||
160655507|NCT00911859|580118737|FG001|Follow-up Period|Withdrawal by Subject|4|||
160655508|NCT00911859|580118738|FG002|Follow-up Period|Withdrawal by Subject|4|||
160632819|NCT01215955|580036085|FG000|Overall Study|Adverse Event|1|||
160577613|NCT01850563|579836234|FG000|Overall Study|Not eligible|3|||
160577614|NCT01850563|579836235|FG001|Overall Study|Not eligible|0|||
160577615|NCT04359823|579836236|FG000|Overall Study|Lost to Follow-up|0|||
160577616|NCT04359823|579836237|FG001|Overall Study|Lost to Follow-up|1|||
160577617|NCT04359823|579836236|FG000|Overall Study|Withdrawal by Subject|0|||
160577618|NCT04359823|579836237|FG001|Overall Study|Withdrawal by Subject|1|||
160577619|NCT03132805|579836238|FG000|Overall Study|Lost to Follow-up|142|||
160577620|NCT03132805|579836239|FG001|Overall Study|Lost to Follow-up|141|||
160577621|NCT03132805|579836240|FG002|Overall Study|Lost to Follow-up|113|||
160577622|NCT03151148|579836243|FG000|Overall Study|Lost to Follow-up|1|||
160577623|NCT03151148|579836244|FG001|Overall Study|Lost to Follow-up|0|||
160577624|NCT03151148|579836243|FG000|Overall Study|Withdrawal by Subject|1|||
160577625|NCT03151148|579836244|FG001|Overall Study|Withdrawal by Subject|0|||
160577626|NCT02115815|579836245|FG000|Overall Study|Withdrawal by Subject|2|||
160577627|NCT02115815|579836246|FG001|Overall Study|Withdrawal by Subject|0|||
160577628|NCT02115815|579836247|FG002|Overall Study|Withdrawal by Subject|0|||
160577629|NCT02115815|579836248|FG003|Overall Study|Withdrawal by Subject|0|||
160577630|NCT02115815|579836249|FG004|Overall Study|Withdrawal by Subject|0|||
160577631|NCT02115815|579836250|FG005|Overall Study|Withdrawal by Subject|0|||
160577632|NCT02115815|579836251|FG006|Overall Study|Withdrawal by Subject|0|||
160577633|NCT02115815|579836245|FG000|Overall Study|Not enough drug to dose participant|0|||
160577634|NCT02115815|579836246|FG001|Overall Study|Not enough drug to dose participant|0|||
160577635|NCT02115815|579836247|FG002|Overall Study|Not enough drug to dose participant|0|||
160577636|NCT02115815|579836248|FG003|Overall Study|Not enough drug to dose participant|0|||
160577637|NCT02115815|579836249|FG004|Overall Study|Not enough drug to dose participant|0|||
160577638|NCT02115815|579836250|FG005|Overall Study|Not enough drug to dose participant|1|||
160577639|NCT02115815|579836251|FG006|Overall Study|Not enough drug to dose participant|0|||
160577640|NCT02115815|579836245|FG000|Overall Study|Missed appointment, randomized in error|0|||
160577641|NCT02115815|579836246|FG001|Overall Study|Missed appointment, randomized in error|0|||
160577642|NCT02115815|579836247|FG002|Overall Study|Missed appointment, randomized in error|0|||
160577643|NCT02115815|579836248|FG003|Overall Study|Missed appointment, randomized in error|0|||
160577644|NCT02115815|579836249|FG004|Overall Study|Missed appointment, randomized in error|0|||
160577645|NCT02115815|579836250|FG005|Overall Study|Missed appointment, randomized in error|1|||
160577646|NCT02115815|579836251|FG006|Overall Study|Missed appointment, randomized in error|0|||
160577647|NCT01228071|579836252|FG000|Overall Study|Protocol Violation|1|||
160577648|NCT01228071|579836252|FG000|Overall Study|Withdrawal by Subject|1|||
160577649|NCT01989546|579836253|FG000|Overall Study|Clinical Progression|1|||
160577650|NCT01989546|579836253|FG000|Overall Study|Disease progression on study|8|||
160577651|NCT00059215|579836257|FG000|Overall Study|Adverse Event|5|||
160577652|NCT00059215|579836258|FG001|Overall Study|Adverse Event|5|||
160577653|NCT00059215|579836259|FG002|Overall Study|Adverse Event|9|||
160577654|NCT00059215|579836260|FG003|Overall Study|Adverse Event|9|||
160577655|NCT00059215|579836257|FG000|Overall Study|Death|0|||
160577656|NCT00059215|579836258|FG001|Overall Study|Death|0|||
160577657|NCT00059215|579836259|FG002|Overall Study|Death|3|||
160577658|NCT00059215|579836260|FG003|Overall Study|Death|0|||
160577659|NCT00059215|579836257|FG000|Overall Study|Lost to Follow-up|1|||
160577660|NCT00059215|579836258|FG001|Overall Study|Lost to Follow-up|2|||
160577661|NCT00059215|579836259|FG002|Overall Study|Lost to Follow-up|0|||
160577662|NCT00059215|579836260|FG003|Overall Study|Lost to Follow-up|0|||
160577663|NCT00059215|579836257|FG000|Overall Study|Withdrawal by Subject|4|||
160577664|NCT00059215|579836258|FG001|Overall Study|Withdrawal by Subject|4|||
160577665|NCT00059215|579836259|FG002|Overall Study|Withdrawal by Subject|1|||
160577666|NCT00059215|579836260|FG003|Overall Study|Withdrawal by Subject|3|||
160577667|NCT00059215|579836257|FG000|Overall Study|Protocol Violation|1|||
160577668|NCT00059215|579836258|FG001|Overall Study|Protocol Violation|0|||
160577669|NCT00059215|579836259|FG002|Overall Study|Protocol Violation|1|||
160577670|NCT00059215|579836260|FG003|Overall Study|Protocol Violation|0|||
160577671|NCT00059215|579836257|FG000|Overall Study|Protocol entry criteria not met|1|||
160577672|NCT00059215|579836258|FG001|Overall Study|Protocol entry criteria not met|1|||
160577673|NCT00059215|579836259|FG002|Overall Study|Protocol entry criteria not met|0|||
160577674|NCT00059215|579836260|FG003|Overall Study|Protocol entry criteria not met|2|||
160577675|NCT00059215|579836257|FG000|Overall Study|Physician Decision|1|||
160577676|NCT00059215|579836258|FG001|Overall Study|Physician Decision|2|||
160577677|NCT00059215|579836259|FG002|Overall Study|Physician Decision|1|||
160577678|NCT00059215|579836260|FG003|Overall Study|Physician Decision|1|||
160577679|NCT04439838|579836261|FG000|Overall Study|Withdrawal by Subject|0|||
160577680|NCT04439838|579836262|FG001|Overall Study|Withdrawal by Subject|0|||
160577681|NCT04439838|579836263|FG002|Overall Study|Withdrawal by Subject|0|||
160577682|NCT04439838|579836264|FG003|Overall Study|Withdrawal by Subject|0|||
160577683|NCT04439838|579836265|FG004|Overall Study|Withdrawal by Subject|0|||
160577684|NCT04439838|579836266|FG005|Overall Study|Withdrawal by Subject|0|||
160577685|NCT04439838|579836267|FG006|Overall Study|Withdrawal by Subject|0|||
160577686|NCT04439838|579836268|FG007|Overall Study|Withdrawal by Subject|0|||
160577687|NCT04439838|579836269|FG008|Overall Study|Withdrawal by Subject|1|||
160577688|NCT04494633|579836274|FG000|Overall Study|Lost to Follow-up|5|||
160655509|NCT00911859|580118736|FG000|Follow-up Period|Study terminated by sponsor|5|||
160655510|NCT00911859|580118737|FG001|Follow-up Period|Study terminated by sponsor|33|||
160577689|NCT04494633|579836275|FG001|Overall Study|Lost to Follow-up|3|||
160577690|NCT04494633|579836274|FG000|Overall Study|Protocol Violation|1|||
160577691|NCT04494633|579836275|FG001|Overall Study|Protocol Violation|1|||
160577692|NCT01254604|579836278|FG000|Overall Study|Lost to Follow-up|1|||
160655511|NCT00911859|580118738|FG002|Follow-up Period|Study terminated by sponsor|27|||
160655512|NCT03008460|580118743|FG000|Overall Study|Protocol deviation|0|||
160655513|NCT03008460|580118744|FG001|Overall Study|Protocol deviation|2|||
160655514|NCT03008460|580118743|FG000|Overall Study|Study drug not dispensed|0|||
160655515|NCT03008460|580118744|FG001|Overall Study|Study drug not dispensed|1|||
160655516|NCT03008460|580118743|FG000|Overall Study|Adverse Event|0|||
160655517|NCT03008460|580118744|FG001|Overall Study|Adverse Event|1|||
160655518|NCT03008460|580118743|FG000|Overall Study|Withdrawal by Subject|5|||
160655519|NCT03008460|580118744|FG001|Overall Study|Withdrawal by Subject|6|||
160655520|NCT03008460|580118743|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
160655521|NCT03008460|580118744|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
160655522|NCT03008460|580118743|FG000|Overall Study|End of study visit outside permitted time window|0|||
160655523|NCT03008460|580118744|FG001|Overall Study|End of study visit outside permitted time window|1|||
160655524|NCT03008460|580118743|FG000|Overall Study|Lost to Follow-up|1|||
160655525|NCT03008460|580118744|FG001|Overall Study|Lost to Follow-up|3|||
160655526|NCT00634179|580118748|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
160655527|NCT04947579|580118749|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
160655528|NCT04947579|580118750|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
160655529|NCT04947579|580118751|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
160655530|NCT04947579|580118752|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
160655531|NCT04947579|580118753|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
160655532|NCT04947579|580118754|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
160655533|NCT04947579|580118749|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
160655534|NCT04947579|580118750|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
160655535|NCT04947579|580118751|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
160655536|NCT04947579|580118752|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
160655537|NCT04947579|580118753|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
160655538|NCT04947579|580118754|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
160655539|NCT04947579|580118749|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
160655540|NCT04947579|580118750|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
160655541|NCT04947579|580118751|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
160655542|NCT04947579|580118752|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
160655543|NCT04947579|580118753|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
160655544|NCT04947579|580118754|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
160655545|NCT04947579|580118749|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
160655546|NCT04947579|580118750|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
160655547|NCT04947579|580118751|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
160655548|NCT04947579|580118752|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
160655549|NCT04947579|580118753|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
160655550|NCT04947579|580118754|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
160655551|NCT04947579|580118749|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
160655552|NCT04947579|580118750|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
160655553|NCT04947579|580118751|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
160655554|NCT04947579|580118752|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
160655555|NCT04947579|580118753|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
160655556|NCT04947579|580118754|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
160655557|NCT04947579|580118749|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
160655558|NCT04947579|580118750|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
160655559|NCT04947579|580118751|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
160655560|NCT04947579|580118752|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
160655561|NCT04947579|580118753|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
160655562|NCT04947579|580118754|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
160655563|NCT04947579|580118749|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
160655564|NCT04947579|580118750|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
160655565|NCT04947579|580118751|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
160655566|NCT04947579|580118752|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
160577693|NCT01254604|579836279|FG001|Overall Study|Lost to Follow-up|1|||
160577694|NCT01254604|579836278|FG000|Overall Study|Protocol Violation|2|||
160577695|NCT01254604|579836279|FG001|Overall Study|Protocol Violation|2|||
160655567|NCT04947579|580118753|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
160655568|NCT04947579|580118754|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
160577696|NCT01254604|579836278|FG000|Overall Study|Withdrawal by Subject|2|||
160577697|NCT01254604|579836279|FG001|Overall Study|Withdrawal by Subject|4|||
160577698|NCT01254604|579836278|FG000|Overall Study|Adverse Event|3|||
160577699|NCT01254604|579836279|FG001|Overall Study|Adverse Event|2|||
160577700|NCT03074162|579836280|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
160577701|NCT03074162|579836281|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
160577702|NCT03074162|579836282|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
160577703|NCT03074162|579836283|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
160577704|NCT03074162|579836284|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
160577705|NCT03074162|579836285|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
160577706|NCT03074162|579836280|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
160577707|NCT03074162|579836281|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
160577708|NCT03074162|579836282|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
160577709|NCT03074162|579836283|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
160577710|NCT03074162|579836284|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
160577711|NCT03074162|579836285|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
160577712|NCT03074162|579836280|FG000|Period 3|Withdrawal by Subject|1|||
160577713|NCT03074162|579836281|FG001|Period 3|Withdrawal by Subject|0|||
160577714|NCT03074162|579836282|FG002|Period 3|Withdrawal by Subject|0|||
160577715|NCT03074162|579836283|FG003|Period 3|Withdrawal by Subject|0|||
160577716|NCT03074162|579836284|FG004|Period 3|Withdrawal by Subject|1|||
160577717|NCT03074162|579836285|FG005|Period 3|Withdrawal by Subject|0|||
160577718|NCT01958671|579836286|FG000|Overall Study|Adverse Event|1|||
160577719|NCT01958671|579836287|FG001|Overall Study|Adverse Event|1|||
160577720|NCT01958671|579836288|FG002|Overall Study|Adverse Event|5|||
160577721|NCT01958671|579836286|FG000|Overall Study|Death|1|||
160577722|NCT01958671|579836287|FG001|Overall Study|Death|0|||
160577723|NCT01958671|579836288|FG002|Overall Study|Death|0|||
160577724|NCT01958671|579836286|FG000|Overall Study|Excluded medication|0|||
160577725|NCT01958671|579836287|FG001|Overall Study|Excluded medication|0|||
160577726|NCT01958671|579836288|FG002|Overall Study|Excluded medication|1|||
160577727|NCT01958671|579836286|FG000|Overall Study|Hyperglycemia|0|||
160577728|NCT01958671|579836287|FG001|Overall Study|Hyperglycemia|0|||
160577729|NCT01958671|579836288|FG002|Overall Study|Hyperglycemia|2|||
160577730|NCT01958671|579836286|FG000|Overall Study|Lost to Follow-up|7|||
160577731|NCT01958671|579836287|FG001|Overall Study|Lost to Follow-up|11|||
160577732|NCT01958671|579836288|FG002|Overall Study|Lost to Follow-up|7|||
160577733|NCT01958671|579836286|FG000|Overall Study|Non-compliance with study drug|1|||
160577734|NCT01958671|579836287|FG001|Overall Study|Non-compliance with study drug|1|||
160577735|NCT01958671|579836288|FG002|Overall Study|Non-compliance with study drug|1|||
160577736|NCT01958671|579836286|FG000|Overall Study|Pregnancy|0|||
160577737|NCT01958671|579836287|FG001|Overall Study|Pregnancy|0|||
160577738|NCT01958671|579836288|FG002|Overall Study|Pregnancy|1|||
160577739|NCT01958671|579836286|FG000|Overall Study|Protocol Violation|0|||
160577740|NCT01958671|579836287|FG001|Overall Study|Protocol Violation|1|||
160577741|NCT01958671|579836288|FG002|Overall Study|Protocol Violation|0|||
160577742|NCT01958671|579836286|FG000|Overall Study|Study site terminated by sponsor|1|||
160577743|NCT01958671|579836287|FG001|Overall Study|Study site terminated by sponsor|0|||
160577744|NCT01958671|579836288|FG002|Overall Study|Study site terminated by sponsor|1|||
160577745|NCT01958671|579836286|FG000|Overall Study|Participant moved|0|||
160577746|NCT01958671|579836287|FG001|Overall Study|Participant moved|0|||
160577747|NCT01958671|579836288|FG002|Overall Study|Participant moved|1|||
160577748|NCT01958671|579836286|FG000|Overall Study|Withdrawal by Subject|8|||
160577749|NCT01958671|579836287|FG001|Overall Study|Withdrawal by Subject|10|||
160577750|NCT01958671|579836288|FG002|Overall Study|Withdrawal by Subject|13|||
160577751|NCT02948777|579836289|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
160577752|NCT03952468|579836296|FG000|Overall Study|Death|0|||
160577753|NCT03952468|579836297|FG001|Overall Study|Death|1|||
160577754|NCT03952468|579836296|FG000|Overall Study|Adverse Event|0|||
160577755|NCT03952468|579836297|FG001|Overall Study|Adverse Event|1|||
160577756|NCT03952468|579836296|FG000|Overall Study|Physician Decision|1|||
160577757|NCT03952468|579836297|FG001|Overall Study|Physician Decision|0|||
160577758|NCT03952468|579836296|FG000|Overall Study|Lost to Follow-up|3|||
160577759|NCT03952468|579836297|FG001|Overall Study|Lost to Follow-up|4|||
160577760|NCT03952468|579836296|FG000|Overall Study|Withdrawal by Subject|2|||
160577761|NCT03952468|579836297|FG001|Overall Study|Withdrawal by Subject|1|||
160577762|NCT01505491|579836300|FG000|Overall Study|Other reason not listed|1|||
160577763|NCT01505491|579836301|FG001|Overall Study|Other reason not listed|0|||
160577764|NCT01505491|579836302|FG002|Overall Study|Other reason not listed|0|||
160577765|NCT01505491|579836300|FG000|Overall Study|Withdrawal by Subject|1|||
160577766|NCT01505491|579836301|FG001|Overall Study|Withdrawal by Subject|1|||
160577767|NCT01505491|579836302|FG002|Overall Study|Withdrawal by Subject|4|||
160577768|NCT01505491|579836300|FG000|Overall Study|Lost to Follow-up|0|||
160577769|NCT01505491|579836301|FG001|Overall Study|Lost to Follow-up|0|||
160577770|NCT01505491|579836302|FG002|Overall Study|Lost to Follow-up|1|||
160577771|NCT03350750|579836304|FG000|Overall Study|Death|1|||
160577772|NCT03350750|579836305|FG001|Overall Study|Death|1|||
160577773|NCT00406315|579836308|FG000|Overall Study|Death|1|||
160998034|NCT00241644|581378526|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
160577774|NCT00406315|579836308|FG000|Overall Study|Adverse Event|39|||
160577775|NCT00406315|579836308|FG000|Overall Study|Laboratory Abnormality|4|||
160577776|NCT00406315|579836308|FG000|Overall Study|Lack of Efficacy|13|||
160577777|NCT00406315|579836308|FG000|Overall Study|Other|33|||
160577778|NCT00406315|579836308|FG000|Overall Study|Lost to Follow-up|21|||
160577779|NCT00406315|579836308|FG000|Overall Study|Withdrawal by Subject|30|||
160577780|NCT01797783|579836311|FG000|Overall Study|Adverse Event|1|||
160577781|NCT01797783|579836312|FG001|Overall Study|Adverse Event|1|||
160577782|NCT01797783|579836311|FG000|Overall Study|Withdrawal by Subject|1|||
160577783|NCT01797783|579836312|FG001|Overall Study|Withdrawal by Subject|0|||
160577784|NCT02202031|579836314|FG000|Overall Study|Lost to Follow-up|1|||
160577785|NCT02202031|579836315|FG001|Overall Study|Lost to Follow-up|0|||
160577786|NCT02202031|579836314|FG000|Overall Study|Too Busy|1|||
160577787|NCT02202031|579836315|FG001|Overall Study|Too Busy|3|||
160577788|NCT02202031|579836314|FG000|Overall Study|Illness/Medical Reason|0|||
160577789|NCT02202031|579836315|FG001|Overall Study|Illness/Medical Reason|2|||
160577790|NCT02202031|579836314|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
160577791|NCT02202031|579836315|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
160577792|NCT02184143|579836316|FG000|Overall Study|Withdrawal by Subject|4|||
160577793|NCT02184143|579836317|FG001|Overall Study|Withdrawal by Subject|4|||
160577794|NCT02184143|579836316|FG000|Overall Study|Lost to Follow-up|5|||
160577795|NCT02184143|579836317|FG001|Overall Study|Lost to Follow-up|3|||
160577796|NCT02184143|579836316|FG000|Overall Study|Death|1|||
160577797|NCT02184143|579836317|FG001|Overall Study|Death|0|||
160577798|NCT00321984|579836319|FG000|Overall Study|Adverse Event|9|||
160577799|NCT00321984|579836320|FG001|Overall Study|Adverse Event|6|||
160577800|NCT00321984|579836321|FG002|Overall Study|Adverse Event|8|||
160577801|NCT00321984|579836319|FG000|Overall Study|Protocol Violation|0|||
160577802|NCT00321984|579836320|FG001|Overall Study|Protocol Violation|1|||
160577803|NCT00321984|579836321|FG002|Overall Study|Protocol Violation|1|||
160577804|NCT00321984|579836319|FG000|Overall Study|Lost to Follow-up|2|||
160577805|NCT00321984|579836320|FG001|Overall Study|Lost to Follow-up|4|||
160577806|NCT00321984|579836321|FG002|Overall Study|Lost to Follow-up|2|||
160577807|NCT00321984|579836319|FG000|Overall Study|Withdrawal by Subject|8|||
160577808|NCT00321984|579836320|FG001|Overall Study|Withdrawal by Subject|6|||
160577809|NCT00321984|579836321|FG002|Overall Study|Withdrawal by Subject|5|||
160577810|NCT00321984|579836319|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
160577811|NCT00321984|579836320|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
160577812|NCT00321984|579836321|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
160577813|NCT00321984|579836319|FG000|Overall Study|Lack of Efficacy|3|||
160577814|NCT00321984|579836320|FG001|Overall Study|Lack of Efficacy|1|||
160577815|NCT00321984|579836321|FG002|Overall Study|Lack of Efficacy|3|||
160577816|NCT00321984|579836319|FG000|Overall Study|Noncompliant|0|||
160577817|NCT00321984|579836320|FG001|Overall Study|Noncompliant|0|||
160577818|NCT00321984|579836321|FG002|Overall Study|Noncompliant|2|||
160577819|NCT00321984|579836319|FG000|Overall Study|Pregnancy|0|||
160577820|NCT00321984|579836320|FG001|Overall Study|Pregnancy|1|||
160577821|NCT00321984|579836321|FG002|Overall Study|Pregnancy|0|||
160577822|NCT00321984|579836319|FG000|Overall Study|Per Subject Request|1|||
160577823|NCT00321984|579836320|FG001|Overall Study|Per Subject Request|0|||
160577824|NCT00321984|579836321|FG002|Overall Study|Per Subject Request|0|||
160577825|NCT00321984|579836319|FG000|Overall Study|Per Investigator Request|1|||
160577826|NCT00321984|579836320|FG001|Overall Study|Per Investigator Request|0|||
160577827|NCT00321984|579836321|FG002|Overall Study|Per Investigator Request|0|||
160577828|NCT00321984|579836319|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
160577829|NCT00321984|579836320|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
160577830|NCT00321984|579836321|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
160577831|NCT02214186|579836324|FG000|Overall Study|Lost to Follow-up|1|||
160577832|NCT02214186|579836325|FG001|Overall Study|Lost to Follow-up|1|||
160577833|NCT02214186|579836324|FG000|Overall Study|Protocol Violation|1|||
160577834|NCT02214186|579836325|FG001|Overall Study|Protocol Violation|1|||
160577835|NCT01525849|579836326|FG000|Overall Study|Lost to Follow-up|3|||
160577836|NCT01525849|579836327|FG001|Overall Study|Lost to Follow-up|2|||
160577837|NCT01525849|579836326|FG000|Overall Study|Withdrawal by Subject|1|||
160577838|NCT01525849|579836327|FG001|Overall Study|Withdrawal by Subject|9|||
160577839|NCT01525849|579836326|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
160577840|NCT01525849|579836327|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
160577841|NCT01525849|579836326|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
160577842|NCT01525849|579836327|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
160577843|NCT01302769|579836328|FG000|Overall Study|Lost to Follow-up|1|||
160577844|NCT01302769|579836329|FG001|Overall Study|Lost to Follow-up|1|||
160577845|NCT01024465|579836330|FG000|Overall Study|Adverse Event|2|||
160577846|NCT01024465|579836330|FG000|Overall Study|Physician Decision|1|||
160577847|NCT03078608|579836334|FG000|Overall Study|Death|1|||
160577848|NCT03078608|579836335|FG001|Overall Study|Death|2|||
160577849|NCT03078608|579836336|FG002|Overall Study|Death|0|||
160577850|NCT03078608|579836337|FG003|Overall Study|Death|0|||
160655569|NCT04947579|580118749|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
160655570|NCT04947579|580118750|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
160655571|NCT04947579|580118751|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
160655572|NCT04947579|580118752|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
160655573|NCT04947579|580118753|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
160655574|NCT04947579|580118754|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
160655575|NCT04947579|580118749|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
160655576|NCT04947579|580118750|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
160655577|NCT04947579|580118751|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
160655578|NCT04947579|580118752|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
160655579|NCT04947579|580118753|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
160655580|NCT04947579|580118754|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
160655581|NCT04947579|580118749|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
160655582|NCT04947579|580118750|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
160655583|NCT04947579|580118751|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
160655584|NCT04947579|580118752|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
160655585|NCT04947579|580118753|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
160655586|NCT04947579|580118754|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
160655587|NCT04947579|580118749|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
160655588|NCT04947579|580118750|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
160655589|NCT04947579|580118751|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
160655590|NCT04947579|580118752|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
160655591|NCT04947579|580118753|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
160655592|NCT04947579|580118754|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
160655593|NCT00767325|580118755|FG000|Overall Study|Lack of Efficacy|2|||
160655594|NCT00767325|580118755|FG000|Overall Study|Adverse Event|7|||
160655595|NCT00767325|580118755|FG000|Overall Study|Lost to Follow-up|3|||
160655596|NCT00767325|580118755|FG000|Overall Study|No longer met study criteria|2|||
160655597|NCT00767325|580118755|FG000|Overall Study|Missed visit due to family reasons|1|||
160655598|NCT03538756|580118756|FG000|Long-Term Follow-up|Adverse Event|0|||
160655599|NCT03538756|580118757|FG001|Long-Term Follow-up|Adverse Event|0|||
160655600|NCT03538756|580118758|FG002|Long-Term Follow-up|Adverse Event|6|||
160655601|NCT03538756|580118756|FG000|Long-Term Follow-up|Death|0|||
160655602|NCT03538756|580118757|FG001|Long-Term Follow-up|Death|0|||
160655603|NCT03538756|580118758|FG002|Long-Term Follow-up|Death|1|||
160655604|NCT03538756|580118756|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
160655605|NCT03538756|580118757|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
160655606|NCT03538756|580118758|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
160655607|NCT03538756|580118756|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
160655608|NCT03538756|580118757|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
160655609|NCT03538756|580118758|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
160655610|NCT03538756|580118756|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
160655611|NCT03538756|580118757|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
160655612|NCT03538756|580118758|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
160655613|NCT00752856|580118759|FG000|Overall Study|randomized but did not do viral kinetics|0|||
160655614|NCT00752856|580118760|FG001|Overall Study|randomized but did not do viral kinetics|1|||
160655615|NCT02688608|580118761|FG000|Overall Study|Lost to Follow-up|1|||
160655616|NCT04529109|580118763|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
160655617|NCT04529109|580118764|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
160655618|NCT01508936|580118766|FG000|Overall Study|Adverse Event|11|||
160655619|NCT01508936|580118767|FG001|Overall Study|Adverse Event|32|||
160655620|NCT01508936|580118766|FG000|Overall Study|Lack of Efficacy|0|||
160655621|NCT01508936|580118767|FG001|Overall Study|Lack of Efficacy|1|||
160655622|NCT01508936|580118766|FG000|Overall Study|Withdrawal by Subject|4|||
160655623|NCT01508936|580118767|FG001|Overall Study|Withdrawal by Subject|18|||
160655624|NCT01508936|580118766|FG000|Overall Study|Protocol Violation|2|||
160655625|NCT01508936|580118767|FG001|Overall Study|Protocol Violation|3|||
160655626|NCT01508936|580118766|FG000|Overall Study|Lost to Follow-up|2|||
160655627|NCT01508936|580118767|FG001|Overall Study|Lost to Follow-up|9|||
160655628|NCT01508936|580118766|FG000|Overall Study|Other|0|||
160655629|NCT01508936|580118767|FG001|Overall Study|Other|5|||
160655630|NCT01508936|580118766|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
160655631|NCT01508936|580118767|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
160655632|NCT00679367|580118768|FG000|Overall Study|Adverse Event|7|||
160655633|NCT00679367|580118768|FG000|Overall Study|inability to swallow oral drugs|1|||
160655634|NCT00679367|580118768|FG000|Overall Study|Lack of Efficacy|3|||
160655635|NCT00679367|580118768|FG000|Overall Study|Withdrawal by Subject|1|||
160655636|NCT01611090|580118769|FG000|Randomized Period|Lost to Follow-up|8|||
160655637|NCT01611090|580118770|FG001|Randomized Period|Lost to Follow-up|3|||
160655638|NCT01611090|580118771|FG002|Randomized Period|Lost to Follow-up|0|||
160655639|NCT01611090|580118769|FG000|Randomized Period|Withdrawal by Subject|22|||
160454889|NCT01928394|579396188|FG018|Follow-up Period|other reason|1|||
160454890|NCT01928394|579396189|FG019|Follow-up Period|other reason|1|||
160454891|NCT01928394|579396190|FG020|Follow-up Period|other reason|0|||
160454892|NCT01928394|579396191|FG021|Follow-up Period|other reason|0|||
160454893|NCT01928394|579396192|FG022|Follow-up Period|other reason|1|||
160454894|NCT01928394|579396170|FG000|Follow-up Period|Lost to Follow-up|0|||
160454895|NCT01928394|579396171|FG001|Follow-up Period|Lost to Follow-up|0|||
160454896|NCT01928394|579396172|FG002|Follow-up Period|Lost to Follow-up|0|||
160454897|NCT01928394|579396173|FG003|Follow-up Period|Lost to Follow-up|0|||
160454898|NCT01928394|579396174|FG004|Follow-up Period|Lost to Follow-up|0|||
160454899|NCT01928394|579396175|FG005|Follow-up Period|Lost to Follow-up|0|||
160454900|NCT01928394|579396176|FG006|Follow-up Period|Lost to Follow-up|0|||
160454901|NCT01928394|579396177|FG007|Follow-up Period|Lost to Follow-up|0|||
160454902|NCT01928394|579396178|FG008|Follow-up Period|Lost to Follow-up|0|||
160454903|NCT01928394|579396179|FG009|Follow-up Period|Lost to Follow-up|0|||
160454904|NCT01928394|579396180|FG010|Follow-up Period|Lost to Follow-up|0|||
160454905|NCT01928394|579396181|FG011|Follow-up Period|Lost to Follow-up|1|||
160454906|NCT01928394|579396182|FG012|Follow-up Period|Lost to Follow-up|1|||
160454907|NCT01928394|579396183|FG013|Follow-up Period|Lost to Follow-up|0|||
160577851|NCT03078608|579836334|FG000|Overall Study|Withdrawal by Subject|8|||
160577852|NCT03078608|579836335|FG001|Overall Study|Withdrawal by Subject|1|||
160577853|NCT03078608|579836336|FG002|Overall Study|Withdrawal by Subject|0|||
160577854|NCT03078608|579836337|FG003|Overall Study|Withdrawal by Subject|0|||
160577855|NCT03078608|579836334|FG000|Overall Study|Lost to Follow-up|5|||
160577856|NCT03078608|579836335|FG001|Overall Study|Lost to Follow-up|8|||
160577857|NCT03078608|579836336|FG002|Overall Study|Lost to Follow-up|4|||
160577858|NCT03078608|579836337|FG003|Overall Study|Lost to Follow-up|1|||
160577859|NCT03694522|579836344|FG000|Overall Study|Withdrawal by Subject|8|||
160577860|NCT03694522|579836345|FG001|Overall Study|Withdrawal by Subject|10|||
160577861|NCT03694522|579836344|FG000|Overall Study|Physician Decision|53|||
160577862|NCT03694522|579836345|FG001|Overall Study|Physician Decision|54|||
160577863|NCT03694522|579836344|FG000|Overall Study|Other|1|||
160577864|NCT03694522|579836345|FG001|Overall Study|Other|1|||
160577865|NCT03694522|579836344|FG000|Overall Study|Lost to Follow-up|0|||
160577866|NCT03694522|579836345|FG001|Overall Study|Lost to Follow-up|1|||
160577867|NCT02760407|579836346|FG000|Overall Study|Death|2|||
160577868|NCT02760407|579836347|FG001|Overall Study|Death|3|||
160577869|NCT02760407|579836348|FG002|Overall Study|Death|1|||
160577870|NCT02760407|579836349|FG003|Overall Study|Death|1|||
160577871|NCT02760407|579836346|FG000|Overall Study|Lost to Follow-up|1|||
160577872|NCT02760407|579836347|FG001|Overall Study|Lost to Follow-up|7|||
160577873|NCT02760407|579836348|FG002|Overall Study|Lost to Follow-up|4|||
160577874|NCT02760407|579836349|FG003|Overall Study|Lost to Follow-up|6|||
160577875|NCT02760407|579836346|FG000|Overall Study|Withdrawal by Subject|25|||
160577876|NCT02760407|579836347|FG001|Overall Study|Withdrawal by Subject|31|||
160577877|NCT02760407|579836348|FG002|Overall Study|Withdrawal by Subject|37|||
160577878|NCT02760407|579836349|FG003|Overall Study|Withdrawal by Subject|25|||
160577879|NCT02760407|579836346|FG000|Overall Study|Violation of Eligibility criteria|0|||
160577880|NCT02760407|579836347|FG001|Overall Study|Violation of Eligibility criteria|0|||
160577881|NCT02760407|579836348|FG002|Overall Study|Violation of Eligibility criteria|1|||
160577882|NCT02760407|579836349|FG003|Overall Study|Violation of Eligibility criteria|1|||
160577883|NCT02760407|579836346|FG000|Overall Study|Personal reasons|0|||
160577884|NCT02760407|579836347|FG001|Overall Study|Personal reasons|0|||
160577885|NCT02760407|579836348|FG002|Overall Study|Personal reasons|0|||
160577886|NCT02760407|579836349|FG003|Overall Study|Personal reasons|1|||
160577887|NCT02760407|579836346|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
160577888|NCT02760407|579836347|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
160577889|NCT02760407|579836348|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
160577890|NCT02760407|579836349|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
160577891|NCT02760407|579836346|FG000|Overall Study|Use of prohibited Medication|0|||
160577892|NCT02760407|579836347|FG001|Overall Study|Use of prohibited Medication|0|||
160577893|NCT02760407|579836348|FG002|Overall Study|Use of prohibited Medication|1|||
160577894|NCT02760407|579836349|FG003|Overall Study|Use of prohibited Medication|0|||
160577895|NCT02760407|579836346|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
160577896|NCT02760407|579836347|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
160577897|NCT02760407|579836348|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
160577898|NCT02760407|579836349|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
160632820|NCT01215955|580036086|FG001|Overall Study|Adverse Event|4|||
160998035|NCT00241644|581378523|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
160454908|NCT01928394|579396184|FG014|Follow-up Period|Lost to Follow-up|1|||
160454909|NCT01928394|579396185|FG015|Follow-up Period|Lost to Follow-up|0|||
160454910|NCT01928394|579396186|FG016|Follow-up Period|Lost to Follow-up|1|||
160454911|NCT01928394|579396187|FG017|Follow-up Period|Lost to Follow-up|0|||
160454912|NCT01928394|579396188|FG018|Follow-up Period|Lost to Follow-up|0|||
160454913|NCT01928394|579396189|FG019|Follow-up Period|Lost to Follow-up|0|||
160655640|NCT01611090|580118770|FG001|Randomized Period|Withdrawal by Subject|26|||
160655641|NCT01611090|580118771|FG002|Randomized Period|Withdrawal by Subject|0|||
160655642|NCT01611090|580118769|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
160655643|NCT01611090|580118770|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
160655644|NCT01611090|580118771|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
160655645|NCT01611090|580118769|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
160655646|NCT01611090|580118770|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
160655647|NCT01611090|580118771|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
160655648|NCT00922779|580118772|FG000|Overall Study|Adverse Event|67|||
160655649|NCT00922779|580118772|FG000|Overall Study|Pregnancy|7|||
160655650|NCT00922779|580118772|FG000|Overall Study|Withdrawal by Subject|308|||
160655651|NCT00922779|580118772|FG000|Overall Study|Lost to Follow-up|44|||
160655652|NCT00922779|580118772|FG000|Overall Study|Other|27|||
160655653|NCT00922779|580118772|FG000|Overall Study|Missing|1874|||
160655654|NCT03968224|580118773|FG000|Overall Study|Lost to Follow-up|11|||
160655655|NCT03968224|580118774|FG001|Overall Study|Lost to Follow-up|18|||
160655656|NCT04256421|580118776|FG000|Overall Study|Death|171|||
160655657|NCT04256421|580118777|FG001|Overall Study|Death|180|||
160655658|NCT04256421|580118776|FG000|Overall Study|Lost to Follow-up|1|||
160655659|NCT04256421|580118777|FG001|Overall Study|Lost to Follow-up|1|||
160655660|NCT04256421|580118776|FG000|Overall Study|Withdrawal by Subject|9|||
160655661|NCT04256421|580118777|FG001|Overall Study|Withdrawal by Subject|10|||
160655662|NCT04256421|580118776|FG000|Overall Study|Ongoing in Study|66|||
160655663|NCT04256421|580118777|FG001|Overall Study|Ongoing in Study|52|||
160655664|NCT01210001|580120204|FG000|Overall Study|Not treated|1|||
160655665|NCT01210001|580120205|FG001|Overall Study|Not treated|0|||
160655666|NCT01210001|580120206|FG002|Overall Study|Not treated|0|||
160655667|NCT01210001|580120204|FG000|Overall Study|Adverse Event|4|||
160655668|NCT01210001|580120205|FG001|Overall Study|Adverse Event|2|||
160655669|NCT01210001|580120206|FG002|Overall Study|Adverse Event|5|||
160655670|NCT01210001|580120204|FG000|Overall Study|Non compliant with protocol|2|||
160655671|NCT01210001|580120205|FG001|Overall Study|Non compliant with protocol|2|||
160655672|NCT01210001|580120206|FG002|Overall Study|Non compliant with protocol|3|||
160655673|NCT01210001|580120204|FG000|Overall Study|Lost to Follow-up|4|||
160655674|NCT01210001|580120205|FG001|Overall Study|Lost to Follow-up|3|||
160655675|NCT01210001|580120206|FG002|Overall Study|Lost to Follow-up|2|||
160655676|NCT01210001|580120204|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
160655677|NCT01210001|580120205|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
160655678|NCT01210001|580120206|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
160655679|NCT01210001|580120204|FG000|Overall Study|Other reason not defined above|2|||
160655680|NCT01210001|580120205|FG001|Overall Study|Other reason not defined above|2|||
160655681|NCT01210001|580120206|FG002|Overall Study|Other reason not defined above|1|||
160655682|NCT00788125|580120207|FG000|Overall Study|Death|6|||
160655683|NCT01374919|580120217|FG000|Overall Study|Withdrawal by Subject|2|||
160655684|NCT02999178|580120218|FG000|Overall Study|Adverse Event|85|||
160655685|NCT02999178|580120219|FG001|Overall Study|Adverse Event|62|||
160655686|NCT02999178|580120218|FG000|Overall Study|Protocol Violation|1|||
160655687|NCT02999178|580120219|FG001|Overall Study|Protocol Violation|2|||
160655688|NCT02999178|580120218|FG000|Overall Study|Lost to Follow-up|0|||
160454914|NCT01928394|579396190|FG020|Follow-up Period|Lost to Follow-up|0|||
160454915|NCT01928394|579396191|FG021|Follow-up Period|Lost to Follow-up|0|||
160454916|NCT01928394|579396192|FG022|Follow-up Period|Lost to Follow-up|1|||
160454917|NCT04707625|579396193|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
160862055|NCT05138653|580887934|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160454919|NCT03209973|579396202|FG000|Overall Study|Withdrawal by Subject|7|||
160454920|NCT03209973|579396202|FG000|Overall Study|Lost to Follow-up|2|||
160454921|NCT03209973|579396202|FG000|Overall Study|Death|8|||
160454922|NCT03209973|579396202|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
160454923|NCT03209973|579396202|FG000|Overall Study|Sponsor Decision|18|||
160454924|NCT03209973|579396202|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
160454925|NCT03209973|579396202|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
160454926|NCT03987022|579396205|FG000|Overall Study|Lost to Follow-up|2|||
160655689|NCT02999178|580120219|FG001|Overall Study|Lost to Follow-up|2|||
160655690|NCT02999178|580120218|FG000|Overall Study|Withdrawal by Subject|21|||
160655691|NCT02999178|580120219|FG001|Overall Study|Withdrawal by Subject|21|||
160655692|NCT02999178|580120218|FG000|Overall Study|Other reason not defined above|7|||
160655693|NCT02999178|580120219|FG001|Overall Study|Other reason not defined above|13|||
160655694|NCT00630305|580120220|FG000|Overall Study|Withdrawal by Subject|1|||
160655695|NCT00630305|580120220|FG000|Overall Study|Inability to insert contact lens|1|||
160655696|NCT01085045|580120221|FG000|Part A|Withdrawal by Subject|4|||
160655697|NCT01085045|580120221|FG000|Part A|Adverse Event|6|||
160655698|NCT01085045|580120221|FG000|Part A|Protocol Violation|1|||
160655699|NCT01085045|580120221|FG000|Part A|Protocol Specified Criteria|7|||
160655700|NCT01085045|580120221|FG000|Part B|Withdrawal by Subject|2|||
160655701|NCT01085045|580120221|FG000|Part B|Protocol Specified Criteria|6|||
160655702|NCT01085045|580120221|FG000|Part B|Lost to Follow-up|1|||
160655703|NCT01085045|580120221|FG000|Part B|Adverse Event|6|||
160655704|NCT02924038|580120222|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
160655705|NCT02924038|580120223|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
160655706|NCT02473640|580120224|FG000|Treatment Period 1|Adverse Event|1|||
160655707|NCT02395822|580120225|FG000|Overall Study|Withdrawal by Subject|1|||
160655708|NCT02395822|580120225|FG000|Overall Study|Death|1|||
160655709|NCT04720664|580120228|FG000|Overall Study|Adverse Event|2|||
160655710|NCT04720664|580120228|FG000|Overall Study|Lack of Efficacy|9|||
160655711|NCT03311646|580120233|FG000|Overall Study|Physician Decision|1|||
160655712|NCT03311646|580120233|FG000|Overall Study|Withdrawal by Subject|5|||
160655713|NCT03311646|580120233|FG000|Overall Study|Lost to Follow-up|5|||
160655714|NCT03311646|580120233|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
160655715|NCT03103100|580120234|FG000|Overall Study|Adverse Event|1|||
160655716|NCT03103100|580120235|FG001|Overall Study|Adverse Event|0|||
160655717|NCT03103100|580120236|FG002|Overall Study|Adverse Event|0|||
160655718|NCT03103100|580120234|FG000|Overall Study|Physician Decision|1|||
160655719|NCT03103100|580120235|FG001|Overall Study|Physician Decision|0|||
160655720|NCT03103100|580120236|FG002|Overall Study|Physician Decision|2|||
160655721|NCT00531206|580120237|FG000|Overall Study|Adverse Event related|5|||
160655722|NCT00531206|580120237|FG000|Overall Study|Lack of Efficacy|2|||
160655723|NCT00531206|580120237|FG000|Overall Study|Lost to Follow-up|5|||
160655724|NCT00531206|580120237|FG000|Overall Study|including non-related adverse events|8|||
160655725|NCT00084084|580120252|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
160655726|NCT00084084|580120252|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
160655727|NCT01047345|580120253|FG000|Base Study|Adverse Event|3|||
160655728|NCT01047345|580120254|FG001|Base Study|Adverse Event|0|||
160655729|NCT01047345|580120255|FG002|Base Study|Adverse Event|0|||
160655730|NCT01047345|580120253|FG000|Base Study|Lost to Follow-up|4|||
160655731|NCT01047345|580120254|FG001|Base Study|Lost to Follow-up|1|||
160655732|NCT01047345|580120255|FG002|Base Study|Lost to Follow-up|0|||
160655733|NCT01047345|580120253|FG000|Base Study|Protocol Violation|3|||
160655734|NCT01047345|580120254|FG001|Base Study|Protocol Violation|1|||
160655735|NCT01047345|580120255|FG002|Base Study|Protocol Violation|0|||
160655736|NCT01047345|580120253|FG000|Base Study|Withdrawal by Subject|12|||
160655737|NCT01047345|580120254|FG001|Base Study|Withdrawal by Subject|4|||
160655738|NCT01047345|580120255|FG002|Base Study|Withdrawal by Subject|0|||
160655739|NCT01047345|580120253|FG000|Extension|Withdrawal by Subject|0|||
160655740|NCT01047345|580120254|FG001|Extension|Withdrawal by Subject|0|||
160655741|NCT01047345|580120255|FG002|Extension|Withdrawal by Subject|1|||
160655742|NCT01047345|580120253|FG000|Extension|Lost to Follow-up|0|||
160655743|NCT01047345|580120254|FG001|Extension|Lost to Follow-up|0|||
160655744|NCT01047345|580120255|FG002|Extension|Lost to Follow-up|5|||
160655745|NCT00454636|580120256|FG000|Overall Study|Adverse Event|10|||
160655746|NCT00454636|580120257|FG001|Overall Study|Adverse Event|6|||
160655747|NCT00454636|580120258|FG002|Overall Study|Adverse Event|9|||
160655748|NCT00454636|580120259|FG003|Overall Study|Adverse Event|15|||
160655749|NCT00454636|580120256|FG000|Overall Study|Disease Progression|11|||
160655750|NCT00454636|580120257|FG001|Overall Study|Disease Progression|12|||
160655751|NCT00454636|580120258|FG002|Overall Study|Disease Progression|4|||
160655752|NCT00454636|580120259|FG003|Overall Study|Disease Progression|11|||
160655753|NCT00454636|580120256|FG000|Overall Study|Protocol Violation|3|||
160655754|NCT00454636|580120257|FG001|Overall Study|Protocol Violation|2|||
160655755|NCT00454636|580120258|FG002|Overall Study|Protocol Violation|3|||
160655756|NCT00454636|580120259|FG003|Overall Study|Protocol Violation|3|||
160655757|NCT00454636|580120256|FG000|Overall Study|Death|6|||
160655758|NCT00454636|580120257|FG001|Overall Study|Death|1|||
160655759|NCT00454636|580120258|FG002|Overall Study|Death|1|||
160655760|NCT00454636|580120259|FG003|Overall Study|Death|1|||
160655761|NCT00454636|580120256|FG000|Overall Study|Patient refusal|1|||
160655762|NCT00454636|580120257|FG001|Overall Study|Patient refusal|1|||
160655763|NCT00454636|580120258|FG002|Overall Study|Patient refusal|3|||
160655764|NCT00454636|580120259|FG003|Overall Study|Patient refusal|2|||
160655765|NCT00454636|580120256|FG000|Overall Study|Lost to Follow-up|0|||
160655766|NCT00454636|580120257|FG001|Overall Study|Lost to Follow-up|1|||
160655767|NCT00454636|580120258|FG002|Overall Study|Lost to Follow-up|0|||
160655768|NCT00454636|580120259|FG003|Overall Study|Lost to Follow-up|0|||
160655769|NCT00806156|580120260|FG000|Overall Study|Death|35|||
160655770|NCT00806156|580120261|FG001|Overall Study|Death|95|||
160655771|NCT00806156|580120260|FG000|Overall Study|Did not meet eligibility criteria|1|||
160655772|NCT00806156|580120261|FG001|Overall Study|Did not meet eligibility criteria|0|||
160655773|NCT00806156|580120260|FG000|Overall Study|Study terminated by Sponsor|2|||
160655774|NCT00806156|580120261|FG001|Overall Study|Study terminated by Sponsor|40|||
160655775|NCT00806156|580120260|FG000|Overall Study|Consent withdrawn by subject|1|||
160655776|NCT00806156|580120261|FG001|Overall Study|Consent withdrawn by subject|3|||
160655777|NCT00806156|580120260|FG000|Overall Study|Lost to Follow-up|0|||
160655778|NCT00806156|580120261|FG001|Overall Study|Lost to Follow-up|1|||
160655779|NCT02899338|580120262|FG000|Overall Study|Adverse Event|1|||
160655780|NCT02899338|580120263|FG001|Overall Study|Adverse Event|2|||
160655781|NCT02899338|580120262|FG000|Overall Study|Withdrawal by Subject|2|||
160655782|NCT02899338|580120263|FG001|Overall Study|Withdrawal by Subject|0|||
160655783|NCT06179108|580120264|FG000|Overall Study|Withdrawal by Subject|16|||
160655784|NCT06179108|580120265|FG001|Overall Study|Withdrawal by Subject|19|||
160655785|NCT06179108|580120266|FG002|Overall Study|Withdrawal by Subject|10|||
160655786|NCT06179108|580120267|FG003|Overall Study|Withdrawal by Subject|11|||
160655787|NCT06179108|580120264|FG000|Overall Study|Lost to Follow-up|12|||
160655788|NCT06179108|580120265|FG001|Overall Study|Lost to Follow-up|4|||
160655789|NCT06179108|580120266|FG002|Overall Study|Lost to Follow-up|1|||
160655790|NCT06179108|580120267|FG003|Overall Study|Lost to Follow-up|9|||
160655791|NCT06179108|580120264|FG000|Overall Study|Adverse Event|2|||
160655792|NCT06179108|580120265|FG001|Overall Study|Adverse Event|3|||
160655793|NCT06179108|580120266|FG002|Overall Study|Adverse Event|3|||
160655794|NCT06179108|580120267|FG003|Overall Study|Adverse Event|2|||
160655795|NCT06179108|580120264|FG000|Overall Study|Protocol Violation|0|||
160655796|NCT06179108|580120265|FG001|Overall Study|Protocol Violation|1|||
160655797|NCT06179108|580120266|FG002|Overall Study|Protocol Violation|0|||
160655798|NCT06179108|580120267|FG003|Overall Study|Protocol Violation|1|||
160655799|NCT06179108|580120264|FG000|Overall Study|Physician Decision|1|||
160655800|NCT06179108|580120265|FG001|Overall Study|Physician Decision|1|||
160655801|NCT06179108|580120266|FG002|Overall Study|Physician Decision|0|||
160655802|NCT06179108|580120267|FG003|Overall Study|Physician Decision|0|||
160655803|NCT06179108|580120264|FG000|Overall Study|Lack of Efficacy|0|||
160655804|NCT06179108|580120265|FG001|Overall Study|Lack of Efficacy|0|||
160655805|NCT06179108|580120266|FG002|Overall Study|Lack of Efficacy|0|||
160655806|NCT06179108|580120267|FG003|Overall Study|Lack of Efficacy|1|||
160655807|NCT06179108|580120264|FG000|Overall Study|Death|0|||
160655808|NCT06179108|580120265|FG001|Overall Study|Death|0|||
160655809|NCT06179108|580120266|FG002|Overall Study|Death|0|||
160655810|NCT06179108|580120267|FG003|Overall Study|Death|1|||
160655811|NCT01370408|580120268|FG000|Overall Study|treatment failure|9|||
160655812|NCT02780687|580120272|FG000|Overall Study|Adverse Event|1|||
160655813|NCT02780687|580120273|FG001|Overall Study|Adverse Event|1|||
160655814|NCT02780687|580120272|FG000|Overall Study|Withdrawal by Subject|2|||
160655815|NCT02780687|580120273|FG001|Overall Study|Withdrawal by Subject|1|||
160655816|NCT02780687|580120272|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
160655817|NCT02780687|580120273|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
160655818|NCT02780687|580120272|FG000|Overall Study|progressive disease|29|||
160655819|NCT02780687|580120273|FG001|Overall Study|progressive disease|6|||
160655820|NCT05014412|580120274|FG000|Overall Study|Death|11|||
160655821|NCT05014412|580120275|FG001|Overall Study|Death|7|||
160655822|NCT05014412|580120276|FG002|Overall Study|Death|4|||
160926691|NCT00973479|581126549|FG001|Overall Study|Lack of Efficacy|7|||
160926692|NCT00973479|581126548|FG000|Overall Study|Adverse Event|12|||
160926693|NCT00973479|581126549|FG001|Overall Study|Adverse Event|32|||
160926694|NCT00973479|581126548|FG000|Overall Study|Protocol Violation|2|||
160926695|NCT00973479|581126549|FG001|Overall Study|Protocol Violation|2|||
160926696|NCT00973479|581126548|FG000|Overall Study|Other|1|||
160926697|NCT00973479|581126549|FG001|Overall Study|Other|7|||
160926698|NCT05075850|581126550|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
160926699|NCT04256785|581126551|FG000|Overall Study|Adverse Event|8|||
160926700|NCT04256785|581126552|FG001|Overall Study|Adverse Event|6|||
160926701|NCT04256785|581126551|FG000|Overall Study|Lack of Efficacy|3|||
160926702|NCT04256785|581126552|FG001|Overall Study|Lack of Efficacy|4|||
160926703|NCT04256785|581126551|FG000|Overall Study|Lost to Follow-up|7|||
160926704|NCT04256785|581126552|FG001|Overall Study|Lost to Follow-up|7|||
160926705|NCT04256785|581126551|FG000|Overall Study|Protocol Violation|1|||
160926706|NCT04256785|581126552|FG001|Overall Study|Protocol Violation|0|||
160926707|NCT04256785|581126551|FG000|Overall Study|Withdrawal by Subject|4|||
160926708|NCT04256785|581126552|FG001|Overall Study|Withdrawal by Subject|1|||
160926709|NCT04256785|581126551|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
160998036|NCT00241644|581378524|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
160655823|NCT05014412|580120277|FG003|Overall Study|Death|7|||
160655824|NCT05014412|580120274|FG000|Overall Study|Withdrawal by Subject|1|||
160655825|NCT05014412|580120275|FG001|Overall Study|Withdrawal by Subject|1|||
160655826|NCT05014412|580120276|FG002|Overall Study|Withdrawal by Subject|1|||
160655827|NCT05014412|580120277|FG003|Overall Study|Withdrawal by Subject|2|||
160655828|NCT05014412|580120274|FG000|Overall Study|Ongoing|21|||
160655829|NCT05014412|580120275|FG001|Overall Study|Ongoing|4|||
160655830|NCT05014412|580120276|FG002|Overall Study|Ongoing|6|||
160655831|NCT05014412|580120277|FG003|Overall Study|Ongoing|20|||
160655832|NCT02353169|580120278|FG000|Overall Study|QTc > 450 msec|1|||
160926710|NCT04256785|581126552|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
160926711|NCT00362115|581126553|FG000|Overall Study|Adverse Event|0|||
160926712|NCT00362115|581126554|FG001|Overall Study|Adverse Event|1|||
160655833|NCT02353169|580120279|FG001|Overall Study|QTc > 450 msec|1|||
160655834|NCT02353169|580120280|FG002|Overall Study|QTc > 450 msec|1|||
160655835|NCT02353169|580120281|FG003|Overall Study|QTc > 450 msec|1|||
160655836|NCT02353169|580120278|FG000|Overall Study|OR team declined|2|||
160926713|NCT00362115|581126555|FG002|Overall Study|Adverse Event|1|||
160926714|NCT00362115|581126556|FG003|Overall Study|Adverse Event|1|||
160926715|NCT00362115|581126557|FG004|Overall Study|Adverse Event|2|||
160926716|NCT00362115|581126558|FG005|Overall Study|Adverse Event|2|||
160926717|NCT00362115|581126559|FG006|Overall Study|Adverse Event|1|||
160926718|NCT00362115|581126553|FG000|Overall Study|Protocol Violation|0|||
160926719|NCT00362115|581126554|FG001|Overall Study|Protocol Violation|0|||
160926720|NCT00362115|581126555|FG002|Overall Study|Protocol Violation|0|||
160926721|NCT00362115|581126556|FG003|Overall Study|Protocol Violation|0|||
160926722|NCT00362115|581126557|FG004|Overall Study|Protocol Violation|0|||
160926723|NCT00362115|581126558|FG005|Overall Study|Protocol Violation|1|||
160926724|NCT00362115|581126559|FG006|Overall Study|Protocol Violation|0|||
160926725|NCT00362115|581126553|FG000|Overall Study|Lost to Follow-up|0|||
160926726|NCT00362115|581126554|FG001|Overall Study|Lost to Follow-up|1|||
160926727|NCT00362115|581126555|FG002|Overall Study|Lost to Follow-up|0|||
160926728|NCT00362115|581126556|FG003|Overall Study|Lost to Follow-up|0|||
160926729|NCT00362115|581126557|FG004|Overall Study|Lost to Follow-up|2|||
160926730|NCT00362115|581126558|FG005|Overall Study|Lost to Follow-up|0|||
160926731|NCT00362115|581126559|FG006|Overall Study|Lost to Follow-up|1|||
160926732|NCT00362115|581126553|FG000|Overall Study|Withdrawal by Subject|1|||
160926733|NCT00362115|581126554|FG001|Overall Study|Withdrawal by Subject|3|||
160926734|NCT00362115|581126555|FG002|Overall Study|Withdrawal by Subject|1|||
160926735|NCT00362115|581126556|FG003|Overall Study|Withdrawal by Subject|0|||
160926736|NCT00362115|581126557|FG004|Overall Study|Withdrawal by Subject|1|||
160926737|NCT00362115|581126558|FG005|Overall Study|Withdrawal by Subject|3|||
160926738|NCT00362115|581126559|FG006|Overall Study|Withdrawal by Subject|4|||
160926739|NCT00362115|581126553|FG000|Overall Study|Lack of Efficacy|1|||
160926740|NCT00362115|581126554|FG001|Overall Study|Lack of Efficacy|0|||
160926741|NCT00362115|581126555|FG002|Overall Study|Lack of Efficacy|5|||
160926742|NCT00362115|581126556|FG003|Overall Study|Lack of Efficacy|2|||
160926743|NCT00362115|581126557|FG004|Overall Study|Lack of Efficacy|2|||
160926744|NCT00362115|581126558|FG005|Overall Study|Lack of Efficacy|0|||
160926745|NCT00362115|581126559|FG006|Overall Study|Lack of Efficacy|3|||
160926746|NCT00362115|581126553|FG000|Overall Study|Physician Decision|0|||
160926747|NCT00362115|581126554|FG001|Overall Study|Physician Decision|0|||
160926748|NCT00362115|581126555|FG002|Overall Study|Physician Decision|0|||
160926749|NCT00362115|581126556|FG003|Overall Study|Physician Decision|0|||
160926750|NCT00362115|581126557|FG004|Overall Study|Physician Decision|0|||
160926751|NCT00362115|581126558|FG005|Overall Study|Physician Decision|0|||
160926752|NCT00362115|581126559|FG006|Overall Study|Physician Decision|3|||
160926753|NCT00362115|581126553|FG000|Overall Study|Other|0|||
160926754|NCT00362115|581126554|FG001|Overall Study|Other|1|||
160926755|NCT00362115|581126555|FG002|Overall Study|Other|0|||
160926756|NCT00362115|581126556|FG003|Overall Study|Other|1|||
160926757|NCT00362115|581126557|FG004|Overall Study|Other|0|||
160926758|NCT00362115|581126558|FG005|Overall Study|Other|1|||
160926759|NCT00362115|581126559|FG006|Overall Study|Other|0|||
160926760|NCT01170091|581126560|FG000|Overall Study|Missing efficacy evaluation|3|||
160926761|NCT01170091|581126560|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
160926762|NCT02188589|581126561|FG000|Overall Study|Withdrawal by Subject|5|||
160926763|NCT00003641|581126562|FG000|Overall Study|Withdrawal by Subject|0|||
160926764|NCT00003641|581126563|FG001|Overall Study|Withdrawal by Subject|100|||
160926765|NCT00003641|581126562|FG000|Overall Study|Adverse Event|0|||
160926766|NCT00003641|581126563|FG001|Overall Study|Adverse Event|38|||
160926767|NCT00003641|581126562|FG000|Overall Study|Disease progression|0|||
160926768|NCT00003641|581126563|FG001|Overall Study|Disease progression|2|||
160926769|NCT00003641|581126562|FG000|Overall Study|Unknown/missing|0|||
160926770|NCT00003641|581126563|FG001|Overall Study|Unknown/missing|22|||
160926771|NCT00003641|581126562|FG000|Overall Study|Should not receive interferon therapy|2|||
160926772|NCT00003641|581126563|FG001|Overall Study|Should not receive interferon therapy|0|||
160926773|NCT00003641|581126562|FG000|Overall Study|Never started interferon|567|||
160926774|NCT00003641|581126563|FG001|Overall Study|Never started interferon|12|||
160926775|NCT00741039|581126567|FG000|Overall Study|Patient non-compliance|2|||
160926776|NCT00741039|581126568|FG001|Overall Study|Patient non-compliance|0|||
160926777|NCT00878709|581126569|FG000|Overall Study|Withdrawal by Subject|197|||
160926778|NCT00878709|581126570|FG001|Overall Study|Withdrawal by Subject|120|||
160632821|NCT01215955|580036087|FG002|Overall Study|Adverse Event|2|||
160926779|NCT00878709|581126569|FG000|Overall Study|Lost to Follow-up|35|||
160926780|NCT00878709|581126570|FG001|Overall Study|Lost to Follow-up|33|||
160926781|NCT00878709|581126569|FG000|Overall Study|Other Reasons|93|||
160926782|NCT00878709|581126570|FG001|Overall Study|Other Reasons|84|||
160926783|NCT00768300|581126571|FG000|Overall Study|Randomized but not treated|1|||
160926784|NCT00768300|581126572|FG001|Overall Study|Randomized but not treated|1|||
160926785|NCT00768300|581126571|FG000|Overall Study|Adverse Event|10|||
160926786|NCT00768300|581126572|FG001|Overall Study|Adverse Event|2|||
160926787|NCT00768300|581126571|FG000|Overall Study|Protocol Violation|6|||
160926788|NCT00768300|581126572|FG001|Overall Study|Protocol Violation|1|||
160926789|NCT00768300|581126571|FG000|Overall Study|Withdrawal by Subject|13|||
160632822|NCT01215955|580036088|FG003|Overall Study|Adverse Event|3|||
160577899|NCT02760407|579836346|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
160577900|NCT02760407|579836347|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
160577901|NCT02760407|579836348|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
160577902|NCT02760407|579836349|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
160926790|NCT00768300|581126572|FG001|Overall Study|Withdrawal by Subject|7|||
160926791|NCT00768300|581126571|FG000|Overall Study|Physician Decision|2|||
160926792|NCT00768300|581126572|FG001|Overall Study|Physician Decision|3|||
160926793|NCT00768300|581126571|FG000|Overall Study|Study discontinued by Sponsor|271|||
160926794|NCT00768300|581126572|FG001|Overall Study|Study discontinued by Sponsor|140|||
160926795|NCT00768300|581126571|FG000|Overall Study|Death|21|||
160926796|NCT00768300|581126572|FG001|Overall Study|Death|5|||
160926797|NCT00768300|581126571|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
160926798|NCT00768300|581126572|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
160926799|NCT00768300|581126571|FG000|Overall Study|Screen failure following randomization|1|||
160926800|NCT00768300|581126572|FG001|Overall Study|Screen failure following randomization|0|||
160926801|NCT00768300|581126571|FG000|Overall Study|Received lung transplant|1|||
160926802|NCT00768300|581126572|FG001|Overall Study|Received lung transplant|1|||
160926803|NCT00768300|581126571|FG000|Overall Study|Lost to Follow-up|0|||
160926804|NCT00768300|581126572|FG001|Overall Study|Lost to Follow-up|1|||
160926805|NCT00768300|581126571|FG000|Overall Study|Began prohibited concomitant medication|0|||
160926806|NCT00768300|581126572|FG001|Overall Study|Began prohibited concomitant medication|1|||
160926807|NCT00768300|581126571|FG000|Overall Study|Treated but never dosed with Study drug|1|||
160926808|NCT00768300|581126572|FG001|Overall Study|Treated but never dosed with Study drug|0|||
160926809|NCT00768300|581126571|FG000|Overall Study|Missing data|1|||
160926810|NCT00768300|581126572|FG001|Overall Study|Missing data|0|||
160926811|NCT02068222|581126573|FG000|Overall Study|Lost to Follow-up|1|||
160926812|NCT01374087|581126576|FG000|Overall Study|Adverse Event|1|||
160926813|NCT01374087|581126577|FG001|Overall Study|Adverse Event|0|||
160926814|NCT01374087|581126576|FG000|Overall Study|Disease progression|2|||
160926815|NCT01374087|581126577|FG001|Overall Study|Disease progression|2|||
160926816|NCT01374087|581126576|FG000|Overall Study|Study discontinued|13|||
160926817|NCT01374087|581126577|FG001|Overall Study|Study discontinued|13|||
160926818|NCT03011307|581126578|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
160926819|NCT03011307|581126579|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
160926820|NCT03011307|581126578|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
160926821|NCT03011307|581126579|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
160926822|NCT03011307|581126578|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
160926823|NCT03011307|581126579|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
160926824|NCT04307446|581128137|FG000|Overall Study|Lost to Follow-up|2|||
160926825|NCT04307446|581128138|FG001|Overall Study|Lost to Follow-up|0|||
160926826|NCT02515942|581128139|FG000|Overall Study|Adverse Event|5|||
160926827|NCT02515942|581128140|FG001|Overall Study|Adverse Event|0|||
160926828|NCT02515942|581128141|FG002|Overall Study|Adverse Event|0|||
160926829|NCT02515942|581128139|FG000|Overall Study|Death|0|||
160926830|NCT02515942|581128140|FG001|Overall Study|Death|0|||
160926831|NCT02515942|581128141|FG002|Overall Study|Death|1|||
160926832|NCT02515942|581128139|FG000|Overall Study|Lack of Efficacy|0|||
160926833|NCT02515942|581128140|FG001|Overall Study|Lack of Efficacy|0|||
160926834|NCT02515942|581128141|FG002|Overall Study|Lack of Efficacy|1|||
160926835|NCT02515942|581128139|FG000|Overall Study|Lost to Follow-up|2|||
160926836|NCT02515942|581128140|FG001|Overall Study|Lost to Follow-up|0|||
160926837|NCT02515942|581128141|FG002|Overall Study|Lost to Follow-up|0|||
160926838|NCT02515942|581128139|FG000|Overall Study|Withdrawal by Subject|0|||
160926839|NCT02515942|581128140|FG001|Overall Study|Withdrawal by Subject|3|||
160926840|NCT02515942|581128141|FG002|Overall Study|Withdrawal by Subject|2|||
160577903|NCT02760407|579836346|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
160577904|NCT02760407|579836347|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
160655837|NCT02353169|580120279|FG001|Overall Study|OR team declined|0|||
160655838|NCT02353169|580120280|FG002|Overall Study|OR team declined|0|||
160655839|NCT02353169|580120281|FG003|Overall Study|OR team declined|0|||
160655840|NCT02353169|580120278|FG000|Overall Study|Inhalational induction|0|||
160655841|NCT02353169|580120279|FG001|Overall Study|Inhalational induction|2|||
160655842|NCT02353169|580120280|FG002|Overall Study|Inhalational induction|0|||
160655843|NCT02353169|580120281|FG003|Overall Study|Inhalational induction|0|||
160655844|NCT02353169|580120278|FG000|Overall Study|ECG data error|0|||
160655845|NCT02353169|580120279|FG001|Overall Study|ECG data error|3|||
160655846|NCT02353169|580120280|FG002|Overall Study|ECG data error|2|||
160655847|NCT02353169|580120281|FG003|Overall Study|ECG data error|2|||
160655848|NCT02353169|580120278|FG000|Overall Study|Pre-op medication|0|||
160655849|NCT02353169|580120279|FG001|Overall Study|Pre-op medication|0|||
160926841|NCT00902564|581128142|FG000|Overall Study|Withdrawal by Subject|2|||
160926842|NCT05620576|581128143|FG000|Overall Study|Adverse Event|1|||
160926843|NCT05620576|581128144|FG001|Overall Study|Adverse Event|1|||
160926844|NCT05620576|581128143|FG000|Overall Study|Lost to Follow-up|3|||
160926845|NCT05620576|581128144|FG001|Overall Study|Lost to Follow-up|1|||
160926846|NCT05620576|581128143|FG000|Overall Study|Physician Decision|0|||
160926847|NCT05620576|581128144|FG001|Overall Study|Physician Decision|1|||
160926848|NCT05620576|581128143|FG000|Overall Study|Protocol Deviation|1|||
160926849|NCT05620576|581128144|FG001|Overall Study|Protocol Deviation|1|||
160926850|NCT05620576|581128143|FG000|Overall Study|Withdrawal by Subject|2|||
160926851|NCT05620576|581128144|FG001|Overall Study|Withdrawal by Subject|3|||
160926852|NCT03336216|581128145|FG000|Randomization|Not reported|2|||
160926853|NCT03336216|581128146|FG001|Randomization|Not reported|0|||
160926854|NCT03336216|581128147|FG002|Randomization|Not reported|1|||
160926855|NCT03336216|581128148|FG003|Randomization|Not reported|0|||
160926856|NCT03336216|581128145|FG000|Randomization|Other reasons|1|||
160926857|NCT03336216|581128146|FG001|Randomization|Other reasons|1|||
160926858|NCT03336216|581128147|FG002|Randomization|Other reasons|1|||
160926859|NCT03336216|581128148|FG003|Randomization|Other reasons|0|||
160926860|NCT03336216|581128145|FG000|Randomization|Participant no longer meets study criteria|0|||
160926861|NCT03336216|581128146|FG001|Randomization|Participant no longer meets study criteria|2|||
160926862|NCT03336216|581128147|FG002|Randomization|Participant no longer meets study criteria|4|||
160926863|NCT03336216|581128148|FG003|Randomization|Participant no longer meets study criteria|1|||
160926864|NCT03336216|581128145|FG000|Randomization|Lost to Follow-up|1|||
160926865|NCT03336216|581128146|FG001|Randomization|Lost to Follow-up|0|||
160926866|NCT03336216|581128147|FG002|Randomization|Lost to Follow-up|0|||
160926867|NCT03336216|581128148|FG003|Randomization|Lost to Follow-up|0|||
160926868|NCT03336216|581128145|FG000|Randomization|Participant withdrew consent|9|||
160926869|NCT03336216|581128146|FG001|Randomization|Participant withdrew consent|1|||
160926870|NCT03336216|581128147|FG002|Randomization|Participant withdrew consent|0|||
160926871|NCT03336216|581128148|FG003|Randomization|Participant withdrew consent|0|||
160926872|NCT03336216|581128145|FG000|Randomization|Adverse Event|1|||
160926873|NCT03336216|581128146|FG001|Randomization|Adverse Event|1|||
160926874|NCT03336216|581128147|FG002|Randomization|Adverse Event|0|||
160926875|NCT03336216|581128148|FG003|Randomization|Adverse Event|0|||
160926876|NCT03336216|581128145|FG000|Treatment|Adverse Event|2|||
160926877|NCT03336216|581128146|FG001|Treatment|Adverse Event|3|||
160926878|NCT03336216|581128147|FG002|Treatment|Adverse Event|4|||
160926879|NCT03336216|581128148|FG003|Treatment|Adverse Event|4|||
160926880|NCT03336216|581128145|FG000|Treatment|Participant request to discontinue treatment|2|||
160926881|NCT03336216|581128146|FG001|Treatment|Participant request to discontinue treatment|1|||
160926882|NCT03336216|581128147|FG002|Treatment|Participant request to discontinue treatment|2|||
160926883|NCT03336216|581128148|FG003|Treatment|Participant request to discontinue treatment|2|||
160926884|NCT03336216|581128145|FG000|Treatment|Participant withdrew consent|7|||
160926885|NCT03336216|581128146|FG001|Treatment|Participant withdrew consent|2|||
160998037|NCT00241644|581378525|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
160998038|NCT00241644|581378526|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
160998039|NCT00241644|581378523|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
160998040|NCT00241644|581378524|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
160998041|NCT00241644|581378525|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
160926886|NCT03336216|581128147|FG002|Treatment|Participant withdrew consent|3|||
160926887|NCT03336216|581128148|FG003|Treatment|Participant withdrew consent|2|||
160926888|NCT03336216|581128145|FG000|Treatment|Death|2|||
160926889|NCT03336216|581128146|FG001|Treatment|Death|3|||
160926890|NCT03336216|581128147|FG002|Treatment|Death|3|||
160926891|NCT03336216|581128148|FG003|Treatment|Death|4|||
160926892|NCT03336216|581128145|FG000|Treatment|Participant no longer meets study criteria|0|||
160926893|NCT03336216|581128146|FG001|Treatment|Participant no longer meets study criteria|1|||
160926894|NCT03336216|581128147|FG002|Treatment|Participant no longer meets study criteria|0|||
160926895|NCT03336216|581128148|FG003|Treatment|Participant no longer meets study criteria|0|||
160998042|NCT00241644|581378526|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
160926896|NCT03336216|581128145|FG000|Treatment|Other reasons|2|||
160926897|NCT03336216|581128146|FG001|Treatment|Other reasons|0|||
160926898|NCT03336216|581128147|FG002|Treatment|Other reasons|0|||
160926899|NCT03336216|581128148|FG003|Treatment|Other reasons|3|||
160926900|NCT03336216|581128145|FG000|Treatment|Disease progression|23|||
160926901|NCT03336216|581128146|FG001|Treatment|Disease progression|34|||
160926902|NCT03336216|581128147|FG002|Treatment|Disease progression|33|||
160926903|NCT03336216|581128148|FG003|Treatment|Disease progression|26|||
160926904|NCT03336216|581128145|FG000|Treatment|Study drug toxicity|0|||
160926905|NCT03336216|581128146|FG001|Treatment|Study drug toxicity|3|||
160926906|NCT03336216|581128147|FG002|Treatment|Study drug toxicity|2|||
160926907|NCT03336216|581128148|FG003|Treatment|Study drug toxicity|0|||
160926908|NCT03336216|581128145|FG000|Treatment|Adverse Event unrelated to study drug|1|||
160926909|NCT03336216|581128146|FG001|Treatment|Adverse Event unrelated to study drug|1|||
160926910|NCT03336216|581128147|FG002|Treatment|Adverse Event unrelated to study drug|1|||
160926911|NCT03336216|581128148|FG003|Treatment|Adverse Event unrelated to study drug|0|||
160926912|NCT03336216|581128145|FG000|Treatment|Disease Recurrence|1|||
160998043|NCT00241644|581378523|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
160998044|NCT00241644|581378524|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
160998045|NCT00241644|581378525|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
160998046|NCT00241644|581378526|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
160998047|NCT00241644|581378523|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
160998048|NCT00241644|581378524|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
160998049|NCT00241644|581378525|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
160998050|NCT00241644|581378526|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
160998051|NCT00864682|581378528|FG000|Overall Study|Protocol Violation|2|||
160998052|NCT00864682|581378529|FG001|Overall Study|Protocol Violation|1|||
160998053|NCT00864682|581378530|FG002|Overall Study|Protocol Violation|2|||
160577905|NCT02760407|579836348|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
160577906|NCT02760407|579836349|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
160577907|NCT02760407|579836346|FG000|Overall Study|Inadequately Enrolled|0|||
160577908|NCT02760407|579836347|FG001|Overall Study|Inadequately Enrolled|0|||
160577909|NCT02760407|579836348|FG002|Overall Study|Inadequately Enrolled|0|||
160577910|NCT02760407|579836349|FG003|Overall Study|Inadequately Enrolled|1|||
160577911|NCT02760407|579836346|FG000|Overall Study|Withdrawal By PI's Decision|0|||
160577912|NCT02760407|579836347|FG001|Overall Study|Withdrawal By PI's Decision|1|||
160577913|NCT02760407|579836348|FG002|Overall Study|Withdrawal By PI's Decision|0|||
160577914|NCT02760407|579836349|FG003|Overall Study|Withdrawal By PI's Decision|0|||
160577915|NCT02760407|579836346|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
160577916|NCT02760407|579836347|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
160577917|NCT02760407|579836348|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
160926913|NCT03336216|581128146|FG001|Treatment|Disease Recurrence|0|||
160926914|NCT03336216|581128147|FG002|Treatment|Disease Recurrence|0|||
160926915|NCT03336216|581128148|FG003|Treatment|Disease Recurrence|0|||
160926916|NCT02622828|581128149|FG000|Overall Study|participant withdrew|3|||
160926917|NCT03616912|581128150|FG000|Overall Study|Adverse Event|17|||
160926918|NCT03616912|581128151|FG001|Overall Study|Adverse Event|21|||
160926919|NCT03616912|581128152|FG002|Overall Study|Adverse Event|9|||
160926920|NCT03616912|581128153|FG003|Overall Study|Adverse Event|0|||
160926921|NCT03616912|581128154|FG004|Overall Study|Adverse Event|0|||
160926922|NCT03616912|581128155|FG005|Overall Study|Adverse Event|0|||
160926923|NCT03616912|581128150|FG000|Overall Study|Death|1|||
160926924|NCT03616912|581128151|FG001|Overall Study|Death|1|||
160926925|NCT03616912|581128152|FG002|Overall Study|Death|0|||
160926926|NCT03616912|581128153|FG003|Overall Study|Death|0|||
160926927|NCT03616912|581128154|FG004|Overall Study|Death|0|||
160926928|NCT03616912|581128155|FG005|Overall Study|Death|0|||
160926929|NCT03616912|581128150|FG000|Overall Study|Lack of Efficacy|13|||
160926930|NCT03616912|581128151|FG001|Overall Study|Lack of Efficacy|6|||
160926931|NCT03616912|581128152|FG002|Overall Study|Lack of Efficacy|8|||
160926932|NCT03616912|581128153|FG003|Overall Study|Lack of Efficacy|4|||
160926933|NCT03616912|581128154|FG004|Overall Study|Lack of Efficacy|5|||
160926934|NCT03616912|581128155|FG005|Overall Study|Lack of Efficacy|1|||
160926935|NCT03616912|581128150|FG000|Overall Study|Lost to Follow-up|1|||
160926936|NCT03616912|581128151|FG001|Overall Study|Lost to Follow-up|2|||
160926937|NCT03616912|581128152|FG002|Overall Study|Lost to Follow-up|3|||
160926938|NCT03616912|581128153|FG003|Overall Study|Lost to Follow-up|0|||
160926939|NCT03616912|581128154|FG004|Overall Study|Lost to Follow-up|0|||
160926940|NCT03616912|581128155|FG005|Overall Study|Lost to Follow-up|0|||
160926941|NCT03616912|581128150|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
160926942|NCT03616912|581128151|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
160926943|NCT03616912|581128152|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
160926944|NCT03616912|581128153|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
160926945|NCT03616912|581128154|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
160926946|NCT03616912|581128155|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
160926947|NCT03616912|581128150|FG000|Overall Study|Withdrawal by Subject|12|||
160926948|NCT03616912|581128151|FG001|Overall Study|Withdrawal by Subject|12|||
160577918|NCT02760407|579836349|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
160577919|NCT02760407|579836346|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
160926949|NCT03616912|581128152|FG002|Overall Study|Withdrawal by Subject|15|||
160926950|NCT03616912|581128153|FG003|Overall Study|Withdrawal by Subject|2|||
160926951|NCT03616912|581128154|FG004|Overall Study|Withdrawal by Subject|0|||
160998054|NCT00094809|581378534|FG000|Overall Study|Protocol deviation|2|||
160998055|NCT00094809|581378535|FG001|Overall Study|Protocol deviation|2|||
160998056|NCT00094809|581378534|FG000|Overall Study|Noncompliance|1|||
160926952|NCT03616912|581128155|FG005|Overall Study|Withdrawal by Subject|2|||
160926953|NCT03616912|581128150|FG000|Overall Study|Study Terminated by Sponsor|0|||
160926954|NCT03616912|581128151|FG001|Overall Study|Study Terminated by Sponsor|0|||
160926955|NCT03616912|581128152|FG002|Overall Study|Study Terminated by Sponsor|0|||
160926956|NCT03616912|581128153|FG003|Overall Study|Study Terminated by Sponsor|10|||
160926957|NCT03616912|581128154|FG004|Overall Study|Study Terminated by Sponsor|9|||
160926958|NCT03616912|581128155|FG005|Overall Study|Study Terminated by Sponsor|11|||
160926959|NCT03616912|581128150|FG000|Overall Study|Protocol Deviation|1|||
160926960|NCT03616912|581128151|FG001|Overall Study|Protocol Deviation|1|||
160926961|NCT03616912|581128152|FG002|Overall Study|Protocol Deviation|0|||
160926962|NCT03616912|581128153|FG003|Overall Study|Protocol Deviation|0|||
160926963|NCT03616912|581128154|FG004|Overall Study|Protocol Deviation|0|||
160926964|NCT03616912|581128155|FG005|Overall Study|Protocol Deviation|0|||
160926965|NCT03616912|581128150|FG000|Overall Study|Pregnancy|1|||
160926966|NCT03616912|581128151|FG001|Overall Study|Pregnancy|0|||
160926967|NCT03616912|581128152|FG002|Overall Study|Pregnancy|4|||
160926968|NCT03616912|581128153|FG003|Overall Study|Pregnancy|0|||
160926969|NCT03616912|581128154|FG004|Overall Study|Pregnancy|0|||
160926970|NCT03616912|581128155|FG005|Overall Study|Pregnancy|0|||
160926971|NCT03616912|581128150|FG000|Overall Study|Protocol Violation|1|||
160926972|NCT03616912|581128151|FG001|Overall Study|Protocol Violation|0|||
160926973|NCT03616912|581128152|FG002|Overall Study|Protocol Violation|2|||
160926974|NCT03616912|581128153|FG003|Overall Study|Protocol Violation|0|||
160926975|NCT03616912|581128154|FG004|Overall Study|Protocol Violation|0|||
160926976|NCT03616912|581128155|FG005|Overall Study|Protocol Violation|0|||
160926977|NCT03616912|581128150|FG000|Overall Study|Physician Decision|2|||
160926978|NCT03616912|581128151|FG001|Overall Study|Physician Decision|0|||
160926979|NCT03616912|581128152|FG002|Overall Study|Physician Decision|0|||
160926980|NCT03616912|581128153|FG003|Overall Study|Physician Decision|0|||
160926981|NCT03616912|581128154|FG004|Overall Study|Physician Decision|1|||
160926982|NCT03616912|581128155|FG005|Overall Study|Physician Decision|0|||
160926983|NCT03616912|581128150|FG000|Overall Study|Randomized But Never Treated|0|||
160926984|NCT03616912|581128151|FG001|Overall Study|Randomized But Never Treated|2|||
160926985|NCT03616912|581128152|FG002|Overall Study|Randomized But Never Treated|0|||
160926986|NCT03616912|581128153|FG003|Overall Study|Randomized But Never Treated|0|||
160926987|NCT03616912|581128154|FG004|Overall Study|Randomized But Never Treated|0|||
160926988|NCT03616912|581128155|FG005|Overall Study|Randomized But Never Treated|0|||
160926989|NCT01124604|581128156|FG000|Overall Study|Adverse Event|10|||
160926990|NCT01124604|581128157|FG001|Overall Study|Adverse Event|1|||
160926991|NCT01124604|581128156|FG000|Overall Study|Lack of Efficacy|1|||
160926992|NCT01124604|581128157|FG001|Overall Study|Lack of Efficacy|0|||
160926993|NCT01124604|581128156|FG000|Overall Study|Withdrawal by Subject|4|||
160926994|NCT01124604|581128157|FG001|Overall Study|Withdrawal by Subject|0|||
160926995|NCT01124604|581128156|FG000|Overall Study|Disease Progression|0|||
160926996|NCT01124604|581128157|FG001|Overall Study|Disease Progression|1|||
160926997|NCT01859507|581128158|FG000|Overall Study|left the country|4|||
160926998|NCT01762943|581128159|FG000|Overall Study|Physician Decision|1|||
160926999|NCT01762943|581128160|FG001|Overall Study|Physician Decision|1|||
160927000|NCT01762943|581128159|FG000|Overall Study|Protocol Violation|1|||
160927001|NCT01762943|581128160|FG001|Overall Study|Protocol Violation|0|||
160927002|NCT01762943|581128159|FG000|Overall Study|Withdrawal by Subject|2|||
160927003|NCT01762943|581128160|FG001|Overall Study|Withdrawal by Subject|1|||
160927004|NCT00539838|581128161|FG000|Overall Study|Fail to return|2|||
160927005|NCT00539838|581128162|FG001|Overall Study|Fail to return|0|||
160927006|NCT00539838|581128163|FG002|Overall Study|Fail to return|0|||
160927007|NCT00539838|581128161|FG000|Overall Study|Withdrawal by Subject|0|||
160927008|NCT00539838|581128162|FG001|Overall Study|Withdrawal by Subject|4|||
160927009|NCT00539838|581128163|FG002|Overall Study|Withdrawal by Subject|0|||
160927010|NCT00539838|581128161|FG000|Overall Study|Death|0|||
160927011|NCT00539838|581128162|FG001|Overall Study|Death|2|||
160927012|NCT00539838|581128163|FG002|Overall Study|Death|0|||
160927013|NCT00539838|581128161|FG000|Overall Study|Did not cooperate|1|||
160927014|NCT00539838|581128162|FG001|Overall Study|Did not cooperate|0|||
160927015|NCT00539838|581128163|FG002|Overall Study|Did not cooperate|1|||
160927016|NCT00539838|581128161|FG000|Overall Study|Administrative|4|||
160927017|NCT00539838|581128162|FG001|Overall Study|Administrative|0|||
160927018|NCT00539838|581128163|FG002|Overall Study|Administrative|8|||
160927019|NCT02474199|581128167|FG000|Overall Study|Lost to Follow-up|1|||
160927020|NCT02474199|581128168|FG001|Overall Study|Lost to Follow-up|0|||
160927021|NCT02474199|581128169|FG002|Overall Study|Lost to Follow-up|0|||
160927022|NCT02474199|581128170|FG003|Overall Study|Lost to Follow-up|0|||
160927023|NCT02474199|581128167|FG000|Overall Study|Withdrawal by Subject|1|||
160927024|NCT02474199|581128168|FG001|Overall Study|Withdrawal by Subject|2|||
160927025|NCT02474199|581128169|FG002|Overall Study|Withdrawal by Subject|0|||
160927026|NCT02474199|581128170|FG003|Overall Study|Withdrawal by Subject|1|||
160927027|NCT02474199|581128167|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
160927028|NCT02474199|581128168|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
160927029|NCT02474199|581128169|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
160927030|NCT02474199|581128170|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
160927031|NCT02474199|581128167|FG000|Overall Study|Did not meet eligibility criteria|0|||
160927032|NCT02474199|581128168|FG001|Overall Study|Did not meet eligibility criteria|0|||
160927033|NCT02474199|581128169|FG002|Overall Study|Did not meet eligibility criteria|2|||
160927034|NCT02474199|581128170|FG003|Overall Study|Did not meet eligibility criteria|2|||
160927035|NCT03090100|581128171|FG000|Overall Study|Adverse Event|9|||
160577920|NCT02760407|579836347|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
160577921|NCT02760407|579836348|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
160577922|NCT02760407|579836349|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
160577923|NCT02760407|579836346|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
160577924|NCT02760407|579836347|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
160577925|NCT02760407|579836348|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
160577926|NCT02760407|579836349|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
160577927|NCT02760407|579836346|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
160577928|NCT02760407|579836347|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
160577929|NCT02760407|579836348|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
160577930|NCT02760407|579836349|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
160577931|NCT02760407|579836346|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
160577932|NCT02760407|579836347|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
160577933|NCT02760407|579836348|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
160577934|NCT02760407|579836349|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
160577935|NCT02760407|579836346|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
160927036|NCT03090100|581128172|FG001|Overall Study|Adverse Event|11|||
160927037|NCT03090100|581128171|FG000|Overall Study|Pregnancy|1|||
160927038|NCT03090100|581128172|FG001|Overall Study|Pregnancy|1|||
160927039|NCT03090100|581128171|FG000|Overall Study|Lack of Efficacy|2|||
160927040|NCT03090100|581128172|FG001|Overall Study|Lack of Efficacy|7|||
160927041|NCT03090100|581128171|FG000|Overall Study|Lost to Follow-up|2|||
160927042|NCT03090100|581128172|FG001|Overall Study|Lost to Follow-up|2|||
160927043|NCT03090100|581128171|FG000|Overall Study|Withdrawal by Subject|7|||
160927044|NCT03090100|581128172|FG001|Overall Study|Withdrawal by Subject|19|||
160927045|NCT03090100|581128171|FG000|Overall Study|Protocol Violation|2|||
160927046|NCT03090100|581128172|FG001|Overall Study|Protocol Violation|6|||
160927047|NCT03090100|581128171|FG000|Overall Study|Non-compliance|2|||
160927048|NCT03090100|581128172|FG001|Overall Study|Non-compliance|0|||
160927049|NCT03090100|581128171|FG000|Overall Study|Other|2|||
160927050|NCT03090100|581128172|FG001|Overall Study|Other|2|||
160927051|NCT00159588|581128175|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
160927052|NCT00159588|581128176|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
160927053|NCT00159588|581128177|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
160927054|NCT00456521|581128178|FG000|Overall Study|Adverse Event|150|||
160927055|NCT00456521|581128179|FG001|Overall Study|Adverse Event|25|||
160927056|NCT00456521|581128178|FG000|Overall Study|Withdrawal by Subject|43|||
160927057|NCT00456521|581128179|FG001|Overall Study|Withdrawal by Subject|24|||
160927058|NCT00456521|581128178|FG000|Overall Study|Lost to Follow-up|22|||
160927059|NCT00456521|581128179|FG001|Overall Study|Lost to Follow-up|17|||
160927060|NCT00456521|581128178|FG000|Overall Study|Lack of Efficacy|3|||
160927061|NCT00456521|581128179|FG001|Overall Study|Lack of Efficacy|6|||
160927062|NCT00456521|581128178|FG000|Overall Study|Protocol Violation|4|||
160927063|NCT00456521|581128179|FG001|Overall Study|Protocol Violation|0|||
160927064|NCT00456521|581128178|FG000|Overall Study|Pregnancy|1|||
160927065|NCT00456521|581128179|FG001|Overall Study|Pregnancy|1|||
160927066|NCT00456521|581128178|FG000|Overall Study|Drug non-compliance, moved, other|26|||
160927067|NCT00456521|581128179|FG001|Overall Study|Drug non-compliance, moved, other|11|||
160927068|NCT02596854|581128180|FG000|Overall Study|Withdrawn|8|||
160927069|NCT03406858|581128183|FG000|Overall Study|Failure to receive treatment drug.|1|||
160927070|NCT03406858|581128183|FG000|Overall Study|ineligible|1|||
160927071|NCT00405587|581128184|FG000|Overall Study|Death|0|||
160927072|NCT00405587|581128185|FG001|Overall Study|Death|0|||
160927073|NCT00405587|581128186|FG002|Overall Study|Death|0|||
160927074|NCT00405587|581128187|FG003|Overall Study|Death|1|||
160927075|NCT00405587|581128184|FG000|Overall Study|Disease Progression|22|||
160927076|NCT00405587|581128185|FG001|Overall Study|Disease Progression|23|||
160927077|NCT00405587|581128186|FG002|Overall Study|Disease Progression|21|||
160927078|NCT00405587|581128187|FG003|Overall Study|Disease Progression|17|||
160927079|NCT00405587|581128184|FG000|Overall Study|Physician Decision|3|||
160927080|NCT00405587|581128185|FG001|Overall Study|Physician Decision|2|||
160927081|NCT00405587|581128186|FG002|Overall Study|Physician Decision|0|||
160927082|NCT00405587|581128187|FG003|Overall Study|Physician Decision|0|||
160927083|NCT00405587|581128184|FG000|Overall Study|Adverse Event|1|||
160927084|NCT00405587|581128185|FG001|Overall Study|Adverse Event|0|||
160927085|NCT00405587|581128186|FG002|Overall Study|Adverse Event|0|||
160927086|NCT00405587|581128187|FG003|Overall Study|Adverse Event|0|||
160927087|NCT00405587|581128184|FG000|Overall Study|Lost to Follow-up|0|||
160927088|NCT00405587|581128185|FG001|Overall Study|Lost to Follow-up|1|||
160927089|NCT00405587|581128186|FG002|Overall Study|Lost to Follow-up|1|||
160927090|NCT00405587|581128187|FG003|Overall Study|Lost to Follow-up|0|||
160927091|NCT00405587|581128184|FG000|Overall Study|Radiation induced necrosis|0|||
160998057|NCT00094809|581378535|FG001|Overall Study|Noncompliance|0|||
160927092|NCT00405587|581128185|FG001|Overall Study|Radiation induced necrosis|1|||
160927093|NCT00405587|581128186|FG002|Overall Study|Radiation induced necrosis|0|||
160927094|NCT00405587|581128187|FG003|Overall Study|Radiation induced necrosis|0|||
160927095|NCT00405587|581128184|FG000|Overall Study|Withdrawal by Subject|0|||
160927096|NCT00405587|581128185|FG001|Overall Study|Withdrawal by Subject|0|||
160927097|NCT00405587|581128186|FG002|Overall Study|Withdrawal by Subject|0|||
160927098|NCT00405587|581128187|FG003|Overall Study|Withdrawal by Subject|2|||
160927099|NCT00405587|581128184|FG000|Overall Study|Participant not dosed|0|||
160927100|NCT00405587|581128185|FG001|Overall Study|Participant not dosed|1|||
160927101|NCT00405587|581128186|FG002|Overall Study|Participant not dosed|0|||
160927102|NCT00405587|581128187|FG003|Overall Study|Participant not dosed|0|||
160927103|NCT06027866|581128188|FG000|Overall Study|Withdrawal by Subject|2|||
160927104|NCT00507442|581128191|FG000|Overall Study|Adverse Event|8|||
160927105|NCT00507442|581128192|FG001|Overall Study|Adverse Event|11|||
160927106|NCT00507442|581128193|FG002|Overall Study|Adverse Event|4|||
160927107|NCT00507442|581128194|FG003|Overall Study|Adverse Event|1|||
160927108|NCT00507442|581128191|FG000|Overall Study|Protocol Violation|0|||
160927109|NCT00507442|581128192|FG001|Overall Study|Protocol Violation|1|||
160927110|NCT00507442|581128193|FG002|Overall Study|Protocol Violation|0|||
160927111|NCT00507442|581128194|FG003|Overall Study|Protocol Violation|0|||
160927112|NCT00507442|581128191|FG000|Overall Study|Lost to Follow-up|0|||
160927113|NCT00507442|581128192|FG001|Overall Study|Lost to Follow-up|0|||
160927114|NCT00507442|581128193|FG002|Overall Study|Lost to Follow-up|1|||
160927115|NCT00507442|581128194|FG003|Overall Study|Lost to Follow-up|0|||
160927116|NCT00507442|581128191|FG000|Overall Study|Physician Decision|0|||
160927117|NCT00507442|581128192|FG001|Overall Study|Physician Decision|2|||
160927118|NCT00507442|581128193|FG002|Overall Study|Physician Decision|4|||
160927119|NCT00507442|581128194|FG003|Overall Study|Physician Decision|1|||
160927120|NCT00507442|581128191|FG000|Overall Study|Progressive Disease|2|||
160927121|NCT00507442|581128192|FG001|Overall Study|Progressive Disease|4|||
160927122|NCT00507442|581128193|FG002|Overall Study|Progressive Disease|2|||
160927123|NCT00507442|581128194|FG003|Overall Study|Progressive Disease|0|||
160927124|NCT00507442|581128191|FG000|Overall Study|Withdrawal by Subject|4|||
160927125|NCT00507442|581128192|FG001|Overall Study|Withdrawal by Subject|4|||
160927126|NCT00507442|581128193|FG002|Overall Study|Withdrawal by Subject|2|||
160927127|NCT00507442|581128194|FG003|Overall Study|Withdrawal by Subject|1|||
160927128|NCT00507442|581128191|FG000|Overall Study|Other|2|||
160927129|NCT00507442|581128192|FG001|Overall Study|Other|5|||
160927130|NCT00507442|581128193|FG002|Overall Study|Other|2|||
160927131|NCT00507442|581128194|FG003|Overall Study|Other|2|||
160927132|NCT02672423|581128196|FG000|Period 1|Adverse Event|0|||
160927133|NCT02672423|581128197|FG001|Period 1|Adverse Event|0|||
160927134|NCT02672423|581128198|FG002|Period 1|Adverse Event|0|||
160927135|NCT02672423|581128199|FG003|Period 1|Adverse Event|0|||
160927136|NCT02672423|581128200|FG004|Period 1|Adverse Event|1|||
160577936|NCT02760407|579836347|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
160577937|NCT02760407|579836348|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
160577938|NCT02760407|579836349|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
160577939|NCT02760407|579836346|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
160577940|NCT02760407|579836347|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
160577941|NCT02760407|579836348|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
160577942|NCT02760407|579836349|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
160577943|NCT02760407|579836346|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
160577944|NCT02760407|579836347|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
160577945|NCT02760407|579836348|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
160927137|NCT02672423|581128201|FG005|Period 1|Adverse Event|0|||
160927138|NCT02672423|581128202|FG006|Period 1|Adverse Event|0|||
160927139|NCT02672423|581128203|FG007|Period 1|Adverse Event|0|||
160998058|NCT00094809|581378534|FG000|Overall Study|Adverse Event|3|||
160998059|NCT00094809|581378535|FG001|Overall Study|Adverse Event|1|||
160998060|NCT00094809|581378534|FG000|Overall Study|Withdrawal by Subject|8|||
160998061|NCT00094809|581378535|FG001|Overall Study|Withdrawal by Subject|9|||
160454927|NCT03987022|579396206|FG001|Overall Study|Lost to Follow-up|2|||
160577946|NCT02760407|579836349|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
160577947|NCT02760407|579836346|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
160577948|NCT02760407|579836347|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
160927140|NCT02672423|581128204|FG008|Period 1|Adverse Event|0|||
160927141|NCT02672423|581128205|FG009|Period 1|Adverse Event|0|||
160927142|NCT02672423|581128196|FG000|Period 2|Withdrawal by Subject|0|||
160927143|NCT02672423|581128197|FG001|Period 2|Withdrawal by Subject|0|||
160927144|NCT02672423|581128198|FG002|Period 2|Withdrawal by Subject|1|||
160927145|NCT02672423|581128199|FG003|Period 2|Withdrawal by Subject|0|||
160927146|NCT02672423|581128200|FG004|Period 2|Withdrawal by Subject|0|||
160927147|NCT02672423|581128201|FG005|Period 2|Withdrawal by Subject|0|||
160927148|NCT02672423|581128202|FG006|Period 2|Withdrawal by Subject|0|||
160927149|NCT02672423|581128203|FG007|Period 2|Withdrawal by Subject|0|||
160927150|NCT02672423|581128204|FG008|Period 2|Withdrawal by Subject|0|||
160927151|NCT02672423|581128205|FG009|Period 2|Withdrawal by Subject|0|||
160927152|NCT02672423|581128196|FG000|Period 3|Withdrawal by Subject|0|||
160927153|NCT02672423|581128197|FG001|Period 3|Withdrawal by Subject|0|||
160927154|NCT02672423|581128198|FG002|Period 3|Withdrawal by Subject|0|||
160927155|NCT02672423|581128199|FG003|Period 3|Withdrawal by Subject|0|||
160927156|NCT02672423|581128200|FG004|Period 3|Withdrawal by Subject|0|||
160927157|NCT02672423|581128201|FG005|Period 3|Withdrawal by Subject|0|||
160927158|NCT02672423|581128202|FG006|Period 3|Withdrawal by Subject|0|||
160927159|NCT02672423|581128203|FG007|Period 3|Withdrawal by Subject|1|||
160927160|NCT02672423|581128204|FG008|Period 3|Withdrawal by Subject|0|||
160927161|NCT02672423|581128205|FG009|Period 3|Withdrawal by Subject|0|||
160927162|NCT02672423|581128196|FG000|Period 3|Physician Decision|0|||
160927163|NCT02672423|581128197|FG001|Period 3|Physician Decision|0|||
160927164|NCT02672423|581128198|FG002|Period 3|Physician Decision|0|||
160927165|NCT02672423|581128199|FG003|Period 3|Physician Decision|0|||
160927166|NCT02672423|581128200|FG004|Period 3|Physician Decision|0|||
160927167|NCT02672423|581128201|FG005|Period 3|Physician Decision|1|||
160927168|NCT02672423|581128202|FG006|Period 3|Physician Decision|0|||
160927169|NCT02672423|581128203|FG007|Period 3|Physician Decision|0|||
160927170|NCT02672423|581128204|FG008|Period 3|Physician Decision|0|||
160927171|NCT02672423|581128205|FG009|Period 3|Physician Decision|0|||
160927172|NCT01046682|581128212|FG000|Overall Study|Adverse Event|2|||
160927173|NCT01046682|581128213|FG001|Overall Study|Adverse Event|0|||
160927174|NCT05071183|581128214|FG000|Overall Study|Death|1|||
160927175|NCT05071183|581128215|FG001|Overall Study|Death|2|||
160927176|NCT05071183|581128216|FG002|Overall Study|Death|0|||
160927177|NCT05071183|581128214|FG000|Overall Study|Other Reasons|1|||
160927178|NCT05071183|581128215|FG001|Overall Study|Other Reasons|3|||
160927179|NCT05071183|581128216|FG002|Overall Study|Other Reasons|2|||
160655850|NCT02353169|580120280|FG002|Overall Study|Pre-op medication|1|||
160927180|NCT02046148|581128217|FG000|Overall Study|Lost to Follow-up|1|||
160927181|NCT02046148|581128218|FG001|Overall Study|Lost to Follow-up|1|||
160927182|NCT02046148|581128217|FG000|Overall Study|Withdrawal by Subject|0|||
160927183|NCT02046148|581128218|FG001|Overall Study|Withdrawal by Subject|2|||
160927184|NCT03506373|581128220|FG000|Overall Study|Adverse Event|6|||
160927185|NCT03506373|581128220|FG000|Overall Study|Withdrawal by Subject|2|||
160927186|NCT03506373|581128220|FG000|Overall Study|Disease progression|5|||
160927187|NCT03506373|581128220|FG000|Overall Study|Other|3|||
160927188|NCT01293240|581128227|FG000|Overall Study|Noncompliance|2|||
160927189|NCT01520363|581128228|FG000|Overall Study|Withdrawal by Subject|2|||
160927190|NCT01520363|581128229|FG001|Overall Study|Withdrawal by Subject|0|||
160927191|NCT01498952|581128233|FG000|Overall Study|Death|2|||
160927192|NCT01498952|581128234|FG001|Overall Study|Death|2|||
160927193|NCT01498952|581128235|FG002|Overall Study|Death|0|||
160927194|NCT01498952|581128236|FG003|Overall Study|Death|0|||
160927195|NCT01498952|581128237|FG004|Overall Study|Death|0|||
160927196|NCT00304356|581128238|FG000|Nitazoxanide|Physician Decision|5|||
160927197|NCT00304356|581128238|FG000|Nitazoxanide|Physician Decision|1|||
160927198|NCT00304356|581128238|FG000|Nitazoxanide|number is 0|1|||
160927199|NCT00304356|581128238|FG000|Nitazoxanide|Physician Decision|1|||
160927200|NCT00304356|581128238|FG000|Nitazoxanide|Physician Decision|1|||
160927201|NCT00304356|581128238|FG000|Nitazoxanide|Physician Decision|1|||
160927202|NCT01154218|581128241|FG000|Third Intervention Period|Adverse Event|0|||
160927203|NCT01154218|581128242|FG001|Third Intervention Period|Adverse Event|1|||
160927204|NCT01154218|581128243|FG002|Third Intervention Period|Adverse Event|0|||
160927205|NCT01154218|581128244|FG003|Third Intervention Period|Adverse Event|0|||
160655851|NCT02353169|580120281|FG003|Overall Study|Pre-op medication|0|||
160655852|NCT00414765|580120282|FG000|Overall Study|Adverse Event|5|||
160655853|NCT00414765|580120283|FG001|Overall Study|Adverse Event|9|||
160927206|NCT01154218|581128241|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
160927207|NCT01154218|581128242|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
160927208|NCT01154218|581128243|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
160927209|NCT01154218|581128244|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
160927210|NCT01154218|581128241|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
160927211|NCT01154218|581128242|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
160927212|NCT01154218|581128243|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
160655854|NCT00414765|580120282|FG000|Overall Study|Withdrawal by Subject|1|||
160655855|NCT00414765|580120283|FG001|Overall Study|Withdrawal by Subject|1|||
160927213|NCT01154218|581128244|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
160927214|NCT01265849|581128245|FG000|Overall Study|Randomized//Treatment not initiated|1|||
160927215|NCT01265849|581128246|FG001|Overall Study|Randomized//Treatment not initiated|4|||
160927216|NCT01265849|581128247|FG002|Overall Study|Randomized//Treatment not initiated|0|||
160927217|NCT01265849|581128245|FG000|Overall Study|Physician Decision|1|||
160927218|NCT01265849|581128246|FG001|Overall Study|Physician Decision|2|||
160655856|NCT00414765|580120282|FG000|Overall Study|Disease Progression|0|||
160927219|NCT01265849|581128247|FG002|Overall Study|Physician Decision|0|||
160927220|NCT01265849|581128245|FG000|Overall Study|Lost to Follow-up|18|||
160927221|NCT01265849|581128246|FG001|Overall Study|Lost to Follow-up|15|||
160927222|NCT01265849|581128247|FG002|Overall Study|Lost to Follow-up|5|||
160927223|NCT01265849|581128245|FG000|Overall Study|Not otherwise specified|1|||
160927224|NCT01265849|581128246|FG001|Overall Study|Not otherwise specified|6|||
160927225|NCT01265849|581128247|FG002|Overall Study|Not otherwise specified|1|||
160927226|NCT01265849|581128245|FG000|Overall Study|Withdrawal by Subject|25|||
160927227|NCT01265849|581128246|FG001|Overall Study|Withdrawal by Subject|34|||
160927228|NCT01265849|581128247|FG002|Overall Study|Withdrawal by Subject|13|||
160655857|NCT00414765|580120283|FG001|Overall Study|Disease Progression|1|||
160655858|NCT05295953|580120284|FG000|Overall Study|Withdrawal by Subject|0|||
160655859|NCT05295953|580120285|FG001|Overall Study|Withdrawal by Subject|1|||
160655860|NCT05694013|580120286|FG000|Overall Study|Death|6|||
160655861|NCT05694013|580120287|FG001|Overall Study|Death|2|||
160655862|NCT05694013|580120286|FG000|Overall Study|Participant Decision|0|||
160655863|NCT05694013|580120287|FG001|Overall Study|Participant Decision|1|||
160655864|NCT05694013|580120286|FG000|Overall Study|Physician Decision|1|||
160655865|NCT05694013|580120287|FG001|Overall Study|Physician Decision|0|||
160655866|NCT05694013|580120286|FG000|Overall Study|Progressive Disease|0|||
160655867|NCT05694013|580120287|FG001|Overall Study|Progressive Disease|1|||
160927229|NCT03194321|581128248|FG000|Overall Study|Withdrawal by Subject|1|||
160927230|NCT03194321|581128248|FG000|Overall Study|Lost to Follow-up|1|||
160927231|NCT03194321|581128248|FG000|Overall Study|Travel for Follow-up|1|||
160927232|NCT00567892|581128259|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
160927233|NCT00567892|581128260|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
160927234|NCT00567892|581128261|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
160927235|NCT00567892|581128262|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
160927236|NCT00567892|581128259|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
160927237|NCT00567892|581128260|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
160927238|NCT00567892|581128261|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
160927239|NCT00567892|581128262|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
160927240|NCT04690751|581128264|FG000|Overall Study|Protocol Violation|0|||
160927241|NCT04690751|581128265|FG001|Overall Study|Protocol Violation|1|||
160927242|NCT04690751|581128266|FG002|Overall Study|Protocol Violation|0|||
160927243|NCT04690751|581128267|FG003|Overall Study|Protocol Violation|1|||
160927244|NCT04690751|581128268|FG004|Overall Study|Protocol Violation|2|||
160927245|NCT04690751|581128269|FG005|Overall Study|Protocol Violation|0|||
160927246|NCT04690751|581128264|FG000|Overall Study|Adverse Event|0|||
160927247|NCT04690751|581128265|FG001|Overall Study|Adverse Event|0|||
160927248|NCT04690751|581128266|FG002|Overall Study|Adverse Event|1|||
160927249|NCT04690751|581128267|FG003|Overall Study|Adverse Event|0|||
160927250|NCT04690751|581128268|FG004|Overall Study|Adverse Event|0|||
160927251|NCT04690751|581128269|FG005|Overall Study|Adverse Event|0|||
160927252|NCT04690751|581128264|FG000|Overall Study|Positive urine drug screen test|0|||
160927253|NCT04690751|581128265|FG001|Overall Study|Positive urine drug screen test|0|||
160927254|NCT04690751|581128266|FG002|Overall Study|Positive urine drug screen test|0|||
160927255|NCT04690751|581128267|FG003|Overall Study|Positive urine drug screen test|0|||
160927256|NCT04690751|581128268|FG004|Overall Study|Positive urine drug screen test|1|||
160927257|NCT04690751|581128269|FG005|Overall Study|Positive urine drug screen test|0|||
160927258|NCT04364620|581128270|FG000|Overall Study|Disease Progression|20|||
160577949|NCT02760407|579836348|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
160577950|NCT02760407|579836349|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
160577951|NCT01905397|579836350|FG000|Overall Study|Death|0|||
160577952|NCT01905397|579836351|FG001|Overall Study|Death|1|||
160577953|NCT01905397|579836350|FG000|Overall Study|Withdrawal by Subject|2|||
160577954|NCT01905397|579836351|FG001|Overall Study|Withdrawal by Subject|0|||
160577955|NCT01905397|579836350|FG000|Overall Study|Surgery canceled/aborted|9|||
160577956|NCT01905397|579836351|FG001|Overall Study|Surgery canceled/aborted|5|||
160577957|NCT01905397|579836350|FG000|Overall Study|Incision < 7 cm|2|||
160577958|NCT01905397|579836351|FG001|Overall Study|Incision < 7 cm|0|||
160927259|NCT04364620|581128270|FG000|Overall Study|Adverse Event|5|||
160927260|NCT04364620|581128270|FG000|Overall Study|Physician Decision|4|||
160927261|NCT04364620|581128270|FG000|Overall Study|Death|3|||
160927262|NCT04364620|581128270|FG000|Overall Study|Other|2|||
160577959|NCT01905397|579836350|FG000|Overall Study|Wrong treatment|1|||
160577960|NCT01905397|579836351|FG001|Overall Study|Wrong treatment|1|||
160577961|NCT01905397|579836350|FG000|Overall Study|Device not applied|3|||
160577962|NCT01905397|579836351|FG001|Overall Study|Device not applied|0|||
160577963|NCT01905397|579836350|FG000|Overall Study|Dressing not applied in operating room|1|||
160577964|NCT01905397|579836351|FG001|Overall Study|Dressing not applied in operating room|0|||
160655868|NCT05694013|580120286|FG000|Overall Study|Study Terminated by Sponsor|12|||
160655869|NCT05694013|580120287|FG001|Overall Study|Study Terminated by Sponsor|17|||
160655870|NCT05694013|580120286|FG000|Overall Study|Withdrawal by Subject|3|||
160927263|NCT04364620|581128270|FG000|Overall Study|Withdrawal by Subject|1|||
160927264|NCT01365507|581129952|FG000|Overall Study|Withdrawal Criteria|8|||
160927265|NCT01365507|581129953|FG001|Overall Study|Withdrawal Criteria|5|||
160927266|NCT01365507|581129952|FG000|Overall Study|Unclassified|1|||
160927267|NCT01365507|581129953|FG001|Overall Study|Unclassified|4|||
160927268|NCT04254978|581129956|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
160454928|NCT03987022|579396205|FG000|Overall Study|Withdrawal by Subject|1|||
160577965|NCT01905397|579836350|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
160577966|NCT01905397|579836351|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
160577967|NCT01921270|579836352|FG000|Overall Study|Withdrawal by Subject|1|||
160577968|NCT00864227|579836353|FG000|Overall Study|Withdrawal by Subject|1|||
160577969|NCT00864227|579836353|FG000|Overall Study|Disease Relapse/Progression|3|||
160927269|NCT04254978|581129956|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
160927270|NCT04254978|581129956|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
160927271|NCT04254978|581129956|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
160927272|NCT04254978|581129956|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
160927273|NCT04254978|581129956|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
160927274|NCT03257631|581129957|FG000|Overall Study|Death|1|||
160927275|NCT03257631|581129958|FG001|Overall Study|Death|0|||
160927276|NCT03257631|581129959|FG002|Overall Study|Death|1|||
160927277|NCT03257631|581129960|FG003|Overall Study|Death|1|||
160927278|NCT03257631|581129957|FG000|Overall Study|Progressive Disease|10|||
160927279|NCT03257631|581129958|FG001|Overall Study|Progressive Disease|9|||
160927280|NCT03257631|581129959|FG002|Overall Study|Progressive Disease|17|||
160927281|NCT03257631|581129960|FG003|Overall Study|Progressive Disease|8|||
160927282|NCT03257631|581129957|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160927283|NCT03257631|581129958|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160927284|NCT03257631|581129959|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
160927285|NCT03257631|581129960|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
160927286|NCT03257631|581129957|FG000|Overall Study|Adverse Event|0|||
160927287|NCT03257631|581129958|FG001|Overall Study|Adverse Event|0|||
160927288|NCT03257631|581129959|FG002|Overall Study|Adverse Event|2|||
160927289|NCT03257631|581129960|FG003|Overall Study|Adverse Event|0|||
160927290|NCT03509675|581129962|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
160927291|NCT03509675|581129963|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
160927292|NCT03509675|581129962|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
160927293|NCT03509675|581129963|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
160927294|NCT03509675|581129962|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
160927295|NCT03509675|581129963|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
160927296|NCT03509675|581129962|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
160927297|NCT03509675|581129963|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
160927298|NCT02658890|581129971|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927299|NCT02658890|581129972|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927300|NCT02658890|581129973|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927301|NCT02658890|581129974|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927302|NCT02658890|581129975|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927303|NCT02658890|581129976|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927304|NCT02658890|581129977|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927305|NCT02658890|581129978|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927306|NCT02658890|581129979|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
160927307|NCT02658890|581129980|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927308|NCT02658890|581129981|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927309|NCT02658890|581129982|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927310|NCT02658890|581129983|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927311|NCT02658890|581129984|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927312|NCT02658890|581129985|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927313|NCT02658890|581129986|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927314|NCT02658890|581129987|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927315|NCT02658890|581129988|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927316|NCT02658890|581129989|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927317|NCT02658890|581129990|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927318|NCT02658890|581129991|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927319|NCT02658890|581129992|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927320|NCT02658890|581129993|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927321|NCT02658890|581129994|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927322|NCT02658890|581129995|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927323|NCT02658890|581129996|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927324|NCT02658890|581129997|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927325|NCT02658890|581129971|FG000|Treatment Phase|Adverse Event|0|||
160454929|NCT03987022|579396206|FG001|Overall Study|Withdrawal by Subject|0|||
160577970|NCT00487279|579836354|FG000|Overall Study|Death|1|||
160454930|NCT05863156|579396209|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
160577971|NCT00487279|579836355|FG001|Overall Study|Death|0|||
160577972|NCT00487279|579836354|FG000|Overall Study|Withdrawal by Subject|0|||
160454931|NCT05863156|579396210|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
160454932|NCT05863156|579396211|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
160454933|NCT01346540|579396212|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
160577973|NCT00487279|579836355|FG001|Overall Study|Withdrawal by Subject|2|||
160577974|NCT00501852|579836356|FG000|Overall Study|Adverse Event|3|||
160577975|NCT00501852|579836356|FG000|Overall Study|Withdrawal by Subject|2|||
160927326|NCT02658890|581129972|FG001|Treatment Phase|Adverse Event|1|||
160927327|NCT02658890|581129973|FG002|Treatment Phase|Adverse Event|2|||
160927328|NCT02658890|581129974|FG003|Treatment Phase|Adverse Event|2|||
160927329|NCT02658890|581129975|FG004|Treatment Phase|Adverse Event|1|||
160927330|NCT02658890|581129976|FG005|Treatment Phase|Adverse Event|0|||
160927331|NCT02658890|581129977|FG006|Treatment Phase|Adverse Event|0|||
160927332|NCT02658890|581129978|FG007|Treatment Phase|Adverse Event|2|||
160927333|NCT02658890|581129979|FG008|Treatment Phase|Adverse Event|1|||
160927334|NCT02658890|581129980|FG009|Treatment Phase|Adverse Event|2|||
160927335|NCT02658890|581129981|FG010|Treatment Phase|Adverse Event|3|||
160927336|NCT02658890|581129982|FG011|Treatment Phase|Adverse Event|0|||
160927337|NCT02658890|581129983|FG012|Treatment Phase|Adverse Event|1|||
160927338|NCT02658890|581129984|FG013|Treatment Phase|Adverse Event|4|||
160927339|NCT02658890|581129985|FG014|Treatment Phase|Adverse Event|0|||
160927340|NCT02658890|581129986|FG015|Treatment Phase|Adverse Event|0|||
160927341|NCT02658890|581129987|FG016|Treatment Phase|Adverse Event|0|||
160927342|NCT02658890|581129988|FG017|Treatment Phase|Adverse Event|0|||
160927343|NCT02658890|581129989|FG018|Treatment Phase|Adverse Event|5|||
160927344|NCT02658890|581129990|FG019|Treatment Phase|Adverse Event|1|||
160927345|NCT02658890|581129991|FG020|Treatment Phase|Adverse Event|3|||
160927346|NCT02658890|581129992|FG021|Treatment Phase|Adverse Event|0|||
160927347|NCT02658890|581129993|FG022|Treatment Phase|Adverse Event|5|||
160927348|NCT02658890|581129994|FG023|Treatment Phase|Adverse Event|0|||
160927349|NCT02658890|581129995|FG024|Treatment Phase|Adverse Event|0|||
160927350|NCT02658890|581129996|FG025|Treatment Phase|Adverse Event|2|||
160927351|NCT02658890|581129997|FG026|Treatment Phase|Adverse Event|1|||
160927352|NCT02658890|581129971|FG000|Treatment Phase|Death|0|||
160927353|NCT02658890|581129972|FG001|Treatment Phase|Death|0|||
160927354|NCT02658890|581129973|FG002|Treatment Phase|Death|0|||
160927355|NCT02658890|581129974|FG003|Treatment Phase|Death|0|||
160927356|NCT02658890|581129975|FG004|Treatment Phase|Death|0|||
160927357|NCT02658890|581129976|FG005|Treatment Phase|Death|0|||
160927358|NCT02658890|581129977|FG006|Treatment Phase|Death|0|||
160927359|NCT02658890|581129978|FG007|Treatment Phase|Death|0|||
160927360|NCT02658890|581129979|FG008|Treatment Phase|Death|0|||
160927361|NCT02658890|581129980|FG009|Treatment Phase|Death|0|||
160927362|NCT02658890|581129981|FG010|Treatment Phase|Death|0|||
160927363|NCT02658890|581129982|FG011|Treatment Phase|Death|0|||
160927364|NCT02658890|581129983|FG012|Treatment Phase|Death|0|||
160927365|NCT02658890|581129984|FG013|Treatment Phase|Death|0|||
160454934|NCT01346540|579396213|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
160454935|NCT01346540|579396212|FG000|Overall Study|Adverse Event|0|||
160454936|NCT01346540|579396213|FG001|Overall Study|Adverse Event|4|||
160927366|NCT02658890|581129985|FG014|Treatment Phase|Death|0|||
160927367|NCT02658890|581129986|FG015|Treatment Phase|Death|0|||
160927368|NCT02658890|581129987|FG016|Treatment Phase|Death|0|||
160927369|NCT02658890|581129988|FG017|Treatment Phase|Death|0|||
160927370|NCT02658890|581129989|FG018|Treatment Phase|Death|1|||
160927371|NCT02658890|581129990|FG019|Treatment Phase|Death|0|||
160927372|NCT02658890|581129991|FG020|Treatment Phase|Death|0|||
160927373|NCT02658890|581129992|FG021|Treatment Phase|Death|0|||
160927374|NCT02658890|581129993|FG022|Treatment Phase|Death|0|||
160927375|NCT02658890|581129994|FG023|Treatment Phase|Death|0|||
160927376|NCT02658890|581129995|FG024|Treatment Phase|Death|0|||
160927377|NCT02658890|581129996|FG025|Treatment Phase|Death|0|||
160927378|NCT02658890|581129997|FG026|Treatment Phase|Death|0|||
160927379|NCT02658890|581129971|FG000|Treatment Phase|Lost to Follow-up|0|||
160927380|NCT02658890|581129972|FG001|Treatment Phase|Lost to Follow-up|0|||
160927381|NCT02658890|581129973|FG002|Treatment Phase|Lost to Follow-up|0|||
160927382|NCT02658890|581129974|FG003|Treatment Phase|Lost to Follow-up|0|||
160927383|NCT02658890|581129975|FG004|Treatment Phase|Lost to Follow-up|0|||
160927384|NCT02658890|581129976|FG005|Treatment Phase|Lost to Follow-up|0|||
160927385|NCT02658890|581129977|FG006|Treatment Phase|Lost to Follow-up|1|||
160927386|NCT02658890|581129978|FG007|Treatment Phase|Lost to Follow-up|0|||
160927387|NCT02658890|581129979|FG008|Treatment Phase|Lost to Follow-up|0|||
160927388|NCT02658890|581129980|FG009|Treatment Phase|Lost to Follow-up|0|||
160927389|NCT02658890|581129981|FG010|Treatment Phase|Lost to Follow-up|0|||
160454937|NCT03362476|579396214|FG000|Overall Study|Withdrawal by Subject|0|||
160927390|NCT02658890|581129982|FG011|Treatment Phase|Lost to Follow-up|0|||
160927391|NCT02658890|581129983|FG012|Treatment Phase|Lost to Follow-up|0|||
160927392|NCT02658890|581129984|FG013|Treatment Phase|Lost to Follow-up|0|||
160927393|NCT02658890|581129985|FG014|Treatment Phase|Lost to Follow-up|0|||
160927394|NCT02658890|581129986|FG015|Treatment Phase|Lost to Follow-up|0|||
160927395|NCT02658890|581129987|FG016|Treatment Phase|Lost to Follow-up|0|||
160927396|NCT02658890|581129988|FG017|Treatment Phase|Lost to Follow-up|0|||
160927397|NCT02658890|581129989|FG018|Treatment Phase|Lost to Follow-up|0|||
160927398|NCT02658890|581129990|FG019|Treatment Phase|Lost to Follow-up|0|||
160927399|NCT02658890|581129991|FG020|Treatment Phase|Lost to Follow-up|0|||
160927400|NCT02658890|581129992|FG021|Treatment Phase|Lost to Follow-up|0|||
160927401|NCT02658890|581129993|FG022|Treatment Phase|Lost to Follow-up|0|||
160927402|NCT02658890|581129994|FG023|Treatment Phase|Lost to Follow-up|0|||
160927403|NCT02658890|581129995|FG024|Treatment Phase|Lost to Follow-up|0|||
160927404|NCT02658890|581129996|FG025|Treatment Phase|Lost to Follow-up|0|||
160927405|NCT02658890|581129997|FG026|Treatment Phase|Lost to Follow-up|0|||
160927406|NCT02658890|581129971|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
160927407|NCT02658890|581129972|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
160927408|NCT02658890|581129973|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
160927409|NCT02658890|581129974|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
160927410|NCT02658890|581129975|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
160927411|NCT02658890|581129976|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
160927412|NCT02658890|581129977|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
160927413|NCT02658890|581129978|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
160927414|NCT02658890|581129979|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
160927415|NCT02658890|581129980|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
160927416|NCT02658890|581129981|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
160927417|NCT02658890|581129982|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
160927418|NCT02658890|581129983|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
160927419|NCT02658890|581129984|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
160927420|NCT02658890|581129985|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
160927421|NCT02658890|581129986|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
160927422|NCT02658890|581129987|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
160998062|NCT00094809|581378534|FG000|Overall Study|Disease progression|3|||
160927423|NCT02658890|581129988|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
160927424|NCT02658890|581129989|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
160927425|NCT02658890|581129990|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
160927426|NCT02658890|581129991|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
160927427|NCT02658890|581129992|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
160927428|NCT02658890|581129993|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
160927429|NCT02658890|581129994|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
160927430|NCT02658890|581129995|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
160927431|NCT02658890|581129996|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
160927432|NCT02658890|581129997|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
160927433|NCT02658890|581129971|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
160927434|NCT02658890|581129972|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
160927435|NCT02658890|581129973|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
160927436|NCT02658890|581129974|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
160927437|NCT02658890|581129975|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
160927438|NCT02658890|581129976|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
160927439|NCT02658890|581129977|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
160927440|NCT02658890|581129978|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
160927441|NCT02658890|581129979|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
160927442|NCT02658890|581129980|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
160927443|NCT02658890|581129981|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
160927444|NCT02658890|581129982|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
160927445|NCT02658890|581129983|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
160927446|NCT02658890|581129984|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
160927447|NCT02658890|581129985|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
160927448|NCT02658890|581129986|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
160927449|NCT02658890|581129987|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
160927450|NCT02658890|581129988|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
160927451|NCT02658890|581129989|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
160927452|NCT02658890|581129990|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
160927453|NCT02658890|581129991|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
160927454|NCT02658890|581129992|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
160927455|NCT02658890|581129993|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
160927456|NCT02658890|581129994|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
160927457|NCT02658890|581129995|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
160927458|NCT02658890|581129996|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
160998063|NCT00094809|581378535|FG001|Overall Study|Disease progression|3|||
160998064|NCT00094809|581378534|FG000|Overall Study|Physician Decision|3|||
160998065|NCT00094809|581378535|FG001|Overall Study|Physician Decision|5|||
160998066|NCT00094809|581378534|FG000|Overall Study|Lost to Follow-up|6|||
160577976|NCT01416610|579836360|FG000|Overall Study|Adverse Event|4|||
160927459|NCT02658890|581129997|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
160927460|NCT02658890|581129971|FG000|Treatment Phase|Other Reasons|0|||
160927461|NCT02658890|581129972|FG001|Treatment Phase|Other Reasons|0|||
160927462|NCT02658890|581129973|FG002|Treatment Phase|Other Reasons|0|||
160927463|NCT02658890|581129974|FG003|Treatment Phase|Other Reasons|0|||
160927464|NCT02658890|581129975|FG004|Treatment Phase|Other Reasons|0|||
160998067|NCT00094809|581378535|FG001|Overall Study|Lost to Follow-up|6|||
160927465|NCT02658890|581129976|FG005|Treatment Phase|Other Reasons|0|||
160927466|NCT02658890|581129977|FG006|Treatment Phase|Other Reasons|1|||
160927467|NCT02658890|581129978|FG007|Treatment Phase|Other Reasons|0|||
160927468|NCT02658890|581129979|FG008|Treatment Phase|Other Reasons|1|||
160927469|NCT02658890|581129980|FG009|Treatment Phase|Other Reasons|0|||
160927470|NCT02658890|581129981|FG010|Treatment Phase|Other Reasons|0|||
160927471|NCT02658890|581129982|FG011|Treatment Phase|Other Reasons|0|||
160927472|NCT02658890|581129983|FG012|Treatment Phase|Other Reasons|0|||
160927473|NCT02658890|581129984|FG013|Treatment Phase|Other Reasons|2|||
160927474|NCT02658890|581129985|FG014|Treatment Phase|Other Reasons|0|||
160927475|NCT02658890|581129986|FG015|Treatment Phase|Other Reasons|0|||
160927476|NCT02658890|581129987|FG016|Treatment Phase|Other Reasons|0|||
160927477|NCT02658890|581129988|FG017|Treatment Phase|Other Reasons|0|||
160927478|NCT02658890|581129989|FG018|Treatment Phase|Other Reasons|1|||
160927479|NCT02658890|581129990|FG019|Treatment Phase|Other Reasons|0|||
160927480|NCT02658890|581129991|FG020|Treatment Phase|Other Reasons|0|||
160927481|NCT02658890|581129992|FG021|Treatment Phase|Other Reasons|0|||
160927482|NCT02658890|581129993|FG022|Treatment Phase|Other Reasons|0|||
160927483|NCT02658890|581129994|FG023|Treatment Phase|Other Reasons|0|||
160927484|NCT02658890|581129995|FG024|Treatment Phase|Other Reasons|1|||
160927485|NCT02658890|581129996|FG025|Treatment Phase|Other Reasons|0|||
160927486|NCT02658890|581129997|FG026|Treatment Phase|Other Reasons|1|||
160927487|NCT02658890|581129971|FG000|Treatment Phase|Progressive Disease|6|||
160927488|NCT02658890|581129972|FG001|Treatment Phase|Progressive Disease|7|||
160927489|NCT02658890|581129973|FG002|Treatment Phase|Progressive Disease|6|||
160927490|NCT02658890|581129974|FG003|Treatment Phase|Progressive Disease|12|||
160927491|NCT02658890|581129975|FG004|Treatment Phase|Progressive Disease|6|||
160927492|NCT02658890|581129976|FG005|Treatment Phase|Progressive Disease|18|||
160927493|NCT02658890|581129977|FG006|Treatment Phase|Progressive Disease|12|||
160927494|NCT02658890|581129978|FG007|Treatment Phase|Progressive Disease|19|||
160927495|NCT02658890|581129979|FG008|Treatment Phase|Progressive Disease|26|||
160927496|NCT02658890|581129980|FG009|Treatment Phase|Progressive Disease|8|||
160927497|NCT02658890|581129981|FG010|Treatment Phase|Progressive Disease|7|||
160927498|NCT02658890|581129982|FG011|Treatment Phase|Progressive Disease|9|||
160927499|NCT02658890|581129983|FG012|Treatment Phase|Progressive Disease|8|||
160927500|NCT02658890|581129984|FG013|Treatment Phase|Progressive Disease|29|||
160927501|NCT02658890|581129985|FG014|Treatment Phase|Progressive Disease|6|||
160927502|NCT02658890|581129986|FG015|Treatment Phase|Progressive Disease|2|||
160927503|NCT02658890|581129987|FG016|Treatment Phase|Progressive Disease|32|||
160927504|NCT02658890|581129988|FG017|Treatment Phase|Progressive Disease|14|||
160927505|NCT02658890|581129989|FG018|Treatment Phase|Progressive Disease|40|||
160927506|NCT02658890|581129990|FG019|Treatment Phase|Progressive Disease|32|||
160927507|NCT02658890|581129991|FG020|Treatment Phase|Progressive Disease|19|||
160927508|NCT02658890|581129992|FG021|Treatment Phase|Progressive Disease|30|||
160927509|NCT02658890|581129993|FG022|Treatment Phase|Progressive Disease|15|||
160927510|NCT02658890|581129994|FG023|Treatment Phase|Progressive Disease|0|||
160927511|NCT02658890|581129995|FG024|Treatment Phase|Progressive Disease|0|||
160927512|NCT02658890|581129996|FG025|Treatment Phase|Progressive Disease|14|||
160927513|NCT02658890|581129997|FG026|Treatment Phase|Progressive Disease|11|||
160927514|NCT02658890|581129971|FG000|Treatment Phase|Study Drug Toxicity|0|||
160927515|NCT02658890|581129972|FG001|Treatment Phase|Study Drug Toxicity|0|||
160927516|NCT02658890|581129973|FG002|Treatment Phase|Study Drug Toxicity|2|||
160927517|NCT02658890|581129974|FG003|Treatment Phase|Study Drug Toxicity|0|||
160927518|NCT02658890|581129975|FG004|Treatment Phase|Study Drug Toxicity|0|||
160927519|NCT02658890|581129976|FG005|Treatment Phase|Study Drug Toxicity|0|||
160927520|NCT02658890|581129977|FG006|Treatment Phase|Study Drug Toxicity|0|||
160927521|NCT02658890|581129978|FG007|Treatment Phase|Study Drug Toxicity|0|||
160927522|NCT02658890|581129979|FG008|Treatment Phase|Study Drug Toxicity|3|||
160927523|NCT02658890|581129980|FG009|Treatment Phase|Study Drug Toxicity|0|||
160454938|NCT03362476|579396215|FG001|Overall Study|Withdrawal by Subject|1|||
160454939|NCT05216406|579396218|FG000|Overall Study|Lost to Follow-up|8|||
160927524|NCT02658890|581129981|FG010|Treatment Phase|Study Drug Toxicity|1|||
160927525|NCT02658890|581129982|FG011|Treatment Phase|Study Drug Toxicity|1|||
160927526|NCT02658890|581129983|FG012|Treatment Phase|Study Drug Toxicity|2|||
160927527|NCT02658890|581129984|FG013|Treatment Phase|Study Drug Toxicity|9|||
160927528|NCT02658890|581129985|FG014|Treatment Phase|Study Drug Toxicity|0|||
160927529|NCT02658890|581129986|FG015|Treatment Phase|Study Drug Toxicity|1|||
160927530|NCT02658890|581129987|FG016|Treatment Phase|Study Drug Toxicity|1|||
160927531|NCT02658890|581129988|FG017|Treatment Phase|Study Drug Toxicity|0|||
160927532|NCT02658890|581129989|FG018|Treatment Phase|Study Drug Toxicity|8|||
160927533|NCT02658890|581129990|FG019|Treatment Phase|Study Drug Toxicity|3|||
160927534|NCT02658890|581129991|FG020|Treatment Phase|Study Drug Toxicity|2|||
160927535|NCT02658890|581129992|FG021|Treatment Phase|Study Drug Toxicity|0|||
160927536|NCT02658890|581129993|FG022|Treatment Phase|Study Drug Toxicity|8|||
160927537|NCT02658890|581129994|FG023|Treatment Phase|Study Drug Toxicity|0|||
160454940|NCT05216406|579396219|FG001|Overall Study|Lost to Follow-up|9|||
160927538|NCT02658890|581129995|FG024|Treatment Phase|Study Drug Toxicity|0|||
160927539|NCT02658890|581129996|FG025|Treatment Phase|Study Drug Toxicity|2|||
160927540|NCT02658890|581129997|FG026|Treatment Phase|Study Drug Toxicity|0|||
160927541|NCT02658890|581129971|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927542|NCT02658890|581129972|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927543|NCT02658890|581129973|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927544|NCT02658890|581129974|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
160927545|NCT02658890|581129975|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927546|NCT02658890|581129976|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927547|NCT02658890|581129977|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927548|NCT02658890|581129978|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927549|NCT02658890|581129979|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927550|NCT02658890|581129980|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
160577977|NCT01416610|579836360|FG000|Overall Study|Adverse Event -Patient decision|3|||
160577978|NCT01416610|579836360|FG000|Overall Study|Lack of Efficacy|4|||
160577979|NCT01416610|579836360|FG000|Overall Study|No reason given|5|||
160577980|NCT01416610|579836360|FG000|Overall Study|Withdrawal by Subject|13|||
160577981|NCT01416610|579836360|FG000|Overall Study|Lost to Follow-up|7|||
160577982|NCT01416610|579836360|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
160577983|NCT01171521|579836361|FG000|Overall Study|Lost to Follow-up|5|||
160577984|NCT01171521|579836361|FG000|Overall Study|screen failure|1|||
160577985|NCT00492921|579836362|FG000|Overall Study|Death|1|||
160577986|NCT00492921|579836363|FG001|Overall Study|Death|0|||
160577987|NCT00492921|579836364|FG002|Overall Study|Death|1|||
160577988|NCT00652093|579836365|FG000|Overall Study|Withdrawal by Subject|0|||
160577989|NCT00652093|579836366|FG001|Overall Study|Withdrawal by Subject|0|||
160577990|NCT00652093|579836367|FG002|Overall Study|Withdrawal by Subject|1|||
160577991|NCT00652093|579836368|FG003|Overall Study|Withdrawal by Subject|0|||
160577992|NCT00652093|579836369|FG004|Overall Study|Withdrawal by Subject|1|||
160927551|NCT02658890|581129981|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927552|NCT02658890|581129982|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927553|NCT02658890|581129983|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927554|NCT02658890|581129984|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927555|NCT02658890|581129985|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927556|NCT02658890|581129986|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927557|NCT02658890|581129987|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927558|NCT02658890|581129988|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927559|NCT02658890|581129989|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
160927560|NCT02658890|581129990|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927561|NCT02658890|581129991|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927562|NCT02658890|581129992|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927563|NCT02658890|581129993|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
160927564|NCT02658890|581129994|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927565|NCT02658890|581129995|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927566|NCT02658890|581129996|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927567|NCT02658890|581129997|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927568|NCT02658890|581129971|FG000|Treatment Phase|Withdrawal by Subject|0|||
160927569|NCT02658890|581129972|FG001|Treatment Phase|Withdrawal by Subject|1|||
160927570|NCT02658890|581129973|FG002|Treatment Phase|Withdrawal by Subject|0|||
160927571|NCT02658890|581129974|FG003|Treatment Phase|Withdrawal by Subject|0|||
160927572|NCT02658890|581129975|FG004|Treatment Phase|Withdrawal by Subject|0|||
160927573|NCT02658890|581129976|FG005|Treatment Phase|Withdrawal by Subject|0|||
160927574|NCT02658890|581129977|FG006|Treatment Phase|Withdrawal by Subject|1|||
160927575|NCT02658890|581129978|FG007|Treatment Phase|Withdrawal by Subject|0|||
160927576|NCT02658890|581129979|FG008|Treatment Phase|Withdrawal by Subject|0|||
160927577|NCT02658890|581129980|FG009|Treatment Phase|Withdrawal by Subject|1|||
160927578|NCT02658890|581129981|FG010|Treatment Phase|Withdrawal by Subject|0|||
160927579|NCT02658890|581129982|FG011|Treatment Phase|Withdrawal by Subject|0|||
160927580|NCT02658890|581129983|FG012|Treatment Phase|Withdrawal by Subject|1|||
160927581|NCT02658890|581129984|FG013|Treatment Phase|Withdrawal by Subject|3|||
160927582|NCT02658890|581129985|FG014|Treatment Phase|Withdrawal by Subject|0|||
160577993|NCT00652093|579836370|FG005|Overall Study|Withdrawal by Subject|0|||
160927583|NCT02658890|581129986|FG015|Treatment Phase|Withdrawal by Subject|0|||
160655871|NCT05694013|580120287|FG001|Overall Study|Withdrawal by Subject|0|||
160927584|NCT02658890|581129987|FG016|Treatment Phase|Withdrawal by Subject|1|||
160927585|NCT02658890|581129988|FG017|Treatment Phase|Withdrawal by Subject|0|||
160927586|NCT02658890|581129989|FG018|Treatment Phase|Withdrawal by Subject|4|||
160927587|NCT02658890|581129990|FG019|Treatment Phase|Withdrawal by Subject|3|||
160927588|NCT02658890|581129991|FG020|Treatment Phase|Withdrawal by Subject|0|||
160927589|NCT02658890|581129992|FG021|Treatment Phase|Withdrawal by Subject|4|||
160998068|NCT00094809|581378534|FG000|Overall Study|Death|19|||
160577994|NCT00652093|579836365|FG000|Overall Study|Physician Decision|0|||
160927590|NCT02658890|581129993|FG022|Treatment Phase|Withdrawal by Subject|1|||
160927591|NCT02658890|581129994|FG023|Treatment Phase|Withdrawal by Subject|1|||
160927592|NCT02658890|581129995|FG024|Treatment Phase|Withdrawal by Subject|0|||
160927593|NCT02658890|581129996|FG025|Treatment Phase|Withdrawal by Subject|0|||
160927594|NCT02658890|581129997|FG026|Treatment Phase|Withdrawal by Subject|0|||
160927595|NCT02404311|581129998|FG000|Part A: Month 0-18|Death|2|||
160927596|NCT02404311|581129999|FG001|Part A: Month 0-18|Death|0|||
160927597|NCT02404311|581130000|FG002|Part A: Month 0-18|Death|0|||
160927598|NCT02404311|581130001|FG003|Part A: Month 0-18|Death|0|||
160927599|NCT02404311|581130002|FG004|Part A: Month 0-18|Death|0|||
160927600|NCT02404311|581129998|FG000|Part A: Month 0-18|Physician Decision|1|||
160927601|NCT02404311|581129999|FG001|Part A: Month 0-18|Physician Decision|0|||
160927602|NCT02404311|581130000|FG002|Part A: Month 0-18|Physician Decision|0|||
160927603|NCT02404311|581130001|FG003|Part A: Month 0-18|Physician Decision|0|||
160927604|NCT02404311|581130002|FG004|Part A: Month 0-18|Physician Decision|0|||
160927605|NCT02404311|581129998|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
160927606|NCT02404311|581129999|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
160927607|NCT02404311|581130000|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
160927608|NCT02404311|581130001|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
160927609|NCT02404311|581130002|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
160927610|NCT02404311|581129998|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
160927611|NCT02404311|581129999|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
160927612|NCT02404311|581130000|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
160927613|NCT02404311|581130001|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
160927614|NCT02404311|581130002|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
160927615|NCT02404311|581129998|FG000|Part A: Month 0-18|HIV Infection|6|||
160927616|NCT02404311|581129999|FG001|Part A: Month 0-18|HIV Infection|2|||
160927617|NCT02404311|581130000|FG002|Part A: Month 0-18|HIV Infection|0|||
160927618|NCT02404311|581130001|FG003|Part A: Month 0-18|HIV Infection|0|||
160927619|NCT02404311|581130002|FG004|Part A: Month 0-18|HIV Infection|0|||
160927620|NCT02404311|581129998|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
160927621|NCT02404311|581129999|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
160927622|NCT02404311|581130000|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
160927623|NCT02404311|581130001|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
160927624|NCT02404311|581130002|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
160927625|NCT00076011|581130007|FG000|Overall Study|Death|1|||
160927626|NCT00076011|581130007|FG000|Overall Study|Adverse Event|10|||
160927627|NCT00076011|581130007|FG000|Overall Study|Lack of Efficacy|25|||
160927628|NCT00076011|581130007|FG000|Overall Study|Withdrawal by Subject|1|||
160927629|NCT00076011|581130007|FG000|Overall Study|Study terminated by sponsor|3|||
160927630|NCT00076011|581130007|FG000|Overall Study|Other|11|||
160927631|NCT00076011|581130007|FG000|Overall Study|Ongoing|1|||
160927632|NCT03314584|581130011|FG000|Overall Study|Withdrawal by Subject|3|||
160927633|NCT03314584|581130012|FG001|Overall Study|Withdrawal by Subject|3|||
160927634|NCT03314584|581130011|FG000|Overall Study|Lost to Follow-up|4|||
160927635|NCT03314584|581130012|FG001|Overall Study|Lost to Follow-up|0|||
160927636|NCT06134817|581130013|FG000|Overall Study|Physician Departure - termination of study|1|||
160927637|NCT00930579|581130020|FG000|Overall Study|Withdrawal by Subject|1|||
160927638|NCT00930579|581130020|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
160927639|NCT02864251|581130025|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
160927640|NCT02864251|581130026|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
160927641|NCT02864251|581130027|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
160927642|NCT02864251|581130025|FG000|Pre-Treatment|Withdrawal by Participant|0|||
160927643|NCT02864251|581130026|FG001|Pre-Treatment|Withdrawal by Participant|0|||
160927644|NCT02864251|581130027|FG002|Pre-Treatment|Withdrawal by Participant|4|||
160927645|NCT02864251|581130025|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
160577995|NCT00652093|579836366|FG001|Overall Study|Physician Decision|0|||
160577996|NCT00652093|579836367|FG002|Overall Study|Physician Decision|0|||
160577997|NCT00652093|579836368|FG003|Overall Study|Physician Decision|0|||
160927646|NCT02864251|581130026|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
160927647|NCT02864251|581130027|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
160927648|NCT02864251|581130025|FG000|Pre-Treatment|Other Reasons|0|||
160927649|NCT02864251|581130026|FG001|Pre-Treatment|Other Reasons|1|||
160577998|NCT00652093|579836369|FG004|Overall Study|Physician Decision|1|||
160454941|NCT04270942|579396220|FG000|Overall Study|Death|1|||
160454942|NCT04797195|579396226|FG000|Overall Study|Death|8|||
160454943|NCT04797195|579396227|FG001|Overall Study|Death|15|||
160927650|NCT02864251|581130027|FG002|Pre-Treatment|Other Reasons|1|||
160927651|NCT02864251|581130025|FG000|Treatment|Disease Progression|109|||
160927652|NCT02864251|581130026|FG001|Treatment|Disease Progression|52|||
160927653|NCT02864251|581130027|FG002|Treatment|Disease Progression|101|||
160927654|NCT02864251|581130025|FG000|Treatment|Study Drug Toxicity|9|||
160927655|NCT02864251|581130026|FG001|Treatment|Study Drug Toxicity|4|||
160454944|NCT04797195|579396226|FG000|Overall Study|Change from PD|15|||
160577999|NCT00652093|579836370|FG005|Overall Study|Physician Decision|0|||
160578000|NCT00866294|579836374|FG000|Overall Study|Adverse Event|12|||
160454945|NCT04797195|579396227|FG001|Overall Study|Change from PD|15|||
160454946|NCT04797195|579396226|FG000|Overall Study|Withdrawal by Subject|3|||
160454947|NCT04797195|579396227|FG001|Overall Study|Withdrawal by Subject|2|||
160454948|NCT01236781|579396228|FG000|Overall Study|Ineligible|2|||
160454949|NCT01236781|579396229|FG001|Overall Study|Ineligible|1|||
160454950|NCT01236781|579396228|FG000|Overall Study|Did not complete study imaging|5|||
160454951|NCT01236781|579396229|FG001|Overall Study|Did not complete study imaging|0|||
160454952|NCT04862416|579396232|FG000|Overall Study|Withdrawal by Subject|0|||
160454953|NCT04862416|579396233|FG001|Overall Study|Withdrawal by Subject|1|||
160454954|NCT04862416|579396234|FG002|Overall Study|Withdrawal by Subject|0|||
160454955|NCT04862416|579396235|FG003|Overall Study|Withdrawal by Subject|1|||
160454956|NCT04862416|579396236|FG004|Overall Study|Withdrawal by Subject|0|||
160454957|NCT04862416|579396237|FG005|Overall Study|Withdrawal by Subject|0|||
160454958|NCT04862416|579396238|FG006|Overall Study|Withdrawal by Subject|0|||
160454959|NCT04862416|579396239|FG007|Overall Study|Withdrawal by Subject|0|||
160454960|NCT04059185|579396242|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
160454961|NCT04059185|579396243|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
160454962|NCT04059185|579396244|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
160454963|NCT04059185|579396242|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
160454964|NCT04059185|579396243|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
160454965|NCT04059185|579396244|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
160454966|NCT04059185|579396242|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
160454967|NCT04059185|579396243|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
160454968|NCT04059185|579396244|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
160454969|NCT04059185|579396242|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
160454970|NCT04059185|579396243|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
160927656|NCT02864251|581130027|FG002|Treatment|Study Drug Toxicity|10|||
160927657|NCT02864251|581130025|FG000|Treatment|Death|0|||
160927658|NCT02864251|581130026|FG001|Treatment|Death|2|||
160927659|NCT02864251|581130027|FG002|Treatment|Death|3|||
160927660|NCT02864251|581130025|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
160927661|NCT02864251|581130026|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
160927662|NCT02864251|581130027|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
160927663|NCT02864251|581130025|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
160927664|NCT02864251|581130026|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
160927665|NCT02864251|581130027|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
160927666|NCT02864251|581130025|FG000|Treatment|Withdrawal by Participant|8|||
160927667|NCT02864251|581130026|FG001|Treatment|Withdrawal by Participant|5|||
160927668|NCT02864251|581130027|FG002|Treatment|Withdrawal by Participant|13|||
160927669|NCT02864251|581130025|FG000|Treatment|Maximum Clinical Benefit|1|||
160927670|NCT02864251|581130026|FG001|Treatment|Maximum Clinical Benefit|0|||
160927671|NCT02864251|581130027|FG002|Treatment|Maximum Clinical Benefit|1|||
160927672|NCT02864251|581130025|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
160927673|NCT02864251|581130026|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
160927674|NCT02864251|581130027|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
160927675|NCT02864251|581130025|FG000|Treatment|Other Reasons|1|||
160927676|NCT02864251|581130026|FG001|Treatment|Other Reasons|1|||
160927677|NCT02864251|581130027|FG002|Treatment|Other Reasons|4|||
160927678|NCT02864251|581130025|FG000|Treatment|Administrative Reason by Sponsor|1|||
160927679|NCT02864251|581130026|FG001|Treatment|Administrative Reason by Sponsor|0|||
160927680|NCT02864251|581130027|FG002|Treatment|Administrative Reason by Sponsor|0|||
160454971|NCT04059185|579396244|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
160454972|NCT04059185|579396242|FG000|Longitudinal Assessment-Adults Only|Death|4|||
160454973|NCT04059185|579396243|FG001|Longitudinal Assessment-Adults Only|Death|4|||
160454974|NCT04059185|579396244|FG002|Longitudinal Assessment-Adults Only|Death|3|||
160454975|NCT04587453|579396258|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
160454976|NCT04587453|579396259|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
160454977|NCT03571581|579396260|FG000|Overall Study|Death|2|||
160454978|NCT03571581|579396260|FG000|Overall Study|Withdrawal by Subject|2|||
160454979|NCT01309672|579396261|FG000|Overall Study|Lack of Efficacy|20|||
160454980|NCT01309672|579396261|FG000|Overall Study|Other|9|||
160927681|NCT04343521|581130028|FG000|Overall Study|Adverse Event|0|||
160927682|NCT04343521|581130029|FG001|Overall Study|Adverse Event|2|||
160927683|NCT04343521|581130028|FG000|Overall Study|Death|1|||
160927684|NCT04343521|581130029|FG001|Overall Study|Death|2|||
160927685|NCT04343521|581130028|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
160927686|NCT04343521|581130029|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
160454981|NCT01309672|579396261|FG000|Overall Study|Adverse Event|5|||
160454982|NCT01309672|579396261|FG000|Overall Study|Withdrawal by Subject|3|||
160454983|NCT04737330|579396264|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
160454984|NCT04737330|579396265|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
160454985|NCT04737330|579396264|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
160578001|NCT00866294|579836375|FG001|Overall Study|Adverse Event|13|||
160578002|NCT00866294|579836376|FG002|Overall Study|Adverse Event|9|||
160578003|NCT00866294|579836374|FG000|Overall Study|Lack of Efficacy|7|||
160578004|NCT00866294|579836375|FG001|Overall Study|Lack of Efficacy|1|||
160578005|NCT00866294|579836376|FG002|Overall Study|Lack of Efficacy|0|||
160578006|NCT00866294|579836374|FG000|Overall Study|Protocol Violation|2|||
160927687|NCT04343521|581130028|FG000|Overall Study|Withdrawal by Subject|70|||
160927688|NCT04343521|581130029|FG001|Overall Study|Withdrawal by Subject|95|||
160927689|NCT04343521|581130028|FG000|Overall Study|Withdrawal by study team|6|||
160927690|NCT04343521|581130029|FG001|Overall Study|Withdrawal by study team|12|||
160927691|NCT00107198|581130030|FG000|Overall Study|Lack of Efficacy|28|||
160927692|NCT00107198|581130030|FG000|Overall Study|Lost to Follow-up|12|||
160927693|NCT00107198|581130030|FG000|Overall Study|Protocol Violation|1|||
160927694|NCT00107198|581130030|FG000|Overall Study|Withdrawal by Subject|6|||
160927695|NCT00107198|581130030|FG000|Overall Study|Ineligible|5|||
160927696|NCT02939560|581130036|FG000|Overall Study|Withdrawal by Subject|2|||
160927697|NCT02939560|581130036|FG000|Overall Study|Protocol Violation|1|||
160927698|NCT03340025|581130039|FG000|Overall Study|Lost to Follow-up|2|||
160927699|NCT03340025|581130040|FG001|Overall Study|Lost to Follow-up|2|||
160927700|NCT02420691|581130043|FG000|Overall Study|Adverse Event|3|||
160927701|NCT02420691|581130043|FG000|Overall Study|Withdrawal by Subject|3|||
160927702|NCT03897179|581130044|FG000|Overall Study|Withdrawal by Subject|1|||
160927703|NCT01480076|581130045|FG000|Overall Study|Run-in Failure|52|||
160927704|NCT01480076|581130045|FG000|Overall Study|Adverse Event|39|||
160927705|NCT01480076|581130045|FG000|Overall Study|Death|2|||
160927706|NCT01480076|581130045|FG000|Overall Study|Disease Progression|5|||
160927707|NCT01480076|581130045|FG000|Overall Study|Non-compliance With Study Protocol|15|||
160927708|NCT01480076|581130045|FG000|Overall Study|Withdrawal by Subject|105|||
160927709|NCT01480076|581130045|FG000|Overall Study|Lost to Follow-up|7|||
160927710|NCT01480076|581130045|FG000|Overall Study|Investigator Decision|13|||
160927711|NCT01480076|581130045|FG000|Overall Study|Other|52|||
160927712|NCT02503332|581130046|FG000|Overall Study|Adverse Event|17|||
160927713|NCT02503332|581130047|FG001|Overall Study|Adverse Event|5|||
160927714|NCT02503332|581130048|FG002|Overall Study|Adverse Event|3|||
160927715|NCT02503332|581130049|FG003|Overall Study|Adverse Event|1|||
160927716|NCT02503332|581130046|FG000|Overall Study|Investigator's Decision|5|||
160927717|NCT02503332|581130047|FG001|Overall Study|Investigator's Decision|1|||
160927718|NCT02503332|581130048|FG002|Overall Study|Investigator's Decision|0|||
160927719|NCT02503332|581130049|FG003|Overall Study|Investigator's Decision|0|||
160927720|NCT02503332|581130046|FG000|Overall Study|Sponsor's Decision|1|||
160927721|NCT02503332|581130047|FG001|Overall Study|Sponsor's Decision|0|||
160927722|NCT02503332|581130048|FG002|Overall Study|Sponsor's Decision|0|||
160927723|NCT02503332|581130049|FG003|Overall Study|Sponsor's Decision|1|||
160927724|NCT02503332|581130046|FG000|Overall Study|Subject Request|6|||
160927725|NCT02503332|581130047|FG001|Overall Study|Subject Request|5|||
160927726|NCT02503332|581130048|FG002|Overall Study|Subject Request|2|||
160927727|NCT02503332|581130049|FG003|Overall Study|Subject Request|1|||
160927728|NCT02503332|581130046|FG000|Overall Study|Death|0|||
160927729|NCT02503332|581130047|FG001|Overall Study|Death|2|||
160927730|NCT02503332|581130048|FG002|Overall Study|Death|2|||
160927731|NCT02503332|581130049|FG003|Overall Study|Death|0|||
160927732|NCT02503332|581130046|FG000|Overall Study|Other|5|||
160927733|NCT02503332|581130047|FG001|Overall Study|Other|6|||
160927734|NCT02503332|581130048|FG002|Overall Study|Other|1|||
160927735|NCT02503332|581130049|FG003|Overall Study|Other|1|||
160927736|NCT05694546|581130051|FG000|Overall Study|Lost to Follow-up|11|||
160927737|NCT02120950|581130052|FG000|Overall Study|Adverse Event|5|||
160927738|NCT02120950|581130053|FG001|Overall Study|Adverse Event|4|||
160578007|NCT00866294|579836375|FG001|Overall Study|Protocol Violation|0|||
160927739|NCT02120950|581130054|FG002|Overall Study|Adverse Event|3|||
160927740|NCT02120950|581130052|FG000|Overall Study|Death|3|||
160927741|NCT02120950|581130053|FG001|Overall Study|Death|0|||
160927742|NCT02120950|581130054|FG002|Overall Study|Death|1|||
160927743|NCT02120950|581130052|FG000|Overall Study|Withdrawal by Subject|6|||
160927744|NCT02120950|581130053|FG001|Overall Study|Withdrawal by Subject|3|||
160927745|NCT02120950|581130054|FG002|Overall Study|Withdrawal by Subject|2|||
160927746|NCT02120950|581130052|FG000|Overall Study|Protocol Violation|1|||
160927747|NCT02120950|581130053|FG001|Overall Study|Protocol Violation|1|||
160927748|NCT02120950|581130054|FG002|Overall Study|Protocol Violation|7|||
160927749|NCT02120950|581130052|FG000|Overall Study|Other reasons|5|||
160578008|NCT00866294|579836376|FG002|Overall Study|Protocol Violation|0|||
160998069|NCT00094809|581378535|FG001|Overall Study|Death|25|||
160578009|NCT00866294|579836374|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
160578010|NCT00866294|579836375|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
160927750|NCT02120950|581130053|FG001|Overall Study|Other reasons|4|||
160927751|NCT02120950|581130054|FG002|Overall Study|Other reasons|1|||
160927752|NCT02120950|581130052|FG000|Overall Study|Lost to Follow-up|0|||
160927753|NCT02120950|581130053|FG001|Overall Study|Lost to Follow-up|2|||
160927754|NCT02120950|581130054|FG002|Overall Study|Lost to Follow-up|1|||
160927755|NCT02424383|581130055|FG000|Overall Study|Withdrawal by Subject|32|||
160927756|NCT02424383|581130055|FG000|Overall Study|Death|170|||
160927757|NCT02424383|581130055|FG000|Overall Study|Sponsor's decision|3|||
160578011|NCT00866294|579836376|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
160578012|NCT00866294|579836374|FG000|Overall Study|Lost to Follow-up|1|||
160578013|NCT00866294|579836375|FG001|Overall Study|Lost to Follow-up|3|||
160578014|NCT00866294|579836376|FG002|Overall Study|Lost to Follow-up|0|||
160578015|NCT00866294|579836374|FG000|Overall Study|Physician Decision|6|||
160578016|NCT00866294|579836375|FG001|Overall Study|Physician Decision|2|||
160578017|NCT00866294|579836376|FG002|Overall Study|Physician Decision|1|||
160927758|NCT02424383|581130055|FG000|Overall Study|Investigator's decision|44|||
160927759|NCT02424383|581130055|FG000|Overall Study|Lost to Follow-up|81|||
160927760|NCT02424383|581130055|FG000|Overall Study|Other|7|||
160927761|NCT02424383|581130055|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
160927762|NCT02439320|581130061|FG000|Overall Study|Adverse Event|0|||
160927763|NCT02439320|581130062|FG001|Overall Study|Adverse Event|2|||
160927764|NCT02439320|581130063|FG002|Overall Study|Adverse Event|0|||
160927765|NCT02439320|581130061|FG000|Overall Study|Lost to Follow-up|37|||
160927766|NCT02439320|581130062|FG001|Overall Study|Lost to Follow-up|34|||
160927767|NCT02439320|581130063|FG002|Overall Study|Lost to Follow-up|42|||
160927768|NCT02439320|581130061|FG000|Overall Study|Death|0|||
160927769|NCT02439320|581130062|FG001|Overall Study|Death|1|||
160927770|NCT02439320|581130063|FG002|Overall Study|Death|0|||
160927771|NCT02439320|581130061|FG000|Overall Study|Noncompliance with Protocol|10|||
160927772|NCT02439320|581130062|FG001|Overall Study|Noncompliance with Protocol|11|||
160927773|NCT02439320|581130063|FG002|Overall Study|Noncompliance with Protocol|7|||
160927774|NCT02439320|581130061|FG000|Overall Study|Pregnancy|0|||
160927775|NCT02439320|581130062|FG001|Overall Study|Pregnancy|1|||
160927776|NCT02439320|581130063|FG002|Overall Study|Pregnancy|1|||
160927777|NCT02439320|581130061|FG000|Overall Study|Withdrawal by Subject|12|||
160927778|NCT02439320|581130062|FG001|Overall Study|Withdrawal by Subject|16|||
160927779|NCT02439320|581130063|FG002|Overall Study|Withdrawal by Subject|14|||
160927780|NCT02439320|581130061|FG000|Overall Study|Physician Decision|2|||
160927781|NCT02439320|581130062|FG001|Overall Study|Physician Decision|1|||
160927782|NCT02439320|581130063|FG002|Overall Study|Physician Decision|0|||
160927783|NCT02439320|581130061|FG000|Overall Study|Sponsor Request|0|||
160927784|NCT02439320|581130062|FG001|Overall Study|Sponsor Request|2|||
160927785|NCT02439320|581130063|FG002|Overall Study|Sponsor Request|1|||
160578018|NCT00916721|579836377|FG000|Overall Study|Lost to Follow-up|0|||
160927786|NCT02439320|581130061|FG000|Overall Study|Randomization Failure|35|||
160927787|NCT02439320|581130062|FG001|Overall Study|Randomization Failure|46|||
160927788|NCT02439320|581130063|FG002|Overall Study|Randomization Failure|34|||
160927789|NCT01251380|581130066|FG000|Overall Study|Other (Not otherwise specified)|12|||
160927790|NCT01251380|581130066|FG000|Overall Study|Withdrawal by Subject|6|||
160927791|NCT01251380|581130066|FG000|Overall Study|Lack of Efficacy|1|||
160927792|NCT01251380|581130066|FG000|Overall Study|Adverse Event|1|||
160927793|NCT01251380|581130066|FG000|Overall Study|Lost to Follow-up|2|||
160927794|NCT02404350|581130070|FG000|Overall Study|Adverse Event|2|||
160927795|NCT02404350|581130071|FG001|Overall Study|Adverse Event|2|||
160927796|NCT02404350|581130072|FG002|Overall Study|Adverse Event|3|||
160927797|NCT02404350|581130073|FG003|Overall Study|Adverse Event|9|||
160927798|NCT02404350|581130070|FG000|Overall Study|Lack of Efficacy|3|||
160927799|NCT02404350|581130071|FG001|Overall Study|Lack of Efficacy|1|||
160927800|NCT02404350|581130072|FG002|Overall Study|Lack of Efficacy|0|||
160927801|NCT02404350|581130073|FG003|Overall Study|Lack of Efficacy|3|||
160927802|NCT02404350|581130070|FG000|Overall Study|Lost to Follow-up|2|||
160927803|NCT02404350|581130071|FG001|Overall Study|Lost to Follow-up|0|||
160927804|NCT02404350|581130072|FG002|Overall Study|Lost to Follow-up|0|||
160927805|NCT02404350|581130073|FG003|Overall Study|Lost to Follow-up|1|||
160927806|NCT02404350|581130070|FG000|Overall Study|Physician Decision|1|||
160998070|NCT00094809|581378534|FG000|Overall Study|Protocol-specified criteria|1|||
160998071|NCT00094809|581378535|FG001|Overall Study|Protocol-specified criteria|1|||
160998072|NCT00094809|581378534|FG000|Overall Study|Other|2|||
160998073|NCT00094809|581378535|FG001|Overall Study|Other|4|||
160578019|NCT00916721|579836378|FG001|Overall Study|Lost to Follow-up|1|||
160578020|NCT00916721|579836377|FG000|Overall Study|Adverse Event|6|||
160927807|NCT02404350|581130071|FG001|Overall Study|Physician Decision|0|||
160927808|NCT02404350|581130072|FG002|Overall Study|Physician Decision|0|||
160927809|NCT02404350|581130073|FG003|Overall Study|Physician Decision|2|||
160927810|NCT02404350|581130070|FG000|Overall Study|Pregnancy|0|||
160927811|NCT02404350|581130071|FG001|Overall Study|Pregnancy|0|||
160927812|NCT02404350|581130072|FG002|Overall Study|Pregnancy|0|||
160927813|NCT02404350|581130073|FG003|Overall Study|Pregnancy|1|||
160927814|NCT02404350|581130070|FG000|Overall Study|Withdrawal by Subject|7|||
160927815|NCT02404350|581130071|FG001|Overall Study|Withdrawal by Subject|3|||
160927816|NCT02404350|581130072|FG002|Overall Study|Withdrawal by Subject|3|||
160927817|NCT02404350|581130073|FG003|Overall Study|Withdrawal by Subject|19|||
160927818|NCT02404350|581130070|FG000|Overall Study|Due to Non-compliance with treatment|0|||
160927819|NCT02404350|581130071|FG001|Overall Study|Due to Non-compliance with treatment|0|||
160927820|NCT02404350|581130072|FG002|Overall Study|Due to Non-compliance with treatment|0|||
160927821|NCT02404350|581130073|FG003|Overall Study|Due to Non-compliance with treatment|1|||
160927822|NCT02404350|581130070|FG000|Overall Study|Due to Technical problems|0|||
160927823|NCT02404350|581130071|FG001|Overall Study|Due to Technical problems|0|||
160927824|NCT02404350|581130072|FG002|Overall Study|Due to Technical problems|0|||
160927825|NCT02404350|581130073|FG003|Overall Study|Due to Technical problems|1|||
160927826|NCT05389657|581130074|FG000|Overall Study|Lost to Follow-up|7|||
160927827|NCT05389657|581130075|FG001|Overall Study|Lost to Follow-up|8|||
160927828|NCT05237206|581130077|FG000|Overall Study|screen failure-did not receive treatment|8|||
160927829|NCT05237206|581130077|FG000|Overall Study|did not receive treatment|3|||
160927830|NCT03261947|581130078|FG000|Overall Study|Death|10|||
160927831|NCT03261947|581130079|FG001|Overall Study|Death|13|||
160927832|NCT03261947|581130080|FG002|Overall Study|Death|17|||
160927833|NCT03261947|581130081|FG003|Overall Study|Death|12|||
160927834|NCT03261947|581130082|FG004|Overall Study|Death|8|||
160927835|NCT03261947|581130078|FG000|Overall Study|Lost to Follow-up|0|||
160927836|NCT03261947|581130079|FG001|Overall Study|Lost to Follow-up|0|||
160927837|NCT03261947|581130080|FG002|Overall Study|Lost to Follow-up|2|||
160927838|NCT03261947|581130081|FG003|Overall Study|Lost to Follow-up|1|||
160927839|NCT03261947|581130082|FG004|Overall Study|Lost to Follow-up|0|||
160927840|NCT03261947|581130078|FG000|Overall Study|Withdrawal by Subject|0|||
160927841|NCT03261947|581130079|FG001|Overall Study|Withdrawal by Subject|0|||
160927842|NCT03261947|581130080|FG002|Overall Study|Withdrawal by Subject|3|||
160927843|NCT03261947|581130081|FG003|Overall Study|Withdrawal by Subject|0|||
160927844|NCT03261947|581130082|FG004|Overall Study|Withdrawal by Subject|1|||
160927845|NCT03261947|581130078|FG000|Overall Study|Site Terminated by Sponsor|0|||
160927846|NCT03261947|581130079|FG001|Overall Study|Site Terminated by Sponsor|0|||
160927847|NCT03261947|581130080|FG002|Overall Study|Site Terminated by Sponsor|4|||
160927848|NCT03261947|581130081|FG003|Overall Study|Site Terminated by Sponsor|7|||
160927849|NCT03261947|581130082|FG004|Overall Study|Site Terminated by Sponsor|5|||
160927850|NCT03261947|581130078|FG000|Overall Study|Reason not Specified|2|||
160927851|NCT03261947|581130079|FG001|Overall Study|Reason not Specified|0|||
160927852|NCT03261947|581130080|FG002|Overall Study|Reason not Specified|4|||
160927853|NCT03261947|581130081|FG003|Overall Study|Reason not Specified|1|||
160927854|NCT03261947|581130082|FG004|Overall Study|Reason not Specified|3|||
160927855|NCT03969992|581130083|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
160927856|NCT03969992|581130084|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
160927857|NCT03969992|581130085|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
160927858|NCT03969992|581130083|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
160927859|NCT03969992|581130084|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
160927860|NCT03969992|581130085|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
160927861|NCT03969992|581130083|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
160927862|NCT03969992|581130084|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
160927863|NCT03969992|581130085|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
160927864|NCT03969992|581130083|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
160927865|NCT03969992|581130084|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
160927866|NCT03969992|581130085|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
160927867|NCT03969992|581130083|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
160927868|NCT03969992|581130084|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
160927869|NCT03969992|581130085|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
160927870|NCT04120974|581130086|FG000|Overall Study|Death|1|||
160927871|NCT04120974|581130086|FG000|Overall Study|Physician Decision|1|||
160927872|NCT04120974|581130086|FG000|Overall Study|Lost to Follow-up|6|||
160927873|NCT02154581|581130090|FG000|Overall Study|Lost to Follow-up|7|||
160927874|NCT02154581|581130091|FG001|Overall Study|Lost to Follow-up|8|||
160927875|NCT03082599|581130096|FG000|Overall Study|Lost to Follow-up|1|||
160927876|NCT03082599|581130097|FG001|Overall Study|Lost to Follow-up|0|||
160927877|NCT00832585|581130101|FG000|Overall Study|Withdrawal by Subject|1|||
160927878|NCT00832585|581130101|FG000|Overall Study|Lost to Follow-up|1|||
160454986|NCT04737330|579396265|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
160454987|NCT04737330|579396264|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
160927879|NCT01344161|581130102|FG000|Overall Study|Lost to Follow-up|4|||
160927880|NCT01344161|581130103|FG001|Overall Study|Lost to Follow-up|1|||
160927881|NCT01344161|581130102|FG000|Overall Study|Pregnancy|0|||
160927882|NCT01344161|581130103|FG001|Overall Study|Pregnancy|1|||
160927883|NCT01344161|581130102|FG000|Overall Study|Protocol Violation|1|||
160927884|NCT01344161|581130103|FG001|Overall Study|Protocol Violation|1|||
160927885|NCT01541969|581131652|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
160927886|NCT01541969|581131653|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
160927887|NCT01541969|581131652|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
160927888|NCT01541969|581131653|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
160927889|NCT01541969|581131652|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
160927890|NCT01541969|581131653|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
160927891|NCT01541969|581131652|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
160927892|NCT01541969|581131653|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
160927893|NCT01541969|581131652|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
160927894|NCT01541969|581131653|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
160927895|NCT01541969|581131652|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
160927896|NCT01541969|581131653|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
160927897|NCT01541969|581131652|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
160927898|NCT01541969|581131653|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
160927899|NCT01541969|581131652|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
160927900|NCT01541969|581131653|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
160927901|NCT01541969|581131652|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
160927902|NCT01541969|581131653|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
160927903|NCT01541969|581131652|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
160927904|NCT01541969|581131653|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
160927905|NCT01614990|581131654|FG000|Overall Study|Protocol Violation|1|||
160927906|NCT01614990|581131655|FG001|Overall Study|Protocol Violation|1|||
160927907|NCT02255500|581131660|FG000|Overall Study|Withdrawal by Subject|1|||
160927908|NCT02255500|581131661|FG001|Overall Study|Withdrawal by Subject|0|||
160927909|NCT02449239|581131664|FG000|Induction Phase|Lack of Efficacy|64|||
160927910|NCT02449239|581131664|FG000|Induction Phase|Adverse Event|1|||
160927911|NCT02449239|581131664|FG000|Induction Phase|Lost to Follow-up|1|||
160927912|NCT02449239|581131664|FG000|Induction Phase|Protocol Violation|1|||
160927913|NCT02449239|581131664|FG000|Induction Phase|Physician Decision|1|||
160927914|NCT02449239|581131664|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
160927915|NCT02449239|581131664|FG000|Induction Phase|Withdrawal by Subject|1|||
160927916|NCT02449239|581131664|FG000|Maintenance Month 3|Lack of Efficacy|14|||
160927917|NCT02449239|581131664|FG000|Maintenance Month 6|Lack of Efficacy|10|||
160927918|NCT02449239|581131664|FG000|Maintenance Month 6|Adverse Event|2|||
160927919|NCT02449239|581131664|FG000|Maintenance Month 6|Physician Decision|1|||
160927920|NCT02449239|581131664|FG000|Maintenance Month 9|Lack of Efficacy|2|||
160927921|NCT02449239|581131664|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
160927922|NCT02449239|581131664|FG000|Maintenance Month 12|Lack of Efficacy|5|||
160927923|NCT02449239|581131664|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
160927924|NCT02449239|581131664|FG000|Maintenance Month 12|Subject moved from area|1|||
160927925|NCT02449239|581131664|FG000|Maintenance Month 15|Lack of Efficacy|1|||
160927926|NCT02449239|581131664|FG000|Maintenance Month 21|Lack of Efficacy|1|||
160927927|NCT02449239|581131664|FG000|Maintenance Month 21|Sponsor decision|1|||
160927928|NCT03239470|581131667|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
160927929|NCT03239470|581131668|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
160927930|NCT01023581|581131669|FG000|Overall Study|Adverse Event|4|||
160927931|NCT01023581|581131670|FG001|Overall Study|Adverse Event|4|||
160927932|NCT01023581|581131671|FG002|Overall Study|Adverse Event|7|||
160927933|NCT01023581|581131672|FG003|Overall Study|Adverse Event|3|||
160927934|NCT01023581|581131673|FG004|Overall Study|Adverse Event|2|||
160927935|NCT01023581|581131674|FG005|Overall Study|Adverse Event|5|||
160927936|NCT01023581|581131675|FG006|Overall Study|Adverse Event|11|||
160927937|NCT01023581|581131669|FG000|Overall Study|Major protocol deviation|2|||
160927938|NCT01023581|581131670|FG001|Overall Study|Major protocol deviation|0|||
160927939|NCT01023581|581131671|FG002|Overall Study|Major protocol deviation|3|||
160927940|NCT01023581|581131672|FG003|Overall Study|Major protocol deviation|0|||
160927941|NCT01023581|581131673|FG004|Overall Study|Major protocol deviation|0|||
160927942|NCT01023581|581131674|FG005|Overall Study|Major protocol deviation|0|||
160927943|NCT01023581|581131675|FG006|Overall Study|Major protocol deviation|0|||
160927944|NCT01023581|581131669|FG000|Overall Study|Lost to Follow-up|4|||
160927945|NCT01023581|581131670|FG001|Overall Study|Lost to Follow-up|8|||
160927946|NCT01023581|581131671|FG002|Overall Study|Lost to Follow-up|7|||
160927947|NCT01023581|581131672|FG003|Overall Study|Lost to Follow-up|2|||
160927948|NCT01023581|581131673|FG004|Overall Study|Lost to Follow-up|5|||
160927949|NCT01023581|581131674|FG005|Overall Study|Lost to Follow-up|2|||
160927950|NCT01023581|581131675|FG006|Overall Study|Lost to Follow-up|2|||
160927951|NCT01023581|581131669|FG000|Overall Study|Withdrawal by Subject|13|||
160927952|NCT01023581|581131670|FG001|Overall Study|Withdrawal by Subject|8|||
160927953|NCT01023581|581131671|FG002|Overall Study|Withdrawal by Subject|16|||
160927954|NCT01023581|581131672|FG003|Overall Study|Withdrawal by Subject|10|||
160927955|NCT01023581|581131673|FG004|Overall Study|Withdrawal by Subject|6|||
160927956|NCT01023581|581131674|FG005|Overall Study|Withdrawal by Subject|8|||
160927957|NCT01023581|581131675|FG006|Overall Study|Withdrawal by Subject|5|||
160927958|NCT01023581|581131669|FG000|Overall Study|Pregnancy|0|||
160927959|NCT01023581|581131670|FG001|Overall Study|Pregnancy|0|||
160927960|NCT01023581|581131671|FG002|Overall Study|Pregnancy|0|||
160927961|NCT01023581|581131672|FG003|Overall Study|Pregnancy|2|||
160927962|NCT01023581|581131673|FG004|Overall Study|Pregnancy|0|||
160927963|NCT01023581|581131674|FG005|Overall Study|Pregnancy|1|||
160927964|NCT01023581|581131675|FG006|Overall Study|Pregnancy|0|||
160927965|NCT01023581|581131669|FG000|Overall Study|Lack of Efficacy|9|||
160927966|NCT01023581|581131670|FG001|Overall Study|Lack of Efficacy|3|||
160927967|NCT01023581|581131671|FG002|Overall Study|Lack of Efficacy|6|||
160927968|NCT01023581|581131672|FG003|Overall Study|Lack of Efficacy|2|||
160927969|NCT01023581|581131673|FG004|Overall Study|Lack of Efficacy|1|||
160927970|NCT01023581|581131674|FG005|Overall Study|Lack of Efficacy|2|||
160927971|NCT01023581|581131675|FG006|Overall Study|Lack of Efficacy|1|||
160927972|NCT01023581|581131669|FG000|Overall Study|Physician Decision|2|||
160927973|NCT01023581|581131670|FG001|Overall Study|Physician Decision|0|||
160927974|NCT01023581|581131671|FG002|Overall Study|Physician Decision|2|||
160927975|NCT01023581|581131672|FG003|Overall Study|Physician Decision|1|||
160927976|NCT01023581|581131673|FG004|Overall Study|Physician Decision|1|||
160927977|NCT01023581|581131674|FG005|Overall Study|Physician Decision|1|||
160927978|NCT01023581|581131675|FG006|Overall Study|Physician Decision|1|||
160927979|NCT01023581|581131669|FG000|Overall Study|Other|1|||
160927980|NCT01023581|581131670|FG001|Overall Study|Other|0|||
160927981|NCT01023581|581131671|FG002|Overall Study|Other|1|||
160927982|NCT01023581|581131672|FG003|Overall Study|Other|0|||
160927983|NCT01023581|581131673|FG004|Overall Study|Other|1|||
160927984|NCT01023581|581131674|FG005|Overall Study|Other|0|||
160927985|NCT01023581|581131675|FG006|Overall Study|Other|0|||
160927986|NCT02532647|581131684|FG000|Overall Study|Did not receive trial medication|1|||
160927987|NCT02532647|581131685|FG001|Overall Study|Did not receive trial medication|0|||
160927988|NCT02532647|581131686|FG002|Overall Study|Did not receive trial medication|1|||
160927989|NCT03412084|581131690|FG000|Overall Study|Withdrawal by Subject|2|||
160927990|NCT03412084|581131691|FG001|Overall Study|Withdrawal by Subject|0|||
160927991|NCT03412084|581131690|FG000|Overall Study|Participant moved|1|||
160927992|NCT03412084|581131691|FG001|Overall Study|Participant moved|0|||
160927993|NCT03412084|581131690|FG000|Overall Study|Lost to Follow-up|1|||
160927994|NCT03412084|581131691|FG001|Overall Study|Lost to Follow-up|1|||
160927995|NCT01928862|581131696|FG000|Overall Study|Lost to Follow-up|1|||
160927996|NCT01928862|581131697|FG001|Overall Study|Lost to Follow-up|0|||
160927997|NCT01928862|581131698|FG002|Overall Study|Lost to Follow-up|0|||
160927998|NCT01928862|581131699|FG003|Overall Study|Lost to Follow-up|0|||
160927999|NCT01928862|581131700|FG004|Overall Study|Lost to Follow-up|1|||
160928000|NCT01752855|581131701|FG000|Overall Study|Adverse Event|1|||
160928001|NCT01752855|581131702|FG001|Overall Study|Adverse Event|0|||
160928002|NCT01752855|581131701|FG000|Overall Study|Withdrew Consent|0|||
160928003|NCT01752855|581131702|FG001|Overall Study|Withdrew Consent|2|||
160928004|NCT01752855|581131701|FG000|Overall Study|Lack of Efficacy|0|||
160928005|NCT01752855|581131702|FG001|Overall Study|Lack of Efficacy|2|||
160928006|NCT01478321|581131703|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
160928007|NCT01478321|581131703|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
160928008|NCT01478321|581131703|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
160928009|NCT01478321|581131703|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
160928010|NCT01478321|581131703|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
160928011|NCT01478321|581131703|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
160928012|NCT01478321|581131703|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
160928013|NCT01478321|581131703|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
160928014|NCT02053753|581131705|FG000|Overall Study|Withdrawal by Subject|2|||
160454988|NCT04737330|579396265|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
160454989|NCT04737330|579396264|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
160454990|NCT04737330|579396265|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
160454991|NCT04737330|579396264|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
160928015|NCT02053753|581131706|FG001|Overall Study|Withdrawal by Subject|4|||
160928016|NCT02053753|581131705|FG000|Overall Study|Decision by Sponsor|1|||
160928017|NCT02053753|581131706|FG001|Overall Study|Decision by Sponsor|1|||
160454992|NCT04737330|579396265|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
160454993|NCT04737330|579396264|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
160454994|NCT04737330|579396265|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
160454995|NCT03295721|579396269|FG000|Overall Study|Adverse Event|1|||
160454996|NCT03295721|579396270|FG001|Overall Study|Adverse Event|0|||
160454997|NCT03295721|579396271|FG002|Overall Study|Adverse Event|0|||
160655872|NCT04817891|580120288|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
160655873|NCT04817891|580120288|FG000|Overall Study|Adverse Event|1|||
160655874|NCT04817891|580120288|FG000|Overall Study|Withdrawal by Subject|1|||
160655875|NCT03982433|580120289|FG000|Overall Study|Lost to Follow-up|1|||
160655876|NCT04981912|580120290|FG000|Overall Study|Physician Decision|2|||
160928018|NCT02053753|581131705|FG000|Overall Study|Lost to Follow-up|4|||
160928019|NCT02053753|581131706|FG001|Overall Study|Lost to Follow-up|3|||
160928020|NCT01505608|581131707|FG000|Phase I|Lack of Efficacy|0|||
160928021|NCT01505608|581131708|FG001|Phase I|Lack of Efficacy|4|||
160928022|NCT01505608|581131707|FG000|Phase I|Adverse Event|0|||
160928023|NCT01505608|581131708|FG001|Phase I|Adverse Event|1|||
160454998|NCT03295721|579396269|FG000|Overall Study|Lost to Follow-up|1|||
160928024|NCT01505608|581131707|FG000|Phase I|Withdrawal by Subject|0|||
160928025|NCT01505608|581131708|FG001|Phase I|Withdrawal by Subject|1|||
160928026|NCT01505608|581131707|FG000|Phase II|Lack of Efficacy|2|||
160578021|NCT00916721|579836378|FG001|Overall Study|Adverse Event|3|||
160578022|NCT00916721|579836377|FG000|Overall Study|Withdrawal by Subject|2|||
160578023|NCT00916721|579836378|FG001|Overall Study|Withdrawal by Subject|2|||
160578024|NCT00916721|579836377|FG000|Overall Study|Protocol Violation|2|||
160578025|NCT00916721|579836378|FG001|Overall Study|Protocol Violation|4|||
160578026|NCT03648996|579836379|FG000|Overall Study|Withdrawal by Subject|0|||
160578027|NCT03648996|579836380|FG001|Overall Study|Withdrawal by Subject|2|||
160578028|NCT03648996|579836381|FG002|Overall Study|Withdrawal by Subject|2|||
160655877|NCT04257929|580120291|FG000|Overall Study|Adverse Event|1|||
160655878|NCT04257929|580120292|FG001|Overall Study|Adverse Event|0|||
160655879|NCT04257929|580120293|FG002|Overall Study|Adverse Event|1|||
160655880|NCT04257929|580120291|FG000|Overall Study|Withdrawal by Subject|1|||
160655881|NCT04257929|580120292|FG001|Overall Study|Withdrawal by Subject|0|||
160928027|NCT01505608|581131708|FG001|Phase II|Lack of Efficacy|1|||
160928028|NCT01505608|581131707|FG000|Phase II|Protocol Violation|0|||
160928029|NCT01505608|581131708|FG001|Phase II|Protocol Violation|1|||
160928030|NCT02932904|581131709|FG000|Overall Study|Reason not Specified|1|||
160928031|NCT02932904|581131710|FG001|Overall Study|Reason not Specified|0|||
160928032|NCT02932904|581131711|FG002|Overall Study|Reason not Specified|2|||
160928033|NCT02932904|581131712|FG003|Overall Study|Reason not Specified|2|||
160928034|NCT02932904|581131709|FG000|Overall Study|Noncompliance with Study Drug|2|||
160928035|NCT02932904|581131710|FG001|Overall Study|Noncompliance with Study Drug|3|||
160928036|NCT02932904|581131711|FG002|Overall Study|Noncompliance with Study Drug|3|||
160928037|NCT02932904|581131712|FG003|Overall Study|Noncompliance with Study Drug|4|||
160928038|NCT02932904|581131709|FG000|Overall Study|Pregnancy|0|||
160928039|NCT02932904|581131710|FG001|Overall Study|Pregnancy|1|||
160928040|NCT02932904|581131711|FG002|Overall Study|Pregnancy|1|||
160928041|NCT02932904|581131712|FG003|Overall Study|Pregnancy|0|||
160928042|NCT02932904|581131709|FG000|Overall Study|Study Termination|0|||
160928043|NCT02932904|581131710|FG001|Overall Study|Study Termination|1|||
160928044|NCT02932904|581131711|FG002|Overall Study|Study Termination|0|||
160928045|NCT02932904|581131712|FG003|Overall Study|Study Termination|0|||
160928046|NCT02932904|581131709|FG000|Overall Study|Voluntary Withdrawal|2|||
160928047|NCT02932904|581131710|FG001|Overall Study|Voluntary Withdrawal|1|||
160928048|NCT02932904|581131711|FG002|Overall Study|Voluntary Withdrawal|4|||
160928049|NCT02932904|581131712|FG003|Overall Study|Voluntary Withdrawal|2|||
160928050|NCT02932904|581131709|FG000|Overall Study|Lost to Follow-up|5|||
160928051|NCT02932904|581131710|FG001|Overall Study|Lost to Follow-up|3|||
160928052|NCT02932904|581131711|FG002|Overall Study|Lost to Follow-up|6|||
160928053|NCT02932904|581131712|FG003|Overall Study|Lost to Follow-up|0|||
160928054|NCT02932904|581131709|FG000|Overall Study|Significant Protocol Deviation|2|||
160928055|NCT02932904|581131710|FG001|Overall Study|Significant Protocol Deviation|3|||
160928056|NCT02932904|581131711|FG002|Overall Study|Significant Protocol Deviation|6|||
160928057|NCT02932904|581131712|FG003|Overall Study|Significant Protocol Deviation|1|||
160928058|NCT02932904|581131709|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
160928059|NCT02932904|581131710|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
160928060|NCT02932904|581131711|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
160928061|NCT02932904|581131712|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
160928062|NCT02932904|581131709|FG000|Overall Study|Randomized But Not Treated|1|||
160928063|NCT02932904|581131710|FG001|Overall Study|Randomized But Not Treated|1|||
160928064|NCT02932904|581131711|FG002|Overall Study|Randomized But Not Treated|0|||
160928065|NCT02932904|581131712|FG003|Overall Study|Randomized But Not Treated|2|||
160928066|NCT00751348|581131718|FG000|Overall Study|Withdrawal by Subject|5|||
160928067|NCT00751348|581131719|FG001|Overall Study|Withdrawal by Subject|2|||
160928068|NCT00751348|581131718|FG000|Overall Study|Migration from study area|1|||
160928069|NCT00751348|581131719|FG001|Overall Study|Migration from study area|0|||
160928070|NCT01476696|581131725|FG000|Overall Study|Sponsor decision|2|||
160928071|NCT01476696|581131726|FG001|Overall Study|Sponsor decision|1|||
160928072|NCT01476696|581131727|FG002|Overall Study|Sponsor decision|0|||
160578029|NCT03648996|579836379|FG000|Overall Study|Physician Decision|2|||
160928073|NCT01476696|581131725|FG000|Overall Study|Withdrawal by Subject|1|||
160928074|NCT01476696|581131726|FG001|Overall Study|Withdrawal by Subject|0|||
160928075|NCT01476696|581131727|FG002|Overall Study|Withdrawal by Subject|0|||
160928076|NCT02063737|581131728|FG000|Overall Study|Lost to Follow-up|11|||
160928077|NCT02063737|581131729|FG001|Overall Study|Lost to Follow-up|4|||
160928078|NCT00129129|581131733|FG000|Primary Phase|Adverse Event|2|||
160928079|NCT00129129|581131734|FG001|Primary Phase|Adverse Event|1|||
160578030|NCT03648996|579836380|FG001|Overall Study|Physician Decision|0|||
160578031|NCT03648996|579836381|FG002|Overall Study|Physician Decision|0|||
160578032|NCT00365976|579836385|FG000|Overall Study|Withdrawal by Subject|1|||
160655882|NCT04257929|580120293|FG002|Overall Study|Withdrawal by Subject|0|||
160928080|NCT00129129|581131735|FG002|Primary Phase|Adverse Event|0|||
160998074|NCT00094809|581378534|FG000|Overall Study|Informed consent signed after treatment|1|||
160578033|NCT00365976|579836386|FG001|Overall Study|Withdrawal by Subject|5|||
160655883|NCT04257929|580120291|FG000|Overall Study|COVID-19|0|||
160928081|NCT00129129|581131736|FG003|Primary Phase|Adverse Event|0|||
160928082|NCT00129129|581131737|FG004|Primary Phase|Adverse Event|0|||
160928083|NCT00129129|581131733|FG000|Primary Phase|Withdrawal by Subject|12|||
160578034|NCT00798967|579836387|FG000|Overall Study|Adverse Event|2|||
160578035|NCT00798967|579836388|FG001|Overall Study|Adverse Event|3|||
160578036|NCT00798967|579836387|FG000|Overall Study|Withdrawal by Subject|0|||
160578037|NCT00798967|579836388|FG001|Overall Study|Withdrawal by Subject|1|||
160578038|NCT00798967|579836387|FG000|Overall Study|Physician Decision|1|||
160578039|NCT00798967|579836388|FG001|Overall Study|Physician Decision|0|||
160578040|NCT00798967|579836387|FG000|Overall Study|Randomized in error by site|1|||
160578041|NCT00798967|579836388|FG001|Overall Study|Randomized in error by site|0|||
160578042|NCT01415440|579836389|FG000|Overall Study|Lost to Follow-up|0|||
160578043|NCT01415440|579836390|FG001|Overall Study|Lost to Follow-up|1|||
160578044|NCT01415440|579836391|FG002|Overall Study|Lost to Follow-up|2|||
160578045|NCT01415440|579836389|FG000|Overall Study|Physician Decision|3|||
160578046|NCT01415440|579836390|FG001|Overall Study|Physician Decision|0|||
160578047|NCT01415440|579836391|FG002|Overall Study|Physician Decision|0|||
160928084|NCT00129129|581131734|FG001|Primary Phase|Withdrawal by Subject|10|||
160928085|NCT00129129|581131735|FG002|Primary Phase|Withdrawal by Subject|0|||
160928086|NCT00129129|581131736|FG003|Primary Phase|Withdrawal by Subject|0|||
160928087|NCT00129129|581131737|FG004|Primary Phase|Withdrawal by Subject|0|||
160928088|NCT00129129|581131733|FG000|Primary Phase|Migration from study area|1|||
160928089|NCT00129129|581131734|FG001|Primary Phase|Migration from study area|3|||
160928090|NCT00129129|581131735|FG002|Primary Phase|Migration from study area|0|||
160928091|NCT00129129|581131736|FG003|Primary Phase|Migration from study area|0|||
160928092|NCT00129129|581131737|FG004|Primary Phase|Migration from study area|0|||
160928093|NCT00129129|581131733|FG000|Primary Phase|Lost to Follow-up|8|||
160928094|NCT00129129|581131734|FG001|Primary Phase|Lost to Follow-up|6|||
160928095|NCT00129129|581131735|FG002|Primary Phase|Lost to Follow-up|0|||
160928096|NCT00129129|581131736|FG003|Primary Phase|Lost to Follow-up|0|||
160928097|NCT00129129|581131737|FG004|Primary Phase|Lost to Follow-up|0|||
160928098|NCT00129129|581131733|FG000|Primary Phase|Other|2|||
160928099|NCT00129129|581131734|FG001|Primary Phase|Other|5|||
160928100|NCT00129129|581131735|FG002|Primary Phase|Other|0|||
160928101|NCT00129129|581131736|FG003|Primary Phase|Other|0|||
160928102|NCT00129129|581131737|FG004|Primary Phase|Other|0|||
160928103|NCT00129129|581131733|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
160928104|NCT00129129|581131734|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
160928105|NCT00129129|581131735|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
160928106|NCT00129129|581131736|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
160928107|NCT00129129|581131737|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
160928108|NCT00129129|581131733|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
160928109|NCT00129129|581131734|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
160928110|NCT00129129|581131735|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
160928111|NCT00129129|581131736|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
160928112|NCT00129129|581131737|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
160928113|NCT00129129|581131733|FG000|Fourth Dose Phase|Migration from study area|0|||
160928114|NCT00129129|581131734|FG001|Fourth Dose Phase|Migration from study area|0|||
160928115|NCT00129129|581131735|FG002|Fourth Dose Phase|Migration from study area|0|||
160928116|NCT00129129|581131736|FG003|Fourth Dose Phase|Migration from study area|0|||
160928117|NCT00129129|581131737|FG004|Fourth Dose Phase|Migration from study area|2|||
160928118|NCT00129129|581131733|FG000|Fourth Dose Phase|Other|0|||
160928119|NCT00129129|581131734|FG001|Fourth Dose Phase|Other|0|||
160928120|NCT00129129|581131735|FG002|Fourth Dose Phase|Other|0|||
160928121|NCT00129129|581131736|FG003|Fourth Dose Phase|Other|1|||
160928122|NCT00129129|581131737|FG004|Fourth Dose Phase|Other|1|||
160928123|NCT00129129|581131733|FG000|Fourth Dose Phase|Protocol Violation|0|||
160928124|NCT00129129|581131734|FG001|Fourth Dose Phase|Protocol Violation|0|||
160928125|NCT00129129|581131735|FG002|Fourth Dose Phase|Protocol Violation|0|||
160928126|NCT00129129|581131736|FG003|Fourth Dose Phase|Protocol Violation|1|||
160928127|NCT00129129|581131737|FG004|Fourth Dose Phase|Protocol Violation|0|||
160998075|NCT00094809|581378535|FG001|Overall Study|Informed consent signed after treatment|0|||
160578048|NCT01415440|579836389|FG000|Overall Study|Withdrawal by Subject|1|||
160578049|NCT01415440|579836390|FG001|Overall Study|Withdrawal by Subject|0|||
160578050|NCT01415440|579836391|FG002|Overall Study|Withdrawal by Subject|0|||
160578051|NCT01781026|579836394|FG000|Overall Study|Lack of Efficacy|2|||
160578052|NCT00227877|579836395|FG000|Pre-visit Assessment|Technical difficulties|7|||
160578053|NCT00227877|579836396|FG001|Pre-visit Assessment|Technical difficulties|3|||
160578054|NCT00227877|579836397|FG002|Pre-visit Assessment|Technical difficulties|0|||
160928128|NCT03089606|581131740|FG000|Overall Study|Progression after Cycle 1|1|||
160928129|NCT03965962|581131741|FG000|Overall Study|Adverse Event|1|||
160928130|NCT03965962|581131742|FG001|Overall Study|Adverse Event|0|||
160928131|NCT03965962|581131743|FG002|Overall Study|Adverse Event|0|||
160928132|NCT03965962|581131744|FG003|Overall Study|Adverse Event|0|||
160928133|NCT03965962|581131741|FG000|Overall Study|Protocol Violation|21|||
160928134|NCT03965962|581131742|FG001|Overall Study|Protocol Violation|4|||
160928135|NCT03965962|581131743|FG002|Overall Study|Protocol Violation|10|||
160928136|NCT03965962|581131744|FG003|Overall Study|Protocol Violation|5|||
160928137|NCT03965962|581131741|FG000|Overall Study|Lost to Follow-up|0|||
160928138|NCT03965962|581131742|FG001|Overall Study|Lost to Follow-up|1|||
160928139|NCT03965962|581131743|FG002|Overall Study|Lost to Follow-up|0|||
160928140|NCT03965962|581131744|FG003|Overall Study|Lost to Follow-up|0|||
160928141|NCT03965962|581131741|FG000|Overall Study|Withdrawal by Subject|3|||
160928142|NCT03965962|581131742|FG001|Overall Study|Withdrawal by Subject|0|||
160928143|NCT03965962|581131743|FG002|Overall Study|Withdrawal by Subject|0|||
160928144|NCT03965962|581131744|FG003|Overall Study|Withdrawal by Subject|1|||
160928145|NCT01358357|581131748|FG000|Open Label Phase|Adverse Event|0|||
160928146|NCT01358357|581131749|FG001|Open Label Phase|Adverse Event|0|||
160928147|NCT01358357|581131750|FG002|Open Label Phase|Adverse Event|59|||
160928148|NCT01358357|581131748|FG000|Open Label Phase|Lack of Efficacy|0|||
160928149|NCT01358357|581131749|FG001|Open Label Phase|Lack of Efficacy|0|||
160928150|NCT01358357|581131750|FG002|Open Label Phase|Lack of Efficacy|107|||
160928151|NCT01358357|581131748|FG000|Open Label Phase|Lost to Follow-up|0|||
160928152|NCT01358357|581131749|FG001|Open Label Phase|Lost to Follow-up|0|||
160928153|NCT01358357|581131750|FG002|Open Label Phase|Lost to Follow-up|76|||
160928154|NCT01358357|581131748|FG000|Open Label Phase|Protocol Violation|0|||
160928155|NCT01358357|581131749|FG001|Open Label Phase|Protocol Violation|0|||
160928156|NCT01358357|581131750|FG002|Open Label Phase|Protocol Violation|45|||
160928157|NCT01358357|581131748|FG000|Open Label Phase|Withdrawal by Subject|0|||
160928158|NCT01358357|581131749|FG001|Open Label Phase|Withdrawal by Subject|0|||
160928159|NCT01358357|581131750|FG002|Open Label Phase|Withdrawal by Subject|112|||
160928160|NCT01358357|581131748|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
160928161|NCT01358357|581131749|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
160928162|NCT01358357|581131750|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
160928163|NCT01358357|581131748|FG000|Open Label Phase|Terminated at study completion|0|||
160928164|NCT01358357|581131749|FG001|Open Label Phase|Terminated at study completion|0|||
160928165|NCT01358357|581131750|FG002|Open Label Phase|Terminated at study completion|5|||
160928166|NCT01358357|581131748|FG000|Open Label Phase|Mood episode|0|||
160928167|NCT01358357|581131749|FG001|Open Label Phase|Mood episode|0|||
160928168|NCT01358357|581131750|FG002|Open Label Phase|Mood episode|42|||
160928169|NCT01358357|581131748|FG000|Double-Blind Phase|Adverse Event|8|||
160928170|NCT01358357|581131749|FG001|Double-Blind Phase|Adverse Event|5|||
160928171|NCT01358357|581131750|FG002|Double-Blind Phase|Adverse Event|0|||
160928172|NCT01358357|581131748|FG000|Double-Blind Phase|Lost to Follow-up|5|||
160928173|NCT01358357|581131749|FG001|Double-Blind Phase|Lost to Follow-up|7|||
160928174|NCT01358357|581131750|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160928175|NCT01358357|581131748|FG000|Double-Blind Phase|Protocol Violation|1|||
160928176|NCT01358357|581131749|FG001|Double-Blind Phase|Protocol Violation|11|||
160928177|NCT01358357|581131750|FG002|Double-Blind Phase|Protocol Violation|0|||
160928178|NCT01358357|581131748|FG000|Double-Blind Phase|Protocol Violation|16|||
160928179|NCT01358357|581131749|FG001|Double-Blind Phase|Protocol Violation|12|||
160928180|NCT01358357|581131750|FG002|Double-Blind Phase|Protocol Violation|0|||
160578055|NCT00227877|579836398|FG003|Pre-visit Assessment|Technical difficulties|0|||
160928181|NCT01358357|581131748|FG000|Double-Blind Phase|Terminated at study completion|2|||
160928182|NCT01358357|581131749|FG001|Double-Blind Phase|Terminated at study completion|0|||
160928183|NCT01358357|581131750|FG002|Double-Blind Phase|Terminated at study completion|0|||
160928184|NCT01358357|581131748|FG000|Double-Blind Phase|Recurrence of mood event|48|||
160928185|NCT01358357|581131749|FG001|Double-Blind Phase|Recurrence of mood event|64|||
160578056|NCT00227877|579836395|FG000|Post-visit Checklist|Lost to Follow-up|24|||
160578057|NCT00227877|579836396|FG001|Post-visit Checklist|Lost to Follow-up|13|||
160578058|NCT00227877|579836397|FG002|Post-visit Checklist|Lost to Follow-up|1|||
160578059|NCT00227877|579836398|FG003|Post-visit Checklist|Lost to Follow-up|0|||
160578060|NCT00227877|579836395|FG000|3-months Follow-up|Completed late|135|||
160578061|NCT00227877|579836396|FG001|3-months Follow-up|Completed late|128|||
160578062|NCT00227877|579836397|FG002|3-months Follow-up|Completed late|34|||
160578063|NCT00227877|579836398|FG003|3-months Follow-up|Completed late|8|||
160578064|NCT00227877|579836395|FG000|3-months Follow-up|Lost to Follow-up|178|||
160578065|NCT00227877|579836396|FG001|3-months Follow-up|Lost to Follow-up|139|||
160578066|NCT00227877|579836397|FG002|3-months Follow-up|Lost to Follow-up|18|||
160578067|NCT00227877|579836398|FG003|3-months Follow-up|Lost to Follow-up|13|||
160578068|NCT00227877|579836395|FG000|12-months Follow-up|Completed late|78|||
160578069|NCT00227877|579836396|FG001|12-months Follow-up|Completed late|74|||
160578070|NCT00227877|579836397|FG002|12-months Follow-up|Completed late|1|||
160928186|NCT01358357|581131750|FG002|Double-Blind Phase|Recurrence of mood event|0|||
160928187|NCT01358357|581131748|FG000|Double-Blind Phase|Administrative|0|||
160928188|NCT01358357|581131749|FG001|Double-Blind Phase|Administrative|1|||
160578071|NCT00227877|579836398|FG003|12-months Follow-up|Completed late|0|||
160578072|NCT00227877|579836395|FG000|12-months Follow-up|Lost to Follow-up|232|||
160928189|NCT01358357|581131750|FG002|Double-Blind Phase|Administrative|0|||
160928190|NCT02590939|581131751|FG000|Overall Study|Withdrawal by Subject|3|||
160928191|NCT02590939|581131752|FG001|Overall Study|Withdrawal by Subject|1|||
160928192|NCT02590939|581131751|FG000|Overall Study|Failed the nociceptive test|2|||
160928193|NCT02590939|581131752|FG001|Overall Study|Failed the nociceptive test|1|||
160928194|NCT00768144|581131757|FG000|Overall Study|Adverse Event|13|||
160928195|NCT00768144|581131757|FG000|Overall Study|Progressive Disease|21|||
160928196|NCT00768144|581131757|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
160578073|NCT00227877|579836396|FG001|12-months Follow-up|Lost to Follow-up|189|||
160578074|NCT00227877|579836397|FG002|12-months Follow-up|Lost to Follow-up|30|||
160578075|NCT00227877|579836398|FG003|12-months Follow-up|Lost to Follow-up|26|||
160928197|NCT00768144|581131757|FG000|Overall Study|Pt Withdrew Consent|1|||
160928198|NCT02225743|581131758|FG000|Overall Study|Withdrawal by Subject|18|||
160928199|NCT02171260|581131759|FG000|Overall Study|Death|0|||
160928200|NCT02171260|581131760|FG001|Overall Study|Death|0|||
160928201|NCT02171260|581131761|FG002|Overall Study|Death|0|||
160928202|NCT02171260|581131762|FG003|Overall Study|Death|1|||
160928203|NCT02171260|581131759|FG000|Overall Study|Physician Decision|1|||
160928204|NCT02171260|581131760|FG001|Overall Study|Physician Decision|0|||
160928205|NCT02171260|581131761|FG002|Overall Study|Physician Decision|1|||
160928206|NCT02171260|581131762|FG003|Overall Study|Physician Decision|0|||
160928207|NCT02171260|581131759|FG000|Overall Study|Withdrawal by Subject|1|||
160928208|NCT02171260|581131760|FG001|Overall Study|Withdrawal by Subject|0|||
160928209|NCT02171260|581131761|FG002|Overall Study|Withdrawal by Subject|0|||
160928210|NCT02171260|581131762|FG003|Overall Study|Withdrawal by Subject|0|||
160928211|NCT02171260|581131759|FG000|Overall Study|Evidence of progressive disease|4|||
160928212|NCT02171260|581131760|FG001|Overall Study|Evidence of progressive disease|6|||
160928213|NCT02171260|581131761|FG002|Overall Study|Evidence of progressive disease|4|||
160928214|NCT02171260|581131762|FG003|Overall Study|Evidence of progressive disease|4|||
160928215|NCT00322842|581131765|FG000|Overall Study|Withdrawal by Subject|0|||
160928216|NCT00322842|581131766|FG001|Overall Study|Withdrawal by Subject|1|||
160928217|NCT00322842|581131765|FG000|Overall Study|Lost to Follow-up|0|||
160928218|NCT00322842|581131766|FG001|Overall Study|Lost to Follow-up|1|||
160928219|NCT00322842|581131765|FG000|Overall Study|Refused transplant|1|||
160928220|NCT00322842|581131766|FG001|Overall Study|Refused transplant|0|||
160928221|NCT00322842|581131765|FG000|Overall Study|Death|1|||
160928222|NCT00322842|581131766|FG001|Overall Study|Death|0|||
160928223|NCT00323492|581131767|FG000|Study Phase 1|Adverse Event|2|||
160928224|NCT00323492|581131768|FG001|Study Phase 1|Adverse Event|0|||
160928225|NCT00323492|581131769|FG002|Study Phase 1|Adverse Event|0|||
160928226|NCT00323492|581131767|FG000|Study Phase 2|Adverse Event|1|||
160928227|NCT00323492|581131768|FG001|Study Phase 2|Adverse Event|0|||
160928228|NCT00323492|581131769|FG002|Study Phase 2|Adverse Event|0|||
160928229|NCT00323492|581131767|FG000|Study Phase 2|Physician Decision|1|||
160928230|NCT00323492|581131768|FG001|Study Phase 2|Physician Decision|0|||
160928231|NCT00323492|581131769|FG002|Study Phase 2|Physician Decision|0|||
160928232|NCT00323492|581131767|FG000|Study Phase 2|Lost to Follow-up|1|||
160928233|NCT00323492|581131768|FG001|Study Phase 2|Lost to Follow-up|0|||
160928234|NCT00323492|581131769|FG002|Study Phase 2|Lost to Follow-up|0|||
160928235|NCT00323492|581131767|FG000|Study Phase 2|Withdrawal by Subject|0|||
160928236|NCT00323492|581131768|FG001|Study Phase 2|Withdrawal by Subject|1|||
160928237|NCT00323492|581131769|FG002|Study Phase 2|Withdrawal by Subject|0|||
160928238|NCT00323492|581131767|FG000|Study Phase 2|Noncompliance with study schedule|0|||
160928239|NCT00323492|581131768|FG001|Study Phase 2|Noncompliance with study schedule|0|||
160928240|NCT00323492|581131769|FG002|Study Phase 2|Noncompliance with study schedule|1|||
160928241|NCT00323492|581131767|FG000|Study Phase 2|Protocol Violation|1|||
160928242|NCT00323492|581131768|FG001|Study Phase 2|Protocol Violation|0|||
160928243|NCT00323492|581131769|FG002|Study Phase 2|Protocol Violation|0|||
160928244|NCT02486042|581131770|FG000|Overall Study|Physician Decision|1|||
160928245|NCT02486042|581131771|FG001|Overall Study|Physician Decision|7|||
160928246|NCT02486042|581131770|FG000|Overall Study|Hospital transfer|2|||
160928247|NCT02486042|581131771|FG001|Overall Study|Hospital transfer|2|||
160928248|NCT02486042|581131770|FG000|Overall Study|Withdrawal by Subject|0|||
160928249|NCT02486042|581131771|FG001|Overall Study|Withdrawal by Subject|2|||
160928250|NCT00673179|581131783|FG000|Overall Study|Toxicity/Complications|3|||
160928251|NCT00673179|581131784|FG001|Overall Study|Toxicity/Complications|0|||
160578076|NCT03090737|579836399|FG000|Overall Study|Other reasons|1|||
160578077|NCT03090737|579836399|FG000|Overall Study|Completed treatment as per protocol|17|||
160578078|NCT03090737|579836399|FG000|Overall Study|Maximum clinical benefit|2|||
160578079|NCT03090737|579836399|FG000|Overall Study|Adverse event unrelated to study drug|7|||
160928252|NCT00352846|581131785|FG000|Overall Study|Disease progression|0|||
160928253|NCT00352846|581131786|FG001|Overall Study|Disease progression|2|||
160928254|NCT00352846|581131785|FG000|Overall Study|Withdrawal by Subject|3|||
160928255|NCT00352846|581131786|FG001|Overall Study|Withdrawal by Subject|8|||
160928256|NCT00352846|581131785|FG000|Overall Study|Ineligible|3|||
160928257|NCT00352846|581131786|FG001|Overall Study|Ineligible|2|||
160928258|NCT00352846|581131785|FG000|Overall Study|Non-compliance|2|||
160928259|NCT00352846|581131786|FG001|Overall Study|Non-compliance|0|||
160928260|NCT00352846|581131785|FG000|Overall Study|Death|0|||
160928261|NCT00352846|581131786|FG001|Overall Study|Death|1|||
160928262|NCT00281684|581131787|FG000|Overall Study|Lost to Follow-up|0|||
160928263|NCT00281684|581131788|FG001|Overall Study|Lost to Follow-up|0|||
160928264|NCT00281684|581131789|FG002|Overall Study|Lost to Follow-up|1|||
160578080|NCT03090737|579836399|FG000|Overall Study|Study drug toxicity|4|||
160578081|NCT03090737|579836399|FG000|Overall Study|Disease progression|98|||
160928265|NCT00281684|581131790|FG003|Overall Study|Lost to Follow-up|0|||
160928266|NCT00281684|581131787|FG000|Overall Study|Withdrawal by Subject|1|||
160578082|NCT03141307|579836400|FG000|In-Hospital|Withdrawal by Subject|0|||
160578083|NCT03141307|579836401|FG001|In-Hospital|Withdrawal by Subject|2|||
160578084|NCT03141307|579836400|FG000|In-Hospital|Protocol Violation|4|||
160578085|NCT03141307|579836401|FG001|In-Hospital|Protocol Violation|0|||
160578086|NCT03141307|579836400|FG000|Follow-Up|Lost to Follow-up|97|||
160578087|NCT03141307|579836401|FG001|Follow-Up|Lost to Follow-up|54|||
160578088|NCT03596177|579836404|FG000|Single Blind Period|Withdrawal by Subject|1|||
160578089|NCT03596177|579836405|FG001|Single Blind Period|Withdrawal by Subject|1|||
160578090|NCT03596177|579836404|FG000|Single Blind Period|Other|1|||
160578091|NCT03596177|579836405|FG001|Single Blind Period|Other|0|||
160578092|NCT03596177|579836404|FG000|Double Blind Period|Withdrawal by Subject|0|||
160578093|NCT03596177|579836405|FG001|Double Blind Period|Withdrawal by Subject|1|||
160578094|NCT03596177|579836404|FG000|Double Blind Period|Other|0|||
160578095|NCT03596177|579836405|FG001|Double Blind Period|Other|4|||
160578096|NCT03596177|579836404|FG000|Double Blind Period|Death during safety follow-up|0|||
160578097|NCT03596177|579836405|FG001|Double Blind Period|Death during safety follow-up|1|||
160578098|NCT04400318|579838246|FG000|Overall Study|Adverse Event|1|||
160578099|NCT04400318|579838247|FG001|Overall Study|Adverse Event|0|||
160578100|NCT04400318|579838246|FG000|Overall Study|Withdrawal by Subject|1|||
160578101|NCT04400318|579838247|FG001|Overall Study|Withdrawal by Subject|1|||
160578102|NCT04400318|579838246|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
160578103|NCT04400318|579838247|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
160578104|NCT02819310|579838255|FG000|Overall Study|Withdrawal by Subject|37|||
160578105|NCT02819310|579838255|FG000|Overall Study|Lost to Follow-up|16|||
160578106|NCT02819310|579838255|FG000|Overall Study|Adverse Event|13|||
160578107|NCT02819310|579838255|FG000|Overall Study|Lack of Efficacy|5|||
160928267|NCT00281684|581131788|FG001|Overall Study|Withdrawal by Subject|0|||
160928268|NCT00281684|581131789|FG002|Overall Study|Withdrawal by Subject|0|||
160928269|NCT00281684|581131790|FG003|Overall Study|Withdrawal by Subject|0|||
160928270|NCT01527682|581131791|FG000|Overall Study|Protocol Violation|8|||
160928271|NCT04668950|581131793|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
160928272|NCT04668950|581131794|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
160928273|NCT04668950|581131793|FG000|Overall Study|Could not confirm started study medication|15|||
160928274|NCT04668950|581131794|FG001|Overall Study|Could not confirm started study medication|15|||
160928275|NCT04668950|581131793|FG000|Overall Study|Could not confirm baseline status|6|||
160928276|NCT04668950|581131794|FG001|Overall Study|Could not confirm baseline status|2|||
160928277|NCT04668950|581131793|FG000|Overall Study|Drop out and did not start medication|15|||
160928278|NCT04668950|581131794|FG001|Overall Study|Drop out and did not start medication|17|||
160928279|NCT04668950|581131793|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
160928280|NCT04668950|581131794|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
160928281|NCT04668950|581131793|FG000|Overall Study|Other|2|||
160928282|NCT04668950|581131794|FG001|Overall Study|Other|4|||
160928283|NCT03979638|581131795|FG000|Period 1|Physician Decision|1|||
160928284|NCT03979638|581131796|FG001|Period 1|Physician Decision|1|||
160928285|NCT03979638|581131795|FG000|Period 1|Withdrawal by Subject|4|||
160928286|NCT03979638|581131796|FG001|Period 1|Withdrawal by Subject|3|||
160928287|NCT03979638|581131795|FG000|Period 1|Study terminated by Sponsor|1|||
160928288|NCT03979638|581131796|FG001|Period 1|Study terminated by Sponsor|3|||
160928289|NCT03979638|581131795|FG000|Period 1|Protocol Violation|1|||
160928290|NCT03979638|581131796|FG001|Period 1|Protocol Violation|0|||
160928291|NCT03979638|581131795|FG000|Period 2|Study terminated by Sponsor|1|||
160928292|NCT03979638|581131796|FG001|Period 2|Study terminated by Sponsor|1|||
160928293|NCT01531387|581131799|FG000|Overall Study|Early termination of study|11|||
160928294|NCT01531387|581131800|FG001|Overall Study|Early termination of study|11|||
160928295|NCT00578942|581131801|FG000|Overall Study|Lost to Follow-up|1|||
160928296|NCT01124643|581131804|FG000|Overall Study|Death|1|||
160928297|NCT04220411|581131805|FG000|Overall Study|Adverse Event|0|||
160928298|NCT04220411|581131806|FG001|Overall Study|Adverse Event|0|||
160928299|NCT04220411|581131807|FG002|Overall Study|Adverse Event|0|||
160928300|NCT04220411|581131808|FG003|Overall Study|Adverse Event|1|||
160578108|NCT02819310|579838255|FG000|Overall Study|Physician Decision|8|||
160578109|NCT02819310|579838255|FG000|Overall Study|Protocol Violation|30|||
160928301|NCT02678676|581131809|FG000|Overall Study|Death|619|||
160928302|NCT02678676|581131810|FG001|Overall Study|Death|649|||
160928303|NCT02678676|581131809|FG000|Overall Study|Withdrawal by Subject|13|||
160928304|NCT02678676|581131810|FG001|Overall Study|Withdrawal by Subject|5|||
160928305|NCT02678676|581131809|FG000|Overall Study|Lost to Follow-up|171|||
160578110|NCT01793051|579838256|FG000|Overall Study|Withdrawal by Subject|6|||
160578111|NCT01793051|579838257|FG001|Overall Study|Withdrawal by Subject|4|||
160928306|NCT02678676|581131810|FG001|Overall Study|Lost to Follow-up|151|||
160578112|NCT01793051|579838256|FG000|Overall Study|Adverse Event|0|||
160578113|NCT01793051|579838257|FG001|Overall Study|Adverse Event|2|||
160928307|NCT02678676|581131809|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
160998076|NCT00094809|581378534|FG000|Overall Study|Study drug not received|2|||
160578114|NCT01793051|579838256|FG000|Overall Study|Too ill to continue|1|||
160578115|NCT01793051|579838257|FG001|Overall Study|Too ill to continue|0|||
160928308|NCT02678676|581131810|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
160928309|NCT01400516|581131814|FG000|Primary Trial|Withdrawal by Subject|0|||
160928310|NCT01400516|581131815|FG001|Primary Trial|Withdrawal by Subject|2|||
160928311|NCT00549562|581131818|FG000|Overall Study|Adverse Event|1|||
160928312|NCT00549562|581131818|FG000|Overall Study|Lack of Efficacy|1|||
160928313|NCT00403273|581133320|FG000|Overall Study|Lost to Follow-up|3|||
160928314|NCT00403273|581133321|FG001|Overall Study|Lost to Follow-up|2|||
160928315|NCT00403273|581133320|FG000|Overall Study|Physician Decision|0|||
160928316|NCT00403273|581133321|FG001|Overall Study|Physician Decision|1|||
160928317|NCT00403273|581133320|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
160928318|NCT00403273|581133321|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
160928319|NCT00502697|581133327|FG000|Overall Study|Withdrawal by Subject|3|||
160928320|NCT00502697|581133328|FG001|Overall Study|Withdrawal by Subject|1|||
160928321|NCT00502697|581133327|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
160928322|NCT00502697|581133328|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
160928323|NCT00502697|581133327|FG000|Overall Study|found not to meet eligibility criteria|3|||
160928324|NCT00502697|581133328|FG001|Overall Study|found not to meet eligibility criteria|4|||
160928325|NCT00502697|581133327|FG000|Overall Study|did not meet assignment criteria|4|||
160928326|NCT00502697|581133328|FG001|Overall Study|did not meet assignment criteria|2|||
160928327|NCT03256552|581133332|FG000|Overall Study|Protocol Violation|1|||
160928328|NCT03256552|581133332|FG000|Overall Study|Physician Decision|1|||
160928329|NCT03256552|581133332|FG000|Overall Study|Adverse Event|1|||
160928330|NCT03256552|581133332|FG000|Overall Study|Withdrawal by Subject|2|||
160928331|NCT03265249|581133341|FG000|Overall Study|Withdrawal by Subject|0|||
160928332|NCT03265249|581133342|FG001|Overall Study|Withdrawal by Subject|1|||
160928333|NCT01012622|581133343|FG000|Overall Study|Withdrawal by Subject|6|||
160928334|NCT01012622|581133343|FG000|Overall Study|Lost to Follow-up|5|||
160578116|NCT01793051|579838256|FG000|Overall Study|Switched chemo|1|||
160578117|NCT01793051|579838257|FG001|Overall Study|Switched chemo|1|||
160578118|NCT01793051|579838256|FG000|Overall Study|Lack of compliance|1|||
160578119|NCT01793051|579838257|FG001|Overall Study|Lack of compliance|0|||
160578120|NCT01793051|579838256|FG000|Overall Study|Requested to be removed from the study|1|||
160578121|NCT01793051|579838257|FG001|Overall Study|Requested to be removed from the study|1|||
160578122|NCT02778867|579838258|FG000|Phase 1|Withdrawal by Subject|2|||
160578123|NCT02778867|579838259|FG001|Phase 1|Withdrawal by Subject|3|||
160578124|NCT02778867|579838260|FG002|Phase 1|Withdrawal by Subject|0|||
160578125|NCT02778867|579838261|FG003|Phase 1|Withdrawal by Subject|0|||
160578126|NCT02778867|579838258|FG000|Phase 2|Withdrawal by Subject|0|||
160578127|NCT02778867|579838259|FG001|Phase 2|Withdrawal by Subject|0|||
160578128|NCT02778867|579838260|FG002|Phase 2|Withdrawal by Subject|1|||
160578129|NCT02778867|579838261|FG003|Phase 2|Withdrawal by Subject|0|||
160578130|NCT02778867|579838258|FG000|Phase 2|Physician Decision|0|||
160578131|NCT02778867|579838259|FG001|Phase 2|Physician Decision|0|||
160578132|NCT02778867|579838260|FG002|Phase 2|Physician Decision|0|||
160578133|NCT02778867|579838261|FG003|Phase 2|Physician Decision|1|||
160578134|NCT02778867|579838258|FG000|Phase 2|Adverse Event|0|||
160578135|NCT02778867|579838259|FG001|Phase 2|Adverse Event|0|||
160578136|NCT02778867|579838260|FG002|Phase 2|Adverse Event|0|||
160578137|NCT02778867|579838261|FG003|Phase 2|Adverse Event|1|||
160578138|NCT02311478|579838262|FG000|Overall Study|Withdrawal by Subject|1|||
160578139|NCT02311478|579838262|FG000|Overall Study|Lost to Follow-up|5|||
160928335|NCT01012622|581133343|FG000|Overall Study|Adverse Event|7|||
160928336|NCT01012622|581133343|FG000|Overall Study|non-compliance with the drug|9|||
160928337|NCT01012622|581133343|FG000|Overall Study|Other|1|||
160928338|NCT01012622|581133343|FG000|Overall Study|screening failure|1|||
160928339|NCT01012622|581133343|FG000|Overall Study|withdrawal of consent by a parent|2|||
160928340|NCT05664490|581133344|FG000|Overall Study|Withdrawal by Subject|0|||
160928341|NCT05664490|581133345|FG001|Overall Study|Withdrawal by Subject|1|||
160928342|NCT05664490|581133344|FG000|Overall Study|Lost to Follow-up|14|||
160928343|NCT05664490|581133345|FG001|Overall Study|Lost to Follow-up|22|||
160928344|NCT00704535|581133346|FG000|Overall Study|Adverse Event|2|||
160928345|NCT00704535|581133346|FG000|Overall Study|Death|2|||
160928346|NCT00704535|581133346|FG000|Overall Study|Lost to Follow-up|8|||
160928347|NCT00704535|581133346|FG000|Overall Study|Protocol Violation|10|||
160578140|NCT02311478|579838262|FG000|Overall Study|Failed IUD Insertion|1|||
160578141|NCT03276936|579838263|FG000|Overall Study|Adverse Event|4|||
160928348|NCT00704535|581133346|FG000|Overall Study|Completed status not on Case Report Form|124|||
160928349|NCT01589445|581133347|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
160578142|NCT03276936|579838264|FG001|Overall Study|Adverse Event|2|||
160578143|NCT03276936|579838263|FG000|Overall Study|Lost to Follow-up|16|||
160578144|NCT03276936|579838264|FG001|Overall Study|Lost to Follow-up|13|||
160578145|NCT03276936|579838263|FG000|Overall Study|Withdrawal by Subject|30|||
160578146|NCT03276936|579838264|FG001|Overall Study|Withdrawal by Subject|20|||
160928350|NCT01589445|581133347|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
160928351|NCT01589445|581133347|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
160928352|NCT01589445|581133347|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
160928353|NCT01589445|581133347|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
160928354|NCT01589445|581133347|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
160928355|NCT01589445|581133347|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
160928356|NCT01589445|581133347|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
160928357|NCT01589445|581133347|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
160928358|NCT01589445|581133347|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
160928359|NCT00314574|581133351|FG000|Overall Study|Death|3|||
160928360|NCT00314574|581133352|FG001|Overall Study|Death|0|||
160928361|NCT00314574|581133351|FG000|Overall Study|Adverse Event|11|||
160928362|NCT00314574|581133352|FG001|Overall Study|Adverse Event|16|||
160928363|NCT00314574|581133351|FG000|Overall Study|Lost to Follow-up|19|||
160928364|NCT00314574|581133352|FG001|Overall Study|Lost to Follow-up|25|||
160928365|NCT00314574|581133351|FG000|Overall Study|Withdrawal by Subject|33|||
160928366|NCT00314574|581133352|FG001|Overall Study|Withdrawal by Subject|22|||
160928367|NCT00314574|581133351|FG000|Overall Study|Physician Decision|22|||
160928368|NCT00314574|581133352|FG001|Overall Study|Physician Decision|15|||
160928369|NCT00314574|581133351|FG000|Overall Study|Pregnancy|6|||
160928370|NCT00314574|581133352|FG001|Overall Study|Pregnancy|4|||
160928371|NCT00314574|581133351|FG000|Overall Study|Data unknown at database lock|0|||
160928372|NCT00314574|581133352|FG001|Overall Study|Data unknown at database lock|1|||
160928373|NCT03144180|581133357|FG000|Overall Study|STAT Delivery|1|||
160928374|NCT03144180|581133358|FG001|Overall Study|STAT Delivery|1|||
160928375|NCT03144180|581133357|FG000|Overall Study|Provider forgot to fill out forms|1|||
160928376|NCT03144180|581133358|FG001|Overall Study|Provider forgot to fill out forms|3|||
160928377|NCT03144180|581133357|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
160928378|NCT03144180|581133358|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
160928379|NCT03144180|581133357|FG000|Overall Study|Scrub tech removed tube cap|0|||
160928380|NCT03144180|581133358|FG001|Overall Study|Scrub tech removed tube cap|1|||
160928381|NCT00743652|581133363|FG000|Overall Study|Parent/Legal Guardian Request|3|||
160928382|NCT00743652|581133364|FG001|Overall Study|Parent/Legal Guardian Request|2|||
160928383|NCT00743652|581133365|FG002|Overall Study|Parent/Legal Guardian Request|2|||
160928384|NCT00743652|581133366|FG003|Overall Study|Parent/Legal Guardian Request|2|||
160928385|NCT00743652|581133367|FG004|Overall Study|Parent/Legal Guardian Request|0|||
160928386|NCT00743652|581133363|FG000|Overall Study|Adverse Event|3|||
160928387|NCT00743652|581133364|FG001|Overall Study|Adverse Event|0|||
160928388|NCT00743652|581133365|FG002|Overall Study|Adverse Event|0|||
160928389|NCT00743652|581133366|FG003|Overall Study|Adverse Event|0|||
160928390|NCT00743652|581133367|FG004|Overall Study|Adverse Event|0|||
160928391|NCT00743652|581133363|FG000|Overall Study|Death|2|||
160928392|NCT00743652|581133364|FG001|Overall Study|Death|0|||
160928393|NCT00743652|581133365|FG002|Overall Study|Death|0|||
160928394|NCT00743652|581133366|FG003|Overall Study|Death|0|||
160928395|NCT00743652|581133367|FG004|Overall Study|Death|0|||
160928396|NCT00743652|581133363|FG000|Overall Study|Investigator Request|0|||
160928397|NCT00743652|581133364|FG001|Overall Study|Investigator Request|0|||
160928398|NCT00743652|581133365|FG002|Overall Study|Investigator Request|0|||
160928399|NCT00743652|581133366|FG003|Overall Study|Investigator Request|2|||
160928400|NCT00743652|581133367|FG004|Overall Study|Investigator Request|0|||
160928401|NCT00743652|581133363|FG000|Overall Study|Other|1|||
160928402|NCT00743652|581133364|FG001|Overall Study|Other|1|||
160928403|NCT00743652|581133365|FG002|Overall Study|Other|0|||
160928404|NCT00743652|581133366|FG003|Overall Study|Other|0|||
160928405|NCT00743652|581133367|FG004|Overall Study|Other|0|||
160928406|NCT00743652|581133363|FG000|Overall Study|Lost to Follow-up|1|||
160928407|NCT00743652|581133364|FG001|Overall Study|Lost to Follow-up|0|||
160928408|NCT00743652|581133365|FG002|Overall Study|Lost to Follow-up|0|||
160928409|NCT00743652|581133366|FG003|Overall Study|Lost to Follow-up|0|||
160928410|NCT00743652|581133367|FG004|Overall Study|Lost to Follow-up|0|||
160928411|NCT00228917|581133368|FG000|Overall Study|Migrated/moved from study area|0|||
160928412|NCT00228917|581133369|FG001|Overall Study|Migrated/moved from study area|0|||
160928413|NCT00228917|581133370|FG002|Overall Study|Migrated/moved from study area|0|||
160928414|NCT00228917|581133371|FG003|Overall Study|Migrated/moved from study area|0|||
160928415|NCT00228917|581133372|FG004|Overall Study|Migrated/moved from study area|0|||
160928416|NCT00228917|581133373|FG005|Overall Study|Migrated/moved from study area|2|||
160928417|NCT00228917|581133374|FG006|Overall Study|Migrated/moved from study area|0|||
160928418|NCT00228917|581133375|FG007|Overall Study|Migrated/moved from study area|0|||
160928419|NCT04372602|581133378|FG000|Overall Study|Withdrawal by Subject|1|||
160928420|NCT04372602|581133379|FG001|Overall Study|Withdrawal by Subject|1|||
160928421|NCT04372602|581133378|FG000|Overall Study|Adverse Event|0|||
160928422|NCT04372602|581133379|FG001|Overall Study|Adverse Event|1|||
160928423|NCT04372602|581133378|FG000|Overall Study|Transitioned to comfort care|0|||
160928424|NCT04372602|581133379|FG001|Overall Study|Transitioned to comfort care|1|||
160928425|NCT01085097|581133380|FG000|Overall Study|Adverse Event|0|||
160928426|NCT01085097|581133381|FG001|Overall Study|Adverse Event|0|||
160928427|NCT01085097|581133382|FG002|Overall Study|Adverse Event|2|||
160928428|NCT01085097|581133380|FG000|Overall Study|Treatment failure|2|||
160928429|NCT01085097|581133381|FG001|Overall Study|Treatment failure|0|||
160928430|NCT01085097|581133382|FG002|Overall Study|Treatment failure|0|||
160928431|NCT01498640|581133383|FG000|Overall Study|Lost to Follow-up|1|||
160928432|NCT01498640|581133383|FG000|Overall Study|Death|1|||
160928433|NCT01498640|581133383|FG000|Overall Study|Other|3|||
160928434|NCT06049043|581133384|FG000|Overall Study|Lost to Follow-up|11|||
160928435|NCT06049043|581133385|FG001|Overall Study|Lost to Follow-up|9|||
160928436|NCT00335972|581133386|FG000|Overall Study|not given treatments|0|||
160928437|NCT00335972|581133387|FG001|Overall Study|not given treatments|3|||
160928438|NCT03190889|581133391|FG000|Overall Study|Lost to Follow-up|7|||
160928439|NCT03190889|581133392|FG001|Overall Study|Lost to Follow-up|7|||
160928440|NCT03190889|581133393|FG002|Overall Study|Lost to Follow-up|3|||
160928441|NCT03190889|581133391|FG000|Overall Study|Withdrawal by Subject|1|||
160928442|NCT03190889|581133392|FG001|Overall Study|Withdrawal by Subject|1|||
160928443|NCT03190889|581133393|FG002|Overall Study|Withdrawal by Subject|2|||
160928444|NCT03190889|581133391|FG000|Overall Study|Did not complete protocol|4|||
160928445|NCT03190889|581133392|FG001|Overall Study|Did not complete protocol|9|||
160928446|NCT03190889|581133393|FG002|Overall Study|Did not complete protocol|0|||
160928447|NCT03190889|581133391|FG000|Overall Study|COVID-19|1|||
160928448|NCT03190889|581133392|FG001|Overall Study|COVID-19|0|||
160928449|NCT03190889|581133393|FG002|Overall Study|COVID-19|2|||
160928450|NCT02140567|581133394|FG000|Overall Study|Problems with recording equipment|6|||
160928451|NCT02882854|581133397|FG000|Overall Study|Lost to Follow-up|1|||
160928452|NCT02882854|581133398|FG001|Overall Study|Lost to Follow-up|2|||
160928453|NCT02882854|581133397|FG000|Overall Study|Physician Decision|0|||
160928454|NCT02882854|581133398|FG001|Overall Study|Physician Decision|1|||
160928455|NCT02039674|581133399|FG000|Overall Study|Adverse Event|0|||
160928456|NCT02039674|581133400|FG001|Overall Study|Adverse Event|0|||
160928457|NCT02039674|581133401|FG002|Overall Study|Adverse Event|0|||
160928458|NCT02039674|581133402|FG003|Overall Study|Adverse Event|1|||
160928459|NCT02039674|581133403|FG004|Overall Study|Adverse Event|0|||
160928460|NCT02039674|581133404|FG005|Overall Study|Adverse Event|0|||
160928461|NCT02039674|581133405|FG006|Overall Study|Adverse Event|0|||
160928462|NCT02039674|581133406|FG007|Overall Study|Adverse Event|0|||
160928463|NCT02039674|581133407|FG008|Overall Study|Adverse Event|2|||
160928464|NCT02039674|581133408|FG009|Overall Study|Adverse Event|1|||
160928465|NCT02039674|581133409|FG010|Overall Study|Adverse Event|0|||
160928466|NCT02039674|581133410|FG011|Overall Study|Adverse Event|2|||
160928467|NCT02039674|581133411|FG012|Overall Study|Adverse Event|3|||
160928468|NCT02039674|581133412|FG013|Overall Study|Adverse Event|1|||
160928469|NCT02039674|581133399|FG000|Overall Study|Death|2|||
160928470|NCT02039674|581133400|FG001|Overall Study|Death|0|||
160928471|NCT02039674|581133401|FG002|Overall Study|Death|2|||
160928472|NCT02039674|581133402|FG003|Overall Study|Death|3|||
160928473|NCT02039674|581133403|FG004|Overall Study|Death|0|||
160928474|NCT02039674|581133404|FG005|Overall Study|Death|0|||
160928475|NCT02039674|581133405|FG006|Overall Study|Death|1|||
160928476|NCT02039674|581133406|FG007|Overall Study|Death|0|||
160928477|NCT02039674|581133407|FG008|Overall Study|Death|2|||
160928478|NCT02039674|581133408|FG009|Overall Study|Death|0|||
160928479|NCT02039674|581133409|FG010|Overall Study|Death|1|||
160928480|NCT02039674|581133410|FG011|Overall Study|Death|3|||
160928481|NCT02039674|581133411|FG012|Overall Study|Death|2|||
160928482|NCT02039674|581133412|FG013|Overall Study|Death|8|||
160998077|NCT00094809|581378535|FG001|Overall Study|Study drug not received|8|||
160998078|NCT00094809|581378534|FG000|Overall Study|Other|1|||
160998079|NCT00094809|581378535|FG001|Overall Study|Other|1|||
160998080|NCT04889664|581378536|FG000|Screen|Lost to Follow-up|1|||
160998081|NCT04889664|581378536|FG000|Screen|Failed to meet screening criteria|1|||
160998082|NCT04889664|581378536|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
160998083|NCT02469064|581378542|FG000|Overall Study|Request not to receive intervention.|1|||
160998084|NCT02469064|581378543|FG001|Overall Study|Request not to receive intervention.|3|||
160998085|NCT02506257|581378556|FG000|Overall Study|Adverse Event|0|||
160578147|NCT03276936|579838263|FG000|Overall Study|Not mentioned|6|||
160928483|NCT02039674|581133399|FG000|Overall Study|Excluded Medication|1|||
160928484|NCT02039674|581133400|FG001|Overall Study|Excluded Medication|1|||
160928485|NCT02039674|581133401|FG002|Overall Study|Excluded Medication|0|||
160928486|NCT02039674|581133402|FG003|Overall Study|Excluded Medication|1|||
160928487|NCT02039674|581133403|FG004|Overall Study|Excluded Medication|0|||
160928488|NCT02039674|581133404|FG005|Overall Study|Excluded Medication|1|||
160928489|NCT02039674|581133405|FG006|Overall Study|Excluded Medication|0|||
160578148|NCT03276936|579838264|FG001|Overall Study|Not mentioned|3|||
160578149|NCT00943319|579838265|FG000|Overall Study|Death|1|||
160928490|NCT02039674|581133406|FG007|Overall Study|Excluded Medication|0|||
160928491|NCT02039674|581133407|FG008|Overall Study|Excluded Medication|2|||
160928492|NCT02039674|581133408|FG009|Overall Study|Excluded Medication|3|||
160928493|NCT02039674|581133409|FG010|Overall Study|Excluded Medication|5|||
160928494|NCT02039674|581133410|FG011|Overall Study|Excluded Medication|6|||
160928495|NCT02039674|581133411|FG012|Overall Study|Excluded Medication|8|||
160454999|NCT03295721|579396270|FG001|Overall Study|Lost to Follow-up|1|||
160578150|NCT02043301|579838266|FG000|Overall Study|Discontinued|0|||
160928496|NCT02039674|581133412|FG013|Overall Study|Excluded Medication|3|||
160928497|NCT02039674|581133399|FG000|Overall Study|Lost to Follow-up|0|||
160998086|NCT02506257|581378557|FG001|Overall Study|Adverse Event|2|||
160998087|NCT02506257|581378558|FG002|Overall Study|Adverse Event|3|||
160998088|NCT02506257|581378559|FG003|Overall Study|Adverse Event|0|||
160998089|NCT02506257|581378556|FG000|Overall Study|Protocol Violation|0|||
160998090|NCT02506257|581378557|FG001|Overall Study|Protocol Violation|0|||
160998091|NCT02506257|581378558|FG002|Overall Study|Protocol Violation|1|||
160998092|NCT02506257|581378559|FG003|Overall Study|Protocol Violation|0|||
160928498|NCT02039674|581133400|FG001|Overall Study|Lost to Follow-up|0|||
160928499|NCT02039674|581133401|FG002|Overall Study|Lost to Follow-up|0|||
160928500|NCT02039674|581133402|FG003|Overall Study|Lost to Follow-up|0|||
160928501|NCT02039674|581133403|FG004|Overall Study|Lost to Follow-up|1|||
160928502|NCT02039674|581133404|FG005|Overall Study|Lost to Follow-up|1|||
160928503|NCT02039674|581133405|FG006|Overall Study|Lost to Follow-up|0|||
160928504|NCT02039674|581133406|FG007|Overall Study|Lost to Follow-up|0|||
160928505|NCT02039674|581133407|FG008|Overall Study|Lost to Follow-up|0|||
160928506|NCT02039674|581133408|FG009|Overall Study|Lost to Follow-up|0|||
160928507|NCT02039674|581133409|FG010|Overall Study|Lost to Follow-up|0|||
160928508|NCT02039674|581133410|FG011|Overall Study|Lost to Follow-up|2|||
160928509|NCT02039674|581133411|FG012|Overall Study|Lost to Follow-up|2|||
160928510|NCT02039674|581133412|FG013|Overall Study|Lost to Follow-up|1|||
160928511|NCT02039674|581133399|FG000|Overall Study|Physician Decision|0|||
160928512|NCT02039674|581133400|FG001|Overall Study|Physician Decision|0|||
160928513|NCT02039674|581133401|FG002|Overall Study|Physician Decision|0|||
160578151|NCT02043301|579838267|FG001|Overall Study|Discontinued|1|||
160578152|NCT02043301|579838268|FG002|Overall Study|Discontinued|0|||
160578153|NCT03703375|579838269|FG000|Randomization Period|Withdrawal by Subject|0|||
160578154|NCT03703375|579838270|FG001|Randomization Period|Withdrawal by Subject|0|||
160578155|NCT03703375|579838271|FG002|Randomization Period|Withdrawal by Subject|0|||
160578156|NCT03703375|579838272|FG003|Randomization Period|Withdrawal by Subject|1|||
160578157|NCT03703375|579838269|FG000|Randomization Period|Completed safety run-in treatment|7|||
160578158|NCT03703375|579838270|FG001|Randomization Period|Completed safety run-in treatment|0|||
160578159|NCT03703375|579838271|FG002|Randomization Period|Completed safety run-in treatment|0|||
160578160|NCT03703375|579838272|FG003|Randomization Period|Completed safety run-in treatment|0|||
160578161|NCT03703375|579838269|FG000|Treatment Period|Other Reasons|0|||
160578162|NCT03703375|579838270|FG001|Treatment Period|Other Reasons|1|||
160578163|NCT03703375|579838271|FG002|Treatment Period|Other Reasons|0|||
160578164|NCT03703375|579838272|FG003|Treatment Period|Other Reasons|3|||
160578165|NCT03703375|579838269|FG000|Treatment Period|Consent Withdrawal|0|||
160578166|NCT03703375|579838270|FG001|Treatment Period|Consent Withdrawal|0|||
160578167|NCT03703375|579838271|FG002|Treatment Period|Consent Withdrawal|0|||
160928514|NCT02039674|581133402|FG003|Overall Study|Physician Decision|0|||
160928515|NCT02039674|581133403|FG004|Overall Study|Physician Decision|0|||
160928516|NCT02039674|581133404|FG005|Overall Study|Physician Decision|0|||
160928517|NCT02039674|581133405|FG006|Overall Study|Physician Decision|0|||
160928518|NCT02039674|581133406|FG007|Overall Study|Physician Decision|0|||
160928519|NCT02039674|581133407|FG008|Overall Study|Physician Decision|0|||
160928520|NCT02039674|581133408|FG009|Overall Study|Physician Decision|0|||
160928521|NCT02039674|581133409|FG010|Overall Study|Physician Decision|0|||
160928522|NCT02039674|581133410|FG011|Overall Study|Physician Decision|1|||
160928523|NCT02039674|581133411|FG012|Overall Study|Physician Decision|1|||
160928524|NCT02039674|581133412|FG013|Overall Study|Physician Decision|0|||
160928525|NCT02039674|581133399|FG000|Overall Study|Progressive Disease|8|||
160928526|NCT02039674|581133400|FG001|Overall Study|Progressive Disease|8|||
160928527|NCT02039674|581133401|FG002|Overall Study|Progressive Disease|6|||
160928528|NCT02039674|581133402|FG003|Overall Study|Progressive Disease|7|||
160998093|NCT00964366|581378560|FG000|Overall Study|Did not qualify at Day 1|1|||
160998094|NCT00964366|581378561|FG001|Overall Study|Did not qualify at Day 1|0|||
160998095|NCT00964366|581378560|FG000|Overall Study|Withdrawal by Subject|0|||
160578168|NCT03703375|579838272|FG003|Treatment Period|Consent Withdrawal|1|||
160578169|NCT03703375|579838269|FG000|Treatment Period|Death|1|||
160928529|NCT02039674|581133403|FG004|Overall Study|Progressive Disease|9|||
160928530|NCT02039674|581133404|FG005|Overall Study|Progressive Disease|10|||
160928531|NCT02039674|581133405|FG006|Overall Study|Progressive Disease|1|||
160928532|NCT02039674|581133406|FG007|Overall Study|Progressive Disease|3|||
160928533|NCT02039674|581133407|FG008|Overall Study|Progressive Disease|6|||
160928534|NCT02039674|581133408|FG009|Overall Study|Progressive Disease|4|||
160928535|NCT02039674|581133409|FG010|Overall Study|Progressive Disease|0|||
160928536|NCT02039674|581133410|FG011|Overall Study|Progressive Disease|34|||
160928537|NCT02039674|581133411|FG012|Overall Study|Progressive Disease|34|||
160928538|NCT02039674|581133412|FG013|Overall Study|Progressive Disease|18|||
160928539|NCT02039674|581133399|FG000|Overall Study|Withdrawal by Subject|1|||
160928540|NCT02039674|581133400|FG001|Overall Study|Withdrawal by Subject|2|||
160998096|NCT00964366|581378561|FG001|Overall Study|Withdrawal by Subject|1|||
160998097|NCT02046616|581378563|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
160578170|NCT03703375|579838270|FG001|Treatment Period|Death|0|||
160928541|NCT02039674|581133401|FG002|Overall Study|Withdrawal by Subject|3|||
160928542|NCT02039674|581133402|FG003|Overall Study|Withdrawal by Subject|0|||
160928543|NCT02039674|581133403|FG004|Overall Study|Withdrawal by Subject|1|||
160928544|NCT02039674|581133404|FG005|Overall Study|Withdrawal by Subject|0|||
160928545|NCT02039674|581133405|FG006|Overall Study|Withdrawal by Subject|0|||
160928546|NCT02039674|581133406|FG007|Overall Study|Withdrawal by Subject|0|||
160928547|NCT02039674|581133407|FG008|Overall Study|Withdrawal by Subject|0|||
160928548|NCT02039674|581133408|FG009|Overall Study|Withdrawal by Subject|1|||
160928549|NCT02039674|581133409|FG010|Overall Study|Withdrawal by Subject|1|||
160928550|NCT02039674|581133410|FG011|Overall Study|Withdrawal by Subject|4|||
160928551|NCT02039674|581133411|FG012|Overall Study|Withdrawal by Subject|6|||
160928552|NCT02039674|581133412|FG013|Overall Study|Withdrawal by Subject|2|||
160928553|NCT02039674|581133399|FG000|Overall Study|Clinical Progression|0|||
160928554|NCT02039674|581133400|FG001|Overall Study|Clinical Progression|0|||
160928555|NCT02039674|581133401|FG002|Overall Study|Clinical Progression|0|||
160928556|NCT02039674|581133402|FG003|Overall Study|Clinical Progression|0|||
160928557|NCT02039674|581133403|FG004|Overall Study|Clinical Progression|0|||
160928558|NCT02039674|581133404|FG005|Overall Study|Clinical Progression|0|||
160928559|NCT02039674|581133405|FG006|Overall Study|Clinical Progression|1|||
160928560|NCT02039674|581133406|FG007|Overall Study|Clinical Progression|0|||
160928561|NCT02039674|581133407|FG008|Overall Study|Clinical Progression|0|||
160928562|NCT02039674|581133408|FG009|Overall Study|Clinical Progression|0|||
160928563|NCT02039674|581133409|FG010|Overall Study|Clinical Progression|0|||
160928564|NCT02039674|581133410|FG011|Overall Study|Clinical Progression|0|||
160928565|NCT02039674|581133411|FG012|Overall Study|Clinical Progression|1|||
160928566|NCT02039674|581133412|FG013|Overall Study|Clinical Progression|0|||
160928567|NCT02039674|581133399|FG000|Overall Study|Sponsor Decision|1|||
160928568|NCT02039674|581133400|FG001|Overall Study|Sponsor Decision|1|||
160928569|NCT02039674|581133401|FG002|Overall Study|Sponsor Decision|1|||
160928570|NCT02039674|581133402|FG003|Overall Study|Sponsor Decision|1|||
160928571|NCT02039674|581133403|FG004|Overall Study|Sponsor Decision|1|||
160928572|NCT02039674|581133404|FG005|Overall Study|Sponsor Decision|0|||
160928573|NCT02039674|581133405|FG006|Overall Study|Sponsor Decision|0|||
160928574|NCT02039674|581133406|FG007|Overall Study|Sponsor Decision|0|||
160928575|NCT02039674|581133407|FG008|Overall Study|Sponsor Decision|0|||
160928576|NCT02039674|581133408|FG009|Overall Study|Sponsor Decision|3|||
160928577|NCT02039674|581133409|FG010|Overall Study|Sponsor Decision|0|||
160928578|NCT02039674|581133410|FG011|Overall Study|Sponsor Decision|8|||
160928579|NCT02039674|581133411|FG012|Overall Study|Sponsor Decision|5|||
160928580|NCT02039674|581133412|FG013|Overall Study|Sponsor Decision|0|||
160928581|NCT02039674|581133399|FG000|Overall Study|Other|0|||
160928582|NCT02039674|581133400|FG001|Overall Study|Other|0|||
160928583|NCT02039674|581133401|FG002|Overall Study|Other|0|||
160928584|NCT02039674|581133402|FG003|Overall Study|Other|0|||
160928585|NCT02039674|581133403|FG004|Overall Study|Other|0|||
160928586|NCT02039674|581133404|FG005|Overall Study|Other|0|||
160928587|NCT02039674|581133405|FG006|Overall Study|Other|0|||
160928588|NCT02039674|581133406|FG007|Overall Study|Other|0|||
160928589|NCT02039674|581133407|FG008|Overall Study|Other|0|||
160928590|NCT02039674|581133408|FG009|Overall Study|Other|0|||
160928591|NCT02039674|581133409|FG010|Overall Study|Other|0|||
160928592|NCT02039674|581133410|FG011|Overall Study|Other|0|||
160928593|NCT02039674|581133411|FG012|Overall Study|Other|1|||
160928594|NCT02039674|581133412|FG013|Overall Study|Other|0|||
160928595|NCT03774433|581133413|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
160928596|NCT00108160|581133414|FG000|Overall Study|Lost to Follow-up|25|||
160928597|NCT00108160|581133415|FG001|Overall Study|Lost to Follow-up|12|||
160928598|NCT00108160|581133414|FG000|Overall Study|Death|1|||
160928599|NCT00108160|581133415|FG001|Overall Study|Death|2|||
160928600|NCT00108160|581133414|FG000|Overall Study|Withdrawal by Subject|4|||
160928601|NCT00108160|581133415|FG001|Overall Study|Withdrawal by Subject|2|||
160928602|NCT00108160|581133414|FG000|Overall Study|Protocol Violation|9|||
160928603|NCT00108160|581133415|FG001|Overall Study|Protocol Violation|5|||
160998098|NCT02046616|581378563|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
160998099|NCT02046616|581378563|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
160655884|NCT04257929|580120292|FG001|Overall Study|COVID-19|1|||
160928604|NCT02081079|581133416|FG000|Overall Study|Lack of Efficacy|3|||
160928605|NCT02081079|581133417|FG001|Overall Study|Lack of Efficacy|2|||
160998100|NCT02046616|581378563|FG000|24-Week Treatment Period|Physician Decision|3|||
160928606|NCT02081079|581133416|FG000|Overall Study|Lost to Follow-up|1|||
160928607|NCT02081079|581133417|FG001|Overall Study|Lost to Follow-up|0|||
160928608|NCT01712854|581133418|FG000|Overall Study|Physician Decision|1|||
160998101|NCT02046616|581378563|FG000|24-Week Treatment Period|Other|1|||
160928609|NCT01150123|581133419|FG000|Overall Study|Withdrawal by Subject|1|||
160928610|NCT01150123|581133420|FG001|Overall Study|Withdrawal by Subject|1|||
160928611|NCT01150123|581133421|FG002|Overall Study|Withdrawal by Subject|2|||
160928612|NCT01150123|581133422|FG003|Overall Study|Withdrawal by Subject|1|||
160928613|NCT01150123|581133423|FG004|Overall Study|Withdrawal by Subject|1|||
160998102|NCT02046616|581378563|FG000|8-Week FU Period|Lost to Follow-up|1|||
160998103|NCT02957539|581378566|FG000|Baseline to Week 16|Lost to Follow-up|8|||
160928614|NCT01150123|581133424|FG005|Overall Study|Withdrawal by Subject|1|||
160928615|NCT01150123|581133425|FG006|Overall Study|Withdrawal by Subject|0|||
160928616|NCT01150123|581133426|FG007|Overall Study|Withdrawal by Subject|3|||
160928617|NCT01150123|581133427|FG008|Overall Study|Withdrawal by Subject|2|||
160928618|NCT01150123|581133428|FG009|Overall Study|Withdrawal by Subject|0|||
160928619|NCT01150123|581133429|FG010|Overall Study|Withdrawal by Subject|1|||
160928620|NCT01150123|581133430|FG011|Overall Study|Withdrawal by Subject|0|||
160928621|NCT01150123|581133431|FG012|Overall Study|Withdrawal by Subject|1|||
160928622|NCT01150123|581133432|FG013|Overall Study|Withdrawal by Subject|0|||
160928623|NCT01150123|581133433|FG014|Overall Study|Withdrawal by Subject|0|||
160928624|NCT01150123|581133434|FG015|Overall Study|Withdrawal by Subject|1|||
160928625|NCT01150123|581133435|FG016|Overall Study|Withdrawal by Subject|0|||
160928626|NCT01150123|581133436|FG017|Overall Study|Withdrawal by Subject|1|||
160928627|NCT01150123|581133419|FG000|Overall Study|Lost to Follow-up|2|||
160928628|NCT01150123|581133420|FG001|Overall Study|Lost to Follow-up|1|||
160928629|NCT01150123|581133421|FG002|Overall Study|Lost to Follow-up|2|||
160928630|NCT01150123|581133422|FG003|Overall Study|Lost to Follow-up|2|||
160928631|NCT01150123|581133423|FG004|Overall Study|Lost to Follow-up|2|||
160928632|NCT01150123|581133424|FG005|Overall Study|Lost to Follow-up|5|||
160928633|NCT01150123|581133425|FG006|Overall Study|Lost to Follow-up|0|||
160928634|NCT01150123|581133426|FG007|Overall Study|Lost to Follow-up|0|||
160928635|NCT01150123|581133427|FG008|Overall Study|Lost to Follow-up|3|||
160928636|NCT01150123|581133428|FG009|Overall Study|Lost to Follow-up|1|||
160928637|NCT01150123|581133429|FG010|Overall Study|Lost to Follow-up|1|||
160928638|NCT01150123|581133430|FG011|Overall Study|Lost to Follow-up|1|||
160928639|NCT01150123|581133431|FG012|Overall Study|Lost to Follow-up|2|||
160928640|NCT01150123|581133432|FG013|Overall Study|Lost to Follow-up|0|||
160928641|NCT01150123|581133433|FG014|Overall Study|Lost to Follow-up|0|||
160928642|NCT01150123|581133434|FG015|Overall Study|Lost to Follow-up|0|||
160928643|NCT01150123|581133435|FG016|Overall Study|Lost to Follow-up|0|||
160928644|NCT01150123|581133436|FG017|Overall Study|Lost to Follow-up|0|||
160928645|NCT01466387|581133437|FG000|Overall Study|Adverse Event|0|||
160928646|NCT01466387|581133438|FG001|Overall Study|Adverse Event|0|||
160928647|NCT01466387|581133439|FG002|Overall Study|Adverse Event|1|||
160928648|NCT01466387|581133440|FG003|Overall Study|Adverse Event|1|||
160928649|NCT01466387|581133441|FG004|Overall Study|Adverse Event|0|||
160928650|NCT01466387|581133442|FG005|Overall Study|Adverse Event|0|||
160928651|NCT01466387|581133437|FG000|Overall Study|Lost to Follow-up|0|||
160928652|NCT01466387|581133438|FG001|Overall Study|Lost to Follow-up|0|||
160928653|NCT01466387|581133439|FG002|Overall Study|Lost to Follow-up|0|||
160928654|NCT01466387|581133440|FG003|Overall Study|Lost to Follow-up|0|||
160928655|NCT01466387|581133441|FG004|Overall Study|Lost to Follow-up|0|||
160928656|NCT01466387|581133442|FG005|Overall Study|Lost to Follow-up|1|||
160928657|NCT01466387|581133437|FG000|Overall Study|Protocol Violation|1|||
160928658|NCT01466387|581133438|FG001|Overall Study|Protocol Violation|0|||
160928659|NCT01466387|581133439|FG002|Overall Study|Protocol Violation|0|||
160928660|NCT01466387|581133440|FG003|Overall Study|Protocol Violation|1|||
160928661|NCT01466387|581133441|FG004|Overall Study|Protocol Violation|0|||
160928662|NCT01466387|581133442|FG005|Overall Study|Protocol Violation|0|||
160928663|NCT01319877|581133443|FG000|Overall Study|Lost to Follow-up|100|||
160928664|NCT01319877|581133444|FG001|Overall Study|Lost to Follow-up|37|||
160928665|NCT01319877|581133443|FG000|Overall Study|Physician Decision|2|||
160928666|NCT01319877|581133444|FG001|Overall Study|Physician Decision|0|||
160928667|NCT01319877|581133443|FG000|Overall Study|Disease Progression|2|||
160928668|NCT01319877|581133444|FG001|Overall Study|Disease Progression|2|||
160928669|NCT01319877|581133443|FG000|Overall Study|Withdrawal by Subject|0|||
160928670|NCT01319877|581133444|FG001|Overall Study|Withdrawal by Subject|1|||
160928671|NCT01319877|581133443|FG000|Overall Study|Reason Not Specified|4|||
160928672|NCT01319877|581133444|FG001|Overall Study|Reason Not Specified|5|||
160928673|NCT02347189|581133447|FG000|Overall Study|No implant attempted of study device|9|||
160928674|NCT02347189|581133447|FG000|Overall Study|No primary outcome data available|2|||
160928675|NCT02677987|581133448|FG000|Overall Study|Withdrawal by Subject|3|||
160928676|NCT02677987|581133449|FG001|Overall Study|Withdrawal by Subject|0|||
160928677|NCT02677987|581133448|FG000|Overall Study|Lost to Follow-up|1|||
160928678|NCT02677987|581133449|FG001|Overall Study|Lost to Follow-up|0|||
160655885|NCT04257929|580120293|FG002|Overall Study|COVID-19|1|||
160928679|NCT03320564|581133450|FG000|Overall Study|Protocol Violation|1|||
160928680|NCT00600938|581133451|FG000|Core Study|Abnormal test procedure result(s)|3|||
160928681|NCT00600938|581133452|FG001|Core Study|Abnormal test procedure result(s)|2|||
160928682|NCT00600938|581133453|FG002|Core Study|Abnormal test procedure result(s)|0|||
160928683|NCT00600938|581133454|FG003|Core Study|Abnormal test procedure result(s)|0|||
160928684|NCT00600938|581133451|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
160928685|NCT00600938|581133452|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
160928686|NCT00600938|581133453|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
160928687|NCT00600938|581133454|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
160928688|NCT00600938|581133451|FG000|Core Study|Patient withdrew consent|7|||
160928689|NCT00600938|581133452|FG001|Core Study|Patient withdrew consent|12|||
160928690|NCT00600938|581133453|FG002|Core Study|Patient withdrew consent|0|||
160655886|NCT04257929|580120291|FG000|Overall Study|Lost to Follow-up|0|||
160928691|NCT00600938|581133454|FG003|Core Study|Patient withdrew consent|0|||
160928692|NCT00600938|581133451|FG000|Core Study|Lost to Follow-up|3|||
160928693|NCT00600938|581133452|FG001|Core Study|Lost to Follow-up|2|||
160928694|NCT00600938|581133453|FG002|Core Study|Lost to Follow-up|0|||
160928695|NCT00600938|581133454|FG003|Core Study|Lost to Follow-up|0|||
160928696|NCT00600938|581133451|FG000|Core Study|Death|1|||
160928697|NCT00600938|581133452|FG001|Core Study|Death|1|||
160928698|NCT00600938|581133453|FG002|Core Study|Death|0|||
160928699|NCT00600938|581133454|FG003|Core Study|Death|0|||
160928700|NCT00600938|581133451|FG000|Core Study|Protocol Violation|1|||
160928701|NCT00600938|581133452|FG001|Core Study|Protocol Violation|2|||
160928702|NCT00600938|581133453|FG002|Core Study|Protocol Violation|0|||
160928703|NCT00600938|581133454|FG003|Core Study|Protocol Violation|0|||
160928704|NCT00600938|581133451|FG000|Extension Study|Adverse Event|1|||
160928705|NCT00600938|581133452|FG001|Extension Study|Adverse Event|0|||
160928706|NCT00600938|581133453|FG002|Extension Study|Adverse Event|2|||
160928707|NCT00600938|581133454|FG003|Extension Study|Adverse Event|0|||
160928708|NCT00600938|581133451|FG000|Extension Study|Abnormal test procedure results|0|||
160928709|NCT00600938|581133452|FG001|Extension Study|Abnormal test procedure results|1|||
160928710|NCT00600938|581133453|FG002|Extension Study|Abnormal test procedure results|1|||
160928711|NCT00600938|581133454|FG003|Extension Study|Abnormal test procedure results|1|||
160928712|NCT00600938|581133451|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
160928713|NCT00600938|581133452|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
160928714|NCT00600938|581133453|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
160928715|NCT00600938|581133454|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
160928716|NCT00600938|581133451|FG000|Extension Study|Withdrawal by Subject|2|||
160928717|NCT00600938|581133452|FG001|Extension Study|Withdrawal by Subject|2|||
160928718|NCT00600938|581133453|FG002|Extension Study|Withdrawal by Subject|3|||
160928719|NCT00600938|581133454|FG003|Extension Study|Withdrawal by Subject|0|||
160928720|NCT00600938|581133451|FG000|Extension Study|Lost to Follow-up|1|||
160928721|NCT00600938|581133452|FG001|Extension Study|Lost to Follow-up|1|||
160928722|NCT00600938|581133453|FG002|Extension Study|Lost to Follow-up|2|||
160928723|NCT00600938|581133454|FG003|Extension Study|Lost to Follow-up|0|||
160928724|NCT00600938|581133451|FG000|Extension Study|Death|1|||
160928725|NCT00600938|581133452|FG001|Extension Study|Death|0|||
160928726|NCT00600938|581133453|FG002|Extension Study|Death|0|||
160928727|NCT00600938|581133454|FG003|Extension Study|Death|0|||
160928728|NCT02680639|581133455|FG000|Screening Period|Screen Failure|7|||
160928729|NCT02680639|581133456|FG001|Screening Period|Screen Failure|0|||
160928730|NCT02680639|581133457|FG002|Screening Period|Screen Failure|0|||
160928731|NCT03200899|581133458|FG000|Overall Study|Lost to Follow-up|10|||
160928732|NCT03200899|581133459|FG001|Overall Study|Lost to Follow-up|23|||
160928733|NCT01342510|581133471|FG000|Overall Study|Protocol Violation|12|||
160928734|NCT01342510|581133472|FG001|Overall Study|Protocol Violation|6|||
160928735|NCT01342510|581133473|FG002|Overall Study|Protocol Violation|13|||
160928736|NCT01342510|581133474|FG003|Overall Study|Protocol Violation|11|||
160928737|NCT00323115|581133479|FG000|Vaccine Administration|Adverse Event|1|||
160928738|NCT00323115|581133479|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
160928739|NCT04837131|581133480|FG000|Overall Study|Death|1|||
160928740|NCT04837131|581133480|FG000|Overall Study|Withdrawal by Subject|1|||
160928741|NCT04837131|581133480|FG000|Overall Study|Adverse Event|1|||
160928742|NCT04837131|581133480|FG000|Overall Study|Protocol Violation|1|||
160928743|NCT02496533|581133481|FG000|Overall Study|Lack of data on outcome|3|||
160928744|NCT02496533|581133482|FG001|Overall Study|Lack of data on outcome|0|||
160928745|NCT02496533|581133481|FG000|Overall Study|Patient did not complete all measures|0|||
160928746|NCT02496533|581133482|FG001|Overall Study|Patient did not complete all measures|4|||
160928747|NCT02496533|581133481|FG000|Overall Study|Late for radiologic testing|0|||
160928748|NCT02496533|581133482|FG001|Overall Study|Late for radiologic testing|2|||
160928749|NCT05756790|581133483|FG000|Overall Study|Withdrawal by Subject|1|||
160928750|NCT05756790|581133484|FG001|Overall Study|Withdrawal by Subject|1|||
160928751|NCT05756790|581133485|FG002|Overall Study|Withdrawal by Subject|1|||
160928752|NCT05756790|581133486|FG003|Overall Study|Withdrawal by Subject|1|||
160928753|NCT05756790|581133487|FG004|Overall Study|Withdrawal by Subject|0|||
160928754|NCT05756790|581133488|FG005|Overall Study|Withdrawal by Subject|0|||
160998104|NCT02957539|581378567|FG001|Baseline to Week 16|Lost to Follow-up|10|||
160998105|NCT02957539|581378568|FG002|Baseline to Week 16|Lost to Follow-up|16|||
160998106|NCT02957539|581378566|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
160928755|NCT05756790|581133483|FG000|Overall Study|Protocol Violation|0|||
160928756|NCT05756790|581133484|FG001|Overall Study|Protocol Violation|0|||
160928757|NCT05756790|581133485|FG002|Overall Study|Protocol Violation|1|||
160928758|NCT05756790|581133486|FG003|Overall Study|Protocol Violation|1|||
160928759|NCT05756790|581133487|FG004|Overall Study|Protocol Violation|0|||
160928760|NCT05756790|581133488|FG005|Overall Study|Protocol Violation|0|||
160928761|NCT05756790|581133483|FG000|Overall Study|Ineligible|0|||
160655887|NCT04257929|580120292|FG001|Overall Study|Lost to Follow-up|0|||
160928762|NCT05756790|581133484|FG001|Overall Study|Ineligible|0|||
160928763|NCT05756790|581133485|FG002|Overall Study|Ineligible|0|||
160998107|NCT02957539|581378567|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
160928764|NCT05756790|581133486|FG003|Overall Study|Ineligible|0|||
160928765|NCT05756790|581133487|FG004|Overall Study|Ineligible|2|||
160928766|NCT05756790|581133488|FG005|Overall Study|Ineligible|2|||
160928767|NCT02268409|581134855|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
160928768|NCT02268409|581134855|FG000|Overall Study|Death|1|||
160928769|NCT02268409|581134855|FG000|Overall Study|Lost to Follow-up|1|||
160928770|NCT02268409|581134855|FG000|Overall Study|Protocol Violation|3|||
160928771|NCT02268409|581134855|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
160928772|NCT02268409|581134855|FG000|Overall Study|Withdrawal by Subject|5|||
160928773|NCT00489853|581134856|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
160928774|NCT00489853|581134857|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
160928775|NCT00489853|581134858|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
160928776|NCT00489853|581134856|FG000|Wash-out Period 1|Adverse Event|0|||
160928777|NCT00489853|581134857|FG001|Wash-out Period 1|Adverse Event|1|||
160928778|NCT00489853|581134858|FG002|Wash-out Period 1|Adverse Event|1|||
160928779|NCT00489853|581134856|FG000|Wash-out Period 1|Protocol Violation|0|||
160928780|NCT00489853|581134857|FG001|Wash-out Period 1|Protocol Violation|1|||
160928781|NCT00489853|581134858|FG002|Wash-out Period 1|Protocol Violation|1|||
160928782|NCT00489853|581134856|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
160928783|NCT00489853|581134857|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
160928784|NCT00489853|581134858|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
160928785|NCT00489853|581134856|FG000|Wash-out Period 2|Adverse Event|1|||
160928786|NCT00489853|581134857|FG001|Wash-out Period 2|Adverse Event|1|||
160928787|NCT00489853|581134858|FG002|Wash-out Period 2|Adverse Event|0|||
160928788|NCT00489853|581134856|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
160928789|NCT00489853|581134857|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
160928790|NCT00489853|581134858|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
160928791|NCT00489853|581134856|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
160928792|NCT00489853|581134857|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
160928793|NCT00489853|581134858|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
160928794|NCT01176292|581134862|FG000|Overall Study|Lost to Follow-up|2|||
160928795|NCT01176292|581134863|FG001|Overall Study|Lost to Follow-up|4|||
160928796|NCT01176292|581134862|FG000|Overall Study|Adverse Event|1|||
160928797|NCT01176292|581134863|FG001|Overall Study|Adverse Event|1|||
160928798|NCT01176292|581134862|FG000|Overall Study|Physician Decision|0|||
160928799|NCT01176292|581134863|FG001|Overall Study|Physician Decision|2|||
160928800|NCT01176292|581134862|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
160928801|NCT01176292|581134863|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
160928802|NCT00380393|581134864|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
160928803|NCT00380393|581134865|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
160928804|NCT00380393|581134864|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
160928805|NCT00380393|581134865|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
160928806|NCT00380393|581134864|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
160928807|NCT00380393|581134865|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
160928808|NCT00380393|581134864|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
160928809|NCT00380393|581134865|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
160928810|NCT00380393|581134864|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
160928811|NCT00380393|581134865|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
160928812|NCT00380393|581134864|FG000|Month 14|Withdrawal by Subject|9|||
160928813|NCT00380393|581134865|FG001|Month 14|Withdrawal by Subject|7|||
160928814|NCT00380393|581134864|FG000|Month 14|Death|1|||
160928815|NCT00380393|581134865|FG001|Month 14|Death|0|||
160928816|NCT00380393|581134864|FG000|Month 14|Lost to Follow-up|0|||
160928817|NCT00380393|581134865|FG001|Month 14|Lost to Follow-up|1|||
160928818|NCT00380393|581134864|FG000|Month 14|Migrated/moved from study area|39|||
160928819|NCT00380393|581134865|FG001|Month 14|Migrated/moved from study area|42|||
160928820|NCT00380393|581134864|FG000|Month 14|Protocol Violation|2|||
160928821|NCT00380393|581134865|FG001|Month 14|Protocol Violation|0|||
160928822|NCT00380393|581134864|FG000|Month 14|Others|6|||
160928823|NCT00380393|581134865|FG001|Month 14|Others|6|||
160928824|NCT00278954|581134876|FG000|Overall Study|Adverse Event|3|||
160928825|NCT00278954|581134876|FG000|Overall Study|Lost to Follow-up|1|||
160928826|NCT00278954|581134876|FG000|Overall Study|Withdrawal by Subject|1|||
160928827|NCT02211131|581134880|FG000|Overall Study|Death|26|||
160928828|NCT02211131|581134881|FG001|Overall Study|Death|16|||
160928829|NCT02211131|581134880|FG000|Overall Study|Lost to Follow-up|4|||
160928830|NCT02211131|581134881|FG001|Overall Study|Lost to Follow-up|3|||
160928831|NCT02211131|581134880|FG000|Overall Study|Decision by Sponsor|1|||
160928832|NCT02211131|581134881|FG001|Overall Study|Decision by Sponsor|1|||
160455000|NCT03295721|579396271|FG002|Overall Study|Lost to Follow-up|1|||
160655888|NCT04257929|580120293|FG002|Overall Study|Lost to Follow-up|1|||
160928833|NCT02211131|581134880|FG000|Overall Study|Withdrawal by Subject|3|||
160928834|NCT02211131|581134881|FG001|Overall Study|Withdrawal by Subject|8|||
160928835|NCT04064294|581134892|FG000|Overall Study|Adverse Event|1|||
160928836|NCT04064294|581134893|FG001|Overall Study|Adverse Event|0|||
160928837|NCT04064294|581134894|FG002|Overall Study|Adverse Event|0|||
160928838|NCT00481195|581134895|FG000|Overall Study|Adverse Event|16|||
160928839|NCT00481195|581134896|FG001|Overall Study|Adverse Event|11|||
160928840|NCT00481195|581134895|FG000|Overall Study|Lack of Efficacy|1|||
160928841|NCT00481195|581134896|FG001|Overall Study|Lack of Efficacy|3|||
160928842|NCT00481195|581134895|FG000|Overall Study|Lost to Follow-up|4|||
160928843|NCT00481195|581134896|FG001|Overall Study|Lost to Follow-up|6|||
160928844|NCT00481195|581134895|FG000|Overall Study|Physician Decision|3|||
160928845|NCT00481195|581134896|FG001|Overall Study|Physician Decision|1|||
160928846|NCT00481195|581134895|FG000|Overall Study|Protocol Violation|10|||
160928847|NCT00481195|581134896|FG001|Overall Study|Protocol Violation|7|||
160928848|NCT00481195|581134895|FG000|Overall Study|Withdrawal by Subject|3|||
160928849|NCT00481195|581134896|FG001|Overall Study|Withdrawal by Subject|9|||
160928850|NCT00481195|581134895|FG000|Overall Study|Miscellaneous|2|||
160928851|NCT00481195|581134896|FG001|Overall Study|Miscellaneous|2|||
160928852|NCT01289847|581134897|FG000|Overall Study|Patient could not comply with visits|1|||
160928853|NCT00006478|581134908|FG000|Overall Study|Vaccine could not be produced|1|||
160928854|NCT00006478|581134908|FG000|Overall Study|Physician Decision|6|||
160928855|NCT04753164|581134909|FG000|Overall Study|Adverse Event|0|||
160928856|NCT04753164|581134910|FG001|Overall Study|Adverse Event|2|||
160928857|NCT04753164|581134909|FG000|Overall Study|Withdrawal by Subject|9|||
160928858|NCT04753164|581134910|FG001|Overall Study|Withdrawal by Subject|7|||
160928859|NCT04753164|581134909|FG000|Overall Study|Lost to Follow-up|6|||
160928860|NCT04753164|581134910|FG001|Overall Study|Lost to Follow-up|6|||
160928861|NCT04753164|581134909|FG000|Overall Study|Other|12|||
160928862|NCT04753164|581134910|FG001|Overall Study|Other|5|||
160928863|NCT00694369|581134911|FG000|Overall Study|Adverse Event|0|||
160928864|NCT00694369|581134912|FG001|Overall Study|Adverse Event|1|||
160928865|NCT00694369|581134913|FG002|Overall Study|Adverse Event|0|||
160928866|NCT00694369|581134914|FG003|Overall Study|Adverse Event|1|||
160928867|NCT00694369|581134915|FG004|Overall Study|Adverse Event|3|||
160928868|NCT00694369|581134911|FG000|Overall Study|Lost to Follow-up|0|||
160928869|NCT00694369|581134912|FG001|Overall Study|Lost to Follow-up|0|||
160928870|NCT00694369|581134913|FG002|Overall Study|Lost to Follow-up|1|||
160928871|NCT00694369|581134914|FG003|Overall Study|Lost to Follow-up|1|||
160928872|NCT00694369|581134915|FG004|Overall Study|Lost to Follow-up|0|||
160928873|NCT00694369|581134911|FG000|Overall Study|Physician Decision|0|||
160928874|NCT00694369|581134912|FG001|Overall Study|Physician Decision|0|||
160928875|NCT00694369|581134913|FG002|Overall Study|Physician Decision|0|||
160928876|NCT00694369|581134914|FG003|Overall Study|Physician Decision|0|||
160928877|NCT00694369|581134915|FG004|Overall Study|Physician Decision|1|||
160928878|NCT00694369|581134911|FG000|Overall Study|Protocol Violation|0|||
160928879|NCT00694369|581134912|FG001|Overall Study|Protocol Violation|1|||
160928880|NCT00694369|581134913|FG002|Overall Study|Protocol Violation|0|||
160928881|NCT00694369|581134914|FG003|Overall Study|Protocol Violation|0|||
160928882|NCT00694369|581134915|FG004|Overall Study|Protocol Violation|0|||
160928883|NCT00694369|581134911|FG000|Overall Study|Withdrawal by Subject|1|||
160928884|NCT00694369|581134912|FG001|Overall Study|Withdrawal by Subject|1|||
160928885|NCT00694369|581134913|FG002|Overall Study|Withdrawal by Subject|1|||
160928886|NCT00694369|581134914|FG003|Overall Study|Withdrawal by Subject|1|||
160928887|NCT00694369|581134915|FG004|Overall Study|Withdrawal by Subject|2|||
160928888|NCT00439556|581134916|FG000|Overall Study|Patient was taken off study for non-comp|0|||
160928889|NCT00439556|581134917|FG001|Overall Study|Patient was taken off study for non-comp|1|||
160928890|NCT00439556|581134918|FG002|Overall Study|Patient was taken off study for non-comp|0|||
160928891|NCT02871739|581134919|FG000|Overall Study|Lost to Follow-up|3|||
160928892|NCT02871739|581134920|FG001|Overall Study|Lost to Follow-up|2|||
160928893|NCT02871739|581134921|FG002|Overall Study|Lost to Follow-up|0|||
160928894|NCT02871739|581134922|FG003|Overall Study|Lost to Follow-up|2|||
160578171|NCT03703375|579838271|FG002|Treatment Period|Death|1|||
160928895|NCT01324388|581134925|FG000|Part 1 of Study|Adverse Event|2|||
160578172|NCT03703375|579838272|FG003|Treatment Period|Death|2|||
160928896|NCT01324388|581134926|FG001|Part 1 of Study|Adverse Event|0|||
160928897|NCT01324388|581134927|FG002|Part 1 of Study|Adverse Event|0|||
160928898|NCT01324388|581134928|FG003|Part 1 of Study|Adverse Event|0|||
160928899|NCT01324388|581134925|FG000|Part 1 of Study|Protocol Violation|1|||
160928900|NCT01324388|581134926|FG001|Part 1 of Study|Protocol Violation|2|||
160998108|NCT02957539|581378568|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
160578173|NCT03703375|579838269|FG000|Treatment Period|Toxicity of Study Treatment|2|||
160928901|NCT01324388|581134927|FG002|Part 1 of Study|Protocol Violation|0|||
160578174|NCT03703375|579838270|FG001|Treatment Period|Toxicity of Study Treatment|0|||
160928902|NCT01324388|581134928|FG003|Part 1 of Study|Protocol Violation|0|||
160928903|NCT01324388|581134925|FG000|Part 1 of Study|Physician Decision|1|||
160928904|NCT01324388|581134926|FG001|Part 1 of Study|Physician Decision|0|||
160928905|NCT01324388|581134927|FG002|Part 1 of Study|Physician Decision|0|||
160928906|NCT01324388|581134928|FG003|Part 1 of Study|Physician Decision|0|||
160928907|NCT01324388|581134925|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
160928908|NCT01324388|581134926|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
160928909|NCT01324388|581134927|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
160928910|NCT01324388|581134928|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
160998109|NCT02957539|581378566|FG000|Week 16 to 32|Withdrawal by Subject|3|||
160632823|NCT01215955|580036085|FG000|Overall Study|Death|2|||
160928911|NCT01324388|581134925|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
160928912|NCT01324388|581134926|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
160928913|NCT01324388|581134927|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
160928914|NCT01324388|581134928|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
160928915|NCT01405963|581134929|FG000|Overall Study|Moved Away|2|||
160928916|NCT01405963|581134930|FG001|Overall Study|Moved Away|0|||
160928917|NCT01405963|581134929|FG000|Overall Study|Adverse Event|0|||
160928918|NCT01405963|581134930|FG001|Overall Study|Adverse Event|1|||
160928919|NCT01405963|581134929|FG000|Overall Study|Lost to Follow-up|0|||
160928920|NCT01405963|581134930|FG001|Overall Study|Lost to Follow-up|1|||
160928921|NCT00850395|581134937|FG000|Overall Study|Death|1|||
160928922|NCT00850395|581134937|FG000|Overall Study|Adverse Event|1|||
160928923|NCT00850395|581134937|FG000|Overall Study|Insufficient clinical response|3|||
160928924|NCT00850395|581134937|FG000|Overall Study|Other|5|||
160928925|NCT01737047|581134938|FG000|Overall Study|Death|10|||
160928926|NCT01737047|581134939|FG001|Overall Study|Death|0|||
160928927|NCT01737047|581134940|FG002|Overall Study|Death|1|||
160928928|NCT01737047|581134938|FG000|Overall Study|Withdrawal by Subject|17|||
160928929|NCT01737047|581134939|FG001|Overall Study|Withdrawal by Subject|11|||
160928930|NCT01737047|581134940|FG002|Overall Study|Withdrawal by Subject|4|||
160928931|NCT02802592|581134941|FG000|Overall Study|Study terminated due to loss of funding|4|||
160928932|NCT04007523|581134942|FG000|Overall Study|Withdrawal by Subject|0|||
160928933|NCT04007523|581134943|FG001|Overall Study|Withdrawal by Subject|1|||
160928934|NCT04007523|581134944|FG002|Overall Study|Withdrawal by Subject|1|||
160928935|NCT04007523|581134945|FG003|Overall Study|Withdrawal by Subject|0|||
160928936|NCT04007523|581134942|FG000|Overall Study|ICU Transfer|0|||
160928937|NCT04007523|581134943|FG001|Overall Study|ICU Transfer|1|||
160928938|NCT04007523|581134944|FG002|Overall Study|ICU Transfer|0|||
160928939|NCT04007523|581134945|FG003|Overall Study|ICU Transfer|0|||
160928940|NCT04007523|581134942|FG000|Overall Study|COVID hospital closure|0|||
160928941|NCT04007523|581134943|FG001|Overall Study|COVID hospital closure|0|||
160928942|NCT04007523|581134944|FG002|Overall Study|COVID hospital closure|1|||
160928943|NCT04007523|581134945|FG003|Overall Study|COVID hospital closure|2|||
160928944|NCT04007523|581134942|FG000|Overall Study|Surgery cancelled|0|||
160928945|NCT04007523|581134943|FG001|Overall Study|Surgery cancelled|0|||
160928946|NCT04007523|581134944|FG002|Overall Study|Surgery cancelled|1|||
160928947|NCT04007523|581134945|FG003|Overall Study|Surgery cancelled|1|||
160928948|NCT01826487|581134946|FG000|Overall Study|Adverse Event|1|||
160928949|NCT01826487|581134947|FG001|Overall Study|Adverse Event|1|||
160928950|NCT01826487|581134946|FG000|Overall Study|Lost to Follow-up|1|||
160928951|NCT01826487|581134947|FG001|Overall Study|Lost to Follow-up|0|||
160928952|NCT01826487|581134946|FG000|Overall Study|Withdrawal by Subject|1|||
160928953|NCT01826487|581134947|FG001|Overall Study|Withdrawal by Subject|3|||
160928954|NCT01826487|581134946|FG000|Overall Study|Protocol Violation|1|||
160928955|NCT01826487|581134947|FG001|Overall Study|Protocol Violation|1|||
160928956|NCT01408030|581134948|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
160928957|NCT01408030|581134949|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
160928958|NCT01408030|581134950|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
160928959|NCT01408030|581134951|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
160928960|NCT01408030|581134948|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
160928961|NCT01408030|581134949|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
160928962|NCT01408030|581134950|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
160928963|NCT01408030|581134951|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
160928964|NCT01408030|581134948|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
160928965|NCT01408030|581134949|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
160928966|NCT01408030|581134950|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
160928967|NCT01408030|581134951|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
160928968|NCT01408030|581134948|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
160928969|NCT01408030|581134949|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
160928970|NCT01408030|581134950|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
160928971|NCT01408030|581134951|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
160928972|NCT01408030|581134948|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
160928973|NCT01408030|581134949|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
160928974|NCT01408030|581134950|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
160928975|NCT01408030|581134951|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
160928976|NCT01408030|581134948|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
160928977|NCT01408030|581134949|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
160928978|NCT01408030|581134950|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
160928979|NCT01408030|581134951|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
160928980|NCT01408030|581134948|FG000|Observation Phase (Off Drug)|Other|1|||
160928981|NCT01408030|581134949|FG001|Observation Phase (Off Drug)|Other|1|||
160928982|NCT01408030|581134950|FG002|Observation Phase (Off Drug)|Other|1|||
160928983|NCT01408030|581134951|FG003|Observation Phase (Off Drug)|Other|1|||
160632824|NCT01215955|580036086|FG001|Overall Study|Death|0|||
160632825|NCT01215955|580036087|FG002|Overall Study|Death|1|||
160928984|NCT02965703|581134952|FG000|Overall Study|Withdrawal by Subject|6|||
160928985|NCT02965703|581134953|FG001|Overall Study|Withdrawal by Subject|3|||
160928986|NCT02965703|581134954|FG002|Overall Study|Withdrawal by Subject|1|||
160928987|NCT02965703|581134952|FG000|Overall Study|Protocol Violation|1|||
160928988|NCT02965703|581134953|FG001|Overall Study|Protocol Violation|0|||
160928989|NCT02965703|581134954|FG002|Overall Study|Protocol Violation|0|||
160928990|NCT02965703|581134952|FG000|Overall Study|Adverse Event|1|||
160928991|NCT02965703|581134953|FG001|Overall Study|Adverse Event|1|||
160928992|NCT02965703|581134954|FG002|Overall Study|Adverse Event|0|||
160928993|NCT02965703|581134952|FG000|Overall Study|Lost to Follow-up|2|||
160928994|NCT02965703|581134953|FG001|Overall Study|Lost to Follow-up|1|||
160928995|NCT02965703|581134954|FG002|Overall Study|Lost to Follow-up|1|||
160928996|NCT00788827|581134960|FG000|Overall Study|Lack of Efficacy|2|||
160928997|NCT03608774|581134961|FG000|Overall Study|Lost to Follow-up|5|||
160928998|NCT03608774|581134962|FG001|Overall Study|Lost to Follow-up|5|||
160928999|NCT03608774|581134961|FG000|Overall Study|Withdrawal by Subject|1|||
160929000|NCT03608774|581134962|FG001|Overall Study|Withdrawal by Subject|0|||
160929001|NCT03608774|581134961|FG000|Overall Study|Protocol Violation|1|||
160929002|NCT03608774|581134962|FG001|Overall Study|Protocol Violation|0|||
160929003|NCT03608774|581134961|FG000|Overall Study|Not eligible at enrollment|0|||
160929004|NCT03608774|581134962|FG001|Overall Study|Not eligible at enrollment|1|||
160929005|NCT03608774|581134961|FG000|Overall Study|Health related event|0|||
160929006|NCT03608774|581134962|FG001|Overall Study|Health related event|1|||
160929007|NCT01586819|581134963|FG000|Overall Study|Withdrawal by Subject|1|||
160929008|NCT01586819|581134964|FG001|Overall Study|Withdrawal by Subject|0|||
160929009|NCT01359254|581134965|FG000|Overall Study|Death|1|||
160929010|NCT01359254|581134966|FG001|Overall Study|Death|0|||
160929011|NCT02028988|581134972|FG000|Overall Study|Withdrawal by Subject|2|||
160929012|NCT00851799|581134975|FG000|Overall Study|Death|1|||
160929013|NCT00851799|581134976|FG001|Overall Study|Death|0|||
160929014|NCT00851799|581134977|FG002|Overall Study|Death|1|||
160929015|NCT00851799|581134975|FG000|Overall Study|Lost to Follow-up|5|||
160929016|NCT00851799|581134976|FG001|Overall Study|Lost to Follow-up|3|||
160929017|NCT00851799|581134977|FG002|Overall Study|Lost to Follow-up|10|||
160929018|NCT00851799|581134975|FG000|Overall Study|Not able to get to clinic|8|||
160929019|NCT00851799|581134976|FG001|Overall Study|Not able to get to clinic|5|||
160929020|NCT00851799|581134977|FG002|Overall Study|Not able to get to clinic|9|||
160929021|NCT00851799|581134975|FG000|Overall Study|Not willing to adhere to requirements|1|||
160929022|NCT00851799|581134976|FG001|Overall Study|Not willing to adhere to requirements|2|||
160929023|NCT00851799|581134977|FG002|Overall Study|Not willing to adhere to requirements|2|||
160929024|NCT00851799|581134975|FG000|Overall Study|Withdrew consent prior study completion|1|||
160929025|NCT00851799|581134976|FG001|Overall Study|Withdrew consent prior study completion|2|||
160929026|NCT00851799|581134977|FG002|Overall Study|Withdrew consent prior study completion|1|||
160929027|NCT00851799|581134975|FG000|Overall Study|Severe Debilitation|0|||
160929028|NCT00851799|581134976|FG001|Overall Study|Severe Debilitation|1|||
160929029|NCT00851799|581134977|FG002|Overall Study|Severe Debilitation|0|||
160929030|NCT00851799|581134975|FG000|Overall Study|Completed protocol due to pregnancy|0|||
160929031|NCT00851799|581134976|FG001|Overall Study|Completed protocol due to pregnancy|0|||
160929032|NCT00851799|581134977|FG002|Overall Study|Completed protocol due to pregnancy|1|||
160929033|NCT04365556|581134980|FG000|Overall Study|No longer eligible due to treatment plan|1|||
160929034|NCT04365556|581134981|FG001|Overall Study|No longer eligible due to treatment plan|0|||
160929035|NCT04365556|581134980|FG000|Overall Study|Lost to Follow-up|3|||
160929036|NCT04365556|581134981|FG001|Overall Study|Lost to Follow-up|2|||
160929037|NCT04439318|581134982|FG000|Overall Study|Ineligible|1|||
160929038|NCT04439318|581134982|FG000|Overall Study|Never Started Treatment|3|||
160929039|NCT04439318|581134982|FG000|Overall Study|Adverse Event|10|||
160929040|NCT04439318|581134982|FG000|Overall Study|Death|2|||
160929041|NCT04439318|581134982|FG000|Overall Study|Disease Progression|25|||
160929042|NCT04439318|581134982|FG000|Overall Study|Other Complicating Disease|2|||
160929043|NCT04439318|581134982|FG000|Overall Study|Withdrawal by Subject|4|||
160929044|NCT04439318|581134982|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
160929045|NCT04439318|581134982|FG000|Overall Study|Non-Compliance|1|||
160929046|NCT04439318|581134982|FG000|Overall Study|Still on Treatment|1|||
160929047|NCT00589108|581136725|FG000|Overall Study|Lost to Follow-up|1|||
160929048|NCT00589108|581136726|FG001|Overall Study|Lost to Follow-up|1|||
160929049|NCT00589108|581136727|FG002|Overall Study|Lost to Follow-up|1|||
160929050|NCT00589108|581136725|FG000|Overall Study|Death|3|||
160655889|NCT05630547|580120294|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
160929051|NCT00589108|581136726|FG001|Overall Study|Death|3|||
160929052|NCT00589108|581136727|FG002|Overall Study|Death|4|||
160929053|NCT03026257|581136731|FG000|Overall Study|Adverse Event|3|||
160929054|NCT03026257|581136732|FG001|Overall Study|Adverse Event|0|||
160929055|NCT03026257|581136733|FG002|Overall Study|Adverse Event|0|||
160929056|NCT03026257|581136734|FG003|Overall Study|Adverse Event|0|||
160929057|NCT03026257|581136735|FG004|Overall Study|Adverse Event|0|||
160929058|NCT03026257|581136736|FG005|Overall Study|Adverse Event|0|||
160929059|NCT03026257|581136731|FG000|Overall Study|Lost to Follow-up|1|||
160929060|NCT03026257|581136732|FG001|Overall Study|Lost to Follow-up|0|||
160929061|NCT03026257|581136733|FG002|Overall Study|Lost to Follow-up|0|||
160929062|NCT03026257|581136734|FG003|Overall Study|Lost to Follow-up|0|||
160929063|NCT03026257|581136735|FG004|Overall Study|Lost to Follow-up|0|||
160929064|NCT03026257|581136736|FG005|Overall Study|Lost to Follow-up|0|||
160929065|NCT03026257|581136731|FG000|Overall Study|Protocol Violation|1|||
160929066|NCT03026257|581136732|FG001|Overall Study|Protocol Violation|0|||
160929067|NCT03026257|581136733|FG002|Overall Study|Protocol Violation|0|||
160929068|NCT03026257|581136734|FG003|Overall Study|Protocol Violation|1|||
160929069|NCT03026257|581136735|FG004|Overall Study|Protocol Violation|1|||
160929070|NCT03026257|581136736|FG005|Overall Study|Protocol Violation|0|||
160929071|NCT03026257|581136731|FG000|Overall Study|Withdrawal by Subject|1|||
160929072|NCT03026257|581136732|FG001|Overall Study|Withdrawal by Subject|1|||
160929073|NCT03026257|581136733|FG002|Overall Study|Withdrawal by Subject|0|||
160929074|NCT03026257|581136734|FG003|Overall Study|Withdrawal by Subject|0|||
160929075|NCT03026257|581136735|FG004|Overall Study|Withdrawal by Subject|0|||
160929076|NCT03026257|581136736|FG005|Overall Study|Withdrawal by Subject|0|||
160929077|NCT02181556|581136737|FG000|Overall Study|Withdrawal by Subject|1|||
160929078|NCT00427635|581136738|FG000|Treatment Phase|Withdrawal by Subject|1|||
160929079|NCT00427635|581136739|FG001|Treatment Phase|Withdrawal by Subject|0|||
160929080|NCT00427635|581136738|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
160929081|NCT00427635|581136739|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
160929082|NCT00838201|581136742|FG000|Overall Study|Investigator decision, or other reasons|2|||
160929083|NCT00838201|581136743|FG001|Overall Study|Investigator decision, or other reasons|3|||
160929084|NCT00838201|581136742|FG000|Overall Study|Noncompliance|0|||
160929085|NCT00838201|581136743|FG001|Overall Study|Noncompliance|1|||
160929086|NCT00838201|581136742|FG000|Overall Study|Administrative decision|1|||
160929087|NCT00838201|581136743|FG001|Overall Study|Administrative decision|2|||
160929088|NCT00838201|581136742|FG000|Overall Study|Disease progression|3|||
160929089|NCT00838201|581136743|FG001|Overall Study|Disease progression|3|||
160929090|NCT00838201|581136742|FG000|Overall Study|Consent withdrawn|16|||
160929091|NCT00838201|581136743|FG001|Overall Study|Consent withdrawn|19|||
160929092|NCT00838201|581136742|FG000|Overall Study|Lost to Follow-up|4|||
160929093|NCT00838201|581136743|FG001|Overall Study|Lost to Follow-up|3|||
160929094|NCT00838201|581136742|FG000|Overall Study|Adverse Event|5|||
160929095|NCT00838201|581136743|FG001|Overall Study|Adverse Event|9|||
160929096|NCT00838201|581136742|FG000|Overall Study|Death|11|||
160929097|NCT00838201|581136743|FG001|Overall Study|Death|13|||
160929098|NCT03873987|581136744|FG000|Overall Study|Adverse Event|1|||
160929099|NCT03873987|581136745|FG001|Overall Study|Adverse Event|0|||
160929100|NCT03873987|581136744|FG000|Overall Study|staff was unable to start a new IV line|1|||
160929101|NCT03873987|581136745|FG001|Overall Study|staff was unable to start a new IV line|0|||
160929102|NCT03873987|581136744|FG000|Overall Study|Lost to Follow-up|0|||
160929103|NCT03873987|581136745|FG001|Overall Study|Lost to Follow-up|1|||
160929104|NCT01465022|581136746|FG000|Overall Study|Lost to Follow-up|15|||
160929105|NCT01465022|581136747|FG001|Overall Study|Lost to Follow-up|14|||
160929106|NCT01465022|581136748|FG002|Overall Study|Lost to Follow-up|0|||
160929107|NCT01465022|581136746|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
160929108|NCT01465022|581136747|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
160929109|NCT01465022|581136748|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
160929110|NCT01465022|581136746|FG000|Overall Study|Not Randomized|0|||
160929111|NCT01465022|581136747|FG001|Overall Study|Not Randomized|0|||
160929112|NCT01465022|581136748|FG002|Overall Study|Not Randomized|70|||
160929113|NCT00004888|581136749|FG000|Overall Study|Adverse Event|5|||
160929114|NCT00004888|581136750|FG001|Overall Study|Adverse Event|10|||
160929115|NCT00004888|581136749|FG000|Overall Study|Withdrawal by Subject|0|||
160929116|NCT00004888|581136750|FG001|Overall Study|Withdrawal by Subject|3|||
160929117|NCT00004888|581136749|FG000|Overall Study|Physician Decision|1|||
160929118|NCT00004888|581136750|FG001|Overall Study|Physician Decision|1|||
160929119|NCT00004888|581136749|FG000|Overall Study|Progressive Disease|4|||
160929120|NCT00004888|581136750|FG001|Overall Study|Progressive Disease|9|||
160929121|NCT00004888|581136749|FG000|Overall Study|Death without progressive disease|0|||
160929122|NCT00004888|581136750|FG001|Overall Study|Death without progressive disease|1|||
160929123|NCT00004888|581136749|FG000|Overall Study|Toxic death|1|||
160929124|NCT00004888|581136750|FG001|Overall Study|Toxic death|0|||
160929125|NCT00136084|581136751|FG000|Overall Study|Death|12|||
160929126|NCT00136084|581136752|FG001|Overall Study|Death|5|||
160998110|NCT02957539|581378567|FG001|Week 16 to 32|Withdrawal by Subject|3|||
160578175|NCT03703375|579838271|FG002|Treatment Period|Toxicity of Study Treatment|4|||
160578176|NCT03703375|579838272|FG003|Treatment Period|Toxicity of Study Treatment|1|||
160929127|NCT00136084|581136751|FG000|Overall Study|Unacceptable toxicity|8|||
160929128|NCT00136084|581136752|FG001|Overall Study|Unacceptable toxicity|11|||
160929129|NCT00136084|581136751|FG000|Overall Study|Relapse|20|||
160929130|NCT00136084|581136752|FG001|Overall Study|Relapse|23|||
160929131|NCT00136084|581136751|FG000|Overall Study|Lost to Follow-up|2|||
160929132|NCT00136084|581136752|FG001|Overall Study|Lost to Follow-up|0|||
160929133|NCT00136084|581136751|FG000|Overall Study|No Response|1|||
160929134|NCT00136084|581136752|FG001|Overall Study|No Response|2|||
160929135|NCT00136084|581136751|FG000|Overall Study|Withdrawal by Subject|5|||
160929136|NCT00136084|581136752|FG001|Overall Study|Withdrawal by Subject|1|||
160929137|NCT02579265|581136753|FG000|Overall Study|Weaned off earlier than 28 days|44|||
160929138|NCT02579265|581136754|FG001|Overall Study|Weaned off earlier than 28 days|43|||
160929139|NCT02579265|581136753|FG000|Overall Study|Adverse Event|2|||
160929140|NCT02579265|581136754|FG001|Overall Study|Adverse Event|0|||
160929141|NCT02579265|581136753|FG000|Overall Study|Any other reason not specified|0|||
160929142|NCT02579265|581136754|FG001|Overall Study|Any other reason not specified|2|||
160929143|NCT02579265|581136753|FG000|Overall Study|Withdrawal by Subject|2|||
160929144|NCT02579265|581136754|FG001|Overall Study|Withdrawal by Subject|0|||
160929145|NCT02579265|581136753|FG000|Overall Study|Physician Decision|1|||
160929146|NCT02579265|581136754|FG001|Overall Study|Physician Decision|0|||
160929147|NCT02579265|581136753|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
160929148|NCT02579265|581136754|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
160929149|NCT02174848|581136755|FG000|Overall Study|Adverse Event|2|||
160929150|NCT02174848|581136756|FG001|Overall Study|Adverse Event|1|||
160929151|NCT02174848|581136755|FG000|Overall Study|Withdrawal by Subject|3|||
160929152|NCT02174848|581136756|FG001|Overall Study|Withdrawal by Subject|3|||
160929153|NCT02174848|581136755|FG000|Overall Study|Lost to Follow-up|0|||
160929154|NCT02174848|581136756|FG001|Overall Study|Lost to Follow-up|1|||
160929155|NCT02174848|581136755|FG000|Overall Study|Worsening of disease|1|||
160929156|NCT02174848|581136756|FG001|Overall Study|Worsening of disease|1|||
160929157|NCT02174848|581136755|FG000|Overall Study|Unable to comply with study requirements|1|||
160929158|NCT02174848|581136756|FG001|Overall Study|Unable to comply with study requirements|0|||
160929159|NCT02520011|581136758|FG000|Overall Study|Adverse Event|0|||
160929160|NCT02520011|581136759|FG001|Overall Study|Adverse Event|1|||
160929161|NCT02520011|581136760|FG002|Overall Study|Adverse Event|2|||
160929162|NCT02520011|581136758|FG000|Overall Study|Death|0|||
160929163|NCT02520011|581136759|FG001|Overall Study|Death|8|||
160929164|NCT02520011|581136760|FG002|Overall Study|Death|1|||
160929165|NCT02520011|581136758|FG000|Overall Study|Lack of Efficacy|4|||
160929166|NCT02520011|581136759|FG001|Overall Study|Lack of Efficacy|26|||
160929167|NCT02520011|581136760|FG002|Overall Study|Lack of Efficacy|4|||
160929168|NCT02520011|581136758|FG000|Overall Study|Physician Decision|0|||
160929169|NCT02520011|581136759|FG001|Overall Study|Physician Decision|2|||
160929170|NCT02520011|581136760|FG002|Overall Study|Physician Decision|0|||
160929171|NCT02520011|581136758|FG000|Overall Study|Withdrawal by Subject|1|||
160929172|NCT02520011|581136759|FG001|Overall Study|Withdrawal by Subject|3|||
160929173|NCT02520011|581136760|FG002|Overall Study|Withdrawal by Subject|0|||
160929174|NCT02520011|581136758|FG000|Overall Study|Protocol Deviation|0|||
160929175|NCT02520011|581136759|FG001|Overall Study|Protocol Deviation|1|||
160929176|NCT02520011|581136760|FG002|Overall Study|Protocol Deviation|0|||
160929177|NCT02520011|581136758|FG000|Overall Study|Patient went to hospice|0|||
160929178|NCT02520011|581136759|FG001|Overall Study|Patient went to hospice|1|||
160929179|NCT02520011|581136760|FG002|Overall Study|Patient went to hospice|0|||
160929180|NCT02520011|581136758|FG000|Overall Study|Progressive disease following response|0|||
160929181|NCT02520011|581136759|FG001|Overall Study|Progressive disease following response|4|||
160929182|NCT02520011|581136760|FG002|Overall Study|Progressive disease following response|2|||
160929183|NCT00644969|581136761|FG000|Treatment Phase|Randomized, not treated|1|||
160929184|NCT00644969|581136762|FG001|Treatment Phase|Randomized, not treated|0|||
160929185|NCT00644969|581136761|FG000|Treatment Phase|Adverse Event|3|||
160929186|NCT00644969|581136762|FG001|Treatment Phase|Adverse Event|0|||
160929187|NCT00644969|581136761|FG000|Treatment Phase|Withdrawal by Subject|4|||
160929188|NCT00644969|581136762|FG001|Treatment Phase|Withdrawal by Subject|0|||
160929189|NCT00644969|581136761|FG000|Treatment Phase|Lost to Follow-up|2|||
160929190|NCT00644969|581136762|FG001|Treatment Phase|Lost to Follow-up|2|||
160929191|NCT00644969|581136761|FG000|Treatment Phase|Other|4|||
160929192|NCT00644969|581136762|FG001|Treatment Phase|Other|1|||
160929193|NCT00644969|581136761|FG000|Post Treatment Phase|Death|1|||
160929194|NCT00644969|581136762|FG001|Post Treatment Phase|Death|0|||
160929195|NCT00644969|581136761|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
160929196|NCT00644969|581136762|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
160929197|NCT00644969|581136761|FG000|Post Treatment Phase|Lost to Follow-up|4|||
160929198|NCT00644969|581136762|FG001|Post Treatment Phase|Lost to Follow-up|1|||
160929199|NCT00644969|581136761|FG000|Post Treatment Phase|Other|1|||
160929200|NCT00644969|581136762|FG001|Post Treatment Phase|Other|0|||
160998111|NCT02957539|581378568|FG002|Week 16 to 32|Withdrawal by Subject|1|||
160998112|NCT02957539|581378566|FG000|Week 16 to 32|Lost to Follow-up|8|||
160998113|NCT02957539|581378567|FG001|Week 16 to 32|Lost to Follow-up|7|||
160998114|NCT02957539|581378568|FG002|Week 16 to 32|Lost to Follow-up|5|||
160929201|NCT00997503|581136768|FG000|Overall Study|Death|53|||
160929202|NCT00997503|581136768|FG000|Overall Study|Withdrawal by Subject|76|||
160929203|NCT00997503|581136768|FG000|Overall Study|Lost to Follow-up|33|||
160929204|NCT00997503|581136768|FG000|Overall Study|Adverse Event|3|||
160929205|NCT00997503|581136768|FG000|Overall Study|Physician Decision|10|||
160929206|NCT00997503|581136768|FG000|Overall Study|Missed 12-month follow-up|85|||
160929207|NCT00997503|581136768|FG000|Overall Study|Other reason|13|||
160998115|NCT02957539|581378566|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
160929208|NCT01933048|581136772|FG000|Overall Study|Lost to Follow-up|15|||
160929209|NCT01933048|581136773|FG001|Overall Study|Lost to Follow-up|18|||
160929210|NCT01933048|581136772|FG000|Overall Study|personal reasons|1|||
160929211|NCT01933048|581136773|FG001|Overall Study|personal reasons|1|||
160929212|NCT01933048|581136772|FG000|Overall Study|Protocol Violation|7|||
160929213|NCT01933048|581136773|FG001|Overall Study|Protocol Violation|8|||
160929214|NCT01933048|581136772|FG000|Overall Study|Physician Decision|1|||
160929215|NCT01933048|581136773|FG001|Overall Study|Physician Decision|0|||
160929216|NCT01933048|581136772|FG000|Overall Study|unknown reasons|1|||
160929217|NCT01933048|581136773|FG001|Overall Study|unknown reasons|1|||
160929218|NCT02780804|581136774|FG000|Overall Study|Death|1|||
160929219|NCT02780804|581136775|FG001|Overall Study|Death|0|||
160929220|NCT02780804|581136776|FG002|Overall Study|Death|0|||
160929221|NCT02780804|581136774|FG000|Overall Study|Lack of Efficacy|5|||
160929222|NCT02780804|581136775|FG001|Overall Study|Lack of Efficacy|8|||
160929223|NCT02780804|581136776|FG002|Overall Study|Lack of Efficacy|4|||
160929224|NCT02780804|581136774|FG000|Overall Study|Physician Decision|0|||
160929225|NCT02780804|581136775|FG001|Overall Study|Physician Decision|0|||
160929226|NCT02780804|581136776|FG002|Overall Study|Physician Decision|2|||
160929227|NCT02780804|581136774|FG000|Overall Study|Withdrawal by Subject|0|||
160929228|NCT02780804|581136775|FG001|Overall Study|Withdrawal by Subject|1|||
160929229|NCT02780804|581136776|FG002|Overall Study|Withdrawal by Subject|0|||
160929230|NCT02476968|581136777|FG000|Overall Study|Other|0|||
160929231|NCT02476968|581136778|FG001|Overall Study|Other|2|||
160929232|NCT02476968|581136779|FG002|Overall Study|Other|0|||
160929233|NCT02476968|581136777|FG000|Overall Study|Lost to Follow-up|10|||
160929234|NCT02476968|581136778|FG001|Overall Study|Lost to Follow-up|0|||
160929235|NCT02476968|581136779|FG002|Overall Study|Lost to Follow-up|1|||
160929236|NCT02476968|581136777|FG000|Overall Study|Death|48|||
160929237|NCT02476968|581136778|FG001|Overall Study|Death|8|||
160929238|NCT02476968|581136779|FG002|Overall Study|Death|1|||
160929239|NCT02476968|581136777|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160929240|NCT02476968|581136778|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160929241|NCT02476968|581136779|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
160929242|NCT02476968|581136777|FG000|Overall Study|Patient decision|37|||
160929243|NCT02476968|581136778|FG001|Overall Study|Patient decision|8|||
160929244|NCT02476968|581136779|FG002|Overall Study|Patient decision|0|||
160929245|NCT04171414|581136789|FG000|Overall Study|Death|1|||
160929246|NCT04171414|581136789|FG000|Overall Study|Withdrawal by Subject|1|||
160929247|NCT01714310|581136790|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
160929248|NCT01714310|581136791|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
160929249|NCT01714310|581136792|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
160929250|NCT01714310|581136790|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
160929251|NCT01714310|581136791|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
160929252|NCT01714310|581136792|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
160929253|NCT01714310|581136790|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
160929254|NCT01714310|581136791|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
160929255|NCT01714310|581136792|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
160929256|NCT01714310|581136790|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
160929257|NCT01714310|581136791|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
160929258|NCT01714310|581136792|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
160929259|NCT02487394|581136793|FG000|Phase 1|Withdrawal by Subject|0|||
160929260|NCT02487394|581136794|FG001|Phase 1|Withdrawal by Subject|1|||
160929261|NCT01641367|581136795|FG000|Cohorts|Death|18|||
160929262|NCT01641367|581136796|FG001|Cohorts|Death|1|||
160929263|NCT01641367|581136797|FG002|Cohorts|Death|2|||
160929264|NCT01641367|581136798|FG003|Cohorts|Death|0|||
160929265|NCT01641367|581136799|FG004|Cohorts|Death|1|||
160929266|NCT01641367|581136800|FG005|Cohorts|Death|1|||
160929267|NCT01641367|581136801|FG006|Cohorts|Death|0|||
160929268|NCT01641367|581136802|FG007|Cohorts|Death|0|||
160929269|NCT01641367|581136795|FG000|Cohorts|Lost to Follow-up|16|||
160929270|NCT01641367|581136796|FG001|Cohorts|Lost to Follow-up|0|||
160655890|NCT05630547|580120295|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
160655891|NCT05630547|580120296|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
160929271|NCT01641367|581136797|FG002|Cohorts|Lost to Follow-up|2|||
160929272|NCT01641367|581136798|FG003|Cohorts|Lost to Follow-up|0|||
160929273|NCT01641367|581136799|FG004|Cohorts|Lost to Follow-up|2|||
160929274|NCT01641367|581136800|FG005|Cohorts|Lost to Follow-up|0|||
160929275|NCT01641367|581136801|FG006|Cohorts|Lost to Follow-up|0|||
160929276|NCT01641367|581136802|FG007|Cohorts|Lost to Follow-up|0|||
160929277|NCT01641367|581136795|FG000|Randomized Adherence Intervention|Death|0|||
160929278|NCT01641367|581136796|FG001|Randomized Adherence Intervention|Death|0|||
160929279|NCT01641367|581136797|FG002|Randomized Adherence Intervention|Death|0|||
160929280|NCT01641367|581136798|FG003|Randomized Adherence Intervention|Death|0|||
160929281|NCT01641367|581136799|FG004|Randomized Adherence Intervention|Death|0|||
160929282|NCT01641367|581136800|FG005|Randomized Adherence Intervention|Death|0|||
160929283|NCT01641367|581136801|FG006|Randomized Adherence Intervention|Death|11|||
160929284|NCT01641367|581136802|FG007|Randomized Adherence Intervention|Death|12|||
160929285|NCT01641367|581136795|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929286|NCT01641367|581136796|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929287|NCT01641367|581136797|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929288|NCT01641367|581136798|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929289|NCT01641367|581136799|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929290|NCT01641367|581136800|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929291|NCT01641367|581136801|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
160929292|NCT01641367|581136802|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
160929293|NCT04920123|581136805|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
160929294|NCT04920123|581136806|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
160929295|NCT04920123|581136807|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
160929296|NCT00218296|581136813|FG000|Overall Study|Lost to Follow-up|9|||
160929297|NCT00218296|581136814|FG001|Overall Study|Lost to Follow-up|7|||
160929298|NCT00218296|581136813|FG000|Overall Study|Withdrawal by Subject|36|||
160929299|NCT00218296|581136814|FG001|Overall Study|Withdrawal by Subject|47|||
160929300|NCT00218296|581136813|FG000|Overall Study|Randomized but did not enter treatment|66|||
160929301|NCT00218296|581136814|FG001|Overall Study|Randomized but did not enter treatment|67|||
160929302|NCT02586493|581136818|FG000|Overall Study|Adverse Event|4|||
160929303|NCT02586493|581136818|FG000|Overall Study|Protocol Violation|6|||
160929304|NCT02586493|581136818|FG000|Overall Study|Lost to Follow-up|1|||
160929305|NCT02586493|581136818|FG000|Overall Study|Withdrawal by Subject|1|||
160929306|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
160929307|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
160929308|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
160929309|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
160929310|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
160929311|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
160929312|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
160929313|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
160929314|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
160929315|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
160929316|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
160929317|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
160929318|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
160929319|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
160929320|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
160929321|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Death|5|||
160929322|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Death|0|||
160929323|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Death|2|||
160929324|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Death|0|||
160929325|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Death|4|||
160929326|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
160929327|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
160929328|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
160929329|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
160929330|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
160929331|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
160929332|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
160929333|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
160929334|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
160929335|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
160929336|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
160929337|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
160929338|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
160929339|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
160929340|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
160929341|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Other|15|||
160929342|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Other|0|||
160929343|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Other|10|||
160929344|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Other|0|||
160929345|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Other|6|||
160929346|NCT01604343|581136832|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
160929347|NCT01604343|581136833|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
160929348|NCT01604343|581136834|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
160929349|NCT01604343|581136835|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
160655892|NCT05630547|580120297|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
160929350|NCT01604343|581136836|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
160655893|NCT05630547|580120294|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
160929351|NCT01604343|581136832|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
160929352|NCT01604343|581136833|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
160929353|NCT01604343|581136834|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
160929354|NCT01604343|581136835|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
160929355|NCT01604343|581136836|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
160929356|NCT01604343|581136832|FG000|Week 52 to Week 104|Adverse Event|0|||
160929357|NCT01604343|581136833|FG001|Week 52 to Week 104|Adverse Event|12|||
160929358|NCT01604343|581136834|FG002|Week 52 to Week 104|Adverse Event|26|||
160929359|NCT01604343|581136835|FG003|Week 52 to Week 104|Adverse Event|21|||
160929360|NCT01604343|581136836|FG004|Week 52 to Week 104|Adverse Event|27|||
160929361|NCT01604343|581136832|FG000|Week 52 to Week 104|Death|0|||
160929362|NCT01604343|581136833|FG001|Week 52 to Week 104|Death|4|||
160929363|NCT01604343|581136834|FG002|Week 52 to Week 104|Death|2|||
160929364|NCT01604343|581136835|FG003|Week 52 to Week 104|Death|5|||
160929365|NCT01604343|581136836|FG004|Week 52 to Week 104|Death|0|||
160929366|NCT01604343|581136832|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
160929367|NCT01604343|581136833|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
160929368|NCT01604343|581136834|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
160929369|NCT01604343|581136835|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
160929370|NCT01604343|581136836|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
160929371|NCT01604343|581136832|FG000|Week 52 to Week 104|Physician Decision|0|||
160929372|NCT01604343|581136833|FG001|Week 52 to Week 104|Physician Decision|1|||
160929373|NCT01604343|581136834|FG002|Week 52 to Week 104|Physician Decision|0|||
160929374|NCT01604343|581136835|FG003|Week 52 to Week 104|Physician Decision|0|||
160929375|NCT01604343|581136836|FG004|Week 52 to Week 104|Physician Decision|2|||
160929376|NCT01604343|581136832|FG000|Week 52 to Week 104|Pregnancy|0|||
160929377|NCT01604343|581136833|FG001|Week 52 to Week 104|Pregnancy|0|||
160929378|NCT01604343|581136834|FG002|Week 52 to Week 104|Pregnancy|1|||
160929379|NCT01604343|581136835|FG003|Week 52 to Week 104|Pregnancy|2|||
160929380|NCT01604343|581136836|FG004|Week 52 to Week 104|Pregnancy|1|||
160929381|NCT01604343|581136832|FG000|Week 52 to Week 104|Other|0|||
160929382|NCT01604343|581136833|FG001|Week 52 to Week 104|Other|11|||
160929383|NCT01604343|581136834|FG002|Week 52 to Week 104|Other|11|||
160929384|NCT01604343|581136835|FG003|Week 52 to Week 104|Other|6|||
160929385|NCT01604343|581136836|FG004|Week 52 to Week 104|Other|3|||
160929386|NCT01604343|581136832|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
160929387|NCT01604343|581136833|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
160929388|NCT01604343|581136834|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
160929389|NCT01604343|581136835|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
160929390|NCT01604343|581136836|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
160929391|NCT01604343|581136832|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
160929392|NCT01604343|581136833|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
160929393|NCT01604343|581136834|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
160929394|NCT01604343|581136835|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
160929395|NCT01604343|581136836|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
160929396|NCT01604343|581136832|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
160929397|NCT01604343|581136833|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
160929398|NCT01604343|581136834|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
160929399|NCT01604343|581136835|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
160929400|NCT01604343|581136836|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
160929401|NCT02711800|581136838|FG000|Overall Study|Lost to Follow-up|1|||
160929402|NCT02711800|581136838|FG000|Overall Study|Withdrawal by Subject|1|||
160929403|NCT01990495|581136848|FG000|Overall Study|Physician Decision|5|||
160929404|NCT01990495|581136849|FG001|Overall Study|Physician Decision|4|||
160929405|NCT00449956|581136850|FG000|Overall Study|Adverse Event|7|||
160929406|NCT00449956|581136851|FG001|Overall Study|Adverse Event|1|||
160929407|NCT00449956|581136852|FG002|Overall Study|Adverse Event|6|||
160929408|NCT00449956|581136850|FG000|Overall Study|Lack of Efficacy|0|||
160929409|NCT00449956|581136851|FG001|Overall Study|Lack of Efficacy|0|||
160929410|NCT00449956|581136852|FG002|Overall Study|Lack of Efficacy|1|||
160929411|NCT00449956|581136850|FG000|Overall Study|Protocol Violation|1|||
160929412|NCT00449956|581136851|FG001|Overall Study|Protocol Violation|1|||
160929413|NCT00449956|581136852|FG002|Overall Study|Protocol Violation|1|||
160998116|NCT02957539|581378567|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
160998117|NCT02957539|581378568|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
160929414|NCT00449956|581136850|FG000|Overall Study|Withdrawal by Subject|0|||
160929415|NCT00449956|581136851|FG001|Overall Study|Withdrawal by Subject|1|||
160929416|NCT00449956|581136852|FG002|Overall Study|Withdrawal by Subject|0|||
160929417|NCT00449956|581136850|FG000|Overall Study|Physician Decision|2|||
160929418|NCT00449956|581136851|FG001|Overall Study|Physician Decision|1|||
160929419|NCT00449956|581136852|FG002|Overall Study|Physician Decision|1|||
160929420|NCT01988571|581136857|FG000|Overall Study|Death|3|||
160929421|NCT01988571|581136858|FG001|Overall Study|Death|1|||
160929422|NCT01988571|581136857|FG000|Overall Study|Physician Decision|2|||
160929423|NCT01988571|581136858|FG001|Overall Study|Physician Decision|1|||
160929424|NCT01988571|581136857|FG000|Overall Study|Lost to Follow-up|3|||
160929425|NCT01988571|581136858|FG001|Overall Study|Lost to Follow-up|0|||
160929426|NCT01988571|581136857|FG000|Overall Study|Withdrawal by Subject|31|||
160929427|NCT01988571|581136858|FG001|Overall Study|Withdrawal by Subject|33|||
160929428|NCT00337103|581136860|FG000|Overall Study|Progressive Disease|414|||
160929429|NCT00337103|581136861|FG001|Overall Study|Progressive Disease|410|||
160929430|NCT00337103|581136860|FG000|Overall Study|Adverse Event|45|||
160929431|NCT00337103|581136861|FG001|Overall Study|Adverse Event|59|||
160929432|NCT00337103|581136860|FG000|Overall Study|Subject Choice|34|||
160929433|NCT00337103|581136861|FG001|Overall Study|Subject Choice|27|||
160929434|NCT00337103|581136860|FG000|Overall Study|Clinical Progression|27|||
160929435|NCT00337103|581136861|FG001|Overall Study|Clinical Progression|24|||
160929436|NCT00337103|581136860|FG000|Overall Study|Physician Decision|15|||
160929437|NCT00337103|581136861|FG001|Overall Study|Physician Decision|14|||
160929438|NCT00337103|581136860|FG000|Overall Study|Withdrawal by Subject|8|||
160929439|NCT00337103|581136861|FG001|Overall Study|Withdrawal by Subject|5|||
160929440|NCT00337103|581136860|FG000|Overall Study|Other|5|||
160929441|NCT00337103|581136861|FG001|Overall Study|Other|6|||
160929442|NCT00337103|581136860|FG000|Overall Study|Entry Criteria Not Met|4|||
160929443|NCT00337103|581136861|FG001|Overall Study|Entry Criteria Not Met|1|||
160929444|NCT00337103|581136860|FG000|Overall Study|Lost to Follow-up|1|||
160929445|NCT00337103|581136861|FG001|Overall Study|Lost to Follow-up|2|||
160929446|NCT00337103|581136860|FG000|Overall Study|Death|1|||
160929447|NCT00337103|581136861|FG001|Overall Study|Death|0|||
160929448|NCT03161483|581136866|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
160929449|NCT03161483|581136867|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
160929450|NCT03161483|581136868|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
160929451|NCT03161483|581136869|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
160929452|NCT03161483|581136866|FG000|Treatment Period|Death|1|||
160929453|NCT03161483|581136867|FG001|Treatment Period|Death|0|||
160929454|NCT03161483|581136868|FG002|Treatment Period|Death|0|||
160929455|NCT03161483|581136869|FG003|Treatment Period|Death|0|||
160929456|NCT03161483|581136866|FG000|Treatment Period|Adverse Event|5|||
160929457|NCT03161483|581136867|FG001|Treatment Period|Adverse Event|2|||
160929458|NCT03161483|581136868|FG002|Treatment Period|Adverse Event|1|||
160929459|NCT03161483|581136869|FG003|Treatment Period|Adverse Event|11|||
160929460|NCT03161483|581136866|FG000|Treatment Period|Pregnancy|1|||
160929461|NCT03161483|581136867|FG001|Treatment Period|Pregnancy|0|||
160929462|NCT03161483|581136868|FG002|Treatment Period|Pregnancy|0|||
160929463|NCT03161483|581136869|FG003|Treatment Period|Pregnancy|0|||
160929464|NCT03161483|581136866|FG000|Treatment Period|Lack of Efficacy|0|||
160929465|NCT03161483|581136867|FG001|Treatment Period|Lack of Efficacy|0|||
160929466|NCT03161483|581136868|FG002|Treatment Period|Lack of Efficacy|0|||
160929467|NCT03161483|581136869|FG003|Treatment Period|Lack of Efficacy|1|||
160929468|NCT03161483|581136866|FG000|Treatment Period|Withdrawal by Subject|2|||
160929469|NCT03161483|581136867|FG001|Treatment Period|Withdrawal by Subject|5|||
160929470|NCT03161483|581136868|FG002|Treatment Period|Withdrawal by Subject|2|||
160929471|NCT03161483|581136869|FG003|Treatment Period|Withdrawal by Subject|6|||
160929472|NCT03161483|581136866|FG000|Treatment Period|Lost to Follow-up|0|||
160929473|NCT03161483|581136867|FG001|Treatment Period|Lost to Follow-up|0|||
160929474|NCT03161483|581136868|FG002|Treatment Period|Lost to Follow-up|0|||
160929475|NCT03161483|581136869|FG003|Treatment Period|Lost to Follow-up|1|||
160929476|NCT03161483|581136866|FG000|Treatment Period|Protocol Violation|0|||
160929477|NCT03161483|581136867|FG001|Treatment Period|Protocol Violation|0|||
160929478|NCT03161483|581136868|FG002|Treatment Period|Protocol Violation|0|||
160929479|NCT03161483|581136869|FG003|Treatment Period|Protocol Violation|1|||
160929480|NCT03161483|581136866|FG000|Treatment Period|Other reasons|1|||
160929481|NCT03161483|581136867|FG001|Treatment Period|Other reasons|1|||
160929482|NCT03161483|581136868|FG002|Treatment Period|Other reasons|0|||
160929483|NCT03161483|581136869|FG003|Treatment Period|Other reasons|0|||
160929484|NCT00600756|581136875|FG000|Analysis After 6 Months|Adverse Event|43|||
160929485|NCT00600756|581136876|FG001|Analysis After 6 Months|Adverse Event|33|||
160929486|NCT00600756|581136875|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
160929487|NCT00600756|581136876|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
160929488|NCT00600756|581136875|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
160929489|NCT00600756|581136876|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
160929490|NCT00600756|581136875|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
160929491|NCT00600756|581136876|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
160929492|NCT00600756|581136875|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
160929493|NCT00600756|581136876|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
160929494|NCT00600756|581136875|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
160929495|NCT00600756|581136876|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
160929496|NCT00600756|581136875|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
160929497|NCT00600756|581136876|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
160929498|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
160929499|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
160929500|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
160929501|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
160929502|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
160929503|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
160929504|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
160929505|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
160929506|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
160929507|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
160929508|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
160929509|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
160929510|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
160929511|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
160929512|NCT03818516|581136877|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
160929513|NCT03742141|581136883|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
160929514|NCT01524692|581136886|FG000|Overall Study|Withdrawal by Subject|3|||
160929515|NCT01709695|581136888|FG000|Overall Study|Withdrawal by Subject|1|||
160929516|NCT01709695|581136889|FG001|Overall Study|Withdrawal by Subject|1|||
160929517|NCT03065244|581136893|FG000|Overall Study|Lost to Follow-up|1|||
160929518|NCT03065244|581136894|FG001|Overall Study|Lost to Follow-up|1|||
160929519|NCT03065244|581136893|FG000|Overall Study|Diagnosed with a different disease|1|||
160929520|NCT03065244|581136894|FG001|Overall Study|Diagnosed with a different disease|1|||
160929521|NCT03065244|581136893|FG000|Overall Study|Protocol Violation|0|||
160929522|NCT03065244|581136894|FG001|Overall Study|Protocol Violation|1|||
160929523|NCT03065244|581136893|FG000|Overall Study|Withdrawal by Subject|1|||
160929524|NCT03065244|581136894|FG001|Overall Study|Withdrawal by Subject|1|||
160929525|NCT03717480|581136895|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
160929526|NCT01894152|581136896|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
160929527|NCT01774786|581136898|FG000|Overall Study|Death|300|||
160929528|NCT01774786|581136899|FG001|Overall Study|Death|319|||
160929529|NCT01774786|581136898|FG000|Overall Study|Lost to Follow-up|6|||
160929530|NCT01774786|581136899|FG001|Overall Study|Lost to Follow-up|7|||
160929531|NCT01774786|581136898|FG000|Overall Study|Withdrawal by Subject|18|||
160929532|NCT01774786|581136899|FG001|Overall Study|Withdrawal by Subject|14|||
160929533|NCT01774786|581136898|FG000|Overall Study|Physician Decision|2|||
160929534|NCT01774786|581136899|FG001|Overall Study|Physician Decision|0|||
160929535|NCT01774786|581136898|FG000|Overall Study|Non-compliance|0|||
160929536|NCT01774786|581136899|FG001|Overall Study|Non-compliance|1|||
160929537|NCT01774786|581136898|FG000|Overall Study|Reason Not Specified|2|||
160929538|NCT01774786|581136899|FG001|Overall Study|Reason Not Specified|5|||
160929539|NCT04544293|581136900|FG000|Double-blind|Adverse Event|2|||
160929540|NCT04544293|581136901|FG001|Double-blind|Adverse Event|1|||
160929541|NCT04544293|581136900|FG000|Double-blind|Pregnancy|0|||
160929542|NCT04544293|581136901|FG001|Double-blind|Pregnancy|1|||
160929543|NCT04544293|581136900|FG000|Double-blind|Lost to Follow-up|0|||
160929544|NCT04544293|581136901|FG001|Double-blind|Lost to Follow-up|1|||
160929545|NCT04544293|581136900|FG000|Open-Label Extension|Study ongoing|79|||
160929546|NCT04544293|581136901|FG001|Open-Label Extension|Study ongoing|81|||
160929547|NCT01062555|581136906|FG000|Phase 1|Death|10|||
160929548|NCT01062555|581136907|FG001|Phase 1|Death|17|||
160929549|NCT01062555|581136908|FG002|Phase 1|Death|0|||
160929550|NCT01062555|581136909|FG003|Phase 1|Death|0|||
160929551|NCT01062555|581136906|FG000|Phase 1|Graft Failure|12|||
160929552|NCT01062555|581136907|FG001|Phase 1|Graft Failure|8|||
160929553|NCT01062555|581136908|FG002|Phase 1|Graft Failure|0|||
160929554|NCT01062555|581136909|FG003|Phase 1|Graft Failure|0|||
160929555|NCT01062555|581136906|FG000|Phase 1|Withdrawal by Subject|1|||
160929556|NCT01062555|581136907|FG001|Phase 1|Withdrawal by Subject|1|||
160929557|NCT01062555|581136908|FG002|Phase 1|Withdrawal by Subject|0|||
160929558|NCT01062555|581136909|FG003|Phase 1|Withdrawal by Subject|0|||
160929559|NCT01062555|581136906|FG000|Phase 2|Death|0|||
160929560|NCT01062555|581136907|FG001|Phase 2|Death|0|||
160929561|NCT01062555|581136908|FG002|Phase 2|Death|8|||
160929562|NCT01062555|581136909|FG003|Phase 2|Death|3|||
160929563|NCT01062555|581136906|FG000|Phase 2|Graft failure|0|||
160998118|NCT02957539|581378566|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
160998119|NCT02957539|581378567|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
160929564|NCT01062555|581136907|FG001|Phase 2|Graft failure|0|||
160929565|NCT01062555|581136908|FG002|Phase 2|Graft failure|7|||
160929566|NCT01062555|581136909|FG003|Phase 2|Graft failure|4|||
160929567|NCT01062555|581136906|FG000|Phase 2|Withdrawal by Subject|0|||
160929568|NCT01062555|581136907|FG001|Phase 2|Withdrawal by Subject|0|||
160929569|NCT01062555|581136908|FG002|Phase 2|Withdrawal by Subject|0|||
160929570|NCT01062555|581136909|FG003|Phase 2|Withdrawal by Subject|7|||
160929571|NCT01062555|581136906|FG000|Phase 2|Protocol Violation|0|||
160929572|NCT01062555|581136907|FG001|Phase 2|Protocol Violation|0|||
160929573|NCT01062555|581136908|FG002|Phase 2|Protocol Violation|0|||
160929574|NCT01062555|581136909|FG003|Phase 2|Protocol Violation|3|||
160929575|NCT01062555|581136906|FG000|Phase 2|Physician Decision|0|||
160929576|NCT01062555|581136907|FG001|Phase 2|Physician Decision|0|||
160929577|NCT01062555|581136908|FG002|Phase 2|Physician Decision|0|||
160929578|NCT01062555|581136909|FG003|Phase 2|Physician Decision|17|||
160929579|NCT00826267|581138460|FG000|Overall Study|Other Adverse Event|1|||
160929580|NCT00826267|581138461|FG001|Overall Study|Other Adverse Event|0|||
160929581|NCT00826267|581138462|FG002|Overall Study|Other Adverse Event|0|||
160929582|NCT05442554|581138463|FG000|Overall Study|Adverse Event|1|||
160929583|NCT01828034|581138464|FG000|Overall Study|Withdrawal by Subject|0|||
160929584|NCT01828034|581138465|FG001|Overall Study|Withdrawal by Subject|0|||
160929585|NCT01828034|581138466|FG002|Overall Study|Withdrawal by Subject|0|||
160929586|NCT01828034|581138467|FG003|Overall Study|Withdrawal by Subject|1|||
160929587|NCT00409617|581138474|FG000|Overall Study|Adverse Event|57|||
160929588|NCT00409617|581138474|FG000|Overall Study|Lack of Efficacy|54|||
160929589|NCT00409617|581138474|FG000|Overall Study|Lost to Follow-up|2|||
160929590|NCT00409617|581138474|FG000|Overall Study|Protocol Violation|24|||
160929591|NCT00409617|581138474|FG000|Overall Study|Withdrawal by Subject|8|||
160929592|NCT00409617|581138474|FG000|Overall Study|Administrative reasons|1|||
160929593|NCT00409617|581138474|FG000|Overall Study|Not described|14|||
160929594|NCT00149747|581138485|FG000|Overall Study|Death|1|||
160929595|NCT00149747|581138486|FG001|Overall Study|Death|0|||
160929596|NCT00149747|581138485|FG000|Overall Study|Withdrawal by Subject|3|||
160929597|NCT00149747|581138486|FG001|Overall Study|Withdrawal by Subject|3|||
160929598|NCT02689258|581138487|FG000|Overall Study|Subject Non-Compliance|0|||
160929599|NCT02689258|581138488|FG001|Overall Study|Subject Non-Compliance|1|||
160929600|NCT02689258|581138489|FG002|Overall Study|Subject Non-Compliance|0|||
160929601|NCT02689258|581138490|FG003|Overall Study|Subject Non-Compliance|0|||
160929602|NCT02689258|581138491|FG004|Overall Study|Subject Non-Compliance|0|||
160929603|NCT02689258|581138492|FG005|Overall Study|Subject Non-Compliance|0|||
160929604|NCT02689258|581138493|FG006|Overall Study|Subject Non-Compliance|0|||
160929605|NCT02689258|581138494|FG007|Overall Study|Subject Non-Compliance|0|||
160929606|NCT02689258|581138495|FG008|Overall Study|Subject Non-Compliance|0|||
160929607|NCT02689258|581138496|FG009|Overall Study|Subject Non-Compliance|0|||
160929608|NCT02689258|581138497|FG010|Overall Study|Subject Non-Compliance|0|||
160929609|NCT02689258|581138498|FG011|Overall Study|Subject Non-Compliance|0|||
160929610|NCT02689258|581138487|FG000|Overall Study|Subject Refusal to Continue|0|||
160929611|NCT02689258|581138488|FG001|Overall Study|Subject Refusal to Continue|1|||
160929612|NCT02689258|581138489|FG002|Overall Study|Subject Refusal to Continue|0|||
160929613|NCT02689258|581138490|FG003|Overall Study|Subject Refusal to Continue|0|||
160929614|NCT02689258|581138491|FG004|Overall Study|Subject Refusal to Continue|0|||
160929615|NCT02689258|581138492|FG005|Overall Study|Subject Refusal to Continue|0|||
160929616|NCT02689258|581138493|FG006|Overall Study|Subject Refusal to Continue|0|||
160929617|NCT02689258|581138494|FG007|Overall Study|Subject Refusal to Continue|0|||
160929618|NCT02689258|581138495|FG008|Overall Study|Subject Refusal to Continue|1|||
160929619|NCT02689258|581138496|FG009|Overall Study|Subject Refusal to Continue|0|||
160929620|NCT02689258|581138497|FG010|Overall Study|Subject Refusal to Continue|0|||
160929621|NCT02689258|581138498|FG011|Overall Study|Subject Refusal to Continue|1|||
160929622|NCT02689258|581138487|FG000|Overall Study|Other|0|||
160929623|NCT02689258|581138488|FG001|Overall Study|Other|2|||
160929624|NCT02689258|581138489|FG002|Overall Study|Other|0|||
160929625|NCT02689258|581138490|FG003|Overall Study|Other|0|||
160929626|NCT02689258|581138491|FG004|Overall Study|Other|1|||
160929627|NCT02689258|581138492|FG005|Overall Study|Other|0|||
160929628|NCT02689258|581138493|FG006|Overall Study|Other|0|||
160929629|NCT02689258|581138494|FG007|Overall Study|Other|0|||
160929630|NCT02689258|581138495|FG008|Overall Study|Other|1|||
160929631|NCT02689258|581138496|FG009|Overall Study|Other|0|||
160929632|NCT02689258|581138497|FG010|Overall Study|Other|0|||
160929633|NCT02689258|581138498|FG011|Overall Study|Other|0|||
160929634|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
160929635|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
160929636|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
160929637|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
160929638|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
160929639|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
160929640|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
160929641|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
160929642|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
160929643|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
160929644|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
160929645|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
160929646|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
160929647|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
160929648|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
160929649|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
160929650|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
160929651|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
160929652|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
160929653|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
160929654|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
160929655|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
160929656|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
160929657|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
160929658|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
160929659|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
160929660|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
160929661|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
160929662|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
160929663|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
160929664|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
160929665|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
160929666|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
160929667|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
160929668|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
160929669|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
160929670|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
160929671|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
160929672|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
160929673|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
160929674|NCT03373383|581138499|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
160929675|NCT03373383|581138500|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
160929676|NCT03373383|581138501|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
160929677|NCT03373383|581138502|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
160929678|NCT03373383|581138503|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
160929679|NCT02159521|581138505|FG000|Overall Study|Enrolled but not treated|3|||
160929680|NCT02159521|581138505|FG000|Overall Study|Withdrawal by Subject|7|||
160929681|NCT02159521|581138505|FG000|Overall Study|Lost to Follow-up|6|||
160929682|NCT02159521|581138505|FG000|Overall Study|Death|1|||
160929683|NCT02159521|581138505|FG000|Overall Study|Other than specified|1|||
160929684|NCT00907374|581138508|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
160929685|NCT00907374|581138509|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
160929686|NCT00594464|581138510|FG000|Overall Study|Withdrawal by Subject|1|||
160929687|NCT00594464|581138510|FG000|Overall Study|Delay in operation|2|||
160929688|NCT00785486|581138511|FG000|Midazolam Alone|Withdrawal by Subject|1|||
160929689|NCT03131440|581138516|FG000|Overall Study|Withdrawal by Subject|1|||
160929690|NCT03131440|581138517|FG001|Overall Study|Withdrawal by Subject|3|||
160929691|NCT03131440|581138518|FG002|Overall Study|Withdrawal by Subject|0|||
160929692|NCT03131440|581138519|FG003|Overall Study|Withdrawal by Subject|0|||
160929693|NCT03131440|581138520|FG004|Overall Study|Withdrawal by Subject|1|||
160929694|NCT03131440|581138521|FG005|Overall Study|Withdrawal by Subject|0|||
160929695|NCT03131440|581138522|FG006|Overall Study|Withdrawal by Subject|0|||
160929696|NCT03131440|581138523|FG007|Overall Study|Withdrawal by Subject|1|||
160929697|NCT03131440|581138524|FG008|Overall Study|Withdrawal by Subject|1|||
160929698|NCT03131440|581138525|FG009|Overall Study|Withdrawal by Subject|1|||
160929699|NCT03131440|581138526|FG010|Overall Study|Withdrawal by Subject|0|||
160929700|NCT03131440|581138527|FG011|Overall Study|Withdrawal by Subject|1|||
160929701|NCT03131440|581138528|FG012|Overall Study|Withdrawal by Subject|1|||
160929702|NCT03131440|581138529|FG013|Overall Study|Withdrawal by Subject|0|||
160929703|NCT03131440|581138530|FG014|Overall Study|Withdrawal by Subject|1|||
160929704|NCT03131440|581138531|FG015|Overall Study|Withdrawal by Subject|0|||
160929705|NCT03131440|581138532|FG016|Overall Study|Withdrawal by Subject|0|||
160929706|NCT03131440|581138533|FG017|Overall Study|Withdrawal by Subject|0|||
160929707|NCT03131440|581138534|FG018|Overall Study|Withdrawal by Subject|1|||
160929708|NCT03131440|581138535|FG019|Overall Study|Withdrawal by Subject|0|||
160929709|NCT03131440|581138536|FG020|Overall Study|Withdrawal by Subject|1|||
160929710|NCT03131440|581138537|FG021|Overall Study|Withdrawal by Subject|1|||
160929711|NCT03131440|581138538|FG022|Overall Study|Withdrawal by Subject|1|||
160929712|NCT03131440|581138539|FG023|Overall Study|Withdrawal by Subject|0|||
160929713|NCT03131440|581138540|FG024|Overall Study|Withdrawal by Subject|0|||
160455001|NCT03295721|579396269|FG000|Overall Study|Withdrawal by Subject|1|||
160578177|NCT03703375|579838269|FG000|Treatment Period|Progression|32|||
160929714|NCT03131440|581138541|FG025|Overall Study|Withdrawal by Subject|0|||
160929715|NCT03131440|581138542|FG026|Overall Study|Withdrawal by Subject|0|||
160929716|NCT03131440|581138543|FG027|Overall Study|Withdrawal by Subject|0|||
160929717|NCT03131440|581138544|FG028|Overall Study|Withdrawal by Subject|0|||
160929718|NCT03131440|581138545|FG029|Overall Study|Withdrawal by Subject|0|||
160929719|NCT03131440|581138546|FG030|Overall Study|Withdrawal by Subject|1|||
160929720|NCT03131440|581138547|FG031|Overall Study|Withdrawal by Subject|0|||
160929721|NCT03131440|581138516|FG000|Overall Study|Lost to Follow-up|0|||
160998120|NCT02957539|581378568|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
160929722|NCT03131440|581138517|FG001|Overall Study|Lost to Follow-up|0|||
160929723|NCT03131440|581138518|FG002|Overall Study|Lost to Follow-up|0|||
160929724|NCT03131440|581138519|FG003|Overall Study|Lost to Follow-up|0|||
160929725|NCT03131440|581138520|FG004|Overall Study|Lost to Follow-up|0|||
160929726|NCT03131440|581138521|FG005|Overall Study|Lost to Follow-up|1|||
160929727|NCT03131440|581138522|FG006|Overall Study|Lost to Follow-up|0|||
160929728|NCT03131440|581138523|FG007|Overall Study|Lost to Follow-up|0|||
160929729|NCT03131440|581138524|FG008|Overall Study|Lost to Follow-up|0|||
160929730|NCT03131440|581138525|FG009|Overall Study|Lost to Follow-up|0|||
160929731|NCT03131440|581138526|FG010|Overall Study|Lost to Follow-up|0|||
160929732|NCT03131440|581138527|FG011|Overall Study|Lost to Follow-up|0|||
160929733|NCT03131440|581138528|FG012|Overall Study|Lost to Follow-up|0|||
160929734|NCT03131440|581138529|FG013|Overall Study|Lost to Follow-up|0|||
160929735|NCT03131440|581138530|FG014|Overall Study|Lost to Follow-up|0|||
160929736|NCT03131440|581138531|FG015|Overall Study|Lost to Follow-up|0|||
160929737|NCT03131440|581138532|FG016|Overall Study|Lost to Follow-up|0|||
160929738|NCT03131440|581138533|FG017|Overall Study|Lost to Follow-up|0|||
160929739|NCT03131440|581138534|FG018|Overall Study|Lost to Follow-up|0|||
160929740|NCT03131440|581138535|FG019|Overall Study|Lost to Follow-up|2|||
160929741|NCT03131440|581138536|FG020|Overall Study|Lost to Follow-up|1|||
160929742|NCT03131440|581138537|FG021|Overall Study|Lost to Follow-up|0|||
160929743|NCT03131440|581138538|FG022|Overall Study|Lost to Follow-up|1|||
160929744|NCT03131440|581138539|FG023|Overall Study|Lost to Follow-up|0|||
160929745|NCT03131440|581138540|FG024|Overall Study|Lost to Follow-up|1|||
160929746|NCT03131440|581138541|FG025|Overall Study|Lost to Follow-up|0|||
160929747|NCT03131440|581138542|FG026|Overall Study|Lost to Follow-up|0|||
160929748|NCT03131440|581138543|FG027|Overall Study|Lost to Follow-up|2|||
160929749|NCT03131440|581138544|FG028|Overall Study|Lost to Follow-up|0|||
160929750|NCT03131440|581138545|FG029|Overall Study|Lost to Follow-up|2|||
160929751|NCT03131440|581138546|FG030|Overall Study|Lost to Follow-up|0|||
160929752|NCT03131440|581138547|FG031|Overall Study|Lost to Follow-up|0|||
160929753|NCT03131440|581138516|FG000|Overall Study|Death|0|||
160929754|NCT03131440|581138517|FG001|Overall Study|Death|0|||
160929755|NCT03131440|581138518|FG002|Overall Study|Death|0|||
160929756|NCT03131440|581138519|FG003|Overall Study|Death|0|||
160929757|NCT03131440|581138520|FG004|Overall Study|Death|0|||
160929758|NCT03131440|581138521|FG005|Overall Study|Death|0|||
160929759|NCT03131440|581138522|FG006|Overall Study|Death|0|||
160929760|NCT03131440|581138523|FG007|Overall Study|Death|0|||
160929761|NCT03131440|581138524|FG008|Overall Study|Death|0|||
160929762|NCT03131440|581138525|FG009|Overall Study|Death|0|||
160929763|NCT03131440|581138526|FG010|Overall Study|Death|0|||
160929764|NCT03131440|581138527|FG011|Overall Study|Death|0|||
160929765|NCT03131440|581138528|FG012|Overall Study|Death|0|||
160929766|NCT03131440|581138529|FG013|Overall Study|Death|0|||
160929767|NCT03131440|581138530|FG014|Overall Study|Death|0|||
160929768|NCT03131440|581138531|FG015|Overall Study|Death|0|||
160929769|NCT03131440|581138532|FG016|Overall Study|Death|0|||
160929770|NCT03131440|581138533|FG017|Overall Study|Death|0|||
160929771|NCT03131440|581138534|FG018|Overall Study|Death|0|||
160929772|NCT03131440|581138535|FG019|Overall Study|Death|0|||
160929773|NCT03131440|581138536|FG020|Overall Study|Death|0|||
160929774|NCT03131440|581138537|FG021|Overall Study|Death|0|||
160929775|NCT03131440|581138538|FG022|Overall Study|Death|0|||
160929776|NCT03131440|581138539|FG023|Overall Study|Death|0|||
160929777|NCT03131440|581138540|FG024|Overall Study|Death|0|||
160929778|NCT03131440|581138541|FG025|Overall Study|Death|1|||
160929779|NCT03131440|581138542|FG026|Overall Study|Death|0|||
160929780|NCT03131440|581138543|FG027|Overall Study|Death|0|||
160929781|NCT03131440|581138544|FG028|Overall Study|Death|0|||
160929782|NCT03131440|581138545|FG029|Overall Study|Death|0|||
160929783|NCT03131440|581138546|FG030|Overall Study|Death|0|||
160929784|NCT03131440|581138547|FG031|Overall Study|Death|0|||
160578178|NCT03703375|579838270|FG001|Treatment Period|Progression|1|||
160929785|NCT00746941|581138550|FG000|Overall Study|Death|2|||
160929786|NCT00746941|581138551|FG001|Overall Study|Death|0|||
160929787|NCT00746941|581138552|FG002|Overall Study|Death|0|||
160929788|NCT00746941|581138553|FG003|Overall Study|Death|6|||
160929789|NCT00746941|581138550|FG000|Overall Study|Physician Decision|0|||
160929790|NCT00746941|581138551|FG001|Overall Study|Physician Decision|0|||
160929791|NCT00746941|581138552|FG002|Overall Study|Physician Decision|2|||
160929792|NCT00746941|581138553|FG003|Overall Study|Physician Decision|0|||
160929793|NCT00746941|581138550|FG000|Overall Study|Withdrawal by Subject|3|||
160929794|NCT00746941|581138551|FG001|Overall Study|Withdrawal by Subject|0|||
160929795|NCT00746941|581138552|FG002|Overall Study|Withdrawal by Subject|0|||
160578179|NCT03703375|579838271|FG002|Treatment Period|Progression|7|||
160578180|NCT03703375|579838272|FG003|Treatment Period|Progression|11|||
160929796|NCT00746941|581138553|FG003|Overall Study|Withdrawal by Subject|2|||
160929797|NCT00746941|581138550|FG000|Overall Study|Other, reason not provided|2|||
160929798|NCT00746941|581138551|FG001|Overall Study|Other, reason not provided|4|||
160929799|NCT00746941|581138552|FG002|Overall Study|Other, reason not provided|0|||
160929800|NCT00746941|581138553|FG003|Overall Study|Other, reason not provided|4|||
160929801|NCT00746941|581138550|FG000|Overall Study|Adverse Event|0|||
160929802|NCT00746941|581138551|FG001|Overall Study|Adverse Event|0|||
160929803|NCT00746941|581138552|FG002|Overall Study|Adverse Event|0|||
160929804|NCT00746941|581138553|FG003|Overall Study|Adverse Event|1|||
160929805|NCT02741700|581138558|FG000|Overall Study|Lost to Follow-up|17|||
160929806|NCT02741700|581138559|FG001|Overall Study|Lost to Follow-up|8|||
160929807|NCT02741700|581138558|FG000|Overall Study|Withdrawal by Subject|2|||
160929808|NCT02741700|581138559|FG001|Overall Study|Withdrawal by Subject|5|||
160929809|NCT02741700|581138558|FG000|Overall Study|Physician Decision|3|||
160929810|NCT02741700|581138559|FG001|Overall Study|Physician Decision|0|||
160929811|NCT02741700|581138558|FG000|Overall Study|Moved out of State|0|||
160929812|NCT02741700|581138559|FG001|Overall Study|Moved out of State|1|||
160929813|NCT02741700|581138558|FG000|Overall Study|Death|4|||
160929814|NCT02741700|581138559|FG001|Overall Study|Death|5|||
160929815|NCT00075582|581138560|FG000|Overall Study|Adverse Event|3|||
160929816|NCT00075582|581138561|FG001|Overall Study|Adverse Event|1|||
160929817|NCT00075582|581138560|FG000|Overall Study|Lack of Efficacy|4|||
160929818|NCT00075582|581138561|FG001|Overall Study|Lack of Efficacy|8|||
160929819|NCT00075582|581138560|FG000|Overall Study|Physician Decision|5|||
160929820|NCT00075582|581138561|FG001|Overall Study|Physician Decision|8|||
160929821|NCT00075582|581138560|FG000|Overall Study|Withdrawal by Subject|2|||
160929822|NCT00075582|581138561|FG001|Overall Study|Withdrawal by Subject|2|||
160929823|NCT00075582|581138560|FG000|Overall Study|Ineligible for study|36|||
160929824|NCT00075582|581138561|FG001|Overall Study|Ineligible for study|16|||
160929825|NCT05045144|581138562|FG000|Overall Study|Lost to Follow-up|3|||
160929826|NCT05045144|581138563|FG001|Overall Study|Lost to Follow-up|2|||
160929827|NCT05045144|581138564|FG002|Overall Study|Lost to Follow-up|3|||
160929828|NCT05045144|581138565|FG003|Overall Study|Lost to Follow-up|5|||
160929829|NCT05045144|581138566|FG004|Overall Study|Lost to Follow-up|13|||
160929830|NCT05045144|581138562|FG000|Overall Study|Withdrawal by Subject|0|||
160929831|NCT05045144|581138563|FG001|Overall Study|Withdrawal by Subject|1|||
160929832|NCT05045144|581138564|FG002|Overall Study|Withdrawal by Subject|0|||
160929833|NCT05045144|581138565|FG003|Overall Study|Withdrawal by Subject|0|||
160929834|NCT05045144|581138566|FG004|Overall Study|Withdrawal by Subject|0|||
160929835|NCT05045144|581138562|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160929836|NCT05045144|581138563|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160929837|NCT05045144|581138564|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160929838|NCT05045144|581138565|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160929839|NCT05045144|581138566|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160929840|NCT02385084|581138567|FG000|Period 2|Protocol Violation|0|||
160929841|NCT02385084|581138568|FG001|Period 2|Protocol Violation|0|||
160929842|NCT02385084|581138569|FG002|Period 2|Protocol Violation|1|||
160929843|NCT02385084|581138570|FG003|Period 2|Protocol Violation|0|||
160929844|NCT02385084|581138571|FG004|Period 2|Protocol Violation|0|||
160929845|NCT02385084|581138572|FG005|Period 2|Protocol Violation|0|||
160929846|NCT02268786|581138573|FG000|Overall Study|No Euploid Embryos available|42|||
160929847|NCT02268786|581138574|FG001|Overall Study|No Euploid Embryos available|0|||
160929848|NCT02268786|581138573|FG000|Overall Study|Withdrawal by Subject|7|||
160929849|NCT02268786|581138574|FG001|Overall Study|Withdrawal by Subject|14|||
160929850|NCT02268786|581138573|FG000|Overall Study|Thaw Failure|6|||
160929851|NCT02268786|581138574|FG001|Overall Study|Thaw Failure|4|||
160929852|NCT02268786|581138573|FG000|Overall Study|Protocol Violation|1|||
160929853|NCT02268786|581138574|FG001|Overall Study|Protocol Violation|0|||
160929854|NCT00744627|581138575|FG000|Overall Study|Adverse Event|6|||
160929855|NCT00744627|581138576|FG001|Overall Study|Adverse Event|9|||
160929856|NCT00744627|581138575|FG000|Overall Study|Lack of Efficacy|7|||
160929857|NCT00744627|581138576|FG001|Overall Study|Lack of Efficacy|3|||
160929858|NCT00744627|581138575|FG000|Overall Study|Noncompliance|0|||
160929859|NCT00744627|581138576|FG001|Overall Study|Noncompliance|1|||
160929860|NCT00744627|581138575|FG000|Overall Study|Protocol Deviations|0|||
160929861|NCT00744627|581138576|FG001|Overall Study|Protocol Deviations|2|||
160929862|NCT00744627|581138575|FG000|Overall Study|Voluntary Withdrawal|9|||
160929863|NCT00744627|581138576|FG001|Overall Study|Voluntary Withdrawal|6|||
160929864|NCT00744627|581138575|FG000|Overall Study|Lost to Follow-up|2|||
160929865|NCT00744627|581138576|FG001|Overall Study|Lost to Follow-up|1|||
160929866|NCT00744627|581138575|FG000|Overall Study|Other|1|||
160929867|NCT00744627|581138576|FG001|Overall Study|Other|0|||
160929868|NCT04809220|581138579|FG000|Overall Study|Adverse Event|4|||
160929869|NCT04809220|581138580|FG001|Overall Study|Adverse Event|0|||
160929870|NCT04809220|581138579|FG000|Overall Study|Death|1|||
160929871|NCT04809220|581138580|FG001|Overall Study|Death|0|||
160929872|NCT04809220|581138579|FG000|Overall Study|Lost to Follow-up|3|||
160929873|NCT04809220|581138580|FG001|Overall Study|Lost to Follow-up|0|||
160929874|NCT04809220|581138579|FG000|Overall Study|Physician Decision|0|||
160929875|NCT04809220|581138580|FG001|Overall Study|Physician Decision|1|||
160929876|NCT04809220|581138579|FG000|Overall Study|Withdrawal by Subject|9|||
160929877|NCT04809220|581138580|FG001|Overall Study|Withdrawal by Subject|5|||
160929878|NCT04809220|581138579|FG000|Overall Study|Due to long-term overseas business trips|1|||
160929879|NCT04809220|581138580|FG001|Overall Study|Due to long-term overseas business trips|0|||
160929880|NCT03560531|581138585|FG000|Overall Study|Death|4|||
160929881|NCT03560531|581138586|FG001|Overall Study|Death|1|||
160929882|NCT03560531|581138587|FG002|Overall Study|Death|1|||
160929883|NCT03560531|581138588|FG003|Overall Study|Death|2|||
160929884|NCT03560531|581138589|FG004|Overall Study|Death|6|||
160929885|NCT03560531|581138590|FG005|Overall Study|Death|1|||
160929886|NCT03560531|581138591|FG006|Overall Study|Death|4|||
160929887|NCT03560531|581138592|FG007|Overall Study|Death|8|||
160929888|NCT03560531|581138593|FG008|Overall Study|Death|1|||
160929889|NCT03560531|581138594|FG009|Overall Study|Death|3|||
160929890|NCT03560531|581138595|FG010|Overall Study|Death|2|||
160929891|NCT03560531|581138596|FG011|Overall Study|Death|0|||
160929892|NCT03560531|581138597|FG012|Overall Study|Death|4|||
160929893|NCT03560531|581138598|FG013|Overall Study|Death|1|||
160929894|NCT03560531|581138585|FG000|Overall Study|Lost to Follow-up|1|||
160929895|NCT03560531|581138586|FG001|Overall Study|Lost to Follow-up|1|||
160929896|NCT03560531|581138587|FG002|Overall Study|Lost to Follow-up|0|||
160929897|NCT03560531|581138588|FG003|Overall Study|Lost to Follow-up|0|||
160929898|NCT03560531|581138589|FG004|Overall Study|Lost to Follow-up|0|||
160929899|NCT03560531|581138590|FG005|Overall Study|Lost to Follow-up|0|||
160929900|NCT03560531|581138591|FG006|Overall Study|Lost to Follow-up|1|||
160929901|NCT03560531|581138592|FG007|Overall Study|Lost to Follow-up|0|||
160929902|NCT03560531|581138593|FG008|Overall Study|Lost to Follow-up|0|||
160929903|NCT03560531|581138594|FG009|Overall Study|Lost to Follow-up|0|||
160929904|NCT03560531|581138595|FG010|Overall Study|Lost to Follow-up|0|||
160929905|NCT03560531|581138596|FG011|Overall Study|Lost to Follow-up|0|||
160929906|NCT03560531|581138597|FG012|Overall Study|Lost to Follow-up|0|||
160929907|NCT03560531|581138598|FG013|Overall Study|Lost to Follow-up|0|||
160929908|NCT03560531|581138585|FG000|Overall Study|Withdrawal by Subject|1|||
160929909|NCT03560531|581138586|FG001|Overall Study|Withdrawal by Subject|0|||
160929910|NCT03560531|581138587|FG002|Overall Study|Withdrawal by Subject|0|||
160929911|NCT03560531|581138588|FG003|Overall Study|Withdrawal by Subject|0|||
160929912|NCT03560531|581138589|FG004|Overall Study|Withdrawal by Subject|0|||
160929913|NCT03560531|581138590|FG005|Overall Study|Withdrawal by Subject|0|||
160929914|NCT03560531|581138591|FG006|Overall Study|Withdrawal by Subject|0|||
160929915|NCT03560531|581138592|FG007|Overall Study|Withdrawal by Subject|3|||
160929916|NCT03560531|581138593|FG008|Overall Study|Withdrawal by Subject|2|||
160929917|NCT03560531|581138594|FG009|Overall Study|Withdrawal by Subject|0|||
160929918|NCT03560531|581138595|FG010|Overall Study|Withdrawal by Subject|0|||
160929919|NCT03560531|581138596|FG011|Overall Study|Withdrawal by Subject|0|||
160929920|NCT03560531|581138597|FG012|Overall Study|Withdrawal by Subject|2|||
160929921|NCT03560531|581138598|FG013|Overall Study|Withdrawal by Subject|0|||
160929922|NCT03560531|581138585|FG000|Overall Study|Study end per-protocol|1|||
160929923|NCT03560531|581138586|FG001|Overall Study|Study end per-protocol|1|||
160929924|NCT03560531|581138587|FG002|Overall Study|Study end per-protocol|2|||
160929925|NCT03560531|581138588|FG003|Overall Study|Study end per-protocol|0|||
160929926|NCT03560531|581138589|FG004|Overall Study|Study end per-protocol|1|||
160929927|NCT03560531|581138590|FG005|Overall Study|Study end per-protocol|0|||
160929928|NCT03560531|581138591|FG006|Overall Study|Study end per-protocol|0|||
160929929|NCT03560531|581138592|FG007|Overall Study|Study end per-protocol|0|||
160929930|NCT03560531|581138593|FG008|Overall Study|Study end per-protocol|0|||
160929931|NCT03560531|581138594|FG009|Overall Study|Study end per-protocol|0|||
160929932|NCT03560531|581138595|FG010|Overall Study|Study end per-protocol|0|||
160929933|NCT03560531|581138596|FG011|Overall Study|Study end per-protocol|0|||
160929934|NCT03560531|581138597|FG012|Overall Study|Study end per-protocol|0|||
160929935|NCT03560531|581138598|FG013|Overall Study|Study end per-protocol|0|||
160929936|NCT03560531|581138585|FG000|Overall Study|Early study termination by sponsor|9|||
160929937|NCT03560531|581138586|FG001|Overall Study|Early study termination by sponsor|0|||
160929938|NCT03560531|581138587|FG002|Overall Study|Early study termination by sponsor|0|||
160929939|NCT03560531|581138588|FG003|Overall Study|Early study termination by sponsor|4|||
160929940|NCT03560531|581138589|FG004|Overall Study|Early study termination by sponsor|8|||
160929941|NCT03560531|581138590|FG005|Overall Study|Early study termination by sponsor|2|||
160929942|NCT03560531|581138591|FG006|Overall Study|Early study termination by sponsor|5|||
160929943|NCT03560531|581138592|FG007|Overall Study|Early study termination by sponsor|64|||
160929944|NCT03560531|581138593|FG008|Overall Study|Early study termination by sponsor|7|||
160929945|NCT03560531|581138594|FG009|Overall Study|Early study termination by sponsor|2|||
160929946|NCT03560531|581138595|FG010|Overall Study|Early study termination by sponsor|16|||
160929947|NCT03560531|581138596|FG011|Overall Study|Early study termination by sponsor|2|||
160929948|NCT03560531|581138597|FG012|Overall Study|Early study termination by sponsor|6|||
160929949|NCT03560531|581138598|FG013|Overall Study|Early study termination by sponsor|2|||
160929950|NCT02968979|581138599|FG000|Overall Study|Protocol Violation|7|||
160929951|NCT02968979|581138599|FG000|Overall Study|Withdrawal by Subject|1|||
160929952|NCT01471379|581138600|FG000|Overall Study|Adverse Event|1|||
160929953|NCT01471379|581138601|FG001|Overall Study|Adverse Event|0|||
160929954|NCT01471379|581138602|FG002|Overall Study|Adverse Event|0|||
160929955|NCT01471379|581138600|FG000|Overall Study|Study terminated|0|||
160929956|NCT01471379|581138601|FG001|Overall Study|Study terminated|1|||
160929957|NCT01471379|581138602|FG002|Overall Study|Study terminated|0|||
160929958|NCT00729183|581138603|FG000|Overall Study|Adverse Event|11|||
160929959|NCT00729183|581138604|FG001|Overall Study|Adverse Event|5|||
160929960|NCT00729183|581138603|FG000|Overall Study|Lack of Efficacy|0|||
160929961|NCT00729183|581138604|FG001|Overall Study|Lack of Efficacy|1|||
160929962|NCT00729183|581138603|FG000|Overall Study|Lost to Follow-up|3|||
160929963|NCT00729183|581138604|FG001|Overall Study|Lost to Follow-up|1|||
160929964|NCT00729183|581138603|FG000|Overall Study|Physician Decision|1|||
160929965|NCT00729183|581138604|FG001|Overall Study|Physician Decision|1|||
160929966|NCT00729183|581138603|FG000|Overall Study|Protocol Violation|1|||
160929967|NCT00729183|581138604|FG001|Overall Study|Protocol Violation|0|||
160929968|NCT00729183|581138603|FG000|Overall Study|Withdrawal by Subject|9|||
160929969|NCT00729183|581138604|FG001|Overall Study|Withdrawal by Subject|7|||
160929970|NCT01200797|581138613|FG000|Overall Study|symptomatic deterioration|2|||
160929971|NCT01200797|581138613|FG000|Overall Study|Adverse Event|4|||
160929972|NCT01200797|581138613|FG000|Overall Study|Disease Progression|13|||
160929973|NCT03745144|581138616|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
160929974|NCT03745144|581138617|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
160929975|NCT03745144|581138618|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
160929976|NCT03745144|581138616|FG000|Period 1|Other|0|||
160929977|NCT03745144|581138617|FG001|Period 1|Other|0|||
160929978|NCT03745144|581138618|FG002|Period 1|Other|1|||
160929979|NCT00642668|581138623|FG000|Overall Study|Lost to Follow-up|1|||
160929980|NCT00642668|581138623|FG000|Overall Study|Adverse Event|2|||
160929981|NCT00642668|581138623|FG000|Overall Study|Death|2|||
160929982|NCT00642668|581138623|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160929983|NCT00642668|581138623|FG000|Overall Study|Failure to Return|1|||
160929984|NCT00642668|581138623|FG000|Overall Study|Dialysis Initiation|5|||
160929985|NCT00642668|581138623|FG000|Overall Study|Blood Transfusion|2|||
160929986|NCT00896337|581138624|FG000|Overall Study|Death|7|||
160929987|NCT00896337|581138624|FG000|Overall Study|Withdrawal by Subject|7|||
160929988|NCT00896337|581138624|FG000|Overall Study|Lost to Follow-up|11|||
160929989|NCT02818777|581138631|FG000|Overall Study|Adverse Event|3|||
160929990|NCT00747435|581138632|FG000|Overall Study|Lost to Follow-up|2|||
160929991|NCT00747435|581138632|FG000|Overall Study|Withdrawal by Subject|3|||
160929992|NCT00747435|581138632|FG000|Overall Study|Still undergoing follow up|1|||
160929993|NCT01324349|581138633|FG000|Overall Study|Death|1|||
160929994|NCT01324349|581138634|FG001|Overall Study|Death|1|||
160929995|NCT01324349|581138633|FG000|Overall Study|Withdrawal by Subject|0|||
160929996|NCT01324349|581138634|FG001|Overall Study|Withdrawal by Subject|1|||
160929997|NCT04151290|581138639|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
160929998|NCT02276612|581138640|FG000|Overall Study|Death|1|||
160929999|NCT02276612|581138641|FG001|Overall Study|Death|0|||
160930000|NCT02276612|581138640|FG000|Overall Study|Pregnancy|1|||
160930001|NCT02276612|581138641|FG001|Overall Study|Pregnancy|0|||
160930002|NCT02276612|581138640|FG000|Overall Study|Withdrew Consent|1|||
160930003|NCT02276612|581138641|FG001|Overall Study|Withdrew Consent|0|||
160930004|NCT02276612|581138640|FG000|Overall Study|Lost to Follow-up|1|||
160930005|NCT02276612|581138641|FG001|Overall Study|Lost to Follow-up|0|||
160930006|NCT04380857|581140217|FG000|Overall Study|Lost to Follow-up|3|||
160930007|NCT04380857|581140218|FG001|Overall Study|Lost to Follow-up|3|||
160930008|NCT02558790|581140219|FG000|Overall Study|Lost to Follow-up|2|||
160930009|NCT02558790|581140219|FG000|Overall Study|Physician Decision|1|||
160930010|NCT02558790|581140219|FG000|Overall Study|Withdrawal by Subject|1|||
160930011|NCT02558790|581140219|FG000|Overall Study|Screen Fail|3|||
160930012|NCT05083442|581140220|FG000|Overall Study|Lost to Follow-up|1|||
160930013|NCT05083442|581140221|FG001|Overall Study|Lost to Follow-up|0|||
160930014|NCT05083442|581140220|FG000|Overall Study|Lack of Efficacy|0|||
160930015|NCT05083442|581140221|FG001|Overall Study|Lack of Efficacy|1|||
160930016|NCT05083442|581140220|FG000|Overall Study|Withdrawal by Subject|1|||
160930017|NCT05083442|581140221|FG001|Overall Study|Withdrawal by Subject|3|||
160930018|NCT05083442|581140220|FG000|Overall Study|scheduling difficulties|1|||
160930019|NCT05083442|581140221|FG001|Overall Study|scheduling difficulties|2|||
160930020|NCT04865354|581140229|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
160930021|NCT04865354|581140230|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
160930022|NCT04865354|581140229|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
160930023|NCT04865354|581140230|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
160930024|NCT04865354|581140229|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
160930025|NCT04865354|581140230|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
160930026|NCT01886833|581140231|FG000|Overall Study|IgA not available from both periods|204|||
160930027|NCT01454726|581140232|FG000|Overall Study|Withdrawal by Subject|0|||
160930028|NCT01454726|581140233|FG001|Overall Study|Withdrawal by Subject|1|||
160930029|NCT04476030|581140236|FG000|Overall Study|Withdrawal by Subject|20|||
160930030|NCT04476030|581140237|FG001|Overall Study|Withdrawal by Subject|16|||
160930031|NCT04476030|581140236|FG000|Overall Study|Adverse Event|10|||
160930032|NCT04476030|581140237|FG001|Overall Study|Adverse Event|11|||
160930033|NCT04476030|581140236|FG000|Overall Study|Lost to Follow-up|7|||
160930034|NCT04476030|581140237|FG001|Overall Study|Lost to Follow-up|4|||
160930035|NCT04476030|581140236|FG000|Overall Study|Physician Decision|1|||
160930036|NCT04476030|581140237|FG001|Overall Study|Physician Decision|1|||
160930037|NCT04476030|581140236|FG000|Overall Study|Protocol Deviation|2|||
160930038|NCT04476030|581140237|FG001|Overall Study|Protocol Deviation|0|||
160930039|NCT04476030|581140236|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
160930040|NCT04476030|581140237|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
160930041|NCT04476030|581140236|FG000|Overall Study|Randomized but not Dosed|2|||
160930042|NCT04476030|581140237|FG001|Overall Study|Randomized but not Dosed|8|||
160930043|NCT02342704|581140238|FG000|Overall Study|Physician Decision|0|||
160930044|NCT02342704|581140239|FG001|Overall Study|Physician Decision|3|||
160930045|NCT02342704|581140238|FG000|Overall Study|Sponsor Termination|49|||
160930046|NCT02342704|581140239|FG001|Overall Study|Sponsor Termination|43|||
160930047|NCT02342704|581140238|FG000|Overall Study|Other|0|||
160930048|NCT02342704|581140239|FG001|Overall Study|Other|1|||
160930049|NCT02342704|581140238|FG000|Overall Study|Withdrawal by Subject|1|||
160930050|NCT02342704|581140239|FG001|Overall Study|Withdrawal by Subject|0|||
160930051|NCT02342704|581140238|FG000|Overall Study|Lost to Follow-up|2|||
160930052|NCT02342704|581140239|FG001|Overall Study|Lost to Follow-up|1|||
160930053|NCT02342704|581140238|FG000|Overall Study|Adverse Event|1|||
160930054|NCT02342704|581140239|FG001|Overall Study|Adverse Event|3|||
160930055|NCT00302003|581140241|FG000|Overall Study|Lack of Efficacy|62|||
160930056|NCT00302003|581140241|FG000|Overall Study|Lost to Follow-up|1|||
160930057|NCT00302003|581140241|FG000|Overall Study|Physician Decision|2|||
160455002|NCT03295721|579396270|FG001|Overall Study|Withdrawal by Subject|0|||
160455003|NCT03295721|579396271|FG002|Overall Study|Withdrawal by Subject|1|||
160455004|NCT03295721|579396269|FG000|Overall Study|Death|0|||
160455005|NCT03295721|579396270|FG001|Overall Study|Death|0|||
160455006|NCT03295721|579396271|FG002|Overall Study|Death|1|||
160455007|NCT05090683|579396276|FG000|Overall Study|Lost to Follow-up|10|||
160455008|NCT05090683|579396277|FG001|Overall Study|Lost to Follow-up|2|||
160455009|NCT05090683|579396276|FG000|Overall Study|Withdrawal by Subject|15|||
160455010|NCT05090683|579396277|FG001|Overall Study|Withdrawal by Subject|0|||
160455011|NCT04479761|579396282|FG000|Overall Study|could not perform the balance tasks|1|||
160455012|NCT04479761|579396283|FG001|Overall Study|could not perform the balance tasks|0|||
160455013|NCT04479761|579396284|FG002|Overall Study|could not perform the balance tasks|0|||
160455014|NCT04479761|579396282|FG000|Overall Study|Adverse Event|1|||
160455015|NCT04479761|579396283|FG001|Overall Study|Adverse Event|0|||
160455016|NCT04479761|579396284|FG002|Overall Study|Adverse Event|0|||
160455017|NCT04479761|579396282|FG000|Overall Study|one control did not meet screening criteria|0|||
160455018|NCT04479761|579396283|FG001|Overall Study|one control did not meet screening criteria|0|||
160455019|NCT04479761|579396284|FG002|Overall Study|one control did not meet screening criteria|1|||
160455020|NCT04479761|579396282|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
160455021|NCT04479761|579396283|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
160455022|NCT04479761|579396284|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
160455023|NCT05309291|579396285|FG000|Overall Study|Adverse Event|0|||
160455024|NCT05309291|579396286|FG001|Overall Study|Adverse Event|1|||
160455025|NCT03663569|579397797|FG000|Overall Study|Discontinuation of study|11|||
160455026|NCT03663569|579397797|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
160455027|NCT03663569|579397797|FG000|Overall Study|Deceased patient|6|||
160455028|NCT03663569|579397797|FG000|Overall Study|Lost to Follow-up|18|||
160930058|NCT00302003|581140241|FG000|Overall Study|Withdrawal by Subject|5|||
160930059|NCT00302003|581140241|FG000|Overall Study|Ineligible|9|||
160930060|NCT00302003|581140241|FG000|Overall Study|Protocol Violation|1|||
160930061|NCT02042924|581140242|FG000|Overall Study|Early Death|1|||
160930062|NCT04033003|581140243|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
160930063|NCT04033003|581140244|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
160930064|NCT04033003|581140243|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
160930065|NCT04033003|581140244|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
160930066|NCT04033003|581140243|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
160930067|NCT04033003|581140244|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
160455029|NCT03663569|579397797|FG000|Overall Study|Withdrawal of consent|5|||
160455030|NCT03663569|579397797|FG000|Overall Study|Patient's request|11|||
160455031|NCT03663569|579397797|FG000|Overall Study|Adverse Event|4|||
160455032|NCT03663569|579397797|FG000|Overall Study|Not come to second visit|3|||
160455033|NCT03663569|579397797|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
160578181|NCT03703375|579838269|FG000|Treatment Period|Completed treatment|7|||
160578182|NCT03703375|579838270|FG001|Treatment Period|Completed treatment|2|||
160578183|NCT03703375|579838271|FG002|Treatment Period|Completed treatment|0|||
160930068|NCT04033003|581140243|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
160998121|NCT01563354|581378570|FG000|Core Phase|Adverse Event|5|||
160455034|NCT03663569|579397797|FG000|Overall Study|Serious adverse event|1|||
160455035|NCT01197378|579397805|FG000|Overall Study|Adverse Event|3|||
160455036|NCT01197378|579397805|FG000|Overall Study|Withdrawal by Subject|1|||
160455037|NCT01197378|579397805|FG000|Overall Study|Physician Decision|1|||
160455038|NCT01197378|579397805|FG000|Overall Study|Other|2|||
160930069|NCT04033003|581140244|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
160930070|NCT04033003|581140243|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
160930071|NCT04033003|581140244|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
160930072|NCT04033003|581140243|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
160930073|NCT04033003|581140244|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
160930074|NCT04033003|581140243|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
160930075|NCT04033003|581140244|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
160930076|NCT04033003|581140243|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
160930077|NCT04033003|581140244|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
160930078|NCT04033003|581140243|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
160930079|NCT04033003|581140244|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
160930080|NCT04033003|581140243|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
160930081|NCT04033003|581140244|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
160930082|NCT04033003|581140243|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
160930083|NCT04033003|581140244|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
160930084|NCT04033003|581140243|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
160930085|NCT04033003|581140244|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
160930086|NCT04033003|581140243|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
160930087|NCT04033003|581140244|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
160930088|NCT02919670|581140245|FG000|Overall Study|Only 17 participants met compliance|43|||
160930089|NCT02919670|581140246|FG001|Overall Study|Only 17 participants met compliance|39|||
160930090|NCT02256891|581140247|FG000|Overall Study|Death|0|||
160930091|NCT02256891|581140248|FG001|Overall Study|Death|2|||
160930092|NCT02256891|581140247|FG000|Overall Study|Lost to Follow-up|0|||
160930093|NCT02256891|581140248|FG001|Overall Study|Lost to Follow-up|3|||
160930094|NCT02256891|581140247|FG000|Overall Study|Physician Decision|7|||
160930095|NCT02256891|581140248|FG001|Overall Study|Physician Decision|3|||
160930096|NCT02256891|581140247|FG000|Overall Study|Screen Fail|5|||
160930097|NCT02256891|581140248|FG001|Overall Study|Screen Fail|4|||
160930098|NCT02256891|581140247|FG000|Overall Study|Equipment Malfunction|0|||
160930099|NCT02256891|581140248|FG001|Overall Study|Equipment Malfunction|1|||
160930100|NCT01675882|581140251|FG000|Overall Study|Adverse Event|0|||
160930101|NCT01675882|581140252|FG001|Overall Study|Adverse Event|2|||
160930102|NCT01675882|581140253|FG002|Overall Study|Adverse Event|1|||
160930103|NCT01675882|581140254|FG003|Overall Study|Adverse Event|0|||
160930104|NCT01675882|581140251|FG000|Overall Study|Participant unwilling to continue|2|||
160930105|NCT01675882|581140252|FG001|Overall Study|Participant unwilling to continue|4|||
160930106|NCT01675882|581140253|FG002|Overall Study|Participant unwilling to continue|2|||
160930107|NCT01675882|581140254|FG003|Overall Study|Participant unwilling to continue|1|||
160930108|NCT01675882|581140251|FG000|Overall Study|Lost to Follow-up|0|||
160930109|NCT01675882|581140252|FG001|Overall Study|Lost to Follow-up|1|||
160930110|NCT01675882|581140253|FG002|Overall Study|Lost to Follow-up|0|||
160930111|NCT01675882|581140254|FG003|Overall Study|Lost to Follow-up|0|||
160930112|NCT01675882|581140251|FG000|Overall Study|Non-compliance|0|||
160930113|NCT01675882|581140252|FG001|Overall Study|Non-compliance|0|||
160930114|NCT01675882|581140253|FG002|Overall Study|Non-compliance|0|||
160930115|NCT01675882|581140254|FG003|Overall Study|Non-compliance|1|||
160930116|NCT00735371|581140255|FG000|Overall Study|Adverse Event|3|||
160930117|NCT00735371|581140256|FG001|Overall Study|Adverse Event|3|||
160930118|NCT00735371|581140257|FG002|Overall Study|Adverse Event|4|||
160930119|NCT00735371|581140258|FG003|Overall Study|Adverse Event|1|||
160930120|NCT00735371|581140255|FG000|Overall Study|Protocol Violation|2|||
160930121|NCT00735371|581140256|FG001|Overall Study|Protocol Violation|2|||
160930122|NCT00735371|581140257|FG002|Overall Study|Protocol Violation|0|||
160930123|NCT00735371|581140258|FG003|Overall Study|Protocol Violation|3|||
160930124|NCT00735371|581140255|FG000|Overall Study|Withdrawal by Subject|0|||
160930125|NCT00735371|581140256|FG001|Overall Study|Withdrawal by Subject|2|||
160930126|NCT00735371|581140257|FG002|Overall Study|Withdrawal by Subject|2|||
160930127|NCT00735371|581140258|FG003|Overall Study|Withdrawal by Subject|0|||
160930128|NCT00735371|581140255|FG000|Overall Study|Lost to Follow-up|1|||
160930129|NCT00735371|581140256|FG001|Overall Study|Lost to Follow-up|1|||
160930130|NCT00735371|581140257|FG002|Overall Study|Lost to Follow-up|3|||
160930131|NCT00735371|581140258|FG003|Overall Study|Lost to Follow-up|1|||
160930132|NCT00735371|581140255|FG000|Overall Study|Lack of Efficacy|4|||
160930133|NCT00735371|581140256|FG001|Overall Study|Lack of Efficacy|2|||
160930134|NCT00735371|581140257|FG002|Overall Study|Lack of Efficacy|0|||
160930135|NCT00735371|581140258|FG003|Overall Study|Lack of Efficacy|4|||
160930136|NCT00735371|581140255|FG000|Overall Study|Sponsor Decision|3|||
160930137|NCT00735371|581140256|FG001|Overall Study|Sponsor Decision|1|||
160930138|NCT00735371|581140257|FG002|Overall Study|Sponsor Decision|0|||
160930139|NCT00735371|581140258|FG003|Overall Study|Sponsor Decision|1|||
160930140|NCT00735371|581140255|FG000|Overall Study|Protocol Violation|0|||
160930141|NCT00735371|581140256|FG001|Overall Study|Protocol Violation|1|||
160930142|NCT00735371|581140257|FG002|Overall Study|Protocol Violation|2|||
160930143|NCT00735371|581140258|FG003|Overall Study|Protocol Violation|0|||
160930144|NCT00735371|581140255|FG000|Overall Study|Prior Vyvanse Exposure|1|||
160930145|NCT00735371|581140256|FG001|Overall Study|Prior Vyvanse Exposure|1|||
160930146|NCT00735371|581140257|FG002|Overall Study|Prior Vyvanse Exposure|0|||
160930147|NCT00735371|581140258|FG003|Overall Study|Prior Vyvanse Exposure|0|||
160930148|NCT00735371|581140255|FG000|Overall Study|Exclusion criteria|1|||
160930149|NCT00735371|581140256|FG001|Overall Study|Exclusion criteria|0|||
160930150|NCT00735371|581140257|FG002|Overall Study|Exclusion criteria|0|||
160930151|NCT00735371|581140258|FG003|Overall Study|Exclusion criteria|0|||
160930152|NCT00436748|581140261|FG000|Overall Study|Ineligibility Determined|1|||
160930153|NCT00436748|581140262|FG001|Overall Study|Ineligibility Determined|1|||
160930154|NCT00436748|581140261|FG000|Overall Study|Adverse Event|0|||
160930155|NCT00436748|581140262|FG001|Overall Study|Adverse Event|2|||
160930156|NCT00436748|581140261|FG000|Overall Study|Consent Withdrawn|1|||
160930157|NCT00436748|581140262|FG001|Overall Study|Consent Withdrawn|4|||
160930158|NCT00436748|581140261|FG000|Overall Study|Administrative Decision|1|||
160578184|NCT03703375|579838272|FG003|Treatment Period|Completed treatment|0|||
160578185|NCT02421120|579838275|FG000|Overall Study|Adverse Event|1|||
160578186|NCT00372190|579838276|FG000|Overall Study|Lost to Follow-up|3|||
160578187|NCT00372190|579838277|FG001|Overall Study|Lost to Follow-up|1|||
160578188|NCT00623467|579838278|FG000|Overall Study|Lost to Follow-up|1|||
160930159|NCT00436748|581140262|FG001|Overall Study|Administrative Decision|0|||
160930160|NCT00436748|581140261|FG000|Overall Study|Lost to Follow-up|0|||
160930161|NCT00436748|581140262|FG001|Overall Study|Lost to Follow-up|1|||
160930162|NCT00436748|581140261|FG000|Overall Study|Protocol-specified Criteria|5|||
160930163|NCT00436748|581140262|FG001|Overall Study|Protocol-specified Criteria|4|||
160930164|NCT00436748|581140261|FG000|Overall Study|Other|3|||
160930165|NCT00436748|581140262|FG001|Overall Study|Other|0|||
160930166|NCT00850200|581140263|FG000|Overall Study|Physician Decision|2|||
160930167|NCT00850200|581140263|FG000|Overall Study|Did not recieve treatment|2|||
160930168|NCT00850200|581140263|FG000|Overall Study|Withdrawal by Subject|1|||
160930169|NCT00097721|581140273|FG000|Overall Study|Adverse Event|8|||
160930170|NCT00097721|581140274|FG001|Overall Study|Adverse Event|1|||
160930171|NCT00097721|581140273|FG000|Overall Study|Withdrawal by Subject|6|||
160930172|NCT00097721|581140274|FG001|Overall Study|Withdrawal by Subject|1|||
160930173|NCT00097721|581140273|FG000|Overall Study|Progressive Disease|55|||
160930174|NCT00097721|581140274|FG001|Overall Study|Progressive Disease|27|||
160930175|NCT00097721|581140273|FG000|Overall Study|Physician Decision|1|||
160930176|NCT00097721|581140274|FG001|Overall Study|Physician Decision|3|||
160930177|NCT00097721|581140273|FG000|Overall Study|Reason not given|1|||
160930178|NCT00097721|581140274|FG001|Overall Study|Reason not given|1|||
160930179|NCT02126969|581140280|FG000|Overall Study|Withdrawal by Subject|1|||
160930180|NCT02126969|581140281|FG001|Overall Study|Withdrawal by Subject|2|||
160930181|NCT02972632|581140282|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
160930182|NCT02972632|581140282|FG000|Overall Study|Lost to Follow-up|4|||
160930183|NCT02972632|581140282|FG000|Overall Study|Voluntary Withdrawal|10|||
160930184|NCT01533246|581140283|FG000|Overall Study|Adverse Event|1|||
160930185|NCT01533246|581140283|FG000|Overall Study|Withdrawal by Subject|1|||
160930186|NCT00354172|581140284|FG000|Overall Study|Did not receive transplant|1|||
160930187|NCT01446965|581140285|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
160930188|NCT01446965|581140286|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
160930189|NCT01446965|581140285|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
160930190|NCT01446965|581140286|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
160930191|NCT02023151|581140287|FG000|Overall Study|Lost to Follow-up|4|||
160930192|NCT03450707|581140288|FG000|Overall Study|Outside enrollment window|4|||
160930193|NCT03450707|581140289|FG001|Overall Study|Outside enrollment window|1|||
160930194|NCT03450707|581140288|FG000|Overall Study|Death|1|||
160930195|NCT03450707|581140289|FG001|Overall Study|Death|0|||
160930196|NCT03450707|581140288|FG000|Overall Study|Indication for thiamine|1|||
160930197|NCT03450707|581140289|FG001|Overall Study|Indication for thiamine|1|||
160930198|NCT03450707|581140288|FG000|Overall Study|Evidence of traumatic brain injury|1|||
160930199|NCT03450707|581140289|FG001|Overall Study|Evidence of traumatic brain injury|0|||
160930200|NCT03450707|581140288|FG000|Overall Study|Following commands|0|||
160930201|NCT03450707|581140289|FG001|Overall Study|Following commands|3|||
160930202|NCT03450707|581140288|FG000|Overall Study|Lactate < 3.5|0|||
160578189|NCT00623467|579838278|FG000|Overall Study|Protocol Violation|4|||
160578190|NCT00623467|579838278|FG000|Overall Study|Withdrawal by Subject|2|||
160930203|NCT03450707|581140289|FG001|Overall Study|Lactate < 3.5|2|||
160578191|NCT00273858|579838292|FG000|Overall Study|Not completed 24 month observation time|334|||
160930204|NCT03450707|581140288|FG000|Overall Study|Rearrest with ECMO|0|||
160930205|NCT03450707|581140289|FG001|Overall Study|Rearrest with ECMO|1|||
160578192|NCT00273858|579838292|FG000|Overall Study|Lost to Follow-up|101|||
160930206|NCT03450707|581140288|FG000|Overall Study|Indication for thiamine + head CT results|0|||
160930207|NCT03450707|581140289|FG001|Overall Study|Indication for thiamine + head CT results|1|||
160930208|NCT03450707|581140288|FG000|Overall Study|Family/patient goals of care|0|||
160930209|NCT03450707|581140289|FG001|Overall Study|Family/patient goals of care|1|||
160930210|NCT02871375|581140290|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
160930211|NCT02871375|581140291|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
160578193|NCT00273858|579838292|FG000|Overall Study|Withdrawal by Subject|21|||
160930212|NCT00004412|581140294|FG000|Randomized Period|Moved to Crossover Period|3|||
160930213|NCT00004412|581140295|FG001|Randomized Period|Moved to Crossover Period|0|||
160930214|NCT00004412|581140296|FG002|Randomized Period|Moved to Crossover Period|0|||
160930215|NCT02016482|581140306|FG000|Period A|Adverse Event|3|||
160930216|NCT02016482|581140307|FG001|Period A|Adverse Event|5|||
160930217|NCT02016482|581140306|FG000|Period A|Withdrawal by Subject|3|||
160930218|NCT02016482|581140307|FG001|Period A|Withdrawal by Subject|4|||
160930219|NCT02016482|581140306|FG000|Period A|Lost to Follow-up|3|||
160930220|NCT02016482|581140307|FG001|Period A|Lost to Follow-up|3|||
160930221|NCT02016482|581140306|FG000|Period A|Lack of Efficacy|2|||
160930222|NCT02016482|581140307|FG001|Period A|Lack of Efficacy|1|||
160930223|NCT02016482|581140306|FG000|Period A|Other|3|||
160930224|NCT02016482|581140307|FG001|Period A|Other|0|||
160930225|NCT02016482|581140306|FG000|Period A|Protocol Violation|0|||
160930226|NCT02016482|581140307|FG001|Period A|Protocol Violation|1|||
160930227|NCT02016482|581140306|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
160930228|NCT02016482|581140307|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
160930229|NCT02016482|581140306|FG000|Period B|Withdrawal by Subject|1|||
160930230|NCT02016482|581140307|FG001|Period B|Withdrawal by Subject|1|||
160930231|NCT02016482|581140306|FG000|Period B|Lost to Follow-up|2|||
160930232|NCT02016482|581140307|FG001|Period B|Lost to Follow-up|0|||
160930233|NCT02016482|581140306|FG000|Period B|Lack of Efficacy|6|||
160930234|NCT02016482|581140307|FG001|Period B|Lack of Efficacy|4|||
160930235|NCT02016482|581140306|FG000|Period B|Other|4|||
160930236|NCT02016482|581140307|FG001|Period B|Other|0|||
160578194|NCT00273858|579838292|FG000|Overall Study|Adverse Event|81|||
160578195|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
160578196|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
160930237|NCT02016482|581140306|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
160930238|NCT02016482|581140307|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
160930239|NCT03387813|581140308|FG000|Overall Study|Death|40|||
160930240|NCT03387813|581140309|FG001|Overall Study|Death|37|||
160930241|NCT03387813|581140310|FG002|Overall Study|Death|190|||
160930242|NCT03387813|581140308|FG000|Overall Study|Withdrawal by Subject|9|||
160930243|NCT03387813|581140309|FG001|Overall Study|Withdrawal by Subject|19|||
160930244|NCT03387813|581140310|FG002|Overall Study|Withdrawal by Subject|32|||
160930245|NCT03387813|581140308|FG000|Overall Study|Lost to Follow-up|3|||
160930246|NCT03387813|581140309|FG001|Overall Study|Lost to Follow-up|9|||
160930247|NCT03387813|581140310|FG002|Overall Study|Lost to Follow-up|15|||
160930248|NCT03387813|581140308|FG000|Overall Study|Non-Compliance|6|||
160930249|NCT03387813|581140309|FG001|Overall Study|Non-Compliance|6|||
160930250|NCT03387813|581140310|FG002|Overall Study|Non-Compliance|31|||
160930251|NCT03387813|581140308|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
160930252|NCT03387813|581140309|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
160930253|NCT03387813|581140310|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
160930254|NCT00606892|581140311|FG000|First Intervention|Protocol Violation|1|||
160930255|NCT00606892|581140312|FG001|First Intervention|Protocol Violation|4|||
160930256|NCT00855309|581140314|FG000|Overall Study|patient never recieved drug|1|||
160930257|NCT00855309|581140315|FG001|Overall Study|patient never recieved drug|0|||
160930258|NCT00829296|581140316|FG000|Overall Study|Adverse Event|5|||
160930259|NCT00829296|581140317|FG001|Overall Study|Adverse Event|4|||
160930260|NCT04960228|581140323|FG000|Overall Study|Withdrawal by Subject|216|||
160930261|NCT04960228|581140324|FG001|Overall Study|Withdrawal by Subject|35|||
160930262|NCT04960228|581140323|FG000|Overall Study|Failed attention check|69|||
160930263|NCT04960228|581140324|FG001|Overall Study|Failed attention check|148|||
160930264|NCT04960228|581140323|FG000|Overall Study|Flagged for response quality by Dynata|3|||
160930265|NCT04960228|581140324|FG001|Overall Study|Flagged for response quality by Dynata|3|||
160930266|NCT01987427|581140325|FG000|Overall Study|Adverse Event|4|||
160930267|NCT01987427|581140326|FG001|Overall Study|Adverse Event|2|||
160930268|NCT01987427|581140327|FG002|Overall Study|Adverse Event|8|||
160578197|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
160578198|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
160930269|NCT01987427|581140325|FG000|Overall Study|Lost to Follow-up|6|||
160930270|NCT01987427|581140326|FG001|Overall Study|Lost to Follow-up|6|||
160578199|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
160578200|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
160930271|NCT01987427|581140327|FG002|Overall Study|Lost to Follow-up|9|||
160930272|NCT01987427|581140325|FG000|Overall Study|Withdrawal by Subject|2|||
160930273|NCT01987427|581140326|FG001|Overall Study|Withdrawal by Subject|1|||
160930274|NCT01987427|581140327|FG002|Overall Study|Withdrawal by Subject|3|||
160930275|NCT01987427|581140325|FG000|Overall Study|Lack of Efficacy|1|||
160930276|NCT01987427|581140326|FG001|Overall Study|Lack of Efficacy|0|||
160930277|NCT01987427|581140327|FG002|Overall Study|Lack of Efficacy|0|||
160930278|NCT01987427|581140325|FG000|Overall Study|Other|1|||
160930279|NCT01987427|581140326|FG001|Overall Study|Other|1|||
160930280|NCT01987427|581140327|FG002|Overall Study|Other|0|||
160930281|NCT02547129|581140332|FG000|Overall Study|Difficulty with ongoing infection|1|||
160930282|NCT02547129|581140333|FG001|Overall Study|Difficulty with ongoing infection|0|||
160930283|NCT00794196|581140335|FG000|Overall Study|Lost to Follow-up|5|||
160930284|NCT00794196|581140336|FG001|Overall Study|Lost to Follow-up|23|||
160930285|NCT02129803|581140337|FG000|Overall Study|Protocol Violation|4|||
160930286|NCT02129803|581140338|FG001|Overall Study|Protocol Violation|0|||
160930287|NCT02129803|581140337|FG000|Overall Study|Physician Decision|0|||
160930288|NCT02129803|581140338|FG001|Overall Study|Physician Decision|1|||
160930289|NCT02129803|581140337|FG000|Overall Study|Difficulty sleeping|1|||
160930290|NCT02129803|581140338|FG001|Overall Study|Difficulty sleeping|0|||
160930291|NCT02129803|581140337|FG000|Overall Study|Morning headache|0|||
160930292|NCT02129803|581140338|FG001|Overall Study|Morning headache|1|||
160930293|NCT02129803|581140337|FG000|Overall Study|Withdrawal by Subject|1|||
160930294|NCT02129803|581140338|FG001|Overall Study|Withdrawal by Subject|1|||
160930295|NCT02319031|581140339|FG000|Treatment Period|Death|1|||
160930296|NCT02319031|581140340|FG001|Treatment Period|Death|0|||
160930297|NCT02907359|581140345|FG000|Overall Study|Death|234|||
160930298|NCT02907359|581140346|FG001|Overall Study|Death|117|||
160930299|NCT02907359|581140345|FG000|Overall Study|Withdrawal by Subject|6|||
160930300|NCT02907359|581140346|FG001|Overall Study|Withdrawal by Subject|11|||
160930301|NCT02907359|581140345|FG000|Overall Study|Lost to Follow-up|1|||
160930302|NCT02907359|581140346|FG001|Overall Study|Lost to Follow-up|0|||
160930303|NCT01354496|581140350|FG000|Period 1|Adverse Event|0|||
160930304|NCT01354496|581140351|FG001|Period 1|Adverse Event|0|||
160930305|NCT01354496|581140352|FG002|Period 1|Adverse Event|1|||
160930306|NCT01354496|581140353|FG003|Period 1|Adverse Event|0|||
160930307|NCT01354496|581140354|FG004|Period 1|Adverse Event|0|||
160930308|NCT01354496|581140355|FG005|Period 1|Adverse Event|0|||
160930309|NCT01354496|581140350|FG000|Period 1|Physician Decision|0|||
160930310|NCT01354496|581140351|FG001|Period 1|Physician Decision|0|||
160930311|NCT01354496|581140352|FG002|Period 1|Physician Decision|1|||
160930312|NCT01354496|581140353|FG003|Period 1|Physician Decision|0|||
160930313|NCT01354496|581140354|FG004|Period 1|Physician Decision|0|||
160930314|NCT01354496|581140355|FG005|Period 1|Physician Decision|0|||
160930315|NCT01354496|581140350|FG000|Period 2|Adverse Event|0|||
160930316|NCT01354496|581140351|FG001|Period 2|Adverse Event|0|||
160930317|NCT01354496|581140352|FG002|Period 2|Adverse Event|0|||
160930318|NCT01354496|581140353|FG003|Period 2|Adverse Event|1|||
160930319|NCT01354496|581140354|FG004|Period 2|Adverse Event|0|||
160930320|NCT01354496|581140355|FG005|Period 2|Adverse Event|0|||
160930321|NCT01354496|581140350|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
160930322|NCT01354496|581140351|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
160930323|NCT01354496|581140352|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
160930324|NCT01354496|581140353|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
160930325|NCT01354496|581140354|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
160930326|NCT01354496|581140355|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
160930327|NCT00500292|581140357|FG000|Overall Study|Adverse Event|3|||
160930328|NCT00500292|581140358|FG001|Overall Study|Adverse Event|6|||
160930329|NCT00500292|581140359|FG002|Overall Study|Adverse Event|4|||
160930330|NCT00500292|581140357|FG000|Overall Study|Condition under investigation worsened|21|||
160930331|NCT00500292|581140358|FG001|Overall Study|Condition under investigation worsened|23|||
160930332|NCT00500292|581140359|FG002|Overall Study|Condition under investigation worsened|19|||
160930333|NCT00500292|581140357|FG000|Overall Study|Withdrawal by Subject|0|||
160930334|NCT00500292|581140358|FG001|Overall Study|Withdrawal by Subject|1|||
160930335|NCT00500292|581140359|FG002|Overall Study|Withdrawal by Subject|0|||
160930336|NCT00500292|581140357|FG000|Overall Study|Other|1|||
160930337|NCT00500292|581140358|FG001|Overall Study|Other|1|||
160930338|NCT00500292|581140359|FG002|Overall Study|Other|4|||
160930339|NCT01332149|581141997|FG000|Overall Study|Adverse Event|11|||
160930340|NCT01332149|581141998|FG001|Overall Study|Adverse Event|9|||
160930341|NCT01332149|581141997|FG000|Overall Study|Other unspecified|5|||
160930342|NCT01332149|581141998|FG001|Overall Study|Other unspecified|7|||
160930343|NCT01332149|581141997|FG000|Overall Study|Protocol Violation|1|||
160930344|NCT01332149|581141998|FG001|Overall Study|Protocol Violation|3|||
160930345|NCT01332149|581141997|FG000|Overall Study|Withdrawal by Subject|4|||
160930346|NCT01332149|581141998|FG001|Overall Study|Withdrawal by Subject|5|||
160930347|NCT01332149|581141997|FG000|Overall Study|Lost to Follow-up|1|||
160930348|NCT01332149|581141998|FG001|Overall Study|Lost to Follow-up|1|||
160930349|NCT01332149|581141997|FG000|Overall Study|Insufficient clinical response|4|||
160930350|NCT01332149|581141998|FG001|Overall Study|Insufficient clinical response|7|||
160930351|NCT01332149|581141997|FG000|Overall Study|Did not meet entrance criteria|3|||
160930352|NCT01332149|581141998|FG001|Overall Study|Did not meet entrance criteria|4|||
160930353|NCT01332149|581141997|FG000|Overall Study|Randomized but not treated|1|||
160930354|NCT01332149|581141998|FG001|Overall Study|Randomized but not treated|2|||
160930355|NCT03711162|581142002|FG000|Overall Study|Adverse Event|5|||
160930356|NCT03711162|581142003|FG001|Overall Study|Adverse Event|2|||
160930357|NCT03711162|581142004|FG002|Overall Study|Adverse Event|4|||
160930358|NCT03711162|581142002|FG000|Overall Study|Death|11|||
160930359|NCT03711162|581142003|FG001|Overall Study|Death|7|||
160930360|NCT03711162|581142004|FG002|Overall Study|Death|8|||
160930361|NCT03711162|581142002|FG000|Overall Study|Lost to Follow-up|1|||
160930362|NCT03711162|581142003|FG001|Overall Study|Lost to Follow-up|0|||
160930363|NCT03711162|581142004|FG002|Overall Study|Lost to Follow-up|1|||
160930364|NCT03711162|581142002|FG000|Overall Study|Study Terminated by Sponsor|139|||
160930365|NCT03711162|581142003|FG001|Overall Study|Study Terminated by Sponsor|152|||
160930366|NCT03711162|581142004|FG002|Overall Study|Study Terminated by Sponsor|146|||
160930367|NCT03711162|581142002|FG000|Overall Study|Withdrawal by Subject|17|||
160930368|NCT03711162|581142003|FG001|Overall Study|Withdrawal by Subject|10|||
160930369|NCT03711162|581142004|FG002|Overall Study|Withdrawal by Subject|10|||
160930370|NCT03711162|581142002|FG000|Overall Study|Miscellaneous|1|||
160930371|NCT03711162|581142003|FG001|Overall Study|Miscellaneous|2|||
160930372|NCT03711162|581142004|FG002|Overall Study|Miscellaneous|2|||
160930373|NCT03711162|581142002|FG000|Overall Study|Not Treated|1|||
160930374|NCT03711162|581142003|FG001|Overall Study|Not Treated|0|||
160930375|NCT03711162|581142004|FG002|Overall Study|Not Treated|1|||
160930376|NCT03711162|581142002|FG000|Overall Study|Physician Decision|0|||
160930377|NCT03711162|581142003|FG001|Overall Study|Physician Decision|2|||
160930378|NCT03711162|581142004|FG002|Overall Study|Physician Decision|0|||
160930379|NCT03711162|581142002|FG000|Overall Study|Lack of Efficacy|0|||
160930380|NCT03711162|581142003|FG001|Overall Study|Lack of Efficacy|0|||
160930381|NCT03711162|581142004|FG002|Overall Study|Lack of Efficacy|2|||
160930382|NCT03711162|581142002|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
160930383|NCT03711162|581142003|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
160930384|NCT03711162|581142004|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
160930385|NCT01275066|581142007|FG000|Overall Study|Withdrawal by Subject|0|||
160930386|NCT01275066|581142008|FG001|Overall Study|Withdrawal by Subject|0|||
160930387|NCT01275066|581142009|FG002|Overall Study|Withdrawal by Subject|1|||
160930388|NCT01275066|581142007|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
160930389|NCT01275066|581142008|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
160930390|NCT01275066|581142009|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
160930391|NCT03240133|581142010|FG000|Overall Study|Withdrawal by Subject|0|||
160930392|NCT03240133|581142011|FG001|Overall Study|Withdrawal by Subject|1|||
160930393|NCT03240133|581142012|FG002|Overall Study|Withdrawal by Subject|0|||
160930394|NCT03240133|581142010|FG000|Overall Study|Adverse Event|1|||
160930395|NCT03240133|581142011|FG001|Overall Study|Adverse Event|1|||
160930396|NCT03240133|581142012|FG002|Overall Study|Adverse Event|0|||
160930397|NCT03240133|581142010|FG000|Overall Study|Rash|1|||
160930398|NCT03240133|581142011|FG001|Overall Study|Rash|0|||
160930399|NCT03240133|581142012|FG002|Overall Study|Rash|0|||
160930400|NCT03240133|581142010|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
160930401|NCT03240133|581142011|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
160930402|NCT03240133|581142012|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
160930403|NCT03240133|581142010|FG000|Overall Study|Intercurrent illness.|0|||
160930404|NCT03240133|581142011|FG001|Overall Study|Intercurrent illness.|1|||
160930405|NCT03240133|581142012|FG002|Overall Study|Intercurrent illness.|0|||
160930406|NCT03240133|581142010|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
160930407|NCT03240133|581142011|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
160930408|NCT03240133|581142012|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
160930409|NCT00749463|581142013|FG000|Overall Study|Adverse Event|0|||
160930410|NCT00749463|581142014|FG001|Overall Study|Adverse Event|4|||
160930411|NCT00749463|581142015|FG002|Overall Study|Adverse Event|1|||
160930412|NCT00749463|581142013|FG000|Overall Study|Withdrawal by Subject|1|||
160930413|NCT00749463|581142014|FG001|Overall Study|Withdrawal by Subject|0|||
160930414|NCT00749463|581142015|FG002|Overall Study|Withdrawal by Subject|0|||
160930415|NCT00116831|581142016|FG000|Overall Study|Adverse Event|14|||
160930416|NCT00116831|581142017|FG001|Overall Study|Adverse Event|16|||
160930417|NCT00116831|581142016|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
160930418|NCT00116831|581142017|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
160930419|NCT00116831|581142016|FG000|Overall Study|Lost to Follow-up|8|||
160930420|NCT00116831|581142017|FG001|Overall Study|Lost to Follow-up|6|||
160930421|NCT00116831|581142016|FG000|Overall Study|Protocol Violation|3|||
160930422|NCT00116831|581142017|FG001|Overall Study|Protocol Violation|6|||
160930423|NCT00116831|581142016|FG000|Overall Study|Hypoglycaemic events|1|||
160930424|NCT00116831|581142017|FG001|Overall Study|Hypoglycaemic events|0|||
160930425|NCT00116831|581142016|FG000|Overall Study|Low haemoglobin on screening|1|||
160930426|NCT00116831|581142017|FG001|Overall Study|Low haemoglobin on screening|0|||
160930427|NCT00116831|581142016|FG000|Overall Study|Withdrawn investigational product|1|||
160930428|NCT00116831|581142017|FG001|Overall Study|Withdrawn investigational product|0|||
160930429|NCT00116831|581142016|FG000|Overall Study|Withdrawal by Subject|32|||
160930430|NCT00116831|581142017|FG001|Overall Study|Withdrawal by Subject|32|||
160930431|NCT00116831|581142016|FG000|Overall Study|Insufficient therapeutic effect|0|||
160930432|NCT00116831|581142017|FG001|Overall Study|Insufficient therapeutic effect|1|||
160930433|NCT00116831|581142016|FG000|Overall Study|Missing data for participant|1|||
160930434|NCT00116831|581142017|FG001|Overall Study|Missing data for participant|0|||
160930435|NCT04904185|581142018|FG000|Overall Study|Expansion failure|1|||
160632826|NCT01215955|580036088|FG003|Overall Study|Death|3|||
160930436|NCT04904185|581142019|FG001|Overall Study|Expansion failure|0|||
160930437|NCT04904185|581142018|FG000|Overall Study|Late response on prior treatment|1|||
160930438|NCT04904185|581142019|FG001|Overall Study|Late response on prior treatment|0|||
160930439|NCT02945410|581142020|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160930440|NCT02945410|581142021|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
160930441|NCT02945410|581142022|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160930442|NCT02945410|581142023|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160930443|NCT02945410|581142024|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160930444|NCT02945410|581142025|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160930445|NCT02945410|581142020|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
160930446|NCT02945410|581142021|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
160930447|NCT02945410|581142022|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
160930448|NCT02945410|581142023|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
160930449|NCT02945410|581142024|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
160930450|NCT02945410|581142025|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
160930451|NCT02945410|581142020|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
160930452|NCT02945410|581142021|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
160930453|NCT02945410|581142022|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
160930454|NCT02945410|581142023|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
160930455|NCT02945410|581142024|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
160930456|NCT02945410|581142025|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
160930457|NCT01344369|581142028|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
160930458|NCT01344369|581142029|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
160930459|NCT01344369|581142028|FG000|Washout of 28 Days|Physician Decision|0|||
160930460|NCT01344369|581142029|FG001|Washout of 28 Days|Physician Decision|1|||
160930461|NCT01344369|581142028|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
160930462|NCT01344369|581142029|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
160930463|NCT00110812|581142030|FG000|Main Study|Death|0|||
160930464|NCT00110812|581142031|FG001|Main Study|Death|0|||
160930465|NCT00110812|581142032|FG002|Main Study|Death|2|||
160930466|NCT00110812|581142030|FG000|Main Study|Withdrawal by Subject|0|||
160930467|NCT00110812|581142031|FG001|Main Study|Withdrawal by Subject|0|||
160930468|NCT00110812|581142032|FG002|Main Study|Withdrawal by Subject|1|||
160930469|NCT00110812|581142030|FG000|Main Study|Lost to Follow-up|8|||
160930470|NCT00110812|581142031|FG001|Main Study|Lost to Follow-up|11|||
160930471|NCT00110812|581142032|FG002|Main Study|Lost to Follow-up|10|||
160930472|NCT00110812|581142030|FG000|Extended Follow-up|Death|1|||
160930473|NCT00110812|581142031|FG001|Extended Follow-up|Death|0|||
160930474|NCT00110812|581142032|FG002|Extended Follow-up|Death|3|||
160930475|NCT00110812|581142030|FG000|Extended Follow-up|Withdrawal by Subject|0|||
160930476|NCT00110812|581142031|FG001|Extended Follow-up|Withdrawal by Subject|1|||
160930477|NCT00110812|581142032|FG002|Extended Follow-up|Withdrawal by Subject|0|||
160930478|NCT00110812|581142030|FG000|Extended Follow-up|Lost to Follow-up|1|||
160930479|NCT00110812|581142031|FG001|Extended Follow-up|Lost to Follow-up|3|||
160930480|NCT00110812|581142032|FG002|Extended Follow-up|Lost to Follow-up|1|||
160930481|NCT04200248|581142035|FG000|Overall Study|Personal reasons|0|||
160930482|NCT04200248|581142036|FG001|Overall Study|Personal reasons|0|||
160930483|NCT04200248|581142037|FG002|Overall Study|Personal reasons|1|||
160930484|NCT04200248|581142035|FG000|Overall Study|Discontinued prior to treatment|3|||
160930485|NCT04200248|581142036|FG001|Overall Study|Discontinued prior to treatment|3|||
160930486|NCT04200248|581142037|FG002|Overall Study|Discontinued prior to treatment|2|||
160930487|NCT01465464|581142062|FG000|Overall Study|Adverse Event|96|||
160930488|NCT01465464|581142063|FG001|Overall Study|Adverse Event|49|||
160930489|NCT01465464|581142062|FG000|Overall Study|Lack of Efficacy|139|||
160930490|NCT01465464|581142063|FG001|Overall Study|Lack of Efficacy|190|||
160930491|NCT01465464|581142062|FG000|Overall Study|Physician Decision|13|||
160930492|NCT01465464|581142063|FG001|Overall Study|Physician Decision|5|||
160930493|NCT01465464|581142062|FG000|Overall Study|Protocol Violation|1|||
160930494|NCT01465464|581142063|FG001|Overall Study|Protocol Violation|1|||
160930495|NCT01465464|581142062|FG000|Overall Study|Withdrawal by Subject|46|||
160930496|NCT01465464|581142063|FG001|Overall Study|Withdrawal by Subject|30|||
160930497|NCT01465464|581142062|FG000|Overall Study|Other|9|||
160930498|NCT01465464|581142063|FG001|Overall Study|Other|3|||
160998122|NCT01563354|581378571|FG001|Core Phase|Adverse Event|15|||
160930499|NCT01465464|581142062|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
160998123|NCT01563354|581378572|FG002|Core Phase|Adverse Event|13|||
160998124|NCT01563354|581378570|FG000|Core Phase|Withdrawal by Subject|1|||
160930500|NCT01465464|581142063|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
160930501|NCT01183975|581142066|FG000|Overall Study|Lost to Follow-up|73|||
160930502|NCT01640366|581142072|FG000|Overall Study|Withdrawal by Subject|1|||
160930503|NCT01640366|581142072|FG000|Overall Study|Protocol Violation|16|||
160930504|NCT01640366|581142072|FG000|Overall Study|Lost to Follow-up|5|||
160578201|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
160930505|NCT02739269|581142075|FG000|Overall Study|Protocol Violation|5|||
160930506|NCT02739269|581142076|FG001|Overall Study|Protocol Violation|0|||
160930507|NCT02739269|581142075|FG000|Overall Study|Cycle cancellation|2|||
160930508|NCT02739269|581142076|FG001|Overall Study|Cycle cancellation|2|||
160998125|NCT01563354|581378571|FG001|Core Phase|Withdrawal by Subject|0|||
160930509|NCT02739269|581142075|FG000|Overall Study|Withdrawal by Subject|0|||
160930510|NCT02739269|581142076|FG001|Overall Study|Withdrawal by Subject|2|||
160930511|NCT02244580|581142077|FG000|Overall Study|No cancer tissues available|241|||
160930512|NCT02136576|581142079|FG000|Overall Study|Lost to Follow-up|2|||
160930513|NCT02136576|581142080|FG001|Overall Study|Lost to Follow-up|0|||
160930514|NCT02136576|581142081|FG002|Overall Study|Lost to Follow-up|0|||
160930515|NCT02197806|581142082|FG000|Overall Study|Adverse Event|0|||
160930516|NCT02197806|581142083|FG001|Overall Study|Adverse Event|1|||
160930517|NCT02197806|581142084|FG002|Overall Study|Adverse Event|0|||
160930518|NCT02197806|581142085|FG003|Overall Study|Adverse Event|1|||
160930519|NCT00680901|581142086|FG000|Overall Study|Ongoing: On Study Treatment|1|||
160930520|NCT00680901|581142087|FG001|Overall Study|Ongoing: On Study Treatment|0|||
160930521|NCT00680901|581142086|FG000|Overall Study|Ongoing: In Follow Up|1|||
160930522|NCT00680901|581142087|FG001|Overall Study|Ongoing: In Follow Up|0|||
160930523|NCT00680901|581142086|FG000|Overall Study|Adverse Event|1|||
160930524|NCT00680901|581142087|FG001|Overall Study|Adverse Event|1|||
160930525|NCT00680901|581142086|FG000|Overall Study|Lost to Follow-up|3|||
160930526|NCT00680901|581142087|FG001|Overall Study|Lost to Follow-up|5|||
160930527|NCT00680901|581142086|FG000|Overall Study|Subject decided to withdraw from the study|4|||
160930528|NCT00680901|581142087|FG001|Overall Study|Subject decided to withdraw from the study|15|||
160930529|NCT00680901|581142086|FG000|Overall Study|Sponsor decision|1|||
160930530|NCT00680901|581142087|FG001|Overall Study|Sponsor decision|0|||
160930531|NCT00680901|581142086|FG000|Overall Study|Physician Decision|0|||
160930532|NCT00680901|581142087|FG001|Overall Study|Physician Decision|2|||
160930533|NCT00680901|581142086|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
160930534|NCT00680901|581142087|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
160930535|NCT00680901|581142086|FG000|Overall Study|Other protocol defined stopping criteria|17|||
160930536|NCT00680901|581142087|FG001|Overall Study|Other protocol defined stopping criteria|17|||
160930537|NCT00537381|581142088|FG000|Overall Study|Adverse Event|13|||
160930538|NCT00537381|581142089|FG001|Overall Study|Adverse Event|9|||
160930539|NCT00537381|581142088|FG000|Overall Study|Death|3|||
160930540|NCT00537381|581142089|FG001|Overall Study|Death|3|||
160930541|NCT00537381|581142088|FG000|Overall Study|Withdrawal by Subject|5|||
160930542|NCT00537381|581142089|FG001|Overall Study|Withdrawal by Subject|14|||
160930543|NCT00537381|581142088|FG000|Overall Study|Physician Decision|7|||
160930544|NCT00537381|581142089|FG001|Overall Study|Physician Decision|6|||
160930545|NCT00537381|581142088|FG000|Overall Study|Disease Progression|9|||
160930546|NCT00537381|581142089|FG001|Overall Study|Disease Progression|18|||
160930547|NCT00537381|581142088|FG000|Overall Study|Sponsor decision|14|||
160930548|NCT00537381|581142089|FG001|Overall Study|Sponsor decision|9|||
160930549|NCT00537381|581142088|FG000|Overall Study|Other|5|||
160930550|NCT00537381|581142089|FG001|Overall Study|Other|3|||
160930551|NCT01708174|581142090|FG000|Treatment Period|Withdrawal by Subject|1|||
160930552|NCT01708174|581142091|FG001|Treatment Period|Withdrawal by Subject|0|||
160930553|NCT01708174|581142092|FG002|Treatment Period|Withdrawal by Subject|0|||
160930554|NCT01708174|581142090|FG000|Treatment Period|Progressive disease|0|||
160930555|NCT01708174|581142091|FG001|Treatment Period|Progressive disease|1|||
160930556|NCT01708174|581142092|FG002|Treatment Period|Progressive disease|0|||
160930557|NCT01708174|581142090|FG000|Treatment Period|Death|0|||
160930558|NCT01708174|581142091|FG001|Treatment Period|Death|0|||
160930559|NCT01708174|581142092|FG002|Treatment Period|Death|1|||
160930560|NCT01708174|581142090|FG000|Treatment Period|Adverse Event|0|||
160930561|NCT01708174|581142091|FG001|Treatment Period|Adverse Event|1|||
160930562|NCT01708174|581142092|FG002|Treatment Period|Adverse Event|0|||
160930563|NCT00923559|581142093|FG000|Overall Study|Lost to Follow-up|2|||
160930564|NCT00923559|581142094|FG001|Overall Study|Lost to Follow-up|3|||
160930565|NCT02268812|581142095|FG000|Overall Study|Adverse Event|8|||
160930566|NCT02268812|581142096|FG001|Overall Study|Adverse Event|26|||
160930567|NCT02268812|581142097|FG002|Overall Study|Adverse Event|7|||
160930568|NCT02268812|581142098|FG003|Overall Study|Adverse Event|10|||
160930569|NCT02268812|581142095|FG000|Overall Study|Protocol deviation|0|||
160930570|NCT02268812|581142096|FG001|Overall Study|Protocol deviation|0|||
160655894|NCT05630547|580120295|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
160930571|NCT02268812|581142097|FG002|Overall Study|Protocol deviation|1|||
160930572|NCT02268812|581142098|FG003|Overall Study|Protocol deviation|0|||
160930573|NCT02268812|581142095|FG000|Overall Study|Withdrawal by Subject|0|||
160930574|NCT02268812|581142096|FG001|Overall Study|Withdrawal by Subject|1|||
160930575|NCT02268812|581142097|FG002|Overall Study|Withdrawal by Subject|0|||
160930576|NCT02268812|581142098|FG003|Overall Study|Withdrawal by Subject|0|||
160930577|NCT02268812|581142095|FG000|Overall Study|Physician Decision|3|||
160930578|NCT02268812|581142096|FG001|Overall Study|Physician Decision|1|||
160930579|NCT02268812|581142097|FG002|Overall Study|Physician Decision|0|||
160930580|NCT02268812|581142098|FG003|Overall Study|Physician Decision|1|||
160930581|NCT02268812|581142095|FG000|Overall Study|Other|5|||
160930582|NCT02268812|581142096|FG001|Overall Study|Other|4|||
160930583|NCT02268812|581142097|FG002|Overall Study|Other|1|||
160930584|NCT02268812|581142098|FG003|Overall Study|Other|3|||
160930585|NCT01951157|581142100|FG000|Overall Study|Progressive Disease|12|||
160930586|NCT01951157|581142101|FG001|Overall Study|Progressive Disease|13|||
160930587|NCT01951157|581142102|FG002|Overall Study|Progressive Disease|10|||
160930588|NCT01951157|581142100|FG000|Overall Study|Treatment-unrelated AE|1|||
160930589|NCT01951157|581142101|FG001|Overall Study|Treatment-unrelated AE|0|||
160930590|NCT01951157|581142102|FG002|Overall Study|Treatment-unrelated AE|3|||
160930591|NCT01951157|581142100|FG000|Overall Study|Study Termination|0|||
160930592|NCT01951157|581142101|FG001|Overall Study|Study Termination|0|||
160930593|NCT01951157|581142102|FG002|Overall Study|Study Termination|1|||
160930594|NCT01951157|581142100|FG000|Overall Study|Physician Decision|5|||
160930595|NCT01951157|581142101|FG001|Overall Study|Physician Decision|3|||
160930596|NCT01951157|581142102|FG002|Overall Study|Physician Decision|2|||
160930597|NCT01951157|581142100|FG000|Overall Study|Non-treatmentrelated death|2|||
160930598|NCT01951157|581142101|FG001|Overall Study|Non-treatmentrelated death|2|||
160930599|NCT01951157|581142102|FG002|Overall Study|Non-treatmentrelated death|2|||
160930600|NCT01951157|581142100|FG000|Overall Study|No treated|0|||
160930601|NCT01951157|581142101|FG001|Overall Study|No treated|1|||
160930602|NCT01951157|581142102|FG002|Overall Study|No treated|0|||
160930603|NCT01951157|581142100|FG000|Overall Study|Treatment-related AE|2|||
160930604|NCT01951157|581142101|FG001|Overall Study|Treatment-related AE|0|||
160930605|NCT01951157|581142102|FG002|Overall Study|Treatment-related AE|4|||
160930606|NCT01951157|581142100|FG000|Overall Study|Consent withdrawn by subject|0|||
160930607|NCT01951157|581142101|FG001|Overall Study|Consent withdrawn by subject|1|||
160930608|NCT01951157|581142102|FG002|Overall Study|Consent withdrawn by subject|3|||
160930609|NCT01951157|581142100|FG000|Overall Study|Treatment-related death|0|||
160930610|NCT01951157|581142101|FG001|Overall Study|Treatment-related death|2|||
160930611|NCT01951157|581142102|FG002|Overall Study|Treatment-related death|0|||
160930612|NCT04964128|581142107|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
160930613|NCT04964128|581142107|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
160930614|NCT00994240|581142109|FG000|Overall Study|Lost to Follow-up|3|||
160930615|NCT00994240|581142110|FG001|Overall Study|Lost to Follow-up|2|||
160930616|NCT00994240|581142109|FG000|Overall Study|Withdrawal by Subject|1|||
160930617|NCT00994240|581142110|FG001|Overall Study|Withdrawal by Subject|0|||
160930618|NCT00994240|581142109|FG000|Overall Study|study termination|2|||
160930619|NCT00994240|581142110|FG001|Overall Study|study termination|3|||
160930620|NCT01177540|581142111|FG000|Overall Study|Adverse Event|1|||
160930621|NCT01177540|581142112|FG001|Overall Study|Adverse Event|0|||
160930622|NCT01070316|581142132|FG000|Extension Phase|Lack of Efficacy|3|||
160930623|NCT01070316|581142132|FG000|Extension Phase|Withdrawal by Subject|1|||
160930624|NCT00748215|581142133|FG000|Overall Study|Withdrawal by Subject|7|||
160930625|NCT00748215|581142134|FG001|Overall Study|Withdrawal by Subject|7|||
160930626|NCT00748215|581142133|FG000|Overall Study|Treatment change|2|||
160930627|NCT00748215|581142134|FG001|Overall Study|Treatment change|1|||
160930628|NCT00748215|581142133|FG000|Overall Study|Change in patient condition|0|||
160930629|NCT00748215|581142134|FG001|Overall Study|Change in patient condition|3|||
160930630|NCT00748215|581142133|FG000|Overall Study|Non-compliant|0|||
160930631|NCT00748215|581142134|FG001|Overall Study|Non-compliant|2|||
160930632|NCT00748215|581142133|FG000|Overall Study|Adverse Event|0|||
160930633|NCT00748215|581142134|FG001|Overall Study|Adverse Event|5|||
160930634|NCT02013167|581142135|FG000|Overall Study|Withdrawal by Subject|15|||
160930635|NCT02013167|581142136|FG001|Overall Study|Withdrawal by Subject|14|||
160930636|NCT02013167|581142135|FG000|Overall Study|Sponsor Decision|1|||
160930637|NCT02013167|581142136|FG001|Overall Study|Sponsor Decision|3|||
160930638|NCT02013167|581142135|FG000|Overall Study|Lost to Follow-up|0|||
160930639|NCT02013167|581142136|FG001|Overall Study|Lost to Follow-up|1|||
160930640|NCT02013167|581142135|FG000|Overall Study|Death|85|||
160930641|NCT02013167|581142136|FG001|Overall Study|Death|160|||
160930642|NCT01113879|581142141|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
160930643|NCT01113879|581142142|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
160930644|NCT00082433|581142146|FG000|Overall Study|Adverse Event|12|||
160930645|NCT00082433|581142147|FG001|Overall Study|Adverse Event|17|||
160930646|NCT00082433|581142146|FG000|Overall Study|Death|8|||
160930647|NCT00082433|581142147|FG001|Overall Study|Death|18|||
160455039|NCT05299723|579397809|FG000|Overall Study|Withdrawal by Subject|0|||
160930648|NCT00082433|581142146|FG000|Overall Study|Disease Progression/Relapse|270|||
160930649|NCT00082433|581142147|FG001|Overall Study|Disease Progression/Relapse|388|||
160930650|NCT00082433|581142146|FG000|Overall Study|Physician Decision|50|||
160455040|NCT05299723|579397810|FG001|Overall Study|Withdrawal by Subject|2|||
160455041|NCT05299723|579397811|FG002|Overall Study|Withdrawal by Subject|0|||
160930651|NCT00082433|581142147|FG001|Overall Study|Physician Decision|61|||
160930652|NCT00082433|581142146|FG000|Overall Study|Lost to Follow-up|1|||
160930653|NCT00082433|581142147|FG001|Overall Study|Lost to Follow-up|2|||
160930654|NCT00082433|581142146|FG000|Overall Study|Study Drug Toxicity|179|||
160455042|NCT00696111|579397812|FG000|Overall Study|Withdrawal by Subject|17|||
160930655|NCT00082433|581142147|FG001|Overall Study|Study Drug Toxicity|66|||
160930656|NCT00082433|581142146|FG000|Overall Study|Withdrawal by Subject|55|||
160930657|NCT00082433|581142147|FG001|Overall Study|Withdrawal by Subject|30|||
160930658|NCT00082433|581142146|FG000|Overall Study|Still On Treatment|2|||
160930659|NCT00082433|581142147|FG001|Overall Study|Still On Treatment|1|||
160930660|NCT00082433|581142146|FG000|Overall Study|Not Treated|12|||
160930661|NCT00082433|581142147|FG001|Overall Study|Not Treated|11|||
160930662|NCT00082433|581142146|FG000|Overall Study|Ineligible|2|||
160930663|NCT00082433|581142147|FG001|Overall Study|Ineligible|1|||
160930664|NCT00082433|581142146|FG000|Overall Study|Noncompliance|2|||
160930665|NCT00082433|581142147|FG001|Overall Study|Noncompliance|1|||
160930666|NCT00082433|581142146|FG000|Overall Study|New primary cancer|1|||
160930667|NCT00082433|581142147|FG001|Overall Study|New primary cancer|0|||
160930668|NCT00082433|581142146|FG000|Overall Study|Impending surgery|0|||
160930669|NCT00082433|581142147|FG001|Overall Study|Impending surgery|1|||
160930670|NCT01796197|581142150|FG000|Overall Study|Lost to Follow-up|1|||
160930671|NCT01796197|581142150|FG000|Overall Study|Lack of Efficacy|1|||
160930672|NCT04097821|581142151|FG000|Overall Study|Subject Decision|0|||
160930673|NCT04097821|581142152|FG001|Overall Study|Subject Decision|0|||
160930674|NCT04097821|581142153|FG002|Overall Study|Subject Decision|0|||
160930675|NCT04097821|581142154|FG003|Overall Study|Subject Decision|1|||
160930676|NCT04097821|581142155|FG004|Overall Study|Subject Decision|2|||
160930677|NCT04097821|581142156|FG005|Overall Study|Subject Decision|2|||
160930678|NCT04097821|581142157|FG006|Overall Study|Subject Decision|0|||
160930679|NCT04097821|581142158|FG007|Overall Study|Subject Decision|1|||
160930680|NCT04097821|581142151|FG000|Overall Study|Death|0|||
160930681|NCT04097821|581142152|FG001|Overall Study|Death|0|||
160930682|NCT04097821|581142153|FG002|Overall Study|Death|3|||
160930683|NCT04097821|581142154|FG003|Overall Study|Death|1|||
160930684|NCT04097821|581142155|FG004|Overall Study|Death|0|||
160930685|NCT04097821|581142156|FG005|Overall Study|Death|0|||
160930686|NCT04097821|581142157|FG006|Overall Study|Death|0|||
160930687|NCT04097821|581142158|FG007|Overall Study|Death|0|||
160930688|NCT04097821|581142151|FG000|Overall Study|Physician Decision|1|||
160930689|NCT04097821|581142152|FG001|Overall Study|Physician Decision|2|||
160930690|NCT04097821|581142153|FG002|Overall Study|Physician Decision|0|||
160930691|NCT04097821|581142154|FG003|Overall Study|Physician Decision|0|||
160930692|NCT04097821|581142155|FG004|Overall Study|Physician Decision|0|||
160930693|NCT04097821|581142156|FG005|Overall Study|Physician Decision|0|||
160930694|NCT04097821|581142157|FG006|Overall Study|Physician Decision|0|||
160930695|NCT04097821|581142158|FG007|Overall Study|Physician Decision|0|||
160930696|NCT04097821|581142151|FG000|Overall Study|Adverse Event|0|||
160930697|NCT04097821|581142152|FG001|Overall Study|Adverse Event|0|||
160930698|NCT04097821|581142153|FG002|Overall Study|Adverse Event|1|||
160930699|NCT04097821|581142154|FG003|Overall Study|Adverse Event|1|||
160930700|NCT04097821|581142155|FG004|Overall Study|Adverse Event|0|||
160930701|NCT04097821|581142156|FG005|Overall Study|Adverse Event|0|||
160930702|NCT04097821|581142157|FG006|Overall Study|Adverse Event|0|||
160930703|NCT04097821|581142158|FG007|Overall Study|Adverse Event|0|||
160930704|NCT04097821|581142151|FG000|Overall Study|New Therapy For Study Indication|0|||
160455043|NCT05274074|579397815|FG000|Overall Study|Lost to Follow-up|2|||
160655895|NCT05630547|580120296|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
160655896|NCT05630547|580120297|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
160655897|NCT05630547|580120294|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
160655898|NCT05630547|580120295|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
160655899|NCT05630547|580120296|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
160655900|NCT05630547|580120297|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
160655901|NCT05630547|580120294|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
160655902|NCT05630547|580120295|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
160655903|NCT05630547|580120296|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
160655904|NCT05630547|580120297|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
160655905|NCT05630547|580120294|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
160655906|NCT05630547|580120295|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
160655907|NCT05630547|580120296|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
160655908|NCT05630547|580120297|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
160930705|NCT04097821|581142152|FG001|Overall Study|New Therapy For Study Indication|0|||
160930706|NCT04097821|581142153|FG002|Overall Study|New Therapy For Study Indication|0|||
160930707|NCT04097821|581142154|FG003|Overall Study|New Therapy For Study Indication|0|||
160455044|NCT05274074|579397816|FG001|Overall Study|Lost to Follow-up|3|||
160655909|NCT05630547|580120294|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
160655910|NCT05630547|580120295|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
160930708|NCT04097821|581142155|FG004|Overall Study|New Therapy For Study Indication|0|||
160930709|NCT04097821|581142156|FG005|Overall Study|New Therapy For Study Indication|0|||
160930710|NCT04097821|581142157|FG006|Overall Study|New Therapy For Study Indication|1|||
160930711|NCT04097821|581142158|FG007|Overall Study|New Therapy For Study Indication|0|||
160930712|NCT00244712|581142162|FG000|Overall Study|Adverse Event|20|||
160930713|NCT00244712|581142163|FG001|Overall Study|Adverse Event|21|||
160455045|NCT05274074|579397815|FG000|Overall Study|Withdrawal by Subject|1|||
160930714|NCT00244712|581142162|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
160930715|NCT00244712|581142163|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
160930716|NCT00244712|581142162|FG000|Overall Study|Lack of Compliance|10|||
160930717|NCT00244712|581142163|FG001|Overall Study|Lack of Compliance|11|||
160930718|NCT00244712|581142162|FG000|Overall Study|Lost to Follow-up|45|||
160930719|NCT00244712|581142163|FG001|Overall Study|Lost to Follow-up|52|||
160930720|NCT00244712|581142162|FG000|Overall Study|Withdrawal by Subject|13|||
160930721|NCT00244712|581142163|FG001|Overall Study|Withdrawal by Subject|23|||
160930722|NCT00244712|581142162|FG000|Overall Study|Protocol Violation, disease progression|13|||
160930723|NCT00244712|581142163|FG001|Overall Study|Protocol Violation, disease progression|11|||
160930724|NCT01077804|581142166|FG000|Overall Study|Unreachable|102|||
160930725|NCT01077804|581142166|FG000|Overall Study|Refused to continue|79|||
160930726|NCT01077804|581142166|FG000|Overall Study|Other|18|||
160930727|NCT02776917|581142167|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
160930728|NCT02620046|581142169|FG000|Overall Study|Adverse Event|22|||
160930729|NCT02620046|581142170|FG001|Overall Study|Adverse Event|42|||
160930730|NCT02620046|581142169|FG000|Overall Study|Lost to Follow-up|4|||
160930731|NCT02620046|581142170|FG001|Overall Study|Lost to Follow-up|10|||
160930732|NCT02620046|581142169|FG000|Overall Study|Withdrawal by Subject|36|||
160930733|NCT02620046|581142170|FG001|Overall Study|Withdrawal by Subject|66|||
160930734|NCT02620046|581142169|FG000|Overall Study|Site Termination|3|||
160930735|NCT02620046|581142170|FG001|Overall Study|Site Termination|3|||
160930736|NCT02620046|581142169|FG000|Overall Study|Pregnancy|3|||
160930737|NCT02620046|581142170|FG001|Overall Study|Pregnancy|7|||
160930738|NCT02620046|581142169|FG000|Overall Study|Lack of Efficacy|81|||
160930739|NCT02620046|581142170|FG001|Overall Study|Lack of Efficacy|146|||
160930740|NCT02620046|581142169|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
160930741|NCT02620046|581142170|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
160930742|NCT02620046|581142169|FG000|Overall Study|Reason Not Specified|13|||
160930743|NCT02620046|581142170|FG001|Overall Study|Reason Not Specified|21|||
160930744|NCT02620046|581142169|FG000|Overall Study|Significant Protocol Deviation|0|||
160930745|NCT02620046|581142170|FG001|Overall Study|Significant Protocol Deviation|1|||
160930746|NCT00560950|581142175|FG000|Overall Study|Lost to Follow-up|1|||
160930747|NCT00560950|581142176|FG001|Overall Study|Lost to Follow-up|0|||
160930748|NCT00574405|581144001|FG000|Overall Study|Withdrawal by Subject|3|||
160930749|NCT00574405|581144002|FG001|Overall Study|Withdrawal by Subject|2|||
160930750|NCT01336738|581144003|FG000|Overall Study|Adverse Event|0|||
160930751|NCT01336738|581144004|FG001|Overall Study|Adverse Event|3|||
160930752|NCT01336738|581144005|FG002|Overall Study|Adverse Event|2|||
160930753|NCT01336738|581144006|FG003|Overall Study|Adverse Event|1|||
160930754|NCT01336738|581144007|FG004|Overall Study|Adverse Event|3|||
160930755|NCT01336738|581144003|FG000|Overall Study|Lost to Follow-up|2|||
160930756|NCT01336738|581144004|FG001|Overall Study|Lost to Follow-up|1|||
160930757|NCT01336738|581144005|FG002|Overall Study|Lost to Follow-up|2|||
160930758|NCT01336738|581144006|FG003|Overall Study|Lost to Follow-up|2|||
160930759|NCT01336738|581144007|FG004|Overall Study|Lost to Follow-up|2|||
160930760|NCT01336738|581144003|FG000|Overall Study|Did not meet entrance criteria|0|||
160930761|NCT01336738|581144004|FG001|Overall Study|Did not meet entrance criteria|1|||
160930762|NCT01336738|581144005|FG002|Overall Study|Did not meet entrance criteria|0|||
160930763|NCT01336738|581144006|FG003|Overall Study|Did not meet entrance criteria|0|||
160930764|NCT01336738|581144007|FG004|Overall Study|Did not meet entrance criteria|0|||
160930765|NCT01336738|581144003|FG000|Overall Study|Protocol Violation|0|||
160930766|NCT01336738|581144004|FG001|Overall Study|Protocol Violation|1|||
160930767|NCT01336738|581144005|FG002|Overall Study|Protocol Violation|0|||
160930768|NCT01336738|581144006|FG003|Overall Study|Protocol Violation|0|||
160930769|NCT01336738|581144007|FG004|Overall Study|Protocol Violation|0|||
160930770|NCT01336738|581144003|FG000|Overall Study|Withdrawal by Subject|2|||
160930771|NCT01336738|581144004|FG001|Overall Study|Withdrawal by Subject|0|||
160930772|NCT01336738|581144005|FG002|Overall Study|Withdrawal by Subject|2|||
160930773|NCT01336738|581144006|FG003|Overall Study|Withdrawal by Subject|1|||
160930774|NCT01336738|581144007|FG004|Overall Study|Withdrawal by Subject|1|||
160930775|NCT01336738|581144003|FG000|Overall Study|Other|3|||
160455046|NCT05274074|579397816|FG001|Overall Study|Withdrawal by Subject|2|||
160455047|NCT04117347|579397817|FG000|Overall Study|Adverse Event|0|||
160455048|NCT04117347|579397818|FG001|Overall Study|Adverse Event|0|||
160455049|NCT04117347|579397819|FG002|Overall Study|Adverse Event|1|||
160930776|NCT01336738|581144004|FG001|Overall Study|Other|3|||
160930777|NCT01336738|581144005|FG002|Overall Study|Other|2|||
160930778|NCT01336738|581144006|FG003|Overall Study|Other|3|||
160930779|NCT01336738|581144007|FG004|Overall Study|Other|4|||
160930780|NCT01083433|581144008|FG000|Overall Study|Lost to Follow-up|2|||
160455050|NCT04117347|579397817|FG000|Overall Study|No time for study|0|||
160930781|NCT01083433|581144009|FG001|Overall Study|Lost to Follow-up|1|||
160930782|NCT01083433|581144010|FG002|Overall Study|Lost to Follow-up|1|||
160930783|NCT01083433|581144008|FG000|Overall Study|Withdrawal by Subject|0|||
160930784|NCT01083433|581144009|FG001|Overall Study|Withdrawal by Subject|5|||
160930785|NCT01083433|581144010|FG002|Overall Study|Withdrawal by Subject|3|||
160930786|NCT01083433|581144008|FG000|Overall Study|Pregnancy|0|||
160930787|NCT01083433|581144009|FG001|Overall Study|Pregnancy|0|||
160930788|NCT01083433|581144010|FG002|Overall Study|Pregnancy|1|||
160930789|NCT02970968|581144012|FG000|Overall Study|Withdrawal by Subject|3|||
160930790|NCT02970968|581144013|FG001|Overall Study|Withdrawal by Subject|3|||
160930791|NCT02970968|581144012|FG000|Overall Study|Adverse Event|1|||
160930792|NCT02970968|581144013|FG001|Overall Study|Adverse Event|2|||
160930793|NCT02970968|581144012|FG000|Overall Study|Lost to Follow-up|1|||
160930794|NCT02970968|581144013|FG001|Overall Study|Lost to Follow-up|1|||
160930795|NCT02970968|581144012|FG000|Overall Study|Non-Compliance|0|||
160930796|NCT02970968|581144013|FG001|Overall Study|Non-Compliance|1|||
160930797|NCT03003520|581144014|FG000|Overall Study|Adverse Event|9|||
160930798|NCT03003520|581144015|FG001|Overall Study|Adverse Event|0|||
160930799|NCT03003520|581144014|FG000|Overall Study|Death|1|||
160930800|NCT03003520|581144015|FG001|Overall Study|Death|0|||
160930801|NCT03003520|581144014|FG000|Overall Study|Other reasons|4|||
160930802|NCT03003520|581144015|FG001|Overall Study|Other reasons|0|||
160930803|NCT03003520|581144014|FG000|Overall Study|Withdrawal by Subject|6|||
160930804|NCT03003520|581144015|FG001|Overall Study|Withdrawal by Subject|0|||
160930805|NCT03003520|581144014|FG000|Overall Study|Progressive disease|9|||
160930806|NCT03003520|581144015|FG001|Overall Study|Progressive disease|1|||
160930807|NCT04982029|581144016|FG000|Overall Study|Lost to Follow-up|2|||
160930808|NCT04982029|581144017|FG001|Overall Study|Lost to Follow-up|3|||
160930809|NCT03264404|581144018|FG000|Overall Study|Death|2|||
160930810|NCT03264404|581144018|FG000|Overall Study|Physician Decision|1|||
160930811|NCT03264404|581144018|FG000|Overall Study|Disease Progression|28|||
160930812|NCT03264404|581144018|FG000|Overall Study|Adverse Event|1|||
160930813|NCT03264404|581144018|FG000|Overall Study|Off study prior to treatment|2|||
160930814|NCT02565381|581144019|FG000|Overall Study|Lost to Follow-up|1|||
160930815|NCT02565381|581144020|FG001|Overall Study|Lost to Follow-up|0|||
160930816|NCT02565381|581144021|FG002|Overall Study|Lost to Follow-up|1|||
160930817|NCT04615949|581144024|FG000|Overall Study|Withdrawal by Subject|2|||
160930818|NCT04615949|581144025|FG001|Overall Study|Withdrawal by Subject|4|||
160930819|NCT04615949|581144024|FG000|Overall Study|Lost to Follow-up|2|||
160930820|NCT04615949|581144025|FG001|Overall Study|Lost to Follow-up|2|||
160930821|NCT04615949|581144024|FG000|Overall Study|Death|0|||
160930822|NCT04615949|581144025|FG001|Overall Study|Death|2|||
160930823|NCT03036566|581144026|FG000|Overall Study|Lost to Follow-up|3|||
160930824|NCT05458856|581144027|FG000|Overall Study|Withdrawal by Subject|5|||
160930825|NCT05458856|581144027|FG000|Overall Study|Death|4|||
160930826|NCT05458856|581144027|FG000|Overall Study|Protocol Deviation|3|||
160930827|NCT05458856|581144027|FG000|Overall Study|Physician Decision|1|||
160930828|NCT01852292|581144031|FG000|Overall Study|Untreated - did not receive study drug|3|||
160930829|NCT01852292|581144032|FG001|Overall Study|Untreated - did not receive study drug|1|||
160930830|NCT01852292|581144031|FG000|Overall Study|Death|9|||
160930831|NCT01852292|581144032|FG001|Overall Study|Death|8|||
160930832|NCT01852292|581144031|FG000|Overall Study|Patient/guardian decision|8|||
160930833|NCT01852292|581144032|FG001|Overall Study|Patient/guardian decision|4|||
160930834|NCT01852292|581144031|FG000|Overall Study|Adverse Event|8|||
160930835|NCT01852292|581144032|FG001|Overall Study|Adverse Event|11|||
160930836|NCT01852292|581144031|FG000|Overall Study|Physician Decision|6|||
160930837|NCT01852292|581144032|FG001|Overall Study|Physician Decision|2|||
160930838|NCT01852292|581144031|FG000|Overall Study|Protocol Violation|2|||
160930839|NCT01852292|581144032|FG001|Overall Study|Protocol Violation|0|||
160930840|NCT01852292|581144031|FG000|Overall Study|Non-compliance with study treatment|1|||
160930841|NCT01852292|581144032|FG001|Overall Study|Non-compliance with study treatment|0|||
160930842|NCT01852292|581144031|FG000|Overall Study|Study terminated by Sponsor|0|||
160930843|NCT01852292|581144032|FG001|Overall Study|Study terminated by Sponsor|1|||
160930844|NCT01852292|581144031|FG000|Overall Study|Progressive disease|42|||
160930845|NCT01852292|581144032|FG001|Overall Study|Progressive disease|52|||
160930846|NCT01914666|581144033|FG000|Treatment Period|Lack of Efficacy|0|||
160930847|NCT01914666|581144034|FG001|Treatment Period|Lack of Efficacy|0|||
160930848|NCT01914666|581144035|FG002|Treatment Period|Lack of Efficacy|2|||
160930849|NCT01914666|581144033|FG000|Treatment Period|Adverse Event|10|||
160930850|NCT01914666|581144034|FG001|Treatment Period|Adverse Event|4|||
160930851|NCT01914666|581144035|FG002|Treatment Period|Adverse Event|2|||
160930852|NCT01914666|581144033|FG000|Treatment Period|Withdrawal by Subject|3|||
160930853|NCT01914666|581144034|FG001|Treatment Period|Withdrawal by Subject|2|||
160930854|NCT01914666|581144035|FG002|Treatment Period|Withdrawal by Subject|2|||
160455051|NCT04117347|579397818|FG001|Overall Study|No time for study|2|||
160455052|NCT04117347|579397819|FG002|Overall Study|No time for study|0|||
160455053|NCT04117347|579397817|FG000|Overall Study|Family emergency|1|||
160930855|NCT01914666|581144033|FG000|Treatment Period|Physician Decision|0|||
160930856|NCT01914666|581144034|FG001|Treatment Period|Physician Decision|0|||
160930857|NCT01914666|581144035|FG002|Treatment Period|Physician Decision|2|||
160930858|NCT02388737|581144036|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
160930859|NCT02388737|581144037|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
160930860|NCT02388737|581144038|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
160930861|NCT02388737|581144036|FG000|Overall Study|Major Protocol Deviation|18|||
160930862|NCT02388737|581144037|FG001|Overall Study|Major Protocol Deviation|25|||
160930863|NCT02388737|581144038|FG002|Overall Study|Major Protocol Deviation|22|||
160930864|NCT02388737|581144036|FG000|Overall Study|Lost to Follow-up|5|||
160930865|NCT02388737|581144037|FG001|Overall Study|Lost to Follow-up|1|||
160930866|NCT02388737|581144038|FG002|Overall Study|Lost to Follow-up|4|||
160930867|NCT02388737|581144036|FG000|Overall Study|Voluntary Withdrawal|10|||
160930868|NCT02388737|581144037|FG001|Overall Study|Voluntary Withdrawal|18|||
160930869|NCT02388737|581144038|FG002|Overall Study|Voluntary Withdrawal|17|||
160930870|NCT02388737|581144036|FG000|Overall Study|Lack of Efficacy|3|||
160930871|NCT02388737|581144037|FG001|Overall Study|Lack of Efficacy|0|||
160930872|NCT02388737|581144038|FG002|Overall Study|Lack of Efficacy|3|||
160930873|NCT02388737|581144036|FG000|Overall Study|Reason Not Specified|5|||
160930874|NCT02388737|581144037|FG001|Overall Study|Reason Not Specified|5|||
160930875|NCT02388737|581144038|FG002|Overall Study|Reason Not Specified|4|||
160930876|NCT03252522|581144039|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
160930877|NCT03252522|581144040|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
160930878|NCT03252522|581144041|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
160930879|NCT03252522|581144039|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
160930880|NCT03252522|581144040|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
160930881|NCT03252522|581144041|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
160930882|NCT03252522|581144039|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
160930883|NCT03252522|581144040|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
160930884|NCT03252522|581144041|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
160930885|NCT03252522|581144039|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
160930886|NCT03252522|581144040|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
160930887|NCT03252522|581144041|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
160930888|NCT03252522|581144039|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
160930889|NCT03252522|581144040|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
160930890|NCT03252522|581144041|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
160930891|NCT03252522|581144039|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
160930892|NCT03252522|581144040|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
160930893|NCT03252522|581144041|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
160930894|NCT03252522|581144039|FG000|Phase 2: Open Label|Adverse Event|0|||
160930895|NCT03252522|581144040|FG001|Phase 2: Open Label|Adverse Event|0|||
160930896|NCT03252522|581144041|FG002|Phase 2: Open Label|Adverse Event|2|||
160930897|NCT03252522|581144039|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
160930898|NCT03252522|581144040|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
160930899|NCT03252522|581144041|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
160930900|NCT03299842|581144043|FG000|Overall Study|Caregiver withdrew consent|2|||
160930901|NCT03299842|581144043|FG000|Overall Study|Child would not keep the watch on|3|||
160930902|NCT00071812|581144044|FG000|24-Week Double-Blind Period|Adverse Event|2|||
160930903|NCT00071812|581144045|FG001|24-Week Double-Blind Period|Adverse Event|3|||
160930904|NCT00071812|581144046|FG002|24-Week Double-Blind Period|Adverse Event|4|||
160930905|NCT00071812|581144047|FG003|24-Week Double-Blind Period|Adverse Event|4|||
160930906|NCT00071812|581144044|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
160930907|NCT00071812|581144045|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
160930908|NCT00071812|581144046|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
160930909|NCT00071812|581144047|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
160930910|NCT00071812|581144044|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
160930911|NCT00071812|581144045|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
160930912|NCT00071812|581144046|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
160930913|NCT00071812|581144047|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
160930914|NCT00071812|581144044|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
160930915|NCT00071812|581144045|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
160930916|NCT00071812|581144046|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
160930917|NCT00071812|581144047|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
160930918|NCT00071812|581144044|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
160930919|NCT00071812|581144045|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
160930920|NCT00071812|581144046|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
160930921|NCT00071812|581144047|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
160930922|NCT00071812|581144044|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
160930923|NCT00071812|581144045|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
160998126|NCT01563354|581378572|FG002|Core Phase|Withdrawal by Subject|3|||
160998127|NCT01563354|581378570|FG000|Core Phase|Lost to Follow-up|1|||
160578202|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
160578203|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
160578204|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
160578205|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
160578206|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
160930924|NCT00071812|581144046|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
160930925|NCT00071812|581144047|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
160930926|NCT00071812|581144044|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160930927|NCT00071812|581144045|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160930928|NCT00071812|581144046|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160998128|NCT01563354|581378571|FG001|Core Phase|Lost to Follow-up|0|||
160998129|NCT01563354|581378572|FG002|Core Phase|Lost to Follow-up|0|||
160930929|NCT00071812|581144047|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
160930930|NCT00071812|581144044|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160930931|NCT00071812|581144045|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160930932|NCT00071812|581144046|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160930933|NCT00071812|581144047|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
160930934|NCT00071812|581144044|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160930935|NCT00071812|581144045|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160930936|NCT00071812|581144046|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160930937|NCT00071812|581144047|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
160930938|NCT00071812|581144044|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
160930939|NCT00071812|581144045|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
160930940|NCT00071812|581144046|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
160930941|NCT00071812|581144047|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
160930942|NCT01940120|581144050|FG000|Overall Study|Death|40|||
160930943|NCT01940120|581144050|FG000|Overall Study|Withdrawal by Subject|8|||
160930944|NCT01572038|581144052|FG000|Overall Study|Death|648|||
160930945|NCT01572038|581144052|FG000|Overall Study|Withdrawal by Subject|204|||
160930946|NCT01572038|581144052|FG000|Overall Study|Lost to Follow-up|81|||
160930947|NCT01572038|581144052|FG000|Overall Study|Physician Decision|20|||
160930948|NCT01572038|581144052|FG000|Overall Study|Patient Decision|14|||
160930949|NCT01572038|581144052|FG000|Overall Study|Progressive Disease|8|||
160930950|NCT01572038|581144052|FG000|Overall Study|Site Closed Before Completing Form|6|||
160930951|NCT01572038|581144052|FG000|Overall Study|Enrolled into Another Trial|3|||
160930952|NCT01572038|581144052|FG000|Overall Study|Participated in Another Trial|3|||
160930953|NCT01572038|581144052|FG000|Overall Study|Termination by Sponsor|2|||
160930954|NCT01572038|581144052|FG000|Overall Study|Patient Deterioration|1|||
160930955|NCT01572038|581144052|FG000|Overall Study|Sponsor Decision|1|||
160930956|NCT04152447|581144053|FG000|Overall Study|Lost to Follow-up|1|||
160930957|NCT04152447|581144054|FG001|Overall Study|Lost to Follow-up|0|||
160930958|NCT04152447|581144053|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
160930959|NCT04152447|581144054|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
160930960|NCT04152447|581144053|FG000|Overall Study|Withdrawal by Subject|0|||
160930961|NCT04152447|581144054|FG001|Overall Study|Withdrawal by Subject|1|||
160930962|NCT04152447|581144053|FG000|Overall Study|Found ineligible after enrolling|1|||
160930963|NCT04152447|581144054|FG001|Overall Study|Found ineligible after enrolling|1|||
160930964|NCT04152447|581144053|FG000|Overall Study|Did not receive VR headset in time.|0|||
160930965|NCT04152447|581144054|FG001|Overall Study|Did not receive VR headset in time.|2|||
160930966|NCT03240575|581144055|FG000|Overall Study|Adverse Event|0|||
160930967|NCT03240575|581144056|FG001|Overall Study|Adverse Event|2|||
160930968|NCT03240575|581144057|FG002|Overall Study|Adverse Event|0|||
160930969|NCT03240575|581144058|FG003|Overall Study|Adverse Event|1|||
160930970|NCT03240575|581144055|FG000|Overall Study|Withdrawal by Subject|2|||
160930971|NCT03240575|581144056|FG001|Overall Study|Withdrawal by Subject|11|||
160930972|NCT03240575|581144057|FG002|Overall Study|Withdrawal by Subject|0|||
160930973|NCT03240575|581144058|FG003|Overall Study|Withdrawal by Subject|1|||
160930974|NCT03240575|581144055|FG000|Overall Study|Other|0|||
160930975|NCT03240575|581144056|FG001|Overall Study|Other|1|||
160930976|NCT03240575|581144057|FG002|Overall Study|Other|0|||
160930977|NCT03240575|581144058|FG003|Overall Study|Other|0|||
160930978|NCT04482179|581144059|FG000|Overall Study|Death|1|||
160930979|NCT04482179|581144060|FG001|Overall Study|Death|0|||
160930980|NCT04482179|581144059|FG000|Overall Study|Withdrawal by Subject|1|||
160930981|NCT04482179|581144060|FG001|Overall Study|Withdrawal by Subject|0|||
160930982|NCT03034954|581144063|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
160930983|NCT03034954|581144064|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
160930984|NCT03568942|581144067|FG000|Overall Study|Family emergency|1|||
160930985|NCT03568942|581144067|FG000|Overall Study|Lost to Follow-up|1|||
160930986|NCT04145895|581144073|FG000|Overall Study|Physician Decision|2|||
160930987|NCT04145895|581144074|FG001|Overall Study|Physician Decision|0|||
160930988|NCT04145895|581144073|FG000|Overall Study|Withdrawal by Subject|0|||
160578207|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
160578208|NCT02232516|579838293|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
160578209|NCT02232516|579838293|FG000|Survival Follow-up|Death|15|||
160930989|NCT04145895|581144074|FG001|Overall Study|Withdrawal by Subject|2|||
160930990|NCT00913744|581144075|FG000|Overall Study|Adverse Event|2|||
160930991|NCT00913744|581144076|FG001|Overall Study|Adverse Event|0|||
160930992|NCT00913744|581144075|FG000|Overall Study|Withdrawal by Subject|2|||
160930993|NCT00913744|581144076|FG001|Overall Study|Withdrawal by Subject|1|||
160930994|NCT00913744|581144075|FG000|Overall Study|Death|1|||
160930995|NCT00913744|581144076|FG001|Overall Study|Death|0|||
160930996|NCT00805935|581144077|FG000|Overall Study|Stimulation Failure|1|||
160930997|NCT00805935|581144078|FG001|Overall Study|Stimulation Failure|5|||
160930998|NCT00805935|581144079|FG002|Overall Study|Stimulation Failure|2|||
160930999|NCT00805935|581144080|FG003|Overall Study|Stimulation Failure|2|||
160931000|NCT00805935|581144077|FG000|Overall Study|Cycle cancelled|0|||
160931001|NCT00805935|581144078|FG001|Overall Study|Cycle cancelled|0|||
160931002|NCT00805935|581144079|FG002|Overall Study|Cycle cancelled|2|||
160931003|NCT00805935|581144080|FG003|Overall Study|Cycle cancelled|0|||
160931004|NCT00805935|581144077|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
160931005|NCT00805935|581144078|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
160931006|NCT00805935|581144079|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
160931007|NCT00805935|581144080|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
160931008|NCT00805935|581144077|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
160931009|NCT00805935|581144078|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
160931010|NCT00805935|581144079|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
160931011|NCT00805935|581144080|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
160931012|NCT00805935|581144077|FG000|Overall Study|Lost to Follow-up|1|||
160931013|NCT00805935|581144078|FG001|Overall Study|Lost to Follow-up|0|||
160931014|NCT00805935|581144079|FG002|Overall Study|Lost to Follow-up|0|||
160931015|NCT00805935|581144080|FG003|Overall Study|Lost to Follow-up|0|||
160931016|NCT00805935|581144077|FG000|Overall Study|No positive serum pregnancy|8|||
160931017|NCT00805935|581144078|FG001|Overall Study|No positive serum pregnancy|7|||
160931018|NCT00805935|581144079|FG002|Overall Study|No positive serum pregnancy|6|||
160931019|NCT00805935|581144080|FG003|Overall Study|No positive serum pregnancy|5|||
160931020|NCT00805935|581144077|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
160931021|NCT00805935|581144078|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
160931022|NCT00805935|581144079|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
160931023|NCT00805935|581144080|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
160931024|NCT00805935|581144077|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
160931025|NCT00805935|581144078|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
160931026|NCT00805935|581144079|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
160931027|NCT00805935|581144080|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
160931028|NCT00805935|581144077|FG000|Overall Study|Biochemical pregnancy|0|||
160931029|NCT00805935|581144078|FG001|Overall Study|Biochemical pregnancy|1|||
160931030|NCT00805935|581144079|FG002|Overall Study|Biochemical pregnancy|0|||
160931031|NCT00805935|581144080|FG003|Overall Study|Biochemical pregnancy|0|||
160931032|NCT00805935|581144077|FG000|Overall Study|Chemical pregnancy|0|||
160931033|NCT00805935|581144078|FG001|Overall Study|Chemical pregnancy|5|||
160931034|NCT00805935|581144079|FG002|Overall Study|Chemical pregnancy|3|||
160931035|NCT00805935|581144080|FG003|Overall Study|Chemical pregnancy|2|||
160931036|NCT00805935|581144077|FG000|Overall Study|Ectopic pregnancy|0|||
160931037|NCT00805935|581144078|FG001|Overall Study|Ectopic pregnancy|0|||
160931038|NCT00805935|581144079|FG002|Overall Study|Ectopic pregnancy|1|||
160931039|NCT00805935|581144080|FG003|Overall Study|Ectopic pregnancy|0|||
160931040|NCT00805935|581144077|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
160931041|NCT00805935|581144078|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
160931042|NCT00805935|581144079|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
160931043|NCT00805935|581144080|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
160931044|NCT00283439|581144081|FG000|Overall Study|Adverse Event|0|||
160931045|NCT00283439|581144082|FG001|Overall Study|Adverse Event|0|||
160931046|NCT00283439|581144083|FG002|Overall Study|Adverse Event|0|||
160931047|NCT00283439|581144084|FG003|Overall Study|Adverse Event|1|||
160931048|NCT00283439|581144081|FG000|Overall Study|Death|0|||
160455054|NCT04117347|579397818|FG001|Overall Study|Family emergency|0|||
160455055|NCT04117347|579397819|FG002|Overall Study|Family emergency|0|||
160455056|NCT03687086|579397820|FG000|Overall Study|Withdrawal by Subject|3|||
160455057|NCT03687086|579397821|FG001|Overall Study|Withdrawal by Subject|4|||
160455058|NCT03687086|579397820|FG000|Overall Study|Lost to Follow-up|1|||
160455059|NCT03687086|579397821|FG001|Overall Study|Lost to Follow-up|1|||
160455060|NCT03687086|579397820|FG000|Overall Study|Death|1|||
160455061|NCT03687086|579397821|FG001|Overall Study|Death|0|||
160455062|NCT03687086|579397820|FG000|Overall Study|Incomplete assessment|0|||
160455063|NCT03687086|579397821|FG001|Overall Study|Incomplete assessment|2|||
160455064|NCT05194956|579397822|FG000|Washout Period|Withdrawal by Subject|0|||
160455065|NCT05194956|579397823|FG001|Washout Period|Withdrawal by Subject|2|||
160455066|NCT05485779|579397826|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
160455067|NCT05485779|579397827|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
160455068|NCT05485779|579397828|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
160455069|NCT05485779|579397829|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
160931049|NCT00283439|581144082|FG001|Overall Study|Death|0|||
160931050|NCT00283439|581144083|FG002|Overall Study|Death|1|||
160931051|NCT00283439|581144084|FG003|Overall Study|Death|0|||
160931052|NCT00283439|581144081|FG000|Overall Study|Disease progression|0|||
160931053|NCT00283439|581144082|FG001|Overall Study|Disease progression|1|||
160931054|NCT00283439|581144083|FG002|Overall Study|Disease progression|0|||
160931055|NCT00283439|581144084|FG003|Overall Study|Disease progression|0|||
160931056|NCT00283439|581144081|FG000|Overall Study|Requirement for alternative therapy|1|||
160455070|NCT05485779|579397830|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
160455071|NCT05485779|579397831|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
160455072|NCT05485779|579397832|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
160455073|NCT05485779|579397833|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
160931057|NCT00283439|581144082|FG001|Overall Study|Requirement for alternative therapy|2|||
160931058|NCT00283439|581144083|FG002|Overall Study|Requirement for alternative therapy|5|||
160931059|NCT00283439|581144084|FG003|Overall Study|Requirement for alternative therapy|2|||
160931060|NCT00283439|581144081|FG000|Overall Study|Stem cell transplant|6|||
160931061|NCT00283439|581144082|FG001|Overall Study|Stem cell transplant|6|||
160931062|NCT00283439|581144083|FG002|Overall Study|Stem cell transplant|4|||
160931063|NCT00283439|581144084|FG003|Overall Study|Stem cell transplant|3|||
160931064|NCT00283439|581144081|FG000|Overall Study|Treatment discontinued|0|||
160931065|NCT00283439|581144082|FG001|Overall Study|Treatment discontinued|2|||
160931066|NCT00283439|581144083|FG002|Overall Study|Treatment discontinued|1|||
160931067|NCT00283439|581144084|FG003|Overall Study|Treatment discontinued|3|||
160931068|NCT00283439|581144081|FG000|Overall Study|Other|1|||
160931069|NCT00283439|581144082|FG001|Overall Study|Other|0|||
160931070|NCT00283439|581144083|FG002|Overall Study|Other|0|||
160931071|NCT00283439|581144084|FG003|Overall Study|Other|0|||
160931072|NCT01539226|581144085|FG000|Overall Study|Withdrawal by Subject|24|||
160931073|NCT01539226|581144086|FG001|Overall Study|Withdrawal by Subject|54|||
160931074|NCT01539226|581144085|FG000|Overall Study|Lost to Follow-up|20|||
160931075|NCT01539226|581144086|FG001|Overall Study|Lost to Follow-up|54|||
160931076|NCT01539226|581144085|FG000|Overall Study|Death|1|||
160931077|NCT01539226|581144086|FG001|Overall Study|Death|2|||
160931078|NCT01539226|581144085|FG000|Overall Study|Adverse Event|2|||
160931079|NCT01539226|581144086|FG001|Overall Study|Adverse Event|0|||
160931080|NCT01539226|581144085|FG000|Overall Study|Pregnancy|13|||
160931081|NCT01539226|581144086|FG001|Overall Study|Pregnancy|29|||
160931082|NCT01539226|581144085|FG000|Overall Study|inappropriate enrollment|0|||
160931083|NCT01539226|581144086|FG001|Overall Study|inappropriate enrollment|1|||
160931084|NCT01539226|581144085|FG000|Overall Study|Multiple Reasons|3|||
160931085|NCT01539226|581144086|FG001|Overall Study|Multiple Reasons|1|||
160931086|NCT01539226|581144085|FG000|Overall Study|not HIV seroconversion-related|93|||
160931087|NCT01539226|581144086|FG001|Overall Study|not HIV seroconversion-related|176|||
160931088|NCT01539226|581144085|FG000|Overall Study|HIV seroconversion-related|55|||
160931089|NCT01539226|581144086|FG001|Overall Study|HIV seroconversion-related|80|||
160931090|NCT01539226|581144085|FG000|Overall Study|Non-compliance|6|||
160931091|NCT01539226|581144086|FG001|Overall Study|Non-compliance|8|||
160931092|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
160931093|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
160931094|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
160931095|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
160931096|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
160931097|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
160931098|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
160931099|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
160931100|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
160931101|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
160931102|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
160578210|NCT02232516|579838293|FG000|Survival Follow-up|Withdrawal by Subject|3|||
160578211|NCT02232516|579838293|FG000|Survival Follow-up|Lost to Follow-up|1|||
160578212|NCT02232516|579838293|FG000|Survival Follow-up|Still in follow-up|5|||
160931103|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
160931104|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
160931105|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
160931106|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
160931107|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
160998130|NCT01563354|581378570|FG000|Core Phase|Death|1|||
160998131|NCT01563354|581378571|FG001|Core Phase|Death|5|||
160998132|NCT01563354|581378572|FG002|Core Phase|Death|2|||
160998133|NCT01563354|581378570|FG000|Core Phase|Diseasse progression|18|||
160455074|NCT05485779|579397834|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
160578213|NCT01070550|579838294|FG000|Overall Study|Adverse Event|43|||
160455075|NCT05485779|579397835|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
160455076|NCT05485779|579397836|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
160578214|NCT01070550|579838295|FG001|Overall Study|Adverse Event|1|||
160578215|NCT01070550|579838296|FG002|Overall Study|Adverse Event|3|||
160578216|NCT01070550|579838297|FG003|Overall Study|Adverse Event|0|||
160931108|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
160931109|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
160931110|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
160931111|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
160931112|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
160931113|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
160998134|NCT01563354|581378571|FG001|Core Phase|Diseasse progression|7|||
160998135|NCT01563354|581378572|FG002|Core Phase|Diseasse progression|8|||
160931114|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
160931115|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
160931116|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
160931117|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
160931118|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
160931119|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
160931120|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
160931121|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
160931122|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
160931123|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
160931124|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
160931125|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
160931126|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
160931127|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
160931128|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
160931129|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
160931130|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
160931131|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
160931132|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
160931133|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
160931134|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
160931135|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
160931136|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
160931137|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
160931138|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
160931139|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
160931140|NCT01632891|581144091|FG000|Overall Study|Lost to Follow-up|0|||
160931141|NCT01632891|581144092|FG001|Overall Study|Lost to Follow-up|1|||
160931142|NCT01632891|581144091|FG000|Overall Study|Withdrawal by Subject|1|||
160931143|NCT01632891|581144092|FG001|Overall Study|Withdrawal by Subject|0|||
160931144|NCT00333229|581144093|FG000|Overall Study|Lack of Efficacy|0|||
160931145|NCT00333229|581144094|FG001|Overall Study|Lack of Efficacy|1|||
160931146|NCT00240071|581144096|FG000|Overall Study|Withdrawal by Subject|3|||
160931147|NCT02821962|581144097|FG000|Overall Study|Lost to Follow-up|2|||
160931148|NCT02821962|581144098|FG001|Overall Study|Lost to Follow-up|0|||
160931149|NCT04206293|581144111|FG000|Overall Study|Consent withdrawal|1|||
160931150|NCT01610791|581144120|FG000|Overall Study|Lost to Follow-up|7|||
160931151|NCT01610791|581144120|FG000|Overall Study|Adverse Event|6|||
160931152|NCT01610791|581144120|FG000|Overall Study|Physician Decision|1|||
160931153|NCT01610791|581144120|FG000|Overall Study|Adverse event and Investigator decision|1|||
160931154|NCT01610791|581144120|FG000|Overall Study|Death|1|||
160931155|NCT01610791|581144120|FG000|Overall Study|Not determined|5|||
160931156|NCT05358821|581144121|FG000|Overall Study|Withdrawal by Subject|0|||
160931157|NCT05358821|581144122|FG001|Overall Study|Withdrawal by Subject|1|||
160931158|NCT05358821|581144123|FG002|Overall Study|Withdrawal by Subject|0|||
160931159|NCT05358821|581144121|FG000|Overall Study|Withdrawal of Consent|0|||
160931160|NCT05358821|581144122|FG001|Overall Study|Withdrawal of Consent|0|||
160931161|NCT05358821|581144123|FG002|Overall Study|Withdrawal of Consent|1|||
160578217|NCT01070550|579838298|FG004|Overall Study|Adverse Event|0|||
160578218|NCT01070550|579838299|FG005|Overall Study|Adverse Event|0|||
160578219|NCT01070550|579838294|FG000|Overall Study|Death|20|||
160578220|NCT01070550|579838295|FG001|Overall Study|Death|4|||
160931162|NCT04627064|581144124|FG000|Overall Study|Progressive disease|8|||
160931163|NCT04627064|581144125|FG001|Overall Study|Progressive disease|0|||
160931164|NCT04627064|581144124|FG000|Overall Study|Withdrawal by Subject|2|||
160931165|NCT04627064|581144125|FG001|Overall Study|Withdrawal by Subject|0|||
160455077|NCT05485779|579397826|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
160455078|NCT05485779|579397827|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
160578221|NCT01070550|579838296|FG002|Overall Study|Death|3|||
160578222|NCT01070550|579838297|FG003|Overall Study|Death|0|||
160578223|NCT01070550|579838298|FG004|Overall Study|Death|0|||
160578224|NCT01070550|579838299|FG005|Overall Study|Death|0|||
160578225|NCT01070550|579838294|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
160931166|NCT04627064|581144124|FG000|Overall Study|Physician Decision|1|||
160931167|NCT04627064|581144125|FG001|Overall Study|Physician Decision|0|||
160931168|NCT02272413|581144129|FG000|Randomized Through Treatment Start|Not treated|3|||
160931169|NCT02272413|581144130|FG001|Randomized Through Treatment Start|Not treated|5|||
160931170|NCT02272413|581144129|FG000|Pre-switch Period|Adverse Event|38|||
160931171|NCT02272413|581144130|FG001|Pre-switch Period|Adverse Event|37|||
160931172|NCT02272413|581144129|FG000|Pre-switch Period|Death|26|||
160578226|NCT01070550|579838295|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
160931173|NCT02272413|581144130|FG001|Pre-switch Period|Death|26|||
160931174|NCT02272413|581144129|FG000|Pre-switch Period|Withdrawal by Subject|27|||
160931175|NCT02272413|581144130|FG001|Pre-switch Period|Withdrawal by Subject|15|||
160931176|NCT02272413|581144129|FG000|Pre-switch Period|Physician Decision|6|||
160931177|NCT02272413|581144130|FG001|Pre-switch Period|Physician Decision|18|||
160931178|NCT02272413|581144129|FG000|Pre-switch Period|Progressive disease|185|||
160931179|NCT02272413|581144130|FG001|Pre-switch Period|Progressive disease|173|||
160931180|NCT02272413|581144129|FG000|Pre-switch Period|Lost to Follow-up|0|||
160931181|NCT02272413|581144130|FG001|Pre-switch Period|Lost to Follow-up|2|||
160931182|NCT02272413|581144129|FG000|Pre-switch Period|Protocol Violation|1|||
160931183|NCT02272413|581144130|FG001|Pre-switch Period|Protocol Violation|0|||
160931184|NCT02272413|581144129|FG000|Pre-switch Period|Other than listed|10|||
160931185|NCT02272413|581144130|FG001|Pre-switch Period|Other than listed|11|||
160931186|NCT02272413|581144129|FG000|Post-switch Period|Adverse Event|4|||
160931187|NCT02272413|581144130|FG001|Post-switch Period|Adverse Event|4|||
160931188|NCT02272413|581144129|FG000|Post-switch Period|Death|3|||
160931189|NCT02272413|581144130|FG001|Post-switch Period|Death|2|||
160931190|NCT02272413|581144129|FG000|Post-switch Period|Withdrawal by Subject|1|||
160931191|NCT02272413|581144130|FG001|Post-switch Period|Withdrawal by Subject|2|||
160931192|NCT02272413|581144129|FG000|Post-switch Period|Physician Decision|1|||
160931193|NCT02272413|581144130|FG001|Post-switch Period|Physician Decision|1|||
160931194|NCT02272413|581144129|FG000|Post-switch Period|Progressive disease|21|||
160931195|NCT02272413|581144130|FG001|Post-switch Period|Progressive disease|21|||
160931196|NCT02272413|581144129|FG000|Post-switch Period|Study terminated by sponsor|8|||
160931197|NCT02272413|581144130|FG001|Post-switch Period|Study terminated by sponsor|11|||
160931198|NCT02272413|581144129|FG000|Post-switch Period|Other than listed|4|||
160931199|NCT02272413|581144130|FG001|Post-switch Period|Other than listed|5|||
160931200|NCT02286193|581144133|FG000|Overall Study|Referred: CRS unable to make contact|62|||
160931201|NCT02286193|581144133|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
160931202|NCT02286193|581144133|FG000|Overall Study|Referred: Declined service|38|||
160931203|NCT00423891|581144134|FG000|Enrolled|Withdrawal by Subject|0|||
160931204|NCT00423891|581144135|FG001|Enrolled|Withdrawal by Subject|0|||
160931205|NCT00423891|581144136|FG002|Enrolled|Withdrawal by Subject|1|||
160931206|NCT00423891|581144134|FG000|Enrolled|Lost to Follow-up|0|||
160931207|NCT00423891|581144135|FG001|Enrolled|Lost to Follow-up|0|||
160931208|NCT00423891|581144136|FG002|Enrolled|Lost to Follow-up|1|||
160931209|NCT00423891|581144134|FG000|Enrolled|No longer met criteria|11|||
160931210|NCT00423891|581144135|FG001|Enrolled|No longer met criteria|2|||
160931211|NCT00423891|581144136|FG002|Enrolled|No longer met criteria|1|||
160931212|NCT00423891|581144134|FG000|Treatment|Withdrawal by Subject|1|||
160931213|NCT00423891|581144135|FG001|Treatment|Withdrawal by Subject|0|||
160931214|NCT00423891|581144136|FG002|Treatment|Withdrawal by Subject|0|||
160931215|NCT00423891|581144134|FG000|Treatment|Lost to Follow-up|1|||
160931216|NCT00423891|581144135|FG001|Treatment|Lost to Follow-up|0|||
160931217|NCT00423891|581144136|FG002|Treatment|Lost to Follow-up|0|||
160931218|NCT00423891|581144134|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
160931219|NCT00423891|581144135|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
160931220|NCT00423891|581144136|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
160931221|NCT00423891|581144134|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
160998136|NCT01563354|581378570|FG000|Core Phase|Protocol deviation|2|||
160998137|NCT01563354|581378571|FG001|Core Phase|Protocol deviation|0|||
160998138|NCT01563354|581378572|FG002|Core Phase|Protocol deviation|0|||
160998139|NCT01563354|581378570|FG000|Core Phase|PI decision - did not enter extension|0|||
160998140|NCT01563354|581378571|FG001|Core Phase|PI decision - did not enter extension|1|||
160998141|NCT01563354|581378572|FG002|Core Phase|PI decision - did not enter extension|0|||
160998142|NCT01563354|581378570|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
160998143|NCT01563354|581378571|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
160998144|NCT01563354|581378572|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
160998145|NCT01563354|581378570|FG000|Extension Phase|Adverse Event|0|||
160998146|NCT01563354|581378571|FG001|Extension Phase|Adverse Event|3|||
160998147|NCT01563354|581378572|FG002|Extension Phase|Adverse Event|2|||
160455079|NCT05485779|579397828|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
160998148|NCT01563354|581378570|FG000|Extension Phase|Withdrawal by Subject|0|||
160998149|NCT01563354|581378571|FG001|Extension Phase|Withdrawal by Subject|1|||
160931222|NCT00423891|581144135|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
160931223|NCT00423891|581144136|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
160931224|NCT04327999|581144139|FG000|Overall Study|Protocol Violation|1|||
160931225|NCT02872116|581144144|FG000|Pre-Treatment|Disease Progression|0|||
160931226|NCT02872116|581144145|FG001|Pre-Treatment|Disease Progression|1|||
160931227|NCT02872116|581144146|FG002|Pre-Treatment|Disease Progression|0|||
160931228|NCT02872116|581144144|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
160931229|NCT02872116|581144145|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
160931230|NCT02872116|581144146|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
160931231|NCT02872116|581144144|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
160931232|NCT02872116|581144145|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
160931233|NCT02872116|581144146|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
160931234|NCT02872116|581144144|FG000|Pre-Treatment|Participant withdrew consent|2|||
160931235|NCT02872116|581144145|FG001|Pre-Treatment|Participant withdrew consent|20|||
160931236|NCT02872116|581144146|FG002|Pre-Treatment|Participant withdrew consent|3|||
160931237|NCT02872116|581144144|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
160931238|NCT02872116|581144145|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
160931239|NCT02872116|581144146|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
160931240|NCT02872116|581144144|FG000|Pre-Treatment|Other reasons|1|||
160931241|NCT02872116|581144145|FG001|Pre-Treatment|Other reasons|2|||
160931242|NCT02872116|581144146|FG002|Pre-Treatment|Other reasons|2|||
160931243|NCT02872116|581144144|FG000|Treatment|Death|121|||
160931244|NCT02872116|581144145|FG001|Treatment|Death|94|||
160931245|NCT02872116|581144146|FG002|Treatment|Death|68|||
160931246|NCT02872116|581144144|FG000|Treatment|Lost to Follow-up|5|||
160931247|NCT02872116|581144145|FG001|Treatment|Lost to Follow-up|7|||
160931248|NCT02872116|581144146|FG002|Treatment|Lost to Follow-up|3|||
160931249|NCT02872116|581144144|FG000|Treatment|Participant withdrew consent|20|||
160931250|NCT02872116|581144145|FG001|Treatment|Participant withdrew consent|40|||
160931251|NCT02872116|581144146|FG002|Treatment|Participant withdrew consent|8|||
160931252|NCT02872116|581144144|FG000|Treatment|Other reasons|13|||
160931253|NCT02872116|581144145|FG001|Treatment|Other reasons|12|||
160931254|NCT02872116|581144146|FG002|Treatment|Other reasons|5|||
160931255|NCT01073865|581144150|FG000|Overall Study|Reasons other than below|19|||
160931256|NCT01073865|581144151|FG001|Overall Study|Reasons other than below|31|||
160931257|NCT01073865|581144150|FG000|Overall Study|Lost to Follow-up|1|||
160931258|NCT01073865|581144151|FG001|Overall Study|Lost to Follow-up|1|||
160931259|NCT01073865|581144150|FG000|Overall Study|Death|3|||
160931260|NCT01073865|581144151|FG001|Overall Study|Death|2|||
160931261|NCT01073865|581144150|FG000|Overall Study|Withdrawal by Subject|5|||
160931262|NCT01073865|581144151|FG001|Overall Study|Withdrawal by Subject|5|||
160931263|NCT00696137|581144152|FG000|Overall Study|Withdrawal by Subject|2|||
160931264|NCT04371380|581144156|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
160931265|NCT04371380|581144157|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
160931266|NCT04371380|581144158|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
160931267|NCT02376166|581144159|FG000|Overall Study|Adverse Event|1|||
160931268|NCT02376166|581144159|FG000|Overall Study|Discontinued metformin early|2|||
160931269|NCT01816139|581145626|FG000|Overall Study|Adverse Event|6|||
160931270|NCT01816139|581145627|FG001|Overall Study|Adverse Event|8|||
160931271|NCT01816139|581145626|FG000|Overall Study|Lack of Efficacy|1|||
160931272|NCT01816139|581145627|FG001|Overall Study|Lack of Efficacy|2|||
160931273|NCT01816139|581145626|FG000|Overall Study|Lost to Follow-up|5|||
160931274|NCT01816139|581145627|FG001|Overall Study|Lost to Follow-up|3|||
160931275|NCT01816139|581145626|FG000|Overall Study|Withdrew Consent|6|||
160931276|NCT01816139|581145627|FG001|Overall Study|Withdrew Consent|4|||
160931277|NCT01816139|581145626|FG000|Overall Study|Protocol Violation|6|||
160931278|NCT01816139|581145627|FG001|Overall Study|Protocol Violation|3|||
160931279|NCT01816139|581145626|FG000|Overall Study|Reason not Specified|4|||
160931280|NCT01816139|581145627|FG001|Overall Study|Reason not Specified|2|||
160931281|NCT02554656|581145628|FG000|Overall Study|Protocol Violation|3|||
160931282|NCT04304001|581145632|FG000|Overall Study|Lost to Follow-up|13|||
160931283|NCT04304001|581145633|FG001|Overall Study|Lost to Follow-up|9|||
160578227|NCT01070550|579838296|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
160931284|NCT04164901|581145634|FG000|Overall Study|Withdrawal by Subject|4|||
160931285|NCT04164901|581145635|FG001|Overall Study|Withdrawal by Subject|4|||
160931286|NCT02465528|581145636|FG000|Overall Study|Progressive disease|0|||
160931287|NCT02465528|581145637|FG001|Overall Study|Progressive disease|2|||
160931288|NCT02465528|581145638|FG002|Overall Study|Progressive disease|9|||
160931289|NCT02465528|581145639|FG003|Overall Study|Progressive disease|4|||
160931290|NCT02465528|581145636|FG000|Overall Study|Study terminated by sponsor|1|||
160931291|NCT02465528|581145637|FG001|Overall Study|Study terminated by sponsor|2|||
160931292|NCT02465528|581145638|FG002|Overall Study|Study terminated by sponsor|0|||
160931293|NCT02465528|581145639|FG003|Overall Study|Study terminated by sponsor|0|||
160931294|NCT02465528|581145636|FG000|Overall Study|Withdrawal by Subject|0|||
160931295|NCT02465528|581145637|FG001|Overall Study|Withdrawal by Subject|0|||
160578228|NCT01070550|579838297|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
160931296|NCT02465528|581145638|FG002|Overall Study|Withdrawal by Subject|2|||
160931297|NCT02465528|581145639|FG003|Overall Study|Withdrawal by Subject|0|||
160578229|NCT01070550|579838298|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
160578230|NCT01070550|579838299|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
160931298|NCT02465528|581145636|FG000|Overall Study|Adverse Event|0|||
160931299|NCT02465528|581145637|FG001|Overall Study|Adverse Event|0|||
160931300|NCT02465528|581145638|FG002|Overall Study|Adverse Event|0|||
160931301|NCT02465528|581145639|FG003|Overall Study|Adverse Event|1|||
160931302|NCT02465528|581145636|FG000|Overall Study|Physician Decision|0|||
160931303|NCT02465528|581145637|FG001|Overall Study|Physician Decision|0|||
160931304|NCT02465528|581145638|FG002|Overall Study|Physician Decision|1|||
160931305|NCT02465528|581145639|FG003|Overall Study|Physician Decision|0|||
160931306|NCT05040152|581145642|FG000|Overall Study|Withdrawal by Subject|5|||
160931307|NCT05040152|581145643|FG001|Overall Study|Withdrawal by Subject|0|||
160931308|NCT05040152|581145642|FG000|Overall Study|Lost to Follow-up|0|||
160931309|NCT05040152|581145643|FG001|Overall Study|Lost to Follow-up|2|||
160931310|NCT02704364|581145646|FG000|Overall Study|Adverse Event|1|||
160931311|NCT02704364|581145647|FG001|Overall Study|Adverse Event|1|||
160931312|NCT02704364|581145648|FG002|Overall Study|Adverse Event|0|||
160931313|NCT02704364|581145646|FG000|Overall Study|Noncompliance with study drug|1|||
160931314|NCT02704364|581145647|FG001|Overall Study|Noncompliance with study drug|1|||
160931315|NCT02704364|581145648|FG002|Overall Study|Noncompliance with study drug|0|||
160931316|NCT02704364|581145646|FG000|Overall Study|Other|0|||
160931317|NCT02704364|581145647|FG001|Overall Study|Other|1|||
160931318|NCT02704364|581145648|FG002|Overall Study|Other|1|||
160931319|NCT02086110|581145655|FG000|Overall Study|Withdrawal by Subject|1|||
160931320|NCT02086110|581145656|FG001|Overall Study|Withdrawal by Subject|1|||
160931321|NCT01869192|581145657|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
160931322|NCT01869192|581145658|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
160931323|NCT01869192|581145657|FG000|Postoperative Chemotherapy|Physician Decision|0|||
160931324|NCT01869192|581145658|FG001|Postoperative Chemotherapy|Physician Decision|2|||
160931325|NCT03792672|581145667|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
160931326|NCT03792672|581145668|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
160931327|NCT03792672|581145669|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
160931328|NCT03792672|581145670|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
160931329|NCT03792672|581145671|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
160931330|NCT03792672|581145672|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
160931331|NCT03792672|581145667|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
160931332|NCT03792672|581145668|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
160931333|NCT03792672|581145669|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
160931334|NCT03792672|581145670|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
160931335|NCT03792672|581145671|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
160931336|NCT03792672|581145672|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
160931337|NCT03792672|581145667|FG000|Treatment Period 4 (2 Days)|Other|1|||
160931338|NCT03792672|581145668|FG001|Treatment Period 4 (2 Days)|Other|0|||
160931339|NCT03792672|581145669|FG002|Treatment Period 4 (2 Days)|Other|0|||
160931340|NCT03792672|581145670|FG003|Treatment Period 4 (2 Days)|Other|0|||
160931341|NCT03792672|581145671|FG004|Treatment Period 4 (2 Days)|Other|0|||
160931342|NCT03792672|581145672|FG005|Treatment Period 4 (2 Days)|Other|0|||
160931343|NCT00453999|581145673|FG000|Overall Study|Adverse Event|1|||
160931344|NCT00453999|581145674|FG001|Overall Study|Adverse Event|2|||
160931345|NCT00453999|581145675|FG002|Overall Study|Adverse Event|1|||
160931346|NCT00453999|581145673|FG000|Overall Study|Lost to Follow-up|0|||
160931347|NCT00453999|581145674|FG001|Overall Study|Lost to Follow-up|1|||
160931348|NCT00453999|581145675|FG002|Overall Study|Lost to Follow-up|1|||
160931349|NCT00453999|581145673|FG000|Overall Study|Withdrawal by Subject|2|||
160931350|NCT00453999|581145674|FG001|Overall Study|Withdrawal by Subject|1|||
160931351|NCT00453999|581145675|FG002|Overall Study|Withdrawal by Subject|1|||
160931352|NCT00453999|581145673|FG000|Overall Study|Subject Request|2|||
160931353|NCT00453999|581145674|FG001|Overall Study|Subject Request|1|||
160931354|NCT00453999|581145675|FG002|Overall Study|Subject Request|0|||
160931355|NCT04238728|581145686|FG000|Overall Study|Withdrawal by Subject|1|||
160931356|NCT04238728|581145686|FG000|Overall Study|Lost to Follow-up|2|||
160931357|NCT04225923|581145693|FG000|Overall Study|Protocol Violation|1|||
160931358|NCT04225923|581145694|FG001|Overall Study|Protocol Violation|0|||
160931359|NCT04225923|581145695|FG002|Overall Study|Protocol Violation|1|||
160931360|NCT04225923|581145693|FG000|Overall Study|Withdrawal by Subject|4|||
160931361|NCT04225923|581145694|FG001|Overall Study|Withdrawal by Subject|1|||
160931362|NCT04225923|581145695|FG002|Overall Study|Withdrawal by Subject|3|||
160931363|NCT04225923|581145693|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
160931364|NCT04225923|581145694|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
160931365|NCT04225923|581145695|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
160931366|NCT01907828|581145701|FG000|Overall Study|Exclusion criteria not met|0|||
160998150|NCT01563354|581378572|FG002|Extension Phase|Withdrawal by Subject|0|||
160998151|NCT01563354|581378570|FG000|Extension Phase|Administration problems|3|||
160998152|NCT01563354|581378571|FG001|Extension Phase|Administration problems|2|||
160931367|NCT01907828|581145702|FG001|Overall Study|Exclusion criteria not met|1|||
160931368|NCT01907828|581145701|FG000|Overall Study|Withdrawal by Subject|3|||
160931369|NCT01907828|581145702|FG001|Overall Study|Withdrawal by Subject|4|||
160931370|NCT01907828|581145701|FG000|Overall Study|Lost to Follow-up|3|||
160931371|NCT01907828|581145702|FG001|Overall Study|Lost to Follow-up|0|||
160931372|NCT01907828|581145701|FG000|Overall Study|Participant refused 24-month follow-up|1|||
160931373|NCT01907828|581145702|FG001|Overall Study|Participant refused 24-month follow-up|0|||
160931374|NCT01907828|581145701|FG000|Overall Study|Participant met exclusion criteria|0|||
160931375|NCT01907828|581145702|FG001|Overall Study|Participant met exclusion criteria|1|||
160931376|NCT01585766|581145703|FG000|Overall Study|Withdrawal by Subject|0|||
160931377|NCT01585766|581145704|FG001|Overall Study|Withdrawal by Subject|1|||
160931378|NCT01585766|581145705|FG002|Overall Study|Withdrawal by Subject|1|||
160931379|NCT01585766|581145706|FG003|Overall Study|Withdrawal by Subject|0|||
160931380|NCT01585766|581145707|FG004|Overall Study|Withdrawal by Subject|0|||
160931381|NCT01585766|581145708|FG005|Overall Study|Withdrawal by Subject|0|||
160931382|NCT01585766|581145703|FG000|Overall Study|Death|0|||
160931383|NCT01585766|581145704|FG001|Overall Study|Death|1|||
160931384|NCT01585766|581145705|FG002|Overall Study|Death|0|||
160931385|NCT01585766|581145706|FG003|Overall Study|Death|0|||
160931386|NCT01585766|581145707|FG004|Overall Study|Death|0|||
160931387|NCT01585766|581145708|FG005|Overall Study|Death|0|||
160931388|NCT01585766|581145703|FG000|Overall Study|Physician Decision|0|||
160931389|NCT01585766|581145704|FG001|Overall Study|Physician Decision|0|||
160931390|NCT01585766|581145705|FG002|Overall Study|Physician Decision|1|||
160931391|NCT01585766|581145706|FG003|Overall Study|Physician Decision|0|||
160931392|NCT01585766|581145707|FG004|Overall Study|Physician Decision|0|||
160931393|NCT01585766|581145708|FG005|Overall Study|Physician Decision|0|||
160931394|NCT01364428|581145709|FG000|Overall Study|Adverse Event|1|||
160931395|NCT01364428|581145710|FG001|Overall Study|Adverse Event|2|||
160931396|NCT01364428|581145709|FG000|Overall Study|Protocol Violation|2|||
160931397|NCT01364428|581145710|FG001|Overall Study|Protocol Violation|0|||
160931398|NCT01364428|581145709|FG000|Overall Study|Withdrawal Criteria|14|||
160931399|NCT01364428|581145710|FG001|Overall Study|Withdrawal Criteria|10|||
160931400|NCT01364428|581145709|FG000|Overall Study|Other|3|||
160931401|NCT01364428|581145710|FG001|Overall Study|Other|3|||
160931402|NCT03925324|581145711|FG000|Overall Study|Death|1|||
160931403|NCT03925324|581145712|FG001|Overall Study|Death|1|||
160931404|NCT04414553|581145713|FG000|Overall Study|Lost to Follow-up|20|||
160931405|NCT00775437|581145729|FG000|Overall Study|Loss of efficacy|2|||
160931406|NCT00775437|581145729|FG000|Overall Study|Withdrawal by Subject|3|||
160931407|NCT00775437|581145729|FG000|Overall Study|Lost to Follow-up|1|||
160931408|NCT04180020|581145734|FG000|Overall Study|missed visit|18|||
160931409|NCT04180020|581145735|FG001|Overall Study|missed visit|16|||
160931410|NCT04180020|581145734|FG000|Overall Study|Death|2|||
160931411|NCT04180020|581145735|FG001|Overall Study|Death|3|||
160931412|NCT04180020|581145734|FG000|Overall Study|Withdrawal by Subject|1|||
160931413|NCT04180020|581145735|FG001|Overall Study|Withdrawal by Subject|5|||
160931414|NCT04180020|581145734|FG000|Overall Study|incarcerated|1|||
160931415|NCT04180020|581145735|FG001|Overall Study|incarcerated|1|||
160931416|NCT04180020|581145734|FG000|Overall Study|Physician Decision|0|||
160931417|NCT04180020|581145735|FG001|Overall Study|Physician Decision|2|||
160931418|NCT03554291|581145736|FG000|Overall Study|Death|2|||
160931419|NCT03554291|581145737|FG001|Overall Study|Death|1|||
160931420|NCT03554291|581145736|FG000|Overall Study|Lost to Follow-up|1|||
160931421|NCT03554291|581145737|FG001|Overall Study|Lost to Follow-up|0|||
160931422|NCT03554291|581145736|FG000|Overall Study|Withdrawal by Subject|1|||
160931423|NCT03554291|581145737|FG001|Overall Study|Withdrawal by Subject|0|||
160931424|NCT03554291|581145736|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
160931425|NCT03554291|581145737|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
160931426|NCT04251221|581145743|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
160931427|NCT04251221|581145744|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
160931428|NCT02120794|581145745|FG000|Overall Study|Withdrawal by Subject|43|||
160931429|NCT02120794|581145745|FG000|Overall Study|Adverse Event|10|||
160931430|NCT02120794|581145745|FG000|Overall Study|Physician Decision|4|||
160931431|NCT02120794|581145745|FG000|Overall Study|Due to insurance coverage|1|||
160931432|NCT01148511|581145747|FG000|Exposed to Study Drug|Protocol Violation|2|||
160931433|NCT01148511|581145748|FG001|Exposed to Study Drug|Protocol Violation|0|||
160931434|NCT01148511|581145749|FG002|Exposed to Study Drug|Protocol Violation|0|||
160931435|NCT01148511|581145747|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
160931436|NCT01148511|581145748|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
160931437|NCT01148511|581145749|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
160931438|NCT01148511|581145747|FG000|Randomized|Adverse Event|0|||
160931439|NCT01148511|581145748|FG001|Randomized|Adverse Event|1|||
160931440|NCT01148511|581145749|FG002|Randomized|Adverse Event|0|||
160931441|NCT01148511|581145747|FG000|Randomized|Protocol Violation|0|||
160931442|NCT01148511|581145748|FG001|Randomized|Protocol Violation|2|||
160931443|NCT01148511|581145749|FG002|Randomized|Protocol Violation|1|||
160931444|NCT01148511|581145747|FG000|Randomized|Lost to Follow-up|0|||
160931445|NCT01148511|581145748|FG001|Randomized|Lost to Follow-up|1|||
160931446|NCT01148511|581145749|FG002|Randomized|Lost to Follow-up|1|||
160931447|NCT01148511|581145747|FG000|Randomized|Consent withdrawal|0|||
160931448|NCT01148511|581145748|FG001|Randomized|Consent withdrawal|5|||
160931449|NCT01148511|581145749|FG002|Randomized|Consent withdrawal|3|||
160931450|NCT01148511|581145747|FG000|Randomized|Other|0|||
160455080|NCT05485779|579397829|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
160931451|NCT01148511|581145748|FG001|Randomized|Other|1|||
160931452|NCT01148511|581145749|FG002|Randomized|Other|1|||
160931453|NCT04258605|581145751|FG000|Overall Study|Death|1|||
160931454|NCT04258605|581145752|FG001|Overall Study|Death|0|||
160931455|NCT04258605|581145751|FG000|Overall Study|Early study termination|21|||
160931456|NCT04258605|581145752|FG001|Overall Study|Early study termination|2|||
160931457|NCT00842348|581145758|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
160931458|NCT00842348|581145759|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
160931459|NCT00842348|581145758|FG000|Study 729|Disease progression/death|19|||
160931460|NCT00842348|581145759|FG001|Study 729|Disease progression/death|30|||
160931461|NCT00842348|581145758|FG000|Study 729|Adverse Event|1|||
160931462|NCT00842348|581145759|FG001|Study 729|Adverse Event|1|||
160931463|NCT00842348|581145758|FG000|Study 729|Protocol Violation|1|||
160931464|NCT00842348|581145759|FG001|Study 729|Protocol Violation|1|||
160931465|NCT00842348|581145758|FG000|Study 729|Withdrawal by Subject|2|||
160931466|NCT00842348|581145759|FG001|Study 729|Withdrawal by Subject|4|||
160931467|NCT00842348|581145758|FG000|Study 729|Due to Sponsor stopping the study|1|||
160931468|NCT00842348|581145759|FG001|Study 729|Due to Sponsor stopping the study|1|||
160931469|NCT00842348|581145758|FG000|Study 729|Due to non-availability of IP|0|||
160931470|NCT00842348|581145759|FG001|Study 729|Due to non-availability of IP|1|||
160931471|NCT00842348|581145758|FG000|Study 729|Sponsor's decision|1|||
160931472|NCT00842348|581145759|FG001|Study 729|Sponsor's decision|0|||
160931473|NCT00842348|581145758|FG000|Study 729|Surgical resection|1|||
160931474|NCT00842348|581145759|FG001|Study 729|Surgical resection|0|||
160931475|NCT00026793|581145764|FG000|Overall Study|Death on study due to underlying disease|4|||
160931476|NCT00026793|581145764|FG000|Overall Study|Physician Decision|2|||
160931477|NCT00026793|581145764|FG000|Overall Study|Off study|2|||
160931478|NCT01449526|581145765|FG000|Overall Study|Lost to Follow-up|1|||
160931479|NCT01449526|581145766|FG001|Overall Study|Lost to Follow-up|2|||
160931480|NCT01449526|581145765|FG000|Overall Study|Withdrawal by Subject|1|||
160931481|NCT01449526|581145766|FG001|Overall Study|Withdrawal by Subject|1|||
160931482|NCT01449526|581145765|FG000|Overall Study|Symptoms/complaints|0|||
160931483|NCT01449526|581145766|FG001|Overall Study|Symptoms/complaints|1|||
160931484|NCT01449526|581145765|FG000|Overall Study|Lack of Motivation|0|||
160931485|NCT01449526|581145766|FG001|Overall Study|Lack of Motivation|1|||
160931486|NCT01449526|581145765|FG000|Overall Study|Cannot maintain visits|0|||
160931487|NCT01449526|581145766|FG001|Overall Study|Cannot maintain visits|1|||
160931488|NCT01132495|581145767|FG000|Overall Study|Various reasons|40|||
160931489|NCT01132495|581145768|FG001|Overall Study|Various reasons|38|||
160931490|NCT01132495|581145769|FG002|Overall Study|Various reasons|20|||
160931491|NCT01132495|581145770|FG003|Overall Study|Various reasons|12|||
160931492|NCT03913091|581145771|FG000|Overall Study|Lost to Follow-up|18|||
160931493|NCT03913091|581145772|FG001|Overall Study|Lost to Follow-up|11|||
160931494|NCT03913091|581145771|FG000|Overall Study|Required additional meds/surgery|1|||
160931495|NCT03913091|581145772|FG001|Overall Study|Required additional meds/surgery|2|||
160931496|NCT03913091|581145771|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
160931497|NCT03913091|581145772|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
160931498|NCT00969553|581145773|FG000|Overall Study|Progressive disease (PD)|2|||
160931499|NCT00969553|581145774|FG001|Overall Study|Progressive disease (PD)|2|||
160931500|NCT00969553|581145775|FG002|Overall Study|Progressive disease (PD)|6|||
160931501|NCT00969553|581145776|FG003|Overall Study|Progressive disease (PD)|9|||
160931502|NCT00969553|581145777|FG004|Overall Study|Progressive disease (PD)|2|||
160931503|NCT00969553|581145778|FG005|Overall Study|Progressive disease (PD)|4|||
160931504|NCT00969553|581145779|FG006|Overall Study|Progressive disease (PD)|2|||
160931505|NCT00969553|581145780|FG007|Overall Study|Progressive disease (PD)|12|||
160931506|NCT00969553|581145781|FG008|Overall Study|Progressive disease (PD)|3|||
160931507|NCT00969553|581145773|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931508|NCT00969553|581145774|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931509|NCT00969553|581145775|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931510|NCT00969553|581145776|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931511|NCT00969553|581145777|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
160931512|NCT00969553|581145778|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931513|NCT00969553|581145779|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931514|NCT00969553|581145780|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931515|NCT00969553|581145781|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931516|NCT00969553|581145773|FG000|Overall Study|Other Adverse Event|0|||
160931517|NCT00969553|581145774|FG001|Overall Study|Other Adverse Event|0|||
160931518|NCT00969553|581145775|FG002|Overall Study|Other Adverse Event|0|||
160578231|NCT01070550|579838294|FG000|Overall Study|Early termination|3|||
160578232|NCT01070550|579838295|FG001|Overall Study|Early termination|0|||
160931519|NCT00969553|581145776|FG003|Overall Study|Other Adverse Event|1|||
160931520|NCT00969553|581145777|FG004|Overall Study|Other Adverse Event|0|||
160931521|NCT00969553|581145778|FG005|Overall Study|Other Adverse Event|0|||
160931522|NCT00969553|581145779|FG006|Overall Study|Other Adverse Event|1|||
160931523|NCT00969553|581145780|FG007|Overall Study|Other Adverse Event|0|||
160931524|NCT00969553|581145781|FG008|Overall Study|Other Adverse Event|0|||
160931525|NCT00969553|581145773|FG000|Overall Study|Refused cont. medication|1|||
160931526|NCT00969553|581145774|FG001|Overall Study|Refused cont. medication|1|||
160578233|NCT01070550|579838296|FG002|Overall Study|Early termination|0|||
160931527|NCT00969553|581145775|FG002|Overall Study|Refused cont. medication|0|||
160931528|NCT00969553|581145776|FG003|Overall Study|Refused cont. medication|2|||
160931529|NCT00969553|581145777|FG004|Overall Study|Refused cont. medication|0|||
160931530|NCT00969553|581145778|FG005|Overall Study|Refused cont. medication|0|||
160931531|NCT00969553|581145779|FG006|Overall Study|Refused cont. medication|0|||
160931532|NCT00969553|581145780|FG007|Overall Study|Refused cont. medication|1|||
160931533|NCT00969553|581145781|FG008|Overall Study|Refused cont. medication|0|||
160931534|NCT00969553|581145773|FG000|Overall Study|Not specified above|0|||
160931535|NCT00969553|581145774|FG001|Overall Study|Not specified above|0|||
160931536|NCT00969553|581145775|FG002|Overall Study|Not specified above|0|||
160931537|NCT00969553|581145776|FG003|Overall Study|Not specified above|4|||
160931538|NCT00969553|581145777|FG004|Overall Study|Not specified above|0|||
160931539|NCT00969553|581145778|FG005|Overall Study|Not specified above|0|||
160931540|NCT00969553|581145779|FG006|Overall Study|Not specified above|1|||
160931541|NCT00969553|581145780|FG007|Overall Study|Not specified above|1|||
160931542|NCT00969553|581145781|FG008|Overall Study|Not specified above|0|||
160931543|NCT04243538|581145782|FG000|Overall Study|Withdrawal by Subject|0|||
160931544|NCT04243538|581145783|FG001|Overall Study|Withdrawal by Subject|2|||
160931545|NCT04243538|581145782|FG000|Overall Study|Lost to Follow-up|0|||
160931546|NCT04243538|581145783|FG001|Overall Study|Lost to Follow-up|3|||
160931547|NCT00655564|581145784|FG000|Overall Study|Adverse Event|1|||
160931548|NCT00655564|581145784|FG000|Overall Study|Lost to Follow-up|1|||
160931549|NCT00655564|581145784|FG000|Overall Study|Desired Alternate Therapy|1|||
160578234|NCT01070550|579838297|FG003|Overall Study|Early termination|0|||
160578235|NCT01070550|579838298|FG004|Overall Study|Early termination|0|||
160578236|NCT01070550|579838299|FG005|Overall Study|Early termination|0|||
160578237|NCT01070550|579838294|FG000|Overall Study|Failed to return|450|||
160931550|NCT04536727|581145785|FG000|Overall Study|Lost to Follow-up|1|||
160931551|NCT04536727|581145786|FG001|Overall Study|Lost to Follow-up|1|||
160931552|NCT04536727|581145785|FG000|Overall Study|Death|0|||
160931553|NCT04536727|581145786|FG001|Overall Study|Death|1|||
160931554|NCT00500370|581145787|FG000|Overall Study|Adverse Event|9|||
160931555|NCT00500370|581145788|FG001|Overall Study|Adverse Event|3|||
160931556|NCT00500370|581145787|FG000|Overall Study|Lost to Follow-up|10|||
160931557|NCT00500370|581145788|FG001|Overall Study|Lost to Follow-up|10|||
160931558|NCT00500370|581145787|FG000|Overall Study|Protocol Violation|2|||
160931559|NCT00500370|581145788|FG001|Overall Study|Protocol Violation|4|||
160931560|NCT00500370|581145787|FG000|Overall Study|Sponsor Decision|2|||
160931561|NCT00500370|581145788|FG001|Overall Study|Sponsor Decision|0|||
160931562|NCT00500370|581145787|FG000|Overall Study|Subject Decision|10|||
160931563|NCT00500370|581145788|FG001|Overall Study|Subject Decision|17|||
160931564|NCT05308901|581147753|FG000|Overall Study|Death|6|||
160931565|NCT02586012|581147754|FG000|Overall Study|Withdrawal by Subject|1|||
160931566|NCT02586012|581147755|FG001|Overall Study|Withdrawal by Subject|1|||
160931567|NCT02586012|581147756|FG002|Overall Study|Withdrawal by Subject|0|||
160931568|NCT02586012|581147757|FG003|Overall Study|Withdrawal by Subject|1|||
160931569|NCT02586012|581147758|FG004|Overall Study|Withdrawal by Subject|0|||
160931570|NCT02586012|581147759|FG005|Overall Study|Withdrawal by Subject|2|||
160931571|NCT02586012|581147754|FG000|Overall Study|Protocol Violation|0|||
160931572|NCT02586012|581147755|FG001|Overall Study|Protocol Violation|0|||
160931573|NCT02586012|581147756|FG002|Overall Study|Protocol Violation|0|||
160931574|NCT02586012|581147757|FG003|Overall Study|Protocol Violation|0|||
160931575|NCT02586012|581147758|FG004|Overall Study|Protocol Violation|0|||
160931576|NCT02586012|581147759|FG005|Overall Study|Protocol Violation|1|||
160931577|NCT02586012|581147754|FG000|Overall Study|study terminated|0|||
160931578|NCT02586012|581147755|FG001|Overall Study|study terminated|2|||
160931579|NCT02586012|581147756|FG002|Overall Study|study terminated|1|||
160931580|NCT02586012|581147757|FG003|Overall Study|study terminated|1|||
160931581|NCT02586012|581147758|FG004|Overall Study|study terminated|1|||
160931582|NCT02586012|581147759|FG005|Overall Study|study terminated|0|||
160931583|NCT01888497|581147760|FG000|Washout Period 1|Withdrawal by Subject|0|||
160578238|NCT01070550|579838295|FG001|Overall Study|Failed to return|33|||
160578239|NCT01070550|579838296|FG002|Overall Study|Failed to return|144|||
160931584|NCT01888497|581147761|FG001|Washout Period 1|Withdrawal by Subject|0|||
160931585|NCT01888497|581147762|FG002|Washout Period 1|Withdrawal by Subject|1|||
160931586|NCT01888497|581147763|FG003|Washout Period 1|Withdrawal by Subject|1|||
160931587|NCT01888497|581147760|FG000|Washout Period 2|Adverse Event|0|||
160931588|NCT01888497|581147761|FG001|Washout Period 2|Adverse Event|0|||
160931589|NCT01888497|581147762|FG002|Washout Period 2|Adverse Event|0|||
160931590|NCT01888497|581147763|FG003|Washout Period 2|Adverse Event|1|||
160931591|NCT01888497|581147760|FG000|Washout Period 2|Withdrawal by Subject|0|||
160931592|NCT01888497|581147761|FG001|Washout Period 2|Withdrawal by Subject|0|||
160931593|NCT01888497|581147762|FG002|Washout Period 2|Withdrawal by Subject|0|||
160931594|NCT01888497|581147763|FG003|Washout Period 2|Withdrawal by Subject|1|||
160931595|NCT01140477|581147766|FG000|Overall Study|Lost to Follow-up|4|||
160578240|NCT01070550|579838297|FG003|Overall Study|Failed to return|40|||
160931596|NCT01140477|581147767|FG001|Overall Study|Lost to Follow-up|0|||
160931597|NCT01140477|581147766|FG000|Overall Study|Withdrawal by Subject|1|||
160931598|NCT01140477|581147767|FG001|Overall Study|Withdrawal by Subject|4|||
160931599|NCT01140477|581147766|FG000|Overall Study|Surgical complication preventing implant|2|||
160931600|NCT01140477|581147767|FG001|Overall Study|Surgical complication preventing implant|0|||
160931601|NCT01140477|581147766|FG000|Overall Study|Death|1|||
160931602|NCT01140477|581147767|FG001|Overall Study|Death|1|||
160931603|NCT01140477|581147766|FG000|Overall Study|Subject explanted|0|||
160931604|NCT01140477|581147767|FG001|Overall Study|Subject explanted|1|||
160931605|NCT04013191|581147768|FG000|Overall Study|Adverse Event|1|||
160931606|NCT04013191|581147769|FG001|Overall Study|Adverse Event|0|||
160931607|NCT04127786|581147782|FG000|Primary Series|Adverse Event|1|||
160931608|NCT04127786|581147783|FG001|Primary Series|Adverse Event|0|||
160931609|NCT04127786|581147784|FG002|Primary Series|Adverse Event|0|||
160931610|NCT04127786|581147785|FG003|Primary Series|Adverse Event|1|||
160931611|NCT04127786|581147786|FG004|Primary Series|Adverse Event|0|||
160931612|NCT04127786|581147787|FG005|Primary Series|Adverse Event|1|||
160931613|NCT04127786|581147782|FG000|Primary Series|Protocol Violation|5|||
160931614|NCT04127786|581147783|FG001|Primary Series|Protocol Violation|3|||
160931615|NCT04127786|581147784|FG002|Primary Series|Protocol Violation|4|||
160931616|NCT04127786|581147785|FG003|Primary Series|Protocol Violation|3|||
160931617|NCT04127786|581147786|FG004|Primary Series|Protocol Violation|2|||
160931618|NCT04127786|581147787|FG005|Primary Series|Protocol Violation|0|||
160931619|NCT04127786|581147782|FG000|Primary Series|Withdrawal by Subject|0|||
160931620|NCT04127786|581147783|FG001|Primary Series|Withdrawal by Subject|0|||
160931621|NCT04127786|581147784|FG002|Primary Series|Withdrawal by Subject|0|||
160931622|NCT04127786|581147785|FG003|Primary Series|Withdrawal by Subject|1|||
160931623|NCT04127786|581147786|FG004|Primary Series|Withdrawal by Subject|0|||
160931624|NCT04127786|581147787|FG005|Primary Series|Withdrawal by Subject|0|||
160931625|NCT04127786|581147782|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
160931626|NCT04127786|581147783|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
160931627|NCT04127786|581147784|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
160931628|NCT04127786|581147785|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
160931629|NCT04127786|581147786|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
160931630|NCT04127786|581147787|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
160931631|NCT04127786|581147782|FG000|Booster Phase|Withdrawal by Subject|2|||
160931632|NCT04127786|581147783|FG001|Booster Phase|Withdrawal by Subject|0|||
160931633|NCT04127786|581147784|FG002|Booster Phase|Withdrawal by Subject|0|||
160931634|NCT04127786|581147785|FG003|Booster Phase|Withdrawal by Subject|0|||
160931635|NCT04127786|581147786|FG004|Booster Phase|Withdrawal by Subject|0|||
160931636|NCT04127786|581147787|FG005|Booster Phase|Withdrawal by Subject|0|||
160931637|NCT01904604|581147788|FG000|Overall Study|Withdrew before receiving dosing|0|||
160931638|NCT01904604|581147789|FG001|Overall Study|Withdrew before receiving dosing|1|||
160931639|NCT01904604|581147790|FG002|Overall Study|Withdrew before receiving dosing|0|||
160931640|NCT01904604|581147788|FG000|Overall Study|Non-compliance|1|||
160931641|NCT01904604|581147789|FG001|Overall Study|Non-compliance|0|||
160931642|NCT01904604|581147790|FG002|Overall Study|Non-compliance|0|||
160931643|NCT01904604|581147788|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
160931644|NCT01904604|581147789|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
160931645|NCT01904604|581147790|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
160931646|NCT01904604|581147788|FG000|Overall Study|Patch site reactions|1|||
160931647|NCT01904604|581147789|FG001|Overall Study|Patch site reactions|1|||
160931648|NCT01904604|581147790|FG002|Overall Study|Patch site reactions|0|||
160931649|NCT01904604|581147788|FG000|Overall Study|Increased syncope|0|||
160931650|NCT01904604|581147789|FG001|Overall Study|Increased syncope|1|||
160931651|NCT01904604|581147790|FG002|Overall Study|Increased syncope|0|||
160931652|NCT01904604|581147788|FG000|Overall Study|Unrelated illness|0|||
160931653|NCT01904604|581147789|FG001|Overall Study|Unrelated illness|1|||
160931654|NCT01904604|581147790|FG002|Overall Study|Unrelated illness|0|||
160931655|NCT01904604|581147788|FG000|Overall Study|Passed Week 52 OFC|1|||
160931656|NCT01904604|581147789|FG001|Overall Study|Passed Week 52 OFC|0|||
160931657|NCT01904604|581147790|FG002|Overall Study|Passed Week 52 OFC|0|||
160931658|NCT01904604|581147788|FG000|Overall Study|Withdrawal by Subject|1|||
160998153|NCT01563354|581378572|FG002|Extension Phase|Administration problems|3|||
160931659|NCT01904604|581147789|FG001|Overall Study|Withdrawal by Subject|2|||
160931660|NCT01904604|581147790|FG002|Overall Study|Withdrawal by Subject|0|||
160931661|NCT01904604|581147788|FG000|Overall Study|Participant Relocated|1|||
160931662|NCT01904604|581147789|FG001|Overall Study|Participant Relocated|1|||
160931663|NCT01904604|581147790|FG002|Overall Study|Participant Relocated|1|||
160998154|NCT01563354|581378570|FG000|Extension Phase|Disease progression|9|||
160998155|NCT01563354|581378571|FG001|Extension Phase|Disease progression|8|||
160998156|NCT01563354|581378572|FG002|Extension Phase|Disease progression|10|||
160998157|NCT01050569|581378586|FG000|Overall Study|Lost to Follow-up|20|||
160455081|NCT05485779|579397830|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
160931664|NCT01904604|581147788|FG000|Overall Study|Lost to Follow-up|0|||
160931665|NCT01904604|581147789|FG001|Overall Study|Lost to Follow-up|0|||
160931666|NCT01904604|581147790|FG002|Overall Study|Lost to Follow-up|1|||
160931667|NCT00394212|581147796|FG000|Overall Study|Lost to Follow-up|3|||
160931668|NCT00394212|581147797|FG001|Overall Study|Lost to Follow-up|0|||
160931669|NCT00394212|581147796|FG000|Overall Study|Withdrawal by Subject|4|||
160931670|NCT00394212|581147797|FG001|Overall Study|Withdrawal by Subject|1|||
160931671|NCT00588445|581147798|FG000|Overall Study|Protocol Violation|1|||
160931672|NCT00588445|581147798|FG000|Overall Study|Withdrawal by Subject|3|||
160931673|NCT00588445|581147798|FG000|Overall Study|Disease Progression|1|||
160931674|NCT00588445|581147798|FG000|Overall Study|Not Treated|10|||
160931675|NCT00358527|581147799|FG000|Overall Study|Adverse Event|4|||
160931676|NCT00358527|581147800|FG001|Overall Study|Adverse Event|0|||
160931677|NCT00358527|581147799|FG000|Overall Study|Withdrawal by Subject|1|||
160931678|NCT00358527|581147800|FG001|Overall Study|Withdrawal by Subject|1|||
160931679|NCT00358527|581147799|FG000|Overall Study|Non-compliance with protocol|6|||
160931680|NCT00358527|581147800|FG001|Overall Study|Non-compliance with protocol|1|||
160931681|NCT00358527|581147799|FG000|Overall Study|Administrative|2|||
160998158|NCT01050569|581378587|FG001|Overall Study|Lost to Follow-up|14|||
160998159|NCT01050569|581378588|FG002|Overall Study|Lost to Follow-up|16|||
160998160|NCT01050569|581378586|FG000|Overall Study|Withdrawal by Subject|9|||
160998161|NCT01050569|581378587|FG001|Overall Study|Withdrawal by Subject|3|||
160998162|NCT01050569|581378588|FG002|Overall Study|Withdrawal by Subject|11|||
160998163|NCT01050569|581378586|FG000|Overall Study|Lack of Efficacy|5|||
160998164|NCT01050569|581378587|FG001|Overall Study|Lack of Efficacy|4|||
160998165|NCT01050569|581378588|FG002|Overall Study|Lack of Efficacy|3|||
160998166|NCT01050569|581378586|FG000|Overall Study|Adverse Event|1|||
160998167|NCT01050569|581378587|FG001|Overall Study|Adverse Event|0|||
160998168|NCT01050569|581378588|FG002|Overall Study|Adverse Event|0|||
160998169|NCT01050569|581378586|FG000|Overall Study|Physician Decision|3|||
160998170|NCT01050569|581378587|FG001|Overall Study|Physician Decision|3|||
160998171|NCT01050569|581378588|FG002|Overall Study|Physician Decision|3|||
160998172|NCT03525119|581378589|FG000|Overall Study|Adverse Event|0|||
160998173|NCT03525119|581378590|FG001|Overall Study|Adverse Event|1|||
160998174|NCT03525119|581378591|FG002|Overall Study|Adverse Event|0|||
160998175|NCT03525119|581378589|FG000|Overall Study|Lost to Follow-up|32|||
160998176|NCT03525119|581378590|FG001|Overall Study|Lost to Follow-up|33|||
160998177|NCT03525119|581378591|FG002|Overall Study|Lost to Follow-up|37|||
160998178|NCT03525119|581378589|FG000|Overall Study|Withdrawal by Subject|5|||
160998179|NCT03525119|581378590|FG001|Overall Study|Withdrawal by Subject|4|||
160998180|NCT03525119|581378591|FG002|Overall Study|Withdrawal by Subject|2|||
160998181|NCT03525119|581378589|FG000|Overall Study|Reason not Specified|2|||
160998182|NCT03525119|581378590|FG001|Overall Study|Reason not Specified|1|||
160998183|NCT03525119|581378591|FG002|Overall Study|Reason not Specified|2|||
160998184|NCT03525119|581378589|FG000|Overall Study|Randomized but not Vaccinated|1|||
160998185|NCT03525119|581378590|FG001|Overall Study|Randomized but not Vaccinated|0|||
160998186|NCT03525119|581378591|FG002|Overall Study|Randomized but not Vaccinated|2|||
160998187|NCT03781336|581378592|FG000|Overall Study|Withdrawal by Subject|2|||
160998188|NCT03781336|581378593|FG001|Overall Study|Withdrawal by Subject|2|||
160998189|NCT01490580|581378594|FG000|Overall Study|Parents withdrew consent|0|||
160998190|NCT01490580|581378595|FG001|Overall Study|Parents withdrew consent|2|||
160998191|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
160998192|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
160998193|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
160998194|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
160998195|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
160998196|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
160998197|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
160998198|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
160998199|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
160998200|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
160998201|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
160998202|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
160998203|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Death|7|||
160998204|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Death|4|||
160998205|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
160578241|NCT01070550|579838298|FG004|Overall Study|Failed to return|1|||
160578242|NCT01070550|579838299|FG005|Overall Study|Failed to return|2|||
160578243|NCT01070550|579838294|FG000|Overall Study|Incomplete treatment|2|||
160578244|NCT01070550|579838295|FG001|Overall Study|Incomplete treatment|0|||
160931682|NCT00358527|581147800|FG001|Overall Study|Administrative|1|||
160998206|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
160998207|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
160998208|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
160998209|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
160998210|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
160998211|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
160998212|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
160578245|NCT01070550|579838296|FG002|Overall Study|Incomplete treatment|0|||
160578246|NCT01070550|579838297|FG003|Overall Study|Incomplete treatment|0|||
160931683|NCT04144166|581147803|FG000|Overall Study|Discharged before study start|1|||
160655911|NCT05630547|580120296|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
160655912|NCT05630547|580120297|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
160655913|NCT05630547|580120294|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
160931684|NCT04144166|581147803|FG000|Overall Study|Pregnancy|1|||
160931685|NCT04144166|581147803|FG000|Overall Study|Nail polish could not be removed from finger|1|||
160931686|NCT00697346|581147804|FG000|Overall Study|Adverse Event|4|||
160931687|NCT00697346|581147805|FG001|Overall Study|Adverse Event|5|||
160931688|NCT00697346|581147806|FG002|Overall Study|Adverse Event|0|||
160931689|NCT00697346|581147804|FG000|Overall Study|Progressive Disease|19|||
160931690|NCT00697346|581147805|FG001|Overall Study|Progressive Disease|18|||
160931691|NCT00697346|581147806|FG002|Overall Study|Progressive Disease|0|||
160931692|NCT00697346|581147804|FG000|Overall Study|Symptomatic Deterioration|0|||
160931693|NCT00697346|581147805|FG001|Overall Study|Symptomatic Deterioration|1|||
160931694|NCT00697346|581147806|FG002|Overall Study|Symptomatic Deterioration|0|||
160931695|NCT00697346|581147804|FG000|Overall Study|Withdrawal by Subject|2|||
160931696|NCT00697346|581147805|FG001|Overall Study|Withdrawal by Subject|2|||
160931697|NCT00697346|581147806|FG002|Overall Study|Withdrawal by Subject|0|||
160931698|NCT00697346|581147804|FG000|Overall Study|Reason not Specified|3|||
160931699|NCT00697346|581147805|FG001|Overall Study|Reason not Specified|0|||
160931700|NCT00697346|581147806|FG002|Overall Study|Reason not Specified|1|||
160931701|NCT03569371|581147807|FG000|Overall Study|Lack of Efficacy|1|||
160931702|NCT03569371|581147807|FG000|Overall Study|Lost to Follow-up|1|||
160931703|NCT03569371|581147807|FG000|Overall Study|Adverse Event|1|||
160931704|NCT03643562|581147808|FG000|Overall Study|Adverse Event|1|||
160931705|NCT03643562|581147809|FG001|Overall Study|Adverse Event|0|||
160931706|NCT03643562|581147808|FG000|Overall Study|Lack of Efficacy|0|||
160931707|NCT03643562|581147809|FG001|Overall Study|Lack of Efficacy|1|||
160931708|NCT03643562|581147808|FG000|Overall Study|Physician Decision|0|||
160931709|NCT03643562|581147809|FG001|Overall Study|Physician Decision|1|||
160931710|NCT03643562|581147808|FG000|Overall Study|Study Terminated by Sponsor|2|||
160931711|NCT03643562|581147809|FG001|Overall Study|Study Terminated by Sponsor|10|||
160931712|NCT03643562|581147808|FG000|Overall Study|Withdrawal by Subject|2|||
160931713|NCT03643562|581147809|FG001|Overall Study|Withdrawal by Subject|2|||
160931714|NCT03643562|581147808|FG000|Overall Study|Other than specified|3|||
160931715|NCT03643562|581147809|FG001|Overall Study|Other than specified|2|||
160931716|NCT01236755|581147811|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
160931717|NCT01236755|581147811|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
160931718|NCT01236755|581147811|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
160931719|NCT01236755|581147811|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
160931720|NCT01481116|581147812|FG000|Overall Study|Adverse Event|26|||
160931721|NCT01481116|581147813|FG001|Overall Study|Adverse Event|26|||
160931722|NCT01481116|581147814|FG002|Overall Study|Adverse Event|42|||
160931723|NCT01481116|581147812|FG000|Overall Study|Major Protocol Deviation|3|||
160931724|NCT01481116|581147813|FG001|Overall Study|Major Protocol Deviation|7|||
160931725|NCT01481116|581147814|FG002|Overall Study|Major Protocol Deviation|1|||
160931726|NCT01481116|581147812|FG000|Overall Study|Lost to Follow-up|8|||
160931727|NCT01481116|581147813|FG001|Overall Study|Lost to Follow-up|12|||
160931728|NCT01481116|581147814|FG002|Overall Study|Lost to Follow-up|11|||
160931729|NCT01481116|581147812|FG000|Overall Study|Withdrawal by Subject|37|||
160931730|NCT01481116|581147813|FG001|Overall Study|Withdrawal by Subject|33|||
160931731|NCT01481116|581147814|FG002|Overall Study|Withdrawal by Subject|37|||
160931732|NCT01481116|581147812|FG000|Overall Study|Study Termination|730|||
160931733|NCT01481116|581147813|FG001|Overall Study|Study Termination|729|||
160931734|NCT01481116|581147814|FG002|Overall Study|Study Termination|713|||
160931735|NCT01481116|581147812|FG000|Overall Study|Pregnancy|0|||
160931736|NCT01481116|581147813|FG001|Overall Study|Pregnancy|0|||
160931737|NCT01481116|581147814|FG002|Overall Study|Pregnancy|1|||
160931738|NCT01481116|581147812|FG000|Overall Study|Lack of Efficacy|3|||
160931739|NCT01481116|581147813|FG001|Overall Study|Lack of Efficacy|3|||
160931740|NCT01481116|581147814|FG002|Overall Study|Lack of Efficacy|1|||
160931741|NCT01481116|581147812|FG000|Overall Study|Contraindications|1|||
160931742|NCT01481116|581147813|FG001|Overall Study|Contraindications|1|||
160998213|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
160655914|NCT05630547|580120295|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
160931743|NCT01481116|581147814|FG002|Overall Study|Contraindications|0|||
160931744|NCT01481116|581147812|FG000|Overall Study|Other|1|||
160931745|NCT01481116|581147813|FG001|Overall Study|Other|1|||
160931746|NCT01481116|581147814|FG002|Overall Study|Other|0|||
160931747|NCT01481116|581147812|FG000|Overall Study|Participant Started Taking Glipizide|1|||
160931748|NCT01481116|581147813|FG001|Overall Study|Participant Started Taking Glipizide|0|||
160931749|NCT01481116|581147814|FG002|Overall Study|Participant Started Taking Glipizide|0|||
160931750|NCT01481116|581147812|FG000|Overall Study|Participant Moved Out of Area|2|||
160931751|NCT01481116|581147813|FG001|Overall Study|Participant Moved Out of Area|0|||
160931752|NCT01481116|581147814|FG002|Overall Study|Participant Moved Out of Area|1|||
160931753|NCT01481116|581147812|FG000|Overall Study|Participant Moved Out of Country|1|||
160931754|NCT01481116|581147813|FG001|Overall Study|Participant Moved Out of Country|0|||
160931755|NCT01481116|581147814|FG002|Overall Study|Participant Moved Out of Country|1|||
160931756|NCT01481116|581147812|FG000|Overall Study|Investigator Decision|3|||
160931757|NCT01481116|581147813|FG001|Overall Study|Investigator Decision|2|||
160931758|NCT01481116|581147814|FG002|Overall Study|Investigator Decision|1|||
160931759|NCT01481116|581147812|FG000|Overall Study|Sponsor Decision|0|||
160931760|NCT01481116|581147813|FG001|Overall Study|Sponsor Decision|1|||
160931761|NCT01481116|581147814|FG002|Overall Study|Sponsor Decision|3|||
160931762|NCT01481116|581147812|FG000|Overall Study|Non-Compliant With Study Drug|0|||
160931763|NCT01481116|581147813|FG001|Overall Study|Non-Compliant With Study Drug|1|||
160931764|NCT01481116|581147814|FG002|Overall Study|Non-Compliant With Study Drug|1|||
160931765|NCT01481116|581147812|FG000|Overall Study|Investigator's Discretion|2|||
160931766|NCT01481116|581147813|FG001|Overall Study|Investigator's Discretion|0|||
160931767|NCT01481116|581147814|FG002|Overall Study|Investigator's Discretion|0|||
160931768|NCT01481116|581147812|FG000|Overall Study|Death|2|||
160931769|NCT01481116|581147813|FG001|Overall Study|Death|1|||
160931770|NCT01481116|581147814|FG002|Overall Study|Death|0|||
160931771|NCT01481116|581147812|FG000|Overall Study|Hypoglycemic Event|4|||
160931772|NCT01481116|581147813|FG001|Overall Study|Hypoglycemic Event|0|||
160931773|NCT01481116|581147814|FG002|Overall Study|Hypoglycemic Event|0|||
160931774|NCT03848845|581147815|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
160931775|NCT03848845|581147816|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
160931776|NCT03848845|581147817|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
160578247|NCT01070550|579838298|FG004|Overall Study|Incomplete treatment|0|||
160931777|NCT03848845|581147818|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
160931778|NCT03848845|581147815|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
160931779|NCT03848845|581147816|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
160931780|NCT03848845|581147817|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
160931781|NCT03848845|581147818|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
160931782|NCT03848845|581147815|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
160931783|NCT03848845|581147816|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
160931784|NCT03848845|581147817|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
160931785|NCT03848845|581147818|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
160931786|NCT03848845|581147815|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
160931787|NCT03848845|581147816|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
160931788|NCT03848845|581147817|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
160931789|NCT03848845|581147818|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
160931790|NCT02433834|581147820|FG000|Overall Study|Protocol-specified criteria|7|||
160931791|NCT02433834|581147820|FG000|Overall Study|Protocol Violation|3|||
160931792|NCT02433834|581147820|FG000|Overall Study|Lost to Follow-up|6|||
160931793|NCT02433834|581147820|FG000|Overall Study|Withdrawal by Subject|14|||
160931794|NCT02433834|581147820|FG000|Overall Study|Adverse Event|6|||
160931795|NCT02433834|581147820|FG000|Overall Study|Physician Decision|1|||
160931796|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
160931797|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
160931798|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
160931799|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
160931800|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
160931801|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
160931802|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
160931803|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
160931804|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
160931805|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
160931806|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
160931807|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
160998214|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
160998215|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
160578248|NCT01070550|579838299|FG005|Overall Study|Incomplete treatment|0|||
160578249|NCT01070550|579838294|FG000|Overall Study|Lab test not done|22|||
160578250|NCT01070550|579838295|FG001|Overall Study|Lab test not done|3|||
160578251|NCT01070550|579838296|FG002|Overall Study|Lab test not done|4|||
160578252|NCT01070550|579838297|FG003|Overall Study|Lab test not done|1|||
160931808|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
160931809|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
160931810|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
160931811|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
160931812|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
160931813|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
160931814|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
160578253|NCT01070550|579838298|FG004|Overall Study|Lab test not done|0|||
160578254|NCT01070550|579838299|FG005|Overall Study|Lab test not done|1|||
160931815|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
160931816|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
160931817|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
160931818|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
160931819|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
160931820|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
160578255|NCT01070550|579838294|FG000|Overall Study|Lack of Efficacy|65|||
160578256|NCT01070550|579838295|FG001|Overall Study|Lack of Efficacy|1|||
160578257|NCT01070550|579838296|FG002|Overall Study|Lack of Efficacy|5|||
160578258|NCT01070550|579838297|FG003|Overall Study|Lack of Efficacy|5|||
160578259|NCT01070550|579838298|FG004|Overall Study|Lack of Efficacy|0|||
160578260|NCT01070550|579838299|FG005|Overall Study|Lack of Efficacy|1|||
160578261|NCT01070550|579838294|FG000|Overall Study|Miscellaneous|12|||
160578262|NCT01070550|579838295|FG001|Overall Study|Miscellaneous|2|||
160578263|NCT01070550|579838296|FG002|Overall Study|Miscellaneous|3|||
160578264|NCT01070550|579838297|FG003|Overall Study|Miscellaneous|1|||
160578265|NCT01070550|579838298|FG004|Overall Study|Miscellaneous|0|||
160578266|NCT01070550|579838299|FG005|Overall Study|Miscellaneous|0|||
160578267|NCT01070550|579838294|FG000|Overall Study|New treatment started|3|||
160578268|NCT01070550|579838295|FG001|Overall Study|New treatment started|1|||
160578269|NCT01070550|579838296|FG002|Overall Study|New treatment started|0|||
160578270|NCT01070550|579838297|FG003|Overall Study|New treatment started|2|||
160578271|NCT01070550|579838298|FG004|Overall Study|New treatment started|0|||
160578272|NCT01070550|579838299|FG005|Overall Study|New treatment started|0|||
160578273|NCT01070550|579838294|FG000|Overall Study|Non-responders|493|||
160578274|NCT01070550|579838295|FG001|Overall Study|Non-responders|4|||
160578275|NCT01070550|579838296|FG002|Overall Study|Non-responders|21|||
160578276|NCT01070550|579838297|FG003|Overall Study|Non-responders|20|||
160578277|NCT01070550|579838298|FG004|Overall Study|Non-responders|0|||
160578278|NCT01070550|579838299|FG005|Overall Study|Non-responders|2|||
160578279|NCT01070550|579838294|FG000|Overall Study|Not categorized|33|||
160578280|NCT01070550|579838295|FG001|Overall Study|Not categorized|2|||
160578281|NCT01070550|579838296|FG002|Overall Study|Not categorized|6|||
160578282|NCT01070550|579838297|FG003|Overall Study|Not categorized|1|||
160578283|NCT01070550|579838298|FG004|Overall Study|Not categorized|0|||
160578284|NCT01070550|579838299|FG005|Overall Study|Not categorized|1|||
160578285|NCT01070550|579838294|FG000|Overall Study|Protocol Violation|15|||
160578286|NCT01070550|579838295|FG001|Overall Study|Protocol Violation|1|||
160578287|NCT01070550|579838296|FG002|Overall Study|Protocol Violation|1|||
160578288|NCT01070550|579838297|FG003|Overall Study|Protocol Violation|1|||
160578289|NCT01070550|579838298|FG004|Overall Study|Protocol Violation|0|||
160578290|NCT01070550|579838299|FG005|Overall Study|Protocol Violation|0|||
160578291|NCT01070550|579838294|FG000|Overall Study|Relapse|44|||
160578292|NCT01070550|579838295|FG001|Overall Study|Relapse|5|||
160578293|NCT01070550|579838296|FG002|Overall Study|Relapse|14|||
160655915|NCT05630547|580120296|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
160655916|NCT05630547|580120297|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
160931821|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
160998216|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
160998217|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
160998218|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
160998219|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
160998220|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
160998221|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
160998222|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
160998223|NCT00319436|581378598|FG000|Overall Study|Withdrawal by Subject|6|||
160998224|NCT00319436|581378599|FG001|Overall Study|Withdrawal by Subject|7|||
160998225|NCT01104415|581378603|FG000|Core Phase|Consent withdrawn by subjects|1|||
160998226|NCT01104415|581378604|FG001|Core Phase|Consent withdrawn by subjects|0|||
160998227|NCT01104415|581378603|FG000|Extension Period|Progressive disease|0|||
160998228|NCT01104415|581378604|FG001|Extension Period|Progressive disease|4|||
160455082|NCT05485779|579397831|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
160455083|NCT05485779|579397832|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
160455084|NCT05485779|579397833|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
160998229|NCT01104415|581378603|FG000|Extension Period|Death|0|||
160998230|NCT01104415|581378604|FG001|Extension Period|Death|1|||
160578294|NCT01070550|579838297|FG003|Overall Study|Relapse|4|||
160578295|NCT01070550|579838298|FG004|Overall Study|Relapse|0|||
160578296|NCT01070550|579838299|FG005|Overall Study|Relapse|0|||
160578297|NCT01070550|579838294|FG000|Overall Study|Result not available|3|||
160578298|NCT01070550|579838295|FG001|Overall Study|Result not available|1|||
160578299|NCT01070550|579838296|FG002|Overall Study|Result not available|3|||
160578300|NCT01070550|579838297|FG003|Overall Study|Result not available|0|||
160998231|NCT01104415|581378603|FG000|Extension Period|Physician Decision|0|||
160998232|NCT01104415|581378604|FG001|Extension Period|Physician Decision|1|||
160998233|NCT01104415|581378603|FG000|Extension Period|Transition to Study LX1606.302|0|||
160998234|NCT01104415|581378604|FG001|Extension Period|Transition to Study LX1606.302|4|||
160998235|NCT01104415|581378603|FG000|Extension Period|Heart surgery/feeling miserable|0|||
160998236|NCT01104415|581378604|FG001|Extension Period|Heart surgery/feeling miserable|1|||
160998237|NCT01839877|581378608|FG000|Overall Study|Protocol Violation|1|||
160998238|NCT00597519|581378609|FG000|Overall Study|Death|1|||
160998239|NCT03098030|581378610|FG000|Overall Study|Death|10|||
160998240|NCT03098030|581378611|FG001|Overall Study|Death|156|||
160998241|NCT03098030|581378612|FG002|Overall Study|Death|156|||
160998242|NCT03098030|581378613|FG003|Overall Study|Death|82|||
160998243|NCT03098030|581378610|FG000|Overall Study|Withdrawal by Subject|0|||
160578301|NCT01070550|579838298|FG004|Overall Study|Result not available|0|||
160578302|NCT01070550|579838299|FG005|Overall Study|Result not available|0|||
160578303|NCT01070550|579838294|FG000|Overall Study|Screen failure|1|||
160578304|NCT01070550|579838295|FG001|Overall Study|Screen failure|0|||
160578305|NCT01070550|579838296|FG002|Overall Study|Screen failure|0|||
160578306|NCT01070550|579838297|FG003|Overall Study|Screen failure|0|||
160578307|NCT01070550|579838298|FG004|Overall Study|Screen failure|0|||
160578308|NCT01070550|579838299|FG005|Overall Study|Screen failure|0|||
160578309|NCT01070550|579838294|FG000|Overall Study|Sponsor decision|1|||
160931822|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
160931823|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
160931824|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
160931825|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
160931826|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
160931827|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
160931828|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
160931829|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
160931830|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
160931831|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
160931832|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
160931833|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
160931834|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
160931835|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
160931836|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
160931837|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
160931838|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
160931839|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
160931840|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
160931841|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
160931842|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
160931843|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
160931844|NCT02643251|581147824|FG000|Overall Study|Adverse Event|3|||
160931845|NCT02643251|581147825|FG001|Overall Study|Adverse Event|1|||
160931846|NCT02643251|581147824|FG000|Overall Study|Withdrawal by Subject|2|||
160931847|NCT02643251|581147825|FG001|Overall Study|Withdrawal by Subject|0|||
160931848|NCT02643251|581147824|FG000|Overall Study|Lost to Follow-up|4|||
160931849|NCT02643251|581147825|FG001|Overall Study|Lost to Follow-up|1|||
160931850|NCT02643251|581147824|FG000|Overall Study|Protocol Violation|1|||
160998244|NCT03098030|581378611|FG001|Overall Study|Withdrawal by Subject|7|||
160998245|NCT03098030|581378612|FG002|Overall Study|Withdrawal by Subject|8|||
160998246|NCT03098030|581378613|FG003|Overall Study|Withdrawal by Subject|2|||
160998247|NCT03098030|581378610|FG000|Overall Study|Lost to Follow-up|0|||
160998248|NCT03098030|581378611|FG001|Overall Study|Lost to Follow-up|0|||
160578310|NCT01070550|579838295|FG001|Overall Study|Sponsor decision|0|||
160578311|NCT01070550|579838296|FG002|Overall Study|Sponsor decision|0|||
160578312|NCT01070550|579838297|FG003|Overall Study|Sponsor decision|0|||
160578313|NCT01070550|579838298|FG004|Overall Study|Sponsor decision|0|||
160578314|NCT01070550|579838299|FG005|Overall Study|Sponsor decision|0|||
160578315|NCT01070550|579838294|FG000|Overall Study|Treatment duration shortened|1|||
160578316|NCT01070550|579838295|FG001|Overall Study|Treatment duration shortened|0|||
160655917|NCT05630547|580120294|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
160998249|NCT03098030|581378612|FG002|Overall Study|Lost to Follow-up|2|||
160578317|NCT01070550|579838296|FG002|Overall Study|Treatment duration shortened|0|||
160578318|NCT01070550|579838297|FG003|Overall Study|Treatment duration shortened|0|||
160578319|NCT01070550|579838298|FG004|Overall Study|Treatment duration shortened|0|||
160931851|NCT02643251|581147825|FG001|Overall Study|Protocol Violation|0|||
160931852|NCT02643251|581147824|FG000|Overall Study|PI Decision to terminate patient|1|||
160998250|NCT03098030|581378613|FG003|Overall Study|Lost to Follow-up|1|||
160931853|NCT02643251|581147825|FG001|Overall Study|PI Decision to terminate patient|0|||
160931854|NCT00348556|581147826|FG000|Overall Study|Adverse Event|1|||
160931855|NCT01956110|581147833|FG000|Overall Study|Protocol Violation|25|||
160931856|NCT01956110|581147834|FG001|Overall Study|Protocol Violation|11|||
160931857|NCT01956110|581147833|FG000|Overall Study|Adverse Event|9|||
160931858|NCT01956110|581147834|FG001|Overall Study|Adverse Event|10|||
160931859|NCT01956110|581147833|FG000|Overall Study|Personal reasons|1|||
160931860|NCT01956110|581147834|FG001|Overall Study|Personal reasons|1|||
160931861|NCT00430092|581147835|FG000|Overall Study|Adverse Event|0|||
160931862|NCT00430092|581147836|FG001|Overall Study|Adverse Event|0|||
160931863|NCT00430092|581147837|FG002|Overall Study|Adverse Event|1|||
160931864|NCT00430092|581147835|FG000|Overall Study|Lack of Efficacy|5|||
160931865|NCT00430092|581147836|FG001|Overall Study|Lack of Efficacy|2|||
160931866|NCT00430092|581147837|FG002|Overall Study|Lack of Efficacy|54|||
160931867|NCT00430092|581147835|FG000|Overall Study|Lost to Follow-up|1|||
160931868|NCT00430092|581147836|FG001|Overall Study|Lost to Follow-up|0|||
160931869|NCT00430092|581147837|FG002|Overall Study|Lost to Follow-up|0|||
160931870|NCT00430092|581147835|FG000|Overall Study|Protocol Violation|0|||
160931871|NCT00430092|581147836|FG001|Overall Study|Protocol Violation|1|||
160931872|NCT00430092|581147837|FG002|Overall Study|Protocol Violation|1|||
160931873|NCT00430092|581147835|FG000|Overall Study|Withdrawal by Subject|0|||
160931874|NCT00430092|581147836|FG001|Overall Study|Withdrawal by Subject|1|||
160931875|NCT00430092|581147837|FG002|Overall Study|Withdrawal by Subject|1|||
160931876|NCT02118428|581147840|FG000|Overall Study|Physician Decision|0|||
160931877|NCT02118428|581147841|FG001|Overall Study|Physician Decision|1|||
160931878|NCT02118428|581147842|FG002|Overall Study|Physician Decision|0|||
160931879|NCT02118428|581147840|FG000|Overall Study|Withdrawal by Subject|2|||
160931880|NCT02118428|581147841|FG001|Overall Study|Withdrawal by Subject|2|||
160931881|NCT02118428|581147842|FG002|Overall Study|Withdrawal by Subject|0|||
160931882|NCT02118428|581147840|FG000|Overall Study|Death|7|||
160931883|NCT02118428|581147841|FG001|Overall Study|Death|5|||
160931884|NCT02118428|581147842|FG002|Overall Study|Death|0|||
160931885|NCT02118428|581147840|FG000|Overall Study|Lost to Follow-up|3|||
160931886|NCT02118428|581147841|FG001|Overall Study|Lost to Follow-up|1|||
160931887|NCT02118428|581147842|FG002|Overall Study|Lost to Follow-up|0|||
160931888|NCT02118428|581147840|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
160931889|NCT02118428|581147841|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
160931890|NCT02118428|581147842|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
160931891|NCT03325166|581147843|FG000|Overall Study|Adverse Event|1|||
160931892|NCT01633944|581147844|FG000|Open-label Titration Phase|Adverse Event|109|||
160998251|NCT03368001|581378617|FG000|Allocation|Lost to Pretest|16|||
160998252|NCT03368001|581378618|FG001|Allocation|Lost to Pretest|25|||
160578320|NCT01070550|579838299|FG005|Overall Study|Treatment duration shortened|0|||
160578321|NCT01070550|579838294|FG000|Overall Study|Treatment interrupted|7|||
160578322|NCT01070550|579838295|FG001|Overall Study|Treatment interrupted|0|||
160578323|NCT01070550|579838296|FG002|Overall Study|Treatment interrupted|1|||
160578324|NCT01070550|579838297|FG003|Overall Study|Treatment interrupted|1|||
160578325|NCT01070550|579838298|FG004|Overall Study|Treatment interrupted|0|||
160578326|NCT01070550|579838299|FG005|Overall Study|Treatment interrupted|0|||
160578327|NCT01070550|579838294|FG000|Overall Study|Treatment not started|14|||
160578328|NCT01070550|579838295|FG001|Overall Study|Treatment not started|2|||
160931893|NCT01633944|581147845|FG001|Open-label Titration Phase|Adverse Event|0|||
160998253|NCT03368001|581378617|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
160998254|NCT03368001|581378618|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
160998255|NCT03368001|581378617|FG000|Posttest|Lost to Posttest|7|||
160998256|NCT03368001|581378618|FG001|Posttest|Lost to Posttest|11|||
160998257|NCT03368001|581378617|FG000|Posttest|Discontinued Intervention|6|||
160998258|NCT03368001|581378618|FG001|Posttest|Discontinued Intervention|19|||
160998259|NCT03368001|581378617|FG000|Follow-up|Lost to Follow-up|6|||
160998260|NCT03368001|581378618|FG001|Follow-up|Lost to Follow-up|3|||
160998261|NCT03612804|581378619|FG000|Overall Study|Death|0|||
160998262|NCT03612804|581378620|FG001|Overall Study|Death|7|||
160578329|NCT01070550|579838296|FG002|Overall Study|Treatment not started|4|||
160998263|NCT03612804|581378621|FG002|Overall Study|Death|0|||
160998264|NCT03612804|581378622|FG003|Overall Study|Death|8|||
160998265|NCT03612804|581378619|FG000|Overall Study|Medication copay coverage issues|0|||
160578330|NCT01070550|579838297|FG003|Overall Study|Treatment not started|0|||
160931894|NCT01633944|581147846|FG002|Open-label Titration Phase|Adverse Event|0|||
160931895|NCT01633944|581147844|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
160931896|NCT01633944|581147845|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
160931897|NCT01633944|581147846|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
160931898|NCT01633944|581147844|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
160931899|NCT01633944|581147845|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
160931900|NCT01633944|581147846|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
160931901|NCT01633944|581147844|FG000|Open-label Titration Phase|Protocol Violation|24|||
160998266|NCT03612804|581378620|FG001|Overall Study|Medication copay coverage issues|0|||
160998267|NCT03612804|581378621|FG002|Overall Study|Medication copay coverage issues|0|||
160931902|NCT01633944|581147845|FG001|Open-label Titration Phase|Protocol Violation|0|||
160931903|NCT01633944|581147846|FG002|Open-label Titration Phase|Protocol Violation|0|||
160931904|NCT01633944|581147844|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
160931905|NCT01633944|581147845|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
160931906|NCT01633944|581147846|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
160931907|NCT01633944|581147844|FG000|Open-label Titration Phase|Other|68|||
160931908|NCT01633944|581147845|FG001|Open-label Titration Phase|Other|0|||
160931909|NCT01633944|581147846|FG002|Open-label Titration Phase|Other|0|||
160931910|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Adverse Event|0|||
160931911|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Adverse Event|13|||
160931912|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Adverse Event|7|||
160931913|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
160931914|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
160931915|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
160931916|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160931917|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
160931918|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
160931919|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
160931920|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
160931921|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
160931922|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
160931923|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
160931924|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
160931925|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
160931926|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
160931927|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
160931928|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
160931929|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
160931930|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
160931931|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Other|0|||
160931932|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Other|7|||
160931933|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Other|0|||
160931934|NCT03354429|581147847|FG000|Overall Study|Withdrawal by Subject|8|||
160931935|NCT03354429|581147848|FG001|Overall Study|Withdrawal by Subject|7|||
160931936|NCT03354429|581147847|FG000|Overall Study|Lost to Follow-up|1|||
160931937|NCT03354429|581147848|FG001|Overall Study|Lost to Follow-up|0|||
160931938|NCT00782210|581147850|FG000|Overall Study|Adverse Event|21|||
160931939|NCT00782210|581147851|FG001|Overall Study|Adverse Event|17|||
160931940|NCT00782210|581147852|FG002|Overall Study|Adverse Event|16|||
160931941|NCT00782210|581147850|FG000|Overall Study|Lost to Follow-up|2|||
160931942|NCT00782210|581147851|FG001|Overall Study|Lost to Follow-up|1|||
160931943|NCT00782210|581147852|FG002|Overall Study|Lost to Follow-up|2|||
160931944|NCT00782210|581147850|FG000|Overall Study|Withdrawal by Subject|11|||
160931945|NCT00782210|581147851|FG001|Overall Study|Withdrawal by Subject|8|||
160931946|NCT00782210|581147852|FG002|Overall Study|Withdrawal by Subject|11|||
160931947|NCT00782210|581147850|FG000|Overall Study|Non compliance with protocol|0|||
160931948|NCT00782210|581147851|FG001|Overall Study|Non compliance with protocol|3|||
160931949|NCT00782210|581147852|FG002|Overall Study|Non compliance with protocol|2|||
160931950|NCT00782210|581147850|FG000|Overall Study|Lack of Efficacy|13|||
160931951|NCT00782210|581147851|FG001|Overall Study|Lack of Efficacy|4|||
160931952|NCT00782210|581147852|FG002|Overall Study|Lack of Efficacy|1|||
160931953|NCT00782210|581147850|FG000|Overall Study|Other reason not described above|3|||
160931954|NCT00782210|581147851|FG001|Overall Study|Other reason not described above|2|||
160931955|NCT00782210|581147852|FG002|Overall Study|Other reason not described above|3|||
160931956|NCT03100825|581147853|FG000|Overall Study|Participant/Guardian Decision|7|||
160931957|NCT03100825|581147853|FG000|Overall Study|Physician Decision|1|||
160931958|NCT00994448|581147855|FG000|Overall Study|Adverse Event|1|||
160931959|NCT00994448|581147856|FG001|Overall Study|Adverse Event|0|||
160931960|NCT00994448|581147855|FG000|Overall Study|Lost to Follow-up|5|||
160931961|NCT00994448|581147856|FG001|Overall Study|Lost to Follow-up|1|||
160931962|NCT00994448|581147855|FG000|Overall Study|Withdrawal by Subject|1|||
160931963|NCT00994448|581147856|FG001|Overall Study|Withdrawal by Subject|1|||
160931964|NCT00994448|581147855|FG000|Overall Study|Physician Decision|1|||
160931965|NCT00994448|581147856|FG001|Overall Study|Physician Decision|0|||
160931966|NCT05923229|581147862|FG000|Overall Study|Withdrawal by Subject|3|||
160931967|NCT05923229|581147863|FG001|Overall Study|Withdrawal by Subject|0|||
160931968|NCT05923229|581147862|FG000|Overall Study|Health related|2|||
160931969|NCT05923229|581147863|FG001|Overall Study|Health related|1|||
160931970|NCT04098458|581147864|FG000|Overall Study|Death|1|||
160931971|NCT04098458|581147864|FG000|Overall Study|did not meet study inclusion criteria|3|||
160931972|NCT00006489|581147865|FG000|Overall Study|Adverse Event|3|||
160998268|NCT03612804|581378622|FG003|Overall Study|Medication copay coverage issues|17|||
160655918|NCT05630547|580120295|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
160931973|NCT00006489|581147866|FG001|Overall Study|Adverse Event|2|||
160931974|NCT00006489|581147867|FG002|Overall Study|Adverse Event|4|||
160931975|NCT00006489|581147868|FG003|Overall Study|Adverse Event|3|||
160931976|NCT00006489|581147865|FG000|Overall Study|Withdrawal by Subject|10|||
160931977|NCT00006489|581147866|FG001|Overall Study|Withdrawal by Subject|9|||
160931978|NCT00006489|581147867|FG002|Overall Study|Withdrawal by Subject|9|||
160931979|NCT00006489|581147868|FG003|Overall Study|Withdrawal by Subject|6|||
160931980|NCT00006489|581147865|FG000|Overall Study|Scheduling Conflict|0|||
160931981|NCT00006489|581147866|FG001|Overall Study|Scheduling Conflict|3|||
160931982|NCT00006489|581147867|FG002|Overall Study|Scheduling Conflict|2|||
160931983|NCT00006489|581147868|FG003|Overall Study|Scheduling Conflict|1|||
160931984|NCT00006489|581147865|FG000|Overall Study|Death|0|||
160931985|NCT00006489|581147866|FG001|Overall Study|Death|0|||
160931986|NCT00006489|581147867|FG002|Overall Study|Death|0|||
160931987|NCT00006489|581147868|FG003|Overall Study|Death|1|||
160931988|NCT01479621|581147869|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
160931989|NCT01479621|581147870|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931990|NCT01479621|581147871|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931991|NCT01479621|581147872|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931992|NCT01479621|581147873|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931993|NCT01479621|581147874|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931994|NCT01479621|581147875|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931995|NCT01479621|581147869|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
160931996|NCT01479621|581147870|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160931997|NCT01479621|581147871|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160931998|NCT01479621|581147872|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160931999|NCT01479621|581147873|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160932000|NCT01479621|581147874|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160932001|NCT01479621|581147875|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160932002|NCT01479621|581147869|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
160932003|NCT01479621|581147870|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932004|NCT01479621|581147871|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932005|NCT01479621|581147872|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932006|NCT01479621|581147873|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932007|NCT01479621|581147874|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932008|NCT01479621|581147875|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932009|NCT01479621|581147869|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
160932010|NCT01479621|581147870|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932011|NCT01479621|581147871|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932012|NCT01479621|581147872|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932013|NCT01479621|581147873|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932014|NCT01479621|581147874|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932015|NCT01479621|581147875|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932016|NCT01479621|581147869|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
160932017|NCT01479621|581147870|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932018|NCT01479621|581147871|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932019|NCT01479621|581147872|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932020|NCT01479621|581147873|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932021|NCT01479621|581147874|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932022|NCT01479621|581147875|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932023|NCT01479621|581147869|FG000|Treatment Period|Adverse Event|0|||
160932024|NCT01479621|581147870|FG001|Treatment Period|Adverse Event|0|||
160932025|NCT01479621|581147871|FG002|Treatment Period|Adverse Event|0|||
160932026|NCT01479621|581147872|FG003|Treatment Period|Adverse Event|0|||
160932027|NCT01479621|581147873|FG004|Treatment Period|Adverse Event|1|||
160932028|NCT01479621|581147874|FG005|Treatment Period|Adverse Event|2|||
160932029|NCT01479621|581147875|FG006|Treatment Period|Adverse Event|2|||
160932030|NCT01479621|581147869|FG000|Treatment Period|Withdrawal by Subject|0|||
160932031|NCT01479621|581147870|FG001|Treatment Period|Withdrawal by Subject|4|||
160932032|NCT01479621|581147871|FG002|Treatment Period|Withdrawal by Subject|2|||
160932033|NCT01479621|581147872|FG003|Treatment Period|Withdrawal by Subject|2|||
160932034|NCT01479621|581147873|FG004|Treatment Period|Withdrawal by Subject|5|||
160932035|NCT01479621|581147874|FG005|Treatment Period|Withdrawal by Subject|5|||
160932036|NCT01479621|581147875|FG006|Treatment Period|Withdrawal by Subject|1|||
160932037|NCT01479621|581147869|FG000|Treatment Period|Physician Decision|0|||
160932038|NCT01479621|581147870|FG001|Treatment Period|Physician Decision|0|||
160932039|NCT01479621|581147871|FG002|Treatment Period|Physician Decision|0|||
160932040|NCT01479621|581147872|FG003|Treatment Period|Physician Decision|0|||
160655919|NCT05630547|580120296|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
160998269|NCT03612804|581378619|FG000|Overall Study|Not current smoker at time of screening|0|||
160998270|NCT03612804|581378620|FG001|Overall Study|Not current smoker at time of screening|1|||
160998271|NCT03612804|581378621|FG002|Overall Study|Not current smoker at time of screening|0|||
160998272|NCT03612804|581378622|FG003|Overall Study|Not current smoker at time of screening|3|||
160998273|NCT03612804|581378619|FG000|Overall Study|Non-veteran status|0|||
160998274|NCT03612804|581378620|FG001|Overall Study|Non-veteran status|1|||
160998275|NCT03612804|581378621|FG002|Overall Study|Non-veteran status|0|||
160998276|NCT03612804|581378622|FG003|Overall Study|Non-veteran status|0|||
160998277|NCT03612804|581378619|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
160932041|NCT01479621|581147873|FG004|Treatment Period|Physician Decision|1|||
160932042|NCT01479621|581147874|FG005|Treatment Period|Physician Decision|1|||
160932043|NCT01479621|581147875|FG006|Treatment Period|Physician Decision|0|||
160932044|NCT01479621|581147869|FG000|Treatment Period|Non-compliance to study drug|0|||
160932045|NCT01479621|581147870|FG001|Treatment Period|Non-compliance to study drug|1|||
160932046|NCT01479621|581147871|FG002|Treatment Period|Non-compliance to study drug|0|||
160932047|NCT01479621|581147872|FG003|Treatment Period|Non-compliance to study drug|0|||
160932048|NCT01479621|581147873|FG004|Treatment Period|Non-compliance to study drug|0|||
160932049|NCT01479621|581147874|FG005|Treatment Period|Non-compliance to study drug|0|||
160932050|NCT01479621|581147875|FG006|Treatment Period|Non-compliance to study drug|1|||
160932051|NCT01479621|581147869|FG000|Treatment Period|Protocol Violation|0|||
160932052|NCT01479621|581147870|FG001|Treatment Period|Protocol Violation|9|||
160932053|NCT01479621|581147871|FG002|Treatment Period|Protocol Violation|6|||
160932054|NCT01479621|581147872|FG003|Treatment Period|Protocol Violation|5|||
160932055|NCT01479621|581147873|FG004|Treatment Period|Protocol Violation|2|||
160932056|NCT01479621|581147874|FG005|Treatment Period|Protocol Violation|10|||
160932057|NCT01479621|581147875|FG006|Treatment Period|Protocol Violation|6|||
160932058|NCT01479621|581147869|FG000|Treatment Period|Pregnancy|0|||
160932059|NCT01479621|581147870|FG001|Treatment Period|Pregnancy|0|||
160932060|NCT01479621|581147871|FG002|Treatment Period|Pregnancy|2|||
160932061|NCT01479621|581147872|FG003|Treatment Period|Pregnancy|0|||
160932062|NCT01479621|581147873|FG004|Treatment Period|Pregnancy|0|||
160932063|NCT01479621|581147874|FG005|Treatment Period|Pregnancy|0|||
160932064|NCT01479621|581147875|FG006|Treatment Period|Pregnancy|0|||
160932065|NCT01479621|581147869|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
160932066|NCT01479621|581147870|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
160932067|NCT01479621|581147871|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
160932068|NCT01479621|581147872|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
160932069|NCT01479621|581147873|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
160932070|NCT01479621|581147874|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
160932071|NCT01479621|581147875|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
160932072|NCT01479621|581147869|FG000|Treatment Period|Lost to Follow-up|0|||
160932073|NCT01479621|581147870|FG001|Treatment Period|Lost to Follow-up|0|||
160932074|NCT01479621|581147871|FG002|Treatment Period|Lost to Follow-up|1|||
160932075|NCT01479621|581147872|FG003|Treatment Period|Lost to Follow-up|0|||
160932076|NCT01479621|581147873|FG004|Treatment Period|Lost to Follow-up|2|||
160932077|NCT01479621|581147874|FG005|Treatment Period|Lost to Follow-up|2|||
160932078|NCT01479621|581147875|FG006|Treatment Period|Lost to Follow-up|1|||
160932079|NCT01479621|581147869|FG000|Treatment Period|Met stopping criteria|0|||
160932080|NCT01479621|581147870|FG001|Treatment Period|Met stopping criteria|8|||
160932081|NCT01479621|581147871|FG002|Treatment Period|Met stopping criteria|7|||
160932082|NCT01479621|581147872|FG003|Treatment Period|Met stopping criteria|4|||
160932083|NCT01479621|581147873|FG004|Treatment Period|Met stopping criteria|9|||
160932084|NCT01479621|581147874|FG005|Treatment Period|Met stopping criteria|20|||
160932085|NCT01479621|581147875|FG006|Treatment Period|Met stopping criteria|6|||
160932086|NCT02308735|581147876|FG000|Overall Study|Physician Decision|2|||
160932087|NCT02308735|581147877|FG001|Overall Study|Physician Decision|0|||
160932088|NCT02308735|581147878|FG002|Overall Study|Physician Decision|0|||
160932089|NCT02308735|581147879|FG003|Overall Study|Physician Decision|2|||
160932090|NCT01417481|581147880|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
160998278|NCT03612804|581378620|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
160932091|NCT01417481|581147881|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
160932092|NCT03029624|581147884|FG000|Overall Study|Adverse Event|1|||
160932093|NCT03029624|581147884|FG000|Overall Study|Withdrawal by Subject|1|||
160932094|NCT03029624|581147884|FG000|Overall Study|Lack of Efficacy|1|||
160932095|NCT03029624|581147884|FG000|Overall Study|MRI need|2|||
160932096|NCT00974571|581147886|FG000|Overall Study|Adverse Event|31|||
160932097|NCT00974571|581147887|FG001|Overall Study|Adverse Event|4|||
160998279|NCT03612804|581378621|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
160998280|NCT03612804|581378622|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
160998281|NCT03612804|581378619|FG000|Overall Study|Provider retired from VA|0|||
160998282|NCT03612804|581378620|FG001|Overall Study|Provider retired from VA|0|||
160578331|NCT01070550|579838298|FG004|Overall Study|Treatment not started|0|||
160578332|NCT01070550|579838299|FG005|Overall Study|Treatment not started|0|||
160578333|NCT01070550|579838294|FG000|Overall Study|Treatment restarted|0|||
160932098|NCT00974571|581147888|FG002|Overall Study|Adverse Event|27|||
160932099|NCT00974571|581147886|FG000|Overall Study|Lack of Efficacy|3|||
160932100|NCT00974571|581147887|FG001|Overall Study|Lack of Efficacy|2|||
160932101|NCT00974571|581147888|FG002|Overall Study|Lack of Efficacy|9|||
160932102|NCT00974571|581147886|FG000|Overall Study|Lost to Follow-up|2|||
160932103|NCT00974571|581147887|FG001|Overall Study|Lost to Follow-up|1|||
160932104|NCT00974571|581147888|FG002|Overall Study|Lost to Follow-up|2|||
160932105|NCT00974571|581147886|FG000|Overall Study|Protocol Violation|13|||
160932106|NCT00974571|581147887|FG001|Overall Study|Protocol Violation|4|||
160932107|NCT00974571|581147888|FG002|Overall Study|Protocol Violation|18|||
160932108|NCT00974571|581147886|FG000|Overall Study|Withdrawal by Subject|14|||
160932109|NCT00974571|581147887|FG001|Overall Study|Withdrawal by Subject|5|||
160932110|NCT00974571|581147888|FG002|Overall Study|Withdrawal by Subject|16|||
160932111|NCT00974571|581147886|FG000|Overall Study|Patient Moved|1|||
160932112|NCT00974571|581147887|FG001|Overall Study|Patient Moved|0|||
160932113|NCT00974571|581147888|FG002|Overall Study|Patient Moved|1|||
160932114|NCT00974571|581147886|FG000|Overall Study|Other|4|||
160932115|NCT00974571|581147887|FG001|Overall Study|Other|0|||
160932116|NCT00974571|581147888|FG002|Overall Study|Other|10|||
160932117|NCT01371656|581147889|FG000|Overall Study|Death|7|||
160932118|NCT01371656|581147890|FG001|Overall Study|Death|4|||
160932119|NCT01371656|581147889|FG000|Overall Study|Physician Decision|46|||
160932120|NCT01371656|581147890|FG001|Overall Study|Physician Decision|7|||
160932121|NCT01371656|581147889|FG000|Overall Study|Withdrawal by Subject|7|||
160932122|NCT01371656|581147890|FG001|Overall Study|Withdrawal by Subject|0|||
160932123|NCT01371656|581147889|FG000|Overall Study|Ineligible|4|||
160932124|NCT01371656|581147890|FG001|Overall Study|Ineligible|3|||
160932125|NCT04334460|581147897|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
160932126|NCT04334460|581147898|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
160932127|NCT04334460|581147897|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
160932128|NCT04334460|581147898|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
160932129|NCT03778931|581147899|FG000|Overall Study|Withdrawal by Subject|12|||
160932130|NCT03778931|581147900|FG001|Overall Study|Withdrawal by Subject|25|||
160932131|NCT03778931|581147899|FG000|Overall Study|Physician Decision|1|||
160932132|NCT03778931|581147900|FG001|Overall Study|Physician Decision|3|||
160932133|NCT03778931|581147899|FG000|Overall Study|Participant Noncompliance|1|||
160932134|NCT03778931|581147900|FG001|Overall Study|Participant Noncompliance|1|||
160932135|NCT03778931|581147899|FG000|Overall Study|Lost to Follow-up|4|||
160932136|NCT03778931|581147900|FG001|Overall Study|Lost to Follow-up|1|||
160932137|NCT03778931|581147899|FG000|Overall Study|Death|69|||
160932138|NCT03778931|581147900|FG001|Overall Study|Death|79|||
160932139|NCT03216850|581147907|FG000|Overall Study|Pre-analytical error|6|||
160932140|NCT01228747|581147910|FG000|Overall Study|Adverse Event|8|||
160932141|NCT01228747|581147911|FG001|Overall Study|Adverse Event|4|||
160932142|NCT01228747|581147910|FG000|Overall Study|Lack of Efficacy|40|||
160932143|NCT01228747|581147911|FG001|Overall Study|Lack of Efficacy|27|||
160932144|NCT01228747|581147910|FG000|Overall Study|Protocol Violation|6|||
160932145|NCT01228747|581147911|FG001|Overall Study|Protocol Violation|5|||
160932146|NCT01228747|581147910|FG000|Overall Study|Lost to Follow-up|4|||
160932147|NCT01228747|581147911|FG001|Overall Study|Lost to Follow-up|3|||
160932148|NCT01228747|581147910|FG000|Overall Study|Withdrawal by Subject|5|||
160932149|NCT01228747|581147911|FG001|Overall Study|Withdrawal by Subject|1|||
160998283|NCT03612804|581378621|FG002|Overall Study|Provider retired from VA|2|||
160998284|NCT03612804|581378622|FG003|Overall Study|Provider retired from VA|0|||
160998285|NCT03612804|581378619|FG000|Overall Study|Withdrawal by Subject|0|||
160998286|NCT03612804|581378620|FG001|Overall Study|Withdrawal by Subject|0|||
160998287|NCT03612804|581378621|FG002|Overall Study|Withdrawal by Subject|7|||
160998288|NCT03612804|581378622|FG003|Overall Study|Withdrawal by Subject|0|||
160998289|NCT03612804|581378619|FG000|Overall Study|Provider involved with study activities|1|||
160998290|NCT03612804|581378620|FG001|Overall Study|Provider involved with study activities|0|||
160998291|NCT03612804|581378621|FG002|Overall Study|Provider involved with study activities|0|||
160998292|NCT03612804|581378622|FG003|Overall Study|Provider involved with study activities|0|||
160932150|NCT01228747|581147910|FG000|Overall Study|Other Reason|2|||
160932151|NCT01228747|581147911|FG001|Overall Study|Other Reason|5|||
160578334|NCT01070550|579838295|FG001|Overall Study|Treatment restarted|1|||
160578335|NCT01070550|579838296|FG002|Overall Study|Treatment restarted|0|||
160578336|NCT01070550|579838297|FG003|Overall Study|Treatment restarted|0|||
160932152|NCT02910167|581147912|FG000|Overall Study|Adverse Event|1|||
160932153|NCT02910167|581147912|FG000|Overall Study|Lost to Follow-up|18|||
160998293|NCT05484726|581378623|FG000|Overall Study|Protocol Violation|3|||
160578337|NCT01070550|579838298|FG004|Overall Study|Treatment restarted|0|||
160578338|NCT01070550|579838299|FG005|Overall Study|Treatment restarted|0|||
160932154|NCT01398956|581147913|FG000|Overall Study|Withdrawal by Subject|4|||
160932155|NCT01398956|581147913|FG000|Overall Study|AE, non-serious non-fatal|4|||
160932156|NCT01398956|581147913|FG000|Overall Study|Withdrawal Criteria No.3|1|||
160932157|NCT01398956|581147913|FG000|Overall Study|Subject moved a long distance|1|||
160932158|NCT01623596|581147916|FG000|Overall Study|Abnormal laboratory values|2|||
160932159|NCT01623596|581147917|FG001|Overall Study|Abnormal laboratory values|0|||
160932160|NCT01623596|581147916|FG000|Overall Study|Administrative problems|9|||
160932161|NCT01623596|581147917|FG001|Overall Study|Administrative problems|13|||
160932162|NCT01623596|581147916|FG000|Overall Study|Adverse Event|20|||
160932163|NCT01623596|581147917|FG001|Overall Study|Adverse Event|29|||
160932164|NCT01623596|581147916|FG000|Overall Study|Death|0|||
160932165|NCT01623596|581147917|FG001|Overall Study|Death|2|||
160932166|NCT01623596|581147916|FG000|Overall Study|Lost to Follow-up|12|||
160932167|NCT01623596|581147917|FG001|Overall Study|Lost to Follow-up|16|||
160932168|NCT01623596|581147916|FG000|Overall Study|Withdrawal by Subject|13|||
160932169|NCT01623596|581147917|FG001|Overall Study|Withdrawal by Subject|31|||
160932170|NCT01623596|581147916|FG000|Overall Study|Patient no longer requires study drug|1|||
160932171|NCT01623596|581147917|FG001|Overall Study|Patient no longer requires study drug|0|||
160932172|NCT01623596|581147916|FG000|Overall Study|Protocol Violation|0|||
160932173|NCT01623596|581147917|FG001|Overall Study|Protocol Violation|6|||
160932174|NCT01623596|581147916|FG000|Overall Study|Lack of Efficacy|5|||
160932175|NCT01623596|581147917|FG001|Overall Study|Lack of Efficacy|3|||
160932176|NCT03274986|581147920|FG000|Overall Study|Withdrawal by Subject|0|||
160932177|NCT03274986|581147921|FG001|Overall Study|Withdrawal by Subject|1|||
160932178|NCT03274986|581147920|FG000|Overall Study|Lost to Follow-up|0|||
160932179|NCT03274986|581147921|FG001|Overall Study|Lost to Follow-up|1|||
160932180|NCT00603746|581147922|FG000|Overall Study|Adverse Event|2|||
160932181|NCT00603746|581147923|FG001|Overall Study|Adverse Event|3|||
160932182|NCT00603746|581147924|FG002|Overall Study|Adverse Event|0|||
160932183|NCT00603746|581147925|FG003|Overall Study|Adverse Event|1|||
160932184|NCT00603746|581147926|FG004|Overall Study|Adverse Event|0|||
160932185|NCT00603746|581147927|FG005|Overall Study|Adverse Event|4|||
160932186|NCT00603746|581147922|FG000|Overall Study|Lack of Efficacy|34|||
160932187|NCT00603746|581147923|FG001|Overall Study|Lack of Efficacy|11|||
160932188|NCT00603746|581147924|FG002|Overall Study|Lack of Efficacy|6|||
160932189|NCT00603746|581147925|FG003|Overall Study|Lack of Efficacy|11|||
160932190|NCT00603746|581147926|FG004|Overall Study|Lack of Efficacy|12|||
160932191|NCT00603746|581147927|FG005|Overall Study|Lack of Efficacy|8|||
160932192|NCT00603746|581147922|FG000|Overall Study|Protocol Violation|0|||
160932193|NCT00603746|581147923|FG001|Overall Study|Protocol Violation|3|||
160932194|NCT00603746|581147924|FG002|Overall Study|Protocol Violation|1|||
160932195|NCT00603746|581147925|FG003|Overall Study|Protocol Violation|0|||
160932196|NCT00603746|581147926|FG004|Overall Study|Protocol Violation|1|||
160932197|NCT00603746|581147927|FG005|Overall Study|Protocol Violation|0|||
160932198|NCT00603746|581147922|FG000|Overall Study|Lost to Follow-up|0|||
160932199|NCT00603746|581147923|FG001|Overall Study|Lost to Follow-up|1|||
160932200|NCT00603746|581147924|FG002|Overall Study|Lost to Follow-up|1|||
160932201|NCT00603746|581147925|FG003|Overall Study|Lost to Follow-up|0|||
160932202|NCT00603746|581147926|FG004|Overall Study|Lost to Follow-up|0|||
160932203|NCT00603746|581147927|FG005|Overall Study|Lost to Follow-up|0|||
160932204|NCT00603746|581147922|FG000|Overall Study|Physician Decision|1|||
160932205|NCT00603746|581147923|FG001|Overall Study|Physician Decision|0|||
160932206|NCT00603746|581147924|FG002|Overall Study|Physician Decision|0|||
160932207|NCT00603746|581147925|FG003|Overall Study|Physician Decision|0|||
160932208|NCT00603746|581147926|FG004|Overall Study|Physician Decision|1|||
160932209|NCT00603746|581147927|FG005|Overall Study|Physician Decision|0|||
160932210|NCT00603746|581147922|FG000|Overall Study|Withdrawal by Subject|1|||
160932211|NCT00603746|581147923|FG001|Overall Study|Withdrawal by Subject|0|||
160932212|NCT00603746|581147924|FG002|Overall Study|Withdrawal by Subject|0|||
160932213|NCT00603746|581147925|FG003|Overall Study|Withdrawal by Subject|1|||
160932214|NCT00603746|581147926|FG004|Overall Study|Withdrawal by Subject|3|||
160932215|NCT00603746|581147927|FG005|Overall Study|Withdrawal by Subject|1|||
160932216|NCT01524627|581147928|FG000|Overall Study|Physician Decision|0|||
160932217|NCT01524627|581147929|FG001|Overall Study|Physician Decision|1|||
160932218|NCT01524627|581147928|FG000|Overall Study|Lost to Follow-up|1|||
160932219|NCT01524627|581147929|FG001|Overall Study|Lost to Follow-up|1|||
160932220|NCT03323658|581147930|FG000|Overall Study|Adverse Event|0|||
160932221|NCT03323658|581147931|FG001|Overall Study|Adverse Event|1|||
160998294|NCT05484726|581378624|FG001|Overall Study|Protocol Violation|3|||
160998295|NCT05484726|581378623|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
160998296|NCT05484726|581378624|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
160932222|NCT03323658|581147932|FG002|Overall Study|Adverse Event|0|||
160932223|NCT05627518|581147933|FG000|Treatment Period 1|Adverse Event|0|||
160932224|NCT05627518|581147934|FG001|Treatment Period 1|Adverse Event|0|||
160932225|NCT05627518|581147935|FG002|Treatment Period 1|Adverse Event|1|||
160932226|NCT05627518|581147936|FG003|Treatment Period 1|Adverse Event|0|||
160932227|NCT05627518|581147937|FG004|Treatment Period 1|Adverse Event|0|||
160932228|NCT05627518|581147938|FG005|Treatment Period 1|Adverse Event|0|||
160932229|NCT05627518|581147939|FG006|Treatment Period 1|Adverse Event|0|||
160932230|NCT05627518|581147940|FG007|Treatment Period 1|Adverse Event|1|||
160932231|NCT05627518|581147933|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160932232|NCT05627518|581147934|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160932233|NCT05627518|581147935|FG002|Treatment Period 1|Withdrawal by Subject|1|||
160932234|NCT05627518|581147936|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160932235|NCT05627518|581147937|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160932236|NCT05627518|581147938|FG005|Treatment Period 1|Withdrawal by Subject|1|||
160932237|NCT05627518|581147939|FG006|Treatment Period 1|Withdrawal by Subject|0|||
160932238|NCT05627518|581147940|FG007|Treatment Period 1|Withdrawal by Subject|0|||
160932239|NCT05627518|581147933|FG000|Treatment Period 1|Protocol Violation|0|||
160932240|NCT05627518|581147934|FG001|Treatment Period 1|Protocol Violation|0|||
160932241|NCT05627518|581147935|FG002|Treatment Period 1|Protocol Violation|0|||
160932242|NCT05627518|581147936|FG003|Treatment Period 1|Protocol Violation|0|||
160932243|NCT05627518|581147937|FG004|Treatment Period 1|Protocol Violation|0|||
160932244|NCT05627518|581147938|FG005|Treatment Period 1|Protocol Violation|0|||
160932245|NCT05627518|581147939|FG006|Treatment Period 1|Protocol Violation|6|||
160932246|NCT05627518|581147940|FG007|Treatment Period 1|Protocol Violation|6|||
160932247|NCT05627518|581147933|FG000|Treatment Period 2|Adverse Event|1|||
160932248|NCT05627518|581147934|FG001|Treatment Period 2|Adverse Event|0|||
160932249|NCT05627518|581147935|FG002|Treatment Period 2|Adverse Event|0|||
160932250|NCT05627518|581147936|FG003|Treatment Period 2|Adverse Event|0|||
160932251|NCT05627518|581147937|FG004|Treatment Period 2|Adverse Event|0|||
160932252|NCT05627518|581147938|FG005|Treatment Period 2|Adverse Event|0|||
160932253|NCT05627518|581147939|FG006|Treatment Period 2|Adverse Event|0|||
160932254|NCT05627518|581147940|FG007|Treatment Period 2|Adverse Event|0|||
160932255|NCT05627518|581147933|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160932256|NCT05627518|581147934|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160932257|NCT05627518|581147935|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160932258|NCT05627518|581147936|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160932259|NCT05627518|581147937|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160932260|NCT05627518|581147938|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160932261|NCT05627518|581147939|FG006|Treatment Period 2|Withdrawal by Subject|0|||
160932262|NCT05627518|581147940|FG007|Treatment Period 2|Withdrawal by Subject|0|||
160932263|NCT02223767|581150572|FG000|Overall Study|Withdrawal by Subject|4|||
160932264|NCT02223767|581150573|FG001|Overall Study|Withdrawal by Subject|4|||
160932265|NCT00192075|581150574|FG000|Overall Study|Disease Progression|23|||
160932266|NCT00192075|581150575|FG001|Overall Study|Disease Progression|6|||
160932267|NCT00192075|581150574|FG000|Overall Study|Adverse Event|1|||
160932268|NCT00192075|581150575|FG001|Overall Study|Adverse Event|3|||
160932269|NCT00192075|581150574|FG000|Overall Study|Death|0|||
160932270|NCT00192075|581150575|FG001|Overall Study|Death|1|||
160932271|NCT00192075|581150574|FG000|Overall Study|Lack of Efficacy|0|||
160932272|NCT00192075|581150575|FG001|Overall Study|Lack of Efficacy|0|||
160932273|NCT00192075|581150574|FG000|Overall Study|Physician Decision|3|||
160932274|NCT00192075|581150575|FG001|Overall Study|Physician Decision|0|||
160932275|NCT00192075|581150574|FG000|Overall Study|Withdrawal by Subject|5|||
160932276|NCT00192075|581150575|FG001|Overall Study|Withdrawal by Subject|5|||
160932277|NCT00192075|581150574|FG000|Overall Study|Patient Non-Compliance|0|||
160932278|NCT00192075|581150575|FG001|Overall Study|Patient Non-Compliance|1|||
160932279|NCT00192075|581150574|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
160932280|NCT00192075|581150575|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
160932281|NCT00192075|581150574|FG000|Overall Study|Other|5|||
160932282|NCT00192075|581150575|FG001|Overall Study|Other|2|||
160932283|NCT00779675|581150576|FG000|Treatment Period|Adverse Event|87|||
160932284|NCT00779675|581150576|FG000|Treatment Period|Treatment Failure|80|||
160932285|NCT00779675|581150576|FG000|Treatment Period|Transferred to Another Study|38|||
160932286|NCT00779675|581150576|FG000|Treatment Period|Lost to Follow-up|23|||
160932287|NCT00779675|581150576|FG000|Treatment Period|Withdrawal by Subject|46|||
160932288|NCT00779675|581150576|FG000|Treatment Period|Protocol Violation|54|||
160932289|NCT00779675|581150576|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
160932290|NCT00779675|581150576|FG000|Treatment Period|Administrative|3|||
160932291|NCT00779675|581150576|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
160932292|NCT00779675|581150576|FG000|Extended Treatment Period|Protocol Violation|13|||
160932293|NCT00779675|581150576|FG000|Extended Treatment Period|Adverse Event|6|||
160655920|NCT05630547|580120297|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
160932294|NCT00779675|581150576|FG000|Extended Treatment Period|Treatment Failure|11|||
160932295|NCT00779675|581150576|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
160932296|NCT00779675|581150576|FG000|Extended Treatment Period|Lost to Follow-up|6|||
160932297|NCT01944059|581150577|FG000|Overall Study|Lost to Follow-up|1|||
160932298|NCT01944059|581150577|FG000|Overall Study|Physician Decision|3|||
160932299|NCT01944059|581150577|FG000|Overall Study|Withdrawal by Subject|1|||
160932300|NCT01944059|581150577|FG000|Overall Study|Adverse Event|2|||
160932301|NCT00463060|581150583|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
160932302|NCT00463060|581150583|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
160932303|NCT01400841|581150584|FG000|Initial Study Phase (6 Months)|Death|1|||
160932304|NCT01400841|581150584|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
160932305|NCT00701129|581150585|FG000|Overall Study|Death|2|||
160655921|NCT05630547|580120294|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
160932306|NCT00910715|581150586|FG000|Overall Study|Lost to Follow-up|22|||
160932307|NCT00910715|581150587|FG001|Overall Study|Lost to Follow-up|26|||
160932308|NCT00910715|581150588|FG002|Overall Study|Lost to Follow-up|0|||
160932309|NCT02412631|581150591|FG000|Overall Study|Adverse Event|1|||
160932310|NCT02412631|581150592|FG001|Overall Study|Adverse Event|2|||
160932311|NCT02412631|581150591|FG000|Overall Study|Lost to Follow-up|5|||
160932312|NCT02412631|581150592|FG001|Overall Study|Lost to Follow-up|9|||
160932313|NCT02412631|581150591|FG000|Overall Study|Withdrawal by Subject|9|||
160932314|NCT02412631|581150592|FG001|Overall Study|Withdrawal by Subject|3|||
160932315|NCT02412631|581150591|FG000|Overall Study|Early stop by FDA|5|||
160932316|NCT02412631|581150592|FG001|Overall Study|Early stop by FDA|2|||
160932317|NCT02412631|581150591|FG000|Overall Study|Unspecified reason|6|||
160932318|NCT02412631|581150592|FG001|Overall Study|Unspecified reason|8|||
160932319|NCT00770120|581150593|FG000|Overall Study|Progression|31|||
160932320|NCT00770120|581150593|FG000|Overall Study|Adverse Event|11|||
160932321|NCT00770120|581150593|FG000|Overall Study|Not Protocol Specified|11|||
160932322|NCT00770120|581150593|FG000|Overall Study|Death|3|||
160932323|NCT00770120|581150593|FG000|Overall Study|Withdrawal by Subject|2|||
160932324|NCT00770120|581150593|FG000|Overall Study|Ineligible|1|||
160932325|NCT00770120|581150593|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
160932326|NCT00770120|581150593|FG000|Overall Study|Reason under Review|1|||
160932327|NCT00706966|581150594|FG000|Overall Study|Adverse Event|1|||
160932328|NCT02884089|581150599|FG000|Period 1|Dosing error|2|||
160932329|NCT02884089|581150600|FG001|Period 1|Dosing error|2|||
160932330|NCT02884089|581150601|FG002|Period 1|Dosing error|0|||
160932331|NCT02884089|581150602|FG003|Period 1|Dosing error|0|||
160932332|NCT02884089|581150599|FG000|Washout Period 1|Lost to Follow-up|0|||
160932333|NCT02884089|581150600|FG001|Washout Period 1|Lost to Follow-up|1|||
160932334|NCT02884089|581150601|FG002|Washout Period 1|Lost to Follow-up|0|||
160932335|NCT02884089|581150602|FG003|Washout Period 1|Lost to Follow-up|1|||
160932336|NCT02884089|581150599|FG000|Washout Period 1|Withdrawal by Subject|0|||
160932337|NCT02884089|581150600|FG001|Washout Period 1|Withdrawal by Subject|1|||
160932338|NCT02884089|581150601|FG002|Washout Period 1|Withdrawal by Subject|0|||
160932339|NCT02884089|581150602|FG003|Washout Period 1|Withdrawal by Subject|0|||
160932340|NCT02884089|581150599|FG000|Period 2|Adverse Event|1|||
160932341|NCT02884089|581150600|FG001|Period 2|Adverse Event|0|||
160932342|NCT02884089|581150601|FG002|Period 2|Adverse Event|0|||
160932343|NCT02884089|581150602|FG003|Period 2|Adverse Event|0|||
160932344|NCT02884089|581150599|FG000|Period 3|Withdrawal by Subject|0|||
160932345|NCT02884089|581150600|FG001|Period 3|Withdrawal by Subject|0|||
160932346|NCT02884089|581150601|FG002|Period 3|Withdrawal by Subject|1|||
160932347|NCT02884089|581150602|FG003|Period 3|Withdrawal by Subject|0|||
160932348|NCT02884089|581150599|FG000|Washout Period 3|Withdrawal by Subject|0|||
160932349|NCT02884089|581150600|FG001|Washout Period 3|Withdrawal by Subject|0|||
160932350|NCT02884089|581150601|FG002|Washout Period 3|Withdrawal by Subject|1|||
160932351|NCT02884089|581150602|FG003|Washout Period 3|Withdrawal by Subject|0|||
160932352|NCT02884089|581150599|FG000|Washout Period 3|Lost to Follow-up|0|||
160932353|NCT02884089|581150600|FG001|Washout Period 3|Lost to Follow-up|0|||
160932354|NCT02884089|581150601|FG002|Washout Period 3|Lost to Follow-up|0|||
160932355|NCT02884089|581150602|FG003|Washout Period 3|Lost to Follow-up|1|||
160932356|NCT02884089|581150599|FG000|Period 4|Withdrawal by Subject|0|||
160932357|NCT02884089|581150600|FG001|Period 4|Withdrawal by Subject|1|||
160932358|NCT02884089|581150601|FG002|Period 4|Withdrawal by Subject|0|||
160932359|NCT02884089|581150602|FG003|Period 4|Withdrawal by Subject|0|||
160932360|NCT02884089|581150599|FG000|Period 4|Lost to Follow-up|1|||
160932361|NCT02884089|581150600|FG001|Period 4|Lost to Follow-up|0|||
160932362|NCT02884089|581150601|FG002|Period 4|Lost to Follow-up|0|||
160932363|NCT02884089|581150602|FG003|Period 4|Lost to Follow-up|0|||
160932364|NCT02884089|581150599|FG000|Follow-up Visit|Withdrawal by Subject|1|||
160932365|NCT02884089|581150600|FG001|Follow-up Visit|Withdrawal by Subject|0|||
160998297|NCT05484726|581378623|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
160998298|NCT05484726|581378624|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
160998299|NCT05484726|581378623|FG000|Overall Study|continued need of mechanical ventilation|2|||
160655922|NCT05630547|580120295|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
160932366|NCT02884089|581150601|FG002|Follow-up Visit|Withdrawal by Subject|0|||
160932367|NCT02884089|581150602|FG003|Follow-up Visit|Withdrawal by Subject|1|||
160932368|NCT01631474|581150603|FG000|Overall Study|Lost to Follow-up|8|||
160932369|NCT01631474|581150604|FG001|Overall Study|Lost to Follow-up|5|||
160932370|NCT01631474|581150605|FG002|Overall Study|Lost to Follow-up|7|||
160932371|NCT01631474|581150606|FG003|Overall Study|Lost to Follow-up|5|||
160932372|NCT01631474|581150607|FG004|Overall Study|Lost to Follow-up|5|||
160932373|NCT01631474|581150603|FG000|Overall Study|Withdrawal by Subject|4|||
160932374|NCT01631474|581150604|FG001|Overall Study|Withdrawal by Subject|4|||
160932375|NCT01631474|581150605|FG002|Overall Study|Withdrawal by Subject|2|||
160932376|NCT01631474|581150606|FG003|Overall Study|Withdrawal by Subject|6|||
160932377|NCT01631474|581150607|FG004|Overall Study|Withdrawal by Subject|5|||
160932378|NCT01631474|581150603|FG000|Overall Study|Lack of Efficacy|2|||
160932379|NCT01631474|581150604|FG001|Overall Study|Lack of Efficacy|2|||
160932380|NCT01631474|581150605|FG002|Overall Study|Lack of Efficacy|0|||
160932381|NCT01631474|581150606|FG003|Overall Study|Lack of Efficacy|0|||
160932382|NCT01631474|581150607|FG004|Overall Study|Lack of Efficacy|2|||
160932383|NCT01631474|581150603|FG000|Overall Study|Noncompliance with Study Drug|0|||
160932384|NCT01631474|581150604|FG001|Overall Study|Noncompliance with Study Drug|0|||
160932385|NCT01631474|581150605|FG002|Overall Study|Noncompliance with Study Drug|0|||
160932386|NCT01631474|581150606|FG003|Overall Study|Noncompliance with Study Drug|0|||
160932387|NCT01631474|581150607|FG004|Overall Study|Noncompliance with Study Drug|1|||
160932388|NCT01631474|581150603|FG000|Overall Study|Adverse Event|0|||
160932389|NCT01631474|581150604|FG001|Overall Study|Adverse Event|1|||
160932390|NCT01631474|581150605|FG002|Overall Study|Adverse Event|0|||
160932391|NCT01631474|581150606|FG003|Overall Study|Adverse Event|0|||
160932392|NCT01631474|581150607|FG004|Overall Study|Adverse Event|0|||
160932393|NCT01467076|581150608|FG000|Overall Study|Lost to Follow-up|1|||
160932394|NCT01467076|581150609|FG001|Overall Study|Lost to Follow-up|0|||
160932395|NCT01467076|581150610|FG002|Overall Study|Lost to Follow-up|0|||
160932396|NCT00654381|581150615|FG000|1st Stage|Adverse Event|3|||
160932397|NCT00654381|581150616|FG001|1st Stage|Adverse Event|3|||
160932398|NCT00654381|581150617|FG002|1st Stage|Adverse Event|3|||
160932399|NCT00654381|581150618|FG003|1st Stage|Adverse Event|3|||
160932400|NCT00654381|581150619|FG004|1st Stage|Adverse Event|2|||
160932401|NCT00654381|581150620|FG005|1st Stage|Adverse Event|1|||
160932402|NCT00654381|581150615|FG000|1st Stage|Withdrawal by Subject|0|||
160932403|NCT00654381|581150616|FG001|1st Stage|Withdrawal by Subject|0|||
160932404|NCT00654381|581150617|FG002|1st Stage|Withdrawal by Subject|0|||
160932405|NCT00654381|581150618|FG003|1st Stage|Withdrawal by Subject|1|||
160932406|NCT00654381|581150619|FG004|1st Stage|Withdrawal by Subject|0|||
160932407|NCT00654381|581150620|FG005|1st Stage|Withdrawal by Subject|1|||
160932408|NCT00654381|581150615|FG000|1st Stage|Investigator's decision|0|||
160932409|NCT00654381|581150616|FG001|1st Stage|Investigator's decision|0|||
160932410|NCT00654381|581150617|FG002|1st Stage|Investigator's decision|0|||
160932411|NCT00654381|581150618|FG003|1st Stage|Investigator's decision|1|||
160932412|NCT00654381|581150619|FG004|1st Stage|Investigator's decision|0|||
160932413|NCT00654381|581150620|FG005|1st Stage|Investigator's decision|0|||
160932414|NCT00654381|581150615|FG000|2nd Stage|Adverse Event|2|||
160998300|NCT05484726|581378624|FG001|Overall Study|continued need of mechanical ventilation|3|||
160998301|NCT05484726|581378623|FG000|Overall Study|Withdrawal by Subject|2|||
160998302|NCT05484726|581378624|FG001|Overall Study|Withdrawal by Subject|3|||
160998303|NCT05484726|581378623|FG000|Overall Study|IVH (G III & IV)|2|||
160998304|NCT05484726|581378624|FG001|Overall Study|IVH (G III & IV)|1|||
160998305|NCT05484726|581378623|FG000|Overall Study|NEC (stage II & III)|2|||
160998306|NCT05484726|581378624|FG001|Overall Study|NEC (stage II & III)|3|||
160998307|NCT04550039|581378632|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
160998308|NCT04550039|581378633|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
160998309|NCT04550039|581378632|FG000|Overall Study|patient self-withdrew from study|0|||
160998310|NCT04550039|581378633|FG001|Overall Study|patient self-withdrew from study|1|||
160998311|NCT04391309|581378634|FG000|Overall Study|Death|1|||
160998312|NCT04391309|581378635|FG001|Overall Study|Death|1|||
160998313|NCT04391309|581378634|FG000|Overall Study|Lost to Follow-up|3|||
160998314|NCT04391309|581378635|FG001|Overall Study|Lost to Follow-up|2|||
160998315|NCT04391309|581378634|FG000|Overall Study|Withdrawal by Subject|2|||
160578339|NCT01070550|579838294|FG000|Overall Study|Treatment stopped|3|||
160578340|NCT01070550|579838295|FG001|Overall Study|Treatment stopped|0|||
160578341|NCT01070550|579838296|FG002|Overall Study|Treatment stopped|0|||
160578342|NCT01070550|579838297|FG003|Overall Study|Treatment stopped|0|||
160578343|NCT01070550|579838298|FG004|Overall Study|Treatment stopped|0|||
160932415|NCT00654381|581150616|FG001|2nd Stage|Adverse Event|0|||
160932416|NCT00654381|581150617|FG002|2nd Stage|Adverse Event|2|||
160932417|NCT00654381|581150618|FG003|2nd Stage|Adverse Event|3|||
160932418|NCT00654381|581150619|FG004|2nd Stage|Adverse Event|7|||
160932419|NCT00654381|581150620|FG005|2nd Stage|Adverse Event|2|||
160932420|NCT00654381|581150615|FG000|2nd Stage|Withdrawal by Subject|0|||
160932421|NCT00654381|581150616|FG001|2nd Stage|Withdrawal by Subject|0|||
160578344|NCT01070550|579838299|FG005|Overall Study|Treatment stopped|0|||
160578345|NCT01070550|579838294|FG000|Overall Study|Treatment unavailable|1|||
160578346|NCT01070550|579838295|FG001|Overall Study|Treatment unavailable|0|||
160932422|NCT00654381|581150617|FG002|2nd Stage|Withdrawal by Subject|0|||
160932423|NCT00654381|581150618|FG003|2nd Stage|Withdrawal by Subject|0|||
160998316|NCT04391309|581378635|FG001|Overall Study|Withdrawal by Subject|2|||
160998317|NCT02781584|581378636|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
160998318|NCT02781584|581378637|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
160998319|NCT02781584|581378638|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
160578347|NCT01070550|579838296|FG002|Overall Study|Treatment unavailable|0|||
160578348|NCT01070550|579838297|FG003|Overall Study|Treatment unavailable|0|||
160932424|NCT00654381|581150619|FG004|2nd Stage|Withdrawal by Subject|1|||
160932425|NCT00654381|581150620|FG005|2nd Stage|Withdrawal by Subject|1|||
160932426|NCT00654381|581150615|FG000|2nd Stage|Investigator's decision|0|||
160998320|NCT02781584|581378639|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
160998321|NCT02781584|581378640|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
160932427|NCT00654381|581150616|FG001|2nd Stage|Investigator's decision|0|||
160932428|NCT00654381|581150617|FG002|2nd Stage|Investigator's decision|1|||
160932429|NCT00654381|581150618|FG003|2nd Stage|Investigator's decision|1|||
160932430|NCT00654381|581150619|FG004|2nd Stage|Investigator's decision|0|||
160932431|NCT00654381|581150620|FG005|2nd Stage|Investigator's decision|0|||
160932432|NCT00654381|581150615|FG000|Extension Stage|Adverse Event|1|||
160932433|NCT00654381|581150616|FG001|Extension Stage|Adverse Event|2|||
160932434|NCT00654381|581150617|FG002|Extension Stage|Adverse Event|9|||
160932435|NCT00654381|581150618|FG003|Extension Stage|Adverse Event|7|||
160932436|NCT00654381|581150619|FG004|Extension Stage|Adverse Event|1|||
160932437|NCT00654381|581150620|FG005|Extension Stage|Adverse Event|1|||
160932438|NCT00654381|581150615|FG000|Extension Stage|Protocol Violation|0|||
160932439|NCT00654381|581150616|FG001|Extension Stage|Protocol Violation|0|||
160932440|NCT00654381|581150617|FG002|Extension Stage|Protocol Violation|0|||
160932441|NCT00654381|581150618|FG003|Extension Stage|Protocol Violation|1|||
160932442|NCT00654381|581150619|FG004|Extension Stage|Protocol Violation|0|||
160932443|NCT00654381|581150620|FG005|Extension Stage|Protocol Violation|0|||
160932444|NCT00654381|581150615|FG000|Extension Stage|Lack of Efficacy|0|||
160932445|NCT00654381|581150616|FG001|Extension Stage|Lack of Efficacy|0|||
160932446|NCT00654381|581150617|FG002|Extension Stage|Lack of Efficacy|1|||
160932447|NCT00654381|581150618|FG003|Extension Stage|Lack of Efficacy|0|||
160932448|NCT00654381|581150619|FG004|Extension Stage|Lack of Efficacy|0|||
160932449|NCT00654381|581150620|FG005|Extension Stage|Lack of Efficacy|0|||
160932450|NCT00654381|581150615|FG000|Extension Stage|Withdrawal by Subject|0|||
160932451|NCT00654381|581150616|FG001|Extension Stage|Withdrawal by Subject|0|||
160932452|NCT00654381|581150617|FG002|Extension Stage|Withdrawal by Subject|1|||
160932453|NCT00654381|581150618|FG003|Extension Stage|Withdrawal by Subject|1|||
160932454|NCT00654381|581150619|FG004|Extension Stage|Withdrawal by Subject|1|||
160932455|NCT00654381|581150620|FG005|Extension Stage|Withdrawal by Subject|1|||
160932456|NCT00654381|581150615|FG000|Extension Stage|Closure of the trial site|0|||
160932457|NCT00654381|581150616|FG001|Extension Stage|Closure of the trial site|0|||
160932458|NCT00654381|581150617|FG002|Extension Stage|Closure of the trial site|0|||
160932459|NCT00654381|581150618|FG003|Extension Stage|Closure of the trial site|0|||
160932460|NCT00654381|581150619|FG004|Extension Stage|Closure of the trial site|1|||
160932461|NCT00654381|581150620|FG005|Extension Stage|Closure of the trial site|1|||
160932462|NCT05288556|581150621|FG000|Overall Study|Protocol Violation|1|||
160932463|NCT05288556|581150621|FG000|Overall Study|Withdrawal by Subject|1|||
160932464|NCT00578175|581150622|FG000|Overall Study|Adverse Event|0|||
160932465|NCT00578175|581150623|FG001|Overall Study|Adverse Event|1|||
160932466|NCT00578175|581150624|FG002|Overall Study|Adverse Event|1|||
160932467|NCT00578175|581150622|FG000|Overall Study|Other reasons|70|||
160932468|NCT00578175|581150623|FG001|Overall Study|Other reasons|42|||
160932469|NCT00578175|581150624|FG002|Overall Study|Other reasons|23|||
160932470|NCT01232296|581150630|FG000|Overall Study|Adverse Event|24|||
160932471|NCT01232296|581150631|FG001|Overall Study|Adverse Event|12|||
160932472|NCT01232296|581150630|FG000|Overall Study|Physician Decision|1|||
160932473|NCT01232296|581150631|FG001|Overall Study|Physician Decision|1|||
160932474|NCT01232296|581150630|FG000|Overall Study|Progressive disease|43|||
160932475|NCT01232296|581150631|FG001|Overall Study|Progressive disease|61|||
160932476|NCT01232296|581150630|FG000|Overall Study|Study terminated by sponsor|0|||
160578349|NCT01070550|579838298|FG004|Overall Study|Treatment unavailable|0|||
160578350|NCT01070550|579838299|FG005|Overall Study|Treatment unavailable|0|||
160578351|NCT01070550|579838294|FG000|Overall Study|Treatment was stopped early|7|||
160578352|NCT01070550|579838295|FG001|Overall Study|Treatment was stopped early|0|||
160578353|NCT01070550|579838296|FG002|Overall Study|Treatment was stopped early|0|||
160578354|NCT01070550|579838297|FG003|Overall Study|Treatment was stopped early|0|||
160578355|NCT01070550|579838298|FG004|Overall Study|Treatment was stopped early|0|||
160578356|NCT01070550|579838299|FG005|Overall Study|Treatment was stopped early|0|||
160578357|NCT01070550|579838294|FG000|Overall Study|Other|5|||
160578358|NCT01070550|579838295|FG001|Overall Study|Other|0|||
160578359|NCT01070550|579838296|FG002|Overall Study|Other|0|||
160578360|NCT01070550|579838297|FG003|Overall Study|Other|1|||
160578361|NCT01070550|579838298|FG004|Overall Study|Other|0|||
160578362|NCT01070550|579838299|FG005|Overall Study|Other|0|||
160655923|NCT05630547|580120296|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
160655924|NCT05630547|580120297|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
160578363|NCT01070550|579838294|FG000|Overall Study|Withdrawal by Subject|35|||
160578364|NCT01070550|579838295|FG001|Overall Study|Withdrawal by Subject|0|||
160578365|NCT01070550|579838296|FG002|Overall Study|Withdrawal by Subject|3|||
160578366|NCT01070550|579838297|FG003|Overall Study|Withdrawal by Subject|0|||
160578367|NCT01070550|579838298|FG004|Overall Study|Withdrawal by Subject|0|||
160578368|NCT01070550|579838299|FG005|Overall Study|Withdrawal by Subject|0|||
160578369|NCT01702363|579838301|FG000|Overall Study|Adverse Event|14|||
160932477|NCT01232296|581150631|FG001|Overall Study|Study terminated by sponsor|1|||
160932478|NCT01232296|581150630|FG000|Overall Study|Technical problems|3|||
160932479|NCT01232296|581150631|FG001|Overall Study|Technical problems|0|||
160932480|NCT01232296|581150630|FG000|Overall Study|Subject/guardian decision|10|||
160932481|NCT01232296|581150631|FG001|Overall Study|Subject/guardian decision|2|||
160932482|NCT01232296|581150630|FG000|Overall Study|Death|1|||
160932483|NCT01232296|581150631|FG001|Overall Study|Death|6|||
160932484|NCT01461096|581150633|FG000|Overall Study|Death|3|||
160932485|NCT01461096|581150634|FG001|Overall Study|Death|6|||
160932486|NCT01461096|581150633|FG000|Overall Study|Severe debilitation, unable to continue|1|||
160932487|NCT01461096|581150634|FG001|Overall Study|Severe debilitation, unable to continue|1|||
160932488|NCT01461096|581150633|FG000|Overall Study|Subj not able to get to clinic|15|||
160932489|NCT01461096|581150634|FG001|Overall Study|Subj not able to get to clinic|13|||
160932490|NCT01461096|581150633|FG000|Overall Study|Site is closing|27|||
160932491|NCT01461096|581150634|FG001|Overall Study|Site is closing|30|||
160932492|NCT01461096|581150633|FG000|Overall Study|Withdrawal by Subject|5|||
160932493|NCT01461096|581150634|FG001|Overall Study|Withdrawal by Subject|3|||
160932494|NCT01461096|581150633|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
160932495|NCT01461096|581150634|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
160932496|NCT01461096|581150633|FG000|Overall Study|Lost to Follow-up|8|||
160932497|NCT01461096|581150634|FG001|Overall Study|Lost to Follow-up|4|||
160932498|NCT04889625|581150636|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
160932499|NCT04889625|581150637|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
160932500|NCT04889625|581150636|FG000|Period 1|Subject out of window|0|||
160932501|NCT04889625|581150637|FG001|Period 1|Subject out of window|1|||
160932502|NCT04889625|581150636|FG000|Period 1|Wrong add power dispensed|0|||
160932503|NCT04889625|581150637|FG001|Period 1|Wrong add power dispensed|1|||
160932504|NCT04889625|581150636|FG000|Period 1|Discontinued due to fitting guide error|1|||
160932505|NCT04889625|581150637|FG001|Period 1|Discontinued due to fitting guide error|1|||
160932506|NCT04889625|581150636|FG000|Period 2|Test article no longer available|1|||
160932507|NCT04889625|581150637|FG001|Period 2|Test article no longer available|0|||
160932508|NCT04889625|581150636|FG000|Period 2|Incorrect lens dispensed|1|||
160932509|NCT04889625|581150637|FG001|Period 2|Incorrect lens dispensed|0|||
160932510|NCT04889625|581150636|FG000|Period 2|Wrong add power dispensed|0|||
160932511|NCT04889625|581150637|FG001|Period 2|Wrong add power dispensed|1|||
160932512|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
160932513|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
160932514|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
160932515|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
160932516|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
160932517|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
160932518|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
160932519|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
160578370|NCT01702363|579838301|FG000|Overall Study|Lack of Efficacy|4|||
160578371|NCT01702363|579838301|FG000|Overall Study|Withdrawal by Subject|2|||
160578372|NCT01312428|579838302|FG000|Overall Study|Study Termination|3|||
160578373|NCT01312428|579838303|FG001|Overall Study|Study Termination|4|||
160578374|NCT00431847|579838309|FG000|Overall Study|completion of less than two study visits|6|||
160578375|NCT00431847|579838310|FG001|Overall Study|completion of less than two study visits|3|||
160578376|NCT00431847|579838311|FG002|Overall Study|completion of less than two study visits|4|||
160578377|NCT00431847|579838312|FG003|Overall Study|completion of less than two study visits|14|||
160578378|NCT00431847|579838313|FG004|Overall Study|completion of less than two study visits|0|||
160578379|NCT00431847|579838309|FG000|Overall Study|Protocol Violation|0|||
160578380|NCT00431847|579838310|FG001|Overall Study|Protocol Violation|0|||
160578381|NCT00431847|579838311|FG002|Overall Study|Protocol Violation|0|||
160578382|NCT00431847|579838312|FG003|Overall Study|Protocol Violation|0|||
160578383|NCT00431847|579838313|FG004|Overall Study|Protocol Violation|1|||
160578384|NCT00339183|579838316|FG000|Overall Study|Adverse Event|5|||
160578385|NCT00339183|579838317|FG001|Overall Study|Adverse Event|3|||
160578386|NCT00339183|579838316|FG000|Overall Study|Withdrawal by Subject|16|||
160578387|NCT00339183|579838317|FG001|Overall Study|Withdrawal by Subject|19|||
160578388|NCT00339183|579838316|FG000|Overall Study|Physician Decision|2|||
160932520|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
160578389|NCT00339183|579838317|FG001|Overall Study|Physician Decision|4|||
160578390|NCT00339183|579838316|FG000|Overall Study|Lost to Follow-up|17|||
160578391|NCT00339183|579838317|FG001|Overall Study|Lost to Follow-up|17|||
160578392|NCT00339183|579838316|FG000|Overall Study|Protocol-specified criteria|12|||
160578393|NCT00339183|579838317|FG001|Overall Study|Protocol-specified criteria|8|||
160578394|NCT00339183|579838316|FG000|Overall Study|Missing reason|3|||
160578395|NCT00339183|579838317|FG001|Overall Study|Missing reason|1|||
160578396|NCT00339183|579838316|FG000|Overall Study|Other|46|||
160578397|NCT00339183|579838317|FG001|Overall Study|Other|40|||
160578398|NCT00339183|579838316|FG000|Overall Study|Ongoing|20|||
160578399|NCT00339183|579838317|FG001|Overall Study|Ongoing|13|||
160578400|NCT00793819|579838318|FG000|Overall Study|Adverse Event|8|||
160578401|NCT00793819|579838319|FG001|Overall Study|Adverse Event|4|||
160932521|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
160932522|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
160932523|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
160932524|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
160932525|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
160932526|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
160932527|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
160932528|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
160932529|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
160932530|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Death|0|||
160932531|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Death|0|||
160932532|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Death|1|||
160932533|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Death|0|||
160932534|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Death|0|||
160932535|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Death|0|||
160932536|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Death|0|||
160932537|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Death|0|||
160932538|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Death|0|||
160932539|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
160932540|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
160932541|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
160932542|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932543|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932544|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932545|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932546|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932547|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932548|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
160932549|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
160932550|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
160932551|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932552|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932553|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932554|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932555|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932556|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932557|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
160932558|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
160932559|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
160932560|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
160932561|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
160932562|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
160932563|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
160932564|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
160932565|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
160932566|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
160932567|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
160932568|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
160932569|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
160932570|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
160932571|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
160932572|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
160932573|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
160932574|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
160932575|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
160932576|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
160932577|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
160932578|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160932579|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160455085|NCT05485779|579397834|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
160455086|NCT05485779|579397835|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
160578402|NCT00793819|579838318|FG000|Overall Study|Lack of Efficacy|1|||
160578403|NCT00793819|579838319|FG001|Overall Study|Lack of Efficacy|1|||
160578404|NCT00793819|579838318|FG000|Overall Study|Withdrawal by Subject|4|||
160578405|NCT00793819|579838319|FG001|Overall Study|Withdrawal by Subject|3|||
160578406|NCT00793819|579838318|FG000|Overall Study|Lost to Follow-up|1|||
160578407|NCT00793819|579838319|FG001|Overall Study|Lost to Follow-up|1|||
160455087|NCT05485779|579397836|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
160578408|NCT00002663|579838320|FG000|Overall Study|Death|4|||
160578409|NCT00002663|579838321|FG001|Overall Study|Death|1|||
160578410|NCT00002663|579838322|FG002|Overall Study|Death|1|||
160578411|NCT00002663|579838323|FG003|Overall Study|Death|0|||
160578412|NCT00002663|579838324|FG004|Overall Study|Death|0|||
160578413|NCT00002663|579838325|FG005|Overall Study|Death|13|||
160578414|NCT00002663|579838326|FG006|Overall Study|Death|0|||
160932580|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160932581|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160932582|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160932583|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160932584|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932585|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
160932586|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932587|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932588|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932589|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932590|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932591|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932592|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932593|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
160932594|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
160932595|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
160932596|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
160932597|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
160932598|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
160932599|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
160932600|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
160932601|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
160932602|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Other|0|||
160932603|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Other|1|||
160932604|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Other|0|||
160932605|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Other|0|||
160932606|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Other|0|||
160932607|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Other|0|||
160932608|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Other|0|||
160932609|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Other|0|||
160932610|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Other|0|||
160932611|NCT00404352|581150640|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
160455088|NCT05485779|579397826|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
160932612|NCT00404352|581150641|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
160932613|NCT00404352|581150642|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
160932614|NCT00404352|581150643|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
160932615|NCT00404352|581150644|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
160932616|NCT00404352|581150645|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
160932617|NCT00404352|581150646|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
160932618|NCT00404352|581150647|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
160932619|NCT00404352|581150648|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
160932620|NCT00404352|581150640|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
160932621|NCT00404352|581150641|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
160932622|NCT00404352|581150642|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
160932623|NCT00404352|581150643|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
160932624|NCT00404352|581150644|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
160932625|NCT00404352|581150645|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
160932626|NCT00404352|581150646|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
160932627|NCT00404352|581150647|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
160932628|NCT00404352|581150648|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
160932629|NCT00404352|581150640|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932630|NCT00404352|581150641|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932631|NCT00404352|581150642|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932632|NCT00404352|581150643|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932633|NCT00404352|581150644|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
160932634|NCT00404352|581150645|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932635|NCT00404352|581150646|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932636|NCT00404352|581150647|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932637|NCT00404352|581150648|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932638|NCT00404352|581150640|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932639|NCT00404352|581150641|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932640|NCT00404352|581150642|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932641|NCT00404352|581150643|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160455089|NCT05485779|579397827|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
160455090|NCT05485779|579397828|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
160455091|NCT05485779|579397829|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
160455092|NCT05485779|579397830|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
160932642|NCT00404352|581150644|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932643|NCT00404352|581150645|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
160932644|NCT00404352|581150646|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932645|NCT00404352|581150647|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932646|NCT00404352|581150648|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932647|NCT00404352|581150640|FG000|Open Label (up to 24 Month)|Disease progression|0|||
160932648|NCT00404352|581150641|FG001|Open Label (up to 24 Month)|Disease progression|0|||
160932649|NCT00404352|581150642|FG002|Open Label (up to 24 Month)|Disease progression|0|||
160932650|NCT00404352|581150643|FG003|Open Label (up to 24 Month)|Disease progression|1|||
160932651|NCT00404352|581150644|FG004|Open Label (up to 24 Month)|Disease progression|0|||
160932652|NCT00404352|581150645|FG005|Open Label (up to 24 Month)|Disease progression|0|||
160932653|NCT00404352|581150646|FG006|Open Label (up to 24 Month)|Disease progression|0|||
160932654|NCT00404352|581150647|FG007|Open Label (up to 24 Month)|Disease progression|0|||
160932655|NCT00404352|581150648|FG008|Open Label (up to 24 Month)|Disease progression|0|||
160932656|NCT00404352|581150640|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932657|NCT00404352|581150641|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932658|NCT00404352|581150642|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932659|NCT00404352|581150643|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932660|NCT00404352|581150644|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932661|NCT00404352|581150645|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932662|NCT00404352|581150646|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
160932663|NCT00404352|581150647|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
160932664|NCT00404352|581150648|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932665|NCT00404352|581150640|FG000|Open Label Extension (up to 36 Months)|Other|0|||
160932666|NCT00404352|581150641|FG001|Open Label Extension (up to 36 Months)|Other|0|||
160932667|NCT00404352|581150642|FG002|Open Label Extension (up to 36 Months)|Other|0|||
160932668|NCT00404352|581150643|FG003|Open Label Extension (up to 36 Months)|Other|0|||
160932669|NCT00404352|581150644|FG004|Open Label Extension (up to 36 Months)|Other|0|||
160932670|NCT00404352|581150645|FG005|Open Label Extension (up to 36 Months)|Other|0|||
160932671|NCT00404352|581150646|FG006|Open Label Extension (up to 36 Months)|Other|0|||
160932672|NCT00404352|581150647|FG007|Open Label Extension (up to 36 Months)|Other|0|||
160932673|NCT00404352|581150648|FG008|Open Label Extension (up to 36 Months)|Other|2|||
160932674|NCT02346136|581150649|FG000|Overall Study|Withdrawal by Subject|7|||
160932675|NCT02346136|581150650|FG001|Overall Study|Withdrawal by Subject|5|||
160932676|NCT02346136|581150649|FG000|Overall Study|Death|1|||
160932677|NCT02346136|581150650|FG001|Overall Study|Death|0|||
160932678|NCT02346136|581150649|FG000|Overall Study|Study termination|14|||
160932679|NCT02346136|581150650|FG001|Overall Study|Study termination|18|||
160932680|NCT00582933|581150654|FG000|Overall Study|Physician Decision|3|||
160932681|NCT03316885|581150657|FG000|Overall Study|Adverse Event|1|||
160932682|NCT03316885|581150657|FG000|Overall Study|Death|10|||
160932683|NCT03316885|581150657|FG000|Overall Study|Lost to Follow-up|4|||
160932684|NCT03316885|581150657|FG000|Overall Study|Withdrawal by Subject|9|||
160932685|NCT03316885|581150657|FG000|Overall Study|COVID related|8|||
160578415|NCT00002663|579838327|FG007|Overall Study|Death|1|||
160578416|NCT00002663|579838328|FG008|Overall Study|Death|1|||
160578417|NCT00002663|579838329|FG009|Overall Study|Death|1|||
160578418|NCT00002663|579838320|FG000|Overall Study|Lost to Follow-up|3|||
160578419|NCT00002663|579838321|FG001|Overall Study|Lost to Follow-up|0|||
160578420|NCT00002663|579838322|FG002|Overall Study|Lost to Follow-up|0|||
160578421|NCT00002663|579838323|FG003|Overall Study|Lost to Follow-up|1|||
160578422|NCT00002663|579838324|FG004|Overall Study|Lost to Follow-up|0|||
160578423|NCT00002663|579838325|FG005|Overall Study|Lost to Follow-up|1|||
160578424|NCT00002663|579838326|FG006|Overall Study|Lost to Follow-up|0|||
160578425|NCT00002663|579838327|FG007|Overall Study|Lost to Follow-up|0|||
160578426|NCT00002663|579838328|FG008|Overall Study|Lost to Follow-up|0|||
160578427|NCT00002663|579838329|FG009|Overall Study|Lost to Follow-up|0|||
160578428|NCT00002663|579838320|FG000|Overall Study|Other|0|||
160578429|NCT00002663|579838321|FG001|Overall Study|Other|1|||
160578430|NCT00002663|579838322|FG002|Overall Study|Other|0|||
160578431|NCT00002663|579838323|FG003|Overall Study|Other|0|||
160578432|NCT00002663|579838324|FG004|Overall Study|Other|0|||
160932686|NCT01736696|581150665|FG000|Overall Study|Withdrawal by Subject|0|||
160932687|NCT01736696|581150666|FG001|Overall Study|Withdrawal by Subject|0|||
160932688|NCT01736696|581150667|FG002|Overall Study|Withdrawal by Subject|1|||
160932689|NCT01736696|581150668|FG003|Overall Study|Withdrawal by Subject|0|||
160932690|NCT01736696|581150669|FG004|Overall Study|Withdrawal by Subject|0|||
160932691|NCT01736696|581150670|FG005|Overall Study|Withdrawal by Subject|0|||
160578433|NCT00002663|579838325|FG005|Overall Study|Other|1|||
160578434|NCT00002663|579838326|FG006|Overall Study|Other|1|||
160578435|NCT00002663|579838327|FG007|Overall Study|Other|0|||
160578436|NCT00002663|579838328|FG008|Overall Study|Other|0|||
160578437|NCT00002663|579838329|FG009|Overall Study|Other|0|||
160578438|NCT00002663|579838320|FG000|Overall Study|Physician Decision|0|||
160578439|NCT00002663|579838321|FG001|Overall Study|Physician Decision|0|||
160578440|NCT00002663|579838322|FG002|Overall Study|Physician Decision|0|||
160932692|NCT01736696|581150671|FG006|Overall Study|Withdrawal by Subject|0|||
160932693|NCT01116232|581150672|FG000|Overall Study|Progressive diease|4|||
160932694|NCT00405548|581150673|FG000|Overall Study|Cognitive Memory problems on study day|1|||
160932695|NCT00405548|581150674|FG001|Overall Study|Cognitive Memory problems on study day|0|||
160932696|NCT00405548|581150673|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
160932697|NCT00405548|581150674|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
160932698|NCT00405548|581150673|FG000|Overall Study|Unable to self-administer shots|1|||
160932699|NCT00405548|581150674|FG001|Overall Study|Unable to self-administer shots|0|||
160932700|NCT00405548|581150673|FG000|Overall Study|Venous access failed during study day|1|||
160932701|NCT00405548|581150674|FG001|Overall Study|Venous access failed during study day|0|||
160932702|NCT00405548|581150673|FG000|Overall Study|Withdrawal by Subject|1|||
160932703|NCT00405548|581150674|FG001|Overall Study|Withdrawal by Subject|0|||
160932704|NCT02036502|581150675|FG000|Part 1:Dose Determination/Escalation|Death|3|||
160932705|NCT02036502|581150676|FG001|Part 1:Dose Determination/Escalation|Death|2|||
160932706|NCT02036502|581150677|FG002|Part 1:Dose Determination/Escalation|Death|0|||
160932707|NCT02036502|581150678|FG003|Part 1:Dose Determination/Escalation|Death|0|||
160932708|NCT02036502|581150679|FG004|Part 1:Dose Determination/Escalation|Death|0|||
160932709|NCT02036502|581150680|FG005|Part 1:Dose Determination/Escalation|Death|0|||
160932710|NCT02036502|581150681|FG006|Part 1:Dose Determination/Escalation|Death|0|||
160932711|NCT02036502|581150682|FG007|Part 1:Dose Determination/Escalation|Death|0|||
160932712|NCT02036502|581150675|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
160932713|NCT02036502|581150676|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932714|NCT02036502|581150677|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932715|NCT02036502|581150678|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932716|NCT02036502|581150679|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932717|NCT02036502|581150680|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932718|NCT02036502|581150681|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932719|NCT02036502|581150682|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932720|NCT02036502|581150675|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160932721|NCT02036502|581150676|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
160932722|NCT02036502|581150677|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160998322|NCT02781584|581378641|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
160998323|NCT02781584|581378642|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
160998324|NCT02781584|581378643|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
160998325|NCT02781584|581378644|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
160998326|NCT02781584|581378645|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
160998327|NCT02781584|581378646|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
160998328|NCT02781584|581378647|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
160998329|NCT02781584|581378648|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
160998330|NCT02781584|581378636|FG000|Pre-treatment Phase|Adverse Event|0|||
160998331|NCT02781584|581378637|FG001|Pre-treatment Phase|Adverse Event|0|||
160998332|NCT02781584|581378638|FG002|Pre-treatment Phase|Adverse Event|0|||
160998333|NCT02781584|581378639|FG003|Pre-treatment Phase|Adverse Event|0|||
160998334|NCT02781584|581378640|FG004|Pre-treatment Phase|Adverse Event|0|||
160998335|NCT02781584|581378641|FG005|Pre-treatment Phase|Adverse Event|0|||
160998336|NCT02781584|581378642|FG006|Pre-treatment Phase|Adverse Event|0|||
160998337|NCT02781584|581378643|FG007|Pre-treatment Phase|Adverse Event|0|||
160998338|NCT02781584|581378644|FG008|Pre-treatment Phase|Adverse Event|0|||
160998339|NCT02781584|581378645|FG009|Pre-treatment Phase|Adverse Event|0|||
160998340|NCT02781584|581378646|FG010|Pre-treatment Phase|Adverse Event|0|||
160998341|NCT02781584|581378647|FG011|Pre-treatment Phase|Adverse Event|1|||
160998342|NCT02781584|581378648|FG012|Pre-treatment Phase|Adverse Event|0|||
160998343|NCT02781584|581378636|FG000|Treatment Phase|Withdrew Consent|0|||
160998344|NCT02781584|581378637|FG001|Treatment Phase|Withdrew Consent|0|||
160998345|NCT02781584|581378638|FG002|Treatment Phase|Withdrew Consent|0|||
160998346|NCT02781584|581378639|FG003|Treatment Phase|Withdrew Consent|0|||
160998347|NCT02781584|581378640|FG004|Treatment Phase|Withdrew Consent|0|||
160998348|NCT02781584|581378641|FG005|Treatment Phase|Withdrew Consent|1|||
160578441|NCT00002663|579838323|FG003|Overall Study|Physician Decision|0|||
160578442|NCT00002663|579838324|FG004|Overall Study|Physician Decision|1|||
160998349|NCT02781584|581378642|FG006|Treatment Phase|Withdrew Consent|0|||
160998350|NCT02781584|581378643|FG007|Treatment Phase|Withdrew Consent|0|||
160578443|NCT00002663|579838325|FG005|Overall Study|Physician Decision|0|||
160932723|NCT02036502|581150678|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160998351|NCT02781584|581378644|FG008|Treatment Phase|Withdrew Consent|0|||
160998352|NCT02781584|581378645|FG009|Treatment Phase|Withdrew Consent|0|||
160998353|NCT02781584|581378646|FG010|Treatment Phase|Withdrew Consent|1|||
160998354|NCT02781584|581378647|FG011|Treatment Phase|Withdrew Consent|2|||
160998355|NCT02781584|581378648|FG012|Treatment Phase|Withdrew Consent|0|||
160998356|NCT02781584|581378636|FG000|Treatment Phase|Adverse Event|0|||
160998357|NCT02781584|581378637|FG001|Treatment Phase|Adverse Event|0|||
160998358|NCT02781584|581378638|FG002|Treatment Phase|Adverse Event|0|||
160998359|NCT02781584|581378639|FG003|Treatment Phase|Adverse Event|0|||
160578444|NCT00002663|579838326|FG006|Overall Study|Physician Decision|0|||
160932724|NCT02036502|581150679|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160932725|NCT02036502|581150680|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160932726|NCT02036502|581150681|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160932727|NCT02036502|581150682|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160932728|NCT02036502|581150675|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
160932729|NCT02036502|581150676|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
160932730|NCT02036502|581150677|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
160932731|NCT02036502|581150678|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
160932732|NCT02036502|581150679|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
160932733|NCT02036502|581150680|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
160932734|NCT02036502|581150681|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
160932735|NCT02036502|581150682|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
160932736|NCT02036502|581150675|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
160932737|NCT02036502|581150676|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
160932738|NCT02036502|581150677|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
160932739|NCT02036502|581150678|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
160932740|NCT02036502|581150679|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
160932741|NCT02036502|581150680|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
160932742|NCT02036502|581150681|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
160932743|NCT02036502|581150682|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
160932744|NCT02036502|581150675|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932745|NCT02036502|581150676|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932746|NCT02036502|581150677|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
160932747|NCT02036502|581150678|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932748|NCT02036502|581150679|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932749|NCT02036502|581150680|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932750|NCT02036502|581150681|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932751|NCT02036502|581150682|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932752|NCT02036502|581150675|FG000|Part 2:Dose Confirmation|Death|0|||
160932753|NCT02036502|581150676|FG001|Part 2:Dose Confirmation|Death|0|||
160932754|NCT02036502|581150677|FG002|Part 2:Dose Confirmation|Death|1|||
160932755|NCT02036502|581150678|FG003|Part 2:Dose Confirmation|Death|0|||
160932756|NCT02036502|581150679|FG004|Part 2:Dose Confirmation|Death|0|||
160932757|NCT02036502|581150680|FG005|Part 2:Dose Confirmation|Death|0|||
160932758|NCT02036502|581150681|FG006|Part 2:Dose Confirmation|Death|0|||
160932759|NCT02036502|581150682|FG007|Part 2:Dose Confirmation|Death|0|||
160932760|NCT02036502|581150675|FG000|Part 2:Dose Confirmation|Not treated|0|||
160932761|NCT02036502|581150676|FG001|Part 2:Dose Confirmation|Not treated|0|||
160932762|NCT02036502|581150677|FG002|Part 2:Dose Confirmation|Not treated|0|||
160932763|NCT02036502|581150678|FG003|Part 2:Dose Confirmation|Not treated|1|||
160932764|NCT02036502|581150679|FG004|Part 2:Dose Confirmation|Not treated|0|||
160932765|NCT02036502|581150680|FG005|Part 2:Dose Confirmation|Not treated|0|||
160932766|NCT02036502|581150681|FG006|Part 2:Dose Confirmation|Not treated|0|||
160932767|NCT02036502|581150682|FG007|Part 2:Dose Confirmation|Not treated|0|||
160932768|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Adverse Event|0|||
160932769|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Adverse Event|0|||
160932770|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Adverse Event|0|||
160932771|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Adverse Event|0|||
160932772|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Adverse Event|0|||
160932773|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Adverse Event|4|||
160932774|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Adverse Event|0|||
160932775|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Adverse Event|2|||
160932776|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Death|0|||
160932777|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Death|0|||
160932778|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Death|0|||
160932779|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Death|0|||
160932780|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Death|0|||
160932781|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Death|24|||
160932782|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Death|0|||
160932783|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Death|3|||
160932784|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932785|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932786|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932787|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932788|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932789|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932790|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932791|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
160932792|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Physician Decision|0|||
160932793|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Physician Decision|0|||
160998360|NCT02781584|581378640|FG004|Treatment Phase|Adverse Event|0|||
160998361|NCT02781584|581378641|FG005|Treatment Phase|Adverse Event|0|||
160578445|NCT00002663|579838327|FG007|Overall Study|Physician Decision|0|||
160932794|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Physician Decision|0|||
160932795|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Physician Decision|0|||
160932796|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Physician Decision|0|||
160932797|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Physician Decision|1|||
160932798|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Physician Decision|0|||
160932799|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Physician Decision|0|||
160932800|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
160932801|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
160932802|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
160932803|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
160932804|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
160932805|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
160932806|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
160932807|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
160932808|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932809|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932810|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932811|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932812|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932813|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
160932814|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932815|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
160932816|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
160932817|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
160932818|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
160932819|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
160932820|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
160932821|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
160932822|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
160932823|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
160932824|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Not Treated|0|||
160932825|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Not Treated|0|||
160932826|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Not Treated|0|||
160932827|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Not Treated|0|||
160998362|NCT02781584|581378642|FG006|Treatment Phase|Adverse Event|0|||
160998363|NCT02781584|581378643|FG007|Treatment Phase|Adverse Event|1|||
160998364|NCT02781584|581378644|FG008|Treatment Phase|Adverse Event|0|||
160998365|NCT02781584|581378645|FG009|Treatment Phase|Adverse Event|0|||
160998366|NCT02781584|581378646|FG010|Treatment Phase|Adverse Event|0|||
160998367|NCT02781584|581378647|FG011|Treatment Phase|Adverse Event|0|||
160998368|NCT02781584|581378648|FG012|Treatment Phase|Adverse Event|0|||
160998369|NCT05826431|581378649|FG000|Overall Study|Withdrawal by Subject|1|||
160998370|NCT04771273|581378654|FG000|Dose Escalation Period|Not treated with trial medication|0|||
160998371|NCT04771273|581378655|FG001|Dose Escalation Period|Not treated with trial medication|1|||
160578446|NCT00002663|579838328|FG008|Overall Study|Physician Decision|1|||
160578447|NCT00002663|579838329|FG009|Overall Study|Physician Decision|1|||
160578448|NCT00002663|579838320|FG000|Overall Study|Adverse Event|0|||
160932828|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Not Treated|0|||
160932829|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Not Treated|2|||
160932830|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Not Treated|0|||
160932831|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Not Treated|0|||
160932832|NCT00811577|581150688|FG000|Overall Study|Lost to Follow-up|7|||
160932833|NCT00811577|581150689|FG001|Overall Study|Lost to Follow-up|1|||
160932834|NCT00811577|581150688|FG000|Overall Study|Withdrawal by Subject|3|||
160932835|NCT00811577|581150689|FG001|Overall Study|Withdrawal by Subject|0|||
160998372|NCT04771273|581378656|FG002|Dose Escalation Period|Not treated with trial medication|1|||
160998373|NCT04771273|581378657|FG003|Dose Escalation Period|Not treated with trial medication|0|||
160998374|NCT04771273|581378654|FG000|Dose Escalation Period|Other reasons than listed|2|||
160998375|NCT04771273|581378655|FG001|Dose Escalation Period|Other reasons than listed|0|||
160998376|NCT04771273|581378656|FG002|Dose Escalation Period|Other reasons than listed|2|||
160998377|NCT04771273|581378657|FG003|Dose Escalation Period|Other reasons than listed|1|||
160578449|NCT00002663|579838321|FG001|Overall Study|Adverse Event|0|||
160998378|NCT04771273|581378654|FG000|Dose Escalation Period|Protocol Violation|0|||
160998379|NCT04771273|581378655|FG001|Dose Escalation Period|Protocol Violation|0|||
160998380|NCT04771273|581378656|FG002|Dose Escalation Period|Protocol Violation|3|||
160998381|NCT04771273|581378657|FG003|Dose Escalation Period|Protocol Violation|1|||
160998382|NCT04771273|581378654|FG000|Dose Escalation Period|Burden of study procedures|1|||
160578450|NCT00002663|579838322|FG002|Overall Study|Adverse Event|0|||
160578451|NCT00002663|579838323|FG003|Overall Study|Adverse Event|1|||
160932836|NCT04011410|581150690|FG000|Overall Study|Withdrawal by Subject|1|||
160932837|NCT01068509|581150691|FG000|Overall Study|Death|0|||
160998383|NCT04771273|581378655|FG001|Dose Escalation Period|Burden of study procedures|0|||
160932838|NCT01068509|581150692|FG001|Overall Study|Death|0|||
160578452|NCT00002663|579838324|FG004|Overall Study|Adverse Event|0|||
160932839|NCT01068509|581150693|FG002|Overall Study|Death|1|||
160932840|NCT01068509|581150691|FG000|Overall Study|Disease Progression|5|||
160932841|NCT01068509|581150692|FG001|Overall Study|Disease Progression|20|||
160932842|NCT01068509|581150693|FG002|Overall Study|Disease Progression|18|||
160932843|NCT01068509|581150691|FG000|Overall Study|Lost to Follow-up|1|||
160932844|NCT01068509|581150692|FG001|Overall Study|Lost to Follow-up|0|||
160932845|NCT01068509|581150693|FG002|Overall Study|Lost to Follow-up|0|||
160932846|NCT01068509|581150691|FG000|Overall Study|Withdrew Consent|0|||
160932847|NCT01068509|581150692|FG001|Overall Study|Withdrew Consent|1|||
160932848|NCT01068509|581150693|FG002|Overall Study|Withdrew Consent|2|||
160932849|NCT01068509|581150691|FG000|Overall Study|Reason Not Specified|0|||
160932850|NCT01068509|581150692|FG001|Overall Study|Reason Not Specified|1|||
160932851|NCT01068509|581150693|FG002|Overall Study|Reason Not Specified|0|||
160932852|NCT02357940|581150694|FG000|Overall Study|Adverse Event|0|||
160932853|NCT02357940|581150695|FG001|Overall Study|Adverse Event|1|||
160932854|NCT02357940|581150694|FG000|Overall Study|Investigator's judgement|0|||
160932855|NCT02357940|581150695|FG001|Overall Study|Investigator's judgement|1|||
160932856|NCT02442778|581150696|FG000|Overall Study|Adverse Event|2|||
160932857|NCT02442778|581150697|FG001|Overall Study|Adverse Event|6|||
160932858|NCT02442778|581150698|FG002|Overall Study|Adverse Event|6|||
160932859|NCT02442778|581150696|FG000|Overall Study|Death|0|||
160932860|NCT02442778|581150697|FG001|Overall Study|Death|2|||
160932861|NCT02442778|581150698|FG002|Overall Study|Death|0|||
160932862|NCT02442778|581150696|FG000|Overall Study|Lack of Efficacy|1|||
160932863|NCT02442778|581150697|FG001|Overall Study|Lack of Efficacy|0|||
160932864|NCT02442778|581150698|FG002|Overall Study|Lack of Efficacy|0|||
160932865|NCT02442778|581150696|FG000|Overall Study|Lost to Follow-up|1|||
160932866|NCT02442778|581150697|FG001|Overall Study|Lost to Follow-up|1|||
160932867|NCT02442778|581150698|FG002|Overall Study|Lost to Follow-up|1|||
160932868|NCT02442778|581150696|FG000|Overall Study|Non-compliance with study drug|2|||
160932869|NCT02442778|581150697|FG001|Overall Study|Non-compliance with study drug|0|||
160932870|NCT02442778|581150698|FG002|Overall Study|Non-compliance with study drug|1|||
160932871|NCT02442778|581150696|FG000|Overall Study|Physician Decision|1|||
160932872|NCT02442778|581150697|FG001|Overall Study|Physician Decision|1|||
160932873|NCT02442778|581150698|FG002|Overall Study|Physician Decision|1|||
160932874|NCT02442778|581150696|FG000|Overall Study|Protocol Deviation|3|||
160932875|NCT02442778|581150697|FG001|Overall Study|Protocol Deviation|0|||
160932876|NCT02442778|581150698|FG002|Overall Study|Protocol Deviation|1|||
160932877|NCT02442778|581150696|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
160932878|NCT02442778|581150697|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
160932879|NCT02442778|581150698|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
160932880|NCT02442778|581150696|FG000|Overall Study|Withdrawal by Subject|4|||
160932881|NCT02442778|581150697|FG001|Overall Study|Withdrawal by Subject|4|||
160932882|NCT02442778|581150698|FG002|Overall Study|Withdrawal by Subject|3|||
160932883|NCT02442778|581150696|FG000|Overall Study|Reason not specified|1|||
160932884|NCT02442778|581150697|FG001|Overall Study|Reason not specified|4|||
160932885|NCT02442778|581150698|FG002|Overall Study|Reason not specified|0|||
160932886|NCT01165138|581150701|FG000|Overall Study|Adverse Event|0|||
160932887|NCT01165138|581150702|FG001|Overall Study|Adverse Event|1|||
160932888|NCT01165138|581150703|FG002|Overall Study|Adverse Event|0|||
160932889|NCT01165138|581150704|FG003|Overall Study|Adverse Event|2|||
160932890|NCT01165138|581150701|FG000|Overall Study|Lack of Efficacy|0|||
160932891|NCT01165138|581150702|FG001|Overall Study|Lack of Efficacy|32|||
160932892|NCT01165138|581150703|FG002|Overall Study|Lack of Efficacy|6|||
160932893|NCT01165138|581150704|FG003|Overall Study|Lack of Efficacy|7|||
160932894|NCT01165138|581150701|FG000|Overall Study|Protocol Violation|0|||
160932895|NCT01165138|581150702|FG001|Overall Study|Protocol Violation|7|||
160932896|NCT01165138|581150703|FG002|Overall Study|Protocol Violation|0|||
160932897|NCT01165138|581150704|FG003|Overall Study|Protocol Violation|2|||
160578453|NCT00002663|579838325|FG005|Overall Study|Adverse Event|0|||
160578454|NCT00002663|579838326|FG006|Overall Study|Adverse Event|0|||
160578455|NCT00002663|579838327|FG007|Overall Study|Adverse Event|1|||
160578456|NCT00002663|579838328|FG008|Overall Study|Adverse Event|0|||
160578457|NCT00002663|579838329|FG009|Overall Study|Adverse Event|0|||
160932898|NCT01165138|581150701|FG000|Overall Study|Lost to Follow-up|0|||
160578458|NCT00446446|579838333|FG000|Overall Study|Death|10|||
160578459|NCT00446446|579838333|FG000|Overall Study|Withdrawal by Subject|6|||
160932899|NCT01165138|581150702|FG001|Overall Study|Lost to Follow-up|0|||
160932900|NCT01165138|581150703|FG002|Overall Study|Lost to Follow-up|1|||
160932901|NCT01165138|581150704|FG003|Overall Study|Lost to Follow-up|2|||
160932902|NCT01165138|581150701|FG000|Overall Study|Physician Decision|0|||
160932903|NCT01165138|581150702|FG001|Overall Study|Physician Decision|6|||
160932904|NCT01165138|581150703|FG002|Overall Study|Physician Decision|7|||
160932905|NCT01165138|581150704|FG003|Overall Study|Physician Decision|6|||
160932906|NCT01165138|581150701|FG000|Overall Study|Withdrawal by Subject|0|||
160932907|NCT01165138|581150702|FG001|Overall Study|Withdrawal by Subject|6|||
160578460|NCT00446446|579838333|FG000|Overall Study|Other|4|||
160932908|NCT01165138|581150703|FG002|Overall Study|Withdrawal by Subject|6|||
160932909|NCT01165138|581150704|FG003|Overall Study|Withdrawal by Subject|3|||
160932910|NCT02641379|581150705|FG000|Overall Study|Exclusion criterion during screening|1|||
160932911|NCT02641379|581150706|FG001|Overall Study|Exclusion criterion during screening|0|||
160932912|NCT02641379|581150707|FG002|Overall Study|Exclusion criterion during screening|0|||
160932913|NCT02641379|581150708|FG003|Overall Study|Exclusion criterion during screening|1|||
160932914|NCT02641379|581150709|FG004|Overall Study|Exclusion criterion during screening|2|||
160932915|NCT02641379|581150710|FG005|Overall Study|Exclusion criterion during screening|0|||
160932916|NCT02641379|581150711|FG006|Overall Study|Exclusion criterion during screening|0|||
160932917|NCT02641379|581150712|FG007|Overall Study|Exclusion criterion during screening|0|||
160932918|NCT02641379|581150713|FG008|Overall Study|Exclusion criterion during screening|0|||
160932919|NCT02641379|581150714|FG009|Overall Study|Exclusion criterion during screening|0|||
160932920|NCT02641379|581150715|FG010|Overall Study|Exclusion criterion during screening|0|||
160932921|NCT02641379|581150705|FG000|Overall Study|Withdrawal of informed consent|0|||
160932922|NCT02641379|581150706|FG001|Overall Study|Withdrawal of informed consent|1|||
160932923|NCT02641379|581150707|FG002|Overall Study|Withdrawal of informed consent|0|||
160932924|NCT02641379|581150708|FG003|Overall Study|Withdrawal of informed consent|0|||
160932925|NCT02641379|581150709|FG004|Overall Study|Withdrawal of informed consent|0|||
160932926|NCT02641379|581150710|FG005|Overall Study|Withdrawal of informed consent|0|||
160932927|NCT02641379|581150711|FG006|Overall Study|Withdrawal of informed consent|0|||
160932928|NCT02641379|581150712|FG007|Overall Study|Withdrawal of informed consent|1|||
160932929|NCT02641379|581150713|FG008|Overall Study|Withdrawal of informed consent|0|||
160932930|NCT02641379|581150714|FG009|Overall Study|Withdrawal of informed consent|0|||
160932931|NCT02641379|581150715|FG010|Overall Study|Withdrawal of informed consent|0|||
160932932|NCT02641379|581150705|FG000|Overall Study|Adverse Event|7|||
160932933|NCT02641379|581150706|FG001|Overall Study|Adverse Event|8|||
160932934|NCT02641379|581150707|FG002|Overall Study|Adverse Event|2|||
160932935|NCT02641379|581150708|FG003|Overall Study|Adverse Event|2|||
160932936|NCT02641379|581150709|FG004|Overall Study|Adverse Event|5|||
160932937|NCT02641379|581150710|FG005|Overall Study|Adverse Event|1|||
160932938|NCT02641379|581150711|FG006|Overall Study|Adverse Event|5|||
160932939|NCT02641379|581150712|FG007|Overall Study|Adverse Event|0|||
160932940|NCT02641379|581150713|FG008|Overall Study|Adverse Event|1|||
160932941|NCT02641379|581150714|FG009|Overall Study|Adverse Event|1|||
160932942|NCT02641379|581150715|FG010|Overall Study|Adverse Event|5|||
160932943|NCT02641379|581150705|FG000|Overall Study|Lack of Efficacy|0|||
160932944|NCT02641379|581150706|FG001|Overall Study|Lack of Efficacy|0|||
160932945|NCT02641379|581150707|FG002|Overall Study|Lack of Efficacy|2|||
160932946|NCT02641379|581150708|FG003|Overall Study|Lack of Efficacy|0|||
160932947|NCT02641379|581150709|FG004|Overall Study|Lack of Efficacy|0|||
160932948|NCT02641379|581150710|FG005|Overall Study|Lack of Efficacy|2|||
160932949|NCT02641379|581150711|FG006|Overall Study|Lack of Efficacy|0|||
160932950|NCT02641379|581150712|FG007|Overall Study|Lack of Efficacy|5|||
160932951|NCT02641379|581150713|FG008|Overall Study|Lack of Efficacy|0|||
160932952|NCT02641379|581150714|FG009|Overall Study|Lack of Efficacy|0|||
160932953|NCT02641379|581150715|FG010|Overall Study|Lack of Efficacy|0|||
160932954|NCT02641379|581150705|FG000|Overall Study|Participant unable to attend study visit|4|||
160932955|NCT02641379|581150706|FG001|Overall Study|Participant unable to attend study visit|10|||
160932956|NCT02641379|581150707|FG002|Overall Study|Participant unable to attend study visit|1|||
160932957|NCT02641379|581150708|FG003|Overall Study|Participant unable to attend study visit|2|||
160932958|NCT02641379|581150709|FG004|Overall Study|Participant unable to attend study visit|5|||
160932959|NCT02641379|581150710|FG005|Overall Study|Participant unable to attend study visit|1|||
160932960|NCT02641379|581150711|FG006|Overall Study|Participant unable to attend study visit|1|||
160932961|NCT02641379|581150712|FG007|Overall Study|Participant unable to attend study visit|1|||
160932962|NCT02641379|581150713|FG008|Overall Study|Participant unable to attend study visit|0|||
160932963|NCT02641379|581150714|FG009|Overall Study|Participant unable to attend study visit|2|||
160932964|NCT02641379|581150715|FG010|Overall Study|Participant unable to attend study visit|0|||
160932965|NCT02641379|581150705|FG000|Overall Study|Participant's compliance|0|||
160932966|NCT02641379|581150706|FG001|Overall Study|Participant's compliance|1|||
160932967|NCT02641379|581150707|FG002|Overall Study|Participant's compliance|0|||
160932968|NCT02641379|581150708|FG003|Overall Study|Participant's compliance|1|||
160932969|NCT02641379|581150709|FG004|Overall Study|Participant's compliance|0|||
160932970|NCT02641379|581150710|FG005|Overall Study|Participant's compliance|2|||
160932971|NCT02641379|581150711|FG006|Overall Study|Participant's compliance|0|||
160932972|NCT02641379|581150712|FG007|Overall Study|Participant's compliance|0|||
160932973|NCT02641379|581150713|FG008|Overall Study|Participant's compliance|1|||
160932974|NCT02641379|581150714|FG009|Overall Study|Participant's compliance|1|||
160932975|NCT02641379|581150715|FG010|Overall Study|Participant's compliance|1|||
160932976|NCT02641379|581150705|FG000|Overall Study|Participant cannot be reached|4|||
160932977|NCT02641379|581150706|FG001|Overall Study|Participant cannot be reached|4|||
160932978|NCT02641379|581150707|FG002|Overall Study|Participant cannot be reached|0|||
160932979|NCT02641379|581150708|FG003|Overall Study|Participant cannot be reached|8|||
160932980|NCT02641379|581150709|FG004|Overall Study|Participant cannot be reached|2|||
160932981|NCT02641379|581150710|FG005|Overall Study|Participant cannot be reached|1|||
160932982|NCT02641379|581150711|FG006|Overall Study|Participant cannot be reached|0|||
160932983|NCT02641379|581150712|FG007|Overall Study|Participant cannot be reached|1|||
160932984|NCT02641379|581150713|FG008|Overall Study|Participant cannot be reached|0|||
160932985|NCT02641379|581150714|FG009|Overall Study|Participant cannot be reached|2|||
160932986|NCT02641379|581150715|FG010|Overall Study|Participant cannot be reached|1|||
160932987|NCT02641379|581150705|FG000|Overall Study|PCR positive at Week 24|15|||
160932988|NCT02641379|581150706|FG001|Overall Study|PCR positive at Week 24|21|||
160932989|NCT02641379|581150707|FG002|Overall Study|PCR positive at Week 24|62|||
160932990|NCT02641379|581150708|FG003|Overall Study|PCR positive at Week 24|0|||
160932991|NCT02641379|581150709|FG004|Overall Study|PCR positive at Week 24|0|||
160932992|NCT02641379|581150710|FG005|Overall Study|PCR positive at Week 24|6|||
160932993|NCT02641379|581150711|FG006|Overall Study|PCR positive at Week 24|3|||
160932994|NCT02641379|581150712|FG007|Overall Study|PCR positive at Week 24|8|||
160932995|NCT02641379|581150713|FG008|Overall Study|PCR positive at Week 24|0|||
160932996|NCT02641379|581150714|FG009|Overall Study|PCR positive at Week 24|1|||
160932997|NCT02641379|581150715|FG010|Overall Study|PCR positive at Week 24|0|||
160932998|NCT02641379|581150705|FG000|Overall Study|PCR positive at follow up 2|1|||
160932999|NCT02641379|581150706|FG001|Overall Study|PCR positive at follow up 2|0|||
160933000|NCT02641379|581150707|FG002|Overall Study|PCR positive at follow up 2|0|||
160933001|NCT02641379|581150708|FG003|Overall Study|PCR positive at follow up 2|0|||
160933002|NCT02641379|581150709|FG004|Overall Study|PCR positive at follow up 2|0|||
160933003|NCT02641379|581150710|FG005|Overall Study|PCR positive at follow up 2|0|||
160933004|NCT02641379|581150711|FG006|Overall Study|PCR positive at follow up 2|0|||
160933005|NCT02641379|581150712|FG007|Overall Study|PCR positive at follow up 2|0|||
160933006|NCT02641379|581150713|FG008|Overall Study|PCR positive at follow up 2|0|||
160933007|NCT02641379|581150714|FG009|Overall Study|PCR positive at follow up 2|0|||
160933008|NCT02641379|581150715|FG010|Overall Study|PCR positive at follow up 2|0|||
160933009|NCT02641379|581150705|FG000|Overall Study|Participant showed relapse|1|||
160933010|NCT02641379|581150706|FG001|Overall Study|Participant showed relapse|0|||
160933011|NCT02641379|581150707|FG002|Overall Study|Participant showed relapse|0|||
160933012|NCT02641379|581150708|FG003|Overall Study|Participant showed relapse|0|||
160933013|NCT02641379|581150709|FG004|Overall Study|Participant showed relapse|0|||
160933014|NCT02641379|581150710|FG005|Overall Study|Participant showed relapse|0|||
160933015|NCT02641379|581150711|FG006|Overall Study|Participant showed relapse|1|||
160933016|NCT02641379|581150712|FG007|Overall Study|Participant showed relapse|0|||
160933017|NCT02641379|581150713|FG008|Overall Study|Participant showed relapse|0|||
160933018|NCT02641379|581150714|FG009|Overall Study|Participant showed relapse|0|||
160933019|NCT02641379|581150715|FG010|Overall Study|Participant showed relapse|0|||
160933020|NCT02641379|581150705|FG000|Overall Study|Participant stopped study/treatment|1|||
160933021|NCT02641379|581150706|FG001|Overall Study|Participant stopped study/treatment|3|||
160933022|NCT02641379|581150707|FG002|Overall Study|Participant stopped study/treatment|1|||
160933023|NCT02641379|581150708|FG003|Overall Study|Participant stopped study/treatment|0|||
160933024|NCT02641379|581150709|FG004|Overall Study|Participant stopped study/treatment|0|||
160933025|NCT02641379|581150710|FG005|Overall Study|Participant stopped study/treatment|1|||
160933026|NCT02641379|581150711|FG006|Overall Study|Participant stopped study/treatment|2|||
160933027|NCT02641379|581150712|FG007|Overall Study|Participant stopped study/treatment|0|||
160933028|NCT02641379|581150713|FG008|Overall Study|Participant stopped study/treatment|1|||
160933029|NCT02641379|581150714|FG009|Overall Study|Participant stopped study/treatment|0|||
160933030|NCT02641379|581150715|FG010|Overall Study|Participant stopped study/treatment|0|||
160933031|NCT02641379|581150705|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
160933032|NCT02641379|581150706|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
160933033|NCT02641379|581150707|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
160933034|NCT02641379|581150708|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
160933035|NCT02641379|581150709|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
160933036|NCT02641379|581150710|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
160933037|NCT02641379|581150711|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
160933038|NCT02641379|581150712|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
160933039|NCT02641379|581150713|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
160933040|NCT02641379|581150714|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
160933041|NCT02641379|581150715|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
160933042|NCT02641379|581150705|FG000|Overall Study|Financial problems|0|||
160933043|NCT02641379|581150706|FG001|Overall Study|Financial problems|1|||
160578461|NCT00446446|579838333|FG000|Overall Study|Disease Progession|2|||
160578462|NCT00446446|579838333|FG000|Overall Study|Adverse Event|1|||
160578463|NCT00446446|579838333|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
160578464|NCT02142894|579838334|FG000|Overall Study|Protocol Violation|8|||
160933044|NCT02641379|581150707|FG002|Overall Study|Financial problems|0|||
160933045|NCT02641379|581150708|FG003|Overall Study|Financial problems|0|||
160933046|NCT02641379|581150709|FG004|Overall Study|Financial problems|0|||
160933047|NCT02641379|581150710|FG005|Overall Study|Financial problems|0|||
160933048|NCT02641379|581150711|FG006|Overall Study|Financial problems|0|||
160933049|NCT02641379|581150712|FG007|Overall Study|Financial problems|0|||
160578465|NCT00611130|579838340|FG000|Overall Study|Lost to Follow-up|25|||
160578466|NCT00611130|579838341|FG001|Overall Study|Lost to Follow-up|29|||
160455093|NCT05485779|579397831|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
160455094|NCT05485779|579397832|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
160455095|NCT05485779|579397833|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
160455096|NCT05485779|579397834|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
160455097|NCT05485779|579397835|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
160455098|NCT05485779|579397836|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
160455099|NCT03676192|579397837|FG000|Induction Study Period|Adverse Event|21|||
160455100|NCT03676192|579397838|FG001|Induction Study Period|Adverse Event|20|||
160455101|NCT03676192|579397837|FG000|Induction Study Period|Death|23|||
160455102|NCT03676192|579397838|FG001|Induction Study Period|Death|20|||
160455103|NCT03676192|579397837|FG000|Induction Study Period|Lost to Follow-up|3|||
160455104|NCT03676192|579397838|FG001|Induction Study Period|Lost to Follow-up|3|||
160455105|NCT03676192|579397837|FG000|Induction Study Period|Physician Decision|6|||
160455106|NCT03676192|579397838|FG001|Induction Study Period|Physician Decision|3|||
160455107|NCT03676192|579397837|FG000|Induction Study Period|Progressive Disease|32|||
160455108|NCT03676192|579397838|FG001|Induction Study Period|Progressive Disease|21|||
160455109|NCT03676192|579397837|FG000|Induction Study Period|Protocol Violation|1|||
160455110|NCT03676192|579397838|FG001|Induction Study Period|Protocol Violation|2|||
160455111|NCT03676192|579397837|FG000|Induction Study Period|Withdrawal by Subject|20|||
160455112|NCT03676192|579397838|FG001|Induction Study Period|Withdrawal by Subject|15|||
160578467|NCT00611130|579838340|FG000|Overall Study|Protocol noncompliance|7|||
160578468|NCT00611130|579838341|FG001|Overall Study|Protocol noncompliance|6|||
160578469|NCT00611130|579838340|FG000|Overall Study|Withdrawal by Subject|6|||
160455113|NCT03386578|579397839|FG000|PK Component|Lost to Follow-up|0|||
160455114|NCT03386578|579397840|FG001|PK Component|Lost to Follow-up|1|||
160455115|NCT03386578|579397841|FG002|PK Component|Lost to Follow-up|0|||
160455116|NCT03386578|579397842|FG003|PK Component|Lost to Follow-up|0|||
160455117|NCT03386578|579397843|FG004|PK Component|Lost to Follow-up|0|||
160455118|NCT03386578|579397844|FG005|PK Component|Lost to Follow-up|0|||
160455119|NCT03386578|579397845|FG006|PK Component|Lost to Follow-up|1|||
160455120|NCT03386578|579397846|FG007|PK Component|Lost to Follow-up|0|||
160578470|NCT00611130|579838341|FG001|Overall Study|Withdrawal by Subject|5|||
160933050|NCT02641379|581150713|FG008|Overall Study|Financial problems|0|||
160933051|NCT02641379|581150714|FG009|Overall Study|Financial problems|0|||
160933052|NCT02641379|581150715|FG010|Overall Study|Financial problems|0|||
160933053|NCT02641379|581150705|FG000|Overall Study|PCR positive at Week 68|0|||
160933054|NCT02641379|581150706|FG001|Overall Study|PCR positive at Week 68|1|||
160933055|NCT02641379|581150707|FG002|Overall Study|PCR positive at Week 68|0|||
160933056|NCT02641379|581150708|FG003|Overall Study|PCR positive at Week 68|0|||
160933057|NCT02641379|581150709|FG004|Overall Study|PCR positive at Week 68|0|||
160933058|NCT02641379|581150710|FG005|Overall Study|PCR positive at Week 68|0|||
160933059|NCT02641379|581150711|FG006|Overall Study|PCR positive at Week 68|0|||
160933060|NCT02641379|581150712|FG007|Overall Study|PCR positive at Week 68|0|||
160933061|NCT02641379|581150713|FG008|Overall Study|PCR positive at Week 68|0|||
160933062|NCT02641379|581150714|FG009|Overall Study|PCR positive at Week 68|0|||
160933063|NCT02641379|581150715|FG010|Overall Study|PCR positive at Week 68|0|||
160933064|NCT02641379|581150705|FG000|Overall Study|PCR positive at Week 48|0|||
160933065|NCT02641379|581150706|FG001|Overall Study|PCR positive at Week 48|1|||
160933066|NCT02641379|581150707|FG002|Overall Study|PCR positive at Week 48|0|||
160933067|NCT02641379|581150708|FG003|Overall Study|PCR positive at Week 48|0|||
160933068|NCT02641379|581150709|FG004|Overall Study|PCR positive at Week 48|0|||
160933069|NCT02641379|581150710|FG005|Overall Study|PCR positive at Week 48|0|||
160933070|NCT02641379|581150711|FG006|Overall Study|PCR positive at Week 48|0|||
160933071|NCT02641379|581150712|FG007|Overall Study|PCR positive at Week 48|0|||
160933072|NCT02641379|581150713|FG008|Overall Study|PCR positive at Week 48|0|||
160578471|NCT00611130|579838340|FG000|Overall Study|Other|5|||
160933073|NCT02641379|581150714|FG009|Overall Study|PCR positive at Week 48|0|||
160455121|NCT03386578|579397847|FG008|PK Component|Lost to Follow-up|0|||
160455122|NCT03386578|579397848|FG009|PK Component|Lost to Follow-up|0|||
160455123|NCT03386578|579397839|FG000|PK Component|Stillbirth/Abortion|0|||
160455124|NCT03386578|579397840|FG001|PK Component|Stillbirth/Abortion|0|||
160455125|NCT03386578|579397841|FG002|PK Component|Stillbirth/Abortion|0|||
160578472|NCT00611130|579838341|FG001|Overall Study|Other|4|||
160933074|NCT02641379|581150715|FG010|Overall Study|PCR positive at Week 48|0|||
160933075|NCT02641379|581150705|FG000|Overall Study|PCR not performed at Week 12|0|||
160933076|NCT02641379|581150706|FG001|Overall Study|PCR not performed at Week 12|0|||
160933077|NCT02641379|581150707|FG002|Overall Study|PCR not performed at Week 12|1|||
160933078|NCT02641379|581150708|FG003|Overall Study|PCR not performed at Week 12|0|||
160933079|NCT02641379|581150709|FG004|Overall Study|PCR not performed at Week 12|0|||
160455126|NCT03386578|579397842|FG003|PK Component|Stillbirth/Abortion|0|||
160455127|NCT03386578|579397843|FG004|PK Component|Stillbirth/Abortion|0|||
160578473|NCT00611130|579838340|FG000|Overall Study|Incarceration|3|||
160655925|NCT05630547|580120294|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
160933080|NCT02641379|581150710|FG005|Overall Study|PCR not performed at Week 12|0|||
160933081|NCT02641379|581150711|FG006|Overall Study|PCR not performed at Week 12|0|||
160933082|NCT02641379|581150712|FG007|Overall Study|PCR not performed at Week 12|0|||
160933083|NCT02641379|581150713|FG008|Overall Study|PCR not performed at Week 12|0|||
160933084|NCT02641379|581150714|FG009|Overall Study|PCR not performed at Week 12|0|||
160933085|NCT02641379|581150715|FG010|Overall Study|PCR not performed at Week 12|0|||
160933086|NCT02641379|581150705|FG000|Overall Study|No PCR at baseline|0|||
160933087|NCT02641379|581150706|FG001|Overall Study|No PCR at baseline|0|||
160933088|NCT02641379|581150707|FG002|Overall Study|No PCR at baseline|1|||
160933089|NCT02641379|581150708|FG003|Overall Study|No PCR at baseline|0|||
160933090|NCT02641379|581150709|FG004|Overall Study|No PCR at baseline|0|||
160933091|NCT02641379|581150710|FG005|Overall Study|No PCR at baseline|0|||
160933092|NCT02641379|581150711|FG006|Overall Study|No PCR at baseline|0|||
160933093|NCT02641379|581150712|FG007|Overall Study|No PCR at baseline|0|||
160933094|NCT02641379|581150713|FG008|Overall Study|No PCR at baseline|0|||
160933095|NCT02641379|581150714|FG009|Overall Study|No PCR at baseline|0|||
160933096|NCT02641379|581150715|FG010|Overall Study|No PCR at baseline|0|||
160933097|NCT02641379|581150705|FG000|Overall Study|PCR positive at Week 28|0|||
160933098|NCT02641379|581150706|FG001|Overall Study|PCR positive at Week 28|0|||
160933099|NCT02641379|581150707|FG002|Overall Study|PCR positive at Week 28|1|||
160933100|NCT02641379|581150708|FG003|Overall Study|PCR positive at Week 28|0|||
160933101|NCT02641379|581150709|FG004|Overall Study|PCR positive at Week 28|0|||
160933102|NCT02641379|581150710|FG005|Overall Study|PCR positive at Week 28|0|||
160933103|NCT02641379|581150711|FG006|Overall Study|PCR positive at Week 28|0|||
160933104|NCT02641379|581150712|FG007|Overall Study|PCR positive at Week 28|0|||
160933105|NCT02641379|581150713|FG008|Overall Study|PCR positive at Week 28|0|||
160933106|NCT02641379|581150714|FG009|Overall Study|PCR positive at Week 28|0|||
160933107|NCT02641379|581150715|FG010|Overall Study|PCR positive at Week 28|0|||
160933108|NCT02641379|581150705|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
160933109|NCT02641379|581150706|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
160933110|NCT02641379|581150707|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
160933111|NCT02641379|581150708|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
160933112|NCT02641379|581150709|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
160933113|NCT02641379|581150710|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
160933114|NCT02641379|581150711|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
160933115|NCT02641379|581150712|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
160933116|NCT02641379|581150713|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
160933117|NCT02641379|581150714|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
160933118|NCT02641379|581150715|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
160933119|NCT02641379|581150705|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
160933120|NCT02641379|581150706|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
160933121|NCT02641379|581150707|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
160933122|NCT02641379|581150708|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
160933123|NCT02641379|581150709|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
160933124|NCT02641379|581150710|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
160933125|NCT02641379|581150711|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
160933126|NCT02641379|581150712|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
160933127|NCT02641379|581150713|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
160933128|NCT02641379|581150714|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
160933129|NCT02641379|581150715|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
160933130|NCT02641379|581150705|FG000|Overall Study|Baseline viral load unavailable|0|||
160933131|NCT02641379|581150706|FG001|Overall Study|Baseline viral load unavailable|0|||
160933132|NCT02641379|581150707|FG002|Overall Study|Baseline viral load unavailable|0|||
160933133|NCT02641379|581150708|FG003|Overall Study|Baseline viral load unavailable|1|||
160933134|NCT02641379|581150709|FG004|Overall Study|Baseline viral load unavailable|0|||
160933135|NCT02641379|581150710|FG005|Overall Study|Baseline viral load unavailable|0|||
160933136|NCT02641379|581150711|FG006|Overall Study|Baseline viral load unavailable|0|||
160998384|NCT04771273|581378656|FG002|Dose Escalation Period|Burden of study procedures|0|||
160998385|NCT04771273|581378657|FG003|Dose Escalation Period|Burden of study procedures|0|||
160455128|NCT03386578|579397844|FG005|PK Component|Stillbirth/Abortion|2|||
160455129|NCT03386578|579397845|FG006|PK Component|Stillbirth/Abortion|0|||
160455130|NCT03386578|579397846|FG007|PK Component|Stillbirth/Abortion|0|||
160933137|NCT02641379|581150712|FG007|Overall Study|Baseline viral load unavailable|0|||
160933138|NCT02641379|581150713|FG008|Overall Study|Baseline viral load unavailable|0|||
160933139|NCT02641379|581150714|FG009|Overall Study|Baseline viral load unavailable|0|||
160933140|NCT02641379|581150715|FG010|Overall Study|Baseline viral load unavailable|0|||
160933141|NCT02641379|581150705|FG000|Overall Study|Blood could not be drawn|0|||
160933142|NCT02641379|581150706|FG001|Overall Study|Blood could not be drawn|0|||
160933143|NCT02641379|581150707|FG002|Overall Study|Blood could not be drawn|0|||
160998386|NCT04771273|581378654|FG000|Dose Escalation Period|Change of residence|0|||
160998387|NCT04771273|581378655|FG001|Dose Escalation Period|Change of residence|0|||
160455131|NCT03386578|579397847|FG008|PK Component|Stillbirth/Abortion|0|||
160933144|NCT02641379|581150708|FG003|Overall Study|Blood could not be drawn|0|||
160933145|NCT02641379|581150709|FG004|Overall Study|Blood could not be drawn|1|||
160933146|NCT02641379|581150710|FG005|Overall Study|Blood could not be drawn|0|||
160933147|NCT02641379|581150711|FG006|Overall Study|Blood could not be drawn|0|||
160933148|NCT02641379|581150712|FG007|Overall Study|Blood could not be drawn|0|||
160933149|NCT02641379|581150713|FG008|Overall Study|Blood could not be drawn|0|||
160933150|NCT02641379|581150714|FG009|Overall Study|Blood could not be drawn|0|||
160933151|NCT02641379|581150715|FG010|Overall Study|Blood could not be drawn|0|||
160933152|NCT02641379|581150705|FG000|Overall Study|Protocol Violation|0|||
160933153|NCT02641379|581150706|FG001|Overall Study|Protocol Violation|0|||
160655926|NCT05630547|580120295|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
160655927|NCT05630547|580120296|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
160655928|NCT05630547|580120297|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
160655929|NCT02153736|580120304|FG000|Overall Study|Lost to Follow-up|1|||
160655930|NCT02153736|580120305|FG001|Overall Study|Lost to Follow-up|0|||
160655931|NCT02153736|580120304|FG000|Overall Study|Medical status change made ineligible|1|||
160655932|NCT02153736|580120305|FG001|Overall Study|Medical status change made ineligible|0|||
160655933|NCT02153736|580120304|FG000|Overall Study|Death|0|||
160655934|NCT02153736|580120305|FG001|Overall Study|Death|1|||
160655935|NCT02153736|580120304|FG000|Overall Study|Withdrawal by Subject|0|||
160655936|NCT02153736|580120305|FG001|Overall Study|Withdrawal by Subject|1|||
160933154|NCT02641379|581150707|FG002|Overall Study|Protocol Violation|0|||
160933155|NCT02641379|581150708|FG003|Overall Study|Protocol Violation|0|||
160933156|NCT02641379|581150709|FG004|Overall Study|Protocol Violation|2|||
160933157|NCT02641379|581150710|FG005|Overall Study|Protocol Violation|0|||
160933158|NCT02641379|581150711|FG006|Overall Study|Protocol Violation|0|||
160933159|NCT02641379|581150712|FG007|Overall Study|Protocol Violation|0|||
160933160|NCT02641379|581150713|FG008|Overall Study|Protocol Violation|1|||
160933161|NCT02641379|581150714|FG009|Overall Study|Protocol Violation|0|||
160933162|NCT02641379|581150715|FG010|Overall Study|Protocol Violation|0|||
160933163|NCT02641379|581150705|FG000|Overall Study|Participation in sili rescue study|0|||
160933164|NCT02641379|581150706|FG001|Overall Study|Participation in sili rescue study|0|||
160933165|NCT02641379|581150707|FG002|Overall Study|Participation in sili rescue study|0|||
160933166|NCT02641379|581150708|FG003|Overall Study|Participation in sili rescue study|0|||
160933167|NCT02641379|581150709|FG004|Overall Study|Participation in sili rescue study|0|||
160933168|NCT02641379|581150710|FG005|Overall Study|Participation in sili rescue study|1|||
160933169|NCT02641379|581150711|FG006|Overall Study|Participation in sili rescue study|0|||
160933170|NCT02641379|581150712|FG007|Overall Study|Participation in sili rescue study|0|||
160933171|NCT02641379|581150713|FG008|Overall Study|Participation in sili rescue study|0|||
160933172|NCT02641379|581150714|FG009|Overall Study|Participation in sili rescue study|0|||
160933173|NCT02641379|581150715|FG010|Overall Study|Participation in sili rescue study|0|||
160933174|NCT02641379|581150705|FG000|Overall Study|Lost to Follow-up|0|||
160933175|NCT02641379|581150706|FG001|Overall Study|Lost to Follow-up|0|||
160933176|NCT02641379|581150707|FG002|Overall Study|Lost to Follow-up|0|||
160933177|NCT02641379|581150708|FG003|Overall Study|Lost to Follow-up|0|||
160933178|NCT02641379|581150709|FG004|Overall Study|Lost to Follow-up|0|||
160933179|NCT02641379|581150710|FG005|Overall Study|Lost to Follow-up|0|||
160933180|NCT02641379|581150711|FG006|Overall Study|Lost to Follow-up|0|||
160933181|NCT02641379|581150712|FG007|Overall Study|Lost to Follow-up|0|||
160933182|NCT02641379|581150713|FG008|Overall Study|Lost to Follow-up|1|||
160933183|NCT02641379|581150714|FG009|Overall Study|Lost to Follow-up|0|||
160933184|NCT02641379|581150715|FG010|Overall Study|Lost to Follow-up|0|||
160933185|NCT02641379|581150705|FG000|Overall Study|Source data not found|0|||
160933186|NCT02641379|581150706|FG001|Overall Study|Source data not found|0|||
160933187|NCT02641379|581150707|FG002|Overall Study|Source data not found|0|||
160933188|NCT02641379|581150708|FG003|Overall Study|Source data not found|0|||
160933189|NCT02641379|581150709|FG004|Overall Study|Source data not found|0|||
160933190|NCT02641379|581150710|FG005|Overall Study|Source data not found|1|||
160655937|NCT01734772|580120306|FG000|Overall Study|Adverse Event|1|||
160655938|NCT01734772|580120307|FG001|Overall Study|Adverse Event|2|||
160655939|NCT01734772|580120306|FG000|Overall Study|Withdrawal by Subject|0|||
160933191|NCT02641379|581150711|FG006|Overall Study|Source data not found|0|||
160933192|NCT02641379|581150712|FG007|Overall Study|Source data not found|0|||
160933193|NCT02641379|581150713|FG008|Overall Study|Source data not found|0|||
160998388|NCT04771273|581378656|FG002|Dose Escalation Period|Change of residence|0|||
160655940|NCT01734772|580120307|FG001|Overall Study|Withdrawal by Subject|1|||
160933194|NCT02641379|581150714|FG009|Overall Study|Source data not found|0|||
160933195|NCT02641379|581150715|FG010|Overall Study|Source data not found|0|||
160933196|NCT02641379|581150705|FG000|Overall Study|Participant showed weight reduction|0|||
160933197|NCT02641379|581150706|FG001|Overall Study|Participant showed weight reduction|0|||
160655941|NCT00720122|580120314|FG000|Overall Study|Lost to Follow-up|1|||
160655942|NCT00720122|580120314|FG000|Overall Study|Physician Decision|1|||
160933198|NCT02641379|581150707|FG002|Overall Study|Participant showed weight reduction|0|||
160933199|NCT02641379|581150708|FG003|Overall Study|Participant showed weight reduction|0|||
160933200|NCT02641379|581150709|FG004|Overall Study|Participant showed weight reduction|0|||
160933201|NCT02641379|581150710|FG005|Overall Study|Participant showed weight reduction|0|||
160933202|NCT02641379|581150711|FG006|Overall Study|Participant showed weight reduction|0|||
160933203|NCT02641379|581150712|FG007|Overall Study|Participant showed weight reduction|1|||
160933204|NCT02641379|581150713|FG008|Overall Study|Participant showed weight reduction|0|||
160933205|NCT02641379|581150714|FG009|Overall Study|Participant showed weight reduction|0|||
160933206|NCT02641379|581150715|FG010|Overall Study|Participant showed weight reduction|0|||
160933207|NCT02641379|581150705|FG000|Overall Study|Non-response Week 12|0|||
160933208|NCT02641379|581150706|FG001|Overall Study|Non-response Week 12|0|||
160933209|NCT02641379|581150707|FG002|Overall Study|Non-response Week 12|0|||
160933210|NCT02641379|581150708|FG003|Overall Study|Non-response Week 12|0|||
160933211|NCT02641379|581150709|FG004|Overall Study|Non-response Week 12|0|||
160933212|NCT02641379|581150710|FG005|Overall Study|Non-response Week 12|0|||
160933213|NCT02641379|581150711|FG006|Overall Study|Non-response Week 12|0|||
160933214|NCT02641379|581150712|FG007|Overall Study|Non-response Week 12|1|||
160933215|NCT02641379|581150713|FG008|Overall Study|Non-response Week 12|0|||
160933216|NCT02641379|581150714|FG009|Overall Study|Non-response Week 12|0|||
160933217|NCT02641379|581150715|FG010|Overall Study|Non-response Week 12|0|||
160933218|NCT02641379|581150705|FG000|Overall Study|No 2 Log drop at Week 12|0|||
160933219|NCT02641379|581150706|FG001|Overall Study|No 2 Log drop at Week 12|0|||
160933220|NCT02641379|581150707|FG002|Overall Study|No 2 Log drop at Week 12|0|||
160933221|NCT02641379|581150708|FG003|Overall Study|No 2 Log drop at Week 12|0|||
160933222|NCT02641379|581150709|FG004|Overall Study|No 2 Log drop at Week 12|0|||
160933223|NCT02641379|581150710|FG005|Overall Study|No 2 Log drop at Week 12|0|||
160933224|NCT02641379|581150711|FG006|Overall Study|No 2 Log drop at Week 12|0|||
160933225|NCT02641379|581150712|FG007|Overall Study|No 2 Log drop at Week 12|0|||
160933226|NCT02641379|581150713|FG008|Overall Study|No 2 Log drop at Week 12|0|||
160933227|NCT02641379|581150714|FG009|Overall Study|No 2 Log drop at Week 12|0|||
160933228|NCT02641379|581150715|FG010|Overall Study|No 2 Log drop at Week 12|1|||
160933229|NCT02641379|581150705|FG000|Overall Study|Negative PCR result|0|||
160933230|NCT02641379|581150706|FG001|Overall Study|Negative PCR result|0|||
160933231|NCT02641379|581150707|FG002|Overall Study|Negative PCR result|0|||
160933232|NCT02641379|581150708|FG003|Overall Study|Negative PCR result|0|||
160933233|NCT02641379|581150709|FG004|Overall Study|Negative PCR result|0|||
160933234|NCT02641379|581150710|FG005|Overall Study|Negative PCR result|0|||
160933235|NCT02641379|581150711|FG006|Overall Study|Negative PCR result|0|||
160933236|NCT02641379|581150712|FG007|Overall Study|Negative PCR result|0|||
160933237|NCT02641379|581150713|FG008|Overall Study|Negative PCR result|0|||
160933238|NCT02641379|581150714|FG009|Overall Study|Negative PCR result|1|||
160933239|NCT02641379|581150715|FG010|Overall Study|Negative PCR result|0|||
160933240|NCT02641379|581150705|FG000|Overall Study|Participant's PCR high|0|||
160933241|NCT02641379|581150706|FG001|Overall Study|Participant's PCR high|0|||
160933242|NCT02641379|581150707|FG002|Overall Study|Participant's PCR high|0|||
160933243|NCT02641379|581150708|FG003|Overall Study|Participant's PCR high|0|||
160933244|NCT02641379|581150709|FG004|Overall Study|Participant's PCR high|0|||
160933245|NCT02641379|581150710|FG005|Overall Study|Participant's PCR high|0|||
160933246|NCT02641379|581150711|FG006|Overall Study|Participant's PCR high|0|||
160933247|NCT02641379|581150712|FG007|Overall Study|Participant's PCR high|1|||
160933248|NCT02641379|581150713|FG008|Overall Study|Participant's PCR high|0|||
160933249|NCT02641379|581150714|FG009|Overall Study|Participant's PCR high|0|||
160933250|NCT02641379|581150715|FG010|Overall Study|Participant's PCR high|0|||
160933251|NCT02641379|581150705|FG000|Overall Study|Participant treated after Week 24|0|||
160933252|NCT02641379|581150706|FG001|Overall Study|Participant treated after Week 24|0|||
160933253|NCT02641379|581150707|FG002|Overall Study|Participant treated after Week 24|0|||
160933254|NCT02641379|581150708|FG003|Overall Study|Participant treated after Week 24|0|||
160933255|NCT02641379|581150709|FG004|Overall Study|Participant treated after Week 24|0|||
160933256|NCT02641379|581150710|FG005|Overall Study|Participant treated after Week 24|0|||
160933257|NCT02641379|581150711|FG006|Overall Study|Participant treated after Week 24|0|||
160933258|NCT02641379|581150712|FG007|Overall Study|Participant treated after Week 24|0|||
160933259|NCT02641379|581150713|FG008|Overall Study|Participant treated after Week 24|1|||
160933260|NCT02641379|581150714|FG009|Overall Study|Participant treated after Week 24|0|||
160578474|NCT00611130|579838341|FG001|Overall Study|Incarceration|2|||
160578475|NCT00611130|579838340|FG000|Overall Study|Administrative|1|||
160933261|NCT02641379|581150715|FG010|Overall Study|Participant treated after Week 24|0|||
160933262|NCT02641379|581150705|FG000|Overall Study|Missing PCR result at Week 8|0|||
160933263|NCT02641379|581150706|FG001|Overall Study|Missing PCR result at Week 8|0|||
160933264|NCT02641379|581150707|FG002|Overall Study|Missing PCR result at Week 8|0|||
160933265|NCT02641379|581150708|FG003|Overall Study|Missing PCR result at Week 8|0|||
160578476|NCT00611130|579838341|FG001|Overall Study|Administrative|1|||
160578477|NCT00611130|579838340|FG000|Overall Study|Adverse Event|1|||
160933266|NCT02641379|581150709|FG004|Overall Study|Missing PCR result at Week 8|0|||
160933267|NCT02641379|581150710|FG005|Overall Study|Missing PCR result at Week 8|0|||
160933268|NCT02641379|581150711|FG006|Overall Study|Missing PCR result at Week 8|0|||
160933269|NCT02641379|581150712|FG007|Overall Study|Missing PCR result at Week 8|0|||
160933270|NCT02641379|581150713|FG008|Overall Study|Missing PCR result at Week 8|0|||
160933271|NCT02641379|581150714|FG009|Overall Study|Missing PCR result at Week 8|1|||
160933272|NCT02641379|581150715|FG010|Overall Study|Missing PCR result at Week 8|0|||
160933273|NCT02641379|581150705|FG000|Overall Study|PCR positive|0|||
160933274|NCT02641379|581150706|FG001|Overall Study|PCR positive|0|||
160933275|NCT02641379|581150707|FG002|Overall Study|PCR positive|0|||
160933276|NCT02641379|581150708|FG003|Overall Study|PCR positive|0|||
160933277|NCT02641379|581150709|FG004|Overall Study|PCR positive|0|||
160933278|NCT02641379|581150710|FG005|Overall Study|PCR positive|0|||
160933279|NCT02641379|581150711|FG006|Overall Study|PCR positive|1|||
160933280|NCT02641379|581150712|FG007|Overall Study|PCR positive|0|||
160933281|NCT02641379|581150713|FG008|Overall Study|PCR positive|0|||
160933282|NCT02641379|581150714|FG009|Overall Study|PCR positive|0|||
160933283|NCT02641379|581150715|FG010|Overall Study|PCR positive|0|||
160933284|NCT01644175|581150718|FG000|Overall Study|Randomized But Not Treated|0|||
160933285|NCT01644175|581150719|FG001|Overall Study|Randomized But Not Treated|2|||
160933286|NCT01644175|581150718|FG000|Overall Study|Adverse Event|8|||
160933287|NCT01644175|581150719|FG001|Overall Study|Adverse Event|13|||
160933288|NCT01644175|581150718|FG000|Overall Study|Death|1|||
160933289|NCT01644175|581150719|FG001|Overall Study|Death|2|||
160933290|NCT01644175|581150718|FG000|Overall Study|Poor compliance to protocol|9|||
160933291|NCT01644175|581150719|FG001|Overall Study|Poor compliance to protocol|10|||
160933292|NCT01644175|581150718|FG000|Overall Study|Physician Decision|1|||
160933293|NCT01644175|581150719|FG001|Overall Study|Physician Decision|2|||
160933294|NCT01644175|581150718|FG000|Overall Study|Participant Moved|1|||
160933295|NCT01644175|581150719|FG001|Overall Study|Participant Moved|2|||
160933296|NCT01644175|581150718|FG000|Overall Study|Consent withdrawn by participant|3|||
160933297|NCT01644175|581150719|FG001|Overall Study|Consent withdrawn by participant|4|||
160933298|NCT01644175|581150718|FG000|Overall Study|Related to Autoinjector Administration|2|||
160933299|NCT01644175|581150719|FG001|Overall Study|Related to Autoinjector Administration|1|||
160933300|NCT01644175|581150718|FG000|Overall Study|Last visit outside protocol visit window|4|||
160933301|NCT01644175|581150719|FG001|Overall Study|Last visit outside protocol visit window|11|||
160933302|NCT01644175|581150718|FG000|Overall Study|Selection criteria finally not met|0|||
160933303|NCT01644175|581150719|FG001|Overall Study|Selection criteria finally not met|1|||
160933304|NCT01644175|581150718|FG000|Overall Study|Site closure|2|||
160933305|NCT01644175|581150719|FG001|Overall Study|Site closure|2|||
160933306|NCT01644175|581150718|FG000|Overall Study|Lost to Follow-up|1|||
160933307|NCT01644175|581150719|FG001|Overall Study|Lost to Follow-up|0|||
160933308|NCT01644175|581150718|FG000|Overall Study|Other than specified above|0|||
160933309|NCT01644175|581150719|FG001|Overall Study|Other than specified above|3|||
160933310|NCT01418937|581150723|FG000|Overall Study|Lost to Follow-up|5|||
160933311|NCT01418937|581150723|FG000|Overall Study|Protocol Violation|1|||
160933312|NCT01418937|581150723|FG000|Overall Study|Pregnancy|1|||
160933313|NCT01418937|581150723|FG000|Overall Study|Withdrawal by Subject|1|||
160933314|NCT00856908|581150744|FG000|Overall Study|Lost to Follow-up|1|||
160933315|NCT00856908|581150745|FG001|Overall Study|Lost to Follow-up|0|||
160933316|NCT01063595|581150746|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
160933317|NCT01063595|581150747|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
160933318|NCT01063595|581150746|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
160933319|NCT01063595|581150747|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
160933320|NCT01063595|581150746|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
160933321|NCT01063595|581150747|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
160933322|NCT01063595|581150746|FG000|First Intervention|Adverse Event|1|||
160933323|NCT01063595|581150747|FG001|First Intervention|Adverse Event|4|||
160455132|NCT03386578|579397848|FG009|PK Component|Stillbirth/Abortion|0|||
160455133|NCT03386578|579397839|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
160455134|NCT03386578|579397840|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
160455135|NCT03386578|579397841|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
160655943|NCT00720122|580120314|FG000|Overall Study|Withdrawal by Subject|7|||
160933324|NCT01063595|581150746|FG000|First Intervention|Withdrawal by Subject|1|||
160933325|NCT01063595|581150747|FG001|First Intervention|Withdrawal by Subject|0|||
160933326|NCT01063595|581150746|FG000|First Intervention|Reason not Specified|0|||
160933327|NCT01063595|581150747|FG001|First Intervention|Reason not Specified|1|||
160933328|NCT04059146|581150753|FG000|Overall Study|Withdrawal by Subject|0|||
160933329|NCT04059146|581150754|FG001|Overall Study|Withdrawal by Subject|1|||
160933330|NCT00451035|581150755|FG000|Overall Study|Disease progression|11|||
160933331|NCT00451035|581150755|FG000|Overall Study|Death|3|||
160933332|NCT00451035|581150755|FG000|Overall Study|New anti-neoplastic therapy|3|||
160933333|NCT01712256|581150758|FG000|Overall Study|Lost to Follow-up|1|||
160933334|NCT00962104|581150759|FG000|Overall Study|Adverse Event|10|||
160933335|NCT00962104|581150760|FG001|Overall Study|Adverse Event|3|||
160933336|NCT00962104|581150759|FG000|Overall Study|Entry Criteria Not Met|1|||
160933337|NCT00962104|581150760|FG001|Overall Study|Entry Criteria Not Met|2|||
160933338|NCT00962104|581150759|FG000|Overall Study|Lack of Efficacy|0|||
160933339|NCT00962104|581150760|FG001|Overall Study|Lack of Efficacy|1|||
160933340|NCT00962104|581150759|FG000|Overall Study|Lost to Follow-up|10|||
160933341|NCT00962104|581150760|FG001|Overall Study|Lost to Follow-up|4|||
160933342|NCT00962104|581150759|FG000|Overall Study|Physician Decision|1|||
160933343|NCT00962104|581150760|FG001|Overall Study|Physician Decision|0|||
160933344|NCT00962104|581150759|FG000|Overall Study|Protocol Violation|6|||
160655944|NCT01867242|580120315|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
160933345|NCT00962104|581150760|FG001|Overall Study|Protocol Violation|8|||
160933346|NCT00962104|581150759|FG000|Overall Study|Sponsor Decision|0|||
160933347|NCT00962104|581150760|FG001|Overall Study|Sponsor Decision|1|||
160933348|NCT00962104|581150759|FG000|Overall Study|Withdrawal by Subject|10|||
160933349|NCT00962104|581150760|FG001|Overall Study|Withdrawal by Subject|6|||
160933350|NCT00962104|581150759|FG000|Overall Study|Other|2|||
160933351|NCT00962104|581150760|FG001|Overall Study|Other|0|||
160933352|NCT00615056|581150762|FG000|Overall Study|Death|31|||
160933353|NCT00615056|581150763|FG001|Overall Study|Death|31|||
160933354|NCT00615056|581150764|FG002|Overall Study|Death|21|||
160933355|NCT00615056|581150765|FG003|Overall Study|Death|23|||
160933356|NCT00615056|581150762|FG000|Overall Study|Lost to Follow-up|1|||
160933357|NCT00615056|581150763|FG001|Overall Study|Lost to Follow-up|2|||
160933358|NCT00615056|581150764|FG002|Overall Study|Lost to Follow-up|4|||
160933359|NCT00615056|581150765|FG003|Overall Study|Lost to Follow-up|5|||
160933360|NCT00615056|581150762|FG000|Overall Study|Other|13|||
160933361|NCT00615056|581150763|FG001|Overall Study|Other|15|||
160933362|NCT00615056|581150764|FG002|Overall Study|Other|10|||
160933363|NCT00615056|581150765|FG003|Overall Study|Other|7|||
160933364|NCT00615056|581150762|FG000|Overall Study|Objective progression or relapse|0|||
160933365|NCT00615056|581150763|FG001|Overall Study|Objective progression or relapse|2|||
160933366|NCT00615056|581150764|FG002|Overall Study|Objective progression or relapse|0|||
160933367|NCT00615056|581150765|FG003|Overall Study|Objective progression or relapse|0|||
160933368|NCT00615056|581150762|FG000|Overall Study|Withdrawal by Subject|0|||
160933369|NCT00615056|581150763|FG001|Overall Study|Withdrawal by Subject|1|||
160933370|NCT00615056|581150764|FG002|Overall Study|Withdrawal by Subject|1|||
160933371|NCT00615056|581150765|FG003|Overall Study|Withdrawal by Subject|0|||
160933372|NCT00615056|581150762|FG000|Overall Study|Discontinued by Sponsor|1|||
160933373|NCT00615056|581150763|FG001|Overall Study|Discontinued by Sponsor|0|||
160933374|NCT00615056|581150764|FG002|Overall Study|Discontinued by Sponsor|0|||
160933375|NCT00615056|581150765|FG003|Overall Study|Discontinued by Sponsor|0|||
160933376|NCT00615056|581150762|FG000|Overall Study|Randomized but not treated|3|||
160933377|NCT00615056|581150763|FG001|Overall Study|Randomized but not treated|0|||
160933378|NCT00615056|581150764|FG002|Overall Study|Randomized but not treated|0|||
160933379|NCT00615056|581150765|FG003|Overall Study|Randomized but not treated|0|||
160933380|NCT00717769|581150766|FG000|Overall Study|Adverse Event|9|||
160933381|NCT00717769|581150767|FG001|Overall Study|Adverse Event|6|||
160933382|NCT00717769|581150768|FG002|Overall Study|Adverse Event|1|||
160933383|NCT00717769|581150766|FG000|Overall Study|Lack of compliance|0|||
160933384|NCT00717769|581150767|FG001|Overall Study|Lack of compliance|2|||
160933385|NCT00717769|581150768|FG002|Overall Study|Lack of compliance|0|||
160933386|NCT00717769|581150766|FG000|Overall Study|Lost to Follow-up|3|||
160933387|NCT00717769|581150767|FG001|Overall Study|Lost to Follow-up|4|||
160933388|NCT00717769|581150768|FG002|Overall Study|Lost to Follow-up|0|||
160933389|NCT00717769|581150766|FG000|Overall Study|Lack of Efficacy|1|||
160933390|NCT00717769|581150767|FG001|Overall Study|Lack of Efficacy|2|||
160933391|NCT00717769|581150768|FG002|Overall Study|Lack of Efficacy|0|||
160933392|NCT00717769|581150766|FG000|Overall Study|Protocol Violation|0|||
160933393|NCT00717769|581150767|FG001|Overall Study|Protocol Violation|2|||
160933394|NCT00717769|581150768|FG002|Overall Study|Protocol Violation|0|||
160998389|NCT04771273|581378657|FG003|Dose Escalation Period|Change of residence|1|||
160655945|NCT01867242|580120316|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
160655946|NCT01867242|580120317|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
160933395|NCT00717769|581150766|FG000|Overall Study|Sponsor decision|1|||
160933396|NCT00717769|581150767|FG001|Overall Study|Sponsor decision|0|||
160933397|NCT00717769|581150768|FG002|Overall Study|Sponsor decision|10|||
160933398|NCT00717769|581150766|FG000|Overall Study|Withdrew consent|2|||
160933399|NCT00717769|581150767|FG001|Overall Study|Withdrew consent|2|||
160933400|NCT00717769|581150768|FG002|Overall Study|Withdrew consent|0|||
160933401|NCT02196324|581150772|FG000|Overall Study|Withdrawal by Subject|8|||
160933402|NCT02196324|581150773|FG001|Overall Study|Withdrawal by Subject|4|||
160933403|NCT02196324|581150772|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
160933404|NCT02196324|581150773|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
160933405|NCT02196324|581150772|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
160998390|NCT04771273|581378654|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
160998391|NCT04771273|581378655|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
160933406|NCT02196324|581150773|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
160933407|NCT02196324|581150772|FG000|Overall Study|Other|1|||
160933408|NCT02196324|581150773|FG001|Overall Study|Other|0|||
160933409|NCT01380184|581150774|FG000|Part 1 (19 Days)|Adverse Event|1|||
160933410|NCT01380184|581150774|FG000|Part 2|Adverse Event|5|||
160933411|NCT01380184|581150774|FG000|Part 2|Disease Progression|8|||
160933412|NCT01380184|581150774|FG000|Part 2|Lost to Follow-up|1|||
160933413|NCT04327986|581150778|FG000|Overall Study|Physician Decision|2|||
160933414|NCT04327986|581150779|FG001|Overall Study|Physician Decision|0|||
160933415|NCT04327986|581150780|FG002|Overall Study|Physician Decision|0|||
160933416|NCT04327986|581150778|FG000|Overall Study|Death|1|||
160933417|NCT04327986|581150779|FG001|Overall Study|Death|0|||
160933418|NCT04327986|581150780|FG002|Overall Study|Death|0|||
160933419|NCT03350503|581150782|FG000|Overall Study|Adverse Event|5|||
160933420|NCT03350503|581150782|FG000|Overall Study|Withdrawal by Subject|5|||
160933421|NCT03350503|581150782|FG000|Overall Study|Continuation impossible due to move|4|||
160933422|NCT03350503|581150782|FG000|Overall Study|Physician Decision|3|||
160933423|NCT00262067|581150785|FG000|Overall Study|Death|190|||
160933424|NCT00262067|581150786|FG001|Overall Study|Death|89|||
160933425|NCT00262067|581150787|FG002|Overall Study|Death|186|||
160933426|NCT00262067|581150788|FG003|Overall Study|Death|99|||
160933427|NCT00262067|581150785|FG000|Overall Study|Lost to Follow-up|5|||
160933428|NCT00262067|581150786|FG001|Overall Study|Lost to Follow-up|4|||
160933429|NCT00262067|581150787|FG002|Overall Study|Lost to Follow-up|7|||
160933430|NCT00262067|581150788|FG003|Overall Study|Lost to Follow-up|5|||
160933431|NCT00262067|581150785|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
160933432|NCT00262067|581150786|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
160933433|NCT00262067|581150787|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
160933434|NCT00262067|581150788|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
160933435|NCT00262067|581150785|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
160933436|NCT00262067|581150786|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
160933437|NCT00262067|581150787|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
160933438|NCT00262067|581150788|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
160933439|NCT03829046|581150789|FG000|Overall Study|Withdrawal by Subject|1|||
160933440|NCT03829046|581150790|FG001|Overall Study|Withdrawal by Subject|0|||
160933441|NCT01581593|581152698|FG000|Overall Study|Withdrawal by Subject|1|||
160933442|NCT01101841|581152699|FG000|Overall Study|Adverse Event|15|||
160933443|NCT01101841|581152700|FG001|Overall Study|Adverse Event|15|||
160933444|NCT01101841|581152699|FG000|Overall Study|Lost to Follow-up|9|||
160933445|NCT01101841|581152700|FG001|Overall Study|Lost to Follow-up|3|||
160933446|NCT01101841|581152699|FG000|Overall Study|Withdrawal by Subject|21|||
160933447|NCT01101841|581152700|FG001|Overall Study|Withdrawal by Subject|40|||
160933448|NCT01101841|581152699|FG000|Overall Study|Protocol Violation|1|||
160933449|NCT01101841|581152700|FG001|Overall Study|Protocol Violation|1|||
160933450|NCT01101841|581152699|FG000|Overall Study|Physician Decision|0|||
160933451|NCT01101841|581152700|FG001|Overall Study|Physician Decision|2|||
160933452|NCT01101841|581152699|FG000|Overall Study|Lack of Efficacy|0|||
160933453|NCT01101841|581152700|FG001|Overall Study|Lack of Efficacy|2|||
160933454|NCT01101841|581152699|FG000|Overall Study|Other|0|||
160933455|NCT01101841|581152700|FG001|Overall Study|Other|1|||
160933456|NCT01101841|581152699|FG000|Overall Study|Suicidality Tracking Scale|3|||
160933457|NCT01101841|581152700|FG001|Overall Study|Suicidality Tracking Scale|1|||
160933458|NCT01101841|581152699|FG000|Overall Study|Eligibility Criteria|1|||
160933459|NCT01101841|581152700|FG001|Overall Study|Eligibility Criteria|2|||
160933460|NCT00653224|581152703|FG000|Overall Study|Adverse Event|2|||
160933461|NCT00653224|581152704|FG001|Overall Study|Adverse Event|1|||
160933462|NCT00653224|581152703|FG000|Overall Study|Lack of Efficacy|1|||
160933463|NCT00653224|581152704|FG001|Overall Study|Lack of Efficacy|2|||
160933464|NCT00653224|581152703|FG000|Overall Study|Loss of efficacy|1|||
160933465|NCT00653224|581152704|FG001|Overall Study|Loss of efficacy|0|||
160933466|NCT00653224|581152703|FG000|Overall Study|Lost to Follow-up|1|||
160933467|NCT00653224|581152704|FG001|Overall Study|Lost to Follow-up|0|||
160933468|NCT00653224|581152703|FG000|Overall Study|Other|2|||
160933469|NCT00653224|581152704|FG001|Overall Study|Other|4|||
160933470|NCT03756558|581152705|FG000|Overall Study|Death|1|||
160998392|NCT04771273|581378656|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
160933471|NCT03756558|581152705|FG000|Overall Study|Lost to Follow-up|2|||
160933472|NCT03756558|581152705|FG000|Overall Study|Withdrawal by Subject|2|||
160933473|NCT02896400|581152707|FG000|1 Month Follow-up|Lost to Follow-up|7|||
160933474|NCT02896400|581152708|FG001|1 Month Follow-up|Lost to Follow-up|7|||
160933475|NCT02896400|581152709|FG002|1 Month Follow-up|Lost to Follow-up|5|||
160933476|NCT02896400|581152710|FG003|1 Month Follow-up|Lost to Follow-up|8|||
160933477|NCT02896400|581152711|FG004|1 Month Follow-up|Lost to Follow-up|9|||
160933478|NCT02896400|581152712|FG005|1 Month Follow-up|Lost to Follow-up|6|||
160998393|NCT04771273|581378657|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
160933479|NCT02896400|581152713|FG006|1 Month Follow-up|Lost to Follow-up|5|||
160933480|NCT02896400|581152714|FG007|1 Month Follow-up|Lost to Follow-up|6|||
160933481|NCT02896400|581152715|FG008|1 Month Follow-up|Lost to Follow-up|4|||
160933482|NCT02896400|581152716|FG009|1 Month Follow-up|Lost to Follow-up|7|||
160933483|NCT02896400|581152717|FG010|1 Month Follow-up|Lost to Follow-up|5|||
160933484|NCT02896400|581152718|FG011|1 Month Follow-up|Lost to Follow-up|5|||
160933485|NCT02896400|581152719|FG012|1 Month Follow-up|Lost to Follow-up|3|||
160933486|NCT02896400|581152720|FG013|1 Month Follow-up|Lost to Follow-up|4|||
160933487|NCT02896400|581152721|FG014|1 Month Follow-up|Lost to Follow-up|1|||
160933488|NCT02896400|581152722|FG015|1 Month Follow-up|Lost to Follow-up|2|||
160933489|NCT02896400|581152707|FG000|1 Month Follow-up|Death|0|||
160933490|NCT02896400|581152708|FG001|1 Month Follow-up|Death|0|||
160933491|NCT02896400|581152709|FG002|1 Month Follow-up|Death|0|||
160933492|NCT02896400|581152710|FG003|1 Month Follow-up|Death|0|||
160933493|NCT02896400|581152711|FG004|1 Month Follow-up|Death|0|||
160933494|NCT02896400|581152712|FG005|1 Month Follow-up|Death|0|||
160933495|NCT02896400|581152713|FG006|1 Month Follow-up|Death|0|||
160933496|NCT02896400|581152714|FG007|1 Month Follow-up|Death|0|||
160933497|NCT02896400|581152715|FG008|1 Month Follow-up|Death|0|||
160933498|NCT02896400|581152716|FG009|1 Month Follow-up|Death|0|||
160933499|NCT02896400|581152717|FG010|1 Month Follow-up|Death|0|||
160933500|NCT02896400|581152718|FG011|1 Month Follow-up|Death|0|||
160933501|NCT02896400|581152719|FG012|1 Month Follow-up|Death|0|||
160933502|NCT02896400|581152720|FG013|1 Month Follow-up|Death|0|||
160933503|NCT02896400|581152721|FG014|1 Month Follow-up|Death|0|||
160933504|NCT02896400|581152722|FG015|1 Month Follow-up|Death|1|||
160933505|NCT02896400|581152707|FG000|3 Month Follow-up|Lost to Follow-up|6|||
160933506|NCT02896400|581152708|FG001|3 Month Follow-up|Lost to Follow-up|3|||
160933507|NCT02896400|581152709|FG002|3 Month Follow-up|Lost to Follow-up|6|||
160933508|NCT02896400|581152710|FG003|3 Month Follow-up|Lost to Follow-up|11|||
160933509|NCT02896400|581152711|FG004|3 Month Follow-up|Lost to Follow-up|12|||
160933510|NCT02896400|581152712|FG005|3 Month Follow-up|Lost to Follow-up|6|||
160933511|NCT02896400|581152713|FG006|3 Month Follow-up|Lost to Follow-up|4|||
160933512|NCT02896400|581152714|FG007|3 Month Follow-up|Lost to Follow-up|3|||
160933513|NCT02896400|581152715|FG008|3 Month Follow-up|Lost to Follow-up|6|||
160933514|NCT02896400|581152716|FG009|3 Month Follow-up|Lost to Follow-up|5|||
160933515|NCT02896400|581152717|FG010|3 Month Follow-up|Lost to Follow-up|6|||
160933516|NCT02896400|581152718|FG011|3 Month Follow-up|Lost to Follow-up|6|||
160933517|NCT02896400|581152719|FG012|3 Month Follow-up|Lost to Follow-up|3|||
160933518|NCT02896400|581152720|FG013|3 Month Follow-up|Lost to Follow-up|5|||
160933519|NCT02896400|581152721|FG014|3 Month Follow-up|Lost to Follow-up|3|||
160933520|NCT02896400|581152722|FG015|3 Month Follow-up|Lost to Follow-up|2|||
160933521|NCT02896400|581152707|FG000|3 Month Follow-up|Death|0|||
160933522|NCT02896400|581152708|FG001|3 Month Follow-up|Death|0|||
160933523|NCT02896400|581152709|FG002|3 Month Follow-up|Death|0|||
160933524|NCT02896400|581152710|FG003|3 Month Follow-up|Death|0|||
160933525|NCT02896400|581152711|FG004|3 Month Follow-up|Death|0|||
160933526|NCT02896400|581152712|FG005|3 Month Follow-up|Death|0|||
160933527|NCT02896400|581152713|FG006|3 Month Follow-up|Death|0|||
160933528|NCT02896400|581152714|FG007|3 Month Follow-up|Death|0|||
160933529|NCT02896400|581152715|FG008|3 Month Follow-up|Death|0|||
160933530|NCT02896400|581152716|FG009|3 Month Follow-up|Death|0|||
160933531|NCT02896400|581152717|FG010|3 Month Follow-up|Death|0|||
160933532|NCT02896400|581152718|FG011|3 Month Follow-up|Death|0|||
160933533|NCT02896400|581152719|FG012|3 Month Follow-up|Death|0|||
160933534|NCT02896400|581152720|FG013|3 Month Follow-up|Death|1|||
160933535|NCT02896400|581152721|FG014|3 Month Follow-up|Death|1|||
160933536|NCT02896400|581152722|FG015|3 Month Follow-up|Death|0|||
160933537|NCT02896400|581152707|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933538|NCT02896400|581152708|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
160933539|NCT02896400|581152709|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933540|NCT02896400|581152710|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933541|NCT02896400|581152711|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
160933542|NCT02896400|581152712|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933543|NCT02896400|581152713|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
160933544|NCT02896400|581152714|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
160933545|NCT02896400|581152715|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933546|NCT02896400|581152716|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933547|NCT02896400|581152717|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
160933548|NCT02896400|581152718|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
160933549|NCT02896400|581152719|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160578478|NCT00611130|579838341|FG001|Overall Study|Adverse Event|0|||
160578479|NCT00611130|579838340|FG000|Overall Study|Death|1|||
160578480|NCT00611130|579838341|FG001|Overall Study|Death|0|||
160578481|NCT00525148|579838347|FG000|Overall Study|Other Adverse Event|3|||
160578482|NCT00525148|579838348|FG001|Overall Study|Other Adverse Event|5|||
160933550|NCT02896400|581152720|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
160933551|NCT02896400|581152721|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
160933552|NCT02896400|581152722|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933553|NCT02896400|581152707|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
160933554|NCT02896400|581152708|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
160933555|NCT02896400|581152709|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
160933556|NCT02896400|581152710|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
160933557|NCT02896400|581152711|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
160933558|NCT02896400|581152712|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
160578483|NCT00525148|579838349|FG002|Overall Study|Other Adverse Event|1|||
160933559|NCT02896400|581152713|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
160933560|NCT02896400|581152714|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
160933561|NCT02896400|581152715|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
160933562|NCT02896400|581152716|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
160933563|NCT02896400|581152717|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
160933564|NCT02896400|581152718|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
160933565|NCT02896400|581152719|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
160933566|NCT02896400|581152720|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
160933567|NCT02896400|581152721|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
160933568|NCT02896400|581152722|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
160933569|NCT02984020|581152723|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
160933570|NCT02984020|581152723|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
160933571|NCT02984020|581152723|FG000|Overall Study|Other significant protocol violation|2|||
160933572|NCT01700179|581152724|FG000|Overall Study|Physician Decision|2|||
160933573|NCT01896895|581152725|FG000|Double-blind MP|Physician Decision|0|||
160933574|NCT01896895|581152726|FG001|Double-blind MP|Physician Decision|0|||
160933575|NCT01896895|581152727|FG002|Double-blind MP|Physician Decision|1|||
160933576|NCT01896895|581152728|FG003|Double-blind MP|Physician Decision|0|||
160933577|NCT01896895|581152725|FG000|Double-blind MP|Withdrawal by Subject|0|||
160933578|NCT01896895|581152726|FG001|Double-blind MP|Withdrawal by Subject|2|||
160933579|NCT01896895|581152727|FG002|Double-blind MP|Withdrawal by Subject|1|||
160933580|NCT01896895|581152728|FG003|Double-blind MP|Withdrawal by Subject|0|||
160933581|NCT01896895|581152725|FG000|Double-blind MP|Lost to Follow-up|1|||
160933582|NCT01896895|581152726|FG001|Double-blind MP|Lost to Follow-up|0|||
160933583|NCT01896895|581152727|FG002|Double-blind MP|Lost to Follow-up|1|||
160933584|NCT01896895|581152728|FG003|Double-blind MP|Lost to Follow-up|0|||
160933585|NCT03277846|581152729|FG000|Overall Study|Inpatient stay too brief|12|||
160933586|NCT03277846|581152730|FG001|Overall Study|Inpatient stay too brief|11|||
160933587|NCT01207778|581152731|FG000|Overall Study|Lost to Follow-up|0|||
160933588|NCT01207778|581152732|FG001|Overall Study|Lost to Follow-up|3|||
160933589|NCT01207778|581152733|FG002|Overall Study|Lost to Follow-up|3|||
160933590|NCT01589822|581152736|FG000|Overall Study|Withdrawal by Subject|1|||
160933591|NCT01589822|581152737|FG001|Overall Study|Withdrawal by Subject|2|||
160933592|NCT01589822|581152738|FG002|Overall Study|Withdrawal by Subject|0|||
160933593|NCT01589822|581152736|FG000|Overall Study|Death|1|||
160933594|NCT01589822|581152737|FG001|Overall Study|Death|0|||
160933595|NCT01589822|581152738|FG002|Overall Study|Death|0|||
160933596|NCT01589822|581152736|FG000|Overall Study|Missed 90 day visit|2|||
160933597|NCT01589822|581152737|FG001|Overall Study|Missed 90 day visit|1|||
160933598|NCT01589822|581152738|FG002|Overall Study|Missed 90 day visit|1|||
160933599|NCT05168475|581152739|FG000|Period 1|Protocol Violation|1|||
160933600|NCT05168475|581152739|FG000|Period 1|IMP shortage|2|||
160933601|NCT05168475|581152739|FG000|Period 1|Not randomised|2|||
160933602|NCT05168475|581152739|FG000|Period 2|IMP shortage|1|||
160933603|NCT00646204|581152740|FG000|Overall Study|Adverse Event|3|||
160933604|NCT00646204|581152741|FG001|Overall Study|Adverse Event|0|||
160933605|NCT00646204|581152740|FG000|Overall Study|Withdrawal by Subject|1|||
160933606|NCT00646204|581152741|FG001|Overall Study|Withdrawal by Subject|0|||
160933607|NCT00773175|581152745|FG000|Overall Study|Adverse Event|2|||
160933608|NCT00773175|581152746|FG001|Overall Study|Adverse Event|0|||
160933609|NCT00773175|581152745|FG000|Overall Study|Consent Withdrawn|0|||
160933610|NCT00773175|581152746|FG001|Overall Study|Consent Withdrawn|2|||
160933611|NCT00503841|581152747|FG000|Overall Study|All screen failures|44|||
160933612|NCT01302964|581152748|FG000|Overall Study|Adverse Event|1|||
160933613|NCT01302964|581152749|FG001|Overall Study|Adverse Event|0|||
160933614|NCT01945489|581152750|FG000|Cycle 1|Adverse Event|2|||
160933615|NCT01945489|581152751|FG001|Cycle 1|Adverse Event|0|||
160933616|NCT01945489|581152750|FG000|Cycle 1|Lost to Follow-up|4|||
160998394|NCT04771273|581378654|FG000|Dose Escalation Period|Adverse Event|8|||
160578484|NCT00525148|579838350|FG003|Overall Study|Other Adverse Event|8|||
160578485|NCT00525148|579838347|FG000|Overall Study|Progressive disease|18|||
160578486|NCT00525148|579838348|FG001|Overall Study|Progressive disease|30|||
160578487|NCT00525148|579838349|FG002|Overall Study|Progressive disease|6|||
160578488|NCT00525148|579838350|FG003|Overall Study|Progressive disease|49|||
160933617|NCT01945489|581152751|FG001|Cycle 1|Lost to Follow-up|0|||
160998395|NCT04771273|581378655|FG001|Dose Escalation Period|Adverse Event|9|||
160933618|NCT01945489|581152750|FG000|Cycle 1|Personal Reasons|4|||
160933619|NCT01945489|581152751|FG001|Cycle 1|Personal Reasons|2|||
160933620|NCT01945489|581152750|FG000|Cycle 1|Protocol Violation|0|||
160933621|NCT01945489|581152751|FG001|Cycle 1|Protocol Violation|1|||
160933622|NCT01945489|581152750|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
160933623|NCT01945489|581152751|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
160933624|NCT01945489|581152750|FG000|Cycle 2|Adverse Event|1|||
160933625|NCT01945489|581152751|FG001|Cycle 2|Adverse Event|0|||
160578489|NCT00525148|579838347|FG000|Overall Study|Refused continuation of study medication|0|||
160998396|NCT04771273|581378656|FG002|Dose Escalation Period|Adverse Event|12|||
160998397|NCT04771273|581378657|FG003|Dose Escalation Period|Adverse Event|2|||
160998398|NCT04771273|581378654|FG000|Maintenance Period|Other than listed|4|||
160998399|NCT04771273|581378655|FG001|Maintenance Period|Other than listed|2|||
160998400|NCT04771273|581378656|FG002|Maintenance Period|Other than listed|0|||
160998401|NCT04771273|581378657|FG003|Maintenance Period|Other than listed|3|||
160998402|NCT04771273|581378654|FG000|Maintenance Period|Burden of study procedures|1|||
160998403|NCT04771273|581378655|FG001|Maintenance Period|Burden of study procedures|0|||
160998404|NCT04771273|581378656|FG002|Maintenance Period|Burden of study procedures|0|||
160998405|NCT04771273|581378657|FG003|Maintenance Period|Burden of study procedures|0|||
160998406|NCT04771273|581378654|FG000|Maintenance Period|Change of residence|0|||
160998407|NCT04771273|581378655|FG001|Maintenance Period|Change of residence|1|||
160998408|NCT04771273|581378656|FG002|Maintenance Period|Change of residence|3|||
160998409|NCT04771273|581378657|FG003|Maintenance Period|Change of residence|0|||
160998410|NCT04771273|581378654|FG000|Maintenance Period|Perceived lack of efficacy|0|||
160998411|NCT04771273|581378655|FG001|Maintenance Period|Perceived lack of efficacy|0|||
160998412|NCT04771273|581378656|FG002|Maintenance Period|Perceived lack of efficacy|0|||
160998413|NCT04771273|581378657|FG003|Maintenance Period|Perceived lack of efficacy|1|||
160655947|NCT00661999|580120318|FG000|Overall Study|Adverse Event|11|||
160933626|NCT01945489|581152750|FG000|Cycle 2|Lost to Follow-up|0|||
160933627|NCT01945489|581152751|FG001|Cycle 2|Lost to Follow-up|1|||
160933628|NCT00145509|581152752|FG000|Overall Study|Adverse Event|10|||
160933629|NCT00145509|581152753|FG001|Overall Study|Adverse Event|3|||
160933630|NCT00145509|581152752|FG000|Overall Study|Lack of Efficacy|3|||
160933631|NCT00145509|581152753|FG001|Overall Study|Lack of Efficacy|1|||
160933632|NCT00145509|581152752|FG000|Overall Study|Lost to Follow-up|5|||
160933633|NCT00145509|581152753|FG001|Overall Study|Lost to Follow-up|9|||
160933634|NCT00145509|581152752|FG000|Overall Study|Withdrew Consent|2|||
160933635|NCT00145509|581152753|FG001|Overall Study|Withdrew Consent|7|||
160933636|NCT00145509|581152752|FG000|Overall Study|Reason not provided|2|||
160933637|NCT00145509|581152753|FG001|Overall Study|Reason not provided|1|||
160933638|NCT01982253|581152761|FG000|Overall Study|Withdrawal by Subject|1|||
160933639|NCT01982253|581152762|FG001|Overall Study|Withdrawal by Subject|0|||
160933640|NCT01982253|581152763|FG002|Overall Study|Withdrawal by Subject|0|||
160933641|NCT01982253|581152761|FG000|Overall Study|Study terminated by sponsor|1|||
160933642|NCT01982253|581152762|FG001|Overall Study|Study terminated by sponsor|4|||
160933643|NCT01982253|581152763|FG002|Overall Study|Study terminated by sponsor|4|||
160933644|NCT02789176|581152767|FG000|Overall Study|Death|0|||
160933645|NCT02789176|581152768|FG001|Overall Study|Death|0|||
160933646|NCT02789176|581152769|FG002|Overall Study|Death|3|||
160933647|NCT02789176|581152770|FG003|Overall Study|Death|0|||
160933648|NCT02789176|581152767|FG000|Overall Study|Withdrawal by Subject|0|||
160933649|NCT02789176|581152768|FG001|Overall Study|Withdrawal by Subject|0|||
160933650|NCT02789176|581152769|FG002|Overall Study|Withdrawal by Subject|1|||
160933651|NCT02789176|581152770|FG003|Overall Study|Withdrawal by Subject|0|||
160933652|NCT02789176|581152767|FG000|Overall Study|Lost to Follow-up|8|||
160933653|NCT02789176|581152768|FG001|Overall Study|Lost to Follow-up|2|||
160933654|NCT02789176|581152769|FG002|Overall Study|Lost to Follow-up|6|||
160933655|NCT02789176|581152770|FG003|Overall Study|Lost to Follow-up|1|||
160933656|NCT00596011|581152773|FG000|Overall Study|Withdrawal by Subject|2|||
160933657|NCT00596011|581152774|FG001|Overall Study|Withdrawal by Subject|3|||
160933658|NCT00596011|581152773|FG000|Overall Study|Adverse Event|11|||
160933659|NCT00596011|581152774|FG001|Overall Study|Adverse Event|7|||
160933660|NCT02347527|581152775|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
160933661|NCT02347527|581152776|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
160933662|NCT02347527|581152777|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
160933663|NCT02347527|581152778|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
160933664|NCT02347527|581152775|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
160933665|NCT02347527|581152776|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
160933666|NCT02347527|581152777|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
160933667|NCT02347527|581152778|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
160998414|NCT04771273|581378654|FG000|Maintenance Period|Adverse Event|4|||
160998415|NCT04771273|581378655|FG001|Maintenance Period|Adverse Event|5|||
160998416|NCT04771273|581378656|FG002|Maintenance Period|Adverse Event|5|||
160998417|NCT04771273|581378657|FG003|Maintenance Period|Adverse Event|0|||
160933668|NCT02347527|581152775|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
160933669|NCT02347527|581152776|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
160933670|NCT02347527|581152777|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
160933671|NCT02347527|581152778|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
160933672|NCT02347527|581152775|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
160933673|NCT02347527|581152776|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
160933674|NCT02347527|581152777|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
160998418|NCT05196737|581378658|FG000|Non-intervention Week|Lost to Follow-up|2|||
160933675|NCT02347527|581152778|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
160933676|NCT02347527|581152775|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
160933677|NCT02347527|581152776|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
160933678|NCT02347527|581152777|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
160933679|NCT02347527|581152778|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
160933680|NCT01466270|581152783|FG000|Overall Study|Withdrawal by Subject|4|||
160933681|NCT01466270|581152784|FG001|Overall Study|Withdrawal by Subject|1|||
160933682|NCT01466270|581152783|FG000|Overall Study|Physician Decision|1|||
160933683|NCT01466270|581152784|FG001|Overall Study|Physician Decision|0|||
160933684|NCT01466270|581152783|FG000|Overall Study|Lost to Follow-up|1|||
160933685|NCT01466270|581152784|FG001|Overall Study|Lost to Follow-up|3|||
160933686|NCT01466270|581152783|FG000|Overall Study|Progression|1|||
160933687|NCT01466270|581152784|FG001|Overall Study|Progression|0|||
160933688|NCT01466270|581152783|FG000|Overall Study|Toxicity|4|||
160933689|NCT01466270|581152784|FG001|Overall Study|Toxicity|1|||
160933690|NCT01466270|581152783|FG000|Overall Study|Multiple|1|||
160933691|NCT01466270|581152784|FG001|Overall Study|Multiple|1|||
160933692|NCT00749775|581152793|FG000|Overall Study|Protocol Violation|24|||
160933693|NCT00749775|581152793|FG000|Overall Study|Lost to Follow-up|36|||
160933694|NCT00749775|581152793|FG000|Overall Study|No visit after first day of treatment|44|||
160933695|NCT00749775|581152793|FG000|Overall Study|No drug administration|3|||
160933696|NCT03364049|581152801|FG000|Overall Study|Death|6|||
160933697|NCT03364049|581152802|FG001|Overall Study|Death|4|||
160933698|NCT03364049|581152803|FG002|Overall Study|Death|5|||
160933699|NCT03364049|581152804|FG003|Overall Study|Death|14|||
160933700|NCT03364049|581152801|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
160933701|NCT03364049|581152802|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
160933702|NCT03364049|581152803|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
160933703|NCT03364049|581152804|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
160933704|NCT03364049|581152801|FG000|Overall Study|Withdrawal by Subject|0|||
160933705|NCT03364049|581152802|FG001|Overall Study|Withdrawal by Subject|1|||
160933706|NCT03364049|581152803|FG002|Overall Study|Withdrawal by Subject|1|||
160933707|NCT03364049|581152804|FG003|Overall Study|Withdrawal by Subject|1|||
160933708|NCT01340976|581152805|FG000|Overall Study|Physician Decision|2|||
160933709|NCT01340976|581152806|FG001|Overall Study|Physician Decision|0|||
160933710|NCT01340976|581152807|FG002|Overall Study|Physician Decision|1|||
160933711|NCT01340976|581152808|FG003|Overall Study|Physician Decision|1|||
160933712|NCT01340976|581152809|FG004|Overall Study|Physician Decision|1|||
160933713|NCT01340976|581152810|FG005|Overall Study|Physician Decision|0|||
160933714|NCT01340976|581152805|FG000|Overall Study|Death|0|||
160933715|NCT01340976|581152806|FG001|Overall Study|Death|1|||
160933716|NCT01340976|581152807|FG002|Overall Study|Death|0|||
160933717|NCT01340976|581152808|FG003|Overall Study|Death|0|||
160933718|NCT01340976|581152809|FG004|Overall Study|Death|0|||
160933719|NCT01340976|581152810|FG005|Overall Study|Death|0|||
160933720|NCT01340976|581152805|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
160933721|NCT01340976|581152806|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
160933722|NCT01340976|581152807|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
160933723|NCT01340976|581152808|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
160933724|NCT01340976|581152809|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
160933725|NCT01340976|581152810|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
160933726|NCT01340976|581152805|FG000|Overall Study|Withdrawal by Subject|0|||
160933727|NCT01340976|581152806|FG001|Overall Study|Withdrawal by Subject|0|||
160933728|NCT01340976|581152807|FG002|Overall Study|Withdrawal by Subject|0|||
160933729|NCT01340976|581152808|FG003|Overall Study|Withdrawal by Subject|1|||
160933730|NCT01340976|581152809|FG004|Overall Study|Withdrawal by Subject|1|||
160578490|NCT00525148|579838348|FG001|Overall Study|Refused continuation of study medication|2|||
160578491|NCT00525148|579838349|FG002|Overall Study|Refused continuation of study medication|0|||
160578492|NCT00525148|579838350|FG003|Overall Study|Refused continuation of study medication|1|||
160578493|NCT00525148|579838347|FG000|Overall Study|Other than stated|2|||
160578494|NCT00525148|579838348|FG001|Overall Study|Other than stated|1|||
160578495|NCT00525148|579838349|FG002|Overall Study|Other than stated|0|||
160578496|NCT00525148|579838350|FG003|Overall Study|Other than stated|3|||
160578497|NCT01137435|579838351|FG000|Overall Study|Lost to Follow-up|24|||
160933731|NCT01340976|581152810|FG005|Overall Study|Withdrawal by Subject|0|||
160933732|NCT01340976|581152805|FG000|Overall Study|Other anemia treatment|1|||
160933733|NCT01340976|581152806|FG001|Overall Study|Other anemia treatment|0|||
160933734|NCT01340976|581152807|FG002|Overall Study|Other anemia treatment|2|||
160933735|NCT01340976|581152808|FG003|Overall Study|Other anemia treatment|1|||
160933736|NCT01340976|581152809|FG004|Overall Study|Other anemia treatment|0|||
160933737|NCT01340976|581152810|FG005|Overall Study|Other anemia treatment|1|||
160933738|NCT01340976|581152805|FG000|Overall Study|Adverse Event|0|||
160578498|NCT01137435|579838351|FG000|Overall Study|Off label usage|4|||
160933739|NCT01340976|581152806|FG001|Overall Study|Adverse Event|1|||
160933740|NCT01340976|581152807|FG002|Overall Study|Adverse Event|0|||
160933741|NCT01340976|581152808|FG003|Overall Study|Adverse Event|0|||
160933742|NCT01340976|581152809|FG004|Overall Study|Adverse Event|0|||
160933743|NCT01340976|581152810|FG005|Overall Study|Adverse Event|0|||
160933744|NCT02953821|581152811|FG000|Overall Study|Adverse Event|0|||
160933745|NCT02953821|581152812|FG001|Overall Study|Adverse Event|4|||
160933746|NCT02953821|581152811|FG000|Overall Study|Death|1|||
160933747|NCT02953821|581152812|FG001|Overall Study|Death|0|||
160933748|NCT02953821|581152811|FG000|Overall Study|Progressive Disease|5|||
160933749|NCT02953821|581152812|FG001|Overall Study|Progressive Disease|1|||
160933750|NCT02953821|581152811|FG000|Overall Study|Lost to Follow-up|2|||
160933751|NCT02953821|581152812|FG001|Overall Study|Lost to Follow-up|0|||
160933752|NCT02953821|581152811|FG000|Overall Study|Physician Decision|1|||
160933753|NCT02953821|581152812|FG001|Overall Study|Physician Decision|1|||
160933754|NCT02953821|581152811|FG000|Overall Study|Withdrawal by Subject|3|||
160933755|NCT02953821|581152812|FG001|Overall Study|Withdrawal by Subject|3|||
160933756|NCT02953821|581152811|FG000|Overall Study|Change of address|0|||
160933757|NCT02953821|581152812|FG001|Overall Study|Change of address|1|||
160933758|NCT02953821|581152811|FG000|Overall Study|Lack of Efficacy|1|||
160933759|NCT02953821|581152812|FG001|Overall Study|Lack of Efficacy|0|||
160933760|NCT02953821|581152811|FG000|Overall Study|Out of state for indeterminate time|0|||
160933761|NCT02953821|581152812|FG001|Overall Study|Out of state for indeterminate time|1|||
160933762|NCT02953821|581152811|FG000|Overall Study|No improvement|0|||
160933763|NCT02953821|581152812|FG001|Overall Study|No improvement|1|||
160933764|NCT02953821|581152811|FG000|Overall Study|Refused follow-up visit|2|||
160933765|NCT02953821|581152812|FG001|Overall Study|Refused follow-up visit|1|||
160933766|NCT01067352|581152813|FG000|Overall Study|Withdrawal by Subject|1|||
160933767|NCT01067352|581152814|FG001|Overall Study|Withdrawal by Subject|2|||
160933768|NCT01067352|581152815|FG002|Overall Study|Withdrawal by Subject|1|||
160933769|NCT01067352|581152813|FG000|Overall Study|Physician Decision|0|||
160933770|NCT01067352|581152814|FG001|Overall Study|Physician Decision|1|||
160933771|NCT01067352|581152815|FG002|Overall Study|Physician Decision|0|||
160933772|NCT00976898|581152816|FG000|Overall Study|Protocol Violation|1|||
160933773|NCT00976898|581152816|FG000|Overall Study|Adverse Event|1|||
160933774|NCT00976898|581152816|FG000|Overall Study|Physician Decision|1|||
160933775|NCT00976898|581152816|FG000|Overall Study|Liver Transplant|1|||
160933776|NCT00976898|581152816|FG000|Overall Study|Progressive Disease|1|||
160933777|NCT03064126|581152817|FG000|Overall Study|Death|40|||
160933778|NCT03064126|581152818|FG001|Overall Study|Death|16|||
160933779|NCT03064126|581152819|FG002|Overall Study|Death|4|||
160933780|NCT03064126|581152820|FG003|Overall Study|Death|2|||
160933781|NCT03064126|581152817|FG000|Overall Study|Withdrawal by Subject|17|||
160933782|NCT03064126|581152818|FG001|Overall Study|Withdrawal by Subject|9|||
160933783|NCT03064126|581152819|FG002|Overall Study|Withdrawal by Subject|0|||
160933784|NCT03064126|581152820|FG003|Overall Study|Withdrawal by Subject|2|||
160933785|NCT03064126|581152817|FG000|Overall Study|Lost to Follow-up|7|||
160933786|NCT03064126|581152818|FG001|Overall Study|Lost to Follow-up|3|||
160933787|NCT03064126|581152819|FG002|Overall Study|Lost to Follow-up|0|||
160933788|NCT03064126|581152820|FG003|Overall Study|Lost to Follow-up|0|||
160933789|NCT03064126|581152817|FG000|Overall Study|Adverse Event|2|||
160933790|NCT03064126|581152818|FG001|Overall Study|Adverse Event|0|||
160933791|NCT03064126|581152819|FG002|Overall Study|Adverse Event|0|||
160933792|NCT03064126|581152820|FG003|Overall Study|Adverse Event|0|||
160933793|NCT03064126|581152817|FG000|Overall Study|Physician Decision|3|||
160933794|NCT03064126|581152818|FG001|Overall Study|Physician Decision|0|||
160933795|NCT03064126|581152819|FG002|Overall Study|Physician Decision|0|||
160933796|NCT03064126|581152820|FG003|Overall Study|Physician Decision|0|||
160933797|NCT03064126|581152817|FG000|Overall Study|Other reason for early termination|3|||
160933798|NCT03064126|581152818|FG001|Overall Study|Other reason for early termination|2|||
160933799|NCT03064126|581152819|FG002|Overall Study|Other reason for early termination|0|||
160933800|NCT03064126|581152820|FG003|Overall Study|Other reason for early termination|0|||
160933801|NCT03064126|581152817|FG000|Overall Study|Missed Visit|3|||
160933802|NCT03064126|581152818|FG001|Overall Study|Missed Visit|1|||
160933803|NCT03064126|581152819|FG002|Overall Study|Missed Visit|0|||
160933804|NCT03064126|581152820|FG003|Overall Study|Missed Visit|0|||
160933805|NCT04649151|581152821|FG000|Overall Study|Pregnancy|0|||
160933806|NCT04649151|581152822|FG001|Overall Study|Pregnancy|0|||
160933807|NCT04649151|581152823|FG002|Overall Study|Pregnancy|0|||
160933808|NCT04649151|581152824|FG003|Overall Study|Pregnancy|0|||
160578499|NCT00399802|579838352|FG000|Overall Study|Adverse Event|0|||
160933809|NCT04649151|581152825|FG004|Overall Study|Pregnancy|3|||
160933810|NCT04649151|581152821|FG000|Overall Study|Physician Decision|10|||
160933811|NCT04649151|581152822|FG001|Overall Study|Physician Decision|0|||
160933812|NCT04649151|581152823|FG002|Overall Study|Physician Decision|0|||
160933813|NCT04649151|581152824|FG003|Overall Study|Physician Decision|1|||
160933814|NCT04649151|581152825|FG004|Overall Study|Physician Decision|1|||
160933815|NCT04649151|581152821|FG000|Overall Study|Protocol Deviation|25|||
160933816|NCT04649151|581152822|FG001|Overall Study|Protocol Deviation|3|||
160933817|NCT04649151|581152823|FG002|Overall Study|Protocol Deviation|0|||
160933818|NCT04649151|581152824|FG003|Overall Study|Protocol Deviation|0|||
160933819|NCT04649151|581152825|FG004|Overall Study|Protocol Deviation|0|||
160933820|NCT04649151|581152821|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
160933821|NCT04649151|581152822|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
160933822|NCT04649151|581152823|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
160933823|NCT04649151|581152824|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
160933824|NCT04649151|581152825|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
160933825|NCT04649151|581152821|FG000|Overall Study|Withdrawal by Subject|370|||
160933826|NCT04649151|581152822|FG001|Overall Study|Withdrawal by Subject|113|||
160933827|NCT04649151|581152823|FG002|Overall Study|Withdrawal by Subject|2|||
160933828|NCT04649151|581152824|FG003|Overall Study|Withdrawal by Subject|7|||
160933829|NCT04649151|581152825|FG004|Overall Study|Withdrawal by Subject|15|||
160933830|NCT04649151|581152821|FG000|Overall Study|Adverse Event|1|||
160933831|NCT04649151|581152822|FG001|Overall Study|Adverse Event|0|||
160933832|NCT04649151|581152823|FG002|Overall Study|Adverse Event|0|||
160933833|NCT04649151|581152824|FG003|Overall Study|Adverse Event|0|||
160933834|NCT04649151|581152825|FG004|Overall Study|Adverse Event|0|||
160933835|NCT04649151|581152821|FG000|Overall Study|Lost to Follow-up|256|||
160933836|NCT04649151|581152822|FG001|Overall Study|Lost to Follow-up|29|||
160933837|NCT04649151|581152823|FG002|Overall Study|Lost to Follow-up|10|||
160933838|NCT04649151|581152824|FG003|Overall Study|Lost to Follow-up|3|||
160933839|NCT04649151|581152825|FG004|Overall Study|Lost to Follow-up|6|||
160933840|NCT04649151|581152821|FG000|Overall Study|Other than specified|59|||
160933841|NCT04649151|581152822|FG001|Overall Study|Other than specified|294|||
160933842|NCT04649151|581152823|FG002|Overall Study|Other than specified|0|||
160933843|NCT04649151|581152824|FG003|Overall Study|Other than specified|0|||
160933844|NCT04649151|581152825|FG004|Overall Study|Other than specified|4|||
160933845|NCT04649151|581152821|FG000|Overall Study|Death|0|||
160933846|NCT04649151|581152822|FG001|Overall Study|Death|0|||
160933847|NCT04649151|581152823|FG002|Overall Study|Death|0|||
160933848|NCT04649151|581152824|FG003|Overall Study|Death|0|||
160933849|NCT04649151|581152825|FG004|Overall Study|Death|1|||
160933850|NCT03752619|581152826|FG000|Overall Study|Lost to Follow-up|2|||
160933851|NCT03752619|581152827|FG001|Overall Study|Lost to Follow-up|1|||
160933852|NCT03752619|581152826|FG000|Overall Study|Withdrawal by Subject|1|||
160933853|NCT03752619|581152827|FG001|Overall Study|Withdrawal by Subject|1|||
160933854|NCT03752619|581152826|FG000|Overall Study|Adverse Event|0|||
160933855|NCT03752619|581152827|FG001|Overall Study|Adverse Event|1|||
160933856|NCT03907683|581152833|FG000|Overall Study|Pregnancy|1|||
160933857|NCT03907683|581152833|FG000|Overall Study|Withdrawal by Subject|1|||
160933858|NCT03400332|581152834|FG000|Pre-Treatment|Other reasons|0|||
160933859|NCT03400332|581152835|FG001|Pre-Treatment|Other reasons|0|||
160933860|NCT03400332|581152836|FG002|Pre-Treatment|Other reasons|0|||
160933861|NCT03400332|581152837|FG003|Pre-Treatment|Other reasons|0|||
160933862|NCT03400332|581152838|FG004|Pre-Treatment|Other reasons|0|||
160933863|NCT03400332|581152839|FG005|Pre-Treatment|Other reasons|0|||
160933864|NCT03400332|581152840|FG006|Pre-Treatment|Other reasons|0|||
160933865|NCT03400332|581152841|FG007|Pre-Treatment|Other reasons|0|||
160933866|NCT03400332|581152842|FG008|Pre-Treatment|Other reasons|1|||
160578500|NCT00399802|579838353|FG001|Overall Study|Adverse Event|2|||
160578501|NCT00399802|579838352|FG000|Overall Study|Participant discontinued by mistake|0|||
160578502|NCT00399802|579838353|FG001|Overall Study|Participant discontinued by mistake|1|||
160578503|NCT04172831|579838356|FG000|Overall Study|Adverse Event|21|||
160578504|NCT04172831|579838357|FG001|Overall Study|Adverse Event|9|||
160933867|NCT03400332|581152834|FG000|Pre-Treatment|No longer met study criteria|0|||
160933868|NCT03400332|581152835|FG001|Pre-Treatment|No longer met study criteria|0|||
160933869|NCT03400332|581152836|FG002|Pre-Treatment|No longer met study criteria|0|||
160933870|NCT03400332|581152837|FG003|Pre-Treatment|No longer met study criteria|0|||
160933871|NCT03400332|581152838|FG004|Pre-Treatment|No longer met study criteria|0|||
160933872|NCT03400332|581152839|FG005|Pre-Treatment|No longer met study criteria|0|||
160578505|NCT04172831|579838356|FG000|Overall Study|Lack of Efficacy|2|||
160578506|NCT04172831|579838357|FG001|Overall Study|Lack of Efficacy|8|||
160578507|NCT04172831|579838356|FG000|Overall Study|Physician Decision|0|||
160933873|NCT03400332|581152840|FG006|Pre-Treatment|No longer met study criteria|0|||
160933874|NCT03400332|581152841|FG007|Pre-Treatment|No longer met study criteria|0|||
160933875|NCT03400332|581152842|FG008|Pre-Treatment|No longer met study criteria|1|||
160933876|NCT03400332|581152834|FG000|Pre-Treatment|Withdrawal by Subject|0|||
160933877|NCT03400332|581152835|FG001|Pre-Treatment|Withdrawal by Subject|0|||
160933878|NCT03400332|581152836|FG002|Pre-Treatment|Withdrawal by Subject|0|||
160933879|NCT03400332|581152837|FG003|Pre-Treatment|Withdrawal by Subject|0|||
160455136|NCT03386578|579397842|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
160578508|NCT04172831|579838357|FG001|Overall Study|Physician Decision|1|||
160933880|NCT03400332|581152838|FG004|Pre-Treatment|Withdrawal by Subject|0|||
160933881|NCT03400332|581152839|FG005|Pre-Treatment|Withdrawal by Subject|0|||
160933882|NCT03400332|581152840|FG006|Pre-Treatment|Withdrawal by Subject|0|||
160933883|NCT03400332|581152841|FG007|Pre-Treatment|Withdrawal by Subject|0|||
160933884|NCT03400332|581152842|FG008|Pre-Treatment|Withdrawal by Subject|1|||
160933885|NCT03400332|581152834|FG000|Treatment|Participant withdrew consent|2|||
160933886|NCT03400332|581152835|FG001|Treatment|Participant withdrew consent|2|||
160933887|NCT03400332|581152836|FG002|Treatment|Participant withdrew consent|0|||
160933888|NCT03400332|581152837|FG003|Treatment|Participant withdrew consent|0|||
160933889|NCT03400332|581152838|FG004|Treatment|Participant withdrew consent|3|||
160933890|NCT03400332|581152839|FG005|Treatment|Participant withdrew consent|3|||
160933891|NCT03400332|581152840|FG006|Treatment|Participant withdrew consent|1|||
160933892|NCT03400332|581152841|FG007|Treatment|Participant withdrew consent|1|||
160933893|NCT03400332|581152842|FG008|Treatment|Participant withdrew consent|1|||
160933894|NCT03400332|581152834|FG000|Treatment|Other reasons|0|||
160933895|NCT03400332|581152835|FG001|Treatment|Other reasons|1|||
160933896|NCT03400332|581152836|FG002|Treatment|Other reasons|1|||
160933897|NCT03400332|581152837|FG003|Treatment|Other reasons|0|||
160933898|NCT03400332|581152838|FG004|Treatment|Other reasons|3|||
160933899|NCT03400332|581152839|FG005|Treatment|Other reasons|1|||
160933900|NCT03400332|581152840|FG006|Treatment|Other reasons|2|||
160933901|NCT03400332|581152841|FG007|Treatment|Other reasons|0|||
160933902|NCT03400332|581152842|FG008|Treatment|Other reasons|1|||
160933903|NCT03400332|581152834|FG000|Treatment|Lost to Follow-up|0|||
160933904|NCT03400332|581152835|FG001|Treatment|Lost to Follow-up|1|||
160933905|NCT03400332|581152836|FG002|Treatment|Lost to Follow-up|0|||
160933906|NCT03400332|581152837|FG003|Treatment|Lost to Follow-up|0|||
160933907|NCT03400332|581152838|FG004|Treatment|Lost to Follow-up|0|||
160933908|NCT03400332|581152839|FG005|Treatment|Lost to Follow-up|0|||
160933909|NCT03400332|581152840|FG006|Treatment|Lost to Follow-up|0|||
160933910|NCT03400332|581152841|FG007|Treatment|Lost to Follow-up|0|||
160933911|NCT03400332|581152842|FG008|Treatment|Lost to Follow-up|0|||
160933912|NCT03400332|581152834|FG000|Treatment|Death|3|||
160933913|NCT03400332|581152835|FG001|Treatment|Death|1|||
160933914|NCT03400332|581152836|FG002|Treatment|Death|2|||
160933915|NCT03400332|581152837|FG003|Treatment|Death|3|||
160933916|NCT03400332|581152838|FG004|Treatment|Death|6|||
160933917|NCT03400332|581152839|FG005|Treatment|Death|2|||
160933918|NCT03400332|581152840|FG006|Treatment|Death|1|||
160933919|NCT03400332|581152841|FG007|Treatment|Death|3|||
160933920|NCT03400332|581152842|FG008|Treatment|Death|6|||
160933921|NCT00048542|581152843|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
160933922|NCT00048542|581152844|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
160933923|NCT00048542|581152845|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160933924|NCT00048542|581152846|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160933925|NCT00048542|581152847|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
160933926|NCT00048542|581152848|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
160933927|NCT00048542|581152849|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
160933928|NCT00048542|581152850|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
160933929|NCT00048542|581152843|FG000|Double-Blind Phase|Protocol Violation|0|||
160933930|NCT00048542|581152844|FG001|Double-Blind Phase|Protocol Violation|0|||
160933931|NCT00048542|581152845|FG002|Double-Blind Phase|Protocol Violation|1|||
160933932|NCT00048542|581152846|FG003|Double-Blind Phase|Protocol Violation|0|||
160933933|NCT00048542|581152847|FG004|Double-Blind Phase|Protocol Violation|0|||
160933934|NCT00048542|581152848|FG005|Double-Blind Phase|Protocol Violation|0|||
160933935|NCT00048542|581152849|FG006|Double-Blind Phase|Protocol Violation|0|||
160933936|NCT00048542|581152850|FG007|Double-Blind Phase|Protocol Violation|0|||
160933937|NCT00048542|581152843|FG000|Double-Blind Phase|Sponsor request or decision|2|||
160933938|NCT00048542|581152844|FG001|Double-Blind Phase|Sponsor request or decision|0|||
160933939|NCT00048542|581152845|FG002|Double-Blind Phase|Sponsor request or decision|0|||
160933940|NCT00048542|581152846|FG003|Double-Blind Phase|Sponsor request or decision|0|||
160933941|NCT00048542|581152847|FG004|Double-Blind Phase|Sponsor request or decision|0|||
160933942|NCT00048542|581152848|FG005|Double-Blind Phase|Sponsor request or decision|0|||
160933943|NCT00048542|581152849|FG006|Double-Blind Phase|Sponsor request or decision|0|||
160933944|NCT00048542|581152850|FG007|Double-Blind Phase|Sponsor request or decision|0|||
160933945|NCT00048542|581152843|FG000|Double-Blind Phase|Randomized in error|1|||
160933946|NCT00048542|581152844|FG001|Double-Blind Phase|Randomized in error|0|||
160933947|NCT00048542|581152845|FG002|Double-Blind Phase|Randomized in error|0|||
160933948|NCT00048542|581152846|FG003|Double-Blind Phase|Randomized in error|0|||
160933949|NCT00048542|581152847|FG004|Double-Blind Phase|Randomized in error|0|||
160933950|NCT00048542|581152848|FG005|Double-Blind Phase|Randomized in error|0|||
160933951|NCT00048542|581152849|FG006|Double-Blind Phase|Randomized in error|0|||
160933952|NCT00048542|581152850|FG007|Double-Blind Phase|Randomized in error|0|||
160933953|NCT00048542|581152843|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933954|NCT00048542|581152844|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933955|NCT00048542|581152845|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933956|NCT00048542|581152846|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933957|NCT00048542|581152847|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
160933958|NCT00048542|581152848|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
160933959|NCT00048542|581152849|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933960|NCT00048542|581152850|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933961|NCT00048542|581152843|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933962|NCT00048542|581152844|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933963|NCT00048542|581152845|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933964|NCT00048542|581152846|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933965|NCT00048542|581152847|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933966|NCT00048542|581152848|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
160933967|NCT00048542|581152849|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933968|NCT00048542|581152850|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933969|NCT00048542|581152843|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933970|NCT00048542|581152844|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933971|NCT00048542|581152845|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933972|NCT00048542|581152846|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933973|NCT00048542|581152847|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
160933974|NCT00048542|581152848|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
160933975|NCT00048542|581152849|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933976|NCT00048542|581152850|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933977|NCT00048542|581152843|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
160933978|NCT00048542|581152844|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
160933979|NCT00048542|581152845|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
160933980|NCT00048542|581152846|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
160933981|NCT00048542|581152847|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
160933982|NCT00048542|581152848|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
160933983|NCT00048542|581152849|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
160933984|NCT00048542|581152850|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
160933985|NCT00048542|581152843|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933986|NCT00048542|581152844|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933987|NCT00048542|581152845|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933988|NCT00048542|581152846|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933989|NCT00048542|581152847|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
160933990|NCT00048542|581152848|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
160933991|NCT00048542|581152849|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933992|NCT00048542|581152850|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933993|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933994|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933995|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933996|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933997|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933998|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933999|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
160934000|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
160934001|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934002|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934003|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934004|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934005|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934006|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934007|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
160934008|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
160934009|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160934010|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160934011|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160934012|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160934013|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160934014|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160455137|NCT03386578|579397843|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
160455138|NCT03386578|579397844|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
160934015|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
160934016|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
160934017|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
160934018|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
160934019|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
160455139|NCT03386578|579397845|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
160934020|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
160934021|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
160934022|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
160455140|NCT03386578|579397846|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
160934023|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
160934024|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
160934025|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934026|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934027|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934028|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934029|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934030|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934031|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
160934032|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
160934033|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934034|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934035|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934036|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934037|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934038|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934039|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
160934040|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
160934041|NCT01455012|581152854|FG000|Overall Study|Adverse Event|0|||
160934042|NCT01455012|581152855|FG001|Overall Study|Adverse Event|2|||
160934043|NCT01455012|581152854|FG000|Overall Study|Lack of Efficacy|6|||
160934044|NCT01455012|581152855|FG001|Overall Study|Lack of Efficacy|1|||
160934045|NCT01455012|581152854|FG000|Overall Study|Withdrawal by Subject|3|||
160934046|NCT01455012|581152855|FG001|Overall Study|Withdrawal by Subject|1|||
160934047|NCT01455012|581152854|FG000|Overall Study|Unknown reason|2|||
160934048|NCT01455012|581152855|FG001|Overall Study|Unknown reason|0|||
160934049|NCT00692770|581152859|FG000|Overall Study|Protocol Violation|2|||
160934050|NCT00692770|581152860|FG001|Overall Study|Protocol Violation|7|||
160934051|NCT00692770|581152859|FG000|Overall Study|Withdrawal by Subject|97|||
160934052|NCT00692770|581152860|FG001|Overall Study|Withdrawal by Subject|36|||
160934053|NCT00692770|581152859|FG000|Overall Study|Adverse Event|136|||
160934054|NCT00692770|581152860|FG001|Overall Study|Adverse Event|41|||
160934055|NCT00692770|581152859|FG000|Overall Study|Death|10|||
160934056|NCT00692770|581152860|FG001|Overall Study|Death|5|||
160934057|NCT00692770|581152859|FG000|Overall Study|Lost to Follow-up|7|||
160934058|NCT00692770|581152860|FG001|Overall Study|Lost to Follow-up|3|||
160934059|NCT00692770|581152859|FG000|Overall Study|Non-compliant with study medication|11|||
160934060|NCT00692770|581152860|FG001|Overall Study|Non-compliant with study medication|5|||
160934061|NCT00692770|581152859|FG000|Overall Study|Progression by clinical judgment|2|||
160934062|NCT00692770|581152860|FG001|Overall Study|Progression by clinical judgment|3|||
160934063|NCT00692770|581152859|FG000|Overall Study|Physician decision not protocol driven|10|||
160934064|NCT00692770|581152860|FG001|Overall Study|Physician decision not protocol driven|14|||
160934065|NCT00692770|581152859|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
160934066|NCT00692770|581152860|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
160934067|NCT00692770|581152859|FG000|Overall Study|Protocol driven decision point|3|||
160934068|NCT00692770|581152860|FG001|Overall Study|Protocol driven decision point|7|||
160934069|NCT00692770|581152859|FG000|Overall Study|Completed all planned assessments|79|||
160934070|NCT00692770|581152860|FG001|Overall Study|Completed all planned assessments|101|||
160934071|NCT00692770|581152859|FG000|Overall Study|Radiological and clinical progression|8|||
160934072|NCT00692770|581152860|FG001|Overall Study|Radiological and clinical progression|8|||
160934073|NCT00692770|581152859|FG000|Overall Study|Clinical endpoint reached|16|||
160934074|NCT00692770|581152860|FG001|Overall Study|Clinical endpoint reached|43|||
160934075|NCT00692770|581152859|FG000|Overall Study|Study terminated by sponsor|2|||
160934076|NCT00692770|581152860|FG001|Overall Study|Study terminated by sponsor|2|||
160934077|NCT00692770|581152859|FG000|Overall Study|Randomized but not treated|3|||
160934078|NCT00692770|581152860|FG001|Overall Study|Randomized but not treated|4|||
160934079|NCT04248816|581152861|FG000|Overall Study|Ineligible post-randomization|7|||
160934080|NCT04248816|581152862|FG001|Overall Study|Ineligible post-randomization|21|||
160934081|NCT04248816|581152863|FG002|Overall Study|Ineligible post-randomization|25|||
160934082|NCT01399593|581152869|FG000|Overall Study|Physician Decision|1|||
160934083|NCT01399593|581152870|FG001|Overall Study|Physician Decision|0|||
160934084|NCT01399593|581152869|FG000|Overall Study|Adverse Event|1|||
160934085|NCT01399593|581152870|FG001|Overall Study|Adverse Event|0|||
160934086|NCT01399593|581152869|FG000|Overall Study|Death|1|||
160934087|NCT01399593|581152870|FG001|Overall Study|Death|1|||
160934088|NCT01399593|581152869|FG000|Overall Study|Transplantectomy|0|||
160934089|NCT01399593|581152870|FG001|Overall Study|Transplantectomy|1|||
160934090|NCT00344773|581152872|FG000|Overall Study|Adverse Event|2|||
160934091|NCT00344773|581152872|FG000|Overall Study|Objective Disease Progression|16|||
160934092|NCT00344773|581152872|FG000|Overall Study|Withdrawal by Subject|1|||
160934093|NCT00344773|581152872|FG000|Overall Study|Not Eligible for the study|2|||
160934094|NCT02849548|581152880|FG000|Overall Study|Lost to Follow-up|1|||
160934095|NCT02849548|581152881|FG001|Overall Study|Lost to Follow-up|2|||
160998419|NCT05196737|581378658|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
160998420|NCT00462943|581378659|FG000|Overall Study|Failure to achieve a response|5|||
160998421|NCT00462943|581378660|FG001|Overall Study|Failure to achieve a response|5|||
160998422|NCT00462943|581378661|FG002|Overall Study|Failure to achieve a response|1|||
160998423|NCT00462943|581378659|FG000|Overall Study|Adverse Event|6|||
160998424|NCT00462943|581378660|FG001|Overall Study|Adverse Event|4|||
160998425|NCT00462943|581378661|FG002|Overall Study|Adverse Event|1|||
160998426|NCT00462943|581378659|FG000|Overall Study|Protocol Violation|1|||
160934096|NCT02849548|581152880|FG000|Overall Study|Protocol Violation|1|||
160934097|NCT02849548|581152881|FG001|Overall Study|Protocol Violation|0|||
160934098|NCT00714259|581152882|FG000|Overall Study|Death|2|||
160934099|NCT04804813|581152884|FG000|Overall Study|Protocol Violation|2|||
160934100|NCT04804813|581152885|FG001|Overall Study|Protocol Violation|0|||
160934101|NCT04804813|581152884|FG000|Overall Study|Withdrawal by Subject|1|||
160934102|NCT04804813|581152885|FG001|Overall Study|Withdrawal by Subject|0|||
160934103|NCT02357147|581152886|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
160934104|NCT02357147|581152887|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
160934105|NCT02357147|581152886|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
160934106|NCT02357147|581152887|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
160934107|NCT02357147|581152886|FG000|Combination Treatment Phase|Investigator Discretion|1|||
160934108|NCT02357147|581152887|FG001|Combination Treatment Phase|Investigator Discretion|1|||
160934109|NCT02357147|581152886|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
160934110|NCT02357147|581152887|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
160934111|NCT02357147|581152886|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
160934112|NCT02357147|581152887|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
160934113|NCT02357147|581152886|FG000|Combination Treatment Phase|Adverse Event|12|||
160934114|NCT02357147|581152887|FG001|Combination Treatment Phase|Adverse Event|4|||
160934115|NCT02357147|581152886|FG000|Combination Treatment Phase|Death|1|||
160934116|NCT02357147|581152887|FG001|Combination Treatment Phase|Death|1|||
160934117|NCT02357147|581152886|FG000|Combination Treatment Phase|Sponsor Decision|0|||
160934118|NCT02357147|581152887|FG001|Combination Treatment Phase|Sponsor Decision|12|||
160934119|NCT02357147|581152886|FG000|Combination Treatment Phase|Other|1|||
160934120|NCT02357147|581152887|FG001|Combination Treatment Phase|Other|0|||
160934121|NCT02357147|581152886|FG000|Combination Treatment Phase|Not treated|0|||
160934122|NCT02357147|581152887|FG001|Combination Treatment Phase|Not treated|2|||
160934123|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
160934124|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
160934125|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160934126|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
160934127|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
160934128|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
160934129|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Adverse Event|0|||
160934130|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Adverse Event|3|||
160934131|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
160934132|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
160934133|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Not Treated|1|||
160934134|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Not Treated|0|||
160934135|NCT02103478|581154964|FG000|Overall Study|Adverse Event|0|||
160934136|NCT02103478|581154965|FG001|Overall Study|Adverse Event|0|||
160934137|NCT02103478|581154966|FG002|Overall Study|Adverse Event|1|||
160934138|NCT02103478|581154967|FG003|Overall Study|Adverse Event|1|||
160934139|NCT02103478|581154968|FG004|Overall Study|Adverse Event|2|||
160934140|NCT02103478|581154969|FG005|Overall Study|Adverse Event|1|||
160934141|NCT02103478|581154970|FG006|Overall Study|Adverse Event|0|||
160934142|NCT02103478|581154971|FG007|Overall Study|Adverse Event|0|||
160934143|NCT02103478|581154972|FG008|Overall Study|Adverse Event|0|||
160934144|NCT02103478|581154964|FG000|Overall Study|Death|2|||
160934145|NCT02103478|581154965|FG001|Overall Study|Death|2|||
160934146|NCT02103478|581154966|FG002|Overall Study|Death|1|||
160934147|NCT02103478|581154967|FG003|Overall Study|Death|1|||
160934148|NCT02103478|581154968|FG004|Overall Study|Death|5|||
160934149|NCT02103478|581154969|FG005|Overall Study|Death|15|||
160934150|NCT02103478|581154970|FG006|Overall Study|Death|14|||
160998427|NCT00462943|581378660|FG001|Overall Study|Protocol Violation|0|||
160998428|NCT00462943|581378661|FG002|Overall Study|Protocol Violation|0|||
160998429|NCT00462943|581378659|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
160998430|NCT00462943|581378660|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
160934151|NCT02103478|581154971|FG007|Overall Study|Death|10|||
160934152|NCT02103478|581154972|FG008|Overall Study|Death|11|||
160934153|NCT02103478|581154964|FG000|Overall Study|Progressive Disease|2|||
160934154|NCT02103478|581154965|FG001|Overall Study|Progressive Disease|1|||
160934155|NCT02103478|581154966|FG002|Overall Study|Progressive Disease|2|||
160934156|NCT02103478|581154967|FG003|Overall Study|Progressive Disease|0|||
160998431|NCT00462943|581378661|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
160934157|NCT02103478|581154968|FG004|Overall Study|Progressive Disease|9|||
160934158|NCT02103478|581154969|FG005|Overall Study|Progressive Disease|1|||
160934159|NCT02103478|581154970|FG006|Overall Study|Progressive Disease|2|||
160934160|NCT02103478|581154971|FG007|Overall Study|Progressive Disease|0|||
160934161|NCT02103478|581154972|FG008|Overall Study|Progressive Disease|1|||
160934162|NCT02103478|581154964|FG000|Overall Study|Withdrawal by Subject|2|||
160934163|NCT02103478|581154965|FG001|Overall Study|Withdrawal by Subject|0|||
160934164|NCT02103478|581154966|FG002|Overall Study|Withdrawal by Subject|0|||
160934165|NCT02103478|581154967|FG003|Overall Study|Withdrawal by Subject|4|||
160934166|NCT02103478|581154968|FG004|Overall Study|Withdrawal by Subject|0|||
160934167|NCT02103478|581154969|FG005|Overall Study|Withdrawal by Subject|0|||
160934168|NCT02103478|581154970|FG006|Overall Study|Withdrawal by Subject|1|||
160934169|NCT02103478|581154971|FG007|Overall Study|Withdrawal by Subject|1|||
160934170|NCT02103478|581154972|FG008|Overall Study|Withdrawal by Subject|0|||
160934171|NCT02103478|581154964|FG000|Overall Study|Lost to Follow-up|0|||
160934172|NCT02103478|581154965|FG001|Overall Study|Lost to Follow-up|0|||
160934173|NCT02103478|581154966|FG002|Overall Study|Lost to Follow-up|0|||
160934174|NCT02103478|581154967|FG003|Overall Study|Lost to Follow-up|0|||
160934175|NCT02103478|581154968|FG004|Overall Study|Lost to Follow-up|0|||
160934176|NCT02103478|581154969|FG005|Overall Study|Lost to Follow-up|0|||
160934177|NCT02103478|581154970|FG006|Overall Study|Lost to Follow-up|0|||
160934178|NCT02103478|581154971|FG007|Overall Study|Lost to Follow-up|1|||
160934179|NCT02103478|581154972|FG008|Overall Study|Lost to Follow-up|0|||
160934180|NCT02103478|581154964|FG000|Overall Study|Other|1|||
160934181|NCT02103478|581154965|FG001|Overall Study|Other|3|||
160934182|NCT02103478|581154966|FG002|Overall Study|Other|2|||
160934183|NCT02103478|581154967|FG003|Overall Study|Other|0|||
160934184|NCT02103478|581154968|FG004|Overall Study|Other|3|||
160934185|NCT02103478|581154969|FG005|Overall Study|Other|8|||
160934186|NCT02103478|581154970|FG006|Overall Study|Other|8|||
160934187|NCT02103478|581154971|FG007|Overall Study|Other|4|||
160934188|NCT02103478|581154972|FG008|Overall Study|Other|2|||
160934189|NCT03219333|581154973|FG000|Overall Study|Withdrawal by Subject|9|||
160934190|NCT03219333|581154974|FG001|Overall Study|Withdrawal by Subject|4|||
160934191|NCT03219333|581154973|FG000|Overall Study|Lost to Follow-up|1|||
160934192|NCT03219333|581154974|FG001|Overall Study|Lost to Follow-up|1|||
160934193|NCT03219333|581154973|FG000|Overall Study|Death|104|||
160934194|NCT03219333|581154974|FG001|Overall Study|Death|72|||
160934195|NCT03219333|581154973|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
160934196|NCT03219333|581154974|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
160934197|NCT03219333|581154973|FG000|Overall Study|Other|2|||
160934198|NCT03219333|581154974|FG001|Overall Study|Other|2|||
160934199|NCT00723606|581154975|FG000|Overall Study|Adverse Event|2|||
160934200|NCT00723606|581154976|FG001|Overall Study|Adverse Event|5|||
160934201|NCT00723606|581154975|FG000|Overall Study|Other|2|||
160934202|NCT00723606|581154976|FG001|Overall Study|Other|0|||
160934203|NCT00723606|581154975|FG000|Overall Study|Withdrawal by Subject|0|||
160578509|NCT04172831|579838356|FG000|Overall Study|Withdrawal by Subject|12|||
160578510|NCT04172831|579838357|FG001|Overall Study|Withdrawal by Subject|11|||
160578511|NCT04172831|579838356|FG000|Overall Study|Lost to Follow-up|4|||
160578512|NCT04172831|579838357|FG001|Overall Study|Lost to Follow-up|9|||
160934204|NCT00723606|581154976|FG001|Overall Study|Withdrawal by Subject|2|||
160934205|NCT02566759|581154977|FG000|All Parts|Withdrawal by Subject|0|||
160934206|NCT02566759|581154978|FG001|All Parts|Withdrawal by Subject|1|||
160934207|NCT02566759|581154979|FG002|All Parts|Withdrawal by Subject|0|||
160934208|NCT02566759|581154980|FG003|All Parts|Withdrawal by Subject|0|||
160934209|NCT02566759|581154981|FG004|All Parts|Withdrawal by Subject|0|||
160934210|NCT02566759|581154982|FG005|All Parts|Withdrawal by Subject|0|||
160934211|NCT02566759|581154983|FG006|All Parts|Withdrawal by Subject|0|||
160934212|NCT02566759|581154984|FG007|All Parts|Withdrawal by Subject|0|||
160934213|NCT02566759|581154985|FG008|All Parts|Withdrawal by Subject|0|||
160578513|NCT04172831|579838356|FG000|Overall Study|COVID-19 related crisis|3|||
160934214|NCT02566759|581154986|FG009|All Parts|Withdrawal by Subject|0|||
160578514|NCT04172831|579838357|FG001|Overall Study|COVID-19 related crisis|3|||
160578515|NCT04172831|579838356|FG000|Overall Study|Subject non-compliance|1|||
160934215|NCT02566759|581154987|FG010|All Parts|Withdrawal by Subject|0|||
160934216|NCT02566759|581154988|FG011|All Parts|Withdrawal by Subject|0|||
160934217|NCT02566759|581154989|FG012|All Parts|Withdrawal by Subject|0|||
160934218|NCT02566759|581154990|FG013|All Parts|Withdrawal by Subject|0|||
160934219|NCT02566759|581154991|FG014|All Parts|Withdrawal by Subject|0|||
160934220|NCT02566759|581154992|FG015|All Parts|Withdrawal by Subject|0|||
160934221|NCT02566759|581154993|FG016|All Parts|Withdrawal by Subject|0|||
160934222|NCT02566759|581154977|FG000|All Parts|Adverse Event|0|||
160934223|NCT02566759|581154978|FG001|All Parts|Adverse Event|0|||
160934224|NCT02566759|581154979|FG002|All Parts|Adverse Event|0|||
160934225|NCT02566759|581154980|FG003|All Parts|Adverse Event|0|||
160934226|NCT02566759|581154981|FG004|All Parts|Adverse Event|0|||
160934227|NCT02566759|581154982|FG005|All Parts|Adverse Event|0|||
160934228|NCT02566759|581154983|FG006|All Parts|Adverse Event|0|||
160934229|NCT02566759|581154984|FG007|All Parts|Adverse Event|0|||
160934230|NCT02566759|581154985|FG008|All Parts|Adverse Event|0|||
160934231|NCT02566759|581154986|FG009|All Parts|Adverse Event|0|||
160934232|NCT02566759|581154987|FG010|All Parts|Adverse Event|0|||
160934233|NCT02566759|581154988|FG011|All Parts|Adverse Event|0|||
160934234|NCT02566759|581154989|FG012|All Parts|Adverse Event|1|||
160934235|NCT02566759|581154990|FG013|All Parts|Adverse Event|3|||
160934236|NCT02566759|581154991|FG014|All Parts|Adverse Event|0|||
160934237|NCT02566759|581154992|FG015|All Parts|Adverse Event|0|||
160934238|NCT02566759|581154993|FG016|All Parts|Adverse Event|0|||
160934239|NCT02566759|581154977|FG000|All Parts|Other|0|||
160934240|NCT02566759|581154978|FG001|All Parts|Other|0|||
160934241|NCT02566759|581154979|FG002|All Parts|Other|0|||
160934242|NCT02566759|581154980|FG003|All Parts|Other|0|||
160934243|NCT02566759|581154981|FG004|All Parts|Other|0|||
160934244|NCT02566759|581154982|FG005|All Parts|Other|0|||
160934245|NCT02566759|581154983|FG006|All Parts|Other|0|||
160934246|NCT02566759|581154984|FG007|All Parts|Other|0|||
160934247|NCT02566759|581154985|FG008|All Parts|Other|0|||
160934248|NCT02566759|581154986|FG009|All Parts|Other|0|||
160934249|NCT02566759|581154987|FG010|All Parts|Other|0|||
160934250|NCT02566759|581154988|FG011|All Parts|Other|0|||
160934251|NCT02566759|581154989|FG012|All Parts|Other|0|||
160934252|NCT02566759|581154990|FG013|All Parts|Other|2|||
160934253|NCT02566759|581154991|FG014|All Parts|Other|0|||
160934254|NCT02566759|581154992|FG015|All Parts|Other|0|||
160934255|NCT02566759|581154993|FG016|All Parts|Other|0|||
160934256|NCT02566759|581154977|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934257|NCT02566759|581154978|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934258|NCT02566759|581154979|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934259|NCT02566759|581154980|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934260|NCT02566759|581154981|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934261|NCT02566759|581154982|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934262|NCT02566759|581154983|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934263|NCT02566759|581154984|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934264|NCT02566759|581154985|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934265|NCT02566759|581154986|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934266|NCT02566759|581154987|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934267|NCT02566759|581154988|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934268|NCT02566759|581154989|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934269|NCT02566759|581154990|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934270|NCT02566759|581154991|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934271|NCT02566759|581154992|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934272|NCT02566759|581154993|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
160934273|NCT01096784|581154994|FG000|Overall Study|Withdrawal by Subject|2|||
160934274|NCT01096784|581154995|FG001|Overall Study|Withdrawal by Subject|1|||
160934275|NCT01096784|581154994|FG000|Overall Study|Adverse Event|11|||
160934276|NCT01096784|581154995|FG001|Overall Study|Adverse Event|9|||
160934277|NCT01096784|581154994|FG000|Overall Study|Protocol Deviation|2|||
160934278|NCT01096784|581154995|FG001|Overall Study|Protocol Deviation|2|||
160934279|NCT01096784|581154994|FG000|Overall Study|Administrative Decision|0|||
160934280|NCT01096784|581154995|FG001|Overall Study|Administrative Decision|1|||
160934281|NCT01096784|581154994|FG000|Overall Study|Other Unspecified|0|||
160934282|NCT01096784|581154995|FG001|Overall Study|Other Unspecified|1|||
160934283|NCT05107128|581154996|FG000|Overall Study|Adverse Event|2|||
160934284|NCT05107128|581154997|FG001|Overall Study|Adverse Event|0|||
160934285|NCT05107128|581154996|FG000|Overall Study|Withdrawal by Subject|3|||
160934286|NCT05107128|581154997|FG001|Overall Study|Withdrawal by Subject|3|||
160934287|NCT05107128|581154996|FG000|Overall Study|Withdrawal of Consent|0|||
160934288|NCT05107128|581154997|FG001|Overall Study|Withdrawal of Consent|1|||
160934289|NCT05107128|581154996|FG000|Overall Study|Reason Not Specified|2|||
160934290|NCT05107128|581154997|FG001|Overall Study|Reason Not Specified|0|||
160934291|NCT03761628|581154998|FG000|Overall Study|Withdrawal by Subject|3|||
160934292|NCT03761628|581154998|FG000|Overall Study|Physician Decision|1|||
160934293|NCT03761628|581154998|FG000|Overall Study|Pregnancy|1|||
160934294|NCT03761628|581154998|FG000|Overall Study|Lost to Follow-up|1|||
160934295|NCT01470469|581155001|FG000|Overall Study|Withdrawal by Subject|4|||
160934296|NCT01470469|581155002|FG001|Overall Study|Withdrawal by Subject|6|||
160934297|NCT01470469|581155001|FG000|Overall Study|Lack of Efficacy|1|||
160934298|NCT01470469|581155002|FG001|Overall Study|Lack of Efficacy|7|||
160934299|NCT01470469|581155001|FG000|Overall Study|Adverse Event|0|||
160934300|NCT01470469|581155002|FG001|Overall Study|Adverse Event|7|||
160934301|NCT01470469|581155001|FG000|Overall Study|Lost to Follow-up|2|||
160934302|NCT01470469|581155002|FG001|Overall Study|Lost to Follow-up|2|||
160934303|NCT01470469|581155001|FG000|Overall Study|Protocol Violation|1|||
160934304|NCT01470469|581155002|FG001|Overall Study|Protocol Violation|1|||
160934305|NCT01470469|581155001|FG000|Overall Study|Other|2|||
160934306|NCT01470469|581155002|FG001|Overall Study|Other|1|||
160934307|NCT05459129|581155003|FG000|Overall Study|Death|1|||
160934308|NCT05459129|581155004|FG001|Overall Study|Death|0|||
160934309|NCT05459129|581155003|FG000|Overall Study|Study Terminated By Sponsor|5|||
160934310|NCT05459129|581155004|FG001|Overall Study|Study Terminated By Sponsor|6|||
160934311|NCT04476017|581155012|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
160934312|NCT04476017|581155013|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
160934313|NCT03362502|581155014|FG000|Overall Study|Death|0|||
160934314|NCT03362502|581155015|FG001|Overall Study|Death|0|||
160934315|NCT03362502|581155016|FG002|Overall Study|Death|1|||
160934316|NCT03795610|581155020|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
160934317|NCT03795610|581155020|FG000|Overall Study|Withdrawal by Subject|1|||
160934318|NCT03795610|581155020|FG000|Overall Study|Screen Failure (Unknown)|1|||
160934319|NCT02775344|581155021|FG000|Overall Study|No ovarian cyst identified|3|||
160934320|NCT02775344|581155022|FG001|Overall Study|No ovarian cyst identified|2|||
160934321|NCT03909165|581155033|FG000|Overall Study|Physician Decision|0|||
160934322|NCT03909165|581155034|FG001|Overall Study|Physician Decision|1|||
160934323|NCT03909165|581155035|FG002|Overall Study|Physician Decision|0|||
160934324|NCT03909165|581155036|FG003|Overall Study|Physician Decision|0|||
160934325|NCT03909165|581155037|FG004|Overall Study|Physician Decision|0|||
160934326|NCT03909165|581155033|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160934327|NCT03909165|581155034|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160934328|NCT03909165|581155035|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160934329|NCT03909165|581155036|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160934330|NCT03909165|581155037|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160934331|NCT03909165|581155033|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
160934332|NCT03909165|581155034|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
160934333|NCT03909165|581155035|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
160934334|NCT03909165|581155036|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
160934335|NCT03909165|581155037|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
160934336|NCT03909165|581155033|FG000|Overall Study|Previous Drug Exposure|0|||
160934337|NCT03909165|581155034|FG001|Overall Study|Previous Drug Exposure|0|||
160934338|NCT03909165|581155035|FG002|Overall Study|Previous Drug Exposure|1|||
160934339|NCT03909165|581155036|FG003|Overall Study|Previous Drug Exposure|0|||
160934340|NCT03909165|581155037|FG004|Overall Study|Previous Drug Exposure|0|||
160934341|NCT03909165|581155033|FG000|Overall Study|Early Discharge|1|||
160934342|NCT03909165|581155034|FG001|Overall Study|Early Discharge|0|||
160934343|NCT03909165|581155035|FG002|Overall Study|Early Discharge|0|||
160934344|NCT03909165|581155036|FG003|Overall Study|Early Discharge|0|||
160934345|NCT03909165|581155037|FG004|Overall Study|Early Discharge|0|||
160934346|NCT06034496|581155038|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
160934347|NCT06034496|581155039|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
160934348|NCT06034496|581155038|FG000|Overall Study|Withdrawal by Subject|5|||
160934349|NCT06034496|581155039|FG001|Overall Study|Withdrawal by Subject|4|||
160934350|NCT02018458|581155040|FG000|Overall Study|Death|4|||
160934351|NCT04033159|581155041|FG000|Washout Period|Physician Decision|0|||
160934352|NCT04033159|581155042|FG001|Washout Period|Physician Decision|1|||
160934353|NCT04033159|581155043|FG002|Washout Period|Physician Decision|0|||
160934354|NCT04033159|581155041|FG000|Washout Period|Study terminated by Sponsor|0|||
160934355|NCT04033159|581155042|FG001|Washout Period|Study terminated by Sponsor|7|||
160934356|NCT04033159|581155043|FG002|Washout Period|Study terminated by Sponsor|0|||
160934357|NCT04033159|581155041|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
160934358|NCT04033159|581155042|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
160934359|NCT04033159|581155043|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
160934360|NCT03277261|581155050|FG000|Overall Study|Adverse Event|17|||
160934361|NCT03277261|581155051|FG001|Overall Study|Adverse Event|1|||
160934362|NCT03277261|581155050|FG000|Overall Study|Participant Withdrawal of Consent|6|||
160934363|NCT03277261|581155051|FG001|Overall Study|Participant Withdrawal of Consent|15|||
160934364|NCT03277261|581155050|FG000|Overall Study|Investigator / Sponsor Decision|4|||
160934365|NCT03277261|581155051|FG001|Overall Study|Investigator / Sponsor Decision|2|||
160934366|NCT03277261|581155050|FG000|Overall Study|Pregnancy|2|||
160934367|NCT03277261|581155051|FG001|Overall Study|Pregnancy|0|||
160578516|NCT04172831|579838357|FG001|Overall Study|Subject non-compliance|1|||
160578517|NCT04172831|579838356|FG000|Overall Study|Family emergency|1|||
160934368|NCT03277261|581155050|FG000|Overall Study|Lost to Follow-up|2|||
160934369|NCT03277261|581155051|FG001|Overall Study|Lost to Follow-up|2|||
160934370|NCT03277261|581155050|FG000|Overall Study|Lack of Efficacy|2|||
160934371|NCT03277261|581155051|FG001|Overall Study|Lack of Efficacy|2|||
160934372|NCT03277261|581155050|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
160934373|NCT03277261|581155051|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
160934374|NCT03762083|581155052|FG000|Overall Study|Withdrawal by Subject|2|||
160578518|NCT04172831|579838357|FG001|Overall Study|Family emergency|0|||
160578519|NCT01899144|579838358|FG000|Treatment Period 2|Other|1|||
160578520|NCT01899144|579838358|FG000|Treatment Period 3|Other|2|||
160934375|NCT03762083|581155052|FG000|Overall Study|Physician Decision|1|||
160934376|NCT01203072|581155053|FG000|Overall Study|Adverse Event|5|||
160934377|NCT01203072|581155054|FG001|Overall Study|Adverse Event|3|||
160578521|NCT01899144|579838358|FG000|Treatment Period 5|Other|1|||
160578522|NCT02021812|579838359|FG000|Overall Study|Death|8|||
160934378|NCT01203072|581155055|FG002|Overall Study|Adverse Event|2|||
160934379|NCT01203072|581155056|FG003|Overall Study|Adverse Event|4|||
160934380|NCT01203072|581155057|FG004|Overall Study|Adverse Event|2|||
160934381|NCT01203072|581155053|FG000|Overall Study|Lack of Efficacy|1|||
160934382|NCT01203072|581155054|FG001|Overall Study|Lack of Efficacy|0|||
160934383|NCT01203072|581155055|FG002|Overall Study|Lack of Efficacy|0|||
160934384|NCT01203072|581155056|FG003|Overall Study|Lack of Efficacy|0|||
160934385|NCT01203072|581155057|FG004|Overall Study|Lack of Efficacy|0|||
160934386|NCT01203072|581155053|FG000|Overall Study|Lost to Follow-up|0|||
160934387|NCT01203072|581155054|FG001|Overall Study|Lost to Follow-up|1|||
160934388|NCT01203072|581155055|FG002|Overall Study|Lost to Follow-up|0|||
160934389|NCT01203072|581155056|FG003|Overall Study|Lost to Follow-up|0|||
160578523|NCT02021812|579838359|FG000|Overall Study|Withdrawal by Subject|3|||
160578524|NCT02021812|579838359|FG000|Overall Study|Lost to Follow-up|2|||
160934390|NCT01203072|581155057|FG004|Overall Study|Lost to Follow-up|0|||
160934391|NCT01203072|581155053|FG000|Overall Study|Protocol Violation|2|||
160934392|NCT01203072|581155054|FG001|Overall Study|Protocol Violation|0|||
160934393|NCT01203072|581155055|FG002|Overall Study|Protocol Violation|0|||
160934394|NCT01203072|581155056|FG003|Overall Study|Protocol Violation|0|||
160934395|NCT01203072|581155057|FG004|Overall Study|Protocol Violation|1|||
160934396|NCT01203072|581155053|FG000|Overall Study|Withdrawal by Subject|2|||
160934397|NCT01203072|581155054|FG001|Overall Study|Withdrawal by Subject|2|||
160934398|NCT01203072|581155055|FG002|Overall Study|Withdrawal by Subject|1|||
160934399|NCT01203072|581155056|FG003|Overall Study|Withdrawal by Subject|2|||
160934400|NCT01203072|581155057|FG004|Overall Study|Withdrawal by Subject|3|||
160934401|NCT00235872|581155058|FG000|Overall Study|Adverse Event|34|||
160934402|NCT00235872|581155058|FG000|Overall Study|Death|1|||
160934403|NCT00235872|581155058|FG000|Overall Study|Lost to Follow-up|1|||
160934404|NCT00235872|581155058|FG000|Overall Study|Withdrawal by Subject|50|||
160934405|NCT00235872|581155058|FG000|Overall Study|Administrative reason|61|||
160934406|NCT00116558|581155059|FG000|Overall Study|Death|11|||
160934407|NCT00116558|581155060|FG001|Overall Study|Death|5|||
160934408|NCT00116558|581155061|FG002|Overall Study|Death|3|||
160934409|NCT00116558|581155059|FG000|Overall Study|Withdrawal by Subject|17|||
160934410|NCT00116558|581155060|FG001|Overall Study|Withdrawal by Subject|3|||
160934411|NCT00116558|581155061|FG002|Overall Study|Withdrawal by Subject|12|||
160934412|NCT00116558|581155059|FG000|Overall Study|disease progression|3|||
160934413|NCT00116558|581155060|FG001|Overall Study|disease progression|7|||
160934414|NCT00116558|581155061|FG002|Overall Study|disease progression|18|||
160934415|NCT02027844|581155062|FG000|Overall Study|Withdrawal by Subject|3|||
160934416|NCT02027844|581155063|FG001|Overall Study|Withdrawal by Subject|2|||
160934417|NCT02027844|581155064|FG002|Overall Study|Withdrawal by Subject|1|||
160934418|NCT02027844|581155062|FG000|Overall Study|Lost to Follow-up|0|||
160934419|NCT02027844|581155063|FG001|Overall Study|Lost to Follow-up|2|||
160934420|NCT02027844|581155064|FG002|Overall Study|Lost to Follow-up|1|||
160934421|NCT02027844|581155062|FG000|Overall Study|Protocol Violation|0|||
160934422|NCT02027844|581155063|FG001|Overall Study|Protocol Violation|2|||
160934423|NCT02027844|581155064|FG002|Overall Study|Protocol Violation|0|||
160934424|NCT02027844|581155062|FG000|Overall Study|Incomlete data|2|||
160934425|NCT02027844|581155063|FG001|Overall Study|Incomlete data|0|||
160934426|NCT02027844|581155064|FG002|Overall Study|Incomlete data|0|||
160934427|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
160934428|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
160934429|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Graft loss|1|||
160934430|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Graft loss|2|||
160934431|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Death|5|||
160578525|NCT02021812|579838359|FG000|Overall Study|Refuse to return, COVD 19|2|||
160578526|NCT02119104|579838360|FG000|Overall Study|Protocol Violation|16|||
160578527|NCT00081289|579838364|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
160578528|NCT00081289|579838365|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
160578529|NCT00081289|579838364|FG000|Overall Study|Ineligible / no protocol treatment|3|||
160578530|NCT00081289|579838365|FG001|Overall Study|Ineligible / no protocol treatment|4|||
160934432|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Death|3|||
160934433|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
160934434|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
160934435|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
160934436|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
160934437|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
160934438|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
160934439|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
160934440|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
160934441|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
160934442|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
160934443|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
160934444|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
160934445|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Death|1|||
160934446|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Death|2|||
160934447|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
160934448|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
160934449|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
160934450|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
160934451|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
160934452|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
160934453|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
160934454|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
160934455|NCT00414661|581155070|FG000|Overall Study|Death|2|||
160934456|NCT00414661|581155071|FG001|Overall Study|Death|5|||
160934457|NCT00414661|581155072|FG002|Overall Study|Death|0|||
160934458|NCT00414661|581155073|FG003|Overall Study|Death|0|||
160934459|NCT00414661|581155070|FG000|Overall Study|Lost to Follow-up|1|||
160934460|NCT00414661|581155071|FG001|Overall Study|Lost to Follow-up|4|||
160934461|NCT00414661|581155072|FG002|Overall Study|Lost to Follow-up|0|||
160934462|NCT00414661|581155073|FG003|Overall Study|Lost to Follow-up|1|||
160934463|NCT00414661|581155070|FG000|Overall Study|Withdrawal by Subject|5|||
160934464|NCT00414661|581155071|FG001|Overall Study|Withdrawal by Subject|2|||
160455141|NCT03386578|579397847|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
160455142|NCT03386578|579397848|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
160455143|NCT03386578|579397839|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
160455144|NCT03386578|579397840|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
160455145|NCT03386578|579397841|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
160455146|NCT03386578|579397842|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
160455147|NCT03386578|579397843|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
160455148|NCT03386578|579397844|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
160455149|NCT03386578|579397845|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
160455150|NCT03386578|579397846|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
160455151|NCT03386578|579397847|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
160455152|NCT03386578|579397848|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
160455153|NCT03386578|579397839|FG000|PrEP Comparison Component Step 1|Death|0|||
160455154|NCT03386578|579397840|FG001|PrEP Comparison Component Step 1|Death|0|||
160455155|NCT03386578|579397841|FG002|PrEP Comparison Component Step 1|Death|1|||
160455156|NCT03386578|579397842|FG003|PrEP Comparison Component Step 1|Death|0|||
160455157|NCT03386578|579397843|FG004|PrEP Comparison Component Step 1|Death|0|||
160455158|NCT03386578|579397844|FG005|PrEP Comparison Component Step 1|Death|0|||
160455159|NCT03386578|579397845|FG006|PrEP Comparison Component Step 1|Death|0|||
160455160|NCT03386578|579397846|FG007|PrEP Comparison Component Step 1|Death|9|||
160455161|NCT03386578|579397847|FG008|PrEP Comparison Component Step 1|Death|5|||
160455162|NCT03386578|579397848|FG009|PrEP Comparison Component Step 1|Death|0|||
160455163|NCT03386578|579397839|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
160455164|NCT03386578|579397840|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
160455165|NCT03386578|579397841|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
160455166|NCT03386578|579397842|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
160455167|NCT03386578|579397843|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
160455168|NCT03386578|579397844|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
160455169|NCT03386578|579397845|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
160455170|NCT03386578|579397846|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
160455171|NCT03386578|579397847|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
160455172|NCT03386578|579397848|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
160455173|NCT03386578|579397839|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
160455174|NCT03386578|579397840|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
160455175|NCT03386578|579397841|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
160455176|NCT03386578|579397842|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
160455177|NCT03386578|579397843|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
160455178|NCT03386578|579397844|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
160455179|NCT03386578|579397845|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
160455180|NCT03386578|579397846|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
160455181|NCT03386578|579397847|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
160455182|NCT03386578|579397848|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
160455183|NCT03386578|579397839|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
160455184|NCT03386578|579397840|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
160655948|NCT00661999|580120319|FG001|Overall Study|Adverse Event|5|||
160934465|NCT00414661|581155072|FG002|Overall Study|Withdrawal by Subject|2|||
160934466|NCT00414661|581155073|FG003|Overall Study|Withdrawal by Subject|2|||
160934467|NCT00414661|581155070|FG000|Overall Study|Other|6|||
160934468|NCT00414661|581155071|FG001|Overall Study|Other|3|||
160934469|NCT00414661|581155072|FG002|Overall Study|Other|0|||
160934470|NCT00414661|581155073|FG003|Overall Study|Other|0|||
160655949|NCT00661999|580120320|FG002|Overall Study|Adverse Event|8|||
160934471|NCT02852265|581155074|FG000|3-month Follow-up|Lost to Follow-up|1|||
160934472|NCT02852265|581155075|FG001|3-month Follow-up|Lost to Follow-up|1|||
160934473|NCT01143090|581155076|FG000|Overall Study|Lack of Efficacy|2|||
160934474|NCT01143090|581155076|FG000|Overall Study|Adverse Event|17|||
160934475|NCT01143090|581155076|FG000|Overall Study|Lost to Follow-up|9|||
160934476|NCT01143090|581155076|FG000|Overall Study|Protocol Violation|2|||
160934477|NCT01143090|581155076|FG000|Overall Study|Withdrawal by Subject|18|||
160934478|NCT01143090|581155076|FG000|Overall Study|Non-compliance with study drug|1|||
160934479|NCT01143090|581155076|FG000|Overall Study|Failure to meet eligibility criteria|1|||
160934480|NCT01143090|581155076|FG000|Overall Study|Administrative|1|||
160934481|NCT01800916|581155079|FG000|Test Period 1 (1 Week)|Convex product user|0|||
160934482|NCT01800916|581155080|FG001|Test Period 1 (1 Week)|Convex product user|0|||
160934483|NCT01800916|581155081|FG002|Test Period 1 (1 Week)|Convex product user|0|||
160934484|NCT01800916|581155082|FG003|Test Period 1 (1 Week)|Convex product user|1|||
160934485|NCT01800916|581155083|FG004|Test Period 1 (1 Week)|Convex product user|0|||
160934486|NCT01800916|581155084|FG005|Test Period 1 (1 Week)|Convex product user|0|||
160934487|NCT01800916|581155085|FG006|Test Period 1 (1 Week)|Convex product user|0|||
160934488|NCT01800916|581155086|FG007|Test Period 1 (1 Week)|Convex product user|0|||
160934489|NCT01800916|581155087|FG008|Test Period 1 (1 Week)|Convex product user|0|||
160934490|NCT01800916|581155079|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
160934491|NCT01800916|581155080|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
160934492|NCT01800916|581155081|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
160934493|NCT01800916|581155082|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
160934494|NCT01800916|581155083|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
160934495|NCT01800916|581155084|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
160934496|NCT01800916|581155085|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
160934497|NCT01800916|581155086|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
160934498|NCT01800916|581155087|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
160934499|NCT00559962|581155102|FG000|Overall Study|Adverse Event|1|||
160934500|NCT00559962|581155103|FG001|Overall Study|Adverse Event|7|||
160934501|NCT00559962|581155104|FG002|Overall Study|Adverse Event|8|||
160934502|NCT00559962|581155105|FG003|Overall Study|Adverse Event|5|||
160934503|NCT00559962|581155106|FG004|Overall Study|Adverse Event|11|||
160934504|NCT00559962|581155107|FG005|Overall Study|Adverse Event|4|||
160934505|NCT00559962|581155108|FG006|Overall Study|Adverse Event|4|||
160934506|NCT00559962|581155109|FG007|Overall Study|Adverse Event|2|||
160934507|NCT00559962|581155102|FG000|Overall Study|Lost to Follow-up|0|||
160934508|NCT00559962|581155103|FG001|Overall Study|Lost to Follow-up|1|||
160934509|NCT00559962|581155104|FG002|Overall Study|Lost to Follow-up|0|||
160934510|NCT00559962|581155105|FG003|Overall Study|Lost to Follow-up|0|||
160934511|NCT00559962|581155106|FG004|Overall Study|Lost to Follow-up|0|||
160934512|NCT00559962|581155107|FG005|Overall Study|Lost to Follow-up|0|||
160934513|NCT00559962|581155108|FG006|Overall Study|Lost to Follow-up|0|||
160934514|NCT00559962|581155109|FG007|Overall Study|Lost to Follow-up|0|||
160934515|NCT00559962|581155102|FG000|Overall Study|Withdrawal by Subject|1|||
160934516|NCT00559962|581155103|FG001|Overall Study|Withdrawal by Subject|1|||
160934517|NCT00559962|581155104|FG002|Overall Study|Withdrawal by Subject|2|||
160934518|NCT00559962|581155105|FG003|Overall Study|Withdrawal by Subject|0|||
160934519|NCT00559962|581155106|FG004|Overall Study|Withdrawal by Subject|3|||
160934520|NCT00559962|581155107|FG005|Overall Study|Withdrawal by Subject|1|||
160934521|NCT00559962|581155108|FG006|Overall Study|Withdrawal by Subject|0|||
160934522|NCT00559962|581155109|FG007|Overall Study|Withdrawal by Subject|2|||
160934523|NCT00559962|581155102|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
160934524|NCT00559962|581155103|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
160934525|NCT00559962|581155104|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
160934526|NCT00559962|581155105|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
160934527|NCT00559962|581155106|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
160934528|NCT00559962|581155107|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
160934529|NCT00559962|581155108|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
160934530|NCT00559962|581155109|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
160655950|NCT00661999|580120318|FG000|Overall Study|Death|8|||
160934531|NCT01639040|581155119|FG000|Overall Study|Adverse Event|1|||
160934532|NCT01639040|581155120|FG001|Overall Study|Adverse Event|0|||
160655951|NCT00661999|580120319|FG001|Overall Study|Death|6|||
160655952|NCT00661999|580120320|FG002|Overall Study|Death|3|||
160655953|NCT00661999|580120318|FG000|Overall Study|Other Reasons|5|||
160934533|NCT04370691|581155121|FG000|Overall Study|Pending visit|48|||
160934534|NCT04370691|581155121|FG000|Overall Study|Have Not Reached Lower Window|15|||
160934535|NCT04370691|581155121|FG000|Overall Study|Termination|14|||
160934536|NCT04370691|581155121|FG000|Overall Study|Missed or Overdue|10|||
160934537|NCT00486265|581155125|FG000|Overall Study|Adverse Event|1|||
160934538|NCT00486265|581155125|FG000|Overall Study|Lack of Efficacy|8|||
160934539|NCT01452412|581155126|FG000|Overall Study|Withdrawal by Subject|15|||
160655954|NCT00661999|580120319|FG001|Overall Study|Other Reasons|12|||
160655955|NCT00661999|580120320|FG002|Overall Study|Other Reasons|23|||
160934540|NCT01452412|581155127|FG001|Overall Study|Withdrawal by Subject|11|||
160934541|NCT01452412|581155126|FG000|Overall Study|Adverse Event|4|||
160934542|NCT01452412|581155127|FG001|Overall Study|Adverse Event|3|||
160934543|NCT01452412|581155126|FG000|Overall Study|Lost to Follow-up|5|||
160934544|NCT01452412|581155127|FG001|Overall Study|Lost to Follow-up|3|||
160934545|NCT01452412|581155126|FG000|Overall Study|Death|1|||
160934546|NCT01452412|581155127|FG001|Overall Study|Death|0|||
160934547|NCT01452412|581155126|FG000|Overall Study|Initiated dialysis|1|||
160934548|NCT01452412|581155127|FG001|Overall Study|Initiated dialysis|0|||
160934549|NCT01452412|581155126|FG000|Overall Study|Other|2|||
160934550|NCT01452412|581155127|FG001|Overall Study|Other|0|||
160934551|NCT03047135|581155128|FG000|Overall Study|Still being treated|3|||
160934552|NCT03013543|581155129|FG000|Overall Study|Withdrawal by Subject|0|||
160934553|NCT03013543|581155130|FG001|Overall Study|Withdrawal by Subject|2|||
160934554|NCT03013543|581155131|FG002|Overall Study|Withdrawal by Subject|0|||
160934555|NCT03013543|581155132|FG003|Overall Study|Withdrawal by Subject|5|||
160934556|NCT03013543|581155133|FG004|Overall Study|Withdrawal by Subject|6|||
160934557|NCT03013543|581155134|FG005|Overall Study|Withdrawal by Subject|2|||
160934558|NCT03013543|581155135|FG006|Overall Study|Withdrawal by Subject|3|||
160934559|NCT03013543|581155136|FG007|Overall Study|Withdrawal by Subject|1|||
160934560|NCT03013543|581155137|FG008|Overall Study|Withdrawal by Subject|0|||
160934561|NCT03013543|581155138|FG009|Overall Study|Withdrawal by Subject|4|||
160934562|NCT03013543|581155129|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
160934563|NCT03013543|581155130|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
160934564|NCT03013543|581155131|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
160934565|NCT03013543|581155132|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
160934566|NCT03013543|581155133|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
160934567|NCT03013543|581155134|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
160934568|NCT03013543|581155135|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
160934569|NCT03013543|581155136|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
160934570|NCT03013543|581155137|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
160934571|NCT03013543|581155138|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
160934572|NCT03013543|581155129|FG000|Overall Study|Other|0|||
160934573|NCT03013543|581155130|FG001|Overall Study|Other|0|||
160934574|NCT03013543|581155131|FG002|Overall Study|Other|2|||
160934575|NCT03013543|581155132|FG003|Overall Study|Other|0|||
160934576|NCT03013543|581155133|FG004|Overall Study|Other|2|||
160934577|NCT03013543|581155134|FG005|Overall Study|Other|0|||
160934578|NCT03013543|581155135|FG006|Overall Study|Other|0|||
160934579|NCT03013543|581155136|FG007|Overall Study|Other|0|||
160934580|NCT03013543|581155137|FG008|Overall Study|Other|1|||
160934581|NCT03013543|581155138|FG009|Overall Study|Other|0|||
160934582|NCT03013543|581155129|FG000|Overall Study|Adverse Event|0|||
160934583|NCT03013543|581155130|FG001|Overall Study|Adverse Event|0|||
160934584|NCT03013543|581155131|FG002|Overall Study|Adverse Event|0|||
160934585|NCT03013543|581155132|FG003|Overall Study|Adverse Event|3|||
160934586|NCT03013543|581155133|FG004|Overall Study|Adverse Event|2|||
160934587|NCT03013543|581155134|FG005|Overall Study|Adverse Event|1|||
160934588|NCT03013543|581155135|FG006|Overall Study|Adverse Event|3|||
160934589|NCT03013543|581155136|FG007|Overall Study|Adverse Event|8|||
160934590|NCT03013543|581155137|FG008|Overall Study|Adverse Event|0|||
160455185|NCT03386578|579397841|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
160455186|NCT03386578|579397842|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
160578531|NCT01651260|579838366|FG000|Overall Study|unable to apply product|3|||
160578532|NCT01952015|579838369|FG000|Induction|Protocol Violation|1|||
160578533|NCT01952015|579838369|FG000|Maintenance|Adverse Event|2|||
160578534|NCT01952015|579838369|FG000|Treatment Period 3|Physician Decision|9|||
160578535|NCT02239094|579838370|FG000|Overall Study|Withdrawal by Subject|1|||
160578536|NCT02239094|579838370|FG000|Overall Study|Remitted before started|1|||
160578537|NCT01469052|579838375|FG000|Overall Study|Adverse Event|2|||
160578538|NCT01469052|579838376|FG001|Overall Study|Adverse Event|3|||
160578539|NCT01469052|579838377|FG002|Overall Study|Adverse Event|0|||
160578540|NCT01469052|579838378|FG003|Overall Study|Adverse Event|2|||
160578541|NCT01469052|579838379|FG004|Overall Study|Adverse Event|0|||
160934591|NCT03013543|581155138|FG009|Overall Study|Adverse Event|2|||
160934592|NCT03013543|581155129|FG000|Overall Study|Death|0|||
160934593|NCT03013543|581155130|FG001|Overall Study|Death|0|||
160934594|NCT03013543|581155131|FG002|Overall Study|Death|0|||
160934595|NCT03013543|581155132|FG003|Overall Study|Death|1|||
160578542|NCT01469052|579838380|FG005|Overall Study|Adverse Event|1|||
160578543|NCT01469052|579838375|FG000|Overall Study|Progressive disease|3|||
160934596|NCT03013543|581155133|FG004|Overall Study|Death|0|||
160934597|NCT03013543|581155134|FG005|Overall Study|Death|0|||
160934598|NCT03013543|581155135|FG006|Overall Study|Death|0|||
160934599|NCT03013543|581155136|FG007|Overall Study|Death|0|||
160934600|NCT03013543|581155137|FG008|Overall Study|Death|0|||
160934601|NCT03013543|581155138|FG009|Overall Study|Death|0|||
160934602|NCT03013543|581155129|FG000|Overall Study|Lack of Efficacy|0|||
160934603|NCT03013543|581155130|FG001|Overall Study|Lack of Efficacy|0|||
160934604|NCT03013543|581155131|FG002|Overall Study|Lack of Efficacy|0|||
160934605|NCT03013543|581155132|FG003|Overall Study|Lack of Efficacy|1|||
160934606|NCT03013543|581155133|FG004|Overall Study|Lack of Efficacy|0|||
160934607|NCT03013543|581155134|FG005|Overall Study|Lack of Efficacy|0|||
160934608|NCT03013543|581155135|FG006|Overall Study|Lack of Efficacy|0|||
160934609|NCT03013543|581155136|FG007|Overall Study|Lack of Efficacy|0|||
160934610|NCT03013543|581155137|FG008|Overall Study|Lack of Efficacy|0|||
160934611|NCT03013543|581155138|FG009|Overall Study|Lack of Efficacy|0|||
160934612|NCT03013543|581155129|FG000|Overall Study|Lost to Follow-up|0|||
160934613|NCT03013543|581155130|FG001|Overall Study|Lost to Follow-up|0|||
160934614|NCT03013543|581155131|FG002|Overall Study|Lost to Follow-up|0|||
160934615|NCT03013543|581155132|FG003|Overall Study|Lost to Follow-up|1|||
160934616|NCT03013543|581155133|FG004|Overall Study|Lost to Follow-up|0|||
160934617|NCT03013543|581155134|FG005|Overall Study|Lost to Follow-up|0|||
160934618|NCT03013543|581155135|FG006|Overall Study|Lost to Follow-up|1|||
160934619|NCT03013543|581155136|FG007|Overall Study|Lost to Follow-up|0|||
160934620|NCT03013543|581155137|FG008|Overall Study|Lost to Follow-up|0|||
160934621|NCT03013543|581155138|FG009|Overall Study|Lost to Follow-up|2|||
160934622|NCT03013543|581155129|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160934623|NCT03013543|581155130|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160934624|NCT03013543|581155131|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160934625|NCT03013543|581155132|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160934626|NCT03013543|581155133|FG004|Overall Study|Non-Compliance With Study Drug|0|||
160934627|NCT03013543|581155134|FG005|Overall Study|Non-Compliance With Study Drug|0|||
160934628|NCT03013543|581155135|FG006|Overall Study|Non-Compliance With Study Drug|0|||
160934629|NCT03013543|581155136|FG007|Overall Study|Non-Compliance With Study Drug|0|||
160934630|NCT03013543|581155137|FG008|Overall Study|Non-Compliance With Study Drug|1|||
160934631|NCT03013543|581155138|FG009|Overall Study|Non-Compliance With Study Drug|0|||
160934632|NCT03013543|581155129|FG000|Overall Study|Physician Decision|0|||
160934633|NCT03013543|581155130|FG001|Overall Study|Physician Decision|0|||
160934634|NCT03013543|581155131|FG002|Overall Study|Physician Decision|0|||
160934635|NCT03013543|581155132|FG003|Overall Study|Physician Decision|0|||
160934636|NCT03013543|581155133|FG004|Overall Study|Physician Decision|1|||
160934637|NCT03013543|581155134|FG005|Overall Study|Physician Decision|0|||
160934638|NCT03013543|581155135|FG006|Overall Study|Physician Decision|0|||
160934639|NCT03013543|581155136|FG007|Overall Study|Physician Decision|0|||
160934640|NCT03013543|581155137|FG008|Overall Study|Physician Decision|0|||
160934641|NCT03013543|581155138|FG009|Overall Study|Physician Decision|0|||
160934642|NCT03013543|581155129|FG000|Overall Study|Protocol Violation|0|||
160934643|NCT03013543|581155130|FG001|Overall Study|Protocol Violation|0|||
160934644|NCT03013543|581155131|FG002|Overall Study|Protocol Violation|0|||
160934645|NCT03013543|581155132|FG003|Overall Study|Protocol Violation|0|||
160934646|NCT03013543|581155133|FG004|Overall Study|Protocol Violation|0|||
160934647|NCT03013543|581155134|FG005|Overall Study|Protocol Violation|0|||
160934648|NCT03013543|581155135|FG006|Overall Study|Protocol Violation|0|||
160934649|NCT03013543|581155136|FG007|Overall Study|Protocol Violation|0|||
160934650|NCT03013543|581155137|FG008|Overall Study|Protocol Violation|0|||
160934651|NCT03013543|581155138|FG009|Overall Study|Protocol Violation|1|||
160934652|NCT00323414|581155139|FG000|Overall Study|Withdrawal by Subject|0|||
160934653|NCT00323414|581155140|FG001|Overall Study|Withdrawal by Subject|1|||
160934654|NCT02552316|581155142|FG000|Overall Study|Withdrawal by Subject|1|||
160934655|NCT02552316|581155142|FG000|Overall Study|Withdrawal due to non-compliance|1|||
160934656|NCT04382911|581155143|FG000|Overall Study|unable to be imaged prior to surgery|2|||
160455187|NCT03386578|579397843|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
160455188|NCT03386578|579397844|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
160578544|NCT01469052|579838376|FG001|Overall Study|Progressive disease|0|||
160578545|NCT01469052|579838377|FG002|Overall Study|Progressive disease|5|||
160578546|NCT01469052|579838378|FG003|Overall Study|Progressive disease|3|||
160578547|NCT01469052|579838379|FG004|Overall Study|Progressive disease|7|||
160578548|NCT01469052|579838380|FG005|Overall Study|Progressive disease|2|||
160578549|NCT01469052|579838375|FG000|Overall Study|Lack of Efficacy|0|||
160578550|NCT01469052|579838376|FG001|Overall Study|Lack of Efficacy|0|||
160578551|NCT01469052|579838377|FG002|Overall Study|Lack of Efficacy|0|||
160934657|NCT04116710|581155147|FG000|Overall Study|Death|4|||
160934658|NCT04116710|581155148|FG001|Overall Study|Death|6|||
160934659|NCT04116710|581155149|FG002|Overall Study|Death|3|||
160934660|NCT04116710|581155150|FG003|Overall Study|Death|1|||
160934661|NCT04116710|581155147|FG000|Overall Study|Withdrawal by Subject|0|||
160934662|NCT04116710|581155148|FG001|Overall Study|Withdrawal by Subject|0|||
160934663|NCT04116710|581155149|FG002|Overall Study|Withdrawal by Subject|0|||
160934664|NCT04116710|581155150|FG003|Overall Study|Withdrawal by Subject|1|||
160934665|NCT01256593|581155151|FG000|Overall Study|Protocol Violation|26|||
160934666|NCT01256593|581155151|FG000|Overall Study|No Drug Administration Information|2|||
160578552|NCT01469052|579838378|FG003|Overall Study|Lack of Efficacy|0|||
160934667|NCT01256593|581155151|FG000|Overall Study|No Visit After Treatment|186|||
160934668|NCT05619692|581155158|FG000|Overall Study|Adverse Event|2|||
160934669|NCT05619692|581155159|FG001|Overall Study|Adverse Event|2|||
160934670|NCT05619692|581155158|FG000|Overall Study|Withdrawal by Participant|3|||
160934671|NCT05619692|581155159|FG001|Overall Study|Withdrawal by Participant|4|||
160934672|NCT05619692|581155158|FG000|Overall Study|Lost to Follow-up|2|||
160934673|NCT05619692|581155159|FG001|Overall Study|Lost to Follow-up|1|||
160934674|NCT05619692|581155158|FG000|Overall Study|Randomized but not treated|1|||
160934675|NCT05619692|581155159|FG001|Overall Study|Randomized but not treated|3|||
160934676|NCT02457598|581155160|FG000|Overall Study|Progressive Disease|2|||
160934677|NCT02457598|581155161|FG001|Overall Study|Progressive Disease|2|||
160934678|NCT02457598|581155162|FG002|Overall Study|Progressive Disease|1|||
160934679|NCT02457598|581155163|FG003|Overall Study|Progressive Disease|11|||
160934680|NCT02457598|581155164|FG004|Overall Study|Progressive Disease|7|||
160934681|NCT02457598|581155165|FG005|Overall Study|Progressive Disease|3|||
160934682|NCT02457598|581155166|FG006|Overall Study|Progressive Disease|2|||
160934683|NCT02457598|581155167|FG007|Overall Study|Progressive Disease|1|||
160934684|NCT02457598|581155168|FG008|Overall Study|Progressive Disease|1|||
160934685|NCT02457598|581155169|FG009|Overall Study|Progressive Disease|2|||
160934686|NCT02457598|581155170|FG010|Overall Study|Progressive Disease|45|||
160934687|NCT02457598|581155171|FG011|Overall Study|Progressive Disease|6|||
160934688|NCT02457598|581155172|FG012|Overall Study|Progressive Disease|2|||
160934689|NCT02457598|581155173|FG013|Overall Study|Progressive Disease|2|||
160934690|NCT02457598|581155174|FG014|Overall Study|Progressive Disease|10|||
160934691|NCT02457598|581155175|FG015|Overall Study|Progressive Disease|1|||
160934692|NCT02457598|581155176|FG016|Overall Study|Progressive Disease|1|||
160934693|NCT02457598|581155160|FG000|Overall Study|Investigator's Discretion|0|||
160934694|NCT02457598|581155161|FG001|Overall Study|Investigator's Discretion|2|||
160934695|NCT02457598|581155162|FG002|Overall Study|Investigator's Discretion|2|||
160934696|NCT02457598|581155163|FG003|Overall Study|Investigator's Discretion|2|||
160934697|NCT02457598|581155164|FG004|Overall Study|Investigator's Discretion|0|||
160934698|NCT02457598|581155165|FG005|Overall Study|Investigator's Discretion|0|||
160934699|NCT02457598|581155166|FG006|Overall Study|Investigator's Discretion|0|||
160934700|NCT02457598|581155167|FG007|Overall Study|Investigator's Discretion|1|||
160934701|NCT02457598|581155168|FG008|Overall Study|Investigator's Discretion|2|||
160934702|NCT02457598|581155169|FG009|Overall Study|Investigator's Discretion|0|||
160934703|NCT02457598|581155170|FG010|Overall Study|Investigator's Discretion|10|||
160934704|NCT02457598|581155171|FG011|Overall Study|Investigator's Discretion|2|||
160934705|NCT02457598|581155172|FG012|Overall Study|Investigator's Discretion|2|||
160934706|NCT02457598|581155173|FG013|Overall Study|Investigator's Discretion|1|||
160934707|NCT02457598|581155174|FG014|Overall Study|Investigator's Discretion|5|||
160934708|NCT02457598|581155175|FG015|Overall Study|Investigator's Discretion|0|||
160934709|NCT02457598|581155176|FG016|Overall Study|Investigator's Discretion|0|||
160934710|NCT02457598|581155160|FG000|Overall Study|Study Terminated by Sponsor|0|||
160934711|NCT02457598|581155161|FG001|Overall Study|Study Terminated by Sponsor|1|||
160934712|NCT02457598|581155162|FG002|Overall Study|Study Terminated by Sponsor|0|||
160934713|NCT02457598|581155163|FG003|Overall Study|Study Terminated by Sponsor|4|||
160934714|NCT02457598|581155164|FG004|Overall Study|Study Terminated by Sponsor|1|||
160934715|NCT02457598|581155165|FG005|Overall Study|Study Terminated by Sponsor|0|||
160934716|NCT02457598|581155166|FG006|Overall Study|Study Terminated by Sponsor|1|||
160934717|NCT02457598|581155167|FG007|Overall Study|Study Terminated by Sponsor|0|||
160934718|NCT02457598|581155168|FG008|Overall Study|Study Terminated by Sponsor|0|||
160934719|NCT02457598|581155169|FG009|Overall Study|Study Terminated by Sponsor|0|||
160934720|NCT02457598|581155170|FG010|Overall Study|Study Terminated by Sponsor|4|||
160934721|NCT02457598|581155171|FG011|Overall Study|Study Terminated by Sponsor|0|||
160934722|NCT02457598|581155172|FG012|Overall Study|Study Terminated by Sponsor|1|||
160934723|NCT02457598|581155173|FG013|Overall Study|Study Terminated by Sponsor|0|||
160934724|NCT02457598|581155174|FG014|Overall Study|Study Terminated by Sponsor|8|||
160934725|NCT02457598|581155175|FG015|Overall Study|Study Terminated by Sponsor|1|||
160934726|NCT02457598|581155176|FG016|Overall Study|Study Terminated by Sponsor|0|||
160934727|NCT02457598|581155160|FG000|Overall Study|Adverse Event|0|||
160934728|NCT02457598|581155161|FG001|Overall Study|Adverse Event|1|||
160934729|NCT02457598|581155162|FG002|Overall Study|Adverse Event|1|||
160934730|NCT02457598|581155163|FG003|Overall Study|Adverse Event|4|||
160934731|NCT02457598|581155164|FG004|Overall Study|Adverse Event|1|||
160934732|NCT02457598|581155165|FG005|Overall Study|Adverse Event|0|||
160934733|NCT02457598|581155166|FG006|Overall Study|Adverse Event|0|||
160934734|NCT02457598|581155167|FG007|Overall Study|Adverse Event|1|||
160934735|NCT02457598|581155168|FG008|Overall Study|Adverse Event|0|||
160934736|NCT02457598|581155169|FG009|Overall Study|Adverse Event|1|||
160934737|NCT02457598|581155170|FG010|Overall Study|Adverse Event|6|||
160934738|NCT02457598|581155171|FG011|Overall Study|Adverse Event|0|||
160934739|NCT02457598|581155172|FG012|Overall Study|Adverse Event|0|||
160934740|NCT02457598|581155173|FG013|Overall Study|Adverse Event|1|||
160934741|NCT02457598|581155174|FG014|Overall Study|Adverse Event|2|||
160934742|NCT02457598|581155175|FG015|Overall Study|Adverse Event|0|||
160934743|NCT02457598|581155176|FG016|Overall Study|Adverse Event|0|||
160934744|NCT02457598|581155160|FG000|Overall Study|Death|0|||
160934745|NCT02457598|581155161|FG001|Overall Study|Death|0|||
160578553|NCT01469052|579838379|FG004|Overall Study|Lack of Efficacy|0|||
160934746|NCT02457598|581155162|FG002|Overall Study|Death|0|||
160934747|NCT02457598|581155163|FG003|Overall Study|Death|3|||
160934748|NCT02457598|581155164|FG004|Overall Study|Death|0|||
160934749|NCT02457598|581155165|FG005|Overall Study|Death|1|||
160578554|NCT01469052|579838380|FG005|Overall Study|Lack of Efficacy|2|||
160578555|NCT01469052|579838375|FG000|Overall Study|Moved to rollover protocol|1|||
160578556|NCT01469052|579838376|FG001|Overall Study|Moved to rollover protocol|0|||
160578557|NCT01469052|579838377|FG002|Overall Study|Moved to rollover protocol|1|||
160934750|NCT02457598|581155166|FG006|Overall Study|Death|0|||
160998432|NCT00462943|581378659|FG000|Overall Study|Disease Progression|15|||
160998433|NCT00462943|581378660|FG001|Overall Study|Disease Progression|15|||
160998434|NCT00462943|581378661|FG002|Overall Study|Disease Progression|9|||
160998435|NCT00462943|581378659|FG000|Overall Study|Death|5|||
160998436|NCT00462943|581378660|FG001|Overall Study|Death|2|||
160998437|NCT00462943|581378661|FG002|Overall Study|Death|7|||
160998438|NCT00462943|581378659|FG000|Overall Study|Stem Cell Transplant|1|||
160998439|NCT00462943|581378660|FG001|Overall Study|Stem Cell Transplant|1|||
160998440|NCT00462943|581378661|FG002|Overall Study|Stem Cell Transplant|0|||
160998441|NCT00462943|581378659|FG000|Overall Study|Bone Marrow Transplant|1|||
160998442|NCT00462943|581378660|FG001|Overall Study|Bone Marrow Transplant|0|||
160998443|NCT00462943|581378661|FG002|Overall Study|Bone Marrow Transplant|0|||
160998444|NCT00462943|581378659|FG000|Overall Study|Required Lymphocyte Infusion|1|||
160998445|NCT00462943|581378660|FG001|Overall Study|Required Lymphocyte Infusion|0|||
160998446|NCT00462943|581378661|FG002|Overall Study|Required Lymphocyte Infusion|0|||
160998447|NCT00462943|581378659|FG000|Overall Study|Transplant - not specified|1|||
160998448|NCT00462943|581378660|FG001|Overall Study|Transplant - not specified|0|||
160998449|NCT00462943|581378661|FG002|Overall Study|Transplant - not specified|1|||
160998450|NCT00462943|581378659|FG000|Overall Study|Physician Decision|1|||
160998451|NCT00462943|581378660|FG001|Overall Study|Physician Decision|0|||
160998452|NCT00462943|581378661|FG002|Overall Study|Physician Decision|0|||
160998453|NCT00462943|581378659|FG000|Overall Study|Withdrawal by Subject|0|||
160998454|NCT00462943|581378660|FG001|Overall Study|Withdrawal by Subject|1|||
160998455|NCT00462943|581378661|FG002|Overall Study|Withdrawal by Subject|0|||
160998456|NCT00995709|581378662|FG000|Overall Study|Adverse Event|4|||
160998457|NCT00995709|581378663|FG001|Overall Study|Adverse Event|2|||
160998458|NCT00995709|581378664|FG002|Overall Study|Adverse Event|0|||
160998459|NCT00995709|581378662|FG000|Overall Study|Lack of Efficacy|0|||
160998460|NCT00995709|581378663|FG001|Overall Study|Lack of Efficacy|1|||
160998461|NCT00995709|581378664|FG002|Overall Study|Lack of Efficacy|4|||
160934751|NCT02457598|581155167|FG007|Overall Study|Death|0|||
160934752|NCT02457598|581155168|FG008|Overall Study|Death|0|||
160934753|NCT02457598|581155169|FG009|Overall Study|Death|0|||
160934754|NCT02457598|581155170|FG010|Overall Study|Death|3|||
160934755|NCT02457598|581155171|FG011|Overall Study|Death|0|||
160934756|NCT02457598|581155172|FG012|Overall Study|Death|0|||
160934757|NCT02457598|581155173|FG013|Overall Study|Death|1|||
160934758|NCT02457598|581155174|FG014|Overall Study|Death|2|||
160934759|NCT02457598|581155175|FG015|Overall Study|Death|0|||
160934760|NCT02457598|581155176|FG016|Overall Study|Death|1|||
160934761|NCT02457598|581155160|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934762|NCT02457598|581155161|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
160934763|NCT02457598|581155162|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934764|NCT02457598|581155163|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
160934765|NCT02457598|581155164|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934766|NCT02457598|581155165|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934767|NCT02457598|581155166|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934768|NCT02457598|581155167|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
160934769|NCT02457598|581155168|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934770|NCT02457598|581155169|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934771|NCT02457598|581155170|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
160934772|NCT02457598|581155171|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934773|NCT02457598|581155172|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934774|NCT02457598|581155173|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934775|NCT02457598|581155174|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
160934776|NCT02457598|581155175|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
160998462|NCT00995709|581378662|FG000|Overall Study|Withdrawal by Subject|0|||
160998463|NCT00995709|581378663|FG001|Overall Study|Withdrawal by Subject|4|||
160578558|NCT01469052|579838378|FG003|Overall Study|Moved to rollover protocol|0|||
160998464|NCT00995709|581378664|FG002|Overall Study|Withdrawal by Subject|1|||
160455189|NCT03386578|579397845|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
160578559|NCT01469052|579838379|FG004|Overall Study|Moved to rollover protocol|0|||
160934777|NCT02457598|581155176|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
160934778|NCT02457598|581155160|FG000|Overall Study|Withdrew Consent|0|||
160934779|NCT02457598|581155161|FG001|Overall Study|Withdrew Consent|0|||
160934780|NCT02457598|581155162|FG002|Overall Study|Withdrew Consent|0|||
160998465|NCT00995709|581378662|FG000|Overall Study|Lost to Follow-up|1|||
160998466|NCT00995709|581378663|FG001|Overall Study|Lost to Follow-up|0|||
160998467|NCT00995709|581378664|FG002|Overall Study|Lost to Follow-up|0|||
160998468|NCT00995709|581378662|FG000|Overall Study|Death|0|||
160578560|NCT01469052|579838380|FG005|Overall Study|Moved to rollover protocol|1|||
160934781|NCT02457598|581155163|FG003|Overall Study|Withdrew Consent|0|||
160934782|NCT02457598|581155164|FG004|Overall Study|Withdrew Consent|0|||
160934783|NCT02457598|581155165|FG005|Overall Study|Withdrew Consent|0|||
160934784|NCT02457598|581155166|FG006|Overall Study|Withdrew Consent|0|||
160934785|NCT02457598|581155167|FG007|Overall Study|Withdrew Consent|2|||
160934786|NCT02457598|581155168|FG008|Overall Study|Withdrew Consent|0|||
160934787|NCT02457598|581155169|FG009|Overall Study|Withdrew Consent|0|||
160934788|NCT02457598|581155170|FG010|Overall Study|Withdrew Consent|3|||
160934789|NCT02457598|581155171|FG011|Overall Study|Withdrew Consent|0|||
160934790|NCT02457598|581155172|FG012|Overall Study|Withdrew Consent|0|||
160934791|NCT02457598|581155173|FG013|Overall Study|Withdrew Consent|1|||
160934792|NCT02457598|581155174|FG014|Overall Study|Withdrew Consent|0|||
160934793|NCT02457598|581155175|FG015|Overall Study|Withdrew Consent|0|||
160934794|NCT02457598|581155176|FG016|Overall Study|Withdrew Consent|0|||
160934795|NCT02457598|581155160|FG000|Overall Study|Unacceptable Toxicity|0|||
160934796|NCT02457598|581155161|FG001|Overall Study|Unacceptable Toxicity|0|||
160934797|NCT02457598|581155162|FG002|Overall Study|Unacceptable Toxicity|0|||
160934798|NCT02457598|581155163|FG003|Overall Study|Unacceptable Toxicity|0|||
160934799|NCT02457598|581155164|FG004|Overall Study|Unacceptable Toxicity|0|||
160998469|NCT00995709|581378663|FG001|Overall Study|Death|1|||
160998470|NCT00995709|581378664|FG002|Overall Study|Death|0|||
160934800|NCT02457598|581155165|FG005|Overall Study|Unacceptable Toxicity|0|||
160934801|NCT02457598|581155166|FG006|Overall Study|Unacceptable Toxicity|0|||
160934802|NCT02457598|581155167|FG007|Overall Study|Unacceptable Toxicity|0|||
160934803|NCT02457598|581155168|FG008|Overall Study|Unacceptable Toxicity|0|||
160934804|NCT02457598|581155169|FG009|Overall Study|Unacceptable Toxicity|0|||
160934805|NCT02457598|581155170|FG010|Overall Study|Unacceptable Toxicity|1|||
160934806|NCT02457598|581155171|FG011|Overall Study|Unacceptable Toxicity|0|||
160934807|NCT02457598|581155172|FG012|Overall Study|Unacceptable Toxicity|1|||
160934808|NCT02457598|581155173|FG013|Overall Study|Unacceptable Toxicity|1|||
160934809|NCT02457598|581155174|FG014|Overall Study|Unacceptable Toxicity|1|||
160934810|NCT02457598|581155175|FG015|Overall Study|Unacceptable Toxicity|0|||
160934811|NCT02457598|581155176|FG016|Overall Study|Unacceptable Toxicity|0|||
160934812|NCT02457598|581155160|FG000|Overall Study|Intercurrent Illness|0|||
160934813|NCT02457598|581155161|FG001|Overall Study|Intercurrent Illness|0|||
160934814|NCT02457598|581155162|FG002|Overall Study|Intercurrent Illness|0|||
160934815|NCT02457598|581155163|FG003|Overall Study|Intercurrent Illness|0|||
160934816|NCT02457598|581155164|FG004|Overall Study|Intercurrent Illness|0|||
160934817|NCT02457598|581155165|FG005|Overall Study|Intercurrent Illness|0|||
160934818|NCT02457598|581155166|FG006|Overall Study|Intercurrent Illness|0|||
160934819|NCT02457598|581155167|FG007|Overall Study|Intercurrent Illness|0|||
160934820|NCT02457598|581155168|FG008|Overall Study|Intercurrent Illness|0|||
160934821|NCT02457598|581155169|FG009|Overall Study|Intercurrent Illness|0|||
160934822|NCT02457598|581155170|FG010|Overall Study|Intercurrent Illness|1|||
160934823|NCT02457598|581155171|FG011|Overall Study|Intercurrent Illness|0|||
160934824|NCT02457598|581155172|FG012|Overall Study|Intercurrent Illness|0|||
160934825|NCT02457598|581155173|FG013|Overall Study|Intercurrent Illness|0|||
160934826|NCT02457598|581155174|FG014|Overall Study|Intercurrent Illness|0|||
160934827|NCT02457598|581155175|FG015|Overall Study|Intercurrent Illness|0|||
160934828|NCT02457598|581155176|FG016|Overall Study|Intercurrent Illness|0|||
160934829|NCT02457598|581155160|FG000|Overall Study|Protocol Violation|0|||
160934830|NCT02457598|581155161|FG001|Overall Study|Protocol Violation|0|||
160934831|NCT02457598|581155162|FG002|Overall Study|Protocol Violation|0|||
160934832|NCT02457598|581155163|FG003|Overall Study|Protocol Violation|0|||
160934833|NCT02457598|581155164|FG004|Overall Study|Protocol Violation|0|||
160934834|NCT02457598|581155165|FG005|Overall Study|Protocol Violation|0|||
160934835|NCT02457598|581155166|FG006|Overall Study|Protocol Violation|0|||
160998471|NCT00995709|581378662|FG000|Overall Study|Protocol Violation|2|||
160998472|NCT00995709|581378663|FG001|Overall Study|Protocol Violation|1|||
160998473|NCT00995709|581378664|FG002|Overall Study|Protocol Violation|0|||
160998474|NCT02698241|581378665|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
160998475|NCT02698241|581378665|FG000|Overall Study|Screening not met|7|||
160998476|NCT02698241|581378665|FG000|Overall Study|Withdrawal by Subject|7|||
160998477|NCT02698241|581378665|FG000|Overall Study|Physician Decision|2|||
160998478|NCT02698241|581378665|FG000|Overall Study|Subject underwent system modification|2|||
160934836|NCT02457598|581155167|FG007|Overall Study|Protocol Violation|0|||
160934837|NCT02457598|581155168|FG008|Overall Study|Protocol Violation|0|||
160934838|NCT02457598|581155169|FG009|Overall Study|Protocol Violation|0|||
160934839|NCT02457598|581155170|FG010|Overall Study|Protocol Violation|1|||
160934840|NCT02457598|581155171|FG011|Overall Study|Protocol Violation|0|||
160998479|NCT02698241|581378665|FG000|Overall Study|Lost to Follow-up|3|||
160934841|NCT02457598|581155172|FG012|Overall Study|Protocol Violation|0|||
160934842|NCT02457598|581155173|FG013|Overall Study|Protocol Violation|0|||
160934843|NCT02457598|581155174|FG014|Overall Study|Protocol Violation|0|||
160934844|NCT02457598|581155175|FG015|Overall Study|Protocol Violation|0|||
160934845|NCT02457598|581155176|FG016|Overall Study|Protocol Violation|0|||
160934846|NCT02703636|581155178|FG000|Overall Study|Adverse Event|14|||
160998480|NCT02698241|581378665|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
160998481|NCT02698241|581378665|FG000|Overall Study|geographic and licensing issue|1|||
160998482|NCT02698241|581378665|FG000|Overall Study|Death|2|||
160998483|NCT01543685|581378668|FG000|Overall Study|Lack of Efficacy|1|||
160998484|NCT01543685|581378669|FG001|Overall Study|Lack of Efficacy|2|||
160934847|NCT02703636|581155178|FG000|Overall Study|Study stopped by sponsor|1|||
160934848|NCT02703636|581155178|FG000|Overall Study|Withdrawal by Subject|1|||
160934849|NCT01110915|581155188|FG000|Overall Study|Death|2|||
160934850|NCT01110915|581155189|FG001|Overall Study|Death|1|||
160934851|NCT01110915|581155188|FG000|Overall Study|Lost to Follow-up|1|||
160934852|NCT01110915|581155189|FG001|Overall Study|Lost to Follow-up|0|||
160934853|NCT01110915|581155188|FG000|Overall Study|Withdrawal by Subject|7|||
160934854|NCT01110915|581155189|FG001|Overall Study|Withdrawal by Subject|1|||
160934855|NCT01215227|581155193|FG000|Overall Study|Adverse Event|11|||
160934856|NCT01215227|581155194|FG001|Overall Study|Adverse Event|11|||
160934857|NCT01215227|581155195|FG002|Overall Study|Adverse Event|4|||
160934858|NCT01215227|581155196|FG003|Overall Study|Adverse Event|8|||
160934859|NCT01215227|581155197|FG004|Overall Study|Adverse Event|7|||
160934860|NCT01215227|581155198|FG005|Overall Study|Adverse Event|6|||
160934861|NCT01215227|581155193|FG000|Overall Study|Treatment Failure|8|||
160934862|NCT01215227|581155194|FG001|Overall Study|Treatment Failure|4|||
160934863|NCT01215227|581155195|FG002|Overall Study|Treatment Failure|1|||
160934864|NCT01215227|581155196|FG003|Overall Study|Treatment Failure|5|||
160934865|NCT01215227|581155197|FG004|Overall Study|Treatment Failure|1|||
160934866|NCT01215227|581155198|FG005|Overall Study|Treatment Failure|1|||
160934867|NCT01215227|581155193|FG000|Overall Study|Lost to Follow-up|1|||
160934868|NCT01215227|581155194|FG001|Overall Study|Lost to Follow-up|4|||
160934869|NCT01215227|581155195|FG002|Overall Study|Lost to Follow-up|1|||
160934870|NCT01215227|581155196|FG003|Overall Study|Lost to Follow-up|1|||
160934871|NCT01215227|581155197|FG004|Overall Study|Lost to Follow-up|1|||
160934872|NCT01215227|581155198|FG005|Overall Study|Lost to Follow-up|2|||
160934873|NCT01215227|581155193|FG000|Overall Study|Subject Withdrew Consent|16|||
160934874|NCT01215227|581155194|FG001|Overall Study|Subject Withdrew Consent|20|||
160934875|NCT01215227|581155195|FG002|Overall Study|Subject Withdrew Consent|7|||
160934876|NCT01215227|581155196|FG003|Overall Study|Subject Withdrew Consent|10|||
160934877|NCT01215227|581155197|FG004|Overall Study|Subject Withdrew Consent|11|||
160934878|NCT01215227|581155198|FG005|Overall Study|Subject Withdrew Consent|8|||
160934879|NCT01215227|581155193|FG000|Overall Study|Non-Compliance With Protocol|2|||
160934880|NCT01215227|581155194|FG001|Overall Study|Non-Compliance With Protocol|6|||
160934881|NCT01215227|581155195|FG002|Overall Study|Non-Compliance With Protocol|1|||
160934882|NCT01215227|581155196|FG003|Overall Study|Non-Compliance With Protocol|0|||
160934883|NCT01215227|581155197|FG004|Overall Study|Non-Compliance With Protocol|0|||
160934884|NCT01215227|581155198|FG005|Overall Study|Non-Compliance With Protocol|0|||
160934885|NCT01215227|581155193|FG000|Overall Study|Administrative|83|||
160934886|NCT01215227|581155194|FG001|Overall Study|Administrative|73|||
160934887|NCT01215227|581155195|FG002|Overall Study|Administrative|42|||
160934888|NCT01215227|581155196|FG003|Overall Study|Administrative|24|||
160934889|NCT01215227|581155197|FG004|Overall Study|Administrative|28|||
160934890|NCT01215227|581155198|FG005|Overall Study|Administrative|40|||
160934891|NCT01215227|581155193|FG000|Overall Study|Missing Status|0|||
160934892|NCT01215227|581155194|FG001|Overall Study|Missing Status|1|||
160934893|NCT01215227|581155195|FG002|Overall Study|Missing Status|0|||
160934894|NCT01215227|581155196|FG003|Overall Study|Missing Status|0|||
160934895|NCT01215227|581155197|FG004|Overall Study|Missing Status|0|||
160934896|NCT01215227|581155198|FG005|Overall Study|Missing Status|0|||
160934897|NCT01215227|581155193|FG000|Overall Study|Randomized but not treated|0|||
160934898|NCT01215227|581155194|FG001|Overall Study|Randomized but not treated|0|||
160934899|NCT01215227|581155195|FG002|Overall Study|Randomized but not treated|1|||
160934900|NCT01215227|581155196|FG003|Overall Study|Randomized but not treated|1|||
160934901|NCT01215227|581155197|FG004|Overall Study|Randomized but not treated|0|||
160934902|NCT01215227|581155198|FG005|Overall Study|Randomized but not treated|1|||
160934903|NCT00293384|581156809|FG000|Overall Study|Non-compliance|2|||
160934904|NCT00293384|581156809|FG000|Overall Study|Missed dosage/study drug|1|||
160934905|NCT00293384|581156809|FG000|Overall Study|Ineligible|2|||
160934906|NCT05723770|581156810|FG000|Overall Study|Lost to Follow-up|4|||
160934907|NCT05723770|581156810|FG000|Overall Study|Withdrawal by Subject|2|||
160934908|NCT01359592|581156811|FG000|Initial Registration|Adverse Event|1|||
160934909|NCT01359592|581156812|FG001|Initial Registration|Adverse Event|0|||
160934910|NCT01359592|581156813|FG002|Initial Registration|Adverse Event|0|||
160934911|NCT01359592|581156814|FG003|Initial Registration|Adverse Event|0|||
160934912|NCT01359592|581156811|FG000|Initial Registration|Death|1|||
160934913|NCT01359592|581156812|FG001|Initial Registration|Death|0|||
160934914|NCT01359592|581156813|FG002|Initial Registration|Death|0|||
160998485|NCT01543685|581378670|FG002|Overall Study|Lack of Efficacy|2|||
160934915|NCT01359592|581156814|FG003|Initial Registration|Death|0|||
160934916|NCT01359592|581156811|FG000|Initial Registration|Other reason not protocol specified|1|||
160934917|NCT01359592|581156812|FG001|Initial Registration|Other reason not protocol specified|0|||
160934918|NCT01359592|581156813|FG002|Initial Registration|Other reason not protocol specified|0|||
160934919|NCT01359592|581156814|FG003|Initial Registration|Other reason not protocol specified|0|||
160934920|NCT01359592|581156811|FG000|Initial Registration|Ineligible|26|||
160934921|NCT01359592|581156812|FG001|Initial Registration|Ineligible|0|||
160934922|NCT01359592|581156813|FG002|Initial Registration|Ineligible|0|||
160934923|NCT01359592|581156814|FG003|Initial Registration|Ineligible|0|||
160934924|NCT01359592|581156811|FG000|PET-Directed Therapy|Adverse Event|0|||
160934925|NCT01359592|581156812|FG001|PET-Directed Therapy|Adverse Event|0|||
160934926|NCT01359592|581156813|FG002|PET-Directed Therapy|Adverse Event|1|||
160934927|NCT01359592|581156814|FG003|PET-Directed Therapy|Adverse Event|0|||
160934928|NCT01359592|581156811|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
160934929|NCT01359592|581156812|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
160934930|NCT01359592|581156813|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
160934931|NCT01359592|581156814|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
160934932|NCT01359592|581156811|FG000|PET-Directed Therapy|Ineligible|0|||
160934933|NCT01359592|581156812|FG001|PET-Directed Therapy|Ineligible|0|||
160934934|NCT01359592|581156813|FG002|PET-Directed Therapy|Ineligible|24|||
160934935|NCT01359592|581156814|FG003|PET-Directed Therapy|Ineligible|0|||
160934936|NCT00326612|581156817|FG000|Overall Study|They did not have a seizure requiring tx|129|||
160934937|NCT00326612|581156818|FG001|Overall Study|They did not have a seizure requiring tx|137|||
160934938|NCT00419562|581156819|FG000|Overall Study|Lost to Follow-up|12|||
160934939|NCT00419562|581156820|FG001|Overall Study|Lost to Follow-up|13|||
160934940|NCT00419562|581156819|FG000|Overall Study|Withdrawal by Subject|20|||
160934941|NCT00419562|581156820|FG001|Overall Study|Withdrawal by Subject|18|||
160934942|NCT00419562|581156819|FG000|Overall Study|Participant Institutionalized|1|||
160934943|NCT00419562|581156820|FG001|Overall Study|Participant Institutionalized|0|||
160934944|NCT02365636|581156821|FG000|Overall Study|Adverse Event|3|||
160934945|NCT02365636|581156822|FG001|Overall Study|Adverse Event|3|||
160934946|NCT02365636|581156823|FG002|Overall Study|Adverse Event|2|||
160934947|NCT02365636|581156821|FG000|Overall Study|Protocol Violation|1|||
160934948|NCT02365636|581156822|FG001|Overall Study|Protocol Violation|4|||
160934949|NCT02365636|581156823|FG002|Overall Study|Protocol Violation|0|||
160934950|NCT02365636|581156821|FG000|Overall Study|Lost to Follow-up|0|||
160934951|NCT02365636|581156822|FG001|Overall Study|Lost to Follow-up|0|||
160934952|NCT02365636|581156823|FG002|Overall Study|Lost to Follow-up|1|||
160934953|NCT02365636|581156821|FG000|Overall Study|Other|2|||
160934954|NCT02365636|581156822|FG001|Overall Study|Other|0|||
160934955|NCT02365636|581156823|FG002|Overall Study|Other|0|||
160934956|NCT00355238|581156824|FG000|Overall Study|Adverse event unrelated to study drug|2|||
160934957|NCT00355238|581156825|FG001|Overall Study|Adverse event unrelated to study drug|2|||
160934958|NCT00355238|581156826|FG002|Overall Study|Adverse event unrelated to study drug|0|||
160934959|NCT00355238|581156827|FG003|Overall Study|Adverse event unrelated to study drug|1|||
160934960|NCT00355238|581156824|FG000|Overall Study|Death|1|||
160934961|NCT00355238|581156825|FG001|Overall Study|Death|0|||
160934962|NCT00355238|581156826|FG002|Overall Study|Death|0|||
160934963|NCT00355238|581156827|FG003|Overall Study|Death|0|||
160934964|NCT00355238|581156824|FG000|Overall Study|Disease progression|37|||
160934965|NCT00355238|581156825|FG001|Overall Study|Disease progression|36|||
160934966|NCT00355238|581156826|FG002|Overall Study|Disease progression|16|||
160934967|NCT00355238|581156827|FG003|Overall Study|Disease progression|11|||
160934968|NCT00355238|581156824|FG000|Overall Study|Study drug toxicity|11|||
160934969|NCT00355238|581156825|FG001|Overall Study|Study drug toxicity|7|||
160934970|NCT00355238|581156826|FG002|Overall Study|Study drug toxicity|5|||
160934971|NCT00355238|581156827|FG003|Overall Study|Study drug toxicity|2|||
160934972|NCT00355238|581156824|FG000|Overall Study|Participant withdrew consent|3|||
160934973|NCT00355238|581156825|FG001|Overall Study|Participant withdrew consent|1|||
160934974|NCT00355238|581156826|FG002|Overall Study|Participant withdrew consent|0|||
160934975|NCT00355238|581156827|FG003|Overall Study|Participant withdrew consent|0|||
160934976|NCT00355238|581156824|FG000|Overall Study|Participant request to discontinue study treatment|1|||
160934977|NCT00355238|581156825|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160934978|NCT00355238|581156826|FG002|Overall Study|Participant request to discontinue study treatment|1|||
160934979|NCT00355238|581156827|FG003|Overall Study|Participant request to discontinue study treatment|0|||
160934980|NCT01454934|581156828|FG000|Overall Study|Clinical progression|28|||
160934981|NCT01454934|581156829|FG001|Overall Study|Clinical progression|25|||
160934982|NCT01454934|581156828|FG000|Overall Study|Other|6|||
160934983|NCT01454934|581156829|FG001|Overall Study|Other|17|||
160934984|NCT01454934|581156828|FG000|Overall Study|Adverse Event|28|||
160934985|NCT01454934|581156829|FG001|Overall Study|Adverse Event|24|||
160934986|NCT01454934|581156828|FG000|Overall Study|Withdrawn consent|2|||
160934987|NCT01454934|581156829|FG001|Overall Study|Withdrawn consent|5|||
160934988|NCT01454934|581156828|FG000|Overall Study|Withdrawal by Subject|11|||
160934989|NCT01454934|581156829|FG001|Overall Study|Withdrawal by Subject|15|||
160934990|NCT01454934|581156828|FG000|Overall Study|Disease progression|194|||
160934991|NCT01454934|581156829|FG001|Overall Study|Disease progression|181|||
160934992|NCT01454934|581156828|FG000|Overall Study|Lost to Follow-up|0|||
160934993|NCT01454934|581156829|FG001|Overall Study|Lost to Follow-up|1|||
160934994|NCT01454934|581156828|FG000|Overall Study|Not treated|1|||
160934995|NCT01454934|581156829|FG001|Overall Study|Not treated|2|||
160934996|NCT00480636|581156830|FG000|Overall Study|Death|12|||
160934997|NCT00480636|581156830|FG000|Overall Study|Lost to Follow-up|4|||
160934998|NCT00480636|581156830|FG000|Overall Study|Other|2|||
160934999|NCT00480636|581156830|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
160935000|NCT03912233|581156831|FG000|Overall Study|Adverse Event|1|||
160935001|NCT03912233|581156832|FG001|Overall Study|Adverse Event|0|||
160935002|NCT03912233|581156833|FG002|Overall Study|Adverse Event|0|||
160935003|NCT03912233|581156834|FG003|Overall Study|Adverse Event|0|||
160935004|NCT03912233|581156835|FG004|Overall Study|Adverse Event|0|||
160935005|NCT03912233|581156836|FG005|Overall Study|Adverse Event|0|||
160935006|NCT03912233|581156831|FG000|Overall Study|Physician Decision|1|||
160935007|NCT03912233|581156832|FG001|Overall Study|Physician Decision|0|||
160935008|NCT03912233|581156833|FG002|Overall Study|Physician Decision|0|||
160935009|NCT03912233|581156834|FG003|Overall Study|Physician Decision|0|||
160935010|NCT03912233|581156835|FG004|Overall Study|Physician Decision|0|||
160935011|NCT03912233|581156836|FG005|Overall Study|Physician Decision|0|||
160935012|NCT03912233|581156831|FG000|Overall Study|Other|0|||
160935013|NCT03912233|581156832|FG001|Overall Study|Other|0|||
160935014|NCT03912233|581156833|FG002|Overall Study|Other|0|||
160935015|NCT03912233|581156834|FG003|Overall Study|Other|0|||
160935016|NCT03912233|581156835|FG004|Overall Study|Other|7|||
160935017|NCT03912233|581156836|FG005|Overall Study|Other|12|||
160935018|NCT02583256|581156837|FG000|Overall Study|Withdrawal by Subject|0|||
160935019|NCT02583256|581156838|FG001|Overall Study|Withdrawal by Subject|1|||
160935020|NCT02583256|581156839|FG002|Overall Study|Withdrawal by Subject|1|||
160935021|NCT02583256|581156840|FG003|Overall Study|Withdrawal by Subject|0|||
160935022|NCT02583256|581156837|FG000|Overall Study|Lost to Follow-up|1|||
160935023|NCT02583256|581156838|FG001|Overall Study|Lost to Follow-up|1|||
160935024|NCT02583256|581156839|FG002|Overall Study|Lost to Follow-up|0|||
160935025|NCT02583256|581156840|FG003|Overall Study|Lost to Follow-up|1|||
160935026|NCT02583256|581156837|FG000|Overall Study|Administrative/Other|2|||
160935027|NCT02583256|581156838|FG001|Overall Study|Administrative/Other|0|||
160935028|NCT02583256|581156839|FG002|Overall Study|Administrative/Other|1|||
160935029|NCT02583256|581156840|FG003|Overall Study|Administrative/Other|2|||
160935030|NCT02177266|581156848|FG000|Overall Study|Adverse Event|0|||
160935031|NCT02177266|581156849|FG001|Overall Study|Adverse Event|1|||
160935032|NCT02177266|581156848|FG000|Overall Study|Withdrawal by Subject|1|||
160935033|NCT02177266|581156849|FG001|Overall Study|Withdrawal by Subject|0|||
160935034|NCT01023659|581156850|FG000|Overall Study|Lost to Follow-up|73|||
160935035|NCT01023659|581156851|FG001|Overall Study|Lost to Follow-up|228|||
160935036|NCT01023659|581156852|FG002|Overall Study|Lost to Follow-up|99|||
160935037|NCT04537806|581156855|FG000|Overall Study|Randomized but not treated|1|||
160935038|NCT04537806|581156856|FG001|Overall Study|Randomized but not treated|0|||
160935039|NCT04537806|581156855|FG000|Overall Study|Adverse Event|1|||
160935040|NCT04537806|581156856|FG001|Overall Study|Adverse Event|1|||
160935041|NCT03019627|581156857|FG000|Overall Study|Adverse Event|8|||
160935042|NCT03019627|581156858|FG001|Overall Study|Adverse Event|0|||
160935043|NCT03019627|581156857|FG000|Overall Study|Unrelated to adverse event|1|||
160935044|NCT03019627|581156858|FG001|Overall Study|Unrelated to adverse event|3|||
160935045|NCT03019627|581156857|FG000|Overall Study|Lost to Follow-up|2|||
160935046|NCT03019627|581156858|FG001|Overall Study|Lost to Follow-up|1|||
160935047|NCT03019627|581156857|FG000|Overall Study|not compliance|2|||
160935048|NCT03019627|581156858|FG001|Overall Study|not compliance|2|||
160935049|NCT03019627|581156857|FG000|Overall Study|Other|2|||
160935050|NCT03019627|581156858|FG001|Overall Study|Other|2|||
160935051|NCT01802775|581156861|FG000|Overall Study|Death|0|||
160935052|NCT01802775|581156862|FG001|Overall Study|Death|3|||
160935053|NCT01802775|581156861|FG000|Overall Study|Reason not provided|0|||
160935054|NCT01802775|581156862|FG001|Overall Study|Reason not provided|1|||
160935055|NCT01802775|581156861|FG000|Overall Study|Physician Decision|1|||
160935056|NCT01802775|581156862|FG001|Overall Study|Physician Decision|0|||
160935057|NCT01802775|581156861|FG000|Overall Study|Adverse Event|1|||
160935058|NCT01802775|581156862|FG001|Overall Study|Adverse Event|1|||
160935059|NCT01802775|581156861|FG000|Overall Study|Withdrawal by Subject|3|||
160935060|NCT01802775|581156862|FG001|Overall Study|Withdrawal by Subject|5|||
160935061|NCT01802775|581156861|FG000|Overall Study|Lost to Follow-up|1|||
160935062|NCT01802775|581156862|FG001|Overall Study|Lost to Follow-up|2|||
160935063|NCT00519649|581156863|FG000|Overall Study|Withdrawal by Subject|1|||
160935064|NCT01465802|581156864|FG000|Overall Study|Study terminated by sponsor|1|||
160935065|NCT01465802|581156865|FG001|Overall Study|Study terminated by sponsor|0|||
160935066|NCT01465802|581156866|FG002|Overall Study|Study terminated by sponsor|0|||
160578561|NCT01469052|579838375|FG000|Overall Study|Other|0|||
160578562|NCT01469052|579838376|FG001|Overall Study|Other|1|||
160935067|NCT01465802|581156867|FG003|Overall Study|Study terminated by sponsor|1|||
160935068|NCT01465802|581156868|FG004|Overall Study|Study terminated by sponsor|7|||
160935069|NCT01465802|581156864|FG000|Overall Study|Withdrawal by Subject|7|||
160935070|NCT01465802|581156865|FG001|Overall Study|Withdrawal by Subject|7|||
160935071|NCT01465802|581156866|FG002|Overall Study|Withdrawal by Subject|0|||
160935072|NCT01465802|581156867|FG003|Overall Study|Withdrawal by Subject|8|||
160935073|NCT01465802|581156868|FG004|Overall Study|Withdrawal by Subject|1|||
160935074|NCT01465802|581156864|FG000|Overall Study|Lost to Follow-up|1|||
160998486|NCT01543685|581378671|FG003|Overall Study|Lack of Efficacy|0|||
160998487|NCT01543685|581378672|FG004|Overall Study|Lack of Efficacy|2|||
160998488|NCT01543685|581378668|FG000|Overall Study|Adverse Event|2|||
160998489|NCT01543685|581378669|FG001|Overall Study|Adverse Event|1|||
160998490|NCT01543685|581378670|FG002|Overall Study|Adverse Event|0|||
160998491|NCT01543685|581378671|FG003|Overall Study|Adverse Event|0|||
160998492|NCT01543685|581378672|FG004|Overall Study|Adverse Event|2|||
160998493|NCT02465359|581378674|FG000|Overall Study|Lack of Efficacy|1|||
160998494|NCT02465359|581378674|FG000|Overall Study|Withdrawal by Subject|1|||
160998495|NCT02465359|581378674|FG000|Overall Study|Adverse Event|1|||
160935075|NCT01465802|581156865|FG001|Overall Study|Lost to Follow-up|1|||
160935076|NCT01465802|581156866|FG002|Overall Study|Lost to Follow-up|0|||
160935077|NCT01465802|581156867|FG003|Overall Study|Lost to Follow-up|0|||
160935078|NCT01465802|581156868|FG004|Overall Study|Lost to Follow-up|0|||
160935079|NCT01465802|581156864|FG000|Overall Study|Reason not specified|9|||
160935080|NCT01465802|581156865|FG001|Overall Study|Reason not specified|4|||
160935081|NCT01465802|581156866|FG002|Overall Study|Reason not specified|0|||
160935082|NCT01465802|581156867|FG003|Overall Study|Reason not specified|10|||
160935083|NCT01465802|581156868|FG004|Overall Study|Reason not specified|2|||
160935084|NCT01465802|581156864|FG000|Overall Study|Death|15|||
160935085|NCT01465802|581156865|FG001|Overall Study|Death|12|||
160935086|NCT01465802|581156866|FG002|Overall Study|Death|0|||
160935087|NCT01465802|581156867|FG003|Overall Study|Death|10|||
160935088|NCT01465802|581156868|FG004|Overall Study|Death|2|||
160935089|NCT00727714|581156869|FG000|Overall Study|Lost to Follow-up|2|||
160935090|NCT00325234|581156872|FG000|Overall Study|Adverse Event|10|||
160935091|NCT00325234|581156873|FG001|Overall Study|Adverse Event|7|||
160935092|NCT00325234|581156872|FG000|Overall Study|Death due to Study Disease|1|||
160935093|NCT00325234|581156873|FG001|Overall Study|Death due to Study Disease|0|||
160935094|NCT00325234|581156872|FG000|Overall Study|Entry Criteria Not Met|1|||
160935095|NCT00325234|581156873|FG001|Overall Study|Entry Criteria Not Met|2|||
160935096|NCT00325234|581156872|FG000|Overall Study|Subject Decision|6|||
160935097|NCT00325234|581156873|FG001|Overall Study|Subject Decision|8|||
160935098|NCT00325234|581156872|FG000|Overall Study|Physician Decision|17|||
160935099|NCT00325234|581156873|FG001|Overall Study|Physician Decision|12|||
160935100|NCT00325234|581156872|FG000|Overall Study|Progressive Disease|34|||
160935101|NCT00325234|581156873|FG001|Overall Study|Progressive Disease|37|||
160935102|NCT01234467|581156874|FG000|Overall Study|Adverse Event|3|||
160935103|NCT01234467|581156874|FG000|Overall Study|Death|2|||
160935104|NCT01234467|581156874|FG000|Overall Study|Withdrawal by Subject|2|||
160935105|NCT01234467|581156874|FG000|Overall Study|Disease Progression|2|||
160935106|NCT01234467|581156874|FG000|Overall Study|Clinical deterioration|1|||
160935107|NCT01234467|581156874|FG000|Overall Study|Physician Decision|1|||
160935108|NCT01234467|581156874|FG000|Overall Study|Other complicating disease (stroke)|1|||
160935109|NCT01120210|581156877|FG000|MAIN INFUSION|Adverse Event|1|||
160935110|NCT01120210|581156878|FG001|MAIN INFUSION|Adverse Event|0|||
160935111|NCT01120210|581156877|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
160935112|NCT01120210|581156878|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
160935113|NCT04049760|581156886|FG000|Overall Study|Withdrawal by Subject|1|||
160935114|NCT03995953|581156889|FG000|Overall Study|Death|3|||
160935115|NCT03995953|581156890|FG001|Overall Study|Death|0|||
160935116|NCT03995953|581156891|FG002|Overall Study|Death|3|||
160935117|NCT03995953|581156892|FG003|Overall Study|Death|0|||
160935118|NCT03995953|581156893|FG004|Overall Study|Death|3|||
160935119|NCT03995953|581156894|FG005|Overall Study|Death|0|||
160935120|NCT03995953|581156895|FG006|Overall Study|Death|0|||
160935121|NCT03995953|581156896|FG007|Overall Study|Death|0|||
160935122|NCT03995953|581156897|FG008|Overall Study|Death|1|||
160935123|NCT03995953|581156898|FG009|Overall Study|Death|0|||
160935124|NCT03995953|581156899|FG010|Overall Study|Death|0|||
160998496|NCT02812966|581378677|FG000|Overall Study|Death|1|||
160578563|NCT01469052|579838377|FG002|Overall Study|Other|0|||
160578564|NCT01469052|579838378|FG003|Overall Study|Other|0|||
160935125|NCT03995953|581156900|FG011|Overall Study|Death|0|||
160935126|NCT03995953|581156889|FG000|Overall Study|Lost to Follow-up|6|||
160935127|NCT03995953|581156890|FG001|Overall Study|Lost to Follow-up|54|||
160935128|NCT03995953|581156891|FG002|Overall Study|Lost to Follow-up|3|||
160935129|NCT03995953|581156892|FG003|Overall Study|Lost to Follow-up|32|||
160935130|NCT03995953|581156893|FG004|Overall Study|Lost to Follow-up|5|||
160998497|NCT02812966|581378678|FG001|Overall Study|Death|0|||
160998498|NCT01066923|581378679|FG000|Overall Study|Withdrawal by Subject|3|||
160578565|NCT01469052|579838379|FG004|Overall Study|Other|1|||
160578566|NCT01469052|579838380|FG005|Overall Study|Other|0|||
160578567|NCT02508701|579838381|FG000|Overall Study|Lost to Follow-up|9|||
160935131|NCT03995953|581156894|FG005|Overall Study|Lost to Follow-up|44|||
160935132|NCT03995953|581156895|FG006|Overall Study|Lost to Follow-up|0|||
160935133|NCT03995953|581156896|FG007|Overall Study|Lost to Follow-up|31|||
160935134|NCT03995953|581156897|FG008|Overall Study|Lost to Follow-up|8|||
160935135|NCT03995953|581156898|FG009|Overall Study|Lost to Follow-up|36|||
160935136|NCT03995953|581156899|FG010|Overall Study|Lost to Follow-up|5|||
160998499|NCT01066923|581378680|FG001|Overall Study|Withdrawal by Subject|3|||
160998500|NCT01066923|581378681|FG002|Overall Study|Withdrawal by Subject|8|||
160935137|NCT03995953|581156900|FG011|Overall Study|Lost to Follow-up|41|||
160935138|NCT03995953|581156889|FG000|Overall Study|Withdrawal by Subject|4|||
160935139|NCT03995953|581156890|FG001|Overall Study|Withdrawal by Subject|0|||
160935140|NCT03995953|581156891|FG002|Overall Study|Withdrawal by Subject|1|||
160935141|NCT03995953|581156892|FG003|Overall Study|Withdrawal by Subject|0|||
160935142|NCT03995953|581156893|FG004|Overall Study|Withdrawal by Subject|1|||
160935143|NCT03995953|581156894|FG005|Overall Study|Withdrawal by Subject|0|||
160935144|NCT03995953|581156895|FG006|Overall Study|Withdrawal by Subject|1|||
160935145|NCT03995953|581156896|FG007|Overall Study|Withdrawal by Subject|0|||
160935146|NCT03995953|581156897|FG008|Overall Study|Withdrawal by Subject|3|||
160935147|NCT03995953|581156898|FG009|Overall Study|Withdrawal by Subject|0|||
160935148|NCT03995953|581156899|FG010|Overall Study|Withdrawal by Subject|3|||
160935149|NCT03995953|581156900|FG011|Overall Study|Withdrawal by Subject|0|||
160935150|NCT03995953|581156889|FG000|Overall Study|Health Issues|0|||
160935151|NCT03995953|581156890|FG001|Overall Study|Health Issues|0|||
160935152|NCT03995953|581156891|FG002|Overall Study|Health Issues|0|||
160935153|NCT03995953|581156892|FG003|Overall Study|Health Issues|0|||
160935154|NCT03995953|581156893|FG004|Overall Study|Health Issues|1|||
160935155|NCT03995953|581156894|FG005|Overall Study|Health Issues|0|||
160935156|NCT03995953|581156895|FG006|Overall Study|Health Issues|0|||
160935157|NCT03995953|581156896|FG007|Overall Study|Health Issues|0|||
160935158|NCT03995953|581156897|FG008|Overall Study|Health Issues|4|||
160935159|NCT03995953|581156898|FG009|Overall Study|Health Issues|0|||
160935160|NCT03995953|581156899|FG010|Overall Study|Health Issues|0|||
160935161|NCT03995953|581156900|FG011|Overall Study|Health Issues|0|||
160935162|NCT03995953|581156889|FG000|Overall Study|Relocated|11|||
160935163|NCT03995953|581156890|FG001|Overall Study|Relocated|0|||
160935164|NCT03995953|581156891|FG002|Overall Study|Relocated|16|||
160935165|NCT03995953|581156892|FG003|Overall Study|Relocated|0|||
160935166|NCT03995953|581156893|FG004|Overall Study|Relocated|14|||
160935167|NCT03995953|581156894|FG005|Overall Study|Relocated|0|||
160935168|NCT03995953|581156895|FG006|Overall Study|Relocated|16|||
160935169|NCT03995953|581156896|FG007|Overall Study|Relocated|0|||
160935170|NCT03995953|581156897|FG008|Overall Study|Relocated|14|||
160935171|NCT03995953|581156898|FG009|Overall Study|Relocated|0|||
160935172|NCT03995953|581156899|FG010|Overall Study|Relocated|15|||
160935173|NCT03995953|581156900|FG011|Overall Study|Relocated|0|||
160935174|NCT02388997|581156901|FG000|Overall Study|Adverse Event|1|||
160935175|NCT02388997|581156902|FG001|Overall Study|Adverse Event|2|||
160935176|NCT02388997|581156901|FG000|Overall Study|Withdrawal by Subject|2|||
160935177|NCT02388997|581156902|FG001|Overall Study|Withdrawal by Subject|1|||
160935178|NCT02388997|581156901|FG000|Overall Study|Lung function exclusion criteria|0|||
160935179|NCT02388997|581156902|FG001|Overall Study|Lung function exclusion criteria|2|||
160935180|NCT02388997|581156901|FG000|Overall Study|Tested positive for virus during run-in|0|||
160935181|NCT02388997|581156902|FG001|Overall Study|Tested positive for virus during run-in|1|||
160935182|NCT02130765|581156903|FG000|Overall Study|Did not receive treatment|4|||
160935183|NCT02130765|581156904|FG001|Overall Study|Did not receive treatment|0|||
160935184|NCT02130765|581156905|FG002|Overall Study|Did not receive treatment|0|||
160935185|NCT02130765|581156906|FG003|Overall Study|Did not receive treatment|0|||
160455190|NCT03386578|579397846|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
160935186|NCT00006184|581156909|FG000|Overall Study|Death|1|||
160935187|NCT00006184|581156910|FG001|Overall Study|Death|0|||
160455191|NCT03386578|579397847|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
160455192|NCT03386578|579397848|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
160935188|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
160935189|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
160935190|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
160935191|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
160935192|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
160935193|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
160935194|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
160935195|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
160935196|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
160935197|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
160935198|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
160935199|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
160935200|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
160935201|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
160455193|NCT04294641|579397851|FG000|Overall Study|Screen failure|4|||
160935202|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
160935203|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
160935204|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
160935205|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
160935206|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
160935207|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
160935208|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
160935209|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
160935210|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
160935211|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
160935212|NCT02161718|581156911|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
160935213|NCT02161718|581156912|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
160455194|NCT01627574|579397854|FG000|Overall Study|Withdrawal by Subject|8|||
160455195|NCT01627574|579397855|FG001|Overall Study|Withdrawal by Subject|5|||
160455196|NCT01627574|579397854|FG000|Overall Study|Lost to Follow-up|13|||
160455197|NCT01627574|579397855|FG001|Overall Study|Lost to Follow-up|13|||
160935214|NCT02161718|581156913|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
160935215|NCT02161718|581156911|FG000|Post- Randomization Period|Lost to Follow-up|0|||
160935216|NCT02161718|581156912|FG001|Post- Randomization Period|Lost to Follow-up|9|||
160935217|NCT02161718|581156913|FG002|Post- Randomization Period|Lost to Follow-up|15|||
160935218|NCT02161718|581156911|FG000|Post- Randomization Period|Adverse Event|0|||
160935219|NCT02161718|581156912|FG001|Post- Randomization Period|Adverse Event|9|||
160935220|NCT02161718|581156913|FG002|Post- Randomization Period|Adverse Event|10|||
160935221|NCT02161718|581156911|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
160935222|NCT02161718|581156912|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
160455198|NCT04730739|579397856|FG000|Overall Study|Death|1|||
160455199|NCT03308877|579397860|FG000|Overall Study|Lost to Follow-up|32|||
160455200|NCT03308877|579397861|FG001|Overall Study|Lost to Follow-up|28|||
160455201|NCT03249090|579397869|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
160455202|NCT03249090|579397870|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
160455203|NCT03249090|579397869|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
160455204|NCT03249090|579397870|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
160455205|NCT03249090|579397869|FG000|3 Month Time Point|Voluntary withdrawal|6|||
160455206|NCT03249090|579397870|FG001|3 Month Time Point|Voluntary withdrawal|3|||
160455207|NCT03249090|579397869|FG000|3 Month Time Point|Changed oncology practice|4|||
160455208|NCT03249090|579397870|FG001|3 Month Time Point|Changed oncology practice|2|||
160455209|NCT03249090|579397869|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
160455210|NCT03249090|579397870|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
160455211|NCT03249090|579397869|FG000|12 Month Time Point|Voluntary withdrawal|35|||
160455212|NCT03249090|579397870|FG001|12 Month Time Point|Voluntary withdrawal|4|||
160455213|NCT03249090|579397869|FG000|12 Month Time Point|Changed oncology practice|20|||
160455214|NCT03249090|579397870|FG001|12 Month Time Point|Changed oncology practice|9|||
160455215|NCT04314778|579397882|FG000|Overall Study|Lost to Follow-up|5|||
160455216|NCT04314778|579397883|FG001|Overall Study|Lost to Follow-up|3|||
160455217|NCT05646355|579397884|FG000|Overall Study|Lost to Follow-up|1|||
160455218|NCT05646355|579397885|FG001|Overall Study|Lost to Follow-up|0|||
160455219|NCT05646355|579397884|FG000|Overall Study|translated materials not available for pilot|2|||
160455220|NCT05646355|579397885|FG001|Overall Study|translated materials not available for pilot|0|||
160455221|NCT05646355|579397884|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
160455222|NCT05646355|579397885|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
160455223|NCT03523572|579397886|FG000|Dose Escalation|Progressive disease|1|||
160455224|NCT03523572|579397887|FG001|Dose Escalation|Progressive disease|0|||
160935223|NCT02161718|581156913|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
160935224|NCT02161718|581156911|FG000|Post- Randomization Period|Physician Decision|0|||
160935225|NCT02161718|581156912|FG001|Post- Randomization Period|Physician Decision|2|||
160935226|NCT02161718|581156913|FG002|Post- Randomization Period|Physician Decision|4|||
160935227|NCT02161718|581156911|FG000|Post- Randomization Period|Protocol Violation|0|||
160935228|NCT02161718|581156912|FG001|Post- Randomization Period|Protocol Violation|2|||
160935229|NCT02161718|581156913|FG002|Post- Randomization Period|Protocol Violation|3|||
160935230|NCT02161718|581156911|FG000|Post- Randomization Period|Lack of Efficacy|0|||
160935231|NCT02161718|581156912|FG001|Post- Randomization Period|Lack of Efficacy|0|||
160935232|NCT02161718|581156913|FG002|Post- Randomization Period|Lack of Efficacy|1|||
160455225|NCT03523572|579397888|FG002|Dose Escalation|Progressive disease|0|||
160935233|NCT02161718|581156911|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
160455226|NCT03523572|579397889|FG003|Dose Escalation|Progressive disease|0|||
160455227|NCT03523572|579397890|FG004|Dose Escalation|Progressive disease|0|||
160455228|NCT03523572|579397891|FG005|Dose Escalation|Progressive disease|0|||
160455229|NCT03523572|579397886|FG000|Dose Escalation|Clinical Progression|0|||
160455230|NCT03523572|579397887|FG001|Dose Escalation|Clinical Progression|1|||
160455231|NCT03523572|579397888|FG002|Dose Escalation|Clinical Progression|0|||
160455232|NCT03523572|579397889|FG003|Dose Escalation|Clinical Progression|0|||
160455233|NCT03523572|579397890|FG004|Dose Escalation|Clinical Progression|0|||
160455234|NCT03523572|579397891|FG005|Dose Escalation|Clinical Progression|0|||
160455235|NCT03523572|579397886|FG000|Dose Escalation|Adverse Event|2|||
160455236|NCT03523572|579397887|FG001|Dose Escalation|Adverse Event|0|||
160455237|NCT03523572|579397888|FG002|Dose Escalation|Adverse Event|0|||
160935234|NCT02161718|581156912|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
160935235|NCT02161718|581156913|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
160935236|NCT02161718|581156911|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
160935237|NCT02161718|581156912|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
160935238|NCT02161718|581156913|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
160935239|NCT02161718|581156911|FG000|Post- Randomization Period|Relocation|0|||
160935240|NCT02161718|581156912|FG001|Post- Randomization Period|Relocation|3|||
160935241|NCT02161718|581156913|FG002|Post- Randomization Period|Relocation|0|||
160935242|NCT02948842|581156915|FG000|Overall Study|Withdrawal by Subject|4|||
160935243|NCT01537783|581156916|FG000|Overall Study|Lost to Follow-up|11|||
160935244|NCT01537783|581156917|FG001|Overall Study|Lost to Follow-up|2|||
160935245|NCT02350309|581156919|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
160935246|NCT02350309|581156920|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
160935247|NCT02350309|581156921|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
160935248|NCT02350309|581156922|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
160935249|NCT02350309|581156923|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
160935250|NCT02350309|581156924|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
160935251|NCT02350309|581156919|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
160935252|NCT02350309|581156920|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
160935253|NCT02350309|581156921|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
160935254|NCT02350309|581156922|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
160935255|NCT02350309|581156923|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
160935256|NCT02350309|581156924|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
160935257|NCT00207142|581156925|FG000|Induction Phase|Adverse Event|9|||
160935258|NCT00207142|581156926|FG001|Induction Phase|Adverse Event|0|||
160935259|NCT00207142|581156927|FG002|Induction Phase|Adverse Event|0|||
160935260|NCT00207142|581156928|FG003|Induction Phase|Adverse Event|0|||
160935261|NCT00207142|581156925|FG000|Induction Phase|Death|1|||
160935262|NCT00207142|581156926|FG001|Induction Phase|Death|0|||
160935263|NCT00207142|581156927|FG002|Induction Phase|Death|0|||
160935264|NCT00207142|581156928|FG003|Induction Phase|Death|0|||
160935265|NCT00207142|581156925|FG000|Induction Phase|Lack of Efficacy|1|||
160935266|NCT00207142|581156926|FG001|Induction Phase|Lack of Efficacy|0|||
160935267|NCT00207142|581156927|FG002|Induction Phase|Lack of Efficacy|0|||
160935268|NCT00207142|581156928|FG003|Induction Phase|Lack of Efficacy|0|||
160935269|NCT00207142|581156925|FG000|Induction Phase|Lost to Follow-up|5|||
160935270|NCT00207142|581156926|FG001|Induction Phase|Lost to Follow-up|0|||
160935271|NCT00207142|581156927|FG002|Induction Phase|Lost to Follow-up|0|||
160935272|NCT00207142|581156928|FG003|Induction Phase|Lost to Follow-up|0|||
160935273|NCT00207142|581156925|FG000|Induction Phase|Physician Decision|2|||
160935274|NCT00207142|581156926|FG001|Induction Phase|Physician Decision|0|||
160935275|NCT00207142|581156927|FG002|Induction Phase|Physician Decision|0|||
160935276|NCT00207142|581156928|FG003|Induction Phase|Physician Decision|0|||
160935277|NCT00207142|581156925|FG000|Induction Phase|Poor/noncompliance|2|||
160935278|NCT00207142|581156926|FG001|Induction Phase|Poor/noncompliance|0|||
160935279|NCT00207142|581156927|FG002|Induction Phase|Poor/noncompliance|0|||
160935280|NCT00207142|581156928|FG003|Induction Phase|Poor/noncompliance|0|||
160935281|NCT00207142|581156925|FG000|Induction Phase|Pregnancy|1|||
160935282|NCT00207142|581156926|FG001|Induction Phase|Pregnancy|0|||
160935283|NCT00207142|581156927|FG002|Induction Phase|Pregnancy|0|||
160935284|NCT00207142|581156928|FG003|Induction Phase|Pregnancy|0|||
160935285|NCT00207142|581156925|FG000|Induction Phase|Subject no longer meets study criteria|3|||
160935286|NCT00207142|581156926|FG001|Induction Phase|Subject no longer meets study criteria|0|||
160935287|NCT00207142|581156927|FG002|Induction Phase|Subject no longer meets study criteria|0|||
160935288|NCT00207142|581156928|FG003|Induction Phase|Subject no longer meets study criteria|0|||
160935289|NCT00207142|581156925|FG000|Induction Phase|Withdrawal by Subject|4|||
160935290|NCT00207142|581156926|FG001|Induction Phase|Withdrawal by Subject|0|||
160935291|NCT00207142|581156927|FG002|Induction Phase|Withdrawal by Subject|0|||
160935292|NCT00207142|581156928|FG003|Induction Phase|Withdrawal by Subject|0|||
160935293|NCT00207142|581156925|FG000|Induction Phase|Incarceration|1|||
160935294|NCT00207142|581156926|FG001|Induction Phase|Incarceration|0|||
160935295|NCT00207142|581156927|FG002|Induction Phase|Incarceration|0|||
160935296|NCT00207142|581156928|FG003|Induction Phase|Incarceration|0|||
160935297|NCT00207142|581156925|FG000|Induction Phase|Missing lab data|1|||
160935298|NCT00207142|581156926|FG001|Induction Phase|Missing lab data|0|||
160998501|NCT01066923|581378682|FG003|Overall Study|Withdrawal by Subject|8|||
160998502|NCT02577523|581380529|FG000|Overall Study|Adverse Event|1|||
160935299|NCT00207142|581156927|FG002|Induction Phase|Missing lab data|0|||
160935300|NCT00207142|581156928|FG003|Induction Phase|Missing lab data|0|||
160998503|NCT02577523|581380530|FG001|Overall Study|Adverse Event|1|||
160998504|NCT02577523|581380529|FG000|Overall Study|Lack of Efficacy|1|||
160998505|NCT02577523|581380530|FG001|Overall Study|Lack of Efficacy|1|||
160998506|NCT02577523|581380529|FG000|Overall Study|Withdrawal by Subject|1|||
160935301|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
160935302|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
160998507|NCT02577523|581380530|FG001|Overall Study|Withdrawal by Subject|0|||
160998508|NCT00487578|581380533|FG000|Overall Study|Adverse Event|1|||
160935303|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
160935304|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
160935305|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
160935306|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
160935307|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
160935308|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
160935309|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
160935310|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
160935311|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
160935312|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
160935313|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
160935314|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
160935315|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
160935316|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
160935317|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
160935318|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
160935319|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
160935320|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
160935321|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
160935322|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
160935323|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
160935324|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
160935325|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
160935326|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
160935327|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
160935328|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
160935329|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Death|0|||
160935330|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Death|0|||
160935331|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Death|0|||
160935332|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Death|1|||
160935333|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
160935334|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
160935335|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
160935336|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
160935337|NCT01554618|581156929|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
160935338|NCT01554618|581156930|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
160935339|NCT01554618|581156929|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
160935340|NCT01554618|581156930|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
160935341|NCT01554618|581156929|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
160935342|NCT01554618|581156930|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
160935343|NCT01554618|581156929|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
160935344|NCT01554618|581156930|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
160935345|NCT01554618|581156929|FG000|Open-Label Extension Period|Physician Decision|0|||
160935346|NCT01554618|581156930|FG001|Open-Label Extension Period|Physician Decision|1|||
160935347|NCT01554618|581156929|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
160935348|NCT01554618|581156930|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
160935349|NCT01857063|581156931|FG000|Period 1 (7 Days)|Adverse Event|0|||
160935350|NCT01857063|581156932|FG001|Period 1 (7 Days)|Adverse Event|1|||
160935351|NCT01857063|581156931|FG000|Period 1 (7 Days)|Physician Decision|1|||
160935352|NCT01857063|581156932|FG001|Period 1 (7 Days)|Physician Decision|0|||
160935353|NCT01857063|581156931|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
160935354|NCT01857063|581156932|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
160935355|NCT01857063|581156931|FG000|Period 2 (7 Days)|Adverse Event|2|||
160935356|NCT01857063|581156932|FG001|Period 2 (7 Days)|Adverse Event|1|||
160935357|NCT01857063|581156931|FG000|Period 2 (7 Days)|Physician Decision|1|||
160935358|NCT01857063|581156932|FG001|Period 2 (7 Days)|Physician Decision|1|||
160935359|NCT01857063|581156931|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
160935360|NCT01857063|581156932|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
160935361|NCT01256710|581156933|FG000|Overall Study|Death|449|||
160935362|NCT01256710|581156933|FG000|Overall Study|System Explant|67|||
160935363|NCT01256710|581156933|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
160998509|NCT00487578|581380534|FG001|Overall Study|Adverse Event|2|||
160998510|NCT00487578|581380533|FG000|Overall Study|Lack of Efficacy|0|||
160998511|NCT00487578|581380534|FG001|Overall Study|Lack of Efficacy|1|||
160998512|NCT00487578|581380533|FG000|Overall Study|Lost to Follow-up|0|||
160998513|NCT00487578|581380534|FG001|Overall Study|Lost to Follow-up|1|||
160935364|NCT01256710|581156933|FG000|Overall Study|Lost to Follow-up|67|||
160935365|NCT01256710|581156933|FG000|Overall Study|Withdrawal by Subject|29|||
160935366|NCT01256710|581156933|FG000|Overall Study|Physician Decision|9|||
160455238|NCT03523572|579397889|FG003|Dose Escalation|Adverse Event|0|||
160935367|NCT01256710|581156933|FG000|Overall Study|Subject Noncompliance|2|||
160935368|NCT01256710|581156933|FG000|Overall Study|Study Terminated by Sponsor|273|||
160935369|NCT00058825|581156934|FG000|Overall Study|Relapse|9|||
160935370|NCT00058825|581156934|FG000|Overall Study|Progressive Disease|5|||
160935371|NCT00058825|581156934|FG000|Overall Study|Graft Failure|5|||
160935372|NCT00058825|581156934|FG000|Overall Study|Death|3|||
160935373|NCT01205165|581156935|FG000|Overall Study|Lost to Follow-up|2|||
160935374|NCT00329407|581156943|FG000|Overall Study|Withdrawal by Subject|1|||
160935375|NCT00978068|581156944|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
160935376|NCT00978068|581156945|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
160935377|NCT00978068|581156944|FG000|Overall Study|Death|1|||
160935378|NCT00978068|581156945|FG001|Overall Study|Death|2|||
160935379|NCT00978068|581156944|FG000|Overall Study|Lost to Follow-up|1|||
160935380|NCT00978068|581156945|FG001|Overall Study|Lost to Follow-up|2|||
160935381|NCT00978068|581156944|FG000|Overall Study|Physician Decision|0|||
160935382|NCT00978068|581156945|FG001|Overall Study|Physician Decision|1|||
160935383|NCT00978068|581156944|FG000|Overall Study|Unable to Comply with Study|0|||
160935384|NCT00978068|581156945|FG001|Overall Study|Unable to Comply with Study|2|||
160935385|NCT02275481|581156946|FG000|Overall Study|Death|2|||
160935386|NCT02275481|581156947|FG001|Overall Study|Death|1|||
160935387|NCT02275481|581156946|FG000|Overall Study|Lost to Follow-up|2|||
160935388|NCT02275481|581156947|FG001|Overall Study|Lost to Follow-up|0|||
160935389|NCT02275481|581156946|FG000|Overall Study|Withdrawal by Subject|3|||
160935390|NCT02275481|581156947|FG001|Overall Study|Withdrawal by Subject|0|||
160935391|NCT02275481|581156946|FG000|Overall Study|all other reasons combined|2|||
160935392|NCT02275481|581156947|FG001|Overall Study|all other reasons combined|1|||
160935393|NCT02275481|581156946|FG000|Overall Study|Physician Decision|0|||
160935394|NCT02275481|581156947|FG001|Overall Study|Physician Decision|1|||
160935395|NCT01393405|581156948|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
160935396|NCT01393405|581156949|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
160935397|NCT01393405|581156950|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
160935398|NCT01393405|581156948|FG000|Induction Period (week1-16)|Adverse Event|16|||
160935399|NCT01393405|581156949|FG001|Induction Period (week1-16)|Adverse Event|0|||
160935400|NCT01393405|581156950|FG002|Induction Period (week1-16)|Adverse Event|0|||
160935401|NCT01393405|581156948|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
160935402|NCT01393405|581156949|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
160935403|NCT01393405|581156950|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
160935404|NCT01393405|581156948|FG000|Maintenance Period Week|Lack of Efficacy|0|||
160935405|NCT01393405|581156949|FG001|Maintenance Period Week|Lack of Efficacy|22|||
160935406|NCT01393405|581156950|FG002|Maintenance Period Week|Lack of Efficacy|22|||
160935407|NCT01393405|581156948|FG000|Maintenance Period Week|Adverse Event|0|||
160935408|NCT01393405|581156949|FG001|Maintenance Period Week|Adverse Event|5|||
160935409|NCT01393405|581156950|FG002|Maintenance Period Week|Adverse Event|2|||
160935410|NCT01393405|581156948|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
160935411|NCT01393405|581156949|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
160935412|NCT01393405|581156950|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
160935413|NCT01393405|581156948|FG000|Maintenance Period Week|Lost to Follow-up|0|||
160935414|NCT01393405|581156949|FG001|Maintenance Period Week|Lost to Follow-up|1|||
160935415|NCT01393405|581156950|FG002|Maintenance Period Week|Lost to Follow-up|0|||
160935416|NCT01434290|581156951|FG000|Overall Study|Protocol Violation|6|||
160935417|NCT01434290|581156952|FG001|Overall Study|Protocol Violation|3|||
160935418|NCT01434290|581156951|FG000|Overall Study|No protocol treatment|2|||
160935419|NCT01434290|581156952|FG001|Overall Study|No protocol treatment|4|||
160935420|NCT02281552|581156953|FG000|Overall Study|Medication error|1|||
160935421|NCT02281552|581156954|FG001|Overall Study|Medication error|0|||
160935422|NCT02281552|581156953|FG000|Overall Study|Insufficient clinical response|0|||
160935423|NCT02281552|581156954|FG001|Overall Study|Insufficient clinical response|1|||
160935424|NCT02281552|581156953|FG000|Overall Study|Adverse Event|3|||
160935425|NCT02281552|581156954|FG001|Overall Study|Adverse Event|9|||
160935426|NCT01224639|581156955|FG000|Overall Study|Withdrawal by Subject|0|||
160935427|NCT01224639|581156956|FG001|Overall Study|Withdrawal by Subject|0|||
160935428|NCT01224639|581156957|FG002|Overall Study|Withdrawal by Subject|0|||
160935429|NCT01224639|581156958|FG003|Overall Study|Withdrawal by Subject|0|||
160935430|NCT01224639|581156959|FG004|Overall Study|Withdrawal by Subject|2|||
160935431|NCT01224639|581156960|FG005|Overall Study|Withdrawal by Subject|0|||
160935432|NCT01224639|581156961|FG006|Overall Study|Withdrawal by Subject|1|||
160935433|NCT01224639|581156962|FG007|Overall Study|Withdrawal by Subject|1|||
160935434|NCT01224639|581156955|FG000|Overall Study|Adverse Event|0|||
160935435|NCT01224639|581156956|FG001|Overall Study|Adverse Event|0|||
160935436|NCT01224639|581156957|FG002|Overall Study|Adverse Event|0|||
160935437|NCT01224639|581156958|FG003|Overall Study|Adverse Event|0|||
160935438|NCT01224639|581156959|FG004|Overall Study|Adverse Event|0|||
160935439|NCT01224639|581156960|FG005|Overall Study|Adverse Event|0|||
160935440|NCT01224639|581156961|FG006|Overall Study|Adverse Event|0|||
160935441|NCT01224639|581156962|FG007|Overall Study|Adverse Event|1|||
160935442|NCT04656132|581156963|FG000|Overall Study|Lost to Follow-up|4|||
160935443|NCT04656132|581156963|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
160935444|NCT04365699|581156964|FG000|Overall Study|Death|2|||
160935445|NCT04365699|581156965|FG001|Overall Study|Death|5|||
160935446|NCT04365699|581156966|FG002|Overall Study|Death|15|||
160935447|NCT03925727|581156968|FG000|Overall Study|Adverse Event|4|||
160935448|NCT03925727|581156969|FG001|Overall Study|Adverse Event|0|||
160935449|NCT03925727|581156970|FG002|Overall Study|Adverse Event|3|||
160935450|NCT03925727|581156968|FG000|Overall Study|Protocol Violation|1|||
160935451|NCT03925727|581156969|FG001|Overall Study|Protocol Violation|2|||
160935452|NCT03925727|581156970|FG002|Overall Study|Protocol Violation|2|||
160935453|NCT03925727|581156968|FG000|Overall Study|Withdrawal by Subject|3|||
160935454|NCT03925727|581156969|FG001|Overall Study|Withdrawal by Subject|2|||
160935455|NCT03925727|581156970|FG002|Overall Study|Withdrawal by Subject|4|||
160935456|NCT03925727|581156968|FG000|Overall Study|Administrative Reasons|3|||
160935457|NCT03925727|581156969|FG001|Overall Study|Administrative Reasons|1|||
160935458|NCT03925727|581156970|FG002|Overall Study|Administrative Reasons|2|||
160935459|NCT03925727|581156968|FG000|Overall Study|Randomized in error or Disqualified|8|||
160935460|NCT03925727|581156969|FG001|Overall Study|Randomized in error or Disqualified|1|||
160935461|NCT03925727|581156970|FG002|Overall Study|Randomized in error or Disqualified|7|||
160935462|NCT03044197|581156983|FG000|Overall Study|Withdrawal by Subject|3|||
160935463|NCT03044197|581156984|FG001|Overall Study|Withdrawal by Subject|1|||
160935464|NCT00834912|581156985|FG000|Treatment Period 1|Adverse Event|0|||
160935465|NCT00834912|581156986|FG001|Treatment Period 1|Adverse Event|1|||
160935466|NCT00834912|581156987|FG002|Treatment Period 1|Adverse Event|0|||
160935467|NCT00834912|581156988|FG003|Treatment Period 1|Adverse Event|1|||
160935468|NCT00834912|581156989|FG004|Treatment Period 1|Adverse Event|0|||
160935469|NCT00834912|581156990|FG005|Treatment Period 1|Adverse Event|0|||
160935470|NCT00834912|581156985|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160935471|NCT00834912|581156986|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160935472|NCT00834912|581156987|FG002|Treatment Period 2|Withdrawal by Subject|1|||
160935473|NCT00834912|581156988|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160935474|NCT00834912|581156989|FG004|Treatment Period 2|Withdrawal by Subject|1|||
160935475|NCT00834912|581156990|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160935476|NCT01574352|581156993|FG000|Overall Study|Withdrawal by Subject|6|||
160935477|NCT01574352|581156994|FG001|Overall Study|Withdrawal by Subject|13|||
160935478|NCT01574352|581156993|FG000|Overall Study|Injury in non-camp related sport|1|||
160935479|NCT01574352|581156994|FG001|Overall Study|Injury in non-camp related sport|0|||
160935480|NCT00256698|581156995|FG000|Overall Study|Withdrawal by Subject|7|||
160935481|NCT00256698|581156996|FG001|Overall Study|Withdrawal by Subject|7|||
160935482|NCT00256698|581156995|FG000|Overall Study|Adverse Event|13|||
160935483|NCT00256698|581156996|FG001|Overall Study|Adverse Event|6|||
160935484|NCT00256698|581156995|FG000|Overall Study|Protocol Violation|6|||
160935485|NCT00256698|581156996|FG001|Overall Study|Protocol Violation|5|||
160935486|NCT00256698|581156995|FG000|Overall Study|Lost to Follow-up|1|||
160935487|NCT00256698|581156996|FG001|Overall Study|Lost to Follow-up|3|||
160935488|NCT00256698|581156995|FG000|Overall Study|disease progression|97|||
160935489|NCT00256698|581156996|FG001|Overall Study|disease progression|105|||
160935490|NCT00256698|581156995|FG000|Overall Study|still ongoing at data cut-off|41|||
160935491|NCT00256698|581156996|FG001|Overall Study|still ongoing at data cut-off|46|||
160935492|NCT00256698|581156995|FG000|Overall Study|withdrawn due to osteoporosis|1|||
160935493|NCT00256698|581156996|FG001|Overall Study|withdrawn due to osteoporosis|0|||
160935494|NCT00256698|581156995|FG000|Overall Study|Prematurely Discontinued|1|||
160935495|NCT00256698|581156996|FG001|Overall Study|Prematurely Discontinued|0|||
160935496|NCT03962543|581156997|FG000|Treatment Phase|Death|0|||
160935497|NCT03962543|581156998|FG001|Treatment Phase|Death|1|||
160935498|NCT03962543|581156997|FG000|Treatment Phase|Withdrawal by Subject|3|||
160935499|NCT03962543|581156998|FG001|Treatment Phase|Withdrawal by Subject|0|||
160935500|NCT03962543|581156997|FG000|Treatment Phase|Adverse Event|3|||
160578568|NCT02508701|579838382|FG001|Overall Study|Lost to Follow-up|5|||
160578569|NCT02508701|579838383|FG002|Overall Study|Lost to Follow-up|5|||
160578570|NCT02508701|579838384|FG003|Overall Study|Lost to Follow-up|3|||
160578571|NCT00530712|579838390|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
160578572|NCT00530712|579838390|FG000|30 Day Follow-up Visit|Missed Visit|5|||
160578573|NCT00530712|579838390|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
160578574|NCT00530712|579838390|FG000|6 Month Follow-up Visit|Missed Visit|3|||
160655956|NCT00661999|580120318|FG000|Overall Study|Withdrawal by Subject|30|||
160935501|NCT03962543|581156998|FG001|Treatment Phase|Adverse Event|12|||
160935502|NCT03962543|581156997|FG000|Treatment Phase|Lost to Follow-up|1|||
160935503|NCT03962543|581156998|FG001|Treatment Phase|Lost to Follow-up|2|||
160935504|NCT03962543|581156997|FG000|Treatment Phase|Radiographic PD|9|||
160935505|NCT03962543|581156998|FG001|Treatment Phase|Radiographic PD|3|||
160935506|NCT03962543|581156997|FG000|Treatment Phase|Participant Decision|3|||
160935507|NCT03962543|581156998|FG001|Treatment Phase|Participant Decision|8|||
160935508|NCT03962543|581156997|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
160935509|NCT03962543|581156998|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
160935510|NCT03962543|581156997|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
160935511|NCT03962543|581156998|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
160578575|NCT00530712|579838390|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
160935512|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
160935513|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
160935514|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
160935515|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
160935516|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
160935517|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
160935518|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
160935519|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
160935520|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
160935521|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
160935522|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
160935523|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
160935524|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
160935525|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
160935526|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
160935527|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
160935528|NCT03548584|581158769|FG000|Overall Study|Lost to Follow-up|0|||
160935529|NCT03548584|581158770|FG001|Overall Study|Lost to Follow-up|0|||
160935530|NCT03548584|581158771|FG002|Overall Study|Lost to Follow-up|1|||
160935531|NCT03548584|581158769|FG000|Overall Study|Adverse Event|1|||
160935532|NCT03548584|581158770|FG001|Overall Study|Adverse Event|11|||
160935533|NCT03548584|581158771|FG002|Overall Study|Adverse Event|5|||
160935534|NCT03548584|581158769|FG000|Overall Study|Site Terminated by Sponsor|1|||
160935535|NCT03548584|581158770|FG001|Overall Study|Site Terminated by Sponsor|3|||
160935536|NCT03548584|581158771|FG002|Overall Study|Site Terminated by Sponsor|2|||
160935537|NCT03548584|581158769|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
160935538|NCT03548584|581158770|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
160935539|NCT03548584|581158771|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
160935540|NCT03548584|581158769|FG000|Overall Study|Lack of Efficacy|0|||
160935541|NCT03548584|581158770|FG001|Overall Study|Lack of Efficacy|1|||
160935542|NCT03548584|581158771|FG002|Overall Study|Lack of Efficacy|0|||
160935543|NCT03548584|581158769|FG000|Overall Study|Non-compliance with Study Drug|0|||
160935544|NCT03548584|581158770|FG001|Overall Study|Non-compliance with Study Drug|1|||
160935545|NCT03548584|581158771|FG002|Overall Study|Non-compliance with Study Drug|0|||
160935546|NCT03548584|581158769|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
160935547|NCT03548584|581158770|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
160935548|NCT03548584|581158771|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
160935549|NCT01677195|581158773|FG000|Overall Study|Lost to Follow-up|14|||
160935550|NCT01677195|581158774|FG001|Overall Study|Lost to Follow-up|22|||
160935551|NCT01677195|581158775|FG002|Overall Study|Lost to Follow-up|22|||
160935552|NCT01677195|581158773|FG000|Overall Study|Withdrawal by Subject|1|||
160935553|NCT01677195|581158774|FG001|Overall Study|Withdrawal by Subject|0|||
160935554|NCT01677195|581158775|FG002|Overall Study|Withdrawal by Subject|1|||
160935555|NCT01677195|581158773|FG000|Overall Study|Adverse Event|6|||
160935556|NCT01677195|581158774|FG001|Overall Study|Adverse Event|4|||
160935557|NCT01677195|581158775|FG002|Overall Study|Adverse Event|1|||
160935558|NCT01677195|581158773|FG000|Overall Study|Physician Decision|1|||
160935559|NCT01677195|581158774|FG001|Overall Study|Physician Decision|2|||
160935560|NCT01677195|581158775|FG002|Overall Study|Physician Decision|2|||
160935561|NCT01677195|581158773|FG000|Overall Study|Pregnancy|0|||
160935562|NCT01677195|581158774|FG001|Overall Study|Pregnancy|1|||
160935563|NCT01677195|581158775|FG002|Overall Study|Pregnancy|0|||
160935564|NCT01677195|581158773|FG000|Overall Study|Protocol Violation|7|||
160935565|NCT01677195|581158774|FG001|Overall Study|Protocol Violation|3|||
160935566|NCT01677195|581158775|FG002|Overall Study|Protocol Violation|4|||
160935567|NCT03633396|581158778|FG000|Overall Study|Withdrawal by Subject|4|||
160935568|NCT03633396|581158779|FG001|Overall Study|Withdrawal by Subject|4|||
160935569|NCT03633396|581158778|FG000|Overall Study|Adverse Event|1|||
160935570|NCT03633396|581158779|FG001|Overall Study|Adverse Event|1|||
160935571|NCT03633396|581158778|FG000|Overall Study|Lack of Efficacy|1|||
160935572|NCT03633396|581158779|FG001|Overall Study|Lack of Efficacy|0|||
160935573|NCT03633396|581158778|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
160935574|NCT03633396|581158779|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
160578576|NCT00530712|579838390|FG000|6 Month Follow-up Visit|Death|2|||
160578577|NCT00530712|579838390|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
160578578|NCT00530712|579838390|FG000|12 Month Follow-up Visit|Missed Visit|3|||
160935575|NCT01012817|581158780|FG000|Overall Study|Withdrawal by Subject|0|||
160935576|NCT01012817|581158781|FG001|Overall Study|Withdrawal by Subject|0|||
160935577|NCT01012817|581158782|FG002|Overall Study|Withdrawal by Subject|0|||
160935578|NCT01012817|581158783|FG003|Overall Study|Withdrawal by Subject|1|||
160935579|NCT01012817|581158784|FG004|Overall Study|Withdrawal by Subject|0|||
160935580|NCT01012817|581158785|FG005|Overall Study|Withdrawal by Subject|0|||
160455239|NCT03523572|579397890|FG004|Dose Escalation|Adverse Event|0|||
160935581|NCT01012817|581158786|FG006|Overall Study|Withdrawal by Subject|0|||
160935582|NCT01012817|581158787|FG007|Overall Study|Withdrawal by Subject|1|||
160935583|NCT01012817|581158788|FG008|Overall Study|Withdrawal by Subject|0|||
160998514|NCT02525796|581380535|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
160998515|NCT02525796|581380536|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
160998516|NCT02525796|581380537|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
160998517|NCT02525796|581380535|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
160998518|NCT02525796|581380536|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
160935584|NCT01012817|581158789|FG009|Overall Study|Withdrawal by Subject|0|||
160935585|NCT01012817|581158790|FG010|Overall Study|Withdrawal by Subject|1|||
160935586|NCT01012817|581158791|FG011|Overall Study|Withdrawal by Subject|1|||
160935587|NCT01012817|581158792|FG012|Overall Study|Withdrawal by Subject|0|||
160935588|NCT01012817|581158793|FG013|Overall Study|Withdrawal by Subject|1|||
160935589|NCT01012817|581158780|FG000|Overall Study|Adverse Event|0|||
160935590|NCT01012817|581158781|FG001|Overall Study|Adverse Event|0|||
160935591|NCT01012817|581158782|FG002|Overall Study|Adverse Event|0|||
160935592|NCT01012817|581158783|FG003|Overall Study|Adverse Event|0|||
160935593|NCT01012817|581158784|FG004|Overall Study|Adverse Event|0|||
160935594|NCT01012817|581158785|FG005|Overall Study|Adverse Event|1|||
160935595|NCT01012817|581158786|FG006|Overall Study|Adverse Event|0|||
160935596|NCT01012817|581158787|FG007|Overall Study|Adverse Event|0|||
160935597|NCT01012817|581158788|FG008|Overall Study|Adverse Event|0|||
160935598|NCT01012817|581158789|FG009|Overall Study|Adverse Event|0|||
160935599|NCT01012817|581158790|FG010|Overall Study|Adverse Event|1|||
160935600|NCT01012817|581158791|FG011|Overall Study|Adverse Event|0|||
160935601|NCT01012817|581158792|FG012|Overall Study|Adverse Event|0|||
160935602|NCT01012817|581158793|FG013|Overall Study|Adverse Event|1|||
160935603|NCT00023673|581158794|FG000|Overall Study|Ineligible / no protocol treatment|0|||
160935604|NCT00023673|581158795|FG001|Overall Study|Ineligible / no protocol treatment|0|||
160935605|NCT00023673|581158796|FG002|Overall Study|Ineligible / no protocol treatment|0|||
160935606|NCT00023673|581158797|FG003|Overall Study|Ineligible / no protocol treatment|1|||
160935607|NCT00023673|581158794|FG000|Overall Study|Patient withdrew consent|0|||
160935608|NCT00023673|581158795|FG001|Overall Study|Patient withdrew consent|0|||
160935609|NCT00023673|581158796|FG002|Overall Study|Patient withdrew consent|0|||
160935610|NCT00023673|581158797|FG003|Overall Study|Patient withdrew consent|1|||
160935611|NCT00110266|581158798|FG000|Overall Study|Adverse Event|27|||
160935612|NCT00110266|581158798|FG000|Overall Study|Abnormal laboratory value|15|||
160935613|NCT00110266|581158798|FG000|Overall Study|Withdrawal by Subject|16|||
160935614|NCT00110266|581158798|FG000|Overall Study|Death|17|||
160935615|NCT00110266|581158798|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160935616|NCT00110266|581158798|FG000|Overall Study|Participant condition no longer requires study drug|1|||
160935617|NCT00634647|581158803|FG000|Overall Study|death on study|3|||
160935618|NCT00634647|581158803|FG000|Overall Study|refused further treatment|3|||
160935619|NCT00634647|581158803|FG000|Overall Study|declined to participate before treatment|1|||
160935620|NCT03852316|581158804|FG000|Overall Study|Protocol Violation|1|||
160935621|NCT03852316|581158804|FG000|Overall Study|Withdrawal by Subject|2|||
160935622|NCT03852316|581158804|FG000|Overall Study|Enrolled but Device not Utilized|1|||
160935623|NCT01018264|581158805|FG000|Overall Study|Withdrawal by Subject|1|||
160935624|NCT01018264|581158806|FG001|Overall Study|Withdrawal by Subject|0|||
160935625|NCT01018264|581158805|FG000|Overall Study|Lost to Follow-up|0|||
160935626|NCT01018264|581158806|FG001|Overall Study|Lost to Follow-up|1|||
160935627|NCT02075840|581158807|FG000|Overall Study|Withdrawal by Subject|13|||
160935628|NCT02075840|581158808|FG001|Overall Study|Withdrawal by Subject|22|||
160935629|NCT02075840|581158807|FG000|Overall Study|Reason not specified|1|||
160935630|NCT02075840|581158808|FG001|Overall Study|Reason not specified|0|||
160935631|NCT02075840|581158807|FG000|Overall Study|Adverse Event|0|||
160935632|NCT02075840|581158808|FG001|Overall Study|Adverse Event|2|||
160935633|NCT02075840|581158807|FG000|Overall Study|Death|35|||
160935634|NCT02075840|581158808|FG001|Overall Study|Death|40|||
160998519|NCT02525796|581380537|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
160998520|NCT02525796|581380535|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
160998521|NCT02525796|581380536|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
160998522|NCT02525796|581380537|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
160935635|NCT02075840|581158807|FG000|Overall Study|Lost to Follow-up|3|||
160935636|NCT02075840|581158808|FG001|Overall Study|Lost to Follow-up|2|||
160935637|NCT02075840|581158807|FG000|Overall Study|Physician Decision|1|||
160935638|NCT02075840|581158808|FG001|Overall Study|Physician Decision|3|||
160935639|NCT02075840|581158807|FG000|Overall Study|Ongoing at CCOD|99|||
160935640|NCT02075840|581158808|FG001|Overall Study|Ongoing at CCOD|82|||
160935641|NCT02644967|581158811|FG000|Overall Study|Death|26|||
160935642|NCT02644967|581158811|FG000|Overall Study|Physician Decision|1|||
160935643|NCT02644967|581158811|FG000|Overall Study|Withdrawal by Subject|2|||
160935644|NCT02644967|581158811|FG000|Overall Study|Protocol Violation|1|||
160935645|NCT02644967|581158811|FG000|Overall Study|Progressive Disease|1|||
160935646|NCT02644967|581158811|FG000|Overall Study|Study Terminated by Sponsor|4|||
160935647|NCT02287896|581158812|FG000|Second Injection Visit|Withdrawal by Subject|0|||
160935648|NCT02287896|581158813|FG001|Second Injection Visit|Withdrawal by Subject|1|||
160935649|NCT05179421|581158814|FG000|First Infusion Day|Adverse Event|1|||
160935650|NCT05179421|581158815|FG001|First Infusion Day|Adverse Event|0|||
160935651|NCT03746522|581158817|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
160935652|NCT03746522|581158818|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
160935653|NCT03746522|581158819|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
160935654|NCT03746522|581158817|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
160935655|NCT03746522|581158818|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
160935656|NCT03746522|581158819|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
160935657|NCT03746522|581158817|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
160935658|NCT03746522|581158818|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
160935659|NCT03746522|581158819|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
160935660|NCT03746522|581158817|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
160935661|NCT03746522|581158818|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
160935662|NCT03746522|581158819|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
160935663|NCT03746522|581158817|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
160935664|NCT03746522|581158818|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
160935665|NCT03746522|581158819|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
160935666|NCT03323099|581158820|FG000|Overall Study|Withdrawal by Subject|6|||
160935667|NCT03323099|581158821|FG001|Overall Study|Withdrawal by Subject|12|||
160935668|NCT03323099|581158820|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
160935669|NCT03323099|581158821|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
160935670|NCT00767676|581158824|FG000|Overall Study|Investigator error|54|||
160935671|NCT05132127|581158828|FG000|Overall Study|Adverse Event|1|||
160935672|NCT05220397|581158829|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
160935673|NCT05220397|581158830|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
160935674|NCT05220397|581158831|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
160935675|NCT05220397|581158832|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
160935676|NCT05220397|581158833|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
160935677|NCT02659020|581158834|FG000|Overall Study|Adverse Event|0|||
160935678|NCT02659020|581158835|FG001|Overall Study|Adverse Event|0|||
160935679|NCT02659020|581158836|FG002|Overall Study|Adverse Event|0|||
160935680|NCT02659020|581158837|FG003|Overall Study|Adverse Event|2|||
160935681|NCT02659020|581158838|FG004|Overall Study|Adverse Event|0|||
160935682|NCT02659020|581158839|FG005|Overall Study|Adverse Event|0|||
160935683|NCT02659020|581158840|FG006|Overall Study|Adverse Event|2|||
160935684|NCT02659020|581158834|FG000|Overall Study|Lost to Follow-up|1|||
160935685|NCT02659020|581158835|FG001|Overall Study|Lost to Follow-up|2|||
160935686|NCT02659020|581158836|FG002|Overall Study|Lost to Follow-up|1|||
160935687|NCT02659020|581158837|FG003|Overall Study|Lost to Follow-up|6|||
160935688|NCT02659020|581158838|FG004|Overall Study|Lost to Follow-up|1|||
160935689|NCT02659020|581158839|FG005|Overall Study|Lost to Follow-up|5|||
160935690|NCT02659020|581158840|FG006|Overall Study|Lost to Follow-up|0|||
160935691|NCT02659020|581158834|FG000|Overall Study|Physician Decision|0|||
160935692|NCT02659020|581158835|FG001|Overall Study|Physician Decision|0|||
160935693|NCT02659020|581158836|FG002|Overall Study|Physician Decision|0|||
160935694|NCT02659020|581158837|FG003|Overall Study|Physician Decision|1|||
160935695|NCT02659020|581158838|FG004|Overall Study|Physician Decision|1|||
160935696|NCT02659020|581158839|FG005|Overall Study|Physician Decision|0|||
160578579|NCT00530712|579838390|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
160578580|NCT00530712|579838390|FG000|12 Month Follow-up Visit|Death|9|||
160578581|NCT02749370|579838391|FG000|Overall Study|Withdrawal by Subject|11|||
160935697|NCT02659020|581158840|FG006|Overall Study|Physician Decision|1|||
160935698|NCT02659020|581158834|FG000|Overall Study|Withdrawal by Subject|2|||
160935699|NCT02659020|581158835|FG001|Overall Study|Withdrawal by Subject|1|||
160935700|NCT02659020|581158836|FG002|Overall Study|Withdrawal by Subject|0|||
160935701|NCT02659020|581158837|FG003|Overall Study|Withdrawal by Subject|3|||
160935702|NCT02659020|581158838|FG004|Overall Study|Withdrawal by Subject|3|||
160935703|NCT02659020|581158839|FG005|Overall Study|Withdrawal by Subject|6|||
160935704|NCT02659020|581158840|FG006|Overall Study|Withdrawal by Subject|3|||
160935705|NCT02659020|581158834|FG000|Overall Study|Progressive Disease|0|||
160935706|NCT02659020|581158835|FG001|Overall Study|Progressive Disease|0|||
160935707|NCT02659020|581158836|FG002|Overall Study|Progressive Disease|0|||
160935708|NCT02659020|581158837|FG003|Overall Study|Progressive Disease|4|||
160935709|NCT02659020|581158838|FG004|Overall Study|Progressive Disease|1|||
160935710|NCT02659020|581158839|FG005|Overall Study|Progressive Disease|0|||
160935711|NCT02659020|581158840|FG006|Overall Study|Progressive Disease|2|||
160935712|NCT02052739|581158841|FG000|Overall Study|Withdrew due to Adverse Event|3|||
160935713|NCT02052739|581158842|FG001|Overall Study|Withdrew due to Adverse Event|0|||
160935714|NCT02052739|581158841|FG000|Overall Study|Participant Died|2|||
160935715|NCT02052739|581158842|FG001|Overall Study|Participant Died|1|||
160935716|NCT02043015|581158843|FG000|Overall Study|Lost to Follow-up|4|||
160935717|NCT02043015|581158843|FG000|Overall Study|Withdrawal by Subject|4|||
160935718|NCT02043015|581158843|FG000|Overall Study|Removed once target enrollment reached|15|||
160935719|NCT02043015|581158843|FG000|Overall Study|Participant moved away from study city|4|||
160935720|NCT02043015|581158843|FG000|Overall Study|Incarceration|1|||
160935721|NCT01077960|581158844|FG000|Overall Study|Adverse Event|6|||
160935722|NCT01077960|581158844|FG000|Overall Study|Protocol Violation|3|||
160935723|NCT01077960|581158844|FG000|Overall Study|Lost to Follow-up|5|||
160935724|NCT01077960|581158844|FG000|Overall Study|Subject decision|1|||
160935725|NCT01077960|581158844|FG000|Overall Study|Reason unspecified|1|||
160935726|NCT03837899|581158845|FG000|Overall Study|Death|6|||
160935727|NCT03837899|581158846|FG001|Overall Study|Death|8|||
160935728|NCT03837899|581158847|FG002|Overall Study|Death|3|||
160935729|NCT03837899|581158848|FG003|Overall Study|Death|7|||
160935730|NCT03837899|581158849|FG004|Overall Study|Death|8|||
160935731|NCT03837899|581158850|FG005|Overall Study|Death|7|||
160935732|NCT03837899|581158845|FG000|Overall Study|Moved to post-trial access program|0|||
160935733|NCT03837899|581158846|FG001|Overall Study|Moved to post-trial access program|1|||
160935734|NCT03837899|581158847|FG002|Overall Study|Moved to post-trial access program|0|||
160935735|NCT03837899|581158848|FG003|Overall Study|Moved to post-trial access program|0|||
160935736|NCT03837899|581158849|FG004|Overall Study|Moved to post-trial access program|0|||
160935737|NCT03837899|581158850|FG005|Overall Study|Moved to post-trial access program|0|||
160935738|NCT03837899|581158845|FG000|Overall Study|Other|0|||
160935739|NCT03837899|581158846|FG001|Overall Study|Other|0|||
160935740|NCT03837899|581158847|FG002|Overall Study|Other|0|||
160935741|NCT03837899|581158848|FG003|Overall Study|Other|0|||
160935742|NCT03837899|581158849|FG004|Overall Study|Other|0|||
160935743|NCT03837899|581158850|FG005|Overall Study|Other|2|||
160935744|NCT03837899|581158845|FG000|Overall Study|Lost to Follow-up|0|||
160935745|NCT03837899|581158846|FG001|Overall Study|Lost to Follow-up|1|||
160935746|NCT03837899|581158847|FG002|Overall Study|Lost to Follow-up|0|||
160935747|NCT03837899|581158848|FG003|Overall Study|Lost to Follow-up|0|||
160935748|NCT03837899|581158849|FG004|Overall Study|Lost to Follow-up|0|||
160935749|NCT03837899|581158850|FG005|Overall Study|Lost to Follow-up|0|||
160935750|NCT03837899|581158845|FG000|Overall Study|Withdrawal by Subject|0|||
160935751|NCT03837899|581158846|FG001|Overall Study|Withdrawal by Subject|0|||
160935752|NCT03837899|581158847|FG002|Overall Study|Withdrawal by Subject|0|||
160935753|NCT03837899|581158848|FG003|Overall Study|Withdrawal by Subject|1|||
160935754|NCT03837899|581158849|FG004|Overall Study|Withdrawal by Subject|0|||
160935755|NCT03837899|581158850|FG005|Overall Study|Withdrawal by Subject|0|||
160935756|NCT03837899|581158845|FG000|Overall Study|Study specific discontinuation criteria|0|||
160935757|NCT03837899|581158846|FG001|Overall Study|Study specific discontinuation criteria|1|||
160935758|NCT03837899|581158847|FG002|Overall Study|Study specific discontinuation criteria|0|||
160935759|NCT03837899|581158848|FG003|Overall Study|Study specific discontinuation criteria|0|||
160935760|NCT03837899|581158849|FG004|Overall Study|Study specific discontinuation criteria|3|||
160935761|NCT03837899|581158850|FG005|Overall Study|Study specific discontinuation criteria|1|||
160935762|NCT01403974|581158851|FG000|Overall Study|Progressive disease according to RECIST|3|||
160935763|NCT01403974|581158852|FG001|Overall Study|Progressive disease according to RECIST|3|||
160935764|NCT01403974|581158853|FG002|Overall Study|Progressive disease according to RECIST|2|||
160935765|NCT01403974|581158854|FG003|Overall Study|Progressive disease according to RECIST|3|||
160935766|NCT01403974|581158855|FG004|Overall Study|Progressive disease according to RECIST|3|||
160935767|NCT01403974|581158856|FG005|Overall Study|Progressive disease according to RECIST|2|||
160935768|NCT01403974|581158857|FG006|Overall Study|Progressive disease according to RECIST|3|||
160935769|NCT01403974|581158858|FG007|Overall Study|Progressive disease according to RECIST|2|||
160935770|NCT01403974|581158859|FG008|Overall Study|Progressive disease according to RECIST|6|||
160935771|NCT01403974|581158860|FG009|Overall Study|Progressive disease according to RECIST|2|||
160935772|NCT01403974|581158861|FG010|Overall Study|Progressive disease according to RECIST|3|||
160935773|NCT01403974|581158862|FG011|Overall Study|Progressive disease according to RECIST|2|||
160935774|NCT01403974|581158863|FG012|Overall Study|Progressive disease according to RECIST|2|||
160935775|NCT01403974|581158864|FG013|Overall Study|Progressive disease according to RECIST|3|||
160935776|NCT01403974|581158865|FG014|Overall Study|Progressive disease according to RECIST|1|||
160935777|NCT01403974|581158866|FG015|Overall Study|Progressive disease according to RECIST|8|||
160935778|NCT01403974|581158851|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
160935779|NCT01403974|581158852|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
160935780|NCT01403974|581158853|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
160935781|NCT01403974|581158854|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
160935782|NCT01403974|581158855|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
160935783|NCT01403974|581158856|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
160935784|NCT01403974|581158857|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
160935785|NCT01403974|581158858|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
160935786|NCT01403974|581158859|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
160935787|NCT01403974|581158860|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
160935788|NCT01403974|581158861|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
160935789|NCT01403974|581158862|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
160935790|NCT01403974|581158863|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
160935791|NCT01403974|581158864|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
160935792|NCT01403974|581158865|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
160935793|NCT01403974|581158866|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
160935794|NCT01403974|581158851|FG000|Overall Study|Refused to continue study medication|0|||
160935795|NCT01403974|581158852|FG001|Overall Study|Refused to continue study medication|0|||
160935796|NCT01403974|581158853|FG002|Overall Study|Refused to continue study medication|0|||
160935797|NCT01403974|581158854|FG003|Overall Study|Refused to continue study medication|0|||
160935798|NCT01403974|581158855|FG004|Overall Study|Refused to continue study medication|0|||
160935799|NCT01403974|581158856|FG005|Overall Study|Refused to continue study medication|1|||
160935800|NCT01403974|581158857|FG006|Overall Study|Refused to continue study medication|0|||
160935801|NCT01403974|581158858|FG007|Overall Study|Refused to continue study medication|0|||
160935802|NCT01403974|581158859|FG008|Overall Study|Refused to continue study medication|1|||
160935803|NCT01403974|581158860|FG009|Overall Study|Refused to continue study medication|0|||
160935804|NCT01403974|581158861|FG010|Overall Study|Refused to continue study medication|1|||
160935805|NCT01403974|581158862|FG011|Overall Study|Refused to continue study medication|0|||
160935806|NCT01403974|581158863|FG012|Overall Study|Refused to continue study medication|0|||
160935807|NCT01403974|581158864|FG013|Overall Study|Refused to continue study medication|0|||
160935808|NCT01403974|581158865|FG014|Overall Study|Refused to continue study medication|0|||
160935809|NCT01403974|581158866|FG015|Overall Study|Refused to continue study medication|4|||
160935810|NCT01403974|581158851|FG000|Overall Study|Adverse Event|0|||
160935811|NCT01403974|581158852|FG001|Overall Study|Adverse Event|0|||
160935812|NCT01403974|581158853|FG002|Overall Study|Adverse Event|1|||
160935813|NCT01403974|581158854|FG003|Overall Study|Adverse Event|0|||
160935814|NCT01403974|581158855|FG004|Overall Study|Adverse Event|0|||
160935815|NCT01403974|581158856|FG005|Overall Study|Adverse Event|0|||
160935816|NCT01403974|581158857|FG006|Overall Study|Adverse Event|0|||
160935817|NCT01403974|581158858|FG007|Overall Study|Adverse Event|1|||
160935818|NCT01403974|581158859|FG008|Overall Study|Adverse Event|0|||
160935819|NCT01403974|581158860|FG009|Overall Study|Adverse Event|0|||
160935820|NCT01403974|581158861|FG010|Overall Study|Adverse Event|0|||
160935821|NCT01403974|581158862|FG011|Overall Study|Adverse Event|0|||
160935822|NCT01403974|581158863|FG012|Overall Study|Adverse Event|1|||
160935823|NCT01403974|581158864|FG013|Overall Study|Adverse Event|0|||
160935824|NCT01403974|581158865|FG014|Overall Study|Adverse Event|0|||
160935825|NCT01403974|581158866|FG015|Overall Study|Adverse Event|0|||
160935826|NCT01403974|581158851|FG000|Overall Study|Other than specified|0|||
160935827|NCT01403974|581158852|FG001|Overall Study|Other than specified|0|||
160935828|NCT01403974|581158853|FG002|Overall Study|Other than specified|0|||
160935829|NCT01403974|581158854|FG003|Overall Study|Other than specified|0|||
160935830|NCT01403974|581158855|FG004|Overall Study|Other than specified|0|||
160935831|NCT01403974|581158856|FG005|Overall Study|Other than specified|0|||
160935832|NCT01403974|581158857|FG006|Overall Study|Other than specified|0|||
160935833|NCT01403974|581158858|FG007|Overall Study|Other than specified|0|||
160935834|NCT01403974|581158859|FG008|Overall Study|Other than specified|0|||
160935835|NCT01403974|581158860|FG009|Overall Study|Other than specified|1|||
160935836|NCT01403974|581158861|FG010|Overall Study|Other than specified|0|||
160935837|NCT01403974|581158862|FG011|Overall Study|Other than specified|1|||
160935838|NCT01403974|581158863|FG012|Overall Study|Other than specified|0|||
160935839|NCT01403974|581158864|FG013|Overall Study|Other than specified|0|||
160935840|NCT01403974|581158865|FG014|Overall Study|Other than specified|0|||
160935841|NCT01403974|581158866|FG015|Overall Study|Other than specified|0|||
160935842|NCT01526889|581158867|FG000|Treatment Period|Adverse Event|2|||
160935843|NCT01526889|581158868|FG001|Treatment Period|Adverse Event|0|||
160935844|NCT01526889|581158867|FG000|Treatment Extension Period|Administrative problems|1|||
160935845|NCT01526889|581158868|FG001|Treatment Extension Period|Administrative problems|0|||
160935846|NCT00393939|581158874|FG000|Overall Study|Protocol Violation|1|||
160935847|NCT00393939|581158875|FG001|Overall Study|Protocol Violation|1|||
160935848|NCT00393939|581158874|FG000|Overall Study|Lost to Follow-up|2|||
160935849|NCT00393939|581158875|FG001|Overall Study|Lost to Follow-up|4|||
160935850|NCT00393939|581158874|FG000|Overall Study|Death|10|||
160935851|NCT00393939|581158875|FG001|Overall Study|Death|4|||
160935852|NCT00393939|581158874|FG000|Overall Study|Sponsor|5|||
160935853|NCT00393939|581158875|FG001|Overall Study|Sponsor|13|||
160935854|NCT00393939|581158874|FG000|Overall Study|Objective progression or relapse|239|||
160935855|NCT00393939|581158875|FG001|Overall Study|Objective progression or relapse|223|||
160935856|NCT00393939|581158874|FG000|Overall Study|Withdrawal by Subject|2|||
160935857|NCT00393939|581158875|FG001|Overall Study|Withdrawal by Subject|7|||
160935858|NCT00393939|581158874|FG000|Overall Study|Other|37|||
160935859|NCT00393939|581158875|FG001|Overall Study|Other|45|||
160935860|NCT01494610|581158876|FG000|Period 1|Withdrawal by Subject|1|||
160935861|NCT01494610|581158877|FG001|Period 1|Withdrawal by Subject|1|||
160935862|NCT01494610|581158876|FG000|Period 3|Adverse Event|1|||
160935863|NCT01494610|581158877|FG001|Period 3|Adverse Event|0|||
160935864|NCT01494610|581158876|FG000|Period 3|Withdrawal by Subject|1|||
160935865|NCT01494610|581158877|FG001|Period 3|Withdrawal by Subject|0|||
160935866|NCT01494610|581158876|FG000|Period 4|Protocol Violation|1|||
160935867|NCT01494610|581158877|FG001|Period 4|Protocol Violation|0|||
160935868|NCT02385799|581158878|FG000|Overall Study|Lost to Follow-up|1|||
160935869|NCT02385799|581158879|FG001|Overall Study|Lost to Follow-up|2|||
160935870|NCT02385799|581158878|FG000|Overall Study|Adverse Event|4|||
160935871|NCT02385799|581158879|FG001|Overall Study|Adverse Event|2|||
160935872|NCT02385799|581158878|FG000|Overall Study|Withdrawal by Subject|0|||
160935873|NCT02385799|581158879|FG001|Overall Study|Withdrawal by Subject|4|||
160935874|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935875|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
160935876|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
160935877|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
160935878|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935879|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935880|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935881|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935882|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935883|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935884|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935885|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935886|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935887|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935888|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935889|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935890|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935891|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935892|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935893|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935894|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935895|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935896|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935897|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935898|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935899|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
160935900|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935901|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935902|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935903|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935904|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935905|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935906|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935907|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935908|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935909|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935910|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935911|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935912|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935913|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935914|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935915|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935916|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935917|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935918|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935919|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160998523|NCT02525796|581380535|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
160935920|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935921|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935922|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935923|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
160935924|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935925|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935926|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935927|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935928|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935929|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935930|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935931|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160998524|NCT02525796|581380536|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
160998525|NCT02525796|581380537|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
160998526|NCT02525796|581380535|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
160935932|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935933|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935934|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935935|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935936|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935937|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935938|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935939|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935940|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935941|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935942|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935943|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935944|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935945|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160998527|NCT02525796|581380536|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
160935946|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
160935947|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
160935948|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
160935949|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
160935950|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935951|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935952|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935953|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935954|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935955|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935956|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935957|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935958|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935959|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935960|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935961|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935962|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935963|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935964|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935965|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935966|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935967|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935968|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935969|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935970|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
160935971|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
160935972|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
160935973|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
160935974|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935975|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935976|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935977|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935978|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935979|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935980|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935981|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935982|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935983|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935984|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935985|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935986|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160578582|NCT02749370|579838391|FG000|Overall Study|Lost to Follow-up|3|||
160578583|NCT03894904|579838397|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
160632827|NCT01215955|580036085|FG000|Overall Study|Entry Criteria Not Met|1|||
160935987|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935988|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935989|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935990|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935991|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935992|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935993|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935994|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160935995|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
160935996|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160935997|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
160935998|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160935999|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936000|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936001|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936002|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936003|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936004|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936005|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936006|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936007|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936008|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936009|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936010|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936011|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936012|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936013|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936014|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936015|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936016|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160998528|NCT02525796|581380537|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
160936017|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936018|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936019|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936020|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
160936021|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936022|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936023|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936024|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936025|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936026|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936027|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936028|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936029|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936030|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936031|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936032|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936033|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936034|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936035|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936036|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936037|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936038|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936039|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160998529|NCT00726999|581380538|FG000|Overall Study|Physician Decision|0|||
160998530|NCT00726999|581380539|FG001|Overall Study|Physician Decision|1|||
160998531|NCT00726999|581380538|FG000|Overall Study|Withdrawal by Subject|2|||
160998532|NCT00726999|581380539|FG001|Overall Study|Withdrawal by Subject|0|||
160655957|NCT00661999|580120319|FG001|Overall Study|Withdrawal by Subject|23|||
160936040|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936041|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936042|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936043|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936044|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936045|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160998533|NCT00726999|581380538|FG000|Overall Study|Protocol Violation|1|||
160998534|NCT00726999|581380539|FG001|Overall Study|Protocol Violation|0|||
160936046|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936047|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936048|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936049|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
160936050|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
160936051|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936052|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936053|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936054|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936055|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
160936056|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
160936057|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
160936058|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
160936059|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936060|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160998535|NCT01198275|581380540|FG000|Overall Study|Adverse Event|2|||
160998536|NCT01198275|581380541|FG001|Overall Study|Adverse Event|3|||
160998537|NCT01198275|581380540|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
160936061|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936062|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936063|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936064|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936065|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936066|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936067|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936068|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936069|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936070|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936071|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936072|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936073|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936074|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936075|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936076|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936077|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936078|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936079|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
160936080|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936081|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
160936082|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936083|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936084|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936085|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936086|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936087|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936088|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936089|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936090|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936091|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936092|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936093|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936094|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936095|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936096|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936097|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936098|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936099|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160998538|NCT01198275|581380541|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
160998539|NCT02810080|581380545|FG000|Overall Study|Adverse Event|3|||
160936100|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936101|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936102|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936103|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936104|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
160936105|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936106|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936107|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936108|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936109|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936110|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936111|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936112|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936113|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936114|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936115|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936116|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936117|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936118|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936119|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936120|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936121|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936122|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936123|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936124|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936125|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
160936126|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936127|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
160936128|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
160936129|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
160936130|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936131|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936132|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936133|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936134|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936135|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936136|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936137|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936138|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936139|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936140|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936141|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936142|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936143|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936144|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936145|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936146|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936147|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936148|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936149|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936150|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936151|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
160936152|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
160936153|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
160936154|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
160936155|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936156|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936157|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936158|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936159|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936160|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936161|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936162|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936163|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936164|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936165|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936166|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936167|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160998540|NCT02810080|581380546|FG001|Overall Study|Adverse Event|0|||
160936168|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
160936169|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936170|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936171|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936172|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936173|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936174|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936175|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936176|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936177|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936178|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936179|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936180|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936181|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936182|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936183|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936184|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936185|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936186|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936187|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936188|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936189|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936190|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936191|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936192|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936193|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936194|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
160936195|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936196|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936197|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
160936198|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936199|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
160936200|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
160936201|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936202|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936203|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936204|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936205|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936206|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936207|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936208|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936209|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936210|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936211|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936212|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936213|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936214|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936215|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936216|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936217|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936218|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936219|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
160936220|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160578584|NCT03894904|579838398|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
160578585|NCT03894904|579838397|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
160998541|NCT02810080|581380545|FG000|Overall Study|Death|0|||
160578586|NCT03894904|579838398|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
160936221|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936222|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936223|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936224|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936225|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936226|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936227|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936228|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936229|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936230|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936231|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936232|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936233|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936234|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936235|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936236|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936237|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936238|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936239|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936240|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936241|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936242|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936243|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936244|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
160936245|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936246|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936247|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936248|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936249|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936250|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936251|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936252|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936253|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936254|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936255|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936256|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936257|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936258|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936259|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936260|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936261|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936262|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936263|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936264|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936265|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936266|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936267|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936268|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936269|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936270|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936271|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936272|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
160936273|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936274|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936275|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936276|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936277|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160998542|NCT02810080|581380546|FG001|Overall Study|Death|2|||
160936278|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936279|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936280|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936281|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936282|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936283|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936284|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936285|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936286|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160455240|NCT03523572|579397891|FG005|Dose Escalation|Adverse Event|0|||
160455241|NCT03523572|579397886|FG000|Dose Escalation|Physician Decision|1|||
160455242|NCT03523572|579397887|FG001|Dose Escalation|Physician Decision|1|||
160455243|NCT03523572|579397888|FG002|Dose Escalation|Physician Decision|0|||
160455244|NCT03523572|579397889|FG003|Dose Escalation|Physician Decision|0|||
160455245|NCT03523572|579397890|FG004|Dose Escalation|Physician Decision|0|||
160455246|NCT03523572|579397891|FG005|Dose Escalation|Physician Decision|0|||
160455247|NCT03523572|579397886|FG000|Dose Expansion|Progressive Disease|0|||
160455248|NCT03523572|579397887|FG001|Dose Expansion|Progressive Disease|0|||
160455249|NCT03523572|579397888|FG002|Dose Expansion|Progressive Disease|9|||
160455250|NCT03523572|579397889|FG003|Dose Expansion|Progressive Disease|11|||
160455251|NCT03523572|579397890|FG004|Dose Expansion|Progressive Disease|15|||
160655958|NCT00661999|580120320|FG002|Overall Study|Withdrawal by Subject|14|||
160655959|NCT00661999|580120318|FG000|Overall Study|Alternative Treatment|1|||
160998543|NCT02810080|581380545|FG000|Overall Study|Physician Decision|4|||
160998544|NCT02810080|581380546|FG001|Overall Study|Physician Decision|0|||
160936287|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936288|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936289|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936290|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936291|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936292|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936293|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936294|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936295|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936296|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
160936297|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936298|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936299|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936300|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936301|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936302|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936303|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936304|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936305|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936306|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936307|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936308|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936309|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936310|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936311|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936312|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936313|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160998545|NCT02810080|581380545|FG000|Overall Study|Withdrawal by Subject|0|||
160998546|NCT02810080|581380546|FG001|Overall Study|Withdrawal by Subject|2|||
160998547|NCT02034916|581380549|FG000|Overall Study|Death|39|||
160998548|NCT02034916|581380550|FG001|Overall Study|Death|28|||
160998549|NCT02034916|581380549|FG000|Overall Study|Withdrawal by Subject|2|||
160998550|NCT02034916|581380550|FG001|Overall Study|Withdrawal by Subject|1|||
160998551|NCT02034916|581380549|FG000|Overall Study|Lost to Follow-up|4|||
160998552|NCT02034916|581380550|FG001|Overall Study|Lost to Follow-up|1|||
160998553|NCT02034916|581380549|FG000|Overall Study|Study terminated by sponsor|4|||
160455252|NCT03523572|579397891|FG005|Dose Expansion|Progressive Disease|2|||
160998554|NCT02034916|581380550|FG001|Overall Study|Study terminated by sponsor|5|||
160455253|NCT03523572|579397886|FG000|Dose Expansion|Clinical Progression|0|||
160455254|NCT03523572|579397887|FG001|Dose Expansion|Clinical Progression|0|||
160455255|NCT03523572|579397888|FG002|Dose Expansion|Clinical Progression|2|||
160998555|NCT01591616|581380555|FG000|Overall Study|Withdrawal by Subject|1|||
160936314|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936315|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936316|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936317|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936318|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936319|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936320|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
160936321|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936322|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936323|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936324|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936325|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936326|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936327|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936328|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936329|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936330|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936331|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936332|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936333|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936334|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936335|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936336|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936337|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936338|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936339|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936340|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936341|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936342|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936343|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936344|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936345|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936346|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936347|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
160936348|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
160936349|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
160936350|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
160936351|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
160936352|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
160936353|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
160936354|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936355|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936356|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936357|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936358|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936359|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936360|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936361|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
160998556|NCT00758602|581380556|FG000|Overall Study|Adverse Event|11|||
160998557|NCT00758602|581380557|FG001|Overall Study|Adverse Event|10|||
160998558|NCT00758602|581380556|FG000|Overall Study|Lost to Follow-up|4|||
160936362|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936363|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936364|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936365|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936366|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936367|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936368|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936369|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936370|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
160998559|NCT00758602|581380557|FG001|Overall Study|Lost to Follow-up|3|||
160936371|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936372|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
160998560|NCT00758602|581380556|FG000|Overall Study|Withdrawal by Subject|1|||
160936373|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
160936374|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936375|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
160936376|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936377|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936378|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936379|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936380|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936381|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936382|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936383|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936384|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936385|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936386|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936387|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936388|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936389|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936390|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936391|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936392|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936393|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936394|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936395|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936396|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
160936397|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936398|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936399|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
160936400|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936401|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936402|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936403|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936404|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936405|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936406|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936407|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936408|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936409|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936410|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936411|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936412|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936413|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936414|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936415|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936416|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160455256|NCT03523572|579397889|FG003|Dose Expansion|Clinical Progression|2|||
160455257|NCT03523572|579397890|FG004|Dose Expansion|Clinical Progression|2|||
160936417|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936418|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936419|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936420|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936421|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936422|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936423|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
160936424|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160455258|NCT03523572|579397891|FG005|Dose Expansion|Clinical Progression|0|||
160455259|NCT03523572|579397886|FG000|Dose Expansion|Adverse Event|0|||
160578587|NCT03242759|579838399|FG000|Overall Study|Adverse Event|5|||
160578588|NCT03242759|579838400|FG001|Overall Study|Adverse Event|1|||
160578589|NCT03242759|579838399|FG000|Overall Study|Withdrawal by Subject|4|||
160578590|NCT03242759|579838400|FG001|Overall Study|Withdrawal by Subject|3|||
160578591|NCT03242759|579838399|FG000|Overall Study|Lost to Follow-up|3|||
160936425|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936426|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936427|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936428|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936429|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936430|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936431|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936432|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936433|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936434|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936435|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936436|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936437|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936438|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936439|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936440|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936441|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936442|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936443|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
160936444|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
160936445|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
160936446|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936447|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
160936448|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
160936449|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
160936450|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936451|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936452|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936453|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936454|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936455|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936456|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936457|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936458|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936459|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936460|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936461|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936462|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936463|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936464|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936465|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936466|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936467|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936468|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
160936469|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
160936470|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936471|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
160936472|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
160936473|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
160936474|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936475|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936476|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936477|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936478|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936479|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936480|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936481|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936482|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936483|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936484|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936485|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936486|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936487|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936488|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160578592|NCT03242759|579838400|FG001|Overall Study|Lost to Follow-up|1|||
160578593|NCT03242759|579838399|FG000|Overall Study|Administrative problems|1|||
160578594|NCT03242759|579838400|FG001|Overall Study|Administrative problems|1|||
160578595|NCT03242759|579838399|FG000|Overall Study|Death|22|||
160936489|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936490|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936491|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936492|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
160936493|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936494|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936495|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
160936496|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
160936497|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
160936498|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936499|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936500|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936501|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936502|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936503|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936504|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936505|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936506|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936507|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936508|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936509|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936510|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936511|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936512|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936513|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936514|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936515|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936516|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
160936517|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936518|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936519|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936520|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936521|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936522|NCT02942017|581158904|FG000|Overall Study|Adverse Event|0|||
160936523|NCT02942017|581158905|FG001|Overall Study|Adverse Event|1|||
160936524|NCT02942017|581158904|FG000|Overall Study|Withdrawal by Subject|0|||
160936525|NCT02942017|581158905|FG001|Overall Study|Withdrawal by Subject|1|||
160998561|NCT00758602|581380557|FG001|Overall Study|Withdrawal by Subject|3|||
160998562|NCT00758602|581380556|FG000|Overall Study|Protocol Violation|0|||
160936526|NCT02942017|581158904|FG000|Overall Study|Lost to Follow-up|1|||
160936527|NCT02942017|581158905|FG001|Overall Study|Lost to Follow-up|1|||
160936528|NCT02942017|581158904|FG000|Overall Study|Randomized but not dosed|1|||
160936529|NCT02942017|581158905|FG001|Overall Study|Randomized but not dosed|3|||
160936530|NCT00477672|581158906|FG000|Overall Study|Adverse Event|3|||
160936531|NCT00477672|581158907|FG001|Overall Study|Adverse Event|5|||
160936532|NCT00477672|581158908|FG002|Overall Study|Adverse Event|6|||
160998563|NCT00758602|581380557|FG001|Overall Study|Protocol Violation|2|||
160998564|NCT00758602|581380556|FG000|Overall Study|Death|0|||
160998565|NCT00758602|581380557|FG001|Overall Study|Death|1|||
160998566|NCT00758602|581380556|FG000|Overall Study|Reason not specified|3|||
160998567|NCT00758602|581380557|FG001|Overall Study|Reason not specified|3|||
160936533|NCT00477672|581158906|FG000|Overall Study|Death|0|||
160936534|NCT00477672|581158907|FG001|Overall Study|Death|1|||
160936535|NCT00477672|581158908|FG002|Overall Study|Death|0|||
160998568|NCT05046132|581380558|FG000|Overall Study|Adverse Event|4|||
160998569|NCT05046132|581380559|FG001|Overall Study|Adverse Event|0|||
160936536|NCT00477672|581158906|FG000|Overall Study|Disease progression|0|||
160936537|NCT00477672|581158907|FG001|Overall Study|Disease progression|1|||
160936538|NCT00477672|581158908|FG002|Overall Study|Disease progression|0|||
160936539|NCT00477672|581158906|FG000|Overall Study|Physician Decision|1|||
160936540|NCT00477672|581158907|FG001|Overall Study|Physician Decision|0|||
160936541|NCT00477672|581158908|FG002|Overall Study|Physician Decision|0|||
160936542|NCT00477672|581158906|FG000|Overall Study|Protocol noncompliance|0|||
160998570|NCT05046132|581380560|FG002|Overall Study|Adverse Event|0|||
160998571|NCT05046132|581380558|FG000|Overall Study|Withdrawal by Subject|3|||
160998572|NCT05046132|581380559|FG001|Overall Study|Withdrawal by Subject|0|||
160936543|NCT00477672|581158907|FG001|Overall Study|Protocol noncompliance|2|||
160998573|NCT05046132|581380560|FG002|Overall Study|Withdrawal by Subject|0|||
160936544|NCT00477672|581158908|FG002|Overall Study|Protocol noncompliance|0|||
160936545|NCT00477672|581158906|FG000|Overall Study|Consent withdrawn|2|||
160936546|NCT00477672|581158907|FG001|Overall Study|Consent withdrawn|5|||
160936547|NCT00477672|581158908|FG002|Overall Study|Consent withdrawn|10|||
160936548|NCT00477672|581158906|FG000|Overall Study|Discretion of Sponsor|1|||
160936549|NCT00477672|581158907|FG001|Overall Study|Discretion of Sponsor|2|||
160936550|NCT00477672|581158908|FG002|Overall Study|Discretion of Sponsor|0|||
160936551|NCT00838565|581158909|FG000|Overall Study|Withdrawal by Subject|0|||
160936552|NCT00838565|581158910|FG001|Overall Study|Withdrawal by Subject|0|||
160936553|NCT00838565|581158911|FG002|Overall Study|Withdrawal by Subject|1|||
160936554|NCT00838565|581158912|FG003|Overall Study|Withdrawal by Subject|0|||
160936555|NCT00838565|581158913|FG004|Overall Study|Withdrawal by Subject|0|||
160936556|NCT00838565|581158914|FG005|Overall Study|Withdrawal by Subject|2|||
160936557|NCT00838565|581158909|FG000|Overall Study|Other|0|||
160936558|NCT00838565|581158910|FG001|Overall Study|Other|2|||
160936559|NCT00838565|581158911|FG002|Overall Study|Other|0|||
160936560|NCT00838565|581158912|FG003|Overall Study|Other|0|||
160936561|NCT00838565|581158913|FG004|Overall Study|Other|0|||
160936562|NCT00838565|581158914|FG005|Overall Study|Other|0|||
160936563|NCT00838565|581158909|FG000|Overall Study|Randomized but not Treated|0|||
160936564|NCT00838565|581158910|FG001|Overall Study|Randomized but not Treated|1|||
160936565|NCT00838565|581158911|FG002|Overall Study|Randomized but not Treated|0|||
160936566|NCT00838565|581158912|FG003|Overall Study|Randomized but not Treated|0|||
160936567|NCT00838565|581158913|FG004|Overall Study|Randomized but not Treated|0|||
160936568|NCT00838565|581158914|FG005|Overall Study|Randomized but not Treated|0|||
160578596|NCT03242759|579838400|FG001|Overall Study|Death|0|||
160578597|NCT03242759|579838399|FG000|Overall Study|Change visit schedule|0|||
160578598|NCT03242759|579838400|FG001|Overall Study|Change visit schedule|1|||
160578599|NCT03117049|579838403|FG000|Overall Study|Continued the follow-up period|109|||
160578600|NCT03117049|579838404|FG001|Overall Study|Continued the follow-up period|129|||
160936569|NCT00458484|581158915|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
160936570|NCT00458484|581158916|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
160936571|NCT00458484|581158917|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
160936572|NCT00458484|581158918|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
160936573|NCT00458484|581158919|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
160936574|NCT00458484|581158920|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
160936575|NCT00458484|581158921|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
160936576|NCT04907032|581158922|FG000|Overall Study|Withdrawal by Subject|7|||
160936577|NCT04907032|581158923|FG001|Overall Study|Withdrawal by Subject|1|||
160936578|NCT01838642|581158924|FG000|Overall Study|Died on study|1|||
160936579|NCT02253810|581158925|FG000|Overall Study|Withdrawal by Subject|2|||
160936580|NCT02253810|581158926|FG001|Overall Study|Withdrawal by Subject|1|||
160936581|NCT02253810|581158925|FG000|Overall Study|Unknown concomitant procedure|3|||
160936582|NCT02253810|581158926|FG001|Overall Study|Unknown concomitant procedure|2|||
160936583|NCT00291668|581158928|FG000|Overall Study|Lack of Efficacy|1|||
160936584|NCT00291668|581158929|FG001|Overall Study|Lack of Efficacy|0|||
160936585|NCT00291668|581158930|FG002|Overall Study|Lack of Efficacy|0|||
160936586|NCT00291668|581158928|FG000|Overall Study|SAE, non-fatal|1|||
160936587|NCT00291668|581158929|FG001|Overall Study|SAE, non-fatal|1|||
160998574|NCT05046132|581380558|FG000|Overall Study|Positive Covid19 Result.|0|||
160998575|NCT05046132|581380559|FG001|Overall Study|Positive Covid19 Result.|1|||
160998576|NCT05046132|581380560|FG002|Overall Study|Positive Covid19 Result.|0|||
160998577|NCT01186848|581380566|FG000|Overall Study|Lost to Follow-up|4|||
160936588|NCT00291668|581158930|FG002|Overall Study|SAE, non-fatal|1|||
160936589|NCT00291668|581158928|FG000|Overall Study|AE, non-serious non-fatal|1|||
160936590|NCT00291668|581158929|FG001|Overall Study|AE, non-serious non-fatal|0|||
160936591|NCT00291668|581158930|FG002|Overall Study|AE, non-serious non-fatal|0|||
160936592|NCT00291668|581158928|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160936593|NCT00291668|581158929|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
160936594|NCT00291668|581158930|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
160936595|NCT01557400|581158931|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
160936596|NCT01557400|581158931|FG000|Overall Study|Adverse Event|3|||
160936597|NCT01557400|581158931|FG000|Overall Study|Lost to Follow-up|5|||
160936598|NCT01557400|581158931|FG000|Overall Study|Withdrawal by Subject|9|||
160936599|NCT04019041|581158934|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
160936600|NCT04019041|581158935|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
160936601|NCT04019041|581158936|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
160998578|NCT01186848|581380566|FG000|Overall Study|Withdrawal by Subject|2|||
160936602|NCT04019041|581158937|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160936603|NCT04019041|581158938|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160936604|NCT04019041|581158939|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160936605|NCT04019041|581158934|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
160936606|NCT04019041|581158935|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
160998579|NCT01186848|581380566|FG000|Overall Study|Adverse Event|2|||
160936607|NCT04019041|581158936|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
160936608|NCT04019041|581158937|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
160936609|NCT04019041|581158938|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
160936610|NCT04019041|581158939|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
160936611|NCT04019041|581158934|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
160936612|NCT04019041|581158935|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
160936613|NCT04019041|581158936|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
160936614|NCT04019041|581158937|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160936615|NCT04019041|581158938|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160936616|NCT04019041|581158939|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160936617|NCT04019041|581158934|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
160936618|NCT04019041|581158935|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
160936619|NCT04019041|581158936|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
160936620|NCT04019041|581158937|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
160936621|NCT04019041|581158938|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
160936622|NCT04019041|581158939|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
160936623|NCT04019041|581158934|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160936624|NCT04019041|581158935|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160936625|NCT04019041|581158936|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160936626|NCT04019041|581158937|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
160936627|NCT04019041|581158938|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
160936628|NCT04019041|581158939|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
160936629|NCT04019041|581158934|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
160936630|NCT04019041|581158935|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
160936631|NCT04019041|581158936|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
160936632|NCT04019041|581158937|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
160936633|NCT04019041|581158938|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
160936634|NCT04019041|581158939|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
160936635|NCT04019041|581158934|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
160936636|NCT04019041|581158935|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
160936637|NCT04019041|581158936|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
160936638|NCT04019041|581158937|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
160936639|NCT04019041|581158938|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
160936640|NCT04019041|581158939|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
160936641|NCT04019041|581158934|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160936642|NCT04019041|581158935|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160936643|NCT04019041|581158936|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160936644|NCT04019041|581158937|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
160936645|NCT04019041|581158938|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
160936646|NCT04019041|581158939|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
160936647|NCT04019041|581158934|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160936648|NCT04019041|581158935|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160936649|NCT04019041|581158936|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160936650|NCT04019041|581158937|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160936651|NCT04019041|581158938|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
160936652|NCT04019041|581158939|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
160936653|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
160936654|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
160936655|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
160936656|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
160936657|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
160998580|NCT00770965|581380583|FG000|Safety Set|Withdrawal by Subject|0|||
160998581|NCT00770965|581380584|FG001|Safety Set|Withdrawal by Subject|0|||
160998582|NCT00770965|581380585|FG002|Safety Set|Withdrawal by Subject|0|||
160998583|NCT00770965|581380586|FG003|Safety Set|Withdrawal by Subject|1|||
160998584|NCT00770965|581380583|FG000|Safety Set|Protocol deviation|0|||
160998585|NCT00770965|581380584|FG001|Safety Set|Protocol deviation|0|||
160936658|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
160936659|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
160936660|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
160936661|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
160936662|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
160998586|NCT00770965|581380585|FG002|Safety Set|Protocol deviation|1|||
160936663|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
160936664|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
160936665|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
160936666|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
160936667|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
160936668|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
160936669|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
160936670|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
160936671|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
160936672|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
160936673|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Other|3|||
160936674|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Other|0|||
160936675|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Other|2|||
160936676|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Other|2|||
160936677|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Other|7|||
160936678|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936679|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936680|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936681|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
160936682|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936683|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936684|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936685|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936686|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936687|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
160936688|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
160936689|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
160936690|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
160936691|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
160936692|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
160936693|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
160936694|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
160936695|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
160936696|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
160936697|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
160936698|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
160936699|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
160936700|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
160936701|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
160936702|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
160936703|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Other|2|||
160936704|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Other|1|||
160936705|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Other|2|||
160936706|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Other|8|||
160936707|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Other|7|||
160936708|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936709|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
160936710|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936711|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936712|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936713|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
160936714|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936715|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936716|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936717|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936718|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
160936719|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
160998587|NCT00770965|581380586|FG003|Safety Set|Protocol deviation|0|||
160936720|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
160936721|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
160936722|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
160936723|NCT00213148|581158940|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
160936724|NCT00213148|581158941|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
160998588|NCT00770965|581380583|FG000|Excluded Set|Administrative problems|14|||
160578601|NCT03117049|579838403|FG000|Overall Study|Died|82|||
160936725|NCT00213148|581158942|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
160936726|NCT00213148|581158943|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
160998589|NCT00770965|581380584|FG001|Excluded Set|Administrative problems|12|||
160578602|NCT03117049|579838404|FG001|Overall Study|Died|93|||
160578603|NCT03117049|579838403|FG000|Overall Study|Consent withdrawal|7|||
160936727|NCT00213148|581158944|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
160936728|NCT00213148|581158940|FG000|Cycle 3 (1 Month)|Other|0|||
160936729|NCT00213148|581158941|FG001|Cycle 3 (1 Month)|Other|0|||
160936730|NCT00213148|581158942|FG002|Cycle 3 (1 Month)|Other|1|||
160936731|NCT00213148|581158943|FG003|Cycle 3 (1 Month)|Other|1|||
160936732|NCT00213148|581158944|FG004|Cycle 3 (1 Month)|Other|0|||
160936733|NCT02321462|581158945|FG000|Overall Study|Withdrawal by Subject|5|||
160936734|NCT02321462|581158946|FG001|Overall Study|Withdrawal by Subject|2|||
160936735|NCT02321462|581158945|FG000|Overall Study|Subject withdrawn before any treatment|1|||
160936736|NCT02321462|581158946|FG001|Overall Study|Subject withdrawn before any treatment|1|||
160998590|NCT00770965|581380585|FG002|Excluded Set|Administrative problems|12|||
160936737|NCT00660348|581158948|FG000|Overall Study|Withdrawal by Subject|1|||
160936738|NCT00660348|581158949|FG001|Overall Study|Withdrawal by Subject|0|||
160936739|NCT02741115|581158950|FG000|Overall Study|Adverse Event|1|||
160936740|NCT02741115|581158951|FG001|Overall Study|Adverse Event|0|||
160936741|NCT02741115|581158950|FG000|Overall Study|Lost to Follow-up|7|||
160936742|NCT02741115|581158951|FG001|Overall Study|Lost to Follow-up|4|||
160936743|NCT02741115|581158950|FG000|Overall Study|Withdrawal by Subject|4|||
160936744|NCT02741115|581158951|FG001|Overall Study|Withdrawal by Subject|2|||
160936745|NCT03945981|581158952|FG000|Overall Study|Lost to Follow-up|12|||
160936746|NCT03945981|581158952|FG000|Overall Study|Physician Decision|4|||
160936747|NCT03945981|581158952|FG000|Overall Study|Withdrawal by Subject|6|||
160936748|NCT03945981|581158952|FG000|Overall Study|Protocol Violation|1|||
160936749|NCT02917031|581158956|FG000|Overall Study|Reason not specified|7|||
160936750|NCT02917031|581158957|FG001|Overall Study|Reason not specified|5|||
160936751|NCT02917031|581158958|FG002|Overall Study|Reason not specified|6|||
160936752|NCT02917031|581158956|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
160936753|NCT02917031|581158957|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
160936754|NCT02917031|581158958|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
160936755|NCT02917031|581158956|FG000|Overall Study|Withdrawal by Subject|3|||
160936756|NCT02917031|581158957|FG001|Overall Study|Withdrawal by Subject|3|||
160936757|NCT02917031|581158958|FG002|Overall Study|Withdrawal by Subject|0|||
160936758|NCT02917031|581158956|FG000|Overall Study|Physician Decision|1|||
160936759|NCT02917031|581158957|FG001|Overall Study|Physician Decision|0|||
160936760|NCT02917031|581158958|FG002|Overall Study|Physician Decision|0|||
160936761|NCT02917031|581158956|FG000|Overall Study|Adverse Event|4|||
160936762|NCT02917031|581158957|FG001|Overall Study|Adverse Event|1|||
160936763|NCT02917031|581158958|FG002|Overall Study|Adverse Event|5|||
160936764|NCT02917031|581158956|FG000|Overall Study|Death|2|||
160936765|NCT02917031|581158957|FG001|Overall Study|Death|3|||
160936766|NCT02917031|581158958|FG002|Overall Study|Death|4|||
160936767|NCT04346615|581160290|FG000|Overall Study|Lost to Follow-up|0|||
160936768|NCT04346615|581160291|FG001|Overall Study|Lost to Follow-up|2|||
160936769|NCT04346615|581160290|FG000|Overall Study|Withdrawal by Subject|1|||
160936770|NCT04346615|581160291|FG001|Overall Study|Withdrawal by Subject|0|||
160936771|NCT04346615|581160290|FG000|Overall Study|Death|5|||
160936772|NCT04346615|581160291|FG001|Overall Study|Death|1|||
160936773|NCT04346615|581160290|FG000|Overall Study|Other|0|||
160936774|NCT04346615|581160291|FG001|Overall Study|Other|2|||
160936775|NCT04346615|581160290|FG000|Overall Study|Randomized not treated|1|||
160936776|NCT04346615|581160291|FG001|Overall Study|Randomized not treated|0|||
160936777|NCT02096835|581160297|FG000|Overall Study|Withdrawal by Subject|1|||
160936778|NCT02096835|581160298|FG001|Overall Study|Withdrawal by Subject|0|||
160936779|NCT02096835|581160299|FG002|Overall Study|Withdrawal by Subject|0|||
160936780|NCT02096835|581160297|FG000|Overall Study|converted to open procedures|1|||
160936781|NCT02096835|581160298|FG001|Overall Study|converted to open procedures|0|||
160936782|NCT02096835|581160299|FG002|Overall Study|converted to open procedures|0|||
160936783|NCT02096835|581160297|FG000|Overall Study|Lost to Follow-up|1|||
160936784|NCT02096835|581160298|FG001|Overall Study|Lost to Follow-up|0|||
160936785|NCT02096835|581160299|FG002|Overall Study|Lost to Follow-up|1|||
160936786|NCT04368429|581160300|FG000|Overall Study|Adverse Event|1|||
160936787|NCT04368429|581160301|FG001|Overall Study|Adverse Event|0|||
160936788|NCT00667342|581160302|FG000|Overall Study|Protocol Violation|1|||
160936789|NCT00667342|581160303|FG001|Overall Study|Protocol Violation|0|||
160936790|NCT00667342|581160304|FG002|Overall Study|Protocol Violation|0|||
160936791|NCT00667342|581160302|FG000|Overall Study|Withdrawal by Subject|1|||
160936792|NCT00667342|581160303|FG001|Overall Study|Withdrawal by Subject|0|||
160936793|NCT00667342|581160304|FG002|Overall Study|Withdrawal by Subject|0|||
160936794|NCT00667342|581160302|FG000|Overall Study|Physician Decision|3|||
160936795|NCT00667342|581160303|FG001|Overall Study|Physician Decision|0|||
160936796|NCT00667342|581160304|FG002|Overall Study|Physician Decision|0|||
160936797|NCT00667342|581160302|FG000|Overall Study|Relapse or tumor progression|9|||
160936798|NCT00667342|581160303|FG001|Overall Study|Relapse or tumor progression|0|||
160936799|NCT00667342|581160304|FG002|Overall Study|Relapse or tumor progression|7|||
160936800|NCT00667342|581160302|FG000|Overall Study|Adverse Event|0|||
160936801|NCT00667342|581160303|FG001|Overall Study|Adverse Event|0|||
160936802|NCT00667342|581160304|FG002|Overall Study|Adverse Event|1|||
160936803|NCT00667342|581160302|FG000|Overall Study|Ineligible|0|||
160578604|NCT03117049|579838404|FG001|Overall Study|Consent withdrawal|6|||
160578605|NCT03117049|579838403|FG000|Overall Study|Missing contact|3|||
160578606|NCT03117049|579838404|FG001|Overall Study|Missing contact|3|||
160936804|NCT00667342|581160303|FG001|Overall Study|Ineligible|0|||
160578607|NCT00651118|579838405|FG000|Overall Study|Adverse Event|4|||
160578608|NCT00651118|579838406|FG001|Overall Study|Adverse Event|0|||
160578609|NCT00651118|579838407|FG002|Overall Study|Adverse Event|1|||
160936805|NCT00667342|581160304|FG002|Overall Study|Ineligible|1|||
160936806|NCT01433263|581160305|FG000|Overall Study|Adverse Event|3|||
160936807|NCT01433263|581160306|FG001|Overall Study|Adverse Event|1|||
160936808|NCT01433263|581160305|FG000|Overall Study|Death|5|||
160936809|NCT01433263|581160306|FG001|Overall Study|Death|3|||
160936810|NCT01433263|581160305|FG000|Overall Study|Lost to Follow-up|0|||
160936811|NCT01433263|581160306|FG001|Overall Study|Lost to Follow-up|1|||
160936812|NCT01433263|581160305|FG000|Overall Study|Protocol Deviation|1|||
160936813|NCT01433263|581160306|FG001|Overall Study|Protocol Deviation|0|||
160936814|NCT01433263|581160305|FG000|Overall Study|Withdrawal by Subject|10|||
160936815|NCT01433263|581160306|FG001|Overall Study|Withdrawal by Subject|7|||
160936816|NCT04709237|581160308|FG000|Overall Study|Lost to Follow-up|1|||
160936817|NCT04709237|581160309|FG001|Overall Study|Lost to Follow-up|0|||
160936818|NCT04709237|581160310|FG002|Overall Study|Lost to Follow-up|0|||
160936819|NCT02610192|581160311|FG000|Overall Study|Received other treatment|8|||
160936820|NCT02610192|581160311|FG000|Overall Study|Physician Decision|1|||
160936821|NCT00640510|581160320|FG000|Overall Study|Lack of Efficacy|0|||
160936822|NCT00640510|581160321|FG001|Overall Study|Lack of Efficacy|1|||
160936823|NCT00640510|581160320|FG000|Overall Study|Protocol Violation|1|||
160936824|NCT00640510|581160321|FG001|Overall Study|Protocol Violation|0|||
160936825|NCT00640510|581160320|FG000|Overall Study|Physician Decision|0|||
160936826|NCT00640510|581160321|FG001|Overall Study|Physician Decision|1|||
160936827|NCT01440322|581160322|FG000|Overall Study|Discomfort|2|||
160936828|NCT01440322|581160323|FG001|Overall Study|Discomfort|0|||
160936829|NCT01440322|581160322|FG000|Overall Study|Biomicroscopy|1|||
160936830|NCT01440322|581160323|FG001|Overall Study|Biomicroscopy|0|||
160936831|NCT01440322|581160322|FG000|Overall Study|Symptoms and Problems|1|||
160936832|NCT01440322|581160323|FG001|Overall Study|Symptoms and Problems|0|||
160936833|NCT01440322|581160322|FG000|Overall Study|Unacceptable Subjective Vision|1|||
160936834|NCT01440322|581160323|FG001|Overall Study|Unacceptable Subjective Vision|0|||
160936835|NCT01440322|581160322|FG000|Overall Study|Other Product Related|1|||
160936836|NCT01440322|581160323|FG001|Overall Study|Other Product Related|0|||
160936837|NCT01440322|581160322|FG000|Overall Study|Unrelated Medical Problem|0|||
160936838|NCT01440322|581160323|FG001|Overall Study|Unrelated Medical Problem|1|||
160936839|NCT01440322|581160322|FG000|Overall Study|Other Non-Product Related|1|||
160936840|NCT01440322|581160323|FG001|Overall Study|Other Non-Product Related|0|||
160936841|NCT04300296|581160327|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
160936842|NCT04300296|581160328|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
160936843|NCT04300296|581160329|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
160936844|NCT04300296|581160330|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
160936845|NCT04300296|581160331|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
160936846|NCT04300296|581160332|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
160936847|NCT04300296|581160327|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
160936848|NCT04300296|581160328|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
160936849|NCT04300296|581160329|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
160936850|NCT04300296|581160330|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
160936851|NCT04300296|581160331|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
160936852|NCT04300296|581160332|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
160936853|NCT04300296|581160327|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
160936854|NCT04300296|581160328|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
160936855|NCT04300296|581160329|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
160936856|NCT04300296|581160330|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
160936857|NCT04300296|581160331|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
160936858|NCT04300296|581160332|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
160936859|NCT04300296|581160327|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
160936860|NCT04300296|581160328|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
160936861|NCT04300296|581160329|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
160936862|NCT04300296|581160330|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
160936863|NCT04300296|581160331|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
160936864|NCT04300296|581160332|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
160936865|NCT04300296|581160327|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
160936866|NCT04300296|581160328|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
160936867|NCT04300296|581160329|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
160936868|NCT04300296|581160330|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
160936869|NCT04300296|581160331|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
160936870|NCT04300296|581160332|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
160936871|NCT04300296|581160327|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
160936872|NCT04300296|581160328|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
160936873|NCT04300296|581160329|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
160936874|NCT04300296|581160330|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
160936875|NCT04300296|581160331|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
160578610|NCT00651118|579838408|FG003|Overall Study|Adverse Event|1|||
160578611|NCT00651118|579838405|FG000|Overall Study|Protocol Violation|2|||
160936876|NCT04300296|581160332|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
160936877|NCT04300296|581160327|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
160936878|NCT04300296|581160328|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
160936879|NCT04300296|581160329|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
160936880|NCT04300296|581160330|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
160936881|NCT04300296|581160331|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
160936882|NCT04300296|581160332|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
160936883|NCT05044234|581160333|FG000|Overall Study|Lost to Follow-up|2|||
160936884|NCT05044234|581160334|FG001|Overall Study|Lost to Follow-up|1|||
160936885|NCT05044234|581160335|FG002|Overall Study|Lost to Follow-up|1|||
160936886|NCT05044234|581160336|FG003|Overall Study|Lost to Follow-up|2|||
160936887|NCT05044234|581160333|FG000|Overall Study|Withdrawal by Subject|6|||
160936888|NCT05044234|581160334|FG001|Overall Study|Withdrawal by Subject|4|||
160936889|NCT05044234|581160335|FG002|Overall Study|Withdrawal by Subject|5|||
160936890|NCT05044234|581160336|FG003|Overall Study|Withdrawal by Subject|8|||
160936891|NCT05044234|581160333|FG000|Overall Study|Study terminated by Sponsor|21|||
160936892|NCT05044234|581160334|FG001|Overall Study|Study terminated by Sponsor|21|||
160936893|NCT05044234|581160335|FG002|Overall Study|Study terminated by Sponsor|20|||
160936894|NCT05044234|581160336|FG003|Overall Study|Study terminated by Sponsor|14|||
160936895|NCT05044234|581160333|FG000|Overall Study|Other, not specified|0|||
160936896|NCT05044234|581160334|FG001|Overall Study|Other, not specified|0|||
160936897|NCT05044234|581160335|FG002|Overall Study|Other, not specified|1|||
160936898|NCT05044234|581160336|FG003|Overall Study|Other, not specified|2|||
160936899|NCT05044234|581160333|FG000|Overall Study|Delayed data entry|0|||
160936900|NCT05044234|581160334|FG001|Overall Study|Delayed data entry|0|||
160936901|NCT05044234|581160335|FG002|Overall Study|Delayed data entry|0|||
160936902|NCT05044234|581160336|FG003|Overall Study|Delayed data entry|1|||
160936903|NCT00279708|581160342|FG000|Overall Study|Withdrawal by Subject|2|||
160936904|NCT00279708|581160343|FG001|Overall Study|Withdrawal by Subject|3|||
160936905|NCT00279708|581160342|FG000|Overall Study|Adverse Event|1|||
160936906|NCT00279708|581160343|FG001|Overall Study|Adverse Event|1|||
160936907|NCT02624284|581160344|FG000|Overall Study|Withdrawal by Subject|3|||
160936908|NCT02624284|581160345|FG001|Overall Study|Withdrawal by Subject|6|||
160936909|NCT02624284|581160346|FG002|Overall Study|Withdrawal by Subject|3|||
160936910|NCT02624284|581160344|FG000|Overall Study|Protocol Violation|9|||
160936911|NCT02624284|581160345|FG001|Overall Study|Protocol Violation|10|||
160936912|NCT02624284|581160346|FG002|Overall Study|Protocol Violation|7|||
160936913|NCT02624284|581160344|FG000|Overall Study|Revealed exclusionary condition|2|||
160936914|NCT02624284|581160345|FG001|Overall Study|Revealed exclusionary condition|2|||
160936915|NCT02624284|581160346|FG002|Overall Study|Revealed exclusionary condition|0|||
160936916|NCT02624284|581160344|FG000|Overall Study|Adverse Event|0|||
160936917|NCT02624284|581160345|FG001|Overall Study|Adverse Event|0|||
160936918|NCT02624284|581160346|FG002|Overall Study|Adverse Event|1|||
160936919|NCT01782313|581160347|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
160936920|NCT01782313|581160347|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
160936921|NCT01782313|581160347|FG000|Treated Cycle 3|Progressive Disease|21|||
160936922|NCT01782313|581160347|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
160936923|NCT01782313|581160347|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
160936924|NCT01782313|581160347|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
160936925|NCT01782313|581160347|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
160936926|NCT01782313|581160347|FG000|Survival Follow up|Lost to Follow-up|1|||
160936927|NCT02940691|581160348|FG000|Overall Study|Lost to Follow-up|5|||
160936928|NCT02940691|581160348|FG000|Overall Study|Incarceration|1|||
160936929|NCT00546715|581160349|FG000|Overall Study|Withdrawal by Subject|0|||
160936930|NCT00546715|581160350|FG001|Overall Study|Withdrawal by Subject|1|||
160936931|NCT00546715|581160351|FG002|Overall Study|Withdrawal by Subject|0|||
160936932|NCT00546715|581160352|FG003|Overall Study|Withdrawal by Subject|0|||
160936933|NCT00418691|581160353|FG000|Overall Study|Lost to Follow-up|1|||
160936934|NCT00418691|581160354|FG001|Overall Study|Lost to Follow-up|2|||
160936935|NCT00418691|581160355|FG002|Overall Study|Lost to Follow-up|3|||
160936936|NCT00418691|581160353|FG000|Overall Study|Started new medication voiding entry|0|||
160936937|NCT00418691|581160354|FG001|Overall Study|Started new medication voiding entry|0|||
160936938|NCT00418691|581160355|FG002|Overall Study|Started new medication voiding entry|1|||
160936939|NCT00418691|581160353|FG000|Overall Study|Progressive Disease|1|||
160936940|NCT00418691|581160354|FG001|Overall Study|Progressive Disease|0|||
160936941|NCT00418691|581160355|FG002|Overall Study|Progressive Disease|1|||
160936942|NCT02477020|581160358|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
160936943|NCT02477020|581160359|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
160936944|NCT02477020|581160358|FG000|Overall Study|Voluntary Withdrawal|7|||
160936945|NCT02477020|581160359|FG001|Overall Study|Voluntary Withdrawal|16|||
160936946|NCT02477020|581160358|FG000|Overall Study|Reason not Specified|3|||
160936947|NCT02477020|581160359|FG001|Overall Study|Reason not Specified|1|||
160936948|NCT02477020|581160358|FG000|Overall Study|Lack of Efficacy|14|||
160936949|NCT02477020|581160359|FG001|Overall Study|Lack of Efficacy|5|||
160936950|NCT01049919|581160360|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
160936951|NCT01049919|581160361|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
160936952|NCT01049919|581160360|FG000|Overall Study|Withdrawal by Subject|5|||
160936953|NCT01049919|581160361|FG001|Overall Study|Withdrawal by Subject|0|||
160936954|NCT01049919|581160360|FG000|Overall Study|Lost to Follow-up|6|||
160936955|NCT01049919|581160361|FG001|Overall Study|Lost to Follow-up|1|||
160936956|NCT01049919|581160360|FG000|Overall Study|Physician Decision|2|||
160936957|NCT01049919|581160361|FG001|Overall Study|Physician Decision|0|||
160936958|NCT01049919|581160360|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
160936959|NCT01049919|581160361|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
160936960|NCT01049919|581160360|FG000|Overall Study|Early study termination by sponsor.|2|||
160936961|NCT01049919|581160361|FG001|Overall Study|Early study termination by sponsor.|0|||
160936962|NCT02975934|581160362|FG000|Treatment Phase|Never initiated study drug|0|||
160936963|NCT02975934|581160363|FG001|Treatment Phase|Never initiated study drug|5|||
160936964|NCT02975934|581160364|FG002|Treatment Phase|Never initiated study drug|0|||
160936965|NCT03491150|581160368|FG000|Overall Study|Adverse Event|1|||
160936966|NCT03491150|581160369|FG001|Overall Study|Adverse Event|0|||
160936967|NCT03491150|581160368|FG000|Overall Study|Study Terminated by Sponsor|74|||
160936968|NCT03491150|581160369|FG001|Overall Study|Study Terminated by Sponsor|70|||
160936969|NCT03491150|581160368|FG000|Overall Study|Other|0|||
160936970|NCT03491150|581160369|FG001|Overall Study|Other|1|||
160936971|NCT03491150|581160368|FG000|Overall Study|Withdrawal by Subject|1|||
160936972|NCT03491150|581160369|FG001|Overall Study|Withdrawal by Subject|2|||
160936973|NCT00499603|581160370|FG000|Overall Study|Adverse Event|0|||
160936974|NCT00499603|581160371|FG001|Overall Study|Adverse Event|1|||
160936975|NCT00937547|581160372|FG000|Overall Study|misdiagnosis|1|||
160936976|NCT00937547|581160373|FG001|Overall Study|misdiagnosis|6|||
160936977|NCT00937547|581160374|FG002|Overall Study|misdiagnosis|7|||
160936978|NCT04439240|581160375|FG000|Overall Study|Ineligible|2|||
160936979|NCT04439240|581160375|FG000|Overall Study|Never started treatment|2|||
160936980|NCT04439240|581160375|FG000|Overall Study|Adverse Event|12|||
160936981|NCT04439240|581160375|FG000|Overall Study|Death|2|||
160936982|NCT04439240|581160375|FG000|Overall Study|Disease progression|25|||
160936983|NCT04439240|581160375|FG000|Overall Study|Other diseases|2|||
160936984|NCT04439240|581160375|FG000|Overall Study|Withdrawal by Subject|3|||
160936985|NCT04439240|581160375|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
160936986|NCT04439240|581160375|FG000|Overall Study|Symptomatic decline|1|||
160936987|NCT04439240|581160375|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
160936988|NCT04439240|581160375|FG000|Overall Study|Clinical progression|1|||
160936989|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
160936990|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
160936991|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
160936992|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
160936993|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
160936994|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
160936995|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
160936996|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
160936997|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
160936998|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
160936999|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
160937000|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
160578612|NCT00651118|579838406|FG001|Overall Study|Protocol Violation|2|||
160937001|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
160937002|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
160937003|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
160937004|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
160937005|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
160937006|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
160937007|NCT00280566|581160377|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
160937008|NCT00280566|581160378|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
160937009|NCT00280566|581160379|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
160937010|NCT00280566|581160377|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
160937011|NCT00280566|581160378|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
160937012|NCT00280566|581160379|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
160937013|NCT00280566|581160377|FG000|Period 2 Double Blind|Adverse Event|0|||
160937014|NCT00280566|581160378|FG001|Period 2 Double Blind|Adverse Event|11|||
160937015|NCT00280566|581160379|FG002|Period 2 Double Blind|Adverse Event|15|||
160937016|NCT00280566|581160377|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
160937017|NCT00280566|581160378|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
160937018|NCT00280566|581160379|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
160937019|NCT00280566|581160377|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
160578613|NCT00651118|579838407|FG002|Overall Study|Protocol Violation|6|||
160937020|NCT00280566|581160378|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
160937021|NCT00280566|581160379|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
160937022|NCT00280566|581160377|FG000|Period 2 Double Blind|miscellaneous|0|||
160937023|NCT00280566|581160378|FG001|Period 2 Double Blind|miscellaneous|10|||
160937024|NCT00280566|581160379|FG002|Period 2 Double Blind|miscellaneous|5|||
160937025|NCT01502644|581160380|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
160937026|NCT01502644|581160381|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
160937027|NCT01502644|581160382|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
160937028|NCT01502644|581160383|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
160937029|NCT01502644|581160380|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
160937030|NCT01502644|581160381|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
160937031|NCT01502644|581160382|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
160937032|NCT01502644|581160383|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
160937033|NCT01502644|581160380|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
160937034|NCT01502644|581160381|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
160937035|NCT01502644|581160382|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
160937036|NCT01502644|581160383|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
160937037|NCT01502644|581160380|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
160937038|NCT01502644|581160381|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
160937039|NCT01502644|581160382|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
160937040|NCT01502644|581160383|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
160937041|NCT01502644|581160380|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
160937042|NCT01502644|581160381|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
160937043|NCT01502644|581160382|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
160937044|NCT01502644|581160383|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
160937045|NCT04958109|581160389|FG000|Overall Study|Withdrawal by Subject|0|||
160937046|NCT04958109|581160390|FG001|Overall Study|Withdrawal by Subject|1|||
160937047|NCT04958109|581160389|FG000|Overall Study|Lost to Follow-up|0|||
160937048|NCT04958109|581160390|FG001|Overall Study|Lost to Follow-up|1|||
160937049|NCT00715793|581160391|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
160937050|NCT00715793|581160392|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
160937051|NCT00715793|581160391|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
160937052|NCT00715793|581160392|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
160937053|NCT02681302|581160393|FG000|Overall Study|Withdrawal by Subject|1|||
160937054|NCT02681302|581160394|FG001|Overall Study|Withdrawal by Subject|1|||
160937055|NCT02681302|581160395|FG002|Overall Study|Withdrawal by Subject|0|||
160937056|NCT02681302|581160396|FG003|Overall Study|Withdrawal by Subject|0|||
160937057|NCT02681302|581160397|FG004|Overall Study|Withdrawal by Subject|1|||
160937058|NCT02681302|581160398|FG005|Overall Study|Withdrawal by Subject|0|||
160937059|NCT02681302|581160393|FG000|Overall Study|Screen Failure|2|||
160937060|NCT02681302|581160394|FG001|Overall Study|Screen Failure|4|||
160937061|NCT02681302|581160395|FG002|Overall Study|Screen Failure|2|||
160937062|NCT02681302|581160396|FG003|Overall Study|Screen Failure|0|||
160937063|NCT02681302|581160397|FG004|Overall Study|Screen Failure|1|||
160937064|NCT02681302|581160398|FG005|Overall Study|Screen Failure|1|||
160937065|NCT02681302|581160393|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
160937066|NCT02681302|581160394|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
160937067|NCT02681302|581160395|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
160937068|NCT02681302|581160396|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
160937069|NCT02681302|581160397|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
160937070|NCT02681302|581160398|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
160937071|NCT04399161|581160399|FG000|Overall Study|Withdrawal by Subject|1|||
160937072|NCT04399161|581160400|FG001|Overall Study|Withdrawal by Subject|0|||
160937073|NCT04399161|581160401|FG002|Overall Study|Withdrawal by Subject|2|||
160937074|NCT04399161|581160399|FG000|Overall Study|Protocol Violation|1|||
160937075|NCT04399161|581160400|FG001|Overall Study|Protocol Violation|2|||
160937076|NCT04399161|581160401|FG002|Overall Study|Protocol Violation|0|||
160937077|NCT03417141|581160402|FG000|Overall Study|Withdrawal by Subject|1|||
160937078|NCT03417141|581160402|FG000|Overall Study|Protocol Violation|3|||
160937079|NCT03571516|581160403|FG000|Overall Study|Severe diarrhea|1|||
160937080|NCT03571516|581160404|FG001|Overall Study|Severe diarrhea|0|||
160937081|NCT03571516|581160403|FG000|Overall Study|Withdrawal by Subject|0|||
160937082|NCT03571516|581160404|FG001|Overall Study|Withdrawal by Subject|1|||
160937083|NCT00613509|581160408|FG000|Cycle 1|Adverse Event|2|||
160937084|NCT00613509|581160409|FG001|Cycle 1|Adverse Event|1|||
160937085|NCT00613509|581160408|FG000|Cycle 1|Disease Progression|2|||
160937086|NCT00613509|581160409|FG001|Cycle 1|Disease Progression|6|||
160937087|NCT00613509|581160408|FG000|Cycle 1|Unacceptable Toxicity|1|||
160578614|NCT00651118|579838408|FG003|Overall Study|Protocol Violation|2|||
160578615|NCT00651118|579838405|FG000|Overall Study|Lost to Follow-up|2|||
160578616|NCT00651118|579838406|FG001|Overall Study|Lost to Follow-up|0|||
160578617|NCT00651118|579838407|FG002|Overall Study|Lost to Follow-up|1|||
160937088|NCT00613509|581160409|FG001|Cycle 1|Unacceptable Toxicity|0|||
160578618|NCT00651118|579838408|FG003|Overall Study|Lost to Follow-up|2|||
160937089|NCT00613509|581160408|FG000|Cycle 1|Other administrative reason|0|||
160937090|NCT00613509|581160409|FG001|Cycle 1|Other administrative reason|1|||
160937091|NCT03465878|581160416|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
160937092|NCT03465878|581160417|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
160937093|NCT03465878|581160418|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
160937094|NCT03465878|581160419|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
160937095|NCT03465878|581160416|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
160937096|NCT03465878|581160417|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
160937097|NCT03465878|581160418|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
160937098|NCT03465878|581160419|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
160937099|NCT03465878|581160416|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
160937100|NCT03465878|581160417|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
160937101|NCT03465878|581160418|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
160937102|NCT03465878|581160419|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
160937103|NCT02540954|581160420|FG000|Overall Study|Physician Decision|3|||
160937104|NCT02540954|581160421|FG001|Overall Study|Physician Decision|1|||
160937105|NCT02540954|581160420|FG000|Overall Study|Withdrawal by Subject|6|||
160937106|NCT02540954|581160421|FG001|Overall Study|Withdrawal by Subject|5|||
160937107|NCT02540954|581160420|FG000|Overall Study|Lost to Follow-up|1|||
160937108|NCT02540954|581160421|FG001|Overall Study|Lost to Follow-up|1|||
160937109|NCT02540954|581160420|FG000|Overall Study|Adverse Event|4|||
160937110|NCT02540954|581160421|FG001|Overall Study|Adverse Event|2|||
160937111|NCT02540954|581160420|FG000|Overall Study|Death|0|||
160937112|NCT02540954|581160421|FG001|Overall Study|Death|3|||
160937113|NCT02540954|581160420|FG000|Overall Study|Treatment failure|1|||
160937114|NCT02540954|581160421|FG001|Overall Study|Treatment failure|0|||
160937115|NCT02540954|581160420|FG000|Overall Study|Other reason|4|||
160937116|NCT02540954|581160421|FG001|Overall Study|Other reason|2|||
160937117|NCT01723228|581160425|FG000|Overall Study|Adverse Event|2|||
160937118|NCT01723228|581160426|FG001|Overall Study|Adverse Event|6|||
160937119|NCT01723228|581160425|FG000|Overall Study|Withdrawal by Subject|2|||
160937120|NCT01723228|581160426|FG001|Overall Study|Withdrawal by Subject|1|||
160937121|NCT01723228|581160425|FG000|Overall Study|Protocol Violation|0|||
160937122|NCT01723228|581160426|FG001|Overall Study|Protocol Violation|2|||
160937123|NCT01723228|581160425|FG000|Overall Study|Lost to Follow-up|2|||
160937124|NCT01723228|581160426|FG001|Overall Study|Lost to Follow-up|1|||
160937125|NCT01723228|581160425|FG000|Overall Study|Other|2|||
160937126|NCT01723228|581160426|FG001|Overall Study|Other|1|||
160937127|NCT01282216|581160427|FG000|Overall Study|Graft failure|0|||
160937128|NCT01282216|581160428|FG001|Overall Study|Graft failure|0|||
160937129|NCT01282216|581160429|FG002|Overall Study|Graft failure|3|||
160937130|NCT01282216|581160430|FG003|Overall Study|Graft failure|2|||
160937131|NCT01282216|581160427|FG000|Overall Study|Physician Decision|0|||
160937132|NCT01282216|581160428|FG001|Overall Study|Physician Decision|0|||
160937133|NCT01282216|581160429|FG002|Overall Study|Physician Decision|11|||
160937134|NCT01282216|581160430|FG003|Overall Study|Physician Decision|0|||
160937135|NCT01282216|581160427|FG000|Overall Study|Relapse|0|||
160937136|NCT01282216|581160428|FG001|Overall Study|Relapse|0|||
160937137|NCT01282216|581160429|FG002|Overall Study|Relapse|17|||
160937138|NCT01282216|581160430|FG003|Overall Study|Relapse|6|||
160937139|NCT01282216|581160427|FG000|Overall Study|Death|0|||
160937140|NCT01282216|581160428|FG001|Overall Study|Death|0|||
160937141|NCT01282216|581160429|FG002|Overall Study|Death|2|||
160937142|NCT01282216|581160430|FG003|Overall Study|Death|0|||
160937143|NCT01806896|581160431|FG000|Overall Study|Adverse Event|2|||
160937144|NCT01806896|581160432|FG001|Overall Study|Adverse Event|0|||
160937145|NCT01806896|581160431|FG000|Overall Study|Other|1|||
160937146|NCT01806896|581160432|FG001|Overall Study|Other|0|||
160937147|NCT01864291|581160433|FG000|Overall Study|need for revision surgery|2|||
160937148|NCT02448875|581160434|FG000|Overall Study|Adverse Event|2|||
160937149|NCT02448875|581160435|FG001|Overall Study|Adverse Event|1|||
160937150|NCT02448875|581160436|FG002|Overall Study|Adverse Event|0|||
160937151|NCT02448875|581160434|FG000|Overall Study|Lost to Follow-up|1|||
160937152|NCT02448875|581160435|FG001|Overall Study|Lost to Follow-up|0|||
160937153|NCT02448875|581160436|FG002|Overall Study|Lost to Follow-up|0|||
160937154|NCT02448875|581160434|FG000|Overall Study|Investigator Decision|3|||
160937155|NCT02448875|581160435|FG001|Overall Study|Investigator Decision|0|||
160937156|NCT02448875|581160436|FG002|Overall Study|Investigator Decision|1|||
160937157|NCT02448875|581160434|FG000|Overall Study|Withdrawal by Subject|1|||
160937158|NCT02448875|581160435|FG001|Overall Study|Withdrawal by Subject|0|||
160937159|NCT02448875|581160436|FG002|Overall Study|Withdrawal by Subject|0|||
160937160|NCT02434770|581160438|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
160937161|NCT02434770|581160439|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
160937162|NCT02434770|581160440|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
160937163|NCT02434770|581160438|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
160937164|NCT02434770|581160439|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
160937165|NCT02434770|581160440|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
160937166|NCT02434770|581160438|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
160937167|NCT02434770|581160439|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
160937168|NCT02434770|581160440|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
160937169|NCT02434770|581160438|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
160937170|NCT02434770|581160439|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
160937171|NCT02434770|581160440|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
160937172|NCT02434770|581160438|FG000|Week 1 to Week 18|Death|1|||
160937173|NCT02434770|581160439|FG001|Week 1 to Week 18|Death|0|||
160937174|NCT02434770|581160440|FG002|Week 1 to Week 18|Death|0|||
160937175|NCT02434770|581160438|FG000|Week 18 to Week|Lost to Follow-up|2|||
160937176|NCT02434770|581160439|FG001|Week 18 to Week|Lost to Follow-up|2|||
160937177|NCT02434770|581160440|FG002|Week 18 to Week|Lost to Follow-up|1|||
160937178|NCT02434770|581160438|FG000|Week 18 to Week|Withdrawal by Subject|0|||
160937179|NCT02434770|581160439|FG001|Week 18 to Week|Withdrawal by Subject|0|||
160937180|NCT02434770|581160440|FG002|Week 18 to Week|Withdrawal by Subject|2|||
160937181|NCT02434770|581160438|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
160937182|NCT02434770|581160439|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
160937183|NCT02434770|581160440|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
160937184|NCT00245765|581160441|FG000|Overall Study|Adverse Event|1|||
160937185|NCT00245765|581160442|FG001|Overall Study|Adverse Event|1|||
160937186|NCT00245765|581160443|FG002|Overall Study|Adverse Event|0|||
160937187|NCT00245765|581160441|FG000|Overall Study|Lack of Efficacy|14|||
160937188|NCT00245765|581160442|FG001|Overall Study|Lack of Efficacy|7|||
160937189|NCT00245765|581160443|FG002|Overall Study|Lack of Efficacy|0|||
160937190|NCT00245765|581160441|FG000|Overall Study|Lost to Follow-up|1|||
160937191|NCT00245765|581160442|FG001|Overall Study|Lost to Follow-up|2|||
160937192|NCT00245765|581160443|FG002|Overall Study|Lost to Follow-up|0|||
160937193|NCT00245765|581160441|FG000|Overall Study|Withdrawal by Subject|1|||
160937194|NCT00245765|581160442|FG001|Overall Study|Withdrawal by Subject|0|||
160937195|NCT00245765|581160443|FG002|Overall Study|Withdrawal by Subject|3|||
160937196|NCT00245765|581160441|FG000|Overall Study|Other reason|2|||
160937197|NCT00245765|581160442|FG001|Overall Study|Other reason|0|||
160937198|NCT00245765|581160443|FG002|Overall Study|Other reason|1|||
160937199|NCT00245765|581160441|FG000|Overall Study|Other|13|||
160937200|NCT00245765|581160442|FG001|Overall Study|Other|4|||
160937201|NCT00245765|581160443|FG002|Overall Study|Other|4|||
160937202|NCT01282424|581160449|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
160937203|NCT01282424|581160449|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
160937204|NCT01282424|581160449|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
160937205|NCT01282424|581160449|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
160937206|NCT01282424|581160449|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
160937207|NCT01282424|581160449|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
160937208|NCT01282424|581160449|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
160937209|NCT01282424|581160449|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
160937210|NCT06425458|581160450|FG000|Overall Study|Removed by study team|2|||
160937211|NCT06425458|581160450|FG000|Overall Study|Lost to Follow-up|5|||
160937212|NCT02777125|581160454|FG000|Overall Study|Consent form violation|14|||
160937213|NCT02777125|581160455|FG001|Overall Study|Consent form violation|12|||
160937214|NCT02777125|581160454|FG000|Overall Study|Assent form violation|21|||
160937215|NCT02777125|581160455|FG001|Overall Study|Assent form violation|23|||
160937216|NCT02777125|581160454|FG000|Overall Study|Protocol Violation|8|||
160937217|NCT02777125|581160455|FG001|Overall Study|Protocol Violation|12|||
160937218|NCT02742103|581161765|FG000|Overall Study|Protocol Violation|1|||
160937219|NCT02742103|581161766|FG001|Overall Study|Protocol Violation|0|||
160937220|NCT02742103|581161765|FG000|Overall Study|Death|2|||
160937221|NCT02742103|581161766|FG001|Overall Study|Death|2|||
160937222|NCT02742103|581161765|FG000|Overall Study|Adverse Event|1|||
160937223|NCT02742103|581161766|FG001|Overall Study|Adverse Event|0|||
160937224|NCT02742103|581161765|FG000|Overall Study|Moved to another town|0|||
160455260|NCT03523572|579397887|FG001|Dose Expansion|Adverse Event|0|||
160937225|NCT02742103|581161766|FG001|Overall Study|Moved to another town|1|||
160937226|NCT02742103|581161765|FG000|Overall Study|Withdrawal by Subject|5|||
160937227|NCT02742103|581161766|FG001|Overall Study|Withdrawal by Subject|2|||
160937228|NCT00533949|581161771|FG000|Overall Study|Protocol Violation|12|||
160937229|NCT00533949|581161772|FG001|Overall Study|Protocol Violation|12|||
160937230|NCT00533949|581161773|FG002|Overall Study|Protocol Violation|9|||
160937231|NCT00533949|581161774|FG003|Overall Study|Protocol Violation|9|||
160937232|NCT00533949|581161771|FG000|Overall Study|Withdrawal by Subject|3|||
160937233|NCT00533949|581161772|FG001|Overall Study|Withdrawal by Subject|2|||
160937234|NCT00533949|581161773|FG002|Overall Study|Withdrawal by Subject|1|||
160578619|NCT00651118|579838405|FG000|Overall Study|administrative|1|||
160937235|NCT00533949|581161774|FG003|Overall Study|Withdrawal by Subject|1|||
160937236|NCT00727194|581161775|FG000|Screening Period|Low QMG scores|0|||
160937237|NCT00727194|581161776|FG001|Screening Period|Low QMG scores|0|||
160937238|NCT00727194|581161777|FG002|Screening Period|Low QMG scores|6|||
160937239|NCT00727194|581161775|FG000|Screening Period|Lacked AChR antibodies|0|||
160937240|NCT00727194|581161776|FG001|Screening Period|Lacked AChR antibodies|0|||
160937241|NCT00727194|581161777|FG002|Screening Period|Lacked AChR antibodies|5|||
160937242|NCT00727194|581161775|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
160937243|NCT00727194|581161776|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
160937244|NCT00727194|581161777|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
160937245|NCT00727194|581161775|FG000|Screening Period|Severe infections|0|||
160937246|NCT00727194|581161776|FG001|Screening Period|Severe infections|0|||
160937247|NCT00727194|581161777|FG002|Screening Period|Severe infections|2|||
160937248|NCT00727194|581161775|FG000|Screening Period|History of thymoma|0|||
160937249|NCT00727194|581161776|FG001|Screening Period|History of thymoma|0|||
160937250|NCT00727194|581161777|FG002|Screening Period|History of thymoma|1|||
160937251|NCT00727194|581161775|FG000|Treatment Period 2|Lack of Efficacy|0|||
160937252|NCT00727194|581161776|FG001|Treatment Period 2|Lack of Efficacy|1|||
160937253|NCT00727194|581161777|FG002|Treatment Period 2|Lack of Efficacy|0|||
160937254|NCT02649972|581161784|FG000|Overall Study|Not treated|1|||
160937255|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Adverse Event|9|||
160937256|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Adverse Event|2|||
160937257|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
160937258|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
160937259|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
160937260|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
160937261|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Physician Decision|1|||
160937262|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Physician Decision|1|||
160937263|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Pregnancy|2|||
160937264|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Pregnancy|0|||
160937265|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
160937266|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
160937267|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Technical problems|1|||
160937268|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Technical problems|0|||
160937269|NCT02896127|581161787|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
160937270|NCT02896127|581161788|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
160937271|NCT02896127|581161787|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
160937272|NCT02896127|581161788|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
160937273|NCT02896127|581161787|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
160937274|NCT02896127|581161788|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
160937275|NCT02896127|581161787|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
160937276|NCT02896127|581161788|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
160937277|NCT02896127|581161787|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
160937278|NCT02896127|581161788|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
160937279|NCT00958776|581161789|FG000|Overall Study|Adverse Event|0|||
160937280|NCT00958776|581161790|FG001|Overall Study|Adverse Event|1|||
160937281|NCT00958776|581161789|FG000|Overall Study|Physician Decision|1|||
160937282|NCT00958776|581161790|FG001|Overall Study|Physician Decision|0|||
160937283|NCT00958776|581161789|FG000|Overall Study|Lost to Follow-up|2|||
160937284|NCT00958776|581161790|FG001|Overall Study|Lost to Follow-up|6|||
160937285|NCT00958776|581161789|FG000|Overall Study|Withdrawal by Subject|7|||
160937286|NCT00958776|581161790|FG001|Overall Study|Withdrawal by Subject|16|||
160937287|NCT00958776|581161789|FG000|Overall Study|Protocol Violation|1|||
160937288|NCT00958776|581161790|FG001|Overall Study|Protocol Violation|1|||
160937289|NCT00958776|581161789|FG000|Overall Study|Death|2|||
160937290|NCT00958776|581161790|FG001|Overall Study|Death|1|||
160937291|NCT00958776|581161789|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
160937292|NCT00958776|581161790|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
160937293|NCT00958776|581161789|FG000|Overall Study|Missing|1|||
160937294|NCT00958776|581161790|FG001|Overall Study|Missing|1|||
160937295|NCT02506816|581161797|FG000|Overall Study|Adverse Event|3|||
160937296|NCT00501540|581161804|FG000|Overall Study|Death|5|||
160937297|NCT02331446|581161805|FG000|Overall Study|Lost to Follow-up|2|||
160937298|NCT02331446|581161806|FG001|Overall Study|Lost to Follow-up|1|||
160937299|NCT02331446|581161807|FG002|Overall Study|Lost to Follow-up|0|||
160937300|NCT02331446|581161808|FG003|Overall Study|Lost to Follow-up|1|||
160937301|NCT02331446|581161805|FG000|Overall Study|Personal Problem|2|||
160937302|NCT02331446|581161806|FG001|Overall Study|Personal Problem|0|||
160937303|NCT02331446|581161807|FG002|Overall Study|Personal Problem|0|||
160937304|NCT02331446|581161808|FG003|Overall Study|Personal Problem|0|||
160937305|NCT02331446|581161805|FG000|Overall Study|Disease|0|||
160937306|NCT02331446|581161806|FG001|Overall Study|Disease|2|||
160937307|NCT02331446|581161807|FG002|Overall Study|Disease|2|||
160937308|NCT02331446|581161808|FG003|Overall Study|Disease|1|||
160937309|NCT02331446|581161805|FG000|Overall Study|Physician Decision|0|||
160937310|NCT02331446|581161806|FG001|Overall Study|Physician Decision|1|||
160998591|NCT00770965|581380586|FG003|Excluded Set|Administrative problems|10|||
160937311|NCT02331446|581161807|FG002|Overall Study|Physician Decision|0|||
160937312|NCT02331446|581161808|FG003|Overall Study|Physician Decision|1|||
160937313|NCT02331446|581161805|FG000|Overall Study|Lost before baseline analysis|0|||
160937314|NCT02331446|581161806|FG001|Overall Study|Lost before baseline analysis|1|||
160937315|NCT02331446|581161807|FG002|Overall Study|Lost before baseline analysis|1|||
160998592|NCT00770965|581380583|FG000|Excluded Set|Withdrawal by Subject|1|||
160998593|NCT00770965|581380584|FG001|Excluded Set|Withdrawal by Subject|1|||
160998594|NCT00770965|581380585|FG002|Excluded Set|Withdrawal by Subject|2|||
160998595|NCT00770965|581380586|FG003|Excluded Set|Withdrawal by Subject|3|||
160998596|NCT02371746|581380587|FG000|Overall Study|Consent withdrawn|0|||
160998597|NCT02371746|581380588|FG001|Overall Study|Consent withdrawn|0|||
160998598|NCT02371746|581380589|FG002|Overall Study|Consent withdrawn|0|||
160998599|NCT02371746|581380590|FG003|Overall Study|Consent withdrawn|0|||
160998600|NCT02371746|581380591|FG004|Overall Study|Consent withdrawn|0|||
160937316|NCT02331446|581161808|FG003|Overall Study|Lost before baseline analysis|0|||
160578620|NCT00651118|579838406|FG001|Overall Study|administrative|4|||
160937317|NCT02984995|581161809|FG000|Overall Study|Required stem cell transplant|13|||
160937318|NCT02984995|581161810|FG001|Overall Study|Required stem cell transplant|2|||
160937319|NCT02984995|581161809|FG000|Overall Study|Progressive disease|11|||
160937320|NCT02984995|581161810|FG001|Overall Study|Progressive disease|1|||
160937321|NCT02984995|581161809|FG000|Overall Study|Adverse Event|1|||
160937322|NCT02984995|581161810|FG001|Overall Study|Adverse Event|0|||
160937323|NCT04354831|581161811|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
160937324|NCT04354831|581161812|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
160937325|NCT00812929|581161813|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
160937326|NCT00812929|581161814|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
160937327|NCT00812929|581161815|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
160937328|NCT00812929|581161816|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
160937329|NCT00812929|581161817|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
160937330|NCT00812929|581161818|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
160937331|NCT00812929|581161819|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
160937332|NCT00812929|581161820|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
160937333|NCT00812929|581161821|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
160937334|NCT00812929|581161822|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
160937335|NCT00812929|581161813|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
160937336|NCT00812929|581161814|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
160937337|NCT00812929|581161815|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
160937338|NCT00812929|581161816|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
160937339|NCT00812929|581161817|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
160937340|NCT00812929|581161818|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
160937341|NCT00812929|581161819|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
160937342|NCT00812929|581161820|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
160937343|NCT00812929|581161821|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
160937344|NCT00812929|581161822|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
160937345|NCT00812929|581161813|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
160937346|NCT00812929|581161814|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
160937347|NCT00812929|581161815|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
160937348|NCT00812929|581161816|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
160937349|NCT00812929|581161817|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
160937350|NCT00812929|581161818|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
160937351|NCT00812929|581161819|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
160937352|NCT00812929|581161820|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
160937353|NCT00812929|581161821|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
160937354|NCT00812929|581161822|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
160937355|NCT02504372|581161824|FG000|Overall Study|Death|136|||
160998601|NCT02371746|581380592|FG005|Overall Study|Consent withdrawn|0|||
160998602|NCT02371746|581380593|FG006|Overall Study|Consent withdrawn|1|||
160998603|NCT00612586|581380594|FG000|Overall Study|Adverse Event|6|||
160578621|NCT00651118|579838407|FG002|Overall Study|administrative|2|||
160578622|NCT00651118|579838408|FG003|Overall Study|administrative|1|||
160578623|NCT00651118|579838405|FG000|Overall Study|Withdrawal by Subject|0|||
160578624|NCT00651118|579838406|FG001|Overall Study|Withdrawal by Subject|1|||
160578625|NCT00651118|579838407|FG002|Overall Study|Withdrawal by Subject|1|||
160937356|NCT02504372|581161825|FG001|Overall Study|Death|154|||
160937357|NCT02504372|581161824|FG000|Overall Study|Lost to Follow-up|0|||
160937358|NCT02504372|581161825|FG001|Overall Study|Lost to Follow-up|2|||
160937359|NCT02504372|581161824|FG000|Overall Study|Withdrawal of consent|25|||
160937360|NCT02504372|581161825|FG001|Overall Study|Withdrawal of consent|16|||
160937361|NCT02504372|581161824|FG000|Overall Study|Participants ongoing|429|||
160937362|NCT02504372|581161825|FG001|Overall Study|Participants ongoing|415|||
160998604|NCT00612586|581380595|FG001|Overall Study|Adverse Event|2|||
160998605|NCT00612586|581380594|FG000|Overall Study|Death|1|||
160998606|NCT00612586|581380595|FG001|Overall Study|Death|0|||
160998607|NCT00612586|581380594|FG000|Overall Study|Entry Criteria Not Met|0|||
160998608|NCT00612586|581380595|FG001|Overall Study|Entry Criteria Not Met|2|||
160578626|NCT00651118|579838408|FG003|Overall Study|Withdrawal by Subject|1|||
160578627|NCT00839098|579838409|FG000|Overall Study|Withdrawal by Subject|2|||
160578628|NCT00839098|579838410|FG001|Overall Study|Withdrawal by Subject|1|||
160578629|NCT00839098|579838411|FG002|Overall Study|Withdrawal by Subject|7|||
160578630|NCT02190435|579838412|FG000|Overall Study|First 12 patients were lead-ins|12|||
160937363|NCT00433654|581161826|FG000|Overall Study|Death|4|||
160937364|NCT00433654|581161827|FG001|Overall Study|Death|0|||
160937365|NCT00433654|581161826|FG000|Overall Study|Missed visit|6|||
160937366|NCT00433654|581161827|FG001|Overall Study|Missed visit|3|||
160937367|NCT00433654|581161826|FG000|Overall Study|Subject not yet due for visit|4|||
160937368|NCT00433654|581161827|FG001|Overall Study|Subject not yet due for visit|0|||
160937369|NCT00433654|581161826|FG000|Overall Study|Withdrawal by Subject|1|||
160937370|NCT00433654|581161827|FG001|Overall Study|Withdrawal by Subject|2|||
160937371|NCT01428193|581161851|FG000|Overall Study|Physician Decision|1|||
160937372|NCT01428193|581161851|FG000|Overall Study|Elevated screening liver enzymes|1|||
160937373|NCT00357370|581161854|FG000|Cohort 2|Lack of Efficacy|0|||
160937374|NCT00357370|581161855|FG001|Cohort 2|Lack of Efficacy|2|||
160937375|NCT00357370|581161856|FG002|Cohort 2|Lack of Efficacy|1|||
160937376|NCT00357370|581161854|FG000|Cohort 2|Adverse Event|1|||
160937377|NCT00357370|581161855|FG001|Cohort 2|Adverse Event|1|||
160937378|NCT00357370|581161856|FG002|Cohort 2|Adverse Event|1|||
160937379|NCT00357370|581161854|FG000|Cohort 2|Lost to Follow-up|0|||
160937380|NCT00357370|581161855|FG001|Cohort 2|Lost to Follow-up|1|||
160937381|NCT00357370|581161856|FG002|Cohort 2|Lost to Follow-up|0|||
160937382|NCT00357370|581161854|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
160937383|NCT00357370|581161855|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
160937384|NCT00357370|581161856|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
160937385|NCT00357370|581161854|FG000|Cohort 2|Withdrawal by Subject|0|||
160937386|NCT00357370|581161855|FG001|Cohort 2|Withdrawal by Subject|2|||
160937387|NCT00357370|581161856|FG002|Cohort 2|Withdrawal by Subject|0|||
160937388|NCT00079274|581161857|FG000|Overall Study|Withdrawal by Subject|111|||
160937389|NCT00079274|581161858|FG001|Overall Study|Withdrawal by Subject|10|||
160937390|NCT00079274|581161859|FG002|Overall Study|Withdrawal by Subject|12|||
160937391|NCT00079274|581161860|FG003|Overall Study|Withdrawal by Subject|163|||
160937392|NCT00079274|581161861|FG004|Overall Study|Withdrawal by Subject|7|||
160937393|NCT00079274|581161862|FG005|Overall Study|Withdrawal by Subject|8|||
160937394|NCT00079274|581161863|FG006|Overall Study|Withdrawal by Subject|0|||
160937395|NCT00079274|581161857|FG000|Overall Study|Adverse Event|130|||
160937396|NCT00079274|581161858|FG001|Overall Study|Adverse Event|8|||
160937397|NCT00079274|581161859|FG002|Overall Study|Adverse Event|8|||
160937398|NCT00079274|581161860|FG003|Overall Study|Adverse Event|184|||
160937399|NCT00079274|581161861|FG004|Overall Study|Adverse Event|7|||
160937400|NCT00079274|581161862|FG005|Overall Study|Adverse Event|8|||
160937401|NCT00079274|581161863|FG006|Overall Study|Adverse Event|0|||
160937402|NCT00079274|581161857|FG000|Overall Study|Recurrence|21|||
160937403|NCT00079274|581161858|FG001|Overall Study|Recurrence|0|||
160937404|NCT00079274|581161859|FG002|Overall Study|Recurrence|1|||
160937405|NCT00079274|581161860|FG003|Overall Study|Recurrence|15|||
160937406|NCT00079274|581161861|FG004|Overall Study|Recurrence|0|||
160937407|NCT00079274|581161862|FG005|Overall Study|Recurrence|2|||
160937408|NCT00079274|581161863|FG006|Overall Study|Recurrence|0|||
160937409|NCT00079274|581161857|FG000|Overall Study|Alternate Treatment|6|||
160937410|NCT00079274|581161858|FG001|Overall Study|Alternate Treatment|1|||
160937411|NCT00079274|581161859|FG002|Overall Study|Alternate Treatment|0|||
160937412|NCT00079274|581161860|FG003|Overall Study|Alternate Treatment|3|||
160937413|NCT00079274|581161861|FG004|Overall Study|Alternate Treatment|0|||
160937414|NCT00079274|581161862|FG005|Overall Study|Alternate Treatment|0|||
160937415|NCT00079274|581161863|FG006|Overall Study|Alternate Treatment|0|||
160937416|NCT00079274|581161857|FG000|Overall Study|Other Medical Problems|6|||
160937417|NCT00079274|581161858|FG001|Overall Study|Other Medical Problems|1|||
160937418|NCT00079274|581161859|FG002|Overall Study|Other Medical Problems|0|||
160937419|NCT00079274|581161860|FG003|Overall Study|Other Medical Problems|7|||
160937420|NCT00079274|581161861|FG004|Overall Study|Other Medical Problems|0|||
160937421|NCT00079274|581161862|FG005|Overall Study|Other Medical Problems|0|||
160937422|NCT00079274|581161863|FG006|Overall Study|Other Medical Problems|0|||
160937423|NCT00079274|581161857|FG000|Overall Study|Death|4|||
160937424|NCT00079274|581161858|FG001|Overall Study|Death|0|||
160937425|NCT00079274|581161859|FG002|Overall Study|Death|1|||
160937426|NCT00079274|581161860|FG003|Overall Study|Death|15|||
160937427|NCT00079274|581161861|FG004|Overall Study|Death|0|||
160937428|NCT00079274|581161862|FG005|Overall Study|Death|0|||
160937429|NCT00079274|581161863|FG006|Overall Study|Death|0|||
160937430|NCT00079274|581161857|FG000|Overall Study|Cytogenetic resistance|0|||
160937431|NCT00079274|581161858|FG001|Overall Study|Cytogenetic resistance|0|||
160937432|NCT00079274|581161859|FG002|Overall Study|Cytogenetic resistance|0|||
160937433|NCT00079274|581161860|FG003|Overall Study|Cytogenetic resistance|2|||
160937434|NCT00079274|581161861|FG004|Overall Study|Cytogenetic resistance|0|||
160937435|NCT00079274|581161862|FG005|Overall Study|Cytogenetic resistance|0|||
160937436|NCT00079274|581161863|FG006|Overall Study|Cytogenetic resistance|0|||
160937437|NCT00079274|581161857|FG000|Overall Study|Other|43|||
160937438|NCT00079274|581161858|FG001|Overall Study|Other|7|||
160937439|NCT00079274|581161859|FG002|Overall Study|Other|5|||
160937440|NCT00079274|581161860|FG003|Overall Study|Other|55|||
160937441|NCT00079274|581161861|FG004|Overall Study|Other|1|||
160937442|NCT00079274|581161862|FG005|Overall Study|Other|2|||
160937443|NCT00079274|581161863|FG006|Overall Study|Other|0|||
160937444|NCT01302392|581161864|FG000|Overall Study|Lost to Follow-up|1|||
160937445|NCT01302392|581161865|FG001|Overall Study|Lost to Follow-up|0|||
160937446|NCT01302392|581161864|FG000|Overall Study|Withdrawal by Subject|6|||
160937447|NCT01302392|581161865|FG001|Overall Study|Withdrawal by Subject|1|||
160937448|NCT00670228|581161866|FG000|Overall Study|Adverse Event|1|||
160937449|NCT00670228|581161867|FG001|Overall Study|Adverse Event|0|||
160937450|NCT00670228|581161866|FG000|Overall Study|Death or MACE|0|||
160937451|NCT00670228|581161867|FG001|Overall Study|Death or MACE|1|||
160937452|NCT00670228|581161866|FG000|Overall Study|Not treated|2|||
160937453|NCT00670228|581161867|FG001|Overall Study|Not treated|2|||
160937454|NCT00670228|581161866|FG000|Overall Study|Not meeting the selection criteria|2|||
160937455|NCT00670228|581161867|FG001|Overall Study|Not meeting the selection criteria|0|||
160937456|NCT03604692|581161871|FG000|Overall Study|Investigator's Decision|0|||
160937457|NCT03604692|581161872|FG001|Overall Study|Investigator's Decision|0|||
160937458|NCT03604692|581161873|FG002|Overall Study|Investigator's Decision|0|||
160937459|NCT03604692|581161874|FG003|Overall Study|Investigator's Decision|1|||
160937460|NCT03604692|581161875|FG004|Overall Study|Investigator's Decision|0|||
160937461|NCT03604692|581161876|FG005|Overall Study|Investigator's Decision|7|||
160937462|NCT03604692|581161871|FG000|Overall Study|Withdrawal by Subject|0|||
160937463|NCT03604692|581161872|FG001|Overall Study|Withdrawal by Subject|0|||
160937464|NCT03604692|581161873|FG002|Overall Study|Withdrawal by Subject|0|||
160937465|NCT03604692|581161874|FG003|Overall Study|Withdrawal by Subject|0|||
160937466|NCT03604692|581161875|FG004|Overall Study|Withdrawal by Subject|0|||
160937467|NCT03604692|581161876|FG005|Overall Study|Withdrawal by Subject|2|||
160937468|NCT03604692|581161871|FG000|Overall Study|Progressive Disease|1|||
160655960|NCT00661999|580120319|FG001|Overall Study|Alternative Treatment|0|||
160655961|NCT00661999|580120320|FG002|Overall Study|Alternative Treatment|0|||
160655962|NCT00661999|580120318|FG000|Overall Study|Other Medical Problems|4|||
160655963|NCT00661999|580120319|FG001|Overall Study|Other Medical Problems|4|||
160937469|NCT03604692|581161872|FG001|Overall Study|Progressive Disease|0|||
160937470|NCT03604692|581161873|FG002|Overall Study|Progressive Disease|1|||
160937471|NCT03604692|581161874|FG003|Overall Study|Progressive Disease|0|||
160937472|NCT03604692|581161875|FG004|Overall Study|Progressive Disease|3|||
160937473|NCT03604692|581161876|FG005|Overall Study|Progressive Disease|4|||
160937474|NCT03604692|581161871|FG000|Overall Study|Difficulty Coming into Site|0|||
160937475|NCT03604692|581161872|FG001|Overall Study|Difficulty Coming into Site|0|||
160937476|NCT03604692|581161873|FG002|Overall Study|Difficulty Coming into Site|0|||
160937477|NCT03604692|581161874|FG003|Overall Study|Difficulty Coming into Site|0|||
160937478|NCT03604692|581161875|FG004|Overall Study|Difficulty Coming into Site|0|||
160937479|NCT03604692|581161876|FG005|Overall Study|Difficulty Coming into Site|1|||
160937480|NCT03604692|581161871|FG000|Overall Study|Death|0|||
160937481|NCT03604692|581161872|FG001|Overall Study|Death|0|||
160937482|NCT03604692|581161873|FG002|Overall Study|Death|1|||
160937483|NCT03604692|581161874|FG003|Overall Study|Death|0|||
160455261|NCT03523572|579397888|FG002|Dose Expansion|Adverse Event|10|||
160455262|NCT03523572|579397889|FG003|Dose Expansion|Adverse Event|1|||
160455263|NCT03523572|579397890|FG004|Dose Expansion|Adverse Event|5|||
160455264|NCT03523572|579397891|FG005|Dose Expansion|Adverse Event|2|||
160455265|NCT03523572|579397886|FG000|Dose Expansion|Withdrawal by Subject|0|||
160455266|NCT03523572|579397887|FG001|Dose Expansion|Withdrawal by Subject|0|||
160455267|NCT03523572|579397888|FG002|Dose Expansion|Withdrawal by Subject|1|||
160455268|NCT03523572|579397889|FG003|Dose Expansion|Withdrawal by Subject|1|||
160937484|NCT03604692|581161875|FG004|Overall Study|Death|0|||
160455269|NCT03523572|579397890|FG004|Dose Expansion|Withdrawal by Subject|0|||
160655964|NCT00661999|580120320|FG002|Overall Study|Other Medical Problems|9|||
160655965|NCT03066999|580120321|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
160655966|NCT03066999|580120322|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
160937485|NCT03604692|581161876|FG005|Overall Study|Death|0|||
160937486|NCT03604692|581161871|FG000|Overall Study|Drug Intolerance|0|||
160655967|NCT01139164|580120325|FG000|Overall Study|Withdrawn prior to study start|0|||
160655968|NCT01139164|580120326|FG001|Overall Study|Withdrawn prior to study start|2|||
160655969|NCT01139164|580120327|FG002|Overall Study|Withdrawn prior to study start|0|||
160655970|NCT01790568|580120328|FG000|Overall Study|Progression prior to transplant|0|||
160655971|NCT01790568|580120329|FG001|Overall Study|Progression prior to transplant|1|||
160655972|NCT01361126|580120330|FG000|Overall Study|Sponsor decision|0|||
160655973|NCT01361126|580120331|FG001|Overall Study|Sponsor decision|2|||
160937487|NCT03604692|581161872|FG001|Overall Study|Drug Intolerance|0|||
160937488|NCT03604692|581161873|FG002|Overall Study|Drug Intolerance|0|||
160937489|NCT03604692|581161874|FG003|Overall Study|Drug Intolerance|1|||
160998609|NCT00612586|581380594|FG000|Overall Study|Withdrawal by Subject|7|||
160998610|NCT00612586|581380595|FG001|Overall Study|Withdrawal by Subject|9|||
160937490|NCT03604692|581161875|FG004|Overall Study|Drug Intolerance|0|||
160455270|NCT03523572|579397891|FG005|Dose Expansion|Withdrawal by Subject|0|||
160937491|NCT03604692|581161876|FG005|Overall Study|Drug Intolerance|0|||
160937492|NCT03604692|581161871|FG000|Overall Study|Noncompliance with follow-up visit|0|||
160455271|NCT03523572|579397886|FG000|Dose Expansion|Physician Decision|0|||
160455272|NCT03523572|579397887|FG001|Dose Expansion|Physician Decision|0|||
160455273|NCT03523572|579397888|FG002|Dose Expansion|Physician Decision|1|||
160455274|NCT03523572|579397889|FG003|Dose Expansion|Physician Decision|0|||
160455275|NCT03523572|579397890|FG004|Dose Expansion|Physician Decision|1|||
160455276|NCT03523572|579397891|FG005|Dose Expansion|Physician Decision|0|||
160455277|NCT03523572|579397886|FG000|Dose Expansion|Miscellaneous|0|||
160455278|NCT03523572|579397887|FG001|Dose Expansion|Miscellaneous|0|||
160455279|NCT03523572|579397888|FG002|Dose Expansion|Miscellaneous|0|||
160455280|NCT03523572|579397889|FG003|Dose Expansion|Miscellaneous|0|||
160455281|NCT03523572|579397890|FG004|Dose Expansion|Miscellaneous|3|||
160455282|NCT03523572|579397891|FG005|Dose Expansion|Miscellaneous|0|||
160455283|NCT04577963|579397893|FG000|Part 2|Death|0|||
160937493|NCT03604692|581161872|FG001|Overall Study|Noncompliance with follow-up visit|0|||
160937494|NCT03604692|581161873|FG002|Overall Study|Noncompliance with follow-up visit|0|||
160937495|NCT03604692|581161874|FG003|Overall Study|Noncompliance with follow-up visit|1|||
160937496|NCT03604692|581161875|FG004|Overall Study|Noncompliance with follow-up visit|0|||
160937497|NCT03604692|581161876|FG005|Overall Study|Noncompliance with follow-up visit|0|||
160937498|NCT03604692|581161871|FG000|Overall Study|Not Treated|0|||
160937499|NCT03604692|581161872|FG001|Overall Study|Not Treated|0|||
160937500|NCT03604692|581161873|FG002|Overall Study|Not Treated|0|||
160937501|NCT03604692|581161874|FG003|Overall Study|Not Treated|0|||
160937502|NCT03604692|581161875|FG004|Overall Study|Not Treated|1|||
160937503|NCT03604692|581161876|FG005|Overall Study|Not Treated|0|||
160937504|NCT00637195|581161877|FG000|Overall Study|Lost to Follow-up|1|||
160937505|NCT00637195|581161878|FG001|Overall Study|Lost to Follow-up|0|||
160937506|NCT00637195|581161877|FG000|Overall Study|Other|2|||
160937507|NCT00637195|581161878|FG001|Overall Study|Other|0|||
160937508|NCT00637195|581161877|FG000|Overall Study|Withdrawal by Subject|0|||
160937509|NCT00637195|581161878|FG001|Overall Study|Withdrawal by Subject|1|||
160937510|NCT00547703|581161881|FG000|Overall Study|Lost to Follow-up|1|||
160937511|NCT00547703|581161882|FG001|Overall Study|Lost to Follow-up|0|||
160937512|NCT01193556|581161885|FG000|Overall Study|Study termination|26|||
160937513|NCT01193556|581161886|FG001|Overall Study|Study termination|25|||
160937514|NCT01696032|581161887|FG000|Overall Study|Withdrawal by Subject|0|||
160937515|NCT01696032|581161888|FG001|Overall Study|Withdrawal by Subject|0|||
160937516|NCT01696032|581161889|FG002|Overall Study|Withdrawal by Subject|1|||
160937517|NCT01696032|581161890|FG003|Overall Study|Withdrawal by Subject|2|||
160937518|NCT01696032|581161887|FG000|Overall Study|Death|14|||
160937519|NCT01696032|581161888|FG001|Overall Study|Death|4|||
160937520|NCT01696032|581161889|FG002|Overall Study|Death|43|||
160937521|NCT01696032|581161890|FG003|Overall Study|Death|18|||
160937522|NCT01696032|581161887|FG000|Overall Study|Lost to Follow-up|0|||
160937523|NCT01696032|581161888|FG001|Overall Study|Lost to Follow-up|1|||
160937524|NCT01696032|581161889|FG002|Overall Study|Lost to Follow-up|0|||
160937525|NCT01696032|581161890|FG003|Overall Study|Lost to Follow-up|0|||
160937526|NCT01696032|581161887|FG000|Overall Study|Database lock|0|||
160937527|NCT01696032|581161888|FG001|Overall Study|Database lock|1|||
160937528|NCT01696032|581161889|FG002|Overall Study|Database lock|7|||
160937529|NCT01696032|581161890|FG003|Overall Study|Database lock|2|||
160937530|NCT00376168|581161891|FG000|Overall Study|Adverse Event|1|||
160937531|NCT00376168|581161892|FG001|Overall Study|Adverse Event|1|||
160937532|NCT00376168|581161891|FG000|Overall Study|Pregnancy|1|||
160937533|NCT00376168|581161892|FG001|Overall Study|Pregnancy|0|||
160937534|NCT01020019|581161893|FG000|Overall Study|Lost to Follow-up|21|||
160937535|NCT01020019|581161894|FG001|Overall Study|Lost to Follow-up|18|||
160937536|NCT01020019|581161893|FG000|Overall Study|Adverse Event|1|||
160937537|NCT01020019|581161894|FG001|Overall Study|Adverse Event|5|||
160937538|NCT01020019|581161893|FG000|Overall Study|not interested in treatment|4|||
160937539|NCT01020019|581161894|FG001|Overall Study|not interested in treatment|4|||
160937540|NCT01020019|581161893|FG000|Overall Study|moving|0|||
160937541|NCT01020019|581161894|FG001|Overall Study|moving|2|||
160937542|NCT05091528|581161895|FG000|Overall Study|Study Termination by Sponsor|0|||
160937543|NCT05091528|581161896|FG001|Overall Study|Study Termination by Sponsor|1|||
160937544|NCT05091528|581161897|FG002|Overall Study|Study Termination by Sponsor|0|||
160937545|NCT05091528|581161898|FG003|Overall Study|Study Termination by Sponsor|1|||
160937546|NCT03316872|581161899|FG000|Overall Study|Death|1|||
160937547|NCT02239536|581161900|FG000|Overall Study|Non-neoplastic polyp|23|||
160937548|NCT02239536|581161901|FG001|Overall Study|Non-neoplastic polyp|17|||
160937549|NCT04074317|581161902|FG000|Third Period|Withdrawal by Subject|0|||
160937550|NCT04074317|581161903|FG001|Third Period|Withdrawal by Subject|0|||
160937551|NCT04074317|581161904|FG002|Third Period|Withdrawal by Subject|0|||
160937552|NCT04074317|581161905|FG003|Third Period|Withdrawal by Subject|1|||
160455284|NCT04577963|579397894|FG001|Part 2|Death|1|||
160937553|NCT04074317|581161906|FG004|Third Period|Withdrawal by Subject|0|||
160937554|NCT04074317|581161907|FG005|Third Period|Withdrawal by Subject|0|||
160937555|NCT01038778|581161908|FG000|Overall Study|Withdrawal by Subject|0|||
160937556|NCT01038778|581161909|FG001|Overall Study|Withdrawal by Subject|2|||
160455285|NCT04577963|579397895|FG002|Part 2|Death|8|||
160455286|NCT04577963|579397896|FG003|Part 2|Death|0|||
160455287|NCT04577963|579397897|FG004|Part 2|Death|20|||
160455288|NCT04577963|579397893|FG000|Part 2|Lost to Follow-up|0|||
160998611|NCT00612586|581380594|FG000|Overall Study|Physician Decision|1|||
160998612|NCT00612586|581380595|FG001|Overall Study|Physician Decision|2|||
160998613|NCT00612586|581380594|FG000|Overall Study|Sponsor Decision|1|||
160998614|NCT00612586|581380595|FG001|Overall Study|Sponsor Decision|1|||
160998615|NCT00612586|581380594|FG000|Overall Study|Progressive Disease|26|||
160937557|NCT01038778|581161910|FG002|Overall Study|Withdrawal by Subject|3|||
160937558|NCT02283788|581161912|FG000|Overall Study|Adverse Event|1|||
160937559|NCT02283788|581161913|FG001|Overall Study|Adverse Event|3|||
160937560|NCT02283788|581161914|FG002|Overall Study|Adverse Event|5|||
160937561|NCT02283788|581161915|FG003|Overall Study|Adverse Event|1|||
160937562|NCT02283788|581161912|FG000|Overall Study|Withdrawal by Subject|0|||
160937563|NCT02283788|581161913|FG001|Overall Study|Withdrawal by Subject|1|||
160937564|NCT02283788|581161914|FG002|Overall Study|Withdrawal by Subject|0|||
160998616|NCT00612586|581380595|FG001|Overall Study|Progressive Disease|24|||
160937565|NCT02283788|581161915|FG003|Overall Study|Withdrawal by Subject|1|||
160937566|NCT04269161|581163424|FG000|Overall Study|Change of modality and no longer eligible|3|||
160937567|NCT04269161|581163425|FG001|Overall Study|Change of modality and no longer eligible|3|||
160937568|NCT04269161|581163424|FG000|Overall Study|Required procedure outside of NICU|1|||
160937569|NCT04269161|581163425|FG001|Overall Study|Required procedure outside of NICU|0|||
160937570|NCT04269161|581163424|FG000|Overall Study|Equipment issue|1|||
160937571|NCT04269161|581163425|FG001|Overall Study|Equipment issue|1|||
160937572|NCT02472756|581163426|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
160937573|NCT02472756|581163426|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
160937574|NCT02472756|581163426|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
160937575|NCT02472756|581163426|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
160937576|NCT02472756|581163426|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
160937577|NCT00326911|581163429|FG000|Overall Study|Hospitalization prior to treatment|0|||
160937578|NCT00326911|581163430|FG001|Overall Study|Hospitalization prior to treatment|1|||
160937579|NCT00326911|581163429|FG000|Overall Study|Physician decision prior to treatment|1|||
160937580|NCT00326911|581163430|FG001|Overall Study|Physician decision prior to treatment|0|||
160937581|NCT00326911|581163429|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
160937582|NCT00326911|581163430|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
160937583|NCT04182100|581163431|FG000|Overall Study|Adverse Event|1|||
160937584|NCT04182100|581163431|FG000|Overall Study|Withdrawal by Subject|1|||
160937585|NCT01632800|581163438|FG000|Overall Study|Subject did not fit in apparatus|1|||
160937586|NCT00813124|581163439|FG000|Overall Study|Death|2|||
160937587|NCT00813124|581163439|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
160937588|NCT00813124|581163439|FG000|Overall Study|Withdrawal by Subject|1|||
160937589|NCT01147653|581163446|FG000|Year 2|Withdrawal by Subject|2|||
160937590|NCT01147653|581163447|FG001|Year 2|Withdrawal by Subject|3|||
160937591|NCT02214121|581163452|FG000|Part A|Patient decision|2|||
160937592|NCT02214121|581163453|FG001|Part A|Patient decision|0|||
160937593|NCT02214121|581163454|FG002|Part A|Patient decision|0|||
160937594|NCT02214121|581163452|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
160937595|NCT02214121|581163453|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
160937596|NCT02214121|581163454|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
160937597|NCT02214121|581163452|FG000|Part A|Other|1|||
160937598|NCT02214121|581163453|FG001|Part A|Other|0|||
160937599|NCT02214121|581163454|FG002|Part A|Other|0|||
160937600|NCT02214121|581163452|FG000|Part B|Patient decision|0|||
160937601|NCT02214121|581163453|FG001|Part B|Patient decision|1|||
160937602|NCT02214121|581163454|FG002|Part B|Patient decision|0|||
160937603|NCT02214121|581163452|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
160937604|NCT02214121|581163453|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
160937605|NCT02214121|581163454|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
160937606|NCT02214121|581163452|FG000|Part B|Lost to Follow-up|0|||
160937607|NCT02214121|581163453|FG001|Part B|Lost to Follow-up|0|||
160937608|NCT02214121|581163454|FG002|Part B|Lost to Follow-up|1|||
160998617|NCT00612586|581380594|FG000|Overall Study|Randomized and Not Treated|1|||
160998618|NCT00612586|581380595|FG001|Overall Study|Randomized and Not Treated|1|||
160998619|NCT02613364|581380596|FG000|Overall Study|Other|19|||
160998620|NCT02613364|581380597|FG001|Overall Study|Other|29|||
160455289|NCT04577963|579397894|FG001|Part 2|Lost to Follow-up|0|||
160937609|NCT02375672|581163455|FG000|Overall Study|remain on follow up|20|||
160937610|NCT02203591|581163456|FG000|Overall Study|Did not meet treatment day baseline|147|||
160937611|NCT02203591|581163457|FG001|Overall Study|Did not meet treatment day baseline|141|||
160937612|NCT02203591|581163458|FG002|Overall Study|Did not meet treatment day baseline|150|||
160937613|NCT02203591|581163459|FG003|Overall Study|Did not meet treatment day baseline|45|||
160998621|NCT02613364|581380598|FG002|Overall Study|Other|17|||
160998622|NCT02613364|581380596|FG000|Overall Study|Too time consuming|21|||
160455290|NCT04577963|579397895|FG002|Part 2|Lost to Follow-up|0|||
160455291|NCT04577963|579397896|FG003|Part 2|Lost to Follow-up|0|||
160937614|NCT02203591|581163460|FG004|Overall Study|Did not meet treatment day baseline|33|||
160937615|NCT02203591|581163461|FG005|Overall Study|Did not meet treatment day baseline|35|||
160937616|NCT02203591|581163462|FG006|Overall Study|Did not meet treatment day baseline|29|||
160937617|NCT02203591|581163463|FG007|Overall Study|Did not meet treatment day baseline|12|||
160937618|NCT02203591|581163456|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
160937619|NCT02203591|581163457|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
160937620|NCT02203591|581163458|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
160937621|NCT02203591|581163459|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
160937622|NCT02203591|581163460|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
160937623|NCT02203591|581163461|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
160937624|NCT02203591|581163462|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
160937625|NCT02203591|581163463|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
160937626|NCT04115358|581163464|FG000|Overall Study|exfoliation|0|||
160937627|NCT04115358|581163465|FG001|Overall Study|exfoliation|0|||
160937628|NCT04115358|581163466|FG002|Overall Study|exfoliation|1|||
160937629|NCT01573624|581163469|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
160937630|NCT01573624|581163470|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
160937631|NCT01573624|581163471|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
160937632|NCT01573624|581163472|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
160937633|NCT01573624|581163473|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
160937634|NCT01573624|581163474|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
160937635|NCT01573624|581163475|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
160937636|NCT01573624|581163469|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
160937637|NCT01573624|581163470|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
160937638|NCT01573624|581163471|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
160937639|NCT01573624|581163472|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
160937640|NCT01573624|581163473|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
160937641|NCT01573624|581163474|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160937642|NCT01573624|581163475|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
160937643|NCT01573624|581163469|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
160937644|NCT01573624|581163470|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160937645|NCT01573624|581163471|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160937646|NCT01573624|581163472|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160937647|NCT01573624|581163473|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160937648|NCT01573624|581163474|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160998623|NCT02613364|581380597|FG001|Overall Study|Too time consuming|26|||
160998624|NCT02613364|581380598|FG002|Overall Study|Too time consuming|26|||
160998625|NCT02613364|581380596|FG000|Overall Study|Withdrawal by Subject|13|||
160998626|NCT02613364|581380597|FG001|Overall Study|Withdrawal by Subject|18|||
160937649|NCT01573624|581163475|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160937650|NCT01573624|581163469|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160937651|NCT01573624|581163470|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160937652|NCT01573624|581163471|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160937653|NCT01573624|581163472|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160937654|NCT01573624|581163473|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160937655|NCT01573624|581163474|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
160937656|NCT01573624|581163475|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160937657|NCT01573624|581163469|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
160937658|NCT01573624|581163470|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
160937659|NCT01573624|581163471|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
160937660|NCT01573624|581163472|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
160937661|NCT01573624|581163473|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
160937662|NCT01573624|581163474|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
160937663|NCT01573624|581163475|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
160937664|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937665|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937666|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937667|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937668|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937669|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
160937670|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937671|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
160998627|NCT02613364|581380598|FG002|Overall Study|Withdrawal by Subject|17|||
160937672|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
160937673|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
160998628|NCT02613364|581380596|FG000|Overall Study|Medical|12|||
160998629|NCT02613364|581380597|FG001|Overall Study|Medical|13|||
160998630|NCT02613364|581380598|FG002|Overall Study|Medical|9|||
160998631|NCT02613364|581380596|FG000|Overall Study|Disliked Study Procedure|1|||
160937674|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
160937675|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
160937676|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
160937677|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
160937678|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
160937679|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160937680|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
160937681|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
160937682|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160937683|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160937684|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160937685|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937686|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937687|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937688|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937689|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937690|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
160937691|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937692|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160937693|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160937694|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160937695|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
160937696|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160937697|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160937698|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160937699|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937700|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937701|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937702|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937703|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937704|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937705|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937706|NCT01573624|581163469|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
160937707|NCT01573624|581163470|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
160937708|NCT01573624|581163471|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
160937709|NCT01573624|581163472|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
160937710|NCT01573624|581163473|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
160937711|NCT01573624|581163474|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
160937712|NCT01573624|581163475|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
160937713|NCT01573624|581163469|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
160937714|NCT01573624|581163470|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
160937715|NCT01573624|581163471|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
160937716|NCT01573624|581163472|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
160937717|NCT01573624|581163473|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
160937718|NCT01573624|581163474|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
160937719|NCT01573624|581163475|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
160937720|NCT01573624|581163469|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
160937721|NCT01573624|581163470|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937722|NCT01573624|581163471|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937723|NCT01573624|581163472|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937724|NCT01573624|581163473|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937725|NCT01573624|581163474|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937726|NCT01573624|581163475|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937727|NCT01573624|581163469|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160937728|NCT01573624|581163470|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
160937729|NCT01573624|581163471|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
160937730|NCT01573624|581163472|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160937731|NCT01573624|581163473|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160937732|NCT01573624|581163474|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
160937733|NCT01573624|581163475|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160937734|NCT01573624|581163469|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
160937735|NCT01573624|581163470|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937736|NCT01573624|581163471|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937737|NCT01573624|581163472|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937738|NCT01573624|581163473|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937739|NCT01573624|581163474|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937740|NCT01573624|581163475|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937741|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
160937742|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
160937743|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
160937744|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
160937745|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
160937746|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
160937747|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
160937748|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
160937749|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
160937750|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
160937751|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
160937752|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
160937753|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
160937754|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
160937755|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937756|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
160937757|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937758|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937759|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937760|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937761|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937762|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937763|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
160937764|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937765|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937766|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937767|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937768|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937769|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160937770|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160937771|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160937772|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160937773|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160937774|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
160937775|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
160937776|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937777|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937778|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937779|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937780|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937781|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937782|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937783|NCT01573624|581163469|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
160937784|NCT01573624|581163470|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160937785|NCT01573624|581163471|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160937786|NCT01573624|581163472|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160937787|NCT01573624|581163473|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
160455292|NCT04577963|579397897|FG004|Part 2|Lost to Follow-up|2|||
160455293|NCT04577963|579397893|FG000|Part 2|Withdrawal by Subject|0|||
160455294|NCT04577963|579397894|FG001|Part 2|Withdrawal by Subject|0|||
160937788|NCT01573624|581163474|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
160937789|NCT01573624|581163475|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
160937790|NCT01573624|581163469|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
160455295|NCT04577963|579397895|FG002|Part 2|Withdrawal by Subject|0|||
160578631|NCT02190435|579838413|FG001|Overall Study|First 12 patients were lead-ins|0|||
160455296|NCT04577963|579397896|FG003|Part 2|Withdrawal by Subject|0|||
160455297|NCT04577963|579397897|FG004|Part 2|Withdrawal by Subject|10|||
160455298|NCT04577963|579397893|FG000|Part 2|Progressive disease|0|||
160455299|NCT04577963|579397894|FG001|Part 2|Progressive disease|0|||
160455300|NCT04577963|579397895|FG002|Part 2|Progressive disease|0|||
160455301|NCT04577963|579397896|FG003|Part 2|Progressive disease|0|||
160455302|NCT04577963|579397897|FG004|Part 2|Progressive disease|2|||
160455303|NCT04577963|579397893|FG000|Part 2|Investigator decision|0|||
160455304|NCT04577963|579397894|FG001|Part 2|Investigator decision|0|||
160455305|NCT04577963|579397895|FG002|Part 2|Investigator decision|0|||
160455306|NCT04577963|579397896|FG003|Part 2|Investigator decision|0|||
160455307|NCT04577963|579397897|FG004|Part 2|Investigator decision|1|||
160455308|NCT04577963|579397893|FG000|Part 2|Sponsor terminated study|0|||
160455309|NCT04577963|579397894|FG001|Part 2|Sponsor terminated study|0|||
160937791|NCT01573624|581163470|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
160937792|NCT01573624|581163471|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
160937793|NCT01573624|581163472|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
160937794|NCT01573624|581163473|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
160937795|NCT01573624|581163474|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
160937796|NCT01573624|581163475|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
160937797|NCT01573624|581163469|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
160937798|NCT01573624|581163470|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937799|NCT01573624|581163471|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937800|NCT01573624|581163472|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937801|NCT01573624|581163473|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937802|NCT01573624|581163474|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937803|NCT01573624|581163475|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937804|NCT01573624|581163469|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
160937805|NCT01573624|581163470|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
160937806|NCT01573624|581163471|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
160937807|NCT01573624|581163472|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
160455310|NCT04577963|579397895|FG002|Part 2|Sponsor terminated study|3|||
160937808|NCT01573624|581163473|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
160937809|NCT01573624|581163474|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
160937810|NCT01573624|581163475|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
160937811|NCT01573624|581163469|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
160937812|NCT01573624|581163470|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937813|NCT01573624|581163471|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937814|NCT01573624|581163472|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937815|NCT01573624|581163473|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937816|NCT01573624|581163474|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937817|NCT01573624|581163475|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937818|NCT03306264|581163478|FG000|Overall Study|Death|33|||
160937819|NCT03306264|581163479|FG001|Overall Study|Death|25|||
160937820|NCT03306264|581163480|FG002|Overall Study|Death|34|||
160937821|NCT03306264|581163481|FG003|Overall Study|Death|34|||
160937822|NCT03306264|581163478|FG000|Overall Study|Complete Consent Withdrawal|4|||
160937823|NCT03306264|581163479|FG001|Overall Study|Complete Consent Withdrawal|4|||
160937824|NCT03306264|581163480|FG002|Overall Study|Complete Consent Withdrawal|1|||
160937825|NCT03306264|581163481|FG003|Overall Study|Complete Consent Withdrawal|8|||
160937826|NCT03306264|581163478|FG000|Overall Study|Lost to Follow-up|1|||
160937827|NCT03306264|581163479|FG001|Overall Study|Lost to Follow-up|0|||
160937828|NCT03306264|581163480|FG002|Overall Study|Lost to Follow-up|1|||
160937829|NCT03306264|581163481|FG003|Overall Study|Lost to Follow-up|0|||
160937830|NCT03306264|581163478|FG000|Overall Study|Rollover to ASTX727-06|10|||
160937831|NCT03306264|581163479|FG001|Overall Study|Rollover to ASTX727-06|18|||
160937832|NCT03306264|581163480|FG002|Overall Study|Rollover to ASTX727-06|4|||
160937833|NCT03306264|581163481|FG003|Overall Study|Rollover to ASTX727-06|2|||
160937834|NCT03306264|581163478|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
160937835|NCT03306264|581163479|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
160937836|NCT03306264|581163480|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
160937837|NCT03306264|581163481|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
160937838|NCT02722928|581163485|FG000|Overall Study|Standard CT was not as required per prot|5|||
160937839|NCT02722928|581163486|FG001|Overall Study|Standard CT was not as required per prot|13|||
160937840|NCT02722928|581163485|FG000|Overall Study|Required Intraoperative MRI|5|||
160937841|NCT02722928|581163486|FG001|Overall Study|Required Intraoperative MRI|7|||
160937842|NCT00094653|581163489|FG000|Overall Study|Death|306|||
160578632|NCT02190435|579838412|FG000|Overall Study|3 consented screen fails|3|||
160578633|NCT02190435|579838413|FG001|Overall Study|3 consented screen fails|0|||
160937843|NCT00094653|581163490|FG001|Overall Study|Death|100|||
160937844|NCT00094653|581163491|FG002|Overall Study|Death|119|||
160455311|NCT04577963|579397896|FG003|Part 2|Sponsor terminated study|1|||
160455312|NCT04577963|579397897|FG004|Part 2|Sponsor terminated study|4|||
160455313|NCT02709161|579397900|FG000|Overall Study|Withdrawal by Subject|1|||
160455314|NCT02709161|579397901|FG001|Overall Study|Withdrawal by Subject|0|||
160455315|NCT05167864|579397907|FG000|Overall Study|Lost to Follow-up|7|||
160455316|NCT05167864|579397908|FG001|Overall Study|Lost to Follow-up|6|||
160455317|NCT05167864|579397909|FG002|Overall Study|Lost to Follow-up|7|||
160455318|NCT05167864|579397910|FG003|Overall Study|Lost to Follow-up|9|||
160455319|NCT01221948|579397911|FG000|Overall Study|Physician Decision|5|||
160455320|NCT01221948|579397911|FG000|Overall Study|Withdrawal by Subject|2|||
160455321|NCT01221948|579397911|FG000|Overall Study|not disclosed|2|||
160455322|NCT01221948|579397911|FG000|Overall Study|Death|1|||
160455323|NCT01221948|579397911|FG000|Overall Study|Protocol Violation|4|||
160455324|NCT00746096|579397912|FG000|Overall Study|Adverse Event|1|||
160455325|NCT00746096|579397913|FG001|Overall Study|Adverse Event|0|||
160455326|NCT00746096|579397912|FG000|Overall Study|Withdrawal by Subject|5|||
160455327|NCT00746096|579397913|FG001|Overall Study|Withdrawal by Subject|1|||
160455328|NCT00746096|579397912|FG000|Overall Study|Lost to Follow-up|2|||
160455329|NCT00746096|579397913|FG001|Overall Study|Lost to Follow-up|1|||
160455330|NCT00746096|579397912|FG000|Overall Study|Protocol Violation|1|||
160455331|NCT00746096|579397913|FG001|Overall Study|Protocol Violation|0|||
160455332|NCT00746096|579397912|FG000|Overall Study|No study drug treatment|1|||
160455333|NCT00746096|579397913|FG001|Overall Study|No study drug treatment|1|||
160455334|NCT03756662|579397914|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
160455335|NCT04295512|579397919|FG000|Overall Study|Lack of family response to schedule assessment|0|||
160455336|NCT04295512|579397920|FG001|Overall Study|Lack of family response to schedule assessment|0|||
160455337|NCT04295512|579397921|FG002|Overall Study|Lack of family response to schedule assessment|0|||
160455338|NCT04295512|579397922|FG003|Overall Study|Lack of family response to schedule assessment|2|||
160455339|NCT04295512|579397919|FG000|Overall Study|Therapist did not refer eligible family|7|||
160455340|NCT04295512|579397920|FG001|Overall Study|Therapist did not refer eligible family|7|||
160455341|NCT04295512|579397921|FG002|Overall Study|Therapist did not refer eligible family|0|||
160455342|NCT04295512|579397922|FG003|Overall Study|Therapist did not refer eligible family|0|||
160455343|NCT05207956|579397926|FG000|Overall Study|Lost to follow up|1|||
160455344|NCT05207956|579397927|FG001|Overall Study|Lost to follow up|2|||
160455345|NCT01009788|579397928|FG000|Overall Study|Withdrawal by Subject|1|||
160455346|NCT01009788|579397929|FG001|Overall Study|Withdrawal by Subject|0|||
160455347|NCT01254864|579397930|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
160455348|NCT01254864|579397931|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
160455349|NCT01254864|579397932|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
160455350|NCT01254864|579397930|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
160455351|NCT01254864|579397931|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
160455352|NCT01254864|579397932|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
160455353|NCT01254864|579397930|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
160455354|NCT01254864|579397931|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
160455355|NCT01254864|579397932|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
160455356|NCT01254864|579397930|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
160455357|NCT01254864|579397931|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
160455358|NCT01254864|579397932|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
160455359|NCT01254864|579397930|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
160455360|NCT01254864|579397931|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
160455361|NCT01254864|579397932|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
160455362|NCT01254864|579397930|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
160455363|NCT01254864|579397931|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
160455364|NCT01254864|579397932|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
160455365|NCT01254864|579397930|FG000|Randomization Phase|Adverse Event|0|||
160455366|NCT01254864|579397931|FG001|Randomization Phase|Adverse Event|5|||
160455367|NCT01254864|579397932|FG002|Randomization Phase|Adverse Event|17|||
160455368|NCT01254864|579397930|FG000|Randomization Phase|Death|0|||
160455369|NCT01254864|579397931|FG001|Randomization Phase|Death|1|||
160455370|NCT01254864|579397932|FG002|Randomization Phase|Death|0|||
160455371|NCT01254864|579397930|FG000|Randomization Phase|Lost to Follow-up|0|||
160455372|NCT01254864|579397931|FG001|Randomization Phase|Lost to Follow-up|0|||
160455373|NCT01254864|579397932|FG002|Randomization Phase|Lost to Follow-up|1|||
160578634|NCT02399475|579838422|FG000|Overall Study|Physician Decision|1|||
160578635|NCT02399475|579838423|FG001|Overall Study|Physician Decision|0|||
160578636|NCT01780389|579838424|FG000|Overall Study|Adverse Event|1|||
160578637|NCT00935220|579838425|FG000|Overall Study|Adverse Event|1|||
160455374|NCT01254864|579397930|FG000|Randomization Phase|Physician Decision|0|||
160455375|NCT01254864|579397931|FG001|Randomization Phase|Physician Decision|20|||
160455376|NCT01254864|579397932|FG002|Randomization Phase|Physician Decision|25|||
160455377|NCT01254864|579397930|FG000|Randomization Phase|Withdrawal by Subject|0|||
160455378|NCT01254864|579397931|FG001|Randomization Phase|Withdrawal by Subject|4|||
160455379|NCT01254864|579397932|FG002|Randomization Phase|Withdrawal by Subject|2|||
160455380|NCT01254864|579397930|FG000|Randomization Phase|Non-Compliance|0|||
160578638|NCT00935220|579838425|FG000|Overall Study|Other reason (not specified)|1|||
160937845|NCT00094653|581163489|FG000|Overall Study|Subject Withdrew Consent|10|||
160937846|NCT00094653|581163490|FG001|Overall Study|Subject Withdrew Consent|2|||
160937847|NCT00094653|581163491|FG002|Overall Study|Subject Withdrew Consent|3|||
160937848|NCT00094653|581163489|FG000|Overall Study|Other|2|||
160937849|NCT00094653|581163490|FG001|Overall Study|Other|2|||
160937850|NCT00094653|581163491|FG002|Overall Study|Other|2|||
160937851|NCT00094653|581163489|FG000|Overall Study|Lost to Follow-up|3|||
160937852|NCT00094653|581163490|FG001|Overall Study|Lost to Follow-up|2|||
160937853|NCT00094653|581163491|FG002|Overall Study|Lost to Follow-up|1|||
160937854|NCT00094653|581163489|FG000|Overall Study|Protocol Violation|0|||
160937855|NCT00094653|581163490|FG001|Overall Study|Protocol Violation|0|||
160937856|NCT00094653|581163491|FG002|Overall Study|Protocol Violation|1|||
160937857|NCT03921411|581163492|FG000|Overall Study|Withdrawal by Subject|1|||
160937858|NCT03921411|581163492|FG000|Overall Study|Protocol Deviation|2|||
160937859|NCT03921411|581163492|FG000|Overall Study|Enrolled, but never treated|2|||
160937860|NCT02114879|581163493|FG000|Overall Study|Withdrawal by Subject|9|||
160937861|NCT02114879|581163494|FG001|Overall Study|Withdrawal by Subject|5|||
160937862|NCT02114879|581163493|FG000|Overall Study|Death|6|||
160937863|NCT02114879|581163494|FG001|Overall Study|Death|11|||
160937864|NCT02114879|581163493|FG000|Overall Study|Lost to Follow-up|4|||
160937865|NCT02114879|581163494|FG001|Overall Study|Lost to Follow-up|6|||
160937866|NCT02114879|581163493|FG000|Overall Study|Physician Decision|0|||
160937867|NCT02114879|581163494|FG001|Overall Study|Physician Decision|2|||
160937868|NCT03120013|581163497|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160937869|NCT03120013|581163498|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160937870|NCT05059600|581163500|FG000|Overall Study|Enrolled but not Treated|10|||
160937871|NCT02152995|581163501|FG000|Overall Study|Withdrawal by Subject|1|||
160937872|NCT02152995|581163502|FG001|Overall Study|Withdrawal by Subject|0|||
160937873|NCT02098109|581163503|FG000|Overall Study|Protocol Violation|3|||
160937874|NCT02098109|581163504|FG001|Overall Study|Protocol Violation|0|||
160937875|NCT01565291|581163506|FG000|Overall Study|Withdrawal by Subject|1|||
160937876|NCT01565291|581163507|FG001|Overall Study|Withdrawal by Subject|0|||
160937877|NCT04552587|581163513|FG000|Overall Study|Lost to Follow-up|4|||
160937878|NCT01822132|581163514|FG000|Overall Study|Lost to Follow-up|4|||
160937879|NCT01822132|581163515|FG001|Overall Study|Lost to Follow-up|2|||
160937880|NCT00313612|581163516|FG000|Overall Study|Patient never received treatment|0|||
160937881|NCT00313612|581163517|FG001|Overall Study|Patient never received treatment|1|||
160937882|NCT04847674|581163518|FG000|Overall Study|Withdrawal by Subject|0|||
160937883|NCT04847674|581163519|FG001|Overall Study|Withdrawal by Subject|1|||
160937884|NCT04847674|581163520|FG002|Overall Study|Withdrawal by Subject|0|||
160937885|NCT04847674|581163518|FG000|Overall Study|Lost to Follow-up|0|||
160937886|NCT04847674|581163519|FG001|Overall Study|Lost to Follow-up|0|||
160937887|NCT04847674|581163520|FG002|Overall Study|Lost to Follow-up|2|||
160937888|NCT04847674|581163518|FG000|Overall Study|Other than specified|21|||
160937889|NCT04847674|581163519|FG001|Overall Study|Other than specified|20|||
160937890|NCT04847674|581163520|FG002|Overall Study|Other than specified|20|||
160937891|NCT00677807|581163523|FG000|Overall Study|Adverse Event|4|||
160937892|NCT00677807|581163524|FG001|Overall Study|Adverse Event|1|||
160937893|NCT00677807|581163525|FG002|Overall Study|Adverse Event|6|||
160937894|NCT00677807|581163523|FG000|Overall Study|Lack of Efficacy|0|||
160937895|NCT00677807|581163524|FG001|Overall Study|Lack of Efficacy|0|||
160455381|NCT01254864|579397931|FG001|Randomization Phase|Non-Compliance|1|||
160455382|NCT01254864|579397932|FG002|Randomization Phase|Non-Compliance|0|||
160455383|NCT01254864|579397930|FG000|Randomization Phase|Comorbidities|0|||
160455384|NCT01254864|579397931|FG001|Randomization Phase|Comorbidities|2|||
160655974|NCT01658943|580120334|FG000|Overall Study|Adverse Event|6|||
160655975|NCT01658943|580120335|FG001|Overall Study|Adverse Event|13|||
160655976|NCT01658943|580120334|FG000|Overall Study|Withdrawal by Subject|9|||
160937896|NCT00677807|581163525|FG002|Overall Study|Lack of Efficacy|2|||
160937897|NCT00677807|581163523|FG000|Overall Study|Participant no longer needs study drug|0|||
160937898|NCT00677807|581163524|FG001|Overall Study|Participant no longer needs study drug|0|||
160937899|NCT00677807|581163525|FG002|Overall Study|Participant no longer needs study drug|1|||
160937900|NCT00677807|581163523|FG000|Overall Study|Withdrawal by Subject|10|||
160937901|NCT00677807|581163524|FG001|Overall Study|Withdrawal by Subject|3|||
160937902|NCT00677807|581163525|FG002|Overall Study|Withdrawal by Subject|6|||
160937903|NCT00677807|581163523|FG000|Overall Study|Lost to Follow-up|2|||
160937904|NCT00677807|581163524|FG001|Overall Study|Lost to Follow-up|2|||
160937905|NCT00677807|581163525|FG002|Overall Study|Lost to Follow-up|2|||
160937906|NCT00677807|581163523|FG000|Overall Study|Administrative problems|1|||
160937907|NCT00677807|581163524|FG001|Overall Study|Administrative problems|1|||
160937908|NCT00677807|581163525|FG002|Overall Study|Administrative problems|2|||
160937909|NCT00677807|581163523|FG000|Overall Study|Death|0|||
160937910|NCT00677807|581163524|FG001|Overall Study|Death|1|||
160937911|NCT00677807|581163525|FG002|Overall Study|Death|1|||
160937912|NCT00677807|581163523|FG000|Overall Study|Protocol Deviation|1|||
160937913|NCT00677807|581163524|FG001|Overall Study|Protocol Deviation|3|||
160937914|NCT00677807|581163525|FG002|Overall Study|Protocol Deviation|0|||
160937915|NCT01393743|581163526|FG000|Core Study|Adverse Event|5|||
160998632|NCT02613364|581380597|FG001|Overall Study|Disliked Study Procedure|1|||
160998633|NCT02613364|581380598|FG002|Overall Study|Disliked Study Procedure|4|||
160998634|NCT02613364|581380596|FG000|Overall Study|Disliked Intervention|0|||
160937916|NCT01393743|581163527|FG001|Core Study|Adverse Event|9|||
160937917|NCT01393743|581163528|FG002|Core Study|Adverse Event|0|||
160937918|NCT01393743|581163526|FG000|Core Study|Lost to Follow-up|1|||
160937919|NCT01393743|581163527|FG001|Core Study|Lost to Follow-up|1|||
160937920|NCT01393743|581163528|FG002|Core Study|Lost to Follow-up|0|||
160937921|NCT01393743|581163526|FG000|Core Study|Participant's Choice|2|||
160937922|NCT01393743|581163527|FG001|Core Study|Participant's Choice|3|||
160937923|NCT01393743|581163528|FG002|Core Study|Participant's Choice|0|||
160937924|NCT01393743|581163526|FG000|Core Study|Inadequate therapeutic effect|2|||
160937925|NCT01393743|581163527|FG001|Core Study|Inadequate therapeutic effect|0|||
160937926|NCT01393743|581163528|FG002|Core Study|Inadequate therapeutic effect|0|||
160937927|NCT01393743|581163526|FG000|Extension Phase|Adverse Event|0|||
160937928|NCT01393743|581163527|FG001|Extension Phase|Adverse Event|0|||
160937929|NCT01393743|581163528|FG002|Extension Phase|Adverse Event|12|||
160937930|NCT01393743|581163526|FG000|Extension Phase|Lost to Follow-up|0|||
160937931|NCT01393743|581163527|FG001|Extension Phase|Lost to Follow-up|0|||
160937932|NCT01393743|581163528|FG002|Extension Phase|Lost to Follow-up|2|||
160937933|NCT01393743|581163526|FG000|Extension Phase|Participant choice|0|||
160937934|NCT01393743|581163527|FG001|Extension Phase|Participant choice|0|||
160937935|NCT01393743|581163528|FG002|Extension Phase|Participant choice|16|||
160937936|NCT01393743|581163526|FG000|Extension Phase|Inadequate therapeutic effect|0|||
160937937|NCT01393743|581163527|FG001|Extension Phase|Inadequate therapeutic effect|0|||
160937938|NCT01393743|581163528|FG002|Extension Phase|Inadequate therapeutic effect|7|||
160937939|NCT01393743|581163526|FG000|Extension Phase|Withdrawal by Subject|0|||
160937940|NCT01393743|581163527|FG001|Extension Phase|Withdrawal by Subject|0|||
160937941|NCT01393743|581163528|FG002|Extension Phase|Withdrawal by Subject|8|||
160937942|NCT01393743|581163526|FG000|Extension Phase|Pregnancy|0|||
160937943|NCT01393743|581163527|FG001|Extension Phase|Pregnancy|0|||
160937944|NCT01393743|581163528|FG002|Extension Phase|Pregnancy|1|||
160937945|NCT01393743|581163526|FG000|Extension Phase|Other|0|||
160937946|NCT01393743|581163527|FG001|Extension Phase|Other|0|||
160998635|NCT02613364|581380597|FG001|Overall Study|Disliked Intervention|3|||
160998636|NCT02613364|581380598|FG002|Overall Study|Disliked Intervention|3|||
160998637|NCT01909336|581380599|FG000|Overall Study|Lost to Follow-up|4|||
160998638|NCT01909336|581380600|FG001|Overall Study|Lost to Follow-up|2|||
160998639|NCT01909336|581380601|FG002|Overall Study|Lost to Follow-up|2|||
160998640|NCT01909336|581380599|FG000|Overall Study|Physician Decision|0|||
160998641|NCT01909336|581380600|FG001|Overall Study|Physician Decision|1|||
160655977|NCT01658943|580120335|FG001|Overall Study|Withdrawal by Subject|2|||
160655978|NCT01658943|580120334|FG000|Overall Study|Progression/Relapse|39|||
160655979|NCT01658943|580120335|FG001|Overall Study|Progression/Relapse|40|||
160655980|NCT01658943|580120334|FG000|Overall Study|Death|4|||
160655981|NCT01658943|580120335|FG001|Overall Study|Death|2|||
160655982|NCT01658943|580120334|FG000|Overall Study|not protocol specified|4|||
160655983|NCT01658943|580120335|FG001|Overall Study|not protocol specified|1|||
160655984|NCT01658943|580120334|FG000|Overall Study|Not eligible|7|||
160655985|NCT01658943|580120335|FG001|Overall Study|Not eligible|9|||
160655986|NCT01658943|580120334|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
160655987|NCT01658943|580120335|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
160655988|NCT04272801|580120338|FG000|Overall Study|Withdrawal by Subject|4|||
160655989|NCT04272801|580120338|FG000|Overall Study|Lost to Follow-up|4|||
160655990|NCT04272801|580120338|FG000|Overall Study|Ineligible|1|||
160655991|NCT02456909|580120339|FG000|Overall Study|Did not receive allocated intervention|24|||
160655992|NCT02456909|580120340|FG001|Overall Study|Did not receive allocated intervention|26|||
160655993|NCT02456909|580120339|FG000|Overall Study|Did not complete the primary outcome|0|||
160655994|NCT02456909|580120340|FG001|Overall Study|Did not complete the primary outcome|1|||
160655995|NCT02768298|580120341|FG000|Overall Study|Adverse Event|1|||
160655996|NCT02768298|580120342|FG001|Overall Study|Adverse Event|4|||
160655997|NCT02768298|580120341|FG000|Overall Study|Death|2|||
160655998|NCT02768298|580120342|FG001|Overall Study|Death|1|||
160655999|NCT02768298|580120341|FG000|Overall Study|Non-compliance with study treatment|0|||
160937947|NCT01393743|581163528|FG002|Extension Phase|Other|14|||
160937948|NCT01524770|581163534|FG000|First Intervention|Withdrawal by Subject|1|||
160937949|NCT01524770|581163535|FG001|First Intervention|Withdrawal by Subject|0|||
160937950|NCT01524770|581163534|FG000|First Intervention|Adverse Event|1|||
160937951|NCT01524770|581163535|FG001|First Intervention|Adverse Event|1|||
160937952|NCT01524770|581163534|FG000|First Intervention|Protocol Violation|1|||
160937953|NCT01524770|581163535|FG001|First Intervention|Protocol Violation|0|||
160937954|NCT03080961|581163537|FG000|Overall Study|Withdrawal by Subject|3|||
160937955|NCT04602624|581163540|FG000|Overall Study|Protocol Deviation|1|||
160937956|NCT04602624|581163540|FG000|Overall Study|Withdrawal by Participant|1|||
160937957|NCT00316199|581163541|FG000|Overall Study|Adverse Event|2|||
160937958|NCT00316199|581163541|FG000|Overall Study|Death|8|||
160937959|NCT00316199|581163541|FG000|Overall Study|Lost to Follow-up|2|||
160937960|NCT04477304|581163542|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
160937961|NCT04477304|581163543|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
160937962|NCT05645432|581163544|FG000|Overall Study|Withdrawal by Subject|1|||
160937963|NCT02349711|581164879|FG000|Overall Study|Withdrawal by Subject|2|||
160937964|NCT02349711|581164880|FG001|Overall Study|Withdrawal by Subject|1|||
160937965|NCT02349711|581164879|FG000|Overall Study|Lost to Follow-up|1|||
160937966|NCT02349711|581164880|FG001|Overall Study|Lost to Follow-up|1|||
160937967|NCT01610700|581164884|FG000|Overall Study|Adverse Event|3|||
160937968|NCT01610700|581164885|FG001|Overall Study|Adverse Event|1|||
160937969|NCT01610700|581164884|FG000|Overall Study|Withdrawal by Subject|0|||
160937970|NCT01610700|581164885|FG001|Overall Study|Withdrawal by Subject|1|||
160937971|NCT01610700|581164884|FG000|Overall Study|subject took one dose of street cannabis|0|||
160937972|NCT01610700|581164885|FG001|Overall Study|subject took one dose of street cannabis|1|||
160937973|NCT02143414|581164887|FG000|Induction|Adverse Event|1|||
160937974|NCT02143414|581164888|FG001|Induction|Adverse Event|2|||
160937975|NCT02143414|581164887|FG000|Induction|Death|1|||
160937976|NCT02143414|581164888|FG001|Induction|Death|2|||
160937977|NCT02143414|581164887|FG000|Induction|Patient refusal|1|||
160937978|NCT02143414|581164888|FG001|Induction|Patient refusal|1|||
160937979|NCT02143414|581164887|FG000|Induction|Refractory|1|||
160937980|NCT02143414|581164888|FG001|Induction|Refractory|0|||
160937981|NCT02143414|581164887|FG000|Induction|Began alternative treatment|1|||
160937982|NCT02143414|581164888|FG001|Induction|Began alternative treatment|0|||
160937983|NCT02143414|581164887|FG000|Induction|Ineligible for postremission|5|||
160937984|NCT02143414|581164888|FG001|Induction|Ineligible for postremission|1|||
160937985|NCT02143414|581164887|FG000|Post-remission|Adverse Event|0|||
160937986|NCT02143414|581164888|FG001|Post-remission|Adverse Event|2|||
160937987|NCT02143414|581164887|FG000|Post-remission|Disease progression/relapse|5|||
160937988|NCT02143414|581164888|FG001|Post-remission|Disease progression/relapse|0|||
160937989|NCT02143414|581164887|FG000|Maintenance|Adverse Event|4|||
160937990|NCT02143414|581164888|FG001|Maintenance|Adverse Event|6|||
160937991|NCT02143414|581164887|FG000|Maintenance|Disease progression/relapse|3|||
160937992|NCT02143414|581164888|FG001|Maintenance|Disease progression/relapse|2|||
160998642|NCT01909336|581380601|FG002|Overall Study|Physician Decision|1|||
160998643|NCT01235949|581380602|FG000|Primary Phase|Migrated/moved from study area|1|||
160998644|NCT01235949|581380603|FG001|Primary Phase|Migrated/moved from study area|1|||
160998645|NCT01235949|581380604|FG002|Primary Phase|Migrated/moved from study area|0|||
160998646|NCT01235949|581380605|FG003|Primary Phase|Migrated/moved from study area|0|||
160998647|NCT01235949|581380606|FG004|Primary Phase|Migrated/moved from study area|1|||
160998648|NCT01235949|581380607|FG005|Primary Phase|Migrated/moved from study area|2|||
160998649|NCT01235949|581380608|FG006|Primary Phase|Migrated/moved from study area|0|||
160998650|NCT01235949|581380609|FG007|Primary Phase|Migrated/moved from study area|0|||
160998651|NCT01235949|581380610|FG008|Primary Phase|Migrated/moved from study area|0|||
160998652|NCT01235949|581380611|FG009|Primary Phase|Migrated/moved from study area|0|||
160998653|NCT01235949|581380612|FG010|Primary Phase|Migrated/moved from study area|0|||
160998654|NCT01235949|581380613|FG011|Primary Phase|Migrated/moved from study area|0|||
160998655|NCT01235949|581380614|FG012|Primary Phase|Migrated/moved from study area|0|||
160998656|NCT01235949|581380615|FG013|Primary Phase|Migrated/moved from study area|0|||
160998657|NCT01235949|581380616|FG014|Primary Phase|Migrated/moved from study area|0|||
160998658|NCT01235949|581380617|FG015|Primary Phase|Migrated/moved from study area|0|||
160998659|NCT01235949|581380618|FG016|Primary Phase|Migrated/moved from study area|0|||
160998660|NCT01235949|581380619|FG017|Primary Phase|Migrated/moved from study area|0|||
160998661|NCT01235949|581380602|FG000|Primary Phase|Adverse Event|0|||
160998662|NCT01235949|581380603|FG001|Primary Phase|Adverse Event|0|||
160998663|NCT01235949|581380604|FG002|Primary Phase|Adverse Event|0|||
160998664|NCT01235949|581380605|FG003|Primary Phase|Adverse Event|1|||
160998665|NCT01235949|581380606|FG004|Primary Phase|Adverse Event|0|||
160998666|NCT01235949|581380607|FG005|Primary Phase|Adverse Event|0|||
160656000|NCT02768298|580120342|FG001|Overall Study|Non-compliance with study treatment|1|||
160656001|NCT02768298|580120341|FG000|Overall Study|Subject/guardian decision|1|||
160937993|NCT02143414|581164887|FG000|Maintenance|Patient refusal|2|||
160937994|NCT02143414|581164888|FG001|Maintenance|Patient refusal|1|||
160937995|NCT02143414|581164887|FG000|Maintenance|Physician Decision|1|||
160937996|NCT02143414|581164888|FG001|Maintenance|Physician Decision|0|||
160937997|NCT02143414|581164887|FG000|Maintenance|Death|0|||
160937998|NCT02143414|581164888|FG001|Maintenance|Death|1|||
160937999|NCT02143414|581164887|FG000|Maintenance|On protocol treatment|0|||
160938000|NCT02143414|581164888|FG001|Maintenance|On protocol treatment|6|||
160938001|NCT00978731|581164892|FG000|Overall Study|Death|4|||
160938002|NCT00978731|581164893|FG001|Overall Study|Death|1|||
160938003|NCT00978731|581164894|FG002|Overall Study|Death|1|||
160938004|NCT00978731|581164895|FG003|Overall Study|Death|0|||
160938005|NCT00978731|581164892|FG000|Overall Study|Lost to Follow-up|0|||
160938006|NCT00978731|581164893|FG001|Overall Study|Lost to Follow-up|0|||
160938007|NCT00978731|581164894|FG002|Overall Study|Lost to Follow-up|0|||
160938008|NCT00978731|581164895|FG003|Overall Study|Lost to Follow-up|1|||
160938009|NCT00978731|581164892|FG000|Overall Study|Adverse Event|5|||
160938010|NCT00978731|581164893|FG001|Overall Study|Adverse Event|2|||
160938011|NCT00978731|581164894|FG002|Overall Study|Adverse Event|0|||
160938012|NCT00978731|581164895|FG003|Overall Study|Adverse Event|0|||
160938013|NCT00978731|581164892|FG000|Overall Study|Participant's request|1|||
160938014|NCT00978731|581164893|FG001|Overall Study|Participant's request|0|||
160938015|NCT00978731|581164894|FG002|Overall Study|Participant's request|0|||
160938016|NCT00978731|581164895|FG003|Overall Study|Participant's request|0|||
160938017|NCT00978731|581164892|FG000|Overall Study|Administrative reason|3|||
160578639|NCT01000064|579838426|FG000|Overall Study|Withdrawal by Subject|1|||
160578640|NCT01000064|579838427|FG001|Overall Study|Withdrawal by Subject|1|||
160578641|NCT00336492|579838430|FG000|Overall Study|Adverse Event|4|||
160578642|NCT00336492|579838431|FG001|Overall Study|Adverse Event|3|||
160578643|NCT00336492|579838432|FG002|Overall Study|Adverse Event|6|||
160578644|NCT00336492|579838430|FG000|Overall Study|Lack of Efficacy|6|||
160578645|NCT00336492|579838431|FG001|Overall Study|Lack of Efficacy|1|||
160578646|NCT00336492|579838432|FG002|Overall Study|Lack of Efficacy|4|||
160578647|NCT00336492|579838430|FG000|Overall Study|Other|5|||
160578648|NCT00336492|579838431|FG001|Overall Study|Other|0|||
160578649|NCT00336492|579838432|FG002|Overall Study|Other|1|||
160578650|NCT04083222|579838433|FG000|Overall Study|Voluntary Withdrawal|0|||
160938018|NCT00978731|581164893|FG001|Overall Study|Administrative reason|3|||
160938019|NCT00978731|581164894|FG002|Overall Study|Administrative reason|1|||
160938020|NCT00978731|581164895|FG003|Overall Study|Administrative reason|0|||
160938021|NCT00978731|581164892|FG000|Overall Study|Deterioration without progression|0|||
160938022|NCT00978731|581164893|FG001|Overall Study|Deterioration without progression|1|||
160938023|NCT00978731|581164894|FG002|Overall Study|Deterioration without progression|0|||
160938024|NCT00978731|581164895|FG003|Overall Study|Deterioration without progression|0|||
160938025|NCT00978731|581164892|FG000|Overall Study|Disease progression/relapse|5|||
160938026|NCT00978731|581164893|FG001|Overall Study|Disease progression/relapse|4|||
160938027|NCT00978731|581164894|FG002|Overall Study|Disease progression/relapse|2|||
160938028|NCT00978731|581164895|FG003|Overall Study|Disease progression/relapse|2|||
160938029|NCT00978731|581164892|FG000|Overall Study|Study closure|3|||
160938030|NCT00978731|581164893|FG001|Overall Study|Study closure|4|||
160938031|NCT00978731|581164894|FG002|Overall Study|Study closure|1|||
160938032|NCT00978731|581164895|FG003|Overall Study|Study closure|1|||
160938033|NCT00978731|581164892|FG000|Overall Study|No response|1|||
160938034|NCT00978731|581164893|FG001|Overall Study|No response|0|||
160938035|NCT00978731|581164894|FG002|Overall Study|No response|0|||
160938036|NCT00978731|581164895|FG003|Overall Study|No response|0|||
160938037|NCT03107988|581164898|FG000|Overall Study|Adverse Event|0|||
160938038|NCT03107988|581164899|FG001|Overall Study|Adverse Event|0|||
160938039|NCT03107988|581164900|FG002|Overall Study|Adverse Event|0|||
160578651|NCT04083222|579838434|FG001|Overall Study|Voluntary Withdrawal|1|||
160938040|NCT03107988|581164901|FG003|Overall Study|Adverse Event|1|||
160938041|NCT03107988|581164902|FG004|Overall Study|Adverse Event|0|||
160938042|NCT03107988|581164903|FG005|Overall Study|Adverse Event|1|||
160938043|NCT03107988|581164904|FG006|Overall Study|Adverse Event|0|||
160998667|NCT01235949|581380608|FG006|Primary Phase|Adverse Event|0|||
160998668|NCT01235949|581380609|FG007|Primary Phase|Adverse Event|0|||
160578652|NCT04083222|579838433|FG000|Overall Study|Reason not Specified|0|||
160578653|NCT04083222|579838434|FG001|Overall Study|Reason not Specified|1|||
160578654|NCT02522481|579838435|FG000|Overall Study|discontinued|1|||
160998669|NCT01235949|581380610|FG008|Primary Phase|Adverse Event|0|||
160998670|NCT01235949|581380611|FG009|Primary Phase|Adverse Event|0|||
160998671|NCT01235949|581380612|FG010|Primary Phase|Adverse Event|0|||
160998672|NCT01235949|581380613|FG011|Primary Phase|Adverse Event|0|||
160998673|NCT01235949|581380614|FG012|Primary Phase|Adverse Event|0|||
160998674|NCT01235949|581380615|FG013|Primary Phase|Adverse Event|0|||
160998675|NCT01235949|581380616|FG014|Primary Phase|Adverse Event|0|||
160998676|NCT01235949|581380617|FG015|Primary Phase|Adverse Event|0|||
160998677|NCT01235949|581380618|FG016|Primary Phase|Adverse Event|0|||
160998678|NCT01235949|581380619|FG017|Primary Phase|Adverse Event|0|||
160998679|NCT01235949|581380602|FG000|Primary Phase|Withdrawal by Subject|3|||
160998680|NCT01235949|581380603|FG001|Primary Phase|Withdrawal by Subject|2|||
160998681|NCT01235949|581380604|FG002|Primary Phase|Withdrawal by Subject|2|||
160998682|NCT01235949|581380605|FG003|Primary Phase|Withdrawal by Subject|0|||
160455385|NCT01254864|579397932|FG002|Randomization Phase|Comorbidities|1|||
160578655|NCT02522481|579838435|FG000|Overall Study|Not dosed|2|||
160938044|NCT03107988|581164905|FG007|Overall Study|Adverse Event|1|||
160938045|NCT03107988|581164906|FG008|Overall Study|Adverse Event|0|||
160998683|NCT01235949|581380606|FG004|Primary Phase|Withdrawal by Subject|0|||
160998684|NCT01235949|581380607|FG005|Primary Phase|Withdrawal by Subject|3|||
160578656|NCT03123939|579838438|FG000|Overall Study|Lack of Efficacy|6|||
160578657|NCT03123939|579838438|FG000|Overall Study|Death|5|||
160578658|NCT03123939|579838438|FG000|Overall Study|Physician Decision|2|||
160938046|NCT03107988|581164907|FG009|Overall Study|Adverse Event|0|||
160938047|NCT03107988|581164908|FG010|Overall Study|Adverse Event|0|||
160938048|NCT03107988|581164909|FG011|Overall Study|Adverse Event|0|||
160938049|NCT03107988|581164910|FG012|Overall Study|Adverse Event|0|||
160938050|NCT03107988|581164898|FG000|Overall Study|Disease Progression or Relapse|1|||
160938051|NCT03107988|581164899|FG001|Overall Study|Disease Progression or Relapse|2|||
160938052|NCT03107988|581164900|FG002|Overall Study|Disease Progression or Relapse|2|||
160938053|NCT03107988|581164901|FG003|Overall Study|Disease Progression or Relapse|5|||
160938054|NCT03107988|581164902|FG004|Overall Study|Disease Progression or Relapse|1|||
160938055|NCT03107988|581164903|FG005|Overall Study|Disease Progression or Relapse|1|||
160938056|NCT03107988|581164904|FG006|Overall Study|Disease Progression or Relapse|0|||
160938057|NCT03107988|581164905|FG007|Overall Study|Disease Progression or Relapse|0|||
160938058|NCT03107988|581164906|FG008|Overall Study|Disease Progression or Relapse|0|||
160938059|NCT03107988|581164907|FG009|Overall Study|Disease Progression or Relapse|1|||
160938060|NCT03107988|581164908|FG010|Overall Study|Disease Progression or Relapse|4|||
160938061|NCT03107988|581164909|FG011|Overall Study|Disease Progression or Relapse|0|||
160938062|NCT03107988|581164910|FG012|Overall Study|Disease Progression or Relapse|0|||
160938063|NCT03107988|581164898|FG000|Overall Study|Ineligible|0|||
160938064|NCT03107988|581164899|FG001|Overall Study|Ineligible|0|||
160938065|NCT03107988|581164900|FG002|Overall Study|Ineligible|0|||
160938066|NCT03107988|581164901|FG003|Overall Study|Ineligible|0|||
160998685|NCT01235949|581380608|FG006|Primary Phase|Withdrawal by Subject|0|||
160998686|NCT01235949|581380609|FG007|Primary Phase|Withdrawal by Subject|0|||
160998687|NCT01235949|581380610|FG008|Primary Phase|Withdrawal by Subject|0|||
160998688|NCT01235949|581380611|FG009|Primary Phase|Withdrawal by Subject|0|||
160998689|NCT01235949|581380612|FG010|Primary Phase|Withdrawal by Subject|0|||
160998690|NCT01235949|581380613|FG011|Primary Phase|Withdrawal by Subject|0|||
160998691|NCT01235949|581380614|FG012|Primary Phase|Withdrawal by Subject|0|||
160998692|NCT01235949|581380615|FG013|Primary Phase|Withdrawal by Subject|0|||
160998693|NCT01235949|581380616|FG014|Primary Phase|Withdrawal by Subject|0|||
160998694|NCT01235949|581380617|FG015|Primary Phase|Withdrawal by Subject|0|||
160998695|NCT01235949|581380618|FG016|Primary Phase|Withdrawal by Subject|0|||
160998696|NCT01235949|581380619|FG017|Primary Phase|Withdrawal by Subject|0|||
160998697|NCT01235949|581380602|FG000|Primary Phase|Lost to Follow-up|0|||
160998698|NCT01235949|581380603|FG001|Primary Phase|Lost to Follow-up|0|||
160998699|NCT01235949|581380604|FG002|Primary Phase|Lost to Follow-up|1|||
160998700|NCT01235949|581380605|FG003|Primary Phase|Lost to Follow-up|1|||
160998701|NCT01235949|581380606|FG004|Primary Phase|Lost to Follow-up|0|||
160998702|NCT01235949|581380607|FG005|Primary Phase|Lost to Follow-up|2|||
160998703|NCT01235949|581380608|FG006|Primary Phase|Lost to Follow-up|0|||
160998704|NCT01235949|581380609|FG007|Primary Phase|Lost to Follow-up|0|||
160998705|NCT01235949|581380610|FG008|Primary Phase|Lost to Follow-up|0|||
160998706|NCT01235949|581380611|FG009|Primary Phase|Lost to Follow-up|0|||
160998707|NCT01235949|581380612|FG010|Primary Phase|Lost to Follow-up|0|||
160998708|NCT01235949|581380613|FG011|Primary Phase|Lost to Follow-up|0|||
160998709|NCT01235949|581380614|FG012|Primary Phase|Lost to Follow-up|0|||
160998710|NCT01235949|581380615|FG013|Primary Phase|Lost to Follow-up|0|||
160998711|NCT01235949|581380616|FG014|Primary Phase|Lost to Follow-up|0|||
160998712|NCT01235949|581380617|FG015|Primary Phase|Lost to Follow-up|0|||
160998713|NCT01235949|581380618|FG016|Primary Phase|Lost to Follow-up|0|||
160998714|NCT01235949|581380619|FG017|Primary Phase|Lost to Follow-up|0|||
160998715|NCT01235949|581380602|FG000|Booster Phase|Migrated/moved from study area|0|||
160998716|NCT01235949|581380603|FG001|Booster Phase|Migrated/moved from study area|0|||
160998717|NCT01235949|581380604|FG002|Booster Phase|Migrated/moved from study area|0|||
160998718|NCT01235949|581380605|FG003|Booster Phase|Migrated/moved from study area|0|||
160998719|NCT01235949|581380606|FG004|Booster Phase|Migrated/moved from study area|0|||
160998720|NCT01235949|581380607|FG005|Booster Phase|Migrated/moved from study area|0|||
160938067|NCT03107988|581164902|FG004|Overall Study|Ineligible|0|||
160938068|NCT03107988|581164903|FG005|Overall Study|Ineligible|0|||
160938069|NCT03107988|581164904|FG006|Overall Study|Ineligible|0|||
160938070|NCT03107988|581164905|FG007|Overall Study|Ineligible|0|||
160938071|NCT03107988|581164906|FG008|Overall Study|Ineligible|1|||
160938072|NCT03107988|581164907|FG009|Overall Study|Ineligible|0|||
160938073|NCT03107988|581164908|FG010|Overall Study|Ineligible|0|||
160938074|NCT03107988|581164909|FG011|Overall Study|Ineligible|0|||
160938075|NCT03107988|581164910|FG012|Overall Study|Ineligible|0|||
160938076|NCT01344057|581164911|FG000|Overall Study|Premature Withdrawal|1|||
160938077|NCT00548808|581164912|FG000|Overall Study|Lost to Follow-up|9|||
160938078|NCT00548808|581164913|FG001|Overall Study|Lost to Follow-up|3|||
160938079|NCT00548808|581164912|FG000|Overall Study|Protocol Violation|8|||
160938080|NCT00548808|581164913|FG001|Overall Study|Protocol Violation|8|||
160998721|NCT01235949|581380608|FG006|Booster Phase|Migrated/moved from study area|0|||
160998722|NCT01235949|581380609|FG007|Booster Phase|Migrated/moved from study area|0|||
160998723|NCT01235949|581380610|FG008|Booster Phase|Migrated/moved from study area|0|||
160938081|NCT00548808|581164912|FG000|Overall Study|Withdrawal by Subject|8|||
160938082|NCT00548808|581164913|FG001|Overall Study|Withdrawal by Subject|4|||
160938083|NCT00548808|581164912|FG000|Overall Study|Physician Decision|6|||
160998724|NCT01235949|581380611|FG009|Booster Phase|Migrated/moved from study area|0|||
160998725|NCT01235949|581380612|FG010|Booster Phase|Migrated/moved from study area|0|||
160998726|NCT01235949|581380613|FG011|Booster Phase|Migrated/moved from study area|1|||
160938084|NCT00548808|581164913|FG001|Overall Study|Physician Decision|3|||
160938085|NCT00548808|581164912|FG000|Overall Study|Adverse Event|4|||
160455386|NCT04141891|579397934|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
160455387|NCT04141891|579397935|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
160455388|NCT04141891|579397934|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
160455389|NCT04141891|579397935|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
160455390|NCT04141891|579397934|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
160455391|NCT04141891|579397935|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
160455392|NCT04141891|579397934|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
160455393|NCT04141891|579397935|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
160455394|NCT04141891|579397934|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
160455395|NCT04141891|579397935|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
160455396|NCT04141891|579397934|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
160455397|NCT04141891|579397935|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
160455398|NCT04141891|579397934|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
160455399|NCT04141891|579397935|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
160455400|NCT04141891|579397934|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
160455401|NCT04141891|579397935|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
160455402|NCT04141891|579397934|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
160455403|NCT04141891|579397935|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
160455404|NCT04141891|579397934|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
160455405|NCT04141891|579397935|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
160455406|NCT04141891|579397934|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
160455407|NCT04141891|579397935|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
160455408|NCT04141891|579397934|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
160455409|NCT04141891|579397935|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
160455410|NCT04141891|579397934|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
160455411|NCT04141891|579397935|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
160455412|NCT04141891|579397934|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
160455413|NCT04141891|579397935|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
160455414|NCT01651403|579397937|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
160455415|NCT01651403|579397938|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
160455416|NCT01651403|579397937|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
160455417|NCT01651403|579397938|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
160455418|NCT01651403|579397937|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
160455419|NCT01651403|579397938|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
160455420|NCT01651403|579397937|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
160455421|NCT01651403|579397938|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
160455422|NCT01651403|579397937|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
160455423|NCT01651403|579397938|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
160455424|NCT01651403|579397937|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
160455425|NCT01651403|579397938|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
160455426|NCT03325985|579397939|FG000|Overall Study|Lost to Follow-up|122|||
160455427|NCT03325985|579397940|FG001|Overall Study|Lost to Follow-up|26|||
160455428|NCT03325985|579397941|FG002|Overall Study|Lost to Follow-up|141|||
160455429|NCT03325985|579397942|FG003|Overall Study|Lost to Follow-up|28|||
160455430|NCT03325985|579397939|FG000|Overall Study|Death|99|||
160455431|NCT03325985|579397940|FG001|Overall Study|Death|36|||
160455432|NCT03325985|579397941|FG002|Overall Study|Death|94|||
160455433|NCT03325985|579397942|FG003|Overall Study|Death|32|||
160455434|NCT03213665|579397943|FG000|Overall Study|Adverse Event|1|||
160455435|NCT03213665|579397943|FG000|Overall Study|Physician Decision|2|||
160455436|NCT03213665|579397943|FG000|Overall Study|Withdrawal by Subject|3|||
160455437|NCT03213665|579397943|FG000|Overall Study|Progressive Disease|13|||
160455438|NCT03034356|579397944|FG000|Baseline|Lost to Follow-up|2|||
160455439|NCT03034356|579397945|FG001|Baseline|Lost to Follow-up|4|||
160455440|NCT03034356|579397944|FG000|Baseline|Withdrawal by Subject|2|||
160455441|NCT03034356|579397945|FG001|Baseline|Withdrawal by Subject|0|||
160455442|NCT03034356|579397944|FG000|Baseline|Physician Decision|0|||
160455443|NCT03034356|579397945|FG001|Baseline|Physician Decision|1|||
160455444|NCT03034356|579397944|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
160578659|NCT03123939|579838438|FG000|Overall Study|Subject/guardian decision|2|||
160938086|NCT00548808|581164913|FG001|Overall Study|Adverse Event|5|||
160938087|NCT00548808|581164912|FG000|Overall Study|Death|2|||
160455445|NCT03034356|579397945|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
160455446|NCT03034356|579397944|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
160455447|NCT03034356|579397945|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
160455448|NCT03034356|579397944|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
160578660|NCT03123939|579838438|FG000|Overall Study|Lost to Follow-up|1|||
160578661|NCT03123939|579838438|FG000|Overall Study|New therapy for study indication|1|||
160938088|NCT00548808|581164913|FG001|Overall Study|Death|0|||
160938089|NCT00548808|581164912|FG000|Overall Study|Entry Criteria Not Met|2|||
160938090|NCT00548808|581164913|FG001|Overall Study|Entry Criteria Not Met|2|||
160938091|NCT00548808|581164912|FG000|Overall Study|Lack of Efficacy|2|||
160938092|NCT00548808|581164913|FG001|Overall Study|Lack of Efficacy|0|||
160938093|NCT00548808|581164912|FG000|Overall Study|Sponsor Decision|1|||
160938094|NCT00548808|581164913|FG001|Overall Study|Sponsor Decision|1|||
160938095|NCT00529386|581164914|FG000|Overall Study|Lost to Follow-up|1|||
160938096|NCT03592641|581164915|FG000|Overall Study|Withdrawal by Subject|1|||
160938097|NCT04027686|581164916|FG000|Overall Study|Lost to Follow-up|2|||
160938098|NCT04027686|581164917|FG001|Overall Study|Lost to Follow-up|0|||
160938099|NCT04027686|581164916|FG000|Overall Study|Withdrawal by Subject|0|||
160938100|NCT04027686|581164917|FG001|Overall Study|Withdrawal by Subject|1|||
160938101|NCT04456699|581164923|FG000|Overall Study|Death|48|||
160938102|NCT04456699|581164924|FG001|Overall Study|Death|50|||
160938103|NCT04456699|581164925|FG002|Overall Study|Death|52|||
160938104|NCT04456699|581164923|FG000|Overall Study|Physician Decision|0|||
160938105|NCT04456699|581164924|FG001|Overall Study|Physician Decision|0|||
160938106|NCT04456699|581164925|FG002|Overall Study|Physician Decision|2|||
160938107|NCT04456699|581164923|FG000|Overall Study|Sponsor Decision|55|||
160938108|NCT04456699|581164924|FG001|Overall Study|Sponsor Decision|61|||
160938109|NCT04456699|581164925|FG002|Overall Study|Sponsor Decision|50|||
160938110|NCT04456699|581164923|FG000|Overall Study|Withdrawal by Subject|8|||
160938111|NCT04456699|581164924|FG001|Overall Study|Withdrawal by Subject|4|||
160938112|NCT04456699|581164925|FG002|Overall Study|Withdrawal by Subject|5|||
160938113|NCT02075437|581164930|FG000|Overall Study|Withdrawal by Subject|5|||
160938114|NCT02075437|581164930|FG000|Overall Study|Lost to Follow-up|1|||
160938115|NCT01541826|581164933|FG000|Overall Study|Lost to Follow-up|2|||
160938116|NCT01541826|581164934|FG001|Overall Study|Lost to Follow-up|3|||
160938117|NCT01541826|581164935|FG002|Overall Study|Lost to Follow-up|0|||
160938118|NCT01541826|581164933|FG000|Overall Study|Withdrawal by Subject|2|||
160938119|NCT01541826|581164934|FG001|Overall Study|Withdrawal by Subject|0|||
160938120|NCT01541826|581164935|FG002|Overall Study|Withdrawal by Subject|0|||
160938121|NCT01365273|581164938|FG000|Overall Study|Lost to Follow-up|1|||
160938122|NCT01365273|581164939|FG001|Overall Study|Lost to Follow-up|0|||
160938123|NCT01365273|581164938|FG000|Overall Study|Protocol Violation|0|||
160938124|NCT01365273|581164939|FG001|Overall Study|Protocol Violation|1|||
160938125|NCT01365273|581164938|FG000|Overall Study|Physician Decision|1|||
160938126|NCT01365273|581164939|FG001|Overall Study|Physician Decision|0|||
160938127|NCT00854581|581164944|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
160938128|NCT00854581|581164944|FG000|Induction (Up to Day 21)|Death|1|||
160938129|NCT00854581|581164944|FG000|Induction (Up to Day 21)|Physician Decision|1|||
160938130|NCT00854581|581164944|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
160938131|NCT02705820|581164947|FG000|Overall Study|Death|2|||
160938132|NCT02705820|581164947|FG000|Overall Study|Disease Progression|34|||
160938133|NCT02705820|581164947|FG000|Overall Study|Clinical Deterioration|3|||
160938134|NCT02702401|581164948|FG000|Overall Study|Death|242|||
160938135|NCT02702401|581164949|FG001|Overall Study|Death|125|||
160938136|NCT02702401|581164948|FG000|Overall Study|Withdrawal by Subject|15|||
160938137|NCT02702401|581164949|FG001|Overall Study|Withdrawal by Subject|5|||
160938138|NCT02702401|581164948|FG000|Overall Study|Sponsor Decision|19|||
160938139|NCT02702401|581164949|FG001|Overall Study|Sponsor Decision|3|||
160938140|NCT02702401|581164948|FG000|Overall Study|Physician Decision|1|||
160938141|NCT02702401|581164949|FG001|Overall Study|Physician Decision|2|||
160998727|NCT01235949|581380614|FG012|Booster Phase|Migrated/moved from study area|1|||
160998728|NCT01235949|581380615|FG013|Booster Phase|Migrated/moved from study area|0|||
160578662|NCT03123939|579838438|FG000|Overall Study|Protocol deviation|1|||
160578663|NCT03123939|579838438|FG000|Overall Study|Progressive disease|18|||
160938142|NCT02702401|581164948|FG000|Overall Study|Lost to Follow-up|1|||
160938143|NCT02702401|581164949|FG001|Overall Study|Lost to Follow-up|0|||
160938144|NCT00989833|581164957|FG000|Overall Study|Lost to Follow-up|0|||
160938145|NCT00989833|581164958|FG001|Overall Study|Lost to Follow-up|1|||
160938146|NCT00989833|581164959|FG002|Overall Study|Lost to Follow-up|0|||
160938147|NCT00989833|581164957|FG000|Overall Study|Protocol Violation|1|||
160938148|NCT00989833|581164958|FG001|Overall Study|Protocol Violation|2|||
160938149|NCT00989833|581164959|FG002|Overall Study|Protocol Violation|1|||
160938150|NCT00989833|581164957|FG000|Overall Study|Withdrawal by Subject|0|||
160938151|NCT00989833|581164958|FG001|Overall Study|Withdrawal by Subject|0|||
160938152|NCT00989833|581164959|FG002|Overall Study|Withdrawal by Subject|1|||
160938153|NCT00989833|581164957|FG000|Overall Study|Incorrectly randomized|1|||
160938154|NCT00989833|581164958|FG001|Overall Study|Incorrectly randomized|0|||
160938155|NCT00989833|581164959|FG002|Overall Study|Incorrectly randomized|0|||
160938156|NCT01420081|581164960|FG000|Overall Study|Death|1|||
160938157|NCT01420081|581164961|FG001|Overall Study|Death|0|||
160938158|NCT01420081|581164962|FG002|Overall Study|Death|8|||
160938159|NCT01420081|581164963|FG003|Overall Study|Death|0|||
160938160|NCT01420081|581164964|FG004|Overall Study|Death|7|||
160938161|NCT01420081|581164965|FG005|Overall Study|Death|12|||
160938162|NCT01420081|581164966|FG006|Overall Study|Death|0|||
160938163|NCT01420081|581164967|FG007|Overall Study|Death|1|||
160938164|NCT01420081|581164968|FG008|Overall Study|Death|1|||
160938165|NCT01420081|581164960|FG000|Overall Study|Lost to Follow-up|0|||
160938166|NCT01420081|581164961|FG001|Overall Study|Lost to Follow-up|0|||
160938167|NCT01420081|581164962|FG002|Overall Study|Lost to Follow-up|0|||
160938168|NCT01420081|581164963|FG003|Overall Study|Lost to Follow-up|0|||
160938169|NCT01420081|581164964|FG004|Overall Study|Lost to Follow-up|1|||
160938170|NCT01420081|581164965|FG005|Overall Study|Lost to Follow-up|1|||
160938171|NCT01420081|581164966|FG006|Overall Study|Lost to Follow-up|0|||
160938172|NCT01420081|581164967|FG007|Overall Study|Lost to Follow-up|0|||
160938173|NCT01420081|581164968|FG008|Overall Study|Lost to Follow-up|0|||
160938174|NCT01420081|581164960|FG000|Overall Study|Study Terminated by Sponsor|2|||
160938175|NCT01420081|581164961|FG001|Overall Study|Study Terminated by Sponsor|1|||
160938176|NCT01420081|581164962|FG002|Overall Study|Study Terminated by Sponsor|1|||
160938177|NCT01420081|581164963|FG003|Overall Study|Study Terminated by Sponsor|3|||
160938178|NCT01420081|581164964|FG004|Overall Study|Study Terminated by Sponsor|11|||
160938179|NCT01420081|581164965|FG005|Overall Study|Study Terminated by Sponsor|7|||
160938180|NCT01420081|581164966|FG006|Overall Study|Study Terminated by Sponsor|3|||
160938181|NCT01420081|581164967|FG007|Overall Study|Study Terminated by Sponsor|2|||
160938182|NCT01420081|581164968|FG008|Overall Study|Study Terminated by Sponsor|2|||
160938183|NCT01420081|581164960|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
160938184|NCT01420081|581164961|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
160938185|NCT01420081|581164962|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
160938186|NCT01420081|581164963|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
160938187|NCT01420081|581164964|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
160938188|NCT01420081|581164965|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
160938189|NCT01420081|581164966|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
160938190|NCT01420081|581164967|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
160938191|NCT01420081|581164968|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
160938192|NCT01420081|581164960|FG000|Overall Study|Other Reasons|0|||
160938193|NCT01420081|581164961|FG001|Overall Study|Other Reasons|0|||
160938194|NCT01420081|581164962|FG002|Overall Study|Other Reasons|1|||
160938195|NCT01420081|581164963|FG003|Overall Study|Other Reasons|0|||
160938196|NCT01420081|581164964|FG004|Overall Study|Other Reasons|0|||
160938197|NCT01420081|581164965|FG005|Overall Study|Other Reasons|0|||
160938198|NCT01420081|581164966|FG006|Overall Study|Other Reasons|0|||
160938199|NCT01420081|581164967|FG007|Overall Study|Other Reasons|0|||
160938200|NCT01420081|581164968|FG008|Overall Study|Other Reasons|0|||
160938201|NCT00678561|581164970|FG000|Overall Study|Adverse Event|0|||
160938202|NCT00678561|581164971|FG001|Overall Study|Adverse Event|1|||
160938203|NCT00678561|581164972|FG002|Overall Study|Adverse Event|1|||
160998729|NCT01235949|581380616|FG014|Booster Phase|Migrated/moved from study area|0|||
160998730|NCT01235949|581380617|FG015|Booster Phase|Migrated/moved from study area|0|||
160578664|NCT03123939|579838438|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
160938204|NCT00678561|581164973|FG003|Overall Study|Adverse Event|0|||
160938205|NCT00678561|581164974|FG004|Overall Study|Adverse Event|1|||
160938206|NCT00678561|581164975|FG005|Overall Study|Adverse Event|0|||
160938207|NCT00678561|581164976|FG006|Overall Study|Adverse Event|0|||
160938208|NCT00678561|581164977|FG007|Overall Study|Adverse Event|0|||
160938209|NCT00678561|581164970|FG000|Overall Study|Protocol Violation|0|||
160938210|NCT00678561|581164971|FG001|Overall Study|Protocol Violation|0|||
160938211|NCT00678561|581164972|FG002|Overall Study|Protocol Violation|0|||
160938212|NCT00678561|581164973|FG003|Overall Study|Protocol Violation|0|||
160938213|NCT00678561|581164974|FG004|Overall Study|Protocol Violation|1|||
160938214|NCT00678561|581164975|FG005|Overall Study|Protocol Violation|1|||
160938215|NCT00678561|581164976|FG006|Overall Study|Protocol Violation|0|||
160938216|NCT00678561|581164977|FG007|Overall Study|Protocol Violation|0|||
160938217|NCT00678561|581164970|FG000|Overall Study|Withdrawal by Subject|0|||
160938218|NCT00678561|581164971|FG001|Overall Study|Withdrawal by Subject|0|||
160938219|NCT00678561|581164972|FG002|Overall Study|Withdrawal by Subject|0|||
160938220|NCT00678561|581164973|FG003|Overall Study|Withdrawal by Subject|0|||
160938221|NCT00678561|581164974|FG004|Overall Study|Withdrawal by Subject|0|||
160938222|NCT00678561|581164975|FG005|Overall Study|Withdrawal by Subject|0|||
160938223|NCT00678561|581164976|FG006|Overall Study|Withdrawal by Subject|0|||
160938224|NCT00678561|581164977|FG007|Overall Study|Withdrawal by Subject|1|||
160938225|NCT00689481|581164978|FG000|Overall Study|Adverse Event|7|||
160938226|NCT00689481|581164979|FG001|Overall Study|Adverse Event|1|||
160938227|NCT00689481|581164978|FG000|Overall Study|Lost to Follow-up|4|||
160938228|NCT00689481|581164979|FG001|Overall Study|Lost to Follow-up|3|||
160938229|NCT00689481|581164978|FG000|Overall Study|Lack of Efficacy|4|||
160938230|NCT00689481|581164979|FG001|Overall Study|Lack of Efficacy|3|||
160938231|NCT00689481|581164978|FG000|Overall Study|Non-compliance with study treatment|1|||
160938232|NCT00689481|581164979|FG001|Overall Study|Non-compliance with study treatment|1|||
160938233|NCT00689481|581164978|FG000|Overall Study|Withdrawal by Subject|8|||
160938234|NCT00689481|581164979|FG001|Overall Study|Withdrawal by Subject|4|||
160938235|NCT00689481|581164978|FG000|Overall Study|Excluded medication started during study|0|||
160938236|NCT00689481|581164979|FG001|Overall Study|Excluded medication started during study|1|||
160938237|NCT00689481|581164978|FG000|Overall Study|Subject early term, left on vacation|0|||
160938238|NCT00689481|581164979|FG001|Overall Study|Subject early term, left on vacation|1|||
160938239|NCT03337724|581164982|FG000|Overall Study|Reason not Specified|12|||
160938240|NCT03337724|581164983|FG001|Overall Study|Reason not Specified|21|||
160938241|NCT03337724|581164984|FG002|Overall Study|Reason not Specified|9|||
160938242|NCT03337724|581164985|FG003|Overall Study|Reason not Specified|9|||
160938243|NCT03337724|581164986|FG004|Overall Study|Reason not Specified|29|||
160938244|NCT03337724|581164982|FG000|Overall Study|Withdrawal by Subject|13|||
160938245|NCT03337724|581164983|FG001|Overall Study|Withdrawal by Subject|15|||
160938246|NCT03337724|581164984|FG002|Overall Study|Withdrawal by Subject|4|||
160938247|NCT03337724|581164985|FG003|Overall Study|Withdrawal by Subject|15|||
160938248|NCT03337724|581164986|FG004|Overall Study|Withdrawal by Subject|6|||
160938249|NCT03337724|581164982|FG000|Overall Study|Protocol Deviation|0|||
160938250|NCT03337724|581164983|FG001|Overall Study|Protocol Deviation|1|||
160938251|NCT03337724|581164984|FG002|Overall Study|Protocol Deviation|1|||
160938252|NCT03337724|581164985|FG003|Overall Study|Protocol Deviation|1|||
160938253|NCT03337724|581164986|FG004|Overall Study|Protocol Deviation|0|||
160938254|NCT03337724|581164982|FG000|Overall Study|Adverse Event|1|||
160938255|NCT03337724|581164983|FG001|Overall Study|Adverse Event|1|||
160938256|NCT03337724|581164984|FG002|Overall Study|Adverse Event|0|||
160938257|NCT03337724|581164985|FG003|Overall Study|Adverse Event|1|||
160938258|NCT03337724|581164986|FG004|Overall Study|Adverse Event|0|||
160938259|NCT03337724|581164982|FG000|Overall Study|Death|40|||
160938260|NCT03337724|581164983|FG001|Overall Study|Death|89|||
160938261|NCT03337724|581164984|FG002|Overall Study|Death|43|||
160938262|NCT03337724|581164985|FG003|Overall Study|Death|76|||
160938263|NCT03337724|581164986|FG004|Overall Study|Death|50|||
160938264|NCT03337724|581164982|FG000|Overall Study|Lost to Follow-up|5|||
160938265|NCT03337724|581164983|FG001|Overall Study|Lost to Follow-up|5|||
160938266|NCT03337724|581164984|FG002|Overall Study|Lost to Follow-up|4|||
160938267|NCT03337724|581164985|FG003|Overall Study|Lost to Follow-up|7|||
160938268|NCT03337724|581164986|FG004|Overall Study|Lost to Follow-up|4|||
160938269|NCT03337724|581164982|FG000|Overall Study|Physician Decision|16|||
160938270|NCT03337724|581164983|FG001|Overall Study|Physician Decision|34|||
160938271|NCT03337724|581164984|FG002|Overall Study|Physician Decision|14|||
160938272|NCT03337724|581164985|FG003|Overall Study|Physician Decision|34|||
160938273|NCT03337724|581164986|FG004|Overall Study|Physician Decision|13|||
160938274|NCT03337724|581164982|FG000|Overall Study|Progressive Disease|0|||
160938275|NCT03337724|581164983|FG001|Overall Study|Progressive Disease|2|||
160938276|NCT03337724|581164984|FG002|Overall Study|Progressive Disease|1|||
160938277|NCT03337724|581164985|FG003|Overall Study|Progressive Disease|2|||
160938278|NCT03337724|581164986|FG004|Overall Study|Progressive Disease|0|||
160938279|NCT03337724|581164982|FG000|Overall Study|Symptomatic Deterioration|0|||
160938280|NCT03337724|581164983|FG001|Overall Study|Symptomatic Deterioration|0|||
160938281|NCT03337724|581164984|FG002|Overall Study|Symptomatic Deterioration|0|||
160938282|NCT03337724|581164985|FG003|Overall Study|Symptomatic Deterioration|1|||
160938283|NCT03337724|581164986|FG004|Overall Study|Symptomatic Deterioration|0|||
160938284|NCT00528528|581164987|FG000|Overall Study|Lost to Follow-up|0|||
160938285|NCT00528528|581164988|FG001|Overall Study|Lost to Follow-up|0|||
160938286|NCT00528528|581164989|FG002|Overall Study|Lost to Follow-up|1|||
160938287|NCT00528528|581164990|FG003|Overall Study|Lost to Follow-up|1|||
160938288|NCT00528528|581164987|FG000|Overall Study|Ineligible to continue the trial|0|||
160938289|NCT00528528|581164988|FG001|Overall Study|Ineligible to continue the trial|0|||
160938290|NCT00528528|581164989|FG002|Overall Study|Ineligible to continue the trial|0|||
160938291|NCT00528528|581164990|FG003|Overall Study|Ineligible to continue the trial|1|||
160938292|NCT00528528|581164987|FG000|Overall Study|Other|0|||
160938293|NCT00528528|581164988|FG001|Overall Study|Other|1|||
160938294|NCT00528528|581164989|FG002|Overall Study|Other|0|||
160938295|NCT00528528|581164990|FG003|Overall Study|Other|0|||
160938296|NCT00528528|581164987|FG000|Overall Study|Withdrawal by Subject|3|||
160938297|NCT00528528|581164988|FG001|Overall Study|Withdrawal by Subject|2|||
160938298|NCT00528528|581164989|FG002|Overall Study|Withdrawal by Subject|1|||
160938299|NCT00528528|581164990|FG003|Overall Study|Withdrawal by Subject|1|||
160938300|NCT00528528|581164987|FG000|Overall Study|Ongoing participant|0|||
160938301|NCT00528528|581164988|FG001|Overall Study|Ongoing participant|0|||
160938302|NCT00528528|581164989|FG002|Overall Study|Ongoing participant|1|||
160938303|NCT00528528|581164990|FG003|Overall Study|Ongoing participant|0|||
160938304|NCT00773097|581164991|FG000|Overall Study|Withdrawal by Subject|1|||
160938305|NCT00773097|581164991|FG000|Overall Study|Physician Decision|6|||
160938306|NCT04084769|581164996|FG000|Overall Study|Protocol Violation|1|||
160938307|NCT04084769|581164997|FG001|Overall Study|Protocol Violation|3|||
160938308|NCT04084769|581164998|FG002|Overall Study|Protocol Violation|0|||
160938309|NCT04084769|581164999|FG003|Overall Study|Protocol Violation|1|||
160938310|NCT04084769|581164996|FG000|Overall Study|Withdrawal by Subject|0|||
160938311|NCT04084769|581164997|FG001|Overall Study|Withdrawal by Subject|1|||
160938312|NCT04084769|581164998|FG002|Overall Study|Withdrawal by Subject|0|||
160938313|NCT04084769|581164999|FG003|Overall Study|Withdrawal by Subject|0|||
160938314|NCT04084769|581164996|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160938315|NCT04084769|581164997|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160938316|NCT04084769|581164998|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160938317|NCT04084769|581164999|FG003|Overall Study|Withdrawal by parent/guardian|1|||
160938318|NCT04084769|581164996|FG000|Overall Study|Lost to Follow-up|2|||
160938319|NCT04084769|581164997|FG001|Overall Study|Lost to Follow-up|0|||
160938320|NCT04084769|581164998|FG002|Overall Study|Lost to Follow-up|0|||
160938321|NCT04084769|581164999|FG003|Overall Study|Lost to Follow-up|0|||
160938322|NCT03508219|581165000|FG000|Overall Study|Death|2|||
160938323|NCT03508219|581165000|FG000|Overall Study|Withdrawal by Subject|1|||
160938324|NCT03508219|581165000|FG000|Overall Study|Lost to Follow-up|4|||
160938325|NCT03508219|581165000|FG000|Overall Study|Missed visit|2|||
160938326|NCT04466891|581165001|FG000|Overall Study|Death|60|||
160938327|NCT04466891|581165002|FG001|Overall Study|Death|6|||
160938328|NCT04466891|581165001|FG000|Overall Study|Withdrawal by Subject|8|||
160938329|NCT04466891|581165002|FG001|Overall Study|Withdrawal by Subject|1|||
160938330|NCT04466891|581165001|FG000|Overall Study|Study terminated by sponsor|5|||
160938331|NCT04466891|581165002|FG001|Overall Study|Study terminated by sponsor|0|||
160938332|NCT04466891|581165001|FG000|Overall Study|Lost to Follow-up|2|||
160938333|NCT04466891|581165002|FG001|Overall Study|Lost to Follow-up|0|||
160938334|NCT04466891|581165001|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
160938335|NCT04466891|581165002|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
160938336|NCT00445328|581165003|FG000|Overall Study|Death|0|||
160938337|NCT00445328|581165004|FG001|Overall Study|Death|1|||
160938338|NCT00445328|581165003|FG000|Overall Study|Adverse Event|0|||
160938339|NCT00445328|581165004|FG001|Overall Study|Adverse Event|3|||
160938340|NCT00445328|581165003|FG000|Overall Study|Other|0|||
160938341|NCT00445328|581165004|FG001|Overall Study|Other|2|||
160938342|NCT00445328|581165003|FG000|Overall Study|Withdrawal by Subject|2|||
160938343|NCT00445328|581165004|FG001|Overall Study|Withdrawal by Subject|0|||
160938344|NCT00445328|581165003|FG000|Overall Study|Protocol Violation|1|||
160938345|NCT00445328|581165004|FG001|Overall Study|Protocol Violation|0|||
160938346|NCT00590954|581165007|FG000|Overall Study|Inevaluable|2|||
160938347|NCT06023394|581165014|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
160938348|NCT06023394|581165015|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
160938349|NCT06023394|581165014|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
160938350|NCT06023394|581165015|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
160938351|NCT06023394|581165014|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
160938352|NCT06023394|581165015|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
160938353|NCT06023394|581165014|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
160938354|NCT06023394|581165015|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
160938355|NCT00941733|581166301|FG000|Overall Study|Death|24|||
160938356|NCT00941733|581166302|FG001|Overall Study|Death|10|||
160938357|NCT00941733|581166301|FG000|Overall Study|Withdrawal by Subject|14|||
160938358|NCT00941733|581166302|FG001|Overall Study|Withdrawal by Subject|6|||
160938359|NCT00941733|581166301|FG000|Overall Study|Adverse Event|20|||
160938360|NCT00941733|581166302|FG001|Overall Study|Adverse Event|4|||
160938361|NCT00941733|581166301|FG000|Overall Study|Lost to Follow-up|1|||
160938362|NCT00941733|581166302|FG001|Overall Study|Lost to Follow-up|2|||
160938363|NCT00941733|581166301|FG000|Overall Study|Protocol Violation|15|||
160938364|NCT00941733|581166302|FG001|Overall Study|Protocol Violation|6|||
160938365|NCT01105533|581166303|FG000|Overall Study|Death|0|||
160938366|NCT01105533|581166304|FG001|Overall Study|Death|0|||
160938367|NCT01105533|581166305|FG002|Overall Study|Death|0|||
160938368|NCT01105533|581166306|FG003|Overall Study|Death|0|||
160938369|NCT01105533|581166307|FG004|Overall Study|Death|1|||
160938370|NCT01105533|581166308|FG005|Overall Study|Death|0|||
160938371|NCT01105533|581166309|FG006|Overall Study|Death|0|||
160938372|NCT01105533|581166310|FG007|Overall Study|Death|0|||
160938373|NCT01105533|581166311|FG008|Overall Study|Death|0|||
160938374|NCT01105533|581166303|FG000|Overall Study|Lack of Efficacy|1|||
160938375|NCT01105533|581166304|FG001|Overall Study|Lack of Efficacy|1|||
160938376|NCT01105533|581166305|FG002|Overall Study|Lack of Efficacy|3|||
160938377|NCT01105533|581166306|FG003|Overall Study|Lack of Efficacy|3|||
160938378|NCT01105533|581166307|FG004|Overall Study|Lack of Efficacy|4|||
160938379|NCT01105533|581166308|FG005|Overall Study|Lack of Efficacy|5|||
160938380|NCT01105533|581166309|FG006|Overall Study|Lack of Efficacy|3|||
160938381|NCT01105533|581166310|FG007|Overall Study|Lack of Efficacy|2|||
160938382|NCT01105533|581166311|FG008|Overall Study|Lack of Efficacy|9|||
160938383|NCT01105533|581166303|FG000|Overall Study|Adverse Event|0|||
160938384|NCT01105533|581166304|FG001|Overall Study|Adverse Event|0|||
160938385|NCT01105533|581166305|FG002|Overall Study|Adverse Event|0|||
160938386|NCT01105533|581166306|FG003|Overall Study|Adverse Event|0|||
160938387|NCT01105533|581166307|FG004|Overall Study|Adverse Event|1|||
160938388|NCT01105533|581166308|FG005|Overall Study|Adverse Event|2|||
160938389|NCT01105533|581166309|FG006|Overall Study|Adverse Event|2|||
160938390|NCT01105533|581166310|FG007|Overall Study|Adverse Event|0|||
160938391|NCT01105533|581166311|FG008|Overall Study|Adverse Event|1|||
160938392|NCT01105533|581166303|FG000|Overall Study|Other|0|||
160938393|NCT01105533|581166304|FG001|Overall Study|Other|0|||
160938394|NCT01105533|581166305|FG002|Overall Study|Other|0|||
160938395|NCT01105533|581166306|FG003|Overall Study|Other|0|||
160938396|NCT01105533|581166307|FG004|Overall Study|Other|1|||
160938397|NCT01105533|581166308|FG005|Overall Study|Other|0|||
160938398|NCT01105533|581166309|FG006|Overall Study|Other|3|||
160938399|NCT01105533|581166310|FG007|Overall Study|Other|1|||
160938400|NCT01105533|581166311|FG008|Overall Study|Other|2|||
160938401|NCT01105533|581166303|FG000|Overall Study|Physician Decision|0|||
160938402|NCT01105533|581166304|FG001|Overall Study|Physician Decision|0|||
160938403|NCT01105533|581166305|FG002|Overall Study|Physician Decision|0|||
160938404|NCT01105533|581166306|FG003|Overall Study|Physician Decision|0|||
160938405|NCT01105533|581166307|FG004|Overall Study|Physician Decision|0|||
160938406|NCT01105533|581166308|FG005|Overall Study|Physician Decision|0|||
160938407|NCT01105533|581166309|FG006|Overall Study|Physician Decision|0|||
160938408|NCT01105533|581166310|FG007|Overall Study|Physician Decision|1|||
160938409|NCT01105533|581166311|FG008|Overall Study|Physician Decision|0|||
160938410|NCT03892889|581166312|FG000|Overall Study|Adverse Event|17|||
160938411|NCT03892889|581166312|FG000|Overall Study|Lack of Efficacy|1|||
160938412|NCT03892889|581166312|FG000|Overall Study|Lost to Follow-up|46|||
160938413|NCT03892889|581166312|FG000|Overall Study|Non-compliance with study drug|22|||
160938414|NCT03892889|581166312|FG000|Overall Study|Pregnancy|1|||
160938415|NCT03892889|581166312|FG000|Overall Study|Protocol Deviation|3|||
160938416|NCT03892889|581166312|FG000|Overall Study|Withdrawal by Subject|50|||
160938417|NCT03892889|581166312|FG000|Overall Study|Withdrawal by Caregiver|1|||
160938418|NCT03892889|581166312|FG000|Overall Study|Study Terminated by Sponsor|50|||
160938419|NCT03892889|581166312|FG000|Overall Study|Physician Decision|8|||
160938420|NCT03892889|581166312|FG000|Overall Study|Reason not Specified|5|||
160938421|NCT01639001|581166316|FG000|Overall Study|Refused further follow-up|9|||
160938422|NCT01639001|581166317|FG001|Overall Study|Refused further follow-up|12|||
160938423|NCT01639001|581166316|FG000|Overall Study|Lost to Follow-up|3|||
160938424|NCT01639001|581166317|FG001|Overall Study|Lost to Follow-up|0|||
160938425|NCT01639001|581166316|FG000|Overall Study|Death|62|||
160938426|NCT01639001|581166317|FG001|Overall Study|Death|61|||
160938427|NCT01639001|581166316|FG000|Overall Study|Randomized but not treated|0|||
160938428|NCT01639001|581166317|FG001|Overall Study|Randomized but not treated|2|||
160938429|NCT01639001|581166316|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
160938430|NCT01639001|581166317|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
160938431|NCT02453594|581166318|FG000|Overall Study|Protocol Violation|0|||
160938432|NCT02453594|581166319|FG001|Overall Study|Protocol Violation|0|||
160938433|NCT02453594|581166320|FG002|Overall Study|Protocol Violation|1|||
160938434|NCT02453594|581166318|FG000|Overall Study|Cohort Was Closed|17|||
160938435|NCT02453594|581166319|FG001|Overall Study|Cohort Was Closed|21|||
160938436|NCT02453594|581166320|FG002|Overall Study|Cohort Was Closed|14|||
160938437|NCT02453594|581166318|FG000|Overall Study|Death|20|||
160938438|NCT02453594|581166319|FG001|Overall Study|Death|24|||
160938439|NCT02453594|581166320|FG002|Overall Study|Death|16|||
160938440|NCT02453594|581166318|FG000|Overall Study|Lost to Follow-up|6|||
160938441|NCT02453594|581166319|FG001|Overall Study|Lost to Follow-up|14|||
160938442|NCT02453594|581166320|FG002|Overall Study|Lost to Follow-up|2|||
160938443|NCT02453594|581166318|FG000|Overall Study|Physician Decision|2|||
160938444|NCT02453594|581166319|FG001|Overall Study|Physician Decision|4|||
160998731|NCT01235949|581380618|FG016|Booster Phase|Migrated/moved from study area|0|||
160998732|NCT01235949|581380619|FG017|Booster Phase|Migrated/moved from study area|1|||
160455449|NCT03034356|579397945|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
160938445|NCT02453594|581166320|FG002|Overall Study|Physician Decision|0|||
160938446|NCT02453594|581166318|FG000|Overall Study|Site Terminated by Sponsor|1|||
160938447|NCT02453594|581166319|FG001|Overall Study|Site Terminated by Sponsor|0|||
160938448|NCT02453594|581166320|FG002|Overall Study|Site Terminated by Sponsor|1|||
160938449|NCT02453594|581166318|FG000|Overall Study|Transitioned to Extension Study|16|||
160938450|NCT02453594|581166319|FG001|Overall Study|Transitioned to Extension Study|9|||
160938451|NCT02453594|581166320|FG002|Overall Study|Transitioned to Extension Study|16|||
160938452|NCT02453594|581166318|FG000|Overall Study|Withdrawal by Subject|7|||
160938453|NCT02453594|581166319|FG001|Overall Study|Withdrawal by Subject|9|||
160938454|NCT02453594|581166320|FG002|Overall Study|Withdrawal by Subject|11|||
160938455|NCT02097134|581166321|FG000|Overall Study|Physician Decision|4|||
160938456|NCT02097134|581166321|FG000|Overall Study|Non-Protocol Therapy|1|||
160938457|NCT02097134|581166321|FG000|Overall Study|Progressive Disease|3|||
160938458|NCT02097134|581166321|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
160938459|NCT00679341|581166323|FG000|Overall Study|Disease progression|42|||
160938460|NCT00679341|581166324|FG001|Overall Study|Disease progression|36|||
160938461|NCT00679341|581166323|FG000|Overall Study|Adverse Event|5|||
160938462|NCT00679341|581166324|FG001|Overall Study|Adverse Event|6|||
160938463|NCT00679341|581166323|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
160938464|NCT00679341|581166324|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
160938465|NCT00679341|581166323|FG000|Overall Study|Death|1|||
160938466|NCT00679341|581166324|FG001|Overall Study|Death|1|||
160938467|NCT00679341|581166323|FG000|Overall Study|Other|1|||
160938468|NCT00679341|581166324|FG001|Overall Study|Other|0|||
160938469|NCT00679341|581166323|FG000|Overall Study|Physician Decision|1|||
160938470|NCT00679341|581166324|FG001|Overall Study|Physician Decision|0|||
160938471|NCT00679341|581166323|FG000|Overall Study|Not treated|0|||
160938472|NCT00679341|581166324|FG001|Overall Study|Not treated|2|||
160938473|NCT00679341|581166323|FG000|Overall Study|Physician/patient decision to withdraw|0|||
160938474|NCT00679341|581166324|FG001|Overall Study|Physician/patient decision to withdraw|6|||
160938475|NCT02660359|581166333|FG000|Overall Study|Protocol Deviation|0|||
160938476|NCT02660359|581166334|FG001|Overall Study|Protocol Deviation|0|||
160938477|NCT02660359|581166335|FG002|Overall Study|Protocol Deviation|1|||
160938478|NCT02660359|581166333|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
160938479|NCT02660359|581166334|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
160938480|NCT02660359|581166335|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
160938481|NCT02660359|581166333|FG000|Overall Study|Lack of Efficacy|1|||
160938482|NCT02660359|581166334|FG001|Overall Study|Lack of Efficacy|1|||
160938483|NCT02660359|581166335|FG002|Overall Study|Lack of Efficacy|1|||
160938484|NCT02660359|581166333|FG000|Overall Study|Adverse Event|0|||
160938485|NCT02660359|581166334|FG001|Overall Study|Adverse Event|1|||
160938486|NCT02660359|581166335|FG002|Overall Study|Adverse Event|0|||
160938487|NCT02660359|581166333|FG000|Overall Study|Other|2|||
160938488|NCT02660359|581166334|FG001|Overall Study|Other|1|||
160938489|NCT02660359|581166335|FG002|Overall Study|Other|3|||
160938490|NCT02660359|581166333|FG000|Overall Study|Withdrawal by Subject|7|||
160938491|NCT02660359|581166334|FG001|Overall Study|Withdrawal by Subject|5|||
160938492|NCT02660359|581166335|FG002|Overall Study|Withdrawal by Subject|8|||
160938493|NCT02660359|581166333|FG000|Overall Study|Lost to Follow-up|3|||
160938494|NCT02660359|581166334|FG001|Overall Study|Lost to Follow-up|3|||
160938495|NCT02660359|581166335|FG002|Overall Study|Lost to Follow-up|0|||
160938496|NCT04879745|581166342|FG000|Overall Study|Lost to Follow-up|4|||
160938497|NCT04879745|581166343|FG001|Overall Study|Lost to Follow-up|1|||
160938498|NCT00120042|581166344|FG000|Overall Study|all completed protocl|0|||
160938499|NCT00120042|581166345|FG001|Overall Study|all completed protocl|0|||
160938500|NCT00120042|581166346|FG002|Overall Study|all completed protocl|0|||
160938501|NCT04532112|581166349|FG000|Overall Study|Adverse Event|3|||
160938502|NCT04532112|581166350|FG001|Overall Study|Adverse Event|0|||
160938503|NCT01126541|581166352|FG000|Overall Study|Adverse Event|0|||
160938504|NCT01126541|581166353|FG001|Overall Study|Adverse Event|2|||
160938505|NCT01126541|581166354|FG002|Overall Study|Adverse Event|4|||
160938506|NCT01126541|581166352|FG000|Overall Study|Death|0|||
160938507|NCT01126541|581166353|FG001|Overall Study|Death|1|||
160938508|NCT01126541|581166354|FG002|Overall Study|Death|0|||
160938509|NCT01126541|581166352|FG000|Overall Study|Lack of Efficacy|6|||
160938510|NCT01126541|581166353|FG001|Overall Study|Lack of Efficacy|1|||
160938511|NCT01126541|581166354|FG002|Overall Study|Lack of Efficacy|11|||
160938512|NCT01126541|581166352|FG000|Overall Study|Lost to Follow-up|1|||
160938513|NCT01126541|581166353|FG001|Overall Study|Lost to Follow-up|2|||
160938514|NCT01126541|581166354|FG002|Overall Study|Lost to Follow-up|2|||
160938515|NCT01126541|581166352|FG000|Overall Study|Withdrawal by Subject|2|||
160938516|NCT01126541|581166353|FG001|Overall Study|Withdrawal by Subject|5|||
160938517|NCT01126541|581166354|FG002|Overall Study|Withdrawal by Subject|6|||
160938518|NCT01126541|581166352|FG000|Overall Study|Protocol Violation|0|||
160938519|NCT01126541|581166353|FG001|Overall Study|Protocol Violation|0|||
160938520|NCT01126541|581166354|FG002|Overall Study|Protocol Violation|1|||
160938521|NCT01126541|581166352|FG000|Overall Study|Administrative reason or other|1|||
160938522|NCT01126541|581166353|FG001|Overall Study|Administrative reason or other|1|||
160938523|NCT01126541|581166354|FG002|Overall Study|Administrative reason or other|2|||
160938524|NCT02939404|581166356|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
160938525|NCT02939404|581166357|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
160938526|NCT02939404|581166356|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
160938527|NCT02939404|581166357|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
160938528|NCT02664038|581166358|FG000|13 Week|Lost to Follow-up|7|||
160938529|NCT02664038|581166359|FG001|13 Week|Lost to Follow-up|14|||
160938530|NCT02664038|581166358|FG000|13 Week|Withdrawal by Subject|1|||
160938531|NCT02664038|581166359|FG001|13 Week|Withdrawal by Subject|0|||
160938532|NCT02664038|581166358|FG000|26 Week|Lost to Follow-up|5|||
160938533|NCT02664038|581166359|FG001|26 Week|Lost to Follow-up|4|||
160938534|NCT06640829|581166364|FG000|Overall Study|Withdrawal by Subject|1|||
160938535|NCT06640829|581166364|FG000|Overall Study|Lost to Follow-up|1|||
160938536|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Adverse Event|41|||
160938537|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Adverse Event|24|||
160938538|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
160938539|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
160938540|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
160938541|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
160938542|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Physician Decision|0|||
160938543|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Physician Decision|6|||
160938544|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
160938545|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
160938546|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
160938547|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
160938548|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
160938549|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
160938550|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
160938551|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
160938552|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
160938553|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
160938554|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
160938555|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
160938556|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
160938557|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
160938558|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
160938559|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
160938560|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
160938561|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
160938562|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
160938563|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
160938564|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
160938565|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
160938566|NCT03025828|581166368|FG000|Overall Study|Lost to Follow-up|1|||
160938567|NCT00480779|581166369|FG000|Overall Study|Other|2|||
160938568|NCT00480779|581166370|FG001|Overall Study|Other|0|||
160938569|NCT00480779|581166369|FG000|Overall Study|Job and Health-related|0|||
160938570|NCT00480779|581166370|FG001|Overall Study|Job and Health-related|3|||
160938571|NCT02519712|581166373|FG000|Overall Study|Disease Relapse|1|||
160938572|NCT02519712|581166373|FG000|Overall Study|Disease Progression|1|||
160938573|NCT02519712|581166373|FG000|Overall Study|Accruals are donors|2|||
160938574|NCT02908529|581166384|FG000|Overall Study|Lost to Follow-up|0|||
160938575|NCT02908529|581166385|FG001|Overall Study|Lost to Follow-up|2|||
160938576|NCT04497987|581166386|FG000|Overall Study|Adverse Event|1|||
160938577|NCT04497987|581166387|FG001|Overall Study|Adverse Event|0|||
160938578|NCT04497987|581166386|FG000|Overall Study|Death|21|||
160938579|NCT04497987|581166387|FG001|Overall Study|Death|13|||
160938580|NCT04497987|581166386|FG000|Overall Study|Lost to Follow-up|19|||
160938581|NCT04497987|581166387|FG001|Overall Study|Lost to Follow-up|17|||
160938582|NCT04497987|581166386|FG000|Overall Study|Other - as reported by the investigator|22|||
160938583|NCT04497987|581166387|FG001|Overall Study|Other - as reported by the investigator|16|||
160938584|NCT04497987|581166386|FG000|Overall Study|Physician Decision|1|||
160938585|NCT04497987|581166387|FG001|Overall Study|Physician Decision|0|||
160938586|NCT04497987|581166386|FG000|Overall Study|Withdrawal by Subject|35|||
160938587|NCT04497987|581166387|FG001|Overall Study|Withdrawal by Subject|21|||
160938588|NCT02553421|581166392|FG000|Overall Study|Lost to Follow-up|21|||
160938589|NCT02553421|581166393|FG001|Overall Study|Lost to Follow-up|1|||
160938590|NCT02553421|581166392|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
160938591|NCT02553421|581166393|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
160938592|NCT02553421|581166392|FG000|Overall Study|Improper Device Placement|3|||
160938593|NCT02553421|581166393|FG001|Overall Study|Improper Device Placement|0|||
160938594|NCT04579679|581166400|FG000|Overall Study|New Antitumor Therapy|6|||
160455450|NCT03034356|579397944|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
160455451|NCT03034356|579397945|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
160938595|NCT04579679|581166401|FG001|Overall Study|New Antitumor Therapy|4|||
160938596|NCT04579679|581166402|FG002|Overall Study|New Antitumor Therapy|7|||
160938597|NCT04579679|581166403|FG003|Overall Study|New Antitumor Therapy|0|||
160938598|NCT04579679|581166400|FG000|Overall Study|Withdrawal of Consent|1|||
160938599|NCT04579679|581166401|FG001|Overall Study|Withdrawal of Consent|1|||
160938600|NCT04579679|581166402|FG002|Overall Study|Withdrawal of Consent|2|||
160455452|NCT02684227|579397946|FG000|Overall Study|Adverse Event|1|||
160938601|NCT04579679|581166403|FG003|Overall Study|Withdrawal of Consent|4|||
160938602|NCT04579679|581166400|FG000|Overall Study|Death|2|||
160938603|NCT04579679|581166401|FG001|Overall Study|Death|2|||
160938604|NCT04579679|581166402|FG002|Overall Study|Death|2|||
160938605|NCT04579679|581166403|FG003|Overall Study|Death|0|||
160938606|NCT04579679|581166400|FG000|Overall Study|Adverse Event|0|||
160938607|NCT04579679|581166401|FG001|Overall Study|Adverse Event|4|||
160938608|NCT04579679|581166402|FG002|Overall Study|Adverse Event|0|||
160938609|NCT04579679|581166403|FG003|Overall Study|Adverse Event|0|||
160938610|NCT04579679|581166400|FG000|Overall Study|Disease Progression|9|||
160938611|NCT04579679|581166401|FG001|Overall Study|Disease Progression|13|||
160938612|NCT04579679|581166402|FG002|Overall Study|Disease Progression|7|||
160938613|NCT04579679|581166403|FG003|Overall Study|Disease Progression|0|||
160938614|NCT04579679|581166400|FG000|Overall Study|Physician Decision|0|||
160938615|NCT04579679|581166401|FG001|Overall Study|Physician Decision|0|||
160938616|NCT04579679|581166402|FG002|Overall Study|Physician Decision|1|||
160938617|NCT04579679|581166403|FG003|Overall Study|Physician Decision|0|||
160938618|NCT04579679|581166400|FG000|Overall Study|Study Terminated by Sponsor|2|||
160938619|NCT04579679|581166401|FG001|Overall Study|Study Terminated by Sponsor|7|||
160938620|NCT04579679|581166402|FG002|Overall Study|Study Terminated by Sponsor|1|||
160938621|NCT04579679|581166403|FG003|Overall Study|Study Terminated by Sponsor|0|||
160938622|NCT02782949|581166404|FG000|Overall Study|Protocol Violation|1|||
160938623|NCT02782949|581166405|FG001|Overall Study|Protocol Violation|0|||
160938624|NCT02782949|581166404|FG000|Overall Study|Withdrawal by Subject|0|||
160938625|NCT02782949|581166405|FG001|Overall Study|Withdrawal by Subject|1|||
160938626|NCT03238911|581166406|FG000|Overall Study|Withdrawal by Subject|1|||
160938627|NCT03238911|581166407|FG001|Overall Study|Withdrawal by Subject|2|||
160938628|NCT03238911|581166406|FG000|Overall Study|Lost to Follow-up|2|||
160938629|NCT03238911|581166407|FG001|Overall Study|Lost to Follow-up|1|||
160938630|NCT03091192|581166411|FG000|Overall Study|Study terminated by sponsor|21|||
160938631|NCT03091192|581166412|FG001|Overall Study|Study terminated by sponsor|14|||
160938632|NCT03091192|581166411|FG000|Overall Study|Death|9|||
160938633|NCT03091192|581166412|FG001|Overall Study|Death|13|||
160938634|NCT03091192|581166411|FG000|Overall Study|Withdrawal by Subject|2|||
160938635|NCT03091192|581166412|FG001|Overall Study|Withdrawal by Subject|0|||
160938636|NCT03091192|581166411|FG000|Overall Study|Lost to Follow-up|1|||
160938637|NCT03091192|581166412|FG001|Overall Study|Lost to Follow-up|0|||
160938638|NCT03195478|581166413|FG000|Overall Study|Disease Progression|5|||
160938639|NCT03195478|581166414|FG001|Overall Study|Disease Progression|4|||
160938640|NCT03195478|581166415|FG002|Overall Study|Disease Progression|6|||
160938641|NCT03195478|581166416|FG003|Overall Study|Disease Progression|1|||
160938642|NCT03195478|581166413|FG000|Overall Study|Study Drug Toxicity|2|||
160938643|NCT03195478|581166414|FG001|Overall Study|Study Drug Toxicity|0|||
160938644|NCT03195478|581166415|FG002|Overall Study|Study Drug Toxicity|0|||
160938645|NCT03195478|581166416|FG003|Overall Study|Study Drug Toxicity|1|||
160938646|NCT03195478|581166413|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
160938647|NCT03195478|581166414|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
160938648|NCT03195478|581166415|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
160938649|NCT03195478|581166416|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
160938650|NCT03195478|581166413|FG000|Overall Study|Participant Withdrew Consent|1|||
160938651|NCT03195478|581166414|FG001|Overall Study|Participant Withdrew Consent|0|||
160938652|NCT03195478|581166415|FG002|Overall Study|Participant Withdrew Consent|0|||
160938653|NCT03195478|581166416|FG003|Overall Study|Participant Withdrew Consent|0|||
160938654|NCT03195478|581166413|FG000|Overall Study|Maximum Clinical benefit|0|||
160938655|NCT03195478|581166414|FG001|Overall Study|Maximum Clinical benefit|0|||
160938656|NCT03195478|581166415|FG002|Overall Study|Maximum Clinical benefit|1|||
160938657|NCT03195478|581166416|FG003|Overall Study|Maximum Clinical benefit|0|||
160938658|NCT03195478|581166413|FG000|Overall Study|Other Reasons|0|||
160938659|NCT03195478|581166414|FG001|Overall Study|Other Reasons|0|||
160938660|NCT03195478|581166415|FG002|Overall Study|Other Reasons|1|||
160938661|NCT03195478|581166416|FG003|Overall Study|Other Reasons|0|||
160938662|NCT03370341|581168665|FG000|Overall Study|Lost to Follow-up|0|||
160938663|NCT03370341|581168666|FG001|Overall Study|Lost to Follow-up|1|||
160938664|NCT01707004|581168669|FG000|Overall Study|Physician Decision|3|||
160938665|NCT02573324|581168673|FG000|Overall Study|Withdrawal by Subject|26|||
160938666|NCT02573324|581168674|FG001|Overall Study|Withdrawal by Subject|23|||
160938667|NCT02573324|581168675|FG002|Overall Study|Withdrawal by Subject|3|||
160938668|NCT02573324|581168673|FG000|Overall Study|Lost to Follow-up|4|||
160938669|NCT02573324|581168674|FG001|Overall Study|Lost to Follow-up|5|||
160938670|NCT02573324|581168675|FG002|Overall Study|Lost to Follow-up|0|||
160998733|NCT01235949|581380602|FG000|Booster Phase|Adverse Event|0|||
160998734|NCT01235949|581380603|FG001|Booster Phase|Adverse Event|0|||
160578665|NCT03123939|579838438|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
160938671|NCT02573324|581168673|FG000|Overall Study|Study Terminated by Sponsor|107|||
160938672|NCT02573324|581168674|FG001|Overall Study|Study Terminated by Sponsor|89|||
160938673|NCT02573324|581168675|FG002|Overall Study|Study Terminated by Sponsor|2|||
160938674|NCT02573324|581168673|FG000|Overall Study|Death|182|||
160938675|NCT02573324|581168674|FG001|Overall Study|Death|200|||
160938676|NCT02573324|581168675|FG002|Overall Study|Death|1|||
160938677|NCT02573324|581168673|FG000|Overall Study|Other, Not Specified|20|||
160938678|NCT02573324|581168674|FG001|Overall Study|Other, Not Specified|27|||
160938679|NCT02573324|581168675|FG002|Overall Study|Other, Not Specified|0|||
160938680|NCT02573324|581168673|FG000|Overall Study|Unknown Reason|2|||
160938681|NCT02573324|581168674|FG001|Overall Study|Unknown Reason|0|||
160938682|NCT02573324|581168675|FG002|Overall Study|Unknown Reason|0|||
160938683|NCT01607905|581168676|FG000|Overall Study|Withdrawal by participant|7|||
160938684|NCT01607905|581168677|FG001|Overall Study|Withdrawal by participant|2|||
160938685|NCT01607905|581168678|FG002|Overall Study|Withdrawal by participant|4|||
160938686|NCT01607905|581168679|FG003|Overall Study|Withdrawal by participant|6|||
160938687|NCT01607905|581168680|FG004|Overall Study|Withdrawal by participant|0|||
160938688|NCT01607905|581168681|FG005|Overall Study|Withdrawal by participant|4|||
160938689|NCT01607905|581168682|FG006|Overall Study|Withdrawal by participant|12|||
160938690|NCT01607905|581168676|FG000|Overall Study|Incidence or severity of AEs|5|||
160998735|NCT01235949|581380604|FG002|Booster Phase|Adverse Event|0|||
160938691|NCT01607905|581168677|FG001|Overall Study|Incidence or severity of AEs|1|||
160938692|NCT01607905|581168678|FG002|Overall Study|Incidence or severity of AEs|1|||
160938693|NCT01607905|581168679|FG003|Overall Study|Incidence or severity of AEs|3|||
160938694|NCT01607905|581168680|FG004|Overall Study|Incidence or severity of AEs|0|||
160938695|NCT01607905|581168681|FG005|Overall Study|Incidence or severity of AEs|2|||
160938696|NCT01607905|581168682|FG006|Overall Study|Incidence or severity of AEs|8|||
160938697|NCT01607905|581168676|FG000|Overall Study|Disease progression|44|||
160938698|NCT01607905|581168677|FG001|Overall Study|Disease progression|16|||
160938699|NCT01607905|581168678|FG002|Overall Study|Disease progression|15|||
160938700|NCT01607905|581168679|FG003|Overall Study|Disease progression|11|||
160938701|NCT01607905|581168680|FG004|Overall Study|Disease progression|6|||
160938702|NCT01607905|581168681|FG005|Overall Study|Disease progression|7|||
160938703|NCT01607905|581168682|FG006|Overall Study|Disease progression|21|||
160938704|NCT01607905|581168676|FG000|Overall Study|Non-compliance with study procedures|0|||
160938705|NCT01607905|581168677|FG001|Overall Study|Non-compliance with study procedures|0|||
160938706|NCT01607905|581168678|FG002|Overall Study|Non-compliance with study procedures|0|||
160938707|NCT01607905|581168679|FG003|Overall Study|Non-compliance with study procedures|0|||
160938708|NCT01607905|581168680|FG004|Overall Study|Non-compliance with study procedures|0|||
160938709|NCT01607905|581168681|FG005|Overall Study|Non-compliance with study procedures|0|||
160938710|NCT01607905|581168682|FG006|Overall Study|Non-compliance with study procedures|1|||
160938711|NCT01607905|581168676|FG000|Overall Study|Death|1|||
160938712|NCT01607905|581168677|FG001|Overall Study|Death|1|||
160938713|NCT01607905|581168678|FG002|Overall Study|Death|1|||
160938714|NCT01607905|581168679|FG003|Overall Study|Death|1|||
160938715|NCT01607905|581168680|FG004|Overall Study|Death|0|||
160938716|NCT01607905|581168681|FG005|Overall Study|Death|0|||
160938717|NCT01607905|581168682|FG006|Overall Study|Death|3|||
160938718|NCT01607905|581168676|FG000|Overall Study|Other treatments become available|1|||
160938719|NCT01607905|581168677|FG001|Overall Study|Other treatments become available|0|||
160938720|NCT01607905|581168678|FG002|Overall Study|Other treatments become available|0|||
160938721|NCT01607905|581168679|FG003|Overall Study|Other treatments become available|0|||
160938722|NCT01607905|581168680|FG004|Overall Study|Other treatments become available|0|||
160938723|NCT01607905|581168681|FG005|Overall Study|Other treatments become available|0|||
160938724|NCT01607905|581168682|FG006|Overall Study|Other treatments become available|1|||
160938725|NCT01607905|581168676|FG000|Overall Study|Investigator discretion|0|||
160938726|NCT01607905|581168677|FG001|Overall Study|Investigator discretion|0|||
160938727|NCT01607905|581168678|FG002|Overall Study|Investigator discretion|0|||
160938728|NCT01607905|581168679|FG003|Overall Study|Investigator discretion|0|||
160938729|NCT01607905|581168680|FG004|Overall Study|Investigator discretion|0|||
160938730|NCT01607905|581168681|FG005|Overall Study|Investigator discretion|1|||
160938731|NCT01607905|581168682|FG006|Overall Study|Investigator discretion|0|||
160938732|NCT01607905|581168676|FG000|Overall Study|Other|1|||
160938733|NCT01607905|581168677|FG001|Overall Study|Other|0|||
160938734|NCT01607905|581168678|FG002|Overall Study|Other|0|||
160938735|NCT01607905|581168679|FG003|Overall Study|Other|0|||
160938736|NCT01607905|581168680|FG004|Overall Study|Other|0|||
160938737|NCT01607905|581168681|FG005|Overall Study|Other|0|||
160938738|NCT01607905|581168682|FG006|Overall Study|Other|1|||
160938739|NCT01607905|581168676|FG000|Overall Study|Randomized but not treated|1|||
160938740|NCT01607905|581168677|FG001|Overall Study|Randomized but not treated|0|||
160938741|NCT01607905|581168678|FG002|Overall Study|Randomized but not treated|0|||
160938742|NCT01607905|581168679|FG003|Overall Study|Randomized but not treated|0|||
160938743|NCT01607905|581168680|FG004|Overall Study|Randomized but not treated|1|||
160938744|NCT01607905|581168681|FG005|Overall Study|Randomized but not treated|1|||
160938745|NCT01607905|581168682|FG006|Overall Study|Randomized but not treated|0|||
160938746|NCT00194012|581168683|FG000|Randomized Phase|Lack of Efficacy|8|||
160938747|NCT00194012|581168684|FG001|Randomized Phase|Lack of Efficacy|18|||
160938748|NCT00194012|581168683|FG000|Randomized Phase|Study nonadherence|2|||
160938749|NCT00194012|581168684|FG001|Randomized Phase|Study nonadherence|1|||
160938750|NCT00194012|581168683|FG000|Randomized Phase|Withdrawal by Subject|3|||
160938751|NCT00194012|581168684|FG001|Randomized Phase|Withdrawal by Subject|3|||
160938752|NCT00194012|581168683|FG000|Randomized Phase|Adverse Event|2|||
160578666|NCT02078713|579840102|FG000|Overall Study|Lost to Follow-up|49|||
160578667|NCT02078713|579840103|FG001|Overall Study|Lost to Follow-up|55|||
160578668|NCT02078713|579840104|FG002|Overall Study|Lost to Follow-up|0|||
160578669|NCT02078713|579840105|FG003|Overall Study|Lost to Follow-up|0|||
160578670|NCT02078713|579840102|FG000|Overall Study|Pregnant at baseline|3|||
160578671|NCT02078713|579840103|FG001|Overall Study|Pregnant at baseline|5|||
160938753|NCT00194012|581168684|FG001|Randomized Phase|Adverse Event|1|||
160938754|NCT00194012|581168683|FG000|Randomized Phase|Participant reported having a rash|1|||
160938755|NCT00194012|581168684|FG001|Randomized Phase|Participant reported having a rash|0|||
160938756|NCT00194012|581168683|FG000|Randomized Phase|Emesis and enuresis|0|||
160938757|NCT00194012|581168684|FG001|Randomized Phase|Emesis and enuresis|1|||
160938758|NCT00194012|581168683|FG000|Randomized Phase|Oral/nasal twitching|0|||
160938759|NCT00194012|581168684|FG001|Randomized Phase|Oral/nasal twitching|1|||
160938760|NCT00194012|581168683|FG000|Open Label Extension (OLE)|Weight Gain|1|||
160455453|NCT02684227|579397947|FG001|Overall Study|Adverse Event|7|||
160455454|NCT02684227|579397946|FG000|Overall Study|Death|0|||
160938761|NCT00194012|581168684|FG001|Open Label Extension (OLE)|Weight Gain|0|||
160938762|NCT00194012|581168683|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
160938763|NCT00194012|581168684|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
160938764|NCT00194012|581168683|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
160938765|NCT00194012|581168684|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
160938766|NCT00194012|581168683|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
160938767|NCT00194012|581168684|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
160938768|NCT00298896|581168690|FG000|Overall Study|Death|3|||
160938769|NCT00298896|581168690|FG000|Overall Study|Physician Decision|2|||
160938770|NCT00298896|581168690|FG000|Overall Study|Intercurrent Illness|1|||
160938771|NCT00298896|581168690|FG000|Overall Study|Disease Progression|41|||
160938772|NCT00298896|581168690|FG000|Overall Study|Withdrawal by Subject|2|||
160938773|NCT00298896|581168690|FG000|Overall Study|Assigned to treatment in error|1|||
160938774|NCT02880371|581168691|FG000|Phase 1b|Lost to Follow-up|1|||
160938775|NCT02880371|581168692|FG001|Phase 1b|Lost to Follow-up|0|||
160938776|NCT02880371|581168693|FG002|Phase 1b|Lost to Follow-up|0|||
160938777|NCT02880371|581168694|FG003|Phase 1b|Lost to Follow-up|0|||
160938778|NCT02880371|581168695|FG004|Phase 1b|Lost to Follow-up|0|||
160938779|NCT02880371|581168696|FG005|Phase 1b|Lost to Follow-up|0|||
160938780|NCT02880371|581168697|FG006|Phase 1b|Lost to Follow-up|0|||
160938781|NCT02880371|581168698|FG007|Phase 1b|Lost to Follow-up|0|||
160938782|NCT02880371|581168691|FG000|Phase 1b|Participants terminated by Sponsor|1|||
160938783|NCT02880371|581168692|FG001|Phase 1b|Participants terminated by Sponsor|0|||
160938784|NCT02880371|581168693|FG002|Phase 1b|Participants terminated by Sponsor|0|||
160938785|NCT02880371|581168694|FG003|Phase 1b|Participants terminated by Sponsor|0|||
160938786|NCT02880371|581168695|FG004|Phase 1b|Participants terminated by Sponsor|0|||
160938787|NCT02880371|581168696|FG005|Phase 1b|Participants terminated by Sponsor|0|||
160938788|NCT02880371|581168697|FG006|Phase 1b|Participants terminated by Sponsor|0|||
160938789|NCT02880371|581168698|FG007|Phase 1b|Participants terminated by Sponsor|0|||
160938790|NCT02880371|581168691|FG000|Phase 1b|Withdrawal by Subject|0|||
160938791|NCT02880371|581168692|FG001|Phase 1b|Withdrawal by Subject|0|||
160938792|NCT02880371|581168693|FG002|Phase 1b|Withdrawal by Subject|1|||
160938793|NCT02880371|581168694|FG003|Phase 1b|Withdrawal by Subject|0|||
160938794|NCT02880371|581168695|FG004|Phase 1b|Withdrawal by Subject|0|||
160938795|NCT02880371|581168696|FG005|Phase 1b|Withdrawal by Subject|0|||
160938796|NCT02880371|581168697|FG006|Phase 1b|Withdrawal by Subject|0|||
160938797|NCT02880371|581168698|FG007|Phase 1b|Withdrawal by Subject|0|||
160938798|NCT02880371|581168691|FG000|Phase 1b|Death|4|||
160938799|NCT02880371|581168692|FG001|Phase 1b|Death|6|||
160938800|NCT02880371|581168693|FG002|Phase 1b|Death|5|||
160938801|NCT02880371|581168694|FG003|Phase 1b|Death|1|||
160938802|NCT02880371|581168695|FG004|Phase 1b|Death|0|||
160938803|NCT02880371|581168696|FG005|Phase 1b|Death|0|||
160938804|NCT02880371|581168697|FG006|Phase 1b|Death|0|||
160938805|NCT02880371|581168698|FG007|Phase 1b|Death|0|||
160938806|NCT02880371|581168691|FG000|Phase 1b|Enrolled but not Treated|0|||
160938807|NCT02880371|581168692|FG001|Phase 1b|Enrolled but not Treated|1|||
160938808|NCT02880371|581168693|FG002|Phase 1b|Enrolled but not Treated|0|||
160938809|NCT02880371|581168694|FG003|Phase 1b|Enrolled but not Treated|0|||
160938810|NCT02880371|581168695|FG004|Phase 1b|Enrolled but not Treated|0|||
160998736|NCT01235949|581380605|FG003|Booster Phase|Adverse Event|0|||
160455455|NCT02684227|579397947|FG001|Overall Study|Death|2|||
160455456|NCT02684227|579397946|FG000|Overall Study|Withdrawal by Subject|0|||
160455457|NCT02684227|579397947|FG001|Overall Study|Withdrawal by Subject|1|||
160455458|NCT02684227|579397946|FG000|Overall Study|Progressive Disease|0|||
160455459|NCT02684227|579397947|FG001|Overall Study|Progressive Disease|2|||
160455460|NCT04571619|579397948|FG000|Phase 1|Death|22|||
160455461|NCT04571619|579397949|FG001|Phase 1|Death|18|||
160656002|NCT02768298|580120342|FG001|Overall Study|Subject/guardian decision|0|||
160656003|NCT02768298|580120341|FG000|Overall Study|Withdrawal of informed consent|0|||
160938811|NCT02880371|581168696|FG005|Phase 1b|Enrolled but not Treated|0|||
160938812|NCT02880371|581168697|FG006|Phase 1b|Enrolled but not Treated|0|||
160998737|NCT01235949|581380606|FG004|Booster Phase|Adverse Event|0|||
160455462|NCT04571619|579397948|FG000|Phase 1|Withdrawal by Subject|7|||
160455463|NCT04571619|579397949|FG001|Phase 1|Withdrawal by Subject|2|||
160455464|NCT04571619|579397948|FG000|Phase 2|Death|13|||
160656004|NCT02768298|580120342|FG001|Overall Study|Withdrawal of informed consent|1|||
160938813|NCT02880371|581168698|FG007|Phase 1b|Enrolled but not Treated|0|||
160938814|NCT02880371|581168691|FG000|Phase 2|Enrolled but not Treated|0|||
160938815|NCT02880371|581168692|FG001|Phase 2|Enrolled but not Treated|0|||
160938816|NCT02880371|581168693|FG002|Phase 2|Enrolled but not Treated|0|||
160938817|NCT02880371|581168694|FG003|Phase 2|Enrolled but not Treated|0|||
160938818|NCT02880371|581168695|FG004|Phase 2|Enrolled but not Treated|0|||
160938819|NCT02880371|581168696|FG005|Phase 2|Enrolled but not Treated|1|||
160938820|NCT02880371|581168697|FG006|Phase 2|Enrolled but not Treated|1|||
160455465|NCT04571619|579397949|FG001|Phase 2|Death|16|||
160938821|NCT02880371|581168698|FG007|Phase 2|Enrolled but not Treated|0|||
160938822|NCT02880371|581168691|FG000|Phase 2|Other|0|||
160938823|NCT02880371|581168692|FG001|Phase 2|Other|0|||
160938824|NCT02880371|581168693|FG002|Phase 2|Other|0|||
160938825|NCT02880371|581168694|FG003|Phase 2|Other|0|||
160938826|NCT02880371|581168695|FG004|Phase 2|Other|0|||
160938827|NCT02880371|581168696|FG005|Phase 2|Other|1|||
160938828|NCT02880371|581168697|FG006|Phase 2|Other|2|||
160938829|NCT02880371|581168698|FG007|Phase 2|Other|1|||
160938830|NCT02880371|581168691|FG000|Phase 2|Participants terminated by Sponsor|0|||
160938831|NCT02880371|581168692|FG001|Phase 2|Participants terminated by Sponsor|0|||
160938832|NCT02880371|581168693|FG002|Phase 2|Participants terminated by Sponsor|0|||
160938833|NCT02880371|581168694|FG003|Phase 2|Participants terminated by Sponsor|0|||
160938834|NCT02880371|581168695|FG004|Phase 2|Participants terminated by Sponsor|1|||
160938835|NCT02880371|581168696|FG005|Phase 2|Participants terminated by Sponsor|6|||
160938836|NCT02880371|581168697|FG006|Phase 2|Participants terminated by Sponsor|1|||
160938837|NCT02880371|581168698|FG007|Phase 2|Participants terminated by Sponsor|5|||
160938838|NCT02880371|581168691|FG000|Phase 2|Death|0|||
160938839|NCT02880371|581168692|FG001|Phase 2|Death|0|||
160938840|NCT02880371|581168693|FG002|Phase 2|Death|0|||
160938841|NCT02880371|581168694|FG003|Phase 2|Death|0|||
160938842|NCT02880371|581168695|FG004|Phase 2|Death|1|||
160938843|NCT02880371|581168696|FG005|Phase 2|Death|10|||
160938844|NCT02880371|581168697|FG006|Phase 2|Death|20|||
160938845|NCT02880371|581168698|FG007|Phase 2|Death|5|||
160938846|NCT02880371|581168691|FG000|Phase 2|Lost to Follow-up|0|||
160938847|NCT02880371|581168692|FG001|Phase 2|Lost to Follow-up|0|||
160938848|NCT02880371|581168693|FG002|Phase 2|Lost to Follow-up|0|||
160938849|NCT02880371|581168694|FG003|Phase 2|Lost to Follow-up|0|||
160938850|NCT02880371|581168695|FG004|Phase 2|Lost to Follow-up|0|||
160938851|NCT02880371|581168696|FG005|Phase 2|Lost to Follow-up|0|||
160938852|NCT02880371|581168697|FG006|Phase 2|Lost to Follow-up|3|||
160938853|NCT02880371|581168698|FG007|Phase 2|Lost to Follow-up|0|||
160938854|NCT02880371|581168691|FG000|Phase 2|Withdrawal by Subject|0|||
160938855|NCT02880371|581168692|FG001|Phase 2|Withdrawal by Subject|0|||
160938856|NCT02880371|581168693|FG002|Phase 2|Withdrawal by Subject|0|||
160938857|NCT02880371|581168694|FG003|Phase 2|Withdrawal by Subject|0|||
160938858|NCT02880371|581168695|FG004|Phase 2|Withdrawal by Subject|0|||
160938859|NCT02880371|581168696|FG005|Phase 2|Withdrawal by Subject|1|||
160938860|NCT02880371|581168697|FG006|Phase 2|Withdrawal by Subject|1|||
160938861|NCT02880371|581168698|FG007|Phase 2|Withdrawal by Subject|0|||
160938862|NCT02880371|581168691|FG000|Phase 2|End of Study page not completed by error|0|||
160938863|NCT02880371|581168692|FG001|Phase 2|End of Study page not completed by error|0|||
160938864|NCT02880371|581168693|FG002|Phase 2|End of Study page not completed by error|0|||
160938865|NCT02880371|581168694|FG003|Phase 2|End of Study page not completed by error|0|||
160938866|NCT02880371|581168695|FG004|Phase 2|End of Study page not completed by error|0|||
160938867|NCT02880371|581168696|FG005|Phase 2|End of Study page not completed by error|1|||
160938868|NCT02880371|581168697|FG006|Phase 2|End of Study page not completed by error|0|||
160938869|NCT02880371|581168698|FG007|Phase 2|End of Study page not completed by error|0|||
160938870|NCT03285646|581168703|FG000|Overall Study|Adverse Event|1|||
160938871|NCT03285646|581168704|FG001|Overall Study|Adverse Event|0|||
160938872|NCT03285646|581168703|FG000|Overall Study|Withdrawal by Subject|10|||
160938873|NCT03285646|581168704|FG001|Overall Study|Withdrawal by Subject|2|||
160938874|NCT03285646|581168703|FG000|Overall Study|Lost to Follow-up|2|||
160938875|NCT03285646|581168704|FG001|Overall Study|Lost to Follow-up|1|||
160938876|NCT03285646|581168703|FG000|Overall Study|Investigator/Sponsor Decision|0|||
160938877|NCT03285646|581168704|FG001|Overall Study|Investigator/Sponsor Decision|1|||
160938878|NCT01694706|581168708|FG000|Overall Study|Adverse Event|0|||
160938879|NCT01694706|581168709|FG001|Overall Study|Adverse Event|1|||
160938880|NCT01694706|581168710|FG002|Overall Study|Adverse Event|0|||
160938881|NCT01694706|581168708|FG000|Overall Study|other reason not defined above|1|||
160938882|NCT01694706|581168709|FG001|Overall Study|other reason not defined above|0|||
160938883|NCT01694706|581168710|FG002|Overall Study|other reason not defined above|0|||
160938884|NCT01923181|581168711|FG000|Overall Study|Protocol Violation|2|||
160938885|NCT01923181|581168712|FG001|Overall Study|Protocol Violation|2|||
160938886|NCT01923181|581168713|FG002|Overall Study|Protocol Violation|0|||
160938887|NCT01923181|581168714|FG003|Overall Study|Protocol Violation|2|||
160938888|NCT01923181|581168715|FG004|Overall Study|Protocol Violation|2|||
160938889|NCT01923181|581168716|FG005|Overall Study|Protocol Violation|1|||
160998738|NCT01235949|581380607|FG005|Booster Phase|Adverse Event|0|||
160938890|NCT01923181|581168717|FG006|Overall Study|Protocol Violation|1|||
160938891|NCT01923181|581168718|FG007|Overall Study|Protocol Violation|2|||
160938892|NCT01923181|581168719|FG008|Overall Study|Protocol Violation|1|||
160938893|NCT01923181|581168711|FG000|Overall Study|Withdrawal by Subject|0|||
160938894|NCT01923181|581168712|FG001|Overall Study|Withdrawal by Subject|1|||
160938895|NCT01923181|581168713|FG002|Overall Study|Withdrawal by Subject|0|||
160938896|NCT01923181|581168714|FG003|Overall Study|Withdrawal by Subject|1|||
160938897|NCT01923181|581168715|FG004|Overall Study|Withdrawal by Subject|4|||
160938898|NCT01923181|581168716|FG005|Overall Study|Withdrawal by Subject|2|||
160938899|NCT01923181|581168717|FG006|Overall Study|Withdrawal by Subject|4|||
160938900|NCT01923181|581168718|FG007|Overall Study|Withdrawal by Subject|3|||
160938901|NCT01923181|581168719|FG008|Overall Study|Withdrawal by Subject|1|||
160938902|NCT01923181|581168711|FG000|Overall Study|Other|1|||
160938903|NCT01923181|581168712|FG001|Overall Study|Other|0|||
160938904|NCT01923181|581168713|FG002|Overall Study|Other|0|||
160938905|NCT01923181|581168714|FG003|Overall Study|Other|1|||
160938906|NCT01923181|581168715|FG004|Overall Study|Other|0|||
160938907|NCT01923181|581168716|FG005|Overall Study|Other|0|||
160938908|NCT01923181|581168717|FG006|Overall Study|Other|0|||
160938909|NCT01923181|581168718|FG007|Overall Study|Other|0|||
160938910|NCT01923181|581168719|FG008|Overall Study|Other|0|||
160938911|NCT01923181|581168711|FG000|Overall Study|Lost to Follow-up|0|||
160938912|NCT01923181|581168712|FG001|Overall Study|Lost to Follow-up|3|||
160938913|NCT01923181|581168713|FG002|Overall Study|Lost to Follow-up|2|||
160938914|NCT01923181|581168714|FG003|Overall Study|Lost to Follow-up|1|||
160938915|NCT01923181|581168715|FG004|Overall Study|Lost to Follow-up|2|||
160938916|NCT01923181|581168716|FG005|Overall Study|Lost to Follow-up|1|||
160938917|NCT01923181|581168717|FG006|Overall Study|Lost to Follow-up|3|||
160938918|NCT01923181|581168718|FG007|Overall Study|Lost to Follow-up|3|||
160938919|NCT01923181|581168719|FG008|Overall Study|Lost to Follow-up|1|||
160938920|NCT04101526|581168720|FG000|Overall Study|Did not complete all sleep diary entries|0|||
160938921|NCT04101526|581168721|FG001|Overall Study|Did not complete all sleep diary entries|1|||
160938922|NCT02944578|581168722|FG000|Overall Study|Physician Decision|1|||
160938923|NCT02944578|581168723|FG001|Overall Study|Physician Decision|0|||
160938924|NCT00424372|581168725|FG000|Overall Study|Death|1|||
160938925|NCT00424372|581168725|FG000|Overall Study|Adverse Event|18|||
160938926|NCT00424372|581168725|FG000|Overall Study|Lack of Efficacy|6|||
160938927|NCT00424372|581168725|FG000|Overall Study|Withdrawal by Subject|4|||
160938928|NCT00424372|581168725|FG000|Overall Study|Protocol Violation|1|||
160938929|NCT00424372|581168725|FG000|Overall Study|Health deterioration|1|||
160938930|NCT00654628|581168726|FG000|6-week Active Treatment Period|Adverse Event|9|||
160938931|NCT00654628|581168726|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
160938932|NCT00654628|581168726|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
160938933|NCT00654628|581168726|FG000|6-week Active Treatment Period|Out of window period|1|||
160938934|NCT00654628|581168726|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
160938935|NCT00654628|581168726|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
160938936|NCT00912405|581168729|FG000|Overall Study|Lost to Follow-up|5|||
160938937|NCT00953329|581168730|FG000|Overall Study|Lack of Efficacy|1|||
160938938|NCT01434823|581168733|FG000|Overall Study|Incomplete data in medical record|4|||
160938939|NCT01434823|581168734|FG001|Overall Study|Incomplete data in medical record|7|||
160938940|NCT00451282|581168739|FG000|Overall Study|Lost to Follow-up|6|||
160938941|NCT00451282|581168740|FG001|Overall Study|Lost to Follow-up|5|||
160938942|NCT01797536|581168741|FG000|Overall Study|Adverse Event|0|||
160938943|NCT01797536|581168742|FG001|Overall Study|Adverse Event|1|||
160938944|NCT01797536|581168743|FG002|Overall Study|Adverse Event|0|||
160938945|NCT01797536|581168744|FG003|Overall Study|Adverse Event|0|||
160938946|NCT00098839|581168745|FG000|Overall Study|Adverse Event|5|||
160938947|NCT00098839|581168746|FG001|Overall Study|Adverse Event|2|||
160938948|NCT00098839|581168745|FG000|Overall Study|Death|1|||
160938949|NCT00098839|581168746|FG001|Overall Study|Death|2|||
160938950|NCT00098839|581168745|FG000|Overall Study|Physician Decision|4|||
160938951|NCT00098839|581168746|FG001|Overall Study|Physician Decision|14|||
160938952|NCT00098839|581168745|FG000|Overall Study|Withdrawal by Subject|1|||
160938953|NCT00098839|581168746|FG001|Overall Study|Withdrawal by Subject|0|||
160938954|NCT00098839|581168745|FG000|Overall Study|Refusal of further protocol therapy|3|||
160938955|NCT00098839|581168746|FG001|Overall Study|Refusal of further protocol therapy|1|||
160938956|NCT00098839|581168745|FG000|Overall Study|Relapse|6|||
160938957|NCT00098839|581168746|FG001|Overall Study|Relapse|3|||
160938958|NCT00098839|581168745|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
160938959|NCT00098839|581168746|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
160938960|NCT00098839|581168745|FG000|Overall Study|Ineligible|2|||
160938961|NCT00098839|581168746|FG001|Overall Study|Ineligible|0|||
160938962|NCT00617240|581168747|FG000|Overall Study|Lack of Efficacy|1|||
160938963|NCT00617240|581168748|FG001|Overall Study|Lack of Efficacy|0|||
160938964|NCT01611259|581168749|FG000|Overall Study|Physician Decision|1|||
160938965|NCT01611259|581168749|FG000|Overall Study|Lack of Efficacy|2|||
160938966|NCT01611259|581168749|FG000|Overall Study|Adverse Event|4|||
160998739|NCT01235949|581380608|FG006|Booster Phase|Adverse Event|0|||
160938967|NCT01611259|581168749|FG000|Overall Study|Withdrawal by Subject|7|||
160998740|NCT01235949|581380609|FG007|Booster Phase|Adverse Event|0|||
160938968|NCT04936685|581168750|FG000|Overall Study|Protocol Violation|1|||
160938969|NCT04936685|581168751|FG001|Overall Study|Protocol Violation|0|||
160938970|NCT02410811|581168755|FG000|Overall Study|Withdrawal by Subject|0|||
160938971|NCT02410811|581168756|FG001|Overall Study|Withdrawal by Subject|0|||
160998741|NCT01235949|581380610|FG008|Booster Phase|Adverse Event|0|||
160938972|NCT02410811|581168757|FG002|Overall Study|Withdrawal by Subject|1|||
160938973|NCT02410811|581168758|FG003|Overall Study|Withdrawal by Subject|0|||
160938974|NCT00353366|581168759|FG000|Overall Study|Adverse Event|8|||
160938975|NCT00353366|581168759|FG000|Overall Study|Protocol Violation|12|||
160938976|NCT00353366|581168759|FG000|Overall Study|Withdrawal by Subject|12|||
160938977|NCT00353366|581168759|FG000|Overall Study|Lost to Follow-up|92|||
160656005|NCT02130466|580120343|FG000|Overall Study|Death|4|||
160938978|NCT00353366|581168759|FG000|Overall Study|Other|19|||
160938979|NCT00259857|581168760|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
160938980|NCT00259857|581168761|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
160938981|NCT00259857|581168760|FG000|24 Months Treatment|Lost to Follow-up|0|||
160938982|NCT00259857|581168761|FG001|24 Months Treatment|Lost to Follow-up|3|||
160938983|NCT05267054|581168762|FG000|Overall Study|Death|13|||
160938984|NCT05267054|581168763|FG001|Overall Study|Death|14|||
160938985|NCT05267054|581168762|FG000|Overall Study|Study Ended by Sponsor|9|||
160938986|NCT05267054|581168763|FG001|Overall Study|Study Ended by Sponsor|13|||
160938987|NCT05267054|581168762|FG000|Overall Study|Lost to Follow-up|1|||
160938988|NCT05267054|581168763|FG001|Overall Study|Lost to Follow-up|1|||
160938989|NCT05267054|581168762|FG000|Overall Study|Withdrawal by Subject|1|||
160938990|NCT05267054|581168763|FG001|Overall Study|Withdrawal by Subject|1|||
160938991|NCT01552226|581168766|FG000|Overall Study|Withdrawal by Subject|4|||
160938992|NCT01552226|581168767|FG001|Overall Study|Withdrawal by Subject|4|||
160938993|NCT01469065|581168771|FG000|Overall Study|Lack of Efficacy|0|||
160938994|NCT01469065|581168772|FG001|Overall Study|Lack of Efficacy|0|||
160938995|NCT01469065|581168773|FG002|Overall Study|Lack of Efficacy|0|||
160938996|NCT01469065|581168774|FG003|Overall Study|Lack of Efficacy|0|||
160938997|NCT01469065|581168775|FG004|Overall Study|Lack of Efficacy|1|||
160938998|NCT01469065|581168771|FG000|Overall Study|Other|0|||
160938999|NCT01469065|581168772|FG001|Overall Study|Other|1|||
160939000|NCT01469065|581168773|FG002|Overall Study|Other|0|||
160939001|NCT01469065|581168774|FG003|Overall Study|Other|0|||
160939002|NCT01469065|581168775|FG004|Overall Study|Other|0|||
160939003|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
160939004|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
160939005|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
160939006|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
160939007|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
160939008|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
160939009|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
160939010|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
160939011|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
160939012|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
160939013|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
160939014|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
160939015|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
160939016|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
160939017|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
160939018|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
160939019|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
160939020|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
160939021|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
160939022|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
160939023|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
160939024|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
160939025|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
160939026|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
160939027|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
160939028|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
160939029|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
160939030|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
160939031|NCT04542070|581168776|FG000|Maintenance + Extension Period|Adverse Event|10|||
160998742|NCT01235949|581380611|FG009|Booster Phase|Adverse Event|0|||
160998743|NCT01235949|581380612|FG010|Booster Phase|Adverse Event|0|||
160998744|NCT01235949|581380613|FG011|Booster Phase|Adverse Event|0|||
160656006|NCT02130466|580120344|FG001|Overall Study|Death|1|||
160656007|NCT02130466|580120345|FG002|Overall Study|Death|1|||
160656008|NCT02130466|580120346|FG003|Overall Study|Death|3|||
160939032|NCT04542070|581168777|FG001|Maintenance + Extension Period|Adverse Event|2|||
160939033|NCT04542070|581168778|FG002|Maintenance + Extension Period|Adverse Event|0|||
160939034|NCT04542070|581168779|FG003|Maintenance + Extension Period|Adverse Event|0|||
160939035|NCT04542070|581168776|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
160939036|NCT04542070|581168777|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
160939037|NCT04542070|581168778|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
160939038|NCT04542070|581168779|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
160939039|NCT04542070|581168776|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
160656009|NCT02130466|580120347|FG004|Overall Study|Death|2|||
160656010|NCT02130466|580120348|FG005|Overall Study|Death|30|||
160939040|NCT04542070|581168777|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
160939041|NCT04542070|581168778|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
160939042|NCT04542070|581168779|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
160939043|NCT04542070|581168776|FG000|Maintenance + Extension Period|Physician Decision|1|||
160455466|NCT04571619|579397948|FG000|Phase 2|Withdrawal by Subject|6|||
160455467|NCT04571619|579397949|FG001|Phase 2|Withdrawal by Subject|4|||
160455468|NCT04183283|579399696|FG000|Period 1|Withdrawal by Subject|0|||
160455469|NCT04183283|579399697|FG001|Period 1|Withdrawal by Subject|1|||
160455470|NCT04183283|579399698|FG002|Period 1|Withdrawal by Subject|0|||
160455471|NCT04183283|579399699|FG003|Period 1|Withdrawal by Subject|0|||
160455472|NCT04183283|579399696|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
160455473|NCT04183283|579399697|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
160455474|NCT04183283|579399698|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
160455475|NCT04183283|579399699|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
160455476|NCT04909801|579399715|FG000|Overall Study|Lack of Efficacy|2|||
160455477|NCT04909801|579399716|FG001|Overall Study|Lack of Efficacy|1|||
160455478|NCT04909801|579399715|FG000|Overall Study|Adverse Event|1|||
160455479|NCT04909801|579399716|FG001|Overall Study|Adverse Event|2|||
160455480|NCT04909801|579399715|FG000|Overall Study|Participant request to discontinue study treatment|1|||
160455481|NCT04909801|579399716|FG001|Overall Study|Participant request to discontinue study treatment|2|||
160455482|NCT04909801|579399715|FG000|Overall Study|Withdrawal by Subject|2|||
160455483|NCT04909801|579399716|FG001|Overall Study|Withdrawal by Subject|1|||
160455484|NCT04909801|579399715|FG000|Overall Study|other reasons|1|||
160455485|NCT04909801|579399716|FG001|Overall Study|other reasons|1|||
160455486|NCT02593773|579399717|FG000|Overall Study|Voluntary Withdrawal|3|||
160455487|NCT02593773|579399717|FG000|Overall Study|Study Terminated by Sponsor|31|||
160455488|NCT02593773|579399717|FG000|Overall Study|Death|1|||
160455489|NCT02694822|579399720|FG000|Phase 1|Death|2|||
160455490|NCT02694822|579399721|FG001|Phase 1|Death|1|||
160455491|NCT02694822|579399722|FG002|Phase 1|Death|6|||
160455492|NCT02694822|579399723|FG003|Phase 1|Death|6|||
160455493|NCT02694822|579399724|FG004|Phase 1|Death|3|||
160455494|NCT02694822|579399725|FG005|Phase 1|Death|0|||
160455495|NCT02694822|579399720|FG000|Phase 1|Withdrawal by Subject|2|||
160455496|NCT02694822|579399721|FG001|Phase 1|Withdrawal by Subject|2|||
160455497|NCT02694822|579399722|FG002|Phase 1|Withdrawal by Subject|4|||
160455498|NCT02694822|579399723|FG003|Phase 1|Withdrawal by Subject|8|||
160455499|NCT02694822|579399724|FG004|Phase 1|Withdrawal by Subject|1|||
160455500|NCT02694822|579399725|FG005|Phase 1|Withdrawal by Subject|0|||
160455501|NCT02694822|579399720|FG000|Phase 2|Death|0|||
160455502|NCT02694822|579399721|FG001|Phase 2|Death|0|||
160455503|NCT02694822|579399722|FG002|Phase 2|Death|0|||
160455504|NCT02694822|579399723|FG003|Phase 2|Death|0|||
160455505|NCT02694822|579399724|FG004|Phase 2|Death|0|||
160455506|NCT02694822|579399725|FG005|Phase 2|Death|26|||
160455507|NCT02694822|579399720|FG000|Phase 2|Withdrawal by Subject|0|||
160455508|NCT02694822|579399721|FG001|Phase 2|Withdrawal by Subject|0|||
160455509|NCT02694822|579399722|FG002|Phase 2|Withdrawal by Subject|0|||
160455510|NCT02694822|579399723|FG003|Phase 2|Withdrawal by Subject|0|||
160455511|NCT02694822|579399724|FG004|Phase 2|Withdrawal by Subject|0|||
160455512|NCT02694822|579399725|FG005|Phase 2|Withdrawal by Subject|13|||
160455513|NCT02694822|579399720|FG000|Phase 2|Administrative Study Closure|0|||
160455514|NCT02694822|579399721|FG001|Phase 2|Administrative Study Closure|0|||
160455515|NCT02694822|579399722|FG002|Phase 2|Administrative Study Closure|0|||
160455516|NCT02694822|579399723|FG003|Phase 2|Administrative Study Closure|0|||
160455517|NCT02694822|579399724|FG004|Phase 2|Administrative Study Closure|0|||
160455518|NCT02694822|579399725|FG005|Phase 2|Administrative Study Closure|2|||
160455519|NCT02694822|579399720|FG000|Phase 2|Lost to Follow-up|0|||
160455520|NCT02694822|579399721|FG001|Phase 2|Lost to Follow-up|0|||
160455521|NCT02694822|579399722|FG002|Phase 2|Lost to Follow-up|0|||
160455522|NCT02694822|579399723|FG003|Phase 2|Lost to Follow-up|0|||
160455523|NCT02694822|579399724|FG004|Phase 2|Lost to Follow-up|0|||
160455524|NCT02694822|579399725|FG005|Phase 2|Lost to Follow-up|1|||
160455525|NCT02694822|579399720|FG000|Phase 2|Participant Transferred to Another Site|0|||
160455526|NCT02694822|579399721|FG001|Phase 2|Participant Transferred to Another Site|0|||
160455527|NCT02694822|579399722|FG002|Phase 2|Participant Transferred to Another Site|0|||
160455528|NCT02694822|579399723|FG003|Phase 2|Participant Transferred to Another Site|0|||
160455529|NCT02694822|579399724|FG004|Phase 2|Participant Transferred to Another Site|0|||
160455530|NCT02694822|579399725|FG005|Phase 2|Participant Transferred to Another Site|1|||
160455531|NCT01868997|579399726|FG000|Overall Study|Adverse Event|2|||
160455532|NCT01868997|579399727|FG001|Overall Study|Adverse Event|5|||
160939044|NCT04542070|581168777|FG001|Maintenance + Extension Period|Physician Decision|1|||
160455533|NCT01868997|579399726|FG000|Overall Study|Lack of Efficacy|2|||
160455534|NCT01868997|579399727|FG001|Overall Study|Lack of Efficacy|0|||
160939045|NCT04542070|581168778|FG002|Maintenance + Extension Period|Physician Decision|0|||
160455535|NCT01868997|579399726|FG000|Overall Study|Other|3|||
160455536|NCT01868997|579399727|FG001|Overall Study|Other|1|||
160455537|NCT05370040|579399728|FG000|Overall Study|Lost to Follow-up|0|||
160455538|NCT05370040|579399729|FG001|Overall Study|Lost to Follow-up|0|||
160455539|NCT05370040|579399730|FG002|Overall Study|Lost to Follow-up|1|||
160455540|NCT05370040|579399731|FG003|Overall Study|Lost to Follow-up|0|||
160455541|NCT05370040|579399732|FG004|Overall Study|Lost to Follow-up|1|||
160455542|NCT05370040|579399733|FG005|Overall Study|Lost to Follow-up|0|||
160455543|NCT04971109|579399734|FG000|Overall Study|Adverse Event|4|||
160455544|NCT04971109|579399735|FG001|Overall Study|Adverse Event|3|||
160455545|NCT04971109|579399734|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
160455546|NCT04971109|579399735|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
160455547|NCT04971109|579399734|FG000|Overall Study|Lost to Follow-up|8|||
160455548|NCT04971109|579399735|FG001|Overall Study|Lost to Follow-up|2|||
160455549|NCT04971109|579399734|FG000|Overall Study|Physician Decision|5|||
160455550|NCT04971109|579399735|FG001|Overall Study|Physician Decision|0|||
160455551|NCT04971109|579399734|FG000|Overall Study|Protocol Violation|0|||
160455552|NCT04971109|579399735|FG001|Overall Study|Protocol Violation|1|||
160455553|NCT04971109|579399734|FG000|Overall Study|Withdrawal by Subject|18|||
160455554|NCT04971109|579399735|FG001|Overall Study|Withdrawal by Subject|3|||
160455555|NCT04971109|579399734|FG000|Overall Study|Subject was randomized in error|1|||
160455556|NCT04971109|579399735|FG001|Overall Study|Subject was randomized in error|0|||
160455557|NCT04778397|579399738|FG000|Overall Study|Death|59|||
160455558|NCT04778397|579399739|FG001|Overall Study|Death|54|||
160455559|NCT04778397|579399740|FG002|Overall Study|Death|11|||
160455560|NCT04778397|579399741|FG003|Overall Study|Death|9|||
160455561|NCT04778397|579399738|FG000|Overall Study|Study Terminated by Sponsor|34|||
160455562|NCT04778397|579399739|FG001|Overall Study|Study Terminated by Sponsor|42|||
160455563|NCT04778397|579399740|FG002|Overall Study|Study Terminated by Sponsor|15|||
160455564|NCT04778397|579399741|FG003|Overall Study|Study Terminated by Sponsor|12|||
160455565|NCT04778397|579399738|FG000|Overall Study|Withdrew Consent|5|||
160939046|NCT04542070|581168779|FG003|Maintenance + Extension Period|Physician Decision|0|||
160939047|NCT04542070|581168776|FG000|Maintenance + Extension Period|Protocol Violation|2|||
160939048|NCT04542070|581168777|FG001|Maintenance + Extension Period|Protocol Violation|5|||
160939049|NCT04542070|581168778|FG002|Maintenance + Extension Period|Protocol Violation|0|||
160939050|NCT04542070|581168779|FG003|Maintenance + Extension Period|Protocol Violation|0|||
160939051|NCT04542070|581168776|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
160939052|NCT04542070|581168777|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
160939053|NCT04542070|581168778|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
160939054|NCT04542070|581168779|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
160939055|NCT04542070|581168776|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
160939056|NCT04542070|581168777|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
160939057|NCT04542070|581168778|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
160939058|NCT04542070|581168779|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
160939059|NCT04542070|581168776|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
160939060|NCT04542070|581168777|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
160939061|NCT04542070|581168778|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
160939062|NCT04542070|581168779|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
160939063|NCT04542070|581168776|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
160939064|NCT04542070|581168777|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
160939065|NCT04542070|581168778|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
160939066|NCT04542070|581168779|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
160939067|NCT04542070|581168776|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
160939068|NCT04542070|581168777|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
160939069|NCT04542070|581168778|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
160939070|NCT04542070|581168779|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
160939071|NCT04542070|581168776|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
160939072|NCT04542070|581168777|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
160939073|NCT04542070|581168778|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
160939074|NCT04542070|581168779|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
160939075|NCT04542070|581168776|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
160455566|NCT04778397|579399739|FG001|Overall Study|Withdrew Consent|4|||
160455567|NCT04778397|579399740|FG002|Overall Study|Withdrew Consent|1|||
160455568|NCT04778397|579399741|FG003|Overall Study|Withdrew Consent|1|||
160455569|NCT04778397|579399738|FG000|Overall Study|Reason Not Specified|1|||
160455570|NCT04778397|579399739|FG001|Overall Study|Reason Not Specified|3|||
160455571|NCT04778397|579399740|FG002|Overall Study|Reason Not Specified|0|||
160939076|NCT04542070|581168777|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
160939077|NCT04542070|581168778|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
160939078|NCT04542070|581168779|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
160939079|NCT03511560|581168782|FG000|Overall Study|Death|0|||
160455572|NCT04778397|579399741|FG003|Overall Study|Reason Not Specified|2|||
160455573|NCT04778397|579399738|FG000|Overall Study|Lost to Follow-up|2|||
160455574|NCT04778397|579399739|FG001|Overall Study|Lost to Follow-up|1|||
160455575|NCT04778397|579399740|FG002|Overall Study|Lost to Follow-up|0|||
160455576|NCT04778397|579399741|FG003|Overall Study|Lost to Follow-up|1|||
160998745|NCT01235949|581380614|FG012|Booster Phase|Adverse Event|0|||
160939080|NCT03511560|581168783|FG001|Overall Study|Death|1|||
160939081|NCT03511560|581168782|FG000|Overall Study|Adverse Event|0|||
160939082|NCT03511560|581168783|FG001|Overall Study|Adverse Event|2|||
160939083|NCT03511560|581168782|FG000|Overall Study|Transplant cancelled|0|||
160939084|NCT03511560|581168783|FG001|Overall Study|Transplant cancelled|1|||
160939085|NCT03511560|581168782|FG000|Overall Study|Patient switched to another drug|1|||
160939086|NCT03511560|581168783|FG001|Overall Study|Patient switched to another drug|0|||
160939087|NCT01813019|581168789|FG000|Overall Study|Adverse Event|0|||
160939088|NCT01813019|581168790|FG001|Overall Study|Adverse Event|3|||
160939089|NCT01813019|581168789|FG000|Overall Study|Withdrawal by Subject|3|||
160939090|NCT01813019|581168790|FG001|Overall Study|Withdrawal by Subject|2|||
160939091|NCT01813019|581168789|FG000|Overall Study|administrative problems|2|||
160939092|NCT01813019|581168790|FG001|Overall Study|administrative problems|0|||
160939093|NCT01813019|581168789|FG000|Overall Study|Protocol Deviation|2|||
160939094|NCT01813019|581168790|FG001|Overall Study|Protocol Deviation|1|||
160939095|NCT03075644|581168791|FG000|Overall Study|Withdrawal by Subject|1|||
160939096|NCT03075644|581168792|FG001|Overall Study|Withdrawal by Subject|1|||
160939097|NCT01458171|581168796|FG000|Overall Study|Adverse Event|1|||
160939098|NCT00578565|581168801|FG000|Overall Study|Adverse Event|3|||
160939099|NCT01192152|581168802|FG000|Period 1|left prematurely (while on treatment B)|0|||
160939100|NCT01192152|581168803|FG001|Period 1|left prematurely (while on treatment B)|1|||
160939101|NCT01192152|581168802|FG000|Period 3|family emergency|1|||
160939102|NCT01192152|581168803|FG001|Period 3|family emergency|0|||
160939103|NCT02143843|581168805|FG000|Overall Study|Adverse Event|8|||
160939104|NCT02143843|581168805|FG000|Overall Study|Lack of Efficacy|2|||
160939105|NCT02143843|581168805|FG000|Overall Study|Withdrawal by Subject|2|||
160939106|NCT01462357|581168807|FG000|Overall Study|Death|0|||
160939107|NCT01462357|581168808|FG001|Overall Study|Death|0|||
160939108|NCT01462357|581168809|FG002|Overall Study|Death|1|||
160939109|NCT01462357|581168807|FG000|Overall Study|Withdrawal by Subject|3|||
160939110|NCT01462357|581168808|FG001|Overall Study|Withdrawal by Subject|11|||
160939111|NCT01462357|581168809|FG002|Overall Study|Withdrawal by Subject|3|||
160939112|NCT01462357|581168807|FG000|Overall Study|Migrated/moved from study area|2|||
160939113|NCT01462357|581168808|FG001|Overall Study|Migrated/moved from study area|3|||
160939114|NCT01462357|581168809|FG002|Overall Study|Migrated/moved from study area|1|||
160939115|NCT01462357|581168807|FG000|Overall Study|Lost to Follow-up|3|||
160939116|NCT01462357|581168808|FG001|Overall Study|Lost to Follow-up|5|||
160939117|NCT01462357|581168809|FG002|Overall Study|Lost to Follow-up|7|||
160939118|NCT01527292|581168815|FG000|Overall Study|Physician Decision|0|||
160939119|NCT01527292|581168816|FG001|Overall Study|Physician Decision|3|||
160939120|NCT00314366|581168817|FG000|Overall Study|not treated due to patient medical condi|1|||
160939121|NCT00314366|581168818|FG001|Overall Study|not treated due to patient medical condi|0|||
160939122|NCT02469610|581168819|FG000|Overall Study|Death|1|||
160939123|NCT02469610|581168820|FG001|Overall Study|Death|0|||
160939124|NCT02469610|581168819|FG000|Overall Study|Lost to Follow-up|1|||
160939125|NCT02469610|581168820|FG001|Overall Study|Lost to Follow-up|0|||
160939126|NCT02469610|581168819|FG000|Overall Study|exclusion criteria|2|||
160939127|NCT02469610|581168820|FG001|Overall Study|exclusion criteria|1|||
160939128|NCT01451424|581168823|FG000|Overall Study|Withdrawal by Subject|1|||
160939129|NCT01451424|581168824|FG001|Overall Study|Withdrawal by Subject|1|||
160939130|NCT01451424|581168825|FG002|Overall Study|Withdrawal by Subject|0|||
160939131|NCT01451424|581168826|FG003|Overall Study|Withdrawal by Subject|2|||
160939132|NCT01451424|581168823|FG000|Overall Study|Lost to Follow-up|0|||
160998746|NCT01235949|581380615|FG013|Booster Phase|Adverse Event|0|||
160998747|NCT01235949|581380616|FG014|Booster Phase|Adverse Event|0|||
160998748|NCT01235949|581380617|FG015|Booster Phase|Adverse Event|1|||
160656011|NCT02130466|580120349|FG006|Overall Study|Death|45|||
160939133|NCT01451424|581168824|FG001|Overall Study|Lost to Follow-up|1|||
160939134|NCT01451424|581168825|FG002|Overall Study|Lost to Follow-up|0|||
160939135|NCT01451424|581168826|FG003|Overall Study|Lost to Follow-up|1|||
160939136|NCT01451424|581168823|FG000|Overall Study|Physician Decision|0|||
160939137|NCT01451424|581168824|FG001|Overall Study|Physician Decision|0|||
160939138|NCT01451424|581168825|FG002|Overall Study|Physician Decision|1|||
160939139|NCT01451424|581168826|FG003|Overall Study|Physician Decision|1|||
160939140|NCT01451424|581168823|FG000|Overall Study|Adverse Event|0|||
160939141|NCT01451424|581168824|FG001|Overall Study|Adverse Event|0|||
160939142|NCT01451424|581168825|FG002|Overall Study|Adverse Event|0|||
160939143|NCT01451424|581168826|FG003|Overall Study|Adverse Event|1|||
160939144|NCT02920983|581168827|FG000|Dispense 1|Unacceptable Lens Fit|0|||
160939145|NCT02920983|581168828|FG001|Dispense 1|Unacceptable Lens Fit|0|||
160939146|NCT02920983|581168829|FG002|Dispense 1|Unacceptable Lens Fit|0|||
160998749|NCT01235949|581380618|FG016|Booster Phase|Adverse Event|0|||
160998750|NCT01235949|581380619|FG017|Booster Phase|Adverse Event|0|||
160939147|NCT02920983|581168830|FG003|Dispense 1|Unacceptable Lens Fit|0|||
160939148|NCT02920983|581168831|FG004|Dispense 1|Unacceptable Lens Fit|1|||
160939149|NCT02920983|581168832|FG005|Dispense 1|Unacceptable Lens Fit|0|||
160939150|NCT02920983|581168827|FG000|Dispense 2|Unscceptable lens fit|1|||
160656012|NCT02130466|580120350|FG007|Overall Study|Death|2|||
160578672|NCT02078713|579840104|FG002|Overall Study|Pregnant at baseline|0|||
160578673|NCT02078713|579840105|FG003|Overall Study|Pregnant at baseline|0|||
160578674|NCT02078713|579840102|FG000|Overall Study|Enrolled twice|0|||
160578675|NCT02078713|579840103|FG001|Overall Study|Enrolled twice|1|||
160578676|NCT02078713|579840104|FG002|Overall Study|Enrolled twice|0|||
160578677|NCT02078713|579840105|FG003|Overall Study|Enrolled twice|0|||
160578678|NCT02653976|579840117|FG000|Overall Study|Withdrawal by Subject|5|||
160578679|NCT02653976|579840117|FG000|Overall Study|Death|4|||
160578680|NCT01675011|579840118|FG000|Overall Study|Trial terminated by Sponsor|3|||
160578681|NCT01675011|579840119|FG001|Overall Study|Trial terminated by Sponsor|1|||
160578682|NCT00366548|579840120|FG000|Infant Series|Adverse Event|1|||
160578683|NCT00366548|579840121|FG001|Infant Series|Adverse Event|3|||
160578684|NCT00366548|579840120|FG000|Infant Series|Protocol Violation|0|||
160578685|NCT00366548|579840121|FG001|Infant Series|Protocol Violation|1|||
160578686|NCT00366548|579840120|FG000|Infant Series|Withdrawal by Subject|3|||
160578687|NCT00366548|579840121|FG001|Infant Series|Withdrawal by Subject|1|||
160578688|NCT00366548|579840120|FG000|After Infant Series|Withdrawal by Subject|3|||
160578689|NCT00366548|579840121|FG001|After Infant Series|Withdrawal by Subject|1|||
160578690|NCT00366548|579840120|FG000|After Infant Series|Adverse Event|2|||
160578691|NCT00366548|579840121|FG001|After Infant Series|Adverse Event|0|||
160578692|NCT00366548|579840120|FG000|After Infant Series|Lost to Follow-up|1|||
160578693|NCT00366548|579840121|FG001|After Infant Series|Lost to Follow-up|0|||
160578694|NCT02849990|579840122|FG000|Overall Study|Adverse Event|1|||
160939151|NCT02920983|581168828|FG001|Dispense 2|Unscceptable lens fit|0|||
160939152|NCT02920983|581168829|FG002|Dispense 2|Unscceptable lens fit|0|||
160939153|NCT02920983|581168830|FG003|Dispense 2|Unscceptable lens fit|0|||
160939154|NCT02920983|581168831|FG004|Dispense 2|Unscceptable lens fit|1|||
160939155|NCT02920983|581168832|FG005|Dispense 2|Unscceptable lens fit|0|||
160939156|NCT02920983|581168827|FG000|Dispense 3|Unacceptable Lens Fit|1|||
160939157|NCT02920983|581168828|FG001|Dispense 3|Unacceptable Lens Fit|1|||
160939158|NCT02920983|581168829|FG002|Dispense 3|Unacceptable Lens Fit|0|||
160939159|NCT02920983|581168830|FG003|Dispense 3|Unacceptable Lens Fit|0|||
160939160|NCT02920983|581168831|FG004|Dispense 3|Unacceptable Lens Fit|1|||
160939161|NCT02920983|581168832|FG005|Dispense 3|Unacceptable Lens Fit|0|||
160939162|NCT01387607|581168838|FG000|Overall Study|Adverse Event|23|||
160939163|NCT01387607|581168839|FG001|Overall Study|Adverse Event|11|||
160939164|NCT01387607|581168838|FG000|Overall Study|Lack of Efficacy|8|||
160939165|NCT01387607|581168839|FG001|Overall Study|Lack of Efficacy|6|||
160939166|NCT01387607|581168838|FG000|Overall Study|Lost to Follow-up|2|||
160939167|NCT01387607|581168839|FG001|Overall Study|Lost to Follow-up|1|||
160939168|NCT01387607|581168838|FG000|Overall Study|No longer meets eligibility criteria|0|||
160939169|NCT01387607|581168839|FG001|Overall Study|No longer meets eligibility criteria|1|||
160939170|NCT01387607|581168838|FG000|Overall Study|Protocol Violation|1|||
160939171|NCT01387607|581168839|FG001|Overall Study|Protocol Violation|5|||
160578695|NCT02849990|579840122|FG000|Overall Study|Withdrawal by Subject|1|||
160578696|NCT01252134|579840123|FG000|Period 1, 8 Hours|Personal Reasons|0|||
160578697|NCT01252134|579840124|FG001|Period 1, 8 Hours|Personal Reasons|1|||
160578698|NCT01252134|579840125|FG002|Period 1, 8 Hours|Personal Reasons|1|||
160578699|NCT01252134|579840126|FG003|Period 1, 8 Hours|Personal Reasons|0|||
160578700|NCT01252134|579840127|FG004|Period 1, 8 Hours|Personal Reasons|0|||
160578701|NCT01252134|579840128|FG005|Period 1, 8 Hours|Personal Reasons|0|||
160578702|NCT02678741|579840130|FG000|Overall Study|Death|4|||
160578703|NCT02678741|579840130|FG000|Overall Study|Withdrawal by Subject|1|||
160578704|NCT02678741|579840130|FG000|Overall Study|ineligible|3|||
160578705|NCT02678741|579840130|FG000|Overall Study|Not RECIST Measurable|2|||
160578706|NCT02678741|579840130|FG000|Overall Study|Lack of Efficacy|10|||
160939172|NCT01387607|581168838|FG000|Overall Study|Withdrawal by Subject|13|||
160939173|NCT01387607|581168839|FG001|Overall Study|Withdrawal by Subject|14|||
160939174|NCT01387607|581168838|FG000|Overall Study|Other|1|||
160656013|NCT02130466|580120351|FG008|Overall Study|Death|3|||
160939175|NCT01387607|581168839|FG001|Overall Study|Other|1|||
160939176|NCT01387607|581168838|FG000|Overall Study|Randomized, not treated|3|||
160578707|NCT01795898|579840131|FG000|Overall Study|Adverse Event|27|||
160578708|NCT01795898|579840131|FG000|Overall Study|Lost to Follow-up|20|||
160578709|NCT01795898|579840131|FG000|Overall Study|Withdrawal of consent|6|||
160578710|NCT01795898|579840131|FG000|Overall Study|Diagnosed with metastasis|1|||
160578711|NCT01795898|579840131|FG000|Overall Study|No pain|1|||
160939177|NCT01387607|581168839|FG001|Overall Study|Randomized, not treated|6|||
160939178|NCT02556710|581170914|FG000|Overall Study|Surgical treatment|3|||
160939179|NCT02556710|581170915|FG001|Overall Study|Surgical treatment|0|||
160939180|NCT02556710|581170914|FG000|Overall Study|Required proscribed pain medication|2|||
160939181|NCT02556710|581170915|FG001|Overall Study|Required proscribed pain medication|1|||
160939182|NCT02556710|581170914|FG000|Overall Study|Lack of Efficacy|1|||
160939183|NCT02556710|581170915|FG001|Overall Study|Lack of Efficacy|0|||
160939184|NCT02556710|581170914|FG000|Overall Study|Worsening osteoarthritis|1|||
160939185|NCT02556710|581170915|FG001|Overall Study|Worsening osteoarthritis|0|||
160939186|NCT02556710|581170914|FG000|Overall Study|Moved out of state|1|||
160939187|NCT02556710|581170915|FG001|Overall Study|Moved out of state|0|||
160939188|NCT02556710|581170914|FG000|Overall Study|Missing reason|3|||
160939189|NCT02556710|581170915|FG001|Overall Study|Missing reason|1|||
160939190|NCT02556710|581170914|FG000|Overall Study|Pain as lack of efficacy|0|||
160939191|NCT02556710|581170915|FG001|Overall Study|Pain as lack of efficacy|4|||
160939192|NCT04524403|581170918|FG000|Overall Study|Withdrawal by Subject|10|||
160939193|NCT04524403|581170919|FG001|Overall Study|Withdrawal by Subject|3|||
160939194|NCT04524403|581170920|FG002|Overall Study|Withdrawal by Subject|8|||
160939195|NCT04524403|581170918|FG000|Overall Study|Lost to Follow-up|3|||
160939196|NCT04524403|581170919|FG001|Overall Study|Lost to Follow-up|4|||
160939197|NCT04524403|581170920|FG002|Overall Study|Lost to Follow-up|3|||
160939198|NCT04524403|581170918|FG000|Overall Study|Adverse Event|3|||
160939199|NCT04524403|581170919|FG001|Overall Study|Adverse Event|1|||
160939200|NCT04524403|581170920|FG002|Overall Study|Adverse Event|4|||
160939201|NCT04524403|581170918|FG000|Overall Study|Non-compliant with study drug|1|||
160939202|NCT04524403|581170919|FG001|Overall Study|Non-compliant with study drug|2|||
160939203|NCT04524403|581170920|FG002|Overall Study|Non-compliant with study drug|3|||
160939204|NCT04524403|581170918|FG000|Overall Study|Moved|0|||
160939205|NCT04524403|581170919|FG001|Overall Study|Moved|1|||
160939206|NCT04524403|581170920|FG002|Overall Study|Moved|0|||
160939207|NCT00991302|581170921|FG000|Overall Study|Death|0|||
160939208|NCT00991302|581170922|FG001|Overall Study|Death|1|||
160939209|NCT00991302|581170921|FG000|Overall Study|Lost to Follow-up|14|||
160939210|NCT00991302|581170922|FG001|Overall Study|Lost to Follow-up|12|||
160939211|NCT01709318|581170923|FG000|Overall Study|Adverse Event|3|||
160939212|NCT01709318|581170924|FG001|Overall Study|Adverse Event|4|||
160939213|NCT01709318|581170925|FG002|Overall Study|Adverse Event|2|||
160939214|NCT01709318|581170926|FG003|Overall Study|Adverse Event|2|||
160939215|NCT01709318|581170927|FG004|Overall Study|Adverse Event|0|||
160939216|NCT01709318|581170928|FG005|Overall Study|Adverse Event|1|||
160939217|NCT01709318|581170929|FG006|Overall Study|Adverse Event|2|||
160939218|NCT01709318|581170923|FG000|Overall Study|Lost to Follow-up|2|||
160939219|NCT01709318|581170924|FG001|Overall Study|Lost to Follow-up|0|||
160939220|NCT01709318|581170925|FG002|Overall Study|Lost to Follow-up|0|||
160939221|NCT01709318|581170926|FG003|Overall Study|Lost to Follow-up|0|||
160939222|NCT01709318|581170927|FG004|Overall Study|Lost to Follow-up|1|||
160939223|NCT01709318|581170928|FG005|Overall Study|Lost to Follow-up|1|||
160939224|NCT01709318|581170929|FG006|Overall Study|Lost to Follow-up|1|||
160939225|NCT01709318|581170923|FG000|Overall Study|Non-compliance with Study Drug|0|||
160939226|NCT01709318|581170924|FG001|Overall Study|Non-compliance with Study Drug|2|||
160939227|NCT01709318|581170925|FG002|Overall Study|Non-compliance with Study Drug|1|||
160939228|NCT01709318|581170926|FG003|Overall Study|Non-compliance with Study Drug|1|||
160939229|NCT01709318|581170927|FG004|Overall Study|Non-compliance with Study Drug|0|||
160939230|NCT01709318|581170928|FG005|Overall Study|Non-compliance with Study Drug|0|||
160939231|NCT01709318|581170929|FG006|Overall Study|Non-compliance with Study Drug|2|||
160939232|NCT01709318|581170923|FG000|Overall Study|Physician Decision|0|||
160939233|NCT01709318|581170924|FG001|Overall Study|Physician Decision|0|||
160939234|NCT01709318|581170925|FG002|Overall Study|Physician Decision|0|||
160939235|NCT01709318|581170926|FG003|Overall Study|Physician Decision|0|||
160939236|NCT01709318|581170927|FG004|Overall Study|Physician Decision|0|||
160939237|NCT01709318|581170928|FG005|Overall Study|Physician Decision|0|||
160939238|NCT01709318|581170929|FG006|Overall Study|Physician Decision|1|||
160939239|NCT01709318|581170923|FG000|Overall Study|Pregnancy|0|||
160939240|NCT01709318|581170924|FG001|Overall Study|Pregnancy|0|||
160939241|NCT01709318|581170925|FG002|Overall Study|Pregnancy|0|||
160939242|NCT01709318|581170926|FG003|Overall Study|Pregnancy|0|||
160998751|NCT01235949|581380602|FG000|Booster Phase|Withdrawal by Subject|0|||
160578712|NCT01795898|579840131|FG000|Overall Study|Death|1|||
160578713|NCT01795898|579840131|FG000|Overall Study|Withdrew consent & had adverse events|3|||
160578714|NCT01795898|579840131|FG000|Overall Study|Physician Decision|1|||
160578715|NCT02531373|579840140|FG000|Overall Study|Lack of Efficacy|0|||
160578716|NCT02531373|579840141|FG001|Overall Study|Lack of Efficacy|0|||
160939243|NCT01709318|581170927|FG004|Overall Study|Pregnancy|1|||
160939244|NCT01709318|581170928|FG005|Overall Study|Pregnancy|0|||
160939245|NCT01709318|581170929|FG006|Overall Study|Pregnancy|0|||
160939246|NCT01709318|581170923|FG000|Overall Study|Protocol Violation|0|||
160939247|NCT01709318|581170924|FG001|Overall Study|Protocol Violation|0|||
160939248|NCT01709318|581170925|FG002|Overall Study|Protocol Violation|0|||
160939249|NCT01709318|581170926|FG003|Overall Study|Protocol Violation|0|||
160578717|NCT02531373|579840142|FG002|Overall Study|Lack of Efficacy|0|||
160939250|NCT01709318|581170927|FG004|Overall Study|Protocol Violation|2|||
160939251|NCT01709318|581170928|FG005|Overall Study|Protocol Violation|0|||
160939252|NCT01709318|581170929|FG006|Overall Study|Protocol Violation|1|||
160939253|NCT01709318|581170923|FG000|Overall Study|Technical Problems|1|||
160939254|NCT01709318|581170924|FG001|Overall Study|Technical Problems|0|||
160939255|NCT01709318|581170925|FG002|Overall Study|Technical Problems|0|||
160578718|NCT02531373|579840143|FG003|Overall Study|Lack of Efficacy|0|||
160939256|NCT01709318|581170926|FG003|Overall Study|Technical Problems|0|||
160939257|NCT01709318|581170927|FG004|Overall Study|Technical Problems|0|||
160939258|NCT01709318|581170928|FG005|Overall Study|Technical Problems|0|||
160939259|NCT01709318|581170929|FG006|Overall Study|Technical Problems|0|||
160939260|NCT01709318|581170923|FG000|Overall Study|Withdrawal by Subject|3|||
160939261|NCT01709318|581170924|FG001|Overall Study|Withdrawal by Subject|0|||
160939262|NCT01709318|581170925|FG002|Overall Study|Withdrawal by Subject|3|||
160939263|NCT01709318|581170926|FG003|Overall Study|Withdrawal by Subject|3|||
160939264|NCT01709318|581170927|FG004|Overall Study|Withdrawal by Subject|0|||
160939265|NCT01709318|581170928|FG005|Overall Study|Withdrawal by Subject|2|||
160939266|NCT01709318|581170929|FG006|Overall Study|Withdrawal by Subject|4|||
160939267|NCT01709318|581170923|FG000|Overall Study|Other Protocol Specified Criteria|0|||
160939268|NCT01709318|581170924|FG001|Overall Study|Other Protocol Specified Criteria|1|||
160578719|NCT02531373|579840144|FG004|Overall Study|Lack of Efficacy|3|||
160578720|NCT02531373|579840145|FG005|Overall Study|Lack of Efficacy|2|||
160578721|NCT02531373|579840146|FG006|Overall Study|Lack of Efficacy|4|||
160939269|NCT01709318|581170925|FG002|Overall Study|Other Protocol Specified Criteria|0|||
160939270|NCT01709318|581170926|FG003|Overall Study|Other Protocol Specified Criteria|0|||
160939271|NCT01709318|581170927|FG004|Overall Study|Other Protocol Specified Criteria|0|||
160939272|NCT01709318|581170928|FG005|Overall Study|Other Protocol Specified Criteria|0|||
160939273|NCT01709318|581170929|FG006|Overall Study|Other Protocol Specified Criteria|0|||
160939274|NCT00646958|581170934|FG000|Overall Study|Lack of Efficacy|1|||
160939275|NCT00646958|581170935|FG001|Overall Study|Lack of Efficacy|0|||
160939276|NCT00646958|581170936|FG002|Overall Study|Lack of Efficacy|0|||
160939277|NCT00646958|581170934|FG000|Overall Study|Adverse Event|4|||
160939278|NCT00646958|581170935|FG001|Overall Study|Adverse Event|0|||
160939279|NCT00646958|581170936|FG002|Overall Study|Adverse Event|0|||
160939280|NCT00646958|581170934|FG000|Overall Study|Lost to Follow-up|1|||
160939281|NCT00646958|581170935|FG001|Overall Study|Lost to Follow-up|5|||
160939282|NCT00646958|581170936|FG002|Overall Study|Lost to Follow-up|7|||
160939283|NCT00646958|581170934|FG000|Overall Study|Protocol Violation|1|||
160939284|NCT00646958|581170935|FG001|Overall Study|Protocol Violation|1|||
160939285|NCT00646958|581170936|FG002|Overall Study|Protocol Violation|0|||
160939286|NCT00646958|581170934|FG000|Overall Study|Abnormal screening lab tests|1|||
160939287|NCT00646958|581170935|FG001|Overall Study|Abnormal screening lab tests|1|||
160939288|NCT00646958|581170936|FG002|Overall Study|Abnormal screening lab tests|0|||
160939289|NCT00646958|581170934|FG000|Overall Study|Withdrawal by Subject|1|||
160939290|NCT00646958|581170935|FG001|Overall Study|Withdrawal by Subject|2|||
160939291|NCT00646958|581170936|FG002|Overall Study|Withdrawal by Subject|0|||
160939292|NCT00646958|581170934|FG000|Overall Study|Did not receive study drug|2|||
160939293|NCT00646958|581170935|FG001|Overall Study|Did not receive study drug|0|||
160939294|NCT00646958|581170936|FG002|Overall Study|Did not receive study drug|2|||
160939295|NCT00827372|581170937|FG000|Overall Study|Adverse Event|5|||
160939296|NCT00827372|581170937|FG000|Overall Study|Lack of Efficacy|3|||
160939297|NCT03085927|581170938|FG000|Overall Study|Withdrawal by Subject|1|||
160939298|NCT03085927|581170939|FG001|Overall Study|Withdrawal by Subject|4|||
160939299|NCT03085927|581170938|FG000|Overall Study|Lost to Follow-up|3|||
160939300|NCT03085927|581170939|FG001|Overall Study|Lost to Follow-up|1|||
160939301|NCT03085927|581170938|FG000|Overall Study|Death|1|||
160939302|NCT03085927|581170939|FG001|Overall Study|Death|0|||
160939303|NCT03085927|581170938|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
160939304|NCT03085927|581170939|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
160939305|NCT03085927|581170938|FG000|Overall Study|Dyad Became Ineligible|0|||
160939306|NCT03085927|581170939|FG001|Overall Study|Dyad Became Ineligible|1|||
160939307|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
160939308|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160939309|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160939310|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160578722|NCT02531373|579840147|FG007|Overall Study|Lack of Efficacy|8|||
160578723|NCT02531373|579840148|FG008|Overall Study|Lack of Efficacy|5|||
160578724|NCT02531373|579840140|FG000|Overall Study|Lost to Follow-up|0|||
160578725|NCT02531373|579840141|FG001|Overall Study|Lost to Follow-up|0|||
160578726|NCT02531373|579840142|FG002|Overall Study|Lost to Follow-up|0|||
160939311|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160939312|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160939313|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
160939314|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160939315|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160939316|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160939317|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160939318|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160939319|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
160939320|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160998752|NCT01235949|581380603|FG001|Booster Phase|Withdrawal by Subject|0|||
160578727|NCT02531373|579840143|FG003|Overall Study|Lost to Follow-up|0|||
160578728|NCT02531373|579840144|FG004|Overall Study|Lost to Follow-up|0|||
160578729|NCT02531373|579840145|FG005|Overall Study|Lost to Follow-up|2|||
160578730|NCT02531373|579840146|FG006|Overall Study|Lost to Follow-up|2|||
160939321|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160939322|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160939323|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160939324|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160939325|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
160939326|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160939327|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160939328|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160939329|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160939330|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160939331|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
160939332|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160939333|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160939334|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160939335|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160939336|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160939337|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
160939338|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
160939339|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
160939340|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
160939341|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
160939342|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
160939343|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Other|6|||
160939344|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Other|0|||
160939345|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Other|0|||
160939346|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Other|0|||
160939347|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Other|0|||
160939348|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Other|0|||
160939349|NCT02139644|581170940|FG000|Treatment Period|Adverse Event|0|||
160939350|NCT02139644|581170941|FG001|Treatment Period|Adverse Event|0|||
160939351|NCT02139644|581170942|FG002|Treatment Period|Adverse Event|3|||
160939352|NCT02139644|581170943|FG003|Treatment Period|Adverse Event|2|||
160939353|NCT02139644|581170944|FG004|Treatment Period|Adverse Event|1|||
160939354|NCT02139644|581170945|FG005|Treatment Period|Adverse Event|6|||
160939355|NCT02139644|581170940|FG000|Treatment Period|Withdrawal by Subject|0|||
160939356|NCT02139644|581170941|FG001|Treatment Period|Withdrawal by Subject|0|||
160998753|NCT01235949|581380604|FG002|Booster Phase|Withdrawal by Subject|0|||
160998754|NCT01235949|581380605|FG003|Booster Phase|Withdrawal by Subject|0|||
160998755|NCT01235949|581380606|FG004|Booster Phase|Withdrawal by Subject|0|||
160998756|NCT01235949|581380607|FG005|Booster Phase|Withdrawal by Subject|0|||
160998757|NCT01235949|581380608|FG006|Booster Phase|Withdrawal by Subject|0|||
160998758|NCT01235949|581380609|FG007|Booster Phase|Withdrawal by Subject|1|||
160998759|NCT01235949|581380610|FG008|Booster Phase|Withdrawal by Subject|1|||
160998760|NCT01235949|581380611|FG009|Booster Phase|Withdrawal by Subject|0|||
160998761|NCT01235949|581380612|FG010|Booster Phase|Withdrawal by Subject|1|||
160998762|NCT01235949|581380613|FG011|Booster Phase|Withdrawal by Subject|1|||
160998763|NCT01235949|581380614|FG012|Booster Phase|Withdrawal by Subject|2|||
160998764|NCT01235949|581380615|FG013|Booster Phase|Withdrawal by Subject|0|||
160998765|NCT01235949|581380616|FG014|Booster Phase|Withdrawal by Subject|2|||
160998766|NCT01235949|581380617|FG015|Booster Phase|Withdrawal by Subject|0|||
160998767|NCT01235949|581380618|FG016|Booster Phase|Withdrawal by Subject|0|||
160998768|NCT01235949|581380619|FG017|Booster Phase|Withdrawal by Subject|0|||
160939357|NCT02139644|581170942|FG002|Treatment Period|Withdrawal by Subject|2|||
160939358|NCT02139644|581170943|FG003|Treatment Period|Withdrawal by Subject|2|||
160939359|NCT02139644|581170944|FG004|Treatment Period|Withdrawal by Subject|3|||
160939360|NCT02139644|581170945|FG005|Treatment Period|Withdrawal by Subject|2|||
160939361|NCT02139644|581170940|FG000|Treatment Period|Non-compliance|0|||
160939362|NCT02139644|581170941|FG001|Treatment Period|Non-compliance|0|||
160939363|NCT02139644|581170942|FG002|Treatment Period|Non-compliance|0|||
160939364|NCT02139644|581170943|FG003|Treatment Period|Non-compliance|1|||
160998769|NCT01235949|581380602|FG000|Booster Phase|Lost to Follow-up|0|||
160998770|NCT01235949|581380603|FG001|Booster Phase|Lost to Follow-up|0|||
160998771|NCT01235949|581380604|FG002|Booster Phase|Lost to Follow-up|0|||
160939365|NCT02139644|581170944|FG004|Treatment Period|Non-compliance|0|||
160939366|NCT02139644|581170945|FG005|Treatment Period|Non-compliance|0|||
160939367|NCT02139644|581170940|FG000|Treatment Period|Protocol Violation|0|||
160939368|NCT02139644|581170941|FG001|Treatment Period|Protocol Violation|0|||
160939369|NCT02139644|581170942|FG002|Treatment Period|Protocol Violation|0|||
160939370|NCT02139644|581170943|FG003|Treatment Period|Protocol Violation|1|||
160998772|NCT01235949|581380605|FG003|Booster Phase|Lost to Follow-up|0|||
160998773|NCT01235949|581380606|FG004|Booster Phase|Lost to Follow-up|0|||
160998774|NCT01235949|581380607|FG005|Booster Phase|Lost to Follow-up|0|||
160998775|NCT01235949|581380608|FG006|Booster Phase|Lost to Follow-up|0|||
160998776|NCT01235949|581380609|FG007|Booster Phase|Lost to Follow-up|0|||
160939371|NCT02139644|581170944|FG004|Treatment Period|Protocol Violation|1|||
160939372|NCT02139644|581170945|FG005|Treatment Period|Protocol Violation|1|||
160939373|NCT02139644|581170940|FG000|Treatment Period|Disease progression|0|||
160939374|NCT02139644|581170941|FG001|Treatment Period|Disease progression|0|||
160939375|NCT02139644|581170942|FG002|Treatment Period|Disease progression|0|||
160939376|NCT02139644|581170943|FG003|Treatment Period|Disease progression|1|||
160939377|NCT02139644|581170944|FG004|Treatment Period|Disease progression|1|||
160939378|NCT02139644|581170945|FG005|Treatment Period|Disease progression|2|||
160939379|NCT02139644|581170940|FG000|Treatment Period|Lost to Follow-up|0|||
160939380|NCT02139644|581170941|FG001|Treatment Period|Lost to Follow-up|0|||
160939381|NCT02139644|581170942|FG002|Treatment Period|Lost to Follow-up|1|||
160939382|NCT02139644|581170943|FG003|Treatment Period|Lost to Follow-up|1|||
160939383|NCT02139644|581170944|FG004|Treatment Period|Lost to Follow-up|1|||
160939384|NCT02139644|581170945|FG005|Treatment Period|Lost to Follow-up|1|||
160939385|NCT02139644|581170940|FG000|Treatment Period|Lack of Efficacy|0|||
160939386|NCT02139644|581170941|FG001|Treatment Period|Lack of Efficacy|0|||
160939387|NCT02139644|581170942|FG002|Treatment Period|Lack of Efficacy|1|||
160939388|NCT02139644|581170943|FG003|Treatment Period|Lack of Efficacy|0|||
160939389|NCT02139644|581170944|FG004|Treatment Period|Lack of Efficacy|1|||
160939390|NCT02139644|581170945|FG005|Treatment Period|Lack of Efficacy|4|||
160939391|NCT02139644|581170940|FG000|Treatment Period|Other|0|||
160939392|NCT02139644|581170941|FG001|Treatment Period|Other|3|||
160939393|NCT02139644|581170942|FG002|Treatment Period|Other|1|||
160939394|NCT02139644|581170943|FG003|Treatment Period|Other|1|||
160939395|NCT02139644|581170944|FG004|Treatment Period|Other|0|||
160939396|NCT02139644|581170945|FG005|Treatment Period|Other|1|||
160939397|NCT00630877|581170948|FG000|Overall Study|Adverse Event|11|||
160939398|NCT00630877|581170949|FG001|Overall Study|Adverse Event|8|||
160939399|NCT00630877|581170950|FG002|Overall Study|Adverse Event|7|||
160939400|NCT00630877|581170948|FG000|Overall Study|Withdrawal by Subject|3|||
160939401|NCT00630877|581170949|FG001|Overall Study|Withdrawal by Subject|4|||
160939402|NCT00630877|581170950|FG002|Overall Study|Withdrawal by Subject|0|||
160939403|NCT00630877|581170948|FG000|Overall Study|Lost to Follow-up|2|||
160939404|NCT00630877|581170949|FG001|Overall Study|Lost to Follow-up|0|||
160939405|NCT00630877|581170950|FG002|Overall Study|Lost to Follow-up|0|||
160939406|NCT00630877|581170948|FG000|Overall Study|Noncompliance|2|||
160939407|NCT00630877|581170949|FG001|Overall Study|Noncompliance|3|||
160939408|NCT00630877|581170950|FG002|Overall Study|Noncompliance|1|||
160939409|NCT00630877|581170948|FG000|Overall Study|Protocol violation|1|||
160939410|NCT00630877|581170949|FG001|Overall Study|Protocol violation|0|||
160939411|NCT00630877|581170950|FG002|Overall Study|Protocol violation|1|||
160939412|NCT00630877|581170948|FG000|Overall Study|Personal reasons|0|||
160939413|NCT00630877|581170949|FG001|Overall Study|Personal reasons|0|||
160939414|NCT00630877|581170950|FG002|Overall Study|Personal reasons|1|||
160939415|NCT01312909|581170951|FG000|Overall Study|Randomized but not treated|1|||
160939416|NCT01312909|581170952|FG001|Overall Study|Randomized but not treated|3|||
160939417|NCT01312909|581170953|FG002|Overall Study|Randomized but not treated|1|||
160939418|NCT01312909|581170951|FG000|Overall Study|Adverse Event|1|||
160939419|NCT01312909|581170952|FG001|Overall Study|Adverse Event|0|||
160939420|NCT01312909|581170953|FG002|Overall Study|Adverse Event|3|||
160939421|NCT01312909|581170951|FG000|Overall Study|Protocol Violation|2|||
160939422|NCT01312909|581170952|FG001|Overall Study|Protocol Violation|0|||
160939423|NCT01312909|581170953|FG002|Overall Study|Protocol Violation|2|||
160939424|NCT01312909|581170951|FG000|Overall Study|Other|9|||
160939425|NCT01312909|581170952|FG001|Overall Study|Other|6|||
160939426|NCT01312909|581170953|FG002|Overall Study|Other|11|||
160939427|NCT01312909|581170951|FG000|Overall Study|Withdrawal by Subject|8|||
160939428|NCT01312909|581170952|FG001|Overall Study|Withdrawal by Subject|10|||
160939429|NCT01312909|581170953|FG002|Overall Study|Withdrawal by Subject|7|||
160939430|NCT01312909|581170951|FG000|Overall Study|Lost to Follow-up|21|||
160939431|NCT01312909|581170952|FG001|Overall Study|Lost to Follow-up|17|||
160939432|NCT01312909|581170953|FG002|Overall Study|Lost to Follow-up|20|||
160939433|NCT01312909|581170951|FG000|Overall Study|Insufficient clinical response|0|||
160939434|NCT01312909|581170952|FG001|Overall Study|Insufficient clinical response|0|||
160939435|NCT01312909|581170953|FG002|Overall Study|Insufficient clinical response|1|||
160939436|NCT01312909|581170951|FG000|Overall Study|Entrance criteria not met|0|||
160939437|NCT01312909|581170952|FG001|Overall Study|Entrance criteria not met|0|||
160939438|NCT01312909|581170953|FG002|Overall Study|Entrance criteria not met|2|||
160939439|NCT02200042|581170954|FG000|Overall Study|Withdrawal by Subject|0|||
160939440|NCT02200042|581170955|FG001|Overall Study|Withdrawal by Subject|1|||
160939441|NCT00306592|581170958|FG000|Overall Study|Adverse Event|8|||
160939442|NCT00306592|581170959|FG001|Overall Study|Adverse Event|15|||
160939443|NCT00306592|581170958|FG000|Overall Study|Lost to Follow-up|1|||
160939444|NCT00306592|581170959|FG001|Overall Study|Lost to Follow-up|0|||
160939445|NCT00306592|581170958|FG000|Overall Study|Noncompliance|0|||
160939446|NCT00306592|581170959|FG001|Overall Study|Noncompliance|2|||
160939447|NCT00306592|581170958|FG000|Overall Study|Persistent Antibodies|6|||
160939448|NCT00306592|581170959|FG001|Overall Study|Persistent Antibodies|3|||
160939449|NCT00306592|581170958|FG000|Overall Study|Voluntary|10|||
160939450|NCT00306592|581170959|FG001|Overall Study|Voluntary|6|||
160939451|NCT00306592|581170958|FG000|Overall Study|Other|5|||
160939452|NCT00306592|581170959|FG001|Overall Study|Other|10|||
160939453|NCT00306592|581170958|FG000|Overall Study|Other|1|||
160939454|NCT00306592|581170959|FG001|Overall Study|Other|2|||
160939455|NCT00306592|581170958|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
160939456|NCT00306592|581170959|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
160939457|NCT00456092|581170961|FG000|Extension Phase|Grade 2 or Greater AE|2|||
160939458|NCT00456092|581170962|FG001|Extension Phase|Grade 2 or Greater AE|2|||
160939459|NCT00456092|581170963|FG002|Extension Phase|Grade 2 or Greater AE|0|||
160939460|NCT00456092|581170964|FG003|Extension Phase|Grade 2 or Greater AE|0|||
160939461|NCT00456092|581170965|FG004|Extension Phase|Grade 2 or Greater AE|2|||
160939462|NCT00456092|581170961|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
160939463|NCT00456092|581170962|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
160939464|NCT00456092|581170963|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
160939465|NCT00456092|581170964|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
160939466|NCT00456092|581170965|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
160939467|NCT00456092|581170961|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
160939468|NCT00456092|581170962|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
160939469|NCT00456092|581170963|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
160939470|NCT00456092|581170964|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
160939471|NCT00456092|581170965|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
160939472|NCT00456092|581170961|FG000|Extension Phase|Withdrew Consent|2|||
160939473|NCT00456092|581170962|FG001|Extension Phase|Withdrew Consent|0|||
160939474|NCT00456092|581170963|FG002|Extension Phase|Withdrew Consent|0|||
160939475|NCT00456092|581170964|FG003|Extension Phase|Withdrew Consent|0|||
160939476|NCT00456092|581170965|FG004|Extension Phase|Withdrew Consent|0|||
160939477|NCT00456092|581170961|FG000|Extension Phase|Lost to Follow-up|1|||
160939478|NCT00456092|581170962|FG001|Extension Phase|Lost to Follow-up|1|||
160939479|NCT00456092|581170963|FG002|Extension Phase|Lost to Follow-up|0|||
160939480|NCT00456092|581170964|FG003|Extension Phase|Lost to Follow-up|0|||
160939481|NCT00456092|581170965|FG004|Extension Phase|Lost to Follow-up|1|||
160939482|NCT00456092|581170961|FG000|Extension Phase|Other|2|||
160939483|NCT00456092|581170962|FG001|Extension Phase|Other|0|||
160939484|NCT00456092|581170963|FG002|Extension Phase|Other|0|||
160939485|NCT00456092|581170964|FG003|Extension Phase|Other|1|||
160939486|NCT00456092|581170965|FG004|Extension Phase|Other|1|||
160939487|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
160939488|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
160939489|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
160939490|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
160939491|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
160939492|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
160939493|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
160939494|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
160939495|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
160939496|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
160939497|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
160939498|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
160939499|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
160939500|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
160939501|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
160939502|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
160939503|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
160939504|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
160939505|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
160939506|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
160939507|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
160939508|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
160939509|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
160939510|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
160939511|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
160939512|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
160939513|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
160939514|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
160998777|NCT01235949|581380610|FG008|Booster Phase|Lost to Follow-up|1|||
160998778|NCT01235949|581380611|FG009|Booster Phase|Lost to Follow-up|1|||
160998779|NCT01235949|581380612|FG010|Booster Phase|Lost to Follow-up|1|||
160939515|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
160998780|NCT01235949|581380613|FG011|Booster Phase|Lost to Follow-up|1|||
160998781|NCT01235949|581380614|FG012|Booster Phase|Lost to Follow-up|0|||
160578731|NCT02531373|579840147|FG007|Overall Study|Lost to Follow-up|0|||
160939516|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
160939517|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
160939518|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
160939519|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
160939520|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
160939521|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
160939522|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
160939523|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
160939524|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
160939525|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
160939526|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
160939527|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Other|1|||
160939528|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Other|0|||
160939529|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Other|1|||
160939530|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Other|0|||
160939531|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Other|0|||
160939532|NCT01252290|581170970|FG000|Overall Study|Withdrawal by Subject|1|||
160939533|NCT02247349|581170971|FG000|Overall Study|Disease Progression|7|||
160939534|NCT02247349|581170972|FG001|Overall Study|Disease Progression|4|||
160939535|NCT02247349|581170973|FG002|Overall Study|Disease Progression|26|||
160939536|NCT02247349|581170974|FG003|Overall Study|Disease Progression|31|||
160939537|NCT02247349|581170975|FG004|Overall Study|Disease Progression|16|||
160939538|NCT02247349|581170976|FG005|Overall Study|Disease Progression|6|||
160939539|NCT02247349|581170971|FG000|Overall Study|Study drug toxicity|0|||
160939540|NCT02247349|581170972|FG001|Overall Study|Study drug toxicity|1|||
160939541|NCT02247349|581170973|FG002|Overall Study|Study drug toxicity|1|||
160578732|NCT02531373|579840148|FG008|Overall Study|Lost to Follow-up|0|||
160578733|NCT02531373|579840140|FG000|Overall Study|Physician Decision|0|||
160578734|NCT02531373|579840141|FG001|Overall Study|Physician Decision|0|||
160578735|NCT02531373|579840142|FG002|Overall Study|Physician Decision|0|||
160578736|NCT02531373|579840143|FG003|Overall Study|Physician Decision|0|||
160578737|NCT02531373|579840144|FG004|Overall Study|Physician Decision|2|||
160939542|NCT02247349|581170974|FG003|Overall Study|Study drug toxicity|1|||
160939543|NCT02247349|581170975|FG004|Overall Study|Study drug toxicity|2|||
160939544|NCT02247349|581170976|FG005|Overall Study|Study drug toxicity|2|||
160939545|NCT02247349|581170971|FG000|Overall Study|Death|0|||
160939546|NCT02247349|581170972|FG001|Overall Study|Death|0|||
160939547|NCT02247349|581170973|FG002|Overall Study|Death|0|||
160939548|NCT02247349|581170974|FG003|Overall Study|Death|1|||
160939549|NCT02247349|581170975|FG004|Overall Study|Death|0|||
160939550|NCT02247349|581170976|FG005|Overall Study|Death|0|||
160939551|NCT02247349|581170971|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
160939552|NCT02247349|581170972|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
160939553|NCT02247349|581170973|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
160939554|NCT02247349|581170974|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
160939555|NCT02247349|581170975|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
160939556|NCT02247349|581170976|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
160939557|NCT02247349|581170971|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160939558|NCT02247349|581170972|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160939559|NCT02247349|581170973|FG002|Overall Study|Participant request to discontinue study treatment|1|||
160939560|NCT02247349|581170974|FG003|Overall Study|Participant request to discontinue study treatment|2|||
160939561|NCT02247349|581170975|FG004|Overall Study|Participant request to discontinue study treatment|1|||
160939562|NCT02247349|581170976|FG005|Overall Study|Participant request to discontinue study treatment|0|||
160939563|NCT02247349|581170971|FG000|Overall Study|Withdrawal by Subject|0|||
160939564|NCT02247349|581170972|FG001|Overall Study|Withdrawal by Subject|1|||
160939565|NCT02247349|581170973|FG002|Overall Study|Withdrawal by Subject|0|||
160939566|NCT02247349|581170974|FG003|Overall Study|Withdrawal by Subject|0|||
160939567|NCT02247349|581170975|FG004|Overall Study|Withdrawal by Subject|0|||
160939568|NCT02247349|581170976|FG005|Overall Study|Withdrawal by Subject|0|||
160939569|NCT02247349|581170971|FG000|Overall Study|Administrative reason by sponsor|0|||
160939570|NCT02247349|581170972|FG001|Overall Study|Administrative reason by sponsor|0|||
160939571|NCT02247349|581170973|FG002|Overall Study|Administrative reason by sponsor|0|||
160939572|NCT02247349|581170974|FG003|Overall Study|Administrative reason by sponsor|0|||
160939573|NCT02247349|581170975|FG004|Overall Study|Administrative reason by sponsor|1|||
160939574|NCT02247349|581170976|FG005|Overall Study|Administrative reason by sponsor|0|||
160939575|NCT02247349|581170971|FG000|Overall Study|Other reasons|0|||
160939576|NCT02247349|581170972|FG001|Overall Study|Other reasons|0|||
160939577|NCT02247349|581170973|FG002|Overall Study|Other reasons|1|||
160939578|NCT02247349|581170974|FG003|Overall Study|Other reasons|0|||
160939579|NCT02247349|581170975|FG004|Overall Study|Other reasons|0|||
160939580|NCT02247349|581170976|FG005|Overall Study|Other reasons|0|||
160939581|NCT03049813|581170977|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
160939582|NCT03049813|581170978|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
160939583|NCT03049813|581170979|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
160939584|NCT03049813|581170980|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
160939585|NCT03049813|581170977|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
160939586|NCT03049813|581170978|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
160939587|NCT03049813|581170979|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
160939588|NCT03049813|581170980|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
160939589|NCT03049813|581170977|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
160939590|NCT03049813|581170978|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
160939591|NCT03049813|581170979|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
160939592|NCT03049813|581170980|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
160939593|NCT03049813|581170977|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
160939594|NCT03049813|581170978|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
160939595|NCT03049813|581170979|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
160939596|NCT03049813|581170980|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
160939597|NCT00382733|581170981|FG000|Overall Study|Withdrawal by Subject|0|||
160939598|NCT00382733|581170982|FG001|Overall Study|Withdrawal by Subject|1|||
160939599|NCT00382733|581170983|FG002|Overall Study|Withdrawal by Subject|0|||
160939600|NCT00382733|581170984|FG003|Overall Study|Withdrawal by Subject|0|||
160939601|NCT00382733|581170985|FG004|Overall Study|Withdrawal by Subject|0|||
160939602|NCT00179413|581170986|FG000|Overall Study|Adverse Event|38|||
160939603|NCT00179413|581170987|FG001|Overall Study|Adverse Event|20|||
160939604|NCT00179413|581170986|FG000|Overall Study|Withdrawal by Subject|87|||
160939605|NCT00179413|581170987|FG001|Overall Study|Withdrawal by Subject|95|||
160939606|NCT00439140|581170990|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
160939607|NCT00439140|581170991|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
160939608|NCT00439140|581170992|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
160939609|NCT00439140|581170990|FG000|Treatment Cycle 1|Personal reasons|0|||
160939610|NCT00439140|581170991|FG001|Treatment Cycle 1|Personal reasons|2|||
160939611|NCT00439140|581170992|FG002|Treatment Cycle 1|Personal reasons|0|||
160939612|NCT00439140|581170990|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
160939613|NCT00439140|581170991|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
160939614|NCT00439140|581170992|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
160939615|NCT00439140|581170990|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
160939616|NCT00439140|581170991|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
160939617|NCT00439140|581170992|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
160939618|NCT00439140|581170990|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
160939619|NCT00439140|581170991|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
160939620|NCT00439140|581170992|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
160939621|NCT01339390|581170995|FG000|Overall Study|Death|32|||
160939622|NCT01339390|581170996|FG001|Overall Study|Death|29|||
160939623|NCT01339390|581170995|FG000|Overall Study|Lost to Follow-up|125|||
160939624|NCT01339390|581170996|FG001|Overall Study|Lost to Follow-up|127|||
160939625|NCT00378703|581170997|FG000|Overall Study|Disease progression|59|||
160939626|NCT00378703|581170998|FG001|Overall Study|Disease progression|43|||
160939627|NCT00378703|581170999|FG002|Overall Study|Disease progression|48|||
160939628|NCT00378703|581171000|FG003|Overall Study|Disease progression|49|||
160939629|NCT00378703|581170997|FG000|Overall Study|Adverse Event|11|||
160939630|NCT00378703|581170998|FG001|Overall Study|Adverse Event|17|||
160939631|NCT00378703|581170999|FG002|Overall Study|Adverse Event|20|||
160939632|NCT00378703|581171000|FG003|Overall Study|Adverse Event|18|||
160939633|NCT00378703|581170997|FG000|Overall Study|Death|2|||
160939634|NCT00378703|581170998|FG001|Overall Study|Death|2|||
160939635|NCT00378703|581170999|FG002|Overall Study|Death|4|||
160939636|NCT00378703|581171000|FG003|Overall Study|Death|3|||
160939637|NCT00378703|581170997|FG000|Overall Study|Withdrawal by Subject|4|||
160939638|NCT00378703|581170998|FG001|Overall Study|Withdrawal by Subject|8|||
160939639|NCT00378703|581170999|FG002|Overall Study|Withdrawal by Subject|5|||
160939640|NCT00378703|581171000|FG003|Overall Study|Withdrawal by Subject|7|||
160939641|NCT00378703|581170997|FG000|Overall Study|Physician Decision|1|||
160578738|NCT02531373|579840145|FG005|Overall Study|Physician Decision|1|||
160939642|NCT00378703|581170998|FG001|Overall Study|Physician Decision|4|||
160939643|NCT00378703|581170999|FG002|Overall Study|Physician Decision|1|||
160939644|NCT00378703|581171000|FG003|Overall Study|Physician Decision|0|||
160939645|NCT00378703|581170997|FG000|Overall Study|Alternative therapy|4|||
160939646|NCT00378703|581170998|FG001|Overall Study|Alternative therapy|2|||
160939647|NCT00378703|581170999|FG002|Overall Study|Alternative therapy|0|||
160939648|NCT00378703|581171000|FG003|Overall Study|Alternative therapy|0|||
160939649|NCT00378703|581170997|FG000|Overall Study|Other complicated disease|0|||
160939650|NCT00378703|581170998|FG001|Overall Study|Other complicated disease|2|||
160939651|NCT00378703|581170999|FG002|Overall Study|Other complicated disease|2|||
160939652|NCT00378703|581171000|FG003|Overall Study|Other complicated disease|0|||
160578739|NCT02531373|579840146|FG006|Overall Study|Physician Decision|0|||
160939653|NCT00378703|581170997|FG000|Overall Study|Symptomatic deterioration|0|||
160939654|NCT00378703|581170998|FG001|Overall Study|Symptomatic deterioration|1|||
160578740|NCT02531373|579840147|FG007|Overall Study|Physician Decision|0|||
160455577|NCT05906784|579399742|FG000|Overall Study|Lost to Follow-up|2|||
160455578|NCT05906784|579399743|FG001|Overall Study|Lost to Follow-up|1|||
160455579|NCT05906784|579399744|FG002|Overall Study|Lost to Follow-up|1|||
160455580|NCT05906784|579399745|FG003|Overall Study|Lost to Follow-up|1|||
160455581|NCT04685135|579399751|FG000|Overall Study|Death|126|||
160455582|NCT04685135|579399752|FG001|Overall Study|Death|53|||
160455583|NCT04685135|579399751|FG000|Overall Study|Withdrawal by Subject|12|||
160455584|NCT04685135|579399752|FG001|Overall Study|Withdrawal by Subject|16|||
160455585|NCT02315703|579399753|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
160939655|NCT00378703|581170999|FG002|Overall Study|Symptomatic deterioration|0|||
160939656|NCT00378703|581171000|FG003|Overall Study|Symptomatic deterioration|2|||
160939657|NCT00378703|581170997|FG000|Overall Study|Surgery|1|||
160939658|NCT00378703|581170998|FG001|Overall Study|Surgery|0|||
160939659|NCT00378703|581170999|FG002|Overall Study|Surgery|0|||
160939660|NCT00378703|581171000|FG003|Overall Study|Surgery|1|||
160939661|NCT00378703|581170997|FG000|Overall Study|Joint decision of physician and patient|1|||
160939662|NCT00378703|581170998|FG001|Overall Study|Joint decision of physician and patient|0|||
160939663|NCT00378703|581170999|FG002|Overall Study|Joint decision of physician and patient|0|||
160939664|NCT00378703|581171000|FG003|Overall Study|Joint decision of physician and patient|0|||
160939665|NCT00378703|581170997|FG000|Overall Study|Adverse events and progressive disease|0|||
160939666|NCT00378703|581170998|FG001|Overall Study|Adverse events and progressive disease|0|||
160939667|NCT00378703|581170999|FG002|Overall Study|Adverse events and progressive disease|0|||
160939668|NCT00378703|581171000|FG003|Overall Study|Adverse events and progressive disease|1|||
160939669|NCT00378703|581170997|FG000|Overall Study|Relocation|0|||
160939670|NCT00378703|581170998|FG001|Overall Study|Relocation|0|||
160939671|NCT00378703|581170999|FG002|Overall Study|Relocation|1|||
160939672|NCT00378703|581171000|FG003|Overall Study|Relocation|0|||
160939673|NCT00378703|581170997|FG000|Overall Study|Ineligible|4|||
160939674|NCT00378703|581170998|FG001|Overall Study|Ineligible|7|||
160939675|NCT00378703|581170999|FG002|Overall Study|Ineligible|7|||
160939676|NCT00378703|581171000|FG003|Overall Study|Ineligible|7|||
160939677|NCT00378703|581170997|FG000|Overall Study|Never started treatment|1|||
160939678|NCT00378703|581170998|FG001|Overall Study|Never started treatment|4|||
160939679|NCT00378703|581170999|FG002|Overall Study|Never started treatment|0|||
160939680|NCT00378703|581171000|FG003|Overall Study|Never started treatment|0|||
160939681|NCT00378703|581170997|FG000|Overall Study|Other|1|||
160939682|NCT00378703|581170998|FG001|Overall Study|Other|1|||
160939683|NCT00378703|581170999|FG002|Overall Study|Other|2|||
160939684|NCT00378703|581171000|FG003|Overall Study|Other|3|||
160939685|NCT03181542|581171003|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
160939686|NCT03181542|581171004|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
160939687|NCT04292730|581171012|FG000|Overall Study|Lost to Follow-up|8|||
160939688|NCT04292730|581171013|FG001|Overall Study|Lost to Follow-up|12|||
160939689|NCT04292730|581171014|FG002|Overall Study|Lost to Follow-up|12|||
160939690|NCT04292730|581171015|FG003|Overall Study|Lost to Follow-up|48|||
160939691|NCT04292730|581171012|FG000|Overall Study|Death|2|||
160939692|NCT04292730|581171013|FG001|Overall Study|Death|2|||
160939693|NCT04292730|581171014|FG002|Overall Study|Death|4|||
160939694|NCT04292730|581171015|FG003|Overall Study|Death|12|||
160939695|NCT04292730|581171012|FG000|Overall Study|Withdrew Consent|2|||
160939696|NCT04292730|581171013|FG001|Overall Study|Withdrew Consent|2|||
160455586|NCT02315703|579399754|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
160455587|NCT02315703|579399755|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
160455588|NCT02315703|579399756|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
160455589|NCT02315703|579399757|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
160939697|NCT04292730|581171014|FG002|Overall Study|Withdrew Consent|5|||
160939698|NCT04292730|581171015|FG003|Overall Study|Withdrew Consent|6|||
160939699|NCT04292730|581171012|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160939700|NCT04292730|581171013|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160939701|NCT04292730|581171014|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160939702|NCT04292730|581171015|FG003|Overall Study|Non-Compliance with Study Drug|0|||
160939703|NCT04292730|581171012|FG000|Overall Study|Protocol Violation|0|||
160939704|NCT04292730|581171013|FG001|Overall Study|Protocol Violation|0|||
160939705|NCT04292730|581171014|FG002|Overall Study|Protocol Violation|1|||
160939706|NCT04292730|581171015|FG003|Overall Study|Protocol Violation|0|||
160939707|NCT04292730|581171012|FG000|Overall Study|Randomized but not Treated|8|||
160939708|NCT04292730|581171013|FG001|Overall Study|Randomized but not Treated|4|||
160939709|NCT04292730|581171014|FG002|Overall Study|Randomized but not Treated|0|||
160939710|NCT04292730|581171015|FG003|Overall Study|Randomized but not Treated|14|||
160939711|NCT01482767|581171019|FG000|Overall Study|Death|1|||
160455590|NCT02315703|579399758|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
160455591|NCT02315703|579399759|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
160578741|NCT02531373|579840148|FG008|Overall Study|Physician Decision|0|||
160939712|NCT01482767|581171020|FG001|Overall Study|Death|1|||
160939713|NCT01482767|581171019|FG000|Overall Study|Withdrawal by Subject|7|||
160939714|NCT01482767|581171020|FG001|Overall Study|Withdrawal by Subject|5|||
160939715|NCT01482767|581171019|FG000|Overall Study|Lost to Follow-up|12|||
160939716|NCT01482767|581171020|FG001|Overall Study|Lost to Follow-up|6|||
160939717|NCT01482767|581171019|FG000|Overall Study|Adverse Event|0|||
160939718|NCT01482767|581171020|FG001|Overall Study|Adverse Event|3|||
160939719|NCT01482767|581171019|FG000|Overall Study|Site closure|22|||
160939720|NCT01482767|581171020|FG001|Overall Study|Site closure|14|||
160939721|NCT01482767|581171019|FG000|Overall Study|Non-adherence to study requirements|4|||
160939722|NCT01482767|581171020|FG001|Overall Study|Non-adherence to study requirements|7|||
160939723|NCT01482767|581171019|FG000|Overall Study|Alternate HCV treatment|7|||
160939724|NCT01482767|581171020|FG001|Overall Study|Alternate HCV treatment|8|||
160939725|NCT01482767|581171019|FG000|Overall Study|Ineligible|0|||
160939726|NCT01482767|581171020|FG001|Overall Study|Ineligible|5|||
160939727|NCT01482767|581171019|FG000|Overall Study|Nurse error|1|||
160939728|NCT01482767|581171020|FG001|Overall Study|Nurse error|0|||
160939729|NCT03400033|581171030|FG000|Overall Study|Withdrawal by Subject|1|||
160939730|NCT03400033|581171031|FG001|Overall Study|Withdrawal by Subject|2|||
160939731|NCT00806546|581171034|FG000|Overall Study|Enrolled, not treated|35|||
160939732|NCT00806546|581171034|FG000|Overall Study|Lost to Follow-up|32|||
160939733|NCT00806546|581171034|FG000|Overall Study|Adverse Event|74|||
160939734|NCT00806546|581171034|FG000|Overall Study|Withdrawal by Subject|75|||
160939735|NCT00806546|581171034|FG000|Overall Study|Protocol Violation|49|||
160939736|NCT00806546|581171034|FG000|Overall Study|Various|42|||
160939737|NCT01247090|581171035|FG000|Overall Study|Physician Decision|1|||
160939738|NCT01247090|581171036|FG001|Overall Study|Physician Decision|0|||
160939739|NCT01247090|581171037|FG002|Overall Study|Physician Decision|0|||
160939740|NCT01247090|581171035|FG000|Overall Study|Withdrawal by Subject|0|||
160939741|NCT01247090|581171036|FG001|Overall Study|Withdrawal by Subject|1|||
160939742|NCT01247090|581171037|FG002|Overall Study|Withdrawal by Subject|0|||
160939743|NCT00006916|581171039|FG000|Overall Study|Device not inserted|4|||
160939744|NCT00006916|581171039|FG000|Overall Study|Complication of device insertion|1|||
160939745|NCT00558103|581171040|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
160939746|NCT00558103|581171041|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
160939747|NCT00558103|581171042|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
160939748|NCT00558103|581171043|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
160939749|NCT00558103|581171044|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
160939750|NCT00558103|581171045|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
160939751|NCT00558103|581171040|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
160939752|NCT00558103|581171041|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
160939753|NCT00558103|581171042|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
160939754|NCT00558103|581171043|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
160939755|NCT00558103|581171044|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
160939756|NCT00558103|581171045|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
160939757|NCT00558103|581171040|FG000|Randomized Treatment Phase|Disease Progression|1|||
160939758|NCT00558103|581171041|FG001|Randomized Treatment Phase|Disease Progression|0|||
160939759|NCT00558103|581171042|FG002|Randomized Treatment Phase|Disease Progression|1|||
160939760|NCT00558103|581171043|FG003|Randomized Treatment Phase|Disease Progression|0|||
160939761|NCT00558103|581171044|FG004|Randomized Treatment Phase|Disease Progression|0|||
160939762|NCT00558103|581171045|FG005|Randomized Treatment Phase|Disease Progression|0|||
160939763|NCT00558103|581171040|FG000|Randomized Treatment Phase|Adverse Event|0|||
160939764|NCT00558103|581171041|FG001|Randomized Treatment Phase|Adverse Event|0|||
160939765|NCT00558103|581171042|FG002|Randomized Treatment Phase|Adverse Event|0|||
160939766|NCT00558103|581171043|FG003|Randomized Treatment Phase|Adverse Event|1|||
160939767|NCT00558103|581171044|FG004|Randomized Treatment Phase|Adverse Event|1|||
160455592|NCT02315703|579399760|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
160455593|NCT02315703|579399753|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
160455594|NCT02315703|579399754|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
160455595|NCT02315703|579399755|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
160939768|NCT00558103|581171045|FG005|Randomized Treatment Phase|Adverse Event|0|||
160939769|NCT00558103|581171040|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
160939770|NCT00558103|581171041|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
160939771|NCT00558103|581171042|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
160939772|NCT00558103|581171043|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
160939773|NCT00558103|581171044|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
160939774|NCT00558103|581171045|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
160939775|NCT00558103|581171040|FG000|Monotherapy Extension Phase|Disease Progression|0|||
160939776|NCT00558103|581171041|FG001|Monotherapy Extension Phase|Disease Progression|0|||
160939777|NCT00558103|581171042|FG002|Monotherapy Extension Phase|Disease Progression|0|||
160939778|NCT00558103|581171043|FG003|Monotherapy Extension Phase|Disease Progression|0|||
160939779|NCT00558103|581171044|FG004|Monotherapy Extension Phase|Disease Progression|0|||
160939780|NCT00558103|581171045|FG005|Monotherapy Extension Phase|Disease Progression|8|||
160939781|NCT02457325|581171056|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
160939782|NCT02457325|581171057|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
160939783|NCT01541930|581171058|FG000|Overall Study|Withdrawal by Subject|1|||
160939784|NCT03385239|581171059|FG000|Overall Study|Voluntary Withdrawal|2|||
160939785|NCT03385239|581171060|FG001|Overall Study|Voluntary Withdrawal|3|||
160939786|NCT03385239|581171061|FG002|Overall Study|Voluntary Withdrawal|2|||
160939787|NCT03385239|581171062|FG003|Overall Study|Voluntary Withdrawal|3|||
160939788|NCT03385239|581171063|FG004|Overall Study|Voluntary Withdrawal|0|||
160939789|NCT03385239|581171059|FG000|Overall Study|Adverse Event|0|||
160939790|NCT03385239|581171060|FG001|Overall Study|Adverse Event|0|||
160939791|NCT03385239|581171061|FG002|Overall Study|Adverse Event|1|||
160939792|NCT03385239|581171062|FG003|Overall Study|Adverse Event|0|||
160939793|NCT03385239|581171063|FG004|Overall Study|Adverse Event|0|||
160939794|NCT03385239|581171059|FG000|Overall Study|Other|0|||
160939795|NCT03385239|581171060|FG001|Overall Study|Other|0|||
160455596|NCT02315703|579399756|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
160455597|NCT02315703|579399757|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
160455598|NCT02315703|579399758|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
160455599|NCT02315703|579399759|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
160455600|NCT02315703|579399760|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
160455601|NCT02315703|579399753|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
160455602|NCT02315703|579399754|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
160939796|NCT03385239|581171061|FG002|Overall Study|Other|0|||
160939797|NCT03385239|581171062|FG003|Overall Study|Other|1|||
160939798|NCT03385239|581171063|FG004|Overall Study|Other|0|||
160939799|NCT01574703|581171064|FG000|Overall Study|Adverse Event|0|||
160939800|NCT01574703|581171065|FG001|Overall Study|Adverse Event|2|||
160939801|NCT01574703|581171066|FG002|Overall Study|Adverse Event|1|||
160939802|NCT01574703|581171067|FG003|Overall Study|Adverse Event|1|||
160939803|NCT01574703|581171064|FG000|Overall Study|Protocol Violation|0|||
160939804|NCT01574703|581171065|FG001|Overall Study|Protocol Violation|0|||
160939805|NCT01574703|581171066|FG002|Overall Study|Protocol Violation|0|||
160455603|NCT02315703|579399755|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
160455604|NCT02315703|579399756|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
160455605|NCT02315703|579399757|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
160455606|NCT02315703|579399758|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
160455607|NCT02315703|579399759|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
160455608|NCT02315703|579399760|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
160455609|NCT02315703|579399753|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
160455610|NCT02315703|579399754|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
160455611|NCT02315703|579399755|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
160455612|NCT02315703|579399756|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
160455613|NCT02315703|579399757|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
160455614|NCT02315703|579399758|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
160455615|NCT02315703|579399759|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
160455616|NCT02315703|579399760|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
160455617|NCT02315703|579399753|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
160455618|NCT02315703|579399754|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
160455619|NCT02315703|579399755|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
160455620|NCT02315703|579399756|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
160455621|NCT02315703|579399757|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
160455622|NCT02315703|579399758|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
160455623|NCT02315703|579399759|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
160455624|NCT02315703|579399760|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
160455625|NCT02315703|579399753|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
160455626|NCT02315703|579399754|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
160455627|NCT02315703|579399755|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
160455628|NCT02315703|579399756|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
160455629|NCT02315703|579399757|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
160455630|NCT02315703|579399758|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
160455631|NCT02315703|579399759|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
160455632|NCT02315703|579399760|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
160939806|NCT01574703|581171067|FG003|Overall Study|Protocol Violation|1|||
160939807|NCT01574703|581171064|FG000|Overall Study|Unspecified Reason|27|||
160939808|NCT01574703|581171065|FG001|Overall Study|Unspecified Reason|15|||
160939809|NCT01574703|581171066|FG002|Overall Study|Unspecified Reason|20|||
160939810|NCT01574703|581171067|FG003|Overall Study|Unspecified Reason|16|||
160578742|NCT02531373|579840140|FG000|Overall Study|Protocol Violation|0|||
160578743|NCT02531373|579840141|FG001|Overall Study|Protocol Violation|0|||
160578744|NCT02531373|579840142|FG002|Overall Study|Protocol Violation|0|||
160939811|NCT01574703|581171064|FG000|Overall Study|Withdrawal by Subject|53|||
160939812|NCT01574703|581171065|FG001|Overall Study|Withdrawal by Subject|52|||
160578745|NCT02531373|579840143|FG003|Overall Study|Protocol Violation|0|||
160939813|NCT01574703|581171066|FG002|Overall Study|Withdrawal by Subject|36|||
160939814|NCT01574703|581171067|FG003|Overall Study|Withdrawal by Subject|61|||
160939815|NCT01574703|581171064|FG000|Overall Study|Met Withdrawal Criteria|0|||
160939816|NCT01574703|581171065|FG001|Overall Study|Met Withdrawal Criteria|1|||
160939817|NCT01574703|581171066|FG002|Overall Study|Met Withdrawal Criteria|1|||
160939818|NCT01574703|581171067|FG003|Overall Study|Met Withdrawal Criteria|0|||
160939819|NCT01574703|581171064|FG000|Overall Study|Lost to Follow-up|43|||
160939820|NCT01574703|581171065|FG001|Overall Study|Lost to Follow-up|41|||
160939821|NCT01574703|581171066|FG002|Overall Study|Lost to Follow-up|46|||
160939822|NCT01574703|581171067|FG003|Overall Study|Lost to Follow-up|35|||
160939823|NCT01574703|581171064|FG000|Overall Study|Death|2|||
160939824|NCT01574703|581171065|FG001|Overall Study|Death|1|||
160939825|NCT01574703|581171066|FG002|Overall Study|Death|1|||
160939826|NCT01574703|581171067|FG003|Overall Study|Death|0|||
160939827|NCT02751983|581171073|FG000|Treatment|Stopped ACT, but Remained in study|2|||
160939828|NCT02751983|581171074|FG001|Treatment|Stopped ACT, but Remained in study|0|||
160939829|NCT02751983|581171073|FG000|Treatment|Discharged prior to beginning ACT|2|||
160939830|NCT02751983|581171074|FG001|Treatment|Discharged prior to beginning ACT|0|||
160939831|NCT02751983|581171073|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
160939832|NCT02751983|581171074|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
160939833|NCT02751983|581171073|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
160939834|NCT02751983|581171074|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
160939835|NCT02751983|581171073|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
160939836|NCT02751983|581171074|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
160939837|NCT00308711|581171075|FG000|Overall Study|Withdrawal by Subject|1|||
160939838|NCT00308711|581171076|FG001|Overall Study|Withdrawal by Subject|0|||
160939839|NCT00308711|581171077|FG002|Overall Study|Withdrawal by Subject|1|||
160939840|NCT00308711|581171075|FG000|Overall Study|Protocol Violation|0|||
160939841|NCT00308711|581171076|FG001|Overall Study|Protocol Violation|1|||
160939842|NCT00308711|581171077|FG002|Overall Study|Protocol Violation|1|||
160939843|NCT00308711|581171075|FG000|Overall Study|Lost to Follow-up|0|||
160939844|NCT00308711|581171076|FG001|Overall Study|Lost to Follow-up|1|||
160939845|NCT00308711|581171077|FG002|Overall Study|Lost to Follow-up|0|||
160939846|NCT00308711|581171075|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
160939847|NCT00308711|581171076|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
160939848|NCT00308711|581171077|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
160939849|NCT00308711|581171075|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
160939850|NCT00308711|581171076|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
160939851|NCT00308711|581171077|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
160939852|NCT02167256|581171080|FG000|Overall Study|Adverse Event|13|||
160939853|NCT02167256|581171081|FG001|Overall Study|Adverse Event|6|||
160939854|NCT02167256|581171080|FG000|Overall Study|Withdrawal by Subject|4|||
160939855|NCT02167256|581171081|FG001|Overall Study|Withdrawal by Subject|4|||
160939856|NCT02167256|581171080|FG000|Overall Study|non-compliance|3|||
160939857|NCT02167256|581171081|FG001|Overall Study|non-compliance|0|||
160939858|NCT02167256|581171080|FG000|Overall Study|Study partner unable to participate|1|||
160939859|NCT02167256|581171081|FG001|Overall Study|Study partner unable to participate|0|||
160939860|NCT03139916|581171082|FG000|Overall Study|Withdrawal by Subject|2|||
160939861|NCT03139916|581171082|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
160939862|NCT01957475|581171083|FG000|Test Period 1|Withdrawal by Subject|1|||
160939863|NCT01957475|581171084|FG001|Test Period 1|Withdrawal by Subject|0|||
160939864|NCT01957475|581171083|FG000|Test Period 1|Other|1|||
160939865|NCT01957475|581171084|FG001|Test Period 1|Other|0|||
160939866|NCT01957475|581171083|FG000|Test Period 1|Lack of Efficacy|0|||
160939867|NCT01957475|581171084|FG001|Test Period 1|Lack of Efficacy|1|||
160939868|NCT01957475|581171083|FG000|Test Period 2|Adverse Event|1|||
160939869|NCT01957475|581171084|FG001|Test Period 2|Adverse Event|0|||
160939870|NCT00414388|581171085|FG000|Overall Study|Adverse Event|1|||
160939871|NCT03467425|581171086|FG000|Overall Study|Adverse Event|9|||
160939872|NCT03467425|581171087|FG001|Overall Study|Adverse Event|9|||
160939873|NCT03467425|581171086|FG000|Overall Study|Lack of Efficacy|3|||
160939874|NCT03467425|581171087|FG001|Overall Study|Lack of Efficacy|1|||
160939875|NCT03467425|581171086|FG000|Overall Study|Protocol Violation|0|||
160939876|NCT03467425|581171087|FG001|Overall Study|Protocol Violation|1|||
160939877|NCT03467425|581171086|FG000|Overall Study|Lost to Follow-up|18|||
160939878|NCT03467425|581171087|FG001|Overall Study|Lost to Follow-up|25|||
160939879|NCT03467425|581171086|FG000|Overall Study|Physician Decision|2|||
160939880|NCT03467425|581171087|FG001|Overall Study|Physician Decision|1|||
160939881|NCT03467425|581171086|FG000|Overall Study|Withdrawal by Subject|15|||
160939882|NCT03467425|581171087|FG001|Overall Study|Withdrawal by Subject|17|||
160939883|NCT02318693|581171088|FG000|Overall Study|Protocol Violation|0|||
160939884|NCT02318693|581171089|FG001|Overall Study|Protocol Violation|1|||
160939885|NCT00025883|581171092|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
160939886|NCT00025883|581171092|FG000|Overall Study|no baseline data|1|||
160939887|NCT00025883|581171092|FG000|Overall Study|Death|1|||
160939888|NCT00025883|581171092|FG000|Overall Study|Adverse Event|1|||
160939889|NCT00025883|581171092|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
160939890|NCT03591575|581171093|FG000|Overall Study|Adverse Event|2|||
160939891|NCT03591575|581171094|FG001|Overall Study|Adverse Event|0|||
160939892|NCT03591575|581171093|FG000|Overall Study|Withdrawal by Subject|4|||
160455633|NCT02315703|579399753|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
160455634|NCT02315703|579399754|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
160455635|NCT02315703|579399755|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
160455636|NCT02315703|579399756|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
160455637|NCT02315703|579399757|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
160455638|NCT02315703|579399758|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
160455639|NCT02315703|579399759|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
160455640|NCT02315703|579399760|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
160455641|NCT02315703|579399753|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
160455642|NCT02315703|579399754|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
160455643|NCT02315703|579399755|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
160455644|NCT02315703|579399756|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
160455645|NCT02315703|579399757|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
160455646|NCT02315703|579399758|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
160455647|NCT02315703|579399759|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
160455648|NCT02315703|579399760|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
160455649|NCT02315703|579399753|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
160455650|NCT02315703|579399754|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
160455651|NCT02315703|579399755|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
160455652|NCT02315703|579399756|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
160455653|NCT02315703|579399757|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
160455654|NCT02315703|579399758|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
160455655|NCT02315703|579399759|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
160455656|NCT02315703|579399760|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
160455657|NCT02240238|579399761|FG000|Phase 1|Adverse Event|0|||
160455658|NCT02240238|579399762|FG001|Phase 1|Adverse Event|0|||
160455659|NCT02240238|579399763|FG002|Phase 1|Adverse Event|0|||
160455660|NCT02240238|579399764|FG003|Phase 1|Adverse Event|0|||
160455661|NCT02240238|579399765|FG004|Phase 1|Adverse Event|0|||
160455662|NCT02240238|579399766|FG005|Phase 1|Adverse Event|0|||
160455663|NCT02240238|579399767|FG006|Phase 1|Adverse Event|3|||
160455664|NCT02240238|579399768|FG007|Phase 1|Adverse Event|1|||
160578746|NCT02531373|579840144|FG004|Overall Study|Protocol Violation|0|||
160578747|NCT02531373|579840145|FG005|Overall Study|Protocol Violation|1|||
160578748|NCT02531373|579840146|FG006|Overall Study|Protocol Violation|1|||
160578749|NCT02531373|579840147|FG007|Overall Study|Protocol Violation|0|||
160578750|NCT02531373|579840148|FG008|Overall Study|Protocol Violation|1|||
160578751|NCT02531373|579840140|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160578752|NCT02531373|579840141|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160578753|NCT02531373|579840142|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160578754|NCT02531373|579840143|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160578755|NCT02531373|579840144|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
160578756|NCT02531373|579840145|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
160939893|NCT03591575|581171094|FG001|Overall Study|Withdrawal by Subject|1|||
160939894|NCT00813358|581171095|FG000|Overall Study|Death|32|||
160939895|NCT00813358|581171095|FG000|Overall Study|Lost to Follow-up|12|||
160939896|NCT00813358|581171095|FG000|Overall Study|other endpoints|5|||
160939897|NCT00813358|581171095|FG000|Overall Study|Withdrawal by Subject|20|||
160939898|NCT00218543|581171096|FG000|Overall Study|Lost to Follow-up|8|||
160939899|NCT00218543|581171096|FG000|Overall Study|relocated|1|||
160939900|NCT00218543|581171096|FG000|Overall Study|Withdrawal by Subject|1|||
160939901|NCT00218543|581171096|FG000|Overall Study|Physician Decision|3|||
160939902|NCT00218543|581171096|FG000|Overall Study|Adverse Event|2|||
160939903|NCT03665038|581171097|FG000|Overall Study|Lost to Follow-up|0|||
160939904|NCT03665038|581171098|FG001|Overall Study|Lost to Follow-up|0|||
160939905|NCT03665038|581171099|FG002|Overall Study|Lost to Follow-up|1|||
160939906|NCT03013491|581171100|FG000|Main Study|Death|2|||
160939907|NCT03013491|581171101|FG001|Main Study|Death|2|||
160939908|NCT03013491|581171102|FG002|Main Study|Death|5|||
160939909|NCT03013491|581171103|FG003|Main Study|Death|3|||
160578757|NCT02531373|579840146|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
160578758|NCT02531373|579840147|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
160578759|NCT02531373|579840148|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
160939910|NCT03013491|581171104|FG004|Main Study|Death|9|||
160939911|NCT03013491|581171105|FG005|Main Study|Death|12|||
160939912|NCT03013491|581171106|FG006|Main Study|Death|3|||
160578760|NCT02531373|579840140|FG000|Overall Study|Withdrawal by Subject|0|||
160939913|NCT03013491|581171107|FG007|Main Study|Death|5|||
160939914|NCT03013491|581171108|FG008|Main Study|Death|1|||
160455665|NCT02240238|579399769|FG008|Phase 1|Adverse Event|0|||
160455666|NCT02240238|579399770|FG009|Phase 1|Adverse Event|0|||
160455667|NCT02240238|579399771|FG010|Phase 1|Adverse Event|0|||
160455668|NCT02240238|579399772|FG011|Phase 1|Adverse Event|0|||
160455669|NCT02240238|579399761|FG000|Phase 1|Death|0|||
160455670|NCT02240238|579399762|FG001|Phase 1|Death|0|||
160455671|NCT02240238|579399763|FG002|Phase 1|Death|0|||
160939915|NCT03013491|581171109|FG009|Main Study|Death|2|||
160939916|NCT03013491|581171110|FG010|Main Study|Death|4|||
160656014|NCT02130466|580120352|FG009|Overall Study|Death|4|||
160939917|NCT03013491|581171111|FG011|Main Study|Death|1|||
160939918|NCT03013491|581171112|FG012|Main Study|Death|1|||
160939919|NCT03013491|581171113|FG013|Main Study|Death|4|||
160939920|NCT03013491|581171114|FG014|Main Study|Death|0|||
160939921|NCT03013491|581171115|FG015|Main Study|Death|3|||
160939922|NCT03013491|581171116|FG016|Main Study|Death|5|||
160939923|NCT03013491|581171117|FG017|Main Study|Death|1|||
160939924|NCT03013491|581171118|FG018|Main Study|Death|47|||
160939925|NCT03013491|581171100|FG000|Main Study|Lost to Follow-up|0|||
160939926|NCT03013491|581171101|FG001|Main Study|Lost to Follow-up|0|||
160939927|NCT03013491|581171102|FG002|Main Study|Lost to Follow-up|1|||
160939928|NCT03013491|581171103|FG003|Main Study|Lost to Follow-up|0|||
160939929|NCT03013491|581171104|FG004|Main Study|Lost to Follow-up|1|||
160939930|NCT03013491|581171105|FG005|Main Study|Lost to Follow-up|0|||
160939931|NCT03013491|581171106|FG006|Main Study|Lost to Follow-up|0|||
160939932|NCT03013491|581171107|FG007|Main Study|Lost to Follow-up|0|||
160939933|NCT03013491|581171108|FG008|Main Study|Lost to Follow-up|0|||
160939934|NCT03013491|581171109|FG009|Main Study|Lost to Follow-up|0|||
160939935|NCT03013491|581171110|FG010|Main Study|Lost to Follow-up|0|||
160939936|NCT03013491|581171111|FG011|Main Study|Lost to Follow-up|0|||
160939937|NCT03013491|581171112|FG012|Main Study|Lost to Follow-up|0|||
160939938|NCT03013491|581171113|FG013|Main Study|Lost to Follow-up|0|||
160939939|NCT03013491|581171114|FG014|Main Study|Lost to Follow-up|0|||
160939940|NCT03013491|581171115|FG015|Main Study|Lost to Follow-up|0|||
160939941|NCT03013491|581171116|FG016|Main Study|Lost to Follow-up|0|||
160939942|NCT03013491|581171117|FG017|Main Study|Lost to Follow-up|0|||
160939943|NCT03013491|581171118|FG018|Main Study|Lost to Follow-up|3|||
160939944|NCT03013491|581171100|FG000|Main Study|Termination of the study by Sponsor|0|||
160939945|NCT03013491|581171101|FG001|Main Study|Termination of the study by Sponsor|0|||
160939946|NCT03013491|581171102|FG002|Main Study|Termination of the study by Sponsor|2|||
160939947|NCT03013491|581171103|FG003|Main Study|Termination of the study by Sponsor|0|||
160939948|NCT03013491|581171104|FG004|Main Study|Termination of the study by Sponsor|1|||
160939949|NCT03013491|581171105|FG005|Main Study|Termination of the study by Sponsor|2|||
160939950|NCT03013491|581171106|FG006|Main Study|Termination of the study by Sponsor|0|||
160939951|NCT03013491|581171107|FG007|Main Study|Termination of the study by Sponsor|0|||
160939952|NCT03013491|581171108|FG008|Main Study|Termination of the study by Sponsor|1|||
160939953|NCT03013491|581171109|FG009|Main Study|Termination of the study by Sponsor|1|||
160939954|NCT03013491|581171110|FG010|Main Study|Termination of the study by Sponsor|1|||
160939955|NCT03013491|581171111|FG011|Main Study|Termination of the study by Sponsor|2|||
160939956|NCT03013491|581171112|FG012|Main Study|Termination of the study by Sponsor|0|||
160939957|NCT03013491|581171113|FG013|Main Study|Termination of the study by Sponsor|0|||
160939958|NCT03013491|581171114|FG014|Main Study|Termination of the study by Sponsor|0|||
160939959|NCT03013491|581171115|FG015|Main Study|Termination of the study by Sponsor|0|||
160939960|NCT03013491|581171116|FG016|Main Study|Termination of the study by Sponsor|0|||
160939961|NCT03013491|581171117|FG017|Main Study|Termination of the study by Sponsor|1|||
160939962|NCT03013491|581171118|FG018|Main Study|Termination of the study by Sponsor|13|||
160939963|NCT03013491|581171100|FG000|Main Study|Withdrawal by Subject|0|||
160939964|NCT03013491|581171101|FG001|Main Study|Withdrawal by Subject|0|||
160939965|NCT03013491|581171102|FG002|Main Study|Withdrawal by Subject|0|||
160939966|NCT03013491|581171103|FG003|Main Study|Withdrawal by Subject|4|||
160939967|NCT03013491|581171104|FG004|Main Study|Withdrawal by Subject|2|||
160656015|NCT02130466|580120353|FG010|Overall Study|Death|5|||
160939968|NCT03013491|581171105|FG005|Main Study|Withdrawal by Subject|1|||
160656016|NCT02130466|580120354|FG011|Overall Study|Death|3|||
160656017|NCT02130466|580120355|FG012|Overall Study|Death|11|||
160656018|NCT02130466|580120356|FG013|Overall Study|Death|7|||
160939969|NCT03013491|581171106|FG006|Main Study|Withdrawal by Subject|0|||
160939970|NCT03013491|581171107|FG007|Main Study|Withdrawal by Subject|0|||
160939971|NCT03013491|581171108|FG008|Main Study|Withdrawal by Subject|0|||
160939972|NCT03013491|581171109|FG009|Main Study|Withdrawal by Subject|0|||
160939973|NCT03013491|581171110|FG010|Main Study|Withdrawal by Subject|1|||
160939974|NCT03013491|581171111|FG011|Main Study|Withdrawal by Subject|2|||
160939975|NCT03013491|581171112|FG012|Main Study|Withdrawal by Subject|0|||
160939976|NCT03013491|581171113|FG013|Main Study|Withdrawal by Subject|2|||
160939977|NCT03013491|581171114|FG014|Main Study|Withdrawal by Subject|0|||
160939978|NCT03013491|581171115|FG015|Main Study|Withdrawal by Subject|0|||
160939979|NCT03013491|581171116|FG016|Main Study|Withdrawal by Subject|0|||
160939980|NCT03013491|581171117|FG017|Main Study|Withdrawal by Subject|0|||
160939981|NCT03013491|581171118|FG018|Main Study|Withdrawal by Subject|18|||
160939982|NCT03013491|581171100|FG000|Main Study|Disease progression|0|||
160656019|NCT02130466|580120343|FG000|Overall Study|Lost to Follow-up|1|||
160656020|NCT02130466|580120344|FG001|Overall Study|Lost to Follow-up|0|||
160939983|NCT03013491|581171101|FG001|Main Study|Disease progression|0|||
160656021|NCT02130466|580120345|FG002|Overall Study|Lost to Follow-up|0|||
160656022|NCT02130466|580120346|FG003|Overall Study|Lost to Follow-up|0|||
160939984|NCT03013491|581171102|FG002|Main Study|Disease progression|0|||
160939985|NCT03013491|581171103|FG003|Main Study|Disease progression|1|||
160939986|NCT03013491|581171104|FG004|Main Study|Disease progression|0|||
160939987|NCT03013491|581171105|FG005|Main Study|Disease progression|0|||
160939988|NCT03013491|581171106|FG006|Main Study|Disease progression|0|||
160939989|NCT03013491|581171107|FG007|Main Study|Disease progression|0|||
160939990|NCT03013491|581171108|FG008|Main Study|Disease progression|1|||
160939991|NCT03013491|581171109|FG009|Main Study|Disease progression|0|||
160455672|NCT02240238|579399764|FG003|Phase 1|Death|0|||
160455673|NCT02240238|579399765|FG004|Phase 1|Death|0|||
160455674|NCT02240238|579399766|FG005|Phase 1|Death|1|||
160939992|NCT03013491|581171110|FG010|Main Study|Disease progression|1|||
160939993|NCT03013491|581171111|FG011|Main Study|Disease progression|0|||
160939994|NCT03013491|581171112|FG012|Main Study|Disease progression|0|||
160939995|NCT03013491|581171113|FG013|Main Study|Disease progression|0|||
160939996|NCT03013491|581171114|FG014|Main Study|Disease progression|0|||
160939997|NCT03013491|581171115|FG015|Main Study|Disease progression|0|||
160939998|NCT03013491|581171116|FG016|Main Study|Disease progression|0|||
160939999|NCT03013491|581171117|FG017|Main Study|Disease progression|0|||
160940000|NCT03013491|581171118|FG018|Main Study|Disease progression|4|||
160940001|NCT03013491|581171100|FG000|Main Study|Symptomatic deterioration|0|||
160940002|NCT03013491|581171101|FG001|Main Study|Symptomatic deterioration|0|||
160940003|NCT03013491|581171102|FG002|Main Study|Symptomatic deterioration|0|||
160940004|NCT03013491|581171103|FG003|Main Study|Symptomatic deterioration|0|||
160940005|NCT03013491|581171104|FG004|Main Study|Symptomatic deterioration|0|||
160940006|NCT03013491|581171105|FG005|Main Study|Symptomatic deterioration|1|||
160940007|NCT03013491|581171106|FG006|Main Study|Symptomatic deterioration|0|||
160940008|NCT03013491|581171107|FG007|Main Study|Symptomatic deterioration|0|||
160940009|NCT03013491|581171108|FG008|Main Study|Symptomatic deterioration|0|||
160940010|NCT03013491|581171109|FG009|Main Study|Symptomatic deterioration|0|||
160940011|NCT03013491|581171110|FG010|Main Study|Symptomatic deterioration|0|||
160940012|NCT03013491|581171111|FG011|Main Study|Symptomatic deterioration|0|||
160940013|NCT03013491|581171112|FG012|Main Study|Symptomatic deterioration|0|||
160940014|NCT03013491|581171113|FG013|Main Study|Symptomatic deterioration|0|||
160940015|NCT03013491|581171114|FG014|Main Study|Symptomatic deterioration|0|||
160940016|NCT03013491|581171115|FG015|Main Study|Symptomatic deterioration|0|||
160940017|NCT03013491|581171116|FG016|Main Study|Symptomatic deterioration|0|||
160940018|NCT03013491|581171117|FG017|Main Study|Symptomatic deterioration|0|||
160940019|NCT03013491|581171118|FG018|Main Study|Symptomatic deterioration|0|||
160940020|NCT03013491|581171100|FG000|Main Study|Protocol version 8.0 approval|0|||
160940021|NCT03013491|581171101|FG001|Main Study|Protocol version 8.0 approval|0|||
160940022|NCT03013491|581171102|FG002|Main Study|Protocol version 8.0 approval|0|||
160940023|NCT03013491|581171103|FG003|Main Study|Protocol version 8.0 approval|0|||
160940024|NCT03013491|581171104|FG004|Main Study|Protocol version 8.0 approval|0|||
160940025|NCT03013491|581171105|FG005|Main Study|Protocol version 8.0 approval|0|||
160940026|NCT03013491|581171106|FG006|Main Study|Protocol version 8.0 approval|0|||
160940027|NCT03013491|581171107|FG007|Main Study|Protocol version 8.0 approval|0|||
160940028|NCT03013491|581171108|FG008|Main Study|Protocol version 8.0 approval|0|||
160940029|NCT03013491|581171109|FG009|Main Study|Protocol version 8.0 approval|0|||
160940030|NCT03013491|581171110|FG010|Main Study|Protocol version 8.0 approval|1|||
160940031|NCT03013491|581171111|FG011|Main Study|Protocol version 8.0 approval|0|||
160940032|NCT03013491|581171112|FG012|Main Study|Protocol version 8.0 approval|0|||
160940033|NCT03013491|581171113|FG013|Main Study|Protocol version 8.0 approval|0|||
160940034|NCT03013491|581171114|FG014|Main Study|Protocol version 8.0 approval|0|||
160940035|NCT03013491|581171115|FG015|Main Study|Protocol version 8.0 approval|0|||
160940036|NCT03013491|581171116|FG016|Main Study|Protocol version 8.0 approval|0|||
160940037|NCT03013491|581171117|FG017|Main Study|Protocol version 8.0 approval|0|||
160940038|NCT03013491|581171118|FG018|Main Study|Protocol version 8.0 approval|0|||
160940039|NCT03013491|581171100|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
160940040|NCT03013491|581171101|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
160940041|NCT03013491|581171102|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
160940042|NCT03013491|581171103|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
160940043|NCT03013491|581171104|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
160940044|NCT03013491|581171105|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
160940045|NCT03013491|581171106|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
160940046|NCT03013491|581171107|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
160940047|NCT03013491|581171108|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
160940048|NCT03013491|581171109|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
160940049|NCT03013491|581171110|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
160940050|NCT03013491|581171111|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
160940051|NCT03013491|581171112|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
160940052|NCT03013491|581171113|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
160940053|NCT03013491|581171114|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
160940054|NCT03013491|581171115|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
160940055|NCT03013491|581171116|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
160455675|NCT02240238|579399767|FG006|Phase 1|Death|0|||
160455676|NCT02240238|579399768|FG007|Phase 1|Death|0|||
160578761|NCT02531373|579840141|FG001|Overall Study|Withdrawal by Subject|0|||
160578762|NCT02531373|579840142|FG002|Overall Study|Withdrawal by Subject|0|||
160578763|NCT02531373|579840143|FG003|Overall Study|Withdrawal by Subject|0|||
160578764|NCT02531373|579840144|FG004|Overall Study|Withdrawal by Subject|3|||
160578765|NCT02531373|579840145|FG005|Overall Study|Withdrawal by Subject|0|||
160578766|NCT02531373|579840146|FG006|Overall Study|Withdrawal by Subject|0|||
160940056|NCT03013491|581171117|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
160940057|NCT03013491|581171118|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
160940058|NCT03013491|581171100|FG000|Main Study|Start of new anticancer therapy|0|||
160940059|NCT03013491|581171101|FG001|Main Study|Start of new anticancer therapy|0|||
160940060|NCT03013491|581171102|FG002|Main Study|Start of new anticancer therapy|0|||
160940061|NCT03013491|581171103|FG003|Main Study|Start of new anticancer therapy|0|||
160940062|NCT03013491|581171104|FG004|Main Study|Start of new anticancer therapy|0|||
160940063|NCT03013491|581171105|FG005|Main Study|Start of new anticancer therapy|0|||
160940064|NCT03013491|581171106|FG006|Main Study|Start of new anticancer therapy|0|||
160940065|NCT03013491|581171107|FG007|Main Study|Start of new anticancer therapy|0|||
160940066|NCT03013491|581171108|FG008|Main Study|Start of new anticancer therapy|0|||
160940067|NCT03013491|581171109|FG009|Main Study|Start of new anticancer therapy|0|||
160940068|NCT03013491|581171110|FG010|Main Study|Start of new anticancer therapy|0|||
160940069|NCT03013491|581171111|FG011|Main Study|Start of new anticancer therapy|0|||
160940070|NCT03013491|581171112|FG012|Main Study|Start of new anticancer therapy|0|||
160940071|NCT03013491|581171113|FG013|Main Study|Start of new anticancer therapy|0|||
160940072|NCT03013491|581171114|FG014|Main Study|Start of new anticancer therapy|0|||
160940073|NCT03013491|581171115|FG015|Main Study|Start of new anticancer therapy|0|||
160940074|NCT03013491|581171116|FG016|Main Study|Start of new anticancer therapy|0|||
160940075|NCT03013491|581171117|FG017|Main Study|Start of new anticancer therapy|0|||
160940076|NCT03013491|581171118|FG018|Main Study|Start of new anticancer therapy|2|||
160940077|NCT03013491|581171100|FG000|Long-term Extension|Disease progression|0|||
160940078|NCT03013491|581171101|FG001|Long-term Extension|Disease progression|0|||
160940079|NCT03013491|581171102|FG002|Long-term Extension|Disease progression|0|||
160940080|NCT03013491|581171103|FG003|Long-term Extension|Disease progression|1|||
160940081|NCT03013491|581171104|FG004|Long-term Extension|Disease progression|0|||
160940082|NCT03013491|581171105|FG005|Long-term Extension|Disease progression|0|||
160940083|NCT03013491|581171106|FG006|Long-term Extension|Disease progression|0|||
160940084|NCT03013491|581171107|FG007|Long-term Extension|Disease progression|0|||
160940085|NCT03013491|581171108|FG008|Long-term Extension|Disease progression|0|||
160940086|NCT03013491|581171109|FG009|Long-term Extension|Disease progression|0|||
160940087|NCT03013491|581171110|FG010|Long-term Extension|Disease progression|0|||
160940088|NCT03013491|581171111|FG011|Long-term Extension|Disease progression|0|||
160940089|NCT03013491|581171112|FG012|Long-term Extension|Disease progression|0|||
160940090|NCT03013491|581171113|FG013|Long-term Extension|Disease progression|0|||
160940091|NCT03013491|581171114|FG014|Long-term Extension|Disease progression|0|||
160998782|NCT01235949|581380615|FG013|Booster Phase|Lost to Follow-up|0|||
160998783|NCT01235949|581380616|FG014|Booster Phase|Lost to Follow-up|0|||
160998784|NCT01235949|581380617|FG015|Booster Phase|Lost to Follow-up|0|||
160998785|NCT01235949|581380618|FG016|Booster Phase|Lost to Follow-up|0|||
160998786|NCT01235949|581380619|FG017|Booster Phase|Lost to Follow-up|1|||
160998787|NCT00754936|581380620|FG000|Overall Study|Lost to Follow-up|3|||
160998788|NCT00754936|581380620|FG000|Overall Study|Physician Decision|1|||
160998789|NCT00754936|581380620|FG000|Overall Study|Withdrawal by Subject|2|||
160998790|NCT00754936|581380620|FG000|Overall Study|Side Effects|3|||
160998791|NCT00754936|581380620|FG000|Overall Study|Inter-current medical events|3|||
160998792|NCT00436644|581380621|FG000|Overall Study|Adverse Event|2|||
160998793|NCT00436644|581380621|FG000|Overall Study|Death|1|||
160998794|NCT00619645|581380622|FG000|Overall Study|Adverse Event|1|||
160998795|NCT04364269|581380627|FG000|Overall Study|Adverse Event|1|||
160998796|NCT04364269|581380628|FG001|Overall Study|Adverse Event|0|||
160998797|NCT04364269|581380629|FG002|Overall Study|Adverse Event|0|||
160998798|NCT04364269|581380627|FG000|Overall Study|Withdrawal by Subject|0|||
160998799|NCT04364269|581380628|FG001|Overall Study|Withdrawal by Subject|1|||
160998800|NCT04364269|581380629|FG002|Overall Study|Withdrawal by Subject|0|||
160578767|NCT02531373|579840147|FG007|Overall Study|Withdrawal by Subject|0|||
160940092|NCT03013491|581171115|FG015|Long-term Extension|Disease progression|0|||
160940093|NCT03013491|581171116|FG016|Long-term Extension|Disease progression|0|||
160940094|NCT03013491|581171117|FG017|Long-term Extension|Disease progression|0|||
160940095|NCT03013491|581171118|FG018|Long-term Extension|Disease progression|1|||
160940096|NCT03013491|581171100|FG000|Long-term Extension|Withdrawal by Subject|0|||
160998801|NCT02026258|581380632|FG000|Randomized|Did not start treatment|2|||
160998802|NCT02026258|581380633|FG001|Randomized|Did not start treatment|1|||
160998803|NCT02026258|581380632|FG000|Randomized|Change in treatment plan|1|||
160998804|NCT02026258|581380633|FG001|Randomized|Change in treatment plan|0|||
160578768|NCT02531373|579840148|FG008|Overall Study|Withdrawal by Subject|0|||
160578769|NCT01623531|579840149|FG000|Overall Study|Death|1|||
160578770|NCT01623531|579840150|FG001|Overall Study|Death|0|||
160940097|NCT03013491|581171101|FG001|Long-term Extension|Withdrawal by Subject|0|||
160940098|NCT03013491|581171102|FG002|Long-term Extension|Withdrawal by Subject|0|||
160940099|NCT03013491|581171103|FG003|Long-term Extension|Withdrawal by Subject|0|||
160940100|NCT03013491|581171104|FG004|Long-term Extension|Withdrawal by Subject|0|||
160940101|NCT03013491|581171105|FG005|Long-term Extension|Withdrawal by Subject|0|||
160940102|NCT03013491|581171106|FG006|Long-term Extension|Withdrawal by Subject|0|||
160940103|NCT03013491|581171107|FG007|Long-term Extension|Withdrawal by Subject|1|||
160940104|NCT03013491|581171108|FG008|Long-term Extension|Withdrawal by Subject|0|||
160940105|NCT03013491|581171109|FG009|Long-term Extension|Withdrawal by Subject|0|||
160940106|NCT03013491|581171110|FG010|Long-term Extension|Withdrawal by Subject|0|||
160940107|NCT03013491|581171111|FG011|Long-term Extension|Withdrawal by Subject|0|||
160940108|NCT03013491|581171112|FG012|Long-term Extension|Withdrawal by Subject|0|||
160940109|NCT03013491|581171113|FG013|Long-term Extension|Withdrawal by Subject|0|||
160940110|NCT03013491|581171114|FG014|Long-term Extension|Withdrawal by Subject|0|||
160940111|NCT03013491|581171115|FG015|Long-term Extension|Withdrawal by Subject|0|||
160940112|NCT03013491|581171116|FG016|Long-term Extension|Withdrawal by Subject|0|||
160940113|NCT03013491|581171117|FG017|Long-term Extension|Withdrawal by Subject|0|||
160940114|NCT03013491|581171118|FG018|Long-term Extension|Withdrawal by Subject|0|||
160940115|NCT03013491|581171100|FG000|Long-term Extension|Adverse Event|0|||
160940116|NCT03013491|581171101|FG001|Long-term Extension|Adverse Event|0|||
160940117|NCT03013491|581171102|FG002|Long-term Extension|Adverse Event|0|||
160940118|NCT03013491|581171103|FG003|Long-term Extension|Adverse Event|0|||
160940119|NCT03013491|581171104|FG004|Long-term Extension|Adverse Event|0|||
160455677|NCT02240238|579399769|FG008|Phase 1|Death|0|||
160455678|NCT02240238|579399770|FG009|Phase 1|Death|0|||
160940120|NCT03013491|581171105|FG005|Long-term Extension|Adverse Event|0|||
160940121|NCT03013491|581171106|FG006|Long-term Extension|Adverse Event|0|||
160940122|NCT03013491|581171107|FG007|Long-term Extension|Adverse Event|0|||
160940123|NCT03013491|581171108|FG008|Long-term Extension|Adverse Event|0|||
160940124|NCT03013491|581171109|FG009|Long-term Extension|Adverse Event|0|||
160940125|NCT03013491|581171110|FG010|Long-term Extension|Adverse Event|0|||
160940126|NCT03013491|581171111|FG011|Long-term Extension|Adverse Event|0|||
160940127|NCT03013491|581171112|FG012|Long-term Extension|Adverse Event|0|||
160940128|NCT03013491|581171113|FG013|Long-term Extension|Adverse Event|0|||
160940129|NCT03013491|581171114|FG014|Long-term Extension|Adverse Event|0|||
160940130|NCT03013491|581171115|FG015|Long-term Extension|Adverse Event|0|||
160940131|NCT03013491|581171116|FG016|Long-term Extension|Adverse Event|0|||
160940132|NCT03013491|581171117|FG017|Long-term Extension|Adverse Event|0|||
160940133|NCT03013491|581171118|FG018|Long-term Extension|Adverse Event|1|||
160940134|NCT03013491|581171100|FG000|Long-term Extension|Death|0|||
160940135|NCT03013491|581171101|FG001|Long-term Extension|Death|0|||
160940136|NCT03013491|581171102|FG002|Long-term Extension|Death|0|||
160940137|NCT03013491|581171103|FG003|Long-term Extension|Death|0|||
160940138|NCT03013491|581171104|FG004|Long-term Extension|Death|0|||
160940139|NCT03013491|581171105|FG005|Long-term Extension|Death|0|||
160940140|NCT03013491|581171106|FG006|Long-term Extension|Death|0|||
160940141|NCT03013491|581171107|FG007|Long-term Extension|Death|0|||
160940142|NCT03013491|581171108|FG008|Long-term Extension|Death|0|||
160940143|NCT03013491|581171109|FG009|Long-term Extension|Death|0|||
160940144|NCT03013491|581171110|FG010|Long-term Extension|Death|0|||
160940145|NCT03013491|581171111|FG011|Long-term Extension|Death|0|||
160940146|NCT03013491|581171112|FG012|Long-term Extension|Death|0|||
160940147|NCT03013491|581171113|FG013|Long-term Extension|Death|0|||
160940148|NCT03013491|581171114|FG014|Long-term Extension|Death|0|||
160940149|NCT03013491|581171115|FG015|Long-term Extension|Death|0|||
160940150|NCT03013491|581171116|FG016|Long-term Extension|Death|0|||
160940151|NCT03013491|581171117|FG017|Long-term Extension|Death|0|||
160940152|NCT03013491|581171118|FG018|Long-term Extension|Death|1|||
160455679|NCT02240238|579399771|FG010|Phase 1|Death|0|||
160455680|NCT02240238|579399772|FG011|Phase 1|Death|0|||
160455681|NCT02240238|579399761|FG000|Phase 1|Sponsor termination|0|||
160455682|NCT02240238|579399762|FG001|Phase 1|Sponsor termination|0|||
160455683|NCT02240238|579399763|FG002|Phase 1|Sponsor termination|0|||
160940153|NCT04740034|581171121|FG000|Overall Study|Death|0|||
160940154|NCT04740034|581171122|FG001|Overall Study|Death|1|||
160940155|NCT04740034|581171123|FG002|Overall Study|Death|2|||
160940156|NCT04740034|581171124|FG003|Overall Study|Death|3|||
160940157|NCT04740034|581171125|FG004|Overall Study|Death|4|||
160940158|NCT04740034|581171126|FG005|Overall Study|Death|4|||
160940159|NCT04740034|581171127|FG006|Overall Study|Death|2|||
160940160|NCT04740034|581171128|FG007|Overall Study|Death|2|||
160940161|NCT04740034|581171129|FG008|Overall Study|Death|2|||
160940162|NCT04740034|581171130|FG009|Overall Study|Death|4|||
160940163|NCT04740034|581171131|FG010|Overall Study|Death|0|||
160940164|NCT04740034|581171121|FG000|Overall Study|Lost to Follow-up|0|||
160940165|NCT04740034|581171122|FG001|Overall Study|Lost to Follow-up|0|||
160455684|NCT02240238|579399764|FG003|Phase 1|Sponsor termination|0|||
160455685|NCT02240238|579399765|FG004|Phase 1|Sponsor termination|0|||
160940166|NCT04740034|581171123|FG002|Overall Study|Lost to Follow-up|0|||
160940167|NCT04740034|581171124|FG003|Overall Study|Lost to Follow-up|1|||
160940168|NCT04740034|581171125|FG004|Overall Study|Lost to Follow-up|2|||
160940169|NCT04740034|581171126|FG005|Overall Study|Lost to Follow-up|2|||
160940170|NCT04740034|581171127|FG006|Overall Study|Lost to Follow-up|0|||
160940171|NCT04740034|581171128|FG007|Overall Study|Lost to Follow-up|0|||
160940172|NCT04740034|581171129|FG008|Overall Study|Lost to Follow-up|0|||
160940173|NCT04740034|581171130|FG009|Overall Study|Lost to Follow-up|1|||
160940174|NCT04740034|581171131|FG010|Overall Study|Lost to Follow-up|0|||
160940175|NCT04740034|581171121|FG000|Overall Study|Withdrawal by Subject|1|||
160940176|NCT04740034|581171122|FG001|Overall Study|Withdrawal by Subject|0|||
160940177|NCT04740034|581171123|FG002|Overall Study|Withdrawal by Subject|0|||
160940178|NCT04740034|581171124|FG003|Overall Study|Withdrawal by Subject|0|||
160940179|NCT04740034|581171125|FG004|Overall Study|Withdrawal by Subject|0|||
160940180|NCT04740034|581171126|FG005|Overall Study|Withdrawal by Subject|0|||
160940181|NCT04740034|581171127|FG006|Overall Study|Withdrawal by Subject|0|||
160940182|NCT04740034|581171128|FG007|Overall Study|Withdrawal by Subject|1|||
160940183|NCT04740034|581171129|FG008|Overall Study|Withdrawal by Subject|0|||
160940184|NCT04740034|581171130|FG009|Overall Study|Withdrawal by Subject|1|||
160940185|NCT04740034|581171131|FG010|Overall Study|Withdrawal by Subject|0|||
160940186|NCT04740034|581171121|FG000|Overall Study|Decision by sponsor|0|||
160940187|NCT04740034|581171122|FG001|Overall Study|Decision by sponsor|0|||
160940188|NCT04740034|581171123|FG002|Overall Study|Decision by sponsor|1|||
160940189|NCT04740034|581171124|FG003|Overall Study|Decision by sponsor|0|||
160940190|NCT04740034|581171125|FG004|Overall Study|Decision by sponsor|0|||
160940191|NCT04740034|581171126|FG005|Overall Study|Decision by sponsor|0|||
160940192|NCT04740034|581171127|FG006|Overall Study|Decision by sponsor|1|||
160940193|NCT04740034|581171128|FG007|Overall Study|Decision by sponsor|2|||
160940194|NCT04740034|581171129|FG008|Overall Study|Decision by sponsor|1|||
160940195|NCT04740034|581171130|FG009|Overall Study|Decision by sponsor|1|||
160940196|NCT04740034|581171131|FG010|Overall Study|Decision by sponsor|2|||
160940197|NCT03890367|581171133|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160940198|NCT03890367|581171134|FG001|Overall Study|Withdrawal by parent/guardian|3|||
160940199|NCT03890367|581171135|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160940200|NCT03890367|581171133|FG000|Overall Study|Protocol deviation|2|||
160940201|NCT03890367|581171134|FG001|Overall Study|Protocol deviation|2|||
160940202|NCT03890367|581171135|FG002|Overall Study|Protocol deviation|1|||
160940203|NCT03890367|581171133|FG000|Overall Study|Lost to Follow-up|1|||
160940204|NCT03890367|581171134|FG001|Overall Study|Lost to Follow-up|1|||
160940205|NCT03890367|581171135|FG002|Overall Study|Lost to Follow-up|0|||
160940206|NCT02383758|581173045|FG000|Overall Study|Withdrawal by Subject|0|||
160940207|NCT02383758|581173046|FG001|Overall Study|Withdrawal by Subject|2|||
160940208|NCT02564471|581173047|FG000|Overall Study|Adverse Event|1|||
160578771|NCT01623531|579840149|FG000|Overall Study|Protocol Violation|2|||
160578772|NCT01623531|579840150|FG001|Overall Study|Protocol Violation|1|||
160578773|NCT01623531|579840149|FG000|Overall Study|Missing data at primary outcome time poi|1|||
160578774|NCT01623531|579840150|FG001|Overall Study|Missing data at primary outcome time poi|1|||
160578775|NCT02834403|579840155|FG000|Overall Study|Physician Decision|2|||
160578776|NCT02834403|579840156|FG001|Overall Study|Physician Decision|1|||
160940209|NCT02564471|581173048|FG001|Overall Study|Adverse Event|0|||
160940210|NCT02564471|581173049|FG002|Overall Study|Adverse Event|0|||
160940211|NCT02564471|581173050|FG003|Overall Study|Adverse Event|0|||
160940212|NCT02564471|581173047|FG000|Overall Study|Withdrawal by Subject|2|||
160940213|NCT02564471|581173048|FG001|Overall Study|Withdrawal by Subject|1|||
160940214|NCT02564471|581173049|FG002|Overall Study|Withdrawal by Subject|3|||
160940215|NCT02564471|581173050|FG003|Overall Study|Withdrawal by Subject|0|||
160940216|NCT02564471|581173047|FG000|Overall Study|Lost to Follow-up|0|||
160940217|NCT02564471|581173048|FG001|Overall Study|Lost to Follow-up|2|||
160940218|NCT02564471|581173049|FG002|Overall Study|Lost to Follow-up|0|||
160940219|NCT02564471|581173050|FG003|Overall Study|Lost to Follow-up|0|||
160940220|NCT01643473|581173053|FG000|Overall Study|Lost to Follow-up|1|||
160940221|NCT01643473|581173054|FG001|Overall Study|Lost to Follow-up|0|||
160940222|NCT01519518|581173055|FG000|Overall Study|Consent not available|7|||
160998805|NCT02026258|581380632|FG000|Randomized|Presence of periodontal disease|1|||
160998806|NCT02026258|581380633|FG001|Randomized|Presence of periodontal disease|1|||
160998807|NCT02026258|581380632|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
160998808|NCT02026258|581380633|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
160578777|NCT02834403|579840157|FG002|Overall Study|Physician Decision|2|||
160656023|NCT02130466|580120347|FG004|Overall Study|Lost to Follow-up|0|||
160578778|NCT02834403|579840158|FG003|Overall Study|Physician Decision|1|||
160578779|NCT02834403|579840159|FG004|Overall Study|Physician Decision|1|||
160578780|NCT02834403|579840160|FG005|Overall Study|Physician Decision|2|||
160578781|NCT02834403|579840161|FG006|Overall Study|Physician Decision|12|||
160656024|NCT02130466|580120348|FG005|Overall Study|Lost to Follow-up|1|||
160656025|NCT02130466|580120349|FG006|Overall Study|Lost to Follow-up|0|||
160940223|NCT01519518|581173056|FG001|Overall Study|Consent not available|10|||
160940224|NCT02033889|581173057|FG000|Overall Study|Adverse Event|3|||
160940225|NCT02033889|581173058|FG001|Overall Study|Adverse Event|1|||
160940226|NCT02033889|581173059|FG002|Overall Study|Adverse Event|3|||
160940227|NCT02033889|581173057|FG000|Overall Study|Death|3|||
160940228|NCT02033889|581173058|FG001|Overall Study|Death|1|||
160940229|NCT02033889|581173059|FG002|Overall Study|Death|2|||
160656026|NCT02130466|580120350|FG007|Overall Study|Lost to Follow-up|0|||
160940230|NCT02033889|581173057|FG000|Overall Study|Excluded Medication|1|||
160940231|NCT02033889|581173058|FG001|Overall Study|Excluded Medication|1|||
160940232|NCT02033889|581173059|FG002|Overall Study|Excluded Medication|0|||
160940233|NCT02033889|581173057|FG000|Overall Study|Lost to Follow-up|8|||
160940234|NCT02033889|581173058|FG001|Overall Study|Lost to Follow-up|5|||
160940235|NCT02033889|581173059|FG002|Overall Study|Lost to Follow-up|6|||
160940236|NCT02033889|581173057|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160578782|NCT02834403|579840155|FG000|Overall Study|Adverse Event|0|||
160578783|NCT02834403|579840156|FG001|Overall Study|Adverse Event|0|||
160578784|NCT02834403|579840157|FG002|Overall Study|Adverse Event|0|||
160578785|NCT02834403|579840158|FG003|Overall Study|Adverse Event|0|||
160578786|NCT02834403|579840159|FG004|Overall Study|Adverse Event|1|||
160940237|NCT02033889|581173058|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160940238|NCT02033889|581173059|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160940239|NCT02033889|581173057|FG000|Overall Study|Physician Decision|0|||
160940240|NCT02033889|581173058|FG001|Overall Study|Physician Decision|1|||
160940241|NCT02033889|581173059|FG002|Overall Study|Physician Decision|1|||
160940242|NCT02033889|581173057|FG000|Overall Study|Participant moved|0|||
160940243|NCT02033889|581173058|FG001|Overall Study|Participant moved|1|||
160940244|NCT02033889|581173059|FG002|Overall Study|Participant moved|0|||
160940245|NCT02033889|581173057|FG000|Overall Study|Withdrawal by Subject|18|||
160940246|NCT02033889|581173058|FG001|Overall Study|Withdrawal by Subject|10|||
160940247|NCT02033889|581173059|FG002|Overall Study|Withdrawal by Subject|13|||
160940248|NCT00182689|581173065|FG000|Overall Study|Adverse Event|8|||
160940249|NCT00182689|581173066|FG001|Overall Study|Adverse Event|11|||
160940250|NCT00182689|581173065|FG000|Overall Study|Withdrawal by Subject|2|||
160940251|NCT00182689|581173066|FG001|Overall Study|Withdrawal by Subject|2|||
160940252|NCT00182689|581173065|FG000|Overall Study|Progression|27|||
160940253|NCT00182689|581173066|FG001|Overall Study|Progression|29|||
160940254|NCT00182689|581173065|FG000|Overall Study|Death|1|||
160940255|NCT00182689|581173066|FG001|Overall Study|Death|0|||
160940256|NCT00182689|581173065|FG000|Overall Study|not protocol specified|0|||
160940257|NCT00182689|581173066|FG001|Overall Study|not protocol specified|3|||
160940258|NCT00182689|581173065|FG000|Overall Study|Ineligible|1|||
160940259|NCT00182689|581173066|FG001|Overall Study|Ineligible|4|||
160940260|NCT00182689|581173065|FG000|Overall Study|Never received treatment|1|||
160940261|NCT00182689|581173066|FG001|Overall Study|Never received treatment|0|||
160940262|NCT01640301|581173067|FG000|Overall Study|Death|0|||
160940263|NCT01640301|581173068|FG001|Overall Study|Death|8|||
160940264|NCT01969838|581173074|FG000|Double-blind Phase|Adverse Event|10|||
160940265|NCT01969838|581173075|FG001|Double-blind Phase|Adverse Event|4|||
160940266|NCT01969838|581173076|FG002|Double-blind Phase|Adverse Event|0|||
160940267|NCT01969838|581173077|FG003|Double-blind Phase|Adverse Event|0|||
160940268|NCT01969838|581173074|FG000|Double-blind Phase|Death|5|||
160940269|NCT01969838|581173075|FG001|Double-blind Phase|Death|2|||
160940270|NCT01969838|581173076|FG002|Double-blind Phase|Death|0|||
160940271|NCT01969838|581173077|FG003|Double-blind Phase|Death|0|||
160940272|NCT01969838|581173074|FG000|Double-blind Phase|Physician Decision|5|||
160940273|NCT01969838|581173075|FG001|Double-blind Phase|Physician Decision|1|||
160940274|NCT01969838|581173076|FG002|Double-blind Phase|Physician Decision|0|||
160940275|NCT01969838|581173077|FG003|Double-blind Phase|Physician Decision|0|||
160940276|NCT01969838|581173074|FG000|Double-blind Phase|Subject Decision|4|||
160940277|NCT01969838|581173075|FG001|Double-blind Phase|Subject Decision|2|||
160940278|NCT01969838|581173076|FG002|Double-blind Phase|Subject Decision|0|||
160940279|NCT01969838|581173077|FG003|Double-blind Phase|Subject Decision|0|||
160940280|NCT01969838|581173074|FG000|Double-blind Phase|Disease Progression|2|||
160940281|NCT01969838|581173075|FG001|Double-blind Phase|Disease Progression|0|||
160578787|NCT02834403|579840160|FG005|Overall Study|Adverse Event|1|||
160578788|NCT02834403|579840161|FG006|Overall Study|Adverse Event|3|||
160578789|NCT02834403|579840155|FG000|Overall Study|Withdrawal by Subject|0|||
160578790|NCT02834403|579840156|FG001|Overall Study|Withdrawal by Subject|1|||
160578791|NCT02834403|579840157|FG002|Overall Study|Withdrawal by Subject|0|||
160578792|NCT02834403|579840158|FG003|Overall Study|Withdrawal by Subject|0|||
160578793|NCT02834403|579840159|FG004|Overall Study|Withdrawal by Subject|1|||
160578794|NCT02834403|579840160|FG005|Overall Study|Withdrawal by Subject|0|||
160578795|NCT02834403|579840161|FG006|Overall Study|Withdrawal by Subject|0|||
160578796|NCT02834403|579840155|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
160578797|NCT02834403|579840156|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
160940282|NCT01969838|581173076|FG002|Double-blind Phase|Disease Progression|0|||
160940283|NCT01969838|581173077|FG003|Double-blind Phase|Disease Progression|0|||
160940284|NCT01969838|581173074|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
160940285|NCT01969838|581173075|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
160940286|NCT01969838|581173076|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
160940287|NCT01969838|581173077|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
160940288|NCT01969838|581173074|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
160940289|NCT01969838|581173075|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
160940290|NCT01969838|581173076|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
160455686|NCT02240238|579399766|FG005|Phase 1|Sponsor termination|1|||
160940291|NCT01969838|581173077|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
160940292|NCT01969838|581173074|FG000|Open-label Phase|Adverse Event|0|||
160940293|NCT01969838|581173075|FG001|Open-label Phase|Adverse Event|0|||
160940294|NCT01969838|581173076|FG002|Open-label Phase|Adverse Event|37|||
160940295|NCT01969838|581173077|FG003|Open-label Phase|Adverse Event|49|||
160940296|NCT01969838|581173074|FG000|Open-label Phase|Disease Progression|0|||
160940297|NCT01969838|581173075|FG001|Open-label Phase|Disease Progression|0|||
160940298|NCT01969838|581173076|FG002|Open-label Phase|Disease Progression|26|||
160940299|NCT01969838|581173077|FG003|Open-label Phase|Disease Progression|27|||
160940300|NCT01969838|581173074|FG000|Open-label Phase|Lack of Efficacy|0|||
160940301|NCT01969838|581173075|FG001|Open-label Phase|Lack of Efficacy|0|||
160940302|NCT01969838|581173076|FG002|Open-label Phase|Lack of Efficacy|17|||
160940303|NCT01969838|581173077|FG003|Open-label Phase|Lack of Efficacy|19|||
160940304|NCT01969838|581173074|FG000|Open-label Phase|Subject Decision|0|||
160940305|NCT01969838|581173075|FG001|Open-label Phase|Subject Decision|0|||
160940306|NCT01969838|581173076|FG002|Open-label Phase|Subject Decision|14|||
160940307|NCT01969838|581173077|FG003|Open-label Phase|Subject Decision|15|||
160940308|NCT01969838|581173074|FG000|Open-label Phase|Death|0|||
160940309|NCT01969838|581173075|FG001|Open-label Phase|Death|0|||
160940310|NCT01969838|581173076|FG002|Open-label Phase|Death|13|||
160940311|NCT01969838|581173077|FG003|Open-label Phase|Death|11|||
160940312|NCT01969838|581173074|FG000|Open-label Phase|Physician Decision|0|||
160940313|NCT01969838|581173075|FG001|Open-label Phase|Physician Decision|0|||
160940314|NCT01969838|581173076|FG002|Open-label Phase|Physician Decision|9|||
160940315|NCT01969838|581173077|FG003|Open-label Phase|Physician Decision|14|||
160940316|NCT01969838|581173074|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
160940317|NCT01969838|581173075|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
160940318|NCT01969838|581173076|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
160940319|NCT01969838|581173077|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
160940320|NCT00408993|581173078|FG000|Overall Study|Adverse Event|15|||
160940321|NCT00408993|581173079|FG001|Overall Study|Adverse Event|4|||
160940322|NCT00408993|581173078|FG000|Overall Study|Protocol Violation|1|||
160940323|NCT00408993|581173079|FG001|Overall Study|Protocol Violation|6|||
160940324|NCT00408993|581173078|FG000|Overall Study|Lack of Efficacy|1|||
160940325|NCT00408993|581173079|FG001|Overall Study|Lack of Efficacy|4|||
160940326|NCT00408993|581173078|FG000|Overall Study|Withdrawal by Subject|2|||
160940327|NCT00408993|581173079|FG001|Overall Study|Withdrawal by Subject|3|||
160940328|NCT04193202|581173084|FG000|Overall Study|Adverse Event|2|||
160940329|NCT04193202|581173085|FG001|Overall Study|Adverse Event|1|||
160940330|NCT04193202|581173084|FG000|Overall Study|Death|0|||
160940331|NCT04193202|581173085|FG001|Overall Study|Death|1|||
160940332|NCT04193202|581173084|FG000|Overall Study|Physician Decision|1|||
160940333|NCT04193202|581173085|FG001|Overall Study|Physician Decision|1|||
160940334|NCT04193202|581173084|FG000|Overall Study|Protocol Violation|2|||
160940335|NCT04193202|581173085|FG001|Overall Study|Protocol Violation|2|||
160940336|NCT04193202|581173084|FG000|Overall Study|Withdrawal by Subject|11|||
160940337|NCT04193202|581173085|FG001|Overall Study|Withdrawal by Subject|5|||
160940338|NCT01777997|581173086|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
160940339|NCT01777997|581173086|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
160940340|NCT01777997|581173086|FG000|Weeks 48 to 72/96 on ART|Death|1|||
160940341|NCT01777997|581173086|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
160940342|NCT02488629|581173088|FG000|Overall Study|Lack of Efficacy|3|||
160940343|NCT02488629|581173089|FG001|Overall Study|Lack of Efficacy|1|||
160940344|NCT02488629|581173090|FG002|Overall Study|Lack of Efficacy|0|||
160940345|NCT02488629|581173091|FG003|Overall Study|Lack of Efficacy|0|||
160940346|NCT02488629|581173088|FG000|Overall Study|Withdrawal by Subject|0|||
160940347|NCT02488629|581173089|FG001|Overall Study|Withdrawal by Subject|1|||
160940348|NCT02488629|581173090|FG002|Overall Study|Withdrawal by Subject|0|||
160940349|NCT02488629|581173091|FG003|Overall Study|Withdrawal by Subject|0|||
160940350|NCT02932891|581173092|FG000|Overall Study|Lost to Follow-up|2|||
160940351|NCT02932891|581173092|FG000|Overall Study|HPA Suppress|2|||
160940352|NCT04622254|581173093|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
160940353|NCT04622254|581173094|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
160940354|NCT04622254|581173095|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
160940355|NCT04622254|581173096|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
160940356|NCT04622254|581173097|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
160940357|NCT04622254|581173098|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
160940358|NCT04622254|581173093|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
160940359|NCT04622254|581173094|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
160940360|NCT04622254|581173095|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
160940361|NCT04622254|581173096|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
160940362|NCT04622254|581173097|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
160940363|NCT04622254|581173098|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
160940364|NCT04622254|581173093|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
160940365|NCT04622254|581173094|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
160940366|NCT04622254|581173095|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
160940367|NCT04622254|581173096|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
160940368|NCT04622254|581173097|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
160940369|NCT04622254|581173098|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
160940370|NCT04622254|581173093|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160940371|NCT04622254|581173094|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
160940372|NCT04622254|581173095|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
160940373|NCT04622254|581173096|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160940374|NCT04622254|581173097|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160940375|NCT04622254|581173098|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160940376|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160940377|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160940378|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160940379|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
160940380|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160940381|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160940382|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160940383|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160940384|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160940385|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
160940386|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160940387|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
160940388|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160940389|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160940390|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160940391|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
160940392|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160940393|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160940394|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160940395|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160940396|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160940397|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
160940398|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160940399|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160940400|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
160940401|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
160940402|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
160940403|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
160940404|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
160940405|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
160940406|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
160940407|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
160940408|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
160940409|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
160940410|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
160940411|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
160940412|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
160940413|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
160940414|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
160940415|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
160940416|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
160940417|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
160940418|NCT02652624|581173099|FG000|Randomized Phase|Pregnancy|3|||
160940419|NCT02652624|581173100|FG001|Randomized Phase|Pregnancy|1|||
160940420|NCT02652624|581173099|FG000|Randomized Phase|Investigator's Discretion|0|||
160940421|NCT02652624|581173100|FG001|Randomized Phase|Investigator's Discretion|2|||
160940422|NCT02652624|581173099|FG000|Randomized Phase|Death|0|||
160940423|NCT02652624|581173100|FG001|Randomized Phase|Death|1|||
160940424|NCT02652624|581173099|FG000|Randomized Phase|Lost to Follow-up|0|||
160940425|NCT02652624|581173100|FG001|Randomized Phase|Lost to Follow-up|1|||
160940426|NCT02652624|581173099|FG000|Extension Phase|Lost to Follow-up|3|||
160940427|NCT02652624|581173100|FG001|Extension Phase|Lost to Follow-up|1|||
160940428|NCT02652624|581173099|FG000|Extension Phase|Pregnancy|1|||
160940429|NCT02652624|581173100|FG001|Extension Phase|Pregnancy|1|||
160940430|NCT02652624|581173099|FG000|Extension Phase|Adverse Event|0|||
160940431|NCT02652624|581173100|FG001|Extension Phase|Adverse Event|1|||
160940432|NCT02652624|581173099|FG000|Extension Phase|Withdrew Consent|0|||
160940433|NCT02652624|581173100|FG001|Extension Phase|Withdrew Consent|1|||
160940434|NCT00577122|581173101|FG000|Overall Study|Adverse Event|0|||
160940435|NCT00577122|581173102|FG001|Overall Study|Adverse Event|2|||
160940436|NCT00577122|581173101|FG000|Overall Study|Progression, relapse during active trt|6|||
160940437|NCT00577122|581173102|FG001|Overall Study|Progression, relapse during active trt|8|||
160940438|NCT00577122|581173101|FG000|Overall Study|Prog, refract disease during active trt|8|||
160940439|NCT00577122|581173102|FG001|Overall Study|Prog, refract disease during active trt|5|||
160940440|NCT00577122|581173101|FG000|Overall Study|Alternative Therapy|0|||
160940441|NCT00577122|581173102|FG001|Overall Study|Alternative Therapy|1|||
160940442|NCT03228680|581173103|FG000|Overall Study|Adverse Event|13|||
160940443|NCT03228680|581173104|FG001|Overall Study|Adverse Event|18|||
160940444|NCT03228680|581173103|FG000|Overall Study|Randomization failure|0|||
160940445|NCT03228680|581173104|FG001|Overall Study|Randomization failure|1|||
160940446|NCT03228680|581173103|FG000|Overall Study|Withdrawal by Subject|1|||
160940447|NCT03228680|581173104|FG001|Overall Study|Withdrawal by Subject|0|||
160940448|NCT03228680|581173103|FG000|Overall Study|Other|9|||
160940449|NCT03228680|581173104|FG001|Overall Study|Other|16|||
160940450|NCT00796861|581173105|FG000|Overall Study|Withdrawal by Subject|2|||
160940451|NCT00796861|581173105|FG000|Overall Study|Death|2|||
160940452|NCT00844545|581173116|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
160940453|NCT00844545|581173116|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
160940454|NCT00844545|581173116|FG000|Extension Treatment Period|Adverse Event|2|||
160940455|NCT00844545|581173116|FG000|Post Treatment Period|Withdrawal by Subject|1|||
160940456|NCT00403455|581173117|FG000|Overall Study|Withdrawal by Subject|1|||
160940457|NCT01358981|581173118|FG000|Period 1|Withdrawal by Subject|0|||
160940458|NCT01358981|581173119|FG001|Period 1|Withdrawal by Subject|0|||
160940459|NCT01358981|581173120|FG002|Period 1|Withdrawal by Subject|0|||
160940460|NCT01358981|581173121|FG003|Period 1|Withdrawal by Subject|1|||
160940461|NCT01358981|581173122|FG004|Period 1|Withdrawal by Subject|0|||
160940462|NCT01358981|581173123|FG005|Period 1|Withdrawal by Subject|0|||
160940463|NCT01358981|581173124|FG006|Period 1|Withdrawal by Subject|0|||
160940464|NCT04574362|581173125|FG000|Overall Study|Other|0|||
160940465|NCT04574362|581173126|FG001|Overall Study|Other|5|||
160940466|NCT04574362|581173125|FG000|Overall Study|COVID-19|0|||
160940467|NCT04574362|581173126|FG001|Overall Study|COVID-19|1|||
160940468|NCT04574362|581173125|FG000|Overall Study|Adverse Event|1|||
160940469|NCT04574362|581173126|FG001|Overall Study|Adverse Event|1|||
160940470|NCT04574362|581173125|FG000|Overall Study|Withdrawal by Subject|2|||
160940471|NCT04574362|581173126|FG001|Overall Study|Withdrawal by Subject|4|||
160940472|NCT04574362|581173125|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
160940473|NCT04574362|581173126|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
160940474|NCT04574362|581173125|FG000|Overall Study|Participant refused to come to the hospital|1|||
160940475|NCT04574362|581173126|FG001|Overall Study|Participant refused to come to the hospital|0|||
160940476|NCT04574362|581173125|FG000|Overall Study|Participant refused the visit|1|||
160940477|NCT04574362|581173126|FG001|Overall Study|Participant refused the visit|0|||
160940478|NCT04574362|581173125|FG000|Overall Study|Participant quit early because of business trip|1|||
160940479|NCT04574362|581173126|FG001|Overall Study|Participant quit early because of business trip|0|||
160940480|NCT01785524|581173127|FG000|Overall Study|Withdrawal by Subject|2|||
160940481|NCT01785524|581173128|FG001|Overall Study|Withdrawal by Subject|2|||
160940482|NCT01060384|581173129|FG000|Overall Study|Withdrawal by Subject|0|||
160940483|NCT01060384|581173130|FG001|Overall Study|Withdrawal by Subject|1|||
160940484|NCT01060384|581173131|FG002|Overall Study|Withdrawal by Subject|0|||
160940485|NCT01060384|581173132|FG003|Overall Study|Withdrawal by Subject|0|||
160940486|NCT01060384|581173133|FG004|Overall Study|Withdrawal by Subject|0|||
160940487|NCT01060384|581173129|FG000|Overall Study|Death|0|||
160940488|NCT01060384|581173130|FG001|Overall Study|Death|0|||
160940489|NCT01060384|581173131|FG002|Overall Study|Death|0|||
160940490|NCT01060384|581173132|FG003|Overall Study|Death|0|||
160940491|NCT01060384|581173133|FG004|Overall Study|Death|1|||
160940492|NCT01060384|581173129|FG000|Overall Study|Intercurrent illness|0|||
160940493|NCT01060384|581173130|FG001|Overall Study|Intercurrent illness|0|||
160940494|NCT01060384|581173131|FG002|Overall Study|Intercurrent illness|0|||
160940495|NCT01060384|581173132|FG003|Overall Study|Intercurrent illness|0|||
160940496|NCT01060384|581173133|FG004|Overall Study|Intercurrent illness|1|||
160940497|NCT01332305|581173134|FG000|Overall Study|Adverse Event|1|||
160940498|NCT01332305|581173135|FG001|Overall Study|Adverse Event|4|||
160940499|NCT01332305|581173136|FG002|Overall Study|Adverse Event|6|||
160940500|NCT01332305|581173137|FG003|Overall Study|Adverse Event|3|||
160940501|NCT01332305|581173138|FG004|Overall Study|Adverse Event|5|||
160940502|NCT01332305|581173134|FG000|Overall Study|Withdrawal by Subject|6|||
160940503|NCT01332305|581173135|FG001|Overall Study|Withdrawal by Subject|5|||
160940504|NCT01332305|581173136|FG002|Overall Study|Withdrawal by Subject|4|||
160940505|NCT01332305|581173137|FG003|Overall Study|Withdrawal by Subject|1|||
160940506|NCT01332305|581173138|FG004|Overall Study|Withdrawal by Subject|0|||
160940507|NCT01332305|581173134|FG000|Overall Study|Lost to Follow-up|0|||
160940508|NCT01332305|581173135|FG001|Overall Study|Lost to Follow-up|2|||
160940509|NCT01332305|581173136|FG002|Overall Study|Lost to Follow-up|3|||
160940510|NCT01332305|581173137|FG003|Overall Study|Lost to Follow-up|2|||
160940511|NCT01332305|581173138|FG004|Overall Study|Lost to Follow-up|3|||
160940512|NCT01332305|581173134|FG000|Overall Study|Protocol Violation|1|||
160940513|NCT01332305|581173135|FG001|Overall Study|Protocol Violation|2|||
160578798|NCT02834403|579840157|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
160578799|NCT02834403|579840158|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
160940514|NCT01332305|581173136|FG002|Overall Study|Protocol Violation|1|||
160940515|NCT01332305|581173137|FG003|Overall Study|Protocol Violation|0|||
160940516|NCT01332305|581173138|FG004|Overall Study|Protocol Violation|3|||
160578800|NCT02834403|579840159|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
160578801|NCT02834403|579840160|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
160578802|NCT02834403|579840161|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
160578803|NCT04705597|579840162|FG000|Overall Study|Death|16|||
160578804|NCT04705597|579840163|FG001|Overall Study|Death|9|||
160578805|NCT04705597|579840162|FG000|Overall Study|Lost to Follow-up|1|||
160578806|NCT04705597|579840163|FG001|Overall Study|Lost to Follow-up|0|||
160578807|NCT04705597|579840162|FG000|Overall Study|Withdrawal by Subject|1|||
160578808|NCT04705597|579840163|FG001|Overall Study|Withdrawal by Subject|2|||
160578809|NCT00390780|579840164|FG000|Overall Study|Not completed|10|||
160578810|NCT00390780|579840165|FG001|Overall Study|Not completed|4|||
160578811|NCT00390780|579840164|FG000|Overall Study|Protocol Violation|6|||
160578812|NCT00390780|579840165|FG001|Overall Study|Protocol Violation|4|||
160578813|NCT00390780|579840164|FG000|Overall Study|Lost to Follow-up|3|||
160578814|NCT00390780|579840165|FG001|Overall Study|Lost to Follow-up|6|||
160578815|NCT00390780|579840164|FG000|Overall Study|Adverse Event|2|||
160578816|NCT00390780|579840165|FG001|Overall Study|Adverse Event|3|||
160578817|NCT00390780|579840164|FG000|Overall Study|Death|1|||
160578818|NCT00390780|579840165|FG001|Overall Study|Death|3|||
160578819|NCT00390780|579840164|FG000|Overall Study|Withdrawal by Subject|1|||
160578820|NCT00390780|579840165|FG001|Overall Study|Withdrawal by Subject|2|||
160578821|NCT00390780|579840164|FG000|Overall Study|Inclusion criteria not satisfied|0|||
160578822|NCT00390780|579840165|FG001|Overall Study|Inclusion criteria not satisfied|2|||
160578823|NCT00390780|579840164|FG000|Overall Study|Lost to follow up and other reasons|0|||
160578824|NCT00390780|579840165|FG001|Overall Study|Lost to follow up and other reasons|1|||
160578825|NCT00390780|579840164|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
160578826|NCT00390780|579840165|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
160578827|NCT00390780|579840164|FG000|Overall Study|SAE, death|0|||
160578828|NCT00390780|579840165|FG001|Overall Study|SAE, death|1|||
160578829|NCT01585961|579840166|FG000|Overall Study|Death|6|||
160940517|NCT01332305|581173134|FG000|Overall Study|Withdrawal by Sponsor|1|||
160940518|NCT01332305|581173135|FG001|Overall Study|Withdrawal by Sponsor|0|||
160940519|NCT01332305|581173136|FG002|Overall Study|Withdrawal by Sponsor|0|||
160940520|NCT01332305|581173137|FG003|Overall Study|Withdrawal by Sponsor|1|||
160940521|NCT01332305|581173138|FG004|Overall Study|Withdrawal by Sponsor|1|||
160940522|NCT01332305|581173134|FG000|Overall Study|Treatment Failure|1|||
160940523|NCT01332305|581173135|FG001|Overall Study|Treatment Failure|1|||
160940524|NCT01332305|581173136|FG002|Overall Study|Treatment Failure|0|||
160940525|NCT01332305|581173137|FG003|Overall Study|Treatment Failure|0|||
160940526|NCT01332305|581173138|FG004|Overall Study|Treatment Failure|0|||
160455687|NCT02240238|579399767|FG006|Phase 1|Sponsor termination|0|||
160455688|NCT02240238|579399768|FG007|Phase 1|Sponsor termination|0|||
160455689|NCT02240238|579399769|FG008|Phase 1|Sponsor termination|0|||
160455690|NCT02240238|579399770|FG009|Phase 1|Sponsor termination|0|||
160455691|NCT02240238|579399771|FG010|Phase 1|Sponsor termination|0|||
160940527|NCT01332305|581173134|FG000|Overall Study|Physician Decision|0|||
160940528|NCT01332305|581173135|FG001|Overall Study|Physician Decision|0|||
160940529|NCT01332305|581173136|FG002|Overall Study|Physician Decision|0|||
160940530|NCT01332305|581173137|FG003|Overall Study|Physician Decision|1|||
160940531|NCT01332305|581173138|FG004|Overall Study|Physician Decision|0|||
160940532|NCT01600040|581173139|FG000|Overall Study|Withdrawal by Subject|1|||
160940533|NCT01401530|581173145|FG000|Overall Study|Disease Progression|1|||
160940534|NCT01401530|581173146|FG001|Overall Study|Disease Progression|2|||
160940535|NCT01401530|581173147|FG002|Overall Study|Disease Progression|1|||
160940536|NCT01401530|581173145|FG000|Overall Study|Adverse Event|1|||
160455692|NCT02240238|579399772|FG011|Phase 1|Sponsor termination|0|||
160578830|NCT01585961|579840166|FG000|Overall Study|Physician Decision|1|||
160578831|NCT01585961|579840166|FG000|Overall Study|Decision to use non-study catheter|1|||
160578832|NCT01585961|579840166|FG000|Overall Study|Withdrawal by Subject|1|||
160578833|NCT01585961|579840166|FG000|Overall Study|Lost to Follow-up|23|||
160940537|NCT01401530|581173146|FG001|Overall Study|Adverse Event|1|||
160940538|NCT01401530|581173147|FG002|Overall Study|Adverse Event|1|||
160940539|NCT01401530|581173145|FG000|Overall Study|Participant Choice|1|||
160940540|NCT01401530|581173146|FG001|Overall Study|Participant Choice|2|||
160455693|NCT02240238|579399761|FG000|Phase 1|Withdrawal by Subject|0|||
160578834|NCT01585961|579840166|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
160578835|NCT01258348|579840167|FG000|Overall Study|Adverse Event|1|||
160578836|NCT01258348|579840168|FG001|Overall Study|Adverse Event|1|||
160578837|NCT01258348|579840169|FG002|Overall Study|Adverse Event|3|||
160578838|NCT01258348|579840170|FG003|Overall Study|Adverse Event|2|||
160455694|NCT02240238|579399762|FG001|Phase 1|Withdrawal by Subject|0|||
160578839|NCT01258348|579840171|FG004|Overall Study|Adverse Event|4|||
160940541|NCT01401530|581173147|FG002|Overall Study|Participant Choice|1|||
160578840|NCT01258348|579840167|FG000|Overall Study|Progressive Disease|0|||
160578841|NCT01258348|579840168|FG001|Overall Study|Progressive Disease|3|||
160578842|NCT01258348|579840169|FG002|Overall Study|Progressive Disease|0|||
160578843|NCT01258348|579840170|FG003|Overall Study|Progressive Disease|2|||
160578844|NCT01258348|579840171|FG004|Overall Study|Progressive Disease|2|||
160578845|NCT01258348|579840167|FG000|Overall Study|Physician Decision|0|||
160578846|NCT01258348|579840168|FG001|Overall Study|Physician Decision|0|||
160578847|NCT01258348|579840169|FG002|Overall Study|Physician Decision|0|||
160578848|NCT01258348|579840170|FG003|Overall Study|Physician Decision|2|||
160578849|NCT01258348|579840171|FG004|Overall Study|Physician Decision|0|||
160578850|NCT01258348|579840167|FG000|Overall Study|Withdrawal by Subject|0|||
160578851|NCT01258348|579840168|FG001|Overall Study|Withdrawal by Subject|1|||
160578852|NCT01258348|579840169|FG002|Overall Study|Withdrawal by Subject|0|||
160940542|NCT01401530|581173145|FG000|Overall Study|Physician Decision|0|||
160940543|NCT01401530|581173146|FG001|Overall Study|Physician Decision|1|||
160940544|NCT01401530|581173147|FG002|Overall Study|Physician Decision|0|||
160940545|NCT03670810|581173148|FG000|Main Study|Adverse Event|37|||
160940546|NCT03670810|581173149|FG001|Main Study|Adverse Event|38|||
160940547|NCT03670810|581173150|FG002|Main Study|Adverse Event|3|||
160940548|NCT03670810|581173151|FG003|Main Study|Adverse Event|4|||
160940549|NCT03670810|581173152|FG004|Main Study|Adverse Event|4|||
160940550|NCT03670810|581173153|FG005|Main Study|Adverse Event|5|||
160940551|NCT03670810|581173154|FG006|Main Study|Adverse Event|0|||
160940552|NCT03670810|581173155|FG007|Main Study|Adverse Event|0|||
160940553|NCT03670810|581173156|FG008|Main Study|Adverse Event|0|||
160940554|NCT03670810|581173148|FG000|Main Study|Lack of Efficacy|8|||
160940555|NCT03670810|581173149|FG001|Main Study|Lack of Efficacy|9|||
160940556|NCT03670810|581173150|FG002|Main Study|Lack of Efficacy|3|||
160940557|NCT03670810|581173151|FG003|Main Study|Lack of Efficacy|4|||
160940558|NCT03670810|581173152|FG004|Main Study|Lack of Efficacy|0|||
160940559|NCT03670810|581173153|FG005|Main Study|Lack of Efficacy|0|||
160940560|NCT03670810|581173154|FG006|Main Study|Lack of Efficacy|0|||
160940561|NCT03670810|581173155|FG007|Main Study|Lack of Efficacy|0|||
160940562|NCT03670810|581173156|FG008|Main Study|Lack of Efficacy|0|||
160940563|NCT03670810|581173148|FG000|Main Study|Lost to Follow-up|9|||
160940564|NCT03670810|581173149|FG001|Main Study|Lost to Follow-up|7|||
160940565|NCT03670810|581173150|FG002|Main Study|Lost to Follow-up|4|||
160940566|NCT03670810|581173151|FG003|Main Study|Lost to Follow-up|6|||
160940567|NCT03670810|581173152|FG004|Main Study|Lost to Follow-up|1|||
160940568|NCT03670810|581173153|FG005|Main Study|Lost to Follow-up|0|||
160940569|NCT03670810|581173154|FG006|Main Study|Lost to Follow-up|0|||
160940570|NCT03670810|581173155|FG007|Main Study|Lost to Follow-up|0|||
160940571|NCT03670810|581173156|FG008|Main Study|Lost to Follow-up|0|||
160940572|NCT03670810|581173148|FG000|Main Study|Non-compliance with Study Drug|0|||
160940573|NCT03670810|581173149|FG001|Main Study|Non-compliance with Study Drug|2|||
160940574|NCT03670810|581173150|FG002|Main Study|Non-compliance with Study Drug|3|||
160940575|NCT03670810|581173151|FG003|Main Study|Non-compliance with Study Drug|0|||
160578853|NCT01258348|579840170|FG003|Overall Study|Withdrawal by Subject|0|||
160578854|NCT01258348|579840171|FG004|Overall Study|Withdrawal by Subject|0|||
160578855|NCT00305006|579840172|FG000|Overall Study|Withdrawal by Subject|1|||
160578856|NCT00305006|579840173|FG001|Overall Study|Withdrawal by Subject|0|||
160940576|NCT03670810|581173152|FG004|Main Study|Non-compliance with Study Drug|0|||
160940577|NCT03670810|581173153|FG005|Main Study|Non-compliance with Study Drug|0|||
160940578|NCT03670810|581173154|FG006|Main Study|Non-compliance with Study Drug|0|||
160940579|NCT03670810|581173155|FG007|Main Study|Non-compliance with Study Drug|1|||
160940580|NCT03670810|581173156|FG008|Main Study|Non-compliance with Study Drug|0|||
160940581|NCT03670810|581173148|FG000|Main Study|Physician Decision|3|||
160940582|NCT03670810|581173149|FG001|Main Study|Physician Decision|0|||
160940583|NCT03670810|581173150|FG002|Main Study|Physician Decision|1|||
160940584|NCT03670810|581173151|FG003|Main Study|Physician Decision|0|||
160940585|NCT03670810|581173152|FG004|Main Study|Physician Decision|0|||
160940586|NCT03670810|581173153|FG005|Main Study|Physician Decision|0|||
160940587|NCT03670810|581173154|FG006|Main Study|Physician Decision|1|||
160940588|NCT03670810|581173155|FG007|Main Study|Physician Decision|1|||
160940589|NCT03670810|581173156|FG008|Main Study|Physician Decision|0|||
160940590|NCT03670810|581173148|FG000|Main Study|Pregnancy|1|||
160940591|NCT03670810|581173149|FG001|Main Study|Pregnancy|2|||
160940592|NCT03670810|581173150|FG002|Main Study|Pregnancy|0|||
160940593|NCT03670810|581173151|FG003|Main Study|Pregnancy|0|||
160940594|NCT03670810|581173152|FG004|Main Study|Pregnancy|0|||
160940595|NCT03670810|581173153|FG005|Main Study|Pregnancy|0|||
160940596|NCT03670810|581173154|FG006|Main Study|Pregnancy|0|||
160578857|NCT00305006|579840172|FG000|Overall Study|Failure to complete pretest|0|||
160578858|NCT00305006|579840173|FG001|Overall Study|Failure to complete pretest|1|||
160578859|NCT02606045|579840174|FG000|Overall Study|Study closed before treament could begin|1|||
160940597|NCT03670810|581173155|FG007|Main Study|Pregnancy|0|||
160940598|NCT03670810|581173156|FG008|Main Study|Pregnancy|0|||
160940599|NCT03670810|581173148|FG000|Main Study|Protocol Deviation|2|||
160940600|NCT03670810|581173149|FG001|Main Study|Protocol Deviation|12|||
160940601|NCT03670810|581173150|FG002|Main Study|Protocol Deviation|8|||
160940602|NCT03670810|581173151|FG003|Main Study|Protocol Deviation|4|||
160940603|NCT03670810|581173152|FG004|Main Study|Protocol Deviation|0|||
160940604|NCT03670810|581173153|FG005|Main Study|Protocol Deviation|0|||
160940605|NCT03670810|581173154|FG006|Main Study|Protocol Deviation|0|||
160940606|NCT03670810|581173155|FG007|Main Study|Protocol Deviation|0|||
160940607|NCT03670810|581173156|FG008|Main Study|Protocol Deviation|0|||
160940608|NCT03670810|581173148|FG000|Main Study|Withdrawal by Subject|21|||
160940609|NCT03670810|581173149|FG001|Main Study|Withdrawal by Subject|21|||
160940610|NCT03670810|581173150|FG002|Main Study|Withdrawal by Subject|8|||
160940611|NCT03670810|581173151|FG003|Main Study|Withdrawal by Subject|9|||
160940612|NCT03670810|581173152|FG004|Main Study|Withdrawal by Subject|5|||
160940613|NCT03670810|581173153|FG005|Main Study|Withdrawal by Subject|2|||
160940614|NCT03670810|581173154|FG006|Main Study|Withdrawal by Subject|1|||
160940615|NCT03670810|581173155|FG007|Main Study|Withdrawal by Subject|1|||
160940616|NCT03670810|581173156|FG008|Main Study|Withdrawal by Subject|0|||
160940617|NCT03670810|581173148|FG000|Main Study|Participant did not want to take the three other treatments|1|||
160940618|NCT03670810|581173149|FG001|Main Study|Participant did not want to take the three other treatments|0|||
160940619|NCT03670810|581173150|FG002|Main Study|Participant did not want to take the three other treatments|0|||
160940620|NCT03670810|581173151|FG003|Main Study|Participant did not want to take the three other treatments|0|||
160940621|NCT03670810|581173152|FG004|Main Study|Participant did not want to take the three other treatments|0|||
160940622|NCT03670810|581173153|FG005|Main Study|Participant did not want to take the three other treatments|0|||
160940623|NCT03670810|581173154|FG006|Main Study|Participant did not want to take the three other treatments|0|||
160940624|NCT03670810|581173155|FG007|Main Study|Participant did not want to take the three other treatments|0|||
160940625|NCT03670810|581173156|FG008|Main Study|Participant did not want to take the three other treatments|0|||
160940626|NCT03670810|581173148|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940627|NCT03670810|581173149|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
160940628|NCT03670810|581173150|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940629|NCT03670810|581173151|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940630|NCT03670810|581173152|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940631|NCT03670810|581173153|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940632|NCT03670810|581173154|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940633|NCT03670810|581173155|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940634|NCT03670810|581173156|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940635|NCT03670810|581173148|FG000|Main Study|Travel and Coronavirus issues|0|||
160940636|NCT03670810|581173149|FG001|Main Study|Travel and Coronavirus issues|0|||
160940637|NCT03670810|581173150|FG002|Main Study|Travel and Coronavirus issues|0|||
160940638|NCT03670810|581173151|FG003|Main Study|Travel and Coronavirus issues|1|||
160940639|NCT03670810|581173152|FG004|Main Study|Travel and Coronavirus issues|0|||
160940640|NCT03670810|581173153|FG005|Main Study|Travel and Coronavirus issues|0|||
160940641|NCT03670810|581173154|FG006|Main Study|Travel and Coronavirus issues|0|||
160940642|NCT03670810|581173155|FG007|Main Study|Travel and Coronavirus issues|0|||
160940643|NCT03670810|581173156|FG008|Main Study|Travel and Coronavirus issues|0|||
160940644|NCT03670810|581173148|FG000|Open Label Extension|Protocol Deviation|0|||
160940645|NCT03670810|581173149|FG001|Open Label Extension|Protocol Deviation|0|||
160940646|NCT03670810|581173150|FG002|Open Label Extension|Protocol Deviation|0|||
160940647|NCT03670810|581173151|FG003|Open Label Extension|Protocol Deviation|0|||
160940648|NCT03670810|581173152|FG004|Open Label Extension|Protocol Deviation|0|||
160940649|NCT03670810|581173153|FG005|Open Label Extension|Protocol Deviation|0|||
160940650|NCT03670810|581173154|FG006|Open Label Extension|Protocol Deviation|0|||
160940651|NCT03670810|581173155|FG007|Open Label Extension|Protocol Deviation|0|||
160940652|NCT03670810|581173156|FG008|Open Label Extension|Protocol Deviation|5|||
160940653|NCT03670810|581173148|FG000|Open Label Extension|Death|0|||
160940654|NCT03670810|581173149|FG001|Open Label Extension|Death|0|||
160940655|NCT03670810|581173150|FG002|Open Label Extension|Death|0|||
160578860|NCT02606045|579840175|FG001|Overall Study|Study closed before treament could begin|2|||
160578861|NCT01996319|579840176|FG000|Overall Study|Protocol Violation|1|||
160578862|NCT01996319|579840177|FG001|Overall Study|Protocol Violation|0|||
160578863|NCT01996319|579840176|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
160578864|NCT01996319|579840177|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
160578865|NCT01996319|579840176|FG000|Overall Study|Adverse Event|2|||
160578866|NCT01996319|579840177|FG001|Overall Study|Adverse Event|2|||
160578867|NCT01671085|579840179|FG000|Overall Study|Withdrawal by Subject|1|||
160578868|NCT01671085|579840180|FG001|Overall Study|Withdrawal by Subject|0|||
160578869|NCT00637273|579840181|FG000|Overall Study|Adverse Event|11|||
160578870|NCT00637273|579840182|FG001|Overall Study|Adverse Event|5|||
160578871|NCT00637273|579840183|FG002|Overall Study|Adverse Event|7|||
160940656|NCT03670810|581173151|FG003|Open Label Extension|Death|0|||
160940657|NCT03670810|581173152|FG004|Open Label Extension|Death|0|||
160940658|NCT03670810|581173153|FG005|Open Label Extension|Death|0|||
160455695|NCT02240238|579399763|FG002|Phase 1|Withdrawal by Subject|0|||
160578872|NCT00637273|579840181|FG000|Overall Study|Lost to Follow-up|8|||
160578873|NCT00637273|579840182|FG001|Overall Study|Lost to Follow-up|9|||
160455696|NCT02240238|579399764|FG003|Phase 1|Withdrawal by Subject|0|||
160455697|NCT02240238|579399765|FG004|Phase 1|Withdrawal by Subject|0|||
160455698|NCT02240238|579399766|FG005|Phase 1|Withdrawal by Subject|2|||
160455699|NCT02240238|579399767|FG006|Phase 1|Withdrawal by Subject|0|||
160455700|NCT02240238|579399768|FG007|Phase 1|Withdrawal by Subject|0|||
160455701|NCT02240238|579399769|FG008|Phase 1|Withdrawal by Subject|0|||
160455702|NCT02240238|579399770|FG009|Phase 1|Withdrawal by Subject|0|||
160455703|NCT02240238|579399771|FG010|Phase 1|Withdrawal by Subject|0|||
160940659|NCT03670810|581173154|FG006|Open Label Extension|Death|0|||
160940660|NCT03670810|581173155|FG007|Open Label Extension|Death|0|||
160940661|NCT03670810|581173156|FG008|Open Label Extension|Death|1|||
160940662|NCT03670810|581173148|FG000|Open Label Extension|COVID-19|0|||
160940663|NCT03670810|581173149|FG001|Open Label Extension|COVID-19|0|||
160940664|NCT03670810|581173150|FG002|Open Label Extension|COVID-19|0|||
160940665|NCT03670810|581173151|FG003|Open Label Extension|COVID-19|0|||
160940666|NCT03670810|581173152|FG004|Open Label Extension|COVID-19|0|||
160940667|NCT03670810|581173153|FG005|Open Label Extension|COVID-19|0|||
160940668|NCT03670810|581173154|FG006|Open Label Extension|COVID-19|0|||
160940669|NCT03670810|581173155|FG007|Open Label Extension|COVID-19|0|||
160940670|NCT03670810|581173156|FG008|Open Label Extension|COVID-19|1|||
160940671|NCT03670810|581173148|FG000|Open Label Extension|Lack of Efficacy|0|||
160940672|NCT03670810|581173149|FG001|Open Label Extension|Lack of Efficacy|0|||
160940673|NCT03670810|581173150|FG002|Open Label Extension|Lack of Efficacy|0|||
160940674|NCT03670810|581173151|FG003|Open Label Extension|Lack of Efficacy|0|||
160940675|NCT03670810|581173152|FG004|Open Label Extension|Lack of Efficacy|0|||
160940676|NCT03670810|581173153|FG005|Open Label Extension|Lack of Efficacy|0|||
160940677|NCT03670810|581173154|FG006|Open Label Extension|Lack of Efficacy|0|||
160940678|NCT03670810|581173155|FG007|Open Label Extension|Lack of Efficacy|0|||
160940679|NCT03670810|581173156|FG008|Open Label Extension|Lack of Efficacy|39|||
160940680|NCT03670810|581173148|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
160940681|NCT03670810|581173149|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
160940682|NCT03670810|581173150|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
160940683|NCT03670810|581173151|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
160940684|NCT03670810|581173152|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
160940685|NCT03670810|581173153|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
160940686|NCT03670810|581173154|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
160940687|NCT03670810|581173155|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
160940688|NCT03670810|581173156|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
160940689|NCT03670810|581173148|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940690|NCT03670810|581173149|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940691|NCT03670810|581173150|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940692|NCT03670810|581173151|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940693|NCT03670810|581173152|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940694|NCT03670810|581173153|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940695|NCT03670810|581173154|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940696|NCT03670810|581173155|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940697|NCT03670810|581173156|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
160940698|NCT03670810|581173148|FG000|Open Label Extension|Withdrawal by Subject|0|||
160940699|NCT03670810|581173149|FG001|Open Label Extension|Withdrawal by Subject|0|||
160940700|NCT03670810|581173150|FG002|Open Label Extension|Withdrawal by Subject|0|||
160940701|NCT03670810|581173151|FG003|Open Label Extension|Withdrawal by Subject|0|||
160940702|NCT03670810|581173152|FG004|Open Label Extension|Withdrawal by Subject|0|||
160940703|NCT03670810|581173153|FG005|Open Label Extension|Withdrawal by Subject|0|||
160940704|NCT03670810|581173154|FG006|Open Label Extension|Withdrawal by Subject|0|||
160940705|NCT03670810|581173155|FG007|Open Label Extension|Withdrawal by Subject|0|||
160940706|NCT03670810|581173156|FG008|Open Label Extension|Withdrawal by Subject|46|||
160940707|NCT03670810|581173148|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940708|NCT03670810|581173149|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940709|NCT03670810|581173150|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940710|NCT03670810|581173151|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940711|NCT03670810|581173152|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160455704|NCT02240238|579399772|FG011|Phase 1|Withdrawal by Subject|0|||
160455705|NCT02240238|579399761|FG000|Phase 1|Physician Decision|0|||
160455706|NCT02240238|579399762|FG001|Phase 1|Physician Decision|0|||
160578874|NCT00637273|579840183|FG002|Overall Study|Lost to Follow-up|13|||
160578875|NCT00637273|579840181|FG000|Overall Study|Protocol Violation|2|||
160455707|NCT02240238|579399763|FG002|Phase 1|Physician Decision|0|||
160455708|NCT02240238|579399764|FG003|Phase 1|Physician Decision|0|||
160455709|NCT02240238|579399765|FG004|Phase 1|Physician Decision|0|||
160940712|NCT03670810|581173153|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940713|NCT03670810|581173154|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940714|NCT03670810|581173155|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940715|NCT03670810|581173156|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
160940716|NCT03670810|581173148|FG000|Open Label Extension|Physician Decision|0|||
160940717|NCT03670810|581173149|FG001|Open Label Extension|Physician Decision|0|||
160940718|NCT03670810|581173150|FG002|Open Label Extension|Physician Decision|0|||
160940719|NCT03670810|581173151|FG003|Open Label Extension|Physician Decision|0|||
160940720|NCT03670810|581173152|FG004|Open Label Extension|Physician Decision|0|||
160940721|NCT03670810|581173153|FG005|Open Label Extension|Physician Decision|0|||
160940722|NCT03670810|581173154|FG006|Open Label Extension|Physician Decision|0|||
160940723|NCT03670810|581173155|FG007|Open Label Extension|Physician Decision|0|||
160940724|NCT03670810|581173156|FG008|Open Label Extension|Physician Decision|2|||
160940725|NCT03670810|581173148|FG000|Open Label Extension|Non-compliance with study drug|0|||
160940726|NCT03670810|581173149|FG001|Open Label Extension|Non-compliance with study drug|0|||
160940727|NCT03670810|581173150|FG002|Open Label Extension|Non-compliance with study drug|0|||
160940728|NCT03670810|581173151|FG003|Open Label Extension|Non-compliance with study drug|0|||
160940729|NCT03670810|581173152|FG004|Open Label Extension|Non-compliance with study drug|0|||
160940730|NCT03670810|581173153|FG005|Open Label Extension|Non-compliance with study drug|0|||
160940731|NCT03670810|581173154|FG006|Open Label Extension|Non-compliance with study drug|0|||
160940732|NCT03670810|581173155|FG007|Open Label Extension|Non-compliance with study drug|0|||
160940733|NCT03670810|581173156|FG008|Open Label Extension|Non-compliance with study drug|5|||
160940734|NCT03670810|581173148|FG000|Open Label Extension|Pregnancy|0|||
160940735|NCT03670810|581173149|FG001|Open Label Extension|Pregnancy|0|||
160940736|NCT03670810|581173150|FG002|Open Label Extension|Pregnancy|0|||
160940737|NCT03670810|581173151|FG003|Open Label Extension|Pregnancy|0|||
160940738|NCT03670810|581173152|FG004|Open Label Extension|Pregnancy|0|||
160940739|NCT03670810|581173153|FG005|Open Label Extension|Pregnancy|0|||
160940740|NCT03670810|581173154|FG006|Open Label Extension|Pregnancy|0|||
160940741|NCT03670810|581173155|FG007|Open Label Extension|Pregnancy|0|||
160940742|NCT03670810|581173156|FG008|Open Label Extension|Pregnancy|3|||
160940743|NCT03670810|581173148|FG000|Open Label Extension|Adverse Event|0|||
160940744|NCT03670810|581173149|FG001|Open Label Extension|Adverse Event|0|||
160940745|NCT03670810|581173150|FG002|Open Label Extension|Adverse Event|0|||
160940746|NCT03670810|581173151|FG003|Open Label Extension|Adverse Event|0|||
160940747|NCT03670810|581173152|FG004|Open Label Extension|Adverse Event|0|||
160940748|NCT03670810|581173153|FG005|Open Label Extension|Adverse Event|0|||
160940749|NCT03670810|581173154|FG006|Open Label Extension|Adverse Event|0|||
160940750|NCT03670810|581173155|FG007|Open Label Extension|Adverse Event|0|||
160940751|NCT03670810|581173156|FG008|Open Label Extension|Adverse Event|24|||
160940752|NCT03670810|581173148|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
160940753|NCT03670810|581173149|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
160940754|NCT03670810|581173150|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
160940755|NCT03670810|581173151|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
160940756|NCT03670810|581173152|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
160940757|NCT03670810|581173153|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
160940758|NCT03670810|581173154|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
160940759|NCT03670810|581173155|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
160940760|NCT03670810|581173156|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
160940761|NCT03670810|581173148|FG000|Open Label Extension|Lost to Follow-up|0|||
160940762|NCT03670810|581173149|FG001|Open Label Extension|Lost to Follow-up|0|||
160940763|NCT03670810|581173150|FG002|Open Label Extension|Lost to Follow-up|0|||
160940764|NCT03670810|581173151|FG003|Open Label Extension|Lost to Follow-up|0|||
160940765|NCT03670810|581173152|FG004|Open Label Extension|Lost to Follow-up|0|||
160940766|NCT03670810|581173153|FG005|Open Label Extension|Lost to Follow-up|0|||
160940767|NCT03670810|581173154|FG006|Open Label Extension|Lost to Follow-up|0|||
160940768|NCT03670810|581173155|FG007|Open Label Extension|Lost to Follow-up|0|||
160940769|NCT03670810|581173156|FG008|Open Label Extension|Lost to Follow-up|23|||
160940770|NCT00678691|581173157|FG000|Overall Study|Adverse Event|6|||
160940771|NCT00678691|581173158|FG001|Overall Study|Adverse Event|4|||
160940772|NCT03192150|581173165|FG000|Overall Study|Adverse Event|14|||
160940773|NCT03192150|581173166|FG001|Overall Study|Adverse Event|12|||
160940774|NCT03192150|581173165|FG000|Overall Study|Lack of Efficacy|23|||
160940775|NCT03192150|581173166|FG001|Overall Study|Lack of Efficacy|30|||
160940776|NCT03192150|581173165|FG000|Overall Study|Lost to Follow-up|1|||
160940777|NCT03192150|581173166|FG001|Overall Study|Lost to Follow-up|1|||
160940778|NCT03192150|581173165|FG000|Overall Study|Withdrawal by Subject|4|||
160940779|NCT03192150|581173166|FG001|Overall Study|Withdrawal by Subject|2|||
160940780|NCT03192150|581173165|FG000|Overall Study|Protocol Violation|5|||
160940781|NCT03192150|581173166|FG001|Overall Study|Protocol Violation|2|||
160940782|NCT03192150|581173165|FG000|Overall Study|Surgery Canceled|6|||
160940783|NCT03192150|581173166|FG001|Overall Study|Surgery Canceled|2|||
160578876|NCT00637273|579840182|FG001|Overall Study|Protocol Violation|4|||
160940784|NCT03192150|581173165|FG000|Overall Study|Other-Various Administrative Reasons|2|||
160940785|NCT03192150|581173166|FG001|Overall Study|Other-Various Administrative Reasons|5|||
160940786|NCT00779766|581173167|FG000|Month 24|Serious Adverse Event|2|||
160940787|NCT00779766|581173168|FG001|Month 24|Serious Adverse Event|3|||
160940788|NCT00779766|581173167|FG000|Month 24|Adverse Event|3|||
160940789|NCT00779766|581173168|FG001|Month 24|Adverse Event|3|||
160940790|NCT00779766|581173167|FG000|Month 24|Protocol Violation|3|||
160940791|NCT00779766|581173168|FG001|Month 24|Protocol Violation|1|||
160940792|NCT00779766|581173167|FG000|Month 24|Withdrawal by Subject|159|||
160940793|NCT00779766|581173168|FG001|Month 24|Withdrawal by Subject|127|||
160578877|NCT00637273|579840183|FG002|Overall Study|Protocol Violation|1|||
160578878|NCT00637273|579840181|FG000|Overall Study|Withdrawal of Consent|18|||
160578879|NCT00637273|579840182|FG001|Overall Study|Withdrawal of Consent|6|||
160578880|NCT00637273|579840183|FG002|Overall Study|Withdrawal of Consent|18|||
160940794|NCT00779766|581173167|FG000|Month 24|Migrated/moved from study area|138|||
160578881|NCT00637273|579840181|FG000|Overall Study|Investigator Decision|1|||
160578882|NCT00637273|579840182|FG001|Overall Study|Investigator Decision|3|||
160578883|NCT00637273|579840183|FG002|Overall Study|Investigator Decision|1|||
160578884|NCT00637273|579840181|FG000|Overall Study|Administrative|2|||
160578885|NCT00637273|579840182|FG001|Overall Study|Administrative|0|||
160578886|NCT00637273|579840183|FG002|Overall Study|Administrative|0|||
160578887|NCT00637273|579840181|FG000|Overall Study|Loss of Glucose Control|1|||
160578888|NCT00637273|579840182|FG001|Overall Study|Loss of Glucose Control|1|||
160578889|NCT00637273|579840183|FG002|Overall Study|Loss of Glucose Control|1|||
160578890|NCT00365716|579840184|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
160578891|NCT00365716|579840185|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
160578892|NCT00365716|579840186|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
160578893|NCT00365716|579840187|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
160578894|NCT00365716|579840188|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
160578895|NCT00365716|579840189|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
160578896|NCT00365716|579840190|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
160578897|NCT00365716|579840184|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
160578898|NCT00365716|579840185|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
160578899|NCT00365716|579840186|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
160578900|NCT00365716|579840187|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
160578901|NCT00365716|579840188|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
160578902|NCT00365716|579840189|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
160578903|NCT00365716|579840190|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
160578904|NCT00365716|579840184|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
160578905|NCT00365716|579840185|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
160578906|NCT00365716|579840186|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
160578907|NCT00365716|579840187|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
160578908|NCT00365716|579840188|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
160578909|NCT00365716|579840189|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
160578910|NCT00365716|579840190|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
160578911|NCT00365716|579840184|FG000|Base Study (Day 1 to Month 7)|Other|0|||
160578912|NCT00365716|579840185|FG001|Base Study (Day 1 to Month 7)|Other|1|||
160578913|NCT00365716|579840186|FG002|Base Study (Day 1 to Month 7)|Other|0|||
160940795|NCT00779766|581173168|FG001|Month 24|Migrated/moved from study area|162|||
160940796|NCT00779766|581173167|FG000|Month 24|Lost to Follow-up|9|||
160940797|NCT00779766|581173168|FG001|Month 24|Lost to Follow-up|9|||
160940798|NCT00779766|581173167|FG000|Month 24|Other|18|||
160940799|NCT00779766|581173168|FG001|Month 24|Other|27|||
160940800|NCT00779766|581173167|FG000|Month 48|Withdrawal by Subject|68|||
160940801|NCT00779766|581173168|FG001|Month 48|Withdrawal by Subject|63|||
160940802|NCT00779766|581173167|FG000|Month 48|Migrated/moved from study area|76|||
160940803|NCT00779766|581173168|FG001|Month 48|Migrated/moved from study area|75|||
160940804|NCT00779766|581173167|FG000|Month 48|Lost to Follow-up|29|||
160940805|NCT00779766|581173168|FG001|Month 48|Lost to Follow-up|30|||
160940806|NCT00779766|581173167|FG000|Month 48|Other|1|||
160940807|NCT00779766|581173168|FG001|Month 48|Other|0|||
160940808|NCT00779766|581173167|FG000|Month 72|Withdrawal by Subject|55|||
160578914|NCT00365716|579840187|FG003|Base Study (Day 1 to Month 7)|Other|0|||
160578915|NCT00365716|579840188|FG004|Base Study (Day 1 to Month 7)|Other|0|||
160578916|NCT00365716|579840189|FG005|Base Study (Day 1 to Month 7)|Other|0|||
160940809|NCT00779766|581173168|FG001|Month 72|Withdrawal by Subject|71|||
160940810|NCT00779766|581173167|FG000|Month 72|Migrated/moved from study area|124|||
160578917|NCT00365716|579840190|FG006|Base Study (Day 1 to Month 7)|Other|0|||
160578918|NCT00365716|579840184|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
160578919|NCT00365716|579840185|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
160940811|NCT00779766|581173168|FG001|Month 72|Migrated/moved from study area|109|||
160940812|NCT00779766|581173167|FG000|Month 72|Lost to Follow-up|6|||
160940813|NCT00779766|581173168|FG001|Month 72|Lost to Follow-up|8|||
160940814|NCT00779766|581173167|FG000|Month 72|Other|0|||
160940815|NCT00779766|581173168|FG001|Month 72|Other|1|||
160940816|NCT01412424|581173169|FG000|Core Treatment Period|Treatment Failure|24|||
160940817|NCT01412424|581173169|FG000|Core Treatment Period|Adverse Event|21|||
160940818|NCT01412424|581173169|FG000|Core Treatment Period|Patient Request|5|||
160940819|NCT01412424|581173169|FG000|Core Treatment Period|Lost to Follow-up|2|||
160940820|NCT01412424|581173169|FG000|Core Treatment Period|Sponsor Request|1|||
160940821|NCT01412424|581173169|FG000|Extension Treatment Period|Adverse Event|2|||
160940822|NCT01412424|581173169|FG000|Extension Treatment Period|Treatment Failure|2|||
160940823|NCT01412424|581173169|FG000|Extension Treatment Period|Patient Request|2|||
160940824|NCT01274637|581173170|FG000|Overall Study|Withdrawal by Subject|0|||
160940825|NCT01274637|581173171|FG001|Overall Study|Withdrawal by Subject|1|||
160940826|NCT01274637|581173170|FG000|Overall Study|Lost to Follow-up|0|||
160940827|NCT01274637|581173171|FG001|Overall Study|Lost to Follow-up|1|||
160940828|NCT01824303|581173185|FG000|Randomized Study|Withdrawal by Subject|1|||
160940829|NCT01824303|581173186|FG001|Randomized Study|Withdrawal by Subject|1|||
160940830|NCT01824303|581173185|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
160940831|NCT01824303|581173186|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
160940832|NCT02606136|581173194|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
160940833|NCT02606136|581173194|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
160940834|NCT02606136|581173194|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
160940835|NCT02606136|581173194|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
160940836|NCT03296696|581173195|FG000|Overall Study|Started Other Antitumor Therapy|1|||
160940837|NCT03296696|581173196|FG001|Overall Study|Started Other Antitumor Therapy|2|||
160940838|NCT03296696|581173197|FG002|Overall Study|Started Other Antitumor Therapy|1|||
160940839|NCT03296696|581173198|FG003|Overall Study|Started Other Antitumor Therapy|2|||
160940840|NCT03296696|581173199|FG004|Overall Study|Started Other Antitumor Therapy|1|||
160940841|NCT03296696|581173200|FG005|Overall Study|Started Other Antitumor Therapy|1|||
160940842|NCT03296696|581173201|FG006|Overall Study|Started Other Antitumor Therapy|2|||
160940843|NCT03296696|581173202|FG007|Overall Study|Started Other Antitumor Therapy|3|||
160940844|NCT03296696|581173203|FG008|Overall Study|Started Other Antitumor Therapy|1|||
160940845|NCT03296696|581173204|FG009|Overall Study|Started Other Antitumor Therapy|0|||
160940846|NCT03296696|581173195|FG000|Overall Study|Death|0|||
160940847|NCT03296696|581173196|FG001|Overall Study|Death|1|||
160940848|NCT03296696|581173197|FG002|Overall Study|Death|1|||
160940849|NCT03296696|581173198|FG003|Overall Study|Death|2|||
160940850|NCT03296696|581173199|FG004|Overall Study|Death|2|||
160940851|NCT03296696|581173200|FG005|Overall Study|Death|3|||
160940852|NCT03296696|581173201|FG006|Overall Study|Death|1|||
160940853|NCT03296696|581173202|FG007|Overall Study|Death|2|||
160940854|NCT03296696|581173203|FG008|Overall Study|Death|0|||
160940855|NCT03296696|581173204|FG009|Overall Study|Death|0|||
160940856|NCT03296696|581173195|FG000|Overall Study|Withdrawal by Subject|0|||
160940857|NCT03296696|581173196|FG001|Overall Study|Withdrawal by Subject|0|||
160940858|NCT03296696|581173197|FG002|Overall Study|Withdrawal by Subject|1|||
160940859|NCT03296696|581173198|FG003|Overall Study|Withdrawal by Subject|0|||
160940860|NCT03296696|581173199|FG004|Overall Study|Withdrawal by Subject|1|||
160940861|NCT03296696|581173200|FG005|Overall Study|Withdrawal by Subject|0|||
160940862|NCT03296696|581173201|FG006|Overall Study|Withdrawal by Subject|0|||
160940863|NCT03296696|581173202|FG007|Overall Study|Withdrawal by Subject|0|||
160940864|NCT03296696|581173203|FG008|Overall Study|Withdrawal by Subject|0|||
160940865|NCT03296696|581173204|FG009|Overall Study|Withdrawal by Subject|1|||
160940866|NCT04694131|581173207|FG000|Overall Study|Withdrawal by Subject|7|||
160940867|NCT04694131|581173207|FG000|Overall Study|Screen Failure|1|||
160940868|NCT04694131|581173207|FG000|Overall Study|High stimulation threshold|3|||
160940869|NCT01350128|581173208|FG000|Overall Study|Withdrawal by Subject|3|||
160940870|NCT01350128|581173208|FG000|Overall Study|Protocol discontinuation criteria|8|||
160940871|NCT01350128|581173208|FG000|Overall Study|Physician Decision|1|||
160940872|NCT01350128|581173208|FG000|Overall Study|Lost to Follow-up|2|||
160940873|NCT02399085|581173212|FG000|Overall Study|Adverse Event|16|||
160940874|NCT02399085|581173212|FG000|Overall Study|Death|2|||
160940875|NCT02399085|581173212|FG000|Overall Study|Withdrawal by Subject|8|||
160940876|NCT02399085|581173212|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
160940877|NCT02399085|581173212|FG000|Overall Study|Physician Decision|5|||
160940878|NCT02170727|581173213|FG000|Overall Study|Lost to Follow-up|1|||
160940879|NCT02170727|581173214|FG001|Overall Study|Lost to Follow-up|0|||
160940880|NCT02170727|581173213|FG000|Overall Study|Withdrawal by Subject|2|||
160940881|NCT02170727|581173214|FG001|Overall Study|Withdrawal by Subject|0|||
160940882|NCT01959581|581173219|FG000|Overall Study|Lost to Follow-up|5|||
160940883|NCT00700011|581173222|FG000|Overall Study|Death|0|||
160940884|NCT00700011|581173223|FG001|Overall Study|Death|1|||
160940885|NCT00004031|581173224|FG000|Overall Study|Adverse Event|5|||
160940886|NCT00004031|581173225|FG001|Overall Study|Adverse Event|0|||
160940887|NCT00004031|581173224|FG000|Overall Study|Refusal unrelated to adverse events|2|||
160940888|NCT00004031|581173225|FG001|Overall Study|Refusal unrelated to adverse events|11|||
160940889|NCT00004031|581173224|FG000|Overall Study|Progression/relapse|9|||
160940890|NCT00004031|581173225|FG001|Overall Study|Progression/relapse|4|||
160940891|NCT00004031|581173224|FG000|Overall Study|Death|3|||
160940892|NCT00004031|581173225|FG001|Overall Study|Death|1|||
160940893|NCT00004031|581173224|FG000|Overall Study|Other- not protocol specified|3|||
160940894|NCT00004031|581173225|FG001|Overall Study|Other- not protocol specified|3|||
160940895|NCT00004031|581173224|FG000|Overall Study|Reason under review|3|||
160940896|NCT00004031|581173225|FG001|Overall Study|Reason under review|2|||
160940897|NCT00600821|581174800|FG000|Overall Study|Death|45|||
160940898|NCT00600821|581174801|FG001|Overall Study|Death|46|||
160940899|NCT00600821|581174800|FG000|Overall Study|Lost to Follow-up|2|||
160940900|NCT00600821|581174801|FG001|Overall Study|Lost to Follow-up|2|||
160940901|NCT00600821|581174800|FG000|Overall Study|Withdrawal by Subject|1|||
160940902|NCT00600821|581174801|FG001|Overall Study|Withdrawal by Subject|1|||
160940903|NCT00600821|581174800|FG000|Overall Study|Terminated by sponsor|8|||
160940904|NCT00600821|581174801|FG001|Overall Study|Terminated by sponsor|6|||
160940905|NCT00600821|581174800|FG000|Overall Study|Objective progression or relapse|0|||
160940906|NCT00600821|581174801|FG001|Overall Study|Objective progression or relapse|1|||
160940907|NCT00600821|581174800|FG000|Overall Study|Randomized but not treated|0|||
160940908|NCT00600821|581174801|FG001|Overall Study|Randomized but not treated|1|||
160940909|NCT00600821|581174800|FG000|Overall Study|Other|2|||
160940910|NCT00600821|581174801|FG001|Overall Study|Other|3|||
160940911|NCT02602288|581174802|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
160940912|NCT02602288|581174803|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
160940913|NCT02602288|581174802|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
160940914|NCT02602288|581174803|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
160940915|NCT02602288|581174802|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
160940916|NCT02602288|581174803|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
160940917|NCT02602288|581174802|FG000|12 Month Follow-up|Lost to Follow-up|0|||
160940918|NCT02602288|581174803|FG001|12 Month Follow-up|Lost to Follow-up|4|||
160940919|NCT02602288|581174802|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
160940920|NCT02602288|581174803|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
160940921|NCT01310413|581174804|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
160940922|NCT01310413|581174805|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
160940923|NCT01310413|581174806|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
160940924|NCT01310413|581174807|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
160940925|NCT01310413|581174808|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
160940926|NCT01310413|581174809|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
160940927|NCT01310413|581174810|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
160940928|NCT01310413|581174804|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
160940929|NCT01310413|581174805|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
160940930|NCT01310413|581174806|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
160940931|NCT01310413|581174807|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
160940932|NCT01310413|581174808|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
160940933|NCT01310413|581174809|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
160940934|NCT01310413|581174810|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
160940935|NCT01310413|581174804|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
160940936|NCT01310413|581174805|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
160940937|NCT01310413|581174806|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
160940938|NCT01310413|581174807|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
160940939|NCT01310413|581174808|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
160940940|NCT01310413|581174809|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
160940941|NCT01310413|581174810|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
160940942|NCT01310413|581174804|FG000|Day 0 to Day 385|Other|1|||
160940943|NCT01310413|581174805|FG001|Day 0 to Day 385|Other|0|||
160940944|NCT01310413|581174806|FG002|Day 0 to Day 385|Other|3|||
160940945|NCT01310413|581174807|FG003|Day 0 to Day 385|Other|0|||
160940946|NCT01310413|581174808|FG004|Day 0 to Day 385|Other|0|||
160940947|NCT01310413|581174809|FG005|Day 0 to Day 385|Other|0|||
160940948|NCT01310413|581174810|FG006|Day 0 to Day 385|Other|0|||
160940949|NCT01310413|581174804|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940950|NCT01310413|581174805|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940951|NCT01310413|581174806|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940952|NCT01310413|581174807|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940953|NCT01310413|581174808|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940954|NCT01310413|581174809|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940955|NCT01310413|581174810|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
160940956|NCT01310413|581174804|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
160940957|NCT01310413|581174805|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
160940958|NCT01310413|581174806|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
160940959|NCT01310413|581174807|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
160578920|NCT00365716|579840186|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
160578921|NCT00365716|579840187|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
160578922|NCT00365716|579840188|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
160940960|NCT01310413|581174808|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
160940961|NCT01310413|581174809|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
160940962|NCT01310413|581174810|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
160940963|NCT02066298|581174812|FG000|Overall Study|Lost to Follow-up|3|||
160578923|NCT00365716|579840189|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
160940964|NCT02066298|581174813|FG001|Overall Study|Lost to Follow-up|2|||
160940965|NCT02066298|581174814|FG002|Overall Study|Lost to Follow-up|3|||
160940966|NCT02066298|581174815|FG003|Overall Study|Lost to Follow-up|2|||
160940967|NCT02066298|581174816|FG004|Overall Study|Lost to Follow-up|3|||
160940968|NCT02066298|581174817|FG005|Overall Study|Lost to Follow-up|4|||
160940969|NCT02066298|581174812|FG000|Overall Study|Withdrawal by Subject|6|||
160940970|NCT02066298|581174813|FG001|Overall Study|Withdrawal by Subject|6|||
160940971|NCT02066298|581174814|FG002|Overall Study|Withdrawal by Subject|6|||
160940972|NCT02066298|581174815|FG003|Overall Study|Withdrawal by Subject|4|||
160940973|NCT02066298|581174816|FG004|Overall Study|Withdrawal by Subject|5|||
160940974|NCT02066298|581174817|FG005|Overall Study|Withdrawal by Subject|8|||
160940975|NCT02066298|581174812|FG000|Overall Study|Physician Decision|0|||
160940976|NCT02066298|581174813|FG001|Overall Study|Physician Decision|0|||
160940977|NCT02066298|581174814|FG002|Overall Study|Physician Decision|1|||
160940978|NCT02066298|581174815|FG003|Overall Study|Physician Decision|0|||
160940979|NCT02066298|581174816|FG004|Overall Study|Physician Decision|1|||
160940980|NCT02066298|581174817|FG005|Overall Study|Physician Decision|0|||
160940981|NCT04260191|581174818|FG000|Overall Study|Decision by Sponsor|0|||
160940982|NCT04260191|581174819|FG001|Overall Study|Decision by Sponsor|1|||
160940983|NCT04260191|581174820|FG002|Overall Study|Decision by Sponsor|0|||
160940984|NCT04260191|581174818|FG000|Overall Study|Withdrawal by Subject|1|||
160940985|NCT04260191|581174819|FG001|Overall Study|Withdrawal by Subject|0|||
160940986|NCT04260191|581174820|FG002|Overall Study|Withdrawal by Subject|3|||
160940987|NCT04260191|581174818|FG000|Overall Study|Death|4|||
160940988|NCT04260191|581174819|FG001|Overall Study|Death|3|||
160940989|NCT04260191|581174820|FG002|Overall Study|Death|2|||
160940990|NCT01513317|581174822|FG000|Overall Study|Withdrawal by Subject|15|||
160940991|NCT01513317|581174823|FG001|Overall Study|Withdrawal by Subject|4|||
160940992|NCT01513317|581174822|FG000|Overall Study|Death|1|||
160940993|NCT01513317|581174823|FG001|Overall Study|Death|1|||
160940994|NCT01513317|581174822|FG000|Overall Study|Study terminated by sponsor|18|||
160940995|NCT01513317|581174823|FG001|Overall Study|Study terminated by sponsor|18|||
160940996|NCT01513317|581174822|FG000|Overall Study|Other|0|||
160940997|NCT01513317|581174823|FG001|Overall Study|Other|1|||
160940998|NCT01265953|581174824|FG000|Overall Study|Non compliance|5|||
160940999|NCT01265953|581174825|FG001|Overall Study|Non compliance|3|||
160941000|NCT02564198|581174826|FG000|Overall Study|Withdrawal by Subject|2|||
160941001|NCT02564198|581174827|FG001|Overall Study|Withdrawal by Subject|4|||
160941002|NCT02564198|581174828|FG002|Overall Study|Withdrawal by Subject|0|||
160941003|NCT02564198|581174826|FG000|Overall Study|Adverse Event|0|||
160941004|NCT02564198|581174827|FG001|Overall Study|Adverse Event|1|||
160941005|NCT02564198|581174828|FG002|Overall Study|Adverse Event|0|||
160941006|NCT00659646|581174829|FG000|Overall Study|Protocol Violation|12|||
160941007|NCT00659646|581174830|FG001|Overall Study|Protocol Violation|8|||
160941008|NCT00659646|581174829|FG000|Overall Study|Adverse Event|1|||
160941009|NCT00659646|581174830|FG001|Overall Study|Adverse Event|0|||
160941010|NCT00659646|581174829|FG000|Overall Study|Lost to Follow-up|1|||
160941011|NCT00659646|581174830|FG001|Overall Study|Lost to Follow-up|0|||
160941012|NCT00659646|581174829|FG000|Overall Study|protocol noncompliance after randomized|1|||
160941013|NCT00659646|581174830|FG001|Overall Study|protocol noncompliance after randomized|0|||
160941014|NCT02391948|581174831|FG000|6-month Assessment|Death|0|||
160941015|NCT02391948|581174832|FG001|6-month Assessment|Death|0|||
160941016|NCT02391948|581174833|FG002|6-month Assessment|Death|0|||
160941017|NCT02391948|581174834|FG003|6-month Assessment|Death|0|||
160941018|NCT02391948|581174835|FG004|6-month Assessment|Death|1|||
160941019|NCT02391948|581174831|FG000|6-month Assessment|Withdrawal by Subject|0|||
160941020|NCT02391948|581174832|FG001|6-month Assessment|Withdrawal by Subject|0|||
160578924|NCT00365716|579840190|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
160941021|NCT02391948|581174833|FG002|6-month Assessment|Withdrawal by Subject|1|||
160941022|NCT02391948|581174834|FG003|6-month Assessment|Withdrawal by Subject|2|||
160941023|NCT02391948|581174835|FG004|6-month Assessment|Withdrawal by Subject|0|||
160941024|NCT02391948|581174831|FG000|6-month Assessment|Lost to Follow-up|4|||
160941025|NCT02391948|581174832|FG001|6-month Assessment|Lost to Follow-up|5|||
160941026|NCT02391948|581174833|FG002|6-month Assessment|Lost to Follow-up|2|||
160941027|NCT02391948|581174834|FG003|6-month Assessment|Lost to Follow-up|3|||
160941028|NCT02391948|581174835|FG004|6-month Assessment|Lost to Follow-up|1|||
160941029|NCT02391948|581174831|FG000|6-month Assessment|Medical issue/illness|1|||
160578925|NCT00365716|579840184|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
160578926|NCT00365716|579840185|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
160941030|NCT02391948|581174832|FG001|6-month Assessment|Medical issue/illness|1|||
160941031|NCT02391948|581174833|FG002|6-month Assessment|Medical issue/illness|0|||
160941032|NCT02391948|581174834|FG003|6-month Assessment|Medical issue/illness|0|||
160941033|NCT02391948|581174835|FG004|6-month Assessment|Medical issue/illness|0|||
160941034|NCT02391948|581174831|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
160941035|NCT02391948|581174832|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
160941036|NCT02391948|581174833|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
160941037|NCT02391948|581174834|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
160941038|NCT02391948|581174835|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
160941039|NCT02391948|581174831|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
160941040|NCT02391948|581174832|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
160941041|NCT02391948|581174833|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
160941042|NCT02391948|581174834|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
160941043|NCT02391948|581174835|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
160941044|NCT02391948|581174831|FG000|12-month Assessment|Death|0|||
160941045|NCT02391948|581174832|FG001|12-month Assessment|Death|0|||
160941046|NCT02391948|581174833|FG002|12-month Assessment|Death|0|||
160941047|NCT02391948|581174834|FG003|12-month Assessment|Death|1|||
160941048|NCT02391948|581174835|FG004|12-month Assessment|Death|0|||
160941049|NCT02391948|581174831|FG000|12-month Assessment|Withdrawal by Subject|1|||
160941050|NCT02391948|581174832|FG001|12-month Assessment|Withdrawal by Subject|0|||
160941051|NCT02391948|581174833|FG002|12-month Assessment|Withdrawal by Subject|0|||
160941052|NCT02391948|581174834|FG003|12-month Assessment|Withdrawal by Subject|1|||
160941053|NCT02391948|581174835|FG004|12-month Assessment|Withdrawal by Subject|0|||
160941054|NCT02391948|581174831|FG000|12-month Assessment|Lost to Follow-up|5|||
160941055|NCT02391948|581174832|FG001|12-month Assessment|Lost to Follow-up|4|||
160941056|NCT02391948|581174833|FG002|12-month Assessment|Lost to Follow-up|4|||
160941057|NCT02391948|581174834|FG003|12-month Assessment|Lost to Follow-up|4|||
160941058|NCT02391948|581174835|FG004|12-month Assessment|Lost to Follow-up|5|||
160941059|NCT02391948|581174831|FG000|12-month Assessment|Medical issue/illness|0|||
160941060|NCT02391948|581174832|FG001|12-month Assessment|Medical issue/illness|1|||
160941061|NCT02391948|581174833|FG002|12-month Assessment|Medical issue/illness|0|||
160941062|NCT02391948|581174834|FG003|12-month Assessment|Medical issue/illness|1|||
160455710|NCT02240238|579399766|FG005|Phase 1|Physician Decision|2|||
160455711|NCT02240238|579399767|FG006|Phase 1|Physician Decision|0|||
160455712|NCT02240238|579399768|FG007|Phase 1|Physician Decision|0|||
160455713|NCT02240238|579399769|FG008|Phase 1|Physician Decision|0|||
160455714|NCT02240238|579399770|FG009|Phase 1|Physician Decision|0|||
160455715|NCT02240238|579399771|FG010|Phase 1|Physician Decision|0|||
160455716|NCT02240238|579399772|FG011|Phase 1|Physician Decision|0|||
160455717|NCT02240238|579399761|FG000|Phase 2|Adverse Event|0|||
160455718|NCT02240238|579399762|FG001|Phase 2|Adverse Event|0|||
160455719|NCT02240238|579399763|FG002|Phase 2|Adverse Event|0|||
160455720|NCT02240238|579399764|FG003|Phase 2|Adverse Event|0|||
160455721|NCT02240238|579399765|FG004|Phase 2|Adverse Event|0|||
160455722|NCT02240238|579399766|FG005|Phase 2|Adverse Event|0|||
160455723|NCT02240238|579399767|FG006|Phase 2|Adverse Event|0|||
160455724|NCT02240238|579399768|FG007|Phase 2|Adverse Event|0|||
160455725|NCT02240238|579399769|FG008|Phase 2|Adverse Event|0|||
160455726|NCT02240238|579399770|FG009|Phase 2|Adverse Event|7|||
160455727|NCT02240238|579399771|FG010|Phase 2|Adverse Event|14|||
160455728|NCT02240238|579399772|FG011|Phase 2|Adverse Event|2|||
160455729|NCT02240238|579399761|FG000|Phase 2|Death|0|||
160455730|NCT02240238|579399762|FG001|Phase 2|Death|0|||
160578927|NCT00365716|579840186|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
160578928|NCT00365716|579840187|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
160941063|NCT02391948|581174835|FG004|12-month Assessment|Medical issue/illness|0|||
160941064|NCT02391948|581174831|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
160941065|NCT02391948|581174832|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
160941066|NCT02391948|581174833|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
160941067|NCT02391948|581174834|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
160941068|NCT02391948|581174835|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
160941069|NCT02391948|581174831|FG000|18-month Assessment|Death|0|||
160455731|NCT02240238|579399763|FG002|Phase 2|Death|0|||
160455732|NCT02240238|579399764|FG003|Phase 2|Death|0|||
160455733|NCT02240238|579399765|FG004|Phase 2|Death|0|||
160455734|NCT02240238|579399766|FG005|Phase 2|Death|0|||
160455735|NCT02240238|579399767|FG006|Phase 2|Death|0|||
160455736|NCT02240238|579399768|FG007|Phase 2|Death|0|||
160578929|NCT00365716|579840188|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
160578930|NCT00365716|579840189|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
160455737|NCT02240238|579399769|FG008|Phase 2|Death|0|||
160455738|NCT02240238|579399770|FG009|Phase 2|Death|3|||
160455739|NCT02240238|579399771|FG010|Phase 2|Death|2|||
160455740|NCT02240238|579399772|FG011|Phase 2|Death|1|||
160455741|NCT02240238|579399761|FG000|Phase 2|Disease progression|0|||
160455742|NCT02240238|579399762|FG001|Phase 2|Disease progression|0|||
160455743|NCT02240238|579399763|FG002|Phase 2|Disease progression|0|||
160455744|NCT02240238|579399764|FG003|Phase 2|Disease progression|0|||
160578931|NCT00365716|579840190|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
160941070|NCT02391948|581174832|FG001|18-month Assessment|Death|0|||
160941071|NCT02391948|581174833|FG002|18-month Assessment|Death|0|||
160941072|NCT02391948|581174834|FG003|18-month Assessment|Death|1|||
160941073|NCT02391948|581174835|FG004|18-month Assessment|Death|1|||
160455745|NCT02240238|579399765|FG004|Phase 2|Disease progression|0|||
160455746|NCT02240238|579399766|FG005|Phase 2|Disease progression|0|||
160455747|NCT02240238|579399767|FG006|Phase 2|Disease progression|0|||
160578932|NCT00365716|579840184|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
160578933|NCT00365716|579840185|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
160578934|NCT00365716|579840186|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
160578935|NCT00365716|579840187|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
160578936|NCT00365716|579840188|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
160578937|NCT00365716|579840189|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
160578938|NCT00365716|579840190|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
160578939|NCT00365716|579840184|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
160578940|NCT00365716|579840185|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
160578941|NCT00365716|579840186|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
160578942|NCT00365716|579840187|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
160578943|NCT00365716|579840188|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
160578944|NCT00365716|579840189|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
160941074|NCT02391948|581174831|FG000|18-month Assessment|Withdrawal by Subject|1|||
160941075|NCT02391948|581174832|FG001|18-month Assessment|Withdrawal by Subject|0|||
160941076|NCT02391948|581174833|FG002|18-month Assessment|Withdrawal by Subject|0|||
160941077|NCT02391948|581174834|FG003|18-month Assessment|Withdrawal by Subject|1|||
160941078|NCT02391948|581174835|FG004|18-month Assessment|Withdrawal by Subject|0|||
160941079|NCT02391948|581174831|FG000|18-month Assessment|Lost to Follow-up|2|||
160941080|NCT02391948|581174832|FG001|18-month Assessment|Lost to Follow-up|6|||
160941081|NCT02391948|581174833|FG002|18-month Assessment|Lost to Follow-up|2|||
160941082|NCT02391948|581174834|FG003|18-month Assessment|Lost to Follow-up|2|||
160941083|NCT02391948|581174835|FG004|18-month Assessment|Lost to Follow-up|3|||
160941084|NCT02391948|581174831|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
160941085|NCT02391948|581174832|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
160941086|NCT02391948|581174833|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
160941087|NCT02391948|581174834|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
160941088|NCT02391948|581174835|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
160941089|NCT02391948|581174831|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
160941090|NCT02391948|581174832|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
160941091|NCT02391948|581174833|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
160941092|NCT02391948|581174834|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
160941093|NCT02391948|581174835|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
160941094|NCT02391948|581174831|FG000|24-month Assessment|Death|0|||
160941095|NCT02391948|581174832|FG001|24-month Assessment|Death|0|||
160941096|NCT02391948|581174833|FG002|24-month Assessment|Death|0|||
160941097|NCT02391948|581174834|FG003|24-month Assessment|Death|0|||
160941098|NCT02391948|581174835|FG004|24-month Assessment|Death|1|||
160941099|NCT02391948|581174831|FG000|24-month Assessment|Withdrawal by Subject|1|||
160941100|NCT02391948|581174832|FG001|24-month Assessment|Withdrawal by Subject|1|||
160941101|NCT02391948|581174833|FG002|24-month Assessment|Withdrawal by Subject|0|||
160941102|NCT02391948|581174834|FG003|24-month Assessment|Withdrawal by Subject|0|||
160941103|NCT02391948|581174835|FG004|24-month Assessment|Withdrawal by Subject|1|||
160941104|NCT02391948|581174831|FG000|24-month Assessment|Lost to Follow-up|5|||
160941105|NCT02391948|581174832|FG001|24-month Assessment|Lost to Follow-up|4|||
160941106|NCT02391948|581174833|FG002|24-month Assessment|Lost to Follow-up|0|||
160941107|NCT02391948|581174834|FG003|24-month Assessment|Lost to Follow-up|0|||
160941108|NCT02391948|581174835|FG004|24-month Assessment|Lost to Follow-up|0|||
160578945|NCT00365716|579840190|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
160578946|NCT00365716|579840184|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
160578947|NCT00365716|579840185|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
160578948|NCT00365716|579840186|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
160578949|NCT00365716|579840187|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
160578950|NCT00365716|579840188|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
160578951|NCT00365716|579840189|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
160578952|NCT00365716|579840190|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
160578953|NCT00365716|579840184|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
160578954|NCT00365716|579840185|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
160941109|NCT02391948|581174831|FG000|24-month Assessment|Medical issue/illness|0|||
160941110|NCT02391948|581174832|FG001|24-month Assessment|Medical issue/illness|0|||
160941111|NCT02391948|581174833|FG002|24-month Assessment|Medical issue/illness|1|||
160941112|NCT02391948|581174834|FG003|24-month Assessment|Medical issue/illness|0|||
160941113|NCT02391948|581174835|FG004|24-month Assessment|Medical issue/illness|0|||
160941114|NCT02391948|581174831|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
160941115|NCT02391948|581174832|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
160941116|NCT02391948|581174833|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
160941117|NCT02391948|581174834|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
160941118|NCT02391948|581174835|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
160941119|NCT02348489|581174836|FG000|Overall Study|Death|336|||
160941120|NCT02348489|581174837|FG001|Overall Study|Death|335|||
160941121|NCT02348489|581174836|FG000|Overall Study|Withdrawal by Subject|14|||
160998809|NCT02026258|581380632|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
160998810|NCT02026258|581380633|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
160998811|NCT02534350|581380634|FG000|Overall Study|Randomized But Not Treated|1|||
160998812|NCT02534350|581380635|FG001|Overall Study|Randomized But Not Treated|0|||
160998813|NCT02534350|581380634|FG000|Overall Study|Protocol Violation|1|||
160998814|NCT02534350|581380635|FG001|Overall Study|Protocol Violation|0|||
160998815|NCT02534350|581380634|FG000|Overall Study|Withdrew Consent|2|||
160998816|NCT02534350|581380635|FG001|Overall Study|Withdrew Consent|0|||
160998817|NCT00972504|581380636|FG000|Overall Study|Adverse Event|2|||
160998818|NCT00972504|581380636|FG000|Overall Study|Investigator discretion|1|||
160998819|NCT00716144|581380637|FG000|Overall Study|Withdrawal by Subject|4|||
160998820|NCT00716144|581380638|FG001|Overall Study|Withdrawal by Subject|2|||
160998821|NCT00716144|581380639|FG002|Overall Study|Withdrawal by Subject|6|||
160998822|NCT00716144|581380640|FG003|Overall Study|Withdrawal by Subject|6|||
160998823|NCT00716144|581380637|FG000|Overall Study|Lost to Follow-up|2|||
160998824|NCT00716144|581380638|FG001|Overall Study|Lost to Follow-up|2|||
160998825|NCT00716144|581380639|FG002|Overall Study|Lost to Follow-up|1|||
160998826|NCT00716144|581380640|FG003|Overall Study|Lost to Follow-up|2|||
160998827|NCT00716144|581380637|FG000|Overall Study|Adverse Event|0|||
160998828|NCT00716144|581380638|FG001|Overall Study|Adverse Event|0|||
160998829|NCT00716144|581380639|FG002|Overall Study|Adverse Event|0|||
160998830|NCT00716144|581380640|FG003|Overall Study|Adverse Event|2|||
160998831|NCT00716144|581380637|FG000|Overall Study|Non-compliance|1|||
160998832|NCT00716144|581380638|FG001|Overall Study|Non-compliance|0|||
160998833|NCT00716144|581380639|FG002|Overall Study|Non-compliance|0|||
160998834|NCT00716144|581380640|FG003|Overall Study|Non-compliance|0|||
160998835|NCT00716144|581380637|FG000|Overall Study|Protocol Violation|2|||
160998836|NCT00716144|581380638|FG001|Overall Study|Protocol Violation|0|||
160998837|NCT00716144|581380639|FG002|Overall Study|Protocol Violation|1|||
160998838|NCT00716144|581380640|FG003|Overall Study|Protocol Violation|0|||
160998839|NCT00716144|581380637|FG000|Overall Study|Physician Decision|0|||
160998840|NCT00716144|581380638|FG001|Overall Study|Physician Decision|1|||
160998841|NCT00716144|581380639|FG002|Overall Study|Physician Decision|2|||
160998842|NCT00716144|581380640|FG003|Overall Study|Physician Decision|2|||
160998843|NCT00716144|581380637|FG000|Overall Study|Intercurrent illness|0|||
160998844|NCT00716144|581380638|FG001|Overall Study|Intercurrent illness|0|||
160998845|NCT00716144|581380639|FG002|Overall Study|Intercurrent illness|1|||
160998846|NCT00716144|581380640|FG003|Overall Study|Intercurrent illness|0|||
160455748|NCT02240238|579399768|FG007|Phase 2|Disease progression|0|||
160455749|NCT02240238|579399769|FG008|Phase 2|Disease progression|0|||
160455750|NCT02240238|579399770|FG009|Phase 2|Disease progression|5|||
160455751|NCT02240238|579399771|FG010|Phase 2|Disease progression|11|||
160455752|NCT02240238|579399772|FG011|Phase 2|Disease progression|1|||
160455753|NCT02240238|579399761|FG000|Phase 2|Withdrawal by Subject|0|||
160455754|NCT02240238|579399762|FG001|Phase 2|Withdrawal by Subject|0|||
160455755|NCT02240238|579399763|FG002|Phase 2|Withdrawal by Subject|0|||
160455756|NCT02240238|579399764|FG003|Phase 2|Withdrawal by Subject|0|||
160941122|NCT02348489|581174837|FG001|Overall Study|Withdrawal by Subject|27|||
160941123|NCT02348489|581174836|FG000|Overall Study|Lost to Follow-up|3|||
160941124|NCT02348489|581174837|FG001|Overall Study|Lost to Follow-up|5|||
160941125|NCT00201006|581174838|FG000|Overall Study|Withdrawal by Subject|7|||
160941126|NCT00201006|581174839|FG001|Overall Study|Withdrawal by Subject|2|||
160941127|NCT00201006|581174840|FG002|Overall Study|Withdrawal by Subject|3|||
160941128|NCT00201006|581174838|FG000|Overall Study|Adverse Event|1|||
160941129|NCT00201006|581174839|FG001|Overall Study|Adverse Event|0|||
160941130|NCT00201006|581174840|FG002|Overall Study|Adverse Event|1|||
160941131|NCT02167035|581174843|FG000|Overall Study|Adverse Event|2|||
160941132|NCT02167035|581174844|FG001|Overall Study|Adverse Event|2|||
160941133|NCT02167035|581174843|FG000|Overall Study|Lost to Follow-up|3|||
160941134|NCT02167035|581174844|FG001|Overall Study|Lost to Follow-up|3|||
160941135|NCT02167035|581174843|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
160941136|NCT02167035|581174844|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
160998847|NCT00716144|581380637|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
160998848|NCT00716144|581380638|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
160998849|NCT00716144|581380639|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
160998850|NCT00716144|581380640|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
160455757|NCT02240238|579399765|FG004|Phase 2|Withdrawal by Subject|0|||
160455758|NCT02240238|579399766|FG005|Phase 2|Withdrawal by Subject|0|||
160941137|NCT02252081|581174845|FG000|Overall Study|Withdrawal by Subject|2|||
160941138|NCT02252081|581174846|FG001|Overall Study|Withdrawal by Subject|1|||
160998851|NCT00716144|581380637|FG000|Overall Study|Adverse event: left foot pain|0|||
160998852|NCT00716144|581380638|FG001|Overall Study|Adverse event: left foot pain|1|||
160998853|NCT00716144|581380639|FG002|Overall Study|Adverse event: left foot pain|0|||
160455759|NCT02240238|579399767|FG006|Phase 2|Withdrawal by Subject|0|||
160941139|NCT02252081|581174845|FG000|Overall Study|Adverse Event|4|||
160941140|NCT02252081|581174846|FG001|Overall Study|Adverse Event|1|||
160941141|NCT02252081|581174845|FG000|Overall Study|non compliance & others|0|||
160941142|NCT02252081|581174846|FG001|Overall Study|non compliance & others|2|||
160941143|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
160941144|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
160941145|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
160941146|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
160941147|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
160941148|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
160941149|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
160941150|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
160941151|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
160941152|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
160941153|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
160941154|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
160941155|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
160941156|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
160941157|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
160941158|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
160941159|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
160941160|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
160941161|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
160941162|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
160941163|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
160941164|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
160941165|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
160941166|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
160941167|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
160941168|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
160941169|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
160941170|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
160941171|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
160941172|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
160941173|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
160941174|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
160941175|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
160941176|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
160941177|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
160941178|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
160941179|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
160941180|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
160941181|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
160941182|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
160941183|NCT03732638|581174853|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
160656027|NCT02130466|580120351|FG008|Overall Study|Lost to Follow-up|0|||
160656028|NCT02130466|580120352|FG009|Overall Study|Lost to Follow-up|0|||
160656029|NCT02130466|580120353|FG010|Overall Study|Lost to Follow-up|0|||
160656030|NCT02130466|580120354|FG011|Overall Study|Lost to Follow-up|0|||
160656031|NCT02130466|580120355|FG012|Overall Study|Lost to Follow-up|1|||
160656032|NCT02130466|580120356|FG013|Overall Study|Lost to Follow-up|0|||
160656033|NCT02130466|580120343|FG000|Overall Study|Physician Decision|0|||
160656034|NCT02130466|580120344|FG001|Overall Study|Physician Decision|0|||
160656035|NCT02130466|580120345|FG002|Overall Study|Physician Decision|0|||
160656036|NCT02130466|580120346|FG003|Overall Study|Physician Decision|0|||
160998854|NCT00716144|581380640|FG003|Overall Study|Adverse event: left foot pain|0|||
160998855|NCT00716144|581380637|FG000|Overall Study|Clinical Depression|0|||
160656037|NCT02130466|580120347|FG004|Overall Study|Physician Decision|0|||
160656038|NCT02130466|580120348|FG005|Overall Study|Physician Decision|1|||
160656039|NCT02130466|580120349|FG006|Overall Study|Physician Decision|1|||
160656040|NCT02130466|580120350|FG007|Overall Study|Physician Decision|0|||
160656041|NCT02130466|580120351|FG008|Overall Study|Physician Decision|0|||
160656042|NCT02130466|580120352|FG009|Overall Study|Physician Decision|0|||
160656043|NCT02130466|580120353|FG010|Overall Study|Physician Decision|0|||
160941184|NCT03732638|581174854|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
160941185|NCT03732638|581174853|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
160941186|NCT03732638|581174854|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
160941187|NCT03732638|581174853|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
160941188|NCT03732638|581174854|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
160941189|NCT03732638|581174853|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
160941190|NCT03732638|581174854|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
160656044|NCT02130466|580120354|FG011|Overall Study|Physician Decision|0|||
160656045|NCT02130466|580120355|FG012|Overall Study|Physician Decision|0|||
160941191|NCT02370888|581174855|FG000|Overall Study|disease progression|2|||
160941192|NCT02370888|581174855|FG000|Overall Study|did not meet chimerism criteria|6|||
160941193|NCT00642304|581174858|FG000|Overall Study|Adverse Event|1|||
160941194|NCT00642304|581174858|FG000|Overall Study|Death|1|||
160941195|NCT00642304|581174858|FG000|Overall Study|Blood transfusion|2|||
160941196|NCT00642304|581174858|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
160941197|NCT00642304|581174858|FG000|Overall Study|Transplantation|1|||
160941198|NCT00482391|581174859|FG000|Overall Study|Withdrawal by Subject|1|||
160941199|NCT00482391|581174859|FG000|Overall Study|Adverse Event|1|||
160941200|NCT00482391|581174859|FG000|Overall Study|Death|1|||
160941201|NCT01859715|581174864|FG000|Overall Study|No 2nd VAS|16|||
160941202|NCT01859715|581174865|FG001|Overall Study|No 2nd VAS|8|||
160941203|NCT01859715|581174866|FG002|Overall Study|No 2nd VAS|23|||
160941204|NCT00086580|581174870|FG000|Treatment Period|Disease progression|9|||
160941205|NCT00086580|581174871|FG001|Treatment Period|Disease progression|8|||
160941206|NCT00086580|581174870|FG000|Treatment Period|Unable to comply with protocol|3|||
160941207|NCT00086580|581174871|FG001|Treatment Period|Unable to comply with protocol|1|||
160941208|NCT00086580|581174870|FG000|Treatment Period|Withdrawal by Subject|7|||
160941209|NCT00086580|581174871|FG001|Treatment Period|Withdrawal by Subject|8|||
160941210|NCT00086580|581174870|FG000|Treatment Period|Physician Decision|13|||
160941211|NCT00086580|581174871|FG001|Treatment Period|Physician Decision|7|||
160941212|NCT00086580|581174870|FG000|Treatment Period|AE - not treatment related|7|||
160941213|NCT00086580|581174871|FG001|Treatment Period|AE - not treatment related|7|||
160941214|NCT00086580|581174870|FG000|Treatment Period|Toxicity - treatment related|15|||
160941215|NCT00086580|581174871|FG001|Treatment Period|Toxicity - treatment related|15|||
160941216|NCT00086580|581174870|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
160941217|NCT00086580|581174871|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
160941218|NCT00086580|581174870|FG000|Treatment Period|Death|5|||
160941219|NCT00086580|581174871|FG001|Treatment Period|Death|7|||
160941220|NCT00086580|581174870|FG000|Treatment Period|Other|5|||
160941221|NCT00086580|581174871|FG001|Treatment Period|Other|3|||
160941222|NCT00086580|581174870|FG000|Follow-up Period|Disease progression|72|||
160941223|NCT00086580|581174871|FG001|Follow-up Period|Disease progression|99|||
160941224|NCT00086580|581174870|FG000|Follow-up Period|Unable to comply with protocol|5|||
160941225|NCT00086580|581174871|FG001|Follow-up Period|Unable to comply with protocol|0|||
160941226|NCT00086580|581174870|FG000|Follow-up Period|Withdrawal by Subject|6|||
160941227|NCT00086580|581174871|FG001|Follow-up Period|Withdrawal by Subject|6|||
160941228|NCT00086580|581174870|FG000|Follow-up Period|Physician Decision|0|||
160941229|NCT00086580|581174871|FG001|Follow-up Period|Physician Decision|1|||
160941230|NCT00086580|581174870|FG000|Follow-up Period|AE - not related|1|||
160941231|NCT00086580|581174871|FG001|Follow-up Period|AE - not related|0|||
160941232|NCT00086580|581174870|FG000|Follow-up Period|Death|13|||
160941233|NCT00086580|581174871|FG001|Follow-up Period|Death|7|||
160941234|NCT00086580|581174870|FG000|Follow-up Period|Other|7|||
160941235|NCT00086580|581174871|FG001|Follow-up Period|Other|6|||
160941236|NCT00086580|581174870|FG000|Observation Period|Unable to comply with protocol|1|||
160941237|NCT00086580|581174871|FG001|Observation Period|Unable to comply with protocol|1|||
160941238|NCT00086580|581174870|FG000|Observation Period|Withdrawal by Subject|4|||
160941239|NCT00086580|581174871|FG001|Observation Period|Withdrawal by Subject|2|||
160941240|NCT00086580|581174870|FG000|Observation Period|Death|33|||
160941241|NCT00086580|581174871|FG001|Observation Period|Death|55|||
160941242|NCT00086580|581174870|FG000|Observation Period|Other|8|||
160941243|NCT00086580|581174871|FG001|Observation Period|Other|7|||
160941244|NCT03235024|581174873|FG000|Overall Study|Adverse Event|2|||
160941245|NCT03235024|581174874|FG001|Overall Study|Adverse Event|2|||
160941246|NCT03235024|581174873|FG000|Overall Study|Death|1|||
160941247|NCT03235024|581174874|FG001|Overall Study|Death|0|||
160998856|NCT00716144|581380638|FG001|Overall Study|Clinical Depression|1|||
160998857|NCT00716144|581380639|FG002|Overall Study|Clinical Depression|0|||
160998858|NCT00716144|581380640|FG003|Overall Study|Clinical Depression|0|||
160941248|NCT03235024|581174873|FG000|Overall Study|Lost to Follow-up|2|||
160941249|NCT03235024|581174874|FG001|Overall Study|Lost to Follow-up|5|||
160941250|NCT03235024|581174873|FG000|Overall Study|Protocol Violation|1|||
160941251|NCT03235024|581174874|FG001|Overall Study|Protocol Violation|0|||
160941252|NCT03235024|581174873|FG000|Overall Study|Withdrawal by Subject|0|||
160941253|NCT03235024|581174874|FG001|Overall Study|Withdrawal by Subject|3|||
160941254|NCT02357576|581174875|FG000|Treatment Period|Withdrawal by Subject|0|||
160941255|NCT02357576|581174876|FG001|Treatment Period|Withdrawal by Subject|1|||
160941256|NCT02357576|581174875|FG000|Treatment Period|Physician Decision|0|||
160941257|NCT02357576|581174876|FG001|Treatment Period|Physician Decision|1|||
160941258|NCT02357576|581174875|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
160941259|NCT02357576|581174876|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
160941260|NCT02357576|581174875|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
160941261|NCT02357576|581174876|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
160455760|NCT02240238|579399768|FG007|Phase 2|Withdrawal by Subject|0|||
160941262|NCT02357576|581174875|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
160941263|NCT02357576|581174876|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
160941264|NCT02357576|581174875|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
160941265|NCT02357576|581174876|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
160941266|NCT00261716|581174877|FG000|Overall Study|Withdrawal by Subject|6|||
160941267|NCT00261716|581174878|FG001|Overall Study|Withdrawal by Subject|8|||
160941268|NCT00261716|581174877|FG000|Overall Study|Lost to Follow-up|0|||
160941269|NCT00261716|581174878|FG001|Overall Study|Lost to Follow-up|2|||
160941270|NCT02047110|581174881|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
160941271|NCT02047110|581174882|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
160941272|NCT02047110|581174883|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
160941273|NCT02047110|581174884|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
160941274|NCT02047110|581174881|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
160941275|NCT02047110|581174882|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
160941276|NCT02047110|581174883|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
160941277|NCT02047110|581174884|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
160941278|NCT02047110|581174881|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
160941279|NCT02047110|581174882|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
160941280|NCT02047110|581174883|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
160941281|NCT02047110|581174884|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
160998859|NCT00880048|581380641|FG000|Overall Study|Adverse Event|2|||
160998860|NCT00880048|581380642|FG001|Overall Study|Adverse Event|3|||
160998861|NCT00880048|581380643|FG002|Overall Study|Adverse Event|5|||
160998862|NCT00880048|581380641|FG000|Overall Study|Lack of Efficacy|1|||
160998863|NCT00880048|581380642|FG001|Overall Study|Lack of Efficacy|2|||
160998864|NCT00880048|581380643|FG002|Overall Study|Lack of Efficacy|2|||
160998865|NCT00880048|581380641|FG000|Overall Study|Protocol Violation|4|||
160998866|NCT00880048|581380642|FG001|Overall Study|Protocol Violation|6|||
160998867|NCT00880048|581380643|FG002|Overall Study|Protocol Violation|5|||
160998868|NCT00880048|581380641|FG000|Overall Study|Lost to Follow-up|6|||
160998869|NCT00880048|581380642|FG001|Overall Study|Lost to Follow-up|6|||
160998870|NCT00880048|581380643|FG002|Overall Study|Lost to Follow-up|5|||
160998871|NCT00880048|581380641|FG000|Overall Study|Physician Decision|1|||
160998872|NCT00880048|581380642|FG001|Overall Study|Physician Decision|1|||
160998873|NCT00880048|581380643|FG002|Overall Study|Physician Decision|7|||
160998874|NCT00880048|581380641|FG000|Overall Study|Withdrawal by Subject|5|||
160998875|NCT00880048|581380642|FG001|Overall Study|Withdrawal by Subject|8|||
160998876|NCT00880048|581380643|FG002|Overall Study|Withdrawal by Subject|5|||
160998877|NCT00880048|581380641|FG000|Overall Study|Study closed/terminated|9|||
160998878|NCT00880048|581380642|FG001|Overall Study|Study closed/terminated|7|||
160998879|NCT00880048|581380643|FG002|Overall Study|Study closed/terminated|6|||
160998880|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
160998881|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
160998882|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
160998883|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
160998884|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
160998885|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
160998886|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
160998887|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
160998888|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
160998889|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
160998890|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
160998891|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
160998892|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
160998893|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
160998894|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
160998895|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
160998896|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
160998897|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
160656046|NCT02130466|580120356|FG013|Overall Study|Physician Decision|0|||
160941282|NCT02047110|581174881|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
160941283|NCT02047110|581174882|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
160998898|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
160998899|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
160998900|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
160998901|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
160998902|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
160998903|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
160998904|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
160455761|NCT02240238|579399769|FG008|Phase 2|Withdrawal by Subject|0|||
160998905|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
160998906|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
160998907|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
160998908|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
160941284|NCT02047110|581174883|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
160941285|NCT02047110|581174884|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
160941286|NCT02047110|581174881|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
160941287|NCT02047110|581174882|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
160941288|NCT02047110|581174883|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
160941289|NCT02047110|581174884|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
160941290|NCT02047110|581174881|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
160941291|NCT02047110|581174882|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
160941292|NCT02047110|581174883|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
160941293|NCT02047110|581174884|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
160941294|NCT02047110|581174881|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
160941295|NCT02047110|581174882|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
160941296|NCT02047110|581174883|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
160941297|NCT02047110|581174884|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
160941298|NCT02047110|581174881|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
160941299|NCT02047110|581174882|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
160941300|NCT02047110|581174883|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
160941301|NCT02047110|581174884|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
160941302|NCT02047110|581174881|FG000|Escape Treatment Period|Adverse Event|1|||
160941303|NCT02047110|581174882|FG001|Escape Treatment Period|Adverse Event|2|||
160941304|NCT02047110|581174883|FG002|Escape Treatment Period|Adverse Event|2|||
160941305|NCT02047110|581174884|FG003|Escape Treatment Period|Adverse Event|0|||
160941306|NCT02047110|581174881|FG000|Escape Treatment Period|Other than specified|1|||
160941307|NCT02047110|581174882|FG001|Escape Treatment Period|Other than specified|2|||
160941308|NCT02047110|581174883|FG002|Escape Treatment Period|Other than specified|0|||
160941309|NCT02047110|581174884|FG003|Escape Treatment Period|Other than specified|1|||
160941310|NCT02047110|581174881|FG000|OLE Treatment Period|Other than specified|0|||
160941311|NCT02047110|581174882|FG001|OLE Treatment Period|Other than specified|0|||
160941312|NCT02047110|581174883|FG002|OLE Treatment Period|Other than specified|1|||
160941313|NCT02047110|581174884|FG003|OLE Treatment Period|Other than specified|0|||
160941314|NCT00699699|581174885|FG000|Overall Study|Adverse Event|36|||
160941315|NCT00699699|581174885|FG000|Overall Study|Individual different reasons|21|||
160941316|NCT00705575|581174886|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160941317|NCT00705575|581174887|FG001|Overall Study|Abnormal laboratory value(s)|3|||
160941318|NCT00705575|581174886|FG000|Overall Study|Abnormal test procedure result(s)|2|||
160941319|NCT00705575|581174887|FG001|Overall Study|Abnormal test procedure result(s)|12|||
160941320|NCT00705575|581174886|FG000|Overall Study|Adverse Event|11|||
160941321|NCT00705575|581174887|FG001|Overall Study|Adverse Event|15|||
160941322|NCT00705575|581174886|FG000|Overall Study|Lost to Follow-up|3|||
160941323|NCT00705575|581174887|FG001|Overall Study|Lost to Follow-up|4|||
160941324|NCT00705575|581174886|FG000|Overall Study|Protocol Violation|2|||
160941325|NCT00705575|581174887|FG001|Overall Study|Protocol Violation|2|||
160941326|NCT00705575|581174886|FG000|Overall Study|Withdrawal by Subject|5|||
160941327|NCT00705575|581174887|FG001|Overall Study|Withdrawal by Subject|10|||
160941328|NCT01000051|581174891|FG000|Overall Study|Withdrawal by Subject|1|||
160941329|NCT01000051|581174892|FG001|Overall Study|Withdrawal by Subject|1|||
160941330|NCT01000051|581174891|FG000|Overall Study|Disease Progression|1|||
160941331|NCT01000051|581174892|FG001|Overall Study|Disease Progression|0|||
160941332|NCT01000051|581174891|FG000|Overall Study|Serious noncompliance|1|||
160941333|NCT01000051|581174892|FG001|Overall Study|Serious noncompliance|0|||
160941334|NCT02802345|581174894|FG000|Overall Study|Not Treated|0|||
160941335|NCT02802345|581174895|FG001|Overall Study|Not Treated|1|||
160941336|NCT02802345|581174894|FG000|Overall Study|Adverse Event|28|||
160941337|NCT02802345|581174895|FG001|Overall Study|Adverse Event|20|||
160941338|NCT02802345|581174894|FG000|Overall Study|Withdrawal by Subject|3|||
160941339|NCT02802345|581174895|FG001|Overall Study|Withdrawal by Subject|3|||
160941340|NCT02802345|581174894|FG000|Overall Study|Protocol Violation|0|||
160941341|NCT02802345|581174895|FG001|Overall Study|Protocol Violation|1|||
160941342|NCT02802345|581174894|FG000|Overall Study|Other than listed|1|||
160941343|NCT02802345|581174895|FG001|Overall Study|Other than listed|5|||
160941344|NCT03969212|581174896|FG000|Overall Study|Adverse Event|1|||
160941345|NCT03969212|581174897|FG001|Overall Study|Adverse Event|0|||
160941346|NCT03969212|581174898|FG002|Overall Study|Adverse Event|0|||
160941347|NCT03969212|581174899|FG003|Overall Study|Adverse Event|0|||
160941348|NCT03969212|581174896|FG000|Overall Study|Lost to Follow-up|2|||
160941349|NCT03969212|581174897|FG001|Overall Study|Lost to Follow-up|2|||
160941350|NCT03969212|581174898|FG002|Overall Study|Lost to Follow-up|2|||
160941351|NCT03969212|581174899|FG003|Overall Study|Lost to Follow-up|2|||
160941352|NCT03969212|581174896|FG000|Overall Study|Protocol Violation|0|||
160941353|NCT03969212|581174897|FG001|Overall Study|Protocol Violation|0|||
160941354|NCT03969212|581174898|FG002|Overall Study|Protocol Violation|0|||
160941355|NCT03969212|581174899|FG003|Overall Study|Protocol Violation|1|||
160941356|NCT03969212|581174896|FG000|Overall Study|Withdrawal by Subject|7|||
160941357|NCT03969212|581174897|FG001|Overall Study|Withdrawal by Subject|13|||
160941358|NCT03969212|581174898|FG002|Overall Study|Withdrawal by Subject|5|||
160578955|NCT00365716|579840186|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
160578956|NCT00365716|579840187|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
160578957|NCT00365716|579840188|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
160578958|NCT00365716|579840189|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
160578959|NCT00365716|579840190|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
160578960|NCT00365716|579840184|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
160578961|NCT00365716|579840185|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
160578962|NCT00365716|579840186|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
160578963|NCT00365716|579840187|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
160578964|NCT00365716|579840188|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
160578965|NCT00365716|579840189|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
160578966|NCT00365716|579840190|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
160578967|NCT00365716|579840184|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
160578968|NCT00365716|579840185|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
160578969|NCT00365716|579840186|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
160578970|NCT00365716|579840187|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
160578971|NCT00365716|579840188|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
160578972|NCT00365716|579840189|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
160578973|NCT00365716|579840190|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
160578974|NCT00365716|579840184|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
160578975|NCT00365716|579840185|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
160578976|NCT00365716|579840186|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
160578977|NCT00365716|579840187|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
160578978|NCT00365716|579840188|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
160578979|NCT00365716|579840189|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
160578980|NCT00365716|579840190|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
160941359|NCT03969212|581174899|FG003|Overall Study|Withdrawal by Subject|11|||
160941360|NCT03969212|581174896|FG000|Overall Study|Physician Decision|0|||
160941361|NCT03969212|581174897|FG001|Overall Study|Physician Decision|0|||
160941362|NCT03969212|581174898|FG002|Overall Study|Physician Decision|1|||
160941363|NCT03969212|581174899|FG003|Overall Study|Physician Decision|0|||
160578981|NCT00365716|579840184|FG000|Extension 1|Lost to Follow-up|0|||
160578982|NCT00365716|579840185|FG001|Extension 1|Lost to Follow-up|0|||
160578983|NCT00365716|579840186|FG002|Extension 1|Lost to Follow-up|0|||
160578984|NCT00365716|579840187|FG003|Extension 1|Lost to Follow-up|0|||
160578985|NCT00365716|579840188|FG004|Extension 1|Lost to Follow-up|0|||
160578986|NCT00365716|579840189|FG005|Extension 1|Lost to Follow-up|1|||
160578987|NCT00365716|579840190|FG006|Extension 1|Lost to Follow-up|0|||
160578988|NCT00365716|579840184|FG000|Extension 1|Other|0|||
160578989|NCT00365716|579840185|FG001|Extension 1|Other|0|||
160578990|NCT00365716|579840186|FG002|Extension 1|Other|0|||
160578991|NCT00365716|579840187|FG003|Extension 1|Other|0|||
160578992|NCT00365716|579840188|FG004|Extension 1|Other|0|||
160578993|NCT00365716|579840189|FG005|Extension 1|Other|9|||
160578994|NCT00365716|579840190|FG006|Extension 1|Other|0|||
160578995|NCT00365716|579840184|FG000|Extension 1|Moved|0|||
160578996|NCT00365716|579840185|FG001|Extension 1|Moved|0|||
160578997|NCT00365716|579840186|FG002|Extension 1|Moved|0|||
160941364|NCT03969212|581174896|FG000|Overall Study|Reason not Specified|22|||
160578998|NCT00365716|579840187|FG003|Extension 1|Moved|0|||
160578999|NCT00365716|579840188|FG004|Extension 1|Moved|0|||
160656047|NCT02130466|580120343|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
160656048|NCT02130466|580120344|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
160656049|NCT02130466|580120345|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
160656050|NCT02130466|580120346|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
160941365|NCT03969212|581174897|FG001|Overall Study|Reason not Specified|23|||
160941366|NCT03969212|581174898|FG002|Overall Study|Reason not Specified|28|||
160941367|NCT03969212|581174899|FG003|Overall Study|Reason not Specified|26|||
160941368|NCT02075320|581174901|FG000|Overall Study|Withdrawal by Subject|2|||
160941369|NCT03773757|581174902|FG000|Overall Study|Withdrawal by Subject|2|||
160941370|NCT03773757|581174903|FG001|Overall Study|Withdrawal by Subject|4|||
160941371|NCT00057746|581174904|FG000|Overall Study|Withdrawal by Subject|0|||
160941372|NCT00057746|581174905|FG001|Overall Study|Withdrawal by Subject|0|||
160941373|NCT00057746|581174906|FG002|Overall Study|Withdrawal by Subject|1|||
160941374|NCT02985736|581174909|FG000|Overall Study|Lost to Follow-up|3|||
160941375|NCT00550836|581174910|FG000|Overall Study|Withdrawal by Subject|3|||
160579000|NCT00365716|579840189|FG005|Extension 1|Moved|4|||
160579001|NCT00365716|579840190|FG006|Extension 1|Moved|0|||
160579002|NCT00365716|579840184|FG000|Extension 1|Withdrawal by Subject|0|||
160579003|NCT00365716|579840185|FG001|Extension 1|Withdrawal by Subject|0|||
160579004|NCT00365716|579840186|FG002|Extension 1|Withdrawal by Subject|0|||
160579005|NCT00365716|579840187|FG003|Extension 1|Withdrawal by Subject|0|||
160579006|NCT00365716|579840188|FG004|Extension 1|Withdrawal by Subject|0|||
160579007|NCT00365716|579840189|FG005|Extension 1|Withdrawal by Subject|3|||
160579008|NCT00365716|579840190|FG006|Extension 1|Withdrawal by Subject|0|||
160941376|NCT00550836|581174911|FG001|Overall Study|Withdrawal by Subject|9|||
160941377|NCT01552772|581174912|FG000|Overall Study|Lost to Follow-up|2|||
160941378|NCT01552772|581174912|FG000|Overall Study|Adverse Event|1|||
160941379|NCT01552772|581174912|FG000|Overall Study|Protocol Deviation|1|||
160941380|NCT01848990|581174913|FG000|Overall Study|Adverse Event|6|||
160941381|NCT01848990|581174914|FG001|Overall Study|Adverse Event|2|||
160941382|NCT01848990|581174915|FG002|Overall Study|Adverse Event|0|||
160941383|NCT01848990|581174913|FG000|Overall Study|Lost to Follow-up|6|||
160941384|NCT01848990|581174914|FG001|Overall Study|Lost to Follow-up|2|||
160941385|NCT01848990|581174915|FG002|Overall Study|Lost to Follow-up|2|||
160941386|NCT01848990|581174913|FG000|Overall Study|Protocol Violation|1|||
160941387|NCT01848990|581174914|FG001|Overall Study|Protocol Violation|1|||
160941388|NCT01848990|581174915|FG002|Overall Study|Protocol Violation|0|||
160941389|NCT01848990|581174913|FG000|Overall Study|Withdrawal by Subject|29|||
160941390|NCT01848990|581174914|FG001|Overall Study|Withdrawal by Subject|10|||
160941391|NCT01848990|581174915|FG002|Overall Study|Withdrawal by Subject|11|||
160941392|NCT01848990|581174913|FG000|Overall Study|Physician Decision|1|||
160941393|NCT01848990|581174914|FG001|Overall Study|Physician Decision|1|||
160941394|NCT01848990|581174915|FG002|Overall Study|Physician Decision|0|||
160941395|NCT01848990|581174913|FG000|Overall Study|Non Compliance|1|||
160941396|NCT01848990|581174914|FG001|Overall Study|Non Compliance|0|||
160941397|NCT01848990|581174915|FG002|Overall Study|Non Compliance|0|||
160941398|NCT01848990|581174913|FG000|Overall Study|Death|1|||
160941399|NCT01848990|581174914|FG001|Overall Study|Death|0|||
160941400|NCT01848990|581174915|FG002|Overall Study|Death|1|||
160941401|NCT01848990|581174913|FG000|Overall Study|Other|1|||
160941402|NCT01848990|581174914|FG001|Overall Study|Other|4|||
160941403|NCT01848990|581174915|FG002|Overall Study|Other|2|||
160941404|NCT00512096|581174924|FG000|Overall Study|Adverse Event|2|||
160941405|NCT00512096|581174924|FG000|Overall Study|Withdrawal by Subject|2|||
160941406|NCT00512096|581174924|FG000|Overall Study|Lack of Efficacy|3|||
160941407|NCT00298038|581174928|FG000|Overall Study|Lost to Follow-up|0|||
160941408|NCT00298038|581174929|FG001|Overall Study|Lost to Follow-up|1|||
160941409|NCT00298038|581174928|FG000|Overall Study|Liver Transplant|0|||
160941410|NCT00298038|581174929|FG001|Overall Study|Liver Transplant|1|||
160941411|NCT00298038|581174928|FG000|Overall Study|Protocol Violation|1|||
160941412|NCT00298038|581174929|FG001|Overall Study|Protocol Violation|3|||
160941413|NCT00298038|581174928|FG000|Overall Study|Death|6|||
160941414|NCT00298038|581174929|FG001|Overall Study|Death|3|||
160941415|NCT00298038|581174928|FG000|Overall Study|Withdrawal by Subject|6|||
160941416|NCT00298038|581174929|FG001|Overall Study|Withdrawal by Subject|9|||
160941417|NCT00298038|581174928|FG000|Overall Study|Adverse Event|8|||
160941418|NCT00298038|581174929|FG001|Overall Study|Adverse Event|7|||
160941419|NCT00298038|581174928|FG000|Overall Study|Breakthrough overt HE episode|28|||
160941420|NCT00298038|581174929|FG001|Overall Study|Breakthrough overt HE episode|69|||
160941421|NCT00298038|581174928|FG000|Overall Study|Noncompliance|1|||
160941422|NCT00298038|581174929|FG001|Overall Study|Noncompliance|0|||
160941423|NCT00298038|581174928|FG000|Overall Study|Cocaine Abuse|1|||
160941424|NCT00298038|581174929|FG001|Overall Study|Cocaine Abuse|0|||
160941425|NCT00298038|581174928|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
160941426|NCT00298038|581174929|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
160941427|NCT02696096|581174930|FG000|Overall Study|ruled out at screening|1|||
160941428|NCT02696096|581174930|FG000|Overall Study|did not attend second fMRI|1|||
160941429|NCT01940705|581174934|FG000|Overall Study|Lost to Follow-up|1|||
160941430|NCT01940705|581174935|FG001|Overall Study|Lost to Follow-up|3|||
160941431|NCT01940705|581174936|FG002|Overall Study|Lost to Follow-up|2|||
160941432|NCT01940705|581174937|FG003|Overall Study|Lost to Follow-up|2|||
160941433|NCT01940705|581174934|FG000|Overall Study|Withdrawal by Subject|2|||
160941434|NCT01940705|581174935|FG001|Overall Study|Withdrawal by Subject|2|||
160941435|NCT01940705|581174936|FG002|Overall Study|Withdrawal by Subject|3|||
160941436|NCT01940705|581174937|FG003|Overall Study|Withdrawal by Subject|2|||
160941437|NCT01940705|581174934|FG000|Overall Study|Intervention not given|0|||
160941438|NCT01940705|581174935|FG001|Overall Study|Intervention not given|3|||
160579009|NCT00365716|579840184|FG000|Extension 1|Pregnancy|0|||
160579010|NCT00365716|579840185|FG001|Extension 1|Pregnancy|0|||
160579011|NCT00365716|579840186|FG002|Extension 1|Pregnancy|0|||
160941439|NCT01940705|581174936|FG002|Overall Study|Intervention not given|3|||
160941440|NCT01940705|581174937|FG003|Overall Study|Intervention not given|0|||
160941441|NCT01940705|581174934|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
160941442|NCT01940705|581174935|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
160941443|NCT01940705|581174936|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
160941444|NCT01940705|581174937|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
160941445|NCT02447991|581174938|FG000|Overall Study|Withdrawn by subject - no data|0|||
160941446|NCT02447991|581174939|FG001|Overall Study|Withdrawn by subject - no data|2|||
160941447|NCT02447991|581174938|FG000|Overall Study|Withdrawn by Subject - with data|4|||
160941448|NCT02447991|581174939|FG001|Overall Study|Withdrawn by Subject - with data|4|||
160941449|NCT02447991|581174938|FG000|Overall Study|Lost to Follow-up - no data|3|||
160579012|NCT00365716|579840187|FG003|Extension 1|Pregnancy|0|||
160941450|NCT02447991|581174939|FG001|Overall Study|Lost to Follow-up - no data|6|||
160941451|NCT02447991|581174938|FG000|Overall Study|Lost to follow-up - with data|0|||
160579013|NCT00365716|579840188|FG004|Extension 1|Pregnancy|0|||
160579014|NCT00365716|579840189|FG005|Extension 1|Pregnancy|4|||
160579015|NCT00365716|579840190|FG006|Extension 1|Pregnancy|0|||
160941452|NCT02447991|581174939|FG001|Overall Study|Lost to follow-up - with data|3|||
160941453|NCT02447991|581174938|FG000|Overall Study|End of study - no treatment results|3|||
160941454|NCT02447991|581174939|FG001|Overall Study|End of study - no treatment results|6|||
160941455|NCT02447991|581174938|FG000|Overall Study|End of study - partial treatment results|0|||
160941456|NCT02447991|581174939|FG001|Overall Study|End of study - partial treatment results|9|||
160941457|NCT00829621|581174940|FG000|Overall Study|Death|1|||
160941458|NCT00829621|581174941|FG001|Overall Study|Death|0|||
160941459|NCT00829621|581174940|FG000|Overall Study|Lost to Follow-up|3|||
160941460|NCT00829621|581174941|FG001|Overall Study|Lost to Follow-up|4|||
160941461|NCT03551210|581174944|FG000|Overall Study|Adverse Event|5|||
160941462|NCT03551210|581174945|FG001|Overall Study|Adverse Event|6|||
160941463|NCT03551210|581174944|FG000|Overall Study|Withdrawal by Subject|1|||
160941464|NCT03551210|581174945|FG001|Overall Study|Withdrawal by Subject|7|||
160941465|NCT03551210|581174944|FG000|Overall Study|Needed in other antibiotic treatment|2|||
160941466|NCT03551210|581174945|FG001|Overall Study|Needed in other antibiotic treatment|5|||
160941467|NCT03551210|581174944|FG000|Overall Study|Lost to Follow-up|1|||
160941468|NCT03551210|581174945|FG001|Overall Study|Lost to Follow-up|1|||
160941469|NCT03551210|581174944|FG000|Overall Study|Absence of visit 4 and 5|1|||
160941470|NCT03551210|581174945|FG001|Overall Study|Absence of visit 4 and 5|0|||
160941471|NCT03551210|581174944|FG000|Overall Study|No drug for dispensing|0|||
160941472|NCT03551210|581174945|FG001|Overall Study|No drug for dispensing|1|||
160941473|NCT03265119|581174946|FG000|Overall Study|Adverse Event|2|||
160941474|NCT03265119|581174947|FG001|Overall Study|Adverse Event|1|||
160941475|NCT03265119|581174946|FG000|Overall Study|Lack of Efficacy|3|||
160941476|NCT03265119|581174947|FG001|Overall Study|Lack of Efficacy|0|||
160941477|NCT03265119|581174946|FG000|Overall Study|Protocol Violation|1|||
160941478|NCT03265119|581174947|FG001|Overall Study|Protocol Violation|2|||
160941479|NCT03265119|581174946|FG000|Overall Study|Withdrawal by Subject|2|||
160941480|NCT03265119|581174947|FG001|Overall Study|Withdrawal by Subject|4|||
160941481|NCT03265119|581174946|FG000|Overall Study|Lost to Follow-up|1|||
160941482|NCT03265119|581174947|FG001|Overall Study|Lost to Follow-up|0|||
160941483|NCT03265119|581174946|FG000|Overall Study|Lack of Compliance|1|||
160941484|NCT03265119|581174947|FG001|Overall Study|Lack of Compliance|0|||
160941485|NCT01076400|581176665|FG000|Overall Study|Adverse Event|2|||
160941486|NCT01076400|581176666|FG001|Overall Study|Adverse Event|0|||
160941487|NCT01076400|581176667|FG002|Overall Study|Adverse Event|0|||
160941488|NCT01076400|581176665|FG000|Overall Study|Progressive Disease|5|||
160941489|NCT01076400|581176666|FG001|Overall Study|Progressive Disease|0|||
160941490|NCT01076400|581176667|FG002|Overall Study|Progressive Disease|0|||
160941491|NCT02766608|581176670|FG000|Overall Study|Adverse Event|27|||
160941492|NCT02766608|581176671|FG001|Overall Study|Adverse Event|22|||
160941493|NCT02766608|581176672|FG002|Overall Study|Adverse Event|17|||
160941494|NCT02766608|581176673|FG003|Overall Study|Adverse Event|13|||
160941495|NCT02766608|581176674|FG004|Overall Study|Adverse Event|12|||
160941496|NCT02766608|581176670|FG000|Overall Study|Withdrawal by Subject|21|||
160941497|NCT02766608|581176671|FG001|Overall Study|Withdrawal by Subject|20|||
160941498|NCT02766608|581176672|FG002|Overall Study|Withdrawal by Subject|24|||
160941499|NCT02766608|581176673|FG003|Overall Study|Withdrawal by Subject|13|||
160941500|NCT02766608|581176674|FG004|Overall Study|Withdrawal by Subject|10|||
160941501|NCT02766608|581176670|FG000|Overall Study|Lack of Efficacy|16|||
160941502|NCT02766608|581176671|FG001|Overall Study|Lack of Efficacy|15|||
160941503|NCT02766608|581176672|FG002|Overall Study|Lack of Efficacy|32|||
160941504|NCT02766608|581176673|FG003|Overall Study|Lack of Efficacy|8|||
160941505|NCT02766608|581176674|FG004|Overall Study|Lack of Efficacy|2|||
160941506|NCT02766608|581176670|FG000|Overall Study|Lost to Follow-up|6|||
160941507|NCT02766608|581176671|FG001|Overall Study|Lost to Follow-up|3|||
160941508|NCT02766608|581176672|FG002|Overall Study|Lost to Follow-up|5|||
160941509|NCT02766608|581176673|FG003|Overall Study|Lost to Follow-up|2|||
160579016|NCT00365716|579840184|FG000|Extension 1|Protocol Violation|0|||
160579017|NCT00365716|579840185|FG001|Extension 1|Protocol Violation|0|||
160941510|NCT02766608|581176674|FG004|Overall Study|Lost to Follow-up|2|||
160941511|NCT02766608|581176670|FG000|Overall Study|Physician Decision|3|||
160941512|NCT02766608|581176671|FG001|Overall Study|Physician Decision|2|||
160941513|NCT02766608|581176672|FG002|Overall Study|Physician Decision|3|||
160941514|NCT02766608|581176673|FG003|Overall Study|Physician Decision|1|||
160579018|NCT00365716|579840186|FG002|Extension 1|Protocol Violation|0|||
160941515|NCT02766608|581176674|FG004|Overall Study|Physician Decision|2|||
160941516|NCT02766608|581176670|FG000|Overall Study|Protocol disc criteria|3|||
160941517|NCT02766608|581176671|FG001|Overall Study|Protocol disc criteria|3|||
160941518|NCT02766608|581176672|FG002|Overall Study|Protocol disc criteria|4|||
160579019|NCT00365716|579840187|FG003|Extension 1|Protocol Violation|0|||
160579020|NCT00365716|579840188|FG004|Extension 1|Protocol Violation|0|||
160579021|NCT00365716|579840189|FG005|Extension 1|Protocol Violation|1|||
160941519|NCT02766608|581176673|FG003|Overall Study|Protocol disc criteria|0|||
160941520|NCT02766608|581176674|FG004|Overall Study|Protocol disc criteria|0|||
160941521|NCT02766608|581176670|FG000|Overall Study|Protocol Violation|0|||
160941522|NCT02766608|581176671|FG001|Overall Study|Protocol Violation|4|||
160941523|NCT02766608|581176672|FG002|Overall Study|Protocol Violation|4|||
160941524|NCT02766608|581176673|FG003|Overall Study|Protocol Violation|0|||
160941525|NCT02766608|581176674|FG004|Overall Study|Protocol Violation|1|||
160941526|NCT02766608|581176670|FG000|Overall Study|Administrative Reasons|3|||
160941527|NCT02766608|581176671|FG001|Overall Study|Administrative Reasons|1|||
160941528|NCT02766608|581176672|FG002|Overall Study|Administrative Reasons|1|||
160941529|NCT02766608|581176673|FG003|Overall Study|Administrative Reasons|0|||
160941530|NCT02766608|581176674|FG004|Overall Study|Administrative Reasons|0|||
160941531|NCT02343458|581176675|FG000|Overall Study|Adverse Event|15|||
160941532|NCT02343458|581176676|FG001|Overall Study|Adverse Event|14|||
160941533|NCT02343458|581176677|FG002|Overall Study|Adverse Event|15|||
160941534|NCT02343458|581176678|FG003|Overall Study|Adverse Event|3|||
160941535|NCT02343458|581176675|FG000|Overall Study|Lack of Efficacy|3|||
160941536|NCT02343458|581176676|FG001|Overall Study|Lack of Efficacy|8|||
160941537|NCT02343458|581176677|FG002|Overall Study|Lack of Efficacy|4|||
160941538|NCT02343458|581176678|FG003|Overall Study|Lack of Efficacy|8|||
160941539|NCT02343458|581176675|FG000|Overall Study|Withdrawal by Subject|18|||
160941540|NCT02343458|581176676|FG001|Overall Study|Withdrawal by Subject|17|||
160941541|NCT02343458|581176677|FG002|Overall Study|Withdrawal by Subject|23|||
160941542|NCT02343458|581176678|FG003|Overall Study|Withdrawal by Subject|14|||
160941543|NCT02343458|581176675|FG000|Overall Study|Physician Decision|1|||
160941544|NCT02343458|581176676|FG001|Overall Study|Physician Decision|4|||
160941545|NCT02343458|581176677|FG002|Overall Study|Physician Decision|2|||
160941546|NCT02343458|581176678|FG003|Overall Study|Physician Decision|2|||
160941547|NCT02343458|581176675|FG000|Overall Study|Lost to Follow-up|5|||
160941548|NCT02343458|581176676|FG001|Overall Study|Lost to Follow-up|5|||
160941549|NCT02343458|581176677|FG002|Overall Study|Lost to Follow-up|3|||
160941550|NCT02343458|581176678|FG003|Overall Study|Lost to Follow-up|1|||
160941551|NCT02343458|581176675|FG000|Overall Study|Protocol Violation|2|||
160455762|NCT02240238|579399770|FG009|Phase 2|Withdrawal by Subject|1|||
160455763|NCT02240238|579399771|FG010|Phase 2|Withdrawal by Subject|1|||
160941552|NCT02343458|581176676|FG001|Overall Study|Protocol Violation|5|||
160941553|NCT02343458|581176677|FG002|Overall Study|Protocol Violation|2|||
160941554|NCT02343458|581176678|FG003|Overall Study|Protocol Violation|2|||
160941555|NCT02343458|581176675|FG000|Overall Study|Protocol Specified Criteria|17|||
160941556|NCT02343458|581176676|FG001|Overall Study|Protocol Specified Criteria|13|||
160941557|NCT02343458|581176677|FG002|Overall Study|Protocol Specified Criteria|14|||
160941558|NCT02343458|581176678|FG003|Overall Study|Protocol Specified Criteria|8|||
160941559|NCT01913041|581176679|FG000|Overall Study|Protocol Violation|35|||
160941560|NCT01913041|581176679|FG000|Overall Study|Withdrawal by Subject|3|||
160941561|NCT01913041|581176679|FG000|Overall Study|Physician Decision|1|||
160941562|NCT02866682|581176682|FG000|Overall Study|Death|0|||
160941563|NCT02866682|581176683|FG001|Overall Study|Death|1|||
160941564|NCT02866682|581176682|FG000|Overall Study|Lost to Follow-up|0|||
160941565|NCT02866682|581176683|FG001|Overall Study|Lost to Follow-up|4|||
160941566|NCT02866682|581176682|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
160941567|NCT02866682|581176683|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
160941568|NCT02866682|581176682|FG000|Overall Study|Other|0|||
160941569|NCT02866682|581176683|FG001|Overall Study|Other|1|||
160941570|NCT01750268|581176684|FG000|Overall Study|Lost to Follow-up|0|||
160941571|NCT01750268|581176685|FG001|Overall Study|Lost to Follow-up|2|||
160941572|NCT01750268|581176684|FG000|Overall Study|Physician Decision|0|||
160941573|NCT01750268|581176685|FG001|Overall Study|Physician Decision|3|||
160941574|NCT01750268|581176684|FG000|Overall Study|Withdrawal by Subject|2|||
160941575|NCT01750268|581176685|FG001|Overall Study|Withdrawal by Subject|0|||
160941576|NCT02086591|581176688|FG000|Overall Study|Adverse Event|1|||
160941577|NCT02086591|581176688|FG000|Overall Study|Withdrawal by Subject|1|||
160941578|NCT02086591|581176688|FG000|Overall Study|protocol terminated|3|||
160941579|NCT01529645|581176689|FG000|Overall Study|Lost to Follow-up|0|||
160941580|NCT01529645|581176690|FG001|Overall Study|Lost to Follow-up|1|||
160941581|NCT01529645|581176691|FG002|Overall Study|Lost to Follow-up|1|||
160941582|NCT01529645|581176692|FG003|Overall Study|Lost to Follow-up|1|||
160941583|NCT01529645|581176693|FG004|Overall Study|Lost to Follow-up|1|||
160941584|NCT01529645|581176694|FG005|Overall Study|Lost to Follow-up|0|||
160941585|NCT01529645|581176695|FG006|Overall Study|Lost to Follow-up|2|||
160455764|NCT02240238|579399772|FG011|Phase 2|Withdrawal by Subject|0|||
160455765|NCT02240238|579399761|FG000|Phase 2|Physician Decision|0|||
160941586|NCT01529645|581176696|FG007|Overall Study|Lost to Follow-up|0|||
160941587|NCT01529645|581176697|FG008|Overall Study|Lost to Follow-up|1|||
160941588|NCT01529645|581176698|FG009|Overall Study|Lost to Follow-up|0|||
160941589|NCT01529645|581176689|FG000|Overall Study|SAE - Premature contractions|0|||
160941590|NCT01529645|581176690|FG001|Overall Study|SAE - Premature contractions|0|||
160941591|NCT01529645|581176691|FG002|Overall Study|SAE - Premature contractions|1|||
160941592|NCT01529645|581176692|FG003|Overall Study|SAE - Premature contractions|0|||
160941593|NCT01529645|581176693|FG004|Overall Study|SAE - Premature contractions|0|||
160941594|NCT01529645|581176694|FG005|Overall Study|SAE - Premature contractions|0|||
160941595|NCT01529645|581176695|FG006|Overall Study|SAE - Premature contractions|0|||
160941596|NCT01529645|581176696|FG007|Overall Study|SAE - Premature contractions|0|||
160941597|NCT01529645|581176697|FG008|Overall Study|SAE - Premature contractions|0|||
160941598|NCT01529645|581176698|FG009|Overall Study|SAE - Premature contractions|0|||
160941599|NCT01529645|581176689|FG000|Overall Study|Withdrawal by Subject|2|||
160941600|NCT01529645|581176690|FG001|Overall Study|Withdrawal by Subject|0|||
160941601|NCT01529645|581176691|FG002|Overall Study|Withdrawal by Subject|0|||
160941602|NCT01529645|581176692|FG003|Overall Study|Withdrawal by Subject|1|||
160941603|NCT01529645|581176693|FG004|Overall Study|Withdrawal by Subject|1|||
160941604|NCT01529645|581176694|FG005|Overall Study|Withdrawal by Subject|1|||
160941605|NCT01529645|581176695|FG006|Overall Study|Withdrawal by Subject|0|||
160941606|NCT01529645|581176696|FG007|Overall Study|Withdrawal by Subject|0|||
160941607|NCT01529645|581176697|FG008|Overall Study|Withdrawal by Subject|0|||
160941608|NCT01529645|581176698|FG009|Overall Study|Withdrawal by Subject|0|||
160941609|NCT00274716|581176699|FG000|Phase A|Other non-reported reason|4|||
160941610|NCT00274716|581176700|FG001|Phase A|Other non-reported reason|2|||
160941611|NCT00274716|581176701|FG002|Phase A|Other non-reported reason|1|||
160941612|NCT00274716|581176702|FG003|Phase A|Other non-reported reason|2|||
160941613|NCT00274716|581176703|FG004|Phase A|Other non-reported reason|0|||
160941614|NCT00274716|581176704|FG005|Phase A|Other non-reported reason|1|||
160941615|NCT00274716|581176699|FG000|Phase A|Participant moved|0|||
160941616|NCT00274716|581176700|FG001|Phase A|Participant moved|0|||
160941617|NCT00274716|581176701|FG002|Phase A|Participant moved|1|||
160941618|NCT00274716|581176702|FG003|Phase A|Participant moved|0|||
160941619|NCT00274716|581176703|FG004|Phase A|Participant moved|0|||
160941620|NCT00274716|581176704|FG005|Phase A|Participant moved|1|||
160941621|NCT00274716|581176699|FG000|Phase A|Site Terminated|0|||
160941622|NCT00274716|581176700|FG001|Phase A|Site Terminated|0|||
160941623|NCT00274716|581176701|FG002|Phase A|Site Terminated|0|||
160941624|NCT00274716|581176702|FG003|Phase A|Site Terminated|1|||
160941625|NCT00274716|581176703|FG004|Phase A|Site Terminated|0|||
160941626|NCT00274716|581176704|FG005|Phase A|Site Terminated|0|||
160941627|NCT00274716|581176699|FG000|Phase A|Protocol Violation|1|||
160941628|NCT00274716|581176700|FG001|Phase A|Protocol Violation|0|||
160941629|NCT00274716|581176701|FG002|Phase A|Protocol Violation|0|||
160941630|NCT00274716|581176702|FG003|Phase A|Protocol Violation|1|||
160941631|NCT00274716|581176703|FG004|Phase A|Protocol Violation|0|||
160941632|NCT00274716|581176704|FG005|Phase A|Protocol Violation|0|||
160941633|NCT00274716|581176699|FG000|Phase A|Met criteria for discontinuation|1|||
160455766|NCT02240238|579399762|FG001|Phase 2|Physician Decision|0|||
160941634|NCT00274716|581176700|FG001|Phase A|Met criteria for discontinuation|1|||
160941635|NCT00274716|581176701|FG002|Phase A|Met criteria for discontinuation|0|||
160941636|NCT00274716|581176702|FG003|Phase A|Met criteria for discontinuation|0|||
160941637|NCT00274716|581176703|FG004|Phase A|Met criteria for discontinuation|0|||
160941638|NCT00274716|581176704|FG005|Phase A|Met criteria for discontinuation|0|||
160941639|NCT00274716|581176699|FG000|Phase A|Withdrawal by Subject|2|||
160941640|NCT00274716|581176700|FG001|Phase A|Withdrawal by Subject|2|||
160941641|NCT00274716|581176701|FG002|Phase A|Withdrawal by Subject|1|||
160941642|NCT00274716|581176702|FG003|Phase A|Withdrawal by Subject|3|||
160941643|NCT00274716|581176703|FG004|Phase A|Withdrawal by Subject|0|||
160941644|NCT00274716|581176704|FG005|Phase A|Withdrawal by Subject|1|||
160941645|NCT00274716|581176699|FG000|Phase A|Adverse Event|2|||
160941646|NCT00274716|581176700|FG001|Phase A|Adverse Event|3|||
160941647|NCT00274716|581176701|FG002|Phase A|Adverse Event|3|||
160941648|NCT00274716|581176702|FG003|Phase A|Adverse Event|0|||
160941649|NCT00274716|581176703|FG004|Phase A|Adverse Event|2|||
160941650|NCT00274716|581176704|FG005|Phase A|Adverse Event|0|||
160941651|NCT00274716|581176699|FG000|Phase A|Completed but did not enter Phase B|1|||
160941652|NCT00274716|581176700|FG001|Phase A|Completed but did not enter Phase B|2|||
160941653|NCT00274716|581176701|FG002|Phase A|Completed but did not enter Phase B|2|||
160941654|NCT00274716|581176702|FG003|Phase A|Completed but did not enter Phase B|2|||
160941655|NCT00274716|581176703|FG004|Phase A|Completed but did not enter Phase B|1|||
160941656|NCT00274716|581176704|FG005|Phase A|Completed but did not enter Phase B|1|||
160455767|NCT02240238|579399763|FG002|Phase 2|Physician Decision|0|||
160656051|NCT02130466|580120347|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
160941657|NCT00274716|581176699|FG000|Phase B|Adverse Event|0|||
160941658|NCT00274716|581176700|FG001|Phase B|Adverse Event|0|||
160941659|NCT00274716|581176701|FG002|Phase B|Adverse Event|2|||
160941660|NCT00274716|581176702|FG003|Phase B|Adverse Event|0|||
160941661|NCT00274716|581176703|FG004|Phase B|Adverse Event|0|||
160941662|NCT00274716|581176704|FG005|Phase B|Adverse Event|1|||
160941663|NCT00274716|581176699|FG000|Phase B|Protocol Violation|0|||
160941664|NCT00274716|581176700|FG001|Phase B|Protocol Violation|2|||
160941665|NCT00274716|581176701|FG002|Phase B|Protocol Violation|0|||
160941666|NCT00274716|581176702|FG003|Phase B|Protocol Violation|0|||
160941667|NCT00274716|581176703|FG004|Phase B|Protocol Violation|0|||
160941668|NCT00274716|581176704|FG005|Phase B|Protocol Violation|0|||
160455768|NCT02240238|579399764|FG003|Phase 2|Physician Decision|0|||
160941669|NCT00274716|581176699|FG000|Phase B|Withdrawal by Subject|0|||
160941670|NCT00274716|581176700|FG001|Phase B|Withdrawal by Subject|1|||
160941671|NCT00274716|581176701|FG002|Phase B|Withdrawal by Subject|0|||
160941672|NCT00274716|581176702|FG003|Phase B|Withdrawal by Subject|0|||
160941673|NCT00274716|581176703|FG004|Phase B|Withdrawal by Subject|0|||
160941674|NCT00274716|581176704|FG005|Phase B|Withdrawal by Subject|0|||
160941675|NCT00274716|581176699|FG000|Phase B|Participant moved|1|||
160941676|NCT00274716|581176700|FG001|Phase B|Participant moved|0|||
160941677|NCT00274716|581176701|FG002|Phase B|Participant moved|0|||
160941678|NCT00274716|581176702|FG003|Phase B|Participant moved|0|||
160941679|NCT00274716|581176703|FG004|Phase B|Participant moved|0|||
160941680|NCT00274716|581176704|FG005|Phase B|Participant moved|0|||
160941681|NCT00274716|581176699|FG000|Phase B|Other non-reported reason|0|||
160941682|NCT00274716|581176700|FG001|Phase B|Other non-reported reason|0|||
160941683|NCT00274716|581176701|FG002|Phase B|Other non-reported reason|1|||
160941684|NCT00274716|581176702|FG003|Phase B|Other non-reported reason|1|||
160941685|NCT00274716|581176703|FG004|Phase B|Other non-reported reason|0|||
160941686|NCT00274716|581176704|FG005|Phase B|Other non-reported reason|0|||
160941687|NCT00274716|581176699|FG000|Phase B|Lost to Follow-up|0|||
160941688|NCT00274716|581176700|FG001|Phase B|Lost to Follow-up|1|||
160941689|NCT00274716|581176701|FG002|Phase B|Lost to Follow-up|0|||
160941690|NCT00274716|581176702|FG003|Phase B|Lost to Follow-up|0|||
160941691|NCT00274716|581176703|FG004|Phase B|Lost to Follow-up|0|||
160941692|NCT00274716|581176704|FG005|Phase B|Lost to Follow-up|0|||
160941693|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
160941694|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
160941695|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
160941696|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
160941697|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
160941698|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
160941699|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
160941700|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
160941701|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
160941702|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
160941703|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
160941704|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
160941705|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
160941706|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
160941707|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
160941708|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
160941709|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
160941710|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
160941711|NCT01257204|581176705|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
160941712|NCT01257204|581176706|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
160941713|NCT01257204|581176707|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
160941714|NCT01257204|581176705|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
160941715|NCT01257204|581176706|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
160941716|NCT01257204|581176707|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
160941717|NCT01257204|581176705|FG000|Follow-up Period (up to Week 48)|Other|0|||
160941718|NCT01257204|581176706|FG001|Follow-up Period (up to Week 48)|Other|0|||
160941719|NCT01257204|581176707|FG002|Follow-up Period (up to Week 48)|Other|5|||
160941720|NCT03394391|581176708|FG000|Overall Study|Lost to Follow-up|1|||
160941721|NCT03394391|581176709|FG001|Overall Study|Lost to Follow-up|2|||
160941722|NCT00723801|581176712|FG000|Overall Study|Lost to Follow-up|1|||
160941723|NCT00723801|581176713|FG001|Overall Study|Lost to Follow-up|2|||
160941724|NCT00723801|581176712|FG000|Overall Study|Protocol Violation|2|||
160941725|NCT00723801|581176713|FG001|Overall Study|Protocol Violation|1|||
160941726|NCT02148003|581176714|FG000|Overall Study|Failed inclusion criteria|1|||
160941727|NCT02148003|581176715|FG001|Overall Study|Failed inclusion criteria|0|||
160941728|NCT02148003|581176714|FG000|Overall Study|Met exclusion criteria|0|||
160941729|NCT02148003|581176715|FG001|Overall Study|Met exclusion criteria|1|||
160941730|NCT02148003|581176714|FG000|Overall Study|Withdrawal by Subject|0|||
160941731|NCT02148003|581176715|FG001|Overall Study|Withdrawal by Subject|1|||
160941732|NCT02489981|581176716|FG000|Overall Study|Adverse Event|21|||
160941733|NCT02489981|581176716|FG000|Overall Study|Insufficient effectiveness|16|||
160941734|NCT02489981|581176716|FG000|Overall Study|Improved|31|||
160941735|NCT02489981|581176716|FG000|Overall Study|Lost to Follow-up|31|||
160941736|NCT02489981|581176716|FG000|Overall Study|Other than listed|28|||
160941737|NCT01565993|581176724|FG000|Overall Study|Physician Decision|0|||
160941738|NCT01565993|581176725|FG001|Overall Study|Physician Decision|3|||
160941739|NCT02039427|581176727|FG000|Overall Study|Duration of surgery > 3h|1|||
160941740|NCT02039427|581176728|FG001|Overall Study|Duration of surgery > 3h|1|||
160941741|NCT02039427|581176729|FG002|Overall Study|Duration of surgery > 3h|0|||
160941742|NCT02039427|581176730|FG003|Overall Study|Duration of surgery > 3h|0|||
160941743|NCT02039427|581176727|FG000|Overall Study|Withdrawal on concent|0|||
160941744|NCT02039427|581176728|FG001|Overall Study|Withdrawal on concent|0|||
160941745|NCT02039427|581176729|FG002|Overall Study|Withdrawal on concent|0|||
160941746|NCT02039427|581176730|FG003|Overall Study|Withdrawal on concent|1|||
160941747|NCT02039427|581176727|FG000|Overall Study|Cancellation of surgery|0|||
160941748|NCT02039427|581176728|FG001|Overall Study|Cancellation of surgery|0|||
160941749|NCT02039427|581176729|FG002|Overall Study|Cancellation of surgery|1|||
160941750|NCT02039427|581176730|FG003|Overall Study|Cancellation of surgery|0|||
160941751|NCT02039427|581176727|FG000|Overall Study|Loss of follow - up|1|||
160941752|NCT02039427|581176728|FG001|Overall Study|Loss of follow - up|0|||
160941753|NCT02039427|581176729|FG002|Overall Study|Loss of follow - up|2|||
160941754|NCT02039427|581176730|FG003|Overall Study|Loss of follow - up|4|||
160941755|NCT02039427|581176727|FG000|Overall Study|Steroid Use|1|||
160941756|NCT02039427|581176728|FG001|Overall Study|Steroid Use|0|||
160941757|NCT02039427|581176729|FG002|Overall Study|Steroid Use|0|||
160941758|NCT02039427|581176730|FG003|Overall Study|Steroid Use|0|||
160941759|NCT01532687|581176735|FG000|Overall Study|Death|2|||
160941760|NCT01532687|581176736|FG001|Overall Study|Death|0|||
160941761|NCT01532687|581176735|FG000|Overall Study|Adverse Event|6|||
160941762|NCT01532687|581176736|FG001|Overall Study|Adverse Event|1|||
160941763|NCT01532687|581176735|FG000|Overall Study|Withdrawal by Subject|1|||
160941764|NCT01532687|581176736|FG001|Overall Study|Withdrawal by Subject|0|||
160941765|NCT01532687|581176735|FG000|Overall Study|Physician Decision|2|||
160941766|NCT01532687|581176736|FG001|Overall Study|Physician Decision|1|||
160941767|NCT01532687|581176735|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
160941768|NCT01532687|581176736|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
160941769|NCT03160703|581176737|FG000|Overall Study|Withdrawal by Subject|0|||
160941770|NCT03160703|581176738|FG001|Overall Study|Withdrawal by Subject|0|||
160941771|NCT03160703|581176739|FG002|Overall Study|Withdrawal by Subject|0|||
160941772|NCT03160703|581176740|FG003|Overall Study|Withdrawal by Subject|1|||
160941773|NCT00087568|581176741|FG000|Overall Study|Adverse Event|4|||
160941774|NCT00087568|581176742|FG001|Overall Study|Adverse Event|0|||
160941775|NCT00087568|581176741|FG000|Overall Study|Withdrawal by Subject|1|||
160941776|NCT00087568|581176742|FG001|Overall Study|Withdrawal by Subject|1|||
160941777|NCT00087568|581176741|FG000|Overall Study|Lost to Follow-up|1|||
160941778|NCT00087568|581176742|FG001|Overall Study|Lost to Follow-up|0|||
160941779|NCT00087568|581176741|FG000|Overall Study|Lack of Efficacy|24|||
160941780|NCT00087568|581176742|FG001|Overall Study|Lack of Efficacy|1|||
160941781|NCT01513291|581176743|FG000|Treatment Period|Adverse Event|8|||
160941782|NCT01513291|581176744|FG001|Treatment Period|Adverse Event|4|||
160941783|NCT01513291|581176745|FG002|Treatment Period|Adverse Event|0|||
160941784|NCT01513291|581176746|FG003|Treatment Period|Adverse Event|0|||
160941785|NCT01513291|581176747|FG004|Treatment Period|Adverse Event|0|||
160941786|NCT01513291|581176743|FG000|Treatment Period|Lack of Efficacy|3|||
160941787|NCT01513291|581176744|FG001|Treatment Period|Lack of Efficacy|0|||
160941788|NCT01513291|581176745|FG002|Treatment Period|Lack of Efficacy|0|||
160941789|NCT01513291|581176746|FG003|Treatment Period|Lack of Efficacy|0|||
160941790|NCT01513291|581176747|FG004|Treatment Period|Lack of Efficacy|0|||
160941791|NCT01513291|581176743|FG000|Treatment Period|Lost to Follow-up|2|||
160941792|NCT01513291|581176744|FG001|Treatment Period|Lost to Follow-up|3|||
160941793|NCT01513291|581176745|FG002|Treatment Period|Lost to Follow-up|0|||
160941794|NCT01513291|581176746|FG003|Treatment Period|Lost to Follow-up|0|||
160941795|NCT01513291|581176747|FG004|Treatment Period|Lost to Follow-up|0|||
160941796|NCT01513291|581176743|FG000|Treatment Period|Physician Decision|1|||
160941797|NCT01513291|581176744|FG001|Treatment Period|Physician Decision|0|||
160941798|NCT01513291|581176745|FG002|Treatment Period|Physician Decision|0|||
160941799|NCT01513291|581176746|FG003|Treatment Period|Physician Decision|0|||
160941800|NCT01513291|581176747|FG004|Treatment Period|Physician Decision|0|||
160941801|NCT01513291|581176743|FG000|Treatment Period|Protocol Violation|1|||
160941802|NCT01513291|581176744|FG001|Treatment Period|Protocol Violation|2|||
160941803|NCT01513291|581176745|FG002|Treatment Period|Protocol Violation|0|||
160941804|NCT01513291|581176746|FG003|Treatment Period|Protocol Violation|0|||
160941805|NCT01513291|581176747|FG004|Treatment Period|Protocol Violation|0|||
160941806|NCT01513291|581176743|FG000|Treatment Period|Withdrawal by Subject|8|||
160941807|NCT01513291|581176744|FG001|Treatment Period|Withdrawal by Subject|5|||
160579022|NCT00365716|579840190|FG006|Extension 1|Protocol Violation|0|||
160579023|NCT00365716|579840184|FG000|Extension 2|Lost to Follow-up|0|||
160941808|NCT01513291|581176745|FG002|Treatment Period|Withdrawal by Subject|0|||
160941809|NCT01513291|581176746|FG003|Treatment Period|Withdrawal by Subject|0|||
160941810|NCT01513291|581176747|FG004|Treatment Period|Withdrawal by Subject|0|||
160941811|NCT01513291|581176743|FG000|Treatment Period|Randomized not treated|0|||
160941812|NCT01513291|581176744|FG001|Treatment Period|Randomized not treated|2|||
160941813|NCT01513291|581176745|FG002|Treatment Period|Randomized not treated|0|||
160941814|NCT01513291|581176746|FG003|Treatment Period|Randomized not treated|0|||
160941815|NCT01513291|581176747|FG004|Treatment Period|Randomized not treated|0|||
160455769|NCT02240238|579399765|FG004|Phase 2|Physician Decision|0|||
160579024|NCT00365716|579840185|FG001|Extension 2|Lost to Follow-up|0|||
160579025|NCT00365716|579840186|FG002|Extension 2|Lost to Follow-up|0|||
160941816|NCT01513291|581176743|FG000|Run-out Period|Lost to Follow-up|0|||
160941817|NCT01513291|581176744|FG001|Run-out Period|Lost to Follow-up|0|||
160941818|NCT01513291|581176745|FG002|Run-out Period|Lost to Follow-up|0|||
160941819|NCT01513291|581176746|FG003|Run-out Period|Lost to Follow-up|1|||
160941820|NCT01513291|581176747|FG004|Run-out Period|Lost to Follow-up|0|||
160941821|NCT01513291|581176743|FG000|Run-out Period|Withdrawal by Subject|0|||
160941822|NCT01513291|581176744|FG001|Run-out Period|Withdrawal by Subject|0|||
160941823|NCT01513291|581176745|FG002|Run-out Period|Withdrawal by Subject|0|||
160941824|NCT01513291|581176746|FG003|Run-out Period|Withdrawal by Subject|1|||
160941825|NCT01513291|581176747|FG004|Run-out Period|Withdrawal by Subject|0|||
160941826|NCT03728582|581176752|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
160941827|NCT03728582|581176753|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
160941828|NCT03728582|581176752|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
160941829|NCT03728582|581176753|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
160941830|NCT02732847|581176754|FG000|Overall Study|some filled early|42|||
160941831|NCT02732847|581176755|FG001|Overall Study|some filled early|42|||
160941832|NCT02992899|581176756|FG000|Overall Study|Withdrawal by Subject|1|||
160941833|NCT02992899|581176757|FG001|Overall Study|Withdrawal by Subject|0|||
160941834|NCT02992899|581176756|FG000|Overall Study|Lost to Follow-up|1|||
160941835|NCT02992899|581176757|FG001|Overall Study|Lost to Follow-up|3|||
160941836|NCT02738775|581176758|FG000|Overall Study|Withdrawal by Subject|0|||
160941837|NCT02738775|581176759|FG001|Overall Study|Withdrawal by Subject|1|||
160941838|NCT02738775|581176760|FG002|Overall Study|Withdrawal by Subject|0|||
160941839|NCT02738775|581176761|FG003|Overall Study|Withdrawal by Subject|0|||
160941840|NCT02738775|581176762|FG004|Overall Study|Withdrawal by Subject|0|||
160941841|NCT02738775|581176763|FG005|Overall Study|Withdrawal by Subject|0|||
160941842|NCT02738775|581176758|FG000|Overall Study|Adverse Event|0|||
160941843|NCT02738775|581176759|FG001|Overall Study|Adverse Event|0|||
160941844|NCT02738775|581176760|FG002|Overall Study|Adverse Event|0|||
160941845|NCT02738775|581176761|FG003|Overall Study|Adverse Event|1|||
160941846|NCT02738775|581176762|FG004|Overall Study|Adverse Event|0|||
160941847|NCT02738775|581176763|FG005|Overall Study|Adverse Event|0|||
160941848|NCT02738775|581176758|FG000|Overall Study|Pregnancy|0|||
160941849|NCT02738775|581176759|FG001|Overall Study|Pregnancy|1|||
160941850|NCT02738775|581176760|FG002|Overall Study|Pregnancy|0|||
160941851|NCT02738775|581176761|FG003|Overall Study|Pregnancy|0|||
160941852|NCT02738775|581176762|FG004|Overall Study|Pregnancy|0|||
160941853|NCT02738775|581176763|FG005|Overall Study|Pregnancy|0|||
160941854|NCT02738775|581176758|FG000|Overall Study|Missing|0|||
160941855|NCT02738775|581176759|FG001|Overall Study|Missing|0|||
160941856|NCT02738775|581176760|FG002|Overall Study|Missing|0|||
160941857|NCT02738775|581176761|FG003|Overall Study|Missing|0|||
160941858|NCT02738775|581176762|FG004|Overall Study|Missing|0|||
160941859|NCT02738775|581176763|FG005|Overall Study|Missing|1|||
160941860|NCT01034397|581176764|FG000|Overall Study|Lack of compliance|0|||
160941861|NCT01034397|581176765|FG001|Overall Study|Lack of compliance|1|||
160941862|NCT01034397|581176764|FG000|Overall Study|Lack of Efficacy|3|||
160941863|NCT01034397|581176765|FG001|Overall Study|Lack of Efficacy|0|||
160941864|NCT01034397|581176764|FG000|Overall Study|Adverse Event|4|||
160941865|NCT01034397|581176765|FG001|Overall Study|Adverse Event|0|||
160941866|NCT01034397|581176764|FG000|Overall Study|Other|0|||
160941867|NCT01034397|581176765|FG001|Overall Study|Other|1|||
160941868|NCT01263873|581176768|FG000|Overall Study|One provider unable to complete numbers|1|||
160941869|NCT01263873|581176769|FG001|Overall Study|One provider unable to complete numbers|1|||
160941870|NCT00047463|581176770|FG000|Overall Study|Withdrawal by Subject|0|||
160998909|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
160998910|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
160998911|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
160998912|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
160998913|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160941871|NCT00047463|581176771|FG001|Overall Study|Withdrawal by Subject|3|||
160941872|NCT03217136|581176772|FG000|Overall Study|Lost to Follow-up|2|||
160941873|NCT03217136|581176773|FG001|Overall Study|Lost to Follow-up|1|||
160998914|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
160455770|NCT02240238|579399766|FG005|Phase 2|Physician Decision|0|||
160941874|NCT03217136|581176772|FG000|Overall Study|Site Randomized Participant in Error|0|||
160941875|NCT03217136|581176773|FG001|Overall Study|Site Randomized Participant in Error|1|||
160941876|NCT03217136|581176772|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
160941877|NCT03217136|581176773|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
160455771|NCT02240238|579399767|FG006|Phase 2|Physician Decision|0|||
160941878|NCT03217136|581176772|FG000|Overall Study|Dispensing Error|1|||
160941879|NCT03217136|581176773|FG001|Overall Study|Dispensing Error|0|||
160941880|NCT03217136|581176772|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160941881|NCT03217136|581176773|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160941882|NCT00720876|581176786|FG000|Overall Study|found to be ineligible after starting tx|2|||
160941883|NCT03495908|581176788|FG000|Overall Study|Withdrawal by Subject|3|||
160941884|NCT03495908|581176789|FG001|Overall Study|Withdrawal by Subject|1|||
160941885|NCT03495908|581176788|FG000|Overall Study|Lost to Follow-up|1|||
160998915|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
160656052|NCT02130466|580120348|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
160941886|NCT03495908|581176789|FG001|Overall Study|Lost to Follow-up|4|||
160941887|NCT03495908|581176788|FG000|Overall Study|Adverse Event|0|||
160941888|NCT03495908|581176789|FG001|Overall Study|Adverse Event|2|||
160656053|NCT02130466|580120349|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
160656054|NCT02130466|580120350|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
160656055|NCT02130466|580120351|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
160656056|NCT02130466|580120352|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
160656057|NCT02130466|580120353|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
160656058|NCT02130466|580120354|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
160656059|NCT02130466|580120355|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
160656060|NCT02130466|580120356|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
160656061|NCT02130466|580120343|FG000|Overall Study|Withdrawal by Subject|1|||
160656062|NCT02130466|580120344|FG001|Overall Study|Withdrawal by Subject|0|||
160656063|NCT02130466|580120345|FG002|Overall Study|Withdrawal by Subject|0|||
160656064|NCT02130466|580120346|FG003|Overall Study|Withdrawal by Subject|0|||
160656065|NCT02130466|580120347|FG004|Overall Study|Withdrawal by Subject|0|||
160941889|NCT03495908|581176788|FG000|Overall Study|Death|1|||
160941890|NCT03495908|581176789|FG001|Overall Study|Death|0|||
160941891|NCT03495908|581176788|FG000|Overall Study|Physician Decision|5|||
160941892|NCT03495908|581176789|FG001|Overall Study|Physician Decision|4|||
160941893|NCT03495908|581176788|FG000|Overall Study|No documented reason|0|||
160941894|NCT03495908|581176789|FG001|Overall Study|No documented reason|2|||
160941895|NCT03304379|581176790|FG000|Overall Study|Protocol Violation|8|||
160941896|NCT03304379|581176791|FG001|Overall Study|Protocol Violation|10|||
160941897|NCT03304379|581176792|FG002|Overall Study|Protocol Violation|5|||
160941898|NCT03304379|581176793|FG003|Overall Study|Protocol Violation|0|||
160941899|NCT03304379|581176794|FG004|Overall Study|Protocol Violation|2|||
160941900|NCT03304379|581176790|FG000|Overall Study|Adverse Event|4|||
160941901|NCT03304379|581176791|FG001|Overall Study|Adverse Event|20|||
160941902|NCT03304379|581176792|FG002|Overall Study|Adverse Event|17|||
160941903|NCT03304379|581176793|FG003|Overall Study|Adverse Event|1|||
160941904|NCT03304379|581176794|FG004|Overall Study|Adverse Event|0|||
160941905|NCT03304379|581176790|FG000|Overall Study|Lack of Efficacy|17|||
160941906|NCT03304379|581176791|FG001|Overall Study|Lack of Efficacy|16|||
160998916|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
160998917|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998918|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998919|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998920|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998921|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998922|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160455772|NCT02240238|579399768|FG007|Phase 2|Physician Decision|0|||
160455773|NCT02240238|579399769|FG008|Phase 2|Physician Decision|0|||
160455774|NCT02240238|579399770|FG009|Phase 2|Physician Decision|1|||
160455775|NCT02240238|579399771|FG010|Phase 2|Physician Decision|3|||
160579026|NCT00365716|579840187|FG003|Extension 2|Lost to Follow-up|0|||
160579027|NCT00365716|579840188|FG004|Extension 2|Lost to Follow-up|0|||
160579028|NCT00365716|579840189|FG005|Extension 2|Lost to Follow-up|0|||
160579029|NCT00365716|579840190|FG006|Extension 2|Lost to Follow-up|2|||
160579030|NCT00365716|579840184|FG000|Extension 2|Other|0|||
160579031|NCT00365716|579840185|FG001|Extension 2|Other|0|||
160579032|NCT00365716|579840186|FG002|Extension 2|Other|0|||
160579033|NCT00365716|579840187|FG003|Extension 2|Other|0|||
160579034|NCT00365716|579840188|FG004|Extension 2|Other|0|||
160579035|NCT00365716|579840189|FG005|Extension 2|Other|0|||
160656066|NCT02130466|580120348|FG005|Overall Study|Withdrawal by Subject|1|||
160656067|NCT02130466|580120349|FG006|Overall Study|Withdrawal by Subject|0|||
160656068|NCT02130466|580120350|FG007|Overall Study|Withdrawal by Subject|0|||
160656069|NCT02130466|580120351|FG008|Overall Study|Withdrawal by Subject|1|||
160656070|NCT02130466|580120352|FG009|Overall Study|Withdrawal by Subject|0|||
160656071|NCT02130466|580120353|FG010|Overall Study|Withdrawal by Subject|0|||
160941907|NCT03304379|581176792|FG002|Overall Study|Lack of Efficacy|20|||
160941908|NCT03304379|581176793|FG003|Overall Study|Lack of Efficacy|0|||
160941909|NCT03304379|581176794|FG004|Overall Study|Lack of Efficacy|0|||
160998923|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998924|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160455776|NCT02240238|579399772|FG011|Phase 2|Physician Decision|0|||
160579036|NCT00365716|579840190|FG006|Extension 2|Other|3|||
160941910|NCT03304379|581176790|FG000|Overall Study|Physician Decision|6|||
160941911|NCT03304379|581176791|FG001|Overall Study|Physician Decision|10|||
160941912|NCT03304379|581176792|FG002|Overall Study|Physician Decision|6|||
160941913|NCT03304379|581176793|FG003|Overall Study|Physician Decision|9|||
160579037|NCT00365716|579840184|FG000|Extension 2|Withdrawal by Subject|0|||
160579038|NCT00365716|579840185|FG001|Extension 2|Withdrawal by Subject|0|||
160579039|NCT00365716|579840186|FG002|Extension 2|Withdrawal by Subject|0|||
160579040|NCT00365716|579840187|FG003|Extension 2|Withdrawal by Subject|0|||
160579041|NCT00365716|579840188|FG004|Extension 2|Withdrawal by Subject|0|||
160579042|NCT00365716|579840189|FG005|Extension 2|Withdrawal by Subject|0|||
160579043|NCT00365716|579840190|FG006|Extension 2|Withdrawal by Subject|5|||
160579044|NCT01849848|579840192|FG000|Overall Study|Physician Decision|1|||
160579045|NCT01849848|579840192|FG000|Overall Study|Progression of the primary disease|3|||
160579046|NCT01120093|579840201|FG000|Treatment Period 1|Adverse Event|0|||
160579047|NCT01120093|579840202|FG001|Treatment Period 1|Adverse Event|0|||
160579048|NCT01120093|579840203|FG002|Treatment Period 1|Adverse Event|1|||
160579049|NCT01120093|579840204|FG003|Treatment Period 1|Adverse Event|0|||
160579050|NCT01120093|579840205|FG004|Treatment Period 1|Adverse Event|1|||
160579051|NCT01120093|579840201|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160579052|NCT01120093|579840202|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160579053|NCT01120093|579840203|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160579054|NCT01120093|579840204|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160579055|NCT01120093|579840205|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160579056|NCT01120093|579840201|FG000|Treatment Period 2|Adverse Event|0|||
160579057|NCT01120093|579840202|FG001|Treatment Period 2|Adverse Event|0|||
160579058|NCT01120093|579840203|FG002|Treatment Period 2|Adverse Event|0|||
160579059|NCT01120093|579840204|FG003|Treatment Period 2|Adverse Event|1|||
160579060|NCT01120093|579840205|FG004|Treatment Period 2|Adverse Event|0|||
160579061|NCT01120093|579840201|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160941914|NCT03304379|581176794|FG004|Overall Study|Physician Decision|10|||
160941915|NCT03304379|581176790|FG000|Overall Study|Withdrawal by Subject|26|||
160941916|NCT03304379|581176791|FG001|Overall Study|Withdrawal by Subject|58|||
160941917|NCT03304379|581176792|FG002|Overall Study|Withdrawal by Subject|66|||
160941918|NCT03304379|581176793|FG003|Overall Study|Withdrawal by Subject|3|||
160941919|NCT03304379|581176794|FG004|Overall Study|Withdrawal by Subject|5|||
160941920|NCT03304379|581176790|FG000|Overall Study|Lost to Follow-up|8|||
160941921|NCT03304379|581176791|FG001|Overall Study|Lost to Follow-up|24|||
160579062|NCT01120093|579840202|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160579063|NCT01120093|579840203|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160579064|NCT01120093|579840204|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160579065|NCT01120093|579840205|FG004|Treatment Period 2|Withdrawal by Subject|1|||
160579066|NCT01120093|579840201|FG000|Treatment Period 3|Lack of Efficacy|0|||
160579067|NCT01120093|579840202|FG001|Treatment Period 3|Lack of Efficacy|0|||
160579068|NCT01120093|579840203|FG002|Treatment Period 3|Lack of Efficacy|0|||
160579069|NCT01120093|579840204|FG003|Treatment Period 3|Lack of Efficacy|1|||
160579070|NCT01120093|579840205|FG004|Treatment Period 3|Lack of Efficacy|0|||
160579071|NCT01120093|579840201|FG000|Treatment Period 3|Adverse Event|0|||
160579072|NCT01120093|579840202|FG001|Treatment Period 3|Adverse Event|0|||
160579073|NCT01120093|579840203|FG002|Treatment Period 3|Adverse Event|0|||
160579074|NCT01120093|579840204|FG003|Treatment Period 3|Adverse Event|0|||
160579075|NCT01120093|579840205|FG004|Treatment Period 3|Adverse Event|1|||
160579076|NCT01120093|579840201|FG000|Treatment Period 3|Withdrawal by Subject|0|||
160579077|NCT01120093|579840202|FG001|Treatment Period 3|Withdrawal by Subject|0|||
160941922|NCT03304379|581176792|FG002|Overall Study|Lost to Follow-up|35|||
160941923|NCT03304379|581176793|FG003|Overall Study|Lost to Follow-up|4|||
160998925|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998926|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998927|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998928|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
160998929|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998930|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998931|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998932|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998933|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998934|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998935|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
160998936|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998937|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998938|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998939|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998940|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160579078|NCT01120093|579840203|FG002|Treatment Period 3|Withdrawal by Subject|1|||
160579079|NCT01120093|579840204|FG003|Treatment Period 3|Withdrawal by Subject|0|||
160579080|NCT01120093|579840205|FG004|Treatment Period 3|Withdrawal by Subject|0|||
160579081|NCT01120093|579840201|FG000|Treatment Period 4|Adverse Event|1|||
160579082|NCT01120093|579840202|FG001|Treatment Period 4|Adverse Event|0|||
160579083|NCT01120093|579840203|FG002|Treatment Period 4|Adverse Event|0|||
160579084|NCT01120093|579840204|FG003|Treatment Period 4|Adverse Event|0|||
160579085|NCT01120093|579840205|FG004|Treatment Period 4|Adverse Event|0|||
160579086|NCT01120093|579840201|FG000|Treatment Period 5|Adverse Event|0|||
160579087|NCT01120093|579840202|FG001|Treatment Period 5|Adverse Event|1|||
160941924|NCT03304379|581176794|FG004|Overall Study|Lost to Follow-up|0|||
160941925|NCT03304379|581176790|FG000|Overall Study|Death|1|||
160941926|NCT03304379|581176791|FG001|Overall Study|Death|2|||
160941927|NCT03304379|581176792|FG002|Overall Study|Death|0|||
160941928|NCT03304379|581176793|FG003|Overall Study|Death|0|||
160941929|NCT03304379|581176794|FG004|Overall Study|Death|0|||
160941930|NCT03304379|581176790|FG000|Overall Study|Other|0|||
160941931|NCT03304379|581176791|FG001|Overall Study|Other|1|||
160941932|NCT03304379|581176792|FG002|Overall Study|Other|0|||
160941933|NCT03304379|581176793|FG003|Overall Study|Other|0|||
160941934|NCT03304379|581176794|FG004|Overall Study|Other|0|||
160941935|NCT01109316|581176801|FG000|Study Period 1|Adverse Event|0|||
160941936|NCT01109316|581176802|FG001|Study Period 1|Adverse Event|0|||
160941937|NCT01109316|581176803|FG002|Study Period 1|Adverse Event|1|||
160941938|NCT01109316|581176804|FG003|Study Period 1|Adverse Event|0|||
160941939|NCT01109316|581176805|FG004|Study Period 1|Adverse Event|0|||
160941940|NCT01109316|581176806|FG005|Study Period 1|Adverse Event|0|||
160941941|NCT01109316|581176801|FG000|Study Period 1|Lost to Follow-up|0|||
160941942|NCT01109316|581176802|FG001|Study Period 1|Lost to Follow-up|0|||
160941943|NCT01109316|581176803|FG002|Study Period 1|Lost to Follow-up|1|||
160941944|NCT01109316|581176804|FG003|Study Period 1|Lost to Follow-up|1|||
160941945|NCT01109316|581176805|FG004|Study Period 1|Lost to Follow-up|0|||
160941946|NCT01109316|581176806|FG005|Study Period 1|Lost to Follow-up|0|||
160941947|NCT01109316|581176801|FG000|Study Period 1|Withdrawal by Subject|0|||
160941948|NCT01109316|581176802|FG001|Study Period 1|Withdrawal by Subject|0|||
160941949|NCT01109316|581176803|FG002|Study Period 1|Withdrawal by Subject|1|||
160941950|NCT01109316|581176804|FG003|Study Period 1|Withdrawal by Subject|0|||
160941951|NCT01109316|581176805|FG004|Study Period 1|Withdrawal by Subject|2|||
160941952|NCT01109316|581176806|FG005|Study Period 1|Withdrawal by Subject|0|||
160941953|NCT01109316|581176801|FG000|Study Period 1|Sponsor Decision|0|||
160941954|NCT01109316|581176802|FG001|Study Period 1|Sponsor Decision|0|||
160941955|NCT01109316|581176803|FG002|Study Period 1|Sponsor Decision|0|||
160941956|NCT01109316|581176804|FG003|Study Period 1|Sponsor Decision|0|||
160941957|NCT01109316|581176805|FG004|Study Period 1|Sponsor Decision|0|||
160941958|NCT01109316|581176806|FG005|Study Period 1|Sponsor Decision|2|||
160941959|NCT01109316|581176801|FG000|Study Period 2|Entry Criteria Not Met|0|||
160579088|NCT01120093|579840203|FG002|Treatment Period 5|Adverse Event|0|||
160579089|NCT01120093|579840204|FG003|Treatment Period 5|Adverse Event|1|||
160579090|NCT01120093|579840205|FG004|Treatment Period 5|Adverse Event|0|||
160579091|NCT03649321|579840208|FG000|Overall Study|Withdrawal by Subject|1|||
160579092|NCT03649321|579840209|FG001|Overall Study|Withdrawal by Subject|0|||
160579093|NCT03649321|579840208|FG000|Overall Study|Death|1|||
160579094|NCT03649321|579840209|FG001|Overall Study|Death|0|||
160579095|NCT05100199|579840210|FG000|Overall Study|Lost to Follow-up|5|||
160579096|NCT05100199|579840211|FG001|Overall Study|Lost to Follow-up|8|||
160579097|NCT05100199|579840212|FG002|Overall Study|Lost to Follow-up|3|||
160579098|NCT05100199|579840213|FG003|Overall Study|Lost to Follow-up|6|||
160579099|NCT05100199|579840210|FG000|Overall Study|Withdrawal by Subject|3|||
160579100|NCT05100199|579840211|FG001|Overall Study|Withdrawal by Subject|3|||
160579101|NCT05100199|579840212|FG002|Overall Study|Withdrawal by Subject|9|||
160579102|NCT05100199|579840213|FG003|Overall Study|Withdrawal by Subject|7|||
160579103|NCT05100199|579840210|FG000|Overall Study|Other|0|||
160579104|NCT05100199|579840211|FG001|Overall Study|Other|0|||
160579105|NCT05100199|579840212|FG002|Overall Study|Other|1|||
160579106|NCT05100199|579840213|FG003|Overall Study|Other|1|||
160579107|NCT01455428|579840214|FG000|Overall Study|Protocol Violation|2|||
160579108|NCT01455428|579840215|FG001|Overall Study|Protocol Violation|1|||
160579109|NCT01455428|579840214|FG000|Overall Study|Adverse Event|6|||
160579110|NCT01455428|579840215|FG001|Overall Study|Adverse Event|2|||
160579111|NCT01455428|579840214|FG000|Overall Study|Lost to Follow-up|1|||
160579112|NCT01455428|579840215|FG001|Overall Study|Lost to Follow-up|1|||
160579113|NCT01455428|579840214|FG000|Overall Study|Withdrawal by Subject|2|||
160579114|NCT01455428|579840215|FG001|Overall Study|Withdrawal by Subject|5|||
160941960|NCT01109316|581176802|FG001|Study Period 2|Entry Criteria Not Met|1|||
160941961|NCT01109316|581176803|FG002|Study Period 2|Entry Criteria Not Met|0|||
160941962|NCT01109316|581176804|FG003|Study Period 2|Entry Criteria Not Met|0|||
160941963|NCT01109316|581176805|FG004|Study Period 2|Entry Criteria Not Met|0|||
160941964|NCT01109316|581176806|FG005|Study Period 2|Entry Criteria Not Met|0|||
160941965|NCT01109316|581176801|FG000|Study Period 2|Physician Decision|0|||
160941966|NCT01109316|581176802|FG001|Study Period 2|Physician Decision|0|||
160941967|NCT01109316|581176803|FG002|Study Period 2|Physician Decision|0|||
160941968|NCT01109316|581176804|FG003|Study Period 2|Physician Decision|1|||
160579115|NCT01455428|579840214|FG000|Overall Study|Did not meet entrance criteria|0|||
160579116|NCT01455428|579840215|FG001|Overall Study|Did not meet entrance criteria|2|||
160579117|NCT01455428|579840214|FG000|Overall Study|Insufficient clinical response|0|||
160579118|NCT01455428|579840215|FG001|Overall Study|Insufficient clinical response|2|||
160579119|NCT01455428|579840214|FG000|Overall Study|Did not receive treatment|1|||
160579120|NCT01455428|579840215|FG001|Overall Study|Did not receive treatment|1|||
160579121|NCT01455428|579840214|FG000|Overall Study|Other|2|||
160941969|NCT01109316|581176805|FG004|Study Period 2|Physician Decision|0|||
160941970|NCT01109316|581176806|FG005|Study Period 2|Physician Decision|0|||
160941971|NCT01109316|581176801|FG000|Study Period 2|Protocol Violation|1|||
160941972|NCT01109316|581176802|FG001|Study Period 2|Protocol Violation|0|||
160579122|NCT01455428|579840215|FG001|Overall Study|Other|4|||
160579123|NCT02062151|579840219|FG000|Overall Study|screen failure|1|||
160579124|NCT00257192|579840222|FG000|Overall Study|Adverse Event|21|||
160579125|NCT00257192|579840223|FG001|Overall Study|Adverse Event|10|||
160579126|NCT00257192|579840222|FG000|Overall Study|Laboratory abnormality|1|||
160579127|NCT00257192|579840223|FG001|Overall Study|Laboratory abnormality|1|||
160579128|NCT00257192|579840222|FG000|Overall Study|Lost to Follow-up|3|||
160579129|NCT00257192|579840223|FG001|Overall Study|Lost to Follow-up|3|||
160579130|NCT00257192|579840222|FG000|Overall Study|Insufficient clinical response|18|||
160579131|NCT00257192|579840223|FG001|Overall Study|Insufficient clinical response|18|||
160579132|NCT00257192|579840222|FG000|Overall Study|Withdrawal by Subject|14|||
160579133|NCT00257192|579840223|FG001|Overall Study|Withdrawal by Subject|2|||
160579134|NCT00257192|579840222|FG000|Overall Study|Randomized but not treated|0|||
160579135|NCT00257192|579840223|FG001|Overall Study|Randomized but not treated|1|||
160579136|NCT00257192|579840222|FG000|Overall Study|Study terminated by sponsor|1|||
160579137|NCT00257192|579840223|FG001|Overall Study|Study terminated by sponsor|0|||
160579138|NCT00257192|579840222|FG000|Overall Study|Miscellaneous|0|||
160579139|NCT00257192|579840223|FG001|Overall Study|Miscellaneous|4|||
160579140|NCT00751101|579840224|FG000|Overall Study|Withdrawal by Subject|1|||
160579141|NCT00751101|579840225|FG001|Overall Study|Withdrawal by Subject|0|||
160579142|NCT00751101|579840224|FG000|Overall Study|No HFS / Never Started Patch/|0|||
160579143|NCT00751101|579840225|FG001|Overall Study|No HFS / Never Started Patch/|4|||
160579144|NCT00751101|579840224|FG000|Overall Study|Never began capecitabine|1|||
160579145|NCT00751101|579840225|FG001|Overall Study|Never began capecitabine|0|||
160579146|NCT00751101|579840224|FG000|Overall Study|Physician Decision|0|||
160579147|NCT00751101|579840225|FG001|Overall Study|Physician Decision|1|||
160579148|NCT00844428|579840229|FG000|Screening Period|Screen Failure|3|||
160579149|NCT00844428|579840229|FG000|Extension Treatment Period|Death|1|||
160579150|NCT00844428|579840229|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
160579151|NCT02092389|579840230|FG000|Overall Study|Adverse Event|1|||
160579152|NCT02092389|579840230|FG000|Overall Study|Other|5|||
160579153|NCT01242020|579840231|FG000|Overall Study|Withdrawal by Subject|2|||
160579154|NCT01242020|579840232|FG001|Overall Study|Withdrawal by Subject|0|||
160579155|NCT01242020|579840231|FG000|Overall Study|Failed screening|1|||
160579156|NCT01242020|579840232|FG001|Overall Study|Failed screening|0|||
160579157|NCT02680847|579840233|FG000|Overall Study|Other|2|||
160941973|NCT01109316|581176803|FG002|Study Period 2|Protocol Violation|0|||
160941974|NCT01109316|581176804|FG003|Study Period 2|Protocol Violation|0|||
160941975|NCT01109316|581176805|FG004|Study Period 2|Protocol Violation|0|||
160941976|NCT01109316|581176806|FG005|Study Period 2|Protocol Violation|0|||
160941977|NCT01109316|581176801|FG000|Study Period 2|Withdrawal by Subject|0|||
160941978|NCT01109316|581176802|FG001|Study Period 2|Withdrawal by Subject|0|||
160941979|NCT01109316|581176803|FG002|Study Period 2|Withdrawal by Subject|1|||
160941980|NCT01109316|581176804|FG003|Study Period 2|Withdrawal by Subject|0|||
160941981|NCT01109316|581176805|FG004|Study Period 2|Withdrawal by Subject|0|||
160941982|NCT01109316|581176806|FG005|Study Period 2|Withdrawal by Subject|1|||
160941983|NCT01109316|581176801|FG000|Study Period 3|Lost to Follow-up|0|||
160941984|NCT01109316|581176802|FG001|Study Period 3|Lost to Follow-up|0|||
160941985|NCT01109316|581176803|FG002|Study Period 3|Lost to Follow-up|0|||
160941986|NCT01109316|581176804|FG003|Study Period 3|Lost to Follow-up|0|||
160941987|NCT01109316|581176805|FG004|Study Period 3|Lost to Follow-up|1|||
160941988|NCT01109316|581176806|FG005|Study Period 3|Lost to Follow-up|0|||
160941989|NCT01109316|581176801|FG000|Study Period 3|Withdrawal by Subject|1|||
160941990|NCT01109316|581176802|FG001|Study Period 3|Withdrawal by Subject|0|||
160941991|NCT01109316|581176803|FG002|Study Period 3|Withdrawal by Subject|0|||
160941992|NCT01109316|581176804|FG003|Study Period 3|Withdrawal by Subject|0|||
160941993|NCT01109316|581176805|FG004|Study Period 3|Withdrawal by Subject|1|||
160941994|NCT01109316|581176806|FG005|Study Period 3|Withdrawal by Subject|0|||
160941995|NCT01559311|581176811|FG000|Overall Study|Protocol Violation|0|||
160941996|NCT01559311|581176812|FG001|Overall Study|Protocol Violation|0|||
160941997|NCT01559311|581176813|FG002|Overall Study|Protocol Violation|2|||
160579158|NCT02680847|579840234|FG001|Overall Study|Other|0|||
160579159|NCT02680847|579840235|FG002|Overall Study|Other|0|||
160579160|NCT02680847|579840233|FG000|Overall Study|No longer met eligibility criteria|2|||
160579161|NCT02680847|579840234|FG001|Overall Study|No longer met eligibility criteria|2|||
160579162|NCT02680847|579840235|FG002|Overall Study|No longer met eligibility criteria|0|||
160941998|NCT01559311|581176811|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
160941999|NCT01559311|581176812|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
160942000|NCT01559311|581176813|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
160942001|NCT01559311|581176811|FG000|Overall Study|Withdrawal by Subject|2|||
160942002|NCT01559311|581176812|FG001|Overall Study|Withdrawal by Subject|1|||
160942003|NCT01559311|581176813|FG002|Overall Study|Withdrawal by Subject|0|||
160942004|NCT01559311|581176811|FG000|Overall Study|Death|0|||
160579163|NCT02680847|579840233|FG000|Overall Study|Unwilling to participate in study|1|||
160579164|NCT02680847|579840234|FG001|Overall Study|Unwilling to participate in study|1|||
160579165|NCT02680847|579840235|FG002|Overall Study|Unwilling to participate in study|0|||
160579166|NCT02680847|579840233|FG000|Overall Study|Lack of Efficacy|0|||
160579167|NCT02680847|579840234|FG001|Overall Study|Lack of Efficacy|0|||
160579168|NCT02680847|579840235|FG002|Overall Study|Lack of Efficacy|2|||
160579169|NCT02680847|579840233|FG000|Overall Study|Adverse Event|0|||
160579170|NCT02680847|579840234|FG001|Overall Study|Adverse Event|0|||
160579171|NCT02680847|579840235|FG002|Overall Study|Adverse Event|1|||
160579172|NCT01161524|579840241|FG000|Core Study (23 Weeks)|Adverse Event|3|||
160579173|NCT01161524|579840242|FG001|Core Study (23 Weeks)|Adverse Event|0|||
160579174|NCT01161524|579840243|FG002|Core Study (23 Weeks)|Adverse Event|0|||
160579175|NCT01161524|579840241|FG000|Core Study (23 Weeks)|Other|1|||
160579176|NCT01161524|579840242|FG001|Core Study (23 Weeks)|Other|0|||
160579177|NCT01161524|579840243|FG002|Core Study (23 Weeks)|Other|0|||
160579178|NCT01161524|579840241|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
160579179|NCT01161524|579840242|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
160579180|NCT01161524|579840243|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
160579181|NCT01161524|579840241|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
160579182|NCT01161524|579840242|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
160579183|NCT01161524|579840243|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
160579184|NCT01161524|579840241|FG000|Core Study (23 Weeks)|Subject Choice|3|||
160579185|NCT01161524|579840242|FG001|Core Study (23 Weeks)|Subject Choice|2|||
160579186|NCT01161524|579840243|FG002|Core Study (23 Weeks)|Subject Choice|0|||
160579187|NCT01161524|579840241|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
160579188|NCT01161524|579840242|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
160579189|NCT01161524|579840243|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
160579190|NCT01161524|579840241|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
160579191|NCT01161524|579840242|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
160579192|NCT01161524|579840243|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
160579193|NCT01161524|579840241|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
160579194|NCT01161524|579840242|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
160579195|NCT01161524|579840243|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
160579196|NCT01161524|579840241|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
160579197|NCT01161524|579840242|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
160579198|NCT01161524|579840243|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
160579199|NCT01161524|579840241|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
160942005|NCT01559311|581176812|FG001|Overall Study|Death|2|||
160942006|NCT01559311|581176813|FG002|Overall Study|Death|3|||
160942007|NCT01559311|581176811|FG000|Overall Study|Lost to Follow-up|0|||
160942008|NCT01559311|581176812|FG001|Overall Study|Lost to Follow-up|3|||
160942009|NCT01559311|581176813|FG002|Overall Study|Lost to Follow-up|2|||
160942010|NCT01559311|581176811|FG000|Overall Study|Adverse Event|0|||
160942011|NCT01559311|581176812|FG001|Overall Study|Adverse Event|0|||
160942012|NCT01559311|581176813|FG002|Overall Study|Adverse Event|1|||
160942013|NCT03027466|581176816|FG000|Overall Study|Opting out of the app|1869|||
160942014|NCT03027466|581176817|FG001|Overall Study|Opting out of the app|1819|||
160942015|NCT03027466|581176818|FG002|Overall Study|Opting out of the app|1743|||
160942016|NCT03027466|581176819|FG003|Overall Study|Opting out of the app|1821|||
160942017|NCT03286140|581176820|FG000|Overall Study|Withdrawal by Subject|10|||
160942018|NCT03286140|581176821|FG001|Overall Study|Withdrawal by Subject|5|||
160942019|NCT03286140|581176820|FG000|Overall Study|Lost to Follow-up|5|||
160942020|NCT03286140|581176821|FG001|Overall Study|Lost to Follow-up|10|||
160942021|NCT03286140|581176820|FG000|Overall Study|Failure to comply|0|||
160942022|NCT03286140|581176821|FG001|Overall Study|Failure to comply|1|||
160942023|NCT01826825|581176826|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
160942024|NCT01826825|581176827|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
160942025|NCT01858194|581176828|FG000|Overall Study|Total Artificial Heart Implant|0|||
160942026|NCT01858194|581176829|FG001|Overall Study|Total Artificial Heart Implant|1|||
160942027|NCT01858194|581176828|FG000|Overall Study|Lost to Follow-up|0|||
160942028|NCT01858194|581176829|FG001|Overall Study|Lost to Follow-up|1|||
160942029|NCT02158039|581176830|FG000|Overall Study|Withdrawal by Subject|1|||
160942030|NCT02158039|581176830|FG000|Overall Study|Screen Failure|9|||
160942031|NCT02563028|581176838|FG000|Overall Study|Lack of equipment|1|||
160942032|NCT02563028|581176838|FG000|Overall Study|Unable to elicit VEP post induction|1|||
160942033|NCT01856543|581176839|FG000|Overall Study|Treatment discontinued|6|||
160942034|NCT01856543|581176840|FG001|Overall Study|Treatment discontinued|3|||
160942035|NCT01856543|581176839|FG000|Overall Study|Withdrawn before start|7|||
160942036|NCT01856543|581176840|FG001|Overall Study|Withdrawn before start|3|||
160942037|NCT02188485|581176845|FG000|Overall Study|Withdrawal by Subject|2|||
160942038|NCT02188485|581176846|FG001|Overall Study|Withdrawal by Subject|1|||
160942039|NCT02188485|581176845|FG000|Overall Study|PI withdrew, lack of capacity|0|||
160942040|NCT02188485|581176846|FG001|Overall Study|PI withdrew, lack of capacity|2|||
160942041|NCT00799617|581176847|FG000|Main Testosterone Trial|Randomized in error|1|||
160942042|NCT00799617|581176848|FG001|Main Testosterone Trial|Randomized in error|1|||
160579200|NCT01161524|579840242|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
160579201|NCT01161524|579840243|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
160579202|NCT01618656|579840244|FG000|Overall Study|Withdrawal by Subject|7|||
160579203|NCT01618656|579840245|FG001|Overall Study|Withdrawal by Subject|3|||
160579204|NCT01618656|579840244|FG000|Overall Study|Physician Decision|1|||
160579205|NCT01618656|579840245|FG001|Overall Study|Physician Decision|1|||
160579206|NCT01276847|579840246|FG000|Overall Study|Withdrawal by Subject|1|||
160579207|NCT01276847|579840247|FG001|Overall Study|Withdrawal by Subject|0|||
160579208|NCT01276847|579840248|FG002|Overall Study|Withdrawal by Subject|0|||
160579209|NCT00504166|579840252|FG000|Overall Study|Adverse Event|1|||
160579210|NCT00504166|579840253|FG001|Overall Study|Adverse Event|4|||
160579211|NCT00504166|579840252|FG000|Overall Study|Withdrawal by Subject|3|||
160579212|NCT00504166|579840253|FG001|Overall Study|Withdrawal by Subject|6|||
160579213|NCT00504166|579840252|FG000|Overall Study|Physician Decision|1|||
160579214|NCT00504166|579840253|FG001|Overall Study|Physician Decision|1|||
160579215|NCT00504166|579840252|FG000|Overall Study|Lost to Follow-up|1|||
160579216|NCT00504166|579840253|FG001|Overall Study|Lost to Follow-up|3|||
160579217|NCT01096550|579840254|FG000|Overall Study|discontinued site|10|||
160579218|NCT01096550|579840255|FG001|Overall Study|discontinued site|11|||
160579219|NCT01096550|579840254|FG000|Overall Study|non-regular treatment track at clinic|1|||
160579220|NCT01096550|579840255|FG001|Overall Study|non-regular treatment track at clinic|1|||
160579221|NCT01096550|579840254|FG000|Overall Study|clinic readmission|1|||
160579222|NCT01096550|579840255|FG001|Overall Study|clinic readmission|1|||
160579223|NCT01096550|579840254|FG000|Overall Study|Withdrawal by Subject|0|||
160579224|NCT01096550|579840255|FG001|Overall Study|Withdrawal by Subject|1|||
160579225|NCT01096550|579840254|FG000|Overall Study|non-African American participant|13|||
160579226|NCT01096550|579840255|FG001|Overall Study|non-African American participant|6|||
160579227|NCT01096550|579840254|FG000|Overall Study|Lost to Follow-up|12|||
160579228|NCT01096550|579840255|FG001|Overall Study|Lost to Follow-up|9|||
160579229|NCT01345786|579840258|FG000|Overall Study|Adverse Event|0|||
160579230|NCT01345786|579840259|FG001|Overall Study|Adverse Event|1|||
160579231|NCT01345786|579840260|FG002|Overall Study|Adverse Event|3|||
160579232|NCT01345786|579840261|FG003|Overall Study|Adverse Event|1|||
160579233|NCT01345786|579840258|FG000|Overall Study|Subject withdrew consent|2|||
160579234|NCT01345786|579840259|FG001|Overall Study|Subject withdrew consent|2|||
160579235|NCT01345786|579840260|FG002|Overall Study|Subject withdrew consent|1|||
160579236|NCT01345786|579840261|FG003|Overall Study|Subject withdrew consent|0|||
160656072|NCT02130466|580120354|FG011|Overall Study|Withdrawal by Subject|0|||
160942043|NCT00799617|581176847|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
160998941|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998942|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998943|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998944|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998945|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998946|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
160998947|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
160998948|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
160998949|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
160579237|NCT01345786|579840258|FG000|Overall Study|Noncompliance with protocol|1|||
160579238|NCT01345786|579840259|FG001|Overall Study|Noncompliance with protocol|0|||
160579239|NCT01345786|579840260|FG002|Overall Study|Noncompliance with protocol|1|||
160579240|NCT01345786|579840261|FG003|Overall Study|Noncompliance with protocol|0|||
160579241|NCT01345786|579840258|FG000|Overall Study|Administrative|3|||
160656073|NCT02130466|580120355|FG012|Overall Study|Withdrawal by Subject|0|||
160942044|NCT00799617|581176848|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
160942045|NCT00799617|581176847|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
160942046|NCT00799617|581176848|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
160942047|NCT00799617|581176847|FG000|Sexual Funtion Trial|No Baseline Data|4|||
160942048|NCT00799617|581176848|FG001|Sexual Funtion Trial|No Baseline Data|7|||
160942049|NCT00799617|581176847|FG000|Physical Function Trial|Lost to Follow-up|6|||
160942050|NCT00799617|581176848|FG001|Physical Function Trial|Lost to Follow-up|11|||
160942051|NCT00799617|581176847|FG000|Vitality Trial|Lost to Follow-up|7|||
160942052|NCT00799617|581176848|FG001|Vitality Trial|Lost to Follow-up|22|||
160942053|NCT00799617|581176847|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
160942054|NCT00799617|581176848|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
160942055|NCT00799617|581176847|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
160942056|NCT00799617|581176848|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
160942057|NCT00799617|581176847|FG000|Bone Trial|Month 12 scan not available|6|||
160998950|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
160998951|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
160579242|NCT01345786|579840259|FG001|Overall Study|Administrative|5|||
160579243|NCT01345786|579840260|FG002|Overall Study|Administrative|0|||
160579244|NCT01345786|579840261|FG003|Overall Study|Administrative|0|||
160579245|NCT01345786|579840258|FG000|Overall Study|Lost to Follow-up|0|||
160579246|NCT01345786|579840259|FG001|Overall Study|Lost to Follow-up|0|||
160579247|NCT01345786|579840260|FG002|Overall Study|Lost to Follow-up|0|||
160942058|NCT00799617|581176848|FG001|Bone Trial|Month 12 scan not available|16|||
160942059|NCT00799617|581176847|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
160942060|NCT00799617|581176848|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
160942061|NCT00799617|581176847|FG000|Anemia Trial|Withdrawal by Subject|3|||
160942062|NCT00799617|581176848|FG001|Anemia Trial|Withdrawal by Subject|3|||
160942063|NCT04545515|581176849|FG000|Overall Study|Adverse Event|1|||
160942064|NCT04545515|581176849|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
160942065|NCT04545515|581176849|FG000|Overall Study|Commercial drug is available for participant|7|||
160942066|NCT02052466|581176850|FG000|Overall Study|Withdrawal by Subject|1|||
160942067|NCT02052466|581176850|FG000|Overall Study|Acromial fracture|1|||
160942068|NCT03851016|581176852|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
160942069|NCT03851016|581176853|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
160942070|NCT01660412|581176854|FG000|Overall Study|Protocol Violation|0|||
160942071|NCT01660412|581176855|FG001|Overall Study|Protocol Violation|3|||
160579248|NCT01345786|579840261|FG003|Overall Study|Lost to Follow-up|2|||
160579249|NCT02260193|579840262|FG000|Overall Study|Lack of Efficacy|0|||
160579250|NCT02260193|579840263|FG001|Overall Study|Lack of Efficacy|1|||
160579251|NCT02260193|579840264|FG002|Overall Study|Lack of Efficacy|6|||
160579252|NCT02260193|579840262|FG000|Overall Study|Adverse Event|3|||
160579253|NCT02260193|579840263|FG001|Overall Study|Adverse Event|4|||
160579254|NCT02260193|579840264|FG002|Overall Study|Adverse Event|1|||
160579255|NCT02260193|579840262|FG000|Overall Study|Protocol Violation|0|||
160579256|NCT02260193|579840263|FG001|Overall Study|Protocol Violation|4|||
160579257|NCT02260193|579840264|FG002|Overall Study|Protocol Violation|0|||
160579258|NCT02260193|579840262|FG000|Overall Study|Withdrawal by Subject|3|||
160579259|NCT02260193|579840263|FG001|Overall Study|Withdrawal by Subject|0|||
160579260|NCT02260193|579840264|FG002|Overall Study|Withdrawal by Subject|2|||
160579261|NCT02260193|579840262|FG000|Overall Study|Kidney Transplantation|0|||
160579262|NCT02260193|579840263|FG001|Overall Study|Kidney Transplantation|0|||
160579263|NCT02260193|579840264|FG002|Overall Study|Kidney Transplantation|1|||
160579264|NCT01963117|579840265|FG000|Overall Study|Death|1|||
160579265|NCT01070784|579840266|FG000|Overall Study|Withdrawal by Subject|6|||
160579266|NCT01070784|579840267|FG001|Overall Study|Withdrawal by Subject|9|||
160579267|NCT01070784|579840266|FG000|Overall Study|Adverse Event|14|||
160579268|NCT01070784|579840267|FG001|Overall Study|Adverse Event|9|||
160579269|NCT02518620|579840268|FG000|Overall Study|Adverse Event|23|||
160579270|NCT02518620|579840269|FG001|Overall Study|Adverse Event|11|||
160579271|NCT02518620|579840268|FG000|Overall Study|Lack of Efficacy|2|||
160579272|NCT02518620|579840269|FG001|Overall Study|Lack of Efficacy|0|||
160579273|NCT02518620|579840268|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160579274|NCT02518620|579840269|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160579275|NCT02518620|579840268|FG000|Overall Study|Physician Decision|1|||
160579276|NCT02518620|579840269|FG001|Overall Study|Physician Decision|1|||
160942072|NCT02080091|581178416|FG000|Overall Study|Study Terminated|22|||
160942073|NCT02080091|581178416|FG000|Overall Study|Death|1|||
160942074|NCT02080091|581178416|FG000|Overall Study|Withdrawal by Subject|1|||
160942075|NCT02080091|581178416|FG000|Overall Study|Other|1|||
160579277|NCT02518620|579840268|FG000|Overall Study|Sponsor's Decision|0|||
160579278|NCT02518620|579840269|FG001|Overall Study|Sponsor's Decision|3|||
160579279|NCT02518620|579840268|FG000|Overall Study|Lost to Follow-up|1|||
160579280|NCT02518620|579840269|FG001|Overall Study|Lost to Follow-up|1|||
160579281|NCT02518620|579840268|FG000|Overall Study|Withdrawal by Subject|17|||
160579282|NCT02518620|579840269|FG001|Overall Study|Withdrawal by Subject|9|||
160942076|NCT03019536|581178417|FG000|Overall Study|Withdrawal by Subject|1|||
160942077|NCT03019536|581178418|FG001|Overall Study|Withdrawal by Subject|1|||
160942078|NCT03019536|581178419|FG002|Overall Study|Withdrawal by Subject|0|||
160942079|NCT03019536|581178417|FG000|Overall Study|Adverse Event|0|||
160942080|NCT03019536|581178418|FG001|Overall Study|Adverse Event|0|||
160942081|NCT03019536|581178419|FG002|Overall Study|Adverse Event|2|||
160942082|NCT03143829|581178423|FG000|Overall Study|Withdrawal by Subject|2|||
160942083|NCT03143829|581178424|FG001|Overall Study|Withdrawal by Subject|5|||
160942084|NCT03143829|581178423|FG000|Overall Study|Lost to Follow-up|0|||
160942085|NCT03143829|581178424|FG001|Overall Study|Lost to Follow-up|2|||
160942086|NCT03143829|581178423|FG000|Overall Study|Death|1|||
160942087|NCT03143829|581178424|FG001|Overall Study|Death|1|||
160942088|NCT03143829|581178423|FG000|Overall Study|changed treatment, no longer eligible|2|||
160942089|NCT03143829|581178424|FG001|Overall Study|changed treatment, no longer eligible|2|||
160942090|NCT02212730|581178426|FG000|Overall Study|Tumor not of the required cell histology|1|||
160942091|NCT02212730|581178427|FG001|Overall Study|Tumor not of the required cell histology|0|||
160942092|NCT02212730|581178426|FG000|Overall Study|Withdrawal by Subject|1|||
160942093|NCT02212730|581178427|FG001|Overall Study|Withdrawal by Subject|0|||
160942094|NCT02212730|581178426|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
160942095|NCT02212730|581178427|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
160942096|NCT02057757|581178428|FG000|Overall Study|Withdrawal by Subject|3|||
160942097|NCT02057757|581178429|FG001|Overall Study|Withdrawal by Subject|5|||
160942098|NCT02057757|581178428|FG000|Overall Study|Death|2|||
160942099|NCT02057757|581178429|FG001|Overall Study|Death|0|||
160942100|NCT02057757|581178428|FG000|Overall Study|Lost to Follow-up|8|||
160942101|NCT02057757|581178429|FG001|Overall Study|Lost to Follow-up|3|||
160942102|NCT02057757|581178428|FG000|Overall Study|Non-compliance|1|||
160942103|NCT02057757|581178429|FG001|Overall Study|Non-compliance|0|||
160942104|NCT00440271|581178430|FG000|Overall Study|Protocol Violation|1|||
160942105|NCT00440271|581178431|FG001|Overall Study|Protocol Violation|1|||
160942106|NCT00440271|581178430|FG000|Overall Study|Adverse Event|0|||
160998952|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
160998953|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
160998954|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
160998955|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
160998956|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
160998957|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998958|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
160579283|NCT02518620|579840268|FG000|Overall Study|Death|1|||
160579284|NCT02518620|579840269|FG001|Overall Study|Death|0|||
160579285|NCT02518620|579840268|FG000|Overall Study|Pregnancy Wish|3|||
160579286|NCT02518620|579840269|FG001|Overall Study|Pregnancy Wish|0|||
160579287|NCT02518620|579840268|FG000|Overall Study|Pregnancy|1|||
160579288|NCT02518620|579840269|FG001|Overall Study|Pregnancy|0|||
160579289|NCT02518620|579840268|FG000|Overall Study|Relocation|2|||
160579290|NCT02518620|579840269|FG001|Overall Study|Relocation|1|||
160579291|NCT03844633|579840273|FG000|1 Week FU|Lost to Follow-up|0|||
160579292|NCT03844633|579840274|FG001|1 Week FU|Lost to Follow-up|1|||
160579293|NCT03844633|579840275|FG002|1 Week FU|Lost to Follow-up|4|||
160579294|NCT03844633|579840273|FG000|12-month Follow-up|Lost to Follow-up|7|||
160579295|NCT03844633|579840274|FG001|12-month Follow-up|Lost to Follow-up|5|||
160579296|NCT03844633|579840275|FG002|12-month Follow-up|Lost to Follow-up|8|||
160579297|NCT02588248|579840280|FG000|Overall Study|Physician Decision|4|||
160579298|NCT02588248|579840281|FG001|Overall Study|Physician Decision|3|||
160579299|NCT01355068|579840282|FG000|First Intervention Period|Adverse Event|0|||
160579300|NCT01355068|579840283|FG001|First Intervention Period|Adverse Event|1|||
160579301|NCT01355068|579840282|FG000|First Intervention Period|Withdrawal by Subject|0|||
160579302|NCT01355068|579840283|FG001|First Intervention Period|Withdrawal by Subject|1|||
160579303|NCT04229446|579840284|FG000|Overall Study|Death|12|||
160579304|NCT04229446|579840285|FG001|Overall Study|Death|10|||
160579305|NCT04229446|579840284|FG000|Overall Study|Lost to Follow-up|5|||
160579306|NCT04229446|579840285|FG001|Overall Study|Lost to Follow-up|8|||
160579307|NCT04191967|579841705|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
160579308|NCT04191967|579841705|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
160579309|NCT02322892|579841708|FG000|Overall Study|Surgery cancelled|1|||
160579310|NCT02322892|579841709|FG001|Overall Study|Surgery cancelled|2|||
160579311|NCT02322892|579841708|FG000|Overall Study|Met exclusion criteria|0|||
160942107|NCT00440271|581178431|FG001|Overall Study|Adverse Event|1|||
160942108|NCT00440271|581178430|FG000|Overall Study|Lost to Follow-up|1|||
160942109|NCT00440271|581178431|FG001|Overall Study|Lost to Follow-up|0|||
160942110|NCT00440271|581178430|FG000|Overall Study|Withdrawal by Subject|0|||
160942111|NCT00440271|581178431|FG001|Overall Study|Withdrawal by Subject|2|||
160942112|NCT00440271|581178430|FG000|Overall Study|Lack of Efficacy|0|||
160942113|NCT00440271|581178431|FG001|Overall Study|Lack of Efficacy|1|||
160942114|NCT00440271|581178430|FG000|Overall Study|Due to closure of trial|8|||
160942115|NCT00440271|581178431|FG001|Overall Study|Due to closure of trial|10|||
160942116|NCT00440271|581178430|FG000|Overall Study|Other|2|||
160942117|NCT00440271|581178431|FG001|Overall Study|Other|0|||
160998959|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998960|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998961|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
160998962|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
160998963|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998964|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998965|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998966|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998967|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998968|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
160579312|NCT02322892|579841709|FG001|Overall Study|Met exclusion criteria|1|||
160942118|NCT04086472|581178443|FG000|Overall Study|Lost to Follow-up|1|||
160942119|NCT04086472|581178444|FG001|Overall Study|Lost to Follow-up|0|||
160942120|NCT04086472|581178445|FG002|Overall Study|Lost to Follow-up|0|||
160579313|NCT02322892|579841708|FG000|Overall Study|Protocol Violation|1|||
160579314|NCT02322892|579841709|FG001|Overall Study|Protocol Violation|0|||
160579315|NCT02601001|579841714|FG000|Dosing Period 2|Adverse Event|0|||
160579316|NCT02601001|579841715|FG001|Dosing Period 2|Adverse Event|0|||
160579317|NCT02601001|579841716|FG002|Dosing Period 2|Adverse Event|0|||
160942121|NCT04086472|581178446|FG003|Overall Study|Lost to Follow-up|0|||
160998969|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
160942122|NCT04086472|581178447|FG004|Overall Study|Lost to Follow-up|1|||
160942123|NCT04086472|581178443|FG000|Overall Study|Physician Decision|0|||
160942124|NCT04086472|581178444|FG001|Overall Study|Physician Decision|1|||
160942125|NCT04086472|581178445|FG002|Overall Study|Physician Decision|1|||
160942126|NCT04086472|581178446|FG003|Overall Study|Physician Decision|0|||
160942127|NCT04086472|581178447|FG004|Overall Study|Physician Decision|0|||
160942128|NCT04086472|581178443|FG000|Overall Study|Withdrawal by Subject|1|||
160942129|NCT04086472|581178444|FG001|Overall Study|Withdrawal by Subject|1|||
160942130|NCT04086472|581178445|FG002|Overall Study|Withdrawal by Subject|1|||
160942131|NCT04086472|581178446|FG003|Overall Study|Withdrawal by Subject|0|||
160942132|NCT04086472|581178447|FG004|Overall Study|Withdrawal by Subject|0|||
160942133|NCT04086472|581178443|FG000|Overall Study|Various reasons|2|||
160942134|NCT04086472|581178444|FG001|Overall Study|Various reasons|0|||
160942135|NCT04086472|581178445|FG002|Overall Study|Various reasons|0|||
160942136|NCT04086472|581178446|FG003|Overall Study|Various reasons|3|||
160942137|NCT04086472|581178447|FG004|Overall Study|Various reasons|1|||
160942138|NCT03348904|581178448|FG000|Overall Study|Administrative reason by the sponsor|0|||
160942139|NCT03348904|581178449|FG001|Overall Study|Administrative reason by the sponsor|1|||
160942140|NCT03348904|581178450|FG002|Overall Study|Administrative reason by the sponsor|0|||
160942141|NCT00436280|581178456|FG000|Period 1: Induction|Adverse Event|8|||
160942142|NCT00436280|581178456|FG000|Period 1: Induction|Progressive Disease|12|||
160942143|NCT00436280|581178456|FG000|Period 1: Induction|Stable Disease|6|||
160942144|NCT00436280|581178456|FG000|Period 1: Induction|Withdrawal by Subject|1|||
160942145|NCT00436280|581178456|FG000|Period 1: Induction|Death|1|||
160942146|NCT00436280|581178456|FG000|Period 2: Consolidation|Adverse Event|1|||
160942147|NCT00436280|581178456|FG000|Period 2: Consolidation|Progressive Disease|10|||
160942148|NCT00436280|581178456|FG000|Period 2: Consolidation|Stable Disease|1|||
160942149|NCT00436280|581178456|FG000|Period 2: Consolidation|Physician Decision|2|||
160942150|NCT00436280|581178456|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
160942151|NCT00436280|581178456|FG000|Period 2: Consolidation|Death|1|||
160942152|NCT00436280|581178456|FG000|Period 3: Maintenance|Adverse Event|6|||
160942153|NCT00436280|581178456|FG000|Period 3: Maintenance|Progressive Disease|12|||
160942154|NCT00048724|581178457|FG000|Overall Study|Adverse Event|53|||
160942155|NCT00048724|581178458|FG001|Overall Study|Adverse Event|12|||
160942156|NCT00048724|581178457|FG000|Overall Study|Withdrawal by Subject|34|||
160942157|NCT00048724|581178458|FG001|Overall Study|Withdrawal by Subject|54|||
160942158|NCT00048724|581178457|FG000|Overall Study|Lost to Follow-up|5|||
160942159|NCT00048724|581178458|FG001|Overall Study|Lost to Follow-up|5|||
160942160|NCT00048724|581178457|FG000|Overall Study|Protocol-defined Clinical Event|17|||
160942161|NCT00048724|581178458|FG001|Overall Study|Protocol-defined Clinical Event|32|||
160942162|NCT00048724|581178457|FG000|Overall Study|Noncompliance With Protocol|4|||
160942163|NCT00048724|581178458|FG001|Overall Study|Noncompliance With Protocol|12|||
160942164|NCT00048724|581178457|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
160942165|NCT00048724|581178458|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
160942166|NCT00048724|581178457|FG000|Overall Study|Administrative|1|||
160942167|NCT00048724|581178458|FG001|Overall Study|Administrative|1|||
160942168|NCT03586869|581178459|FG000|Overall Study|Progressive Disease|3|||
160942169|NCT04116229|581178460|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
160942170|NCT04116229|581178461|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
160942171|NCT04116229|581178460|FG000|Overall Study|Scheduling not possible.|0|||
160942172|NCT04116229|581178461|FG001|Overall Study|Scheduling not possible.|1|||
160942173|NCT02809976|581178464|FG000|Overall Study|Lost to Follow-up|1|||
160942174|NCT02809976|581178464|FG000|Overall Study|Withdrawal by Subject|1|||
160942175|NCT00226941|581178465|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
160942176|NCT00226941|581178466|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
160942177|NCT00226941|581178467|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
160942178|NCT00226941|581178468|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
160998970|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
160998971|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
160942179|NCT00226941|581178465|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
160942180|NCT00226941|581178466|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
160942181|NCT00226941|581178467|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
160942182|NCT00226941|581178468|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
160942183|NCT01163682|581178470|FG000|Overall Study|Lost to Follow-up|6|||
160942184|NCT01163682|581178471|FG001|Overall Study|Lost to Follow-up|9|||
160942185|NCT00211081|581178473|FG000|Overall Study|Withdrawal by Subject|2|||
160942186|NCT01931839|581178474|FG000|Overall Study|Death|0|||
160942187|NCT01931839|581178475|FG001|Overall Study|Death|1|||
160942188|NCT01931839|581178476|FG002|Overall Study|Death|2|||
160942189|NCT01931839|581178477|FG003|Overall Study|Death|0|||
160942190|NCT01931839|581178478|FG004|Overall Study|Death|0|||
160942191|NCT01931839|581178479|FG005|Overall Study|Death|0|||
160942192|NCT01931839|581178480|FG006|Overall Study|Death|0|||
160942193|NCT01931839|581178474|FG000|Overall Study|Physician Decision|1|||
160998972|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
160998973|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
160998974|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
160998975|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
160998976|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
160998977|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
160998978|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
160998979|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160998980|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160998981|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160998982|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160998983|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160455777|NCT02240238|579399761|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160455778|NCT02240238|579399762|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160998984|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160998985|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
160998986|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
160998987|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
160998988|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
160998989|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
160998990|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160998991|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160998992|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160998993|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160998994|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160998995|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160579318|NCT02601001|579841717|FG003|Dosing Period 2|Adverse Event|0|||
160579319|NCT02601001|579841718|FG004|Dosing Period 2|Adverse Event|0|||
160579320|NCT02601001|579841719|FG005|Dosing Period 2|Adverse Event|0|||
160579321|NCT02601001|579841720|FG006|Dosing Period 2|Adverse Event|1|||
160579322|NCT01790438|579841721|FG000|Overall Study|Adverse Event|3|||
160579323|NCT01790438|579841722|FG001|Overall Study|Adverse Event|2|||
160579324|NCT01790438|579841721|FG000|Overall Study|Death|4|||
160579325|NCT01790438|579841722|FG001|Overall Study|Death|0|||
160579326|NCT01790438|579841721|FG000|Overall Study|Lost to Follow-up|5|||
160579327|NCT01790438|579841722|FG001|Overall Study|Lost to Follow-up|2|||
160579328|NCT01790438|579841721|FG000|Overall Study|Withdrawal by Subject|13|||
160579329|NCT01790438|579841722|FG001|Overall Study|Withdrawal by Subject|2|||
160579330|NCT01790438|579841721|FG000|Overall Study|Physician Decision|3|||
160579331|NCT01790438|579841722|FG001|Overall Study|Physician Decision|1|||
160579332|NCT01790438|579841721|FG000|Overall Study|Sponsor Decision|0|||
160579333|NCT01790438|579841722|FG001|Overall Study|Sponsor Decision|3|||
160579334|NCT01790438|579841721|FG000|Overall Study|Protocol Required Discontinuation|7|||
160579335|NCT01790438|579841722|FG001|Overall Study|Protocol Required Discontinuation|1|||
160579336|NCT01356602|579841725|FG000|Overall Study|Protocol Deviation|0|||
160579337|NCT01356602|579841726|FG001|Overall Study|Protocol Deviation|1|||
160579338|NCT01356602|579841727|FG002|Overall Study|Protocol Deviation|1|||
160579339|NCT01356602|579841725|FG000|Overall Study|Administrative Problems|1|||
160579340|NCT01356602|579841726|FG001|Overall Study|Administrative Problems|4|||
160579341|NCT01356602|579841727|FG002|Overall Study|Administrative Problems|5|||
160579342|NCT01356602|579841725|FG000|Overall Study|Lost to Follow-up|4|||
160579343|NCT01356602|579841726|FG001|Overall Study|Lost to Follow-up|5|||
160579344|NCT01356602|579841727|FG002|Overall Study|Lost to Follow-up|6|||
160579345|NCT01356602|579841725|FG000|Overall Study|Withdrawal by Subject|4|||
160998996|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
160455779|NCT02240238|579399763|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160455780|NCT02240238|579399764|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160455781|NCT02240238|579399765|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160455782|NCT02240238|579399766|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160455783|NCT02240238|579399767|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160455784|NCT02240238|579399768|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160579346|NCT01356602|579841726|FG001|Overall Study|Withdrawal by Subject|3|||
160579347|NCT01356602|579841727|FG002|Overall Study|Withdrawal by Subject|7|||
160579348|NCT01356602|579841725|FG000|Overall Study|Lack of Efficacy|0|||
160579349|NCT01356602|579841726|FG001|Overall Study|Lack of Efficacy|1|||
160579350|NCT01356602|579841727|FG002|Overall Study|Lack of Efficacy|4|||
160579351|NCT01356602|579841725|FG000|Overall Study|Adverse Event|0|||
160942194|NCT01931839|581178475|FG001|Overall Study|Physician Decision|0|||
160942195|NCT01931839|581178476|FG002|Overall Study|Physician Decision|1|||
160942196|NCT01931839|581178477|FG003|Overall Study|Physician Decision|0|||
160942197|NCT01931839|581178478|FG004|Overall Study|Physician Decision|0|||
160942198|NCT01931839|581178479|FG005|Overall Study|Physician Decision|0|||
160942199|NCT01931839|581178480|FG006|Overall Study|Physician Decision|1|||
160942200|NCT01931839|581178474|FG000|Overall Study|Withdrawal of consent|0|||
160942201|NCT01931839|581178475|FG001|Overall Study|Withdrawal of consent|0|||
160998997|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
160998998|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
160998999|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160999000|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
160999001|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999002|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999003|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999004|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999005|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999006|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999007|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
160999008|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
160999009|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
160999010|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
160999011|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
160999012|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
160999013|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
160999014|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
160999015|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
160999016|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
160999017|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
160999018|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
160999019|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
160999020|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
160999021|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
160999022|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
160999023|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999024|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999025|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999026|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999027|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999028|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999029|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999030|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
160999031|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
160999032|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999033|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999034|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999035|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999036|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999037|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999038|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999039|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999040|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999041|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999042|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
160999043|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
160999044|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999045|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999046|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999047|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160455785|NCT02240238|579399769|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160579352|NCT01356602|579841726|FG001|Overall Study|Adverse Event|1|||
160579353|NCT01356602|579841727|FG002|Overall Study|Adverse Event|1|||
160999048|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999049|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160579354|NCT03123354|579841728|FG000|Overall Study|Physician Decision|6|||
160942202|NCT01931839|581178476|FG002|Overall Study|Withdrawal of consent|0|||
160942203|NCT01931839|581178477|FG003|Overall Study|Withdrawal of consent|0|||
160942204|NCT01931839|581178478|FG004|Overall Study|Withdrawal of consent|1|||
160942205|NCT01931839|581178479|FG005|Overall Study|Withdrawal of consent|0|||
160942206|NCT01931839|581178480|FG006|Overall Study|Withdrawal of consent|0|||
160942207|NCT01931839|581178474|FG000|Overall Study|Adverse Event|9|||
160942208|NCT01931839|581178475|FG001|Overall Study|Adverse Event|4|||
160942209|NCT01931839|581178476|FG002|Overall Study|Adverse Event|1|||
160942210|NCT01931839|581178477|FG003|Overall Study|Adverse Event|3|||
160942211|NCT01931839|581178478|FG004|Overall Study|Adverse Event|0|||
160942212|NCT01931839|581178479|FG005|Overall Study|Adverse Event|0|||
160942213|NCT01931839|581178480|FG006|Overall Study|Adverse Event|1|||
160942214|NCT01931839|581178474|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
160942215|NCT01931839|581178475|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
160942216|NCT01931839|581178476|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
160942217|NCT01931839|581178477|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
160942218|NCT01931839|581178478|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
160942219|NCT01931839|581178479|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
160942220|NCT01931839|581178480|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
160942221|NCT01931839|581178474|FG000|Overall Study|Other non-compliance|15|||
160942222|NCT01931839|581178475|FG001|Overall Study|Other non-compliance|9|||
160579355|NCT01931462|579841729|FG000|Overall Study|Withdrawal by Subject|1|||
160579356|NCT04907539|579841730|FG000|Overall Study|Consent withdrawn|1|||
160579357|NCT04907539|579841731|FG001|Overall Study|Consent withdrawn|0|||
160579358|NCT04907539|579841730|FG000|Overall Study|Death|14|||
160579359|NCT04907539|579841731|FG001|Overall Study|Death|3|||
160579360|NCT01701583|579841732|FG000|Overall Study|Withdrawal by Subject|2|||
160579361|NCT01701583|579841733|FG001|Overall Study|Withdrawal by Subject|0|||
160579362|NCT05070429|579841734|FG000|Overall Study|Death|0|||
160579363|NCT05070429|579841735|FG001|Overall Study|Death|4|||
160579364|NCT05070429|579841734|FG000|Overall Study|Withdrawal by Subject|2|||
160579365|NCT05070429|579841735|FG001|Overall Study|Withdrawal by Subject|1|||
160579366|NCT05070429|579841734|FG000|Overall Study|Other|15|||
160579367|NCT05070429|579841735|FG001|Overall Study|Other|5|||
160579368|NCT03041116|579841736|FG000|Double-blind|Death|0|||
160579369|NCT03041116|579841737|FG001|Double-blind|Death|2|||
160579370|NCT03041116|579841736|FG000|Double-blind|Withdrawal by Subject|0|||
160579371|NCT03041116|579841737|FG001|Double-blind|Withdrawal by Subject|4|||
160579372|NCT03041116|579841736|FG000|Open-label|Death|1|||
160579373|NCT03041116|579841737|FG001|Open-label|Death|0|||
160579374|NCT03041116|579841736|FG000|Open-label|Termination of the study by Sponsor|39|||
160579375|NCT03041116|579841737|FG001|Open-label|Termination of the study by Sponsor|37|||
160579376|NCT03041116|579841736|FG000|Open-label|Withdrawal by Subject|1|||
160579377|NCT03041116|579841737|FG001|Open-label|Withdrawal by Subject|0|||
160579378|NCT01345123|579841738|FG000|Overall Study|participants no longer with health plan|79|||
160579379|NCT01345123|579841739|FG001|Overall Study|participants no longer with health plan|85|||
160579380|NCT01345123|579841740|FG002|Overall Study|participants no longer with health plan|88|||
160579381|NCT01798134|579841741|FG000|Overall Study|Lost to Follow-up|1|||
160579382|NCT01798134|579841741|FG000|Overall Study|Withdrawal by Subject|3|||
160579383|NCT01798134|579841741|FG000|Overall Study|Death|2|||
160579384|NCT01798134|579841741|FG000|Overall Study|Adverse Event|3|||
160579385|NCT01798134|579841741|FG000|Overall Study|Physician Decision|3|||
160579386|NCT01798134|579841741|FG000|Overall Study|Liver transplant/surgery|4|||
160579387|NCT02436577|579841742|FG000|Overall Study|Protocol Deviation|0|||
160579388|NCT02436577|579841743|FG001|Overall Study|Protocol Deviation|1|||
160579389|NCT02436577|579841744|FG002|Overall Study|Protocol Deviation|0|||
160579390|NCT02436577|579841745|FG003|Overall Study|Protocol Deviation|0|||
160579391|NCT02436577|579841746|FG004|Overall Study|Protocol Deviation|0|||
160579392|NCT02436577|579841747|FG005|Overall Study|Protocol Deviation|0|||
160579393|NCT00615290|579841748|FG000|Overall Study|Adverse Event|2|||
160579394|NCT00615290|579841748|FG000|Overall Study|Lost to Follow-up|3|||
160579395|NCT00615290|579841748|FG000|Overall Study|Withdrawal by Subject|1|||
160942223|NCT01931839|581178476|FG002|Overall Study|Other non-compliance|12|||
160942224|NCT01931839|581178477|FG003|Overall Study|Other non-compliance|3|||
160579396|NCT00615290|579841748|FG000|Overall Study|Other|2|||
160579397|NCT01675531|579841751|FG000|Overall Study|Adverse Event|9|||
160579398|NCT01675531|579841751|FG000|Overall Study|Withdrawal by Subject|7|||
160579399|NCT01675531|579841751|FG000|Overall Study|Lack of Efficacy|1|||
160579400|NCT01675531|579841751|FG000|Overall Study|Protocol Violation|8|||
160579401|NCT02853331|579841752|FG000|Overall Study|Death|59|||
160579402|NCT02853331|579841753|FG001|Overall Study|Death|95|||
160579403|NCT02853331|579841752|FG000|Overall Study|Withdrawal by Subject|5|||
160579404|NCT02853331|579841753|FG001|Overall Study|Withdrawal by Subject|9|||
160579405|NCT02853331|579841752|FG000|Overall Study|Ongoing in study|368|||
160579406|NCT02853331|579841753|FG001|Overall Study|Ongoing in study|325|||
160579407|NCT00570739|579841754|FG000|Overall Study|Adverse Event|8|||
160656074|NCT02130466|580120356|FG013|Overall Study|Withdrawal by Subject|0|||
160942225|NCT01931839|581178478|FG004|Overall Study|Other non-compliance|0|||
160942226|NCT01931839|581178479|FG005|Overall Study|Other non-compliance|3|||
160656075|NCT00336024|580120357|FG000|Overall Study|Death|2|||
160656076|NCT00336024|580120358|FG001|Overall Study|Death|1|||
160656077|NCT00336024|580120357|FG000|Overall Study|Physician Decision|4|||
160656078|NCT00336024|580120358|FG001|Overall Study|Physician Decision|1|||
160656079|NCT00336024|580120357|FG000|Overall Study|Protocol Violation|1|||
160656080|NCT00336024|580120358|FG001|Overall Study|Protocol Violation|0|||
160656081|NCT00336024|580120357|FG000|Overall Study|Withdrawal by Subject|1|||
160999050|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999051|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999052|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999053|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999054|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
160999055|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999056|NCT00639002|581380661|FG000|Overall Study|Death|1|||
160999057|NCT00639002|581380661|FG000|Overall Study|Adverse Event|1|||
160999058|NCT00639002|581380661|FG000|Overall Study|Protocol Violation|1|||
160999059|NCT00639002|581380661|FG000|Overall Study|Disease progression|3|||
160999060|NCT00639002|581380661|FG000|Overall Study|Physician Decision|6|||
160999061|NCT00639002|581380661|FG000|Overall Study|Lack of Efficacy|1|||
160579408|NCT00570739|579841755|FG001|Overall Study|Adverse Event|6|||
160579409|NCT00570739|579841756|FG002|Overall Study|Adverse Event|2|||
160579410|NCT00570739|579841757|FG003|Overall Study|Adverse Event|2|||
160579411|NCT00570739|579841754|FG000|Overall Study|Lost to Follow-up|4|||
160579412|NCT00570739|579841755|FG001|Overall Study|Lost to Follow-up|5|||
160579413|NCT00570739|579841756|FG002|Overall Study|Lost to Follow-up|4|||
160579414|NCT00570739|579841757|FG003|Overall Study|Lost to Follow-up|1|||
160579415|NCT00570739|579841754|FG000|Overall Study|Physician Decision|1|||
160579416|NCT00570739|579841755|FG001|Overall Study|Physician Decision|1|||
160579417|NCT00570739|579841756|FG002|Overall Study|Physician Decision|0|||
160579418|NCT00570739|579841757|FG003|Overall Study|Physician Decision|0|||
160579419|NCT00570739|579841754|FG000|Overall Study|Withdrawal by Subject|7|||
160579420|NCT00570739|579841755|FG001|Overall Study|Withdrawal by Subject|7|||
160579421|NCT00570739|579841756|FG002|Overall Study|Withdrawal by Subject|3|||
160579422|NCT00570739|579841757|FG003|Overall Study|Withdrawal by Subject|5|||
160579423|NCT00570739|579841754|FG000|Overall Study|Required restricted medication|0|||
160579424|NCT00570739|579841755|FG001|Overall Study|Required restricted medication|0|||
160579425|NCT00570739|579841756|FG002|Overall Study|Required restricted medication|1|||
160579426|NCT00570739|579841757|FG003|Overall Study|Required restricted medication|0|||
160579427|NCT00570739|579841754|FG000|Overall Study|Met discontinuation criteria|1|||
160579428|NCT00570739|579841755|FG001|Overall Study|Met discontinuation criteria|0|||
160579429|NCT00570739|579841756|FG002|Overall Study|Met discontinuation criteria|1|||
160579430|NCT00570739|579841757|FG003|Overall Study|Met discontinuation criteria|1|||
160579431|NCT00570739|579841754|FG000|Overall Study|Other|0|||
160579432|NCT00570739|579841755|FG001|Overall Study|Other|2|||
160579433|NCT00570739|579841756|FG002|Overall Study|Other|5|||
160579434|NCT00570739|579841757|FG003|Overall Study|Other|3|||
160579435|NCT02086565|579841759|FG000|Overall Study|Lost to Follow-up|9|||
160579436|NCT02086565|579841760|FG001|Overall Study|Lost to Follow-up|7|||
160579437|NCT02086565|579841759|FG000|Overall Study|Withdrawal by Subject|2|||
160579438|NCT02086565|579841760|FG001|Overall Study|Withdrawal by Subject|1|||
160579439|NCT02086565|579841759|FG000|Overall Study|Death|3|||
160656082|NCT00336024|580120358|FG001|Overall Study|Withdrawal by Subject|2|||
160656083|NCT00336024|580120357|FG000|Overall Study|Failure to fulfill consolidation|1|||
160656084|NCT00336024|580120358|FG001|Overall Study|Failure to fulfill consolidation|1|||
160999062|NCT00768651|581380664|FG000|Overall Study|Withdrawal by Subject|1|||
160999063|NCT02357784|581380665|FG000|Overall Study|Withdrawal by Subject|1|||
160999064|NCT01697319|581380667|FG000|Primary Phase|Withdrawal by Subject|1|||
160999065|NCT01697319|581380667|FG000|Extension Phase|Terminated by Sponsor|15|||
160579440|NCT02086565|579841760|FG001|Overall Study|Death|2|||
160579441|NCT02086565|579841759|FG000|Overall Study|withdrawn by research team|2|||
160999066|NCT04222959|581380670|FG000|Overall Study|Lost to Follow-up|76|||
160579442|NCT02086565|579841760|FG001|Overall Study|withdrawn by research team|2|||
160579443|NCT00739297|579841761|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
160579444|NCT00739297|579841762|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
160579445|NCT00739297|579841763|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
160579446|NCT00739297|579841764|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
160579447|NCT00739297|579841765|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
160579448|NCT00739297|579841766|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
160656085|NCT00336024|580120357|FG000|Overall Study|Progressive Disease|4|||
160999067|NCT04222959|581380671|FG001|Overall Study|Lost to Follow-up|28|||
160999068|NCT04248829|581380675|FG000|Overall Study|Disease progression|44|||
160999069|NCT04248829|581380676|FG001|Overall Study|Disease progression|109|||
160579449|NCT00739297|579841767|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
160579450|NCT00739297|579841761|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
160579451|NCT00739297|579841762|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
160942227|NCT01931839|581178480|FG006|Overall Study|Other non-compliance|0|||
160942228|NCT01931839|581178474|FG000|Overall Study|Lost to Follow-up|1|||
160942229|NCT01931839|581178475|FG001|Overall Study|Lost to Follow-up|2|||
160942230|NCT01931839|581178476|FG002|Overall Study|Lost to Follow-up|4|||
160942231|NCT01931839|581178477|FG003|Overall Study|Lost to Follow-up|5|||
160942232|NCT01931839|581178478|FG004|Overall Study|Lost to Follow-up|0|||
160942233|NCT01931839|581178479|FG005|Overall Study|Lost to Follow-up|0|||
160942234|NCT01931839|581178480|FG006|Overall Study|Lost to Follow-up|0|||
160942235|NCT01931839|581178474|FG000|Overall Study|Other|4|||
160942236|NCT01931839|581178475|FG001|Overall Study|Other|2|||
160942237|NCT01931839|581178476|FG002|Overall Study|Other|6|||
160942238|NCT01931839|581178477|FG003|Overall Study|Other|0|||
160942239|NCT01931839|581178478|FG004|Overall Study|Other|0|||
160942240|NCT01931839|581178479|FG005|Overall Study|Other|0|||
160942241|NCT01931839|581178480|FG006|Overall Study|Other|0|||
160942242|NCT00113516|581178481|FG000|Part 1|Adverse Event|6|||
160942243|NCT00113516|581178482|FG001|Part 1|Adverse Event|0|||
160942244|NCT00113516|581178481|FG000|Part 1|Death|3|||
160942245|NCT00113516|581178482|FG001|Part 1|Death|0|||
160942246|NCT00113516|581178481|FG000|Part 1|Other|3|||
160942247|NCT00113516|581178482|FG001|Part 1|Other|0|||
160942248|NCT00113516|581178481|FG000|Part 1|Withdrawal by Subject|2|||
160942249|NCT00113516|581178482|FG001|Part 1|Withdrawal by Subject|0|||
160942250|NCT00113516|581178481|FG000|Part 1|Lack of Efficacy|2|||
160942251|NCT00113516|581178482|FG001|Part 1|Lack of Efficacy|0|||
160942252|NCT00113516|581178481|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
160942253|NCT00113516|581178482|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
160942254|NCT00113516|581178481|FG000|Part 1|Laboratory Abnormality|1|||
160942255|NCT00113516|581178482|FG001|Part 1|Laboratory Abnormality|0|||
160942256|NCT00113516|581178481|FG000|Part 1|Ongoing|1|||
160942257|NCT00113516|581178482|FG001|Part 1|Ongoing|0|||
160942258|NCT00113516|581178481|FG000|Part 1|Missing|65|||
160942259|NCT00113516|581178482|FG001|Part 1|Missing|0|||
160942260|NCT00113516|581178481|FG000|Part 2|Adverse Event|0|||
160942261|NCT00113516|581178482|FG001|Part 2|Adverse Event|16|||
160942262|NCT00113516|581178481|FG000|Part 2|Death|0|||
160942263|NCT00113516|581178482|FG001|Part 2|Death|5|||
160942264|NCT00113516|581178481|FG000|Part 2|Lack of Efficacy|0|||
160942265|NCT00113516|581178482|FG001|Part 2|Lack of Efficacy|37|||
160942266|NCT00113516|581178481|FG000|Part 2|Withdrawal by Subject|0|||
160942267|NCT00113516|581178482|FG001|Part 2|Withdrawal by Subject|3|||
160942268|NCT00113516|581178481|FG000|Part 2|Other|0|||
160942269|NCT00113516|581178482|FG001|Part 2|Other|3|||
160942270|NCT00113516|581178481|FG000|Part 2|Laboratory Abnormality|0|||
160942271|NCT00113516|581178482|FG001|Part 2|Laboratory Abnormality|1|||
160942272|NCT00113516|581178481|FG000|Part 2|Ongoing|0|||
160942273|NCT00113516|581178482|FG001|Part 2|Ongoing|1|||
160942274|NCT03755765|581178491|FG000|Overall Study|Withdrawal by Subject|2|||
160942275|NCT03755765|581178492|FG001|Overall Study|Withdrawal by Subject|4|||
160942276|NCT03755765|581178493|FG002|Overall Study|Withdrawal by Subject|4|||
160942277|NCT02104557|581178494|FG000|Overall Study|Adverse Event|24|||
160942278|NCT02104557|581178494|FG000|Overall Study|Lost to Follow-up|34|||
160942279|NCT02104557|581178494|FG000|Overall Study|Violated the usage and dosage|14|||
160942280|NCT02104557|581178494|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
160942281|NCT02104557|581178494|FG000|Overall Study|Administered Sayana prior to the contract|1|||
160942282|NCT02104557|581178494|FG000|Overall Study|Other|17|||
160942283|NCT02104557|581178494|FG000|Overall Study|Change to other contraception methods|5|||
160942284|NCT02104557|581178494|FG000|Overall Study|Discontinuation due to no pain|1|||
160942285|NCT02104557|581178494|FG000|Overall Study|Withdrawal consent|2|||
160942286|NCT02104557|581178494|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
160942287|NCT02104557|581178494|FG000|Overall Study|Discontinuation of contraception|9|||
160942288|NCT01158222|581178498|FG000|Overall Study|Not eligible for intermediate phase|17|||
160942289|NCT00111228|581178501|FG000|Overall Study|Withdrawal by Subject|5|||
160942290|NCT00111228|581178502|FG001|Overall Study|Withdrawal by Subject|1|||
160942291|NCT00111228|581178503|FG002|Overall Study|Withdrawal by Subject|0|||
160942292|NCT02579616|581178504|FG000|Overall Study|Participants did not receive treatment|3|||
160942293|NCT01430585|581178505|FG000|Overall Study|Death|1|||
160942294|NCT01430585|581178505|FG000|Overall Study|Objective Progression or Relapse|3|||
160942295|NCT01430585|581178505|FG000|Overall Study|Study Terminated by Sponsor|3|||
160942296|NCT01430585|581178505|FG000|Overall Study|Other|7|||
160942297|NCT01448850|581178506|FG000|Overall Study|Death|3|||
160942298|NCT01448850|581178507|FG001|Overall Study|Death|6|||
160942299|NCT01448850|581178506|FG000|Overall Study|Withdrawal by Subject|13|||
160656086|NCT00336024|580120358|FG001|Overall Study|Progressive Disease|7|||
160942300|NCT01448850|581178507|FG001|Overall Study|Withdrawal by Subject|21|||
160942301|NCT01448850|581178506|FG000|Overall Study|Lost to Follow-up|3|||
160942302|NCT01448850|581178507|FG001|Overall Study|Lost to Follow-up|1|||
160942303|NCT01448850|581178506|FG000|Overall Study|Other|15|||
160942304|NCT01448850|581178507|FG001|Overall Study|Other|12|||
160942305|NCT01490060|581178510|FG000|Cycle 1|Change of Treatment|0|||
160942306|NCT01490060|581178511|FG001|Cycle 1|Change of Treatment|1|||
160942307|NCT01490060|581178512|FG002|Cycle 1|Change of Treatment|1|||
160942308|NCT01490060|581178513|FG003|Cycle 1|Change of Treatment|1|||
160942309|NCT01490060|581178510|FG000|Cycle 1|Insurance Denied|0|||
160942310|NCT01490060|581178511|FG001|Cycle 1|Insurance Denied|0|||
160942311|NCT01490060|581178512|FG002|Cycle 1|Insurance Denied|2|||
160942312|NCT01490060|581178513|FG003|Cycle 1|Insurance Denied|0|||
160942313|NCT01490060|581178510|FG000|Cycle 1|Withdrawal by Subject|0|||
160942314|NCT01490060|581178511|FG001|Cycle 1|Withdrawal by Subject|0|||
160942315|NCT01490060|581178512|FG002|Cycle 1|Withdrawal by Subject|0|||
160942316|NCT01490060|581178513|FG003|Cycle 1|Withdrawal by Subject|1|||
160942317|NCT01490060|581178510|FG000|Cycle 1|Treatment at Another Facility|0|||
160942318|NCT01490060|581178511|FG001|Cycle 1|Treatment at Another Facility|0|||
160942319|NCT01490060|581178512|FG002|Cycle 1|Treatment at Another Facility|0|||
160942320|NCT01490060|581178513|FG003|Cycle 1|Treatment at Another Facility|1|||
160942321|NCT01490060|581178510|FG000|Cycle 2|Change of Treatment|1|||
160942322|NCT01490060|581178511|FG001|Cycle 2|Change of Treatment|1|||
160942323|NCT01490060|581178512|FG002|Cycle 2|Change of Treatment|0|||
160942324|NCT01490060|581178513|FG003|Cycle 2|Change of Treatment|0|||
160942325|NCT01490060|581178510|FG000|Cycle 2|Non-Compliance|0|||
160942326|NCT01490060|581178511|FG001|Cycle 2|Non-Compliance|0|||
160942327|NCT01490060|581178512|FG002|Cycle 2|Non-Compliance|1|||
160942328|NCT01490060|581178513|FG003|Cycle 2|Non-Compliance|0|||
160942329|NCT01490060|581178510|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
160942330|NCT01490060|581178511|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
160942331|NCT01490060|581178512|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
160942332|NCT01490060|581178513|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
160942333|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
160942334|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
160942335|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
160942336|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
160942337|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
160942338|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
160656087|NCT00336024|580120357|FG000|Overall Study|Ineligible|7|||
160656088|NCT00336024|580120358|FG001|Overall Study|Ineligible|7|||
160942339|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
160942340|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
160942341|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
160942342|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
160942343|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
160942344|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
160942345|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
160942346|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
160942347|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
160942348|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
160942349|NCT02464969|581178514|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
160942350|NCT02464969|581178515|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
160942351|NCT02464969|581178514|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
160942352|NCT02464969|581178515|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
160942353|NCT02464969|581178514|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
160942354|NCT02464969|581178515|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
160942355|NCT02863354|581178516|FG000|Year 1|Lost to Follow-up|1|||
160942356|NCT02863354|581178517|FG001|Year 1|Lost to Follow-up|1|||
160942357|NCT02863354|581178516|FG000|Year 1|Withdrawal by Subject|3|||
160942358|NCT02863354|581178517|FG001|Year 1|Withdrawal by Subject|0|||
160942359|NCT02863354|581178516|FG000|Year 1|Death|0|||
160942360|NCT02863354|581178517|FG001|Year 1|Death|1|||
160942361|NCT02863354|581178516|FG000|Year 2|Lost to Follow-up|2|||
160999070|NCT04248829|581380675|FG000|Overall Study|Adverse Event|19|||
160999071|NCT04248829|581380676|FG001|Overall Study|Adverse Event|18|||
160656089|NCT05067504|580120359|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
160656090|NCT05067504|580120360|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
160656091|NCT05067504|580120359|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
160656092|NCT05067504|580120360|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
160656093|NCT05067504|580120359|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
160942362|NCT02863354|581178517|FG001|Year 2|Lost to Follow-up|2|||
160942363|NCT00724451|581178523|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
160942364|NCT00724451|581178523|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
160942365|NCT00724451|581178523|FG000|Overall Study|Not Eligible for Treatment|431|||
160942366|NCT00724451|581178523|FG000|Overall Study|Participant Refused Treatment|89|||
160942367|NCT00724451|581178523|FG000|Overall Study|Never Started Treatment|89|||
160942368|NCT00724451|581178523|FG000|Overall Study|Unknown; No Data Sources Available|9|||
160942369|NCT00724451|581178523|FG000|Overall Study|Physician Decision|116|||
160942370|NCT00724451|581178523|FG000|Overall Study|Withdrawal by Subject|45|||
160942371|NCT00724451|581178523|FG000|Overall Study|Investigator + Participant Decision|13|||
160942372|NCT00414050|581178525|FG000|Overall Study|Adverse Event|1|||
160942373|NCT00414050|581178526|FG001|Overall Study|Adverse Event|1|||
160942374|NCT00414050|581178527|FG002|Overall Study|Adverse Event|1|||
160942375|NCT00414050|581178528|FG003|Overall Study|Adverse Event|1|||
160942376|NCT00414050|581178525|FG000|Overall Study|Lost to Follow-up|2|||
160942377|NCT00414050|581178526|FG001|Overall Study|Lost to Follow-up|2|||
160942378|NCT00414050|581178527|FG002|Overall Study|Lost to Follow-up|1|||
160942379|NCT00414050|581178528|FG003|Overall Study|Lost to Follow-up|1|||
160942380|NCT00414050|581178525|FG000|Overall Study|Withdrawal by Subject|5|||
160942381|NCT00414050|581178526|FG001|Overall Study|Withdrawal by Subject|3|||
160942382|NCT00414050|581178527|FG002|Overall Study|Withdrawal by Subject|2|||
160942383|NCT00414050|581178528|FG003|Overall Study|Withdrawal by Subject|4|||
160942384|NCT00414050|581178525|FG000|Overall Study|Subject discontinued for other reason|1|||
160942385|NCT00414050|581178526|FG001|Overall Study|Subject discontinued for other reason|2|||
160942386|NCT00414050|581178527|FG002|Overall Study|Subject discontinued for other reason|2|||
160942387|NCT00414050|581178528|FG003|Overall Study|Subject discontinued for other reason|1|||
160942388|NCT00414050|581178525|FG000|Overall Study|Subject Moved|0|||
160942389|NCT00414050|581178526|FG001|Overall Study|Subject Moved|0|||
160942390|NCT00414050|581178527|FG002|Overall Study|Subject Moved|0|||
160455786|NCT02240238|579399770|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
160455787|NCT02240238|579399771|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160942391|NCT00414050|581178528|FG003|Overall Study|Subject Moved|1|||
160942392|NCT02550652|581178535|FG000|Overall Study|Death|1|||
160942393|NCT02550652|581178536|FG001|Overall Study|Death|4|||
160942394|NCT02550652|581178535|FG000|Overall Study|Lack of Efficacy|1|||
160942395|NCT02550652|581178536|FG001|Overall Study|Lack of Efficacy|0|||
160942396|NCT02550652|581178535|FG000|Overall Study|Withdrawal by Subject|4|||
160942397|NCT02550652|581178536|FG001|Overall Study|Withdrawal by Subject|7|||
160942398|NCT02550652|581178535|FG000|Overall Study|Post Trial Access|1|||
160942399|NCT02550652|581178536|FG001|Overall Study|Post Trial Access|0|||
160942400|NCT02550652|581178535|FG000|Overall Study|Lost to Follow-up|1|||
160942401|NCT02550652|581178536|FG001|Overall Study|Lost to Follow-up|3|||
160942402|NCT02550652|581178535|FG000|Overall Study|Physician Decision|0|||
160942403|NCT02550652|581178536|FG001|Overall Study|Physician Decision|2|||
160942404|NCT02550652|581178535|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
160942405|NCT02550652|581178536|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
160942406|NCT01706250|581178537|FG000|Overall Study|Lost to Follow-up|2|||
160942407|NCT00515827|581178543|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
160942408|NCT00515827|581178544|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
160942409|NCT00515827|581178543|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
160942410|NCT00515827|581178544|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
160942411|NCT03254134|581178546|FG000|Overall Study|Not eligible patients|599|||
160942412|NCT03254134|581178547|FG001|Overall Study|Not eligible patients|3630|||
160942413|NCT00205712|581178548|FG000|Overall Study|Lost to Follow-up|0|||
160942414|NCT00205712|581178549|FG001|Overall Study|Lost to Follow-up|1|||
160942415|NCT01009099|581178550|FG000|Overall Study|Lost to Follow-up|1|||
160942416|NCT01009099|581178551|FG001|Overall Study|Lost to Follow-up|0|||
160942417|NCT01009099|581178550|FG000|Overall Study|Physician Decision|3|||
160942418|NCT01009099|581178551|FG001|Overall Study|Physician Decision|2|||
160942419|NCT01009099|581178550|FG000|Overall Study|Withdrawal by Subject|1|||
160942420|NCT01009099|581178551|FG001|Overall Study|Withdrawal by Subject|1|||
160942421|NCT01009099|581178550|FG000|Overall Study|Death|0|||
160942422|NCT01009099|581178551|FG001|Overall Study|Death|1|||
160942423|NCT01712984|581178552|FG000|Overall Study|Adverse Event|0|||
160942424|NCT01712984|581178553|FG001|Overall Study|Adverse Event|0|||
160942425|NCT01712984|581178554|FG002|Overall Study|Adverse Event|1|||
160942426|NCT01712984|581178552|FG000|Overall Study|Protocol Violation|2|||
160942427|NCT01712984|581178553|FG001|Overall Study|Protocol Violation|0|||
160942428|NCT01712984|581178554|FG002|Overall Study|Protocol Violation|1|||
160942429|NCT01712984|581178552|FG000|Overall Study|Lost to Follow-up|8|||
160942430|NCT01712984|581178553|FG001|Overall Study|Lost to Follow-up|10|||
160942431|NCT01712984|581178554|FG002|Overall Study|Lost to Follow-up|1|||
160942432|NCT01712984|581178552|FG000|Overall Study|Withdrawal by Subject|6|||
160942433|NCT01712984|581178553|FG001|Overall Study|Withdrawal by Subject|6|||
160942434|NCT01712984|581178554|FG002|Overall Study|Withdrawal by Subject|7|||
160942435|NCT00096044|581178557|FG000|Overall Study|Withdrawal by Subject|9|||
160942436|NCT00096044|581178557|FG000|Overall Study|Adverse Event|21|||
160942437|NCT00096044|581178557|FG000|Overall Study|Disease Progression|4|||
160942438|NCT03149237|581178558|FG000|Overall Study|Withdrawal by Subject|4|||
160942439|NCT03149237|581178559|FG001|Overall Study|Withdrawal by Subject|5|||
160942440|NCT02442830|581178560|FG000|Overall Study|Technical Failure|0|||
160942441|NCT02442830|581178561|FG001|Overall Study|Technical Failure|1|||
160942442|NCT04587193|581178562|FG000|Overall Study|Screen failure after consent|3|||
160942443|NCT04587193|581178563|FG001|Overall Study|Screen failure after consent|0|||
160942444|NCT04587193|581178562|FG000|Overall Study|Device broke during study|3|||
160942445|NCT04587193|581178563|FG001|Overall Study|Device broke during study|2|||
160942446|NCT00508742|581178564|FG000|Period 1: Infant Series|Adverse Event|5|||
160942447|NCT00508742|581178565|FG001|Period 1: Infant Series|Adverse Event|4|||
160942448|NCT00508742|581178564|FG000|Period 1: Infant Series|Protocol Violation|1|||
160942449|NCT00508742|581178565|FG001|Period 1: Infant Series|Protocol Violation|0|||
160942450|NCT00508742|581178564|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
160942451|NCT00508742|581178565|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
160942452|NCT00508742|581178564|FG000|Period 1: Infant Series|Physician Decision|1|||
160942453|NCT00508742|581178565|FG001|Period 1: Infant Series|Physician Decision|0|||
160942454|NCT00508742|581178564|FG000|Period 1: Infant Series|Other|4|||
160942455|NCT00508742|581178565|FG001|Period 1: Infant Series|Other|1|||
160942456|NCT00508742|581178564|FG000|Period 2: After Infant Series|Adverse Event|2|||
160942457|NCT00508742|581178565|FG001|Period 2: After Infant Series|Adverse Event|6|||
160942458|NCT00508742|581178564|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
160942459|NCT00508742|581178565|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
160942460|NCT00508742|581178564|FG000|Period 2: After Infant Series|Protocol Violation|1|||
160942461|NCT00508742|581178565|FG001|Period 2: After Infant Series|Protocol Violation|0|||
160942462|NCT00508742|581178564|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
160942463|NCT00508742|581178565|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
160942464|NCT00508742|581178564|FG000|Period 2: After Infant Series|Failed to Return|1|||
160942465|NCT00508742|581178565|FG001|Period 2: After Infant Series|Failed to Return|0|||
160942466|NCT00508742|581178564|FG000|Period 2: After Infant Series|Other|2|||
160942467|NCT00508742|581178565|FG001|Period 2: After Infant Series|Other|1|||
160942468|NCT00508742|581178564|FG000|Period 3: Toddler Dose|Adverse Event|1|||
160942469|NCT00508742|581178565|FG001|Period 3: Toddler Dose|Adverse Event|0|||
160942470|NCT00508742|581178564|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
160942471|NCT00508742|581178565|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
160942472|NCT00508742|581178564|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
160942473|NCT00508742|581178565|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
160942474|NCT00508742|581178564|FG000|Period 3: Toddler Dose|Other|5|||
160942475|NCT00508742|581178565|FG001|Period 3: Toddler Dose|Other|4|||
160942476|NCT02501096|581178566|FG000|Overall Study|Lost to Follow-up|0|||
160942477|NCT02501096|581178567|FG001|Overall Study|Lost to Follow-up|0|||
160942478|NCT02501096|581178568|FG002|Overall Study|Lost to Follow-up|0|||
160942479|NCT02501096|581178569|FG003|Overall Study|Lost to Follow-up|0|||
160942480|NCT02501096|581178570|FG004|Overall Study|Lost to Follow-up|1|||
160942481|NCT02501096|581178571|FG005|Overall Study|Lost to Follow-up|1|||
160942482|NCT02501096|581178572|FG006|Overall Study|Lost to Follow-up|3|||
160942483|NCT02501096|581178573|FG007|Overall Study|Lost to Follow-up|0|||
160942484|NCT02501096|581178574|FG008|Overall Study|Lost to Follow-up|0|||
160942485|NCT02501096|581178566|FG000|Overall Study|Withdrawal by Subject|1|||
160942486|NCT02501096|581178567|FG001|Overall Study|Withdrawal by Subject|0|||
160942487|NCT02501096|581178568|FG002|Overall Study|Withdrawal by Subject|7|||
160942488|NCT02501096|581178569|FG003|Overall Study|Withdrawal by Subject|13|||
160942489|NCT02501096|581178570|FG004|Overall Study|Withdrawal by Subject|2|||
160942490|NCT02501096|581178571|FG005|Overall Study|Withdrawal by Subject|2|||
160942491|NCT02501096|581178572|FG006|Overall Study|Withdrawal by Subject|2|||
160942492|NCT02501096|581178573|FG007|Overall Study|Withdrawal by Subject|3|||
160942493|NCT02501096|581178574|FG008|Overall Study|Withdrawal by Subject|0|||
160942494|NCT02501096|581178566|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
160942495|NCT02501096|581178567|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
160942496|NCT02501096|581178568|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
160942497|NCT02501096|581178569|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
160942498|NCT02501096|581178570|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
160942499|NCT02501096|581178571|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
160942500|NCT02501096|581178572|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
160942501|NCT02501096|581178573|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
160942502|NCT02501096|581178574|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
160942503|NCT02501096|581178566|FG000|Overall Study|Death|1|||
160942504|NCT02501096|581178567|FG001|Overall Study|Death|1|||
160942505|NCT02501096|581178568|FG002|Overall Study|Death|88|||
160942506|NCT02501096|581178569|FG003|Overall Study|Death|74|||
160942507|NCT02501096|581178570|FG004|Overall Study|Death|15|||
160942508|NCT02501096|581178571|FG005|Overall Study|Death|16|||
160942509|NCT02501096|581178572|FG006|Overall Study|Death|15|||
160942510|NCT02501096|581178573|FG007|Overall Study|Death|16|||
160942511|NCT02501096|581178574|FG008|Overall Study|Death|1|||
160942512|NCT00437034|581178575|FG000|Overall Study|Adverse Event|1|||
160942513|NCT00437034|581178575|FG000|Overall Study|Disease progression during treatment|5|||
160942514|NCT00595582|581178576|FG000|Overall Study|Pilot study that PI terminated|2|||
160942515|NCT00595582|581178576|FG000|Overall Study|Lost to Follow-up|1|||
160942516|NCT00595582|581178576|FG000|Overall Study|Adverse Event|2|||
160942517|NCT00595582|581178576|FG000|Overall Study|Physician Decision|5|||
160942518|NCT03878134|581178577|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
160942519|NCT00586469|581178578|FG000|Overall Study|Adverse Event|0|||
160942520|NCT00586469|581178579|FG001|Overall Study|Adverse Event|1|||
160942521|NCT04055116|581178580|FG000|First Intervention|Physician Decision|2|||
160942522|NCT04055116|581178581|FG001|First Intervention|Physician Decision|7|||
160942523|NCT01978184|581178582|FG000|Overall Study|Progressive disease|5|||
160942524|NCT01978184|581178583|FG001|Overall Study|Progressive disease|5|||
160942525|NCT01978184|581178582|FG000|Overall Study|Other than PDA|2|||
160942526|NCT01978184|581178583|FG001|Overall Study|Other than PDA|2|||
160942527|NCT01978184|581178582|FG000|Overall Study|Physician Decision|0|||
160942528|NCT01978184|581178583|FG001|Overall Study|Physician Decision|3|||
160942529|NCT01978184|581178582|FG000|Overall Study|Noncompliance|1|||
160579452|NCT00739297|579841763|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
160579453|NCT00739297|579841764|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
160579454|NCT00739297|579841765|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
160579455|NCT00739297|579841766|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
160579456|NCT00739297|579841767|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
160579457|NCT01400971|579841768|FG000|Overall Study|Death|82|||
160579458|NCT01400971|579841768|FG000|Overall Study|Lost to Follow-up|196|||
160579459|NCT01400971|579841768|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
160579460|NCT01400971|579841768|FG000|Overall Study|Physician Decision|57|||
160579461|NCT01400971|579841768|FG000|Overall Study|Withdrawal by Subject|158|||
160579462|NCT01400971|579841768|FG000|Overall Study|Other|422|||
160579463|NCT00789477|579841773|FG000|Overall Study|Withdrawal by Subject|2|||
160579464|NCT00789477|579841774|FG001|Overall Study|Withdrawal by Subject|1|||
160579465|NCT00789477|579841775|FG002|Overall Study|Withdrawal by Subject|3|||
160579466|NCT00789477|579841776|FG003|Overall Study|Withdrawal by Subject|2|||
160579467|NCT00789477|579841777|FG004|Overall Study|Withdrawal by Subject|3|||
160579468|NCT00789477|579841773|FG000|Overall Study|Protocol Violation|1|||
160579469|NCT00789477|579841774|FG001|Overall Study|Protocol Violation|0|||
160579470|NCT00789477|579841775|FG002|Overall Study|Protocol Violation|0|||
160579471|NCT00789477|579841776|FG003|Overall Study|Protocol Violation|1|||
160579472|NCT00789477|579841777|FG004|Overall Study|Protocol Violation|0|||
160579473|NCT00789477|579841773|FG000|Overall Study|Adverse Event|3|||
160579474|NCT00789477|579841774|FG001|Overall Study|Adverse Event|3|||
160579475|NCT00789477|579841775|FG002|Overall Study|Adverse Event|1|||
160579476|NCT00789477|579841776|FG003|Overall Study|Adverse Event|0|||
160579477|NCT00789477|579841777|FG004|Overall Study|Adverse Event|0|||
160579478|NCT00789477|579841773|FG000|Overall Study|Death|1|||
160579479|NCT00789477|579841774|FG001|Overall Study|Death|1|||
160579480|NCT00789477|579841775|FG002|Overall Study|Death|2|||
160579481|NCT00789477|579841776|FG003|Overall Study|Death|2|||
160579482|NCT00789477|579841777|FG004|Overall Study|Death|0|||
160579483|NCT00789477|579841773|FG000|Overall Study|Lost to Follow-up|0|||
160579484|NCT00789477|579841774|FG001|Overall Study|Lost to Follow-up|1|||
160579485|NCT00789477|579841775|FG002|Overall Study|Lost to Follow-up|4|||
160579486|NCT00789477|579841776|FG003|Overall Study|Lost to Follow-up|2|||
160579487|NCT00789477|579841777|FG004|Overall Study|Lost to Follow-up|4|||
160579488|NCT00789477|579841773|FG000|Overall Study|Lack of Efficacy|2|||
160579489|NCT00789477|579841774|FG001|Overall Study|Lack of Efficacy|0|||
160579490|NCT00789477|579841775|FG002|Overall Study|Lack of Efficacy|0|||
160579491|NCT00789477|579841776|FG003|Overall Study|Lack of Efficacy|0|||
160579492|NCT00789477|579841777|FG004|Overall Study|Lack of Efficacy|0|||
160579493|NCT00789477|579841773|FG000|Overall Study|Other|2|||
160579494|NCT00789477|579841774|FG001|Overall Study|Other|0|||
160579495|NCT00789477|579841775|FG002|Overall Study|Other|1|||
160579496|NCT00789477|579841776|FG003|Overall Study|Other|3|||
160579497|NCT00789477|579841777|FG004|Overall Study|Other|0|||
160579498|NCT00455858|579841778|FG000|Overall Study|Lost to Follow-up|2|||
160579499|NCT00455858|579841778|FG000|Overall Study|Protocol Violation|1|||
160579500|NCT00455858|579841778|FG000|Overall Study|Lack of Efficacy|1|||
160579501|NCT00455858|579841778|FG000|Overall Study|Well controlled FPG without insulin|1|||
160579502|NCT00455858|579841778|FG000|Overall Study|Withdrawal|1|||
160942530|NCT01978184|581178583|FG001|Overall Study|Noncompliance|2|||
160942531|NCT01978184|581178582|FG000|Overall Study|Death|1|||
160942532|NCT01978184|581178583|FG001|Overall Study|Death|0|||
160579503|NCT02375698|579841779|FG000|Overall Study|Withdrawal by Subject|0|||
160579504|NCT02375698|579841780|FG001|Overall Study|Withdrawal by Subject|2|||
160579505|NCT02375698|579841779|FG000|Overall Study|Physician Decision|2|||
160579506|NCT02375698|579841780|FG001|Overall Study|Physician Decision|0|||
160579507|NCT01595646|579841782|FG000|Overall Study|Withdrawal by Subject|1|||
160579508|NCT01595646|579841783|FG001|Overall Study|Withdrawal by Subject|0|||
160579509|NCT01595646|579841784|FG002|Overall Study|Withdrawal by Subject|0|||
160579510|NCT01927562|579841786|FG000|Overall Study|Lost to Follow-up|30|||
160579511|NCT01927562|579841786|FG000|Overall Study|Withdrawal by Subject|3|||
160579512|NCT01927562|579841786|FG000|Overall Study|Physician Decision|5|||
160942533|NCT01978184|581178582|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
160579513|NCT00642616|579841787|FG000|Overall Study|Adverse Event|2|||
160579514|NCT00642616|579841788|FG001|Overall Study|Adverse Event|0|||
160579515|NCT00642616|579841789|FG002|Overall Study|Adverse Event|1|||
160942534|NCT01978184|581178583|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
160579516|NCT00642616|579841790|FG003|Overall Study|Adverse Event|0|||
160579517|NCT00642616|579841787|FG000|Overall Study|Study Terminated by Sponsor|7|||
160579518|NCT00642616|579841788|FG001|Overall Study|Study Terminated by Sponsor|6|||
160579519|NCT00642616|579841789|FG002|Overall Study|Study Terminated by Sponsor|4|||
160579520|NCT00642616|579841790|FG003|Overall Study|Study Terminated by Sponsor|5|||
160579521|NCT00642616|579841787|FG000|Overall Study|Withdrawal by Subject|0|||
160579522|NCT00642616|579841788|FG001|Overall Study|Withdrawal by Subject|1|||
160579523|NCT00642616|579841789|FG002|Overall Study|Withdrawal by Subject|1|||
160579524|NCT00642616|579841790|FG003|Overall Study|Withdrawal by Subject|1|||
160579525|NCT00642616|579841787|FG000|Overall Study|Protocol Violation|0|||
160579526|NCT00642616|579841788|FG001|Overall Study|Protocol Violation|0|||
160579527|NCT00642616|579841789|FG002|Overall Study|Protocol Violation|2|||
160579528|NCT00642616|579841790|FG003|Overall Study|Protocol Violation|0|||
160579529|NCT00642616|579841787|FG000|Overall Study|Physician Decision|0|||
160579530|NCT00642616|579841788|FG001|Overall Study|Physician Decision|0|||
160579531|NCT00642616|579841789|FG002|Overall Study|Physician Decision|1|||
160579532|NCT00642616|579841790|FG003|Overall Study|Physician Decision|1|||
160579533|NCT01041573|579841795|FG000|Overall Study|Withdrawal by Subject|2|||
160579534|NCT01041573|579841796|FG001|Overall Study|Withdrawal by Subject|5|||
160579535|NCT01041573|579841797|FG002|Overall Study|Withdrawal by Subject|2|||
160579536|NCT01041573|579841798|FG003|Overall Study|Withdrawal by Subject|0|||
160579537|NCT01041573|579841795|FG000|Overall Study|Death|1|||
160579538|NCT01041573|579841796|FG001|Overall Study|Death|0|||
160579539|NCT01041573|579841797|FG002|Overall Study|Death|0|||
160579540|NCT01041573|579841798|FG003|Overall Study|Death|0|||
160579541|NCT01041573|579841795|FG000|Overall Study|Lost to Follow-up|0|||
160579542|NCT01041573|579841796|FG001|Overall Study|Lost to Follow-up|1|||
160579543|NCT01041573|579841797|FG002|Overall Study|Lost to Follow-up|2|||
160579544|NCT01041573|579841798|FG003|Overall Study|Lost to Follow-up|1|||
160579545|NCT01041573|579841795|FG000|Overall Study|Adverse Event|0|||
160579546|NCT01041573|579841796|FG001|Overall Study|Adverse Event|2|||
160579547|NCT01041573|579841797|FG002|Overall Study|Adverse Event|0|||
160579548|NCT01041573|579841798|FG003|Overall Study|Adverse Event|0|||
160579549|NCT01041573|579841795|FG000|Overall Study|relocation|1|||
160579550|NCT01041573|579841796|FG001|Overall Study|relocation|4|||
160942535|NCT02770391|581178584|FG000|Overall Study|Lost to Follow-up|2|||
160942536|NCT02770391|581178584|FG000|Overall Study|Withdrawal by Subject|1|||
160942537|NCT02770391|581178584|FG000|Overall Study|Surgery delayed unevaluable|2|||
160942538|NCT02770391|581178584|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
160942539|NCT01976845|581178587|FG000|Overall Study|Physician Decision|8|||
160942540|NCT01976845|581178588|FG001|Overall Study|Physician Decision|8|||
160942541|NCT01976845|581178589|FG002|Overall Study|Physician Decision|3|||
160942542|NCT04258839|581179846|FG000|Overall Study|Adverse Event|2|||
160942543|NCT04258839|581179847|FG001|Overall Study|Adverse Event|4|||
160942544|NCT04258839|581179846|FG000|Overall Study|Lack of Efficacy|0|||
160942545|NCT04258839|581179847|FG001|Overall Study|Lack of Efficacy|2|||
160942546|NCT04258839|581179846|FG000|Overall Study|Lost to Follow-up|2|||
160942547|NCT04258839|581179847|FG001|Overall Study|Lost to Follow-up|0|||
160942548|NCT04258839|581179846|FG000|Overall Study|Withdrawal by Subject|1|||
160942549|NCT04258839|581179847|FG001|Overall Study|Withdrawal by Subject|2|||
160942550|NCT04258839|581179846|FG000|Overall Study|Withdrawal by Caregiver|5|||
160942551|NCT04258839|581179847|FG001|Overall Study|Withdrawal by Caregiver|6|||
160942552|NCT04258839|581179846|FG000|Overall Study|Reason not Specified|0|||
160942553|NCT04258839|581179847|FG001|Overall Study|Reason not Specified|1|||
160942554|NCT02293005|581179848|FG000|Overall Study|Adverse Event|2|||
160942555|NCT02293005|581179848|FG000|Overall Study|Death|4|||
160942556|NCT02293005|581179848|FG000|Overall Study|Lost to Follow-up|1|||
160942557|NCT02293005|581179848|FG000|Overall Study|Withdrawal by Subject|2|||
160942558|NCT02293005|581179848|FG000|Overall Study|Progression|17|||
160999072|NCT04248829|581380675|FG000|Overall Study|Withdrawal by Subject|11|||
160942559|NCT03328897|581179849|FG000|Randomized-treatment Epoch|Adverse Event|4|||
160942560|NCT03328897|581179850|FG001|Randomized-treatment Epoch|Adverse Event|1|||
160999073|NCT04248829|581380676|FG001|Overall Study|Withdrawal by Subject|2|||
160942561|NCT03328897|581179851|FG002|Randomized-treatment Epoch|Adverse Event|1|||
160942562|NCT03328897|581179849|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
160999074|NCT04248829|581380675|FG000|Overall Study|Lost to Follow-up|0|||
160999075|NCT04248829|581380676|FG001|Overall Study|Lost to Follow-up|1|||
160579551|NCT01041573|579841797|FG002|Overall Study|relocation|3|||
160579552|NCT01041573|579841798|FG003|Overall Study|relocation|1|||
160579553|NCT01041573|579841795|FG000|Overall Study|further blood extraction|0|||
160579554|NCT01041573|579841796|FG001|Overall Study|further blood extraction|1|||
160579555|NCT01041573|579841797|FG002|Overall Study|further blood extraction|0|||
160579556|NCT01041573|579841798|FG003|Overall Study|further blood extraction|0|||
160579557|NCT01041573|579841795|FG000|Overall Study|positive to anti-HCV|1|||
160579558|NCT01041573|579841796|FG001|Overall Study|positive to anti-HCV|0|||
160942563|NCT03328897|581179850|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
160942564|NCT03328897|581179851|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
160942565|NCT03328897|581179849|FG000|Randomized-treatment Epoch|Pregnancy|3|||
160999076|NCT04248829|581380675|FG000|Overall Study|Death|12|||
160942566|NCT03328897|581179850|FG001|Randomized-treatment Epoch|Pregnancy|0|||
160942567|NCT03328897|581179851|FG002|Randomized-treatment Epoch|Pregnancy|0|||
160942568|NCT03328897|581179849|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
160942569|NCT03328897|581179850|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
160942570|NCT03328897|581179851|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
160942571|NCT03328897|581179849|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
160942572|NCT03328897|581179850|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
160942573|NCT03328897|581179851|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
160942574|NCT03328897|581179849|FG000|Follow-up Epoch|Adverse Event|4|||
160942575|NCT03328897|581179850|FG001|Follow-up Epoch|Adverse Event|0|||
160942576|NCT03328897|581179851|FG002|Follow-up Epoch|Adverse Event|1|||
160942577|NCT03328897|581179849|FG000|Follow-up Epoch|Lack of Efficacy|1|||
160942578|NCT03328897|581179850|FG001|Follow-up Epoch|Lack of Efficacy|1|||
160942579|NCT03328897|581179851|FG002|Follow-up Epoch|Lack of Efficacy|1|||
160942580|NCT03328897|581179849|FG000|Follow-up Epoch|Lost to Follow-up|0|||
160942581|NCT03328897|581179850|FG001|Follow-up Epoch|Lost to Follow-up|1|||
160942582|NCT03328897|581179851|FG002|Follow-up Epoch|Lost to Follow-up|0|||
160942583|NCT03328897|581179849|FG000|Follow-up Epoch|Pregnancy|1|||
160942584|NCT03328897|581179850|FG001|Follow-up Epoch|Pregnancy|0|||
160942585|NCT03328897|581179851|FG002|Follow-up Epoch|Pregnancy|0|||
160942586|NCT03328897|581179849|FG000|Follow-up Epoch|Patient/guardian decision|2|||
160942587|NCT03328897|581179850|FG001|Follow-up Epoch|Patient/guardian decision|1|||
160942588|NCT03328897|581179851|FG002|Follow-up Epoch|Patient/guardian decision|0|||
160942589|NCT00608829|581179852|FG000|Overall Study|Death|6|||
160942590|NCT00608829|581179852|FG000|Overall Study|Withdrawal by Subject|4|||
160942591|NCT00608829|581179852|FG000|Overall Study|Subject refuses to follow up or return.|5|||
160942592|NCT02648698|581179860|FG000|Overall Study|Protocol Violation|1|||
160942593|NCT02648698|581179861|FG001|Overall Study|Protocol Violation|5|||
160942594|NCT00672477|581179864|FG000|Overall Study|Adverse Event|10|||
160942595|NCT00672477|581179865|FG001|Overall Study|Adverse Event|7|||
160942596|NCT00672477|581179864|FG000|Overall Study|Death|7|||
160942597|NCT00672477|581179865|FG001|Overall Study|Death|11|||
160942598|NCT00672477|581179864|FG000|Overall Study|Physician Decision|2|||
160942599|NCT00672477|581179865|FG001|Overall Study|Physician Decision|0|||
160942600|NCT00672477|581179864|FG000|Overall Study|Protocol Violation|1|||
160942601|NCT00672477|581179865|FG001|Overall Study|Protocol Violation|1|||
160942602|NCT00672477|581179864|FG000|Overall Study|Withdrawal by Subject|5|||
160942603|NCT00672477|581179865|FG001|Overall Study|Withdrawal by Subject|3|||
160942604|NCT00672477|581179864|FG000|Overall Study|Lack of Efficacy|1|||
160942605|NCT00672477|581179865|FG001|Overall Study|Lack of Efficacy|1|||
160942606|NCT00672477|581179864|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
160942607|NCT00672477|581179865|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
160942608|NCT00938431|581179868|FG000|Overall Study|Adverse Event|5|||
160942609|NCT00938431|581179869|FG001|Overall Study|Adverse Event|8|||
160999077|NCT04248829|581380676|FG001|Overall Study|Death|14|||
160999078|NCT04248829|581380675|FG000|Overall Study|Physician Decision|2|||
160999079|NCT04248829|581380676|FG001|Overall Study|Physician Decision|4|||
160999080|NCT04248829|581380675|FG000|Overall Study|Any reason not specifically recorded|0|||
160455788|NCT02240238|579399772|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
160455789|NCT02240238|579399761|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160455790|NCT02240238|579399762|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160455791|NCT02240238|579399763|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160455792|NCT02240238|579399764|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160455793|NCT02240238|579399765|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160455794|NCT02240238|579399766|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160455795|NCT02240238|579399767|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160455796|NCT02240238|579399768|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160455797|NCT02240238|579399769|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160455798|NCT02240238|579399770|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
160455799|NCT02240238|579399771|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160455800|NCT02240238|579399772|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
160942610|NCT00938431|581179870|FG002|Overall Study|Adverse Event|6|||
160942611|NCT00938431|581179868|FG000|Overall Study|Lack of Efficacy|0|||
160942612|NCT00938431|581179869|FG001|Overall Study|Lack of Efficacy|1|||
160942613|NCT00938431|581179870|FG002|Overall Study|Lack of Efficacy|0|||
160942614|NCT00938431|581179868|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
160942615|NCT00938431|581179869|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
160942616|NCT00938431|581179870|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
160942617|NCT00938431|581179868|FG000|Overall Study|Dosing compliance issue|0|||
160999081|NCT04248829|581380676|FG001|Overall Study|Any reason not specifically recorded|2|||
160942618|NCT00938431|581179869|FG001|Overall Study|Dosing compliance issue|0|||
160999082|NCT02299336|581380677|FG000|Overall Study|Withdrawal by Subject|11|||
160942619|NCT00938431|581179870|FG002|Overall Study|Dosing compliance issue|1|||
160942620|NCT00938431|581179868|FG000|Overall Study|Reached maximum dose early|0|||
160942621|NCT00938431|581179869|FG001|Overall Study|Reached maximum dose early|0|||
160942622|NCT00938431|581179870|FG002|Overall Study|Reached maximum dose early|1|||
160942623|NCT03738865|581179875|FG000|Overall Study|Withdrawal by Subject|3|||
160942624|NCT03738865|581179876|FG001|Overall Study|Withdrawal by Subject|3|||
160942625|NCT03738865|581179875|FG000|Overall Study|Adverse Event|2|||
160942626|NCT03738865|581179876|FG001|Overall Study|Adverse Event|0|||
160942627|NCT03738865|581179875|FG000|Overall Study|Physician Decision|0|||
160942628|NCT03738865|581179876|FG001|Overall Study|Physician Decision|1|||
160942629|NCT01175824|581179877|FG000|Overall Study|Adverse Event|2|||
160455801|NCT02240238|579399761|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455802|NCT02240238|579399762|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455803|NCT02240238|579399763|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455804|NCT02240238|579399764|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455805|NCT02240238|579399765|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455806|NCT02240238|579399766|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455807|NCT02240238|579399767|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455808|NCT02240238|579399768|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455809|NCT02240238|579399769|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455810|NCT02240238|579399770|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455811|NCT02240238|579399771|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
160455812|NCT02240238|579399772|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
160455813|NCT02240238|579399761|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455814|NCT02240238|579399762|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455815|NCT02240238|579399763|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455816|NCT02240238|579399764|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455817|NCT02240238|579399765|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455818|NCT02240238|579399766|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455819|NCT02240238|579399767|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455820|NCT02240238|579399768|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455821|NCT02240238|579399769|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455822|NCT02240238|579399770|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455823|NCT02240238|579399771|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
160455824|NCT02240238|579399772|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
160455825|NCT02240238|579399761|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455826|NCT02240238|579399762|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455827|NCT02240238|579399763|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455828|NCT02240238|579399764|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455829|NCT02240238|579399765|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455830|NCT02240238|579399766|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455831|NCT02240238|579399767|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455832|NCT02240238|579399768|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455833|NCT02240238|579399769|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455834|NCT02240238|579399770|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455835|NCT02240238|579399771|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
160455836|NCT02240238|579399772|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
160455837|NCT02240238|579399761|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160455838|NCT02240238|579399762|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160455839|NCT02240238|579399763|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160455840|NCT02240238|579399764|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160455841|NCT02240238|579399765|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160455842|NCT02240238|579399766|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160455843|NCT02240238|579399767|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160455844|NCT02240238|579399768|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160455845|NCT02240238|579399769|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160455846|NCT02240238|579399770|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160455847|NCT02240238|579399771|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
160455848|NCT02240238|579399772|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
160579559|NCT01041573|579841797|FG002|Overall Study|positive to anti-HCV|0|||
160579560|NCT01041573|579841798|FG003|Overall Study|positive to anti-HCV|0|||
160579561|NCT02955186|579841799|FG000|Overall Study|Withdrawal by Subject|6|||
160579562|NCT02955186|579841800|FG001|Overall Study|Withdrawal by Subject|2|||
160579563|NCT02955186|579841799|FG000|Overall Study|Protocol Violation|1|||
160579564|NCT02955186|579841800|FG001|Overall Study|Protocol Violation|0|||
160942630|NCT01175824|581179878|FG001|Overall Study|Adverse Event|1|||
160942631|NCT01175824|581179877|FG000|Overall Study|Lack of Efficacy|2|||
160579565|NCT00751881|579841802|FG000|Core Treatment Period|Not treated|1|||
160579566|NCT00751881|579841803|FG001|Core Treatment Period|Not treated|1|||
160579567|NCT00751881|579841804|FG002|Core Treatment Period|Not treated|2|||
160579568|NCT00751881|579841802|FG000|Core Treatment Period|Adverse Event|26|||
160579569|NCT00751881|579841803|FG001|Core Treatment Period|Adverse Event|54|||
160579570|NCT00751881|579841804|FG002|Core Treatment Period|Adverse Event|58|||
160579571|NCT00751881|579841802|FG000|Core Treatment Period|Lack of Efficacy|37|||
160579572|NCT00751881|579841803|FG001|Core Treatment Period|Lack of Efficacy|30|||
160579573|NCT00751881|579841804|FG002|Core Treatment Period|Lack of Efficacy|20|||
160579574|NCT00751881|579841802|FG000|Core Treatment Period|Poor compliance to protocol|15|||
160579575|NCT00751881|579841803|FG001|Core Treatment Period|Poor compliance to protocol|3|||
160579576|NCT00751881|579841804|FG002|Core Treatment Period|Poor compliance to protocol|4|||
160579577|NCT00751881|579841802|FG000|Core Treatment Period|Lost to Follow-up|6|||
160579578|NCT00751881|579841803|FG001|Core Treatment Period|Lost to Follow-up|4|||
160579579|NCT00751881|579841804|FG002|Core Treatment Period|Lost to Follow-up|3|||
160579580|NCT00751881|579841802|FG000|Core Treatment Period|Other: protocol deviation|3|||
160579581|NCT00751881|579841803|FG001|Core Treatment Period|Other: protocol deviation|3|||
160579582|NCT00751881|579841804|FG002|Core Treatment Period|Other: protocol deviation|7|||
160579583|NCT00751881|579841802|FG000|Core Treatment Period|Other: wish to parent|5|||
160579584|NCT00751881|579841803|FG001|Core Treatment Period|Other: wish to parent|7|||
160579585|NCT00751881|579841804|FG002|Core Treatment Period|Other: wish to parent|4|||
160579586|NCT00751881|579841802|FG000|Core Treatment Period|Other: personal/family constraints|6|||
160579587|NCT00751881|579841803|FG001|Core Treatment Period|Other: personal/family constraints|7|||
160579588|NCT00751881|579841804|FG002|Core Treatment Period|Other: personal/family constraints|10|||
160579589|NCT00751881|579841802|FG000|Core Treatment Period|Other: MS treatment change|6|||
160579590|NCT00751881|579841803|FG001|Core Treatment Period|Other: MS treatment change|4|||
160579591|NCT00751881|579841804|FG002|Core Treatment Period|Other: MS treatment change|4|||
160579592|NCT00751881|579841802|FG000|Core Treatment Period|Other: tolerability complaints|2|||
160579593|NCT00751881|579841803|FG001|Core Treatment Period|Other: tolerability complaints|0|||
160579594|NCT00751881|579841804|FG002|Core Treatment Period|Other: tolerability complaints|0|||
160579595|NCT00751881|579841802|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
160579596|NCT00751881|579841803|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
160579597|NCT00751881|579841804|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
160579598|NCT00751881|579841802|FG000|Extension Study Period|Adverse Event|18|||
160579599|NCT00751881|579841803|FG001|Extension Study Period|Adverse Event|20|||
160579600|NCT00751881|579841804|FG002|Extension Study Period|Adverse Event|21|||
160579601|NCT00751881|579841802|FG000|Extension Study Period|Lack of Efficacy|14|||
160579602|NCT00751881|579841803|FG001|Extension Study Period|Lack of Efficacy|10|||
160579603|NCT00751881|579841804|FG002|Extension Study Period|Lack of Efficacy|20|||
160579604|NCT00751881|579841802|FG000|Extension Study Period|Lost to Follow-up|4|||
160579605|NCT00751881|579841803|FG001|Extension Study Period|Lost to Follow-up|9|||
160579606|NCT00751881|579841804|FG002|Extension Study Period|Lost to Follow-up|6|||
160579607|NCT00751881|579841802|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
160579608|NCT00751881|579841803|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
160579609|NCT00751881|579841804|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
160579610|NCT00751881|579841802|FG000|Extension Study Period|Other than specified above|26|||
160579611|NCT00751881|579841803|FG001|Extension Study Period|Other than specified above|30|||
160579612|NCT00751881|579841804|FG002|Extension Study Period|Other than specified above|18|||
160579613|NCT04770155|579841805|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
160579614|NCT04770155|579841806|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
160579615|NCT04770155|579841807|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
160579616|NCT04770155|579841808|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
160579617|NCT04770155|579841809|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
160579618|NCT04770155|579841810|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
160579619|NCT04770155|579841811|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
160579620|NCT04770155|579841812|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
160579621|NCT01632878|579841816|FG000|Screening|Physician Decision|268|||
160579622|NCT01632878|579841816|FG000|Treatment|Lost to Follow-up|41|||
160942632|NCT01175824|581179878|FG001|Overall Study|Lack of Efficacy|0|||
160942633|NCT01175824|581179877|FG000|Overall Study|Lost to Follow-up|0|||
160942634|NCT01175824|581179878|FG001|Overall Study|Lost to Follow-up|1|||
160942635|NCT01175824|581179877|FG000|Overall Study|Physician Decision|0|||
160942636|NCT01175824|581179878|FG001|Overall Study|Physician Decision|4|||
160579623|NCT01632878|579841816|FG000|Treatment|Withdrawal by Subject|36|||
160942637|NCT01175824|581179877|FG000|Overall Study|Protocol Violation|2|||
160942638|NCT01175824|581179878|FG001|Overall Study|Protocol Violation|5|||
160942639|NCT01175824|581179877|FG000|Overall Study|Withdrawal by Subject|3|||
160942640|NCT01175824|581179878|FG001|Overall Study|Withdrawal by Subject|7|||
160942641|NCT01175824|581179877|FG000|Overall Study|Sponsor Decision|1|||
160455849|NCT02240238|579399761|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160455850|NCT02240238|579399762|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160455851|NCT02240238|579399763|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160455852|NCT02240238|579399764|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160455853|NCT02240238|579399765|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160455854|NCT02240238|579399766|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160455855|NCT02240238|579399767|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160455856|NCT02240238|579399768|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160455857|NCT02240238|579399769|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160942642|NCT01175824|581179878|FG001|Overall Study|Sponsor Decision|0|||
160942643|NCT01175824|581179877|FG000|Overall Study|Entry Criteria Not Met|6|||
160942644|NCT01175824|581179878|FG001|Overall Study|Entry Criteria Not Met|4|||
160942645|NCT03455855|581179879|FG000|Overall Study|Lost to Follow-up|4|||
160942646|NCT03455855|581179880|FG001|Overall Study|Lost to Follow-up|2|||
160942647|NCT01774903|581179881|FG000|Overall Study|Adverse Event|7|||
160942648|NCT01774903|581179881|FG000|Overall Study|Withdrawal by Subject|2|||
160942649|NCT01774903|581179881|FG000|Overall Study|Lack of Efficacy|1|||
160942650|NCT01774903|581179881|FG000|Overall Study|Ineligible to continue the trial|1|||
160942651|NCT00924950|581179882|FG000|Overall Study|Lost to Follow-up|2|||
160942652|NCT01602315|581179883|FG000|Overall Study|Protocol Violation|0|||
160942653|NCT01602315|581179884|FG001|Overall Study|Protocol Violation|0|||
160455858|NCT02240238|579399770|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160455859|NCT02240238|579399771|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
160455860|NCT02240238|579399772|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
160455861|NCT02240238|579399761|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455862|NCT02240238|579399762|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455863|NCT02240238|579399763|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455864|NCT02240238|579399764|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455865|NCT02240238|579399765|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455866|NCT02240238|579399766|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455867|NCT02240238|579399767|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455868|NCT02240238|579399768|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455869|NCT02240238|579399769|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455870|NCT02240238|579399770|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455871|NCT02240238|579399771|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
160455872|NCT02240238|579399772|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
160455873|NCT02724969|579399787|FG000|Overall Study|Lost to Follow-up|12|||
160455874|NCT02724969|579399788|FG001|Overall Study|Lost to Follow-up|6|||
160455875|NCT02724969|579399787|FG000|Overall Study|Withdrawal by Subject|3|||
160455876|NCT02724969|579399788|FG001|Overall Study|Withdrawal by Subject|3|||
160455877|NCT02724969|579399787|FG000|Overall Study|Infant demise|0|||
160455878|NCT02724969|579399788|FG001|Overall Study|Infant demise|2|||
160455879|NCT05147116|579399791|FG000|Overall Study|Withdrawal by Subject|0|||
160455880|NCT05147116|579399792|FG001|Overall Study|Withdrawal by Subject|1|||
160455881|NCT03625115|579399793|FG000|Overall Study|Withdrawal by Subject|4|||
160455882|NCT03625115|579399794|FG001|Overall Study|Withdrawal by Subject|7|||
160455883|NCT03625115|579399793|FG000|Overall Study|Lost to Follow-up|17|||
160455884|NCT03625115|579399794|FG001|Overall Study|Lost to Follow-up|24|||
160455885|NCT03672916|579399795|FG000|Overall Study|Death|6|||
160579624|NCT01632878|579841816|FG000|Treatment|Physician Decision|34|||
160579625|NCT01632878|579841816|FG000|Treatment|missing information|4|||
160942654|NCT01602315|581179885|FG002|Overall Study|Protocol Violation|0|||
160942655|NCT01602315|581179886|FG003|Overall Study|Protocol Violation|0|||
160942656|NCT01602315|581179887|FG004|Overall Study|Protocol Violation|0|||
160942657|NCT01602315|581179888|FG005|Overall Study|Protocol Violation|1|||
160942658|NCT01602315|581179889|FG006|Overall Study|Protocol Violation|0|||
160942659|NCT01602315|581179883|FG000|Overall Study|Physician Decision|2|||
160942660|NCT01602315|581179884|FG001|Overall Study|Physician Decision|0|||
160942661|NCT01602315|581179885|FG002|Overall Study|Physician Decision|0|||
160942662|NCT01602315|581179886|FG003|Overall Study|Physician Decision|0|||
160942663|NCT01602315|581179887|FG004|Overall Study|Physician Decision|2|||
160942664|NCT01602315|581179888|FG005|Overall Study|Physician Decision|1|||
160942665|NCT01602315|581179889|FG006|Overall Study|Physician Decision|1|||
160942666|NCT01602315|581179883|FG000|Overall Study|Disease progression|6|||
160942667|NCT01602315|581179884|FG001|Overall Study|Disease progression|3|||
160942668|NCT01602315|581179885|FG002|Overall Study|Disease progression|10|||
160942669|NCT01602315|581179886|FG003|Overall Study|Disease progression|1|||
160942670|NCT01602315|581179887|FG004|Overall Study|Disease progression|41|||
160455886|NCT03672916|579399795|FG000|Overall Study|Lost to Follow-up|29|||
160455887|NCT03672916|579399795|FG000|Overall Study|Adverse Event|6|||
160942671|NCT01602315|581179888|FG005|Overall Study|Disease progression|12|||
160942672|NCT01602315|581179889|FG006|Overall Study|Disease progression|15|||
160999083|NCT02299336|581380677|FG000|Overall Study|Adverse Event|1|||
160999084|NCT02299336|581380677|FG000|Overall Study|Death|1|||
160999085|NCT02299336|581380677|FG000|Overall Study|Lost to Follow-up|1|||
160999086|NCT01867580|581380680|FG000|Overall Study|Withdrawal by Subject|2|||
160999087|NCT01867580|581380681|FG001|Overall Study|Withdrawal by Subject|3|||
160579626|NCT01632878|579841816|FG000|Treatment|no information on study completion|43|||
160579627|NCT02698423|579841817|FG000|Overall Study|Lost to Follow-up|19|||
160579628|NCT02698423|579841818|FG001|Overall Study|Lost to Follow-up|24|||
160579629|NCT03634072|579841821|FG000|Overall Study|Early termination of overall study|1|||
160579630|NCT03634072|579841822|FG001|Overall Study|Early termination of overall study|0|||
160579631|NCT01765764|579841823|FG000|Treatment Period|Adverse Event|1|||
160579632|NCT01765764|579841824|FG001|Treatment Period|Adverse Event|2|||
160579633|NCT01765764|579841825|FG002|Treatment Period|Adverse Event|1|||
160579634|NCT01765764|579841823|FG000|Treatment Period|Lost to Follow-up|0|||
160579635|NCT01765764|579841824|FG001|Treatment Period|Lost to Follow-up|3|||
160579636|NCT01765764|579841825|FG002|Treatment Period|Lost to Follow-up|2|||
160579637|NCT01765764|579841823|FG000|Treatment Period|Personal Reasons|1|||
160579638|NCT01765764|579841824|FG001|Treatment Period|Personal Reasons|2|||
160579639|NCT01765764|579841825|FG002|Treatment Period|Personal Reasons|1|||
160579640|NCT01765764|579841823|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
160579641|NCT01765764|579841824|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
160579642|NCT01765764|579841825|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
160579643|NCT00064662|579841828|FG000|Overall Study|Death|1|||
160942673|NCT01602315|581179883|FG000|Overall Study|Death|1|||
160942674|NCT01602315|581179884|FG001|Overall Study|Death|1|||
160942675|NCT01602315|581179885|FG002|Overall Study|Death|1|||
160942676|NCT01602315|581179886|FG003|Overall Study|Death|1|||
160942677|NCT01602315|581179887|FG004|Overall Study|Death|7|||
160942678|NCT01602315|581179888|FG005|Overall Study|Death|2|||
160942679|NCT01602315|581179889|FG006|Overall Study|Death|2|||
160942680|NCT01602315|581179883|FG000|Overall Study|Withdrawal by Subject|2|||
160942681|NCT01602315|581179884|FG001|Overall Study|Withdrawal by Subject|0|||
160942682|NCT01602315|581179885|FG002|Overall Study|Withdrawal by Subject|2|||
160942683|NCT01602315|581179886|FG003|Overall Study|Withdrawal by Subject|0|||
160942684|NCT01602315|581179887|FG004|Overall Study|Withdrawal by Subject|6|||
160942685|NCT01602315|581179888|FG005|Overall Study|Withdrawal by Subject|0|||
160942686|NCT01602315|581179889|FG006|Overall Study|Withdrawal by Subject|1|||
160942687|NCT01602315|581179883|FG000|Overall Study|Adverse Event|5|||
160942688|NCT01602315|581179884|FG001|Overall Study|Adverse Event|1|||
160942689|NCT01602315|581179885|FG002|Overall Study|Adverse Event|5|||
160942690|NCT01602315|581179886|FG003|Overall Study|Adverse Event|4|||
160942691|NCT01602315|581179887|FG004|Overall Study|Adverse Event|15|||
160942692|NCT01602315|581179888|FG005|Overall Study|Adverse Event|3|||
160942693|NCT01602315|581179889|FG006|Overall Study|Adverse Event|9|||
160942694|NCT01602315|581179883|FG000|Overall Study|Subject/guardian decision|0|||
160942695|NCT01602315|581179884|FG001|Overall Study|Subject/guardian decision|0|||
160942696|NCT01602315|581179885|FG002|Overall Study|Subject/guardian decision|0|||
160942697|NCT01602315|581179886|FG003|Overall Study|Subject/guardian decision|0|||
160942698|NCT01602315|581179887|FG004|Overall Study|Subject/guardian decision|0|||
160942699|NCT01602315|581179888|FG005|Overall Study|Subject/guardian decision|0|||
160942700|NCT01602315|581179889|FG006|Overall Study|Subject/guardian decision|1|||
160942701|NCT01602315|581179883|FG000|Overall Study|Cross-over patients to combo treatment|0|||
160942702|NCT01602315|581179884|FG001|Overall Study|Cross-over patients to combo treatment|0|||
160942703|NCT01602315|581179885|FG002|Overall Study|Cross-over patients to combo treatment|0|||
160942704|NCT01602315|581179886|FG003|Overall Study|Cross-over patients to combo treatment|0|||
160942705|NCT01602315|581179887|FG004|Overall Study|Cross-over patients to combo treatment|0|||
160942706|NCT01602315|581179888|FG005|Overall Study|Cross-over patients to combo treatment|16|||
160942707|NCT01602315|581179889|FG006|Overall Study|Cross-over patients to combo treatment|0|||
160942708|NCT00982319|581179892|FG000|Overall Study|Surgery date change|1|||
160942709|NCT00982319|581179893|FG001|Overall Study|Surgery date change|0|||
160942710|NCT00982319|581179892|FG000|Overall Study|Preop values out of acceptable range|1|||
160942711|NCT00982319|581179893|FG001|Overall Study|Preop values out of acceptable range|1|||
160942712|NCT00982319|581179892|FG000|Overall Study|Pregnancy|0|||
160942713|NCT00982319|581179893|FG001|Overall Study|Pregnancy|1|||
160942714|NCT00961259|581179898|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
160942715|NCT00961259|581179899|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
160942716|NCT00961259|581179900|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
160942717|NCT01252251|581179901|FG000|Overall Study|Withdrawal by Subject|1|||
160942718|NCT02691455|581179904|FG000|Overall Study|Withdrawal by Subject|1|||
160579644|NCT00064662|579841829|FG001|Overall Study|Death|1|||
160942719|NCT02691455|581179905|FG001|Overall Study|Withdrawal by Subject|2|||
160942720|NCT02691455|581179904|FG000|Overall Study|Lost to Follow-up|15|||
160579645|NCT00064662|579841828|FG000|Overall Study|Lost to Follow-up|57|||
160579646|NCT00064662|579841829|FG001|Overall Study|Lost to Follow-up|44|||
160942721|NCT02691455|581179905|FG001|Overall Study|Lost to Follow-up|15|||
160999088|NCT01867580|581380680|FG000|Overall Study|Physician Decision|17|||
160942722|NCT01743092|581179906|FG000|Overall Study|Lost to Follow-up|14|||
160942723|NCT01743092|581179907|FG001|Overall Study|Lost to Follow-up|15|||
160942724|NCT03603964|581179908|FG000|Overall Study|Death|9|||
160942725|NCT03603964|581179908|FG000|Overall Study|Withdrawal by participant|7|||
160942726|NCT03603964|581179908|FG000|Overall Study|Study terminated by Sponsor|19|||
160942727|NCT00563797|581179909|FG000|Overall Study|Lost to Follow-up|7|||
160942728|NCT00563797|581179910|FG001|Overall Study|Lost to Follow-up|2|||
160942729|NCT00179647|581179914|FG000|Overall Study|Adverse Event|294|||
160942730|NCT00179647|581179914|FG000|Overall Study|Lack of Efficacy|478|||
160942731|NCT00179647|581179914|FG000|Overall Study|Withdrawal by Subject|83|||
160942732|NCT00179647|581179914|FG000|Overall Study|Lost to Follow-up|4|||
160942733|NCT00179647|581179914|FG000|Overall Study|Death|94|||
160942734|NCT00179647|581179914|FG000|Overall Study|Other|960|||
160942735|NCT00622635|581179915|FG000|Treatment Period 1|Adverse Event|0|||
160942736|NCT00622635|581179916|FG001|Treatment Period 1|Adverse Event|0|||
160942737|NCT00622635|581179917|FG002|Treatment Period 1|Adverse Event|1|||
160942738|NCT00622635|581179918|FG003|Treatment Period 1|Adverse Event|0|||
160942739|NCT00622635|581179919|FG004|Treatment Period 1|Adverse Event|0|||
160999089|NCT01867580|581380681|FG001|Overall Study|Physician Decision|12|||
160999090|NCT01867580|581380680|FG000|Overall Study|Lost to Follow-up|3|||
160999091|NCT01867580|581380681|FG001|Overall Study|Lost to Follow-up|5|||
160999092|NCT01867580|581380680|FG000|Overall Study|Sponsor terminated study|1|||
160999093|NCT01867580|581380681|FG001|Overall Study|Sponsor terminated study|0|||
160999094|NCT01867580|581380680|FG000|Overall Study|Missed follow-up assessment|2|||
160999095|NCT01867580|581380681|FG001|Overall Study|Missed follow-up assessment|1|||
160999096|NCT01867580|581380680|FG000|Overall Study|Interruption to therapy|3|||
160999097|NCT01867580|581380681|FG001|Overall Study|Interruption to therapy|0|||
160999098|NCT01867580|581380680|FG000|Overall Study|Osteomyelitis|0|||
160999099|NCT01867580|581380681|FG001|Overall Study|Osteomyelitis|1|||
160999100|NCT01867580|581380680|FG000|Overall Study|Continuation of therapy|0|||
160999101|NCT01867580|581380681|FG001|Overall Study|Continuation of therapy|1|||
160999102|NCT01867580|581380680|FG000|Overall Study|Wound recurrence|0|||
160999103|NCT01867580|581380681|FG001|Overall Study|Wound recurrence|1|||
160999104|NCT01304147|581380682|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
160999105|NCT01304147|581380683|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
160999106|NCT01278862|581380684|FG000|Overall Study|Lost to Follow-up|1|||
160999107|NCT01278862|581380685|FG001|Overall Study|Lost to Follow-up|1|||
160579647|NCT00064662|579841828|FG000|Overall Study|Withdrawal by Subject|14|||
160579648|NCT00064662|579841829|FG001|Overall Study|Withdrawal by Subject|14|||
160579649|NCT00064662|579841828|FG000|Overall Study|Administratively withdrawn|2|||
160579650|NCT00064662|579841829|FG001|Overall Study|Administratively withdrawn|2|||
160579651|NCT01095250|579841836|FG000|Overall Study|administrative reasons|8|||
160579652|NCT01095250|579841837|FG001|Overall Study|administrative reasons|10|||
160579653|NCT01095250|579841838|FG002|Overall Study|administrative reasons|7|||
160579654|NCT01095250|579841839|FG003|Overall Study|administrative reasons|5|||
160579655|NCT01095250|579841836|FG000|Overall Study|Withdrawal by Subject|0|||
160579656|NCT01095250|579841837|FG001|Overall Study|Withdrawal by Subject|0|||
160579657|NCT01095250|579841838|FG002|Overall Study|Withdrawal by Subject|1|||
160579658|NCT01095250|579841839|FG003|Overall Study|Withdrawal by Subject|0|||
160579659|NCT01323673|579841840|FG000|Overall Study|Adverse Event|0|||
160579660|NCT01323673|579841841|FG001|Overall Study|Adverse Event|1|||
160579661|NCT01323673|579841840|FG000|Overall Study|Lost to Follow-up|0|||
160579662|NCT01323673|579841841|FG001|Overall Study|Lost to Follow-up|1|||
160579663|NCT01323673|579841840|FG000|Overall Study|Protocol Violation|1|||
160579664|NCT01323673|579841841|FG001|Overall Study|Protocol Violation|0|||
160579665|NCT01323673|579841840|FG000|Overall Study|Withdrawal by Subject|2|||
160579666|NCT01323673|579841841|FG001|Overall Study|Withdrawal by Subject|3|||
160579667|NCT01937130|579844017|FG000|Overall Study|Withdrawal by Subject|0|||
160579668|NCT01937130|579844018|FG001|Overall Study|Withdrawal by Subject|0|||
160579669|NCT01937130|579844019|FG002|Overall Study|Withdrawal by Subject|0|||
160999108|NCT02952261|581380687|FG000|Overall Study|Withdrawal by Subject|4|||
160999109|NCT02952261|581380688|FG001|Overall Study|Withdrawal by Subject|5|||
160579670|NCT01937130|579844020|FG003|Overall Study|Withdrawal by Subject|1|||
160455888|NCT03672916|579399795|FG000|Overall Study|Withdrawal by Subject|11|||
160579671|NCT01937130|579844017|FG000|Overall Study|Adverse Event|0|||
160579672|NCT01937130|579844018|FG001|Overall Study|Adverse Event|1|||
160579673|NCT01937130|579844019|FG002|Overall Study|Adverse Event|0|||
160579674|NCT01937130|579844020|FG003|Overall Study|Adverse Event|1|||
160579675|NCT01937130|579844017|FG000|Overall Study|Death|1|||
160999110|NCT02952261|581380687|FG000|Overall Study|Protocol Violation|1|||
160579676|NCT01937130|579844018|FG001|Overall Study|Death|1|||
160579677|NCT01937130|579844019|FG002|Overall Study|Death|1|||
160942740|NCT00622635|581179920|FG005|Treatment Period 1|Adverse Event|0|||
160579678|NCT01937130|579844020|FG003|Overall Study|Death|0|||
160579679|NCT01937130|579844017|FG000|Overall Study|Lost to Follow-up|2|||
160942741|NCT00622635|581179915|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160942742|NCT00622635|581179916|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160942743|NCT00622635|581179917|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160999111|NCT02952261|581380688|FG001|Overall Study|Protocol Violation|0|||
160942744|NCT00622635|581179918|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160942745|NCT00622635|581179919|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160942746|NCT00622635|581179920|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160579680|NCT01937130|579844018|FG001|Overall Study|Lost to Follow-up|0|||
160579681|NCT01937130|579844019|FG002|Overall Study|Lost to Follow-up|2|||
160579682|NCT01937130|579844020|FG003|Overall Study|Lost to Follow-up|0|||
160579683|NCT01937130|579844017|FG000|Overall Study|Physician Decision|0|||
160942747|NCT00622635|581179915|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
160942748|NCT00622635|581179916|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
160942749|NCT00622635|581179917|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
160942750|NCT00622635|581179918|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
160942751|NCT00622635|581179919|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
160942752|NCT00622635|581179920|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
160942753|NCT00622635|581179915|FG000|Treatment Period 2|Adverse Event|1|||
160942754|NCT00622635|581179916|FG001|Treatment Period 2|Adverse Event|0|||
160942755|NCT00622635|581179917|FG002|Treatment Period 2|Adverse Event|0|||
160942756|NCT00622635|581179918|FG003|Treatment Period 2|Adverse Event|0|||
160942757|NCT00622635|581179919|FG004|Treatment Period 2|Adverse Event|0|||
160942758|NCT00622635|581179920|FG005|Treatment Period 2|Adverse Event|0|||
160942759|NCT00622635|581179915|FG000|Treatment Period 3|Adverse Event|0|||
160942760|NCT00622635|581179916|FG001|Treatment Period 3|Adverse Event|0|||
160942761|NCT00622635|581179917|FG002|Treatment Period 3|Adverse Event|0|||
160942762|NCT00622635|581179918|FG003|Treatment Period 3|Adverse Event|2|||
160942763|NCT00622635|581179919|FG004|Treatment Period 3|Adverse Event|0|||
160942764|NCT00622635|581179920|FG005|Treatment Period 3|Adverse Event|0|||
160942765|NCT00622635|581179915|FG000|Treatment Period 3|Withdrawal by Subject|0|||
160942766|NCT00622635|581179916|FG001|Treatment Period 3|Withdrawal by Subject|0|||
160942767|NCT00622635|581179917|FG002|Treatment Period 3|Withdrawal by Subject|0|||
160942768|NCT00622635|581179918|FG003|Treatment Period 3|Withdrawal by Subject|1|||
160942769|NCT00622635|581179919|FG004|Treatment Period 3|Withdrawal by Subject|0|||
160942770|NCT00622635|581179920|FG005|Treatment Period 3|Withdrawal by Subject|0|||
160942771|NCT05013905|581179923|FG000|Overall Study|Adverse Event|1|||
160942772|NCT05013905|581179923|FG000|Overall Study|Lack of Efficacy|1|||
160942773|NCT01849588|581179926|FG000|Overall Study|Lack of Efficacy|3|||
160942774|NCT02486406|581179934|FG000|Overall Study|Withdrew consent|1|||
160942775|NCT02486406|581179935|FG001|Overall Study|Withdrew consent|0|||
160942776|NCT02486406|581179936|FG002|Overall Study|Withdrew consent|0|||
160942777|NCT02486406|581179937|FG003|Overall Study|Withdrew consent|1|||
160942778|NCT02486406|581179934|FG000|Overall Study|Lost to Follow-up|1|||
160942779|NCT02486406|581179935|FG001|Overall Study|Lost to Follow-up|3|||
160942780|NCT02486406|581179936|FG002|Overall Study|Lost to Follow-up|1|||
160942781|NCT02486406|581179937|FG003|Overall Study|Lost to Follow-up|3|||
160942782|NCT02486406|581179934|FG000|Overall Study|Other, not specified|0|||
160942783|NCT02486406|581179935|FG001|Overall Study|Other, not specified|0|||
160942784|NCT02486406|581179936|FG002|Overall Study|Other, not specified|1|||
160942785|NCT02486406|581179937|FG003|Overall Study|Other, not specified|0|||
160942786|NCT03509948|581179949|FG000|Overall Study|Protocol Violation|0|||
160942787|NCT03509948|581179950|FG001|Overall Study|Protocol Violation|1|||
160942788|NCT01071512|581179961|FG000|Overall Study|Adverse Event|1|||
160942789|NCT01071512|581179961|FG000|Overall Study|Development of antibodies to drug|2|||
160942790|NCT01071512|581179961|FG000|Overall Study|positive anti-JC virus antibody test|2|||
160942791|NCT00183872|581179962|FG000|Overall Study|Death|3|||
160942792|NCT00183872|581179962|FG000|Overall Study|Adverse Event|9|||
160942793|NCT00183872|581179962|FG000|Overall Study|Withdrawal by Subject|2|||
160942794|NCT00183872|581179962|FG000|Overall Study|Drug delayed more than 28 days|2|||
160942795|NCT00853658|581179963|FG000|Overall Study|Death|713|||
160579684|NCT01937130|579844018|FG001|Overall Study|Physician Decision|1|||
160942796|NCT00853658|581179964|FG001|Overall Study|Death|768|||
160942797|NCT00853658|581179965|FG002|Overall Study|Death|753|||
160942798|NCT00853658|581179963|FG000|Overall Study|Lost to Follow-up|11|||
160942799|NCT00853658|581179964|FG001|Overall Study|Lost to Follow-up|6|||
160579685|NCT01937130|579844019|FG002|Overall Study|Physician Decision|0|||
160942800|NCT00853658|581179965|FG002|Overall Study|Lost to Follow-up|11|||
160942801|NCT00853658|581179963|FG000|Overall Study|H.A. Request|26|||
160942802|NCT00853658|581179964|FG001|Overall Study|H.A. Request|23|||
160942803|NCT00853658|581179965|FG002|Overall Study|H.A. Request|19|||
160942804|NCT00853658|581179963|FG000|Overall Study|IRB request|0|||
160942805|NCT00853658|581179964|FG001|Overall Study|IRB request|0|||
160942806|NCT00853658|581179965|FG002|Overall Study|IRB request|2|||
160942807|NCT00853658|581179963|FG000|Overall Study|Vital Status known (alive) at study end|2|||
160942808|NCT00853658|581179964|FG001|Overall Study|Vital Status known (alive) at study end|3|||
160942809|NCT00853658|581179965|FG002|Overall Study|Vital Status known (alive) at study end|3|||
160942810|NCT00853658|581179963|FG000|Overall Study|Vital Status unknown at study end|1|||
160942811|NCT00853658|581179964|FG001|Overall Study|Vital Status unknown at study end|1|||
160942812|NCT00853658|581179965|FG002|Overall Study|Vital Status unknown at study end|0|||
160455889|NCT04197336|579399796|FG000|Overall Study|Withdrawal by Subject|1|||
160579686|NCT01937130|579844020|FG003|Overall Study|Physician Decision|0|||
160579687|NCT01937130|579844017|FG000|Overall Study|Patients unable to swallow|0|||
160579688|NCT01937130|579844018|FG001|Overall Study|Patients unable to swallow|1|||
160579689|NCT01937130|579844019|FG002|Overall Study|Patients unable to swallow|0|||
160579690|NCT01937130|579844020|FG003|Overall Study|Patients unable to swallow|0|||
160579691|NCT01937130|579844017|FG000|Overall Study|Patient lost to FU due to death|2|||
160579692|NCT01937130|579844018|FG001|Overall Study|Patient lost to FU due to death|0|||
160579693|NCT01937130|579844019|FG002|Overall Study|Patient lost to FU due to death|0|||
160579694|NCT01937130|579844020|FG003|Overall Study|Patient lost to FU due to death|0|||
160579695|NCT01431144|579844021|FG000|Overall Study|Implant mobility and removal|2|||
160579696|NCT01431144|579844022|FG001|Overall Study|Implant mobility and removal|0|||
160579697|NCT00953043|579844027|FG000|Overall Study|Withdrawal by Subject|4|||
160579698|NCT00953043|579844028|FG001|Overall Study|Withdrawal by Subject|0|||
160579699|NCT00953043|579844027|FG000|Overall Study|Physician Decision|0|||
160579700|NCT00953043|579844028|FG001|Overall Study|Physician Decision|2|||
160579701|NCT00747617|579844029|FG000|Overall Study|Lost to Follow-up|3|||
160579702|NCT00747617|579844030|FG001|Overall Study|Lost to Follow-up|1|||
160579703|NCT03509207|579844031|FG000|Overall Study|Death|2|||
160579704|NCT02125331|579844032|FG000|Overall Study|Protocol Violation|1|||
160579705|NCT02125331|579844033|FG001|Overall Study|Protocol Violation|0|||
160579706|NCT02125331|579844032|FG000|Overall Study|technical problem|2|||
160579707|NCT02125331|579844033|FG001|Overall Study|technical problem|0|||
160579708|NCT02125331|579844032|FG000|Overall Study|screen failure|2|||
160579709|NCT02125331|579844033|FG001|Overall Study|screen failure|0|||
160579710|NCT01432262|579844034|FG000|Overall Study|Withdrawal by Subject|2|||
160579711|NCT01432262|579844035|FG001|Overall Study|Withdrawal by Subject|1|||
160579712|NCT00165646|579844036|FG000|Overall Study|Adverse Event|1|||
160579713|NCT00165646|579844037|FG001|Overall Study|Adverse Event|1|||
160942813|NCT00853658|581179963|FG000|Overall Study|Vital Status at study end N/A|8|||
160942814|NCT00853658|581179964|FG001|Overall Study|Vital Status at study end N/A|10|||
160942815|NCT00853658|581179965|FG002|Overall Study|Vital Status at study end N/A|10|||
160942816|NCT00853658|581179963|FG000|Overall Study|Patient's request|21|||
160942817|NCT00853658|581179964|FG001|Overall Study|Patient's request|17|||
160942818|NCT00853658|581179965|FG002|Overall Study|Patient's request|11|||
160942819|NCT00853658|581179963|FG000|Overall Study|Missing study completion information|5|||
160942820|NCT00853658|581179964|FG001|Overall Study|Missing study completion information|4|||
160942821|NCT00853658|581179965|FG002|Overall Study|Missing study completion information|6|||
160942822|NCT02797262|581179966|FG000|Overall Study|Withdrawal by Subject|5|||
160942823|NCT02797262|581179967|FG001|Overall Study|Withdrawal by Subject|1|||
160942824|NCT02797262|581179966|FG000|Overall Study|Lost to Follow-up|10|||
160942825|NCT02797262|581179967|FG001|Overall Study|Lost to Follow-up|7|||
160942826|NCT02797262|581179966|FG000|Overall Study|Death|1|||
160942827|NCT02797262|581179967|FG001|Overall Study|Death|2|||
160942828|NCT02797262|581179966|FG000|Overall Study|Adverse Event|1|||
160942829|NCT02797262|581179967|FG001|Overall Study|Adverse Event|0|||
160942830|NCT02797262|581179966|FG000|Overall Study|COVID-19|2|||
160942831|NCT02797262|581179967|FG001|Overall Study|COVID-19|1|||
160942832|NCT02797262|581179966|FG000|Overall Study|Out-of-country|1|||
160942833|NCT02797262|581179967|FG001|Overall Study|Out-of-country|0|||
160942834|NCT01600586|581179968|FG000|Overall Study|Physician Decision|3|||
160942835|NCT01600586|581179969|FG001|Overall Study|Physician Decision|3|||
160942836|NCT01227512|581179971|FG000|Overall Study|Physician Decision|6|||
160942837|NCT01227512|581179972|FG001|Overall Study|Physician Decision|6|||
160942838|NCT01227512|581179971|FG000|Overall Study|Adverse Event|4|||
160942839|NCT01227512|581179972|FG001|Overall Study|Adverse Event|3|||
160942840|NCT01227512|581179971|FG000|Overall Study|Withdrawal by Subject|3|||
160942841|NCT01227512|581179972|FG001|Overall Study|Withdrawal by Subject|0|||
160942842|NCT01227512|581179971|FG000|Overall Study|Participant met withdrawal criteria|0|||
160942843|NCT01227512|581179972|FG001|Overall Study|Participant met withdrawal criteria|1|||
160942844|NCT01069289|581179974|FG000|Overall Study|Withdrawal by Subject|15|||
160942845|NCT01069289|581179975|FG001|Overall Study|Withdrawal by Subject|26|||
160942846|NCT01069289|581179974|FG000|Overall Study|Adverse Event|21|||
160942847|NCT01069289|581179975|FG001|Overall Study|Adverse Event|28|||
160942848|NCT01069289|581179974|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
160942849|NCT01069289|581179975|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160942850|NCT01069289|581179974|FG000|Overall Study|Severe non-compliance to protocol|3|||
160942851|NCT01069289|581179975|FG001|Overall Study|Severe non-compliance to protocol|2|||
160579714|NCT00165646|579844038|FG002|Overall Study|Adverse Event|1|||
160579715|NCT00165646|579844036|FG000|Overall Study|Lack of Efficacy|1|||
160579716|NCT00165646|579844037|FG001|Overall Study|Lack of Efficacy|2|||
160579717|NCT00165646|579844038|FG002|Overall Study|Lack of Efficacy|0|||
160579718|NCT00165646|579844036|FG000|Overall Study|Withdrawal by Subject|0|||
160942852|NCT01069289|581179974|FG000|Overall Study|Due to deteriorating health condition|1|||
160942853|NCT01069289|581179975|FG001|Overall Study|Due to deteriorating health condition|0|||
160579719|NCT00165646|579844037|FG001|Overall Study|Withdrawal by Subject|2|||
160942854|NCT01818336|581181296|FG000|Overall Study|Declined retest visit|0|||
160942855|NCT01818336|581181297|FG001|Overall Study|Declined retest visit|11|||
160942856|NCT01818336|581181296|FG000|Overall Study|Lost to Follow-up|0|||
160942857|NCT01818336|581181297|FG001|Overall Study|Lost to Follow-up|1|||
160942858|NCT03042312|581181300|FG000|Overall Study|Administrative Reason|1|||
160942859|NCT03042312|581181301|FG001|Overall Study|Administrative Reason|1|||
160942860|NCT03042312|581181300|FG000|Overall Study|Adverse Event|0|||
160942861|NCT03042312|581181301|FG001|Overall Study|Adverse Event|1|||
160942862|NCT03042312|581181300|FG000|Overall Study|Lost to Follow-up|1|||
160942863|NCT03042312|581181301|FG001|Overall Study|Lost to Follow-up|3|||
160942864|NCT03042312|581181300|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
160942865|NCT03042312|581181301|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
160942866|NCT03042312|581181300|FG000|Overall Study|Withdrawal by Subject|4|||
160942867|NCT03042312|581181301|FG001|Overall Study|Withdrawal by Subject|5|||
160942868|NCT03422003|581181312|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
160942869|NCT03422003|581181313|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
160942870|NCT03422003|581181312|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
160942871|NCT03422003|581181313|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
160942872|NCT00317772|581181314|FG000|Overall Study|Adverse Event|0|||
160942873|NCT00317772|581181315|FG001|Overall Study|Adverse Event|0|||
160942874|NCT00317772|581181316|FG002|Overall Study|Adverse Event|0|||
160942875|NCT00317772|581181317|FG003|Overall Study|Adverse Event|2|||
160942876|NCT00317772|581181314|FG000|Overall Study|Disease Progression|2|||
160942877|NCT00317772|581181315|FG001|Overall Study|Disease Progression|2|||
160942878|NCT00317772|581181316|FG002|Overall Study|Disease Progression|1|||
160942879|NCT00317772|581181317|FG003|Overall Study|Disease Progression|7|||
160942880|NCT00966940|581181318|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
160942881|NCT00966940|581181319|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
160942882|NCT00966940|581181318|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
160942883|NCT00966940|581181319|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
160942884|NCT01040871|581181322|FG000|Overall Study|Adverse Event|6|||
160942885|NCT01040871|581181323|FG001|Overall Study|Adverse Event|2|||
160942886|NCT01040871|581181322|FG000|Overall Study|Withdrawal by Subject|2|||
160942887|NCT01040871|581181323|FG001|Overall Study|Withdrawal by Subject|0|||
160942888|NCT01040871|581181322|FG000|Overall Study|Death|1|||
160942889|NCT01040871|581181323|FG001|Overall Study|Death|3|||
160942890|NCT01040871|581181322|FG000|Overall Study|Lack of Efficacy|1|||
160942891|NCT01040871|581181323|FG001|Overall Study|Lack of Efficacy|1|||
160942892|NCT01040871|581181322|FG000|Overall Study|drug supply issue|1|||
160579720|NCT00165646|579844038|FG002|Overall Study|Withdrawal by Subject|1|||
160942893|NCT01040871|581181323|FG001|Overall Study|drug supply issue|0|||
160942894|NCT01040871|581181322|FG000|Overall Study|Randomized and Not Treated|2|||
160942895|NCT01040871|581181323|FG001|Overall Study|Randomized and Not Treated|1|||
160942896|NCT02886572|581181324|FG000|Overall Study|Death|8|||
160942897|NCT03087591|581181326|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
160942898|NCT03087591|581181326|FG000|Overall Study|Withdrawal by Subject|1|||
160942899|NCT02621606|581181327|FG000|Overall Study|Withdrawal by Subject|0|||
160942900|NCT02621606|581181328|FG001|Overall Study|Withdrawal by Subject|1|||
160942901|NCT02621606|581181329|FG002|Overall Study|Withdrawal by Subject|0|||
160942902|NCT01933334|581181330|FG000|Overall Study|Adverse Event|5|||
160942903|NCT01933334|581181331|FG001|Overall Study|Adverse Event|1|||
160942904|NCT01933334|581181330|FG000|Overall Study|Withdrawal by Subject|0|||
160942905|NCT01933334|581181331|FG001|Overall Study|Withdrawal by Subject|1|||
160942906|NCT00767000|581181332|FG000|54-week Study|Adverse Event|4|||
160942907|NCT00767000|581181333|FG001|54-week Study|Adverse Event|6|||
160942908|NCT00767000|581181334|FG002|54-week Study|Adverse Event|6|||
160942909|NCT00767000|581181335|FG003|54-week Study|Adverse Event|8|||
160942910|NCT00767000|581181336|FG004|54-week Study|Adverse Event|4|||
160942911|NCT00767000|581181332|FG000|54-week Study|Creaninine/creatinine clearance|2|||
160942912|NCT00767000|581181333|FG001|54-week Study|Creaninine/creatinine clearance|1|||
160942913|NCT00767000|581181334|FG002|54-week Study|Creaninine/creatinine clearance|2|||
160942914|NCT00767000|581181335|FG003|54-week Study|Creaninine/creatinine clearance|2|||
160942915|NCT00767000|581181336|FG004|54-week Study|Creaninine/creatinine clearance|4|||
160942916|NCT00767000|581181332|FG000|54-week Study|Hyperglycemia|0|||
160942917|NCT00767000|581181333|FG001|54-week Study|Hyperglycemia|0|||
160942918|NCT00767000|581181334|FG002|54-week Study|Hyperglycemia|1|||
160942919|NCT00767000|581181335|FG003|54-week Study|Hyperglycemia|0|||
160942920|NCT00767000|581181336|FG004|54-week Study|Hyperglycemia|1|||
160942921|NCT00767000|581181332|FG000|54-week Study|Hypoglycemia|0|||
160942922|NCT00767000|581181333|FG001|54-week Study|Hypoglycemia|1|||
160942923|NCT00767000|581181334|FG002|54-week Study|Hypoglycemia|0|||
160942924|NCT00767000|581181335|FG003|54-week Study|Hypoglycemia|0|||
160942925|NCT00767000|581181336|FG004|54-week Study|Hypoglycemia|0|||
160942926|NCT00767000|581181332|FG000|54-week Study|Interruption of study medication|0|||
160942927|NCT00767000|581181333|FG001|54-week Study|Interruption of study medication|0|||
160942928|NCT00767000|581181334|FG002|54-week Study|Interruption of study medication|1|||
160942929|NCT00767000|581181335|FG003|54-week Study|Interruption of study medication|0|||
160942930|NCT00767000|581181336|FG004|54-week Study|Interruption of study medication|0|||
160942931|NCT00767000|581181332|FG000|54-week Study|Lack of Efficacy|2|||
160942932|NCT00767000|581181333|FG001|54-week Study|Lack of Efficacy|0|||
160942933|NCT00767000|581181334|FG002|54-week Study|Lack of Efficacy|1|||
160942934|NCT00767000|581181335|FG003|54-week Study|Lack of Efficacy|0|||
160942935|NCT00767000|581181336|FG004|54-week Study|Lack of Efficacy|5|||
160942936|NCT00767000|581181332|FG000|54-week Study|Lost to Follow-up|4|||
160942937|NCT00767000|581181333|FG001|54-week Study|Lost to Follow-up|0|||
160942938|NCT00767000|581181334|FG002|54-week Study|Lost to Follow-up|1|||
160942939|NCT00767000|581181335|FG003|54-week Study|Lost to Follow-up|4|||
160942940|NCT00767000|581181336|FG004|54-week Study|Lost to Follow-up|2|||
160942941|NCT00767000|581181332|FG000|54-week Study|Physician Decision|4|||
160942942|NCT00767000|581181333|FG001|54-week Study|Physician Decision|0|||
160942943|NCT00767000|581181334|FG002|54-week Study|Physician Decision|1|||
160942944|NCT00767000|581181335|FG003|54-week Study|Physician Decision|1|||
160942945|NCT00767000|581181336|FG004|54-week Study|Physician Decision|1|||
160942946|NCT00767000|581181332|FG000|54-week Study|Progressive disease|0|||
160942947|NCT00767000|581181333|FG001|54-week Study|Progressive disease|0|||
160942948|NCT00767000|581181334|FG002|54-week Study|Progressive disease|1|||
160942949|NCT00767000|581181335|FG003|54-week Study|Progressive disease|0|||
160942950|NCT00767000|581181336|FG004|54-week Study|Progressive disease|0|||
160942951|NCT00767000|581181332|FG000|54-week Study|Protocol Violation|0|||
160942952|NCT00767000|581181333|FG001|54-week Study|Protocol Violation|0|||
160942953|NCT00767000|581181334|FG002|54-week Study|Protocol Violation|1|||
160942954|NCT00767000|581181335|FG003|54-week Study|Protocol Violation|2|||
160942955|NCT00767000|581181336|FG004|54-week Study|Protocol Violation|0|||
160942956|NCT00767000|581181332|FG000|54-week Study|Withdrawal by Subject|2|||
160942957|NCT00767000|581181333|FG001|54-week Study|Withdrawal by Subject|3|||
160942958|NCT00767000|581181334|FG002|54-week Study|Withdrawal by Subject|5|||
160942959|NCT00767000|581181335|FG003|54-week Study|Withdrawal by Subject|11|||
160942960|NCT00767000|581181336|FG004|54-week Study|Withdrawal by Subject|13|||
160942961|NCT00767000|581181332|FG000|54-week Study|Study terminated by sponsor|90|||
160942962|NCT00767000|581181333|FG001|54-week Study|Study terminated by sponsor|102|||
160942963|NCT00767000|581181334|FG002|54-week Study|Study terminated by sponsor|89|||
160942964|NCT00767000|581181335|FG003|54-week Study|Study terminated by sponsor|196|||
160942965|NCT00767000|581181336|FG004|54-week Study|Study terminated by sponsor|194|||
160942966|NCT00767000|581181332|FG000|54-week Study|Reason not reported|0|||
160942967|NCT00767000|581181333|FG001|54-week Study|Reason not reported|0|||
160999112|NCT05233085|581380689|FG000|Overall Study|Adverse Event|1|||
160999113|NCT05233085|581380690|FG001|Overall Study|Adverse Event|0|||
160999114|NCT05233085|581380691|FG002|Overall Study|Adverse Event|0|||
160999115|NCT05233085|581380692|FG003|Overall Study|Adverse Event|0|||
160999116|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
160999117|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
160999118|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
160999119|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999120|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999121|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999122|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999123|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999124|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999125|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
160999126|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
160999127|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
160999128|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160579721|NCT00165646|579844036|FG000|Overall Study|Physician Decision|2|||
160579722|NCT00165646|579844037|FG001|Overall Study|Physician Decision|0|||
160579723|NCT00165646|579844038|FG002|Overall Study|Physician Decision|2|||
160579724|NCT00165646|579844036|FG000|Overall Study|Protocol Violation|1|||
160579725|NCT00165646|579844037|FG001|Overall Study|Protocol Violation|0|||
160579726|NCT00165646|579844038|FG002|Overall Study|Protocol Violation|0|||
160579727|NCT04657016|579844039|FG000|Overall Study|Adverse Event|2|||
160579728|NCT04657016|579844040|FG001|Overall Study|Adverse Event|4|||
160579729|NCT04657016|579844039|FG000|Overall Study|Death|1|||
160942968|NCT00767000|581181334|FG002|54-week Study|Reason not reported|0|||
160942969|NCT00767000|581181335|FG003|54-week Study|Reason not reported|1|||
160942970|NCT00767000|581181336|FG004|54-week Study|Reason not reported|0|||
160942971|NCT00767000|581181332|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
160942972|NCT00767000|581181333|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
160999129|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160999130|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160455890|NCT05868382|579399797|FG000|Overall Study|Lost to Follow-up|5|||
160579730|NCT04657016|579844040|FG001|Overall Study|Death|1|||
160942973|NCT00767000|581181334|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
160942974|NCT00767000|581181335|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
160942975|NCT00767000|581181336|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
160942976|NCT01324024|581181340|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
160942977|NCT01324024|581181341|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160942978|NCT00097591|581181343|FG000|Overall Study|Withdrawal of consent|342|||
160942979|NCT00097591|581181344|FG001|Overall Study|Withdrawal of consent|323|||
160942980|NCT00097591|581181343|FG000|Overall Study|Less than 6 months on study drug|9|||
160942981|NCT00097591|581181344|FG001|Overall Study|Less than 6 months on study drug|7|||
160942982|NCT00097591|581181343|FG000|Overall Study|Unable to attend termination visit|53|||
160942983|NCT00097591|581181344|FG001|Overall Study|Unable to attend termination visit|51|||
160942984|NCT00097591|581181343|FG000|Overall Study|Lost to follow up|6|||
160942985|NCT00097591|581181344|FG001|Overall Study|Lost to follow up|10|||
160942986|NCT00097591|581181343|FG000|Overall Study|Other|0|||
160942987|NCT00097591|581181344|FG001|Overall Study|Other|3|||
160942988|NCT00009737|581181351|FG000|Overall Study|Adverse Event|112|||
160455891|NCT05868382|579399798|FG001|Overall Study|Lost to Follow-up|0|||
160942989|NCT00009737|581181352|FG001|Overall Study|Adverse Event|75|||
160455892|NCT05868382|579399799|FG002|Overall Study|Lost to Follow-up|6|||
160579731|NCT04657016|579844039|FG000|Overall Study|Lost to Follow-up|24|||
160579732|NCT04657016|579844040|FG001|Overall Study|Lost to Follow-up|12|||
160942990|NCT00009737|581181351|FG000|Overall Study|Death|4|||
160942991|NCT00009737|581181352|FG001|Overall Study|Death|6|||
160942992|NCT00009737|581181351|FG000|Overall Study|Lack of Efficacy|17|||
160942993|NCT00009737|581181352|FG001|Overall Study|Lack of Efficacy|15|||
160942994|NCT00009737|581181351|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
160942995|NCT00009737|581181352|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
160942996|NCT00009737|581181351|FG000|Overall Study|Other Protocol Violation|1|||
160942997|NCT00009737|581181352|FG001|Overall Study|Other Protocol Violation|0|||
160942998|NCT00009737|581181351|FG000|Overall Study|Refused Treatment|15|||
160942999|NCT00009737|581181352|FG001|Overall Study|Refused Treatment|16|||
160943000|NCT00009737|581181351|FG000|Overall Study|Lost to Follow-up|1|||
160943001|NCT00009737|581181352|FG001|Overall Study|Lost to Follow-up|1|||
160943002|NCT00009737|581181351|FG000|Overall Study|Administrative/Other Reasons|7|||
160943003|NCT00009737|581181352|FG001|Overall Study|Administrative/Other Reasons|1|||
160943004|NCT00530023|581181353|FG000|Overall Study|Withdrawal by Subject|0|||
160943005|NCT00530023|581181354|FG001|Overall Study|Withdrawal by Subject|1|||
160943006|NCT00003498|581181355|FG000|Overall Study|Not evaluable.|4|||
160943007|NCT00812812|581181365|FG000|Overall Study|Adverse Event|2|||
160943008|NCT00812812|581181366|FG001|Overall Study|Adverse Event|1|||
160943009|NCT00812812|581181365|FG000|Overall Study|Lack of Efficacy|1|||
160943010|NCT00812812|581181366|FG001|Overall Study|Lack of Efficacy|0|||
160943011|NCT00812812|581181365|FG000|Overall Study|Lost to Follow-up|0|||
160943012|NCT00812812|581181366|FG001|Overall Study|Lost to Follow-up|1|||
160943013|NCT00812812|581181365|FG000|Overall Study|Withdrawal by Subject|0|||
160943014|NCT00812812|581181366|FG001|Overall Study|Withdrawal by Subject|2|||
160943015|NCT02114892|581181367|FG000|Overall Study|Lost to Follow-up|1|||
160943016|NCT02114892|581181368|FG001|Overall Study|Lost to Follow-up|2|||
160943017|NCT02013765|581181369|FG000|Overall Study|Trial was terminated by sponsor|1|||
160943018|NCT02178475|581181375|FG000|Overall Study|Withdrawal by Subject|7|||
160943019|NCT02178475|581181375|FG000|Overall Study|Lost to Follow-up|10|||
160943020|NCT02178475|581181375|FG000|Overall Study|Death|13|||
160943021|NCT02178475|581181375|FG000|Overall Study|Protocol-specified Criteria|99|||
160943022|NCT00718042|581181376|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
160943023|NCT00718042|581181377|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
160943024|NCT00718042|581181378|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
160943025|NCT00718042|581181379|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
160943026|NCT00718042|581181380|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
160943027|NCT00718042|581181381|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
160943028|NCT00718042|581181376|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
160943029|NCT00718042|581181377|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
160943030|NCT00718042|581181378|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
160943031|NCT00718042|581181379|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
160943032|NCT00718042|581181380|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
160943033|NCT00718042|581181381|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
160943034|NCT00718042|581181376|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
160943035|NCT00718042|581181377|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
160943036|NCT00718042|581181378|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
160943037|NCT00718042|581181379|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
160943038|NCT00718042|581181380|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
160943039|NCT00718042|581181381|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
160943040|NCT00718042|581181376|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
160943041|NCT00718042|581181377|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
160943042|NCT00718042|581181378|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
160943043|NCT00718042|581181379|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
160943044|NCT00718042|581181380|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
160943045|NCT00718042|581181381|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
160943046|NCT00718042|581181376|FG000|Donor Follow-up|Lost to Follow-up|13|||
160943047|NCT00718042|581181377|FG001|Donor Follow-up|Lost to Follow-up|0|||
160943048|NCT00718042|581181378|FG002|Donor Follow-up|Lost to Follow-up|0|||
160943049|NCT00718042|581181379|FG003|Donor Follow-up|Lost to Follow-up|0|||
160943050|NCT00718042|581181380|FG004|Donor Follow-up|Lost to Follow-up|19|||
160943051|NCT00718042|581181381|FG005|Donor Follow-up|Lost to Follow-up|0|||
160943052|NCT04327934|581181382|FG000|Overall Study|Did not qualify|7|||
160943053|NCT04327934|581181383|FG001|Overall Study|Did not qualify|4|||
160943054|NCT04327934|581181382|FG000|Overall Study|Physician Decision|0|||
160943055|NCT04327934|581181383|FG001|Overall Study|Physician Decision|1|||
160943056|NCT02443298|581181384|FG000|Overall Study|Adverse Event|3|||
160943057|NCT02443298|581181385|FG001|Overall Study|Adverse Event|3|||
160943058|NCT02443298|581181384|FG000|Overall Study|Withdrawal by Subject|1|||
160943059|NCT02443298|581181385|FG001|Overall Study|Withdrawal by Subject|2|||
160943060|NCT03095417|581181386|FG000|Overall Study|missed|1|||
160943061|NCT03095417|581181387|FG001|Overall Study|missed|2|||
160943062|NCT03095417|581181388|FG002|Overall Study|missed|0|||
160943063|NCT03095417|581181389|FG003|Overall Study|missed|1|||
160943064|NCT03095417|581181386|FG000|Overall Study|Lost to Follow-up|2|||
160943065|NCT03095417|581181387|FG001|Overall Study|Lost to Follow-up|2|||
160943066|NCT03095417|581181388|FG002|Overall Study|Lost to Follow-up|1|||
160943067|NCT03095417|581181389|FG003|Overall Study|Lost to Follow-up|0|||
160943068|NCT03095417|581181386|FG000|Overall Study|refusal|0|||
160943069|NCT03095417|581181387|FG001|Overall Study|refusal|1|||
160943070|NCT03095417|581181388|FG002|Overall Study|refusal|0|||
160943071|NCT03095417|581181389|FG003|Overall Study|refusal|1|||
160943072|NCT03095417|581181386|FG000|Overall Study|Withdrawal by Subject|8|||
160943073|NCT03095417|581181387|FG001|Overall Study|Withdrawal by Subject|2|||
160943074|NCT03095417|581181388|FG002|Overall Study|Withdrawal by Subject|5|||
160943075|NCT03095417|581181389|FG003|Overall Study|Withdrawal by Subject|4|||
160943076|NCT03095417|581181386|FG000|Overall Study|Physician Decision|1|||
160943077|NCT03095417|581181387|FG001|Overall Study|Physician Decision|2|||
160943078|NCT03095417|581181388|FG002|Overall Study|Physician Decision|2|||
160943079|NCT03095417|581181389|FG003|Overall Study|Physician Decision|2|||
160943080|NCT03095417|581181386|FG000|Overall Study|Death|1|||
160943081|NCT03095417|581181387|FG001|Overall Study|Death|2|||
160943082|NCT03095417|581181388|FG002|Overall Study|Death|1|||
160943083|NCT03095417|581181389|FG003|Overall Study|Death|3|||
160943084|NCT02571452|581181390|FG000|Overall Study Treatment|Protocol Violation|0|||
160943085|NCT02571452|581181391|FG001|Overall Study Treatment|Protocol Violation|1|||
160943086|NCT02571452|581181390|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
160943087|NCT02571452|581181391|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
160943088|NCT02571452|581181390|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
160943089|NCT02571452|581181391|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
160943090|NCT01877421|581181392|FG000|Phase 2|Lost to Follow-up|0|||
160943091|NCT01877421|581181393|FG001|Phase 2|Lost to Follow-up|0|||
160943092|NCT01877421|581181394|FG002|Phase 2|Lost to Follow-up|0|||
160943093|NCT01877421|581181395|FG003|Phase 2|Lost to Follow-up|0|||
160943094|NCT01877421|581181396|FG004|Phase 2|Lost to Follow-up|0|||
160943095|NCT01877421|581181397|FG005|Phase 2|Lost to Follow-up|0|||
160943096|NCT01877421|581181398|FG006|Phase 2|Lost to Follow-up|1|||
160943097|NCT01877421|581181399|FG007|Phase 2|Lost to Follow-up|0|||
160943098|NCT01877421|581181400|FG008|Phase 2|Lost to Follow-up|0|||
160943099|NCT01877421|581181401|FG009|Phase 2|Lost to Follow-up|0|||
160943100|NCT01877421|581181402|FG010|Phase 2|Lost to Follow-up|0|||
160943101|NCT01877421|581181403|FG011|Phase 2|Lost to Follow-up|0|||
160943102|NCT01877421|581181404|FG012|Phase 2|Lost to Follow-up|0|||
160943103|NCT01877421|581181405|FG013|Phase 2|Lost to Follow-up|0|||
160943104|NCT01877421|581181406|FG014|Phase 2|Lost to Follow-up|0|||
160943105|NCT01877421|581181407|FG015|Phase 2|Lost to Follow-up|0|||
160943106|NCT01877421|581181408|FG016|Phase 2|Lost to Follow-up|0|||
160943107|NCT01877421|581181409|FG017|Phase 2|Lost to Follow-up|0|||
160943108|NCT01877421|581181392|FG000|Phase 2|Withdrawal by Subject|0|||
160943109|NCT01877421|581181393|FG001|Phase 2|Withdrawal by Subject|0|||
160943110|NCT01877421|581181394|FG002|Phase 2|Withdrawal by Subject|0|||
160943111|NCT01877421|581181395|FG003|Phase 2|Withdrawal by Subject|0|||
160943112|NCT01877421|581181396|FG004|Phase 2|Withdrawal by Subject|0|||
160943113|NCT01877421|581181397|FG005|Phase 2|Withdrawal by Subject|0|||
160943114|NCT01877421|581181398|FG006|Phase 2|Withdrawal by Subject|0|||
160943115|NCT01877421|581181399|FG007|Phase 2|Withdrawal by Subject|0|||
160943116|NCT01877421|581181400|FG008|Phase 2|Withdrawal by Subject|1|||
160943117|NCT01877421|581181401|FG009|Phase 2|Withdrawal by Subject|0|||
160943118|NCT01877421|581181402|FG010|Phase 2|Withdrawal by Subject|1|||
160943119|NCT01877421|581181403|FG011|Phase 2|Withdrawal by Subject|0|||
160943120|NCT01877421|581181404|FG012|Phase 2|Withdrawal by Subject|1|||
160943121|NCT01877421|581181405|FG013|Phase 2|Withdrawal by Subject|0|||
160943122|NCT01877421|581181406|FG014|Phase 2|Withdrawal by Subject|0|||
160943123|NCT01877421|581181407|FG015|Phase 2|Withdrawal by Subject|1|||
160943124|NCT01877421|581181408|FG016|Phase 2|Withdrawal by Subject|0|||
160943125|NCT01877421|581181409|FG017|Phase 2|Withdrawal by Subject|0|||
160943126|NCT01877421|581181392|FG000|Phase 2|Protocol Violation|0|||
160943127|NCT01877421|581181393|FG001|Phase 2|Protocol Violation|0|||
160943128|NCT01877421|581181394|FG002|Phase 2|Protocol Violation|0|||
160943129|NCT01877421|581181395|FG003|Phase 2|Protocol Violation|0|||
160943130|NCT01877421|581181396|FG004|Phase 2|Protocol Violation|0|||
160943131|NCT01877421|581181397|FG005|Phase 2|Protocol Violation|0|||
160943132|NCT01877421|581181398|FG006|Phase 2|Protocol Violation|0|||
160943133|NCT01877421|581181399|FG007|Phase 2|Protocol Violation|0|||
160943134|NCT01877421|581181400|FG008|Phase 2|Protocol Violation|0|||
160943135|NCT01877421|581181401|FG009|Phase 2|Protocol Violation|0|||
160943136|NCT01877421|581181402|FG010|Phase 2|Protocol Violation|1|||
160943137|NCT01877421|581181403|FG011|Phase 2|Protocol Violation|0|||
160943138|NCT01877421|581181404|FG012|Phase 2|Protocol Violation|0|||
160943139|NCT01877421|581181405|FG013|Phase 2|Protocol Violation|0|||
160943140|NCT01877421|581181406|FG014|Phase 2|Protocol Violation|0|||
160943141|NCT01877421|581181407|FG015|Phase 2|Protocol Violation|0|||
160943142|NCT01877421|581181408|FG016|Phase 2|Protocol Violation|0|||
160943143|NCT01877421|581181409|FG017|Phase 2|Protocol Violation|0|||
160943144|NCT03698773|581181423|FG000|Overall Study|Lost to Follow-up|2|||
160943145|NCT03698773|581181424|FG001|Overall Study|Lost to Follow-up|1|||
160943146|NCT01158924|581181426|FG000|Overall Study|Withdrawal by Subject|1|||
160943147|NCT01158924|581181427|FG001|Overall Study|Withdrawal by Subject|2|||
160943148|NCT01158924|581181426|FG000|Overall Study|Lost to Follow-up|0|||
160943149|NCT01158924|581181427|FG001|Overall Study|Lost to Follow-up|1|||
160943150|NCT01260922|581181431|FG000|First Intervention|Withdrawal by Subject|0|||
160943151|NCT01260922|581181432|FG001|First Intervention|Withdrawal by Subject|1|||
160943152|NCT01260922|581181431|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
160943153|NCT01260922|581181432|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
160943154|NCT01260922|581181431|FG000|Second Intervention|Emesis|0|||
160943155|NCT01260922|581181432|FG001|Second Intervention|Emesis|2|||
160943156|NCT01599650|581181437|FG000|Overall Study|Administrative issue|1|||
160943157|NCT01599650|581181438|FG001|Overall Study|Administrative issue|0|||
160943158|NCT01599650|581181439|FG002|Overall Study|Administrative issue|1|||
160943159|NCT01599650|581181437|FG000|Overall Study|Physician Decision|2|||
160943160|NCT01599650|581181438|FG001|Overall Study|Physician Decision|0|||
160943161|NCT01599650|581181439|FG002|Overall Study|Physician Decision|7|||
160943162|NCT01599650|581181437|FG000|Overall Study|Protocol Violation|0|||
160943163|NCT01599650|581181438|FG001|Overall Study|Protocol Violation|3|||
160943164|NCT01599650|581181439|FG002|Overall Study|Protocol Violation|0|||
160943165|NCT01599650|581181437|FG000|Overall Study|Death|2|||
160943166|NCT01599650|581181438|FG001|Overall Study|Death|1|||
160943167|NCT01599650|581181439|FG002|Overall Study|Death|2|||
160943168|NCT01599650|581181437|FG000|Overall Study|Lost to Follow-up|3|||
160943169|NCT01599650|581181438|FG001|Overall Study|Lost to Follow-up|3|||
160943170|NCT01599650|581181439|FG002|Overall Study|Lost to Follow-up|3|||
160943171|NCT01599650|581181437|FG000|Overall Study|Withdrawal by Subject|11|||
160943172|NCT01599650|581181438|FG001|Overall Study|Withdrawal by Subject|11|||
160943173|NCT01599650|581181439|FG002|Overall Study|Withdrawal by Subject|10|||
160943174|NCT01599650|581181437|FG000|Overall Study|Adverse Event|3|||
160943175|NCT01599650|581181438|FG001|Overall Study|Adverse Event|8|||
160943176|NCT01599650|581181439|FG002|Overall Study|Adverse Event|4|||
160943177|NCT01731171|581181440|FG000|Overall Study|Withdrawal by Subject|4|||
160943178|NCT01731171|581181441|FG001|Overall Study|Withdrawal by Subject|1|||
160999131|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160999132|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160999133|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160999134|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
160999135|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
160943179|NCT01731171|581181440|FG000|Overall Study|Lost to Follow-up|3|||
160999136|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
160999137|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160999138|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160999139|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160999140|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160999141|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160943180|NCT01731171|581181441|FG001|Overall Study|Lost to Follow-up|2|||
160943181|NCT01731171|581181440|FG000|Overall Study|Moved out of Area|0|||
160943182|NCT01731171|581181441|FG001|Overall Study|Moved out of Area|2|||
160943183|NCT01731171|581181440|FG000|Overall Study|Terminated for Lack of Adherence|0|||
160943184|NCT01731171|581181441|FG001|Overall Study|Terminated for Lack of Adherence|1|||
160943185|NCT01731171|581181440|FG000|Overall Study|Terminated for Safety Reasons|0|||
160943186|NCT01731171|581181441|FG001|Overall Study|Terminated for Safety Reasons|1|||
160943187|NCT01410110|581181442|FG000|Overall Study|Withdrawal by Subject|4|||
160943188|NCT01410110|581181443|FG001|Overall Study|Withdrawal by Subject|2|||
160943189|NCT01416805|581181444|FG000|Overall Study|Lost to Follow-up|4|||
160943190|NCT01416805|581181445|FG001|Overall Study|Lost to Follow-up|4|||
160943191|NCT02604589|581181452|FG000|Overall Study|catheter dislodgement|0|||
160943192|NCT02604589|581181453|FG001|Overall Study|catheter dislodgement|0|||
160943193|NCT02604589|581181454|FG002|Overall Study|catheter dislodgement|1|||
160943194|NCT01700946|581181460|FG000|Overall Study|Lost to Follow-up|1|||
160943195|NCT01700946|581181461|FG001|Overall Study|Lost to Follow-up|0|||
160943196|NCT01700946|581181460|FG000|Overall Study|Physician Decision|7|||
160943197|NCT01700946|581181461|FG001|Overall Study|Physician Decision|12|||
160943198|NCT01700946|581181460|FG000|Overall Study|Withdrawal by Subject|0|||
160943199|NCT01700946|581181461|FG001|Overall Study|Withdrawal by Subject|2|||
160943200|NCT01700946|581181460|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
160943201|NCT01700946|581181461|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
160943202|NCT01700946|581181460|FG000|Overall Study|Relapse|2|||
160943203|NCT01700946|581181461|FG001|Overall Study|Relapse|1|||
160943204|NCT01700946|581181460|FG000|Overall Study|Unacceptable toxicity|1|||
160943205|NCT01700946|581181461|FG001|Overall Study|Unacceptable toxicity|0|||
160943206|NCT04632940|581181465|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
160943207|NCT04632940|581181466|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
160943208|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
160943209|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
160943210|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
160943211|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
160943212|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
160999142|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160999143|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
160999144|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999145|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
160999146|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999147|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999148|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999149|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999150|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999151|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999152|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
160999153|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
160999154|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
160999155|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999156|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999157|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999158|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999159|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999160|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999161|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999162|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
160999163|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
160999164|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999165|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999166|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999167|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999168|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999169|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999170|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
160999171|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
160999172|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999173|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999174|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999175|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999176|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999177|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999178|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999179|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
160999180|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
160999181|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
160999182|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
160999183|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
160999184|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
160999185|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
160943213|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
160943214|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
160943215|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
160943216|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
160943217|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
160943218|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Other than specified|0|||
160943219|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Other than specified|1|||
160943220|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
160943221|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
160943222|NCT00684424|581181467|FG000|Overall Study|Adverse Event|1|||
160943223|NCT00684424|581181467|FG000|Overall Study|Lost to Follow-up|2|||
160943224|NCT00684424|581181467|FG000|Overall Study|Other|2|||
160943225|NCT02520531|581181470|FG000|Overall Study|Revision of study device components|2|||
160943226|NCT02520531|581181471|FG001|Overall Study|Revision of study device components|2|||
160943227|NCT02520531|581181470|FG000|Overall Study|Death|1|||
160943228|NCT02520531|581181471|FG001|Overall Study|Death|2|||
160943229|NCT02520531|581181470|FG000|Overall Study|Lost to Follow-up|1|||
160943230|NCT02520531|581181471|FG001|Overall Study|Lost to Follow-up|1|||
160943231|NCT02520531|581181470|FG000|Overall Study|Meet exclusion criterion|0|||
160943232|NCT02520531|581181471|FG001|Overall Study|Meet exclusion criterion|1|||
160943233|NCT02520531|581181470|FG000|Overall Study|Withdrawal by Subject|1|||
160943234|NCT02520531|581181471|FG001|Overall Study|Withdrawal by Subject|0|||
160943235|NCT02520531|581181470|FG000|Overall Study|Not study device|1|||
160943236|NCT02520531|581181471|FG001|Overall Study|Not study device|0|||
160943237|NCT02805257|581183802|FG000|Overall Study|Lost to Follow-up|7|||
160943238|NCT02805257|581183803|FG001|Overall Study|Lost to Follow-up|6|||
160943239|NCT02805257|581183802|FG000|Overall Study|Death|0|||
160943240|NCT02805257|581183803|FG001|Overall Study|Death|1|||
160943241|NCT01043874|581183806|FG000|Overall Study|Adverse Event|3|||
160943242|NCT01043874|581183806|FG000|Overall Study|Withdrawal by Subject|1|||
160943243|NCT01043874|581183806|FG000|Overall Study|Lack of Efficacy|1|||
160943244|NCT01043874|581183806|FG000|Overall Study|Administrative Problems|1|||
160943245|NCT01404312|581183807|FG000|Overall Study|Death|21|||
160943246|NCT01404312|581183808|FG001|Overall Study|Death|27|||
160943247|NCT01404312|581183807|FG000|Overall Study|Withdrawal by Subject|15|||
160943248|NCT01404312|581183808|FG001|Overall Study|Withdrawal by Subject|18|||
160943249|NCT01404312|581183807|FG000|Overall Study|Participant Unable to get to clinic|93|||
160943250|NCT01404312|581183808|FG001|Overall Study|Participant Unable to get to clinic|103|||
160943251|NCT01404312|581183807|FG000|Overall Study|Lost to Follow-up|115|||
160943252|NCT01404312|581183808|FG001|Overall Study|Lost to Follow-up|111|||
160943253|NCT01404312|581183807|FG000|Overall Study|Site closed|22|||
160943254|NCT01404312|581183808|FG001|Overall Study|Site closed|21|||
160943255|NCT01404312|581183807|FG000|Overall Study|Participant not willing to adhere to req|31|||
160943256|NCT01404312|581183808|FG001|Overall Study|Participant not willing to adhere to req|29|||
160943257|NCT01404312|581183807|FG000|Overall Study|Severe debilitation, unable to continue|1|||
160943258|NCT01404312|581183808|FG001|Overall Study|Severe debilitation, unable to continue|2|||
160943259|NCT02696850|581183809|FG000|Overall Study|Withdrawal by Subject|3|||
160943260|NCT02696850|581183810|FG001|Overall Study|Withdrawal by Subject|3|||
160943261|NCT02696850|581183809|FG000|Overall Study|Lost to Follow-up|8|||
160943262|NCT02696850|581183810|FG001|Overall Study|Lost to Follow-up|5|||
160943263|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
160943264|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
160943265|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
160943266|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
160943267|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Death|235|||
160943268|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Death|167|||
160943269|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Death|1|||
160943270|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Death|0|||
160943271|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
160943272|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
160943273|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
160943274|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
160943275|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
160943276|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
160943277|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
160943278|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
160943279|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Other|1|||
160943280|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Other|2|||
160943281|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Other|0|||
160943282|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Other|0|||
160943283|NCT00673049|581183811|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
160943284|NCT00673049|581183812|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
160943285|NCT00673049|581183813|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
160943286|NCT00673049|581183814|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
160943287|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
160656094|NCT05067504|580120360|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
160656095|NCT05771428|580122345|FG000|Overall Study|Adverse Event|0|||
160656096|NCT05771428|580122346|FG001|Overall Study|Adverse Event|1|||
160656097|NCT05771428|580122347|FG002|Overall Study|Adverse Event|1|||
160656098|NCT05771428|580122348|FG003|Overall Study|Adverse Event|1|||
160656099|NCT05771428|580122345|FG000|Overall Study|Withdrawal by Subject|3|||
160656100|NCT05771428|580122346|FG001|Overall Study|Withdrawal by Subject|2|||
160656101|NCT05771428|580122347|FG002|Overall Study|Withdrawal by Subject|1|||
160656102|NCT05771428|580122348|FG003|Overall Study|Withdrawal by Subject|4|||
160656103|NCT05771428|580122345|FG000|Overall Study|Other|0|||
160656104|NCT05771428|580122346|FG001|Overall Study|Other|1|||
160656105|NCT05771428|580122347|FG002|Overall Study|Other|2|||
160656106|NCT05771428|580122348|FG003|Overall Study|Other|1|||
160656107|NCT05771428|580122345|FG000|Overall Study|Randomized but Not Treated|0|||
160656108|NCT05771428|580122346|FG001|Overall Study|Randomized but Not Treated|0|||
160656109|NCT05771428|580122347|FG002|Overall Study|Randomized but Not Treated|1|||
160656110|NCT05771428|580122348|FG003|Overall Study|Randomized but Not Treated|0|||
160656111|NCT04025229|580122349|FG000|Overall Study|Adverse Event|1|||
160656112|NCT04025229|580122350|FG001|Overall Study|Adverse Event|0|||
160656113|NCT04025229|580122349|FG000|Overall Study|Withdrawal by Subject|0|||
160656114|NCT04025229|580122350|FG001|Overall Study|Withdrawal by Subject|2|||
160943288|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
160943289|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
160943290|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
160943291|NCT00673049|581183811|FG000|After Progression on Erlotinib|Death|0|||
160943292|NCT00673049|581183812|FG001|After Progression on Erlotinib|Death|0|||
160943293|NCT00673049|581183813|FG002|After Progression on Erlotinib|Death|0|||
160943294|NCT00673049|581183814|FG003|After Progression on Erlotinib|Death|71|||
160943295|NCT00673049|581183811|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
160943296|NCT00673049|581183812|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
160943297|NCT00673049|581183813|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
160943298|NCT00673049|581183814|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
160943299|NCT00673049|581183811|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
160943300|NCT00673049|581183812|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
160943301|NCT00673049|581183813|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
160943302|NCT00673049|581183814|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
160943303|NCT00673049|581183811|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
160943304|NCT00673049|581183812|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
160943305|NCT00673049|581183813|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
160943306|NCT00673049|581183814|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
160943307|NCT04265755|581183815|FG000|Overall Study|Withdrawal by Subject|39|||
160943308|NCT04265755|581183815|FG000|Overall Study|Decision by sponsor|2|||
160943309|NCT04265755|581183815|FG000|Overall Study|Lost to Follow-up|11|||
160943310|NCT04265755|581183815|FG000|Overall Study|Death|1|||
160943311|NCT01863446|581183816|FG000|Overall Study|Withdrawal by Subject|1|||
160943312|NCT01863446|581183817|FG001|Overall Study|Withdrawal by Subject|0|||
160943313|NCT01863446|581183818|FG002|Overall Study|Withdrawal by Subject|1|||
160943314|NCT01863446|581183819|FG003|Overall Study|Withdrawal by Subject|2|||
160943315|NCT01863446|581183816|FG000|Overall Study|Physician Decision|0|||
160943316|NCT01863446|581183817|FG001|Overall Study|Physician Decision|0|||
160943317|NCT01863446|581183818|FG002|Overall Study|Physician Decision|1|||
160943318|NCT01863446|581183819|FG003|Overall Study|Physician Decision|0|||
160943319|NCT02554773|581183820|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
160999186|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
160999187|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
160999188|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
160999189|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
160999190|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
160999191|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
160999192|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
160999193|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
160656115|NCT04025229|580122349|FG000|Overall Study|Death|0|||
160656116|NCT04025229|580122350|FG001|Overall Study|Death|1|||
160656117|NCT04025229|580122349|FG000|Overall Study|Physician Decision|0|||
160656118|NCT04025229|580122350|FG001|Overall Study|Physician Decision|1|||
160656119|NCT03815942|580122351|FG000|Overall Study|Withdrawal by Subject|0|||
160656120|NCT03815942|580122352|FG001|Overall Study|Withdrawal by Subject|17|||
160656121|NCT00366899|580122353|FG000|Infant Series|Withdrawal by Subject|4|||
160656122|NCT00366899|580122354|FG001|Infant Series|Withdrawal by Subject|7|||
160656123|NCT00366899|580122353|FG000|Infant Series|Protocol Violation|2|||
160656124|NCT00366899|580122354|FG001|Infant Series|Protocol Violation|1|||
160656125|NCT00366899|580122353|FG000|Infant Series|Failed to return|1|||
160943320|NCT02554773|581183821|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
160943321|NCT02554773|581183820|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
160943322|NCT02554773|581183821|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
160943323|NCT02554773|581183820|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
160943324|NCT02554773|581183821|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
160943325|NCT02554773|581183820|FG000|Original Dose Regimen (SAS 1)|Death|1|||
160943326|NCT02554773|581183821|FG001|Original Dose Regimen (SAS 1)|Death|0|||
160943327|NCT02554773|581183820|FG000|Original Dose Regimen (SAS 1)|Other|4|||
160943328|NCT02554773|581183821|FG001|Original Dose Regimen (SAS 1)|Other|0|||
160943329|NCT02554773|581183820|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
160943330|NCT02554773|581183821|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
160943331|NCT02554773|581183820|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
160943332|NCT02554773|581183821|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
160943333|NCT02554773|581183820|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
160943334|NCT02554773|581183821|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
160943335|NCT02554773|581183820|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
160943336|NCT02554773|581183821|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
160943337|NCT02956629|581183822|FG000|Overall Study|Adverse Event|0|||
160943338|NCT02956629|581183823|FG001|Overall Study|Adverse Event|0|||
160943339|NCT02956629|581183824|FG002|Overall Study|Adverse Event|1|||
160943340|NCT02956629|581183825|FG003|Overall Study|Adverse Event|0|||
160943341|NCT02956629|581183826|FG004|Overall Study|Adverse Event|0|||
160943342|NCT02956629|581183827|FG005|Overall Study|Adverse Event|0|||
160943343|NCT02956629|581183822|FG000|Overall Study|Lost to Follow-up|2|||
160943344|NCT02956629|581183823|FG001|Overall Study|Lost to Follow-up|5|||
160943345|NCT02956629|581183824|FG002|Overall Study|Lost to Follow-up|3|||
160943346|NCT02956629|581183825|FG003|Overall Study|Lost to Follow-up|1|||
160943347|NCT02956629|581183826|FG004|Overall Study|Lost to Follow-up|0|||
160943348|NCT02956629|581183827|FG005|Overall Study|Lost to Follow-up|1|||
160943349|NCT02956629|581183822|FG000|Overall Study|Withdrawal by Subject|3|||
160943350|NCT02956629|581183823|FG001|Overall Study|Withdrawal by Subject|1|||
160943351|NCT02956629|581183824|FG002|Overall Study|Withdrawal by Subject|0|||
160943352|NCT02956629|581183825|FG003|Overall Study|Withdrawal by Subject|0|||
160943353|NCT02956629|581183826|FG004|Overall Study|Withdrawal by Subject|0|||
160943354|NCT02956629|581183827|FG005|Overall Study|Withdrawal by Subject|0|||
160943355|NCT00406029|581183831|FG000|Overall Study|Adverse Event|12|||
160943356|NCT00406029|581183832|FG001|Overall Study|Adverse Event|2|||
160943357|NCT00406029|581183833|FG002|Overall Study|Adverse Event|5|||
160943358|NCT00406029|581183834|FG003|Overall Study|Adverse Event|10|||
160943359|NCT00406029|581183835|FG004|Overall Study|Adverse Event|7|||
160943360|NCT00406029|581183831|FG000|Overall Study|Withdrawal by Subject|3|||
160943361|NCT00406029|581183832|FG001|Overall Study|Withdrawal by Subject|4|||
160943362|NCT00406029|581183833|FG002|Overall Study|Withdrawal by Subject|2|||
160943363|NCT00406029|581183834|FG003|Overall Study|Withdrawal by Subject|2|||
160943364|NCT00406029|581183835|FG004|Overall Study|Withdrawal by Subject|0|||
160943365|NCT00406029|581183831|FG000|Overall Study|Protocol Violation|1|||
160943366|NCT00406029|581183832|FG001|Overall Study|Protocol Violation|2|||
160943367|NCT00406029|581183833|FG002|Overall Study|Protocol Violation|0|||
160943368|NCT00406029|581183834|FG003|Overall Study|Protocol Violation|2|||
160943369|NCT00406029|581183835|FG004|Overall Study|Protocol Violation|0|||
160943370|NCT00406029|581183831|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
160943371|NCT00406029|581183832|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
160943372|NCT00406029|581183833|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
160943373|NCT00406029|581183834|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
160943374|NCT00406029|581183835|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
160943375|NCT00406029|581183831|FG000|Overall Study|Randomized in Error|0|||
160943376|NCT00406029|581183832|FG001|Overall Study|Randomized in Error|0|||
160943377|NCT00406029|581183833|FG002|Overall Study|Randomized in Error|2|||
160943378|NCT00406029|581183834|FG003|Overall Study|Randomized in Error|3|||
160943379|NCT00406029|581183835|FG004|Overall Study|Randomized in Error|1|||
160943380|NCT02822794|581183836|FG000|Overall Study|Withdrew Consent|1|||
160943381|NCT02822794|581183837|FG001|Overall Study|Withdrew Consent|0|||
160943382|NCT04788147|581183838|FG000|Overall Study|Screen Failure|3|||
160999194|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
160999195|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
160999196|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
160999197|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999198|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160943383|NCT04788147|581183839|FG001|Overall Study|Screen Failure|10|||
160943384|NCT04788147|581183838|FG000|Overall Study|Incomplete RMRS image session|2|||
160943385|NCT04788147|581183839|FG001|Overall Study|Incomplete RMRS image session|0|||
160943386|NCT02266381|581183840|FG000|Overall Study|Physician Decision|3|||
160943387|NCT02266381|581183841|FG001|Overall Study|Physician Decision|5|||
160943388|NCT02266381|581183842|FG002|Overall Study|Physician Decision|4|||
160943389|NCT03732248|581183843|FG000|Overall Study|Withdrawal by Subject|1|||
160943390|NCT03732248|581183844|FG001|Overall Study|Withdrawal by Subject|0|||
160943391|NCT05101252|581183845|FG000|Overall Study|Unsatisfactory Test Article|1|||
160862056|NCT05138653|580887935|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862057|NCT05138653|580887920|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862058|NCT05138653|580887921|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862059|NCT05138653|580887922|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862060|NCT05138653|580887923|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862061|NCT05138653|580887924|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862062|NCT05138653|580887925|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862063|NCT05138653|580887926|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
160862064|NCT05138653|580887927|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862065|NCT05138653|580887928|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862066|NCT05138653|580887929|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862067|NCT05138653|580887930|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862068|NCT05138653|580887931|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862069|NCT05138653|580887932|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862070|NCT05138653|580887933|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862071|NCT05138653|580887934|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862072|NCT05138653|580887935|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862073|NCT05138653|580887920|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862074|NCT05138653|580887921|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862075|NCT05138653|580887922|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862076|NCT05138653|580887923|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862077|NCT05138653|580887924|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862078|NCT05138653|580887925|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862079|NCT05138653|580887926|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862080|NCT05138653|580887927|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862081|NCT05138653|580887928|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862082|NCT05138653|580887929|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862083|NCT05138653|580887930|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
160862084|NCT05138653|580887931|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862085|NCT05138653|580887932|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
160862086|NCT05138653|580887933|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862087|NCT05138653|580887934|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
160862088|NCT05138653|580887935|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862089|NCT05138653|580887920|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862090|NCT05138653|580887921|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862091|NCT05138653|580887922|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862092|NCT05138653|580887923|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862093|NCT05138653|580887924|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862094|NCT05138653|580887925|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862095|NCT05138653|580887926|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862096|NCT05138653|580887927|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862097|NCT05138653|580887928|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862098|NCT05138653|580887929|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862099|NCT05138653|580887930|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862100|NCT05138653|580887931|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862101|NCT05138653|580887932|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862102|NCT05138653|580887933|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862103|NCT05138653|580887934|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862104|NCT05138653|580887935|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
160862105|NCT05138653|580887920|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862106|NCT05138653|580887921|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862107|NCT05138653|580887922|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862108|NCT05138653|580887923|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862109|NCT05138653|580887924|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862110|NCT05138653|580887925|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862111|NCT05138653|580887926|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862112|NCT05138653|580887927|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862113|NCT05138653|580887928|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862114|NCT05138653|580887929|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862115|NCT05138653|580887930|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862116|NCT05138653|580887931|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862117|NCT05138653|580887932|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160943392|NCT05101252|581183846|FG001|Overall Study|Unsatisfactory Test Article|0|||
160943393|NCT05101252|581183845|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160943394|NCT05101252|581183846|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
160943395|NCT05101252|581183845|FG000|Overall Study|Withdrew Consent during study|0|||
160943396|NCT05101252|581183846|FG001|Overall Study|Withdrew Consent during study|1|||
160943397|NCT05101252|581183845|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
160943398|NCT05101252|581183846|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
160943399|NCT01649856|581183853|FG000|Overall Study|Withdrawal by Subject|14|||
160943400|NCT01649856|581183854|FG001|Overall Study|Withdrawal by Subject|14|||
160943401|NCT01649856|581183853|FG000|Overall Study|Protocol Violation|4|||
160943402|NCT01649856|581183854|FG001|Overall Study|Protocol Violation|4|||
160943403|NCT01649856|581183853|FG000|Overall Study|Treatment Failure|1|||
160943404|NCT01649856|581183854|FG001|Overall Study|Treatment Failure|1|||
160943405|NCT01649856|581183853|FG000|Overall Study|Death|69|||
160943406|NCT01649856|581183854|FG001|Overall Study|Death|34|||
160943407|NCT01649856|581183853|FG000|Overall Study|Stable or Progressed Disease|5|||
160943408|NCT01649856|581183854|FG001|Overall Study|Stable or Progressed Disease|3|||
160943409|NCT01649856|581183853|FG000|Overall Study|Lost to Follow-up|20|||
160943410|NCT01649856|581183854|FG001|Overall Study|Lost to Follow-up|16|||
160943411|NCT01649856|581183853|FG000|Overall Study|Lack of Compliance|6|||
160943412|NCT01649856|581183854|FG001|Overall Study|Lack of Compliance|1|||
160943413|NCT01649856|581183853|FG000|Overall Study|Other|20|||
160943414|NCT01649856|581183854|FG001|Overall Study|Other|5|||
160943415|NCT00835406|581183855|FG000|Period: First Intervention|Adverse Event|0|||
160943416|NCT00835406|581183856|FG001|Period: First Intervention|Adverse Event|1|||
160943417|NCT00835406|581183855|FG000|Period: First Intervention|Withdrawal by Subject|2|||
160943418|NCT00835406|581183856|FG001|Period: First Intervention|Withdrawal by Subject|0|||
160943419|NCT00835406|581183855|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
160943420|NCT00835406|581183856|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
160943421|NCT00281840|581183857|FG000|Overall Study|Adverse Event|12|||
160943422|NCT00281840|581183857|FG000|Overall Study|Physician Decision|6|||
160943423|NCT00281840|581183857|FG000|Overall Study|Withdrawal by Subject|3|||
160943424|NCT00281840|581183857|FG000|Overall Study|Disease Progression|2|||
160943425|NCT00281840|581183857|FG000|Overall Study|exceed maximum delay in treatment|1|||
160943426|NCT00281840|581183857|FG000|Overall Study|Complicating Disease|1|||
160943427|NCT02138214|581183858|FG000|Overall Study|Withdrawal by Subject|0|||
160943428|NCT02138214|581183859|FG001|Overall Study|Withdrawal by Subject|1|||
160943429|NCT02138214|581183860|FG002|Overall Study|Withdrawal by Subject|0|||
160943430|NCT02138214|581183858|FG000|Overall Study|Lost to Follow-up|0|||
160943431|NCT02138214|581183859|FG001|Overall Study|Lost to Follow-up|2|||
160943432|NCT02138214|581183860|FG002|Overall Study|Lost to Follow-up|4|||
160943433|NCT02138214|581183858|FG000|Overall Study|Screen Failure|0|||
160943434|NCT02138214|581183859|FG001|Overall Study|Screen Failure|1|||
160943435|NCT02138214|581183860|FG002|Overall Study|Screen Failure|0|||
160943436|NCT02185768|581183861|FG000|Overall Study|Patients were not treated|2|||
160943437|NCT01079234|581183862|FG000|Main: Week 0 to 26|Adverse Event|5|||
160943438|NCT01079234|581183863|FG001|Main: Week 0 to 26|Adverse Event|4|||
160943439|NCT01079234|581183864|FG002|Main: Week 0 to 26|Adverse Event|1|||
160943440|NCT01079234|581183865|FG003|Main: Week 0 to 26|Adverse Event|0|||
160943441|NCT01079234|581183862|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
160943442|NCT01079234|581183863|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
160943443|NCT01079234|581183864|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
160943444|NCT01079234|581183865|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
160943445|NCT01079234|581183862|FG000|Main: Week 0 to 26|Protocol Violation|6|||
160943446|NCT01079234|581183863|FG001|Main: Week 0 to 26|Protocol Violation|2|||
160943447|NCT01079234|581183864|FG002|Main: Week 0 to 26|Protocol Violation|4|||
160943448|NCT01079234|581183865|FG003|Main: Week 0 to 26|Protocol Violation|0|||
160943449|NCT01079234|581183862|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
160943450|NCT01079234|581183863|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
160943451|NCT01079234|581183864|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
160943452|NCT01079234|581183865|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
160943453|NCT01079234|581183862|FG000|Main: Week 0 to 26|Unclassified|7|||
160943454|NCT01079234|581183863|FG001|Main: Week 0 to 26|Unclassified|13|||
160943455|NCT01079234|581183864|FG002|Main: Week 0 to 26|Unclassified|4|||
160943456|NCT01079234|581183865|FG003|Main: Week 0 to 26|Unclassified|0|||
160943457|NCT01079234|581183862|FG000|Extension: Week 27 to 52|Adverse Event|0|||
160943458|NCT01079234|581183863|FG001|Extension: Week 27 to 52|Adverse Event|0|||
160943459|NCT01079234|581183864|FG002|Extension: Week 27 to 52|Adverse Event|1|||
160943460|NCT01079234|581183865|FG003|Extension: Week 27 to 52|Adverse Event|0|||
160943461|NCT01079234|581183862|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
160943462|NCT01079234|581183863|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
160943463|NCT01079234|581183864|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
160943464|NCT01079234|581183865|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
160943465|NCT01079234|581183862|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
160943466|NCT01079234|581183863|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
160943467|NCT01079234|581183864|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
160999199|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
160999200|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160579733|NCT04657016|579844039|FG000|Overall Study|Physician Decision|1|||
160579734|NCT04657016|579844040|FG001|Overall Study|Physician Decision|2|||
160579735|NCT04657016|579844039|FG000|Overall Study|Pregnancy|2|||
160579736|NCT04657016|579844040|FG001|Overall Study|Pregnancy|2|||
160579737|NCT04657016|579844039|FG000|Overall Study|Protocol Deviation|1|||
160579738|NCT04657016|579844040|FG001|Overall Study|Protocol Deviation|0|||
160943468|NCT01079234|581183865|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
160943469|NCT01079234|581183862|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
160943470|NCT01079234|581183863|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
160943471|NCT01079234|581183864|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
160943472|NCT01079234|581183865|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
160943473|NCT01079234|581183862|FG000|Extension: Week 27 to 52|Unclassified|0|||
160943474|NCT01079234|581183863|FG001|Extension: Week 27 to 52|Unclassified|0|||
160943475|NCT01079234|581183864|FG002|Extension: Week 27 to 52|Unclassified|4|||
160943476|NCT01079234|581183865|FG003|Extension: Week 27 to 52|Unclassified|7|||
160943477|NCT03221257|581183866|FG000|Overall Study|Lost to Follow-up|0|||
160943478|NCT03221257|581183867|FG001|Overall Study|Lost to Follow-up|1|||
160943479|NCT03221257|581183866|FG000|Overall Study|Withdrawal by Subject|1|||
160943480|NCT03221257|581183867|FG001|Overall Study|Withdrawal by Subject|1|||
160943481|NCT01334866|581183870|FG000|Overall Study|Withdrawal by Subject|10|||
160943482|NCT01334866|581183870|FG000|Overall Study|Lost to Follow-up|3|||
160943483|NCT01334866|581183870|FG000|Overall Study|Physician Decision|3|||
160943484|NCT01334866|581183870|FG000|Overall Study|medically necessary prior to procedure|2|||
160943485|NCT01334866|581183870|FG000|Overall Study|medically necessary post-procedure|1|||
160943486|NCT02460224|581183873|FG000|Overall Study|Adverse Event|0|||
160943487|NCT02460224|581183874|FG001|Overall Study|Adverse Event|0|||
160943488|NCT02460224|581183875|FG002|Overall Study|Adverse Event|0|||
160943489|NCT02460224|581183876|FG003|Overall Study|Adverse Event|0|||
160943490|NCT02460224|581183877|FG004|Overall Study|Adverse Event|0|||
160943491|NCT02460224|581183878|FG005|Overall Study|Adverse Event|0|||
160943492|NCT02460224|581183879|FG006|Overall Study|Adverse Event|1|||
160943493|NCT02460224|581183880|FG007|Overall Study|Adverse Event|0|||
160943494|NCT02460224|581183881|FG008|Overall Study|Adverse Event|0|||
160943495|NCT02460224|581183882|FG009|Overall Study|Adverse Event|0|||
160943496|NCT02460224|581183883|FG010|Overall Study|Adverse Event|0|||
160943497|NCT02460224|581183884|FG011|Overall Study|Adverse Event|0|||
160943498|NCT02460224|581183885|FG012|Overall Study|Adverse Event|1|||
160943499|NCT02460224|581183886|FG013|Overall Study|Adverse Event|0|||
160943500|NCT02460224|581183887|FG014|Overall Study|Adverse Event|0|||
160943501|NCT02460224|581183888|FG015|Overall Study|Adverse Event|0|||
160943502|NCT02460224|581183889|FG016|Overall Study|Adverse Event|1|||
160943503|NCT02460224|581183890|FG017|Overall Study|Adverse Event|0|||
160943504|NCT02460224|581183891|FG018|Overall Study|Adverse Event|1|||
160943505|NCT02460224|581183892|FG019|Overall Study|Adverse Event|0|||
160943506|NCT02460224|581183893|FG020|Overall Study|Adverse Event|1|||
160943507|NCT02460224|581183894|FG021|Overall Study|Adverse Event|1|||
160943508|NCT02460224|581183895|FG022|Overall Study|Adverse Event|1|||
160943509|NCT02460224|581183896|FG023|Overall Study|Adverse Event|0|||
160943510|NCT02460224|581183897|FG024|Overall Study|Adverse Event|0|||
160943511|NCT02460224|581183898|FG025|Overall Study|Adverse Event|0|||
160943512|NCT02460224|581183899|FG026|Overall Study|Adverse Event|11|||
160943513|NCT02460224|581183900|FG027|Overall Study|Adverse Event|1|||
160579739|NCT04657016|579844039|FG000|Overall Study|Withdrawal by Subject|28|||
160579740|NCT04657016|579844040|FG001|Overall Study|Withdrawal by Subject|14|||
160579741|NCT04657016|579844039|FG000|Overall Study|Other - as reported by the investigator|6|||
160579742|NCT04657016|579844040|FG001|Overall Study|Other - as reported by the investigator|0|||
160579743|NCT01104558|579844041|FG000|Overall Study|Protocol Violation|6|||
160579744|NCT01104558|579844041|FG000|Overall Study|Missing of primary efficacy assessment|10|||
160579745|NCT01104558|579844041|FG000|Overall Study|Missing of genetic analysis results|1|||
160943514|NCT02460224|581183901|FG028|Overall Study|Adverse Event|6|||
160943515|NCT02460224|581183873|FG000|Overall Study|Death|0|||
160579746|NCT00696657|579844042|FG000|Overall Study|Protocol Violation|0|||
160579747|NCT00696657|579844043|FG001|Overall Study|Protocol Violation|0|||
160943516|NCT02460224|581183874|FG001|Overall Study|Death|0|||
160943517|NCT02460224|581183875|FG002|Overall Study|Death|0|||
160943518|NCT02460224|581183876|FG003|Overall Study|Death|0|||
160943519|NCT02460224|581183877|FG004|Overall Study|Death|0|||
160943520|NCT02460224|581183878|FG005|Overall Study|Death|2|||
160943521|NCT02460224|581183879|FG006|Overall Study|Death|1|||
160943522|NCT02460224|581183880|FG007|Overall Study|Death|0|||
160943523|NCT02460224|581183881|FG008|Overall Study|Death|0|||
160943524|NCT02460224|581183882|FG009|Overall Study|Death|1|||
160943525|NCT02460224|581183883|FG010|Overall Study|Death|0|||
160943526|NCT02460224|581183884|FG011|Overall Study|Death|0|||
160943527|NCT02460224|581183885|FG012|Overall Study|Death|0|||
160943528|NCT02460224|581183886|FG013|Overall Study|Death|1|||
160943529|NCT02460224|581183887|FG014|Overall Study|Death|0|||
160943530|NCT02460224|581183888|FG015|Overall Study|Death|0|||
160943531|NCT02460224|581183889|FG016|Overall Study|Death|2|||
160943532|NCT02460224|581183890|FG017|Overall Study|Death|1|||
160943533|NCT02460224|581183891|FG018|Overall Study|Death|0|||
160943534|NCT02460224|581183892|FG019|Overall Study|Death|2|||
160943535|NCT02460224|581183893|FG020|Overall Study|Death|0|||
160943536|NCT02460224|581183894|FG021|Overall Study|Death|0|||
160943537|NCT02460224|581183895|FG022|Overall Study|Death|0|||
160943538|NCT02460224|581183896|FG023|Overall Study|Death|0|||
160943539|NCT02460224|581183897|FG024|Overall Study|Death|1|||
160943540|NCT02460224|581183898|FG025|Overall Study|Death|1|||
160943541|NCT02460224|581183899|FG026|Overall Study|Death|5|||
160943542|NCT02460224|581183900|FG027|Overall Study|Death|0|||
160943543|NCT02460224|581183901|FG028|Overall Study|Death|1|||
160943544|NCT02460224|581183873|FG000|Overall Study|Lost to Follow-up|0|||
160943545|NCT02460224|581183874|FG001|Overall Study|Lost to Follow-up|0|||
160943546|NCT02460224|581183875|FG002|Overall Study|Lost to Follow-up|0|||
160943547|NCT02460224|581183876|FG003|Overall Study|Lost to Follow-up|0|||
160943548|NCT02460224|581183877|FG004|Overall Study|Lost to Follow-up|0|||
160943549|NCT02460224|581183878|FG005|Overall Study|Lost to Follow-up|0|||
160943550|NCT02460224|581183879|FG006|Overall Study|Lost to Follow-up|0|||
160943551|NCT02460224|581183880|FG007|Overall Study|Lost to Follow-up|0|||
160999201|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999202|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999203|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999204|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999205|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999206|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
160943552|NCT02460224|581183881|FG008|Overall Study|Lost to Follow-up|0|||
160943553|NCT02460224|581183882|FG009|Overall Study|Lost to Follow-up|0|||
160999207|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
160999208|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
160999209|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
160999210|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
160999211|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
160999212|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
160579748|NCT00696657|579844044|FG002|Overall Study|Protocol Violation|0|||
160579749|NCT00696657|579844045|FG003|Overall Study|Protocol Violation|0|||
160579750|NCT00696657|579844046|FG004|Overall Study|Protocol Violation|0|||
160579751|NCT00696657|579844047|FG005|Overall Study|Protocol Violation|1|||
160579752|NCT00696657|579844048|FG006|Overall Study|Protocol Violation|0|||
160579753|NCT00696657|579844049|FG007|Overall Study|Protocol Violation|0|||
160579754|NCT00696657|579844050|FG008|Overall Study|Protocol Violation|1|||
160579755|NCT00696657|579844042|FG000|Overall Study|Lack of Efficacy|0|||
160579756|NCT00696657|579844043|FG001|Overall Study|Lack of Efficacy|1|||
160579757|NCT00696657|579844044|FG002|Overall Study|Lack of Efficacy|0|||
160999213|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
160999214|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
160999215|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160999216|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
160999217|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160999218|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160999219|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
160999220|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160999221|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160579758|NCT00696657|579844045|FG003|Overall Study|Lack of Efficacy|0|||
160579759|NCT00696657|579844046|FG004|Overall Study|Lack of Efficacy|0|||
160579760|NCT00696657|579844047|FG005|Overall Study|Lack of Efficacy|0|||
160579761|NCT00696657|579844048|FG006|Overall Study|Lack of Efficacy|0|||
160943554|NCT02460224|581183883|FG010|Overall Study|Lost to Follow-up|0|||
160943555|NCT02460224|581183884|FG011|Overall Study|Lost to Follow-up|0|||
160943556|NCT02460224|581183885|FG012|Overall Study|Lost to Follow-up|0|||
160943557|NCT02460224|581183886|FG013|Overall Study|Lost to Follow-up|0|||
160579762|NCT00696657|579844049|FG007|Overall Study|Lack of Efficacy|0|||
160943558|NCT02460224|581183887|FG014|Overall Study|Lost to Follow-up|0|||
160943559|NCT02460224|581183888|FG015|Overall Study|Lost to Follow-up|0|||
160943560|NCT02460224|581183889|FG016|Overall Study|Lost to Follow-up|0|||
160943561|NCT02460224|581183890|FG017|Overall Study|Lost to Follow-up|0|||
160943562|NCT02460224|581183891|FG018|Overall Study|Lost to Follow-up|0|||
160943563|NCT02460224|581183892|FG019|Overall Study|Lost to Follow-up|0|||
160943564|NCT02460224|581183893|FG020|Overall Study|Lost to Follow-up|0|||
160943565|NCT02460224|581183894|FG021|Overall Study|Lost to Follow-up|0|||
160579763|NCT00696657|579844050|FG008|Overall Study|Lack of Efficacy|0|||
160579764|NCT00696657|579844042|FG000|Overall Study|Withdrawal criteria|1|||
160943566|NCT02460224|581183895|FG022|Overall Study|Lost to Follow-up|1|||
160943567|NCT02460224|581183896|FG023|Overall Study|Lost to Follow-up|0|||
160943568|NCT02460224|581183897|FG024|Overall Study|Lost to Follow-up|0|||
160943569|NCT02460224|581183898|FG025|Overall Study|Lost to Follow-up|0|||
160943570|NCT02460224|581183899|FG026|Overall Study|Lost to Follow-up|0|||
160943571|NCT02460224|581183900|FG027|Overall Study|Lost to Follow-up|0|||
160943572|NCT02460224|581183901|FG028|Overall Study|Lost to Follow-up|0|||
160943573|NCT02460224|581183873|FG000|Overall Study|Physician Decision|0|||
160943574|NCT02460224|581183874|FG001|Overall Study|Physician Decision|1|||
160943575|NCT02460224|581183875|FG002|Overall Study|Physician Decision|0|||
160943576|NCT02460224|581183876|FG003|Overall Study|Physician Decision|0|||
160943577|NCT02460224|581183877|FG004|Overall Study|Physician Decision|1|||
160943578|NCT02460224|581183878|FG005|Overall Study|Physician Decision|0|||
160943579|NCT02460224|581183879|FG006|Overall Study|Physician Decision|0|||
160943580|NCT02460224|581183880|FG007|Overall Study|Physician Decision|1|||
160943581|NCT02460224|581183881|FG008|Overall Study|Physician Decision|0|||
160943582|NCT02460224|581183882|FG009|Overall Study|Physician Decision|0|||
160943583|NCT02460224|581183883|FG010|Overall Study|Physician Decision|0|||
160943584|NCT02460224|581183884|FG011|Overall Study|Physician Decision|1|||
160943585|NCT02460224|581183885|FG012|Overall Study|Physician Decision|0|||
160943586|NCT02460224|581183886|FG013|Overall Study|Physician Decision|1|||
160943587|NCT02460224|581183887|FG014|Overall Study|Physician Decision|0|||
160943588|NCT02460224|581183888|FG015|Overall Study|Physician Decision|0|||
160943589|NCT02460224|581183889|FG016|Overall Study|Physician Decision|2|||
160943590|NCT02460224|581183890|FG017|Overall Study|Physician Decision|1|||
160943591|NCT02460224|581183891|FG018|Overall Study|Physician Decision|1|||
160943592|NCT02460224|581183892|FG019|Overall Study|Physician Decision|2|||
160943593|NCT02460224|581183893|FG020|Overall Study|Physician Decision|1|||
160943594|NCT02460224|581183894|FG021|Overall Study|Physician Decision|1|||
160943595|NCT02460224|581183895|FG022|Overall Study|Physician Decision|0|||
160943596|NCT02460224|581183896|FG023|Overall Study|Physician Decision|0|||
160943597|NCT02460224|581183897|FG024|Overall Study|Physician Decision|1|||
160943598|NCT02460224|581183898|FG025|Overall Study|Physician Decision|0|||
160943599|NCT02460224|581183899|FG026|Overall Study|Physician Decision|14|||
160943600|NCT02460224|581183900|FG027|Overall Study|Physician Decision|1|||
160943601|NCT02460224|581183901|FG028|Overall Study|Physician Decision|6|||
160943602|NCT02460224|581183873|FG000|Overall Study|Progressive disease|15|||
160943603|NCT02460224|581183874|FG001|Overall Study|Progressive disease|11|||
160943604|NCT02460224|581183875|FG002|Overall Study|Progressive disease|5|||
160943605|NCT02460224|581183876|FG003|Overall Study|Progressive disease|6|||
160943606|NCT02460224|581183877|FG004|Overall Study|Progressive disease|3|||
160943607|NCT02460224|581183878|FG005|Overall Study|Progressive disease|26|||
160943608|NCT02460224|581183879|FG006|Overall Study|Progressive disease|28|||
160943609|NCT02460224|581183880|FG007|Overall Study|Progressive disease|4|||
160943610|NCT02460224|581183881|FG008|Overall Study|Progressive disease|5|||
160943611|NCT02460224|581183882|FG009|Overall Study|Progressive disease|9|||
160943612|NCT02460224|581183883|FG010|Overall Study|Progressive disease|5|||
160943613|NCT02460224|581183884|FG011|Overall Study|Progressive disease|4|||
160943614|NCT02460224|581183885|FG012|Overall Study|Progressive disease|5|||
160943615|NCT02460224|581183886|FG013|Overall Study|Progressive disease|4|||
160943616|NCT02460224|581183887|FG014|Overall Study|Progressive disease|5|||
160943617|NCT02460224|581183888|FG015|Overall Study|Progressive disease|5|||
160943618|NCT02460224|581183889|FG016|Overall Study|Progressive disease|15|||
160943619|NCT02460224|581183890|FG017|Overall Study|Progressive disease|3|||
160943620|NCT02460224|581183891|FG018|Overall Study|Progressive disease|8|||
160943621|NCT02460224|581183892|FG019|Overall Study|Progressive disease|3|||
160943622|NCT02460224|581183893|FG020|Overall Study|Progressive disease|4|||
160943623|NCT02460224|581183894|FG021|Overall Study|Progressive disease|9|||
160943624|NCT02460224|581183895|FG022|Overall Study|Progressive disease|4|||
160943625|NCT02460224|581183896|FG023|Overall Study|Progressive disease|11|||
160943626|NCT02460224|581183897|FG024|Overall Study|Progressive disease|4|||
160943627|NCT02460224|581183898|FG025|Overall Study|Progressive disease|5|||
160943628|NCT02460224|581183899|FG026|Overall Study|Progressive disease|85|||
160943629|NCT02460224|581183900|FG027|Overall Study|Progressive disease|17|||
160943630|NCT02460224|581183901|FG028|Overall Study|Progressive disease|77|||
160999222|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160943631|NCT02460224|581183873|FG000|Overall Study|Subject/guardian decision|2|||
160943632|NCT02460224|581183874|FG001|Overall Study|Subject/guardian decision|0|||
160943633|NCT02460224|581183875|FG002|Overall Study|Subject/guardian decision|1|||
160943634|NCT02460224|581183876|FG003|Overall Study|Subject/guardian decision|0|||
160943635|NCT02460224|581183877|FG004|Overall Study|Subject/guardian decision|2|||
160943636|NCT02460224|581183878|FG005|Overall Study|Subject/guardian decision|2|||
160943637|NCT02460224|581183879|FG006|Overall Study|Subject/guardian decision|0|||
160943638|NCT02460224|581183880|FG007|Overall Study|Subject/guardian decision|0|||
160943639|NCT02460224|581183881|FG008|Overall Study|Subject/guardian decision|1|||
160943640|NCT02460224|581183882|FG009|Overall Study|Subject/guardian decision|1|||
160999223|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160943641|NCT02460224|581183883|FG010|Overall Study|Subject/guardian decision|0|||
160943642|NCT02460224|581183884|FG011|Overall Study|Subject/guardian decision|1|||
160943643|NCT02460224|581183885|FG012|Overall Study|Subject/guardian decision|0|||
160943644|NCT02460224|581183886|FG013|Overall Study|Subject/guardian decision|0|||
160943645|NCT02460224|581183887|FG014|Overall Study|Subject/guardian decision|0|||
160943646|NCT02460224|581183888|FG015|Overall Study|Subject/guardian decision|1|||
160943647|NCT02460224|581183889|FG016|Overall Study|Subject/guardian decision|0|||
160943648|NCT02460224|581183890|FG017|Overall Study|Subject/guardian decision|1|||
160943649|NCT02460224|581183891|FG018|Overall Study|Subject/guardian decision|2|||
160943650|NCT02460224|581183892|FG019|Overall Study|Subject/guardian decision|0|||
160943651|NCT02460224|581183893|FG020|Overall Study|Subject/guardian decision|0|||
160943652|NCT02460224|581183894|FG021|Overall Study|Subject/guardian decision|1|||
160943653|NCT02460224|581183895|FG022|Overall Study|Subject/guardian decision|0|||
160943654|NCT02460224|581183896|FG023|Overall Study|Subject/guardian decision|0|||
160943655|NCT02460224|581183897|FG024|Overall Study|Subject/guardian decision|0|||
160943656|NCT02460224|581183898|FG025|Overall Study|Subject/guardian decision|0|||
160943657|NCT02460224|581183899|FG026|Overall Study|Subject/guardian decision|6|||
160943658|NCT02460224|581183900|FG027|Overall Study|Subject/guardian decision|2|||
160943659|NCT02460224|581183901|FG028|Overall Study|Subject/guardian decision|3|||
160943660|NCT02774681|581183910|FG000|Treatment on Study|Progressive Disease|7|||
160943661|NCT02774681|581183910|FG000|Follow-Up for 3 Years|Death|11|||
160943662|NCT02774681|581183910|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
160943663|NCT03146650|581183913|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
160943664|NCT03146650|581183913|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
160943665|NCT03146650|581183913|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
160943666|NCT03146650|581183913|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
160943667|NCT03146650|581183913|FG000|2 Year Follow-up|Death|11|||
160943668|NCT03146650|581183913|FG000|2 Year Follow-up|Still in follow-up|7|||
160943669|NCT03146650|581183913|FG000|2 Year Follow-up|Lost to Follow-up|1|||
160943670|NCT02460198|581183916|FG000|Overall Study|Adverse Event|1|||
160943671|NCT02460198|581183917|FG001|Overall Study|Adverse Event|3|||
160943672|NCT02460198|581183916|FG000|Overall Study|Death|36|||
160943673|NCT02460198|581183917|FG001|Overall Study|Death|28|||
160999224|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999225|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
160999226|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
160999227|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999228|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999229|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999230|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999231|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999232|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999233|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999234|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999235|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999236|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999237|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999238|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999239|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999240|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999241|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
160999242|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
160999243|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
160999244|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
160999245|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
160999246|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
160999247|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
160999248|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
160999249|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
160999250|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
160999251|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160999252|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
160999253|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
160999254|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160999255|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160999256|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160999257|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160999258|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
160999259|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160943674|NCT02460198|581183916|FG000|Overall Study|Lost to Follow-up|1|||
160943675|NCT02460198|581183917|FG001|Overall Study|Lost to Follow-up|1|||
160943676|NCT02460198|581183916|FG000|Overall Study|Transferred to Extension Study|15|||
160943677|NCT02460198|581183917|FG001|Overall Study|Transferred to Extension Study|15|||
160943678|NCT02460198|581183916|FG000|Overall Study|Withdrawal by Subject|2|||
160943679|NCT02460198|581183917|FG001|Overall Study|Withdrawal by Subject|4|||
160943680|NCT02460198|581183916|FG000|Overall Study|Site Terminated By Sponsor|0|||
160943681|NCT02460198|581183917|FG001|Overall Study|Site Terminated By Sponsor|1|||
160943682|NCT02460198|581183916|FG000|Overall Study|Did Not Continue on Extension Study|6|||
160943683|NCT02460198|581183917|FG001|Overall Study|Did Not Continue on Extension Study|11|||
160943684|NCT00931307|581183918|FG000|Overall Study|Lack of Efficacy|12|||
160943685|NCT00931307|581183918|FG000|Overall Study|Biomicroscopy|1|||
160943686|NCT00965848|581183921|FG000|Overall Study|Protocol Violation|3|||
160943687|NCT00965848|581183922|FG001|Overall Study|Protocol Violation|0|||
160943688|NCT00965848|581183923|FG002|Overall Study|Protocol Violation|1|||
160943689|NCT00965848|581183921|FG000|Overall Study|Death|11|||
160943690|NCT00965848|581183922|FG001|Overall Study|Death|1|||
160943691|NCT00965848|581183923|FG002|Overall Study|Death|5|||
160943692|NCT00965848|581183921|FG000|Overall Study|Lost to Follow-up|0|||
160943693|NCT00965848|581183922|FG001|Overall Study|Lost to Follow-up|0|||
160943694|NCT00965848|581183923|FG002|Overall Study|Lost to Follow-up|1|||
160943695|NCT00965848|581183921|FG000|Overall Study|Withdrawal by Subject|1|||
160943696|NCT00965848|581183922|FG001|Overall Study|Withdrawal by Subject|0|||
160943697|NCT00965848|581183923|FG002|Overall Study|Withdrawal by Subject|0|||
160943698|NCT00965848|581183921|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
160943699|NCT00965848|581183922|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
160943700|NCT00965848|581183923|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
160943701|NCT00965848|581183921|FG000|Overall Study|Not Clinically Evaluable|7|||
160943702|NCT00965848|581183922|FG001|Overall Study|Not Clinically Evaluable|1|||
160943703|NCT00965848|581183923|FG002|Overall Study|Not Clinically Evaluable|1|||
160943704|NCT00965848|581183921|FG000|Overall Study|Other|5|||
160943705|NCT00965848|581183922|FG001|Overall Study|Other|0|||
160943706|NCT00965848|581183923|FG002|Overall Study|Other|1|||
160943707|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
160943708|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
160943709|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
160943710|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
160943711|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
160943712|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
160943713|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
160943714|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
160943715|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
160943716|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
160579765|NCT00696657|579844043|FG001|Overall Study|Withdrawal criteria|3|||
160579766|NCT00696657|579844044|FG002|Overall Study|Withdrawal criteria|2|||
160579767|NCT00696657|579844045|FG003|Overall Study|Withdrawal criteria|2|||
160579768|NCT00696657|579844046|FG004|Overall Study|Withdrawal criteria|0|||
160579769|NCT00696657|579844047|FG005|Overall Study|Withdrawal criteria|0|||
160579770|NCT00696657|579844048|FG006|Overall Study|Withdrawal criteria|1|||
160579771|NCT00696657|579844049|FG007|Overall Study|Withdrawal criteria|1|||
160579772|NCT00696657|579844050|FG008|Overall Study|Withdrawal criteria|2|||
160579773|NCT00696657|579844042|FG000|Overall Study|Unclassified|0|||
160579774|NCT00696657|579844043|FG001|Overall Study|Unclassified|1|||
160579775|NCT00696657|579844044|FG002|Overall Study|Unclassified|3|||
160579776|NCT00696657|579844045|FG003|Overall Study|Unclassified|2|||
160943717|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
160943718|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
160943719|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
160943720|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
160943721|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
160943722|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
160943723|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
160943724|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
160943725|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
160943726|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
160943727|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
160943728|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
160943729|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
160943730|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
160943731|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
160943732|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
160943733|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
160579777|NCT00696657|579844046|FG004|Overall Study|Unclassified|4|||
160943734|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
160943735|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
160943736|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
160943737|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
160999260|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160579778|NCT00696657|579844047|FG005|Overall Study|Unclassified|2|||
160579779|NCT00696657|579844048|FG006|Overall Study|Unclassified|0|||
160579780|NCT00696657|579844049|FG007|Overall Study|Unclassified|0|||
160579781|NCT00696657|579844050|FG008|Overall Study|Unclassified|1|||
160579782|NCT00696657|579844042|FG000|Overall Study|Adverse Event|0|||
160579783|NCT00696657|579844043|FG001|Overall Study|Adverse Event|0|||
160579784|NCT00696657|579844044|FG002|Overall Study|Adverse Event|3|||
160943738|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
160943739|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
160943740|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
160943741|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
160943742|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
160943743|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
160943744|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
160943745|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
160943746|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
160943747|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
160943748|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
160943749|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
160943750|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
160943751|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
160943752|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
160943753|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
160943754|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
160943755|NCT00691210|581183928|FG000|Overall Study|Progression of Disease|0|||
160943756|NCT00691210|581183929|FG001|Overall Study|Progression of Disease|0|||
160943757|NCT00691210|581183930|FG002|Overall Study|Progression of Disease|0|||
160943758|NCT00691210|581183931|FG003|Overall Study|Progression of Disease|2|||
160943759|NCT00691210|581183932|FG004|Overall Study|Progression of Disease|0|||
160943760|NCT00691210|581183933|FG005|Overall Study|Progression of Disease|0|||
160943761|NCT00691210|581183934|FG006|Overall Study|Progression of Disease|0|||
160943762|NCT00691210|581183935|FG007|Overall Study|Progression of Disease|0|||
160943763|NCT00691210|581183928|FG000|Overall Study|Lack of Efficacy|0|||
160943764|NCT00691210|581183929|FG001|Overall Study|Lack of Efficacy|0|||
160943765|NCT00691210|581183930|FG002|Overall Study|Lack of Efficacy|0|||
160943766|NCT00691210|581183931|FG003|Overall Study|Lack of Efficacy|1|||
160943767|NCT00691210|581183932|FG004|Overall Study|Lack of Efficacy|0|||
160943768|NCT00691210|581183933|FG005|Overall Study|Lack of Efficacy|1|||
160943769|NCT00691210|581183934|FG006|Overall Study|Lack of Efficacy|0|||
160943770|NCT00691210|581183935|FG007|Overall Study|Lack of Efficacy|0|||
160943771|NCT02047604|581183938|FG000|Overall Study|Withdrawal by Subject|0|||
160943772|NCT02047604|581183939|FG001|Overall Study|Withdrawal by Subject|0|||
160943773|NCT02047604|581183940|FG002|Overall Study|Withdrawal by Subject|0|||
160943774|NCT02047604|581183941|FG003|Overall Study|Withdrawal by Subject|0|||
160943775|NCT02047604|581183942|FG004|Overall Study|Withdrawal by Subject|1|||
160943776|NCT02047604|581183943|FG005|Overall Study|Withdrawal by Subject|1|||
160943777|NCT00983814|581183944|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
160943778|NCT00983814|581183945|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
160943779|NCT00983814|581183946|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
160943780|NCT00983814|581183944|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
160943781|NCT00983814|581183945|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
160943782|NCT00983814|581183946|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
160943783|NCT00983814|581183944|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
160943784|NCT00983814|581183945|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
160943785|NCT00983814|581183946|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
160943786|NCT00983814|581183944|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
160943787|NCT00983814|581183945|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
160943788|NCT00983814|581183946|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
160943789|NCT00983814|581183944|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
160943790|NCT00983814|581183945|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
160943791|NCT00983814|581183946|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
160943792|NCT01181895|581183947|FG000|Overall Study|Adverse Event|3|||
160943793|NCT01181895|581183948|FG001|Overall Study|Adverse Event|1|||
160943794|NCT01181895|581183949|FG002|Overall Study|Adverse Event|1|||
160579785|NCT00696657|579844045|FG003|Overall Study|Adverse Event|7|||
160579786|NCT00696657|579844046|FG004|Overall Study|Adverse Event|6|||
160943795|NCT01181895|581183947|FG000|Overall Study|Lack of Efficacy|8|||
160943796|NCT01181895|581183948|FG001|Overall Study|Lack of Efficacy|9|||
160943797|NCT01181895|581183949|FG002|Overall Study|Lack of Efficacy|9|||
160943798|NCT01181895|581183947|FG000|Overall Study|Protocol Violation|2|||
160943799|NCT01181895|581183948|FG001|Overall Study|Protocol Violation|1|||
160579787|NCT00696657|579844047|FG005|Overall Study|Adverse Event|9|||
160943800|NCT01181895|581183949|FG002|Overall Study|Protocol Violation|0|||
160943801|NCT01181895|581183947|FG000|Overall Study|Lost to Follow-up|0|||
160943802|NCT01181895|581183948|FG001|Overall Study|Lost to Follow-up|1|||
160943803|NCT01181895|581183949|FG002|Overall Study|Lost to Follow-up|2|||
160943804|NCT01181895|581183947|FG000|Overall Study|Investigator Discretion|1|||
160579788|NCT00696657|579844048|FG006|Overall Study|Adverse Event|14|||
160579789|NCT00696657|579844049|FG007|Overall Study|Adverse Event|2|||
160943805|NCT01181895|581183948|FG001|Overall Study|Investigator Discretion|2|||
160943806|NCT01181895|581183949|FG002|Overall Study|Investigator Discretion|1|||
160999261|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
160999262|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
160999263|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160999264|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160999265|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160999266|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160999267|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
160999268|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
160999269|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999270|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999271|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
160999272|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999273|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999274|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999275|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999276|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999277|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999278|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999279|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
160999280|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
160999281|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999282|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999283|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999284|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999285|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
160999286|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999287|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
160999288|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
160943807|NCT01181895|581183947|FG000|Overall Study|Withdrawal by Subject|3|||
160943808|NCT01181895|581183948|FG001|Overall Study|Withdrawal by Subject|0|||
160943809|NCT01181895|581183949|FG002|Overall Study|Withdrawal by Subject|5|||
160943810|NCT00555438|581183950|FG000|10 Days Post-operative|Death|4|||
160943811|NCT00555438|581183950|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
160943812|NCT02707640|581183951|FG000|Overall Study|Adverse Event|4|||
160943813|NCT02707640|581183952|FG001|Overall Study|Adverse Event|2|||
160943814|NCT02707640|581183951|FG000|Overall Study|Death|1|||
160943815|NCT02707640|581183952|FG001|Overall Study|Death|2|||
160943816|NCT02707640|581183951|FG000|Overall Study|Physician Decision|2|||
160943817|NCT02707640|581183952|FG001|Overall Study|Physician Decision|0|||
160943818|NCT02707640|581183951|FG000|Overall Study|Withdrawal by Subject|0|||
160943819|NCT02707640|581183952|FG001|Overall Study|Withdrawal by Subject|1|||
160943820|NCT02707640|581183951|FG000|Overall Study|Participant's Personal Decision|1|||
160943821|NCT02707640|581183952|FG001|Overall Study|Participant's Personal Decision|2|||
160943822|NCT02707640|581183951|FG000|Overall Study|Sponsor Discretion|1|||
160943823|NCT02707640|581183952|FG001|Overall Study|Sponsor Discretion|0|||
160943824|NCT02517905|581183953|FG000|Overall Study|Lost to Follow-up|4|||
160943825|NCT02517905|581183954|FG001|Overall Study|Lost to Follow-up|0|||
160943826|NCT02517905|581183953|FG000|Overall Study|Withdrawal by Subject|4|||
160943827|NCT02517905|581183954|FG001|Overall Study|Withdrawal by Subject|0|||
160943828|NCT02517905|581183953|FG000|Overall Study|Screen failure|2|||
160943829|NCT02517905|581183954|FG001|Overall Study|Screen failure|2|||
160943830|NCT05789875|581183955|FG000|Overall Study|Lost to Follow-up|6|||
160943831|NCT00023452|581183956|FG000|Overall Study|Ineligible for Study|163|||
160943832|NCT00023452|581183957|FG001|Overall Study|Ineligible for Study|159|||
160943833|NCT00023452|581183956|FG000|Overall Study|Out of Window|129|||
160943834|NCT00023452|581183957|FG001|Overall Study|Out of Window|69|||
160943835|NCT00023452|581183956|FG000|Overall Study|Death|2|||
160943836|NCT00023452|581183957|FG001|Overall Study|Death|0|||
160999289|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
160999290|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
160999291|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
160943837|NCT00023452|581183956|FG000|Overall Study|Withdrawal by Subject|66|||
160943838|NCT00023452|581183957|FG001|Overall Study|Withdrawal by Subject|54|||
160999292|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
160999293|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
160999294|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
160999295|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
160943839|NCT00023452|581183956|FG000|Overall Study|Adverse Event|139|||
160943840|NCT00023452|581183957|FG001|Overall Study|Adverse Event|196|||
160943841|NCT00023452|581183956|FG000|Overall Study|Lost to Follow-up|293|||
160455893|NCT05868382|579399800|FG003|Overall Study|Lost to Follow-up|4|||
160943842|NCT00023452|581183957|FG001|Overall Study|Lost to Follow-up|60|||
160943843|NCT00023452|581183956|FG000|Overall Study|Physician Decision|49|||
160943844|NCT00023452|581183957|FG001|Overall Study|Physician Decision|21|||
160943845|NCT00023452|581183956|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
160943846|NCT00023452|581183957|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
160943847|NCT00023452|581183956|FG000|Overall Study|Pregnant|53|||
160943848|NCT00023452|581183957|FG001|Overall Study|Pregnant|20|||
160943849|NCT00023452|581183956|FG000|Overall Study|Other|204|||
160943850|NCT00023452|581183957|FG001|Overall Study|Other|69|||
160943851|NCT01994395|581183958|FG000|Overall Study|Withdrawal by Subject|1|||
160943852|NCT01994395|581183959|FG001|Overall Study|Withdrawal by Subject|2|||
160943853|NCT00459134|581183967|FG000|Overall Study|Physician Decision|1|||
160943854|NCT00459134|581183968|FG001|Overall Study|Physician Decision|1|||
160943855|NCT00459134|581183967|FG000|Overall Study|Withdrawal by Subject|8|||
160943856|NCT00459134|581183968|FG001|Overall Study|Withdrawal by Subject|7|||
160943857|NCT00459134|581183967|FG000|Overall Study|Lost to Follow-up|6|||
160943858|NCT00459134|581183968|FG001|Overall Study|Lost to Follow-up|7|||
160943859|NCT00459134|581183967|FG000|Overall Study|Surgery|1|||
160943860|NCT00459134|581183968|FG001|Overall Study|Surgery|2|||
160943861|NCT00459134|581183967|FG000|Overall Study|Toxicity|4|||
160943862|NCT00459134|581183968|FG001|Overall Study|Toxicity|5|||
160943863|NCT00459134|581183967|FG000|Overall Study|Progression|1|||
160943864|NCT00459134|581183968|FG001|Overall Study|Progression|0|||
160943865|NCT00459134|581183967|FG000|Overall Study|Multiple Reasons|2|||
160943866|NCT00459134|581183968|FG001|Overall Study|Multiple Reasons|3|||
160943867|NCT03333486|581183969|FG000|Overall Study|Withdrawal by Subject|1|||
160943868|NCT03333486|581183969|FG000|Overall Study|Lost to Follow-up|1|||
160943869|NCT01755416|581183973|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
160943870|NCT01755416|581183974|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
160943871|NCT03246529|581183982|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
160943872|NCT03246529|581183983|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
160943873|NCT03246529|581183984|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
160943874|NCT03246529|581183982|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
160943875|NCT03246529|581183983|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
160943876|NCT03246529|581183984|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
160943877|NCT03246529|581183982|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
160943878|NCT03246529|581183983|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
160943879|NCT03246529|581183984|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
160943880|NCT03246529|581183982|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
160943881|NCT03246529|581183983|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
160943882|NCT03246529|581183984|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
160943883|NCT03246529|581183982|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
160943884|NCT03246529|581183983|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
160943885|NCT03246529|581183984|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
160943886|NCT03246529|581183982|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
160943887|NCT03246529|581183983|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
160943888|NCT03246529|581183984|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
160943889|NCT03246529|581183982|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
160943890|NCT03246529|581183983|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
160943891|NCT03246529|581183984|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
160943892|NCT03246529|581183982|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
160943893|NCT03246529|581183983|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
160943894|NCT03246529|581183984|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
160943895|NCT03246529|581183982|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
160943896|NCT03246529|581183983|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
160943897|NCT03246529|581183984|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
160943898|NCT00441337|581183985|FG000|Overall Study|Disease Progression|6|||
160943899|NCT00441337|581183986|FG001|Overall Study|Disease Progression|6|||
160943900|NCT00441337|581183987|FG002|Overall Study|Disease Progression|4|||
160943901|NCT00441337|581183988|FG003|Overall Study|Disease Progression|18|||
160943902|NCT00441337|581183985|FG000|Overall Study|Lost to Follow-up|0|||
160943903|NCT00441337|581183986|FG001|Overall Study|Lost to Follow-up|0|||
160579790|NCT00696657|579844050|FG008|Overall Study|Adverse Event|5|||
160579791|NCT00523341|579844054|FG000|Overall Study|Withdrawal by Subject|399|||
160943904|NCT00441337|581183987|FG002|Overall Study|Lost to Follow-up|0|||
160943905|NCT00441337|581183988|FG003|Overall Study|Lost to Follow-up|1|||
160943906|NCT00441337|581183985|FG000|Overall Study|Sponsor Decision|0|||
160943907|NCT00441337|581183986|FG001|Overall Study|Sponsor Decision|0|||
160943908|NCT00441337|581183987|FG002|Overall Study|Sponsor Decision|1|||
160943909|NCT00441337|581183988|FG003|Overall Study|Sponsor Decision|2|||
160943910|NCT00441337|581183985|FG000|Overall Study|Did not meet inclusion criteria|0|||
160943911|NCT00441337|581183986|FG001|Overall Study|Did not meet inclusion criteria|0|||
160579792|NCT00523341|579844055|FG001|Overall Study|Withdrawal by Subject|427|||
160579793|NCT00523341|579844054|FG000|Overall Study|Other|181|||
160579794|NCT00523341|579844055|FG001|Overall Study|Other|198|||
160579795|NCT00523341|579844054|FG000|Overall Study|Adverse Event|122|||
160579796|NCT00523341|579844055|FG001|Overall Study|Adverse Event|155|||
160579797|NCT00523341|579844054|FG000|Overall Study|Death|101|||
160579798|NCT00523341|579844055|FG001|Overall Study|Death|110|||
160943912|NCT00441337|581183987|FG002|Overall Study|Did not meet inclusion criteria|1|||
160943913|NCT00441337|581183988|FG003|Overall Study|Did not meet inclusion criteria|0|||
160943914|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
160943915|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
160943916|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
160943917|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Death|1|||
160943918|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Death|0|||
160943919|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Death|0|||
160943920|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
160943921|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
160943922|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
160943923|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
160943924|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
160943925|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
160943926|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
160943927|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
160943928|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
160943929|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
160943930|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
160943931|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
160943932|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
160943933|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
160943934|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
160943935|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
160943936|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
160943937|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
160943938|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
160943939|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
160943940|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
160943941|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
160943942|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
160943943|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
160943944|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
160943945|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
160943946|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
160943947|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Other|0|||
160943948|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Other|2|||
160943949|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Other|2|||
160943950|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
160943951|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
160943952|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
160943953|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
160943954|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
160943955|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
160943956|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
160943957|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
160943958|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
160943959|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
160943960|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
160943961|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
160999296|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999297|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999298|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
160579799|NCT00523341|579844054|FG000|Overall Study|Lost to Follow-up|73|||
160579800|NCT00523341|579844055|FG001|Overall Study|Lost to Follow-up|61|||
160579801|NCT00523341|579844054|FG000|Overall Study|Non-compliance|20|||
160579802|NCT00523341|579844055|FG001|Overall Study|Non-compliance|13|||
160579803|NCT00523341|579844054|FG000|Overall Study|Physician Decision|14|||
160579804|NCT00523341|579844055|FG001|Overall Study|Physician Decision|13|||
160656126|NCT00366899|580122354|FG001|Infant Series|Failed to return|1|||
160943962|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
160943963|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
160943964|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
160943965|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
160943966|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
160943967|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
160943968|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
160943969|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
160943970|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
160943971|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
160943972|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
160943973|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
160943974|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Other|1|||
160943975|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Other|0|||
160943976|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Other|0|||
160943977|NCT06748040|581183992|FG000|Overall Study|Death|3|||
160943978|NCT06748040|581183993|FG001|Overall Study|Death|4|||
160943979|NCT06748040|581183992|FG000|Overall Study|Lost to Follow-up|134|||
160943980|NCT06748040|581183993|FG001|Overall Study|Lost to Follow-up|132|||
160943981|NCT06748040|581183992|FG000|Overall Study|Withdrawal by Subject|3|||
160943982|NCT06748040|581183993|FG001|Overall Study|Withdrawal by Subject|5|||
160943983|NCT03136068|581185759|FG000|Overall Study|Lost to Follow-up|1|||
160943984|NCT03136068|581185760|FG001|Overall Study|Lost to Follow-up|1|||
160943985|NCT03136068|581185759|FG000|Overall Study|Protocol Violation|1|||
160943986|NCT03136068|581185760|FG001|Overall Study|Protocol Violation|0|||
160943987|NCT00432380|581185764|FG000|Overall Study|Migrated/moved from study area|3|||
160943988|NCT00432380|581185765|FG001|Overall Study|Migrated/moved from study area|4|||
160943989|NCT00432380|581185766|FG002|Overall Study|Migrated/moved from study area|1|||
160943990|NCT00432380|581185764|FG000|Overall Study|Adverse Event|1|||
160943991|NCT00432380|581185765|FG001|Overall Study|Adverse Event|0|||
160943992|NCT00432380|581185766|FG002|Overall Study|Adverse Event|0|||
160943993|NCT01071395|581185767|FG000|Overall Study|Withdrawal by Subject|2|||
160943994|NCT01071395|581185768|FG001|Overall Study|Withdrawal by Subject|1|||
160943995|NCT01071395|581185767|FG000|Overall Study|Adverse Event|3|||
160943996|NCT01071395|581185768|FG001|Overall Study|Adverse Event|1|||
160943997|NCT00612066|581185769|FG000|Overall Study|Adverse Event|1|||
160943998|NCT01337089|581185770|FG000|Overall Study|Adverse Event|237|||
160943999|NCT01337089|581185770|FG000|Overall Study|Withdrawal by Subject|129|||
160944000|NCT01337089|581185770|FG000|Overall Study|Withdrawal by Investigator|33|||
160944001|NCT01337089|581185770|FG000|Overall Study|Met Withdrawal Criteria|3|||
160944002|NCT01337089|581185770|FG000|Overall Study|Lost to Follow-up|2|||
160944003|NCT04419493|581185771|FG000|Wash-out After Period 1|Adverse Event|1|||
160944004|NCT04419493|581185772|FG001|Wash-out After Period 1|Adverse Event|2|||
160944005|NCT04419493|581185773|FG002|Wash-out After Period 1|Adverse Event|1|||
160944006|NCT04419493|581185774|FG003|Wash-out After Period 1|Adverse Event|0|||
160944007|NCT00524134|581185775|FG000|Overall Study|Withdrawal by Subject|1|||
160944008|NCT00524134|581185775|FG000|Overall Study|Physician Decision|1|||
160944009|NCT03794089|581185776|FG000|Overall Study|Lost to Follow-up|4|||
160944010|NCT03794089|581185777|FG001|Overall Study|Lost to Follow-up|1|||
160944011|NCT03794089|581185776|FG000|Overall Study|Withdrawal by Subject|2|||
160944012|NCT03794089|581185777|FG001|Overall Study|Withdrawal by Subject|0|||
160944013|NCT03985423|581185778|FG000|Overall Study|Adverse Event|1|||
160944014|NCT03985423|581185778|FG000|Overall Study|Death|2|||
160944015|NCT03985423|581185778|FG000|Overall Study|Physician Decision|1|||
160944016|NCT03985423|581185778|FG000|Overall Study|Withdrawal by Subject|2|||
160944017|NCT03985423|581185778|FG000|Overall Study|Lack of insurance and citizenship|1|||
160944018|NCT01045447|581185789|FG000|Overall Study|Adverse Event|0|||
160944019|NCT01045447|581185790|FG001|Overall Study|Adverse Event|1|||
160944020|NCT01045447|581185789|FG000|Overall Study|Lack of Efficacy|3|||
160944021|NCT01045447|581185790|FG001|Overall Study|Lack of Efficacy|1|||
160944022|NCT01045447|581185789|FG000|Overall Study|Protocol Violation|6|||
160999299|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160944023|NCT01045447|581185790|FG001|Overall Study|Protocol Violation|3|||
160944024|NCT01045447|581185789|FG000|Overall Study|Withdrawal Criteria|10|||
160944025|NCT01045447|581185790|FG001|Overall Study|Withdrawal Criteria|10|||
160944026|NCT01045447|581185789|FG000|Overall Study|Unclassified|17|||
160944027|NCT01045447|581185790|FG001|Overall Study|Unclassified|13|||
160944028|NCT01782131|581185794|FG000|Overall Study|Death|93|||
160944029|NCT01782131|581185795|FG001|Overall Study|Death|96|||
160944030|NCT01782131|581185794|FG000|Overall Study|Lost to Follow-up|1|||
160944031|NCT01782131|581185795|FG001|Overall Study|Lost to Follow-up|3|||
160944032|NCT01782131|581185794|FG000|Overall Study|Withdrawal by Subject|10|||
160944033|NCT01782131|581185795|FG001|Overall Study|Withdrawal by Subject|10|||
160944034|NCT01782131|581185794|FG000|Overall Study|Randomized but not treated|5|||
160944035|NCT01782131|581185795|FG001|Overall Study|Randomized but not treated|5|||
160944036|NCT01782131|581185794|FG000|Overall Study|Reason not provided|0|||
160944037|NCT01782131|581185795|FG001|Overall Study|Reason not provided|1|||
160944038|NCT01627249|581185796|FG000|Overall Study|Death|3|||
160944039|NCT01627249|581185797|FG001|Overall Study|Death|5|||
160944040|NCT01627249|581185798|FG002|Overall Study|Death|3|||
160944041|NCT01627249|581185796|FG000|Overall Study|Withdrawal by Subject|12|||
160944042|NCT01627249|581185797|FG001|Overall Study|Withdrawal by Subject|6|||
160944043|NCT01627249|581185798|FG002|Overall Study|Withdrawal by Subject|9|||
160944044|NCT01627249|581185796|FG000|Overall Study|Missed Visit|1|||
160944045|NCT01627249|581185797|FG001|Overall Study|Missed Visit|1|||
160944046|NCT01627249|581185798|FG002|Overall Study|Missed Visit|0|||
160944047|NCT00796718|581185799|FG000|Overall Study|Adverse Event|2|||
160944048|NCT00796718|581185799|FG000|Overall Study|Exclusion Criteria|1|||
160944049|NCT00796718|581185799|FG000|Overall Study|Lost to Follow-up|5|||
160944050|NCT00796718|581185799|FG000|Overall Study|Withdrawal by Informed Consent|1|||
160944051|NCT03266588|581185800|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
160944052|NCT03266588|581185801|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
160944053|NCT03266588|581185802|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
160944054|NCT03266588|581185800|FG000|Observational Period|Withdrawal by Subject|44|||
160944055|NCT03266588|581185801|FG001|Observational Period|Withdrawal by Subject|22|||
160944056|NCT03266588|581185802|FG002|Observational Period|Withdrawal by Subject|13|||
160944057|NCT03266588|581185800|FG000|Observational Period|Non-compliance|18|||
160944058|NCT03266588|581185801|FG001|Observational Period|Non-compliance|12|||
160944059|NCT03266588|581185802|FG002|Observational Period|Non-compliance|10|||
160944060|NCT03266588|581185800|FG000|Observational Period|Lost to Follow-up|8|||
160944061|NCT03266588|581185801|FG001|Observational Period|Lost to Follow-up|12|||
160944062|NCT03266588|581185802|FG002|Observational Period|Lost to Follow-up|4|||
160944063|NCT03266588|581185800|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
160944064|NCT03266588|581185801|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
160944065|NCT03266588|581185802|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
160944066|NCT03266588|581185800|FG000|Observational Period|Protocol Deviation|1|||
160944067|NCT03266588|581185801|FG001|Observational Period|Protocol Deviation|0|||
160944068|NCT03266588|581185802|FG002|Observational Period|Protocol Deviation|0|||
160944069|NCT03266588|581185800|FG000|Observational Period|Other Reasons|3|||
160944070|NCT03266588|581185801|FG001|Observational Period|Other Reasons|0|||
160944071|NCT03266588|581185802|FG002|Observational Period|Other Reasons|1|||
160944072|NCT03266588|581185800|FG000|Long-term Treatment Period|Adverse Event|33|||
160944073|NCT03266588|581185801|FG001|Long-term Treatment Period|Adverse Event|17|||
160944074|NCT03266588|581185802|FG002|Long-term Treatment Period|Adverse Event|8|||
160944075|NCT03266588|581185800|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
160944076|NCT03266588|581185801|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
160944077|NCT03266588|581185802|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
160944078|NCT03266588|581185800|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
160944079|NCT03266588|581185801|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
160944080|NCT03266588|581185802|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
160944081|NCT03266588|581185800|FG000|Long-term Treatment Period|Non-Compliance|126|||
160944082|NCT03266588|581185801|FG001|Long-term Treatment Period|Non-Compliance|57|||
160944083|NCT03266588|581185802|FG002|Long-term Treatment Period|Non-Compliance|7|||
160944084|NCT03266588|581185800|FG000|Long-term Treatment Period|Pregnancy|11|||
160944085|NCT03266588|581185801|FG001|Long-term Treatment Period|Pregnancy|5|||
160579805|NCT00523341|579844054|FG000|Overall Study|Requirement for Alternative Therapy|4|||
160579806|NCT00523341|579844055|FG001|Overall Study|Requirement for Alternative Therapy|14|||
160944086|NCT03266588|581185802|FG002|Long-term Treatment Period|Pregnancy|0|||
160944087|NCT03266588|581185800|FG000|Long-term Treatment Period|Protocol Deviation|17|||
160944088|NCT03266588|581185801|FG001|Long-term Treatment Period|Protocol Deviation|10|||
160944089|NCT03266588|581185802|FG002|Long-term Treatment Period|Protocol Deviation|4|||
160944090|NCT03266588|581185800|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
160944091|NCT03266588|581185801|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
160579807|NCT00523341|579844054|FG000|Overall Study|Protocol Deviation|6|||
160579808|NCT00523341|579844055|FG001|Overall Study|Protocol Deviation|5|||
160579809|NCT00523341|579844054|FG000|Overall Study|Ineligibility Determined|3|||
160579810|NCT00523341|579844055|FG001|Overall Study|Ineligibility Determined|4|||
160944092|NCT03266588|581185802|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
160944093|NCT03266588|581185800|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
160944094|NCT03266588|581185801|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
160944095|NCT03266588|581185802|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
160944096|NCT03266588|581185800|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
160944097|NCT03266588|581185801|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
160579811|NCT00523341|579844054|FG000|Overall Study|Disease Progression|1|||
160656127|NCT00366899|580122353|FG000|Infant Series|Lost to Follow-up|0|||
160944098|NCT03266588|581185802|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
160944099|NCT03266588|581185800|FG000|Long-term Treatment Period|Other Reasons|5|||
160944100|NCT03266588|581185801|FG001|Long-term Treatment Period|Other Reasons|0|||
160944101|NCT03266588|581185802|FG002|Long-term Treatment Period|Other Reasons|0|||
160944102|NCT03266588|581185800|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
160944103|NCT03266588|581185801|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
160944104|NCT03266588|581185802|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
160944105|NCT02627677|581185804|FG000|Overall Study|Adverse event (not progressive disease)|1|||
160944106|NCT02627677|581185805|FG001|Overall Study|Adverse event (not progressive disease)|4|||
160944107|NCT02627677|581185806|FG002|Overall Study|Adverse event (not progressive disease)|1|||
160944108|NCT02627677|581185804|FG000|Overall Study|Progressive disease|1|||
160944109|NCT02627677|581185805|FG001|Overall Study|Progressive disease|3|||
160944110|NCT02627677|581185806|FG002|Overall Study|Progressive disease|0|||
160944111|NCT02627677|581185804|FG000|Overall Study|Lack of Efficacy|1|||
160944112|NCT02627677|581185805|FG001|Overall Study|Lack of Efficacy|2|||
160944113|NCT02627677|581185806|FG002|Overall Study|Lack of Efficacy|0|||
160944114|NCT02627677|581185804|FG000|Overall Study|Lost to Follow-up|0|||
160944115|NCT02627677|581185805|FG001|Overall Study|Lost to Follow-up|0|||
160944116|NCT02627677|581185806|FG002|Overall Study|Lost to Follow-up|1|||
160944117|NCT02627677|581185804|FG000|Overall Study|Pregnancy|0|||
160944118|NCT02627677|581185805|FG001|Overall Study|Pregnancy|1|||
160944119|NCT02627677|581185806|FG002|Overall Study|Pregnancy|0|||
160944120|NCT02627677|581185804|FG000|Overall Study|Study Terminated by Sponsor|5|||
160944121|NCT02627677|581185805|FG001|Overall Study|Study Terminated by Sponsor|10|||
160944122|NCT02627677|581185806|FG002|Overall Study|Study Terminated by Sponsor|6|||
160944123|NCT02627677|581185804|FG000|Overall Study|Physician Decision|0|||
160944124|NCT02627677|581185805|FG001|Overall Study|Physician Decision|0|||
160944125|NCT02627677|581185806|FG002|Overall Study|Physician Decision|2|||
160944126|NCT02627677|581185804|FG000|Overall Study|Withdrawal by Subject|2|||
160944127|NCT02627677|581185805|FG001|Overall Study|Withdrawal by Subject|1|||
160944128|NCT02627677|581185806|FG002|Overall Study|Withdrawal by Subject|1|||
160944129|NCT02627677|581185804|FG000|Overall Study|Reason not Specified|0|||
160944130|NCT02627677|581185805|FG001|Overall Study|Reason not Specified|0|||
160944131|NCT02627677|581185806|FG002|Overall Study|Reason not Specified|1|||
160944132|NCT02627677|581185804|FG000|Overall Study|Randomized but not Treated|1|||
160944133|NCT02627677|581185805|FG001|Overall Study|Randomized but not Treated|0|||
160944134|NCT02627677|581185806|FG002|Overall Study|Randomized but not Treated|0|||
160944135|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Adverse Event|5|||
160944136|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Adverse Event|8|||
160944137|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Adverse Event|4|||
160944138|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Adverse Event|8|||
160944139|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
160944140|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
160944141|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
160944142|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
160944143|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
160944144|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
160944145|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
160944146|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
160944147|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Physician Decision|1|||
160944148|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Physician Decision|0|||
160944149|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Physician Decision|0|||
160944150|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Physician Decision|0|||
160944151|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
160944152|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
160944153|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
160944154|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
160944155|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Pregnancy|0|||
160944156|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Pregnancy|1|||
160944157|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Pregnancy|0|||
160944158|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Pregnancy|0|||
160944159|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
160944160|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
160944161|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
160944162|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
160944163|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Death|0|||
160999300|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160944164|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Death|1|||
160944165|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Death|0|||
160944166|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Death|0|||
160944167|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
160944168|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
160944169|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
160944170|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
160944171|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
160944172|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
160579812|NCT00523341|579844055|FG001|Overall Study|Disease Progression|0|||
160579813|NCT02433210|579844056|FG000|Overall Study|Physician Decision|1|||
160944173|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
160944174|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
160944175|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160944176|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160944177|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160944178|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
160944179|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160944180|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160944181|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160944182|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
160944183|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
160944184|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
160944185|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
160944186|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
160944187|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160944188|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160944189|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160944190|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
160944191|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
160944192|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
160944193|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
160944194|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
160944195|NCT01073618|581185820|FG000|Overall Study|Death|208|||
160944196|NCT01073618|581185820|FG000|Overall Study|Adverse Event|19|||
160944197|NCT01073618|581185820|FG000|Overall Study|Other|80|||
160944198|NCT02044510|581185823|FG000|Overall Study|Adverse Event|1|||
160944199|NCT02044510|581185824|FG001|Overall Study|Adverse Event|2|||
160944200|NCT00975975|581185831|FG000|Overall Study|Death|6|||
160944201|NCT02496884|581185836|FG000|Overall Study|Counted twice as enrolled|2|||
160944202|NCT02496884|581185837|FG001|Overall Study|Counted twice as enrolled|0|||
160944203|NCT02496884|581185838|FG002|Overall Study|Counted twice as enrolled|0|||
160944204|NCT02496884|581185839|FG003|Overall Study|Counted twice as enrolled|0|||
160944205|NCT02496884|581185836|FG000|Overall Study|Withdrawal by Subject|0|||
160944206|NCT02496884|581185837|FG001|Overall Study|Withdrawal by Subject|3|||
160944207|NCT02496884|581185838|FG002|Overall Study|Withdrawal by Subject|0|||
160944208|NCT02496884|581185839|FG003|Overall Study|Withdrawal by Subject|0|||
160944209|NCT00807092|581185842|FG000|Overall Study|Adverse Event|0|||
160944210|NCT00807092|581185843|FG001|Overall Study|Adverse Event|1|||
160944211|NCT00807092|581185842|FG000|Overall Study|Protocol Violation|0|||
160944212|NCT00807092|581185843|FG001|Overall Study|Protocol Violation|2|||
160944213|NCT00807092|581185842|FG000|Overall Study|Withdrawal by Subject|1|||
160944214|NCT00807092|581185843|FG001|Overall Study|Withdrawal by Subject|0|||
160944215|NCT00807092|581185842|FG000|Overall Study|CGMS data collection failed|0|||
160944216|NCT00807092|581185843|FG001|Overall Study|CGMS data collection failed|1|||
160944217|NCT03224468|581185852|FG000|Overall Study|Did not obtain MM card|53|||
160944218|NCT03224468|581185853|FG001|Overall Study|Did not obtain MM card|0|||
160944219|NCT03224468|581185852|FG000|Overall Study|Lost to Follow-up|4|||
160944220|NCT03224468|581185853|FG001|Overall Study|Lost to Follow-up|11|||
160944221|NCT03224468|581185852|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
160944222|NCT03224468|581185853|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
160944223|NCT04713748|581185854|FG000|Overall Study|Not enough kits allocated|35|||
160944224|NCT04067141|581185855|FG000|First Intervention|Withdrawal by Subject|0|||
160944225|NCT04067141|581185856|FG001|First Intervention|Withdrawal by Subject|1|||
160944226|NCT04067141|581185855|FG000|Second Intervention|Adverse Event|0|||
160944227|NCT04067141|581185856|FG001|Second Intervention|Adverse Event|2|||
160944228|NCT01557946|581185857|FG000|Overall Study|Adverse Event|3|||
160944229|NCT01557946|581185858|FG001|Overall Study|Adverse Event|0|||
160944230|NCT05402995|581185861|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
160944231|NCT05402995|581185862|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
160944232|NCT05402995|581185863|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
160944233|NCT05402995|581185864|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
160944234|NCT00958880|581185876|FG000|Overall Study|Lost to Follow-up|2|||
160944235|NCT00958880|581185877|FG001|Overall Study|Lost to Follow-up|2|||
160944236|NCT01971346|581185878|FG000|Overall Study|Protocol Violation|3|||
160944237|NCT01971346|581185878|FG000|Overall Study|Lost to Follow-up|2|||
160944238|NCT01971346|581185878|FG000|Overall Study|Withdrawal by Subject|2|||
160944239|NCT01971346|581185878|FG000|Overall Study|Physician Decision|1|||
160944240|NCT04187196|581185879|FG000|Overall Study|Screen Failure|2|||
160944241|NCT04187196|581185880|FG001|Overall Study|Screen Failure|0|||
160944242|NCT01687166|581185881|FG000|Overall Study|Attempt subject|2|||
160944243|NCT01687166|581185882|FG001|Overall Study|Attempt subject|3|||
160944244|NCT01687166|581185883|FG002|Overall Study|Attempt subject|2|||
160944245|NCT01687166|581185884|FG003|Overall Study|Attempt subject|0|||
160944246|NCT01687166|581185881|FG000|Overall Study|Did not meet eligibility criteria|4|||
160944247|NCT01687166|581185882|FG001|Overall Study|Did not meet eligibility criteria|6|||
160944248|NCT01687166|581185883|FG002|Overall Study|Did not meet eligibility criteria|1|||
160944249|NCT01687166|581185884|FG003|Overall Study|Did not meet eligibility criteria|1|||
160944250|NCT01687166|581185881|FG000|Overall Study|Adverse Event|2|||
160944251|NCT01687166|581185882|FG001|Overall Study|Adverse Event|1|||
160944252|NCT01687166|581185883|FG002|Overall Study|Adverse Event|0|||
160944253|NCT01687166|581185884|FG003|Overall Study|Adverse Event|0|||
160944254|NCT01687166|581185881|FG000|Overall Study|Physician Decision|3|||
160944255|NCT01687166|581185882|FG001|Overall Study|Physician Decision|2|||
160944256|NCT01687166|581185883|FG002|Overall Study|Physician Decision|1|||
160944257|NCT01687166|581185884|FG003|Overall Study|Physician Decision|0|||
160944258|NCT01687166|581185881|FG000|Overall Study|Withdrawal by Subject|11|||
160944259|NCT01687166|581185882|FG001|Overall Study|Withdrawal by Subject|4|||
160944260|NCT01687166|581185883|FG002|Overall Study|Withdrawal by Subject|3|||
160944261|NCT01687166|581185884|FG003|Overall Study|Withdrawal by Subject|0|||
160944262|NCT01687166|581185881|FG000|Overall Study|Lost to Follow-up|2|||
160944263|NCT01687166|581185882|FG001|Overall Study|Lost to Follow-up|5|||
160944264|NCT01687166|581185883|FG002|Overall Study|Lost to Follow-up|1|||
160944265|NCT01687166|581185884|FG003|Overall Study|Lost to Follow-up|0|||
160944266|NCT01687166|581185881|FG000|Overall Study|Equipment/Device Availability|0|||
160944267|NCT01687166|581185882|FG001|Overall Study|Equipment/Device Availability|1|||
160944268|NCT01687166|581185883|FG002|Overall Study|Equipment/Device Availability|0|||
160944269|NCT01687166|581185884|FG003|Overall Study|Equipment/Device Availability|0|||
160944270|NCT01687166|581185881|FG000|Overall Study|Death|1|||
160944271|NCT01687166|581185882|FG001|Overall Study|Death|1|||
160944272|NCT01687166|581185883|FG002|Overall Study|Death|0|||
160944273|NCT01687166|581185884|FG003|Overall Study|Death|0|||
160944274|NCT01687166|581185881|FG000|Overall Study|Protocol Violation|1|||
160944275|NCT01687166|581185882|FG001|Overall Study|Protocol Violation|1|||
160944276|NCT01687166|581185883|FG002|Overall Study|Protocol Violation|1|||
160944277|NCT01687166|581185884|FG003|Overall Study|Protocol Violation|0|||
160944278|NCT01687166|581185881|FG000|Overall Study|Subject moved out of state|0|||
160944279|NCT01687166|581185882|FG001|Overall Study|Subject moved out of state|1|||
160944280|NCT01687166|581185883|FG002|Overall Study|Subject moved out of state|0|||
160944281|NCT01687166|581185884|FG003|Overall Study|Subject moved out of state|0|||
160944282|NCT01687166|581185881|FG000|Overall Study|Patient unable to be compliant|1|||
160944283|NCT01687166|581185882|FG001|Overall Study|Patient unable to be compliant|0|||
160944284|NCT01687166|581185883|FG002|Overall Study|Patient unable to be compliant|0|||
160944285|NCT01687166|581185884|FG003|Overall Study|Patient unable to be compliant|0|||
160944286|NCT01687166|581185881|FG000|Overall Study|Physician choice to use different device|1|||
160944287|NCT01687166|581185882|FG001|Overall Study|Physician choice to use different device|2|||
160944288|NCT01687166|581185883|FG002|Overall Study|Physician choice to use different device|4|||
160944289|NCT01687166|581185884|FG003|Overall Study|Physician choice to use different device|0|||
160944290|NCT01687166|581185881|FG000|Overall Study|Insurance|0|||
160944291|NCT01687166|581185882|FG001|Overall Study|Insurance|0|||
160944292|NCT01687166|581185883|FG002|Overall Study|Insurance|1|||
160944293|NCT01687166|581185884|FG003|Overall Study|Insurance|1|||
160944294|NCT02755831|581185885|FG000|Overall Study|Lost to Follow-up|3|||
160944295|NCT02755831|581185886|FG001|Overall Study|Lost to Follow-up|3|||
160944296|NCT02316717|581185887|FG000|Overall Study|Adverse Event|2|||
160944297|NCT02316717|581185888|FG001|Overall Study|Adverse Event|2|||
160944298|NCT02316717|581185889|FG002|Overall Study|Adverse Event|0|||
160944299|NCT02316717|581185887|FG000|Overall Study|Lost to Follow-up|1|||
160944300|NCT02316717|581185888|FG001|Overall Study|Lost to Follow-up|2|||
160944301|NCT02316717|581185889|FG002|Overall Study|Lost to Follow-up|1|||
160944302|NCT02316717|581185887|FG000|Overall Study|Non compliance|3|||
160944303|NCT02316717|581185888|FG001|Overall Study|Non compliance|1|||
160944304|NCT02316717|581185889|FG002|Overall Study|Non compliance|0|||
160944305|NCT02316717|581185887|FG000|Overall Study|Protocol Violation|2|||
160944306|NCT02316717|581185888|FG001|Overall Study|Protocol Violation|0|||
160944307|NCT02316717|581185889|FG002|Overall Study|Protocol Violation|0|||
160944308|NCT02316717|581185887|FG000|Overall Study|Withdrawal by Subject|2|||
160944309|NCT02316717|581185888|FG001|Overall Study|Withdrawal by Subject|1|||
160944310|NCT02316717|581185889|FG002|Overall Study|Withdrawal by Subject|1|||
160944311|NCT02316717|581185887|FG000|Overall Study|Death|0|||
160944312|NCT02316717|581185888|FG001|Overall Study|Death|0|||
160944313|NCT02316717|581185889|FG002|Overall Study|Death|1|||
160944314|NCT02316717|581185887|FG000|Overall Study|Physician Decision|0|||
160944315|NCT02316717|581185888|FG001|Overall Study|Physician Decision|1|||
160944316|NCT02316717|581185889|FG002|Overall Study|Physician Decision|0|||
160944317|NCT02316717|581185887|FG000|Overall Study|TBC|1|||
160944318|NCT02316717|581185888|FG001|Overall Study|TBC|0|||
160944319|NCT02316717|581185889|FG002|Overall Study|TBC|0|||
160944320|NCT02296112|581185890|FG000|Overall Study|Disease progression|7|||
160944321|NCT02296112|581185890|FG000|Overall Study|Toxicity|1|||
160944322|NCT02296112|581185890|FG000|Overall Study|Began an alternate therapy|1|||
160944323|NCT00298831|581185891|FG000|Overall Study|Adverse Event|1|||
160944324|NCT00298831|581185891|FG000|Overall Study|Lost to Follow-up|3|||
160944325|NCT00298831|581185891|FG000|Overall Study|Withdrawal by Subject|1|||
160944326|NCT00298831|581185891|FG000|Overall Study|Participants did not receive treatment|27|||
160944327|NCT01516879|581185892|FG000|Overall Study|Withdrawal by Subject|9|||
160944328|NCT01516879|581185893|FG001|Overall Study|Withdrawal by Subject|11|||
160944329|NCT01516879|581185892|FG000|Overall Study|Death|0|||
160944330|NCT01516879|581185893|FG001|Overall Study|Death|2|||
160944331|NCT01516879|581185892|FG000|Overall Study|Lost to Follow-up|2|||
160944332|NCT01516879|581185893|FG001|Overall Study|Lost to Follow-up|11|||
160944333|NCT01516879|581185892|FG000|Overall Study|Other|5|||
160944334|NCT01516879|581185893|FG001|Overall Study|Other|10|||
160944335|NCT04568122|581185894|FG000|Overall Study|Lost to Follow-up|48|||
160944336|NCT04568122|581185895|FG001|Overall Study|Lost to Follow-up|44|||
160944337|NCT04568122|581185896|FG002|Overall Study|Lost to Follow-up|4|||
160944338|NCT04568122|581185897|FG003|Overall Study|Lost to Follow-up|0|||
160944339|NCT04568122|581185898|FG004|Overall Study|Lost to Follow-up|0|||
160944340|NCT01916304|581185904|FG000|Overall Study|Screening failure|17|||
160944341|NCT04666441|581185905|FG000|Overall Study|Lost to Follow-up|1|||
160944342|NCT04666441|581185906|FG001|Overall Study|Lost to Follow-up|4|||
160579814|NCT02433210|579844057|FG001|Overall Study|Physician Decision|0|||
160579815|NCT02433210|579844058|FG002|Overall Study|Physician Decision|0|||
160944343|NCT04666441|581185907|FG002|Overall Study|Lost to Follow-up|1|||
160944344|NCT04666441|581185908|FG003|Overall Study|Lost to Follow-up|3|||
160944345|NCT04666441|581185909|FG004|Overall Study|Lost to Follow-up|0|||
160944346|NCT04666441|581185910|FG005|Overall Study|Lost to Follow-up|2|||
160944347|NCT04666441|581185911|FG006|Overall Study|Lost to Follow-up|2|||
160944348|NCT04666441|581185912|FG007|Overall Study|Lost to Follow-up|2|||
160944349|NCT04666441|581185905|FG000|Overall Study|Subject Decision|1|||
160944350|NCT04666441|581185906|FG001|Overall Study|Subject Decision|1|||
160944351|NCT04666441|581185907|FG002|Overall Study|Subject Decision|3|||
160944352|NCT04666441|581185908|FG003|Overall Study|Subject Decision|1|||
160944353|NCT04666441|581185909|FG004|Overall Study|Subject Decision|0|||
160944354|NCT04666441|581185910|FG005|Overall Study|Subject Decision|1|||
160999301|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999302|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999303|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999304|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999305|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160999306|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
160999307|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
160999308|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160999309|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160999310|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160999311|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160999312|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
160999313|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
160999314|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999315|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999316|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999317|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999318|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999319|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999320|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999321|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999322|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
160999323|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999324|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
160999325|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999326|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999327|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999328|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999329|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160579816|NCT01605071|579844059|FG000|Overall Study|Withdrawal by Subject|3|||
160579817|NCT01605071|579844060|FG001|Overall Study|Withdrawal by Subject|2|||
160944355|NCT04666441|581185911|FG006|Overall Study|Subject Decision|3|||
160944356|NCT04666441|581185912|FG007|Overall Study|Subject Decision|2|||
160944357|NCT00766415|581185921|FG000|Overall Study|Withdrawal by Subject|0|||
160944358|NCT00766415|581185922|FG001|Overall Study|Withdrawal by Subject|1|||
160944359|NCT01114516|581185929|FG000|Overall Study|Lost to Follow-up|2|||
160944360|NCT01114516|581185930|FG001|Overall Study|Lost to Follow-up|1|||
160579818|NCT02163993|579844063|FG000|Treatment Period|Adverse Event|0|||
160579819|NCT02163993|579844064|FG001|Treatment Period|Adverse Event|1|||
160944361|NCT01431508|581185933|FG000|Overall Study|Lack of Efficacy|1|||
160944362|NCT01431508|581185933|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
160944363|NCT00132769|581185934|FG000|Overall Study|Withdrawal by Subject|1|||
160944364|NCT00132769|581185935|FG001|Overall Study|Withdrawal by Subject|3|||
160944365|NCT00132769|581185934|FG000|Overall Study|Lack of Efficacy|7|||
160944366|NCT00132769|581185935|FG001|Overall Study|Lack of Efficacy|6|||
160944367|NCT00132769|581185934|FG000|Overall Study|Adverse Event|2|||
160944368|NCT00132769|581185935|FG001|Overall Study|Adverse Event|1|||
160944369|NCT00132769|581185934|FG000|Overall Study|Protocol Violation|1|||
160944370|NCT00132769|581185935|FG001|Overall Study|Protocol Violation|1|||
160944371|NCT00129259|581185936|FG000|Overall Study|Lost to Follow-up|1|||
160944372|NCT00129259|581185937|FG001|Overall Study|Lost to Follow-up|1|||
160944373|NCT00129259|581185936|FG000|Overall Study|Withdrawal by Subject|2|||
160944374|NCT00129259|581185937|FG001|Overall Study|Withdrawal by Subject|1|||
160944375|NCT00129259|581185936|FG000|Overall Study|Only available minimal phone assessments|0|||
160944376|NCT00129259|581185937|FG001|Overall Study|Only available minimal phone assessments|1|||
160944377|NCT02758236|581185939|FG000|Overall Study|Investigator discretion|43|||
160944378|NCT01632579|581185942|FG000|Washout Period|Adverse Event|1|||
160944379|NCT01632579|581185943|FG001|Washout Period|Adverse Event|0|||
160455894|NCT05868382|579399801|FG004|Overall Study|Lost to Follow-up|2|||
160455895|NCT05868382|579399802|FG005|Overall Study|Lost to Follow-up|6|||
160944380|NCT01632579|581185944|FG002|Washout Period|Adverse Event|0|||
160944381|NCT01632579|581185945|FG003|Washout Period|Adverse Event|0|||
160944382|NCT01632579|581185946|FG004|Washout Period|Adverse Event|0|||
160944383|NCT01632579|581185947|FG005|Washout Period|Adverse Event|0|||
160944384|NCT01632579|581185948|FG006|Washout Period|Adverse Event|0|||
160944385|NCT01632579|581185949|FG007|Washout Period|Adverse Event|0|||
160944386|NCT01632579|581185950|FG008|Washout Period|Adverse Event|0|||
160944387|NCT01632579|581185942|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
160944388|NCT01632579|581185943|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
160944389|NCT01632579|581185944|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
160944390|NCT01632579|581185945|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
160944391|NCT01632579|581185946|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
160944392|NCT01632579|581185947|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
160944393|NCT01632579|581185948|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
160944394|NCT01632579|581185949|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
160944395|NCT01632579|581185950|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
160944396|NCT02039505|581188020|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
160944397|NCT02039505|581188021|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
160944398|NCT02039505|581188022|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
160944399|NCT02039505|581188023|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
160944400|NCT02039505|581188024|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
160944401|NCT02039505|581188025|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
160944402|NCT02039505|581188026|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
160944403|NCT02039505|581188020|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
160944404|NCT02039505|581188021|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
160944405|NCT02039505|581188022|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
160944406|NCT02039505|581188023|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
160944407|NCT02039505|581188024|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
160944408|NCT02039505|581188025|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
160944409|NCT02039505|581188026|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
160944410|NCT02039505|581188020|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
160944411|NCT02039505|581188021|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944412|NCT02039505|581188022|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944413|NCT02039505|581188023|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944414|NCT02039505|581188024|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944415|NCT02039505|581188025|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944416|NCT02039505|581188026|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944417|NCT02039505|581188020|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
160944418|NCT02039505|581188021|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
160944419|NCT02039505|581188022|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
160944420|NCT02039505|581188023|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
160944421|NCT02039505|581188024|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
160455896|NCT05868382|579399797|FG000|Overall Study|Withdrawal by Subject|1|||
160455897|NCT05868382|579399798|FG001|Overall Study|Withdrawal by Subject|0|||
160944422|NCT02039505|581188025|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
160944423|NCT02039505|581188026|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
160944424|NCT02039505|581188020|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
160944425|NCT02039505|581188021|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
160944426|NCT02039505|581188022|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
160944427|NCT02039505|581188023|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
160944428|NCT02039505|581188024|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
160944429|NCT02039505|581188025|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
160944430|NCT02039505|581188026|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
160944431|NCT02039505|581188020|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
160944432|NCT02039505|581188021|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
160944433|NCT02039505|581188022|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
160944434|NCT02039505|581188023|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
160944435|NCT02039505|581188024|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
160944436|NCT02039505|581188025|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
160944437|NCT02039505|581188026|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
160944438|NCT02039505|581188020|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944439|NCT02039505|581188021|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944440|NCT02039505|581188022|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944441|NCT02039505|581188023|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
160944442|NCT02039505|581188024|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944443|NCT02039505|581188025|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944444|NCT02039505|581188026|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944445|NCT02039505|581188020|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944446|NCT02039505|581188021|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944447|NCT02039505|581188022|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944448|NCT02039505|581188023|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944449|NCT02039505|581188024|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944450|NCT02039505|581188025|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944451|NCT02039505|581188026|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
160944452|NCT02039505|581188020|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944453|NCT02039505|581188021|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944454|NCT02039505|581188022|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944455|NCT02039505|581188023|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944456|NCT02039505|581188024|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944457|NCT02039505|581188025|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944458|NCT02039505|581188026|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
160944459|NCT02039505|581188020|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944460|NCT02039505|581188021|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944461|NCT02039505|581188022|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944462|NCT02039505|581188023|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944463|NCT02039505|581188024|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944464|NCT02039505|581188025|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944465|NCT02039505|581188026|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
160944466|NCT02039505|581188020|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944467|NCT02039505|581188021|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944468|NCT02039505|581188022|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944469|NCT02039505|581188023|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944470|NCT02039505|581188024|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944471|NCT02039505|581188025|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944472|NCT02039505|581188026|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
160944473|NCT00353704|581188033|FG000|Overall Study|Protocol Violation|3|||
160944474|NCT00353704|581188034|FG001|Overall Study|Protocol Violation|1|||
160944475|NCT01154166|581188035|FG000|Overall Study|Adverse Event|14|||
160944476|NCT01154166|581188036|FG001|Overall Study|Adverse Event|9|||
160944477|NCT01154166|581188035|FG000|Overall Study|Lost to Follow-up|1|||
160944478|NCT01154166|581188036|FG001|Overall Study|Lost to Follow-up|1|||
160944479|NCT01154166|581188035|FG000|Overall Study|Protocol Violation|4|||
160944480|NCT01154166|581188036|FG001|Overall Study|Protocol Violation|1|||
160944481|NCT01154166|581188035|FG000|Overall Study|Withdrawal by Subject|10|||
160944482|NCT01154166|581188036|FG001|Overall Study|Withdrawal by Subject|1|||
160944483|NCT01154166|581188035|FG000|Overall Study|Lack of Efficacy|3|||
160944484|NCT01154166|581188036|FG001|Overall Study|Lack of Efficacy|0|||
160944485|NCT01154166|581188035|FG000|Overall Study|Disease Progression|1|||
160944486|NCT01154166|581188036|FG001|Overall Study|Disease Progression|0|||
160944487|NCT01154166|581188035|FG000|Overall Study|Poor Compliance|1|||
160944488|NCT01154166|581188036|FG001|Overall Study|Poor Compliance|0|||
160944489|NCT01375049|581188037|FG000|Overall Study|Adverse Event|2|||
160944490|NCT01375049|581188037|FG000|Overall Study|Lost to Follow-up|1|||
160944491|NCT01375049|581188037|FG000|Overall Study|Withdrawal by Subject|2|||
160944492|NCT01375049|581188037|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
160579820|NCT02163993|579844065|FG002|Treatment Period|Adverse Event|0|||
160944493|NCT03614793|581188038|FG000|Overall Study|Lost to Follow-up|1|||
160944494|NCT03614793|581188039|FG001|Overall Study|Lost to Follow-up|2|||
160944495|NCT03614793|581188038|FG000|Overall Study|Lack of Efficacy|0|||
160944496|NCT03614793|581188039|FG001|Overall Study|Lack of Efficacy|5|||
160944497|NCT03614793|581188038|FG000|Overall Study|Withdrawal by Subject|0|||
160944498|NCT03614793|581188039|FG001|Overall Study|Withdrawal by Subject|1|||
160944499|NCT03614793|581188038|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
160944500|NCT03614793|581188039|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
160944501|NCT02082522|581188040|FG000|Overall Study|Sponsor termination|5|||
160944502|NCT02082522|581188041|FG001|Overall Study|Sponsor termination|3|||
160944503|NCT02082522|581188040|FG000|Overall Study|Withdrawal by Subject|2|||
160944504|NCT02082522|581188041|FG001|Overall Study|Withdrawal by Subject|4|||
160944505|NCT02082522|581188040|FG000|Overall Study|Death|1|||
160944506|NCT02082522|581188041|FG001|Overall Study|Death|0|||
160944507|NCT02082522|581188040|FG000|Overall Study|Lost to Follow-up|1|||
160944508|NCT02082522|581188041|FG001|Overall Study|Lost to Follow-up|0|||
160944509|NCT02082522|581188040|FG000|Overall Study|Physician Decision|3|||
160944510|NCT02082522|581188041|FG001|Overall Study|Physician Decision|1|||
160944511|NCT02082522|581188040|FG000|Overall Study|Disease progression|2|||
160944512|NCT02082522|581188041|FG001|Overall Study|Disease progression|2|||
160944513|NCT02082522|581188040|FG000|Overall Study|Chemotherapy change|1|||
160944514|NCT02082522|581188041|FG001|Overall Study|Chemotherapy change|3|||
160944515|NCT00633984|581188042|FG000|Overall Study|Lost to Follow-up|0|||
160944516|NCT00633984|581188043|FG001|Overall Study|Lost to Follow-up|6|||
160944517|NCT00633984|581188042|FG000|Overall Study|Withdrawal by Subject|8|||
160944518|NCT00633984|581188043|FG001|Overall Study|Withdrawal by Subject|7|||
160944519|NCT00633984|581188042|FG000|Overall Study|Hospitalized|1|||
160944520|NCT00633984|581188043|FG001|Overall Study|Hospitalized|0|||
160944521|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
160944522|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
160944523|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
160944524|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Death|1|||
160944525|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
160944526|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
160944527|NCT02840877|581188044|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
160944528|NCT02840877|581188044|FG000|12 Weeks to 6 Months|Treatment failure|1|||
160944529|NCT02840877|581188044|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
160944530|NCT02840877|581188044|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
160944531|NCT02840877|581188044|FG000|12 Weeks to 6 Months|Death|1|||
160944532|NCT02840877|581188044|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
160944533|NCT02840877|581188044|FG000|6 Months to 18 Months|Treatment failure|7|||
160944534|NCT02840877|581188044|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
160944535|NCT02840877|581188044|FG000|6 Months to 18 Months|Moved/transferred out|6|||
160944536|NCT02840877|581188044|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
160944537|NCT02840877|581188044|FG000|6 Months to 18 Months|Death|4|||
160944538|NCT02840877|581188044|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
160944539|NCT02840877|581188044|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
160944540|NCT02840877|581188044|FG000|6 Months to 18 Months|Still in study.|14|||
160944541|NCT01168999|581188045|FG000|Overall Study|Lost to Follow-up|2|||
160944542|NCT01168999|581188046|FG001|Overall Study|Lost to Follow-up|1|||
160944543|NCT01168999|581188047|FG002|Overall Study|Lost to Follow-up|0|||
160944544|NCT01168999|581188048|FG003|Overall Study|Lost to Follow-up|0|||
160944545|NCT04317586|581188049|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
160944546|NCT04317586|581188049|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
160944547|NCT01276327|581188050|FG000|Overall Study|Adverse Event|1|||
160944548|NCT01276327|581188051|FG001|Overall Study|Adverse Event|3|||
160944549|NCT01276327|581188050|FG000|Overall Study|Withdrawal by Subject|1|||
160944550|NCT01276327|581188051|FG001|Overall Study|Withdrawal by Subject|0|||
160944551|NCT01794949|581188052|FG000|Overall Study|Lost to Follow-up|1|||
160944552|NCT01794949|581188053|FG001|Overall Study|Lost to Follow-up|0|||
160944553|NCT03003676|581188054|FG000|Overall Study|Lack of Efficacy|5|||
160944554|NCT03003676|581188055|FG001|Overall Study|Lack of Efficacy|7|||
160944555|NCT03003676|581188054|FG000|Overall Study|Withdrawal by Subject|0|||
160944556|NCT03003676|581188055|FG001|Overall Study|Withdrawal by Subject|1|||
160944557|NCT03003676|581188054|FG000|Overall Study|Hepatitis B infection|1|||
160944558|NCT03003676|581188055|FG001|Overall Study|Hepatitis B infection|0|||
160944559|NCT03766646|581188057|FG000|Overall Study|Withdrawal by Subject|1|||
160944560|NCT03766646|581188058|FG001|Overall Study|Withdrawal by Subject|0|||
160944561|NCT03766646|581188057|FG000|Overall Study|Protocol Violation|0|||
160944562|NCT03766646|581188058|FG001|Overall Study|Protocol Violation|3|||
160944563|NCT02530619|581188068|FG000|Registered for Study|Withdrawal by Subject|2|||
160944564|NCT02530619|581188068|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
160944565|NCT02530619|581188068|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
160944566|NCT02530619|581188068|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
160999330|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160944567|NCT02530619|581188068|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
160944568|NCT02530619|581188068|FG000|Follow-up Period (6 Months)|Death|4|||
160944569|NCT02530619|581188068|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
160944570|NCT02530619|581188068|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
160944571|NCT01854554|581188081|FG000|Overall Study|Denial of Insurance Coverage|12|||
160944572|NCT01854554|581188082|FG001|Overall Study|Denial of Insurance Coverage|0|||
160944573|NCT01854554|581188081|FG000|Overall Study|Decided to get treatment locally|1|||
160944574|NCT01854554|581188082|FG001|Overall Study|Decided to get treatment locally|5|||
160944575|NCT01854554|581188081|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
160944576|NCT01854554|581188082|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
160944577|NCT01854554|581188081|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
160944578|NCT01854554|581188082|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
160944579|NCT01854554|581188081|FG000|Overall Study|Progression|0|||
160944580|NCT01854554|581188082|FG001|Overall Study|Progression|1|||
160944581|NCT01854554|581188081|FG000|Overall Study|Lost to Follow-up|0|||
160944582|NCT01854554|581188082|FG001|Overall Study|Lost to Follow-up|1|||
160944583|NCT02819726|581188085|FG000|Part A (All Participants)|Lost to Follow-up|0|||
160944584|NCT02819726|581188086|FG001|Part A (All Participants)|Lost to Follow-up|1|||
160944585|NCT02819726|581188087|FG002|Part A (All Participants)|Lost to Follow-up|0|||
160944586|NCT02819726|581188088|FG003|Part A (All Participants)|Lost to Follow-up|0|||
160944587|NCT02819726|581188085|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
160944588|NCT02819726|581188086|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
160944589|NCT02819726|581188087|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
160944590|NCT02819726|581188088|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
160944591|NCT02819726|581188085|FG000|Part A (All Participants)|Protocol non-compliance|3|||
160944592|NCT02819726|581188086|FG001|Part A (All Participants)|Protocol non-compliance|4|||
160944593|NCT02819726|581188087|FG002|Part A (All Participants)|Protocol non-compliance|5|||
160944594|NCT02819726|581188088|FG003|Part A (All Participants)|Protocol non-compliance|0|||
160944595|NCT02819726|581188085|FG000|Part B (All Participants)|Lost to Follow-up|1|||
160944596|NCT02819726|581188086|FG001|Part B (All Participants)|Lost to Follow-up|1|||
160944597|NCT02819726|581188087|FG002|Part B (All Participants)|Lost to Follow-up|2|||
160944598|NCT02819726|581188088|FG003|Part B (All Participants)|Lost to Follow-up|2|||
160944599|NCT02819726|581188085|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
160944600|NCT02819726|581188086|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
160944601|NCT02819726|581188087|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
160944602|NCT02819726|581188088|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
160944603|NCT02819726|581188085|FG000|Part B (All Participants)|Protocol non-compliance|0|||
160944604|NCT02819726|581188086|FG001|Part B (All Participants)|Protocol non-compliance|0|||
160944605|NCT02819726|581188087|FG002|Part B (All Participants)|Protocol non-compliance|1|||
160944606|NCT02819726|581188088|FG003|Part B (All Participants)|Protocol non-compliance|0|||
160944607|NCT00359762|581188089|FG000|Period II|Adverse Event|17|||
160944608|NCT00359762|581188090|FG001|Period II|Adverse Event|0|||
160944609|NCT00359762|581188091|FG002|Period II|Adverse Event|0|||
160944610|NCT00359762|581188092|FG003|Period II|Adverse Event|0|||
160944611|NCT00359762|581188093|FG004|Period II|Adverse Event|49|||
160944612|NCT00359762|581188089|FG000|Period II|Protocol Violation|18|||
160944613|NCT00359762|581188090|FG001|Period II|Protocol Violation|0|||
160944614|NCT00359762|581188091|FG002|Period II|Protocol Violation|0|||
160944615|NCT00359762|581188092|FG003|Period II|Protocol Violation|0|||
160944616|NCT00359762|581188093|FG004|Period II|Protocol Violation|11|||
160944617|NCT00359762|581188089|FG000|Period II|Physician Decision|17|||
160944618|NCT00359762|581188090|FG001|Period II|Physician Decision|0|||
160944619|NCT00359762|581188091|FG002|Period II|Physician Decision|0|||
160944620|NCT00359762|581188092|FG003|Period II|Physician Decision|0|||
160944621|NCT00359762|581188093|FG004|Period II|Physician Decision|23|||
160944622|NCT00359762|581188089|FG000|Period II|Death|2|||
160944623|NCT00359762|581188090|FG001|Period II|Death|0|||
160944624|NCT00359762|581188091|FG002|Period II|Death|0|||
160944625|NCT00359762|581188092|FG003|Period II|Death|0|||
160944626|NCT00359762|581188093|FG004|Period II|Death|4|||
160944627|NCT00359762|581188089|FG000|Period II|Lack of Efficacy|11|||
160944628|NCT00359762|581188090|FG001|Period II|Lack of Efficacy|0|||
160944629|NCT00359762|581188091|FG002|Period II|Lack of Efficacy|0|||
160944630|NCT00359762|581188092|FG003|Period II|Lack of Efficacy|0|||
160944631|NCT00359762|581188093|FG004|Period II|Lack of Efficacy|8|||
160944632|NCT00359762|581188089|FG000|Period II|Lost to follow up|5|||
160944633|NCT00359762|581188090|FG001|Period II|Lost to follow up|0|||
160944634|NCT00359762|581188091|FG002|Period II|Lost to follow up|0|||
160944635|NCT00359762|581188092|FG003|Period II|Lost to follow up|0|||
160656128|NCT00366899|580122354|FG001|Infant Series|Lost to Follow-up|2|||
160944636|NCT00359762|581188093|FG004|Period II|Lost to follow up|5|||
160944637|NCT00359762|581188089|FG000|Period II|Entry Criteria Not Met|8|||
160944638|NCT00359762|581188090|FG001|Period II|Entry Criteria Not Met|0|||
160944639|NCT00359762|581188091|FG002|Period II|Entry Criteria Not Met|0|||
160944640|NCT00359762|581188092|FG003|Period II|Entry Criteria Not Met|0|||
160944641|NCT00359762|581188093|FG004|Period II|Entry Criteria Not Met|4|||
160944642|NCT00359762|581188089|FG000|Period II|Subject Decision|50|||
160944643|NCT00359762|581188090|FG001|Period II|Subject Decision|0|||
160944644|NCT00359762|581188091|FG002|Period II|Subject Decision|0|||
160944645|NCT00359762|581188092|FG003|Period II|Subject Decision|0|||
160944646|NCT00359762|581188093|FG004|Period II|Subject Decision|70|||
160944647|NCT00359762|581188089|FG000|Period III|Protocol Violation|0|||
160944648|NCT00359762|581188090|FG001|Period III|Protocol Violation|5|||
160944649|NCT00359762|581188091|FG002|Period III|Protocol Violation|3|||
160944650|NCT00359762|581188092|FG003|Period III|Protocol Violation|8|||
160944651|NCT00359762|581188093|FG004|Period III|Protocol Violation|0|||
160944652|NCT00359762|581188089|FG000|Period III|Adverse Event|0|||
160944653|NCT00359762|581188090|FG001|Period III|Adverse Event|3|||
160944654|NCT00359762|581188091|FG002|Period III|Adverse Event|4|||
160944655|NCT00359762|581188092|FG003|Period III|Adverse Event|10|||
160944656|NCT00359762|581188093|FG004|Period III|Adverse Event|0|||
160944657|NCT00359762|581188089|FG000|Period III|Physician Decision|0|||
160944658|NCT00359762|581188090|FG001|Period III|Physician Decision|5|||
160944659|NCT00359762|581188091|FG002|Period III|Physician Decision|9|||
160944660|NCT00359762|581188092|FG003|Period III|Physician Decision|15|||
160944661|NCT00359762|581188093|FG004|Period III|Physician Decision|0|||
160944662|NCT00359762|581188089|FG000|Period III|Lack of Efficacy|0|||
160944663|NCT00359762|581188090|FG001|Period III|Lack of Efficacy|7|||
160944664|NCT00359762|581188091|FG002|Period III|Lack of Efficacy|5|||
160944665|NCT00359762|581188092|FG003|Period III|Lack of Efficacy|9|||
160944666|NCT00359762|581188093|FG004|Period III|Lack of Efficacy|0|||
160944667|NCT00359762|581188089|FG000|Period III|Lost to follow up|0|||
160944668|NCT00359762|581188090|FG001|Period III|Lost to follow up|1|||
160944669|NCT00359762|581188091|FG002|Period III|Lost to follow up|1|||
160944670|NCT00359762|581188092|FG003|Period III|Lost to follow up|2|||
160944671|NCT00359762|581188093|FG004|Period III|Lost to follow up|0|||
160999331|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999332|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999333|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999334|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
160999335|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999336|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999337|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999338|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999339|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999340|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
160999341|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999342|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
160999343|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999344|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999345|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999346|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999347|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999348|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999349|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
160999350|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
160999351|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
160999352|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
160999353|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
160999354|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
160999355|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
160999356|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
160999357|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
160999358|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
160999359|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
160999360|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
160999361|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
160999362|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
160999363|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
160944672|NCT00359762|581188089|FG000|Period III|Entry Criteria Not Met|0|||
160944673|NCT00359762|581188090|FG001|Period III|Entry Criteria Not Met|1|||
160944674|NCT00359762|581188091|FG002|Period III|Entry Criteria Not Met|0|||
160944675|NCT00359762|581188092|FG003|Period III|Entry Criteria Not Met|1|||
160944676|NCT00359762|581188093|FG004|Period III|Entry Criteria Not Met|0|||
160944677|NCT00359762|581188089|FG000|Period III|Subject Decision|0|||
160944678|NCT00359762|581188090|FG001|Period III|Subject Decision|7|||
160944679|NCT00359762|581188091|FG002|Period III|Subject Decision|8|||
160944680|NCT00359762|581188092|FG003|Period III|Subject Decision|20|||
160999364|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
160999365|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
160944681|NCT00359762|581188093|FG004|Period III|Subject Decision|0|||
160944682|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
160944683|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
160944684|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
160944685|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944686|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944687|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944688|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944689|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944690|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944691|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
160944692|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
160944693|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
160944694|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160944695|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160944696|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160579821|NCT02163993|579844066|FG003|Treatment Period|Adverse Event|0|||
160944697|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160944698|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160944699|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160944700|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944701|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
160944702|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
160944703|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944704|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944705|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944706|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944707|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944708|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944709|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
160944710|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
160944711|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
160944712|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160944713|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160944714|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160944715|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160579822|NCT02163993|579844067|FG004|Treatment Period|Adverse Event|1|||
160579823|NCT02163993|579844063|FG000|Treatment Period|Lost to Follow-up|2|||
160579824|NCT02163993|579844064|FG001|Treatment Period|Lost to Follow-up|3|||
160579825|NCT02163993|579844065|FG002|Treatment Period|Lost to Follow-up|1|||
160579826|NCT02163993|579844066|FG003|Treatment Period|Lost to Follow-up|3|||
160944716|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160944717|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160944718|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944719|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
160944720|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944721|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944722|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944723|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944724|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944725|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944726|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944727|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
160944728|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944729|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944730|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944731|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944732|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944733|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944734|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944735|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944736|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944737|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
160944738|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
160944739|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944740|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944741|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944742|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944743|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944744|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944745|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
160944746|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
160944747|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
160944748|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
160944749|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
160944750|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
160944751|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
160944752|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
160944753|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
160944754|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
160944755|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
160944756|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
160944757|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
160944758|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
160944759|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
160944760|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
160944761|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
160944762|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
160944763|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944764|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944765|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
160944766|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944767|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944768|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944769|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944770|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944771|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944772|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
160944773|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
160944774|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
160999366|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
160999367|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
160999368|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160999369|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
160999370|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
160999371|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160999372|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160999373|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160999374|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160999375|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
160999376|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
160999377|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
160999378|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
160999379|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
160999380|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
160999381|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
160999382|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
160999383|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
160999384|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
160999385|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
160999386|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999387|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999388|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999389|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999390|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999391|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999392|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999393|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
160999394|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999395|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160999396|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
160999397|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
160656129|NCT00366899|580122353|FG000|Infant Series|Adverse Event|0|||
160944775|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
160579827|NCT02163993|579844067|FG004|Treatment Period|Lost to Follow-up|1|||
160579828|NCT02163993|579844063|FG000|Treatment Period|Physician Decision|1|||
160579829|NCT02163993|579844064|FG001|Treatment Period|Physician Decision|0|||
160579830|NCT02163993|579844065|FG002|Treatment Period|Physician Decision|0|||
160579831|NCT02163993|579844066|FG003|Treatment Period|Physician Decision|0|||
160579832|NCT02163993|579844067|FG004|Treatment Period|Physician Decision|0|||
160579833|NCT02163993|579844063|FG000|Treatment Period|Protocol Violation|2|||
160579834|NCT02163993|579844064|FG001|Treatment Period|Protocol Violation|1|||
160579835|NCT02163993|579844065|FG002|Treatment Period|Protocol Violation|0|||
160579836|NCT02163993|579844066|FG003|Treatment Period|Protocol Violation|1|||
160579837|NCT02163993|579844067|FG004|Treatment Period|Protocol Violation|2|||
160579838|NCT02163993|579844063|FG000|Treatment Period|Withdrawal by Subject|6|||
160579839|NCT02163993|579844064|FG001|Treatment Period|Withdrawal by Subject|4|||
160579840|NCT02163993|579844065|FG002|Treatment Period|Withdrawal by Subject|1|||
160579841|NCT02163993|579844066|FG003|Treatment Period|Withdrawal by Subject|4|||
160579842|NCT02163993|579844067|FG004|Treatment Period|Withdrawal by Subject|1|||
160579843|NCT02163993|579844063|FG000|Treatment Period|Not treated|1|||
160579844|NCT02163993|579844064|FG001|Treatment Period|Not treated|0|||
160579845|NCT02163993|579844065|FG002|Treatment Period|Not treated|0|||
160579846|NCT02163993|579844066|FG003|Treatment Period|Not treated|1|||
160579847|NCT02163993|579844067|FG004|Treatment Period|Not treated|2|||
160579848|NCT02163993|579844063|FG000|Post-treatment Period|Adverse Event|0|||
160579849|NCT02163993|579844064|FG001|Post-treatment Period|Adverse Event|0|||
160579850|NCT02163993|579844065|FG002|Post-treatment Period|Adverse Event|1|||
160579851|NCT02163993|579844066|FG003|Post-treatment Period|Adverse Event|0|||
160579852|NCT02163993|579844067|FG004|Post-treatment Period|Adverse Event|0|||
160579853|NCT02163993|579844063|FG000|Post-treatment Period|Lost to Follow-up|2|||
160579854|NCT02163993|579844064|FG001|Post-treatment Period|Lost to Follow-up|2|||
160579855|NCT02163993|579844065|FG002|Post-treatment Period|Lost to Follow-up|3|||
160579856|NCT02163993|579844066|FG003|Post-treatment Period|Lost to Follow-up|1|||
160579857|NCT02163993|579844067|FG004|Post-treatment Period|Lost to Follow-up|0|||
160579858|NCT02163993|579844063|FG000|Post-treatment Period|Protocol Violation|0|||
160579859|NCT02163993|579844064|FG001|Post-treatment Period|Protocol Violation|0|||
160579860|NCT02163993|579844065|FG002|Post-treatment Period|Protocol Violation|0|||
160579861|NCT02163993|579844066|FG003|Post-treatment Period|Protocol Violation|0|||
160579862|NCT02163993|579844067|FG004|Post-treatment Period|Protocol Violation|1|||
160579863|NCT02163993|579844063|FG000|Post-treatment Period|Withdrawal by Subject|2|||
160579864|NCT02163993|579844064|FG001|Post-treatment Period|Withdrawal by Subject|4|||
160579865|NCT02163993|579844065|FG002|Post-treatment Period|Withdrawal by Subject|0|||
160579866|NCT02163993|579844066|FG003|Post-treatment Period|Withdrawal by Subject|1|||
160579867|NCT02163993|579844067|FG004|Post-treatment Period|Withdrawal by Subject|2|||
160944776|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
160944777|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
160944778|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
160944779|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
160944780|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
160944781|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944782|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
160944783|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
160944784|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
160944785|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944786|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944787|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944788|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944789|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944790|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
160579868|NCT01808118|579844068|FG000|Period 1|Adverse Event|15|||
160944791|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
160944792|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
160944793|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
160944794|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
160944795|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
160579869|NCT01808118|579844069|FG001|Period 1|Adverse Event|0|||
160579870|NCT01808118|579844070|FG002|Period 1|Adverse Event|0|||
160579871|NCT01808118|579844068|FG000|Period 1|Withdrew consent|24|||
160579872|NCT01808118|579844069|FG001|Period 1|Withdrew consent|0|||
160579873|NCT01808118|579844070|FG002|Period 1|Withdrew consent|0|||
160579874|NCT01808118|579844068|FG000|Period 1|Lost to Follow-up|9|||
160579875|NCT01808118|579844069|FG001|Period 1|Lost to Follow-up|0|||
160579876|NCT01808118|579844070|FG002|Period 1|Lost to Follow-up|0|||
160579877|NCT01808118|579844068|FG000|Period 1|Did not meet criteria for remission|303|||
160579878|NCT01808118|579844069|FG001|Period 1|Did not meet criteria for remission|0|||
160579879|NCT01808118|579844070|FG002|Period 1|Did not meet criteria for remission|0|||
160944796|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
160944797|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
160579880|NCT01808118|579844068|FG000|Period 1|Enrolled in error|7|||
160579881|NCT01808118|579844069|FG001|Period 1|Enrolled in error|0|||
160579882|NCT01808118|579844070|FG002|Period 1|Enrolled in error|0|||
160944798|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
160944799|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
160944800|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
160944801|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
160944802|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
160944803|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
160944804|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
160944805|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
160944806|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
160944807|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
160944808|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944809|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
160944810|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
160944811|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944812|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944813|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944814|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944815|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
160944816|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944817|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944818|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944819|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
160944820|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944821|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160579883|NCT01808118|579844068|FG000|Period 1|Did not meet inclusion criteria|3|||
160579884|NCT01808118|579844069|FG001|Period 1|Did not meet inclusion criteria|0|||
160579885|NCT01808118|579844070|FG002|Period 1|Did not meet inclusion criteria|0|||
160579886|NCT01808118|579844068|FG000|Period 1|Non-conformance with inclusion criteria|3|||
160579887|NCT01808118|579844069|FG001|Period 1|Non-conformance with inclusion criteria|0|||
160944822|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944823|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944824|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944825|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944826|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
160944827|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
160944828|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
160944829|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
160944830|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
160944831|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
160944832|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
160944833|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
160944834|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
160944835|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944836|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944837|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
160944838|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944839|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160999398|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160579888|NCT01808118|579844070|FG002|Period 1|Non-conformance with inclusion criteria|0|||
160579889|NCT01808118|579844068|FG000|Period 1|Investigator decision: site closure|2|||
160579890|NCT01808118|579844069|FG001|Period 1|Investigator decision: site closure|0|||
160579891|NCT01808118|579844070|FG002|Period 1|Investigator decision: site closure|0|||
160579892|NCT01808118|579844068|FG000|Period 1|Non-compliance per sponsor|1|||
160944840|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944841|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944842|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944843|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944844|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160579893|NCT01808118|579844069|FG001|Period 1|Non-compliance per sponsor|0|||
160579894|NCT01808118|579844070|FG002|Period 1|Non-compliance per sponsor|0|||
160579895|NCT01808118|579844068|FG000|Period 1|Lack of Efficacy|1|||
160579896|NCT01808118|579844069|FG001|Period 1|Lack of Efficacy|0|||
160944845|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
160944846|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
160944847|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160944848|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160944849|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160944850|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160944851|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
160944852|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160944853|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944854|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
160944855|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944856|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944857|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944858|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944859|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944860|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944861|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
160944862|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944863|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
160944864|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944865|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944866|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944867|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944868|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944869|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944870|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944871|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944872|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944873|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944874|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944875|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944876|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944877|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944878|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944879|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
160944880|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
160944881|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
160944882|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
160944883|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
160944884|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
160944885|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
160944886|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
160944887|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
160944888|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
160944889|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
160944890|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
160944891|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
160944892|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
160944893|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
160944894|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
160944895|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
160944896|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
160944897|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
160944898|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944899|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944900|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944901|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
160455898|NCT05868382|579399799|FG002|Overall Study|Withdrawal by Subject|0|||
160455899|NCT05868382|579399800|FG003|Overall Study|Withdrawal by Subject|0|||
160455900|NCT05868382|579399801|FG004|Overall Study|Withdrawal by Subject|1|||
160455901|NCT05868382|579399802|FG005|Overall Study|Withdrawal by Subject|0|||
160455902|NCT03655028|579399805|FG000|12-weeks Follow up|Death|1|||
160944902|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
160455903|NCT03655028|579399806|FG001|12-weeks Follow up|Death|0|||
160455904|NCT03655028|579399805|FG000|12-weeks Follow up|Physician Decision|3|||
160455905|NCT03655028|579399806|FG001|12-weeks Follow up|Physician Decision|3|||
160455906|NCT03655028|579399805|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
160944903|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944904|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944905|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
160944906|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944907|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944908|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
160944909|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944910|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944911|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944912|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944913|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944914|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944915|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944916|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944917|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944918|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
160944919|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944920|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944921|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944922|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944923|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944924|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944925|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944926|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
160944927|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
160944928|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944929|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944930|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944931|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944932|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
160944933|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944934|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
160944935|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
160944936|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
160944937|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
160944938|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
160944939|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
160944940|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
160944941|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
160944942|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
160944943|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
160944944|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
160944945|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
160944946|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
160944947|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
160944948|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
160944949|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
160944950|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
160944951|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
160944952|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944953|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944954|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
160944955|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944956|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944957|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944958|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944959|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944960|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
160944961|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944962|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944963|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944964|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160999399|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160999400|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160455907|NCT03655028|579399806|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
160944965|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944966|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944967|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944968|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
160944969|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944970|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944971|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944972|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
160944973|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944974|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944975|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944976|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944977|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
160944978|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
160944979|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944980|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944981|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
160944982|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944983|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944984|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944985|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944986|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944987|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944988|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944989|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
160944990|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944991|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944992|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944993|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944994|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944995|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
160944996|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944997|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160944998|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
160944999|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
160945000|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160945001|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160945002|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160945003|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160945004|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
160945005|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160945006|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945007|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945008|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
160945009|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945010|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945011|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945012|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945013|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945014|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945015|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945016|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945017|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
160945018|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160579897|NCT01808118|579844070|FG002|Period 1|Lack of Efficacy|0|||
160579898|NCT01808118|579844068|FG000|Period 2|Adverse Event|0|||
160579899|NCT01808118|579844069|FG001|Period 2|Adverse Event|4|||
160579900|NCT01808118|579844070|FG002|Period 2|Adverse Event|0|||
160579901|NCT01808118|579844068|FG000|Period 2|Withdrew consent|0|||
160579902|NCT01808118|579844069|FG001|Period 2|Withdrew consent|7|||
160579903|NCT01808118|579844070|FG002|Period 2|Withdrew consent|6|||
160579904|NCT01808118|579844068|FG000|Period 2|Lost to Follow-up|0|||
160579905|NCT01808118|579844069|FG001|Period 2|Lost to Follow-up|0|||
160579906|NCT01808118|579844070|FG002|Period 2|Lost to Follow-up|2|||
160579907|NCT01808118|579844068|FG000|Period 2|Investigator no longer conducting trials|0|||
160579908|NCT01808118|579844069|FG001|Period 2|Investigator no longer conducting trials|1|||
160945019|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945020|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945021|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945022|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945023|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945024|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945025|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945026|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945027|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945028|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945029|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945030|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945031|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945032|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
160945033|NCT02613481|581188105|FG000|Overall Study|Lost to Follow-up|7|||
160945034|NCT02613481|581188105|FG000|Overall Study|Withdrawal by Subject|2|||
160945035|NCT01033747|581188106|FG000|Overall Study|Adverse Event|9|||
160945036|NCT01033747|581188107|FG001|Overall Study|Adverse Event|4|||
160945037|NCT01033747|581188106|FG000|Overall Study|Abnormal Laboratory Value|1|||
160945038|NCT01033747|581188107|FG001|Overall Study|Abnormal Laboratory Value|0|||
160945039|NCT01033747|581188106|FG000|Overall Study|Abnormal test procedure|0|||
160945040|NCT01033747|581188107|FG001|Overall Study|Abnormal test procedure|1|||
160945041|NCT01033747|581188106|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
160945042|NCT01033747|581188107|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
160945043|NCT01033747|581188106|FG000|Overall Study|Protocol Violation|1|||
160945044|NCT01033747|581188107|FG001|Overall Study|Protocol Violation|0|||
160945045|NCT01033747|581188106|FG000|Overall Study|Withdrawal by Subject|9|||
160945046|NCT01033747|581188107|FG001|Overall Study|Withdrawal by Subject|6|||
160945047|NCT01033747|581188106|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
160945048|NCT01033747|581188107|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
160945049|NCT01033747|581188106|FG000|Overall Study|Stopped at end of Extension 1|2|||
160455908|NCT03655028|579399805|FG000|12-weeks Follow up|Lost to Follow-up|4|||
160455909|NCT03655028|579399806|FG001|12-weeks Follow up|Lost to Follow-up|4|||
160455910|NCT03655028|579399805|FG000|24-weeks|Lost to Follow-up|1|||
160455911|NCT03655028|579399806|FG001|24-weeks|Lost to Follow-up|1|||
160455912|NCT03655028|579399805|FG000|24-weeks|Death|0|||
160455913|NCT03655028|579399806|FG001|24-weeks|Death|1|||
160455914|NCT03513302|579399807|FG000|First Intervention (14 Days)|Screen failure|15|||
160455915|NCT03513302|579399808|FG001|First Intervention (14 Days)|Screen failure|16|||
160455916|NCT05256654|579399809|FG000|Overall Study|Adverse Event|0|||
160455917|NCT05256654|579399810|FG001|Overall Study|Adverse Event|0|||
160455918|NCT05256654|579399811|FG002|Overall Study|Adverse Event|1|||
160455919|NCT05256654|579399812|FG003|Overall Study|Adverse Event|0|||
160455920|NCT05256654|579399809|FG000|Overall Study|Lost to Follow-up|0|||
160455921|NCT05256654|579399810|FG001|Overall Study|Lost to Follow-up|0|||
160455922|NCT05256654|579399811|FG002|Overall Study|Lost to Follow-up|0|||
160455923|NCT05256654|579399812|FG003|Overall Study|Lost to Follow-up|1|||
160455924|NCT05256654|579399809|FG000|Overall Study|Withdrawal by Subject|1|||
160455925|NCT05256654|579399810|FG001|Overall Study|Withdrawal by Subject|2|||
160455926|NCT05256654|579399811|FG002|Overall Study|Withdrawal by Subject|1|||
160455927|NCT05256654|579399812|FG003|Overall Study|Withdrawal by Subject|3|||
160945050|NCT01033747|581188107|FG001|Overall Study|Stopped at end of Extension 1|0|||
160945051|NCT02647658|581188112|FG000|Overall Study|Consent refusal|15|||
160945052|NCT02647658|581188113|FG001|Overall Study|Consent refusal|24|||
160945053|NCT00803023|581188114|FG000|Overall Study|Adverse Event|5|||
160945054|NCT00803023|581188115|FG001|Overall Study|Adverse Event|4|||
160945055|NCT00803023|581188116|FG002|Overall Study|Adverse Event|8|||
160945056|NCT00803023|581188117|FG003|Overall Study|Adverse Event|6|||
160945057|NCT00803023|581188114|FG000|Overall Study|Withdrawal by Subject|0|||
160945058|NCT00803023|581188115|FG001|Overall Study|Withdrawal by Subject|2|||
160945059|NCT00803023|581188116|FG002|Overall Study|Withdrawal by Subject|0|||
160945060|NCT00803023|581188117|FG003|Overall Study|Withdrawal by Subject|0|||
160945061|NCT00803023|581188114|FG000|Overall Study|Lost to Follow-up|0|||
160945062|NCT00803023|581188115|FG001|Overall Study|Lost to Follow-up|1|||
160945063|NCT00803023|581188116|FG002|Overall Study|Lost to Follow-up|2|||
160945064|NCT00803023|581188117|FG003|Overall Study|Lost to Follow-up|1|||
160945065|NCT00803023|581188114|FG000|Overall Study|Lack of Efficacy|0|||
160455928|NCT05256654|579399809|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
160656130|NCT00366899|580122354|FG001|Infant Series|Adverse Event|1|||
160656131|NCT00366899|580122353|FG000|Infant Series|Physician Decision|1|||
160945066|NCT00803023|581188115|FG001|Overall Study|Lack of Efficacy|1|||
160945067|NCT00803023|581188116|FG002|Overall Study|Lack of Efficacy|1|||
160945068|NCT00803023|581188117|FG003|Overall Study|Lack of Efficacy|1|||
160945069|NCT01542528|581188118|FG000|Overall Study|Lost to Follow-up|2|||
160945070|NCT01542528|581188119|FG001|Overall Study|Lost to Follow-up|1|||
160945071|NCT01542528|581188118|FG000|Overall Study|Physician Decision|1|||
160945072|NCT01542528|581188119|FG001|Overall Study|Physician Decision|0|||
160945073|NCT01542528|581188118|FG000|Overall Study|Withdrawal by Subject|9|||
160945074|NCT01542528|581188119|FG001|Overall Study|Withdrawal by Subject|6|||
160945075|NCT05282004|581188120|FG000|Overall Study|Adverse Event|2|||
160945076|NCT04808609|581188121|FG000|Overall Study|Lost to Follow-up|0|||
160945077|NCT04808609|581188122|FG001|Overall Study|Lost to Follow-up|2|||
160945078|NCT04808609|581188121|FG000|Overall Study|Administrative Withdrawal|0|||
160945079|NCT04808609|581188122|FG001|Overall Study|Administrative Withdrawal|1|||
160945080|NCT00562159|581188123|FG000|Overall Study|Adverse Event|11|||
160945081|NCT00562159|581188124|FG001|Overall Study|Adverse Event|8|||
160945082|NCT00562159|581188123|FG000|Overall Study|Lost to Follow-up|5|||
160945083|NCT00562159|581188124|FG001|Overall Study|Lost to Follow-up|4|||
160945084|NCT00562159|581188123|FG000|Overall Study|Withdrawal by Subject|9|||
160945085|NCT00562159|581188124|FG001|Overall Study|Withdrawal by Subject|8|||
160945086|NCT00562159|581188123|FG000|Overall Study|Protocol Violation|12|||
160945087|NCT00562159|581188124|FG001|Overall Study|Protocol Violation|12|||
160945088|NCT00562159|581188123|FG000|Overall Study|Did not meet protocol eligibility|1|||
160945089|NCT00562159|581188124|FG001|Overall Study|Did not meet protocol eligibility|1|||
160945090|NCT04382326|581188128|FG000|Overall Study|Adverse Event, not serious|1|||
160945091|NCT04382326|581188129|FG001|Overall Study|Adverse Event, not serious|2|||
160945092|NCT04382326|581188128|FG000|Overall Study|Other|1|||
160945093|NCT04382326|581188129|FG001|Overall Study|Other|0|||
160945094|NCT04382326|581188128|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
160945095|NCT04382326|581188129|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
160945096|NCT04382326|581188128|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
160945097|NCT04382326|581188129|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
160945098|NCT04382326|581188128|FG000|Overall Study|Protocol Violation|29|||
160945099|NCT04382326|581188129|FG001|Overall Study|Protocol Violation|23|||
160945100|NCT04382326|581188128|FG000|Overall Study|Physician Decision|0|||
160945101|NCT04382326|581188129|FG001|Overall Study|Physician Decision|1|||
160945102|NCT04382326|581188128|FG000|Overall Study|Lost to Follow-up|48|||
160945103|NCT04382326|581188129|FG001|Overall Study|Lost to Follow-up|63|||
160945104|NCT04382326|581188128|FG000|Overall Study|Adverse Event, non-fatal|1|||
160945105|NCT04382326|581188129|FG001|Overall Study|Adverse Event, non-fatal|1|||
160945106|NCT01181921|581188132|FG000|Overall Study|Lost to Follow-up|1|||
160945107|NCT02461589|581188138|FG000|Overall Study|Withdrawal by Subject|5|||
160945108|NCT02461589|581188139|FG001|Overall Study|Withdrawal by Subject|1|||
160945109|NCT02461589|581188140|FG002|Overall Study|Withdrawal by Subject|3|||
160945110|NCT02461589|581188141|FG003|Overall Study|Withdrawal by Subject|2|||
160945111|NCT02461589|581188142|FG004|Overall Study|Withdrawal by Subject|1|||
160945112|NCT02461589|581188143|FG005|Overall Study|Withdrawal by Subject|2|||
160945113|NCT02461589|581188144|FG006|Overall Study|Withdrawal by Subject|1|||
160945114|NCT02461589|581188145|FG007|Overall Study|Withdrawal by Subject|3|||
160945115|NCT02461589|581188146|FG008|Overall Study|Withdrawal by Subject|3|||
160945116|NCT02461589|581188147|FG009|Overall Study|Withdrawal by Subject|1|||
160945117|NCT02461589|581188138|FG000|Overall Study|Lost to Follow-up|0|||
160945118|NCT02461589|581188139|FG001|Overall Study|Lost to Follow-up|0|||
160945119|NCT02461589|581188140|FG002|Overall Study|Lost to Follow-up|2|||
160945120|NCT02461589|581188141|FG003|Overall Study|Lost to Follow-up|3|||
160945121|NCT02461589|581188142|FG004|Overall Study|Lost to Follow-up|1|||
160945122|NCT02461589|581188143|FG005|Overall Study|Lost to Follow-up|1|||
160945123|NCT02461589|581188144|FG006|Overall Study|Lost to Follow-up|3|||
160945124|NCT02461589|581188145|FG007|Overall Study|Lost to Follow-up|1|||
160999401|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160579909|NCT01808118|579844070|FG002|Period 2|Investigator no longer conducting trials|0|||
160579910|NCT01808118|579844068|FG000|Period 2|Switched to other therapy|0|||
160579911|NCT01808118|579844069|FG001|Period 2|Switched to other therapy|1|||
160579912|NCT01808118|579844070|FG002|Period 2|Switched to other therapy|0|||
160579913|NCT03097328|579844076|FG000|Overall Study|Still on Therapy|2|||
160579914|NCT03097328|579844076|FG000|Overall Study|Progressive Disease|29|||
160945125|NCT02461589|581188146|FG008|Overall Study|Lost to Follow-up|3|||
160945126|NCT02461589|581188147|FG009|Overall Study|Lost to Follow-up|1|||
160945127|NCT02461589|581188138|FG000|Overall Study|Death|0|||
160999402|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
160579915|NCT03097328|579844076|FG000|Overall Study|Adverse Event|4|||
160999403|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
160579916|NCT03097328|579844076|FG000|Overall Study|Withdrawal by Subject|1|||
160656132|NCT00366899|580122354|FG001|Infant Series|Physician Decision|0|||
160945128|NCT02461589|581188139|FG001|Overall Study|Death|0|||
160945129|NCT02461589|581188140|FG002|Overall Study|Death|0|||
160945130|NCT02461589|581188141|FG003|Overall Study|Death|0|||
160945131|NCT02461589|581188142|FG004|Overall Study|Death|0|||
160945132|NCT02461589|581188143|FG005|Overall Study|Death|0|||
160945133|NCT02461589|581188144|FG006|Overall Study|Death|0|||
160945134|NCT02461589|581188145|FG007|Overall Study|Death|1|||
160945135|NCT02461589|581188146|FG008|Overall Study|Death|0|||
160945136|NCT02461589|581188147|FG009|Overall Study|Death|0|||
160945137|NCT02461589|581188138|FG000|Overall Study|Unclassified|0|||
160945138|NCT02461589|581188139|FG001|Overall Study|Unclassified|0|||
160945139|NCT02461589|581188140|FG002|Overall Study|Unclassified|0|||
160945140|NCT02461589|581188141|FG003|Overall Study|Unclassified|0|||
160945141|NCT02461589|581188142|FG004|Overall Study|Unclassified|0|||
160945142|NCT02461589|581188143|FG005|Overall Study|Unclassified|0|||
160945143|NCT02461589|581188144|FG006|Overall Study|Unclassified|1|||
160945144|NCT02461589|581188145|FG007|Overall Study|Unclassified|0|||
160945145|NCT02461589|581188146|FG008|Overall Study|Unclassified|0|||
160945146|NCT02461589|581188147|FG009|Overall Study|Unclassified|2|||
160945147|NCT02461589|581188138|FG000|Overall Study|Missing follow-up information|1|||
160945148|NCT02461589|581188139|FG001|Overall Study|Missing follow-up information|1|||
160945149|NCT02461589|581188140|FG002|Overall Study|Missing follow-up information|0|||
160945150|NCT02461589|581188141|FG003|Overall Study|Missing follow-up information|0|||
160945151|NCT02461589|581188142|FG004|Overall Study|Missing follow-up information|0|||
160945152|NCT02461589|581188143|FG005|Overall Study|Missing follow-up information|0|||
160945153|NCT02461589|581188144|FG006|Overall Study|Missing follow-up information|1|||
160945154|NCT02461589|581188145|FG007|Overall Study|Missing follow-up information|0|||
160945155|NCT02461589|581188146|FG008|Overall Study|Missing follow-up information|0|||
160945156|NCT02461589|581188147|FG009|Overall Study|Missing follow-up information|0|||
160945157|NCT02461589|581188138|FG000|Overall Study|Withdrawal from trial before exposure|0|||
160945158|NCT02461589|581188139|FG001|Overall Study|Withdrawal from trial before exposure|0|||
160945159|NCT02461589|581188140|FG002|Overall Study|Withdrawal from trial before exposure|0|||
160945160|NCT02461589|581188141|FG003|Overall Study|Withdrawal from trial before exposure|0|||
160945161|NCT02461589|581188142|FG004|Overall Study|Withdrawal from trial before exposure|0|||
160945162|NCT02461589|581188143|FG005|Overall Study|Withdrawal from trial before exposure|0|||
160945163|NCT02461589|581188144|FG006|Overall Study|Withdrawal from trial before exposure|0|||
160945164|NCT02461589|581188145|FG007|Overall Study|Withdrawal from trial before exposure|0|||
160945165|NCT02461589|581188146|FG008|Overall Study|Withdrawal from trial before exposure|0|||
160945166|NCT02461589|581188147|FG009|Overall Study|Withdrawal from trial before exposure|1|||
160945167|NCT01978119|581188152|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
160945168|NCT01978119|581188153|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
160945169|NCT01978119|581188152|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
160945170|NCT01978119|581188153|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160945171|NCT01978119|581188152|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160945172|NCT01978119|581188153|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
160945173|NCT02519504|581188155|FG000|Overall Study|Protocol Violation|6|||
160945174|NCT02519504|581188156|FG001|Overall Study|Protocol Violation|5|||
160945175|NCT02519504|581188155|FG000|Overall Study|Ineligible for direct testing|12|||
160945176|NCT02519504|581188156|FG001|Overall Study|Ineligible for direct testing|12|||
160945177|NCT02519504|581188155|FG000|Overall Study|Did not participate in direct testing|95|||
160945178|NCT02519504|581188156|FG001|Overall Study|Did not participate in direct testing|86|||
160945179|NCT02548962|581188157|FG000|Overall Study|Withdrawal by Subject|1|||
160945180|NCT02548962|581188158|FG001|Overall Study|Withdrawal by Subject|0|||
160945181|NCT01958918|581188159|FG000|Overall Study|Death|1|||
160945182|NCT01958918|581188160|FG001|Overall Study|Death|3|||
160945183|NCT01958918|581188159|FG000|Overall Study|Lost to Follow-up|4|||
160945184|NCT01958918|581188160|FG001|Overall Study|Lost to Follow-up|7|||
160945185|NCT01958918|581188159|FG000|Overall Study|Withdrawal by Subject|13|||
160945186|NCT01958918|581188160|FG001|Overall Study|Withdrawal by Subject|8|||
160945187|NCT01958918|581188159|FG000|Overall Study|Lack of Efficacy|13|||
160945188|NCT01958918|581188160|FG001|Overall Study|Lack of Efficacy|10|||
160945189|NCT01958918|581188159|FG000|Overall Study|Adverse Event|12|||
160945190|NCT01958918|581188160|FG001|Overall Study|Adverse Event|12|||
160945191|NCT01958918|581188159|FG000|Overall Study|administrative problems|0|||
160945192|NCT01958918|581188160|FG001|Overall Study|administrative problems|2|||
160945193|NCT03653429|581188168|FG000|Overall Study|Physician Decision|4|||
160945194|NCT03653429|581188169|FG001|Overall Study|Physician Decision|10|||
160945195|NCT00403546|581188170|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
160945196|NCT00403546|581188171|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
160945197|NCT00403546|581188172|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
160945198|NCT00403546|581188170|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
160945199|NCT00403546|581188171|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
160455929|NCT05256654|579399810|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
160455930|NCT05256654|579399811|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
160945200|NCT00403546|581188172|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
160945201|NCT00403546|581188170|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
160945202|NCT00403546|581188171|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
160455931|NCT05256654|579399812|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
160455932|NCT05256654|579399809|FG000|Overall Study|Other|0|||
160945203|NCT00403546|581188172|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
160945204|NCT00403546|581188170|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
160945205|NCT00403546|581188171|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
160945206|NCT00403546|581188172|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
160945207|NCT00403546|581188170|FG000|Screening Phase|Screening Failure|22|||
160945208|NCT00403546|581188171|FG001|Screening Phase|Screening Failure|0|||
160945209|NCT00403546|581188172|FG002|Screening Phase|Screening Failure|0|||
160945210|NCT00403546|581188170|FG000|Screening Phase|Adverse Event|1|||
160945211|NCT00403546|581188171|FG001|Screening Phase|Adverse Event|0|||
160945212|NCT00403546|581188172|FG002|Screening Phase|Adverse Event|0|||
160945213|NCT00403546|581188170|FG000|Screening Phase|Terminated Prior to Randomization|5|||
160945214|NCT00403546|581188171|FG001|Screening Phase|Terminated Prior to Randomization|0|||
160945215|NCT00403546|581188172|FG002|Screening Phase|Terminated Prior to Randomization|0|||
160945216|NCT00403546|581188170|FG000|Randomized Trial|Early Terminations|0|||
160945217|NCT00403546|581188171|FG001|Randomized Trial|Early Terminations|17|||
160945218|NCT00403546|581188172|FG002|Randomized Trial|Early Terminations|16|||
160945219|NCT00793910|581188173|FG000|Overall Study|discarded study pills|0|||
160945220|NCT00793910|581188174|FG001|Overall Study|discarded study pills|1|||
160945221|NCT00793910|581188173|FG000|Overall Study|did not pick up medications|1|||
160945222|NCT00793910|581188174|FG001|Overall Study|did not pick up medications|1|||
160945223|NCT00793910|581188173|FG000|Overall Study|ineligible based on entry criteria|2|||
160945224|NCT00793910|581188174|FG001|Overall Study|ineligible based on entry criteria|3|||
160945225|NCT00793910|581188173|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
160945226|NCT00793910|581188174|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
160945227|NCT00793910|581188173|FG000|Overall Study|Withdrawal by Subject|0|||
160945228|NCT00793910|581188174|FG001|Overall Study|Withdrawal by Subject|1|||
160945229|NCT03634579|581188177|FG000|Overall Study|study termination|9|||
160945230|NCT02480621|581188178|FG000|Randomization|Withdrawal by Subject|1|||
160945231|NCT02480621|581188179|FG001|Randomization|Withdrawal by Subject|0|||
160945232|NCT02480621|581188178|FG000|Randomization|Surgeon did not give intervention|0|||
160945233|NCT02480621|581188179|FG001|Randomization|Surgeon did not give intervention|1|||
160945234|NCT02480621|581188178|FG000|Follow Up|Lost to Follow-up|4|||
160945235|NCT02480621|581188179|FG001|Follow Up|Lost to Follow-up|2|||
160945236|NCT01723904|581188182|FG000|Overall Study|Noncompliant|3|||
160945237|NCT01723904|581188182|FG000|Overall Study|Adverse Event|5|||
160945238|NCT01723904|581188182|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
160945239|NCT02610140|581188193|FG000|Randomization and Treatment Period|Radiological progression|23|||
160945240|NCT02610140|581188194|FG001|Randomization and Treatment Period|Radiological progression|15|||
160945241|NCT02610140|581188193|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
160945242|NCT02610140|581188194|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
160945243|NCT02610140|581188193|FG000|Randomization and Treatment Period|Protocol Violation|1|||
160945244|NCT02610140|581188194|FG001|Randomization and Treatment Period|Protocol Violation|0|||
160945245|NCT02610140|581188193|FG000|Randomization and Treatment Period|Physician Decision|0|||
160656133|NCT00366899|580122353|FG000|Infant Series|Randomized but not consented|1|||
160945246|NCT02610140|581188194|FG001|Randomization and Treatment Period|Physician Decision|1|||
160945247|NCT02610140|581188193|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
160945248|NCT02610140|581188194|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
160945249|NCT02610140|581188193|FG000|Randomization and Treatment Period|Death|7|||
160945250|NCT02610140|581188194|FG001|Randomization and Treatment Period|Death|1|||
160945251|NCT02610140|581188193|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
160945252|NCT02610140|581188194|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
160945253|NCT02610140|581188193|FG000|Randomization and Treatment Period|Adverse Event|44|||
160945254|NCT02610140|581188194|FG001|Randomization and Treatment Period|Adverse Event|13|||
160945255|NCT02610140|581188193|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
160945256|NCT02610140|581188194|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
160945257|NCT02610140|581188193|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
160945258|NCT02610140|581188194|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
160945259|NCT02610140|581188193|FG000|Randomization and Treatment Period|Not treated|3|||
160945260|NCT02610140|581188194|FG001|Randomization and Treatment Period|Not treated|10|||
160945261|NCT02610140|581188193|FG000|Safety Follow-up|Other|0|||
160945262|NCT02610140|581188194|FG001|Safety Follow-up|Other|2|||
160945263|NCT02610140|581188193|FG000|Safety Follow-up|Lost to Follow-up|1|||
160945264|NCT02610140|581188194|FG001|Safety Follow-up|Lost to Follow-up|0|||
160945265|NCT02610140|581188193|FG000|Safety Follow-up|No follow-up|5|||
160945266|NCT02610140|581188194|FG001|Safety Follow-up|No follow-up|3|||
160945267|NCT02610140|581188193|FG000|Safety Follow-up|Death|12|||
160945268|NCT02610140|581188194|FG001|Safety Follow-up|Death|2|||
160945269|NCT02610140|581188193|FG000|Safety Follow-up|Deterioration of general conditions|15|||
160945270|NCT02610140|581188194|FG001|Safety Follow-up|Deterioration of general conditions|5|||
160945271|NCT02610140|581188193|FG000|Safety Follow-up|Withdrawal by Subject|12|||
160945272|NCT02610140|581188194|FG001|Safety Follow-up|Withdrawal by Subject|12|||
160945273|NCT02610140|581188193|FG000|Active Follow-up|Progressive disease - radiological|30|||
160945274|NCT02610140|581188194|FG001|Active Follow-up|Progressive disease - radiological|22|||
160945275|NCT02610140|581188193|FG000|Active Follow-up|Death|8|||
160945276|NCT02610140|581188194|FG001|Active Follow-up|Death|1|||
160945277|NCT02610140|581188193|FG000|Active Follow-up|Withdrawal by Subject|4|||
160945278|NCT02610140|581188194|FG001|Active Follow-up|Withdrawal by Subject|0|||
160945279|NCT02610140|581188193|FG000|Active Follow-up|Progressive disease - clinical|1|||
160945280|NCT02610140|581188194|FG001|Active Follow-up|Progressive disease - clinical|2|||
160945281|NCT02610140|581188193|FG000|Active Follow-up|Deterioration of general conditions|1|||
160945282|NCT02610140|581188194|FG001|Active Follow-up|Deterioration of general conditions|0|||
160945283|NCT02610140|581188193|FG000|Active Follow-up|Ongoing but not completed|4|||
160945284|NCT02610140|581188194|FG001|Active Follow-up|Ongoing but not completed|1|||
160945285|NCT02610140|581188193|FG000|Long-term Follow-up|Death|86|||
160945286|NCT02610140|581188194|FG001|Long-term Follow-up|Death|44|||
160945287|NCT02610140|581188193|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
160945288|NCT02610140|581188194|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
160945289|NCT02610140|581188193|FG000|Long-term Follow-up|Lost to Follow-up|1|||
160945290|NCT02610140|581188194|FG001|Long-term Follow-up|Lost to Follow-up|2|||
160945291|NCT02610140|581188193|FG000|Long-term Follow-up|Ongoing but not completed|30|||
160945292|NCT02610140|581188194|FG001|Long-term Follow-up|Ongoing but not completed|17|||
160945293|NCT00887341|581188195|FG000|Overall Study|Refused treatment|1|||
160945294|NCT00887341|581188196|FG001|Overall Study|Refused treatment|0|||
160945295|NCT00887341|581188195|FG000|Overall Study|Withdrawal by Subject|1|||
160945296|NCT00887341|581188196|FG001|Overall Study|Withdrawal by Subject|1|||
160945297|NCT00887341|581188195|FG000|Overall Study|Adverse Event|0|||
160945298|NCT00887341|581188196|FG001|Overall Study|Adverse Event|1|||
160945299|NCT00887341|581188195|FG000|Overall Study|Lost to Follow-up|0|||
160945300|NCT00887341|581188196|FG001|Overall Study|Lost to Follow-up|1|||
160579917|NCT03097328|579844076|FG000|Overall Study|Physician Decision|1|||
160579918|NCT03097328|579844076|FG000|Overall Study|Patient Decision|1|||
160579919|NCT03097328|579844076|FG000|Overall Study|Ineligible for Study Drug|1|||
160579920|NCT02023164|579844077|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
160945301|NCT02617589|581188197|FG000|Randomization|Request to Discontinue Study Treatment|1|||
160945302|NCT02617589|581188198|FG001|Randomization|Request to Discontinue Study Treatment|3|||
160945303|NCT02617589|581188197|FG000|Randomization|Participant Withdrew Consent|1|||
160945304|NCT02617589|581188198|FG001|Randomization|Participant Withdrew Consent|2|||
160945305|NCT02617589|581188197|FG000|Treatment|Other Reasons|3|||
160945306|NCT02617589|581188198|FG001|Treatment|Other Reasons|3|||
160945307|NCT02617589|581188197|FG000|Treatment|Poor/Non Compliance|1|||
160945308|NCT02617589|581188198|FG001|Treatment|Poor/Non Compliance|1|||
160945309|NCT02617589|581188197|FG000|Treatment|Maximum Clinical Benefit|0|||
160945310|NCT02617589|581188198|FG001|Treatment|Maximum Clinical Benefit|2|||
160945311|NCT02617589|581188197|FG000|Treatment|Participant Withdrew Consent|2|||
160945312|NCT02617589|581188198|FG001|Treatment|Participant Withdrew Consent|6|||
160945313|NCT02617589|581188197|FG000|Treatment|Participant Request to Discontinue|12|||
160945314|NCT02617589|581188198|FG001|Treatment|Participant Request to Discontinue|21|||
160945315|NCT02617589|581188197|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
160945316|NCT02617589|581188198|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
160945317|NCT02617589|581188197|FG000|Treatment|Death|1|||
160945318|NCT02617589|581188198|FG001|Treatment|Death|1|||
160945319|NCT02617589|581188197|FG000|Treatment|Study Drug Toxicity|27|||
160945320|NCT02617589|581188198|FG001|Treatment|Study Drug Toxicity|20|||
160945321|NCT02617589|581188197|FG000|Treatment|Disease Progression|216|||
160945322|NCT02617589|581188198|FG001|Treatment|Disease Progression|136|||
160945323|NCT01752933|581188201|FG000|Treatment|Disease Progression|3|||
160945324|NCT01752933|581188202|FG001|Treatment|Disease Progression|29|||
160945325|NCT01752933|581188201|FG000|Treatment|Withdrawal by Subject|0|||
160945326|NCT01752933|581188202|FG001|Treatment|Withdrawal by Subject|5|||
160945327|NCT01752933|581188201|FG000|Treatment|Adverse Event|1|||
160945328|NCT01752933|581188202|FG001|Treatment|Adverse Event|4|||
160945329|NCT01752933|581188201|FG000|Treatment|Physician Decision|0|||
160579921|NCT02023164|579844078|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
160579922|NCT03650452|579844080|FG000|Overall Study|Physician Decision|1|||
160579923|NCT03650452|579844081|FG001|Overall Study|Physician Decision|0|||
160945330|NCT01752933|581188202|FG001|Treatment|Physician Decision|3|||
160945331|NCT01752933|581188201|FG000|Treatment|Death|0|||
160945332|NCT01752933|581188202|FG001|Treatment|Death|2|||
160579924|NCT03650452|579844080|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
160945333|NCT01752933|581188201|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
160945334|NCT01752933|581188202|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
160945335|NCT01752933|581188201|FG000|Treatment|Patient noncompliant|0|||
160945336|NCT01752933|581188202|FG001|Treatment|Patient noncompliant|1|||
160579925|NCT03650452|579844081|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160579926|NCT03650452|579844080|FG000|Overall Study|Adverse Event|3|||
160945337|NCT01752933|581188201|FG000|Treatment|Patient unable to travel to appointments|0|||
160945338|NCT01752933|581188202|FG001|Treatment|Patient unable to travel to appointments|1|||
160945339|NCT01752933|581188201|FG000|Overall Study and Follow-up|Death|4|||
160579927|NCT03650452|579844081|FG001|Overall Study|Adverse Event|4|||
160579928|NCT03650452|579844080|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
160579929|NCT03650452|579844081|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
160579930|NCT01984346|579844084|FG000|Overall Study|Physician Decision|4|||
160579931|NCT01984346|579844085|FG001|Overall Study|Physician Decision|2|||
160579932|NCT01984346|579844084|FG000|Overall Study|Withdrawal by Subject|2|||
160579933|NCT01984346|579844085|FG001|Overall Study|Withdrawal by Subject|2|||
160579934|NCT01984346|579844084|FG000|Overall Study|Enrollment Closed|8|||
160579935|NCT01984346|579844085|FG001|Overall Study|Enrollment Closed|1|||
160945340|NCT01752933|581188202|FG001|Overall Study and Follow-up|Death|34|||
160945341|NCT01752933|581188201|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
160945342|NCT01752933|581188202|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
160945343|NCT01752933|581188201|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
160945344|NCT01752933|581188202|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
160945345|NCT01752933|581188201|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
160945346|NCT01752933|581188202|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
160945347|NCT01591681|581188203|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
160945348|NCT01591681|581188203|FG000|Overall Study|Failed to use system during run-in|1|||
160945349|NCT03062891|581188204|FG000|Overall Study|Withdrawal by Subject|2|||
160945350|NCT03062891|581188205|FG001|Overall Study|Withdrawal by Subject|0|||
160945351|NCT03062891|581188204|FG000|Overall Study|Lost to Follow-up|50|||
160945352|NCT03062891|581188205|FG001|Overall Study|Lost to Follow-up|38|||
160945353|NCT01208233|581188211|FG000|Overall Study|Adverse Event|0|||
160945354|NCT01208233|581188212|FG001|Overall Study|Adverse Event|1|||
160945355|NCT01208233|581188213|FG002|Overall Study|Adverse Event|2|||
160945356|NCT01208233|581188214|FG003|Overall Study|Adverse Event|0|||
160945357|NCT01208233|581188215|FG004|Overall Study|Adverse Event|3|||
160945358|NCT01208233|581188216|FG005|Overall Study|Adverse Event|5|||
160945359|NCT01208233|581188211|FG000|Overall Study|Death|0|||
160945360|NCT01208233|581188212|FG001|Overall Study|Death|0|||
160945361|NCT01208233|581188213|FG002|Overall Study|Death|0|||
160945362|NCT01208233|581188214|FG003|Overall Study|Death|0|||
160945363|NCT01208233|581188215|FG004|Overall Study|Death|3|||
160945364|NCT01208233|581188216|FG005|Overall Study|Death|5|||
160945365|NCT01208233|581188211|FG000|Overall Study|Did not meet entrance criteria|2|||
160945366|NCT01208233|581188212|FG001|Overall Study|Did not meet entrance criteria|1|||
160945367|NCT01208233|581188213|FG002|Overall Study|Did not meet entrance criteria|1|||
160945368|NCT01208233|581188214|FG003|Overall Study|Did not meet entrance criteria|0|||
160945369|NCT01208233|581188215|FG004|Overall Study|Did not meet entrance criteria|1|||
160945370|NCT01208233|581188216|FG005|Overall Study|Did not meet entrance criteria|0|||
160945371|NCT01208233|581188211|FG000|Overall Study|Medication error without adverse event|0|||
160945372|NCT01208233|581188212|FG001|Overall Study|Medication error without adverse event|0|||
160945373|NCT01208233|581188213|FG002|Overall Study|Medication error without adverse event|0|||
160945374|NCT01208233|581188214|FG003|Overall Study|Medication error without adverse event|0|||
160945375|NCT01208233|581188215|FG004|Overall Study|Medication error without adverse event|0|||
160945376|NCT01208233|581188216|FG005|Overall Study|Medication error without adverse event|1|||
160945377|NCT01208233|581188211|FG000|Overall Study|Study terminated by sponsor|0|||
160945378|NCT01208233|581188212|FG001|Overall Study|Study terminated by sponsor|0|||
160945379|NCT01208233|581188213|FG002|Overall Study|Study terminated by sponsor|0|||
160945380|NCT01208233|581188214|FG003|Overall Study|Study terminated by sponsor|0|||
160945381|NCT01208233|581188215|FG004|Overall Study|Study terminated by sponsor|10|||
160945382|NCT01208233|581188216|FG005|Overall Study|Study terminated by sponsor|7|||
160945383|NCT01208233|581188211|FG000|Overall Study|Protocol Violation|0|||
160945384|NCT01208233|581188212|FG001|Overall Study|Protocol Violation|0|||
160945385|NCT01208233|581188213|FG002|Overall Study|Protocol Violation|0|||
160945386|NCT01208233|581188214|FG003|Overall Study|Protocol Violation|0|||
160945387|NCT01208233|581188215|FG004|Overall Study|Protocol Violation|3|||
160945388|NCT01208233|581188216|FG005|Overall Study|Protocol Violation|0|||
160945389|NCT01208233|581188211|FG000|Overall Study|Other|2|||
160945390|NCT01208233|581188212|FG001|Overall Study|Other|1|||
160945391|NCT01208233|581188213|FG002|Overall Study|Other|0|||
160945392|NCT01208233|581188214|FG003|Overall Study|Other|0|||
160945393|NCT01208233|581188215|FG004|Overall Study|Other|0|||
160945394|NCT01208233|581188216|FG005|Overall Study|Other|1|||
160945395|NCT01208233|581188211|FG000|Overall Study|Withdrawal by Subject|1|||
160579936|NCT01984346|579844084|FG000|Overall Study|Insurance Coverage|1|||
160579937|NCT01984346|579844085|FG001|Overall Study|Insurance Coverage|0|||
160579938|NCT01984346|579844084|FG000|Overall Study|Intra-operative Exclusion|2|||
160945396|NCT01208233|581188212|FG001|Overall Study|Withdrawal by Subject|0|||
160945397|NCT01208233|581188213|FG002|Overall Study|Withdrawal by Subject|1|||
160579939|NCT01984346|579844085|FG001|Overall Study|Intra-operative Exclusion|0|||
160579940|NCT02042404|579844088|FG000|Overall Study|Death|1|||
160945398|NCT01208233|581188214|FG003|Overall Study|Withdrawal by Subject|1|||
160945399|NCT01208233|581188215|FG004|Overall Study|Withdrawal by Subject|4|||
160945400|NCT01208233|581188216|FG005|Overall Study|Withdrawal by Subject|2|||
160579941|NCT02042404|579844089|FG001|Overall Study|Death|0|||
160579942|NCT02042404|579844088|FG000|Overall Study|Unrelated Adverse Event|3|||
160579943|NCT02042404|579844089|FG001|Overall Study|Unrelated Adverse Event|0|||
160579944|NCT02042404|579844088|FG000|Overall Study|Inability to meet time requirements|1|||
160579945|NCT02042404|579844089|FG001|Overall Study|Inability to meet time requirements|0|||
160579946|NCT03100942|579844090|FG000|Randomized Treatment Period|Withdrew Consent|4|||
160579947|NCT03100942|579844091|FG001|Randomized Treatment Period|Withdrew Consent|5|||
160579948|NCT03100942|579844092|FG002|Randomized Treatment Period|Withdrew Consent|3|||
160579949|NCT03100942|579844093|FG003|Randomized Treatment Period|Withdrew Consent|3|||
160579950|NCT03100942|579844094|FG004|Randomized Treatment Period|Withdrew Consent|0|||
160579951|NCT03100942|579844095|FG005|Randomized Treatment Period|Withdrew Consent|0|||
160579952|NCT03100942|579844096|FG006|Randomized Treatment Period|Withdrew Consent|0|||
160579953|NCT03100942|579844090|FG000|Randomized Treatment Period|Adverse Event|5|||
160579954|NCT03100942|579844091|FG001|Randomized Treatment Period|Adverse Event|2|||
160579955|NCT03100942|579844092|FG002|Randomized Treatment Period|Adverse Event|1|||
160579956|NCT03100942|579844093|FG003|Randomized Treatment Period|Adverse Event|0|||
160579957|NCT03100942|579844094|FG004|Randomized Treatment Period|Adverse Event|0|||
160579958|NCT03100942|579844095|FG005|Randomized Treatment Period|Adverse Event|0|||
160579959|NCT03100942|579844096|FG006|Randomized Treatment Period|Adverse Event|0|||
160579960|NCT03100942|579844090|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
160579961|NCT03100942|579844091|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
160579962|NCT03100942|579844092|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
160579963|NCT03100942|579844093|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
160579964|NCT03100942|579844094|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
160579965|NCT03100942|579844095|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
160579966|NCT03100942|579844096|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
160579967|NCT03100942|579844090|FG000|Randomized Treatment Period|Protocol Violation|0|||
160579968|NCT03100942|579844091|FG001|Randomized Treatment Period|Protocol Violation|1|||
160579969|NCT03100942|579844092|FG002|Randomized Treatment Period|Protocol Violation|1|||
160579970|NCT03100942|579844093|FG003|Randomized Treatment Period|Protocol Violation|1|||
160579971|NCT03100942|579844094|FG004|Randomized Treatment Period|Protocol Violation|0|||
160579972|NCT03100942|579844095|FG005|Randomized Treatment Period|Protocol Violation|0|||
160579973|NCT03100942|579844096|FG006|Randomized Treatment Period|Protocol Violation|0|||
160579974|NCT03100942|579844090|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
160579975|NCT03100942|579844091|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
160579976|NCT03100942|579844092|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
160579977|NCT03100942|579844093|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
160579978|NCT03100942|579844094|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
160579979|NCT03100942|579844095|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
160579980|NCT03100942|579844096|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
160579981|NCT03100942|579844090|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
160579982|NCT03100942|579844091|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
160579983|NCT03100942|579844092|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
160579984|NCT03100942|579844093|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
160579985|NCT03100942|579844094|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
160579986|NCT03100942|579844095|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
160579987|NCT03100942|579844096|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
160579988|NCT03100942|579844090|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
160579989|NCT03100942|579844091|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
160579990|NCT03100942|579844092|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
160579991|NCT03100942|579844093|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
160579992|NCT03100942|579844094|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
160579993|NCT03100942|579844095|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
160579994|NCT03100942|579844096|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
160579995|NCT01876732|579844101|FG000|Overall Study|MMA was not over 800mg/dL|75|||
160579996|NCT00536731|579844102|FG000|Overall Study|Adverse Event|3|||
160579997|NCT00536731|579844103|FG001|Overall Study|Adverse Event|2|||
160579998|NCT00536731|579844104|FG002|Overall Study|Adverse Event|3|||
160579999|NCT00536731|579844102|FG000|Overall Study|Withdrawal by Subject|0|||
160580000|NCT00536731|579844103|FG001|Overall Study|Withdrawal by Subject|2|||
160580001|NCT00536731|579844104|FG002|Overall Study|Withdrawal by Subject|0|||
160580002|NCT00536731|579844102|FG000|Overall Study|Intake of prohibited conc. medication|0|||
160580003|NCT00536731|579844103|FG001|Overall Study|Intake of prohibited conc. medication|0|||
160580004|NCT00536731|579844104|FG002|Overall Study|Intake of prohibited conc. medication|1|||
160580005|NCT00536731|579844102|FG000|Overall Study|Safety reasons|0|||
160580006|NCT00536731|579844103|FG001|Overall Study|Safety reasons|0|||
160580007|NCT00536731|579844104|FG002|Overall Study|Safety reasons|1|||
160580008|NCT00536731|579844102|FG000|Overall Study|Other|1|||
160580009|NCT00536731|579844103|FG001|Overall Study|Other|1|||
160580010|NCT00536731|579844104|FG002|Overall Study|Other|0|||
160580011|NCT00718419|579844105|FG000|Overall Study|Adverse Event|2|||
160455933|NCT05256654|579399810|FG001|Overall Study|Other|0|||
160455934|NCT05256654|579399811|FG002|Overall Study|Other|0|||
160455935|NCT05256654|579399812|FG003|Overall Study|Other|1|||
160455936|NCT05204654|579399819|FG000|Overall Study|Study terminated due to time restraint|2|||
160455937|NCT05204654|579399820|FG001|Overall Study|Study terminated due to time restraint|2|||
160455938|NCT03626220|579399827|FG000|Overall Study|Withdrawal by Subject|2|||
160455939|NCT03626220|579399828|FG001|Overall Study|Withdrawal by Subject|0|||
160455940|NCT04625725|579399829|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
160455941|NCT04625725|579399830|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
160455942|NCT04625725|579399831|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
160455943|NCT04625725|579399832|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
160455944|NCT04625725|579399833|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
160455945|NCT04625725|579399834|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
160455946|NCT04625725|579399829|FG000|Provent Main Study|Withdrawal by Subject|242|||
160455947|NCT04625725|579399830|FG001|Provent Main Study|Withdrawal by Subject|144|||
160455948|NCT04625725|579399831|FG002|Provent Main Study|Withdrawal by Subject|0|||
160455949|NCT04625725|579399832|FG003|Provent Main Study|Withdrawal by Subject|0|||
160455950|NCT04625725|579399833|FG004|Provent Main Study|Withdrawal by Subject|0|||
160455951|NCT04625725|579399834|FG005|Provent Main Study|Withdrawal by Subject|0|||
160455952|NCT04625725|579399829|FG000|Provent Main Study|Physician Decision|5|||
160455953|NCT04625725|579399830|FG001|Provent Main Study|Physician Decision|0|||
160455954|NCT04625725|579399831|FG002|Provent Main Study|Physician Decision|0|||
160580012|NCT00718419|579844106|FG001|Overall Study|Adverse Event|1|||
160580013|NCT00718419|579844105|FG000|Overall Study|Physician Decision|1|||
160945401|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945402|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945403|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945404|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945405|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
160945406|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945407|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945408|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
160945409|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
160945410|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945411|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
160945412|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
160945413|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945414|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945415|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945416|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945417|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
160945418|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
160945419|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
160945420|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
160945421|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
160945422|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
160945423|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
160945424|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
160945425|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
160945426|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
160945427|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
160945428|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
160999404|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160999405|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
160999406|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
160999407|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160999408|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160999409|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160999410|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160999411|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
160999412|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160455955|NCT04625725|579399832|FG003|Provent Main Study|Physician Decision|0|||
160580014|NCT00718419|579844106|FG001|Overall Study|Physician Decision|6|||
160999413|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
160580015|NCT00718419|579844105|FG000|Overall Study|Sponsor decision|0|||
160580016|NCT00718419|579844106|FG001|Overall Study|Sponsor decision|1|||
160455956|NCT04625725|579399833|FG004|Provent Main Study|Physician Decision|0|||
160580017|NCT00718419|579844105|FG000|Overall Study|Withdrawal by Subject|0|||
160580018|NCT00718419|579844106|FG001|Overall Study|Withdrawal by Subject|5|||
160945429|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
160945430|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
160945431|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
160945432|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
160945433|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945434|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945435|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160999414|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
160999415|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
160999416|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
160999417|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
160999418|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
160999419|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
160999420|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
160999421|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
160999422|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999423|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
160999424|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999425|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999426|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999427|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999428|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999429|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999430|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999431|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999432|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
160999433|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
160999434|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999435|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999436|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999437|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999438|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999439|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999440|NCT03141788|581380702|FG000|Overall Study|Lost to Follow-up|1|||
160999441|NCT03141788|581380702|FG000|Overall Study|Protocol Violation|3|||
160999442|NCT03141788|581380702|FG000|Overall Study|Withdrawal by Subject|4|||
160945436|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945437|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945438|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
160999443|NCT03169244|581382715|FG000|Overall Study|Lost to Follow-up|1|||
160999444|NCT03169244|581382716|FG001|Overall Study|Lost to Follow-up|2|||
160999445|NCT03169244|581382715|FG000|Overall Study|Adverse Event|1|||
160999446|NCT03169244|581382716|FG001|Overall Study|Adverse Event|0|||
160999447|NCT03169244|581382715|FG000|Overall Study|Withdrawal by Subject|2|||
160999448|NCT03169244|581382716|FG001|Overall Study|Withdrawal by Subject|2|||
160999449|NCT03169244|581382715|FG000|Overall Study|Physician Decision|1|||
160999450|NCT03169244|581382716|FG001|Overall Study|Physician Decision|0|||
160999451|NCT02631148|581382717|FG000|Overall Study|8 were ineligible|8|||
160999452|NCT02631148|581382718|FG001|Overall Study|8 were ineligible|0|||
160999453|NCT02631148|581382717|FG000|Overall Study|Withdrawal by Subject|1|||
160999454|NCT02631148|581382718|FG001|Overall Study|Withdrawal by Subject|0|||
160999455|NCT02631148|581382717|FG000|Overall Study|PAH not available to study participant|1|||
160999456|NCT02631148|581382718|FG001|Overall Study|PAH not available to study participant|0|||
160999457|NCT00708032|581382722|FG000|Overall Study|Adverse Event|0|||
160999458|NCT00708032|581382723|FG001|Overall Study|Adverse Event|2|||
160999459|NCT00708032|581382722|FG000|Overall Study|Lost to Follow-up|1|||
160999460|NCT00708032|581382723|FG001|Overall Study|Lost to Follow-up|2|||
160999461|NCT00708032|581382722|FG000|Overall Study|Pregnancy|0|||
160999462|NCT00708032|581382723|FG001|Overall Study|Pregnancy|1|||
160999463|NCT00708032|581382722|FG000|Overall Study|Poor vision|0|||
160999464|NCT00708032|581382723|FG001|Overall Study|Poor vision|6|||
160999465|NCT00708032|581382722|FG000|Overall Study|Visit out of range at month 12|4|||
160999466|NCT00708032|581382723|FG001|Overall Study|Visit out of range at month 12|1|||
160999467|NCT00708032|581382722|FG000|Overall Study|Did not meet protocol criteria|1|||
160999468|NCT00708032|581382723|FG001|Overall Study|Did not meet protocol criteria|2|||
160999469|NCT00708032|581382722|FG000|Overall Study|Protocol Violation|4|||
160999470|NCT00708032|581382723|FG001|Overall Study|Protocol Violation|1|||
160999471|NCT00708032|581382722|FG000|Overall Study|Withdrawal by Subject|0|||
160999472|NCT00708032|581382723|FG001|Overall Study|Withdrawal by Subject|1|||
160999473|NCT00391846|581382724|FG000|Overall Study|Adverse Event|4|||
160999474|NCT00391846|581382725|FG001|Overall Study|Adverse Event|1|||
160999475|NCT00391846|581382724|FG000|Overall Study|Did not meet the required elig. crit|2|||
160945439|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
160945440|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945441|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945442|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
160945443|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
160945444|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
160945445|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945446|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945447|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945448|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945449|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945450|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945451|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945452|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945453|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945454|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
160945455|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945456|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945457|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945458|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945459|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945460|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
160945461|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945462|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160580019|NCT00718419|579844105|FG000|Overall Study|Progressive Disease|7|||
160580020|NCT00718419|579844106|FG001|Overall Study|Progressive Disease|25|||
160580021|NCT00718419|579844105|FG000|Overall Study|Death Due to Progressive Disease|2|||
160580022|NCT00718419|579844106|FG001|Overall Study|Death Due to Progressive Disease|0|||
160580023|NCT00718419|579844105|FG000|Overall Study|Death Due to Study Drug Related|0|||
160580024|NCT00718419|579844106|FG001|Overall Study|Death Due to Study Drug Related|1|||
160580025|NCT00718419|579844105|FG000|Overall Study|Death Due to Adverse Events|1|||
160580026|NCT00718419|579844106|FG001|Overall Study|Death Due to Adverse Events|0|||
160580027|NCT04184622|579844109|FG000|Primary Treatment Period|Adverse Event|6|||
160580028|NCT04184622|579844110|FG001|Primary Treatment Period|Adverse Event|4|||
160580029|NCT04184622|579844111|FG002|Primary Treatment Period|Adverse Event|8|||
160580030|NCT04184622|579844112|FG003|Primary Treatment Period|Adverse Event|6|||
160580031|NCT04184622|579844109|FG000|Primary Treatment Period|Death|4|||
160580032|NCT04184622|579844110|FG001|Primary Treatment Period|Death|4|||
160580033|NCT04184622|579844111|FG002|Primary Treatment Period|Death|2|||
160580034|NCT04184622|579844112|FG003|Primary Treatment Period|Death|1|||
160580035|NCT04184622|579844109|FG000|Primary Treatment Period|Lost to Follow-up|41|||
160580036|NCT04184622|579844110|FG001|Primary Treatment Period|Lost to Follow-up|17|||
160580037|NCT04184622|579844111|FG002|Primary Treatment Period|Lost to Follow-up|15|||
160580038|NCT04184622|579844112|FG003|Primary Treatment Period|Lost to Follow-up|13|||
160580039|NCT04184622|579844109|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
160580040|NCT04184622|579844110|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
160580041|NCT04184622|579844111|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
160580042|NCT04184622|579844112|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
160580043|NCT04184622|579844109|FG000|Primary Treatment Period|Physician Decision|0|||
160945463|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945464|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945465|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945466|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945467|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945468|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945469|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945470|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
160945471|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945472|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945473|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945474|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945475|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945476|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160580044|NCT04184622|579844110|FG001|Primary Treatment Period|Physician Decision|0|||
160580045|NCT04184622|579844111|FG002|Primary Treatment Period|Physician Decision|3|||
160945477|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945478|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945479|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945480|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945481|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945482|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945483|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945484|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945485|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945486|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945487|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945488|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945489|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
160945490|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945491|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945492|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945493|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945494|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945495|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945496|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945497|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
160945498|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945499|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945500|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945501|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945502|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
160945503|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945504|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945505|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945506|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945507|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
160945508|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945509|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945510|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945511|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945512|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945513|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945514|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945515|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945516|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945517|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945518|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945519|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945520|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945521|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945522|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945523|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945524|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945525|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
160945526|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
160945527|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
160945528|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
160945529|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945530|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945531|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945532|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945533|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945534|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945535|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945536|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945537|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945538|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945539|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945540|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945541|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
160945542|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
160945543|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
160455957|NCT04625725|579399834|FG005|Provent Main Study|Physician Decision|0|||
160455958|NCT04625725|579399829|FG000|Provent Main Study|Protocol Violation|1|||
160455959|NCT04625725|579399830|FG001|Provent Main Study|Protocol Violation|0|||
160455960|NCT04625725|579399831|FG002|Provent Main Study|Protocol Violation|0|||
160455961|NCT04625725|579399832|FG003|Provent Main Study|Protocol Violation|0|||
160455962|NCT04625725|579399833|FG004|Provent Main Study|Protocol Violation|0|||
160455963|NCT04625725|579399834|FG005|Provent Main Study|Protocol Violation|0|||
160945544|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
160455964|NCT04625725|579399829|FG000|Provent Main Study|Lost to Follow-up|357|||
160455965|NCT04625725|579399830|FG001|Provent Main Study|Lost to Follow-up|200|||
160455966|NCT04625725|579399831|FG002|Provent Main Study|Lost to Follow-up|0|||
160455967|NCT04625725|579399832|FG003|Provent Main Study|Lost to Follow-up|0|||
160455968|NCT04625725|579399833|FG004|Provent Main Study|Lost to Follow-up|0|||
160945545|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945546|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945547|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945548|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945549|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945550|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945551|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945552|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945553|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945554|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945555|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945556|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945557|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
160945558|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
160945559|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
160455969|NCT04625725|579399834|FG005|Provent Main Study|Lost to Follow-up|0|||
160455970|NCT04625725|579399829|FG000|Provent Main Study|Death|22|||
160455971|NCT04625725|579399830|FG001|Provent Main Study|Death|10|||
160455972|NCT04625725|579399831|FG002|Provent Main Study|Death|0|||
160455973|NCT04625725|579399832|FG003|Provent Main Study|Death|0|||
160455974|NCT04625725|579399833|FG004|Provent Main Study|Death|0|||
160455975|NCT04625725|579399834|FG005|Provent Main Study|Death|0|||
160455976|NCT04625725|579399829|FG000|Provent Main Study|Adverse Event|2|||
160455977|NCT04625725|579399830|FG001|Provent Main Study|Adverse Event|1|||
160455978|NCT04625725|579399831|FG002|Provent Main Study|Adverse Event|0|||
160455979|NCT04625725|579399832|FG003|Provent Main Study|Adverse Event|0|||
160455980|NCT04625725|579399833|FG004|Provent Main Study|Adverse Event|0|||
160455981|NCT04625725|579399834|FG005|Provent Main Study|Adverse Event|0|||
160455982|NCT04625725|579399829|FG000|Provent Main Study|Participants dosed in sub-study|310|||
160455983|NCT04625725|579399830|FG001|Provent Main Study|Participants dosed in sub-study|193|||
160999476|NCT00391846|581382725|FG001|Overall Study|Did not meet the required elig. crit|2|||
160999477|NCT00391846|581382724|FG000|Overall Study|Withdrawal by Subject|2|||
160999478|NCT00391846|581382725|FG001|Overall Study|Withdrawal by Subject|3|||
160455984|NCT04625725|579399831|FG002|Provent Main Study|Participants dosed in sub-study|0|||
160455985|NCT04625725|579399832|FG003|Provent Main Study|Participants dosed in sub-study|0|||
160945560|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
160945561|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945562|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945563|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945564|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945565|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945566|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945567|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945568|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945569|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945570|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945571|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945572|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160999479|NCT00391846|581382724|FG000|Overall Study|Developed study specific DC criteria|0|||
160455986|NCT04625725|579399833|FG004|Provent Main Study|Participants dosed in sub-study|0|||
160455987|NCT04625725|579399834|FG005|Provent Main Study|Participants dosed in sub-study|0|||
160455988|NCT04625725|579399829|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
160455989|NCT04625725|579399830|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
160455990|NCT04625725|579399831|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
160580046|NCT04184622|579844112|FG003|Primary Treatment Period|Physician Decision|1|||
160580047|NCT04184622|579844109|FG000|Primary Treatment Period|Pregnancy|4|||
160455991|NCT04625725|579399832|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
160945573|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
160945574|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945575|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945576|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945577|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945578|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945579|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945580|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945581|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945582|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945583|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945584|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945585|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945586|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945587|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945588|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945589|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
160945590|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
160945591|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
160945592|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
160945593|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945594|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945595|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945596|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945597|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945598|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945599|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945600|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945601|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945602|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945603|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945604|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945605|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945606|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945607|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945608|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
160945609|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945610|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945611|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945612|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945613|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945614|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945615|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945616|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945617|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945618|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945619|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945620|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945621|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
160945622|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
160945623|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945624|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
160945625|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945626|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945627|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945628|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945629|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945630|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945631|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945632|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945633|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945634|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945635|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945636|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945637|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
160945638|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160580048|NCT04184622|579844110|FG001|Primary Treatment Period|Pregnancy|3|||
160945639|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945640|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945641|NCT01539291|581189987|FG000|Study GS-US-312-0116|Adverse Event|9|||
160945642|NCT01539291|581189988|FG001|Study GS-US-312-0116|Adverse Event|0|||
160945643|NCT01539291|581189989|FG002|Study GS-US-312-0116|Adverse Event|0|||
160945644|NCT01539291|581189990|FG003|Study GS-US-312-0116|Adverse Event|0|||
160945645|NCT01539291|581189987|FG000|Study GS-US-312-0116|Physician Decision|1|||
160945646|NCT01539291|581189988|FG001|Study GS-US-312-0116|Physician Decision|0|||
160945647|NCT01539291|581189989|FG002|Study GS-US-312-0116|Physician Decision|0|||
160945648|NCT01539291|581189990|FG003|Study GS-US-312-0116|Physician Decision|0|||
160945649|NCT01539291|581189987|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
160945650|NCT01539291|581189988|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
160945651|NCT01539291|581189989|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
160945652|NCT01539291|581189990|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
160945653|NCT01539291|581189987|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
160945654|NCT01539291|581189988|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
160945655|NCT01539291|581189989|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
160945656|NCT01539291|581189990|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
160945657|NCT01539291|581189987|FG000|Study GS-US-312-0116|Other|1|||
160945658|NCT01539291|581189988|FG001|Study GS-US-312-0116|Other|0|||
160945659|NCT01539291|581189989|FG002|Study GS-US-312-0116|Other|0|||
160945660|NCT01539291|581189990|FG003|Study GS-US-312-0116|Other|0|||
160945661|NCT01539291|581189987|FG000|Study GS-US-312-0117|Adverse Event|22|||
160945662|NCT01539291|581189988|FG001|Study GS-US-312-0117|Adverse Event|1|||
160945663|NCT01539291|581189989|FG002|Study GS-US-312-0117|Adverse Event|9|||
160945664|NCT01539291|581189990|FG003|Study GS-US-312-0117|Adverse Event|12|||
160945665|NCT01539291|581189987|FG000|Study GS-US-312-0117|Physician Decision|9|||
160945666|NCT01539291|581189988|FG001|Study GS-US-312-0117|Physician Decision|0|||
160945667|NCT01539291|581189989|FG002|Study GS-US-312-0117|Physician Decision|6|||
160945668|NCT01539291|581189990|FG003|Study GS-US-312-0117|Physician Decision|4|||
160945669|NCT01539291|581189987|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
160945670|NCT01539291|581189988|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
160945671|NCT01539291|581189989|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
160945672|NCT01539291|581189990|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
160945673|NCT01539291|581189987|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
160945674|NCT01539291|581189988|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
160945675|NCT01539291|581189989|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
160945676|NCT01539291|581189990|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
160945677|NCT01539291|581189987|FG000|Study GS-US-312-0117|Other|2|||
160945678|NCT01539291|581189988|FG001|Study GS-US-312-0117|Other|1|||
160945679|NCT01539291|581189989|FG002|Study GS-US-312-0117|Other|1|||
160945680|NCT01539291|581189990|FG003|Study GS-US-312-0117|Other|1|||
160945681|NCT00129987|581189995|FG000|1st Educational Session|Withdrawal by Subject|141|||
160945682|NCT00129987|581189996|FG001|1st Educational Session|Withdrawal by Subject|109|||
160945683|NCT00129987|581189995|FG000|1 Year|Withdrawal by Subject|32|||
160945684|NCT00129987|581189996|FG001|1 Year|Withdrawal by Subject|21|||
160945685|NCT00581945|581189997|FG000|Overall Study|Adverse Event|4|||
160945686|NCT00581945|581189998|FG001|Overall Study|Adverse Event|4|||
160945687|NCT00581945|581189997|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160945688|NCT00581945|581189998|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160945689|NCT00581945|581189997|FG000|Overall Study|Withdrawal by Subject|2|||
160945690|NCT00581945|581189998|FG001|Overall Study|Withdrawal by Subject|6|||
160945691|NCT00581945|581189997|FG000|Overall Study|Death|1|||
160945692|NCT00581945|581189998|FG001|Overall Study|Death|0|||
160945693|NCT02979535|581189999|FG000|Overall Study|Non compliance with the protocol|78|||
160945694|NCT02979535|581190000|FG001|Overall Study|Non compliance with the protocol|82|||
160945695|NCT02979535|581189999|FG000|Overall Study|Consent withdrawn by participant|11|||
160945696|NCT02979535|581190000|FG001|Overall Study|Consent withdrawn by participant|18|||
160945697|NCT02979535|581189999|FG000|Overall Study|Lost to Follow-up|6|||
160999480|NCT00391846|581382725|FG001|Overall Study|Developed study specific DC criteria|1|||
160999481|NCT00150176|581382726|FG000|Overall Study|Adverse Event|16|||
160999482|NCT00150176|581382727|FG001|Overall Study|Adverse Event|53|||
160999483|NCT00150176|581382726|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
160580049|NCT04184622|579844111|FG002|Primary Treatment Period|Pregnancy|4|||
160945698|NCT02979535|581190000|FG001|Overall Study|Lost to Follow-up|1|||
160945699|NCT02032901|581190004|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
160580050|NCT04184622|579844112|FG003|Primary Treatment Period|Pregnancy|1|||
160945700|NCT02032901|581190005|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
160945701|NCT02032901|581190004|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
160945702|NCT02032901|581190005|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
160945703|NCT01722331|581190006|FG000|Part 1|Adverse Event|5|||
160945704|NCT01722331|581190007|FG001|Part 1|Adverse Event|0|||
160945705|NCT01722331|581190008|FG002|Part 1|Adverse Event|0|||
160945706|NCT01722331|581190009|FG003|Part 1|Adverse Event|0|||
160945707|NCT01722331|581190010|FG004|Part 1|Adverse Event|0|||
160945708|NCT01722331|581190011|FG005|Part 1|Adverse Event|0|||
160945709|NCT01722331|581190012|FG006|Part 1|Adverse Event|0|||
160945710|NCT01722331|581190006|FG000|Part 1|Lack of Efficacy|0|||
160945711|NCT01722331|581190007|FG001|Part 1|Lack of Efficacy|0|||
160945712|NCT01722331|581190008|FG002|Part 1|Lack of Efficacy|1|||
160945713|NCT01722331|581190009|FG003|Part 1|Lack of Efficacy|0|||
160945714|NCT01722331|581190010|FG004|Part 1|Lack of Efficacy|2|||
160945715|NCT01722331|581190011|FG005|Part 1|Lack of Efficacy|0|||
160945716|NCT01722331|581190012|FG006|Part 1|Lack of Efficacy|0|||
160945717|NCT01722331|581190006|FG000|Part 1|Lost to Follow-up|1|||
160945718|NCT01722331|581190007|FG001|Part 1|Lost to Follow-up|0|||
160945719|NCT01722331|581190008|FG002|Part 1|Lost to Follow-up|2|||
160945720|NCT01722331|581190009|FG003|Part 1|Lost to Follow-up|0|||
160945721|NCT01722331|581190010|FG004|Part 1|Lost to Follow-up|1|||
160945722|NCT01722331|581190011|FG005|Part 1|Lost to Follow-up|0|||
160945723|NCT01722331|581190012|FG006|Part 1|Lost to Follow-up|0|||
160945724|NCT01722331|581190006|FG000|Part 1|Physician Decision|0|||
160945725|NCT01722331|581190007|FG001|Part 1|Physician Decision|0|||
160945726|NCT01722331|581190008|FG002|Part 1|Physician Decision|3|||
160945727|NCT01722331|581190009|FG003|Part 1|Physician Decision|0|||
160945728|NCT01722331|581190010|FG004|Part 1|Physician Decision|1|||
160945729|NCT01722331|581190011|FG005|Part 1|Physician Decision|0|||
160945730|NCT01722331|581190012|FG006|Part 1|Physician Decision|0|||
160945731|NCT01722331|581190006|FG000|Part 1|Pregnancy|1|||
160945732|NCT01722331|581190007|FG001|Part 1|Pregnancy|0|||
160945733|NCT01722331|581190008|FG002|Part 1|Pregnancy|0|||
160945734|NCT01722331|581190009|FG003|Part 1|Pregnancy|0|||
160945735|NCT01722331|581190010|FG004|Part 1|Pregnancy|0|||
160945736|NCT01722331|581190011|FG005|Part 1|Pregnancy|0|||
160945737|NCT01722331|581190012|FG006|Part 1|Pregnancy|0|||
160945738|NCT01722331|581190006|FG000|Part 1|Progressive Disease|0|||
160945739|NCT01722331|581190007|FG001|Part 1|Progressive Disease|0|||
160945740|NCT01722331|581190008|FG002|Part 1|Progressive Disease|0|||
160945741|NCT01722331|581190009|FG003|Part 1|Progressive Disease|0|||
160945742|NCT01722331|581190010|FG004|Part 1|Progressive Disease|1|||
160945743|NCT01722331|581190011|FG005|Part 1|Progressive Disease|0|||
160945744|NCT01722331|581190012|FG006|Part 1|Progressive Disease|0|||
160945745|NCT01722331|581190006|FG000|Part 1|Protocol Violation|1|||
160945746|NCT01722331|581190007|FG001|Part 1|Protocol Violation|0|||
160945747|NCT01722331|581190008|FG002|Part 1|Protocol Violation|0|||
160945748|NCT01722331|581190009|FG003|Part 1|Protocol Violation|0|||
160945749|NCT01722331|581190010|FG004|Part 1|Protocol Violation|1|||
160945750|NCT01722331|581190011|FG005|Part 1|Protocol Violation|0|||
160945751|NCT01722331|581190012|FG006|Part 1|Protocol Violation|0|||
160945752|NCT01722331|581190006|FG000|Part 1|Withdrawal by Subject|2|||
160580051|NCT04184622|579844109|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
160945753|NCT01722331|581190007|FG001|Part 1|Withdrawal by Subject|0|||
160945754|NCT01722331|581190008|FG002|Part 1|Withdrawal by Subject|3|||
160945755|NCT01722331|581190009|FG003|Part 1|Withdrawal by Subject|0|||
160945756|NCT01722331|581190010|FG004|Part 1|Withdrawal by Subject|3|||
160945757|NCT01722331|581190011|FG005|Part 1|Withdrawal by Subject|0|||
160945758|NCT01722331|581190012|FG006|Part 1|Withdrawal by Subject|0|||
160945759|NCT01722331|581190006|FG000|Part 2|Adverse Event|3|||
160945760|NCT01722331|581190007|FG001|Part 2|Adverse Event|0|||
160945761|NCT01722331|581190008|FG002|Part 2|Adverse Event|0|||
160945762|NCT01722331|581190009|FG003|Part 2|Adverse Event|0|||
160999484|NCT00150176|581382727|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
160999485|NCT00150176|581382726|FG000|Overall Study|Withdrawal by Subject|19|||
160580052|NCT04184622|579844110|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
160580053|NCT04184622|579844111|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
160945763|NCT01722331|581190010|FG004|Part 2|Adverse Event|0|||
160945764|NCT01722331|581190011|FG005|Part 2|Adverse Event|1|||
160945765|NCT01722331|581190012|FG006|Part 2|Adverse Event|0|||
160945766|NCT01722331|581190006|FG000|Part 2|Lack of Efficacy|3|||
160945767|NCT01722331|581190007|FG001|Part 2|Lack of Efficacy|0|||
160945768|NCT01722331|581190008|FG002|Part 2|Lack of Efficacy|11|||
160945769|NCT01722331|581190009|FG003|Part 2|Lack of Efficacy|0|||
160945770|NCT01722331|581190010|FG004|Part 2|Lack of Efficacy|0|||
160945771|NCT01722331|581190011|FG005|Part 2|Lack of Efficacy|3|||
160945772|NCT01722331|581190012|FG006|Part 2|Lack of Efficacy|3|||
160945773|NCT01722331|581190006|FG000|Part 2|Lost to Follow-up|0|||
160945774|NCT01722331|581190007|FG001|Part 2|Lost to Follow-up|0|||
160999486|NCT00150176|581382727|FG001|Overall Study|Withdrawal by Subject|12|||
160945775|NCT01722331|581190008|FG002|Part 2|Lost to Follow-up|3|||
160945776|NCT01722331|581190009|FG003|Part 2|Lost to Follow-up|0|||
160945777|NCT01722331|581190010|FG004|Part 2|Lost to Follow-up|0|||
160945778|NCT01722331|581190011|FG005|Part 2|Lost to Follow-up|1|||
160945779|NCT01722331|581190012|FG006|Part 2|Lost to Follow-up|1|||
160945780|NCT01722331|581190006|FG000|Part 2|Non-Compliance with Study Drug|1|||
160945781|NCT01722331|581190007|FG001|Part 2|Non-Compliance with Study Drug|0|||
160945782|NCT01722331|581190008|FG002|Part 2|Non-Compliance with Study Drug|1|||
160945783|NCT01722331|581190009|FG003|Part 2|Non-Compliance with Study Drug|0|||
160945784|NCT01722331|581190010|FG004|Part 2|Non-Compliance with Study Drug|0|||
160945785|NCT01722331|581190011|FG005|Part 2|Non-Compliance with Study Drug|0|||
160945786|NCT01722331|581190012|FG006|Part 2|Non-Compliance with Study Drug|0|||
160945787|NCT01722331|581190006|FG000|Part 2|Physician Decision|0|||
160945788|NCT01722331|581190007|FG001|Part 2|Physician Decision|0|||
160945789|NCT01722331|581190008|FG002|Part 2|Physician Decision|2|||
160945790|NCT01722331|581190009|FG003|Part 2|Physician Decision|0|||
160945791|NCT01722331|581190010|FG004|Part 2|Physician Decision|0|||
160945792|NCT01722331|581190011|FG005|Part 2|Physician Decision|0|||
160945793|NCT01722331|581190012|FG006|Part 2|Physician Decision|0|||
160945794|NCT01722331|581190006|FG000|Part 2|Pregnancy|0|||
160945795|NCT01722331|581190007|FG001|Part 2|Pregnancy|0|||
160945796|NCT01722331|581190008|FG002|Part 2|Pregnancy|0|||
160945797|NCT01722331|581190009|FG003|Part 2|Pregnancy|0|||
160945798|NCT01722331|581190010|FG004|Part 2|Pregnancy|0|||
160945799|NCT01722331|581190011|FG005|Part 2|Pregnancy|1|||
160945800|NCT01722331|581190012|FG006|Part 2|Pregnancy|0|||
160945801|NCT01722331|581190006|FG000|Part 2|Progressive Disease|0|||
160945802|NCT01722331|581190007|FG001|Part 2|Progressive Disease|0|||
160945803|NCT01722331|581190008|FG002|Part 2|Progressive Disease|1|||
160945804|NCT01722331|581190009|FG003|Part 2|Progressive Disease|0|||
160945805|NCT01722331|581190010|FG004|Part 2|Progressive Disease|0|||
160945806|NCT01722331|581190011|FG005|Part 2|Progressive Disease|0|||
160945807|NCT01722331|581190012|FG006|Part 2|Progressive Disease|0|||
160945808|NCT01722331|581190006|FG000|Part 2|Protocol Violation|1|||
160945809|NCT01722331|581190007|FG001|Part 2|Protocol Violation|0|||
160945810|NCT01722331|581190008|FG002|Part 2|Protocol Violation|0|||
160945811|NCT01722331|581190009|FG003|Part 2|Protocol Violation|0|||
160945812|NCT01722331|581190010|FG004|Part 2|Protocol Violation|0|||
160945813|NCT01722331|581190011|FG005|Part 2|Protocol Violation|0|||
160945814|NCT01722331|581190012|FG006|Part 2|Protocol Violation|0|||
160945815|NCT01722331|581190006|FG000|Part 2|Withdrawal by Subject|5|||
160945816|NCT01722331|581190007|FG001|Part 2|Withdrawal by Subject|0|||
160945817|NCT01722331|581190008|FG002|Part 2|Withdrawal by Subject|3|||
160945818|NCT01722331|581190009|FG003|Part 2|Withdrawal by Subject|0|||
160945819|NCT01722331|581190010|FG004|Part 2|Withdrawal by Subject|0|||
160945820|NCT01722331|581190011|FG005|Part 2|Withdrawal by Subject|2|||
160945821|NCT01722331|581190012|FG006|Part 2|Withdrawal by Subject|2|||
160945822|NCT01722331|581190006|FG000|Part 2|Other Protocol Specified Criteria|6|||
160945823|NCT01722331|581190007|FG001|Part 2|Other Protocol Specified Criteria|0|||
160945824|NCT01722331|581190008|FG002|Part 2|Other Protocol Specified Criteria|10|||
160945825|NCT01722331|581190009|FG003|Part 2|Other Protocol Specified Criteria|0|||
160945826|NCT01722331|581190010|FG004|Part 2|Other Protocol Specified Criteria|0|||
160945827|NCT01722331|581190011|FG005|Part 2|Other Protocol Specified Criteria|2|||
160945828|NCT01722331|581190012|FG006|Part 2|Other Protocol Specified Criteria|1|||
160945829|NCT01722331|581190006|FG000|Part 3|Adverse Event|2|||
160945830|NCT01722331|581190007|FG001|Part 3|Adverse Event|2|||
160945831|NCT01722331|581190008|FG002|Part 3|Adverse Event|0|||
160945832|NCT01722331|581190009|FG003|Part 3|Adverse Event|1|||
160945833|NCT01722331|581190010|FG004|Part 3|Adverse Event|0|||
160945834|NCT01722331|581190011|FG005|Part 3|Adverse Event|0|||
160945835|NCT01722331|581190012|FG006|Part 3|Adverse Event|0|||
160945836|NCT01722331|581190006|FG000|Part 3|Death|1|||
160945837|NCT01722331|581190007|FG001|Part 3|Death|0|||
160945838|NCT01722331|581190008|FG002|Part 3|Death|0|||
160945839|NCT01722331|581190009|FG003|Part 3|Death|0|||
160945840|NCT01722331|581190010|FG004|Part 3|Death|0|||
160945841|NCT01722331|581190011|FG005|Part 3|Death|0|||
160945842|NCT01722331|581190012|FG006|Part 3|Death|0|||
160945843|NCT01722331|581190006|FG000|Part 3|Lack of Efficacy|1|||
160945844|NCT01722331|581190007|FG001|Part 3|Lack of Efficacy|0|||
160945845|NCT01722331|581190008|FG002|Part 3|Lack of Efficacy|0|||
160945846|NCT01722331|581190009|FG003|Part 3|Lack of Efficacy|0|||
160945847|NCT01722331|581190010|FG004|Part 3|Lack of Efficacy|0|||
160945848|NCT01722331|581190011|FG005|Part 3|Lack of Efficacy|0|||
160945849|NCT01722331|581190012|FG006|Part 3|Lack of Efficacy|0|||
160945850|NCT01722331|581190006|FG000|Part 3|Lost to Follow-up|3|||
160945851|NCT01722331|581190007|FG001|Part 3|Lost to Follow-up|4|||
160945852|NCT01722331|581190008|FG002|Part 3|Lost to Follow-up|0|||
160580054|NCT04184622|579844112|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
160945853|NCT01722331|581190009|FG003|Part 3|Lost to Follow-up|0|||
160945854|NCT01722331|581190010|FG004|Part 3|Lost to Follow-up|0|||
160945855|NCT01722331|581190011|FG005|Part 3|Lost to Follow-up|1|||
160945856|NCT01722331|581190012|FG006|Part 3|Lost to Follow-up|0|||
160945857|NCT01722331|581190006|FG000|Part 3|Non-Compliance with Study Drug|0|||
160945858|NCT01722331|581190007|FG001|Part 3|Non-Compliance with Study Drug|1|||
160945859|NCT01722331|581190008|FG002|Part 3|Non-Compliance with Study Drug|0|||
160945860|NCT01722331|581190009|FG003|Part 3|Non-Compliance with Study Drug|0|||
160945861|NCT01722331|581190010|FG004|Part 3|Non-Compliance with Study Drug|0|||
160945862|NCT01722331|581190011|FG005|Part 3|Non-Compliance with Study Drug|0|||
160945863|NCT01722331|581190012|FG006|Part 3|Non-Compliance with Study Drug|0|||
160945864|NCT01722331|581190006|FG000|Part 3|Physician Decision|1|||
160945865|NCT01722331|581190007|FG001|Part 3|Physician Decision|1|||
160945866|NCT01722331|581190008|FG002|Part 3|Physician Decision|0|||
160945867|NCT01722331|581190009|FG003|Part 3|Physician Decision|0|||
160945868|NCT01722331|581190010|FG004|Part 3|Physician Decision|0|||
160945869|NCT01722331|581190011|FG005|Part 3|Physician Decision|0|||
160945870|NCT01722331|581190012|FG006|Part 3|Physician Decision|1|||
160945871|NCT01722331|581190006|FG000|Part 3|Protocol Violation|2|||
160580055|NCT04184622|579844109|FG000|Additional Treatment Period|Adverse Event|1|||
160945872|NCT01722331|581190007|FG001|Part 3|Protocol Violation|1|||
160945873|NCT01722331|581190008|FG002|Part 3|Protocol Violation|0|||
160945874|NCT01722331|581190009|FG003|Part 3|Protocol Violation|0|||
160945875|NCT01722331|581190010|FG004|Part 3|Protocol Violation|0|||
160945876|NCT01722331|581190011|FG005|Part 3|Protocol Violation|0|||
160945877|NCT01722331|581190012|FG006|Part 3|Protocol Violation|0|||
160945878|NCT01722331|581190006|FG000|Part 3|Withdrawal by Subject|4|||
160945879|NCT01722331|581190007|FG001|Part 3|Withdrawal by Subject|7|||
160945880|NCT01722331|581190008|FG002|Part 3|Withdrawal by Subject|0|||
160945881|NCT01722331|581190009|FG003|Part 3|Withdrawal by Subject|0|||
160945882|NCT01722331|581190010|FG004|Part 3|Withdrawal by Subject|0|||
160945883|NCT01722331|581190011|FG005|Part 3|Withdrawal by Subject|2|||
160945884|NCT01722331|581190012|FG006|Part 3|Withdrawal by Subject|1|||
160945885|NCT01722331|581190006|FG000|Part 3|Other Protocol Specified Criteria|1|||
160945886|NCT01722331|581190007|FG001|Part 3|Other Protocol Specified Criteria|1|||
160945887|NCT01722331|581190008|FG002|Part 3|Other Protocol Specified Criteria|0|||
160945888|NCT01722331|581190009|FG003|Part 3|Other Protocol Specified Criteria|0|||
160945889|NCT01722331|581190010|FG004|Part 3|Other Protocol Specified Criteria|0|||
160945890|NCT01722331|581190011|FG005|Part 3|Other Protocol Specified Criteria|0|||
160945891|NCT01722331|581190012|FG006|Part 3|Other Protocol Specified Criteria|0|||
160945892|NCT00086346|581190018|FG000|Randomization|Did not receive test article|4|||
160945893|NCT00086346|581190019|FG001|Randomization|Did not receive test article|4|||
160945894|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Adverse Event|94|||
160945895|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Adverse Event|11|||
160945896|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
160945897|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
160945898|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
160945899|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
160945900|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
160945901|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
160945902|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
160945903|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
160945904|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
160945905|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
160945906|NCT04495374|581190020|FG000|Overall Study|Protocol Violation|2|||
160945907|NCT04495374|581190021|FG001|Overall Study|Protocol Violation|1|||
160945908|NCT02807948|581190022|FG000|Overall Study|Physician Decision|1|||
160945909|NCT02807948|581190023|FG001|Overall Study|Physician Decision|0|||
160945910|NCT03727750|581190024|FG000|Overall Study|Death|45|||
160945911|NCT03727750|581190024|FG000|Overall Study|Withdrawal by Subject|2|||
160945912|NCT03727750|581190024|FG000|Overall Study|Lost to Follow-up|1|||
160945913|NCT03727750|581190024|FG000|Overall Study|Other|1|||
160945914|NCT01575561|581190025|FG000|Overall Study|Adverse Event|9|||
160945915|NCT01575561|581190025|FG000|Overall Study|Lack of Efficacy|8|||
160945916|NCT01575561|581190025|FG000|Overall Study|Lost to Follow-up|6|||
160945917|NCT01575561|581190025|FG000|Overall Study|Protocol Violation|4|||
160945918|NCT01575561|581190025|FG000|Overall Study|Withdrawal by Subject|11|||
160945919|NCT01575561|581190025|FG000|Overall Study|administration|1|||
160945920|NCT01038921|581190026|FG000|Overall Study|Withdrawal by Subject|1|||
160945921|NCT01038921|581190027|FG001|Overall Study|Withdrawal by Subject|0|||
160945922|NCT01038921|581190026|FG000|Overall Study|Physician Decision|1|||
160945923|NCT01038921|581190027|FG001|Overall Study|Physician Decision|0|||
160945924|NCT03295201|581190029|FG000|Overall Study|Lost to Follow-up|1|||
160945925|NCT03295201|581190030|FG001|Overall Study|Lost to Follow-up|1|||
160945926|NCT03295201|581190029|FG000|Overall Study|Hospital admission|0|||
160945927|NCT03295201|581190030|FG001|Overall Study|Hospital admission|1|||
160945928|NCT00572572|581190031|FG000|Overall Study|Withdrawal by Subject|3|||
160945929|NCT00572572|581190032|FG001|Overall Study|Withdrawal by Subject|6|||
160945930|NCT01831089|581190033|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
160945931|NCT01831089|581190034|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
160945932|NCT01831089|581190035|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
160945933|NCT01831089|581190036|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
160945934|NCT01831089|581190037|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
160580056|NCT04184622|579844110|FG001|Additional Treatment Period|Adverse Event|2|||
160580057|NCT04184622|579844111|FG002|Additional Treatment Period|Adverse Event|1|||
160945935|NCT01831089|581190038|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
160945936|NCT01831089|581190033|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
160945937|NCT01831089|581190034|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
160945938|NCT01831089|581190035|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
160945939|NCT01831089|581190036|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
160945940|NCT01831089|581190037|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
160945941|NCT01831089|581190038|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
160580058|NCT04184622|579844112|FG003|Additional Treatment Period|Adverse Event|0|||
160945942|NCT01831089|581190033|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
160999487|NCT00150176|581382726|FG000|Overall Study|Lost to Follow-up|3|||
160945943|NCT01831089|581190034|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
160945944|NCT01831089|581190035|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
160945945|NCT01831089|581190036|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
160945946|NCT01831089|581190037|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
160945947|NCT01831089|581190038|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
160945948|NCT01831089|581190033|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
160945949|NCT01831089|581190034|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
160945950|NCT01831089|581190035|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
160945951|NCT01831089|581190036|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
160945952|NCT01831089|581190037|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
160945953|NCT01831089|581190038|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
160945954|NCT01831089|581190033|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
160945955|NCT01831089|581190034|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
160945956|NCT01831089|581190035|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
160945957|NCT01831089|581190036|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
160945958|NCT01831089|581190037|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
160945959|NCT01831089|581190038|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
160945960|NCT01831089|581190033|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
160945961|NCT01831089|581190034|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
160945962|NCT01831089|581190035|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
160945963|NCT01831089|581190036|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
160945964|NCT01831089|581190037|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
160945965|NCT01831089|581190038|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
160945966|NCT01831089|581190033|FG000|Cohort III: Dose Level 3|Global end of study|0|||
160945967|NCT01831089|581190034|FG001|Cohort III: Dose Level 3|Global end of study|0|||
160945968|NCT01831089|581190035|FG002|Cohort III: Dose Level 3|Global end of study|1|||
160945969|NCT01831089|581190036|FG003|Cohort III: Dose Level 3|Global end of study|0|||
160945970|NCT01831089|581190037|FG004|Cohort III: Dose Level 3|Global end of study|0|||
160945971|NCT01831089|581190038|FG005|Cohort III: Dose Level 3|Global end of study|0|||
160945972|NCT01831089|581190033|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
160945973|NCT01831089|581190034|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
160945974|NCT01831089|581190035|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
160945975|NCT01831089|581190036|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
160945976|NCT01831089|581190037|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
160945977|NCT01831089|581190038|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
160945978|NCT01831089|581190033|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
160945979|NCT01831089|581190034|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
160945980|NCT01831089|581190035|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
160945981|NCT01831089|581190036|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
160945982|NCT01831089|581190037|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
160945983|NCT01831089|581190038|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
160945984|NCT01831089|581190033|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
160945985|NCT01831089|581190034|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
160945986|NCT01831089|581190035|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
160945987|NCT01831089|581190036|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
160945988|NCT01831089|581190037|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
160945989|NCT01831089|581190038|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
160945990|NCT01831089|581190033|FG000|Cohort V: Dose Level 5|Death|0|||
160945991|NCT01831089|581190034|FG001|Cohort V: Dose Level 5|Death|0|||
160945992|NCT01831089|581190035|FG002|Cohort V: Dose Level 5|Death|0|||
160945993|NCT01831089|581190036|FG003|Cohort V: Dose Level 5|Death|0|||
160945994|NCT01831089|581190037|FG004|Cohort V: Dose Level 5|Death|1|||
160945995|NCT01831089|581190038|FG005|Cohort V: Dose Level 5|Death|0|||
160945996|NCT01831089|581190033|FG000|Cohort V: Dose Level 5|Global end of study|0|||
160945997|NCT01831089|581190034|FG001|Cohort V: Dose Level 5|Global end of study|0|||
160945998|NCT01831089|581190035|FG002|Cohort V: Dose Level 5|Global end of study|0|||
160945999|NCT01831089|581190036|FG003|Cohort V: Dose Level 5|Global end of study|0|||
160946000|NCT01831089|581190037|FG004|Cohort V: Dose Level 5|Global end of study|2|||
160946001|NCT01831089|581190038|FG005|Cohort V: Dose Level 5|Global end of study|0|||
160946002|NCT01831089|581190033|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
160946003|NCT01831089|581190034|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
160946004|NCT01831089|581190035|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
160946005|NCT01831089|581190036|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
160946006|NCT01831089|581190037|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
160946007|NCT01831089|581190038|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
160946008|NCT01831089|581190033|FG000|Cohort B: Arm B|Progressive disease|0|||
160946009|NCT01831089|581190034|FG001|Cohort B: Arm B|Progressive disease|0|||
160946010|NCT01831089|581190035|FG002|Cohort B: Arm B|Progressive disease|0|||
160946011|NCT01831089|581190036|FG003|Cohort B: Arm B|Progressive disease|0|||
160946012|NCT01831089|581190037|FG004|Cohort B: Arm B|Progressive disease|0|||
160946013|NCT01831089|581190038|FG005|Cohort B: Arm B|Progressive disease|8|||
160946014|NCT01831089|581190033|FG000|Cohort B: Arm B|Physician Decision|0|||
160455992|NCT04625725|579399833|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
160455993|NCT04625725|579399834|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
160455994|NCT04625725|579399829|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
160455995|NCT04625725|579399830|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
160455996|NCT04625725|579399831|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
160455997|NCT04625725|579399832|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
160455998|NCT04625725|579399833|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
160455999|NCT04625725|579399834|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
160946015|NCT01831089|581190034|FG001|Cohort B: Arm B|Physician Decision|0|||
160946016|NCT01831089|581190035|FG002|Cohort B: Arm B|Physician Decision|0|||
160946017|NCT01831089|581190036|FG003|Cohort B: Arm B|Physician Decision|0|||
160946018|NCT01831089|581190037|FG004|Cohort B: Arm B|Physician Decision|0|||
160946019|NCT01831089|581190038|FG005|Cohort B: Arm B|Physician Decision|2|||
160946020|NCT01831089|581190033|FG000|Cohort B: Arm B|Never treated|0|||
160946021|NCT01831089|581190034|FG001|Cohort B: Arm B|Never treated|0|||
160946022|NCT01831089|581190035|FG002|Cohort B: Arm B|Never treated|0|||
160946023|NCT01831089|581190036|FG003|Cohort B: Arm B|Never treated|0|||
160946024|NCT01831089|581190037|FG004|Cohort B: Arm B|Never treated|0|||
160946025|NCT01831089|581190038|FG005|Cohort B: Arm B|Never treated|2|||
160946026|NCT01831089|581190033|FG000|Cohort B: Arm B|Adverse Event|0|||
160946027|NCT01831089|581190034|FG001|Cohort B: Arm B|Adverse Event|0|||
160946028|NCT01831089|581190035|FG002|Cohort B: Arm B|Adverse Event|0|||
160946029|NCT01831089|581190036|FG003|Cohort B: Arm B|Adverse Event|0|||
160946030|NCT01831089|581190037|FG004|Cohort B: Arm B|Adverse Event|0|||
160946031|NCT01831089|581190038|FG005|Cohort B: Arm B|Adverse Event|1|||
160946032|NCT01831089|581190033|FG000|Cohort B: Arm B|Global end of study|0|||
160946033|NCT01831089|581190034|FG001|Cohort B: Arm B|Global end of study|0|||
160946034|NCT01831089|581190035|FG002|Cohort B: Arm B|Global end of study|0|||
160946035|NCT01831089|581190036|FG003|Cohort B: Arm B|Global end of study|0|||
160946036|NCT01831089|581190037|FG004|Cohort B: Arm B|Global end of study|0|||
160946037|NCT01831089|581190038|FG005|Cohort B: Arm B|Global end of study|1|||
160946038|NCT00889421|581190042|FG000|Overall Study|Lack of Efficacy|3|||
160946039|NCT03551938|581190043|FG000|3-Month Follow Up|Lost to Follow-up|39|||
160456000|NCT04625725|579399829|FG000|Provent Main Study|INCARCERATION|3|||
160456001|NCT04625725|579399830|FG001|Provent Main Study|INCARCERATION|0|||
160456002|NCT04625725|579399831|FG002|Provent Main Study|INCARCERATION|0|||
160456003|NCT04625725|579399832|FG003|Provent Main Study|INCARCERATION|0|||
160456004|NCT04625725|579399833|FG004|Provent Main Study|INCARCERATION|0|||
160456005|NCT04625725|579399834|FG005|Provent Main Study|INCARCERATION|0|||
160456006|NCT04625725|579399829|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
160456007|NCT04625725|579399830|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
160456008|NCT04625725|579399831|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
160456009|NCT04625725|579399832|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
160456010|NCT04625725|579399833|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
160456011|NCT04625725|579399834|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
160456012|NCT04625725|579399829|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
160456013|NCT04625725|579399830|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
160456014|NCT04625725|579399831|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
160456015|NCT04625725|579399832|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
160456016|NCT04625725|579399833|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
160456017|NCT04625725|579399834|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
160456018|NCT04625725|579399829|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
160456019|NCT04625725|579399830|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
160946040|NCT03551938|581190044|FG001|3-Month Follow Up|Lost to Follow-up|38|||
160946041|NCT03551938|581190043|FG000|6-Month Follow Up|Lost to Follow-up|46|||
160946042|NCT03551938|581190044|FG001|6-Month Follow Up|Lost to Follow-up|42|||
160946043|NCT03551938|581190043|FG000|9-Month Follow Up|Lost to Follow-up|44|||
160946044|NCT03551938|581190044|FG001|9-Month Follow Up|Lost to Follow-up|43|||
160946045|NCT01114646|581190045|FG000|Overall Study|Withdrawal by Subject|3|||
160946046|NCT01114646|581190046|FG001|Overall Study|Withdrawal by Subject|2|||
160946047|NCT00659269|581190056|FG000|Overall Study|Physician Decision|1|||
160946048|NCT00659269|581190057|FG001|Overall Study|Physician Decision|1|||
160946049|NCT00908960|581190059|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
160946050|NCT00908960|581190060|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
160946051|NCT00908960|581190061|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
160946052|NCT00781326|581190062|FG000|Phase I|Adverse Event|1|||
160946053|NCT00781326|581190062|FG000|Phase I|Withdrawal by Subject|1|||
160946054|NCT00781326|581190062|FG000|Phase I|Physician Decision|2|||
160456020|NCT04625725|579399831|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
160456021|NCT04625725|579399832|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
160946055|NCT00096941|581190063|FG000|Overall Study|disease progression|3|||
160946056|NCT02401672|581190064|FG000|Overall Study|Withdrawal by Subject|1|||
160946057|NCT02401672|581190065|FG001|Overall Study|Withdrawal by Subject|3|||
160946058|NCT05061446|581190071|FG000|Overall Study|Adverse Event|2|||
160946059|NCT05061446|581190072|FG001|Overall Study|Adverse Event|0|||
160946060|NCT05061446|581190073|FG002|Overall Study|Adverse Event|0|||
160946061|NCT05061446|581190071|FG000|Overall Study|Participant no longer available due to personal reason|0|||
160946062|NCT05061446|581190072|FG001|Overall Study|Participant no longer available due to personal reason|1|||
160946063|NCT05061446|581190073|FG002|Overall Study|Participant no longer available due to personal reason|0|||
160946064|NCT04111497|581190074|FG000|Overall Study|relapse of primary disease|1|||
160946065|NCT04111497|581190074|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
160946066|NCT01993719|581190077|FG000|First Drug Administration|Not treated|1|||
160946067|NCT01993719|581190078|FG001|First Drug Administration|Not treated|0|||
160946068|NCT01993719|581190079|FG002|First Drug Administration|Not treated|0|||
160946069|NCT01993719|581190080|FG003|First Drug Administration|Not treated|0|||
160946070|NCT01993719|581190081|FG004|First Drug Administration|Not treated|0|||
160946071|NCT05857527|581190082|FG000|Overall Study|Withdrawal by Subject|0|||
160946072|NCT05857527|581190083|FG001|Overall Study|Withdrawal by Subject|1|||
160946073|NCT02799082|581190085|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
160946074|NCT02799082|581190086|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
160946075|NCT02799082|581190085|FG000|Overall Study|Protocol Violation|0|||
160946076|NCT02799082|581190086|FG001|Overall Study|Protocol Violation|1|||
160946077|NCT01592708|581190087|FG000|Overall Study|Protocol Violation|3|||
160946078|NCT01592708|581190088|FG001|Overall Study|Protocol Violation|0|||
160946079|NCT01748994|581190090|FG000|Overall Study|Lost to Follow-up|8|||
160946080|NCT01748994|581190091|FG001|Overall Study|Lost to Follow-up|6|||
160946081|NCT03105362|581190092|FG000|Overall Study|Withdrawal by Subject|1|||
160946082|NCT03105362|581190092|FG000|Overall Study|Lost to Follow-up|1|||
160946083|NCT00861341|581190094|FG000|Overall Study|Withdrawal by Subject|2|||
160946084|NCT01440946|581190095|FG000|Overall Study|Lost to Follow-up|1|||
160946085|NCT01440946|581190096|FG001|Overall Study|Lost to Follow-up|1|||
160946086|NCT01440946|581190095|FG000|Overall Study|Physician Decision|1|||
160946087|NCT01440946|581190096|FG001|Overall Study|Physician Decision|0|||
160946088|NCT01975389|581190097|FG000|Overall Study|Adverse Event|10|||
160946089|NCT01975389|581190098|FG001|Overall Study|Adverse Event|6|||
160946090|NCT01975389|581190097|FG000|Overall Study|Death|61|||
160946091|NCT01975389|581190098|FG001|Overall Study|Death|54|||
160946092|NCT01975389|581190097|FG000|Overall Study|Lost to Follow-up|81|||
160946093|NCT01975389|581190098|FG001|Overall Study|Lost to Follow-up|86|||
160946094|NCT01975389|581190097|FG000|Overall Study|Withdrawal by Subject|90|||
160946095|NCT01975389|581190098|FG001|Overall Study|Withdrawal by Subject|76|||
160946096|NCT01975389|581190097|FG000|Overall Study|Other|6|||
160946097|NCT01975389|581190098|FG001|Overall Study|Other|9|||
160946098|NCT01975389|581190097|FG000|Overall Study|Randomized, not treated|4|||
160946099|NCT01975389|581190098|FG001|Overall Study|Randomized, not treated|5|||
160946100|NCT01312961|581190099|FG000|Overall Study|Adverse Event|3|||
160946101|NCT01312961|581190100|FG001|Overall Study|Adverse Event|3|||
160946102|NCT01312961|581190099|FG000|Overall Study|Lack of Efficacy|11|||
160946103|NCT01312961|581190100|FG001|Overall Study|Lack of Efficacy|1|||
160946104|NCT01312961|581190099|FG000|Overall Study|Poor compliance to protocol|1|||
160946105|NCT01312961|581190100|FG001|Overall Study|Poor compliance to protocol|0|||
160946106|NCT01312961|581190099|FG000|Overall Study|Other than specified above|2|||
160946107|NCT01312961|581190100|FG001|Overall Study|Other than specified above|3|||
160946108|NCT01337297|581190106|FG000|Overall Study|They entered to single anodal tDCS|4|||
160946109|NCT01337297|581190107|FG001|Overall Study|They entered to single anodal tDCS|3|||
160946110|NCT01337297|581190106|FG000|Overall Study|Lost to Follow-up|1|||
160946111|NCT01337297|581190107|FG001|Overall Study|Lost to Follow-up|3|||
160946112|NCT01800903|581190108|FG000|Second Test Period|unable to catheterise|1|||
160946113|NCT01800903|581190109|FG001|Second Test Period|unable to catheterise|0|||
160946114|NCT01800903|581190110|FG002|Second Test Period|unable to catheterise|0|||
160946115|NCT01800903|581190111|FG003|Second Test Period|unable to catheterise|0|||
160946116|NCT01800903|581190112|FG004|Second Test Period|unable to catheterise|0|||
160946117|NCT01800903|581190113|FG005|Second Test Period|unable to catheterise|0|||
160946118|NCT02778204|581190114|FG000|Overall Study|Adverse Event|1|||
160946119|NCT02778204|581190115|FG001|Overall Study|Adverse Event|0|||
160946120|NCT02778204|581190116|FG002|Overall Study|Adverse Event|0|||
160946121|NCT02778204|581190117|FG003|Overall Study|Adverse Event|0|||
160946122|NCT02778204|581190114|FG000|Overall Study|Withdrawal by Subject|0|||
160946123|NCT02778204|581190115|FG001|Overall Study|Withdrawal by Subject|0|||
160946124|NCT02778204|581190116|FG002|Overall Study|Withdrawal by Subject|1|||
160946125|NCT02778204|581190117|FG003|Overall Study|Withdrawal by Subject|2|||
160946126|NCT02778204|581190114|FG000|Overall Study|Lost to Follow-up|1|||
160946127|NCT02778204|581190115|FG001|Overall Study|Lost to Follow-up|0|||
160946128|NCT02778204|581190116|FG002|Overall Study|Lost to Follow-up|2|||
160999488|NCT00150176|581382727|FG001|Overall Study|Lost to Follow-up|3|||
160946129|NCT02778204|581190117|FG003|Overall Study|Lost to Follow-up|1|||
160946130|NCT02778204|581190114|FG000|Overall Study|Protocol Violation|0|||
160946131|NCT02778204|581190115|FG001|Overall Study|Protocol Violation|0|||
160946132|NCT02778204|581190116|FG002|Overall Study|Protocol Violation|1|||
160946133|NCT02778204|581190117|FG003|Overall Study|Protocol Violation|0|||
160946134|NCT02778204|581190114|FG000|Overall Study|Eligibility Violation|0|||
160946135|NCT02778204|581190115|FG001|Overall Study|Eligibility Violation|0|||
160946136|NCT02778204|581190116|FG002|Overall Study|Eligibility Violation|0|||
160946137|NCT02778204|581190117|FG003|Overall Study|Eligibility Violation|1|||
160946138|NCT01720069|581190118|FG000|Overall Study|Could not use e-diary correctly|0|||
160946139|NCT01720069|581190119|FG001|Overall Study|Could not use e-diary correctly|1|||
160946140|NCT01720069|581190120|FG002|Overall Study|Could not use e-diary correctly|1|||
160946141|NCT01720069|581190118|FG000|Overall Study|Randomised without baseline values|0|||
160946142|NCT01720069|581190119|FG001|Overall Study|Randomised without baseline values|0|||
160946143|NCT01720069|581190120|FG002|Overall Study|Randomised without baseline values|1|||
160946144|NCT01720069|581190118|FG000|Overall Study|Adverse Event|0|||
160946145|NCT01720069|581190119|FG001|Overall Study|Adverse Event|0|||
160946146|NCT01720069|581190120|FG002|Overall Study|Adverse Event|1|||
160946147|NCT01720069|581190118|FG000|Overall Study|Lack of Efficacy|0|||
160946148|NCT01720069|581190119|FG001|Overall Study|Lack of Efficacy|4|||
160946149|NCT01720069|581190120|FG002|Overall Study|Lack of Efficacy|0|||
160946150|NCT01720069|581190118|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
160946151|NCT01720069|581190119|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
160946152|NCT01720069|581190120|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
160946153|NCT01720069|581190118|FG000|Overall Study|Withdrawal by Subject|0|||
160946154|NCT01720069|581190119|FG001|Overall Study|Withdrawal by Subject|2|||
160946155|NCT01720069|581190120|FG002|Overall Study|Withdrawal by Subject|1|||
160946156|NCT01720069|581190118|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
160946157|NCT01720069|581190119|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
160946158|NCT01720069|581190120|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
160946159|NCT01720069|581190118|FG000|Overall Study|Non-compliance on using e-diary|0|||
160946160|NCT01720069|581190119|FG001|Overall Study|Non-compliance on using e-diary|0|||
160946161|NCT01720069|581190120|FG002|Overall Study|Non-compliance on using e-diary|1|||
160946162|NCT01720069|581190118|FG000|Overall Study|Lost to Follow-up|0|||
160946163|NCT01720069|581190119|FG001|Overall Study|Lost to Follow-up|0|||
160946164|NCT01720069|581190120|FG002|Overall Study|Lost to Follow-up|1|||
160946165|NCT00360334|581190121|FG000|Overall Study|Adverse Event|7|||
160946166|NCT00360334|581190122|FG001|Overall Study|Adverse Event|4|||
160946167|NCT00360334|581190121|FG000|Overall Study|Protocol Violation|1|||
160946168|NCT00360334|581190122|FG001|Overall Study|Protocol Violation|1|||
160946169|NCT00360334|581190121|FG000|Overall Study|Physician Decision|2|||
160946170|NCT00360334|581190122|FG001|Overall Study|Physician Decision|3|||
160946171|NCT00360334|581190121|FG000|Overall Study|Lack of Efficacy|0|||
160946172|NCT00360334|581190122|FG001|Overall Study|Lack of Efficacy|1|||
160946173|NCT00360334|581190121|FG000|Overall Study|Entry criterion not met|1|||
160946174|NCT00360334|581190122|FG001|Overall Study|Entry criterion not met|2|||
160946175|NCT00360334|581190121|FG000|Overall Study|Subject decision|8|||
160946176|NCT00360334|581190122|FG001|Overall Study|Subject decision|2|||
160946177|NCT01898793|581190124|FG000|Overall Study|Death|2|||
160946178|NCT01898793|581190125|FG001|Overall Study|Death|1|||
160946179|NCT01898793|581190126|FG002|Overall Study|Death|4|||
160946180|NCT01898793|581190127|FG003|Overall Study|Death|0|||
160946181|NCT01898793|581190128|FG004|Overall Study|Death|0|||
160946182|NCT01898793|581190129|FG005|Overall Study|Death|0|||
160946183|NCT01898793|581190130|FG006|Overall Study|Death|0|||
160946184|NCT01306617|581190134|FG000|Overall Study|Adverse Event|1|||
160946185|NCT01306617|581190135|FG001|Overall Study|Adverse Event|0|||
160946186|NCT01306617|581190136|FG002|Overall Study|Adverse Event|0|||
160946187|NCT01306617|581190134|FG000|Overall Study|Virologic Failure|0|||
160946188|NCT01306617|581190135|FG001|Overall Study|Virologic Failure|0|||
160946189|NCT01306617|581190136|FG002|Overall Study|Virologic Failure|5|||
160946190|NCT01306617|581190134|FG000|Overall Study|Non-compliance|0|||
160946191|NCT01306617|581190135|FG001|Overall Study|Non-compliance|1|||
160946192|NCT01306617|581190136|FG002|Overall Study|Non-compliance|0|||
160946193|NCT04028388|581190137|FG000|Overall Study|Evaluations missing|3|||
160946194|NCT04028388|581190138|FG001|Overall Study|Evaluations missing|6|||
160946195|NCT04028388|581190137|FG000|Overall Study|Not started|2|||
160946196|NCT04028388|581190138|FG001|Overall Study|Not started|0|||
160946197|NCT00162136|581190139|FG000|Overall Study|Adverse Event|1|||
160946198|NCT00162136|581190139|FG000|Overall Study|Death|1|||
160946199|NCT00162136|581190139|FG000|Overall Study|Disease Progression/Relapse|23|||
160999489|NCT00150176|581382726|FG000|Overall Study|OTHER|11|||
160999490|NCT00150176|581382727|FG001|Overall Study|OTHER|13|||
160456022|NCT04625725|579399833|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
160946200|NCT00162136|581190139|FG000|Overall Study|Investigator Request|5|||
160946201|NCT00162136|581190139|FG000|Overall Study|Study Drug Toxicity|4|||
160946202|NCT00162136|581190139|FG000|Overall Study|Withdrawal by Subject|1|||
160946203|NCT00836875|581190141|FG000|Overall Study|Death|3|||
160946204|NCT00836875|581190142|FG001|Overall Study|Death|2|||
160946205|NCT00836875|581190141|FG000|Overall Study|Withdrawal by Subject|0|||
160946206|NCT00836875|581190142|FG001|Overall Study|Withdrawal by Subject|1|||
160946207|NCT03964454|581190151|FG000|Overall Study|Lost to Follow-up|13|||
160946208|NCT03964454|581190152|FG001|Overall Study|Lost to Follow-up|7|||
160946209|NCT03964454|581190151|FG000|Overall Study|Withdrawal by Subject|4|||
160580059|NCT04184622|579844109|FG000|Additional Treatment Period|Death|0|||
160580060|NCT04184622|579844110|FG001|Additional Treatment Period|Death|0|||
160580061|NCT04184622|579844111|FG002|Additional Treatment Period|Death|1|||
160580062|NCT04184622|579844112|FG003|Additional Treatment Period|Death|1|||
160580063|NCT04184622|579844109|FG000|Additional Treatment Period|Lost to Follow-up|6|||
160580064|NCT04184622|579844110|FG001|Additional Treatment Period|Lost to Follow-up|4|||
160580065|NCT04184622|579844111|FG002|Additional Treatment Period|Lost to Follow-up|8|||
160580066|NCT04184622|579844112|FG003|Additional Treatment Period|Lost to Follow-up|6|||
160580067|NCT04184622|579844109|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
160580068|NCT04184622|579844110|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
160580069|NCT04184622|579844111|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
160580070|NCT04184622|579844112|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
160580071|NCT04184622|579844109|FG000|Additional Treatment Period|Physician Decision|0|||
160580072|NCT04184622|579844110|FG001|Additional Treatment Period|Physician Decision|0|||
160580073|NCT04184622|579844111|FG002|Additional Treatment Period|Physician Decision|1|||
160580074|NCT04184622|579844112|FG003|Additional Treatment Period|Physician Decision|0|||
160580075|NCT04184622|579844109|FG000|Additional Treatment Period|Pregnancy|0|||
160946210|NCT03964454|581190152|FG001|Overall Study|Withdrawal by Subject|11|||
160946211|NCT04450264|581191943|FG000|Overall Study|Incomplete survey|13|||
160946212|NCT04450264|581191944|FG001|Overall Study|Incomplete survey|19|||
160946213|NCT00116805|581191948|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
160946214|NCT00116805|581191949|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
160946215|NCT00116805|581191948|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
160946216|NCT00116805|581191949|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
160946217|NCT00116805|581191948|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
160946218|NCT00116805|581191949|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
160946219|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
160946220|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
160946221|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
160946222|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
160946223|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
160946224|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
160946225|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
160946226|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
160946227|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
160946228|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
160946229|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
160946230|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
160946231|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
160946232|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
160946233|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
160946234|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
160946235|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
160946236|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
160946237|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
160946238|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
160946239|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
160946240|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
160946241|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
160946242|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
160946243|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
160946244|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
160946245|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
160946246|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
160946247|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
160946248|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
160946249|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
160946250|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
160946251|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
160946252|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
160946253|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
160946254|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
160946255|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
160580076|NCT04184622|579844110|FG001|Additional Treatment Period|Pregnancy|0|||
160580077|NCT04184622|579844111|FG002|Additional Treatment Period|Pregnancy|0|||
160580078|NCT04184622|579844112|FG003|Additional Treatment Period|Pregnancy|1|||
160580079|NCT04184622|579844109|FG000|Additional Treatment Period|Protocol deviation|0|||
160999491|NCT04035668|581382732|FG000|Overall Study|Adverse Event|3|||
160999492|NCT04035668|581382733|FG001|Overall Study|Adverse Event|4|||
160999493|NCT04035668|581382734|FG002|Overall Study|Adverse Event|2|||
160999494|NCT04035668|581382732|FG000|Overall Study|Lost to Follow-up|0|||
160999495|NCT04035668|581382733|FG001|Overall Study|Lost to Follow-up|1|||
160999496|NCT04035668|581382734|FG002|Overall Study|Lost to Follow-up|0|||
160999497|NCT04035668|581382732|FG000|Overall Study|Physician Decision|2|||
160999498|NCT04035668|581382733|FG001|Overall Study|Physician Decision|1|||
160999499|NCT04035668|581382734|FG002|Overall Study|Physician Decision|1|||
160580080|NCT04184622|579844110|FG001|Additional Treatment Period|Protocol deviation|0|||
160580081|NCT04184622|579844111|FG002|Additional Treatment Period|Protocol deviation|1|||
160580082|NCT04184622|579844112|FG003|Additional Treatment Period|Protocol deviation|0|||
160946256|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
160946257|NCT00116805|581191948|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
160946258|NCT00116805|581191949|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
160946259|NCT00116805|581191948|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
160946260|NCT00116805|581191949|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
160946261|NCT00116805|581191948|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
160946262|NCT00116805|581191949|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
160946263|NCT00116805|581191948|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
160946264|NCT00116805|581191949|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
160946265|NCT00116805|581191948|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
160946266|NCT00116805|581191949|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
160946267|NCT00116805|581191948|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
160946268|NCT00116805|581191949|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
160946269|NCT00116805|581191948|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
160946270|NCT00116805|581191949|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
160946271|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
160946272|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
160946273|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
160946274|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
160946275|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
160946276|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
160946277|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
160946278|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
160946279|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
160946280|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
160946281|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
160946282|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
160946283|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
160946284|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
160946285|NCT00116805|581191948|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
160946286|NCT00116805|581191949|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
160946287|NCT00116805|581191948|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
160946288|NCT00116805|581191949|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
160946289|NCT00116805|581191948|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
160946290|NCT00116805|581191949|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
160946291|NCT00116805|581191948|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
160946292|NCT00116805|581191949|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
160946293|NCT00116805|581191948|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
160946294|NCT00116805|581191949|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
160946295|NCT00116805|581191948|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
160946296|NCT00116805|581191949|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
160946297|NCT00116805|581191948|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
160946298|NCT00116805|581191949|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
160580083|NCT04184622|579844109|FG000|Additional Treatment Period|Site closed|1|||
160580084|NCT04184622|579844110|FG001|Additional Treatment Period|Site closed|0|||
160946299|NCT00116805|581191948|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
160946300|NCT00116805|581191949|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
160580085|NCT04184622|579844111|FG002|Additional Treatment Period|Site closed|1|||
160580086|NCT04184622|579844112|FG003|Additional Treatment Period|Site closed|0|||
160999500|NCT04035668|581382732|FG000|Overall Study|Subject Decision|2|||
160946301|NCT00116805|581191948|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
160946302|NCT00116805|581191949|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
160999501|NCT04035668|581382733|FG001|Overall Study|Subject Decision|2|||
160999502|NCT04035668|581382734|FG002|Overall Study|Subject Decision|0|||
160580087|NCT04184622|579844109|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
160946303|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
160946304|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
160946305|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
160946306|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
160946307|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Adverse Event|5|||
160946308|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Adverse Event|3|||
160946309|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Adverse Event|4|||
160946310|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Adverse Event|10|||
160946311|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
160946312|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
160946313|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
160946314|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
160946315|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
160946316|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
160946317|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
160946318|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
160946319|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Pregnancy|5|||
160946320|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Pregnancy|0|||
160946321|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Pregnancy|3|||
160946322|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Pregnancy|2|||
160946323|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Non-compliance|1|||
160946324|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Non-compliance|4|||
160946325|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Non-compliance|0|||
160946326|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Non-compliance|3|||
160946327|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Other|0|||
160946328|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Other|3|||
160946329|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Other|3|||
160946330|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Other|1|||
160946331|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
160946332|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
160946333|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
160946334|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
160946335|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
160946336|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
160946337|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
160946338|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
160946339|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
160946340|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
160946341|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
160946342|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
160946343|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
160946344|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
160946345|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
160946346|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
160946347|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
160946348|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
160946349|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
160946350|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
160946351|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
160946352|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
160946353|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
160946354|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
160946355|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
160946356|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
160946357|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
160946358|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
160946359|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
160946360|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
160946361|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
160946362|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
160946363|NCT01159938|581191954|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
160946364|NCT01159938|581191955|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
160580088|NCT04184622|579844110|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
160946365|NCT01159938|581191956|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
160999503|NCT02477670|581382735|FG000|Stage 1|Adverse Event|2|||
160580089|NCT04184622|579844111|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
160580090|NCT04184622|579844112|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
160580091|NCT04184622|579844109|FG000|Safety Follow-up Period|Adverse Event|6|||
160580092|NCT04184622|579844110|FG001|Safety Follow-up Period|Adverse Event|8|||
160580093|NCT04184622|579844111|FG002|Safety Follow-up Period|Adverse Event|9|||
160580094|NCT04184622|579844112|FG003|Safety Follow-up Period|Adverse Event|16|||
160580095|NCT04184622|579844109|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
160580096|NCT04184622|579844110|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
160580097|NCT04184622|579844111|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
160580098|NCT04184622|579844112|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
160946366|NCT01159938|581191957|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
160946367|NCT01159938|581191958|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
160946368|NCT02105116|581191960|FG000|Overall Study|not eligible for step 2 of trial|5|||
160946369|NCT02105116|581191960|FG000|Overall Study|Death|1|||
160946370|NCT02318329|581191962|FG000|Overall Study|Progressive Disease|2|||
160946371|NCT02318329|581191963|FG001|Overall Study|Progressive Disease|3|||
160946372|NCT02318329|581191964|FG002|Overall Study|Progressive Disease|2|||
160946373|NCT02318329|581191965|FG003|Overall Study|Progressive Disease|3|||
160946374|NCT02318329|581191966|FG004|Overall Study|Progressive Disease|3|||
160946375|NCT02318329|581191967|FG005|Overall Study|Progressive Disease|3|||
160946376|NCT02318329|581191968|FG006|Overall Study|Progressive Disease|1|||
160946377|NCT02318329|581191969|FG007|Overall Study|Progressive Disease|1|||
160946378|NCT02318329|581191970|FG008|Overall Study|Progressive Disease|5|||
160946379|NCT02318329|581191971|FG009|Overall Study|Progressive Disease|39|||
160946380|NCT02318329|581191962|FG000|Overall Study|Death|0|||
160946381|NCT02318329|581191963|FG001|Overall Study|Death|0|||
160946382|NCT02318329|581191964|FG002|Overall Study|Death|0|||
160946383|NCT02318329|581191965|FG003|Overall Study|Death|0|||
160946384|NCT02318329|581191966|FG004|Overall Study|Death|0|||
160946385|NCT02318329|581191967|FG005|Overall Study|Death|0|||
160946386|NCT02318329|581191968|FG006|Overall Study|Death|0|||
160946387|NCT02318329|581191969|FG007|Overall Study|Death|0|||
160946388|NCT02318329|581191970|FG008|Overall Study|Death|0|||
160946389|NCT02318329|581191971|FG009|Overall Study|Death|5|||
160946390|NCT02318329|581191962|FG000|Overall Study|Lost to Follow-up|0|||
160946391|NCT02318329|581191963|FG001|Overall Study|Lost to Follow-up|0|||
160946392|NCT02318329|581191964|FG002|Overall Study|Lost to Follow-up|0|||
160946393|NCT02318329|581191965|FG003|Overall Study|Lost to Follow-up|0|||
160946394|NCT02318329|581191966|FG004|Overall Study|Lost to Follow-up|0|||
160946395|NCT02318329|581191967|FG005|Overall Study|Lost to Follow-up|0|||
160946396|NCT02318329|581191968|FG006|Overall Study|Lost to Follow-up|0|||
160946397|NCT02318329|581191969|FG007|Overall Study|Lost to Follow-up|0|||
160946398|NCT02318329|581191970|FG008|Overall Study|Lost to Follow-up|0|||
160946399|NCT02318329|581191971|FG009|Overall Study|Lost to Follow-up|1|||
160999504|NCT02477670|581382736|FG001|Stage 1|Adverse Event|7|||
160999505|NCT02477670|581382737|FG002|Stage 1|Adverse Event|0|||
160999506|NCT02477670|581382738|FG003|Stage 1|Adverse Event|0|||
160999507|NCT02477670|581382739|FG004|Stage 1|Adverse Event|0|||
160999508|NCT02477670|581382740|FG005|Stage 1|Adverse Event|0|||
160999509|NCT02477670|581382741|FG006|Stage 1|Adverse Event|0|||
160999510|NCT02477670|581382735|FG000|Stage 1|Lost to Follow-up|0|||
160999511|NCT02477670|581382736|FG001|Stage 1|Lost to Follow-up|2|||
160999512|NCT02477670|581382737|FG002|Stage 1|Lost to Follow-up|0|||
160999513|NCT02477670|581382738|FG003|Stage 1|Lost to Follow-up|0|||
160580099|NCT04184622|579844109|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
160580100|NCT04184622|579844110|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
160580101|NCT04184622|579844111|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
160580102|NCT04184622|579844112|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
160946400|NCT02318329|581191962|FG000|Overall Study|Withdrawal by Subject|0|||
160946401|NCT02318329|581191963|FG001|Overall Study|Withdrawal by Subject|0|||
160946402|NCT02318329|581191964|FG002|Overall Study|Withdrawal by Subject|0|||
160946403|NCT02318329|581191965|FG003|Overall Study|Withdrawal by Subject|0|||
160946404|NCT02318329|581191966|FG004|Overall Study|Withdrawal by Subject|0|||
160946405|NCT02318329|581191967|FG005|Overall Study|Withdrawal by Subject|0|||
160946406|NCT02318329|581191968|FG006|Overall Study|Withdrawal by Subject|0|||
160580103|NCT04184622|579844109|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
160946407|NCT02318329|581191969|FG007|Overall Study|Withdrawal by Subject|0|||
160999514|NCT02477670|581382739|FG004|Stage 1|Lost to Follow-up|0|||
160999515|NCT02477670|581382740|FG005|Stage 1|Lost to Follow-up|0|||
160946408|NCT02318329|581191970|FG008|Overall Study|Withdrawal by Subject|0|||
160946409|NCT02318329|581191971|FG009|Overall Study|Withdrawal by Subject|6|||
160946410|NCT02318329|581191962|FG000|Overall Study|Other|1|||
160946411|NCT02318329|581191963|FG001|Overall Study|Other|1|||
160946412|NCT02318329|581191964|FG002|Overall Study|Other|1|||
160946413|NCT02318329|581191965|FG003|Overall Study|Other|0|||
160946414|NCT02318329|581191966|FG004|Overall Study|Other|0|||
160946415|NCT02318329|581191967|FG005|Overall Study|Other|0|||
160946416|NCT02318329|581191968|FG006|Overall Study|Other|0|||
160946417|NCT02318329|581191969|FG007|Overall Study|Other|0|||
160999516|NCT02477670|581382741|FG006|Stage 1|Lost to Follow-up|0|||
160999517|NCT02477670|581382735|FG000|Stage 1|Withdrawal by Subject|1|||
160946418|NCT02318329|581191970|FG008|Overall Study|Other|1|||
160946419|NCT02318329|581191971|FG009|Overall Study|Other|1|||
160946420|NCT04837482|581191972|FG000|Period 2|Withdrawal by Subject|0|||
160946421|NCT04837482|581191973|FG001|Period 2|Withdrawal by Subject|1|||
160946422|NCT04820673|581191974|FG000|Overall Study|Adverse Event|6|||
160946423|NCT04820673|581191974|FG000|Overall Study|Due to Lack of Effectiveness|1|||
160946424|NCT04820673|581191974|FG000|Overall Study|Pregnancy|1|||
160946425|NCT04820673|581191974|FG000|Overall Study|Voluntary Withdrawal|20|||
160946426|NCT04820673|581191974|FG000|Overall Study|Lost to Follow-up|10|||
160946427|NCT00587587|581191977|FG000|Overall Study|Lost to Follow-up|6|||
160946428|NCT00587587|581191978|FG001|Overall Study|Lost to Follow-up|1|||
160946429|NCT00982020|581191981|FG000|Overall Study|Adverse Event|19|||
160946430|NCT00982020|581191982|FG001|Overall Study|Adverse Event|15|||
160946431|NCT00982020|581191981|FG000|Overall Study|Withdrawal by Subject|11|||
160946432|NCT00982020|581191982|FG001|Overall Study|Withdrawal by Subject|14|||
160946433|NCT00982020|581191981|FG000|Overall Study|Lost to Follow-up|5|||
160946434|NCT00982020|581191982|FG001|Overall Study|Lost to Follow-up|11|||
160946435|NCT00982020|581191981|FG000|Overall Study|Lack of Efficacy|10|||
160946436|NCT00982020|581191982|FG001|Overall Study|Lack of Efficacy|4|||
160946437|NCT00982020|581191981|FG000|Overall Study|Parent/Caregiver Decision|5|||
160946438|NCT00982020|581191982|FG001|Overall Study|Parent/Caregiver Decision|5|||
160946439|NCT00982020|581191981|FG000|Overall Study|Treatment Non-compliance|3|||
160946440|NCT00982020|581191982|FG001|Overall Study|Treatment Non-compliance|6|||
160946441|NCT00982020|581191981|FG000|Overall Study|Physician Decision|2|||
160946442|NCT00982020|581191982|FG001|Overall Study|Physician Decision|5|||
160946443|NCT00982020|581191981|FG000|Overall Study|Entry Criteria Not Met|2|||
160946444|NCT00982020|581191982|FG001|Overall Study|Entry Criteria Not Met|1|||
160946445|NCT00982020|581191981|FG000|Overall Study|Protocol Violation|0|||
160946446|NCT00982020|581191982|FG001|Overall Study|Protocol Violation|2|||
160946447|NCT00982020|581191981|FG000|Overall Study|Clinical Relapse|0|||
160946448|NCT00982020|581191982|FG001|Overall Study|Clinical Relapse|1|||
160946449|NCT00466193|581191983|FG000|Overall Study|Adverse Event|0|||
160946450|NCT00466193|581191984|FG001|Overall Study|Adverse Event|1|||
160946451|NCT00466193|581191983|FG000|Overall Study|Lost to Follow-up|2|||
160946452|NCT00466193|581191984|FG001|Overall Study|Lost to Follow-up|4|||
160946453|NCT00466193|581191983|FG000|Overall Study|Physician Decision|1|||
160946454|NCT00466193|581191984|FG001|Overall Study|Physician Decision|0|||
160946455|NCT00466193|581191983|FG000|Overall Study|Protocol Violation|1|||
160946456|NCT00466193|581191984|FG001|Overall Study|Protocol Violation|1|||
160946457|NCT00466193|581191983|FG000|Overall Study|Withdrawal by Subject|7|||
160946458|NCT00466193|581191984|FG001|Overall Study|Withdrawal by Subject|2|||
160946459|NCT00466193|581191983|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
160946460|NCT00466193|581191984|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
160946461|NCT02473614|581191988|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
160946462|NCT02473614|581191989|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
160946463|NCT02525133|581191990|FG000|Overall Study|Adverse Event|0|||
160946464|NCT02525133|581191991|FG001|Overall Study|Adverse Event|1|||
160946465|NCT02525133|581191990|FG000|Overall Study|Death|0|||
160946466|NCT02525133|581191991|FG001|Overall Study|Death|1|||
160946467|NCT02525133|581191990|FG000|Overall Study|did not meet randomization criteria|1|||
160946468|NCT02525133|581191991|FG001|Overall Study|did not meet randomization criteria|0|||
160946469|NCT02525133|581191990|FG000|Overall Study|Lost to Follow-up|5|||
160946470|NCT02525133|581191991|FG001|Overall Study|Lost to Follow-up|1|||
160946471|NCT02525133|581191990|FG000|Overall Study|randomized not enrolled|3|||
160946472|NCT02525133|581191991|FG001|Overall Study|randomized not enrolled|0|||
160946473|NCT02525133|581191990|FG000|Overall Study|Withdrawal by Subject|1|||
160946474|NCT02525133|581191991|FG001|Overall Study|Withdrawal by Subject|0|||
160946475|NCT01343082|581191992|FG000|The run-in Period|Not meeting criteria|3|||
160946476|NCT01343082|581191993|FG001|The run-in Period|Not meeting criteria|4|||
160946477|NCT01343082|581191994|FG002|The run-in Period|Not meeting criteria|5|||
160946478|NCT01343082|581191992|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
160946479|NCT01343082|581191993|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
160946480|NCT01343082|581191994|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
160946481|NCT01343082|581191992|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
160946482|NCT01343082|581191993|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
160946483|NCT01343082|581191994|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
160946484|NCT01343082|581191992|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
160580104|NCT04184622|579844110|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
160946485|NCT01343082|581191993|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
160946486|NCT01343082|581191994|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
160946487|NCT01343082|581191992|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
160946488|NCT01343082|581191993|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
160946489|NCT01343082|581191994|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
160946490|NCT01075074|581191995|FG000|Overall Study|Surgeon changed to open incisional case|1|||
160946491|NCT01075074|581191996|FG001|Overall Study|Surgeon changed to open incisional case|2|||
160580105|NCT04184622|579844111|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
160580106|NCT04184622|579844112|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
160580107|NCT04184622|579844109|FG000|Safety Follow-up Period|Physician Decision|1|||
160580108|NCT04184622|579844110|FG001|Safety Follow-up Period|Physician Decision|0|||
160580109|NCT04184622|579844111|FG002|Safety Follow-up Period|Physician Decision|0|||
160580110|NCT04184622|579844112|FG003|Safety Follow-up Period|Physician Decision|1|||
160580111|NCT04184622|579844109|FG000|Safety Follow-up Period|Pregnancy|1|||
160580112|NCT04184622|579844110|FG001|Safety Follow-up Period|Pregnancy|3|||
160580113|NCT04184622|579844111|FG002|Safety Follow-up Period|Pregnancy|0|||
160580114|NCT04184622|579844112|FG003|Safety Follow-up Period|Pregnancy|6|||
160580115|NCT04184622|579844109|FG000|Safety Follow-up Period|Protocol deviation|1|||
160580116|NCT04184622|579844110|FG001|Safety Follow-up Period|Protocol deviation|0|||
160580117|NCT04184622|579844111|FG002|Safety Follow-up Period|Protocol deviation|0|||
160580118|NCT04184622|579844112|FG003|Safety Follow-up Period|Protocol deviation|0|||
160580119|NCT04184622|579844109|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
160580120|NCT04184622|579844110|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
160580121|NCT04184622|579844111|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
160580122|NCT04184622|579844112|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
160580123|NCT02795988|579844113|FG000|Phase 1b|Withdrawal by Subject|0|||
160580124|NCT02795988|579844114|FG001|Phase 1b|Withdrawal by Subject|1|||
160580125|NCT02795988|579844115|FG002|Phase 1b|Withdrawal by Subject|0|||
160580126|NCT02795988|579844116|FG003|Phase 1b|Withdrawal by Subject|0|||
160580127|NCT02795988|579844117|FG004|Phase 1b|Withdrawal by Subject|0|||
160580128|NCT02795988|579844118|FG005|Phase 1b|Withdrawal by Subject|0|||
160580129|NCT02795988|579844119|FG006|Phase 1b|Withdrawal by Subject|0|||
160580130|NCT02795988|579844113|FG000|Phase 1b|Death|1|||
160580131|NCT02795988|579844114|FG001|Phase 1b|Death|2|||
160580132|NCT02795988|579844115|FG002|Phase 1b|Death|1|||
160580133|NCT02795988|579844116|FG003|Phase 1b|Death|0|||
160580134|NCT02795988|579844117|FG004|Phase 1b|Death|0|||
160580135|NCT02795988|579844118|FG005|Phase 1b|Death|0|||
160580136|NCT02795988|579844119|FG006|Phase 1b|Death|0|||
160580137|NCT02795988|579844113|FG000|Phase 1b|Physician Decision|0|||
160580138|NCT02795988|579844114|FG001|Phase 1b|Physician Decision|0|||
160580139|NCT02795988|579844115|FG002|Phase 1b|Physician Decision|1|||
160580140|NCT02795988|579844116|FG003|Phase 1b|Physician Decision|0|||
160580141|NCT02795988|579844117|FG004|Phase 1b|Physician Decision|0|||
160580142|NCT02795988|579844118|FG005|Phase 1b|Physician Decision|0|||
160580143|NCT02795988|579844119|FG006|Phase 1b|Physician Decision|0|||
160580144|NCT02795988|579844113|FG000|Phase 1b|Progressive Disease|2|||
160580145|NCT02795988|579844114|FG001|Phase 1b|Progressive Disease|2|||
160580146|NCT02795988|579844115|FG002|Phase 1b|Progressive Disease|0|||
160580147|NCT02795988|579844116|FG003|Phase 1b|Progressive Disease|0|||
160580148|NCT02795988|579844117|FG004|Phase 1b|Progressive Disease|0|||
160580149|NCT02795988|579844118|FG005|Phase 1b|Progressive Disease|0|||
160580150|NCT02795988|579844119|FG006|Phase 1b|Progressive Disease|0|||
160580151|NCT02795988|579844113|FG000|Phase 2|Withdrawal by Subject|0|||
160580152|NCT02795988|579844114|FG001|Phase 2|Withdrawal by Subject|0|||
160580153|NCT02795988|579844115|FG002|Phase 2|Withdrawal by Subject|0|||
160580154|NCT02795988|579844116|FG003|Phase 2|Withdrawal by Subject|1|||
160580155|NCT02795988|579844117|FG004|Phase 2|Withdrawal by Subject|0|||
160580156|NCT02795988|579844118|FG005|Phase 2|Withdrawal by Subject|0|||
160580157|NCT02795988|579844119|FG006|Phase 2|Withdrawal by Subject|0|||
160580158|NCT02795988|579844113|FG000|Phase 2|Death|0|||
160580159|NCT02795988|579844114|FG001|Phase 2|Death|0|||
160580160|NCT02795988|579844115|FG002|Phase 2|Death|0|||
160580161|NCT02795988|579844116|FG003|Phase 2|Death|17|||
160580162|NCT02795988|579844117|FG004|Phase 2|Death|17|||
160580163|NCT02795988|579844118|FG005|Phase 2|Death|0|||
160580164|NCT02795988|579844119|FG006|Phase 2|Death|0|||
160580165|NCT02795988|579844113|FG000|Phase 2|Other|0|||
160580166|NCT02795988|579844114|FG001|Phase 2|Other|0|||
160580167|NCT02795988|579844115|FG002|Phase 2|Other|0|||
160580168|NCT02795988|579844116|FG003|Phase 2|Other|1|||
160580169|NCT02795988|579844117|FG004|Phase 2|Other|0|||
160580170|NCT02795988|579844118|FG005|Phase 2|Other|0|||
160580171|NCT02795988|579844119|FG006|Phase 2|Other|0|||
160580172|NCT02795988|579844113|FG000|Phase 2 Extension|Death|0|||
160580173|NCT02795988|579844114|FG001|Phase 2 Extension|Death|0|||
160580174|NCT02795988|579844115|FG002|Phase 2 Extension|Death|0|||
160580175|NCT02795988|579844116|FG003|Phase 2 Extension|Death|0|||
160580176|NCT02795988|579844117|FG004|Phase 2 Extension|Death|0|||
160580177|NCT02795988|579844118|FG005|Phase 2 Extension|Death|5|||
160580178|NCT02795988|579844119|FG006|Phase 2 Extension|Death|6|||
160580179|NCT02795988|579844113|FG000|Phase 2 Extension|Other reasons|0|||
160580180|NCT02795988|579844114|FG001|Phase 2 Extension|Other reasons|0|||
160580181|NCT02795988|579844115|FG002|Phase 2 Extension|Other reasons|0|||
160580182|NCT02795988|579844116|FG003|Phase 2 Extension|Other reasons|0|||
160580183|NCT02795988|579844117|FG004|Phase 2 Extension|Other reasons|0|||
160580184|NCT02795988|579844118|FG005|Phase 2 Extension|Other reasons|2|||
160580185|NCT02795988|579844119|FG006|Phase 2 Extension|Other reasons|1|||
160580186|NCT00726323|579844120|FG000|Overall Study|Withdrawal by Subject|3|||
160946492|NCT01075074|581191997|FG002|Overall Study|Surgeon changed to open incisional case|2|||
160946493|NCT00844194|581191999|FG000|Overall Study|Adverse Event|17|||
160946494|NCT00844194|581192000|FG001|Overall Study|Adverse Event|5|||
160946495|NCT00844194|581191999|FG000|Overall Study|Protocol Violation|1|||
160946496|NCT00844194|581192000|FG001|Overall Study|Protocol Violation|1|||
160946497|NCT00844194|581191999|FG000|Overall Study|Lost to Follow-up|1|||
160946498|NCT00844194|581192000|FG001|Overall Study|Lost to Follow-up|1|||
160946499|NCT00844194|581191999|FG000|Overall Study|Withdrawal by Subject|2|||
160946500|NCT00844194|581192000|FG001|Overall Study|Withdrawal by Subject|1|||
160946501|NCT00844194|581191999|FG000|Overall Study|Lack of Efficacy|3|||
160946502|NCT00844194|581192000|FG001|Overall Study|Lack of Efficacy|0|||
160946503|NCT00844194|581191999|FG000|Overall Study|Other reason (not specified)|1|||
160946504|NCT00844194|581192000|FG001|Overall Study|Other reason (not specified)|0|||
160946505|NCT02667912|581192001|FG000|Overall Study|Death|3|||
160946506|NCT02667912|581192002|FG001|Overall Study|Death|1|||
160946507|NCT02667912|581192001|FG000|Overall Study|Withdrawal by Subject|1|||
160946508|NCT02667912|581192002|FG001|Overall Study|Withdrawal by Subject|2|||
160946509|NCT02667912|581192001|FG000|Overall Study|Withdrawal by Subject|1|||
160946510|NCT02667912|581192002|FG001|Overall Study|Withdrawal by Subject|0|||
160946511|NCT04443218|581192003|FG000|Overall Study|Exited study for other reasons|9|||
160946512|NCT04443218|581192003|FG000|Overall Study|Withdrawal by Subject|1|||
160946513|NCT04443218|581192003|FG000|Overall Study|Lost to Follow-up|4|||
160946514|NCT04443218|581192003|FG000|Overall Study|Death|19|||
160946515|NCT01047683|581192004|FG000|Overall Study|Adverse Event|3|||
160946516|NCT01047683|581192005|FG001|Overall Study|Adverse Event|1|||
160946517|NCT01047683|581192006|FG002|Overall Study|Adverse Event|0|||
160946518|NCT01047683|581192004|FG000|Overall Study|Withdrew Consent|1|||
160946519|NCT01047683|581192005|FG001|Overall Study|Withdrew Consent|4|||
160946520|NCT01047683|581192006|FG002|Overall Study|Withdrew Consent|2|||
160946521|NCT01047683|581192004|FG000|Overall Study|Lost to Follow-up|0|||
160946522|NCT01047683|581192005|FG001|Overall Study|Lost to Follow-up|1|||
160946523|NCT01047683|581192006|FG002|Overall Study|Lost to Follow-up|0|||
160999518|NCT02477670|581382736|FG001|Stage 1|Withdrawal by Subject|2|||
160999519|NCT02477670|581382737|FG002|Stage 1|Withdrawal by Subject|0|||
160999520|NCT02477670|581382738|FG003|Stage 1|Withdrawal by Subject|0|||
160999521|NCT02477670|581382739|FG004|Stage 1|Withdrawal by Subject|0|||
160999522|NCT02477670|581382740|FG005|Stage 1|Withdrawal by Subject|0|||
160999523|NCT02477670|581382741|FG006|Stage 1|Withdrawal by Subject|0|||
160999524|NCT02477670|581382735|FG000|Stage 1|Non-compliance with Study Drug|1|||
160999525|NCT02477670|581382736|FG001|Stage 1|Non-compliance with Study Drug|2|||
160999526|NCT02477670|581382737|FG002|Stage 1|Non-compliance with Study Drug|0|||
160999527|NCT02477670|581382738|FG003|Stage 1|Non-compliance with Study Drug|0|||
160999528|NCT02477670|581382739|FG004|Stage 1|Non-compliance with Study Drug|0|||
160999529|NCT02477670|581382740|FG005|Stage 1|Non-compliance with Study Drug|0|||
160999530|NCT02477670|581382741|FG006|Stage 1|Non-compliance with Study Drug|0|||
160580187|NCT00726323|579844121|FG001|Overall Study|Withdrawal by Subject|1|||
160580188|NCT00726323|579844120|FG000|Overall Study|Physician Decision|1|||
160580189|NCT00726323|579844121|FG001|Overall Study|Physician Decision|0|||
160580190|NCT00726323|579844120|FG000|Overall Study|Progressive disease|23|||
160580191|NCT00726323|579844121|FG001|Overall Study|Progressive disease|16|||
160580192|NCT00726323|579844120|FG000|Overall Study|Clinical progression|0|||
160580193|NCT00726323|579844121|FG001|Overall Study|Clinical progression|3|||
160580194|NCT00726323|579844120|FG000|Overall Study|Adverse Event|9|||
160580195|NCT00726323|579844121|FG001|Overall Study|Adverse Event|9|||
160580196|NCT00726323|579844120|FG000|Overall Study|Death|1|||
160580197|NCT00726323|579844121|FG001|Overall Study|Death|0|||
160580198|NCT00726323|579844120|FG000|Overall Study|Participant wished to discontinue|0|||
160580199|NCT00726323|579844121|FG001|Overall Study|Participant wished to discontinue|1|||
160580200|NCT00726323|579844120|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
160580201|NCT00726323|579844121|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
160580202|NCT02341014|579844122|FG000|Overall Study|Adverse Event|0|||
160580203|NCT02341014|579844123|FG001|Overall Study|Adverse Event|1|||
160580204|NCT02341014|579844124|FG002|Overall Study|Adverse Event|0|||
160580205|NCT02341014|579844125|FG003|Overall Study|Adverse Event|0|||
160580206|NCT02341014|579844126|FG004|Overall Study|Adverse Event|2|||
160580207|NCT05058664|579844127|FG000|Overall Study|No follow-up data provided|4|||
160946524|NCT01047683|581192004|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
160946525|NCT01047683|581192005|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
160946526|NCT01047683|581192006|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
160946527|NCT03447769|581192007|FG000|Overall Study|Progressive disease|138|||
160946528|NCT03447769|581192008|FG001|Overall Study|Progressive disease|148|||
160946529|NCT03447769|581192007|FG000|Overall Study|Study terminated by Sponsor|60|||
160946530|NCT03447769|581192008|FG001|Overall Study|Study terminated by Sponsor|44|||
160946531|NCT03447769|581192007|FG000|Overall Study|Adverse Event|34|||
160946532|NCT03447769|581192008|FG001|Overall Study|Adverse Event|31|||
160946533|NCT03447769|581192007|FG000|Overall Study|Patient decision|27|||
160946534|NCT03447769|581192008|FG001|Overall Study|Patient decision|27|||
160946535|NCT03447769|581192007|FG000|Overall Study|Protocol deviation|4|||
160580208|NCT05058664|579844128|FG001|Overall Study|No follow-up data provided|0|||
160580209|NCT05058664|579844129|FG002|Overall Study|No follow-up data provided|2|||
160580210|NCT05058664|579844127|FG000|Overall Study|Withdrawal by Subject|0|||
160580211|NCT05058664|579844128|FG001|Overall Study|Withdrawal by Subject|0|||
160580212|NCT05058664|579844129|FG002|Overall Study|Withdrawal by Subject|1|||
160580213|NCT01617681|579844131|FG000|Period 1 Double Blind|Adverse Event|2|||
160580214|NCT01617681|579844132|FG001|Period 1 Double Blind|Adverse Event|0|||
160580215|NCT01617681|579844133|FG002|Period 1 Double Blind|Adverse Event|0|||
160946536|NCT03447769|581192008|FG001|Overall Study|Protocol deviation|6|||
160946537|NCT03447769|581192007|FG000|Overall Study|Death|2|||
160946538|NCT03447769|581192008|FG001|Overall Study|Death|7|||
160946539|NCT03447769|581192007|FG000|Overall Study|Technical problems|1|||
160946540|NCT03447769|581192008|FG001|Overall Study|Technical problems|0|||
160946541|NCT03447769|581192007|FG000|Overall Study|Lost to Follow-up|0|||
160946542|NCT03447769|581192008|FG001|Overall Study|Lost to Follow-up|1|||
160946543|NCT03447769|581192007|FG000|Overall Study|Physician Decision|13|||
160946544|NCT03447769|581192008|FG001|Overall Study|Physician Decision|5|||
160946545|NCT01485861|581192011|FG000|Phase Ib|Death|1|||
160946546|NCT01485861|581192012|FG001|Phase Ib|Death|0|||
160946547|NCT01485861|581192013|FG002|Phase Ib|Death|0|||
160946548|NCT01485861|581192014|FG003|Phase Ib|Death|0|||
160946549|NCT01485861|581192015|FG004|Phase Ib|Death|0|||
160946550|NCT01485861|581192016|FG005|Phase Ib|Death|0|||
160946551|NCT01485861|581192011|FG000|Phase Ib|Physician Decision|1|||
160946552|NCT01485861|581192012|FG001|Phase Ib|Physician Decision|1|||
160946553|NCT01485861|581192013|FG002|Phase Ib|Physician Decision|0|||
160946554|NCT01485861|581192014|FG003|Phase Ib|Physician Decision|0|||
160946555|NCT01485861|581192015|FG004|Phase Ib|Physician Decision|0|||
160946556|NCT01485861|581192016|FG005|Phase Ib|Physician Decision|0|||
160946557|NCT01485861|581192011|FG000|Phase Ib|Adverse Event|0|||
160946558|NCT01485861|581192012|FG001|Phase Ib|Adverse Event|4|||
160946559|NCT01485861|581192013|FG002|Phase Ib|Adverse Event|0|||
160946560|NCT01485861|581192014|FG003|Phase Ib|Adverse Event|0|||
160946561|NCT01485861|581192015|FG004|Phase Ib|Adverse Event|0|||
160946562|NCT01485861|581192016|FG005|Phase Ib|Adverse Event|0|||
160946563|NCT01485861|581192011|FG000|Phase Ib|Progression of disease|5|||
160946564|NCT01485861|581192012|FG001|Phase Ib|Progression of disease|0|||
160946565|NCT01485861|581192013|FG002|Phase Ib|Progression of disease|0|||
160946566|NCT01485861|581192014|FG003|Phase Ib|Progression of disease|0|||
160946567|NCT01485861|581192015|FG004|Phase Ib|Progression of disease|0|||
160946568|NCT01485861|581192016|FG005|Phase Ib|Progression of disease|0|||
160946569|NCT01485861|581192011|FG000|Phase Ib|Other|3|||
160946570|NCT01485861|581192012|FG001|Phase Ib|Other|0|||
160946571|NCT01485861|581192013|FG002|Phase Ib|Other|0|||
160946572|NCT01485861|581192014|FG003|Phase Ib|Other|0|||
160946573|NCT01485861|581192015|FG004|Phase Ib|Other|0|||
160946574|NCT01485861|581192016|FG005|Phase Ib|Other|0|||
160946575|NCT01485861|581192011|FG000|Phase Ib|Withdrawal by Subject|4|||
160946576|NCT01485861|581192012|FG001|Phase Ib|Withdrawal by Subject|1|||
160946577|NCT01485861|581192013|FG002|Phase Ib|Withdrawal by Subject|0|||
160946578|NCT01485861|581192014|FG003|Phase Ib|Withdrawal by Subject|0|||
160946579|NCT01485861|581192015|FG004|Phase Ib|Withdrawal by Subject|0|||
160946580|NCT01485861|581192016|FG005|Phase Ib|Withdrawal by Subject|0|||
160946581|NCT01485861|581192011|FG000|Phase II|Death|0|||
160946582|NCT01485861|581192012|FG001|Phase II|Death|0|||
160946583|NCT01485861|581192013|FG002|Phase II|Death|67|||
160946584|NCT01485861|581192014|FG003|Phase II|Death|71|||
160580216|NCT01617681|579844134|FG003|Period 1 Double Blind|Adverse Event|2|||
160580217|NCT01617681|579844135|FG004|Period 1 Double Blind|Adverse Event|0|||
160580218|NCT01617681|579844131|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
160580219|NCT01617681|579844132|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
160580220|NCT01617681|579844133|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
160946585|NCT01485861|581192015|FG004|Phase II|Death|68|||
160946586|NCT01485861|581192016|FG005|Phase II|Death|0|||
160946587|NCT01485861|581192011|FG000|Phase II|Progression of Disease|0|||
160946588|NCT01485861|581192012|FG001|Phase II|Progression of Disease|0|||
160946589|NCT01485861|581192013|FG002|Phase II|Progression of Disease|1|||
160946590|NCT01485861|581192014|FG003|Phase II|Progression of Disease|0|||
160946591|NCT01485861|581192015|FG004|Phase II|Progression of Disease|0|||
160946592|NCT01485861|581192016|FG005|Phase II|Progression of Disease|0|||
160946593|NCT01485861|581192011|FG000|Phase II|Other|0|||
160946594|NCT01485861|581192012|FG001|Phase II|Other|0|||
160946595|NCT01485861|581192013|FG002|Phase II|Other|0|||
160946596|NCT01485861|581192014|FG003|Phase II|Other|1|||
160946597|NCT01485861|581192015|FG004|Phase II|Other|0|||
160946598|NCT01485861|581192016|FG005|Phase II|Other|0|||
160946599|NCT01485861|581192011|FG000|Phase II|Withdrawal by Subject|0|||
160946600|NCT01485861|581192012|FG001|Phase II|Withdrawal by Subject|0|||
160946601|NCT01485861|581192013|FG002|Phase II|Withdrawal by Subject|6|||
160946602|NCT01485861|581192014|FG003|Phase II|Withdrawal by Subject|3|||
160946603|NCT01485861|581192015|FG004|Phase II|Withdrawal by Subject|4|||
160946604|NCT01485861|581192016|FG005|Phase II|Withdrawal by Subject|0|||
160946605|NCT01485861|581192011|FG000|Phase II|Lost to Follow-up|0|||
160946606|NCT01485861|581192012|FG001|Phase II|Lost to Follow-up|0|||
160456023|NCT04625725|579399834|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
160456024|NCT04625725|579399829|FG000|Provent Main Study|MISSING REASON|0|||
160456025|NCT04625725|579399830|FG001|Provent Main Study|MISSING REASON|1|||
160456026|NCT04625725|579399831|FG002|Provent Main Study|MISSING REASON|0|||
160456027|NCT04625725|579399832|FG003|Provent Main Study|MISSING REASON|0|||
160456028|NCT04625725|579399833|FG004|Provent Main Study|MISSING REASON|0|||
160456029|NCT04625725|579399834|FG005|Provent Main Study|MISSING REASON|0|||
160456030|NCT04625725|579399829|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
160456031|NCT04625725|579399830|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
160456032|NCT04625725|579399831|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
160456033|NCT04625725|579399832|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
160456034|NCT04625725|579399833|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
160456035|NCT04625725|579399834|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
160456036|NCT04625725|579399829|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
160456037|NCT04625725|579399830|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
160456038|NCT04625725|579399831|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
160456039|NCT04625725|579399832|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
160456040|NCT04625725|579399833|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
160456041|NCT04625725|579399834|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
160456042|NCT04625725|579399829|FG000|Provent Sub Study|Lost to Follow-up|0|||
160456043|NCT04625725|579399830|FG001|Provent Sub Study|Lost to Follow-up|0|||
160456044|NCT04625725|579399831|FG002|Provent Sub Study|Lost to Follow-up|20|||
160456045|NCT04625725|579399832|FG003|Provent Sub Study|Lost to Follow-up|10|||
160456046|NCT04625725|579399833|FG004|Provent Sub Study|Lost to Follow-up|6|||
160456047|NCT04625725|579399834|FG005|Provent Sub Study|Lost to Follow-up|4|||
160456048|NCT04625725|579399829|FG000|Provent Sub Study|Death|0|||
160456049|NCT04625725|579399830|FG001|Provent Sub Study|Death|0|||
160456050|NCT04625725|579399831|FG002|Provent Sub Study|Death|8|||
160456051|NCT04625725|579399832|FG003|Provent Sub Study|Death|5|||
160456052|NCT04625725|579399833|FG004|Provent Sub Study|Death|0|||
160456053|NCT04625725|579399834|FG005|Provent Sub Study|Death|1|||
160456054|NCT04625725|579399829|FG000|Provent Sub Study|Adverse Event|0|||
160456055|NCT04625725|579399830|FG001|Provent Sub Study|Adverse Event|0|||
160456056|NCT04625725|579399831|FG002|Provent Sub Study|Adverse Event|0|||
160456057|NCT04625725|579399832|FG003|Provent Sub Study|Adverse Event|0|||
160456058|NCT04625725|579399833|FG004|Provent Sub Study|Adverse Event|0|||
160456059|NCT04625725|579399834|FG005|Provent Sub Study|Adverse Event|1|||
160456060|NCT04625725|579399829|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
160456061|NCT04625725|579399830|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
160456062|NCT04625725|579399831|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
160456063|NCT04625725|579399832|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
160456064|NCT04625725|579399833|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
160456065|NCT04625725|579399834|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
160456066|NCT04625725|579399829|FG000|Provent Sub Study|Withdrawal by Subject|0|||
160456067|NCT04625725|579399830|FG001|Provent Sub Study|Withdrawal by Subject|0|||
160456068|NCT04625725|579399831|FG002|Provent Sub Study|Withdrawal by Subject|11|||
160456069|NCT04625725|579399832|FG003|Provent Sub Study|Withdrawal by Subject|13|||
160456070|NCT04625725|579399833|FG004|Provent Sub Study|Withdrawal by Subject|5|||
160456071|NCT04625725|579399834|FG005|Provent Sub Study|Withdrawal by Subject|6|||
160456072|NCT04625725|579399829|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
160456073|NCT04625725|579399830|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
160456074|NCT04625725|579399831|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
160456075|NCT04625725|579399832|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
160456076|NCT04625725|579399833|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
160456077|NCT04625725|579399834|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
160456078|NCT04308681|579399841|FG000|Pre-Treatment|Not reported|1|||
160456079|NCT04308681|579399842|FG001|Pre-Treatment|Not reported|1|||
160456080|NCT04308681|579399843|FG002|Pre-Treatment|Not reported|0|||
160456081|NCT04308681|579399844|FG003|Pre-Treatment|Not reported|0|||
160456082|NCT04308681|579399845|FG004|Pre-Treatment|Not reported|0|||
160946607|NCT01485861|581192013|FG002|Phase II|Lost to Follow-up|2|||
160456083|NCT04308681|579399846|FG005|Pre-Treatment|Not reported|2|||
160456084|NCT04308681|579399847|FG006|Pre-Treatment|Not reported|0|||
160456085|NCT04308681|579399848|FG007|Pre-Treatment|Not reported|0|||
160946608|NCT01485861|581192014|FG003|Phase II|Lost to Follow-up|3|||
160946609|NCT01485861|581192015|FG004|Phase II|Lost to Follow-up|5|||
160456086|NCT04308681|579399841|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
160456087|NCT04308681|579399842|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
160456088|NCT04308681|579399843|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
160456089|NCT04308681|579399844|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
160946610|NCT01485861|581192016|FG005|Phase II|Lost to Follow-up|0|||
160946611|NCT01485861|581192011|FG000|Phase II|Study Ended|0|||
160946612|NCT01485861|581192012|FG001|Phase II|Study Ended|0|||
160946613|NCT01485861|581192013|FG002|Phase II|Study Ended|7|||
160946614|NCT01485861|581192014|FG003|Phase II|Study Ended|8|||
160946615|NCT01485861|581192015|FG004|Phase II|Study Ended|6|||
160946616|NCT01485861|581192016|FG005|Phase II|Study Ended|0|||
160946617|NCT01485861|581192011|FG000|Safety Phase|Death|0|||
160946618|NCT01485861|581192012|FG001|Safety Phase|Death|0|||
160946619|NCT01485861|581192013|FG002|Safety Phase|Death|0|||
160946620|NCT01485861|581192014|FG003|Safety Phase|Death|0|||
160999531|NCT02477670|581382735|FG000|Stage 2|Adverse Event|0|||
160999532|NCT02477670|581382736|FG001|Stage 2|Adverse Event|0|||
160999533|NCT02477670|581382737|FG002|Stage 2|Adverse Event|1|||
160999534|NCT02477670|581382738|FG003|Stage 2|Adverse Event|0|||
160999535|NCT02477670|581382739|FG004|Stage 2|Adverse Event|0|||
160999536|NCT02477670|581382740|FG005|Stage 2|Adverse Event|0|||
160999537|NCT02477670|581382741|FG006|Stage 2|Adverse Event|0|||
160999538|NCT02477670|581382735|FG000|Stage 2|Antipsychotic Medication Changed|0|||
160999539|NCT02477670|581382736|FG001|Stage 2|Antipsychotic Medication Changed|0|||
160999540|NCT02477670|581382737|FG002|Stage 2|Antipsychotic Medication Changed|1|||
160999541|NCT02477670|581382738|FG003|Stage 2|Antipsychotic Medication Changed|0|||
160999542|NCT02477670|581382739|FG004|Stage 2|Antipsychotic Medication Changed|0|||
160999543|NCT02477670|581382740|FG005|Stage 2|Antipsychotic Medication Changed|0|||
160999544|NCT02477670|581382741|FG006|Stage 2|Antipsychotic Medication Changed|0|||
160999545|NCT02477670|581382735|FG000|Stage 2|Withdrawal by Subject|0|||
160999546|NCT02477670|581382736|FG001|Stage 2|Withdrawal by Subject|0|||
160999547|NCT02477670|581382737|FG002|Stage 2|Withdrawal by Subject|0|||
160999548|NCT02477670|581382738|FG003|Stage 2|Withdrawal by Subject|1|||
160999549|NCT02477670|581382739|FG004|Stage 2|Withdrawal by Subject|0|||
160999550|NCT02477670|581382740|FG005|Stage 2|Withdrawal by Subject|0|||
160999551|NCT02477670|581382741|FG006|Stage 2|Withdrawal by Subject|0|||
160999552|NCT02937831|581382742|FG000|Overall Study|Protocol Violation|4|||
160999553|NCT01759264|581382743|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
160999554|NCT01759264|581382743|FG000|Overall Study|Adverse Event|1|||
160999555|NCT01759264|581382743|FG000|Overall Study|Other|2|||
160999556|NCT01759264|581382743|FG000|Overall Study|Lost to Follow-up|2|||
160999557|NCT01759264|581382743|FG000|Overall Study|Withdrawal by Subject|3|||
160999558|NCT01759264|581382743|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
160999559|NCT00114244|581382744|FG000|Overall Study|Adverse Event|2|||
160999560|NCT00114244|581382745|FG001|Overall Study|Adverse Event|5|||
160999561|NCT00114244|581382744|FG000|Overall Study|Withdrawal by Subject|0|||
160999562|NCT00114244|581382745|FG001|Overall Study|Withdrawal by Subject|2|||
160999563|NCT00753012|581382751|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
160999564|NCT00753012|581382752|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
160999565|NCT00753012|581382751|FG000|Overall Study|Adverse Event|2|||
160999566|NCT00753012|581382752|FG001|Overall Study|Adverse Event|0|||
160999567|NCT00753012|581382751|FG000|Overall Study|Withdrawal by Subject|0|||
160999568|NCT00753012|581382752|FG001|Overall Study|Withdrawal by Subject|1|||
160999569|NCT00753012|581382751|FG000|Overall Study|Lost to Follow-up|4|||
160999570|NCT00753012|581382752|FG001|Overall Study|Lost to Follow-up|0|||
160999571|NCT00753012|581382751|FG000|Overall Study|Confounded endpoint data|1|||
160999572|NCT00753012|581382752|FG001|Overall Study|Confounded endpoint data|0|||
160999573|NCT01930045|581382753|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
160999574|NCT01930045|581382754|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
160999575|NCT01930045|581382755|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
160999576|NCT01930045|581382756|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
160999577|NCT01930045|581382757|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
160999578|NCT01930045|581382758|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
160999579|NCT01930045|581382753|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
160999580|NCT01930045|581382754|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
160456090|NCT04308681|579399845|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
160946621|NCT01485861|581192015|FG004|Safety Phase|Death|0|||
160946622|NCT01485861|581192016|FG005|Safety Phase|Death|2|||
160456091|NCT04308681|579399846|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
160580221|NCT01617681|579844134|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
160946623|NCT01485861|581192011|FG000|Safety Phase|Adverse Event|0|||
160946624|NCT01485861|581192012|FG001|Safety Phase|Adverse Event|0|||
160999581|NCT01930045|581382755|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
160999582|NCT01930045|581382756|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
160999583|NCT01930045|581382757|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
160999584|NCT01930045|581382758|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
160999585|NCT01370694|581382761|FG000|Overall Study|Switched to rituximab|4|||
160999586|NCT01370694|581382761|FG000|Overall Study|Progressive disease|2|||
160946625|NCT01485861|581192013|FG002|Safety Phase|Adverse Event|0|||
160946626|NCT01485861|581192014|FG003|Safety Phase|Adverse Event|0|||
160946627|NCT01485861|581192015|FG004|Safety Phase|Adverse Event|0|||
160946628|NCT01485861|581192016|FG005|Safety Phase|Adverse Event|1|||
160946629|NCT01485861|581192011|FG000|Safety Phase|Other|0|||
160946630|NCT01485861|581192012|FG001|Safety Phase|Other|0|||
160580222|NCT01617681|579844135|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
160580223|NCT01617681|579844131|FG000|Period 2 Open Label|Adverse Event|0|||
160946631|NCT01485861|581192013|FG002|Safety Phase|Other|0|||
160946632|NCT01485861|581192014|FG003|Safety Phase|Other|0|||
160946633|NCT01485861|581192015|FG004|Safety Phase|Other|0|||
160946634|NCT01485861|581192016|FG005|Safety Phase|Other|5|||
160946635|NCT01485861|581192011|FG000|Safety Phase|Progression of Disease|0|||
160946636|NCT01485861|581192012|FG001|Safety Phase|Progression of Disease|0|||
160946637|NCT01485861|581192013|FG002|Safety Phase|Progression of Disease|0|||
160946638|NCT01485861|581192014|FG003|Safety Phase|Progression of Disease|0|||
160946639|NCT01485861|581192015|FG004|Safety Phase|Progression of Disease|0|||
160580224|NCT01617681|579844132|FG001|Period 2 Open Label|Adverse Event|0|||
160580225|NCT01617681|579844133|FG002|Period 2 Open Label|Adverse Event|0|||
160580226|NCT01617681|579844134|FG003|Period 2 Open Label|Adverse Event|0|||
160580227|NCT01617681|579844135|FG004|Period 2 Open Label|Adverse Event|3|||
160580228|NCT01617681|579844131|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
160580229|NCT01617681|579844132|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
160580230|NCT01617681|579844133|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
160580231|NCT01617681|579844134|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
160580232|NCT01617681|579844135|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
160580233|NCT00109733|579844141|FG000|Overall Study|Protocol Violation|0|||
160580234|NCT00109733|579844142|FG001|Overall Study|Protocol Violation|1|||
160580235|NCT00109733|579844141|FG000|Overall Study|Stopped taking study drug|1|||
160580236|NCT00109733|579844142|FG001|Overall Study|Stopped taking study drug|1|||
160580237|NCT00109733|579844141|FG000|Overall Study|Non-compliant|0|||
160580238|NCT00109733|579844142|FG001|Overall Study|Non-compliant|1|||
160580239|NCT00109733|579844141|FG000|Overall Study|Could not commit time for study|1|||
160580240|NCT00109733|579844142|FG001|Overall Study|Could not commit time for study|1|||
160580241|NCT01234402|579844151|FG000|Overall Study|Lost to Follow-up|0|||
160580242|NCT01234402|579844152|FG001|Overall Study|Lost to Follow-up|1|||
160580243|NCT01234402|579844153|FG002|Overall Study|Lost to Follow-up|3|||
160580244|NCT01234402|579844151|FG000|Overall Study|Withdrawal by Subject|1|||
160580245|NCT01234402|579844152|FG001|Overall Study|Withdrawal by Subject|3|||
160580246|NCT01234402|579844153|FG002|Overall Study|Withdrawal by Subject|4|||
160580247|NCT01234402|579844151|FG000|Overall Study|Never treated: Death|0|||
160580248|NCT01234402|579844152|FG001|Overall Study|Never treated: Death|0|||
160580249|NCT01234402|579844153|FG002|Overall Study|Never treated: Death|1|||
160580250|NCT01234402|579844151|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
160580251|NCT01234402|579844152|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
160580252|NCT01234402|579844153|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
160580253|NCT01234402|579844151|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
160580254|NCT01234402|579844152|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
160580255|NCT01234402|579844153|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
160946640|NCT01485861|581192016|FG005|Safety Phase|Progression of Disease|9|||
160946641|NCT01485861|581192011|FG000|Safety Phase|Withdrawal by Subject|0|||
160946642|NCT01485861|581192012|FG001|Safety Phase|Withdrawal by Subject|0|||
160946643|NCT01485861|581192013|FG002|Safety Phase|Withdrawal by Subject|0|||
160946644|NCT01485861|581192014|FG003|Safety Phase|Withdrawal by Subject|0|||
160946645|NCT01485861|581192015|FG004|Safety Phase|Withdrawal by Subject|0|||
160946646|NCT01485861|581192016|FG005|Safety Phase|Withdrawal by Subject|6|||
160946647|NCT01485861|581192011|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
160946648|NCT01485861|581192012|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
160946649|NCT01485861|581192013|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
160946650|NCT01485861|581192014|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
160946651|NCT01485861|581192015|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
160946652|NCT01485861|581192016|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
160946653|NCT03795922|581192017|FG000|Overall Study|Adverse Event|2|||
160946654|NCT03795922|581192018|FG001|Overall Study|Adverse Event|1|||
160946655|NCT03795922|581192017|FG000|Overall Study|Withdrawal by Subject|5|||
160946656|NCT03795922|581192018|FG001|Overall Study|Withdrawal by Subject|13|||
160946657|NCT03795922|581192017|FG000|Overall Study|Lost to Follow-up|2|||
160946658|NCT03795922|581192018|FG001|Overall Study|Lost to Follow-up|3|||
160946659|NCT03795922|581192017|FG000|Overall Study|Pregnancy|0|||
160946660|NCT03795922|581192018|FG001|Overall Study|Pregnancy|1|||
160946661|NCT03795922|581192017|FG000|Overall Study|Physician Decision|1|||
160946662|NCT03795922|581192018|FG001|Overall Study|Physician Decision|2|||
160946663|NCT03795922|581192017|FG000|Overall Study|Protocol Violation|0|||
160946664|NCT03795922|581192018|FG001|Overall Study|Protocol Violation|1|||
160946665|NCT03795922|581192017|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
160946666|NCT03795922|581192018|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
160946667|NCT03056690|581192029|FG000|Overall Study|Adverse Event|3|||
160946668|NCT03056690|581192030|FG001|Overall Study|Adverse Event|2|||
160946669|NCT03056690|581192029|FG000|Overall Study|Lack of Efficacy|1|||
160946670|NCT03056690|581192030|FG001|Overall Study|Lack of Efficacy|2|||
160946671|NCT03056690|581192029|FG000|Overall Study|Lost to Follow-up|3|||
160946672|NCT03056690|581192030|FG001|Overall Study|Lost to Follow-up|2|||
160946673|NCT03056690|581192029|FG000|Overall Study|Protocol Violation|2|||
160946674|NCT03056690|581192030|FG001|Overall Study|Protocol Violation|2|||
160946675|NCT03056690|581192029|FG000|Overall Study|Withdrawal by Subject|3|||
160946676|NCT03056690|581192030|FG001|Overall Study|Withdrawal by Subject|6|||
160946677|NCT03056690|581192029|FG000|Overall Study|Non-compliance with Study Drug|1|||
160946678|NCT03056690|581192030|FG001|Overall Study|Non-compliance with Study Drug|0|||
160946679|NCT03056690|581192029|FG000|Overall Study|Miscellaneous|1|||
160946680|NCT03056690|581192030|FG001|Overall Study|Miscellaneous|2|||
160946681|NCT02328326|581192036|FG000|Overall Study|Withdrawal by Subject|10|||
160946682|NCT02328326|581192037|FG001|Overall Study|Withdrawal by Subject|3|||
160946683|NCT02328326|581192036|FG000|Overall Study|Death|2|||
160946684|NCT02328326|581192037|FG001|Overall Study|Death|1|||
160946685|NCT02328326|581192036|FG000|Overall Study|Lost to Follow-up|10|||
160946686|NCT02328326|581192037|FG001|Overall Study|Lost to Follow-up|4|||
160946687|NCT02543346|581192038|FG000|Second Priming Visit|Withdrawal by Subject|0|||
160946688|NCT02543346|581192039|FG001|Second Priming Visit|Withdrawal by Subject|2|||
160946689|NCT02543346|581192040|FG002|Second Priming Visit|Withdrawal by Subject|2|||
160946690|NCT02543346|581192041|FG003|Second Priming Visit|Withdrawal by Subject|2|||
160946691|NCT02543346|581192038|FG000|Second Priming Visit|Adverse Event|1|||
160946692|NCT02543346|581192039|FG001|Second Priming Visit|Adverse Event|0|||
160946693|NCT02543346|581192040|FG002|Second Priming Visit|Adverse Event|0|||
160946694|NCT02543346|581192041|FG003|Second Priming Visit|Adverse Event|0|||
160946695|NCT02209324|581192044|FG000|Overall Study|Adverse Event|2|||
160946696|NCT02209324|581192044|FG000|Overall Study|Lack of Efficacy|1|||
160946697|NCT02209324|581192044|FG000|Overall Study|Lost to Follow-up|1|||
160946698|NCT02209324|581192044|FG000|Overall Study|Physician Decision|3|||
160946699|NCT02209324|581192044|FG000|Overall Study|Protocol Violation|14|||
160946700|NCT02209324|581192044|FG000|Overall Study|Withdrawal by Subject|8|||
160946701|NCT02209324|581192044|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
160946702|NCT02209324|581192044|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
160946703|NCT02209324|581192044|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
160946704|NCT01985126|581192045|FG000|Overall Study|Death|15|||
160946705|NCT01985126|581192046|FG001|Overall Study|Death|69|||
160946706|NCT01985126|581192045|FG000|Overall Study|Lost to Follow-up|0|||
160946707|NCT01985126|581192046|FG001|Overall Study|Lost to Follow-up|8|||
160946708|NCT01985126|581192045|FG000|Overall Study|Study Terminated By Sponsor|1|||
160946709|NCT01985126|581192046|FG001|Overall Study|Study Terminated By Sponsor|22|||
160946710|NCT01985126|581192045|FG000|Overall Study|Withdrawal by Subject|2|||
160946711|NCT01985126|581192046|FG001|Overall Study|Withdrawal by Subject|7|||
160946712|NCT03433456|581192049|FG000|Overall Study|Death|1|||
160946713|NCT03433456|581192050|FG001|Overall Study|Death|1|||
160946714|NCT03433456|581192049|FG000|Overall Study|Lost to Follow-up|14|||
160946715|NCT03433456|581192050|FG001|Overall Study|Lost to Follow-up|11|||
160946716|NCT03433456|581192049|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
160946717|NCT03433456|581192050|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
160946718|NCT01198600|581192055|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
160946719|NCT01198600|581192056|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
160946720|NCT01198600|581192057|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
160946721|NCT01198600|581192058|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
160946722|NCT01198600|581192055|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
160946723|NCT01198600|581192056|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
160946724|NCT01198600|581192057|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
160946725|NCT01198600|581192058|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
160946726|NCT01198600|581192055|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
160946727|NCT01198600|581192056|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
160946728|NCT01198600|581192057|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
160999587|NCT04842604|581382766|FG000|Overall Study|Death|1|||
160946729|NCT01198600|581192058|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
160946730|NCT01198600|581192055|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
160946731|NCT01198600|581192056|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
160946732|NCT01198600|581192057|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
160946733|NCT01198600|581192058|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
160946734|NCT01198600|581192055|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
160946735|NCT01198600|581192056|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
160946736|NCT01198600|581192057|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
160946737|NCT01198600|581192058|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
160946738|NCT01198600|581192055|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
160946739|NCT01198600|581192056|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
160946740|NCT01198600|581192057|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
160946741|NCT01198600|581192058|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
160946742|NCT01198600|581192055|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
160946743|NCT01198600|581192056|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
160580256|NCT02280291|579844155|FG000|Overall Study|Lost to Follow-up|2|||
160580257|NCT02280291|579844156|FG001|Overall Study|Lost to Follow-up|1|||
160580258|NCT02280291|579844157|FG002|Overall Study|Lost to Follow-up|3|||
160580259|NCT02280291|579844158|FG003|Overall Study|Lost to Follow-up|8|||
160946744|NCT01198600|581192057|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
160946745|NCT01198600|581192058|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
160946746|NCT01785602|581192059|FG000|Overall Study|Withdrawal by Subject|2|||
160946747|NCT01785602|581192060|FG001|Overall Study|Withdrawal by Subject|0|||
160946748|NCT01785602|581192059|FG000|Overall Study|Lost to Follow-up|1|||
160946749|NCT01785602|581192060|FG001|Overall Study|Lost to Follow-up|1|||
160946750|NCT01785602|581192059|FG000|Overall Study|Adverse Event|3|||
160946751|NCT01785602|581192060|FG001|Overall Study|Adverse Event|5|||
160946752|NCT01785602|581192059|FG000|Overall Study|Administrative problems|7|||
160946753|NCT01785602|581192060|FG001|Overall Study|Administrative problems|3|||
160946754|NCT02141516|581192063|FG000|Overall Study|Adverse Event|0|||
160946755|NCT02141516|581192064|FG001|Overall Study|Adverse Event|1|||
160946756|NCT02141516|581192065|FG002|Overall Study|Adverse Event|0|||
160946757|NCT02141516|581192063|FG000|Overall Study|Lost to Follow-up|0|||
160946758|NCT02141516|581192064|FG001|Overall Study|Lost to Follow-up|1|||
160946759|NCT02141516|581192065|FG002|Overall Study|Lost to Follow-up|0|||
160946760|NCT02141516|581192063|FG000|Overall Study|Other|0|||
160946761|NCT02141516|581192064|FG001|Overall Study|Other|3|||
160946762|NCT02141516|581192065|FG002|Overall Study|Other|0|||
160946763|NCT03251924|581192067|FG000|Overall Study|Disease Progression|6|||
160946764|NCT03251924|581192068|FG001|Overall Study|Disease Progression|6|||
160946765|NCT03251924|581192069|FG002|Overall Study|Disease Progression|7|||
160946766|NCT03251924|581192070|FG003|Overall Study|Disease Progression|8|||
160946767|NCT03251924|581192071|FG004|Overall Study|Disease Progression|8|||
160946768|NCT03251924|581192072|FG005|Overall Study|Disease Progression|7|||
160946769|NCT03251924|581192073|FG006|Overall Study|Disease Progression|6|||
160946770|NCT03251924|581192074|FG007|Overall Study|Disease Progression|10|||
160946771|NCT03251924|581192075|FG008|Overall Study|Disease Progression|6|||
160946772|NCT03251924|581192067|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
160946773|NCT03251924|581192068|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
160946774|NCT03251924|581192069|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
160946775|NCT03251924|581192070|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
160946776|NCT03251924|581192071|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
160946777|NCT03251924|581192072|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
160946778|NCT03251924|581192073|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
160946779|NCT03251924|581192074|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
160946780|NCT03251924|581192075|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
160946781|NCT03251924|581192067|FG000|Overall Study|Death|0|||
160946782|NCT03251924|581192068|FG001|Overall Study|Death|1|||
160946783|NCT03251924|581192069|FG002|Overall Study|Death|0|||
160946784|NCT03251924|581192070|FG003|Overall Study|Death|1|||
160946785|NCT03251924|581192071|FG004|Overall Study|Death|1|||
160946786|NCT03251924|581192072|FG005|Overall Study|Death|1|||
160946787|NCT03251924|581192073|FG006|Overall Study|Death|0|||
160946788|NCT03251924|581192074|FG007|Overall Study|Death|0|||
160946789|NCT03251924|581192075|FG008|Overall Study|Death|0|||
160946790|NCT03251924|581192067|FG000|Overall Study|Study Drug Toxicity|0|||
160946791|NCT03251924|581192068|FG001|Overall Study|Study Drug Toxicity|0|||
160946792|NCT03251924|581192069|FG002|Overall Study|Study Drug Toxicity|0|||
160946793|NCT03251924|581192070|FG003|Overall Study|Study Drug Toxicity|1|||
160946794|NCT03251924|581192071|FG004|Overall Study|Study Drug Toxicity|0|||
160946795|NCT03251924|581192072|FG005|Overall Study|Study Drug Toxicity|0|||
160946796|NCT03251924|581192073|FG006|Overall Study|Study Drug Toxicity|0|||
160946797|NCT03251924|581192074|FG007|Overall Study|Study Drug Toxicity|0|||
160946798|NCT03251924|581192075|FG008|Overall Study|Study Drug Toxicity|1|||
160946799|NCT03251924|581192067|FG000|Overall Study|Other Reasons|0|||
160946800|NCT03251924|581192068|FG001|Overall Study|Other Reasons|0|||
160946801|NCT03251924|581192069|FG002|Overall Study|Other Reasons|0|||
160946802|NCT03251924|581192070|FG003|Overall Study|Other Reasons|0|||
160946803|NCT03251924|581192071|FG004|Overall Study|Other Reasons|0|||
160456092|NCT04308681|579399847|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
160946804|NCT03251924|581192072|FG005|Overall Study|Other Reasons|0|||
160946805|NCT03251924|581192073|FG006|Overall Study|Other Reasons|0|||
160999588|NCT04842604|581382767|FG001|Overall Study|Death|0|||
160456093|NCT04308681|579399848|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
160580260|NCT02280291|579844155|FG000|Overall Study|Protocol Violation|1|||
160580261|NCT02280291|579844156|FG001|Overall Study|Protocol Violation|0|||
160946806|NCT03251924|581192074|FG007|Overall Study|Other Reasons|0|||
160946807|NCT03251924|581192075|FG008|Overall Study|Other Reasons|1|||
160946808|NCT03251924|581192067|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160946809|NCT03251924|581192068|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160946810|NCT03251924|581192069|FG002|Overall Study|Participant request to discontinue study treatment|0|||
160946811|NCT03251924|581192070|FG003|Overall Study|Participant request to discontinue study treatment|0|||
160999589|NCT04842604|581382766|FG000|Overall Study|Other|4|||
160946812|NCT03251924|581192071|FG004|Overall Study|Participant request to discontinue study treatment|0|||
160946813|NCT03251924|581192072|FG005|Overall Study|Participant request to discontinue study treatment|0|||
160946814|NCT03251924|581192073|FG006|Overall Study|Participant request to discontinue study treatment|0|||
160946815|NCT03251924|581192074|FG007|Overall Study|Participant request to discontinue study treatment|1|||
160946816|NCT03251924|581192075|FG008|Overall Study|Participant request to discontinue study treatment|0|||
160946817|NCT00784043|581192076|FG000|Overall Study|Withdrawal by Subject|8|||
160946818|NCT00784043|581192077|FG001|Overall Study|Withdrawal by Subject|5|||
160946819|NCT00784043|581192076|FG000|Overall Study|Protocol Terminated|23|||
160946820|NCT00784043|581192077|FG001|Overall Study|Protocol Terminated|1|||
160946821|NCT02127307|581192084|FG000|Overall Study|Protocol Violation|36|||
160946822|NCT02127307|581192084|FG000|Overall Study|Lost to Follow-up|2|||
160946823|NCT02127307|581192084|FG000|Overall Study|Death|101|||
160946824|NCT02127307|581192084|FG000|Overall Study|Other than specified above|169|||
160946825|NCT00235989|581192085|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
160946826|NCT00235989|581192086|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
160946827|NCT00235989|581192087|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
160946828|NCT00235989|581192088|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
160946829|NCT00235989|581192089|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
160946830|NCT00235989|581192090|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
160946831|NCT00235989|581192085|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
160946832|NCT00235989|581192086|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
160946833|NCT00235989|581192087|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
160946834|NCT00235989|581192088|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
160946835|NCT00235989|581192089|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
160946836|NCT00235989|581192090|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
160946837|NCT00235989|581192085|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
160946838|NCT00235989|581192086|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
160946839|NCT00235989|581192087|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
160946840|NCT00235989|581192088|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
160946841|NCT00235989|581192089|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
160946842|NCT00235989|581192090|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
160946843|NCT00235989|581192085|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
160946844|NCT00235989|581192086|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
160946845|NCT00235989|581192087|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
160946846|NCT00235989|581192088|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
160946847|NCT00235989|581192089|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
160946848|NCT00235989|581192090|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
160946849|NCT00235989|581192085|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
160946850|NCT00235989|581192086|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
160946851|NCT00235989|581192087|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
160946852|NCT00235989|581192088|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
160946853|NCT00235989|581192089|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
160946854|NCT00235989|581192090|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
160946855|NCT00983580|581192096|FG000|Overall Study|Cancel Prior to treatment|1|||
160946856|NCT00983580|581192097|FG001|Overall Study|Cancel Prior to treatment|3|||
160946857|NCT00983580|581192096|FG000|Overall Study|Protocol Violation|1|||
160946858|NCT00983580|581192097|FG001|Overall Study|Protocol Violation|1|||
160946859|NCT00983580|581192096|FG000|Overall Study|Ineligible|3|||
160946860|NCT00983580|581192097|FG001|Overall Study|Ineligible|0|||
160946861|NCT01992536|581193808|FG000|Overall Study|Administrative Reason|0|||
160946862|NCT01992536|581193809|FG001|Overall Study|Administrative Reason|0|||
160946863|NCT01992536|581193810|FG002|Overall Study|Administrative Reason|0|||
160946864|NCT01992536|581193811|FG003|Overall Study|Administrative Reason|0|||
160999590|NCT04842604|581382767|FG001|Overall Study|Other|4|||
160999591|NCT04842604|581382766|FG000|Overall Study|Randomized but not treated|1|||
160999592|NCT04842604|581382767|FG001|Overall Study|Randomized but not treated|0|||
160999593|NCT00344019|581382768|FG000|Overall Study|did not meet final inclusion criteria|0|||
160999594|NCT00344019|581382769|FG001|Overall Study|did not meet final inclusion criteria|0|||
160999595|NCT00344019|581382770|FG002|Overall Study|did not meet final inclusion criteria|74|||
160999596|NCT01193153|581382771|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
160999597|NCT01193153|581382772|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
160946865|NCT01992536|581193812|FG004|Overall Study|Administrative Reason|0|||
160946866|NCT01992536|581193813|FG005|Overall Study|Administrative Reason|0|||
160946867|NCT01992536|581193814|FG006|Overall Study|Administrative Reason|7|||
160946868|NCT01992536|581193815|FG007|Overall Study|Administrative Reason|0|||
160999598|NCT01193153|581382771|FG000|Open-label Lead in Period|Pregnancy|1|||
160946869|NCT01992536|581193816|FG008|Overall Study|Administrative Reason|0|||
160946870|NCT01992536|581193817|FG009|Overall Study|Administrative Reason|0|||
160946871|NCT01992536|581193808|FG000|Overall Study|Lost to Follow-up|4|||
160999599|NCT01193153|581382772|FG001|Open-label Lead in Period|Pregnancy|0|||
160580262|NCT02280291|579844157|FG002|Overall Study|Protocol Violation|0|||
160580263|NCT02280291|579844158|FG003|Overall Study|Protocol Violation|0|||
160580264|NCT02280291|579844155|FG000|Overall Study|Other|1|||
160580265|NCT02280291|579844156|FG001|Overall Study|Other|1|||
160580266|NCT02280291|579844157|FG002|Overall Study|Other|0|||
160580267|NCT02280291|579844158|FG003|Overall Study|Other|0|||
160580268|NCT00316303|579844159|FG000|Overall Study|Lost to Follow-up|11|||
160580269|NCT00316303|579844160|FG001|Overall Study|Lost to Follow-up|16|||
160580270|NCT01106534|579844161|FG000|Overall Study|Withdrawal by Subject|18|||
160580271|NCT01106534|579844161|FG000|Overall Study|Lost to Follow-up|2|||
160580272|NCT01106534|579844161|FG000|Overall Study|Death|16|||
160946872|NCT01992536|581193809|FG001|Overall Study|Lost to Follow-up|2|||
160580273|NCT01106534|579844161|FG000|Overall Study|Physician Decision|1|||
160580274|NCT03015610|579844162|FG000|Overall Study|Lost to Follow-up|1|||
160580275|NCT03015610|579844163|FG001|Overall Study|Lost to Follow-up|5|||
160580276|NCT01603641|579844164|FG000|Overall Study|Did not Receive Treatment|3|||
160580277|NCT01603641|579844164|FG000|Overall Study|Adverse Event|1|||
160580278|NCT01603641|579844164|FG000|Overall Study|Lack of Efficacy|1|||
160580279|NCT01603641|579844164|FG000|Overall Study|Lost to Follow-up|6|||
160580280|NCT01603641|579844164|FG000|Overall Study|Personal Reasons|18|||
160580281|NCT01603641|579844164|FG000|Overall Study|Other Miscellaneous Reasons|6|||
160580282|NCT00358917|579844165|FG000|Overall Study|Adverse Event|14|||
160580283|NCT00358917|579844166|FG001|Overall Study|Adverse Event|21|||
160580284|NCT00358917|579844165|FG000|Overall Study|Withdrawal by Subject|5|||
160580285|NCT00358917|579844166|FG001|Overall Study|Withdrawal by Subject|7|||
160580286|NCT00358917|579844165|FG000|Overall Study|Lost to Follow-up|20|||
160580287|NCT00358917|579844166|FG001|Overall Study|Lost to Follow-up|17|||
160580288|NCT00358917|579844165|FG000|Overall Study|Noncompliance|12|||
160580289|NCT00358917|579844166|FG001|Overall Study|Noncompliance|11|||
160580290|NCT00358917|579844165|FG000|Overall Study|Death|2|||
160580291|NCT00358917|579844166|FG001|Overall Study|Death|3|||
160580292|NCT00358917|579844165|FG000|Overall Study|Virologic failure|11|||
160580293|NCT00358917|579844166|FG001|Overall Study|Virologic failure|8|||
160580294|NCT00358917|579844165|FG000|Overall Study|Unable to Continue Participation|2|||
160580295|NCT00358917|579844166|FG001|Overall Study|Unable to Continue Participation|2|||
160580296|NCT01558089|579844170|FG000|Overall Study|Adverse Event|1|||
160580297|NCT01558089|579844170|FG000|Overall Study|Lack of Efficacy|1|||
160580298|NCT01558089|579844170|FG000|Overall Study|Lost to Follow-up|5|||
160580299|NCT01558089|579844170|FG000|Overall Study|Withdrawal by Subject|6|||
160580300|NCT01597193|579844171|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
160580301|NCT01597193|579844172|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
160580302|NCT01597193|579844173|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
160580303|NCT01597193|579844174|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
160580304|NCT01597193|579844175|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
160580305|NCT01597193|579844176|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
160580306|NCT01597193|579844177|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
160946873|NCT01992536|581193810|FG002|Overall Study|Lost to Follow-up|1|||
160946874|NCT01992536|581193811|FG003|Overall Study|Lost to Follow-up|0|||
160946875|NCT01992536|581193812|FG004|Overall Study|Lost to Follow-up|0|||
160946876|NCT01992536|581193813|FG005|Overall Study|Lost to Follow-up|1|||
160946877|NCT01992536|581193814|FG006|Overall Study|Lost to Follow-up|0|||
160946878|NCT01992536|581193815|FG007|Overall Study|Lost to Follow-up|0|||
160946879|NCT01992536|581193816|FG008|Overall Study|Lost to Follow-up|1|||
160946880|NCT01992536|581193817|FG009|Overall Study|Lost to Follow-up|1|||
160946881|NCT01992536|581193808|FG000|Overall Study|Withdrawal by Subject|0|||
160946882|NCT01992536|581193809|FG001|Overall Study|Withdrawal by Subject|1|||
160946883|NCT01992536|581193810|FG002|Overall Study|Withdrawal by Subject|0|||
160946884|NCT01992536|581193811|FG003|Overall Study|Withdrawal by Subject|2|||
160580307|NCT01597193|579844171|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
160580308|NCT01597193|579844172|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
160580309|NCT01597193|579844173|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
160580310|NCT01597193|579844174|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
160580311|NCT01597193|579844175|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
160580312|NCT01597193|579844176|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
160580313|NCT01597193|579844177|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
160946885|NCT01992536|581193812|FG004|Overall Study|Withdrawal by Subject|0|||
160946886|NCT01992536|581193813|FG005|Overall Study|Withdrawal by Subject|0|||
160946887|NCT01992536|581193814|FG006|Overall Study|Withdrawal by Subject|0|||
160946888|NCT01992536|581193815|FG007|Overall Study|Withdrawal by Subject|0|||
160946889|NCT01992536|581193816|FG008|Overall Study|Withdrawal by Subject|0|||
160946890|NCT01992536|581193817|FG009|Overall Study|Withdrawal by Subject|0|||
160946891|NCT01762761|581193818|FG000|Overall Study|Adverse Event|15|||
160946892|NCT01762761|581193819|FG001|Overall Study|Adverse Event|17|||
160946893|NCT01762761|581193818|FG000|Overall Study|Lack of Efficacy|9|||
160946894|NCT01762761|581193819|FG001|Overall Study|Lack of Efficacy|25|||
160946895|NCT01762761|581193818|FG000|Overall Study|Protocol Violation|1|||
160946896|NCT01762761|581193819|FG001|Overall Study|Protocol Violation|1|||
160946897|NCT01762761|581193818|FG000|Overall Study|Study closed/terminated|0|||
160946898|NCT01762761|581193819|FG001|Overall Study|Study closed/terminated|2|||
160946899|NCT01762761|581193818|FG000|Overall Study|Lost to Follow-up|3|||
160946900|NCT01762761|581193819|FG001|Overall Study|Lost to Follow-up|6|||
160946901|NCT01762761|581193818|FG000|Overall Study|Physician Decision|4|||
160946902|NCT01762761|581193819|FG001|Overall Study|Physician Decision|6|||
160946903|NCT01762761|581193818|FG000|Overall Study|Withdrawal by Subject|7|||
160946904|NCT01762761|581193819|FG001|Overall Study|Withdrawal by Subject|8|||
160946905|NCT02352493|581193822|FG000|Overall Study|Pregnancy|0|||
160946906|NCT02352493|581193823|FG001|Overall Study|Pregnancy|0|||
160946907|NCT02352493|581193824|FG002|Overall Study|Pregnancy|0|||
160946908|NCT02352493|581193825|FG003|Overall Study|Pregnancy|0|||
160946909|NCT02352493|581193826|FG004|Overall Study|Pregnancy|0|||
160946910|NCT02352493|581193827|FG005|Overall Study|Pregnancy|0|||
160946911|NCT02352493|581193828|FG006|Overall Study|Pregnancy|1|||
160580314|NCT01597193|579844171|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
160580315|NCT01597193|579844172|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
160580316|NCT01597193|579844173|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
160580317|NCT01597193|579844174|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
160580318|NCT01597193|579844175|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
160580319|NCT01597193|579844176|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
160580320|NCT01597193|579844177|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
160580321|NCT01597193|579844171|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
160580322|NCT01597193|579844172|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
160580323|NCT01597193|579844173|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
160580324|NCT01597193|579844174|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
160580325|NCT01597193|579844175|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
160580326|NCT01597193|579844176|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
160580327|NCT01597193|579844177|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
160580328|NCT01597193|579844171|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
160580329|NCT01597193|579844172|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
160580330|NCT01597193|579844173|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
160580331|NCT01597193|579844174|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
160580332|NCT01597193|579844175|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
160580333|NCT01597193|579844176|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
160580334|NCT01597193|579844177|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
160580335|NCT03184701|579844179|FG000|Overall Study|Death|3|||
160580336|NCT03184701|579844179|FG000|Overall Study|Physician Decision|3|||
160580337|NCT03184701|579844179|FG000|Overall Study|Withdrawal by Subject|6|||
160580338|NCT03184701|579844179|FG000|Overall Study|Lost to Follow-up|5|||
160580339|NCT00590681|579844182|FG000|Overall Study|Withdrawal by Subject|7|||
160580340|NCT00590681|579844182|FG000|Overall Study|Adverse Event|8|||
160580341|NCT00590681|579844182|FG000|Overall Study|Death|3|||
160580342|NCT00590681|579844182|FG000|Overall Study|Lost to Follow-up|1|||
160580343|NCT00590681|579844182|FG000|Overall Study|disease progression|1|||
160580344|NCT01259297|579844183|FG000|Double Blind Randomized Period|Death|1|||
160580345|NCT01259297|579844184|FG001|Double Blind Randomized Period|Death|1|||
160580346|NCT01259297|579844185|FG002|Double Blind Randomized Period|Death|1|||
160580347|NCT01259297|579844186|FG003|Double Blind Randomized Period|Death|2|||
160580348|NCT01259297|579844187|FG004|Double Blind Randomized Period|Death|1|||
160580349|NCT01259297|579844188|FG005|Double Blind Randomized Period|Death|5|||
160946912|NCT02352493|581193829|FG007|Overall Study|Pregnancy|0|||
160946913|NCT02352493|581193830|FG008|Overall Study|Pregnancy|1|||
160946914|NCT02352493|581193831|FG009|Overall Study|Pregnancy|0|||
160946915|NCT02352493|581193832|FG010|Overall Study|Pregnancy|0|||
160946916|NCT02352493|581193833|FG011|Overall Study|Pregnancy|0|||
160946917|NCT02352493|581193834|FG012|Overall Study|Pregnancy|0|||
160946918|NCT02352493|581193835|FG013|Overall Study|Pregnancy|0|||
160946919|NCT02352493|581193836|FG014|Overall Study|Pregnancy|0|||
160946920|NCT02352493|581193837|FG015|Overall Study|Pregnancy|0|||
160946921|NCT02352493|581193838|FG016|Overall Study|Pregnancy|0|||
160999600|NCT01193153|581382771|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
160999601|NCT01193153|581382772|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
160456094|NCT04308681|579399841|FG000|Treatment up to Week 26|Other reasons|2|||
160946922|NCT02352493|581193839|FG017|Overall Study|Pregnancy|0|||
160946923|NCT02352493|581193822|FG000|Overall Study|Withdrawal by Subject|0|||
160946924|NCT02352493|581193823|FG001|Overall Study|Withdrawal by Subject|0|||
160946925|NCT02352493|581193824|FG002|Overall Study|Withdrawal by Subject|0|||
160580350|NCT01259297|579844189|FG006|Double Blind Randomized Period|Death|2|||
160580351|NCT01259297|579844190|FG007|Double Blind Randomized Period|Death|1|||
160946926|NCT02352493|581193825|FG003|Overall Study|Withdrawal by Subject|0|||
160946927|NCT02352493|581193826|FG004|Overall Study|Withdrawal by Subject|0|||
160946928|NCT02352493|581193827|FG005|Overall Study|Withdrawal by Subject|0|||
160946929|NCT02352493|581193828|FG006|Overall Study|Withdrawal by Subject|0|||
160946930|NCT02352493|581193829|FG007|Overall Study|Withdrawal by Subject|0|||
160946931|NCT02352493|581193830|FG008|Overall Study|Withdrawal by Subject|1|||
160946932|NCT02352493|581193831|FG009|Overall Study|Withdrawal by Subject|0|||
160456095|NCT04308681|579399842|FG001|Treatment up to Week 26|Other reasons|0|||
160456096|NCT04308681|579399843|FG002|Treatment up to Week 26|Other reasons|0|||
160456097|NCT04308681|579399844|FG003|Treatment up to Week 26|Other reasons|0|||
160456098|NCT04308681|579399845|FG004|Treatment up to Week 26|Other reasons|1|||
160456099|NCT04308681|579399846|FG005|Treatment up to Week 26|Other reasons|1|||
160456100|NCT04308681|579399847|FG006|Treatment up to Week 26|Other reasons|0|||
160456101|NCT04308681|579399848|FG007|Treatment up to Week 26|Other reasons|0|||
160456102|NCT04308681|579399841|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
160456103|NCT04308681|579399842|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
160456104|NCT04308681|579399843|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
160456105|NCT04308681|579399844|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
160456106|NCT04308681|579399845|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
160456107|NCT04308681|579399846|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
160456108|NCT04308681|579399847|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
160456109|NCT04308681|579399848|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
160456110|NCT04308681|579399841|FG000|Treatment up to Week 26|Adverse Event|6|||
160456111|NCT04308681|579399842|FG001|Treatment up to Week 26|Adverse Event|5|||
160456112|NCT04308681|579399843|FG002|Treatment up to Week 26|Adverse Event|5|||
160946933|NCT02352493|581193832|FG010|Overall Study|Withdrawal by Subject|0|||
160946934|NCT02352493|581193833|FG011|Overall Study|Withdrawal by Subject|0|||
160946935|NCT02352493|581193834|FG012|Overall Study|Withdrawal by Subject|0|||
160946936|NCT02352493|581193835|FG013|Overall Study|Withdrawal by Subject|0|||
160946937|NCT02352493|581193836|FG014|Overall Study|Withdrawal by Subject|1|||
160946938|NCT02352493|581193837|FG015|Overall Study|Withdrawal by Subject|0|||
160946939|NCT02352493|581193838|FG016|Overall Study|Withdrawal by Subject|0|||
160946940|NCT02352493|581193839|FG017|Overall Study|Withdrawal by Subject|0|||
160946941|NCT02352493|581193822|FG000|Overall Study|Lost to Follow-up|0|||
160946942|NCT02352493|581193823|FG001|Overall Study|Lost to Follow-up|0|||
160946943|NCT02352493|581193824|FG002|Overall Study|Lost to Follow-up|0|||
160946944|NCT02352493|581193825|FG003|Overall Study|Lost to Follow-up|0|||
160456113|NCT04308681|579399844|FG003|Treatment up to Week 26|Adverse Event|0|||
160456114|NCT04308681|579399845|FG004|Treatment up to Week 26|Adverse Event|6|||
160946945|NCT02352493|581193826|FG004|Overall Study|Lost to Follow-up|0|||
160946946|NCT02352493|581193827|FG005|Overall Study|Lost to Follow-up|0|||
160946947|NCT02352493|581193828|FG006|Overall Study|Lost to Follow-up|0|||
160946948|NCT02352493|581193829|FG007|Overall Study|Lost to Follow-up|0|||
160946949|NCT02352493|581193830|FG008|Overall Study|Lost to Follow-up|0|||
160456115|NCT04308681|579399846|FG005|Treatment up to Week 26|Adverse Event|1|||
160456116|NCT04308681|579399847|FG006|Treatment up to Week 26|Adverse Event|0|||
160456117|NCT04308681|579399848|FG007|Treatment up to Week 26|Adverse Event|0|||
160456118|NCT04308681|579399841|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
160456119|NCT04308681|579399842|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
160456120|NCT04308681|579399843|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
160456121|NCT04308681|579399844|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
160456122|NCT04308681|579399845|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
160456123|NCT04308681|579399846|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
160456124|NCT04308681|579399847|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
160456125|NCT04308681|579399848|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
160456126|NCT04308681|579399841|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
160456127|NCT04308681|579399842|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
160456128|NCT04308681|579399843|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
160456129|NCT04308681|579399844|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
160456130|NCT04308681|579399845|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
160456131|NCT04308681|579399846|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
160456132|NCT04308681|579399847|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
160456133|NCT04308681|579399848|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
160456134|NCT04308681|579399841|FG000|OTE - 26 Weeks|Death|0|||
160456135|NCT04308681|579399842|FG001|OTE - 26 Weeks|Death|1|||
160456136|NCT04308681|579399843|FG002|OTE - 26 Weeks|Death|0|||
160456137|NCT04308681|579399844|FG003|OTE - 26 Weeks|Death|0|||
160456138|NCT04308681|579399845|FG004|OTE - 26 Weeks|Death|0|||
160456139|NCT04308681|579399846|FG005|OTE - 26 Weeks|Death|0|||
160580352|NCT01259297|579844183|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
160946950|NCT02352493|581193831|FG009|Overall Study|Lost to Follow-up|1|||
160946951|NCT02352493|581193832|FG010|Overall Study|Lost to Follow-up|0|||
160946952|NCT02352493|581193833|FG011|Overall Study|Lost to Follow-up|0|||
160946953|NCT02352493|581193834|FG012|Overall Study|Lost to Follow-up|1|||
160946954|NCT02352493|581193835|FG013|Overall Study|Lost to Follow-up|2|||
160946955|NCT02352493|581193836|FG014|Overall Study|Lost to Follow-up|0|||
160456140|NCT04308681|579399847|FG006|OTE - 26 Weeks|Death|1|||
160456141|NCT04308681|579399848|FG007|OTE - 26 Weeks|Death|0|||
160456142|NCT04308681|579399841|FG000|OTE - 26 Weeks|Adverse Event|0|||
160456143|NCT04308681|579399842|FG001|OTE - 26 Weeks|Adverse Event|2|||
160946956|NCT02352493|581193837|FG015|Overall Study|Lost to Follow-up|0|||
160946957|NCT02352493|581193838|FG016|Overall Study|Lost to Follow-up|0|||
160946958|NCT02352493|581193839|FG017|Overall Study|Lost to Follow-up|0|||
160946959|NCT02162810|581193840|FG000|Overall Study|Protocol Violation|1|||
160946960|NCT02162810|581193841|FG001|Overall Study|Protocol Violation|0|||
160946961|NCT02162810|581193840|FG000|Overall Study|patients did not report compliance|4|||
160946962|NCT02162810|581193841|FG001|Overall Study|patients did not report compliance|1|||
160946963|NCT00389324|581193842|FG000|Run-In Phase|Adverse Event|1|||
160946964|NCT00389324|581193842|FG000|Run-In Phase|Lost to Follow-up|1|||
160946965|NCT00389324|581193842|FG000|Run-In Phase|Withdrawal by Subject|1|||
160946966|NCT00389324|581193842|FG000|Subcutaneous Phase|Adverse Event|2|||
160946967|NCT00389324|581193842|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
160580353|NCT01259297|579844184|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
160580354|NCT01259297|579844185|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
160580355|NCT01259297|579844186|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
160580356|NCT01259297|579844187|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
160580357|NCT01259297|579844188|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
160580358|NCT01259297|579844189|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
160580359|NCT01259297|579844190|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
160580360|NCT01259297|579844183|FG000|Double Blind Randomized Period|Other reasons|0|||
160580361|NCT01259297|579844184|FG001|Double Blind Randomized Period|Other reasons|1|||
160580362|NCT01259297|579844185|FG002|Double Blind Randomized Period|Other reasons|0|||
160580363|NCT01259297|579844186|FG003|Double Blind Randomized Period|Other reasons|0|||
160580364|NCT01259297|579844187|FG004|Double Blind Randomized Period|Other reasons|1|||
160946968|NCT00389324|581193842|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
160946969|NCT00389324|581193842|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
160946970|NCT02317575|581193843|FG000|Period 1|Difficulty with venous cannulation|0|||
160946971|NCT02317575|581193844|FG001|Period 1|Difficulty with venous cannulation|1|||
160946972|NCT02317575|581193845|FG002|Period 1|Difficulty with venous cannulation|0|||
160946973|NCT02317575|581193846|FG003|Period 1|Difficulty with venous cannulation|0|||
160946974|NCT02317575|581193847|FG004|Period 1|Difficulty with venous cannulation|0|||
160946975|NCT02317575|581193843|FG000|Period 1|Withdrawal by Subject|1|||
160946976|NCT02317575|581193844|FG001|Period 1|Withdrawal by Subject|0|||
160946977|NCT02317575|581193845|FG002|Period 1|Withdrawal by Subject|0|||
160946978|NCT02317575|581193846|FG003|Period 1|Withdrawal by Subject|0|||
160946979|NCT02317575|581193847|FG004|Period 1|Withdrawal by Subject|0|||
160946980|NCT01465334|581193848|FG000|Overall Study|Disease Progression|1|||
160946981|NCT01465334|581193849|FG001|Overall Study|Disease Progression|0|||
160946982|NCT01465334|581193848|FG000|Overall Study|Adverse Event|1|||
160946983|NCT01465334|581193849|FG001|Overall Study|Adverse Event|0|||
160946984|NCT01465334|581193848|FG000|Overall Study|Richter's transformation|0|||
160946985|NCT01465334|581193849|FG001|Overall Study|Richter's transformation|3|||
160946986|NCT01465334|581193848|FG000|Overall Study|Refractory Disease|0|||
160946987|NCT01465334|581193849|FG001|Overall Study|Refractory Disease|3|||
160946988|NCT03936244|581193853|FG000|Overall Study|Lost to Follow-up|5|||
160946989|NCT03936244|581193854|FG001|Overall Study|Lost to Follow-up|1|||
160946990|NCT03936244|581193853|FG000|Overall Study|Physician Decision|7|||
160946991|NCT03936244|581193854|FG001|Overall Study|Physician Decision|3|||
160946992|NCT01925183|581193857|FG000|Overall Study|Adverse Event|1|||
160946993|NCT01925183|581193858|FG001|Overall Study|Adverse Event|0|||
160946994|NCT01046110|581193859|FG000|Overall Study|Adverse Event|9|||
160946995|NCT01046110|581193860|FG001|Overall Study|Adverse Event|2|||
160946996|NCT01046110|581193859|FG000|Overall Study|Lack of Efficacy|0|||
160946997|NCT01046110|581193860|FG001|Overall Study|Lack of Efficacy|1|||
160946998|NCT01046110|581193859|FG000|Overall Study|Protocol Violation|7|||
160946999|NCT01046110|581193860|FG001|Overall Study|Protocol Violation|12|||
160947000|NCT01046110|581193859|FG000|Overall Study|Withdrawal Criteria|3|||
160947001|NCT01046110|581193860|FG001|Overall Study|Withdrawal Criteria|5|||
160947002|NCT01046110|581193859|FG000|Overall Study|Unclassified|36|||
160947003|NCT01046110|581193860|FG001|Overall Study|Unclassified|35|||
160456144|NCT04308681|579399843|FG002|OTE - 26 Weeks|Adverse Event|8|||
160580365|NCT01259297|579844188|FG005|Double Blind Randomized Period|Other reasons|2|||
160947004|NCT01233817|581193863|FG000|Overall Study|Lost to Follow-up|1|||
160947005|NCT01233817|581193863|FG000|Overall Study|Withdrawal by Subject|2|||
160947006|NCT02159482|581193864|FG000|Overall Study|Withdrawal by Subject|2|||
160947007|NCT02159482|581193864|FG000|Overall Study|Physician Decision|3|||
160947008|NCT01248884|581193867|FG000|Overall Study|Withdrawal by Subject|1|||
160947009|NCT01248884|581193868|FG001|Overall Study|Withdrawal by Subject|3|||
160947010|NCT01248884|581193869|FG002|Overall Study|Withdrawal by Subject|1|||
160947011|NCT01248884|581193867|FG000|Overall Study|Adverse Event|1|||
160947012|NCT01248884|581193868|FG001|Overall Study|Adverse Event|0|||
160947013|NCT01248884|581193869|FG002|Overall Study|Adverse Event|0|||
160947014|NCT04479618|581193870|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
160947015|NCT04479618|581193871|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
160580366|NCT01259297|579844189|FG006|Double Blind Randomized Period|Other reasons|3|||
160580367|NCT01259297|579844190|FG007|Double Blind Randomized Period|Other reasons|1|||
160580368|NCT01555463|579844191|FG000|Treatment|Adverse Event|6|||
160580369|NCT01555463|579844192|FG001|Treatment|Adverse Event|12|||
160580370|NCT01555463|579844191|FG000|Treatment|Withdrawal by Subject|24|||
160580371|NCT01555463|579844192|FG001|Treatment|Withdrawal by Subject|36|||
160580372|NCT01555463|579844191|FG000|Treatment|Lost to Follow-up|28|||
160580373|NCT01555463|579844192|FG001|Treatment|Lost to Follow-up|23|||
160580374|NCT01555463|579844191|FG000|Treatment|Protocol Violation|4|||
160580375|NCT01555463|579844192|FG001|Treatment|Protocol Violation|5|||
160580376|NCT01555463|579844191|FG000|Treatment|Other reason|2|||
160580377|NCT01555463|579844192|FG001|Treatment|Other reason|3|||
160580378|NCT01555463|579844191|FG000|Follow up|Adverse Event|2|||
160580379|NCT01555463|579844192|FG001|Follow up|Adverse Event|5|||
160580380|NCT01555463|579844191|FG000|Follow up|Death|0|||
160580381|NCT01555463|579844192|FG001|Follow up|Death|1|||
160580382|NCT01555463|579844191|FG000|Follow up|Withdrawal by Subject|22|||
160580383|NCT01555463|579844192|FG001|Follow up|Withdrawal by Subject|22|||
160580384|NCT01555463|579844191|FG000|Follow up|Lost to Follow-up|9|||
160580385|NCT01555463|579844192|FG001|Follow up|Lost to Follow-up|10|||
160580386|NCT01555463|579844191|FG000|Follow up|Protocol Violation|2|||
160580387|NCT01555463|579844192|FG001|Follow up|Protocol Violation|4|||
160580388|NCT01555463|579844191|FG000|Follow up|Other reason|3|||
160580389|NCT01555463|579844192|FG001|Follow up|Other reason|3|||
160580390|NCT01165203|579844193|FG000|Active Phase|Serious Adverse Event|1|||
160580391|NCT01165203|579844194|FG001|Active Phase|Serious Adverse Event|0|||
160580392|NCT01165203|579844193|FG000|Active Phase|Withdrawal by Subject|2|||
160580393|NCT01165203|579844194|FG001|Active Phase|Withdrawal by Subject|1|||
160580394|NCT01165203|579844193|FG000|Active Phase|Migrated/moved from study area|0|||
160580395|NCT01165203|579844194|FG001|Active Phase|Migrated/moved from study area|1|||
160580396|NCT01165203|579844193|FG000|Active Phase|Lost to Follow-up|2|||
160580397|NCT01165203|579844194|FG001|Active Phase|Lost to Follow-up|0|||
160580398|NCT01165203|579844193|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
160580399|NCT01165203|579844194|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
160580400|NCT01165203|579844193|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
160580401|NCT01165203|579844194|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
160580402|NCT01165203|579844193|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
160580403|NCT01165203|579844194|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
160580404|NCT01165203|579844193|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
160580405|NCT01165203|579844194|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
160580406|NCT01165203|579844193|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
160580407|NCT01165203|579844194|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
160580408|NCT02815397|579844196|FG000|Overall Study|Physician Decision|2|||
160580409|NCT04598165|579844199|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
160580410|NCT04598165|579844200|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
160580411|NCT04598165|579844199|FG000|Completed 6-week Follow-up|Death|2|||
160580412|NCT04598165|579844200|FG001|Completed 6-week Follow-up|Death|1|||
160580413|NCT04598165|579844199|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
160580414|NCT04598165|579844200|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
160580415|NCT04598165|579844199|FG000|Completed 6-week Follow-up|Ineligible|4|||
160580416|NCT04598165|579844200|FG001|Completed 6-week Follow-up|Ineligible|3|||
160580417|NCT04598165|579844199|FG000|Completed 6-week Follow-up|Partner refusal|0|||
160580418|NCT04598165|579844200|FG001|Completed 6-week Follow-up|Partner refusal|1|||
160580419|NCT04598165|579844199|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
160580420|NCT04598165|579844200|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
160580421|NCT00705224|579844201|FG000|Overall Study|Adverse Event|1|||
160947016|NCT04479618|581193872|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
160947017|NCT04479618|581193870|FG000|Overall Study|Lack of Efficacy|1|||
160947018|NCT04479618|581193871|FG001|Overall Study|Lack of Efficacy|0|||
160947019|NCT04479618|581193872|FG002|Overall Study|Lack of Efficacy|0|||
160580422|NCT00705224|579844201|FG000|Overall Study|Lack of Efficacy|2|||
160580423|NCT00705224|579844201|FG000|Overall Study|Withdrawal by Subject|3|||
160580424|NCT00705224|579844201|FG000|Overall Study|Lost to Follow-up|5|||
160580425|NCT01746732|579845468|FG000|Lead-In Period|Withdrawal by Subject|1|||
160580426|NCT01746732|579845469|FG001|Lead-In Period|Withdrawal by Subject|0|||
160580427|NCT01746732|579845470|FG002|Lead-In Period|Withdrawal by Subject|0|||
160580428|NCT01746732|579845468|FG000|Period 1|Physician Decision|0|||
160580429|NCT01746732|579845469|FG001|Period 1|Physician Decision|1|||
160580430|NCT01746732|579845470|FG002|Period 1|Physician Decision|0|||
160947020|NCT04479618|581193870|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
160580431|NCT01746732|579845468|FG000|Period 2|Withdrawal by Subject|0|||
160580432|NCT01746732|579845469|FG001|Period 2|Withdrawal by Subject|0|||
160580433|NCT01746732|579845470|FG002|Period 2|Withdrawal by Subject|2|||
160947021|NCT04479618|581193871|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
160947022|NCT04479618|581193872|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
160947023|NCT04479618|581193870|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
160947024|NCT04479618|581193871|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
160947025|NCT04479618|581193872|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
160947026|NCT04479618|581193870|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
160947027|NCT04479618|581193871|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
160947028|NCT04479618|581193872|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
160947029|NCT04479618|581193870|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
160947030|NCT04479618|581193871|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
160947031|NCT04479618|581193872|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
160947032|NCT01430130|581193873|FG000|Overall Study|Lost to Follow-up|1|||
160947033|NCT01430130|581193873|FG000|Overall Study|Infection on Control Side of Incision|1|||
160947034|NCT01243944|581193876|FG000|Overall Study|Adverse Event|15|||
160947035|NCT01243944|581193877|FG001|Overall Study|Adverse Event|13|||
160947036|NCT01243944|581193876|FG000|Overall Study|Lost to Follow-up|2|||
160947037|NCT01243944|581193877|FG001|Overall Study|Lost to Follow-up|1|||
160947038|NCT01243944|581193876|FG000|Overall Study|Physician Decision|2|||
160947039|NCT01243944|581193877|FG001|Overall Study|Physician Decision|7|||
160947040|NCT01243944|581193876|FG000|Overall Study|Disease progression|12|||
160947041|NCT01243944|581193877|FG001|Overall Study|Disease progression|11|||
160947042|NCT01243944|581193876|FG000|Overall Study|Protocol deviation|1|||
160947043|NCT01243944|581193877|FG001|Overall Study|Protocol deviation|1|||
160947044|NCT01243944|581193876|FG000|Overall Study|Participant decision|10|||
160947045|NCT01243944|581193877|FG001|Overall Study|Participant decision|15|||
160947046|NCT01243944|581193876|FG000|Overall Study|Death|2|||
160947047|NCT01243944|581193877|FG001|Overall Study|Death|3|||
160947048|NCT01243944|581193876|FG000|Overall Study|Non-compliance with study treatment|1|||
160947049|NCT01243944|581193877|FG001|Overall Study|Non-compliance with study treatment|0|||
160947050|NCT02673697|581193880|FG000|Overall Study|Adverse Event|2|||
160947051|NCT02673697|581193881|FG001|Overall Study|Adverse Event|0|||
160947052|NCT02673697|581193880|FG000|Overall Study|Death|32|||
160947053|NCT02673697|581193881|FG001|Overall Study|Death|24|||
160947054|NCT02673697|581193880|FG000|Overall Study|Lost to Follow-up|5|||
160947055|NCT02673697|581193881|FG001|Overall Study|Lost to Follow-up|2|||
160947056|NCT02673697|581193880|FG000|Overall Study|Physician Decision|2|||
160947057|NCT02673697|581193881|FG001|Overall Study|Physician Decision|1|||
160947058|NCT02673697|581193880|FG000|Overall Study|Withdrawal by Subject|10|||
160947059|NCT02673697|581193881|FG001|Overall Study|Withdrawal by Subject|7|||
160947060|NCT02673697|581193880|FG000|Overall Study|Change subj medical status|1|||
160947061|NCT02673697|581193881|FG001|Overall Study|Change subj medical status|2|||
160947062|NCT02673697|581193880|FG000|Overall Study|Explant|10|||
160947063|NCT02673697|581193881|FG001|Overall Study|Explant|5|||
160947064|NCT02673697|581193880|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
160947065|NCT02673697|581193881|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
160947066|NCT00437489|581193882|FG000|Overall Study|Study terminated by sponsor|23|||
160947067|NCT00437489|581193883|FG001|Overall Study|Study terminated by sponsor|21|||
160947068|NCT00437489|581193882|FG000|Overall Study|Lost to Follow-up|0|||
160947069|NCT00437489|581193883|FG001|Overall Study|Lost to Follow-up|1|||
160947070|NCT01525082|581193891|FG000|Overall Study|Death|1|||
160947071|NCT00022516|581193899|FG000|Overall Study|Adverse Event|0|||
160947072|NCT00022516|581193900|FG001|Overall Study|Adverse Event|59|||
160947073|NCT00022516|581193899|FG000|Overall Study|Lack of Efficacy|0|||
160947074|NCT00022516|581193900|FG001|Overall Study|Lack of Efficacy|27|||
160947075|NCT00022516|581193899|FG000|Overall Study|Physician Decision|0|||
160947076|NCT00022516|581193900|FG001|Overall Study|Physician Decision|1|||
160947077|NCT00022516|581193899|FG000|Overall Study|Protocol Violation|1|||
160947078|NCT00022516|581193900|FG001|Overall Study|Protocol Violation|3|||
160947079|NCT00022516|581193899|FG000|Overall Study|Withdrawal by Subject|2|||
160947080|NCT00022516|581193900|FG001|Overall Study|Withdrawal by Subject|113|||
160947081|NCT00022516|581193899|FG000|Overall Study|Incomplete documentation|0|||
160947082|NCT00022516|581193900|FG001|Overall Study|Incomplete documentation|27|||
160947083|NCT03321019|581193902|FG000|Overall Study|Withdrawal by Subject|0|||
160947084|NCT03321019|581193903|FG001|Overall Study|Withdrawal by Subject|6|||
160947085|NCT03321019|581193902|FG000|Overall Study|Lost to Follow-up|0|||
160947086|NCT03321019|581193903|FG001|Overall Study|Lost to Follow-up|22|||
160947087|NCT03880578|581193904|FG000|Overall Study|Withdrawal by Subject|0|||
160947088|NCT03880578|581193905|FG001|Overall Study|Withdrawal by Subject|3|||
160947089|NCT03880578|581193906|FG002|Overall Study|Withdrawal by Subject|1|||
160947090|NCT03880578|581193904|FG000|Overall Study|Death|0|||
160456145|NCT04308681|579399844|FG003|OTE - 26 Weeks|Adverse Event|3|||
160947091|NCT03880578|581193905|FG001|Overall Study|Death|1|||
160947092|NCT03880578|581193906|FG002|Overall Study|Death|0|||
160947093|NCT01568047|581193908|FG000|Overall Study|Ineligibility|1|||
160947094|NCT01568047|581193909|FG001|Overall Study|Ineligibility|0|||
160580434|NCT01746732|579845468|FG000|Period 2|Adverse Event|0|||
160580435|NCT01746732|579845469|FG001|Period 2|Adverse Event|0|||
160580436|NCT01746732|579845470|FG002|Period 2|Adverse Event|1|||
160580437|NCT01746732|579845468|FG000|Period 2|Lost to Follow-up|0|||
160580438|NCT01746732|579845469|FG001|Period 2|Lost to Follow-up|0|||
160580439|NCT01746732|579845470|FG002|Period 2|Lost to Follow-up|1|||
160580440|NCT02817555|579845471|FG000|Overall Study|Death|1|||
160580441|NCT02817555|579845472|FG001|Overall Study|Death|3|||
160580442|NCT02817555|579845471|FG000|Overall Study|moved away|1|||
160580443|NCT02817555|579845472|FG001|Overall Study|moved away|0|||
160580444|NCT02817555|579845471|FG000|Overall Study|transplant|1|||
160580445|NCT02817555|579845472|FG001|Overall Study|transplant|1|||
160580446|NCT02817555|579845471|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
160580447|NCT02817555|579845472|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
160580448|NCT00137436|579845473|FG000|Overall Study|Adverse Event|13|||
160580449|NCT00137436|579845473|FG000|Overall Study|Death|2|||
160580450|NCT00137436|579845473|FG000|Overall Study|Lack of Efficacy|17|||
160580451|NCT00137436|579845473|FG000|Overall Study|Withdrawal by Subject|6|||
160580452|NCT00137436|579845473|FG000|Overall Study|Other|5|||
160580453|NCT00701727|579845474|FG000|First Treatment Period|Adverse Event|0|||
160580454|NCT00701727|579845475|FG001|First Treatment Period|Adverse Event|0|||
160580455|NCT00701727|579845474|FG000|First Treatment Period|Withdrawal by Subject|1|||
160580456|NCT00701727|579845475|FG001|First Treatment Period|Withdrawal by Subject|0|||
160580457|NCT00701727|579845474|FG000|First Treatment Period|sponsor decision|0|||
160580458|NCT00701727|579845475|FG001|First Treatment Period|sponsor decision|1|||
160580459|NCT00701727|579845474|FG000|First Treatment Period|Lost to Follow-up|0|||
160580460|NCT00701727|579845475|FG001|First Treatment Period|Lost to Follow-up|1|||
160580461|NCT00701727|579845474|FG000|Second Treatment Period|Withdrawal by Subject|2|||
160580462|NCT00701727|579845475|FG001|Second Treatment Period|Withdrawal by Subject|0|||
160580463|NCT00912015|579845476|FG000|Overall Study|Lack of Efficacy|1|||
160580464|NCT00912015|579845477|FG001|Overall Study|Lack of Efficacy|0|||
160580465|NCT00912015|579845478|FG002|Overall Study|Lack of Efficacy|0|||
160580466|NCT00912015|579845479|FG003|Overall Study|Lack of Efficacy|0|||
160580467|NCT00912015|579845476|FG000|Overall Study|Withdrawal by Subject|8|||
160580468|NCT00912015|579845477|FG001|Overall Study|Withdrawal by Subject|8|||
160580469|NCT00912015|579845478|FG002|Overall Study|Withdrawal by Subject|3|||
160580470|NCT00912015|579845479|FG003|Overall Study|Withdrawal by Subject|0|||
160947095|NCT01568047|581193910|FG002|Overall Study|Ineligibility|0|||
160947096|NCT01568047|581193911|FG003|Overall Study|Ineligibility|0|||
160947097|NCT01568047|581193908|FG000|Overall Study|Withdrawal by Subject|0|||
160947098|NCT01568047|581193909|FG001|Overall Study|Withdrawal by Subject|1|||
160947099|NCT01568047|581193910|FG002|Overall Study|Withdrawal by Subject|0|||
160947100|NCT01568047|581193911|FG003|Overall Study|Withdrawal by Subject|0|||
160947101|NCT01568047|581193908|FG000|Overall Study|Adverse Event|0|||
160947102|NCT01568047|581193909|FG001|Overall Study|Adverse Event|0|||
160947103|NCT01568047|581193910|FG002|Overall Study|Adverse Event|1|||
160947104|NCT01568047|581193911|FG003|Overall Study|Adverse Event|1|||
160947105|NCT03783923|581193912|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
160947106|NCT03783923|581193913|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
160947107|NCT03783923|581193912|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
160947108|NCT03783923|581193913|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
160947109|NCT03783923|581193912|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
160947110|NCT03783923|581193913|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
160947111|NCT03783923|581193912|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
160947112|NCT03783923|581193913|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
160947113|NCT03783923|581193912|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
160947114|NCT03783923|581193913|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
160947115|NCT01944046|581193921|FG000|Randomized to DB|Adverse Event|5|||
160947116|NCT01944046|581193922|FG001|Randomized to DB|Adverse Event|2|||
160947117|NCT01944046|581193921|FG000|Randomized to DB|Clinical Worsening|3|||
160947118|NCT01944046|581193922|FG001|Randomized to DB|Clinical Worsening|2|||
160580471|NCT00912015|579845476|FG000|Overall Study|Protocol Violation|1|||
160580472|NCT00912015|579845477|FG001|Overall Study|Protocol Violation|0|||
160580473|NCT00912015|579845478|FG002|Overall Study|Protocol Violation|0|||
160947119|NCT01944046|581193921|FG000|Randomized to DB|Lost to Follow-up|3|||
160999602|NCT01193153|581382771|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
160999603|NCT01193153|581382772|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
160999604|NCT01193153|581382771|FG000|Open-label Lead in Period|Other|14|||
160580474|NCT00912015|579845479|FG003|Overall Study|Protocol Violation|1|||
160947120|NCT01944046|581193922|FG001|Randomized to DB|Lost to Follow-up|3|||
160999605|NCT01193153|581382772|FG001|Open-label Lead in Period|Other|0|||
160580475|NCT00912015|579845476|FG000|Overall Study|Adverse Event|6|||
160580476|NCT00912015|579845477|FG001|Overall Study|Adverse Event|0|||
160580477|NCT00912015|579845478|FG002|Overall Study|Adverse Event|0|||
160580478|NCT00912015|579845479|FG003|Overall Study|Adverse Event|1|||
160580479|NCT05137041|579845480|FG000|Overall Study|Lost to Follow-up|1|||
160580480|NCT05137041|579845481|FG001|Overall Study|Lost to Follow-up|1|||
160580481|NCT05137041|579845480|FG000|Overall Study|Withdrawal by Subject|0|||
160580482|NCT05137041|579845481|FG001|Overall Study|Withdrawal by Subject|2|||
160580483|NCT05137041|579845480|FG000|Overall Study|Reason not Specified|0|||
160580484|NCT05137041|579845481|FG001|Overall Study|Reason not Specified|1|||
160580485|NCT02090114|579845482|FG000|Overall Study|Withdrawal by Subject|3|||
160580486|NCT02090114|579845483|FG001|Overall Study|Withdrawal by Subject|6|||
160580487|NCT02090114|579845484|FG002|Overall Study|Withdrawal by Subject|2|||
160580488|NCT02090114|579845485|FG003|Overall Study|Withdrawal by Subject|1|||
160580489|NCT02090114|579845482|FG000|Overall Study|Physician Decision|5|||
160580490|NCT02090114|579845483|FG001|Overall Study|Physician Decision|0|||
160580491|NCT02090114|579845484|FG002|Overall Study|Physician Decision|1|||
160580492|NCT02090114|579845485|FG003|Overall Study|Physician Decision|1|||
160947121|NCT01944046|581193921|FG000|Randomized to DB|Withdrawal by Subject|2|||
160947122|NCT01944046|581193922|FG001|Randomized to DB|Withdrawal by Subject|4|||
160947123|NCT01944046|581193921|FG000|Randomized to DB|Physician Decision|1|||
160947124|NCT01944046|581193922|FG001|Randomized to DB|Physician Decision|2|||
160947125|NCT01944046|581193921|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
160947126|NCT01944046|581193922|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
160947127|NCT01944046|581193921|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
160947128|NCT01944046|581193922|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
160947129|NCT01944046|581193921|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
160947130|NCT01944046|581193922|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
160947131|NCT01944046|581193921|FG000|Open Label Eligible and Consented|Adverse Event|6|||
160947132|NCT01944046|581193922|FG001|Open Label Eligible and Consented|Adverse Event|1|||
160947133|NCT01944046|581193921|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
160947134|NCT01944046|581193922|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
160947135|NCT01944046|581193921|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
160947136|NCT01944046|581193922|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
160947137|NCT02056301|581193925|FG000|Overall Study|Protocol Violation|1|||
160947138|NCT02056301|581193926|FG001|Overall Study|Protocol Violation|2|||
160947139|NCT02056301|581193925|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
160947140|NCT02056301|581193926|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
160947141|NCT02056301|581193925|FG000|Overall Study|Withdrawal by Subject|0|||
160947142|NCT02056301|581193926|FG001|Overall Study|Withdrawal by Subject|1|||
160947143|NCT02056301|581193925|FG000|Overall Study|Issues with epidural|0|||
160947144|NCT02056301|581193926|FG001|Overall Study|Issues with epidural|3|||
160947145|NCT02041429|581193928|FG000|Overall Study|Progressive Disease|2|||
160947146|NCT02041429|581193929|FG001|Overall Study|Progressive Disease|2|||
160947147|NCT02041429|581193930|FG002|Overall Study|Progressive Disease|3|||
160947148|NCT02041429|581193931|FG003|Overall Study|Progressive Disease|2|||
160947149|NCT02041429|581193928|FG000|Overall Study|Toxicity|0|||
160947150|NCT02041429|581193929|FG001|Overall Study|Toxicity|1|||
160947151|NCT02041429|581193930|FG002|Overall Study|Toxicity|4|||
160947152|NCT02041429|581193931|FG003|Overall Study|Toxicity|2|||
160947153|NCT02041429|581193928|FG000|Overall Study|Withdrawal by Subject|0|||
160947154|NCT02041429|581193929|FG001|Overall Study|Withdrawal by Subject|1|||
160947155|NCT02041429|581193930|FG002|Overall Study|Withdrawal by Subject|0|||
160947156|NCT02041429|581193931|FG003|Overall Study|Withdrawal by Subject|0|||
160947157|NCT02041429|581193928|FG000|Overall Study|On Maintenance Therapy|1|||
160947158|NCT02041429|581193929|FG001|Overall Study|On Maintenance Therapy|0|||
160947159|NCT02041429|581193930|FG002|Overall Study|On Maintenance Therapy|0|||
160947160|NCT02041429|581193931|FG003|Overall Study|On Maintenance Therapy|2|||
160947161|NCT00153101|581193932|FG000|Overall Study|Lost to Follow-up|14|||
160947162|NCT00153101|581193933|FG001|Overall Study|Lost to Follow-up|14|||
160999606|NCT01193153|581382771|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
160999607|NCT01193153|581382772|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
160999608|NCT01193153|581382771|FG000|Open-label Lead in Period|Adverse Event|41|||
160999609|NCT01193153|581382772|FG001|Open-label Lead in Period|Adverse Event|0|||
160999610|NCT01193153|581382771|FG000|Open-label Lead in Period|Death|1|||
160999611|NCT01193153|581382772|FG001|Open-label Lead in Period|Death|0|||
160999612|NCT01193153|581382771|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
160999613|NCT01193153|581382772|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
160580493|NCT02090114|579845482|FG000|Overall Study|Adverse Event|1|||
160580494|NCT02090114|579845483|FG001|Overall Study|Adverse Event|2|||
160580495|NCT02090114|579845484|FG002|Overall Study|Adverse Event|2|||
160580496|NCT02090114|579845485|FG003|Overall Study|Adverse Event|0|||
160580497|NCT02090114|579845482|FG000|Overall Study|Progressive Disease|20|||
160947163|NCT00153101|581193934|FG002|Overall Study|Lost to Follow-up|12|||
160947164|NCT00153101|581193935|FG003|Overall Study|Lost to Follow-up|5|||
160947165|NCT00153101|581193936|FG004|Overall Study|Lost to Follow-up|5|||
160947166|NCT00153101|581193932|FG000|Overall Study|Withdrawal by Subject|3|||
160947167|NCT00153101|581193933|FG001|Overall Study|Withdrawal by Subject|4|||
160456146|NCT04308681|579399845|FG004|OTE - 26 Weeks|Adverse Event|0|||
160947168|NCT00153101|581193934|FG002|Overall Study|Withdrawal by Subject|3|||
160580498|NCT02090114|579845483|FG001|Overall Study|Progressive Disease|21|||
160999614|NCT01193153|581382771|FG000|Open-label Stabilization Period|Adverse Event|9|||
160999615|NCT01193153|581382772|FG001|Open-label Stabilization Period|Adverse Event|0|||
160999616|NCT01193153|581382771|FG000|Open-label Stabilization Period|Death|2|||
160999617|NCT01193153|581382772|FG001|Open-label Stabilization Period|Death|0|||
160999618|NCT01193153|581382771|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
160999619|NCT01193153|581382772|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
160999620|NCT01193153|581382771|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
160999621|NCT01193153|581382772|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
160999622|NCT01193153|581382771|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
160999623|NCT01193153|581382772|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
160999624|NCT01193153|581382771|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
160999625|NCT01193153|581382772|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
160999626|NCT01193153|581382771|FG000|Open-label Stabilization Period|Other|8|||
160999627|NCT01193153|581382772|FG001|Open-label Stabilization Period|Other|0|||
160999628|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Other|2|||
160999629|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Other|3|||
160999630|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
160999631|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
160999632|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Death|2|||
160999633|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Death|0|||
160999634|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
160999635|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
160999636|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
160999637|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
160999638|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
160999639|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
160999640|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
160947169|NCT00153101|581193935|FG003|Overall Study|Withdrawal by Subject|3|||
160947170|NCT00153101|581193936|FG004|Overall Study|Withdrawal by Subject|5|||
160947171|NCT03169153|581193937|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
160947172|NCT03169153|581193938|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
160947173|NCT03169153|581193937|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
160947174|NCT03169153|581193938|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
160947175|NCT03169153|581193937|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
160947176|NCT03169153|581193938|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
160947177|NCT03169153|581193937|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
160947178|NCT03169153|581193938|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
160947179|NCT00439777|581193939|FG000|Treatment Period|Death|29|||
160999641|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
160999642|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
160999643|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
160999644|NCT02503202|581382775|FG000|Base Study: Up to Month 6|Death|1|||
160999645|NCT02503202|581382776|FG001|Base Study: Up to Month 6|Death|1|||
160580499|NCT02090114|579845484|FG002|Overall Study|Progressive Disease|23|||
160580500|NCT02090114|579845485|FG003|Overall Study|Progressive Disease|6|||
160580501|NCT02090114|579845482|FG000|Overall Study|Death|1|||
160580502|NCT02090114|579845483|FG001|Overall Study|Death|0|||
160580503|NCT02090114|579845484|FG002|Overall Study|Death|1|||
160580504|NCT02090114|579845485|FG003|Overall Study|Death|0|||
160580505|NCT00051558|579845486|FG000|Overall Study|Adverse Event|30|||
160580506|NCT00051558|579845487|FG001|Overall Study|Adverse Event|18|||
160580507|NCT00051558|579845486|FG000|Overall Study|Withdrawal by Subject|29|||
160580508|NCT00051558|579845487|FG001|Overall Study|Withdrawal by Subject|42|||
160580509|NCT00051558|579845486|FG000|Overall Study|Death|9|||
160580510|NCT00051558|579845487|FG001|Overall Study|Death|15|||
160580511|NCT00051558|579845486|FG000|Overall Study|Lost to Follow-up|4|||
160580512|NCT00051558|579845487|FG001|Overall Study|Lost to Follow-up|13|||
160580513|NCT00051558|579845486|FG000|Overall Study|Protocol Violation|3|||
160580514|NCT00051558|579845487|FG001|Overall Study|Protocol Violation|4|||
160580515|NCT00051558|579845486|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
160580516|NCT00051558|579845487|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
160580517|NCT00051558|579845486|FG000|Overall Study|Sponsor Decision|6|||
160580518|NCT00051558|579845487|FG001|Overall Study|Sponsor Decision|1|||
160580519|NCT00051558|579845486|FG000|Overall Study|Other|2|||
160947180|NCT00439777|581193940|FG001|Treatment Period|Death|21|||
160947181|NCT00439777|581193939|FG000|Treatment Period|Study terminated by sponsor|125|||
160947182|NCT00439777|581193940|FG001|Treatment Period|Study terminated by sponsor|132|||
160947183|NCT00439777|581193939|FG000|Treatment Period|Site closed by investigator|0|||
160999646|NCT02503202|581382777|FG002|Base Study: Up to Month 6|Death|0|||
160456147|NCT04308681|579399846|FG005|OTE - 26 Weeks|Adverse Event|1|||
160580520|NCT00051558|579845487|FG001|Overall Study|Other|1|||
160580521|NCT00051558|579845486|FG000|Overall Study|Significant Lab Value|2|||
160947184|NCT00439777|581193940|FG001|Treatment Period|Site closed by investigator|1|||
160947185|NCT00439777|581193939|FG000|Treatment Period|Did not take study treatment|7|||
160947186|NCT00439777|581193940|FG001|Treatment Period|Did not take study treatment|8|||
160947187|NCT00439777|581193939|FG000|Treatment Period|Adverse Event|111|||
160947188|NCT00439777|581193940|FG001|Treatment Period|Adverse Event|92|||
160947189|NCT00439777|581193939|FG000|Treatment Period|Protocol Violation|23|||
160947190|NCT00439777|581193940|FG001|Treatment Period|Protocol Violation|30|||
160947191|NCT00439777|581193939|FG000|Treatment Period|Withdrawal by Subject|66|||
160947192|NCT00439777|581193940|FG001|Treatment Period|Withdrawal by Subject|118|||
160947193|NCT00439777|581193939|FG000|Treatment Period|Lack of Efficacy|1|||
160947194|NCT00439777|581193940|FG001|Treatment Period|Lack of Efficacy|4|||
160947195|NCT00439777|581193939|FG000|Treatment Period|Lost to Follow-up|8|||
160947196|NCT00439777|581193940|FG001|Treatment Period|Lost to Follow-up|10|||
160947197|NCT00439777|581193939|FG000|Treatment Period|Protocol driven decision point|1|||
160947198|NCT00439777|581193940|FG001|Treatment Period|Protocol driven decision point|3|||
160947199|NCT00439777|581193939|FG000|Treatment Period|Physician Decision|7|||
160947200|NCT00439777|581193940|FG001|Treatment Period|Physician Decision|18|||
160947201|NCT00439777|581193939|FG000|Treatment Period|Clinical endpoint reached|26|||
160947202|NCT00439777|581193940|FG001|Treatment Period|Clinical endpoint reached|13|||
160947203|NCT00439777|581193939|FG000|Treatment Period|Technical problems|3|||
160947204|NCT00439777|581193940|FG001|Treatment Period|Technical problems|1|||
160947205|NCT00439777|581193939|FG000|Treatment Period|Participant convenience|12|||
160947206|NCT00439777|581193940|FG001|Treatment Period|Participant convenience|8|||
160947207|NCT00439777|581193939|FG000|Observational Period|Protocol Violation|0|||
160947208|NCT00439777|581193940|FG001|Observational Period|Protocol Violation|2|||
160947209|NCT00439777|581193939|FG000|Observational Period|Withdrawal by Subject|9|||
160947210|NCT00439777|581193940|FG001|Observational Period|Withdrawal by Subject|5|||
160947211|NCT00439777|581193939|FG000|Observational Period|Lost to Follow-up|1|||
160947212|NCT00439777|581193940|FG001|Observational Period|Lost to Follow-up|11|||
160947213|NCT00439777|581193939|FG000|Observational Period|Death|27|||
160947214|NCT00439777|581193940|FG001|Observational Period|Death|20|||
160947215|NCT00439777|581193939|FG000|Observational Period|Study terminated by sponsor|3|||
160947216|NCT00439777|581193940|FG001|Observational Period|Study terminated by sponsor|1|||
160947217|NCT00439777|581193939|FG000|Observational Period|Protocol driven decision point|0|||
160947218|NCT00439777|581193940|FG001|Observational Period|Protocol driven decision point|1|||
160947219|NCT00439777|581193939|FG000|Observational Period|Lack of Efficacy|1|||
160947220|NCT00439777|581193940|FG001|Observational Period|Lack of Efficacy|0|||
160947221|NCT00439777|581193939|FG000|Observational Period|Technical problems|0|||
160947222|NCT00439777|581193940|FG001|Observational Period|Technical problems|1|||
160947223|NCT03791398|581193943|FG000|Overall Study|Progression of Disease Under Study|2|||
160947224|NCT03791398|581193944|FG001|Overall Study|Progression of Disease Under Study|0|||
160947225|NCT03791398|581193945|FG002|Overall Study|Progression of Disease Under Study|0|||
160947226|NCT00766376|581193946|FG000|Overall Study|Withdrawal by Subject|27|||
160947227|NCT01072201|581193947|FG000|Overall Study|Lost to Follow-up|0|||
160947228|NCT01072201|581193948|FG001|Overall Study|Lost to Follow-up|1|||
160947229|NCT04382612|581193949|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
160947230|NCT01328002|581193951|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
160947231|NCT01328002|581193952|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
160947232|NCT01328002|581193951|FG000|Open-Label Period|Adverse Event|8|||
160947233|NCT01328002|581193952|FG001|Open-Label Period|Adverse Event|0|||
160947234|NCT01328002|581193951|FG000|Open-Label Period|Lack of Efficacy|3|||
160947235|NCT01328002|581193952|FG001|Open-Label Period|Lack of Efficacy|0|||
160947236|NCT01328002|581193951|FG000|Open-Label Period|Protocol Violation|2|||
160947237|NCT01328002|581193952|FG001|Open-Label Period|Protocol Violation|0|||
160947238|NCT01328002|581193951|FG000|Open-Label Period|Withdrawal by Subject|9|||
160947239|NCT01328002|581193952|FG001|Open-Label Period|Withdrawal by Subject|0|||
160947240|NCT01328002|581193951|FG000|Open-Label Period|Lost to Follow-up|6|||
160947241|NCT01328002|581193952|FG001|Open-Label Period|Lost to Follow-up|0|||
160947242|NCT01328002|581193951|FG000|Open-Label Period|Other Reason|2|||
160947243|NCT01328002|581193952|FG001|Open-Label Period|Other Reason|0|||
160947244|NCT01328002|581193951|FG000|Double-Blind Period|Adverse Event|1|||
160947245|NCT01328002|581193952|FG001|Double-Blind Period|Adverse Event|0|||
160947246|NCT01328002|581193951|FG000|Double-Blind Period|Lack of Efficacy|1|||
160947247|NCT01328002|581193952|FG001|Double-Blind Period|Lack of Efficacy|0|||
160947248|NCT01578551|581193953|FG000|Overall Study|Adverse Event|1|||
160947249|NCT01578551|581193954|FG001|Overall Study|Adverse Event|0|||
160947250|NCT00061048|581193956|FG000|Overall Study|Adverse Event|2|||
160947251|NCT00061048|581193956|FG000|Overall Study|disease progression|20|||
160947252|NCT02752048|581193957|FG000|Overall Study|Withdrawal by Subject|0|||
160947253|NCT02752048|581193958|FG001|Overall Study|Withdrawal by Subject|0|||
160947254|NCT02752048|581193959|FG002|Overall Study|Withdrawal by Subject|3|||
160456148|NCT04308681|579399847|FG006|OTE - 26 Weeks|Adverse Event|2|||
160947255|NCT03779841|581193963|FG000|Randomized Population|Did Not Receive Treatment|3|||
160947256|NCT03779841|581193964|FG001|Randomized Population|Did Not Receive Treatment|1|||
160999647|NCT02503202|581382778|FG003|Base Study: Up to Month 6|Death|0|||
160580522|NCT00051558|579845487|FG001|Overall Study|Significant Lab Value|0|||
160580523|NCT00051558|579845486|FG000|Overall Study|Physician Decision|5|||
160947257|NCT03779841|581193965|FG002|Randomized Population|Did Not Receive Treatment|0|||
160947258|NCT03779841|581193963|FG000|Treated (Safety) Population|Adverse Event|1|||
160947259|NCT03779841|581193964|FG001|Treated (Safety) Population|Adverse Event|1|||
160947260|NCT03779841|581193965|FG002|Treated (Safety) Population|Adverse Event|0|||
160947261|NCT03779841|581193963|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
160947262|NCT03779841|581193964|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
160947263|NCT03779841|581193965|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
160947264|NCT03779841|581193963|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
160947265|NCT03779841|581193964|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
160947266|NCT03779841|581193965|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
160947267|NCT03779841|581193963|FG000|Treated (Safety) Population|Death|1|||
160947268|NCT03779841|581193964|FG001|Treated (Safety) Population|Death|0|||
160947269|NCT03779841|581193965|FG002|Treated (Safety) Population|Death|2|||
160947270|NCT02788175|581193966|FG000|Overall Study|Protocol Violation|3|||
160947271|NCT02788175|581193966|FG000|Overall Study|Withdrawal by Subject|4|||
160947272|NCT02788175|581193966|FG000|Overall Study|Ineligible prior to study agent|6|||
160947273|NCT00818441|581193967|FG000|Overall Study|Death|69|||
160947274|NCT00818441|581193968|FG001|Overall Study|Death|26|||
160947275|NCT00818441|581193967|FG000|Overall Study|Other|5|||
160947276|NCT00818441|581193968|FG001|Overall Study|Other|0|||
160947277|NCT00818441|581193967|FG000|Overall Study|Lost to Follow-up|2|||
160947278|NCT00818441|581193968|FG001|Overall Study|Lost to Follow-up|1|||
160947279|NCT00818441|581193967|FG000|Overall Study|Withdrawal by Subject|2|||
160947280|NCT00818441|581193968|FG001|Overall Study|Withdrawal by Subject|0|||
160947281|NCT00818441|581193967|FG000|Overall Study|Adverse Event|0|||
160947282|NCT00818441|581193968|FG001|Overall Study|Adverse Event|1|||
160947283|NCT00818441|581193967|FG000|Overall Study|Study terminated by sponsor|11|||
160947284|NCT00818441|581193968|FG001|Overall Study|Study terminated by sponsor|2|||
160947285|NCT00898677|581193969|FG000|Overall Study|Adverse Event|0|||
160947286|NCT00898677|581193970|FG001|Overall Study|Adverse Event|0|||
160947287|NCT00898677|581193971|FG002|Overall Study|Adverse Event|1|||
160947288|NCT00898677|581193972|FG003|Overall Study|Adverse Event|0|||
160947289|NCT00898677|581193969|FG000|Overall Study|Lost to Follow-up|0|||
160947290|NCT00898677|581193970|FG001|Overall Study|Lost to Follow-up|0|||
160947291|NCT00898677|581193971|FG002|Overall Study|Lost to Follow-up|2|||
160947292|NCT00898677|581193972|FG003|Overall Study|Lost to Follow-up|0|||
160947293|NCT00898677|581193969|FG000|Overall Study|Protocol Violation|1|||
160947294|NCT00898677|581193970|FG001|Overall Study|Protocol Violation|1|||
160947295|NCT00898677|581193971|FG002|Overall Study|Protocol Violation|2|||
160947296|NCT00898677|581193972|FG003|Overall Study|Protocol Violation|0|||
160947297|NCT00898677|581193969|FG000|Overall Study|Withdrawal by Subject|0|||
160947298|NCT00898677|581193970|FG001|Overall Study|Withdrawal by Subject|0|||
160947299|NCT00898677|581193971|FG002|Overall Study|Withdrawal by Subject|0|||
160947300|NCT00898677|581193972|FG003|Overall Study|Withdrawal by Subject|1|||
160947301|NCT00898677|581193969|FG000|Overall Study|Not Treated: Adverse Event|0|||
160947302|NCT00898677|581193970|FG001|Overall Study|Not Treated: Adverse Event|2|||
160947303|NCT00898677|581193971|FG002|Overall Study|Not Treated: Adverse Event|1|||
160947304|NCT00898677|581193972|FG003|Overall Study|Not Treated: Adverse Event|0|||
160947305|NCT00898677|581193969|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
160947306|NCT00898677|581193970|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
160999648|NCT02503202|581382779|FG004|Base Study: Up to Month 6|Death|0|||
160999649|NCT02503202|581382775|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
160999650|NCT02503202|581382776|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
160999651|NCT02503202|581382777|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
160999652|NCT02503202|581382778|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
160999653|NCT02503202|581382779|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
160580524|NCT00051558|579845487|FG001|Overall Study|Physician Decision|0|||
160580525|NCT00414310|579845491|FG000|Overall Study|Not treated|1|||
160580526|NCT00414310|579845492|FG001|Overall Study|Not treated|0|||
160580527|NCT01441440|579845496|FG000|Overall Study|Death|1|||
160580528|NCT01441440|579845497|FG001|Overall Study|Death|0|||
160580529|NCT01441440|579845498|FG002|Overall Study|Death|1|||
160580530|NCT01441440|579845496|FG000|Overall Study|Adverse Event|2|||
160947307|NCT00898677|581193971|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
160947308|NCT00898677|581193972|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
160947309|NCT00898677|581193969|FG000|Overall Study|Not Treated: Pregnancy|0|||
160947310|NCT00898677|581193970|FG001|Overall Study|Not Treated: Pregnancy|0|||
160947311|NCT00898677|581193971|FG002|Overall Study|Not Treated: Pregnancy|1|||
160947312|NCT00898677|581193972|FG003|Overall Study|Not Treated: Pregnancy|0|||
160580531|NCT01441440|579845497|FG001|Overall Study|Adverse Event|9|||
160580532|NCT01441440|579845498|FG002|Overall Study|Adverse Event|9|||
160580533|NCT01441440|579845496|FG000|Overall Study|Lost to Follow-up|0|||
160947313|NCT00898677|581193969|FG000|Overall Study|Not Treated: Protocol Violation|2|||
160947314|NCT00898677|581193970|FG001|Overall Study|Not Treated: Protocol Violation|0|||
160947315|NCT00898677|581193971|FG002|Overall Study|Not Treated: Protocol Violation|2|||
160947316|NCT00898677|581193972|FG003|Overall Study|Not Treated: Protocol Violation|0|||
160947317|NCT00898677|581193969|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
160947318|NCT00898677|581193970|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
160947319|NCT00898677|581193971|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
160947320|NCT00898677|581193972|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
160947321|NCT00898677|581193969|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
160947322|NCT00898677|581193970|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
160947323|NCT00898677|581193971|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
160947324|NCT00898677|581193972|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
160947325|NCT00898677|581193969|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
160947326|NCT00898677|581193970|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
160947327|NCT00898677|581193971|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
160947328|NCT00898677|581193972|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
160947329|NCT00898677|581193969|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
160947330|NCT00898677|581193970|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
160947331|NCT00898677|581193971|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
160947332|NCT00898677|581193972|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
160947333|NCT00898677|581193969|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
160947334|NCT00898677|581193970|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
160947335|NCT00898677|581193971|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
160947336|NCT00898677|581193972|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
160947337|NCT00898677|581193969|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
160947338|NCT00898677|581193970|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
160947339|NCT00898677|581193971|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
160947340|NCT00898677|581193972|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
160947341|NCT00898677|581193969|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
160947342|NCT00898677|581193970|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
160947343|NCT00898677|581193971|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
160947344|NCT00898677|581193972|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
160947345|NCT00852397|581193973|FG000|Overall Study|Adverse Event|4|||
160947346|NCT00852397|581193974|FG001|Overall Study|Adverse Event|6|||
160947347|NCT00852397|581193975|FG002|Overall Study|Adverse Event|4|||
160947348|NCT00852397|581193973|FG000|Overall Study|Death|0|||
160947349|NCT00852397|581193974|FG001|Overall Study|Death|0|||
160947350|NCT00852397|581193975|FG002|Overall Study|Death|1|||
160947351|NCT00852397|581193973|FG000|Overall Study|Withdrawal by Subject|4|||
160947352|NCT00852397|581193974|FG001|Overall Study|Withdrawal by Subject|1|||
160947353|NCT00852397|581193975|FG002|Overall Study|Withdrawal by Subject|2|||
160947354|NCT00852397|581193973|FG000|Overall Study|Study terminated by sponsor|2|||
160947355|NCT00852397|581193974|FG001|Overall Study|Study terminated by sponsor|1|||
160947356|NCT00852397|581193975|FG002|Overall Study|Study terminated by sponsor|6|||
160947357|NCT00852397|581193973|FG000|Overall Study|Difficulty in study site visit|1|||
160947358|NCT00852397|581193974|FG001|Overall Study|Difficulty in study site visit|0|||
160947359|NCT00852397|581193975|FG002|Overall Study|Difficulty in study site visit|0|||
160456149|NCT04308681|579399848|FG007|OTE - 26 Weeks|Adverse Event|0|||
160456150|NCT04308681|579399841|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
160947360|NCT00852397|581193973|FG000|Overall Study|Protocol Violation|0|||
160947361|NCT00852397|581193974|FG001|Overall Study|Protocol Violation|0|||
160947362|NCT00852397|581193975|FG002|Overall Study|Protocol Violation|1|||
160947363|NCT00774995|581193979|FG000|Overall Study|Protocol Violation|0|||
160947364|NCT00774995|581193980|FG001|Overall Study|Protocol Violation|0|||
160947365|NCT00774995|581193981|FG002|Overall Study|Protocol Violation|1|||
160947366|NCT00774995|581193982|FG003|Overall Study|Protocol Violation|0|||
160947367|NCT00074282|581195898|FG000|Step 1|Adverse Event|32|||
160947368|NCT00074282|581195899|FG001|Step 1|Adverse Event|0|||
160947369|NCT00074282|581195900|FG002|Step 1|Adverse Event|0|||
160947370|NCT00074282|581195898|FG000|Step 1|Death|6|||
160947371|NCT00074282|581195899|FG001|Step 1|Death|0|||
160947372|NCT00074282|581195900|FG002|Step 1|Death|0|||
160947373|NCT00074282|581195898|FG000|Step 1|Withdrawal by Subject|7|||
160947374|NCT00074282|581195899|FG001|Step 1|Withdrawal by Subject|0|||
160947375|NCT00074282|581195900|FG002|Step 1|Withdrawal by Subject|0|||
160947376|NCT00074282|581195898|FG000|Step 1|Disease progression|2|||
160947377|NCT00074282|581195899|FG001|Step 1|Disease progression|0|||
160947378|NCT00074282|581195900|FG002|Step 1|Disease progression|0|||
160947379|NCT00074282|581195898|FG000|Step 1|Alternative therapy|2|||
160947380|NCT00074282|581195899|FG001|Step 1|Alternative therapy|0|||
160947381|NCT00074282|581195900|FG002|Step 1|Alternative therapy|0|||
160947382|NCT00074282|581195898|FG000|Step 1|Other complicating disease|2|||
160947383|NCT00074282|581195899|FG001|Step 1|Other complicating disease|0|||
160947384|NCT00074282|581195900|FG002|Step 1|Other complicating disease|0|||
160947385|NCT00074282|581195898|FG000|Step 1|Physician Decision|1|||
160947386|NCT00074282|581195899|FG001|Step 1|Physician Decision|0|||
160947387|NCT00074282|581195900|FG002|Step 1|Physician Decision|0|||
160947388|NCT00074282|581195898|FG000|Step 1|Ineligible|4|||
160580534|NCT01441440|579845497|FG001|Overall Study|Lost to Follow-up|2|||
160947389|NCT00074282|581195899|FG001|Step 1|Ineligible|0|||
160947390|NCT00074282|581195900|FG002|Step 1|Ineligible|0|||
160947391|NCT00074282|581195898|FG000|Step 1|Never started treatment|2|||
160947392|NCT00074282|581195899|FG001|Step 1|Never started treatment|0|||
160947393|NCT00074282|581195900|FG002|Step 1|Never started treatment|0|||
160947394|NCT00074282|581195898|FG000|Step 2|Adverse Event|0|||
160947395|NCT00074282|581195899|FG001|Step 2|Adverse Event|2|||
160947396|NCT00074282|581195900|FG002|Step 2|Adverse Event|12|||
160947397|NCT00074282|581195898|FG000|Step 2|Disease progression|0|||
160947398|NCT00074282|581195899|FG001|Step 2|Disease progression|0|||
160947399|NCT00074282|581195900|FG002|Step 2|Disease progression|5|||
160947400|NCT00074282|581195898|FG000|Step 2|Death|0|||
160947401|NCT00074282|581195899|FG001|Step 2|Death|0|||
160947402|NCT00074282|581195900|FG002|Step 2|Death|3|||
160947403|NCT00074282|581195898|FG000|Step 2|Withdrawal by Subject|0|||
160947404|NCT00074282|581195899|FG001|Step 2|Withdrawal by Subject|0|||
160580535|NCT01441440|579845498|FG002|Overall Study|Lost to Follow-up|1|||
160580536|NCT01441440|579845496|FG000|Overall Study|Withdrawal by Subject|11|||
160580537|NCT01441440|579845497|FG001|Overall Study|Withdrawal by Subject|9|||
160580538|NCT01441440|579845498|FG002|Overall Study|Withdrawal by Subject|9|||
160580539|NCT01441440|579845496|FG000|Overall Study|Pregnancy|1|||
160580540|NCT01441440|579845497|FG001|Overall Study|Pregnancy|0|||
160580541|NCT01441440|579845498|FG002|Overall Study|Pregnancy|0|||
160580542|NCT01441440|579845496|FG000|Overall Study|Lack of Efficacy|1|||
160580543|NCT01441440|579845497|FG001|Overall Study|Lack of Efficacy|0|||
160580544|NCT01441440|579845498|FG002|Overall Study|Lack of Efficacy|1|||
160580545|NCT01441440|579845496|FG000|Overall Study|Moving|0|||
160580546|NCT01441440|579845497|FG001|Overall Study|Moving|1|||
160580547|NCT01441440|579845498|FG002|Overall Study|Moving|1|||
160580548|NCT01441440|579845496|FG000|Overall Study|Work-related matter|0|||
160580549|NCT01441440|579845497|FG001|Overall Study|Work-related matter|1|||
160580550|NCT01441440|579845498|FG002|Overall Study|Work-related matter|0|||
160580551|NCT01441440|579845496|FG000|Overall Study|Difficllty in keeping the schedule|1|||
160580552|NCT01441440|579845497|FG001|Overall Study|Difficllty in keeping the schedule|1|||
160580553|NCT01441440|579845498|FG002|Overall Study|Difficllty in keeping the schedule|0|||
160580554|NCT01993329|579845499|FG000|Period 2|Adverse Event|0|||
160580555|NCT01993329|579845500|FG001|Period 2|Adverse Event|0|||
160580556|NCT01993329|579845501|FG002|Period 2|Adverse Event|0|||
160580557|NCT01993329|579845502|FG003|Period 2|Adverse Event|0|||
160580558|NCT01993329|579845503|FG004|Period 2|Adverse Event|0|||
160580559|NCT01993329|579845504|FG005|Period 2|Adverse Event|1|||
160580560|NCT01993329|579845499|FG000|Wash-out|Personal reasons|0|||
160580561|NCT01993329|579845500|FG001|Wash-out|Personal reasons|1|||
160580562|NCT01993329|579845501|FG002|Wash-out|Personal reasons|0|||
160580563|NCT01993329|579845502|FG003|Wash-out|Personal reasons|0|||
160580564|NCT01993329|579845503|FG004|Wash-out|Personal reasons|0|||
160580565|NCT01993329|579845504|FG005|Wash-out|Personal reasons|0|||
160580566|NCT00883558|579845505|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
160580567|NCT00883558|579845506|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
160580568|NCT00883558|579845507|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
160580569|NCT00883558|579845505|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
160580570|NCT00883558|579845506|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
160580571|NCT00883558|579845507|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
160580572|NCT00883558|579845505|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
160580573|NCT00883558|579845506|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
160580574|NCT00883558|579845507|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
160580575|NCT00883558|579845505|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
160580576|NCT00883558|579845506|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
160580577|NCT00883558|579845507|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
160580578|NCT00883558|579845505|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
160580579|NCT00883558|579845506|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
160580580|NCT00883558|579845507|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
160580581|NCT03539458|579845508|FG000|Overall Study|Death|1|||
160580582|NCT02985450|579845524|FG000|Overall Study|Lost to Follow-up|7|||
160580583|NCT00069576|579845525|FG000|Original Trial|Lost to Follow-up|25|||
160580584|NCT00069576|579845526|FG001|Original Trial|Lost to Follow-up|33|||
160580585|NCT00069576|579845525|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
160580586|NCT00069576|579845526|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
160580587|NCT00905307|579845527|FG000|Overall Study|Switched to Open Label Rescue|7|||
160580588|NCT00905307|579845528|FG001|Overall Study|Switched to Open Label Rescue|17|||
160580589|NCT00905307|579845529|FG002|Overall Study|Switched to Open Label Rescue|11|||
160580590|NCT00905307|579845530|FG003|Overall Study|Switched to Open Label Rescue|11|||
160947405|NCT00074282|581195900|FG002|Step 2|Withdrawal by Subject|2|||
160947406|NCT00074282|581195898|FG000|Step 2|Physician Decision|0|||
160947407|NCT00074282|581195899|FG001|Step 2|Physician Decision|0|||
160947408|NCT00074282|581195900|FG002|Step 2|Physician Decision|1|||
160947409|NCT00074282|581195898|FG000|Step 2|Ineligible|0|||
160947410|NCT00074282|581195899|FG001|Step 2|Ineligible|0|||
160580591|NCT00905307|579845531|FG004|Overall Study|Switched to Open Label Rescue|4|||
160580592|NCT00905307|579845532|FG005|Overall Study|Switched to Open Label Rescue|15|||
160580593|NCT00905307|579845527|FG000|Overall Study|Lost to Follow-up|0|||
160580594|NCT00905307|579845528|FG001|Overall Study|Lost to Follow-up|0|||
160580595|NCT00905307|579845529|FG002|Overall Study|Lost to Follow-up|0|||
160580596|NCT00905307|579845530|FG003|Overall Study|Lost to Follow-up|0|||
160580597|NCT00905307|579845531|FG004|Overall Study|Lost to Follow-up|1|||
160580598|NCT00905307|579845532|FG005|Overall Study|Lost to Follow-up|1|||
160580599|NCT00905307|579845527|FG000|Overall Study|Adverse Event|3|||
160580600|NCT00905307|579845528|FG001|Overall Study|Adverse Event|4|||
160580601|NCT00905307|579845529|FG002|Overall Study|Adverse Event|5|||
160580602|NCT00905307|579845530|FG003|Overall Study|Adverse Event|11|||
160580603|NCT00905307|579845531|FG004|Overall Study|Adverse Event|3|||
160580604|NCT00905307|579845532|FG005|Overall Study|Adverse Event|5|||
160580605|NCT00905307|579845527|FG000|Overall Study|Withdrawal by Subject|5|||
160580606|NCT00905307|579845528|FG001|Overall Study|Withdrawal by Subject|13|||
160580607|NCT00905307|579845529|FG002|Overall Study|Withdrawal by Subject|15|||
160580608|NCT00905307|579845530|FG003|Overall Study|Withdrawal by Subject|11|||
160580609|NCT00905307|579845531|FG004|Overall Study|Withdrawal by Subject|4|||
160580610|NCT00905307|579845532|FG005|Overall Study|Withdrawal by Subject|13|||
160580611|NCT00905307|579845527|FG000|Overall Study|Protocol Violation|1|||
160580612|NCT00905307|579845528|FG001|Overall Study|Protocol Violation|0|||
160580613|NCT00905307|579845529|FG002|Overall Study|Protocol Violation|1|||
160580614|NCT00905307|579845530|FG003|Overall Study|Protocol Violation|0|||
160580615|NCT00905307|579845531|FG004|Overall Study|Protocol Violation|0|||
160580616|NCT00905307|579845532|FG005|Overall Study|Protocol Violation|0|||
160580617|NCT00905307|579845527|FG000|Overall Study|Lack of Efficacy|6|||
160580618|NCT00905307|579845528|FG001|Overall Study|Lack of Efficacy|3|||
160580619|NCT00905307|579845529|FG002|Overall Study|Lack of Efficacy|5|||
160580620|NCT00905307|579845530|FG003|Overall Study|Lack of Efficacy|4|||
160580621|NCT00905307|579845531|FG004|Overall Study|Lack of Efficacy|4|||
160580622|NCT00905307|579845532|FG005|Overall Study|Lack of Efficacy|8|||
160580623|NCT05590793|579845533|FG000|Overall Study|Withdrawal by Subject|6|||
160580624|NCT05590793|579845533|FG000|Overall Study|Physician Decision|1|||
160580625|NCT04060667|579845534|FG000|Overall Study|Lost to Follow-up|75|||
160580626|NCT04060667|579845535|FG001|Overall Study|Lost to Follow-up|10|||
160580627|NCT04488822|579845536|FG000|Overall Study|Adverse Event|8|||
160580628|NCT04488822|579845536|FG000|Overall Study|Withdrawal by Subject|1|||
160580629|NCT03838367|579845537|FG000|Overall Study|Early termination of study|3|||
160580630|NCT03838367|579845538|FG001|Overall Study|Early termination of study|4|||
160580631|NCT03838367|579845539|FG002|Overall Study|Early termination of study|3|||
160580632|NCT03838367|579845540|FG003|Overall Study|Early termination of study|0|||
160580633|NCT03406104|579845541|FG000|Overall Study|Lost to Follow-up|2|||
160580634|NCT03406104|579845541|FG000|Overall Study|Withdrawal by Subject|2|||
160580635|NCT03406104|579845541|FG000|Overall Study|due to Covid patient did not want to travel|1|||
160580636|NCT03406104|579845541|FG000|Overall Study|Death|2|||
160580637|NCT00114972|579845544|FG000|Overall Study|Withdrawal by Subject|40|||
160580638|NCT00114972|579845545|FG001|Overall Study|Withdrawal by Subject|7|||
160580639|NCT00114972|579845544|FG000|Overall Study|Lost to Follow-up|8|||
160580640|NCT00114972|579845545|FG001|Overall Study|Lost to Follow-up|5|||
160580641|NCT01757704|579845552|FG000|Overall Study|Protocol Violation|1|||
160580642|NCT01757704|579845553|FG001|Overall Study|Protocol Violation|3|||
160580643|NCT02890329|579845554|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
160580644|NCT02890329|579845555|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
160947411|NCT00074282|581195900|FG002|Step 2|Ineligible|1|||
160947412|NCT00464542|581195901|FG000|Pre-treatment|Withdrawal by Subject|2|||
160947413|NCT02055352|581195903|FG000|Overall Study|Adverse Event|0|||
160947414|NCT02055352|581195904|FG001|Overall Study|Adverse Event|1|||
160947415|NCT02055352|581195903|FG000|Overall Study|Non-eligible|0|||
160947416|NCT02055352|581195904|FG001|Overall Study|Non-eligible|1|||
160947417|NCT02055352|581195903|FG000|Overall Study|Poor compliance|1|||
160947418|NCT02055352|581195904|FG001|Overall Study|Poor compliance|1|||
160947419|NCT02055352|581195903|FG000|Overall Study|Death|1|||
160947420|NCT02055352|581195904|FG001|Overall Study|Death|2|||
160947421|NCT02055352|581195903|FG000|Overall Study|Patient decision|1|||
160947422|NCT02055352|581195904|FG001|Overall Study|Patient decision|1|||
160580645|NCT02890329|579845556|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
160580646|NCT02890329|579845557|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
160580647|NCT02890329|579845558|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
160580648|NCT02890329|579845559|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
160580649|NCT02890329|579845554|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
160580650|NCT02890329|579845555|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
160580651|NCT02890329|579845556|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
160580652|NCT02890329|579845557|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
160947423|NCT02055352|581195903|FG000|Overall Study|Use of prohibited treatment|0|||
160947424|NCT02055352|581195904|FG001|Overall Study|Use of prohibited treatment|3|||
160947425|NCT02055352|581195903|FG000|Overall Study|AE, study drug would be detrimental|1|||
160947426|NCT02055352|581195904|FG001|Overall Study|AE, study drug would be detrimental|3|||
160947427|NCT02055352|581195903|FG000|Overall Study|Withdrawal of informed consent|1|||
160947428|NCT02055352|581195904|FG001|Overall Study|Withdrawal of informed consent|0|||
160947429|NCT02055352|581195903|FG000|Overall Study|Reason unknown|1|||
160947430|NCT02055352|581195904|FG001|Overall Study|Reason unknown|5|||
160947431|NCT02246998|581195905|FG000|Overall Study|Adverse Event|0|||
160947432|NCT02246998|581195906|FG001|Overall Study|Adverse Event|1|||
160947433|NCT02246998|581195907|FG002|Overall Study|Adverse Event|1|||
160947434|NCT02246998|581195908|FG003|Overall Study|Adverse Event|0|||
160947435|NCT02246998|581195905|FG000|Overall Study|Lost to Follow-up|1|||
160947436|NCT02246998|581195906|FG001|Overall Study|Lost to Follow-up|0|||
160947437|NCT02246998|581195907|FG002|Overall Study|Lost to Follow-up|0|||
160580653|NCT02890329|579845558|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
160580654|NCT02890329|579845559|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
160580655|NCT02890329|579845554|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
160580656|NCT02890329|579845555|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
160580657|NCT02890329|579845556|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
160947438|NCT02246998|581195908|FG003|Overall Study|Lost to Follow-up|1|||
160947439|NCT02246998|581195905|FG000|Overall Study|Randomized but Never Dosed|1|||
160947440|NCT02246998|581195906|FG001|Overall Study|Randomized but Never Dosed|2|||
160947441|NCT02246998|581195907|FG002|Overall Study|Randomized but Never Dosed|2|||
160947442|NCT02246998|581195908|FG003|Overall Study|Randomized but Never Dosed|1|||
160947443|NCT01303627|581195910|FG000|Overall Study|the failure while performing URS|0|||
160947444|NCT01303627|581195911|FG001|Overall Study|the failure while performing URS|1|||
160947445|NCT01709227|581195915|FG000|Overall Study|Physician Decision|1|||
160947446|NCT01709227|581195916|FG001|Overall Study|Physician Decision|0|||
160947447|NCT01709227|581195915|FG000|Overall Study|Pleural Peritoneal communication|0|||
160947448|NCT01709227|581195916|FG001|Overall Study|Pleural Peritoneal communication|9|||
160947449|NCT04831736|581195919|FG000|Overall Study|Withdrawal by Subject|0|||
160947450|NCT04831736|581195920|FG001|Overall Study|Withdrawal by Subject|1|||
160947451|NCT00795600|581195921|FG000|Overall Study|Adverse Event|1|||
160947452|NCT00795600|581195922|FG001|Overall Study|Adverse Event|1|||
160947453|NCT00795600|581195921|FG000|Overall Study|Protocol Violation|1|||
160947454|NCT00795600|581195922|FG001|Overall Study|Protocol Violation|2|||
160947455|NCT00795600|581195921|FG000|Overall Study|Withdrawal by Subject|1|||
160947456|NCT00795600|581195922|FG001|Overall Study|Withdrawal by Subject|0|||
160947457|NCT00795600|581195921|FG000|Overall Study|Unclassified|1|||
160947458|NCT00795600|581195922|FG001|Overall Study|Unclassified|1|||
160947459|NCT01659021|581195923|FG000|Main Study|Adverse Event|2|||
160947460|NCT01659021|581195924|FG001|Main Study|Adverse Event|3|||
160947461|NCT01659021|581195923|FG000|Main Study|Lost to Follow-up|1|||
160947462|NCT01659021|581195924|FG001|Main Study|Lost to Follow-up|0|||
160947463|NCT01659021|581195923|FG000|Main Study|Unknown Reasons|2|||
160947464|NCT01659021|581195924|FG001|Main Study|Unknown Reasons|1|||
160947465|NCT01659021|581195923|FG000|Main Study|Physician Decision|34|||
160947466|NCT01659021|581195924|FG001|Main Study|Physician Decision|16|||
160947467|NCT01659021|581195923|FG000|Main Study|Withdrawal by Subject|19|||
160947468|NCT01659021|581195924|FG001|Main Study|Withdrawal by Subject|16|||
160947469|NCT01659021|581195923|FG000|Main Study|Study Terminated by Sponsor|16|||
160947470|NCT01659021|581195924|FG001|Main Study|Study Terminated by Sponsor|1|||
160947471|NCT01659021|581195923|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
160947472|NCT01659021|581195924|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
160947473|NCT01659021|581195923|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
160947474|NCT01659021|581195924|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
160947475|NCT01202773|581195925|FG000|Overall Study|Adverse Event|4|||
160947476|NCT01202773|581195926|FG001|Overall Study|Adverse Event|5|||
160947477|NCT01202773|581195927|FG002|Overall Study|Adverse Event|5|||
160947478|NCT01202773|581195925|FG000|Overall Study|Lack of Efficacy|5|||
160947479|NCT01202773|581195926|FG001|Overall Study|Lack of Efficacy|4|||
160580658|NCT02890329|579845557|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
160580659|NCT02890329|579845558|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
160580660|NCT02890329|579845559|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
160580661|NCT02890329|579845554|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
160947480|NCT01202773|581195927|FG002|Overall Study|Lack of Efficacy|9|||
160947481|NCT01202773|581195925|FG000|Overall Study|Entry Criteria Not Met|2|||
160947482|NCT01202773|581195926|FG001|Overall Study|Entry Criteria Not Met|0|||
160947483|NCT01202773|581195927|FG002|Overall Study|Entry Criteria Not Met|1|||
160947484|NCT01202773|581195925|FG000|Overall Study|Lost to Follow-up|1|||
160947485|NCT01202773|581195926|FG001|Overall Study|Lost to Follow-up|2|||
160947486|NCT01202773|581195927|FG002|Overall Study|Lost to Follow-up|2|||
160947487|NCT01202773|581195925|FG000|Overall Study|Withdrawal by Subject|13|||
160947488|NCT01202773|581195926|FG001|Overall Study|Withdrawal by Subject|6|||
160947489|NCT01202773|581195927|FG002|Overall Study|Withdrawal by Subject|5|||
160947490|NCT01202773|581195925|FG000|Overall Study|Physician Decision|2|||
160580662|NCT02890329|579845555|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
160580663|NCT02890329|579845556|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
160580664|NCT02890329|579845557|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
160580665|NCT02890329|579845558|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
160580666|NCT02890329|579845559|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
160580667|NCT00616239|579845560|FG000|Overall Study|Withdrawal by Subject|2|||
160580668|NCT00085540|579845565|FG000|Overall Study|Withdrawal by Subject|0|||
160580669|NCT00085540|579845566|FG001|Overall Study|Withdrawal by Subject|1|||
160580670|NCT00085540|579845565|FG000|Overall Study|Protocol Violation|0|||
160580671|NCT00085540|579845566|FG001|Overall Study|Protocol Violation|1|||
160580672|NCT01605396|579845567|FG000|Overall Study|Adverse Event|5|||
160580673|NCT01605396|579845568|FG001|Overall Study|Adverse Event|3|||
160580674|NCT01605396|579845567|FG000|Overall Study|Lost to Follow-up|1|||
160580675|NCT01605396|579845568|FG001|Overall Study|Lost to Follow-up|0|||
160580676|NCT01605396|579845567|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160580677|NCT01605396|579845568|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160580678|NCT01605396|579845567|FG000|Overall Study|Physician Decision|2|||
160580679|NCT01605396|579845568|FG001|Overall Study|Physician Decision|2|||
160580680|NCT01605396|579845567|FG000|Overall Study|Progressive Disease|23|||
160580681|NCT01605396|579845568|FG001|Overall Study|Progressive Disease|27|||
160580682|NCT01605396|579845567|FG000|Overall Study|Withdrawal by Subject|4|||
160580683|NCT01605396|579845568|FG001|Overall Study|Withdrawal by Subject|2|||
160580684|NCT01605396|579845567|FG000|Overall Study|Transfer Off Study|4|||
160580685|NCT01605396|579845568|FG001|Overall Study|Transfer Off Study|5|||
160580686|NCT00426751|579845571|FG000|Overall Study|Adverse Event|8|||
160580687|NCT00426751|579845572|FG001|Overall Study|Adverse Event|1|||
160947491|NCT01202773|581195926|FG001|Overall Study|Physician Decision|0|||
160947492|NCT01202773|581195927|FG002|Overall Study|Physician Decision|0|||
160947493|NCT01202773|581195925|FG000|Overall Study|Protocol Violation|11|||
160947494|NCT01202773|581195926|FG001|Overall Study|Protocol Violation|6|||
160456151|NCT04308681|579399842|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
160456152|NCT04308681|579399843|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
160456153|NCT04308681|579399844|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
160456154|NCT04308681|579399845|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
160456155|NCT04308681|579399846|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
160456156|NCT04308681|579399847|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
160456157|NCT04308681|579399848|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
160456158|NCT02631746|579399854|FG000|Overall Study|Lack of Efficacy|3|||
160456159|NCT02361216|579399855|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
160947495|NCT01202773|581195927|FG002|Overall Study|Protocol Violation|10|||
160947496|NCT01202773|581195925|FG000|Overall Study|Sponsor Decision|19|||
160947497|NCT01202773|581195926|FG001|Overall Study|Sponsor Decision|20|||
160947498|NCT01202773|581195927|FG002|Overall Study|Sponsor Decision|23|||
160947499|NCT00575588|581195930|FG000|Overall Study|Adverse Event|11|||
160947500|NCT00575588|581195931|FG001|Overall Study|Adverse Event|13|||
160947501|NCT00575588|581195930|FG000|Overall Study|Withdrawal by Subject|27|||
160947502|NCT00575588|581195931|FG001|Overall Study|Withdrawal by Subject|31|||
160947503|NCT00575588|581195930|FG000|Overall Study|Lost to Follow-up|1|||
160456160|NCT02361216|579399856|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
160456161|NCT02361216|579399855|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
160456162|NCT02361216|579399856|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
160580688|NCT00426751|579845571|FG000|Overall Study|Lost to Follow-up|7|||
160580689|NCT00426751|579845572|FG001|Overall Study|Lost to Follow-up|6|||
160580690|NCT00426751|579845571|FG000|Overall Study|Consent Withdrawn|0|||
160580691|NCT00426751|579845572|FG001|Overall Study|Consent Withdrawn|1|||
160580692|NCT00426751|579845571|FG000|Overall Study|Other Reasons|7|||
160580693|NCT00426751|579845572|FG001|Overall Study|Other Reasons|12|||
160580694|NCT02504892|579845573|FG000|Overall Study|Adverse event-pneumonitis|2|||
160580695|NCT01413178|579845574|FG000|Overall Study|Toxicity|1|||
160947504|NCT00575588|581195931|FG001|Overall Study|Lost to Follow-up|3|||
160947505|NCT00575588|581195930|FG000|Overall Study|Death|4|||
160947506|NCT00575588|581195931|FG001|Overall Study|Death|2|||
160947507|NCT00575588|581195930|FG000|Overall Study|Incorrect enrollment|8|||
160947508|NCT00575588|581195931|FG001|Overall Study|Incorrect enrollment|4|||
160947509|NCT00575588|581195930|FG000|Overall Study|Study specific discontinuation criteria|203|||
160580696|NCT01413178|579845575|FG001|Overall Study|Toxicity|0|||
160580697|NCT01413178|579845574|FG000|Overall Study|Ineligible|0|||
160580698|NCT01413178|579845575|FG001|Overall Study|Ineligible|2|||
160580699|NCT00576693|579845576|FG000|Overall Study|Lost to Follow-up|7|||
160580700|NCT00576693|579845577|FG001|Overall Study|Lost to Follow-up|11|||
160580701|NCT00576693|579845576|FG000|Overall Study|Withdrawal by Subject|3|||
160947510|NCT00575588|581195931|FG001|Overall Study|Study specific discontinuation criteria|218|||
160947511|NCT00575588|581195930|FG000|Overall Study|Severe non-compliance to protocol|5|||
160947512|NCT00575588|581195931|FG001|Overall Study|Severe non-compliance to protocol|7|||
160947513|NCT00575588|581195930|FG000|Overall Study|Safety reasons|2|||
160580702|NCT00576693|579845577|FG001|Overall Study|Withdrawal by Subject|13|||
160580703|NCT03283163|579845578|FG000|Overall Study|Lost to Follow-up|1|||
160947514|NCT00575588|581195931|FG001|Overall Study|Safety reasons|1|||
160947515|NCT00575588|581195930|FG000|Overall Study|Elevated triglyceride|1|||
160947516|NCT00575588|581195931|FG001|Overall Study|Elevated triglyceride|0|||
160947517|NCT00575588|581195930|FG000|Overall Study|Patient moved|1|||
160947518|NCT00575588|581195931|FG001|Overall Study|Patient moved|3|||
160947519|NCT00575588|581195930|FG000|Overall Study|Impossible to determine HbA1c|0|||
160947520|NCT00575588|581195931|FG001|Overall Study|Impossible to determine HbA1c|1|||
160947521|NCT00614939|581195933|FG000|Overall Study|Withdrawal by Subject|10|||
160947522|NCT00614939|581195934|FG001|Overall Study|Withdrawal by Subject|17|||
160947523|NCT00614939|581195933|FG000|Overall Study|Study specific discontinuation criteris|13|||
160947524|NCT00614939|581195934|FG001|Overall Study|Study specific discontinuation criteris|16|||
160947525|NCT00614939|581195933|FG000|Overall Study|Adverse Event|2|||
160947526|NCT00614939|581195934|FG001|Overall Study|Adverse Event|5|||
160947527|NCT00614939|581195933|FG000|Overall Study|Incorrect enrollment|1|||
160947528|NCT00614939|581195934|FG001|Overall Study|Incorrect enrollment|2|||
160947529|NCT00614939|581195933|FG000|Overall Study|Death|4|||
160947530|NCT00614939|581195934|FG001|Overall Study|Death|3|||
160947531|NCT00614939|581195933|FG000|Overall Study|Poor/non-compliance|4|||
160947532|NCT00614939|581195934|FG001|Overall Study|Poor/non-compliance|0|||
160947533|NCT00614939|581195933|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
160947534|NCT00614939|581195934|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
160947535|NCT00840970|581195935|FG000|Overall Study|Adverse Event|0|||
160947536|NCT00840970|581195936|FG001|Overall Study|Adverse Event|0|||
160947537|NCT00840970|581195937|FG002|Overall Study|Adverse Event|1|||
160947538|NCT03465540|581195938|FG000|Overall Study|Withdrawal by Subject|0|||
160947539|NCT03465540|581195939|FG001|Overall Study|Withdrawal by Subject|0|||
160947540|NCT03465540|581195940|FG002|Overall Study|Withdrawal by Subject|1|||
160947541|NCT03465540|581195941|FG003|Overall Study|Withdrawal by Subject|1|||
160947542|NCT03465540|581195942|FG004|Overall Study|Withdrawal by Subject|1|||
160947543|NCT03465540|581195943|FG005|Overall Study|Withdrawal by Subject|0|||
160947544|NCT03465540|581195938|FG000|Overall Study|Lost to Follow-up|0|||
160947545|NCT03465540|581195939|FG001|Overall Study|Lost to Follow-up|1|||
160947546|NCT03465540|581195940|FG002|Overall Study|Lost to Follow-up|0|||
160947547|NCT03465540|581195941|FG003|Overall Study|Lost to Follow-up|0|||
160947548|NCT03465540|581195942|FG004|Overall Study|Lost to Follow-up|1|||
160947549|NCT03465540|581195943|FG005|Overall Study|Lost to Follow-up|0|||
160947550|NCT03465540|581195938|FG000|Overall Study|Death|1|||
160947551|NCT03465540|581195939|FG001|Overall Study|Death|1|||
160947552|NCT03465540|581195940|FG002|Overall Study|Death|0|||
160947553|NCT03465540|581195941|FG003|Overall Study|Death|2|||
160947554|NCT03465540|581195942|FG004|Overall Study|Death|0|||
160947555|NCT03465540|581195943|FG005|Overall Study|Death|2|||
160947556|NCT03465540|581195938|FG000|Overall Study|Protocol specified criteria|0|||
160580704|NCT03283163|579845578|FG000|Overall Study|other life commitments|6|||
160580705|NCT03283163|579845578|FG000|Overall Study|COVID-19 institution wide halting|1|||
160947557|NCT03465540|581195939|FG001|Overall Study|Protocol specified criteria|2|||
160947558|NCT03465540|581195940|FG002|Overall Study|Protocol specified criteria|2|||
160947559|NCT03465540|581195941|FG003|Overall Study|Protocol specified criteria|0|||
160947560|NCT03465540|581195942|FG004|Overall Study|Protocol specified criteria|2|||
160947561|NCT03465540|581195943|FG005|Overall Study|Protocol specified criteria|0|||
160947562|NCT00504829|581195944|FG000|Overall Study|Protocol Violation|6|||
160947563|NCT00504829|581195945|FG001|Overall Study|Protocol Violation|4|||
160947564|NCT00504829|581195946|FG002|Overall Study|Protocol Violation|10|||
160947565|NCT01854827|581195947|FG000|Overall Study|Death|1|||
160947566|NCT00736996|581195948|FG000|Overall Study|Lost to Follow-up|1|||
160947567|NCT00736996|581195949|FG001|Overall Study|Lost to Follow-up|9|||
160947568|NCT00736996|581195950|FG002|Overall Study|Lost to Follow-up|2|||
160947569|NCT00462384|581195951|FG000|Overall Study|Adverse Event|2|||
160947570|NCT00462384|581195951|FG000|Overall Study|Death|2|||
160947571|NCT00462384|581195951|FG000|Overall Study|Withdrawal by Subject|1|||
160580706|NCT03283163|579845578|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
160632828|NCT01215955|580036086|FG001|Overall Study|Entry Criteria Not Met|3|||
160947572|NCT00462384|581195951|FG000|Overall Study|Other|4|||
160947573|NCT04000165|581195952|FG000|Overall Study|Physician Decision|1|||
160947574|NCT04000165|581195952|FG000|Overall Study|Withdrawal by Subject|1|||
160947575|NCT01751568|581195957|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
160947576|NCT01751568|581195958|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
160947577|NCT01751568|581195959|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
160947578|NCT02660944|581195968|FG000|Overall Study|Adverse Event|3|||
160947579|NCT02660944|581195969|FG001|Overall Study|Adverse Event|4|||
160947580|NCT02660944|581195968|FG000|Overall Study|Physician Decision|3|||
160947581|NCT02660944|581195969|FG001|Overall Study|Physician Decision|1|||
160947582|NCT02660944|581195968|FG000|Overall Study|Withdrawal by Subject|5|||
160947583|NCT02660944|581195969|FG001|Overall Study|Withdrawal by Subject|3|||
160947584|NCT02660944|581195968|FG000|Overall Study|Lost to Follow-up|4|||
160947585|NCT02660944|581195969|FG001|Overall Study|Lost to Follow-up|1|||
160947586|NCT02660944|581195968|FG000|Overall Study|Subject schedule|0|||
160947587|NCT02660944|581195969|FG001|Overall Study|Subject schedule|1|||
160947588|NCT02660944|581195968|FG000|Overall Study|Exclusion criteria met|2|||
160947589|NCT02660944|581195969|FG001|Overall Study|Exclusion criteria met|0|||
160947590|NCT02843568|581195970|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
160947591|NCT02843568|581195971|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
160947592|NCT02843568|581195970|FG000|Overall Study|Death|3|||
160947593|NCT02843568|581195971|FG001|Overall Study|Death|3|||
160947594|NCT02843568|581195970|FG000|Overall Study|Withdrawal by Subject|1|||
160947595|NCT02843568|581195971|FG001|Overall Study|Withdrawal by Subject|1|||
160947596|NCT02843568|581195970|FG000|Overall Study|Lost to Follow-up|2|||
160947597|NCT02843568|581195971|FG001|Overall Study|Lost to Follow-up|0|||
160947598|NCT03586999|581195972|FG000|Overall Study|Lack of Efficacy|2|||
160947599|NCT04096560|581195973|FG000|Overall Study|Reason not Specified|1|||
160947600|NCT04096560|581195974|FG001|Overall Study|Reason not Specified|0|||
160947601|NCT04096560|581195975|FG002|Overall Study|Reason not Specified|0|||
160947602|NCT04096560|581195976|FG003|Overall Study|Reason not Specified|0|||
160947603|NCT04096560|581195977|FG004|Overall Study|Reason not Specified|1|||
160947604|NCT04096560|581195978|FG005|Overall Study|Reason not Specified|1|||
160947605|NCT04096560|581195979|FG006|Overall Study|Reason not Specified|1|||
160947606|NCT04096560|581195980|FG007|Overall Study|Reason not Specified|0|||
160947607|NCT04096560|581195973|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947608|NCT04096560|581195974|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947609|NCT04096560|581195975|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947610|NCT04096560|581195976|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947611|NCT04096560|581195977|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947612|NCT04096560|581195978|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
160947613|NCT04096560|581195979|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
160947614|NCT04096560|581195980|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947615|NCT04096560|581195973|FG000|Overall Study|Study Terminated by Sponsor|0|||
160947616|NCT04096560|581195974|FG001|Overall Study|Study Terminated by Sponsor|0|||
160947617|NCT04096560|581195975|FG002|Overall Study|Study Terminated by Sponsor|0|||
160947618|NCT04096560|581195976|FG003|Overall Study|Study Terminated by Sponsor|5|||
160947619|NCT04096560|581195977|FG004|Overall Study|Study Terminated by Sponsor|6|||
160947620|NCT04096560|581195978|FG005|Overall Study|Study Terminated by Sponsor|4|||
160947621|NCT04096560|581195979|FG006|Overall Study|Study Terminated by Sponsor|6|||
160947622|NCT04096560|581195980|FG007|Overall Study|Study Terminated by Sponsor|1|||
160947623|NCT04096560|581195973|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947624|NCT04096560|581195974|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947625|NCT04096560|581195975|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947626|NCT04096560|581195976|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947627|NCT04096560|581195977|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947628|NCT04096560|581195978|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947629|NCT04096560|581195979|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947630|NCT04096560|581195980|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
160947631|NCT00534352|581195983|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
160947632|NCT00534352|581195983|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
160947633|NCT00534352|581195983|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
160947634|NCT00534352|581195983|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
160947635|NCT00534352|581195983|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
160947636|NCT00534352|581195983|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
160947637|NCT03264989|581195986|FG000|Overall Study|Lost to Follow-up|1|||
160947638|NCT03264989|581195987|FG001|Overall Study|Lost to Follow-up|0|||
160947639|NCT03264989|581195986|FG000|Overall Study|New Therapy for study Indication|1|||
160947640|NCT03264989|581195987|FG001|Overall Study|New Therapy for study Indication|0|||
160947641|NCT03264989|581195986|FG000|Overall Study|Protocol Violation|0|||
160947642|NCT03264989|581195987|FG001|Overall Study|Protocol Violation|1|||
160947643|NCT03264989|581195986|FG000|Overall Study|Patient decision|13|||
160947644|NCT03264989|581195987|FG001|Overall Study|Patient decision|0|||
160947645|NCT03264989|581195986|FG000|Overall Study|Physician Decision|6|||
160580707|NCT03283163|579845578|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
160580708|NCT04238663|579845579|FG000|Overall Study|Lost to Follow-up|0|||
160580709|NCT04238663|579845580|FG001|Overall Study|Lost to Follow-up|1|||
160947646|NCT03264989|581195987|FG001|Overall Study|Physician Decision|4|||
160947647|NCT03264989|581195986|FG000|Overall Study|Adverse Event|2|||
160947648|NCT03264989|581195987|FG001|Overall Study|Adverse Event|1|||
160947649|NCT03264989|581195986|FG000|Overall Study|Death|1|||
160947650|NCT03264989|581195987|FG001|Overall Study|Death|1|||
160947651|NCT03264989|581195986|FG000|Overall Study|Pregnancy|2|||
160947652|NCT03264989|581195987|FG001|Overall Study|Pregnancy|0|||
160947653|NCT03264989|581195986|FG000|Overall Study|End of Study|19|||
160947654|NCT03264989|581195987|FG001|Overall Study|End of Study|5|||
160947655|NCT00833924|581195993|FG000|Overall Study|Death|21|||
160947656|NCT00833924|581195993|FG000|Overall Study|Conversion|2|||
160947657|NCT00833924|581195993|FG000|Overall Study|Lost to Follow-up|2|||
160947658|NCT00833924|581195993|FG000|Overall Study|Withdrawal by Subject|13|||
160947659|NCT00833924|581195993|FG000|Overall Study|In study follow-up|71|||
160947660|NCT00797667|581195994|FG000|Overall Study|Lack of Efficacy|0|||
160947661|NCT00797667|581195995|FG001|Overall Study|Lack of Efficacy|1|||
160947662|NCT00797667|581195996|FG002|Overall Study|Lack of Efficacy|0|||
160947663|NCT00797667|581195994|FG000|Overall Study|Lost to Follow-up|8|||
160947664|NCT00797667|581195995|FG001|Overall Study|Lost to Follow-up|12|||
160947665|NCT00797667|581195996|FG002|Overall Study|Lost to Follow-up|2|||
160947666|NCT00797667|581195994|FG000|Overall Study|Physician Decision|3|||
160947667|NCT00797667|581195995|FG001|Overall Study|Physician Decision|1|||
160947668|NCT00797667|581195996|FG002|Overall Study|Physician Decision|0|||
160947669|NCT00797667|581195994|FG000|Overall Study|Pregnancy|2|||
160947670|NCT00797667|581195995|FG001|Overall Study|Pregnancy|0|||
160947671|NCT00797667|581195996|FG002|Overall Study|Pregnancy|0|||
160947672|NCT00797667|581195994|FG000|Overall Study|Protocol Violation|2|||
160947673|NCT00797667|581195995|FG001|Overall Study|Protocol Violation|7|||
160947674|NCT00797667|581195996|FG002|Overall Study|Protocol Violation|0|||
160947675|NCT00797667|581195994|FG000|Overall Study|Study Terminated by Sponsor|217|||
160947676|NCT00797667|581195995|FG001|Overall Study|Study Terminated by Sponsor|216|||
160947677|NCT00797667|581195996|FG002|Overall Study|Study Terminated by Sponsor|115|||
160947678|NCT00797667|581195994|FG000|Overall Study|Withdrawal by Subject|9|||
160947679|NCT00797667|581195995|FG001|Overall Study|Withdrawal by Subject|14|||
160947680|NCT00797667|581195996|FG002|Overall Study|Withdrawal by Subject|2|||
160947681|NCT00797667|581195994|FG000|Overall Study|Adverse Event|19|||
160947682|NCT00797667|581195995|FG001|Overall Study|Adverse Event|8|||
160947683|NCT00797667|581195996|FG002|Overall Study|Adverse Event|8|||
160947684|NCT01986829|581196001|FG000|Overall Study|Death|1|||
160947685|NCT02504866|581196002|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
160947686|NCT02504866|581196003|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
160947687|NCT02504866|581196004|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
160947688|NCT01229436|581196005|FG000|Overall Study|Withdrawal by Subject|2|||
160580710|NCT04238663|579845581|FG002|Overall Study|Lost to Follow-up|0|||
160580711|NCT02566525|579845582|FG000|Overall Study|Protocol Violation|3|||
160580712|NCT02566525|579845583|FG001|Overall Study|Protocol Violation|5|||
160580713|NCT01721408|579845584|FG000|Overall Study|Adverse Event|6|||
160580714|NCT01721408|579845585|FG001|Overall Study|Adverse Event|1|||
160580715|NCT01721408|579845584|FG000|Overall Study|Death|1|||
160580716|NCT01721408|579845585|FG001|Overall Study|Death|0|||
160580717|NCT01721408|579845584|FG000|Overall Study|Insufficient clinical response|15|||
160580718|NCT01721408|579845585|FG001|Overall Study|Insufficient clinical response|6|||
160580719|NCT01721408|579845584|FG000|Overall Study|No longer willing to participate study|9|||
160456163|NCT02361216|579399855|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
160456164|NCT02361216|579399856|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
160580720|NCT01721408|579845585|FG001|Overall Study|No longer willing to participate study|10|||
160580721|NCT01721408|579845584|FG000|Overall Study|Protocol Violation|0|||
160947689|NCT01229436|581196005|FG000|Overall Study|Lost to Follow-up|3|||
160947690|NCT01775137|581196010|FG000|Overall Study|Death|1|||
160580722|NCT01721408|579845585|FG001|Overall Study|Protocol Violation|2|||
160456165|NCT02361216|579399855|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
160456166|NCT02361216|579399856|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
160456167|NCT02361216|579399855|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
160456168|NCT02361216|579399856|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
160456169|NCT02361216|579399855|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
160456170|NCT02361216|579399856|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
160456171|NCT00323856|579399857|FG000|Overall Study|Withdrawal by Subject|1|||
160456172|NCT00323856|579399857|FG000|Overall Study|Was uncooperative and noncompliant|1|||
160456173|NCT00323856|579399857|FG000|Overall Study|Reason not specified|1|||
160456174|NCT00323856|579399857|FG000|Overall Study|Missing|2|||
160456175|NCT04086121|579399858|FG000|Overall Study|Other than listed|8|||
160947691|NCT01775137|581196010|FG000|Overall Study|Protocol deviation|2|||
160947692|NCT01775137|581196010|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160947693|NCT01775137|581196010|FG000|Overall Study|Adverse Event|1|||
160999654|NCT02503202|581382775|FG000|Base Study: Up to Month 6|Physician Decision|0|||
160456176|NCT04086121|579399858|FG000|Overall Study|Withdrawal by Subject|3|||
160456177|NCT04086121|579399858|FG000|Overall Study|Lost to Follow-up|2|||
160456178|NCT04086121|579399858|FG000|Overall Study|Adverse Event|1|||
160580723|NCT01721408|579845584|FG000|Overall Study|Other|3|||
160580724|NCT01721408|579845585|FG001|Overall Study|Other|3|||
160580725|NCT01721408|579845584|FG000|Overall Study|Lost to Follow-up|1|||
160580726|NCT01721408|579845585|FG001|Overall Study|Lost to Follow-up|2|||
160947694|NCT01775137|581196010|FG000|Overall Study|Withdrawal by participants|5|||
160947695|NCT04796610|581196011|FG000|Overall Study|Withdrawal by Subject|1|||
160947696|NCT04796610|581196012|FG001|Overall Study|Withdrawal by Subject|0|||
160947697|NCT04796610|581196013|FG002|Overall Study|Withdrawal by Subject|0|||
160947698|NCT04796610|581196014|FG003|Overall Study|Withdrawal by Subject|0|||
160947699|NCT04796610|581196011|FG000|Overall Study|Lost to Follow-up|2|||
160947700|NCT04796610|581196012|FG001|Overall Study|Lost to Follow-up|0|||
160456179|NCT04167553|579399863|FG000|Overall Study|Withdrawal by Subject|1|||
160456180|NCT04167553|579399864|FG001|Overall Study|Withdrawal by Subject|0|||
160456181|NCT04167553|579399865|FG002|Overall Study|Withdrawal by Subject|1|||
160456182|NCT04167553|579399866|FG003|Overall Study|Withdrawal by Subject|2|||
160456183|NCT04167553|579399867|FG004|Overall Study|Withdrawal by Subject|1|||
160456184|NCT04167553|579399868|FG005|Overall Study|Withdrawal by Subject|0|||
160456185|NCT04167553|579399869|FG006|Overall Study|Withdrawal by Subject|0|||
160456186|NCT04167553|579399863|FG000|Overall Study|Physician Decision|0|||
160456187|NCT04167553|579399864|FG001|Overall Study|Physician Decision|0|||
160456188|NCT04167553|579399865|FG002|Overall Study|Physician Decision|0|||
160456189|NCT04167553|579399866|FG003|Overall Study|Physician Decision|0|||
160456190|NCT04167553|579399867|FG004|Overall Study|Physician Decision|2|||
160456191|NCT04167553|579399868|FG005|Overall Study|Physician Decision|2|||
160456192|NCT04167553|579399869|FG006|Overall Study|Physician Decision|0|||
160456193|NCT04167553|579399863|FG000|Overall Study|Lost to Follow-up|0|||
160456194|NCT04167553|579399864|FG001|Overall Study|Lost to Follow-up|0|||
160456195|NCT04167553|579399865|FG002|Overall Study|Lost to Follow-up|2|||
160456196|NCT04167553|579399866|FG003|Overall Study|Lost to Follow-up|0|||
160456197|NCT04167553|579399867|FG004|Overall Study|Lost to Follow-up|0|||
160456198|NCT04167553|579399868|FG005|Overall Study|Lost to Follow-up|0|||
160456199|NCT04167553|579399869|FG006|Overall Study|Lost to Follow-up|0|||
160456200|NCT05285137|579399872|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
160456201|NCT05285137|579399873|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
160456202|NCT05285137|579399874|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
160456203|NCT05285137|579399875|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
160456204|NCT05285137|579399876|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
160456205|NCT05285137|579399877|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
160456206|NCT05285137|579399878|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
160456207|NCT05285137|579399879|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
160456208|NCT05285137|579399880|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
160456209|NCT05285137|579399872|FG000|Overall Study|Lost to Follow-up|0|||
160456210|NCT05285137|579399873|FG001|Overall Study|Lost to Follow-up|0|||
160456211|NCT05285137|579399874|FG002|Overall Study|Lost to Follow-up|1|||
160456212|NCT05285137|579399875|FG003|Overall Study|Lost to Follow-up|3|||
160456213|NCT05285137|579399876|FG004|Overall Study|Lost to Follow-up|0|||
160456214|NCT05285137|579399877|FG005|Overall Study|Lost to Follow-up|0|||
160456215|NCT05285137|579399878|FG006|Overall Study|Lost to Follow-up|1|||
160580727|NCT01721408|579845584|FG000|Overall Study|Does not meet entrance criteria|1|||
160580728|NCT01721408|579845585|FG001|Overall Study|Does not meet entrance criteria|0|||
160580729|NCT01187901|579845588|FG000|Overall Study|Protocol Violation|1|||
160580730|NCT01187901|579845589|FG001|Overall Study|Protocol Violation|0|||
160580731|NCT01187901|579845588|FG000|Overall Study|Lost to Follow-up|1|||
160580732|NCT01187901|579845589|FG001|Overall Study|Lost to Follow-up|2|||
160580733|NCT01187901|579845588|FG000|Overall Study|Unrelated Health Reasons|1|||
160580734|NCT01187901|579845589|FG001|Overall Study|Unrelated Health Reasons|2|||
160580735|NCT01187901|579845588|FG000|Overall Study|Suspected Allergic Reaction|1|||
160580736|NCT01187901|579845589|FG001|Overall Study|Suspected Allergic Reaction|1|||
160580737|NCT01187901|579845588|FG000|Overall Study|Adverse Event|3|||
160580738|NCT01187901|579845589|FG001|Overall Study|Adverse Event|0|||
160580739|NCT01187901|579845588|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
160580740|NCT01187901|579845589|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
160580741|NCT01187901|579845588|FG000|Overall Study|Pregnancy|0|||
160580742|NCT01187901|579845589|FG001|Overall Study|Pregnancy|2|||
160580743|NCT04160468|579845590|FG000|Overall Study|Lost to Follow-up|19|||
160580744|NCT04160468|579845591|FG001|Overall Study|Lost to Follow-up|4|||
160580745|NCT04160468|579845590|FG000|Overall Study|Randomized but not dosed|6|||
160947701|NCT04796610|581196013|FG002|Overall Study|Lost to Follow-up|1|||
160947702|NCT04796610|581196014|FG003|Overall Study|Lost to Follow-up|1|||
160456216|NCT05285137|579399879|FG007|Overall Study|Lost to Follow-up|0|||
160456217|NCT05285137|579399880|FG008|Overall Study|Lost to Follow-up|0|||
160456218|NCT05285137|579399872|FG000|Overall Study|Physician Decision|0|||
160580746|NCT04160468|579845591|FG001|Overall Study|Randomized but not dosed|0|||
160580747|NCT04160468|579845590|FG000|Overall Study|Withdrawal by Subject|4|||
160456219|NCT05285137|579399873|FG001|Overall Study|Physician Decision|1|||
160456220|NCT05285137|579399874|FG002|Overall Study|Physician Decision|0|||
160456221|NCT05285137|579399875|FG003|Overall Study|Physician Decision|0|||
160456222|NCT05285137|579399876|FG004|Overall Study|Physician Decision|0|||
160456223|NCT05285137|579399877|FG005|Overall Study|Physician Decision|0|||
160456224|NCT05285137|579399878|FG006|Overall Study|Physician Decision|0|||
160456225|NCT05285137|579399879|FG007|Overall Study|Physician Decision|0|||
160456226|NCT05285137|579399880|FG008|Overall Study|Physician Decision|0|||
160580748|NCT04160468|579845591|FG001|Overall Study|Withdrawal by Subject|1|||
160947703|NCT01459796|581196015|FG000|Overall Study|Non compliance with protocol|2|||
160580749|NCT04160468|579845590|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
160580750|NCT04160468|579845591|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
160580751|NCT04160468|579845590|FG000|Overall Study|Participant incarcerated|1|||
160580752|NCT04160468|579845591|FG001|Overall Study|Participant incarcerated|0|||
160580753|NCT03987620|579845594|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
160580754|NCT03987620|579845595|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
160580755|NCT03987620|579845594|FG000|Overall Study|Adverse Event|3|||
160580756|NCT03987620|579845595|FG001|Overall Study|Adverse Event|0|||
160580757|NCT03987620|579845594|FG000|Overall Study|Lost to Follow-up|1|||
160580758|NCT03987620|579845595|FG001|Overall Study|Lost to Follow-up|2|||
160580759|NCT03987620|579845594|FG000|Overall Study|Physician Decision|0|||
160580760|NCT03987620|579845595|FG001|Overall Study|Physician Decision|1|||
160580761|NCT03987620|579845594|FG000|Overall Study|Pregnancy|1|||
160580762|NCT03987620|579845595|FG001|Overall Study|Pregnancy|0|||
160580763|NCT03987620|579845594|FG000|Overall Study|Withdrawal by Subject|7|||
160580764|NCT03987620|579845595|FG001|Overall Study|Withdrawal by Subject|1|||
160580765|NCT03987620|579845594|FG000|Overall Study|Other|2|||
160580766|NCT03987620|579845595|FG001|Overall Study|Other|5|||
160580767|NCT02149836|579845596|FG000|Overall Study|Withdrawal by Subject|1|||
160580768|NCT04430582|579845598|FG000|Overall Study|Found to meet exclusionary criteria|1|||
160580769|NCT04430582|579845599|FG001|Overall Study|Found to meet exclusionary criteria|0|||
160580770|NCT04430582|579845598|FG000|Overall Study|Withdrawal by Subject|0|||
160580771|NCT04430582|579845599|FG001|Overall Study|Withdrawal by Subject|1|||
160580772|NCT03607682|579845600|FG000|Overall Study|Withdrawal by Subject|1|||
160580773|NCT03607682|579845600|FG000|Overall Study|Disease progression|1|||
160580774|NCT01770353|579845601|FG000|Overall Study|Progressive disease|2|||
160580775|NCT01770353|579845602|FG001|Overall Study|Progressive disease|1|||
160580776|NCT01770353|579845601|FG000|Overall Study|Adverse Event|0|||
160580777|NCT01770353|579845602|FG001|Overall Study|Adverse Event|1|||
160580778|NCT01770353|579845601|FG000|Overall Study|Protocol Violation|1|||
160580779|NCT01770353|579845602|FG001|Overall Study|Protocol Violation|0|||
160580780|NCT01770353|579845601|FG000|Overall Study|Physician Decision|0|||
160999655|NCT02503202|581382776|FG001|Base Study: Up to Month 6|Physician Decision|0|||
160999656|NCT02503202|581382777|FG002|Base Study: Up to Month 6|Physician Decision|0|||
160999657|NCT02503202|581382778|FG003|Base Study: Up to Month 6|Physician Decision|0|||
160999658|NCT02503202|581382779|FG004|Base Study: Up to Month 6|Physician Decision|1|||
160999659|NCT02503202|581382775|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
160999660|NCT02503202|581382776|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
160999661|NCT02503202|581382777|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
160999662|NCT02503202|581382778|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
160999663|NCT02503202|581382779|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
160999664|NCT02503202|581382775|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
160999665|NCT02503202|581382776|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
160999666|NCT02503202|581382777|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
160999667|NCT02503202|581382778|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
160999668|NCT02503202|581382779|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
160999669|NCT02503202|581382775|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
160999670|NCT02503202|581382776|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
160999671|NCT02503202|581382777|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
160999672|NCT02503202|581382778|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
160999673|NCT02503202|581382779|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
160999674|NCT02503202|581382775|FG000|Extension: Month 6 to 24|Death|1|||
160999675|NCT02503202|581382776|FG001|Extension: Month 6 to 24|Death|0|||
160999676|NCT02503202|581382777|FG002|Extension: Month 6 to 24|Death|0|||
160999677|NCT02503202|581382778|FG003|Extension: Month 6 to 24|Death|0|||
160999678|NCT02503202|581382779|FG004|Extension: Month 6 to 24|Death|0|||
160999679|NCT02503202|581382775|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
160999680|NCT02503202|581382776|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
160999681|NCT02503202|581382777|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
160999682|NCT02503202|581382778|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
160580781|NCT01770353|579845602|FG001|Overall Study|Physician Decision|3|||
160580782|NCT01770353|579845601|FG000|Overall Study|Clinical deterioration|3|||
160999683|NCT02503202|581382779|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
160999684|NCT02503202|581382775|FG000|Extension: Month 6 to 24|Physician Decision|1|||
160999685|NCT02503202|581382776|FG001|Extension: Month 6 to 24|Physician Decision|0|||
160580783|NCT01770353|579845602|FG001|Overall Study|Clinical deterioration|6|||
160580784|NCT01770353|579845601|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
160580785|NCT01770353|579845602|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
160580786|NCT00376688|579845603|FG000|Overall Study|Adverse Event|3|||
160580787|NCT00376688|579845603|FG000|Overall Study|Death|1|||
160999686|NCT02503202|581382777|FG002|Extension: Month 6 to 24|Physician Decision|1|||
160999687|NCT02503202|581382778|FG003|Extension: Month 6 to 24|Physician Decision|3|||
160580788|NCT00370149|579845604|FG000|Overall Study|Physician Decision|16|||
160580789|NCT00370149|579845605|FG001|Overall Study|Physician Decision|16|||
160999688|NCT02503202|581382779|FG004|Extension: Month 6 to 24|Physician Decision|0|||
160999689|NCT02503202|581382775|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
160999690|NCT02503202|581382776|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
160999691|NCT02503202|581382777|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
160999692|NCT02503202|581382778|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
160999693|NCT02503202|581382779|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
160999694|NCT01119950|581382780|FG000|Overall Study|Adverse Event|25|||
160999695|NCT01119950|581382780|FG000|Overall Study|Withdrawal by Subject|9|||
160999696|NCT01119950|581382780|FG000|Overall Study|Protocol Violation|5|||
160999697|NCT01119950|581382780|FG000|Overall Study|Lost to Follow-up|4|||
160999698|NCT01119950|581382780|FG000|Overall Study|Administrative|2|||
160999699|NCT01119950|581382780|FG000|Overall Study|Abnormal lab value|1|||
160999700|NCT01119950|581382780|FG000|Overall Study|Death|1|||
160580790|NCT00370149|579845604|FG000|Overall Study|Protocol Violation|1|||
160580791|NCT00370149|579845605|FG001|Overall Study|Protocol Violation|0|||
160580792|NCT00370149|579845604|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
160580793|NCT00370149|579845605|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
160580794|NCT00370149|579845604|FG000|Overall Study|Pre-existing infection|0|||
160580795|NCT00370149|579845605|FG001|Overall Study|Pre-existing infection|1|||
160580796|NCT00370149|579845604|FG000|Overall Study|Antibiotic coated dressing placed|0|||
160580797|NCT00370149|579845605|FG001|Overall Study|Antibiotic coated dressing placed|1|||
160580798|NCT00620321|579847002|FG000|Overall Study|Adverse Event|1|||
160580799|NCT00620321|579847003|FG001|Overall Study|Adverse Event|1|||
160580800|NCT00620321|579847002|FG000|Overall Study|Death|1|||
160580801|NCT00620321|579847003|FG001|Overall Study|Death|1|||
160580802|NCT00620321|579847002|FG000|Overall Study|Physician Decision|0|||
160580803|NCT00620321|579847003|FG001|Overall Study|Physician Decision|7|||
160580804|NCT00620321|579847002|FG000|Overall Study|Progressive Disease|5|||
160580805|NCT00620321|579847003|FG001|Overall Study|Progressive Disease|5|||
160580806|NCT00620321|579847002|FG000|Overall Study|Sponsor Decision|0|||
160580807|NCT00620321|579847003|FG001|Overall Study|Sponsor Decision|1|||
160580808|NCT00620321|579847002|FG000|Overall Study|Withdrawal by Subject|1|||
160580809|NCT00620321|579847003|FG001|Overall Study|Withdrawal by Subject|1|||
160580810|NCT02410902|579847004|FG000|Overall Study|Adverse Event|2|||
160580811|NCT02410902|579847005|FG001|Overall Study|Adverse Event|3|||
160580812|NCT02410902|579847004|FG000|Overall Study|Lost to Follow-up|4|||
160580813|NCT02410902|579847005|FG001|Overall Study|Lost to Follow-up|1|||
160580814|NCT02410902|579847004|FG000|Overall Study|Protocol Violation|1|||
160580815|NCT02410902|579847005|FG001|Overall Study|Protocol Violation|4|||
160580816|NCT02410902|579847004|FG000|Overall Study|Withdrawal by Subject|6|||
160947704|NCT01459796|581196016|FG001|Overall Study|Non compliance with protocol|4|||
160947705|NCT01459796|581196015|FG000|Overall Study|Adverse Event|5|||
160947706|NCT01459796|581196016|FG001|Overall Study|Adverse Event|5|||
160947707|NCT01459796|581196015|FG000|Overall Study|Withdrawal by Subject|6|||
160947708|NCT01459796|581196016|FG001|Overall Study|Withdrawal by Subject|3|||
160947709|NCT01459796|581196015|FG000|Overall Study|Lost to Follow-up|5|||
160947710|NCT01459796|581196016|FG001|Overall Study|Lost to Follow-up|4|||
160947711|NCT01459796|581196015|FG000|Overall Study|Reason unspecified|1|||
160947712|NCT01459796|581196016|FG001|Overall Study|Reason unspecified|2|||
160947713|NCT01459796|581196015|FG000|Overall Study|Decision by the sponsor|75|||
160947714|NCT01459796|581196016|FG001|Overall Study|Decision by the sponsor|108|||
160947715|NCT00733824|581196017|FG000|Phase I|Withdrawal by Subject|1|||
160947716|NCT00733824|581196018|FG001|Phase I|Withdrawal by Subject|0|||
160947717|NCT00733824|581196019|FG002|Phase I|Withdrawal by Subject|0|||
160947718|NCT00733824|581196020|FG003|Phase I|Withdrawal by Subject|0|||
160947719|NCT00733824|581196021|FG004|Phase I|Withdrawal by Subject|0|||
160947720|NCT00701051|581196022|FG000|Screening|Failed Screening|40|||
160947721|NCT00701051|581196023|FG001|Screening|Failed Screening|0|||
160947722|NCT00701051|581196024|FG002|Screening|Failed Screening|0|||
160947723|NCT00701051|581196022|FG000|Screening|Time conflicts|19|||
160947724|NCT00701051|581196023|FG001|Screening|Time conflicts|0|||
160947725|NCT00701051|581196024|FG002|Screening|Time conflicts|0|||
160947726|NCT00701051|581196022|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
160947727|NCT00701051|581196023|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
160947728|NCT00701051|581196024|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
160947729|NCT01343056|581196025|FG000|Overall Study|Lost to Follow-up|7|||
160947730|NCT01343056|581196026|FG001|Overall Study|Lost to Follow-up|5|||
160947731|NCT01343056|581196027|FG002|Overall Study|Lost to Follow-up|3|||
160947732|NCT01343056|581196028|FG003|Overall Study|Lost to Follow-up|9|||
160947733|NCT02059148|581196029|FG000|Treatment 1|Protocol Violation|0|||
160947734|NCT02059148|581196030|FG001|Treatment 1|Protocol Violation|0|||
160947735|NCT02059148|581196031|FG002|Treatment 1|Protocol Violation|0|||
160947736|NCT02059148|581196032|FG003|Treatment 1|Protocol Violation|0|||
160947737|NCT02059148|581196033|FG004|Treatment 1|Protocol Violation|0|||
160947738|NCT02059148|581196034|FG005|Treatment 1|Protocol Violation|1|||
160947739|NCT03231371|581196035|FG000|Overall Study|Withdrawal by Subject|1|||
160947740|NCT03231371|581196035|FG000|Overall Study|chose or were ineligible to have MRI|12|||
160999701|NCT01988233|581382781|FG000|Overall Study|Lost to Follow-up|64|||
160947741|NCT03029208|581196040|FG000|Overall Study|Withdrawal by Subject|2|||
160947742|NCT03029208|581196041|FG001|Overall Study|Withdrawal by Subject|3|||
160947743|NCT03029208|581196040|FG000|Overall Study|Lost to Follow-up|0|||
160947744|NCT03029208|581196041|FG001|Overall Study|Lost to Follow-up|1|||
160947745|NCT03893448|581196044|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
160947746|NCT03893448|581196045|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
160947747|NCT03893448|581196044|FG000|Overall Study|Physician Decision|8|||
160947748|NCT03893448|581196045|FG001|Overall Study|Physician Decision|14|||
160947749|NCT03893448|581196044|FG000|Overall Study|Lost to Follow-up|34|||
160947750|NCT03893448|581196045|FG001|Overall Study|Lost to Follow-up|27|||
160580817|NCT02410902|579847005|FG001|Overall Study|Withdrawal by Subject|8|||
160580818|NCT02410902|579847004|FG000|Overall Study|Non-Compliance|8|||
160580819|NCT02410902|579847005|FG001|Overall Study|Non-Compliance|2|||
160580820|NCT00392171|579847009|FG000|Overall Study|Did not meet inclusion criteria|4|||
160580821|NCT00392171|579847009|FG000|Overall Study|Disease progression|101|||
160580822|NCT02750800|579847011|FG000|Overall Study|Adverse Event|18|||
160580823|NCT02750800|579847011|FG000|Overall Study|Lost to Follow-up|12|||
160580824|NCT02750800|579847011|FG000|Overall Study|Investigator decision|53|||
160580825|NCT02750800|579847011|FG000|Overall Study|Patient request|12|||
160580826|NCT02750800|579847011|FG000|Overall Study|Other, not specified|3|||
160580827|NCT00643487|579847015|FG000|Overall Study|Technical difficulty|3|||
160580828|NCT05628181|579847017|FG000|Overall Study|Death|2|||
160580829|NCT05628181|579847018|FG001|Overall Study|Death|4|||
160580830|NCT05628181|579847019|FG002|Overall Study|Death|0|||
160580831|NCT03508622|579847020|FG000|Overall Study|Protocol Violation|1|||
160947751|NCT03893448|581196044|FG000|Overall Study|Death|1|||
160947752|NCT03893448|581196045|FG001|Overall Study|Death|0|||
160947753|NCT03321981|581196046|FG000|Overall Study|Progressive Disease (PD)|15|||
160947754|NCT03321981|581196047|FG001|Overall Study|Progressive Disease (PD)|30|||
160947755|NCT03321981|581196048|FG002|Overall Study|Progressive Disease (PD)|47|||
160947756|NCT03321981|581196046|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
160947757|NCT03321981|581196047|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
160947758|NCT03321981|581196048|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
160947759|NCT03321981|581196046|FG000|Overall Study|Adverse Event|0|||
160947760|NCT03321981|581196047|FG001|Overall Study|Adverse Event|0|||
160580832|NCT03508622|579847021|FG001|Overall Study|Protocol Violation|0|||
160580833|NCT03508622|579847020|FG000|Overall Study|Withdrawal by Subject|1|||
160580834|NCT03508622|579847021|FG001|Overall Study|Withdrawal by Subject|0|||
160580835|NCT03508622|579847020|FG000|Overall Study|Lost to Follow-up|16|||
160580836|NCT03508622|579847021|FG001|Overall Study|Lost to Follow-up|0|||
160580837|NCT03508622|579847020|FG000|Overall Study|Incomplete data|0|||
160580838|NCT03508622|579847021|FG001|Overall Study|Incomplete data|24|||
160580839|NCT00506077|579847022|FG000|Treatment Period 1|Adverse Event|2|||
160580840|NCT00506077|579847023|FG001|Treatment Period 1|Adverse Event|1|||
160580841|NCT00506077|579847022|FG000|Treatment Period 1|Lost to Follow-up|0|||
160580842|NCT00506077|579847023|FG001|Treatment Period 1|Lost to Follow-up|2|||
160580843|NCT00506077|579847022|FG000|Treatment Period 1|Withdrawal by Subject|2|||
160580844|NCT00506077|579847023|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160580845|NCT00506077|579847022|FG000|Treatment Period 2|Adverse Event|0|||
160580846|NCT00506077|579847023|FG001|Treatment Period 2|Adverse Event|1|||
160580847|NCT00506077|579847022|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160580848|NCT00506077|579847023|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160580849|NCT01005719|579847024|FG000|Period 1|Adverse Event|0|||
160580850|NCT01005719|579847025|FG001|Period 1|Adverse Event|0|||
160580851|NCT01005719|579847026|FG002|Period 1|Adverse Event|0|||
160580852|NCT01005719|579847027|FG003|Period 1|Adverse Event|1|||
160580853|NCT01005719|579847028|FG004|Period 1|Adverse Event|0|||
160580854|NCT01005719|579847029|FG005|Period 1|Adverse Event|0|||
160580855|NCT01005719|579847024|FG000|Period 1|Delay in completing study procedures|0|||
160580856|NCT01005719|579847025|FG001|Period 1|Delay in completing study procedures|0|||
160580857|NCT01005719|579847026|FG002|Period 1|Delay in completing study procedures|0|||
160580858|NCT01005719|579847027|FG003|Period 1|Delay in completing study procedures|0|||
160580859|NCT01005719|579847028|FG004|Period 1|Delay in completing study procedures|0|||
160580860|NCT01005719|579847029|FG005|Period 1|Delay in completing study procedures|1|||
160580861|NCT01005719|579847024|FG000|Period 2|Adverse Event|0|||
160947761|NCT03321981|581196048|FG002|Overall Study|Adverse Event|2|||
160947762|NCT03321981|581196046|FG000|Overall Study|symptomatic deterioration|0|||
160947763|NCT03321981|581196047|FG001|Overall Study|symptomatic deterioration|1|||
160947764|NCT03321981|581196048|FG002|Overall Study|symptomatic deterioration|1|||
160947765|NCT03321981|581196046|FG000|Overall Study|Lack of compliance|0|||
160947766|NCT03321981|581196047|FG001|Overall Study|Lack of compliance|1|||
160580862|NCT01005719|579847025|FG001|Period 2|Adverse Event|0|||
160580863|NCT01005719|579847026|FG002|Period 2|Adverse Event|0|||
160580864|NCT01005719|579847027|FG003|Period 2|Adverse Event|0|||
160580865|NCT01005719|579847028|FG004|Period 2|Adverse Event|1|||
160580866|NCT01005719|579847029|FG005|Period 2|Adverse Event|1|||
160580867|NCT01753076|579847030|FG000|Overall Study|Adverse Event|17|||
160580868|NCT01753076|579847031|FG001|Overall Study|Adverse Event|18|||
160947767|NCT03321981|581196048|FG002|Overall Study|Lack of compliance|0|||
160947768|NCT03321981|581196046|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
160947769|NCT03321981|581196047|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
160947770|NCT03321981|581196048|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
160947771|NCT03321981|581196046|FG000|Overall Study|Death|0|||
160947772|NCT03321981|581196047|FG001|Overall Study|Death|1|||
160947773|NCT03321981|581196048|FG002|Overall Study|Death|0|||
160947774|NCT03321981|581196046|FG000|Overall Study|Subject withdrawal of investigational product|0|||
160947775|NCT03321981|581196047|FG001|Overall Study|Subject withdrawal of investigational product|1|||
160947776|NCT03321981|581196048|FG002|Overall Study|Subject withdrawal of investigational product|0|||
160947777|NCT03321981|581196046|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
160947778|NCT03321981|581196047|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
160947779|NCT03321981|581196048|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
160947780|NCT03321981|581196046|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
160947781|NCT03321981|581196047|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
160947782|NCT03321981|581196048|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
160947783|NCT04934670|581196049|FG000|Overall Study|Death|4|||
160947784|NCT04934670|581196050|FG001|Overall Study|Death|0|||
160947785|NCT04934670|581196049|FG000|Overall Study|Lost to Follow-up|1|||
160947786|NCT04934670|581196050|FG001|Overall Study|Lost to Follow-up|4|||
160947787|NCT03067441|581196051|FG000|Overall Study|Withdrawal by Subject|16|||
160947788|NCT03067441|581196052|FG001|Overall Study|Withdrawal by Subject|34|||
160947789|NCT03067441|581196051|FG000|Overall Study|Lost to Follow-up|7|||
160947790|NCT03067441|581196052|FG001|Overall Study|Lost to Follow-up|5|||
160947791|NCT03067441|581196051|FG000|Overall Study|Adverse Event|7|||
160947792|NCT03067441|581196052|FG001|Overall Study|Adverse Event|14|||
160947793|NCT03067441|581196051|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
160947794|NCT03067441|581196052|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
160947795|NCT03067441|581196051|FG000|Overall Study|Physician Decision|1|||
160947796|NCT03067441|581196052|FG001|Overall Study|Physician Decision|3|||
160947797|NCT03067441|581196051|FG000|Overall Study|Other|1|||
160947798|NCT03067441|581196052|FG001|Overall Study|Other|1|||
160947799|NCT00856583|581196053|FG000|Overall Study|Lack of Efficacy|389|||
160947800|NCT00856583|581196054|FG001|Overall Study|Lack of Efficacy|377|||
160947801|NCT00856583|581196053|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
160947802|NCT00856583|581196054|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
160947803|NCT00856583|581196053|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
160947804|NCT00856583|581196054|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
160947805|NCT00856583|581196053|FG000|Overall Study|Non-compliance|305|||
160947806|NCT00856583|581196054|FG001|Overall Study|Non-compliance|262|||
160947807|NCT00856583|581196053|FG000|Overall Study|Withdrawal by Subject|1092|||
160947808|NCT00856583|581196054|FG001|Overall Study|Withdrawal by Subject|919|||
160947809|NCT00856583|581196053|FG000|Overall Study|Physician Decision|59|||
160947810|NCT00856583|581196054|FG001|Overall Study|Physician Decision|82|||
160947811|NCT00856583|581196053|FG000|Overall Study|Pregnancy|14|||
160947812|NCT00856583|581196054|FG001|Overall Study|Pregnancy|5|||
160947813|NCT00856583|581196053|FG000|Overall Study|Other|92|||
160947814|NCT00856583|581196054|FG001|Overall Study|Other|104|||
160947815|NCT00856583|581196053|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
160947816|NCT00856583|581196054|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
160947817|NCT04496258|581196062|FG000|Overall Study|Withdrawal by Subject|2|||
160947818|NCT04496258|581196063|FG001|Overall Study|Withdrawal by Subject|1|||
160947819|NCT01427712|581196064|FG000|Overall Study|Transfer to a different hospital|2|||
160947820|NCT01427712|581196064|FG000|Overall Study|Lost to Follow-up|1|||
160947821|NCT01427712|581196064|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
160947822|NCT01427712|581196064|FG000|Overall Study|Failure to visit|1|||
160456227|NCT05285137|579399872|FG000|Overall Study|Pregnancy|0|||
160947823|NCT00661492|581196065|FG000|Overall Study|Adverse Event|16|||
160947824|NCT00661492|581196066|FG001|Overall Study|Adverse Event|13|||
160947825|NCT00661492|581196065|FG000|Overall Study|Disease Progression|44|||
160947826|NCT00661492|581196066|FG001|Overall Study|Disease Progression|14|||
160456228|NCT05285137|579399873|FG001|Overall Study|Pregnancy|0|||
160456229|NCT05285137|579399874|FG002|Overall Study|Pregnancy|0|||
160456230|NCT05285137|579399875|FG003|Overall Study|Pregnancy|0|||
160947827|NCT00661492|581196065|FG000|Overall Study|Patient Request|6|||
160947828|NCT00661492|581196066|FG001|Overall Study|Patient Request|1|||
160947829|NCT00661492|581196065|FG000|Overall Study|Investigator Request|1|||
160947830|NCT00661492|581196066|FG001|Overall Study|Investigator Request|0|||
160947831|NCT00661492|581196065|FG000|Overall Study|Lost to Follow-up|0|||
160947832|NCT00661492|581196066|FG001|Overall Study|Lost to Follow-up|1|||
160947833|NCT00661492|581196065|FG000|Overall Study|Other|1|||
160456231|NCT05285137|579399876|FG004|Overall Study|Pregnancy|0|||
160456232|NCT05285137|579399877|FG005|Overall Study|Pregnancy|0|||
160947834|NCT00661492|581196066|FG001|Overall Study|Other|0|||
160947835|NCT00803634|581196067|FG000|Overall Study|Withdrew Consent|1|||
160947836|NCT00803634|581196068|FG001|Overall Study|Withdrew Consent|0|||
160947837|NCT00803634|581196067|FG000|Overall Study|Lost to Follow-up|2|||
160947838|NCT00803634|581196068|FG001|Overall Study|Lost to Follow-up|3|||
160947839|NCT00803634|581196067|FG000|Overall Study|Death|3|||
160947840|NCT00803634|581196068|FG001|Overall Study|Death|2|||
160580869|NCT01753076|579847030|FG000|Overall Study|Lack of Efficacy|3|||
160580870|NCT01753076|579847031|FG001|Overall Study|Lack of Efficacy|1|||
160580871|NCT01753076|579847030|FG000|Overall Study|Lost to Follow-up|2|||
160580872|NCT01753076|579847031|FG001|Overall Study|Lost to Follow-up|1|||
160580873|NCT01753076|579847030|FG000|Overall Study|Physician Decision|4|||
160580874|NCT01753076|579847031|FG001|Overall Study|Physician Decision|2|||
160580875|NCT01753076|579847030|FG000|Overall Study|Withdrawal by Subject|14|||
160580876|NCT01753076|579847031|FG001|Overall Study|Withdrawal by Subject|24|||
160580877|NCT01753076|579847030|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
160580878|NCT01753076|579847031|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
160580879|NCT02575079|579847032|FG000|Overall Study|Death|3|||
160580880|NCT02575079|579847033|FG001|Overall Study|Death|0|||
160580881|NCT02575079|579847032|FG000|Overall Study|Withdrawal by Subject|3|||
160580882|NCT02575079|579847033|FG001|Overall Study|Withdrawal by Subject|0|||
160580883|NCT02918266|579847034|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
160580884|NCT02918266|579847035|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
160580885|NCT02918266|579847036|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
160580886|NCT02918266|579847037|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
160580887|NCT02918266|579847038|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
160580888|NCT02918266|579847039|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
160580889|NCT02918266|579847040|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
160580890|NCT02918266|579847041|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
160580891|NCT02918266|579847042|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
160580892|NCT02918266|579847043|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
160580893|NCT02918266|579847044|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
160580894|NCT01259856|579847045|FG000|Overall Study|Adverse Event|12|||
160580895|NCT01259856|579847046|FG001|Overall Study|Adverse Event|9|||
160580896|NCT01259856|579847045|FG000|Overall Study|Death|0|||
160580897|NCT01259856|579847046|FG001|Overall Study|Death|1|||
160580898|NCT01259856|579847045|FG000|Overall Study|Lack of Efficacy|3|||
160580899|NCT01259856|579847046|FG001|Overall Study|Lack of Efficacy|1|||
160580900|NCT01259856|579847045|FG000|Overall Study|Lost to Follow-up|1|||
160580901|NCT01259856|579847046|FG001|Overall Study|Lost to Follow-up|1|||
160580902|NCT01259856|579847045|FG000|Overall Study|Physician Decision|2|||
160580903|NCT01259856|579847046|FG001|Overall Study|Physician Decision|1|||
160580904|NCT01259856|579847045|FG000|Overall Study|Withdrawal by Subject|9|||
160580905|NCT01259856|579847046|FG001|Overall Study|Withdrawal by Subject|10|||
160580906|NCT01259856|579847045|FG000|Overall Study|Treatment never started|0|||
160580907|NCT01259856|579847046|FG001|Overall Study|Treatment never started|6|||
160580908|NCT01259856|579847045|FG000|Overall Study|Study closure by sponsor|40|||
160580909|NCT01259856|579847046|FG001|Overall Study|Study closure by sponsor|41|||
160580910|NCT01259856|579847045|FG000|Overall Study|Patient developed other disease|0|||
160580911|NCT01259856|579847046|FG001|Overall Study|Patient developed other disease|1|||
160580912|NCT01259856|579847045|FG000|Overall Study|Transfer to another study|0|||
160580913|NCT01259856|579847046|FG001|Overall Study|Transfer to another study|1|||
160580914|NCT01259856|579847045|FG000|Overall Study|Unknown/missing|2|||
160580915|NCT01259856|579847046|FG001|Overall Study|Unknown/missing|2|||
160580916|NCT00788775|579847049|FG000|Overall Study|Progressive Disease|8|||
160580917|NCT00788775|579847050|FG001|Overall Study|Progressive Disease|6|||
160580918|NCT00788775|579847049|FG000|Overall Study|Withdrawal by Subject|0|||
160580919|NCT00788775|579847050|FG001|Overall Study|Withdrawal by Subject|2|||
160580920|NCT00788775|579847049|FG000|Overall Study|Patient Non-Compliance|1|||
160580921|NCT00788775|579847050|FG001|Overall Study|Patient Non-Compliance|0|||
160580922|NCT00788775|579847049|FG000|Overall Study|Patient's measurable disease resected.|1|||
160947841|NCT01652716|581196069|FG000|Overall Study|Loss of glucose control|1|||
160580923|NCT00788775|579847050|FG001|Overall Study|Patient's measurable disease resected.|0|||
160656134|NCT00366899|580122354|FG001|Infant Series|Randomized but not consented|0|||
160947842|NCT01652716|581196070|FG001|Overall Study|Loss of glucose control|0|||
160947843|NCT01652716|581196069|FG000|Overall Study|Administrative|0|||
160947844|NCT01652716|581196070|FG001|Overall Study|Administrative|2|||
160947845|NCT01652716|581196069|FG000|Overall Study|Investigator decision|1|||
160580924|NCT01293032|579847051|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
160580925|NCT01293032|579847052|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
160580926|NCT01293032|579847053|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
160580927|NCT01293032|579847054|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
160580928|NCT01293032|579847051|FG000|Treatment|Adverse Event|0|||
160580929|NCT01293032|579847052|FG001|Treatment|Adverse Event|0|||
160580930|NCT01293032|579847053|FG002|Treatment|Adverse Event|1|||
160947846|NCT01652716|581196070|FG001|Overall Study|Investigator decision|4|||
160947847|NCT01652716|581196069|FG000|Overall Study|Lost to Follow-up|12|||
160947848|NCT01652716|581196070|FG001|Overall Study|Lost to Follow-up|11|||
160947849|NCT01652716|581196069|FG000|Overall Study|Protocol Violation|2|||
160947850|NCT01652716|581196070|FG001|Overall Study|Protocol Violation|1|||
160947851|NCT01652716|581196069|FG000|Overall Study|Adverse Event|7|||
160947852|NCT01652716|581196070|FG001|Overall Study|Adverse Event|10|||
160947853|NCT01652716|581196069|FG000|Overall Study|Withdrawal by Subject|33|||
160947854|NCT01652716|581196070|FG001|Overall Study|Withdrawal by Subject|18|||
160947855|NCT04745169|581198320|FG000|Overall Study|Kidney transplantation|1|||
160947856|NCT04745169|581198320|FG000|Overall Study|Participant health problems|3|||
160947857|NCT04745169|581198320|FG000|Overall Study|Physician Decision|2|||
160947858|NCT00993447|581198321|FG000|Overall Study|Withdrawal by Subject|23|||
160947859|NCT00993447|581198322|FG001|Overall Study|Withdrawal by Subject|8|||
160947860|NCT00993447|581198321|FG000|Overall Study|Protocol Violation|12|||
160947861|NCT00993447|581198322|FG001|Overall Study|Protocol Violation|8|||
160947862|NCT00993447|581198321|FG000|Overall Study|Lost to Follow-up|1|||
160947863|NCT00993447|581198322|FG001|Overall Study|Lost to Follow-up|3|||
160947864|NCT00993447|581198321|FG000|Overall Study|Adverse Event|1|||
160947865|NCT00993447|581198322|FG001|Overall Study|Adverse Event|0|||
160947866|NCT00970502|581198323|FG000|Overall Study|Withdrawal by Subject|1|||
160947867|NCT02707055|581198324|FG000|Phase 1|Withdrawal by Subject|1|||
160580931|NCT01293032|579847054|FG003|Treatment|Adverse Event|1|||
160947868|NCT02707055|581198325|FG001|Phase 1|Withdrawal by Subject|2|||
160947869|NCT02707055|581198324|FG000|Phase 1|Physician Decision|0|||
160947870|NCT02707055|581198325|FG001|Phase 1|Physician Decision|1|||
160947871|NCT02707055|581198324|FG000|Phase 2|Adverse Event|1|||
160947872|NCT02707055|581198325|FG001|Phase 2|Adverse Event|2|||
160947873|NCT01880424|581198326|FG000|Overall Study|Adverse Event|7|||
160947874|NCT01880424|581198327|FG001|Overall Study|Adverse Event|6|||
160947875|NCT01880424|581198326|FG000|Overall Study|Lack of Efficacy|1|||
160580932|NCT01293032|579847051|FG000|Treatment|Withdrawal by Subject|2|||
160947876|NCT01880424|581198327|FG001|Overall Study|Lack of Efficacy|4|||
160947877|NCT01880424|581198326|FG000|Overall Study|Lost to Follow-up|3|||
160947878|NCT01880424|581198327|FG001|Overall Study|Lost to Follow-up|2|||
160947879|NCT01880424|581198326|FG000|Overall Study|Protocol Violation|11|||
160947880|NCT01880424|581198327|FG001|Overall Study|Protocol Violation|13|||
160947881|NCT01880424|581198326|FG000|Overall Study|Withdrawal by Subject|10|||
160947882|NCT01880424|581198327|FG001|Overall Study|Withdrawal by Subject|30|||
160580933|NCT01293032|579847052|FG001|Treatment|Withdrawal by Subject|4|||
160580934|NCT01293032|579847053|FG002|Treatment|Withdrawal by Subject|0|||
160580935|NCT01293032|579847054|FG003|Treatment|Withdrawal by Subject|0|||
160580936|NCT01293032|579847051|FG000|Treatment|Disease Progression, relapse|0|||
160580937|NCT01293032|579847052|FG001|Treatment|Disease Progression, relapse|1|||
160580938|NCT01293032|579847053|FG002|Treatment|Disease Progression, relapse|0|||
160580939|NCT01293032|579847054|FG003|Treatment|Disease Progression, relapse|0|||
160580940|NCT01087528|579847059|FG000|Overall Study|Withdrawal by Subject|1|||
160580941|NCT01087528|579847059|FG000|Overall Study|Incomplete CE procedure|6|||
160580942|NCT03116399|579847062|FG000|Overall Study|Death|8|||
160580943|NCT03116399|579847063|FG001|Overall Study|Death|3|||
160580944|NCT03116399|579847062|FG000|Overall Study|Lost to Follow-up|7|||
160580945|NCT03116399|579847063|FG001|Overall Study|Lost to Follow-up|11|||
160580946|NCT03116399|579847062|FG000|Overall Study|Investigator Decision|1|||
160580947|NCT03116399|579847063|FG001|Overall Study|Investigator Decision|1|||
160580948|NCT03116399|579847062|FG000|Overall Study|Withdrawal by Subject|24|||
160580949|NCT03116399|579847063|FG001|Overall Study|Withdrawal by Subject|9|||
160580950|NCT01035255|579847069|FG000|Overall Study|Death|724|||
160580951|NCT01035255|579847070|FG001|Overall Study|Death|844|||
160580952|NCT01035255|579847069|FG000|Overall Study|Lost to Follow-up|2|||
160947883|NCT01880424|581198326|FG000|Overall Study|Other|1|||
160947884|NCT01880424|581198327|FG001|Overall Study|Other|0|||
160947885|NCT02280044|581198332|FG000|Overall Study|Planned alternate|0|||
160947886|NCT02280044|581198333|FG001|Overall Study|Planned alternate|2|||
160947887|NCT05706506|581198334|FG000|Overall Study|Adverse Event|1|||
160947888|NCT05706506|581198334|FG000|Overall Study|Withdrawal by Subject|4|||
160947889|NCT05706506|581198334|FG000|Overall Study|Lost to Follow-up|2|||
160947890|NCT05706506|581198334|FG000|Overall Study|Inadvertent Enrolment|12|||
160947891|NCT05706506|581198334|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
160947892|NCT05706506|581198334|FG000|Overall Study|Participant Moved Out of State|1|||
160947893|NCT01075321|581198338|FG000|Overall Study|Withdrawal by Subject|0|||
160947894|NCT01075321|581198339|FG001|Overall Study|Withdrawal by Subject|0|||
160947895|NCT01075321|581198340|FG002|Overall Study|Withdrawal by Subject|1|||
160580953|NCT01035255|579847070|FG001|Overall Study|Lost to Follow-up|5|||
160580954|NCT01035255|579847069|FG000|Overall Study|patient's request|15|||
160580955|NCT01035255|579847070|FG001|Overall Study|patient's request|13|||
160580956|NCT00195260|579847076|FG000|Part 1: Dose Escalation|Adverse Event|0|||
160580957|NCT00195260|579847077|FG001|Part 1: Dose Escalation|Adverse Event|1|||
160580958|NCT00195260|579847078|FG002|Part 1: Dose Escalation|Adverse Event|0|||
160947896|NCT01075321|581198341|FG003|Overall Study|Withdrawal by Subject|1|||
160580959|NCT00195260|579847079|FG003|Part 1: Dose Escalation|Adverse Event|1|||
160580960|NCT00195260|579847080|FG004|Part 1: Dose Escalation|Adverse Event|1|||
160580961|NCT00195260|579847081|FG005|Part 1: Dose Escalation|Adverse Event|0|||
160580962|NCT00195260|579847082|FG006|Part 1: Dose Escalation|Adverse Event|3|||
160580963|NCT00195260|579847083|FG007|Part 1: Dose Escalation|Adverse Event|0|||
160580964|NCT00195260|579847084|FG008|Part 1: Dose Escalation|Adverse Event|0|||
160580965|NCT00195260|579847085|FG009|Part 1: Dose Escalation|Adverse Event|0|||
160580966|NCT00195260|579847086|FG010|Part 1: Dose Escalation|Adverse Event|0|||
160580967|NCT00195260|579847076|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160580968|NCT00195260|579847077|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160580969|NCT00195260|579847078|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160580970|NCT00195260|579847079|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160580971|NCT00195260|579847080|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
160580972|NCT00195260|579847081|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160580973|NCT00195260|579847082|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160580974|NCT00195260|579847083|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
160580975|NCT00195260|579847084|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160580976|NCT00195260|579847085|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160580977|NCT00195260|579847086|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160580978|NCT00195260|579847076|FG000|Part 1: Dose Escalation|Death|0|||
160580979|NCT00195260|579847077|FG001|Part 1: Dose Escalation|Death|0|||
160580980|NCT00195260|579847078|FG002|Part 1: Dose Escalation|Death|0|||
160580981|NCT00195260|579847079|FG003|Part 1: Dose Escalation|Death|0|||
160580982|NCT00195260|579847080|FG004|Part 1: Dose Escalation|Death|0|||
160862118|NCT05138653|580887933|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
160580983|NCT00195260|579847081|FG005|Part 1: Dose Escalation|Death|0|||
160580984|NCT00195260|579847082|FG006|Part 1: Dose Escalation|Death|0|||
160580985|NCT00195260|579847083|FG007|Part 1: Dose Escalation|Death|1|||
160580986|NCT00195260|579847084|FG008|Part 1: Dose Escalation|Death|0|||
160580987|NCT00195260|579847085|FG009|Part 1: Dose Escalation|Death|0|||
160580988|NCT00195260|579847086|FG010|Part 1: Dose Escalation|Death|0|||
160580989|NCT00195260|579847076|FG000|Part 1: Dose Escalation|Disease Progression|3|||
160580990|NCT00195260|579847077|FG001|Part 1: Dose Escalation|Disease Progression|2|||
160656135|NCT00366899|580122353|FG000|After Infant Series|Lost to Follow-up|4|||
160656136|NCT00366899|580122354|FG001|After Infant Series|Lost to Follow-up|3|||
160862119|NCT05138653|580887934|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862120|NCT05138653|580887935|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862121|NCT04272242|580887936|FG000|Overall Study|Withdrawal by Subject|3|||
160862122|NCT04272242|580887936|FG000|Overall Study|Lost to Follow-up|1|||
160862123|NCT04272242|580887936|FG000|Overall Study|Adverse Event|1|||
160862124|NCT03204188|580887944|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
160862125|NCT03204188|580887944|FG000|Immunotherapy Phase (1 Year)|Death|1|||
160862126|NCT03204188|580887944|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
160862127|NCT03204188|580887944|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
160862128|NCT01520506|580889654|FG000|Overall Study|Missed Visit|4|||
160862129|NCT01520506|580889654|FG000|Overall Study|Lost to Follow-up|1|||
160862130|NCT01520506|580889654|FG000|Overall Study|Withdrawal by Subject|1|||
160862131|NCT00906204|580889655|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
160862132|NCT00906204|580889656|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
160862133|NCT00906204|580889655|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
160862134|NCT00906204|580889656|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
160862135|NCT00906204|580889655|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
160862136|NCT00906204|580889656|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
160862137|NCT00906204|580889655|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
160862138|NCT00906204|580889656|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
160862139|NCT00906204|580889655|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
160862140|NCT00906204|580889656|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
160862141|NCT00696072|580889657|FG000|Overall Study|continuing active treatment|10|||
160862142|NCT00696072|580889658|FG001|Overall Study|continuing active treatment|13|||
160862143|NCT00696072|580889657|FG000|Overall Study|Adverse Event|10|||
160862144|NCT00696072|580889658|FG001|Overall Study|Adverse Event|6|||
160862145|NCT00696072|580889657|FG000|Overall Study|Patient Request|3|||
160862146|NCT00696072|580889658|FG001|Overall Study|Patient Request|7|||
160862147|NCT00696072|580889657|FG000|Overall Study|Investigator Request|1|||
160862148|NCT00696072|580889658|FG001|Overall Study|Investigator Request|4|||
160862149|NCT00696072|580889657|FG000|Overall Study|Sponsor Request|0|||
160580991|NCT00195260|579847078|FG002|Part 1: Dose Escalation|Disease Progression|5|||
160580992|NCT00195260|579847079|FG003|Part 1: Dose Escalation|Disease Progression|6|||
160580993|NCT00195260|579847080|FG004|Part 1: Dose Escalation|Disease Progression|4|||
160580994|NCT00195260|579847081|FG005|Part 1: Dose Escalation|Disease Progression|6|||
160580995|NCT00195260|579847082|FG006|Part 1: Dose Escalation|Disease Progression|7|||
160862150|NCT00696072|580889658|FG001|Overall Study|Sponsor Request|1|||
160862151|NCT00696072|580889657|FG000|Overall Study|Disease Progression|32|||
160580996|NCT00195260|579847083|FG007|Part 1: Dose Escalation|Disease Progression|4|||
160580997|NCT00195260|579847084|FG008|Part 1: Dose Escalation|Disease Progression|0|||
160580998|NCT00195260|579847085|FG009|Part 1: Dose Escalation|Disease Progression|0|||
160580999|NCT00195260|579847086|FG010|Part 1: Dose Escalation|Disease Progression|0|||
160581000|NCT00195260|579847076|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
160581001|NCT00195260|579847077|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
160581002|NCT00195260|579847078|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
160581003|NCT00195260|579847079|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
160581004|NCT00195260|579847080|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
160581005|NCT00195260|579847081|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
160581006|NCT00195260|579847082|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
160581007|NCT00195260|579847083|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
160581008|NCT00195260|579847084|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
160581009|NCT00195260|579847085|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
160581010|NCT00195260|579847086|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
160581011|NCT00195260|579847076|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
160581012|NCT00195260|579847077|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
160581013|NCT00195260|579847078|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
160581014|NCT00195260|579847079|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
160581015|NCT00195260|579847080|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
160581016|NCT00195260|579847081|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
160581017|NCT00195260|579847082|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
160581018|NCT00195260|579847083|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
160581019|NCT00195260|579847084|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
160581020|NCT00195260|579847085|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
160581021|NCT00195260|579847086|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
160581022|NCT00195260|579847076|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
160581023|NCT00195260|579847077|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
160581024|NCT00195260|579847078|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
160581025|NCT00195260|579847079|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
160581026|NCT00195260|579847080|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
160581027|NCT00195260|579847081|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
160581028|NCT00195260|579847082|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
160581029|NCT00195260|579847083|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
160581030|NCT00195260|579847084|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
160581031|NCT00195260|579847085|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
160581032|NCT00195260|579847086|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
160581033|NCT00195260|579847076|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
160581034|NCT00195260|579847077|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
160581035|NCT00195260|579847078|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
160581036|NCT00195260|579847079|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
160581037|NCT00195260|579847080|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
160581038|NCT00195260|579847081|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
160581039|NCT00195260|579847082|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
160581040|NCT00195260|579847083|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
160581041|NCT00195260|579847084|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
160581042|NCT00195260|579847085|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
160581043|NCT00195260|579847086|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
160581044|NCT00195260|579847076|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
160581045|NCT00195260|579847077|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
160581046|NCT00195260|579847078|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
160581047|NCT00195260|579847079|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
160581048|NCT00195260|579847080|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
160581049|NCT00195260|579847081|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
160581050|NCT00195260|579847082|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
160581051|NCT00195260|579847083|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
160581052|NCT00195260|579847084|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
160581053|NCT00195260|579847085|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
160581054|NCT00195260|579847086|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
160581055|NCT02749721|579847087|FG000|Screening|Withdrawal by Subject|1|||
160581056|NCT02749721|579847087|FG000|Screening|Lost to Follow-up|2|||
160581057|NCT02749721|579847087|FG000|Screening|Protocol Violation|3|||
160581058|NCT02749721|579847087|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
160581059|NCT02749721|579847087|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
160999702|NCT01988233|581382782|FG001|Overall Study|Lost to Follow-up|51|||
160999703|NCT02148133|581382783|FG000|Overall Study|Investigator discretion|1|||
160999704|NCT02148133|581382783|FG000|Overall Study|Lack of Efficacy|1|||
160999705|NCT02148133|581382783|FG000|Overall Study|Protocol deviation|1|||
160947897|NCT01075321|581198338|FG000|Overall Study|Protocol Violation|0|||
160947898|NCT01075321|581198339|FG001|Overall Study|Protocol Violation|0|||
160947899|NCT01075321|581198340|FG002|Overall Study|Protocol Violation|1|||
160947900|NCT01075321|581198341|FG003|Overall Study|Protocol Violation|0|||
160947901|NCT01075321|581198338|FG000|Overall Study|Treatment Incomplete due to progression|1|||
160947902|NCT01075321|581198339|FG001|Overall Study|Treatment Incomplete due to progression|0|||
160947903|NCT01075321|581198340|FG002|Overall Study|Treatment Incomplete due to progression|0|||
160947904|NCT01075321|581198341|FG003|Overall Study|Treatment Incomplete due to progression|0|||
160947905|NCT01075321|581198338|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
160947906|NCT01075321|581198339|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
160947907|NCT01075321|581198340|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
160947908|NCT01075321|581198341|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
160947909|NCT02646423|581198342|FG000|Overall Study|Adverse Event|5|||
160947910|NCT02646423|581198343|FG001|Overall Study|Adverse Event|7|||
160947911|NCT02646423|581198342|FG000|Overall Study|Ineligible|2|||
160947912|NCT02646423|581198343|FG001|Overall Study|Ineligible|1|||
160947913|NCT00003457|581198344|FG000|Overall Study|Not evaluable|9|||
160947914|NCT01054729|581198348|FG000|Overall Study|Randomized but Not Treated|0|||
160947915|NCT01054729|581198349|FG001|Overall Study|Randomized but Not Treated|1|||
160947916|NCT01054729|581198350|FG002|Overall Study|Randomized but Not Treated|0|||
160947917|NCT01054729|581198351|FG003|Overall Study|Randomized but Not Treated|0|||
160947918|NCT01054729|581198348|FG000|Overall Study|Adverse Event|1|||
160947919|NCT01054729|581198349|FG001|Overall Study|Adverse Event|1|||
160947920|NCT01054729|581198350|FG002|Overall Study|Adverse Event|2|||
160947921|NCT01054729|581198351|FG003|Overall Study|Adverse Event|1|||
160947922|NCT01054729|581198348|FG000|Overall Study|Withdrawal by Subject|1|||
160947923|NCT01054729|581198349|FG001|Overall Study|Withdrawal by Subject|0|||
160947924|NCT01054729|581198350|FG002|Overall Study|Withdrawal by Subject|1|||
160947925|NCT01054729|581198351|FG003|Overall Study|Withdrawal by Subject|0|||
160947926|NCT01054729|581198348|FG000|Overall Study|Lost to Follow-up|0|||
160947927|NCT01054729|581198349|FG001|Overall Study|Lost to Follow-up|1|||
160947928|NCT01054729|581198350|FG002|Overall Study|Lost to Follow-up|0|||
160947929|NCT01054729|581198351|FG003|Overall Study|Lost to Follow-up|0|||
160947930|NCT01054729|581198348|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
160947931|NCT01054729|581198349|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
160947932|NCT01054729|581198350|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
160947933|NCT01054729|581198351|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
160947934|NCT01054729|581198348|FG000|Overall Study|Non-responder|1|||
160947935|NCT01054729|581198349|FG001|Overall Study|Non-responder|0|||
160947936|NCT01054729|581198350|FG002|Overall Study|Non-responder|1|||
160947937|NCT01054729|581198351|FG003|Overall Study|Non-responder|1|||
160947938|NCT01054729|581198348|FG000|Overall Study|PEG/RBV Non-responder|1|||
160947939|NCT01054729|581198349|FG001|Overall Study|PEG/RBV Non-responder|0|||
160947940|NCT01054729|581198350|FG002|Overall Study|PEG/RBV Non-responder|1|||
160947941|NCT01054729|581198351|FG003|Overall Study|PEG/RBV Non-responder|0|||
160947942|NCT01054729|581198348|FG000|Overall Study|Personal/Obligations|0|||
160947943|NCT01054729|581198349|FG001|Overall Study|Personal/Obligations|1|||
160947944|NCT01054729|581198350|FG002|Overall Study|Personal/Obligations|0|||
160947945|NCT01054729|581198351|FG003|Overall Study|Personal/Obligations|0|||
160947946|NCT01054729|581198348|FG000|Overall Study|Subject moved|0|||
160947947|NCT01054729|581198349|FG001|Overall Study|Subject moved|0|||
160947948|NCT01054729|581198350|FG002|Overall Study|Subject moved|1|||
160947949|NCT01054729|581198351|FG003|Overall Study|Subject moved|0|||
160947950|NCT01054729|581198348|FG000|Overall Study|Lack of Efficacy|0|||
160947951|NCT01054729|581198349|FG001|Overall Study|Lack of Efficacy|0|||
160947952|NCT01054729|581198350|FG002|Overall Study|Lack of Efficacy|0|||
160947953|NCT01054729|581198351|FG003|Overall Study|Lack of Efficacy|1|||
160947954|NCT00321919|581198352|FG000|Overall Study|Adverse Event|17|||
160947955|NCT00321919|581198353|FG001|Overall Study|Adverse Event|10|||
160947956|NCT00321919|581198352|FG000|Overall Study|Death|21|||
160947957|NCT00321919|581198353|FG001|Overall Study|Death|17|||
160947958|NCT00321919|581198352|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160947959|NCT00321919|581198353|FG001|Overall Study|Insufficient Therapeutic Response|0|||
160947960|NCT00321919|581198352|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
160947961|NCT00321919|581198353|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
160947962|NCT00321919|581198352|FG000|Overall Study|Refused Treatment|23|||
160947963|NCT00321919|581198353|FG001|Overall Study|Refused Treatment|14|||
160947964|NCT00321919|581198352|FG000|Overall Study|Other Protocol Violation|2|||
160947965|NCT00321919|581198353|FG001|Overall Study|Other Protocol Violation|3|||
160947966|NCT00321919|581198352|FG000|Overall Study|Failure to Return|3|||
160947967|NCT00321919|581198353|FG001|Overall Study|Failure to Return|1|||
160947968|NCT00321919|581198352|FG000|Overall Study|Other withdrawal reason|7|||
160947969|NCT00321919|581198353|FG001|Overall Study|Other withdrawal reason|6|||
160947970|NCT02624804|581198354|FG000|Overall Study|Screen Failure|5|||
160947971|NCT02590354|581198355|FG000|Phase 1|Active hepatitis B or C infection|1|||
160947972|NCT02590354|581198355|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
160947973|NCT02590354|581198355|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
160947974|NCT02590354|581198355|FG000|Phase 1|Subject does not want to participate|20|||
160947975|NCT02590354|581198355|FG000|Phase 1|Lost to Follow-up|1|||
160947976|NCT02590354|581198355|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
160947977|NCT00996996|581198356|FG000|Overall Study|Progressive Disease|10|||
160947978|NCT00996996|581198356|FG000|Overall Study|Non-compliance|8|||
160947979|NCT00996996|581198356|FG000|Overall Study|Lost to Follow-up|9|||
160947980|NCT00996996|581198356|FG000|Overall Study|Death|5|||
160947981|NCT00996996|581198356|FG000|Overall Study|Did Not Receive Study Medications|1|||
160947982|NCT01227889|581198357|FG000|Randomized Phase (RP)|Adverse Event|13|||
160947983|NCT01227889|581198358|FG001|Randomized Phase (RP)|Adverse Event|0|||
160947984|NCT01227889|581198357|FG000|Randomized Phase (RP)|Physician Decision|13|||
160947985|NCT01227889|581198358|FG001|Randomized Phase (RP)|Physician Decision|5|||
160947986|NCT01227889|581198357|FG000|Randomized Phase (RP)|Progressive Disease|135|||
160947987|NCT01227889|581198358|FG001|Randomized Phase (RP)|Progressive Disease|52|||
160947988|NCT01227889|581198357|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
160947989|NCT01227889|581198358|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
160581060|NCT01379534|579847088|FG000|Treatment Phase|Withdrawal by Subject|2|||
160581061|NCT01379534|579847089|FG001|Treatment Phase|Withdrawal by Subject|2|||
160581062|NCT01379534|579847088|FG000|Treatment Phase|Progressive disease|13|||
160581063|NCT01379534|579847089|FG001|Treatment Phase|Progressive disease|22|||
160581064|NCT01379534|579847088|FG000|Treatment Phase|Adverse Event|7|||
160581065|NCT01379534|579847089|FG001|Treatment Phase|Adverse Event|7|||
160581066|NCT01379534|579847088|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
160581067|NCT01379534|579847089|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
160581068|NCT01379534|579847088|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
160581069|NCT01379534|579847089|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
160581070|NCT01379534|579847088|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
160581071|NCT01379534|579847089|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
160581072|NCT01379534|579847088|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
160581073|NCT01379534|579847089|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
160581074|NCT02691247|579847090|FG000|Overall Study|Withdrawal by Subject|1|||
160581075|NCT02691247|579847091|FG001|Overall Study|Withdrawal by Subject|2|||
160581076|NCT02691247|579847092|FG002|Overall Study|Withdrawal by Subject|2|||
160581077|NCT02691247|579847090|FG000|Overall Study|Lost to Follow-up|2|||
160581078|NCT02691247|579847091|FG001|Overall Study|Lost to Follow-up|0|||
160581079|NCT02691247|579847092|FG002|Overall Study|Lost to Follow-up|1|||
160581080|NCT01519245|579847093|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
160581081|NCT01519245|579847094|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
160581082|NCT00772967|579847095|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
160581083|NCT00772967|579847096|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
160581084|NCT00772967|579847097|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
160581085|NCT00772967|579847098|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
160581086|NCT00772967|579847099|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
160581087|NCT00772967|579847100|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
160581088|NCT00772967|579847095|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
160581089|NCT00772967|579847096|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
160581090|NCT00772967|579847097|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
160581091|NCT00772967|579847098|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
160581092|NCT00772967|579847099|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
160581093|NCT00772967|579847100|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
160581094|NCT00772967|579847095|FG000|Crossover Treatment 3|Adverse Event|0|||
160581095|NCT00772967|579847096|FG001|Crossover Treatment 3|Adverse Event|0|||
160581096|NCT00772967|579847097|FG002|Crossover Treatment 3|Adverse Event|0|||
160581097|NCT00772967|579847098|FG003|Crossover Treatment 3|Adverse Event|0|||
160581098|NCT00772967|579847099|FG004|Crossover Treatment 3|Adverse Event|1|||
160581099|NCT00772967|579847100|FG005|Crossover Treatment 3|Adverse Event|0|||
160581100|NCT00231062|579847101|FG000|Overall Study|Physician Decision|6|||
160581101|NCT00803244|579847102|FG000|Overall Study|Adverse Event|1|||
160581102|NCT00803244|579847103|FG001|Overall Study|Adverse Event|2|||
160581103|NCT00803244|579847102|FG000|Overall Study|Withdrawal by Subject|2|||
160581104|NCT00803244|579847103|FG001|Overall Study|Withdrawal by Subject|3|||
160581105|NCT00803244|579847102|FG000|Overall Study|Any other reason not above-mentioned|4|||
160581106|NCT00803244|579847103|FG001|Overall Study|Any other reason not above-mentioned|10|||
160581107|NCT03321929|579847105|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
160581108|NCT02873715|579847106|FG000|Overall Study|Lost to Follow-up|84|||
160581109|NCT02873715|579847107|FG001|Overall Study|Lost to Follow-up|94|||
160581110|NCT02873715|579847106|FG000|Overall Study|Withdrawal by Subject|7|||
160947990|NCT01227889|581198357|FG000|Randomized Phase (RP)|Missing|1|||
160947991|NCT01227889|581198358|FG001|Randomized Phase (RP)|Missing|3|||
160581111|NCT02873715|579847107|FG001|Overall Study|Withdrawal by Subject|26|||
160947992|NCT01227889|581198357|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
160947993|NCT01227889|581198358|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
160947994|NCT01227889|581198357|FG000|Crossover Phase|Adverse Event|0|||
160999706|NCT02148133|581382783|FG000|Overall Study|Protocol-defined stopping criteria|2|||
160999707|NCT03808883|581382784|FG000|Overall Study|Withdrawal by Subject|2|||
160999708|NCT03808883|581382785|FG001|Overall Study|Withdrawal by Subject|0|||
160999709|NCT03808883|581382784|FG000|Overall Study|Did not complete pre test or post test survey|4|||
160999710|NCT03808883|581382785|FG001|Overall Study|Did not complete pre test or post test survey|3|||
160999711|NCT00855465|581382787|FG000|Treatment Period|Adverse Event|4|||
160999712|NCT00855465|581382788|FG001|Treatment Period|Adverse Event|2|||
160999713|NCT00855465|581382787|FG000|Treatment Period|Death|2|||
160999714|NCT00855465|581382788|FG001|Treatment Period|Death|2|||
160999715|NCT00855465|581382787|FG000|Treatment Period|Lack of Efficacy|2|||
160999716|NCT00855465|581382788|FG001|Treatment Period|Lack of Efficacy|1|||
160999717|NCT00855465|581382787|FG000|Treatment Period|Non-compliance|1|||
160999718|NCT00855465|581382788|FG001|Treatment Period|Non-compliance|0|||
160999719|NCT00855465|581382787|FG000|Treatment Period|Protocol Violation|2|||
160999720|NCT00855465|581382788|FG001|Treatment Period|Protocol Violation|0|||
160999721|NCT00855465|581382787|FG000|Treatment Period|Withdrawal by Subject|2|||
160581112|NCT02144220|579847108|FG000|Overall Study|technology incompatibility|9|||
160581113|NCT02144220|579847108|FG000|Overall Study|Lack of Efficacy|4|||
160581114|NCT02144220|579847108|FG000|Overall Study|Physician Decision|3|||
160581115|NCT02144220|579847108|FG000|Overall Study|Withdrawal by Subject|2|||
160581116|NCT02144220|579847108|FG000|Overall Study|Protocol Violation|1|||
160581117|NCT00443430|579847111|FG000|Overall Study|Lack of Efficacy|3|||
160581118|NCT00443430|579847112|FG001|Overall Study|Lack of Efficacy|3|||
160581119|NCT00443430|579847111|FG000|Overall Study|Adverse Event|1|||
160581120|NCT00443430|579847112|FG001|Overall Study|Adverse Event|1|||
160581121|NCT00592501|579847113|FG000|Overall Study|Withdrawal by Subject|1|||
160581122|NCT00592501|579847113|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
160581123|NCT00053846|579847114|FG000|Overall Study|Changed mind|8|||
160581124|NCT00053846|579847115|FG001|Overall Study|Changed mind|13|||
160581125|NCT00053846|579847114|FG000|Overall Study|Became too ill|8|||
160581126|NCT00053846|579847115|FG001|Overall Study|Became too ill|7|||
160581127|NCT00053846|579847114|FG000|Overall Study|Expired|5|||
160581128|NCT00053846|579847115|FG001|Overall Study|Expired|0|||
160581129|NCT00053846|579847114|FG000|Overall Study|Became ineligible|3|||
160581130|NCT00053846|579847115|FG001|Overall Study|Became ineligible|1|||
160581131|NCT00053846|579847114|FG000|Overall Study|Did not return data|1|||
160581132|NCT00053846|579847115|FG001|Overall Study|Did not return data|2|||
160581133|NCT00053846|579847114|FG000|Overall Study|Quit due to side effects|1|||
160581134|NCT00053846|579847115|FG001|Overall Study|Quit due to side effects|3|||
160581135|NCT00053846|579847114|FG000|Overall Study|Pills too large|0|||
160581136|NCT00053846|579847115|FG001|Overall Study|Pills too large|1|||
160581137|NCT00933335|579847116|FG000|Overall Study|Lost to Follow-up|1|||
160581138|NCT00933335|579847117|FG001|Overall Study|Lost to Follow-up|3|||
160581139|NCT00933335|579847116|FG000|Overall Study|Withdrawal by Subject|0|||
160581140|NCT00933335|579847117|FG001|Overall Study|Withdrawal by Subject|1|||
160581141|NCT00933335|579847116|FG000|Overall Study|Progressive Disease|0|||
160581142|NCT00933335|579847117|FG001|Overall Study|Progressive Disease|11|||
160581143|NCT00933335|579847116|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
160581144|NCT00933335|579847117|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
160581145|NCT00933335|579847116|FG000|Overall Study|Co-morbid Illness|1|||
160581146|NCT00933335|579847117|FG001|Overall Study|Co-morbid Illness|0|||
160581147|NCT02229864|579847118|FG000|Overall Study|Death|2|||
160581148|NCT02229864|579847118|FG000|Overall Study|Lost to Follow-up|1|||
160581149|NCT02650284|579847121|FG000|Overall Study|Lost to Follow-up|3|||
160581150|NCT02650284|579847122|FG001|Overall Study|Lost to Follow-up|3|||
160581151|NCT02650284|579847121|FG000|Overall Study|Consent incorrectly taken|0|||
160581152|NCT02650284|579847122|FG001|Overall Study|Consent incorrectly taken|1|||
160581153|NCT02275026|579847131|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
160581154|NCT02275026|579847131|FG000|Overall Study|Withdrawal by Subject|4|||
160581155|NCT02275026|579847131|FG000|Overall Study|Ineligible due to medical history|13|||
160581156|NCT02275026|579847131|FG000|Overall Study|MRI malfunction precluded testing|1|||
160581157|NCT02275026|579847131|FG000|Overall Study|Ineligible after MRI findings|1|||
160656137|NCT00366899|580122353|FG000|After Infant Series|Withdrawal by Subject|1|||
160656138|NCT00366899|580122354|FG001|After Infant Series|Withdrawal by Subject|4|||
160656139|NCT00366899|580122353|FG000|After Infant Series|Adverse Event|1|||
160581158|NCT02275026|579847131|FG000|Overall Study|Lost to Follow-up|2|||
160656140|NCT00366899|580122354|FG001|After Infant Series|Adverse Event|2|||
160656141|NCT00366899|580122353|FG000|After Infant Series|Protocol Violation|1|||
160656142|NCT00366899|580122354|FG001|After Infant Series|Protocol Violation|0|||
160656143|NCT00366899|580122353|FG000|Toddler Dose|Withdrawal by Subject|1|||
160999722|NCT00855465|581382788|FG001|Treatment Period|Withdrawal by Subject|0|||
160999723|NCT00855465|581382787|FG000|Treatment Period|Not treated|1|||
160581159|NCT02275026|579847131|FG000|Overall Study|Scanner failure|1|||
160581160|NCT00374907|579847132|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
160581161|NCT00374907|579847133|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
160581162|NCT00374907|579847132|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
160999724|NCT00855465|581382788|FG001|Treatment Period|Not treated|0|||
160999725|NCT00855465|581382787|FG000|Follow-up Period (FUP)|Adverse Event|0|||
160999726|NCT00855465|581382788|FG001|Follow-up Period (FUP)|Adverse Event|1|||
160999727|NCT00855465|581382787|FG000|Follow-up Period (FUP)|Death|0|||
160999728|NCT00855465|581382788|FG001|Follow-up Period (FUP)|Death|1|||
160999729|NCT00855465|581382787|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
160999730|NCT00855465|581382788|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
160999731|NCT00855465|581382787|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
160999732|NCT00855465|581382788|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
160999733|NCT00855465|581382787|FG000|Follow-up Period (FUP)|Missing|1|||
160999734|NCT00855465|581382788|FG001|Follow-up Period (FUP)|Missing|0|||
160999735|NCT04173572|581382799|FG000|Overall Study|Withdrawal by Subject|1|||
160999736|NCT04173572|581382800|FG001|Overall Study|Withdrawal by Subject|5|||
160999737|NCT04173572|581382799|FG000|Overall Study|Lost to Follow-up|3|||
160999738|NCT04173572|581382800|FG001|Overall Study|Lost to Follow-up|1|||
160999739|NCT00082810|581382802|FG000|Overall Study|Adverse Event|3|||
160999740|NCT00082810|581382802|FG000|Overall Study|Progressive disease|24|||
160999741|NCT00082810|581382802|FG000|Overall Study|Withdrawal by Subject|4|||
160999742|NCT02341625|581382803|FG000|Overall Study|Disease Progression|2|||
160999743|NCT02341625|581382804|FG001|Overall Study|Disease Progression|2|||
160999744|NCT02341625|581382805|FG002|Overall Study|Disease Progression|3|||
160999745|NCT02341625|581382806|FG003|Overall Study|Disease Progression|6|||
160999746|NCT02341625|581382807|FG004|Overall Study|Disease Progression|7|||
160999747|NCT02341625|581382808|FG005|Overall Study|Disease Progression|7|||
160999748|NCT02341625|581382809|FG006|Overall Study|Disease Progression|28|||
160999749|NCT02341625|581382810|FG007|Overall Study|Disease Progression|5|||
160999750|NCT02341625|581382811|FG008|Overall Study|Disease Progression|4|||
160999751|NCT02341625|581382812|FG009|Overall Study|Disease Progression|19|||
160999752|NCT02341625|581382803|FG000|Overall Study|Study Drug Toxicity|0|||
160999753|NCT02341625|581382804|FG001|Overall Study|Study Drug Toxicity|0|||
160999754|NCT02341625|581382805|FG002|Overall Study|Study Drug Toxicity|0|||
160999755|NCT02341625|581382806|FG003|Overall Study|Study Drug Toxicity|1|||
160999756|NCT02341625|581382807|FG004|Overall Study|Study Drug Toxicity|0|||
160999757|NCT02341625|581382808|FG005|Overall Study|Study Drug Toxicity|3|||
160999758|NCT02341625|581382809|FG006|Overall Study|Study Drug Toxicity|10|||
160999759|NCT02341625|581382810|FG007|Overall Study|Study Drug Toxicity|0|||
160999760|NCT02341625|581382811|FG008|Overall Study|Study Drug Toxicity|0|||
160999761|NCT02341625|581382812|FG009|Overall Study|Study Drug Toxicity|3|||
160999762|NCT02341625|581382803|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999763|NCT02341625|581382804|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999764|NCT02341625|581382805|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999765|NCT02341625|581382806|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999766|NCT02341625|581382807|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999767|NCT02341625|581382808|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999768|NCT02341625|581382809|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
160999769|NCT02341625|581382810|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
160999770|NCT02341625|581382811|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999771|NCT02341625|581382812|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
160999772|NCT02341625|581382803|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999773|NCT02341625|581382804|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999774|NCT02341625|581382805|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999775|NCT02341625|581382806|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999776|NCT02341625|581382807|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999777|NCT02341625|581382808|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999778|NCT02341625|581382809|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
160456233|NCT05285137|579399878|FG006|Overall Study|Pregnancy|1|||
160456234|NCT05285137|579399879|FG007|Overall Study|Pregnancy|0|||
160456235|NCT05285137|579399880|FG008|Overall Study|Pregnancy|0|||
160456236|NCT05285137|579399872|FG000|Overall Study|Withdrawal by Subject|0|||
160456237|NCT05285137|579399873|FG001|Overall Study|Withdrawal by Subject|1|||
160456238|NCT05285137|579399874|FG002|Overall Study|Withdrawal by Subject|2|||
160456239|NCT05285137|579399875|FG003|Overall Study|Withdrawal by Subject|1|||
160456240|NCT05285137|579399876|FG004|Overall Study|Withdrawal by Subject|0|||
160456241|NCT05285137|579399877|FG005|Overall Study|Withdrawal by Subject|0|||
160456242|NCT05285137|579399878|FG006|Overall Study|Withdrawal by Subject|0|||
160456243|NCT05285137|579399879|FG007|Overall Study|Withdrawal by Subject|0|||
160456244|NCT05285137|579399880|FG008|Overall Study|Withdrawal by Subject|1|||
160456245|NCT05209152|579399881|FG000|Overall Study|Sponsor decision|1|||
160456246|NCT05209152|579399882|FG001|Overall Study|Sponsor decision|2|||
160456247|NCT05209152|579399881|FG000|Overall Study|Death|3|||
160456248|NCT05209152|579399882|FG001|Overall Study|Death|1|||
160999779|NCT02341625|581382810|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
160999780|NCT02341625|581382811|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999781|NCT02341625|581382812|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160581163|NCT00374907|579847133|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
160581164|NCT00374907|579847132|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
160581165|NCT00374907|579847133|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
160581166|NCT00374907|579847132|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
160581167|NCT00374907|579847133|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
160581168|NCT00374907|579847132|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
160581169|NCT00374907|579847133|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
160581170|NCT00878072|579847135|FG000|Overall Study|Withdrew consent|2|||
160581171|NCT01200511|579847144|FG000|Overall Study|Lost to Follow-up|3|||
160581172|NCT01200511|579847144|FG000|Overall Study|Withdrawal by Subject|1|||
160581173|NCT01200511|579847144|FG000|Overall Study|Adverse Event|1|||
160581174|NCT00540449|579847150|FG000|Overall Study|Adverse Event|12|||
160581175|NCT00540449|579847151|FG001|Overall Study|Adverse Event|32|||
160581176|NCT00540449|579847150|FG000|Overall Study|Sponsor's Decision|1|||
160581177|NCT00540449|579847151|FG001|Overall Study|Sponsor's Decision|1|||
160581178|NCT00540449|579847150|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
160581179|NCT00540449|579847151|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
160581180|NCT00540449|579847150|FG000|Overall Study|Lost to Follow-up|19|||
160581181|NCT00540449|579847151|FG001|Overall Study|Lost to Follow-up|17|||
160581182|NCT00540449|579847150|FG000|Overall Study|Subject Non-Compliant|7|||
160581183|NCT00540449|579847151|FG001|Overall Study|Subject Non-Compliant|5|||
160581184|NCT00540449|579847150|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
160581185|NCT00540449|579847151|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
160581186|NCT00540449|579847150|FG000|Overall Study|Withdrawal by Subject|10|||
160581187|NCT00540449|579847151|FG001|Overall Study|Withdrawal by Subject|10|||
160581188|NCT00540449|579847150|FG000|Overall Study|Other|1|||
160581189|NCT00540449|579847151|FG001|Overall Study|Other|4|||
160581190|NCT00237796|579847152|FG000|Overall Study|Baseline and one other ILSS required|10|||
160581191|NCT00237796|579847153|FG001|Overall Study|Baseline and one other ILSS required|5|||
160581192|NCT00337467|579847154|FG000|Overall Study|Adverse Event|3|||
160581193|NCT00337467|579847154|FG000|Overall Study|Subject Withdrew Consent|2|||
160581194|NCT00337467|579847154|FG000|Overall Study|Pregnancy|1|||
160581195|NCT00337467|579847154|FG000|Overall Study|Lost to Follow-up|2|||
160581196|NCT00337467|579847154|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
160581197|NCT03141086|579847155|FG000|Overall Study|Study Terminated By Sponsor|1|||
160581198|NCT03141086|579847156|FG001|Overall Study|Study Terminated By Sponsor|1|||
160581199|NCT03141086|579847155|FG000|Overall Study|Withdrawal by Subject|0|||
160581200|NCT03141086|579847156|FG001|Overall Study|Withdrawal by Subject|1|||
160581201|NCT03141086|579847155|FG000|Overall Study|Protocol Violation|0|||
160581202|NCT03141086|579847156|FG001|Overall Study|Protocol Violation|1|||
160581203|NCT03141086|579847155|FG000|Overall Study|Adverse Event|0|||
160581204|NCT03141086|579847156|FG001|Overall Study|Adverse Event|2|||
160581205|NCT05128162|579847157|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
160581206|NCT05128162|579847157|FG000|Overall Study|Physician Decision|1|||
160581207|NCT04920084|579848417|FG000|Overall Study|Adverse Event|1|||
160581208|NCT04920084|579848417|FG000|Overall Study|Lost to Follow-up|2|||
160581209|NCT04920084|579848417|FG000|Overall Study|Withdrawal by Subject|2|||
160581210|NCT01096446|579848418|FG000|Overall Study|Death|1|||
160581211|NCT01096446|579848419|FG001|Overall Study|Death|0|||
160581212|NCT01096446|579848418|FG000|Overall Study|Protocol Violation|2|||
160581213|NCT01096446|579848419|FG001|Overall Study|Protocol Violation|0|||
160581214|NCT02279524|579848420|FG000|Overall Study|Withdrawal by Subject|3|||
160581215|NCT02279524|579848421|FG001|Overall Study|Withdrawal by Subject|6|||
160581216|NCT02279524|579848422|FG002|Overall Study|Withdrawal by Subject|3|||
160581217|NCT02279524|579848420|FG000|Overall Study|Adverse Event|4|||
160581218|NCT02279524|579848421|FG001|Overall Study|Adverse Event|3|||
160581219|NCT02279524|579848422|FG002|Overall Study|Adverse Event|2|||
160581220|NCT02279524|579848420|FG000|Overall Study|Lost to Follow-up|1|||
160947995|NCT01227889|581198358|FG001|Crossover Phase|Adverse Event|1|||
160947996|NCT01227889|581198357|FG000|Crossover Phase|Physician Decision|0|||
160581221|NCT02279524|579848421|FG001|Overall Study|Lost to Follow-up|1|||
160581222|NCT02279524|579848422|FG002|Overall Study|Lost to Follow-up|0|||
160581223|NCT02279524|579848420|FG000|Overall Study|Disallowed medication|1|||
160947997|NCT01227889|581198358|FG001|Crossover Phase|Physician Decision|3|||
160947998|NCT01227889|581198357|FG000|Crossover Phase|Progressive Disease|0|||
160947999|NCT01227889|581198358|FG001|Crossover Phase|Progressive Disease|31|||
160581224|NCT02279524|579848421|FG001|Overall Study|Disallowed medication|1|||
160581225|NCT02279524|579848422|FG002|Overall Study|Disallowed medication|2|||
160581226|NCT02279524|579848420|FG000|Overall Study|Bariatric surgery|1|||
160581227|NCT02279524|579848421|FG001|Overall Study|Bariatric surgery|0|||
160581228|NCT02279524|579848422|FG002|Overall Study|Bariatric surgery|0|||
160581229|NCT03488472|579848425|FG000|Overall Study|disease progression additional mets|1|||
160948000|NCT01227889|581198357|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
160581230|NCT00028002|579848426|FG000|Overall Study|Withdrawal by Subject|3|||
160581231|NCT00028002|579848426|FG000|Overall Study|Ineligible|8|||
160581232|NCT01881620|579848429|FG000|Overall Study|Protocol Violation|4|||
160999782|NCT02341625|581382803|FG000|Overall Study|Participant Withdrew Consent|0|||
160999783|NCT02341625|581382804|FG001|Overall Study|Participant Withdrew Consent|0|||
160999784|NCT02341625|581382805|FG002|Overall Study|Participant Withdrew Consent|0|||
160999785|NCT02341625|581382806|FG003|Overall Study|Participant Withdrew Consent|1|||
160999786|NCT02341625|581382807|FG004|Overall Study|Participant Withdrew Consent|0|||
160999787|NCT02341625|581382808|FG005|Overall Study|Participant Withdrew Consent|0|||
160999788|NCT02341625|581382809|FG006|Overall Study|Participant Withdrew Consent|0|||
160999789|NCT02341625|581382810|FG007|Overall Study|Participant Withdrew Consent|0|||
160999790|NCT02341625|581382811|FG008|Overall Study|Participant Withdrew Consent|0|||
160999791|NCT02341625|581382812|FG009|Overall Study|Participant Withdrew Consent|0|||
160581233|NCT04467164|579848431|FG000|Washout (1 Week)|Lost to Follow-up|2|||
160581234|NCT04467164|579848432|FG001|Washout (1 Week)|Lost to Follow-up|0|||
160581235|NCT00879814|579848433|FG000|Overall Study|Adverse Event|0|||
160581236|NCT00879814|579848434|FG001|Overall Study|Adverse Event|1|||
160581237|NCT00879814|579848435|FG002|Overall Study|Adverse Event|0|||
160581238|NCT00879814|579848436|FG003|Overall Study|Adverse Event|0|||
160581239|NCT00879814|579848433|FG000|Overall Study|Lost to Follow-up|1|||
160581240|NCT00879814|579848434|FG001|Overall Study|Lost to Follow-up|0|||
160581241|NCT00879814|579848435|FG002|Overall Study|Lost to Follow-up|0|||
160581242|NCT00879814|579848436|FG003|Overall Study|Lost to Follow-up|2|||
160581243|NCT00879814|579848433|FG000|Overall Study|Participant Failed to Return|0|||
160581244|NCT00879814|579848434|FG001|Overall Study|Participant Failed to Return|0|||
160581245|NCT00879814|579848435|FG002|Overall Study|Participant Failed to Return|0|||
160581246|NCT00879814|579848436|FG003|Overall Study|Participant Failed to Return|1|||
160581247|NCT00879814|579848433|FG000|Overall Study|Withdrawal by Subject|3|||
160581248|NCT00879814|579848434|FG001|Overall Study|Withdrawal by Subject|1|||
160581249|NCT00879814|579848435|FG002|Overall Study|Withdrawal by Subject|1|||
160581250|NCT00879814|579848436|FG003|Overall Study|Withdrawal by Subject|2|||
160581251|NCT00879814|579848433|FG000|Overall Study|Physician Decision|0|||
160581252|NCT00879814|579848434|FG001|Overall Study|Physician Decision|0|||
160581253|NCT00879814|579848435|FG002|Overall Study|Physician Decision|1|||
160581254|NCT00879814|579848436|FG003|Overall Study|Physician Decision|0|||
160581255|NCT00879814|579848433|FG000|Overall Study|Other|0|||
160581256|NCT00879814|579848434|FG001|Overall Study|Other|0|||
160581257|NCT00879814|579848435|FG002|Overall Study|Other|1|||
160581258|NCT00879814|579848436|FG003|Overall Study|Other|0|||
160581259|NCT00630812|579848437|FG000|Randomisation to First Dose|Adverse Event|1|||
160581260|NCT00630812|579848438|FG001|Randomisation to First Dose|Adverse Event|1|||
160581261|NCT00630812|579848437|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
160581262|NCT00630812|579848438|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
160581263|NCT00630812|579848437|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
160581264|NCT00630812|579848438|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
160581265|NCT00630812|579848437|FG000|Randomisation to First Dose|Protocol Violation|4|||
160581266|NCT00630812|579848438|FG001|Randomisation to First Dose|Protocol Violation|1|||
160581267|NCT00630812|579848437|FG000|Double Blind Treatment Period|Adverse Event|13|||
160581268|NCT00630812|579848438|FG001|Double Blind Treatment Period|Adverse Event|5|||
160581269|NCT00630812|579848437|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
160581270|NCT00630812|579848438|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
160581271|NCT00630812|579848437|FG000|Double Blind Treatment Period|Physician Decision|2|||
160581272|NCT00630812|579848438|FG001|Double Blind Treatment Period|Physician Decision|1|||
160581273|NCT00630812|579848437|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160581274|NCT00630812|579848438|FG001|Double Blind Treatment Period|Protocol Violation|0|||
160581275|NCT00630812|579848437|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
160581276|NCT00630812|579848438|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
160581277|NCT00630812|579848437|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
160581278|NCT00630812|579848438|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
160999792|NCT02341625|581382803|FG000|Overall Study|Completed Treatment as per Protocol|0|||
160581279|NCT00630812|579848437|FG000|Double Blind Treatment Period|Non-compliance|0|||
160581280|NCT00630812|579848438|FG001|Double Blind Treatment Period|Non-compliance|1|||
160581281|NCT00972478|579848439|FG000|Overall Study|Adverse Event|3|||
160581282|NCT00972478|579848440|FG001|Overall Study|Adverse Event|16|||
160581283|NCT00972478|579848439|FG000|Overall Study|Withdrawal by Subject|1|||
160581284|NCT00972478|579848440|FG001|Overall Study|Withdrawal by Subject|8|||
160999793|NCT02341625|581382804|FG001|Overall Study|Completed Treatment as per Protocol|0|||
160999794|NCT02341625|581382805|FG002|Overall Study|Completed Treatment as per Protocol|0|||
160999795|NCT02341625|581382806|FG003|Overall Study|Completed Treatment as per Protocol|0|||
160999796|NCT02341625|581382807|FG004|Overall Study|Completed Treatment as per Protocol|0|||
160999797|NCT02341625|581382808|FG005|Overall Study|Completed Treatment as per Protocol|0|||
160581285|NCT00972478|579848439|FG000|Overall Study|Progression/Relapse|0|||
160581286|NCT00972478|579848440|FG001|Overall Study|Progression/Relapse|2|||
160581287|NCT00972478|579848439|FG000|Overall Study|Death|0|||
160656144|NCT00366899|580122354|FG001|Toddler Dose|Withdrawal by Subject|1|||
160656145|NCT00366899|580122353|FG000|Toddler Dose|Protocol Violation|1|||
160581288|NCT00972478|579848440|FG001|Overall Study|Death|2|||
160948001|NCT01227889|581198358|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
160948002|NCT01227889|581198357|FG000|Crossover Phase|Withdrawal by Subject|0|||
160948003|NCT01227889|581198358|FG001|Crossover Phase|Withdrawal by Subject|1|||
160948004|NCT01148810|581198361|FG000|Overall Study|Adverse Event|0|||
160456249|NCT03221426|579399885|FG000|Overall Study|Ongoing in study|212|||
160456250|NCT03221426|579399886|FG001|Overall Study|Ongoing in study|193|||
160456251|NCT03221426|579399887|FG002|Overall Study|Ongoing in study|61|||
160948005|NCT01148810|581198362|FG001|Overall Study|Adverse Event|2|||
160948006|NCT01148810|581198361|FG000|Overall Study|Lack of Efficacy|0|||
160948007|NCT01148810|581198362|FG001|Overall Study|Lack of Efficacy|1|||
160948008|NCT01148810|581198361|FG000|Overall Study|Withdrawal by Subject|0|||
160948009|NCT01148810|581198362|FG001|Overall Study|Withdrawal by Subject|2|||
160948010|NCT01148810|581198361|FG000|Overall Study|Protocol Violation|1|||
160948011|NCT01148810|581198362|FG001|Overall Study|Protocol Violation|0|||
160948012|NCT02731131|581198369|FG000|Overall Study|Psychiatric Disorder|0|||
160948013|NCT02731131|581198370|FG001|Overall Study|Psychiatric Disorder|1|||
160948014|NCT02731131|581198369|FG000|Overall Study|Refused Therapy|0|||
160948015|NCT02731131|581198370|FG001|Overall Study|Refused Therapy|1|||
160948016|NCT02348216|581198376|FG000|Overall Study|Death|5|||
160948017|NCT02348216|581198377|FG001|Overall Study|Death|53|||
160948018|NCT02348216|581198378|FG002|Overall Study|Death|11|||
160948019|NCT02348216|581198379|FG003|Overall Study|Death|20|||
160948020|NCT02348216|581198380|FG004|Overall Study|Death|16|||
160948021|NCT02348216|581198381|FG005|Overall Study|Death|32|||
160948022|NCT02348216|581198382|FG006|Overall Study|Death|17|||
160948023|NCT02348216|581198376|FG000|Overall Study|Full consent withdrawal|0|||
160948024|NCT02348216|581198377|FG001|Overall Study|Full consent withdrawal|0|||
160948025|NCT02348216|581198378|FG002|Overall Study|Full consent withdrawal|0|||
160948026|NCT02348216|581198379|FG003|Overall Study|Full consent withdrawal|1|||
160948027|NCT02348216|581198380|FG004|Overall Study|Full consent withdrawal|3|||
160948028|NCT02348216|581198381|FG005|Overall Study|Full consent withdrawal|0|||
160948029|NCT02348216|581198382|FG006|Overall Study|Full consent withdrawal|3|||
160948030|NCT02348216|581198376|FG000|Overall Study|Lost to Follow-up|0|||
160948031|NCT02348216|581198377|FG001|Overall Study|Lost to Follow-up|5|||
160948032|NCT02348216|581198378|FG002|Overall Study|Lost to Follow-up|2|||
160948033|NCT02348216|581198379|FG003|Overall Study|Lost to Follow-up|0|||
160948034|NCT02348216|581198380|FG004|Overall Study|Lost to Follow-up|1|||
160948035|NCT02348216|581198381|FG005|Overall Study|Lost to Follow-up|1|||
160948036|NCT02348216|581198382|FG006|Overall Study|Lost to Follow-up|1|||
160948037|NCT02348216|581198376|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
160948038|NCT02348216|581198377|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
160948039|NCT02348216|581198378|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
160948040|NCT02348216|581198379|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
160948041|NCT02348216|581198380|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
160948042|NCT02348216|581198381|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
160456252|NCT03221426|579399888|FG003|Overall Study|Ongoing in study|55|||
160456253|NCT03221426|579399885|FG000|Overall Study|Withdrawal by Subject|12|||
160456254|NCT03221426|579399886|FG001|Overall Study|Withdrawal by Subject|4|||
160456255|NCT03221426|579399887|FG002|Overall Study|Withdrawal by Subject|2|||
160456256|NCT03221426|579399888|FG003|Overall Study|Withdrawal by Subject|3|||
160456257|NCT03221426|579399885|FG000|Overall Study|Lost to Follow-up|4|||
160456258|NCT03221426|579399886|FG001|Overall Study|Lost to Follow-up|1|||
160456259|NCT03221426|579399887|FG002|Overall Study|Lost to Follow-up|1|||
160456260|NCT03221426|579399888|FG003|Overall Study|Lost to Follow-up|0|||
160456261|NCT03221426|579399885|FG000|Overall Study|Death|174|||
160456262|NCT03221426|579399886|FG001|Overall Study|Death|204|||
160581289|NCT00972478|579848439|FG000|Overall Study|Not protocol specified|1|||
160581290|NCT00972478|579848440|FG001|Overall Study|Not protocol specified|1|||
160948043|NCT02348216|581198382|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
160948044|NCT02348216|581198376|FG000|Overall Study|Reason not specified|2|||
160948045|NCT02348216|581198377|FG001|Overall Study|Reason not specified|19|||
160948046|NCT02348216|581198378|FG002|Overall Study|Reason not specified|11|||
160948047|NCT02348216|581198379|FG003|Overall Study|Reason not specified|17|||
160948048|NCT02348216|581198380|FG004|Overall Study|Reason not specified|21|||
160456263|NCT03221426|579399887|FG002|Overall Study|Death|36|||
160456264|NCT03221426|579399888|FG003|Overall Study|Death|45|||
160456265|NCT05809453|579401375|FG000|Overall Study|Withdrawal by Subject|1|||
160456266|NCT05809453|579401376|FG001|Overall Study|Withdrawal by Subject|0|||
160456267|NCT05809453|579401377|FG002|Overall Study|Withdrawal by Subject|0|||
160581291|NCT00972478|579848439|FG000|Overall Study|Ineligible|1|||
160948049|NCT02348216|581198381|FG005|Overall Study|Reason not specified|17|||
160948050|NCT02348216|581198382|FG006|Overall Study|Reason not specified|19|||
160456268|NCT05809453|579401378|FG003|Overall Study|Withdrawal by Subject|0|||
160456269|NCT03220035|579401381|FG000|Overall Study|Adverse Event|1|||
160456270|NCT03220035|579401381|FG000|Overall Study|Protocol Violation|1|||
160456271|NCT03220035|579401381|FG000|Overall Study|Progressive Disease|2|||
160581292|NCT00972478|579848440|FG001|Overall Study|Ineligible|7|||
160456272|NCT04850898|579401382|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
160456273|NCT04850898|579401383|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
160456274|NCT04550221|579401384|FG000|Overall Study|Lost to Follow-up|0|||
160456275|NCT04550221|579401385|FG001|Overall Study|Lost to Follow-up|4|||
160456276|NCT04550221|579401384|FG000|Overall Study|Withdrawn|3|||
160456277|NCT04550221|579401385|FG001|Overall Study|Withdrawn|0|||
160456278|NCT04550221|579401384|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
160456279|NCT04550221|579401385|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
160456280|NCT05452460|579401386|FG000|Overall Study|Lost to Follow-up|3|||
160948051|NCT01055639|581198383|FG000|Overall Study|Adverse Event|0|||
160948052|NCT01055639|581198384|FG001|Overall Study|Adverse Event|1|||
160948053|NCT01055639|581198383|FG000|Overall Study|Lack of Efficacy|0|||
160948054|NCT01055639|581198384|FG001|Overall Study|Lack of Efficacy|1|||
160948055|NCT01055639|581198383|FG000|Overall Study|Lost to Follow-up|8|||
160948056|NCT01055639|581198384|FG001|Overall Study|Lost to Follow-up|11|||
160948057|NCT01055639|581198383|FG000|Overall Study|Protocol Violation|5|||
160948058|NCT01055639|581198384|FG001|Overall Study|Protocol Violation|5|||
160948059|NCT01055639|581198383|FG000|Overall Study|Withdrawal by Subject|8|||
160948060|NCT01055639|581198384|FG001|Overall Study|Withdrawal by Subject|11|||
160948061|NCT00765245|581198385|FG000|Overall Study|disease progression|3|||
160948062|NCT00765245|581198386|FG001|Overall Study|disease progression|2|||
160948063|NCT00765245|581198385|FG000|Overall Study|Withdrawal by Subject|3|||
160456281|NCT05452460|579401387|FG001|Overall Study|Lost to Follow-up|3|||
160456282|NCT05452460|579401386|FG000|Overall Study|Did not receive intervention|1|||
160456283|NCT05452460|579401387|FG001|Overall Study|Did not receive intervention|0|||
160456284|NCT04447040|579401388|FG000|Overall Study|Lost to Follow-up|2|||
160456285|NCT04447040|579401389|FG001|Overall Study|Lost to Follow-up|1|||
160456286|NCT04447040|579401390|FG002|Overall Study|Lost to Follow-up|3|||
160948064|NCT00765245|581198386|FG001|Overall Study|Withdrawal by Subject|0|||
160948065|NCT00765245|581198385|FG000|Overall Study|Adverse Event|5|||
160948066|NCT00765245|581198386|FG001|Overall Study|Adverse Event|0|||
160948067|NCT00765245|581198385|FG000|Overall Study|Physician Decision|1|||
160948068|NCT00765245|581198386|FG001|Overall Study|Physician Decision|0|||
160948069|NCT00765245|581198385|FG000|Overall Study|Death|1|||
160948070|NCT00765245|581198386|FG001|Overall Study|Death|0|||
160948071|NCT02079805|581198388|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160948072|NCT02079805|581198389|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
160948073|NCT02079805|581198388|FG000|Overall Study|Voluntary Withdrawal|0|||
160948074|NCT02079805|581198389|FG001|Overall Study|Voluntary Withdrawal|1|||
160948075|NCT01753193|581198390|FG000|Overall Study|Withdrawal by Subject|23|||
160948076|NCT01753193|581198390|FG000|Overall Study|Lost to Follow-up|6|||
160948077|NCT01753193|581198390|FG000|Overall Study|Death|1|||
160948078|NCT01753193|581198390|FG000|Overall Study|Other|16|||
160948079|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
160948080|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
160948081|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
160948082|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
160948083|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
160948084|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
160948085|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
160948086|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
160948087|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
160948088|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
160948089|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
160948090|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
160948091|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
160948092|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
160948093|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
160456287|NCT04447040|579401391|FG003|Overall Study|Lost to Follow-up|3|||
160948094|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
160948095|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
160948096|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
160948097|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
160948098|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
160948099|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
160948100|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
160456288|NCT04447040|579401392|FG004|Overall Study|Lost to Follow-up|1|||
160456289|NCT04447040|579401393|FG005|Overall Study|Lost to Follow-up|3|||
160456290|NCT04447040|579401388|FG000|Overall Study|Withdrawal by Subject|0|||
160456291|NCT04447040|579401389|FG001|Overall Study|Withdrawal by Subject|1|||
160456292|NCT04447040|579401390|FG002|Overall Study|Withdrawal by Subject|1|||
160456293|NCT04447040|579401391|FG003|Overall Study|Withdrawal by Subject|1|||
160581293|NCT00972478|579848439|FG000|Overall Study|Not start protocol treatment|1|||
160581294|NCT00972478|579848440|FG001|Overall Study|Not start protocol treatment|2|||
160581295|NCT02561000|579848441|FG000|Overall Study|Withdrawal by Subject|2|||
160581296|NCT02561000|579848442|FG001|Overall Study|Withdrawal by Subject|3|||
160581297|NCT02561000|579848443|FG002|Overall Study|Withdrawal by Subject|0|||
160581298|NCT02561000|579848441|FG000|Overall Study|Adverse Event|0|||
160581299|NCT02561000|579848442|FG001|Overall Study|Adverse Event|1|||
160581300|NCT02561000|579848443|FG002|Overall Study|Adverse Event|0|||
160581301|NCT03430245|579848444|FG000|Overall Study|Withdrawal by Subject|6|||
160581302|NCT03430245|579848444|FG000|Overall Study|Lost to Follow-up|1|||
160581303|NCT04742907|579848451|FG000|Overall Study|Adverse Event|1|||
160581304|NCT04742907|579848452|FG001|Overall Study|Adverse Event|0|||
160581305|NCT04742907|579848453|FG002|Overall Study|Adverse Event|1|||
160581306|NCT04742907|579848451|FG000|Overall Study|Lost to Follow-up|3|||
160581307|NCT04742907|579848452|FG001|Overall Study|Lost to Follow-up|3|||
160581308|NCT04742907|579848453|FG002|Overall Study|Lost to Follow-up|2|||
160581309|NCT04742907|579848451|FG000|Overall Study|Physician Decision|0|||
160581310|NCT04742907|579848452|FG001|Overall Study|Physician Decision|1|||
160581311|NCT04742907|579848453|FG002|Overall Study|Physician Decision|0|||
160581312|NCT04742907|579848451|FG000|Overall Study|Protocol Violation|1|||
160581313|NCT04742907|579848452|FG001|Overall Study|Protocol Violation|1|||
160581314|NCT04742907|579848453|FG002|Overall Study|Protocol Violation|1|||
160581315|NCT04742907|579848451|FG000|Overall Study|Withdrawal by Subject|5|||
160581316|NCT04742907|579848452|FG001|Overall Study|Withdrawal by Subject|6|||
160581317|NCT04742907|579848453|FG002|Overall Study|Withdrawal by Subject|4|||
160581318|NCT04742907|579848451|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
160581319|NCT04742907|579848452|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
160581320|NCT04742907|579848453|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
160948101|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
160948102|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
160948103|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
160948104|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
160948105|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
160948106|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
160948107|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
160948108|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
160948109|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
160948110|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
160948111|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
160948112|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
160948113|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
160948114|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
160948115|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
160948116|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
160948117|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
160948118|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
160948119|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
160948120|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
160948121|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
160948122|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
160948123|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
160948124|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
160948125|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
160948126|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
160948127|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
160581321|NCT04742907|579848451|FG000|Overall Study|Did Not Receive the Study Drug|2|||
160948128|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
160948129|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
160581322|NCT04742907|579848452|FG001|Overall Study|Did Not Receive the Study Drug|4|||
160581323|NCT04742907|579848453|FG002|Overall Study|Did Not Receive the Study Drug|4|||
160656146|NCT00366899|580122354|FG001|Toddler Dose|Protocol Violation|0|||
160948130|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
160948131|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
160948132|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
160948133|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
160948134|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
160948135|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
160948136|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
160948137|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
160948138|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
160948139|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
160948140|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
160948141|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
160948142|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
160948143|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
160948144|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
160948145|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
160948146|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
160948147|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
160948148|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
160948149|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
160948150|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
160948151|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
160948152|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
160948153|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
160948154|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Administrative|1|||
160948155|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Administrative|1|||
160948156|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Administrative|0|||
160948157|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Administrative|1|||
160948158|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Administrative|0|||
160948159|NCT00583557|581198396|FG000|Overall Study|Withdrawal by Subject|18|||
160948160|NCT00583557|581198396|FG000|Overall Study|Adverse Event|9|||
160948161|NCT00583557|581198396|FG000|Overall Study|Lack of Efficacy|31|||
160948162|NCT00583557|581198396|FG000|Overall Study|Lack of Compliance|5|||
160948163|NCT00583557|581198396|FG000|Overall Study|Other|5|||
160948164|NCT00583557|581198396|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
160948165|NCT01131312|581198397|FG000|Overall Study|Lost to Follow-up|425|||
160948166|NCT01131312|581198398|FG001|Overall Study|Lost to Follow-up|229|||
160948167|NCT01131312|581198399|FG002|Overall Study|Lost to Follow-up|351|||
160948168|NCT02347761|581198400|FG000|All Collected|Death|1|||
160948169|NCT02347761|581198401|FG001|All Collected|Death|0|||
160948170|NCT02347761|581198402|FG002|All Collected|Death|0|||
160948171|NCT02347761|581198400|FG000|All Collected|Lost to Follow-up|3|||
160948172|NCT02347761|581198401|FG001|All Collected|Lost to Follow-up|2|||
160948173|NCT02347761|581198402|FG002|All Collected|Lost to Follow-up|3|||
160948174|NCT02347761|581198400|FG000|All Collected|Withdrawal by Subject|11|||
160948175|NCT02347761|581198401|FG001|All Collected|Withdrawal by Subject|11|||
160948176|NCT02347761|581198402|FG002|All Collected|Withdrawal by Subject|22|||
160948177|NCT02347761|581198400|FG000|All Collected|invetigator disretion|2|||
160948178|NCT02347761|581198401|FG001|All Collected|invetigator disretion|0|||
160948179|NCT02347761|581198402|FG002|All Collected|invetigator disretion|0|||
160948180|NCT02347761|581198400|FG000|All Collected|instillation site pain|0|||
160948181|NCT02347761|581198401|FG001|All Collected|instillation site pain|0|||
160948182|NCT02347761|581198402|FG002|All Collected|instillation site pain|1|||
160948183|NCT02347761|581198400|FG000|All Collected|exacerbation of COPD|0|||
160948184|NCT02347761|581198401|FG001|All Collected|exacerbation of COPD|0|||
160948185|NCT02347761|581198402|FG002|All Collected|exacerbation of COPD|1|||
160948186|NCT02347761|581198400|FG000|All Collected|moved/travel|0|||
160948187|NCT02347761|581198401|FG001|All Collected|moved/travel|1|||
160948188|NCT02347761|581198402|FG002|All Collected|moved/travel|0|||
160948189|NCT02347761|581198400|FG000|On Study Treatment|Lack of Efficacy|2|||
160948190|NCT02347761|581198401|FG001|On Study Treatment|Lack of Efficacy|3|||
160948191|NCT02347761|581198402|FG002|On Study Treatment|Lack of Efficacy|4|||
160948192|NCT02347761|581198400|FG000|On Study Treatment|non-compliance with study medication|0|||
160948193|NCT02347761|581198401|FG001|On Study Treatment|non-compliance with study medication|0|||
160948194|NCT02347761|581198402|FG002|On Study Treatment|non-compliance with study medication|2|||
160948195|NCT02347761|581198400|FG000|On Study Treatment|Withdrawal by Subject|7|||
160948196|NCT02347761|581198401|FG001|On Study Treatment|Withdrawal by Subject|3|||
160948197|NCT02347761|581198402|FG002|On Study Treatment|Withdrawal by Subject|5|||
160948198|NCT02347761|581198400|FG000|On Study Treatment|move/travel|2|||
160948199|NCT02347761|581198401|FG001|On Study Treatment|move/travel|6|||
160999798|NCT02341625|581382809|FG006|Overall Study|Completed Treatment as per Protocol|0|||
160948200|NCT02347761|581198402|FG002|On Study Treatment|move/travel|5|||
160948201|NCT02347761|581198400|FG000|On Study Treatment|dissastisfaction with device|2|||
160948202|NCT02347761|581198401|FG001|On Study Treatment|dissastisfaction with device|1|||
160948203|NCT02347761|581198402|FG002|On Study Treatment|dissastisfaction with device|4|||
160948204|NCT02347761|581198400|FG000|On Study Treatment|Lost to Follow-up|2|||
160948205|NCT02347761|581198401|FG001|On Study Treatment|Lost to Follow-up|1|||
160948206|NCT02347761|581198402|FG002|On Study Treatment|Lost to Follow-up|1|||
160948207|NCT02347761|581198400|FG000|On Study Treatment|investigator discretion|2|||
160948208|NCT02347761|581198401|FG001|On Study Treatment|investigator discretion|0|||
160948209|NCT02347761|581198402|FG002|On Study Treatment|investigator discretion|0|||
160948210|NCT02347761|581198400|FG000|On Study Treatment|durg not working|0|||
160948211|NCT02347761|581198401|FG001|On Study Treatment|durg not working|1|||
160948212|NCT02347761|581198402|FG002|On Study Treatment|durg not working|1|||
160948213|NCT02347761|581198400|FG000|On Study Treatment|Adverse Event|10|||
160948214|NCT02347761|581198401|FG001|On Study Treatment|Adverse Event|8|||
160948215|NCT02347761|581198402|FG002|On Study Treatment|Adverse Event|20|||
160999799|NCT02341625|581382810|FG007|Overall Study|Completed Treatment as per Protocol|0|||
160581324|NCT01428063|579848454|FG000|Overall Study|Lack of Efficacy|8|||
160581325|NCT01428063|579848455|FG001|Overall Study|Lack of Efficacy|4|||
160581326|NCT01428063|579848456|FG002|Overall Study|Lack of Efficacy|1|||
160581327|NCT01428063|579848454|FG000|Overall Study|Adverse Event|2|||
160581328|NCT01428063|579848455|FG001|Overall Study|Adverse Event|3|||
160581329|NCT01428063|579848456|FG002|Overall Study|Adverse Event|0|||
160581330|NCT01428063|579848454|FG000|Overall Study|Lost to Follow-up|0|||
160581331|NCT01428063|579848455|FG001|Overall Study|Lost to Follow-up|2|||
160581332|NCT01428063|579848456|FG002|Overall Study|Lost to Follow-up|0|||
160581333|NCT01428063|579848454|FG000|Overall Study|No longer meets study criteria|0|||
160581334|NCT01428063|579848455|FG001|Overall Study|No longer meets study criteria|1|||
160581335|NCT01428063|579848456|FG002|Overall Study|No longer meets study criteria|0|||
160581336|NCT05761444|579848457|FG000|Overall Study|Protocol Violation|2|||
160581337|NCT05761444|579848458|FG001|Overall Study|Protocol Violation|1|||
160581338|NCT05761444|579848457|FG000|Overall Study|Adverse Event|2|||
160581339|NCT05761444|579848458|FG001|Overall Study|Adverse Event|2|||
160581340|NCT05761444|579848457|FG000|Overall Study|Withdrawal by Subject|3|||
160581341|NCT05761444|579848458|FG001|Overall Study|Withdrawal by Subject|2|||
160581342|NCT05761444|579848457|FG000|Overall Study|Other|1|||
160581343|NCT05761444|579848458|FG001|Overall Study|Other|0|||
160581344|NCT03196505|579848461|FG000|Overall Study|Physician Decision|26|||
160581345|NCT03196505|579848462|FG001|Overall Study|Physician Decision|26|||
160581346|NCT00578864|579848463|FG000|Overall Study|Death|1|||
160581347|NCT00578864|579848464|FG001|Overall Study|Death|0|||
160581348|NCT04590937|579848476|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
160581349|NCT01544595|579848477|FG000|Status at Week 68|Adverse Event|3|||
160581350|NCT01544595|579848478|FG001|Status at Week 68|Adverse Event|2|||
160581351|NCT01544595|579848479|FG002|Status at Week 68|Adverse Event|1|||
160581352|NCT01544595|579848480|FG003|Status at Week 68|Adverse Event|0|||
160581353|NCT01544595|579848481|FG004|Status at Week 68|Adverse Event|0|||
160581354|NCT01544595|579848482|FG005|Status at Week 68|Adverse Event|0|||
160581355|NCT01544595|579848477|FG000|Status at Week 68|Lack of Efficacy|1|||
160581356|NCT01544595|579848478|FG001|Status at Week 68|Lack of Efficacy|0|||
160581357|NCT01544595|579848479|FG002|Status at Week 68|Lack of Efficacy|0|||
160581358|NCT01544595|579848480|FG003|Status at Week 68|Lack of Efficacy|0|||
160581359|NCT01544595|579848481|FG004|Status at Week 68|Lack of Efficacy|0|||
160581360|NCT01544595|579848482|FG005|Status at Week 68|Lack of Efficacy|0|||
160581361|NCT01544595|579848477|FG000|Status at Week 68|Lost to Follow-up|1|||
160581362|NCT01544595|579848478|FG001|Status at Week 68|Lost to Follow-up|1|||
160581363|NCT01544595|579848479|FG002|Status at Week 68|Lost to Follow-up|0|||
160581364|NCT01544595|579848480|FG003|Status at Week 68|Lost to Follow-up|0|||
160581365|NCT01544595|579848481|FG004|Status at Week 68|Lost to Follow-up|0|||
160581366|NCT01544595|579848482|FG005|Status at Week 68|Lost to Follow-up|0|||
160581367|NCT01544595|579848477|FG000|Status at Week 68|Non-compliance with study treatment|1|||
160581368|NCT01544595|579848478|FG001|Status at Week 68|Non-compliance with study treatment|0|||
160581369|NCT01544595|579848479|FG002|Status at Week 68|Non-compliance with study treatment|0|||
160581370|NCT01544595|579848480|FG003|Status at Week 68|Non-compliance with study treatment|1|||
160581371|NCT01544595|579848481|FG004|Status at Week 68|Non-compliance with study treatment|0|||
160948216|NCT02682264|581198403|FG000|Overall Study|Withdrawal by Subject|56|||
160948217|NCT02682264|581198404|FG001|Overall Study|Withdrawal by Subject|45|||
160948218|NCT02682264|581198403|FG000|Overall Study|Lost to Follow-up|49|||
160948219|NCT02682264|581198404|FG001|Overall Study|Lost to Follow-up|41|||
160948220|NCT02682264|581198403|FG000|Overall Study|Lack of Efficacy|14|||
160948221|NCT02682264|581198404|FG001|Overall Study|Lack of Efficacy|16|||
160948222|NCT02682264|581198403|FG000|Overall Study|Withdrawal by Parent|6|||
160581372|NCT01544595|579848482|FG005|Status at Week 68|Non-compliance with study treatment|0|||
160581373|NCT01544595|579848477|FG000|Status at Week 68|Protocol Violation|2|||
160656147|NCT00920140|580122355|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
160948223|NCT02682264|581198404|FG001|Overall Study|Withdrawal by Parent|7|||
160581374|NCT01544595|579848478|FG001|Status at Week 68|Protocol Violation|0|||
160581375|NCT01544595|579848479|FG002|Status at Week 68|Protocol Violation|1|||
160581376|NCT01544595|579848480|FG003|Status at Week 68|Protocol Violation|1|||
160581377|NCT01544595|579848481|FG004|Status at Week 68|Protocol Violation|0|||
160581378|NCT01544595|579848482|FG005|Status at Week 68|Protocol Violation|0|||
160581379|NCT01544595|579848477|FG000|Status at Week 68|Technical problems|1|||
160456294|NCT04447040|579401392|FG004|Overall Study|Withdrawal by Subject|0|||
160456295|NCT04447040|579401393|FG005|Overall Study|Withdrawal by Subject|0|||
160656148|NCT00920140|580122356|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
160948224|NCT02682264|581198403|FG000|Overall Study|Adverse Event|9|||
160948225|NCT02682264|581198404|FG001|Overall Study|Adverse Event|0|||
160948226|NCT02682264|581198403|FG000|Overall Study|Noncompliance with study drug|1|||
160948227|NCT02682264|581198404|FG001|Overall Study|Noncompliance with study drug|4|||
160948228|NCT02682264|581198403|FG000|Overall Study|Pregnancy|1|||
160948229|NCT02682264|581198404|FG001|Overall Study|Pregnancy|2|||
160948230|NCT02682264|581198403|FG000|Overall Study|Recovery|1|||
160948231|NCT02682264|581198404|FG001|Overall Study|Recovery|2|||
160948232|NCT02682264|581198403|FG000|Overall Study|Progressive Disease|1|||
160948233|NCT02682264|581198404|FG001|Overall Study|Progressive Disease|0|||
160948234|NCT02682264|581198403|FG000|Overall Study|Technical Problems|0|||
160948235|NCT02682264|581198404|FG001|Overall Study|Technical Problems|1|||
160948236|NCT02682264|581198403|FG000|Overall Study|Moved abroad and unable to continue|0|||
160948237|NCT02682264|581198404|FG001|Overall Study|Moved abroad and unable to continue|3|||
160948238|NCT02682264|581198403|FG000|Overall Study|Stopped test article application|0|||
160948239|NCT02682264|581198404|FG001|Overall Study|Stopped test article application|1|||
160948240|NCT01255358|581198405|FG000|Overall Study|Adverse Event|2|||
160948241|NCT01255358|581198405|FG000|Overall Study|Protocol Violation|2|||
160948242|NCT04079933|581198408|FG000|Overall Study|Withdrawal by Subject|3|||
160948243|NCT04079933|581198409|FG001|Overall Study|Withdrawal by Subject|4|||
160948244|NCT04079933|581198408|FG000|Overall Study|Lost to Follow-up|0|||
160948245|NCT04079933|581198409|FG001|Overall Study|Lost to Follow-up|1|||
160948246|NCT03207750|581198410|FG000|Overall Study|Adverse Event|3|||
160948247|NCT03207750|581198411|FG001|Overall Study|Adverse Event|2|||
160948248|NCT03207750|581198410|FG000|Overall Study|Lost to Follow-up|21|||
160948249|NCT03207750|581198411|FG001|Overall Study|Lost to Follow-up|29|||
160948250|NCT03207750|581198410|FG000|Overall Study|Protocol Violation|0|||
160948251|NCT03207750|581198411|FG001|Overall Study|Protocol Violation|1|||
160948252|NCT03207750|581198410|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
160948253|NCT03207750|581198411|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
160948254|NCT03207750|581198410|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
160948255|NCT03207750|581198411|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
160948256|NCT03207750|581198410|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
160948257|NCT03207750|581198411|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
160948258|NCT03207750|581198410|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
160948259|NCT03207750|581198411|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
160948260|NCT03207750|581198410|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
160948261|NCT03207750|581198411|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
160948262|NCT02493361|581198412|FG000|Overall Study|Withdrawal by Subject|3|||
160948263|NCT02937545|581198416|FG000|Overall Study|Withdrawal by Subject|1|||
160948264|NCT02937545|581198417|FG001|Overall Study|Withdrawal by Subject|2|||
160948265|NCT02937545|581198418|FG002|Overall Study|Withdrawal by Subject|6|||
160948266|NCT02937545|581198419|FG003|Overall Study|Withdrawal by Subject|7|||
160948267|NCT02937545|581198416|FG000|Overall Study|Lost to Follow-up|1|||
160948268|NCT02937545|581198417|FG001|Overall Study|Lost to Follow-up|0|||
160948269|NCT02937545|581198418|FG002|Overall Study|Lost to Follow-up|0|||
160948270|NCT02937545|581198419|FG003|Overall Study|Lost to Follow-up|0|||
160948271|NCT02504294|581198422|FG000|Overall Study|Adverse Event|15|||
160948272|NCT02504294|581198423|FG001|Overall Study|Adverse Event|12|||
160948273|NCT02504294|581198422|FG000|Overall Study|Withdrawal by Subject|7|||
160948274|NCT02504294|581198423|FG001|Overall Study|Withdrawal by Subject|1|||
160948275|NCT02504294|581198422|FG000|Overall Study|Protocol Violation|27|||
160948276|NCT02504294|581198423|FG001|Overall Study|Protocol Violation|26|||
160948277|NCT02504294|581198422|FG000|Overall Study|Physician Decision|1|||
160948278|NCT02504294|581198423|FG001|Overall Study|Physician Decision|2|||
160948279|NCT02504294|581198422|FG000|Overall Study|Lost to Follow-up|6|||
160948280|NCT02504294|581198423|FG001|Overall Study|Lost to Follow-up|7|||
160948281|NCT02252211|581198426|FG000|Overall Study|Adverse Event|0|||
160948282|NCT02252211|581198427|FG001|Overall Study|Adverse Event|1|||
160948283|NCT02252211|581198428|FG002|Overall Study|Adverse Event|0|||
160999800|NCT02341625|581382811|FG008|Overall Study|Completed Treatment as per Protocol|0|||
160948284|NCT02252211|581198426|FG000|Overall Study|Progressive disease|3|||
160948285|NCT02252211|581198427|FG001|Overall Study|Progressive disease|2|||
160948286|NCT02252211|581198428|FG002|Overall Study|Progressive disease|0|||
160948287|NCT02252211|581198426|FG000|Overall Study|Withdrawal by Subject|1|||
160948288|NCT02252211|581198427|FG001|Overall Study|Withdrawal by Subject|0|||
160948289|NCT02252211|581198428|FG002|Overall Study|Withdrawal by Subject|0|||
160948290|NCT02252211|581198426|FG000|Overall Study|Serious Adverse Event During Screening|1|||
160948291|NCT02252211|581198427|FG001|Overall Study|Serious Adverse Event During Screening|0|||
160948292|NCT02252211|581198428|FG002|Overall Study|Serious Adverse Event During Screening|1|||
160948293|NCT05799495|581198433|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
160948294|NCT05799495|581198434|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
160948295|NCT05799495|581198435|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
160948296|NCT05799495|581198436|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
160948297|NCT05799495|581198433|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
160948298|NCT05799495|581198434|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
160948299|NCT05799495|581198435|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
160948300|NCT05799495|581198436|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
160948301|NCT05799495|581198433|FG000|Treatment (Up to 5 Days)|Other|0|||
160948302|NCT05799495|581198434|FG001|Treatment (Up to 5 Days)|Other|1|||
160948303|NCT05799495|581198435|FG002|Treatment (Up to 5 Days)|Other|0|||
160948304|NCT05799495|581198436|FG003|Treatment (Up to 5 Days)|Other|0|||
160948305|NCT05799495|581198433|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
160948306|NCT05799495|581198434|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
160948307|NCT05799495|581198435|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
160948308|NCT05799495|581198436|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
160948309|NCT05799495|581198433|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
160948310|NCT05799495|581198434|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
160948311|NCT05799495|581198435|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
160948312|NCT05799495|581198436|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
160948313|NCT05799495|581198433|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160948314|NCT05799495|581198434|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160948315|NCT05799495|581198435|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
160948316|NCT05799495|581198436|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160948317|NCT03694548|581198440|FG000|Part A Survey|Protocol Violation|3|||
160948318|NCT03694548|581198441|FG001|Part A Survey|Protocol Violation|3|||
160948319|NCT03694548|581198442|FG002|Part A Survey|Protocol Violation|0|||
160948320|NCT03694548|581198440|FG000|Part B Yoga Program|Protocol Violation|0|||
160948321|NCT03694548|581198441|FG001|Part B Yoga Program|Protocol Violation|0|||
160948322|NCT03694548|581198442|FG002|Part B Yoga Program|Protocol Violation|3|||
160948323|NCT03694548|581198440|FG000|Part B Yoga Program|Did not attend intervention|0|||
160948324|NCT03694548|581198441|FG001|Part B Yoga Program|Did not attend intervention|0|||
160948325|NCT03694548|581198442|FG002|Part B Yoga Program|Did not attend intervention|8|||
160948326|NCT04177108|581198443|FG000|Overall Study|Withdrawal by Subject|4|||
160948327|NCT04177108|581198444|FG001|Overall Study|Withdrawal by Subject|8|||
160948328|NCT04177108|581198445|FG002|Overall Study|Withdrawal by Subject|9|||
160948329|NCT04177108|581198446|FG003|Overall Study|Withdrawal by Subject|11|||
160948330|NCT04177108|581198447|FG004|Overall Study|Withdrawal by Subject|13|||
160948331|NCT04177108|581198443|FG000|Overall Study|Physician Decision|23|||
160948332|NCT04177108|581198444|FG001|Overall Study|Physician Decision|15|||
160948333|NCT04177108|581198445|FG002|Overall Study|Physician Decision|18|||
160948334|NCT04177108|581198446|FG003|Overall Study|Physician Decision|29|||
160948335|NCT04177108|581198447|FG004|Overall Study|Physician Decision|23|||
160948336|NCT04177108|581198443|FG000|Overall Study|Reason Not Specified|0|||
160948337|NCT04177108|581198444|FG001|Overall Study|Reason Not Specified|1|||
160948338|NCT04177108|581198445|FG002|Overall Study|Reason Not Specified|0|||
160948339|NCT04177108|581198446|FG003|Overall Study|Reason Not Specified|0|||
160948340|NCT04177108|581198447|FG004|Overall Study|Reason Not Specified|2|||
160948341|NCT04177108|581198443|FG000|Overall Study|Lost to Follow-up|0|||
160948342|NCT04177108|581198444|FG001|Overall Study|Lost to Follow-up|0|||
160948343|NCT04177108|581198445|FG002|Overall Study|Lost to Follow-up|1|||
160948344|NCT04177108|581198446|FG003|Overall Study|Lost to Follow-up|1|||
160948345|NCT04177108|581198447|FG004|Overall Study|Lost to Follow-up|1|||
160948346|NCT04177108|581198443|FG000|Overall Study|Death|16|||
160948347|NCT04177108|581198444|FG001|Overall Study|Death|19|||
160948348|NCT04177108|581198445|FG002|Overall Study|Death|13|||
160948349|NCT04177108|581198446|FG003|Overall Study|Death|17|||
160948350|NCT04177108|581198447|FG004|Overall Study|Death|18|||
160948351|NCT01143259|581198449|FG000|Overall Study|Withdrawal by Subject|3|||
160948352|NCT01143259|581198450|FG001|Overall Study|Withdrawal by Subject|2|||
160948353|NCT01143259|581198449|FG000|Overall Study|Protocol Violation|13|||
160948354|NCT01143259|581198450|FG001|Overall Study|Protocol Violation|9|||
160948355|NCT01143259|581198449|FG000|Overall Study|Screen Failure|7|||
160999801|NCT02341625|581382812|FG009|Overall Study|Completed Treatment as per Protocol|1|||
160999802|NCT02341625|581382803|FG000|Overall Study|Other Reasons|0|||
160999803|NCT02341625|581382804|FG001|Overall Study|Other Reasons|0|||
160999804|NCT02341625|581382805|FG002|Overall Study|Other Reasons|0|||
160948356|NCT01143259|581198450|FG001|Overall Study|Screen Failure|9|||
160948357|NCT00099983|581198451|FG000|Overall Study|Lost to Follow-up|2|||
160948358|NCT00099983|581198452|FG001|Overall Study|Lost to Follow-up|3|||
160948359|NCT00099983|581198451|FG000|Overall Study|Missing Source Documents|14|||
160948360|NCT00099983|581198452|FG001|Overall Study|Missing Source Documents|15|||
160948361|NCT00099983|581198451|FG000|Overall Study|Withdrawal by Subject|3|||
160948362|NCT00099983|581198452|FG001|Overall Study|Withdrawal by Subject|2|||
160948363|NCT00099983|581198451|FG000|Overall Study|Adverse Event|1|||
160948364|NCT00099983|581198452|FG001|Overall Study|Adverse Event|1|||
160948365|NCT00099983|581198451|FG000|Overall Study|Lack of Efficacy|0|||
160948366|NCT00099983|581198452|FG001|Overall Study|Lack of Efficacy|1|||
160948367|NCT00099983|581198451|FG000|Overall Study|Unable to return for appointments|1|||
160948368|NCT00099983|581198452|FG001|Overall Study|Unable to return for appointments|1|||
160948369|NCT00099983|581198451|FG000|Overall Study|Moved|1|||
160948370|NCT00099983|581198452|FG001|Overall Study|Moved|0|||
160948371|NCT00099983|581198451|FG000|Overall Study|Other psychiatric problem|1|||
160948372|NCT00099983|581198452|FG001|Overall Study|Other psychiatric problem|0|||
160948373|NCT00099983|581198451|FG000|Overall Study|Incarcerated|0|||
160948374|NCT00099983|581198452|FG001|Overall Study|Incarcerated|1|||
160948375|NCT00099983|581198451|FG000|Overall Study|Intolerant of burden of visits|0|||
160948376|NCT00099983|581198452|FG001|Overall Study|Intolerant of burden of visits|1|||
160948377|NCT00099983|581198451|FG000|Overall Study|Other issue|1|||
160948378|NCT00099983|581198452|FG001|Overall Study|Other issue|0|||
160948379|NCT02641080|581198453|FG000|Overall Study|Physician Decision|2|||
160948380|NCT02641080|581198454|FG001|Overall Study|Physician Decision|0|||
160948381|NCT02641080|581198453|FG000|Overall Study|Withdrawal by Subject|0|||
160948382|NCT02641080|581198454|FG001|Overall Study|Withdrawal by Subject|1|||
160948383|NCT02641080|581198453|FG000|Overall Study|Rehab Center denied use of pumps|0|||
160948384|NCT02641080|581198454|FG001|Overall Study|Rehab Center denied use of pumps|3|||
160948385|NCT02641080|581198453|FG000|Overall Study|Lost to Follow-up|0|||
160948386|NCT02641080|581198454|FG001|Overall Study|Lost to Follow-up|3|||
160948387|NCT06281548|581198455|FG000|Overall Study|Lost to Follow-up|3|||
160948388|NCT03835533|581198456|FG000|Overall Study|Death|5|||
160948389|NCT03835533|581198457|FG001|Overall Study|Death|10|||
160948390|NCT03835533|581198458|FG002|Overall Study|Death|9|||
160948391|NCT03835533|581198456|FG000|Overall Study|Withdrawal by Subject|2|||
160948392|NCT03835533|581198457|FG001|Overall Study|Withdrawal by Subject|2|||
160948393|NCT03835533|581198458|FG002|Overall Study|Withdrawal by Subject|2|||
160948394|NCT03835533|581198456|FG000|Overall Study|Lost to Follow-up|1|||
160948395|NCT03835533|581198457|FG001|Overall Study|Lost to Follow-up|0|||
160948396|NCT03835533|581198458|FG002|Overall Study|Lost to Follow-up|0|||
160948397|NCT01866709|581198459|FG000|Overall Study|Adverse Event|1|||
160948398|NCT01866709|581198460|FG001|Overall Study|Adverse Event|0|||
160948399|NCT00499889|581198461|FG000|Overall Study|Infection prior to treatment|1|||
160948400|NCT02207829|581198462|FG000|Overall Study|Adverse Event|10|||
160948401|NCT02207829|581198463|FG001|Overall Study|Adverse Event|9|||
160999805|NCT02341625|581382806|FG003|Overall Study|Other Reasons|0|||
160999806|NCT02341625|581382807|FG004|Overall Study|Other Reasons|1|||
160999807|NCT02341625|581382808|FG005|Overall Study|Other Reasons|0|||
160999808|NCT02341625|581382809|FG006|Overall Study|Other Reasons|5|||
160581380|NCT01544595|579848478|FG001|Status at Week 68|Technical problems|0|||
160581381|NCT01544595|579848479|FG002|Status at Week 68|Technical problems|0|||
160581382|NCT01544595|579848480|FG003|Status at Week 68|Technical problems|1|||
160581383|NCT01544595|579848481|FG004|Status at Week 68|Technical problems|0|||
160581384|NCT01544595|579848482|FG005|Status at Week 68|Technical problems|0|||
160656149|NCT00920140|580122357|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
160656150|NCT00920140|580122358|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
160656151|NCT00920140|580122359|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
160999809|NCT02341625|581382810|FG007|Overall Study|Other Reasons|0|||
160581385|NCT01544595|579848477|FG000|Status at Week 68|Withdrawal by Subject|0|||
160581386|NCT01544595|579848478|FG001|Status at Week 68|Withdrawal by Subject|1|||
160581387|NCT01544595|579848479|FG002|Status at Week 68|Withdrawal by Subject|1|||
160581388|NCT01544595|579848480|FG003|Status at Week 68|Withdrawal by Subject|2|||
160581389|NCT01544595|579848481|FG004|Status at Week 68|Withdrawal by Subject|0|||
160581390|NCT01544595|579848482|FG005|Status at Week 68|Withdrawal by Subject|0|||
160581391|NCT01544595|579848477|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
160581392|NCT01544595|579848478|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
160581393|NCT01544595|579848479|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
160581394|NCT01544595|579848480|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
160581395|NCT01544595|579848481|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
160581396|NCT01544595|579848482|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
160581397|NCT01544595|579848477|FG000|Status at Week 156|Withdrawal by Subject|9|||
160656152|NCT00920140|580122355|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
160656153|NCT00920140|580122356|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
160656154|NCT00920140|580122357|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
160656155|NCT00920140|580122358|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
160948402|NCT02207829|581198462|FG000|Overall Study|Lack of Efficacy|7|||
160581398|NCT01544595|579848478|FG001|Status at Week 156|Withdrawal by Subject|10|||
160948403|NCT02207829|581198463|FG001|Overall Study|Lack of Efficacy|5|||
160948404|NCT02207829|581198462|FG000|Overall Study|Lost to Follow-up|2|||
160948405|NCT02207829|581198463|FG001|Overall Study|Lost to Follow-up|2|||
160948406|NCT02207829|581198462|FG000|Overall Study|Protocol deviation|5|||
160948407|NCT02207829|581198463|FG001|Overall Study|Protocol deviation|4|||
160948408|NCT02207829|581198462|FG000|Overall Study|Withdrew consent|18|||
160948409|NCT02207829|581198463|FG001|Overall Study|Withdrew consent|14|||
160948410|NCT03299192|581198464|FG000|Overall Study|Fell before classes started|1|||
160948411|NCT03299192|581198465|FG001|Overall Study|Fell before classes started|0|||
160948412|NCT03299192|581198466|FG002|Overall Study|Fell before classes started|0|||
160948413|NCT03299192|581198464|FG000|Overall Study|Other|0|||
160948414|NCT03299192|581198465|FG001|Overall Study|Other|2|||
160948415|NCT03299192|581198466|FG002|Overall Study|Other|1|||
160948416|NCT01418209|581198472|FG000|Overall Study|Withdrawal by Subject|1|||
160948417|NCT01418209|581198473|FG001|Overall Study|Withdrawal by Subject|0|||
160948418|NCT01418209|581198474|FG002|Overall Study|Withdrawal by Subject|1|||
160948419|NCT01418209|581198472|FG000|Overall Study|Did not provide hot flash diary data|1|||
160948420|NCT01418209|581198473|FG001|Overall Study|Did not provide hot flash diary data|3|||
160948421|NCT01418209|581198474|FG002|Overall Study|Did not provide hot flash diary data|3|||
160948422|NCT00101101|581198475|FG000|Overall Study|never received vaccine|20|||
160948423|NCT01603875|581198476|FG000|Overall Study|Preexisting rabies antibody|3|||
160948424|NCT01603875|581198477|FG001|Overall Study|Preexisting rabies antibody|4|||
160948425|NCT01603875|581198478|FG002|Overall Study|Preexisting rabies antibody|3|||
160948426|NCT01603875|581198476|FG000|Overall Study|Lost to Follow-up|4|||
160948427|NCT01603875|581198477|FG001|Overall Study|Lost to Follow-up|3|||
160948428|NCT01603875|581198478|FG002|Overall Study|Lost to Follow-up|6|||
160948429|NCT01603875|581198476|FG000|Overall Study|Protocol Violation|0|||
160948430|NCT01603875|581198477|FG001|Overall Study|Protocol Violation|1|||
160948431|NCT01603875|581198478|FG002|Overall Study|Protocol Violation|0|||
160948432|NCT04122443|581198484|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
160948433|NCT04122443|581198485|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
160948434|NCT04122443|581198486|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
160948435|NCT04122443|581198484|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
160948436|NCT04122443|581198485|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
160948437|NCT04122443|581198486|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
160948438|NCT05204134|581198487|FG000|Overall Study|Withdrawal by Subject|3|||
160948439|NCT05204134|581198487|FG000|Overall Study|Physician Decision|1|||
160948440|NCT01312467|581198491|FG000|Overall Study|Adverse Event|4|||
160948441|NCT01312467|581198491|FG000|Overall Study|Lost to Follow-up|1|||
160948442|NCT01312467|581198491|FG000|Overall Study|Withdrawal by Subject|2|||
160948443|NCT01312467|581198491|FG000|Overall Study|Deported to country of origin|1|||
160948444|NCT01312467|581198491|FG000|Overall Study|Another medical condition|1|||
160581399|NCT01544595|579848479|FG002|Status at Week 156|Withdrawal by Subject|4|||
160581400|NCT01544595|579848480|FG003|Status at Week 156|Withdrawal by Subject|9|||
160581401|NCT01544595|579848481|FG004|Status at Week 156|Withdrawal by Subject|20|||
160581402|NCT01544595|579848482|FG005|Status at Week 156|Withdrawal by Subject|6|||
160581403|NCT01544595|579848477|FG000|Status at Week 156|Adverse Event|9|||
160581404|NCT01544595|579848478|FG001|Status at Week 156|Adverse Event|11|||
160581405|NCT01544595|579848479|FG002|Status at Week 156|Adverse Event|1|||
160581406|NCT01544595|579848480|FG003|Status at Week 156|Adverse Event|3|||
160581407|NCT01544595|579848481|FG004|Status at Week 156|Adverse Event|4|||
160581408|NCT01544595|579848482|FG005|Status at Week 156|Adverse Event|2|||
160581409|NCT01544595|579848477|FG000|Status at Week 156|Lost to Follow-up|4|||
160581410|NCT01544595|579848478|FG001|Status at Week 156|Lost to Follow-up|4|||
160581411|NCT01544595|579848479|FG002|Status at Week 156|Lost to Follow-up|0|||
160581412|NCT01544595|579848480|FG003|Status at Week 156|Lost to Follow-up|1|||
160581413|NCT01544595|579848481|FG004|Status at Week 156|Lost to Follow-up|4|||
160581414|NCT01544595|579848482|FG005|Status at Week 156|Lost to Follow-up|1|||
160581415|NCT01544595|579848477|FG000|Status at Week 156|Non-compliance with study treatement|0|||
160581416|NCT01544595|579848478|FG001|Status at Week 156|Non-compliance with study treatement|1|||
160581417|NCT01544595|579848479|FG002|Status at Week 156|Non-compliance with study treatement|0|||
160581418|NCT01544595|579848480|FG003|Status at Week 156|Non-compliance with study treatement|1|||
160581419|NCT01544595|579848481|FG004|Status at Week 156|Non-compliance with study treatement|0|||
160581420|NCT01544595|579848482|FG005|Status at Week 156|Non-compliance with study treatement|1|||
160581421|NCT01544595|579848477|FG000|Status at Week 156|Physician Decision|0|||
160581422|NCT01544595|579848478|FG001|Status at Week 156|Physician Decision|3|||
160581423|NCT01544595|579848479|FG002|Status at Week 156|Physician Decision|1|||
160581424|NCT01544595|579848480|FG003|Status at Week 156|Physician Decision|0|||
160581425|NCT01544595|579848481|FG004|Status at Week 156|Physician Decision|0|||
160581426|NCT01544595|579848482|FG005|Status at Week 156|Physician Decision|0|||
160581427|NCT01544595|579848477|FG000|Status at Week 156|Pregnancy|2|||
160581428|NCT01544595|579848478|FG001|Status at Week 156|Pregnancy|3|||
160656156|NCT00920140|580122359|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
160948445|NCT01312467|581198491|FG000|Overall Study|Ineligible|4|||
160948446|NCT01059617|581198494|FG000|Overall Study|Other|7|||
160581429|NCT01544595|579848479|FG002|Status at Week 156|Pregnancy|0|||
160581430|NCT01544595|579848480|FG003|Status at Week 156|Pregnancy|0|||
160581431|NCT01544595|579848481|FG004|Status at Week 156|Pregnancy|0|||
160581432|NCT01544595|579848482|FG005|Status at Week 156|Pregnancy|0|||
160581433|NCT01544595|579848477|FG000|Status at Week 156|Protocol Violation|3|||
160948447|NCT01059617|581198495|FG001|Overall Study|Other|1|||
160948448|NCT01059617|581198496|FG002|Overall Study|Other|8|||
160948449|NCT01059617|581198497|FG003|Overall Study|Other|6|||
160948450|NCT01968434|581198498|FG000|Overall Study|Lost to Follow-up|3|||
160948451|NCT01968434|581198499|FG001|Overall Study|Lost to Follow-up|6|||
160948452|NCT02199691|581198500|FG000|Overall Study|Protocol Violation|3|||
160948453|NCT02199691|581198501|FG001|Overall Study|Protocol Violation|3|||
160948454|NCT02199691|581198502|FG002|Overall Study|Protocol Violation|6|||
160948455|NCT02199691|581198503|FG003|Overall Study|Protocol Violation|7|||
160948456|NCT02199691|581198500|FG000|Overall Study|Withdrawal by Subject|5|||
160948457|NCT02199691|581198501|FG001|Overall Study|Withdrawal by Subject|3|||
160948458|NCT02199691|581198502|FG002|Overall Study|Withdrawal by Subject|12|||
160948459|NCT02199691|581198503|FG003|Overall Study|Withdrawal by Subject|13|||
160948460|NCT02199691|581198500|FG000|Overall Study|Lost to Follow-up|2|||
160948461|NCT02199691|581198501|FG001|Overall Study|Lost to Follow-up|1|||
160948462|NCT02199691|581198502|FG002|Overall Study|Lost to Follow-up|9|||
160948463|NCT02199691|581198503|FG003|Overall Study|Lost to Follow-up|10|||
160948464|NCT00612313|581198506|FG000|Overall Study|Withdrawal by Subject|6|||
160948465|NCT00612313|581198507|FG001|Overall Study|Withdrawal by Subject|9|||
160948466|NCT00612313|581198506|FG000|Overall Study|Lost to Follow-up|11|||
160948467|NCT00612313|581198507|FG001|Overall Study|Lost to Follow-up|4|||
160948468|NCT00136955|581200429|FG000|Overall Study|Adverse Event|8|||
160948469|NCT00136955|581200429|FG000|Overall Study|Lost to Follow-up|1|||
160948470|NCT00136955|581200429|FG000|Overall Study|Withdrawal by Subject|2|||
160948471|NCT00136955|581200429|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
160948472|NCT02239510|581200430|FG000|Overall Study|Lost to Follow-up|2|||
160948473|NCT02239510|581200431|FG001|Overall Study|Lost to Follow-up|1|||
160948474|NCT01773226|581200432|FG000|Overall Study|Withdrawal by Subject|1|||
160948475|NCT05349617|581200438|FG000|Overall Study|Death|1|||
160948476|NCT05349617|581200439|FG001|Overall Study|Death|1|||
160948477|NCT05349617|581200438|FG000|Overall Study|Lost to Follow-up|3|||
160948478|NCT05349617|581200439|FG001|Overall Study|Lost to Follow-up|8|||
160456296|NCT01208662|579401394|FG000|Induction and Consolidation|Disease Progression|23|||
160456297|NCT01208662|579401395|FG001|Induction and Consolidation|Disease Progression|13|||
160456298|NCT01208662|579401396|FG002|Induction and Consolidation|Disease Progression|0|||
160456299|NCT01208662|579401394|FG000|Induction and Consolidation|Adverse Event|16|||
160456300|NCT01208662|579401395|FG001|Induction and Consolidation|Adverse Event|18|||
160456301|NCT01208662|579401396|FG002|Induction and Consolidation|Adverse Event|2|||
160456302|NCT01208662|579401394|FG000|Induction and Consolidation|MD or Participant Decision|16|||
160456303|NCT01208662|579401395|FG001|Induction and Consolidation|MD or Participant Decision|34|||
160456304|NCT01208662|579401396|FG002|Induction and Consolidation|MD or Participant Decision|4|||
160456305|NCT01208662|579401394|FG000|Induction and Consolidation|Death|1|||
160456306|NCT01208662|579401395|FG001|Induction and Consolidation|Death|3|||
160456307|NCT01208662|579401396|FG002|Induction and Consolidation|Death|1|||
160948479|NCT05349617|581200438|FG000|Overall Study|Withdrawal by Subject|2|||
160456308|NCT01208662|579401394|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
160456309|NCT01208662|579401395|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
160456310|NCT01208662|579401396|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
160456311|NCT01208662|579401394|FG000|Maintenance|Disease Progression|156|||
160456312|NCT01208662|579401395|FG001|Maintenance|Disease Progression|102|||
160456313|NCT01208662|579401396|FG002|Maintenance|Disease Progression|0|||
160456314|NCT01208662|579401394|FG000|Maintenance|Adverse Event|12|||
160456315|NCT01208662|579401395|FG001|Maintenance|Adverse Event|28|||
160456316|NCT01208662|579401396|FG002|Maintenance|Adverse Event|0|||
160456317|NCT01208662|579401394|FG000|Maintenance|MD or Participant Decision|24|||
160456318|NCT01208662|579401395|FG001|Maintenance|MD or Participant Decision|36|||
160456319|NCT01208662|579401396|FG002|Maintenance|MD or Participant Decision|0|||
160456320|NCT01208662|579401394|FG000|Maintenance|Death|0|||
160456321|NCT01208662|579401395|FG001|Maintenance|Death|3|||
160456322|NCT01208662|579401396|FG002|Maintenance|Death|0|||
160456323|NCT01208662|579401394|FG000|Maintenance|Discontinued for other reasons|21|||
160456324|NCT01208662|579401395|FG001|Maintenance|Discontinued for other reasons|31|||
160456325|NCT01208662|579401396|FG002|Maintenance|Discontinued for other reasons|0|||
160456326|NCT01208662|579401394|FG000|Maintenance|Still on Treatment|78|||
160456327|NCT01208662|579401395|FG001|Maintenance|Still on Treatment|89|||
160456328|NCT01208662|579401396|FG002|Maintenance|Still on Treatment|0|||
160456329|NCT04433208|579401397|FG000|Overall Study|Withdrawal by Subject|0|||
160581434|NCT01544595|579848478|FG001|Status at Week 156|Protocol Violation|1|||
160581435|NCT01544595|579848479|FG002|Status at Week 156|Protocol Violation|2|||
160948480|NCT05349617|581200439|FG001|Overall Study|Withdrawal by Subject|10|||
160948481|NCT03811912|581200444|FG000|Overall Study|Withdrew Consent|4|||
160948482|NCT03811912|581200445|FG001|Overall Study|Withdrew Consent|2|||
160948483|NCT04401579|581200446|FG000|Overall Study|Death|23|||
160948484|NCT04401579|581200447|FG001|Overall Study|Death|36|||
160948485|NCT04401579|581200446|FG000|Overall Study|Lost to Follow-up|40|||
160456330|NCT04433208|579401398|FG001|Overall Study|Withdrawal by Subject|1|||
160456331|NCT04433208|579401399|FG002|Overall Study|Withdrawal by Subject|1|||
160456332|NCT04433208|579401400|FG003|Overall Study|Withdrawal by Subject|0|||
160456333|NCT04433208|579401401|FG004|Overall Study|Withdrawal by Subject|2|||
160948486|NCT04401579|581200447|FG001|Overall Study|Lost to Follow-up|41|||
160948487|NCT04401579|581200446|FG000|Overall Study|Withdrawal by Subject|8|||
160948488|NCT04401579|581200447|FG001|Overall Study|Withdrawal by Subject|16|||
160948489|NCT04401579|581200446|FG000|Overall Study|Physician Decision|1|||
160581436|NCT01544595|579848480|FG003|Status at Week 156|Protocol Violation|2|||
160581437|NCT01544595|579848481|FG004|Status at Week 156|Protocol Violation|0|||
160581438|NCT01544595|579848482|FG005|Status at Week 156|Protocol Violation|0|||
160581439|NCT01544595|579848477|FG000|Status at Week 156|Technical problems|3|||
160581440|NCT01544595|579848478|FG001|Status at Week 156|Technical problems|1|||
160581441|NCT01544595|579848479|FG002|Status at Week 156|Technical problems|0|||
160581442|NCT01544595|579848480|FG003|Status at Week 156|Technical problems|1|||
160581443|NCT01544595|579848481|FG004|Status at Week 156|Technical problems|0|||
160581444|NCT01544595|579848482|FG005|Status at Week 156|Technical problems|0|||
160581445|NCT01544595|579848477|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
160581446|NCT01544595|579848478|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
160581447|NCT01544595|579848479|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
160581448|NCT01544595|579848480|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
160581449|NCT01544595|579848481|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
160581450|NCT01544595|579848482|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
160581451|NCT01544595|579848477|FG000|Status at Week 156|Lack of Efficacy|1|||
160581452|NCT01544595|579848478|FG001|Status at Week 156|Lack of Efficacy|0|||
160948490|NCT04401579|581200447|FG001|Overall Study|Physician Decision|2|||
160948491|NCT04401579|581200446|FG000|Overall Study|Became ineligible after enrollment|1|||
160948492|NCT04401579|581200447|FG001|Overall Study|Became ineligible after enrollment|1|||
160948493|NCT04401579|581200446|FG000|Overall Study|Enrolled but treatment not administered|7|||
160948494|NCT04401579|581200447|FG001|Overall Study|Enrolled but treatment not administered|9|||
160581453|NCT01544595|579848479|FG002|Status at Week 156|Lack of Efficacy|1|||
160581454|NCT01544595|579848480|FG003|Status at Week 156|Lack of Efficacy|4|||
160581455|NCT01544595|579848481|FG004|Status at Week 156|Lack of Efficacy|10|||
160581456|NCT01544595|579848482|FG005|Status at Week 156|Lack of Efficacy|5|||
160581457|NCT01929044|579848483|FG000|Overall Study|Adverse Event|1|||
160581458|NCT01929044|579848484|FG001|Overall Study|Adverse Event|0|||
160581459|NCT01929044|579848483|FG000|Overall Study|Protocol Violation|9|||
160656157|NCT00920140|580122355|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160656158|NCT00920140|580122356|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
160948495|NCT04401579|581200446|FG000|Overall Study|Adverse Event|2|||
160948496|NCT04401579|581200447|FG001|Overall Study|Adverse Event|1|||
160948497|NCT04401579|581200446|FG000|Overall Study|Scheduling error|1|||
160948498|NCT04401579|581200447|FG001|Overall Study|Scheduling error|2|||
160948499|NCT04401579|581200446|FG000|Overall Study|Transferred to another hospital|1|||
160948500|NCT04401579|581200447|FG001|Overall Study|Transferred to another hospital|2|||
160948501|NCT00489970|581200448|FG000|Persistence Year 9|Lost to Follow-up|2|||
160948502|NCT00489970|581200449|FG001|Persistence Year 9|Lost to Follow-up|2|||
160948503|NCT00489970|581200450|FG002|Persistence Year 9|Lost to Follow-up|3|||
160948504|NCT00489970|581200448|FG000|Persistence Year 9|Other|1|||
160948505|NCT00489970|581200449|FG001|Persistence Year 9|Other|0|||
160948506|NCT00489970|581200450|FG002|Persistence Year 9|Other|2|||
160948507|NCT03320070|581200451|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
160948508|NCT03320070|581200452|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
160948509|NCT03320070|581200451|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
160948510|NCT03320070|581200452|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
160999810|NCT02341625|581382811|FG008|Overall Study|Other Reasons|0|||
160999811|NCT02341625|581382812|FG009|Overall Study|Other Reasons|2|||
160999812|NCT02341625|581382803|FG000|Overall Study|Not Reported|0|||
160999813|NCT02341625|581382804|FG001|Overall Study|Not Reported|0|||
160999814|NCT02341625|581382805|FG002|Overall Study|Not Reported|0|||
160999815|NCT02341625|581382806|FG003|Overall Study|Not Reported|0|||
160999816|NCT02341625|581382807|FG004|Overall Study|Not Reported|0|||
160999817|NCT02341625|581382808|FG005|Overall Study|Not Reported|0|||
160948511|NCT03320070|581200451|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
160948512|NCT03320070|581200452|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
160948513|NCT03320070|581200451|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
160948514|NCT03320070|581200452|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
160948515|NCT03320070|581200451|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
160948516|NCT03320070|581200452|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
160948517|NCT03320070|581200451|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
160948518|NCT03320070|581200452|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
160948519|NCT03586648|581200453|FG000|Period 1|Withdrawal by Subject|0|||
160999818|NCT02341625|581382809|FG006|Overall Study|Not Reported|0|||
160948520|NCT03586648|581200454|FG001|Period 1|Withdrawal by Subject|1|||
160656159|NCT00920140|580122357|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160948521|NCT03586648|581200453|FG000|Period 1|Lost to Follow-up|1|||
160999819|NCT02341625|581382810|FG007|Overall Study|Not Reported|0|||
160999820|NCT02341625|581382811|FG008|Overall Study|Not Reported|0|||
160581460|NCT01929044|579848484|FG001|Overall Study|Protocol Violation|14|||
160581461|NCT01929044|579848483|FG000|Overall Study|Not Treated|1|||
160581462|NCT01929044|579848484|FG001|Overall Study|Not Treated|3|||
160656160|NCT00920140|580122358|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160581463|NCT02026271|579848487|FG000|Overall Study|Adverse Event|2|||
160581464|NCT02026271|579848488|FG001|Overall Study|Adverse Event|3|||
160581465|NCT02026271|579848489|FG002|Overall Study|Adverse Event|2|||
160581466|NCT02026271|579848490|FG003|Overall Study|Adverse Event|3|||
160581467|NCT02026271|579848491|FG004|Overall Study|Adverse Event|0|||
160581468|NCT02026271|579848487|FG000|Overall Study|Withdrawal by Subject|0|||
160581469|NCT02026271|579848488|FG001|Overall Study|Withdrawal by Subject|0|||
160581470|NCT02026271|579848489|FG002|Overall Study|Withdrawal by Subject|0|||
160581471|NCT02026271|579848490|FG003|Overall Study|Withdrawal by Subject|0|||
160581472|NCT02026271|579848491|FG004|Overall Study|Withdrawal by Subject|1|||
160581473|NCT02807454|579848492|FG000|Overall Study|Adverse Event|1|||
160581474|NCT02807454|579848493|FG001|Overall Study|Adverse Event|0|||
160581475|NCT02807454|579848492|FG000|Overall Study|Withdrawal by Subject|0|||
160581476|NCT02807454|579848493|FG001|Overall Study|Withdrawal by Subject|1|||
160581477|NCT02807454|579848492|FG000|Overall Study|Progressive Disease|30|||
160581478|NCT02807454|579848493|FG001|Overall Study|Progressive Disease|3|||
160581479|NCT02807454|579848492|FG000|Overall Study|Other Reasons|1|||
160581480|NCT02807454|579848493|FG001|Overall Study|Other Reasons|1|||
160581481|NCT02379923|579848496|FG000|Overall Study|Death|5|||
160581482|NCT03288779|579848497|FG000|Overall Study|Withdrawal by Subject|3|||
160581483|NCT03382899|579848498|FG000|Overall Study|Ineligibility Determined|0|||
160581484|NCT03382899|579848499|FG001|Overall Study|Ineligibility Determined|1|||
160581485|NCT03382899|579848498|FG000|Overall Study|Lost to Follow-up|0|||
160581486|NCT03382899|579848499|FG001|Overall Study|Lost to Follow-up|1|||
160581487|NCT03382899|579848498|FG000|Overall Study|Sponsor's decision|31|||
160581488|NCT03382899|579848499|FG001|Overall Study|Sponsor's decision|28|||
160581489|NCT03382899|579848498|FG000|Overall Study|Withdrawal by Subject|0|||
160581490|NCT03382899|579848499|FG001|Overall Study|Withdrawal by Subject|5|||
160581491|NCT00524745|579848500|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
160581492|NCT00524745|579848501|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
160581493|NCT00524745|579848502|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
160581494|NCT00524745|579848503|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
160581495|NCT03643432|579848504|FG000|Overall Study|Lost to Follow-up|1|||
160948522|NCT03586648|581200454|FG001|Period 1|Lost to Follow-up|1|||
160948523|NCT03586648|581200453|FG000|Period 1|Adverse Event|1|||
160948524|NCT03586648|581200454|FG001|Period 1|Adverse Event|0|||
160948525|NCT03586648|581200453|FG000|Period 1|Study related symptoms or complaints|2|||
160948526|NCT03586648|581200454|FG001|Period 1|Study related symptoms or complaints|1|||
160948527|NCT03586648|581200453|FG000|Period 1|Physician Decision|0|||
160948528|NCT03586648|581200454|FG001|Period 1|Physician Decision|1|||
160948529|NCT03586648|581200453|FG000|Period 2|Adverse Event|1|||
160948530|NCT03586648|581200454|FG001|Period 2|Adverse Event|0|||
160948531|NCT02367911|581200457|FG000|Overall Study|Withdrawal by Subject|3|||
160948532|NCT02367911|581200458|FG001|Overall Study|Withdrawal by Subject|2|||
160948533|NCT02367911|581200457|FG000|Overall Study|Lost to Follow-up|2|||
160948534|NCT02367911|581200458|FG001|Overall Study|Lost to Follow-up|2|||
160948535|NCT00263666|581200459|FG000|Overall Study|Adverse Event|6|||
160948536|NCT00263666|581200460|FG001|Overall Study|Adverse Event|8|||
160948537|NCT00263666|581200459|FG000|Overall Study|Lost to Follow-up|1|||
160948538|NCT00263666|581200460|FG001|Overall Study|Lost to Follow-up|2|||
160948539|NCT00263666|581200459|FG000|Overall Study|Withdrawal by Subject|0|||
160948540|NCT00263666|581200460|FG001|Overall Study|Withdrawal by Subject|1|||
160948541|NCT00896168|581200461|FG000|Overall Study|Adverse Event|4|||
160948542|NCT00896168|581200462|FG001|Overall Study|Adverse Event|7|||
160948543|NCT00896168|581200461|FG000|Overall Study|Treatment failure|8|||
160948544|NCT00896168|581200462|FG001|Overall Study|Treatment failure|10|||
160948545|NCT00896168|581200461|FG000|Overall Study|Lost to Follow-up|1|||
160948546|NCT00896168|581200462|FG001|Overall Study|Lost to Follow-up|1|||
160948547|NCT00896168|581200461|FG000|Overall Study|Other|1|||
160948548|NCT00896168|581200462|FG001|Overall Study|Other|1|||
160948549|NCT00902304|581200463|FG000|Overall Study|Adverse Event|4|||
160948550|NCT00902304|581200464|FG001|Overall Study|Adverse Event|10|||
160948551|NCT00902304|581200465|FG002|Overall Study|Adverse Event|25|||
160948552|NCT00902304|581200463|FG000|Overall Study|Investigator discretion|3|||
160948553|NCT00902304|581200464|FG001|Overall Study|Investigator discretion|5|||
160948554|NCT00902304|581200465|FG002|Overall Study|Investigator discretion|13|||
160948555|NCT00902304|581200463|FG000|Overall Study|Lost to Follow-up|7|||
160948556|NCT00902304|581200464|FG001|Overall Study|Lost to Follow-up|7|||
160948557|NCT00902304|581200465|FG002|Overall Study|Lost to Follow-up|7|||
160581496|NCT03643432|579848505|FG001|Overall Study|Lost to Follow-up|0|||
160581497|NCT00804193|579848506|FG000|Overall Study|Lack of baseline fungus|32|||
160581498|NCT00804193|579848507|FG001|Overall Study|Lack of baseline fungus|31|||
160581499|NCT00804193|579848508|FG002|Overall Study|Lack of baseline fungus|19|||
160581500|NCT00804193|579848506|FG000|Overall Study|Adverse Event|0|||
160948558|NCT00902304|581200463|FG000|Overall Study|Protocol Violation|9|||
160948559|NCT00902304|581200464|FG001|Overall Study|Protocol Violation|18|||
160948560|NCT00902304|581200465|FG002|Overall Study|Protocol Violation|20|||
160948561|NCT00902304|581200463|FG000|Overall Study|Withdrawal by Subject|32|||
160948562|NCT00902304|581200464|FG001|Overall Study|Withdrawal by Subject|22|||
160581501|NCT00804193|579848507|FG001|Overall Study|Adverse Event|0|||
160581502|NCT00804193|579848508|FG002|Overall Study|Adverse Event|2|||
160581503|NCT00804193|579848506|FG000|Overall Study|Lack of Efficacy|1|||
160656161|NCT00920140|580122359|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160656162|NCT00920140|580122355|FG000|Phase 2|Adverse Event|0|||
160656163|NCT00920140|580122356|FG001|Phase 2|Adverse Event|0|||
160656164|NCT00920140|580122357|FG002|Phase 2|Adverse Event|14|||
160656165|NCT00920140|580122358|FG003|Phase 2|Adverse Event|2|||
160656166|NCT00920140|580122359|FG004|Phase 2|Adverse Event|3|||
160656167|NCT00920140|580122355|FG000|Phase 2|Lack of Efficacy|0|||
160656168|NCT00920140|580122356|FG001|Phase 2|Lack of Efficacy|0|||
160656169|NCT00920140|580122357|FG002|Phase 2|Lack of Efficacy|29|||
160656170|NCT00920140|580122358|FG003|Phase 2|Lack of Efficacy|14|||
160656171|NCT00920140|580122359|FG004|Phase 2|Lack of Efficacy|5|||
160656172|NCT00920140|580122355|FG000|Phase 2|Lost to Follow-up|0|||
160656173|NCT00920140|580122356|FG001|Phase 2|Lost to Follow-up|0|||
160656174|NCT00920140|580122357|FG002|Phase 2|Lost to Follow-up|0|||
160656175|NCT00920140|580122358|FG003|Phase 2|Lost to Follow-up|1|||
160656176|NCT00920140|580122359|FG004|Phase 2|Lost to Follow-up|0|||
160656177|NCT00920140|580122355|FG000|Phase 2|Physician Decision|0|||
160656178|NCT00920140|580122356|FG001|Phase 2|Physician Decision|0|||
160656179|NCT00920140|580122357|FG002|Phase 2|Physician Decision|3|||
160656180|NCT00920140|580122358|FG003|Phase 2|Physician Decision|3|||
160656181|NCT00920140|580122359|FG004|Phase 2|Physician Decision|2|||
160581504|NCT00804193|579848507|FG001|Overall Study|Lack of Efficacy|1|||
160581505|NCT00804193|579848508|FG002|Overall Study|Lack of Efficacy|3|||
160581506|NCT00804193|579848506|FG000|Overall Study|Protocol Violation|0|||
160581507|NCT00804193|579848507|FG001|Overall Study|Protocol Violation|8|||
160581508|NCT00804193|579848508|FG002|Overall Study|Protocol Violation|2|||
160581509|NCT00804193|579848506|FG000|Overall Study|Lost to Follow-up|3|||
160581510|NCT00804193|579848507|FG001|Overall Study|Lost to Follow-up|3|||
160581511|NCT00804193|579848508|FG002|Overall Study|Lost to Follow-up|4|||
160581512|NCT00804193|579848506|FG000|Overall Study|Withdrawal by Subject|3|||
160581513|NCT00804193|579848507|FG001|Overall Study|Withdrawal by Subject|1|||
160581514|NCT00804193|579848508|FG002|Overall Study|Withdrawal by Subject|2|||
160581515|NCT01193348|579848511|FG000|Screening Period|Screen Failure|5|||
160581516|NCT01193348|579848511|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
160581517|NCT01193348|579848511|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
160581518|NCT01193348|579848511|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
160581519|NCT01193348|579848511|FG000|Extension Treatment Period|Physician Decision|1|||
160581520|NCT01193348|579848511|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
160581521|NCT00968253|579848512|FG000|Overall Study|Death|0|||
160581522|NCT00968253|579848513|FG001|Overall Study|Death|0|||
160581523|NCT00968253|579848514|FG002|Overall Study|Death|2|||
160581524|NCT00968253|579848512|FG000|Overall Study|Withdrawal by Subject|0|||
160581525|NCT00968253|579848513|FG001|Overall Study|Withdrawal by Subject|0|||
160581526|NCT00968253|579848514|FG002|Overall Study|Withdrawal by Subject|1|||
160581527|NCT00968253|579848512|FG000|Overall Study|Disease Progression|0|||
160581528|NCT00968253|579848513|FG001|Overall Study|Disease Progression|3|||
160581529|NCT00968253|579848514|FG002|Overall Study|Disease Progression|3|||
160581530|NCT00968253|579848512|FG000|Overall Study|Adverse Event|0|||
160581531|NCT00968253|579848513|FG001|Overall Study|Adverse Event|0|||
160581532|NCT00968253|579848514|FG002|Overall Study|Adverse Event|1|||
160581533|NCT01745393|579848515|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
160581534|NCT01745393|579848516|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
160581535|NCT01745393|579848515|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
160581536|NCT01745393|579848516|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
160581537|NCT01745393|579848515|FG000|12-month Follow-up|Lost to Follow-up|6|||
160581538|NCT01745393|579848516|FG001|12-month Follow-up|Lost to Follow-up|5|||
160656182|NCT00920140|580122355|FG000|Phase 2|Withdrawal by Subject|0|||
160656183|NCT00920140|580122356|FG001|Phase 2|Withdrawal by Subject|0|||
160656184|NCT00920140|580122357|FG002|Phase 2|Withdrawal by Subject|4|||
160656185|NCT00920140|580122358|FG003|Phase 2|Withdrawal by Subject|2|||
160656186|NCT00920140|580122359|FG004|Phase 2|Withdrawal by Subject|1|||
160656187|NCT01400425|580122360|FG000|Overall Study|Withdrawal by Subject|10|||
160656188|NCT00720096|580122362|FG000|Overall Study|Withdrawal by Subject|0|||
160948563|NCT00902304|581200465|FG002|Overall Study|Withdrawal by Subject|43|||
160581539|NCT00905021|579848521|FG000|Overall Study|Adverse Event|2|||
160581540|NCT02488759|579848523|FG000|Overall Study|Disease progression|73|||
160581541|NCT02488759|579848524|FG001|Overall Study|Disease progression|111|||
160581542|NCT02488759|579848525|FG002|Overall Study|Disease progression|62|||
160581543|NCT02488759|579848526|FG003|Overall Study|Disease progression|7|||
160656189|NCT00720096|580122363|FG001|Overall Study|Withdrawal by Subject|2|||
160656190|NCT04557124|580122364|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
160656191|NCT04557124|580122365|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
160656192|NCT04557124|580122364|FG000|Mid-point (1 Month)|Missed testing|5|||
160656193|NCT04557124|580122365|FG001|Mid-point (1 Month)|Missed testing|4|||
160656194|NCT04557124|580122364|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
160581544|NCT02488759|579848527|FG004|Overall Study|Disease progression|4|||
160581545|NCT02488759|579848528|FG005|Overall Study|Disease progression|2|||
160581546|NCT02488759|579848523|FG000|Overall Study|Study drug toxicity|11|||
160581547|NCT02488759|579848524|FG001|Overall Study|Study drug toxicity|33|||
160581548|NCT02488759|579848525|FG002|Overall Study|Study drug toxicity|31|||
160581549|NCT02488759|579848526|FG003|Overall Study|Study drug toxicity|0|||
160948564|NCT00902304|581200463|FG000|Overall Study|includes pregnancy|3|||
160948565|NCT00902304|581200464|FG001|Overall Study|includes pregnancy|9|||
160948566|NCT00902304|581200465|FG002|Overall Study|includes pregnancy|2|||
160948567|NCT02492100|581200466|FG000|Overall Study|Death|1|||
160948568|NCT03832010|581200467|FG000|Overall Study|Withdrawal by Subject|2|||
160581550|NCT02488759|579848527|FG004|Overall Study|Study drug toxicity|0|||
160581551|NCT02488759|579848528|FG005|Overall Study|Study drug toxicity|2|||
160581552|NCT02488759|579848523|FG000|Overall Study|Adverse event unrelated to study drug|9|||
160581553|NCT02488759|579848524|FG001|Overall Study|Adverse event unrelated to study drug|11|||
160581554|NCT02488759|579848525|FG002|Overall Study|Adverse event unrelated to study drug|7|||
160581555|NCT02488759|579848526|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160581556|NCT02488759|579848527|FG004|Overall Study|Adverse event unrelated to study drug|1|||
160581557|NCT02488759|579848528|FG005|Overall Study|Adverse event unrelated to study drug|0|||
160581558|NCT02488759|579848523|FG000|Overall Study|Participant request to discontinue study treatment|6|||
160581559|NCT02488759|579848524|FG001|Overall Study|Participant request to discontinue study treatment|8|||
160581560|NCT02488759|579848525|FG002|Overall Study|Participant request to discontinue study treatment|4|||
160581561|NCT02488759|579848526|FG003|Overall Study|Participant request to discontinue study treatment|0|||
160581562|NCT02488759|579848527|FG004|Overall Study|Participant request to discontinue study treatment|0|||
160581563|NCT02488759|579848528|FG005|Overall Study|Participant request to discontinue study treatment|0|||
160581564|NCT02488759|579848523|FG000|Overall Study|Withdrawal by Subject|4|||
160581565|NCT02488759|579848524|FG001|Overall Study|Withdrawal by Subject|0|||
160581566|NCT02488759|579848525|FG002|Overall Study|Withdrawal by Subject|3|||
160581567|NCT02488759|579848526|FG003|Overall Study|Withdrawal by Subject|0|||
160581568|NCT02488759|579848527|FG004|Overall Study|Withdrawal by Subject|0|||
160581569|NCT02488759|579848528|FG005|Overall Study|Withdrawal by Subject|2|||
160581570|NCT02488759|579848523|FG000|Overall Study|Lost to Follow-up|0|||
160581571|NCT02488759|579848524|FG001|Overall Study|Lost to Follow-up|0|||
160581572|NCT02488759|579848525|FG002|Overall Study|Lost to Follow-up|2|||
160581573|NCT02488759|579848526|FG003|Overall Study|Lost to Follow-up|0|||
160581574|NCT02488759|579848527|FG004|Overall Study|Lost to Follow-up|0|||
160581575|NCT02488759|579848528|FG005|Overall Study|Lost to Follow-up|0|||
160581576|NCT02488759|579848523|FG000|Overall Study|Maximum clinical benefit|3|||
160581577|NCT02488759|579848524|FG001|Overall Study|Maximum clinical benefit|0|||
160581578|NCT02488759|579848525|FG002|Overall Study|Maximum clinical benefit|1|||
160581579|NCT02488759|579848526|FG003|Overall Study|Maximum clinical benefit|0|||
160581580|NCT02488759|579848527|FG004|Overall Study|Maximum clinical benefit|0|||
160581581|NCT02488759|579848528|FG005|Overall Study|Maximum clinical benefit|0|||
160581582|NCT02488759|579848523|FG000|Overall Study|Other reasons|7|||
160581583|NCT02488759|579848524|FG001|Overall Study|Other reasons|32|||
160581584|NCT02488759|579848525|FG002|Overall Study|Other reasons|23|||
160581585|NCT02488759|579848526|FG003|Overall Study|Other reasons|1|||
160581586|NCT02488759|579848527|FG004|Overall Study|Other reasons|1|||
160581587|NCT02488759|579848528|FG005|Overall Study|Other reasons|1|||
160581588|NCT03860844|579848529|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
160581589|NCT03860844|579848530|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
160581590|NCT03860844|579848531|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
160581591|NCT03860844|579848529|FG000|Overall Study|Progressive disease|5|||
160581592|NCT03860844|579848530|FG001|Overall Study|Progressive disease|3|||
160581593|NCT03860844|579848531|FG002|Overall Study|Progressive disease|4|||
160581594|NCT03860844|579848529|FG000|Overall Study|Other, Not related to COVID-19|0|||
160581595|NCT03860844|579848530|FG001|Overall Study|Other, Not related to COVID-19|1|||
160581596|NCT03860844|579848531|FG002|Overall Study|Other, Not related to COVID-19|0|||
160581597|NCT01678807|579848539|FG000|Overall Study|Adverse Event|4|||
160581598|NCT01678807|579848540|FG001|Overall Study|Adverse Event|4|||
160581599|NCT01678807|579848541|FG002|Overall Study|Adverse Event|0|||
160581600|NCT01678807|579848539|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
160948569|NCT03832010|581200468|FG001|Overall Study|Withdrawal by Subject|1|||
160948570|NCT03832010|581200469|FG002|Overall Study|Withdrawal by Subject|0|||
160948571|NCT03832010|581200467|FG000|Overall Study|Lost to Follow-up|2|||
160948572|NCT03832010|581200468|FG001|Overall Study|Lost to Follow-up|1|||
160581601|NCT01678807|579848540|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
160581602|NCT01678807|579848541|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
160581603|NCT02574312|579848542|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
160581604|NCT02574312|579848543|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
160581605|NCT05306873|579850283|FG000|Stage 2|Study stopped|1|||
160581606|NCT05306873|579850284|FG001|Stage 2|Study stopped|1|||
160581607|NCT05306873|579850285|FG002|Stage 2|Study stopped|0|||
160581608|NCT05306873|579850286|FG003|Stage 2|Study stopped|0|||
160581609|NCT05306873|579850283|FG000|Stage 2|Stage 2 Treatment Failure|2|||
160456334|NCT04433208|579401402|FG005|Overall Study|Withdrawal by Subject|1|||
160581610|NCT05306873|579850284|FG001|Stage 2|Stage 2 Treatment Failure|3|||
160581611|NCT05306873|579850285|FG002|Stage 2|Stage 2 Treatment Failure|0|||
160581612|NCT05306873|579850286|FG003|Stage 2|Stage 2 Treatment Failure|0|||
160581613|NCT05306873|579850283|FG000|Stage 2|Logistical issues due to participant moving|1|||
160581614|NCT05306873|579850284|FG001|Stage 2|Logistical issues due to participant moving|0|||
160581615|NCT05306873|579850285|FG002|Stage 2|Logistical issues due to participant moving|0|||
160581616|NCT05306873|579850286|FG003|Stage 2|Logistical issues due to participant moving|0|||
160581617|NCT05306873|579850283|FG000|Stage 3|Stage 3 Treatment Failure|0|||
160581618|NCT05306873|579850284|FG001|Stage 3|Stage 3 Treatment Failure|0|||
160581619|NCT05306873|579850285|FG002|Stage 3|Stage 3 Treatment Failure|0|||
160581620|NCT05306873|579850286|FG003|Stage 3|Stage 3 Treatment Failure|1|||
160581621|NCT05306873|579850283|FG000|Stage 3|Study Stopped|0|||
160581622|NCT05306873|579850284|FG001|Stage 3|Study Stopped|0|||
160581623|NCT05306873|579850285|FG002|Stage 3|Study Stopped|1|||
160581624|NCT05306873|579850286|FG003|Stage 3|Study Stopped|0|||
160581625|NCT00074412|579850290|FG000|Overall Study|Death|30|||
160581626|NCT00074412|579850291|FG001|Overall Study|Death|26|||
160581627|NCT00074412|579850290|FG000|Overall Study|Lost to Follow-up|52|||
160581628|NCT00074412|579850291|FG001|Overall Study|Lost to Follow-up|58|||
160581629|NCT01043185|579850292|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
160581630|NCT01043185|579850293|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
160581631|NCT01043185|579850294|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
160581632|NCT01043185|579850295|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
160581633|NCT01043185|579850296|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
160581634|NCT01043185|579850297|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
160581635|NCT01043185|579850298|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
160581636|NCT01043185|579850299|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
160581637|NCT01043185|579850300|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
160581638|NCT01043185|579850301|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
160581639|NCT00418834|579850302|FG000|Overall Study|Adverse Event|16|||
160581640|NCT00418834|579850303|FG001|Overall Study|Adverse Event|9|||
160581641|NCT00418834|579850302|FG000|Overall Study|Lost to Follow-up|0|||
160581642|NCT00418834|579850303|FG001|Overall Study|Lost to Follow-up|1|||
160581643|NCT00418834|579850302|FG000|Overall Study|Protocol Violation|4|||
160581644|NCT00418834|579850303|FG001|Overall Study|Protocol Violation|3|||
160581645|NCT00418834|579850302|FG000|Overall Study|Withdrawal by Subject|3|||
160581646|NCT00418834|579850303|FG001|Overall Study|Withdrawal by Subject|7|||
160581647|NCT01953328|579850304|FG000|Overall Study|Withdrawal by Subject|0|||
160581648|NCT01953328|579850305|FG001|Overall Study|Withdrawal by Subject|0|||
160581649|NCT01953328|579850306|FG002|Overall Study|Withdrawal by Subject|0|||
160581650|NCT01953328|579850307|FG003|Overall Study|Withdrawal by Subject|0|||
160581651|NCT01953328|579850308|FG004|Overall Study|Withdrawal by Subject|1|||
160581652|NCT01953328|579850309|FG005|Overall Study|Withdrawal by Subject|0|||
160581653|NCT01953328|579850310|FG006|Overall Study|Withdrawal by Subject|0|||
160581654|NCT01953328|579850311|FG007|Overall Study|Withdrawal by Subject|0|||
160581655|NCT01953328|579850304|FG000|Overall Study|Lost to Follow-up|0|||
160581656|NCT01953328|579850305|FG001|Overall Study|Lost to Follow-up|0|||
160581657|NCT01953328|579850306|FG002|Overall Study|Lost to Follow-up|0|||
160581658|NCT01953328|579850307|FG003|Overall Study|Lost to Follow-up|0|||
160581659|NCT01953328|579850308|FG004|Overall Study|Lost to Follow-up|1|||
160581660|NCT01953328|579850309|FG005|Overall Study|Lost to Follow-up|0|||
160581661|NCT01953328|579850310|FG006|Overall Study|Lost to Follow-up|0|||
160581662|NCT01953328|579850311|FG007|Overall Study|Lost to Follow-up|0|||
160581663|NCT01755195|579850314|FG000|Overall Study|Participant noncompliance|2|||
160581664|NCT01755195|579850314|FG000|Overall Study|Switched to alternative treatment|4|||
160581665|NCT01755195|579850314|FG000|Overall Study|Withdrawal by Subject|1|||
160581666|NCT01755195|579850314|FG000|Overall Study|Participant refused to start treatment|1|||
160581667|NCT01755195|579850314|FG000|Overall Study|Participant has been consented for another trial|1|||
160581668|NCT01755195|579850314|FG000|Overall Study|Refused further treatment|3|||
160581669|NCT01755195|579850314|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
160581670|NCT05113953|579850315|FG000|Overall Study|Adverse Event|5|||
160862152|NCT00696072|580889658|FG001|Overall Study|Disease Progression|30|||
160862153|NCT00696072|580889657|FG000|Overall Study|Non-specified|1|||
160862154|NCT00696072|580889658|FG001|Overall Study|Non-specified|2|||
160862155|NCT01597596|580889659|FG000|Overall Study|Study terminated by sponsor|1|||
160862156|NCT01597596|580889660|FG001|Overall Study|Study terminated by sponsor|0|||
160862157|NCT01597596|580889659|FG000|Overall Study|Physician Decision|0|||
160862158|NCT01597596|580889660|FG001|Overall Study|Physician Decision|1|||
160862159|NCT00124943|580889661|FG000|Phase II|Adverse Event|0|||
160862160|NCT00124943|580889662|FG001|Phase II|Adverse Event|2|||
160862161|NCT00124943|580889663|FG002|Phase II|Adverse Event|0|||
160862162|NCT00124943|580889664|FG003|Phase II|Adverse Event|1|||
160862163|NCT00124943|580889661|FG000|Phase II|Protocol Violation|0|||
160862164|NCT00124943|580889662|FG001|Phase II|Protocol Violation|0|||
160456335|NCT04433208|579401397|FG000|Overall Study|Lost to Follow-up|0|||
160456336|NCT04433208|579401398|FG001|Overall Study|Lost to Follow-up|0|||
160948573|NCT03832010|581200469|FG002|Overall Study|Lost to Follow-up|1|||
160948574|NCT04969783|581200470|FG000|Overall Study|Lost to Follow-up|2|||
160948575|NCT04969783|581200471|FG001|Overall Study|Lost to Follow-up|0|||
160948576|NCT04969783|581200470|FG000|Overall Study|Withdrawal by Subject|4|||
160948577|NCT04969783|581200471|FG001|Overall Study|Withdrawal by Subject|0|||
160948578|NCT04969783|581200470|FG000|Overall Study|Physician Decision|6|||
160948579|NCT04969783|581200471|FG001|Overall Study|Physician Decision|0|||
160948580|NCT02489500|581200472|FG000|Overall Study|Death|1|||
160948581|NCT02489500|581200473|FG001|Overall Study|Death|1|||
160948582|NCT00987467|581200478|FG000|Overall Study|Lost to Follow-up|2|||
160948583|NCT02019719|581200481|FG000|Overall Study|Adverse Event|1|||
160948584|NCT02019719|581200482|FG001|Overall Study|Adverse Event|0|||
160948585|NCT02019719|581200483|FG002|Overall Study|Adverse Event|0|||
160948586|NCT02019719|581200484|FG003|Overall Study|Adverse Event|1|||
160948587|NCT02019719|581200485|FG004|Overall Study|Adverse Event|1|||
160948588|NCT02019719|581200481|FG000|Overall Study|Protocol Violation|1|||
160948589|NCT02019719|581200482|FG001|Overall Study|Protocol Violation|1|||
160948590|NCT02019719|581200483|FG002|Overall Study|Protocol Violation|0|||
160948591|NCT02019719|581200484|FG003|Overall Study|Protocol Violation|0|||
160456337|NCT04433208|579401399|FG002|Overall Study|Lost to Follow-up|0|||
160581671|NCT05113953|579850316|FG001|Overall Study|Adverse Event|0|||
160581672|NCT05113953|579850317|FG002|Overall Study|Adverse Event|3|||
160581673|NCT05113953|579850315|FG000|Overall Study|Lost to Follow-up|3|||
160581674|NCT05113953|579850316|FG001|Overall Study|Lost to Follow-up|4|||
160581675|NCT05113953|579850317|FG002|Overall Study|Lost to Follow-up|2|||
160581676|NCT05113953|579850315|FG000|Overall Study|Non-compliance with Study Drug|1|||
160581677|NCT05113953|579850316|FG001|Overall Study|Non-compliance with Study Drug|0|||
160581678|NCT05113953|579850317|FG002|Overall Study|Non-compliance with Study Drug|0|||
160581679|NCT05113953|579850315|FG000|Overall Study|Withdrawal by Subject|2|||
160581680|NCT05113953|579850316|FG001|Overall Study|Withdrawal by Subject|6|||
160581681|NCT05113953|579850317|FG002|Overall Study|Withdrawal by Subject|4|||
160581682|NCT05113953|579850315|FG000|Overall Study|Reason not Specified|2|||
160581683|NCT05113953|579850316|FG001|Overall Study|Reason not Specified|0|||
160581684|NCT05113953|579850317|FG002|Overall Study|Reason not Specified|0|||
160581685|NCT03470922|579850324|FG000|Overall Study|Death|107|||
160581686|NCT03470922|579850325|FG001|Overall Study|Death|118|||
160581687|NCT03470922|579850324|FG000|Overall Study|Lost to Follow-up|5|||
160581688|NCT03470922|579850325|FG001|Overall Study|Lost to Follow-up|5|||
160581689|NCT03470922|579850324|FG000|Overall Study|Participant Withdrew Consent|4|||
160581690|NCT03470922|579850325|FG001|Overall Study|Participant Withdrew Consent|9|||
160581691|NCT03470922|579850324|FG000|Overall Study|Other reasons|1|||
160581692|NCT03470922|579850325|FG001|Overall Study|Other reasons|0|||
160948592|NCT02019719|581200485|FG004|Overall Study|Protocol Violation|0|||
160948593|NCT02019719|581200481|FG000|Overall Study|Protocol defined stopping criteria|2|||
160948594|NCT02019719|581200482|FG001|Overall Study|Protocol defined stopping criteria|0|||
160581693|NCT03470922|579850324|FG000|Overall Study|Not reported|1|||
160581694|NCT03470922|579850325|FG001|Overall Study|Not reported|0|||
160581695|NCT02340819|579850326|FG000|Overall Study|Adverse Event|1|||
160581696|NCT02340819|579850326|FG000|Overall Study|Withdrawal by Subject|2|||
160581697|NCT02340819|579850326|FG000|Overall Study|Discontinued with other reason|1|||
160581698|NCT02626819|579850327|FG000|Overall Study|Lost to Follow-up|3|||
160581699|NCT02626819|579850328|FG001|Overall Study|Lost to Follow-up|2|||
160581700|NCT02626819|579850327|FG000|Overall Study|Withdrawal by Subject|1|||
160581701|NCT02626819|579850328|FG001|Overall Study|Withdrawal by Subject|0|||
160581702|NCT02626819|579850327|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
160581703|NCT02626819|579850328|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
160581704|NCT02361762|579850329|FG000|Overall Study|Withdrawal by Subject|0|||
160581705|NCT02361762|579850330|FG001|Overall Study|Withdrawal by Subject|1|||
160581706|NCT02361762|579850329|FG000|Overall Study|Lost to Follow-up|0|||
160581707|NCT02361762|579850330|FG001|Overall Study|Lost to Follow-up|1|||
160581708|NCT00502307|579850331|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
160581709|NCT00502307|579850332|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
160948595|NCT02019719|581200483|FG002|Overall Study|Protocol defined stopping criteria|0|||
160948596|NCT02019719|581200484|FG003|Overall Study|Protocol defined stopping criteria|1|||
160456338|NCT04433208|579401400|FG003|Overall Study|Lost to Follow-up|0|||
160581710|NCT00502307|579850333|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
160948597|NCT02019719|581200485|FG004|Overall Study|Protocol defined stopping criteria|1|||
160456339|NCT04433208|579401401|FG004|Overall Study|Lost to Follow-up|0|||
160581711|NCT00502307|579850331|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
160581712|NCT00502307|579850332|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
160581713|NCT00502307|579850333|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
160581714|NCT00502307|579850331|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
160581715|NCT00502307|579850332|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
160581716|NCT00502307|579850333|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
160948598|NCT02019719|581200481|FG000|Overall Study|Physician Decision|2|||
160948599|NCT02019719|581200482|FG001|Overall Study|Physician Decision|0|||
160948600|NCT02019719|581200483|FG002|Overall Study|Physician Decision|0|||
160948601|NCT02019719|581200484|FG003|Overall Study|Physician Decision|0|||
160948602|NCT02019719|581200485|FG004|Overall Study|Physician Decision|0|||
160948603|NCT02417246|581200486|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
160948604|NCT02417246|581200487|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
160948605|NCT02417246|581200486|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
160948606|NCT02417246|581200487|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
160581717|NCT00502307|579850331|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
160581718|NCT00502307|579850332|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
160581719|NCT00502307|579850333|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
160581720|NCT00502307|579850331|FG000|Maintenance Period|Progressive disease|80|||
160581721|NCT00502307|579850332|FG001|Maintenance Period|Progressive disease|0|||
160581722|NCT00502307|579850333|FG002|Maintenance Period|Progressive disease|0|||
160581723|NCT00502307|579850331|FG000|Maintenance Period|Discontinued due to other reasons|68|||
160581724|NCT00502307|579850332|FG001|Maintenance Period|Discontinued due to other reasons|0|||
160581725|NCT00502307|579850333|FG002|Maintenance Period|Discontinued due to other reasons|0|||
160581726|NCT02273050|579850336|FG000|Overall Study|Adverse Event|4|||
160581727|NCT02273050|579850337|FG001|Overall Study|Adverse Event|3|||
160581728|NCT02273050|579850338|FG002|Overall Study|Adverse Event|3|||
160581729|NCT02273050|579850336|FG000|Overall Study|Death|0|||
160581730|NCT02273050|579850337|FG001|Overall Study|Death|0|||
160581731|NCT02273050|579850338|FG002|Overall Study|Death|1|||
160581732|NCT02273050|579850336|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
160581733|NCT02273050|579850337|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
160581734|NCT02273050|579850338|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
160581735|NCT02273050|579850336|FG000|Overall Study|Lack of Efficacy|0|||
160581736|NCT02273050|579850337|FG001|Overall Study|Lack of Efficacy|1|||
160581737|NCT02273050|579850338|FG002|Overall Study|Lack of Efficacy|1|||
160581738|NCT02273050|579850336|FG000|Overall Study|Withdrawal by Subject|17|||
160581739|NCT02273050|579850337|FG001|Overall Study|Withdrawal by Subject|14|||
160581740|NCT02273050|579850338|FG002|Overall Study|Withdrawal by Subject|16|||
160581741|NCT02273050|579850336|FG000|Overall Study|Lost to Follow-up|0|||
160581742|NCT02273050|579850337|FG001|Overall Study|Lost to Follow-up|2|||
160581743|NCT02273050|579850338|FG002|Overall Study|Lost to Follow-up|3|||
160581744|NCT02273050|579850336|FG000|Overall Study|Protocol Violation|3|||
160581745|NCT02273050|579850337|FG001|Overall Study|Protocol Violation|1|||
160656195|NCT04557124|580122365|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
160948607|NCT02417246|581200486|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
160948608|NCT02417246|581200487|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
160948609|NCT02417246|581200486|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
160948610|NCT02417246|581200487|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
160948611|NCT04408469|581200497|FG000|Overall Study|Lost to Follow-up|6|||
160948612|NCT04408469|581200498|FG001|Overall Study|Lost to Follow-up|9|||
160948613|NCT04408469|581200497|FG000|Overall Study|Withdrawal by Subject|6|||
160948614|NCT04408469|581200498|FG001|Overall Study|Withdrawal by Subject|1|||
160948615|NCT04408469|581200497|FG000|Overall Study|Dismissal due to ineligibility|0|||
160948616|NCT04408469|581200498|FG001|Overall Study|Dismissal due to ineligibility|1|||
160948617|NCT04321460|581200499|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
160948618|NCT04321460|581200500|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
160948619|NCT03669081|581200503|FG000|Overall Study|Data could not be validated|1|||
160948620|NCT03669081|581200504|FG001|Overall Study|Data could not be validated|1|||
160948621|NCT01308749|581200509|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
160948622|NCT01308749|581200510|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
160948623|NCT01308749|581200509|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
160948624|NCT01308749|581200510|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
160948625|NCT01308749|581200509|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
160948626|NCT01308749|581200510|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
160948627|NCT02546544|581200511|FG000|Overall Study|Disease Progression|14|||
160948628|NCT02546544|581200511|FG000|Overall Study|Adverse Event|1|||
160948629|NCT02546544|581200511|FG000|Overall Study|Withdrawal by Subject|1|||
160948630|NCT01921348|581200512|FG000|Overall Study|Withdrawal by Subject|1|||
160948631|NCT01921348|581200513|FG001|Overall Study|Withdrawal by Subject|0|||
160948632|NCT01921348|581200512|FG000|Overall Study|Lost to Follow-up|0|||
160581746|NCT02273050|579850338|FG002|Overall Study|Protocol Violation|4|||
160581747|NCT02273752|579850339|FG000|Overall Study|Trial was terminated early|2|||
160581748|NCT00903032|579850340|FG000|Overall Study|Withdrawal by Subject|5|||
160581749|NCT00903032|579850341|FG001|Overall Study|Withdrawal by Subject|3|||
160948633|NCT01921348|581200513|FG001|Overall Study|Lost to Follow-up|2|||
160948634|NCT02223390|581200514|FG000|Overall Study|Lost to Follow-up|9|||
160948635|NCT02223390|581200515|FG001|Overall Study|Lost to Follow-up|4|||
160948636|NCT01197950|581200521|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
160948637|NCT01197950|581200522|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
160948638|NCT01197950|581200523|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
160948639|NCT02553330|581200524|FG000|Overall Study|Study Terminated by Sponsor|2|||
160948640|NCT02553330|581200525|FG001|Overall Study|Study Terminated by Sponsor|13|||
160948641|NCT02553330|581200526|FG002|Overall Study|Study Terminated by Sponsor|12|||
160948642|NCT02553330|581200524|FG000|Overall Study|Withdrawal by Subject|3|||
160948643|NCT02553330|581200525|FG001|Overall Study|Withdrawal by Subject|19|||
160948644|NCT02553330|581200526|FG002|Overall Study|Withdrawal by Subject|21|||
160948645|NCT02553330|581200524|FG000|Overall Study|Other|0|||
160948646|NCT02553330|581200525|FG001|Overall Study|Other|1|||
160948647|NCT02553330|581200526|FG002|Overall Study|Other|0|||
160948648|NCT02553330|581200524|FG000|Overall Study|Non compliance to study treatment|0|||
160948649|NCT02553330|581200525|FG001|Overall Study|Non compliance to study treatment|1|||
160948650|NCT02553330|581200526|FG002|Overall Study|Non compliance to study treatment|0|||
160948651|NCT02553330|581200524|FG000|Overall Study|Adverse Event|0|||
160948652|NCT02553330|581200525|FG001|Overall Study|Adverse Event|1|||
160948653|NCT02553330|581200526|FG002|Overall Study|Adverse Event|0|||
160948654|NCT02553330|581200524|FG000|Overall Study|Lost to Follow-up|0|||
160948655|NCT02553330|581200525|FG001|Overall Study|Lost to Follow-up|4|||
160948656|NCT02553330|581200526|FG002|Overall Study|Lost to Follow-up|4|||
160948657|NCT02896855|581200527|FG000|Overall Study|Death|50|||
160948658|NCT02896855|581200528|FG001|Overall Study|Death|40|||
160948659|NCT02896855|581200527|FG000|Overall Study|Lost to Follow-up|15|||
160948660|NCT02896855|581200528|FG001|Overall Study|Lost to Follow-up|9|||
160948661|NCT02896855|581200527|FG000|Overall Study|Withdrawal by Subject|7|||
160948662|NCT02896855|581200528|FG001|Overall Study|Withdrawal by Subject|4|||
160948663|NCT01205685|581200529|FG000|Overall Study|Disease Progression|10|||
160948664|NCT01205685|581200529|FG000|Overall Study|Withdrawal by Subject|1|||
160948665|NCT02169674|581200530|FG000|Overall Study|Withdrawal by Subject|2|||
160948666|NCT02169674|581200531|FG001|Overall Study|Withdrawal by Subject|1|||
160948667|NCT02169674|581200530|FG000|Overall Study|Seroprotected|30|||
160948668|NCT02169674|581200531|FG001|Overall Study|Seroprotected|76|||
160948669|NCT02169674|581200530|FG000|Overall Study|Lost to Follow-up|0|||
160948670|NCT02169674|581200531|FG001|Overall Study|Lost to Follow-up|1|||
160948671|NCT01666002|581200532|FG000|Overall Study|Lost to Follow-up|5|||
160948672|NCT01666002|581200533|FG001|Overall Study|Lost to Follow-up|0|||
160948673|NCT02511431|581200534|FG000|Treatment|Lost to Follow-up|0|||
160948674|NCT02511431|581200535|FG001|Treatment|Lost to Follow-up|0|||
160948675|NCT02511431|581200536|FG002|Treatment|Lost to Follow-up|1|||
160581750|NCT00903032|579850340|FG000|Overall Study|Lost to Follow-up|2|||
160581751|NCT00903032|579850341|FG001|Overall Study|Lost to Follow-up|2|||
160581752|NCT01429792|579850342|FG000|Overall Study|Other Reasons|67|||
160581753|NCT01429792|579850342|FG000|Overall Study|Unknown Disposition|94|||
160581754|NCT01429792|579850342|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
160581755|NCT01429792|579850342|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
160581756|NCT01429792|579850342|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
160581757|NCT01429792|579850342|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
160581758|NCT01429792|579850342|FG000|Overall Study|Withdrawal by Subject|70|||
160581759|NCT01429792|579850342|FG000|Overall Study|Lost to Follow-up|88|||
160581760|NCT04346628|579850345|FG000|Overall Study|Lost to Follow-up|4|||
160581761|NCT04346628|579850346|FG001|Overall Study|Lost to Follow-up|4|||
160581762|NCT04346628|579850345|FG000|Overall Study|Withdrew (had personal reasons)|2|||
160581763|NCT04346628|579850346|FG001|Overall Study|Withdrew (had personal reasons)|5|||
160581764|NCT04346628|579850345|FG000|Overall Study|Withdrew (medication intolerant)|0|||
160581765|NCT04346628|579850346|FG001|Overall Study|Withdrew (medication intolerant)|3|||
160581766|NCT04346628|579850345|FG000|Overall Study|Withdrew (declined intervention)|0|||
160581767|NCT04346628|579850346|FG001|Overall Study|Withdrew (declined intervention)|1|||
160581768|NCT01763905|579850347|FG000|Overall Study|Withdrawal by Subject|1|||
160948676|NCT02511431|581200537|FG003|Treatment|Lost to Follow-up|0|||
160948677|NCT02511431|581200538|FG004|Treatment|Lost to Follow-up|0|||
160948678|NCT02511431|581200539|FG005|Treatment|Lost to Follow-up|1|||
160948679|NCT03058679|581200547|FG000|Baseline to Week 6|Lost to Follow-up|3|||
160948680|NCT03058679|581200548|FG001|Baseline to Week 6|Lost to Follow-up|2|||
160581769|NCT01763905|579850348|FG001|Overall Study|Withdrawal by Subject|1|||
160581770|NCT01763905|579850349|FG002|Overall Study|Withdrawal by Subject|0|||
160581771|NCT01763905|579850350|FG003|Overall Study|Withdrawal by Subject|1|||
160581772|NCT01763905|579850347|FG000|Overall Study|Decision by sponsor|5|||
160948681|NCT03058679|581200547|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
160948682|NCT03058679|581200548|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
160948683|NCT03058679|581200547|FG000|Baseline to Week 6|Adverse Event|6|||
160948684|NCT03058679|581200548|FG001|Baseline to Week 6|Adverse Event|6|||
160948685|NCT03058679|581200547|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
160948686|NCT03058679|581200548|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
160948687|NCT03058679|581200547|FG000|Baseline to Week 6|Difficulty following the diet|0|||
160948688|NCT03058679|581200548|FG001|Baseline to Week 6|Difficulty following the diet|2|||
160948689|NCT03058679|581200547|FG000|Baseline to Week 6|Physician Decision|1|||
160581773|NCT01763905|579850348|FG001|Overall Study|Decision by sponsor|0|||
160581774|NCT01763905|579850349|FG002|Overall Study|Decision by sponsor|8|||
160581775|NCT01763905|579850350|FG003|Overall Study|Decision by sponsor|0|||
160581776|NCT01763905|579850347|FG000|Overall Study|Lost to Follow-up|0|||
160581777|NCT01763905|579850348|FG001|Overall Study|Lost to Follow-up|0|||
160581778|NCT01763905|579850349|FG002|Overall Study|Lost to Follow-up|1|||
160581779|NCT01763905|579850350|FG003|Overall Study|Lost to Follow-up|0|||
160581780|NCT02324842|579850357|FG000|Overall Study|Lost to Follow-up|1|||
160581781|NCT02324842|579850358|FG001|Overall Study|Lost to Follow-up|1|||
160581782|NCT02324842|579850359|FG002|Overall Study|Lost to Follow-up|2|||
160581783|NCT03298412|579850362|FG000|Run-in Period|Other, Not Specified|1|||
160581784|NCT03298412|579850362|FG000|Run-in Period|Disease Progression|1|||
160581785|NCT03298412|579850362|FG000|Run-in Period|Ineligibility Determined|1|||
160581786|NCT03298412|579850362|FG000|Run-in Period|Decision by Sponsor|6|||
160581787|NCT03456713|579850365|FG000|Overall Study|Lost to Follow-up|1|||
160581788|NCT03456713|579850366|FG001|Overall Study|Lost to Follow-up|0|||
160948690|NCT03058679|581200548|FG001|Baseline to Week 6|Physician Decision|0|||
160948691|NCT03058679|581200547|FG000|Week 6 to Week 12|Change in medication|5|||
160948692|NCT03058679|581200548|FG001|Week 6 to Week 12|Change in medication|7|||
160948693|NCT03058679|581200547|FG000|Week 6 to Week 12|Adverse Event|4|||
160948694|NCT03058679|581200548|FG001|Week 6 to Week 12|Adverse Event|3|||
160948695|NCT03058679|581200547|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
160948696|NCT03058679|581200548|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
160948697|NCT03058679|581200547|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
160948698|NCT03058679|581200548|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
160948699|NCT04137380|581200553|FG000|Overall Study|Physician Decision|0|||
160948700|NCT04137380|581200554|FG001|Overall Study|Physician Decision|0|||
160948701|NCT04137380|581200555|FG002|Overall Study|Physician Decision|0|||
160948702|NCT04137380|581200556|FG003|Overall Study|Physician Decision|1|||
160948703|NCT04137380|581200557|FG004|Overall Study|Physician Decision|0|||
160948704|NCT04137380|581200558|FG005|Overall Study|Physician Decision|0|||
160948705|NCT04137380|581200559|FG006|Overall Study|Physician Decision|0|||
160948706|NCT02265705|581200565|FG000|Treatment Period Week 0-24|Adverse Event|3|||
160948707|NCT02265705|581200566|FG001|Treatment Period Week 0-24|Adverse Event|2|||
160948708|NCT02265705|581200567|FG002|Treatment Period Week 0-24|Adverse Event|0|||
160948709|NCT02265705|581200568|FG003|Treatment Period Week 0-24|Adverse Event|0|||
160948710|NCT02265705|581200569|FG004|Treatment Period Week 0-24|Adverse Event|0|||
160948711|NCT02265705|581200570|FG005|Treatment Period Week 0-24|Adverse Event|0|||
160948712|NCT02265705|581200571|FG006|Treatment Period Week 0-24|Adverse Event|0|||
160948713|NCT02265705|581200565|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
160948714|NCT02265705|581200566|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
160948715|NCT02265705|581200567|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
160948716|NCT02265705|581200568|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
160948717|NCT02265705|581200569|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
160948718|NCT02265705|581200570|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
160948719|NCT02265705|581200571|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
160948720|NCT02265705|581200565|FG000|Treatment Period Week 0-24|Physician Decision|1|||
160948721|NCT02265705|581200566|FG001|Treatment Period Week 0-24|Physician Decision|0|||
160948722|NCT02265705|581200567|FG002|Treatment Period Week 0-24|Physician Decision|0|||
160948723|NCT02265705|581200568|FG003|Treatment Period Week 0-24|Physician Decision|0|||
160948724|NCT02265705|581200569|FG004|Treatment Period Week 0-24|Physician Decision|0|||
160948725|NCT02265705|581200570|FG005|Treatment Period Week 0-24|Physician Decision|0|||
160948726|NCT02265705|581200571|FG006|Treatment Period Week 0-24|Physician Decision|0|||
160948727|NCT02265705|581200565|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
160948728|NCT02265705|581200566|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
160948729|NCT02265705|581200567|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
160948730|NCT02265705|581200568|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
160948731|NCT02265705|581200569|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
160581789|NCT03456713|579850367|FG002|Overall Study|Lost to Follow-up|0|||
160581790|NCT03456713|579850368|FG003|Overall Study|Lost to Follow-up|0|||
160581791|NCT01263691|579850369|FG000|Overall Study|Lost to Follow-up|1|||
160581792|NCT01263691|579850370|FG001|Overall Study|Lost to Follow-up|0|||
160948732|NCT02265705|581200570|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
160948733|NCT02265705|581200571|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
160948734|NCT02265705|581200565|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
160999821|NCT02341625|581382812|FG009|Overall Study|Not Reported|3|||
160581793|NCT01263691|579850371|FG002|Overall Study|Lost to Follow-up|1|||
160581794|NCT01263691|579850372|FG003|Overall Study|Lost to Follow-up|1|||
160581795|NCT01263691|579850373|FG004|Overall Study|Lost to Follow-up|0|||
160581796|NCT01263691|579850374|FG005|Overall Study|Lost to Follow-up|0|||
160948735|NCT02265705|581200566|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
160948736|NCT02265705|581200567|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
160948737|NCT02265705|581200568|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
160948738|NCT02265705|581200569|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
160948739|NCT02265705|581200570|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
160581797|NCT01263691|579850369|FG000|Overall Study|Withdrawal by Subject|1|||
160581798|NCT01263691|579850370|FG001|Overall Study|Withdrawal by Subject|0|||
160581799|NCT01263691|579850371|FG002|Overall Study|Withdrawal by Subject|0|||
160581800|NCT01263691|579850372|FG003|Overall Study|Withdrawal by Subject|0|||
160581801|NCT01263691|579850373|FG004|Overall Study|Withdrawal by Subject|0|||
160581802|NCT01263691|579850374|FG005|Overall Study|Withdrawal by Subject|0|||
160581803|NCT01263691|579850369|FG000|Overall Study|Adverse Event|1|||
160581804|NCT01263691|579850370|FG001|Overall Study|Adverse Event|0|||
160581805|NCT01263691|579850371|FG002|Overall Study|Adverse Event|0|||
160581806|NCT01263691|579850372|FG003|Overall Study|Adverse Event|0|||
160581807|NCT01263691|579850373|FG004|Overall Study|Adverse Event|0|||
160581808|NCT01263691|579850374|FG005|Overall Study|Adverse Event|0|||
160581809|NCT01202227|579850375|FG000|Overall Study|Adverse Event|16|||
160581810|NCT01202227|579850375|FG000|Overall Study|Withdrawal by Subject|2|||
160948740|NCT02265705|581200571|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
160948741|NCT02265705|581200565|FG000|Rescue Period|Withdrawal by Subject|0|||
160948742|NCT02265705|581200566|FG001|Rescue Period|Withdrawal by Subject|0|||
160948743|NCT02265705|581200567|FG002|Rescue Period|Withdrawal by Subject|1|||
160948744|NCT02265705|581200568|FG003|Rescue Period|Withdrawal by Subject|0|||
160948745|NCT02265705|581200569|FG004|Rescue Period|Withdrawal by Subject|0|||
160948746|NCT02265705|581200570|FG005|Rescue Period|Withdrawal by Subject|0|||
160948747|NCT02265705|581200571|FG006|Rescue Period|Withdrawal by Subject|0|||
160948748|NCT02265705|581200565|FG000|Rescue Period|Death|0|||
160948749|NCT02265705|581200566|FG001|Rescue Period|Death|0|||
160948750|NCT02265705|581200567|FG002|Rescue Period|Death|1|||
160948751|NCT02265705|581200568|FG003|Rescue Period|Death|0|||
160948752|NCT02265705|581200569|FG004|Rescue Period|Death|0|||
160948753|NCT02265705|581200570|FG005|Rescue Period|Death|0|||
160948754|NCT02265705|581200571|FG006|Rescue Period|Death|0|||
160948755|NCT02265705|581200565|FG000|Rescue Period|Lack of Efficacy|0|||
160948756|NCT02265705|581200566|FG001|Rescue Period|Lack of Efficacy|0|||
160948757|NCT02265705|581200567|FG002|Rescue Period|Lack of Efficacy|1|||
160948758|NCT02265705|581200568|FG003|Rescue Period|Lack of Efficacy|0|||
160948759|NCT02265705|581200569|FG004|Rescue Period|Lack of Efficacy|0|||
160948760|NCT02265705|581200570|FG005|Rescue Period|Lack of Efficacy|0|||
160948761|NCT02265705|581200571|FG006|Rescue Period|Lack of Efficacy|0|||
160948762|NCT02265705|581200565|FG000|Open Label Period|Adverse Event|0|||
160948763|NCT02265705|581200566|FG001|Open Label Period|Adverse Event|0|||
160948764|NCT02265705|581200567|FG002|Open Label Period|Adverse Event|0|||
160948765|NCT02265705|581200568|FG003|Open Label Period|Adverse Event|2|||
160948766|NCT02265705|581200569|FG004|Open Label Period|Adverse Event|2|||
160948767|NCT02265705|581200570|FG005|Open Label Period|Adverse Event|0|||
160948768|NCT02265705|581200571|FG006|Open Label Period|Adverse Event|0|||
160948769|NCT02265705|581200565|FG000|Open Label Period|Physician Decision|0|||
160948770|NCT02265705|581200566|FG001|Open Label Period|Physician Decision|0|||
160948771|NCT02265705|581200567|FG002|Open Label Period|Physician Decision|0|||
160948772|NCT02265705|581200568|FG003|Open Label Period|Physician Decision|0|||
160948773|NCT02265705|581200569|FG004|Open Label Period|Physician Decision|1|||
160948774|NCT02265705|581200570|FG005|Open Label Period|Physician Decision|0|||
160948775|NCT02265705|581200571|FG006|Open Label Period|Physician Decision|0|||
160948776|NCT02265705|581200565|FG000|Open Label Period|Withdrawal by Subject|0|||
160948777|NCT02265705|581200566|FG001|Open Label Period|Withdrawal by Subject|0|||
160948778|NCT02265705|581200567|FG002|Open Label Period|Withdrawal by Subject|0|||
160948779|NCT02265705|581200568|FG003|Open Label Period|Withdrawal by Subject|0|||
160948780|NCT02265705|581200569|FG004|Open Label Period|Withdrawal by Subject|2|||
160948781|NCT02265705|581200570|FG005|Open Label Period|Withdrawal by Subject|0|||
160948782|NCT02265705|581200571|FG006|Open Label Period|Withdrawal by Subject|0|||
160948783|NCT02265705|581200565|FG000|Follow-up Period|Sponsor Decision|0|||
160948784|NCT02265705|581200566|FG001|Follow-up Period|Sponsor Decision|0|||
160948785|NCT02265705|581200567|FG002|Follow-up Period|Sponsor Decision|0|||
160948786|NCT02265705|581200568|FG003|Follow-up Period|Sponsor Decision|0|||
160948787|NCT02265705|581200569|FG004|Follow-up Period|Sponsor Decision|0|||
160581811|NCT01202227|579850375|FG000|Overall Study|Lack of Efficacy|1|||
160581812|NCT01894477|579850376|FG000|Overall Study|Protocol Violation|0|||
160656196|NCT04557124|580122364|FG000|Post-testing (2 Months)|Missed testing|1|||
160948788|NCT02265705|581200570|FG005|Follow-up Period|Sponsor Decision|1|||
160948789|NCT02265705|581200571|FG006|Follow-up Period|Sponsor Decision|6|||
160948790|NCT02265705|581200565|FG000|Follow-up Period|Adverse Event|0|||
160948791|NCT02265705|581200566|FG001|Follow-up Period|Adverse Event|0|||
160456340|NCT04433208|579401402|FG005|Overall Study|Lost to Follow-up|1|||
160581813|NCT01894477|579850377|FG001|Overall Study|Protocol Violation|1|||
160581814|NCT01894477|579850376|FG000|Overall Study|protocol changed due SC changed to cord|0|||
160656197|NCT04557124|580122365|FG001|Post-testing (2 Months)|Missed testing|5|||
160948792|NCT02265705|581200567|FG002|Follow-up Period|Adverse Event|0|||
160948793|NCT02265705|581200568|FG003|Follow-up Period|Adverse Event|0|||
160948794|NCT02265705|581200569|FG004|Follow-up Period|Adverse Event|0|||
160948795|NCT02265705|581200570|FG005|Follow-up Period|Adverse Event|0|||
160948796|NCT02265705|581200571|FG006|Follow-up Period|Adverse Event|3|||
160948797|NCT02265705|581200565|FG000|Follow-up Period|Physician Decision|0|||
160581815|NCT01894477|579850377|FG001|Overall Study|protocol changed due SC changed to cord|1|||
160581816|NCT03656926|579850393|FG000|Overall Study|Adverse Event|5|||
160581817|NCT03656926|579850394|FG001|Overall Study|Adverse Event|4|||
160581818|NCT03656926|579850393|FG000|Overall Study|Withdrawal by Subject|7|||
160581819|NCT03656926|579850394|FG001|Overall Study|Withdrawal by Subject|2|||
160581820|NCT03656926|579850393|FG000|Overall Study|Screen fail after randomization|1|||
160581821|NCT03656926|579850394|FG001|Overall Study|Screen fail after randomization|0|||
160581822|NCT03656926|579850393|FG000|Overall Study|PI decision due to patient condition|1|||
160581823|NCT03656926|579850394|FG001|Overall Study|PI decision due to patient condition|0|||
160581824|NCT03656926|579850393|FG000|Overall Study|Patient unresponsiveness|1|||
160581825|NCT03656926|579850394|FG001|Overall Study|Patient unresponsiveness|0|||
160581826|NCT00850759|579850398|FG000|Overall Study|Lost to Follow-up|7|||
160581827|NCT00850759|579850399|FG001|Overall Study|Lost to Follow-up|5|||
160581828|NCT00850759|579850400|FG002|Overall Study|Lost to Follow-up|5|||
160581829|NCT00850759|579850401|FG003|Overall Study|Lost to Follow-up|3|||
160581830|NCT02389816|579850403|FG000|Overall Study|Randomized but Not Treated|1|||
160581831|NCT02389816|579850404|FG001|Overall Study|Randomized but Not Treated|0|||
160581832|NCT02389816|579850405|FG002|Overall Study|Randomized but Not Treated|0|||
160581833|NCT02389816|579850403|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
160581834|NCT02389816|579850404|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
160581835|NCT02389816|579850405|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
160581836|NCT02389816|579850403|FG000|Overall Study|Major Protocol Deviation|1|||
160581837|NCT02389816|579850404|FG001|Overall Study|Major Protocol Deviation|0|||
160581838|NCT02389816|579850405|FG002|Overall Study|Major Protocol Deviation|0|||
160581839|NCT02389816|579850403|FG000|Overall Study|Lost to Follow-up|1|||
160581840|NCT02389816|579850404|FG001|Overall Study|Lost to Follow-up|0|||
160581841|NCT02389816|579850405|FG002|Overall Study|Lost to Follow-up|0|||
160581842|NCT02389816|579850403|FG000|Overall Study|Withdrawal of Consent|6|||
160581843|NCT02389816|579850404|FG001|Overall Study|Withdrawal of Consent|4|||
160581844|NCT02389816|579850405|FG002|Overall Study|Withdrawal of Consent|4|||
160581845|NCT02389816|579850403|FG000|Overall Study|Lack of Efficacy|1|||
160581846|NCT02389816|579850404|FG001|Overall Study|Lack of Efficacy|0|||
160581847|NCT02389816|579850405|FG002|Overall Study|Lack of Efficacy|0|||
160581848|NCT02389816|579850403|FG000|Overall Study|Non Compliance with Study Drug|1|||
160581849|NCT02389816|579850404|FG001|Overall Study|Non Compliance with Study Drug|1|||
160656198|NCT04557124|580122364|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
160862165|NCT00124943|580889663|FG002|Phase II|Protocol Violation|0|||
160862166|NCT00124943|580889664|FG003|Phase II|Protocol Violation|1|||
160862167|NCT00124943|580889661|FG000|Phase II|Lost to Follow-up|0|||
160862168|NCT00124943|580889662|FG001|Phase II|Lost to Follow-up|0|||
160862169|NCT00124943|580889663|FG002|Phase II|Lost to Follow-up|0|||
160862170|NCT00124943|580889664|FG003|Phase II|Lost to Follow-up|1|||
160862171|NCT00124943|580889661|FG000|Phase II|Withdrawal by Subject|0|||
160862172|NCT00124943|580889662|FG001|Phase II|Withdrawal by Subject|0|||
160862173|NCT00124943|580889663|FG002|Phase II|Withdrawal by Subject|0|||
160862174|NCT00124943|580889664|FG003|Phase II|Withdrawal by Subject|2|||
160862175|NCT03181932|580889665|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
160862176|NCT03181932|580889666|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
160862177|NCT03181932|580889665|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
160862178|NCT03181932|580889666|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
160862179|NCT03181932|580889665|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
160862180|NCT03181932|580889666|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
160862181|NCT03181932|580889665|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
160862182|NCT03181932|580889666|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
160862183|NCT03181932|580889665|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
160862184|NCT03181932|580889666|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
160862185|NCT03181932|580889665|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
160862186|NCT03181932|580889666|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
160862187|NCT03181932|580889665|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
160862188|NCT03181932|580889666|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
160862189|NCT03181932|580889665|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
160862190|NCT03181932|580889666|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
160862191|NCT03181932|580889665|FG000|Period 2 (Open-label Period)|Reason missing|2|||
160862192|NCT03181932|580889666|FG001|Period 2 (Open-label Period)|Reason missing|0|||
160862193|NCT00408317|580889673|FG000|First Intervention Period|Adverse Event|0|||
160862194|NCT00408317|580889674|FG001|First Intervention Period|Adverse Event|1|||
160862195|NCT00408317|580889673|FG000|Second Intervention Period|Adverse Event|2|||
160862196|NCT00408317|580889674|FG001|Second Intervention Period|Adverse Event|0|||
160862197|NCT00408317|580889673|FG000|Second Intervention Period|Protocol Violation|0|||
160862198|NCT00408317|580889674|FG001|Second Intervention Period|Protocol Violation|1|||
160862199|NCT00408317|580889673|FG000|Second Intervention Period|Withdrawal of consent|0|||
160862200|NCT00408317|580889674|FG001|Second Intervention Period|Withdrawal of consent|1|||
160862201|NCT00360230|580889681|FG000|Overall Study|Withdrawal by Subject|1|||
160581850|NCT02389816|579850405|FG002|Overall Study|Non Compliance with Study Drug|1|||
160581851|NCT02389816|579850403|FG000|Overall Study|Reason not Specified|0|||
160581852|NCT02389816|579850404|FG001|Overall Study|Reason not Specified|2|||
160581853|NCT02389816|579850405|FG002|Overall Study|Reason not Specified|0|||
160581854|NCT01253044|579850406|FG000|Overall Study|Lost to Follow-up|38|||
160581855|NCT01253044|579850407|FG001|Overall Study|Lost to Follow-up|29|||
160581856|NCT02868216|579850408|FG000|Overall Study|Death|0|||
160581857|NCT02868216|579850409|FG001|Overall Study|Death|1|||
160581858|NCT02868216|579850408|FG000|Overall Study|coronary artery bypass|1|||
160581859|NCT02868216|579850409|FG001|Overall Study|coronary artery bypass|0|||
160581860|NCT02868216|579850408|FG000|Overall Study|Withdrawal by Subject|7|||
160581861|NCT02868216|579850409|FG001|Overall Study|Withdrawal by Subject|5|||
160581862|NCT00987623|579850410|FG000|Overall Study|Lost to Follow-up|2|||
160581863|NCT00987623|579850411|FG001|Overall Study|Lost to Follow-up|1|||
160581864|NCT00987623|579850410|FG000|Overall Study|Time/job conflict|2|||
160581865|NCT00987623|579850411|FG001|Overall Study|Time/job conflict|0|||
160581866|NCT00987623|579850410|FG000|Overall Study|Discomfort|1|||
160581867|NCT00987623|579850411|FG001|Overall Study|Discomfort|0|||
160581868|NCT00987623|579850410|FG000|Overall Study|Biomicroscopy|0|||
160581869|NCT00987623|579850411|FG001|Overall Study|Biomicroscopy|1|||
160581870|NCT00987623|579850410|FG000|Overall Study|Influenza|0|||
160581871|NCT00987623|579850411|FG001|Overall Study|Influenza|1|||
160581872|NCT03161678|579850414|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
160581873|NCT03161678|579850415|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
160581874|NCT03161678|579850416|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
160581875|NCT03161678|579850417|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
160581876|NCT03161678|579850418|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
160581877|NCT03161678|579850419|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
160581878|NCT03161678|579850414|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
160581879|NCT03161678|579850415|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
160581880|NCT03161678|579850416|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
160581881|NCT03161678|579850417|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
160581882|NCT03161678|579850418|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
160581883|NCT03161678|579850419|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
160581884|NCT03161678|579850414|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
160581885|NCT03161678|579850415|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
160581886|NCT03161678|579850416|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
160581887|NCT03161678|579850417|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
160581888|NCT03161678|579850418|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
160581889|NCT03161678|579850419|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
160581890|NCT03161678|579850414|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
160581891|NCT03161678|579850415|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
160581892|NCT03161678|579850416|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
160581893|NCT03161678|579850417|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
160581894|NCT03161678|579850418|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
160581895|NCT03161678|579850419|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
160581896|NCT00752609|579850420|FG000|Overall Study|Adverse Event|2|||
160581897|NCT00752609|579850421|FG001|Overall Study|Adverse Event|2|||
160581898|NCT00752609|579850420|FG000|Overall Study|Withdrawal by Subject|3|||
160581899|NCT00752609|579850421|FG001|Overall Study|Withdrawal by Subject|0|||
160581900|NCT00752609|579850420|FG000|Overall Study|Physician Decision|1|||
160581901|NCT00752609|579850421|FG001|Overall Study|Physician Decision|0|||
160581902|NCT00752609|579850420|FG000|Overall Study|Death|1|||
160581903|NCT00752609|579850421|FG001|Overall Study|Death|0|||
160581904|NCT00752609|579850420|FG000|Overall Study|Met exclusion criteria|1|||
160948798|NCT02265705|581200566|FG001|Follow-up Period|Physician Decision|0|||
160948799|NCT02265705|581200567|FG002|Follow-up Period|Physician Decision|0|||
160948800|NCT02265705|581200568|FG003|Follow-up Period|Physician Decision|0|||
160948801|NCT02265705|581200569|FG004|Follow-up Period|Physician Decision|0|||
160948802|NCT02265705|581200570|FG005|Follow-up Period|Physician Decision|0|||
160581905|NCT00752609|579850421|FG001|Overall Study|Met exclusion criteria|0|||
160581906|NCT00752609|579850420|FG000|Overall Study|Received Aranesp in error|1|||
160581907|NCT00752609|579850421|FG001|Overall Study|Received Aranesp in error|0|||
160581908|NCT00938327|579850422|FG000|Overall Study|Adverse Event|2|||
160581909|NCT00938327|579850422|FG000|Overall Study|Protocol Violation|1|||
160581910|NCT00938327|579850422|FG000|Overall Study|Withdrawal by Subject|4|||
160581911|NCT00938327|579850422|FG000|Overall Study|Lost to Follow-up|37|||
160581912|NCT00938327|579850422|FG000|Overall Study|2nd dose received outside of the study|7|||
160581913|NCT00938327|579850422|FG000|Overall Study|Vaccine not received as out of stock|9|||
160581914|NCT03880227|579850425|FG000|First Visit|Withdrawal by Subject|1|||
160581915|NCT03880227|579850426|FG001|First Visit|Withdrawal by Subject|0|||
160948803|NCT02265705|581200571|FG006|Follow-up Period|Physician Decision|1|||
160581916|NCT03880227|579850427|FG002|First Visit|Withdrawal by Subject|0|||
160581917|NCT03880227|579850428|FG003|First Visit|Withdrawal by Subject|0|||
160948804|NCT02265705|581200565|FG000|Follow-up Period|Withdrawal by Subject|0|||
160948805|NCT02265705|581200566|FG001|Follow-up Period|Withdrawal by Subject|0|||
160948806|NCT02265705|581200567|FG002|Follow-up Period|Withdrawal by Subject|0|||
160948807|NCT02265705|581200568|FG003|Follow-up Period|Withdrawal by Subject|0|||
160948808|NCT02265705|581200569|FG004|Follow-up Period|Withdrawal by Subject|0|||
160948809|NCT02265705|581200570|FG005|Follow-up Period|Withdrawal by Subject|0|||
160948810|NCT02265705|581200571|FG006|Follow-up Period|Withdrawal by Subject|1|||
160948811|NCT02828111|581200575|FG000|Overall Study|Withdrawal by Subject|0|||
160948812|NCT02828111|581200576|FG001|Overall Study|Withdrawal by Subject|0|||
160948813|NCT02828111|581200577|FG002|Overall Study|Withdrawal by Subject|2|||
160948814|NCT02828111|581200578|FG003|Overall Study|Withdrawal by Subject|0|||
160948815|NCT02828111|581200579|FG004|Overall Study|Withdrawal by Subject|0|||
160948816|NCT02828111|581200575|FG000|Overall Study|Lost to Follow-up|0|||
160948817|NCT02828111|581200576|FG001|Overall Study|Lost to Follow-up|0|||
160948818|NCT02828111|581200577|FG002|Overall Study|Lost to Follow-up|0|||
160948819|NCT02828111|581200578|FG003|Overall Study|Lost to Follow-up|1|||
160948820|NCT02828111|581200579|FG004|Overall Study|Lost to Follow-up|1|||
160948821|NCT03285477|581200588|FG000|Treatment and Response Assessment Period|Death|1|||
160948822|NCT03285477|581200589|FG001|Treatment and Response Assessment Period|Death|0|||
160948823|NCT03285477|581200588|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
160948824|NCT03285477|581200589|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
160948825|NCT03285477|581200588|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
160948826|NCT03285477|581200589|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
160948827|NCT03285477|581200588|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
160948828|NCT03285477|581200589|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
160948829|NCT03285477|581200588|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
160948830|NCT03285477|581200589|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
160948831|NCT00560833|581200602|FG000|Overall Study|Adverse Event|16|||
160948832|NCT00560833|581200603|FG001|Overall Study|Adverse Event|10|||
160948833|NCT00560833|581200604|FG002|Overall Study|Adverse Event|25|||
160948834|NCT00560833|581200605|FG003|Overall Study|Adverse Event|23|||
160999822|NCT00177216|581382813|FG000|Overall Study|Withdrawal by Subject|6|||
160999823|NCT00177216|581382814|FG001|Overall Study|Withdrawal by Subject|3|||
160999824|NCT00177216|581382815|FG002|Overall Study|Withdrawal by Subject|1|||
160999825|NCT00988637|581382818|FG000|Overall Study|Lost to Follow-up|2|||
160999826|NCT00988637|581382819|FG001|Overall Study|Lost to Follow-up|1|||
160999827|NCT00988637|581382818|FG000|Overall Study|Withdrawal by Subject|1|||
160999828|NCT00988637|581382819|FG001|Overall Study|Withdrawal by Subject|1|||
160999829|NCT00988637|581382818|FG000|Overall Study|non-compliance with study drug|0|||
160999830|NCT00988637|581382819|FG001|Overall Study|non-compliance with study drug|1|||
160999831|NCT01161498|581382820|FG000|Overall Study|Disease Progression|0|||
160999832|NCT01161498|581382821|FG001|Overall Study|Disease Progression|1|||
160999833|NCT03310983|581382827|FG000|Overall Study|Lost to Follow-up|15|||
160999834|NCT03310983|581382828|FG001|Overall Study|Lost to Follow-up|17|||
160999835|NCT01656304|581382829|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
160999836|NCT00823979|581382832|FG000|Overall Study|Lack of Efficacy|13|||
160999837|NCT00823979|581382833|FG001|Overall Study|Lack of Efficacy|16|||
160999838|NCT00823979|581382834|FG002|Overall Study|Lack of Efficacy|9|||
160999839|NCT00823979|581382832|FG000|Overall Study|Lost to Follow-up|2|||
160999840|NCT00823979|581382833|FG001|Overall Study|Lost to Follow-up|1|||
160999841|NCT00823979|581382834|FG002|Overall Study|Lost to Follow-up|0|||
160999842|NCT00823979|581382832|FG000|Overall Study|Withdrawal by Subject|2|||
160999843|NCT00823979|581382833|FG001|Overall Study|Withdrawal by Subject|3|||
160999844|NCT00823979|581382834|FG002|Overall Study|Withdrawal by Subject|2|||
160999845|NCT00823979|581382832|FG000|Overall Study|Protocol Violation|1|||
160999846|NCT00823979|581382833|FG001|Overall Study|Protocol Violation|1|||
160999847|NCT00823979|581382834|FG002|Overall Study|Protocol Violation|0|||
160999848|NCT00823979|581382832|FG000|Overall Study|Pregnancy|0|||
160581918|NCT03880227|579850425|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
160581919|NCT03880227|579850426|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
160581920|NCT03880227|579850427|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
160581921|NCT03880227|579850428|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
160581922|NCT03880227|579850425|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
160581923|NCT03880227|579850426|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
160581924|NCT03880227|579850427|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
160581925|NCT03880227|579850428|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
160581926|NCT03880227|579850425|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
160581927|NCT03880227|579850426|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
160581928|NCT03880227|579850427|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
160581929|NCT03880227|579850428|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
160581930|NCT01635933|579850429|FG000|Overall Study|Adverse Event|1|||
160581931|NCT01635933|579850430|FG001|Overall Study|Adverse Event|0|||
160581932|NCT01635933|579850429|FG000|Overall Study|Lost to Follow-up|0|||
160581933|NCT01635933|579850430|FG001|Overall Study|Lost to Follow-up|5|||
160581934|NCT01635933|579850429|FG000|Overall Study|Subject decision|1|||
160581935|NCT01635933|579850430|FG001|Overall Study|Subject decision|1|||
160948835|NCT00560833|581200606|FG004|Overall Study|Adverse Event|35|||
160948836|NCT00560833|581200602|FG000|Overall Study|Lost to Follow-up|0|||
160948837|NCT00560833|581200603|FG001|Overall Study|Lost to Follow-up|0|||
160948838|NCT00560833|581200604|FG002|Overall Study|Lost to Follow-up|1|||
160948839|NCT00560833|581200605|FG003|Overall Study|Lost to Follow-up|0|||
160948840|NCT00560833|581200606|FG004|Overall Study|Lost to Follow-up|0|||
160948841|NCT00560833|581200602|FG000|Overall Study|Lack of Efficacy|22|||
160948842|NCT00560833|581200603|FG001|Overall Study|Lack of Efficacy|9|||
160948843|NCT00560833|581200604|FG002|Overall Study|Lack of Efficacy|6|||
160948844|NCT00560833|581200605|FG003|Overall Study|Lack of Efficacy|4|||
160948845|NCT00560833|581200606|FG004|Overall Study|Lack of Efficacy|4|||
160948846|NCT00560833|581200602|FG000|Overall Study|Participant uncooperative|5|||
160948847|NCT00560833|581200603|FG001|Overall Study|Participant uncooperative|5|||
160948848|NCT00560833|581200604|FG002|Overall Study|Participant uncooperative|4|||
160948849|NCT00560833|581200605|FG003|Overall Study|Participant uncooperative|4|||
160948850|NCT00560833|581200606|FG004|Overall Study|Participant uncooperative|2|||
160948851|NCT00560833|581200602|FG000|Overall Study|Other|1|||
160948852|NCT00560833|581200603|FG001|Overall Study|Other|1|||
160948853|NCT00560833|581200604|FG002|Overall Study|Other|3|||
160948854|NCT00560833|581200605|FG003|Overall Study|Other|0|||
160948855|NCT00560833|581200606|FG004|Overall Study|Other|0|||
160948856|NCT00560833|581200602|FG000|Overall Study|Never received drug|0|||
160948857|NCT00560833|581200603|FG001|Overall Study|Never received drug|1|||
160948858|NCT00560833|581200604|FG002|Overall Study|Never received drug|0|||
160948859|NCT00560833|581200605|FG003|Overall Study|Never received drug|0|||
160948860|NCT00560833|581200606|FG004|Overall Study|Never received drug|1|||
160948861|NCT03283670|581200607|FG000|Placebo Gas|Withdrawal by Subject|2|||
160948862|NCT03283670|581200607|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
160948863|NCT03283670|581200607|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
160948864|NCT01307501|581200608|FG000|Overall Study|Treatment Failure|1|||
160948865|NCT01307501|581200608|FG000|Overall Study|Death|20|||
160948866|NCT01307501|581200608|FG000|Overall Study|Lost to Follow-up|1|||
160948867|NCT01307501|581200608|FG000|Overall Study|Starting Hospice|1|||
160948868|NCT01209624|581200611|FG000|Overall Study|Death|2|||
160581936|NCT01635933|579850429|FG000|Overall Study|Noncompliance|0|||
160581937|NCT01635933|579850430|FG001|Overall Study|Noncompliance|1|||
160581938|NCT01635933|579850429|FG000|Overall Study|No longer had transportation|0|||
160581939|NCT01635933|579850430|FG001|Overall Study|No longer had transportation|1|||
160581940|NCT02084134|579850431|FG000|Overall Study|Protocol Violation|4|||
160581941|NCT02084134|579850432|FG001|Overall Study|Protocol Violation|2|||
160581942|NCT02084134|579850431|FG000|Overall Study|Death|0|||
160581943|NCT02084134|579850432|FG001|Overall Study|Death|1|||
160581944|NCT04333433|579850433|FG000|Overall Study|Withdrawal by Subject|6|||
160581945|NCT04333433|579850434|FG001|Overall Study|Withdrawal by Subject|3|||
160581946|NCT04333433|579850433|FG000|Overall Study|Death|3|||
160581947|NCT04333433|579850434|FG001|Overall Study|Death|0|||
160581948|NCT04333433|579850433|FG000|Overall Study|Lost to Follow-up|6|||
160862202|NCT00360230|580889682|FG001|Overall Study|Withdrawal by Subject|1|||
160862203|NCT00360230|580889683|FG002|Overall Study|Withdrawal by Subject|0|||
160862204|NCT00360230|580889684|FG003|Overall Study|Withdrawal by Subject|1|||
160862205|NCT00360230|580889685|FG004|Overall Study|Withdrawal by Subject|1|||
160862206|NCT00360230|580889686|FG005|Overall Study|Withdrawal by Subject|1|||
160862207|NCT00360230|580889687|FG006|Overall Study|Withdrawal by Subject|0|||
160862208|NCT00360230|580889681|FG000|Overall Study|Migrated|4|||
160862209|NCT00360230|580889682|FG001|Overall Study|Migrated|1|||
160862210|NCT00360230|580889683|FG002|Overall Study|Migrated|3|||
160862211|NCT00360230|580889684|FG003|Overall Study|Migrated|1|||
160862212|NCT00360230|580889685|FG004|Overall Study|Migrated|4|||
160862213|NCT00360230|580889686|FG005|Overall Study|Migrated|1|||
160862214|NCT00360230|580889687|FG006|Overall Study|Migrated|1|||
160862215|NCT00360230|580889681|FG000|Overall Study|Other|1|||
160862216|NCT00360230|580889682|FG001|Overall Study|Other|0|||
160862217|NCT00360230|580889683|FG002|Overall Study|Other|0|||
160862218|NCT00360230|580889684|FG003|Overall Study|Other|0|||
160862219|NCT00360230|580889685|FG004|Overall Study|Other|0|||
160862220|NCT00360230|580889686|FG005|Overall Study|Other|0|||
160862221|NCT00360230|580889687|FG006|Overall Study|Other|0|||
160862222|NCT00360230|580889681|FG000|Overall Study|Protocol Violation|0|||
160862223|NCT00360230|580889682|FG001|Overall Study|Protocol Violation|0|||
160862224|NCT00360230|580889683|FG002|Overall Study|Protocol Violation|0|||
160862225|NCT00360230|580889684|FG003|Overall Study|Protocol Violation|0|||
160862226|NCT00360230|580889685|FG004|Overall Study|Protocol Violation|0|||
160862227|NCT00360230|580889686|FG005|Overall Study|Protocol Violation|1|||
160948869|NCT01209624|581200611|FG000|Overall Study|Adverse Event|13|||
160948870|NCT01209624|581200611|FG000|Overall Study|Lack of Efficacy|17|||
160862228|NCT00360230|580889687|FG006|Overall Study|Protocol Violation|0|||
160862229|NCT00360230|580889681|FG000|Overall Study|Death|0|||
160862230|NCT00360230|580889682|FG001|Overall Study|Death|1|||
160862231|NCT00360230|580889683|FG002|Overall Study|Death|0|||
160862232|NCT00360230|580889684|FG003|Overall Study|Death|0|||
160862233|NCT00360230|580889685|FG004|Overall Study|Death|0|||
160862234|NCT00360230|580889686|FG005|Overall Study|Death|1|||
160581949|NCT04333433|579850434|FG001|Overall Study|Lost to Follow-up|1|||
160581950|NCT04333433|579850433|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
160581951|NCT04333433|579850434|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
160581952|NCT05468086|579850435|FG000|Overall Study|Withdrawal by Subject|3|||
160581953|NCT05468086|579850435|FG000|Overall Study|Subject was found ineligible after consent|1|||
160581954|NCT01108809|579850436|FG000|Overall Study|Adverse Event|3|||
160581955|NCT01108809|579850436|FG000|Overall Study|Lost to Follow-up|1|||
160581956|NCT01402284|579850442|FG000|Overall Study|Withdrawal consent|2|||
160581957|NCT01402284|579850442|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
160581958|NCT01402284|579850442|FG000|Overall Study|Physician Decision|1|||
160581959|NCT01402284|579850442|FG000|Overall Study|Disease progression on study|10|||
160581960|NCT05281523|579850444|FG000|Overall Study|Adverse Event|1|||
160948871|NCT01209624|581200611|FG000|Overall Study|Lost to Follow-up|290|||
160948872|NCT01209624|581200611|FG000|Overall Study|Other|4|||
160948873|NCT03564496|581200612|FG000|Overall Study|Withdrawal by Subject|1|||
160948874|NCT03564496|581200613|FG001|Overall Study|Withdrawal by Subject|1|||
160948875|NCT03564496|581200614|FG002|Overall Study|Withdrawal by Subject|0|||
160948876|NCT03564496|581200612|FG000|Overall Study|Screen failure|0|||
160948877|NCT03564496|581200613|FG001|Overall Study|Screen failure|3|||
160948878|NCT03564496|581200614|FG002|Overall Study|Screen failure|0|||
160948879|NCT00428610|581200615|FG000|Overall Study|Death Due to Adverse Event|3|||
160948880|NCT00428610|581200616|FG001|Overall Study|Death Due to Adverse Event|0|||
160948881|NCT00428610|581200617|FG002|Overall Study|Death Due to Adverse Event|5|||
160948882|NCT00428610|581200615|FG000|Overall Study|Death Due to Progressive Disease|0|||
160948883|NCT00428610|581200616|FG001|Overall Study|Death Due to Progressive Disease|0|||
160948884|NCT00428610|581200617|FG002|Overall Study|Death Due to Progressive Disease|2|||
160948885|NCT00428610|581200615|FG000|Overall Study|Adverse Event|2|||
160948886|NCT00428610|581200616|FG001|Overall Study|Adverse Event|3|||
160948887|NCT00428610|581200617|FG002|Overall Study|Adverse Event|2|||
160948888|NCT00428610|581200615|FG000|Overall Study|Investigator Decision|2|||
160948889|NCT00428610|581200616|FG001|Overall Study|Investigator Decision|1|||
160948890|NCT00428610|581200617|FG002|Overall Study|Investigator Decision|1|||
160948891|NCT00428610|581200615|FG000|Overall Study|Progressive Disease|42|||
160948892|NCT00428610|581200616|FG001|Overall Study|Progressive Disease|14|||
160948893|NCT00428610|581200617|FG002|Overall Study|Progressive Disease|22|||
160948894|NCT00428610|581200615|FG000|Overall Study|Withdrawal by Subject|4|||
160948895|NCT00428610|581200616|FG001|Overall Study|Withdrawal by Subject|0|||
160948896|NCT00428610|581200617|FG002|Overall Study|Withdrawal by Subject|0|||
160948897|NCT04827576|581202915|FG000|Overall Study|Death|5|||
160948898|NCT04827576|581202916|FG001|Overall Study|Death|17|||
160948899|NCT04827576|581202917|FG002|Overall Study|Death|17|||
160581961|NCT05281523|579850445|FG001|Overall Study|Adverse Event|1|||
160581962|NCT05281523|579850444|FG000|Overall Study|Physician Decision|1|||
160581963|NCT05281523|579850445|FG001|Overall Study|Physician Decision|1|||
160581964|NCT05281523|579850444|FG000|Overall Study|Withdrawal by Subject|5|||
160581965|NCT05281523|579850445|FG001|Overall Study|Withdrawal by Subject|15|||
160581966|NCT05281523|579850444|FG000|Overall Study|GCP violations|3|||
160581967|NCT05281523|579850445|FG001|Overall Study|GCP violations|4|||
160581968|NCT04038255|579851810|FG000|Overall Study|Lost to Follow-up|0|||
160581969|NCT04038255|579851811|FG001|Overall Study|Lost to Follow-up|9|||
160581970|NCT04038255|579851812|FG002|Overall Study|Lost to Follow-up|5|||
160581971|NCT04038255|579851810|FG000|Overall Study|Withdrawal by Subject|0|||
160948900|NCT04827576|581202918|FG003|Overall Study|Death|32|||
160948901|NCT04827576|581202915|FG000|Overall Study|Study Terminated by Sponsor|2|||
160948902|NCT04827576|581202916|FG001|Overall Study|Study Terminated by Sponsor|9|||
160456341|NCT02424617|579401405|FG000|Overall Study|Adverse Event|0|||
160456342|NCT02424617|579401406|FG001|Overall Study|Adverse Event|1|||
160581972|NCT04038255|579851811|FG001|Overall Study|Withdrawal by Subject|0|||
160581973|NCT04038255|579851812|FG002|Overall Study|Withdrawal by Subject|1|||
160948903|NCT04827576|581202917|FG002|Overall Study|Study Terminated by Sponsor|7|||
160948904|NCT04827576|581202918|FG003|Overall Study|Study Terminated by Sponsor|5|||
160948905|NCT04827576|581202915|FG000|Overall Study|Investigator's Discretion|1|||
160948906|NCT04827576|581202916|FG001|Overall Study|Investigator's Discretion|0|||
160948907|NCT04827576|581202917|FG002|Overall Study|Investigator's Discretion|2|||
160456343|NCT02424617|579401407|FG002|Overall Study|Adverse Event|0|||
160581974|NCT05183867|579851813|FG000|Overall Study|Withdrawal by Subject|3|||
160581975|NCT05183867|579851814|FG001|Overall Study|Withdrawal by Subject|2|||
160581976|NCT05183867|579851815|FG002|Overall Study|Withdrawal by Subject|0|||
160581977|NCT02614287|579851818|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
160581978|NCT02614287|579851819|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
160948908|NCT04827576|581202918|FG003|Overall Study|Investigator's Discretion|5|||
160948909|NCT04827576|581202915|FG000|Overall Study|Withdrew Consent|0|||
160948910|NCT04827576|581202916|FG001|Overall Study|Withdrew Consent|3|||
160948911|NCT04827576|581202917|FG002|Overall Study|Withdrew Consent|0|||
160948912|NCT04827576|581202918|FG003|Overall Study|Withdrew Consent|0|||
160999849|NCT00823979|581382833|FG001|Overall Study|Pregnancy|1|||
160948913|NCT04827576|581202915|FG000|Overall Study|Lost to Follow-up|1|||
160948914|NCT04827576|581202916|FG001|Overall Study|Lost to Follow-up|0|||
160948915|NCT04827576|581202917|FG002|Overall Study|Lost to Follow-up|0|||
160948916|NCT04827576|581202918|FG003|Overall Study|Lost to Follow-up|0|||
160948917|NCT04295564|581202919|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
160948918|NCT04295564|581202920|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
160948919|NCT03859323|581202921|FG000|Overall Study|Lost to Follow-up|0|||
160948920|NCT03859323|581202922|FG001|Overall Study|Lost to Follow-up|0|||
160948921|NCT03859323|581202923|FG002|Overall Study|Lost to Follow-up|0|||
160948922|NCT03859323|581202924|FG003|Overall Study|Lost to Follow-up|0|||
160948923|NCT03859323|581202925|FG004|Overall Study|Lost to Follow-up|0|||
160948924|NCT03859323|581202926|FG005|Overall Study|Lost to Follow-up|0|||
160948925|NCT03859323|581202927|FG006|Overall Study|Lost to Follow-up|1|||
160948926|NCT03859323|581202928|FG007|Overall Study|Lost to Follow-up|0|||
160948927|NCT03859323|581202929|FG008|Overall Study|Lost to Follow-up|0|||
160948928|NCT03859323|581202930|FG009|Overall Study|Lost to Follow-up|0|||
160948929|NCT03859323|581202931|FG010|Overall Study|Lost to Follow-up|0|||
160948930|NCT03859323|581202932|FG011|Overall Study|Lost to Follow-up|0|||
160948931|NCT03859323|581202933|FG012|Overall Study|Lost to Follow-up|0|||
160948932|NCT03859323|581202921|FG000|Overall Study|Withdrawal by Subject|0|||
160948933|NCT03859323|581202922|FG001|Overall Study|Withdrawal by Subject|0|||
160948934|NCT03859323|581202923|FG002|Overall Study|Withdrawal by Subject|1|||
160948935|NCT03859323|581202924|FG003|Overall Study|Withdrawal by Subject|0|||
160948936|NCT03859323|581202925|FG004|Overall Study|Withdrawal by Subject|0|||
160948937|NCT03859323|581202926|FG005|Overall Study|Withdrawal by Subject|1|||
160948938|NCT03859323|581202927|FG006|Overall Study|Withdrawal by Subject|0|||
160948939|NCT03859323|581202928|FG007|Overall Study|Withdrawal by Subject|0|||
160948940|NCT03859323|581202929|FG008|Overall Study|Withdrawal by Subject|0|||
160948941|NCT03859323|581202930|FG009|Overall Study|Withdrawal by Subject|1|||
160948942|NCT03859323|581202931|FG010|Overall Study|Withdrawal by Subject|1|||
160948943|NCT03859323|581202932|FG011|Overall Study|Withdrawal by Subject|2|||
160948944|NCT03859323|581202933|FG012|Overall Study|Withdrawal by Subject|1|||
160948945|NCT03859323|581202921|FG000|Overall Study|Pregnancy|0|||
160948946|NCT03859323|581202922|FG001|Overall Study|Pregnancy|0|||
160948947|NCT03859323|581202923|FG002|Overall Study|Pregnancy|0|||
160948948|NCT03859323|581202924|FG003|Overall Study|Pregnancy|0|||
160948949|NCT03859323|581202925|FG004|Overall Study|Pregnancy|0|||
160948950|NCT03859323|581202926|FG005|Overall Study|Pregnancy|0|||
160948951|NCT03859323|581202927|FG006|Overall Study|Pregnancy|0|||
160948952|NCT03859323|581202928|FG007|Overall Study|Pregnancy|0|||
160948953|NCT03859323|581202929|FG008|Overall Study|Pregnancy|0|||
160948954|NCT03859323|581202930|FG009|Overall Study|Pregnancy|1|||
160948955|NCT03859323|581202931|FG010|Overall Study|Pregnancy|0|||
160948956|NCT03859323|581202932|FG011|Overall Study|Pregnancy|0|||
160948957|NCT03859323|581202933|FG012|Overall Study|Pregnancy|0|||
160948958|NCT01682460|581202935|FG000|Overall Study|Withdrawal by Subject|2|||
160948959|NCT01682460|581202935|FG000|Overall Study|Did not meet inclusion criteria|2|||
160948960|NCT00724282|581202939|FG000|Overall Study|Withdrawal by Subject|3|||
160948961|NCT00724282|581202939|FG000|Overall Study|Physician Decision|1|||
160948962|NCT01438411|581202940|FG000|Overall Study|Adverse Event|8|||
160948963|NCT01438411|581202940|FG000|Overall Study|Lost to Follow-up|1|||
160948964|NCT01438411|581202940|FG000|Overall Study|Lack of Efficacy|1|||
160999850|NCT00823979|581382834|FG002|Overall Study|Pregnancy|0|||
160999851|NCT00823979|581382832|FG000|Overall Study|Adverse Event|0|||
160999852|NCT00823979|581382833|FG001|Overall Study|Adverse Event|2|||
160999853|NCT00823979|581382834|FG002|Overall Study|Adverse Event|4|||
160999854|NCT00823979|581382832|FG000|Overall Study|Other|2|||
160999855|NCT00823979|581382833|FG001|Overall Study|Other|0|||
160999856|NCT00823979|581382834|FG002|Overall Study|Other|1|||
160999857|NCT00823979|581382832|FG000|Overall Study|Randomized but not Treated|4|||
160456344|NCT02424617|579401408|FG003|Overall Study|Adverse Event|0|||
160456345|NCT02424617|579401405|FG000|Overall Study|Investigator Decision|0|||
160456346|NCT02424617|579401406|FG001|Overall Study|Investigator Decision|0|||
160581979|NCT02614287|579851818|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
160581980|NCT02614287|579851819|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
160948965|NCT01438411|581202940|FG000|Overall Study|Withdrawal by Subject|3|||
160456347|NCT02424617|579401407|FG002|Overall Study|Investigator Decision|0|||
160581981|NCT02614287|579851818|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
160948966|NCT01863680|581202941|FG000|Overall Study|Adverse Event|17|||
160948967|NCT01863680|581202941|FG000|Overall Study|Risk of OHSS|17|||
160948968|NCT01863680|581202941|FG000|Overall Study|Spontaneous pregnancy|2|||
160948969|NCT01863680|581202941|FG000|Overall Study|Withdrawal by Subject|1|||
160948970|NCT01863680|581202941|FG000|Overall Study|Did not undergo IVF/ET|14|||
160948971|NCT01863680|581202941|FG000|Overall Study|Other|6|||
160948972|NCT00618514|581202942|FG000|Overall Study|Lost to Follow-up|11|||
160948973|NCT00618514|581202943|FG001|Overall Study|Lost to Follow-up|12|||
160948974|NCT00618514|581202944|FG002|Overall Study|Lost to Follow-up|4|||
160999858|NCT00823979|581382833|FG001|Overall Study|Randomized but not Treated|3|||
160999859|NCT00823979|581382834|FG002|Overall Study|Randomized but not Treated|1|||
160999860|NCT00823979|581382832|FG000|Overall Study|Study Terminated by Sponsor|5|||
160656199|NCT04557124|580122365|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
160948975|NCT00566228|581202951|FG000|Overall Study|Withdrawal by Subject|1|||
160948976|NCT00566228|581202952|FG001|Overall Study|Withdrawal by Subject|0|||
160948977|NCT00566228|581202951|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
160948978|NCT00566228|581202952|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
160948979|NCT00566228|581202951|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
160948980|NCT00566228|581202952|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
160948981|NCT00566228|581202951|FG000|Overall Study|progressed before infusion could occur|0|||
160948982|NCT00566228|581202952|FG001|Overall Study|progressed before infusion could occur|1|||
160948983|NCT02041195|581202955|FG000|Overall Study|Adverse Event|1|||
160948984|NCT02041195|581202956|FG001|Overall Study|Adverse Event|2|||
160948985|NCT02041195|581202957|FG002|Overall Study|Adverse Event|0|||
160948986|NCT02041195|581202958|FG003|Overall Study|Adverse Event|0|||
160948987|NCT02041195|581202959|FG004|Overall Study|Adverse Event|0|||
160948988|NCT02041195|581202960|FG005|Overall Study|Adverse Event|0|||
160948989|NCT02041195|581202961|FG006|Overall Study|Adverse Event|3|||
160948990|NCT02041195|581202962|FG007|Overall Study|Adverse Event|0|||
160948991|NCT02041195|581202955|FG000|Overall Study|Withdrawal by Subject|1|||
160948992|NCT02041195|581202956|FG001|Overall Study|Withdrawal by Subject|0|||
160948993|NCT02041195|581202957|FG002|Overall Study|Withdrawal by Subject|0|||
160948994|NCT02041195|581202958|FG003|Overall Study|Withdrawal by Subject|0|||
160948995|NCT02041195|581202959|FG004|Overall Study|Withdrawal by Subject|0|||
160948996|NCT02041195|581202960|FG005|Overall Study|Withdrawal by Subject|0|||
160948997|NCT02041195|581202961|FG006|Overall Study|Withdrawal by Subject|4|||
160948998|NCT02041195|581202962|FG007|Overall Study|Withdrawal by Subject|3|||
160948999|NCT02041195|581202955|FG000|Overall Study|Unable to comply with study visits|0|||
160949000|NCT02041195|581202956|FG001|Overall Study|Unable to comply with study visits|1|||
160949001|NCT02041195|581202957|FG002|Overall Study|Unable to comply with study visits|0|||
160949002|NCT02041195|581202958|FG003|Overall Study|Unable to comply with study visits|0|||
160949003|NCT02041195|581202959|FG004|Overall Study|Unable to comply with study visits|1|||
160949004|NCT02041195|581202960|FG005|Overall Study|Unable to comply with study visits|0|||
160949005|NCT02041195|581202961|FG006|Overall Study|Unable to comply with study visits|0|||
160949006|NCT02041195|581202962|FG007|Overall Study|Unable to comply with study visits|0|||
160949007|NCT00674986|581202963|FG000|Overall Study|Adverse Event|2|||
160949008|NCT00674986|581202964|FG001|Overall Study|Adverse Event|1|||
160949009|NCT00674986|581202963|FG000|Overall Study|Subject withdrew consent|12|||
160949010|NCT00674986|581202964|FG001|Overall Study|Subject withdrew consent|19|||
160949011|NCT00674986|581202963|FG000|Overall Study|Lost to Follow-up|25|||
160949012|NCT00674986|581202964|FG001|Overall Study|Lost to Follow-up|53|||
160949013|NCT00674986|581202963|FG000|Overall Study|Other reasons|4|||
160949014|NCT00674986|581202964|FG001|Overall Study|Other reasons|8|||
160949015|NCT00377234|581202965|FG000|Overall Study|Adverse Event|14|||
160949016|NCT00377234|581202966|FG001|Overall Study|Adverse Event|17|||
160949017|NCT00377234|581202965|FG000|Overall Study|Withdrawal by Subject|11|||
160949018|NCT00377234|581202966|FG001|Overall Study|Withdrawal by Subject|9|||
160949019|NCT00377234|581202965|FG000|Overall Study|Lost to Follow-up|4|||
160949020|NCT00377234|581202966|FG001|Overall Study|Lost to Follow-up|2|||
160949021|NCT00377234|581202965|FG000|Overall Study|Administrative|2|||
160949022|NCT00377234|581202966|FG001|Overall Study|Administrative|1|||
160949023|NCT00377234|581202965|FG000|Overall Study|Not assigned|3|||
160949024|NCT00377234|581202966|FG001|Overall Study|Not assigned|2|||
160949025|NCT02053350|581202973|FG000|Overall Study|Withdrawal by Subject|1|||
160949026|NCT02053350|581202973|FG000|Overall Study|Adverse Event|4|||
160949027|NCT01275625|581202974|FG000|Overall Study|Death|1|||
160949028|NCT01275625|581202974|FG000|Overall Study|Lack of Efficacy|2|||
160949029|NCT01275625|581202974|FG000|Overall Study|Lost to Follow-up|1|||
160949030|NCT01275625|581202974|FG000|Overall Study|Withdrawal by Subject|3|||
160949031|NCT01275625|581202974|FG000|Overall Study|Protocol Violation|1|||
160949032|NCT01275625|581202974|FG000|Overall Study|Adverse Event|4|||
160949033|NCT01275625|581202974|FG000|Overall Study|Other|1|||
160656200|NCT04557124|580122364|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
160949034|NCT03521635|581202975|FG000|Overall Study|Adverse Event|1|||
160949035|NCT03521635|581202976|FG001|Overall Study|Adverse Event|1|||
160949036|NCT03521635|581202975|FG000|Overall Study|Refused to complete study visit|1|||
160949037|NCT03521635|581202976|FG001|Overall Study|Refused to complete study visit|0|||
160949038|NCT03521635|581202975|FG000|Overall Study|Refused to continue trial medication|2|||
160949039|NCT03521635|581202976|FG001|Overall Study|Refused to continue trial medication|2|||
160949040|NCT03521635|581202975|FG000|Overall Study|Lost to Follow-up|0|||
160949041|NCT03521635|581202976|FG001|Overall Study|Lost to Follow-up|1|||
160949042|NCT03521635|581202975|FG000|Overall Study|Meet exclusion criteria|0|||
160949043|NCT03521635|581202976|FG001|Overall Study|Meet exclusion criteria|1|||
160949044|NCT03521635|581202975|FG000|Overall Study|Patient not taken study medicine|0|||
160949045|NCT03521635|581202976|FG001|Overall Study|Patient not taken study medicine|1|||
160949046|NCT01747772|581202977|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
160656201|NCT04557124|580122365|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
160949047|NCT02244944|581202978|FG000|Overall Study|Withdrawal by Subject|1|||
160949048|NCT02244944|581202978|FG000|Overall Study|Study Terminated|1|||
160949049|NCT00626522|581202981|FG000|Overall Study|Protocol Violation|0|||
160949050|NCT00626522|581202982|FG001|Overall Study|Protocol Violation|0|||
160949051|NCT00626522|581202983|FG002|Overall Study|Protocol Violation|0|||
160949052|NCT00626522|581202984|FG003|Overall Study|Protocol Violation|0|||
160949053|NCT00626522|581202985|FG004|Overall Study|Protocol Violation|1|||
160999861|NCT00823979|581382833|FG001|Overall Study|Study Terminated by Sponsor|5|||
160999862|NCT00823979|581382834|FG002|Overall Study|Study Terminated by Sponsor|7|||
160999863|NCT03396913|581382835|FG000|Overall Study|Lost to Follow-up|0|||
160999864|NCT03396913|581382836|FG001|Overall Study|Lost to Follow-up|6|||
160999865|NCT03523091|581382837|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
160999866|NCT03523091|581382838|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
160999867|NCT03523091|581382837|FG000|Overall Study|Withdrawal by Subject|0|||
160999868|NCT03523091|581382838|FG001|Overall Study|Withdrawal by Subject|3|||
160999869|NCT03523091|581382837|FG000|Overall Study|Increase Botox dose|0|||
160999870|NCT03523091|581382838|FG001|Overall Study|Increase Botox dose|1|||
160999871|NCT01093534|581382839|FG000|Overall Study|Adverse Event|2|||
160999872|NCT01093534|581382840|FG001|Overall Study|Adverse Event|5|||
160999873|NCT01093534|581382841|FG002|Overall Study|Adverse Event|2|||
160999874|NCT01093534|581382839|FG000|Overall Study|Lack of Efficacy|2|||
160999875|NCT01093534|581382840|FG001|Overall Study|Lack of Efficacy|1|||
160999876|NCT01093534|581382841|FG002|Overall Study|Lack of Efficacy|1|||
160999877|NCT01093534|581382839|FG000|Overall Study|Withdrawal by Subject|5|||
160999878|NCT01093534|581382840|FG001|Overall Study|Withdrawal by Subject|7|||
160999879|NCT01093534|581382841|FG002|Overall Study|Withdrawal by Subject|2|||
160999880|NCT01093534|581382839|FG000|Overall Study|Other|1|||
160999881|NCT01093534|581382840|FG001|Overall Study|Other|3|||
160999882|NCT01093534|581382841|FG002|Overall Study|Other|4|||
160999883|NCT04436120|581382845|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
160999884|NCT04436120|581382846|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
160999885|NCT04436120|581382847|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
160999886|NCT04436120|581382848|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
160999887|NCT04436120|581382849|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
160999888|NCT04436120|581382850|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
160999889|NCT04436120|581382851|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
160999890|NCT01981356|581382870|FG000|Overall Study|Lost to Follow-up|4|||
160999891|NCT01981356|581382871|FG001|Overall Study|Lost to Follow-up|1|||
160999892|NCT01981356|581382870|FG000|Overall Study|Withdrawal by Subject|1|||
160999893|NCT01981356|581382871|FG001|Overall Study|Withdrawal by Subject|1|||
160999894|NCT01981356|581382870|FG000|Overall Study|Protocol Violation|2|||
160999895|NCT01981356|581382871|FG001|Overall Study|Protocol Violation|0|||
160999896|NCT03284957|581384911|FG000|Overall Study|Adverse Event|0|||
160999897|NCT03284957|581384912|FG001|Overall Study|Adverse Event|0|||
160999898|NCT03284957|581384913|FG002|Overall Study|Adverse Event|0|||
160999899|NCT03284957|581384914|FG003|Overall Study|Adverse Event|0|||
160999900|NCT03284957|581384915|FG004|Overall Study|Adverse Event|0|||
160999901|NCT03284957|581384916|FG005|Overall Study|Adverse Event|1|||
160949054|NCT00626522|581202986|FG005|Overall Study|Protocol Violation|0|||
160999902|NCT03284957|581384917|FG006|Overall Study|Adverse Event|1|||
160999903|NCT03284957|581384918|FG007|Overall Study|Adverse Event|1|||
160999904|NCT03284957|581384919|FG008|Overall Study|Adverse Event|0|||
160999905|NCT03284957|581384920|FG009|Overall Study|Adverse Event|4|||
160999906|NCT03284957|581384921|FG010|Overall Study|Adverse Event|1|||
160999907|NCT03284957|581384922|FG011|Overall Study|Adverse Event|1|||
160999908|NCT03284957|581384923|FG012|Overall Study|Adverse Event|0|||
160999909|NCT03284957|581384924|FG013|Overall Study|Adverse Event|0|||
160999910|NCT03284957|581384925|FG014|Overall Study|Adverse Event|0|||
160999911|NCT03284957|581384926|FG015|Overall Study|Adverse Event|0|||
160999912|NCT03284957|581384911|FG000|Overall Study|Progressive Disease|3|||
160999913|NCT03284957|581384912|FG001|Overall Study|Progressive Disease|3|||
160999914|NCT03284957|581384913|FG002|Overall Study|Progressive Disease|4|||
160999915|NCT03284957|581384914|FG003|Overall Study|Progressive Disease|3|||
160999916|NCT03284957|581384915|FG004|Overall Study|Progressive Disease|3|||
160999917|NCT03284957|581384916|FG005|Overall Study|Progressive Disease|5|||
160999918|NCT03284957|581384917|FG006|Overall Study|Progressive Disease|45|||
160999919|NCT03284957|581384918|FG007|Overall Study|Progressive Disease|8|||
160999920|NCT03284957|581384919|FG008|Overall Study|Progressive Disease|5|||
160999921|NCT03284957|581384920|FG009|Overall Study|Progressive Disease|18|||
160999922|NCT03284957|581384921|FG010|Overall Study|Progressive Disease|7|||
160999923|NCT03284957|581384922|FG011|Overall Study|Progressive Disease|2|||
160456348|NCT02424617|579401408|FG003|Overall Study|Investigator Decision|1|||
160581982|NCT02614287|579851819|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
160949055|NCT00626522|581202981|FG000|Overall Study|Adverse Event|2|||
160999924|NCT03284957|581384923|FG012|Overall Study|Progressive Disease|3|||
160999925|NCT03284957|581384924|FG013|Overall Study|Progressive Disease|1|||
160949056|NCT00626522|581202982|FG001|Overall Study|Adverse Event|1|||
160999926|NCT03284957|581384925|FG014|Overall Study|Progressive Disease|1|||
160456349|NCT02424617|579401405|FG000|Overall Study|Withdrawal by Subject|1|||
160456350|NCT02424617|579401406|FG001|Overall Study|Withdrawal by Subject|1|||
160456351|NCT02424617|579401407|FG002|Overall Study|Withdrawal by Subject|0|||
160456352|NCT02424617|579401408|FG003|Overall Study|Withdrawal by Subject|1|||
160456353|NCT02424617|579401405|FG000|Overall Study|Progressive Disease|7|||
160456354|NCT02424617|579401406|FG001|Overall Study|Progressive Disease|6|||
160456355|NCT02424617|579401407|FG002|Overall Study|Progressive Disease|11|||
160456356|NCT02424617|579401408|FG003|Overall Study|Progressive Disease|10|||
160456357|NCT02424617|579401405|FG000|Overall Study|Other|0|||
160456358|NCT02424617|579401406|FG001|Overall Study|Other|0|||
160456359|NCT02424617|579401407|FG002|Overall Study|Other|0|||
160456360|NCT02424617|579401408|FG003|Overall Study|Other|1|||
160456361|NCT05269966|579401412|FG000|Overall Study|Adverse Event|4|||
160456362|NCT05269966|579401412|FG000|Overall Study|Withdrawal by Subject|1|||
160456363|NCT05269966|579401412|FG000|Overall Study|Lost to Follow-up|4|||
160949057|NCT00626522|581202983|FG002|Overall Study|Adverse Event|2|||
160949058|NCT00626522|581202984|FG003|Overall Study|Adverse Event|0|||
160949059|NCT00626522|581202985|FG004|Overall Study|Adverse Event|1|||
160949060|NCT00626522|581202986|FG005|Overall Study|Adverse Event|1|||
160949061|NCT00626522|581202981|FG000|Overall Study|Withdrawal by Subject|2|||
160949062|NCT00626522|581202982|FG001|Overall Study|Withdrawal by Subject|5|||
160949063|NCT00626522|581202983|FG002|Overall Study|Withdrawal by Subject|5|||
160949064|NCT00626522|581202984|FG003|Overall Study|Withdrawal by Subject|0|||
160949065|NCT00626522|581202985|FG004|Overall Study|Withdrawal by Subject|4|||
160949066|NCT00626522|581202986|FG005|Overall Study|Withdrawal by Subject|1|||
160949067|NCT00626522|581202981|FG000|Overall Study|COPD exacerbation|0|||
160949068|NCT00626522|581202982|FG001|Overall Study|COPD exacerbation|0|||
160949069|NCT00626522|581202983|FG002|Overall Study|COPD exacerbation|0|||
160949070|NCT00626522|581202984|FG003|Overall Study|COPD exacerbation|1|||
160949071|NCT00626522|581202985|FG004|Overall Study|COPD exacerbation|1|||
160949072|NCT00626522|581202986|FG005|Overall Study|COPD exacerbation|0|||
160949073|NCT00626522|581202981|FG000|Overall Study|Lost to Follow-up|0|||
160949074|NCT00626522|581202982|FG001|Overall Study|Lost to Follow-up|1|||
160949075|NCT00626522|581202983|FG002|Overall Study|Lost to Follow-up|0|||
160949076|NCT00626522|581202984|FG003|Overall Study|Lost to Follow-up|0|||
160949077|NCT00626522|581202985|FG004|Overall Study|Lost to Follow-up|0|||
160949078|NCT00626522|581202986|FG005|Overall Study|Lost to Follow-up|0|||
160949079|NCT00626522|581202981|FG000|Overall Study|Inconsistent reason reported|1|||
160949080|NCT00626522|581202982|FG001|Overall Study|Inconsistent reason reported|0|||
160949081|NCT00626522|581202983|FG002|Overall Study|Inconsistent reason reported|0|||
160949082|NCT00626522|581202984|FG003|Overall Study|Inconsistent reason reported|0|||
160949083|NCT00626522|581202985|FG004|Overall Study|Inconsistent reason reported|0|||
160949084|NCT00626522|581202986|FG005|Overall Study|Inconsistent reason reported|0|||
160949085|NCT00626522|581202981|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
160949086|NCT00626522|581202982|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
160949087|NCT00626522|581202983|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
160949088|NCT00626522|581202984|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
160949089|NCT00626522|581202985|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
160949090|NCT00626522|581202986|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
160949091|NCT01928719|581202987|FG000|Overall Study|Lost to Follow-up|26|||
160949092|NCT01928719|581202988|FG001|Overall Study|Lost to Follow-up|11|||
160949093|NCT01928719|581202987|FG000|Overall Study|Withdrawal by Subject|22|||
160949094|NCT01928719|581202988|FG001|Overall Study|Withdrawal by Subject|7|||
160949095|NCT01928719|581202987|FG000|Overall Study|Protocol Violation|3|||
160949096|NCT01928719|581202988|FG001|Overall Study|Protocol Violation|1|||
160949097|NCT01928719|581202987|FG000|Overall Study|Adverse Event|1|||
160949098|NCT01928719|581202988|FG001|Overall Study|Adverse Event|0|||
160949099|NCT03725982|581202989|FG000|First Intervention|Withdrawal by Subject|0|||
160949100|NCT03725982|581202990|FG001|First Intervention|Withdrawal by Subject|1|||
160949101|NCT03725982|581202989|FG000|First Intervention|Physician Decision|1|||
160949102|NCT03725982|581202990|FG001|First Intervention|Physician Decision|1|||
160949103|NCT01003899|581202991|FG000|Overall Study|Other Adverse Event|8|||
160949104|NCT01003899|581202991|FG000|Overall Study|Not entered|4|||
160949105|NCT01003899|581202991|FG000|Overall Study|Not treated|1|||
160949106|NCT01003899|581202991|FG000|Overall Study|Progressive disease|34|||
160949107|NCT00512135|581202994|FG000|Overall Study|Not Treated|5|||
160949108|NCT00512135|581202994|FG000|Overall Study|Lack of Efficacy|2|||
160949109|NCT00512135|581202994|FG000|Overall Study|Adverse Event|6|||
160949110|NCT00512135|581202994|FG000|Overall Study|Withdrawal by Subject|22|||
160949111|NCT00512135|581202994|FG000|Overall Study|Lost to Follow-up|27|||
160949112|NCT00512135|581202994|FG000|Overall Study|Other|22|||
160456364|NCT05269966|579401412|FG000|Overall Study|Physician Decision|1|||
160456365|NCT06262347|579401415|FG000|Overall Study|Lost to Follow-up|4|||
160456366|NCT06262347|579401416|FG001|Overall Study|Lost to Follow-up|3|||
160949113|NCT00262834|581202995|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
160456367|NCT06262347|579401415|FG000|Overall Study|Withdrawal by Subject|0|||
160456368|NCT06262347|579401416|FG001|Overall Study|Withdrawal by Subject|1|||
160581983|NCT02614287|579851818|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
160581984|NCT02614287|579851819|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
160581985|NCT02614287|579851818|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
160581986|NCT02614287|579851819|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
160581987|NCT02614287|579851818|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
160581988|NCT02614287|579851819|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
160581989|NCT02614287|579851818|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
160581990|NCT02614287|579851819|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
160581991|NCT02614287|579851818|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
160581992|NCT02614287|579851819|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
160581993|NCT00423085|579851821|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
160581994|NCT00423085|579851822|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
160581995|NCT00423085|579851823|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
160581996|NCT00423085|579851824|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
160581997|NCT00423085|579851821|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
160581998|NCT00423085|579851822|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
160581999|NCT00423085|579851823|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
160582000|NCT00423085|579851824|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
160582001|NCT00423085|579851821|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
160582002|NCT00423085|579851822|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
160582003|NCT00423085|579851823|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
160582004|NCT00423085|579851824|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
160582005|NCT00423085|579851821|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
160582006|NCT00423085|579851822|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
160582007|NCT00423085|579851823|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
160582008|NCT00423085|579851824|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
160582009|NCT00423085|579851821|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
160582010|NCT00423085|579851822|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
160582011|NCT00423085|579851823|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
160582012|NCT00423085|579851824|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
160582013|NCT00423085|579851821|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
160582014|NCT00423085|579851822|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
160582015|NCT00423085|579851823|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
160582016|NCT00423085|579851824|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
160582017|NCT00423085|579851821|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
160582018|NCT00423085|579851822|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
160582019|NCT00423085|579851823|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
160582020|NCT00423085|579851824|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
160582021|NCT00423085|579851821|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
160582022|NCT00423085|579851822|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
160582023|NCT00423085|579851823|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
160582024|NCT00423085|579851824|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
160582025|NCT00423085|579851821|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
160582026|NCT00423085|579851822|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
160582027|NCT00423085|579851823|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
160582028|NCT00423085|579851824|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
160949114|NCT00262834|581202996|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
160949115|NCT03422250|581202997|FG000|Intervention|Adverse Event|0|||
160949116|NCT03422250|581202998|FG001|Intervention|Adverse Event|1|||
160949117|NCT03422250|581202999|FG002|Intervention|Adverse Event|0|||
160949118|NCT03422250|581203000|FG003|Intervention|Adverse Event|1|||
160949119|NCT03422250|581202997|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
160949120|NCT03422250|581202998|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
160949121|NCT03422250|581202999|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
160949122|NCT03422250|581203000|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
160949123|NCT03422250|581202997|FG000|Follow-up|Withdrawal by Subject|0|||
160949124|NCT03422250|581202998|FG001|Follow-up|Withdrawal by Subject|0|||
160949125|NCT03422250|581202999|FG002|Follow-up|Withdrawal by Subject|0|||
160949126|NCT03422250|581203000|FG003|Follow-up|Withdrawal by Subject|1|||
160582029|NCT00423085|579851821|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
160949127|NCT03422250|581202997|FG000|Follow-up|Adverse Event|0|||
160582030|NCT00423085|579851822|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
160582031|NCT00423085|579851823|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
160656202|NCT00001849|580122366|FG000|Overall Study|Death|4|||
160949128|NCT03422250|581202998|FG001|Follow-up|Adverse Event|0|||
160949129|NCT03422250|581202999|FG002|Follow-up|Adverse Event|0|||
160949130|NCT03422250|581203000|FG003|Follow-up|Adverse Event|1|||
160949131|NCT00377819|581203003|FG000|Overall Study|Adverse Event|2|||
160949132|NCT00377819|581203004|FG001|Overall Study|Adverse Event|3|||
160949133|NCT00377819|581203003|FG000|Overall Study|Withdrawal by Subject|10|||
160949134|NCT00377819|581203004|FG001|Overall Study|Withdrawal by Subject|4|||
160949135|NCT00377819|581203003|FG000|Overall Study|Death|0|||
160949136|NCT00377819|581203004|FG001|Overall Study|Death|1|||
160949137|NCT00377819|581203003|FG000|Overall Study|Lost to Follow-up|0|||
160949138|NCT00377819|581203004|FG001|Overall Study|Lost to Follow-up|1|||
160949139|NCT00377819|581203003|FG000|Overall Study|Protocol Violation|1|||
160949140|NCT00377819|581203004|FG001|Overall Study|Protocol Violation|1|||
160949141|NCT02416791|581203005|FG000|6 Months|Lost to Follow-up|0|||
160949142|NCT02416791|581203006|FG001|6 Months|Lost to Follow-up|0|||
160949143|NCT02416791|581203007|FG002|6 Months|Lost to Follow-up|1|||
160949144|NCT01054820|581203008|FG000|Overall Study|Withdrawal by Subject|2|||
160949145|NCT00467870|581203015|FG000|Overall Study|Adverse Event|13|||
160949146|NCT00467870|581203016|FG001|Overall Study|Adverse Event|9|||
160949147|NCT00467870|581203017|FG002|Overall Study|Adverse Event|1|||
160949148|NCT00467870|581203018|FG003|Overall Study|Adverse Event|15|||
160949149|NCT00467870|581203019|FG004|Overall Study|Adverse Event|15|||
160949150|NCT00467870|581203020|FG005|Overall Study|Adverse Event|1|||
160949151|NCT00467870|581203015|FG000|Overall Study|Protocol Violation|2|||
160949152|NCT00467870|581203016|FG001|Overall Study|Protocol Violation|1|||
160949153|NCT00467870|581203017|FG002|Overall Study|Protocol Violation|1|||
160949154|NCT00467870|581203018|FG003|Overall Study|Protocol Violation|2|||
160949155|NCT00467870|581203019|FG004|Overall Study|Protocol Violation|0|||
160949156|NCT00467870|581203020|FG005|Overall Study|Protocol Violation|0|||
160949157|NCT00467870|581203015|FG000|Overall Study|Withdrawal by Subject|14|||
160949158|NCT00467870|581203016|FG001|Overall Study|Withdrawal by Subject|21|||
160949159|NCT00467870|581203017|FG002|Overall Study|Withdrawal by Subject|0|||
160949160|NCT00467870|581203018|FG003|Overall Study|Withdrawal by Subject|9|||
160949161|NCT00467870|581203019|FG004|Overall Study|Withdrawal by Subject|10|||
160949162|NCT00467870|581203020|FG005|Overall Study|Withdrawal by Subject|1|||
160949163|NCT00467870|581203015|FG000|Overall Study|Lost to Follow-up|5|||
160949164|NCT00467870|581203016|FG001|Overall Study|Lost to Follow-up|3|||
160949165|NCT00467870|581203017|FG002|Overall Study|Lost to Follow-up|1|||
160949166|NCT00467870|581203018|FG003|Overall Study|Lost to Follow-up|1|||
160582032|NCT00423085|579851824|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
160582033|NCT00423085|579851821|FG000|52-Week Open-Label Extension Phase|Death|0|||
160582034|NCT00423085|579851822|FG001|52-Week Open-Label Extension Phase|Death|0|||
160582035|NCT00423085|579851823|FG002|52-Week Open-Label Extension Phase|Death|0|||
160582036|NCT00423085|579851824|FG003|52-Week Open-Label Extension Phase|Death|2|||
160582037|NCT03331666|579851825|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
160582038|NCT03331666|579851826|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
160582039|NCT02326467|579851827|FG000|Overall Study|Withdrawal by Subject|1|||
160582040|NCT00434512|579851828|FG000|Overall Study|Migrated/moved from study area|0|||
160582041|NCT00434512|579851829|FG001|Overall Study|Migrated/moved from study area|0|||
160582042|NCT00434512|579851830|FG002|Overall Study|Migrated/moved from study area|0|||
160582043|NCT00434512|579851831|FG003|Overall Study|Migrated/moved from study area|1|||
160582044|NCT00434512|579851832|FG004|Overall Study|Migrated/moved from study area|1|||
160582045|NCT00434512|579851833|FG005|Overall Study|Migrated/moved from study area|1|||
160582046|NCT00434512|579851828|FG000|Overall Study|Other|0|||
160582047|NCT00434512|579851829|FG001|Overall Study|Other|1|||
160582048|NCT00434512|579851830|FG002|Overall Study|Other|0|||
160582049|NCT00434512|579851831|FG003|Overall Study|Other|0|||
160582050|NCT00434512|579851832|FG004|Overall Study|Other|0|||
160582051|NCT00434512|579851833|FG005|Overall Study|Other|0|||
160949167|NCT00467870|581203019|FG004|Overall Study|Lost to Follow-up|3|||
160949168|NCT00467870|581203020|FG005|Overall Study|Lost to Follow-up|0|||
160949169|NCT00467870|581203015|FG000|Overall Study|Subject Non-compliance|3|||
160949170|NCT00467870|581203016|FG001|Overall Study|Subject Non-compliance|4|||
160949171|NCT00467870|581203017|FG002|Overall Study|Subject Non-compliance|0|||
160949172|NCT00467870|581203018|FG003|Overall Study|Subject Non-compliance|1|||
160949173|NCT00467870|581203019|FG004|Overall Study|Subject Non-compliance|5|||
160582052|NCT02750813|579851837|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
160949174|NCT00467870|581203020|FG005|Overall Study|Subject Non-compliance|0|||
160456369|NCT03476343|579401417|FG000|Overall Study|Clinical exam moved to another scanner|7|||
160582053|NCT02750813|579851838|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
160656203|NCT00001849|580122366|FG000|Overall Study|Lost to Follow-up|2|||
160949175|NCT00467870|581203015|FG000|Overall Study|Other/Unknown|8|||
160949176|NCT00467870|581203016|FG001|Overall Study|Other/Unknown|5|||
160949177|NCT00467870|581203017|FG002|Overall Study|Other/Unknown|1|||
160949178|NCT00467870|581203018|FG003|Overall Study|Other/Unknown|5|||
160949179|NCT00467870|581203019|FG004|Overall Study|Other/Unknown|4|||
160949180|NCT00467870|581203020|FG005|Overall Study|Other/Unknown|0|||
160949181|NCT03489304|581203021|FG000|Overall Study|Lost to Follow-up|4|||
160949182|NCT02239679|581203022|FG000|Overall Study|Lost to Follow-up|1|||
160949183|NCT02239679|581203023|FG001|Overall Study|Lost to Follow-up|0|||
160582054|NCT02750813|579851837|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
160582055|NCT02750813|579851838|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
160582056|NCT01998581|579851839|FG000|Overall Study|Refused repeat treatment|20|||
160582057|NCT01998581|579851840|FG001|Overall Study|Refused repeat treatment|4|||
160582058|NCT01998581|579851839|FG000|Overall Study|Protocol Violation|1|||
160582059|NCT01998581|579851840|FG001|Overall Study|Protocol Violation|0|||
160582060|NCT01998581|579851839|FG000|Overall Study|Withdrawal by Subject|8|||
160582061|NCT01998581|579851840|FG001|Overall Study|Withdrawal by Subject|1|||
160582062|NCT01998581|579851839|FG000|Overall Study|Lost to Follow-up|12|||
160582063|NCT01998581|579851840|FG001|Overall Study|Lost to Follow-up|4|||
160582064|NCT01998581|579851839|FG000|Overall Study|Adverse Event|1|||
160582065|NCT01998581|579851840|FG001|Overall Study|Adverse Event|1|||
160582066|NCT01998581|579851839|FG000|Overall Study|Other reasons|3|||
160582067|NCT01998581|579851840|FG001|Overall Study|Other reasons|2|||
160582068|NCT01998581|579851839|FG000|Overall Study|Randomized but withdrew before treatment|1|||
160582069|NCT01998581|579851840|FG001|Overall Study|Randomized but withdrew before treatment|0|||
160582070|NCT00441441|579851841|FG000|Overall Study|Adverse Event|2|||
160582071|NCT00441441|579851842|FG001|Overall Study|Adverse Event|1|||
160582072|NCT00441441|579851841|FG000|Overall Study|Protocol Violation|4|||
160582073|NCT00441441|579851842|FG001|Overall Study|Protocol Violation|6|||
160582074|NCT00441441|579851841|FG000|Overall Study|Exacerbation of asthma|1|||
160582075|NCT00441441|579851842|FG001|Overall Study|Exacerbation of asthma|2|||
160582076|NCT00441441|579851841|FG000|Overall Study|Withdrawal by Subject|1|||
160582077|NCT00441441|579851842|FG001|Overall Study|Withdrawal by Subject|2|||
160582078|NCT00441441|579851841|FG000|Overall Study|Other|3|||
160582079|NCT00441441|579851842|FG001|Overall Study|Other|3|||
160582080|NCT05619172|579851846|FG000|Safety Cohort 1|Death|7|||
160582081|NCT05619172|579851847|FG001|Safety Cohort 1|Death|0|||
160582082|NCT05619172|579851846|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
160582083|NCT05619172|579851847|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
160582084|NCT05619172|579851846|FG000|Safety Cohort 2|Death|0|||
160949184|NCT02239679|581203024|FG002|Overall Study|Lost to Follow-up|0|||
160949185|NCT02239679|581203022|FG000|Overall Study|Withdrawal by Subject|2|||
160949186|NCT02239679|581203023|FG001|Overall Study|Withdrawal by Subject|3|||
160949187|NCT02239679|581203024|FG002|Overall Study|Withdrawal by Subject|1|||
160949188|NCT01917526|581203025|FG000|Overall Study|Protocol Violation|1|||
160949189|NCT01917526|581203026|FG001|Overall Study|Protocol Violation|1|||
160949190|NCT00760929|581203030|FG000|Overall Study|Adverse Event|2|||
160949191|NCT00760929|581203031|FG001|Overall Study|Adverse Event|0|||
160949192|NCT00760929|581203032|FG002|Overall Study|Adverse Event|6|||
160949193|NCT00760929|581203033|FG003|Overall Study|Adverse Event|10|||
160949194|NCT00760929|581203030|FG000|Overall Study|Lack of Efficacy|0|||
160949195|NCT00760929|581203031|FG001|Overall Study|Lack of Efficacy|2|||
160949196|NCT00760929|581203032|FG002|Overall Study|Lack of Efficacy|1|||
160949197|NCT00760929|581203033|FG003|Overall Study|Lack of Efficacy|0|||
160949198|NCT00760929|581203030|FG000|Overall Study|Withdrawal by Subject|1|||
160949199|NCT00760929|581203031|FG001|Overall Study|Withdrawal by Subject|0|||
160949200|NCT00760929|581203032|FG002|Overall Study|Withdrawal by Subject|9|||
160949201|NCT00760929|581203033|FG003|Overall Study|Withdrawal by Subject|1|||
160949202|NCT00760929|581203030|FG000|Overall Study|Lost to Follow-up|0|||
160949203|NCT00760929|581203031|FG001|Overall Study|Lost to Follow-up|0|||
160949204|NCT00760929|581203032|FG002|Overall Study|Lost to Follow-up|1|||
160582085|NCT05619172|579851847|FG001|Safety Cohort 2|Death|1|||
160582086|NCT05619172|579851846|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
160582087|NCT05619172|579851847|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
160582088|NCT03165721|579851848|FG000|Overall Study|Refused further treatment|3|||
160582089|NCT03165721|579851849|FG001|Overall Study|Refused further treatment|0|||
160582090|NCT03165721|579851850|FG002|Overall Study|Refused further treatment|0|||
160582091|NCT03165721|579851848|FG000|Overall Study|Physician Decision|1|||
160582092|NCT03165721|579851849|FG001|Overall Study|Physician Decision|0|||
160949205|NCT00760929|581203033|FG003|Overall Study|Lost to Follow-up|0|||
160582093|NCT03165721|579851850|FG002|Overall Study|Physician Decision|0|||
160582094|NCT01457118|579851852|FG000|Overall Study|Adverse Event|1|||
160582095|NCT01457118|579851853|FG001|Overall Study|Adverse Event|0|||
160582096|NCT01457118|579851854|FG002|Overall Study|Adverse Event|0|||
160582097|NCT01457118|579851855|FG003|Overall Study|Adverse Event|1|||
160582098|NCT01457118|579851852|FG000|Overall Study|Clinical Progression|0|||
160582099|NCT01457118|579851853|FG001|Overall Study|Clinical Progression|1|||
160582100|NCT01457118|579851854|FG002|Overall Study|Clinical Progression|0|||
160949206|NCT00760929|581203030|FG000|Overall Study|Progression of Disease|21|||
160949207|NCT00760929|581203031|FG001|Overall Study|Progression of Disease|26|||
160582101|NCT01457118|579851855|FG003|Overall Study|Clinical Progression|1|||
160582102|NCT01457118|579851852|FG000|Overall Study|Physician Decision|2|||
160582103|NCT01457118|579851853|FG001|Overall Study|Physician Decision|0|||
160582104|NCT01457118|579851854|FG002|Overall Study|Physician Decision|0|||
160582105|NCT01457118|579851855|FG003|Overall Study|Physician Decision|0|||
160582106|NCT01457118|579851852|FG000|Overall Study|Progressive Disease by RECIST|12|||
160582107|NCT01457118|579851853|FG001|Overall Study|Progressive Disease by RECIST|3|||
160949208|NCT00760929|581203032|FG002|Overall Study|Progression of Disease|38|||
160582108|NCT01457118|579851854|FG002|Overall Study|Progressive Disease by RECIST|1|||
160582109|NCT01457118|579851855|FG003|Overall Study|Progressive Disease by RECIST|0|||
160582110|NCT01457118|579851852|FG000|Overall Study|Withdrawal by Subject|5|||
160582111|NCT01457118|579851853|FG001|Overall Study|Withdrawal by Subject|0|||
160582112|NCT01457118|579851854|FG002|Overall Study|Withdrawal by Subject|0|||
160582113|NCT01457118|579851855|FG003|Overall Study|Withdrawal by Subject|0|||
160582114|NCT01727713|579851860|FG000|Overall Study|Lost to Follow-up|5|||
160582115|NCT01727713|579851860|FG000|Overall Study|Adverse Event|10|||
160862235|NCT00360230|580889687|FG006|Overall Study|Death|1|||
160862236|NCT02703597|580889688|FG000|Assignment to Baseline|Lost to Follow-up|17|||
160862237|NCT02703597|580889689|FG001|Assignment to Baseline|Lost to Follow-up|16|||
160862238|NCT02703597|580889688|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
160862239|NCT02703597|580889689|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
160862240|NCT02703597|580889688|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
160862241|NCT02703597|580889689|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
160862242|NCT02703597|580889688|FG000|First Post-test to First Follow-up|Site drop out|0|||
160862243|NCT02703597|580889689|FG001|First Post-test to First Follow-up|Site drop out|58|||
160862244|NCT02703597|580889688|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
160862245|NCT02703597|580889689|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
160862246|NCT02703597|580889688|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
160862247|NCT02703597|580889689|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
160862248|NCT02703597|580889688|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
160862249|NCT02703597|580889689|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
160862250|NCT00581308|580889690|FG000|Pre Discharge|Lost to Follow-up|1|||
160862251|NCT00581308|580889690|FG000|Pre Discharge|Device Removed|1|||
160862252|NCT00581308|580889690|FG000|Month 1|Lost to Follow-up|3|||
160862253|NCT00581308|580889690|FG000|Month 1|Withdrawal by Subject|2|||
160862254|NCT00581308|580889690|FG000|Month 1|Device Removed|2|||
160862255|NCT00581308|580889690|FG000|Month 1|Uknown|1|||
160862256|NCT00581308|580889690|FG000|Month 6|Lost to Follow-up|1|||
160862257|NCT00581308|580889690|FG000|Month 6|Withdrawal by Subject|2|||
160862258|NCT00581308|580889690|FG000|Month 12|Death|1|||
160862259|NCT00581308|580889690|FG000|Month 12|Lost to Follow-up|14|||
160862260|NCT00581308|580889690|FG000|Month 12|Withdrawal by Subject|3|||
160862261|NCT00581308|580889690|FG000|Month 12|Device Removed|1|||
160862262|NCT00581308|580889690|FG000|Month 12|Other|1|||
160862263|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
160862264|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
160862265|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
160862266|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
160862267|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
160862268|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
160862269|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
160862270|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
160862271|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
160862272|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
160862273|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
160862274|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
160862275|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
160862276|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
160862277|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
160862278|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Other|1|||
160862279|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Other|5|||
160862280|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Other|0|||
160862281|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Other|2|||
160862282|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Other|3|||
160862283|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
160862284|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
160862285|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
160862286|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
160862287|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
160862288|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
160862289|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
160862290|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
160862291|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
160862292|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
160862293|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
160862294|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
160862295|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
160862296|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
160862297|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
160862298|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
160862299|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
160862300|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
160949209|NCT00760929|581203033|FG003|Overall Study|Progression of Disease|42|||
160949210|NCT00760929|581203030|FG000|Overall Study|Other|2|||
160949211|NCT00760929|581203031|FG001|Overall Study|Other|0|||
160949212|NCT00760929|581203032|FG002|Overall Study|Other|2|||
160949213|NCT00760929|581203033|FG003|Overall Study|Other|1|||
160949214|NCT00760929|581203030|FG000|Overall Study|Death|0|||
160949215|NCT00760929|581203031|FG001|Overall Study|Death|0|||
160949216|NCT00760929|581203032|FG002|Overall Study|Death|1|||
160949217|NCT00760929|581203033|FG003|Overall Study|Death|0|||
160949218|NCT00760929|581203030|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
160949219|NCT00760929|581203031|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
160949220|NCT00760929|581203032|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
160949221|NCT00760929|581203033|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
160949222|NCT02099838|581203034|FG000|Overall Study|Death|1|||
160949223|NCT02099838|581203035|FG001|Overall Study|Death|0|||
160949224|NCT02099838|581203034|FG000|Overall Study|Lost to Follow-up|3|||
160949225|NCT02099838|581203035|FG001|Overall Study|Lost to Follow-up|1|||
160949226|NCT02099838|581203034|FG000|Overall Study|Withdrawal by Subject|0|||
160949227|NCT02099838|581203035|FG001|Overall Study|Withdrawal by Subject|1|||
160949228|NCT04121962|581203036|FG000|Overall Study|Lost to Follow-up|42|||
160949229|NCT04121962|581203037|FG001|Overall Study|Lost to Follow-up|39|||
160949230|NCT01175382|581203038|FG000|Overall Study|Lost to Follow-up|4|||
160949231|NCT01175382|581203039|FG001|Overall Study|Lost to Follow-up|3|||
160949232|NCT01175382|581203040|FG002|Overall Study|Lost to Follow-up|1|||
160949233|NCT01175382|581203038|FG000|Overall Study|Physician Decision|0|||
160949234|NCT01175382|581203039|FG001|Overall Study|Physician Decision|1|||
160949235|NCT01175382|581203040|FG002|Overall Study|Physician Decision|0|||
160949236|NCT01175382|581203038|FG000|Overall Study|Withdrawal by Subject|0|||
160949237|NCT01175382|581203039|FG001|Overall Study|Withdrawal by Subject|0|||
160949238|NCT01175382|581203040|FG002|Overall Study|Withdrawal by Subject|1|||
160949239|NCT01175382|581203038|FG000|Overall Study|No longer having problem|1|||
160949240|NCT01175382|581203039|FG001|Overall Study|No longer having problem|0|||
160949241|NCT01175382|581203040|FG002|Overall Study|No longer having problem|1|||
160949242|NCT01175382|581203038|FG000|Overall Study|Unable/unwilling to attend visits|3|||
160949243|NCT01175382|581203039|FG001|Overall Study|Unable/unwilling to attend visits|1|||
160949244|NCT01175382|581203040|FG002|Overall Study|Unable/unwilling to attend visits|2|||
160949245|NCT01175382|581203038|FG000|Overall Study|Unwilling to follow protocol|0|||
160949246|NCT01175382|581203039|FG001|Overall Study|Unwilling to follow protocol|1|||
160949247|NCT01175382|581203040|FG002|Overall Study|Unwilling to follow protocol|0|||
160949248|NCT01175382|581203038|FG000|Overall Study|Unable to tolerate study meds|0|||
160949249|NCT01175382|581203039|FG001|Overall Study|Unable to tolerate study meds|1|||
160949250|NCT01175382|581203040|FG002|Overall Study|Unable to tolerate study meds|1|||
160949251|NCT00774787|581203041|FG000|Overall Study|Lost to Follow-up|1|||
160949252|NCT04535037|581203042|FG000|Overall Study|Protocol Violation|1|||
160949253|NCT04535037|581203043|FG001|Overall Study|Protocol Violation|0|||
160949254|NCT04535037|581203042|FG000|Overall Study|Withdrawal by Subject|8|||
160949255|NCT04535037|581203043|FG001|Overall Study|Withdrawal by Subject|9|||
160949256|NCT04535037|581203042|FG000|Overall Study|Migrated / moved from the study area|1|||
160949257|NCT04535037|581203043|FG001|Overall Study|Migrated / moved from the study area|4|||
160949258|NCT04535037|581203042|FG000|Overall Study|Other|2|||
160949259|NCT04535037|581203043|FG001|Overall Study|Other|5|||
160949260|NCT02031276|581203044|FG000|Period 1 Double-blind IV|Adverse Event|6|||
160949261|NCT02031276|581203045|FG001|Period 1 Double-blind IV|Adverse Event|5|||
160456370|NCT03476343|579401417|FG000|Overall Study|Clinical order cancelled|4|||
160456371|NCT03476343|579401417|FG000|Overall Study|Neonate did not settle down for the scan|1|||
160456372|NCT05974501|579401418|FG000|Overall Study|Physician Decision|0|||
160456373|NCT05974501|579401419|FG001|Overall Study|Physician Decision|1|||
160949262|NCT02031276|581203046|FG002|Period 1 Double-blind IV|Adverse Event|1|||
160949263|NCT02031276|581203044|FG000|Period 1 Double-blind IV|Other|0|||
160949264|NCT02031276|581203045|FG001|Period 1 Double-blind IV|Other|1|||
160949265|NCT02031276|581203046|FG002|Period 1 Double-blind IV|Other|0|||
160949266|NCT02031276|581203044|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
160949267|NCT02031276|581203045|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
160949268|NCT02031276|581203046|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
160949269|NCT02031276|581203044|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
160949270|NCT02031276|581203045|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
160949271|NCT02031276|581203046|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
160456374|NCT04304144|579401420|FG000|DLT Observation Period|Physician Decision|0|||
160949272|NCT02031276|581203044|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
160949273|NCT02031276|581203045|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
160949274|NCT02031276|581203046|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
160949275|NCT02031276|581203044|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
160949276|NCT02031276|581203045|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
160949277|NCT02031276|581203046|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
160456375|NCT04304144|579401421|FG001|DLT Observation Period|Physician Decision|1|||
160949278|NCT02031276|581203044|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
160949279|NCT02031276|581203045|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
160949280|NCT02031276|581203046|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
160949281|NCT02031276|581203044|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
160949282|NCT02031276|581203045|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
160949283|NCT02031276|581203046|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
160949284|NCT02031276|581203044|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
160949285|NCT02031276|581203045|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
160949286|NCT02031276|581203046|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
160949287|NCT03525834|581203059|FG000|Overall Study|Progressive disease|1|||
160949288|NCT00346034|581203062|FG000|Overall Study|Adverse Event|34|||
160949289|NCT00346034|581203062|FG000|Overall Study|Lack of Efficacy|8|||
160949290|NCT00346034|581203062|FG000|Overall Study|Withdrawal by Subject|13|||
160949291|NCT00346034|581203062|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
160949292|NCT00346034|581203062|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
160949293|NCT00941603|581203063|FG000|Overall Study|Adverse Event|10|||
160949294|NCT00941603|581203064|FG001|Overall Study|Adverse Event|15|||
160949295|NCT00941603|581203065|FG002|Overall Study|Adverse Event|5|||
160949296|NCT00941603|581203066|FG003|Overall Study|Adverse Event|1|||
160949297|NCT00941603|581203067|FG004|Overall Study|Adverse Event|4|||
160949298|NCT00941603|581203068|FG005|Overall Study|Adverse Event|0|||
160949299|NCT00941603|581203063|FG000|Overall Study|Lost to Follow-up|0|||
160949300|NCT00941603|581203064|FG001|Overall Study|Lost to Follow-up|0|||
160949301|NCT00941603|581203065|FG002|Overall Study|Lost to Follow-up|0|||
160949302|NCT00941603|581203066|FG003|Overall Study|Lost to Follow-up|1|||
160949303|NCT00941603|581203067|FG004|Overall Study|Lost to Follow-up|0|||
160949304|NCT00941603|581203068|FG005|Overall Study|Lost to Follow-up|2|||
160949305|NCT00941603|581203063|FG000|Overall Study|Withdrawal by Subject|0|||
160949306|NCT00941603|581203064|FG001|Overall Study|Withdrawal by Subject|0|||
160949307|NCT00941603|581203065|FG002|Overall Study|Withdrawal by Subject|0|||
160949308|NCT00941603|581203066|FG003|Overall Study|Withdrawal by Subject|2|||
160949309|NCT00941603|581203067|FG004|Overall Study|Withdrawal by Subject|0|||
160949310|NCT00941603|581203068|FG005|Overall Study|Withdrawal by Subject|1|||
160949311|NCT00941603|581203063|FG000|Overall Study|Protocol Violation|0|||
160949312|NCT00941603|581203064|FG001|Overall Study|Protocol Violation|1|||
160949313|NCT00941603|581203065|FG002|Overall Study|Protocol Violation|0|||
160949314|NCT00941603|581203066|FG003|Overall Study|Protocol Violation|0|||
160949315|NCT00941603|581203067|FG004|Overall Study|Protocol Violation|0|||
160949316|NCT00941603|581203068|FG005|Overall Study|Protocol Violation|0|||
160949317|NCT00941603|581203063|FG000|Overall Study|Did not meet protocol eligibility|1|||
160949318|NCT00941603|581203064|FG001|Overall Study|Did not meet protocol eligibility|0|||
160949319|NCT00941603|581203065|FG002|Overall Study|Did not meet protocol eligibility|0|||
160949320|NCT00941603|581203066|FG003|Overall Study|Did not meet protocol eligibility|0|||
160949321|NCT00941603|581203067|FG004|Overall Study|Did not meet protocol eligibility|0|||
160949322|NCT00941603|581203068|FG005|Overall Study|Did not meet protocol eligibility|0|||
160949323|NCT03879798|581203071|FG000|Overall Study|Adverse Event|0|||
160949324|NCT03879798|581203072|FG001|Overall Study|Adverse Event|0|||
160949325|NCT03879798|581203073|FG002|Overall Study|Adverse Event|0|||
160949326|NCT03879798|581203074|FG003|Overall Study|Adverse Event|0|||
160949327|NCT03879798|581203075|FG004|Overall Study|Adverse Event|0|||
160949328|NCT03879798|581203076|FG005|Overall Study|Adverse Event|1|||
160949329|NCT03879798|581203071|FG000|Overall Study|Lack of Efficacy|0|||
160949330|NCT03879798|581203072|FG001|Overall Study|Lack of Efficacy|0|||
160949331|NCT03879798|581203073|FG002|Overall Study|Lack of Efficacy|0|||
160582116|NCT01727713|579851860|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
160582117|NCT01727713|579851860|FG000|Overall Study|Withdrawal by Subject|13|||
160582118|NCT01727713|579851860|FG000|Overall Study|Protocol Deviation|2|||
160582119|NCT01842308|579851867|FG000|Overall Study|Withdrawal by Subject|0|||
160582120|NCT01842308|579851868|FG001|Overall Study|Withdrawal by Subject|0|||
160949332|NCT03879798|581203074|FG003|Overall Study|Lack of Efficacy|0|||
160949333|NCT03879798|581203075|FG004|Overall Study|Lack of Efficacy|0|||
160949334|NCT03879798|581203076|FG005|Overall Study|Lack of Efficacy|1|||
160949335|NCT03879798|581203071|FG000|Overall Study|Withdrawal by Subject|0|||
160949336|NCT03879798|581203072|FG001|Overall Study|Withdrawal by Subject|0|||
160949337|NCT03879798|581203073|FG002|Overall Study|Withdrawal by Subject|0|||
160949338|NCT03879798|581203074|FG003|Overall Study|Withdrawal by Subject|0|||
160949339|NCT03879798|581203075|FG004|Overall Study|Withdrawal by Subject|0|||
160949340|NCT03879798|581203076|FG005|Overall Study|Withdrawal by Subject|1|||
160949341|NCT01343407|581203077|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
160949342|NCT01343407|581203078|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
160949343|NCT01343407|581203079|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
160949344|NCT01343407|581203080|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
160582121|NCT01842308|579851869|FG002|Overall Study|Withdrawal by Subject|0|||
160949345|NCT01343407|581203081|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
160949346|NCT01343407|581203082|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
160949347|NCT01343407|581203077|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
160949348|NCT01343407|581203078|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
160949349|NCT01343407|581203079|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
160949350|NCT01343407|581203080|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
160949351|NCT01343407|581203081|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
160949352|NCT01343407|581203082|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
160949353|NCT06027216|581203083|FG000|Overall Study|Did not qualify|8|||
160949354|NCT00345579|581203087|FG000|Overall Study|Adverse Event|9|||
160949355|NCT00345579|581203088|FG001|Overall Study|Adverse Event|6|||
160949356|NCT00345579|581203087|FG000|Overall Study|Protocol Violation|14|||
160949357|NCT00345579|581203088|FG001|Overall Study|Protocol Violation|5|||
160949358|NCT00345579|581203087|FG000|Overall Study|Withdrawal by Subject|50|||
160949359|NCT00345579|581203088|FG001|Overall Study|Withdrawal by Subject|17|||
160949360|NCT00345579|581203087|FG000|Overall Study|Lost to Follow-up|82|||
160949361|NCT00345579|581203088|FG001|Overall Study|Lost to Follow-up|36|||
160949362|NCT00345579|581203087|FG000|Overall Study|Other|9|||
160949363|NCT00345579|581203088|FG001|Overall Study|Other|1|||
160949364|NCT03646513|581203089|FG000|Overall Study|Premature study termination|4|||
160949365|NCT01732835|581203090|FG000|6-month Primary Endpoint|Did not receive device|19|||
160949366|NCT01732835|581203090|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
160949367|NCT01732835|581203090|FG000|6-month Primary Endpoint|Adverse Event|3|||
160949368|NCT01732835|581203090|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
160949369|NCT01732835|581203090|FG000|2-year Extended Follow-up|Adverse Event|3|||
160949370|NCT01732835|581203090|FG000|2-year Extended Follow-up|Death|1|||
160949371|NCT02043782|581203095|FG000|Period 1|Adverse Event|0|||
160949372|NCT02043782|581203096|FG001|Period 1|Adverse Event|0|||
160949373|NCT02043782|581203097|FG002|Period 1|Adverse Event|1|||
160949374|NCT02043782|581203098|FG003|Period 1|Adverse Event|0|||
160949375|NCT02043782|581203099|FG004|Period 1|Adverse Event|0|||
160949376|NCT02043782|581203100|FG005|Period 1|Adverse Event|0|||
160949377|NCT00874029|581203101|FG000|Overall Study|Withdrawal by Subject|10|||
160949378|NCT00874029|581203101|FG000|Overall Study|Pregnancy|4|||
160949379|NCT00874029|581203101|FG000|Overall Study|Physician Decision|1|||
160949380|NCT00874029|581203101|FG000|Overall Study|Adverse Event|1|||
160949381|NCT00874029|581203101|FG000|Overall Study|Lost to Follow-up|5|||
160949382|NCT02007577|581203102|FG000|Overall Study|Adverse Event|1|||
160949383|NCT02007577|581203103|FG001|Overall Study|Adverse Event|0|||
160949384|NCT02007577|581203102|FG000|Overall Study|Withdrawal by Subject|0|||
160949385|NCT02007577|581203103|FG001|Overall Study|Withdrawal by Subject|1|||
160949386|NCT01767116|581203104|FG000|Overall Study|Lost to Follow-up|2|||
160949387|NCT01767116|581203105|FG001|Overall Study|Lost to Follow-up|2|||
160949388|NCT00968669|581203106|FG000|Overall Study|Lost to Follow-up|5|||
160949389|NCT00968669|581203107|FG001|Overall Study|Lost to Follow-up|2|||
160949390|NCT00968669|581203108|FG002|Overall Study|Lost to Follow-up|1|||
160949391|NCT00968669|581203109|FG003|Overall Study|Lost to Follow-up|4|||
160949392|NCT00968669|581203106|FG000|Overall Study|Withdrawal by Subject|9|||
160949393|NCT00968669|581203107|FG001|Overall Study|Withdrawal by Subject|7|||
160949394|NCT00968669|581203108|FG002|Overall Study|Withdrawal by Subject|5|||
160582122|NCT01842308|579851870|FG003|Overall Study|Withdrawal by Subject|0|||
160949395|NCT00968669|581203109|FG003|Overall Study|Withdrawal by Subject|3|||
160949396|NCT00968669|581203106|FG000|Overall Study|Pregnancy|0|||
160949397|NCT00968669|581203107|FG001|Overall Study|Pregnancy|0|||
160949398|NCT00968669|581203108|FG002|Overall Study|Pregnancy|2|||
160949399|NCT00968669|581203109|FG003|Overall Study|Pregnancy|0|||
160582123|NCT01842308|579851871|FG004|Overall Study|Withdrawal by Subject|1|||
160582124|NCT01217190|579851872|FG000|Second Dosing|Withdrawal by Subject|0|||
160582125|NCT01217190|579851873|FG001|Second Dosing|Withdrawal by Subject|2|||
160582126|NCT01594476|579851874|FG000|Overall Study|Protocol Violation|1|||
160949400|NCT00968669|581203106|FG000|Overall Study|AE|1|||
160949401|NCT00968669|581203107|FG001|Overall Study|AE|0|||
160582127|NCT01594476|579851875|FG001|Overall Study|Protocol Violation|3|||
160582128|NCT05114590|579851876|FG000|Overall Study|Adverse Event|1|||
160949402|NCT00968669|581203108|FG002|Overall Study|AE|0|||
160949403|NCT00968669|581203109|FG003|Overall Study|AE|0|||
160949404|NCT00968669|581203106|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
160949405|NCT00968669|581203107|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
160949406|NCT00968669|581203108|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
160949407|NCT00968669|581203109|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
160949408|NCT00968669|581203106|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
160949409|NCT00968669|581203107|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
160949410|NCT00968669|581203108|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
160949411|NCT00968669|581203109|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
160949412|NCT00968669|581203106|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
160949413|NCT00968669|581203107|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
160456376|NCT04304144|579401422|FG002|DLT Observation Period|Physician Decision|0|||
160949414|NCT00968669|581203108|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
160949415|NCT00968669|581203109|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
160949416|NCT00968669|581203106|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
160949417|NCT00968669|581203107|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
160999927|NCT03284957|581384926|FG015|Overall Study|Progressive Disease|2|||
160949418|NCT00968669|581203108|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
160949419|NCT00968669|581203109|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
160949420|NCT00968669|581203106|FG000|Overall Study|EARLY WITHDRAWAL|0|||
160949421|NCT00968669|581203107|FG001|Overall Study|EARLY WITHDRAWAL|1|||
160949422|NCT00968669|581203108|FG002|Overall Study|EARLY WITHDRAWAL|0|||
160949423|NCT00968669|581203109|FG003|Overall Study|EARLY WITHDRAWAL|0|||
160949424|NCT00968669|581203106|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
160949425|NCT00968669|581203107|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
160949426|NCT00968669|581203108|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
160949427|NCT00968669|581203109|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
160949428|NCT00968669|581203106|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
160949429|NCT00968669|581203107|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
160949430|NCT00968669|581203108|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
160949431|NCT00968669|581203109|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
160949432|NCT00968669|581203106|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
160949433|NCT00968669|581203107|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
160949434|NCT00968669|581203108|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
160949435|NCT00968669|581203109|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
160949436|NCT00968669|581203106|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
160949437|NCT00968669|581203107|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
160949438|NCT00968669|581203108|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
160949439|NCT00968669|581203109|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
160949440|NCT00968669|581203106|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
160949441|NCT00968669|581203107|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
160949442|NCT00968669|581203108|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
160949443|NCT00968669|581203109|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
160949444|NCT00968669|581203106|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
160949445|NCT00968669|581203107|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
160949446|NCT00968669|581203108|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
160949447|NCT00968669|581203109|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
160949448|NCT00968669|581203106|FG000|Overall Study|SPONSOR DECISION|0|||
160949449|NCT00968669|581203107|FG001|Overall Study|SPONSOR DECISION|1|||
160949450|NCT00968669|581203108|FG002|Overall Study|SPONSOR DECISION|0|||
160949451|NCT00968669|581203109|FG003|Overall Study|SPONSOR DECISION|0|||
160949452|NCT00968669|581203106|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
160949453|NCT00968669|581203107|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
160949454|NCT00968669|581203108|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
160949455|NCT00968669|581203109|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
160949456|NCT00968669|581203106|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
160949457|NCT00968669|581203107|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
160949458|NCT00968669|581203108|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
160949459|NCT00968669|581203109|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
160949460|NCT00968669|581203106|FG000|Overall Study|SUBJECT INCARCERATED|0|||
160949461|NCT00968669|581203107|FG001|Overall Study|SUBJECT INCARCERATED|1|||
160949462|NCT00968669|581203108|FG002|Overall Study|SUBJECT INCARCERATED|0|||
160949463|NCT00968669|581203109|FG003|Overall Study|SUBJECT INCARCERATED|0|||
160949464|NCT00968669|581203106|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
160949465|NCT00968669|581203107|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
160949466|NCT00968669|581203108|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
160949467|NCT00968669|581203109|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
160949468|NCT00968669|581203106|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
160949469|NCT00968669|581203107|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
160949470|NCT00968669|581203108|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
160949471|NCT00968669|581203109|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
160949472|NCT02338362|581203112|FG000|Overall Study|Withdrawal by Subject|1|||
160949473|NCT02338362|581203113|FG001|Overall Study|Withdrawal by Subject|1|||
160949474|NCT01669343|581203114|FG000|Part A: All Patients|Withdrawal by Subject|7|||
160949475|NCT01669343|581203114|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
160949476|NCT01669343|581203114|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
160949477|NCT01669343|581203114|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
160949478|NCT01669343|581203114|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
160949479|NCT02371369|581203119|FG000|Part 1|Physician Decision|0|||
160582129|NCT05114590|579851876|FG000|Overall Study|Investigator decision|1|||
160582130|NCT05114590|579851876|FG000|Overall Study|Lost to Follow-up|5|||
160582131|NCT05114590|579851876|FG000|Overall Study|Withdrawal by Subject|5|||
160949480|NCT02371369|581203120|FG001|Part 1|Physician Decision|3|||
160949481|NCT02371369|581203119|FG000|Part 1|Adverse Event|8|||
160949482|NCT02371369|581203120|FG001|Part 1|Adverse Event|0|||
160949483|NCT02371369|581203119|FG000|Part 1|Withdrawal by Subject|1|||
160582132|NCT05114590|579851876|FG000|Overall Study|Other|2|||
160949484|NCT02371369|581203120|FG001|Part 1|Withdrawal by Subject|6|||
160949485|NCT02371369|581203119|FG000|Part 1|Disease progression|0|||
160456377|NCT04304144|579401423|FG003|DLT Observation Period|Physician Decision|0|||
160456378|NCT04304144|579401420|FG000|Continued Treatment Period|Adverse Event|0|||
160862301|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
160862302|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
160862303|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
160862304|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
160862305|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
160862306|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
160862307|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
160862308|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Other|0|||
160862309|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Other|1|||
160862310|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Other|0|||
160862311|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Other|1|||
160862312|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Other|0|||
160862313|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Not treated|0|||
160862314|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Not treated|0|||
160862315|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Not treated|2|||
160862316|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Not treated|0|||
160862317|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Not treated|0|||
160862318|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
160862319|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
160862320|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
160862321|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
160862322|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
160862323|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
160862324|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
160862325|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
160862326|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
160862327|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
160862328|NCT05966142|580889702|FG000|Overall Study|Death|3|||
160862329|NCT05966142|580889703|FG001|Overall Study|Death|3|||
160862330|NCT05966142|580889702|FG000|Overall Study|Lost to Follow-up|55|||
160862331|NCT05966142|580889703|FG001|Overall Study|Lost to Follow-up|52|||
160862332|NCT05966142|580889702|FG000|Overall Study|Physician Decision|1|||
160862333|NCT05966142|580889703|FG001|Overall Study|Physician Decision|0|||
160862334|NCT05966142|580889702|FG000|Overall Study|Withdrawal by Subject|9|||
160862335|NCT05966142|580889703|FG001|Overall Study|Withdrawal by Subject|8|||
160862336|NCT05966142|580889702|FG000|Overall Study|Duplicate Enrollment|1|||
160862337|NCT05966142|580889703|FG001|Overall Study|Duplicate Enrollment|0|||
160862338|NCT05966142|580889702|FG000|Overall Study|Study Logistical Reason|1|||
160862339|NCT05966142|580889703|FG001|Overall Study|Study Logistical Reason|0|||
160862340|NCT05966142|580889702|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
160862341|NCT05966142|580889703|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
160862342|NCT00894803|580889704|FG000|Overall Study|Death|20|||
160862343|NCT00894803|580889705|FG001|Overall Study|Death|4|||
160862344|NCT00894803|580889704|FG000|Overall Study|Lost to Follow-up|0|||
160862345|NCT00894803|580889705|FG001|Overall Study|Lost to Follow-up|1|||
160862346|NCT01710345|580889706|FG000|Overall Study|Adverse Event|0|||
160862347|NCT01710345|580889707|FG001|Overall Study|Adverse Event|2|||
160862348|NCT01710345|580889708|FG002|Overall Study|Adverse Event|0|||
160862349|NCT01710345|580889706|FG000|Overall Study|Lack of Efficacy|2|||
160862350|NCT01710345|580889707|FG001|Overall Study|Lack of Efficacy|3|||
160862351|NCT01710345|580889708|FG002|Overall Study|Lack of Efficacy|1|||
160862352|NCT01710345|580889706|FG000|Overall Study|Drug Dosing Error|1|||
160862353|NCT01710345|580889707|FG001|Overall Study|Drug Dosing Error|0|||
160862354|NCT01710345|580889708|FG002|Overall Study|Drug Dosing Error|0|||
160862355|NCT00627393|580889712|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
160862356|NCT00627393|580889713|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
160862357|NCT00627393|580889712|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
160862358|NCT00627393|580889713|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
160862359|NCT00627393|580889712|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
160862360|NCT00627393|580889713|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
160862361|NCT00627393|580889712|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
160862362|NCT00627393|580889713|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
160862363|NCT03337308|580889716|FG000|Overall Study|Adverse Event|2|||
160862364|NCT03337308|580889717|FG001|Overall Study|Adverse Event|3|||
160862365|NCT03337308|580889718|FG002|Overall Study|Adverse Event|3|||
160862366|NCT03337308|580889719|FG003|Overall Study|Adverse Event|1|||
160862367|NCT03337308|580889716|FG000|Overall Study|Lost to Follow-up|1|||
160862368|NCT03337308|580889717|FG001|Overall Study|Lost to Follow-up|2|||
160862369|NCT03337308|580889718|FG002|Overall Study|Lost to Follow-up|0|||
160862370|NCT03337308|580889719|FG003|Overall Study|Lost to Follow-up|0|||
160862371|NCT03337308|580889716|FG000|Overall Study|Withdrawal by Subject|2|||
160862372|NCT03337308|580889717|FG001|Overall Study|Withdrawal by Subject|1|||
160862373|NCT03337308|580889718|FG002|Overall Study|Withdrawal by Subject|2|||
160949486|NCT02371369|581203120|FG001|Part 1|Disease progression|1|||
160949487|NCT02371369|581203119|FG000|Part 1|Protocol Violation|0|||
160949488|NCT02371369|581203120|FG001|Part 1|Protocol Violation|1|||
160949489|NCT02371369|581203119|FG000|Part 2|Adverse Event|6|||
160949490|NCT02371369|581203120|FG001|Part 2|Adverse Event|5|||
160949491|NCT02371369|581203119|FG000|Part 2|Withdrawal by Subject|16|||
160949492|NCT02371369|581203120|FG001|Part 2|Withdrawal by Subject|6|||
160949493|NCT02371369|581203119|FG000|Part 2|Investigator decision|1|||
160949494|NCT02371369|581203120|FG001|Part 2|Investigator decision|2|||
160949495|NCT02371369|581203119|FG000|Part 2|Death|0|||
160949496|NCT02371369|581203120|FG001|Part 2|Death|1|||
160949497|NCT02371369|581203119|FG000|Part 2|Disease progression|1|||
160949498|NCT02371369|581203120|FG001|Part 2|Disease progression|0|||
160949499|NCT02371369|581203119|FG000|Part 2|Subject Noncompliance|1|||
160949500|NCT02371369|581203120|FG001|Part 2|Subject Noncompliance|0|||
160949501|NCT02371369|581203119|FG000|Part 2|Lost to Follow-up|1|||
160949502|NCT02371369|581203120|FG001|Part 2|Lost to Follow-up|1|||
160949503|NCT02371369|581203119|FG000|Part 2|Subject transitioned to commercial supply|6|||
160949504|NCT02371369|581203120|FG001|Part 2|Subject transitioned to commercial supply|4|||
160949505|NCT02371369|581203119|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
160949506|NCT02371369|581203120|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
160949507|NCT02371369|581203119|FG000|Part 2|Surgical resection of tumor|1|||
160949508|NCT02371369|581203120|FG001|Part 2|Surgical resection of tumor|1|||
160949509|NCT02371369|581203119|FG000|Part 2|Other|0|||
160949510|NCT02371369|581203120|FG001|Part 2|Other|1|||
160949511|NCT01024387|581203121|FG000|Overall Study|Radiographic Progression|29|||
160949512|NCT01024387|581203121|FG000|Overall Study|Symptomatic Progression|10|||
160949513|NCT01024387|581203121|FG000|Overall Study|Physician Decision|5|||
160949514|NCT01024387|581203121|FG000|Overall Study|Withdrawal by Subject|5|||
160949515|NCT01024387|581203121|FG000|Overall Study|Death|2|||
160999928|NCT03284957|581384911|FG000|Overall Study|Withdrawal by Subject|0|||
160999929|NCT03284957|581384912|FG001|Overall Study|Withdrawal by Subject|0|||
160999930|NCT03284957|581384913|FG002|Overall Study|Withdrawal by Subject|0|||
160999931|NCT03284957|581384914|FG003|Overall Study|Withdrawal by Subject|0|||
160999932|NCT03284957|581384915|FG004|Overall Study|Withdrawal by Subject|0|||
160999933|NCT03284957|581384916|FG005|Overall Study|Withdrawal by Subject|0|||
160999934|NCT03284957|581384917|FG006|Overall Study|Withdrawal by Subject|0|||
160999935|NCT03284957|581384918|FG007|Overall Study|Withdrawal by Subject|0|||
160999936|NCT03284957|581384919|FG008|Overall Study|Withdrawal by Subject|0|||
160999937|NCT03284957|581384920|FG009|Overall Study|Withdrawal by Subject|2|||
160999938|NCT03284957|581384921|FG010|Overall Study|Withdrawal by Subject|0|||
160999939|NCT03284957|581384922|FG011|Overall Study|Withdrawal by Subject|0|||
160999940|NCT03284957|581384923|FG012|Overall Study|Withdrawal by Subject|0|||
160999941|NCT03284957|581384924|FG013|Overall Study|Withdrawal by Subject|0|||
160999942|NCT03284957|581384925|FG014|Overall Study|Withdrawal by Subject|0|||
160999943|NCT03284957|581384926|FG015|Overall Study|Withdrawal by Subject|0|||
160999944|NCT03284957|581384911|FG000|Overall Study|Other|0|||
160999945|NCT03284957|581384912|FG001|Overall Study|Other|0|||
160999946|NCT03284957|581384913|FG002|Overall Study|Other|0|||
160999947|NCT03284957|581384914|FG003|Overall Study|Other|0|||
160999948|NCT03284957|581384915|FG004|Overall Study|Other|0|||
160999949|NCT03284957|581384916|FG005|Overall Study|Other|0|||
160999950|NCT03284957|581384917|FG006|Overall Study|Other|3|||
160999951|NCT03284957|581384918|FG007|Overall Study|Other|0|||
160999952|NCT03284957|581384919|FG008|Overall Study|Other|1|||
160999953|NCT03284957|581384920|FG009|Overall Study|Other|6|||
160999954|NCT03284957|581384921|FG010|Overall Study|Other|0|||
160999955|NCT03284957|581384922|FG011|Overall Study|Other|0|||
160999956|NCT03284957|581384923|FG012|Overall Study|Other|0|||
160999957|NCT03284957|581384924|FG013|Overall Study|Other|0|||
160999958|NCT03284957|581384925|FG014|Overall Study|Other|2|||
160456379|NCT04304144|579401421|FG001|Continued Treatment Period|Adverse Event|1|||
160456380|NCT04304144|579401422|FG002|Continued Treatment Period|Adverse Event|0|||
160949516|NCT01024387|581203121|FG000|Overall Study|Prolonged Treatment Delay|1|||
160949517|NCT01024387|581203121|FG000|Overall Study|Adverse Event|3|||
160949518|NCT01024387|581203121|FG000|Overall Study|Other|5|||
160949519|NCT03855189|581203122|FG000|Overall Study|Adverse Event|5|||
160999959|NCT03284957|581384926|FG015|Overall Study|Other|0|||
160999960|NCT03351075|581384927|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
160999961|NCT03351075|581384928|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
160999962|NCT03351075|581384927|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
160999963|NCT03351075|581384928|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
160999964|NCT03351075|581384927|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
160999965|NCT03351075|581384928|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
160456381|NCT04304144|579401423|FG003|Continued Treatment Period|Adverse Event|0|||
160949520|NCT03855189|581203123|FG001|Overall Study|Adverse Event|2|||
160949521|NCT03855189|581203124|FG002|Overall Study|Adverse Event|4|||
160949522|NCT03855189|581203122|FG000|Overall Study|Treatment Failure|1|||
160456382|NCT04304144|579401420|FG000|Continued Treatment Period|Death|0|||
160999966|NCT03351075|581384927|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
160999967|NCT03351075|581384928|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
160999968|NCT05219253|581384934|FG000|Overall Study|Withdrawal by Subject|1|||
160999969|NCT05219253|581384935|FG001|Overall Study|Withdrawal by Subject|2|||
160999970|NCT03086369|581384936|FG000|Overall Study|Lost to Follow-up|1|||
160999971|NCT03086369|581384937|FG001|Overall Study|Lost to Follow-up|0|||
160999972|NCT03086369|581384938|FG002|Overall Study|Lost to Follow-up|0|||
160999973|NCT03086369|581384939|FG003|Overall Study|Lost to Follow-up|2|||
160999974|NCT03086369|581384940|FG004|Overall Study|Lost to Follow-up|1|||
160999975|NCT03086369|581384936|FG000|Overall Study|Physician Decision|0|||
160999976|NCT03086369|581384937|FG001|Overall Study|Physician Decision|0|||
160999977|NCT03086369|581384938|FG002|Overall Study|Physician Decision|0|||
160999978|NCT03086369|581384939|FG003|Overall Study|Physician Decision|1|||
160999979|NCT03086369|581384940|FG004|Overall Study|Physician Decision|2|||
160999980|NCT03086369|581384936|FG000|Overall Study|Withdrawal by Subject|0|||
160999981|NCT03086369|581384937|FG001|Overall Study|Withdrawal by Subject|0|||
160999982|NCT03086369|581384938|FG002|Overall Study|Withdrawal by Subject|0|||
160999983|NCT03086369|581384939|FG003|Overall Study|Withdrawal by Subject|5|||
160999984|NCT03086369|581384940|FG004|Overall Study|Withdrawal by Subject|3|||
160999985|NCT03086369|581384936|FG000|Overall Study|Progressive Disease|0|||
160999986|NCT03086369|581384937|FG001|Overall Study|Progressive Disease|0|||
160999987|NCT03086369|581384938|FG002|Overall Study|Progressive Disease|0|||
160999988|NCT03086369|581384939|FG003|Overall Study|Progressive Disease|1|||
160999989|NCT03086369|581384940|FG004|Overall Study|Progressive Disease|1|||
160999990|NCT03544515|581384941|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
160999991|NCT03544515|581384942|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
160999992|NCT03544515|581384941|FG000|Overall Study|Lost to Follow-up|2|||
160999993|NCT03544515|581384942|FG001|Overall Study|Lost to Follow-up|0|||
160999994|NCT01070888|581384943|FG000|First Intervention (14 Days)|Adverse Event|0|||
160999995|NCT01070888|581384944|FG001|First Intervention (14 Days)|Adverse Event|1|||
160999996|NCT01070888|581384943|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
160999997|NCT01070888|581384944|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
160999998|NCT01070888|581384943|FG000|Washout (14 Days)|Physician Decision|1|||
160999999|NCT01070888|581384944|FG001|Washout (14 Days)|Physician Decision|0|||
161000000|NCT00178399|581384945|FG000|Overall Study|Physician Decision|4|||
161000001|NCT00178399|581384945|FG000|Overall Study|Withdrawal by Subject|8|||
161000002|NCT00178399|581384945|FG000|Overall Study|Lost to Follow-up|1|||
161000003|NCT00357396|581384946|FG000|Overall Study|Adverse Event|1|||
161000004|NCT00357396|581384947|FG001|Overall Study|Adverse Event|0|||
161000005|NCT00955825|581384948|FG000|Overall Study|Adverse Event|15|||
161000006|NCT00955825|581384949|FG001|Overall Study|Adverse Event|2|||
161000007|NCT00955825|581384948|FG000|Overall Study|Withdrawal by Subject|4|||
161000008|NCT00955825|581384949|FG001|Overall Study|Withdrawal by Subject|6|||
161000009|NCT00955825|581384948|FG000|Overall Study|Any other reason not above-mentioned|7|||
161000010|NCT00955825|581384949|FG001|Overall Study|Any other reason not above-mentioned|9|||
161000011|NCT02385669|581384950|FG000|Overall Study|Adverse Event|2|||
161000012|NCT00004124|581384951|FG000|Overall Study|Received no protocol therapy|12|||
161000013|NCT00004124|581384952|FG001|Overall Study|Received no protocol therapy|20|||
161000014|NCT00393848|581384957|FG000|Overall Study|Surgical schedule|0|||
161000015|NCT00393848|581384958|FG001|Overall Study|Surgical schedule|0|||
161000016|NCT00393848|581384959|FG002|Overall Study|Surgical schedule|0|||
161000017|NCT00393848|581384960|FG003|Overall Study|Surgical schedule|1|||
161000018|NCT00393848|581384957|FG000|Overall Study|Personal reasons|0|||
161000019|NCT00393848|581384958|FG001|Overall Study|Personal reasons|0|||
161000020|NCT00393848|581384959|FG002|Overall Study|Personal reasons|2|||
161000021|NCT00393848|581384960|FG003|Overall Study|Personal reasons|0|||
161000022|NCT03743246|581384963|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
161000023|NCT03743246|581384964|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
161000024|NCT03743246|581384965|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
161000025|NCT03743246|581384966|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
160582133|NCT01425190|579851877|FG000|Overall Study|Full dose not consumed.|1|||
160582134|NCT01425190|579851878|FG001|Overall Study|Full dose not consumed.|0|||
161000026|NCT03743246|581384963|FG000|Pre-Treatment Period|Death|0|||
161000027|NCT03743246|581384964|FG001|Pre-Treatment Period|Death|1|||
161000028|NCT03743246|581384965|FG002|Pre-Treatment Period|Death|0|||
160582135|NCT01425190|579851879|FG002|Overall Study|Full dose not consumed.|0|||
161000029|NCT03743246|581384966|FG003|Pre-Treatment Period|Death|1|||
161000030|NCT03743246|581384963|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
161000031|NCT03743246|581384964|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
161000032|NCT03743246|581384965|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
161000033|NCT03743246|581384966|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
161000034|NCT03743246|581384963|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
161000035|NCT03743246|581384964|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161000036|NCT03743246|581384965|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161000037|NCT03743246|581384966|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161000038|NCT03743246|581384963|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
161000039|NCT03743246|581384964|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
160582136|NCT02552355|579851881|FG000|Overall Study|Adverse Event|0|||
160582137|NCT02552355|579851882|FG001|Overall Study|Adverse Event|2|||
160582138|NCT02552355|579851883|FG002|Overall Study|Adverse Event|2|||
160582139|NCT02552355|579851884|FG003|Overall Study|Adverse Event|0|||
160582140|NCT02552355|579851881|FG000|Overall Study|Withdrawal by Subject|0|||
160582141|NCT02552355|579851882|FG001|Overall Study|Withdrawal by Subject|0|||
160582142|NCT02552355|579851883|FG002|Overall Study|Withdrawal by Subject|0|||
160582143|NCT02552355|579851884|FG003|Overall Study|Withdrawal by Subject|1|||
160582144|NCT00850460|579851887|FG000|Overall Study|Lost to Follow-up|4|||
160582145|NCT00850460|579851888|FG001|Overall Study|Lost to Follow-up|4|||
160582146|NCT03007953|579851891|FG000|Overall Study|Withdrawal by Subject|5|||
160582147|NCT03007953|579851892|FG001|Overall Study|Withdrawal by Subject|2|||
160582148|NCT03007953|579851891|FG000|Overall Study|Death|5|||
160582149|NCT03007953|579851892|FG001|Overall Study|Death|7|||
160582150|NCT03007953|579851891|FG000|Overall Study|Lost to Follow-up|3|||
160656204|NCT00001849|580122366|FG000|Overall Study|Withdrawal by Subject|2|||
160656205|NCT00001849|580122366|FG000|Overall Study|tumor remained occult|6|||
160862374|NCT03337308|580889719|FG003|Overall Study|Withdrawal by Subject|1|||
160862375|NCT03337308|580889716|FG000|Overall Study|Protocol Violation|0|||
160862376|NCT03337308|580889717|FG001|Overall Study|Protocol Violation|1|||
160862377|NCT03337308|580889718|FG002|Overall Study|Protocol Violation|0|||
160862378|NCT03337308|580889719|FG003|Overall Study|Protocol Violation|0|||
160862379|NCT00283296|580889721|FG000|Overall Study|in-home trial not completed|5|||
160862380|NCT03558737|580889722|FG000|Overall Study|Death|1|||
160862381|NCT03558737|580889723|FG001|Overall Study|Death|1|||
160862382|NCT01294553|580889724|FG000|Overall Study|Duplicated Participants|1|||
160862383|NCT01294553|580889724|FG000|Overall Study|Protocol Violation|268|||
160862384|NCT00795535|580889725|FG000|Overall Study|incomplete data and technical problems|20|||
160862385|NCT01903460|580889726|FG000|Overall Study|Adverse Event|0|||
160862386|NCT01903460|580889727|FG001|Overall Study|Adverse Event|0|||
160862387|NCT01903460|580889728|FG002|Overall Study|Adverse Event|0|||
160862388|NCT01903460|580889729|FG003|Overall Study|Adverse Event|1|||
160862389|NCT03104868|580889730|FG000|6 Week Follow up|Lost to Follow-up|5|||
160862390|NCT03104868|580889731|FG001|6 Week Follow up|Lost to Follow-up|8|||
160862391|NCT03104868|580889730|FG000|6 Week Follow up|Death|1|||
160862392|NCT03104868|580889731|FG001|6 Week Follow up|Death|1|||
160862393|NCT03104868|580889730|FG000|6 Week Follow up|Withdrawal by Subject|7|||
160862394|NCT03104868|580889731|FG001|6 Week Follow up|Withdrawal by Subject|6|||
160862395|NCT03104868|580889730|FG000|6 Week Follow up|Completed Later Timepoint|24|||
160862396|NCT03104868|580889731|FG001|6 Week Follow up|Completed Later Timepoint|22|||
160862397|NCT03104868|580889730|FG000|6 Month Follow up|Lost to Follow-up|2|||
160862398|NCT03104868|580889731|FG001|6 Month Follow up|Lost to Follow-up|2|||
160862399|NCT03104868|580889730|FG000|6 Month Follow up|Death|0|||
160862400|NCT03104868|580889731|FG001|6 Month Follow up|Death|1|||
160862401|NCT03104868|580889730|FG000|6 Month Follow up|Completed Later Timepoint|22|||
160862402|NCT03104868|580889731|FG001|6 Month Follow up|Completed Later Timepoint|32|||
160862403|NCT03104868|580889730|FG000|12 Month Follow up|Lost to Follow-up|1|||
160862404|NCT03104868|580889731|FG001|12 Month Follow up|Lost to Follow-up|2|||
160862405|NCT03104868|580889730|FG000|12 Month Follow up|Death|0|||
160862406|NCT03104868|580889731|FG001|12 Month Follow up|Death|1|||
160862407|NCT03104868|580889730|FG000|12 Month Follow up|Withdrawal by Subject|0|||
160862408|NCT03104868|580889731|FG001|12 Month Follow up|Withdrawal by Subject|3|||
160862409|NCT03104868|580889730|FG000|12 Month Follow up|Completed Later Timepoint|32|||
160862410|NCT03104868|580889731|FG001|12 Month Follow up|Completed Later Timepoint|29|||
160862411|NCT03104868|580889730|FG000|18 Month Follow up|Lost to Follow-up|7|||
160862412|NCT03104868|580889731|FG001|18 Month Follow up|Lost to Follow-up|11|||
160862413|NCT03104868|580889730|FG000|18 Month Follow up|Death|2|||
160862414|NCT03104868|580889731|FG001|18 Month Follow up|Death|1|||
160862415|NCT03104868|580889730|FG000|18 Month Follow up|Withdrawal by Subject|1|||
160862416|NCT03104868|580889731|FG001|18 Month Follow up|Withdrawal by Subject|2|||
160862417|NCT03104868|580889730|FG000|18 Month Follow up|Graft Loss|1|||
160862418|NCT03104868|580889731|FG001|18 Month Follow up|Graft Loss|1|||
160862419|NCT03104868|580889730|FG000|18 Month Follow up|Completed Later Timepoint|19|||
160862420|NCT03104868|580889731|FG001|18 Month Follow up|Completed Later Timepoint|20|||
160862421|NCT03104868|580889730|FG000|24 Month Follow up|Lost to Follow-up|15|||
160862422|NCT03104868|580889731|FG001|24 Month Follow up|Lost to Follow-up|16|||
160862423|NCT03104868|580889730|FG000|24 Month Follow up|Death|3|||
160862424|NCT03104868|580889731|FG001|24 Month Follow up|Death|2|||
160862425|NCT03104868|580889730|FG000|24 Month Follow up|Withdrawal by Subject|1|||
160862426|NCT03104868|580889731|FG001|24 Month Follow up|Withdrawal by Subject|0|||
160862427|NCT03104868|580889730|FG000|24 Month Follow up|Graft Loss|2|||
160862428|NCT03104868|580889731|FG001|24 Month Follow up|Graft Loss|0|||
160862429|NCT00888173|580889735|FG000|Overall Study|Wrong Primary|1|||
160862430|NCT00888173|580889735|FG000|Overall Study|Ineligible: required test not done|1|||
160862431|NCT02059278|580889736|FG000|Overall Study|Adverse Event|1|||
160862432|NCT02059278|580889737|FG001|Overall Study|Adverse Event|1|||
160456383|NCT04304144|579401421|FG001|Continued Treatment Period|Death|0|||
160456384|NCT04304144|579401422|FG002|Continued Treatment Period|Death|1|||
160456385|NCT04304144|579401423|FG003|Continued Treatment Period|Death|2|||
160456386|NCT04304144|579401420|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
160456387|NCT04304144|579401421|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
160456388|NCT04304144|579401422|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
160456389|NCT04304144|579401423|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
160456390|NCT04304144|579401420|FG000|Continued Treatment Period|Other than specified|2|||
160456391|NCT04304144|579401421|FG001|Continued Treatment Period|Other than specified|0|||
160456392|NCT04304144|579401422|FG002|Continued Treatment Period|Other than specified|1|||
160456393|NCT04304144|579401423|FG003|Continued Treatment Period|Other than specified|1|||
160456394|NCT04101357|579401424|FG000|Overall Study|Death|1|||
160949523|NCT03855189|581203123|FG001|Overall Study|Treatment Failure|1|||
160949524|NCT03855189|581203124|FG002|Overall Study|Treatment Failure|2|||
160949525|NCT03855189|581203122|FG000|Overall Study|Noncompliance with Protocol|0|||
160949526|NCT03855189|581203123|FG001|Overall Study|Noncompliance with Protocol|1|||
160949527|NCT03855189|581203124|FG002|Overall Study|Noncompliance with Protocol|0|||
160949528|NCT03855189|581203122|FG000|Overall Study|Did Not Return|4|||
160456395|NCT04101357|579401425|FG001|Overall Study|Death|1|||
160456396|NCT04101357|579401426|FG002|Overall Study|Death|1|||
160456397|NCT04101357|579401427|FG003|Overall Study|Death|2|||
160456398|NCT04101357|579401428|FG004|Overall Study|Death|4|||
160456399|NCT04101357|579401429|FG005|Overall Study|Death|11|||
160456400|NCT04101357|579401430|FG006|Overall Study|Death|4|||
160456401|NCT04101357|579401431|FG007|Overall Study|Death|4|||
160456402|NCT04101357|579401432|FG008|Overall Study|Death|5|||
160456403|NCT04101357|579401433|FG009|Overall Study|Death|2|||
160456404|NCT04101357|579401434|FG010|Overall Study|Death|3|||
160456405|NCT04101357|579401424|FG000|Overall Study|Trial closure|0|||
160456406|NCT04101357|579401425|FG001|Overall Study|Trial closure|0|||
160456407|NCT04101357|579401426|FG002|Overall Study|Trial closure|0|||
160456408|NCT04101357|579401427|FG003|Overall Study|Trial closure|0|||
160456409|NCT04101357|579401428|FG004|Overall Study|Trial closure|0|||
160456410|NCT04101357|579401429|FG005|Overall Study|Trial closure|2|||
160456411|NCT04101357|579401430|FG006|Overall Study|Trial closure|2|||
160456412|NCT04101357|579401431|FG007|Overall Study|Trial closure|0|||
160456413|NCT04101357|579401432|FG008|Overall Study|Trial closure|0|||
160456414|NCT04101357|579401433|FG009|Overall Study|Trial closure|0|||
160456415|NCT04101357|579401434|FG010|Overall Study|Trial closure|1|||
160456416|NCT04101357|579401424|FG000|Overall Study|Lost to Follow-up|0|||
160582151|NCT03007953|579851892|FG001|Overall Study|Lost to Follow-up|2|||
160582152|NCT03007953|579851891|FG000|Overall Study|Enrolled in Hospice|3|||
160582153|NCT03007953|579851892|FG001|Overall Study|Enrolled in Hospice|2|||
160582154|NCT02224846|579851893|FG000|Period 1 (Month 3)|Adverse Event|2|||
160949529|NCT03855189|581203123|FG001|Overall Study|Did Not Return|3|||
160949530|NCT03855189|581203124|FG002|Overall Study|Did Not Return|0|||
160949531|NCT04307186|581203125|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
160949532|NCT04307186|581203125|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
160949533|NCT04307186|581203125|FG000|Washout 3-14 Days|Progressive disease|1|||
160949534|NCT04307186|581203125|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
160949535|NCT04307186|581203125|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
160949536|NCT01618838|581203128|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
160949537|NCT01587651|581203129|FG000|Overall Study|Adverse Event|0|||
160949538|NCT01587651|581203130|FG001|Overall Study|Adverse Event|1|||
160949539|NCT01587651|581203131|FG002|Overall Study|Adverse Event|0|||
160949540|NCT01587651|581203129|FG000|Overall Study|Protocol Violation|0|||
160949541|NCT01587651|581203130|FG001|Overall Study|Protocol Violation|1|||
160949542|NCT01587651|581203131|FG002|Overall Study|Protocol Violation|1|||
160949543|NCT01587651|581203129|FG000|Overall Study|Withdrawal by Subject|0|||
160949544|NCT01587651|581203130|FG001|Overall Study|Withdrawal by Subject|1|||
161000040|NCT03743246|581384965|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
160456417|NCT04101357|579401425|FG001|Overall Study|Lost to Follow-up|0|||
160582155|NCT02224846|579851894|FG001|Period 1 (Month 3)|Adverse Event|1|||
160949545|NCT01587651|581203131|FG002|Overall Study|Withdrawal by Subject|0|||
161000041|NCT03743246|581384966|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
160456418|NCT04101357|579401426|FG002|Overall Study|Lost to Follow-up|0|||
160456419|NCT04101357|579401427|FG003|Overall Study|Lost to Follow-up|1|||
160456420|NCT04101357|579401428|FG004|Overall Study|Lost to Follow-up|0|||
160456421|NCT04101357|579401429|FG005|Overall Study|Lost to Follow-up|0|||
160456422|NCT04101357|579401430|FG006|Overall Study|Lost to Follow-up|0|||
160456423|NCT04101357|579401431|FG007|Overall Study|Lost to Follow-up|1|||
160456424|NCT04101357|579401432|FG008|Overall Study|Lost to Follow-up|0|||
160582156|NCT02224846|579851893|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
160949546|NCT03238001|581203132|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
160949547|NCT03238001|581203132|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
160456425|NCT04101357|579401433|FG009|Overall Study|Lost to Follow-up|0|||
160456426|NCT04101357|579401434|FG010|Overall Study|Lost to Follow-up|0|||
160456427|NCT04101357|579401424|FG000|Overall Study|Withdrawal by Subject|1|||
160582157|NCT02224846|579851894|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
160582158|NCT02224846|579851893|FG000|Period 1 (Month 3)|Protocol Violation|4|||
160582159|NCT02224846|579851894|FG001|Period 1 (Month 3)|Protocol Violation|8|||
160582160|NCT02224846|579851893|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
160582161|NCT02224846|579851894|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
160582162|NCT02224846|579851893|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
160582163|NCT02224846|579851894|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
160582164|NCT02224846|579851893|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
160582165|NCT02224846|579851894|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
160582166|NCT02224846|579851893|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
160582167|NCT02224846|579851894|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
160582168|NCT02224846|579851893|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
160582169|NCT02224846|579851894|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
160582170|NCT02224846|579851893|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
160582171|NCT02224846|579851894|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
160582172|NCT02224846|579851893|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
160582173|NCT02224846|579851894|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
160582174|NCT02224846|579851893|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
160582175|NCT02224846|579851894|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
160582176|NCT02224846|579851893|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
160582177|NCT02224846|579851894|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
160582178|NCT02224846|579851893|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
160582179|NCT02224846|579851894|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
160582180|NCT02224846|579851893|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
160582181|NCT02224846|579851894|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
160582182|NCT02224846|579851893|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
160582183|NCT02224846|579851894|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
160582184|NCT02224846|579851893|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
160582185|NCT02224846|579851894|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
160582186|NCT02224846|579851893|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
160582187|NCT02224846|579851894|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
160582188|NCT02582749|579851897|FG000|Overall Study|Study terminated by funder|5|||
160582189|NCT02582749|579851898|FG001|Overall Study|Study terminated by funder|10|||
160582190|NCT02582749|579851897|FG000|Overall Study|Withdrawal by Subject|0|||
160582191|NCT02582749|579851898|FG001|Overall Study|Withdrawal by Subject|1|||
160582192|NCT02213198|579851899|FG000|Baseline|No show for intake|7|||
160582193|NCT02213198|579851900|FG001|Baseline|No show for intake|9|||
160582194|NCT02213198|579851899|FG000|Baseline|Withdrawal by Subject|34|||
160582195|NCT02213198|579851900|FG001|Baseline|Withdrawal by Subject|11|||
160582196|NCT02213198|579851899|FG000|Baseline|transferred out of clinic|7|||
160582197|NCT02213198|579851900|FG001|Baseline|transferred out of clinic|9|||
160582198|NCT02213198|579851899|FG000|Baseline|Lost to Follow-up|40|||
160582199|NCT02213198|579851900|FG001|Baseline|Lost to Follow-up|21|||
160582200|NCT02213198|579851899|FG000|Baseline|incarcerated,violent|0|||
160582201|NCT02213198|579851900|FG001|Baseline|incarcerated,violent|1|||
160582202|NCT02213198|579851899|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
160582203|NCT02213198|579851900|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
160582204|NCT02213198|579851899|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
160582205|NCT02213198|579851900|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
160582206|NCT02213198|579851899|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
160582207|NCT02213198|579851900|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
160582208|NCT02213198|579851899|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
160582209|NCT02213198|579851900|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
160582210|NCT02213198|579851899|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
160582211|NCT02213198|579851900|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
160582212|NCT02213198|579851899|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
160582213|NCT02213198|579851900|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
160582214|NCT01518192|579851901|FG000|Overall Study|Lost to Follow-up|29|||
160582215|NCT01518192|579851902|FG001|Overall Study|Lost to Follow-up|26|||
160582216|NCT01518192|579851903|FG002|Overall Study|Lost to Follow-up|35|||
160582217|NCT00001262|579851904|FG000|Overall Study|Death|10|||
160949548|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
160582218|NCT00001262|579851905|FG001|Overall Study|Death|11|||
160582219|NCT00001262|579851906|FG002|Overall Study|Death|0|||
160582220|NCT00001262|579851904|FG000|Overall Study|Withdrawal by Subject|0|||
160582221|NCT00001262|579851905|FG001|Overall Study|Withdrawal by Subject|3|||
160582222|NCT00001262|579851906|FG002|Overall Study|Withdrawal by Subject|0|||
160582223|NCT00783705|579851908|FG000|Overall Study|Adverse Event|2|||
160582224|NCT00783705|579851909|FG001|Overall Study|Adverse Event|0|||
160582225|NCT00783705|579851908|FG000|Overall Study|Withdrawal by Subject|3|||
160582226|NCT00783705|579851909|FG001|Overall Study|Withdrawal by Subject|2|||
160582227|NCT00783705|579851908|FG000|Overall Study|Lost to Follow-up|1|||
160582228|NCT00783705|579851909|FG001|Overall Study|Lost to Follow-up|3|||
160582229|NCT00748540|579851910|FG000|Overall Study|Physician Decision|1|||
160582230|NCT04743635|579851911|FG000|Overall Study|Lost to Follow-up|2|||
160582231|NCT04743635|579851912|FG001|Overall Study|Lost to Follow-up|0|||
160582232|NCT01954121|579851913|FG000|Overall Study|Lack of Efficacy|94|||
160582233|NCT01954121|579851914|FG001|Overall Study|Lack of Efficacy|41|||
160582234|NCT01954121|579851913|FG000|Overall Study|Protocol Violation|0|||
160582235|NCT01954121|579851914|FG001|Overall Study|Protocol Violation|2|||
161000042|NCT03743246|581384963|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
161000043|NCT03743246|581384964|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
161000044|NCT03743246|581384965|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
161000045|NCT03743246|581384966|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
161000046|NCT03743246|581384963|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
161000047|NCT03743246|581384964|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
161000048|NCT03743246|581384965|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
161000049|NCT03743246|581384966|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
161000050|NCT03743246|581384963|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
160582236|NCT01954121|579851913|FG000|Overall Study|Lost to Follow-up|5|||
160582237|NCT01954121|579851914|FG001|Overall Study|Lost to Follow-up|6|||
160582238|NCT01954121|579851913|FG000|Overall Study|Withdrawal by Subject|18|||
160582239|NCT01954121|579851914|FG001|Overall Study|Withdrawal by Subject|12|||
160582240|NCT01954121|579851913|FG000|Overall Study|Pregnancy|1|||
160582241|NCT01954121|579851914|FG001|Overall Study|Pregnancy|1|||
160582242|NCT01954121|579851913|FG000|Overall Study|AE, serious fatal|1|||
160582243|NCT01954121|579851914|FG001|Overall Study|AE, serious fatal|0|||
160582244|NCT01954121|579851913|FG000|Overall Study|AE, non-serious non-fatal|5|||
160582245|NCT01954121|579851914|FG001|Overall Study|AE, non-serious non-fatal|22|||
160582246|NCT01954121|579851913|FG000|Overall Study|SAE, non-fatal|1|||
160582247|NCT01954121|579851914|FG001|Overall Study|SAE, non-fatal|4|||
160582248|NCT01954121|579851913|FG000|Overall Study|Non-compliant with study procedures|1|||
160582249|NCT01954121|579851914|FG001|Overall Study|Non-compliant with study procedures|0|||
160582250|NCT01954121|579851913|FG000|Overall Study|Non-compliant patient|1|||
160582251|NCT01954121|579851914|FG001|Overall Study|Non-compliant patient|1|||
160582252|NCT01954121|579851913|FG000|Overall Study|Subject did not follow instructions|0|||
160582253|NCT01954121|579851914|FG001|Overall Study|Subject did not follow instructions|2|||
160582254|NCT00872170|579851916|FG000|Overall Study|Adverse Event|1|||
160582255|NCT00872170|579851917|FG001|Overall Study|Adverse Event|0|||
160582256|NCT00601523|579851918|FG000|Overall Study|Adverse Event|42|||
160582257|NCT00601523|579851919|FG001|Overall Study|Adverse Event|14|||
160582258|NCT00601523|579851918|FG000|Overall Study|Lack of Efficacy|3|||
160582259|NCT00601523|579851919|FG001|Overall Study|Lack of Efficacy|0|||
160582260|NCT00601523|579851918|FG000|Overall Study|Protocol Violation|5|||
160582261|NCT00601523|579851919|FG001|Overall Study|Protocol Violation|1|||
160582262|NCT00601523|579851918|FG000|Overall Study|Lost to Follow-up|0|||
160582263|NCT00601523|579851919|FG001|Overall Study|Lost to Follow-up|1|||
160582264|NCT00601523|579851918|FG000|Overall Study|Withdrawal by Subject|18|||
160582265|NCT00601523|579851919|FG001|Overall Study|Withdrawal by Subject|9|||
160582266|NCT00601523|579851918|FG000|Overall Study|Other|9|||
160582267|NCT00601523|579851919|FG001|Overall Study|Other|1|||
160862433|NCT02059278|580889736|FG000|Overall Study|Lost to Follow-up|1|||
160862434|NCT02059278|580889737|FG001|Overall Study|Lost to Follow-up|0|||
160862435|NCT02059278|580889736|FG000|Overall Study|Withdrawal by Subject|0|||
160862436|NCT02059278|580889737|FG001|Overall Study|Withdrawal by Subject|3|||
160862437|NCT02059278|580889736|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
160862438|NCT02059278|580889737|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
160862439|NCT00829426|580889738|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
160862440|NCT00829426|580889739|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
160862441|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
160862442|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
160862443|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
160862444|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
160862445|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Adverse Event|2|||
160862446|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Adverse Event|5|||
160862447|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Adverse Event|1|||
160862448|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Adverse Event|2|||
160862449|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Death|13|||
160862450|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Death|17|||
160862451|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Death|1|||
160862452|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Death|0|||
160862453|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
160862454|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
160862455|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
160862456|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
160862457|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Disease Progression|2|||
160862458|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Disease Progression|0|||
160862459|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Disease Progression|0|||
160949549|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
160949550|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
160949551|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
160949552|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
160949553|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
160949554|NCT03149328|581203138|FG000|Overall Study|Withdrawal by Subject|30|||
160949555|NCT03149328|581203139|FG001|Overall Study|Withdrawal by Subject|26|||
160949556|NCT03149328|581203138|FG000|Overall Study|Changed Dialysis Modality|18|||
160949557|NCT03149328|581203139|FG001|Overall Study|Changed Dialysis Modality|1|||
160949558|NCT03149328|581203138|FG000|Overall Study|Transplant|9|||
160949559|NCT03149328|581203139|FG001|Overall Study|Transplant|1|||
160949560|NCT03149328|581203138|FG000|Overall Study|Lost to Follow-up|25|||
160949561|NCT03149328|581203139|FG001|Overall Study|Lost to Follow-up|16|||
160949562|NCT03149328|581203138|FG000|Overall Study|Left Study Site|1|||
160949563|NCT03149328|581203139|FG001|Overall Study|Left Study Site|2|||
160949564|NCT03149328|581203138|FG000|Overall Study|Language Barrier|1|||
160949565|NCT03149328|581203139|FG001|Overall Study|Language Barrier|0|||
160949566|NCT01110239|581203140|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
160949567|NCT01110239|581203141|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
160949568|NCT01110239|581203142|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
160949569|NCT01110239|581203143|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
160949570|NCT01110239|581203140|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
160949571|NCT01110239|581203141|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
160949572|NCT01110239|581203142|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
160949573|NCT01110239|581203143|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
160949574|NCT00080223|581203148|FG000|Overall Study|Adverse Event|23|||
160949575|NCT00080223|581203148|FG000|Overall Study|Death|21|||
160949576|NCT00080223|581203148|FG000|Overall Study|Withdrawal by Subject|13|||
160949577|NCT00080223|581203148|FG000|Overall Study|Lung Transplantation|9|||
160949578|NCT00080223|581203148|FG000|Overall Study|Non-compliance With Study Treatment|7|||
160949579|NCT00080223|581203148|FG000|Overall Study|Participant unwilling to continue|2|||
160949580|NCT00080223|581203148|FG000|Overall Study|Physician Decision|1|||
161000051|NCT03743246|581384964|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
161000052|NCT03743246|581384965|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
161000053|NCT03743246|581384966|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
161000054|NCT03743246|581384963|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
161000055|NCT03743246|581384964|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
161000056|NCT03743246|581384965|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
161000057|NCT03743246|581384966|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
161000058|NCT00395018|581384967|FG000|On-Treatment|Death|4|||
161000059|NCT00395018|581384967|FG000|On-Treatment|Other Reason|2|||
161000060|NCT00395018|581384967|FG000|On-Treatment|Poor/non-compliance|2|||
161000061|NCT00395018|581384967|FG000|On-Treatment|Subject no longer meets study criteria|2|||
161000062|NCT00395018|581384967|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
161000063|NCT00395018|581384967|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
161000064|NCT00395018|581384967|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
161000065|NCT04439799|581384968|FG000|Overall Study|Lost to Follow-up|6|||
161000066|NCT04439799|581384969|FG001|Overall Study|Lost to Follow-up|6|||
161000067|NCT04439799|581384968|FG000|Overall Study|Withdrawal by Subject|2|||
161000068|NCT04439799|581384969|FG001|Overall Study|Withdrawal by Subject|6|||
161000069|NCT04439799|581384968|FG000|Overall Study|Adverse Event|2|||
161000070|NCT04439799|581384969|FG001|Overall Study|Adverse Event|5|||
161000071|NCT00371566|581384970|FG000|Treatment Phase|Withdrawal by Subject|0|||
161000072|NCT00371566|581384971|FG001|Treatment Phase|Withdrawal by Subject|1|||
161000073|NCT00371566|581384970|FG000|Treatment Phase|Adverse Event|0|||
161000074|NCT00371566|581384971|FG001|Treatment Phase|Adverse Event|1|||
161000075|NCT00371566|581384970|FG000|Treatment Phase|Protocol Violation|0|||
161000076|NCT00371566|581384971|FG001|Treatment Phase|Protocol Violation|1|||
161000077|NCT00371566|581384970|FG000|Chemoradiation Phase|Physician Decision|2|||
161000078|NCT00371566|581384971|FG001|Chemoradiation Phase|Physician Decision|0|||
160582268|NCT01617434|579851920|FG000|Overall Study|Adverse Event|12|||
160582269|NCT01617434|579851921|FG001|Overall Study|Adverse Event|3|||
160582270|NCT01617434|579851920|FG000|Overall Study|Protocol Violation|8|||
160582271|NCT01617434|579851921|FG001|Overall Study|Protocol Violation|7|||
160582272|NCT01617434|579851920|FG000|Overall Study|Withdrawal Criteria|12|||
160582273|NCT01617434|579851921|FG001|Overall Study|Withdrawal Criteria|37|||
160582274|NCT01617434|579851920|FG000|Overall Study|Unclassified|3|||
160582275|NCT01617434|579851921|FG001|Overall Study|Unclassified|4|||
160582276|NCT01987986|579851922|FG000|Overall Study|Lost to Follow-up|1|||
160582277|NCT01987986|579851923|FG001|Overall Study|Lost to Follow-up|0|||
161000079|NCT00371566|581384970|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
161000080|NCT00371566|581384971|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
161000081|NCT00371566|581384970|FG000|Chemoradiation Phase|Non compliant|0|||
160582278|NCT01987986|579851924|FG002|Overall Study|Lost to Follow-up|0|||
160582279|NCT01987986|579851925|FG003|Overall Study|Lost to Follow-up|0|||
161000082|NCT00371566|581384971|FG001|Chemoradiation Phase|Non compliant|1|||
161000083|NCT00371566|581384970|FG000|Chemoradiation Phase|Progressive Disease|1|||
161000084|NCT00371566|581384971|FG001|Chemoradiation Phase|Progressive Disease|1|||
161000085|NCT00371566|581384970|FG000|Chemoradiation Phase|Death|2|||
161000086|NCT00371566|581384971|FG001|Chemoradiation Phase|Death|0|||
161000087|NCT00371566|581384970|FG000|Follow Up Phase|Death|0|||
160582280|NCT01987986|579851922|FG000|Overall Study|Adverse Event|1|||
160582281|NCT01987986|579851923|FG001|Overall Study|Adverse Event|0|||
160582282|NCT01987986|579851924|FG002|Overall Study|Adverse Event|2|||
160582283|NCT01987986|579851925|FG003|Overall Study|Adverse Event|0|||
160582284|NCT02928406|579851929|FG000|Overall Study|Death|780|||
160582285|NCT02928406|579851929|FG000|Overall Study|Progressive disease|3|||
160582286|NCT02928406|579851929|FG000|Overall Study|Lost to Follow-up|49|||
160582287|NCT02928406|579851929|FG000|Overall Study|Non-compliance|2|||
160582288|NCT02928406|579851929|FG000|Overall Study|Withdrawal by Subject|40|||
160582289|NCT02928406|579851929|FG000|Overall Study|Study terminated by sponsor|57|||
160582290|NCT02928406|579851929|FG000|Overall Study|Physician Decision|1|||
160582291|NCT02928406|579851929|FG000|Overall Study|Various reasons|72|||
160582292|NCT00786838|579851930|FG000|Overall Study|Physician Decision|4|||
160582293|NCT00786838|579851930|FG000|Overall Study|Death|4|||
160582294|NCT00786838|579851930|FG000|Overall Study|Adverse Event|6|||
160582295|NCT00786838|579851930|FG000|Overall Study|Progressive disease|31|||
160582296|NCT00786838|579851930|FG000|Overall Study|Withdrawal by Subject|4|||
160582297|NCT04937816|579851931|FG000|Overall Study|Study drug stopped, reason missing|5|||
160582298|NCT04937816|579851932|FG001|Overall Study|Study drug stopped, reason missing|3|||
160582299|NCT04937816|579851933|FG002|Overall Study|Study drug stopped, reason missing|4|||
160582300|NCT04937816|579851934|FG003|Overall Study|Study drug stopped, reason missing|6|||
160656206|NCT00442936|580122367|FG000|Overall Study|Protocol Violation|1|||
160656207|NCT00442936|580122368|FG001|Overall Study|Protocol Violation|0|||
160656208|NCT00442936|580122369|FG002|Overall Study|Protocol Violation|1|||
160456428|NCT04101357|579401425|FG001|Overall Study|Withdrawal by Subject|0|||
160582301|NCT04937816|579851935|FG004|Overall Study|Study drug stopped, reason missing|1|||
160582302|NCT04937816|579851936|FG005|Overall Study|Study drug stopped, reason missing|0|||
160582303|NCT04937816|579851937|FG006|Overall Study|Study drug stopped, reason missing|0|||
160582304|NCT04937816|579851931|FG000|Overall Study|Other than stated below|173|||
160582305|NCT04937816|579851932|FG001|Overall Study|Other than stated below|143|||
160656209|NCT00442936|580122370|FG003|Overall Study|Protocol Violation|1|||
160862460|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Disease Progression|0|||
160862461|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
160862462|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
160862463|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
160862464|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
160862465|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
160862466|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
160862467|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
160862468|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
160862469|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
160862470|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
160862471|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
160862472|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
160862473|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Participant Decision|9|||
160862474|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Participant Decision|12|||
160862475|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Participant Decision|1|||
160862476|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Participant Decision|1|||
160862477|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
160862478|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
160862479|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
160862480|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
160862481|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
160862482|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
160862483|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
160862484|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
160862485|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
160862486|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
160862487|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
160862488|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
160862489|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
160862490|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
160862491|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
160862492|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
160862493|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
160862494|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
160862495|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
160582306|NCT04937816|579851933|FG002|Overall Study|Other than stated below|125|||
160582307|NCT04937816|579851934|FG003|Overall Study|Other than stated below|44|||
160582308|NCT04937816|579851935|FG004|Overall Study|Other than stated below|45|||
160582309|NCT04937816|579851936|FG005|Overall Study|Other than stated below|28|||
160582310|NCT04937816|579851937|FG006|Overall Study|Other than stated below|31|||
160582311|NCT04937816|579851931|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
160582312|NCT04937816|579851932|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
160582313|NCT04937816|579851933|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
160582314|NCT04937816|579851934|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
160582315|NCT04937816|579851935|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
160582316|NCT04937816|579851936|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
160582317|NCT04937816|579851937|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
160582318|NCT04937816|579851931|FG000|Overall Study|Lost to Follow-up|15|||
160582319|NCT04937816|579851932|FG001|Overall Study|Lost to Follow-up|9|||
160582320|NCT04937816|579851933|FG002|Overall Study|Lost to Follow-up|6|||
160582321|NCT04937816|579851934|FG003|Overall Study|Lost to Follow-up|6|||
160582322|NCT04937816|579851935|FG004|Overall Study|Lost to Follow-up|16|||
160582323|NCT04937816|579851936|FG005|Overall Study|Lost to Follow-up|11|||
160582324|NCT04937816|579851937|FG006|Overall Study|Lost to Follow-up|17|||
160582325|NCT04937816|579851931|FG000|Overall Study|Protocol Violation|15|||
160582326|NCT04937816|579851932|FG001|Overall Study|Protocol Violation|15|||
160582327|NCT04937816|579851933|FG002|Overall Study|Protocol Violation|12|||
160582328|NCT04937816|579851934|FG003|Overall Study|Protocol Violation|30|||
160582329|NCT04937816|579851935|FG004|Overall Study|Protocol Violation|24|||
160582330|NCT04937816|579851936|FG005|Overall Study|Protocol Violation|5|||
160582331|NCT04937816|579851937|FG006|Overall Study|Protocol Violation|5|||
160582332|NCT04937816|579851931|FG000|Overall Study|Adverse Event|303|||
160582333|NCT04937816|579851932|FG001|Overall Study|Adverse Event|267|||
160582334|NCT04937816|579851933|FG002|Overall Study|Adverse Event|273|||
160582335|NCT04937816|579851934|FG003|Overall Study|Adverse Event|553|||
160582336|NCT04937816|579851935|FG004|Overall Study|Adverse Event|575|||
160582337|NCT04937816|579851936|FG005|Overall Study|Adverse Event|343|||
160582338|NCT04937816|579851937|FG006|Overall Study|Adverse Event|337|||
160582339|NCT04937816|579851931|FG000|Overall Study|Not treated|4|||
160582340|NCT04937816|579851932|FG001|Overall Study|Not treated|2|||
160582341|NCT04937816|579851933|FG002|Overall Study|Not treated|2|||
160582342|NCT04937816|579851934|FG003|Overall Study|Not treated|2|||
160582343|NCT04937816|579851935|FG004|Overall Study|Not treated|1|||
160582344|NCT04937816|579851936|FG005|Overall Study|Not treated|4|||
160582345|NCT04937816|579851937|FG006|Overall Study|Not treated|0|||
160582346|NCT00436215|579851938|FG000|Overall Study|Refused further treatment|3|||
160582347|NCT00436215|579851938|FG000|Overall Study|Small bowel obstruction|1|||
160582348|NCT05513053|579851939|FG000|Overall Study|Lost to Follow-up|9|||
160582349|NCT05513053|579851940|FG001|Overall Study|Lost to Follow-up|11|||
160582350|NCT05513053|579851939|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160582351|NCT05513053|579851940|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160582352|NCT05513053|579851939|FG000|Overall Study|Withdrawal by Subject|2|||
160582353|NCT05513053|579851940|FG001|Overall Study|Withdrawal by Subject|9|||
160582354|NCT05513053|579851939|FG000|Overall Study|Protocol Violation|6|||
160582355|NCT05513053|579851940|FG001|Overall Study|Protocol Violation|3|||
160582356|NCT05513053|579851939|FG000|Overall Study|Adverse Event|0|||
160582357|NCT05513053|579851940|FG001|Overall Study|Adverse Event|2|||
160582358|NCT04491877|579853600|FG000|Overall Study|Protocol Deviation|1|||
160582359|NCT04491877|579853601|FG001|Overall Study|Protocol Deviation|0|||
160582360|NCT04491877|579853602|FG002|Overall Study|Protocol Deviation|2|||
160582361|NCT04491877|579853603|FG003|Overall Study|Protocol Deviation|0|||
160582362|NCT04491877|579853604|FG004|Overall Study|Protocol Deviation|0|||
160582363|NCT04491877|579853605|FG005|Overall Study|Protocol Deviation|0|||
160656210|NCT02428699|580122371|FG000|Washout Period 1|Screen Failure|1|||
160656211|NCT02428699|580122372|FG001|Washout Period 1|Screen Failure|2|||
160656212|NCT03127137|580122373|FG000|Overall Study|Requested sedation after consent|1|||
160582364|NCT04491877|579853606|FG006|Overall Study|Protocol Deviation|1|||
160582365|NCT04491877|579853607|FG007|Overall Study|Protocol Deviation|1|||
160582366|NCT04491877|579853608|FG008|Overall Study|Protocol Deviation|0|||
160582367|NCT04491877|579853600|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160582368|NCT04491877|579853601|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160582369|NCT04491877|579853602|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160582370|NCT04491877|579853603|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
160582371|NCT04491877|579853604|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
160582372|NCT04491877|579853605|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
160582373|NCT04491877|579853606|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
160582374|NCT04491877|579853607|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
160949581|NCT00791765|581204893|FG000|Weeks 1 to 12|Adverse Event|0|||
160949582|NCT00791765|581204894|FG001|Weeks 1 to 12|Adverse Event|1|||
160949583|NCT00791765|581204893|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
160949584|NCT00791765|581204894|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
160949585|NCT00791765|581204893|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
160949586|NCT00791765|581204894|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
160949587|NCT00791765|581204893|FG000|Weeks 1 to 12|Physician Decision|1|||
160949588|NCT00791765|581204894|FG001|Weeks 1 to 12|Physician Decision|0|||
160949589|NCT00791765|581204893|FG000|Weeks 1 to 12|Disease progression|3|||
160949590|NCT00791765|581204894|FG001|Weeks 1 to 12|Disease progression|0|||
160949591|NCT00791765|581204893|FG000|Weeks 1 to 12|Ineligibility determined|0|||
160949592|NCT00791765|581204894|FG001|Weeks 1 to 12|Ineligibility determined|3|||
160949593|NCT00791765|581204893|FG000|Weeks 13 to 24|Protocol deviation|2|||
160949594|NCT00791765|581204894|FG001|Weeks 13 to 24|Protocol deviation|0|||
160949595|NCT00791765|581204893|FG000|Weeks 13 to 24|Adverse Event|0|||
160949596|NCT00791765|581204894|FG001|Weeks 13 to 24|Adverse Event|3|||
160949597|NCT00791765|581204893|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
160949598|NCT00791765|581204894|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
160949599|NCT00791765|581204893|FG000|Weeks 13 to 24|Disease progression|0|||
160949600|NCT00791765|581204894|FG001|Weeks 13 to 24|Disease progression|1|||
160949601|NCT00791765|581204893|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
160582375|NCT04491877|579853608|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
160949602|NCT00791765|581204894|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
160949603|NCT00791765|581204893|FG000|Weeks 13 to 24|Other|0|||
160949604|NCT00791765|581204894|FG001|Weeks 13 to 24|Other|1|||
160949605|NCT04537923|581204895|FG000|Overall Study|Adverse Event|2|||
160949606|NCT04537923|581204896|FG001|Overall Study|Adverse Event|1|||
160949607|NCT04537923|581204897|FG002|Overall Study|Adverse Event|2|||
160949608|NCT04537923|581204898|FG003|Overall Study|Adverse Event|4|||
160949609|NCT04537923|581204895|FG000|Overall Study|Death|3|||
160949610|NCT04537923|581204896|FG001|Overall Study|Death|3|||
160949611|NCT04537923|581204897|FG002|Overall Study|Death|1|||
160949612|NCT04537923|581204898|FG003|Overall Study|Death|11|||
160949613|NCT04537923|581204895|FG000|Overall Study|Lost to Follow-up|1|||
160949614|NCT04537923|581204896|FG001|Overall Study|Lost to Follow-up|2|||
160949615|NCT04537923|581204897|FG002|Overall Study|Lost to Follow-up|1|||
160949616|NCT04537923|581204898|FG003|Overall Study|Lost to Follow-up|6|||
160949617|NCT04537923|581204895|FG000|Overall Study|Physician Decision|1|||
160949618|NCT04537923|581204896|FG001|Overall Study|Physician Decision|0|||
160949619|NCT04537923|581204897|FG002|Overall Study|Physician Decision|2|||
160949620|NCT04537923|581204898|FG003|Overall Study|Physician Decision|5|||
160949621|NCT04537923|581204895|FG000|Overall Study|Pregnancy|1|||
160949622|NCT04537923|581204896|FG001|Overall Study|Pregnancy|0|||
160949623|NCT04537923|581204897|FG002|Overall Study|Pregnancy|0|||
160949624|NCT04537923|581204898|FG003|Overall Study|Pregnancy|0|||
160949625|NCT04537923|581204895|FG000|Overall Study|Withdrawal by Subject|4|||
160949626|NCT04537923|581204896|FG001|Overall Study|Withdrawal by Subject|4|||
160949627|NCT04537923|581204897|FG002|Overall Study|Withdrawal by Subject|4|||
160949628|NCT04537923|581204898|FG003|Overall Study|Withdrawal by Subject|58|||
160949629|NCT04537923|581204895|FG000|Overall Study|Missed study visits|2|||
160949630|NCT04537923|581204896|FG001|Overall Study|Missed study visits|0|||
160949631|NCT04537923|581204897|FG002|Overall Study|Missed study visits|0|||
160949632|NCT04537923|581204898|FG003|Overall Study|Missed study visits|3|||
160949633|NCT04537923|581204895|FG000|Overall Study|Sponsor's decision|0|||
160949634|NCT04537923|581204896|FG001|Overall Study|Sponsor's decision|0|||
160949635|NCT04537923|581204897|FG002|Overall Study|Sponsor's decision|1|||
160949636|NCT04537923|581204898|FG003|Overall Study|Sponsor's decision|1|||
160949637|NCT04537923|581204895|FG000|Overall Study|Safety reasons|1|||
160949638|NCT04537923|581204896|FG001|Overall Study|Safety reasons|0|||
160949639|NCT04537923|581204897|FG002|Overall Study|Safety reasons|0|||
160949640|NCT04537923|581204898|FG003|Overall Study|Safety reasons|0|||
160949641|NCT01261611|581204899|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
160949642|NCT01261611|581204900|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
160949643|NCT01261611|581204901|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
160949644|NCT01261611|581204899|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
160949645|NCT01261611|581204900|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
160949646|NCT01261611|581204901|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
160949647|NCT01261611|581204899|FG000|Treatment Cycle 1|Adverse Event|0|||
160949648|NCT01261611|581204900|FG001|Treatment Cycle 1|Adverse Event|1|||
160949649|NCT01261611|581204901|FG002|Treatment Cycle 1|Adverse Event|0|||
160949650|NCT01261611|581204899|FG000|Treatment Cycle 1|Protocol Violation|0|||
160949651|NCT01261611|581204900|FG001|Treatment Cycle 1|Protocol Violation|0|||
160582376|NCT04491877|579853600|FG000|Overall Study|Lost to Follow-up|0|||
160949652|NCT01261611|581204901|FG002|Treatment Cycle 1|Protocol Violation|2|||
160949653|NCT01261611|581204899|FG000|Treatment Cycle 2|Completed study|4|||
160949654|NCT01261611|581204900|FG001|Treatment Cycle 2|Completed study|0|||
160949655|NCT01261611|581204901|FG002|Treatment Cycle 2|Completed study|0|||
160949656|NCT01261611|581204899|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
160582377|NCT04491877|579853601|FG001|Overall Study|Lost to Follow-up|2|||
160949657|NCT01261611|581204900|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
160949658|NCT01261611|581204901|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
160949659|NCT01261611|581204899|FG000|Treatment Cycle 2|Adverse Event|1|||
160949660|NCT01261611|581204900|FG001|Treatment Cycle 2|Adverse Event|0|||
160949661|NCT01261611|581204901|FG002|Treatment Cycle 2|Adverse Event|0|||
160949662|NCT01261611|581204899|FG000|Treatment Cycle 2|Protocol Violation|2|||
160949663|NCT01261611|581204900|FG001|Treatment Cycle 2|Protocol Violation|0|||
160949664|NCT01261611|581204901|FG002|Treatment Cycle 2|Protocol Violation|0|||
160949665|NCT01261611|581204899|FG000|Treatment Cycle 2|Not otherwise specified|2|||
160949666|NCT01261611|581204900|FG001|Treatment Cycle 2|Not otherwise specified|0|||
160949667|NCT01261611|581204901|FG002|Treatment Cycle 2|Not otherwise specified|0|||
160949668|NCT01261611|581204899|FG000|Treatment Cycle 3|Completed study|24|||
160949669|NCT01261611|581204900|FG001|Treatment Cycle 3|Completed study|0|||
160949670|NCT01261611|581204901|FG002|Treatment Cycle 3|Completed study|0|||
160949671|NCT01261611|581204899|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
160949672|NCT01261611|581204900|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
160949673|NCT01261611|581204901|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
160582378|NCT04491877|579853602|FG002|Overall Study|Lost to Follow-up|0|||
160582379|NCT04491877|579853603|FG003|Overall Study|Lost to Follow-up|0|||
160582380|NCT04491877|579853604|FG004|Overall Study|Lost to Follow-up|0|||
160582381|NCT04491877|579853605|FG005|Overall Study|Lost to Follow-up|0|||
160582382|NCT04491877|579853606|FG006|Overall Study|Lost to Follow-up|2|||
160582383|NCT04491877|579853607|FG007|Overall Study|Lost to Follow-up|1|||
160582384|NCT04491877|579853608|FG008|Overall Study|Lost to Follow-up|1|||
160582385|NCT02429258|579853612|FG000|Overall Study|Withdrawal by Subject|2|||
160582386|NCT02429258|579853613|FG001|Overall Study|Withdrawal by Subject|0|||
160582387|NCT02429258|579853612|FG000|Overall Study|Protocol Violation|0|||
160949674|NCT01261611|581204899|FG000|Treatment Cycle 3|Adverse Event|1|||
160949675|NCT01261611|581204900|FG001|Treatment Cycle 3|Adverse Event|0|||
160949676|NCT01261611|581204901|FG002|Treatment Cycle 3|Adverse Event|0|||
160949677|NCT01261611|581204899|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
160949678|NCT01261611|581204900|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
160949679|NCT01261611|581204901|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
160949680|NCT01261611|581204899|FG000|Treatment Cycle 4|Completed study|87|||
160949681|NCT01261611|581204900|FG001|Treatment Cycle 4|Completed study|0|||
160949682|NCT01261611|581204901|FG002|Treatment Cycle 4|Completed study|0|||
160949683|NCT01261611|581204899|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
160949684|NCT01261611|581204900|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
160949685|NCT01261611|581204901|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
160949686|NCT01261611|581204899|FG000|Treatment Cycle 4|Adverse Event|1|||
160949687|NCT01261611|581204900|FG001|Treatment Cycle 4|Adverse Event|0|||
160949688|NCT01261611|581204901|FG002|Treatment Cycle 4|Adverse Event|0|||
160949689|NCT01261611|581204899|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
160949690|NCT01261611|581204900|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
160949691|NCT01261611|581204901|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
160949692|NCT01261611|581204899|FG000|Treatment Cycle 4|Not otherwise specified|3|||
160949693|NCT01261611|581204900|FG001|Treatment Cycle 4|Not otherwise specified|0|||
160949694|NCT01261611|581204901|FG002|Treatment Cycle 4|Not otherwise specified|0|||
160949695|NCT01261611|581204899|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
160949696|NCT01261611|581204900|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
160949697|NCT01261611|581204901|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
160949698|NCT01261611|581204899|FG000|Treatment Cycle 5|Adverse Event|1|||
160949699|NCT01261611|581204900|FG001|Treatment Cycle 5|Adverse Event|0|||
160949700|NCT01261611|581204901|FG002|Treatment Cycle 5|Adverse Event|0|||
160949701|NCT01261611|581204899|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
160949702|NCT01261611|581204900|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
160949703|NCT01261611|581204901|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
160949704|NCT02527798|581204902|FG000|Overall Study|Physician Decision|1|||
160949705|NCT02527798|581204903|FG001|Overall Study|Physician Decision|0|||
160949706|NCT02527798|581204904|FG002|Overall Study|Physician Decision|1|||
160949707|NCT02527798|581204905|FG003|Overall Study|Physician Decision|1|||
160949708|NCT02527798|581204906|FG004|Overall Study|Physician Decision|0|||
160949709|NCT02527798|581204907|FG005|Overall Study|Physician Decision|0|||
160949710|NCT02527798|581204902|FG000|Overall Study|Death|0|||
160949711|NCT02527798|581204903|FG001|Overall Study|Death|0|||
160949712|NCT02527798|581204904|FG002|Overall Study|Death|1|||
160949713|NCT02527798|581204905|FG003|Overall Study|Death|0|||
161000088|NCT00371566|581384971|FG001|Follow Up Phase|Death|5|||
161000089|NCT00371566|581384970|FG000|Follow Up Phase|Disease progression|1|||
160582388|NCT02429258|579853613|FG001|Overall Study|Protocol Violation|1|||
160582389|NCT03364335|579853614|FG000|Overall Study|Adverse Event|3|||
160582390|NCT03364335|579853615|FG001|Overall Study|Adverse Event|4|||
160582391|NCT03364335|579853616|FG002|Overall Study|Adverse Event|1|||
160949714|NCT02527798|581204906|FG004|Overall Study|Death|0|||
160949715|NCT02527798|581204907|FG005|Overall Study|Death|0|||
160949716|NCT02527798|581204902|FG000|Overall Study|Withdrawal by Subject|0|||
160949717|NCT02527798|581204903|FG001|Overall Study|Withdrawal by Subject|1|||
160949718|NCT02527798|581204904|FG002|Overall Study|Withdrawal by Subject|2|||
160949719|NCT02527798|581204905|FG003|Overall Study|Withdrawal by Subject|0|||
160949720|NCT02527798|581204906|FG004|Overall Study|Withdrawal by Subject|0|||
160949721|NCT02527798|581204907|FG005|Overall Study|Withdrawal by Subject|0|||
160582392|NCT03364335|579853617|FG003|Overall Study|Adverse Event|2|||
160582393|NCT03364335|579853618|FG004|Overall Study|Adverse Event|0|||
160949722|NCT02527798|581204902|FG000|Overall Study|Reason undisclosed|1|||
160949723|NCT02527798|581204903|FG001|Overall Study|Reason undisclosed|0|||
160456429|NCT04101357|579401426|FG002|Overall Study|Withdrawal by Subject|0|||
160456430|NCT04101357|579401427|FG003|Overall Study|Withdrawal by Subject|0|||
160456431|NCT04101357|579401428|FG004|Overall Study|Withdrawal by Subject|0|||
160456432|NCT04101357|579401429|FG005|Overall Study|Withdrawal by Subject|0|||
160456433|NCT04101357|579401430|FG006|Overall Study|Withdrawal by Subject|0|||
160456434|NCT04101357|579401431|FG007|Overall Study|Withdrawal by Subject|0|||
160456435|NCT04101357|579401432|FG008|Overall Study|Withdrawal by Subject|1|||
160456436|NCT04101357|579401433|FG009|Overall Study|Withdrawal by Subject|1|||
160456437|NCT04101357|579401434|FG010|Overall Study|Withdrawal by Subject|0|||
160456438|NCT04101357|579401424|FG000|Overall Study|Other|0|||
160456439|NCT04101357|579401425|FG001|Overall Study|Other|0|||
160456440|NCT04101357|579401426|FG002|Overall Study|Other|0|||
160456441|NCT04101357|579401427|FG003|Overall Study|Other|0|||
160456442|NCT04101357|579401428|FG004|Overall Study|Other|0|||
160456443|NCT04101357|579401429|FG005|Overall Study|Other|1|||
160456444|NCT04101357|579401430|FG006|Overall Study|Other|2|||
160456445|NCT04101357|579401431|FG007|Overall Study|Other|1|||
160456446|NCT04101357|579401432|FG008|Overall Study|Other|0|||
160456447|NCT04101357|579401433|FG009|Overall Study|Other|0|||
160456448|NCT04101357|579401434|FG010|Overall Study|Other|0|||
160456449|NCT04101357|579401424|FG000|Overall Study|Enrolled but not treated|0|||
160456450|NCT04101357|579401425|FG001|Overall Study|Enrolled but not treated|0|||
160456451|NCT04101357|579401426|FG002|Overall Study|Enrolled but not treated|0|||
160456452|NCT04101357|579401427|FG003|Overall Study|Enrolled but not treated|0|||
160456453|NCT04101357|579401428|FG004|Overall Study|Enrolled but not treated|0|||
160456454|NCT04101357|579401429|FG005|Overall Study|Enrolled but not treated|1|||
160456455|NCT04101357|579401430|FG006|Overall Study|Enrolled but not treated|1|||
160456456|NCT04101357|579401431|FG007|Overall Study|Enrolled but not treated|0|||
160456457|NCT04101357|579401432|FG008|Overall Study|Enrolled but not treated|0|||
160456458|NCT04101357|579401433|FG009|Overall Study|Enrolled but not treated|0|||
160456459|NCT04101357|579401434|FG010|Overall Study|Enrolled but not treated|0|||
160456460|NCT02497950|579401437|FG000|Overall Study|Death|209|||
160456461|NCT02497950|579401437|FG000|Overall Study|Transplanted|85|||
160456462|NCT02497950|579401437|FG000|Overall Study|Explanted|8|||
160456463|NCT02497950|579401437|FG000|Overall Study|Device Permanently Deactivated|4|||
160456464|NCT02497950|579401437|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
160456465|NCT02497950|579401437|FG000|Overall Study|Lost to Follow-up|6|||
160456466|NCT02497950|579401437|FG000|Overall Study|Withdrawal by Subject|2|||
160456467|NCT02497950|579401437|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
160456468|NCT02497950|579401437|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
160456469|NCT04660539|579401438|FG000|Overall Study|Adverse Event|10|||
160456470|NCT04660539|579401438|FG000|Overall Study|Lack of Efficacy|4|||
160456471|NCT04660539|579401438|FG000|Overall Study|Lost to Follow-up|5|||
160456472|NCT04660539|579401438|FG000|Overall Study|Non-Compliance With Study Drug|3|||
160456473|NCT04660539|579401438|FG000|Overall Study|Reason not Specified|12|||
160456474|NCT04660539|579401438|FG000|Overall Study|Pregnancy|2|||
160456475|NCT04660539|579401438|FG000|Overall Study|Protocol Violation|2|||
160456476|NCT04660539|579401438|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
160456477|NCT04660539|579401438|FG000|Overall Study|Withdrawal by Subject|21|||
160456478|NCT03852550|579401441|FG000|Overall Study|Lost to Follow-up|4|||
160456479|NCT03852550|579401442|FG001|Overall Study|Lost to Follow-up|3|||
160456480|NCT03852550|579401441|FG000|Overall Study|Only parent outcomes completed|0|||
160456481|NCT03852550|579401442|FG001|Overall Study|Only parent outcomes completed|1|||
160456482|NCT03852550|579401441|FG000|Overall Study|Withdrawal by Subject|1|||
160456483|NCT03852550|579401442|FG001|Overall Study|Withdrawal by Subject|0|||
160582394|NCT03364335|579853614|FG000|Overall Study|Lost to Follow-up|7|||
160582395|NCT03364335|579853615|FG001|Overall Study|Lost to Follow-up|7|||
160582396|NCT03364335|579853616|FG002|Overall Study|Lost to Follow-up|10|||
160582397|NCT03364335|579853617|FG003|Overall Study|Lost to Follow-up|11|||
160456484|NCT01828112|579401446|FG000|Treatment Phase|Adverse Event|7|||
160456485|NCT01828112|579401447|FG001|Treatment Phase|Adverse Event|8|||
160456486|NCT01828112|579401448|FG002|Treatment Phase|Adverse Event|0|||
160456487|NCT01828112|579401446|FG000|Treatment Phase|Death|9|||
160456488|NCT01828112|579401447|FG001|Treatment Phase|Death|5|||
160456489|NCT01828112|579401448|FG002|Treatment Phase|Death|0|||
160456490|NCT01828112|579401446|FG000|Treatment Phase|No longer required treatment|0|||
160456491|NCT01828112|579401447|FG001|Treatment Phase|No longer required treatment|1|||
160456492|NCT01828112|579401448|FG002|Treatment Phase|No longer required treatment|0|||
160456493|NCT01828112|579401446|FG000|Treatment Phase|Physician Decision|6|||
160456494|NCT01828112|579401447|FG001|Treatment Phase|Physician Decision|7|||
160456495|NCT01828112|579401448|FG002|Treatment Phase|Physician Decision|0|||
160582398|NCT03364335|579853618|FG004|Overall Study|Lost to Follow-up|11|||
160582399|NCT00492856|579853619|FG000|Induction|Adverse Event|2|||
160456496|NCT01828112|579401446|FG000|Treatment Phase|Pregnancy|1|||
160456497|NCT01828112|579401447|FG001|Treatment Phase|Pregnancy|0|||
160582400|NCT00492856|579853620|FG001|Induction|Adverse Event|0|||
160456498|NCT01828112|579401448|FG002|Treatment Phase|Pregnancy|0|||
160456499|NCT01828112|579401446|FG000|Treatment Phase|Progressive disease|79|||
160582401|NCT00492856|579853621|FG002|Induction|Adverse Event|0|||
161000090|NCT00371566|581384971|FG001|Follow Up Phase|Disease progression|0|||
161000091|NCT00371566|581384970|FG000|Follow Up Phase|Withdrawal by Subject|0|||
161000092|NCT00371566|581384971|FG001|Follow Up Phase|Withdrawal by Subject|1|||
161000093|NCT00371566|581384970|FG000|Follow Up Phase|Physician Decision|1|||
161000094|NCT00371566|581384971|FG001|Follow Up Phase|Physician Decision|1|||
161000095|NCT00371566|581384970|FG000|Follow Up Phase|Lost to Follow-up|1|||
161000096|NCT00371566|581384971|FG001|Follow Up Phase|Lost to Follow-up|0|||
161000097|NCT00530842|581384976|FG000|Overall Study|Adverse Event|10|||
161000098|NCT00530842|581384977|FG001|Overall Study|Adverse Event|6|||
161000099|NCT00530842|581384976|FG000|Overall Study|Lack of Efficacy|2|||
161000100|NCT00530842|581384977|FG001|Overall Study|Lack of Efficacy|1|||
161000101|NCT00530842|581384976|FG000|Overall Study|Lost to Follow-up|0|||
161000102|NCT00530842|581384977|FG001|Overall Study|Lost to Follow-up|4|||
161000103|NCT00530842|581384976|FG000|Overall Study|Protocol Violation|3|||
161000104|NCT00530842|581384977|FG001|Overall Study|Protocol Violation|2|||
161000105|NCT00530842|581384976|FG000|Overall Study|Withdrawal by Subject|4|||
161000106|NCT00530842|581384977|FG001|Overall Study|Withdrawal by Subject|5|||
161000107|NCT00530842|581384976|FG000|Overall Study|Individual different reasons|4|||
161000108|NCT00530842|581384977|FG001|Overall Study|Individual different reasons|3|||
161000109|NCT00530842|581384976|FG000|Period 1|Adverse Event|7|||
161000110|NCT00530842|581384977|FG001|Period 1|Adverse Event|3|||
161000111|NCT00530842|581384976|FG000|Period 1|Lack of Efficacy|1|||
161000112|NCT00530842|581384977|FG001|Period 1|Lack of Efficacy|1|||
161000113|NCT00530842|581384976|FG000|Period 1|Protocol Violation|2|||
161000114|NCT00530842|581384977|FG001|Period 1|Protocol Violation|1|||
161000115|NCT00530842|581384976|FG000|Period 1|Withdrawal by Subject|2|||
161000116|NCT00530842|581384977|FG001|Period 1|Withdrawal by Subject|3|||
161000117|NCT00530842|581384976|FG000|Period 1|Individual different reasons|2|||
161000118|NCT00530842|581384977|FG001|Period 1|Individual different reasons|3|||
161000119|NCT00530842|581384976|FG000|Period 2|Adverse Event|3|||
161000120|NCT00530842|581384977|FG001|Period 2|Adverse Event|3|||
161000121|NCT00530842|581384976|FG000|Period 2|Lack of Efficacy|1|||
161000122|NCT00530842|581384977|FG001|Period 2|Lack of Efficacy|0|||
161000123|NCT00530842|581384976|FG000|Period 2|Lost to Follow-up|0|||
161000124|NCT00530842|581384977|FG001|Period 2|Lost to Follow-up|4|||
161000125|NCT00530842|581384976|FG000|Period 2|Protocol Violation|1|||
161000126|NCT00530842|581384977|FG001|Period 2|Protocol Violation|0|||
161000127|NCT00530842|581384976|FG000|Period 2|Withdrawal by Subject|1|||
161000128|NCT00530842|581384977|FG001|Period 2|Withdrawal by Subject|2|||
161000129|NCT00530842|581384976|FG000|Period 2|Individual different reasons|2|||
161000130|NCT00530842|581384977|FG001|Period 2|Individual different reasons|0|||
161000131|NCT03478696|581384993|FG000|Overall Study|Adverse Event|1|||
160949724|NCT02527798|581204904|FG002|Overall Study|Reason undisclosed|1|||
160949725|NCT02527798|581204905|FG003|Overall Study|Reason undisclosed|0|||
160949726|NCT02527798|581204906|FG004|Overall Study|Reason undisclosed|0|||
160949727|NCT02527798|581204907|FG005|Overall Study|Reason undisclosed|0|||
160949728|NCT02527798|581204902|FG000|Overall Study|Did not receive intervention|1|||
160949729|NCT02527798|581204903|FG001|Overall Study|Did not receive intervention|1|||
160949730|NCT02527798|581204904|FG002|Overall Study|Did not receive intervention|0|||
160949731|NCT02527798|581204905|FG003|Overall Study|Did not receive intervention|0|||
160949732|NCT02527798|581204906|FG004|Overall Study|Did not receive intervention|0|||
160949733|NCT02527798|581204907|FG005|Overall Study|Did not receive intervention|0|||
160949734|NCT01808690|581204909|FG000|Overall Study|Withdrawal by Subject|1|||
160949735|NCT01808690|581204910|FG001|Overall Study|Withdrawal by Subject|2|||
160949736|NCT02891187|581204911|FG000|Overall Study|Lost to Follow-up|1|||
160949737|NCT02891187|581204912|FG001|Overall Study|Lost to Follow-up|2|||
160949738|NCT01585103|581204914|FG000|Overall Study|Unable to swallow Cytosponge|6|||
160949739|NCT01349569|581204915|FG000|Overall Study|Lack of Efficacy|4|||
160949740|NCT03581305|581204916|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
160949741|NCT03581305|581204917|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
160949742|NCT03581305|581204916|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
161000132|NCT03478696|581384994|FG001|Overall Study|Adverse Event|5|||
161000133|NCT03478696|581384993|FG000|Overall Study|Lost to Follow-up|1|||
161000134|NCT03478696|581384994|FG001|Overall Study|Lost to Follow-up|0|||
161000135|NCT03478696|581384993|FG000|Overall Study|Physician Decision|6|||
160949743|NCT03581305|581204917|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
160949744|NCT03581305|581204916|FG000|Serotonergic Study|Withdrawal by Subject|5|||
160949745|NCT03581305|581204917|FG001|Serotonergic Study|Withdrawal by Subject|1|||
161000136|NCT03478696|581384994|FG001|Overall Study|Physician Decision|3|||
161000137|NCT03478696|581384993|FG000|Overall Study|Withdrawal by Subject|9|||
161000138|NCT03478696|581384994|FG001|Overall Study|Withdrawal by Subject|4|||
161000139|NCT00741988|581385003|FG000|Overall Study|Adverse Event|2|||
161000140|NCT00741988|581385004|FG001|Overall Study|Adverse Event|4|||
160949746|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
160949747|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
160949748|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
161000141|NCT00741988|581385003|FG000|Overall Study|Lack of Efficacy|2|||
161000142|NCT00741988|581385004|FG001|Overall Study|Lack of Efficacy|0|||
161000143|NCT03863834|581385014|FG000|Overall Study|Lost to Follow-up|3|||
161000144|NCT02685488|581385015|FG000|Overall Study|Withdrawal by Subject|0|||
161000145|NCT02685488|581385016|FG001|Overall Study|Withdrawal by Subject|1|||
161000146|NCT02020616|581385017|FG000|Overall Study|Adverse Event|0|||
161000147|NCT02020616|581385018|FG001|Overall Study|Adverse Event|0|||
161000148|NCT02020616|581385019|FG002|Overall Study|Adverse Event|0|||
161000149|NCT02020616|581385020|FG003|Overall Study|Adverse Event|0|||
161000150|NCT02020616|581385021|FG004|Overall Study|Adverse Event|0|||
161000151|NCT02020616|581385022|FG005|Overall Study|Adverse Event|1|||
161000152|NCT02020616|581385023|FG006|Overall Study|Adverse Event|1|||
161000153|NCT02020616|581385017|FG000|Overall Study|Physician Decision|0|||
161000154|NCT02020616|581385018|FG001|Overall Study|Physician Decision|0|||
161000155|NCT02020616|581385019|FG002|Overall Study|Physician Decision|0|||
161000156|NCT02020616|581385020|FG003|Overall Study|Physician Decision|0|||
161000157|NCT02020616|581385021|FG004|Overall Study|Physician Decision|0|||
161000158|NCT02020616|581385022|FG005|Overall Study|Physician Decision|1|||
161000159|NCT02020616|581385023|FG006|Overall Study|Physician Decision|2|||
161000160|NCT02020616|581385017|FG000|Overall Study|Withdrawal by Subject|0|||
161000161|NCT02020616|581385018|FG001|Overall Study|Withdrawal by Subject|0|||
161000162|NCT02020616|581385019|FG002|Overall Study|Withdrawal by Subject|1|||
161000163|NCT02020616|581385020|FG003|Overall Study|Withdrawal by Subject|0|||
161000164|NCT02020616|581385021|FG004|Overall Study|Withdrawal by Subject|0|||
161000165|NCT02020616|581385022|FG005|Overall Study|Withdrawal by Subject|1|||
161000166|NCT02020616|581385023|FG006|Overall Study|Withdrawal by Subject|1|||
161000167|NCT02020616|581385017|FG000|Overall Study|Lost to Follow-up|0|||
161000168|NCT02020616|581385018|FG001|Overall Study|Lost to Follow-up|1|||
161000169|NCT02020616|581385019|FG002|Overall Study|Lost to Follow-up|0|||
161000170|NCT02020616|581385020|FG003|Overall Study|Lost to Follow-up|1|||
161000171|NCT02020616|581385021|FG004|Overall Study|Lost to Follow-up|1|||
161000172|NCT02020616|581385022|FG005|Overall Study|Lost to Follow-up|1|||
161000173|NCT02020616|581385023|FG006|Overall Study|Lost to Follow-up|0|||
161000174|NCT02020616|581385017|FG000|Overall Study|Early Termination Criteria Met|0|||
161000175|NCT02020616|581385018|FG001|Overall Study|Early Termination Criteria Met|0|||
161000176|NCT02020616|581385019|FG002|Overall Study|Early Termination Criteria Met|1|||
161000177|NCT02020616|581385020|FG003|Overall Study|Early Termination Criteria Met|0|||
161000178|NCT02020616|581385021|FG004|Overall Study|Early Termination Criteria Met|0|||
161000179|NCT02020616|581385022|FG005|Overall Study|Early Termination Criteria Met|1|||
161000180|NCT02020616|581385023|FG006|Overall Study|Early Termination Criteria Met|0|||
161000181|NCT02020616|581385017|FG000|Overall Study|Randomized in Error|0|||
161000182|NCT02020616|581385018|FG001|Overall Study|Randomized in Error|0|||
161000183|NCT02020616|581385019|FG002|Overall Study|Randomized in Error|0|||
161000184|NCT02020616|581385020|FG003|Overall Study|Randomized in Error|1|||
161000185|NCT02020616|581385021|FG004|Overall Study|Randomized in Error|0|||
161000186|NCT02020616|581385022|FG005|Overall Study|Randomized in Error|0|||
161000187|NCT02020616|581385023|FG006|Overall Study|Randomized in Error|0|||
161000188|NCT02020616|581385017|FG000|Overall Study|Lack of Efficacy|0|||
161000189|NCT02020616|581385018|FG001|Overall Study|Lack of Efficacy|0|||
161000190|NCT02020616|581385019|FG002|Overall Study|Lack of Efficacy|0|||
161000191|NCT02020616|581385020|FG003|Overall Study|Lack of Efficacy|0|||
161000192|NCT02020616|581385021|FG004|Overall Study|Lack of Efficacy|1|||
160582402|NCT00492856|579853622|FG003|Induction|Adverse Event|0|||
160582403|NCT00492856|579853619|FG000|Induction|Withdrawal by Subject|1|||
160582404|NCT00492856|579853620|FG001|Induction|Withdrawal by Subject|0|||
160582405|NCT00492856|579853621|FG002|Induction|Withdrawal by Subject|0|||
160582406|NCT00492856|579853622|FG003|Induction|Withdrawal by Subject|0|||
161000193|NCT02020616|581385022|FG005|Overall Study|Lack of Efficacy|0|||
161000194|NCT02020616|581385023|FG006|Overall Study|Lack of Efficacy|0|||
161000195|NCT05019729|581385024|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
160582407|NCT00492856|579853619|FG000|Induction|Death|3|||
160582408|NCT00492856|579853620|FG001|Induction|Death|0|||
160582409|NCT00492856|579853621|FG002|Induction|Death|0|||
160582410|NCT00492856|579853622|FG003|Induction|Death|0|||
161000196|NCT05019729|581385025|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161000197|NCT05019729|581385026|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161000198|NCT05019729|581385027|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161000199|NCT05019729|581385028|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
161000200|NCT05019729|581385029|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161000201|NCT03008915|581385030|FG000|Treatment 1|Withdrawal by Subject|0|||
161000202|NCT03008915|581385031|FG001|Treatment 1|Withdrawal by Subject|1|||
161000203|NCT00712166|581385034|FG000|Overall Study|Noncompliance|0|||
161000204|NCT00712166|581385035|FG001|Overall Study|Noncompliance|1|||
160582411|NCT00492856|579853619|FG000|Consolidation|Adverse Event|6|||
160582412|NCT00492856|579853620|FG001|Consolidation|Adverse Event|0|||
160582413|NCT00492856|579853621|FG002|Consolidation|Adverse Event|0|||
160582414|NCT00492856|579853622|FG003|Consolidation|Adverse Event|0|||
161000205|NCT01773122|581385036|FG000|Overall Study|Due to amended age eligibility criteria|3|||
161000206|NCT01773122|581385037|FG001|Overall Study|Due to amended age eligibility criteria|1|||
161000207|NCT01773122|581385038|FG002|Overall Study|Due to amended age eligibility criteria|0|||
161000208|NCT01773122|581385039|FG003|Overall Study|Due to amended age eligibility criteria|1|||
161000209|NCT02289560|581385042|FG000|Overall Study|Lost to Follow-up|6|||
161000210|NCT02289560|581385042|FG000|Overall Study|Alternative Treatment|4|||
161000211|NCT02289560|581385042|FG000|Overall Study|Inadequate Treatment|2|||
160949749|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
160949750|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
160949751|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
160949752|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
160949753|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
160949754|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
160949755|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
160949756|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
161000212|NCT02289560|581385042|FG000|Overall Study|Withdrawal by Subject|23|||
161000213|NCT02540213|581385043|FG000|Overall Study|Death/adverse event|18|||
161000214|NCT02540213|581385043|FG000|Overall Study|Administrative reasons|3|||
161000215|NCT02540213|581385043|FG000|Overall Study|Kidney transplant|3|||
161000216|NCT02540213|581385043|FG000|Overall Study|Lack of Efficacy|6|||
161000217|NCT02540213|581385043|FG000|Overall Study|Consent withdrawn|7|||
161000218|NCT02540213|581385043|FG000|Overall Study|Enrolled but not treated|2|||
161000219|NCT01264718|581385044|FG000|Overall Study|Lost to Follow-up|3|||
161000220|NCT01264718|581385045|FG001|Overall Study|Lost to Follow-up|2|||
161000221|NCT01264718|581385044|FG000|Overall Study|Withdrawal by Subject|9|||
161000222|NCT01264718|581385045|FG001|Overall Study|Withdrawal by Subject|15|||
161000223|NCT01264718|581385044|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
161000224|NCT01264718|581385045|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
161000225|NCT02908464|581385046|FG000|Overall Study|Withdrawal by Subject|2|||
161000226|NCT02908464|581385047|FG001|Overall Study|Withdrawal by Subject|1|||
161000227|NCT02908464|581385046|FG000|Overall Study|Found ineligible after randomization|0|||
161000228|NCT02908464|581385047|FG001|Overall Study|Found ineligible after randomization|2|||
161000229|NCT01769391|581385050|FG000|Overall Study|Death|10|||
161000230|NCT01769391|581385051|FG001|Overall Study|Death|1|||
161000231|NCT01769391|581385050|FG000|Overall Study|Adverse Event|0|||
161000232|NCT01769391|581385051|FG001|Overall Study|Adverse Event|3|||
161000233|NCT01769391|581385050|FG000|Overall Study|Progressive Disease|1|||
161000234|NCT01769391|581385051|FG001|Overall Study|Progressive Disease|2|||
161000235|NCT01769391|581385050|FG000|Overall Study|Withdrawal by Subject|4|||
161000236|NCT01769391|581385051|FG001|Overall Study|Withdrawal by Subject|3|||
161000237|NCT01769391|581385050|FG000|Overall Study|Investigator Decision|2|||
161000238|NCT01769391|581385051|FG001|Overall Study|Investigator Decision|0|||
161000239|NCT03386929|581385052|FG000|Overall Study|Death|0|||
161000240|NCT03386929|581385053|FG001|Overall Study|Death|0|||
161000241|NCT03386929|581385054|FG002|Overall Study|Death|1|||
161000242|NCT03386929|581385052|FG000|Overall Study|Withdrawal by Subject|0|||
161000243|NCT03386929|581385053|FG001|Overall Study|Withdrawal by Subject|1|||
161000244|NCT03386929|581385054|FG002|Overall Study|Withdrawal by Subject|0|||
161000245|NCT03386929|581385052|FG000|Overall Study|Physician Decision|0|||
161000246|NCT03386929|581385053|FG001|Overall Study|Physician Decision|0|||
161000247|NCT03386929|581385054|FG002|Overall Study|Physician Decision|1|||
161000248|NCT03386929|581385052|FG000|Overall Study|Progression|4|||
161000249|NCT03386929|581385053|FG001|Overall Study|Progression|4|||
161000250|NCT03386929|581385054|FG002|Overall Study|Progression|0|||
161000251|NCT03386929|581385052|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
161000252|NCT03386929|581385053|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
161000253|NCT03386929|581385054|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
161000254|NCT03386929|581385052|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
161000255|NCT03386929|581385053|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
161000256|NCT03386929|581385054|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
161000257|NCT03538054|581385055|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
161000258|NCT03538054|581385055|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
161000259|NCT03538054|581385055|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
161000260|NCT02351180|581385058|FG000|Overall Study|Withdrawal by Subject|1|||
161000261|NCT02351180|581385059|FG001|Overall Study|Withdrawal by Subject|0|||
161000262|NCT00208767|581385060|FG000|Overall Study|Adverse Event|9|||
161000263|NCT00208767|581385061|FG001|Overall Study|Adverse Event|1|||
160456500|NCT01828112|579401447|FG001|Treatment Phase|Progressive disease|87|||
160949757|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
160582415|NCT00492856|579853619|FG000|Consolidation|Not protocol specified|2|||
161000264|NCT00208767|581385060|FG000|Overall Study|Withdrawal by Subject|14|||
161000265|NCT00208767|581385061|FG001|Overall Study|Withdrawal by Subject|3|||
161000266|NCT00208767|581385060|FG000|Overall Study|Death|1|||
161000267|NCT00208767|581385061|FG001|Overall Study|Death|0|||
161000268|NCT00208767|581385060|FG000|Overall Study|Lost to Follow-up|3|||
160949758|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
160949759|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
160949760|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
160949761|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
160949762|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
160949763|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
160949764|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
160949765|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
160949766|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
160949767|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
161000269|NCT00208767|581385061|FG001|Overall Study|Lost to Follow-up|3|||
161000270|NCT02317016|581385062|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
161000271|NCT02317016|581385062|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
161000272|NCT02317016|581385062|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
161000273|NCT02317016|581385062|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
161000274|NCT02317016|581385062|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
161000275|NCT02317016|581385062|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
161000276|NCT02317016|581385062|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
161000277|NCT00536380|581385063|FG000|Overall Study|Adverse Event|0|||
161000278|NCT00536380|581385064|FG001|Overall Study|Adverse Event|2|||
161000279|NCT00536380|581385065|FG002|Overall Study|Adverse Event|2|||
161000280|NCT00536380|581385063|FG000|Overall Study|Lost to Follow-up|0|||
161000281|NCT00536380|581385064|FG001|Overall Study|Lost to Follow-up|0|||
161000282|NCT00536380|581385065|FG002|Overall Study|Lost to Follow-up|1|||
161000283|NCT00536380|581385063|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
161000284|NCT00536380|581385064|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
161000285|NCT00536380|581385065|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
161000286|NCT00536380|581385063|FG000|Overall Study|Withdrawal related to study drug|7|||
161000287|NCT00536380|581385064|FG001|Overall Study|Withdrawal related to study drug|5|||
161000288|NCT00536380|581385065|FG002|Overall Study|Withdrawal related to study drug|2|||
161000289|NCT00536380|581385063|FG000|Overall Study|Noncompliance with protocol|3|||
161000290|NCT00536380|581385064|FG001|Overall Study|Noncompliance with protocol|2|||
161000291|NCT00536380|581385065|FG002|Overall Study|Noncompliance with protocol|2|||
161000292|NCT00536380|581385063|FG000|Overall Study|Did not meet protocol eligibility|0|||
161000293|NCT00536380|581385064|FG001|Overall Study|Did not meet protocol eligibility|0|||
161000294|NCT00536380|581385065|FG002|Overall Study|Did not meet protocol eligibility|1|||
161000295|NCT00536380|581385063|FG000|Overall Study|Administrative|0|||
161000296|NCT00536380|581385064|FG001|Overall Study|Administrative|0|||
161000297|NCT00536380|581385065|FG002|Overall Study|Administrative|1|||
161000298|NCT03545984|581385066|FG000|Overall Study|CSF cases not present during rotation|11|||
161000299|NCT03545984|581385067|FG001|Overall Study|CSF cases not present during rotation|9|||
161000300|NCT00387465|581385068|FG000|Overall Study|Withdrawal by Subject|0|||
161000301|NCT00387465|581385069|FG001|Overall Study|Withdrawal by Subject|1|||
161000302|NCT00387465|581385070|FG002|Overall Study|Withdrawal by Subject|0|||
161000303|NCT03418324|581385071|FG000|Overall Study|Death|0|||
161000304|NCT03418324|581385072|FG001|Overall Study|Death|1|||
161000305|NCT03418324|581385071|FG000|Overall Study|Physician Decision|1|||
161000306|NCT03418324|581385072|FG001|Overall Study|Physician Decision|1|||
161000307|NCT01768676|581385073|FG000|Overall Study|Adverse Event|3|||
161000308|NCT01768676|581385074|FG001|Overall Study|Adverse Event|3|||
161000309|NCT01768676|581385073|FG000|Overall Study|Lost to Follow-up|13|||
160862496|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
160862497|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
160862498|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
160862499|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
160862500|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
160862501|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
160456501|NCT01828112|579401448|FG002|Treatment Phase|Progressive disease|0|||
160862502|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
160862503|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
160862504|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
160862505|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
160862506|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
160862507|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
160862508|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
160949768|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
160862509|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
160456502|NCT01828112|579401446|FG000|Treatment Phase|Study terminated by sponsor|1|||
160582416|NCT00492856|579853620|FG001|Consolidation|Not protocol specified|0|||
160949769|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
160949770|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160862510|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
160862511|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
160862512|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
160862513|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
160862514|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
160862515|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
160862516|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
160862517|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
160862518|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
160862519|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
160862520|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
160862521|NCT04408989|580889744|FG000|Overall Study|Lost to Follow-up|0|||
160862522|NCT04408989|580889745|FG001|Overall Study|Lost to Follow-up|0|||
160862523|NCT04408989|580889746|FG002|Overall Study|Lost to Follow-up|1|||
160862524|NCT04408989|580889744|FG000|Overall Study|Withdrawal by Subject|0|||
160862525|NCT04408989|580889745|FG001|Overall Study|Withdrawal by Subject|0|||
160862526|NCT04408989|580889746|FG002|Overall Study|Withdrawal by Subject|2|||
160862527|NCT04363320|580889749|FG000|Overall Study|Lost to Follow-up|43|||
160862528|NCT04363320|580889750|FG001|Overall Study|Lost to Follow-up|42|||
160862529|NCT04363320|580889751|FG002|Overall Study|Lost to Follow-up|24|||
160862530|NCT04363320|580889752|FG003|Overall Study|Lost to Follow-up|29|||
160862531|NCT04363320|580889749|FG000|Overall Study|Death|0|||
160862532|NCT04363320|580889750|FG001|Overall Study|Death|0|||
160862533|NCT04363320|580889751|FG002|Overall Study|Death|1|||
160862534|NCT04363320|580889752|FG003|Overall Study|Death|0|||
160862535|NCT00604565|580889756|FG000|Overall Study|Study terminated|0|||
160862536|NCT00604565|580889757|FG001|Overall Study|Study terminated|3|||
161000310|NCT01768676|581385074|FG001|Overall Study|Lost to Follow-up|16|||
161000311|NCT01768676|581385073|FG000|Overall Study|Protocol Violation|1|||
161000312|NCT01768676|581385074|FG001|Overall Study|Protocol Violation|1|||
161000313|NCT01768676|581385073|FG000|Overall Study|Physician Decision|4|||
161000314|NCT01768676|581385074|FG001|Overall Study|Physician Decision|1|||
161000315|NCT01768676|581385073|FG000|Overall Study|Withdrawal by Subject|3|||
161000316|NCT01768676|581385074|FG001|Overall Study|Withdrawal by Subject|10|||
161000317|NCT00605033|581385075|FG000|Overall Study|Adverse Event|2|||
161000318|NCT00605033|581385076|FG001|Overall Study|Adverse Event|2|||
161000319|NCT00605033|581385075|FG000|Overall Study|Lost to Follow-up|1|||
161000320|NCT00605033|581385076|FG001|Overall Study|Lost to Follow-up|1|||
161000321|NCT00605033|581385075|FG000|Overall Study|Withdrawal by Subject|3|||
161000322|NCT00605033|581385076|FG001|Overall Study|Withdrawal by Subject|4|||
161000323|NCT00605033|581385075|FG000|Overall Study|Protocol Violation|1|||
161000324|NCT00605033|581385076|FG001|Overall Study|Protocol Violation|1|||
161000325|NCT03121950|581385079|FG000|Overall Study|Withdrawal by Subject|11|||
161000326|NCT03121950|581385080|FG001|Overall Study|Withdrawal by Subject|2|||
160949771|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949772|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949773|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949774|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949775|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949776|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949777|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949778|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949779|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949780|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949781|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949782|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949783|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161000327|NCT02754479|581385084|FG000|Overall Study|Lost to Follow-up|1|||
161000328|NCT03183518|581385085|FG000|Overall Study|Other (Not specified)|2|||
161000329|NCT03183518|581385085|FG000|Overall Study|Other (Withdrawal of consent)|1|||
160949784|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949785|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161000330|NCT02132702|581385086|FG000|Overall Study|Protocol Violation|2|||
161000331|NCT02132702|581385086|FG000|Overall Study|Adverse Event|3|||
160949786|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949787|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949788|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
161000332|NCT02132702|581385086|FG000|Overall Study|Withdrawal by Subject|3|||
161000333|NCT01244828|581385089|FG000|Overall Study|Adverse Event|37|||
161000334|NCT01244828|581385089|FG000|Overall Study|Withdrawal by Subject|31|||
161000335|NCT01244828|581385089|FG000|Overall Study|Lack of Efficacy|7|||
160862537|NCT02260934|580889767|FG000|Overall Study|Lost to Follow-up|2|||
160862538|NCT02260934|580889768|FG001|Overall Study|Lost to Follow-up|1|||
160862539|NCT02260934|580889767|FG000|Overall Study|Withdrawal by Subject|0|||
161000336|NCT01244828|581385089|FG000|Overall Study|Lost to Follow-up|2|||
160949789|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
160949790|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
160949791|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949792|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949793|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949794|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949795|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949796|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949797|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949798|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949799|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949800|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949801|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949802|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949803|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949804|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949805|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949806|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
160949807|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
160949808|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
160949809|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
160949810|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
160949811|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
160949812|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
160949813|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
160949814|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
160949815|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
160949816|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
160949817|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
160949818|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
160949819|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
160949820|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
160949821|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
160949822|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
160949823|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
160949824|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
160949825|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
160949826|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
160949827|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949828|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949829|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949830|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949831|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949832|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949833|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949834|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949835|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949836|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949837|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949838|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949839|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949840|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949841|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949842|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949843|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949844|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949845|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949846|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
160949847|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
160949848|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949849|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
160949850|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
160949851|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949852|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949853|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949854|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949855|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160456503|NCT01828112|579401447|FG001|Treatment Phase|Study terminated by sponsor|0|||
160456504|NCT01828112|579401448|FG002|Treatment Phase|Study terminated by sponsor|0|||
160456505|NCT01828112|579401446|FG000|Treatment Phase|Subject/guardian decision|12|||
160456506|NCT01828112|579401447|FG001|Treatment Phase|Subject/guardian decision|8|||
160456507|NCT01828112|579401448|FG002|Treatment Phase|Subject/guardian decision|0|||
160456508|NCT01828112|579401446|FG000|Extension Treatment Phase|Adverse Event|0|||
160456509|NCT01828112|579401447|FG001|Extension Treatment Phase|Adverse Event|0|||
160456510|NCT01828112|579401448|FG002|Extension Treatment Phase|Adverse Event|6|||
160456511|NCT01828112|579401446|FG000|Extension Treatment Phase|Death|0|||
160456512|NCT01828112|579401447|FG001|Extension Treatment Phase|Death|0|||
160456513|NCT01828112|579401448|FG002|Extension Treatment Phase|Death|17|||
160456514|NCT01828112|579401446|FG000|Extension Treatment Phase|Physician Decision|0|||
160456515|NCT01828112|579401447|FG001|Extension Treatment Phase|Physician Decision|0|||
160456516|NCT01828112|579401448|FG002|Extension Treatment Phase|Physician Decision|5|||
160456517|NCT01828112|579401446|FG000|Extension Treatment Phase|Progressive disease|0|||
160456518|NCT01828112|579401447|FG001|Extension Treatment Phase|Progressive disease|0|||
160456519|NCT01828112|579401448|FG002|Extension Treatment Phase|Progressive disease|46|||
160456520|NCT01828112|579401446|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
160456521|NCT01828112|579401447|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
160456522|NCT01828112|579401448|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
160456523|NCT01828112|579401446|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
160456524|NCT01828112|579401447|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
160456525|NCT01828112|579401448|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
160456526|NCT05565820|579401456|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
160456527|NCT05565820|579401457|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
160456528|NCT05565820|579401456|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
160456529|NCT05565820|579401457|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
160456530|NCT00429364|579401461|FG000|Overall Study|Withdrawal by Subject|11|||
160456531|NCT00429364|579401462|FG001|Overall Study|Withdrawal by Subject|5|||
160456532|NCT00429364|579401461|FG000|Overall Study|Physician Decision|4|||
160456533|NCT00429364|579401462|FG001|Overall Study|Physician Decision|2|||
160456534|NCT00429364|579401461|FG000|Overall Study|Lost to Follow-up|7|||
160456535|NCT00429364|579401462|FG001|Overall Study|Lost to Follow-up|6|||
160456536|NCT00429364|579401461|FG000|Overall Study|Death|0|||
160456537|NCT00429364|579401462|FG001|Overall Study|Death|1|||
160456538|NCT00429364|579401461|FG000|Overall Study|Underwent aortic root surgery|10|||
160456539|NCT00429364|579401462|FG001|Overall Study|Underwent aortic root surgery|18|||
160456540|NCT00429364|579401461|FG000|Overall Study|Pregnancy|0|||
160456541|NCT00429364|579401462|FG001|Overall Study|Pregnancy|1|||
160456542|NCT05425420|579401464|FG000|Overall Study|Physician Decision|1|||
160456543|NCT05425420|579401464|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
160456544|NCT03673501|579401465|FG000|Overall Study|Participants ongoing.|36|||
160456545|NCT03673501|579401466|FG001|Overall Study|Participants ongoing.|24|||
160456546|NCT05683340|579401467|FG000|Overall Study|Adverse Event|1|||
160456547|NCT05683340|579401468|FG001|Overall Study|Adverse Event|1|||
160456548|NCT05683340|579401467|FG000|Overall Study|Protocol Violation|1|||
160456549|NCT05683340|579401468|FG001|Overall Study|Protocol Violation|0|||
160456550|NCT05683340|579401467|FG000|Overall Study|Withdrawal by Subject|0|||
160456551|NCT05683340|579401468|FG001|Overall Study|Withdrawal by Subject|2|||
160456552|NCT02224144|579401472|FG000|Overall Study|Lost to Follow-up|3|||
160456553|NCT02224144|579401473|FG001|Overall Study|Lost to Follow-up|1|||
160456554|NCT02224144|579401472|FG000|Overall Study|Death|2|||
160456555|NCT02224144|579401473|FG001|Overall Study|Death|0|||
160456556|NCT02224144|579401472|FG000|Overall Study|Withdrawal by Subject|0|||
160456557|NCT02224144|579401473|FG001|Overall Study|Withdrawal by Subject|1|||
160456558|NCT03505008|579401474|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
160456559|NCT03505008|579401475|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
160456560|NCT03505008|579401476|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
160456561|NCT03505008|579401477|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
160456562|NCT03505008|579401474|FG000|Before Week 24 Randomization|Adverse Event|10|||
160656213|NCT03127137|580122374|FG001|Overall Study|Requested sedation after consent|0|||
160656214|NCT03127137|580122373|FG000|Overall Study|Malfunction in electronic data collection|1|||
160656215|NCT03127137|580122374|FG001|Overall Study|Malfunction in electronic data collection|0|||
160456563|NCT03505008|579401475|FG001|Before Week 24 Randomization|Adverse Event|0|||
160456564|NCT03505008|579401476|FG002|Before Week 24 Randomization|Adverse Event|0|||
160456565|NCT03505008|579401477|FG003|Before Week 24 Randomization|Adverse Event|0|||
160456566|NCT03505008|579401474|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
160456567|NCT03505008|579401475|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
160456568|NCT03505008|579401476|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
160456569|NCT03505008|579401477|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
160456570|NCT03505008|579401474|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
160456571|NCT03505008|579401475|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
160949856|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949857|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949858|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949859|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949860|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949861|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949862|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949863|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949864|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949865|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949866|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949867|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949868|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949869|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949870|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
160949871|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949872|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949873|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949874|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949875|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949876|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949877|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949878|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949879|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949880|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949881|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949882|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949883|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949884|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949885|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949886|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949887|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949888|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949889|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949890|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949891|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
160949892|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
160949893|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949894|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949895|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
160949896|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
160949897|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
160949898|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949899|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949900|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949901|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949902|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949903|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949904|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949905|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949906|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949907|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949908|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949909|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949910|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949911|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161000337|NCT01244828|581385089|FG000|Overall Study|Other reason (not specified)|1|||
161000338|NCT00573833|581385090|FG000|Overall Study|Not Treated|2|||
161000339|NCT05052983|581385091|FG000|Overall Study|Lack of Efficacy|3|||
160949912|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
160949913|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949914|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
160949915|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
160949916|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
161000340|NCT05052983|581385092|FG001|Overall Study|Lack of Efficacy|12|||
160949917|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949918|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949919|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949920|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949921|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949922|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949923|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949924|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949925|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949926|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949927|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949928|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949929|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949930|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949931|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949932|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
160949933|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949934|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949935|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
160949936|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949937|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949938|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949939|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949940|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949941|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949942|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949943|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949944|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949945|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949946|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949947|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949948|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949949|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949950|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949951|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949952|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
160949953|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949954|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949955|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949956|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949957|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949958|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949959|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949960|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949961|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949962|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949963|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949964|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949965|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949966|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949967|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949968|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949969|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949970|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949971|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
160949972|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949973|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949974|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949975|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949976|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949977|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161000341|NCT05052983|581385091|FG000|Overall Study|Adverse Event|1|||
161000342|NCT05052983|581385092|FG001|Overall Study|Adverse Event|0|||
161000343|NCT04493242|581385093|FG000|Overall Study|Death|10|||
161000344|NCT04493242|581385094|FG001|Overall Study|Death|14|||
161000345|NCT04493242|581385095|FG002|Overall Study|Death|16|||
161000346|NCT04493242|581385093|FG000|Overall Study|Lost to Follow-up|1|||
160456572|NCT03505008|579401476|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
160456573|NCT03505008|579401477|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
160456574|NCT03505008|579401474|FG000|Before Week 24 Randomization|Physician Decision|2|||
160949978|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949979|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949980|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949981|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949982|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160456575|NCT03505008|579401475|FG001|Before Week 24 Randomization|Physician Decision|0|||
160456576|NCT03505008|579401476|FG002|Before Week 24 Randomization|Physician Decision|0|||
160456577|NCT03505008|579401477|FG003|Before Week 24 Randomization|Physician Decision|0|||
160456578|NCT03505008|579401474|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
160456579|NCT03505008|579401475|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
160456580|NCT03505008|579401476|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
160456581|NCT03505008|579401477|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
160456582|NCT03505008|579401474|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
160456583|NCT03505008|579401475|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
160456584|NCT03505008|579401476|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
160456585|NCT03505008|579401477|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
160456586|NCT03505008|579401474|FG000|Before Week 24 Randomization|Complication|1|||
160456587|NCT03505008|579401475|FG001|Before Week 24 Randomization|Complication|0|||
160456588|NCT03505008|579401476|FG002|Before Week 24 Randomization|Complication|0|||
160456589|NCT03505008|579401477|FG003|Before Week 24 Randomization|Complication|0|||
160456590|NCT03505008|579401474|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
160456591|NCT03505008|579401475|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
160456592|NCT03505008|579401476|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
160456593|NCT03505008|579401477|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
160456594|NCT03505008|579401474|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
160456595|NCT03505008|579401475|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
160456596|NCT03505008|579401476|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
160456597|NCT03505008|579401477|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
160456598|NCT03505008|579401474|FG000|After Week 24 Randomization|Adverse Event|0|||
160456599|NCT03505008|579401475|FG001|After Week 24 Randomization|Adverse Event|1|||
160456600|NCT03505008|579401476|FG002|After Week 24 Randomization|Adverse Event|2|||
160456601|NCT03505008|579401477|FG003|After Week 24 Randomization|Adverse Event|2|||
160456602|NCT03505008|579401474|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
160456603|NCT03505008|579401475|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
160456604|NCT03505008|579401476|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
160456605|NCT03505008|579401477|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
160456606|NCT03505008|579401474|FG000|After Week 24 Randomization|Protocol Violation|0|||
160456607|NCT03505008|579401475|FG001|After Week 24 Randomization|Protocol Violation|0|||
160456608|NCT03505008|579401476|FG002|After Week 24 Randomization|Protocol Violation|1|||
160456609|NCT03505008|579401477|FG003|After Week 24 Randomization|Protocol Violation|0|||
160456610|NCT02437136|579401478|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
160456611|NCT02437136|579401479|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
160456612|NCT02437136|579401480|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
160456613|NCT02437136|579401481|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
160456614|NCT02437136|579401482|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
160456615|NCT02437136|579401483|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
160456616|NCT02437136|579401484|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
160456617|NCT02437136|579401478|FG000|Expansion (Phase 2)|Death|0|||
160456618|NCT02437136|579401479|FG001|Expansion (Phase 2)|Death|0|||
160456619|NCT02437136|579401480|FG002|Expansion (Phase 2)|Death|0|||
160456620|NCT02437136|579401481|FG003|Expansion (Phase 2)|Death|6|||
160456621|NCT02437136|579401482|FG004|Expansion (Phase 2)|Death|37|||
160456622|NCT02437136|579401483|FG005|Expansion (Phase 2)|Death|29|||
160456623|NCT02437136|579401484|FG006|Expansion (Phase 2)|Death|24|||
160456624|NCT02437136|579401478|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
160456625|NCT02437136|579401479|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
160456626|NCT02437136|579401480|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
160456627|NCT02437136|579401481|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
160456628|NCT02437136|579401482|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
160949983|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160456629|NCT02437136|579401483|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
160456630|NCT02437136|579401484|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
160456631|NCT02437136|579401478|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
160456632|NCT02437136|579401479|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
160456633|NCT02437136|579401480|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
160456634|NCT02437136|579401481|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
160456635|NCT02437136|579401482|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
160456636|NCT02437136|579401483|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
160949984|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949985|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949986|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160582417|NCT00492856|579853621|FG002|Consolidation|Not protocol specified|0|||
160582418|NCT00492856|579853622|FG003|Consolidation|Not protocol specified|0|||
160582419|NCT00492856|579853619|FG000|Consolidation|Lost to Follow-up|1|||
160949987|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949988|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949989|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949990|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949991|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161000347|NCT04493242|581385094|FG001|Overall Study|Lost to Follow-up|1|||
161000348|NCT04493242|581385095|FG002|Overall Study|Lost to Follow-up|0|||
161000349|NCT04493242|581385093|FG000|Overall Study|Withdrawal by Subject|1|||
161000350|NCT04493242|581385094|FG001|Overall Study|Withdrawal by Subject|0|||
161000351|NCT04493242|581385095|FG002|Overall Study|Withdrawal by Subject|0|||
161000352|NCT04493242|581385093|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
160656216|NCT03127137|580122373|FG000|Overall Study|Post procedure testing could not be obtained|0|||
161000353|NCT04493242|581385094|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
160582420|NCT00492856|579853620|FG001|Consolidation|Lost to Follow-up|0|||
160582421|NCT00492856|579853621|FG002|Consolidation|Lost to Follow-up|0|||
160582422|NCT00492856|579853622|FG003|Consolidation|Lost to Follow-up|0|||
160582423|NCT00492856|579853619|FG000|Post-consolidation|Adverse Event|0|||
160582424|NCT00492856|579853620|FG001|Post-consolidation|Adverse Event|4|||
160582425|NCT00492856|579853621|FG002|Post-consolidation|Adverse Event|0|||
160582426|NCT00492856|579853622|FG003|Post-consolidation|Adverse Event|1|||
160582427|NCT00492856|579853619|FG000|Post-consolidation|Withdrawal by Subject|0|||
160582428|NCT00492856|579853620|FG001|Post-consolidation|Withdrawal by Subject|4|||
160582429|NCT00492856|579853621|FG002|Post-consolidation|Withdrawal by Subject|0|||
160582430|NCT00492856|579853622|FG003|Post-consolidation|Withdrawal by Subject|0|||
160582431|NCT00492856|579853619|FG000|Post-consolidation|Death|0|||
160656217|NCT03127137|580122374|FG001|Overall Study|Post procedure testing could not be obtained|1|||
160656218|NCT04424407|580122375|FG000|Overall Study|Withdrawal by Subject|2|||
160656219|NCT04424407|580122375|FG000|Overall Study|Lost to Follow-up|1|||
160949992|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
160949993|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949994|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
160949995|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161000354|NCT04493242|581385095|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
161000355|NCT04493242|581385093|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
161000356|NCT04493242|581385094|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
161000357|NCT04493242|581385095|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
161000358|NCT00849147|581385096|FG000|Overall Study|Withdrawal by Subject|1|||
161000359|NCT00849147|581385096|FG000|Overall Study|Protocol Violation|2|||
161000360|NCT00849147|581385096|FG000|Overall Study|Disease Relapse/Progression|2|||
161000361|NCT05147233|581387072|FG000|Overall Study|Adverse Event|0|||
161000362|NCT05147233|581387073|FG001|Overall Study|Adverse Event|1|||
161000363|NCT05147233|581387072|FG000|Overall Study|Lost to Follow-up|1|||
161000364|NCT05147233|581387073|FG001|Overall Study|Lost to Follow-up|1|||
161000365|NCT05147233|581387072|FG000|Overall Study|Protocol Violation|0|||
161000366|NCT05147233|581387073|FG001|Overall Study|Protocol Violation|1|||
161000367|NCT05147233|581387072|FG000|Overall Study|Withdrawal by Subject|2|||
161000368|NCT05147233|581387073|FG001|Overall Study|Withdrawal by Subject|1|||
161000369|NCT04513522|581387074|FG000|Overall Study|Other reasons|1|||
161000370|NCT04513522|581387074|FG000|Overall Study|Adverse event unrelated to study drug|9|||
161000371|NCT04513522|581387074|FG000|Overall Study|Study drug toxicity|14|||
161000372|NCT04513522|581387074|FG000|Overall Study|Disease progression|39|||
161000373|NCT04513522|581387074|FG000|Overall Study|Participants withdrew consent|2|||
161000374|NCT04517864|581387075|FG000|Placebo-Controlled Phase|Adverse Event|1|||
161000375|NCT04517864|581387076|FG001|Placebo-Controlled Phase|Adverse Event|0|||
161000376|NCT04517864|581387077|FG002|Placebo-Controlled Phase|Adverse Event|0|||
161000377|NCT04517864|581387075|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
161000378|NCT04517864|581387076|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
161000379|NCT04517864|581387077|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
161000380|NCT04517864|581387075|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
161000381|NCT04517864|581387076|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
160582432|NCT00492856|579853620|FG001|Post-consolidation|Death|1|||
161000382|NCT04517864|581387077|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
161000383|NCT04517864|581387075|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
160582433|NCT00492856|579853621|FG002|Post-consolidation|Death|0|||
160582434|NCT00492856|579853622|FG003|Post-consolidation|Death|0|||
160582435|NCT00492856|579853619|FG000|Post-consolidation|Not protocol specified|0|||
160656220|NCT00264797|580122376|FG000|Overall Study|Withdrawal by Subject|11|||
160656221|NCT00264797|580122377|FG001|Overall Study|Withdrawal by Subject|11|||
160949996|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
160949997|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
160949998|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949999|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950000|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950001|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950002|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950003|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950004|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950005|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950006|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950007|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950008|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950009|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950010|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950011|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
160950012|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
160950013|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
160950014|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
160950015|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
160950016|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
160950017|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
160950018|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950019|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950020|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950021|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950022|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950023|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950024|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950025|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950026|NCT01490632|581204918|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950027|NCT01490632|581204919|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950028|NCT01490632|581204920|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950029|NCT01490632|581204921|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950030|NCT01490632|581204922|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950031|NCT01490632|581204923|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950032|NCT01490632|581204924|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950033|NCT01490632|581204925|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950034|NCT01490632|581204926|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950035|NCT01490632|581204927|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950036|NCT01490632|581204928|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950037|NCT01490632|581204929|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950038|NCT01490632|581204930|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950039|NCT01490632|581204931|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950040|NCT01490632|581204932|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
160950041|NCT01490632|581204933|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
160950042|NCT01490632|581204934|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950043|NCT01490632|581204935|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950044|NCT01490632|581204936|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950045|NCT01490632|581204937|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950046|NCT01490632|581204918|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950047|NCT01490632|581204919|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950048|NCT01490632|581204920|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950049|NCT01490632|581204921|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950050|NCT01490632|581204922|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950051|NCT01490632|581204923|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950052|NCT01490632|581204924|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950053|NCT01490632|581204925|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161000384|NCT04517864|581387076|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
160950054|NCT01490632|581204926|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161000385|NCT04517864|581387077|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
161000386|NCT04517864|581387075|FG000|Active Therapy Extension Phase|Adverse Event|1|||
161000387|NCT04517864|581387076|FG001|Active Therapy Extension Phase|Adverse Event|0|||
160950055|NCT01490632|581204927|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950056|NCT01490632|581204928|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950057|NCT01490632|581204929|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950058|NCT01490632|581204930|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950059|NCT01490632|581204931|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
160950060|NCT01490632|581204932|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950061|NCT01490632|581204933|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160456637|NCT02437136|579401484|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
160456638|NCT02056834|579401487|FG000|Overall Study|Lost to Follow-up|7|||
160456639|NCT02780700|579401489|FG000|Overall Study|Progressive disease|1|||
160456640|NCT04580914|579401491|FG000|Overall Study|Withdrawal by Subject|6|||
160456641|NCT04580914|579401491|FG000|Overall Study|Lost to Follow-up|2|||
160456642|NCT02828358|579401495|FG000|Overall Study|Physician Decision|7|||
160456643|NCT02828358|579401496|FG001|Overall Study|Physician Decision|1|||
160456644|NCT02828358|579401495|FG000|Overall Study|Treatment Failure|6|||
160456645|NCT02828358|579401496|FG001|Overall Study|Treatment Failure|0|||
160456646|NCT02828358|579401495|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
160456647|NCT02828358|579401496|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
160456648|NCT02828358|579401495|FG000|Overall Study|Refusal of further protocol therapy|2|||
160456649|NCT02828358|579401496|FG001|Overall Study|Refusal of further protocol therapy|0|||
160456650|NCT02828358|579401495|FG000|Overall Study|Relapse|25|||
160456651|NCT02828358|579401496|FG001|Overall Study|Relapse|0|||
160456652|NCT02828358|579401495|FG000|Overall Study|Still on therapy|5|||
160456653|NCT02828358|579401496|FG001|Overall Study|Still on therapy|0|||
160456654|NCT03993392|579401510|FG000|Overall Study|Withdrawal by Subject|3|||
160456655|NCT03993392|579401510|FG000|Overall Study|Lost to Follow-up|2|||
160456656|NCT03993392|579401510|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
160456657|NCT05292391|579401513|FG000|Overall Study|Lost to Follow-up|0|||
160456658|NCT05292391|579401514|FG001|Overall Study|Lost to Follow-up|0|||
160456659|NCT05292391|579401515|FG002|Overall Study|Lost to Follow-up|0|||
160456660|NCT05292391|579401516|FG003|Overall Study|Lost to Follow-up|1|||
160456661|NCT05292391|579401517|FG004|Overall Study|Lost to Follow-up|0|||
160456662|NCT04857723|579401518|FG000|Overall Study|Withdrawal by Subject|2|||
160456663|NCT06262477|579403462|FG000|Overall Study|Withdrawal by Subject|1|||
160456664|NCT06262477|579403463|FG001|Overall Study|Withdrawal by Subject|0|||
160456665|NCT06262477|579403462|FG000|Overall Study|Adverse Event|0|||
160456666|NCT06262477|579403463|FG001|Overall Study|Adverse Event|1|||
160456667|NCT06262477|579403462|FG000|Overall Study|Lost to Follow-up|0|||
160456668|NCT06262477|579403463|FG001|Overall Study|Lost to Follow-up|1|||
160456669|NCT01064440|579403464|FG000|Overall Study|Lost to Follow-up|1|||
160456670|NCT01064440|579403465|FG001|Overall Study|Lost to Follow-up|1|||
160456671|NCT01064440|579403466|FG002|Overall Study|Lost to Follow-up|1|||
160456672|NCT01064440|579403464|FG000|Overall Study|Non-compliance|0|||
160456673|NCT01064440|579403465|FG001|Overall Study|Non-compliance|1|||
160456674|NCT01064440|579403466|FG002|Overall Study|Non-compliance|0|||
160456675|NCT01064440|579403464|FG000|Overall Study|Death|1|||
160456676|NCT01064440|579403465|FG001|Overall Study|Death|0|||
160456677|NCT01064440|579403466|FG002|Overall Study|Death|1|||
160456678|NCT01064440|579403464|FG000|Overall Study|Withdrawal by Subject|0|||
160456679|NCT01064440|579403465|FG001|Overall Study|Withdrawal by Subject|1|||
160456680|NCT01064440|579403466|FG002|Overall Study|Withdrawal by Subject|1|||
160456681|NCT01064440|579403464|FG000|Overall Study|Other: amputation|1|||
160456682|NCT01064440|579403465|FG001|Overall Study|Other: amputation|0|||
160656222|NCT00264797|580122376|FG000|Overall Study|Lost to Follow-up|9|||
160950062|NCT01490632|581204934|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950063|NCT01490632|581204935|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950064|NCT01490632|581204936|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950065|NCT01490632|581204937|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950066|NCT01490632|581204918|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950067|NCT01490632|581204919|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950068|NCT01490632|581204920|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950069|NCT01490632|581204921|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950070|NCT01490632|581204922|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950071|NCT01490632|581204923|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950072|NCT01490632|581204924|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950073|NCT01490632|581204925|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950074|NCT01490632|581204926|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160456683|NCT01064440|579403466|FG002|Overall Study|Other: amputation|0|||
160456684|NCT04024020|579403470|FG000|Overall Study|Withdrawal by Subject|2|||
160456685|NCT04024020|579403471|FG001|Overall Study|Withdrawal by Subject|2|||
160456686|NCT05618587|579403484|FG000|Overall Study|Lost to Follow-up|2|||
160456687|NCT05618587|579403485|FG001|Overall Study|Lost to Follow-up|0|||
160456688|NCT04871529|579403490|FG000|Overall Study|Withdrawal by Subject|0|||
160656223|NCT00264797|580122377|FG001|Overall Study|Lost to Follow-up|17|||
160950075|NCT01490632|581204927|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950076|NCT01490632|581204928|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950077|NCT01490632|581204929|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950078|NCT01490632|581204930|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950079|NCT01490632|581204931|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950080|NCT01490632|581204932|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
160950081|NCT01490632|581204933|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
160950082|NCT01490632|581204934|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950083|NCT01490632|581204935|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950084|NCT01490632|581204936|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950085|NCT01490632|581204937|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950086|NCT01490632|581204918|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950087|NCT01490632|581204919|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950088|NCT01490632|581204920|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950089|NCT01490632|581204921|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950090|NCT01490632|581204922|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950091|NCT01490632|581204923|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950092|NCT01490632|581204924|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950093|NCT01490632|581204925|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950094|NCT01490632|581204926|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950095|NCT01490632|581204927|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950096|NCT01490632|581204928|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950097|NCT01490632|581204929|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950098|NCT01490632|581204930|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
160950099|NCT01490632|581204931|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
160950100|NCT01490632|581204932|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
160950101|NCT01490632|581204933|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
160950102|NCT01490632|581204934|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950103|NCT01490632|581204935|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161000388|NCT04517864|581387077|FG002|Active Therapy Extension Phase|Adverse Event|0|||
161000389|NCT04517864|581387075|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
161000390|NCT04517864|581387076|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
161000391|NCT04517864|581387077|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
161000392|NCT04517864|581387075|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
161000393|NCT04517864|581387076|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
161000394|NCT04517864|581387077|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
161000395|NCT04517864|581387075|FG000|Active Therapy Extension Phase|Physician Decision|1|||
161000396|NCT04517864|581387076|FG001|Active Therapy Extension Phase|Physician Decision|0|||
161000397|NCT04517864|581387077|FG002|Active Therapy Extension Phase|Physician Decision|0|||
161000398|NCT04517864|581387075|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
161000399|NCT04517864|581387076|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
161000400|NCT04517864|581387077|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
161000401|NCT04517864|581387075|FG000|Extension Phase|Adverse Event|0|||
161000402|NCT04517864|581387076|FG001|Extension Phase|Adverse Event|0|||
161000403|NCT04517864|581387077|FG002|Extension Phase|Adverse Event|1|||
161000404|NCT04517864|581387075|FG000|Extension Phase|Lack of Efficacy|0|||
161000405|NCT04517864|581387076|FG001|Extension Phase|Lack of Efficacy|0|||
161000406|NCT04517864|581387077|FG002|Extension Phase|Lack of Efficacy|2|||
161000407|NCT04517864|581387075|FG000|Extension Phase|Study Terminated By Sponsor|0|||
161000408|NCT04517864|581387076|FG001|Extension Phase|Study Terminated By Sponsor|0|||
161000409|NCT04517864|581387077|FG002|Extension Phase|Study Terminated By Sponsor|32|||
161000410|NCT04517864|581387075|FG000|Extension Phase|Withdrawal by Subject|0|||
161000411|NCT04517864|581387076|FG001|Extension Phase|Withdrawal by Subject|0|||
161000412|NCT04517864|581387077|FG002|Extension Phase|Withdrawal by Subject|3|||
161000413|NCT04517864|581387075|FG000|Extension Phase|Approved Drug Available for Indication|0|||
161000414|NCT04517864|581387076|FG001|Extension Phase|Approved Drug Available for Indication|0|||
161000415|NCT04517864|581387077|FG002|Extension Phase|Approved Drug Available for Indication|7|||
161000416|NCT04722003|581387080|FG000|Overall Study|Lost to Follow-up|2|||
160456689|NCT04871529|579403491|FG001|Overall Study|Withdrawal by Subject|1|||
160456690|NCT04871529|579403490|FG000|Overall Study|Death|0|||
161000417|NCT04722003|581387081|FG001|Overall Study|Lost to Follow-up|0|||
161000418|NCT04722003|581387080|FG000|Overall Study|Physician Decision|1|||
160456691|NCT04871529|579403491|FG001|Overall Study|Death|1|||
160582436|NCT00492856|579853620|FG001|Post-consolidation|Not protocol specified|1|||
160582437|NCT00492856|579853621|FG002|Post-consolidation|Not protocol specified|0|||
160456692|NCT04871529|579403490|FG000|Overall Study|Not protocol specified|0|||
160456693|NCT04871529|579403491|FG001|Overall Study|Not protocol specified|1|||
160456694|NCT05184452|579403492|FG000|Overall Study|Lost to Follow-up|0|||
160456695|NCT05184452|579403493|FG001|Overall Study|Lost to Follow-up|0|||
160456696|NCT05184452|579403494|FG002|Overall Study|Lost to Follow-up|0|||
160456697|NCT05184452|579403495|FG003|Overall Study|Lost to Follow-up|0|||
160456698|NCT05184452|579403496|FG004|Overall Study|Lost to Follow-up|0|||
160456699|NCT05184452|579403497|FG005|Overall Study|Lost to Follow-up|2|||
160456700|NCT05184452|579403498|FG006|Overall Study|Lost to Follow-up|0|||
160456701|NCT05184452|579403499|FG007|Overall Study|Lost to Follow-up|0|||
160456702|NCT05184452|579403500|FG008|Overall Study|Lost to Follow-up|0|||
160456703|NCT05184452|579403501|FG009|Overall Study|Lost to Follow-up|1|||
160456704|NCT05184452|579403492|FG000|Overall Study|Withdrawal by Subject|0|||
160456705|NCT05184452|579403493|FG001|Overall Study|Withdrawal by Subject|0|||
160456706|NCT05184452|579403494|FG002|Overall Study|Withdrawal by Subject|0|||
160456707|NCT05184452|579403495|FG003|Overall Study|Withdrawal by Subject|0|||
160456708|NCT05184452|579403496|FG004|Overall Study|Withdrawal by Subject|0|||
160456709|NCT05184452|579403497|FG005|Overall Study|Withdrawal by Subject|1|||
160456710|NCT05184452|579403498|FG006|Overall Study|Withdrawal by Subject|0|||
160456711|NCT05184452|579403499|FG007|Overall Study|Withdrawal by Subject|0|||
160456712|NCT05184452|579403500|FG008|Overall Study|Withdrawal by Subject|0|||
160456713|NCT05184452|579403501|FG009|Overall Study|Withdrawal by Subject|1|||
160456714|NCT05586490|579403502|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
160456715|NCT05586490|579403503|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
160456716|NCT05586490|579403504|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
160456717|NCT05586490|579403505|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
160456718|NCT05586490|579403506|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
160456719|NCT05586490|579403502|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
160456720|NCT05586490|579403503|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
160456721|NCT05586490|579403504|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
160456722|NCT05586490|579403505|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
160456723|NCT05586490|579403506|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
160456724|NCT05586490|579403502|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
160456725|NCT05586490|579403503|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
160456726|NCT05586490|579403504|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
160456727|NCT05586490|579403505|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
160456728|NCT05586490|579403506|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
160456729|NCT05873556|579403507|FG000|Overall Study|Lost to Follow-up|4|||
160456730|NCT05873556|579403508|FG001|Overall Study|Lost to Follow-up|1|||
160456731|NCT03606408|579403510|FG000|Overall Study|Adverse Event|13|||
160456732|NCT03606408|579403510|FG000|Overall Study|Withdrawal by Subject|7|||
160456733|NCT03606408|579403510|FG000|Overall Study|Physician Decision|4|||
160456734|NCT03606408|579403510|FG000|Overall Study|Lack of Efficacy|2|||
160456735|NCT03606408|579403510|FG000|Overall Study|Death|1|||
160456736|NCT03606408|579403510|FG000|Overall Study|new therapy for study indication|1|||
160456737|NCT04689256|579403511|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
160456738|NCT04689256|579403512|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
160456739|NCT04862234|579403515|FG000|Overall Study|Surgery cancellation|1|||
160456740|NCT04862234|579403516|FG001|Overall Study|Surgery cancellation|2|||
160456741|NCT04862234|579403515|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
160456742|NCT04862234|579403516|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
160456743|NCT04862234|579403515|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
160456744|NCT04862234|579403516|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
160456745|NCT05828017|579403530|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
160456746|NCT05290493|579403531|FG000|Overall Study|Withdrawal by Subject|2|||
160456747|NCT05290493|579403532|FG001|Overall Study|Withdrawal by Subject|2|||
160456748|NCT05290493|579403531|FG000|Overall Study|Adverse Event|1|||
160582438|NCT00492856|579853622|FG003|Post-consolidation|Not protocol specified|0|||
160582439|NCT00492856|579853619|FG000|Post-consolidation|Lost to Follow-up|0|||
160456749|NCT05290493|579403532|FG001|Overall Study|Adverse Event|0|||
160456750|NCT05012163|579403536|FG000|Overall Study|Protocol Violation|0|||
160456751|NCT05012163|579403537|FG001|Overall Study|Protocol Violation|0|||
160456752|NCT05012163|579403538|FG002|Overall Study|Protocol Violation|1|||
160456753|NCT05012163|579403539|FG003|Overall Study|Protocol Violation|1|||
160582440|NCT00492856|579853620|FG001|Post-consolidation|Lost to Follow-up|2|||
160582441|NCT00492856|579853621|FG002|Post-consolidation|Lost to Follow-up|0|||
160456754|NCT04132518|579403549|FG000|Overall Study|Prematurely withdrawn from the study|0|||
160456755|NCT04132518|579403550|FG001|Overall Study|Prematurely withdrawn from the study|9|||
160456756|NCT04132518|579403551|FG002|Overall Study|Prematurely withdrawn from the study|1|||
160456757|NCT05524402|579403552|FG000|Overall Study|Withdrawal by Subject|3|||
160582442|NCT00492856|579853622|FG003|Post-consolidation|Lost to Follow-up|0|||
160582443|NCT00492856|579853619|FG000|Post-consolidation|Observation Arm|0|||
160456758|NCT05524402|579403553|FG001|Overall Study|Withdrawal by Subject|1|||
160456759|NCT05524402|579403552|FG000|Overall Study|Lost to Follow-up|2|||
160456760|NCT05524402|579403553|FG001|Overall Study|Lost to Follow-up|1|||
160456761|NCT05976334|579403554|FG000|Part B|Death|0|||
160456762|NCT05976334|579403555|FG001|Part B|Death|1|||
160456763|NCT05976334|579403554|FG000|Part B|Study Terminated by Sponsor|0|||
160456764|NCT05976334|579403555|FG001|Part B|Study Terminated by Sponsor|1|||
160456765|NCT05976334|579403554|FG000|Part B|Reason Not Specified|0|||
160456766|NCT05976334|579403555|FG001|Part B|Reason Not Specified|1|||
160456767|NCT03381586|579403556|FG000|Overall Study|Adverse Event|1|||
160456768|NCT03381586|579403557|FG001|Overall Study|Adverse Event|1|||
160456769|NCT03381586|579403556|FG000|Overall Study|Protocol Violation|1|||
160456770|NCT03381586|579403557|FG001|Overall Study|Protocol Violation|0|||
160456771|NCT03381586|579403556|FG000|Overall Study|Withdrawal by Subject|1|||
160456772|NCT03381586|579403557|FG001|Overall Study|Withdrawal by Subject|2|||
160456773|NCT05280574|579403563|FG000|Overall Study|Withdrawal by Subject|0|||
160456774|NCT05280574|579403564|FG001|Overall Study|Withdrawal by Subject|2|||
160456775|NCT05280574|579403565|FG002|Overall Study|Withdrawal by Subject|0|||
160456776|NCT05363163|579403566|FG000|Overall Study|Withdrawal by Subject|13|||
160456777|NCT05838027|579403572|FG000|Overall Study|Lost to Follow-up|5|||
160456778|NCT05838027|579403573|FG001|Overall Study|Lost to Follow-up|1|||
160456779|NCT05838027|579403572|FG000|Overall Study|Withdrawal by Subject|1|||
160456780|NCT05838027|579403573|FG001|Overall Study|Withdrawal by Subject|0|||
160456781|NCT05237284|579403574|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
160456782|NCT05237284|579403575|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
160456783|NCT05237284|579403576|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
160456784|NCT05237284|579403577|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
160456785|NCT05237284|579403574|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
160456786|NCT05237284|579403575|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
160456787|NCT05237284|579403576|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
160456788|NCT05237284|579403577|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
160456789|NCT05237284|579403574|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
160456790|NCT05237284|579403575|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
160456791|NCT05237284|579403576|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
160456792|NCT05237284|579403577|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
160456793|NCT05237284|579403574|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
160456794|NCT05237284|579403575|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
160456795|NCT05237284|579403576|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
160456796|NCT05237284|579403577|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
160456797|NCT05237284|579403574|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
160456798|NCT05237284|579403575|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
160456799|NCT05237284|579403576|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
160456800|NCT05237284|579403577|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
160456801|NCT05237284|579403574|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
160456802|NCT05237284|579403575|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
160456803|NCT05237284|579403576|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
160456804|NCT05237284|579403577|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
160456805|NCT05237284|579403574|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
160456806|NCT05237284|579403575|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
160456807|NCT05237284|579403576|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
160456808|NCT05237284|579403577|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
160456809|NCT05237284|579403574|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
160456810|NCT05237284|579403575|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
160456811|NCT05237284|579403576|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
160456812|NCT05237284|579403577|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
160456813|NCT05237284|579403574|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
160456814|NCT05237284|579403575|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
160456815|NCT05237284|579403576|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
160456816|NCT05237284|579403577|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
160456817|NCT04599634|579403578|FG000|Overall Study|Dose limiting toxicity|0|||
160456818|NCT04599634|579403579|FG001|Overall Study|Dose limiting toxicity|0|||
160456819|NCT04599634|579403580|FG002|Overall Study|Dose limiting toxicity|2|||
160456820|NCT04599634|579403581|FG003|Overall Study|Dose limiting toxicity|0|||
160456821|NCT04999111|579403582|FG000|Overall Study|Lost to Follow-up|21|||
160456822|NCT04999111|579403583|FG001|Overall Study|Lost to Follow-up|16|||
160456823|NCT04999111|579403584|FG002|Overall Study|Lost to Follow-up|2|||
160456824|NCT04999111|579403585|FG003|Overall Study|Lost to Follow-up|26|||
160456825|NCT04999111|579403586|FG004|Overall Study|Lost to Follow-up|30|||
160456826|NCT04999111|579403587|FG005|Overall Study|Lost to Follow-up|6|||
160950104|NCT01490632|581204936|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950105|NCT01490632|581204937|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950106|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
160950107|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
160950108|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
160950109|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
160950110|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
160950111|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
160950112|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
160950113|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
160950114|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
160950115|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
160950116|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
160950117|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
160950118|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
160950119|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
161000419|NCT04722003|581387081|FG001|Overall Study|Physician Decision|0|||
161000420|NCT01376089|581387086|FG000|Overall Study|Patient received no contrast media|3|||
161000421|NCT01376089|581387087|FG001|Overall Study|Patient received no contrast media|4|||
161000422|NCT03262935|581387088|FG000|Overall Study|Withdrawal by Subject|6|||
161000423|NCT03262935|581387089|FG001|Overall Study|Withdrawal by Subject|7|||
161000424|NCT03262935|581387088|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
161000425|NCT03262935|581387089|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
161000426|NCT03262935|581387088|FG000|Overall Study|Death|181|||
161000427|NCT03262935|581387089|FG001|Overall Study|Death|94|||
161000428|NCT03262935|581387088|FG000|Overall Study|Lost to Follow-up|9|||
161000429|NCT03262935|581387089|FG001|Overall Study|Lost to Follow-up|4|||
161000430|NCT03262935|581387088|FG000|Overall Study|Other reason|5|||
161000431|NCT03262935|581387089|FG001|Overall Study|Other reason|0|||
161000432|NCT01811706|581387090|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
161000433|NCT01811706|581387091|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
161000434|NCT03557008|581387092|FG000|Overall Study|Withdrawal by Subject|2|||
161000435|NCT03557008|581387093|FG001|Overall Study|Withdrawal by Subject|2|||
161000436|NCT03557008|581387092|FG000|Overall Study|Early termination from study|3|||
161000437|NCT03557008|581387093|FG001|Overall Study|Early termination from study|1|||
161000438|NCT01458210|581387094|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
161000439|NCT01458210|581387094|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
161000440|NCT01458210|581387094|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
161000441|NCT01458210|581387094|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
161000442|NCT02224924|581387097|FG000|Overall Study|Withdrawal by Subject|7|||
161000443|NCT02224924|581387098|FG001|Overall Study|Withdrawal by Subject|6|||
161000444|NCT02224924|581387097|FG000|Overall Study|Biopsy cancelled|20|||
161000445|NCT02224924|581387098|FG001|Overall Study|Biopsy cancelled|14|||
161000446|NCT02224924|581387097|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
161000447|NCT02224924|581387098|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
161000448|NCT02224924|581387097|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
161000449|NCT02224924|581387098|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
161000450|NCT03020745|581387099|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000451|NCT03020745|581387100|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000452|NCT03020745|581387101|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000453|NCT03020745|581387102|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000454|NCT03020745|581387103|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000455|NCT03020745|581387104|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000456|NCT03020745|581387105|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000457|NCT03020745|581387106|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000458|NCT03020745|581387107|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
161000459|NCT03020745|581387108|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000460|NCT03020745|581387099|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000461|NCT03020745|581387100|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
160950120|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
160950121|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
161000462|NCT03020745|581387101|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000463|NCT03020745|581387102|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000464|NCT03020745|581387103|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000465|NCT03020745|581387104|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000466|NCT03020745|581387105|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000467|NCT03020745|581387106|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
161000468|NCT03020745|581387107|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000469|NCT03020745|581387108|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
160950122|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
161000470|NCT03020745|581387099|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000471|NCT03020745|581387100|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
160950123|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
160656224|NCT00264797|580122376|FG000|Overall Study|Moved from area|3|||
160656225|NCT00264797|580122377|FG001|Overall Study|Moved from area|1|||
160950124|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
160950125|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
160950126|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Death|0|||
160950127|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Death|0|||
160950128|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Death|0|||
160950129|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Death|0|||
160950130|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Death|0|||
160950131|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Death|0|||
160950132|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Death|0|||
160950133|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Death|0|||
160950134|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Death|0|||
161000472|NCT03020745|581387101|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000473|NCT03020745|581387102|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000474|NCT03020745|581387103|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000475|NCT03020745|581387104|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
161000476|NCT03020745|581387105|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000477|NCT03020745|581387106|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000478|NCT03020745|581387107|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
161000479|NCT03020745|581387108|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000480|NCT03020745|581387099|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000481|NCT03020745|581387100|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000482|NCT03020745|581387101|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000483|NCT03020745|581387102|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000484|NCT03020745|581387103|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000485|NCT03020745|581387104|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000486|NCT03020745|581387105|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000487|NCT03020745|581387106|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000488|NCT03020745|581387107|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
160950135|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Death|0|||
160950136|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Death|0|||
160950137|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Death|0|||
160950138|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Death|0|||
160950139|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Death|0|||
160950140|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Death|0|||
161000489|NCT03020745|581387108|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000490|NCT01867216|581387109|FG000|Overall Study|Withdrawal by Subject|2|||
161000491|NCT01867216|581387110|FG001|Overall Study|Withdrawal by Subject|0|||
161000492|NCT01867216|581387111|FG002|Overall Study|Withdrawal by Subject|0|||
161000493|NCT01867216|581387112|FG003|Overall Study|Withdrawal by Subject|0|||
161000494|NCT01867216|581387113|FG004|Overall Study|Withdrawal by Subject|1|||
161000495|NCT01867216|581387114|FG005|Overall Study|Withdrawal by Subject|0|||
161000496|NCT01867216|581387115|FG006|Overall Study|Withdrawal by Subject|1|||
161000497|NCT01867216|581387109|FG000|Overall Study|Physician Decision|1|||
161000498|NCT01867216|581387110|FG001|Overall Study|Physician Decision|0|||
161000499|NCT01867216|581387111|FG002|Overall Study|Physician Decision|0|||
161000500|NCT01867216|581387112|FG003|Overall Study|Physician Decision|0|||
161000501|NCT01867216|581387113|FG004|Overall Study|Physician Decision|0|||
161000502|NCT01867216|581387114|FG005|Overall Study|Physician Decision|0|||
161000503|NCT01867216|581387115|FG006|Overall Study|Physician Decision|0|||
161000504|NCT01867216|581387109|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
160656226|NCT00264797|580122376|FG000|Overall Study|Practical Problems|2|||
160656227|NCT00264797|580122377|FG001|Overall Study|Practical Problems|3|||
160656228|NCT00264797|580122376|FG000|Overall Study|Incarceration|4|||
160656229|NCT00264797|580122377|FG001|Overall Study|Incarceration|5|||
160656230|NCT00264797|580122376|FG000|Overall Study|Pressure/advice from Outsiders|1|||
160656231|NCT00264797|580122377|FG001|Overall Study|Pressure/advice from Outsiders|1|||
160656232|NCT00264797|580122376|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
160656233|NCT00264797|580122377|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
160656234|NCT00264797|580122376|FG000|Overall Study|Other|3|||
160656235|NCT00264797|580122377|FG001|Overall Study|Other|4|||
160656236|NCT03992196|580122378|FG000|Enrollment|lost to follow-up prior dosing|1|||
160656237|NCT03992196|580122379|FG001|Enrollment|lost to follow-up prior dosing|0|||
160656238|NCT03992196|580122380|FG002|Enrollment|lost to follow-up prior dosing|0|||
160656239|NCT03992196|580122378|FG000|Treatment|Protocol Violation|0|||
160656240|NCT03992196|580122379|FG001|Treatment|Protocol Violation|0|||
160656241|NCT03992196|580122380|FG002|Treatment|Protocol Violation|1|||
160656242|NCT03992196|580122378|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
160656243|NCT03992196|580122379|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
160656244|NCT03992196|580122380|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
160656245|NCT03992196|580122378|FG000|Treatment|Withdrawal due to non-compliance|0|||
160656246|NCT03992196|580122379|FG001|Treatment|Withdrawal due to non-compliance|0|||
160950141|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Death|0|||
160950142|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Death|0|||
160950143|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Death|0|||
160950144|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Death|1|||
160950145|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Death|0|||
160950146|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950147|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950148|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950149|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950150|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950151|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950152|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950153|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950154|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950155|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950156|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950157|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950158|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950159|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950160|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950161|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950162|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950163|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
160950164|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
160950165|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
160950166|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950167|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950168|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950169|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950170|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950171|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950172|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950173|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950174|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950175|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950176|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950177|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950178|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950179|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950180|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950181|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950182|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950183|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950184|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
160950185|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950186|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
160950187|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
160950188|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
160950189|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
160950190|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
160950191|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
160950192|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
160950193|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
160950194|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
160950195|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
160950196|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
160950197|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
160950198|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
160950199|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
160950200|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
160950201|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
160950202|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
160950203|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
160950204|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
160950205|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
160950206|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
160950207|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
160950208|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
160950209|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
161000505|NCT01867216|581387110|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
160582444|NCT00492856|579853620|FG001|Post-consolidation|Observation Arm|0|||
160582445|NCT00492856|579853621|FG002|Post-consolidation|Observation Arm|27|||
160950210|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
160950211|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
160950212|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
160950213|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
160950214|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
160950215|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
160950216|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
160950217|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
160950218|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
160950219|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
160950220|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
160950221|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
160950222|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
160950223|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
160950224|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
160950225|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
160950226|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950227|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950228|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950229|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950230|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950231|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950232|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950233|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950234|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950235|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950236|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950237|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950238|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950239|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950240|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950241|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950242|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950243|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
160950244|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
160950245|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
160950246|NCT02332720|581204938|FG000|Part A and Part B|Lost to Follow-up|1|||
160582446|NCT00492856|579853622|FG003|Post-consolidation|Observation Arm|0|||
160582447|NCT03987919|579853623|FG000|Overall Study|Adverse Event|1|||
160582448|NCT03987919|579853624|FG001|Overall Study|Adverse Event|4|||
160582449|NCT03987919|579853625|FG002|Overall Study|Adverse Event|1|||
160950247|NCT02332720|581204939|FG001|Part A and Part B|Lost to Follow-up|0|||
160950248|NCT02332720|581204940|FG002|Part A and Part B|Lost to Follow-up|0|||
160950249|NCT02332720|581204941|FG003|Part A and Part B|Lost to Follow-up|0|||
160950250|NCT02332720|581204942|FG004|Part A and Part B|Lost to Follow-up|0|||
160950251|NCT02332720|581204943|FG005|Part A and Part B|Lost to Follow-up|2|||
160950252|NCT02332720|581204944|FG006|Part A and Part B|Lost to Follow-up|1|||
160950253|NCT02332720|581204945|FG007|Part A and Part B|Lost to Follow-up|1|||
160950254|NCT02332720|581204946|FG008|Part A and Part B|Lost to Follow-up|0|||
160950255|NCT02332720|581204947|FG009|Part A and Part B|Lost to Follow-up|0|||
160950256|NCT02332720|581204948|FG010|Part A and Part B|Lost to Follow-up|0|||
160950257|NCT02332720|581204949|FG011|Part A and Part B|Lost to Follow-up|0|||
160950258|NCT02332720|581204950|FG012|Part A and Part B|Lost to Follow-up|0|||
160950259|NCT02332720|581204951|FG013|Part A and Part B|Lost to Follow-up|0|||
160950260|NCT02332720|581204952|FG014|Part A and Part B|Lost to Follow-up|0|||
160950261|NCT02332720|581204953|FG015|Part A and Part B|Lost to Follow-up|1|||
160950262|NCT02332720|581204954|FG016|Part A and Part B|Lost to Follow-up|0|||
160950263|NCT02332720|581204955|FG017|Part A and Part B|Lost to Follow-up|0|||
160950264|NCT02332720|581204956|FG018|Part A and Part B|Lost to Follow-up|0|||
160950265|NCT02332720|581204957|FG019|Part A and Part B|Lost to Follow-up|0|||
160950266|NCT02332720|581204958|FG020|Part A and Part B|Lost to Follow-up|0|||
160950267|NCT02332720|581204959|FG021|Part A and Part B|Lost to Follow-up|0|||
160950268|NCT02332720|581204960|FG022|Part A and Part B|Lost to Follow-up|0|||
160950269|NCT02332720|581204938|FG000|Part A and Part B|Adverse Event|0|||
160950270|NCT02332720|581204939|FG001|Part A and Part B|Adverse Event|0|||
160950271|NCT02332720|581204940|FG002|Part A and Part B|Adverse Event|0|||
160950272|NCT02332720|581204941|FG003|Part A and Part B|Adverse Event|0|||
160582450|NCT03987919|579853626|FG003|Overall Study|Adverse Event|3|||
160950273|NCT02332720|581204942|FG004|Part A and Part B|Adverse Event|0|||
160950274|NCT02332720|581204943|FG005|Part A and Part B|Adverse Event|0|||
160950275|NCT02332720|581204944|FG006|Part A and Part B|Adverse Event|0|||
160950276|NCT02332720|581204945|FG007|Part A and Part B|Adverse Event|0|||
160950277|NCT02332720|581204946|FG008|Part A and Part B|Adverse Event|0|||
160950278|NCT02332720|581204947|FG009|Part A and Part B|Adverse Event|0|||
160950279|NCT02332720|581204948|FG010|Part A and Part B|Adverse Event|0|||
160950280|NCT02332720|581204949|FG011|Part A and Part B|Adverse Event|0|||
160950281|NCT02332720|581204950|FG012|Part A and Part B|Adverse Event|0|||
160950282|NCT02332720|581204951|FG013|Part A and Part B|Adverse Event|0|||
160950283|NCT02332720|581204952|FG014|Part A and Part B|Adverse Event|0|||
160950284|NCT02332720|581204953|FG015|Part A and Part B|Adverse Event|0|||
160950285|NCT02332720|581204954|FG016|Part A and Part B|Adverse Event|0|||
160950286|NCT02332720|581204955|FG017|Part A and Part B|Adverse Event|1|||
160950287|NCT02332720|581204956|FG018|Part A and Part B|Adverse Event|0|||
160950288|NCT02332720|581204957|FG019|Part A and Part B|Adverse Event|0|||
160950289|NCT02332720|581204958|FG020|Part A and Part B|Adverse Event|0|||
160950290|NCT02332720|581204959|FG021|Part A and Part B|Adverse Event|0|||
160950291|NCT02332720|581204960|FG022|Part A and Part B|Adverse Event|0|||
160950292|NCT02332720|581204938|FG000|Part A and Part B|Physician Decision|0|||
160950293|NCT02332720|581204939|FG001|Part A and Part B|Physician Decision|0|||
160950294|NCT02332720|581204940|FG002|Part A and Part B|Physician Decision|0|||
160950295|NCT02332720|581204941|FG003|Part A and Part B|Physician Decision|0|||
160950296|NCT02332720|581204942|FG004|Part A and Part B|Physician Decision|0|||
160950297|NCT02332720|581204943|FG005|Part A and Part B|Physician Decision|0|||
160950298|NCT02332720|581204944|FG006|Part A and Part B|Physician Decision|0|||
160950299|NCT02332720|581204945|FG007|Part A and Part B|Physician Decision|0|||
160950300|NCT02332720|581204946|FG008|Part A and Part B|Physician Decision|0|||
160950301|NCT02332720|581204947|FG009|Part A and Part B|Physician Decision|0|||
160950302|NCT02332720|581204948|FG010|Part A and Part B|Physician Decision|0|||
160950303|NCT02332720|581204949|FG011|Part A and Part B|Physician Decision|0|||
160950304|NCT02332720|581204950|FG012|Part A and Part B|Physician Decision|0|||
160950305|NCT02332720|581204951|FG013|Part A and Part B|Physician Decision|0|||
160950306|NCT02332720|581204952|FG014|Part A and Part B|Physician Decision|0|||
161000506|NCT01867216|581387111|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161000507|NCT01867216|581387112|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161000508|NCT01867216|581387113|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161000509|NCT01867216|581387114|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161000510|NCT01867216|581387115|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161000511|NCT00186186|581387116|FG000|Overall Study|Lack of Efficacy|3|||
161000512|NCT00186186|581387116|FG000|Overall Study|Withdrawal by Subject|3|||
161000513|NCT00186186|581387116|FG000|Overall Study|Not reported as to reason|2|||
161000514|NCT02567656|581387120|FG000|Overall Study|Premature discontinuation due to PD|1|||
161000515|NCT02567656|581387121|FG001|Overall Study|Premature discontinuation due to PD|1|||
161000516|NCT02567656|581387122|FG002|Overall Study|Premature discontinuation due to PD|2|||
161000517|NCT02567656|581387123|FG003|Overall Study|Premature discontinuation due to PD|0|||
161000518|NCT02567656|581387124|FG004|Overall Study|Premature discontinuation due to PD|0|||
161000519|NCT02567656|581387125|FG005|Overall Study|Premature discontinuation due to PD|0|||
161000520|NCT01616654|581387126|FG000|Overall Study|Lack of Efficacy|1|||
161000521|NCT01616654|581387127|FG001|Overall Study|Lack of Efficacy|0|||
161000522|NCT01616654|581387128|FG002|Overall Study|Lack of Efficacy|0|||
161000523|NCT01616654|581387129|FG003|Overall Study|Lack of Efficacy|0|||
161000524|NCT01616654|581387130|FG004|Overall Study|Lack of Efficacy|1|||
161000525|NCT01616654|581387126|FG000|Overall Study|Adverse Event|0|||
161000526|NCT01616654|581387127|FG001|Overall Study|Adverse Event|1|||
161000527|NCT01616654|581387128|FG002|Overall Study|Adverse Event|2|||
160456827|NCT04999111|579403582|FG000|Overall Study|Physician Decision|1|||
160456828|NCT04999111|579403583|FG001|Overall Study|Physician Decision|3|||
160456829|NCT04999111|579403584|FG002|Overall Study|Physician Decision|0|||
160456830|NCT04999111|579403585|FG003|Overall Study|Physician Decision|1|||
160456831|NCT04999111|579403586|FG004|Overall Study|Physician Decision|2|||
160456832|NCT04999111|579403587|FG005|Overall Study|Physician Decision|0|||
160456833|NCT04999111|579403582|FG000|Overall Study|Withdrawal by Subject|23|||
160456834|NCT04999111|579403583|FG001|Overall Study|Withdrawal by Subject|29|||
160456835|NCT04999111|579403584|FG002|Overall Study|Withdrawal by Subject|15|||
160456836|NCT04999111|579403585|FG003|Overall Study|Withdrawal by Subject|30|||
160456837|NCT04999111|579403586|FG004|Overall Study|Withdrawal by Subject|35|||
160656247|NCT03992196|580122380|FG002|Treatment|Withdrawal due to non-compliance|1|||
160950307|NCT02332720|581204953|FG015|Part A and Part B|Physician Decision|0|||
160950308|NCT02332720|581204954|FG016|Part A and Part B|Physician Decision|0|||
160950309|NCT02332720|581204955|FG017|Part A and Part B|Physician Decision|0|||
160950310|NCT02332720|581204956|FG018|Part A and Part B|Physician Decision|1|||
160950311|NCT02332720|581204957|FG019|Part A and Part B|Physician Decision|0|||
160950312|NCT02332720|581204958|FG020|Part A and Part B|Physician Decision|0|||
161000528|NCT01616654|581387129|FG003|Overall Study|Adverse Event|1|||
161000529|NCT01616654|581387130|FG004|Overall Study|Adverse Event|0|||
161000530|NCT01616654|581387126|FG000|Overall Study|Withdrawal by Subject|2|||
161000531|NCT01616654|581387127|FG001|Overall Study|Withdrawal by Subject|2|||
160456838|NCT04999111|579403587|FG005|Overall Study|Withdrawal by Subject|10|||
160456839|NCT04999111|579403582|FG000|Overall Study|Other|6|||
160456840|NCT04999111|579403583|FG001|Overall Study|Other|6|||
160456841|NCT04999111|579403584|FG002|Overall Study|Other|3|||
160456842|NCT04999111|579403585|FG003|Overall Study|Other|8|||
160456843|NCT04999111|579403586|FG004|Overall Study|Other|8|||
160456844|NCT04999111|579403587|FG005|Overall Study|Other|5|||
160456845|NCT04999111|579403582|FG000|Overall Study|Non-compliance with study schedule|1|||
160456846|NCT04999111|579403583|FG001|Overall Study|Non-compliance with study schedule|0|||
160456847|NCT04999111|579403584|FG002|Overall Study|Non-compliance with study schedule|0|||
160456848|NCT04999111|579403585|FG003|Overall Study|Non-compliance with study schedule|1|||
160456849|NCT04999111|579403586|FG004|Overall Study|Non-compliance with study schedule|1|||
160456850|NCT04999111|579403587|FG005|Overall Study|Non-compliance with study schedule|1|||
160456851|NCT04999111|579403582|FG000|Overall Study|Randomized but not vaccinated|1|||
160582451|NCT03987919|579853623|FG000|Overall Study|Death|4|||
160582452|NCT03987919|579853624|FG001|Overall Study|Death|4|||
160950313|NCT02332720|581204959|FG021|Part A and Part B|Physician Decision|0|||
160950314|NCT02332720|581204960|FG022|Part A and Part B|Physician Decision|0|||
160950315|NCT02332720|581204938|FG000|Part A and Part B|Withdrawal by Subject|0|||
160950316|NCT02332720|581204939|FG001|Part A and Part B|Withdrawal by Subject|0|||
160950317|NCT02332720|581204940|FG002|Part A and Part B|Withdrawal by Subject|0|||
160950318|NCT02332720|581204941|FG003|Part A and Part B|Withdrawal by Subject|0|||
160950319|NCT02332720|581204942|FG004|Part A and Part B|Withdrawal by Subject|0|||
160950320|NCT02332720|581204943|FG005|Part A and Part B|Withdrawal by Subject|1|||
160950321|NCT02332720|581204944|FG006|Part A and Part B|Withdrawal by Subject|0|||
160950322|NCT02332720|581204945|FG007|Part A and Part B|Withdrawal by Subject|0|||
160950323|NCT02332720|581204946|FG008|Part A and Part B|Withdrawal by Subject|0|||
160950324|NCT02332720|581204947|FG009|Part A and Part B|Withdrawal by Subject|0|||
160950325|NCT02332720|581204948|FG010|Part A and Part B|Withdrawal by Subject|0|||
160950326|NCT02332720|581204949|FG011|Part A and Part B|Withdrawal by Subject|0|||
160950327|NCT02332720|581204950|FG012|Part A and Part B|Withdrawal by Subject|0|||
160950328|NCT02332720|581204951|FG013|Part A and Part B|Withdrawal by Subject|0|||
160950329|NCT02332720|581204952|FG014|Part A and Part B|Withdrawal by Subject|0|||
160950330|NCT02332720|581204953|FG015|Part A and Part B|Withdrawal by Subject|0|||
160950331|NCT02332720|581204954|FG016|Part A and Part B|Withdrawal by Subject|0|||
160950332|NCT02332720|581204955|FG017|Part A and Part B|Withdrawal by Subject|0|||
160950333|NCT02332720|581204956|FG018|Part A and Part B|Withdrawal by Subject|0|||
160950334|NCT02332720|581204957|FG019|Part A and Part B|Withdrawal by Subject|1|||
160950335|NCT02332720|581204958|FG020|Part A and Part B|Withdrawal by Subject|0|||
160950336|NCT02332720|581204959|FG021|Part A and Part B|Withdrawal by Subject|0|||
160950337|NCT02332720|581204960|FG022|Part A and Part B|Withdrawal by Subject|0|||
160950338|NCT05732454|581204961|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
160950339|NCT05732454|581204962|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
160950340|NCT05732454|581204961|FG000|Part 1: DB Period|Adverse Event|1|||
160950341|NCT05732454|581204962|FG001|Part 1: DB Period|Adverse Event|0|||
160950342|NCT05732454|581204961|FG000|Part 1: DB Period|Lost to Follow-up|1|||
160950343|NCT05732454|581204962|FG001|Part 1: DB Period|Lost to Follow-up|0|||
160950344|NCT05732454|581204961|FG000|Part 1: DB Period|Protocol Violation|0|||
160950345|NCT05732454|581204962|FG001|Part 1: DB Period|Protocol Violation|1|||
160950346|NCT05732454|581204961|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
160950347|NCT05732454|581204962|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
160950348|NCT05732454|581204961|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
160950349|NCT05732454|581204962|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
160950350|NCT05732454|581204961|FG000|Part 1: OLE Period|Adverse Event|0|||
160950351|NCT05732454|581204962|FG001|Part 1: OLE Period|Adverse Event|1|||
160950352|NCT05732454|581204961|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
160950353|NCT05732454|581204962|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
160950354|NCT00838110|581204965|FG000|Overall Study|Death|0|||
160582453|NCT03987919|579853625|FG002|Overall Study|Death|4|||
160582454|NCT03987919|579853626|FG003|Overall Study|Death|1|||
160582455|NCT03987919|579853623|FG000|Overall Study|Lost to Follow-up|5|||
160582456|NCT03987919|579853624|FG001|Overall Study|Lost to Follow-up|6|||
160950355|NCT00838110|581204966|FG001|Overall Study|Death|0|||
160950356|NCT00838110|581204967|FG002|Overall Study|Death|1|||
160950357|NCT00838110|581204968|FG003|Overall Study|Death|2|||
160950358|NCT00838110|581204965|FG000|Overall Study|Adverse Event|11|||
160950359|NCT00838110|581204966|FG001|Overall Study|Adverse Event|10|||
160950360|NCT00838110|581204967|FG002|Overall Study|Adverse Event|8|||
160456852|NCT04999111|579403583|FG001|Overall Study|Randomized but not vaccinated|2|||
160456853|NCT04999111|579403584|FG002|Overall Study|Randomized but not vaccinated|0|||
160456854|NCT04999111|579403585|FG003|Overall Study|Randomized but not vaccinated|3|||
160582457|NCT03987919|579853625|FG002|Overall Study|Lost to Follow-up|8|||
160582458|NCT03987919|579853626|FG003|Overall Study|Lost to Follow-up|12|||
160950361|NCT00838110|581204968|FG003|Overall Study|Adverse Event|7|||
160950362|NCT00838110|581204965|FG000|Overall Study|Withdrawal by Subject|5|||
160950363|NCT00838110|581204966|FG001|Overall Study|Withdrawal by Subject|6|||
160950364|NCT00838110|581204967|FG002|Overall Study|Withdrawal by Subject|3|||
160950365|NCT00838110|581204968|FG003|Overall Study|Withdrawal by Subject|4|||
160456855|NCT04999111|579403586|FG004|Overall Study|Randomized but not vaccinated|3|||
160950366|NCT00838110|581204965|FG000|Overall Study|Other|3|||
160950367|NCT00838110|581204966|FG001|Overall Study|Other|3|||
160950368|NCT00838110|581204967|FG002|Overall Study|Other|3|||
160950369|NCT00838110|581204968|FG003|Overall Study|Other|2|||
160950370|NCT00838110|581204965|FG000|Overall Study|Protocol Violation|0|||
160950371|NCT00838110|581204966|FG001|Overall Study|Protocol Violation|2|||
160950372|NCT00838110|581204967|FG002|Overall Study|Protocol Violation|1|||
160950373|NCT00838110|581204968|FG003|Overall Study|Protocol Violation|1|||
160950374|NCT00838110|581204965|FG000|Overall Study|Lost to Follow-up|3|||
160950375|NCT00838110|581204966|FG001|Overall Study|Lost to Follow-up|0|||
160950376|NCT00838110|581204967|FG002|Overall Study|Lost to Follow-up|0|||
160950377|NCT00838110|581204968|FG003|Overall Study|Lost to Follow-up|0|||
160950378|NCT00838110|581204965|FG000|Overall Study|Did not meet eligibility criteria|0|||
160950379|NCT00838110|581204966|FG001|Overall Study|Did not meet eligibility criteria|0|||
160950380|NCT00838110|581204967|FG002|Overall Study|Did not meet eligibility criteria|1|||
160950381|NCT00838110|581204968|FG003|Overall Study|Did not meet eligibility criteria|2|||
160950382|NCT00838110|581204965|FG000|Overall Study|Randomized but not treated|0|||
160950383|NCT00838110|581204966|FG001|Overall Study|Randomized but not treated|1|||
160950384|NCT00838110|581204967|FG002|Overall Study|Randomized but not treated|0|||
160950385|NCT00838110|581204968|FG003|Overall Study|Randomized but not treated|0|||
160950386|NCT00352365|581204969|FG000|Induction Therapy|Adverse Event|7|||
160950387|NCT00352365|581204969|FG000|Induction Therapy|Progression/Relapse|8|||
160950388|NCT00352365|581204969|FG000|Induction Therapy|Death|7|||
160950389|NCT00352365|581204969|FG000|Induction Therapy|Not protocol specified|1|||
160950390|NCT00352365|581204969|FG000|Induction Therapy|Not eligible|3|||
160950391|NCT00352365|581204969|FG000|Induction Therapy|Death before starting protocol therapy|1|||
160950392|NCT00352365|581204969|FG000|Maintenance Therapy|Progression/Relapse|3|||
160950393|NCT00352365|581204969|FG000|Maintenance Therapy|Death|2|||
160950394|NCT00352365|581204969|FG000|Maintenance Therapy|Not protocol specified|3|||
160950395|NCT00352365|581204969|FG000|Maintenance Therapy|Not eligible|4|||
160950396|NCT01262651|581204970|FG000|Overall Study|Adverse Event|40|||
160950397|NCT01262651|581204971|FG001|Overall Study|Adverse Event|35|||
160950398|NCT01262651|581204970|FG000|Overall Study|Withdrawal by Subject|15|||
160950399|NCT01262651|581204971|FG001|Overall Study|Withdrawal by Subject|11|||
160950400|NCT01262651|581204970|FG000|Overall Study|Withdrawal by Investigator|2|||
160950401|NCT01262651|581204971|FG001|Overall Study|Withdrawal by Investigator|2|||
160950402|NCT01262651|581204970|FG000|Overall Study|Met Withdrawal Criteria|1|||
160950403|NCT01262651|581204971|FG001|Overall Study|Met Withdrawal Criteria|0|||
160950404|NCT04743908|581204972|FG000|Overall Study|Death|1|||
160950405|NCT04743908|581204973|FG001|Overall Study|Death|0|||
160950406|NCT04743908|581204972|FG000|Overall Study|Lost to Follow-up|181|||
160950407|NCT04743908|581204973|FG001|Overall Study|Lost to Follow-up|180|||
160950408|NCT04743908|581204972|FG000|Overall Study|Withdrawal by Subject|1|||
160950409|NCT04743908|581204973|FG001|Overall Study|Withdrawal by Subject|2|||
160950410|NCT03822533|581204974|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
160950411|NCT03822533|581204975|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
160950412|NCT03822533|581204974|FG000|3 Month Follow-up|Lost to Follow-up|2|||
160950413|NCT03822533|581204975|FG001|3 Month Follow-up|Lost to Follow-up|2|||
160950414|NCT03822533|581204974|FG000|6 Month Follow-up|Lost to Follow-up|3|||
160950415|NCT03822533|581204975|FG001|6 Month Follow-up|Lost to Follow-up|0|||
160950416|NCT03822533|581204974|FG000|12 Month Follow-up|Lost to Follow-up|2|||
160950417|NCT03822533|581204975|FG001|12 Month Follow-up|Lost to Follow-up|3|||
160950418|NCT03822533|581204974|FG000|12 Month Follow-up|Pregnancy|0|||
160950419|NCT03822533|581204975|FG001|12 Month Follow-up|Pregnancy|1|||
160950420|NCT03822533|581204974|FG000|12 Month Follow-up|Surgery|2|||
160950421|NCT03822533|581204975|FG001|12 Month Follow-up|Surgery|0|||
160950422|NCT03822533|581204974|FG000|12 Month Follow-up|Wrong address|1|||
160950423|NCT03822533|581204975|FG001|12 Month Follow-up|Wrong address|0|||
160950424|NCT03822533|581204974|FG000|12 Month Follow-up|No symptoms|1|||
160950425|NCT03822533|581204975|FG001|12 Month Follow-up|No symptoms|0|||
160950426|NCT03822533|581204974|FG000|12 Month Follow-up|Changed primary care center|0|||
160950427|NCT03822533|581204975|FG001|12 Month Follow-up|Changed primary care center|1|||
160950428|NCT02261363|581204978|FG000|Overall Study|Lost to Follow-up|21|||
160950429|NCT01517802|581204979|FG000|Overall Study|Death|1|||
160456856|NCT04999111|579403587|FG005|Overall Study|Randomized but not vaccinated|0|||
160950430|NCT02605954|581204980|FG000|Overall Study|Adverse Event|5|||
160950431|NCT02605954|581204981|FG001|Overall Study|Adverse Event|1|||
160950432|NCT02605954|581204980|FG000|Overall Study|Investigator's Discretion|1|||
160950433|NCT02605954|581204981|FG001|Overall Study|Investigator's Discretion|0|||
160950434|NCT02605954|581204980|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160950435|NCT02605954|581204981|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160950436|NCT02605954|581204980|FG000|Overall Study|Withdrew Consent|2|||
160950437|NCT02605954|581204981|FG001|Overall Study|Withdrew Consent|2|||
160950438|NCT02605954|581204980|FG000|Overall Study|Lost to Follow-up|3|||
160950439|NCT02605954|581204981|FG001|Overall Study|Lost to Follow-up|0|||
160950440|NCT02605954|581204980|FG000|Overall Study|Randomized but not treated|0|||
160950441|NCT02605954|581204981|FG001|Overall Study|Randomized but not treated|1|||
161000532|NCT01616654|581387128|FG002|Overall Study|Withdrawal by Subject|3|||
161000533|NCT01616654|581387129|FG003|Overall Study|Withdrawal by Subject|1|||
161000534|NCT01616654|581387130|FG004|Overall Study|Withdrawal by Subject|5|||
161000535|NCT01616654|581387126|FG000|Overall Study|Protocol Violation|0|||
161000536|NCT01616654|581387127|FG001|Overall Study|Protocol Violation|5|||
161000537|NCT01616654|581387128|FG002|Overall Study|Protocol Violation|2|||
161000538|NCT01616654|581387129|FG003|Overall Study|Protocol Violation|4|||
161000539|NCT01616654|581387130|FG004|Overall Study|Protocol Violation|4|||
161000540|NCT01616654|581387126|FG000|Overall Study|Lost to Follow-up|1|||
161000541|NCT01616654|581387127|FG001|Overall Study|Lost to Follow-up|0|||
161000542|NCT01616654|581387128|FG002|Overall Study|Lost to Follow-up|3|||
161000543|NCT01616654|581387129|FG003|Overall Study|Lost to Follow-up|2|||
161000544|NCT01616654|581387130|FG004|Overall Study|Lost to Follow-up|1|||
161000545|NCT01616654|581387126|FG000|Overall Study|Pregnancy|1|||
161000546|NCT01616654|581387127|FG001|Overall Study|Pregnancy|0|||
161000547|NCT01616654|581387128|FG002|Overall Study|Pregnancy|0|||
161000548|NCT01616654|581387129|FG003|Overall Study|Pregnancy|0|||
161000549|NCT01616654|581387130|FG004|Overall Study|Pregnancy|1|||
161000550|NCT02057692|581387131|FG000|Overall Study|Adverse Event|1|||
161000551|NCT02057692|581387132|FG001|Overall Study|Adverse Event|0|||
161000552|NCT02057692|581387133|FG002|Overall Study|Adverse Event|0|||
161000553|NCT02057692|581387134|FG003|Overall Study|Adverse Event|0|||
161000554|NCT02057692|581387131|FG000|Overall Study|Lost to Follow-up|0|||
161000555|NCT02057692|581387132|FG001|Overall Study|Lost to Follow-up|0|||
161000556|NCT02057692|581387133|FG002|Overall Study|Lost to Follow-up|0|||
161000557|NCT02057692|581387134|FG003|Overall Study|Lost to Follow-up|1|||
161000558|NCT03923491|581387135|FG000|Overall Study|Lost to Follow-up|5|||
161000559|NCT03923491|581387136|FG001|Overall Study|Lost to Follow-up|8|||
161000560|NCT03923491|581387135|FG000|Overall Study|Withdrawal by Subject|4|||
161000561|NCT03923491|581387136|FG001|Overall Study|Withdrawal by Subject|6|||
161000562|NCT03622580|581387141|FG000|Overall Study|Death|16|||
161000563|NCT03622580|581387142|FG001|Overall Study|Death|21|||
161000564|NCT03622580|581387143|FG002|Overall Study|Death|13|||
161000565|NCT03622580|581387141|FG000|Overall Study|Adverse Event|6|||
161000566|NCT03622580|581387142|FG001|Overall Study|Adverse Event|6|||
161000567|NCT03622580|581387143|FG002|Overall Study|Adverse Event|5|||
161000568|NCT03622580|581387141|FG000|Overall Study|Withdrawal by Subject|12|||
161000569|NCT03622580|581387142|FG001|Overall Study|Withdrawal by Subject|7|||
161000570|NCT03622580|581387143|FG002|Overall Study|Withdrawal by Subject|19|||
161000571|NCT03622580|581387141|FG000|Overall Study|Lost to Follow-up|12|||
161000572|NCT03622580|581387142|FG001|Overall Study|Lost to Follow-up|9|||
161000573|NCT03622580|581387143|FG002|Overall Study|Lost to Follow-up|9|||
161000574|NCT03622580|581387141|FG000|Overall Study|Protocol Violation|1|||
161000575|NCT03622580|581387142|FG001|Overall Study|Protocol Violation|0|||
161000576|NCT03622580|581387143|FG002|Overall Study|Protocol Violation|1|||
161000577|NCT03622580|581387141|FG000|Overall Study|Physician Decision|3|||
161000578|NCT03622580|581387142|FG001|Overall Study|Physician Decision|0|||
161000579|NCT03622580|581387143|FG002|Overall Study|Physician Decision|1|||
161000580|NCT03622580|581387141|FG000|Overall Study|Pregnancy|0|||
161000581|NCT03622580|581387142|FG001|Overall Study|Pregnancy|1|||
161000582|NCT03622580|581387143|FG002|Overall Study|Pregnancy|0|||
161000583|NCT03622580|581387141|FG000|Overall Study|Lack of Efficacy|0|||
161000584|NCT03622580|581387142|FG001|Overall Study|Lack of Efficacy|0|||
161000585|NCT03622580|581387143|FG002|Overall Study|Lack of Efficacy|1|||
161000586|NCT03622580|581387141|FG000|Overall Study|Other|2|||
161000587|NCT03622580|581387142|FG001|Overall Study|Other|0|||
161000588|NCT03622580|581387143|FG002|Overall Study|Other|3|||
161000589|NCT03959241|581387148|FG000|Overall Study|Withdrawal by Subject|7|||
161000590|NCT03959241|581387149|FG001|Overall Study|Withdrawal by Subject|8|||
161000591|NCT03959241|581387148|FG000|Overall Study|Lost to Follow-up|1|||
161000592|NCT03959241|581387149|FG001|Overall Study|Lost to Follow-up|0|||
161000593|NCT03959241|581387148|FG000|Overall Study|Move to Hospice Care|1|||
161000594|NCT03959241|581387149|FG001|Overall Study|Move to Hospice Care|0|||
161000595|NCT03959241|581387148|FG000|Overall Study|Screen Failure|1|||
161000596|NCT03959241|581387149|FG001|Overall Study|Screen Failure|0|||
161000597|NCT03959241|581387148|FG000|Overall Study|Disease Relapse|0|||
161000598|NCT03959241|581387149|FG001|Overall Study|Disease Relapse|1|||
161000599|NCT03959241|581387148|FG000|Overall Study|Off Study|1|||
161000600|NCT03959241|581387149|FG001|Overall Study|Off Study|0|||
161000601|NCT00943735|581387150|FG000|Overall Study|Adverse Event|12|||
161000602|NCT00943735|581387150|FG000|Overall Study|Withdrawal by Subject|8|||
161000603|NCT00943735|581387150|FG000|Overall Study|Death|1|||
161000604|NCT00943735|581387150|FG000|Overall Study|Other|8|||
161000605|NCT00943735|581387150|FG000|Overall Study|Other|3|||
161000606|NCT00545844|581387151|FG000|Overall Study|Lost to Follow-up|9|||
161000607|NCT00545844|581387151|FG000|Overall Study|Protocol Violation|1|||
161000608|NCT00545844|581387151|FG000|Overall Study|Withdrawal by Subject|2|||
161000609|NCT01329328|581387152|FG000|Overall Study|Withdrawal by Subject|2|||
161000610|NCT01329328|581387153|FG001|Overall Study|Withdrawal by Subject|4|||
161000611|NCT01329328|581387154|FG002|Overall Study|Withdrawal by Subject|3|||
161000612|NCT01565928|581387155|FG000|Overall Study|Adverse Event|3|||
160950442|NCT00455195|581204982|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
160950443|NCT00455195|581204983|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
160950444|NCT00455195|581204982|FG000|Double-blind Study AGLU02704|Death|1|||
160950445|NCT00455195|581204983|FG001|Double-blind Study AGLU02704|Death|0|||
160950446|NCT00455195|581204982|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
160950447|NCT00455195|581204983|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
160950448|NCT00455195|581204982|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
160950449|NCT00455195|581204983|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
160950450|NCT02117570|581204984|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
160950451|NCT02117570|581204985|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
160950452|NCT02117570|581204986|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
160950453|NCT02117570|581204984|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
160950454|NCT02117570|581204985|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
160950455|NCT02117570|581204986|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
160950456|NCT02117570|581204984|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
160950457|NCT02117570|581204985|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
160950458|NCT02117570|581204986|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
160950459|NCT02117570|581204984|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
160950460|NCT02117570|581204985|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
160950461|NCT02117570|581204986|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
160950462|NCT02117570|581204984|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
160950463|NCT02117570|581204985|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
160950464|NCT02117570|581204986|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
160950465|NCT02117570|581204984|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
160950466|NCT02117570|581204985|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
160950467|NCT02117570|581204986|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
160950468|NCT02117570|581204984|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
160950469|NCT02117570|581204985|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
160950470|NCT02117570|581204986|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
160950471|NCT02148250|581204987|FG000|Screening|Withdrawal by Subject|5|||
160950472|NCT02148250|581204988|FG001|Screening|Withdrawal by Subject|0|||
160950473|NCT01286779|581204989|FG000|Overall Study|Withdrawal by Subject|9|||
160950474|NCT01286779|581204989|FG000|Overall Study|Protocol Violation|5|||
160950475|NCT01286779|581204989|FG000|Overall Study|Physician Decision|2|||
160950476|NCT01286779|581204989|FG000|Overall Study|Participant had scheduled surgery|1|||
160950477|NCT01286779|581204989|FG000|Overall Study|Participant moved to another country|1|||
160950478|NCT01286779|581204989|FG000|Overall Study|Discontinued by sponsor|1|||
160950479|NCT00563784|581204990|FG000|Overall Study|Withdrawal by Subject|2|||
160582459|NCT03987919|579853623|FG000|Overall Study|Physician Decision|0|||
160950480|NCT00563784|581204990|FG000|Overall Study|Screen Failures|20|||
160950481|NCT04004611|581204991|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950482|NCT04004611|581204992|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950483|NCT04004611|581204993|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950484|NCT04004611|581204994|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950485|NCT04004611|581204995|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950486|NCT04004611|581204996|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950487|NCT04004611|581204997|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950488|NCT04004611|581204998|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950489|NCT04004611|581204999|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
160950490|NCT04004611|581204991|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950491|NCT04004611|581204992|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950492|NCT04004611|581204993|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950493|NCT04004611|581204994|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950494|NCT04004611|581204995|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950495|NCT04004611|581204996|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
160950496|NCT04004611|581204997|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
160950497|NCT04004611|581204998|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950498|NCT04004611|581204999|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
161000613|NCT01565928|581387155|FG000|Overall Study|Other|3|||
161000614|NCT01565928|581387155|FG000|Overall Study|Progressive Disease|13|||
161000615|NCT01565928|581387155|FG000|Overall Study|Withdrawal by Subject|1|||
161000616|NCT01565928|581387155|FG000|Overall Study|Death|2|||
161000617|NCT01191788|581387157|FG000|Overall Study|Lost to Follow-up|21|||
160582460|NCT03987919|579853624|FG001|Overall Study|Physician Decision|2|||
160582461|NCT03987919|579853625|FG002|Overall Study|Physician Decision|0|||
160950499|NCT04004611|581204991|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950500|NCT04004611|581204992|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950501|NCT04004611|581204993|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161000618|NCT01191788|581387158|FG001|Overall Study|Lost to Follow-up|22|||
160456857|NCT04999111|579403582|FG000|Overall Study|Adverse Event|1|||
160456858|NCT04999111|579403583|FG001|Overall Study|Adverse Event|1|||
160456859|NCT04999111|579403584|FG002|Overall Study|Adverse Event|0|||
160456860|NCT04999111|579403585|FG003|Overall Study|Adverse Event|0|||
160456861|NCT04999111|579403586|FG004|Overall Study|Adverse Event|0|||
160456862|NCT04999111|579403587|FG005|Overall Study|Adverse Event|0|||
160456863|NCT04999111|579403582|FG000|Overall Study|Initiated prohibited medication|0|||
160456864|NCT04999111|579403583|FG001|Overall Study|Initiated prohibited medication|0|||
160456865|NCT04999111|579403584|FG002|Overall Study|Initiated prohibited medication|0|||
160456866|NCT04999111|579403585|FG003|Overall Study|Initiated prohibited medication|0|||
160456867|NCT04999111|579403586|FG004|Overall Study|Initiated prohibited medication|1|||
160456868|NCT04999111|579403587|FG005|Overall Study|Initiated prohibited medication|0|||
160456869|NCT03714815|579403588|FG000|Overall Study|Physician Decision|2|||
160456870|NCT03714815|579403588|FG000|Overall Study|Withdrawal by Subject|2|||
160456871|NCT03714815|579403588|FG000|Overall Study|Death|11|||
160456872|NCT04056611|579403597|FG000|Overall Study|Physician Decision|1|||
160456873|NCT03733925|579403598|FG000|Overall Study|Lost to Follow-up|1|||
160456874|NCT03733925|579403598|FG000|Overall Study|Withdrawal by Subject|2|||
160456875|NCT03733925|579403598|FG000|Overall Study|Adverse Event|2|||
160456876|NCT03733925|579403598|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160456877|NCT03213873|579403599|FG000|Overall Study|Withdrawal by Subject|8|||
160950502|NCT04004611|581204994|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160456878|NCT03213873|579403600|FG001|Overall Study|Withdrawal by Subject|9|||
160456879|NCT03213873|579403599|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
160456880|NCT03213873|579403600|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
160456881|NCT03213873|579403599|FG000|Overall Study|Lost to Follow-up|0|||
160456882|NCT03213873|579403600|FG001|Overall Study|Lost to Follow-up|2|||
160456883|NCT03824366|579403617|FG000|Overall Study|Death|1|||
160456884|NCT03824366|579403617|FG000|Overall Study|Previously unidentified metal artifact|1|||
160456885|NCT03824366|579403617|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
160456886|NCT03824366|579403617|FG000|Overall Study|Withdrawal by Subject|1|||
160456887|NCT05533190|579403622|FG000|Overall Study|Lost to Follow-up|19|||
160456888|NCT05533190|579403623|FG001|Overall Study|Lost to Follow-up|7|||
160950503|NCT04004611|581204995|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
160950504|NCT04004611|581204996|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950505|NCT04004611|581204997|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950506|NCT04004611|581204998|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950507|NCT04004611|581204999|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950508|NCT04004611|581204991|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
160950509|NCT04004611|581204992|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
160950510|NCT04004611|581204993|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
160950511|NCT04004611|581204994|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
160950512|NCT04004611|581204995|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
160950513|NCT04004611|581204996|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
160950514|NCT04004611|581204997|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
160950515|NCT04004611|581204998|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
160950516|NCT04004611|581204999|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
160950517|NCT04004611|581204991|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
160950518|NCT04004611|581204992|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950519|NCT04004611|581204993|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
160950520|NCT04004611|581204994|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950521|NCT04004611|581204995|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950522|NCT04004611|581204996|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950523|NCT04004611|581204997|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950524|NCT04004611|581204998|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950525|NCT04004611|581204999|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950526|NCT04004611|581204991|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950527|NCT04004611|581204992|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
160950528|NCT04004611|581204993|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950529|NCT04004611|581204994|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950530|NCT04004611|581204995|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950531|NCT04004611|581204996|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950532|NCT04004611|581204997|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950533|NCT04004611|581204998|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950534|NCT04004611|581204999|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950535|NCT00304070|581205000|FG000|Overall Study|Death|0|||
160950536|NCT00304070|581205001|FG001|Overall Study|Death|0|||
160950537|NCT00304070|581205002|FG002|Overall Study|Death|3|||
160950538|NCT00304070|581205000|FG000|Overall Study|Lost to Follow-up|0|||
160456889|NCT05533190|579403622|FG000|Overall Study|Failed to download app|1|||
160950539|NCT00304070|581205001|FG001|Overall Study|Lost to Follow-up|0|||
160950540|NCT00304070|581205002|FG002|Overall Study|Lost to Follow-up|1|||
160950541|NCT00304070|581205000|FG000|Overall Study|Physician Decision|0|||
160950542|NCT00304070|581205001|FG001|Overall Study|Physician Decision|0|||
160950543|NCT00304070|581205002|FG002|Overall Study|Physician Decision|3|||
160950544|NCT00304070|581205000|FG000|Overall Study|Withdrawal by Subject|0|||
160950545|NCT00304070|581205001|FG001|Overall Study|Withdrawal by Subject|0|||
160950546|NCT00304070|581205002|FG002|Overall Study|Withdrawal by Subject|1|||
160950547|NCT00304070|581205000|FG000|Overall Study|Progressive Disease|3|||
160950548|NCT00304070|581205001|FG001|Overall Study|Progressive Disease|7|||
160950549|NCT00304070|581205002|FG002|Overall Study|Progressive Disease|4|||
160950550|NCT03950739|581205003|FG000|Treatment Phase|Adverse Event|2|||
160950551|NCT03950739|581205003|FG000|Optional Extension Phase|Death|1|||
160950552|NCT03950739|581205003|FG000|Optional Extension Phase|Progressive Disease|5|||
160950553|NCT03950739|581205003|FG000|Optional Extension Phase|Adverse Event|7|||
160950554|NCT03950739|581205003|FG000|Optional Extension Phase|Lost to Follow-up|2|||
160950555|NCT03950739|581205003|FG000|Optional Extension Phase|Site Closure|2|||
160456890|NCT05533190|579403623|FG001|Overall Study|Failed to download app|0|||
160456891|NCT05533190|579403622|FG000|Overall Study|Thought app was a scam|1|||
160950556|NCT03950739|581205003|FG000|Optional Extension Phase|Pregnancy|1|||
160950557|NCT03625570|581205004|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
160950558|NCT03625570|581205005|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
160950559|NCT03625570|581205004|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
160950560|NCT03625570|581205005|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
160950561|NCT03625570|581205004|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
160950562|NCT03625570|581205005|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
160950563|NCT00093145|581205006|FG000|Overall Study|Unacceptable Toxicity Only|2|||
160950564|NCT00093145|581205006|FG000|Overall Study|Physician Decision|5|||
160950565|NCT00093145|581205006|FG000|Overall Study|Withdrawal by Subject|9|||
160950566|NCT00093145|581205006|FG000|Overall Study|Other|1|||
160950567|NCT01175668|581205007|FG000|Overall Study|Withdrawal by Subject|2|||
160950568|NCT01175668|581205008|FG001|Overall Study|Withdrawal by Subject|0|||
160950569|NCT03359096|581205009|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
160950570|NCT03359096|581205010|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
160950571|NCT03359096|581205009|FG000|First Intervention (4 Weeks)|Death|1|||
160950572|NCT03359096|581205010|FG001|First Intervention (4 Weeks)|Death|0|||
160950573|NCT03359096|581205009|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
160950574|NCT03359096|581205010|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
160950575|NCT04102501|581205013|FG000|Overall Study|Withdrawal by Subject|7|||
160950576|NCT04102501|581205014|FG001|Overall Study|Withdrawal by Subject|9|||
160950577|NCT04102501|581205013|FG000|Overall Study|Adverse Event|1|||
160950578|NCT04102501|581205014|FG001|Overall Study|Adverse Event|3|||
160950579|NCT00968617|581205015|FG000|Overall Study|Study terminated by sponsor|6|||
160950580|NCT04433767|581205016|FG000|Overall Study|Adverse Event|1|||
160950581|NCT01434602|581205021|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
160950582|NCT01434602|581205022|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
160950583|NCT01434602|581205023|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
160950584|NCT01434602|581205024|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
160950585|NCT01434602|581205025|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
160950586|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
160950587|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
160950588|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
160950589|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
160950590|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
160950591|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
160950592|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
160950593|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
160950594|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
160950595|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
160950596|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
160950597|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
160950598|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
160950599|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
160950600|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
160456892|NCT05533190|579403623|FG001|Overall Study|Thought app was a scam|0|||
160950601|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
160950602|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
160950603|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
160950604|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
160950605|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
160950606|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
160950607|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
160950608|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
160950609|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
160950610|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
160950611|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
160950612|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
160950613|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
160950614|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
160950615|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
160950616|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
160950617|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
160950618|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
160950619|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
160950620|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
160950621|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
160950622|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
160950623|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
160950624|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
160950625|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
160950626|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
160950627|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
160950628|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
160950629|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
160950630|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
160950631|NCT03864900|581205032|FG000|Overall Study|Withdrawal by Subject|1|||
160950632|NCT03864900|581205033|FG001|Overall Study|Withdrawal by Subject|1|||
160950633|NCT03864900|581205032|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
160950634|NCT03864900|581205033|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
160950635|NCT00759109|581205036|FG000|Overall Study|Adverse Event|17|||
160950636|NCT00759109|581205037|FG001|Overall Study|Adverse Event|12|||
160950637|NCT00759109|581205036|FG000|Overall Study|Inability to comply|1|||
160950638|NCT00759109|581205037|FG001|Overall Study|Inability to comply|1|||
160950639|NCT00759109|581205036|FG000|Overall Study|Withdrawal by Subject|9|||
160950640|NCT00759109|581205037|FG001|Overall Study|Withdrawal by Subject|5|||
160950641|NCT00759109|581205036|FG000|Overall Study|Death|4|||
160950642|NCT00759109|581205037|FG001|Overall Study|Death|3|||
160950643|NCT00759109|581205036|FG000|Overall Study|Lost to Follow-up|4|||
160950644|NCT00759109|581205037|FG001|Overall Study|Lost to Follow-up|6|||
160950645|NCT00759109|581205036|FG000|Overall Study|Started new therapy|2|||
160950646|NCT00759109|581205037|FG001|Overall Study|Started new therapy|6|||
160950647|NCT00759109|581205036|FG000|Overall Study|HCV RNA negative|1|||
160950648|NCT00759109|581205037|FG001|Overall Study|HCV RNA negative|0|||
160950649|NCT00759109|581205036|FG000|Overall Study|Participant moved to a different city|0|||
160950650|NCT00759109|581205037|FG001|Overall Study|Participant moved to a different city|1|||
160950651|NCT00759109|581205036|FG000|Overall Study|Participant had a liver transplant|0|||
160950652|NCT00759109|581205037|FG001|Overall Study|Participant had a liver transplant|1|||
160950653|NCT00759109|581205036|FG000|Overall Study|Lost during study|1|||
160950654|NCT00759109|581205037|FG001|Overall Study|Lost during study|0|||
160950655|NCT03325712|581205043|FG000|Overall Study|Protocol Violation|0|||
160950656|NCT03325712|581205044|FG001|Overall Study|Protocol Violation|0|||
160950657|NCT03325712|581205045|FG002|Overall Study|Protocol Violation|0|||
160950658|NCT03325712|581205046|FG003|Overall Study|Protocol Violation|0|||
160950659|NCT03325712|581205047|FG004|Overall Study|Protocol Violation|1|||
160950660|NCT03325712|581205048|FG005|Overall Study|Protocol Violation|0|||
160950661|NCT03325712|581205049|FG006|Overall Study|Protocol Violation|0|||
160582462|NCT03987919|579853626|FG003|Overall Study|Physician Decision|4|||
160582463|NCT03987919|579853623|FG000|Overall Study|Pregnancy|1|||
160582464|NCT03987919|579853624|FG001|Overall Study|Pregnancy|0|||
160582465|NCT03987919|579853625|FG002|Overall Study|Pregnancy|1|||
160950662|NCT03325712|581205050|FG007|Overall Study|Protocol Violation|0|||
160950663|NCT03325712|581205043|FG000|Overall Study|Adverse Event|0|||
160950664|NCT03325712|581205044|FG001|Overall Study|Adverse Event|0|||
160582466|NCT03987919|579853626|FG003|Overall Study|Pregnancy|1|||
160582467|NCT03987919|579853623|FG000|Overall Study|Protocol Violation|0|||
161000619|NCT03621761|581387163|FG000|Overall Study|Lost to Follow-up|1|||
161000620|NCT03621761|581387164|FG001|Overall Study|Lost to Follow-up|1|||
161000621|NCT03621761|581387165|FG002|Overall Study|Lost to Follow-up|2|||
161000622|NCT03621761|581387163|FG000|Overall Study|Withdrawal by Subject|2|||
161000623|NCT03621761|581387164|FG001|Overall Study|Withdrawal by Subject|1|||
160950665|NCT03325712|581205045|FG002|Overall Study|Adverse Event|0|||
160950666|NCT03325712|581205046|FG003|Overall Study|Adverse Event|0|||
161000624|NCT03621761|581387165|FG002|Overall Study|Withdrawal by Subject|1|||
161000625|NCT03621761|581387163|FG000|Overall Study|Became Ineligible|0|||
161000626|NCT03621761|581387164|FG001|Overall Study|Became Ineligible|2|||
161000627|NCT03621761|581387165|FG002|Overall Study|Became Ineligible|0|||
161000628|NCT01713530|581387168|FG000|Overall Study|Adverse Event|0|||
161000629|NCT01713530|581387169|FG001|Overall Study|Adverse Event|5|||
160950667|NCT03325712|581205047|FG004|Overall Study|Adverse Event|1|||
160950668|NCT03325712|581205048|FG005|Overall Study|Adverse Event|0|||
160950669|NCT03325712|581205049|FG006|Overall Study|Adverse Event|0|||
160950670|NCT03325712|581205050|FG007|Overall Study|Adverse Event|0|||
160950671|NCT02265237|581205051|FG000|As Treated (Overall Study)|Adverse Event|1|||
160950672|NCT02265237|581205052|FG001|As Treated (Overall Study)|Adverse Event|1|||
160950673|NCT02265237|581205053|FG002|As Treated (Overall Study)|Adverse Event|0|||
160950674|NCT02265237|581205054|FG003|As Treated (Overall Study)|Adverse Event|0|||
160950675|NCT02265237|581205051|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
160950676|NCT02265237|581205052|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
160950677|NCT02265237|581205053|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
160950678|NCT02265237|581205054|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
160950679|NCT02265237|581205051|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
160950680|NCT02265237|581205052|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
160950681|NCT02265237|581205053|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
160950682|NCT02265237|581205054|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
160950683|NCT02265237|581205051|FG000|As Treated (Overall Study)|Other|2|||
160950684|NCT02265237|581205052|FG001|As Treated (Overall Study)|Other|0|||
160950685|NCT02265237|581205053|FG002|As Treated (Overall Study)|Other|3|||
160950686|NCT02265237|581205054|FG003|As Treated (Overall Study)|Other|1|||
160950687|NCT01178853|581205056|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
160950688|NCT01178853|581205057|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
160950689|NCT01178853|581205056|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
160950690|NCT01178853|581205057|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
160950691|NCT01178853|581205056|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
160950692|NCT01178853|581205057|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
160950693|NCT01178853|581205056|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
160950694|NCT01178853|581205057|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
160950695|NCT01178853|581205056|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
160950696|NCT01178853|581205057|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
160950697|NCT03550313|581205058|FG000|Overall Study|Adverse Event|0|||
160950698|NCT03550313|581205059|FG001|Overall Study|Adverse Event|1|||
160950699|NCT03550313|581205060|FG002|Overall Study|Adverse Event|0|||
160950700|NCT03550313|581205058|FG000|Overall Study|Lost to Follow-up|5|||
160950701|NCT03550313|581205059|FG001|Overall Study|Lost to Follow-up|7|||
160950702|NCT03550313|581205060|FG002|Overall Study|Lost to Follow-up|12|||
160950703|NCT03550313|581205058|FG000|Overall Study|Study terminated by sponsor|44|||
160950704|NCT03550313|581205059|FG001|Overall Study|Study terminated by sponsor|37|||
160950705|NCT03550313|581205060|FG002|Overall Study|Study terminated by sponsor|48|||
160950706|NCT03550313|581205058|FG000|Overall Study|No longer met eligibility criteria|3|||
160950707|NCT03550313|581205059|FG001|Overall Study|No longer met eligibility criteria|5|||
161000630|NCT01713530|581387168|FG000|Overall Study|Withdrawal criteria|21|||
161000631|NCT01713530|581387169|FG001|Overall Study|Withdrawal criteria|12|||
161000632|NCT01713530|581387168|FG000|Overall Study|Unclassified|4|||
161000633|NCT01713530|581387169|FG001|Overall Study|Unclassified|2|||
161000634|NCT03939819|581387170|FG000|Overall Study|Death|2|||
161000635|NCT03939819|581387171|FG001|Overall Study|Death|0|||
161000636|NCT03987451|581387172|FG000|Overall Study|Lost to Follow-up|1|||
161000637|NCT03987451|581387173|FG001|Overall Study|Lost to Follow-up|0|||
161000638|NCT03987451|581387172|FG000|Overall Study|Withdrawal by Subject|1|||
160456893|NCT05533190|579403622|FG000|Overall Study|Withdrawal by Subject|2|||
160456894|NCT05533190|579403623|FG001|Overall Study|Withdrawal by Subject|0|||
160456895|NCT01199133|579403630|FG000|Year 1|Adverse Event|16|||
160456896|NCT01199133|579403631|FG001|Year 1|Adverse Event|4|||
160950708|NCT03550313|581205060|FG002|Overall Study|No longer met eligibility criteria|6|||
160950709|NCT03550313|581205058|FG000|Overall Study|Withdrawal by parent/guardian|20|||
160950710|NCT03550313|581205059|FG001|Overall Study|Withdrawal by parent/guardian|18|||
160950711|NCT03550313|581205060|FG002|Overall Study|Withdrawal by parent/guardian|26|||
160950712|NCT03550313|581205058|FG000|Overall Study|Other|4|||
160950713|NCT03550313|581205059|FG001|Overall Study|Other|2|||
160950714|NCT03550313|581205060|FG002|Overall Study|Other|2|||
160950715|NCT03550313|581205058|FG000|Overall Study|Randomized but not vaccinated|3|||
161000639|NCT03987451|581387173|FG001|Overall Study|Withdrawal by Subject|1|||
160950716|NCT03550313|581205059|FG001|Overall Study|Randomized but not vaccinated|23|||
160950717|NCT03550313|581205060|FG002|Overall Study|Randomized but not vaccinated|2|||
160950718|NCT03550313|581205058|FG000|Overall Study|Sites terminated due to quality issues|18|||
160950719|NCT03550313|581205059|FG001|Overall Study|Sites terminated due to quality issues|17|||
160950720|NCT03550313|581205060|FG002|Overall Study|Sites terminated due to quality issues|18|||
160950721|NCT00839072|581205061|FG000|First Intervention Period|Withdrawal by Subject|1|||
160950722|NCT00839072|581205062|FG001|First Intervention Period|Withdrawal by Subject|0|||
160950723|NCT00839072|581205061|FG000|First Intervention Period|Adverse Event|1|||
160950724|NCT00839072|581205062|FG001|First Intervention Period|Adverse Event|1|||
160950725|NCT00839072|581205061|FG000|Second Intervention Period|Withdrawal by Subject|1|||
160950726|NCT00839072|581205062|FG001|Second Intervention Period|Withdrawal by Subject|0|||
160950727|NCT00380068|581205063|FG000|Overall Study|Adverse Event|40|||
160950728|NCT00380068|581205063|FG000|Overall Study|Withdrawal by Subject|10|||
160950729|NCT00380068|581205063|FG000|Overall Study|Not compliant|6|||
160950730|NCT00380068|581205063|FG000|Overall Study|Lost to Follow-up|1|||
160950731|NCT00380068|581205063|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
160950732|NCT00380068|581205063|FG000|Overall Study|Lung transplant|3|||
160950733|NCT00380068|581205063|FG000|Overall Study|Physician Decision|2|||
160950734|NCT00380068|581205063|FG000|Overall Study|Partipant moved away|1|||
160950735|NCT00380068|581205063|FG000|Overall Study|Lack of Efficacy|5|||
160950736|NCT01297062|581205064|FG000|Overall Study|Adverse Event|2|||
160950737|NCT01297062|581205065|FG001|Overall Study|Adverse Event|0|||
160950738|NCT01297062|581205066|FG002|Overall Study|Adverse Event|1|||
160950739|NCT01297062|581205067|FG003|Overall Study|Adverse Event|0|||
160950740|NCT01297062|581205068|FG004|Overall Study|Adverse Event|0|||
160950741|NCT01297062|581205069|FG005|Overall Study|Adverse Event|0|||
160950742|NCT01297062|581205070|FG006|Overall Study|Adverse Event|0|||
160950743|NCT01297062|581205064|FG000|Overall Study|Physician Decision|1|||
160950744|NCT01297062|581205065|FG001|Overall Study|Physician Decision|0|||
160950745|NCT01297062|581205066|FG002|Overall Study|Physician Decision|1|||
160950746|NCT01297062|581205067|FG003|Overall Study|Physician Decision|0|||
160950747|NCT01297062|581205068|FG004|Overall Study|Physician Decision|0|||
160950748|NCT01297062|581205069|FG005|Overall Study|Physician Decision|0|||
160950749|NCT01297062|581205070|FG006|Overall Study|Physician Decision|6|||
160950750|NCT01297062|581205064|FG000|Overall Study|Protocol Violation|0|||
160950751|NCT01297062|581205065|FG001|Overall Study|Protocol Violation|0|||
160950752|NCT01297062|581205066|FG002|Overall Study|Protocol Violation|0|||
160950753|NCT01297062|581205067|FG003|Overall Study|Protocol Violation|0|||
160950754|NCT01297062|581205068|FG004|Overall Study|Protocol Violation|1|||
160950755|NCT01297062|581205069|FG005|Overall Study|Protocol Violation|0|||
160950756|NCT01297062|581205070|FG006|Overall Study|Protocol Violation|0|||
160950757|NCT01297062|581205064|FG000|Overall Study|Subject Decision|1|||
160950758|NCT01297062|581205065|FG001|Overall Study|Subject Decision|1|||
160950759|NCT01297062|581205066|FG002|Overall Study|Subject Decision|0|||
160950760|NCT01297062|581205067|FG003|Overall Study|Subject Decision|1|||
160950761|NCT01297062|581205068|FG004|Overall Study|Subject Decision|1|||
160950762|NCT01297062|581205069|FG005|Overall Study|Subject Decision|1|||
160950763|NCT01297062|581205070|FG006|Overall Study|Subject Decision|2|||
160950764|NCT04964089|581205071|FG000|Overall Study|Adverse Event|8|||
160950765|NCT04964089|581205072|FG001|Overall Study|Adverse Event|6|||
160950766|NCT04964089|581205071|FG000|Overall Study|Non-compliance with study schedule|1|||
160950767|NCT04964089|581205072|FG001|Overall Study|Non-compliance with study schedule|0|||
160950768|NCT04964089|581205071|FG000|Overall Study|Withdrawal by Subject|6|||
160950769|NCT04964089|581205072|FG001|Overall Study|Withdrawal by Subject|5|||
160950770|NCT04964089|581205071|FG000|Overall Study|Lost to Follow-up|1|||
160950771|NCT04964089|581205072|FG001|Overall Study|Lost to Follow-up|1|||
160950772|NCT04964089|581205071|FG000|Overall Study|Progressive disease|4|||
160950773|NCT04964089|581205072|FG001|Overall Study|Progressive disease|0|||
160950774|NCT04964089|581205071|FG000|Overall Study|Physician Decision|1|||
160950775|NCT04964089|581205072|FG001|Overall Study|Physician Decision|0|||
160950776|NCT04964089|581205071|FG000|Overall Study|Participant did not want to continue study treatment|1|||
160950777|NCT04964089|581205072|FG001|Overall Study|Participant did not want to continue study treatment|0|||
160950778|NCT04964089|581205071|FG000|Overall Study|Participant moved to different state|1|||
160950779|NCT04964089|581205072|FG001|Overall Study|Participant moved to different state|0|||
160950780|NCT04964089|581205071|FG000|Overall Study|Participant decided to discontinue|0|||
160950781|NCT04964089|581205072|FG001|Overall Study|Participant decided to discontinue|1|||
160950782|NCT03191903|581205073|FG000|Overall Study|Withdrawal by Subject|6|||
160950783|NCT03191903|581205074|FG001|Overall Study|Withdrawal by Subject|5|||
160950784|NCT03191903|581205075|FG002|Overall Study|Withdrawal by Subject|4|||
160950785|NCT03191903|581205073|FG000|Overall Study|Adverse Event|1|||
160950786|NCT03191903|581205074|FG001|Overall Study|Adverse Event|0|||
160950787|NCT03191903|581205075|FG002|Overall Study|Adverse Event|0|||
160950788|NCT00503685|581205079|FG000|Overall Study|Adverse Event|0|||
160950789|NCT00503685|581205080|FG001|Overall Study|Adverse Event|0|||
160950790|NCT00503685|581205081|FG002|Overall Study|Adverse Event|2|||
160950791|NCT00503685|581205079|FG000|Overall Study|Withdrawal by Subject|0|||
161000640|NCT02441036|581387174|FG000|Overall Study|No tissue resected|0|||
160456897|NCT01199133|579403630|FG000|Year 1|Withdrawal by Subject|8|||
160456898|NCT01199133|579403631|FG001|Year 1|Withdrawal by Subject|4|||
160456899|NCT01199133|579403630|FG000|Year 1|Any other reason not above-mentioned|6|||
160456900|NCT01199133|579403631|FG001|Year 1|Any other reason not above-mentioned|7|||
160456901|NCT01199133|579403630|FG000|Year 2|Adverse Event|1|||
160456902|NCT01199133|579403631|FG001|Year 2|Adverse Event|0|||
160456903|NCT01199133|579403630|FG000|Year 2|Withdrawal by Subject|1|||
160456904|NCT01199133|579403631|FG001|Year 2|Withdrawal by Subject|1|||
160456905|NCT01199133|579403630|FG000|Year 2|Any other reason not above-mentioned|1|||
160456906|NCT01199133|579403631|FG001|Year 2|Any other reason not above-mentioned|2|||
160456907|NCT02575950|579403632|FG000|Overall Study|Withdrawal by Subject|0|||
160456908|NCT02575950|579403633|FG001|Overall Study|Withdrawal by Subject|0|||
160456909|NCT02575950|579403634|FG002|Overall Study|Withdrawal by Subject|0|||
160456910|NCT02575950|579403635|FG003|Overall Study|Withdrawal by Subject|2|||
160456911|NCT02575950|579403632|FG000|Overall Study|Lost to Follow-up|0|||
160456912|NCT02575950|579403633|FG001|Overall Study|Lost to Follow-up|1|||
160456913|NCT02575950|579403634|FG002|Overall Study|Lost to Follow-up|0|||
160456914|NCT02575950|579403635|FG003|Overall Study|Lost to Follow-up|3|||
160456915|NCT03106740|579404737|FG000|Overall Study|Lost to Follow-up|2|||
160950792|NCT00503685|581205080|FG001|Overall Study|Withdrawal by Subject|1|||
160950793|NCT00503685|581205081|FG002|Overall Study|Withdrawal by Subject|0|||
160950794|NCT00503685|581205079|FG000|Overall Study|Protocol Violation|0|||
160950795|NCT00503685|581205080|FG001|Overall Study|Protocol Violation|1|||
160950796|NCT00503685|581205081|FG002|Overall Study|Protocol Violation|0|||
160950797|NCT00503685|581205079|FG000|Overall Study|Eligibility Criteria Not Met|0|||
160950798|NCT00503685|581205080|FG001|Overall Study|Eligibility Criteria Not Met|1|||
160950799|NCT00503685|581205081|FG002|Overall Study|Eligibility Criteria Not Met|0|||
160950800|NCT00927927|581205082|FG000|Overall Study|Withdrawal by Subject|0|||
160950801|NCT00927927|581205083|FG001|Overall Study|Withdrawal by Subject|0|||
160950802|NCT00927927|581205084|FG002|Overall Study|Withdrawal by Subject|0|||
160950803|NCT00927927|581205085|FG003|Overall Study|Withdrawal by Subject|0|||
160950804|NCT00927927|581205086|FG004|Overall Study|Withdrawal by Subject|0|||
160950805|NCT00927927|581205087|FG005|Overall Study|Withdrawal by Subject|0|||
160950806|NCT00927927|581205088|FG006|Overall Study|Withdrawal by Subject|0|||
160950807|NCT00927927|581205089|FG007|Overall Study|Withdrawal by Subject|2|||
160950808|NCT00927927|581205090|FG008|Overall Study|Withdrawal by Subject|0|||
160950809|NCT00927927|581205091|FG009|Overall Study|Withdrawal by Subject|0|||
160950810|NCT00927927|581205092|FG010|Overall Study|Withdrawal by Subject|0|||
160950811|NCT00927927|581205093|FG011|Overall Study|Withdrawal by Subject|2|||
160950812|NCT00927927|581205094|FG012|Overall Study|Withdrawal by Subject|0|||
160950813|NCT00927927|581205095|FG013|Overall Study|Withdrawal by Subject|0|||
160950814|NCT00927927|581205096|FG014|Overall Study|Withdrawal by Subject|0|||
160950815|NCT03135522|581205105|FG000|Overall Study|Adverse Event|1|||
160950816|NCT03135522|581205106|FG001|Overall Study|Adverse Event|0|||
160950817|NCT03403634|581205107|FG000|Overall Study|Disease progression|3|||
160950818|NCT03403634|581205107|FG000|Overall Study|Did not meet eligibility criteria|4|||
160950819|NCT00924287|581207282|FG000|Overall Study|Death|1|||
160950820|NCT00156065|581207289|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
160950821|NCT00156065|581207290|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
160950822|NCT00156065|581207291|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
160950823|NCT00156065|581207289|FG000|Overall Study|Adverse Event|8|||
160950824|NCT00156065|581207290|FG001|Overall Study|Adverse Event|11|||
160950825|NCT00156065|581207291|FG002|Overall Study|Adverse Event|4|||
160950826|NCT00156065|581207289|FG000|Overall Study|Lack of Efficacy|2|||
160950827|NCT00156065|581207290|FG001|Overall Study|Lack of Efficacy|9|||
160950828|NCT00156065|581207291|FG002|Overall Study|Lack of Efficacy|3|||
160950829|NCT00156065|581207289|FG000|Overall Study|Withdrawal by Subject|13|||
160950830|NCT00156065|581207290|FG001|Overall Study|Withdrawal by Subject|26|||
160950831|NCT00156065|581207291|FG002|Overall Study|Withdrawal by Subject|16|||
160950832|NCT00156065|581207289|FG000|Overall Study|Lost to Follow-up|5|||
160456916|NCT03106740|579404738|FG001|Overall Study|Lost to Follow-up|2|||
160456917|NCT03106740|579404737|FG000|Overall Study|Withdrawal by Subject|2|||
160456918|NCT03106740|579404738|FG001|Overall Study|Withdrawal by Subject|4|||
160456919|NCT03106740|579404737|FG000|Overall Study|Physician Decision|0|||
160456920|NCT03106740|579404738|FG001|Overall Study|Physician Decision|1|||
160950833|NCT00156065|581207290|FG001|Overall Study|Lost to Follow-up|7|||
160950834|NCT00156065|581207291|FG002|Overall Study|Lost to Follow-up|1|||
160950835|NCT00156065|581207289|FG000|Overall Study|Other|2|||
160950836|NCT00156065|581207290|FG001|Overall Study|Other|9|||
160950837|NCT00156065|581207291|FG002|Overall Study|Other|3|||
160950838|NCT01432366|581207292|FG000|Overall Study|Non-Responder|7|||
160950839|NCT01432366|581207292|FG000|Overall Study|Adverse Event|8|||
160950840|NCT01432366|581207292|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
160950841|NCT01432366|581207292|FG000|Overall Study|Pregnancy|1|||
160950842|NCT01432366|581207292|FG000|Overall Study|Lost to Follow-up|13|||
160950843|NCT01432366|581207292|FG000|Overall Study|Lack of Efficacy|1|||
160950844|NCT01432366|581207292|FG000|Overall Study|Site Closed|20|||
161000641|NCT02441036|581387175|FG001|Overall Study|No tissue resected|1|||
160950845|NCT01432366|581207292|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
160950846|NCT01432366|581207292|FG000|Overall Study|Other|14|||
160950847|NCT02395120|581207293|FG000|Overall Study|Missed follow-up dental exam|57|||
160950848|NCT02395120|581207294|FG001|Overall Study|Missed follow-up dental exam|62|||
160950849|NCT02395120|581207295|FG002|Overall Study|Missed follow-up dental exam|6|||
160950850|NCT02395120|581207296|FG003|Overall Study|Missed follow-up dental exam|6|||
160950851|NCT02395120|581207297|FG004|Overall Study|Missed follow-up dental exam|51|||
160950852|NCT04546581|581207299|FG000|Overall Study|Adverse Event|9|||
160950853|NCT04546581|581207300|FG001|Overall Study|Adverse Event|3|||
160950854|NCT04546581|581207299|FG000|Overall Study|Physician Decision|0|||
160950855|NCT04546581|581207300|FG001|Overall Study|Physician Decision|1|||
160950856|NCT04546581|581207299|FG000|Overall Study|Protocol Violation|1|||
160950857|NCT04546581|581207300|FG001|Overall Study|Protocol Violation|2|||
160950858|NCT04546581|581207299|FG000|Overall Study|Withdrawal by Subject|3|||
160950859|NCT04546581|581207300|FG001|Overall Study|Withdrawal by Subject|7|||
160950860|NCT02526693|581207301|FG000|Overall Study|Physician Decision|3|||
160950861|NCT02526693|581207302|FG001|Overall Study|Physician Decision|1|||
160950862|NCT01798927|581207303|FG000|Overall Study|Withdrawal by Subject|1|||
160950863|NCT01159691|581207304|FG000|Overall Study|Lost to Follow-up|2|||
160950864|NCT01159691|581207304|FG000|Overall Study|Unknown reasons|1|||
160950865|NCT01159691|581207304|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
160950866|NCT01159691|581207304|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
160950867|NCT01159691|581207304|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
160950868|NCT01159691|581207304|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
160950869|NCT01159691|581207304|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
160950870|NCT01159691|581207304|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
160950871|NCT04579757|581207315|FG000|Overall Study|Adverse Event|0|||
160950872|NCT04579757|581207316|FG001|Overall Study|Adverse Event|0|||
160950873|NCT04579757|581207317|FG002|Overall Study|Adverse Event|0|||
160950874|NCT04579757|581207318|FG003|Overall Study|Adverse Event|2|||
160950875|NCT04579757|581207319|FG004|Overall Study|Adverse Event|1|||
160950876|NCT04579757|581207320|FG005|Overall Study|Adverse Event|1|||
160950877|NCT04579757|581207321|FG006|Overall Study|Adverse Event|0|||
160950878|NCT04579757|581207322|FG007|Overall Study|Adverse Event|0|||
160950879|NCT04579757|581207323|FG008|Overall Study|Adverse Event|0|||
160950880|NCT04579757|581207315|FG000|Overall Study|Death|4|||
160950881|NCT04579757|581207316|FG001|Overall Study|Death|1|||
160950882|NCT04579757|581207317|FG002|Overall Study|Death|14|||
160950883|NCT04579757|581207318|FG003|Overall Study|Death|3|||
160950884|NCT04579757|581207319|FG004|Overall Study|Death|2|||
160950885|NCT04579757|581207320|FG005|Overall Study|Death|7|||
160950886|NCT04579757|581207321|FG006|Overall Study|Death|0|||
160950887|NCT04579757|581207322|FG007|Overall Study|Death|1|||
160950888|NCT04579757|581207323|FG008|Overall Study|Death|3|||
160950889|NCT04579757|581207315|FG000|Overall Study|Physician Decision|0|||
160950890|NCT04579757|581207316|FG001|Overall Study|Physician Decision|0|||
160950891|NCT04579757|581207317|FG002|Overall Study|Physician Decision|0|||
160950892|NCT04579757|581207318|FG003|Overall Study|Physician Decision|2|||
160950893|NCT04579757|581207319|FG004|Overall Study|Physician Decision|1|||
160950894|NCT04579757|581207320|FG005|Overall Study|Physician Decision|1|||
160950895|NCT04579757|581207321|FG006|Overall Study|Physician Decision|1|||
160950896|NCT04579757|581207322|FG007|Overall Study|Physician Decision|0|||
160950897|NCT04579757|581207323|FG008|Overall Study|Physician Decision|0|||
160950898|NCT04579757|581207315|FG000|Overall Study|Study Terminated By Sponsor|0|||
160950899|NCT04579757|581207316|FG001|Overall Study|Study Terminated By Sponsor|0|||
160950900|NCT04579757|581207317|FG002|Overall Study|Study Terminated By Sponsor|0|||
160950901|NCT04579757|581207318|FG003|Overall Study|Study Terminated By Sponsor|0|||
161000642|NCT02441036|581387176|FG002|Overall Study|No tissue resected|0|||
161000643|NCT02441036|581387177|FG003|Overall Study|No tissue resected|1|||
160950902|NCT04579757|581207319|FG004|Overall Study|Study Terminated By Sponsor|2|||
160950903|NCT04579757|581207320|FG005|Overall Study|Study Terminated By Sponsor|0|||
160950904|NCT04579757|581207321|FG006|Overall Study|Study Terminated By Sponsor|0|||
160950905|NCT04579757|581207322|FG007|Overall Study|Study Terminated By Sponsor|2|||
160950906|NCT04579757|581207323|FG008|Overall Study|Study Terminated By Sponsor|0|||
160950907|NCT04579757|581207315|FG000|Overall Study|Withdrawal by Subject|1|||
160950908|NCT04579757|581207316|FG001|Overall Study|Withdrawal by Subject|1|||
161000644|NCT02441036|581387178|FG004|Overall Study|No tissue resected|0|||
160656248|NCT03992196|580122378|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
160950909|NCT04579757|581207317|FG002|Overall Study|Withdrawal by Subject|0|||
160950910|NCT04579757|581207318|FG003|Overall Study|Withdrawal by Subject|0|||
160950911|NCT04579757|581207319|FG004|Overall Study|Withdrawal by Subject|2|||
160950912|NCT04579757|581207320|FG005|Overall Study|Withdrawal by Subject|1|||
160950913|NCT04579757|581207321|FG006|Overall Study|Withdrawal by Subject|0|||
160950914|NCT04579757|581207322|FG007|Overall Study|Withdrawal by Subject|3|||
160950915|NCT04579757|581207323|FG008|Overall Study|Withdrawal by Subject|0|||
160950916|NCT04579757|581207315|FG000|Overall Study|Radiological or Clinical PD|1|||
160950917|NCT04579757|581207316|FG001|Overall Study|Radiological or Clinical PD|4|||
160950918|NCT04579757|581207317|FG002|Overall Study|Radiological or Clinical PD|1|||
160950919|NCT04579757|581207318|FG003|Overall Study|Radiological or Clinical PD|3|||
160950920|NCT04579757|581207319|FG004|Overall Study|Radiological or Clinical PD|9|||
160950921|NCT04579757|581207320|FG005|Overall Study|Radiological or Clinical PD|4|||
160950922|NCT04579757|581207321|FG006|Overall Study|Radiological or Clinical PD|2|||
160950923|NCT04579757|581207322|FG007|Overall Study|Radiological or Clinical PD|2|||
160950924|NCT04579757|581207323|FG008|Overall Study|Radiological or Clinical PD|0|||
160950925|NCT04579757|581207315|FG000|Overall Study|Start of New Therapy|0|||
160950926|NCT04579757|581207316|FG001|Overall Study|Start of New Therapy|0|||
160950927|NCT04579757|581207317|FG002|Overall Study|Start of New Therapy|0|||
160950928|NCT04579757|581207318|FG003|Overall Study|Start of New Therapy|0|||
160950929|NCT04579757|581207319|FG004|Overall Study|Start of New Therapy|2|||
160950930|NCT04579757|581207320|FG005|Overall Study|Start of New Therapy|1|||
160950931|NCT04579757|581207321|FG006|Overall Study|Start of New Therapy|0|||
160950932|NCT04579757|581207322|FG007|Overall Study|Start of New Therapy|0|||
160950933|NCT04579757|581207323|FG008|Overall Study|Start of New Therapy|0|||
160950934|NCT01153633|581207324|FG000|Overall Study|Protocol Violation|1|||
160950935|NCT01153633|581207325|FG001|Overall Study|Protocol Violation|1|||
160950936|NCT01153633|581207324|FG000|Overall Study|Therapeutic failure|3|||
160950937|NCT01153633|581207325|FG001|Overall Study|Therapeutic failure|3|||
160950938|NCT00384085|581207326|FG000|Overall Study|Adverse Event|5|||
160950939|NCT00384085|581207327|FG001|Overall Study|Adverse Event|5|||
160950940|NCT00384085|581207328|FG002|Overall Study|Adverse Event|4|||
160950941|NCT00384085|581207326|FG000|Overall Study|Lack of Efficacy|0|||
160950942|NCT00384085|581207327|FG001|Overall Study|Lack of Efficacy|3|||
160950943|NCT00384085|581207328|FG002|Overall Study|Lack of Efficacy|2|||
160950944|NCT00384085|581207326|FG000|Overall Study|No longer Requires Study Treatment|1|||
160950945|NCT00384085|581207327|FG001|Overall Study|No longer Requires Study Treatment|0|||
160950946|NCT00384085|581207328|FG002|Overall Study|No longer Requires Study Treatment|1|||
160950947|NCT00384085|581207326|FG000|Overall Study|Protocol Violation|2|||
160950948|NCT00384085|581207327|FG001|Overall Study|Protocol Violation|2|||
160950949|NCT00384085|581207328|FG002|Overall Study|Protocol Violation|2|||
160950950|NCT00384085|581207326|FG000|Overall Study|Lost to Follow-up|9|||
160950951|NCT00384085|581207327|FG001|Overall Study|Lost to Follow-up|9|||
160950952|NCT00384085|581207328|FG002|Overall Study|Lost to Follow-up|10|||
160950953|NCT00384085|581207326|FG000|Overall Study|Progressive Disease|0|||
160950954|NCT00384085|581207327|FG001|Overall Study|Progressive Disease|1|||
160950955|NCT00384085|581207328|FG002|Overall Study|Progressive Disease|0|||
160950956|NCT00384085|581207326|FG000|Overall Study|Withdrawal by Subject|14|||
160950957|NCT00384085|581207327|FG001|Overall Study|Withdrawal by Subject|19|||
160950958|NCT00384085|581207328|FG002|Overall Study|Withdrawal by Subject|29|||
160950959|NCT00384085|581207326|FG000|Overall Study|Patient non-compliant|4|||
160950960|NCT00384085|581207327|FG001|Overall Study|Patient non-compliant|4|||
160950961|NCT00384085|581207328|FG002|Overall Study|Patient non-compliant|5|||
160950962|NCT00384085|581207326|FG000|Overall Study|Physician Decision|1|||
160950963|NCT00384085|581207327|FG001|Overall Study|Physician Decision|0|||
160950964|NCT00384085|581207328|FG002|Overall Study|Physician Decision|0|||
160950965|NCT00384085|581207326|FG000|Overall Study|Loss of site personnel|1|||
160950966|NCT00384085|581207327|FG001|Overall Study|Loss of site personnel|0|||
160950967|NCT00384085|581207328|FG002|Overall Study|Loss of site personnel|1|||
160950968|NCT00384085|581207326|FG000|Overall Study|Sponsor decision|1|||
160950969|NCT00384085|581207327|FG001|Overall Study|Sponsor decision|2|||
160950970|NCT00384085|581207328|FG002|Overall Study|Sponsor decision|1|||
160950971|NCT00384085|581207326|FG000|Overall Study|Patient moved|1|||
160950972|NCT00384085|581207327|FG001|Overall Study|Patient moved|0|||
160950973|NCT00384085|581207328|FG002|Overall Study|Patient moved|1|||
160950974|NCT00384085|581207326|FG000|Overall Study|Patient required surgery|0|||
160950975|NCT00384085|581207327|FG001|Overall Study|Patient required surgery|1|||
160950976|NCT00384085|581207328|FG002|Overall Study|Patient required surgery|0|||
160950977|NCT05912400|581207329|FG000|Overall Study|Lost to Follow-up|1|||
160950978|NCT05912400|581207330|FG001|Overall Study|Lost to Follow-up|0|||
160950979|NCT05912400|581207329|FG000|Overall Study|Physician Decision|6|||
160950980|NCT05912400|581207330|FG001|Overall Study|Physician Decision|0|||
160950981|NCT05912400|581207329|FG000|Overall Study|Withdrawal by Subject|1|||
160950982|NCT05912400|581207330|FG001|Overall Study|Withdrawal by Subject|0|||
160950983|NCT01944631|581207334|FG000|Overall Study|Adverse Event|1|||
160950984|NCT01944631|581207335|FG001|Overall Study|Adverse Event|0|||
160950985|NCT01944631|581207334|FG000|Overall Study|Lost to Follow-up|3|||
160950986|NCT01944631|581207335|FG001|Overall Study|Lost to Follow-up|1|||
160950987|NCT01944631|581207334|FG000|Overall Study|Withdrawal by Subject|0|||
160950988|NCT01944631|581207335|FG001|Overall Study|Withdrawal by Subject|1|||
160950989|NCT01843192|581207336|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
160950990|NCT01843192|581207337|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
160950991|NCT01843192|581207338|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
161000645|NCT00079183|581387181|FG000|Overall Study|Withdrawal by Subject|4|||
160950992|NCT00328510|581207341|FG000|Overall Study|Gag disorder, could not use frame|4|||
160950993|NCT00328510|581207342|FG001|Overall Study|Gag disorder, could not use frame|0|||
160582468|NCT03987919|579853624|FG001|Overall Study|Protocol Violation|1|||
160950994|NCT00328510|581207341|FG000|Overall Study|Dentition problems, could not use frame|1|||
160950995|NCT00328510|581207342|FG001|Overall Study|Dentition problems, could not use frame|0|||
160950996|NCT00328510|581207341|FG000|Overall Study|Withdrawal by Subject|4|||
160950997|NCT00328510|581207342|FG001|Overall Study|Withdrawal by Subject|2|||
160950998|NCT00328510|581207341|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
160950999|NCT00328510|581207342|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
160951000|NCT00328510|581207341|FG000|Overall Study|Treatment changed to a single fraction|1|||
160951001|NCT00328510|581207342|FG001|Overall Study|Treatment changed to a single fraction|1|||
160951002|NCT01412944|581207343|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
160951003|NCT01412944|581207344|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
160951004|NCT01412944|581207345|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
160951005|NCT01412944|581207346|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
160951006|NCT01412944|581207347|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
160951007|NCT01412944|581207348|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
160951008|NCT01412944|581207343|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
160951009|NCT01412944|581207344|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
160951010|NCT01412944|581207345|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
160951011|NCT01412944|581207346|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
160951012|NCT01412944|581207347|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
160951013|NCT01412944|581207348|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
160582469|NCT03987919|579853625|FG002|Overall Study|Protocol Violation|0|||
160582470|NCT03987919|579853626|FG003|Overall Study|Protocol Violation|0|||
160582471|NCT03987919|579853623|FG000|Overall Study|Site terminated by Sponsor|0|||
160951014|NCT01412944|581207343|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
160951015|NCT01412944|581207344|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
160951016|NCT01412944|581207345|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
160951017|NCT01412944|581207346|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
160951018|NCT01412944|581207347|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
160951019|NCT01412944|581207348|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
160951020|NCT01412944|581207343|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
160951021|NCT01412944|581207344|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
160951022|NCT01412944|581207345|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
160951023|NCT01412944|581207346|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
160951024|NCT01412944|581207347|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
160951025|NCT01412944|581207348|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
160951026|NCT01412944|581207343|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
160951027|NCT01412944|581207344|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
160951028|NCT01412944|581207345|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
160951029|NCT01412944|581207346|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
160951030|NCT01412944|581207347|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
160951031|NCT01412944|581207348|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
160951032|NCT01412944|581207343|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
160951033|NCT01412944|581207344|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
160951034|NCT01412944|581207345|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
160951035|NCT01412944|581207346|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
160951036|NCT01412944|581207347|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
160951037|NCT01412944|581207348|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
160951038|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951039|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951040|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
160951041|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
160951042|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
160951043|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951044|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Adverse Event|0|||
160951045|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Adverse Event|0|||
160951046|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Adverse Event|0|||
160951047|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Adverse Event|0|||
160951048|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Adverse Event|1|||
160951049|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Adverse Event|0|||
160951050|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
160951051|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
160951052|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
160951053|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
160951054|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
160951055|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
160951056|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951057|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951058|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
160456921|NCT03106740|579404737|FG000|Overall Study|Partial data|1|||
160456922|NCT03106740|579404738|FG001|Overall Study|Partial data|0|||
160456923|NCT04565990|579404739|FG000|Overall Study|Death|5|||
160456924|NCT04565990|579404739|FG000|Overall Study|Lost to Follow-up|1|||
160456925|NCT04565990|579404739|FG000|Overall Study|Withdrawal by Subject|1|||
160456926|NCT04797858|579404740|FG000|Overall Study|Withdrawal by Subject|0|||
160456927|NCT04797858|579404741|FG001|Overall Study|Withdrawal by Subject|1|||
160456928|NCT04797858|579404740|FG000|Overall Study|Excluded due to administrative error|7|||
160456929|NCT04797858|579404741|FG001|Overall Study|Excluded due to administrative error|8|||
160456930|NCT04766892|579404745|FG000|Overall Study|Withdrawal by Subject|1|||
160456931|NCT04766892|579404745|FG000|Overall Study|Lost to Follow-up|1|||
160456932|NCT04766892|579404745|FG000|Overall Study|Adverse Event|3|||
160456933|NCT04766892|579404745|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
160456934|NCT04359654|579404746|FG000|Overall Study|Withdrawal by Subject|1|||
160456935|NCT04359654|579404747|FG001|Overall Study|Withdrawal by Subject|0|||
160456936|NCT04359654|579404746|FG000|Overall Study|Adverse Event|0|||
160456937|NCT04359654|579404747|FG001|Overall Study|Adverse Event|1|||
160456938|NCT02446236|579404750|FG000|Overall Study|Screen Failure|1|||
160456939|NCT02446236|579404751|FG001|Overall Study|Screen Failure|0|||
160456940|NCT02446236|579404752|FG002|Overall Study|Screen Failure|1|||
160456941|NCT02446236|579404750|FG000|Overall Study|Actively Receiving Therapy|0|||
160456942|NCT02446236|579404751|FG001|Overall Study|Actively Receiving Therapy|0|||
160456943|NCT02446236|579404752|FG002|Overall Study|Actively Receiving Therapy|1|||
160456944|NCT04136912|579404755|FG000|Overall Study|Operational reasons|0|||
160456945|NCT04136912|579404756|FG001|Overall Study|Operational reasons|0|||
160456946|NCT04136912|579404757|FG002|Overall Study|Operational reasons|2|||
160456947|NCT03556293|579404758|FG000|Overall Study|Ineligible for analysis|1904|||
160456948|NCT03556293|579404759|FG001|Overall Study|Ineligible for analysis|1471|||
160456949|NCT03556293|579404760|FG002|Overall Study|Ineligible for analysis|1091|||
160456950|NCT03556293|579404761|FG003|Overall Study|Ineligible for analysis|1269|||
160456951|NCT03292484|579404762|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
160456952|NCT03292484|579404762|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
160456953|NCT03292484|579404762|FG000|Overall Study|Protocol Violation|2|||
160456954|NCT03292484|579404762|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
160456955|NCT03292484|579404762|FG000|Overall Study|Sponsor decision|349|||
160456956|NCT03292484|579404762|FG000|Overall Study|Lost to Follow-up|7|||
160456957|NCT03292484|579404762|FG000|Overall Study|Coronavirus Disease 2019|1|||
160456958|NCT03292484|579404762|FG000|Overall Study|Other|20|||
160456959|NCT04709419|579404763|FG000|Overall Study|Physician Decision|1|||
160456960|NCT04709419|579404764|FG001|Overall Study|Physician Decision|0|||
160456961|NCT04526886|579404766|FG000|Overall Study|Physician Decision|4|||
160456962|NCT03276676|579404769|FG000|Overall Study|Withdrawal by Subject|2|||
160456963|NCT03276676|579404770|FG001|Overall Study|Withdrawal by Subject|1|||
160456964|NCT02962076|579404772|FG000|Overall Study|MHED tracer not available|5|||
160456965|NCT02962076|579404772|FG000|Overall Study|Protocol Violation|1|||
160456966|NCT02962076|579404772|FG000|Overall Study|Physician Decision|1|||
160456967|NCT03926130|579404784|FG000|Overall Study|Adverse Event|9|||
160456968|NCT03926130|579404785|FG001|Overall Study|Adverse Event|11|||
160456969|NCT03926130|579404786|FG002|Overall Study|Adverse Event|2|||
160456970|NCT03926130|579404787|FG003|Overall Study|Adverse Event|0|||
160456971|NCT03926130|579404784|FG000|Overall Study|Death|2|||
160456972|NCT03926130|579404785|FG001|Overall Study|Death|0|||
160456973|NCT03926130|579404786|FG002|Overall Study|Death|1|||
160456974|NCT03926130|579404787|FG003|Overall Study|Death|0|||
160456975|NCT03926130|579404784|FG000|Overall Study|Lack of Efficacy|14|||
160456976|NCT03926130|579404785|FG001|Overall Study|Lack of Efficacy|11|||
160456977|NCT03926130|579404786|FG002|Overall Study|Lack of Efficacy|7|||
160456978|NCT03926130|579404787|FG003|Overall Study|Lack of Efficacy|1|||
160456979|NCT03926130|579404784|FG000|Overall Study|Lost to Follow-up|0|||
160456980|NCT03926130|579404785|FG001|Overall Study|Lost to Follow-up|7|||
160456981|NCT03926130|579404786|FG002|Overall Study|Lost to Follow-up|1|||
160456982|NCT03926130|579404787|FG003|Overall Study|Lost to Follow-up|0|||
160456983|NCT03926130|579404784|FG000|Overall Study|As Reported by Investigator|2|||
160456984|NCT03926130|579404785|FG001|Overall Study|As Reported by Investigator|6|||
160456985|NCT03926130|579404786|FG002|Overall Study|As Reported by Investigator|6|||
160456986|NCT03926130|579404787|FG003|Overall Study|As Reported by Investigator|0|||
160456987|NCT03926130|579404784|FG000|Overall Study|Physician Decision|3|||
160456988|NCT03926130|579404785|FG001|Overall Study|Physician Decision|2|||
160456989|NCT03926130|579404786|FG002|Overall Study|Physician Decision|1|||
160456990|NCT03926130|579404787|FG003|Overall Study|Physician Decision|0|||
160456991|NCT03926130|579404784|FG000|Overall Study|Pregnancy|2|||
160456992|NCT03926130|579404785|FG001|Overall Study|Pregnancy|2|||
160456993|NCT03926130|579404786|FG002|Overall Study|Pregnancy|1|||
160456994|NCT03926130|579404787|FG003|Overall Study|Pregnancy|0|||
160456995|NCT03926130|579404784|FG000|Overall Study|Withdrawal by Subject|20|||
160456996|NCT03926130|579404785|FG001|Overall Study|Withdrawal by Subject|28|||
160456997|NCT03926130|579404786|FG002|Overall Study|Withdrawal by Subject|18|||
160456998|NCT03926130|579404787|FG003|Overall Study|Withdrawal by Subject|1|||
160951059|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951060|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951061|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
160951062|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951063|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951064|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951065|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951066|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
160951067|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951068|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
160951069|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
160951070|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951071|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951072|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951073|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951074|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
160951075|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
160951076|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
160951077|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
160951078|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
160951079|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
160951080|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951081|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
160951082|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951083|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951084|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951085|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951086|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951087|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
160951088|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951089|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951090|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951091|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951092|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Adverse Event|0|||
160951093|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Adverse Event|1|||
160951094|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Adverse Event|0|||
160951095|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Adverse Event|0|||
160951096|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Adverse Event|0|||
160951097|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Adverse Event|0|||
160951098|NCT01990950|581207349|FG000|Overall Study|Death|3|||
160951099|NCT01990950|581207349|FG000|Overall Study|Lost to Follow-up|2|||
160951100|NCT01990950|581207349|FG000|Overall Study|Withdrawal by Subject|6|||
160951101|NCT02863926|581207350|FG000|Overall Study|Physician Decision|1|||
160951102|NCT02863926|581207351|FG001|Overall Study|Physician Decision|0|||
160951103|NCT02863926|581207350|FG000|Overall Study|Lost to Follow-up|1|||
160951104|NCT02863926|581207351|FG001|Overall Study|Lost to Follow-up|1|||
160951105|NCT02301143|581207354|FG000|Induction Period|Enrolled But Not Treated|1|||
160951106|NCT02301143|581207355|FG001|Induction Period|Enrolled But Not Treated|0|||
160951107|NCT02301143|581207354|FG000|Induction Period|Death|1|||
160951108|NCT02301143|581207355|FG001|Induction Period|Death|0|||
160951109|NCT02301143|581207354|FG000|Induction Period|Adverse Event|22|||
160951110|NCT02301143|581207355|FG001|Induction Period|Adverse Event|0|||
160951111|NCT02301143|581207354|FG000|Induction Period|Progressive Disease|8|||
160951112|NCT02301143|581207355|FG001|Induction Period|Progressive Disease|0|||
160951113|NCT02301143|581207354|FG000|Induction Period|Withdrawal by Subject|3|||
160951114|NCT02301143|581207355|FG001|Induction Period|Withdrawal by Subject|0|||
160951115|NCT02301143|581207354|FG000|Induction Period|Noncompliance with Study Drug|1|||
160951116|NCT02301143|581207355|FG001|Induction Period|Noncompliance with Study Drug|0|||
160951117|NCT02301143|581207354|FG000|Induction Period|Physician Decision|4|||
160951118|NCT02301143|581207355|FG001|Induction Period|Physician Decision|0|||
160951119|NCT02301143|581207354|FG000|Induction Period|Symptomatic Deterioration|2|||
160951120|NCT02301143|581207355|FG001|Induction Period|Symptomatic Deterioration|0|||
160951121|NCT02301143|581207354|FG000|Induction Period|Protocol Violation|2|||
160951122|NCT02301143|581207355|FG001|Induction Period|Protocol Violation|0|||
160951123|NCT02301143|581207354|FG000|Induction Period|Other|1|||
160582472|NCT03987919|579853624|FG001|Overall Study|Site terminated by Sponsor|0|||
160951124|NCT02301143|581207355|FG001|Induction Period|Other|0|||
160951125|NCT02301143|581207354|FG000|Investigator's Choice|Adverse Event|0|||
160951126|NCT02301143|581207355|FG001|Investigator's Choice|Adverse Event|3|||
160951127|NCT02301143|581207354|FG000|Investigator's Choice|Progressive Disease|0|||
160951128|NCT02301143|581207355|FG001|Investigator's Choice|Progressive Disease|3|||
160951129|NCT02301143|581207354|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
160951130|NCT02301143|581207355|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
160951131|NCT02301143|581207354|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
160456999|NCT03926130|579404784|FG000|Overall Study|Non-Compliance|1|||
160457000|NCT03926130|579404785|FG001|Overall Study|Non-Compliance|1|||
160457001|NCT03926130|579404786|FG002|Overall Study|Non-Compliance|0|||
160457002|NCT03926130|579404787|FG003|Overall Study|Non-Compliance|0|||
160457003|NCT03926130|579404784|FG000|Overall Study|Disposition Not Captured|0|||
160457004|NCT03926130|579404785|FG001|Overall Study|Disposition Not Captured|2|||
160457005|NCT03926130|579404786|FG002|Overall Study|Disposition Not Captured|1|||
160457006|NCT03926130|579404787|FG003|Overall Study|Disposition Not Captured|0|||
160457007|NCT03583333|579404788|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
160457008|NCT03583333|579404789|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
160457009|NCT03583333|579404788|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
160457010|NCT03583333|579404789|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
160457011|NCT03583333|579404788|FG000|Overall Study|Withdrawal by Subject|9|||
160457012|NCT03583333|579404789|FG001|Overall Study|Withdrawal by Subject|5|||
160457013|NCT03583333|579404788|FG000|Overall Study|Physician Decision|3|||
160457014|NCT03583333|579404789|FG001|Overall Study|Physician Decision|2|||
160457015|NCT03583333|579404788|FG000|Overall Study|Death|12|||
160457016|NCT03583333|579404789|FG001|Overall Study|Death|7|||
160457017|NCT05069896|579404797|FG000|Overall Study|Adverse Event|0|||
160457018|NCT05069896|579404798|FG001|Overall Study|Adverse Event|1|||
160457019|NCT05069896|579404799|FG002|Overall Study|Adverse Event|1|||
160457020|NCT05069896|579404800|FG003|Overall Study|Adverse Event|0|||
160457021|NCT05069896|579404801|FG004|Overall Study|Adverse Event|0|||
160457022|NCT05069896|579404802|FG005|Overall Study|Adverse Event|0|||
160457023|NCT05069896|579404797|FG000|Overall Study|Lost to Follow-up|0|||
160457024|NCT05069896|579404798|FG001|Overall Study|Lost to Follow-up|0|||
160457025|NCT05069896|579404799|FG002|Overall Study|Lost to Follow-up|1|||
161000646|NCT00079183|581387181|FG000|Overall Study|Study medication non-compliance|2|||
161000647|NCT00079183|581387181|FG000|Overall Study|Specimen collection non-compliance|1|||
161000648|NCT00762606|581387182|FG000|Overall Study|Lost to Follow-up|18|||
161000649|NCT00762606|581387183|FG001|Overall Study|Lost to Follow-up|13|||
161000650|NCT03257813|581387184|FG000|Overall Study|Protocol Violation|6|||
161000651|NCT03257813|581387185|FG001|Overall Study|Protocol Violation|3|||
161000652|NCT01069341|581387188|FG000|Overall Study|Lost to Follow-up|1|||
161000653|NCT03299816|581387193|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
161000654|NCT03299816|581387194|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
161000655|NCT03299816|581387193|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
160457026|NCT05069896|579404800|FG003|Overall Study|Lost to Follow-up|0|||
160457027|NCT05069896|579404801|FG004|Overall Study|Lost to Follow-up|1|||
160457028|NCT05069896|579404802|FG005|Overall Study|Lost to Follow-up|2|||
160457029|NCT04068831|579404803|FG000|Overall Study|Disease Progression|10|||
160457030|NCT04068831|579404804|FG001|Overall Study|Disease Progression|8|||
160457031|NCT03580356|579404808|FG000|Treatment Period|Withdrawal by Subject|13|||
160457032|NCT03580356|579404809|FG001|Treatment Period|Withdrawal by Subject|0|||
160457033|NCT03580356|579404810|FG002|Treatment Period|Withdrawal by Subject|13|||
160457034|NCT03580356|579404811|FG003|Treatment Period|Withdrawal by Subject|1|||
160457035|NCT03580356|579404812|FG004|Treatment Period|Withdrawal by Subject|17|||
160457036|NCT03580356|579404813|FG005|Treatment Period|Withdrawal by Subject|0|||
160457037|NCT03580356|579404814|FG006|Treatment Period|Withdrawal by Subject|5|||
160457038|NCT03580356|579404815|FG007|Treatment Period|Withdrawal by Subject|0|||
160457039|NCT03580356|579404808|FG000|Treatment Period|Adverse Event|10|||
160457040|NCT03580356|579404809|FG001|Treatment Period|Adverse Event|0|||
160457041|NCT03580356|579404810|FG002|Treatment Period|Adverse Event|13|||
160457042|NCT03580356|579404811|FG003|Treatment Period|Adverse Event|0|||
160457043|NCT03580356|579404812|FG004|Treatment Period|Adverse Event|5|||
160457044|NCT03580356|579404813|FG005|Treatment Period|Adverse Event|0|||
160457045|NCT03580356|579404814|FG006|Treatment Period|Adverse Event|8|||
160582473|NCT03987919|579853625|FG002|Overall Study|Site terminated by Sponsor|0|||
160582474|NCT03987919|579853626|FG003|Overall Study|Site terminated by Sponsor|1|||
160582475|NCT03987919|579853623|FG000|Overall Study|Withdrawal by Subject|7|||
160582476|NCT03987919|579853624|FG001|Overall Study|Withdrawal by Subject|7|||
160582477|NCT03987919|579853625|FG002|Overall Study|Withdrawal by Subject|8|||
160582478|NCT03987919|579853626|FG003|Overall Study|Withdrawal by Subject|4|||
160582479|NCT03987919|579853623|FG000|Overall Study|Other - as reported by the investigator|1|||
160582480|NCT03987919|579853624|FG001|Overall Study|Other - as reported by the investigator|3|||
160457046|NCT03580356|579404815|FG007|Treatment Period|Adverse Event|0|||
160457047|NCT03580356|579404808|FG000|Treatment Period|Protocol Violation|5|||
160457048|NCT03580356|579404809|FG001|Treatment Period|Protocol Violation|0|||
160656249|NCT03992196|580122379|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
160457049|NCT03580356|579404810|FG002|Treatment Period|Protocol Violation|6|||
160457050|NCT03580356|579404811|FG003|Treatment Period|Protocol Violation|1|||
160656250|NCT03992196|580122380|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
160457051|NCT03580356|579404812|FG004|Treatment Period|Protocol Violation|9|||
160457052|NCT03580356|579404813|FG005|Treatment Period|Protocol Violation|1|||
160582481|NCT03987919|579853625|FG002|Overall Study|Other - as reported by the investigator|2|||
160457053|NCT03580356|579404814|FG006|Treatment Period|Protocol Violation|1|||
160457054|NCT03580356|579404815|FG007|Treatment Period|Protocol Violation|0|||
160457055|NCT03580356|579404808|FG000|Treatment Period|Lack of Efficacy|6|||
160457056|NCT03580356|579404809|FG001|Treatment Period|Lack of Efficacy|0|||
160457057|NCT03580356|579404810|FG002|Treatment Period|Lack of Efficacy|2|||
160457058|NCT03580356|579404811|FG003|Treatment Period|Lack of Efficacy|0|||
160457059|NCT03580356|579404812|FG004|Treatment Period|Lack of Efficacy|3|||
160457060|NCT03580356|579404813|FG005|Treatment Period|Lack of Efficacy|0|||
160457061|NCT03580356|579404814|FG006|Treatment Period|Lack of Efficacy|3|||
160457062|NCT03580356|579404815|FG007|Treatment Period|Lack of Efficacy|0|||
160457063|NCT03580356|579404808|FG000|Treatment Period|Pregnancy|1|||
160457064|NCT03580356|579404809|FG001|Treatment Period|Pregnancy|0|||
160457065|NCT03580356|579404810|FG002|Treatment Period|Pregnancy|7|||
160457066|NCT03580356|579404811|FG003|Treatment Period|Pregnancy|0|||
160457067|NCT03580356|579404812|FG004|Treatment Period|Pregnancy|2|||
160457068|NCT03580356|579404813|FG005|Treatment Period|Pregnancy|0|||
160457069|NCT03580356|579404814|FG006|Treatment Period|Pregnancy|1|||
160457070|NCT03580356|579404815|FG007|Treatment Period|Pregnancy|0|||
160457071|NCT03580356|579404808|FG000|Treatment Period|Physician Decision|2|||
160457072|NCT03580356|579404809|FG001|Treatment Period|Physician Decision|0|||
160457073|NCT03580356|579404810|FG002|Treatment Period|Physician Decision|1|||
160457074|NCT03580356|579404811|FG003|Treatment Period|Physician Decision|0|||
160457075|NCT03580356|579404812|FG004|Treatment Period|Physician Decision|4|||
160457076|NCT03580356|579404813|FG005|Treatment Period|Physician Decision|0|||
160582482|NCT03987919|579853626|FG003|Overall Study|Other - as reported by the investigator|0|||
160582483|NCT03725202|579853629|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
160582484|NCT03725202|579853630|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
160582485|NCT03725202|579853631|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
160582486|NCT03725202|579853632|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
160582487|NCT03725202|579853633|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
160582488|NCT03725202|579853634|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
160582489|NCT03725202|579853635|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
160457077|NCT03580356|579404814|FG006|Treatment Period|Physician Decision|2|||
160457078|NCT03580356|579404815|FG007|Treatment Period|Physician Decision|0|||
160457079|NCT03580356|579404808|FG000|Treatment Period|Lost to Follow-up|1|||
160457080|NCT03580356|579404809|FG001|Treatment Period|Lost to Follow-up|1|||
160457081|NCT03580356|579404810|FG002|Treatment Period|Lost to Follow-up|1|||
160457082|NCT03580356|579404811|FG003|Treatment Period|Lost to Follow-up|0|||
160457083|NCT03580356|579404812|FG004|Treatment Period|Lost to Follow-up|3|||
160457084|NCT03580356|579404813|FG005|Treatment Period|Lost to Follow-up|0|||
160457085|NCT03580356|579404814|FG006|Treatment Period|Lost to Follow-up|1|||
160457086|NCT03580356|579404815|FG007|Treatment Period|Lost to Follow-up|0|||
160457087|NCT03580356|579404808|FG000|Treatment Period|Death|0|||
160457088|NCT03580356|579404809|FG001|Treatment Period|Death|0|||
160457089|NCT03580356|579404810|FG002|Treatment Period|Death|1|||
160457090|NCT03580356|579404811|FG003|Treatment Period|Death|0|||
160457091|NCT03580356|579404812|FG004|Treatment Period|Death|0|||
160457092|NCT03580356|579404813|FG005|Treatment Period|Death|0|||
160457093|NCT03580356|579404814|FG006|Treatment Period|Death|0|||
160457094|NCT03580356|579404815|FG007|Treatment Period|Death|0|||
160457095|NCT03580356|579404808|FG000|Treatment Period|Technical problems|0|||
160457096|NCT03580356|579404809|FG001|Treatment Period|Technical problems|0|||
160457097|NCT03580356|579404810|FG002|Treatment Period|Technical problems|0|||
160457098|NCT03580356|579404811|FG003|Treatment Period|Technical problems|0|||
160457099|NCT03580356|579404812|FG004|Treatment Period|Technical problems|1|||
160457100|NCT03580356|579404813|FG005|Treatment Period|Technical problems|0|||
160457101|NCT03580356|579404814|FG006|Treatment Period|Technical problems|0|||
160457102|NCT03580356|579404815|FG007|Treatment Period|Technical problems|0|||
160457103|NCT03580356|579404808|FG000|Treatment Period|Misrandomized, no treatment|0|||
160457104|NCT03580356|579404809|FG001|Treatment Period|Misrandomized, no treatment|0|||
160582490|NCT03725202|579853636|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
160582491|NCT03725202|579853629|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
160656251|NCT03992196|580122378|FG000|Treatment|Withdrawal by parent/guardian|0|||
160656252|NCT03992196|580122379|FG001|Treatment|Withdrawal by parent/guardian|0|||
160656253|NCT03992196|580122380|FG002|Treatment|Withdrawal by parent/guardian|2|||
160457105|NCT03580356|579404810|FG002|Treatment Period|Misrandomized, no treatment|1|||
160457106|NCT03580356|579404811|FG003|Treatment Period|Misrandomized, no treatment|0|||
161000656|NCT03299816|581387194|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
160457107|NCT03580356|579404812|FG004|Treatment Period|Misrandomized, no treatment|2|||
160457108|NCT03580356|579404813|FG005|Treatment Period|Misrandomized, no treatment|0|||
160457109|NCT03580356|579404814|FG006|Treatment Period|Misrandomized, no treatment|0|||
160457110|NCT03580356|579404815|FG007|Treatment Period|Misrandomized, no treatment|0|||
160656254|NCT00755196|580122382|FG000|Overall Study|Lost to Follow-up|1|||
160457111|NCT03580356|579404808|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
160582492|NCT03725202|579853630|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
160656255|NCT00755196|580122382|FG000|Overall Study|Lack of Efficiency|1|||
160457112|NCT03580356|579404809|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
160457113|NCT03580356|579404810|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
160457114|NCT03580356|579404811|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
160457115|NCT03580356|579404812|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
160457116|NCT03580356|579404813|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
160457117|NCT03580356|579404814|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
160457118|NCT03580356|579404815|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
160457119|NCT03580356|579404808|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
160457120|NCT03580356|579404809|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
160457121|NCT03580356|579404810|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
160457122|NCT03580356|579404811|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
160457123|NCT03580356|579404812|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
160457124|NCT03580356|579404813|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
160457125|NCT03580356|579404814|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
160457126|NCT03580356|579404815|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
160457127|NCT03580356|579404808|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
160457128|NCT03580356|579404809|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
160457129|NCT03580356|579404810|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
160457130|NCT03580356|579404811|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
160457131|NCT03580356|579404812|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
160457132|NCT03580356|579404813|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
160457133|NCT03580356|579404814|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
160457134|NCT03580356|579404815|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
160457135|NCT03580356|579404808|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
160457136|NCT03580356|579404809|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
160457137|NCT03580356|579404810|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
160457138|NCT03580356|579404811|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
160457139|NCT03580356|579404812|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
160457140|NCT03580356|579404813|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
160457141|NCT03580356|579404814|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
160457142|NCT03580356|579404815|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
160457143|NCT03580356|579404808|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
160457144|NCT03580356|579404809|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
160457145|NCT03580356|579404810|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
160457146|NCT03580356|579404811|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
160457147|NCT03580356|579404812|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
160457148|NCT03580356|579404813|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
160457149|NCT03580356|579404814|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
160457150|NCT03580356|579404815|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
160457151|NCT03580356|579404808|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
160457152|NCT03580356|579404809|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
160457153|NCT03580356|579404810|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
160457154|NCT03580356|579404811|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
160457155|NCT03580356|579404812|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
160457156|NCT03580356|579404813|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
160457157|NCT03580356|579404814|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
160457158|NCT03580356|579404815|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
160582493|NCT03725202|579853631|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
160582494|NCT03725202|579853632|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
160582495|NCT03725202|579853633|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
160582496|NCT03725202|579853634|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
160582497|NCT03725202|579853635|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
160582498|NCT03725202|579853636|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
160582499|NCT03725202|579853629|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
160582500|NCT03725202|579853630|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
160582501|NCT03725202|579853631|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
160582502|NCT03725202|579853632|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
160582503|NCT03725202|579853633|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
160582504|NCT03725202|579853634|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
160582505|NCT03725202|579853635|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
160951132|NCT02301143|581207355|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
160457159|NCT03580356|579404808|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
160457160|NCT03580356|579404809|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
160951133|NCT02301143|581207354|FG000|Investigator's Choice|Other|0|||
160457161|NCT03580356|579404810|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
160457162|NCT03580356|579404811|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
160457163|NCT03580356|579404812|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
160656256|NCT02388763|580122383|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
160951134|NCT02301143|581207355|FG001|Investigator's Choice|Other|1|||
160951135|NCT02301143|581207354|FG000|Investigator's Choice|Unresectable Surgery|0|||
160951136|NCT02301143|581207355|FG001|Investigator's Choice|Unresectable Surgery|1|||
160951137|NCT03214367|581207358|FG000|Lead-in Period|Withdrawal by Subject|50|||
160951138|NCT03214367|581207359|FG001|Lead-in Period|Withdrawal by Subject|0|||
160951139|NCT03214367|581207360|FG002|Lead-in Period|Withdrawal by Subject|0|||
160951140|NCT03214367|581207361|FG003|Lead-in Period|Withdrawal by Subject|0|||
160951141|NCT03214367|581207362|FG004|Lead-in Period|Withdrawal by Subject|2|||
160951142|NCT03214367|581207363|FG005|Lead-in Period|Withdrawal by Subject|0|||
160951143|NCT03214367|581207364|FG006|Lead-in Period|Withdrawal by Subject|0|||
160951144|NCT03214367|581207365|FG007|Lead-in Period|Withdrawal by Subject|0|||
160951145|NCT03214367|581207358|FG000|Lead-in Period|Adverse Event|3|||
160951146|NCT03214367|581207359|FG001|Lead-in Period|Adverse Event|0|||
160951147|NCT03214367|581207360|FG002|Lead-in Period|Adverse Event|0|||
160951148|NCT03214367|581207361|FG003|Lead-in Period|Adverse Event|0|||
160951149|NCT03214367|581207362|FG004|Lead-in Period|Adverse Event|0|||
160951150|NCT03214367|581207363|FG005|Lead-in Period|Adverse Event|0|||
160951151|NCT03214367|581207364|FG006|Lead-in Period|Adverse Event|0|||
160951152|NCT03214367|581207365|FG007|Lead-in Period|Adverse Event|0|||
160951153|NCT03214367|581207358|FG000|Lead-in Period|Lost to Follow-up|12|||
160951154|NCT03214367|581207359|FG001|Lead-in Period|Lost to Follow-up|0|||
160951155|NCT03214367|581207360|FG002|Lead-in Period|Lost to Follow-up|0|||
160951156|NCT03214367|581207361|FG003|Lead-in Period|Lost to Follow-up|0|||
160951157|NCT03214367|581207362|FG004|Lead-in Period|Lost to Follow-up|0|||
160951158|NCT03214367|581207363|FG005|Lead-in Period|Lost to Follow-up|0|||
160951159|NCT03214367|581207364|FG006|Lead-in Period|Lost to Follow-up|0|||
160951160|NCT03214367|581207365|FG007|Lead-in Period|Lost to Follow-up|0|||
160951161|NCT03214367|581207358|FG000|Lead-in Period|Sponsor Decision|11|||
160951162|NCT03214367|581207359|FG001|Lead-in Period|Sponsor Decision|0|||
160951163|NCT03214367|581207360|FG002|Lead-in Period|Sponsor Decision|0|||
160951164|NCT03214367|581207361|FG003|Lead-in Period|Sponsor Decision|0|||
160951165|NCT03214367|581207362|FG004|Lead-in Period|Sponsor Decision|0|||
160951166|NCT03214367|581207363|FG005|Lead-in Period|Sponsor Decision|0|||
160951167|NCT03214367|581207364|FG006|Lead-in Period|Sponsor Decision|0|||
160951168|NCT03214367|581207365|FG007|Lead-in Period|Sponsor Decision|0|||
160951169|NCT03214367|581207358|FG000|Lead-in Period|Physician Decision|12|||
160951170|NCT03214367|581207359|FG001|Lead-in Period|Physician Decision|0|||
160951171|NCT03214367|581207360|FG002|Lead-in Period|Physician Decision|0|||
160951172|NCT03214367|581207361|FG003|Lead-in Period|Physician Decision|0|||
160951173|NCT03214367|581207362|FG004|Lead-in Period|Physician Decision|0|||
160951174|NCT03214367|581207363|FG005|Lead-in Period|Physician Decision|0|||
160951175|NCT03214367|581207364|FG006|Lead-in Period|Physician Decision|0|||
160951176|NCT03214367|581207365|FG007|Lead-in Period|Physician Decision|0|||
160951177|NCT03214367|581207358|FG000|Lead-in Period|Protocol Violation|5|||
160951178|NCT03214367|581207359|FG001|Lead-in Period|Protocol Violation|0|||
160951179|NCT03214367|581207360|FG002|Lead-in Period|Protocol Violation|0|||
160951180|NCT03214367|581207361|FG003|Lead-in Period|Protocol Violation|0|||
160951181|NCT03214367|581207362|FG004|Lead-in Period|Protocol Violation|0|||
160951182|NCT03214367|581207363|FG005|Lead-in Period|Protocol Violation|0|||
160951183|NCT03214367|581207364|FG006|Lead-in Period|Protocol Violation|0|||
160951184|NCT03214367|581207365|FG007|Lead-in Period|Protocol Violation|0|||
160951185|NCT03214367|581207358|FG000|Lead-in Period|Treatment Interruption|1|||
160951186|NCT03214367|581207359|FG001|Lead-in Period|Treatment Interruption|0|||
160951187|NCT03214367|581207360|FG002|Lead-in Period|Treatment Interruption|0|||
160951188|NCT03214367|581207361|FG003|Lead-in Period|Treatment Interruption|0|||
160951189|NCT03214367|581207362|FG004|Lead-in Period|Treatment Interruption|0|||
160951190|NCT03214367|581207363|FG005|Lead-in Period|Treatment Interruption|0|||
160951191|NCT03214367|581207364|FG006|Lead-in Period|Treatment Interruption|0|||
160951192|NCT03214367|581207365|FG007|Lead-in Period|Treatment Interruption|0|||
160951193|NCT03214367|581207358|FG000|Treatment Period|Adverse Event|0|||
160951194|NCT03214367|581207359|FG001|Treatment Period|Adverse Event|1|||
160951195|NCT03214367|581207360|FG002|Treatment Period|Adverse Event|4|||
160951196|NCT03214367|581207361|FG003|Treatment Period|Adverse Event|2|||
160951197|NCT03214367|581207362|FG004|Treatment Period|Adverse Event|0|||
160951198|NCT03214367|581207363|FG005|Treatment Period|Adverse Event|0|||
160951199|NCT03214367|581207364|FG006|Treatment Period|Adverse Event|0|||
160951200|NCT03214367|581207365|FG007|Treatment Period|Adverse Event|0|||
160951201|NCT03214367|581207358|FG000|Treatment Period|Death|0|||
160951202|NCT03214367|581207359|FG001|Treatment Period|Death|1|||
160951203|NCT03214367|581207360|FG002|Treatment Period|Death|1|||
160951204|NCT03214367|581207361|FG003|Treatment Period|Death|1|||
160951205|NCT03214367|581207362|FG004|Treatment Period|Death|0|||
160951206|NCT03214367|581207363|FG005|Treatment Period|Death|0|||
160951207|NCT03214367|581207364|FG006|Treatment Period|Death|0|||
160951208|NCT03214367|581207365|FG007|Treatment Period|Death|0|||
160951209|NCT03214367|581207358|FG000|Treatment Period|Lost to Follow-up|0|||
160951210|NCT03214367|581207359|FG001|Treatment Period|Lost to Follow-up|5|||
160951211|NCT03214367|581207360|FG002|Treatment Period|Lost to Follow-up|3|||
160951212|NCT03214367|581207361|FG003|Treatment Period|Lost to Follow-up|2|||
160951213|NCT03214367|581207362|FG004|Treatment Period|Lost to Follow-up|0|||
161000657|NCT03299816|581387193|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
161000658|NCT03299816|581387194|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
161000659|NCT00790790|581387200|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
161000660|NCT00790790|581387201|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
161000661|NCT00790790|581387202|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
161000662|NCT00790790|581387200|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
161000663|NCT00790790|581387201|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
161000664|NCT00790790|581387202|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
161000665|NCT00790790|581387200|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
161000666|NCT00790790|581387201|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
161000667|NCT00790790|581387202|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
161000668|NCT00790790|581387200|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
161000669|NCT00790790|581387201|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
160951214|NCT03214367|581207363|FG005|Treatment Period|Lost to Follow-up|2|||
160951215|NCT03214367|581207364|FG006|Treatment Period|Lost to Follow-up|1|||
160951216|NCT03214367|581207365|FG007|Treatment Period|Lost to Follow-up|0|||
160951217|NCT03214367|581207358|FG000|Treatment Period|Sponsor Decision|0|||
160951218|NCT03214367|581207359|FG001|Treatment Period|Sponsor Decision|3|||
160951219|NCT03214367|581207360|FG002|Treatment Period|Sponsor Decision|0|||
160951220|NCT03214367|581207361|FG003|Treatment Period|Sponsor Decision|0|||
160951221|NCT03214367|581207362|FG004|Treatment Period|Sponsor Decision|0|||
160951222|NCT03214367|581207363|FG005|Treatment Period|Sponsor Decision|0|||
160951223|NCT03214367|581207364|FG006|Treatment Period|Sponsor Decision|0|||
160951224|NCT03214367|581207365|FG007|Treatment Period|Sponsor Decision|0|||
160951225|NCT03214367|581207358|FG000|Treatment Period|Physician Decision|0|||
160951226|NCT03214367|581207359|FG001|Treatment Period|Physician Decision|1|||
160951227|NCT03214367|581207360|FG002|Treatment Period|Physician Decision|2|||
161000670|NCT00790790|581387202|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
161000671|NCT00790790|581387200|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
161000672|NCT00790790|581387201|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
161000673|NCT00790790|581387202|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
161000674|NCT02194933|581387203|FG000|Overall Study|Lost to Follow-up|1|||
161000675|NCT02194933|581387204|FG001|Overall Study|Lost to Follow-up|2|||
161000676|NCT02194933|581387203|FG000|Overall Study|Participant met withdrawal criteria|1|||
161000677|NCT02194933|581387204|FG001|Overall Study|Participant met withdrawal criteria|3|||
161000678|NCT02194933|581387203|FG000|Overall Study|Withdrawal by Subject|0|||
161000679|NCT02194933|581387204|FG001|Overall Study|Withdrawal by Subject|2|||
161000680|NCT02194933|581387203|FG000|Overall Study|Lack of Efficacy|1|||
161000681|NCT02194933|581387204|FG001|Overall Study|Lack of Efficacy|2|||
161000682|NCT00756730|581387207|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
161000683|NCT00756730|581387208|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
161000684|NCT00756730|581387207|FG000|Overall Study|persistent low-level viremmia|0|||
161000685|NCT00756730|581387208|FG001|Overall Study|persistent low-level viremmia|1|||
161000686|NCT05382104|581387212|FG000|Period 2 (2 Days)|Adverse Event|0|||
161000687|NCT05382104|581387213|FG001|Period 2 (2 Days)|Adverse Event|1|||
161000688|NCT05382104|581387214|FG002|Period 2 (2 Days)|Adverse Event|0|||
161000689|NCT05382104|581387215|FG003|Period 2 (2 Days)|Adverse Event|0|||
161000690|NCT05382104|581387216|FG004|Period 2 (2 Days)|Adverse Event|0|||
161000691|NCT05382104|581387217|FG005|Period 2 (2 Days)|Adverse Event|0|||
161000692|NCT02807493|581387219|FG000|Overall Study|Adverse Event|5|||
161000693|NCT02807493|581387220|FG001|Overall Study|Adverse Event|2|||
161000694|NCT02807493|581387219|FG000|Overall Study|Lost to Follow-up|6|||
161000695|NCT02807493|581387220|FG001|Overall Study|Lost to Follow-up|0|||
161000696|NCT02807493|581387219|FG000|Overall Study|Physician Decision|4|||
161000697|NCT02807493|581387220|FG001|Overall Study|Physician Decision|1|||
161000698|NCT02807493|581387219|FG000|Overall Study|Protocol Violation|7|||
161000699|NCT02807493|581387220|FG001|Overall Study|Protocol Violation|0|||
161000700|NCT02807493|581387219|FG000|Overall Study|Withdrawal by Subject|17|||
161000701|NCT02807493|581387220|FG001|Overall Study|Withdrawal by Subject|10|||
160582506|NCT03725202|579853636|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
160582507|NCT03725202|579853629|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
160951228|NCT03214367|581207361|FG003|Treatment Period|Physician Decision|0|||
160951229|NCT03214367|581207362|FG004|Treatment Period|Physician Decision|0|||
160951230|NCT03214367|581207363|FG005|Treatment Period|Physician Decision|0|||
161000702|NCT02807493|581387219|FG000|Overall Study|Other withdrawal|17|||
161000703|NCT02807493|581387220|FG001|Overall Study|Other withdrawal|0|||
161000704|NCT02807493|581387219|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
161000705|NCT02807493|581387220|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
161000706|NCT01493778|581387221|FG000|Overall Study|Withdrawal by Subject|8|||
160582508|NCT03725202|579853630|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161000707|NCT05190419|581387222|FG000|Overall Study|Lack of Efficacy|8|||
160582509|NCT03725202|579853631|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
160632829|NCT01215955|580036087|FG002|Overall Study|Entry Criteria Not Met|4|||
160951231|NCT03214367|581207364|FG006|Treatment Period|Physician Decision|0|||
160951232|NCT03214367|581207365|FG007|Treatment Period|Physician Decision|0|||
160951233|NCT03214367|581207358|FG000|Treatment Period|Protocol Violation|0|||
160951234|NCT03214367|581207359|FG001|Treatment Period|Protocol Violation|3|||
160951235|NCT03214367|581207360|FG002|Treatment Period|Protocol Violation|0|||
160951236|NCT03214367|581207361|FG003|Treatment Period|Protocol Violation|0|||
160951237|NCT03214367|581207362|FG004|Treatment Period|Protocol Violation|0|||
160951238|NCT03214367|581207363|FG005|Treatment Period|Protocol Violation|0|||
160951239|NCT03214367|581207364|FG006|Treatment Period|Protocol Violation|0|||
160951240|NCT03214367|581207365|FG007|Treatment Period|Protocol Violation|0|||
160951241|NCT03214367|581207358|FG000|Treatment Period|Withdrawal by Subject|0|||
160951242|NCT03214367|581207359|FG001|Treatment Period|Withdrawal by Subject|20|||
160951243|NCT03214367|581207360|FG002|Treatment Period|Withdrawal by Subject|23|||
160951244|NCT03214367|581207361|FG003|Treatment Period|Withdrawal by Subject|14|||
160951245|NCT03214367|581207362|FG004|Treatment Period|Withdrawal by Subject|0|||
160951246|NCT03214367|581207363|FG005|Treatment Period|Withdrawal by Subject|1|||
160951247|NCT03214367|581207364|FG006|Treatment Period|Withdrawal by Subject|1|||
160951248|NCT03214367|581207365|FG007|Treatment Period|Withdrawal by Subject|1|||
160951249|NCT03268811|581207368|FG000|Overall Study|Adverse Event|0|||
160951250|NCT03268811|581207369|FG001|Overall Study|Adverse Event|1|||
160951251|NCT00320216|581207370|FG000|Overall Study|Adverse Event|0|||
160951252|NCT00320216|581207371|FG001|Overall Study|Adverse Event|6|||
160951253|NCT00320216|581207372|FG002|Overall Study|Adverse Event|0|||
160951254|NCT00320216|581207373|FG003|Overall Study|Adverse Event|2|||
160951255|NCT00320216|581207374|FG004|Overall Study|Adverse Event|2|||
160951256|NCT00320216|581207370|FG000|Overall Study|Lack of Efficacy|6|||
160951257|NCT00320216|581207371|FG001|Overall Study|Lack of Efficacy|2|||
160951258|NCT00320216|581207372|FG002|Overall Study|Lack of Efficacy|1|||
160951259|NCT00320216|581207373|FG003|Overall Study|Lack of Efficacy|0|||
160951260|NCT00320216|581207374|FG004|Overall Study|Lack of Efficacy|1|||
160951261|NCT00320216|581207370|FG000|Overall Study|Lost to Follow-up|3|||
160951262|NCT00320216|581207371|FG001|Overall Study|Lost to Follow-up|0|||
160951263|NCT00320216|581207372|FG002|Overall Study|Lost to Follow-up|0|||
160951264|NCT00320216|581207373|FG003|Overall Study|Lost to Follow-up|0|||
160951265|NCT00320216|581207374|FG004|Overall Study|Lost to Follow-up|0|||
160951266|NCT00320216|581207370|FG000|Overall Study|Other|7|||
160951267|NCT00320216|581207371|FG001|Overall Study|Other|2|||
160951268|NCT00320216|581207372|FG002|Overall Study|Other|5|||
160951269|NCT00320216|581207373|FG003|Overall Study|Other|1|||
160951270|NCT00320216|581207374|FG004|Overall Study|Other|3|||
160951271|NCT00779246|581207383|FG000|Overall Study|Missing sufficient data for analysis|33|||
160951272|NCT00779246|581207384|FG001|Overall Study|Missing sufficient data for analysis|53|||
160951273|NCT02844946|581207386|FG000|Overall Study|Lost to Follow-up|7|||
160951274|NCT02844946|581207387|FG001|Overall Study|Lost to Follow-up|0|||
160951275|NCT02806986|581207388|FG000|Treatment Stage 1|Adverse Event|1|||
160951276|NCT02806986|581207388|FG000|Treatment Stage 2|Adverse Event|3|||
160951277|NCT02806986|581207388|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
160951278|NCT02334748|581207390|FG000|Overall Study|Adverse Event|1|||
160951279|NCT02334748|581207390|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
160951280|NCT02334748|581207390|FG000|Overall Study|Patient no longer required study drug|2|||
160951281|NCT02334748|581207390|FG000|Overall Study|Lack of Efficacy|4|||
160951282|NCT01046643|581207391|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
160951283|NCT01046643|581207392|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
160951284|NCT01046643|581207393|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
160951285|NCT01046643|581207394|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
160951286|NCT01310036|581207395|FG000|Overall Study|Administrative/other|10|||
160951287|NCT01310036|581207395|FG000|Overall Study|Withdrew Consent|11|||
160951288|NCT01310036|581207395|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
160951289|NCT01310036|581207395|FG000|Overall Study|Progression of Disease|164|||
160951290|NCT01310036|581207395|FG000|Overall Study|Death|1|||
160951291|NCT01310036|581207395|FG000|Overall Study|Adverse event or intercurrent illness|12|||
160951292|NCT00817089|581207396|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
160951293|NCT00817089|581207397|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
160951294|NCT00817089|581207398|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
160951295|NCT00817089|581207399|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
160951296|NCT00817089|581207396|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
160951297|NCT00817089|581207397|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
160951298|NCT00817089|581207398|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
160951299|NCT00817089|581207399|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
160951300|NCT00709722|581207400|FG000|Overall Study|Adverse Event|1|||
160951301|NCT04667117|581207401|FG000|Investigational Period|Lost to Follow-up|0|||
160951302|NCT04667117|581207402|FG001|Investigational Period|Lost to Follow-up|0|||
160951303|NCT04667117|581207403|FG002|Investigational Period|Lost to Follow-up|1|||
160951304|NCT04667117|581207401|FG000|Investigational Period|Protocol Deviation|0|||
160951305|NCT04667117|581207402|FG001|Investigational Period|Protocol Deviation|1|||
160951306|NCT04667117|581207403|FG002|Investigational Period|Protocol Deviation|0|||
160951307|NCT04667117|581207401|FG000|Extension Period|Lost to Follow-up|1|||
160457164|NCT03580356|579404813|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
160457165|NCT03580356|579404814|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
160457166|NCT03580356|579404815|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
160457167|NCT05715528|579404816|FG000|Overall Study|Randomized but never treated|11|||
160457168|NCT05715528|579404817|FG001|Overall Study|Randomized but never treated|13|||
160457169|NCT05715528|579404816|FG000|Overall Study|Withdrew consent|7|||
160457170|NCT05715528|579404817|FG001|Overall Study|Withdrew consent|15|||
160457171|NCT05715528|579404816|FG000|Overall Study|Lost to Follow-up|5|||
160457172|NCT05715528|579404817|FG001|Overall Study|Lost to Follow-up|13|||
160457173|NCT05715528|579404816|FG000|Overall Study|Investigator's discretion|3|||
160457174|NCT05715528|579404817|FG001|Overall Study|Investigator's discretion|1|||
160457175|NCT05715528|579404816|FG000|Overall Study|Protocol Violation|2|||
160457176|NCT05715528|579404817|FG001|Overall Study|Protocol Violation|0|||
160457177|NCT05715528|579404816|FG000|Overall Study|Non-compliance with study drug|0|||
160457178|NCT05715528|579404817|FG001|Overall Study|Non-compliance with study drug|1|||
160457179|NCT03118518|579404818|FG000|Overall Study|Early Exit after treatment|2|||
160457180|NCT03118518|579404819|FG001|Overall Study|Early Exit after treatment|8|||
160457181|NCT03118518|579404818|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
160457182|NCT03118518|579404819|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
160457183|NCT02834390|579404820|FG000|Induction Phase|Progressive disease|0|||
160457184|NCT02834390|579404821|FG001|Induction Phase|Progressive disease|1|||
160457185|NCT02834390|579404820|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
160457186|NCT02834390|579404821|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
160457187|NCT02834390|579404820|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
160457188|NCT02834390|579404821|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
160457189|NCT02834390|579404820|FG000|Consolidation Phase|Physician Decision|1|||
160457190|NCT02834390|579404821|FG001|Consolidation Phase|Physician Decision|1|||
160457191|NCT03485729|579404829|FG000|Overall Study|Withdrawal by Subject|0|||
160457192|NCT03485729|579404830|FG001|Overall Study|Withdrawal by Subject|0|||
160457193|NCT03485729|579404831|FG002|Overall Study|Withdrawal by Subject|1|||
160457194|NCT03485729|579404829|FG000|Overall Study|Disease progression|8|||
160457195|NCT03485729|579404830|FG001|Overall Study|Disease progression|13|||
160457196|NCT03485729|579404831|FG002|Overall Study|Disease progression|1|||
160457197|NCT03485729|579404829|FG000|Overall Study|Hospice care|1|||
160951308|NCT04667117|581207402|FG001|Extension Period|Lost to Follow-up|0|||
160951309|NCT04667117|581207403|FG002|Extension Period|Lost to Follow-up|0|||
160951310|NCT01953926|581207414|FG000|Overall Study|Withdrawal by Subject|23|||
160457198|NCT03485729|579404830|FG001|Overall Study|Hospice care|0|||
160457199|NCT03485729|579404831|FG002|Overall Study|Hospice care|0|||
160457200|NCT03485729|579404829|FG000|Overall Study|Poor performance status|1|||
160457201|NCT03485729|579404830|FG001|Overall Study|Poor performance status|0|||
160457202|NCT03485729|579404831|FG002|Overall Study|Poor performance status|0|||
160457203|NCT03485729|579404829|FG000|Overall Study|Illness|0|||
160457204|NCT03485729|579404830|FG001|Overall Study|Illness|1|||
160457205|NCT03485729|579404831|FG002|Overall Study|Illness|0|||
160457206|NCT05035654|579404832|FG000|Overall Study|Physician Decision|0|||
160457207|NCT05035654|579404833|FG001|Overall Study|Physician Decision|1|||
160457208|NCT05035654|579404834|FG002|Overall Study|Physician Decision|0|||
160457209|NCT05035654|579404832|FG000|Overall Study|Adverse Event|0|||
160457210|NCT05035654|579404833|FG001|Overall Study|Adverse Event|1|||
160457211|NCT05035654|579404834|FG002|Overall Study|Adverse Event|0|||
160457212|NCT05035654|579404832|FG000|Overall Study|Withdrawal by Subject|0|||
160457213|NCT05035654|579404833|FG001|Overall Study|Withdrawal by Subject|0|||
160457214|NCT05035654|579404834|FG002|Overall Study|Withdrawal by Subject|4|||
160457215|NCT05035654|579404832|FG000|Overall Study|Bilateral Dislodgement|1|||
160457216|NCT05035654|579404833|FG001|Overall Study|Bilateral Dislodgement|0|||
160457217|NCT05035654|579404834|FG002|Overall Study|Bilateral Dislodgement|0|||
160457218|NCT05552508|579404836|FG000|Overall Study|Adverse Event|3|||
160582510|NCT03725202|579853632|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
160582511|NCT03725202|579853633|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
160951311|NCT01953926|581207415|FG001|Overall Study|Withdrawal by Subject|3|||
160951312|NCT01953926|581207416|FG002|Overall Study|Withdrawal by Subject|3|||
160951313|NCT01953926|581207417|FG003|Overall Study|Withdrawal by Subject|5|||
160457219|NCT04451772|579404838|FG000|Overall Study|Adverse Event|1|||
160457220|NCT04451772|579404839|FG001|Overall Study|Adverse Event|0|||
160951314|NCT01953926|581207418|FG004|Overall Study|Withdrawal by Subject|6|||
160951315|NCT01953926|581207419|FG005|Overall Study|Withdrawal by Subject|0|||
160951316|NCT01953926|581207420|FG006|Overall Study|Withdrawal by Subject|1|||
160457221|NCT04451772|579404840|FG002|Overall Study|Adverse Event|1|||
160457222|NCT04451772|579404841|FG003|Overall Study|Adverse Event|1|||
160457223|NCT04451772|579404842|FG004|Overall Study|Adverse Event|0|||
160457224|NCT04451772|579404843|FG005|Overall Study|Adverse Event|3|||
160457225|NCT04451772|579404838|FG000|Overall Study|Withdrawal by Subject|2|||
160457226|NCT04451772|579404839|FG001|Overall Study|Withdrawal by Subject|7|||
160457227|NCT04451772|579404840|FG002|Overall Study|Withdrawal by Subject|2|||
160951317|NCT01953926|581207414|FG000|Overall Study|Physician Decision|1|||
160951318|NCT01953926|581207415|FG001|Overall Study|Physician Decision|0|||
160951319|NCT01953926|581207416|FG002|Overall Study|Physician Decision|0|||
160951320|NCT01953926|581207417|FG003|Overall Study|Physician Decision|0|||
160951321|NCT01953926|581207418|FG004|Overall Study|Physician Decision|2|||
160951322|NCT01953926|581207419|FG005|Overall Study|Physician Decision|0|||
160951323|NCT01953926|581207420|FG006|Overall Study|Physician Decision|0|||
160951324|NCT01953926|581207414|FG000|Overall Study|Lost to Follow-up|18|||
160951325|NCT01953926|581207415|FG001|Overall Study|Lost to Follow-up|3|||
160951326|NCT01953926|581207416|FG002|Overall Study|Lost to Follow-up|0|||
160951327|NCT01953926|581207417|FG003|Overall Study|Lost to Follow-up|5|||
160951328|NCT01953926|581207418|FG004|Overall Study|Lost to Follow-up|3|||
160951329|NCT01953926|581207419|FG005|Overall Study|Lost to Follow-up|0|||
160951330|NCT01953926|581207420|FG006|Overall Study|Lost to Follow-up|0|||
160951331|NCT01953926|581207414|FG000|Overall Study|Protocol Violation|1|||
160951332|NCT01953926|581207415|FG001|Overall Study|Protocol Violation|0|||
160951333|NCT01953926|581207416|FG002|Overall Study|Protocol Violation|0|||
160951334|NCT01953926|581207417|FG003|Overall Study|Protocol Violation|0|||
160951335|NCT01953926|581207418|FG004|Overall Study|Protocol Violation|0|||
160951336|NCT01953926|581207419|FG005|Overall Study|Protocol Violation|0|||
160951337|NCT01953926|581207420|FG006|Overall Study|Protocol Violation|0|||
160951338|NCT01953926|581207414|FG000|Overall Study|Other, Disease progression|2|||
160951339|NCT01953926|581207415|FG001|Overall Study|Other, Disease progression|1|||
160951340|NCT01953926|581207416|FG002|Overall Study|Other, Disease progression|0|||
160951341|NCT01953926|581207417|FG003|Overall Study|Other, Disease progression|0|||
160951342|NCT01953926|581207418|FG004|Overall Study|Other, Disease progression|1|||
160951343|NCT01953926|581207419|FG005|Overall Study|Other, Disease progression|0|||
160951344|NCT01953926|581207420|FG006|Overall Study|Other, Disease progression|0|||
160951345|NCT01953926|581207414|FG000|Overall Study|Discontinuation of study by sponsor|41|||
160951346|NCT01953926|581207415|FG001|Overall Study|Discontinuation of study by sponsor|7|||
160951347|NCT01953926|581207416|FG002|Overall Study|Discontinuation of study by sponsor|5|||
160951348|NCT01953926|581207417|FG003|Overall Study|Discontinuation of study by sponsor|12|||
160951349|NCT01953926|581207418|FG004|Overall Study|Discontinuation of study by sponsor|46|||
160951350|NCT01953926|581207419|FG005|Overall Study|Discontinuation of study by sponsor|5|||
160951351|NCT01953926|581207420|FG006|Overall Study|Discontinuation of study by sponsor|6|||
160951352|NCT01953926|581207414|FG000|Overall Study|Not Treated|1|||
160951353|NCT01953926|581207415|FG001|Overall Study|Not Treated|0|||
160951354|NCT01953926|581207416|FG002|Overall Study|Not Treated|1|||
160951355|NCT01953926|581207417|FG003|Overall Study|Not Treated|0|||
160951356|NCT01953926|581207418|FG004|Overall Study|Not Treated|0|||
160951357|NCT01953926|581207419|FG005|Overall Study|Not Treated|0|||
160951358|NCT01953926|581207420|FG006|Overall Study|Not Treated|0|||
160951359|NCT01949480|581207422|FG000|Overall Study|Physician Decision|5|||
160951360|NCT01949480|581207423|FG001|Overall Study|Physician Decision|8|||
160951361|NCT00144339|581207424|FG000|Overall Study|Adverse Event|746|||
160951362|NCT00144339|581207425|FG001|Overall Study|Adverse Event|627|||
160951363|NCT00144339|581207424|FG000|Overall Study|Protocol Violation|75|||
160951364|NCT00144339|581207425|FG001|Overall Study|Protocol Violation|48|||
160951365|NCT00144339|581207424|FG000|Overall Study|Withdrawal by Subject|403|||
160951366|NCT00144339|581207425|FG001|Overall Study|Withdrawal by Subject|300|||
160951367|NCT00144339|581207424|FG000|Overall Study|Lost to Follow-up|76|||
160951368|NCT00144339|581207425|FG001|Overall Study|Lost to Follow-up|64|||
160951369|NCT00144339|581207424|FG000|Overall Study|Other|58|||
160951370|NCT00144339|581207425|FG001|Overall Study|Other|60|||
160457228|NCT04451772|579404841|FG003|Overall Study|Withdrawal by Subject|1|||
160457229|NCT04451772|579404842|FG004|Overall Study|Withdrawal by Subject|1|||
160951371|NCT00305058|581207426|FG000|Overall Study|Participant too young|1|||
160951372|NCT00305058|581207427|FG001|Overall Study|Participant too young|0|||
160951373|NCT00305058|581207426|FG000|Overall Study|Missing data collection instrument|3|||
160951374|NCT00305058|581207427|FG001|Overall Study|Missing data collection instrument|2|||
160951375|NCT00305058|581207426|FG000|Overall Study|Missing outcome data|3|||
160951376|NCT00305058|581207427|FG001|Overall Study|Missing outcome data|2|||
160951377|NCT04798586|581207430|FG000|Overall Study|Death|2|||
160951378|NCT02308033|581207431|FG000|Overall Study|Normal Gram stain at Baseline|13|||
160951379|NCT02308033|581207432|FG001|Overall Study|Normal Gram stain at Baseline|10|||
160951380|NCT02308033|581207431|FG000|Overall Study|Positive for STD at Baseline|7|||
160951381|NCT02308033|581207432|FG001|Overall Study|Positive for STD at Baseline|4|||
160951382|NCT02308033|581207431|FG000|Overall Study|Lost to Follow-up|6|||
160951383|NCT02308033|581207432|FG001|Overall Study|Lost to Follow-up|5|||
160951384|NCT03165045|581207433|FG000|Visit 1|No registration after visit 1|9|||
160951385|NCT03165045|581207433|FG000|Visit 1|No treatment documented|10|||
160457230|NCT04451772|579404843|FG005|Overall Study|Withdrawal by Subject|0|||
160951386|NCT03165045|581207433|FG000|Visit 1|No visit 1|10|||
160951387|NCT03165045|581207433|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
160951388|NCT03165045|581207433|FG000|Visit 2|No available total CCQ score at all|29|||
160951389|NCT03165045|581207433|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
160951390|NCT04323436|581207439|FG000|Overall Study|Adverse Event|7|||
160951391|NCT04323436|581207440|FG001|Overall Study|Adverse Event|0|||
160457231|NCT04451772|579404838|FG000|Overall Study|Other, not specified|1|||
160457232|NCT04451772|579404839|FG001|Overall Study|Other, not specified|2|||
160457233|NCT04451772|579404840|FG002|Overall Study|Other, not specified|1|||
160457234|NCT04451772|579404841|FG003|Overall Study|Other, not specified|0|||
160457235|NCT04451772|579404842|FG004|Overall Study|Other, not specified|0|||
160457236|NCT04451772|579404843|FG005|Overall Study|Other, not specified|1|||
160457237|NCT04451772|579404838|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
160951392|NCT04323436|581207441|FG002|Overall Study|Adverse Event|0|||
160951393|NCT04323436|581207439|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
160951394|NCT04323436|581207440|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
160951395|NCT04323436|581207441|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
160457238|NCT04451772|579404839|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
160457239|NCT04451772|579404840|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
160457240|NCT04451772|579404841|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
160457241|NCT04451772|579404842|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
160457242|NCT04451772|579404843|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
160457243|NCT04311632|579404844|FG000|Overall Study|Withdrawal by Subject|0|||
160457244|NCT04311632|579404845|FG001|Overall Study|Withdrawal by Subject|0|||
160457245|NCT04311632|579404846|FG002|Overall Study|Withdrawal by Subject|1|||
160457246|NCT05856435|579404847|FG000|Overall Study|Lost to Follow-up|6|||
160457247|NCT04632225|579404848|FG000|Overall Study|Withdrawal by Subject|2|||
160457248|NCT04632225|579404849|FG001|Overall Study|Withdrawal by Subject|2|||
160457249|NCT05660434|579404850|FG000|Overall Study|Never obtained study materials|2|||
160457250|NCT05660434|579404851|FG001|Overall Study|Never obtained study materials|1|||
160457251|NCT03213678|579404855|FG000|Overall Study|Death|1|||
160457252|NCT03213678|579404855|FG000|Overall Study|Physician Decision|1|||
160457253|NCT03213678|579404855|FG000|Overall Study|Progressive disease|16|||
160457254|NCT02413489|579404856|FG000|Overall Study|Death|11|||
160457255|NCT02413489|579404857|FG001|Overall Study|Death|3|||
160457256|NCT02413489|579404858|FG002|Overall Study|Death|4|||
160457257|NCT02413489|579404856|FG000|Overall Study|Withdrawal by Subject|2|||
160457258|NCT02413489|579404857|FG001|Overall Study|Withdrawal by Subject|0|||
160457259|NCT02413489|579404858|FG002|Overall Study|Withdrawal by Subject|0|||
160457260|NCT02413489|579404856|FG000|Overall Study|Study Terminated By Sponsor|2|||
160457261|NCT02413489|579404857|FG001|Overall Study|Study Terminated By Sponsor|13|||
160457262|NCT02413489|579404858|FG002|Overall Study|Study Terminated By Sponsor|1|||
160457263|NCT03717935|579404859|FG000|Overall Study|Withdrawal by Subject|0|||
160457264|NCT03717935|579404860|FG001|Overall Study|Withdrawal by Subject|2|||
160457265|NCT04456296|579404861|FG000|Overall Study|Withdrawal by Subject|14|||
160457266|NCT04456296|579404862|FG001|Overall Study|Withdrawal by Subject|21|||
160457267|NCT04456296|579404863|FG002|Overall Study|Withdrawal by Subject|21|||
160457268|NCT04456296|579404861|FG000|Overall Study|Adverse Event|2|||
160457269|NCT04456296|579404862|FG001|Overall Study|Adverse Event|2|||
160457270|NCT04456296|579404863|FG002|Overall Study|Adverse Event|2|||
160457271|NCT04456296|579404861|FG000|Overall Study|Death|1|||
160457272|NCT04456296|579404862|FG001|Overall Study|Death|0|||
160457273|NCT04456296|579404863|FG002|Overall Study|Death|0|||
160457274|NCT04456296|579404861|FG000|Overall Study|Lost to Follow-up|3|||
160457275|NCT04456296|579404862|FG001|Overall Study|Lost to Follow-up|5|||
160457276|NCT04456296|579404863|FG002|Overall Study|Lost to Follow-up|6|||
160457277|NCT04456296|579404861|FG000|Overall Study|Other than specified|0|||
160457278|NCT04456296|579404862|FG001|Overall Study|Other than specified|1|||
160457279|NCT04456296|579404863|FG002|Overall Study|Other than specified|4|||
160457280|NCT04456296|579404861|FG000|Overall Study|Randomized, not treated|2|||
160457281|NCT04456296|579404862|FG001|Overall Study|Randomized, not treated|1|||
160457282|NCT04456296|579404863|FG002|Overall Study|Randomized, not treated|0|||
160457283|NCT05736458|579404864|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
160457284|NCT05736458|579404865|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
160951396|NCT04323436|581207439|FG000|Overall Study|Death|1|||
160951397|NCT04323436|581207440|FG001|Overall Study|Death|0|||
160951398|NCT04323436|581207441|FG002|Overall Study|Death|0|||
160951399|NCT04323436|581207439|FG000|Overall Study|Physician Decision|2|||
160951400|NCT04323436|581207440|FG001|Overall Study|Physician Decision|0|||
160951401|NCT04323436|581207441|FG002|Overall Study|Physician Decision|0|||
160951402|NCT04323436|581207439|FG000|Overall Study|Progressive disease|10|||
160457285|NCT05736458|579404866|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
160457286|NCT05736458|579404864|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
160457287|NCT05736458|579404865|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
160457288|NCT05736458|579404866|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
160457289|NCT05736458|579404864|FG000|TMS/fMRI #1|Physician Decision|0|||
160457290|NCT05736458|579404865|FG001|TMS/fMRI #1|Physician Decision|0|||
160457291|NCT05736458|579404866|FG002|TMS/fMRI #1|Physician Decision|2|||
160457292|NCT05736458|579404864|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
160951403|NCT04323436|581207440|FG001|Overall Study|Progressive disease|0|||
160951404|NCT04323436|581207441|FG002|Overall Study|Progressive disease|0|||
160951405|NCT04323436|581207439|FG000|Overall Study|Subject decision|3|||
160951406|NCT04323436|581207440|FG001|Overall Study|Subject decision|0|||
160951407|NCT04323436|581207441|FG002|Overall Study|Subject decision|0|||
160951408|NCT00142909|581207442|FG000|Randomization|Various Reasons|7|||
160951409|NCT00142909|581207443|FG001|Randomization|Various Reasons|10|||
160951410|NCT00142909|581207442|FG000|Medications Begin|Protocol Violation|2|||
160951411|NCT00142909|581207443|FG001|Medications Begin|Protocol Violation|0|||
160951412|NCT00142909|581207442|FG000|Medications Begin|Withdrawal by Subject|5|||
160951413|NCT00142909|581207443|FG001|Medications Begin|Withdrawal by Subject|3|||
160951414|NCT00142909|581207442|FG000|Medications Begin|Withdrawal by Subject|2|||
160951415|NCT00142909|581207443|FG001|Medications Begin|Withdrawal by Subject|0|||
160951416|NCT01682837|581207446|FG000|Baseline|Withdrawal by Subject|5|||
160951417|NCT03021187|581207449|FG000|Overall Study|Death|0|||
160951418|NCT03021187|581207450|FG001|Overall Study|Death|0|||
160951419|NCT03021187|581207451|FG002|Overall Study|Death|3|||
160951420|NCT03021187|581207452|FG003|Overall Study|Death|0|||
160951421|NCT03021187|581207449|FG000|Overall Study|Withdrawal by Subject|0|||
160951422|NCT03021187|581207450|FG001|Overall Study|Withdrawal by Subject|6|||
160951423|NCT03021187|581207451|FG002|Overall Study|Withdrawal by Subject|2|||
160951424|NCT03021187|581207452|FG003|Overall Study|Withdrawal by Subject|5|||
160951425|NCT03021187|581207449|FG000|Overall Study|Lost to Follow-up|10|||
160951426|NCT03021187|581207450|FG001|Overall Study|Lost to Follow-up|3|||
160951427|NCT03021187|581207451|FG002|Overall Study|Lost to Follow-up|1|||
160951428|NCT03021187|581207452|FG003|Overall Study|Lost to Follow-up|4|||
160951429|NCT01664078|581207453|FG000|Overall Study|Death|9|||
160951430|NCT01664078|581207453|FG000|Overall Study|Withdrawal by Subject|4|||
160951431|NCT01664078|581207453|FG000|Overall Study|Lost to Follow-up|2|||
160951432|NCT01664078|581207453|FG000|Overall Study|missed 5 year visit|1|||
160951433|NCT01664078|581207453|FG000|Overall Study|Other|53|||
160951434|NCT03351049|581207454|FG000|Overall Study|Withdrawal|26|||
160951435|NCT03351049|581207455|FG001|Overall Study|Withdrawal|22|||
160951436|NCT04726709|581209013|FG000|Overall Study|Withdrawal by Subject|2|||
160951437|NCT04726709|581209014|FG001|Overall Study|Withdrawal by Subject|2|||
160951438|NCT04447404|581209028|FG000|Overall Study|Death|2|||
160951439|NCT04447404|581209029|FG001|Overall Study|Death|0|||
160951440|NCT00574080|581209030|FG000|Overall Study|Death|10|||
160951441|NCT00574080|581209031|FG001|Overall Study|Death|10|||
160951442|NCT01221597|581209032|FG000|Overall Study|Adverse Event|4|||
160951443|NCT01221597|581209033|FG001|Overall Study|Adverse Event|1|||
160951444|NCT01221597|581209032|FG000|Overall Study|Withdrawal by Subject|20|||
160951445|NCT01221597|581209033|FG001|Overall Study|Withdrawal by Subject|6|||
160951446|NCT01221597|581209032|FG000|Overall Study|Lost to Follow-up|6|||
160951447|NCT01221597|581209033|FG001|Overall Study|Lost to Follow-up|5|||
160951448|NCT01221597|581209032|FG000|Overall Study|Protocol Violation|1|||
160951449|NCT01221597|581209033|FG001|Overall Study|Protocol Violation|0|||
160951450|NCT01221597|581209032|FG000|Overall Study|Other|3|||
160951451|NCT01221597|581209033|FG001|Overall Study|Other|4|||
160951452|NCT01221597|581209032|FG000|Overall Study|Death|2|||
160951453|NCT01221597|581209033|FG001|Overall Study|Death|0|||
160951454|NCT00148343|581209035|FG000|Overall Study|Withdrawal by Subject|12|||
160951455|NCT00148343|581209036|FG001|Overall Study|Withdrawal by Subject|7|||
160951456|NCT00148343|581209035|FG000|Overall Study|Physician Decision|3|||
160951457|NCT00148343|581209036|FG001|Overall Study|Physician Decision|4|||
160951458|NCT02384759|581209049|FG000|Overall Study|Patients not treated|3|||
160951459|NCT02384759|581209050|FG001|Overall Study|Patients not treated|2|||
160951460|NCT01605617|581209051|FG000|First Intervention|Adverse Event|0|||
160951461|NCT01605617|581209052|FG001|First Intervention|Adverse Event|1|||
160951462|NCT01605617|581209051|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
160951463|NCT01605617|581209052|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
160951464|NCT00121238|581209053|FG000|Overall Study|disease progression before intervention|1|||
160951465|NCT00121238|581209053|FG000|Overall Study|Protocol Violation|2|||
160951466|NCT01380327|581209054|FG000|Overall Study|Lost to Follow-up|0|||
161000708|NCT05190419|581387223|FG001|Overall Study|Lack of Efficacy|0|||
161000709|NCT05190419|581387224|FG002|Overall Study|Lack of Efficacy|1|||
160951467|NCT01380327|581209055|FG001|Overall Study|Lost to Follow-up|1|||
161000710|NCT05190419|581387225|FG003|Overall Study|Lack of Efficacy|0|||
161000711|NCT05190419|581387222|FG000|Overall Study|Withdrawal by Subject|7|||
160951468|NCT01380327|581209056|FG002|Overall Study|Lost to Follow-up|1|||
160951469|NCT01380327|581209054|FG000|Overall Study|Protocol Violation|3|||
160951470|NCT01380327|581209055|FG001|Overall Study|Protocol Violation|2|||
160951471|NCT01380327|581209056|FG002|Overall Study|Protocol Violation|3|||
160951472|NCT01380327|581209054|FG000|Overall Study|Withdrawal by Subject|0|||
160951473|NCT01380327|581209055|FG001|Overall Study|Withdrawal by Subject|0|||
160951474|NCT01380327|581209056|FG002|Overall Study|Withdrawal by Subject|1|||
160951475|NCT01380327|581209054|FG000|Overall Study|Housing situation precluded ability to k|0|||
160951476|NCT01380327|581209055|FG001|Overall Study|Housing situation precluded ability to k|0|||
160951477|NCT01380327|581209056|FG002|Overall Study|Housing situation precluded ability to k|1|||
161000712|NCT05190419|581387223|FG001|Overall Study|Withdrawal by Subject|1|||
160951478|NCT01380327|581209054|FG000|Overall Study|Questionable onset of epilepsy|0|||
160951479|NCT01380327|581209055|FG001|Overall Study|Questionable onset of epilepsy|0|||
160951480|NCT01380327|581209056|FG002|Overall Study|Questionable onset of epilepsy|1|||
160951481|NCT01540851|581209057|FG000|Overall Study|Lost to Follow-up|14|||
160951482|NCT01540851|581209058|FG001|Overall Study|Lost to Follow-up|15|||
160951483|NCT01540851|581209057|FG000|Overall Study|Withdrawal by Subject|7|||
160951484|NCT01540851|581209058|FG001|Overall Study|Withdrawal by Subject|3|||
160457293|NCT05736458|579404865|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
160457294|NCT05736458|579404866|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
160457295|NCT05654662|579404876|FG000|Overall Study|Withdrawal by Subject|1|||
160457296|NCT05654662|579404877|FG001|Overall Study|Withdrawal by Subject|0|||
160457297|NCT05654662|579404876|FG000|Overall Study|A death in the family|1|||
160457298|NCT05654662|579404877|FG001|Overall Study|A death in the family|0|||
160457299|NCT04230681|579404878|FG000|Overall Study|Physician Decision|2|||
160457300|NCT04230681|579404879|FG001|Overall Study|Physician Decision|3|||
160457301|NCT04230681|579404878|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
160457302|NCT04230681|579404879|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
160457303|NCT04230681|579404878|FG000|Overall Study|IV inadvertently removed|0|||
160457304|NCT04230681|579404879|FG001|Overall Study|IV inadvertently removed|1|||
160457305|NCT01880515|579406357|FG000|Overall Study|Lost to Follow-up|3|||
160457306|NCT01880515|579406358|FG001|Overall Study|Lost to Follow-up|2|||
160457307|NCT01880515|579406357|FG000|Overall Study|Disease Progression|5|||
160457308|NCT01880515|579406358|FG001|Overall Study|Disease Progression|7|||
160457309|NCT03505710|579406359|FG000|Overall Study|Progressive Disease|24|||
160457310|NCT03505710|579406360|FG001|Overall Study|Progressive Disease|17|||
160457311|NCT03505710|579406361|FG002|Overall Study|Progressive Disease|43|||
160457312|NCT03505710|579406359|FG000|Overall Study|Clinical Progression|6|||
160457313|NCT03505710|579406360|FG001|Overall Study|Clinical Progression|8|||
160457314|NCT03505710|579406361|FG002|Overall Study|Clinical Progression|3|||
160457315|NCT03505710|579406359|FG000|Overall Study|Adverse Event|12|||
160457316|NCT03505710|579406360|FG001|Overall Study|Adverse Event|6|||
160457317|NCT03505710|579406361|FG002|Overall Study|Adverse Event|28|||
160457318|NCT03505710|579406359|FG000|Overall Study|Withdrawal by Subject|1|||
160457319|NCT03505710|579406360|FG001|Overall Study|Withdrawal by Subject|3|||
160457320|NCT03505710|579406361|FG002|Overall Study|Withdrawal by Subject|7|||
160457321|NCT03505710|579406359|FG000|Overall Study|Physician Decision|1|||
160457322|NCT03505710|579406360|FG001|Overall Study|Physician Decision|1|||
160457323|NCT03505710|579406361|FG002|Overall Study|Physician Decision|2|||
160457324|NCT03505710|579406359|FG000|Overall Study|Death|4|||
160457325|NCT03505710|579406360|FG001|Overall Study|Death|5|||
160457326|NCT03505710|579406361|FG002|Overall Study|Death|6|||
160457327|NCT03505710|579406359|FG000|Overall Study|Other Reasons|1|||
160457328|NCT03505710|579406360|FG001|Overall Study|Other Reasons|1|||
160457329|NCT03505710|579406361|FG002|Overall Study|Other Reasons|1|||
160457330|NCT03505710|579406359|FG000|Overall Study|Study Terminated by Sponsor|0|||
160457331|NCT03505710|579406360|FG001|Overall Study|Study Terminated by Sponsor|0|||
160457332|NCT03505710|579406361|FG002|Overall Study|Study Terminated by Sponsor|1|||
160457333|NCT04414722|579406362|FG000|Overall Study|Lost to Follow-up|3|||
160457334|NCT04414722|579406363|FG001|Overall Study|Lost to Follow-up|4|||
160457335|NCT04414722|579406364|FG002|Overall Study|Lost to Follow-up|3|||
160457336|NCT04414722|579406365|FG003|Overall Study|Lost to Follow-up|2|||
160457337|NCT04414722|579406366|FG004|Overall Study|Lost to Follow-up|3|||
160457338|NCT04414722|579406362|FG000|Overall Study|Withdrawal by Subject|6|||
160457339|NCT04414722|579406363|FG001|Overall Study|Withdrawal by Subject|3|||
160457340|NCT04414722|579406364|FG002|Overall Study|Withdrawal by Subject|1|||
160457341|NCT04414722|579406365|FG003|Overall Study|Withdrawal by Subject|5|||
160457342|NCT04414722|579406366|FG004|Overall Study|Withdrawal by Subject|1|||
160457343|NCT04414722|579406362|FG000|Overall Study|Physician Decision|0|||
160457344|NCT04414722|579406363|FG001|Overall Study|Physician Decision|1|||
160457345|NCT04414722|579406364|FG002|Overall Study|Physician Decision|2|||
160457346|NCT04414722|579406365|FG003|Overall Study|Physician Decision|0|||
160457347|NCT04414722|579406366|FG004|Overall Study|Physician Decision|0|||
160457348|NCT04414722|579406362|FG000|Overall Study|Non-participatory|0|||
160457349|NCT04414722|579406363|FG001|Overall Study|Non-participatory|1|||
160457350|NCT04414722|579406364|FG002|Overall Study|Non-participatory|1|||
160457351|NCT04414722|579406365|FG003|Overall Study|Non-participatory|0|||
160457352|NCT04414722|579406366|FG004|Overall Study|Non-participatory|0|||
160951485|NCT03593655|581209059|FG000|First Product Use Period|Withdrawal by Subject|1|||
160457353|NCT03711474|579406367|FG000|Overall Study|Physician Decision|2|||
160457354|NCT03711474|579406368|FG001|Overall Study|Physician Decision|0|||
160457355|NCT04615273|579406371|FG000|Overall Study|Withdrawal by Subject|3|||
160457356|NCT04615273|579406372|FG001|Overall Study|Withdrawal by Subject|1|||
160457357|NCT04615273|579406373|FG002|Overall Study|Withdrawal by Subject|2|||
160457358|NCT04615273|579406371|FG000|Overall Study|Adverse Event|1|||
160457359|NCT04615273|579406372|FG001|Overall Study|Adverse Event|0|||
160582512|NCT03725202|579853634|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
160951486|NCT03593655|581209060|FG001|First Product Use Period|Withdrawal by Subject|1|||
161000713|NCT05190419|581387224|FG002|Overall Study|Withdrawal by Subject|2|||
161000714|NCT05190419|581387225|FG003|Overall Study|Withdrawal by Subject|2|||
161000715|NCT05190419|581387222|FG000|Overall Study|Adverse Event|2|||
161000716|NCT05190419|581387223|FG001|Overall Study|Adverse Event|10|||
161000717|NCT05190419|581387224|FG002|Overall Study|Adverse Event|11|||
161000718|NCT05190419|581387225|FG003|Overall Study|Adverse Event|21|||
161000719|NCT05190419|581387222|FG000|Overall Study|Lost to Follow-up|1|||
161000720|NCT05190419|581387223|FG001|Overall Study|Lost to Follow-up|2|||
161000721|NCT05190419|581387224|FG002|Overall Study|Lost to Follow-up|3|||
161000722|NCT05190419|581387225|FG003|Overall Study|Lost to Follow-up|1|||
161000723|NCT05190419|581387222|FG000|Overall Study|Other|1|||
161000724|NCT05190419|581387223|FG001|Overall Study|Other|1|||
161000725|NCT05190419|581387224|FG002|Overall Study|Other|0|||
161000726|NCT05190419|581387225|FG003|Overall Study|Other|3|||
161000727|NCT01227707|581387226|FG000|Overall Study|Adverse Event|10|||
161000728|NCT01227707|581387226|FG000|Overall Study|Progression of disease|3|||
161000729|NCT01227707|581387226|FG000|Overall Study|Withdrawal by Subject|1|||
161000730|NCT01227707|581387226|FG000|Overall Study|Patient non-compliance|3|||
161000731|NCT01227707|581387226|FG000|Overall Study|Medical decision|6|||
161000732|NCT01227707|581387226|FG000|Overall Study|Death|1|||
161000733|NCT03210402|581387227|FG000|Overall Study|Withdrawal by Subject|0|||
161000734|NCT03210402|581387228|FG001|Overall Study|Withdrawal by Subject|1|||
161000735|NCT00811057|581387229|FG000|Overall Study|Protocol Violation|5|||
161000736|NCT00811057|581387230|FG001|Overall Study|Protocol Violation|10|||
161000737|NCT00811057|581387231|FG002|Overall Study|Protocol Violation|10|||
161000738|NCT05328297|581388860|FG000|Overall Study|Adverse Event|5|||
161000739|NCT05328297|581388861|FG001|Overall Study|Adverse Event|7|||
160457360|NCT04615273|579406373|FG002|Overall Study|Adverse Event|1|||
160457361|NCT04615273|579406371|FG000|Overall Study|Lost to Follow-up|0|||
160457362|NCT04615273|579406372|FG001|Overall Study|Lost to Follow-up|1|||
161000740|NCT05328297|581388860|FG000|Overall Study|Withdrawal by Subject|4|||
161000741|NCT05328297|581388861|FG001|Overall Study|Withdrawal by Subject|3|||
161000742|NCT05328297|581388860|FG000|Overall Study|Lack of Efficacy|1|||
161000743|NCT05328297|581388861|FG001|Overall Study|Lack of Efficacy|0|||
161000744|NCT05328297|581388860|FG000|Overall Study|Lost to Follow-up|1|||
161000745|NCT05328297|581388861|FG001|Overall Study|Lost to Follow-up|0|||
161000746|NCT05328297|581388860|FG000|Overall Study|Protocol Violation|1|||
161000747|NCT05328297|581388861|FG001|Overall Study|Protocol Violation|0|||
161000748|NCT05328297|581388860|FG000|Overall Study|Randomized but not treated|1|||
161000749|NCT05328297|581388861|FG001|Overall Study|Randomized but not treated|1|||
161000750|NCT00028769|581388864|FG000|Overall Study|Adverse Event|2|||
160457363|NCT04615273|579406373|FG002|Overall Study|Lost to Follow-up|0|||
160457364|NCT04615273|579406371|FG000|Overall Study|Physician Decision|0|||
160457365|NCT04615273|579406372|FG001|Overall Study|Physician Decision|0|||
160457366|NCT04615273|579406373|FG002|Overall Study|Physician Decision|1|||
160457367|NCT04615273|579406371|FG000|Overall Study|Other|0|||
160457368|NCT04615273|579406372|FG001|Overall Study|Other|1|||
160457369|NCT04615273|579406373|FG002|Overall Study|Other|0|||
160457370|NCT04615273|579406371|FG000|Overall Study|Randomized but not treated|1|||
160457371|NCT04615273|579406372|FG001|Overall Study|Randomized but not treated|3|||
160457372|NCT04615273|579406373|FG002|Overall Study|Randomized but not treated|1|||
160457373|NCT03677141|579406374|FG000|Overall Study|Death|2|||
160457374|NCT03677141|579406375|FG001|Overall Study|Death|1|||
160457375|NCT03677141|579406376|FG002|Overall Study|Death|6|||
160457376|NCT03677141|579406377|FG003|Overall Study|Death|9|||
161000751|NCT00028769|581388864|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
161000752|NCT00028769|581388864|FG000|Overall Study|Progression or Death|31|||
161000753|NCT00028769|581388864|FG000|Overall Study|Other - Not Protocol Specified|1|||
161000754|NCT00028769|581388864|FG000|Overall Study|Ineligible|5|||
161000755|NCT00028769|581388864|FG000|Overall Study|Not Analyzable|1|||
161000756|NCT02496702|581388867|FG000|Overall Study|Lost to Follow-up|8|||
161000757|NCT02496702|581388868|FG001|Overall Study|Lost to Follow-up|6|||
161000758|NCT02496702|581388867|FG000|Overall Study|Only partially tested|0|||
161000759|NCT02496702|581388868|FG001|Overall Study|Only partially tested|2|||
161000760|NCT00941655|581388871|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
161000761|NCT00941655|581388872|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
160457377|NCT03677141|579406378|FG004|Overall Study|Death|5|||
160457378|NCT03677141|579406379|FG005|Overall Study|Death|3|||
160457379|NCT03677141|579406374|FG000|Overall Study|Lost to Follow-up|0|||
160457380|NCT03677141|579406375|FG001|Overall Study|Lost to Follow-up|0|||
160457381|NCT03677141|579406376|FG002|Overall Study|Lost to Follow-up|0|||
161000762|NCT00941655|581388871|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
160457382|NCT03677141|579406377|FG003|Overall Study|Lost to Follow-up|2|||
160457383|NCT03677141|579406378|FG004|Overall Study|Lost to Follow-up|0|||
160457384|NCT03677141|579406379|FG005|Overall Study|Lost to Follow-up|0|||
160457385|NCT03677141|579406374|FG000|Overall Study|Screen failure or enrolled in error|0|||
160457386|NCT03677141|579406375|FG001|Overall Study|Screen failure or enrolled in error|0|||
161000763|NCT00941655|581388872|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
161000764|NCT00941655|581388871|FG000|Overall Study|progressed while on chemo|0|||
160582513|NCT03725202|579853635|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
160582514|NCT03725202|579853636|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
160582515|NCT03725202|579853629|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
160582516|NCT03725202|579853630|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
160582517|NCT03725202|579853631|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
160951487|NCT03593655|581209059|FG000|First Product Use Period|Lost to Follow-up|1|||
160951488|NCT03593655|581209060|FG001|First Product Use Period|Lost to Follow-up|3|||
160951489|NCT03593655|581209059|FG000|Second Product Use Period|Withdrawal by Subject|1|||
160951490|NCT03593655|581209060|FG001|Second Product Use Period|Withdrawal by Subject|1|||
160951491|NCT03593655|581209059|FG000|Second Product Use Period|Lost to Follow-up|1|||
160951492|NCT03593655|581209060|FG001|Second Product Use Period|Lost to Follow-up|0|||
160951493|NCT03593655|581209059|FG000|Third Product Use Period|Lost to Follow-up|1|||
160951494|NCT03593655|581209060|FG001|Third Product Use Period|Lost to Follow-up|2|||
160951495|NCT03593655|581209059|FG000|Third Product Use Period|Physician Decision|0|||
160951496|NCT03593655|581209060|FG001|Third Product Use Period|Physician Decision|1|||
160951497|NCT03593655|581209059|FG000|Third Product Use Period|Withdrawal by Subject|0|||
160951498|NCT03593655|581209060|FG001|Third Product Use Period|Withdrawal by Subject|1|||
160951499|NCT05046795|581209061|FG000|Overall Study|Adverse Event|13|||
160951500|NCT05046795|581209062|FG001|Overall Study|Adverse Event|15|||
160951501|NCT05046795|581209061|FG000|Overall Study|Withdrawal by Subject|4|||
160951502|NCT05046795|581209062|FG001|Overall Study|Withdrawal by Subject|7|||
160951503|NCT05046795|581209061|FG000|Overall Study|Physician Decision|1|||
160582518|NCT03725202|579853632|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
160582519|NCT03725202|579853633|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
160582520|NCT03725202|579853634|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
160951504|NCT05046795|581209062|FG001|Overall Study|Physician Decision|2|||
160951505|NCT05046795|581209061|FG000|Overall Study|Protocol Violation|1|||
160951506|NCT05046795|581209062|FG001|Overall Study|Protocol Violation|2|||
160951507|NCT05046795|581209061|FG000|Overall Study|Death|1|||
160951508|NCT05046795|581209062|FG001|Overall Study|Death|0|||
160951509|NCT05046795|581209061|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
160951510|NCT05046795|581209062|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
160951511|NCT00690755|581209063|FG000|Overall Study|Physician Decision|2|||
160951512|NCT00690755|581209064|FG001|Overall Study|Physician Decision|0|||
160951513|NCT00690755|581209065|FG002|Overall Study|Physician Decision|46|||
160951514|NCT00690755|581209066|FG003|Overall Study|Physician Decision|5|||
160951515|NCT00690755|581209067|FG004|Overall Study|Physician Decision|0|||
160951516|NCT00690755|581209068|FG005|Overall Study|Physician Decision|4|||
160951517|NCT00690755|581209069|FG006|Overall Study|Physician Decision|0|||
160951518|NCT04287920|581209073|FG000|Overall Study|Lost to Follow-up|1|||
160951519|NCT04287920|581209074|FG001|Overall Study|Lost to Follow-up|1|||
160951520|NCT04287920|581209073|FG000|Overall Study|Withdrawal by Subject|0|||
160951521|NCT04287920|581209074|FG001|Overall Study|Withdrawal by Subject|3|||
160951522|NCT03538626|581209075|FG000|Overall Study|Withdrawal by Subject|0|||
160951523|NCT03538626|581209076|FG001|Overall Study|Withdrawal by Subject|1|||
160951524|NCT03538626|581209077|FG002|Overall Study|Withdrawal by Subject|0|||
160951525|NCT03538626|581209078|FG003|Overall Study|Withdrawal by Subject|0|||
160951526|NCT03538626|581209079|FG004|Overall Study|Withdrawal by Subject|0|||
160951527|NCT03538626|581209080|FG005|Overall Study|Withdrawal by Subject|0|||
160951528|NCT03538626|581209081|FG006|Overall Study|Withdrawal by Subject|0|||
160951529|NCT03538626|581209082|FG007|Overall Study|Withdrawal by Subject|0|||
160951530|NCT03538626|581209075|FG000|Overall Study|Lost to Follow-up|0|||
160951531|NCT03538626|581209076|FG001|Overall Study|Lost to Follow-up|0|||
160951532|NCT03538626|581209077|FG002|Overall Study|Lost to Follow-up|0|||
160951533|NCT03538626|581209078|FG003|Overall Study|Lost to Follow-up|0|||
160951534|NCT03538626|581209079|FG004|Overall Study|Lost to Follow-up|0|||
160951535|NCT03538626|581209080|FG005|Overall Study|Lost to Follow-up|0|||
160951536|NCT03538626|581209081|FG006|Overall Study|Lost to Follow-up|1|||
160951537|NCT03538626|581209082|FG007|Overall Study|Lost to Follow-up|0|||
160951538|NCT00288587|581209083|FG000|Overall Study|Death|4|||
160951539|NCT00288587|581209084|FG001|Overall Study|Death|4|||
161000765|NCT00941655|581388872|FG001|Overall Study|progressed while on chemo|2|||
160951540|NCT00288587|581209083|FG000|Overall Study|Transplant|0|||
160951541|NCT00288587|581209084|FG001|Overall Study|Transplant|3|||
161000766|NCT00941655|581388871|FG000|Overall Study|refused further treatment|0|||
161000767|NCT00941655|581388872|FG001|Overall Study|refused further treatment|1|||
160951542|NCT00288587|581209083|FG000|Overall Study|Adverse Event|0|||
160951543|NCT00288587|581209084|FG001|Overall Study|Adverse Event|1|||
160951544|NCT00288587|581209083|FG000|Overall Study|Physician Decision|0|||
160951545|NCT00288587|581209084|FG001|Overall Study|Physician Decision|2|||
160951546|NCT00288587|581209083|FG000|Overall Study|Severe Aortic Stenosis|1|||
160951547|NCT00288587|581209084|FG001|Overall Study|Severe Aortic Stenosis|0|||
160951548|NCT02232893|581209090|FG000|Overall Study|Withdrawal by Subject|4|||
160951549|NCT02232893|581209091|FG001|Overall Study|Withdrawal by Subject|1|||
160951550|NCT02232893|581209090|FG000|Overall Study|Adverse Event|0|||
160951551|NCT02232893|581209091|FG001|Overall Study|Adverse Event|1|||
160951552|NCT02232893|581209090|FG000|Overall Study|Sponsor request early termination|0|||
160951553|NCT02232893|581209091|FG001|Overall Study|Sponsor request early termination|1|||
160951554|NCT02232893|581209090|FG000|Overall Study|Developed exclusion criteria|0|||
160951555|NCT02232893|581209091|FG001|Overall Study|Developed exclusion criteria|1|||
160951556|NCT02232893|581209090|FG000|Overall Study|Other|0|||
160951557|NCT02232893|581209091|FG001|Overall Study|Other|3|||
160951558|NCT01764945|581209092|FG000|Overall Study|Adverse Event|0|||
160951559|NCT01764945|581209093|FG001|Overall Study|Adverse Event|1|||
160951560|NCT01764945|581209094|FG002|Overall Study|Adverse Event|0|||
160951561|NCT01764945|581209095|FG003|Overall Study|Adverse Event|0|||
160951562|NCT01764945|581209096|FG004|Overall Study|Adverse Event|0|||
160951563|NCT01764945|581209097|FG005|Overall Study|Adverse Event|0|||
160951564|NCT01764945|581209098|FG006|Overall Study|Adverse Event|1|||
160951565|NCT01764945|581209099|FG007|Overall Study|Adverse Event|0|||
160951566|NCT05077267|581209102|FG000|Treatment Period|Lost to Follow-up|0|||
160951567|NCT05077267|581209103|FG001|Treatment Period|Lost to Follow-up|1|||
160951568|NCT05077267|581209104|FG002|Treatment Period|Lost to Follow-up|0|||
160951569|NCT05077267|581209102|FG000|Treatment Period|Withdrawal by Subject|0|||
160951570|NCT05077267|581209103|FG001|Treatment Period|Withdrawal by Subject|1|||
160951571|NCT05077267|581209104|FG002|Treatment Period|Withdrawal by Subject|0|||
160951572|NCT05077267|581209102|FG000|Follow-up Period|Lost to Follow-up|0|||
160951573|NCT05077267|581209103|FG001|Follow-up Period|Lost to Follow-up|5|||
160951574|NCT05077267|581209104|FG002|Follow-up Period|Lost to Follow-up|7|||
160951575|NCT05077267|581209102|FG000|Follow-up Period|Withdrawal by Subject|0|||
160951576|NCT05077267|581209103|FG001|Follow-up Period|Withdrawal by Subject|2|||
160951577|NCT05077267|581209104|FG002|Follow-up Period|Withdrawal by Subject|5|||
160951578|NCT05077267|581209102|FG000|Follow-up Period|Study terminated by sponsor|0|||
160951579|NCT05077267|581209103|FG001|Follow-up Period|Study terminated by sponsor|27|||
160951580|NCT05077267|581209104|FG002|Follow-up Period|Study terminated by sponsor|23|||
160951581|NCT05077267|581209102|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
160951582|NCT05077267|581209103|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
160951583|NCT05077267|581209104|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
160951584|NCT05077267|581209102|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
160951585|NCT05077267|581209103|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
160951586|NCT05077267|581209104|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
160951587|NCT02911948|581209107|FG000|Overall Study|Protocol Violation|0|||
160951588|NCT02911948|581209108|FG001|Overall Study|Protocol Violation|1|||
160951589|NCT02911948|581209107|FG000|Overall Study|Withdrawal by Subject|0|||
160951590|NCT02911948|581209108|FG001|Overall Study|Withdrawal by Subject|2|||
160951591|NCT02911948|581209107|FG000|Overall Study|Lack of Efficacy|0|||
160951592|NCT02911948|581209108|FG001|Overall Study|Lack of Efficacy|1|||
160951593|NCT02911948|581209107|FG000|Overall Study|Unclassified|0|||
160951594|NCT02911948|581209108|FG001|Overall Study|Unclassified|3|||
160951595|NCT00586105|581209115|FG000|Overall Study|Adverse Event|4|||
160951596|NCT00586105|581209115|FG000|Overall Study|Death|2|||
160951597|NCT00586105|581209115|FG000|Overall Study|Protocol Violation|1|||
160951598|NCT00586105|581209115|FG000|Overall Study|Withdrawal by Subject|3|||
160951599|NCT00586105|581209115|FG000|Overall Study|Disease progression|19|||
160951600|NCT00586105|581209115|FG000|Overall Study|Switched to commercial drug|9|||
160951601|NCT00586105|581209115|FG000|Overall Study|Reason not reported|1|||
160951602|NCT01136291|581209119|FG000|Overall Study|Lost to Follow-up|1|||
160951603|NCT01136291|581209120|FG001|Overall Study|Lost to Follow-up|1|||
160951604|NCT03965052|581209121|FG000|Overall Study|Protocol Violation|1|||
160951605|NCT03965052|581209122|FG001|Overall Study|Protocol Violation|0|||
160951606|NCT01660763|581209137|FG000|Overall Study|Lack of Efficacy|45|||
160951607|NCT01660763|581209138|FG001|Overall Study|Lack of Efficacy|50|||
160951608|NCT01660763|581209137|FG000|Overall Study|Adverse Event|22|||
160951609|NCT01660763|581209138|FG001|Overall Study|Adverse Event|7|||
160951610|NCT01660763|581209137|FG000|Overall Study|Protocol Violation|1|||
160951611|NCT01660763|581209138|FG001|Overall Study|Protocol Violation|0|||
160951612|NCT01660763|581209137|FG000|Overall Study|Withdrawal by Subject|4|||
160951613|NCT01660763|581209138|FG001|Overall Study|Withdrawal by Subject|0|||
160951614|NCT01660763|581209137|FG000|Overall Study|Patient ready for early discharge|28|||
160951615|NCT01660763|581209138|FG001|Overall Study|Patient ready for early discharge|4|||
160951616|NCT00345397|581209139|FG000|Overall Study|Death|1|||
160951617|NCT04782323|581209140|FG000|Overall Study|Death|1|||
160951618|NCT04782323|581209141|FG001|Overall Study|Death|0|||
160951619|NCT04782323|581209142|FG002|Overall Study|Death|0|||
160951620|NCT04782323|581209143|FG003|Overall Study|Death|0|||
160951621|NCT04782323|581209144|FG004|Overall Study|Death|1|||
160951622|NCT04782323|581209145|FG005|Overall Study|Death|1|||
160951623|NCT04782323|581209146|FG006|Overall Study|Death|1|||
160951624|NCT04782323|581209147|FG007|Overall Study|Death|0|||
160951625|NCT04782323|581209140|FG000|Overall Study|Withdrawal by Subject|0|||
160951626|NCT04782323|581209141|FG001|Overall Study|Withdrawal by Subject|0|||
160951627|NCT04782323|581209142|FG002|Overall Study|Withdrawal by Subject|1|||
160951628|NCT04782323|581209143|FG003|Overall Study|Withdrawal by Subject|0|||
160951629|NCT04782323|581209144|FG004|Overall Study|Withdrawal by Subject|0|||
160951630|NCT04782323|581209145|FG005|Overall Study|Withdrawal by Subject|1|||
160951631|NCT04782323|581209146|FG006|Overall Study|Withdrawal by Subject|0|||
160951632|NCT04782323|581209147|FG007|Overall Study|Withdrawal by Subject|1|||
160951633|NCT04782323|581209140|FG000|Overall Study|Lost to Follow-up|0|||
160951634|NCT04782323|581209141|FG001|Overall Study|Lost to Follow-up|1|||
160951635|NCT04782323|581209142|FG002|Overall Study|Lost to Follow-up|1|||
160951636|NCT04782323|581209143|FG003|Overall Study|Lost to Follow-up|0|||
160951637|NCT04782323|581209144|FG004|Overall Study|Lost to Follow-up|0|||
160951638|NCT04782323|581209145|FG005|Overall Study|Lost to Follow-up|1|||
160951639|NCT04782323|581209146|FG006|Overall Study|Lost to Follow-up|1|||
160951640|NCT04782323|581209147|FG007|Overall Study|Lost to Follow-up|2|||
160951641|NCT04782323|581209140|FG000|Overall Study|randomization in error|1|||
160951642|NCT04782323|581209141|FG001|Overall Study|randomization in error|0|||
160951643|NCT04782323|581209142|FG002|Overall Study|randomization in error|0|||
160951644|NCT04782323|581209143|FG003|Overall Study|randomization in error|0|||
160951645|NCT04782323|581209144|FG004|Overall Study|randomization in error|0|||
160951646|NCT04782323|581209145|FG005|Overall Study|randomization in error|0|||
160951647|NCT04782323|581209146|FG006|Overall Study|randomization in error|0|||
160951648|NCT04782323|581209147|FG007|Overall Study|randomization in error|0|||
160951649|NCT04369469|581209148|FG000|Overall Study|Lost to Follow-up|2|||
160951650|NCT04369469|581209149|FG001|Overall Study|Lost to Follow-up|4|||
160951651|NCT04369469|581209148|FG000|Overall Study|Physician Decision|2|||
160951652|NCT04369469|581209149|FG001|Overall Study|Physician Decision|1|||
160951653|NCT04369469|581209148|FG000|Overall Study|Withdrawal by Subject|2|||
160951654|NCT04369469|581209149|FG001|Overall Study|Withdrawal by Subject|3|||
160951655|NCT04369469|581209148|FG000|Overall Study|Adverse Event|1|||
160951656|NCT04369469|581209149|FG001|Overall Study|Adverse Event|0|||
160951657|NCT04369469|581209148|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
160951658|NCT04369469|581209149|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
160951659|NCT04369469|581209148|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
160951660|NCT04369469|581209149|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
160951661|NCT04369469|581209148|FG000|Overall Study|Unable to Provide Consent|0|||
160951662|NCT04369469|581209149|FG001|Overall Study|Unable to Provide Consent|1|||
160951663|NCT03832192|581209152|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
160951664|NCT03832192|581209153|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
160951665|NCT03099382|581209154|FG000|Overall Study|Protocol Violation|2|||
160951666|NCT03099382|581209155|FG001|Overall Study|Protocol Violation|3|||
160951667|NCT00499369|581209158|FG000|Overall Study|Adverse Event|2|||
160951668|NCT00499369|581209159|FG001|Overall Study|Adverse Event|2|||
160951669|NCT00499369|581209160|FG002|Overall Study|Adverse Event|3|||
160951670|NCT00499369|581209161|FG003|Overall Study|Adverse Event|1|||
160951671|NCT00499369|581209162|FG004|Overall Study|Adverse Event|2|||
160951672|NCT00499369|581209158|FG000|Overall Study|Withdrawal by Subject|0|||
160951673|NCT00499369|581209159|FG001|Overall Study|Withdrawal by Subject|1|||
160951674|NCT00499369|581209160|FG002|Overall Study|Withdrawal by Subject|1|||
160951675|NCT00499369|581209161|FG003|Overall Study|Withdrawal by Subject|0|||
160951676|NCT00499369|581209162|FG004|Overall Study|Withdrawal by Subject|0|||
160951677|NCT00499369|581209158|FG000|Overall Study|Progression|10|||
160951678|NCT00499369|581209159|FG001|Overall Study|Progression|12|||
160951679|NCT00499369|581209160|FG002|Overall Study|Progression|9|||
160862540|NCT02260934|580889768|FG001|Overall Study|Withdrawal by Subject|2|||
160862541|NCT02260934|580889767|FG000|Overall Study|Participant Relocated|1|||
160862542|NCT02260934|580889768|FG001|Overall Study|Participant Relocated|0|||
160862543|NCT02260934|580889767|FG000|Overall Study|Site error|0|||
160862544|NCT02260934|580889768|FG001|Overall Study|Site error|1|||
160862545|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
160862546|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
160862547|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
160862548|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
160862549|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
160862550|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
160862551|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
160862552|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
160862553|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
160862554|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
160862555|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
160862556|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
160862557|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
160862558|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
160862559|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
160862560|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
160862561|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
160862562|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
160862563|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
160862564|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
160862565|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
160862566|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
160862567|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Other|6|||
160862568|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Other|8|||
160862569|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
160862570|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
160862571|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
160862572|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
160862573|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
160862574|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
160862575|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
160862576|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
160862577|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
160862578|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
160862579|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
160862580|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
160862581|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Death|0|||
160862582|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Death|2|||
160862583|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
160862584|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
160862585|NCT05632211|580889773|FG000|Overall Study|Withdrawal by Subject|2|||
160862586|NCT05632211|580889774|FG001|Overall Study|Withdrawal by Subject|0|||
160862587|NCT05632211|580889775|FG002|Overall Study|Withdrawal by Subject|2|||
160862588|NCT05632211|580889773|FG000|Overall Study|Other reasons|1|||
160862589|NCT05632211|580889774|FG001|Overall Study|Other reasons|1|||
160862590|NCT05632211|580889775|FG002|Overall Study|Other reasons|1|||
160862591|NCT02628873|580889776|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
160862592|NCT02628873|580889777|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
160862593|NCT02628873|580889776|FG000|Second Test (1 Hour)|Physician Decision|1|||
160862594|NCT02628873|580889777|FG001|Second Test (1 Hour)|Physician Decision|0|||
160862595|NCT03597347|580889780|FG000|Overall Study|Withdrawal by Subject|1|||
160862596|NCT03597347|580889781|FG001|Overall Study|Withdrawal by Subject|1|||
160862597|NCT03597347|580889782|FG002|Overall Study|Withdrawal by Subject|0|||
160862598|NCT03597347|580889780|FG000|Overall Study|Withdrawal due to Covid-19|3|||
160862599|NCT03597347|580889781|FG001|Overall Study|Withdrawal due to Covid-19|0|||
160862600|NCT03597347|580889782|FG002|Overall Study|Withdrawal due to Covid-19|0|||
160862601|NCT03597347|580889780|FG000|Overall Study|Sponsor decision to terminate study|3|||
160862602|NCT03597347|580889781|FG001|Overall Study|Sponsor decision to terminate study|2|||
160862603|NCT03597347|580889782|FG002|Overall Study|Sponsor decision to terminate study|4|||
160862604|NCT04606134|580889783|FG000|Overall Study|Adverse Event|0|||
160862605|NCT04606134|580889784|FG001|Overall Study|Adverse Event|1|||
160862606|NCT00541658|580889786|FG000|Overall Study|Adverse Event|28|||
160862607|NCT00541658|580889787|FG001|Overall Study|Adverse Event|37|||
160862608|NCT00541658|580889788|FG002|Overall Study|Adverse Event|25|||
160862609|NCT00541658|580889786|FG000|Overall Study|Physician Decision|0|||
160862610|NCT00541658|580889787|FG001|Overall Study|Physician Decision|0|||
160862611|NCT00541658|580889788|FG002|Overall Study|Physician Decision|4|||
160862612|NCT00541658|580889786|FG000|Overall Study|Lost to Follow-up|3|||
160862613|NCT00541658|580889787|FG001|Overall Study|Lost to Follow-up|3|||
160862614|NCT00541658|580889788|FG002|Overall Study|Lost to Follow-up|6|||
160862615|NCT00541658|580889786|FG000|Overall Study|Protocol Violation|0|||
160862616|NCT00541658|580889787|FG001|Overall Study|Protocol Violation|1|||
160862617|NCT00541658|580889788|FG002|Overall Study|Protocol Violation|1|||
160862618|NCT00541658|580889786|FG000|Overall Study|Withdrawal by Subject|28|||
160862619|NCT00541658|580889787|FG001|Overall Study|Withdrawal by Subject|32|||
160862620|NCT00541658|580889788|FG002|Overall Study|Withdrawal by Subject|32|||
160862621|NCT00541658|580889786|FG000|Overall Study|Took No Study Drug|1|||
160862622|NCT00541658|580889787|FG001|Overall Study|Took No Study Drug|0|||
160862623|NCT00541658|580889788|FG002|Overall Study|Took No Study Drug|0|||
160862624|NCT01099267|580889789|FG000|MDS-003 Study|Adverse Event|37|||
160862625|NCT01099267|580889789|FG000|MDS-003 Study|Lack of Efficacy|52|||
160862626|NCT01099267|580889789|FG000|MDS-003 Study|Withdrawal by Subject|8|||
160862627|NCT01099267|580889789|FG000|MDS-003 Study|Lost to Follow-up|1|||
160862628|NCT01099267|580889789|FG000|MDS-003 Study|Death|11|||
160862629|NCT01099267|580889789|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
160862630|NCT01099267|580889789|FG000|MDS-003 Study|Disease Progression|7|||
160862631|NCT01099267|580889789|FG000|MDS-003 Study|Investigator Decision|2|||
160862632|NCT01099267|580889789|FG000|MDS-003 Study|Non-Compliance|2|||
160862633|NCT01099267|580889789|FG000|MDS-003 Study|Loss of Response|1|||
160862634|NCT01099267|580889789|FG000|MDS-003 Study|Secondary Malign Disease|1|||
160862635|NCT04986904|580889790|FG000|Overall Study|Lost to Follow-up|11|||
160862636|NCT04986904|580889790|FG000|Overall Study|Withdrawal by Subject|1|||
160951680|NCT00499369|581209161|FG003|Overall Study|Progression|6|||
160862637|NCT05194124|580889802|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160951681|NCT00499369|581209162|FG004|Overall Study|Progression|10|||
160951682|NCT00499369|581209158|FG000|Overall Study|Death|0|||
160862638|NCT05194124|580889803|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862639|NCT05194124|580889804|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862640|NCT05194124|580889805|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
160862641|NCT05194124|580889806|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862642|NCT05194124|580889807|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
160862643|NCT05194124|580889808|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862644|NCT05194124|580889809|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862645|NCT05194124|580889810|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862646|NCT05194124|580889811|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862647|NCT05194124|580889802|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862648|NCT05194124|580889803|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862649|NCT05194124|580889804|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862650|NCT05194124|580889805|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862651|NCT05194124|580889806|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862652|NCT05194124|580889807|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862653|NCT05194124|580889808|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862654|NCT05194124|580889809|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862655|NCT05194124|580889810|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862656|NCT05194124|580889811|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
160862657|NCT05408429|580889816|FG000|Overall Study|Lost to Follow-up|1|||
160862658|NCT05408429|580889817|FG001|Overall Study|Lost to Follow-up|1|||
160862659|NCT05408429|580889818|FG002|Overall Study|Lost to Follow-up|0|||
160862660|NCT05408429|580889816|FG000|Overall Study|Withdrawal by Subject|5|||
160862661|NCT05408429|580889817|FG001|Overall Study|Withdrawal by Subject|0|||
160862662|NCT05408429|580889818|FG002|Overall Study|Withdrawal by Subject|1|||
160862663|NCT03642873|580889819|FG000|Third Intervention (1 Day)|Screen failure|0|||
160862664|NCT03642873|580889820|FG001|Third Intervention (1 Day)|Screen failure|0|||
160862665|NCT03642873|580889821|FG002|Third Intervention (1 Day)|Screen failure|0|||
160862666|NCT03642873|580889822|FG003|Third Intervention (1 Day)|Screen failure|0|||
160862667|NCT03642873|580889823|FG004|Third Intervention (1 Day)|Screen failure|1|||
160862668|NCT03642873|580889824|FG005|Third Intervention (1 Day)|Screen failure|0|||
160862669|NCT03312231|580889825|FG000|Overall Study|Lost to Follow-up|2|||
160862670|NCT03312231|580889826|FG001|Overall Study|Lost to Follow-up|6|||
160862671|NCT03312231|580889827|FG002|Overall Study|Lost to Follow-up|1|||
160862672|NCT03312231|580889828|FG003|Overall Study|Lost to Follow-up|3|||
160862673|NCT03312231|580889829|FG004|Overall Study|Lost to Follow-up|1|||
160862674|NCT03312231|580889825|FG000|Overall Study|Withdrawal by Subject|0|||
160862675|NCT03312231|580889826|FG001|Overall Study|Withdrawal by Subject|3|||
160862676|NCT03312231|580889827|FG002|Overall Study|Withdrawal by Subject|1|||
160862677|NCT03312231|580889828|FG003|Overall Study|Withdrawal by Subject|0|||
160862678|NCT03312231|580889829|FG004|Overall Study|Withdrawal by Subject|0|||
160951683|NCT00499369|581209159|FG001|Overall Study|Death|1|||
160951684|NCT00499369|581209160|FG002|Overall Study|Death|0|||
160951685|NCT00499369|581209161|FG003|Overall Study|Death|0|||
160951686|NCT00499369|581209162|FG004|Overall Study|Death|0|||
160951687|NCT00499369|581209158|FG000|Overall Study|Not protocol specified|2|||
160951688|NCT00499369|581209159|FG001|Overall Study|Not protocol specified|0|||
161000768|NCT00941655|581388871|FG000|Overall Study|withdrew consent|0|||
161000769|NCT00941655|581388872|FG001|Overall Study|withdrew consent|1|||
161000770|NCT00941655|581388871|FG000|Overall Study|non-compliant|0|||
160951689|NCT00499369|581209160|FG002|Overall Study|Not protocol specified|3|||
160951690|NCT00499369|581209161|FG003|Overall Study|Not protocol specified|1|||
160951691|NCT00499369|581209162|FG004|Overall Study|Not protocol specified|0|||
160951692|NCT00499369|581209158|FG000|Overall Study|Ineligible|2|||
160951693|NCT00499369|581209159|FG001|Overall Study|Ineligible|2|||
160951694|NCT00499369|581209160|FG002|Overall Study|Ineligible|1|||
160951695|NCT00499369|581209161|FG003|Overall Study|Ineligible|1|||
160951696|NCT00499369|581209162|FG004|Overall Study|Ineligible|0|||
160862679|NCT03312231|580889825|FG000|Overall Study|Death|0|||
160862680|NCT03312231|580889826|FG001|Overall Study|Death|1|||
160862681|NCT03312231|580889827|FG002|Overall Study|Death|1|||
160862682|NCT03312231|580889828|FG003|Overall Study|Death|0|||
160862683|NCT03312231|580889829|FG004|Overall Study|Death|0|||
160862684|NCT03312231|580889825|FG000|Overall Study|Study Vaccination not Received|1|||
160862685|NCT03312231|580889826|FG001|Overall Study|Study Vaccination not Received|1|||
160862686|NCT03312231|580889827|FG002|Overall Study|Study Vaccination not Received|1|||
160862687|NCT03312231|580889828|FG003|Overall Study|Study Vaccination not Received|0|||
160862688|NCT03312231|580889829|FG004|Overall Study|Study Vaccination not Received|0|||
160862689|NCT03157830|580889833|FG000|Overall Study|Lost to Follow-up|1|||
160951697|NCT01898195|581209164|FG000|Smoking Abstinence|Did not have good measurements|35|||
160951698|NCT01898195|581209165|FG001|Smoking Abstinence|Did not have good measurements|38|||
160862690|NCT03157830|580889833|FG000|Overall Study|Withdrawal by Subject|1|||
160862691|NCT04607005|580889834|FG000|Overall Study|Adverse Event|0|||
160862692|NCT04607005|580889835|FG001|Overall Study|Adverse Event|1|||
160862693|NCT04607005|580889834|FG000|Overall Study|Lack of Efficacy|1|||
160862694|NCT04607005|580889835|FG001|Overall Study|Lack of Efficacy|6|||
160862695|NCT04607005|580889834|FG000|Overall Study|Withdrawal by Subject|4|||
160862696|NCT04607005|580889835|FG001|Overall Study|Withdrawal by Subject|9|||
160862697|NCT04607005|580889834|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
160862698|NCT04607005|580889835|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
160862699|NCT03472885|580889836|FG000|24-Week Treatment Period|Adverse Event|1|||
160862700|NCT00091949|580891363|FG000|Overall Study|Withdrawal by Subject|117|||
160862701|NCT00091949|580891364|FG001|Overall Study|Withdrawal by Subject|110|||
160862702|NCT00091949|580891363|FG000|Overall Study|Lost to Follow-up|58|||
160862703|NCT00091949|580891364|FG001|Overall Study|Lost to Follow-up|41|||
160862704|NCT01256788|580891367|FG000|Overall Study|Lost to Follow-up|5|||
160862705|NCT01256788|580891368|FG001|Overall Study|Lost to Follow-up|8|||
160862706|NCT01256788|580891369|FG002|Overall Study|Lost to Follow-up|3|||
160862707|NCT01352715|580891371|FG000|Overall Study|Death|3|||
160862708|NCT01352715|580891372|FG001|Overall Study|Death|3|||
160862709|NCT01352715|580891371|FG000|Overall Study|Lost to Follow-up|5|||
160862710|NCT01352715|580891372|FG001|Overall Study|Lost to Follow-up|7|||
160862711|NCT01352715|580891371|FG000|Overall Study|Withdrawal by Subject|4|||
160862712|NCT01352715|580891372|FG001|Overall Study|Withdrawal by Subject|8|||
160862713|NCT01352715|580891371|FG000|Overall Study|site closure|16|||
160862714|NCT01352715|580891372|FG001|Overall Study|site closure|15|||
160862715|NCT01352715|580891371|FG000|Overall Study|no final visit in closeout period|15|||
160862716|NCT01352715|580891372|FG001|Overall Study|no final visit in closeout period|12|||
160862717|NCT01352715|580891371|FG000|Overall Study|major ineligibility|2|||
160862718|NCT01352715|580891372|FG001|Overall Study|major ineligibility|1|||
160862719|NCT02000440|580891373|FG000|Overall Study|Adverse Event|3|||
160862720|NCT02000440|580891373|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
160862721|NCT02383576|580891375|FG000|Overall Study|Death|53|||
160862722|NCT02383576|580891376|FG001|Overall Study|Death|33|||
160951699|NCT01898195|581209166|FG002|Smoking Abstinence|Did not have good measurements|36|||
160951700|NCT01802411|581209167|FG000|Overall Study|Death|2|||
160951701|NCT01802411|581209168|FG001|Overall Study|Death|1|||
160951702|NCT01802411|581209167|FG000|Overall Study|Adverse Event|2|||
160951703|NCT01802411|581209168|FG001|Overall Study|Adverse Event|7|||
160951704|NCT01802411|581209167|FG000|Overall Study|Lack of Efficacy|8|||
160951705|NCT01802411|581209168|FG001|Overall Study|Lack of Efficacy|10|||
160951706|NCT01802411|581209167|FG000|Overall Study|Withdrawal by Subject|0|||
160951707|NCT01802411|581209168|FG001|Overall Study|Withdrawal by Subject|2|||
160951708|NCT01802411|581209167|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
160951709|NCT01802411|581209168|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
160862723|NCT02383576|580891375|FG000|Overall Study|Lost to Follow-up|7|||
160862724|NCT02383576|580891376|FG001|Overall Study|Lost to Follow-up|1|||
160862725|NCT02383576|580891375|FG000|Overall Study|Withdrew Consent|1|||
160862726|NCT02383576|580891376|FG001|Overall Study|Withdrew Consent|6|||
160862727|NCT02383576|580891375|FG000|Overall Study|Investigator's Decision|0|||
160862728|NCT02383576|580891376|FG001|Overall Study|Investigator's Decision|1|||
160862729|NCT02383576|580891375|FG000|Overall Study|Administrative/Other|2|||
160862730|NCT02383576|580891376|FG001|Overall Study|Administrative/Other|4|||
160862731|NCT00871975|580891377|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
160862732|NCT00871975|580891377|FG000|Overall Study|Catheters could not be inserted|1|||
160862733|NCT00871975|580891377|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
160862734|NCT00871975|580891377|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
160862735|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
160862736|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
160862737|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
160862738|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
160582521|NCT03725202|579853635|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
160582522|NCT03725202|579853636|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
160582523|NCT03725202|579853629|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
160582524|NCT03725202|579853630|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
160862739|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
160862740|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
160862741|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
160862742|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
160862743|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
160862744|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
160862745|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
160862746|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
160862747|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
160862748|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
160862749|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
160862750|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Other|119|||
160862751|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Other|0|||
160862752|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Other|0|||
160862753|NCT01436149|580891381|FG000|Randomized Phase|Adverse Event|9|||
160862754|NCT01436149|580891382|FG001|Randomized Phase|Adverse Event|10|||
160862755|NCT01436149|580891383|FG002|Randomized Phase|Adverse Event|11|||
160862756|NCT01436149|580891381|FG000|Randomized Phase|Protocol Violation|4|||
160862757|NCT01436149|580891382|FG001|Randomized Phase|Protocol Violation|5|||
160862758|NCT01436149|580891383|FG002|Randomized Phase|Protocol Violation|0|||
160862759|NCT01436149|580891381|FG000|Randomized Phase|Withdrawal by Subject|16|||
160862760|NCT01436149|580891382|FG001|Randomized Phase|Withdrawal by Subject|10|||
160862761|NCT01436149|580891383|FG002|Randomized Phase|Withdrawal by Subject|10|||
160862762|NCT01436149|580891381|FG000|Randomized Phase|Lost to Follow-up|34|||
160862763|NCT01436149|580891382|FG001|Randomized Phase|Lost to Follow-up|5|||
160862764|NCT01436149|580891383|FG002|Randomized Phase|Lost to Follow-up|6|||
160862765|NCT01436149|580891381|FG000|Randomized Phase|Lack of Efficacy|0|||
160862766|NCT01436149|580891382|FG001|Randomized Phase|Lack of Efficacy|0|||
160862767|NCT01436149|580891383|FG002|Randomized Phase|Lack of Efficacy|1|||
160862768|NCT01436149|580891381|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
160862769|NCT01436149|580891382|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
160862770|NCT01436149|580891383|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
160951710|NCT01802411|581209167|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
160951711|NCT01802411|581209168|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
160951712|NCT01802411|581209167|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
160951713|NCT01802411|581209168|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
160951714|NCT01337245|581209172|FG000|Overall Study|Lost to Follow-up|1|||
160951715|NCT03930745|581209173|FG000|Overall Study|Lost to Follow-up|10|||
160951716|NCT03930745|581209174|FG001|Overall Study|Lost to Follow-up|5|||
160951717|NCT03930745|581209173|FG000|Overall Study|Withdrawal by Subject|1|||
160951718|NCT03930745|581209174|FG001|Overall Study|Withdrawal by Subject|2|||
160951719|NCT03930745|581209173|FG000|Overall Study|Protocol Violation|2|||
160951720|NCT03930745|581209174|FG001|Overall Study|Protocol Violation|2|||
160951721|NCT03930745|581209173|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
160951722|NCT03930745|581209174|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
160951723|NCT03930745|581209173|FG000|Overall Study|Adverse Event|0|||
160951724|NCT03930745|581209174|FG001|Overall Study|Adverse Event|1|||
160951725|NCT03930745|581209173|FG000|Overall Study|Pregnancy|0|||
160951726|NCT03930745|581209174|FG001|Overall Study|Pregnancy|1|||
160951727|NCT02715765|581209175|FG000|Overall Study|Study Termination|3|||
160951728|NCT02715765|581209176|FG001|Overall Study|Study Termination|0|||
160951729|NCT02715765|581209177|FG002|Overall Study|Study Termination|0|||
160951730|NCT04095858|581209178|FG000|Overall Study|Death|1|||
160951731|NCT04095858|581209179|FG001|Overall Study|Death|0|||
160951732|NCT04095858|581209178|FG000|Overall Study|Study terminated by Sponsor|2|||
160951733|NCT04095858|581209179|FG001|Overall Study|Study terminated by Sponsor|4|||
160951734|NCT01344460|581209180|FG000|Overall Study|Withdrawal by Subject|1|||
160951735|NCT01344460|581209180|FG000|Overall Study|Lost to Follow-up|2|||
160951736|NCT02838017|581209182|FG000|Overall Study|Lost to Follow-up|14|||
160951737|NCT02838017|581209183|FG001|Overall Study|Lost to Follow-up|11|||
160951738|NCT01692197|581209184|FG000|Overall Study|Failed Screening|3|||
160951739|NCT02120924|581209185|FG000|Overall Study|Lack of Efficacy|1|||
160951740|NCT02120924|581209186|FG001|Overall Study|Lack of Efficacy|2|||
160951741|NCT02120924|581209187|FG002|Overall Study|Lack of Efficacy|3|||
160951742|NCT02120924|581209185|FG000|Overall Study|Adverse Event|0|||
160951743|NCT02120924|581209186|FG001|Overall Study|Adverse Event|1|||
160951744|NCT02120924|581209187|FG002|Overall Study|Adverse Event|3|||
160951745|NCT02120924|581209185|FG000|Overall Study|Withdrawal by Subject|16|||
160951746|NCT02120924|581209186|FG001|Overall Study|Withdrawal by Subject|20|||
160951747|NCT02120924|581209187|FG002|Overall Study|Withdrawal by Subject|8|||
160951748|NCT02120924|581209185|FG000|Overall Study|Lost to Follow-up|14|||
160951749|NCT02120924|581209186|FG001|Overall Study|Lost to Follow-up|14|||
161000771|NCT00941655|581388872|FG001|Overall Study|non-compliant|1|||
161000772|NCT00446550|581388873|FG000|Overall Study|Adverse Event|1|||
161000773|NCT00446550|581388874|FG001|Overall Study|Adverse Event|0|||
160951750|NCT02120924|581209187|FG002|Overall Study|Lost to Follow-up|11|||
160951751|NCT02120924|581209185|FG000|Overall Study|Pregnancy|2|||
160951752|NCT02120924|581209186|FG001|Overall Study|Pregnancy|0|||
160951753|NCT02120924|581209187|FG002|Overall Study|Pregnancy|0|||
161000774|NCT02983617|581388875|FG000|Overall Study|Adverse Event|0|||
160951754|NCT02120924|581209185|FG000|Overall Study|Protocol Violation|3|||
160951755|NCT02120924|581209186|FG001|Overall Study|Protocol Violation|7|||
160951756|NCT02120924|581209187|FG002|Overall Study|Protocol Violation|2|||
160951757|NCT02120924|581209185|FG000|Overall Study|Physician Decision|0|||
160951758|NCT02120924|581209186|FG001|Overall Study|Physician Decision|1|||
160951759|NCT02120924|581209187|FG002|Overall Study|Physician Decision|1|||
160951760|NCT02120924|581209185|FG000|Overall Study|Death|1|||
160951761|NCT02120924|581209186|FG001|Overall Study|Death|0|||
161000775|NCT02983617|581388876|FG001|Overall Study|Adverse Event|7|||
161000776|NCT02983617|581388875|FG000|Overall Study|Death|0|||
161000777|NCT02983617|581388876|FG001|Overall Study|Death|1|||
161000778|NCT02983617|581388875|FG000|Overall Study|Investigator's Discretion|0|||
161000779|NCT02983617|581388876|FG001|Overall Study|Investigator's Discretion|1|||
161000780|NCT02027558|581388879|FG000|Overall Study|Death|0|||
161000781|NCT02027558|581388880|FG001|Overall Study|Death|1|||
161000782|NCT02027558|581388879|FG000|Overall Study|Withdrawal by Subject|2|||
161000783|NCT02027558|581388880|FG001|Overall Study|Withdrawal by Subject|0|||
161000784|NCT02027558|581388879|FG000|Overall Study|Lost to Follow-up|4|||
161000785|NCT02027558|581388880|FG001|Overall Study|Lost to Follow-up|1|||
160457387|NCT03677141|579406376|FG002|Overall Study|Screen failure or enrolled in error|0|||
160951762|NCT02120924|581209187|FG002|Overall Study|Death|0|||
160951763|NCT02120924|581209185|FG000|Overall Study|Compliance with IP|5|||
160951764|NCT02120924|581209186|FG001|Overall Study|Compliance with IP|1|||
160951765|NCT02120924|581209187|FG002|Overall Study|Compliance with IP|1|||
160951766|NCT03483623|581209188|FG000|Overall Study|43 complete sets achieved|1|||
160951767|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
160951768|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
160951769|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
160862771|NCT01436149|580891381|FG000|Randomized Phase|Other|12|||
160862772|NCT01436149|580891382|FG001|Randomized Phase|Other|5|||
160862773|NCT01436149|580891383|FG002|Randomized Phase|Other|11|||
160862774|NCT01690143|580891384|FG000|Overall Study|Withdrawal by Subject|1|||
160862775|NCT04849364|580891385|FG000|Overall Study|Eligibility criteria not meet|0|||
160862776|NCT04849364|580891386|FG001|Overall Study|Eligibility criteria not meet|1|||
160862777|NCT04849364|580891387|FG002|Overall Study|Eligibility criteria not meet|0|||
160862778|NCT01643668|580891388|FG000|Overall Study|Death|1|||
160862779|NCT00307801|580891397|FG000|Overall Study|Adverse Event|12|||
160862780|NCT00307801|580891398|FG001|Overall Study|Adverse Event|4|||
160862781|NCT00307801|580891397|FG000|Overall Study|Withdrawal by Subject|9|||
160862782|NCT00307801|580891398|FG001|Overall Study|Withdrawal by Subject|4|||
160862783|NCT00307801|580891397|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
160862784|NCT00307801|580891398|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
160862785|NCT00307801|580891397|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
160862786|NCT00307801|580891398|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
160862787|NCT00307801|580891397|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
160862788|NCT00307801|580891398|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
160862789|NCT00307801|580891397|FG000|Overall Study|Wrong Randomization|1|||
160951770|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
160951771|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
161000786|NCT02027558|581388879|FG000|Overall Study|Refused assessment|3|||
161000787|NCT02027558|581388880|FG001|Overall Study|Refused assessment|0|||
161000788|NCT04218110|581388881|FG000|Overall Study|Withdrawal by Subject|0|||
161000789|NCT04218110|581388882|FG001|Overall Study|Withdrawal by Subject|0|||
160457388|NCT03677141|579406377|FG003|Overall Study|Screen failure or enrolled in error|0|||
160457389|NCT03677141|579406378|FG004|Overall Study|Screen failure or enrolled in error|2|||
160457390|NCT03677141|579406379|FG005|Overall Study|Screen failure or enrolled in error|0|||
160457391|NCT03677141|579406374|FG000|Overall Study|Physician Decision|0|||
160457392|NCT03677141|579406375|FG001|Overall Study|Physician Decision|0|||
160457393|NCT03677141|579406376|FG002|Overall Study|Physician Decision|0|||
160457394|NCT03677141|579406377|FG003|Overall Study|Physician Decision|0|||
160457395|NCT03677141|579406378|FG004|Overall Study|Physician Decision|1|||
160457396|NCT03677141|579406379|FG005|Overall Study|Physician Decision|0|||
160457397|NCT03677141|579406374|FG000|Overall Study|Withdrawal by Subject|0|||
160457398|NCT03677141|579406375|FG001|Overall Study|Withdrawal by Subject|0|||
160457399|NCT03677141|579406376|FG002|Overall Study|Withdrawal by Subject|1|||
160582525|NCT03725202|579853631|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
160582526|NCT03725202|579853632|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
160582527|NCT03725202|579853633|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
160582528|NCT03725202|579853634|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161000790|NCT04218110|581388883|FG002|Overall Study|Withdrawal by Subject|0|||
161000791|NCT04218110|581388884|FG003|Overall Study|Withdrawal by Subject|1|||
161000792|NCT00516386|581388885|FG000|Overall Study|not interested in the study|4|||
161000793|NCT00516386|581388885|FG000|Overall Study|Lost to Follow-up|2|||
160457400|NCT03677141|579406377|FG003|Overall Study|Withdrawal by Subject|1|||
160457401|NCT03677141|579406378|FG004|Overall Study|Withdrawal by Subject|1|||
160951772|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
160951773|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
160951774|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
160951775|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
161000794|NCT02698891|581388886|FG000|Overall Study|Withdrawal by Subject|2|||
161000795|NCT02698891|581388886|FG000|Overall Study|deemed ineligible|1|||
161000796|NCT02698891|581388886|FG000|Overall Study|Adverse Event|9|||
160862790|NCT00307801|580891398|FG001|Overall Study|Wrong Randomization|0|||
160862791|NCT00307801|580891397|FG000|Overall Study|Lack of Efficacy|0|||
160862792|NCT00307801|580891398|FG001|Overall Study|Lack of Efficacy|2|||
160862793|NCT00307801|580891397|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
160862794|NCT00307801|580891398|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
160862795|NCT00307801|580891397|FG000|Overall Study|Frustration with e-diary|1|||
160862796|NCT00307801|580891398|FG001|Overall Study|Frustration with e-diary|0|||
160862797|NCT00307801|580891397|FG000|Overall Study|Protocol Violation|3|||
160862798|NCT00307801|580891398|FG001|Overall Study|Protocol Violation|2|||
160862799|NCT00307801|580891397|FG000|Overall Study|No reason specified|2|||
160862800|NCT00307801|580891398|FG001|Overall Study|No reason specified|0|||
160862801|NCT00307801|580891397|FG000|Overall Study|Pregnancy|0|||
160862802|NCT00307801|580891398|FG001|Overall Study|Pregnancy|1|||
160862803|NCT03944577|580891404|FG000|Overall Study|Adverse Event|3|||
160862804|NCT03011099|580891407|FG000|Overall Study|Withdrawal by Subject|0|||
160862805|NCT03011099|580891408|FG001|Overall Study|Withdrawal by Subject|2|||
160862806|NCT01217229|580891411|FG000|Overall Study|Adverse Event|1|||
160862807|NCT01217229|580891411|FG000|Overall Study|Disease progression, deterioration|2|||
160862808|NCT01217229|580891411|FG000|Overall Study|Disease progression, Cheson criteria|14|||
160862809|NCT01217229|580891411|FG000|Overall Study|Protocol Violation|1|||
160862810|NCT01217229|580891411|FG000|Overall Study|Disease progression not confirmed|2|||
160862811|NCT00577889|580891414|FG000|Overall Study|Withdrawal by Subject|1|||
160862812|NCT00577889|580891415|FG001|Overall Study|Withdrawal by Subject|0|||
160862813|NCT00577889|580891416|FG002|Overall Study|Withdrawal by Subject|0|||
160862814|NCT01523756|580891418|FG000|Baseline Period|Adverse Event|0|||
160862815|NCT01523756|580891419|FG001|Baseline Period|Adverse Event|1|||
160862816|NCT01523756|580891418|FG000|Test Period 1|Adverse Event|1|||
160951776|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
160951777|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
160951778|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
160951779|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
160457402|NCT03677141|579406379|FG005|Overall Study|Withdrawal by Subject|0|||
160457403|NCT04003246|579406383|FG000|Overall Study|Death|9|||
160457404|NCT01314105|579406388|FG000|Overall Study|Progressive Disease|6|||
160457405|NCT01314105|579406389|FG001|Overall Study|Progressive Disease|10|||
160457406|NCT01314105|579406388|FG000|Overall Study|Refused to continue taking medication|0|||
160457407|NCT01314105|579406389|FG001|Overall Study|Refused to continue taking medication|1|||
160457408|NCT01314105|579406388|FG000|Overall Study|Other Adverse Event|1|||
160457409|NCT01314105|579406389|FG001|Overall Study|Other Adverse Event|1|||
160457410|NCT03640286|579406395|FG000|Overall Study|Adverse Event|6|||
160457411|NCT03640286|579406396|FG001|Overall Study|Adverse Event|6|||
160582529|NCT03725202|579853635|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
160862817|NCT01523756|580891419|FG001|Test Period 1|Adverse Event|0|||
160951780|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
160951781|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
160951782|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
160951783|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
160951784|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
160951785|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
160951786|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
160951787|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
160951788|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
160951789|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
160951790|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
160951791|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
160951792|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
160951793|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
160951794|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
160951795|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
160951796|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
160951797|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
160951798|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
160951799|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
160951800|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
160951801|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
160951802|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
160951803|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
160862818|NCT01523756|580891418|FG000|Test Period 2|Withdrawal by Subject|0|||
160862819|NCT01523756|580891419|FG001|Test Period 2|Withdrawal by Subject|1|||
160582530|NCT03725202|579853636|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
160951804|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
160951805|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
160951806|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
160951807|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
160862820|NCT03224819|580891422|FG000|Overall Study|Withdrawal by Subject|0|||
160951808|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
160951809|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
160862821|NCT03224819|580891423|FG001|Overall Study|Withdrawal by Subject|0|||
160862822|NCT03224819|580891424|FG002|Overall Study|Withdrawal by Subject|0|||
160862823|NCT03224819|580891425|FG003|Overall Study|Withdrawal by Subject|0|||
160862824|NCT03224819|580891426|FG004|Overall Study|Withdrawal by Subject|0|||
160862825|NCT03224819|580891427|FG005|Overall Study|Withdrawal by Subject|0|||
160862826|NCT03224819|580891428|FG006|Overall Study|Withdrawal by Subject|0|||
160862827|NCT03224819|580891429|FG007|Overall Study|Withdrawal by Subject|0|||
160862828|NCT03224819|580891430|FG008|Overall Study|Withdrawal by Subject|0|||
160862829|NCT03224819|580891431|FG009|Overall Study|Withdrawal by Subject|0|||
160862830|NCT03224819|580891432|FG010|Overall Study|Withdrawal by Subject|0|||
160862831|NCT03224819|580891433|FG011|Overall Study|Withdrawal by Subject|0|||
160862832|NCT03224819|580891434|FG012|Overall Study|Withdrawal by Subject|1|||
160862833|NCT03224819|580891435|FG013|Overall Study|Withdrawal by Subject|0|||
160862834|NCT03224819|580891422|FG000|Overall Study|Sponsor Decision|0|||
160951810|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
160951811|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
160951812|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
160862835|NCT03224819|580891423|FG001|Overall Study|Sponsor Decision|0|||
160862836|NCT03224819|580891424|FG002|Overall Study|Sponsor Decision|0|||
160862837|NCT03224819|580891425|FG003|Overall Study|Sponsor Decision|1|||
160951813|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
160951814|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
160951815|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
160951816|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
160582531|NCT03725202|579853629|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
160582532|NCT03725202|579853630|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
160862838|NCT03224819|580891426|FG004|Overall Study|Sponsor Decision|1|||
160862839|NCT03224819|580891427|FG005|Overall Study|Sponsor Decision|2|||
160862840|NCT03224819|580891428|FG006|Overall Study|Sponsor Decision|1|||
160862841|NCT03224819|580891429|FG007|Overall Study|Sponsor Decision|1|||
160862842|NCT03224819|580891430|FG008|Overall Study|Sponsor Decision|1|||
160862843|NCT03224819|580891431|FG009|Overall Study|Sponsor Decision|2|||
160862844|NCT03224819|580891432|FG010|Overall Study|Sponsor Decision|1|||
160862845|NCT03224819|580891433|FG011|Overall Study|Sponsor Decision|1|||
160862846|NCT03224819|580891434|FG012|Overall Study|Sponsor Decision|1|||
160862847|NCT03224819|580891435|FG013|Overall Study|Sponsor Decision|0|||
160862848|NCT03224819|580891422|FG000|Overall Study|Lost to Follow-up|0|||
160862849|NCT03224819|580891423|FG001|Overall Study|Lost to Follow-up|0|||
160951817|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
160951818|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
160862850|NCT03224819|580891424|FG002|Overall Study|Lost to Follow-up|0|||
160862851|NCT03224819|580891425|FG003|Overall Study|Lost to Follow-up|0|||
160862852|NCT03224819|580891426|FG004|Overall Study|Lost to Follow-up|0|||
160862853|NCT03224819|580891427|FG005|Overall Study|Lost to Follow-up|0|||
160862854|NCT03224819|580891428|FG006|Overall Study|Lost to Follow-up|0|||
160862855|NCT03224819|580891429|FG007|Overall Study|Lost to Follow-up|0|||
160862856|NCT03224819|580891430|FG008|Overall Study|Lost to Follow-up|1|||
160862857|NCT03224819|580891431|FG009|Overall Study|Lost to Follow-up|0|||
160862858|NCT03224819|580891432|FG010|Overall Study|Lost to Follow-up|0|||
160862859|NCT03224819|580891433|FG011|Overall Study|Lost to Follow-up|0|||
160862860|NCT03224819|580891434|FG012|Overall Study|Lost to Follow-up|0|||
160862861|NCT03224819|580891435|FG013|Overall Study|Lost to Follow-up|0|||
160862862|NCT03224819|580891422|FG000|Overall Study|Death|0|||
160862863|NCT03224819|580891423|FG001|Overall Study|Death|1|||
160862864|NCT03224819|580891424|FG002|Overall Study|Death|0|||
160862865|NCT03224819|580891425|FG003|Overall Study|Death|0|||
160862866|NCT03224819|580891426|FG004|Overall Study|Death|0|||
160862867|NCT03224819|580891427|FG005|Overall Study|Death|0|||
160862868|NCT03224819|580891428|FG006|Overall Study|Death|0|||
160862869|NCT03224819|580891429|FG007|Overall Study|Death|1|||
160457412|NCT03640286|579406395|FG000|Overall Study|Lost to Follow-up|3|||
160862870|NCT03224819|580891430|FG008|Overall Study|Death|0|||
160862871|NCT03224819|580891431|FG009|Overall Study|Death|0|||
160862872|NCT03224819|580891432|FG010|Overall Study|Death|0|||
160862873|NCT03224819|580891433|FG011|Overall Study|Death|1|||
160862874|NCT03224819|580891434|FG012|Overall Study|Death|0|||
160862875|NCT03224819|580891435|FG013|Overall Study|Death|0|||
160862876|NCT03783078|580891436|FG000|Overall Study|Death|31|||
160862877|NCT03783078|580891436|FG000|Overall Study|Sponsor Decision|23|||
160862878|NCT03783078|580891436|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160862879|NCT01467960|580891437|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
160862880|NCT01467960|580891438|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
160862881|NCT01467960|580891439|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
160862882|NCT01467960|580891440|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
160862883|NCT01467960|580891441|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
160862884|NCT01467960|580891442|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
160862885|NCT00474812|580891443|FG000|Overall Study|Withdrawal by Subject|5|||
160862886|NCT00474812|580891443|FG000|Overall Study|No Initiation of treatment|2|||
160862887|NCT00737672|580891452|FG000|Overall Study|Graft Abandonment|48|||
160862888|NCT00737672|580891453|FG001|Overall Study|Graft Abandonment|56|||
160862889|NCT00737672|580891452|FG000|Overall Study|Death|23|||
160862890|NCT00737672|580891453|FG001|Overall Study|Death|22|||
160862891|NCT00737672|580891452|FG000|Overall Study|Withdrawal by Subject|1|||
160862892|NCT00737672|580891453|FG001|Overall Study|Withdrawal by Subject|2|||
160862893|NCT00737672|580891452|FG000|Overall Study|Lost to Follow-up|1|||
160862894|NCT00737672|580891453|FG001|Overall Study|Lost to Follow-up|0|||
160862895|NCT00737672|580891452|FG000|Overall Study|Miscellaneous|7|||
160862896|NCT00737672|580891453|FG001|Overall Study|Miscellaneous|1|||
160862897|NCT00737672|580891452|FG000|Overall Study|Physician Decision|0|||
160862898|NCT00737672|580891453|FG001|Overall Study|Physician Decision|2|||
160862899|NCT00107653|580891461|FG000|Overall Study|Adverse Event|24|||
160862900|NCT00107653|580891462|FG001|Overall Study|Adverse Event|43|||
160862901|NCT00107653|580891461|FG000|Overall Study|Insufficient Therapeutic Response|25|||
160862902|NCT00107653|580891462|FG001|Overall Study|Insufficient Therapeutic Response|11|||
160862903|NCT00107653|580891461|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
160862904|NCT00107653|580891462|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
160862905|NCT00107653|580891461|FG000|Overall Study|Protocol Violation|1|||
160862906|NCT00107653|580891462|FG001|Overall Study|Protocol Violation|0|||
160862907|NCT00107653|580891461|FG000|Overall Study|Withdrawal by Subject|12|||
160862908|NCT00107653|580891462|FG001|Overall Study|Withdrawal by Subject|13|||
160951819|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
160951820|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
160951821|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
160951822|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
160951823|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
160951824|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
160951825|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
160951826|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
160951827|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
160951828|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
160457413|NCT03640286|579406396|FG001|Overall Study|Lost to Follow-up|6|||
160951829|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
160951830|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
160951831|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
160951832|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
160951833|NCT03073603|581211002|FG000|Overall Study|Noncompliance|3|||
160951834|NCT03073603|581211003|FG001|Overall Study|Noncompliance|1|||
160951835|NCT03073603|581211002|FG000|Overall Study|Adverse Event|5|||
160951836|NCT03073603|581211003|FG001|Overall Study|Adverse Event|3|||
160951837|NCT03073603|581211002|FG000|Overall Study|Physician Decision|1|||
160951838|NCT03073603|581211003|FG001|Overall Study|Physician Decision|2|||
160951839|NCT03073603|581211002|FG000|Overall Study|Required treatment not allowed by protocol|1|||
160951840|NCT03073603|581211003|FG001|Overall Study|Required treatment not allowed by protocol|0|||
160951841|NCT03073603|581211002|FG000|Overall Study|Financial or insurance-related|8|||
160951842|NCT03073603|581211003|FG001|Overall Study|Financial or insurance-related|0|||
160951843|NCT03073603|581211002|FG000|Overall Study|Withdrawal by Subject|0|||
160951844|NCT03073603|581211003|FG001|Overall Study|Withdrawal by Subject|1|||
160951845|NCT03073603|581211002|FG000|Overall Study|Discontinued DMT|4|||
160951846|NCT03073603|581211003|FG001|Overall Study|Discontinued DMT|0|||
160951847|NCT03073603|581211002|FG000|Overall Study|Restarted DMT|0|||
160951848|NCT03073603|581211003|FG001|Overall Study|Restarted DMT|1|||
160951849|NCT02473952|581211006|FG000|Overall Study|Adverse Event|2|||
160951850|NCT02473952|581211007|FG001|Overall Study|Adverse Event|2|||
160951851|NCT02473952|581211006|FG000|Overall Study|Withdrawal by Subject|0|||
160951852|NCT02473952|581211007|FG001|Overall Study|Withdrawal by Subject|6|||
160951853|NCT02103439|581211010|FG000|Overall Study|Adverse Event|0|||
160951854|NCT02103439|581211011|FG001|Overall Study|Adverse Event|2|||
160951855|NCT02103439|581211010|FG000|Overall Study|Withdrawal by Subject|3|||
160951856|NCT02103439|581211011|FG001|Overall Study|Withdrawal by Subject|1|||
160951857|NCT02370602|581211013|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
160862909|NCT00107653|580891461|FG000|Overall Study|Lost to Follow-up|13|||
160862910|NCT00107653|580891462|FG001|Overall Study|Lost to Follow-up|5|||
160862911|NCT00107653|580891461|FG000|Overall Study|Administrative Reasons|3|||
160862912|NCT00107653|580891462|FG001|Overall Study|Administrative Reasons|3|||
160862913|NCT02018562|580891465|FG000|Overall Study|Withdrawal by Subject|2|||
160951858|NCT02370602|581211014|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
160951859|NCT02370602|581211015|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
160951860|NCT02370602|581211016|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
160951861|NCT02370602|581211017|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
160951862|NCT02370602|581211018|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
160951863|NCT04827212|581211019|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
160862914|NCT02018562|580891466|FG001|Overall Study|Withdrawal by Subject|0|||
160862915|NCT02018562|580891465|FG000|Overall Study|Discharged prior to study completion|1|||
160862916|NCT02018562|580891466|FG001|Overall Study|Discharged prior to study completion|0|||
160862917|NCT03435211|580891467|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
160862918|NCT01253291|580891469|FG000|Overall Study|Withdrawal by Subject|1|||
160862919|NCT01253291|580891470|FG001|Overall Study|Withdrawal by Subject|1|||
160862920|NCT01253291|580891471|FG002|Overall Study|Withdrawal by Subject|0|||
160862921|NCT01253291|580891472|FG003|Overall Study|Withdrawal by Subject|0|||
160862922|NCT01253291|580891473|FG004|Overall Study|Withdrawal by Subject|0|||
160862923|NCT01253291|580891469|FG000|Overall Study|Adverse Event|0|||
160862924|NCT01253291|580891470|FG001|Overall Study|Adverse Event|1|||
160862925|NCT01253291|580891471|FG002|Overall Study|Adverse Event|0|||
160862926|NCT01253291|580891472|FG003|Overall Study|Adverse Event|0|||
160862927|NCT01253291|580891473|FG004|Overall Study|Adverse Event|0|||
160862928|NCT01253291|580891469|FG000|Overall Study|Lack of Efficacy|1|||
160862929|NCT01253291|580891470|FG001|Overall Study|Lack of Efficacy|0|||
160862930|NCT01253291|580891471|FG002|Overall Study|Lack of Efficacy|0|||
160862931|NCT01253291|580891472|FG003|Overall Study|Lack of Efficacy|0|||
160862932|NCT01253291|580891473|FG004|Overall Study|Lack of Efficacy|0|||
160862933|NCT01253291|580891469|FG000|Overall Study|Physician Decision|2|||
160862934|NCT01253291|580891470|FG001|Overall Study|Physician Decision|0|||
160862935|NCT01253291|580891471|FG002|Overall Study|Physician Decision|0|||
160862936|NCT01253291|580891472|FG003|Overall Study|Physician Decision|0|||
160862937|NCT01253291|580891473|FG004|Overall Study|Physician Decision|2|||
160862938|NCT01838395|580891477|FG000|Overall Study|Withdrawal by Subject|0|||
160862939|NCT01838395|580891478|FG001|Overall Study|Withdrawal by Subject|0|||
160862940|NCT01838395|580891479|FG002|Overall Study|Withdrawal by Subject|0|||
160862941|NCT01838395|580891480|FG003|Overall Study|Withdrawal by Subject|0|||
160862942|NCT01838395|580891481|FG004|Overall Study|Withdrawal by Subject|1|||
160862943|NCT01838395|580891482|FG005|Overall Study|Withdrawal by Subject|0|||
160862944|NCT01838395|580891477|FG000|Overall Study|Death|0|||
160862945|NCT01838395|580891478|FG001|Overall Study|Death|0|||
160862946|NCT01838395|580891479|FG002|Overall Study|Death|1|||
160862947|NCT01838395|580891480|FG003|Overall Study|Death|0|||
160862948|NCT01838395|580891481|FG004|Overall Study|Death|0|||
160862949|NCT01838395|580891482|FG005|Overall Study|Death|0|||
160862950|NCT01838395|580891477|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
160862951|NCT01838395|580891478|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
160862952|NCT01838395|580891479|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
160862953|NCT01838395|580891480|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
160862954|NCT01838395|580891481|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
160862955|NCT01838395|580891482|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
160862956|NCT02195518|580891483|FG000|Overall Study|Adverse Event|1|||
160862957|NCT02195518|580891483|FG000|Overall Study|Protocol Violation|4|||
160862958|NCT02195518|580891483|FG000|Overall Study|Pregnancy|2|||
160862959|NCT02195518|580891483|FG000|Overall Study|Withdrawal by Subject|1|||
160862960|NCT02195518|580891483|FG000|Overall Study|Lost to Follow-up|1|||
160862961|NCT00651742|580891491|FG000|Overall Study|Objective Disease Progression|22|||
160862962|NCT00651742|580891491|FG000|Overall Study|Toxicity|3|||
160862963|NCT00651742|580891491|FG000|Overall Study|Investigator Judgment|1|||
160862964|NCT00651742|580891491|FG000|Overall Study|Withdrawal of Consent|1|||
160862965|NCT00651742|580891491|FG000|Overall Study|Enrolled but not treated|1|||
160862966|NCT05720897|580891494|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
160862967|NCT05720897|580891495|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
160862968|NCT00400179|580891496|FG000|Overall Study|Adverse Event|2|||
160862969|NCT00400179|580891497|FG001|Overall Study|Adverse Event|2|||
160862970|NCT00400179|580891496|FG000|Overall Study|Death|1|||
160862971|NCT00400179|580891497|FG001|Overall Study|Death|2|||
160862972|NCT00400179|580891496|FG000|Overall Study|Withdrew Consent|1|||
160951864|NCT04827212|581211020|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
160951865|NCT04827212|581211019|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
160862973|NCT00400179|580891497|FG001|Overall Study|Withdrew Consent|5|||
160862974|NCT00400179|580891496|FG000|Overall Study|Disease progression|1|||
160862975|NCT00400179|580891497|FG001|Overall Study|Disease progression|1|||
160862976|NCT00400179|580891496|FG000|Overall Study|Intercurrent illness|0|||
160862977|NCT00400179|580891497|FG001|Overall Study|Intercurrent illness|1|||
160862978|NCT00400179|580891496|FG000|Overall Study|Investigator judgment|0|||
160862979|NCT00400179|580891497|FG001|Overall Study|Investigator judgment|1|||
160862980|NCT00400179|580891496|FG000|Overall Study|Randomization error/patient ineligible|1|||
160862981|NCT00400179|580891497|FG001|Overall Study|Randomization error/patient ineligible|6|||
160862982|NCT04780061|580891498|FG000|Overall Study|Withdrawal by Subject|5|||
160862983|NCT04780061|580891499|FG001|Overall Study|Withdrawal by Subject|8|||
160862984|NCT04780061|580891498|FG000|Overall Study|Adverse Event|2|||
160862985|NCT04780061|580891499|FG001|Overall Study|Adverse Event|2|||
160862986|NCT04780061|580891498|FG000|Overall Study|Lost to Follow-up|1|||
160951866|NCT04827212|581211020|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
160951867|NCT00599326|581211021|FG000|Overall Study|Lost to Follow-up|1|||
160951868|NCT00599326|581211021|FG000|Overall Study|Noncompliant|1|||
160951869|NCT00784810|581211022|FG000|Overall Study|Adverse Event|32|||
160951870|NCT00784810|581211023|FG001|Overall Study|Adverse Event|20|||
160951871|NCT00784810|581211022|FG000|Overall Study|Lack of Efficacy|14|||
160951872|NCT00784810|581211023|FG001|Overall Study|Lack of Efficacy|11|||
160951873|NCT00784810|581211022|FG000|Overall Study|Withdrawal by Subject|11|||
160862987|NCT04780061|580891499|FG001|Overall Study|Lost to Follow-up|5|||
160862988|NCT01535040|580891500|FG000|Overall Study|Physician Decision|0|||
160862989|NCT01535040|580891501|FG001|Overall Study|Physician Decision|1|||
160862990|NCT01535040|580891500|FG000|Overall Study|Withdrawal by Subject|13|||
160862991|NCT01535040|580891501|FG001|Overall Study|Withdrawal by Subject|10|||
160862992|NCT01535040|580891500|FG000|Overall Study|Never Started|9|||
160862993|NCT01535040|580891501|FG001|Overall Study|Never Started|4|||
160862994|NCT01535040|580891500|FG000|Overall Study|Toxicity|7|||
160862995|NCT01535040|580891501|FG001|Overall Study|Toxicity|5|||
160862996|NCT01535040|580891500|FG000|Overall Study|Multiple Reasons|1|||
160862997|NCT01535040|580891501|FG001|Overall Study|Multiple Reasons|1|||
160862998|NCT01074970|580891504|FG000|Overall Study|Never Treated|0|||
160862999|NCT01074970|580891505|FG001|Overall Study|Never Treated|0|||
160863000|NCT01074970|580891506|FG002|Overall Study|Never Treated|8|||
160863001|NCT01074970|580891507|FG003|Overall Study|Never Treated|1|||
160863002|NCT01074970|580891504|FG000|Overall Study|Adverse Event|1|||
160863003|NCT01074970|580891505|FG001|Overall Study|Adverse Event|0|||
160863004|NCT01074970|580891506|FG002|Overall Study|Adverse Event|4|||
160863005|NCT01074970|580891507|FG003|Overall Study|Adverse Event|3|||
160863006|NCT01074970|580891504|FG000|Overall Study|Disease progression during treatment|3|||
160863007|NCT01074970|580891505|FG001|Overall Study|Disease progression during treatment|1|||
160863008|NCT01074970|580891506|FG002|Overall Study|Disease progression during treatment|2|||
160863009|NCT01074970|580891507|FG003|Overall Study|Disease progression during treatment|9|||
160863010|NCT01074970|580891504|FG000|Overall Study|Lost to Follow-up|0|||
160863011|NCT01074970|580891505|FG001|Overall Study|Lost to Follow-up|0|||
160863012|NCT01074970|580891506|FG002|Overall Study|Lost to Follow-up|1|||
160863013|NCT01074970|580891507|FG003|Overall Study|Lost to Follow-up|0|||
160863014|NCT01074970|580891504|FG000|Overall Study|Withdrawal by Subject|0|||
160863015|NCT01074970|580891505|FG001|Overall Study|Withdrawal by Subject|0|||
160863016|NCT01074970|580891506|FG002|Overall Study|Withdrawal by Subject|6|||
160863017|NCT01074970|580891507|FG003|Overall Study|Withdrawal by Subject|4|||
160863018|NCT00734149|580891508|FG000|Overall Study|Withdrawal by Subject|1|||
160863019|NCT04314284|580891509|FG000|Overall Study|Withdrawal by Subject|4|||
160863020|NCT04314284|580891510|FG001|Overall Study|Withdrawal by Subject|7|||
160863021|NCT04314284|580891509|FG000|Overall Study|Consented but did not complete survey|0|||
160863022|NCT04314284|580891510|FG001|Overall Study|Consented but did not complete survey|6|||
160863023|NCT01652235|580891513|FG000|Overall Study|Death|9|||
160582533|NCT03725202|579853631|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
160582534|NCT03725202|579853632|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
160582535|NCT03725202|579853633|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
160863024|NCT01652235|580891513|FG000|Overall Study|Lost to Follow-up|5|||
160863025|NCT01652235|580891513|FG000|Overall Study|Withdrawal by Subject|2|||
160863026|NCT02023086|580891516|FG000|Overall Study|Withdrawal by Subject|2|||
160582536|NCT03725202|579853634|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
160863027|NCT02023086|580891517|FG001|Overall Study|Withdrawal by Subject|0|||
160863028|NCT03589859|580891518|FG000|Overall Study|Withdrawal by Subject|0|||
160863029|NCT03589859|580891519|FG001|Overall Study|Withdrawal by Subject|6|||
160863030|NCT03043794|580891522|FG000|Overall Study|Lost to Follow-up|1|||
160863031|NCT00626106|580891524|FG000|Overall Study|Withdrawal by Subject|2|||
160863032|NCT00626106|580891525|FG001|Overall Study|Withdrawal by Subject|1|||
160863033|NCT00626106|580891524|FG000|Overall Study|Lost to Follow-up|1|||
160863034|NCT00626106|580891525|FG001|Overall Study|Lost to Follow-up|4|||
160863035|NCT00626106|580891524|FG000|Overall Study|Death|64|||
160863036|NCT00626106|580891525|FG001|Overall Study|Death|19|||
160863037|NCT05417438|580891526|FG000|Overall Study|Withdrawal by Subject|3|||
160863038|NCT02201953|580891531|FG000|Overall Study|Randomized but Never Treated|1|||
160863039|NCT02201953|580891532|FG001|Overall Study|Randomized but Never Treated|5|||
160863040|NCT02201953|580891531|FG000|Overall Study|Lack of Efficacy|9|||
160863041|NCT02201953|580891532|FG001|Overall Study|Lack of Efficacy|30|||
160863042|NCT02201953|580891531|FG000|Overall Study|Lost to Follow-up|8|||
160863043|NCT02201953|580891532|FG001|Overall Study|Lost to Follow-up|8|||
160863044|NCT02201953|580891531|FG000|Overall Study|Withdrew Consent|2|||
160863045|NCT02201953|580891532|FG001|Overall Study|Withdrew Consent|5|||
160863046|NCT02201953|580891531|FG000|Overall Study|Adverse Event|0|||
160863047|NCT02201953|580891532|FG001|Overall Study|Adverse Event|5|||
160863048|NCT02201953|580891531|FG000|Overall Study|Death|0|||
160863049|NCT02201953|580891532|FG001|Overall Study|Death|3|||
160863050|NCT02266888|580892959|FG000|Overall Study|Death|2|||
160863051|NCT02266888|580892960|FG001|Overall Study|Death|2|||
160863052|NCT02266888|580892961|FG002|Overall Study|Death|4|||
160863053|NCT02266888|580892962|FG003|Overall Study|Death|2|||
160951874|NCT00784810|581211023|FG001|Overall Study|Withdrawal by Subject|9|||
160951875|NCT00784810|581211022|FG000|Overall Study|Administrative|5|||
160951876|NCT00784810|581211023|FG001|Overall Study|Administrative|8|||
160863054|NCT02266888|580892959|FG000|Overall Study|Physician Decision|0|||
160863055|NCT02266888|580892960|FG001|Overall Study|Physician Decision|1|||
160951877|NCT00784810|581211022|FG000|Overall Study|Lost to Follow-up|1|||
160951878|NCT00784810|581211023|FG001|Overall Study|Lost to Follow-up|1|||
160951879|NCT03966157|581211024|FG000|Overall Study|Physician Decision|1|||
160951880|NCT03966157|581211025|FG001|Overall Study|Physician Decision|0|||
160951881|NCT04969250|581211030|FG000|Overall Study|Protocol Violation|0|||
160951882|NCT04969250|581211031|FG001|Overall Study|Protocol Violation|2|||
160951883|NCT04969250|581211032|FG002|Overall Study|Protocol Violation|3|||
160951884|NCT04969250|581211033|FG003|Overall Study|Protocol Violation|8|||
160863056|NCT02266888|580892961|FG002|Overall Study|Physician Decision|2|||
160863057|NCT02266888|580892962|FG003|Overall Study|Physician Decision|2|||
160863058|NCT02266888|580892959|FG000|Overall Study|Study Terminated|5|||
160863059|NCT02266888|580892960|FG001|Overall Study|Study Terminated|1|||
160863060|NCT02266888|580892961|FG002|Overall Study|Study Terminated|0|||
160863061|NCT02266888|580892962|FG003|Overall Study|Study Terminated|0|||
160951885|NCT04969250|581211030|FG000|Overall Study|Withdrawal by Subject|0|||
160863062|NCT02266888|580892959|FG000|Overall Study|No Longer Eligible|0|||
160863063|NCT02266888|580892960|FG001|Overall Study|No Longer Eligible|0|||
160863064|NCT02266888|580892961|FG002|Overall Study|No Longer Eligible|0|||
160951886|NCT04969250|581211031|FG001|Overall Study|Withdrawal by Subject|1|||
160951887|NCT04969250|581211032|FG002|Overall Study|Withdrawal by Subject|0|||
160951888|NCT04969250|581211033|FG003|Overall Study|Withdrawal by Subject|0|||
160951889|NCT03305016|581211034|FG000|Overall Study|Withdrawal by Subject|2|||
160951890|NCT02119416|581211035|FG000|Overall Study|Protocol Violation|1|||
160951891|NCT02119416|581211036|FG001|Overall Study|Protocol Violation|1|||
160951892|NCT02119416|581211037|FG002|Overall Study|Protocol Violation|1|||
160951893|NCT02119416|581211035|FG000|Overall Study|wrong pubertal stage|1|||
160951894|NCT02119416|581211036|FG001|Overall Study|wrong pubertal stage|0|||
160951895|NCT02119416|581211037|FG002|Overall Study|wrong pubertal stage|1|||
160951896|NCT03434119|581211038|FG000|Overall Study|Randomized but not treated|1|||
160951897|NCT03434119|581211039|FG001|Overall Study|Randomized but not treated|0|||
160951898|NCT03434119|581211038|FG000|Overall Study|Adverse Event|1|||
161000797|NCT00002842|581388887|FG000|Overall Study|ineligible for surgical resection|27|||
161000798|NCT02694978|581388892|FG000|Overall Study|Adverse Event|10|||
161000799|NCT02694978|581388893|FG001|Overall Study|Adverse Event|9|||
161000800|NCT02694978|581388892|FG000|Overall Study|Withdrawal by Subject|22|||
161000801|NCT02694978|581388893|FG001|Overall Study|Withdrawal by Subject|19|||
161000802|NCT02694978|581388892|FG000|Overall Study|Lost to Follow-up|14|||
161000803|NCT02694978|581388893|FG001|Overall Study|Lost to Follow-up|17|||
161000804|NCT02694978|581388892|FG000|Overall Study|Death|4|||
161000805|NCT02694978|581388893|FG001|Overall Study|Death|1|||
160457414|NCT03640286|579406395|FG000|Overall Study|Pregnancy|1|||
160951899|NCT03434119|581211039|FG001|Overall Study|Adverse Event|0|||
161000806|NCT02694978|581388892|FG000|Overall Study|Other-Decision of Participant|6|||
160951900|NCT03434119|581211038|FG000|Overall Study|Poor Compliance to Protocol|0|||
161000807|NCT02694978|581388893|FG001|Overall Study|Other-Decision of Participant|1|||
160457415|NCT03640286|579406396|FG001|Overall Study|Pregnancy|0|||
160951901|NCT03434119|581211039|FG001|Overall Study|Poor Compliance to Protocol|1|||
160951902|NCT03434119|581211038|FG000|Overall Study|Study Terminated by Sponsor|91|||
161000808|NCT02694978|581388892|FG000|Overall Study|Other-Investigator's decision|1|||
160457416|NCT03640286|579406395|FG000|Overall Study|Withdrawal by Subject|10|||
160951903|NCT03434119|581211039|FG001|Overall Study|Study Terminated by Sponsor|102|||
160951904|NCT03434119|581211038|FG000|Overall Study|Withdrawal by Subject|7|||
160457417|NCT03640286|579406396|FG001|Overall Study|Withdrawal by Subject|10|||
160951905|NCT03434119|581211039|FG001|Overall Study|Withdrawal by Subject|5|||
161000809|NCT02694978|581388893|FG001|Overall Study|Other-Investigator's decision|0|||
160951906|NCT03434119|581211038|FG000|Overall Study|Other than specified|7|||
160951907|NCT03434119|581211039|FG001|Overall Study|Other than specified|5|||
160863065|NCT02266888|580892962|FG003|Overall Study|No Longer Eligible|2|||
160951908|NCT04420689|581211040|FG000|Overall Study|COVID-19 related hospitalization|0|||
160951909|NCT04420689|581211041|FG001|Overall Study|COVID-19 related hospitalization|0|||
160951910|NCT04420689|581211042|FG002|Overall Study|COVID-19 related hospitalization|0|||
160951911|NCT04420689|581211043|FG003|Overall Study|COVID-19 related hospitalization|0|||
160951912|NCT04420689|581211044|FG004|Overall Study|COVID-19 related hospitalization|1|||
160951913|NCT04420689|581211045|FG005|Overall Study|COVID-19 related hospitalization|0|||
160951914|NCT04420689|581211046|FG006|Overall Study|COVID-19 related hospitalization|0|||
160951915|NCT04420689|581211040|FG000|Overall Study|Physician Decision|0|||
160951916|NCT04420689|581211041|FG001|Overall Study|Physician Decision|0|||
160951917|NCT04420689|581211042|FG002|Overall Study|Physician Decision|0|||
160951918|NCT04420689|581211043|FG003|Overall Study|Physician Decision|0|||
160951919|NCT04420689|581211044|FG004|Overall Study|Physician Decision|0|||
160951920|NCT04420689|581211045|FG005|Overall Study|Physician Decision|1|||
160951921|NCT04420689|581211046|FG006|Overall Study|Physician Decision|0|||
160951922|NCT04360824|581211049|FG000|Overall Study|Withdrawal by Subject|2|||
160951923|NCT04360824|581211050|FG001|Overall Study|Withdrawal by Subject|1|||
160951924|NCT04360824|581211049|FG000|Overall Study|Did not receive assigned treatment|1|||
160951925|NCT04360824|581211050|FG001|Overall Study|Did not receive assigned treatment|3|||
160951926|NCT02278328|581211054|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
160951927|NCT02278328|581211055|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
160951928|NCT02278328|581211056|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
160951929|NCT02278328|581211054|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
160951930|NCT02278328|581211055|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
160951931|NCT02278328|581211056|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
160951932|NCT02278328|581211054|FG000|Neuropsych Screening|incomplete consent|0|||
160951933|NCT02278328|581211055|FG001|Neuropsych Screening|incomplete consent|0|||
160951934|NCT02278328|581211056|FG002|Neuropsych Screening|incomplete consent|2|||
160951935|NCT00377676|581211057|FG000|Overall Study|Adverse Event|498|||
160951936|NCT00377676|581211058|FG001|Overall Study|Adverse Event|107|||
160951937|NCT00377676|581211057|FG000|Overall Study|Protocol Violation|33|||
160951938|NCT00377676|581211058|FG001|Overall Study|Protocol Violation|27|||
160951939|NCT00377676|581211057|FG000|Overall Study|Death|5|||
160951940|NCT00377676|581211058|FG001|Overall Study|Death|2|||
160951941|NCT00377676|581211057|FG000|Overall Study|Withdrawal by Subject|187|||
160951942|NCT00377676|581211058|FG001|Overall Study|Withdrawal by Subject|72|||
161000810|NCT02694978|581388892|FG000|Overall Study|Other-Unable to be reached|0|||
161000811|NCT02694978|581388893|FG001|Overall Study|Other-Unable to be reached|1|||
160863066|NCT02266888|580892959|FG000|Overall Study|Randomization Closed|0|||
160863067|NCT02266888|580892960|FG001|Overall Study|Randomization Closed|0|||
160863068|NCT02266888|580892961|FG002|Overall Study|Randomization Closed|4|||
160863069|NCT02266888|580892962|FG003|Overall Study|Randomization Closed|0|||
160863070|NCT02266888|580892959|FG000|Overall Study|Personnel unavailable at transplant|0|||
160863071|NCT02266888|580892960|FG001|Overall Study|Personnel unavailable at transplant|0|||
160863072|NCT02266888|580892961|FG002|Overall Study|Personnel unavailable at transplant|0|||
160863073|NCT02266888|580892962|FG003|Overall Study|Personnel unavailable at transplant|1|||
160863074|NCT02266888|580892959|FG000|Overall Study|Transfer of care|0|||
160863075|NCT02266888|580892960|FG001|Overall Study|Transfer of care|0|||
160863076|NCT02266888|580892961|FG002|Overall Study|Transfer of care|1|||
160863077|NCT02266888|580892962|FG003|Overall Study|Transfer of care|0|||
160863078|NCT03877510|580892965|FG000|Overall Study|Death|6|||
160863079|NCT03877510|580892965|FG000|Overall Study|Lost to Follow-up|2|||
160863080|NCT03877510|580892965|FG000|Overall Study|Non-compliance with study drug|2|||
161000812|NCT02694978|581388892|FG000|Overall Study|Other-Protocol noncompliant|2|||
161000813|NCT02694978|581388893|FG001|Overall Study|Other-Protocol noncompliant|1|||
161000814|NCT02694978|581388892|FG000|Overall Study|Other-Personal reasons|3|||
161000815|NCT02694978|581388893|FG001|Overall Study|Other-Personal reasons|3|||
161000816|NCT02694978|581388892|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
161000817|NCT02694978|581388893|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
161000818|NCT01613716|581388896|FG000|Overall Study|screen failures|3|||
161000819|NCT01613716|581388896|FG000|Overall Study|Lost to Follow-up|4|||
161000820|NCT02296424|581388899|FG000|Part 1|New therapy for study indication|0|||
161000821|NCT02296424|581388900|FG001|Part 1|New therapy for study indication|1|||
161000822|NCT02296424|581388901|FG002|Part 1|New therapy for study indication|0|||
161000823|NCT02296424|581388902|FG003|Part 1|New therapy for study indication|0|||
160863081|NCT03877510|580892965|FG000|Overall Study|Lack of Efficacy|14|||
160863082|NCT03877510|580892965|FG000|Overall Study|Adverse Event|20|||
160863083|NCT03877510|580892965|FG000|Overall Study|Withdrawal by Subject|22|||
160863084|NCT03877510|580892965|FG000|Overall Study|Miscellaneous|1|||
160863085|NCT03040336|580892966|FG000|Overall Study|Death|1|||
160863086|NCT03040336|580892967|FG001|Overall Study|Death|0|||
161000824|NCT02296424|581388899|FG000|Part 1|Protocol Violation|0|||
160863087|NCT03040336|580892966|FG000|Overall Study|Withdrawal by Subject|2|||
160863088|NCT03040336|580892967|FG001|Overall Study|Withdrawal by Subject|3|||
160863089|NCT01524796|580892969|FG000|Overall Study|Adverse Event|13|||
160863090|NCT01524796|580892969|FG000|Overall Study|Lack of Efficacy|3|||
160863091|NCT01524796|580892969|FG000|Overall Study|Lost to Follow-up|1|||
160863092|NCT01524796|580892969|FG000|Overall Study|The price|1|||
160863093|NCT01524796|580892969|FG000|Overall Study|Withdrawal by Subject|4|||
160863094|NCT01524796|580892969|FG000|Overall Study|Move|1|||
160863095|NCT01524796|580892969|FG000|Overall Study|Deterioration of pains|1|||
160863096|NCT01524796|580892969|FG000|Overall Study|Gall stone surgery|1|||
160457418|NCT03640286|579406395|FG000|Overall Study|Non-compliance|4|||
160863097|NCT01524796|580892969|FG000|Overall Study|Nervous about confidentiality|1|||
160863098|NCT01524796|580892969|FG000|Overall Study|Switch to carbamazapine|1|||
160863099|NCT01524796|580892969|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
160863100|NCT02435992|580892972|FG000|Overall Study|non compliance with protocol|2|||
160863101|NCT02435992|580892973|FG001|Overall Study|non compliance with protocol|0|||
160863102|NCT02435992|580892974|FG002|Overall Study|non compliance with protocol|1|||
160863103|NCT02435992|580892975|FG003|Overall Study|non compliance with protocol|0|||
160863104|NCT02435992|580892976|FG004|Overall Study|non compliance with protocol|0|||
160863105|NCT02435992|580892972|FG000|Overall Study|Adverse Event|11|||
160863106|NCT02435992|580892973|FG001|Overall Study|Adverse Event|6|||
160863107|NCT02435992|580892974|FG002|Overall Study|Adverse Event|12|||
160863108|NCT02435992|580892975|FG003|Overall Study|Adverse Event|0|||
160863109|NCT02435992|580892976|FG004|Overall Study|Adverse Event|0|||
160863110|NCT02435992|580892972|FG000|Overall Study|Lack of Efficacy|4|||
160863111|NCT02435992|580892973|FG001|Overall Study|Lack of Efficacy|10|||
160863112|NCT02435992|580892974|FG002|Overall Study|Lack of Efficacy|9|||
160863113|NCT02435992|580892975|FG003|Overall Study|Lack of Efficacy|0|||
160863114|NCT02435992|580892976|FG004|Overall Study|Lack of Efficacy|0|||
160863115|NCT02435992|580892972|FG000|Overall Study|Withdrawal by Subject|10|||
160863116|NCT02435992|580892973|FG001|Overall Study|Withdrawal by Subject|8|||
160863117|NCT02435992|580892974|FG002|Overall Study|Withdrawal by Subject|20|||
160863118|NCT02435992|580892975|FG003|Overall Study|Withdrawal by Subject|0|||
160863119|NCT02435992|580892976|FG004|Overall Study|Withdrawal by Subject|0|||
160863120|NCT02435992|580892972|FG000|Overall Study|Other Reason|1|||
160863121|NCT02435992|580892973|FG001|Overall Study|Other Reason|0|||
160863122|NCT02435992|580892974|FG002|Overall Study|Other Reason|0|||
160863123|NCT02435992|580892975|FG003|Overall Study|Other Reason|0|||
160863124|NCT02435992|580892976|FG004|Overall Study|Other Reason|0|||
160863125|NCT02435992|580892972|FG000|Overall Study|Physician Decision|0|||
160863126|NCT02435992|580892973|FG001|Overall Study|Physician Decision|0|||
160457419|NCT03640286|579406396|FG001|Overall Study|Non-compliance|10|||
160457420|NCT03640286|579406395|FG000|Overall Study|Medication change|1|||
160457421|NCT03640286|579406396|FG001|Overall Study|Medication change|0|||
160457422|NCT03640286|579406395|FG000|Overall Study|Other|1|||
160582537|NCT03725202|579853635|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
160582538|NCT03725202|579853636|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
160582539|NCT03725202|579853629|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
160863127|NCT02435992|580892974|FG002|Overall Study|Physician Decision|1|||
160863128|NCT02435992|580892975|FG003|Overall Study|Physician Decision|0|||
160863129|NCT02435992|580892976|FG004|Overall Study|Physician Decision|0|||
160863130|NCT02224560|580892979|FG000|Overall Study|Protocol Deviation|1|||
160863131|NCT02224560|580892980|FG001|Overall Study|Protocol Deviation|0|||
160863132|NCT02224560|580892981|FG002|Overall Study|Protocol Deviation|0|||
160863133|NCT02224560|580892979|FG000|Overall Study|Withdrawal by Subject|2|||
160863134|NCT02224560|580892980|FG001|Overall Study|Withdrawal by Subject|0|||
160863135|NCT02224560|580892981|FG002|Overall Study|Withdrawal by Subject|1|||
160863136|NCT02224560|580892979|FG000|Overall Study|Met Withdrawal Criteria|1|||
160863137|NCT02224560|580892980|FG001|Overall Study|Met Withdrawal Criteria|0|||
160863138|NCT02224560|580892981|FG002|Overall Study|Met Withdrawal Criteria|0|||
160863139|NCT02224560|580892979|FG000|Overall Study|Adverse Event|4|||
160863140|NCT02224560|580892980|FG001|Overall Study|Adverse Event|1|||
160863141|NCT02224560|580892981|FG002|Overall Study|Adverse Event|1|||
160863142|NCT02224560|580892979|FG000|Overall Study|Withdrawn by Investigator|1|||
160863143|NCT02224560|580892980|FG001|Overall Study|Withdrawn by Investigator|1|||
160863144|NCT02224560|580892981|FG002|Overall Study|Withdrawn by Investigator|0|||
160863145|NCT00728689|580892982|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
160863146|NCT00728689|580892983|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
160863147|NCT01523366|580892984|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160863148|NCT01523366|580892985|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161000825|NCT02296424|581388900|FG001|Part 1|Protocol Violation|1|||
161000826|NCT02296424|581388901|FG002|Part 1|Protocol Violation|0|||
160863149|NCT01523366|580892984|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
160863150|NCT01523366|580892985|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
160863151|NCT02461758|580892986|FG000|Overall Study|Lost to Follow-up|0|||
160863152|NCT02461758|580892987|FG001|Overall Study|Lost to Follow-up|1|||
160863153|NCT02461758|580892988|FG002|Overall Study|Lost to Follow-up|1|||
160863154|NCT02461758|580892989|FG003|Overall Study|Lost to Follow-up|0|||
160457423|NCT03640286|579406396|FG001|Overall Study|Other|2|||
160863155|NCT04543279|580892991|FG000|Overall Study|Withdrawal by Subject|1|||
160863156|NCT04543279|580892992|FG001|Overall Study|Withdrawal by Subject|0|||
160863157|NCT04543279|580892991|FG000|Overall Study|Adverse Event|1|||
161000827|NCT02296424|581388902|FG003|Part 1|Protocol Violation|0|||
161000828|NCT02296424|581388899|FG000|Part 1|Withdrawal by Subject|0|||
161000829|NCT02296424|581388900|FG001|Part 1|Withdrawal by Subject|2|||
161000830|NCT02296424|581388901|FG002|Part 1|Withdrawal by Subject|0|||
161000831|NCT02296424|581388902|FG003|Part 1|Withdrawal by Subject|0|||
161000832|NCT02296424|581388899|FG000|Part 1|Study terminated by sponsor|0|||
161000833|NCT02296424|581388900|FG001|Part 1|Study terminated by sponsor|1|||
161000834|NCT02296424|581388901|FG002|Part 1|Study terminated by sponsor|0|||
161000835|NCT02296424|581388902|FG003|Part 1|Study terminated by sponsor|0|||
161000836|NCT02296424|581388899|FG000|Part 1|Adverse Event|2|||
160863158|NCT04543279|580892992|FG001|Overall Study|Adverse Event|0|||
160863159|NCT04543279|580892991|FG000|Overall Study|Physician Decision|1|||
160863160|NCT04543279|580892992|FG001|Overall Study|Physician Decision|0|||
160863161|NCT00929695|580892995|FG000|Overall Study|Death|2|||
160863162|NCT00929695|580892996|FG001|Overall Study|Death|1|||
160863163|NCT00929695|580892995|FG000|Overall Study|Withdrawal by Subject|0|||
160863164|NCT00929695|580892996|FG001|Overall Study|Withdrawal by Subject|2|||
160863165|NCT00929695|580892995|FG000|Overall Study|discharge home|4|||
160863166|NCT00929695|580892996|FG001|Overall Study|discharge home|3|||
160863167|NCT00929695|580892995|FG000|Overall Study|incorrect stratification|2|||
160863168|NCT00929695|580892996|FG001|Overall Study|incorrect stratification|0|||
160863169|NCT04030143|580892997|FG000|Overall Study|Adverse Event|5|||
160863170|NCT04030143|580892998|FG001|Overall Study|Adverse Event|10|||
160863171|NCT04030143|580892997|FG000|Overall Study|Lost to Follow-up|3|||
160863172|NCT04030143|580892998|FG001|Overall Study|Lost to Follow-up|7|||
160863173|NCT04030143|580892997|FG000|Overall Study|Protocol Deviation|2|||
160863174|NCT04030143|580892998|FG001|Overall Study|Protocol Deviation|2|||
160863175|NCT04030143|580892997|FG000|Overall Study|Withdrawal by Subject|16|||
160863176|NCT04030143|580892998|FG001|Overall Study|Withdrawal by Subject|18|||
160863177|NCT04030143|580892997|FG000|Overall Study|Physician Decision|1|||
160863178|NCT04030143|580892998|FG001|Overall Study|Physician Decision|1|||
160863179|NCT04030143|580892997|FG000|Overall Study|Due to Covid-19|2|||
160863180|NCT04030143|580892998|FG001|Overall Study|Due to Covid-19|3|||
160863181|NCT04030143|580892997|FG000|Overall Study|Not Due to Covid-19|1|||
160863182|NCT04030143|580892998|FG001|Overall Study|Not Due to Covid-19|1|||
160863183|NCT03216226|580892999|FG000|Overall Study|Adverse Event|3|||
160863184|NCT03216226|580893000|FG001|Overall Study|Adverse Event|0|||
160863185|NCT03216226|580892999|FG000|Overall Study|Protocol Violation|1|||
160863186|NCT03216226|580893000|FG001|Overall Study|Protocol Violation|3|||
160863187|NCT03216226|580892999|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
160863188|NCT03216226|580893000|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
160863189|NCT03216226|580892999|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
160863190|NCT03216226|580893000|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
160863191|NCT03216226|580892999|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
160863192|NCT03216226|580893000|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
160863193|NCT01210313|580893006|FG000|Overall Study|Withdrawal by Subject|3|||
160863194|NCT01210313|580893006|FG000|Overall Study|Adverse Event|2|||
160863195|NCT01210313|580893006|FG000|Overall Study|Distant recurrence|4|||
160863196|NCT01210313|580893006|FG000|Overall Study|Non-compliance|7|||
160863197|NCT03113487|580893009|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
160582540|NCT03725202|579853630|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
160582541|NCT03725202|579853631|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
160582542|NCT03725202|579853632|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
160582543|NCT03725202|579853633|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
160582544|NCT03725202|579853634|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
160582545|NCT03725202|579853635|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
160582546|NCT03725202|579853636|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
160582547|NCT03725202|579853629|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
160582548|NCT03725202|579853630|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
160863198|NCT01502293|580893010|FG000|Overall Study|Progressive Disease|20|||
161000837|NCT02296424|581388900|FG001|Part 1|Adverse Event|11|||
161000838|NCT02296424|581388901|FG002|Part 1|Adverse Event|0|||
161000839|NCT02296424|581388902|FG003|Part 1|Adverse Event|0|||
161000840|NCT02296424|581388899|FG000|Part 1|Lack of Efficacy|5|||
161000841|NCT02296424|581388900|FG001|Part 1|Lack of Efficacy|17|||
161000842|NCT02296424|581388901|FG002|Part 1|Lack of Efficacy|0|||
160582549|NCT03725202|579853631|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
160582550|NCT03725202|579853632|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
160863199|NCT01502293|580893011|FG001|Overall Study|Progressive Disease|12|||
160863200|NCT01502293|580893012|FG002|Overall Study|Progressive Disease|2|||
160863201|NCT01502293|580893010|FG000|Overall Study|Withdrawal by Subject|3|||
160863202|NCT01502293|580893011|FG001|Overall Study|Withdrawal by Subject|3|||
160863203|NCT01502293|580893012|FG002|Overall Study|Withdrawal by Subject|1|||
160863204|NCT01502293|580893010|FG000|Overall Study|Adverse Event|0|||
160863205|NCT01502293|580893011|FG001|Overall Study|Adverse Event|2|||
160863206|NCT01502293|580893012|FG002|Overall Study|Adverse Event|0|||
160582551|NCT03725202|579853633|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
160582552|NCT03725202|579853634|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
160582553|NCT03725202|579853635|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
160582554|NCT03725202|579853636|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
160582555|NCT03725202|579853629|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
160582556|NCT03725202|579853630|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
160582557|NCT03725202|579853631|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
160582558|NCT03725202|579853632|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
160582559|NCT03725202|579853633|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
160863207|NCT01502293|580893010|FG000|Overall Study|Reason Not Specified|2|||
160863208|NCT01502293|580893011|FG001|Overall Study|Reason Not Specified|0|||
160863209|NCT01502293|580893012|FG002|Overall Study|Reason Not Specified|0|||
160863210|NCT01502293|580893010|FG000|Overall Study|Physician Decision|0|||
160863211|NCT01502293|580893011|FG001|Overall Study|Physician Decision|0|||
160863212|NCT01502293|580893012|FG002|Overall Study|Physician Decision|1|||
160863213|NCT00391586|580893014|FG000|Overall Study|Progressive disease|13|||
160863214|NCT00391586|580893014|FG000|Overall Study|Adverse Event|5|||
160863215|NCT00391586|580893014|FG000|Overall Study|Physician Decision|2|||
160863216|NCT00391586|580893014|FG000|Overall Study|Death|4|||
160863217|NCT01409707|580893015|FG000|Overall Study|Withdrawal by Subject|5|||
160863218|NCT01409707|580893016|FG001|Overall Study|Withdrawal by Subject|17|||
160863219|NCT01409707|580893017|FG002|Overall Study|Withdrawal by Subject|16|||
160863220|NCT03058146|580893018|FG000|Overall Study|Withdrawal by Subject|4|||
160863221|NCT03058146|580893019|FG001|Overall Study|Withdrawal by Subject|1|||
160863222|NCT03058146|580893018|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
160863223|NCT03058146|580893019|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
160863224|NCT00632229|580893020|FG000|Overall Study|Adverse Event|6|||
160863225|NCT00632229|580893021|FG001|Overall Study|Adverse Event|0|||
160863226|NCT00632229|580893020|FG000|Overall Study|Lost to Follow-up|0|||
160863227|NCT00632229|580893021|FG001|Overall Study|Lost to Follow-up|3|||
160863228|NCT00632229|580893020|FG000|Overall Study|Lack of Efficacy|0|||
160863229|NCT00632229|580893021|FG001|Overall Study|Lack of Efficacy|2|||
160863230|NCT00632229|580893020|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
160863231|NCT00632229|580893021|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
160863232|NCT03041181|580893022|FG000|Overall Study|Disease Progression|1|||
160863233|NCT03041181|580893023|FG001|Overall Study|Disease Progression|2|||
160863234|NCT01716234|580893024|FG000|Overall Study|Protocol Violation|0|||
160863235|NCT01716234|580893025|FG001|Overall Study|Protocol Violation|0|||
160863236|NCT01716234|580893026|FG002|Overall Study|Protocol Violation|0|||
160863237|NCT01716234|580893027|FG003|Overall Study|Protocol Violation|1|||
160863238|NCT01716234|580893028|FG004|Overall Study|Protocol Violation|1|||
160863239|NCT01716234|580893029|FG005|Overall Study|Protocol Violation|1|||
160863240|NCT01716234|580893030|FG006|Overall Study|Protocol Violation|0|||
160863241|NCT01716234|580893024|FG000|Overall Study|Lack of Efficacy|0|||
160863242|NCT01716234|580893025|FG001|Overall Study|Lack of Efficacy|0|||
160863243|NCT01716234|580893026|FG002|Overall Study|Lack of Efficacy|0|||
160863244|NCT01716234|580893027|FG003|Overall Study|Lack of Efficacy|1|||
160863245|NCT01716234|580893028|FG004|Overall Study|Lack of Efficacy|0|||
160863246|NCT01716234|580893029|FG005|Overall Study|Lack of Efficacy|0|||
160863247|NCT01716234|580893030|FG006|Overall Study|Lack of Efficacy|0|||
160863248|NCT01716234|580893024|FG000|Overall Study|Did not meet protocol eligibility|0|||
160863249|NCT01716234|580893025|FG001|Overall Study|Did not meet protocol eligibility|0|||
160863250|NCT01716234|580893026|FG002|Overall Study|Did not meet protocol eligibility|1|||
160863251|NCT01716234|580893027|FG003|Overall Study|Did not meet protocol eligibility|0|||
160863252|NCT01716234|580893028|FG004|Overall Study|Did not meet protocol eligibility|0|||
160863253|NCT01716234|580893029|FG005|Overall Study|Did not meet protocol eligibility|4|||
160863254|NCT01716234|580893030|FG006|Overall Study|Did not meet protocol eligibility|0|||
160863255|NCT01716234|580893024|FG000|Overall Study|Adverse Event|7|||
160951943|NCT00377676|581211057|FG000|Overall Study|Lost to Follow-up|120|||
160951944|NCT00377676|581211058|FG001|Overall Study|Lost to Follow-up|56|||
160951945|NCT00377676|581211057|FG000|Overall Study|Other|118|||
160951946|NCT00377676|581211058|FG001|Overall Study|Other|58|||
160951947|NCT03834779|581211064|FG000|Overall Study|Death|1|||
160951948|NCT03834779|581211065|FG001|Overall Study|Death|2|||
160951949|NCT03834779|581211064|FG000|Overall Study|Lost to Follow-up|6|||
161000843|NCT02296424|581388902|FG003|Part 1|Lack of Efficacy|0|||
160582560|NCT03725202|579853634|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161000844|NCT02296424|581388899|FG000|Part 1|16 directly started part II|16|||
161000845|NCT02296424|581388900|FG001|Part 1|16 directly started part II|0|||
160582561|NCT03725202|579853635|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
160582562|NCT03725202|579853636|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
160863256|NCT01716234|580893025|FG001|Overall Study|Adverse Event|10|||
160863257|NCT01716234|580893026|FG002|Overall Study|Adverse Event|2|||
160951950|NCT03834779|581211065|FG001|Overall Study|Lost to Follow-up|4|||
160951951|NCT03579459|581211066|FG000|Overall Study|Adverse Event|7|||
160951952|NCT03579459|581211067|FG001|Overall Study|Adverse Event|6|||
160951953|NCT03579459|581211068|FG002|Overall Study|Adverse Event|2|||
160863258|NCT01716234|580893027|FG003|Overall Study|Adverse Event|8|||
160863259|NCT01716234|580893028|FG004|Overall Study|Adverse Event|3|||
160951954|NCT03579459|581211069|FG003|Overall Study|Adverse Event|6|||
160951955|NCT03579459|581211066|FG000|Overall Study|Death|1|||
160951956|NCT03579459|581211067|FG001|Overall Study|Death|0|||
160951957|NCT03579459|581211068|FG002|Overall Study|Death|1|||
160951958|NCT03579459|581211069|FG003|Overall Study|Death|2|||
160951959|NCT03579459|581211066|FG000|Overall Study|Lost to Follow-up|6|||
160863260|NCT01716234|580893029|FG005|Overall Study|Adverse Event|6|||
160863261|NCT01716234|580893030|FG006|Overall Study|Adverse Event|0|||
160863262|NCT01716234|580893024|FG000|Overall Study|Withdrawal by Subject|3|||
160863263|NCT01716234|580893025|FG001|Overall Study|Withdrawal by Subject|0|||
160863264|NCT01716234|580893026|FG002|Overall Study|Withdrawal by Subject|2|||
160863265|NCT01716234|580893027|FG003|Overall Study|Withdrawal by Subject|2|||
160863266|NCT01716234|580893028|FG004|Overall Study|Withdrawal by Subject|1|||
160863267|NCT01716234|580893029|FG005|Overall Study|Withdrawal by Subject|3|||
160951960|NCT03579459|581211067|FG001|Overall Study|Lost to Follow-up|2|||
160951961|NCT03579459|581211068|FG002|Overall Study|Lost to Follow-up|4|||
160863268|NCT01716234|580893030|FG006|Overall Study|Withdrawal by Subject|0|||
160863269|NCT02667119|580893031|FG000|Overall Study|Lost to Follow-up|3|||
160951962|NCT03579459|581211069|FG003|Overall Study|Lost to Follow-up|1|||
160951963|NCT03579459|581211066|FG000|Overall Study|Physician Decision|0|||
160863270|NCT02667119|580893032|FG001|Overall Study|Lost to Follow-up|0|||
160863271|NCT00521079|580893035|FG000|Overall Study|Adverse Event|7|||
160863272|NCT00521079|580893036|FG001|Overall Study|Adverse Event|1|||
160863273|NCT00521079|580893035|FG000|Overall Study|Lost to Follow-up|2|||
160863274|NCT00521079|580893036|FG001|Overall Study|Lost to Follow-up|1|||
160863275|NCT00521079|580893035|FG000|Overall Study|Withdrawal by Subject|5|||
160863276|NCT00521079|580893036|FG001|Overall Study|Withdrawal by Subject|3|||
160863277|NCT02002598|580893039|FG000|Dose Level 1|Withdrawal by Subject|1|||
160863278|NCT02002598|580893040|FG001|Dose Level 1|Withdrawal by Subject|0|||
160863279|NCT02002598|580893041|FG002|Dose Level 1|Withdrawal by Subject|0|||
160863280|NCT02002598|580893042|FG003|Dose Level 1|Withdrawal by Subject|0|||
160863281|NCT02002598|580893043|FG004|Dose Level 1|Withdrawal by Subject|0|||
160951964|NCT03579459|581211067|FG001|Overall Study|Physician Decision|1|||
160951965|NCT03579459|581211068|FG002|Overall Study|Physician Decision|0|||
160951966|NCT03579459|581211069|FG003|Overall Study|Physician Decision|1|||
160951967|NCT03579459|581211066|FG000|Overall Study|Protocol Violation|1|||
160951968|NCT03579459|581211067|FG001|Overall Study|Protocol Violation|2|||
160951969|NCT03579459|581211068|FG002|Overall Study|Protocol Violation|3|||
160951970|NCT03579459|581211069|FG003|Overall Study|Protocol Violation|5|||
160951971|NCT03579459|581211066|FG000|Overall Study|Withdrawal by Subject|12|||
160951972|NCT03579459|581211067|FG001|Overall Study|Withdrawal by Subject|8|||
160863282|NCT04672239|580893044|FG000|Week 2 Survey|Failed survey check items|1|||
160863283|NCT04672239|580893045|FG001|Week 2 Survey|Failed survey check items|2|||
160863284|NCT04672239|580893046|FG002|Week 2 Survey|Failed survey check items|3|||
160863285|NCT04672239|580893044|FG000|Week 2 Survey|Partially completed survey|7|||
160863286|NCT04672239|580893045|FG001|Week 2 Survey|Partially completed survey|1|||
160863287|NCT04672239|580893046|FG002|Week 2 Survey|Partially completed survey|4|||
160863288|NCT04672239|580893044|FG000|Week 2 Survey|Withdrawal by Subject|0|||
160863289|NCT04672239|580893045|FG001|Week 2 Survey|Withdrawal by Subject|1|||
160863290|NCT04672239|580893046|FG002|Week 2 Survey|Withdrawal by Subject|0|||
160863291|NCT04672239|580893044|FG000|Week 2 Survey|Lost to Follow-up|3|||
160863292|NCT04672239|580893045|FG001|Week 2 Survey|Lost to Follow-up|2|||
160863293|NCT04672239|580893046|FG002|Week 2 Survey|Lost to Follow-up|5|||
160863294|NCT04672239|580893044|FG000|Week 6 Survey|Failed survey check items|2|||
160863295|NCT04672239|580893045|FG001|Week 6 Survey|Failed survey check items|2|||
160863296|NCT04672239|580893046|FG002|Week 6 Survey|Failed survey check items|2|||
160863297|NCT04672239|580893044|FG000|Week 6 Survey|Partially completed survey|3|||
160863298|NCT04672239|580893045|FG001|Week 6 Survey|Partially completed survey|3|||
160863299|NCT04672239|580893046|FG002|Week 6 Survey|Partially completed survey|2|||
160863300|NCT04672239|580893044|FG000|Week 6 Survey|Withdrawal by Subject|1|||
160863301|NCT04672239|580893045|FG001|Week 6 Survey|Withdrawal by Subject|1|||
160863302|NCT04672239|580893046|FG002|Week 6 Survey|Withdrawal by Subject|1|||
160863303|NCT04672239|580893044|FG000|Week 6 Survey|Withdrawn by PI|0|||
160863304|NCT04672239|580893045|FG001|Week 6 Survey|Withdrawn by PI|1|||
160863305|NCT04672239|580893046|FG002|Week 6 Survey|Withdrawn by PI|0|||
160863306|NCT04672239|580893044|FG000|Week 6 Survey|Lost to Follow-up|12|||
160863307|NCT04672239|580893045|FG001|Week 6 Survey|Lost to Follow-up|2|||
160863308|NCT04672239|580893046|FG002|Week 6 Survey|Lost to Follow-up|5|||
160457424|NCT03640286|579406395|FG000|Overall Study|Joined another lifestyle program|0|||
160457425|NCT03640286|579406396|FG001|Overall Study|Joined another lifestyle program|1|||
160457426|NCT02839265|579406405|FG000|Overall Study|Screen Failure|2|||
160863309|NCT04672239|580893044|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
160863310|NCT04672239|580893045|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
160863311|NCT04672239|580893046|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
160951973|NCT03579459|581211068|FG002|Overall Study|Withdrawal by Subject|11|||
160863312|NCT04672239|580893044|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
160863313|NCT04672239|580893045|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
160863314|NCT04672239|580893046|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
160863315|NCT04672239|580893044|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
160863316|NCT04672239|580893045|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
160863317|NCT04672239|580893046|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
160863318|NCT04672239|580893044|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
160863319|NCT04672239|580893045|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
160863320|NCT04672239|580893046|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
160863321|NCT04672239|580893044|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
160863322|NCT04672239|580893045|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
160863323|NCT04672239|580893046|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
160863324|NCT04672239|580893044|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
160863325|NCT04672239|580893045|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
160863326|NCT04672239|580893046|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
160863327|NCT04672239|580893044|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
160863328|NCT04672239|580893045|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
160863329|NCT04672239|580893046|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
160863330|NCT04123470|580893047|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
160863331|NCT04123470|580893048|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
160863332|NCT04123470|580893047|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
160863333|NCT04123470|580893048|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
160863334|NCT04123470|580893047|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
160863335|NCT04123470|580893048|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
160863336|NCT04123470|580893047|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
160863337|NCT04123470|580893048|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
160863338|NCT05972993|580893049|FG000|Overall Study|Lost to Follow-up|2|||
160863339|NCT05972993|580893050|FG001|Overall Study|Lost to Follow-up|0|||
160863340|NCT05972993|580893051|FG002|Overall Study|Lost to Follow-up|1|||
160863341|NCT05972993|580893052|FG003|Overall Study|Lost to Follow-up|0|||
160863342|NCT05972993|580893053|FG004|Overall Study|Lost to Follow-up|0|||
160863343|NCT05972993|580893054|FG005|Overall Study|Lost to Follow-up|0|||
160863344|NCT05972993|580893055|FG006|Overall Study|Lost to Follow-up|0|||
160863345|NCT05972993|580893056|FG007|Overall Study|Lost to Follow-up|2|||
160863346|NCT05972993|580893057|FG008|Overall Study|Lost to Follow-up|0|||
160863347|NCT04825678|580893059|FG000|Overall Study|Decision by Sponsor|2|||
160863348|NCT04825678|580893060|FG001|Overall Study|Decision by Sponsor|3|||
160863349|NCT04825678|580893059|FG000|Overall Study|Withdrawal of Consent From Study|7|||
160863350|NCT04825678|580893060|FG001|Overall Study|Withdrawal of Consent From Study|9|||
160863351|NCT04825678|580893059|FG000|Overall Study|Lost to Follow-up|3|||
160863352|NCT04825678|580893060|FG001|Overall Study|Lost to Follow-up|4|||
160863353|NCT04825678|580893059|FG000|Overall Study|Never Received Investigational Product|1|||
160863354|NCT04825678|580893060|FG001|Overall Study|Never Received Investigational Product|1|||
160863355|NCT04050553|580893063|FG000|Period 1|Physician Decision|2|||
160863356|NCT04050553|580893064|FG001|Period 1|Physician Decision|2|||
160863357|NCT04050553|580893063|FG000|Period 1|Adverse Event|1|||
160863358|NCT04050553|580893064|FG001|Period 1|Adverse Event|1|||
160863359|NCT04050553|580893063|FG000|Period 1|Withdrawal by Subject|0|||
160863360|NCT04050553|580893064|FG001|Period 1|Withdrawal by Subject|1|||
160863361|NCT04050553|580893063|FG000|Wash-out|Adverse Event|0|||
160863362|NCT04050553|580893064|FG001|Wash-out|Adverse Event|1|||
160863363|NCT04050553|580893063|FG000|Wash-out|Withdrawal by Subject|0|||
160863364|NCT04050553|580893064|FG001|Wash-out|Withdrawal by Subject|1|||
160863365|NCT05430854|580893066|FG000|Overall Study|Trial terminated by Sponsor|39|||
160863366|NCT05430854|580893067|FG001|Overall Study|Trial terminated by Sponsor|50|||
160863367|NCT05430854|580893068|FG002|Overall Study|Trial terminated by Sponsor|46|||
160863368|NCT05430854|580893066|FG000|Overall Study|Withdrawal by Subject|0|||
160863369|NCT05430854|580893067|FG001|Overall Study|Withdrawal by Subject|3|||
160863370|NCT05430854|580893068|FG002|Overall Study|Withdrawal by Subject|0|||
160863371|NCT00911170|580893074|FG000|Treatment Period|Randomized in error|1|||
160863372|NCT00911170|580893075|FG001|Treatment Period|Randomized in error|1|||
160863373|NCT00911170|580893074|FG000|Treatment Period|Ineligibility determined|1|||
160863374|NCT00911170|580893075|FG001|Treatment Period|Ineligibility determined|3|||
160863375|NCT00911170|580893074|FG000|Treatment Period|Protocol deviation|1|||
160863376|NCT00911170|580893075|FG001|Treatment Period|Protocol deviation|2|||
160863377|NCT00911170|580893074|FG000|Treatment Period|Adverse Event|9|||
160863378|NCT00911170|580893075|FG001|Treatment Period|Adverse Event|10|||
160863379|NCT00911170|580893074|FG000|Treatment Period|Withdrawal by Subject|4|||
160863380|NCT00911170|580893075|FG001|Treatment Period|Withdrawal by Subject|4|||
160863381|NCT00911170|580893074|FG000|Treatment Period|Disease progression|0|||
160863382|NCT00911170|580893075|FG001|Treatment Period|Disease progression|2|||
160863383|NCT00911170|580893074|FG000|Treatment Period|Physician Decision|5|||
160863384|NCT00911170|580893075|FG001|Treatment Period|Physician Decision|5|||
160863385|NCT00911170|580893074|FG000|Treatment Period|Lost to Follow-up|0|||
160951974|NCT03579459|581211069|FG003|Overall Study|Withdrawal by Subject|8|||
160951975|NCT03579459|581211066|FG000|Overall Study|Medication error without associated adverse event|2|||
160951976|NCT03579459|581211067|FG001|Overall Study|Medication error without associated adverse event|1|||
160951977|NCT03579459|581211068|FG002|Overall Study|Medication error without associated adverse event|1|||
160951978|NCT03579459|581211069|FG003|Overall Study|Medication error without associated adverse event|0|||
160951979|NCT03579459|581211066|FG000|Overall Study|Other|0|||
160951980|NCT03579459|581211067|FG001|Overall Study|Other|1|||
160951981|NCT03579459|581211068|FG002|Overall Study|Other|1|||
160951982|NCT03579459|581211069|FG003|Overall Study|Other|0|||
160951983|NCT03579459|581211066|FG000|Overall Study|Randomized not vaccinated|0|||
160951984|NCT03579459|581211067|FG001|Overall Study|Randomized not vaccinated|2|||
160951985|NCT03579459|581211068|FG002|Overall Study|Randomized not vaccinated|0|||
160951986|NCT03579459|581211069|FG003|Overall Study|Randomized not vaccinated|1|||
160951987|NCT02528214|581211070|FG000|Overall Study|Protocol Violation|0|||
160951988|NCT02528214|581211071|FG001|Overall Study|Protocol Violation|1|||
160951989|NCT02528214|581211070|FG000|Overall Study|Adverse Event|0|||
160951990|NCT02528214|581211071|FG001|Overall Study|Adverse Event|1|||
160951991|NCT02528214|581211070|FG000|Overall Study|Other than specified above|0|||
160951992|NCT02528214|581211071|FG001|Overall Study|Other than specified above|1|||
160951993|NCT00407537|581211072|FG000|Overall Study|Death|5|||
160951994|NCT00407537|581211073|FG001|Overall Study|Death|2|||
160951995|NCT00407537|581211072|FG000|Overall Study|Adverse Event|36|||
160951996|NCT00407537|581211073|FG001|Overall Study|Adverse Event|0|||
160951997|NCT00407537|581211072|FG000|Overall Study|Lost to Follow-up|12|||
160951998|NCT00407537|581211073|FG001|Overall Study|Lost to Follow-up|19|||
160951999|NCT00407537|581211072|FG000|Overall Study|Other|6|||
160952000|NCT00407537|581211073|FG001|Overall Study|Other|7|||
160952001|NCT00407537|581211072|FG000|Overall Study|Withdrawal by Subject|34|||
160656257|NCT02388763|580122384|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
160656258|NCT02388763|580122383|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
160656259|NCT02388763|580122384|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
160656260|NCT01604850|580122385|FG000|Overall Study|Enrolled but never treated|0|||
160656261|NCT01604850|580122386|FG001|Overall Study|Enrolled but never treated|1|||
160656262|NCT01604850|580122385|FG000|Overall Study|Efficacy Failure|50|||
160656263|NCT01604850|580122386|FG001|Overall Study|Efficacy Failure|29|||
160656264|NCT01604850|580122385|FG000|Overall Study|Lost to Follow-up|1|||
160656265|NCT01604850|580122386|FG001|Overall Study|Lost to Follow-up|0|||
160656266|NCT01604850|580122385|FG000|Overall Study|Subject withdrew consent|1|||
160656267|NCT01604850|580122386|FG001|Overall Study|Subject withdrew consent|0|||
160656268|NCT01703832|580122387|FG000|Overall Study|Withdrawal by Subject|1|||
160656269|NCT01703832|580122388|FG001|Overall Study|Withdrawal by Subject|0|||
160656270|NCT00243932|580122389|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
160656271|NCT00243932|580122390|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
160656272|NCT00243932|580122391|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
160656273|NCT01458405|580122397|FG000|Phase 1 (up to 12 Months)|Other|0|||
160656274|NCT01458405|580122398|FG001|Phase 1 (up to 12 Months)|Other|1|||
160656275|NCT01458405|580122399|FG002|Phase 1 (up to 12 Months)|Other|0|||
160656276|NCT01458405|580122400|FG003|Phase 1 (up to 12 Months)|Other|0|||
160656277|NCT01458405|580122397|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
160656278|NCT01458405|580122398|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
160656279|NCT01458405|580122399|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
160656280|NCT01458405|580122400|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
160656281|NCT01458405|580122397|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
160656282|NCT01458405|580122398|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
160656283|NCT01458405|580122399|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
160656284|NCT01458405|580122400|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
160656285|NCT01458405|580122397|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
160656286|NCT01458405|580122398|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
160656287|NCT01458405|580122399|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
160656288|NCT01458405|580122400|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
160656289|NCT02497781|580122401|FG000|Overall Study|Withdrawal by Subject|2|||
160656290|NCT02497781|580122402|FG001|Overall Study|Withdrawal by Subject|0|||
160656291|NCT02497781|580122401|FG000|Overall Study|Lack of Efficacy|0|||
160656292|NCT02497781|580122402|FG001|Overall Study|Lack of Efficacy|1|||
160656293|NCT02497781|580122401|FG000|Overall Study|Randomised but not treated|1|||
160656294|NCT02497781|580122402|FG001|Overall Study|Randomised but not treated|1|||
160656295|NCT02497781|580122401|FG000|Overall Study|Lost to Follow-up|1|||
160656296|NCT02497781|580122402|FG001|Overall Study|Lost to Follow-up|1|||
160656297|NCT01193608|580122403|FG000|Overall Study|Other|0|||
160656298|NCT01193608|580122404|FG001|Overall Study|Other|1|||
160656299|NCT01193608|580122405|FG002|Overall Study|Other|0|||
160656300|NCT01193608|580122406|FG003|Overall Study|Other|0|||
160656301|NCT01193608|580122407|FG004|Overall Study|Other|0|||
160656302|NCT01193608|580122408|FG005|Overall Study|Other|0|||
160656303|NCT01193608|580122403|FG000|Overall Study|Withdrawal by Subject|0|||
160952002|NCT00407537|581211073|FG001|Overall Study|Withdrawal by Subject|16|||
160952003|NCT03043664|581211075|FG000|Overall Study|Lost to Follow-up|1|||
160952004|NCT00325468|581211076|FG000|Overall Study|Adverse Event|1|||
160952005|NCT00325468|581211077|FG001|Overall Study|Adverse Event|1|||
160952006|NCT00325468|581211078|FG002|Overall Study|Adverse Event|0|||
160952007|NCT00325468|581211079|FG003|Overall Study|Adverse Event|5|||
160952008|NCT00325468|581211080|FG004|Overall Study|Adverse Event|1|||
160952009|NCT00325468|581211076|FG000|Overall Study|Death|2|||
160952010|NCT00325468|581211077|FG001|Overall Study|Death|0|||
160952011|NCT00325468|581211078|FG002|Overall Study|Death|2|||
160952012|NCT00325468|581211079|FG003|Overall Study|Death|4|||
160952013|NCT00325468|581211080|FG004|Overall Study|Death|0|||
160952014|NCT00325468|581211076|FG000|Overall Study|Lost to Follow-up|0|||
160952015|NCT00325468|581211077|FG001|Overall Study|Lost to Follow-up|0|||
160952016|NCT00325468|581211078|FG002|Overall Study|Lost to Follow-up|1|||
160952017|NCT00325468|581211079|FG003|Overall Study|Lost to Follow-up|2|||
160952018|NCT00325468|581211080|FG004|Overall Study|Lost to Follow-up|2|||
160952019|NCT00325468|581211076|FG000|Overall Study|Physician Decision|1|||
160952020|NCT00325468|581211077|FG001|Overall Study|Physician Decision|1|||
160952021|NCT00325468|581211078|FG002|Overall Study|Physician Decision|0|||
160952022|NCT00325468|581211079|FG003|Overall Study|Physician Decision|1|||
160952023|NCT00325468|581211080|FG004|Overall Study|Physician Decision|0|||
160952024|NCT00325468|581211076|FG000|Overall Study|Withdrawal by Subject|3|||
160952025|NCT00325468|581211077|FG001|Overall Study|Withdrawal by Subject|1|||
160952026|NCT00325468|581211078|FG002|Overall Study|Withdrawal by Subject|0|||
160952027|NCT00325468|581211079|FG003|Overall Study|Withdrawal by Subject|14|||
160952028|NCT00325468|581211080|FG004|Overall Study|Withdrawal by Subject|4|||
160952029|NCT00325468|581211076|FG000|Overall Study|site closure etc|4|||
161000846|NCT02296424|581388901|FG002|Part 1|16 directly started part II|0|||
161000847|NCT02296424|581388902|FG003|Part 1|16 directly started part II|0|||
161000848|NCT02296424|581388899|FG000|Part 2|Lack of Efficacy|0|||
161000849|NCT02296424|581388900|FG001|Part 2|Lack of Efficacy|0|||
161000850|NCT02296424|581388901|FG002|Part 2|Lack of Efficacy|1|||
161000851|NCT02296424|581388902|FG003|Part 2|Lack of Efficacy|0|||
161000852|NCT02296424|581388899|FG000|Part 2|Adverse Event|0|||
161000853|NCT02296424|581388900|FG001|Part 2|Adverse Event|0|||
161000854|NCT02296424|581388901|FG002|Part 2|Adverse Event|1|||
161000855|NCT02296424|581388902|FG003|Part 2|Adverse Event|0|||
160863386|NCT00911170|580893075|FG001|Treatment Period|Lost to Follow-up|1|||
160863387|NCT00911170|580893074|FG000|Treatment Period|Death|6|||
161000856|NCT02296424|581388899|FG000|Part 2|Lost to Follow-up|0|||
161000857|NCT02296424|581388900|FG001|Part 2|Lost to Follow-up|0|||
161000858|NCT02296424|581388901|FG002|Part 2|Lost to Follow-up|1|||
161000859|NCT02296424|581388902|FG003|Part 2|Lost to Follow-up|0|||
161000860|NCT00743444|581388903|FG000|First Intervention|Catheter placement problems|0|||
161000861|NCT00743444|581388904|FG001|First Intervention|Catheter placement problems|1|||
161000862|NCT00743444|581388903|FG000|Washout Period|Adverse Event|0|||
161000863|NCT00743444|581388904|FG001|Washout Period|Adverse Event|1|||
161000864|NCT00807144|581388905|FG000|Overall Study|Lost to Follow-up|0|||
161000865|NCT00807144|581388906|FG001|Overall Study|Lost to Follow-up|1|||
161000866|NCT03823300|581388922|FG000|Overall Study|Withdrawal by Subject|16|||
161000867|NCT03823300|581388923|FG001|Overall Study|Withdrawal by Subject|22|||
161000868|NCT03823300|581388922|FG000|Overall Study|Death|10|||
161000869|NCT03823300|581388923|FG001|Overall Study|Death|14|||
161000870|NCT03823300|581388922|FG000|Overall Study|Adverse Event|3|||
161000871|NCT03823300|581388923|FG001|Overall Study|Adverse Event|5|||
161000872|NCT03823300|581388922|FG000|Overall Study|Physician Decision|1|||
161000873|NCT03823300|581388923|FG001|Overall Study|Physician Decision|7|||
161000874|NCT03823300|581388922|FG000|Overall Study|Lost to Follow-up|1|||
161000875|NCT03823300|581388923|FG001|Overall Study|Lost to Follow-up|3|||
161000876|NCT03823300|581388922|FG000|Overall Study|Protocol Violation|1|||
161000877|NCT03823300|581388923|FG001|Overall Study|Protocol Violation|1|||
160457427|NCT02839265|579406405|FG000|Overall Study|Death|1|||
160863388|NCT00911170|580893075|FG001|Treatment Period|Death|9|||
160863389|NCT00911170|580893074|FG000|Long Term Follow-Up|Continuing in study|274|||
160863390|NCT00911170|580893075|FG001|Long Term Follow-Up|Continuing in study|269|||
160863391|NCT00911170|580893074|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
160863392|NCT00911170|580893075|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
160863393|NCT00911170|580893074|FG000|Long Term Follow-Up|Physician Decision|5|||
160863394|NCT00911170|580893075|FG001|Long Term Follow-Up|Physician Decision|4|||
160863395|NCT00911170|580893074|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
160863396|NCT00911170|580893075|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
160863397|NCT00911170|580893074|FG000|Long Term Follow-Up|Death|116|||
160863398|NCT00911170|580893075|FG001|Long Term Follow-Up|Death|121|||
160863399|NCT02681523|580893076|FG000|Overall Study|Adverse Event|1|||
160863400|NCT02681523|580893076|FG000|Overall Study|Patient Non-compliance|1|||
160863401|NCT03253393|580893080|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
160863402|NCT03253393|580893081|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
160863403|NCT03253393|580893082|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
160952030|NCT00325468|581211077|FG001|Overall Study|site closure etc|2|||
160952031|NCT00325468|581211078|FG002|Overall Study|site closure etc|1|||
160952032|NCT00325468|581211079|FG003|Overall Study|site closure etc|8|||
160952033|NCT00325468|581211080|FG004|Overall Study|site closure etc|1|||
160952034|NCT03732209|581211081|FG000|Overall Study|Lost to Follow-up|4|||
160952035|NCT03732209|581211082|FG001|Overall Study|Lost to Follow-up|4|||
160952036|NCT03732209|581211081|FG000|Overall Study|Withdrawal by Subject|8|||
160952037|NCT03732209|581211082|FG001|Overall Study|Withdrawal by Subject|9|||
160952038|NCT01127178|581211083|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
160952039|NCT01127178|581211084|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
160952040|NCT01127178|581211083|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
160952041|NCT01127178|581211084|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
160952042|NCT01127178|581211083|FG000|Dose Escalation: Treatment Phase|Other|2|||
160952043|NCT01127178|581211084|FG001|Dose Escalation: Treatment Phase|Other|0|||
160952044|NCT01127178|581211083|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
160952045|NCT01127178|581211084|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
160952046|NCT01127178|581211083|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
160952047|NCT01127178|581211084|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
160952048|NCT01127178|581211083|FG000|Dose Escalation: Extension Phase|Other|1|||
160952049|NCT01127178|581211084|FG001|Dose Escalation: Extension Phase|Other|0|||
160952050|NCT04139317|581211085|FG000|Overall Study|Adverse Event|10|||
160952051|NCT04139317|581211086|FG001|Overall Study|Adverse Event|2|||
160952052|NCT04139317|581211085|FG000|Overall Study|Death|6|||
160952053|NCT04139317|581211086|FG001|Overall Study|Death|4|||
160952054|NCT04139317|581211085|FG000|Overall Study|Lost to Follow-up|1|||
160952055|NCT04139317|581211086|FG001|Overall Study|Lost to Follow-up|0|||
160952056|NCT04139317|581211085|FG000|Overall Study|Physician Decision|3|||
160952057|NCT04139317|581211086|FG001|Overall Study|Physician Decision|1|||
160952058|NCT04139317|581211085|FG000|Overall Study|Progressive Disease|19|||
160952059|NCT04139317|581211086|FG001|Overall Study|Progressive Disease|9|||
160952060|NCT04139317|581211085|FG000|Overall Study|Subject Decision|2|||
160952061|NCT04139317|581211086|FG001|Overall Study|Subject Decision|2|||
160952062|NCT00782340|581211089|FG000|Open Label Titration|Adverse Event|12|||
160952063|NCT00782340|581211090|FG001|Open Label Titration|Adverse Event|0|||
160952064|NCT00782340|581211091|FG002|Open Label Titration|Adverse Event|0|||
160952065|NCT00782340|581211089|FG000|Open Label Titration|Treatment failure|50|||
160952066|NCT00782340|581211090|FG001|Open Label Titration|Treatment failure|0|||
160952067|NCT00782340|581211091|FG002|Open Label Titration|Treatment failure|0|||
160952068|NCT00782340|581211089|FG000|Open Label Titration|Protocol Violation|5|||
160952069|NCT00782340|581211090|FG001|Open Label Titration|Protocol Violation|0|||
160952070|NCT00782340|581211091|FG002|Open Label Titration|Protocol Violation|0|||
160952071|NCT00782340|581211089|FG000|Open Label Titration|Withdrawal by Subject|5|||
160952072|NCT00782340|581211090|FG001|Open Label Titration|Withdrawal by Subject|0|||
160952073|NCT00782340|581211091|FG002|Open Label Titration|Withdrawal by Subject|0|||
160952074|NCT00782340|581211089|FG000|Open Label Titration|Enrollment capped|16|||
160952075|NCT00782340|581211090|FG001|Open Label Titration|Enrollment capped|0|||
160952076|NCT00782340|581211091|FG002|Open Label Titration|Enrollment capped|0|||
160952077|NCT00782340|581211089|FG000|Open Label Titration|Did not meet responder criteria|2|||
160952078|NCT00782340|581211090|FG001|Open Label Titration|Did not meet responder criteria|0|||
160952079|NCT00782340|581211091|FG002|Open Label Titration|Did not meet responder criteria|0|||
160952080|NCT00782340|581211089|FG000|Open Label Titration|Lost to Follow-up|5|||
160952081|NCT00782340|581211090|FG001|Open Label Titration|Lost to Follow-up|0|||
160952082|NCT00782340|581211091|FG002|Open Label Titration|Lost to Follow-up|0|||
160952083|NCT00782340|581211089|FG000|Open Label Titration|Randomized in error|6|||
160952084|NCT00782340|581211090|FG001|Open Label Titration|Randomized in error|0|||
160952085|NCT00782340|581211091|FG002|Open Label Titration|Randomized in error|0|||
160952086|NCT02365467|581211092|FG000|Overall Study|Death|3|||
160952087|NCT01306162|581211093|FG000|Period 1|Adverse Event|0|||
160952088|NCT01306162|581211094|FG001|Period 1|Adverse Event|0|||
160952089|NCT01306162|581211095|FG002|Period 1|Adverse Event|0|||
160952090|NCT01306162|581211096|FG003|Period 1|Adverse Event|1|||
160952091|NCT01306162|581211093|FG000|Washout 1|Non-compliance to protocol|0|||
160952092|NCT01306162|581211094|FG001|Washout 1|Non-compliance to protocol|1|||
160952093|NCT01306162|581211095|FG002|Washout 1|Non-compliance to protocol|0|||
160952094|NCT01306162|581211096|FG003|Washout 1|Non-compliance to protocol|0|||
160952095|NCT01109992|581211097|FG000|Overall Study|Withdrawal by Subject|0|||
160952096|NCT01109992|581211098|FG001|Overall Study|Withdrawal by Subject|1|||
160952097|NCT01109992|581211097|FG000|Overall Study|Movement during rest scan.|0|||
160952098|NCT01109992|581211098|FG001|Overall Study|Movement during rest scan.|1|||
160952099|NCT02952924|581211101|FG000|Overall Study|Protocol Violation|0|||
160952100|NCT02952924|581211102|FG001|Overall Study|Protocol Violation|0|||
160952101|NCT02952924|581211103|FG002|Overall Study|Protocol Violation|0|||
160952102|NCT02952924|581211104|FG003|Overall Study|Protocol Violation|0|||
160952103|NCT02952924|581211105|FG004|Overall Study|Protocol Violation|0|||
160952104|NCT02952924|581211106|FG005|Overall Study|Protocol Violation|0|||
160952105|NCT02952924|581211107|FG006|Overall Study|Protocol Violation|0|||
160952106|NCT02952924|581211108|FG007|Overall Study|Protocol Violation|0|||
160952107|NCT02952924|581211109|FG008|Overall Study|Protocol Violation|0|||
160952108|NCT02952924|581211110|FG009|Overall Study|Protocol Violation|0|||
160952109|NCT02952924|581211111|FG010|Overall Study|Protocol Violation|0|||
160952110|NCT02952924|581211112|FG011|Overall Study|Protocol Violation|0|||
160952111|NCT02952924|581211113|FG012|Overall Study|Protocol Violation|0|||
160952112|NCT02952924|581211114|FG013|Overall Study|Protocol Violation|0|||
160952113|NCT02952924|581211115|FG014|Overall Study|Protocol Violation|0|||
160952114|NCT02952924|581211116|FG015|Overall Study|Protocol Violation|0|||
160952115|NCT02952924|581211117|FG016|Overall Study|Protocol Violation|0|||
160952116|NCT02952924|581211118|FG017|Overall Study|Protocol Violation|0|||
160952117|NCT02952924|581211119|FG018|Overall Study|Protocol Violation|0|||
160952118|NCT02952924|581211120|FG019|Overall Study|Protocol Violation|1|||
160952119|NCT02952924|581211121|FG020|Overall Study|Protocol Violation|0|||
160952120|NCT02952924|581211122|FG021|Overall Study|Protocol Violation|0|||
160952121|NCT02952924|581211101|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
160952122|NCT02952924|581211102|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
160952123|NCT02952924|581211103|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
160952124|NCT02952924|581211104|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
160952125|NCT02952924|581211105|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
160952126|NCT02952924|581211106|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
160952127|NCT02952924|581211107|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
160952128|NCT02952924|581211108|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
160952129|NCT02952924|581211109|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
160952130|NCT02952924|581211110|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
160952131|NCT02952924|581211111|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
160952132|NCT02952924|581211112|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
160952133|NCT02952924|581211113|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
160952134|NCT02952924|581211114|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
160952135|NCT02952924|581211115|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
160952136|NCT02952924|581211116|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
160952137|NCT02952924|581211117|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
160952138|NCT02952924|581211118|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
160952139|NCT02952924|581211119|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
160952140|NCT02952924|581211120|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
160952141|NCT02952924|581211121|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
160952142|NCT02952924|581211122|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
160952143|NCT02952924|581211101|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952144|NCT02952924|581211102|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952145|NCT02952924|581211103|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952146|NCT02952924|581211104|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952147|NCT02952924|581211105|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952148|NCT02952924|581211106|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952149|NCT02952924|581211107|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952150|NCT02952924|581211108|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952151|NCT02952924|581211109|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952152|NCT02952924|581211110|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952153|NCT02952924|581211111|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952154|NCT02952924|581211112|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952155|NCT02952924|581211113|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952156|NCT02952924|581211114|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952157|NCT02952924|581211115|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952158|NCT02952924|581211116|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952159|NCT02952924|581211117|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
160632830|NCT01215955|580036088|FG003|Overall Study|Entry Criteria Not Met|7|||
160952160|NCT02952924|581211118|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952161|NCT02952924|581211119|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952162|NCT02952924|581211120|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952163|NCT02952924|581211121|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952164|NCT02952924|581211122|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
160952165|NCT02952924|581211101|FG000|Overall Study|Noncompliance with study drug|0|||
160952166|NCT02952924|581211102|FG001|Overall Study|Noncompliance with study drug|0|||
160952167|NCT02952924|581211103|FG002|Overall Study|Noncompliance with study drug|0|||
160952168|NCT02952924|581211104|FG003|Overall Study|Noncompliance with study drug|0|||
161000878|NCT03823300|581388922|FG000|Overall Study|Lack of Efficacy|1|||
160952169|NCT02952924|581211105|FG004|Overall Study|Noncompliance with study drug|0|||
160457428|NCT02839265|579406405|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
160952170|NCT02952924|581211106|FG005|Overall Study|Noncompliance with study drug|0|||
160952171|NCT02952924|581211107|FG006|Overall Study|Noncompliance with study drug|0|||
160952172|NCT02952924|581211108|FG007|Overall Study|Noncompliance with study drug|0|||
160952173|NCT02952924|581211109|FG008|Overall Study|Noncompliance with study drug|0|||
160952174|NCT02952924|581211110|FG009|Overall Study|Noncompliance with study drug|0|||
160952175|NCT02952924|581211111|FG010|Overall Study|Noncompliance with study drug|0|||
160952176|NCT02952924|581211112|FG011|Overall Study|Noncompliance with study drug|0|||
160952177|NCT02952924|581211113|FG012|Overall Study|Noncompliance with study drug|0|||
160952178|NCT02952924|581211114|FG013|Overall Study|Noncompliance with study drug|0|||
160952179|NCT02952924|581211115|FG014|Overall Study|Noncompliance with study drug|0|||
160952180|NCT02952924|581211116|FG015|Overall Study|Noncompliance with study drug|0|||
160952181|NCT02952924|581211117|FG016|Overall Study|Noncompliance with study drug|0|||
160952182|NCT02952924|581211118|FG017|Overall Study|Noncompliance with study drug|0|||
160952183|NCT02952924|581211119|FG018|Overall Study|Noncompliance with study drug|0|||
160952184|NCT02952924|581211120|FG019|Overall Study|Noncompliance with study drug|0|||
160952185|NCT02952924|581211121|FG020|Overall Study|Noncompliance with study drug|0|||
160952186|NCT02952924|581211122|FG021|Overall Study|Noncompliance with study drug|1|||
160952187|NCT01435577|581211125|FG000|Overall Study|Adverse Event|10|||
160952188|NCT01435577|581211126|FG001|Overall Study|Adverse Event|0|||
160952189|NCT01435577|581211125|FG000|Overall Study|Lack of Efficacy|7|||
160952190|NCT01435577|581211126|FG001|Overall Study|Lack of Efficacy|51|||
160952191|NCT01435577|581211125|FG000|Overall Study|Alternative treatment started|0|||
160952192|NCT01435577|581211126|FG001|Overall Study|Alternative treatment started|1|||
160952193|NCT01934218|581211128|FG000|Double-blind Phase|Adverse Event|8|||
160952194|NCT01934218|581211129|FG001|Double-blind Phase|Adverse Event|8|||
160952195|NCT01934218|581211128|FG000|Double-blind Phase|Lack of Efficacy|6|||
160952196|NCT01934218|581211129|FG001|Double-blind Phase|Lack of Efficacy|7|||
160952197|NCT01934218|581211128|FG000|Double-blind Phase|Lost to Follow-up|7|||
160952198|NCT01934218|581211129|FG001|Double-blind Phase|Lost to Follow-up|14|||
160952199|NCT01934218|581211128|FG000|Double-blind Phase|Physician Decision|1|||
160952200|NCT01934218|581211129|FG001|Double-blind Phase|Physician Decision|2|||
160952201|NCT01934218|581211128|FG000|Double-blind Phase|Protocol Violation|4|||
160952202|NCT01934218|581211129|FG001|Double-blind Phase|Protocol Violation|0|||
160952203|NCT01934218|581211128|FG000|Double-blind Phase|Withdrawal by Subject|16|||
160952204|NCT01934218|581211129|FG001|Double-blind Phase|Withdrawal by Subject|13|||
160952205|NCT01934218|581211128|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
160952206|NCT01934218|581211129|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
160952207|NCT01934218|581211128|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
160952208|NCT01934218|581211129|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
160457429|NCT03484819|579406418|FG000|Overall Study|Death|2|||
160457430|NCT03484819|579406418|FG000|Overall Study|Adverse Event|2|||
160457431|NCT03484819|579406418|FG000|Overall Study|Physician Decision|1|||
160457432|NCT03484819|579406418|FG000|Overall Study|Withdrawal by Subject|2|||
160457433|NCT03484819|579406418|FG000|Overall Study|Disease Progression|4|||
160952209|NCT01934218|581211128|FG000|Open-Label Phase|Adverse Event|2|||
160952210|NCT01934218|581211129|FG001|Open-Label Phase|Adverse Event|4|||
160457434|NCT03484819|579406418|FG000|Overall Study|Complicating Condition|1|||
160952211|NCT01934218|581211128|FG000|Open-Label Phase|Lack of Efficacy|1|||
160952212|NCT01934218|581211129|FG001|Open-Label Phase|Lack of Efficacy|4|||
160952213|NCT01934218|581211128|FG000|Open-Label Phase|Lost to Follow-up|4|||
160952214|NCT01934218|581211129|FG001|Open-Label Phase|Lost to Follow-up|2|||
160952215|NCT01934218|581211128|FG000|Open-Label Phase|Physician Decision|1|||
160952216|NCT01934218|581211129|FG001|Open-Label Phase|Physician Decision|0|||
160952217|NCT01934218|581211128|FG000|Open-Label Phase|Protocol Violation|1|||
160952218|NCT01934218|581211129|FG001|Open-Label Phase|Protocol Violation|0|||
160952219|NCT01934218|581211128|FG000|Open-Label Phase|Withdrawal by Subject|13|||
160952220|NCT01934218|581211129|FG001|Open-Label Phase|Withdrawal by Subject|11|||
160457435|NCT05970861|579406419|FG000|Overall Study|Physician Decision|4|||
160952221|NCT01934218|581211128|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
160952222|NCT01934218|581211129|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
160457436|NCT05970861|579406420|FG001|Overall Study|Physician Decision|4|||
160457437|NCT05970861|579406419|FG000|Overall Study|Lost to Follow-up|4|||
160457438|NCT05970861|579406420|FG001|Overall Study|Lost to Follow-up|3|||
160582563|NCT03725202|579853629|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
160457439|NCT02990338|579406421|FG000|Overall Study|Randomized and not treated|4|||
160582564|NCT03725202|579853630|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
160952223|NCT01934218|581211128|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
160952224|NCT01934218|581211129|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
160457440|NCT02990338|579406422|FG001|Overall Study|Randomized and not treated|2|||
160457441|NCT02990338|579406421|FG000|Overall Study|Adverse Event|23|||
160582565|NCT03725202|579853631|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
160952225|NCT03273946|581211133|FG000|Overall Study|Withdrawal by Subject|5|||
160952226|NCT03273946|581211133|FG000|Overall Study|Unwillingness of the guardian|1|||
160952227|NCT03273946|581211133|FG000|Overall Study|Participant refused to use the drug|2|||
160952228|NCT03273946|581211133|FG000|Overall Study|Participant relative refused to use drug|1|||
160952229|NCT01220557|581211134|FG000|Overall Study|Lost to Follow-up|5|||
160952230|NCT01220557|581211135|FG001|Overall Study|Lost to Follow-up|3|||
160952231|NCT01220557|581211134|FG000|Overall Study|attended less than 6 lessons|1|||
160952232|NCT01220557|581211135|FG001|Overall Study|attended less than 6 lessons|2|||
160952233|NCT01090453|581211137|FG000|Overall Study|Withdrawal by Subject|1|||
160952234|NCT01090453|581211138|FG001|Overall Study|Withdrawal by Subject|2|||
160952235|NCT01090453|581211137|FG000|Overall Study|Lost to Follow-up|7|||
160952236|NCT01090453|581211138|FG001|Overall Study|Lost to Follow-up|7|||
160952237|NCT01090453|581211137|FG000|Overall Study|Non serious AEs|1|||
160952238|NCT01090453|581211138|FG001|Overall Study|Non serious AEs|0|||
160952239|NCT01090453|581211137|FG000|Overall Study|Protocol Violation|2|||
160952240|NCT01090453|581211138|FG001|Overall Study|Protocol Violation|0|||
160952241|NCT01090453|581211137|FG000|Overall Study|Other|2|||
160952242|NCT01090453|581211138|FG001|Overall Study|Other|4|||
160952243|NCT01090453|581211137|FG000|Overall Study|Eligibility Criteria|0|||
160952244|NCT01090453|581211138|FG001|Overall Study|Eligibility Criteria|1|||
160952245|NCT01870843|581211139|FG000|Overall Study|Adverse Event|10|||
160952246|NCT01870843|581211139|FG000|Overall Study|Lost to Follow-up|24|||
160952247|NCT01870843|581211139|FG000|Overall Study|Death|1|||
160952248|NCT01870843|581211139|FG000|Overall Study|Withdrawal by Subject|18|||
160952249|NCT03588572|581211143|FG000|Visitation 1|Lack of Efficacy|1|||
160952250|NCT03588572|581211144|FG001|Visitation 1|Lack of Efficacy|1|||
160952251|NCT03588572|581211143|FG000|Visitation 2|Lost to Follow-up|1|||
160952252|NCT03588572|581211144|FG001|Visitation 2|Lost to Follow-up|1|||
160952253|NCT03588572|581211143|FG000|Visitation 2|Lack of Efficacy|0|||
160952254|NCT03588572|581211144|FG001|Visitation 2|Lack of Efficacy|1|||
160952255|NCT03588572|581211143|FG000|Visitation 2|Withdrawal by Subject|1|||
160952256|NCT03588572|581211144|FG001|Visitation 2|Withdrawal by Subject|0|||
160952257|NCT03588572|581211143|FG000|Visitation 3|Lost to Follow-up|1|||
160952258|NCT03588572|581211144|FG001|Visitation 3|Lost to Follow-up|1|||
160952259|NCT03588572|581211143|FG000|Visitation 3|Physician Decision|1|||
160952260|NCT03588572|581211144|FG001|Visitation 3|Physician Decision|1|||
160952261|NCT03588572|581211143|FG000|Visitation 3|Withdrawal by Subject|1|||
160952262|NCT03588572|581211144|FG001|Visitation 3|Withdrawal by Subject|0|||
160952263|NCT01165281|581211145|FG000|Overall Study|Adverse Event|12|||
160952264|NCT01165281|581211146|FG001|Overall Study|Adverse Event|14|||
160952265|NCT01165281|581211145|FG000|Overall Study|Death|3|||
160952266|NCT01165281|581211146|FG001|Overall Study|Death|4|||
160952267|NCT01165281|581211145|FG000|Overall Study|Lack of Efficacy|4|||
160952268|NCT01165281|581211146|FG001|Overall Study|Lack of Efficacy|1|||
160952269|NCT01165281|581211145|FG000|Overall Study|Lost to Follow-up|0|||
160952270|NCT01165281|581211146|FG001|Overall Study|Lost to Follow-up|1|||
160952271|NCT01165281|581211145|FG000|Overall Study|Physician Decision|8|||
160952272|NCT01165281|581211146|FG001|Overall Study|Physician Decision|1|||
160952273|NCT01165281|581211145|FG000|Overall Study|Protocol Violation|6|||
160952274|NCT01165281|581211146|FG001|Overall Study|Protocol Violation|5|||
160952275|NCT01165281|581211145|FG000|Overall Study|Withdrawal by Subject|8|||
160952276|NCT01165281|581211146|FG001|Overall Study|Withdrawal by Subject|7|||
160952277|NCT01165281|581211145|FG000|Overall Study|Noncompliance with Study Drug|1|||
160952278|NCT01165281|581211146|FG001|Overall Study|Noncompliance with Study Drug|4|||
160952279|NCT01165281|581211145|FG000|Overall Study|Progressive Disease|10|||
160952280|NCT01165281|581211146|FG001|Overall Study|Progressive Disease|14|||
160952281|NCT01165281|581211145|FG000|Overall Study|Other|6|||
160952282|NCT01165281|581211146|FG001|Overall Study|Other|0|||
160952283|NCT02863991|581211147|FG000|Overall Study|Death|0|||
160952284|NCT02863991|581211148|FG001|Overall Study|Death|3|||
160952285|NCT02863991|581211147|FG000|Overall Study|Lack of Efficacy|0|||
160952286|NCT02863991|581211148|FG001|Overall Study|Lack of Efficacy|1|||
160952287|NCT02863991|581211147|FG000|Overall Study|Study Terminated|2|||
160952288|NCT02863991|581211148|FG001|Overall Study|Study Terminated|8|||
160952289|NCT00364858|581211149|FG000|Overall Study|Adverse Event|1|||
160952290|NCT00364858|581211150|FG001|Overall Study|Adverse Event|5|||
160952291|NCT00364858|581211149|FG000|Overall Study|Withdrawal by Subject|1|||
160952292|NCT00364858|581211150|FG001|Overall Study|Withdrawal by Subject|1|||
160952293|NCT00364858|581211149|FG000|Overall Study|Pregnancy|1|||
160952294|NCT00364858|581211150|FG001|Overall Study|Pregnancy|1|||
160952295|NCT00364858|581211149|FG000|Overall Study|Clinical failure|2|||
160952296|NCT00364858|581211150|FG001|Overall Study|Clinical failure|13|||
160952297|NCT00364858|581211149|FG000|Overall Study|Discontinuation at baseline|1|||
160952298|NCT00364858|581211150|FG001|Overall Study|Discontinuation at baseline|0|||
160952299|NCT00364858|581211149|FG000|Overall Study|Non-compliant|1|||
160952300|NCT00364858|581211150|FG001|Overall Study|Non-compliant|0|||
160952301|NCT00364858|581211149|FG000|Overall Study|Return to Q2 regimen|0|||
160952302|NCT00364858|581211150|FG001|Overall Study|Return to Q2 regimen|1|||
160952303|NCT00364858|581211149|FG000|Overall Study|Clinical baseline issue|0|||
160952304|NCT00364858|581211150|FG001|Overall Study|Clinical baseline issue|1|||
160952305|NCT00363766|581211151|FG000|Overall Study|Progressive Disease|15|||
160952306|NCT00363766|581211152|FG001|Overall Study|Progressive Disease|9|||
160952307|NCT00363766|581211151|FG000|Overall Study|Adverse Event|10|||
160952308|NCT00363766|581211152|FG001|Overall Study|Adverse Event|2|||
160952309|NCT00363766|581211151|FG000|Overall Study|Disease Related Death|1|||
160952310|NCT00363766|581211152|FG001|Overall Study|Disease Related Death|3|||
160952311|NCT00363766|581211151|FG000|Overall Study|Not Disease Related Death|3|||
160952312|NCT00363766|581211152|FG001|Overall Study|Not Disease Related Death|4|||
160952313|NCT00363766|581211151|FG000|Overall Study|Withdrawal by Subject|2|||
160952314|NCT00363766|581211152|FG001|Overall Study|Withdrawal by Subject|0|||
160952315|NCT00363766|581211151|FG000|Overall Study|Physician Decision|1|||
160952316|NCT00363766|581211152|FG001|Overall Study|Physician Decision|2|||
160952317|NCT00558285|581211153|FG000|Overall Study|Adverse Event|1|||
160952318|NCT00558285|581211154|FG001|Overall Study|Adverse Event|1|||
160952319|NCT00558285|581211155|FG002|Overall Study|Adverse Event|4|||
160952320|NCT00558285|581211156|FG003|Overall Study|Adverse Event|1|||
160952321|NCT00558285|581211157|FG004|Overall Study|Adverse Event|2|||
160952322|NCT00558285|581211153|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160952323|NCT00558285|581211154|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160952324|NCT00558285|581211155|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160952325|NCT00558285|581211156|FG003|Overall Study|Abnormal test procedure result(s)|0|||
160952326|NCT00558285|581211157|FG004|Overall Study|Abnormal test procedure result(s)|0|||
160952327|NCT00558285|581211153|FG000|Overall Study|Subject withdrew consent|2|||
160952328|NCT00558285|581211154|FG001|Overall Study|Subject withdrew consent|0|||
160952329|NCT00558285|581211155|FG002|Overall Study|Subject withdrew consent|1|||
160952330|NCT00558285|581211156|FG003|Overall Study|Subject withdrew consent|1|||
160952331|NCT00558285|581211157|FG004|Overall Study|Subject withdrew consent|1|||
160952332|NCT00558285|581211153|FG000|Overall Study|Lost to Follow-up|1|||
160952333|NCT00558285|581211154|FG001|Overall Study|Lost to Follow-up|1|||
160952334|NCT00558285|581211155|FG002|Overall Study|Lost to Follow-up|0|||
160952335|NCT00558285|581211156|FG003|Overall Study|Lost to Follow-up|0|||
160952336|NCT00558285|581211157|FG004|Overall Study|Lost to Follow-up|0|||
160952337|NCT00558285|581211153|FG000|Overall Study|Administrative problems|0|||
160952338|NCT00558285|581211154|FG001|Overall Study|Administrative problems|0|||
160952339|NCT00558285|581211155|FG002|Overall Study|Administrative problems|0|||
160952340|NCT00558285|581211156|FG003|Overall Study|Administrative problems|1|||
160952341|NCT00558285|581211157|FG004|Overall Study|Administrative problems|1|||
160952342|NCT00558285|581211153|FG000|Overall Study|Protocol deviation|1|||
160656304|NCT01193608|580122404|FG001|Overall Study|Withdrawal by Subject|1|||
160656305|NCT01193608|580122405|FG002|Overall Study|Withdrawal by Subject|2|||
160656306|NCT01193608|580122406|FG003|Overall Study|Withdrawal by Subject|3|||
160656307|NCT01193608|580122407|FG004|Overall Study|Withdrawal by Subject|3|||
160656308|NCT01193608|580122408|FG005|Overall Study|Withdrawal by Subject|0|||
160656309|NCT01193608|580122403|FG000|Overall Study|Lost to Follow-up|0|||
160656310|NCT01193608|580122404|FG001|Overall Study|Lost to Follow-up|0|||
160656311|NCT01193608|580122405|FG002|Overall Study|Lost to Follow-up|0|||
160656312|NCT01193608|580122406|FG003|Overall Study|Lost to Follow-up|0|||
160656313|NCT01193608|580122407|FG004|Overall Study|Lost to Follow-up|1|||
160656314|NCT01193608|580122408|FG005|Overall Study|Lost to Follow-up|2|||
160656315|NCT01193608|580122403|FG000|Overall Study|Adverse Event|0|||
160656316|NCT01193608|580122404|FG001|Overall Study|Adverse Event|0|||
160656317|NCT01193608|580122405|FG002|Overall Study|Adverse Event|0|||
160656318|NCT01193608|580122406|FG003|Overall Study|Adverse Event|0|||
160656319|NCT01193608|580122407|FG004|Overall Study|Adverse Event|1|||
160656320|NCT01193608|580122408|FG005|Overall Study|Adverse Event|0|||
160656321|NCT01249664|580122409|FG000|Overall Study|Withdrawal by Subject|5|||
160656322|NCT01249664|580122410|FG001|Overall Study|Withdrawal by Subject|0|||
160656323|NCT01249664|580122409|FG000|Overall Study|Adverse Event|1|||
160656324|NCT01249664|580122410|FG001|Overall Study|Adverse Event|0|||
160656325|NCT01400113|580122411|FG000|Overall Study|Withdrawal by Subject|1|||
160656326|NCT01400113|580122412|FG001|Overall Study|Withdrawal by Subject|1|||
160656327|NCT00282256|580122413|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
160656328|NCT00282256|580122413|FG000|Extension Treatment Period|Adverse Event|2|||
160656329|NCT01025037|580122418|FG000|Overall Study|Adverse Event|3|||
160656330|NCT01025037|580122418|FG000|Overall Study|Lost to Follow-up|7|||
160656331|NCT01025037|580122418|FG000|Overall Study|Withdrawal by Subject|1|||
160656332|NCT02674334|580122423|FG000|Overall Study|Lost to Follow-up|5|||
160656333|NCT02674334|580122424|FG001|Overall Study|Lost to Follow-up|3|||
160656334|NCT02674334|580122423|FG000|Overall Study|participant difficulty breathing|1|||
160656335|NCT02674334|580122424|FG001|Overall Study|participant difficulty breathing|0|||
160656336|NCT02674334|580122423|FG000|Overall Study|NIRS not recording|1|||
160656337|NCT02674334|580122424|FG001|Overall Study|NIRS not recording|0|||
160656338|NCT00860405|580122435|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
160656339|NCT00860405|580122436|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
160656340|NCT00864097|580122437|FG000|Overall Study|Death|0|||
160952343|NCT00558285|581211154|FG001|Overall Study|Protocol deviation|1|||
160952344|NCT00558285|581211155|FG002|Overall Study|Protocol deviation|0|||
160952345|NCT00558285|581211156|FG003|Overall Study|Protocol deviation|1|||
160952346|NCT00558285|581211157|FG004|Overall Study|Protocol deviation|0|||
160952347|NCT02730819|581211164|FG000|Overall Study|Lost to Follow-up|9|||
160952348|NCT02345512|581211165|FG000|Overall Study|Adverse Event|1|||
160952349|NCT02345512|581211165|FG000|Overall Study|Withdrawal by Subject|1|||
160952350|NCT01660906|581211166|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
160952351|NCT02121847|581211167|FG000|Overall Study|Administrative Reasons|1|||
160952352|NCT02121847|581211167|FG000|Overall Study|Adverse Event|2|||
160952353|NCT01308580|581211176|FG000|Overall Study|Lost to Follow-up|12|||
160952354|NCT01308580|581211177|FG001|Overall Study|Lost to Follow-up|7|||
160952355|NCT03823651|581211178|FG000|Overall Study|Death|5|||
160952356|NCT03823651|581211179|FG001|Overall Study|Death|0|||
160952357|NCT03823651|581211178|FG000|Overall Study|Physician Decision|1|||
160952358|NCT03823651|581211179|FG001|Overall Study|Physician Decision|0|||
160952359|NCT03823651|581211178|FG000|Overall Study|Caregiver to patient who died|0|||
160952360|NCT03823651|581211179|FG001|Overall Study|Caregiver to patient who died|5|||
160952361|NCT03823651|581211178|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
160952362|NCT03823651|581211179|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
160952363|NCT03864614|581211183|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
160952364|NCT03864614|581211184|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
160952365|NCT03864614|581211185|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
160952366|NCT03864614|581211186|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
160952367|NCT03864614|581211183|FG000|Overall Study|Withdrawal by Subject|72|||
160952368|NCT03864614|581211184|FG001|Overall Study|Withdrawal by Subject|100|||
160952369|NCT03864614|581211185|FG002|Overall Study|Withdrawal by Subject|1|||
160952370|NCT03864614|581211186|FG003|Overall Study|Withdrawal by Subject|21|||
160952371|NCT03864614|581211183|FG000|Overall Study|Lost to Follow-up|45|||
160952372|NCT03864614|581211184|FG001|Overall Study|Lost to Follow-up|54|||
160952373|NCT03864614|581211185|FG002|Overall Study|Lost to Follow-up|0|||
160952374|NCT03864614|581211186|FG003|Overall Study|Lost to Follow-up|9|||
160952375|NCT03864614|581211183|FG000|Overall Study|Adverse Event|42|||
160952376|NCT03864614|581211184|FG001|Overall Study|Adverse Event|30|||
160952377|NCT03864614|581211185|FG002|Overall Study|Adverse Event|1|||
160952378|NCT03864614|581211186|FG003|Overall Study|Adverse Event|9|||
160952379|NCT03864614|581211183|FG000|Overall Study|Protocol Deviation|6|||
160952380|NCT03864614|581211184|FG001|Overall Study|Protocol Deviation|26|||
160952381|NCT03864614|581211185|FG002|Overall Study|Protocol Deviation|0|||
160952382|NCT03864614|581211186|FG003|Overall Study|Protocol Deviation|1|||
160952383|NCT03864614|581211183|FG000|Overall Study|Physician Decision|7|||
160952384|NCT03864614|581211184|FG001|Overall Study|Physician Decision|10|||
160952385|NCT03864614|581211185|FG002|Overall Study|Physician Decision|1|||
160952386|NCT03864614|581211186|FG003|Overall Study|Physician Decision|5|||
160952387|NCT03864614|581211183|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
160952388|NCT03864614|581211184|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
160952389|NCT03864614|581211185|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
160952390|NCT03864614|581211186|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
160952391|NCT03864614|581211183|FG000|Overall Study|Sponsor Decision|1|||
160952392|NCT03864614|581211184|FG001|Overall Study|Sponsor Decision|2|||
160952393|NCT03864614|581211185|FG002|Overall Study|Sponsor Decision|0|||
160952394|NCT03864614|581211186|FG003|Overall Study|Sponsor Decision|0|||
160952395|NCT03864614|581211183|FG000|Overall Study|Pregnancy|0|||
160952396|NCT03864614|581211184|FG001|Overall Study|Pregnancy|1|||
160952397|NCT03864614|581211185|FG002|Overall Study|Pregnancy|0|||
160952398|NCT03864614|581211186|FG003|Overall Study|Pregnancy|0|||
160952399|NCT03864614|581211183|FG000|Overall Study|Other|7|||
160952400|NCT03864614|581211184|FG001|Overall Study|Other|9|||
160952401|NCT03864614|581211185|FG002|Overall Study|Other|1|||
160952402|NCT03864614|581211186|FG003|Overall Study|Other|4|||
160952403|NCT03864614|581211183|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
160952404|NCT03864614|581211184|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
160952405|NCT03864614|581211185|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
160952406|NCT03864614|581211186|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
160952407|NCT01850004|581211187|FG000|Overall Study|Poor/Non-compliance|1|||
160952408|NCT01850004|581211187|FG000|Overall Study|Participant Withdrew Consent|9|||
160952409|NCT01850004|581211187|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
160952410|NCT01850004|581211187|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
160952411|NCT01850004|581211187|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
160952412|NCT01850004|581211187|FG000|Overall Study|Other Reasons|2|||
160952413|NCT01850004|581211187|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
160952414|NCT01850004|581211187|FG000|Overall Study|Maximum Clinical Benefit|4|||
160952415|NCT03147248|581213815|FG000|Overall Study|Adverse Event|0|||
160952416|NCT03147248|581213816|FG001|Overall Study|Adverse Event|2|||
160952417|NCT03147248|581213817|FG002|Overall Study|Adverse Event|2|||
160952418|NCT03147248|581213818|FG003|Overall Study|Adverse Event|2|||
160952419|NCT03147248|581213819|FG004|Overall Study|Adverse Event|6|||
160952420|NCT03147248|581213820|FG005|Overall Study|Adverse Event|11|||
160952421|NCT03147248|581213815|FG000|Overall Study|Disease progression|1|||
160952422|NCT03147248|581213816|FG001|Overall Study|Disease progression|0|||
160952423|NCT03147248|581213817|FG002|Overall Study|Disease progression|0|||
160952424|NCT03147248|581213818|FG003|Overall Study|Disease progression|0|||
160952425|NCT03147248|581213819|FG004|Overall Study|Disease progression|0|||
160952426|NCT03147248|581213820|FG005|Overall Study|Disease progression|2|||
160952427|NCT03147248|581213815|FG000|Overall Study|Withdrawal by Subject|0|||
160952428|NCT03147248|581213816|FG001|Overall Study|Withdrawal by Subject|0|||
160952429|NCT03147248|581213817|FG002|Overall Study|Withdrawal by Subject|0|||
160952430|NCT03147248|581213818|FG003|Overall Study|Withdrawal by Subject|0|||
160952431|NCT03147248|581213819|FG004|Overall Study|Withdrawal by Subject|12|||
160952432|NCT03147248|581213820|FG005|Overall Study|Withdrawal by Subject|9|||
160952433|NCT03147248|581213815|FG000|Overall Study|Protocol Violation|0|||
160952434|NCT03147248|581213816|FG001|Overall Study|Protocol Violation|0|||
160952435|NCT03147248|581213817|FG002|Overall Study|Protocol Violation|0|||
160952436|NCT03147248|581213818|FG003|Overall Study|Protocol Violation|0|||
160952437|NCT03147248|581213819|FG004|Overall Study|Protocol Violation|2|||
160952438|NCT03147248|581213820|FG005|Overall Study|Protocol Violation|0|||
160952439|NCT03147248|581213815|FG000|Overall Study|Lost to Follow-up|0|||
160952440|NCT03147248|581213816|FG001|Overall Study|Lost to Follow-up|0|||
160952441|NCT03147248|581213817|FG002|Overall Study|Lost to Follow-up|0|||
160952442|NCT03147248|581213818|FG003|Overall Study|Lost to Follow-up|0|||
160952443|NCT03147248|581213819|FG004|Overall Study|Lost to Follow-up|2|||
160952444|NCT03147248|581213820|FG005|Overall Study|Lost to Follow-up|0|||
160952445|NCT03147248|581213815|FG000|Overall Study|Pregnancy|0|||
160952446|NCT03147248|581213816|FG001|Overall Study|Pregnancy|0|||
160952447|NCT03147248|581213817|FG002|Overall Study|Pregnancy|0|||
160952448|NCT03147248|581213818|FG003|Overall Study|Pregnancy|0|||
160952449|NCT03147248|581213819|FG004|Overall Study|Pregnancy|1|||
160952450|NCT03147248|581213820|FG005|Overall Study|Pregnancy|0|||
160952451|NCT03147248|581213815|FG000|Overall Study|Death|0|||
160952452|NCT03147248|581213816|FG001|Overall Study|Death|0|||
160952453|NCT03147248|581213817|FG002|Overall Study|Death|0|||
160952454|NCT03147248|581213818|FG003|Overall Study|Death|0|||
160952455|NCT03147248|581213819|FG004|Overall Study|Death|0|||
160952456|NCT03147248|581213820|FG005|Overall Study|Death|4|||
160952457|NCT03147248|581213815|FG000|Overall Study|Physician Decision|0|||
160952458|NCT03147248|581213816|FG001|Overall Study|Physician Decision|0|||
160952459|NCT03147248|581213817|FG002|Overall Study|Physician Decision|0|||
160952460|NCT03147248|581213818|FG003|Overall Study|Physician Decision|0|||
160952461|NCT03147248|581213819|FG004|Overall Study|Physician Decision|2|||
160952462|NCT03147248|581213820|FG005|Overall Study|Physician Decision|4|||
160952463|NCT03147248|581213815|FG000|Overall Study|Prolonged Dosing Interval|0|||
160952464|NCT03147248|581213816|FG001|Overall Study|Prolonged Dosing Interval|0|||
160952465|NCT03147248|581213817|FG002|Overall Study|Prolonged Dosing Interval|0|||
160952466|NCT03147248|581213818|FG003|Overall Study|Prolonged Dosing Interval|0|||
160952467|NCT03147248|581213819|FG004|Overall Study|Prolonged Dosing Interval|1|||
160952468|NCT03147248|581213820|FG005|Overall Study|Prolonged Dosing Interval|1|||
160952469|NCT01914926|581213822|FG000|Overall Study|Adverse Event|1|||
160952470|NCT01914926|581213823|FG001|Overall Study|Adverse Event|0|||
160952471|NCT01914926|581213822|FG000|Overall Study|uncooperative, agitated and removed|0|||
160952472|NCT01914926|581213823|FG001|Overall Study|uncooperative, agitated and removed|1|||
160952473|NCT02536508|581213824|FG000|Overall Study|Withdrawal by Subject|18|||
160952474|NCT02536508|581213825|FG001|Overall Study|Withdrawal by Subject|13|||
160952475|NCT02536508|581213826|FG002|Overall Study|Withdrawal by Subject|7|||
160952476|NCT02536508|581213824|FG000|Overall Study|Adverse Event|14|||
160952477|NCT02536508|581213825|FG001|Overall Study|Adverse Event|13|||
160952478|NCT02536508|581213826|FG002|Overall Study|Adverse Event|6|||
160952479|NCT02536508|581213824|FG000|Overall Study|Lost to Follow-up|12|||
160952480|NCT02536508|581213825|FG001|Overall Study|Lost to Follow-up|4|||
160582566|NCT03725202|579853632|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
160582567|NCT03725202|579853633|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
160952481|NCT02536508|581213826|FG002|Overall Study|Lost to Follow-up|0|||
160952482|NCT02536508|581213824|FG000|Overall Study|Lack of Efficacy|3|||
160952483|NCT02536508|581213825|FG001|Overall Study|Lack of Efficacy|5|||
160952484|NCT02536508|581213826|FG002|Overall Study|Lack of Efficacy|4|||
160952485|NCT02536508|581213824|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
160952486|NCT02536508|581213825|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
160952487|NCT02536508|581213826|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
160952488|NCT02536508|581213824|FG000|Overall Study|Physician Decision|0|||
160952489|NCT02536508|581213825|FG001|Overall Study|Physician Decision|4|||
160952490|NCT02536508|581213826|FG002|Overall Study|Physician Decision|2|||
160952491|NCT02536508|581213824|FG000|Overall Study|Major Protocol Deviation|2|||
160952492|NCT02536508|581213825|FG001|Overall Study|Major Protocol Deviation|2|||
160952493|NCT02536508|581213826|FG002|Overall Study|Major Protocol Deviation|2|||
160952494|NCT02536508|581213824|FG000|Overall Study|Administrative Reasons|0|||
160952495|NCT02536508|581213825|FG001|Overall Study|Administrative Reasons|1|||
160952496|NCT02536508|581213826|FG002|Overall Study|Administrative Reasons|0|||
160952497|NCT00856856|581213832|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
160952498|NCT00856856|581213832|FG000|4-year Clinical Follow-up|Missed visit|1|||
160952499|NCT00434057|581213833|FG000|Overall Study|Withdrawal by Subject|1|||
160952500|NCT00823719|581213837|FG000|Overall Study|Adverse Event|1|||
160952501|NCT00823719|581213838|FG001|Overall Study|Adverse Event|2|||
160952502|NCT00823719|581213837|FG000|Overall Study|Physician Decision|1|||
160952503|NCT00823719|581213838|FG001|Overall Study|Physician Decision|4|||
160952504|NCT00823719|581213837|FG000|Overall Study|Withdrawal by Subject|0|||
160952505|NCT00823719|581213838|FG001|Overall Study|Withdrawal by Subject|1|||
160952506|NCT00823719|581213837|FG000|Overall Study|Disease Progression|4|||
160952507|NCT00823719|581213838|FG001|Overall Study|Disease Progression|4|||
160952508|NCT00922428|581213839|FG000|Overall Study|retrospective/extremely implausible data|2|||
160952509|NCT00922428|581213839|FG000|Overall Study|no medication use or questionable use|13|||
160952510|NCT03701555|581213841|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
160952511|NCT03701555|581213842|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
160952512|NCT03701555|581213843|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
160952513|NCT03701555|581213844|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
160952514|NCT03701555|581213845|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
160952515|NCT03701555|581213846|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
160952516|NCT03701555|581213847|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
160952517|NCT03701555|581213848|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
160952518|NCT03701555|581213849|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
160952519|NCT03701555|581213850|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
160952520|NCT03701555|581213851|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
160952521|NCT03701555|581213852|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
160952522|NCT03701555|581213853|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
160952523|NCT03701555|581213854|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
160952524|NCT03701555|581213855|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
160952525|NCT03701555|581213856|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
160952526|NCT03701555|581213857|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
160952527|NCT03701555|581213858|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
160952528|NCT03701555|581213859|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
160952529|NCT03701555|581213860|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
160952530|NCT03701555|581213861|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
160952531|NCT03701555|581213862|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
160952532|NCT03701555|581213863|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
160952533|NCT03701555|581213864|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
160952534|NCT03701555|581213865|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
160952535|NCT03701555|581213866|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
160952536|NCT03701555|581213867|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
160952537|NCT03701555|581213868|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
160952538|NCT03701555|581213869|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
160952539|NCT03701555|581213870|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
160952540|NCT03701555|581213871|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
160952541|NCT03701555|581213872|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
160952542|NCT03701555|581213873|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
160952543|NCT03701555|581213874|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
160952544|NCT03701555|581213875|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
160952545|NCT03701555|581213876|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
160952546|NCT03701555|581213841|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
161000879|NCT03823300|581388923|FG001|Overall Study|Lack of Efficacy|1|||
161000880|NCT03823300|581388922|FG000|Overall Study|Not Eligible|0|||
161000881|NCT03823300|581388923|FG001|Overall Study|Not Eligible|1|||
161000882|NCT03823300|581388922|FG000|Overall Study|Other|1|||
161000883|NCT03823300|581388923|FG001|Overall Study|Other|0|||
161000884|NCT00831415|581388924|FG000|Overall Study|Adverse Event|14|||
161000885|NCT00831415|581388924|FG000|Overall Study|Failed to return|3|||
161000886|NCT00831415|581388924|FG000|Overall Study|Physician Decision|6|||
160457442|NCT02990338|579406422|FG001|Overall Study|Adverse Event|22|||
160457443|NCT02990338|579406421|FG000|Overall Study|Progressive disease|118|||
160656341|NCT00864097|580122438|FG001|Overall Study|Death|1|||
160952547|NCT03701555|581213842|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
160952548|NCT03701555|581213843|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
160952549|NCT03701555|581213844|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
160952550|NCT03701555|581213845|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
160457444|NCT02990338|579406422|FG001|Overall Study|Progressive disease|107|||
160457445|NCT02990338|579406421|FG000|Overall Study|Poor compliance to protocol|0|||
160952551|NCT03701555|581213846|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
160952552|NCT03701555|581213847|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
160952553|NCT03701555|581213848|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
160952554|NCT03701555|581213849|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
160952555|NCT03701555|581213850|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
160952556|NCT03701555|581213851|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
160952557|NCT03701555|581213852|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
160952558|NCT03701555|581213853|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
160952559|NCT03701555|581213854|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
160952560|NCT03701555|581213855|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
161000887|NCT00831415|581388924|FG000|Overall Study|Lost to Follow-up|9|||
160952561|NCT03701555|581213856|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
160952562|NCT03701555|581213857|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
160952563|NCT03701555|581213858|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
160952564|NCT03701555|581213859|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
160952565|NCT03701555|581213860|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
160952566|NCT03701555|581213861|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
160952567|NCT03701555|581213862|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
160952568|NCT03701555|581213863|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
160952569|NCT03701555|581213864|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
160952570|NCT03701555|581213865|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
160952571|NCT03701555|581213866|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
160952572|NCT03701555|581213867|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
160952573|NCT03701555|581213868|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
160952574|NCT03701555|581213869|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
160952575|NCT03701555|581213870|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
160952576|NCT03701555|581213871|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
160952577|NCT03701555|581213872|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
160952578|NCT03701555|581213873|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
160952579|NCT03701555|581213874|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
160952580|NCT03701555|581213875|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
160952581|NCT03701555|581213876|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
160952582|NCT03701555|581213841|FG000|Part 2 (Day 1)|Other|0|||
160952583|NCT03701555|581213842|FG001|Part 2 (Day 1)|Other|0|||
160952584|NCT03701555|581213843|FG002|Part 2 (Day 1)|Other|0|||
160952585|NCT03701555|581213844|FG003|Part 2 (Day 1)|Other|0|||
160952586|NCT03701555|581213845|FG004|Part 2 (Day 1)|Other|0|||
160952587|NCT03701555|581213846|FG005|Part 2 (Day 1)|Other|0|||
160952588|NCT03701555|581213847|FG006|Part 2 (Day 1)|Other|0|||
160952589|NCT03701555|581213848|FG007|Part 2 (Day 1)|Other|0|||
160952590|NCT03701555|581213849|FG008|Part 2 (Day 1)|Other|0|||
160952591|NCT03701555|581213850|FG009|Part 2 (Day 1)|Other|0|||
160952592|NCT03701555|581213851|FG010|Part 2 (Day 1)|Other|3|||
160952593|NCT03701555|581213852|FG011|Part 2 (Day 1)|Other|1|||
160952594|NCT03701555|581213853|FG012|Part 2 (Day 1)|Other|0|||
160952595|NCT03701555|581213854|FG013|Part 2 (Day 1)|Other|1|||
160952596|NCT03701555|581213855|FG014|Part 2 (Day 1)|Other|0|||
160952597|NCT03701555|581213856|FG015|Part 2 (Day 1)|Other|2|||
160952598|NCT03701555|581213857|FG016|Part 2 (Day 1)|Other|2|||
160952599|NCT03701555|581213858|FG017|Part 2 (Day 1)|Other|0|||
160952600|NCT03701555|581213859|FG018|Part 2 (Day 1)|Other|0|||
160952601|NCT03701555|581213860|FG019|Part 2 (Day 1)|Other|0|||
160952602|NCT03701555|581213861|FG020|Part 2 (Day 1)|Other|0|||
160952603|NCT03701555|581213862|FG021|Part 2 (Day 1)|Other|0|||
160952604|NCT03701555|581213863|FG022|Part 2 (Day 1)|Other|0|||
160952605|NCT03701555|581213864|FG023|Part 2 (Day 1)|Other|0|||
160952606|NCT03701555|581213865|FG024|Part 2 (Day 1)|Other|0|||
160952607|NCT03701555|581213866|FG025|Part 2 (Day 1)|Other|0|||
160952608|NCT03701555|581213867|FG026|Part 2 (Day 1)|Other|0|||
160952609|NCT03701555|581213868|FG027|Part 2 (Day 1)|Other|0|||
160952610|NCT03701555|581213869|FG028|Part 2 (Day 1)|Other|0|||
160952611|NCT03701555|581213870|FG029|Part 2 (Day 1)|Other|0|||
160952612|NCT03701555|581213871|FG030|Part 2 (Day 1)|Other|0|||
160952613|NCT03701555|581213872|FG031|Part 2 (Day 1)|Other|0|||
160952614|NCT03701555|581213873|FG032|Part 2 (Day 1)|Other|0|||
160952615|NCT03701555|581213874|FG033|Part 2 (Day 1)|Other|0|||
160582568|NCT03725202|579853634|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
160952616|NCT03701555|581213875|FG034|Part 2 (Day 1)|Other|0|||
160952617|NCT03701555|581213876|FG035|Part 2 (Day 1)|Other|0|||
160952618|NCT03701555|581213841|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
160952619|NCT03701555|581213842|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
160952620|NCT03701555|581213843|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
160952621|NCT03701555|581213844|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
160952622|NCT03701555|581213845|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
160582569|NCT03725202|579853635|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
160582570|NCT03725202|579853636|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
160582571|NCT03725202|579853629|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
160952623|NCT03701555|581213846|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
160952624|NCT03701555|581213847|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
160582572|NCT03725202|579853630|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
160952625|NCT03701555|581213848|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
160952626|NCT03701555|581213849|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
160952627|NCT03701555|581213850|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
160952628|NCT03701555|581213851|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
160952629|NCT03701555|581213852|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
160952630|NCT03701555|581213853|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
160952631|NCT03701555|581213854|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
160952632|NCT03701555|581213855|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
160952633|NCT03701555|581213856|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
160952634|NCT03701555|581213857|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
160952635|NCT03701555|581213858|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
160952636|NCT03701555|581213859|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
160952637|NCT03701555|581213860|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
160952638|NCT03701555|581213861|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
160952639|NCT03701555|581213862|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
160952640|NCT03701555|581213863|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
160952641|NCT03701555|581213864|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
160952642|NCT03701555|581213865|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
160952643|NCT03701555|581213866|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
160952644|NCT03701555|581213867|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
160952645|NCT03701555|581213868|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
160952646|NCT03701555|581213869|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
160952647|NCT03701555|581213870|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
160952648|NCT03701555|581213871|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
160952649|NCT03701555|581213872|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
160952650|NCT03701555|581213873|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
160952651|NCT03701555|581213874|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
160952652|NCT03701555|581213875|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
160952653|NCT03701555|581213876|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
160952654|NCT03701555|581213841|FG000|Part 3 (Day 1)|Subject Decision|0|||
160952655|NCT03701555|581213842|FG001|Part 3 (Day 1)|Subject Decision|0|||
160952656|NCT03701555|581213843|FG002|Part 3 (Day 1)|Subject Decision|0|||
160952657|NCT03701555|581213844|FG003|Part 3 (Day 1)|Subject Decision|0|||
160952658|NCT03701555|581213845|FG004|Part 3 (Day 1)|Subject Decision|0|||
160952659|NCT03701555|581213846|FG005|Part 3 (Day 1)|Subject Decision|0|||
160952660|NCT03701555|581213847|FG006|Part 3 (Day 1)|Subject Decision|0|||
160952661|NCT03701555|581213848|FG007|Part 3 (Day 1)|Subject Decision|0|||
160952662|NCT03701555|581213849|FG008|Part 3 (Day 1)|Subject Decision|0|||
160952663|NCT03701555|581213850|FG009|Part 3 (Day 1)|Subject Decision|0|||
160952664|NCT03701555|581213851|FG010|Part 3 (Day 1)|Subject Decision|0|||
160952665|NCT03701555|581213852|FG011|Part 3 (Day 1)|Subject Decision|0|||
160952666|NCT03701555|581213853|FG012|Part 3 (Day 1)|Subject Decision|0|||
160952667|NCT03701555|581213854|FG013|Part 3 (Day 1)|Subject Decision|0|||
160952668|NCT03701555|581213855|FG014|Part 3 (Day 1)|Subject Decision|0|||
160952669|NCT03701555|581213856|FG015|Part 3 (Day 1)|Subject Decision|0|||
160952670|NCT03701555|581213857|FG016|Part 3 (Day 1)|Subject Decision|0|||
160952671|NCT03701555|581213858|FG017|Part 3 (Day 1)|Subject Decision|0|||
160952672|NCT03701555|581213859|FG018|Part 3 (Day 1)|Subject Decision|0|||
160952673|NCT03701555|581213860|FG019|Part 3 (Day 1)|Subject Decision|0|||
160952674|NCT03701555|581213861|FG020|Part 3 (Day 1)|Subject Decision|0|||
160952675|NCT03701555|581213862|FG021|Part 3 (Day 1)|Subject Decision|0|||
160952676|NCT03701555|581213863|FG022|Part 3 (Day 1)|Subject Decision|0|||
160952677|NCT03701555|581213864|FG023|Part 3 (Day 1)|Subject Decision|0|||
160952678|NCT03701555|581213865|FG024|Part 3 (Day 1)|Subject Decision|0|||
160952679|NCT03701555|581213866|FG025|Part 3 (Day 1)|Subject Decision|0|||
160952680|NCT03701555|581213867|FG026|Part 3 (Day 1)|Subject Decision|1|||
160952681|NCT03701555|581213868|FG027|Part 3 (Day 1)|Subject Decision|0|||
160952682|NCT03701555|581213869|FG028|Part 3 (Day 1)|Subject Decision|0|||
160952683|NCT03701555|581213870|FG029|Part 3 (Day 1)|Subject Decision|0|||
160952684|NCT03701555|581213871|FG030|Part 3 (Day 1)|Subject Decision|0|||
160952685|NCT03701555|581213872|FG031|Part 3 (Day 1)|Subject Decision|2|||
160952686|NCT03701555|581213873|FG032|Part 3 (Day 1)|Subject Decision|1|||
160952687|NCT03701555|581213874|FG033|Part 3 (Day 1)|Subject Decision|1|||
160952688|NCT03701555|581213875|FG034|Part 3 (Day 1)|Subject Decision|0|||
160952689|NCT03701555|581213876|FG035|Part 3 (Day 1)|Subject Decision|0|||
160952690|NCT03701555|581213841|FG000|Part 3 (Day 1)|Other|0|||
160952691|NCT03701555|581213842|FG001|Part 3 (Day 1)|Other|0|||
160952692|NCT03701555|581213843|FG002|Part 3 (Day 1)|Other|0|||
160952693|NCT03701555|581213844|FG003|Part 3 (Day 1)|Other|0|||
160952694|NCT03701555|581213845|FG004|Part 3 (Day 1)|Other|0|||
161000888|NCT00831415|581388924|FG000|Overall Study|Protocol Violation|3|||
161000889|NCT00831415|581388924|FG000|Overall Study|Withdrawal by Subject|35|||
161000890|NCT00831415|581388924|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
160582573|NCT03725202|579853631|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
160632831|NCT01215955|580036085|FG000|Overall Study|Lack of Efficacy|1|||
160952695|NCT03701555|581213846|FG005|Part 3 (Day 1)|Other|0|||
160952696|NCT03701555|581213847|FG006|Part 3 (Day 1)|Other|0|||
160952697|NCT03701555|581213848|FG007|Part 3 (Day 1)|Other|0|||
160952698|NCT03701555|581213849|FG008|Part 3 (Day 1)|Other|0|||
160952699|NCT03701555|581213850|FG009|Part 3 (Day 1)|Other|0|||
160952700|NCT03701555|581213851|FG010|Part 3 (Day 1)|Other|0|||
160952701|NCT03701555|581213852|FG011|Part 3 (Day 1)|Other|0|||
160952702|NCT03701555|581213853|FG012|Part 3 (Day 1)|Other|0|||
160952703|NCT03701555|581213854|FG013|Part 3 (Day 1)|Other|0|||
160952704|NCT03701555|581213855|FG014|Part 3 (Day 1)|Other|0|||
160952705|NCT03701555|581213856|FG015|Part 3 (Day 1)|Other|0|||
160952706|NCT03701555|581213857|FG016|Part 3 (Day 1)|Other|0|||
160952707|NCT03701555|581213858|FG017|Part 3 (Day 1)|Other|0|||
160952708|NCT03701555|581213859|FG018|Part 3 (Day 1)|Other|0|||
160952709|NCT03701555|581213860|FG019|Part 3 (Day 1)|Other|0|||
160952710|NCT03701555|581213861|FG020|Part 3 (Day 1)|Other|0|||
160952711|NCT03701555|581213862|FG021|Part 3 (Day 1)|Other|0|||
160952712|NCT03701555|581213863|FG022|Part 3 (Day 1)|Other|0|||
160952713|NCT03701555|581213864|FG023|Part 3 (Day 1)|Other|0|||
160952714|NCT03701555|581213865|FG024|Part 3 (Day 1)|Other|1|||
160952715|NCT03701555|581213866|FG025|Part 3 (Day 1)|Other|1|||
160952716|NCT03701555|581213867|FG026|Part 3 (Day 1)|Other|0|||
160952717|NCT03701555|581213868|FG027|Part 3 (Day 1)|Other|0|||
160952718|NCT03701555|581213869|FG028|Part 3 (Day 1)|Other|0|||
160952719|NCT03701555|581213870|FG029|Part 3 (Day 1)|Other|1|||
160952720|NCT03701555|581213871|FG030|Part 3 (Day 1)|Other|1|||
160952721|NCT03701555|581213872|FG031|Part 3 (Day 1)|Other|0|||
160952722|NCT03701555|581213873|FG032|Part 3 (Day 1)|Other|1|||
160952723|NCT03701555|581213874|FG033|Part 3 (Day 1)|Other|1|||
160952724|NCT03701555|581213875|FG034|Part 3 (Day 1)|Other|0|||
160952725|NCT03701555|581213876|FG035|Part 3 (Day 1)|Other|0|||
160952726|NCT04757649|581213877|FG000|Overall Study|Withdrawal by Subject|1|||
160952727|NCT04757649|581213877|FG000|Overall Study|Adverse Event|1|||
160952728|NCT02508311|581213885|FG000|Overall Study|Withdrawal by Subject|1|||
160952729|NCT02508311|581213886|FG001|Overall Study|Withdrawal by Subject|0|||
160952730|NCT04862143|581213887|FG000|Overall Study|Adverse Event|1|||
160952731|NCT04862143|581213887|FG000|Overall Study|Study terminated by sponsor|1|||
160952732|NCT04955639|581213888|FG000|Overall Study|Withdrawal by Subject|2|||
160952733|NCT04955639|581213889|FG001|Overall Study|Withdrawal by Subject|2|||
160952734|NCT04955639|581213888|FG000|Overall Study|Week 26 survey not completed|2|||
160952735|NCT04955639|581213889|FG001|Overall Study|Week 26 survey not completed|2|||
160952736|NCT00413153|581213890|FG000|Overall Study|Withdrawal by Subject|1|||
160952737|NCT00413153|581213891|FG001|Overall Study|Withdrawal by Subject|1|||
160952738|NCT00413153|581213890|FG000|Overall Study|Adverse Event|1|||
160952739|NCT00413153|581213891|FG001|Overall Study|Adverse Event|0|||
160952740|NCT03204279|581213892|FG000|Overall Study|Withdrawal by Subject|0|||
160952741|NCT03204279|581213893|FG001|Overall Study|Withdrawal by Subject|1|||
160952742|NCT02862106|581213898|FG000|Overall Study|Adverse Event|4|||
160952743|NCT02862106|581213899|FG001|Overall Study|Adverse Event|0|||
160952744|NCT02862106|581213898|FG000|Overall Study|Protocol Violation|16|||
160952745|NCT02862106|581213899|FG001|Overall Study|Protocol Violation|1|||
160952746|NCT02862106|581213898|FG000|Overall Study|Lost to Follow-up|15|||
160952747|NCT02862106|581213899|FG001|Overall Study|Lost to Follow-up|5|||
160952748|NCT02862106|581213898|FG000|Overall Study|Withdrawal by Subject|2|||
160952749|NCT02862106|581213899|FG001|Overall Study|Withdrawal by Subject|0|||
160952750|NCT02862106|581213898|FG000|Overall Study|Subjects moved to other city|1|||
160952751|NCT02862106|581213899|FG001|Overall Study|Subjects moved to other city|0|||
160952752|NCT01040130|581213900|FG000|Overall Study|Adverse Event|1|||
160952753|NCT01040130|581213901|FG001|Overall Study|Adverse Event|1|||
160952754|NCT01040130|581213902|FG002|Overall Study|Adverse Event|0|||
160952755|NCT01040130|581213903|FG003|Overall Study|Adverse Event|5|||
160952756|NCT01040130|581213904|FG004|Overall Study|Adverse Event|0|||
160952757|NCT01040130|581213905|FG005|Overall Study|Adverse Event|3|||
160952758|NCT01040130|581213900|FG000|Overall Study|Protocol Violation|0|||
160952759|NCT01040130|581213901|FG001|Overall Study|Protocol Violation|0|||
160952760|NCT01040130|581213902|FG002|Overall Study|Protocol Violation|2|||
160952761|NCT01040130|581213903|FG003|Overall Study|Protocol Violation|0|||
160952762|NCT01040130|581213904|FG004|Overall Study|Protocol Violation|0|||
160952763|NCT01040130|581213905|FG005|Overall Study|Protocol Violation|0|||
160952764|NCT01040130|581213900|FG000|Overall Study|Withdrawal by Subject|0|||
160952765|NCT01040130|581213901|FG001|Overall Study|Withdrawal by Subject|2|||
160952766|NCT01040130|581213902|FG002|Overall Study|Withdrawal by Subject|0|||
160952767|NCT01040130|581213903|FG003|Overall Study|Withdrawal by Subject|0|||
160952768|NCT01040130|581213904|FG004|Overall Study|Withdrawal by Subject|0|||
160952769|NCT01040130|581213905|FG005|Overall Study|Withdrawal by Subject|1|||
160952770|NCT01040130|581213900|FG000|Overall Study|Other reasons not listed above|2|||
160952771|NCT01040130|581213901|FG001|Overall Study|Other reasons not listed above|0|||
160656342|NCT00864097|580122439|FG002|Overall Study|Death|0|||
160952772|NCT01040130|581213902|FG002|Overall Study|Other reasons not listed above|0|||
160952773|NCT01040130|581213903|FG003|Overall Study|Other reasons not listed above|0|||
160952774|NCT01040130|581213904|FG004|Overall Study|Other reasons not listed above|0|||
160952775|NCT01040130|581213905|FG005|Overall Study|Other reasons not listed above|0|||
160952776|NCT00833989|581213911|FG000|Overall Study|Physician Decision|0|||
160952777|NCT00833989|581213912|FG001|Overall Study|Physician Decision|0|||
160952778|NCT00833989|581213913|FG002|Overall Study|Physician Decision|0|||
160952779|NCT00833989|581213914|FG003|Overall Study|Physician Decision|1|||
160952780|NCT00833989|581213911|FG000|Overall Study|Withdrawal by Subject|3|||
160952781|NCT00833989|581213912|FG001|Overall Study|Withdrawal by Subject|0|||
160952782|NCT00833989|581213913|FG002|Overall Study|Withdrawal by Subject|1|||
160952783|NCT00833989|581213914|FG003|Overall Study|Withdrawal by Subject|1|||
160952784|NCT02310750|581213917|FG000|HP Period 1|Lost to Follow-up|0|||
160952785|NCT02310750|581213918|FG001|HP Period 1|Lost to Follow-up|0|||
160952786|NCT02310750|581213919|FG002|HP Period 1|Lost to Follow-up|0|||
160952787|NCT02310750|581213920|FG003|HP Period 1|Lost to Follow-up|0|||
160952788|NCT02310750|581213921|FG004|HP Period 1|Lost to Follow-up|0|||
160952789|NCT02310750|581213922|FG005|HP Period 1|Lost to Follow-up|0|||
160952790|NCT02310750|581213923|FG006|HP Period 1|Lost to Follow-up|1|||
160952791|NCT02310750|581213924|FG007|HP Period 1|Lost to Follow-up|0|||
160952792|NCT02310750|581213925|FG008|HP Period 1|Lost to Follow-up|0|||
160952793|NCT02310750|581213926|FG009|HP Period 1|Lost to Follow-up|0|||
160952794|NCT02310750|581213927|FG010|HP Period 1|Lost to Follow-up|0|||
160952795|NCT02310750|581213928|FG011|HP Period 1|Lost to Follow-up|0|||
160952796|NCT02310750|581213929|FG012|HP Period 1|Lost to Follow-up|0|||
160952797|NCT02310750|581213930|FG013|HP Period 1|Lost to Follow-up|0|||
160952798|NCT02310750|581213931|FG014|HP Period 1|Lost to Follow-up|0|||
160952799|NCT02310750|581213932|FG015|HP Period 1|Lost to Follow-up|0|||
160952800|NCT02310750|581213917|FG000|HP Period 1|Withdrawal by Subject|1|||
160952801|NCT02310750|581213918|FG001|HP Period 1|Withdrawal by Subject|0|||
160952802|NCT02310750|581213919|FG002|HP Period 1|Withdrawal by Subject|0|||
160952803|NCT02310750|581213920|FG003|HP Period 1|Withdrawal by Subject|1|||
160952804|NCT02310750|581213921|FG004|HP Period 1|Withdrawal by Subject|0|||
160952805|NCT02310750|581213922|FG005|HP Period 1|Withdrawal by Subject|0|||
160952806|NCT02310750|581213923|FG006|HP Period 1|Withdrawal by Subject|0|||
160952807|NCT02310750|581213924|FG007|HP Period 1|Withdrawal by Subject|0|||
160952808|NCT02310750|581213925|FG008|HP Period 1|Withdrawal by Subject|0|||
160952809|NCT02310750|581213926|FG009|HP Period 1|Withdrawal by Subject|0|||
160952810|NCT02310750|581213927|FG010|HP Period 1|Withdrawal by Subject|0|||
160952811|NCT02310750|581213928|FG011|HP Period 1|Withdrawal by Subject|0|||
160952812|NCT02310750|581213929|FG012|HP Period 1|Withdrawal by Subject|0|||
160952813|NCT02310750|581213930|FG013|HP Period 1|Withdrawal by Subject|0|||
160952814|NCT02310750|581213931|FG014|HP Period 1|Withdrawal by Subject|0|||
160952815|NCT02310750|581213932|FG015|HP Period 1|Withdrawal by Subject|0|||
160952816|NCT02310750|581213917|FG000|HP Washout 1|Lost to Follow-up|0|||
160952817|NCT02310750|581213918|FG001|HP Washout 1|Lost to Follow-up|0|||
160952818|NCT02310750|581213919|FG002|HP Washout 1|Lost to Follow-up|1|||
160952819|NCT02310750|581213920|FG003|HP Washout 1|Lost to Follow-up|1|||
160952820|NCT02310750|581213921|FG004|HP Washout 1|Lost to Follow-up|2|||
160952821|NCT02310750|581213922|FG005|HP Washout 1|Lost to Follow-up|2|||
160952822|NCT02310750|581213923|FG006|HP Washout 1|Lost to Follow-up|3|||
160952823|NCT02310750|581213924|FG007|HP Washout 1|Lost to Follow-up|0|||
160952824|NCT02310750|581213925|FG008|HP Washout 1|Lost to Follow-up|0|||
160952825|NCT02310750|581213926|FG009|HP Washout 1|Lost to Follow-up|0|||
160952826|NCT02310750|581213927|FG010|HP Washout 1|Lost to Follow-up|0|||
160952827|NCT02310750|581213928|FG011|HP Washout 1|Lost to Follow-up|0|||
160952828|NCT02310750|581213929|FG012|HP Washout 1|Lost to Follow-up|0|||
160952829|NCT02310750|581213930|FG013|HP Washout 1|Lost to Follow-up|0|||
160952830|NCT02310750|581213931|FG014|HP Washout 1|Lost to Follow-up|0|||
160952831|NCT02310750|581213932|FG015|HP Washout 1|Lost to Follow-up|0|||
160952832|NCT02310750|581213917|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952833|NCT02310750|581213918|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952834|NCT02310750|581213919|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952835|NCT02310750|581213920|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
160952836|NCT02310750|581213921|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952837|NCT02310750|581213922|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
160952838|NCT02310750|581213923|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952839|NCT02310750|581213924|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952840|NCT02310750|581213925|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
160952841|NCT02310750|581213926|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
160952842|NCT02310750|581213927|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952843|NCT02310750|581213928|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952844|NCT02310750|581213929|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952845|NCT02310750|581213930|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952846|NCT02310750|581213931|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952847|NCT02310750|581213932|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952848|NCT02310750|581213917|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952849|NCT02310750|581213918|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952850|NCT02310750|581213919|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952851|NCT02310750|581213920|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952852|NCT02310750|581213921|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952853|NCT02310750|581213922|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952854|NCT02310750|581213923|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952855|NCT02310750|581213924|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952856|NCT02310750|581213925|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952857|NCT02310750|581213926|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
160952858|NCT02310750|581213927|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952859|NCT02310750|581213928|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952860|NCT02310750|581213929|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952861|NCT02310750|581213930|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952862|NCT02310750|581213931|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952863|NCT02310750|581213932|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952864|NCT02310750|581213917|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952865|NCT02310750|581213918|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952866|NCT02310750|581213919|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952867|NCT02310750|581213920|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952868|NCT02310750|581213921|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952869|NCT02310750|581213922|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952870|NCT02310750|581213923|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952871|NCT02310750|581213924|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
160952872|NCT02310750|581213925|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
160952873|NCT02310750|581213926|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
160952874|NCT02310750|581213927|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952875|NCT02310750|581213928|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952876|NCT02310750|581213929|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952877|NCT02310750|581213930|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952878|NCT02310750|581213931|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952879|NCT02310750|581213932|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952880|NCT02310750|581213917|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952881|NCT02310750|581213918|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952882|NCT02310750|581213919|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952883|NCT02310750|581213920|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952884|NCT02310750|581213921|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952885|NCT02310750|581213922|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952886|NCT02310750|581213923|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952887|NCT02310750|581213924|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
160952888|NCT02310750|581213925|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
160952889|NCT02310750|581213926|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952890|NCT02310750|581213927|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952891|NCT02310750|581213928|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952892|NCT02310750|581213929|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952893|NCT02310750|581213930|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952894|NCT02310750|581213931|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952895|NCT02310750|581213932|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952896|NCT02310750|581213917|FG000|HP Washout 2|Lost to Follow-up|0|||
160952897|NCT02310750|581213918|FG001|HP Washout 2|Lost to Follow-up|0|||
160952898|NCT02310750|581213919|FG002|HP Washout 2|Lost to Follow-up|0|||
160952899|NCT02310750|581213920|FG003|HP Washout 2|Lost to Follow-up|0|||
160952900|NCT02310750|581213921|FG004|HP Washout 2|Lost to Follow-up|1|||
160952901|NCT02310750|581213922|FG005|HP Washout 2|Lost to Follow-up|0|||
160952902|NCT02310750|581213923|FG006|HP Washout 2|Lost to Follow-up|7|||
160952903|NCT02310750|581213924|FG007|HP Washout 2|Lost to Follow-up|0|||
160952904|NCT02310750|581213925|FG008|HP Washout 2|Lost to Follow-up|0|||
160952905|NCT02310750|581213926|FG009|HP Washout 2|Lost to Follow-up|0|||
160952906|NCT02310750|581213927|FG010|HP Washout 2|Lost to Follow-up|0|||
160952907|NCT02310750|581213928|FG011|HP Washout 2|Lost to Follow-up|0|||
160952908|NCT02310750|581213929|FG012|HP Washout 2|Lost to Follow-up|0|||
160952909|NCT02310750|581213930|FG013|HP Washout 2|Lost to Follow-up|0|||
160952910|NCT02310750|581213931|FG014|HP Washout 2|Lost to Follow-up|0|||
160952911|NCT02310750|581213932|FG015|HP Washout 2|Lost to Follow-up|0|||
160952912|NCT03585244|581213933|FG000|Overall Study|Withdrawal by Subject|15|||
160952913|NCT02199028|581213938|FG000|Week 1|Adverse Event|1|||
161000891|NCT00831415|581388924|FG000|Overall Study|Death|1|||
161000892|NCT00486330|581388925|FG000|Overall Study|Adverse Event|2|||
161000893|NCT01290224|581388926|FG000|Overall Study|Adverse Event|1|||
161000894|NCT01290224|581388926|FG000|Overall Study|Refused Further Treatment|4|||
161000895|NCT01027286|581388927|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
161000896|NCT01027286|581388928|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
160457446|NCT02990338|579406422|FG001|Overall Study|Poor compliance to protocol|1|||
160582574|NCT03725202|579853632|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
160582575|NCT03725202|579853633|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
160582576|NCT03725202|579853634|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
160582577|NCT03725202|579853635|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
160582578|NCT03725202|579853636|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
160952914|NCT02199028|581213939|FG001|Week 1|Adverse Event|0|||
160952915|NCT02199028|581213938|FG000|Week 3|Adverse Event|1|||
160952916|NCT02199028|581213939|FG001|Week 3|Adverse Event|0|||
160952917|NCT01881126|581213940|FG000|Overall Study|Non-compliance|1|||
160952918|NCT01881126|581213941|FG001|Overall Study|Non-compliance|1|||
160952919|NCT01881126|581213940|FG000|Overall Study|Adverse Event|0|||
160952920|NCT01881126|581213941|FG001|Overall Study|Adverse Event|1|||
160952921|NCT05045625|581213944|FG000|Overall Study|Lost to Follow-up|3|||
160952922|NCT03867734|581213945|FG000|Overall Study|Lost to Follow-up|2|||
161000897|NCT01027286|581388927|FG000|Overall Study|Lost to Follow-up|0|||
160582579|NCT01520324|579853637|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
160952923|NCT01827904|581213946|FG000|Main Study|Withdrawal by Subject|1|||
160952924|NCT01827904|581213947|FG001|Main Study|Withdrawal by Subject|0|||
160952925|NCT01827904|581213948|FG002|Main Study|Withdrawal by Subject|0|||
160952926|NCT01827904|581213946|FG000|Main Study|Adverse Event|1|||
160952927|NCT01827904|581213947|FG001|Main Study|Adverse Event|0|||
160952928|NCT01827904|581213948|FG002|Main Study|Adverse Event|0|||
160952929|NCT01827904|581213946|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
160952930|NCT01827904|581213947|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
160952931|NCT01827904|581213948|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
160952932|NCT01827904|581213946|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
160952933|NCT01827904|581213947|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
160952934|NCT01827904|581213948|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
160952935|NCT01827904|581213946|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
160952936|NCT01827904|581213947|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
160952937|NCT01827904|581213948|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
160952938|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
160952939|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
160952940|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
160952941|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
160952942|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
160952943|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
160952944|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
160952945|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
160952946|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
160952947|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
160952948|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
160952949|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
160952950|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Physician Decision|1|||
160952951|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Physician Decision|0|||
160952952|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Physician Decision|0|||
160952953|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
160952954|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
160952955|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
160952956|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
160952957|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
160952958|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
160952959|NCT01910519|581213949|FG000|Overall Study|Withdrawal by Subject|2|||
160952960|NCT01910519|581213950|FG001|Overall Study|Withdrawal by Subject|0|||
160952961|NCT01910519|581213949|FG000|Overall Study|Adverse Event|2|||
160952962|NCT01910519|581213950|FG001|Overall Study|Adverse Event|0|||
160952963|NCT04266028|581213951|FG000|Overall Study|Adverse Event|0|||
160952964|NCT04266028|581213952|FG001|Overall Study|Adverse Event|0|||
160952965|NCT04266028|581213953|FG002|Overall Study|Adverse Event|1|||
160952966|NCT04266028|581213954|FG003|Overall Study|Adverse Event|0|||
160952967|NCT04266028|581213955|FG004|Overall Study|Adverse Event|1|||
160952968|NCT04266028|581213956|FG005|Overall Study|Adverse Event|0|||
160952969|NCT04266028|581213957|FG006|Overall Study|Adverse Event|2|||
160952970|NCT04266028|581213958|FG007|Overall Study|Adverse Event|0|||
160952971|NCT04266028|581213951|FG000|Overall Study|temporary halt of the study|0|||
160952972|NCT04266028|581213952|FG001|Overall Study|temporary halt of the study|0|||
160952973|NCT04266028|581213953|FG002|Overall Study|temporary halt of the study|0|||
160952974|NCT04266028|581213954|FG003|Overall Study|temporary halt of the study|0|||
160952975|NCT04266028|581213955|FG004|Overall Study|temporary halt of the study|0|||
160952976|NCT04266028|581213956|FG005|Overall Study|temporary halt of the study|0|||
160952977|NCT04266028|581213957|FG006|Overall Study|temporary halt of the study|2|||
160952978|NCT04266028|581213958|FG007|Overall Study|temporary halt of the study|1|||
160952979|NCT04266028|581213951|FG000|Overall Study|Onset of birch pollen season|0|||
160952980|NCT04266028|581213952|FG001|Overall Study|Onset of birch pollen season|0|||
160952981|NCT04266028|581213953|FG002|Overall Study|Onset of birch pollen season|0|||
160952982|NCT04266028|581213954|FG003|Overall Study|Onset of birch pollen season|0|||
160952983|NCT04266028|581213955|FG004|Overall Study|Onset of birch pollen season|1|||
160952984|NCT04266028|581213956|FG005|Overall Study|Onset of birch pollen season|0|||
160952985|NCT04266028|581213957|FG006|Overall Study|Onset of birch pollen season|0|||
160952986|NCT04266028|581213958|FG007|Overall Study|Onset of birch pollen season|0|||
160952987|NCT01458574|581213959|FG000|Overall Study|Adverse Event|5|||
160952988|NCT01458574|581213960|FG001|Overall Study|Adverse Event|9|||
160952989|NCT01458574|581213961|FG002|Overall Study|Adverse Event|7|||
160582580|NCT01328249|579853640|FG000|Overall Study|Adverse Event|3|||
160952990|NCT01458574|581213959|FG000|Overall Study|Lack of Efficacy|70|||
160952991|NCT01458574|581213960|FG001|Overall Study|Lack of Efficacy|53|||
160952992|NCT01458574|581213961|FG002|Overall Study|Lack of Efficacy|132|||
160582581|NCT01328249|579853641|FG001|Overall Study|Adverse Event|0|||
160952993|NCT01458574|581213959|FG000|Overall Study|Lost to Follow-up|3|||
160952994|NCT01458574|581213960|FG001|Overall Study|Lost to Follow-up|2|||
160952995|NCT01458574|581213961|FG002|Overall Study|Lost to Follow-up|1|||
160952996|NCT01458574|581213959|FG000|Overall Study|Pregnancy|1|||
160952997|NCT01458574|581213960|FG001|Overall Study|Pregnancy|1|||
160952998|NCT01458574|581213961|FG002|Overall Study|Pregnancy|0|||
160952999|NCT01458574|581213959|FG000|Overall Study|Protocol Violation|0|||
160953000|NCT01458574|581213960|FG001|Overall Study|Protocol Violation|1|||
160953001|NCT01458574|581213961|FG002|Overall Study|Protocol Violation|0|||
160953002|NCT01458574|581213959|FG000|Overall Study|Withdrawal by Subject|6|||
160953003|NCT01458574|581213960|FG001|Overall Study|Withdrawal by Subject|3|||
160953004|NCT01458574|581213961|FG002|Overall Study|Withdrawal by Subject|5|||
160953005|NCT01458574|581213959|FG000|Overall Study|Other|2|||
160953006|NCT01458574|581213960|FG001|Overall Study|Other|1|||
160953007|NCT01458574|581213961|FG002|Overall Study|Other|0|||
160953008|NCT01458574|581213959|FG000|Overall Study|Randomized but not treated|0|||
160953009|NCT01458574|581213960|FG001|Overall Study|Randomized but not treated|1|||
160953010|NCT01458574|581213961|FG002|Overall Study|Randomized but not treated|0|||
160953011|NCT02125786|581213962|FG000|Overall Study|Still in Follow-up|3|||
160953012|NCT02125786|581213962|FG000|Overall Study|Screen Failure|2|||
160953013|NCT02125786|581213962|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
160953014|NCT02125786|581213962|FG000|Overall Study|Progressive Disease|44|||
160953015|NCT02125786|581213962|FG000|Overall Study|Death|8|||
160953016|NCT01365494|581213963|FG000|Overall Study|Adverse Event|1|||
160953017|NCT01365494|581213964|FG001|Overall Study|Adverse Event|0|||
160953018|NCT01365494|581213963|FG000|Overall Study|Withdrawal by Subject|0|||
160953019|NCT01365494|581213964|FG001|Overall Study|Withdrawal by Subject|1|||
160953020|NCT01365494|581213963|FG000|Overall Study|Lost to Follow-up|1|||
160953021|NCT01365494|581213964|FG001|Overall Study|Lost to Follow-up|2|||
160953022|NCT00718718|581213965|FG000|Prior to Week 12|Adverse Event|0|||
160953023|NCT00718718|581213966|FG001|Prior to Week 12|Adverse Event|0|||
160953024|NCT00718718|581213967|FG002|Prior to Week 12|Adverse Event|0|||
160953025|NCT00718718|581213968|FG003|Prior to Week 12|Adverse Event|0|||
160953026|NCT00718718|581213969|FG004|Prior to Week 12|Adverse Event|0|||
160953027|NCT00718718|581213970|FG005|Prior to Week 12|Adverse Event|0|||
160953028|NCT00718718|581213971|FG006|Prior to Week 12|Adverse Event|0|||
160953029|NCT00718718|581213972|FG007|Prior to Week 12|Adverse Event|1|||
160953030|NCT00718718|581213973|FG008|Prior to Week 12|Adverse Event|1|||
160953031|NCT00718718|581213974|FG009|Prior to Week 12|Adverse Event|0|||
160953032|NCT00718718|581213965|FG000|Prior to Week 12|Withdrawal by Subject|0|||
160953033|NCT00718718|581213966|FG001|Prior to Week 12|Withdrawal by Subject|0|||
160953034|NCT00718718|581213967|FG002|Prior to Week 12|Withdrawal by Subject|0|||
160953035|NCT00718718|581213968|FG003|Prior to Week 12|Withdrawal by Subject|0|||
160953036|NCT00718718|581213969|FG004|Prior to Week 12|Withdrawal by Subject|3|||
160953037|NCT00718718|581213970|FG005|Prior to Week 12|Withdrawal by Subject|0|||
160953038|NCT00718718|581213971|FG006|Prior to Week 12|Withdrawal by Subject|1|||
160953039|NCT00718718|581213972|FG007|Prior to Week 12|Withdrawal by Subject|1|||
160656343|NCT00864097|580122440|FG003|Overall Study|Death|0|||
160953040|NCT00718718|581213973|FG008|Prior to Week 12|Withdrawal by Subject|1|||
160953041|NCT00718718|581213974|FG009|Prior to Week 12|Withdrawal by Subject|0|||
160953042|NCT00718718|581213965|FG000|Prior to Week 12|Other|1|||
160953043|NCT00718718|581213966|FG001|Prior to Week 12|Other|0|||
160953044|NCT00718718|581213967|FG002|Prior to Week 12|Other|1|||
160953045|NCT00718718|581213968|FG003|Prior to Week 12|Other|0|||
160953046|NCT00718718|581213969|FG004|Prior to Week 12|Other|0|||
160953047|NCT00718718|581213970|FG005|Prior to Week 12|Other|0|||
160953048|NCT00718718|581213971|FG006|Prior to Week 12|Other|0|||
160953049|NCT00718718|581213972|FG007|Prior to Week 12|Other|0|||
160953050|NCT00718718|581213973|FG008|Prior to Week 12|Other|0|||
160953051|NCT00718718|581213974|FG009|Prior to Week 12|Other|0|||
160953052|NCT00718718|581213965|FG000|Week 12 to End of Study|Adverse Event|0|||
160953053|NCT00718718|581213966|FG001|Week 12 to End of Study|Adverse Event|0|||
160953054|NCT00718718|581213967|FG002|Week 12 to End of Study|Adverse Event|0|||
160953055|NCT00718718|581213968|FG003|Week 12 to End of Study|Adverse Event|0|||
160953056|NCT00718718|581213969|FG004|Week 12 to End of Study|Adverse Event|0|||
160953057|NCT00718718|581213970|FG005|Week 12 to End of Study|Adverse Event|0|||
160953058|NCT00718718|581213971|FG006|Week 12 to End of Study|Adverse Event|0|||
160953059|NCT00718718|581213972|FG007|Week 12 to End of Study|Adverse Event|1|||
160656344|NCT00864097|580122437|FG000|Overall Study|Adverse Event|6|||
160953060|NCT00718718|581213973|FG008|Week 12 to End of Study|Adverse Event|0|||
160953061|NCT00718718|581213974|FG009|Week 12 to End of Study|Adverse Event|0|||
160953062|NCT00718718|581213965|FG000|Week 12 to End of Study|Death|0|||
160953063|NCT00718718|581213966|FG001|Week 12 to End of Study|Death|0|||
160953064|NCT00718718|581213967|FG002|Week 12 to End of Study|Death|0|||
160953065|NCT00718718|581213968|FG003|Week 12 to End of Study|Death|0|||
160953066|NCT00718718|581213969|FG004|Week 12 to End of Study|Death|0|||
160953067|NCT00718718|581213970|FG005|Week 12 to End of Study|Death|1|||
160953068|NCT00718718|581213971|FG006|Week 12 to End of Study|Death|0|||
160953069|NCT00718718|581213972|FG007|Week 12 to End of Study|Death|0|||
160953070|NCT00718718|581213973|FG008|Week 12 to End of Study|Death|0|||
160953071|NCT00718718|581213974|FG009|Week 12 to End of Study|Death|0|||
160953072|NCT00718718|581213965|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
160953073|NCT00718718|581213966|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
160953074|NCT00718718|581213967|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
160953075|NCT00718718|581213968|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
160953076|NCT00718718|581213969|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
160953077|NCT00718718|581213970|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
160953078|NCT00718718|581213971|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
160953079|NCT00718718|581213972|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
160953080|NCT00718718|581213973|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
160953081|NCT00718718|581213974|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
160953082|NCT00718718|581213965|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
160953083|NCT00718718|581213966|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
160953084|NCT00718718|581213967|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
160953085|NCT00718718|581213968|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
160953086|NCT00718718|581213969|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
160953087|NCT00718718|581213970|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
160953088|NCT00718718|581213971|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
160953089|NCT00718718|581213972|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
160953090|NCT00718718|581213973|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
160953091|NCT00718718|581213974|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
160953092|NCT00718718|581213965|FG000|Week 12 to End of Study|Other|0|||
160953093|NCT00718718|581213966|FG001|Week 12 to End of Study|Other|1|||
160953094|NCT00718718|581213967|FG002|Week 12 to End of Study|Other|0|||
160953095|NCT00718718|581213968|FG003|Week 12 to End of Study|Other|1|||
160953096|NCT00718718|581213969|FG004|Week 12 to End of Study|Other|0|||
160953097|NCT00718718|581213970|FG005|Week 12 to End of Study|Other|0|||
160953098|NCT00718718|581213971|FG006|Week 12 to End of Study|Other|1|||
160953099|NCT00718718|581213972|FG007|Week 12 to End of Study|Other|0|||
160953100|NCT00718718|581213973|FG008|Week 12 to End of Study|Other|0|||
160953101|NCT00718718|581213974|FG009|Week 12 to End of Study|Other|0|||
160953102|NCT02663128|581213975|FG000|Period 2|Physician Decision|0|||
160953103|NCT02663128|581213976|FG001|Period 2|Physician Decision|0|||
160953104|NCT02663128|581213977|FG002|Period 2|Physician Decision|0|||
160953105|NCT02663128|581213978|FG003|Period 2|Physician Decision|0|||
160953106|NCT02663128|581213979|FG004|Period 2|Physician Decision|1|||
160953107|NCT02663128|581213980|FG005|Period 2|Physician Decision|0|||
160953108|NCT02720484|581213984|FG000|Treatment on Study|Adverse Event|1|||
160953109|NCT02720484|581213984|FG000|Treatment on Study|Withdrawal by Subject|1|||
160953110|NCT02720484|581213984|FG000|Treatment on Study|Progressive Disease|4|||
160953111|NCT02720484|581213984|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
160953112|NCT02720484|581213984|FG000|Follow Up for 2 Years|Death|3|||
160953113|NCT02720484|581213984|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
160953114|NCT05070897|581213985|FG000|Overall Study|Protocol Violation|123|||
160953115|NCT05070897|581213986|FG001|Overall Study|Protocol Violation|68|||
160953116|NCT01617629|581213989|FG000|Overall Study|Death|2|||
160953117|NCT01617629|581213989|FG000|Overall Study|Investigator's Clinical Judgement|1|||
160953118|NCT01617629|581213989|FG000|Overall Study|Reason Not Specified|1|||
160953119|NCT01617629|581213989|FG000|Overall Study|Participant Withdrew Consent|2|||
160953120|NCT01663636|581213990|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
160953121|NCT01663636|581213991|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
160953122|NCT03832946|581213992|FG000|Overall Study|Adverse Event|3|||
160953123|NCT03832946|581213993|FG001|Overall Study|Adverse Event|1|||
160953124|NCT03832946|581213992|FG000|Overall Study|Lost to Follow-up|1|||
160953125|NCT03832946|581213993|FG001|Overall Study|Lost to Follow-up|0|||
160953126|NCT03832946|581213992|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
160953127|NCT03832946|581213993|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
160953128|NCT03832946|581213992|FG000|Overall Study|Lack of Efficacy|1|||
160953129|NCT03832946|581213993|FG001|Overall Study|Lack of Efficacy|0|||
160953130|NCT03832946|581213992|FG000|Overall Study|Withdrawal by Subject|12|||
160953131|NCT03832946|581213993|FG001|Overall Study|Withdrawal by Subject|9|||
160953132|NCT03394924|581213996|FG000|Overall Study|Adverse Event|0|||
160656345|NCT00864097|580122438|FG001|Overall Study|Adverse Event|8|||
160656346|NCT00864097|580122439|FG002|Overall Study|Adverse Event|11|||
160953133|NCT03394924|581213997|FG001|Overall Study|Adverse Event|5|||
160953134|NCT03394924|581213998|FG002|Overall Study|Adverse Event|0|||
160953135|NCT03394924|581213996|FG000|Overall Study|Withdrawal by Subject|2|||
160953136|NCT03394924|581213997|FG001|Overall Study|Withdrawal by Subject|0|||
160953137|NCT03394924|581213998|FG002|Overall Study|Withdrawal by Subject|0|||
160953138|NCT03394924|581213996|FG000|Overall Study|Lost to Follow-up|0|||
160953139|NCT03394924|581213997|FG001|Overall Study|Lost to Follow-up|1|||
160953140|NCT03394924|581213998|FG002|Overall Study|Lost to Follow-up|0|||
160953141|NCT03394924|581213996|FG000|Overall Study|Did not meet all inclusion criteria|1|||
160953142|NCT03394924|581213997|FG001|Overall Study|Did not meet all inclusion criteria|0|||
160953143|NCT03394924|581213998|FG002|Overall Study|Did not meet all inclusion criteria|0|||
160656347|NCT00864097|580122440|FG003|Overall Study|Adverse Event|9|||
160953144|NCT03277313|581214008|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
160953145|NCT03277313|581214009|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
160953146|NCT03277313|581214008|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
160953147|NCT03277313|581214009|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
160953148|NCT03277313|581214008|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
160953149|NCT03277313|581214009|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
160953150|NCT03277313|581214008|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
160953151|NCT03277313|581214009|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
160953152|NCT03277313|581214008|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
160953153|NCT03277313|581214009|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
160953154|NCT02005471|581214014|FG000|Main Study|Adverse Event|0|||
160953155|NCT02005471|581214015|FG001|Main Study|Adverse Event|1|||
160953156|NCT02005471|581214016|FG002|Main Study|Adverse Event|0|||
160953157|NCT02005471|581214017|FG003|Main Study|Adverse Event|0|||
160953158|NCT02005471|581214014|FG000|Main Study|Death|83|||
160953159|NCT02005471|581214015|FG001|Main Study|Death|52|||
160953160|NCT02005471|581214016|FG002|Main Study|Death|0|||
160953161|NCT02005471|581214017|FG003|Main Study|Death|0|||
160953162|NCT02005471|581214014|FG000|Main Study|Lost to Follow-up|4|||
160953163|NCT02005471|581214015|FG001|Main Study|Lost to Follow-up|5|||
160953164|NCT02005471|581214016|FG002|Main Study|Lost to Follow-up|0|||
160953165|NCT02005471|581214017|FG003|Main Study|Lost to Follow-up|0|||
160953166|NCT02005471|581214014|FG000|Main Study|Physician Decision|3|||
160953167|NCT02005471|581214015|FG001|Main Study|Physician Decision|1|||
160953168|NCT02005471|581214016|FG002|Main Study|Physician Decision|0|||
160953169|NCT02005471|581214017|FG003|Main Study|Physician Decision|0|||
160953170|NCT02005471|581214014|FG000|Main Study|Withdrawal by Subject|26|||
160953171|NCT02005471|581214015|FG001|Main Study|Withdrawal by Subject|11|||
160953172|NCT02005471|581214016|FG002|Main Study|Withdrawal by Subject|0|||
160953173|NCT02005471|581214017|FG003|Main Study|Withdrawal by Subject|0|||
160953174|NCT02005471|581214014|FG000|Main Study|Reason not Specified|0|||
160953175|NCT02005471|581214015|FG001|Main Study|Reason not Specified|6|||
160953176|NCT02005471|581214016|FG002|Main Study|Reason not Specified|0|||
160953177|NCT02005471|581214017|FG003|Main Study|Reason not Specified|0|||
160953178|NCT02005471|581214014|FG000|Main Study|Randomized but not Dosed|8|||
160953179|NCT02005471|581214015|FG001|Main Study|Randomized but not Dosed|0|||
160953180|NCT02005471|581214016|FG002|Main Study|Randomized but not Dosed|0|||
160953181|NCT02005471|581214017|FG003|Main Study|Randomized but not Dosed|0|||
160953182|NCT02005471|581214014|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
160953183|NCT02005471|581214015|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
160953184|NCT02005471|581214016|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
160953185|NCT02005471|581214017|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
160953186|NCT02005471|581214014|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
160953187|NCT02005471|581214015|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
160953188|NCT02005471|581214016|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
160953189|NCT02005471|581214017|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
160953190|NCT02005471|581214014|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
160953191|NCT02005471|581214015|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
160953192|NCT02005471|581214016|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
160953193|NCT02005471|581214017|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
160953194|NCT02663817|581214018|FG000|Overall Study|Screen failure|2|||
160953195|NCT03478891|581214019|FG000|Overall Study|Enrolled, but product never administered|0|||
160953196|NCT03478891|581214020|FG001|Overall Study|Enrolled, but product never administered|0|||
160953197|NCT03478891|581214021|FG002|Overall Study|Enrolled, but product never administered|1|||
160953198|NCT03478891|581214019|FG000|Overall Study|Moved from area|0|||
160953199|NCT03478891|581214020|FG001|Overall Study|Moved from area|0|||
160953200|NCT03478891|581214021|FG002|Overall Study|Moved from area|1|||
160953201|NCT03478891|581214019|FG000|Overall Study|Lost to Follow-up|1|||
160953202|NCT03478891|581214020|FG001|Overall Study|Lost to Follow-up|0|||
160953203|NCT03478891|581214021|FG002|Overall Study|Lost to Follow-up|1|||
160953204|NCT00932893|581214022|FG000|Overall Study|Death|115|||
160953205|NCT00932893|581214023|FG001|Overall Study|Death|24|||
160953206|NCT00932893|581214022|FG000|Overall Study|Lost to Follow-up|8|||
160953207|NCT00932893|581214023|FG001|Overall Study|Lost to Follow-up|0|||
160953208|NCT00932893|581214022|FG000|Overall Study|Withdrawal by Subject|5|||
160953209|NCT00932893|581214023|FG001|Overall Study|Withdrawal by Subject|2|||
160582582|NCT01328249|579853640|FG000|Overall Study|Disease progression|1|||
160582583|NCT01328249|579853641|FG001|Overall Study|Disease progression|0|||
160582584|NCT01328249|579853640|FG000|Overall Study|Withdrawal by Subject|1|||
160582585|NCT01328249|579853641|FG001|Overall Study|Withdrawal by Subject|1|||
161000898|NCT01027286|581388928|FG001|Overall Study|Lost to Follow-up|1|||
161000899|NCT03804918|581388929|FG000|Overall Study|Participant did not use the app|1|||
161000900|NCT05694065|581388930|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
161000901|NCT05694065|581388930|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
160582586|NCT01328249|579853640|FG000|Overall Study|Moved before end of treatment visit|1|||
160953210|NCT00932893|581214022|FG000|Overall Study|Other|5|||
160953211|NCT00932893|581214023|FG001|Overall Study|Other|144|||
160953212|NCT05350449|581214028|FG000|Overall Study|Withdrawal by Subject|4|||
160953213|NCT05350449|581214029|FG001|Overall Study|Withdrawal by Subject|8|||
160953214|NCT01912612|581215966|FG000|Overall Study|Adverse Event|4|||
160953215|NCT01912612|581215967|FG001|Overall Study|Adverse Event|0|||
160953216|NCT01912612|581215968|FG002|Overall Study|Adverse Event|0|||
160953217|NCT01912612|581215966|FG000|Overall Study|Withdrew consent|1|||
160953218|NCT01912612|581215967|FG001|Overall Study|Withdrew consent|0|||
160953219|NCT01912612|581215968|FG002|Overall Study|Withdrew consent|0|||
160953220|NCT01912612|581215966|FG000|Overall Study|Study design change|0|||
160953221|NCT01912612|581215967|FG001|Overall Study|Study design change|0|||
160953222|NCT01912612|581215968|FG002|Overall Study|Study design change|3|||
160953223|NCT01588184|581215969|FG000|Overall Study|Death|1|||
160953224|NCT01588184|581215970|FG001|Overall Study|Death|0|||
160953225|NCT01588184|581215971|FG002|Overall Study|Death|0|||
160953226|NCT01588184|581215972|FG003|Overall Study|Death|1|||
160953227|NCT01588184|581215973|FG004|Overall Study|Death|1|||
160953228|NCT01588184|581215974|FG005|Overall Study|Death|1|||
160953229|NCT01588184|581215969|FG000|Overall Study|Withdrawal by Subject|2|||
160953230|NCT01588184|581215970|FG001|Overall Study|Withdrawal by Subject|4|||
160953231|NCT01588184|581215971|FG002|Overall Study|Withdrawal by Subject|0|||
160953232|NCT01588184|581215972|FG003|Overall Study|Withdrawal by Subject|1|||
160953233|NCT01588184|581215973|FG004|Overall Study|Withdrawal by Subject|0|||
160953234|NCT01588184|581215974|FG005|Overall Study|Withdrawal by Subject|0|||
160953235|NCT01588184|581215969|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
160953236|NCT01588184|581215970|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
160953237|NCT01588184|581215971|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
160953238|NCT01588184|581215972|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
160953239|NCT01588184|581215973|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
160953240|NCT01588184|581215974|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
160457447|NCT02990338|579406421|FG000|Overall Study|Withdrawal by Subject|6|||
160457448|NCT02990338|579406422|FG001|Overall Study|Withdrawal by Subject|8|||
160457449|NCT02990338|579406421|FG000|Overall Study|Physician's decision|2|||
160953241|NCT01588184|581215969|FG000|Overall Study|multiple reasons|0|||
160953242|NCT01588184|581215970|FG001|Overall Study|multiple reasons|3|||
160953243|NCT01588184|581215971|FG002|Overall Study|multiple reasons|0|||
160953244|NCT01588184|581215972|FG003|Overall Study|multiple reasons|1|||
160953245|NCT01588184|581215973|FG004|Overall Study|multiple reasons|0|||
160953246|NCT01588184|581215974|FG005|Overall Study|multiple reasons|0|||
160953247|NCT01983293|581215976|FG000|Overall Study|Withdrawal by Subject|29|||
160953248|NCT01983293|581215977|FG001|Overall Study|Withdrawal by Subject|15|||
160953249|NCT01983293|581215976|FG000|Overall Study|Missing 12-month visit|3|||
160953250|NCT01983293|581215977|FG001|Overall Study|Missing 12-month visit|3|||
160953251|NCT01983293|581215976|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
160953252|NCT01983293|581215977|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
160953253|NCT03750552|581215978|FG000|Overall Study|Adverse Event|5|||
160953254|NCT03750552|581215979|FG001|Overall Study|Adverse Event|1|||
160953255|NCT03750552|581215978|FG000|Overall Study|Withdrawal by Subject|1|||
160953256|NCT03750552|581215979|FG001|Overall Study|Withdrawal by Subject|1|||
160953257|NCT03750552|581215978|FG000|Overall Study|Other|2|||
160953258|NCT03750552|581215979|FG001|Overall Study|Other|0|||
160457450|NCT02990338|579406422|FG001|Overall Study|Physician's decision|6|||
160953259|NCT02062632|581215980|FG000|Overall Study|No treatment data|1|||
160953260|NCT00773968|581215983|FG000|Overall Study|Adverse Event|2|||
160953261|NCT00773968|581215983|FG000|Overall Study|Death|1|||
160953262|NCT00773968|581215983|FG000|Overall Study|Failure to Return|2|||
160953263|NCT00773968|581215983|FG000|Overall Study|Lack of Efficacy|3|||
160953264|NCT00773968|581215983|FG000|Overall Study|Protocol Violation|1|||
160953265|NCT00773968|581215983|FG000|Overall Study|Withdrawal by Subject|11|||
160457451|NCT02990338|579406421|FG000|Overall Study|Treatment extension study|0|||
160953266|NCT00773968|581215983|FG000|Overall Study|Screen Failure|17|||
160953267|NCT00773968|581215983|FG000|Overall Study|Other|8|||
160953268|NCT02008890|581215986|FG000|Period 1|Withdrawal by Subject|7|||
160953269|NCT02008890|581215987|FG001|Period 1|Withdrawal by Subject|7|||
160953270|NCT02008890|581215988|FG002|Period 1|Withdrawal by Subject|5|||
160953271|NCT02008890|581215989|FG003|Period 1|Withdrawal by Subject|0|||
160953272|NCT02008890|581215990|FG004|Period 1|Withdrawal by Subject|0|||
160953273|NCT02008890|581215986|FG000|Period 1|Pregnancy|1|||
160457452|NCT02990338|579406422|FG001|Overall Study|Treatment extension study|6|||
160457453|NCT02990338|579406421|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
160656348|NCT00864097|580122437|FG000|Overall Study|Lack of Efficacy|9|||
160953274|NCT02008890|581215987|FG001|Period 1|Pregnancy|0|||
160953275|NCT02008890|581215988|FG002|Period 1|Pregnancy|0|||
160953276|NCT02008890|581215989|FG003|Period 1|Pregnancy|0|||
160953277|NCT02008890|581215990|FG004|Period 1|Pregnancy|0|||
160953278|NCT02008890|581215986|FG000|Period 1|Physician Decision|1|||
160953279|NCT02008890|581215987|FG001|Period 1|Physician Decision|0|||
160953280|NCT02008890|581215988|FG002|Period 1|Physician Decision|1|||
160953281|NCT02008890|581215989|FG003|Period 1|Physician Decision|0|||
160953282|NCT02008890|581215990|FG004|Period 1|Physician Decision|0|||
160953283|NCT02008890|581215986|FG000|Period 1|Adverse Event|6|||
160953284|NCT02008890|581215987|FG001|Period 1|Adverse Event|8|||
160953285|NCT02008890|581215988|FG002|Period 1|Adverse Event|6|||
160953286|NCT02008890|581215989|FG003|Period 1|Adverse Event|0|||
160953287|NCT02008890|581215990|FG004|Period 1|Adverse Event|0|||
160953288|NCT02008890|581215986|FG000|Period 2|Adverse Event|12|||
160953289|NCT02008890|581215987|FG001|Period 2|Adverse Event|7|||
160953290|NCT02008890|581215988|FG002|Period 2|Adverse Event|0|||
160953291|NCT02008890|581215989|FG003|Period 2|Adverse Event|5|||
160953292|NCT02008890|581215990|FG004|Period 2|Adverse Event|5|||
160953293|NCT02008890|581215986|FG000|Period 2|Withdrawal by Subject|11|||
160953294|NCT02008890|581215987|FG001|Period 2|Withdrawal by Subject|8|||
160953295|NCT02008890|581215988|FG002|Period 2|Withdrawal by Subject|0|||
160953296|NCT02008890|581215989|FG003|Period 2|Withdrawal by Subject|7|||
160953297|NCT02008890|581215990|FG004|Period 2|Withdrawal by Subject|2|||
160953298|NCT02008890|581215986|FG000|Period 2|Physician Decision|4|||
160953299|NCT02008890|581215987|FG001|Period 2|Physician Decision|0|||
160953300|NCT02008890|581215988|FG002|Period 2|Physician Decision|0|||
160953301|NCT02008890|581215989|FG003|Period 2|Physician Decision|2|||
160953302|NCT02008890|581215990|FG004|Period 2|Physician Decision|1|||
160953303|NCT02008890|581215986|FG000|Period 2|Lost to Follow-up|0|||
160953304|NCT02008890|581215987|FG001|Period 2|Lost to Follow-up|0|||
160953305|NCT02008890|581215988|FG002|Period 2|Lost to Follow-up|1|||
160953306|NCT02008890|581215989|FG003|Period 2|Lost to Follow-up|0|||
160953307|NCT02008890|581215990|FG004|Period 2|Lost to Follow-up|0|||
160953308|NCT02008890|581215986|FG000|Extension Period|Withdrawal by Subject|3|||
160953309|NCT02008890|581215987|FG001|Extension Period|Withdrawal by Subject|2|||
160953310|NCT02008890|581215988|FG002|Extension Period|Withdrawal by Subject|0|||
160953311|NCT02008890|581215989|FG003|Extension Period|Withdrawal by Subject|4|||
160953312|NCT02008890|581215990|FG004|Extension Period|Withdrawal by Subject|2|||
160953313|NCT02008890|581215986|FG000|Extension Period|Lost to Follow-up|1|||
160953314|NCT02008890|581215987|FG001|Extension Period|Lost to Follow-up|0|||
160953315|NCT02008890|581215988|FG002|Extension Period|Lost to Follow-up|0|||
160953316|NCT02008890|581215989|FG003|Extension Period|Lost to Follow-up|0|||
160953317|NCT02008890|581215990|FG004|Extension Period|Lost to Follow-up|0|||
160953318|NCT02008890|581215986|FG000|Extension Period|Adverse Event|1|||
160953319|NCT02008890|581215987|FG001|Extension Period|Adverse Event|3|||
160953320|NCT02008890|581215988|FG002|Extension Period|Adverse Event|0|||
160953321|NCT02008890|581215989|FG003|Extension Period|Adverse Event|0|||
160953322|NCT02008890|581215990|FG004|Extension Period|Adverse Event|2|||
160953323|NCT02207816|581215991|FG000|Overall Study|Serious Adverse Event|0|||
160953324|NCT02207816|581215992|FG001|Overall Study|Serious Adverse Event|5|||
160582587|NCT01328249|579853641|FG001|Overall Study|Moved before end of treatment visit|0|||
160582588|NCT01328249|579853640|FG000|Overall Study|Subject choice|1|||
160582589|NCT01328249|579853641|FG001|Overall Study|Subject choice|1|||
160582590|NCT01328249|579853640|FG000|Overall Study|Protocol Violation|0|||
160582591|NCT01328249|579853641|FG001|Overall Study|Protocol Violation|1|||
160582592|NCT00748553|579853642|FG000|Overall Study|Adverse Event|0|||
160582593|NCT00748553|579853643|FG001|Overall Study|Adverse Event|1|||
160582594|NCT00748553|579853642|FG000|Overall Study|disease progression|2|||
160953325|NCT02207816|581215993|FG002|Overall Study|Serious Adverse Event|2|||
160953326|NCT02207816|581215991|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
160953327|NCT02207816|581215992|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
160953328|NCT02207816|581215993|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
160953329|NCT02207816|581215991|FG000|Overall Study|Withdrawal by Subject|4|||
160953330|NCT02207816|581215992|FG001|Overall Study|Withdrawal by Subject|9|||
160953331|NCT02207816|581215993|FG002|Overall Study|Withdrawal by Subject|7|||
160953332|NCT02207816|581215991|FG000|Overall Study|Migrated/Moved From Study Area|41|||
160953333|NCT02207816|581215992|FG001|Overall Study|Migrated/Moved From Study Area|60|||
160953334|NCT02207816|581215993|FG002|Overall Study|Migrated/Moved From Study Area|51|||
160953335|NCT02207816|581215991|FG000|Overall Study|Lost to Follow-up|3|||
160953336|NCT02207816|581215992|FG001|Overall Study|Lost to Follow-up|9|||
160582595|NCT00748553|579853643|FG001|Overall Study|disease progression|0|||
160582596|NCT00748553|579853642|FG000|Overall Study|noncompliance|1|||
160953337|NCT02207816|581215993|FG002|Overall Study|Lost to Follow-up|1|||
160953338|NCT02207816|581215991|FG000|Overall Study|Other|1|||
160953339|NCT02207816|581215992|FG001|Overall Study|Other|2|||
160953340|NCT02207816|581215993|FG002|Overall Study|Other|4|||
160953341|NCT02522494|581215994|FG000|Overall Study|Lost to Follow-up|6|||
160953342|NCT02522494|581215995|FG001|Overall Study|Lost to Follow-up|2|||
160953343|NCT02522494|581215994|FG000|Overall Study|Withdrawal by Subject|1|||
160582597|NCT00748553|579853643|FG001|Overall Study|noncompliance|0|||
160582598|NCT00948818|579853645|FG000|Overall Study|Adverse Event|10|||
160656349|NCT00864097|580122438|FG001|Overall Study|Lack of Efficacy|3|||
160953344|NCT02522494|581215995|FG001|Overall Study|Withdrawal by Subject|0|||
160953345|NCT02522494|581215994|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
160953346|NCT02522494|581215995|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
160582599|NCT00948818|579853646|FG001|Overall Study|Adverse Event|32|||
160582600|NCT00948818|579853645|FG000|Overall Study|Protocol Violation|9|||
160582601|NCT00948818|579853646|FG001|Overall Study|Protocol Violation|10|||
160582602|NCT00948818|579853645|FG000|Overall Study|Withdrawal by Subject|25|||
160582603|NCT00948818|579853646|FG001|Overall Study|Withdrawal by Subject|25|||
160582604|NCT00948818|579853645|FG000|Overall Study|Lost to Follow-up|10|||
160582605|NCT00948818|579853646|FG001|Overall Study|Lost to Follow-up|17|||
160582606|NCT00948818|579853645|FG000|Overall Study|Lack of Efficacy|4|||
160582607|NCT00948818|579853646|FG001|Overall Study|Lack of Efficacy|5|||
160582608|NCT00948818|579853645|FG000|Overall Study|Other Reason|4|||
160582609|NCT00948818|579853646|FG001|Overall Study|Other Reason|5|||
160582610|NCT02330549|579853647|FG000|Overall Study|Adverse Event|1|||
160582611|NCT02330549|579853648|FG001|Overall Study|Adverse Event|0|||
160582612|NCT02330549|579853647|FG000|Overall Study|Subject withdrew consent|2|||
160582613|NCT02330549|579853648|FG001|Overall Study|Subject withdrew consent|1|||
160582614|NCT02330549|579853647|FG000|Overall Study|Failure to meet randomization criteria|1|||
160953347|NCT02522494|581215994|FG000|Overall Study|Participant did not watch the video|1|||
160953348|NCT02522494|581215995|FG001|Overall Study|Participant did not watch the video|0|||
160953349|NCT02522494|581215994|FG000|Overall Study|Death|0|||
160953350|NCT02522494|581215995|FG001|Overall Study|Death|1|||
160953351|NCT02349295|581215998|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
160953352|NCT02349295|581215999|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
160953353|NCT02349295|581216000|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
160953354|NCT02349295|581216001|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953355|NCT02349295|581216002|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953356|NCT02349295|581216003|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953357|NCT02349295|581216004|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953358|NCT02349295|581216005|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953359|NCT02349295|581216006|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953360|NCT02349295|581216007|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953361|NCT02349295|581216008|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953362|NCT02349295|581216009|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953363|NCT02349295|581216010|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953364|NCT02349295|581216011|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953365|NCT02349295|581215998|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
160953366|NCT02349295|581215999|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
160953367|NCT02349295|581216000|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
160953368|NCT02349295|581216001|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953369|NCT02349295|581216002|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953370|NCT02349295|581216003|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953371|NCT02349295|581216004|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953372|NCT02349295|581216005|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953373|NCT02349295|581216006|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953374|NCT02349295|581216007|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953375|NCT02349295|581216008|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953376|NCT02349295|581216009|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953377|NCT02349295|581216010|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953378|NCT02349295|581216011|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953379|NCT02349295|581215998|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
160953380|NCT02349295|581215999|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
160953381|NCT02349295|581216000|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
160953382|NCT02349295|581216001|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953383|NCT02349295|581216002|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953384|NCT02349295|581216003|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161000902|NCT05694065|581388930|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
161000903|NCT00813904|581388931|FG000|Overall Study|Death|1|||
161000904|NCT01087762|581388932|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
161000905|NCT01087762|581388933|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
161000906|NCT01087762|581388934|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
160953385|NCT02349295|581216004|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161000907|NCT01087762|581388935|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
160953386|NCT02349295|581216005|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161000908|NCT01087762|581388936|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
161000909|NCT01087762|581388932|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
160582615|NCT02330549|579853648|FG001|Overall Study|Failure to meet randomization criteria|0|||
160582616|NCT00495495|579853649|FG000|Overall Study|Protocol Violation|99|||
160953387|NCT02349295|581216006|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161000910|NCT01087762|581388933|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
161000911|NCT01087762|581388934|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
160582617|NCT00745368|579853650|FG000|Overall Study|Unable to provide sample|3|||
160582618|NCT02364947|579853653|FG000|Overall Study|Withdrawal by Subject|10|||
160953388|NCT02349295|581216007|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953389|NCT02349295|581216008|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953390|NCT02349295|581216009|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953391|NCT02349295|581216010|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953392|NCT02349295|581216011|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953393|NCT02349295|581215998|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
160953394|NCT02349295|581215999|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
160953395|NCT02349295|581216000|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
160953396|NCT02349295|581216001|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953397|NCT02349295|581216002|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953398|NCT02349295|581216003|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953399|NCT02349295|581216004|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953400|NCT02349295|581216005|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953401|NCT02349295|581216006|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953402|NCT02349295|581216007|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953403|NCT02349295|581216008|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953404|NCT02349295|581216009|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953405|NCT02349295|581216010|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953406|NCT02349295|581216011|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953407|NCT02349295|581215998|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953408|NCT02349295|581215999|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
160953409|NCT02349295|581216000|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
160953410|NCT02349295|581216001|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953411|NCT02349295|581216002|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953412|NCT02349295|581216003|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953413|NCT02349295|581216004|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953414|NCT02349295|581216005|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953415|NCT02349295|581216006|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953416|NCT02349295|581216007|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953417|NCT02349295|581216008|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953418|NCT02349295|581216009|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953419|NCT02349295|581216010|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953420|NCT02349295|581216011|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953421|NCT02349295|581215998|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
160953422|NCT02349295|581215999|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
160953423|NCT02349295|581216000|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
160953424|NCT02349295|581216001|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
160953425|NCT02349295|581216002|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
160953426|NCT02349295|581216003|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
160953427|NCT02349295|581216004|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
161000912|NCT01087762|581388935|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
160582619|NCT02364947|579853654|FG001|Overall Study|Withdrawal by Subject|8|||
160582620|NCT02364947|579853655|FG002|Overall Study|Withdrawal by Subject|9|||
160582621|NCT02364947|579853653|FG000|Overall Study|Adverse Event|45|||
160582622|NCT02364947|579853654|FG001|Overall Study|Adverse Event|33|||
160582623|NCT02364947|579853655|FG002|Overall Study|Adverse Event|11|||
160582624|NCT02364947|579853653|FG000|Overall Study|Protocol Violation|1|||
160582625|NCT02364947|579853654|FG001|Overall Study|Protocol Violation|1|||
160582626|NCT02364947|579853655|FG002|Overall Study|Protocol Violation|1|||
160582627|NCT02364947|579853653|FG000|Overall Study|Physician Decision|3|||
160582628|NCT02364947|579853654|FG001|Overall Study|Physician Decision|2|||
160582629|NCT02364947|579853655|FG002|Overall Study|Physician Decision|5|||
160582630|NCT02364947|579853653|FG000|Overall Study|Death|0|||
160582631|NCT02364947|579853654|FG001|Overall Study|Death|1|||
160656350|NCT00864097|580122439|FG002|Overall Study|Lack of Efficacy|7|||
160953428|NCT02349295|581216005|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
160953429|NCT02349295|581216006|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
160953430|NCT02349295|581216007|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
160953431|NCT02349295|581216008|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
160953432|NCT02349295|581216009|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
160953433|NCT02349295|581216010|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
160953434|NCT02349295|581216011|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
160953435|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953436|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953437|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953438|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953439|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953440|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160582632|NCT02364947|579853655|FG002|Overall Study|Death|0|||
160656351|NCT00864097|580122440|FG003|Overall Study|Lack of Efficacy|2|||
160953441|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953442|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
160953443|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
160953444|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
160953445|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
160953446|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953447|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953448|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953449|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953450|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953451|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953452|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953453|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953454|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953455|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953456|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
160953457|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
160953458|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
160953459|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
160953460|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953461|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953462|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953463|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953464|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953465|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953466|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953467|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953468|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953469|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953470|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
160953471|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953472|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
160953473|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953474|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953475|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953476|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953477|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
160953478|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
160953479|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
160953480|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
160953481|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
160953482|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
160953483|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
160953484|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
160953485|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
160953486|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
160953487|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
160953488|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
160953489|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
160953490|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
160953491|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953492|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953493|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953494|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953495|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953496|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160582633|NCT02702518|579853659|FG000|Overall Study|Lost to Follow-up|3|||
160582634|NCT02702518|579853660|FG001|Overall Study|Lost to Follow-up|4|||
160582635|NCT00853489|579853661|FG000|Overall Study|Lost to Follow-up|5|||
160582636|NCT00853489|579853662|FG001|Overall Study|Lost to Follow-up|2|||
160953497|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953498|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
160953499|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
160953500|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
160582637|NCT05525975|579853663|FG000|Overall Study|Surgery cancellation|4|||
160582638|NCT05525975|579853664|FG001|Overall Study|Surgery cancellation|5|||
160457454|NCT02990338|579406422|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
160457455|NCT02990338|579406421|FG000|Overall Study|Continue with therapy available commercially|0|||
160457456|NCT02990338|579406422|FG001|Overall Study|Continue with therapy available commercially|1|||
160457457|NCT05100628|579406424|FG000|Overall Study|Progressive Disease|1|||
160457458|NCT05100628|579406425|FG001|Overall Study|Progressive Disease|0|||
160457459|NCT05100628|579406426|FG002|Overall Study|Progressive Disease|0|||
160457460|NCT05100628|579406427|FG003|Overall Study|Progressive Disease|0|||
160457461|NCT05100628|579406424|FG000|Overall Study|Study Terminated by Sponsor|0|||
160457462|NCT05100628|579406425|FG001|Overall Study|Study Terminated by Sponsor|0|||
160457463|NCT05100628|579406426|FG002|Overall Study|Study Terminated by Sponsor|3|||
160457464|NCT05100628|579406427|FG003|Overall Study|Study Terminated by Sponsor|0|||
160457465|NCT05100628|579406424|FG000|Overall Study|unkown|0|||
160457466|NCT05100628|579406425|FG001|Overall Study|unkown|1|||
160457467|NCT05100628|579406426|FG002|Overall Study|unkown|0|||
160457468|NCT05100628|579406427|FG003|Overall Study|unkown|0|||
160457469|NCT03914469|579406430|FG000|Overall Study|Lost to Follow-up|1|||
160457470|NCT03914469|579406431|FG001|Overall Study|Lost to Follow-up|4|||
160582639|NCT05525975|579853663|FG000|Overall Study|didn't fill prescription|1|||
160953501|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
160953502|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953503|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953504|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953505|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953506|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953507|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953508|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953509|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953510|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953511|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953512|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
160953513|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
160953514|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953515|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953516|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953517|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953518|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953519|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953520|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953521|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953522|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953523|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953524|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953525|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953526|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
160953527|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
160953528|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953529|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953530|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953531|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953532|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953533|NCT02349295|581215998|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953534|NCT02349295|581215999|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953535|NCT02349295|581216000|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953536|NCT02349295|581216001|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161000913|NCT01087762|581388936|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
160457471|NCT03252288|579406434|FG000|Overall Study|Death|1|||
160457472|NCT03252288|579406435|FG001|Overall Study|Death|0|||
160457473|NCT03252288|579406436|FG002|Overall Study|Death|0|||
160457474|NCT03252288|579406434|FG000|Overall Study|Death|11|||
160582640|NCT05525975|579853664|FG001|Overall Study|didn't fill prescription|0|||
160457475|NCT03252288|579406435|FG001|Overall Study|Death|0|||
160457476|NCT03252288|579406436|FG002|Overall Study|Death|0|||
160457477|NCT03252288|579406434|FG000|Overall Study|Withdrawal by Subject|2|||
160457478|NCT03252288|579406435|FG001|Overall Study|Withdrawal by Subject|0|||
160457479|NCT03252288|579406436|FG002|Overall Study|Withdrawal by Subject|0|||
160582641|NCT05525975|579853663|FG000|Overall Study|Withdrawal by Subject|0|||
160457480|NCT03252288|579406434|FG000|Overall Study|Lost to Follow-up|79|||
160457481|NCT03252288|579406435|FG001|Overall Study|Lost to Follow-up|0|||
160953537|NCT02349295|581216002|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953538|NCT02349295|581216003|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953539|NCT02349295|581216004|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953540|NCT02349295|581216005|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953541|NCT02349295|581216006|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953542|NCT02349295|581216007|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953543|NCT02349295|581216008|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953544|NCT02349295|581216009|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
160953545|NCT02349295|581216010|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
160953546|NCT02349295|581216011|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
160953547|NCT02349295|581215998|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953548|NCT02349295|581215999|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953549|NCT02349295|581216000|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953550|NCT02349295|581216001|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953551|NCT02349295|581216002|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953552|NCT02349295|581216003|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953553|NCT02349295|581216004|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953554|NCT02349295|581216005|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953555|NCT02349295|581216006|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953556|NCT02349295|581216007|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953557|NCT02349295|581216008|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953558|NCT02349295|581216009|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
160953559|NCT02349295|581216010|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
160953560|NCT02349295|581216011|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953561|NCT02349295|581215998|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953562|NCT02349295|581215999|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953563|NCT02349295|581216000|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953564|NCT02349295|581216001|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953565|NCT02349295|581216002|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953566|NCT02349295|581216003|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953567|NCT02349295|581216004|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953568|NCT02349295|581216005|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953569|NCT02349295|581216006|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953570|NCT02349295|581216007|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953571|NCT02349295|581216008|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953572|NCT02349295|581216009|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
160953573|NCT02349295|581216010|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
160953574|NCT02349295|581216011|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953575|NCT02349295|581215998|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953576|NCT02349295|581215999|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953577|NCT02349295|581216000|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953578|NCT02349295|581216001|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953579|NCT02349295|581216002|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953580|NCT02349295|581216003|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953581|NCT02349295|581216004|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953582|NCT02349295|581216005|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953583|NCT02349295|581216006|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953584|NCT02349295|581216007|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953585|NCT02349295|581216008|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953586|NCT02349295|581216009|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
160953587|NCT02349295|581216010|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160582642|NCT05525975|579853664|FG001|Overall Study|Withdrawal by Subject|3|||
160582643|NCT02245568|579853668|FG000|Overall Study|Study terminated by Sponsor|346|||
160582644|NCT02245568|579853668|FG000|Overall Study|Adverse Event|144|||
160582645|NCT02245568|579853668|FG000|Overall Study|Lack of Efficacy|98|||
160582646|NCT02245568|579853668|FG000|Overall Study|Withdrawal by Caregiver|85|||
160582647|NCT02245568|579853668|FG000|Overall Study|Withdrawal by Subject|77|||
160582648|NCT02245568|579853668|FG000|Overall Study|Withdrawal by Legal Representative|31|||
160953588|NCT02349295|581216011|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953589|NCT02349295|581215998|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953590|NCT02349295|581215999|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161000914|NCT01087762|581388932|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
161000915|NCT01087762|581388933|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
160582649|NCT02245568|579853668|FG000|Overall Study|Missing (Site closure)|16|||
160582650|NCT02245568|579853668|FG000|Overall Study|Physician Decision|14|||
160582651|NCT02245568|579853668|FG000|Overall Study|Non-compliance with study drug|11|||
160457482|NCT03252288|579406436|FG002|Overall Study|Lost to Follow-up|0|||
160457483|NCT03252288|579406434|FG000|Overall Study|Loss of baseline data on tablets|6|||
160457484|NCT03252288|579406435|FG001|Overall Study|Loss of baseline data on tablets|0|||
160457485|NCT03252288|579406436|FG002|Overall Study|Loss of baseline data on tablets|0|||
160457486|NCT00677365|579406437|FG000|Overall Study|Adverse Event|2|||
160457487|NCT00677365|579406438|FG001|Overall Study|Adverse Event|1|||
160457488|NCT00677365|579406439|FG002|Overall Study|Adverse Event|1|||
160457489|NCT00677365|579406440|FG003|Overall Study|Adverse Event|2|||
160457490|NCT00677365|579406437|FG000|Overall Study|Withdrawal by Subject|0|||
160457491|NCT00677365|579406438|FG001|Overall Study|Withdrawal by Subject|0|||
160457492|NCT00677365|579406439|FG002|Overall Study|Withdrawal by Subject|1|||
160457493|NCT00677365|579406440|FG003|Overall Study|Withdrawal by Subject|0|||
160457494|NCT00677365|579406437|FG000|Overall Study|Other reason|0|||
160457495|NCT00677365|579406438|FG001|Overall Study|Other reason|0|||
160457496|NCT00677365|579406439|FG002|Overall Study|Other reason|0|||
160457497|NCT00677365|579406440|FG003|Overall Study|Other reason|1|||
160457498|NCT05900154|579406441|FG000|Follow-Up Period|Lost to Follow-up|1|||
160457499|NCT05900154|579406442|FG001|Follow-Up Period|Lost to Follow-up|2|||
160457500|NCT05900154|579406443|FG002|Follow-Up Period|Lost to Follow-up|1|||
160457501|NCT05900154|579406444|FG003|Follow-Up Period|Lost to Follow-up|0|||
160457502|NCT05900154|579406445|FG004|Follow-Up Period|Lost to Follow-up|1|||
160953591|NCT02349295|581216000|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160457503|NCT05900154|579406446|FG005|Follow-Up Period|Lost to Follow-up|1|||
160457504|NCT04102111|579406449|FG000|Overall Study|Withdrawal by Subject|2|||
160457505|NCT04102111|579406450|FG001|Overall Study|Withdrawal by Subject|3|||
160457506|NCT04102111|579406449|FG000|Overall Study|Adverse Event|1|||
160457507|NCT04102111|579406450|FG001|Overall Study|Adverse Event|1|||
160457508|NCT04102111|579406449|FG000|Overall Study|Study terminated by sponsor|1|||
160457509|NCT04102111|579406450|FG001|Overall Study|Study terminated by sponsor|3|||
160457510|NCT03334695|579406451|FG000|Overall Study|Lost to Follow-up|3|||
160457511|NCT03334695|579406452|FG001|Overall Study|Lost to Follow-up|3|||
160457512|NCT03334695|579406451|FG000|Overall Study|Physician Decision|1|||
160457513|NCT03334695|579406452|FG001|Overall Study|Physician Decision|2|||
160582652|NCT02245568|579853668|FG000|Overall Study|Death|9|||
160582653|NCT02245568|579853668|FG000|Overall Study|Blue staining|6|||
160582654|NCT02245568|579853668|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
160582655|NCT02245568|579853668|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
160582656|NCT02245568|579853668|FG000|Overall Study|Lost to Follow-up|5|||
160953592|NCT02349295|581216001|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953593|NCT02349295|581216002|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953594|NCT02349295|581216003|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953595|NCT02349295|581216004|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953596|NCT02349295|581216005|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953597|NCT02349295|581216006|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953598|NCT02349295|581216007|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953599|NCT02349295|581216008|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953600|NCT02349295|581216009|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
160953601|NCT02349295|581216010|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953602|NCT02349295|581216011|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953603|NCT03240588|581216012|FG000|Overall Study|Death|3|||
160953604|NCT03240588|581216013|FG001|Overall Study|Death|0|||
160953605|NCT03240588|581216014|FG002|Overall Study|Death|0|||
160953606|NCT03240588|581216012|FG000|Overall Study|Adverse Event|5|||
160953607|NCT03240588|581216013|FG001|Overall Study|Adverse Event|4|||
160953608|NCT03240588|581216014|FG002|Overall Study|Adverse Event|0|||
160953609|NCT03240588|581216012|FG000|Overall Study|Lost to Follow-up|9|||
160953610|NCT03240588|581216013|FG001|Overall Study|Lost to Follow-up|4|||
160953611|NCT03240588|581216014|FG002|Overall Study|Lost to Follow-up|0|||
160953612|NCT03240588|581216012|FG000|Overall Study|Physician Decision|3|||
160457514|NCT03334695|579406451|FG000|Overall Study|Protocol Violation|0|||
160457515|NCT03334695|579406452|FG001|Overall Study|Protocol Violation|1|||
160457516|NCT02641730|579406453|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
160457517|NCT02641730|579406454|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
160953613|NCT03240588|581216013|FG001|Overall Study|Physician Decision|2|||
160953614|NCT03240588|581216014|FG002|Overall Study|Physician Decision|0|||
160953615|NCT03240588|581216012|FG000|Overall Study|Did not meet eligibility criteria|0|||
160953616|NCT03240588|581216013|FG001|Overall Study|Did not meet eligibility criteria|6|||
160457518|NCT02641730|579406455|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
160457519|NCT02641730|579406456|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
160457520|NCT02641730|579406457|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
160457521|NCT02641730|579406453|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
160457522|NCT02641730|579406454|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
161000916|NCT01087762|581388934|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
160457523|NCT02641730|579406455|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
160457524|NCT02641730|579406456|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
160457525|NCT02641730|579406457|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
160457526|NCT02641730|579406453|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
160457527|NCT02641730|579406454|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
160457528|NCT02641730|579406455|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
160953617|NCT03240588|581216014|FG002|Overall Study|Did not meet eligibility criteria|0|||
160953618|NCT03240588|581216012|FG000|Overall Study|No longer meets protocol criteria|12|||
160953619|NCT03240588|581216013|FG001|Overall Study|No longer meets protocol criteria|7|||
160953620|NCT03240588|581216014|FG002|Overall Study|No longer meets protocol criteria|0|||
160953621|NCT03240588|581216012|FG000|Overall Study|Withdrawal by Subject|60|||
160953622|NCT03240588|581216013|FG001|Overall Study|Withdrawal by Subject|52|||
160953623|NCT03240588|581216014|FG002|Overall Study|Withdrawal by Subject|7|||
160953624|NCT03240588|581216012|FG000|Overall Study|Other, additional details not available.|0|||
160953625|NCT03240588|581216013|FG001|Overall Study|Other, additional details not available.|12|||
160953626|NCT03240588|581216014|FG002|Overall Study|Other, additional details not available.|1|||
160953627|NCT03240588|581216012|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
160953628|NCT03240588|581216013|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
160953629|NCT03240588|581216014|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
160953630|NCT03240588|581216012|FG000|Overall Study|Closure of study|55|||
160953631|NCT03240588|581216013|FG001|Overall Study|Closure of study|3|||
160953632|NCT03240588|581216014|FG002|Overall Study|Closure of study|0|||
160953633|NCT03240588|581216012|FG000|Overall Study|Subject non-compliance|23|||
160953634|NCT03240588|581216013|FG001|Overall Study|Subject non-compliance|2|||
160953635|NCT03240588|581216014|FG002|Overall Study|Subject non-compliance|1|||
160953636|NCT03240588|581216012|FG000|Overall Study|Device Deficiency|1|||
160457529|NCT02641730|579406456|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
160457530|NCT02641730|579406457|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
160582657|NCT01051986|579853672|FG000|Overall Study|Death|1|||
160582658|NCT01051986|579853673|FG001|Overall Study|Death|0|||
160582659|NCT01051986|579853672|FG000|Overall Study|Withdrawal by Subject|2|||
160582660|NCT01051986|579853673|FG001|Overall Study|Withdrawal by Subject|1|||
160582661|NCT01051986|579853672|FG000|Overall Study|Protocol Violation|2|||
160582662|NCT01051986|579853673|FG001|Overall Study|Protocol Violation|3|||
160582663|NCT00262080|579853674|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
160582664|NCT00262080|579853675|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
160582665|NCT00262080|579853676|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
160582666|NCT00262080|579853674|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
160582667|NCT00262080|579853675|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
160582668|NCT00262080|579853676|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
160582669|NCT00262080|579853674|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
160582670|NCT00262080|579853675|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
160582671|NCT00262080|579853676|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
160582672|NCT00262080|579853674|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
160582673|NCT00262080|579853675|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
160582674|NCT00262080|579853676|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
160582675|NCT00262080|579853674|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
160582676|NCT00262080|579853675|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
160582677|NCT00262080|579853676|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
160582678|NCT00262080|579853674|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
160582679|NCT00262080|579853675|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
160582680|NCT00262080|579853676|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
160582681|NCT04009096|579853681|FG000|Overall Study|Withdrawal by Subject|0|||
160582682|NCT04009096|579853682|FG001|Overall Study|Withdrawal by Subject|7|||
160582683|NCT04009096|579853683|FG002|Overall Study|Withdrawal by Subject|0|||
160582684|NCT04009096|579853681|FG000|Overall Study|Physician Decision|0|||
160582685|NCT04009096|579853682|FG001|Overall Study|Physician Decision|1|||
160582686|NCT04009096|579853683|FG002|Overall Study|Physician Decision|0|||
160582687|NCT00769704|579853684|FG000|Overall Study|Lost to Follow-up|3|||
160582688|NCT00769704|579853685|FG001|Overall Study|Lost to Follow-up|2|||
160582689|NCT00769704|579853684|FG000|Overall Study|Death|95|||
160582690|NCT00769704|579853685|FG001|Overall Study|Death|190|||
160953637|NCT03240588|581216013|FG001|Overall Study|Device Deficiency|0|||
160457531|NCT02641730|579406453|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
160457532|NCT02641730|579406454|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
160582691|NCT00769704|579853684|FG000|Overall Study|Withdrawal by Subject|12|||
160582692|NCT00769704|579853685|FG001|Overall Study|Withdrawal by Subject|5|||
160582693|NCT00769704|579853684|FG000|Overall Study|Other|1|||
160582694|NCT00769704|579853685|FG001|Overall Study|Other|2|||
160953638|NCT03240588|581216014|FG002|Overall Study|Device Deficiency|0|||
160953639|NCT03240588|581216012|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
160953640|NCT03240588|581216013|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
160953641|NCT03240588|581216014|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
160953642|NCT01259713|581216018|FG000|Overall Study|Adverse Event|54|||
160953643|NCT01259713|581216019|FG001|Overall Study|Adverse Event|23|||
160953644|NCT01259713|581216018|FG000|Overall Study|Death Not Related to IFI|8|||
160953645|NCT01259713|581216019|FG001|Overall Study|Death Not Related to IFI|1|||
160953646|NCT01259713|581216018|FG000|Overall Study|Investigators Discretion|14|||
160953647|NCT01259713|581216019|FG001|Overall Study|Investigators Discretion|6|||
160953648|NCT01259713|581216018|FG000|Overall Study|Lack of Efficacy|2|||
160953649|NCT01259713|581216019|FG001|Overall Study|Lack of Efficacy|0|||
160953650|NCT01259713|581216018|FG000|Overall Study|Protocol Violation|5|||
160953651|NCT01259713|581216019|FG001|Overall Study|Protocol Violation|4|||
160953652|NCT01259713|581216018|FG000|Overall Study|Subject Withdrew Consent|12|||
160953653|NCT01259713|581216019|FG001|Overall Study|Subject Withdrew Consent|7|||
160953654|NCT02091726|581216020|FG000|Overall Study|Lost to Follow-up|6|||
160953655|NCT06111742|581216027|FG000|Overall Study|Did not receive intervention|1|||
160953656|NCT06111742|581216028|FG001|Overall Study|Did not receive intervention|0|||
160953657|NCT06111742|581216029|FG002|Overall Study|Did not receive intervention|0|||
160953658|NCT06111742|581216027|FG000|Overall Study|Withdrawal by Subject|2|||
160953659|NCT06111742|581216028|FG001|Overall Study|Withdrawal by Subject|0|||
160953660|NCT06111742|581216029|FG002|Overall Study|Withdrawal by Subject|0|||
160953661|NCT03461003|581216030|FG000|Overall Study|Lost to Follow-up|2|||
160953662|NCT03461003|581216031|FG001|Overall Study|Lost to Follow-up|2|||
160953663|NCT03461003|581216030|FG000|Overall Study|Withdrawal by Subject|3|||
160953664|NCT03461003|581216031|FG001|Overall Study|Withdrawal by Subject|1|||
160953665|NCT00620750|581216037|FG000|Overall Study|Lost to Follow-up|25|||
160953666|NCT04477187|581216038|FG000|Overall Study|Lost to Follow-up|2|||
161000917|NCT01087762|581388935|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
161000918|NCT01087762|581388936|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
161000919|NCT01087762|581388932|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
161000920|NCT01087762|581388933|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
161000921|NCT01087762|581388934|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
161000922|NCT01087762|581388935|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
161000923|NCT01087762|581388936|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
161000924|NCT01087762|581388932|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
161000925|NCT01087762|581388933|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
161000926|NCT01087762|581388934|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
161000927|NCT01087762|581388935|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
161000928|NCT01087762|581388936|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
161000929|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
161000930|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
161000931|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
161000932|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
161000933|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
161000934|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
161000935|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
161000936|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
161000937|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
161000938|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
161000939|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
161000940|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
161000941|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
161000942|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
161000943|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
161000944|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
161000945|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
161000946|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
161000947|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
160457533|NCT02641730|579406455|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
160457534|NCT02641730|579406456|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
160656352|NCT00864097|580122437|FG000|Overall Study|Lost to Follow-up|0|||
160457535|NCT02641730|579406457|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
160953667|NCT02047045|581216039|FG000|Baseline|Withdrawal by Subject|3|||
160953668|NCT02047045|581216040|FG001|Baseline|Withdrawal by Subject|2|||
160953669|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
160953670|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
160953671|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
160953672|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
160953673|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
160953674|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
160953675|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
160953676|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
160953677|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
160953678|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
160953679|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
160953680|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
160953681|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
160953682|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
160953683|NCT02047045|581216039|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
160953684|NCT02047045|581216040|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
160953685|NCT03508843|581216042|FG000|Overall Study|Withdrawal by Subject|1|||
160953686|NCT03508843|581216042|FG000|Overall Study|technical difficulties|2|||
160953687|NCT04717596|581216043|FG000|Overall Study|Withdrawal by Subject|4|||
160953688|NCT00765843|581216044|FG000|Overall Study|Lost to Follow-up|1|||
160953689|NCT00765843|581216045|FG001|Overall Study|Lost to Follow-up|3|||
160953690|NCT00765843|581216046|FG002|Overall Study|Lost to Follow-up|2|||
160953691|NCT00765843|581216044|FG000|Overall Study|did not return to receive intervention|0|||
160953692|NCT00765843|581216045|FG001|Overall Study|did not return to receive intervention|1|||
160953693|NCT00765843|581216046|FG002|Overall Study|did not return to receive intervention|0|||
160953694|NCT00765843|581216044|FG000|Overall Study|Adverse Event|0|||
160953695|NCT00765843|581216045|FG001|Overall Study|Adverse Event|0|||
160953696|NCT00765843|581216046|FG002|Overall Study|Adverse Event|1|||
160953697|NCT03555396|581216047|FG000|Overall Study|Death|3|||
160953698|NCT03555396|581216048|FG001|Overall Study|Death|1|||
160953699|NCT03555396|581216047|FG000|Overall Study|Lost to Follow-up|0|||
160953700|NCT03555396|581216048|FG001|Overall Study|Lost to Follow-up|2|||
160953701|NCT04066114|581216049|FG000|Overall Study|Adverse Event|1|||
160953702|NCT04066114|581216050|FG001|Overall Study|Adverse Event|0|||
160953703|NCT04066114|581216051|FG002|Overall Study|Adverse Event|0|||
160953704|NCT04066114|581216049|FG000|Overall Study|Withdrawal by Subject|1|||
160953705|NCT04066114|581216050|FG001|Overall Study|Withdrawal by Subject|0|||
160953706|NCT04066114|581216051|FG002|Overall Study|Withdrawal by Subject|0|||
160953707|NCT04066114|581216049|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
160953708|NCT04066114|581216050|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
160953709|NCT04066114|581216051|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
160953710|NCT02460991|581216052|FG000|Overall Study|Withdrawal by Subject|0|||
160953711|NCT02460991|581216053|FG001|Overall Study|Withdrawal by Subject|2|||
160953712|NCT02564523|581216054|FG000|Overall Study|Withdrawal by Subject|3|||
160953713|NCT02564523|581216055|FG001|Overall Study|Withdrawal by Subject|0|||
160953714|NCT02564523|581216056|FG002|Overall Study|Withdrawal by Subject|1|||
160953715|NCT02564523|581216057|FG003|Overall Study|Withdrawal by Subject|0|||
160953716|NCT02564523|581216058|FG004|Overall Study|Withdrawal by Subject|1|||
160953717|NCT02564523|581216059|FG005|Overall Study|Withdrawal by Subject|0|||
160953718|NCT02564523|581216060|FG006|Overall Study|Withdrawal by Subject|1|||
160953719|NCT02564523|581216061|FG007|Overall Study|Withdrawal by Subject|0|||
160953720|NCT02564523|581216062|FG008|Overall Study|Withdrawal by Subject|0|||
160953721|NCT02564523|581216063|FG009|Overall Study|Withdrawal by Subject|0|||
160953722|NCT02564523|581216064|FG010|Overall Study|Withdrawal by Subject|1|||
160953723|NCT02564523|581216065|FG011|Overall Study|Withdrawal by Subject|0|||
160953724|NCT02564523|581216066|FG012|Overall Study|Withdrawal by Subject|1|||
160953725|NCT02564523|581216067|FG013|Overall Study|Withdrawal by Subject|0|||
160953726|NCT02564523|581216068|FG014|Overall Study|Withdrawal by Subject|0|||
160953727|NCT02564523|581216069|FG015|Overall Study|Withdrawal by Subject|0|||
160953728|NCT02564523|581216070|FG016|Overall Study|Withdrawal by Subject|0|||
160953729|NCT02564523|581216071|FG017|Overall Study|Withdrawal by Subject|0|||
160953730|NCT02564523|581216054|FG000|Overall Study|Adverse Event|0|||
160953731|NCT02564523|581216055|FG001|Overall Study|Adverse Event|0|||
160953732|NCT02564523|581216056|FG002|Overall Study|Adverse Event|0|||
160953733|NCT02564523|581216057|FG003|Overall Study|Adverse Event|0|||
160953734|NCT02564523|581216058|FG004|Overall Study|Adverse Event|0|||
160953735|NCT02564523|581216059|FG005|Overall Study|Adverse Event|0|||
160953736|NCT02564523|581216060|FG006|Overall Study|Adverse Event|0|||
160953737|NCT02564523|581216061|FG007|Overall Study|Adverse Event|0|||
160953738|NCT02564523|581216062|FG008|Overall Study|Adverse Event|0|||
160457536|NCT02641730|579406453|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
160457537|NCT02641730|579406454|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
160953739|NCT02564523|581216063|FG009|Overall Study|Adverse Event|0|||
160953740|NCT02564523|581216064|FG010|Overall Study|Adverse Event|0|||
160953741|NCT02564523|581216065|FG011|Overall Study|Adverse Event|0|||
160953742|NCT02564523|581216066|FG012|Overall Study|Adverse Event|0|||
160953743|NCT02564523|581216067|FG013|Overall Study|Adverse Event|0|||
160953744|NCT02564523|581216068|FG014|Overall Study|Adverse Event|0|||
160953745|NCT02564523|581216069|FG015|Overall Study|Adverse Event|0|||
160457538|NCT02641730|579406455|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
160953746|NCT02564523|581216070|FG016|Overall Study|Adverse Event|0|||
160953747|NCT02564523|581216071|FG017|Overall Study|Adverse Event|1|||
160953748|NCT02564523|581216054|FG000|Overall Study|Death|0|||
160457539|NCT02641730|579406456|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
160457540|NCT02641730|579406457|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
160457541|NCT02641730|579406453|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
160457542|NCT02641730|579406454|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
160457543|NCT02641730|579406455|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
160457544|NCT02641730|579406456|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
160953749|NCT02564523|581216055|FG001|Overall Study|Death|0|||
160953750|NCT02564523|581216056|FG002|Overall Study|Death|0|||
160953751|NCT02564523|581216057|FG003|Overall Study|Death|0|||
160953752|NCT02564523|581216058|FG004|Overall Study|Death|0|||
160953753|NCT02564523|581216059|FG005|Overall Study|Death|0|||
160953754|NCT02564523|581216060|FG006|Overall Study|Death|1|||
160953755|NCT02564523|581216061|FG007|Overall Study|Death|0|||
160953756|NCT02564523|581216062|FG008|Overall Study|Death|0|||
160953757|NCT02564523|581216063|FG009|Overall Study|Death|0|||
160953758|NCT02564523|581216064|FG010|Overall Study|Death|1|||
160953759|NCT02564523|581216065|FG011|Overall Study|Death|0|||
160953760|NCT02564523|581216066|FG012|Overall Study|Death|0|||
160953761|NCT02564523|581216067|FG013|Overall Study|Death|0|||
160953762|NCT02564523|581216068|FG014|Overall Study|Death|0|||
160953763|NCT02564523|581216069|FG015|Overall Study|Death|0|||
160953764|NCT02564523|581216070|FG016|Overall Study|Death|0|||
160953765|NCT02564523|581216071|FG017|Overall Study|Death|0|||
160953766|NCT02564523|581216054|FG000|Overall Study|Lost to Follow-up|2|||
160953767|NCT02564523|581216055|FG001|Overall Study|Lost to Follow-up|1|||
160953768|NCT02564523|581216056|FG002|Overall Study|Lost to Follow-up|4|||
160953769|NCT02564523|581216057|FG003|Overall Study|Lost to Follow-up|0|||
160953770|NCT02564523|581216058|FG004|Overall Study|Lost to Follow-up|1|||
160953771|NCT02564523|581216059|FG005|Overall Study|Lost to Follow-up|0|||
160953772|NCT02564523|581216060|FG006|Overall Study|Lost to Follow-up|1|||
160953773|NCT02564523|581216061|FG007|Overall Study|Lost to Follow-up|0|||
160953774|NCT02564523|581216062|FG008|Overall Study|Lost to Follow-up|0|||
160953775|NCT02564523|581216063|FG009|Overall Study|Lost to Follow-up|0|||
160953776|NCT02564523|581216064|FG010|Overall Study|Lost to Follow-up|0|||
160953777|NCT02564523|581216065|FG011|Overall Study|Lost to Follow-up|1|||
160953778|NCT02564523|581216066|FG012|Overall Study|Lost to Follow-up|1|||
160953779|NCT02564523|581216067|FG013|Overall Study|Lost to Follow-up|0|||
160953780|NCT02564523|581216068|FG014|Overall Study|Lost to Follow-up|0|||
160953781|NCT02564523|581216069|FG015|Overall Study|Lost to Follow-up|0|||
160953782|NCT02564523|581216070|FG016|Overall Study|Lost to Follow-up|0|||
160953783|NCT02564523|581216071|FG017|Overall Study|Lost to Follow-up|0|||
160953784|NCT02564523|581216054|FG000|Overall Study|Physician Decision|0|||
160953785|NCT02564523|581216055|FG001|Overall Study|Physician Decision|0|||
160953786|NCT02564523|581216056|FG002|Overall Study|Physician Decision|0|||
160953787|NCT02564523|581216057|FG003|Overall Study|Physician Decision|0|||
160953788|NCT02564523|581216058|FG004|Overall Study|Physician Decision|1|||
160953789|NCT02564523|581216059|FG005|Overall Study|Physician Decision|0|||
160953790|NCT02564523|581216060|FG006|Overall Study|Physician Decision|0|||
160953791|NCT02564523|581216061|FG007|Overall Study|Physician Decision|0|||
160953792|NCT02564523|581216062|FG008|Overall Study|Physician Decision|0|||
160953793|NCT02564523|581216063|FG009|Overall Study|Physician Decision|0|||
160953794|NCT02564523|581216064|FG010|Overall Study|Physician Decision|1|||
160953795|NCT02564523|581216065|FG011|Overall Study|Physician Decision|0|||
160953796|NCT02564523|581216066|FG012|Overall Study|Physician Decision|0|||
160953797|NCT02564523|581216067|FG013|Overall Study|Physician Decision|0|||
160953798|NCT02564523|581216068|FG014|Overall Study|Physician Decision|0|||
160953799|NCT02564523|581216069|FG015|Overall Study|Physician Decision|0|||
160953800|NCT02564523|581216070|FG016|Overall Study|Physician Decision|0|||
160953801|NCT02564523|581216071|FG017|Overall Study|Physician Decision|0|||
160953802|NCT02564523|581216054|FG000|Overall Study|Protocol Violation|2|||
160953803|NCT02564523|581216055|FG001|Overall Study|Protocol Violation|2|||
160953804|NCT02564523|581216056|FG002|Overall Study|Protocol Violation|5|||
160953805|NCT02564523|581216057|FG003|Overall Study|Protocol Violation|0|||
160953806|NCT02564523|581216058|FG004|Overall Study|Protocol Violation|1|||
160656353|NCT00864097|580122438|FG001|Overall Study|Lost to Follow-up|1|||
160953807|NCT02564523|581216059|FG005|Overall Study|Protocol Violation|0|||
160953808|NCT02564523|581216060|FG006|Overall Study|Protocol Violation|0|||
160953809|NCT02564523|581216061|FG007|Overall Study|Protocol Violation|0|||
160953810|NCT02564523|581216062|FG008|Overall Study|Protocol Violation|0|||
160953811|NCT02564523|581216063|FG009|Overall Study|Protocol Violation|0|||
160953812|NCT02564523|581216064|FG010|Overall Study|Protocol Violation|0|||
160953813|NCT02564523|581216065|FG011|Overall Study|Protocol Violation|0|||
160953814|NCT02564523|581216066|FG012|Overall Study|Protocol Violation|0|||
160953815|NCT02564523|581216067|FG013|Overall Study|Protocol Violation|0|||
160953816|NCT02564523|581216068|FG014|Overall Study|Protocol Violation|0|||
160953817|NCT02564523|581216069|FG015|Overall Study|Protocol Violation|0|||
160953818|NCT02564523|581216070|FG016|Overall Study|Protocol Violation|0|||
160953819|NCT02564523|581216071|FG017|Overall Study|Protocol Violation|0|||
160953820|NCT02564523|581216054|FG000|Overall Study|Other|3|||
160953821|NCT02564523|581216055|FG001|Overall Study|Other|0|||
160953822|NCT02564523|581216056|FG002|Overall Study|Other|0|||
160953823|NCT02564523|581216057|FG003|Overall Study|Other|1|||
160953824|NCT02564523|581216058|FG004|Overall Study|Other|0|||
160953825|NCT02564523|581216059|FG005|Overall Study|Other|0|||
160953826|NCT02564523|581216060|FG006|Overall Study|Other|0|||
160953827|NCT02564523|581216061|FG007|Overall Study|Other|0|||
160953828|NCT02564523|581216062|FG008|Overall Study|Other|0|||
160953829|NCT02564523|581216063|FG009|Overall Study|Other|0|||
160953830|NCT02564523|581216064|FG010|Overall Study|Other|0|||
160953831|NCT02564523|581216065|FG011|Overall Study|Other|0|||
160953832|NCT02564523|581216066|FG012|Overall Study|Other|0|||
160953833|NCT02564523|581216067|FG013|Overall Study|Other|0|||
160953834|NCT02564523|581216068|FG014|Overall Study|Other|0|||
160953835|NCT02564523|581216069|FG015|Overall Study|Other|0|||
160953836|NCT02564523|581216070|FG016|Overall Study|Other|0|||
160953837|NCT02564523|581216071|FG017|Overall Study|Other|0|||
160953838|NCT00448539|581216074|FG000|Overall Study|Medication non-compliance|4|||
160953839|NCT00448539|581216075|FG001|Overall Study|Medication non-compliance|1|||
160953840|NCT00448539|581216074|FG000|Overall Study|Protocol Violation|1|||
160953841|NCT00448539|581216075|FG001|Overall Study|Protocol Violation|0|||
160953842|NCT00448539|581216074|FG000|Overall Study|Request of the investigator or sponsor|67|||
160953843|NCT00448539|581216075|FG001|Overall Study|Request of the investigator or sponsor|54|||
160953844|NCT00448539|581216074|FG000|Overall Study|Withdrawal by Subject|20|||
160953845|NCT00448539|581216075|FG001|Overall Study|Withdrawal by Subject|24|||
160953846|NCT00448539|581216074|FG000|Overall Study|Diary non-compliance|1|||
160953847|NCT00448539|581216075|FG001|Overall Study|Diary non-compliance|0|||
160953848|NCT00448539|581216074|FG000|Overall Study|Adverse Event|9|||
160953849|NCT00448539|581216075|FG001|Overall Study|Adverse Event|26|||
160953850|NCT00448539|581216074|FG000|Overall Study|Lack of Efficacy|27|||
160953851|NCT00448539|581216075|FG001|Overall Study|Lack of Efficacy|40|||
160953852|NCT00448539|581216074|FG000|Overall Study|Miscellaneous|2|||
160953853|NCT00448539|581216075|FG001|Overall Study|Miscellaneous|1|||
160953854|NCT00448539|581216074|FG000|Overall Study|Change of meds|2|||
160953855|NCT00448539|581216075|FG001|Overall Study|Change of meds|3|||
160953856|NCT00448539|581216074|FG000|Overall Study|Lost to Follow-up|1|||
160953857|NCT00448539|581216075|FG001|Overall Study|Lost to Follow-up|3|||
160953858|NCT03349710|581216076|FG000|Treatment Period|Death|0|||
160953859|NCT03349710|581216077|FG001|Treatment Period|Death|0|||
160953860|NCT03349710|581216078|FG002|Treatment Period|Death|1|||
160953861|NCT03349710|581216079|FG003|Treatment Period|Death|0|||
160953862|NCT03349710|581216076|FG000|Treatment Period|Disease Progression|0|||
160953863|NCT03349710|581216077|FG001|Treatment Period|Disease Progression|2|||
160953864|NCT03349710|581216078|FG002|Treatment Period|Disease Progression|0|||
160953865|NCT03349710|581216079|FG003|Treatment Period|Disease Progression|1|||
160953866|NCT03349710|581216076|FG000|Treatment Period|Study Drug Toxicity|1|||
160953867|NCT03349710|581216077|FG001|Treatment Period|Study Drug Toxicity|0|||
160953868|NCT03349710|581216078|FG002|Treatment Period|Study Drug Toxicity|1|||
160953869|NCT03349710|581216079|FG003|Treatment Period|Study Drug Toxicity|1|||
160953870|NCT03349710|581216076|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
160953871|NCT03349710|581216077|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
160953872|NCT03349710|581216078|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
160953873|NCT03349710|581216079|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
160953874|NCT03349710|581216076|FG000|Treatment Period|admin reason by sponsor|0|||
160953875|NCT03349710|581216077|FG001|Treatment Period|admin reason by sponsor|7|||
160953876|NCT03349710|581216078|FG002|Treatment Period|admin reason by sponsor|0|||
160953877|NCT03349710|581216079|FG003|Treatment Period|admin reason by sponsor|19|||
160953878|NCT03349710|581216076|FG000|Treatment Period|Other Reason|2|||
160953879|NCT03349710|581216077|FG001|Treatment Period|Other Reason|0|||
160953880|NCT03349710|581216078|FG002|Treatment Period|Other Reason|2|||
160953881|NCT03349710|581216079|FG003|Treatment Period|Other Reason|1|||
160953882|NCT03349710|581216076|FG000|Treatment Period|completed|6|||
160953883|NCT03349710|581216077|FG001|Treatment Period|completed|0|||
160953884|NCT03349710|581216078|FG002|Treatment Period|completed|18|||
160953885|NCT03349710|581216079|FG003|Treatment Period|completed|1|||
160953886|NCT03349710|581216076|FG000|Treatment Period|participant request to discontinue|0|||
160953887|NCT03349710|581216077|FG001|Treatment Period|participant request to discontinue|0|||
160953888|NCT03349710|581216078|FG002|Treatment Period|participant request to discontinue|4|||
160457545|NCT02641730|579406457|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
160953889|NCT03349710|581216079|FG003|Treatment Period|participant request to discontinue|0|||
160953890|NCT03349710|581216076|FG000|Treatment Period|participant withdrew consent|1|||
160953891|NCT03349710|581216077|FG001|Treatment Period|participant withdrew consent|0|||
160953892|NCT03349710|581216078|FG002|Treatment Period|participant withdrew consent|0|||
160953893|NCT03349710|581216079|FG003|Treatment Period|participant withdrew consent|0|||
160953894|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
160953895|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
160953896|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
160953897|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
160953898|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
160953899|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
160953900|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
160953901|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
160953902|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
160953903|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
160953904|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
160953905|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
160953906|NCT00695903|581216080|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
160953907|NCT00695903|581216081|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
160953908|NCT00695903|581216080|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
160953909|NCT00695903|581216081|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
160953910|NCT00695903|581216080|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
160953911|NCT00695903|581216081|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
160953912|NCT03621696|581216084|FG000|Overall Study|Not eligible|0|||
160953913|NCT03621696|581216085|FG001|Overall Study|Not eligible|0|||
160953914|NCT03621696|581216086|FG002|Overall Study|Not eligible|0|||
160953915|NCT03621696|581216087|FG003|Overall Study|Not eligible|5|||
160953916|NCT03621696|581216084|FG000|Overall Study|Withdrawal by Subject|1|||
160953917|NCT03621696|581216085|FG001|Overall Study|Withdrawal by Subject|1|||
160953918|NCT03621696|581216086|FG002|Overall Study|Withdrawal by Subject|1|||
160953919|NCT03621696|581216087|FG003|Overall Study|Withdrawal by Subject|0|||
160953920|NCT03621696|581216084|FG000|Overall Study|Physician Decision|0|||
160953921|NCT03621696|581216085|FG001|Overall Study|Physician Decision|0|||
160953922|NCT03621696|581216086|FG002|Overall Study|Physician Decision|1|||
160953923|NCT03621696|581216087|FG003|Overall Study|Physician Decision|0|||
160953924|NCT03526250|581216088|FG000|Overall Study|Adverse Event|4|||
160953925|NCT03526250|581216088|FG000|Overall Study|Progressive Disease|16|||
160953926|NCT03526250|581216088|FG000|Overall Study|No Treatment|3|||
160953927|NCT04420221|581216089|FG000|Overall Study|Withdrawal by Subject|0|||
160953928|NCT04420221|581216090|FG001|Overall Study|Withdrawal by Subject|0|||
160953929|NCT04420221|581216091|FG002|Overall Study|Withdrawal by Subject|0|||
160953930|NCT04420221|581216092|FG003|Overall Study|Withdrawal by Subject|0|||
160953931|NCT04420221|581216093|FG004|Overall Study|Withdrawal by Subject|0|||
160953932|NCT04420221|581216094|FG005|Overall Study|Withdrawal by Subject|20|||
160953933|NCT04420221|581216095|FG006|Overall Study|Withdrawal by Subject|5|||
160953934|NCT04420221|581216089|FG000|Overall Study|Other|0|||
160953935|NCT04420221|581216090|FG001|Overall Study|Other|0|||
160953936|NCT04420221|581216091|FG002|Overall Study|Other|0|||
160953937|NCT04420221|581216092|FG003|Overall Study|Other|0|||
160953938|NCT04420221|581216093|FG004|Overall Study|Other|0|||
160953939|NCT04420221|581216094|FG005|Overall Study|Other|1|||
160953940|NCT04420221|581216095|FG006|Overall Study|Other|1|||
160953941|NCT04420221|581216089|FG000|Overall Study|Lost to Follow-up|0|||
160953942|NCT04420221|581216090|FG001|Overall Study|Lost to Follow-up|0|||
160953943|NCT04420221|581216091|FG002|Overall Study|Lost to Follow-up|0|||
160953944|NCT04420221|581216092|FG003|Overall Study|Lost to Follow-up|0|||
160953945|NCT04420221|581216093|FG004|Overall Study|Lost to Follow-up|0|||
160953946|NCT04420221|581216094|FG005|Overall Study|Lost to Follow-up|3|||
160953947|NCT04420221|581216095|FG006|Overall Study|Lost to Follow-up|2|||
160953948|NCT04420221|581216089|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
160953949|NCT04420221|581216090|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
160953950|NCT04420221|581216091|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
160953951|NCT04420221|581216092|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
160953952|NCT04420221|581216093|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
160953953|NCT04420221|581216094|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
160953954|NCT04420221|581216095|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
160953955|NCT05348681|581216096|FG000|Overall Study|Study terminated by Sponsor|8|||
160953956|NCT05348681|581216097|FG001|Overall Study|Study terminated by Sponsor|3|||
160953957|NCT05348681|581216096|FG000|Overall Study|Withdrawal by Subject|1|||
160953958|NCT05348681|581216097|FG001|Overall Study|Withdrawal by Subject|1|||
160953959|NCT05348681|581216096|FG000|Overall Study|Lost to Follow-up|1|||
160953960|NCT05348681|581216097|FG001|Overall Study|Lost to Follow-up|1|||
160953961|NCT05348681|581216096|FG000|Overall Study|Adverse Event|1|||
160953962|NCT05348681|581216097|FG001|Overall Study|Adverse Event|0|||
161000948|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
161000949|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
160953963|NCT05348681|581216096|FG000|Overall Study|Other|2|||
160953964|NCT05348681|581216097|FG001|Overall Study|Other|1|||
160953965|NCT00553267|581216100|FG000|Overall Study|Adverse Event|8|||
160953966|NCT00553267|581216101|FG001|Overall Study|Adverse Event|10|||
160953967|NCT00553267|581216102|FG002|Overall Study|Adverse Event|5|||
160953968|NCT00553267|581216100|FG000|Overall Study|Non compliant with protocol|3|||
160953969|NCT00553267|581216101|FG001|Overall Study|Non compliant with protocol|3|||
160953970|NCT00553267|581216102|FG002|Overall Study|Non compliant with protocol|2|||
160953971|NCT00553267|581216100|FG000|Overall Study|Lost to Follow-up|0|||
160953972|NCT00553267|581216101|FG001|Overall Study|Lost to Follow-up|0|||
161000950|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
160953973|NCT00553267|581216102|FG002|Overall Study|Lost to Follow-up|1|||
160953974|NCT00553267|581216100|FG000|Overall Study|Consent withdrawn|2|||
160953975|NCT00553267|581216101|FG001|Overall Study|Consent withdrawn|3|||
160953976|NCT00553267|581216102|FG002|Overall Study|Consent withdrawn|1|||
160953977|NCT00553267|581216100|FG000|Overall Study|Specified category|1|||
160953978|NCT00553267|581216101|FG001|Overall Study|Specified category|2|||
160953979|NCT00553267|581216102|FG002|Overall Study|Specified category|1|||
160953980|NCT04389840|581216103|FG000|Overall Study|Adverse Event|0|||
160953981|NCT04389840|581216104|FG001|Overall Study|Adverse Event|0|||
160953982|NCT04389840|581216105|FG002|Overall Study|Adverse Event|0|||
160953983|NCT04389840|581216106|FG003|Overall Study|Adverse Event|1|||
160953984|NCT04389840|581216107|FG004|Overall Study|Adverse Event|0|||
160953985|NCT04389840|581216108|FG005|Overall Study|Adverse Event|0|||
160953986|NCT04389840|581216103|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
160953987|NCT04389840|581216104|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
160953988|NCT04389840|581216105|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
160953989|NCT04389840|581216106|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
160953990|NCT04389840|581216107|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
160953991|NCT04389840|581216108|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
160953992|NCT04389840|581216103|FG000|Overall Study|Death|0|||
160953993|NCT04389840|581216104|FG001|Overall Study|Death|1|||
160953994|NCT04389840|581216105|FG002|Overall Study|Death|0|||
160953995|NCT04389840|581216106|FG003|Overall Study|Death|0|||
160953996|NCT04389840|581216107|FG004|Overall Study|Death|0|||
160953997|NCT04389840|581216108|FG005|Overall Study|Death|0|||
160953998|NCT01618864|581216109|FG000|Overall Study|Withdrawal by Subject|2|||
160953999|NCT01618864|581216109|FG000|Overall Study|Lost to Follow-up|2|||
160954000|NCT00096135|581216115|FG000|Overall Study|Physician Decision|20|||
160954001|NCT00096135|581216116|FG001|Overall Study|Physician Decision|4|||
160954002|NCT00096135|581216115|FG000|Overall Study|Refusal of further protocol therapy|4|||
160954003|NCT00096135|581216116|FG001|Overall Study|Refusal of further protocol therapy|1|||
160954004|NCT00096135|581216115|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
160954005|NCT00096135|581216116|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
160954006|NCT00096135|581216115|FG000|Overall Study|Other, specify|15|||
160954007|NCT00096135|581216116|FG001|Overall Study|Other, specify|3|||
160954008|NCT00096135|581216115|FG000|Overall Study|Ineligible|2|||
160954009|NCT00096135|581216116|FG001|Overall Study|Ineligible|0|||
160954010|NCT01003249|581216127|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160954011|NCT01003249|581216128|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160954012|NCT01003249|581216127|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
160954013|NCT01003249|581216128|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
160954014|NCT01003249|581216127|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
160954015|NCT01003249|581216128|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160954016|NCT01003249|581216127|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
160954017|NCT01003249|581216128|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
160954018|NCT00627705|581216130|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
160954019|NCT00627705|581216131|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
160954020|NCT00627705|581216130|FG000|Overall Study|Adverse Event|1|||
160954021|NCT00627705|581216131|FG001|Overall Study|Adverse Event|0|||
160954022|NCT00627705|581216130|FG000|Overall Study|Withdrawal by Subject|0|||
160954023|NCT00627705|581216131|FG001|Overall Study|Withdrawal by Subject|2|||
160954024|NCT00627705|581216130|FG000|Overall Study|Lost to Follow-up|0|||
160954025|NCT00627705|581216131|FG001|Overall Study|Lost to Follow-up|1|||
160954026|NCT02535065|581216134|FG000|Overall Study|Death|13|||
160954027|NCT02535065|581216134|FG000|Overall Study|Lost to Follow-up|1|||
160954028|NCT02535065|581216134|FG000|Overall Study|Withdrawal by Subject|6|||
160954029|NCT03712917|581216135|FG000|Overall Study|Pregnancy|0|||
160954030|NCT03712917|581216136|FG001|Overall Study|Pregnancy|0|||
160954031|NCT03712917|581216137|FG002|Overall Study|Pregnancy|1|||
160954032|NCT03712917|581216135|FG000|Overall Study|Adverse Event|0|||
160954033|NCT03712917|581216136|FG001|Overall Study|Adverse Event|4|||
160954034|NCT03712917|581216137|FG002|Overall Study|Adverse Event|3|||
160954035|NCT03712917|581216135|FG000|Overall Study|Lost to Follow-up|9|||
160954036|NCT03712917|581216136|FG001|Overall Study|Lost to Follow-up|4|||
160954037|NCT03712917|581216137|FG002|Overall Study|Lost to Follow-up|5|||
160954038|NCT00110617|581216138|FG000|Overall Study|Adverse Event|2|||
160954039|NCT00110617|581216139|FG001|Overall Study|Adverse Event|4|||
160954040|NCT00110617|581216138|FG000|Overall Study|Abnormal Laboratory Value|4|||
160954041|NCT00110617|581216139|FG001|Overall Study|Abnormal Laboratory Value|2|||
160954042|NCT00110617|581216138|FG000|Overall Study|Lack of Efficacy|1|||
160954043|NCT00110617|581216139|FG001|Overall Study|Lack of Efficacy|0|||
160954044|NCT00110617|581216138|FG000|Overall Study|Patient no longer requires study drug|1|||
160954045|NCT00110617|581216139|FG001|Overall Study|Patient no longer requires study drug|0|||
160954046|NCT00110617|581216138|FG000|Overall Study|Protocol Violation|5|||
160954047|NCT00110617|581216139|FG001|Overall Study|Protocol Violation|0|||
160954048|NCT00110617|581216138|FG000|Overall Study|Withdrawal by Subject|10|||
160954049|NCT00110617|581216139|FG001|Overall Study|Withdrawal by Subject|4|||
160954050|NCT00110617|581216138|FG000|Overall Study|Lost to Follow-up|9|||
160954051|NCT00110617|581216139|FG001|Overall Study|Lost to Follow-up|1|||
160954052|NCT00110617|581216138|FG000|Overall Study|Administrative problems|6|||
160954053|NCT00110617|581216139|FG001|Overall Study|Administrative problems|5|||
160954054|NCT00110617|581216138|FG000|Overall Study|Death|1|||
160954055|NCT00110617|581216139|FG001|Overall Study|Death|1|||
160954056|NCT00110617|581216138|FG000|Overall Study|Did not receive study drug|0|||
160954057|NCT00110617|581216139|FG001|Overall Study|Did not receive study drug|12|||
160954058|NCT04764396|581216140|FG000|Overall Study|Physician Decision|1|||
160954059|NCT04764396|581216141|FG001|Overall Study|Physician Decision|0|||
160954060|NCT03230916|581216142|FG000|Overall Study|Withdrawal by Subject|0|||
160954061|NCT03230916|581216143|FG001|Overall Study|Withdrawal by Subject|0|||
160954062|NCT03230916|581216144|FG002|Overall Study|Withdrawal by Subject|0|||
160954063|NCT03230916|581216145|FG003|Overall Study|Withdrawal by Subject|0|||
160954064|NCT03230916|581216146|FG004|Overall Study|Withdrawal by Subject|0|||
160954065|NCT03230916|581216147|FG005|Overall Study|Withdrawal by Subject|1|||
160954066|NCT03230916|581216148|FG006|Overall Study|Withdrawal by Subject|0|||
160954067|NCT03230916|581216149|FG007|Overall Study|Withdrawal by Subject|0|||
160954068|NCT03230916|581216150|FG008|Overall Study|Withdrawal by Subject|0|||
160954069|NCT03230916|581216151|FG009|Overall Study|Withdrawal by Subject|0|||
160954070|NCT03230916|581216152|FG010|Overall Study|Withdrawal by Subject|0|||
160954071|NCT03156023|581216155|FG000|Overall Study|Withdrawal by Subject|1|||
160954072|NCT03156023|581216156|FG001|Overall Study|Withdrawal by Subject|0|||
160954073|NCT03156023|581216157|FG002|Overall Study|Withdrawal by Subject|2|||
160954074|NCT03156023|581216158|FG003|Overall Study|Withdrawal by Subject|1|||
160954075|NCT03156023|581216159|FG004|Overall Study|Withdrawal by Subject|1|||
160954076|NCT03156023|581216155|FG000|Overall Study|Lost to Follow-up|0|||
160954077|NCT03156023|581216156|FG001|Overall Study|Lost to Follow-up|0|||
160954078|NCT03156023|581216157|FG002|Overall Study|Lost to Follow-up|0|||
160954079|NCT03156023|581216158|FG003|Overall Study|Lost to Follow-up|0|||
160954080|NCT03156023|581216159|FG004|Overall Study|Lost to Follow-up|1|||
160954081|NCT01296568|581219154|FG000|Continued Access Phase|Lost to Follow-up|1|||
160954082|NCT01296568|581219154|FG000|Continued Access Phase|Withdrawal by Subject|1|||
160954083|NCT01296568|581219154|FG000|Continued Access Phase|Disease Progression|1|||
160954084|NCT00321854|581219157|FG000|Overall Study|Adverse Event|41|||
160954085|NCT00321854|581219158|FG001|Overall Study|Adverse Event|43|||
160954086|NCT00321854|581219157|FG000|Overall Study|Lack of Efficacy|9|||
160954087|NCT00321854|581219158|FG001|Overall Study|Lack of Efficacy|14|||
160954088|NCT00321854|581219157|FG000|Overall Study|Protocol Violation|6|||
160954089|NCT00321854|581219158|FG001|Overall Study|Protocol Violation|5|||
160954090|NCT00321854|581219157|FG000|Overall Study|Lost to Follow-up|0|||
160954091|NCT00321854|581219158|FG001|Overall Study|Lost to Follow-up|2|||
160954092|NCT00321854|581219157|FG000|Overall Study|Withdrawal by Subject|6|||
160954093|NCT00321854|581219158|FG001|Overall Study|Withdrawal by Subject|17|||
160954094|NCT00321854|581219157|FG000|Overall Study|Other|1|||
160954095|NCT00321854|581219158|FG001|Overall Study|Other|1|||
160954096|NCT01369342|581219159|FG000|Overall Study|Withdrawal by Subject|7|||
160954097|NCT01369342|581219160|FG001|Overall Study|Withdrawal by Subject|7|||
160954098|NCT01369342|581219161|FG002|Overall Study|Withdrawal by Subject|2|||
160954099|NCT01369342|581219159|FG000|Overall Study|Lost to Follow-up|5|||
160954100|NCT01369342|581219160|FG001|Overall Study|Lost to Follow-up|2|||
160954101|NCT01369342|581219161|FG002|Overall Study|Lost to Follow-up|1|||
160954102|NCT01369342|581219159|FG000|Overall Study|Not Treated|1|||
160954103|NCT01369342|581219160|FG001|Overall Study|Not Treated|0|||
160954104|NCT01369342|581219161|FG002|Overall Study|Not Treated|0|||
160954105|NCT01816594|581219162|FG000|Overall Study|Local Progress|0|||
160954106|NCT01816594|581219163|FG001|Overall Study|Local Progress|2|||
160954107|NCT01816594|581219162|FG000|Overall Study|Adverse Event|9|||
160954108|NCT01816594|581219163|FG001|Overall Study|Adverse Event|0|||
160954109|NCT01816594|581219162|FG000|Overall Study|Withdrawal by Subject|1|||
160954110|NCT01816594|581219163|FG001|Overall Study|Withdrawal by Subject|0|||
160954111|NCT01816594|581219162|FG000|Overall Study|Physician Decision|1|||
160954112|NCT01816594|581219163|FG001|Overall Study|Physician Decision|0|||
160954113|NCT03905655|581219164|FG000|Overall Study|Adverse Event|1|||
160954114|NCT03905655|581219165|FG001|Overall Study|Adverse Event|0|||
160954115|NCT03905655|581219166|FG002|Overall Study|Adverse Event|1|||
160954116|NCT03905655|581219167|FG003|Overall Study|Adverse Event|1|||
160954117|NCT04723576|581219168|FG000|Overall Study|Withdrawal by Subject|2133|||
160954118|NCT04723576|581219169|FG001|Overall Study|Withdrawal by Subject|3234|||
160954119|NCT02277106|581219173|FG000|Stage 2|Adverse Event|0|||
160954120|NCT02277106|581219174|FG001|Stage 2|Adverse Event|0|||
160954121|NCT02277106|581219175|FG002|Stage 2|Adverse Event|1|||
160954122|NCT01064739|581219176|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
160954123|NCT02479412|581219177|FG000|Overall Study|Adverse Event|0|||
160954124|NCT02479412|581219178|FG001|Overall Study|Adverse Event|0|||
160954125|NCT02479412|581219179|FG002|Overall Study|Adverse Event|1|||
160954126|NCT02479412|581219180|FG003|Overall Study|Adverse Event|0|||
160954127|NCT02479412|581219181|FG004|Overall Study|Adverse Event|0|||
160954128|NCT02479412|581219182|FG005|Overall Study|Adverse Event|0|||
160954129|NCT02479412|581219183|FG006|Overall Study|Adverse Event|0|||
160954130|NCT02479412|581219184|FG007|Overall Study|Adverse Event|0|||
160954131|NCT02479412|581219185|FG008|Overall Study|Adverse Event|0|||
160954132|NCT02479412|581219177|FG000|Overall Study|Study-specific withdrawal criteria|0|||
160954133|NCT02479412|581219178|FG001|Overall Study|Study-specific withdrawal criteria|0|||
160954134|NCT02479412|581219179|FG002|Overall Study|Study-specific withdrawal criteria|1|||
160954135|NCT02479412|581219180|FG003|Overall Study|Study-specific withdrawal criteria|1|||
160954136|NCT02479412|581219181|FG004|Overall Study|Study-specific withdrawal criteria|0|||
160954137|NCT02479412|581219182|FG005|Overall Study|Study-specific withdrawal criteria|0|||
160954138|NCT02479412|581219183|FG006|Overall Study|Study-specific withdrawal criteria|0|||
160954139|NCT02479412|581219184|FG007|Overall Study|Study-specific withdrawal criteria|1|||
160954140|NCT02479412|581219185|FG008|Overall Study|Study-specific withdrawal criteria|1|||
160954141|NCT02479412|581219177|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
160954142|NCT02479412|581219178|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
160954143|NCT02479412|581219179|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
160954144|NCT02479412|581219180|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
160954145|NCT02479412|581219181|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
160954146|NCT02479412|581219182|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
160954147|NCT02479412|581219183|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
160954148|NCT02479412|581219184|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
160954149|NCT02479412|581219185|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
160954150|NCT00454051|581219186|FG000|Overall Study|Adverse Event|1|||
160954151|NCT00454051|581219187|FG001|Overall Study|Adverse Event|2|||
160954152|NCT00454051|581219186|FG000|Overall Study|Withdrawal by Subject|1|||
160954153|NCT00454051|581219187|FG001|Overall Study|Withdrawal by Subject|0|||
160954154|NCT00454051|581219186|FG000|Overall Study|Protocol Violation|1|||
160954155|NCT00454051|581219187|FG001|Overall Study|Protocol Violation|1|||
160954156|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
160954157|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
160954158|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
160954159|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
160954160|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
160954161|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
160954162|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
160954163|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
160954164|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
160954165|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
160954166|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
160954167|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
160954168|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
160954169|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
160954170|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
160954171|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
160954172|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
160954173|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
160954174|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160954175|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
160954176|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
160954177|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
160954178|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
160954179|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
160954180|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160954181|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Adverse Event|9|||
160954182|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Adverse Event|14|||
160954183|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160954184|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
160954185|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
160954186|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
160954187|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
160954188|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
160954189|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
160954190|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
160954191|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
160954192|NCT04258020|581219191|FG000|Overall Study|Withdrawal by Subject|1|||
160954193|NCT04258020|581219192|FG001|Overall Study|Withdrawal by Subject|0|||
160954194|NCT02097472|581219193|FG000|Received Vaccination 2|Adverse Event|0|||
160954195|NCT02097472|581219194|FG001|Received Vaccination 2|Adverse Event|0|||
161000951|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
161000952|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
161000953|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
161000954|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
160954196|NCT02097472|581219195|FG002|Received Vaccination 2|Adverse Event|0|||
160954197|NCT02097472|581219196|FG003|Received Vaccination 2|Adverse Event|0|||
160954198|NCT02097472|581219197|FG004|Received Vaccination 2|Adverse Event|0|||
160954199|NCT02097472|581219198|FG005|Received Vaccination 2|Adverse Event|0|||
160954200|NCT02097472|581219199|FG006|Received Vaccination 2|Adverse Event|1|||
160954201|NCT02097472|581219200|FG007|Received Vaccination 2|Adverse Event|0|||
160954202|NCT03117738|581219203|FG000|Overall Study|Withdrawal by Subject|3|||
160954203|NCT03117738|581219204|FG001|Overall Study|Withdrawal by Subject|1|||
160954204|NCT03117738|581219203|FG000|Overall Study|Lost to Follow-up|1|||
160954205|NCT03117738|581219204|FG001|Overall Study|Lost to Follow-up|4|||
160954206|NCT01669629|581219205|FG000|Period 1|protocol deviation|1|||
160954207|NCT01669629|581219206|FG001|Period 1|protocol deviation|2|||
160954208|NCT01292928|581219207|FG000|Overall Study|Death|8|||
160954209|NCT01292928|581219207|FG000|Overall Study|Withdrawal by Subject|8|||
160954210|NCT01292928|581219207|FG000|Overall Study|Lost to Follow-up|6|||
160954211|NCT01292928|581219207|FG000|Overall Study|Physician Decision|2|||
160954212|NCT00130533|581219208|FG000|Overall Study|Withdrawal by Subject|33|||
160954213|NCT00130533|581219209|FG001|Overall Study|Withdrawal by Subject|6|||
160954214|NCT00130533|581219208|FG000|Overall Study|Adverse Event|34|||
160954215|NCT00130533|581219209|FG001|Overall Study|Adverse Event|1|||
160954216|NCT00130533|581219208|FG000|Overall Study|Disease relapse|9|||
160954217|NCT00130533|581219209|FG001|Overall Study|Disease relapse|13|||
160954218|NCT00130533|581219208|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
160954219|NCT00130533|581219209|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
160954220|NCT00130533|581219208|FG000|Overall Study|Death|4|||
160954221|NCT00130533|581219209|FG001|Overall Study|Death|2|||
160954222|NCT00130533|581219208|FG000|Overall Study|Protocol Violation|5|||
160954223|NCT00130533|581219209|FG001|Overall Study|Protocol Violation|1|||
160954224|NCT00130533|581219208|FG000|Overall Study|Lost to Follow-up|1|||
160954225|NCT00130533|581219209|FG001|Overall Study|Lost to Follow-up|1|||
160954226|NCT00130533|581219208|FG000|Overall Study|Sponsor´s decision|2|||
160954227|NCT00130533|581219209|FG001|Overall Study|Sponsor´s decision|0|||
160954228|NCT00130533|581219208|FG000|Overall Study|Second Primary Malignancy|0|||
160954229|NCT00130533|581219209|FG001|Overall Study|Second Primary Malignancy|1|||
160954230|NCT00130533|581219208|FG000|Overall Study|Other|12|||
160954231|NCT00130533|581219209|FG001|Overall Study|Other|5|||
160954232|NCT01059565|581219210|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
160954233|NCT01059565|581219211|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
160954234|NCT01059565|581219210|FG000|24-Week Randomized Phase|Adverse Event|5|||
160954235|NCT01059565|581219211|FG001|24-Week Randomized Phase|Adverse Event|0|||
160954236|NCT01059565|581219210|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
160954237|NCT01059565|581219211|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
160954238|NCT01059565|581219210|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
160954239|NCT01059565|581219211|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
160954240|NCT01059565|581219210|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
161000955|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
161000956|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
160954241|NCT01059565|581219211|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
160954242|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Adverse Event|2|||
160954243|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Adverse Event|0|||
160954244|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
160954245|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
160954246|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
160954247|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
160954248|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
160954249|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
160954250|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
160954251|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
160954252|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
160954253|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
160457546|NCT05460871|579406458|FG000|Overall Study|Withdrawal by Subject|1|||
160954254|NCT03927950|581219217|FG000|Overall Study|Adverse Event|9|||
160954255|NCT03263429|581219218|FG000|Overall Study|Withdrawal by Subject|0|||
160954256|NCT03263429|581219219|FG001|Overall Study|Withdrawal by Subject|1|||
160954257|NCT03263429|581219220|FG002|Overall Study|Withdrawal by Subject|0|||
160954258|NCT03263429|581219218|FG000|Overall Study|Follow-Up Period Completed|0|||
160457547|NCT05460871|579406459|FG001|Overall Study|Withdrawal by Subject|2|||
160954259|NCT03263429|581219219|FG001|Overall Study|Follow-Up Period Completed|2|||
160954260|NCT03263429|581219220|FG002|Overall Study|Follow-Up Period Completed|0|||
160954261|NCT03263429|581219218|FG000|Overall Study|Death|3|||
160954262|NCT03263429|581219219|FG001|Overall Study|Death|5|||
160954263|NCT03263429|581219220|FG002|Overall Study|Death|16|||
160954264|NCT03263429|581219218|FG000|Overall Study|Participant unable to return|0|||
160954265|NCT03263429|581219219|FG001|Overall Study|Participant unable to return|0|||
160954266|NCT03263429|581219220|FG002|Overall Study|Participant unable to return|1|||
160954267|NCT03263429|581219218|FG000|Overall Study|Study Closed|0|||
160954268|NCT03263429|581219219|FG001|Overall Study|Study Closed|0|||
160954269|NCT03263429|581219220|FG002|Overall Study|Study Closed|1|||
160954270|NCT04530448|581219221|FG000|Overall Study|Physician Decision|3|||
160954271|NCT04530448|581219222|FG001|Overall Study|Physician Decision|0|||
160954272|NCT01519206|581219223|FG000|Overall Study|Lost to Follow-up|3|||
160954273|NCT01519206|581219223|FG000|Overall Study|Missed Visit|2|||
160954274|NCT01491854|581219224|FG000|Overall Study|mainly due to premature termination|93|||
160954275|NCT01491854|581219224|FG000|Overall Study|Death|1|||
160954276|NCT01491854|581219224|FG000|Overall Study|Withdrawal by Subject|3|||
160954277|NCT01491854|581219224|FG000|Overall Study|Lost to Follow-up|33|||
160954278|NCT02014116|581219225|FG000|Overall Study|Progressive Disease|3|||
160954279|NCT02014116|581219226|FG001|Overall Study|Progressive Disease|4|||
160954280|NCT02014116|581219227|FG002|Overall Study|Progressive Disease|2|||
160954281|NCT02014116|581219228|FG003|Overall Study|Progressive Disease|6|||
160954282|NCT02014116|581219229|FG004|Overall Study|Progressive Disease|1|||
160954283|NCT02014116|581219230|FG005|Overall Study|Progressive Disease|13|||
160954284|NCT02014116|581219231|FG006|Overall Study|Progressive Disease|1|||
160954285|NCT02014116|581219232|FG007|Overall Study|Progressive Disease|3|||
160954286|NCT02014116|581219233|FG008|Overall Study|Progressive Disease|7|||
160954287|NCT02014116|581219225|FG000|Overall Study|Adverse Event|0|||
160954288|NCT02014116|581219226|FG001|Overall Study|Adverse Event|0|||
160954289|NCT02014116|581219227|FG002|Overall Study|Adverse Event|0|||
160954290|NCT02014116|581219228|FG003|Overall Study|Adverse Event|0|||
160954291|NCT02014116|581219229|FG004|Overall Study|Adverse Event|1|||
160954292|NCT02014116|581219230|FG005|Overall Study|Adverse Event|0|||
160954293|NCT02014116|581219231|FG006|Overall Study|Adverse Event|0|||
160954294|NCT02014116|581219232|FG007|Overall Study|Adverse Event|1|||
160954295|NCT02014116|581219233|FG008|Overall Study|Adverse Event|0|||
160954296|NCT02014116|581219225|FG000|Overall Study|Lost to Follow-up|0|||
160954297|NCT02014116|581219226|FG001|Overall Study|Lost to Follow-up|0|||
160954298|NCT02014116|581219227|FG002|Overall Study|Lost to Follow-up|0|||
160954299|NCT02014116|581219228|FG003|Overall Study|Lost to Follow-up|0|||
160954300|NCT02014116|581219229|FG004|Overall Study|Lost to Follow-up|0|||
160954301|NCT02014116|581219230|FG005|Overall Study|Lost to Follow-up|1|||
160954302|NCT02014116|581219231|FG006|Overall Study|Lost to Follow-up|0|||
160954303|NCT02014116|581219232|FG007|Overall Study|Lost to Follow-up|0|||
160954304|NCT02014116|581219233|FG008|Overall Study|Lost to Follow-up|1|||
160954305|NCT02014116|581219225|FG000|Overall Study|Death|0|||
160954306|NCT02014116|581219226|FG001|Overall Study|Death|0|||
160954307|NCT02014116|581219227|FG002|Overall Study|Death|0|||
160954308|NCT02014116|581219228|FG003|Overall Study|Death|0|||
160954309|NCT02014116|581219229|FG004|Overall Study|Death|0|||
160954310|NCT02014116|581219230|FG005|Overall Study|Death|0|||
160954311|NCT02014116|581219231|FG006|Overall Study|Death|0|||
160954312|NCT02014116|581219232|FG007|Overall Study|Death|1|||
160954313|NCT02014116|581219233|FG008|Overall Study|Death|1|||
160954314|NCT02014116|581219225|FG000|Overall Study|Withdrawal by Subject|0|||
160954315|NCT02014116|581219226|FG001|Overall Study|Withdrawal by Subject|0|||
160954316|NCT02014116|581219227|FG002|Overall Study|Withdrawal by Subject|1|||
160954317|NCT02014116|581219228|FG003|Overall Study|Withdrawal by Subject|1|||
160954318|NCT02014116|581219229|FG004|Overall Study|Withdrawal by Subject|0|||
160954319|NCT02014116|581219230|FG005|Overall Study|Withdrawal by Subject|1|||
160457548|NCT02938923|579406460|FG000|Overall Study|Death|1|||
160457549|NCT02938923|579406461|FG001|Overall Study|Death|0|||
160582695|NCT00450372|579853686|FG000|Overall Study|Physician Decision|1|||
160582696|NCT03010423|579853687|FG000|Overall Study|Study termination|8|||
160582697|NCT05131451|579853688|FG000|Overall Study|Protocol Violation|1|||
160582698|NCT05131451|579853689|FG001|Overall Study|Protocol Violation|0|||
160582699|NCT01863849|579853703|FG000|Overall Study|Lost to Follow-up|1|||
160582700|NCT01863849|579853704|FG001|Overall Study|Lost to Follow-up|0|||
160582701|NCT01533935|579853705|FG000|Overall Study|Adverse Event|5|||
160582702|NCT01533935|579853706|FG001|Overall Study|Adverse Event|7|||
160954320|NCT02014116|581219231|FG006|Overall Study|Withdrawal by Subject|0|||
160582703|NCT01533935|579853707|FG002|Overall Study|Adverse Event|1|||
160954321|NCT02014116|581219232|FG007|Overall Study|Withdrawal by Subject|0|||
160954322|NCT02014116|581219233|FG008|Overall Study|Withdrawal by Subject|0|||
160954323|NCT02014116|581219225|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
160954324|NCT02014116|581219226|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
160954325|NCT02014116|581219227|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
160954326|NCT02014116|581219228|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
160954327|NCT02014116|581219229|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
160954328|NCT02014116|581219230|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
160954329|NCT02014116|581219231|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
160954330|NCT02014116|581219232|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
160954331|NCT02014116|581219233|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
160954332|NCT02014116|581219225|FG000|Overall Study|Physician Decision|0|||
160954333|NCT02014116|581219226|FG001|Overall Study|Physician Decision|0|||
160954334|NCT02014116|581219227|FG002|Overall Study|Physician Decision|0|||
160954335|NCT02014116|581219228|FG003|Overall Study|Physician Decision|0|||
160954336|NCT02014116|581219229|FG004|Overall Study|Physician Decision|0|||
160954337|NCT02014116|581219230|FG005|Overall Study|Physician Decision|0|||
160954338|NCT02014116|581219231|FG006|Overall Study|Physician Decision|0|||
160954339|NCT02014116|581219232|FG007|Overall Study|Physician Decision|0|||
160954340|NCT02014116|581219233|FG008|Overall Study|Physician Decision|1|||
160954341|NCT01026974|581219245|FG000|Overall Study|Withdrawal by Subject|0|||
160954342|NCT01026974|581219246|FG001|Overall Study|Withdrawal by Subject|1|||
160954343|NCT01026974|581219247|FG002|Overall Study|Withdrawal by Subject|7|||
160954344|NCT01026974|581219248|FG003|Overall Study|Withdrawal by Subject|2|||
160954345|NCT01026974|581219245|FG000|Overall Study|Lost to Follow-up|1|||
160954346|NCT01026974|581219246|FG001|Overall Study|Lost to Follow-up|1|||
160954347|NCT01026974|581219247|FG002|Overall Study|Lost to Follow-up|4|||
160954348|NCT01026974|581219248|FG003|Overall Study|Lost to Follow-up|0|||
160954349|NCT01026974|581219245|FG000|Overall Study|Adverse Event|0|||
160954350|NCT01026974|581219246|FG001|Overall Study|Adverse Event|0|||
160954351|NCT01026974|581219247|FG002|Overall Study|Adverse Event|0|||
160954352|NCT01026974|581219248|FG003|Overall Study|Adverse Event|1|||
160954353|NCT01026974|581219245|FG000|Overall Study|Inappropriate enrollment|0|||
160954354|NCT01026974|581219246|FG001|Overall Study|Inappropriate enrollment|0|||
160954355|NCT01026974|581219247|FG002|Overall Study|Inappropriate enrollment|1|||
160954356|NCT01026974|581219248|FG003|Overall Study|Inappropriate enrollment|0|||
160954357|NCT02864082|581219255|FG000|Overall Study|Adverse Event|1|||
160954358|NCT02864082|581219256|FG001|Overall Study|Adverse Event|1|||
160954359|NCT02864082|581219255|FG000|Overall Study|Lost to Follow-up|0|||
160954360|NCT02864082|581219256|FG001|Overall Study|Lost to Follow-up|1|||
160954361|NCT02864082|581219255|FG000|Overall Study|Withdrawal by Subject|2|||
160954362|NCT02864082|581219256|FG001|Overall Study|Withdrawal by Subject|2|||
160954363|NCT05545072|581219264|FG000|Overall Study|Lost to Follow-up|1|||
160954364|NCT05545072|581219265|FG001|Overall Study|Lost to Follow-up|0|||
160954365|NCT05545072|581219264|FG000|Overall Study|Study ended prematurely due to funding|2|||
160954366|NCT05545072|581219265|FG001|Overall Study|Study ended prematurely due to funding|2|||
160954367|NCT02395042|581219266|FG000|Treatment 1 Period|Adverse Event|1|||
160954368|NCT02395042|581219267|FG001|Treatment 1 Period|Adverse Event|3|||
160954369|NCT02395042|581219268|FG002|Treatment 1 Period|Adverse Event|1|||
160954370|NCT02395042|581219266|FG000|Treatment 1 Period|Lack of Efficacy|1|||
160954371|NCT02395042|581219267|FG001|Treatment 1 Period|Lack of Efficacy|1|||
160954372|NCT02395042|581219268|FG002|Treatment 1 Period|Lack of Efficacy|0|||
160954373|NCT02395042|581219266|FG000|Treatment 1 Period|Lost to Follow-up|1|||
160954374|NCT02395042|581219267|FG001|Treatment 1 Period|Lost to Follow-up|0|||
160954375|NCT02395042|581219268|FG002|Treatment 1 Period|Lost to Follow-up|0|||
160954376|NCT02395042|581219266|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
160954377|NCT02395042|581219267|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
160954378|NCT02395042|581219268|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
160954379|NCT02395042|581219266|FG000|Treatment 2 Period|Lack of Efficacy|1|||
160954380|NCT02395042|581219267|FG001|Treatment 2 Period|Lack of Efficacy|1|||
160954381|NCT02395042|581219268|FG002|Treatment 2 Period|Lack of Efficacy|0|||
160954382|NCT03638141|581219269|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
160954383|NCT03996473|581219270|FG000|Treatment Assignment|Withdrawal by Subject|1|||
160954384|NCT03996473|581219270|FG000|Treatment Assignment|Progressive disease|6|||
160954385|NCT03996473|581219270|FG000|Treatment Assignment|Study drug never administered|1|||
160954386|NCT03996473|581219270|FG000|Active Follow-up|Death|1|||
160954387|NCT03996473|581219270|FG000|Long-term Follow-up|Death|5|||
160954388|NCT03759873|581219271|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
160954389|NCT03759873|581219272|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
160954390|NCT03759873|581219273|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
160954391|NCT03759873|581219274|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
160954392|NCT03759873|581219271|FG000|Overall Study|Moved outside eligible area|0|||
160954393|NCT03759873|581219272|FG001|Overall Study|Moved outside eligible area|2|||
160954394|NCT03759873|581219273|FG002|Overall Study|Moved outside eligible area|0|||
160954395|NCT03759873|581219274|FG003|Overall Study|Moved outside eligible area|0|||
160954396|NCT03759873|581219271|FG000|Overall Study|Withdrawal by Subject|0|||
160656354|NCT00864097|580122439|FG002|Overall Study|Lost to Follow-up|0|||
160656355|NCT00864097|580122440|FG003|Overall Study|Lost to Follow-up|1|||
160954397|NCT03759873|581219272|FG001|Overall Study|Withdrawal by Subject|0|||
160954398|NCT03759873|581219273|FG002|Overall Study|Withdrawal by Subject|1|||
160954399|NCT03759873|581219274|FG003|Overall Study|Withdrawal by Subject|0|||
160954400|NCT03579563|581219277|FG000|Overall Study|Lost to Follow-up|0|||
160954401|NCT03579563|581219278|FG001|Overall Study|Lost to Follow-up|0|||
160954402|NCT03579563|581219279|FG002|Overall Study|Lost to Follow-up|0|||
160954403|NCT03579563|581219280|FG003|Overall Study|Lost to Follow-up|0|||
160954404|NCT03579563|581219281|FG004|Overall Study|Lost to Follow-up|1|||
160954405|NCT03579563|581219282|FG005|Overall Study|Lost to Follow-up|0|||
160954406|NCT03579563|581219277|FG000|Overall Study|Lack of Efficacy|1|||
160954407|NCT03579563|581219278|FG001|Overall Study|Lack of Efficacy|1|||
160954408|NCT03579563|581219279|FG002|Overall Study|Lack of Efficacy|4|||
160954409|NCT03579563|581219280|FG003|Overall Study|Lack of Efficacy|1|||
160954410|NCT03579563|581219281|FG004|Overall Study|Lack of Efficacy|2|||
160954411|NCT03579563|581219282|FG005|Overall Study|Lack of Efficacy|3|||
160954412|NCT03579563|581219277|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
160954413|NCT03579563|581219278|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
160954414|NCT03579563|581219279|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
160954415|NCT03579563|581219280|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
160954416|NCT03579563|581219281|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
160954417|NCT03579563|581219282|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
160954418|NCT03579563|581219277|FG000|Overall Study|Time/distance concern|0|||
160954419|NCT03579563|581219278|FG001|Overall Study|Time/distance concern|0|||
160954420|NCT03579563|581219279|FG002|Overall Study|Time/distance concern|1|||
160954421|NCT03579563|581219280|FG003|Overall Study|Time/distance concern|0|||
160954422|NCT03579563|581219281|FG004|Overall Study|Time/distance concern|0|||
160954423|NCT03579563|581219282|FG005|Overall Study|Time/distance concern|1|||
160954424|NCT03579563|581219277|FG000|Overall Study|COVID shutdown|2|||
160954425|NCT03579563|581219278|FG001|Overall Study|COVID shutdown|3|||
160954426|NCT03579563|581219279|FG002|Overall Study|COVID shutdown|4|||
160954427|NCT03579563|581219280|FG003|Overall Study|COVID shutdown|3|||
160954428|NCT03579563|581219281|FG004|Overall Study|COVID shutdown|1|||
160954429|NCT03579563|581219282|FG005|Overall Study|COVID shutdown|2|||
160954430|NCT03579563|581219277|FG000|Overall Study|Protocol administration error|1|||
160954431|NCT03579563|581219278|FG001|Overall Study|Protocol administration error|0|||
160954432|NCT03579563|581219279|FG002|Overall Study|Protocol administration error|1|||
160954433|NCT03579563|581219280|FG003|Overall Study|Protocol administration error|0|||
160954434|NCT03579563|581219281|FG004|Overall Study|Protocol administration error|1|||
160954435|NCT03579563|581219282|FG005|Overall Study|Protocol administration error|5|||
160954436|NCT02105948|581219284|FG000|Overall Study|Adverse Event|10|||
160954437|NCT02105948|581219285|FG001|Overall Study|Adverse Event|7|||
160954438|NCT02105948|581219286|FG002|Overall Study|Adverse Event|11|||
160954439|NCT02105948|581219287|FG003|Overall Study|Adverse Event|11|||
160954440|NCT02105948|581219284|FG000|Overall Study|Lack of Efficacy|0|||
160954441|NCT02105948|581219285|FG001|Overall Study|Lack of Efficacy|1|||
160954442|NCT02105948|581219286|FG002|Overall Study|Lack of Efficacy|3|||
160954443|NCT02105948|581219287|FG003|Overall Study|Lack of Efficacy|2|||
160954444|NCT02105948|581219284|FG000|Overall Study|Lost to Follow-up|0|||
160954445|NCT02105948|581219285|FG001|Overall Study|Lost to Follow-up|0|||
160954446|NCT02105948|581219286|FG002|Overall Study|Lost to Follow-up|2|||
160954447|NCT02105948|581219287|FG003|Overall Study|Lost to Follow-up|1|||
160954448|NCT02105948|581219284|FG000|Overall Study|Physician Decision|2|||
160954449|NCT02105948|581219285|FG001|Overall Study|Physician Decision|2|||
160954450|NCT02105948|581219286|FG002|Overall Study|Physician Decision|2|||
160954451|NCT02105948|581219287|FG003|Overall Study|Physician Decision|2|||
160954452|NCT02105948|581219284|FG000|Overall Study|Withdrawal by Subject|15|||
160954453|NCT02105948|581219285|FG001|Overall Study|Withdrawal by Subject|10|||
160954454|NCT02105948|581219286|FG002|Overall Study|Withdrawal by Subject|10|||
160954455|NCT02105948|581219287|FG003|Overall Study|Withdrawal by Subject|11|||
160954456|NCT00522275|581219288|FG000|Overall Study|Adverse Event|35|||
160954457|NCT00522275|581219288|FG000|Overall Study|Lack of Efficacy|80|||
160954458|NCT00522275|581219288|FG000|Overall Study|Subject withdrew consent|16|||
160954459|NCT00522275|581219288|FG000|Overall Study|Protocol deviation|1|||
160954460|NCT00522275|581219288|FG000|Overall Study|Unsatisfactory compliance|11|||
160954461|NCT00522275|581219288|FG000|Overall Study|Lost to Follow-up|8|||
160954462|NCT00522275|581219288|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
160954463|NCT00522275|581219288|FG000|Overall Study|Other: Subject is pregnant|2|||
160954464|NCT00522275|581219288|FG000|Overall Study|Other: Subject relocated|2|||
160954465|NCT00522275|581219288|FG000|Overall Study|Other: Subject arrested|1|||
160954466|NCT00522275|581219288|FG000|Overall Study|Other: Site / clinic closed|4|||
160954467|NCT00522275|581219288|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
160954468|NCT00522275|581219288|FG000|Overall Study|Other: Sponsor request|2|||
160954469|NCT00522275|581219288|FG000|Overall Study|Other: Subject ran out of medication|1|||
160954470|NCT00522275|581219288|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
160954471|NCT04558346|581219297|FG000|Overall Study|Withdrawal by Subject|2|||
160954472|NCT04558346|581219298|FG001|Overall Study|Withdrawal by Subject|0|||
160954473|NCT04558346|581219297|FG000|Overall Study|Lost to Follow-up|0|||
160954474|NCT04558346|581219298|FG001|Overall Study|Lost to Follow-up|1|||
160656356|NCT00864097|580122437|FG000|Overall Study|Withdrawal by Subject|15|||
160954475|NCT04558346|581219297|FG000|Overall Study|Adverse Event|0|||
160954476|NCT04558346|581219298|FG001|Overall Study|Adverse Event|1|||
160954477|NCT01462344|581219301|FG000|Overall Study|Withdrawal by Subject|245|||
160954478|NCT01462344|581219302|FG001|Overall Study|Withdrawal by Subject|226|||
160954479|NCT01462344|581219301|FG000|Overall Study|Adverse Event|24|||
160954480|NCT01462344|581219302|FG001|Overall Study|Adverse Event|23|||
160954481|NCT01462344|581219301|FG000|Overall Study|Asthma Exacerbation|34|||
160954482|NCT01462344|581219302|FG001|Overall Study|Asthma Exacerbation|35|||
160954483|NCT01462344|581219301|FG000|Overall Study|Lack of Efficacy|5|||
160954484|NCT01462344|581219302|FG001|Overall Study|Lack of Efficacy|6|||
160954485|NCT01462344|581219301|FG000|Overall Study|Protocol Violation|68|||
160954486|NCT01462344|581219302|FG001|Overall Study|Protocol Violation|53|||
160954487|NCT01462344|581219301|FG000|Overall Study|Lost to Follow-up|7|||
160954488|NCT01462344|581219302|FG001|Overall Study|Lost to Follow-up|7|||
160954489|NCT00724971|581219303|FG000|Overall Study|Adverse Event|5|||
160954490|NCT00724971|581219303|FG000|Overall Study|Withdrawal by Subject|1|||
160954491|NCT01962974|581219304|FG000|Overall Study|Study termination|7|||
160954492|NCT02276482|581219305|FG000|Overall Study|Adverse Event|1|||
160954493|NCT02276482|581219306|FG001|Overall Study|Adverse Event|0|||
160954494|NCT02276482|581219305|FG000|Overall Study|Withdrawal by Subject|1|||
160954495|NCT02276482|581219306|FG001|Overall Study|Withdrawal by Subject|0|||
160954496|NCT02276482|581219305|FG000|Overall Study|Gram-negative infection|1|||
160954497|NCT02276482|581219306|FG001|Overall Study|Gram-negative infection|0|||
160954498|NCT02276482|581219305|FG000|Overall Study|Reason not specified|0|||
160954499|NCT02276482|581219306|FG001|Overall Study|Reason not specified|1|||
160954500|NCT01410448|581219312|FG000|Overall Study|No conversion to everolimus|0|||
160954501|NCT01410448|581219313|FG001|Overall Study|No conversion to everolimus|24|||
160954502|NCT01410448|581219312|FG000|Overall Study|Graft loss|4|||
160954503|NCT01410448|581219313|FG001|Overall Study|Graft loss|1|||
160954504|NCT01410448|581219312|FG000|Overall Study|Administrative issues|2|||
160954505|NCT01410448|581219313|FG001|Overall Study|Administrative issues|1|||
160954506|NCT01410448|581219312|FG000|Overall Study|Lost to Follow-up|1|||
160954507|NCT01410448|581219313|FG001|Overall Study|Lost to Follow-up|0|||
160954508|NCT01410448|581219312|FG000|Overall Study|Withdrawal by Subject|3|||
160954509|NCT01410448|581219313|FG001|Overall Study|Withdrawal by Subject|2|||
160954510|NCT01410448|581219312|FG000|Overall Study|Protocol Violation|0|||
160954511|NCT01410448|581219313|FG001|Overall Study|Protocol Violation|4|||
160954512|NCT01410448|581219312|FG000|Overall Study|Death|2|||
160954513|NCT01410448|581219313|FG001|Overall Study|Death|3|||
160954514|NCT01218438|581219316|FG000|Epoch 1|Physician Decision|2|||
160954515|NCT01218438|581219316|FG000|Epoch 1|Adverse Event|1|||
160954516|NCT01218438|581219316|FG000|Epoch 3|Withdrawal by Subject|3|||
160954517|NCT01218438|581219316|FG000|Epoch 3|Adverse Event|1|||
160954518|NCT01218438|581219316|FG000|Epoch 4|Physician Decision|1|||
160954519|NCT01218438|581219316|FG000|Epoch 4|Withdrawal by Subject|2|||
160954520|NCT01438541|581219319|FG000|Overall Study|Physician Decision|1|||
160954521|NCT01438541|581219319|FG000|Overall Study|Withdrawal by Subject|1|||
160954522|NCT01438541|581219319|FG000|Overall Study|discharge from the hospital|5|||
160954523|NCT02091167|581219320|FG000|Overall Study|Lost to Follow-up|0|||
160954524|NCT02091167|581219321|FG001|Overall Study|Lost to Follow-up|2|||
160954525|NCT01218646|581219322|FG000|Overall Study|Adverse Event|0|||
160954526|NCT01218646|581219323|FG001|Overall Study|Adverse Event|0|||
160954527|NCT01218646|581219324|FG002|Overall Study|Adverse Event|1|||
160954528|NCT01218646|581219325|FG003|Overall Study|Adverse Event|0|||
160954529|NCT01218646|581219322|FG000|Overall Study|Lost to Follow-up|1|||
160954530|NCT01218646|581219323|FG001|Overall Study|Lost to Follow-up|0|||
160954531|NCT01218646|581219324|FG002|Overall Study|Lost to Follow-up|0|||
160954532|NCT01218646|581219325|FG003|Overall Study|Lost to Follow-up|0|||
160954533|NCT01218646|581219322|FG000|Overall Study|Protocol Violation|0|||
160954534|NCT01218646|581219323|FG001|Overall Study|Protocol Violation|0|||
160954535|NCT01218646|581219324|FG002|Overall Study|Protocol Violation|1|||
161000957|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
161000958|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
161000959|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
161000960|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
161000961|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
160954536|NCT01218646|581219325|FG003|Overall Study|Protocol Violation|1|||
160954537|NCT00722761|581219326|FG000|Overall Study|Lost to Follow-up|1|||
160656357|NCT00864097|580122438|FG001|Overall Study|Withdrawal by Subject|11|||
160954538|NCT00722761|581219327|FG001|Overall Study|Lost to Follow-up|4|||
160954539|NCT00722761|581219326|FG000|Overall Study|Withdrawal by Subject|5|||
160954540|NCT00722761|581219327|FG001|Overall Study|Withdrawal by Subject|2|||
160954541|NCT02693665|581219333|FG000|Overall Study|Death|3|||
160954542|NCT02693665|581219334|FG001|Overall Study|Death|2|||
160954543|NCT02693665|581219333|FG000|Overall Study|Lost to Follow-up|7|||
160954544|NCT02693665|581219334|FG001|Overall Study|Lost to Follow-up|3|||
160656358|NCT00864097|580122439|FG002|Overall Study|Withdrawal by Subject|11|||
160954545|NCT02693665|581219333|FG000|Overall Study|Protocol Violation|1|||
160954546|NCT02693665|581219334|FG001|Overall Study|Protocol Violation|0|||
160954547|NCT02693665|581219333|FG000|Overall Study|Withdrawal by Subject|2|||
160954548|NCT02693665|581219334|FG001|Overall Study|Withdrawal by Subject|0|||
160954549|NCT02693665|581219333|FG000|Overall Study|patient wanted to leave it behind|1|||
160954550|NCT02693665|581219334|FG001|Overall Study|patient wanted to leave it behind|0|||
160954551|NCT02693665|581219333|FG000|Overall Study|anxiety|1|||
160954552|NCT02693665|581219334|FG001|Overall Study|anxiety|0|||
160954553|NCT02693665|581219333|FG000|Overall Study|family issues|1|||
160954554|NCT02693665|581219334|FG001|Overall Study|family issues|0|||
160954555|NCT02693665|581219333|FG000|Overall Study|no reason given|1|||
160954556|NCT02693665|581219334|FG001|Overall Study|no reason given|0|||
160954557|NCT03096782|581219335|FG000|Overall Study|Death|1|||
160954558|NCT03096782|581219335|FG000|Overall Study|Participant Relapsed|1|||
160954559|NCT02075593|581219336|FG000|Overall Study|Withdrawal by Subject|1|||
160954560|NCT05819749|581219341|FG000|Overall Study|Lost to Follow-up|1|||
160954561|NCT00844857|581221702|FG000|Overall Study|Adverse Event|24|||
160954562|NCT00844857|581221703|FG001|Overall Study|Adverse Event|5|||
160954563|NCT00844857|581221702|FG000|Overall Study|Sponsor Decision|1|||
160954564|NCT00844857|581221703|FG001|Overall Study|Sponsor Decision|1|||
160954565|NCT00844857|581221702|FG000|Overall Study|Physician Decision|2|||
160954566|NCT00844857|581221703|FG001|Overall Study|Physician Decision|0|||
160954567|NCT00844857|581221702|FG000|Overall Study|Parent/Caregiver Decision|6|||
160954568|NCT00844857|581221703|FG001|Overall Study|Parent/Caregiver Decision|2|||
160954569|NCT00844857|581221702|FG000|Overall Study|Withdrawal by Subject|8|||
160954570|NCT00844857|581221703|FG001|Overall Study|Withdrawal by Subject|7|||
160954571|NCT00844857|581221702|FG000|Overall Study|Protocol Violation|6|||
160954572|NCT00844857|581221703|FG001|Overall Study|Protocol Violation|0|||
160954573|NCT00844857|581221702|FG000|Overall Study|Lack of Efficacy|5|||
160954574|NCT00844857|581221703|FG001|Overall Study|Lack of Efficacy|5|||
160954575|NCT00844857|581221702|FG000|Overall Study|Clinical Relapse|0|||
160954576|NCT00844857|581221703|FG001|Overall Study|Clinical Relapse|1|||
160954577|NCT00844857|581221702|FG000|Overall Study|Entry Criteria Not Met|0|||
160954578|NCT00844857|581221703|FG001|Overall Study|Entry Criteria Not Met|1|||
160954579|NCT00844857|581221702|FG000|Overall Study|Lost to Follow-up|2|||
161000962|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
161000963|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
161000964|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
161000965|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
161000966|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
161000967|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
161000968|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
161000969|NCT01405924|581388939|FG000|Overall Study|Protocol Violation|8|||
161000970|NCT01405924|581388939|FG000|Overall Study|Missing/Incomplete Data|2|||
161000971|NCT02393716|581388940|FG000|Overall Study|Death|29|||
161000972|NCT02393716|581388940|FG000|Overall Study|Withdrawal by Subject|8|||
161000973|NCT02393716|581388940|FG000|Overall Study|Device Explanted|8|||
161000974|NCT02393716|581388940|FG000|Overall Study|Missed visit|16|||
161000975|NCT01924767|581388941|FG000|Overall Study|Adverse Event|1|||
161000976|NCT01924767|581388942|FG001|Overall Study|Adverse Event|0|||
161000977|NCT01924767|581388943|FG002|Overall Study|Adverse Event|1|||
161000978|NCT01924767|581388944|FG003|Overall Study|Adverse Event|0|||
161000979|NCT01924767|581388945|FG004|Overall Study|Adverse Event|0|||
161000980|NCT01648140|581388946|FG000|Overall Study|Physician Decision|1|||
161000981|NCT01648140|581388947|FG001|Overall Study|Physician Decision|0|||
161000982|NCT01648140|581388948|FG002|Overall Study|Physician Decision|0|||
161000983|NCT01648140|581388949|FG003|Overall Study|Physician Decision|0|||
161000984|NCT01648140|581388946|FG000|Overall Study|Lack of Efficacy|4|||
161000985|NCT01648140|581388947|FG001|Overall Study|Lack of Efficacy|7|||
161000986|NCT01648140|581388948|FG002|Overall Study|Lack of Efficacy|1|||
161000987|NCT01648140|581388949|FG003|Overall Study|Lack of Efficacy|0|||
161000988|NCT01648140|581388946|FG000|Overall Study|Adverse Event|3|||
161000989|NCT01648140|581388947|FG001|Overall Study|Adverse Event|1|||
160582704|NCT01533935|579853708|FG003|Overall Study|Adverse Event|5|||
160582705|NCT01533935|579853709|FG004|Overall Study|Adverse Event|3|||
160582706|NCT01533935|579853705|FG000|Overall Study|Protocol Violation|0|||
160582707|NCT01533935|579853706|FG001|Overall Study|Protocol Violation|2|||
161000990|NCT01648140|581388948|FG002|Overall Study|Adverse Event|2|||
160954580|NCT00844857|581221703|FG001|Overall Study|Lost to Follow-up|3|||
160954581|NCT00844857|581221702|FG000|Overall Study|Did Not Take Study Drug|3|||
160954582|NCT00844857|581221703|FG001|Overall Study|Did Not Take Study Drug|1|||
161000991|NCT01648140|581388949|FG003|Overall Study|Adverse Event|0|||
161000992|NCT01648140|581388946|FG000|Overall Study|Withdrawal by Subject|2|||
161000993|NCT01648140|581388947|FG001|Overall Study|Withdrawal by Subject|3|||
161000994|NCT01648140|581388948|FG002|Overall Study|Withdrawal by Subject|3|||
160954583|NCT00844857|581221702|FG000|Overall Study|Good Clinical Practice Violations|21|||
160954584|NCT00844857|581221703|FG001|Overall Study|Good Clinical Practice Violations|11|||
160954585|NCT00570674|581221704|FG000|Overall Study|Withdrawal by Subject|0|||
160954586|NCT00570674|581221705|FG001|Overall Study|Withdrawal by Subject|0|||
160954587|NCT00570674|581221706|FG002|Overall Study|Withdrawal by Subject|1|||
161000995|NCT01648140|581388949|FG003|Overall Study|Withdrawal by Subject|2|||
160582708|NCT01533935|579853707|FG002|Overall Study|Protocol Violation|0|||
160582709|NCT01533935|579853708|FG003|Overall Study|Protocol Violation|0|||
160954588|NCT00570674|581221707|FG003|Overall Study|Withdrawal by Subject|0|||
160954589|NCT00570674|581221708|FG004|Overall Study|Withdrawal by Subject|0|||
160954590|NCT00570674|581221709|FG005|Overall Study|Withdrawal by Subject|0|||
160954591|NCT00570674|581221710|FG006|Overall Study|Withdrawal by Subject|0|||
160954592|NCT03069482|581221711|FG000|Overall Study|Lost to Follow-up|0|||
160954593|NCT03069482|581221712|FG001|Overall Study|Lost to Follow-up|1|||
160954594|NCT03069482|581221711|FG000|Overall Study|Physician Decision|1|||
160954595|NCT03069482|581221712|FG001|Overall Study|Physician Decision|0|||
160954596|NCT01949311|581221723|FG000|Overall Study|Lost to Follow-up|73|||
160954597|NCT01949311|581221723|FG000|Overall Study|Terminated by Sponsor|708|||
160954598|NCT01949311|581221723|FG000|Overall Study|Withdrawal by Subject|375|||
160954599|NCT01949311|581221723|FG000|Overall Study|Lack of Efficacy|50|||
160954600|NCT01949311|581221723|FG000|Overall Study|Protocol Deviation|34|||
160954601|NCT01949311|581221723|FG000|Overall Study|Pregnancy|20|||
160954602|NCT01949311|581221723|FG000|Overall Study|Physician Decision|9|||
160954603|NCT01949311|581221723|FG000|Overall Study|Other|4|||
160954604|NCT01949311|581221723|FG000|Overall Study|Adverse Event|107|||
160954605|NCT02338154|581221724|FG000|Overall Study|Death|46|||
160954606|NCT02338154|581221724|FG000|Overall Study|Valve Implant Failure|17|||
160954607|NCT02338154|581221724|FG000|Overall Study|Valve Explant|11|||
160954608|NCT02338154|581221724|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
160954609|NCT02338154|581221724|FG000|Overall Study|Lost to Follow-up|8|||
160954610|NCT02338154|581221724|FG000|Overall Study|Other Reason|3|||
160954611|NCT02338154|581221724|FG000|Overall Study|Patients Without Exit Form|47|||
160954612|NCT02338154|581221724|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
160954613|NCT01559844|581221729|FG000|Overall Study|Consent Withdrawn|7|||
160954614|NCT01559844|581221729|FG000|Overall Study|Death|5|||
160954615|NCT01559844|581221729|FG000|Overall Study|Efficacy Failure|10|||
160954616|NCT01559844|581221729|FG000|Overall Study|No Longer A Transplant Candidate|3|||
160954617|NCT00951041|581221730|FG000|Overall Study|Withdrawal by Subject|1|||
160954618|NCT00951041|581221731|FG001|Overall Study|Withdrawal by Subject|1|||
160954619|NCT00951041|581221730|FG000|Overall Study|Lost to Follow-up|1|||
160954620|NCT00951041|581221731|FG001|Overall Study|Lost to Follow-up|0|||
160954621|NCT00951041|581221730|FG000|Overall Study|Other|3|||
160954622|NCT00951041|581221731|FG001|Overall Study|Other|0|||
160954623|NCT02388724|581221735|FG000|Overall Study|Reason not Specified|0|||
160954624|NCT02388724|581221736|FG001|Overall Study|Reason not Specified|1|||
160954625|NCT02388724|581221735|FG000|Overall Study|Major Protocol Deviation|3|||
160954626|NCT02388724|581221736|FG001|Overall Study|Major Protocol Deviation|3|||
160954627|NCT02388724|581221735|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
160954628|NCT02388724|581221736|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
160954629|NCT02388724|581221735|FG000|Overall Study|Voluntary Withdrawal|6|||
160954630|NCT02388724|581221736|FG001|Overall Study|Voluntary Withdrawal|5|||
160954631|NCT02388724|581221735|FG000|Overall Study|Randomized but not Treated|0|||
160954632|NCT02388724|581221736|FG001|Overall Study|Randomized but not Treated|2|||
160954633|NCT01217073|581221737|FG000|Base Period|Adverse Event|1|||
160954634|NCT01217073|581221738|FG001|Base Period|Adverse Event|0|||
160954635|NCT01217073|581221739|FG002|Base Period|Adverse Event|1|||
160954636|NCT01217073|581221740|FG003|Base Period|Adverse Event|0|||
160954637|NCT01217073|581221741|FG004|Base Period|Adverse Event|4|||
160954638|NCT01217073|581221742|FG005|Base Period|Adverse Event|1|||
160954639|NCT01217073|581221743|FG006|Base Period|Adverse Event|0|||
160582710|NCT01533935|579853709|FG004|Overall Study|Protocol Violation|0|||
160954640|NCT01217073|581221744|FG007|Base Period|Adverse Event|0|||
160954641|NCT01217073|581221737|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
160954642|NCT01217073|581221738|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954643|NCT01217073|581221739|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954644|NCT01217073|581221740|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954645|NCT01217073|581221741|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954646|NCT01217073|581221742|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954647|NCT01217073|581221743|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954648|NCT01217073|581221744|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160582711|NCT01533935|579853705|FG000|Overall Study|Lost to Follow-up|0|||
160954649|NCT01217073|581221737|FG000|Base Period|Excluded medication|0|||
160954650|NCT01217073|581221738|FG001|Base Period|Excluded medication|0|||
160954651|NCT01217073|581221739|FG002|Base Period|Excluded medication|0|||
160954652|NCT01217073|581221740|FG003|Base Period|Excluded medication|0|||
160954653|NCT01217073|581221741|FG004|Base Period|Excluded medication|1|||
160954654|NCT01217073|581221742|FG005|Base Period|Excluded medication|0|||
161000996|NCT01648140|581388946|FG000|Overall Study|Lost to Follow-up|2|||
160954655|NCT01217073|581221743|FG006|Base Period|Excluded medication|0|||
160954656|NCT01217073|581221744|FG007|Base Period|Excluded medication|0|||
160954657|NCT01217073|581221737|FG000|Base Period|Lack of Efficacy|0|||
160954658|NCT01217073|581221738|FG001|Base Period|Lack of Efficacy|0|||
160954659|NCT01217073|581221739|FG002|Base Period|Lack of Efficacy|0|||
160582712|NCT01533935|579853706|FG001|Overall Study|Lost to Follow-up|0|||
160954660|NCT01217073|581221740|FG003|Base Period|Lack of Efficacy|0|||
160582713|NCT01533935|579853707|FG002|Overall Study|Lost to Follow-up|1|||
160954661|NCT01217073|581221741|FG004|Base Period|Lack of Efficacy|0|||
160954662|NCT01217073|581221742|FG005|Base Period|Lack of Efficacy|1|||
160954663|NCT01217073|581221743|FG006|Base Period|Lack of Efficacy|0|||
160954664|NCT01217073|581221744|FG007|Base Period|Lack of Efficacy|0|||
160954665|NCT01217073|581221737|FG000|Base Period|Lost to Follow-up|0|||
160954666|NCT01217073|581221738|FG001|Base Period|Lost to Follow-up|0|||
160954667|NCT01217073|581221739|FG002|Base Period|Lost to Follow-up|1|||
160954668|NCT01217073|581221740|FG003|Base Period|Lost to Follow-up|1|||
160954669|NCT01217073|581221741|FG004|Base Period|Lost to Follow-up|3|||
160954670|NCT01217073|581221742|FG005|Base Period|Lost to Follow-up|0|||
160954671|NCT01217073|581221743|FG006|Base Period|Lost to Follow-up|0|||
160954672|NCT01217073|581221744|FG007|Base Period|Lost to Follow-up|0|||
160954673|NCT01217073|581221737|FG000|Base Period|Physician Decision|0|||
160954674|NCT01217073|581221738|FG001|Base Period|Physician Decision|0|||
160954675|NCT01217073|581221739|FG002|Base Period|Physician Decision|0|||
160954676|NCT01217073|581221740|FG003|Base Period|Physician Decision|0|||
160954677|NCT01217073|581221741|FG004|Base Period|Physician Decision|1|||
160954678|NCT01217073|581221742|FG005|Base Period|Physician Decision|0|||
160954679|NCT01217073|581221743|FG006|Base Period|Physician Decision|0|||
160954680|NCT01217073|581221744|FG007|Base Period|Physician Decision|0|||
160954681|NCT01217073|581221737|FG000|Base Period|Protocol Violation|1|||
160954682|NCT01217073|581221738|FG001|Base Period|Protocol Violation|0|||
160954683|NCT01217073|581221739|FG002|Base Period|Protocol Violation|0|||
160954684|NCT01217073|581221740|FG003|Base Period|Protocol Violation|0|||
160954685|NCT01217073|581221741|FG004|Base Period|Protocol Violation|1|||
160954686|NCT01217073|581221742|FG005|Base Period|Protocol Violation|2|||
160954687|NCT01217073|581221743|FG006|Base Period|Protocol Violation|0|||
160954688|NCT01217073|581221744|FG007|Base Period|Protocol Violation|0|||
160954689|NCT01217073|581221737|FG000|Base Period|Withdrawal by Subject|4|||
160954690|NCT01217073|581221738|FG001|Base Period|Withdrawal by Subject|5|||
160954691|NCT01217073|581221739|FG002|Base Period|Withdrawal by Subject|5|||
160954692|NCT01217073|581221740|FG003|Base Period|Withdrawal by Subject|1|||
160954693|NCT01217073|581221741|FG004|Base Period|Withdrawal by Subject|5|||
160954694|NCT01217073|581221742|FG005|Base Period|Withdrawal by Subject|5|||
160954695|NCT01217073|581221743|FG006|Base Period|Withdrawal by Subject|0|||
160954696|NCT01217073|581221744|FG007|Base Period|Withdrawal by Subject|0|||
160954697|NCT01217073|581221737|FG000|Extension Period|Adverse Event|0|||
160954698|NCT01217073|581221738|FG001|Extension Period|Adverse Event|0|||
160954699|NCT01217073|581221739|FG002|Extension Period|Adverse Event|0|||
160954700|NCT01217073|581221740|FG003|Extension Period|Adverse Event|0|||
160954701|NCT01217073|581221741|FG004|Extension Period|Adverse Event|0|||
160954702|NCT01217073|581221742|FG005|Extension Period|Adverse Event|0|||
160954703|NCT01217073|581221743|FG006|Extension Period|Adverse Event|19|||
160954704|NCT01217073|581221744|FG007|Extension Period|Adverse Event|5|||
160954705|NCT01217073|581221737|FG000|Extension Period|ALT/AST|0|||
160954706|NCT01217073|581221738|FG001|Extension Period|ALT/AST|0|||
160954707|NCT01217073|581221739|FG002|Extension Period|ALT/AST|0|||
160954708|NCT01217073|581221740|FG003|Extension Period|ALT/AST|0|||
160954709|NCT01217073|581221741|FG004|Extension Period|ALT/AST|0|||
160954710|NCT01217073|581221742|FG005|Extension Period|ALT/AST|0|||
160954711|NCT01217073|581221743|FG006|Extension Period|ALT/AST|2|||
160954712|NCT01217073|581221744|FG007|Extension Period|ALT/AST|0|||
160954713|NCT01217073|581221737|FG000|Extension Period|Contraindication to study medication|0|||
160954714|NCT01217073|581221738|FG001|Extension Period|Contraindication to study medication|0|||
160954715|NCT01217073|581221739|FG002|Extension Period|Contraindication to study medication|0|||
160954716|NCT01217073|581221740|FG003|Extension Period|Contraindication to study medication|0|||
160954717|NCT01217073|581221741|FG004|Extension Period|Contraindication to study medication|0|||
160954718|NCT01217073|581221742|FG005|Extension Period|Contraindication to study medication|0|||
160954719|NCT01217073|581221743|FG006|Extension Period|Contraindication to study medication|1|||
161000997|NCT01648140|581388947|FG001|Overall Study|Lost to Follow-up|1|||
161000998|NCT01648140|581388948|FG002|Overall Study|Lost to Follow-up|2|||
161000999|NCT01648140|581388949|FG003|Overall Study|Lost to Follow-up|0|||
161001000|NCT01183780|581388951|FG000|Overall Study|Withdrawal by Subject|25|||
160954720|NCT01217073|581221744|FG007|Extension Period|Contraindication to study medication|0|||
160954721|NCT01217073|581221737|FG000|Extension Period|Creatinine/eGFR|0|||
160582714|NCT01533935|579853708|FG003|Overall Study|Lost to Follow-up|0|||
160954722|NCT01217073|581221738|FG001|Extension Period|Creatinine/eGFR|0|||
160954723|NCT01217073|581221739|FG002|Extension Period|Creatinine/eGFR|0|||
160582715|NCT01533935|579853709|FG004|Overall Study|Lost to Follow-up|0|||
160954724|NCT01217073|581221740|FG003|Extension Period|Creatinine/eGFR|0|||
160582716|NCT01533935|579853705|FG000|Overall Study|Withdrawal by Subject|0|||
160954725|NCT01217073|581221741|FG004|Extension Period|Creatinine/eGFR|0|||
160954726|NCT01217073|581221742|FG005|Extension Period|Creatinine/eGFR|0|||
160954727|NCT01217073|581221743|FG006|Extension Period|Creatinine/eGFR|11|||
160954728|NCT01217073|581221744|FG007|Extension Period|Creatinine/eGFR|1|||
160954729|NCT01217073|581221737|FG000|Extension Period|Death|0|||
161001001|NCT01183780|581388952|FG001|Overall Study|Withdrawal by Subject|14|||
161001002|NCT01183780|581388951|FG000|Overall Study|Lost to Follow-up|6|||
160954730|NCT01217073|581221738|FG001|Extension Period|Death|0|||
160954731|NCT01217073|581221739|FG002|Extension Period|Death|0|||
160954732|NCT01217073|581221740|FG003|Extension Period|Death|0|||
160954733|NCT01217073|581221741|FG004|Extension Period|Death|0|||
160954734|NCT01217073|581221742|FG005|Extension Period|Death|0|||
160954735|NCT01217073|581221743|FG006|Extension Period|Death|1|||
160954736|NCT01217073|581221744|FG007|Extension Period|Death|0|||
160954737|NCT01217073|581221737|FG000|Extension Period|Excluded medication|0|||
160954738|NCT01217073|581221738|FG001|Extension Period|Excluded medication|0|||
160954739|NCT01217073|581221739|FG002|Extension Period|Excluded medication|0|||
160954740|NCT01217073|581221740|FG003|Extension Period|Excluded medication|0|||
160954741|NCT01217073|581221741|FG004|Extension Period|Excluded medication|0|||
160954742|NCT01217073|581221742|FG005|Extension Period|Excluded medication|0|||
160954743|NCT01217073|581221743|FG006|Extension Period|Excluded medication|2|||
160954744|NCT01217073|581221744|FG007|Extension Period|Excluded medication|0|||
160954745|NCT01217073|581221737|FG000|Extension Period|Lack of Efficacy|0|||
160954746|NCT01217073|581221738|FG001|Extension Period|Lack of Efficacy|0|||
160954747|NCT01217073|581221739|FG002|Extension Period|Lack of Efficacy|0|||
160954748|NCT01217073|581221740|FG003|Extension Period|Lack of Efficacy|0|||
160954749|NCT01217073|581221741|FG004|Extension Period|Lack of Efficacy|0|||
160954750|NCT01217073|581221742|FG005|Extension Period|Lack of Efficacy|0|||
160954751|NCT01217073|581221743|FG006|Extension Period|Lack of Efficacy|3|||
160954752|NCT01217073|581221744|FG007|Extension Period|Lack of Efficacy|0|||
160954753|NCT01217073|581221737|FG000|Extension Period|Lost to Follow-up|0|||
160954754|NCT01217073|581221738|FG001|Extension Period|Lost to Follow-up|0|||
160954755|NCT01217073|581221739|FG002|Extension Period|Lost to Follow-up|0|||
160954756|NCT01217073|581221740|FG003|Extension Period|Lost to Follow-up|0|||
160954757|NCT01217073|581221741|FG004|Extension Period|Lost to Follow-up|0|||
160954758|NCT01217073|581221742|FG005|Extension Period|Lost to Follow-up|0|||
160954759|NCT01217073|581221743|FG006|Extension Period|Lost to Follow-up|9|||
160954760|NCT01217073|581221744|FG007|Extension Period|Lost to Follow-up|1|||
160954761|NCT01217073|581221737|FG000|Extension Period|Non-compliance with study drug|0|||
160954762|NCT01217073|581221738|FG001|Extension Period|Non-compliance with study drug|0|||
160954763|NCT01217073|581221739|FG002|Extension Period|Non-compliance with study drug|0|||
160954764|NCT01217073|581221740|FG003|Extension Period|Non-compliance with study drug|0|||
160954765|NCT01217073|581221741|FG004|Extension Period|Non-compliance with study drug|0|||
160954766|NCT01217073|581221742|FG005|Extension Period|Non-compliance with study drug|0|||
160954767|NCT01217073|581221743|FG006|Extension Period|Non-compliance with study drug|0|||
160954768|NCT01217073|581221744|FG007|Extension Period|Non-compliance with study drug|1|||
160954769|NCT01217073|581221737|FG000|Extension Period|Physician Decision|0|||
160954770|NCT01217073|581221738|FG001|Extension Period|Physician Decision|0|||
160954771|NCT01217073|581221739|FG002|Extension Period|Physician Decision|0|||
160954772|NCT01217073|581221740|FG003|Extension Period|Physician Decision|0|||
160954773|NCT01217073|581221741|FG004|Extension Period|Physician Decision|0|||
160954774|NCT01217073|581221742|FG005|Extension Period|Physician Decision|0|||
160954775|NCT01217073|581221743|FG006|Extension Period|Physician Decision|4|||
161001003|NCT01183780|581388952|FG001|Overall Study|Lost to Follow-up|11|||
161001004|NCT01505881|581388953|FG000|Overall Study|Adverse Event|0|||
161001005|NCT01505881|581388954|FG001|Overall Study|Adverse Event|1|||
160582717|NCT01533935|579853706|FG001|Overall Study|Withdrawal by Subject|4|||
160582718|NCT01533935|579853707|FG002|Overall Study|Withdrawal by Subject|5|||
160582719|NCT01533935|579853708|FG003|Overall Study|Withdrawal by Subject|2|||
160582720|NCT01533935|579853709|FG004|Overall Study|Withdrawal by Subject|4|||
160582721|NCT01533935|579853705|FG000|Overall Study|Other reason not defined above|1|||
160582722|NCT01533935|579853706|FG001|Overall Study|Other reason not defined above|0|||
160582723|NCT01533935|579853707|FG002|Overall Study|Other reason not defined above|1|||
160582724|NCT01533935|579853708|FG003|Overall Study|Other reason not defined above|0|||
160582725|NCT01533935|579853709|FG004|Overall Study|Other reason not defined above|1|||
160582726|NCT01554956|579853710|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
160582727|NCT01554956|579853711|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
160582728|NCT01554956|579853712|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
160582729|NCT01554956|579853710|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
160582730|NCT01554956|579853711|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
160582731|NCT01554956|579853712|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
160582732|NCT01554956|579853710|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
160582733|NCT01554956|579853711|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
160582734|NCT01554956|579853712|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
160582735|NCT00069095|579853713|FG000|Primary Treatment Phase|Ongoing|0|||
160954776|NCT01217073|581221744|FG007|Extension Period|Physician Decision|1|||
160954777|NCT01217073|581221737|FG000|Extension Period|Protocol Violation|0|||
160954778|NCT01217073|581221738|FG001|Extension Period|Protocol Violation|0|||
160954779|NCT01217073|581221739|FG002|Extension Period|Protocol Violation|0|||
160954780|NCT01217073|581221740|FG003|Extension Period|Protocol Violation|0|||
161001006|NCT01505881|581388953|FG000|Overall Study|Lost to Follow-up|2|||
161001007|NCT01505881|581388954|FG001|Overall Study|Lost to Follow-up|0|||
160954781|NCT01217073|581221741|FG004|Extension Period|Protocol Violation|0|||
160954782|NCT01217073|581221742|FG005|Extension Period|Protocol Violation|0|||
160954783|NCT01217073|581221743|FG006|Extension Period|Protocol Violation|2|||
160954784|NCT01217073|581221744|FG007|Extension Period|Protocol Violation|1|||
160954785|NCT01217073|581221737|FG000|Extension Period|Site discontinued study participation|0|||
160954786|NCT01217073|581221738|FG001|Extension Period|Site discontinued study participation|0|||
160954787|NCT01217073|581221739|FG002|Extension Period|Site discontinued study participation|0|||
160954788|NCT01217073|581221740|FG003|Extension Period|Site discontinued study participation|0|||
160954789|NCT01217073|581221741|FG004|Extension Period|Site discontinued study participation|0|||
160954790|NCT01217073|581221742|FG005|Extension Period|Site discontinued study participation|0|||
160954791|NCT01217073|581221743|FG006|Extension Period|Site discontinued study participation|7|||
160954792|NCT01217073|581221744|FG007|Extension Period|Site discontinued study participation|2|||
160954793|NCT01217073|581221737|FG000|Extension Period|Withdrawal by Subject|0|||
160954794|NCT01217073|581221738|FG001|Extension Period|Withdrawal by Subject|0|||
160954795|NCT01217073|581221739|FG002|Extension Period|Withdrawal by Subject|0|||
160954796|NCT01217073|581221740|FG003|Extension Period|Withdrawal by Subject|0|||
160954797|NCT01217073|581221741|FG004|Extension Period|Withdrawal by Subject|0|||
160954798|NCT01217073|581221742|FG005|Extension Period|Withdrawal by Subject|0|||
160954799|NCT01217073|581221743|FG006|Extension Period|Withdrawal by Subject|30|||
160954800|NCT01217073|581221744|FG007|Extension Period|Withdrawal by Subject|8|||
160954801|NCT02696317|581221747|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
160954802|NCT02696317|581221748|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
160954803|NCT02696317|581221747|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
160954804|NCT02696317|581221748|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
160954805|NCT01343368|581221749|FG000|Overall Study|Death|1|||
160954806|NCT01343368|581221750|FG001|Overall Study|Death|0|||
160954807|NCT01343368|581221749|FG000|Overall Study|Lost to Follow-up|1|||
160954808|NCT01343368|581221750|FG001|Overall Study|Lost to Follow-up|0|||
160954809|NCT00237744|581221751|FG000|Overall Study|Withdrawal by Subject|3|||
160954810|NCT00237744|581221752|FG001|Overall Study|Withdrawal by Subject|1|||
160954811|NCT00237744|581221753|FG002|Overall Study|Withdrawal by Subject|0|||
160954812|NCT04402866|581221756|FG000|Overall Study|Discontinued Prior to Treatment|0|||
160954813|NCT04402866|581221757|FG001|Overall Study|Discontinued Prior to Treatment|0|||
160954814|NCT04402866|581221758|FG002|Overall Study|Discontinued Prior to Treatment|0|||
160954815|NCT04402866|581221759|FG003|Overall Study|Discontinued Prior to Treatment|0|||
160954816|NCT04402866|581221760|FG004|Overall Study|Discontinued Prior to Treatment|2|||
160954817|NCT04402866|581221761|FG005|Overall Study|Discontinued Prior to Treatment|3|||
160954818|NCT04402866|581221756|FG000|Overall Study|Adverse Event|2|||
160954819|NCT04402866|581221757|FG001|Overall Study|Adverse Event|1|||
160954820|NCT04402866|581221758|FG002|Overall Study|Adverse Event|0|||
160954821|NCT04402866|581221759|FG003|Overall Study|Adverse Event|0|||
160954822|NCT04402866|581221760|FG004|Overall Study|Adverse Event|13|||
160954823|NCT04402866|581221761|FG005|Overall Study|Adverse Event|8|||
160954824|NCT04402866|581221756|FG000|Overall Study|Miscellaneous|0|||
160954825|NCT04402866|581221757|FG001|Overall Study|Miscellaneous|0|||
160954826|NCT04402866|581221758|FG002|Overall Study|Miscellaneous|1|||
160954827|NCT04402866|581221759|FG003|Overall Study|Miscellaneous|0|||
160582736|NCT00069095|579853714|FG001|Primary Treatment Phase|Ongoing|0|||
160582737|NCT00069095|579853715|FG002|Primary Treatment Phase|Ongoing|5|||
160582738|NCT00069095|579853716|FG003|Primary Treatment Phase|Ongoing|7|||
160582739|NCT00069095|579853717|FG004|Primary Treatment Phase|Ongoing|7|||
160582740|NCT00069095|579853718|FG005|Primary Treatment Phase|Ongoing|4|||
160582741|NCT00069095|579853713|FG000|Primary Treatment Phase|Admin/Other|29|||
160582742|NCT00069095|579853714|FG001|Primary Treatment Phase|Admin/Other|38|||
160582743|NCT00069095|579853715|FG002|Primary Treatment Phase|Admin/Other|31|||
160582744|NCT00069095|579853716|FG003|Primary Treatment Phase|Admin/Other|45|||
160582745|NCT00069095|579853717|FG004|Primary Treatment Phase|Admin/Other|48|||
160582746|NCT00069095|579853718|FG005|Primary Treatment Phase|Admin/Other|42|||
160582747|NCT00069095|579853713|FG000|Primary Treatment Phase|Adverse Event|99|||
160582748|NCT00069095|579853714|FG001|Primary Treatment Phase|Adverse Event|92|||
160582749|NCT00069095|579853715|FG002|Primary Treatment Phase|Adverse Event|71|||
160582750|NCT00069095|579853716|FG003|Primary Treatment Phase|Adverse Event|72|||
160582751|NCT00069095|579853717|FG004|Primary Treatment Phase|Adverse Event|109|||
160582752|NCT00069095|579853718|FG005|Primary Treatment Phase|Adverse Event|101|||
160582753|NCT00069095|579853713|FG000|Primary Treatment Phase|Death|14|||
160582754|NCT00069095|579853714|FG001|Primary Treatment Phase|Death|8|||
160582755|NCT00069095|579853715|FG002|Primary Treatment Phase|Death|2|||
160582756|NCT00069095|579853716|FG003|Primary Treatment Phase|Death|5|||
160582757|NCT00069095|579853717|FG004|Primary Treatment Phase|Death|8|||
160582758|NCT00069095|579853718|FG005|Primary Treatment Phase|Death|8|||
160457550|NCT02938923|579406462|FG002|Overall Study|Death|0|||
160457551|NCT02938923|579406460|FG000|Overall Study|Physician Decision|0|||
160582759|NCT00069095|579853713|FG000|Primary Treatment Phase|Failure to return|5|||
160582760|NCT00069095|579853714|FG001|Primary Treatment Phase|Failure to return|5|||
160457552|NCT02938923|579406461|FG001|Overall Study|Physician Decision|2|||
160954828|NCT04402866|581221760|FG004|Overall Study|Miscellaneous|0|||
160954829|NCT04402866|581221761|FG005|Overall Study|Miscellaneous|0|||
160954830|NCT04402866|581221756|FG000|Overall Study|Lost to Follow-up|0|||
160954831|NCT04402866|581221757|FG001|Overall Study|Lost to Follow-up|0|||
160954832|NCT04402866|581221758|FG002|Overall Study|Lost to Follow-up|0|||
160954833|NCT04402866|581221759|FG003|Overall Study|Lost to Follow-up|0|||
160954834|NCT04402866|581221760|FG004|Overall Study|Lost to Follow-up|0|||
160954835|NCT04402866|581221761|FG005|Overall Study|Lost to Follow-up|1|||
160954836|NCT04402866|581221756|FG000|Overall Study|Withdrawal by Subject|0|||
160954837|NCT04402866|581221757|FG001|Overall Study|Withdrawal by Subject|0|||
160954838|NCT04402866|581221758|FG002|Overall Study|Withdrawal by Subject|0|||
161001008|NCT01505881|581388953|FG000|Overall Study|Withdrawal by Subject|2|||
161001009|NCT01505881|581388954|FG001|Overall Study|Withdrawal by Subject|0|||
161001010|NCT01147341|581388955|FG000|Double Blind Period|Lack of Efficacy|1|||
161001011|NCT01147341|581388956|FG001|Double Blind Period|Lack of Efficacy|1|||
161001012|NCT01147341|581388955|FG000|Double Blind Period|Withdrawal by Subject|0|||
161001013|NCT01147341|581388956|FG001|Double Blind Period|Withdrawal by Subject|1|||
161001014|NCT01147341|581388955|FG000|Open Label Period|Lack of Efficacy|3|||
160457553|NCT02938923|579406462|FG002|Overall Study|Physician Decision|0|||
160457554|NCT02938923|579406460|FG000|Overall Study|Withdrawal by Subject|0|||
160457555|NCT02938923|579406461|FG001|Overall Study|Withdrawal by Subject|1|||
160457556|NCT02938923|579406462|FG002|Overall Study|Withdrawal by Subject|1|||
160457557|NCT00721149|579406463|FG000|Overall Study|Physician Decision|1|||
160457558|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
160457559|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
160457560|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
160457561|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
160457562|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
160457563|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
160457564|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
160457565|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
160457566|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
160457567|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
160457568|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
160457569|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
160457570|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
160457571|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
160457572|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
160457573|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
160457574|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
160457575|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
160457576|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
160457577|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
160457578|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
160457579|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
160457580|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
160457581|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
160457582|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
160457583|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
160457584|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
160457585|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
160457586|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
160457587|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
160457588|NCT04614948|579406466|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
160457589|NCT04614948|579406467|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
160457590|NCT04614948|579406468|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
161001015|NCT01147341|581388956|FG001|Open Label Period|Lack of Efficacy|0|||
161001016|NCT01147341|581388955|FG000|Open Label Period|Subject moved|1|||
161001017|NCT01147341|581388956|FG001|Open Label Period|Subject moved|0|||
161001018|NCT01596504|581388957|FG000|Overall Study|Participant's Private Reason|0|||
160457591|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
160457592|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
160457593|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
160582761|NCT00069095|579853715|FG002|Primary Treatment Phase|Failure to return|0|||
160954839|NCT04402866|581221759|FG003|Overall Study|Withdrawal by Subject|0|||
160954840|NCT04402866|581221760|FG004|Overall Study|Withdrawal by Subject|0|||
160954841|NCT04402866|581221761|FG005|Overall Study|Withdrawal by Subject|2|||
161001019|NCT01596504|581388958|FG001|Overall Study|Participant's Private Reason|1|||
161001020|NCT01596504|581388959|FG002|Overall Study|Participant's Private Reason|0|||
161001021|NCT01596504|581388957|FG000|Overall Study|Adverse Event|1|||
161001022|NCT01596504|581388958|FG001|Overall Study|Adverse Event|2|||
160954842|NCT03667053|581221762|FG000|Overall Study|Withdrawal by Subject|1|||
160954843|NCT03667053|581221763|FG001|Overall Study|Withdrawal by Subject|0|||
160954844|NCT03667053|581221764|FG002|Overall Study|Withdrawal by Subject|0|||
160954845|NCT02732938|581221766|FG000|Overall Study|Death|0|||
160954846|NCT02732938|581221767|FG001|Overall Study|Death|11|||
160954847|NCT02732938|581221768|FG002|Overall Study|Death|0|||
160954848|NCT02732938|581221766|FG000|Overall Study|Randomized but did not receive treatment|0|||
160954849|NCT02732938|581221767|FG001|Overall Study|Randomized but did not receive treatment|1|||
160954850|NCT02732938|581221768|FG002|Overall Study|Randomized but did not receive treatment|0|||
160954851|NCT02732938|581221766|FG000|Overall Study|Refused further follow-up|1|||
160954852|NCT02732938|581221767|FG001|Overall Study|Refused further follow-up|0|||
160954853|NCT02732938|581221768|FG002|Overall Study|Refused further follow-up|0|||
160954854|NCT02732938|581221766|FG000|Overall Study|Study terminated by sponsor|3|||
160954855|NCT02732938|581221767|FG001|Overall Study|Study terminated by sponsor|6|||
160954856|NCT02732938|581221768|FG002|Overall Study|Study terminated by sponsor|0|||
160954857|NCT02015676|581221769|FG000|Overall Study|Adverse Event|2|||
160954858|NCT02015676|581221770|FG001|Overall Study|Adverse Event|18|||
160954859|NCT02015676|581221771|FG002|Overall Study|Adverse Event|0|||
160954860|NCT02015676|581221769|FG000|Overall Study|Lack of Efficacy|2|||
160954861|NCT02015676|581221770|FG001|Overall Study|Lack of Efficacy|4|||
160954862|NCT02015676|581221771|FG002|Overall Study|Lack of Efficacy|0|||
160954863|NCT02015676|581221769|FG000|Overall Study|Protocol Violation|1|||
160954864|NCT02015676|581221770|FG001|Overall Study|Protocol Violation|0|||
160954865|NCT02015676|581221771|FG002|Overall Study|Protocol Violation|0|||
160954866|NCT02015676|581221769|FG000|Overall Study|Withdrawal by Subject|1|||
160954867|NCT02015676|581221770|FG001|Overall Study|Withdrawal by Subject|7|||
160954868|NCT02015676|581221771|FG002|Overall Study|Withdrawal by Subject|1|||
160954869|NCT02015676|581221769|FG000|Overall Study|Administrative reasons|0|||
160954870|NCT02015676|581221770|FG001|Overall Study|Administrative reasons|3|||
160954871|NCT02015676|581221771|FG002|Overall Study|Administrative reasons|1|||
160954872|NCT02015676|581221769|FG000|Overall Study|Death|0|||
160954873|NCT02015676|581221770|FG001|Overall Study|Death|1|||
160954874|NCT02015676|581221771|FG002|Overall Study|Death|0|||
160954875|NCT02015676|581221769|FG000|Overall Study|Disease progression|3|||
160954876|NCT02015676|581221770|FG001|Overall Study|Disease progression|1|||
160954877|NCT02015676|581221771|FG002|Overall Study|Disease progression|1|||
160954878|NCT00476476|581221773|FG000|Overall Study|Adverse Event|2|||
160954879|NCT00476476|581221774|FG001|Overall Study|Adverse Event|7|||
160954880|NCT00476476|581221773|FG000|Overall Study|Progressive Disease|0|||
160954881|NCT00476476|581221774|FG001|Overall Study|Progressive Disease|17|||
161001023|NCT01596504|581388959|FG002|Overall Study|Adverse Event|1|||
161001024|NCT01596504|581388957|FG000|Overall Study|Withdrawal by Subject|1|||
161001025|NCT01596504|581388958|FG001|Overall Study|Withdrawal by Subject|0|||
161001026|NCT01596504|581388959|FG002|Overall Study|Withdrawal by Subject|0|||
161001027|NCT00949975|581388960|FG000|Overall Study|Voluntary discontinuation|6|||
161001028|NCT00949975|581388961|FG001|Overall Study|Voluntary discontinuation|5|||
161001029|NCT00949975|581388962|FG002|Overall Study|Voluntary discontinuation|3|||
161001030|NCT00949975|581388963|FG003|Overall Study|Voluntary discontinuation|6|||
161001031|NCT00949975|581388960|FG000|Overall Study|Adverse Event|11|||
161001032|NCT00949975|581388961|FG001|Overall Study|Adverse Event|11|||
161001033|NCT00949975|581388962|FG002|Overall Study|Adverse Event|10|||
161001034|NCT00949975|581388963|FG003|Overall Study|Adverse Event|10|||
161001035|NCT00949975|581388960|FG000|Overall Study|Safety reason|0|||
161001036|NCT00949975|581388961|FG001|Overall Study|Safety reason|1|||
161001037|NCT00949975|581388962|FG002|Overall Study|Safety reason|0|||
161001038|NCT00949975|581388963|FG003|Overall Study|Safety reason|0|||
161001039|NCT00949975|581388960|FG000|Overall Study|Study-specific criteria|0|||
161001040|NCT00949975|581388961|FG001|Overall Study|Study-specific criteria|1|||
161001041|NCT00949975|581388962|FG002|Overall Study|Study-specific criteria|1|||
161001042|NCT00949975|581388963|FG003|Overall Study|Study-specific criteria|0|||
161001043|NCT00949975|581388960|FG000|Overall Study|Incorrect enrolment|5|||
161001044|NCT00949975|581388961|FG001|Overall Study|Incorrect enrolment|10|||
161001045|NCT00949975|581388962|FG002|Overall Study|Incorrect enrolment|4|||
161001046|NCT00949975|581388963|FG003|Overall Study|Incorrect enrolment|7|||
161001047|NCT00949975|581388960|FG000|Overall Study|Severe non-compliance|3|||
161001048|NCT00949975|581388961|FG001|Overall Study|Severe non-compliance|1|||
160457594|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
160954882|NCT00971048|581221778|FG000|Overall Study|Protocol Violation|1|||
160954883|NCT00971048|581221779|FG001|Overall Study|Protocol Violation|2|||
160954884|NCT00971048|581221780|FG002|Overall Study|Protocol Violation|0|||
161001049|NCT00949975|581388962|FG002|Overall Study|Severe non-compliance|0|||
161001050|NCT00949975|581388963|FG003|Overall Study|Severe non-compliance|2|||
161001051|NCT00949975|581388960|FG000|Overall Study|Lost to Follow-up|1|||
161001052|NCT00949975|581388961|FG001|Overall Study|Lost to Follow-up|0|||
161001053|NCT00949975|581388962|FG002|Overall Study|Lost to Follow-up|1|||
161001054|NCT00949975|581388963|FG003|Overall Study|Lost to Follow-up|3|||
161001055|NCT00949975|581388960|FG000|Overall Study|Other|1|||
160954885|NCT00971048|581221781|FG003|Overall Study|Protocol Violation|1|||
161001056|NCT00949975|581388961|FG001|Overall Study|Other|0|||
160457595|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
160457596|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
160457597|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
160457598|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
160457599|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
160457600|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
160954886|NCT00971048|581221778|FG000|Overall Study|Adverse Event|0|||
160954887|NCT00971048|581221779|FG001|Overall Study|Adverse Event|0|||
160954888|NCT00971048|581221780|FG002|Overall Study|Adverse Event|1|||
160954889|NCT00971048|581221781|FG003|Overall Study|Adverse Event|0|||
160954890|NCT00971048|581221778|FG000|Overall Study|Physician Decision|0|||
160954891|NCT00971048|581221779|FG001|Overall Study|Physician Decision|0|||
160954892|NCT00971048|581221780|FG002|Overall Study|Physician Decision|0|||
160954893|NCT00971048|581221781|FG003|Overall Study|Physician Decision|1|||
160954894|NCT04349553|581221785|FG000|Overall Study|Withdrawal by Subject|1|||
160954895|NCT04349553|581221786|FG001|Overall Study|Withdrawal by Subject|0|||
160954896|NCT04349553|581221787|FG002|Overall Study|Withdrawal by Subject|1|||
160954897|NCT04349553|581221788|FG003|Overall Study|Withdrawal by Subject|0|||
160954898|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
160954899|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
160954900|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
160954901|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
160954902|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
160954903|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
160954904|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
160954905|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
160954906|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
160954907|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
160954908|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
160954909|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
160954910|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
160954911|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
160954912|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
160954913|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
160954914|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
160954915|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
160954916|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
160954917|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
160954918|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
160954919|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
160954920|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
160954921|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
160954922|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
160954923|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
160954924|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
160954925|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
160954926|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
160954927|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
160954928|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
160954929|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
160954930|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
160954931|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
160954932|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
160954933|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
160954934|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
160954935|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
160954936|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
160954937|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
160954938|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
160954939|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
160954940|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
160457601|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
160457602|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
160954941|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
160954942|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
161001057|NCT00949975|581388962|FG002|Overall Study|Other|0|||
160457603|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
160656359|NCT00864097|580122440|FG003|Overall Study|Withdrawal by Subject|12|||
160954943|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
160954944|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
160954945|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
160954946|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
160954947|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
160954948|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
160954949|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
160954950|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
160954951|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
160954952|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
160954953|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
160954954|NCT02647359|581221795|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
160954955|NCT02647359|581221796|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
160954956|NCT02647359|581221795|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
160954957|NCT02647359|581221796|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
160954958|NCT02647359|581221795|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
161001058|NCT00949975|581388963|FG003|Overall Study|Other|0|||
161001059|NCT04246762|581388964|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
161001060|NCT02878330|581388965|FG000|Overall Study|Death|3|||
161001061|NCT02878330|581388966|FG001|Overall Study|Death|2|||
160582762|NCT00069095|579853716|FG003|Primary Treatment Phase|Failure to return|0|||
160582763|NCT00069095|579853717|FG004|Primary Treatment Phase|Failure to return|0|||
160582764|NCT00069095|579853718|FG005|Primary Treatment Phase|Failure to return|2|||
160582765|NCT00069095|579853713|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
160582766|NCT00069095|579853714|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
160582767|NCT00069095|579853715|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
160582768|NCT00069095|579853716|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
160582769|NCT00069095|579853717|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
160954959|NCT02647359|581221796|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
160954960|NCT02647359|581221795|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
160954961|NCT02647359|581221796|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
161001062|NCT02878330|581388965|FG000|Overall Study|Lost to Follow-up|11|||
161001063|NCT02878330|581388966|FG001|Overall Study|Lost to Follow-up|26|||
161001064|NCT02878330|581388965|FG000|Overall Study|Withdrawal by Subject|11|||
161001065|NCT02878330|581388966|FG001|Overall Study|Withdrawal by Subject|21|||
161001066|NCT02878330|581388965|FG000|Overall Study|Other|4|||
161001067|NCT02878330|581388966|FG001|Overall Study|Other|7|||
161001068|NCT03615924|581388967|FG000|Overall Study|Withdrawal by Subject|2|||
161001069|NCT03615924|581388968|FG001|Overall Study|Withdrawal by Subject|5|||
161001070|NCT03615924|581388967|FG000|Overall Study|Death|3|||
161001071|NCT03615924|581388968|FG001|Overall Study|Death|1|||
161001072|NCT03615924|581388967|FG000|Overall Study|Lost to Follow-up|1|||
161001073|NCT03615924|581388968|FG001|Overall Study|Lost to Follow-up|0|||
161001074|NCT03615924|581388967|FG000|Overall Study|Randomized in error|1|||
161001075|NCT03615924|581388968|FG001|Overall Study|Randomized in error|0|||
161001076|NCT03615924|581388967|FG000|Overall Study|Study termination by Sponsor|94|||
161001077|NCT03615924|581388968|FG001|Overall Study|Study termination by Sponsor|86|||
161001078|NCT02954848|581388969|FG000|Overall Study|Randomized but Not Treated|0|||
161001079|NCT02954848|581388970|FG001|Overall Study|Randomized but Not Treated|1|||
161001080|NCT02954848|581388969|FG000|Overall Study|Adverse Event|2|||
161001081|NCT02954848|581388970|FG001|Overall Study|Adverse Event|3|||
161001082|NCT02954848|581388969|FG000|Overall Study|Withdrawal by Participant|0|||
161001083|NCT02954848|581388970|FG001|Overall Study|Withdrawal by Participant|1|||
161001084|NCT00922207|581388971|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
161001085|NCT00922207|581388972|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
161001086|NCT00922207|581388973|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
161001087|NCT00922207|581388971|FG000|Overall Study|Insufficient Therapeutic Response|0|||
161001088|NCT00922207|581388972|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161001089|NCT00922207|581388973|FG002|Overall Study|Insufficient Therapeutic Response|1|||
160457604|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
160457605|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
160582770|NCT00069095|579853718|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
160582771|NCT00069095|579853713|FG000|Primary Treatment Phase|Refused treatment|15|||
160582772|NCT00069095|579853714|FG001|Primary Treatment Phase|Refused treatment|26|||
161001090|NCT00922207|581388971|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
161001091|NCT00922207|581388972|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161001092|NCT00922207|581388973|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
161001093|NCT00922207|581388971|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
161001094|NCT00922207|581388972|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
161001095|NCT00922207|581388973|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
160954962|NCT02647359|581221795|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
160954963|NCT02647359|581221796|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
160954964|NCT02647359|581221795|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
160954965|NCT02647359|581221796|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
160954966|NCT00413413|581221797|FG000|Single-Blind|Adverse Event|0|||
160954967|NCT00413413|581221798|FG001|Single-Blind|Adverse Event|9|||
160954968|NCT00413413|581221799|FG002|Single-Blind|Adverse Event|0|||
160954969|NCT00413413|581221797|FG000|Single-Blind|Lack of Efficacy|0|||
160954970|NCT00413413|581221798|FG001|Single-Blind|Lack of Efficacy|5|||
160954971|NCT00413413|581221799|FG002|Single-Blind|Lack of Efficacy|0|||
160954972|NCT00413413|581221797|FG000|Single-Blind|Subject no longer requires study drug|0|||
160954973|NCT00413413|581221798|FG001|Single-Blind|Subject no longer requires study drug|151|||
160954974|NCT00413413|581221799|FG002|Single-Blind|Subject no longer requires study drug|0|||
160954975|NCT00413413|581221797|FG000|Single-Blind|Protocol Violation|0|||
160954976|NCT00413413|581221798|FG001|Single-Blind|Protocol Violation|16|||
160954977|NCT00413413|581221799|FG002|Single-Blind|Protocol Violation|0|||
160954978|NCT00413413|581221797|FG000|Single-Blind|Withdrawal by Subject|0|||
160954979|NCT00413413|581221798|FG001|Single-Blind|Withdrawal by Subject|27|||
160954980|NCT00413413|581221799|FG002|Single-Blind|Withdrawal by Subject|0|||
160954981|NCT00413413|581221797|FG000|Single-Blind|Lost to Follow-up|0|||
160954982|NCT00413413|581221798|FG001|Single-Blind|Lost to Follow-up|8|||
160954983|NCT00413413|581221799|FG002|Single-Blind|Lost to Follow-up|0|||
160954984|NCT00413413|581221797|FG000|Double-Blind|Adverse Event|6|||
160954985|NCT00413413|581221798|FG001|Double-Blind|Adverse Event|0|||
160954986|NCT00413413|581221799|FG002|Double-Blind|Adverse Event|5|||
160954987|NCT00413413|581221797|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
160954988|NCT00413413|581221798|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
160954989|NCT00413413|581221799|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
160954990|NCT00413413|581221797|FG000|Double-Blind|Protocol deviation|1|||
160954991|NCT00413413|581221798|FG001|Double-Blind|Protocol deviation|2|||
160954992|NCT00413413|581221799|FG002|Double-Blind|Protocol deviation|1|||
160954993|NCT00413413|581221797|FG000|Double-Blind|Subject withdrew consent|4|||
160954994|NCT00413413|581221798|FG001|Double-Blind|Subject withdrew consent|6|||
160954995|NCT00413413|581221799|FG002|Double-Blind|Subject withdrew consent|9|||
160954996|NCT00413413|581221797|FG000|Double-Blind|Lost to Follow-up|3|||
160954997|NCT00413413|581221798|FG001|Double-Blind|Lost to Follow-up|4|||
160954998|NCT00413413|581221799|FG002|Double-Blind|Lost to Follow-up|2|||
160954999|NCT02219932|581221806|FG000|Overall Study|Other|5|||
160955000|NCT02219932|581221807|FG001|Overall Study|Other|11|||
160955001|NCT02219932|581221806|FG000|Overall Study|Death|1|||
160955002|NCT02219932|581221807|FG001|Overall Study|Death|1|||
160955003|NCT02219932|581221806|FG000|Overall Study|Investigator Decision|0|||
160955004|NCT02219932|581221807|FG001|Overall Study|Investigator Decision|1|||
160955005|NCT02219932|581221806|FG000|Overall Study|Consent Withdrawn|11|||
160955006|NCT02219932|581221807|FG001|Overall Study|Consent Withdrawn|7|||
160955007|NCT02219932|581221806|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
160955008|NCT02219932|581221807|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
160955009|NCT02219932|581221806|FG000|Overall Study|Protocol Violation|10|||
160955010|NCT02219932|581221807|FG001|Overall Study|Protocol Violation|6|||
160955011|NCT02219932|581221806|FG000|Overall Study|Pregnancy|1|||
160955012|NCT02219932|581221807|FG001|Overall Study|Pregnancy|0|||
160955013|NCT02219932|581221806|FG000|Overall Study|Lost to Follow-up|4|||
160955014|NCT02219932|581221807|FG001|Overall Study|Lost to Follow-up|2|||
160955015|NCT02219932|581221806|FG000|Overall Study|Adverse Event|23|||
160955016|NCT02219932|581221807|FG001|Overall Study|Adverse Event|21|||
160955017|NCT00511004|581221810|FG000|Overall Study|Lost to Follow-up|0|||
160955018|NCT00511004|581221811|FG001|Overall Study|Lost to Follow-up|0|||
160955019|NCT00511004|581221812|FG002|Overall Study|Lost to Follow-up|4|||
160955020|NCT04642638|581221813|FG000|Overall Study|Withdrawal by Subject|23|||
160955021|NCT04642638|581221814|FG001|Overall Study|Withdrawal by Subject|29|||
160955022|NCT04642638|581221815|FG002|Overall Study|Withdrawal by Subject|9|||
160955023|NCT04642638|581221816|FG003|Overall Study|Withdrawal by Subject|7|||
160955024|NCT04642638|581221817|FG004|Overall Study|Withdrawal by Subject|61|||
160955025|NCT04642638|581221818|FG005|Overall Study|Withdrawal by Subject|27|||
160955026|NCT04642638|581221813|FG000|Overall Study|Lost to Follow-up|17|||
160955027|NCT04642638|581221814|FG001|Overall Study|Lost to Follow-up|18|||
160955028|NCT04642638|581221815|FG002|Overall Study|Lost to Follow-up|5|||
160955029|NCT04642638|581221816|FG003|Overall Study|Lost to Follow-up|5|||
160955030|NCT04642638|581221817|FG004|Overall Study|Lost to Follow-up|6|||
160955031|NCT04642638|581221818|FG005|Overall Study|Lost to Follow-up|3|||
160955032|NCT04642638|581221813|FG000|Overall Study|Adverse Event|0|||
160955033|NCT04642638|581221814|FG001|Overall Study|Adverse Event|0|||
160955034|NCT04642638|581221815|FG002|Overall Study|Adverse Event|1|||
160955035|NCT04642638|581221816|FG003|Overall Study|Adverse Event|0|||
160955036|NCT04642638|581221817|FG004|Overall Study|Adverse Event|10|||
160955037|NCT04642638|581221818|FG005|Overall Study|Adverse Event|3|||
160955038|NCT04642638|581221813|FG000|Overall Study|Reason Not Specified|1|||
160955039|NCT04642638|581221814|FG001|Overall Study|Reason Not Specified|4|||
160955040|NCT04642638|581221815|FG002|Overall Study|Reason Not Specified|0|||
160955041|NCT04642638|581221816|FG003|Overall Study|Reason Not Specified|0|||
160955042|NCT04642638|581221817|FG004|Overall Study|Reason Not Specified|38|||
160955043|NCT04642638|581221818|FG005|Overall Study|Reason Not Specified|16|||
160955044|NCT04642638|581221813|FG000|Overall Study|Physician Decision|0|||
160955045|NCT04642638|581221814|FG001|Overall Study|Physician Decision|0|||
160955046|NCT04642638|581221815|FG002|Overall Study|Physician Decision|0|||
160955047|NCT04642638|581221816|FG003|Overall Study|Physician Decision|0|||
160955048|NCT04642638|581221817|FG004|Overall Study|Physician Decision|2|||
160955049|NCT04642638|581221818|FG005|Overall Study|Physician Decision|1|||
160955050|NCT04642638|581221813|FG000|Overall Study|Protocol Deviation|0|||
160955051|NCT04642638|581221814|FG001|Overall Study|Protocol Deviation|0|||
160955052|NCT04642638|581221815|FG002|Overall Study|Protocol Deviation|0|||
160955053|NCT04642638|581221816|FG003|Overall Study|Protocol Deviation|0|||
160955054|NCT04642638|581221817|FG004|Overall Study|Protocol Deviation|1|||
160955055|NCT04642638|581221818|FG005|Overall Study|Protocol Deviation|3|||
160955056|NCT04642638|581221813|FG000|Overall Study|Study Terminated|0|||
160955057|NCT04642638|581221814|FG001|Overall Study|Study Terminated|0|||
160955058|NCT04642638|581221815|FG002|Overall Study|Study Terminated|0|||
160955059|NCT04642638|581221816|FG003|Overall Study|Study Terminated|0|||
160955060|NCT04642638|581221817|FG004|Overall Study|Study Terminated|484|||
160955061|NCT04642638|581221818|FG005|Overall Study|Study Terminated|250|||
160955062|NCT04642638|581221813|FG000|Overall Study|Pregnancy|0|||
160955063|NCT04642638|581221814|FG001|Overall Study|Pregnancy|0|||
160955064|NCT04642638|581221815|FG002|Overall Study|Pregnancy|0|||
160955065|NCT04642638|581221816|FG003|Overall Study|Pregnancy|0|||
160955066|NCT04642638|581221817|FG004|Overall Study|Pregnancy|1|||
160955067|NCT04642638|581221818|FG005|Overall Study|Pregnancy|0|||
160955068|NCT00990652|581221819|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
160955069|NCT00990652|581221819|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
160955070|NCT01869491|581221822|FG000|Overall Study|Adverse Event|3|||
160955071|NCT01869491|581221823|FG001|Overall Study|Adverse Event|5|||
160955072|NCT01869491|581221822|FG000|Overall Study|Lack of Efficacy|0|||
160955073|NCT01869491|581221823|FG001|Overall Study|Lack of Efficacy|3|||
160955074|NCT01869491|581221822|FG000|Overall Study|Withdrawal by Subject|6|||
160955075|NCT01869491|581221823|FG001|Overall Study|Withdrawal by Subject|7|||
160955076|NCT01869491|581221822|FG000|Overall Study|Lost to Follow-up|11|||
160955077|NCT01869491|581221823|FG001|Overall Study|Lost to Follow-up|9|||
160955078|NCT01869491|581221822|FG000|Overall Study|No further need of investigational product|1|||
160955079|NCT01869491|581221823|FG001|Overall Study|No further need of investigational product|0|||
160955080|NCT05177770|581221824|FG000|Overall Study|Death|4|||
160955081|NCT05177770|581221824|FG000|Overall Study|Withdrawal by Subject|1|||
160955082|NCT05177770|581221824|FG000|Overall Study|Adverse Event prior to dosing|1|||
160955083|NCT01672801|581221828|FG000|Overall Study|Screen Failure|0|||
160955084|NCT01672801|581221829|FG001|Overall Study|Screen Failure|1|||
160457606|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
160955085|NCT06476366|581221830|FG000|Overall Study|Lost to Follow-up|1|||
160955086|NCT06476366|581221831|FG001|Overall Study|Lost to Follow-up|3|||
160955087|NCT06476366|581221830|FG000|Overall Study|Adverse Event|1|||
160955088|NCT06476366|581221831|FG001|Overall Study|Adverse Event|0|||
160955089|NCT04313881|581221836|FG000|Overall Study|Death|138|||
160955090|NCT04313881|581221837|FG001|Overall Study|Death|126|||
160955091|NCT04313881|581221836|FG000|Overall Study|Study terminated by sponsor|108|||
160955092|NCT04313881|581221837|FG001|Overall Study|Study terminated by sponsor|129|||
160955093|NCT04313881|581221836|FG000|Overall Study|Consent withdrawn|19|||
160955094|NCT04313881|581221837|FG001|Overall Study|Consent withdrawn|15|||
160955095|NCT04313881|581221836|FG000|Overall Study|Reason not Specified|3|||
160955096|NCT04313881|581221837|FG001|Overall Study|Reason not Specified|1|||
160955097|NCT00727272|581221838|FG000|Washout Period A|Adverse Event|0|||
160955098|NCT00727272|581221839|FG001|Washout Period A|Adverse Event|0|||
160955099|NCT00727272|581221840|FG002|Washout Period A|Adverse Event|1|||
160955100|NCT00727272|581221838|FG000|Washout Period B|Withdrawal by Subject|0|||
160955101|NCT00727272|581221839|FG001|Washout Period B|Withdrawal by Subject|0|||
160955102|NCT00727272|581221840|FG002|Washout Period B|Withdrawal by Subject|1|||
160955103|NCT00651664|581221841|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
160955104|NCT00651664|581221842|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
160955105|NCT00651664|581221843|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
160955106|NCT00651664|581221844|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
160955107|NCT00651664|581221845|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
160955108|NCT00651664|581221846|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
160955109|NCT00651664|581221847|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
160955110|NCT00651664|581221848|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
160955111|NCT00651664|581221849|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
160955112|NCT00651664|581221850|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
160955113|NCT00651664|581221841|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955114|NCT00651664|581221842|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955115|NCT00651664|581221843|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955116|NCT00651664|581221844|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955117|NCT00651664|581221845|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
160955118|NCT00651664|581221846|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
160955119|NCT00651664|581221847|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955120|NCT00651664|581221848|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
160955121|NCT00651664|581221849|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955122|NCT00651664|581221850|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
160955123|NCT00651664|581221841|FG000|Overall Study|Progressive Disease|3|||
160955124|NCT00651664|581221842|FG001|Overall Study|Progressive Disease|3|||
160955125|NCT00651664|581221843|FG002|Overall Study|Progressive Disease|3|||
160955126|NCT00651664|581221844|FG003|Overall Study|Progressive Disease|12|||
160955127|NCT00651664|581221845|FG004|Overall Study|Progressive Disease|4|||
160955128|NCT00651664|581221846|FG005|Overall Study|Progressive Disease|1|||
160955129|NCT00651664|581221847|FG006|Overall Study|Progressive Disease|3|||
160955130|NCT00651664|581221848|FG007|Overall Study|Progressive Disease|6|||
160955131|NCT00651664|581221849|FG008|Overall Study|Progressive Disease|5|||
160955132|NCT00651664|581221850|FG009|Overall Study|Progressive Disease|5|||
160955133|NCT00651664|581221841|FG000|Overall Study|Patient Declined Further Treatment|0|||
160955134|NCT00651664|581221842|FG001|Overall Study|Patient Declined Further Treatment|0|||
160955135|NCT00651664|581221843|FG002|Overall Study|Patient Declined Further Treatment|0|||
160955136|NCT00651664|581221844|FG003|Overall Study|Patient Declined Further Treatment|1|||
160955137|NCT00651664|581221845|FG004|Overall Study|Patient Declined Further Treatment|1|||
160955138|NCT00651664|581221846|FG005|Overall Study|Patient Declined Further Treatment|1|||
160955139|NCT00651664|581221847|FG006|Overall Study|Patient Declined Further Treatment|0|||
160955140|NCT00651664|581221848|FG007|Overall Study|Patient Declined Further Treatment|0|||
160955141|NCT00651664|581221849|FG008|Overall Study|Patient Declined Further Treatment|0|||
161001096|NCT00922207|581388971|FG000|Overall Study|Withdrew Consent|2|||
161001097|NCT00922207|581388972|FG001|Overall Study|Withdrew Consent|5|||
161001098|NCT00922207|581388973|FG002|Overall Study|Withdrew Consent|2|||
160955142|NCT00651664|581221850|FG009|Overall Study|Patient Declined Further Treatment|1|||
160955143|NCT00651664|581221841|FG000|Overall Study|Symptomatic Deterioration|0|||
160955144|NCT00651664|581221842|FG001|Overall Study|Symptomatic Deterioration|0|||
160955145|NCT00651664|581221843|FG002|Overall Study|Symptomatic Deterioration|0|||
160955146|NCT00651664|581221844|FG003|Overall Study|Symptomatic Deterioration|1|||
160955147|NCT00651664|581221845|FG004|Overall Study|Symptomatic Deterioration|0|||
160955148|NCT00651664|581221846|FG005|Overall Study|Symptomatic Deterioration|0|||
160955149|NCT00651664|581221847|FG006|Overall Study|Symptomatic Deterioration|1|||
160955150|NCT00651664|581221848|FG007|Overall Study|Symptomatic Deterioration|0|||
160955151|NCT00651664|581221849|FG008|Overall Study|Symptomatic Deterioration|1|||
160955152|NCT00651664|581221850|FG009|Overall Study|Symptomatic Deterioration|0|||
160955153|NCT00651664|581221841|FG000|Overall Study|Reason not Specified|0|||
160955154|NCT00651664|581221842|FG001|Overall Study|Reason not Specified|0|||
160955155|NCT00651664|581221843|FG002|Overall Study|Reason not Specified|0|||
160955156|NCT00651664|581221844|FG003|Overall Study|Reason not Specified|0|||
160955157|NCT00651664|581221845|FG004|Overall Study|Reason not Specified|0|||
160955158|NCT00651664|581221846|FG005|Overall Study|Reason not Specified|0|||
160955159|NCT00651664|581221847|FG006|Overall Study|Reason not Specified|1|||
160955160|NCT00651664|581221848|FG007|Overall Study|Reason not Specified|0|||
160955161|NCT00651664|581221849|FG008|Overall Study|Reason not Specified|0|||
160955162|NCT00651664|581221850|FG009|Overall Study|Reason not Specified|0|||
160955163|NCT01272934|581221853|FG000|Overall Study|Adverse Event|0|||
160955164|NCT01272934|581221854|FG001|Overall Study|Adverse Event|1|||
160955165|NCT01272934|581221853|FG000|Overall Study|Abnormal Laboratory Value|0|||
161001099|NCT00922207|581388971|FG000|Overall Study|Abnormality of Laboratory Test|0|||
161001100|NCT00922207|581388972|FG001|Overall Study|Abnormality of Laboratory Test|1|||
161001101|NCT00922207|581388973|FG002|Overall Study|Abnormality of Laboratory Test|1|||
161001102|NCT01802632|581388974|FG000|Overall Study|Death|28|||
161001103|NCT01802632|581388975|FG001|Overall Study|Death|1|||
161001104|NCT01802632|581388976|FG002|Overall Study|Death|38|||
160457607|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
160457608|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
160457609|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
160582773|NCT00069095|579853715|FG002|Primary Treatment Phase|Refused treatment|17|||
160955166|NCT01272934|581221854|FG001|Overall Study|Abnormal Laboratory Value|1|||
160955167|NCT00214136|581221855|FG000|Overall Study|Death|5|||
160955168|NCT04313634|581221856|FG000|Overall Study|Adverse Event|2|||
160955169|NCT04313634|581221857|FG001|Overall Study|Adverse Event|2|||
160955170|NCT04313634|581221858|FG002|Overall Study|Adverse Event|0|||
160955171|NCT04313634|581221856|FG000|Overall Study|Withdrawal by Subject|1|||
161001105|NCT01802632|581388977|FG003|Overall Study|Death|0|||
161001106|NCT01802632|581388978|FG004|Overall Study|Death|2|||
161001107|NCT01802632|581388979|FG005|Overall Study|Death|0|||
160582774|NCT00069095|579853716|FG003|Primary Treatment Phase|Refused treatment|31|||
161001108|NCT01802632|581388974|FG000|Overall Study|Withdrawal by Subject|4|||
161001109|NCT01802632|581388975|FG001|Overall Study|Withdrawal by Subject|2|||
160457610|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
160457611|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
160457612|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
160457613|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
160457614|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
160457615|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
160457616|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
160457617|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
160955172|NCT04313634|581221857|FG001|Overall Study|Withdrawal by Subject|0|||
160955173|NCT04313634|581221858|FG002|Overall Study|Withdrawal by Subject|1|||
160955174|NCT04313634|581221856|FG000|Overall Study|Protocol Violation|0|||
160955175|NCT04313634|581221857|FG001|Overall Study|Protocol Violation|0|||
160955176|NCT04313634|581221858|FG002|Overall Study|Protocol Violation|1|||
160955177|NCT00319098|581221861|FG000|Overall Study|Serious adverse event|3|||
160955178|NCT00319098|581221862|FG001|Overall Study|Serious adverse event|0|||
160955179|NCT00319098|581221861|FG000|Overall Study|Adverse Event|20|||
160955180|NCT00319098|581221862|FG001|Overall Study|Adverse Event|1|||
160955181|NCT00319098|581221861|FG000|Overall Study|Withdrawal by Subject|37|||
160955182|NCT00319098|581221862|FG001|Overall Study|Withdrawal by Subject|8|||
160955183|NCT00319098|581221861|FG000|Overall Study|Migrated/moved from study area|2|||
160955184|NCT00319098|581221862|FG001|Overall Study|Migrated/moved from study area|1|||
160955185|NCT00319098|581221861|FG000|Overall Study|Lost to Follow-up|37|||
160955186|NCT00319098|581221862|FG001|Overall Study|Lost to Follow-up|13|||
160955187|NCT00319098|581221861|FG000|Overall Study|Others|33|||
160955188|NCT00319098|581221862|FG001|Overall Study|Others|8|||
160955189|NCT00319098|581221861|FG000|Overall Study|Protocol Violation|3|||
160955190|NCT00319098|581221862|FG001|Overall Study|Protocol Violation|1|||
160955191|NCT03449030|581221863|FG000|Overall Study|Withdrawal by Subject|0|||
160955192|NCT03449030|581221864|FG001|Overall Study|Withdrawal by Subject|0|||
160955193|NCT03449030|581221865|FG002|Overall Study|Withdrawal by Subject|0|||
160955194|NCT03449030|581221866|FG003|Overall Study|Withdrawal by Subject|1|||
160955195|NCT03449030|581221867|FG004|Overall Study|Withdrawal by Subject|1|||
160955196|NCT03449030|581221868|FG005|Overall Study|Withdrawal by Subject|1|||
160955197|NCT03449030|581221869|FG006|Overall Study|Withdrawal by Subject|1|||
160955198|NCT03449030|581221870|FG007|Overall Study|Withdrawal by Subject|2|||
160955199|NCT03449030|581221871|FG008|Overall Study|Withdrawal by Subject|0|||
160955200|NCT03449030|581221872|FG009|Overall Study|Withdrawal by Subject|0|||
160955201|NCT03449030|581221863|FG000|Overall Study|Symptomatic Deterioration|0|||
160955202|NCT03449030|581221864|FG001|Overall Study|Symptomatic Deterioration|1|||
160955203|NCT03449030|581221865|FG002|Overall Study|Symptomatic Deterioration|0|||
160955204|NCT03449030|581221866|FG003|Overall Study|Symptomatic Deterioration|0|||
160955205|NCT03449030|581221867|FG004|Overall Study|Symptomatic Deterioration|0|||
160955206|NCT03449030|581221868|FG005|Overall Study|Symptomatic Deterioration|1|||
160955207|NCT03449030|581221869|FG006|Overall Study|Symptomatic Deterioration|1|||
160955208|NCT03449030|581221870|FG007|Overall Study|Symptomatic Deterioration|0|||
160955209|NCT03449030|581221871|FG008|Overall Study|Symptomatic Deterioration|2|||
160955210|NCT03449030|581221872|FG009|Overall Study|Symptomatic Deterioration|0|||
160955211|NCT03449030|581221863|FG000|Overall Study|Progressive Disease|1|||
160955212|NCT03449030|581221864|FG001|Overall Study|Progressive Disease|0|||
160955213|NCT03449030|581221865|FG002|Overall Study|Progressive Disease|1|||
160955214|NCT03449030|581221866|FG003|Overall Study|Progressive Disease|4|||
160457618|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
160955215|NCT03449030|581221867|FG004|Overall Study|Progressive Disease|5|||
160955216|NCT03449030|581221868|FG005|Overall Study|Progressive Disease|3|||
160955217|NCT03449030|581221869|FG006|Overall Study|Progressive Disease|0|||
160955218|NCT03449030|581221870|FG007|Overall Study|Progressive Disease|1|||
160955219|NCT03449030|581221871|FG008|Overall Study|Progressive Disease|1|||
160955220|NCT03449030|581221872|FG009|Overall Study|Progressive Disease|1|||
160955221|NCT03449030|581221863|FG000|Overall Study|Adverse Event|0|||
160955222|NCT03449030|581221864|FG001|Overall Study|Adverse Event|0|||
160955223|NCT03449030|581221865|FG002|Overall Study|Adverse Event|0|||
160955224|NCT03449030|581221866|FG003|Overall Study|Adverse Event|0|||
160955225|NCT03449030|581221867|FG004|Overall Study|Adverse Event|0|||
160955226|NCT03449030|581221868|FG005|Overall Study|Adverse Event|2|||
160955227|NCT03449030|581221869|FG006|Overall Study|Adverse Event|0|||
160955228|NCT03449030|581221870|FG007|Overall Study|Adverse Event|0|||
160955229|NCT03449030|581221871|FG008|Overall Study|Adverse Event|0|||
160955230|NCT03449030|581221872|FG009|Overall Study|Adverse Event|0|||
160955231|NCT03449030|581221863|FG000|Overall Study|Death|0|||
160955232|NCT03449030|581221864|FG001|Overall Study|Death|0|||
160955233|NCT03449030|581221865|FG002|Overall Study|Death|0|||
160955234|NCT03449030|581221866|FG003|Overall Study|Death|0|||
160955235|NCT03449030|581221867|FG004|Overall Study|Death|1|||
160955236|NCT03449030|581221868|FG005|Overall Study|Death|0|||
160955237|NCT03449030|581221869|FG006|Overall Study|Death|0|||
160955238|NCT03449030|581221870|FG007|Overall Study|Death|0|||
160955239|NCT03449030|581221871|FG008|Overall Study|Death|0|||
160955240|NCT03449030|581221872|FG009|Overall Study|Death|0|||
160955241|NCT00965523|581221873|FG000|Study 221|Progressive Disease|4|||
160955242|NCT00965523|581221873|FG000|Study 221|Physician Decision|3|||
160955243|NCT00965523|581221873|FG000|Study 224|Progressive Disease|5|||
160955244|NCT00965523|581221873|FG000|Study 224|Physician Decision|1|||
160955245|NCT04656847|581221878|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
160457619|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
160457620|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
160457621|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
160457622|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
160457623|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
160457624|NCT04614948|579406466|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
160457625|NCT04614948|579406467|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
160457626|NCT04614948|579406468|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
160457627|NCT04271046|579406469|FG000|Overall Study|Death|0|||
160457628|NCT04271046|579406470|FG001|Overall Study|Death|2|||
160457629|NCT04271046|579406471|FG002|Overall Study|Death|0|||
160457630|NCT04271046|579406472|FG003|Overall Study|Death|2|||
160457631|NCT04271046|579406469|FG000|Overall Study|Lost to Follow-up|12|||
160457632|NCT04271046|579406470|FG001|Overall Study|Lost to Follow-up|12|||
160457633|NCT04271046|579406471|FG002|Overall Study|Lost to Follow-up|11|||
160457634|NCT04271046|579406472|FG003|Overall Study|Lost to Follow-up|11|||
160457635|NCT04271046|579406469|FG000|Overall Study|Patient with Dementia Died|2|||
160457636|NCT04271046|579406470|FG001|Overall Study|Patient with Dementia Died|0|||
160955246|NCT03301051|581221879|FG000|Overall Study|Adverse Event|0|||
160955247|NCT03301051|581221880|FG001|Overall Study|Adverse Event|4|||
160457637|NCT04271046|579406471|FG002|Overall Study|Patient with Dementia Died|2|||
160955248|NCT03301051|581221879|FG000|Overall Study|Withdrawal by Subject|59|||
160955249|NCT03301051|581221880|FG001|Overall Study|Withdrawal by Subject|65|||
160955250|NCT03301051|581221879|FG000|Overall Study|Lost to Follow-up|263|||
160955251|NCT03301051|581221880|FG001|Overall Study|Lost to Follow-up|282|||
160955252|NCT03301051|581221879|FG000|Overall Study|Protocol Violation|1|||
160955253|NCT03301051|581221880|FG001|Overall Study|Protocol Violation|3|||
160955254|NCT03301051|581221879|FG000|Overall Study|Physician Decision|1|||
160955255|NCT03301051|581221880|FG001|Overall Study|Physician Decision|3|||
160955256|NCT03301051|581221879|FG000|Overall Study|Death|1|||
160955257|NCT03301051|581221880|FG001|Overall Study|Death|1|||
160955258|NCT03301051|581221879|FG000|Overall Study|Miscellaneous|8|||
160955259|NCT03301051|581221880|FG001|Overall Study|Miscellaneous|4|||
160955260|NCT03301051|581221879|FG000|Overall Study|Randomized, not vaccinated|13|||
160955261|NCT03301051|581221880|FG001|Overall Study|Randomized, not vaccinated|10|||
160955262|NCT00047879|581221881|FG000|Overall Study|Progressive disease|4|||
160955263|NCT00047879|581221882|FG001|Overall Study|Progressive disease|3|||
160955264|NCT01196975|581221883|FG000|Overall Study|Adverse Event|2|||
160955265|NCT01196975|581221884|FG001|Overall Study|Adverse Event|2|||
160955266|NCT01196975|581221885|FG002|Overall Study|Adverse Event|0|||
160955267|NCT01196975|581221886|FG003|Overall Study|Adverse Event|0|||
160955268|NCT01196975|581221887|FG004|Overall Study|Adverse Event|2|||
160955269|NCT01196975|581221883|FG000|Overall Study|Withdrawal by Subject|2|||
160955270|NCT01196975|581221884|FG001|Overall Study|Withdrawal by Subject|1|||
160955271|NCT01196975|581221885|FG002|Overall Study|Withdrawal by Subject|0|||
160955272|NCT01196975|581221886|FG003|Overall Study|Withdrawal by Subject|1|||
160955273|NCT01196975|581221887|FG004|Overall Study|Withdrawal by Subject|0|||
160955274|NCT01196975|581221883|FG000|Overall Study|Lost to Follow-up|11|||
160955275|NCT01196975|581221884|FG001|Overall Study|Lost to Follow-up|6|||
160955276|NCT01196975|581221885|FG002|Overall Study|Lost to Follow-up|5|||
160955277|NCT01196975|581221886|FG003|Overall Study|Lost to Follow-up|5|||
160955278|NCT01196975|581221887|FG004|Overall Study|Lost to Follow-up|11|||
160955279|NCT01358526|581221895|FG000|Open-label Titration Period|Adverse Event|95|||
160955280|NCT01358526|581221896|FG001|Open-label Titration Period|Adverse Event|0|||
160955281|NCT01358526|581221897|FG002|Open-label Titration Period|Adverse Event|0|||
160955282|NCT01358526|581221895|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
160955283|NCT01358526|581221896|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
160955284|NCT01358526|581221897|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
160955285|NCT01358526|581221895|FG000|Open-label Titration Period|Lost to Follow-up|25|||
160955286|NCT01358526|581221896|FG001|Open-label Titration Period|Lost to Follow-up|0|||
160955287|NCT01358526|581221897|FG002|Open-label Titration Period|Lost to Follow-up|0|||
160457638|NCT04271046|579406472|FG003|Overall Study|Patient with Dementia Died|0|||
160955288|NCT01358526|581221895|FG000|Open-label Titration Period|Lack of Efficacy|107|||
160457639|NCT04271046|579406469|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
160955289|NCT01358526|581221896|FG001|Open-label Titration Period|Lack of Efficacy|0|||
160457640|NCT04271046|579406470|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
160955290|NCT01358526|581221897|FG002|Open-label Titration Period|Lack of Efficacy|0|||
160955291|NCT01358526|581221895|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
160955292|NCT01358526|581221896|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
160955293|NCT01358526|581221897|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
160955294|NCT01358526|581221895|FG000|Open-label Titration Period|Administrative|8|||
160955295|NCT01358526|581221896|FG001|Open-label Titration Period|Administrative|0|||
160955296|NCT01358526|581221897|FG002|Open-label Titration Period|Administrative|0|||
160955297|NCT01358526|581221895|FG000|Open-label Titration Period|Did not qualify|178|||
160955298|NCT01358526|581221896|FG001|Open-label Titration Period|Did not qualify|0|||
160955299|NCT01358526|581221897|FG002|Open-label Titration Period|Did not qualify|0|||
160955300|NCT01358526|581221895|FG000|Double-blind Phase|Adverse Event|0|||
160955301|NCT01358526|581221896|FG001|Double-blind Phase|Adverse Event|24|||
160955302|NCT01358526|581221897|FG002|Double-blind Phase|Adverse Event|23|||
160955303|NCT01358526|581221895|FG000|Double-blind Phase|Withdrawal by Subject|0|||
160955304|NCT01358526|581221896|FG001|Double-blind Phase|Withdrawal by Subject|10|||
160955305|NCT01358526|581221897|FG002|Double-blind Phase|Withdrawal by Subject|8|||
160955306|NCT01358526|581221895|FG000|Double-blind Phase|Lost to Follow-up|0|||
160955307|NCT01358526|581221896|FG001|Double-blind Phase|Lost to Follow-up|4|||
160955308|NCT01358526|581221897|FG002|Double-blind Phase|Lost to Follow-up|1|||
160955309|NCT01358526|581221895|FG000|Double-blind Phase|Lack of Efficacy|0|||
160955310|NCT01358526|581221896|FG001|Double-blind Phase|Lack of Efficacy|31|||
160955311|NCT01358526|581221897|FG002|Double-blind Phase|Lack of Efficacy|73|||
160955312|NCT01358526|581221895|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
160955313|NCT01358526|581221896|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
160955314|NCT01358526|581221897|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
160955315|NCT01358526|581221895|FG000|Double-blind Phase|Administrative|0|||
160955316|NCT01358526|581221896|FG001|Double-blind Phase|Administrative|6|||
160955317|NCT01358526|581221897|FG002|Double-blind Phase|Administrative|10|||
160955318|NCT00360529|581221898|FG000|Overall Study|Adverse Event|10|||
160955319|NCT00360529|581221899|FG001|Overall Study|Adverse Event|23|||
160955320|NCT00360529|581221900|FG002|Overall Study|Adverse Event|33|||
160955321|NCT00360529|581221898|FG000|Overall Study|Protocol Violation|3|||
160955322|NCT00360529|581221899|FG001|Overall Study|Protocol Violation|3|||
160955323|NCT00360529|581221900|FG002|Overall Study|Protocol Violation|11|||
160955324|NCT00360529|581221898|FG000|Overall Study|Lost to Follow-up|14|||
160955325|NCT00360529|581221899|FG001|Overall Study|Lost to Follow-up|10|||
160955326|NCT00360529|581221900|FG002|Overall Study|Lost to Follow-up|13|||
160955327|NCT00360529|581221898|FG000|Overall Study|Withdrawal by Subject|22|||
160955328|NCT00360529|581221899|FG001|Overall Study|Withdrawal by Subject|14|||
160955329|NCT00360529|581221900|FG002|Overall Study|Withdrawal by Subject|18|||
160955330|NCT00360529|581221898|FG000|Overall Study|Lack of Efficacy|8|||
160955331|NCT00360529|581221899|FG001|Overall Study|Lack of Efficacy|6|||
160955332|NCT00360529|581221900|FG002|Overall Study|Lack of Efficacy|5|||
160955333|NCT00360529|581221898|FG000|Overall Study|Reason discontinued not explained above|4|||
160955334|NCT00360529|581221899|FG001|Overall Study|Reason discontinued not explained above|9|||
160955335|NCT00360529|581221900|FG002|Overall Study|Reason discontinued not explained above|11|||
160955336|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
160955337|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
160955338|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
160955339|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
160955340|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
160955341|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
160955342|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
160955343|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
160955344|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
160955345|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
160955346|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
160955347|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
160955348|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
160955349|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
160955350|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
160955351|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
160955352|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
160955353|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
160955354|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
160955355|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
160955356|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
160955357|NCT01781572|581221905|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
160955358|NCT01781572|581221906|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
160955359|NCT01781572|581221907|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
160955360|NCT01781572|581221905|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
160955361|NCT01781572|581221906|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
160582775|NCT00069095|579853717|FG004|Primary Treatment Phase|Refused treatment|24|||
160582776|NCT00069095|579853718|FG005|Primary Treatment Phase|Refused treatment|27|||
160582777|NCT00069095|579853713|FG000|Primary Treatment Phase|Withdrew|2|||
160955362|NCT01781572|581221907|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
160955363|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
160955364|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
160955365|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
160955366|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
160955367|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
160955368|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
160955369|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
160955370|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
160955371|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
160955372|NCT01781572|581221905|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
160955373|NCT01781572|581221906|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
160955374|NCT01781572|581221907|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
160955375|NCT01781572|581221905|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
160955376|NCT01781572|581221906|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
160955377|NCT01781572|581221907|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
160955378|NCT01781572|581221905|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
160955379|NCT01781572|581221906|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
160955380|NCT01781572|581221907|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
160955381|NCT01781572|581221905|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
160955382|NCT01781572|581221906|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
160955383|NCT01781572|581221907|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
160955384|NCT01781572|581221905|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
160955385|NCT01781572|581221906|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
160955386|NCT01781572|581221907|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
160955387|NCT01781572|581221905|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
160955388|NCT01781572|581221906|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
160955389|NCT01781572|581221907|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
160955390|NCT00907153|581223513|FG000|Overall Study|Lost to Follow-up|1|||
160955391|NCT00907153|581223514|FG001|Overall Study|Lost to Follow-up|1|||
160955392|NCT00907153|581223513|FG000|Overall Study|Withdrawal by Subject|1|||
160955393|NCT00907153|581223514|FG001|Overall Study|Withdrawal by Subject|3|||
160955394|NCT03393000|581223522|FG000|Overall Study|Death|11|||
160955395|NCT03393000|581223522|FG000|Overall Study|Withdrawal by Subject|2|||
160955396|NCT03393000|581223522|FG000|Overall Study|Physician Decision|1|||
160955397|NCT01773070|581223523|FG000|Overall Study|Withdrawal by Subject|24|||
160955398|NCT01773070|581223523|FG000|Overall Study|Lost to Follow-up|39|||
160955399|NCT01773070|581223523|FG000|Overall Study|Other|15|||
160955400|NCT01773070|581223523|FG000|Overall Study|Death (unrelated to study procedures)|3|||
160955401|NCT02181803|581223524|FG000|Overall Study|Withdrawal by Subject|0|||
160955402|NCT02181803|581223525|FG001|Overall Study|Withdrawal by Subject|2|||
160955403|NCT02181803|581223526|FG002|Overall Study|Withdrawal by Subject|0|||
160955404|NCT02181803|581223527|FG003|Overall Study|Withdrawal by Subject|0|||
160955405|NCT02181803|581223528|FG004|Overall Study|Withdrawal by Subject|0|||
160955406|NCT02181803|581223529|FG005|Overall Study|Withdrawal by Subject|0|||
160955407|NCT02181803|581223530|FG006|Overall Study|Withdrawal by Subject|0|||
160955408|NCT02181803|581223531|FG007|Overall Study|Withdrawal by Subject|0|||
160955409|NCT02181803|581223532|FG008|Overall Study|Withdrawal by Subject|0|||
160955410|NCT02181803|581223524|FG000|Overall Study|Physician Decision|0|||
160955411|NCT02181803|581223525|FG001|Overall Study|Physician Decision|0|||
160955412|NCT02181803|581223526|FG002|Overall Study|Physician Decision|0|||
160955413|NCT02181803|581223527|FG003|Overall Study|Physician Decision|1|||
160955414|NCT02181803|581223528|FG004|Overall Study|Physician Decision|0|||
160955415|NCT02181803|581223529|FG005|Overall Study|Physician Decision|0|||
160955416|NCT02181803|581223530|FG006|Overall Study|Physician Decision|0|||
160955417|NCT02181803|581223531|FG007|Overall Study|Physician Decision|1|||
160955418|NCT02181803|581223532|FG008|Overall Study|Physician Decision|0|||
160955419|NCT02181803|581223524|FG000|Overall Study|Adverse Event|0|||
160955420|NCT02181803|581223525|FG001|Overall Study|Adverse Event|2|||
160955421|NCT02181803|581223526|FG002|Overall Study|Adverse Event|0|||
160955422|NCT02181803|581223527|FG003|Overall Study|Adverse Event|1|||
160955423|NCT02181803|581223528|FG004|Overall Study|Adverse Event|0|||
160955424|NCT02181803|581223529|FG005|Overall Study|Adverse Event|0|||
160955425|NCT02181803|581223530|FG006|Overall Study|Adverse Event|1|||
160955426|NCT02181803|581223531|FG007|Overall Study|Adverse Event|0|||
160955427|NCT02181803|581223532|FG008|Overall Study|Adverse Event|0|||
160955428|NCT04786444|581223534|FG000|Overall Study|Withdrawal by Subject|4|||
160955429|NCT04786444|581223535|FG001|Overall Study|Withdrawal by Subject|7|||
160955430|NCT04786444|581223536|FG002|Overall Study|Withdrawal by Subject|2|||
160955431|NCT04786444|581223534|FG000|Overall Study|Lost to Follow-up|11|||
160955432|NCT04786444|581223535|FG001|Overall Study|Lost to Follow-up|9|||
160955433|NCT04786444|581223536|FG002|Overall Study|Lost to Follow-up|10|||
160955434|NCT04786444|581223534|FG000|Overall Study|Subject would like to become pregnant|0|||
160955435|NCT04786444|581223535|FG001|Overall Study|Subject would like to become pregnant|1|||
160955436|NCT04786444|581223536|FG002|Overall Study|Subject would like to become pregnant|0|||
160955437|NCT03166618|581223537|FG000|Overall Study|Study was Terminated|0|||
160955438|NCT03166618|581223538|FG001|Overall Study|Study was Terminated|1|||
160955439|NCT01925950|581223539|FG000|Part 2|Withdrawal by Subject|1|||
160955440|NCT01925950|581223540|FG001|Part 2|Withdrawal by Subject|0|||
160955441|NCT03137303|581223542|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
160955442|NCT03137303|581223543|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
160955443|NCT03137303|581223542|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
160955444|NCT03137303|581223543|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
160955445|NCT03137303|581223542|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
160955446|NCT03137303|581223543|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
160955447|NCT03137303|581223542|FG000|T3: 9-month Follow-up|Death|1|||
160955448|NCT03137303|581223543|FG001|T3: 9-month Follow-up|Death|0|||
160955449|NCT03137303|581223542|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
160955450|NCT03137303|581223543|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
160955451|NCT03137303|581223542|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
160955452|NCT03137303|581223543|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
160955453|NCT03137303|581223542|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
160955454|NCT03137303|581223543|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
160955455|NCT03561090|581223544|FG000|Overall Study|Adverse Event|11|||
160955456|NCT03561090|581223545|FG001|Overall Study|Adverse Event|7|||
160955457|NCT03561090|581223544|FG000|Overall Study|Non-Compliance With Study Drug|2|||
160955458|NCT03561090|581223545|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160955459|NCT03561090|581223544|FG000|Overall Study|Protocol Violation|2|||
160955460|NCT03561090|581223545|FG001|Overall Study|Protocol Violation|2|||
160955461|NCT03561090|581223544|FG000|Overall Study|Withdrawal by Subject|7|||
160955462|NCT03561090|581223545|FG001|Overall Study|Withdrawal by Subject|7|||
160955463|NCT03561090|581223544|FG000|Overall Study|Lost to Follow-up|7|||
160955464|NCT03561090|581223545|FG001|Overall Study|Lost to Follow-up|2|||
160955465|NCT03561090|581223544|FG000|Overall Study|Study Terminated by Sponsor|10|||
160955466|NCT03561090|581223545|FG001|Overall Study|Study Terminated by Sponsor|15|||
160955467|NCT03561090|581223544|FG000|Overall Study|Randomized by Mistake|1|||
160955468|NCT03561090|581223545|FG001|Overall Study|Randomized by Mistake|1|||
160955469|NCT03561090|581223544|FG000|Overall Study|Other Not Specified|0|||
160955470|NCT03561090|581223545|FG001|Overall Study|Other Not Specified|2|||
160955471|NCT00725452|581223555|FG000|Overall Study|Adverse Event|3|||
160955472|NCT00725452|581223555|FG000|Overall Study|Lack of Efficacy|2|||
160955473|NCT00725452|581223555|FG000|Overall Study|Reason not specified|1|||
160955474|NCT00725452|581223555|FG000|Overall Study|Physician Decision|1|||
160955475|NCT00725452|581223555|FG000|Overall Study|Withdrawal by Subject|3|||
160955476|NCT00725452|581223555|FG000|Overall Study|Lost to Follow-up|1|||
160955477|NCT00713648|581223556|FG000|Overall Study|Adverse Event|1|||
160955478|NCT00713648|581223556|FG000|Overall Study|Unclassified|2|||
160955479|NCT00713648|581223556|FG000|Overall Study|According to Protocol|2|||
160955480|NCT00713648|581223556|FG000|Overall Study|Development of antibodies|3|||
160955481|NCT02566031|581223559|FG000|Overall Study|Patient/guardian decision|14|||
160955482|NCT02566031|581223560|FG001|Overall Study|Patient/guardian decision|7|||
160955483|NCT02566031|581223559|FG000|Overall Study|Protocol deviation|2|||
160955484|NCT02566031|581223560|FG001|Overall Study|Protocol deviation|3|||
160955485|NCT02566031|581223559|FG000|Overall Study|Adverse Event|3|||
160955486|NCT02566031|581223560|FG001|Overall Study|Adverse Event|1|||
160955487|NCT02566031|581223559|FG000|Overall Study|Lost to Follow-up|1|||
160955488|NCT02566031|581223560|FG001|Overall Study|Lost to Follow-up|1|||
160955489|NCT03031938|581223561|FG000|Overall Study|Death|1|||
160955490|NCT03031938|581223562|FG001|Overall Study|Death|0|||
160955491|NCT01910129|581223571|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
160955492|NCT01910129|581223572|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
160955493|NCT01910129|581223573|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
160955494|NCT01910129|581223571|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
160955495|NCT01910129|581223572|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
160955496|NCT01910129|581223573|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
160955497|NCT02415400|581223575|FG000|Overall Study|Adverse Event|0|||
160955498|NCT02415400|581223576|FG001|Overall Study|Adverse Event|1|||
160955499|NCT02415400|581223577|FG002|Overall Study|Adverse Event|1|||
160955500|NCT02415400|581223578|FG003|Overall Study|Adverse Event|2|||
160955501|NCT02415400|581223575|FG000|Overall Study|Participant request to stop therapy|4|||
160955502|NCT02415400|581223576|FG001|Overall Study|Participant request to stop therapy|3|||
160955503|NCT02415400|581223577|FG002|Overall Study|Participant request to stop therapy|8|||
160955504|NCT02415400|581223578|FG003|Overall Study|Participant request to stop therapy|6|||
160955505|NCT02415400|581223575|FG000|Overall Study|Participant withdrew consent|14|||
160955506|NCT02415400|581223576|FG001|Overall Study|Participant withdrew consent|12|||
160955507|NCT02415400|581223577|FG002|Overall Study|Participant withdrew consent|30|||
160955508|NCT02415400|581223578|FG003|Overall Study|Participant withdrew consent|21|||
160955509|NCT02415400|581223575|FG000|Overall Study|Death|39|||
160955510|NCT02415400|581223576|FG001|Overall Study|Death|41|||
160955511|NCT02415400|581223577|FG002|Overall Study|Death|35|||
160955512|NCT02415400|581223578|FG003|Overall Study|Death|42|||
160955513|NCT02415400|581223575|FG000|Overall Study|Lost to Follow-up|3|||
161001110|NCT01802632|581388976|FG002|Overall Study|Withdrawal by Subject|7|||
161001111|NCT01802632|581388977|FG003|Overall Study|Withdrawal by Subject|3|||
161001112|NCT01802632|581388978|FG004|Overall Study|Withdrawal by Subject|0|||
161001113|NCT01802632|581388979|FG005|Overall Study|Withdrawal by Subject|1|||
161001114|NCT01802632|581388974|FG000|Overall Study|Objective Disease Progression|1|||
161001115|NCT01802632|581388975|FG001|Overall Study|Objective Disease Progression|12|||
160457641|NCT04271046|579406471|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
160457642|NCT04271046|579406472|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
160457643|NCT01570361|579406473|FG000|Overall Study|Subject discontinued|1|||
160955514|NCT02415400|581223576|FG001|Overall Study|Lost to Follow-up|3|||
160955515|NCT02415400|581223577|FG002|Overall Study|Lost to Follow-up|2|||
160955516|NCT02415400|581223578|FG003|Overall Study|Lost to Follow-up|5|||
160955517|NCT02415400|581223575|FG000|Overall Study|Poor/Non-Compliance|0|||
160955518|NCT02415400|581223576|FG001|Overall Study|Poor/Non-Compliance|1|||
160955519|NCT02415400|581223577|FG002|Overall Study|Poor/Non-Compliance|3|||
160955520|NCT02415400|581223578|FG003|Overall Study|Poor/Non-Compliance|4|||
160955521|NCT02415400|581223575|FG000|Overall Study|Participant no longer meets criteria|2|||
160955522|NCT02415400|581223576|FG001|Overall Study|Participant no longer meets criteria|0|||
160955523|NCT02415400|581223577|FG002|Overall Study|Participant no longer meets criteria|0|||
160955524|NCT02415400|581223578|FG003|Overall Study|Participant no longer meets criteria|1|||
160955525|NCT02415400|581223575|FG000|Overall Study|Participant doesn't answer phone|1|||
160955526|NCT02415400|581223576|FG001|Overall Study|Participant doesn't answer phone|0|||
160955527|NCT02415400|581223577|FG002|Overall Study|Participant doesn't answer phone|0|||
160955528|NCT02415400|581223578|FG003|Overall Study|Participant doesn't answer phone|0|||
160955529|NCT02415400|581223575|FG000|Overall Study|Participant wanted home visits|1|||
160955530|NCT02415400|581223576|FG001|Overall Study|Participant wanted home visits|0|||
160955531|NCT02415400|581223577|FG002|Overall Study|Participant wanted home visits|0|||
160955532|NCT02415400|581223578|FG003|Overall Study|Participant wanted home visits|0|||
160955533|NCT02415400|581223575|FG000|Overall Study|Randomized in error|2|||
160955534|NCT02415400|581223576|FG001|Overall Study|Randomized in error|0|||
160955535|NCT02415400|581223577|FG002|Overall Study|Randomized in error|0|||
160955536|NCT02415400|581223578|FG003|Overall Study|Randomized in error|0|||
160955537|NCT02415400|581223575|FG000|Overall Study|No study drug on site|0|||
160955538|NCT02415400|581223576|FG001|Overall Study|No study drug on site|1|||
160955539|NCT02415400|581223577|FG002|Overall Study|No study drug on site|0|||
160955540|NCT02415400|581223578|FG003|Overall Study|No study drug on site|0|||
160955541|NCT02415400|581223575|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
160955542|NCT02415400|581223576|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
160955543|NCT02415400|581223577|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
160955544|NCT02415400|581223578|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
160955545|NCT02415400|581223575|FG000|Overall Study|Coagulation values cannot be set|0|||
160955546|NCT02415400|581223576|FG001|Overall Study|Coagulation values cannot be set|0|||
160955547|NCT02415400|581223577|FG002|Overall Study|Coagulation values cannot be set|1|||
160955548|NCT02415400|581223578|FG003|Overall Study|Coagulation values cannot be set|0|||
160955549|NCT02415400|581223575|FG000|Overall Study|State regulations prevent participation|0|||
160955550|NCT02415400|581223576|FG001|Overall Study|State regulations prevent participation|0|||
160955551|NCT02415400|581223577|FG002|Overall Study|State regulations prevent participation|1|||
160955552|NCT02415400|581223578|FG003|Overall Study|State regulations prevent participation|0|||
160955553|NCT02415400|581223575|FG000|Overall Study|Poor treatment monitoring|0|||
160955554|NCT02415400|581223576|FG001|Overall Study|Poor treatment monitoring|0|||
160955555|NCT02415400|581223577|FG002|Overall Study|Poor treatment monitoring|1|||
160955556|NCT02415400|581223578|FG003|Overall Study|Poor treatment monitoring|0|||
160955557|NCT02415400|581223575|FG000|Overall Study|Participant in jail|0|||
160955558|NCT02415400|581223576|FG001|Overall Study|Participant in jail|0|||
160955559|NCT02415400|581223577|FG002|Overall Study|Participant in jail|1|||
160955560|NCT02415400|581223578|FG003|Overall Study|Participant in jail|0|||
160955561|NCT02415400|581223575|FG000|Overall Study|Investigator decision|0|||
160955562|NCT02415400|581223576|FG001|Overall Study|Investigator decision|0|||
160955563|NCT02415400|581223577|FG002|Overall Study|Investigator decision|1|||
160955564|NCT02415400|581223578|FG003|Overall Study|Investigator decision|1|||
160955565|NCT02415400|581223575|FG000|Overall Study|Site closure; participant won't transfer|0|||
160955566|NCT02415400|581223576|FG001|Overall Study|Site closure; participant won't transfer|0|||
160955567|NCT02415400|581223577|FG002|Overall Study|Site closure; participant won't transfer|0|||
160955568|NCT02415400|581223578|FG003|Overall Study|Site closure; participant won't transfer|1|||
160955569|NCT01226745|581223579|FG000|Overall Study|Did not complete schedule of assessments|8|||
160955570|NCT01226745|581223580|FG001|Overall Study|Did not complete schedule of assessments|3|||
160955571|NCT01226745|581223581|FG002|Overall Study|Did not complete schedule of assessments|6|||
160955572|NCT01226745|581223582|FG003|Overall Study|Did not complete schedule of assessments|0|||
161001116|NCT01802632|581388976|FG002|Overall Study|Objective Disease Progression|104|||
161001117|NCT01802632|581388977|FG003|Overall Study|Objective Disease Progression|6|||
161001118|NCT01802632|581388978|FG004|Overall Study|Objective Disease Progression|4|||
160457644|NCT01570361|579406474|FG001|Overall Study|Subject discontinued|2|||
160955573|NCT01226745|581223583|FG004|Overall Study|Did not complete schedule of assessments|0|||
160955574|NCT01226745|581223584|FG005|Overall Study|Did not complete schedule of assessments|1|||
160955575|NCT01226745|581223579|FG000|Overall Study|Lost to Follow-up|2|||
160955576|NCT01226745|581223580|FG001|Overall Study|Lost to Follow-up|6|||
160955577|NCT01226745|581223581|FG002|Overall Study|Lost to Follow-up|6|||
160955578|NCT01226745|581223582|FG003|Overall Study|Lost to Follow-up|1|||
160955579|NCT01226745|581223583|FG004|Overall Study|Lost to Follow-up|1|||
160955580|NCT01226745|581223584|FG005|Overall Study|Lost to Follow-up|2|||
160955581|NCT01226745|581223579|FG000|Overall Study|Death|1|||
160955582|NCT01226745|581223580|FG001|Overall Study|Death|0|||
160955583|NCT01226745|581223581|FG002|Overall Study|Death|0|||
160955584|NCT01226745|581223582|FG003|Overall Study|Death|0|||
160955585|NCT01226745|581223583|FG004|Overall Study|Death|0|||
160955586|NCT01226745|581223584|FG005|Overall Study|Death|1|||
160955587|NCT01226745|581223579|FG000|Overall Study|Other|6|||
160955588|NCT01226745|581223580|FG001|Overall Study|Other|7|||
160955589|NCT01226745|581223581|FG002|Overall Study|Other|8|||
160955590|NCT01226745|581223582|FG003|Overall Study|Other|4|||
160955591|NCT01226745|581223583|FG004|Overall Study|Other|3|||
160955592|NCT01226745|581223584|FG005|Overall Study|Other|1|||
160955593|NCT03595904|581223593|FG000|Overall Study|Protocol Violation|3|||
160955594|NCT03595904|581223594|FG001|Overall Study|Protocol Violation|1|||
160955595|NCT03595904|581223593|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
160955596|NCT03595904|581223594|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
161001119|NCT01802632|581388979|FG005|Overall Study|Objective Disease Progression|4|||
161001120|NCT01802632|581388974|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
161001121|NCT01802632|581388975|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
161001122|NCT01802632|581388976|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
161001123|NCT01802632|581388977|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
161001124|NCT01802632|581388978|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
161001125|NCT01802632|581388979|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
161001126|NCT01802632|581388974|FG000|Overall Study|Other (not specified)|0|||
161001127|NCT01802632|581388975|FG001|Overall Study|Other (not specified)|0|||
161001128|NCT01802632|581388976|FG002|Overall Study|Other (not specified)|7|||
161001129|NCT01802632|581388977|FG003|Overall Study|Other (not specified)|1|||
161001130|NCT01802632|581388978|FG004|Overall Study|Other (not specified)|0|||
161001131|NCT01802632|581388979|FG005|Overall Study|Other (not specified)|1|||
161001132|NCT00367991|581388980|FG000|Overall Study|Withdrawal by Subject|1|||
161001133|NCT00367991|581388981|FG001|Overall Study|Withdrawal by Subject|1|||
161001134|NCT00367991|581388980|FG000|Overall Study|Adverse Event|1|||
161001135|NCT00367991|581388981|FG001|Overall Study|Adverse Event|1|||
161001136|NCT01184508|581388985|FG000|Overall Study|Adverse Event|4|||
161001137|NCT01184508|581388986|FG001|Overall Study|Adverse Event|6|||
161001138|NCT01184508|581388985|FG000|Overall Study|Lack of Efficacy|1|||
161001139|NCT01184508|581388986|FG001|Overall Study|Lack of Efficacy|1|||
161001140|NCT01184508|581388985|FG000|Overall Study|Lost to Follow-up|1|||
161001141|NCT01184508|581388986|FG001|Overall Study|Lost to Follow-up|1|||
161001142|NCT01184508|581388985|FG000|Overall Study|Physician Decision|1|||
161001143|NCT01184508|581388986|FG001|Overall Study|Physician Decision|0|||
161001144|NCT01184508|581388985|FG000|Overall Study|Protocol Violation|3|||
161001145|NCT01184508|581388986|FG001|Overall Study|Protocol Violation|1|||
161001146|NCT01184508|581388985|FG000|Overall Study|Sponsor Decision|5|||
161001147|NCT01184508|581388986|FG001|Overall Study|Sponsor Decision|2|||
161001148|NCT01184508|581388985|FG000|Overall Study|Withdrawal by Subject|1|||
160457645|NCT01570361|579406473|FG000|Overall Study|Sponsor closing the study|51|||
160457646|NCT01570361|579406474|FG001|Overall Study|Sponsor closing the study|50|||
160457647|NCT01570361|579406473|FG000|Overall Study|Subject excluded|5|||
160955597|NCT03595904|581223593|FG000|Overall Study|Insurance complications|1|||
160955598|NCT03595904|581223594|FG001|Overall Study|Insurance complications|0|||
160955599|NCT03595904|581223593|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
160955600|NCT03595904|581223594|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
160955601|NCT01581281|581223595|FG000|Overall Study|Early Study Closure|15|||
160955602|NCT01581281|581223596|FG001|Overall Study|Early Study Closure|6|||
160955603|NCT01581281|581223597|FG002|Overall Study|Early Study Closure|12|||
160955604|NCT02187991|581223600|FG000|Overall Study|Adverse Event|13|||
161001149|NCT01184508|581388986|FG001|Overall Study|Withdrawal by Subject|3|||
161001150|NCT01184508|581388985|FG000|Overall Study|Randomized, Not Treated|0|||
161001151|NCT01184508|581388986|FG001|Overall Study|Randomized, Not Treated|1|||
161001152|NCT02969863|581388989|FG000|Overall Study|Physician Decision|1|||
161001153|NCT02969863|581388990|FG001|Overall Study|Physician Decision|0|||
161001154|NCT02969863|581388991|FG002|Overall Study|Physician Decision|0|||
161001155|NCT02969863|581388992|FG003|Overall Study|Physician Decision|0|||
161001156|NCT02969863|581388993|FG004|Overall Study|Physician Decision|0|||
161001157|NCT02969863|581388994|FG005|Overall Study|Physician Decision|0|||
161001158|NCT02705586|581388996|FG000|Overall Study|Health Issues|2|||
161001159|NCT02705586|581388996|FG000|Overall Study|Transportation Difficulties|5|||
160457648|NCT01570361|579406474|FG001|Overall Study|Subject excluded|3|||
161001160|NCT02705586|581388996|FG000|Overall Study|Vacation/Planned Absence|1|||
160955605|NCT02187991|581223601|FG001|Overall Study|Adverse Event|14|||
160955606|NCT02187991|581223602|FG002|Overall Study|Adverse Event|3|||
160955607|NCT02187991|581223603|FG003|Overall Study|Adverse Event|2|||
160955608|NCT02187991|581223600|FG000|Overall Study|Withdrawal by Subject|9|||
160955609|NCT02187991|581223601|FG001|Overall Study|Withdrawal by Subject|6|||
160955610|NCT02187991|581223602|FG002|Overall Study|Withdrawal by Subject|3|||
160955611|NCT02187991|581223603|FG003|Overall Study|Withdrawal by Subject|2|||
160955612|NCT02187991|581223600|FG000|Overall Study|Physician Decision|4|||
160955613|NCT02187991|581223601|FG001|Overall Study|Physician Decision|4|||
160955614|NCT02187991|581223602|FG002|Overall Study|Physician Decision|0|||
160955615|NCT02187991|581223603|FG003|Overall Study|Physician Decision|2|||
160955616|NCT02187991|581223600|FG000|Overall Study|Other, unrelated complication|7|||
160955617|NCT02187991|581223601|FG001|Overall Study|Other, unrelated complication|1|||
160955618|NCT02187991|581223602|FG002|Overall Study|Other, unrelated complication|1|||
160955619|NCT02187991|581223603|FG003|Overall Study|Other, unrelated complication|2|||
160955620|NCT02187991|581223600|FG000|Overall Study|Death|1|||
160955621|NCT02187991|581223601|FG001|Overall Study|Death|3|||
160955622|NCT02187991|581223602|FG002|Overall Study|Death|0|||
160955623|NCT02187991|581223603|FG003|Overall Study|Death|0|||
160955624|NCT01392560|581223606|FG000|Overall Study|Adverse Event|2|||
160955625|NCT01392560|581223606|FG000|Overall Study|not entered|8|||
160955626|NCT01392560|581223606|FG000|Overall Study|discontinued during placebo run-in|2|||
160955627|NCT00295750|581223609|FG000|Overall Study|Adverse Event|19|||
160955628|NCT00295750|581223610|FG001|Overall Study|Adverse Event|15|||
160955629|NCT00295750|581223611|FG002|Overall Study|Adverse Event|12|||
160955630|NCT00295750|581223609|FG000|Overall Study|Lack of Efficacy|1|||
160955631|NCT00295750|581223610|FG001|Overall Study|Lack of Efficacy|1|||
160955632|NCT00295750|581223611|FG002|Overall Study|Lack of Efficacy|0|||
160955633|NCT00295750|581223609|FG000|Overall Study|Lost to Follow-up|1|||
160955634|NCT00295750|581223610|FG001|Overall Study|Lost to Follow-up|4|||
160955635|NCT00295750|581223611|FG002|Overall Study|Lost to Follow-up|1|||
160955636|NCT00295750|581223609|FG000|Overall Study|Taking prohibited therapy|2|||
160955637|NCT00295750|581223610|FG001|Overall Study|Taking prohibited therapy|3|||
160955638|NCT00295750|581223611|FG002|Overall Study|Taking prohibited therapy|2|||
161001161|NCT02808338|581388997|FG000|Screening|Screen Failure|10|||
161001162|NCT02808338|581388997|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
161001163|NCT02808338|581388997|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
161001164|NCT00961636|581389011|FG000|Overall Study|Adverse Event|35|||
161001165|NCT00961636|581389012|FG001|Overall Study|Adverse Event|54|||
161001166|NCT00961636|581389013|FG002|Overall Study|Adverse Event|13|||
161001167|NCT00961636|581389011|FG000|Overall Study|Flushing Symptoms|29|||
161001168|NCT00961636|581389012|FG001|Overall Study|Flushing Symptoms|46|||
161001169|NCT00961636|581389013|FG002|Overall Study|Flushing Symptoms|3|||
161001170|NCT00961636|581389011|FG000|Overall Study|Lost to Follow-up|2|||
161001171|NCT00961636|581389012|FG001|Overall Study|Lost to Follow-up|3|||
161001172|NCT00961636|581389013|FG002|Overall Study|Lost to Follow-up|1|||
161001173|NCT00961636|581389011|FG000|Overall Study|Physician Decision|3|||
161001174|NCT00961636|581389012|FG001|Overall Study|Physician Decision|1|||
161001175|NCT00961636|581389013|FG002|Overall Study|Physician Decision|1|||
161001176|NCT00961636|581389011|FG000|Overall Study|Protocol Violation|9|||
161001177|NCT00961636|581389012|FG001|Overall Study|Protocol Violation|5|||
161001178|NCT00961636|581389013|FG002|Overall Study|Protocol Violation|1|||
161001179|NCT00961636|581389011|FG000|Overall Study|Withdrawal by Subject|29|||
161001180|NCT00961636|581389012|FG001|Overall Study|Withdrawal by Subject|22|||
161001181|NCT00961636|581389013|FG002|Overall Study|Withdrawal by Subject|13|||
161001182|NCT02041104|581389014|FG000|Overall Study|Lost to Follow-up|1|||
160457649|NCT01570361|579406473|FG000|Overall Study|Subject withdrew consent|14|||
160457650|NCT01570361|579406474|FG001|Overall Study|Subject withdrew consent|9|||
160457651|NCT01570361|579406473|FG000|Overall Study|Adverse Event|2|||
160457652|NCT01570361|579406474|FG001|Overall Study|Adverse Event|1|||
160457653|NCT01570361|579406473|FG000|Overall Study|Lost to Follow-up|4|||
160457654|NCT01570361|579406474|FG001|Overall Study|Lost to Follow-up|4|||
161001183|NCT02041104|581389015|FG001|Overall Study|Lost to Follow-up|4|||
161001184|NCT02041104|581389014|FG000|Overall Study|discomfort during OGTT|0|||
161001185|NCT02041104|581389015|FG001|Overall Study|discomfort during OGTT|3|||
160955639|NCT00295750|581223609|FG000|Overall Study|Administrative errors|2|||
160955640|NCT00295750|581223610|FG001|Overall Study|Administrative errors|4|||
160955641|NCT00295750|581223611|FG002|Overall Study|Administrative errors|5|||
160955642|NCT00295750|581223609|FG000|Overall Study|Trial drug errors|1|||
160955643|NCT00295750|581223610|FG001|Overall Study|Trial drug errors|1|||
160955644|NCT00295750|581223611|FG002|Overall Study|Trial drug errors|0|||
161001186|NCT03215927|581390499|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
161001187|NCT03215927|581390500|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
161001188|NCT03215927|581390499|FG000|Open Label Extension|Adverse Event|1|||
161001189|NCT03215927|581390500|FG001|Open Label Extension|Adverse Event|0|||
160457655|NCT01570361|579406473|FG000|Overall Study|Death|5|||
160457656|NCT01570361|579406474|FG001|Overall Study|Death|4|||
160955645|NCT00295750|581223609|FG000|Overall Study|Disease progression|2|||
160955646|NCT00295750|581223610|FG001|Overall Study|Disease progression|1|||
160955647|NCT00295750|581223611|FG002|Overall Study|Disease progression|0|||
160955648|NCT00295750|581223609|FG000|Overall Study|Personal reasons|0|||
160955649|NCT00295750|581223610|FG001|Overall Study|Personal reasons|1|||
160955650|NCT00295750|581223611|FG002|Overall Study|Personal reasons|0|||
160955651|NCT00295750|581223609|FG000|Overall Study|Randomized but never received trial drug|4|||
160955652|NCT00295750|581223610|FG001|Overall Study|Randomized but never received trial drug|3|||
160955653|NCT00295750|581223611|FG002|Overall Study|Randomized but never received trial drug|3|||
160955654|NCT00295750|581223609|FG000|Overall Study|Withdrawal by Subject|9|||
160955655|NCT00295750|581223610|FG001|Overall Study|Withdrawal by Subject|4|||
160955656|NCT00295750|581223611|FG002|Overall Study|Withdrawal by Subject|7|||
160955657|NCT00295750|581223609|FG000|Overall Study|Protocol Violation|2|||
160955658|NCT00295750|581223610|FG001|Overall Study|Protocol Violation|4|||
160955659|NCT00295750|581223611|FG002|Overall Study|Protocol Violation|2|||
160955660|NCT01650259|581223612|FG000|Overall Study|Improvement|105|||
160955661|NCT01650259|581223613|FG001|Overall Study|Improvement|0|||
160955662|NCT01650259|581223612|FG000|Overall Study|Adverse Event|127|||
160955663|NCT01650259|581223613|FG001|Overall Study|Adverse Event|0|||
160955664|NCT01650259|581223612|FG000|Overall Study|Lack of Efficacy|143|||
160955665|NCT01650259|581223613|FG001|Overall Study|Lack of Efficacy|0|||
160955666|NCT01650259|581223612|FG000|Overall Study|Lost to Follow-up|435|||
160955667|NCT01650259|581223613|FG001|Overall Study|Lost to Follow-up|0|||
160955668|NCT01650259|581223612|FG000|Overall Study|Patients had no visit after entry|70|||
160955669|NCT01650259|581223613|FG001|Overall Study|Patients had no visit after entry|0|||
160955670|NCT01650259|581223612|FG000|Overall Study|CRF not collected|98|||
160955671|NCT01650259|581223613|FG001|Overall Study|CRF not collected|82|||
160955672|NCT01650259|581223612|FG000|Overall Study|Not treated|1|||
160955673|NCT01650259|581223613|FG001|Overall Study|Not treated|7|||
160955674|NCT01650259|581223612|FG000|Overall Study|Other than listed|64|||
160955675|NCT01650259|581223613|FG001|Overall Study|Other than listed|146|||
160955676|NCT04072159|581223619|FG000|Overall Study|Lost to Follow-up|6|||
160955677|NCT04072159|581223620|FG001|Overall Study|Lost to Follow-up|6|||
160955678|NCT04072159|581223619|FG000|Overall Study|Withdrawal by Subject|2|||
160955679|NCT04072159|581223620|FG001|Overall Study|Withdrawal by Subject|0|||
160955680|NCT00659334|581223631|FG000|Overall Study|Screen Failure|8|||
160955681|NCT00659334|581223632|FG001|Overall Study|Screen Failure|5|||
160955682|NCT00659334|581223633|FG002|Overall Study|Screen Failure|0|||
160955683|NCT00659334|581223634|FG003|Overall Study|Screen Failure|0|||
160955684|NCT00659334|581223635|FG004|Overall Study|Screen Failure|0|||
160955685|NCT00659334|581223636|FG005|Overall Study|Screen Failure|0|||
160955686|NCT00659334|581223637|FG006|Overall Study|Screen Failure|1|||
160955687|NCT03034577|581223638|FG000|Overall Study|Withdrawal by Subject|6|||
160955688|NCT03034577|581223639|FG001|Overall Study|Withdrawal by Subject|9|||
160955689|NCT03034577|581223638|FG000|Overall Study|Lost to Follow-up|25|||
160955690|NCT03034577|581223639|FG001|Overall Study|Lost to Follow-up|26|||
160955691|NCT01174342|581223640|FG000|Overall Study|Conversion to cesarean section|4|||
160955692|NCT02625623|581223641|FG000|Overall Study|Participants randomized but not treated|9|||
160955693|NCT02625623|581223642|FG001|Overall Study|Participants randomized but not treated|1|||
160955694|NCT02298192|581223651|FG000|Overall Study|Unclassified|3|||
160955695|NCT02298192|581223652|FG001|Overall Study|Unclassified|2|||
160955696|NCT02298192|581223651|FG000|Overall Study|Withdrawal criteria|2|||
160955697|NCT02298192|581223652|FG001|Overall Study|Withdrawal criteria|0|||
160955698|NCT02298192|581223651|FG000|Overall Study|Withdrawal by Subject|6|||
160955699|NCT02298192|581223652|FG001|Overall Study|Withdrawal by Subject|1|||
160955700|NCT02298192|581223651|FG000|Overall Study|Lost to Follow-up|2|||
160955701|NCT02298192|581223652|FG001|Overall Study|Lost to Follow-up|1|||
160955702|NCT02298192|581223651|FG000|Overall Study|Adverse Event|6|||
160955703|NCT02298192|581223652|FG001|Overall Study|Adverse Event|2|||
160955704|NCT02352948|581223653|FG000|Overall Study|Death|47|||
160955705|NCT02352948|581223654|FG001|Overall Study|Death|48|||
160955706|NCT02352948|581223655|FG002|Overall Study|Death|114|||
160955707|NCT02352948|581223656|FG003|Overall Study|Death|74|||
160656360|NCT00864097|580122437|FG000|Overall Study|Protocol Violation|2|||
160955708|NCT02352948|581223657|FG004|Overall Study|Death|77|||
160955709|NCT02352948|581223658|FG005|Overall Study|Death|44|||
160955710|NCT02352948|581223653|FG000|Overall Study|Lost to Follow-up|1|||
160955711|NCT02352948|581223654|FG001|Overall Study|Lost to Follow-up|0|||
160656361|NCT00864097|580122438|FG001|Overall Study|Protocol Violation|1|||
160955712|NCT02352948|581223655|FG002|Overall Study|Lost to Follow-up|2|||
160955713|NCT02352948|581223656|FG003|Overall Study|Lost to Follow-up|1|||
160955714|NCT02352948|581223657|FG004|Overall Study|Lost to Follow-up|2|||
160955715|NCT02352948|581223658|FG005|Overall Study|Lost to Follow-up|1|||
160656362|NCT00864097|580122439|FG002|Overall Study|Protocol Violation|0|||
160955716|NCT02352948|581223653|FG000|Overall Study|Withdrawal by Subject|1|||
160955717|NCT02352948|581223654|FG001|Overall Study|Withdrawal by Subject|10|||
160955718|NCT02352948|581223655|FG002|Overall Study|Withdrawal by Subject|11|||
161001190|NCT03215927|581390499|FG000|Open Label Extension|Lack of Efficacy|1|||
160656363|NCT00864097|580122440|FG003|Overall Study|Protocol Violation|1|||
160955719|NCT02352948|581223656|FG003|Overall Study|Withdrawal by Subject|23|||
160955720|NCT02352948|581223657|FG004|Overall Study|Withdrawal by Subject|9|||
160955721|NCT02352948|581223658|FG005|Overall Study|Withdrawal by Subject|4|||
160955722|NCT02352948|581223653|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160955723|NCT02352948|581223654|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160955724|NCT02352948|581223655|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
160955725|NCT02352948|581223656|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
160955726|NCT02352948|581223657|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
160955727|NCT02352948|581223658|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
160955728|NCT02352948|581223653|FG000|Overall Study|Other|0|||
160955729|NCT02352948|581223654|FG001|Overall Study|Other|0|||
160955730|NCT02352948|581223655|FG002|Overall Study|Other|2|||
160656364|NCT00864097|580122437|FG000|Overall Study|Terminated by sponsor|105|||
160656365|NCT00864097|580122438|FG001|Overall Study|Terminated by sponsor|112|||
160656366|NCT00864097|580122439|FG002|Overall Study|Terminated by sponsor|102|||
160656367|NCT00864097|580122440|FG003|Overall Study|Terminated by sponsor|99|||
160656368|NCT00864097|580122437|FG000|Overall Study|Randomized but not treated|2|||
160656369|NCT00864097|580122438|FG001|Overall Study|Randomized but not treated|0|||
160656370|NCT00864097|580122439|FG002|Overall Study|Randomized but not treated|1|||
160656371|NCT00864097|580122440|FG003|Overall Study|Randomized but not treated|0|||
160656372|NCT00864097|580122437|FG000|Overall Study|Other|0|||
160656373|NCT00864097|580122438|FG001|Overall Study|Other|0|||
160656374|NCT00864097|580122439|FG002|Overall Study|Other|0|||
160656375|NCT00864097|580122440|FG003|Overall Study|Other|1|||
160656376|NCT03661528|580122442|FG000|Overall Study|Death|1|||
160656377|NCT03661528|580122443|FG001|Overall Study|Death|0|||
160656378|NCT03661528|580122442|FG000|Overall Study|Physician Decision|3|||
160656379|NCT03661528|580122443|FG001|Overall Study|Physician Decision|1|||
160656380|NCT03661528|580122442|FG000|Overall Study|Other than Specified|5|||
160656381|NCT03661528|580122443|FG001|Overall Study|Other than Specified|2|||
160656382|NCT03661528|580122442|FG000|Overall Study|Withdrawal by Subject|5|||
160656383|NCT03661528|580122443|FG001|Overall Study|Withdrawal by Subject|3|||
160656384|NCT03661528|580122442|FG000|Overall Study|Disease Progression|8|||
160656385|NCT03661528|580122443|FG001|Overall Study|Disease Progression|13|||
160656386|NCT03661528|580122442|FG000|Overall Study|Adverse Event|61|||
160656387|NCT03661528|580122443|FG001|Overall Study|Adverse Event|55|||
160656388|NCT00320112|580122445|FG000|Overall Study|Lost to Follow-up|3|||
160656389|NCT00320112|580122446|FG001|Overall Study|Lost to Follow-up|4|||
160656390|NCT00320112|580122445|FG000|Overall Study|Withdrawal by Subject|3|||
160656391|NCT00320112|580122446|FG001|Overall Study|Withdrawal by Subject|0|||
160656392|NCT00320112|580122445|FG000|Overall Study|Death|2|||
160955731|NCT02352948|581223656|FG003|Overall Study|Other|0|||
160955732|NCT02352948|581223657|FG004|Overall Study|Other|0|||
160955733|NCT02352948|581223658|FG005|Overall Study|Other|0|||
160955734|NCT00045110|581223664|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
160955735|NCT00045110|581223665|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
160955736|NCT00045110|581223666|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
160955737|NCT00045110|581223664|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
160955738|NCT00045110|581223665|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
160955739|NCT00045110|581223666|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
160955740|NCT00045110|581223664|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
160955741|NCT00045110|581223665|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
160955742|NCT00045110|581223666|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
160955743|NCT03662750|581223668|FG000|Overall Study|Withdrawal by Subject|1|||
160955744|NCT02010060|581223669|FG000|Overall Study|Lost to Follow-up|1|||
160955745|NCT02010060|581223670|FG001|Overall Study|Lost to Follow-up|2|||
160955746|NCT02010060|581223671|FG002|Overall Study|Lost to Follow-up|2|||
160955747|NCT02010060|581223669|FG000|Overall Study|Injury|0|||
160955748|NCT02010060|581223670|FG001|Overall Study|Injury|1|||
160457657|NCT01570361|579406473|FG000|Overall Study|Other|0|||
160457658|NCT01570361|579406474|FG001|Overall Study|Other|2|||
160457659|NCT04129554|579406475|FG000|Overall Study|Withdrawal by Subject|4|||
160656393|NCT00320112|580122446|FG001|Overall Study|Death|1|||
160955749|NCT02010060|581223671|FG002|Overall Study|Injury|0|||
160955750|NCT04414696|581223672|FG000|3-month Follow up|Withdrawal by Subject|1|||
160457660|NCT04129554|579406476|FG001|Overall Study|Withdrawal by Subject|3|||
160656394|NCT00814463|580122448|FG000|Overall Study|Lost to Follow-up|1|||
160656395|NCT00486837|580122451|FG000|Overall Study|Withdrawal by Subject|1|||
160656396|NCT00486837|580122452|FG001|Overall Study|Withdrawal by Subject|0|||
160656397|NCT00486837|580122451|FG000|Overall Study|Adverse Event|1|||
160656398|NCT00486837|580122452|FG001|Overall Study|Adverse Event|1|||
160656399|NCT00486837|580122451|FG000|Overall Study|Protocol Violation|4|||
160656400|NCT00486837|580122452|FG001|Overall Study|Protocol Violation|2|||
160955751|NCT04414696|581223673|FG001|3-month Follow up|Withdrawal by Subject|0|||
160955752|NCT04414696|581223672|FG000|3-month Follow up|Lost to Follow-up|22|||
160955753|NCT04414696|581223673|FG001|3-month Follow up|Lost to Follow-up|23|||
160656401|NCT00486837|580122451|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
160955754|NCT04414696|581223672|FG000|6-month Follow up|Withdrawal by Subject|1|||
160955755|NCT04414696|581223673|FG001|6-month Follow up|Withdrawal by Subject|2|||
160955756|NCT04414696|581223672|FG000|6-month Follow up|Lost to Follow-up|5|||
160955757|NCT04414696|581223673|FG001|6-month Follow up|Lost to Follow-up|2|||
160955758|NCT00660010|581223676|FG000|Overall Study|Withdrawal by Subject|2|||
160955759|NCT00660010|581223676|FG000|Overall Study|Lost to Follow-up|3|||
160955760|NCT00660010|581223676|FG000|Overall Study|Adverse Event|1|||
160955761|NCT00660010|581223676|FG000|Overall Study|Noncompliance with visit schedule|3|||
160955762|NCT00726752|581223677|FG000|Overall Study|Lack of Efficacy|6|||
160955763|NCT06167031|581223680|FG000|Overall Study|Lost to Follow-up|5|||
160955764|NCT06167031|581223681|FG001|Overall Study|Lost to Follow-up|1|||
160955765|NCT01292603|581225807|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
160955766|NCT01292603|581225808|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
160955767|NCT01292603|581225809|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
160955768|NCT01292603|581225810|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
160955769|NCT01292603|581225811|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
160955770|NCT01292603|581225812|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
160955771|NCT01292603|581225807|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
160955772|NCT01292603|581225808|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
160955773|NCT01292603|581225809|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
160955774|NCT01292603|581225810|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
160955775|NCT01292603|581225811|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
160955776|NCT01292603|581225812|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
160955777|NCT01292603|581225807|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
160955778|NCT01292603|581225808|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
160955779|NCT01292603|581225809|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
160656402|NCT00486837|580122452|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
160656403|NCT01199861|580122455|FG000|Overall Study|Administrative problems|1|||
160656404|NCT01199861|580122456|FG001|Overall Study|Administrative problems|0|||
160656405|NCT01199861|580122455|FG000|Overall Study|Adverse Event|1|||
160656406|NCT01199861|580122456|FG001|Overall Study|Adverse Event|0|||
160656407|NCT05956665|580122457|FG000|Overall Study|Death|1|||
160656408|NCT05956665|580122457|FG000|Overall Study|Withdrawal by Subject|1|||
160656409|NCT05049460|580122458|FG000|Overall Study|Withdrawal by Subject|2|||
160656410|NCT05049460|580122459|FG001|Overall Study|Withdrawal by Subject|2|||
160656411|NCT05049460|580122458|FG000|Overall Study|Lost to Follow-up|2|||
160656412|NCT05049460|580122459|FG001|Overall Study|Lost to Follow-up|2|||
160656413|NCT00977470|580122460|FG000|Overall Study|Lack of Efficacy|32|||
160656414|NCT00977470|580122461|FG001|Overall Study|Lack of Efficacy|30|||
160656415|NCT00977470|580122460|FG000|Overall Study|Physician Decision|2|||
160656416|NCT00977470|580122461|FG001|Overall Study|Physician Decision|0|||
160656417|NCT00977470|580122460|FG000|Overall Study|Adverse Event|1|||
160656418|NCT00977470|580122461|FG001|Overall Study|Adverse Event|2|||
160656419|NCT00977470|580122460|FG000|Overall Study|Protocol Violation|1|||
160656420|NCT00977470|580122461|FG001|Overall Study|Protocol Violation|0|||
160656421|NCT00977470|580122460|FG000|Overall Study|Withdrawal by Subject|0|||
160656422|NCT00977470|580122461|FG001|Overall Study|Withdrawal by Subject|2|||
160656423|NCT00977470|580122460|FG000|Overall Study|Death|0|||
160656424|NCT00977470|580122461|FG001|Overall Study|Death|2|||
160656425|NCT00977470|580122460|FG000|Overall Study|clinical decline|0|||
160656426|NCT00977470|580122461|FG001|Overall Study|clinical decline|1|||
160656427|NCT00977470|580122460|FG000|Overall Study|prolonged recovery post-surgery|0|||
160656428|NCT00977470|580122461|FG001|Overall Study|prolonged recovery post-surgery|1|||
160656429|NCT00977470|580122460|FG000|Overall Study|Still on-study|2|||
160656430|NCT00977470|580122461|FG001|Overall Study|Still on-study|0|||
160656431|NCT00368277|580122462|FG000|Overall Study|Adverse Event|33|||
160656432|NCT00368277|580122463|FG001|Overall Study|Adverse Event|49|||
160656433|NCT00368277|580122462|FG000|Overall Study|Death|2|||
160955780|NCT01292603|581225810|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
160955781|NCT01292603|581225811|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
160955782|NCT01292603|581225812|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
160955783|NCT01292603|581225807|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
160955784|NCT01292603|581225808|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
160955785|NCT01292603|581225809|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
160955786|NCT01292603|581225810|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
160656434|NCT00368277|580122463|FG001|Overall Study|Death|1|||
160656435|NCT00368277|580122462|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
160955787|NCT01292603|581225811|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
160656436|NCT00368277|580122463|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
160656437|NCT00368277|580122462|FG000|Overall Study|Protocol deviation|7|||
160656438|NCT00368277|580122463|FG001|Overall Study|Protocol deviation|0|||
160656439|NCT00368277|580122462|FG000|Overall Study|Patient withdrew consent|32|||
160656440|NCT00368277|580122463|FG001|Overall Study|Patient withdrew consent|28|||
160656441|NCT00368277|580122462|FG000|Overall Study|Lost to Follow-up|8|||
160656442|NCT00368277|580122463|FG001|Overall Study|Lost to Follow-up|6|||
160955788|NCT01292603|581225812|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
160955789|NCT01292603|581225807|FG000|Part 1: Regular Follow-Up Period|Death|3|||
160955790|NCT01292603|581225808|FG001|Part 1: Regular Follow-Up Period|Death|1|||
160955791|NCT01292603|581225809|FG002|Part 1: Regular Follow-Up Period|Death|3|||
160955792|NCT01292603|581225810|FG003|Part 1: Regular Follow-Up Period|Death|1|||
160955793|NCT01292603|581225811|FG004|Part 1: Regular Follow-Up Period|Death|0|||
160955794|NCT01292603|581225812|FG005|Part 1: Regular Follow-Up Period|Death|0|||
160955795|NCT01292603|581225807|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
160955796|NCT01292603|581225808|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
160955797|NCT01292603|581225809|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
160955798|NCT01292603|581225810|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
160955799|NCT01292603|581225811|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
160955800|NCT01292603|581225812|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
160955801|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Death|0|||
160955802|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Death|0|||
160955803|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Death|0|||
160955804|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Death|0|||
160955805|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Death|1|||
160955806|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Death|0|||
160955807|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
160955808|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
160955809|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
160955810|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
160955811|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
160955812|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
160955813|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
160955814|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
160955815|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
160955816|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
160955817|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
160955818|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
160955819|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
160955820|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
160955821|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
160955822|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
160955823|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
160955824|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
160955825|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
160955826|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
160955827|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
160955828|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
160955829|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
160955830|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
160955831|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
160955832|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
160955833|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
160955834|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
160955835|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
160955836|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
160955837|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Death|0|||
160955838|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Death|0|||
160955839|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Death|0|||
160955840|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Death|0|||
160955841|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Death|6|||
160955842|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Death|3|||
160955843|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
160955844|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
160955845|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
160955846|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
160955847|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
160955848|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
160955849|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
160955850|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
160955851|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
160955852|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
160955853|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
160955854|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
160955855|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
160955856|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
160955857|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
160955858|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
160955859|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
160955860|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
160955861|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
160955862|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
160955863|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
160955864|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
160955865|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
160955866|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
160955867|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
160955868|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
160955869|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
160955870|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
160955871|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
160955872|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
160955873|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
160955874|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
160955875|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
160955876|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
160955877|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
160955878|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
160656443|NCT00918567|580122464|FG000|Overall Study|Lack of Efficacy|3|||
160656444|NCT00918567|580122465|FG001|Overall Study|Lack of Efficacy|1|||
160656445|NCT00918567|580122464|FG000|Overall Study|Withdrawal by Subject|1|||
160656446|NCT00918567|580122465|FG001|Overall Study|Withdrawal by Subject|1|||
160656447|NCT00918567|580122464|FG000|Overall Study|Adverse Event|1|||
160656448|NCT00918567|580122465|FG001|Overall Study|Adverse Event|0|||
160656449|NCT00117949|580122466|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
160656450|NCT00117949|580122467|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
160656451|NCT00117949|580122468|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
160656452|NCT00117949|580122469|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
160656453|NCT00117949|580122466|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
160656454|NCT00117949|580122467|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
160656455|NCT00117949|580122468|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
160656456|NCT00117949|580122469|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
160656457|NCT00117949|580122466|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
160656458|NCT00117949|580122467|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
160656459|NCT00117949|580122468|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
160656460|NCT00117949|580122469|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
160656461|NCT00117949|580122466|FG000|Overall Study|PSA increase >=10ng/mL|0|||
160656462|NCT00117949|580122467|FG001|Overall Study|PSA increase >=10ng/mL|1|||
160656463|NCT00117949|580122468|FG002|Overall Study|PSA increase >=10ng/mL|1|||
160656464|NCT00117949|580122469|FG003|Overall Study|PSA increase >=10ng/mL|0|||
160656465|NCT00117949|580122466|FG000|Overall Study|PSA reduction <=50%|0|||
160656466|NCT00117949|580122467|FG001|Overall Study|PSA reduction <=50%|2|||
160656467|NCT00117949|580122468|FG002|Overall Study|PSA reduction <=50%|2|||
160656468|NCT00117949|580122469|FG003|Overall Study|PSA reduction <=50%|4|||
160656469|NCT00117949|580122466|FG000|Overall Study|Hepatic abnormalities|0|||
160656470|NCT00117949|580122467|FG001|Overall Study|Hepatic abnormalities|1|||
160656471|NCT00117949|580122468|FG002|Overall Study|Hepatic abnormalities|0|||
160656472|NCT00117949|580122469|FG003|Overall Study|Hepatic abnormalities|1|||
160656473|NCT05275998|580122470|FG000|Overall Study|Adverse Event|0|||
160656474|NCT05275998|580122471|FG001|Overall Study|Adverse Event|0|||
160656475|NCT05275998|580122472|FG002|Overall Study|Adverse Event|0|||
160656476|NCT05275998|580122473|FG003|Overall Study|Adverse Event|1|||
160656477|NCT05275998|580122470|FG000|Overall Study|Withdrawal by Subject|0|||
160656478|NCT05275998|580122471|FG001|Overall Study|Withdrawal by Subject|0|||
160656479|NCT05275998|580122472|FG002|Overall Study|Withdrawal by Subject|0|||
160656480|NCT05275998|580122473|FG003|Overall Study|Withdrawal by Subject|1|||
160656481|NCT05275998|580122470|FG000|Overall Study|Physician Decision|0|||
160656482|NCT05275998|580122471|FG001|Overall Study|Physician Decision|0|||
160955879|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
161001191|NCT03215927|581390500|FG001|Open Label Extension|Lack of Efficacy|0|||
160656483|NCT05275998|580122472|FG002|Overall Study|Physician Decision|0|||
160656484|NCT05275998|580122473|FG003|Overall Study|Physician Decision|1|||
160656485|NCT05275998|580122470|FG000|Overall Study|Protocol Violation|0|||
160656486|NCT05275998|580122471|FG001|Overall Study|Protocol Violation|0|||
160656487|NCT05275998|580122472|FG002|Overall Study|Protocol Violation|1|||
160955880|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
161001192|NCT03215927|581390499|FG000|Open Label Extension|Death|0|||
160656488|NCT05275998|580122473|FG003|Overall Study|Protocol Violation|0|||
160656489|NCT01936948|580122474|FG000|Overall Study|no 30-day follow-up data|0|||
160656490|NCT01936948|580122475|FG001|Overall Study|no 30-day follow-up data|3|||
160656491|NCT01936948|580122476|FG002|Overall Study|no 30-day follow-up data|3|||
160656492|NCT01936948|580122477|FG003|Overall Study|no 30-day follow-up data|3|||
160656493|NCT00406848|580122478|FG000|Overall Study|Withdrawal by Subject|27|||
160656494|NCT00406848|580122479|FG001|Overall Study|Withdrawal by Subject|22|||
160656495|NCT00406848|580122478|FG000|Overall Study|Adverse Event|38|||
160656496|NCT00406848|580122479|FG001|Overall Study|Adverse Event|7|||
160656497|NCT00406848|580122478|FG000|Overall Study|Lack of Efficacy|9|||
160656498|NCT00406848|580122479|FG001|Overall Study|Lack of Efficacy|14|||
160656499|NCT00406848|580122478|FG000|Overall Study|Protocol Violation|10|||
160656500|NCT00406848|580122479|FG001|Overall Study|Protocol Violation|6|||
160656501|NCT00406848|580122478|FG000|Overall Study|Lost to Follow-up|6|||
160656502|NCT00406848|580122479|FG001|Overall Study|Lost to Follow-up|2|||
160656503|NCT00406848|580122478|FG000|Overall Study|Physician Decision|2|||
160656504|NCT00406848|580122479|FG001|Overall Study|Physician Decision|2|||
160656505|NCT00406848|580122478|FG000|Overall Study|Sponsor Decision|1|||
160656506|NCT00406848|580122479|FG001|Overall Study|Sponsor Decision|1|||
160656507|NCT04803357|580122480|FG000|Overall Study|Withdrawal by Subject|31|||
160656508|NCT04803357|580122481|FG001|Overall Study|Withdrawal by Subject|5|||
160656509|NCT02576990|580122482|FG000|Overall Study|Death|29|||
160656510|NCT02576990|580122483|FG001|Overall Study|Death|18|||
160656511|NCT02576990|580122482|FG000|Overall Study|Physician Decision|1|||
160656512|NCT02576990|580122483|FG001|Overall Study|Physician Decision|0|||
160656513|NCT02576990|580122482|FG000|Overall Study|Screen failure|2|||
160656514|NCT02576990|580122483|FG001|Overall Study|Screen failure|0|||
160656515|NCT02576990|580122482|FG000|Overall Study|Sponsor's decision|24|||
160656516|NCT02576990|580122483|FG001|Overall Study|Sponsor's decision|4|||
160656517|NCT02576990|580122482|FG000|Overall Study|Withdrawal by Subject|0|||
160656518|NCT02576990|580122483|FG001|Overall Study|Withdrawal by Subject|2|||
160955881|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
160955882|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
160656519|NCT00936390|580122484|FG000|Overall Study|Protocol Violation|21|||
160656520|NCT00936390|580122485|FG001|Overall Study|Protocol Violation|25|||
160955883|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
160955884|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
160955885|NCT01292603|581225807|FG000|Overall Survival Status|Death|3|||
160955886|NCT01292603|581225808|FG001|Overall Survival Status|Death|1|||
160955887|NCT01292603|581225809|FG002|Overall Survival Status|Death|3|||
160955888|NCT01292603|581225810|FG003|Overall Survival Status|Death|1|||
160955889|NCT01292603|581225811|FG004|Overall Survival Status|Death|16|||
160955890|NCT01292603|581225812|FG005|Overall Survival Status|Death|10|||
160955891|NCT02120027|581225813|FG000|Overall Study|Adverse Event|4|||
160955892|NCT02120027|581225814|FG001|Overall Study|Adverse Event|5|||
160955893|NCT02120027|581225813|FG000|Overall Study|Lack of Efficacy|3|||
160955894|NCT02120027|581225814|FG001|Overall Study|Lack of Efficacy|5|||
160955895|NCT02120027|581225813|FG000|Overall Study|Lost to Follow-up|5|||
160955896|NCT02120027|581225814|FG001|Overall Study|Lost to Follow-up|13|||
160656521|NCT02093689|580122486|FG000|Overall Study|Physician Decision|4|||
160656522|NCT02093689|580122487|FG001|Overall Study|Physician Decision|0|||
160656523|NCT02093689|580122488|FG002|Overall Study|Physician Decision|0|||
160656524|NCT00475020|580122489|FG000|Overall Study|Physician Decision|3|||
160656525|NCT00475020|580122489|FG000|Overall Study|Insurance Denial|1|||
160656526|NCT00475020|580122489|FG000|Overall Study|Donor not able to donate the last minute|1|||
160656527|NCT01575054|580122490|FG000|Overall Study|Other Reasons|5|||
160656528|NCT01575054|580122491|FG001|Overall Study|Other Reasons|3|||
160656529|NCT01575054|580122490|FG000|Overall Study|Protocol Violation|2|||
160955897|NCT02120027|581225813|FG000|Overall Study|Other|4|||
160955898|NCT02120027|581225814|FG001|Overall Study|Other|0|||
160955899|NCT02120027|581225813|FG000|Overall Study|Physician Decision|4|||
160955900|NCT02120027|581225814|FG001|Overall Study|Physician Decision|3|||
160955901|NCT02120027|581225813|FG000|Overall Study|Protocol Violation|18|||
160955902|NCT02120027|581225814|FG001|Overall Study|Protocol Violation|21|||
160955903|NCT02120027|581225813|FG000|Overall Study|Study terminated by Sponsor|45|||
160955904|NCT02120027|581225814|FG001|Overall Study|Study terminated by Sponsor|47|||
160955905|NCT02120027|581225813|FG000|Overall Study|Withdrawal by Subject|33|||
160457661|NCT04129554|579406475|FG000|Overall Study|Other|0|||
160457662|NCT04129554|579406476|FG001|Overall Study|Other|2|||
160656530|NCT01575054|580122491|FG001|Overall Study|Protocol Violation|1|||
160656531|NCT01575054|580122490|FG000|Overall Study|Personal Reasons|10|||
160656532|NCT01575054|580122491|FG001|Overall Study|Personal Reasons|11|||
160457663|NCT05158504|579406477|FG000|Overall Study|Lost to Follow-up|2|||
160656533|NCT01575054|580122490|FG000|Overall Study|Lost to Follow-up|3|||
160656534|NCT01575054|580122491|FG001|Overall Study|Lost to Follow-up|3|||
160656535|NCT01575054|580122490|FG000|Overall Study|Adverse Event|9|||
160656536|NCT01575054|580122491|FG001|Overall Study|Adverse Event|8|||
160955906|NCT02120027|581225814|FG001|Overall Study|Withdrawal by Subject|25|||
160955907|NCT03162224|581225815|FG000|Overall Study|Death|4|||
160955908|NCT03162224|581225816|FG001|Overall Study|Death|5|||
160955909|NCT03162224|581225817|FG002|Overall Study|Death|8|||
160955910|NCT03162224|581225815|FG000|Overall Study|Withdrawal by Subject|1|||
160955911|NCT03162224|581225816|FG001|Overall Study|Withdrawal by Subject|0|||
160955912|NCT03162224|581225817|FG002|Overall Study|Withdrawal by Subject|1|||
160955913|NCT03162224|581225815|FG000|Overall Study|Lost to Follow-up|0|||
160955914|NCT03162224|581225816|FG001|Overall Study|Lost to Follow-up|1|||
160955915|NCT03162224|581225817|FG002|Overall Study|Lost to Follow-up|0|||
160955916|NCT03162224|581225815|FG000|Overall Study|Other|6|||
160955917|NCT03162224|581225816|FG001|Overall Study|Other|2|||
160955918|NCT03162224|581225817|FG002|Overall Study|Other|1|||
160955919|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
160955920|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
160955921|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
160955922|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
160955923|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
160955924|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
160955925|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
160955926|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
160955927|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
160955928|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
160955929|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
160955930|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
160955931|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
160955932|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
160955933|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
160955934|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
160955935|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
160955936|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
160955937|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
160955938|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
160955939|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Other|0|||
160955940|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Other|1|||
160955941|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Other|1|||
160582778|NCT00069095|579853714|FG001|Primary Treatment Phase|Withdrew|3|||
160582779|NCT00069095|579853715|FG002|Primary Treatment Phase|Withdrew|8|||
160955942|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Other|0|||
160955943|NCT04162769|581225818|FG000|OLE Period (52-Week)|Adverse Event|0|||
160955944|NCT04162769|581225819|FG001|OLE Period (52-Week)|Adverse Event|0|||
160955945|NCT04162769|581225820|FG002|OLE Period (52-Week)|Adverse Event|0|||
160955946|NCT04162769|581225821|FG003|OLE Period (52-Week)|Adverse Event|5|||
160955947|NCT04162769|581225818|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
160955948|NCT04162769|581225819|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
160955949|NCT04162769|581225820|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
160955950|NCT04162769|581225821|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
160955951|NCT04162769|581225818|FG000|OLE Period (52-Week)|Physician Decision|0|||
160955952|NCT04162769|581225819|FG001|OLE Period (52-Week)|Physician Decision|0|||
160955953|NCT04162769|581225820|FG002|OLE Period (52-Week)|Physician Decision|0|||
160955954|NCT04162769|581225821|FG003|OLE Period (52-Week)|Physician Decision|1|||
160955955|NCT04162769|581225818|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
160955956|NCT04162769|581225819|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
160955957|NCT04162769|581225820|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
160955958|NCT04162769|581225821|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
160955959|NCT04162769|581225818|FG000|OLE Period (52-Week)|Protocol deviation|0|||
160457664|NCT05158504|579406478|FG001|Overall Study|Lost to Follow-up|3|||
160582780|NCT00069095|579853716|FG003|Primary Treatment Phase|Withdrew|2|||
160582781|NCT00069095|579853717|FG004|Primary Treatment Phase|Withdrew|4|||
160582782|NCT00069095|579853718|FG005|Primary Treatment Phase|Withdrew|9|||
160582783|NCT00069095|579853713|FG000|Primary Treatment Phase|Other Violation|0|||
160582784|NCT00069095|579853714|FG001|Primary Treatment Phase|Other Violation|1|||
160582785|NCT00069095|579853715|FG002|Primary Treatment Phase|Other Violation|1|||
160582786|NCT00069095|579853716|FG003|Primary Treatment Phase|Other Violation|1|||
160582787|NCT00069095|579853717|FG004|Primary Treatment Phase|Other Violation|0|||
160582788|NCT00069095|579853718|FG005|Primary Treatment Phase|Other Violation|1|||
160582789|NCT00069095|579853713|FG000|Primary Treatment Phase|Violation criteria|0|||
160582790|NCT00069095|579853714|FG001|Primary Treatment Phase|Violation criteria|2|||
160582791|NCT00069095|579853715|FG002|Primary Treatment Phase|Violation criteria|4|||
160582792|NCT00069095|579853716|FG003|Primary Treatment Phase|Violation criteria|3|||
160582793|NCT00069095|579853717|FG004|Primary Treatment Phase|Violation criteria|1|||
160582794|NCT00069095|579853718|FG005|Primary Treatment Phase|Violation criteria|5|||
160582795|NCT00069095|579853713|FG000|Post-study Treatment Phase|Missing reason|1|||
160632832|NCT01215955|580036086|FG001|Overall Study|Lack of Efficacy|2|||
160955960|NCT04162769|581225819|FG001|OLE Period (52-Week)|Protocol deviation|0|||
160955961|NCT04162769|581225820|FG002|OLE Period (52-Week)|Protocol deviation|0|||
160955962|NCT04162769|581225821|FG003|OLE Period (52-Week)|Protocol deviation|2|||
160955963|NCT01972841|581225824|FG000|Overall Study|Randomized but Never Received Treatment|2|||
160955964|NCT01972841|581225825|FG001|Overall Study|Randomized but Never Received Treatment|5|||
160656537|NCT03365947|580122494|FG000|Overall Study|Lost to Follow-up|0|||
160656538|NCT03365947|580122495|FG001|Overall Study|Lost to Follow-up|0|||
160656539|NCT03365947|580122496|FG002|Overall Study|Lost to Follow-up|0|||
160656540|NCT03365947|580122497|FG003|Overall Study|Lost to Follow-up|0|||
160656541|NCT03365947|580122498|FG004|Overall Study|Lost to Follow-up|0|||
160656542|NCT03365947|580122499|FG005|Overall Study|Lost to Follow-up|1|||
160656543|NCT03365947|580122500|FG006|Overall Study|Lost to Follow-up|0|||
160656544|NCT03365947|580122501|FG007|Overall Study|Lost to Follow-up|0|||
160656545|NCT03365947|580122502|FG008|Overall Study|Lost to Follow-up|0|||
160656546|NCT03365947|580122503|FG009|Overall Study|Lost to Follow-up|0|||
160656547|NCT03365947|580122504|FG010|Overall Study|Lost to Follow-up|0|||
160656548|NCT03365947|580122505|FG011|Overall Study|Lost to Follow-up|0|||
160656549|NCT03365947|580122506|FG012|Overall Study|Lost to Follow-up|0|||
160656550|NCT03365947|580122507|FG013|Overall Study|Lost to Follow-up|0|||
161001193|NCT03215927|581390500|FG001|Open Label Extension|Death|1|||
160656551|NCT03365947|580122508|FG014|Overall Study|Lost to Follow-up|0|||
160656552|NCT03365947|580122509|FG015|Overall Study|Lost to Follow-up|0|||
160656553|NCT03365947|580122510|FG016|Overall Study|Lost to Follow-up|0|||
160656554|NCT03365947|580122511|FG017|Overall Study|Lost to Follow-up|0|||
160656555|NCT03365947|580122512|FG018|Overall Study|Lost to Follow-up|0|||
160656556|NCT02518685|580122513|FG000|Overall Study|Adverse Event|29|||
160656557|NCT02518685|580122514|FG001|Overall Study|Adverse Event|1|||
160656558|NCT02518685|580122513|FG000|Overall Study|Withdrawal by Subject|10|||
160656559|NCT02518685|580122514|FG001|Overall Study|Withdrawal by Subject|3|||
160656560|NCT02518685|580122513|FG000|Overall Study|relocation, study fatigue|7|||
160656561|NCT02518685|580122514|FG001|Overall Study|relocation, study fatigue|2|||
160656562|NCT02518685|580122513|FG000|Overall Study|Pregnancy|1|||
160656563|NCT02518685|580122514|FG001|Overall Study|Pregnancy|0|||
160656564|NCT02518685|580122513|FG000|Overall Study|Physician Decision|1|||
160656565|NCT02518685|580122514|FG001|Overall Study|Physician Decision|0|||
160656566|NCT02518685|580122513|FG000|Overall Study|Lost to Follow-up|1|||
160656567|NCT02518685|580122514|FG001|Overall Study|Lost to Follow-up|4|||
160656568|NCT01922349|580122515|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
160656569|NCT01922349|580122516|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
160656570|NCT01922349|580122517|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
160656571|NCT01922349|580122518|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
160656572|NCT05109234|580122519|FG000|Overall Study|Adverse Event|2|||
160656573|NCT05109234|580122520|FG001|Overall Study|Adverse Event|2|||
160656574|NCT05109234|580122519|FG000|Overall Study|Lack of Efficacy|5|||
160656575|NCT05109234|580122520|FG001|Overall Study|Lack of Efficacy|0|||
160656576|NCT05109234|580122519|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
160656577|NCT05109234|580122520|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
160955965|NCT01972841|581225826|FG002|Overall Study|Randomized but Never Received Treatment|4|||
160955966|NCT01972841|581225827|FG003|Overall Study|Randomized but Never Received Treatment|2|||
160955967|NCT01972841|581225828|FG004|Overall Study|Randomized but Never Received Treatment|6|||
160656578|NCT05109234|580122519|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
160656579|NCT05109234|580122520|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
160955968|NCT01972841|581225829|FG005|Overall Study|Randomized but Never Received Treatment|13|||
160955969|NCT01972841|581225824|FG000|Overall Study|Adverse Event|13|||
160955970|NCT01972841|581225825|FG001|Overall Study|Adverse Event|8|||
161001194|NCT03779048|581390501|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
161001195|NCT03779048|581390502|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
161001196|NCT03779048|581390503|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
161001197|NCT03779048|581390501|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
161001198|NCT03779048|581390502|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
161001199|NCT03779048|581390503|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
161001200|NCT03779048|581390501|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
160955971|NCT01972841|581225826|FG002|Overall Study|Adverse Event|12|||
161001201|NCT03779048|581390502|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
161001202|NCT03779048|581390503|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
160457665|NCT03606512|579406479|FG000|Overall Study|Lost to Follow-up|0|||
160656580|NCT05109234|580122519|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
160656581|NCT05109234|580122520|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
160656582|NCT05109234|580122519|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
160656583|NCT05109234|580122520|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
160457666|NCT03606512|579406480|FG001|Overall Study|Lost to Follow-up|1|||
160656584|NCT03805438|580124356|FG000|Overall Study|Lack of Efficacy|1|||
160656585|NCT03805438|580124356|FG000|Overall Study|Protocol Violation|1|||
160457667|NCT03606512|579406479|FG000|Overall Study|'moved from study area|0|||
160457668|NCT03606512|579406480|FG001|Overall Study|'moved from study area|1|||
160656586|NCT02684344|580124357|FG000|Overall Study|Withdrawal by Subject|0|||
160656587|NCT02684344|580124358|FG001|Overall Study|Withdrawal by Subject|1|||
160656588|NCT01451762|580124359|FG000|Overall Study|Lost to Follow-up|3|||
160955972|NCT01972841|581225827|FG003|Overall Study|Adverse Event|9|||
160656589|NCT01451762|580124360|FG001|Overall Study|Lost to Follow-up|6|||
160656590|NCT01451762|580124361|FG002|Overall Study|Lost to Follow-up|6|||
160656591|NCT01494506|580124362|FG000|Overall Study|Lack of Efficacy|77|||
160656592|NCT01494506|580124363|FG001|Overall Study|Lack of Efficacy|83|||
160656593|NCT01494506|580124364|FG002|Overall Study|Lack of Efficacy|57|||
160656594|NCT01494506|580124362|FG000|Overall Study|Adverse Event|17|||
160656595|NCT01494506|580124363|FG001|Overall Study|Adverse Event|10|||
160656596|NCT01494506|580124364|FG002|Overall Study|Adverse Event|11|||
160656597|NCT01494506|580124362|FG000|Overall Study|Death|9|||
160656598|NCT01494506|580124363|FG001|Overall Study|Death|5|||
160656599|NCT01494506|580124364|FG002|Overall Study|Death|2|||
160955973|NCT01972841|581225828|FG004|Overall Study|Adverse Event|21|||
160955974|NCT01972841|581225829|FG005|Overall Study|Adverse Event|26|||
160955975|NCT01972841|581225824|FG000|Overall Study|Lack of Efficacy|1|||
160955976|NCT01972841|581225825|FG001|Overall Study|Lack of Efficacy|0|||
160955977|NCT01972841|581225826|FG002|Overall Study|Lack of Efficacy|0|||
160955978|NCT01972841|581225827|FG003|Overall Study|Lack of Efficacy|2|||
160955979|NCT01972841|581225828|FG004|Overall Study|Lack of Efficacy|4|||
160656600|NCT01494506|580124362|FG000|Overall Study|Physician Decision|7|||
160656601|NCT01494506|580124363|FG001|Overall Study|Physician Decision|5|||
160656602|NCT01494506|580124364|FG002|Overall Study|Physician Decision|4|||
160656603|NCT01494506|580124362|FG000|Overall Study|Withdrawal by Subject|17|||
160656604|NCT01494506|580124363|FG001|Overall Study|Withdrawal by Subject|20|||
160656605|NCT01494506|580124364|FG002|Overall Study|Withdrawal by Subject|14|||
160656606|NCT01494506|580124362|FG000|Overall Study|Clinical Deterioration|21|||
160656607|NCT01494506|580124363|FG001|Overall Study|Clinical Deterioration|17|||
160656608|NCT01494506|580124364|FG002|Overall Study|Clinical Deterioration|13|||
160656609|NCT01494506|580124362|FG000|Overall Study|Sponsor Decision|0|||
160955980|NCT01972841|581225829|FG005|Overall Study|Lack of Efficacy|1|||
160656610|NCT01494506|580124363|FG001|Overall Study|Sponsor Decision|0|||
160656611|NCT01494506|580124364|FG002|Overall Study|Sponsor Decision|1|||
160656612|NCT01494506|580124362|FG000|Overall Study|Other|0|||
160656613|NCT01494506|580124363|FG001|Overall Study|Other|3|||
160955981|NCT01972841|581225824|FG000|Overall Study|Lost to Follow-up|4|||
160955982|NCT01972841|581225825|FG001|Overall Study|Lost to Follow-up|2|||
160955983|NCT01972841|581225826|FG002|Overall Study|Lost to Follow-up|4|||
160955984|NCT01972841|581225827|FG003|Overall Study|Lost to Follow-up|2|||
160955985|NCT01972841|581225828|FG004|Overall Study|Lost to Follow-up|9|||
160955986|NCT01972841|581225829|FG005|Overall Study|Lost to Follow-up|3|||
160955987|NCT01972841|581225824|FG000|Overall Study|Protocol Violation|2|||
160955988|NCT01972841|581225825|FG001|Overall Study|Protocol Violation|2|||
160955989|NCT01972841|581225826|FG002|Overall Study|Protocol Violation|3|||
160955990|NCT01972841|581225827|FG003|Overall Study|Protocol Violation|5|||
160955991|NCT01972841|581225828|FG004|Overall Study|Protocol Violation|9|||
160955992|NCT01972841|581225829|FG005|Overall Study|Protocol Violation|4|||
160955993|NCT01972841|581225824|FG000|Overall Study|Withdrawal by participants|21|||
160955994|NCT01972841|581225825|FG001|Overall Study|Withdrawal by participants|27|||
160955995|NCT01972841|581225826|FG002|Overall Study|Withdrawal by participants|23|||
160955996|NCT01972841|581225827|FG003|Overall Study|Withdrawal by participants|16|||
160955997|NCT01972841|581225828|FG004|Overall Study|Withdrawal by participants|33|||
160955998|NCT01972841|581225829|FG005|Overall Study|Withdrawal by participants|34|||
160955999|NCT01972841|581225824|FG000|Overall Study|Miscellaneous|0|||
160956000|NCT01972841|581225825|FG001|Overall Study|Miscellaneous|0|||
160956001|NCT01972841|581225826|FG002|Overall Study|Miscellaneous|4|||
160956002|NCT01972841|581225827|FG003|Overall Study|Miscellaneous|1|||
160656614|NCT01494506|580124364|FG002|Overall Study|Other|1|||
160656615|NCT02777528|580124367|FG000|Overall Study|Still in study|24|||
160656616|NCT02777528|580124368|FG001|Overall Study|Still in study|10|||
160656617|NCT02777528|580124369|FG002|Overall Study|Still in study|1|||
160656618|NCT02777528|580124367|FG000|Overall Study|Study Device Explanted|1|||
160656619|NCT02777528|580124368|FG001|Overall Study|Study Device Explanted|0|||
160656620|NCT02777528|580124369|FG002|Overall Study|Study Device Explanted|0|||
160656621|NCT02777528|580124367|FG000|Overall Study|Death|14|||
160656622|NCT02777528|580124368|FG001|Overall Study|Death|7|||
160656623|NCT02777528|580124369|FG002|Overall Study|Death|1|||
160656624|NCT02777528|580124367|FG000|Overall Study|Withdrawal by Subject|2|||
160956003|NCT01972841|581225828|FG004|Overall Study|Miscellaneous|0|||
160956004|NCT01972841|581225829|FG005|Overall Study|Miscellaneous|4|||
160956005|NCT01972841|581225824|FG000|Overall Study|Did not have end of treatment page|0|||
160956006|NCT01972841|581225825|FG001|Overall Study|Did not have end of treatment page|0|||
160956007|NCT01972841|581225826|FG002|Overall Study|Did not have end of treatment page|0|||
160656625|NCT02777528|580124368|FG001|Overall Study|Withdrawal by Subject|2|||
160656626|NCT02777528|580124369|FG002|Overall Study|Withdrawal by Subject|1|||
160656627|NCT02777528|580124367|FG000|Overall Study|Physician Decision|2|||
160656628|NCT02777528|580124368|FG001|Overall Study|Physician Decision|1|||
160656629|NCT02777528|580124369|FG002|Overall Study|Physician Decision|0|||
160656630|NCT02777528|580124367|FG000|Overall Study|Lost to Follow-up|2|||
160956008|NCT01972841|581225827|FG003|Overall Study|Did not have end of treatment page|0|||
160956009|NCT01972841|581225828|FG004|Overall Study|Did not have end of treatment page|1|||
160956010|NCT01972841|581225829|FG005|Overall Study|Did not have end of treatment page|0|||
160956011|NCT02734212|581225830|FG000|Overall Study|Lost to Follow-up|5|||
160956012|NCT02734212|581225831|FG001|Overall Study|Lost to Follow-up|10|||
160956013|NCT00688636|581225832|FG000|Overall Study|Adverse Event|2|||
160956014|NCT00688636|581225833|FG001|Overall Study|Adverse Event|1|||
160956015|NCT01572727|581225834|FG000|Overall Study|Adverse Event|43|||
160956016|NCT01572727|581225835|FG001|Overall Study|Adverse Event|15|||
160956017|NCT01572727|581225834|FG000|Overall Study|Lost to Follow-up|1|||
160956018|NCT01572727|581225835|FG001|Overall Study|Lost to Follow-up|1|||
160956019|NCT01572727|581225834|FG000|Overall Study|Physician Decision|23|||
160956020|NCT01572727|581225835|FG001|Overall Study|Physician Decision|9|||
160956021|NCT01572727|581225834|FG000|Overall Study|Progressive disease|59|||
160956022|NCT01572727|581225835|FG001|Overall Study|Progressive disease|82|||
160956023|NCT01572727|581225834|FG000|Overall Study|Protocol Violation|0|||
160956024|NCT01572727|581225835|FG001|Overall Study|Protocol Violation|1|||
160956025|NCT01572727|581225834|FG000|Overall Study|Study terminated by sponsor|61|||
160956026|NCT01572727|581225835|FG001|Overall Study|Study terminated by sponsor|83|||
160956027|NCT01572727|581225834|FG000|Overall Study|Parent/guardian decision|14|||
160956028|NCT01572727|581225835|FG001|Overall Study|Parent/guardian decision|9|||
160956029|NCT01572727|581225834|FG000|Overall Study|Death|2|||
160956030|NCT01572727|581225835|FG001|Overall Study|Death|2|||
160956031|NCT01572727|581225834|FG000|Overall Study|Untreated|4|||
160956032|NCT01572727|581225835|FG001|Overall Study|Untreated|7|||
160956033|NCT04053764|581225836|FG000|Overall Study|Withdrawal by Subject|6|||
160956034|NCT04053764|581225837|FG001|Overall Study|Withdrawal by Subject|2|||
160956035|NCT04053764|581225836|FG000|Overall Study|Physician Decision|2|||
161001203|NCT01286272|581390504|FG000|Overall Study|Ineligible after beginning treatment|1|||
161001204|NCT01286272|581390505|FG001|Overall Study|Ineligible after beginning treatment|3|||
161001205|NCT03979365|581390508|FG000|Overall Study|Death|1|||
161001206|NCT03979365|581390509|FG001|Overall Study|Death|3|||
161001207|NCT03979365|581390508|FG000|Overall Study|Withdrawal by Subject|0|||
161001208|NCT03979365|581390509|FG001|Overall Study|Withdrawal by Subject|1|||
161001209|NCT03979365|581390508|FG000|Overall Study|Drug Conversion|0|||
161001210|NCT03979365|581390509|FG001|Overall Study|Drug Conversion|3|||
161001211|NCT04001829|581390510|FG000|Overall Study|Never start protocol therapy|5|||
161001212|NCT04001829|581390511|FG001|Overall Study|Never start protocol therapy|5|||
161001213|NCT04001829|581390510|FG000|Overall Study|Adverse Event|11|||
161001214|NCT04001829|581390511|FG001|Overall Study|Adverse Event|7|||
161001215|NCT04001829|581390510|FG000|Overall Study|Alternative therapy|1|||
161001216|NCT04001829|581390511|FG001|Overall Study|Alternative therapy|2|||
161001217|NCT04001829|581390510|FG000|Overall Study|Disease progression/relapse|2|||
161001218|NCT04001829|581390511|FG001|Overall Study|Disease progression/relapse|1|||
161001219|NCT04001829|581390510|FG000|Overall Study|Other complicating disease|1|||
161001220|NCT04001829|581390511|FG001|Overall Study|Other complicating disease|0|||
161001221|NCT04001829|581390510|FG000|Overall Study|Withdrawal by Subject|1|||
160582796|NCT00069095|579853714|FG001|Post-study Treatment Phase|Missing reason|3|||
160582797|NCT00069095|579853715|FG002|Post-study Treatment Phase|Missing reason|12|||
160582798|NCT00069095|579853716|FG003|Post-study Treatment Phase|Missing reason|8|||
160582799|NCT00069095|579853717|FG004|Post-study Treatment Phase|Missing reason|18|||
160582800|NCT00069095|579853718|FG005|Post-study Treatment Phase|Missing reason|17|||
160582801|NCT00069095|579853713|FG000|Post-study Treatment Phase|Adverse Event|2|||
160582802|NCT00069095|579853714|FG001|Post-study Treatment Phase|Adverse Event|3|||
160582803|NCT00069095|579853715|FG002|Post-study Treatment Phase|Adverse Event|1|||
160582804|NCT00069095|579853716|FG003|Post-study Treatment Phase|Adverse Event|0|||
160582805|NCT00069095|579853717|FG004|Post-study Treatment Phase|Adverse Event|5|||
160582806|NCT00069095|579853718|FG005|Post-study Treatment Phase|Adverse Event|1|||
160582807|NCT00069095|579853713|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
160582808|NCT00069095|579853714|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
160582809|NCT00069095|579853715|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
160582810|NCT00069095|579853716|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
160582811|NCT00069095|579853717|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
160582812|NCT00069095|579853718|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
160582813|NCT00069095|579853713|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
160582814|NCT00069095|579853714|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
160582815|NCT00069095|579853715|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
160956036|NCT04053764|581225837|FG001|Overall Study|Physician Decision|1|||
161001222|NCT04001829|581390511|FG001|Overall Study|Withdrawal by Subject|4|||
161001223|NCT04001829|581390510|FG000|Overall Study|Ineligible|2|||
161001224|NCT04001829|581390511|FG001|Overall Study|Ineligible|2|||
161001225|NCT04001829|581390510|FG000|Overall Study|Reason missing due to delinquent data|1|||
160457669|NCT05513937|579406481|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
160632833|NCT01215955|580036087|FG002|Overall Study|Lack of Efficacy|1|||
160956037|NCT04053764|581225836|FG000|Overall Study|Adverse Event|1|||
160956038|NCT04053764|581225837|FG001|Overall Study|Adverse Event|0|||
160956039|NCT04053764|581225836|FG000|Overall Study|Pregnancy|1|||
160956040|NCT04053764|581225837|FG001|Overall Study|Pregnancy|0|||
160956041|NCT02384954|581225841|FG000|Phase 1|Progressive Disease|2|||
160956042|NCT02384954|581225842|FG001|Phase 1|Progressive Disease|0|||
160956043|NCT02384954|581225843|FG002|Phase 1|Progressive Disease|1|||
160956044|NCT02384954|581225844|FG003|Phase 1|Progressive Disease|1|||
160956045|NCT02384954|581225845|FG004|Phase 1|Progressive Disease|0|||
160956046|NCT02384954|581225846|FG005|Phase 1|Progressive Disease|0|||
160956047|NCT02384954|581225847|FG006|Phase 1|Progressive Disease|0|||
160956048|NCT02384954|581225848|FG007|Phase 1|Progressive Disease|0|||
160956049|NCT02384954|581225849|FG008|Phase 1|Progressive Disease|0|||
160956050|NCT02384954|581225841|FG000|Phase 1|Adverse Event|0|||
160956051|NCT02384954|581225842|FG001|Phase 1|Adverse Event|0|||
160956052|NCT02384954|581225843|FG002|Phase 1|Adverse Event|1|||
160956053|NCT02384954|581225844|FG003|Phase 1|Adverse Event|0|||
160656631|NCT02777528|580124368|FG001|Overall Study|Lost to Follow-up|0|||
160656632|NCT02777528|580124369|FG002|Overall Study|Lost to Follow-up|0|||
160656633|NCT02777528|580124367|FG000|Overall Study|Discontinued due to Other|1|||
160656634|NCT02777528|580124368|FG001|Overall Study|Discontinued due to Other|0|||
160656635|NCT02777528|580124369|FG002|Overall Study|Discontinued due to Other|0|||
160656636|NCT00453362|580124370|FG000|Overall Study|Adverse Event|5|||
160656637|NCT00453362|580124370|FG000|Overall Study|Death|7|||
160656638|NCT00453362|580124370|FG000|Overall Study|Physician Decision|2|||
160956054|NCT02384954|581225845|FG004|Phase 1|Adverse Event|0|||
160956055|NCT02384954|581225846|FG005|Phase 1|Adverse Event|0|||
160956056|NCT02384954|581225847|FG006|Phase 1|Adverse Event|0|||
160956057|NCT02384954|581225848|FG007|Phase 1|Adverse Event|0|||
160956058|NCT02384954|581225849|FG008|Phase 1|Adverse Event|0|||
160956059|NCT02384954|581225841|FG000|Phase 2|Progressive Disease|0|||
160956060|NCT02384954|581225842|FG001|Phase 2|Progressive Disease|0|||
160956061|NCT02384954|581225843|FG002|Phase 2|Progressive Disease|0|||
160956062|NCT02384954|581225844|FG003|Phase 2|Progressive Disease|0|||
160956063|NCT02384954|581225845|FG004|Phase 2|Progressive Disease|0|||
160956064|NCT02384954|581225846|FG005|Phase 2|Progressive Disease|0|||
160956065|NCT02384954|581225847|FG006|Phase 2|Progressive Disease|0|||
160956066|NCT02384954|581225848|FG007|Phase 2|Progressive Disease|1|||
160956067|NCT02384954|581225849|FG008|Phase 2|Progressive Disease|2|||
160956068|NCT02384954|581225841|FG000|Phase 2|Adverse Event|0|||
160956069|NCT02384954|581225842|FG001|Phase 2|Adverse Event|0|||
160956070|NCT02384954|581225843|FG002|Phase 2|Adverse Event|0|||
160956071|NCT02384954|581225844|FG003|Phase 2|Adverse Event|0|||
160956072|NCT02384954|581225845|FG004|Phase 2|Adverse Event|0|||
160956073|NCT02384954|581225846|FG005|Phase 2|Adverse Event|0|||
160956074|NCT02384954|581225847|FG006|Phase 2|Adverse Event|0|||
160956075|NCT02384954|581225848|FG007|Phase 2|Adverse Event|1|||
160956076|NCT02384954|581225849|FG008|Phase 2|Adverse Event|1|||
160956077|NCT02384954|581225841|FG000|Phase 2|Failure to meet continuation criteria|0|||
160956078|NCT02384954|581225842|FG001|Phase 2|Failure to meet continuation criteria|0|||
160956079|NCT02384954|581225843|FG002|Phase 2|Failure to meet continuation criteria|0|||
160956080|NCT02384954|581225844|FG003|Phase 2|Failure to meet continuation criteria|0|||
160956081|NCT02384954|581225845|FG004|Phase 2|Failure to meet continuation criteria|0|||
160956082|NCT02384954|581225846|FG005|Phase 2|Failure to meet continuation criteria|0|||
160956083|NCT02384954|581225847|FG006|Phase 2|Failure to meet continuation criteria|0|||
160956084|NCT02384954|581225848|FG007|Phase 2|Failure to meet continuation criteria|1|||
160956085|NCT02384954|581225849|FG008|Phase 2|Failure to meet continuation criteria|0|||
160956086|NCT04732286|581225850|FG000|Overall Study|Progressive Disease|2|||
160956087|NCT04732286|581225850|FG000|Overall Study|Physician Decision|1|||
160956088|NCT04732286|581225850|FG000|Overall Study|Study Terminated by Sponsor|31|||
160956089|NCT04732286|581225850|FG000|Overall Study|Withdrawal by Subject|10|||
160956090|NCT04732286|581225850|FG000|Overall Study|Non-compliance With Study Drug|1|||
160956091|NCT04732286|581225850|FG000|Overall Study|Lost to Follow-up|4|||
160956092|NCT04732286|581225850|FG000|Overall Study|Death|51|||
160956093|NCT02372396|581225856|FG000|Overall Study|Lost to Follow-up|7|||
160956094|NCT02372396|581225857|FG001|Overall Study|Lost to Follow-up|9|||
160956095|NCT02081846|581225860|FG000|Overall Study|Withdrawal by Subject|1|||
160956096|NCT02081846|581225861|FG001|Overall Study|Withdrawal by Subject|0|||
160956097|NCT02081846|581225860|FG000|Overall Study|invalid consent|1|||
160956098|NCT02081846|581225861|FG001|Overall Study|invalid consent|0|||
160956099|NCT03265600|581225862|FG000|Overall Study|Lost to Follow-up|17|||
160956100|NCT03265600|581225863|FG001|Overall Study|Lost to Follow-up|5|||
160656639|NCT00453362|580124370|FG000|Overall Study|Withdrawal by Subject|3|||
160656640|NCT00453362|580124370|FG000|Overall Study|Progression of disease|56|||
160656641|NCT00453362|580124370|FG000|Overall Study|Screening Failure|14|||
160956101|NCT03265600|581225862|FG000|Overall Study|Withdrawal by Subject|4|||
160956102|NCT03265600|581225863|FG001|Overall Study|Withdrawal by Subject|2|||
160956103|NCT03265600|581225862|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
160656642|NCT02127281|580124371|FG000|Overall Study|Lost to Follow-up|1|||
160656643|NCT02127281|580124372|FG001|Overall Study|Lost to Follow-up|0|||
160956104|NCT03265600|581225863|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
160956105|NCT00535730|581225864|FG000|Overall Study|Adverse Event|1|||
160956106|NCT00535730|581225865|FG001|Overall Study|Adverse Event|1|||
160956107|NCT00535730|581225864|FG000|Overall Study|Lost to Follow-up|0|||
160956108|NCT00535730|581225865|FG001|Overall Study|Lost to Follow-up|1|||
160956109|NCT00535730|581225864|FG000|Overall Study|Physician Decision|0|||
161001226|NCT04001829|581390511|FG001|Overall Study|Reason missing due to delinquent data|0|||
161001227|NCT04496960|581390512|FG000|Overall Study|Physician Decision|0|||
161001228|NCT04496960|581390513|FG001|Overall Study|Physician Decision|1|||
161001229|NCT03175172|581390514|FG000|Overall Study|Death|3|||
161001230|NCT03175172|581390514|FG000|Overall Study|Withdrawal by Subject|3|||
161001231|NCT03175172|581390514|FG000|Overall Study|Lost to Follow-up|1|||
160956110|NCT00535730|581225865|FG001|Overall Study|Physician Decision|1|||
160956111|NCT00535730|581225864|FG000|Overall Study|Protocol Violation|1|||
160956112|NCT00535730|581225865|FG001|Overall Study|Protocol Violation|0|||
160956113|NCT00535730|581225864|FG000|Overall Study|Withdrawal by Subject|0|||
160956114|NCT00535730|581225865|FG001|Overall Study|Withdrawal by Subject|4|||
160956115|NCT00936858|581225866|FG000|Overall Study|Death|3|||
160956116|NCT00936858|581225866|FG000|Overall Study|Progression|29|||
160956117|NCT00936858|581225866|FG000|Overall Study|Withdrawal by Subject|5|||
160956118|NCT00936858|581225866|FG000|Overall Study|Adverse Event|1|||
160956119|NCT00936858|581225866|FG000|Overall Study|Physician Decision|7|||
160956120|NCT00936858|581225866|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
160956121|NCT00936858|581225866|FG000|Overall Study|Lost to Follow-up|1|||
160956122|NCT00584727|581225872|FG000|First Intervention|Discontinuation|0|||
160956123|NCT00584727|581225873|FG001|First Intervention|Discontinuation|0|||
160956124|NCT00584727|581225874|FG002|First Intervention|Discontinuation|1|||
160956125|NCT00584727|581225875|FG003|First Intervention|Discontinuation|0|||
160956126|NCT00584727|581225876|FG004|First Intervention|Discontinuation|0|||
160956127|NCT00584727|581225877|FG005|First Intervention|Discontinuation|0|||
160956128|NCT00584727|581225872|FG000|Third Intervention|Protocol Violation|0|||
160956129|NCT00584727|581225873|FG001|Third Intervention|Protocol Violation|0|||
161001232|NCT03175172|581390514|FG000|Overall Study|Study Terminated by Sponsor|3|||
161001233|NCT05011396|581390517|FG000|Overall Study|Lost to Follow-up|3|||
161001234|NCT05011396|581390518|FG001|Overall Study|Lost to Follow-up|1|||
161001235|NCT05011396|581390517|FG000|Overall Study|Withdrawal by Subject|0|||
161001236|NCT05011396|581390518|FG001|Overall Study|Withdrawal by Subject|1|||
161001237|NCT05011396|581390517|FG000|Overall Study|Positive Drug Screen|0|||
161001238|NCT05011396|581390518|FG001|Overall Study|Positive Drug Screen|1|||
161001239|NCT05855655|581390527|FG000|Overall Study|Withdrawal by Subject|0|||
161001240|NCT05855655|581390528|FG001|Overall Study|Withdrawal by Subject|1|||
161001241|NCT05855655|581390527|FG000|Overall Study|Lost to Follow-up|4|||
161001242|NCT05855655|581390528|FG001|Overall Study|Lost to Follow-up|0|||
161001243|NCT01426269|581390529|FG000|Period 1: 12 Weeks|Adverse Event|5|||
161001244|NCT01426269|581390530|FG001|Period 1: 12 Weeks|Adverse Event|0|||
161001245|NCT01426269|581390531|FG002|Period 1: 12 Weeks|Adverse Event|0|||
161001246|NCT01426269|581390529|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
161001247|NCT01426269|581390530|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
161001248|NCT01426269|581390531|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
161001249|NCT01426269|581390529|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
161001250|NCT01426269|581390530|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
161001251|NCT01426269|581390531|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
161001252|NCT01426269|581390529|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
161001253|NCT01426269|581390530|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
161001254|NCT01426269|581390531|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
161001255|NCT01426269|581390529|FG000|Period 1: 12 Weeks|Pregnancy|1|||
161001256|NCT01426269|581390530|FG001|Period 1: 12 Weeks|Pregnancy|0|||
161001257|NCT01426269|581390531|FG002|Period 1: 12 Weeks|Pregnancy|0|||
161001258|NCT01426269|581390529|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
161001259|NCT01426269|581390530|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
161001260|NCT01426269|581390531|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
161001261|NCT01426269|581390529|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
161001262|NCT01426269|581390530|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
161001263|NCT01426269|581390531|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
161001264|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Adverse Event|0|||
161001265|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Adverse Event|1|||
161001266|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Adverse Event|2|||
161001267|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
161001268|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
161001269|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
160582816|NCT00069095|579853716|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
160956130|NCT00584727|581225874|FG002|Third Intervention|Protocol Violation|1|||
161001270|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
161001271|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
161001272|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
161001273|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
161001274|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
161001275|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
160956131|NCT00584727|581225875|FG003|Third Intervention|Protocol Violation|0|||
160956132|NCT00584727|581225876|FG004|Third Intervention|Protocol Violation|4|||
160956133|NCT00584727|581225877|FG005|Third Intervention|Protocol Violation|2|||
160956134|NCT00989287|581225880|FG000|Overall Study|Adverse Event|1|||
160956135|NCT00989287|581225881|FG001|Overall Study|Adverse Event|0|||
160956136|NCT00989287|581225880|FG000|Overall Study|Lost to Follow-up|0|||
160956137|NCT00989287|581225881|FG001|Overall Study|Lost to Follow-up|1|||
160956138|NCT00695669|581225882|FG000|Overall Study|Adverse Event|0|||
160956139|NCT00695669|581225883|FG001|Overall Study|Adverse Event|0|||
160956140|NCT00695669|581225884|FG002|Overall Study|Adverse Event|2|||
160956141|NCT00695669|581225885|FG003|Overall Study|Adverse Event|0|||
160956142|NCT00695669|581225882|FG000|Overall Study|Lost to Follow-up|4|||
160956143|NCT00695669|581225883|FG001|Overall Study|Lost to Follow-up|4|||
160956144|NCT00695669|581225884|FG002|Overall Study|Lost to Follow-up|1|||
160956145|NCT00695669|581225885|FG003|Overall Study|Lost to Follow-up|4|||
160956146|NCT00092131|581225886|FG000|Treatment Period I|Adverse Event|1|||
160956147|NCT00092131|581225887|FG001|Treatment Period I|Adverse Event|0|||
160956148|NCT00092131|581225886|FG000|Treatment Period II|Adverse Event|0|||
160956149|NCT00092131|581225887|FG001|Treatment Period II|Adverse Event|1|||
160956150|NCT02341417|581225888|FG000|Overall Study|Withdrawal by Subject|0|||
160956151|NCT02341417|581225889|FG001|Overall Study|Withdrawal by Subject|2|||
160956152|NCT02341417|581225890|FG002|Overall Study|Withdrawal by Subject|0|||
160956153|NCT02341417|581225888|FG000|Overall Study|Decision by sponsor|2|||
160956154|NCT02341417|581225889|FG001|Overall Study|Decision by sponsor|0|||
160956155|NCT02341417|581225890|FG002|Overall Study|Decision by sponsor|0|||
161001276|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Site closed|0|||
160457670|NCT05513937|579406482|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
160457671|NCT05513937|579406483|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
160457672|NCT05513937|579406484|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
160457673|NCT05513937|579406481|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
160457674|NCT05513937|579406482|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
160457675|NCT05513937|579406483|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
160457676|NCT05513937|579406484|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
160457677|NCT05513937|579406481|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
160457678|NCT05513937|579406482|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
160457679|NCT05513937|579406483|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
160457680|NCT05513937|579406484|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
160457681|NCT05513937|579406481|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
160457682|NCT05513937|579406482|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
160457683|NCT05513937|579406483|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
160457684|NCT05513937|579406484|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
161001277|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Site closed|6|||
160457685|NCT05513937|579406481|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
160457686|NCT05513937|579406482|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
160582817|NCT00069095|579853717|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
160582818|NCT00069095|579853718|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
160582819|NCT00069095|579853713|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
160582820|NCT00069095|579853714|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
160582821|NCT00069095|579853715|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
160582822|NCT00069095|579853716|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
160582823|NCT00069095|579853717|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
160582824|NCT00069095|579853718|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
160582825|NCT00069095|579853713|FG000|Post-study Treatment Phase|Participant had complete response|1|||
160582826|NCT00069095|579853714|FG001|Post-study Treatment Phase|Participant had complete response|1|||
160582827|NCT00069095|579853715|FG002|Post-study Treatment Phase|Participant had complete response|0|||
160582828|NCT00069095|579853716|FG003|Post-study Treatment Phase|Participant had complete response|0|||
160582829|NCT00069095|579853717|FG004|Post-study Treatment Phase|Participant had complete response|0|||
160582830|NCT00069095|579853718|FG005|Post-study Treatment Phase|Participant had complete response|0|||
160582831|NCT00069095|579853713|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
160582832|NCT00069095|579853714|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
160582833|NCT00069095|579853715|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
160582834|NCT00069095|579853716|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
160582835|NCT00069095|579853717|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
160582836|NCT00069095|579853718|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
160956156|NCT02341417|581225888|FG000|Overall Study|Death|0|||
160956157|NCT02341417|581225889|FG001|Overall Study|Death|0|||
160956158|NCT02341417|581225890|FG002|Overall Study|Death|1|||
160956159|NCT03570619|581225901|FG000|Overall Study|Adverse Event|2|||
160956160|NCT03570619|581225902|FG001|Overall Study|Adverse Event|0|||
161001278|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Site closed|5|||
160656644|NCT04885296|580124373|FG000|Period 1|Covid-19 Related|1|||
160656645|NCT04885296|580124374|FG001|Period 1|Covid-19 Related|0|||
160656646|NCT04885296|580124373|FG000|Period 1|Adverse Event|0|||
160656647|NCT04885296|580124374|FG001|Period 1|Adverse Event|1|||
160656648|NCT04885296|580124373|FG000|Period 1|Withdrawal by Subject|1|||
160656649|NCT04885296|580124374|FG001|Period 1|Withdrawal by Subject|1|||
160656650|NCT04885296|580124373|FG000|Period 1|Test Article No Longer Available|1|||
160656651|NCT04885296|580124374|FG001|Period 1|Test Article No Longer Available|0|||
160656652|NCT04885296|580124373|FG000|Period 1|Dispensed Study lens in Error|1|||
160656653|NCT04885296|580124374|FG001|Period 1|Dispensed Study lens in Error|0|||
160656654|NCT04885296|580124373|FG000|Period 1|Lost to Follow-up|1|||
160656655|NCT04885296|580124374|FG001|Period 1|Lost to Follow-up|0|||
160656656|NCT04885296|580124373|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
160656657|NCT04885296|580124374|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
160656658|NCT00433147|580124376|FG000|Overall Study|Adverse Event|0|||
160656659|NCT00433147|580124377|FG001|Overall Study|Adverse Event|1|||
160656660|NCT00433147|580124378|FG002|Overall Study|Adverse Event|0|||
160656661|NCT00433147|580124379|FG003|Overall Study|Adverse Event|0|||
160656662|NCT01882647|580124380|FG000|Overall Study|Lost to Follow-up|2|||
160656663|NCT01882647|580124381|FG001|Overall Study|Lost to Follow-up|2|||
160656664|NCT01882647|580124380|FG000|Overall Study|Withdrawal by Subject|0|||
160656665|NCT01882647|580124381|FG001|Overall Study|Withdrawal by Subject|4|||
160656666|NCT03601637|580124384|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
160656667|NCT03601637|580124385|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
160656668|NCT03601637|580124384|FG000|Overall Study|Adverse Event|1|||
160656669|NCT03601637|580124385|FG001|Overall Study|Adverse Event|1|||
160656670|NCT03601637|580124384|FG000|Overall Study|Other|0|||
160656671|NCT03601637|580124385|FG001|Overall Study|Other|1|||
160656672|NCT05037097|580124387|FG000|Overall Study|Withdrawal by Subject|0|||
160656673|NCT05037097|580124388|FG001|Overall Study|Withdrawal by Subject|1|||
160656674|NCT05037097|580124389|FG002|Overall Study|Withdrawal by Subject|0|||
160656675|NCT05037097|580124390|FG003|Overall Study|Withdrawal by Subject|1|||
160656676|NCT05037097|580124391|FG004|Overall Study|Withdrawal by Subject|0|||
160656677|NCT05037097|580124392|FG005|Overall Study|Withdrawal by Subject|2|||
160656678|NCT05037097|580124393|FG006|Overall Study|Withdrawal by Subject|0|||
160656679|NCT05037097|580124394|FG007|Overall Study|Withdrawal by Subject|0|||
160656680|NCT05037097|580124387|FG000|Overall Study|Lost to Follow-up|0|||
160656681|NCT05037097|580124388|FG001|Overall Study|Lost to Follow-up|1|||
160656682|NCT05037097|580124389|FG002|Overall Study|Lost to Follow-up|0|||
160656683|NCT05037097|580124390|FG003|Overall Study|Lost to Follow-up|0|||
160656684|NCT05037097|580124391|FG004|Overall Study|Lost to Follow-up|1|||
160656685|NCT05037097|580124392|FG005|Overall Study|Lost to Follow-up|1|||
160656686|NCT05037097|580124393|FG006|Overall Study|Lost to Follow-up|0|||
160656687|NCT05037097|580124394|FG007|Overall Study|Lost to Follow-up|0|||
160656688|NCT02322047|580124395|FG000|Overall Study|Physician Decision|1|||
160656689|NCT02322047|580124396|FG001|Overall Study|Physician Decision|0|||
160656690|NCT02322047|580124397|FG002|Overall Study|Physician Decision|0|||
160656691|NCT02322047|580124398|FG003|Overall Study|Physician Decision|0|||
160656692|NCT02322047|580124395|FG000|Overall Study|Withdrawal by Subject|1|||
160656693|NCT02322047|580124396|FG001|Overall Study|Withdrawal by Subject|0|||
160656694|NCT02322047|580124397|FG002|Overall Study|Withdrawal by Subject|0|||
160656695|NCT02322047|580124398|FG003|Overall Study|Withdrawal by Subject|1|||
160656696|NCT02322047|580124395|FG000|Overall Study|Adverse Event|0|||
160656697|NCT02322047|580124396|FG001|Overall Study|Adverse Event|1|||
160656698|NCT02322047|580124397|FG002|Overall Study|Adverse Event|0|||
160656699|NCT02322047|580124398|FG003|Overall Study|Adverse Event|0|||
160656700|NCT02322047|580124395|FG000|Overall Study|Lost to Follow-up|0|||
160656701|NCT02322047|580124396|FG001|Overall Study|Lost to Follow-up|0|||
160656702|NCT02322047|580124397|FG002|Overall Study|Lost to Follow-up|1|||
160656703|NCT02322047|580124398|FG003|Overall Study|Lost to Follow-up|1|||
160656704|NCT02918877|580124399|FG000|Overall Study|Withdrawal by Subject|2|||
160656705|NCT02918877|580124400|FG001|Overall Study|Withdrawal by Subject|2|||
160656706|NCT02918877|580124399|FG000|Overall Study|Surgery cancelled|1|||
160656707|NCT02918877|580124400|FG001|Overall Study|Surgery cancelled|0|||
160656708|NCT02918877|580124399|FG000|Overall Study|Physician Decision|1|||
160656709|NCT02918877|580124400|FG001|Overall Study|Physician Decision|0|||
160656710|NCT02918877|580124399|FG000|Overall Study|Received intraoperative steroids|1|||
160656711|NCT02918877|580124400|FG001|Overall Study|Received intraoperative steroids|0|||
160656712|NCT02918877|580124399|FG000|Overall Study|Unable to obtain lab samples|1|||
160656713|NCT02918877|580124400|FG001|Overall Study|Unable to obtain lab samples|0|||
160656714|NCT02918877|580124399|FG000|Overall Study|Unsafe to perform BAL|0|||
160656715|NCT02918877|580124400|FG001|Overall Study|Unsafe to perform BAL|1|||
160656716|NCT05346055|580124403|FG000|Overall Study|Withdrawal by Subject|1|||
160656717|NCT05346055|580124403|FG000|Overall Study|Protocol Violation|1|||
160656718|NCT05346055|580124403|FG000|Overall Study|Therapist decision|1|||
160656719|NCT00376220|580124406|FG000|Overall Study|Lost to Follow-up|7|||
160656720|NCT00376220|580124407|FG001|Overall Study|Lost to Follow-up|10|||
160656721|NCT00376220|580124406|FG000|Overall Study|Withdrawal by Subject|3|||
160956161|NCT03570619|581225903|FG002|Overall Study|Adverse Event|1|||
160956162|NCT03570619|581225901|FG000|Overall Study|new diagnosis of new malignancy|1|||
160956163|NCT03570619|581225902|FG001|Overall Study|new diagnosis of new malignancy|0|||
160956164|NCT03570619|581225903|FG002|Overall Study|new diagnosis of new malignancy|0|||
160956165|NCT03570619|581225901|FG000|Overall Study|Physician Decision|1|||
160956166|NCT03570619|581225902|FG001|Overall Study|Physician Decision|1|||
160956167|NCT03570619|581225903|FG002|Overall Study|Physician Decision|0|||
160956168|NCT03570619|581225901|FG000|Overall Study|Withdrawal by Subject|0|||
160956169|NCT03570619|581225902|FG001|Overall Study|Withdrawal by Subject|2|||
160956170|NCT03570619|581225903|FG002|Overall Study|Withdrawal by Subject|0|||
160582837|NCT00069095|579853713|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
160582838|NCT00069095|579853714|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
160656722|NCT00376220|580124407|FG001|Overall Study|Withdrawal by Subject|2|||
160656723|NCT02564263|580124408|FG000|Overall Study|Adverse Event|31|||
160656724|NCT02564263|580124409|FG001|Overall Study|Adverse Event|29|||
160656725|NCT02564263|580124408|FG000|Overall Study|Death|270|||
160656726|NCT02564263|580124409|FG001|Overall Study|Death|262|||
160656727|NCT02564263|580124408|FG000|Overall Study|Withdrawal by Subject|4|||
160656728|NCT02564263|580124409|FG001|Overall Study|Withdrawal by Subject|19|||
160656729|NCT02564263|580124408|FG000|Overall Study|Sponsor's decision|9|||
160656730|NCT02564263|580124409|FG001|Overall Study|Sponsor's decision|4|||
160656731|NCT02906709|580124410|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
160656732|NCT02906709|580124411|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
160656733|NCT02906709|580124410|FG000|Phase A (Week 0 to Week 16)|Death|0|||
160656734|NCT02906709|580124411|FG001|Phase A (Week 0 to Week 16)|Death|1|||
160656735|NCT02906709|580124410|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
160656736|NCT02906709|580124411|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
160656737|NCT02906709|580124410|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
160656738|NCT02906709|580124411|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
160656739|NCT00977106|580124412|FG000|Overall Study|Adverse Event|5|||
160656740|NCT00977106|580124413|FG001|Overall Study|Adverse Event|6|||
160656741|NCT00977106|580124412|FG000|Overall Study|Withdrawal by Subject|2|||
160656742|NCT00977106|580124413|FG001|Overall Study|Withdrawal by Subject|2|||
160656743|NCT00977106|580124412|FG000|Overall Study|Lack of Efficacy|2|||
160656744|NCT00977106|580124413|FG001|Overall Study|Lack of Efficacy|2|||
160656745|NCT00977106|580124412|FG000|Overall Study|Protocol Violation|0|||
160656746|NCT00977106|580124413|FG001|Overall Study|Protocol Violation|1|||
160656747|NCT00977106|580124412|FG000|Overall Study|Other|1|||
160656748|NCT00977106|580124413|FG001|Overall Study|Other|0|||
160656749|NCT01124149|580124414|FG000|Acute Phase|Withdrawal by Subject|22|||
160656750|NCT01124149|580124414|FG000|Acute Phase|Adverse Event|21|||
160656751|NCT01124149|580124414|FG000|Acute Phase|Lack of Efficacy|17|||
160656752|NCT01124149|580124414|FG000|Acute Phase|Protocol Violation|14|||
160656753|NCT01124149|580124414|FG000|Acute Phase|Lost to Follow-up|2|||
160656754|NCT01124149|580124414|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
160656755|NCT01124149|580124414|FG000|Acute Phase|Sponsor request|1|||
160656756|NCT01124149|580124414|FG000|Acute Phase|UC symptoms not ameliorated|1|||
160582839|NCT00069095|579853715|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
160582840|NCT00069095|579853716|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
160582841|NCT00069095|579853717|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
160582842|NCT00069095|579853718|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
160582843|NCT00069095|579853713|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
160582844|NCT00069095|579853714|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
160582845|NCT00069095|579853715|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
160582846|NCT00069095|579853716|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
160582847|NCT00069095|579853717|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
160582848|NCT00069095|579853718|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
160582849|NCT00069095|579853713|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
160656757|NCT01124149|580124414|FG000|Acute Phase|Non-compliance|1|||
160656758|NCT01124149|580124414|FG000|Acute Phase|Low hemoglobin|1|||
160656759|NCT01124149|580124414|FG000|Acute Phase|Travelling to another country|1|||
160956171|NCT04773587|581225904|FG000|Overall Study|Lost to Follow-up|11|||
160956172|NCT04773587|581225905|FG001|Overall Study|Lost to Follow-up|3|||
160956173|NCT04773587|581225904|FG000|Overall Study|Adverse Event|6|||
160956174|NCT04773587|581225905|FG001|Overall Study|Adverse Event|3|||
160956175|NCT04773587|581225904|FG000|Overall Study|Lack of Efficacy|5|||
160956176|NCT04773587|581225905|FG001|Overall Study|Lack of Efficacy|2|||
160956177|NCT04773587|581225904|FG000|Overall Study|Withdrawal by Subject|4|||
160956178|NCT04773587|581225905|FG001|Overall Study|Withdrawal by Subject|5|||
160656760|NCT01124149|580124414|FG000|Acute Phase|Sponsor decision|1|||
160656761|NCT01124149|580124414|FG000|Maintenance Phase|Lack of Efficacy|40|||
160656762|NCT01124149|580124414|FG000|Maintenance Phase|Adverse Event|24|||
160656763|NCT01124149|580124414|FG000|Maintenance Phase|Lost to Follow-up|15|||
160656764|NCT01124149|580124414|FG000|Maintenance Phase|Withdrawal by Subject|10|||
160457687|NCT05513937|579406483|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
160457688|NCT05513937|579406484|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
160457689|NCT05513937|579406481|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
160457690|NCT05513937|579406482|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
160457691|NCT05513937|579406483|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
160457692|NCT05513937|579406484|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
160457693|NCT02846545|579406485|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
160457694|NCT02846545|579406486|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
160457695|NCT02846545|579406485|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
160956179|NCT04773587|581225904|FG000|Overall Study|Noncompliance|1|||
160956180|NCT04773587|581225905|FG001|Overall Study|Noncompliance|0|||
160956181|NCT04773587|581225904|FG000|Overall Study|Protocol Violation|1|||
160956182|NCT04773587|581225905|FG001|Overall Study|Protocol Violation|0|||
160956183|NCT04773587|581225904|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
160956184|NCT04773587|581225905|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
160956185|NCT02372409|581225906|FG000|Overall Study|Lost to Follow-up|1|||
160956186|NCT02372409|581225907|FG001|Overall Study|Lost to Follow-up|0|||
160956187|NCT02372409|581225906|FG000|Overall Study|Disease progression|1|||
160956188|NCT02372409|581225907|FG001|Overall Study|Disease progression|1|||
160956189|NCT01808313|581225910|FG000|Overall Study|Adverse Event|5|||
160457696|NCT02846545|579406486|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
160457697|NCT02846545|579406485|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
160956190|NCT01808313|581225910|FG000|Overall Study|Protocol Violation|2|||
160956191|NCT01808313|581225910|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
160956192|NCT01808313|581225910|FG000|Overall Study|Lost to Follow-up|1|||
160956193|NCT01808313|581225910|FG000|Overall Study|Physician Decision|1|||
160956194|NCT03086447|581225916|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160956195|NCT03086447|581225917|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
160956196|NCT03086447|581225916|FG000|Overall Study|Lost Lens|2|||
160956197|NCT03086447|581225917|FG001|Overall Study|Lost Lens|5|||
160956198|NCT03086447|581225916|FG000|Overall Study|Product quality complaint|0|||
160956199|NCT03086447|581225917|FG001|Overall Study|Product quality complaint|1|||
160956200|NCT03086447|581225916|FG000|Overall Study|Lens Damage|1|||
160956201|NCT03086447|581225917|FG001|Overall Study|Lens Damage|6|||
160956202|NCT03086447|581225916|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
160956203|NCT03086447|581225917|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
160956204|NCT03086447|581225916|FG000|Overall Study|Test Article No Longer Available|1|||
160956205|NCT03086447|581225917|FG001|Overall Study|Test Article No Longer Available|0|||
160956206|NCT03086447|581225916|FG000|Overall Study|Protocol Violation|2|||
160457698|NCT02846545|579406486|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
160457699|NCT02846545|579406485|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
160457700|NCT02846545|579406486|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
160457701|NCT02846545|579406485|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
160457702|NCT02846545|579406486|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
160457703|NCT03663205|579406489|FG000|Overall Study|Death|144|||
160457704|NCT03663205|579406490|FG001|Overall Study|Death|69|||
160457705|NCT03663205|579406489|FG000|Overall Study|Sponsor decision|53|||
160457706|NCT03663205|579406490|FG001|Overall Study|Sponsor decision|19|||
160457707|NCT03663205|579406489|FG000|Overall Study|Withdrawal by Subject|8|||
160457708|NCT03663205|579406490|FG001|Overall Study|Withdrawal by Subject|11|||
160457709|NCT03663205|579406489|FG000|Overall Study|Lost to Follow-up|7|||
160457710|NCT03663205|579406490|FG001|Overall Study|Lost to Follow-up|9|||
160457711|NCT03663205|579406489|FG000|Overall Study|Transferred to long term extension study|11|||
160457712|NCT03663205|579406490|FG001|Overall Study|Transferred to long term extension study|3|||
160457713|NCT04505410|579406491|FG000|Overall Study|Adverse Event|2|||
160457714|NCT04505410|579406492|FG001|Overall Study|Adverse Event|0|||
160457715|NCT04505410|579406491|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
160457716|NCT04505410|579406492|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
160457717|NCT04505410|579406491|FG000|Overall Study|did not want to follow diet|1|||
160457718|NCT04505410|579406492|FG001|Overall Study|did not want to follow diet|0|||
160457719|NCT04505410|579406491|FG000|Overall Study|flare up of ulcerative colitis|0|||
160457720|NCT04505410|579406492|FG001|Overall Study|flare up of ulcerative colitis|1|||
160457721|NCT04505410|579406491|FG000|Overall Study|Lost to Follow-up|0|||
160457722|NCT04505410|579406492|FG001|Overall Study|Lost to Follow-up|2|||
160457723|NCT04505410|579406491|FG000|Overall Study|Lost to Follow-up|1|||
160457724|NCT04505410|579406492|FG001|Overall Study|Lost to Follow-up|0|||
160457725|NCT04505410|579406491|FG000|Overall Study|initiated another diet on their own|0|||
160457726|NCT04505410|579406492|FG001|Overall Study|initiated another diet on their own|2|||
160457727|NCT05962814|579406493|FG000|Overall Study|failed eligibility|1|||
160457728|NCT03057054|579406494|FG000|Overall Study|Death|4|||
160457729|NCT03057054|579406495|FG001|Overall Study|Death|4|||
160457730|NCT03057054|579406494|FG000|Overall Study|Withdrawal by Subject|6|||
160457731|NCT03057054|579406495|FG001|Overall Study|Withdrawal by Subject|3|||
160956207|NCT03086447|581225917|FG001|Overall Study|Protocol Violation|4|||
160956208|NCT03086447|581225916|FG000|Overall Study|Lost to Follow-up|0|||
160956209|NCT03086447|581225917|FG001|Overall Study|Lost to Follow-up|1|||
160956210|NCT03086447|581225916|FG000|Overall Study|Adverse Event|3|||
160956211|NCT03086447|581225917|FG001|Overall Study|Adverse Event|0|||
160956212|NCT03086447|581225916|FG000|Overall Study|Lens Discomfort|2|||
160956213|NCT03086447|581225917|FG001|Overall Study|Lens Discomfort|1|||
160956214|NCT00435370|581225919|FG000|Overall Study|Adverse Event|8|||
160956215|NCT00435370|581225920|FG001|Overall Study|Adverse Event|8|||
160956216|NCT00435370|581225919|FG000|Overall Study|Withdrawal by Subject|10|||
160956217|NCT00435370|581225920|FG001|Overall Study|Withdrawal by Subject|10|||
160956218|NCT00435370|581225919|FG000|Overall Study|Antipsychotic medication changed|4|||
160956219|NCT00435370|581225920|FG001|Overall Study|Antipsychotic medication changed|2|||
160956220|NCT02132611|581225921|FG000|Overall Study|Death|2|||
160956221|NCT01965834|581225923|FG000|Overall Study|Lack of Efficacy|4|||
160956222|NCT03674177|581225926|FG000|Overall Study|Lost to Follow-up|2|||
160956223|NCT03674177|581225927|FG001|Overall Study|Lost to Follow-up|1|||
160956224|NCT03674177|581225928|FG002|Overall Study|Lost to Follow-up|0|||
160956225|NCT03674177|581225929|FG003|Overall Study|Lost to Follow-up|2|||
160956226|NCT03387852|581225930|FG000|Overall Study|Adverse event (AE)|3|||
160956227|NCT03387852|581225931|FG001|Overall Study|Adverse event (AE)|0|||
160956228|NCT03387852|581225932|FG002|Overall Study|Adverse event (AE)|2|||
160956229|NCT03387852|581225933|FG003|Overall Study|Adverse event (AE)|0|||
160956230|NCT03387852|581225930|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
160956231|NCT03387852|581225931|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
160956232|NCT03387852|581225932|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
160956233|NCT03387852|581225933|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
160956234|NCT03387852|581225930|FG000|Overall Study|Withdrawal by participant|1|||
160956235|NCT03387852|581225931|FG001|Overall Study|Withdrawal by participant|1|||
160956236|NCT03387852|581225932|FG002|Overall Study|Withdrawal by participant|3|||
160956237|NCT03387852|581225933|FG003|Overall Study|Withdrawal by participant|2|||
160956238|NCT03387852|581225930|FG000|Overall Study|Other- Unspecified|1|||
160956239|NCT03387852|581225931|FG001|Overall Study|Other- Unspecified|1|||
160956240|NCT03387852|581225932|FG002|Overall Study|Other- Unspecified|2|||
160956241|NCT03387852|581225933|FG003|Overall Study|Other- Unspecified|1|||
160956242|NCT03387852|581225930|FG000|Overall Study|Poor compliance to protocol|0|||
160956243|NCT03387852|581225931|FG001|Overall Study|Poor compliance to protocol|0|||
160956244|NCT03387852|581225932|FG002|Overall Study|Poor compliance to protocol|0|||
160956245|NCT03387852|581225933|FG003|Overall Study|Poor compliance to protocol|1|||
160956246|NCT03387852|581225930|FG000|Overall Study|Randomized and not treated|0|||
160956247|NCT03387852|581225931|FG001|Overall Study|Randomized and not treated|0|||
160956248|NCT03387852|581225932|FG002|Overall Study|Randomized and not treated|0|||
160956249|NCT03387852|581225933|FG003|Overall Study|Randomized and not treated|1|||
160457732|NCT03057054|579406494|FG000|Overall Study|Ineligible|1|||
160956250|NCT02194621|581225934|FG000|Overall Study|6 withdrew prior to randomization|2|||
160956251|NCT02194621|581225935|FG001|Overall Study|6 withdrew prior to randomization|2|||
160956252|NCT02194621|581225936|FG002|Overall Study|6 withdrew prior to randomization|2|||
160956253|NCT02194621|581225934|FG000|Overall Study|Withdrawal by Subject|4|||
160956254|NCT02194621|581225935|FG001|Overall Study|Withdrawal by Subject|4|||
160956255|NCT02194621|581225936|FG002|Overall Study|Withdrawal by Subject|7|||
160956256|NCT02493127|581225944|FG000|Overall Study|Lost to Follow-up|1|||
160956257|NCT02493127|581225945|FG001|Overall Study|Lost to Follow-up|1|||
160956258|NCT00714168|581225946|FG000|Overall Study|Pregnancy|5|||
160956259|NCT00714168|581225947|FG001|Overall Study|Pregnancy|4|||
160956260|NCT00714168|581225946|FG000|Overall Study|Lost to Follow-up|32|||
160956261|NCT00714168|581225947|FG001|Overall Study|Lost to Follow-up|50|||
160956262|NCT00714168|581225946|FG000|Overall Study|Relocation|4|||
160956263|NCT00714168|581225947|FG001|Overall Study|Relocation|3|||
160956264|NCT00714168|581225946|FG000|Overall Study|Non-study medical condition|3|||
160956265|NCT00714168|581225947|FG001|Overall Study|Non-study medical condition|2|||
160956266|NCT00809757|581225952|FG000|Overall Study|Adverse Event|2|||
160956267|NCT00809757|581225953|FG001|Overall Study|Adverse Event|3|||
160956268|NCT00809757|581225954|FG002|Overall Study|Adverse Event|3|||
160956269|NCT00809757|581225952|FG000|Overall Study|Lost to Follow-up|0|||
160956270|NCT00809757|581225953|FG001|Overall Study|Lost to Follow-up|0|||
160956271|NCT00809757|581225954|FG002|Overall Study|Lost to Follow-up|1|||
160956272|NCT00809757|581225952|FG000|Overall Study|Protocol Violation|1|||
160956273|NCT00809757|581225953|FG001|Overall Study|Protocol Violation|1|||
160956274|NCT00809757|581225954|FG002|Overall Study|Protocol Violation|1|||
160956275|NCT00809757|581225952|FG000|Overall Study|Withdrawal by Subject|2|||
160956276|NCT00809757|581225953|FG001|Overall Study|Withdrawal by Subject|1|||
160956277|NCT00809757|581225954|FG002|Overall Study|Withdrawal by Subject|3|||
160956278|NCT00809757|581225952|FG000|Overall Study|Subject Uncooperative|1|||
160956279|NCT00809757|581225953|FG001|Overall Study|Subject Uncooperative|0|||
160956280|NCT00809757|581225954|FG002|Overall Study|Subject Uncooperative|2|||
160956281|NCT00809757|581225952|FG000|Overall Study|Noncompliance with Medication|0|||
160956282|NCT00809757|581225953|FG001|Overall Study|Noncompliance with Medication|0|||
160956283|NCT00809757|581225954|FG002|Overall Study|Noncompliance with Medication|1|||
160956284|NCT00253864|581225955|FG000|Overall Study|Lost to Follow-up|5|||
160956285|NCT00253864|581225956|FG001|Overall Study|Lost to Follow-up|8|||
160956286|NCT00744653|581225957|FG000|Overall Study|antineoplastic treatment|11|||
160956287|NCT00744653|581225957|FG000|Overall Study|Death|1|||
160956288|NCT00744653|581225957|FG000|Overall Study|Lost to Follow-up|1|||
160956289|NCT00744653|581225957|FG000|Overall Study|Physician Decision|3|||
160956290|NCT03826667|581225958|FG000|Overall Study|Protocol deviation|21|||
160956291|NCT00808808|581225959|FG000|Overall Study|Vaccinated; survey not completed|131|||
160956292|NCT00808808|581225960|FG001|Overall Study|Vaccinated; survey not completed|169|||
160956293|NCT00808808|581225961|FG002|Overall Study|Vaccinated; survey not completed|302|||
160956294|NCT00808808|581225959|FG000|Overall Study|Employee was not vaccinated.|2686|||
160956295|NCT00808808|581225960|FG001|Overall Study|Employee was not vaccinated.|2268|||
160956296|NCT00808808|581225961|FG002|Overall Study|Employee was not vaccinated.|2255|||
160956297|NCT01453595|581225963|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
160582850|NCT00069095|579853714|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
160582851|NCT00069095|579853715|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
160582852|NCT00069095|579853716|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
160956298|NCT01453595|581225964|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160956299|NCT01453595|581225965|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161001279|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Relapsed|0|||
161001280|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Relapsed|9|||
160457733|NCT03057054|579406495|FG001|Overall Study|Ineligible|1|||
160582853|NCT00069095|579853717|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
160582854|NCT00069095|579853718|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
160582855|NCT00069095|579853713|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
160582856|NCT00069095|579853714|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
160582857|NCT00069095|579853715|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
160582858|NCT00069095|579853716|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
160582859|NCT00069095|579853717|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
160582860|NCT00069095|579853718|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
160582861|NCT00069095|579853713|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
160582862|NCT00069095|579853714|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
160582863|NCT00069095|579853715|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
160582864|NCT00069095|579853716|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
160582865|NCT00069095|579853717|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
160582866|NCT00069095|579853718|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
160582867|NCT00069095|579853713|FG000|Post-study Treatment Phase|Surgery|0|||
160582868|NCT00069095|579853714|FG001|Post-study Treatment Phase|Surgery|0|||
160582869|NCT00069095|579853715|FG002|Post-study Treatment Phase|Surgery|0|||
160582870|NCT00069095|579853716|FG003|Post-study Treatment Phase|Surgery|1|||
160582871|NCT00069095|579853717|FG004|Post-study Treatment Phase|Surgery|1|||
160582872|NCT00069095|579853718|FG005|Post-study Treatment Phase|Surgery|0|||
160582873|NCT00069095|579853713|FG000|Post-study Treatment Phase|Death|0|||
160582874|NCT00069095|579853714|FG001|Post-study Treatment Phase|Death|0|||
160582875|NCT00069095|579853715|FG002|Post-study Treatment Phase|Death|0|||
160582876|NCT00069095|579853716|FG003|Post-study Treatment Phase|Death|0|||
160582877|NCT00069095|579853717|FG004|Post-study Treatment Phase|Death|1|||
160582878|NCT00069095|579853718|FG005|Post-study Treatment Phase|Death|0|||
160582879|NCT00069095|579853713|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
160582880|NCT00069095|579853714|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
160582881|NCT00069095|579853715|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
160582882|NCT00069095|579853716|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
160582883|NCT00069095|579853717|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
160582884|NCT00069095|579853718|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
160582885|NCT00069095|579853713|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
160582886|NCT00069095|579853714|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
160582887|NCT00069095|579853715|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
160582888|NCT00069095|579853716|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
160582889|NCT00069095|579853717|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
160582890|NCT00069095|579853718|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
160582891|NCT00069095|579853713|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
160582892|NCT00069095|579853714|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
160582893|NCT00069095|579853715|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
160582894|NCT00069095|579853716|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
160582895|NCT00069095|579853717|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
160956300|NCT01128413|581225970|FG000|Overall Study|Withdrawal by Subject|1|||
160956301|NCT01128413|581225971|FG001|Overall Study|Withdrawal by Subject|0|||
160956302|NCT01128413|581225970|FG000|Overall Study|NICOM Monitor Problems|2|||
160457734|NCT05507333|579407901|FG000|Overall Study|Protocol Violation|1|||
160582896|NCT00069095|579853718|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
160656765|NCT01124149|580124414|FG000|Maintenance Phase|Protocol Violation|5|||
160656766|NCT01124149|580124414|FG000|Maintenance Phase|Coordinator error|1|||
160656767|NCT01124149|580124414|FG000|Maintenance Phase|Non-compliance|1|||
160656768|NCT01644500|580124415|FG000|Overall Study|Adverse Event|6|||
160656769|NCT01644500|580124416|FG001|Overall Study|Adverse Event|1|||
160656770|NCT01644500|580124417|FG002|Overall Study|Adverse Event|2|||
160656771|NCT01644500|580124415|FG000|Overall Study|Death|0|||
160656772|NCT01644500|580124416|FG001|Overall Study|Death|1|||
160656773|NCT01644500|580124417|FG002|Overall Study|Death|0|||
160656774|NCT01644500|580124415|FG000|Overall Study|Lost to Follow-up|3|||
160656775|NCT01644500|580124416|FG001|Overall Study|Lost to Follow-up|8|||
160656776|NCT01644500|580124417|FG002|Overall Study|Lost to Follow-up|0|||
160656777|NCT01644500|580124415|FG000|Overall Study|Protocol Violation|1|||
160656778|NCT01644500|580124416|FG001|Overall Study|Protocol Violation|1|||
160956303|NCT01128413|581225971|FG001|Overall Study|NICOM Monitor Problems|1|||
160956304|NCT01128413|581225970|FG000|Overall Study|Pt made DNR|1|||
160956305|NCT01128413|581225971|FG001|Overall Study|Pt made DNR|0|||
160956306|NCT03762473|581225972|FG000|Overall Study|Death|1|||
160956307|NCT03762473|581225973|FG001|Overall Study|Death|0|||
160956308|NCT01864564|581225974|FG000|Overall Study|Lost to Follow-up|17|||
160956309|NCT01864564|581225975|FG001|Overall Study|Lost to Follow-up|23|||
160582897|NCT00069095|579853713|FG000|Post-study Treatment Phase|Investigator decision|0|||
160582898|NCT00069095|579853714|FG001|Post-study Treatment Phase|Investigator decision|0|||
160582899|NCT00069095|579853715|FG002|Post-study Treatment Phase|Investigator decision|0|||
160582900|NCT00069095|579853716|FG003|Post-study Treatment Phase|Investigator decision|0|||
160582901|NCT00069095|579853717|FG004|Post-study Treatment Phase|Investigator decision|0|||
160582902|NCT00069095|579853718|FG005|Post-study Treatment Phase|Investigator decision|1|||
160582903|NCT00069095|579853713|FG000|Follow-up Phase|Death|174|||
160582904|NCT00069095|579853714|FG001|Follow-up Phase|Death|206|||
160582905|NCT00069095|579853715|FG002|Follow-up Phase|Death|120|||
160582906|NCT00069095|579853716|FG003|Follow-up Phase|Death|112|||
160582907|NCT00069095|579853717|FG004|Follow-up Phase|Death|92|||
160582908|NCT00069095|579853718|FG005|Follow-up Phase|Death|101|||
160582909|NCT05610176|579853719|FG000|Overall Study|Death|6|||
160582910|NCT01052012|579853721|FG000|Overall Study|Not treated|2|||
160582911|NCT01052012|579853722|FG001|Overall Study|Not treated|5|||
160582912|NCT01052012|579853723|FG002|Overall Study|Not treated|0|||
160582913|NCT01052012|579853724|FG003|Overall Study|Not treated|0|||
160582914|NCT01052012|579853725|FG004|Overall Study|Not treated|11|||
160582915|NCT01052012|579853726|FG005|Overall Study|Not treated|8|||
160656779|NCT01644500|580124417|FG002|Overall Study|Protocol Violation|0|||
160956310|NCT01864564|581225974|FG000|Overall Study|Withdrawal by Subject|20|||
160956311|NCT01864564|581225975|FG001|Overall Study|Withdrawal by Subject|11|||
160956312|NCT01864564|581225974|FG000|Overall Study|Protocol Violation|0|||
160956313|NCT01864564|581225975|FG001|Overall Study|Protocol Violation|27|||
160956314|NCT01864564|581225974|FG000|Overall Study|not reported|0|||
160956315|NCT01864564|581225975|FG001|Overall Study|not reported|34|||
160956316|NCT03077724|581225976|FG000|Overall Study|Lost to Follow-up|5|||
160956317|NCT03077724|581225977|FG001|Overall Study|Lost to Follow-up|1|||
160956318|NCT03077724|581225976|FG000|Overall Study|Withdrawal by Subject|3|||
160956319|NCT03077724|581225977|FG001|Overall Study|Withdrawal by Subject|1|||
160956320|NCT02269670|581225978|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
160956321|NCT00234065|581225979|FG000|Overall Study|Adverse Event|268|||
160956322|NCT00234065|581225980|FG001|Overall Study|Adverse Event|166|||
160956323|NCT00234065|581225979|FG000|Overall Study|Withdrawal by Subject|73|||
160956324|NCT00234065|581225980|FG001|Overall Study|Withdrawal by Subject|56|||
160956325|NCT00234065|581225979|FG000|Overall Study|Physician Decision|23|||
160956326|NCT00234065|581225980|FG001|Overall Study|Physician Decision|22|||
160956327|NCT00234065|581225979|FG000|Overall Study|Not Classified|111|||
160956328|NCT00234065|581225980|FG001|Overall Study|Not Classified|112|||
160956329|NCT00126438|581225981|FG000|Overall Study|Withdrawal due to adverse event|1|||
160956330|NCT00126438|581225982|FG001|Overall Study|Withdrawal due to adverse event|0|||
160956331|NCT00126438|581225981|FG000|Overall Study|Lost to Follow-up|22|||
160956332|NCT00126438|581225982|FG001|Overall Study|Lost to Follow-up|0|||
160956333|NCT00126438|581225981|FG000|Overall Study|Protocol Violation|8|||
160956334|NCT00126438|581225982|FG001|Overall Study|Protocol Violation|8|||
160956335|NCT00126438|581225981|FG000|Overall Study|Withdrawal by Subject|3|||
160956336|NCT00126438|581225982|FG001|Overall Study|Withdrawal by Subject|2|||
160956337|NCT02313428|581225983|FG000|Overall Study|Lost to Follow-up|1|||
160656780|NCT01644500|580124415|FG000|Overall Study|Withdrawal by Subject|11|||
160656781|NCT01644500|580124416|FG001|Overall Study|Withdrawal by Subject|12|||
160656782|NCT01644500|580124417|FG002|Overall Study|Withdrawal by Subject|12|||
160956338|NCT02313428|581225984|FG001|Overall Study|Lost to Follow-up|1|||
160956339|NCT05374421|581225985|FG000|Overall Study|Withdrawal by Subject|3|||
160956340|NCT05374421|581225986|FG001|Overall Study|Withdrawal by Subject|4|||
160582916|NCT01052012|579853721|FG000|Overall Study|Adverse Event|1|||
160582917|NCT01052012|579853722|FG001|Overall Study|Adverse Event|0|||
160582918|NCT01052012|579853723|FG002|Overall Study|Adverse Event|0|||
160956341|NCT00003508|581227950|FG000|Overall Study|Not evaluable|5|||
160956342|NCT02160314|581227951|FG000|Overall Study|Adverse Event|0|||
160956343|NCT02160314|581227952|FG001|Overall Study|Adverse Event|6|||
160956344|NCT02160314|581227951|FG000|Overall Study|Protocol Violation|0|||
160956345|NCT02160314|581227952|FG001|Overall Study|Protocol Violation|4|||
160582919|NCT01052012|579853724|FG003|Overall Study|Adverse Event|1|||
160582920|NCT01052012|579853725|FG004|Overall Study|Adverse Event|0|||
160582921|NCT01052012|579853726|FG005|Overall Study|Adverse Event|0|||
160582922|NCT01052012|579853721|FG000|Overall Study|Lost to Follow-up|0|||
160582923|NCT01052012|579853722|FG001|Overall Study|Lost to Follow-up|0|||
160582924|NCT01052012|579853723|FG002|Overall Study|Lost to Follow-up|0|||
160582925|NCT01052012|579853724|FG003|Overall Study|Lost to Follow-up|0|||
160582926|NCT01052012|579853725|FG004|Overall Study|Lost to Follow-up|1|||
160582927|NCT01052012|579853726|FG005|Overall Study|Lost to Follow-up|0|||
160582928|NCT01052012|579853721|FG000|Overall Study|Withdrawal by Subject|1|||
160582929|NCT01052012|579853722|FG001|Overall Study|Withdrawal by Subject|1|||
160582930|NCT01052012|579853723|FG002|Overall Study|Withdrawal by Subject|0|||
160582931|NCT01052012|579853724|FG003|Overall Study|Withdrawal by Subject|0|||
160582932|NCT01052012|579853725|FG004|Overall Study|Withdrawal by Subject|3|||
160582933|NCT01052012|579853726|FG005|Overall Study|Withdrawal by Subject|1|||
160582934|NCT01052012|579853721|FG000|Overall Study|Physician Decision|0|||
160582935|NCT01052012|579853722|FG001|Overall Study|Physician Decision|0|||
160582936|NCT01052012|579853723|FG002|Overall Study|Physician Decision|0|||
160582937|NCT01052012|579853724|FG003|Overall Study|Physician Decision|0|||
160582938|NCT01052012|579853725|FG004|Overall Study|Physician Decision|0|||
160582939|NCT01052012|579853726|FG005|Overall Study|Physician Decision|1|||
160582940|NCT01052012|579853721|FG000|Overall Study|Other|0|||
160582941|NCT01052012|579853722|FG001|Overall Study|Other|0|||
160582942|NCT01052012|579853723|FG002|Overall Study|Other|0|||
160582943|NCT01052012|579853724|FG003|Overall Study|Other|0|||
160582944|NCT01052012|579853725|FG004|Overall Study|Other|1|||
160582945|NCT01052012|579853726|FG005|Overall Study|Other|0|||
160582946|NCT03196297|579853730|FG000|Main Period|Withdrawal by Subject|4|||
160582947|NCT03196297|579853730|FG000|Extension Period|Withdrawal by Subject|1|||
160582948|NCT03196297|579853730|FG000|Extension Period|Lack of Efficacy|2|||
160582949|NCT02538666|579853731|FG000|Pre-Treatment|Disease progression|1|||
160582950|NCT02538666|579853732|FG001|Pre-Treatment|Disease progression|0|||
160582951|NCT02538666|579853733|FG002|Pre-Treatment|Disease progression|0|||
160582952|NCT02538666|579853731|FG000|Pre-Treatment|no longer meets study criteria|1|||
160582953|NCT02538666|579853732|FG001|Pre-Treatment|no longer meets study criteria|0|||
160582954|NCT02538666|579853733|FG002|Pre-Treatment|no longer meets study criteria|0|||
160582955|NCT02538666|579853731|FG000|Pre-Treatment|Withdrew Consent|0|||
160582956|NCT02538666|579853732|FG001|Pre-Treatment|Withdrew Consent|1|||
160582957|NCT02538666|579853733|FG002|Pre-Treatment|Withdrew Consent|1|||
160582958|NCT02538666|579853731|FG000|Treatment|Disease progression|270|||
160582959|NCT02538666|579853732|FG001|Treatment|Disease progression|227|||
160582960|NCT02538666|579853733|FG002|Treatment|Disease progression|165|||
160582961|NCT02538666|579853731|FG000|Treatment|Study drug toxicity|1|||
160582962|NCT02538666|579853732|FG001|Treatment|Study drug toxicity|29|||
160582963|NCT02538666|579853733|FG002|Treatment|Study drug toxicity|92|||
160582964|NCT02538666|579853731|FG000|Treatment|Death|0|||
160582965|NCT02538666|579853732|FG001|Treatment|Death|2|||
160582966|NCT02538666|579853733|FG002|Treatment|Death|3|||
160582967|NCT02538666|579853731|FG000|Treatment|Adverse event unrelated to study drug|8|||
160582968|NCT02538666|579853732|FG001|Treatment|Adverse event unrelated to study drug|10|||
160582969|NCT02538666|579853733|FG002|Treatment|Adverse event unrelated to study drug|15|||
160582970|NCT02538666|579853731|FG000|Treatment|Participant request to discontinue study treatment|3|||
160582971|NCT02538666|579853732|FG001|Treatment|Participant request to discontinue study treatment|6|||
160582972|NCT02538666|579853733|FG002|Treatment|Participant request to discontinue study treatment|11|||
160582973|NCT02538666|579853731|FG000|Treatment|Participant withdrew consent|2|||
160582974|NCT02538666|579853732|FG001|Treatment|Participant withdrew consent|5|||
160582975|NCT02538666|579853733|FG002|Treatment|Participant withdrew consent|3|||
160582976|NCT02538666|579853731|FG000|Treatment|Lost to Follow-up|0|||
160582977|NCT02538666|579853732|FG001|Treatment|Lost to Follow-up|1|||
160582978|NCT02538666|579853733|FG002|Treatment|Lost to Follow-up|1|||
160582979|NCT02538666|579853731|FG000|Treatment|Maximum clinical benefit|4|||
160656783|NCT01644500|580124415|FG000|Overall Study|Physician Decision|1|||
160956346|NCT02160314|581227951|FG000|Overall Study|Withdrawal by Subject|1|||
160956347|NCT02160314|581227952|FG001|Overall Study|Withdrawal by Subject|2|||
160582980|NCT02538666|579853732|FG001|Treatment|Maximum clinical benefit|3|||
160582981|NCT02538666|579853733|FG002|Treatment|Maximum clinical benefit|4|||
160582982|NCT02538666|579853731|FG000|Treatment|Poor/non-compliance|0|||
160582983|NCT02538666|579853732|FG001|Treatment|Poor/non-compliance|1|||
160582984|NCT02538666|579853733|FG002|Treatment|Poor/non-compliance|0|||
160582985|NCT02538666|579853731|FG000|Treatment|Participant no longer meets study criteria|0|||
160582986|NCT02538666|579853732|FG001|Treatment|Participant no longer meets study criteria|2|||
160582987|NCT02538666|579853733|FG002|Treatment|Participant no longer meets study criteria|0|||
160582988|NCT02538666|579853731|FG000|Treatment|Administrative reason by sponsor|0|||
160956348|NCT02160314|581227951|FG000|Overall Study|Lost to Follow-up|0|||
160956349|NCT02160314|581227952|FG001|Overall Study|Lost to Follow-up|1|||
160956350|NCT00593567|581227953|FG000|Overall Study|Adverse Event|2|||
160956351|NCT00593567|581227954|FG001|Overall Study|Adverse Event|0|||
160956352|NCT00593567|581227953|FG000|Overall Study|Physician Decision|2|||
160956353|NCT00593567|581227954|FG001|Overall Study|Physician Decision|0|||
160956354|NCT00593567|581227953|FG000|Overall Study|Protocol Violation|13|||
160956355|NCT00593567|581227954|FG001|Overall Study|Protocol Violation|7|||
160956356|NCT00593567|581227953|FG000|Overall Study|Lack of Efficacy|2|||
160956357|NCT00593567|581227954|FG001|Overall Study|Lack of Efficacy|1|||
160956358|NCT00593567|581227953|FG000|Overall Study|Withdrawal by Subject|1|||
160956359|NCT00593567|581227954|FG001|Overall Study|Withdrawal by Subject|2|||
160956360|NCT03576768|581227960|FG000|Overall Study|Lost to Follow-up|3|||
160956361|NCT03576768|581227961|FG001|Overall Study|Lost to Follow-up|3|||
160956362|NCT03576768|581227962|FG002|Overall Study|Lost to Follow-up|0|||
160956363|NCT03576768|581227963|FG003|Overall Study|Lost to Follow-up|0|||
160956364|NCT00590902|581227964|FG000|Overall Study|Death|1|||
160956365|NCT00785291|581227965|FG000|Overall Study|Never began treatment|8|||
160956366|NCT00785291|581227966|FG001|Overall Study|Never began treatment|4|||
160956367|NCT00785291|581227967|FG002|Overall Study|Never began treatment|4|||
160956368|NCT00785291|581227965|FG000|Overall Study|Adverse Event|39|||
160956369|NCT00785291|581227966|FG001|Overall Study|Adverse Event|70|||
160956370|NCT00785291|581227967|FG002|Overall Study|Adverse Event|56|||
160956371|NCT00785291|581227965|FG000|Overall Study|Death|7|||
160956372|NCT00785291|581227966|FG001|Overall Study|Death|4|||
160956373|NCT00785291|581227967|FG002|Overall Study|Death|3|||
160956374|NCT00785291|581227965|FG000|Overall Study|Withdrawal by Subject|35|||
160956375|NCT00785291|581227966|FG001|Overall Study|Withdrawal by Subject|36|||
160956376|NCT00785291|581227967|FG002|Overall Study|Withdrawal by Subject|17|||
160956377|NCT00785291|581227965|FG000|Overall Study|Alternative Therapy|12|||
160956378|NCT00785291|581227966|FG001|Overall Study|Alternative Therapy|6|||
160956379|NCT00785291|581227967|FG002|Overall Study|Alternative Therapy|7|||
160956380|NCT00785291|581227965|FG000|Overall Study|Complicating illness|6|||
160956381|NCT00785291|581227966|FG001|Overall Study|Complicating illness|4|||
160956382|NCT00785291|581227967|FG002|Overall Study|Complicating illness|4|||
160956383|NCT00785291|581227965|FG000|Overall Study|Other Medical Reasons|29|||
160956384|NCT00785291|581227966|FG001|Overall Study|Other Medical Reasons|25|||
160956385|NCT00785291|581227967|FG002|Overall Study|Other Medical Reasons|15|||
160956386|NCT02119260|581227968|FG000|Overall Study|Adverse Event|1|||
160956387|NCT02119260|581227969|FG001|Overall Study|Adverse Event|0|||
160956388|NCT02119260|581227970|FG002|Overall Study|Adverse Event|0|||
160956389|NCT02119260|581227971|FG003|Overall Study|Adverse Event|0|||
160956390|NCT02119260|581227972|FG004|Overall Study|Adverse Event|0|||
160956391|NCT02119260|581227973|FG005|Overall Study|Adverse Event|0|||
160956392|NCT02119260|581227974|FG006|Overall Study|Adverse Event|0|||
160956393|NCT02119260|581227968|FG000|Overall Study|Withdrew consent|0|||
160956394|NCT02119260|581227969|FG001|Overall Study|Withdrew consent|1|||
160956395|NCT02119260|581227970|FG002|Overall Study|Withdrew consent|1|||
160956396|NCT02119260|581227971|FG003|Overall Study|Withdrew consent|0|||
160956397|NCT02119260|581227972|FG004|Overall Study|Withdrew consent|0|||
160956398|NCT02119260|581227973|FG005|Overall Study|Withdrew consent|0|||
160956399|NCT02119260|581227974|FG006|Overall Study|Withdrew consent|0|||
160956400|NCT02979639|581227976|FG000|Overall Study|Withdrawal based on medical judgement|1|||
160956401|NCT02979639|581227976|FG000|Overall Study|Lost to Follow-up|8|||
160457735|NCT05311176|579407904|FG000|Overall Study|Death|6|||
160632834|NCT01215955|580036088|FG003|Overall Study|Lack of Efficacy|0|||
160632835|NCT01215955|580036085|FG000|Overall Study|Lost to Follow-up|4|||
160632836|NCT01215955|580036086|FG001|Overall Study|Lost to Follow-up|4|||
160632837|NCT01215955|580036087|FG002|Overall Study|Lost to Follow-up|8|||
160632838|NCT01215955|580036088|FG003|Overall Study|Lost to Follow-up|9|||
160632839|NCT01215955|580036085|FG000|Overall Study|Physician Decision|4|||
160632840|NCT01215955|580036086|FG001|Overall Study|Physician Decision|10|||
160632841|NCT01215955|580036087|FG002|Overall Study|Physician Decision|8|||
160632842|NCT01215955|580036088|FG003|Overall Study|Physician Decision|11|||
160632843|NCT01215955|580036085|FG000|Overall Study|Protocol Violation|17|||
160632844|NCT01215955|580036086|FG001|Overall Study|Protocol Violation|13|||
160632845|NCT01215955|580036087|FG002|Overall Study|Protocol Violation|8|||
160632846|NCT01215955|580036088|FG003|Overall Study|Protocol Violation|8|||
160632847|NCT01215955|580036085|FG000|Overall Study|Sponsor Decision|1|||
160632848|NCT01215955|580036086|FG001|Overall Study|Sponsor Decision|2|||
160632849|NCT01215955|580036087|FG002|Overall Study|Sponsor Decision|0|||
160632850|NCT01215955|580036088|FG003|Overall Study|Sponsor Decision|1|||
160632851|NCT01215955|580036085|FG000|Overall Study|Withdrawal by Subject|14|||
160632852|NCT01215955|580036086|FG001|Overall Study|Withdrawal by Subject|15|||
160632853|NCT01215955|580036087|FG002|Overall Study|Withdrawal by Subject|13|||
160632854|NCT01215955|580036088|FG003|Overall Study|Withdrawal by Subject|9|||
160632855|NCT01215955|580036085|FG000|Overall Study|Quality Issues|0|||
160632856|NCT01215955|580036086|FG001|Overall Study|Quality Issues|0|||
160632857|NCT01215955|580036087|FG002|Overall Study|Quality Issues|3|||
160956402|NCT02979639|581227976|FG000|Overall Study|Withdrawal by Subject|3|||
160956403|NCT02979639|581227976|FG000|Overall Study|Adverse Event|2|||
160956404|NCT01877408|581227980|FG000|Overall Study|Lost to Follow-up|0|||
160956405|NCT01877408|581227981|FG001|Overall Study|Lost to Follow-up|2|||
160956406|NCT03870763|581227984|FG000|Overall Study|Study terminated by sponsor|0|||
160956407|NCT03870763|581227985|FG001|Overall Study|Study terminated by sponsor|2|||
160956408|NCT03870763|581227986|FG002|Overall Study|Study terminated by sponsor|0|||
160956409|NCT03870763|581227984|FG000|Overall Study|Withdrawal by Subject|0|||
160956410|NCT03870763|581227985|FG001|Overall Study|Withdrawal by Subject|1|||
160956411|NCT03870763|581227986|FG002|Overall Study|Withdrawal by Subject|0|||
160956412|NCT03870763|581227984|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
160956413|NCT03870763|581227985|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
160956414|NCT03870763|581227986|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
160956415|NCT04279314|581227987|FG000|Overall Study|Adverse Event|55|||
160956416|NCT04279314|581227987|FG000|Overall Study|Withdrawal by Subject|5|||
160956417|NCT04279314|581227987|FG000|Overall Study|Lack of Efficacy|5|||
160956418|NCT04279314|581227987|FG000|Overall Study|Protocol Violation|3|||
160956419|NCT04279314|581227987|FG000|Overall Study|Other (not COVID-19 related)|2|||
160956420|NCT01471054|581227992|FG000|Overall Study|Study terminated prematurely|4|||
160956421|NCT01471054|581227993|FG001|Overall Study|Study terminated prematurely|0|||
160956422|NCT00360308|581227994|FG000|Overall Study|Adverse Event|15|||
160956423|NCT00360308|581227995|FG001|Overall Study|Adverse Event|14|||
160956424|NCT00360308|581227996|FG002|Overall Study|Adverse Event|25|||
160956425|NCT00360308|581227994|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
160956426|NCT00360308|581227995|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
160956427|NCT00360308|581227996|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
160956428|NCT00360308|581227994|FG000|Overall Study|Protocol Violation|2|||
160956429|NCT00360308|581227995|FG001|Overall Study|Protocol Violation|1|||
160956430|NCT00360308|581227996|FG002|Overall Study|Protocol Violation|2|||
160956431|NCT00360308|581227994|FG000|Overall Study|Withdrawal by Subject|11|||
160956432|NCT00360308|581227995|FG001|Overall Study|Withdrawal by Subject|7|||
161001281|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Relapsed|18|||
161001282|NCT00419094|581390535|FG000|Overall Study|Adverse Event|3|||
161001283|NCT00419094|581390536|FG001|Overall Study|Adverse Event|7|||
160656784|NCT01644500|580124416|FG001|Overall Study|Physician Decision|1|||
160656785|NCT01644500|580124417|FG002|Overall Study|Physician Decision|1|||
160656786|NCT02419313|580124418|FG000|First Intervention|Lost to Follow-up|2|||
160656787|NCT02419313|580124419|FG001|First Intervention|Lost to Follow-up|0|||
160656788|NCT02419313|580124418|FG000|Second Intervention|Lost to Follow-up|1|||
160656789|NCT02419313|580124419|FG001|Second Intervention|Lost to Follow-up|0|||
160656790|NCT00322491|580124426|FG000|Overall Study|Adverse Event|1|||
160656791|NCT00322491|580124427|FG001|Overall Study|Adverse Event|0|||
160656792|NCT00322491|580124426|FG000|Overall Study|Death|1|||
160656793|NCT00322491|580124427|FG001|Overall Study|Death|2|||
160656794|NCT00524459|580124433|FG000|Overall Study|Withdrawal by Subject|1|||
160656795|NCT00524459|580124433|FG000|Overall Study|Other|1|||
160656796|NCT02319148|580124438|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
160656797|NCT02319148|580124439|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
160656798|NCT02319148|580124440|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
160656799|NCT02319148|580124441|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
160656800|NCT02319148|580124438|FG000|Second Intervention Period|No longer willing to participate|0|||
160656801|NCT02319148|580124439|FG001|Second Intervention Period|No longer willing to participate|1|||
160656802|NCT02319148|580124440|FG002|Second Intervention Period|No longer willing to participate|0|||
160656803|NCT02319148|580124441|FG003|Second Intervention Period|No longer willing to participate|0|||
160656804|NCT02319148|580124438|FG000|Second Intervention Period|Other|0|||
160656805|NCT02319148|580124439|FG001|Second Intervention Period|Other|0|||
160656806|NCT02319148|580124440|FG002|Second Intervention Period|Other|0|||
160656807|NCT02319148|580124441|FG003|Second Intervention Period|Other|1|||
160656808|NCT01574248|580124442|FG000|Overall Study|Withdrawal by Subject|2|||
160656809|NCT01574248|580124443|FG001|Overall Study|Withdrawal by Subject|0|||
161001284|NCT00419094|581390535|FG000|Overall Study|Lack of Efficacy|1|||
161001285|NCT00419094|581390536|FG001|Overall Study|Lack of Efficacy|0|||
160656810|NCT01574248|580124442|FG000|Overall Study|Missing primary endpoint data|1|||
161001286|NCT00419094|581390535|FG000|Overall Study|Lost to Follow-up|0|||
161001287|NCT00419094|581390536|FG001|Overall Study|Lost to Follow-up|2|||
160656811|NCT01574248|580124443|FG001|Overall Study|Missing primary endpoint data|0|||
160656812|NCT00048048|580124446|FG000|Core Treatment|Withdrawal by Subject|0|||
160656813|NCT00048048|580124447|FG001|Core Treatment|Withdrawal by Subject|0|||
160656814|NCT00048048|580124448|FG002|Core Treatment|Withdrawal by Subject|1|||
160656815|NCT00048048|580124449|FG003|Core Treatment|Withdrawal by Subject|0|||
160956433|NCT00360308|581227996|FG002|Overall Study|Withdrawal by Subject|14|||
160956434|NCT00360308|581227994|FG000|Overall Study|Lack of Efficacy|3|||
160956435|NCT00360308|581227995|FG001|Overall Study|Lack of Efficacy|0|||
160956436|NCT00360308|581227996|FG002|Overall Study|Lack of Efficacy|2|||
160956437|NCT00360308|581227994|FG000|Overall Study|Other|2|||
161001288|NCT00419094|581390535|FG000|Overall Study|Protocol Violation|1|||
161001289|NCT00419094|581390536|FG001|Overall Study|Protocol Violation|14|||
161001290|NCT00419094|581390535|FG000|Overall Study|Withdrawal of consent|1|||
161001291|NCT00419094|581390536|FG001|Overall Study|Withdrawal of consent|5|||
161001292|NCT00419094|581390535|FG000|Overall Study|Other: Error determining exit criteria|1|||
161001293|NCT00419094|581390536|FG001|Overall Study|Other: Error determining exit criteria|0|||
161001294|NCT00419094|581390535|FG000|Overall Study|Other: Patient non-compliant|0|||
161001295|NCT00419094|581390536|FG001|Overall Study|Other: Patient non-compliant|1|||
161001296|NCT00419094|581390535|FG000|Overall Study|Other: No contact for extended period|0|||
161001297|NCT00419094|581390536|FG001|Overall Study|Other: No contact for extended period|1|||
161001298|NCT01337635|581390537|FG000|Overall Study|Lost to Follow-up|0|||
161001299|NCT01337635|581390538|FG001|Overall Study|Lost to Follow-up|1|||
161001300|NCT03287622|581390542|FG000|Overall Study|Withdrawal by Subject|1|||
160582989|NCT02538666|579853732|FG001|Treatment|Administrative reason by sponsor|0|||
160582990|NCT02538666|579853733|FG002|Treatment|Administrative reason by sponsor|1|||
160582991|NCT02538666|579853731|FG000|Treatment|Other reasons|8|||
160582992|NCT02538666|579853732|FG001|Treatment|Other reasons|15|||
160582993|NCT02538666|579853733|FG002|Treatment|Other reasons|5|||
160582994|NCT02538666|579853731|FG000|Treatment|Not reported|2|||
160582995|NCT02538666|579853732|FG001|Treatment|Not reported|2|||
160582996|NCT02538666|579853733|FG002|Treatment|Not reported|2|||
160582997|NCT00320385|579853736|FG000|Overall Study|Lost to Follow-up|7|||
160582998|NCT00320385|579853737|FG001|Overall Study|Lost to Follow-up|10|||
160582999|NCT00320385|579853736|FG000|Overall Study|Withdrawal by Subject|6|||
160583000|NCT00320385|579853737|FG001|Overall Study|Withdrawal by Subject|7|||
160583001|NCT00320385|579853736|FG000|Overall Study|Sponsor Terminated Study|2|||
160583002|NCT00320385|579853737|FG001|Overall Study|Sponsor Terminated Study|1|||
160583003|NCT00320385|579853736|FG000|Overall Study|Investigator Decision|0|||
160583004|NCT00320385|579853737|FG001|Overall Study|Investigator Decision|1|||
160583005|NCT00320385|579853736|FG000|Overall Study|Death|1|||
160583006|NCT00320385|579853737|FG001|Overall Study|Death|2|||
160583007|NCT00320385|579853736|FG000|Overall Study|Serious Adverse Event|1|||
160583008|NCT00320385|579853737|FG001|Overall Study|Serious Adverse Event|0|||
160583009|NCT00320385|579853736|FG000|Overall Study|Withdrew Consent|1|||
160583010|NCT00320385|579853737|FG001|Overall Study|Withdrew Consent|0|||
160583011|NCT00320385|579853736|FG000|Overall Study|Adverse Event|0|||
160583012|NCT00320385|579853737|FG001|Overall Study|Adverse Event|1|||
160583013|NCT04370028|579853738|FG000|Overall Study|Withdrawal by Subject|695|||
160583014|NCT04370028|579853738|FG000|Overall Study|Protocol Violation|9|||
160583015|NCT04370028|579853738|FG000|Overall Study|Adverse Event|3|||
160583016|NCT03342469|579853748|FG000|Overall Study|Withdrawal by Subject|0|||
160583017|NCT03342469|579853749|FG001|Overall Study|Withdrawal by Subject|1|||
160583018|NCT03342469|579853750|FG002|Overall Study|Withdrawal by Subject|0|||
160583019|NCT03342469|579853751|FG003|Overall Study|Withdrawal by Subject|0|||
160583020|NCT00540436|579853753|FG000|First 12-Week Treatment Period|Adverse Event|1|||
160583021|NCT00540436|579853753|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
160583022|NCT00540436|579853753|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
160583023|NCT00540436|579853753|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
160583024|NCT01515306|579853754|FG000|Overall Study|Adverse Event|3|||
160583025|NCT01515306|579853755|FG001|Overall Study|Adverse Event|2|||
160583026|NCT01515306|579853754|FG000|Overall Study|Progressive Disease|19|||
160583027|NCT01515306|579853755|FG001|Overall Study|Progressive Disease|9|||
160583028|NCT01515306|579853754|FG000|Overall Study|Withdrawal by Subject|1|||
160583029|NCT01515306|579853755|FG001|Overall Study|Withdrawal by Subject|2|||
160583030|NCT01515306|579853754|FG000|Overall Study|Physician Decision|1|||
160583031|NCT01515306|579853755|FG001|Overall Study|Physician Decision|1|||
160583032|NCT01064648|579853756|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
160583033|NCT01064648|579853757|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
160583034|NCT01064648|579853758|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
160583035|NCT01064648|579853759|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
160583036|NCT01064648|579853756|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
160583037|NCT01064648|579853757|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
160583038|NCT01064648|579853758|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
160583039|NCT01064648|579853759|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
160583040|NCT01064648|579853756|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
160583041|NCT01064648|579853757|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
160583042|NCT01064648|579853758|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
160583043|NCT01064648|579853759|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
160583044|NCT01064648|579853756|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
160583045|NCT01064648|579853757|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
160583046|NCT01064648|579853758|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
160583047|NCT01064648|579853759|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
160583048|NCT01064648|579853756|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
160583049|NCT01064648|579853757|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
161001301|NCT03287622|581390543|FG001|Overall Study|Withdrawal by Subject|0|||
161001302|NCT03287622|581390542|FG000|Overall Study|Lost to Follow-up|27|||
161001303|NCT03287622|581390543|FG001|Overall Study|Lost to Follow-up|15|||
161001304|NCT03287622|581390542|FG000|Overall Study|No prescripion after surgery|28|||
160583050|NCT01064648|579853758|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
160583051|NCT01064648|579853759|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
160583052|NCT01064648|579853756|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
160583053|NCT01064648|579853757|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
160583054|NCT01064648|579853758|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
160583055|NCT01064648|579853759|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
160583056|NCT01064648|579853756|FG000|Phase II|Adverse Event|0|||
160583057|NCT01064648|579853757|FG001|Phase II|Adverse Event|0|||
160583058|NCT01064648|579853758|FG002|Phase II|Adverse Event|15|||
160583059|NCT01064648|579853759|FG003|Phase II|Adverse Event|8|||
160583060|NCT01064648|579853756|FG000|Phase II|Death|0|||
160583061|NCT01064648|579853757|FG001|Phase II|Death|0|||
160583062|NCT01064648|579853758|FG002|Phase II|Death|4|||
160583063|NCT01064648|579853759|FG003|Phase II|Death|5|||
160583064|NCT01064648|579853756|FG000|Phase II|Withdrawal by Subject|0|||
160583065|NCT01064648|579853757|FG001|Phase II|Withdrawal by Subject|0|||
160583066|NCT01064648|579853758|FG002|Phase II|Withdrawal by Subject|2|||
160583067|NCT01064648|579853759|FG003|Phase II|Withdrawal by Subject|5|||
160583068|NCT01064648|579853756|FG000|Phase II|Progression|0|||
160583069|NCT01064648|579853757|FG001|Phase II|Progression|0|||
160583070|NCT01064648|579853758|FG002|Phase II|Progression|21|||
160583071|NCT01064648|579853759|FG003|Phase II|Progression|27|||
160583072|NCT01064648|579853756|FG000|Phase II|Non-protocol specified|0|||
160583073|NCT01064648|579853757|FG001|Phase II|Non-protocol specified|0|||
160583074|NCT01064648|579853758|FG002|Phase II|Non-protocol specified|5|||
160583075|NCT01064648|579853759|FG003|Phase II|Non-protocol specified|3|||
160583076|NCT01064648|579853756|FG000|Phase II|Under Review|0|||
160583077|NCT01064648|579853757|FG001|Phase II|Under Review|0|||
160583078|NCT01064648|579853758|FG002|Phase II|Under Review|2|||
160583079|NCT01064648|579853759|FG003|Phase II|Under Review|0|||
160583080|NCT05513391|579853760|FG000|Overall Study|Adverse Event|1|||
160583081|NCT05513391|579853761|FG001|Overall Study|Adverse Event|0|||
160583082|NCT05513391|579853760|FG000|Overall Study|Protocol Deviation|0|||
160583083|NCT05513391|579853761|FG001|Overall Study|Protocol Deviation|1|||
160583084|NCT05513391|579853760|FG000|Overall Study|Withdrawal by Subject|3|||
160583085|NCT05513391|579853761|FG001|Overall Study|Withdrawal by Subject|1|||
160583086|NCT05513391|579853760|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160583087|NCT05513391|579853761|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
160583088|NCT05513391|579853760|FG000|Overall Study|Lost to Follow-up|0|||
160583089|NCT05513391|579853761|FG001|Overall Study|Lost to Follow-up|2|||
160583090|NCT02429427|579853762|FG000|Overall Study|Adverse Event|220|||
160583091|NCT02429427|579853763|FG001|Overall Study|Adverse Event|92|||
160583092|NCT02429427|579853762|FG000|Overall Study|Protocol Violation|10|||
160583093|NCT02429427|579853763|FG001|Overall Study|Protocol Violation|6|||
160583094|NCT02429427|579853762|FG000|Overall Study|Lost to Follow-up|15|||
160583095|NCT02429427|579853763|FG001|Overall Study|Lost to Follow-up|6|||
160583096|NCT02429427|579853762|FG000|Overall Study|Withdrawal by Subject|64|||
160583097|NCT02429427|579853763|FG001|Overall Study|Withdrawal by Subject|34|||
160583098|NCT02429427|579853762|FG000|Overall Study|Other|62|||
160583099|NCT02429427|579853763|FG001|Overall Study|Other|41|||
160583100|NCT00683475|579855749|FG000|Overall Study|Withdrawal by Subject|1|||
160583101|NCT00683475|579855750|FG001|Overall Study|Withdrawal by Subject|0|||
160583102|NCT00683475|579855749|FG000|Overall Study|Never Treated: Adverse Event|2|||
160583103|NCT00683475|579855750|FG001|Overall Study|Never Treated: Adverse Event|3|||
160583104|NCT00683475|579855749|FG000|Overall Study|Never Treated: Progressive Disease|1|||
160583105|NCT00683475|579855750|FG001|Overall Study|Never Treated: Progressive Disease|0|||
160583106|NCT01251276|579855754|FG000|Overall Study|Protocol Violation|1|||
160583107|NCT01251276|579855755|FG001|Overall Study|Protocol Violation|0|||
160583108|NCT01251276|579855754|FG000|Overall Study|Lost to Follow-up|0|||
160583109|NCT01251276|579855755|FG001|Overall Study|Lost to Follow-up|1|||
160583110|NCT01725152|579855756|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
160583111|NCT01725152|579855757|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
160583112|NCT01725152|579855756|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
161001305|NCT03287622|581390543|FG001|Overall Study|No prescripion after surgery|31|||
160583113|NCT01725152|579855757|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
160583114|NCT01725152|579855756|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
160583115|NCT01725152|579855757|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
160583116|NCT01725152|579855756|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
160583117|NCT01725152|579855757|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
160583118|NCT02044159|579855758|FG000|Overall Study|Consent declined (deferred consent)|2|||
160583119|NCT02044159|579855759|FG001|Overall Study|Consent declined (deferred consent)|4|||
160583120|NCT02044159|579855758|FG000|Overall Study|No longer eligible, drug not given|1|||
160583121|NCT02044159|579855759|FG001|Overall Study|No longer eligible, drug not given|0|||
160656816|NCT00048048|580124450|FG004|Core Treatment|Withdrawal by Subject|0|||
160656817|NCT00048048|580124451|FG005|Core Treatment|Withdrawal by Subject|0|||
160656818|NCT00048048|580124452|FG006|Core Treatment|Withdrawal by Subject|0|||
160656819|NCT00048048|580124453|FG007|Core Treatment|Withdrawal by Subject|0|||
160656820|NCT00048048|580124454|FG008|Core Treatment|Withdrawal by Subject|0|||
160656821|NCT00048048|580124455|FG009|Core Treatment|Withdrawal by Subject|0|||
160656822|NCT00048048|580124456|FG010|Core Treatment|Withdrawal by Subject|0|||
160656823|NCT00048048|580124457|FG011|Core Treatment|Withdrawal by Subject|0|||
160656824|NCT00048048|580124446|FG000|Core Treatment|Adverse Event|0|||
160656825|NCT00048048|580124447|FG001|Core Treatment|Adverse Event|0|||
160656826|NCT00048048|580124448|FG002|Core Treatment|Adverse Event|0|||
160656827|NCT00048048|580124449|FG003|Core Treatment|Adverse Event|0|||
160656828|NCT00048048|580124450|FG004|Core Treatment|Adverse Event|0|||
160656829|NCT00048048|580124451|FG005|Core Treatment|Adverse Event|0|||
160656830|NCT00048048|580124452|FG006|Core Treatment|Adverse Event|0|||
160656831|NCT00048048|580124453|FG007|Core Treatment|Adverse Event|1|||
160656832|NCT00048048|580124454|FG008|Core Treatment|Adverse Event|0|||
160656833|NCT00048048|580124455|FG009|Core Treatment|Adverse Event|0|||
160656834|NCT00048048|580124456|FG010|Core Treatment|Adverse Event|0|||
160656835|NCT00048048|580124457|FG011|Core Treatment|Adverse Event|0|||
160656836|NCT00048048|580124446|FG000|Extension Year 1|Early withdrawals|0|||
160656837|NCT00048048|580124447|FG001|Extension Year 1|Early withdrawals|0|||
160656838|NCT00048048|580124448|FG002|Extension Year 1|Early withdrawals|0|||
160656839|NCT00048048|580124449|FG003|Extension Year 1|Early withdrawals|0|||
160656840|NCT00048048|580124450|FG004|Extension Year 1|Early withdrawals|0|||
160656841|NCT00048048|580124451|FG005|Extension Year 1|Early withdrawals|0|||
160656842|NCT00048048|580124452|FG006|Extension Year 1|Early withdrawals|0|||
160656843|NCT00048048|580124453|FG007|Extension Year 1|Early withdrawals|0|||
160656844|NCT00048048|580124454|FG008|Extension Year 1|Early withdrawals|0|||
160656845|NCT00048048|580124455|FG009|Extension Year 1|Early withdrawals|2|||
160656846|NCT00048048|580124456|FG010|Extension Year 1|Early withdrawals|2|||
160656847|NCT00048048|580124457|FG011|Extension Year 1|Early withdrawals|4|||
160656848|NCT00048048|580124446|FG000|Extension Year 2|Early withdrawals|0|||
160656849|NCT00048048|580124447|FG001|Extension Year 2|Early withdrawals|0|||
160656850|NCT00048048|580124448|FG002|Extension Year 2|Early withdrawals|0|||
160656851|NCT00048048|580124449|FG003|Extension Year 2|Early withdrawals|0|||
160656852|NCT00048048|580124450|FG004|Extension Year 2|Early withdrawals|0|||
160656853|NCT00048048|580124451|FG005|Extension Year 2|Early withdrawals|0|||
160656854|NCT00048048|580124452|FG006|Extension Year 2|Early withdrawals|0|||
160656855|NCT00048048|580124453|FG007|Extension Year 2|Early withdrawals|0|||
160656856|NCT00048048|580124454|FG008|Extension Year 2|Early withdrawals|0|||
160656857|NCT00048048|580124455|FG009|Extension Year 2|Early withdrawals|0|||
160656858|NCT00048048|580124456|FG010|Extension Year 2|Early withdrawals|4|||
160656859|NCT00048048|580124457|FG011|Extension Year 2|Early withdrawals|2|||
160656860|NCT05518487|580124460|FG000|Overall Study|Withdrawal by Subject|3|||
160656861|NCT00543309|580124461|FG000|Overall Study|Physician Decision|0|||
160656862|NCT00543309|580124462|FG001|Overall Study|Physician Decision|1|||
161001306|NCT03287622|581390542|FG000|Overall Study|prolonged Length of stay|2|||
161001307|NCT03287622|581390543|FG001|Overall Study|prolonged Length of stay|0|||
161001308|NCT03287622|581390542|FG000|Overall Study|surgery related|0|||
161001309|NCT03287622|581390543|FG001|Overall Study|surgery related|2|||
161001310|NCT03192046|581390551|FG000|Overall Study|Withdrawal by Subject|1|||
161001311|NCT03192046|581390552|FG001|Overall Study|Withdrawal by Subject|1|||
161001312|NCT01194154|581390555|FG000|Overall Study|Adverse Event|12|||
161001313|NCT01194154|581390556|FG001|Overall Study|Adverse Event|7|||
160956438|NCT00360308|581227995|FG001|Overall Study|Other|1|||
160956439|NCT00360308|581227996|FG002|Overall Study|Other|1|||
160956440|NCT00360308|581227994|FG000|Overall Study|Study termination by sponsor|43|||
160956441|NCT00360308|581227995|FG001|Overall Study|Study termination by sponsor|55|||
160656863|NCT00543309|580124463|FG002|Overall Study|Physician Decision|0|||
160656864|NCT02194998|580124468|FG000|On-HCV Treatment|Did not pick up study medication|0|||
160656865|NCT02194998|580124469|FG001|On-HCV Treatment|Did not pick up study medication|1|||
160656866|NCT02194998|580124470|FG002|On-HCV Treatment|Did not pick up study medication|0|||
160656867|NCT02194998|580124471|FG003|On-HCV Treatment|Did not pick up study medication|0|||
160656868|NCT02194998|580124468|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
160656869|NCT02194998|580124469|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
160656870|NCT02194998|580124470|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
160656871|NCT02194998|580124471|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
160956442|NCT00360308|581227996|FG002|Overall Study|Study termination by sponsor|44|||
160956443|NCT00082173|581227997|FG000|Overall Study|Withdrawal by Subject|3|||
160956444|NCT00082173|581227998|FG001|Overall Study|Withdrawal by Subject|5|||
160956445|NCT00082173|581227997|FG000|Overall Study|Lost to Follow-up|1|||
160956446|NCT00082173|581227998|FG001|Overall Study|Lost to Follow-up|0|||
160956447|NCT00082173|581227997|FG000|Overall Study|Adverse Event|1|||
160956448|NCT00082173|581227998|FG001|Overall Study|Adverse Event|0|||
160956449|NCT00082173|581227997|FG000|Overall Study|Culture negative or resistant at baselin|5|||
160656872|NCT00525590|580124472|FG000|Overall Study|Adverse Event|3|||
160656873|NCT00525590|580124472|FG000|Overall Study|Physician Decision|3|||
160656874|NCT00525590|580124472|FG000|Overall Study|Withdrawal by Subject|16|||
160956450|NCT00082173|581227998|FG001|Overall Study|Culture negative or resistant at baselin|6|||
160956451|NCT01733732|581227999|FG000|Overall Study|Adverse Event|1|||
160956452|NCT01733732|581228000|FG001|Overall Study|Adverse Event|0|||
160956453|NCT01733732|581227999|FG000|Overall Study|Did not attend all study visits|1|||
160956454|NCT01733732|581228000|FG001|Overall Study|Did not attend all study visits|0|||
160956455|NCT03280121|581228003|FG000|Overall Study|Physician Decision|1|||
160956456|NCT03280121|581228003|FG000|Overall Study|Lost to Follow-up|1|||
160956457|NCT03280121|581228003|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
160956458|NCT02633137|581228018|FG000|Overall Study|Adverse Event|1|||
160956459|NCT02633137|581228018|FG000|Overall Study|Lack of Efficacy|2|||
160956460|NCT02633137|581228018|FG000|Overall Study|Withdrawal by Subject|1|||
160956461|NCT04307004|581228019|FG000|Randomization 1|Withdrawal by Subject|25|||
160956462|NCT04307004|581228020|FG001|Randomization 1|Withdrawal by Subject|26|||
160956463|NCT04307004|581228021|FG002|Randomization 1|Withdrawal by Subject|0|||
160956464|NCT04307004|581228022|FG003|Randomization 1|Withdrawal by Subject|0|||
160956465|NCT04307004|581228019|FG000|Randomization 2|Withdrawal by Subject|0|||
160956466|NCT04307004|581228020|FG001|Randomization 2|Withdrawal by Subject|0|||
160956467|NCT04307004|581228021|FG002|Randomization 2|Withdrawal by Subject|28|||
160956468|NCT04307004|581228022|FG003|Randomization 2|Withdrawal by Subject|23|||
160956469|NCT01324271|581228023|FG000|Overall Study|Lost to Follow-up|3|||
160956470|NCT01324271|581228024|FG001|Overall Study|Lost to Follow-up|0|||
160956471|NCT01324271|581228023|FG000|Overall Study|Physician Decision|1|||
160656875|NCT00525590|580124472|FG000|Overall Study|Lost to Follow-up|1|||
160656876|NCT00525590|580124472|FG000|Overall Study|Death|9|||
160656877|NCT00525590|580124472|FG000|Overall Study|Other|13|||
160656878|NCT00762086|580124473|FG000|Overall Study|Adverse Event|2|||
160656879|NCT00762086|580124474|FG001|Overall Study|Adverse Event|0|||
160656880|NCT00762086|580124473|FG000|Overall Study|Lost to Follow-up|0|||
160656881|NCT00762086|580124474|FG001|Overall Study|Lost to Follow-up|2|||
160656882|NCT00762086|580124473|FG000|Overall Study|Non compliance|1|||
160656883|NCT00762086|580124474|FG001|Overall Study|Non compliance|0|||
160656884|NCT00762086|580124473|FG000|Overall Study|Withdrawal by Subject|2|||
160656885|NCT00762086|580124474|FG001|Overall Study|Withdrawal by Subject|2|||
160656886|NCT00762086|580124473|FG000|Overall Study|Ineligible to participate in the study|1|||
160656887|NCT00762086|580124474|FG001|Overall Study|Ineligible to participate in the study|0|||
160656888|NCT03130699|580124480|FG000|Overall Study|Lost to Follow-up|34|||
160656889|NCT03130699|580124481|FG001|Overall Study|Lost to Follow-up|37|||
160656890|NCT03130699|580124482|FG002|Overall Study|Lost to Follow-up|26|||
160656891|NCT03130699|580124480|FG000|Overall Study|Withdrawal by Subject|5|||
160656892|NCT03130699|580124481|FG001|Overall Study|Withdrawal by Subject|1|||
160656893|NCT03130699|580124482|FG002|Overall Study|Withdrawal by Subject|0|||
160656894|NCT03130699|580124480|FG000|Overall Study|Withdrawal by PI|1|||
160656895|NCT03130699|580124481|FG001|Overall Study|Withdrawal by PI|2|||
160656896|NCT03130699|580124482|FG002|Overall Study|Withdrawal by PI|5|||
160656897|NCT03130699|580124480|FG000|Overall Study|Death|0|||
160656898|NCT03130699|580124481|FG001|Overall Study|Death|0|||
160656899|NCT03130699|580124482|FG002|Overall Study|Death|1|||
160656900|NCT04534283|580124485|FG000|Overall Study|Physician Decision|2|||
160656901|NCT04534283|580124485|FG000|Overall Study|Withdrawal by Subject|1|||
160656902|NCT04534283|580124485|FG000|Overall Study|Disease Progression|12|||
160656903|NCT04534283|580124485|FG000|Overall Study|Adverse Event|1|||
160656904|NCT03257462|580124488|FG000|Cohort A|Lost to Follow-up|1|||
160656905|NCT03257462|580124489|FG001|Cohort A|Lost to Follow-up|0|||
160656906|NCT03257462|580124490|FG002|Cohort A|Lost to Follow-up|0|||
160656907|NCT03257462|580124491|FG003|Cohort A|Lost to Follow-up|0|||
160656908|NCT03257462|580124488|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
160656909|NCT03257462|580124489|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
160656910|NCT03257462|580124490|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
160656911|NCT03257462|580124491|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
160656912|NCT00796822|580124492|FG000|Overall Study|Lost to Follow-up|2|||
160656913|NCT00796822|580124493|FG001|Overall Study|Lost to Follow-up|0|||
160656914|NCT00796822|580124492|FG000|Overall Study|Adverse Event|1|||
160956472|NCT01324271|581228024|FG001|Overall Study|Physician Decision|0|||
160656915|NCT00796822|580124493|FG001|Overall Study|Adverse Event|0|||
160656916|NCT06354270|580124494|FG000|Overall Study|Withdrawal by Subject|1|||
160656917|NCT06354270|580124495|FG001|Overall Study|Withdrawal by Subject|0|||
160656918|NCT05097989|580124496|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
160656919|NCT05097989|580124497|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
160656920|NCT05097989|580124498|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
160956473|NCT02807558|581228025|FG000|Overall Study|Consent withdrawn by participant|4|||
160956474|NCT02807558|581228026|FG001|Overall Study|Consent withdrawn by participant|0|||
160956475|NCT02807558|581228027|FG002|Overall Study|Consent withdrawn by participant|4|||
160956476|NCT02807558|581228028|FG003|Overall Study|Consent withdrawn by participant|2|||
160956477|NCT02807558|581228029|FG004|Overall Study|Consent withdrawn by participant|1|||
160956478|NCT02807558|581228030|FG005|Overall Study|Consent withdrawn by participant|0|||
160956479|NCT02807558|581228025|FG000|Overall Study|Non-compliance with Study Drug|0|||
160956480|NCT02807558|581228026|FG001|Overall Study|Non-compliance with Study Drug|0|||
160956481|NCT02807558|581228027|FG002|Overall Study|Non-compliance with Study Drug|1|||
160457736|NCT05311176|579407904|FG000|Overall Study|Sponsor discontinued the study|1|||
160457737|NCT05247034|579407905|FG000|Overall Study|Lost to Follow-up|3|||
160457738|NCT05247034|579407906|FG001|Overall Study|Lost to Follow-up|2|||
160457739|NCT05247034|579407905|FG000|Overall Study|Organizational problems when attending appointments|1|||
160457740|NCT05247034|579407906|FG001|Overall Study|Organizational problems when attending appointments|0|||
160457741|NCT01960452|579407909|FG000|Overall Study|Withdrawal by Subject|2|||
160457742|NCT01960452|579407910|FG001|Overall Study|Withdrawal by Subject|1|||
160457743|NCT01960452|579407909|FG000|Overall Study|Sleep apnea in Night 1|1|||
160457744|NCT01960452|579407910|FG001|Overall Study|Sleep apnea in Night 1|0|||
160457745|NCT01960452|579407909|FG000|Overall Study|Poor Sleep in Night 1|0|||
160457746|NCT01960452|579407910|FG001|Overall Study|Poor Sleep in Night 1|2|||
160457747|NCT01960452|579407909|FG000|Overall Study|No Sex/Age Match Night 1|1|||
160457748|NCT01960452|579407910|FG001|Overall Study|No Sex/Age Match Night 1|0|||
160457749|NCT01960452|579407909|FG000|Overall Study|No Sex/Age Match Night 2|0|||
160457750|NCT01960452|579407910|FG001|Overall Study|No Sex/Age Match Night 2|2|||
160457751|NCT01960452|579407909|FG000|Overall Study|Technical Difficulties Night 2|2|||
160457752|NCT01960452|579407910|FG001|Overall Study|Technical Difficulties Night 2|0|||
160457753|NCT02668692|579407911|FG000|Overall Study|Adverse Event|1|||
160457754|NCT02668692|579407912|FG001|Overall Study|Adverse Event|0|||
160457755|NCT03981926|579407913|FG000|Overall Study|Lost to Follow-up|5|||
160457756|NCT03981926|579407914|FG001|Overall Study|Lost to Follow-up|9|||
160457757|NCT04820322|579407921|FG000|Overall Study|Adverse Event|1|||
160457758|NCT04820322|579407922|FG001|Overall Study|Adverse Event|0|||
160457759|NCT03156465|579407923|FG000|Overall Study|Withdrawal by Subject|2|||
160457760|NCT03181516|579407924|FG000|Overall Study|Withdrawal by Subject|14|||
160457761|NCT03181516|579407925|FG001|Overall Study|Withdrawal by Subject|7|||
160457762|NCT03181516|579407924|FG000|Overall Study|Lost to Follow-up|2|||
160457763|NCT03181516|579407925|FG001|Overall Study|Lost to Follow-up|2|||
160583122|NCT02044159|579855758|FG000|Overall Study|Nurse declined to give study drug|1|||
160583123|NCT02044159|579855759|FG001|Overall Study|Nurse declined to give study drug|0|||
160583124|NCT01111539|579855762|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
160583125|NCT01111539|579855763|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160583126|NCT01111539|579855764|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160583127|NCT01111539|579855765|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160583128|NCT01111539|579855766|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160583129|NCT01111539|579855762|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
160583130|NCT01111539|579855763|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160583131|NCT01111539|579855764|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160583132|NCT01111539|579855765|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160583133|NCT01111539|579855766|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160583134|NCT01111539|579855762|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
160583135|NCT01111539|579855763|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160583136|NCT01111539|579855764|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160583137|NCT01111539|579855765|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160583138|NCT01111539|579855766|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160583139|NCT01111539|579855762|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
160583140|NCT01111539|579855763|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
160583141|NCT01111539|579855764|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
160583142|NCT01111539|579855765|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
160583143|NCT01111539|579855766|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
160583144|NCT01111539|579855762|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
160583145|NCT01111539|579855763|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
160583146|NCT01111539|579855764|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
160583147|NCT01111539|579855765|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
160583148|NCT01111539|579855766|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
160583149|NCT01111539|579855762|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
160583150|NCT01111539|579855763|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160583151|NCT01111539|579855764|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160956482|NCT02807558|581228028|FG003|Overall Study|Non-compliance with Study Drug|0|||
160956483|NCT02807558|581228029|FG004|Overall Study|Non-compliance with Study Drug|0|||
160457764|NCT04544007|579407929|FG000|Overall Study|Withdrawal by Subject|1|||
160956484|NCT02807558|581228030|FG005|Overall Study|Non-compliance with Study Drug|0|||
160457765|NCT04544007|579407929|FG000|Overall Study|Confirmed Progressive Disease|1|||
160457766|NCT05405985|579407932|FG000|Overall Study|Withdrawal by Subject|1|||
160457767|NCT05405985|579407933|FG001|Overall Study|Withdrawal by Subject|0|||
160457768|NCT04605159|579407938|FG000|Overall Study|Adverse Event|6|||
160457769|NCT04605159|579407939|FG001|Overall Study|Adverse Event|3|||
160457770|NCT04605159|579407940|FG002|Overall Study|Adverse Event|21|||
160956485|NCT02807558|581228025|FG000|Overall Study|Adverse Event|0|||
160956486|NCT02807558|581228026|FG001|Overall Study|Adverse Event|0|||
160956487|NCT02807558|581228027|FG002|Overall Study|Adverse Event|9|||
160656921|NCT05097989|580124499|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
160656922|NCT05097989|580124500|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
160656923|NCT05097989|580124501|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
160656924|NCT05097989|580124502|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
160656925|NCT05097989|580124503|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
160656926|NCT05097989|580124504|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
160656927|NCT05097989|580124496|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
160656928|NCT05097989|580124497|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
160656929|NCT05097989|580124498|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
160656930|NCT05097989|580124499|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
160656931|NCT05097989|580124500|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
160656932|NCT05097989|580124501|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
160656933|NCT05097989|580124502|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
160656934|NCT05097989|580124503|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
160656935|NCT05097989|580124504|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
160656936|NCT05097989|580124496|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
160656937|NCT05097989|580124497|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
160656938|NCT05097989|580124498|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
160656939|NCT05097989|580124499|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
160656940|NCT05097989|580124500|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
160656941|NCT05097989|580124501|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
160656942|NCT05097989|580124502|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
160656943|NCT05097989|580124503|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
160656944|NCT05097989|580124504|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
160656945|NCT05097989|580124496|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
160656946|NCT05097989|580124497|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
160656947|NCT05097989|580124498|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
160656948|NCT05097989|580124499|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
160656949|NCT05097989|580124500|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
160656950|NCT05097989|580124501|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
160656951|NCT05097989|580124502|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
160656952|NCT05097989|580124503|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
160656953|NCT05097989|580124504|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
160656954|NCT05097989|580124496|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
160656955|NCT05097989|580124497|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
160656956|NCT05097989|580124498|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
160656957|NCT05097989|580124499|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
160956488|NCT02807558|581228028|FG003|Overall Study|Adverse Event|0|||
160956489|NCT02807558|581228029|FG004|Overall Study|Adverse Event|0|||
160956490|NCT02807558|581228030|FG005|Overall Study|Adverse Event|0|||
160956491|NCT02807558|581228025|FG000|Overall Study|Death|23|||
160956492|NCT02807558|581228026|FG001|Overall Study|Death|2|||
160956493|NCT02807558|581228027|FG002|Overall Study|Death|3|||
160956494|NCT02807558|581228028|FG003|Overall Study|Death|43|||
160956495|NCT02807558|581228029|FG004|Overall Study|Death|24|||
160956496|NCT02807558|581228030|FG005|Overall Study|Death|15|||
160956497|NCT02807558|581228025|FG000|Overall Study|Progressive Disease|0|||
160956498|NCT02807558|581228026|FG001|Overall Study|Progressive Disease|0|||
160956499|NCT02807558|581228027|FG002|Overall Study|Progressive Disease|1|||
160956500|NCT02807558|581228028|FG003|Overall Study|Progressive Disease|0|||
160956501|NCT02807558|581228029|FG004|Overall Study|Progressive Disease|0|||
160956502|NCT02807558|581228030|FG005|Overall Study|Progressive Disease|0|||
160956503|NCT02807558|581228025|FG000|Overall Study|Other than specified|1|||
160956504|NCT02807558|581228026|FG001|Overall Study|Other than specified|0|||
160956505|NCT02807558|581228027|FG002|Overall Study|Other than specified|2|||
160956506|NCT02807558|581228028|FG003|Overall Study|Other than specified|0|||
160956507|NCT02807558|581228029|FG004|Overall Study|Other than specified|1|||
160956508|NCT02807558|581228030|FG005|Overall Study|Other than specified|1|||
160956509|NCT02807558|581228025|FG000|Overall Study|Lack of Efficacy|0|||
161001314|NCT01194154|581390555|FG000|Overall Study|Lost to Follow-up|2|||
160656958|NCT05097989|580124500|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
160956510|NCT02807558|581228026|FG001|Overall Study|Lack of Efficacy|0|||
160956511|NCT02807558|581228027|FG002|Overall Study|Lack of Efficacy|9|||
160956512|NCT02807558|581228028|FG003|Overall Study|Lack of Efficacy|0|||
160956513|NCT02807558|581228029|FG004|Overall Study|Lack of Efficacy|0|||
160956514|NCT02807558|581228030|FG005|Overall Study|Lack of Efficacy|0|||
160956515|NCT06116591|581228031|FG000|Overall Study|No longer met eligibility criteria|0|||
160956516|NCT06116591|581228032|FG001|Overall Study|No longer met eligibility criteria|1|||
160457771|NCT04605159|579407941|FG003|Overall Study|Adverse Event|4|||
160457772|NCT04605159|579407938|FG000|Overall Study|Lost to Follow-up|74|||
160457773|NCT04605159|579407939|FG001|Overall Study|Lost to Follow-up|45|||
160457774|NCT04605159|579407940|FG002|Overall Study|Lost to Follow-up|119|||
160457775|NCT04605159|579407941|FG003|Overall Study|Lost to Follow-up|80|||
160457776|NCT04605159|579407938|FG000|Overall Study|Protocol Violation|4|||
160457777|NCT04605159|579407939|FG001|Overall Study|Protocol Violation|5|||
160457778|NCT04605159|579407940|FG002|Overall Study|Protocol Violation|2|||
160583152|NCT01111539|579855765|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160583153|NCT01111539|579855766|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160583154|NCT01111539|579855762|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
160583155|NCT01111539|579855763|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
160956517|NCT06116591|581228031|FG000|Overall Study|Other: Change in life situation|0|||
160956518|NCT06116591|581228032|FG001|Overall Study|Other: Change in life situation|1|||
160956519|NCT05585307|581228033|FG000|Overall Study|Lost to Follow-up|0|||
160956520|NCT05585307|581228034|FG001|Overall Study|Lost to Follow-up|0|||
160956521|NCT05585307|581228035|FG002|Overall Study|Lost to Follow-up|0|||
160956522|NCT05585307|581228036|FG003|Overall Study|Lost to Follow-up|0|||
160956523|NCT05585307|581228037|FG004|Overall Study|Lost to Follow-up|0|||
160956524|NCT05585307|581228038|FG005|Overall Study|Lost to Follow-up|0|||
160956525|NCT05585307|581228039|FG006|Overall Study|Lost to Follow-up|1|||
160956526|NCT05585307|581228040|FG007|Overall Study|Lost to Follow-up|0|||
160956527|NCT02085408|581228043|FG000|Step 1: Induction|Disease Progression|19|||
160956528|NCT02085408|581228044|FG001|Step 1: Induction|Disease Progression|19|||
160956529|NCT02085408|581228043|FG000|Step 1: Induction|Adverse Event|18|||
160956530|NCT02085408|581228044|FG001|Step 1: Induction|Adverse Event|17|||
160956531|NCT02085408|581228043|FG000|Step 1: Induction|Death|33|||
160956532|NCT02085408|581228044|FG001|Step 1: Induction|Death|30|||
160583156|NCT01111539|579855764|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
160583157|NCT01111539|579855765|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
160956533|NCT02085408|581228043|FG000|Step 1: Induction|Withdrawal by Subject|16|||
160956534|NCT02085408|581228044|FG001|Step 1: Induction|Withdrawal by Subject|8|||
160956535|NCT02085408|581228043|FG000|Step 1: Induction|Alternative Therapy|15|||
160956536|NCT02085408|581228044|FG001|Step 1: Induction|Alternative Therapy|19|||
160956537|NCT02085408|581228043|FG000|Step 1: Induction|Complicating Disease|2|||
160956538|NCT02085408|581228044|FG001|Step 1: Induction|Complicating Disease|3|||
160956539|NCT02085408|581228043|FG000|Step 1: Induction|Other|27|||
160956540|NCT02085408|581228044|FG001|Step 1: Induction|Other|39|||
160956541|NCT02085408|581228043|FG000|Step 1: Induction|Never started treatment|6|||
160956542|NCT02085408|581228044|FG001|Step 1: Induction|Never started treatment|4|||
160956543|NCT02085408|581228043|FG000|Step 2: Consolidation|Disease Progression|5|||
160956544|NCT02085408|581228044|FG001|Step 2: Consolidation|Disease Progression|20|||
160956545|NCT02085408|581228043|FG000|Step 2: Consolidation|Adverse Event|9|||
160956546|NCT02085408|581228044|FG001|Step 2: Consolidation|Adverse Event|8|||
160956547|NCT02085408|581228043|FG000|Step 2: Consolidation|Death|4|||
160956548|NCT02085408|581228044|FG001|Step 2: Consolidation|Death|3|||
160956549|NCT02085408|581228043|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
160956550|NCT02085408|581228044|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
160956551|NCT02085408|581228043|FG000|Step 2: Consolidation|Alternative Therapy|9|||
160956552|NCT02085408|581228044|FG001|Step 2: Consolidation|Alternative Therapy|3|||
160956553|NCT02085408|581228043|FG000|Step 2: Consolidation|Complicating Disease|0|||
160956554|NCT02085408|581228044|FG001|Step 2: Consolidation|Complicating Disease|2|||
160956555|NCT02085408|581228043|FG000|Step 2: Consolidation|Other|6|||
160956556|NCT02085408|581228044|FG001|Step 2: Consolidation|Other|6|||
160956557|NCT02085408|581228043|FG000|Step 2: Consolidation|Never started treatment|4|||
160583158|NCT01111539|579855766|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
160583159|NCT01111539|579855762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
160956558|NCT02085408|581228044|FG001|Step 2: Consolidation|Never started treatment|3|||
160956559|NCT02085408|581228043|FG000|Step 3: Maintenance|Disease Progression|13|||
160956560|NCT02085408|581228044|FG001|Step 3: Maintenance|Disease Progression|11|||
160956561|NCT02085408|581228043|FG000|Step 3: Maintenance|Adverse Event|2|||
160956562|NCT02085408|581228044|FG001|Step 3: Maintenance|Adverse Event|4|||
160457779|NCT04605159|579407941|FG003|Overall Study|Protocol Violation|0|||
160457780|NCT04605159|579407938|FG000|Overall Study|Withdrawal by Subject|66|||
160632858|NCT01215955|580036088|FG003|Overall Study|Quality Issues|2|||
160956563|NCT02085408|581228043|FG000|Step 3: Maintenance|Death|1|||
160956564|NCT02085408|581228044|FG001|Step 3: Maintenance|Death|2|||
160956565|NCT02085408|581228043|FG000|Step 3: Maintenance|Alternative Therapy|1|||
160956566|NCT02085408|581228044|FG001|Step 3: Maintenance|Alternative Therapy|1|||
160956567|NCT02085408|581228043|FG000|Step 3: Maintenance|Complicating Disease|0|||
160956568|NCT02085408|581228044|FG001|Step 3: Maintenance|Complicating Disease|1|||
160956569|NCT02085408|581228043|FG000|Step 3: Maintenance|Other|3|||
160956570|NCT02085408|581228044|FG001|Step 3: Maintenance|Other|2|||
161001315|NCT01194154|581390556|FG001|Overall Study|Lost to Follow-up|3|||
161001316|NCT01194154|581390555|FG000|Overall Study|Protocol Violation|0|||
160457781|NCT04605159|579407939|FG001|Overall Study|Withdrawal by Subject|37|||
160583160|NCT01111539|579855763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
160583161|NCT01111539|579855764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
160583162|NCT01111539|579855765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
160583163|NCT01111539|579855766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
160583164|NCT01111539|579855762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160583165|NCT01111539|579855763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160956571|NCT02085408|581228043|FG000|Step 3: Maintenance|Never started treatment|5|||
160956572|NCT02085408|581228044|FG001|Step 3: Maintenance|Never started treatment|1|||
160956573|NCT01474681|581228047|FG000|Overall Study|Death|0|||
160956574|NCT01474681|581228048|FG001|Overall Study|Death|3|||
160956575|NCT01474681|581228049|FG002|Overall Study|Death|2|||
160956576|NCT01474681|581228050|FG003|Overall Study|Death|6|||
160956577|NCT01483924|581228054|FG000|Overall Study|Withdrawal by Subject|2|||
160956578|NCT01483924|581228055|FG001|Overall Study|Withdrawal by Subject|0|||
160956579|NCT01483924|581228056|FG002|Overall Study|Withdrawal by Subject|0|||
160956580|NCT01483924|581228057|FG003|Overall Study|Withdrawal by Subject|1|||
160956581|NCT01483924|581228058|FG004|Overall Study|Withdrawal by Subject|1|||
160956582|NCT01483924|581228054|FG000|Overall Study|Adverse Event|0|||
160956583|NCT01483924|581228055|FG001|Overall Study|Adverse Event|0|||
160956584|NCT01483924|581228056|FG002|Overall Study|Adverse Event|1|||
160956585|NCT01483924|581228057|FG003|Overall Study|Adverse Event|1|||
160956586|NCT01483924|581228058|FG004|Overall Study|Adverse Event|0|||
160956587|NCT01483924|581228054|FG000|Overall Study|Non-compliance|0|||
160956588|NCT01483924|581228055|FG001|Overall Study|Non-compliance|0|||
160956589|NCT01483924|581228056|FG002|Overall Study|Non-compliance|0|||
160956590|NCT01483924|581228057|FG003|Overall Study|Non-compliance|1|||
160956591|NCT01483924|581228058|FG004|Overall Study|Non-compliance|1|||
160956592|NCT01483924|581228054|FG000|Overall Study|Sponsor concern over ECG result|0|||
160956593|NCT01483924|581228055|FG001|Overall Study|Sponsor concern over ECG result|0|||
160956594|NCT01483924|581228056|FG002|Overall Study|Sponsor concern over ECG result|0|||
160956595|NCT01483924|581228057|FG003|Overall Study|Sponsor concern over ECG result|1|||
160956596|NCT01483924|581228058|FG004|Overall Study|Sponsor concern over ECG result|0|||
160956597|NCT00003298|581228059|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
160956598|NCT00003298|581228059|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
160956599|NCT00003298|581228059|FG000|Surgery|Unresectable at surgery|3|||
160956600|NCT00003298|581228059|FG000|Surgery|Progression before surgery|2|||
160956601|NCT00003298|581228059|FG000|Surgery|Unevaluable and off study|2|||
160956602|NCT00003298|581228059|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
160956603|NCT00003298|581228059|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
160956604|NCT00003298|581228059|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
160956605|NCT00003298|581228059|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
160956606|NCT00003298|581228059|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
160956607|NCT00003298|581228059|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
160956608|NCT00003298|581228059|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
160956609|NCT00003298|581228059|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
160956610|NCT00003298|581228059|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
160956611|NCT00003298|581228059|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
160956612|NCT00335322|581228063|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
160956613|NCT00335322|581228064|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
160956614|NCT00335322|581228065|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
160956615|NCT02195986|581228066|FG000|Overall Study|Adverse Event|3|||
160956616|NCT02195986|581228067|FG001|Overall Study|Adverse Event|0|||
160956617|NCT02195986|581228068|FG002|Overall Study|Adverse Event|0|||
160956618|NCT02195986|581228066|FG000|Overall Study|Withdrawal by Subject|0|||
160956619|NCT02195986|581228067|FG001|Overall Study|Withdrawal by Subject|3|||
160956620|NCT02195986|581228068|FG002|Overall Study|Withdrawal by Subject|0|||
160956621|NCT02195986|581228066|FG000|Overall Study|Family Emergency|0|||
160956622|NCT02195986|581228067|FG001|Overall Study|Family Emergency|0|||
160956623|NCT02195986|581228068|FG002|Overall Study|Family Emergency|1|||
160457782|NCT04605159|579407940|FG002|Overall Study|Withdrawal by Subject|68|||
160583166|NCT01111539|579855764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
160583167|NCT01111539|579855765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160583168|NCT01111539|579855766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
160956624|NCT02195986|581228066|FG000|Overall Study|Protocol Violation|0|||
160956625|NCT02195986|581228067|FG001|Overall Study|Protocol Violation|1|||
160956626|NCT02195986|581228068|FG002|Overall Study|Protocol Violation|1|||
160956627|NCT02195986|581228066|FG000|Overall Study|Non-compliance|0|||
161001317|NCT01194154|581390556|FG001|Overall Study|Protocol Violation|1|||
160956628|NCT02195986|581228067|FG001|Overall Study|Non-compliance|1|||
160956629|NCT02195986|581228068|FG002|Overall Study|Non-compliance|0|||
160956630|NCT02834780|581228071|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
160956631|NCT02834780|581228072|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
160956632|NCT02834780|581228073|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
160956633|NCT02834780|581228074|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
160956634|NCT02834780|581228075|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
160956635|NCT02834780|581228076|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
160956636|NCT02834780|581228077|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
160956637|NCT02834780|581228078|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
160956638|NCT02834780|581228079|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
160956639|NCT02834780|581228080|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
160956640|NCT02834780|581228081|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
160956641|NCT02834780|581228082|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
161001318|NCT01194154|581390555|FG000|Overall Study|Withdrawal by Subject|5|||
161001319|NCT01194154|581390556|FG001|Overall Study|Withdrawal by Subject|6|||
161001320|NCT01194154|581390555|FG000|Overall Study|Blood pressure increase|5|||
161001321|NCT01194154|581390556|FG001|Overall Study|Blood pressure increase|3|||
161001322|NCT01194154|581390555|FG000|Overall Study|Hemoglobin decrease|0|||
161001323|NCT01194154|581390556|FG001|Overall Study|Hemoglobin decrease|1|||
161001324|NCT01194154|581390555|FG000|Overall Study|Hemoglobin increase|12|||
161001325|NCT01194154|581390556|FG001|Overall Study|Hemoglobin increase|3|||
161001326|NCT01194154|581390555|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
161001327|NCT01194154|581390556|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
161001328|NCT01194154|581390555|FG000|Overall Study|Treatment with prohibited medication|4|||
161001329|NCT01194154|581390556|FG001|Overall Study|Treatment with prohibited medication|5|||
161001330|NCT01194154|581390555|FG000|Overall Study|Other|4|||
161001331|NCT01194154|581390556|FG001|Overall Study|Other|0|||
161001332|NCT01194154|581390555|FG000|Overall Study|Did not receive study medication|2|||
161001333|NCT01194154|581390556|FG001|Overall Study|Did not receive study medication|4|||
161001334|NCT00842257|581390557|FG000|Overall Study|Adverse Event|1|||
161001335|NCT01901276|581390558|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
161001336|NCT01901276|581390559|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
161001337|NCT02314117|581390560|FG000|Overall Study|Lost to Follow-up|9|||
161001338|NCT02314117|581390561|FG001|Overall Study|Lost to Follow-up|14|||
161001339|NCT02314117|581390560|FG000|Overall Study|Withdrawal by Subject|3|||
161001340|NCT02314117|581390561|FG001|Overall Study|Withdrawal by Subject|2|||
161001341|NCT04347954|581390565|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
161001342|NCT04347954|581390566|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
161001343|NCT04347954|581390567|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
161001344|NCT04347954|581390565|FG000|Overall Study|Lost to Follow-up|0|||
161001345|NCT04347954|581390566|FG001|Overall Study|Lost to Follow-up|1|||
161001346|NCT04347954|581390567|FG002|Overall Study|Lost to Follow-up|0|||
161001347|NCT00909363|581390568|FG000|Overall Study|Withdrawal by Subject|1|||
161001348|NCT00909363|581390569|FG001|Overall Study|Withdrawal by Subject|0|||
161001349|NCT00909363|581390570|FG002|Overall Study|Withdrawal by Subject|0|||
161001350|NCT00909363|581390568|FG000|Overall Study|Lack of Efficacy|1|||
161001351|NCT00909363|581390569|FG001|Overall Study|Lack of Efficacy|0|||
161001352|NCT00909363|581390570|FG002|Overall Study|Lack of Efficacy|0|||
161001353|NCT05641311|581390571|FG000|Dosing Period 1|Adverse Event|1|||
161001354|NCT05641311|581390572|FG001|Dosing Period 1|Adverse Event|0|||
161001355|NCT03515304|581390579|FG000|Overall Study|Lost to Follow-up|0|||
161001356|NCT03515304|581390580|FG001|Overall Study|Lost to Follow-up|3|||
161001357|NCT02045836|581390583|FG000|Overall Study|Adverse Event|4|||
161001358|NCT02045836|581390584|FG001|Overall Study|Adverse Event|4|||
161001359|NCT02045836|581390583|FG000|Overall Study|Withdrawal by Subject|1|||
161001360|NCT02045836|581390584|FG001|Overall Study|Withdrawal by Subject|1|||
161001361|NCT02045836|581390583|FG000|Overall Study|Lost to Follow-up|4|||
161001362|NCT02045836|581390584|FG001|Overall Study|Lost to Follow-up|7|||
161001363|NCT02045836|581390583|FG000|Overall Study|Migrated from study area|0|||
161001364|NCT02045836|581390584|FG001|Overall Study|Migrated from study area|2|||
161001365|NCT00057837|581390585|FG000|Overall Study|Progression/relapse|12|||
160457783|NCT04605159|579407941|FG003|Overall Study|Withdrawal by Subject|50|||
160457784|NCT04605159|579407938|FG000|Overall Study|Migrated / moved from the study area|32|||
160457785|NCT04605159|579407939|FG001|Overall Study|Migrated / moved from the study area|22|||
160457786|NCT04605159|579407940|FG002|Overall Study|Migrated / moved from the study area|41|||
160457787|NCT04605159|579407941|FG003|Overall Study|Migrated / moved from the study area|21|||
160457788|NCT04605159|579407938|FG000|Overall Study|Other|1|||
160457789|NCT04605159|579407939|FG001|Overall Study|Other|2|||
161001366|NCT00057837|581390586|FG001|Overall Study|Progression/relapse|14|||
161001367|NCT00057837|581390585|FG000|Overall Study|Adverse Event|2|||
161001368|NCT00057837|581390586|FG001|Overall Study|Adverse Event|12|||
161001369|NCT00057837|581390585|FG000|Overall Study|Death|5|||
160457790|NCT04605159|579407940|FG002|Overall Study|Other|7|||
160457791|NCT04605159|579407941|FG003|Overall Study|Other|3|||
160457792|NCT02323880|579407942|FG000|Overall Study|Adverse Event|2|||
160956642|NCT02834780|581228083|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
161001370|NCT00057837|581390586|FG001|Overall Study|Death|4|||
161001371|NCT00057837|581390585|FG000|Overall Study|Withdrawal by Subject|5|||
160956643|NCT02834780|581228071|FG000|Overall Study|Withdrawal by Subject|0|||
160956644|NCT02834780|581228072|FG001|Overall Study|Withdrawal by Subject|0|||
160956645|NCT02834780|581228073|FG002|Overall Study|Withdrawal by Subject|1|||
160956646|NCT02834780|581228074|FG003|Overall Study|Withdrawal by Subject|0|||
160956647|NCT02834780|581228075|FG004|Overall Study|Withdrawal by Subject|0|||
160956648|NCT02834780|581228076|FG005|Overall Study|Withdrawal by Subject|0|||
160956649|NCT02834780|581228077|FG006|Overall Study|Withdrawal by Subject|0|||
160956650|NCT02834780|581228078|FG007|Overall Study|Withdrawal by Subject|0|||
160956651|NCT02834780|581228079|FG008|Overall Study|Withdrawal by Subject|0|||
160956652|NCT02834780|581228080|FG009|Overall Study|Withdrawal by Subject|0|||
160956653|NCT02834780|581228081|FG010|Overall Study|Withdrawal by Subject|1|||
160956654|NCT02834780|581228082|FG011|Overall Study|Withdrawal by Subject|0|||
160956655|NCT02834780|581228083|FG012|Overall Study|Withdrawal by Subject|0|||
160956656|NCT02834780|581228071|FG000|Overall Study|Adverse Event|0|||
160956657|NCT02834780|581228072|FG001|Overall Study|Adverse Event|0|||
160956658|NCT02834780|581228073|FG002|Overall Study|Adverse Event|0|||
160956659|NCT02834780|581228074|FG003|Overall Study|Adverse Event|0|||
160956660|NCT02834780|581228075|FG004|Overall Study|Adverse Event|1|||
160956661|NCT02834780|581228076|FG005|Overall Study|Adverse Event|0|||
160956662|NCT02834780|581228077|FG006|Overall Study|Adverse Event|1|||
160956663|NCT02834780|581228078|FG007|Overall Study|Adverse Event|1|||
160956664|NCT02834780|581228079|FG008|Overall Study|Adverse Event|0|||
160956665|NCT02834780|581228080|FG009|Overall Study|Adverse Event|2|||
160956666|NCT02834780|581228081|FG010|Overall Study|Adverse Event|0|||
160956667|NCT02834780|581228082|FG011|Overall Study|Adverse Event|3|||
160956668|NCT02834780|581228083|FG012|Overall Study|Adverse Event|2|||
160956669|NCT02834780|581228071|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956670|NCT02834780|581228072|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
160956671|NCT02834780|581228073|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
160956672|NCT02834780|581228074|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956673|NCT02834780|581228075|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956674|NCT02834780|581228076|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956675|NCT02834780|581228077|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956676|NCT02834780|581228078|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
160956677|NCT02834780|581228079|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
160956678|NCT02834780|581228080|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
160956679|NCT02834780|581228081|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956680|NCT02834780|581228082|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
160956681|NCT02834780|581228083|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
160956682|NCT02834780|581228071|FG000|Overall Study|Other|1|||
160956683|NCT02834780|581228072|FG001|Overall Study|Other|0|||
160956684|NCT02834780|581228073|FG002|Overall Study|Other|1|||
160956685|NCT02834780|581228074|FG003|Overall Study|Other|2|||
160956686|NCT02834780|581228075|FG004|Overall Study|Other|0|||
160956687|NCT02834780|581228076|FG005|Overall Study|Other|0|||
160956688|NCT02834780|581228077|FG006|Overall Study|Other|0|||
160956689|NCT02834780|581228078|FG007|Overall Study|Other|0|||
160956690|NCT02834780|581228079|FG008|Overall Study|Other|0|||
160956691|NCT02834780|581228080|FG009|Overall Study|Other|0|||
160956692|NCT02834780|581228081|FG010|Overall Study|Other|0|||
160956693|NCT02834780|581228082|FG011|Overall Study|Other|0|||
160956694|NCT02834780|581228083|FG012|Overall Study|Other|1|||
160956695|NCT03150056|581228084|FG000|Overall Study|Withdrawal by Subject|0|||
160956696|NCT03150056|581228085|FG001|Overall Study|Withdrawal by Subject|0|||
160956697|NCT03150056|581228086|FG002|Overall Study|Withdrawal by Subject|0|||
160956698|NCT03150056|581228087|FG003|Overall Study|Withdrawal by Subject|0|||
160956699|NCT03150056|581228088|FG004|Overall Study|Withdrawal by Subject|0|||
160956700|NCT03150056|581228089|FG005|Overall Study|Withdrawal by Subject|2|||
160956701|NCT03150056|581228084|FG000|Overall Study|Study terminated by Sponsor|1|||
160956702|NCT03150056|581228085|FG001|Overall Study|Study terminated by Sponsor|3|||
160956703|NCT03150056|581228086|FG002|Overall Study|Study terminated by Sponsor|1|||
160956704|NCT03150056|581228087|FG003|Overall Study|Study terminated by Sponsor|1|||
160956705|NCT03150056|581228088|FG004|Overall Study|Study terminated by Sponsor|5|||
160956706|NCT03150056|581228089|FG005|Overall Study|Study terminated by Sponsor|6|||
160956707|NCT03150056|581228084|FG000|Overall Study|Death|9|||
160956708|NCT03150056|581228085|FG001|Overall Study|Death|2|||
160956709|NCT03150056|581228086|FG002|Overall Study|Death|2|||
160956710|NCT03150056|581228087|FG003|Overall Study|Death|7|||
160956711|NCT03150056|581228088|FG004|Overall Study|Death|8|||
160956712|NCT03150056|581228089|FG005|Overall Study|Death|10|||
160956713|NCT02270450|581228094|FG000|Overall Study|Refusal unrelated to adverse event|3|||
160956714|NCT02270450|581228095|FG001|Overall Study|Refusal unrelated to adverse event|1|||
160956715|NCT02270450|581228096|FG002|Overall Study|Refusal unrelated to adverse event|5|||
160956716|NCT02270450|581228097|FG003|Overall Study|Refusal unrelated to adverse event|14|||
160956717|NCT02270450|581228094|FG000|Overall Study|Progression/relapse|1|||
160956718|NCT02270450|581228095|FG001|Overall Study|Progression/relapse|2|||
160956719|NCT02270450|581228096|FG002|Overall Study|Progression/relapse|4|||
160956720|NCT02270450|581228097|FG003|Overall Study|Progression/relapse|9|||
160956721|NCT02270450|581228094|FG000|Overall Study|Death|19|||
160956722|NCT02270450|581228095|FG001|Overall Study|Death|19|||
160956723|NCT02270450|581228096|FG002|Overall Study|Death|31|||
160956724|NCT02270450|581228097|FG003|Overall Study|Death|59|||
160956725|NCT02363738|581228098|FG000|Overall Study|Adverse Event|5|||
160956726|NCT02363738|581228099|FG001|Overall Study|Adverse Event|2|||
160956727|NCT02363738|581228098|FG000|Overall Study|Lack of Efficacy|1|||
160956728|NCT02363738|581228099|FG001|Overall Study|Lack of Efficacy|2|||
160956729|NCT02363738|581228098|FG000|Overall Study|Lost to Follow-up|2|||
160956730|NCT02363738|581228099|FG001|Overall Study|Lost to Follow-up|1|||
160956731|NCT01939028|581228106|FG000|Overall Study|Withdrawal by Subject|5|||
160956732|NCT01939028|581228106|FG000|Overall Study|Physician Decision|7|||
160956733|NCT03282227|581228107|FG000|Overall Study|Exposure Goals Achieved|60|||
160956734|NCT03282227|581228107|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
160956735|NCT03282227|581228107|FG000|Overall Study|Adverse Event|15|||
160956736|NCT03282227|581228107|FG000|Overall Study|Lost to Follow-up|21|||
160956737|NCT03282227|581228107|FG000|Overall Study|Withdrawal by Subject|20|||
160956738|NCT03282227|581228107|FG000|Overall Study|Lack of Efficacy|12|||
160956739|NCT03282227|581228107|FG000|Overall Study|Sponsor decision|3|||
160956740|NCT03282227|581228107|FG000|Overall Study|Physician Decision|2|||
160956741|NCT03282227|581228107|FG000|Overall Study|Pregnancy|2|||
160956742|NCT03282227|581228107|FG000|Overall Study|Other|1|||
160956743|NCT00700401|581228111|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
160956744|NCT00700401|581228111|FG000|Overall Study|Adverse Event|5|||
160956745|NCT00700401|581228111|FG000|Overall Study|Refused Treatment|2|||
160956746|NCT00700401|581228111|FG000|Overall Study|Lost to Follow-up|1|||
160956747|NCT00700401|581228111|FG000|Overall Study|Treatment never started|1|||
160956748|NCT00700401|581228111|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
160956749|NCT00700401|581228111|FG000|Overall Study|Withdrawal by Subject|2|||
160956750|NCT02491671|581228112|FG000|Overall Study|Adverse Event|6|||
160956751|NCT02491671|581228113|FG001|Overall Study|Adverse Event|8|||
160956752|NCT02491671|581228112|FG000|Overall Study|Death|0|||
160956753|NCT02491671|581228113|FG001|Overall Study|Death|2|||
160956754|NCT02491671|581228112|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
160956755|NCT02491671|581228113|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
160956756|NCT02251990|581228117|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
160956757|NCT02251990|581228118|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
160956758|NCT02251990|581228117|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
160956759|NCT02251990|581228118|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
160956760|NCT02251990|581228117|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
160956761|NCT02251990|581228118|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
160956762|NCT02251990|581228117|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
160956763|NCT02251990|581228118|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
160956764|NCT02251990|581228117|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
160956765|NCT02251990|581228118|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
160956766|NCT02251990|581228117|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
160956767|NCT02251990|581228118|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
160956768|NCT00322348|581228119|FG000|Overall Study|Adverse Event|0|||
160956769|NCT00322348|581228120|FG001|Overall Study|Adverse Event|1|||
160956770|NCT00322348|581228119|FG000|Overall Study|Withdrawal by Subject|1|||
160956771|NCT00322348|581228120|FG001|Overall Study|Withdrawal by Subject|4|||
160956772|NCT00322348|581228119|FG000|Overall Study|Lost to Follow-up|1|||
160956773|NCT00322348|581228120|FG001|Overall Study|Lost to Follow-up|0|||
160956774|NCT00322348|581228119|FG000|Overall Study|Death|0|||
161001372|NCT00057837|581390586|FG001|Overall Study|Withdrawal by Subject|3|||
161001373|NCT00057837|581390585|FG000|Overall Study|Alternative therapy|0|||
160457793|NCT02323880|579407943|FG001|Overall Study|Adverse Event|0|||
160457794|NCT02323880|579407944|FG002|Overall Study|Adverse Event|1|||
160457795|NCT02323880|579407945|FG003|Overall Study|Adverse Event|1|||
160457796|NCT02323880|579407946|FG004|Overall Study|Adverse Event|1|||
160583169|NCT01111539|579855762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
160956775|NCT00322348|581228120|FG001|Overall Study|Death|2|||
160956776|NCT00322348|581228119|FG000|Overall Study|Disease Progression|30|||
160956777|NCT00322348|581228120|FG001|Overall Study|Disease Progression|25|||
160956778|NCT00322348|581228119|FG000|Overall Study|Reasons not specified|5|||
160956779|NCT00322348|581228120|FG001|Overall Study|Reasons not specified|1|||
160956780|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
160956781|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
160956782|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
160956783|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
160956784|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
160956785|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
161001374|NCT00057837|581390586|FG001|Overall Study|Alternative therapy|1|||
160956786|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
160956787|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
161001375|NCT00057837|581390585|FG000|Overall Study|Other complicating disease|2|||
161001376|NCT00057837|581390586|FG001|Overall Study|Other complicating disease|1|||
161001377|NCT00057837|581390585|FG000|Overall Study|Physician Decision|1|||
161001378|NCT00057837|581390586|FG001|Overall Study|Physician Decision|0|||
161001379|NCT00057837|581390585|FG000|Overall Study|Ineligible|3|||
161001380|NCT00057837|581390586|FG001|Overall Study|Ineligible|3|||
161001381|NCT00057837|581390585|FG000|Overall Study|Never started treatment|1|||
161001382|NCT00057837|581390586|FG001|Overall Study|Never started treatment|1|||
161001383|NCT02000817|581390587|FG000|Overall Study|Withdrawal by Subject|2|||
161001384|NCT02000817|581390588|FG001|Overall Study|Withdrawal by Subject|0|||
161001385|NCT02000817|581390589|FG002|Overall Study|Withdrawal by Subject|0|||
161001386|NCT02000817|581390590|FG003|Overall Study|Withdrawal by Subject|0|||
161001387|NCT02000817|581390587|FG000|Overall Study|Adverse Event|0|||
161001388|NCT02000817|581390588|FG001|Overall Study|Adverse Event|1|||
161001389|NCT02000817|581390589|FG002|Overall Study|Adverse Event|0|||
161001390|NCT02000817|581390590|FG003|Overall Study|Adverse Event|0|||
161001391|NCT02000817|581390587|FG000|Overall Study|Lost to Follow-up|0|||
161001392|NCT02000817|581390588|FG001|Overall Study|Lost to Follow-up|0|||
161001393|NCT02000817|581390589|FG002|Overall Study|Lost to Follow-up|1|||
161001394|NCT02000817|581390590|FG003|Overall Study|Lost to Follow-up|0|||
161001395|NCT03383146|581390591|FG000|Overall Study|Screen Failure|1|||
161001396|NCT03383146|581390592|FG001|Overall Study|Screen Failure|0|||
161001397|NCT03383146|581390591|FG000|Overall Study|Adverse Event|6|||
161001398|NCT03383146|581390592|FG001|Overall Study|Adverse Event|18|||
161001399|NCT03383146|581390591|FG000|Overall Study|Lack of Efficacy|0|||
161001400|NCT03383146|581390592|FG001|Overall Study|Lack of Efficacy|3|||
161001401|NCT03383146|581390591|FG000|Overall Study|Withdrawal by Subject|20|||
161001402|NCT03383146|581390592|FG001|Overall Study|Withdrawal by Subject|36|||
161001403|NCT03383146|581390591|FG000|Overall Study|Lost to Follow-up|5|||
161001404|NCT03383146|581390592|FG001|Overall Study|Lost to Follow-up|15|||
161001405|NCT03383146|581390591|FG000|Overall Study|Death|0|||
161001406|NCT03383146|581390592|FG001|Overall Study|Death|2|||
161001407|NCT03383146|581390591|FG000|Overall Study|Physician Decision|0|||
161001408|NCT03383146|581390592|FG001|Overall Study|Physician Decision|1|||
161001409|NCT03383146|581390591|FG000|Overall Study|Protocol Deviation|1|||
161001410|NCT03383146|581390592|FG001|Overall Study|Protocol Deviation|8|||
161001411|NCT03383146|581390591|FG000|Overall Study|Study Terminated by the Sponsor|48|||
160457797|NCT02323880|579407947|FG005|Overall Study|Adverse Event|0|||
160457798|NCT02323880|579407948|FG006|Overall Study|Adverse Event|1|||
160457799|NCT02323880|579407949|FG007|Overall Study|Adverse Event|0|||
160457800|NCT02323880|579407942|FG000|Overall Study|Death|0|||
160457801|NCT02323880|579407943|FG001|Overall Study|Death|0|||
160457802|NCT02323880|579407944|FG002|Overall Study|Death|0|||
160457803|NCT02323880|579407945|FG003|Overall Study|Death|0|||
160457804|NCT02323880|579407946|FG004|Overall Study|Death|0|||
160457805|NCT02323880|579407947|FG005|Overall Study|Death|1|||
160457806|NCT02323880|579407948|FG006|Overall Study|Death|0|||
160956788|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
160956789|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
160956790|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
160956791|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
160956792|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
160956793|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
160956794|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
160956795|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160956796|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161001412|NCT03383146|581390592|FG001|Overall Study|Study Terminated by the Sponsor|95|||
160956797|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161001413|NCT03383146|581390591|FG000|Overall Study|Reason not Specified|4|||
161001414|NCT03383146|581390592|FG001|Overall Study|Reason not Specified|6|||
161001415|NCT01317420|581390593|FG000|Overall Study|Progressive disease according to RECIST|2|||
161001416|NCT01317420|581390594|FG001|Overall Study|Progressive disease according to RECIST|3|||
161001417|NCT01317420|581390595|FG002|Overall Study|Progressive disease according to RECIST|3|||
161001418|NCT01317420|581390596|FG003|Overall Study|Progressive disease according to RECIST|3|||
160457807|NCT02323880|579407949|FG007|Overall Study|Death|0|||
160457808|NCT02323880|579407942|FG000|Overall Study|Lack of Efficacy|4|||
160457809|NCT02323880|579407943|FG001|Overall Study|Lack of Efficacy|11|||
161001419|NCT01317420|581390597|FG004|Overall Study|Progressive disease according to RECIST|3|||
160457810|NCT02323880|579407944|FG002|Overall Study|Lack of Efficacy|5|||
160457811|NCT02323880|579407945|FG003|Overall Study|Lack of Efficacy|5|||
160457812|NCT02323880|579407946|FG004|Overall Study|Lack of Efficacy|4|||
160457813|NCT02323880|579407947|FG005|Overall Study|Lack of Efficacy|8|||
160457814|NCT02323880|579407948|FG006|Overall Study|Lack of Efficacy|4|||
160457815|NCT02323880|579407949|FG007|Overall Study|Lack of Efficacy|6|||
160457816|NCT02323880|579407942|FG000|Overall Study|Physician Decision|0|||
160457817|NCT02323880|579407943|FG001|Overall Study|Physician Decision|0|||
161001420|NCT01317420|581390598|FG005|Overall Study|Progressive disease according to RECIST|3|||
160457818|NCT02323880|579407944|FG002|Overall Study|Physician Decision|0|||
160956798|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160956799|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160956800|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
160956801|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
160956802|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
160956803|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
160956804|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
160956805|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
160956806|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
160956807|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
160956808|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
160956809|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
160956810|NCT03152552|581228122|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
160956811|NCT03152552|581228123|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
160956812|NCT03152552|581228124|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
160956813|NCT03152552|581228125|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
160956814|NCT03152552|581228126|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
160956815|NCT01857531|581228129|FG000|Overall Study|Withdrawal by Subject|4|||
160956816|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
160956817|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
160956818|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
160956819|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
160956820|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
160956821|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
160956822|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
160956823|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
160956824|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
160956825|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
160956826|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
160956827|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
160956828|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
160956829|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
160956830|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
160956831|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
160956832|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
160956833|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
160956834|NCT00355082|581228130|FG000|Continuation Phase|Adverse Event|2|||
160956835|NCT00355082|581228131|FG001|Continuation Phase|Adverse Event|0|||
160956836|NCT00355082|581228132|FG002|Continuation Phase|Adverse Event|1|||
160956837|NCT00355082|581228130|FG000|Continuation Phase|Lost to Follow-up|2|||
160956838|NCT00355082|581228131|FG001|Continuation Phase|Lost to Follow-up|0|||
160956839|NCT00355082|581228132|FG002|Continuation Phase|Lost to Follow-up|1|||
160956840|NCT00355082|581228130|FG000|Continuation Phase|Protocol Violation|1|||
160956841|NCT00355082|581228131|FG001|Continuation Phase|Protocol Violation|0|||
160956842|NCT00355082|581228132|FG002|Continuation Phase|Protocol Violation|1|||
160956843|NCT00355082|581228130|FG000|Continuation Phase|Withdrawal by Subject|4|||
160956844|NCT00355082|581228131|FG001|Continuation Phase|Withdrawal by Subject|0|||
160956845|NCT00355082|581228132|FG002|Continuation Phase|Withdrawal by Subject|0|||
160956846|NCT00355082|581228130|FG000|Continuation Phase|Lack of Efficacy|5|||
160956847|NCT00355082|581228131|FG001|Continuation Phase|Lack of Efficacy|0|||
160956848|NCT00355082|581228132|FG002|Continuation Phase|Lack of Efficacy|0|||
160956849|NCT00355082|581228130|FG000|Continuation Phase|Site Closed by Sponsor|8|||
160956850|NCT00355082|581228131|FG001|Continuation Phase|Site Closed by Sponsor|0|||
160956851|NCT00355082|581228132|FG002|Continuation Phase|Site Closed by Sponsor|0|||
160956852|NCT00355082|581228130|FG000|Continuation Phase|Scheduling Error|1|||
160956853|NCT00355082|581228131|FG001|Continuation Phase|Scheduling Error|0|||
160956854|NCT00355082|581228132|FG002|Continuation Phase|Scheduling Error|0|||
160956855|NCT00355082|581228130|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
160956856|NCT00355082|581228131|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
160956857|NCT00355082|581228132|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
160956858|NCT00622167|581228133|FG000|Overall Study|Did not meet angiographic criteria|20|||
160956859|NCT03738150|581228142|FG000|Base Study|Withdrawal by Subject|1|||
160956860|NCT03738150|581228142|FG000|Extension Study|Withdrawal by Subject|1|||
160956861|NCT04598152|581228145|FG000|Overall Study|Lost to Follow-up|0|||
160956862|NCT04598152|581228146|FG001|Overall Study|Lost to Follow-up|1|||
160956863|NCT03346759|581228147|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
160956864|NCT03346759|581228148|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
160956865|NCT03346759|581228147|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
160956866|NCT03346759|581228148|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
160457819|NCT02323880|579407945|FG003|Overall Study|Physician Decision|0|||
160956867|NCT03346759|581228147|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
160956868|NCT03346759|581228148|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
160956869|NCT03943095|581228149|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
160956870|NCT03943095|581228150|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
160956871|NCT03943095|581228149|FG000|Overall Study|Withdrawal by Subject|1|||
160956872|NCT03943095|581228150|FG001|Overall Study|Withdrawal by Subject|0|||
160956873|NCT04988308|581228151|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
160956874|NCT04988308|581228152|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
160956875|NCT04988308|581228153|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
160956876|NCT04988308|581228154|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160956877|NCT04988308|581228155|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160956878|NCT04988308|581228156|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160956879|NCT04988308|581228151|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
160956880|NCT04988308|581228152|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
160956881|NCT04988308|581228153|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
160956882|NCT04988308|581228154|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
160956883|NCT04988308|581228155|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
160956884|NCT04988308|581228156|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
160956885|NCT04988308|581228151|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
160956886|NCT04988308|581228152|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
160956887|NCT04988308|581228153|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
160956888|NCT04988308|581228154|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
160956889|NCT04988308|581228155|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
160956890|NCT04988308|581228156|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
160956891|NCT04988308|581228151|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
160956892|NCT04988308|581228152|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
160956893|NCT04988308|581228153|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
160956894|NCT04988308|581228154|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160956895|NCT04988308|581228155|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160956896|NCT04988308|581228156|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160956897|NCT04988308|581228151|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
160956898|NCT04988308|581228152|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
160956899|NCT04988308|581228153|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
160956900|NCT04988308|581228154|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
160956901|NCT04988308|581228155|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
160956902|NCT04988308|581228156|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
160956903|NCT04988308|581228151|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160956904|NCT04988308|581228152|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160956905|NCT04988308|581228153|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160956906|NCT04988308|581228154|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
160956907|NCT04988308|581228155|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
160956908|NCT04988308|581228156|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
160956909|NCT04988308|581228151|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160956910|NCT04988308|581228152|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160956911|NCT04988308|581228153|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160956912|NCT04988308|581228154|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
160956913|NCT04988308|581228155|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
160956914|NCT04988308|581228156|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
160956915|NCT04988308|581228151|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160956916|NCT04988308|581228152|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160956917|NCT04988308|581228153|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160956918|NCT04988308|581228154|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
160956919|NCT04988308|581228155|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
160956920|NCT04988308|581228156|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
160956921|NCT04988308|581228151|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
160956922|NCT04988308|581228152|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
160956923|NCT04988308|581228153|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
160956924|NCT04988308|581228154|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
160956925|NCT04988308|581228155|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
160956926|NCT04988308|581228156|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
160956927|NCT04177758|581228166|FG000|Overall Study|Lost to Follow-up|19|||
160956928|NCT04177758|581228167|FG001|Overall Study|Lost to Follow-up|11|||
160656959|NCT05097989|580124501|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
160656960|NCT05097989|580124502|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
160656961|NCT05097989|580124503|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
160956929|NCT02763384|581228168|FG000|Overall Study|Physician Decision|1|||
160956930|NCT02763384|581228168|FG000|Overall Study|Rapid decline - went on hospice|1|||
160956931|NCT02057874|581230284|FG000|Overall Study|participant did not return for scan|1|||
160956932|NCT01738984|581230287|FG000|Overall Study|Pregnancy|4|||
160956933|NCT01738984|581230288|FG001|Overall Study|Pregnancy|0|||
160956934|NCT01738984|581230287|FG000|Overall Study|Withdrawal by Subject|1|||
160956935|NCT01738984|581230288|FG001|Overall Study|Withdrawal by Subject|0|||
160956936|NCT01738984|581230287|FG000|Overall Study|Lost to Follow-up|59|||
160956937|NCT01738984|581230288|FG001|Overall Study|Lost to Follow-up|39|||
160956938|NCT02621931|581230293|FG000|Overall Study|Death|0|||
160956939|NCT02621931|581230294|FG001|Overall Study|Death|1|||
160956940|NCT02621931|581230295|FG002|Overall Study|Death|0|||
160956941|NCT02621931|581230293|FG000|Overall Study|Adverse Event|8|||
160956942|NCT02621931|581230294|FG001|Overall Study|Adverse Event|5|||
160956943|NCT02621931|581230295|FG002|Overall Study|Adverse Event|7|||
160956944|NCT02621931|581230293|FG000|Overall Study|Withdrawal by Subject|12|||
160956945|NCT02621931|581230294|FG001|Overall Study|Withdrawal by Subject|10|||
160956946|NCT02621931|581230295|FG002|Overall Study|Withdrawal by Subject|11|||
160956947|NCT02621931|581230293|FG000|Overall Study|Protocol Violation|2|||
160956948|NCT02621931|581230294|FG001|Overall Study|Protocol Violation|2|||
160956949|NCT02621931|581230295|FG002|Overall Study|Protocol Violation|2|||
160956950|NCT02621931|581230293|FG000|Overall Study|Pregnancy|2|||
160956951|NCT02621931|581230294|FG001|Overall Study|Pregnancy|0|||
160956952|NCT02621931|581230295|FG002|Overall Study|Pregnancy|0|||
160956953|NCT02621931|581230293|FG000|Overall Study|Noncompliance to study procedures|0|||
160956954|NCT02621931|581230294|FG001|Overall Study|Noncompliance to study procedures|1|||
160956955|NCT02621931|581230295|FG002|Overall Study|Noncompliance to study procedures|2|||
160956956|NCT02621931|581230293|FG000|Overall Study|Lost to Follow-up|8|||
160956957|NCT02621931|581230294|FG001|Overall Study|Lost to Follow-up|7|||
160956958|NCT02621931|581230295|FG002|Overall Study|Lost to Follow-up|10|||
160956959|NCT02621931|581230293|FG000|Overall Study|Lack of Efficacy|0|||
160956960|NCT02621931|581230294|FG001|Overall Study|Lack of Efficacy|0|||
160956961|NCT02621931|581230295|FG002|Overall Study|Lack of Efficacy|1|||
160956962|NCT02621931|581230293|FG000|Overall Study|Other|1|||
160956963|NCT02621931|581230294|FG001|Overall Study|Other|1|||
160956964|NCT02621931|581230295|FG002|Overall Study|Other|3|||
160956965|NCT00920426|581230296|FG000|ITZ111451|Adverse Event|1|||
160956966|NCT00920426|581230297|FG001|ITZ111451|Adverse Event|0|||
160956967|NCT00920426|581230298|FG002|ITZ111451|Adverse Event|0|||
160956968|NCT00920426|581230299|FG003|ITZ111451|Adverse Event|0|||
160956969|NCT00886340|581230301|FG000|Overall Study|Withdrawal by Subject|0|||
160956970|NCT00886340|581230302|FG001|Overall Study|Withdrawal by Subject|7|||
160956971|NCT02985866|581230303|FG000|Overall Study|Poor CGM data|1|||
160956972|NCT02985866|581230304|FG001|Overall Study|Poor CGM data|1|||
160956973|NCT02925455|581230308|FG000|Overall Study|Withdrawal by Subject|2|||
160956974|NCT02925455|581230309|FG001|Overall Study|Withdrawal by Subject|0|||
160956975|NCT00985725|581230313|FG000|Overall Study|Adverse Event|4|||
160956976|NCT00985725|581230314|FG001|Overall Study|Adverse Event|1|||
160956977|NCT00985725|581230313|FG000|Overall Study|Protocol Violation|1|||
160956978|NCT00985725|581230314|FG001|Overall Study|Protocol Violation|3|||
160956979|NCT00985725|581230313|FG000|Overall Study|Withdrawal by Subject|4|||
160956980|NCT00985725|581230314|FG001|Overall Study|Withdrawal by Subject|4|||
160956981|NCT00985725|581230313|FG000|Overall Study|Lost to Follow-up|1|||
160956982|NCT00985725|581230314|FG001|Overall Study|Lost to Follow-up|1|||
160956983|NCT00985725|581230313|FG000|Overall Study|Lack of Efficacy|0|||
160956984|NCT00985725|581230314|FG001|Overall Study|Lack of Efficacy|1|||
160956985|NCT00985725|581230313|FG000|Overall Study|Non-compliance|1|||
160956986|NCT00985725|581230314|FG001|Overall Study|Non-compliance|2|||
160956987|NCT00985725|581230313|FG000|Overall Study|Out-of-window visits|0|||
160956988|NCT00985725|581230314|FG001|Overall Study|Out-of-window visits|1|||
160956989|NCT03151005|581230318|FG000|Overall Study|Lost to Follow-up|5|||
160956990|NCT03151005|581230319|FG001|Overall Study|Lost to Follow-up|5|||
160956991|NCT01549613|581230320|FG000|Overall Study|Lost to Follow-up|11|||
160956992|NCT01549613|581230321|FG001|Overall Study|Lost to Follow-up|11|||
160457820|NCT02323880|579407946|FG004|Overall Study|Physician Decision|1|||
160457821|NCT02323880|579407947|FG005|Overall Study|Physician Decision|1|||
160956993|NCT02131272|581230322|FG000|Overall Study|Withdrawal by parent|0|||
160956994|NCT02131272|581230323|FG001|Overall Study|Withdrawal by parent|1|||
160956995|NCT02131272|581230322|FG000|Overall Study|Withdrawal by Subject|0|||
160956996|NCT02131272|581230323|FG001|Overall Study|Withdrawal by Subject|1|||
160956997|NCT02131272|581230322|FG000|Overall Study|Withdrawal Criteria|1|||
160956998|NCT02131272|581230323|FG001|Overall Study|Withdrawal Criteria|0|||
160956999|NCT00381940|581230324|FG000|Overall Study|Lack of Efficacy|3|||
160957000|NCT00381940|581230324|FG000|Overall Study|Protocol Violation|1|||
160957001|NCT00381940|581230324|FG000|Overall Study|Ineligible|1|||
160957002|NCT00464815|581230325|FG000|Overall Study|Withdrawal by Subject|6|||
160957003|NCT00464815|581230326|FG001|Overall Study|Withdrawal by Subject|3|||
160957004|NCT00515502|581230334|FG000|Treatment Period 1|Adverse Event|0|||
160957005|NCT00515502|581230335|FG001|Treatment Period 1|Adverse Event|0|||
160957006|NCT00515502|581230336|FG002|Treatment Period 1|Adverse Event|0|||
160957007|NCT00515502|581230337|FG003|Treatment Period 1|Adverse Event|0|||
160957008|NCT00515502|581230338|FG004|Treatment Period 1|Adverse Event|0|||
160957009|NCT00515502|581230339|FG005|Treatment Period 1|Adverse Event|0|||
160957010|NCT00515502|581230340|FG006|Treatment Period 1|Adverse Event|1|||
160957011|NCT00515502|581230341|FG007|Treatment Period 1|Adverse Event|0|||
160957012|NCT00515502|581230342|FG008|Treatment Period 1|Adverse Event|1|||
160957013|NCT00515502|581230343|FG009|Treatment Period 1|Adverse Event|0|||
160957014|NCT00515502|581230344|FG010|Treatment Period 1|Adverse Event|0|||
160957015|NCT00515502|581230345|FG011|Treatment Period 1|Adverse Event|1|||
160957016|NCT00515502|581230334|FG000|Treatment Period 2|Adverse Event|0|||
160957017|NCT00515502|581230335|FG001|Treatment Period 2|Adverse Event|1|||
160957018|NCT00515502|581230336|FG002|Treatment Period 2|Adverse Event|0|||
160957019|NCT00515502|581230337|FG003|Treatment Period 2|Adverse Event|0|||
160957020|NCT00515502|581230338|FG004|Treatment Period 2|Adverse Event|0|||
160957021|NCT00515502|581230339|FG005|Treatment Period 2|Adverse Event|0|||
160957022|NCT00515502|581230340|FG006|Treatment Period 2|Adverse Event|0|||
160957023|NCT00515502|581230341|FG007|Treatment Period 2|Adverse Event|0|||
160957024|NCT00515502|581230342|FG008|Treatment Period 2|Adverse Event|0|||
160957025|NCT00515502|581230343|FG009|Treatment Period 2|Adverse Event|0|||
160957026|NCT00515502|581230344|FG010|Treatment Period 2|Adverse Event|0|||
160957027|NCT00515502|581230345|FG011|Treatment Period 2|Adverse Event|0|||
160957028|NCT03252587|581230346|FG000|Overall Study|Adverse Event|3|||
160957029|NCT03252587|581230347|FG001|Overall Study|Adverse Event|8|||
160957030|NCT03252587|581230348|FG002|Overall Study|Adverse Event|6|||
160957031|NCT03252587|581230349|FG003|Overall Study|Adverse Event|12|||
160957032|NCT03252587|581230346|FG000|Overall Study|Lack of Efficacy|7|||
160957033|NCT03252587|581230347|FG001|Overall Study|Lack of Efficacy|2|||
160957034|NCT03252587|581230348|FG002|Overall Study|Lack of Efficacy|2|||
160957035|NCT03252587|581230349|FG003|Overall Study|Lack of Efficacy|4|||
160957036|NCT03252587|581230346|FG000|Overall Study|Lost to Follow-up|2|||
160957037|NCT03252587|581230347|FG001|Overall Study|Lost to Follow-up|0|||
160957038|NCT03252587|581230348|FG002|Overall Study|Lost to Follow-up|0|||
160957039|NCT03252587|581230349|FG003|Overall Study|Lost to Follow-up|2|||
160957040|NCT03252587|581230346|FG000|Overall Study|Pregnancy|2|||
160957041|NCT03252587|581230347|FG001|Overall Study|Pregnancy|1|||
160957042|NCT03252587|581230348|FG002|Overall Study|Pregnancy|0|||
160957043|NCT03252587|581230349|FG003|Overall Study|Pregnancy|1|||
160957044|NCT03252587|581230346|FG000|Overall Study|Withdrawal by Subject|8|||
160957045|NCT03252587|581230347|FG001|Overall Study|Withdrawal by Subject|4|||
160957046|NCT03252587|581230348|FG002|Overall Study|Withdrawal by Subject|4|||
160957047|NCT03252587|581230349|FG003|Overall Study|Withdrawal by Subject|4|||
160957048|NCT03252587|581230346|FG000|Overall Study|Other Reasons|2|||
160957049|NCT03252587|581230347|FG001|Overall Study|Other Reasons|5|||
160957050|NCT03252587|581230348|FG002|Overall Study|Other Reasons|5|||
160957051|NCT03252587|581230349|FG003|Overall Study|Other Reasons|4|||
160957052|NCT04052204|581230350|FG000|Overall Study|Death|1|||
160957053|NCT04052204|581230351|FG001|Overall Study|Death|0|||
160957054|NCT04052204|581230352|FG002|Overall Study|Death|0|||
160957055|NCT04052204|581230350|FG000|Overall Study|Progressive disease|1|||
160957056|NCT04052204|581230351|FG001|Overall Study|Progressive disease|0|||
160957057|NCT04052204|581230352|FG002|Overall Study|Progressive disease|0|||
160957058|NCT04052204|581230350|FG000|Overall Study|Other|1|||
160957059|NCT04052204|581230351|FG001|Overall Study|Other|0|||
160957060|NCT04052204|581230352|FG002|Overall Study|Other|0|||
160957061|NCT03647501|581230353|FG000|Overall Study|Lost to Follow-up|1|||
160957062|NCT03647501|581230354|FG001|Overall Study|Lost to Follow-up|1|||
160957063|NCT03647501|581230353|FG000|Overall Study|Withdrawal by Subject|0|||
160957064|NCT03647501|581230354|FG001|Overall Study|Withdrawal by Subject|1|||
160957065|NCT03945188|581230355|FG000|Overall Study|Protocol Violation|1|||
161001421|NCT01317420|581390599|FG006|Overall Study|Progressive disease according to RECIST|3|||
161001422|NCT01317420|581390600|FG007|Overall Study|Progressive disease according to RECIST|3|||
161001423|NCT01317420|581390601|FG008|Overall Study|Progressive disease according to RECIST|3|||
161001424|NCT01317420|581390602|FG009|Overall Study|Progressive disease according to RECIST|2|||
161001425|NCT01317420|581390603|FG010|Overall Study|Progressive disease according to RECIST|3|||
160583170|NCT01111539|579855763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
160957066|NCT03945188|581230356|FG001|Overall Study|Protocol Violation|0|||
160957067|NCT03945188|581230355|FG000|Overall Study|Disease worsening|79|||
160957068|NCT03945188|581230356|FG001|Overall Study|Disease worsening|73|||
160957069|NCT03945188|581230355|FG000|Overall Study|Physician Decision|2|||
160957070|NCT03945188|581230356|FG001|Overall Study|Physician Decision|2|||
160957071|NCT03945188|581230355|FG000|Overall Study|Lack of Efficacy|7|||
160957072|NCT03945188|581230356|FG001|Overall Study|Lack of Efficacy|4|||
160957073|NCT03945188|581230355|FG000|Overall Study|Pregnancy|2|||
160957074|NCT03945188|581230356|FG001|Overall Study|Pregnancy|0|||
160957075|NCT03945188|581230355|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
160957076|NCT03945188|581230356|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
160957077|NCT03945188|581230355|FG000|Overall Study|Adverse Event|10|||
160957078|NCT03945188|581230356|FG001|Overall Study|Adverse Event|5|||
160957079|NCT03945188|581230355|FG000|Overall Study|Other|2|||
160957080|NCT03945188|581230356|FG001|Overall Study|Other|2|||
160957081|NCT03945188|581230355|FG000|Overall Study|Lost to Follow-up|1|||
160957082|NCT03945188|581230356|FG001|Overall Study|Lost to Follow-up|2|||
160957083|NCT01613248|581230357|FG000|Overall Study|Adverse Event|0|||
160957084|NCT01613248|581230358|FG001|Overall Study|Adverse Event|0|||
160957085|NCT01613248|581230359|FG002|Overall Study|Adverse Event|0|||
160957086|NCT01613248|581230360|FG003|Overall Study|Adverse Event|1|||
160957087|NCT01613248|581230361|FG004|Overall Study|Adverse Event|0|||
160957088|NCT01613248|581230362|FG005|Overall Study|Adverse Event|0|||
160957089|NCT01613248|581230357|FG000|Overall Study|Withdrawal by Subject|3|||
160957090|NCT01613248|581230358|FG001|Overall Study|Withdrawal by Subject|2|||
160957091|NCT01613248|581230359|FG002|Overall Study|Withdrawal by Subject|2|||
160957092|NCT01613248|581230360|FG003|Overall Study|Withdrawal by Subject|5|||
160957093|NCT01613248|581230361|FG004|Overall Study|Withdrawal by Subject|0|||
160957094|NCT01613248|581230362|FG005|Overall Study|Withdrawal by Subject|1|||
160957095|NCT01613248|581230357|FG000|Overall Study|Lost to Follow-up|5|||
160957096|NCT01613248|581230358|FG001|Overall Study|Lost to Follow-up|7|||
160957097|NCT01613248|581230359|FG002|Overall Study|Lost to Follow-up|4|||
160957098|NCT01613248|581230360|FG003|Overall Study|Lost to Follow-up|8|||
160957099|NCT01613248|581230361|FG004|Overall Study|Lost to Follow-up|4|||
160957100|NCT01613248|581230362|FG005|Overall Study|Lost to Follow-up|2|||
160957101|NCT01613248|581230357|FG000|Overall Study|Study Terminated by Sponsor|4|||
160957102|NCT01613248|581230358|FG001|Overall Study|Study Terminated by Sponsor|6|||
160957103|NCT01613248|581230359|FG002|Overall Study|Study Terminated by Sponsor|8|||
160957104|NCT01613248|581230360|FG003|Overall Study|Study Terminated by Sponsor|8|||
160957105|NCT01613248|581230361|FG004|Overall Study|Study Terminated by Sponsor|9|||
160957106|NCT01613248|581230362|FG005|Overall Study|Study Terminated by Sponsor|11|||
160957107|NCT01613248|581230357|FG000|Overall Study|Physician Decision|8|||
160957108|NCT01613248|581230358|FG001|Overall Study|Physician Decision|8|||
160957109|NCT01613248|581230359|FG002|Overall Study|Physician Decision|9|||
160957110|NCT01613248|581230360|FG003|Overall Study|Physician Decision|4|||
160957111|NCT01613248|581230361|FG004|Overall Study|Physician Decision|7|||
160957112|NCT01613248|581230362|FG005|Overall Study|Physician Decision|6|||
160957113|NCT01613248|581230357|FG000|Overall Study|Lack of Qualifying Event|9|||
160957114|NCT01613248|581230358|FG001|Overall Study|Lack of Qualifying Event|11|||
160957115|NCT01613248|581230359|FG002|Overall Study|Lack of Qualifying Event|10|||
160957116|NCT01613248|581230360|FG003|Overall Study|Lack of Qualifying Event|11|||
160957117|NCT01613248|581230361|FG004|Overall Study|Lack of Qualifying Event|15|||
160957118|NCT01613248|581230362|FG005|Overall Study|Lack of Qualifying Event|18|||
160957119|NCT01613248|581230357|FG000|Overall Study|Pregnancy|0|||
160957120|NCT01613248|581230358|FG001|Overall Study|Pregnancy|0|||
160957121|NCT01613248|581230359|FG002|Overall Study|Pregnancy|0|||
160957122|NCT01613248|581230360|FG003|Overall Study|Pregnancy|1|||
160957123|NCT01613248|581230361|FG004|Overall Study|Pregnancy|0|||
160957124|NCT01613248|581230362|FG005|Overall Study|Pregnancy|0|||
160957125|NCT01433354|581230364|FG000|Overall Study|Adverse Event|6|||
160957126|NCT01433354|581230364|FG000|Overall Study|Lost to Follow-up|1|||
160957127|NCT01433354|581230364|FG000|Overall Study|Administrative problems|90|||
160957128|NCT01433354|581230364|FG000|Overall Study|Protocol Violation|2|||
160957129|NCT01433354|581230364|FG000|Overall Study|Lack of Efficacy|17|||
160957130|NCT01433354|581230364|FG000|Overall Study|Subject Withdrew Consent|3|||
160957131|NCT03321396|581230373|FG000|Overall Study|Physician Decision|1|||
160957132|NCT04391023|581230376|FG000|Overall Study|Withdrawal by Subject|2|||
160957133|NCT04391023|581230377|FG001|Overall Study|Withdrawal by Subject|2|||
160957134|NCT01270347|581230379|FG000|Core Phase|Adverse Event|1|||
160957135|NCT01270347|581230380|FG001|Core Phase|Adverse Event|6|||
160957136|NCT01270347|581230379|FG000|Core Phase|Withdrawal by Subject|1|||
160957137|NCT01270347|581230380|FG001|Core Phase|Withdrawal by Subject|2|||
160957138|NCT01270347|581230379|FG000|Core Phase|Lost to Follow-up|0|||
160957139|NCT01270347|581230380|FG001|Core Phase|Lost to Follow-up|1|||
160957140|NCT01270347|581230379|FG000|Core Phase|Miscellaneous|8|||
160957141|NCT01270347|581230380|FG001|Core Phase|Miscellaneous|14|||
160957142|NCT01270347|581230379|FG000|Extension Phase|Adverse Event|1|||
160957143|NCT01270347|581230380|FG001|Extension Phase|Adverse Event|3|||
160957144|NCT01270347|581230379|FG000|Extension Phase|Withdrawal by Subject|3|||
160957145|NCT01270347|581230380|FG001|Extension Phase|Withdrawal by Subject|4|||
160957146|NCT01270347|581230379|FG000|Extension Phase|Miscellaneous|2|||
161001426|NCT01317420|581390604|FG011|Overall Study|Progressive disease according to RECIST|11|||
161001427|NCT01317420|581390605|FG012|Overall Study|Progressive disease according to RECIST|16|||
160957147|NCT01270347|581230380|FG001|Extension Phase|Miscellaneous|2|||
160957148|NCT00492284|581230381|FG000|Overall Study|Adverse Event|0|||
160957149|NCT00492284|581230382|FG001|Overall Study|Adverse Event|1|||
160957150|NCT00492284|581230383|FG002|Overall Study|Adverse Event|1|||
160957151|NCT00492284|581230384|FG003|Overall Study|Adverse Event|2|||
160957152|NCT00492284|581230381|FG000|Overall Study|Lost to Follow-up|0|||
160957153|NCT00492284|581230382|FG001|Overall Study|Lost to Follow-up|0|||
160957154|NCT00492284|581230383|FG002|Overall Study|Lost to Follow-up|3|||
160957155|NCT00492284|581230384|FG003|Overall Study|Lost to Follow-up|1|||
160957156|NCT00492284|581230381|FG000|Overall Study|Death|0|||
160957157|NCT00492284|581230382|FG001|Overall Study|Death|3|||
160957158|NCT00492284|581230383|FG002|Overall Study|Death|2|||
160957159|NCT00492284|581230384|FG003|Overall Study|Death|5|||
160957160|NCT00492284|581230381|FG000|Overall Study|Withdrawal by Subject|1|||
160957161|NCT00492284|581230382|FG001|Overall Study|Withdrawal by Subject|0|||
160957162|NCT00492284|581230383|FG002|Overall Study|Withdrawal by Subject|0|||
160957163|NCT00492284|581230384|FG003|Overall Study|Withdrawal by Subject|2|||
160957164|NCT02576678|581230387|FG000|Overall Study|Adverse Event|0|||
160957165|NCT02576678|581230388|FG001|Overall Study|Adverse Event|0|||
160957166|NCT02576678|581230389|FG002|Overall Study|Adverse Event|2|||
160957167|NCT02576678|581230387|FG000|Overall Study|Withdrawal by Subject|3|||
160957168|NCT02576678|581230388|FG001|Overall Study|Withdrawal by Subject|1|||
160957169|NCT02576678|581230389|FG002|Overall Study|Withdrawal by Subject|2|||
160957170|NCT02576678|581230387|FG000|Overall Study|Lost to Follow-up|0|||
160957171|NCT02576678|581230388|FG001|Overall Study|Lost to Follow-up|0|||
160957172|NCT02576678|581230389|FG002|Overall Study|Lost to Follow-up|1|||
160957173|NCT02576678|581230387|FG000|Overall Study|Miscellaneous|2|||
160957174|NCT02576678|581230388|FG001|Overall Study|Miscellaneous|0|||
160957175|NCT02576678|581230389|FG002|Overall Study|Miscellaneous|0|||
160957176|NCT02293538|581230397|FG000|Overall Study|Adverse Event|0|||
160957177|NCT02293538|581230398|FG001|Overall Study|Adverse Event|1|||
160957178|NCT02293538|581230397|FG000|Overall Study|Lost to Follow-up|1|||
160957179|NCT02293538|581230398|FG001|Overall Study|Lost to Follow-up|0|||
160957180|NCT02293538|581230397|FG000|Overall Study|Withdrawal by Subject|0|||
160957181|NCT02293538|581230398|FG001|Overall Study|Withdrawal by Subject|1|||
160957182|NCT01041638|581230399|FG000|Overall Study|Adverse Event|4|||
160957183|NCT01041638|581230399|FG000|Overall Study|Death|1|||
160957184|NCT01041638|581230399|FG000|Overall Study|Lack of Efficacy|7|||
160957185|NCT01041638|581230399|FG000|Overall Study|Physician Decision|4|||
160957186|NCT01041638|581230399|FG000|Overall Study|Withdrawal by Subject|11|||
160957187|NCT01922076|581230401|FG000|Overall Study|Adverse Event|0|||
160957188|NCT01922076|581230402|FG001|Overall Study|Adverse Event|0|||
160957189|NCT01922076|581230403|FG002|Overall Study|Adverse Event|0|||
160957190|NCT01922076|581230404|FG003|Overall Study|Adverse Event|0|||
160957191|NCT01922076|581230405|FG004|Overall Study|Adverse Event|1|||
160957192|NCT01922076|581230406|FG005|Overall Study|Adverse Event|0|||
160957193|NCT01922076|581230407|FG006|Overall Study|Adverse Event|0|||
160957194|NCT01922076|581230401|FG000|Overall Study|Physician Decision|0|||
160957195|NCT01922076|581230402|FG001|Overall Study|Physician Decision|0|||
160957196|NCT01922076|581230403|FG002|Overall Study|Physician Decision|1|||
160957197|NCT01922076|581230404|FG003|Overall Study|Physician Decision|0|||
160957198|NCT01922076|581230405|FG004|Overall Study|Physician Decision|0|||
160957199|NCT01922076|581230406|FG005|Overall Study|Physician Decision|0|||
160957200|NCT01922076|581230407|FG006|Overall Study|Physician Decision|0|||
160957201|NCT01922076|581230401|FG000|Overall Study|Withdrawal by Subject|0|||
160957202|NCT01922076|581230402|FG001|Overall Study|Withdrawal by Subject|0|||
160957203|NCT01922076|581230403|FG002|Overall Study|Withdrawal by Subject|0|||
160957204|NCT01922076|581230404|FG003|Overall Study|Withdrawal by Subject|1|||
160957205|NCT01922076|581230405|FG004|Overall Study|Withdrawal by Subject|0|||
160957206|NCT01922076|581230406|FG005|Overall Study|Withdrawal by Subject|1|||
160957207|NCT01922076|581230407|FG006|Overall Study|Withdrawal by Subject|1|||
160957208|NCT00683644|581230413|FG000|Overall Study|Withdrawal by Subject|4|||
160957209|NCT00683644|581230414|FG001|Overall Study|Withdrawal by Subject|2|||
160957210|NCT00683644|581230413|FG000|Overall Study|Lost to Follow-up|1|||
160957211|NCT00683644|581230414|FG001|Overall Study|Lost to Follow-up|4|||
160957212|NCT00683644|581230413|FG000|Overall Study|Adverse Event|1|||
160957213|NCT00683644|581230414|FG001|Overall Study|Adverse Event|2|||
160957214|NCT00683644|581230413|FG000|Overall Study|Low copper, other health problems,|7|||
160957215|NCT00683644|581230414|FG001|Overall Study|Low copper, other health problems,|6|||
160957216|NCT03240692|581230415|FG000|Overall Study|Physician Decision|1|||
160957217|NCT03240692|581230415|FG000|Overall Study|Withdrawal by Subject|1|||
160957218|NCT02576067|581230416|FG000|Overall Study|Death|0|||
161001428|NCT01317420|581390593|FG000|Overall Study|Other adverse event|1|||
161001429|NCT01317420|581390594|FG001|Overall Study|Other adverse event|0|||
160957219|NCT02576067|581230417|FG001|Overall Study|Death|1|||
160957220|NCT02576067|581230416|FG000|Overall Study|Lack of Efficacy|1|||
160957221|NCT02576067|581230417|FG001|Overall Study|Lack of Efficacy|0|||
160957222|NCT02576067|581230416|FG000|Overall Study|Lost to Follow-up|11|||
160957223|NCT02576067|581230417|FG001|Overall Study|Lost to Follow-up|0|||
160957224|NCT02576067|581230416|FG000|Overall Study|Withdrawal by Subject|11|||
160957225|NCT02576067|581230417|FG001|Overall Study|Withdrawal by Subject|2|||
160957226|NCT02576067|581230416|FG000|Overall Study|study closure of main CIRT trial)|0|||
160457822|NCT02323880|579407948|FG006|Overall Study|Physician Decision|1|||
160957227|NCT02576067|581230417|FG001|Overall Study|study closure of main CIRT trial)|8|||
160957228|NCT02576067|581230416|FG000|Overall Study|not randomized, failed run-in|7|||
160957229|NCT02576067|581230417|FG001|Overall Study|not randomized, failed run-in|0|||
160957230|NCT02576067|581230416|FG000|Overall Study|screen failure/ re-enrolled|0|||
160957231|NCT02576067|581230417|FG001|Overall Study|screen failure/ re-enrolled|25|||
160957232|NCT02576067|581230416|FG000|Overall Study|Physician Decision|4|||
161001430|NCT01317420|581390595|FG002|Overall Study|Other adverse event|0|||
161001431|NCT01317420|581390596|FG003|Overall Study|Other adverse event|0|||
160957233|NCT02576067|581230417|FG001|Overall Study|Physician Decision|0|||
160957234|NCT04084314|581230418|FG000|Overall Study|Subject/guardian decision|91|||
160957235|NCT04084314|581230418|FG000|Overall Study|Adverse Event|24|||
160957236|NCT04084314|581230418|FG000|Overall Study|Lost to Follow-up|19|||
160957237|NCT04084314|581230418|FG000|Overall Study|New therapy for study indication|9|||
160957238|NCT04084314|581230418|FG000|Overall Study|Pregnancy|9|||
160957239|NCT04084314|581230418|FG000|Overall Study|Withdrawal of informed consent|8|||
160957240|NCT04084314|581230418|FG000|Overall Study|Physician Decision|4|||
160957241|NCT04084314|581230418|FG000|Overall Study|Protocol Deviation|3|||
160957242|NCT01300546|581230419|FG000|Overall Study|Withdrawal by Subject|1|||
160957243|NCT01300546|581230420|FG001|Overall Study|Withdrawal by Subject|0|||
160957244|NCT01300546|581230419|FG000|Overall Study|Lost to Follow-up|0|||
160957245|NCT01300546|581230420|FG001|Overall Study|Lost to Follow-up|2|||
160957246|NCT01300546|581230419|FG000|Overall Study|Lack of Efficacy|0|||
160957247|NCT01300546|581230420|FG001|Overall Study|Lack of Efficacy|3|||
160957248|NCT01300546|581230419|FG000|Overall Study|Adverse Event|0|||
160957249|NCT01300546|581230420|FG001|Overall Study|Adverse Event|1|||
160957250|NCT05207813|581230423|FG000|Overall Study|Lost to Follow-up|2|||
160957251|NCT01954017|581230424|FG000|Overall Study|Adverse Event|0|||
160957252|NCT01954017|581230425|FG001|Overall Study|Adverse Event|0|||
160957253|NCT01954017|581230426|FG002|Overall Study|Adverse Event|1|||
160957254|NCT01954017|581230424|FG000|Overall Study|Death|2|||
160957255|NCT01954017|581230425|FG001|Overall Study|Death|1|||
160957256|NCT01954017|581230426|FG002|Overall Study|Death|1|||
160957257|NCT01954017|581230424|FG000|Overall Study|Withdrawal by Subject|0|||
160957258|NCT01954017|581230425|FG001|Overall Study|Withdrawal by Subject|1|||
160583171|NCT01111539|579855764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
160957259|NCT01954017|581230426|FG002|Overall Study|Withdrawal by Subject|0|||
160957260|NCT01954017|581230424|FG000|Overall Study|Protocol Violation|0|||
160957261|NCT01954017|581230425|FG001|Overall Study|Protocol Violation|3|||
160957262|NCT01954017|581230426|FG002|Overall Study|Protocol Violation|2|||
160957263|NCT01954017|581230424|FG000|Overall Study|Necrotizing enterocolitis|1|||
160957264|NCT01954017|581230425|FG001|Overall Study|Necrotizing enterocolitis|0|||
160957265|NCT01954017|581230426|FG002|Overall Study|Necrotizing enterocolitis|1|||
160957266|NCT01954017|581230424|FG000|Overall Study|Enteral intake stopped >7 days|0|||
160957267|NCT01954017|581230425|FG001|Overall Study|Enteral intake stopped >7 days|1|||
160957268|NCT01954017|581230426|FG002|Overall Study|Enteral intake stopped >7 days|1|||
160957269|NCT01954017|581230424|FG000|Overall Study|All other reasons|2|||
160957270|NCT01954017|581230425|FG001|Overall Study|All other reasons|2|||
160957271|NCT01954017|581230426|FG002|Overall Study|All other reasons|7|||
160957272|NCT00679939|581230431|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
160957273|NCT00679939|581230432|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
160957274|NCT00679939|581230431|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
160957275|NCT00679939|581230432|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
161001432|NCT01317420|581390597|FG004|Overall Study|Other adverse event|0|||
161001433|NCT01317420|581390598|FG005|Overall Study|Other adverse event|0|||
161001434|NCT01317420|581390599|FG006|Overall Study|Other adverse event|0|||
161001435|NCT01317420|581390600|FG007|Overall Study|Other adverse event|0|||
161001436|NCT01317420|581390601|FG008|Overall Study|Other adverse event|0|||
161001437|NCT01317420|581390602|FG009|Overall Study|Other adverse event|0|||
161001438|NCT01317420|581390603|FG010|Overall Study|Other adverse event|0|||
161001439|NCT01317420|581390604|FG011|Overall Study|Other adverse event|0|||
161001440|NCT01317420|581390605|FG012|Overall Study|Other adverse event|2|||
160583172|NCT01111539|579855765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
160583173|NCT01111539|579855766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
160957276|NCT00679939|581230431|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
160957277|NCT00679939|581230432|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
160957278|NCT00679939|581230431|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
160957279|NCT00679939|581230432|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
160957280|NCT00679939|581230431|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
160957281|NCT00679939|581230432|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
160957282|NCT00679939|581230431|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
160957283|NCT00679939|581230432|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
160957284|NCT00679939|581230431|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
160957285|NCT00679939|581230432|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
160957286|NCT00679939|581230431|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
160957287|NCT00679939|581230432|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
160957288|NCT00679939|581230431|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
160957289|NCT00679939|581230432|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
160957290|NCT00679939|581230431|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
160957291|NCT00679939|581230432|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
160957292|NCT04657211|581230435|FG000|Overall Study|Withdrawal by Subject|21|||
161001441|NCT01317420|581390593|FG000|Overall Study|Non-compliant with protocol|0|||
161001442|NCT01317420|581390594|FG001|Overall Study|Non-compliant with protocol|0|||
161001443|NCT01317420|581390595|FG002|Overall Study|Non-compliant with protocol|0|||
160957293|NCT04657211|581230435|FG000|Overall Study|Lost to Follow-up|113|||
160957294|NCT04657211|581230435|FG000|Overall Study|Death|47|||
160957295|NCT04657211|581230435|FG000|Overall Study|Transfer to another institution|21|||
160957296|NCT04657211|581230435|FG000|Overall Study|Other|29|||
160957297|NCT06273774|581230436|FG000|Overall Study|Participant was out of state.|0|||
160957298|NCT06273774|581230437|FG001|Overall Study|Participant was out of state.|0|||
160957299|NCT06273774|581230438|FG002|Overall Study|Participant was out of state.|0|||
160957300|NCT06273774|581230439|FG003|Overall Study|Participant was out of state.|0|||
160957301|NCT06273774|581230440|FG004|Overall Study|Participant was out of state.|0|||
160957302|NCT06273774|581230441|FG005|Overall Study|Participant was out of state.|1|||
160957303|NCT06273774|581230436|FG000|Overall Study|Lost to Follow-up|0|||
160957304|NCT06273774|581230437|FG001|Overall Study|Lost to Follow-up|0|||
160957305|NCT06273774|581230438|FG002|Overall Study|Lost to Follow-up|0|||
160957306|NCT06273774|581230439|FG003|Overall Study|Lost to Follow-up|0|||
160957307|NCT06273774|581230440|FG004|Overall Study|Lost to Follow-up|1|||
160957308|NCT06273774|581230441|FG005|Overall Study|Lost to Follow-up|0|||
160957309|NCT00955357|581231947|FG000|Titration Phase|Adverse Event|9|||
160957310|NCT00955357|581231948|FG001|Titration Phase|Adverse Event|46|||
160957311|NCT00955357|581231947|FG000|Titration Phase|Lack of Efficacy|0|||
160957312|NCT00955357|581231948|FG001|Titration Phase|Lack of Efficacy|2|||
160957313|NCT00955357|581231947|FG000|Titration Phase|Protocol Violation|3|||
160957314|NCT00955357|581231948|FG001|Titration Phase|Protocol Violation|7|||
160957315|NCT00955357|581231947|FG000|Titration Phase|Lost to Follow-up|1|||
160957316|NCT00955357|581231948|FG001|Titration Phase|Lost to Follow-up|3|||
160957317|NCT00955357|581231947|FG000|Titration Phase|Withdrawal by Subject|3|||
160957318|NCT00955357|581231948|FG001|Titration Phase|Withdrawal by Subject|5|||
160957319|NCT00955357|581231947|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
160957320|NCT00955357|581231948|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
160957321|NCT00955357|581231947|FG000|Titration Phase|Study medication not tolerated|0|||
160957322|NCT00955357|581231948|FG001|Titration Phase|Study medication not tolerated|1|||
160957323|NCT00955357|581231947|FG000|Titration Phase|Non compliance to study procedures|0|||
160957324|NCT00955357|581231948|FG001|Titration Phase|Non compliance to study procedures|1|||
160957325|NCT00955357|581231947|FG000|Maintenance Phase|Adverse Event|3|||
160957326|NCT00955357|581231948|FG001|Maintenance Phase|Adverse Event|23|||
160957327|NCT00955357|581231947|FG000|Maintenance Phase|Lack of Efficacy|0|||
160957328|NCT00955357|581231948|FG001|Maintenance Phase|Lack of Efficacy|4|||
160957329|NCT00955357|581231947|FG000|Maintenance Phase|Protocol Violation|2|||
160957330|NCT00955357|581231948|FG001|Maintenance Phase|Protocol Violation|6|||
160957331|NCT00955357|581231947|FG000|Maintenance Phase|Lost to Follow-up|2|||
160957332|NCT00955357|581231948|FG001|Maintenance Phase|Lost to Follow-up|7|||
160957333|NCT00955357|581231947|FG000|Maintenance Phase|Withdrawal by Subject|4|||
160957334|NCT00955357|581231948|FG001|Maintenance Phase|Withdrawal by Subject|4|||
160957335|NCT00955357|581231947|FG000|Maintenance Phase|Patient moving out of area|0|||
160957336|NCT00955357|581231948|FG001|Maintenance Phase|Patient moving out of area|1|||
160957337|NCT00955357|581231947|FG000|Maintenance Phase|Non compliance to study procedures|1|||
160957338|NCT00955357|581231948|FG001|Maintenance Phase|Non compliance to study procedures|0|||
160957339|NCT02943408|581231949|FG000|Overall Study|Lost to Follow-up|7|||
160957340|NCT02943408|581231950|FG001|Overall Study|Lost to Follow-up|1|||
160957341|NCT02943408|581231949|FG000|Overall Study|Withdrawal by Subject|0|||
160957342|NCT02943408|581231950|FG001|Overall Study|Withdrawal by Subject|1|||
160957343|NCT03224182|581231951|FG000|Overall Study|Study Drug Not Instilled|6|||
160957344|NCT03224182|581231952|FG001|Overall Study|Study Drug Not Instilled|1|||
160957345|NCT03224182|581231951|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
160957346|NCT03224182|581231952|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
160957347|NCT03224182|581231951|FG000|Overall Study|Withdrew of Consent|4|||
161001444|NCT01317420|581390596|FG003|Overall Study|Non-compliant with protocol|0|||
161001445|NCT01317420|581390597|FG004|Overall Study|Non-compliant with protocol|0|||
161001446|NCT01317420|581390598|FG005|Overall Study|Non-compliant with protocol|0|||
161001447|NCT01317420|581390599|FG006|Overall Study|Non-compliant with protocol|0|||
161001448|NCT01317420|581390600|FG007|Overall Study|Non-compliant with protocol|0|||
161001449|NCT01317420|581390601|FG008|Overall Study|Non-compliant with protocol|0|||
161001450|NCT01317420|581390602|FG009|Overall Study|Non-compliant with protocol|0|||
161001451|NCT01317420|581390603|FG010|Overall Study|Non-compliant with protocol|0|||
160957348|NCT03224182|581231952|FG001|Overall Study|Withdrew of Consent|2|||
160957349|NCT03224182|581231951|FG000|Overall Study|Investigator Decision|3|||
160957350|NCT03224182|581231952|FG001|Overall Study|Investigator Decision|1|||
160957351|NCT03224182|581231951|FG000|Overall Study|Sponsor Decision|26|||
160957352|NCT03224182|581231952|FG001|Overall Study|Sponsor Decision|12|||
160957353|NCT03224182|581231951|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
160957354|NCT03224182|581231952|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
160957355|NCT03224182|581231951|FG000|Overall Study|Lost to Follow-up|1|||
160957356|NCT03224182|581231952|FG001|Overall Study|Lost to Follow-up|0|||
161001452|NCT01317420|581390604|FG011|Overall Study|Non-compliant with protocol|0|||
161001453|NCT01317420|581390605|FG012|Overall Study|Non-compliant with protocol|1|||
160457823|NCT02323880|579407949|FG007|Overall Study|Physician Decision|0|||
160457824|NCT02323880|579407942|FG000|Overall Study|Withdrawal by Subject|0|||
160457825|NCT02323880|579407943|FG001|Overall Study|Withdrawal by Subject|2|||
160457826|NCT02323880|579407944|FG002|Overall Study|Withdrawal by Subject|0|||
160457827|NCT02323880|579407945|FG003|Overall Study|Withdrawal by Subject|0|||
160457828|NCT02323880|579407946|FG004|Overall Study|Withdrawal by Subject|0|||
160457829|NCT02323880|579407947|FG005|Overall Study|Withdrawal by Subject|0|||
160457830|NCT02323880|579407948|FG006|Overall Study|Withdrawal by Subject|0|||
160457831|NCT02323880|579407949|FG007|Overall Study|Withdrawal by Subject|0|||
160457832|NCT04934072|579407951|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
160457833|NCT04934072|579407952|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
160457834|NCT04934072|579407953|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
160457835|NCT04934072|579407954|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
160457836|NCT04934072|579407955|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
160457837|NCT04934072|579407951|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
160457838|NCT04934072|579407952|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
160457839|NCT04934072|579407953|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
160457840|NCT04934072|579407954|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
160457841|NCT04934072|579407955|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
160457842|NCT04934072|579407951|FG000|Day 0 to Week 52|Other|3|||
160457843|NCT04934072|579407952|FG001|Day 0 to Week 52|Other|1|||
160457844|NCT04934072|579407953|FG002|Day 0 to Week 52|Other|0|||
160457845|NCT04934072|579407954|FG003|Day 0 to Week 52|Other|0|||
160457846|NCT04934072|579407955|FG004|Day 0 to Week 52|Other|0|||
160457847|NCT04934072|579407951|FG000|Day 0 to Week 52|Adverse Event|1|||
160457848|NCT04934072|579407952|FG001|Day 0 to Week 52|Adverse Event|3|||
160457849|NCT04934072|579407953|FG002|Day 0 to Week 52|Adverse Event|0|||
160457850|NCT04934072|579407954|FG003|Day 0 to Week 52|Adverse Event|0|||
160457851|NCT04934072|579407955|FG004|Day 0 to Week 52|Adverse Event|0|||
160457852|NCT04934072|579407951|FG000|Week 52 to Week 78|Adverse Event|0|||
160457853|NCT04934072|579407952|FG001|Week 52 to Week 78|Adverse Event|0|||
160457854|NCT04934072|579407953|FG002|Week 52 to Week 78|Adverse Event|0|||
160457855|NCT04934072|579407954|FG003|Week 52 to Week 78|Adverse Event|1|||
160457856|NCT04934072|579407955|FG004|Week 52 to Week 78|Adverse Event|1|||
160457857|NCT04934072|579407951|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
160457858|NCT04934072|579407952|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
160457859|NCT04934072|579407953|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
160457860|NCT04934072|579407954|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
160457861|NCT04934072|579407955|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
160457862|NCT04934072|579407951|FG000|Week 52 to Week 78|Other|0|||
160457863|NCT04934072|579407952|FG001|Week 52 to Week 78|Other|0|||
160457864|NCT04934072|579407953|FG002|Week 52 to Week 78|Other|1|||
160457865|NCT04934072|579407954|FG003|Week 52 to Week 78|Other|0|||
160457866|NCT04934072|579407955|FG004|Week 52 to Week 78|Other|0|||
160957357|NCT03224182|581231951|FG000|Overall Study|Participant Had Recurrence|11|||
160957358|NCT03224182|581231952|FG001|Overall Study|Participant Had Recurrence|5|||
160957359|NCT03224182|581231951|FG000|Overall Study|Death|0|||
160957360|NCT03224182|581231952|FG001|Overall Study|Death|1|||
160957361|NCT03224182|581231951|FG000|Overall Study|Reason not Specified|3|||
160957362|NCT03224182|581231952|FG001|Overall Study|Reason not Specified|3|||
160957363|NCT03224182|581231951|FG000|Overall Study|Other|1|||
160957364|NCT03224182|581231952|FG001|Overall Study|Other|0|||
160957365|NCT00643916|581231953|FG000|Overall Study|Protocol Violation|0|||
160957366|NCT00643916|581231954|FG001|Overall Study|Protocol Violation|1|||
160957367|NCT00643916|581231955|FG002|Overall Study|Protocol Violation|1|||
160957368|NCT00643916|581231956|FG003|Overall Study|Protocol Violation|1|||
160957369|NCT00643916|581231957|FG004|Overall Study|Protocol Violation|0|||
160957370|NCT00643916|581231958|FG005|Overall Study|Protocol Violation|0|||
160957371|NCT00643916|581231953|FG000|Overall Study|Lost to Follow-up|0|||
160957372|NCT00643916|581231954|FG001|Overall Study|Lost to Follow-up|1|||
160957373|NCT00643916|581231955|FG002|Overall Study|Lost to Follow-up|0|||
160957374|NCT00643916|581231956|FG003|Overall Study|Lost to Follow-up|0|||
160457867|NCT05424380|579407960|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
160457868|NCT05424380|579407961|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
160457869|NCT05424380|579407962|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
160457870|NCT05424380|579407963|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
160457871|NCT05424380|579407964|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
160457872|NCT05424380|579407965|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
160457873|NCT05424380|579407960|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
160457874|NCT05424380|579407961|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
160457875|NCT05424380|579407962|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
160457876|NCT05424380|579407963|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
160457877|NCT05424380|579407964|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
160457878|NCT05424380|579407965|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
160457879|NCT05424380|579407960|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
160457880|NCT05424380|579407961|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
160957375|NCT00643916|581231957|FG004|Overall Study|Lost to Follow-up|0|||
160957376|NCT00643916|581231958|FG005|Overall Study|Lost to Follow-up|0|||
160957377|NCT00643916|581231953|FG000|Overall Study|Withdrawal by Subject|2|||
160957378|NCT00643916|581231954|FG001|Overall Study|Withdrawal by Subject|2|||
160957379|NCT00643916|581231955|FG002|Overall Study|Withdrawal by Subject|2|||
160957380|NCT00643916|581231956|FG003|Overall Study|Withdrawal by Subject|1|||
160957381|NCT00643916|581231957|FG004|Overall Study|Withdrawal by Subject|0|||
160957382|NCT00643916|581231958|FG005|Overall Study|Withdrawal by Subject|1|||
160957383|NCT00643916|581231953|FG000|Overall Study|Not Vaccinated|2|||
160957384|NCT00643916|581231954|FG001|Overall Study|Not Vaccinated|2|||
160957385|NCT00643916|581231955|FG002|Overall Study|Not Vaccinated|3|||
160957386|NCT00643916|581231956|FG003|Overall Study|Not Vaccinated|0|||
160957387|NCT00643916|581231957|FG004|Overall Study|Not Vaccinated|2|||
160957388|NCT00643916|581231958|FG005|Overall Study|Not Vaccinated|0|||
160957389|NCT02184611|581231960|FG000|Overall Study|Lack of Efficacy|11|||
160957390|NCT02184611|581231961|FG001|Overall Study|Lack of Efficacy|15|||
160957391|NCT02184611|581231960|FG000|Overall Study|Withdrawal by Subject|5|||
160957392|NCT02184611|581231961|FG001|Overall Study|Withdrawal by Subject|6|||
160957393|NCT02184611|581231960|FG000|Overall Study|Adverse Event|4|||
160957394|NCT02184611|581231961|FG001|Overall Study|Adverse Event|5|||
160957395|NCT02184611|581231960|FG000|Overall Study|Protocol Violation|1|||
160957396|NCT02184611|581231961|FG001|Overall Study|Protocol Violation|1|||
160957397|NCT02184611|581231960|FG000|Overall Study|Protocol defined stopping criteria|0|||
160957398|NCT02184611|581231961|FG001|Overall Study|Protocol defined stopping criteria|1|||
160957399|NCT00686166|581231964|FG000|Overall Study|Adverse Event|7|||
160957400|NCT00686166|581231964|FG000|Overall Study|Withdrawal by Subject|1|||
160957401|NCT00686166|581231964|FG000|Overall Study|Progression/Relapse|1|||
160957402|NCT00686166|581231964|FG000|Overall Study|Death|1|||
160957403|NCT00686166|581231964|FG000|Overall Study|Not Protocol Specified|1|||
160957404|NCT00686166|581231964|FG000|Overall Study|Ineligible|5|||
160957405|NCT00686166|581231964|FG000|Overall Study|Did not begin protocol therapy|4|||
160957406|NCT01514448|581231965|FG000|Overall Study|Death|7|||
160957407|NCT01514448|581231966|FG001|Overall Study|Death|8|||
160957408|NCT01514448|581231965|FG000|Overall Study|Withdrawal by Subject|2|||
160957409|NCT01514448|581231966|FG001|Overall Study|Withdrawal by Subject|0|||
160957410|NCT01514448|581231965|FG000|Overall Study|Lost to Follow-up|2|||
160957411|NCT01514448|581231966|FG001|Overall Study|Lost to Follow-up|0|||
160957412|NCT01514448|581231965|FG000|Overall Study|New Cancer Therapy|1|||
160957413|NCT01514448|581231966|FG001|Overall Study|New Cancer Therapy|0|||
160957414|NCT02314624|581231967|FG000|Overall Study|No participating patient|16|||
160957415|NCT02314624|581231968|FG001|Overall Study|No participating patient|13|||
160957416|NCT02314624|581231967|FG000|Overall Study|Participant withdrew|7|||
160957417|NCT02314624|581231968|FG001|Overall Study|Participant withdrew|2|||
160957418|NCT02314624|581231967|FG000|Overall Study|Lost to Follow-up|2|||
160957419|NCT02314624|581231968|FG001|Overall Study|Lost to Follow-up|5|||
160957420|NCT02314624|581231967|FG000|Overall Study|Dropped/Excluded by PI|6|||
160957421|NCT02314624|581231968|FG001|Overall Study|Dropped/Excluded by PI|6|||
160957422|NCT03912259|581231969|FG000|Overall Study|Adverse Event (AE)|2|||
160957423|NCT03912259|581231970|FG001|Overall Study|Adverse Event (AE)|4|||
160957424|NCT03912259|581231969|FG000|Overall Study|Lack of Efficacy|4|||
160957425|NCT03912259|581231970|FG001|Overall Study|Lack of Efficacy|1|||
160957426|NCT03912259|581231969|FG000|Overall Study|Withdrawal by Subject|11|||
160957427|NCT03912259|581231970|FG001|Overall Study|Withdrawal by Subject|1|||
160957428|NCT05159622|581231973|FG000|Overall Study|Lost to Follow-up|4|||
160957429|NCT05159622|581231974|FG001|Overall Study|Lost to Follow-up|5|||
160957430|NCT02163733|581231975|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
160957431|NCT02163733|581231976|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
160957432|NCT02163733|581231977|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
160957433|NCT02163733|581231975|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
160957434|NCT02163733|581231976|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
160957435|NCT02163733|581231977|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
160957436|NCT02723864|581231978|FG000|Overall Study|Refused further treatment|1|||
160957437|NCT02723864|581231979|FG001|Overall Study|Refused further treatment|0|||
160957438|NCT02723864|581231980|FG002|Overall Study|Refused further treatment|0|||
160957439|NCT02723864|581231981|FG003|Overall Study|Refused further treatment|0|||
160957440|NCT02723864|581231982|FG004|Overall Study|Refused further treatment|1|||
160957441|NCT02723864|581231983|FG005|Overall Study|Refused further treatment|2|||
160957442|NCT02723864|581231984|FG006|Overall Study|Refused further treatment|0|||
160957443|NCT02723864|581231978|FG000|Overall Study|Exceed treatment hold time|0|||
160957444|NCT02723864|581231979|FG001|Overall Study|Exceed treatment hold time|1|||
160957445|NCT02723864|581231980|FG002|Overall Study|Exceed treatment hold time|0|||
160957446|NCT02723864|581231981|FG003|Overall Study|Exceed treatment hold time|0|||
160957447|NCT02723864|581231982|FG004|Overall Study|Exceed treatment hold time|0|||
160957448|NCT02723864|581231983|FG005|Overall Study|Exceed treatment hold time|0|||
160957449|NCT02723864|581231984|FG006|Overall Study|Exceed treatment hold time|0|||
160957450|NCT02723864|581231978|FG000|Overall Study|Clinical progression|0|||
160957451|NCT02723864|581231979|FG001|Overall Study|Clinical progression|0|||
160957452|NCT02723864|581231980|FG002|Overall Study|Clinical progression|1|||
160957453|NCT02723864|581231981|FG003|Overall Study|Clinical progression|0|||
160957454|NCT02723864|581231982|FG004|Overall Study|Clinical progression|0|||
160957455|NCT02723864|581231983|FG005|Overall Study|Clinical progression|3|||
160957456|NCT02723864|581231984|FG006|Overall Study|Clinical progression|1|||
160957457|NCT02723864|581231978|FG000|Overall Study|Physician Decision|0|||
160957458|NCT02723864|581231979|FG001|Overall Study|Physician Decision|0|||
160957459|NCT02723864|581231980|FG002|Overall Study|Physician Decision|0|||
160957460|NCT02723864|581231981|FG003|Overall Study|Physician Decision|0|||
160957461|NCT02723864|581231982|FG004|Overall Study|Physician Decision|0|||
160957462|NCT02723864|581231983|FG005|Overall Study|Physician Decision|0|||
160957463|NCT02723864|581231984|FG006|Overall Study|Physician Decision|1|||
160957464|NCT02723864|581231978|FG000|Overall Study|Changes in patient condition|0|||
160957465|NCT02723864|581231979|FG001|Overall Study|Changes in patient condition|0|||
160957466|NCT02723864|581231980|FG002|Overall Study|Changes in patient condition|0|||
160957467|NCT02723864|581231981|FG003|Overall Study|Changes in patient condition|0|||
160957468|NCT02723864|581231982|FG004|Overall Study|Changes in patient condition|0|||
160957469|NCT02723864|581231983|FG005|Overall Study|Changes in patient condition|1|||
160957470|NCT02723864|581231984|FG006|Overall Study|Changes in patient condition|0|||
160957471|NCT02723864|581231978|FG000|Overall Study|Patient choice|0|||
160957472|NCT02723864|581231979|FG001|Overall Study|Patient choice|0|||
160957473|NCT02723864|581231980|FG002|Overall Study|Patient choice|0|||
160957474|NCT02723864|581231981|FG003|Overall Study|Patient choice|0|||
160957475|NCT02723864|581231982|FG004|Overall Study|Patient choice|0|||
160957476|NCT02723864|581231983|FG005|Overall Study|Patient choice|1|||
160957477|NCT02723864|581231984|FG006|Overall Study|Patient choice|0|||
160957478|NCT02723864|581231978|FG000|Overall Study|Adverse Event|0|||
160957479|NCT02723864|581231979|FG001|Overall Study|Adverse Event|0|||
160957480|NCT02723864|581231980|FG002|Overall Study|Adverse Event|0|||
160957481|NCT02723864|581231981|FG003|Overall Study|Adverse Event|0|||
160957482|NCT02723864|581231982|FG004|Overall Study|Adverse Event|0|||
160957483|NCT02723864|581231983|FG005|Overall Study|Adverse Event|1|||
160957484|NCT02723864|581231984|FG006|Overall Study|Adverse Event|0|||
160957485|NCT02723864|581231978|FG000|Overall Study|Started new treatment|0|||
160957486|NCT02723864|581231979|FG001|Overall Study|Started new treatment|0|||
160957487|NCT02723864|581231980|FG002|Overall Study|Started new treatment|0|||
160957488|NCT02723864|581231981|FG003|Overall Study|Started new treatment|0|||
160957489|NCT02723864|581231982|FG004|Overall Study|Started new treatment|0|||
160957490|NCT02723864|581231983|FG005|Overall Study|Started new treatment|1|||
160957491|NCT02723864|581231984|FG006|Overall Study|Started new treatment|0|||
160957492|NCT02723864|581231978|FG000|Overall Study|Switched to alternative treatment|0|||
160957493|NCT02723864|581231979|FG001|Overall Study|Switched to alternative treatment|0|||
160957494|NCT02723864|581231980|FG002|Overall Study|Switched to alternative treatment|0|||
160957495|NCT02723864|581231981|FG003|Overall Study|Switched to alternative treatment|0|||
160957496|NCT02723864|581231982|FG004|Overall Study|Switched to alternative treatment|0|||
160957497|NCT02723864|581231983|FG005|Overall Study|Switched to alternative treatment|1|||
160957498|NCT02723864|581231984|FG006|Overall Study|Switched to alternative treatment|0|||
160957499|NCT02723864|581231978|FG000|Overall Study|Late determination of ineligibility|0|||
160957500|NCT02723864|581231979|FG001|Overall Study|Late determination of ineligibility|0|||
160957501|NCT02723864|581231980|FG002|Overall Study|Late determination of ineligibility|0|||
160957502|NCT02723864|581231981|FG003|Overall Study|Late determination of ineligibility|0|||
160957503|NCT02723864|581231982|FG004|Overall Study|Late determination of ineligibility|0|||
160457881|NCT05424380|579407962|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
160457882|NCT05424380|579407963|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
160583174|NCT01111539|579855762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
160583175|NCT01111539|579855763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
160957504|NCT02723864|581231983|FG005|Overall Study|Late determination of ineligibility|1|||
160957505|NCT02723864|581231984|FG006|Overall Study|Late determination of ineligibility|0|||
160957506|NCT03232983|581231985|FG000|Period 1|Physician Decision|0|||
160957507|NCT03232983|581231986|FG001|Period 1|Physician Decision|0|||
160583176|NCT01111539|579855764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
160957508|NCT03232983|581231987|FG002|Period 1|Physician Decision|1|||
160957509|NCT03232983|581231988|FG003|Period 1|Physician Decision|0|||
160957510|NCT03232983|581231985|FG000|Washout Period 2|Physician Decision|0|||
160957511|NCT03232983|581231986|FG001|Washout Period 2|Physician Decision|0|||
160957512|NCT03232983|581231987|FG002|Washout Period 2|Physician Decision|1|||
160957513|NCT03232983|581231988|FG003|Washout Period 2|Physician Decision|0|||
160957514|NCT03232983|581231985|FG000|Washout Period 2|Withdrawal by Subject|0|||
160957515|NCT03232983|581231986|FG001|Washout Period 2|Withdrawal by Subject|0|||
160957516|NCT03232983|581231987|FG002|Washout Period 2|Withdrawal by Subject|0|||
160957517|NCT03232983|581231988|FG003|Washout Period 2|Withdrawal by Subject|1|||
161001454|NCT01317420|581390593|FG000|Overall Study|Refused to cont. taking trial medication|0|||
161001455|NCT01317420|581390594|FG001|Overall Study|Refused to cont. taking trial medication|0|||
160957518|NCT03232983|581231985|FG000|Period 4|Withdrawal by Subject|1|||
160957519|NCT03232983|581231986|FG001|Period 4|Withdrawal by Subject|0|||
160957520|NCT03232983|581231987|FG002|Period 4|Withdrawal by Subject|0|||
160957521|NCT03232983|581231988|FG003|Period 4|Withdrawal by Subject|0|||
160957522|NCT00746590|581231989|FG000|Overall Study|Death|1|||
160957523|NCT02633800|581231994|FG000|Overall Study|Death|3|||
160957524|NCT02633800|581231995|FG001|Overall Study|Death|3|||
160957525|NCT02633800|581231994|FG000|Overall Study|Reason not provided|1|||
160957526|NCT02633800|581231995|FG001|Overall Study|Reason not provided|0|||
160957527|NCT02633800|581231994|FG000|Overall Study|Radiologic(al) progression|23|||
160957528|NCT02633800|581231995|FG001|Overall Study|Radiologic(al) progression|23|||
160957529|NCT02633800|581231994|FG000|Overall Study|Clinical progression|3|||
160957530|NCT02633800|581231995|FG001|Overall Study|Clinical progression|6|||
160957531|NCT02633800|581231994|FG000|Overall Study|Study terminated by sponsor|6|||
160957532|NCT02633800|581231995|FG001|Overall Study|Study terminated by sponsor|5|||
160957533|NCT02633800|581231994|FG000|Overall Study|Adverse event, non-fatal|7|||
160957534|NCT02633800|581231995|FG001|Overall Study|Adverse event, non-fatal|2|||
160957535|NCT02633800|581231994|FG000|Overall Study|Withdrawal by Subject|0|||
160957536|NCT02633800|581231995|FG001|Overall Study|Withdrawal by Subject|3|||
160957537|NCT02633800|581231994|FG000|Overall Study|Patient Request|1|||
160957538|NCT02633800|581231995|FG001|Overall Study|Patient Request|1|||
160957539|NCT03643952|581231999|FG000|Overall Study|Lack of Efficacy|1|||
160957540|NCT01358968|581232000|FG000|Period 2|Adverse Event|0|||
160957541|NCT01358968|581232001|FG001|Period 2|Adverse Event|1|||
160957542|NCT01358968|581232002|FG002|Period 2|Adverse Event|0|||
160957543|NCT01358968|581232003|FG003|Period 2|Adverse Event|0|||
160957544|NCT01358968|581232000|FG000|Continued Access Phase|Progression of Disease|0|||
160957545|NCT01358968|581232001|FG001|Continued Access Phase|Progression of Disease|0|||
160957546|NCT01358968|581232002|FG002|Continued Access Phase|Progression of Disease|8|||
160957547|NCT01358968|581232003|FG003|Continued Access Phase|Progression of Disease|4|||
160957548|NCT01358968|581232000|FG000|Continued Access Phase|Protocol Violation|0|||
160957549|NCT01358968|581232001|FG001|Continued Access Phase|Protocol Violation|0|||
160957550|NCT01358968|581232002|FG002|Continued Access Phase|Protocol Violation|0|||
160957551|NCT01358968|581232003|FG003|Continued Access Phase|Protocol Violation|2|||
160957552|NCT01358968|581232000|FG000|Continued Access Phase|Withdrawal by Subject|0|||
160957553|NCT01358968|581232001|FG001|Continued Access Phase|Withdrawal by Subject|0|||
160957554|NCT01358968|581232002|FG002|Continued Access Phase|Withdrawal by Subject|3|||
160957555|NCT01358968|581232003|FG003|Continued Access Phase|Withdrawal by Subject|0|||
160957556|NCT01358968|581232000|FG000|Continued Access Phase|Death|0|||
160957557|NCT01358968|581232001|FG001|Continued Access Phase|Death|0|||
160957558|NCT01358968|581232002|FG002|Continued Access Phase|Death|1|||
160957559|NCT01358968|581232003|FG003|Continued Access Phase|Death|1|||
160957560|NCT01597050|581232004|FG000|Overall Study|Withdrawal by Subject|1|||
160957561|NCT01597050|581232005|FG001|Overall Study|Withdrawal by Subject|0|||
160957562|NCT00483184|581232006|FG000|Overall Study|Withdrawal by Subject|2|||
160957563|NCT00483184|581232007|FG001|Overall Study|Withdrawal by Subject|2|||
160957564|NCT00483184|581232008|FG002|Overall Study|Withdrawal by Subject|0|||
160957565|NCT00483184|581232006|FG000|Overall Study|Lost to Follow-up|1|||
160957566|NCT00483184|581232007|FG001|Overall Study|Lost to Follow-up|0|||
160957567|NCT00483184|581232008|FG002|Overall Study|Lost to Follow-up|0|||
160957568|NCT00483184|581232006|FG000|Overall Study|Adverse Event|1|||
160957569|NCT00483184|581232007|FG001|Overall Study|Adverse Event|2|||
160957570|NCT00483184|581232008|FG002|Overall Study|Adverse Event|2|||
160957571|NCT00483184|581232006|FG000|Overall Study|Protocol Violation|1|||
160957572|NCT00483184|581232007|FG001|Overall Study|Protocol Violation|0|||
160957573|NCT00483184|581232008|FG002|Overall Study|Protocol Violation|1|||
160957574|NCT00530855|581232012|FG000|Overall Study|Lack of Efficacy|20|||
160957575|NCT00530855|581232012|FG000|Overall Study|Withdrawal by Subject|30|||
160957576|NCT00530855|581232012|FG000|Overall Study|Fatal Serious AE|3|||
160957577|NCT00530855|581232012|FG000|Overall Study|Non Fatal Serious AE|7|||
160957578|NCT00530855|581232012|FG000|Overall Study|Non Fatal Non Serious AE|12|||
160957579|NCT00530855|581232012|FG000|Overall Study|Protocol Violation|3|||
160957580|NCT00530855|581232012|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
160957581|NCT00530855|581232012|FG000|Overall Study|Lost to Follow-up|9|||
160957582|NCT00530855|581232012|FG000|Overall Study|Other reason for premature termination|17|||
160957583|NCT01618162|581232017|FG000|Overall Study|Protocol Violation|13|||
160957584|NCT01618162|581232018|FG001|Overall Study|Protocol Violation|10|||
160957585|NCT01618162|581232017|FG000|Overall Study|Adverse Event|9|||
160957586|NCT01618162|581232018|FG001|Overall Study|Adverse Event|2|||
160957587|NCT01618162|581232017|FG000|Overall Study|Withdrawal Criteria|2|||
160957588|NCT01618162|581232018|FG001|Overall Study|Withdrawal Criteria|10|||
160957589|NCT01618162|581232017|FG000|Overall Study|Unclassified|14|||
160957590|NCT01618162|581232018|FG001|Overall Study|Unclassified|13|||
160957591|NCT04794803|581232019|FG000|Overall Study|Death|1|||
160957592|NCT04794803|581232020|FG001|Overall Study|Death|3|||
160957593|NCT04794803|581232019|FG000|Overall Study|Lost to Follow-up|2|||
160957594|NCT04794803|581232020|FG001|Overall Study|Lost to Follow-up|2|||
160957595|NCT04794803|581232019|FG000|Overall Study|Withdrawal by Subject|1|||
160957596|NCT04794803|581232020|FG001|Overall Study|Withdrawal by Subject|0|||
160957597|NCT04794803|581232019|FG000|Overall Study|Physician Decision|1|||
160957598|NCT04794803|581232020|FG001|Overall Study|Physician Decision|1|||
160957599|NCT04794803|581232019|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
160957600|NCT04794803|581232020|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
160957601|NCT04794803|581232019|FG000|Overall Study|Refused to continue the treatment|1|||
160957602|NCT04794803|581232020|FG001|Overall Study|Refused to continue the treatment|0|||
160957603|NCT04794803|581232019|FG000|Overall Study|Patient admitted to ICU|0|||
160957604|NCT04794803|581232020|FG001|Overall Study|Patient admitted to ICU|1|||
160957605|NCT04124926|581232021|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
160957606|NCT04124926|581232022|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
160957607|NCT04124926|581232023|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
160957608|NCT04124926|581232024|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
160957609|NCT04124926|581232025|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
160957610|NCT04124926|581232021|FG000|Healing Phase|Protocol Violation|0|||
160957611|NCT04124926|581232022|FG001|Healing Phase|Protocol Violation|1|||
160957612|NCT04124926|581232023|FG002|Healing Phase|Protocol Violation|0|||
160957613|NCT04124926|581232024|FG003|Healing Phase|Protocol Violation|0|||
160957614|NCT04124926|581232025|FG004|Healing Phase|Protocol Violation|0|||
160957615|NCT04124926|581232021|FG000|Healing Phase|Lost to Follow-up|5|||
160957616|NCT04124926|581232022|FG001|Healing Phase|Lost to Follow-up|4|||
160957617|NCT04124926|581232023|FG002|Healing Phase|Lost to Follow-up|0|||
160957618|NCT04124926|581232024|FG003|Healing Phase|Lost to Follow-up|0|||
160957619|NCT04124926|581232025|FG004|Healing Phase|Lost to Follow-up|0|||
160957620|NCT04124926|581232021|FG000|Healing Phase|Voluntary Withdrawal|10|||
160957621|NCT04124926|581232022|FG001|Healing Phase|Voluntary Withdrawal|7|||
160957622|NCT04124926|581232023|FG002|Healing Phase|Voluntary Withdrawal|0|||
160957623|NCT04124926|581232024|FG003|Healing Phase|Voluntary Withdrawal|0|||
160957624|NCT04124926|581232025|FG004|Healing Phase|Voluntary Withdrawal|0|||
160957625|NCT04124926|581232021|FG000|Healing Phase|Withdrawal of Consent|5|||
160957626|NCT04124926|581232022|FG001|Healing Phase|Withdrawal of Consent|3|||
160957627|NCT04124926|581232023|FG002|Healing Phase|Withdrawal of Consent|0|||
160957628|NCT04124926|581232024|FG003|Healing Phase|Withdrawal of Consent|0|||
160957629|NCT04124926|581232025|FG004|Healing Phase|Withdrawal of Consent|0|||
160957630|NCT04124926|581232021|FG000|Healing Phase|Miscellaneous|8|||
160957631|NCT04124926|581232022|FG001|Healing Phase|Miscellaneous|7|||
160957632|NCT04124926|581232023|FG002|Healing Phase|Miscellaneous|0|||
160957633|NCT04124926|581232024|FG003|Healing Phase|Miscellaneous|0|||
160957634|NCT04124926|581232025|FG004|Healing Phase|Miscellaneous|0|||
160957635|NCT04124926|581232021|FG000|Healing Phase|Randomized but not Treated|0|||
160957636|NCT04124926|581232022|FG001|Healing Phase|Randomized but not Treated|3|||
160957637|NCT04124926|581232023|FG002|Healing Phase|Randomized but not Treated|0|||
160957638|NCT04124926|581232024|FG003|Healing Phase|Randomized but not Treated|0|||
160957639|NCT04124926|581232025|FG004|Healing Phase|Randomized but not Treated|0|||
160957640|NCT04124926|581232021|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
160957641|NCT04124926|581232022|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
160957642|NCT04124926|581232023|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
160957643|NCT04124926|581232024|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
160957644|NCT04124926|581232025|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
160957645|NCT04124926|581232021|FG000|Maintenance Phase|Protocol Violation|0|||
160957646|NCT04124926|581232022|FG001|Maintenance Phase|Protocol Violation|0|||
160957647|NCT04124926|581232023|FG002|Maintenance Phase|Protocol Violation|3|||
160957648|NCT04124926|581232024|FG003|Maintenance Phase|Protocol Violation|0|||
160957649|NCT04124926|581232025|FG004|Maintenance Phase|Protocol Violation|0|||
160957650|NCT04124926|581232021|FG000|Maintenance Phase|Lost to Follow-up|0|||
160957651|NCT04124926|581232022|FG001|Maintenance Phase|Lost to Follow-up|0|||
160957652|NCT04124926|581232023|FG002|Maintenance Phase|Lost to Follow-up|7|||
160957653|NCT04124926|581232024|FG003|Maintenance Phase|Lost to Follow-up|8|||
160957654|NCT04124926|581232025|FG004|Maintenance Phase|Lost to Follow-up|9|||
160957655|NCT04124926|581232021|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
160957656|NCT04124926|581232022|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
160957657|NCT04124926|581232023|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
160957658|NCT04124926|581232024|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
160957659|NCT04124926|581232025|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
160957660|NCT04124926|581232021|FG000|Maintenance Phase|Pregnancy|0|||
160957661|NCT04124926|581232022|FG001|Maintenance Phase|Pregnancy|0|||
161001456|NCT01317420|581390595|FG002|Overall Study|Refused to cont. taking trial medication|0|||
160957662|NCT04124926|581232023|FG002|Maintenance Phase|Pregnancy|0|||
160957663|NCT04124926|581232024|FG003|Maintenance Phase|Pregnancy|1|||
160957664|NCT04124926|581232025|FG004|Maintenance Phase|Pregnancy|0|||
160957665|NCT04124926|581232021|FG000|Maintenance Phase|Lack of Efficacy|0|||
160957666|NCT04124926|581232022|FG001|Maintenance Phase|Lack of Efficacy|0|||
160957667|NCT04124926|581232023|FG002|Maintenance Phase|Lack of Efficacy|0|||
160957668|NCT04124926|581232024|FG003|Maintenance Phase|Lack of Efficacy|0|||
160957669|NCT04124926|581232025|FG004|Maintenance Phase|Lack of Efficacy|1|||
160957670|NCT04124926|581232021|FG000|Maintenance Phase|Withdrawal of Consent|0|||
160457883|NCT05424380|579407964|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
160457884|NCT05424380|579407965|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
160457885|NCT05424380|579407960|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
160457886|NCT05424380|579407961|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
160457887|NCT05424380|579407962|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
160957671|NCT04124926|581232022|FG001|Maintenance Phase|Withdrawal of Consent|0|||
160957672|NCT04124926|581232023|FG002|Maintenance Phase|Withdrawal of Consent|5|||
160957673|NCT04124926|581232024|FG003|Maintenance Phase|Withdrawal of Consent|5|||
160957674|NCT04124926|581232025|FG004|Maintenance Phase|Withdrawal of Consent|5|||
160957675|NCT04124926|581232021|FG000|Maintenance Phase|Miscellaneous|0|||
160957676|NCT04124926|581232022|FG001|Maintenance Phase|Miscellaneous|0|||
160957677|NCT04124926|581232023|FG002|Maintenance Phase|Miscellaneous|1|||
160957678|NCT04124926|581232024|FG003|Maintenance Phase|Miscellaneous|2|||
160957679|NCT04124926|581232025|FG004|Maintenance Phase|Miscellaneous|4|||
160957680|NCT04124926|581232021|FG000|Maintenance Phase|Randomized but not Treated|0|||
160957681|NCT04124926|581232022|FG001|Maintenance Phase|Randomized but not Treated|0|||
160957682|NCT04124926|581232023|FG002|Maintenance Phase|Randomized but not Treated|2|||
160957683|NCT04124926|581232024|FG003|Maintenance Phase|Randomized but not Treated|2|||
160957684|NCT04124926|581232025|FG004|Maintenance Phase|Randomized but not Treated|0|||
160957685|NCT01654549|581232031|FG000|Overall Study|H.pylori eradication not successful|0|||
160957686|NCT01654549|581232032|FG001|Overall Study|H.pylori eradication not successful|1|||
160957687|NCT02013622|581232035|FG000|Overall Study|Lost to Follow-up|10|||
160957688|NCT02013622|581232035|FG000|Overall Study|Adverse Event|3|||
160957689|NCT02013622|581232035|FG000|Overall Study|Met Withdrawal Criteria|3|||
160957690|NCT02013622|581232035|FG000|Overall Study|Withdrawal by Subject|6|||
160957691|NCT02013622|581232035|FG000|Overall Study|Protocol Deviation|1|||
160957692|NCT02013622|581232035|FG000|Overall Study|Lack of Efficacy|1|||
160957693|NCT00937924|581232036|FG000|Overall Study|Lost to Follow-up|44|||
160957694|NCT00937924|581232037|FG001|Overall Study|Lost to Follow-up|44|||
160957695|NCT00937924|581232038|FG002|Overall Study|Lost to Follow-up|41|||
160957696|NCT00224874|581232041|FG000|Overall Study|Withdrawal by Subject|0|||
160957697|NCT00224874|581232042|FG001|Overall Study|Withdrawal by Subject|0|||
160957698|NCT00224874|581232043|FG002|Overall Study|Withdrawal by Subject|1|||
160957699|NCT00224874|581232044|FG003|Overall Study|Withdrawal by Subject|0|||
160957700|NCT02355002|581232045|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
160957701|NCT02355002|581232046|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
160957702|NCT02355002|581232045|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
160957703|NCT02355002|581232046|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
160957704|NCT02355002|581232045|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
160957705|NCT02355002|581232046|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
160957706|NCT02355002|581232045|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
160957707|NCT02355002|581232046|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
160957708|NCT02355002|581232045|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
160957709|NCT02355002|581232046|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
160957710|NCT02355002|581232045|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
160957711|NCT02355002|581232046|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
160957712|NCT02355002|581232045|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
160957713|NCT02355002|581232046|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
160957714|NCT03152526|581232047|FG000|Overall Study|Withdrawal by Subject|0|||
160957715|NCT03152526|581232048|FG001|Overall Study|Withdrawal by Subject|1|||
160957716|NCT05554237|581232049|FG000|Part 2 (7 Days)|Adverse Event|0|||
160957717|NCT05554237|581232050|FG001|Part 2 (7 Days)|Adverse Event|0|||
160957718|NCT05554237|581232051|FG002|Part 2 (7 Days)|Adverse Event|0|||
160957719|NCT05554237|581232052|FG003|Part 2 (7 Days)|Adverse Event|0|||
160957720|NCT05554237|581232053|FG004|Part 2 (7 Days)|Adverse Event|2|||
160957721|NCT05554237|581232054|FG005|Part 2 (7 Days)|Adverse Event|0|||
160957722|NCT05554237|581232055|FG006|Part 2 (7 Days)|Adverse Event|0|||
160957723|NCT05554237|581232056|FG007|Part 2 (7 Days)|Adverse Event|0|||
160457888|NCT05424380|579407963|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
160457889|NCT05424380|579407964|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
160457890|NCT05424380|579407965|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
160957724|NCT05554237|581232057|FG008|Part 2 (7 Days)|Adverse Event|0|||
160957725|NCT05554237|581232058|FG009|Part 2 (7 Days)|Adverse Event|1|||
160957726|NCT05554237|581232059|FG010|Part 2 (7 Days)|Adverse Event|0|||
160957727|NCT05554237|581232060|FG011|Part 2 (7 Days)|Adverse Event|0|||
160957728|NCT05554237|581232061|FG012|Part 2 (7 Days)|Adverse Event|1|||
160957729|NCT05554237|581232062|FG013|Part 2 (7 Days)|Adverse Event|0|||
160457891|NCT05424380|579407960|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
160457892|NCT05424380|579407961|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
160457893|NCT05424380|579407962|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
160457894|NCT05424380|579407963|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
160957730|NCT05130970|581232063|FG000|Overall Study|Adverse Event|1|||
160957731|NCT05130970|581232064|FG001|Overall Study|Adverse Event|1|||
160957732|NCT05130970|581232063|FG000|Overall Study|Death|0|||
160957733|NCT05130970|581232064|FG001|Overall Study|Death|1|||
160957734|NCT05130970|581232063|FG000|Overall Study|Lost to Follow-up|0|||
160957735|NCT05130970|581232064|FG001|Overall Study|Lost to Follow-up|1|||
160957736|NCT05130970|581232063|FG000|Overall Study|Physician Decision|0|||
160957737|NCT05130970|581232064|FG001|Overall Study|Physician Decision|1|||
160957738|NCT05130970|581232063|FG000|Overall Study|Withdrawal by Subject|1|||
160957739|NCT05130970|581232064|FG001|Overall Study|Withdrawal by Subject|1|||
160957740|NCT03644186|581232065|FG000|Overall Study|Withdrawal by Subject|1|||
160957741|NCT03644186|581232066|FG001|Overall Study|Withdrawal by Subject|1|||
160957742|NCT02701985|581232067|FG000|Overall Study|Withdrawal by Subject|1|||
160957743|NCT02701985|581232068|FG001|Overall Study|Withdrawal by Subject|1|||
160957744|NCT02701985|581232067|FG000|Overall Study|Lost to Follow-up|1|||
160957745|NCT02701985|581232068|FG001|Overall Study|Lost to Follow-up|0|||
160957746|NCT02701985|581232067|FG000|Overall Study|Death|1|||
160957747|NCT02701985|581232068|FG001|Overall Study|Death|0|||
160957748|NCT02701985|581232067|FG000|Overall Study|Adverse Event|0|||
160957749|NCT02701985|581232068|FG001|Overall Study|Adverse Event|5|||
160957750|NCT02192502|581232071|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
160957751|NCT02192502|581232072|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
160957752|NCT02192502|581232071|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
160957753|NCT02192502|581232072|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
160957754|NCT02192502|581232071|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
160957755|NCT02192502|581232072|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
160957756|NCT04009291|581232073|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
160957757|NCT04009291|581232074|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
160957758|NCT04009291|581232075|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
160957759|NCT04009291|581232076|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
160957760|NCT04009291|581232077|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
160957761|NCT04009291|581232073|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
160957762|NCT04009291|581232074|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
160957763|NCT04009291|581232075|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
160957764|NCT04009291|581232076|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
160957765|NCT04009291|581232077|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
160957766|NCT02189798|581232078|FG000|Extended Use Phase|Withdrawal by Subject|0|||
160957767|NCT02189798|581232079|FG001|Extended Use Phase|Withdrawal by Subject|4|||
160957768|NCT02189798|581232078|FG000|Extended Use Phase|Physician Decision|1|||
160957769|NCT02189798|581232079|FG001|Extended Use Phase|Physician Decision|0|||
160957770|NCT02189798|581232078|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
160957771|NCT02189798|581232079|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
160957772|NCT02189798|581232078|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
160957773|NCT02189798|581232079|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
160957774|NCT02189798|581232078|FG000|Extended Use Phase|Travel Issues|2|||
160957775|NCT02189798|581232079|FG001|Extended Use Phase|Travel Issues|1|||
160957776|NCT02189798|581232078|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
160957777|NCT02189798|581232079|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
160957778|NCT00729833|581232087|FG000|Overall Study|Death|5|||
160957779|NCT00729833|581232088|FG001|Overall Study|Death|1|||
160957780|NCT00729833|581232089|FG002|Overall Study|Death|3|||
160957781|NCT00729833|581232090|FG003|Overall Study|Death|5|||
160957782|NCT00729833|581232087|FG000|Overall Study|Study Terminated by Sponsor|0|||
160957783|NCT00729833|581232088|FG001|Overall Study|Study Terminated by Sponsor|0|||
160957784|NCT00729833|581232089|FG002|Overall Study|Study Terminated by Sponsor|1|||
160957785|NCT00729833|581232090|FG003|Overall Study|Study Terminated by Sponsor|0|||
160957786|NCT00729833|581232087|FG000|Overall Study|Lost to Follow-up|1|||
160957787|NCT00729833|581232088|FG001|Overall Study|Lost to Follow-up|0|||
160957788|NCT00729833|581232089|FG002|Overall Study|Lost to Follow-up|0|||
160957789|NCT00729833|581232090|FG003|Overall Study|Lost to Follow-up|0|||
160957790|NCT00729833|581232087|FG000|Overall Study|Withdrawal by Subject|3|||
160957791|NCT00729833|581232088|FG001|Overall Study|Withdrawal by Subject|1|||
160957792|NCT00729833|581232089|FG002|Overall Study|Withdrawal by Subject|3|||
160957793|NCT00729833|581232090|FG003|Overall Study|Withdrawal by Subject|0|||
160957794|NCT00729833|581232087|FG000|Overall Study|Unspecified Reasons|11|||
160957795|NCT00729833|581232088|FG001|Overall Study|Unspecified Reasons|5|||
160957796|NCT00729833|581232089|FG002|Overall Study|Unspecified Reasons|5|||
160957797|NCT00729833|581232090|FG003|Overall Study|Unspecified Reasons|1|||
160957798|NCT01687257|581232091|FG000|Overall Study|Efficacy Failure|6|||
160957799|NCT01687257|581232092|FG001|Overall Study|Efficacy Failure|0|||
160957800|NCT01687257|581232093|FG002|Overall Study|Efficacy Failure|5|||
161001457|NCT01317420|581390596|FG003|Overall Study|Refused to cont. taking trial medication|0|||
161001458|NCT01317420|581390597|FG004|Overall Study|Refused to cont. taking trial medication|0|||
160957801|NCT01687257|581232091|FG000|Overall Study|Subject Withdrew Consent|1|||
160957802|NCT01687257|581232092|FG001|Overall Study|Subject Withdrew Consent|1|||
160957803|NCT01687257|581232093|FG002|Overall Study|Subject Withdrew Consent|1|||
160957804|NCT01687257|581232091|FG000|Overall Study|Adverse Event|1|||
160957805|NCT01687257|581232092|FG001|Overall Study|Adverse Event|0|||
160957806|NCT01687257|581232093|FG002|Overall Study|Adverse Event|0|||
160957807|NCT01687257|581232091|FG000|Overall Study|Investigator's Discretion|0|||
160957808|NCT01687257|581232092|FG001|Overall Study|Investigator's Discretion|3|||
160957809|NCT01687257|581232093|FG002|Overall Study|Investigator's Discretion|0|||
160957810|NCT04899349|581232096|FG000|Overall Study|Study terminated by Sponsor|2|||
160957811|NCT04899349|581232097|FG001|Overall Study|Study terminated by Sponsor|0|||
160957812|NCT03336619|581232099|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
160957813|NCT03336619|581232100|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
160957814|NCT03336619|581232099|FG000|Overall Study|Withdrawal by Subject|17|||
160957815|NCT03336619|581232100|FG001|Overall Study|Withdrawal by Subject|16|||
160957816|NCT03336619|581232099|FG000|Overall Study|Adverse Event|2|||
160957817|NCT03336619|581232100|FG001|Overall Study|Adverse Event|5|||
160957818|NCT03336619|581232099|FG000|Overall Study|Physician Decision|3|||
160957819|NCT03336619|581232100|FG001|Overall Study|Physician Decision|0|||
160957820|NCT02820623|581232101|FG000|Overall Study|Withdrawal by Subject|1|||
160957821|NCT02820623|581232102|FG001|Overall Study|Withdrawal by Subject|3|||
160957822|NCT02820623|581232103|FG002|Overall Study|Withdrawal by Subject|3|||
160957823|NCT02820623|581232101|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
160957824|NCT02820623|581232102|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
161001459|NCT01317420|581390598|FG005|Overall Study|Refused to cont. taking trial medication|0|||
161001460|NCT01317420|581390599|FG006|Overall Study|Refused to cont. taking trial medication|0|||
161001461|NCT01317420|581390600|FG007|Overall Study|Refused to cont. taking trial medication|0|||
161001462|NCT01317420|581390601|FG008|Overall Study|Refused to cont. taking trial medication|0|||
161001463|NCT01317420|581390602|FG009|Overall Study|Refused to cont. taking trial medication|0|||
161001464|NCT01317420|581390603|FG010|Overall Study|Refused to cont. taking trial medication|0|||
161001465|NCT01317420|581390604|FG011|Overall Study|Refused to cont. taking trial medication|0|||
161001466|NCT01317420|581390605|FG012|Overall Study|Refused to cont. taking trial medication|1|||
161001467|NCT01317420|581390593|FG000|Overall Study|Reason other than those specified|0|||
161001468|NCT01317420|581390594|FG001|Overall Study|Reason other than those specified|0|||
161001469|NCT01317420|581390595|FG002|Overall Study|Reason other than those specified|0|||
161001470|NCT01317420|581390596|FG003|Overall Study|Reason other than those specified|0|||
161001471|NCT01317420|581390597|FG004|Overall Study|Reason other than those specified|0|||
161001472|NCT01317420|581390598|FG005|Overall Study|Reason other than those specified|0|||
161001473|NCT01317420|581390599|FG006|Overall Study|Reason other than those specified|0|||
161001474|NCT01317420|581390600|FG007|Overall Study|Reason other than those specified|0|||
161001475|NCT01317420|581390601|FG008|Overall Study|Reason other than those specified|0|||
161001476|NCT01317420|581390602|FG009|Overall Study|Reason other than those specified|1|||
161001477|NCT01317420|581390603|FG010|Overall Study|Reason other than those specified|0|||
161001478|NCT01317420|581390604|FG011|Overall Study|Reason other than those specified|0|||
161001479|NCT01317420|581390605|FG012|Overall Study|Reason other than those specified|0|||
161001480|NCT05686421|581390606|FG000|Overall Study|Screen failure|22|||
161001481|NCT05686421|581390607|FG001|Overall Study|Screen failure|0|||
161001482|NCT05686421|581390608|FG002|Overall Study|Screen failure|0|||
161001483|NCT05686421|581390609|FG003|Overall Study|Screen failure|0|||
161001484|NCT04210180|581390610|FG000|Overall Study|Withdrawal by Subject|2|||
161001485|NCT00367055|581390611|FG000|Overall Study|Adverse Event|6|||
161001486|NCT00367055|581390612|FG001|Overall Study|Adverse Event|3|||
161001487|NCT00367055|581390611|FG000|Overall Study|Patient's Willing|3|||
161001488|NCT00367055|581390612|FG001|Overall Study|Patient's Willing|2|||
161001489|NCT00367055|581390611|FG000|Overall Study|Lack of Efficacy|1|||
161001490|NCT00367055|581390612|FG001|Overall Study|Lack of Efficacy|2|||
161001491|NCT00367055|581390611|FG000|Overall Study|Lost to Follow-up|1|||
161001492|NCT00367055|581390612|FG001|Overall Study|Lost to Follow-up|1|||
161001493|NCT00367055|581390611|FG000|Overall Study|Protocol Violation|0|||
161001494|NCT00367055|581390612|FG001|Overall Study|Protocol Violation|1|||
160957825|NCT02820623|581232103|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
161001495|NCT00367055|581390611|FG000|Overall Study|Stopping Criterion Met|0|||
161001496|NCT00367055|581390612|FG001|Overall Study|Stopping Criterion Met|1|||
161001497|NCT00367055|581390611|FG000|Overall Study|Participant Living too Far from Hospital|0|||
160457895|NCT05424380|579407964|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
160457896|NCT05424380|579407965|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
160457897|NCT05424380|579407960|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
160457898|NCT05424380|579407961|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
160457899|NCT05424380|579407962|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
160457900|NCT05424380|579407963|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161001498|NCT00367055|581390612|FG001|Overall Study|Participant Living too Far from Hospital|1|||
161001499|NCT00324038|581390613|FG000|Overall Study|Adverse Event|38|||
160957826|NCT02820623|581232101|FG000|Overall Study|Therapist unable to enroll clients|1|||
160957827|NCT02820623|581232102|FG001|Overall Study|Therapist unable to enroll clients|1|||
160957828|NCT02820623|581232103|FG002|Overall Study|Therapist unable to enroll clients|3|||
160957829|NCT02820623|581232101|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
160957830|NCT02820623|581232102|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
160957831|NCT02820623|581232103|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
160957832|NCT02653482|581232104|FG000|Overall Study|Death|1|||
160957833|NCT02653482|581232105|FG001|Overall Study|Death|1|||
160957834|NCT05132699|581232107|FG000|Overall Study|Withdrawal by Subject|3|||
160957835|NCT05132699|581232108|FG001|Overall Study|Withdrawal by Subject|0|||
160957836|NCT04370054|581232109|FG000|Treatment Phase|Lost to Follow-up|1|||
160957837|NCT04370054|581232109|FG000|Treatment Phase|Withdrawal by Subject|1|||
160957838|NCT04370054|581232109|FG000|Follow-Up Phase|Ongoing|75|||
160957839|NCT02096900|581232110|FG000|Overall Study|Did not receive medication|3|||
160957840|NCT02096900|581232111|FG001|Overall Study|Did not receive medication|1|||
160957841|NCT02096900|581232110|FG000|Overall Study|Surgery cancelled- medication received|1|||
160957842|NCT02096900|581232111|FG001|Overall Study|Surgery cancelled- medication received|1|||
160957843|NCT00710424|581232114|FG000|Overall Study|Adverse Event|30|||
160957844|NCT00710424|581232115|FG001|Overall Study|Adverse Event|12|||
160957845|NCT00710424|581232114|FG000|Overall Study|Lack of Efficacy|4|||
160957846|NCT00710424|581232115|FG001|Overall Study|Lack of Efficacy|5|||
160957847|NCT00710424|581232114|FG000|Overall Study|Withdrawal by Subject|5|||
160957848|NCT00710424|581232115|FG001|Overall Study|Withdrawal by Subject|3|||
160957849|NCT00710424|581232114|FG000|Overall Study|Lost to Follow-up|0|||
160957850|NCT00710424|581232115|FG001|Overall Study|Lost to Follow-up|1|||
160957851|NCT00710424|581232114|FG000|Overall Study|Refused medication, no side effects|1|||
160957852|NCT00710424|581232115|FG001|Overall Study|Refused medication, no side effects|0|||
160957853|NCT00710424|581232114|FG000|Overall Study|Non-compliance with stable analgesia|1|||
160957854|NCT00710424|581232115|FG001|Overall Study|Non-compliance with stable analgesia|0|||
160957855|NCT00710424|581232114|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
160957856|NCT00710424|581232115|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
160957857|NCT00710424|581232114|FG000|Overall Study|Subject thought medication changed|1|||
160957858|NCT00710424|581232115|FG001|Overall Study|Subject thought medication changed|0|||
160957859|NCT00710424|581232114|FG000|Overall Study|Ceased treatment due to travel|1|||
160957860|NCT00710424|581232115|FG001|Overall Study|Ceased treatment due to travel|0|||
160957861|NCT00710424|581232114|FG000|Overall Study|Subject preferred paracetamol|0|||
160957862|NCT00710424|581232115|FG001|Overall Study|Subject preferred paracetamol|1|||
160957863|NCT00710424|581232114|FG000|Overall Study|Felt good so stopped treatment|0|||
160957864|NCT00710424|581232115|FG001|Overall Study|Felt good so stopped treatment|1|||
160957865|NCT01621126|581234004|FG000|Overall Study|Physician Decision|6|||
160957866|NCT03751631|581234005|FG000|Overall Study|Withdrawal by Subject|0|||
160957867|NCT03751631|581234006|FG001|Overall Study|Withdrawal by Subject|0|||
160957868|NCT03751631|581234007|FG002|Overall Study|Withdrawal by Subject|1|||
160957869|NCT03751631|581234008|FG003|Overall Study|Withdrawal by Subject|1|||
160957870|NCT03751631|581234009|FG004|Overall Study|Withdrawal by Subject|0|||
160957871|NCT03751631|581234010|FG005|Overall Study|Withdrawal by Subject|0|||
160957872|NCT02481310|581234011|FG000|Follow up|Still in follow up|0|||
160957873|NCT02481310|581234012|FG001|Follow up|Still in follow up|3|||
160957874|NCT02481310|581234013|FG002|Follow up|Still in follow up|0|||
160957875|NCT00447057|581234017|FG000|Overall Study|Adverse Event|4|||
160957876|NCT00447057|581234018|FG001|Overall Study|Adverse Event|10|||
160957877|NCT00447057|581234019|FG002|Overall Study|Adverse Event|0|||
160957878|NCT00447057|581234020|FG003|Overall Study|Adverse Event|3|||
160957879|NCT00447057|581234017|FG000|Overall Study|Death due to study disease|6|||
160957880|NCT00447057|581234018|FG001|Overall Study|Death due to study disease|4|||
160957881|NCT00447057|581234019|FG002|Overall Study|Death due to study disease|1|||
160957882|NCT00447057|581234020|FG003|Overall Study|Death due to study disease|1|||
160957883|NCT00447057|581234017|FG000|Overall Study|Lost to Follow-up|0|||
160957884|NCT00447057|581234018|FG001|Overall Study|Lost to Follow-up|1|||
160957885|NCT00447057|581234019|FG002|Overall Study|Lost to Follow-up|0|||
160957886|NCT00447057|581234020|FG003|Overall Study|Lost to Follow-up|0|||
160957887|NCT00447057|581234017|FG000|Overall Study|Entry criteria not met|1|||
160957888|NCT00447057|581234018|FG001|Overall Study|Entry criteria not met|1|||
161001500|NCT00324038|581390614|FG001|Overall Study|Adverse Event|23|||
160457901|NCT05424380|579407964|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
160457902|NCT05424380|579407965|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
160957889|NCT00447057|581234019|FG002|Overall Study|Entry criteria not met|0|||
160457903|NCT05424380|579407960|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
160457904|NCT05424380|579407961|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
160656962|NCT05097989|580124504|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
160957890|NCT00447057|581234020|FG003|Overall Study|Entry criteria not met|0|||
160957891|NCT00447057|581234017|FG000|Overall Study|Protocol Violation|0|||
160957892|NCT00447057|581234018|FG001|Overall Study|Protocol Violation|1|||
160957893|NCT00447057|581234019|FG002|Overall Study|Protocol Violation|0|||
160957894|NCT00447057|581234020|FG003|Overall Study|Protocol Violation|0|||
160957895|NCT00447057|581234017|FG000|Overall Study|Withdrawal by Subject|4|||
160957896|NCT00447057|581234018|FG001|Overall Study|Withdrawal by Subject|5|||
160957897|NCT00447057|581234019|FG002|Overall Study|Withdrawal by Subject|1|||
160957898|NCT00447057|581234020|FG003|Overall Study|Withdrawal by Subject|1|||
160957899|NCT00447057|581234017|FG000|Overall Study|Physician Decision|9|||
160957900|NCT00447057|581234018|FG001|Overall Study|Physician Decision|6|||
160957901|NCT00447057|581234019|FG002|Overall Study|Physician Decision|3|||
160957902|NCT00447057|581234020|FG003|Overall Study|Physician Decision|1|||
160957903|NCT00447057|581234017|FG000|Overall Study|Sponsor decision|1|||
160957904|NCT00447057|581234018|FG001|Overall Study|Sponsor decision|1|||
160957905|NCT00447057|581234019|FG002|Overall Study|Sponsor decision|0|||
160957906|NCT00447057|581234020|FG003|Overall Study|Sponsor decision|0|||
160957907|NCT00447057|581234017|FG000|Overall Study|Progressive disease|58|||
160957908|NCT00447057|581234018|FG001|Overall Study|Progressive disease|43|||
160957909|NCT00447057|581234019|FG002|Overall Study|Progressive disease|13|||
160957910|NCT00447057|581234020|FG003|Overall Study|Progressive disease|18|||
160957911|NCT00447057|581234017|FG000|Overall Study|Death due to adverse event|0|||
160957912|NCT00447057|581234018|FG001|Overall Study|Death due to adverse event|0|||
160957913|NCT00447057|581234019|FG002|Overall Study|Death due to adverse event|1|||
160957914|NCT00447057|581234020|FG003|Overall Study|Death due to adverse event|2|||
160957915|NCT00447057|581234017|FG000|Overall Study|Death, study drug related|0|||
160957916|NCT00447057|581234018|FG001|Overall Study|Death, study drug related|1|||
160957917|NCT00447057|581234019|FG002|Overall Study|Death, study drug related|0|||
160957918|NCT00447057|581234020|FG003|Overall Study|Death, study drug related|0|||
160957919|NCT00677833|581234021|FG000|Overall Study|Withdrawal by Subject|4|||
160957920|NCT00677833|581234022|FG001|Overall Study|Withdrawal by Subject|0|||
160957921|NCT00677833|581234023|FG002|Overall Study|Withdrawal by Subject|1|||
160957922|NCT00677833|581234024|FG003|Overall Study|Withdrawal by Subject|3|||
160957923|NCT00677833|581234021|FG000|Overall Study|Lost to Follow-up|0|||
160957924|NCT00677833|581234022|FG001|Overall Study|Lost to Follow-up|0|||
160957925|NCT00677833|581234023|FG002|Overall Study|Lost to Follow-up|1|||
160957926|NCT00677833|581234024|FG003|Overall Study|Lost to Follow-up|0|||
160957927|NCT02606279|581234029|FG000|Overall Study|Lost to Follow-up|0|||
160957928|NCT02606279|581234030|FG001|Overall Study|Lost to Follow-up|1|||
160957929|NCT03318523|581234031|FG000|PC Period: Up to Year 1|Adverse Event|1|||
160957930|NCT03318523|581234032|FG001|PC Period: Up to Year 1|Adverse Event|0|||
160957931|NCT03318523|581234033|FG002|PC Period: Up to Year 1|Adverse Event|2|||
160957932|NCT03318523|581234034|FG003|PC Period: Up to Year 1|Adverse Event|0|||
160957933|NCT03318523|581234035|FG004|PC Period: Up to Year 1|Adverse Event|0|||
160957934|NCT03318523|581234036|FG005|PC Period: Up to Year 1|Adverse Event|0|||
160957935|NCT03318523|581234037|FG006|PC Period: Up to Year 1|Adverse Event|0|||
160957936|NCT03318523|581234038|FG007|PC Period: Up to Year 1|Adverse Event|0|||
160957937|NCT03318523|581234039|FG008|PC Period: Up to Year 1|Adverse Event|0|||
160957938|NCT03318523|581234040|FG009|PC Period: Up to Year 1|Adverse Event|0|||
160957939|NCT03318523|581234031|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
160957940|NCT03318523|581234032|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
160957941|NCT03318523|581234033|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957942|NCT03318523|581234034|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
160957943|NCT03318523|581234035|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957944|NCT03318523|581234036|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957945|NCT03318523|581234037|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957946|NCT03318523|581234038|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957947|NCT03318523|581234039|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957948|NCT03318523|581234040|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957949|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957950|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957951|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957952|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957953|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
160957954|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957955|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957956|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
160957957|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957958|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
160957959|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
160957960|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
160457905|NCT05424380|579407962|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
160957961|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
160957962|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
160457906|NCT05424380|579407963|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
160957963|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
160957964|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
161001501|NCT00324038|581390613|FG000|Overall Study|Lack of Efficacy|5|||
160957965|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
160957966|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
160957967|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
160957968|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
160957969|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957970|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957971|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957972|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957973|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957974|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
160957975|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957976|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957977|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957978|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957979|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957980|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957981|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957982|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957983|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957984|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957985|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957986|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957987|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957988|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
160957989|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
160957990|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
160957991|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
160957992|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
160957993|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
160957994|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
160957995|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
160957996|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
160957997|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
160957998|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
160957999|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958000|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958001|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958002|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958003|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
160958004|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958005|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958006|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
160958007|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
160958008|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958009|NCT01615328|581234043|FG000|Overall Study|Lost to Follow-up|3|||
160958010|NCT01615328|581234044|FG001|Overall Study|Lost to Follow-up|5|||
160958021|NCT00815295|581234055|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
160958022|NCT00815295|581234056|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
160958023|NCT00815295|581234057|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
160958024|NCT02794285|581234060|FG000|Overall Study|Adverse Event|11|||
160958025|NCT02794285|581234061|FG001|Overall Study|Adverse Event|4|||
160958026|NCT02794285|581234062|FG002|Overall Study|Adverse Event|5|||
160958027|NCT02794285|581234063|FG003|Overall Study|Adverse Event|8|||
160958028|NCT02794285|581234060|FG000|Overall Study|Condition Under Investigation Improved|1|||
160958029|NCT02794285|581234061|FG001|Overall Study|Condition Under Investigation Improved|0|||
161001502|NCT00324038|581390614|FG001|Overall Study|Lack of Efficacy|13|||
161001503|NCT00324038|581390613|FG000|Overall Study|Lost to Follow-up|0|||
160958030|NCT02794285|581234062|FG002|Overall Study|Condition Under Investigation Improved|0|||
160958031|NCT02794285|581234063|FG003|Overall Study|Condition Under Investigation Improved|0|||
160958032|NCT02794285|581234060|FG000|Overall Study|Condition Under Investigation Worsened|0|||
160958033|NCT02794285|581234061|FG001|Overall Study|Condition Under Investigation Worsened|2|||
160958034|NCT02794285|581234062|FG002|Overall Study|Condition Under Investigation Worsened|1|||
160958035|NCT02794285|581234063|FG003|Overall Study|Condition Under Investigation Worsened|0|||
160958036|NCT02794285|581234060|FG000|Overall Study|Death|2|||
160958037|NCT02794285|581234061|FG001|Overall Study|Death|1|||
160958038|NCT02794285|581234062|FG002|Overall Study|Death|2|||
160958039|NCT02794285|581234063|FG003|Overall Study|Death|0|||
160958040|NCT02794285|581234060|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
160958041|NCT02794285|581234061|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
160958042|NCT02794285|581234062|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
160958043|NCT02794285|581234063|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
160958044|NCT02794285|581234060|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
160958045|NCT02794285|581234061|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
160958046|NCT02794285|581234062|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
160958047|NCT02794285|581234063|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
160958048|NCT02794285|581234060|FG000|Overall Study|Lack of Efficacy|10|||
160958049|NCT02794285|581234061|FG001|Overall Study|Lack of Efficacy|6|||
160958050|NCT02794285|581234062|FG002|Overall Study|Lack of Efficacy|3|||
160958051|NCT02794285|581234063|FG003|Overall Study|Lack of Efficacy|3|||
160958052|NCT02794285|581234060|FG000|Overall Study|Lost to Follow-up|5|||
160958053|NCT02794285|581234061|FG001|Overall Study|Lost to Follow-up|6|||
160958054|NCT02794285|581234062|FG002|Overall Study|Lost to Follow-up|3|||
160958055|NCT02794285|581234063|FG003|Overall Study|Lost to Follow-up|1|||
160958056|NCT02794285|581234060|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
160958057|NCT02794285|581234061|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
160958058|NCT02794285|581234062|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
160958059|NCT02794285|581234063|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
160958060|NCT02794285|581234060|FG000|Overall Study|Withdrawal by Subject|38|||
160958061|NCT02794285|581234061|FG001|Overall Study|Withdrawal by Subject|29|||
160958062|NCT02794285|581234062|FG002|Overall Study|Withdrawal by Subject|20|||
160958063|NCT02794285|581234063|FG003|Overall Study|Withdrawal by Subject|12|||
160958064|NCT02794285|581234060|FG000|Overall Study|Missing|1|||
160958065|NCT02794285|581234061|FG001|Overall Study|Missing|0|||
160958066|NCT02794285|581234062|FG002|Overall Study|Missing|0|||
160958067|NCT02794285|581234063|FG003|Overall Study|Missing|0|||
160958068|NCT02794285|581234060|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
160958069|NCT02794285|581234061|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
160958070|NCT02794285|581234062|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
160958071|NCT02794285|581234063|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
160958072|NCT02794285|581234060|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
160958073|NCT02794285|581234061|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
160958074|NCT02794285|581234062|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
160958075|NCT02794285|581234063|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
160958076|NCT04969198|581234082|FG000|Overall Study|Withdrawal by Subject|20|||
160958077|NCT04969198|581234082|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
160958078|NCT04969198|581234082|FG000|Overall Study|Lost to Follow-up|20|||
160958079|NCT01640808|581234083|FG000|Overall Study|Unable to continue dynamic CT|14|||
160958080|NCT01640808|581234084|FG001|Overall Study|Unable to continue dynamic CT|4|||
160958081|NCT01640808|581234083|FG000|Overall Study|Withdrawal by Subject|12|||
160958082|NCT01640808|581234084|FG001|Overall Study|Withdrawal by Subject|4|||
160958083|NCT01640808|581234083|FG000|Overall Study|Lost to Follow-up|4|||
160958084|NCT01640808|581234084|FG001|Overall Study|Lost to Follow-up|0|||
160958085|NCT01640808|581234083|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
160958086|NCT01640808|581234084|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
160958087|NCT01640808|581234083|FG000|Overall Study|Administration of anticancer drugs|2|||
160958088|NCT01640808|581234084|FG001|Overall Study|Administration of anticancer drugs|1|||
160958089|NCT01640808|581234083|FG000|Overall Study|Physician Decision|19|||
160958090|NCT01640808|581234084|FG001|Overall Study|Physician Decision|5|||
160958091|NCT01640808|581234083|FG000|Overall Study|Randomized but not treated|4|||
160958092|NCT01640808|581234084|FG001|Overall Study|Randomized but not treated|2|||
160958093|NCT02477111|581234085|FG000|Overall Study|Death|28|||
160656963|NCT05097989|580124496|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
160958094|NCT02477111|581234085|FG000|Overall Study|Withdrawal by Subject|19|||
160958095|NCT02477111|581234085|FG000|Overall Study|Lost to Follow-up|4|||
160958096|NCT01381692|581234086|FG000|Overall Study|Adverse Event|1|||
160958097|NCT01381692|581234087|FG001|Overall Study|Adverse Event|0|||
160958098|NCT01381692|581234088|FG002|Overall Study|Adverse Event|0|||
160958099|NCT01381692|581234089|FG003|Overall Study|Adverse Event|0|||
160958100|NCT01381692|581234090|FG004|Overall Study|Adverse Event|0|||
160958101|NCT01381692|581234091|FG005|Overall Study|Adverse Event|0|||
160958102|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
160457907|NCT05424380|579407964|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
160457908|NCT05424380|579407965|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
160457909|NCT05424380|579407960|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
160457910|NCT05424380|579407961|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
160457911|NCT05424380|579407962|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
160457912|NCT05424380|579407963|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
160958103|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
160958104|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
160958105|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
160958106|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
160958107|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
160958108|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
160958109|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
160958110|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
160958111|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
160958112|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
160958113|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
160958114|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
160958115|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
160958116|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
160958117|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
160958118|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
160958119|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
160958120|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
160958121|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
160958122|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
160958123|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
160958124|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
160958125|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
160958126|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
160958127|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
160958128|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
160958129|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
160958130|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
160958131|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
160958132|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
160958133|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
161001504|NCT00324038|581390614|FG001|Overall Study|Lost to Follow-up|2|||
161001505|NCT00324038|581390613|FG000|Overall Study|Other|6|||
161001506|NCT00324038|581390614|FG001|Overall Study|Other|13|||
161001507|NCT01579916|581390618|FG000|Overall Study|Lost to Follow-up|6|||
161001508|NCT01579916|581390619|FG001|Overall Study|Lost to Follow-up|1|||
161001509|NCT01579916|581390618|FG000|Overall Study|Withdrawal by Subject|1|||
161001510|NCT01579916|581390619|FG001|Overall Study|Withdrawal by Subject|1|||
161001511|NCT01579916|581390618|FG000|Overall Study|Death|1|||
161001512|NCT01579916|581390619|FG001|Overall Study|Death|0|||
161001513|NCT03264456|581390620|FG000|Overall Study|Withdrawal by Subject|3|||
161001514|NCT03264456|581390620|FG000|Overall Study|Lost to Follow-up|1|||
161001515|NCT01123083|581390623|FG000|Overall Study|Investigator recommendation|1|||
161001516|NCT01123083|581390624|FG001|Overall Study|Investigator recommendation|1|||
160457913|NCT05424380|579407964|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
160457914|NCT05424380|579407965|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
160457915|NCT05424380|579407960|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
160457916|NCT05424380|579407961|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
160457917|NCT05424380|579407962|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
160457918|NCT05424380|579407963|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
160457919|NCT05424380|579407964|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
160457920|NCT05424380|579407965|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
160457921|NCT05424380|579407960|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
160457922|NCT05424380|579407961|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
160457923|NCT05424380|579407962|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
160457924|NCT05424380|579407963|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
160457925|NCT05424380|579407964|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
160457926|NCT05424380|579407965|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161001517|NCT01123083|581390623|FG000|Overall Study|Administrative reasons|0|||
160457927|NCT05424380|579407960|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
160958134|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
160958135|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
160958136|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
160958137|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
160958138|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
160958139|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
160958140|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
160958141|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
160958142|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
160958143|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
160958144|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
160958145|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
160958146|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
160958147|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
160958148|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
160958149|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
160958150|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
160958151|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
160958152|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
160958153|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
160958154|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
160958155|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
160958156|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
160958157|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
160958158|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
160958159|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
160958160|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
160958161|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
160958162|NCT03896035|581234099|FG000|Overall Study|Lost to Follow-up|2|||
160958163|NCT03896035|581234100|FG001|Overall Study|Lost to Follow-up|6|||
160958164|NCT03896035|581234099|FG000|Overall Study|Withdrawal by Subject|0|||
160958165|NCT03896035|581234100|FG001|Overall Study|Withdrawal by Subject|1|||
160958166|NCT03896035|581234099|FG000|Overall Study|Health/family health issues during COVID|0|||
160958167|NCT03896035|581234100|FG001|Overall Study|Health/family health issues during COVID|4|||
160958168|NCT01362140|581234101|FG000|Overall Study|Noncompliance|1|||
160958169|NCT01362140|581234102|FG001|Overall Study|Noncompliance|0|||
160958170|NCT01362140|581234101|FG000|Overall Study|Adverse Event|2|||
160958171|NCT01362140|581234102|FG001|Overall Study|Adverse Event|2|||
160958172|NCT01362140|581234101|FG000|Overall Study|Withdrawal by Subject|3|||
160958173|NCT01362140|581234102|FG001|Overall Study|Withdrawal by Subject|3|||
160958174|NCT01362140|581234101|FG000|Overall Study|Administrative Decision|0|||
160958175|NCT01362140|581234102|FG001|Overall Study|Administrative Decision|1|||
160958176|NCT01362140|581234101|FG000|Overall Study|Death|2|||
160958177|NCT01362140|581234102|FG001|Overall Study|Death|1|||
160958178|NCT01362140|581234101|FG000|Overall Study|Other|1|||
160958179|NCT01362140|581234102|FG001|Overall Study|Other|1|||
160958180|NCT01362140|581234101|FG000|Overall Study|Protocol-specified Criteria|1|||
160958181|NCT01362140|581234102|FG001|Overall Study|Protocol-specified Criteria|2|||
160958182|NCT01362140|581234101|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
160958183|NCT01362140|581234102|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
160958184|NCT05553808|581234103|FG000|Overall Study|Death|25|||
160958185|NCT05553808|581234104|FG001|Overall Study|Death|62|||
160958186|NCT05553808|581234103|FG000|Overall Study|Site Closed|6|||
160958187|NCT05553808|581234104|FG001|Overall Study|Site Closed|6|||
160958188|NCT05553808|581234103|FG000|Overall Study|Lost to Follow-up|1|||
160958189|NCT05553808|581234104|FG001|Overall Study|Lost to Follow-up|0|||
160958190|NCT05553808|581234103|FG000|Overall Study|Withdrawal by Subject|3|||
160958191|NCT05553808|581234104|FG001|Overall Study|Withdrawal by Subject|2|||
160958192|NCT02273141|581234107|FG000|Overall Study|Adverse Event|0|||
160583177|NCT01111539|579855765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
160583178|NCT01111539|579855766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
160958193|NCT02273141|581234108|FG001|Overall Study|Adverse Event|1|||
160958194|NCT02273141|581234107|FG000|Overall Study|Lost to Follow-up|1|||
160958195|NCT02273141|581234108|FG001|Overall Study|Lost to Follow-up|3|||
160958196|NCT02273141|581234107|FG000|Overall Study|Withdrawal by Subject|10|||
160457928|NCT05424380|579407961|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
160457929|NCT05424380|579407962|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
160583179|NCT01111539|579855762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
160457930|NCT05424380|579407963|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
160457931|NCT05424380|579407964|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
160457932|NCT05424380|579407965|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
160457933|NCT05424380|579407960|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
160457934|NCT05424380|579407961|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
160457935|NCT05424380|579407962|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
160457936|NCT05424380|579407963|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
160457937|NCT05424380|579407964|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
160457938|NCT05424380|579407965|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
160457939|NCT05424380|579407960|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
160958197|NCT02273141|581234108|FG001|Overall Study|Withdrawal by Subject|15|||
160958198|NCT02273141|581234107|FG000|Overall Study|Various|6|||
160958199|NCT02273141|581234108|FG001|Overall Study|Various|6|||
160958200|NCT01556438|581234109|FG000|Overall Study|Adverse Event|4|||
160958201|NCT01556438|581234110|FG001|Overall Study|Adverse Event|2|||
160958202|NCT01556438|581234109|FG000|Overall Study|Sponsor Decision|0|||
160958203|NCT01556438|581234110|FG001|Overall Study|Sponsor Decision|2|||
160958204|NCT01556438|581234109|FG000|Overall Study|Progressive Disease|0|||
160958205|NCT01556438|581234110|FG001|Overall Study|Progressive Disease|6|||
160958206|NCT01556438|581234109|FG000|Overall Study|Death|0|||
160958207|NCT01556438|581234110|FG001|Overall Study|Death|1|||
160958208|NCT00529399|581234113|FG000|Overall Study|Lost to Follow-up|1|||
160958209|NCT00529399|581234114|FG001|Overall Study|Lost to Follow-up|0|||
160958210|NCT00529399|581234115|FG002|Overall Study|Lost to Follow-up|1|||
160958211|NCT00529399|581234113|FG000|Overall Study|Withdrawal by Subject|1|||
160958212|NCT00529399|581234114|FG001|Overall Study|Withdrawal by Subject|0|||
160958213|NCT00529399|581234115|FG002|Overall Study|Withdrawal by Subject|1|||
160958214|NCT00529399|581234113|FG000|Overall Study|Non-compliant|0|||
160958215|NCT00529399|581234114|FG001|Overall Study|Non-compliant|1|||
160958216|NCT00529399|581234115|FG002|Overall Study|Non-compliant|0|||
160958217|NCT03695172|581234116|FG000|Overall Study|Withdrawal by Subject|1|||
160958218|NCT03695172|581234117|FG001|Overall Study|Withdrawal by Subject|1|||
160958219|NCT03695172|581234118|FG002|Overall Study|Withdrawal by Subject|0|||
160958220|NCT01506193|581234119|FG000|Overall Study|Protocol Violation|1|||
160958221|NCT01506193|581234120|FG001|Overall Study|Protocol Violation|0|||
160958222|NCT01506193|581234121|FG002|Overall Study|Protocol Violation|1|||
160958223|NCT01506193|581234119|FG000|Overall Study|Migrated/moved from study area|0|||
160958224|NCT01506193|581234120|FG001|Overall Study|Migrated/moved from study area|0|||
160958225|NCT01506193|581234121|FG002|Overall Study|Migrated/moved from study area|1|||
160958226|NCT01506193|581234119|FG000|Overall Study|Adverse event, non-fatal|0|||
160958227|NCT01506193|581234120|FG001|Overall Study|Adverse event, non-fatal|0|||
160958228|NCT01506193|581234121|FG002|Overall Study|Adverse event, non-fatal|1|||
160958229|NCT01506193|581234119|FG000|Overall Study|Withdrawal by Subject|5|||
160958230|NCT01506193|581234120|FG001|Overall Study|Withdrawal by Subject|1|||
160958231|NCT01506193|581234121|FG002|Overall Study|Withdrawal by Subject|8|||
160958232|NCT01506193|581234119|FG000|Overall Study|Lost to Follow-up|8|||
160958233|NCT01506193|581234120|FG001|Overall Study|Lost to Follow-up|3|||
160958234|NCT01506193|581234121|FG002|Overall Study|Lost to Follow-up|3|||
160958235|NCT01388816|581234139|FG000|Overall Study|Adverse Event|0|||
160958236|NCT01388816|581234140|FG001|Overall Study|Adverse Event|2|||
160958237|NCT01388816|581234141|FG002|Overall Study|Adverse Event|0|||
160958238|NCT01388816|581234142|FG003|Overall Study|Adverse Event|0|||
160958239|NCT01388816|581234139|FG000|Overall Study|Lost to Follow-up|0|||
160958240|NCT01388816|581234140|FG001|Overall Study|Lost to Follow-up|1|||
160457940|NCT05424380|579407961|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
160457941|NCT05424380|579407962|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
160457942|NCT05424380|579407963|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
160457943|NCT05424380|579407964|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
160583180|NCT01111539|579855763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
160583181|NCT01111539|579855764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
160583182|NCT01111539|579855765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
160583183|NCT01111539|579855766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
160583184|NCT01111539|579855762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
160958241|NCT01388816|581234141|FG002|Overall Study|Lost to Follow-up|0|||
160958242|NCT01388816|581234142|FG003|Overall Study|Lost to Follow-up|0|||
160958243|NCT01388816|581234139|FG000|Overall Study|Withdrawal by Subject|2|||
160958244|NCT01388816|581234140|FG001|Overall Study|Withdrawal by Subject|1|||
160958245|NCT01388816|581234141|FG002|Overall Study|Withdrawal by Subject|1|||
160958246|NCT01388816|581234142|FG003|Overall Study|Withdrawal by Subject|0|||
160958247|NCT01388816|581234139|FG000|Overall Study|Protocol Violation|0|||
160958248|NCT01388816|581234140|FG001|Overall Study|Protocol Violation|0|||
160958249|NCT01388816|581234141|FG002|Overall Study|Protocol Violation|2|||
160958250|NCT01388816|581234142|FG003|Overall Study|Protocol Violation|0|||
160958251|NCT04575467|581234143|FG000|Overall Study|Adverse Event|0|||
160958252|NCT04575467|581234144|FG001|Overall Study|Adverse Event|1|||
160958253|NCT04575467|581234145|FG002|Overall Study|Adverse Event|0|||
160958254|NCT04575467|581234146|FG003|Overall Study|Adverse Event|0|||
160958255|NCT00743366|581234147|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
160958256|NCT00743366|581234148|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
160958257|NCT01328574|581234149|FG000|Overall Study|Refused further treatment|1|||
160958258|NCT03206203|581234150|FG000|Treatment|Death|38|||
160958259|NCT03206203|581234151|FG001|Treatment|Death|26|||
160958260|NCT03206203|581234152|FG002|Treatment|Death|0|||
160958261|NCT03206203|581234150|FG000|Treatment|Withdrawal by Subject|1|||
160958262|NCT03206203|581234151|FG001|Treatment|Withdrawal by Subject|0|||
160958263|NCT03206203|581234152|FG002|Treatment|Withdrawal by Subject|0|||
160583185|NCT01111539|579855763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
160583186|NCT01111539|579855764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
160583187|NCT01111539|579855765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
160583188|NCT01111539|579855766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
160583189|NCT01111539|579855762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160583190|NCT01111539|579855763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160583191|NCT01111539|579855764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160583192|NCT01111539|579855765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160583193|NCT01111539|579855766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
160583194|NCT03580382|579855771|FG000|Overall Study|Early Termination of Study|0|||
160583195|NCT03580382|579855772|FG001|Overall Study|Early Termination of Study|3|||
160583196|NCT02808312|579855773|FG000|Overall Study|Enrolled but Never Treated|0|||
160583197|NCT02808312|579855774|FG001|Overall Study|Enrolled but Never Treated|0|||
160583198|NCT02808312|579855775|FG002|Overall Study|Enrolled but Never Treated|1|||
160583199|NCT02808312|579855776|FG003|Overall Study|Enrolled but Never Treated|0|||
160583200|NCT02808312|579855777|FG004|Overall Study|Enrolled but Never Treated|0|||
160583201|NCT03628417|579855778|FG000|Overall Study|Death|1|||
160583202|NCT03628417|579855779|FG001|Overall Study|Death|1|||
160583203|NCT02420223|579855780|FG000|Overall Study|Adverse Event|1|||
160583204|NCT02420223|579855781|FG001|Overall Study|Adverse Event|0|||
160583205|NCT02420223|579855780|FG000|Overall Study|Physician Decision|0|||
160583206|NCT02420223|579855781|FG001|Overall Study|Physician Decision|2|||
160583207|NCT01361009|579855782|FG000|Overall Study|Protocol Violation|116|||
160583208|NCT01826422|579855783|FG000|Overall Study|Withdrawal by Subject|1|||
160583209|NCT01826422|579855784|FG001|Overall Study|Withdrawal by Subject|3|||
160583210|NCT04263142|579855785|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
160583211|NCT04263142|579855786|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
160583212|NCT04263142|579855787|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
160583213|NCT04263142|579855788|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
160583214|NCT04263142|579855789|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
160583215|NCT04263142|579855785|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
160583216|NCT04263142|579855786|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
160583217|NCT04263142|579855787|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
160583218|NCT04263142|579855788|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
160583219|NCT04263142|579855789|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
160583220|NCT00520676|579855790|FG000|Overall Study|Death|84|||
160958264|NCT03206203|581234150|FG000|Treatment|Lost to Follow-up|4|||
160958265|NCT03206203|581234151|FG001|Treatment|Lost to Follow-up|0|||
160958266|NCT03206203|581234152|FG002|Treatment|Lost to Follow-up|0|||
160958267|NCT03206203|581234150|FG000|Treatment|N/A in Follow-Up|8|||
160958268|NCT03206203|581234151|FG001|Treatment|N/A in Follow-Up|1|||
160958269|NCT03206203|581234152|FG002|Treatment|N/A in Follow-Up|0|||
160958270|NCT03206203|581234150|FG000|Treatment|Disease progression|0|||
160958271|NCT03206203|581234151|FG001|Treatment|Disease progression|1|||
160958272|NCT03206203|581234152|FG002|Treatment|Disease progression|0|||
160958273|NCT03206203|581234150|FG000|Treatment|Refused follow-up|0|||
160958274|NCT03206203|581234151|FG001|Treatment|Refused follow-up|1|||
160958275|NCT03206203|581234152|FG002|Treatment|Refused follow-up|0|||
160583221|NCT00520676|579855791|FG001|Overall Study|Death|81|||
160583222|NCT00520676|579855790|FG000|Overall Study|Lost to Follow-up|6|||
160583223|NCT00520676|579855791|FG001|Overall Study|Lost to Follow-up|10|||
160583224|NCT00520676|579855790|FG000|Overall Study|Physician Decision|4|||
160583225|NCT00520676|579855791|FG001|Overall Study|Physician Decision|1|||
160583226|NCT00520676|579855790|FG000|Overall Study|Withdrawal by Subject|7|||
160583227|NCT00520676|579855791|FG001|Overall Study|Withdrawal by Subject|11|||
160583228|NCT03439748|579855792|FG000|Overall Study|Withdrawal by Subject|11|||
160583229|NCT03439748|579855793|FG001|Overall Study|Withdrawal by Subject|17|||
160583230|NCT01856595|579855794|FG000|Overall Study|Withdrawal by Subject|0|||
160958276|NCT03206203|581234150|FG000|Treatment|Cross over to Arm 1|0|||
160958277|NCT03206203|581234151|FG001|Treatment|Cross over to Arm 1|19|||
160958278|NCT03206203|581234152|FG002|Treatment|Cross over to Arm 1|0|||
160958279|NCT03206203|581234150|FG000|Optional Cross-Over|Death|0|||
160958280|NCT03206203|581234151|FG001|Optional Cross-Over|Death|0|||
160958281|NCT03206203|581234152|FG002|Optional Cross-Over|Death|14|||
160958282|NCT03206203|581234150|FG000|Optional Cross-Over|Refused follow-up|0|||
160958283|NCT03206203|581234151|FG001|Optional Cross-Over|Refused follow-up|0|||
160958284|NCT03206203|581234152|FG002|Optional Cross-Over|Refused follow-up|2|||
160958285|NCT03998618|581234155|FG000|Overall Study|Death|7|||
160958286|NCT03998618|581234156|FG001|Overall Study|Death|11|||
160958287|NCT03998618|581234155|FG000|Overall Study|hospice enrollment|3|||
160958288|NCT03998618|581234156|FG001|Overall Study|hospice enrollment|3|||
160958289|NCT03998618|581234155|FG000|Overall Study|Not feeling well/health problems|3|||
160958290|NCT03998618|581234156|FG001|Overall Study|Not feeling well/health problems|5|||
160583231|NCT01856595|579855795|FG001|Overall Study|Withdrawal by Subject|1|||
160583232|NCT01856595|579855796|FG002|Overall Study|Withdrawal by Subject|0|||
160583233|NCT01856595|579855797|FG003|Overall Study|Withdrawal by Subject|0|||
160583234|NCT01856595|579855798|FG004|Overall Study|Withdrawal by Subject|0|||
160583235|NCT01856595|579855799|FG005|Overall Study|Withdrawal by Subject|0|||
160583236|NCT01856595|579855800|FG006|Overall Study|Withdrawal by Subject|1|||
160583237|NCT01856595|579855801|FG007|Overall Study|Withdrawal by Subject|0|||
160583238|NCT01856595|579855802|FG008|Overall Study|Withdrawal by Subject|0|||
160583239|NCT04426825|579855804|FG000|Overall Study|Death|17|||
160583240|NCT04426825|579855804|FG000|Overall Study|Lost to Follow-up|1|||
160583241|NCT04426825|579855804|FG000|Overall Study|Study terminated by sponsor|5|||
160583242|NCT04402008|579855807|FG000|Overall Study|Adverse Event|0|||
160583243|NCT04402008|579855808|FG001|Overall Study|Adverse Event|0|||
160583244|NCT04402008|579855809|FG002|Overall Study|Adverse Event|0|||
160583245|NCT04402008|579855810|FG003|Overall Study|Adverse Event|1|||
160583246|NCT04402008|579855811|FG004|Overall Study|Adverse Event|0|||
160583247|NCT04402008|579855812|FG005|Overall Study|Adverse Event|0|||
160583248|NCT04402008|579855813|FG006|Overall Study|Adverse Event|0|||
160583249|NCT04402008|579855807|FG000|Overall Study|Disease Progression|3|||
160583250|NCT04402008|579855808|FG001|Overall Study|Disease Progression|2|||
160583251|NCT04402008|579855809|FG002|Overall Study|Disease Progression|3|||
160583252|NCT04402008|579855810|FG003|Overall Study|Disease Progression|3|||
160583253|NCT04402008|579855811|FG004|Overall Study|Disease Progression|4|||
160583254|NCT04402008|579855812|FG005|Overall Study|Disease Progression|3|||
160583255|NCT04402008|579855813|FG006|Overall Study|Disease Progression|10|||
160583256|NCT04402008|579855807|FG000|Overall Study|Withdrawal by Subject|0|||
160583257|NCT04402008|579855808|FG001|Overall Study|Withdrawal by Subject|1|||
160583258|NCT04402008|579855809|FG002|Overall Study|Withdrawal by Subject|0|||
160583259|NCT04402008|579855810|FG003|Overall Study|Withdrawal by Subject|0|||
160583260|NCT04402008|579855811|FG004|Overall Study|Withdrawal by Subject|1|||
160583261|NCT04402008|579855812|FG005|Overall Study|Withdrawal by Subject|0|||
160583262|NCT04402008|579855813|FG006|Overall Study|Withdrawal by Subject|0|||
160583263|NCT04402008|579855807|FG000|Overall Study|Sponsor Decision|0|||
160583264|NCT04402008|579855808|FG001|Overall Study|Sponsor Decision|0|||
160583265|NCT04402008|579855809|FG002|Overall Study|Sponsor Decision|0|||
160583266|NCT04402008|579855810|FG003|Overall Study|Sponsor Decision|0|||
160583267|NCT04402008|579855811|FG004|Overall Study|Sponsor Decision|0|||
160583268|NCT04402008|579855812|FG005|Overall Study|Sponsor Decision|0|||
160583269|NCT04402008|579855813|FG006|Overall Study|Sponsor Decision|3|||
160583270|NCT04402008|579855807|FG000|Overall Study|Death|0|||
160583271|NCT04402008|579855808|FG001|Overall Study|Death|0|||
160583272|NCT04402008|579855809|FG002|Overall Study|Death|0|||
160583273|NCT04402008|579855810|FG003|Overall Study|Death|0|||
160583274|NCT04402008|579855811|FG004|Overall Study|Death|1|||
160583275|NCT04402008|579855812|FG005|Overall Study|Death|0|||
160583276|NCT04402008|579855813|FG006|Overall Study|Death|2|||
160583277|NCT04402008|579855807|FG000|Overall Study|Other|0|||
160583278|NCT04402008|579855808|FG001|Overall Study|Other|0|||
160583279|NCT04402008|579855809|FG002|Overall Study|Other|0|||
160583280|NCT04402008|579855810|FG003|Overall Study|Other|0|||
160583281|NCT04402008|579855811|FG004|Overall Study|Other|0|||
160656964|NCT05097989|580124497|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
160656965|NCT05097989|580124498|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
160958291|NCT03998618|581234155|FG000|Overall Study|Lost to Follow-up|6|||
160958292|NCT03998618|581234156|FG001|Overall Study|Lost to Follow-up|6|||
160958293|NCT03998618|581234155|FG000|Overall Study|Withdrawal by Subject|0|||
160583282|NCT04402008|579855812|FG005|Overall Study|Other|0|||
160958294|NCT03998618|581234156|FG001|Overall Study|Withdrawal by Subject|4|||
160583283|NCT04402008|579855813|FG006|Overall Study|Other|5|||
160583284|NCT00913978|579855814|FG000|Overall Study|Surgeon choice|1|||
160583285|NCT00913978|579855815|FG001|Overall Study|Surgeon choice|3|||
160583286|NCT04716933|579855816|FG000|Overall Study|Sponsor Decision|36|||
160583287|NCT04716933|579855817|FG001|Overall Study|Sponsor Decision|33|||
160958295|NCT02308748|581234161|FG000|Period 1|Withdrawal by Subject|0|||
160583288|NCT04716933|579855816|FG000|Overall Study|Death|65|||
160583289|NCT04716933|579855817|FG001|Overall Study|Death|67|||
160583290|NCT03249792|579855818|FG000|Arms 1, 2, and 4|Death|1|||
160583291|NCT03249792|579855819|FG001|Arms 1, 2, and 4|Death|1|||
160583292|NCT03249792|579855820|FG002|Arms 1, 2, and 4|Death|0|||
160958296|NCT02308748|581234162|FG001|Period 1|Withdrawal by Subject|0|||
160958297|NCT02308748|581234163|FG002|Period 1|Withdrawal by Subject|1|||
160958298|NCT02308748|581234164|FG003|Period 1|Withdrawal by Subject|0|||
160958299|NCT02308748|581234165|FG004|Period 1|Withdrawal by Subject|0|||
160583293|NCT03249792|579855821|FG003|Arms 1, 2, and 4|Death|2|||
160583294|NCT03249792|579855822|FG004|Arms 1, 2, and 4|Death|3|||
160583295|NCT03249792|579855823|FG005|Arms 1, 2, and 4|Death|2|||
160583296|NCT03249792|579855824|FG006|Arms 1, 2, and 4|Death|2|||
160583297|NCT03249792|579855825|FG007|Arms 1, 2, and 4|Death|4|||
160583298|NCT03249792|579855826|FG008|Arms 1, 2, and 4|Death|2|||
160583299|NCT03249792|579855827|FG009|Arms 1, 2, and 4|Death|1|||
160583300|NCT03249792|579855828|FG010|Arms 1, 2, and 4|Death|7|||
160583301|NCT03249792|579855829|FG011|Arms 1, 2, and 4|Death|7|||
160583302|NCT03249792|579855830|FG012|Arms 1, 2, and 4|Death|12|||
160583303|NCT03249792|579855831|FG013|Arms 1, 2, and 4|Death|7|||
160583304|NCT03249792|579855832|FG014|Arms 1, 2, and 4|Death|0|||
160583305|NCT03249792|579855833|FG015|Arms 1, 2, and 4|Death|4|||
160583306|NCT03249792|579855834|FG016|Arms 1, 2, and 4|Death|4|||
160583307|NCT03249792|579855835|FG017|Arms 1, 2, and 4|Death|12|||
160583308|NCT03249792|579855836|FG018|Arms 1, 2, and 4|Death|6|||
160583309|NCT03249792|579855837|FG019|Arms 1, 2, and 4|Death|4|||
160583310|NCT03249792|579855838|FG020|Arms 1, 2, and 4|Death|2|||
160583311|NCT03249792|579855839|FG021|Arms 1, 2, and 4|Death|3|||
160583312|NCT03249792|579855840|FG022|Arms 1, 2, and 4|Death|1|||
160583313|NCT03249792|579855841|FG023|Arms 1, 2, and 4|Death|1|||
160958300|NCT02308748|581234166|FG005|Period 1|Withdrawal by Subject|0|||
160958301|NCT02308748|581234167|FG006|Period 1|Withdrawal by Subject|0|||
160958302|NCT02308748|581234168|FG007|Period 1|Withdrawal by Subject|0|||
160958303|NCT02308748|581234169|FG008|Period 1|Withdrawal by Subject|0|||
160583314|NCT03249792|579855842|FG024|Arms 1, 2, and 4|Death|4|||
160583315|NCT03249792|579855843|FG025|Arms 1, 2, and 4|Death|0|||
160583316|NCT03249792|579855844|FG026|Arms 1, 2, and 4|Death|0|||
160958304|NCT02308748|581234170|FG009|Period 1|Withdrawal by Subject|0|||
160583317|NCT03249792|579855845|FG027|Arms 1, 2, and 4|Death|0|||
160583318|NCT03249792|579855846|FG028|Arms 1, 2, and 4|Death|0|||
160583319|NCT03249792|579855847|FG029|Arms 1, 2, and 4|Death|0|||
160583320|NCT03249792|579855848|FG030|Arms 1, 2, and 4|Death|0|||
160583321|NCT03249792|579855849|FG031|Arms 1, 2, and 4|Death|0|||
160583322|NCT03249792|579855850|FG032|Arms 1, 2, and 4|Death|0|||
160583323|NCT03249792|579855818|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583324|NCT03249792|579855819|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583325|NCT03249792|579855820|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
160583326|NCT03249792|579855821|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583327|NCT03249792|579855822|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583328|NCT03249792|579855823|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
160583329|NCT03249792|579855824|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
160583330|NCT03249792|579855825|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583331|NCT03249792|579855826|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
160583332|NCT03249792|579855827|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
160583333|NCT03249792|579855828|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
160583334|NCT03249792|579855829|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
160583335|NCT03249792|579855830|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
160583336|NCT03249792|579855831|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
160583337|NCT03249792|579855832|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583338|NCT03249792|579855833|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583339|NCT03249792|579855834|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
160583340|NCT03249792|579855835|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583341|NCT03249792|579855836|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
160583342|NCT03249792|579855837|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583343|NCT03249792|579855838|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583344|NCT03249792|579855839|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583345|NCT03249792|579855840|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
160583346|NCT03249792|579855841|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
160583347|NCT03249792|579855842|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160958305|NCT02308748|581234161|FG000|Period 2|Adverse Event|0|||
160958306|NCT02308748|581234162|FG001|Period 2|Adverse Event|0|||
160958307|NCT02308748|581234163|FG002|Period 2|Adverse Event|0|||
160958308|NCT02308748|581234164|FG003|Period 2|Adverse Event|0|||
160457944|NCT05424380|579407965|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
160457945|NCT05424380|579407960|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
160457946|NCT05424380|579407961|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
160583348|NCT03249792|579855843|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583349|NCT03249792|579855844|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583350|NCT03249792|579855845|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583351|NCT03249792|579855846|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583352|NCT03249792|579855847|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583353|NCT03249792|579855848|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583354|NCT03249792|579855849|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583355|NCT03249792|579855850|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
160583356|NCT03249792|579855818|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
160583357|NCT03249792|579855819|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
160583358|NCT03249792|579855820|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
160958309|NCT02308748|581234165|FG004|Period 2|Adverse Event|0|||
160958310|NCT02308748|581234166|FG005|Period 2|Adverse Event|0|||
160958311|NCT02308748|581234167|FG006|Period 2|Adverse Event|0|||
160583359|NCT03249792|579855821|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
160583360|NCT03249792|579855822|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
160583361|NCT03249792|579855823|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
160583362|NCT03249792|579855824|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
160583363|NCT03249792|579855825|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
160583364|NCT03249792|579855826|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
160583365|NCT03249792|579855827|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
160583366|NCT03249792|579855828|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
160583367|NCT03249792|579855829|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
160583368|NCT03249792|579855830|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
160583369|NCT03249792|579855831|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
160583370|NCT03249792|579855832|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
160583371|NCT03249792|579855833|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
160583372|NCT03249792|579855834|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
160583373|NCT03249792|579855835|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
160583374|NCT03249792|579855836|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
160583375|NCT03249792|579855837|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
160583376|NCT03249792|579855838|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
160583377|NCT03249792|579855839|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
160583378|NCT03249792|579855840|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
160583379|NCT03249792|579855841|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
160583380|NCT03249792|579855842|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
160583381|NCT03249792|579855843|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
160583382|NCT03249792|579855844|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
160583383|NCT03249792|579855845|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
160583384|NCT03249792|579855846|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
160583385|NCT03249792|579855847|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
160583386|NCT03249792|579855848|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
160583387|NCT03249792|579855849|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
160583388|NCT03249792|579855850|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
160583389|NCT03249792|579855818|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583390|NCT03249792|579855819|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583391|NCT03249792|579855820|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
160958312|NCT02308748|581234168|FG007|Period 2|Adverse Event|1|||
160958313|NCT02308748|581234169|FG008|Period 2|Adverse Event|0|||
160958314|NCT02308748|581234170|FG009|Period 2|Adverse Event|0|||
160958315|NCT02308748|581234161|FG000|Period 3|Protocol Violation|0|||
160958316|NCT02308748|581234162|FG001|Period 3|Protocol Violation|0|||
160958317|NCT02308748|581234163|FG002|Period 3|Protocol Violation|0|||
160958318|NCT02308748|581234164|FG003|Period 3|Protocol Violation|0|||
160958319|NCT02308748|581234165|FG004|Period 3|Protocol Violation|0|||
160958320|NCT02308748|581234166|FG005|Period 3|Protocol Violation|0|||
160958321|NCT02308748|581234167|FG006|Period 3|Protocol Violation|0|||
160958322|NCT02308748|581234168|FG007|Period 3|Protocol Violation|0|||
160958323|NCT02308748|581234169|FG008|Period 3|Protocol Violation|0|||
160958324|NCT02308748|581234170|FG009|Period 3|Protocol Violation|1|||
160958325|NCT02308748|581234161|FG000|Period 5|Adverse Event|1|||
160958326|NCT02308748|581234162|FG001|Period 5|Adverse Event|0|||
160958327|NCT02308748|581234163|FG002|Period 5|Adverse Event|0|||
160958328|NCT02308748|581234164|FG003|Period 5|Adverse Event|0|||
160958329|NCT02308748|581234165|FG004|Period 5|Adverse Event|0|||
160958330|NCT02308748|581234166|FG005|Period 5|Adverse Event|0|||
160958331|NCT02308748|581234167|FG006|Period 5|Adverse Event|0|||
160958332|NCT02308748|581234168|FG007|Period 5|Adverse Event|0|||
160958333|NCT02308748|581234169|FG008|Period 5|Adverse Event|1|||
160958334|NCT02308748|581234170|FG009|Period 5|Adverse Event|0|||
160958335|NCT01152580|581234171|FG000|Overall Study|Withdrawal by Subject|0|||
160958336|NCT01152580|581234172|FG001|Overall Study|Withdrawal by Subject|1|||
160958337|NCT01994954|581234173|FG000|Overall Study|Death|1|||
160958338|NCT01994954|581234174|FG001|Overall Study|Death|0|||
160958339|NCT01994954|581234173|FG000|Overall Study|Withdrawal by Subject|9|||
160958340|NCT01994954|581234174|FG001|Overall Study|Withdrawal by Subject|14|||
160457947|NCT05424380|579407962|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
160457948|NCT05424380|579407963|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
160958341|NCT01994954|581234173|FG000|Overall Study|Physician Decision|2|||
160583392|NCT03249792|579855821|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583393|NCT03249792|579855822|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583394|NCT03249792|579855823|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583395|NCT03249792|579855824|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583396|NCT03249792|579855825|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583397|NCT03249792|579855826|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
160583398|NCT03249792|579855827|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583399|NCT03249792|579855828|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583400|NCT03249792|579855829|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583401|NCT03249792|579855830|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
160958342|NCT01994954|581234174|FG001|Overall Study|Physician Decision|2|||
160958343|NCT01994954|581234173|FG000|Overall Study|Lost to Follow-up|8|||
160958344|NCT01994954|581234174|FG001|Overall Study|Lost to Follow-up|10|||
160958345|NCT01994954|581234173|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
160958346|NCT01994954|581234174|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
160583402|NCT03249792|579855831|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583403|NCT03249792|579855832|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583404|NCT03249792|579855833|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583405|NCT03249792|579855834|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
160583406|NCT03249792|579855835|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
160583407|NCT03249792|579855836|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
160958347|NCT00449176|581234176|FG000|Overall Study|Withdrawal by Subject|39|||
160958348|NCT00449176|581234177|FG001|Overall Study|Withdrawal by Subject|43|||
160958349|NCT00449176|581234178|FG002|Overall Study|Withdrawal by Subject|59|||
160958350|NCT00449176|581234176|FG000|Overall Study|Lost to Follow-up|13|||
160958351|NCT00449176|581234177|FG001|Overall Study|Lost to Follow-up|8|||
160958352|NCT00449176|581234178|FG002|Overall Study|Lost to Follow-up|12|||
160958353|NCT00449176|581234176|FG000|Overall Study|Adverse Event|51|||
160958354|NCT00449176|581234177|FG001|Overall Study|Adverse Event|107|||
160958355|NCT00449176|581234178|FG002|Overall Study|Adverse Event|15|||
160958356|NCT00449176|581234176|FG000|Overall Study|Lack of Efficacy|13|||
160958357|NCT00449176|581234177|FG001|Overall Study|Lack of Efficacy|7|||
160958358|NCT00449176|581234178|FG002|Overall Study|Lack of Efficacy|50|||
160958359|NCT00449176|581234176|FG000|Overall Study|Study drug non-compliant|14|||
160958360|NCT00449176|581234177|FG001|Overall Study|Study drug non-compliant|11|||
160958361|NCT00449176|581234178|FG002|Overall Study|Study drug non-compliant|11|||
160958362|NCT00449176|581234176|FG000|Overall Study|all other|22|||
160958363|NCT00449176|581234177|FG001|Overall Study|all other|19|||
160958364|NCT00449176|581234178|FG002|Overall Study|all other|20|||
160958365|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
160958366|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
160958367|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|disease progression|58|||
160958368|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|disease progression|47|||
160958369|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Death|3|||
160958370|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Death|6|||
160958371|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
160958372|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
160958373|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
160958374|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
160958375|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
160958376|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
160958377|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Other|2|||
160958378|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Other|1|||
160958379|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
160958380|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
160583408|NCT03249792|579855837|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
160583409|NCT03249792|579855838|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583410|NCT03249792|579855839|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583411|NCT03249792|579855840|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583412|NCT03249792|579855841|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583413|NCT03249792|579855842|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583414|NCT03249792|579855843|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583415|NCT03249792|579855844|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583416|NCT03249792|579855845|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583417|NCT03249792|579855846|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583418|NCT03249792|579855847|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583419|NCT03249792|579855848|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583420|NCT03249792|579855849|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583421|NCT03249792|579855850|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
160583422|NCT03249792|579855818|FG000|Switch Over Period|Withdrawal by Subject|0|||
160583423|NCT03249792|579855819|FG001|Switch Over Period|Withdrawal by Subject|0|||
160583424|NCT03249792|579855820|FG002|Switch Over Period|Withdrawal by Subject|0|||
160583425|NCT03249792|579855821|FG003|Switch Over Period|Withdrawal by Subject|0|||
160583426|NCT03249792|579855822|FG004|Switch Over Period|Withdrawal by Subject|0|||
160583427|NCT03249792|579855823|FG005|Switch Over Period|Withdrawal by Subject|0|||
160958381|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
160958382|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
160583428|NCT03249792|579855824|FG006|Switch Over Period|Withdrawal by Subject|0|||
160583429|NCT03249792|579855825|FG007|Switch Over Period|Withdrawal by Subject|0|||
160583430|NCT03249792|579855826|FG008|Switch Over Period|Withdrawal by Subject|0|||
160583431|NCT03249792|579855827|FG009|Switch Over Period|Withdrawal by Subject|0|||
160583432|NCT03249792|579855828|FG010|Switch Over Period|Withdrawal by Subject|0|||
160583433|NCT03249792|579855829|FG011|Switch Over Period|Withdrawal by Subject|0|||
160656966|NCT05097989|580124499|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
160656967|NCT05097989|580124500|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
160958383|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Death|0|||
160583434|NCT03249792|579855830|FG012|Switch Over Period|Withdrawal by Subject|0|||
160656968|NCT05097989|580124501|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
160958384|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Death|1|||
160958385|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
160958386|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
160583435|NCT03249792|579855831|FG013|Switch Over Period|Withdrawal by Subject|0|||
160583436|NCT03249792|579855832|FG014|Switch Over Period|Withdrawal by Subject|0|||
160583437|NCT03249792|579855833|FG015|Switch Over Period|Withdrawal by Subject|0|||
160583438|NCT03249792|579855834|FG016|Switch Over Period|Withdrawal by Subject|0|||
160583439|NCT03249792|579855835|FG017|Switch Over Period|Withdrawal by Subject|0|||
160583440|NCT03249792|579855836|FG018|Switch Over Period|Withdrawal by Subject|0|||
160583441|NCT03249792|579855837|FG019|Switch Over Period|Withdrawal by Subject|0|||
160583442|NCT03249792|579855838|FG020|Switch Over Period|Withdrawal by Subject|0|||
160583443|NCT03249792|579855839|FG021|Switch Over Period|Withdrawal by Subject|0|||
160583444|NCT03249792|579855840|FG022|Switch Over Period|Withdrawal by Subject|0|||
160583445|NCT03249792|579855841|FG023|Switch Over Period|Withdrawal by Subject|0|||
160583446|NCT03249792|579855842|FG024|Switch Over Period|Withdrawal by Subject|0|||
160583447|NCT03249792|579855843|FG025|Switch Over Period|Withdrawal by Subject|0|||
160583448|NCT03249792|579855844|FG026|Switch Over Period|Withdrawal by Subject|0|||
160583449|NCT03249792|579855845|FG027|Switch Over Period|Withdrawal by Subject|0|||
160583450|NCT03249792|579855846|FG028|Switch Over Period|Withdrawal by Subject|0|||
160583451|NCT03249792|579855847|FG029|Switch Over Period|Withdrawal by Subject|0|||
160583452|NCT03249792|579855848|FG030|Switch Over Period|Withdrawal by Subject|0|||
160583453|NCT03249792|579855849|FG031|Switch Over Period|Withdrawal by Subject|1|||
160583454|NCT03249792|579855850|FG032|Switch Over Period|Withdrawal by Subject|0|||
160583455|NCT03249792|579855818|FG000|Switch Over Period|Progressive Disease|0|||
160583456|NCT03249792|579855819|FG001|Switch Over Period|Progressive Disease|0|||
160583457|NCT03249792|579855820|FG002|Switch Over Period|Progressive Disease|0|||
160583458|NCT03249792|579855821|FG003|Switch Over Period|Progressive Disease|0|||
160583459|NCT03249792|579855822|FG004|Switch Over Period|Progressive Disease|0|||
160583460|NCT03249792|579855823|FG005|Switch Over Period|Progressive Disease|0|||
160583461|NCT03249792|579855824|FG006|Switch Over Period|Progressive Disease|0|||
160583462|NCT03249792|579855825|FG007|Switch Over Period|Progressive Disease|0|||
160583463|NCT03249792|579855826|FG008|Switch Over Period|Progressive Disease|0|||
160583464|NCT03249792|579855827|FG009|Switch Over Period|Progressive Disease|0|||
160583465|NCT03249792|579855828|FG010|Switch Over Period|Progressive Disease|0|||
160583466|NCT03249792|579855829|FG011|Switch Over Period|Progressive Disease|0|||
160583467|NCT03249792|579855830|FG012|Switch Over Period|Progressive Disease|0|||
160583468|NCT03249792|579855831|FG013|Switch Over Period|Progressive Disease|0|||
160583469|NCT03249792|579855832|FG014|Switch Over Period|Progressive Disease|0|||
160583470|NCT03249792|579855833|FG015|Switch Over Period|Progressive Disease|0|||
160583471|NCT03249792|579855834|FG016|Switch Over Period|Progressive Disease|0|||
160583472|NCT03249792|579855835|FG017|Switch Over Period|Progressive Disease|0|||
160583473|NCT03249792|579855836|FG018|Switch Over Period|Progressive Disease|0|||
160583474|NCT03249792|579855837|FG019|Switch Over Period|Progressive Disease|0|||
160583475|NCT03249792|579855838|FG020|Switch Over Period|Progressive Disease|0|||
160583476|NCT03249792|579855839|FG021|Switch Over Period|Progressive Disease|0|||
160583477|NCT03249792|579855840|FG022|Switch Over Period|Progressive Disease|0|||
160583478|NCT03249792|579855841|FG023|Switch Over Period|Progressive Disease|0|||
160583479|NCT03249792|579855842|FG024|Switch Over Period|Progressive Disease|0|||
160583480|NCT03249792|579855843|FG025|Switch Over Period|Progressive Disease|0|||
160583481|NCT03249792|579855844|FG026|Switch Over Period|Progressive Disease|1|||
160583482|NCT03249792|579855845|FG027|Switch Over Period|Progressive Disease|0|||
160583483|NCT03249792|579855846|FG028|Switch Over Period|Progressive Disease|1|||
160583484|NCT03249792|579855847|FG029|Switch Over Period|Progressive Disease|2|||
160583485|NCT03249792|579855848|FG030|Switch Over Period|Progressive Disease|1|||
160583486|NCT03249792|579855849|FG031|Switch Over Period|Progressive Disease|0|||
160583487|NCT03249792|579855850|FG032|Switch Over Period|Progressive Disease|1|||
160583488|NCT03249792|579855818|FG000|Switch Over Period|Adverse Event|0|||
160583489|NCT03249792|579855819|FG001|Switch Over Period|Adverse Event|0|||
161001518|NCT01123083|581390624|FG001|Overall Study|Administrative reasons|4|||
161001519|NCT01123083|581390623|FG000|Overall Study|Lost to Follow-up|2|||
160457949|NCT05424380|579407964|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
160583490|NCT03249792|579855820|FG002|Switch Over Period|Adverse Event|0|||
160583491|NCT03249792|579855821|FG003|Switch Over Period|Adverse Event|0|||
160583492|NCT03249792|579855822|FG004|Switch Over Period|Adverse Event|0|||
160583493|NCT03249792|579855823|FG005|Switch Over Period|Adverse Event|0|||
160583494|NCT03249792|579855824|FG006|Switch Over Period|Adverse Event|0|||
160583495|NCT03249792|579855825|FG007|Switch Over Period|Adverse Event|0|||
160583496|NCT03249792|579855826|FG008|Switch Over Period|Adverse Event|0|||
160583497|NCT03249792|579855827|FG009|Switch Over Period|Adverse Event|0|||
160583498|NCT03249792|579855828|FG010|Switch Over Period|Adverse Event|0|||
160583499|NCT03249792|579855829|FG011|Switch Over Period|Adverse Event|0|||
160583500|NCT03249792|579855830|FG012|Switch Over Period|Adverse Event|0|||
160583501|NCT03249792|579855831|FG013|Switch Over Period|Adverse Event|0|||
160583502|NCT03249792|579855832|FG014|Switch Over Period|Adverse Event|0|||
160583503|NCT03249792|579855833|FG015|Switch Over Period|Adverse Event|0|||
160583504|NCT03249792|579855834|FG016|Switch Over Period|Adverse Event|0|||
161001520|NCT01123083|581390624|FG001|Overall Study|Lost to Follow-up|6|||
160583505|NCT03249792|579855835|FG017|Switch Over Period|Adverse Event|0|||
160583506|NCT03249792|579855836|FG018|Switch Over Period|Adverse Event|0|||
160583507|NCT03249792|579855837|FG019|Switch Over Period|Adverse Event|0|||
160457950|NCT05424380|579407965|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
160457951|NCT04218851|579407972|FG000|Overall Study|Death|1|||
160457952|NCT04218851|579407973|FG001|Overall Study|Death|3|||
160457953|NCT00844415|579407974|FG000|Overall Study|Withdrawal by Subject|1|||
160583508|NCT03249792|579855838|FG020|Switch Over Period|Adverse Event|0|||
160583509|NCT03249792|579855839|FG021|Switch Over Period|Adverse Event|0|||
160583510|NCT03249792|579855840|FG022|Switch Over Period|Adverse Event|0|||
160583511|NCT03249792|579855841|FG023|Switch Over Period|Adverse Event|0|||
160583512|NCT03249792|579855842|FG024|Switch Over Period|Adverse Event|0|||
160583513|NCT03249792|579855843|FG025|Switch Over Period|Adverse Event|1|||
160583514|NCT03249792|579855844|FG026|Switch Over Period|Adverse Event|0|||
160583515|NCT03249792|579855845|FG027|Switch Over Period|Adverse Event|1|||
160583516|NCT03249792|579855846|FG028|Switch Over Period|Adverse Event|0|||
160583517|NCT03249792|579855847|FG029|Switch Over Period|Adverse Event|0|||
160583518|NCT03249792|579855848|FG030|Switch Over Period|Adverse Event|0|||
160583519|NCT03249792|579855849|FG031|Switch Over Period|Adverse Event|0|||
160583520|NCT03249792|579855850|FG032|Switch Over Period|Adverse Event|0|||
160583521|NCT00995345|579855853|FG000|Overall Study|Withdrawal by Subject|4|||
160583522|NCT00995345|579855854|FG001|Overall Study|Withdrawal by Subject|2|||
160583523|NCT00995345|579855855|FG002|Overall Study|Withdrawal by Subject|1|||
160583524|NCT00995345|579855856|FG003|Overall Study|Withdrawal by Subject|3|||
160583525|NCT00995345|579855857|FG004|Overall Study|Withdrawal by Subject|1|||
160583526|NCT00995345|579855853|FG000|Overall Study|Adverse Event|3|||
160583527|NCT00995345|579855854|FG001|Overall Study|Adverse Event|1|||
160583528|NCT00995345|579855855|FG002|Overall Study|Adverse Event|2|||
160583529|NCT00995345|579855856|FG003|Overall Study|Adverse Event|0|||
160583530|NCT00995345|579855857|FG004|Overall Study|Adverse Event|1|||
160583531|NCT00995345|579855853|FG000|Overall Study|Lost to Follow-up|2|||
160457954|NCT01820611|579407981|FG000|Overall Study|Death|8|||
160457955|NCT01820611|579407981|FG000|Overall Study|Adverse Event|1|||
160457956|NCT01820611|579407981|FG000|Overall Study|Withdrawal by Subject|9|||
160457957|NCT03015532|579407982|FG000|Overall Study|Adverse Event|0|||
160457958|NCT03015532|579407983|FG001|Overall Study|Adverse Event|0|||
160457959|NCT03015532|579407984|FG002|Overall Study|Adverse Event|0|||
160457960|NCT03015532|579407985|FG003|Overall Study|Adverse Event|0|||
160457961|NCT03015532|579407986|FG004|Overall Study|Adverse Event|0|||
160457962|NCT03015532|579407987|FG005|Overall Study|Adverse Event|2|||
160457963|NCT03015532|579407988|FG006|Overall Study|Adverse Event|1|||
160457964|NCT03015532|579407989|FG007|Overall Study|Adverse Event|0|||
160457965|NCT03015532|579407982|FG000|Overall Study|Withdrawal by Subject|0|||
160457966|NCT03015532|579407983|FG001|Overall Study|Withdrawal by Subject|0|||
160457967|NCT03015532|579407984|FG002|Overall Study|Withdrawal by Subject|0|||
160583532|NCT00995345|579855854|FG001|Overall Study|Lost to Follow-up|2|||
160583533|NCT00995345|579855855|FG002|Overall Study|Lost to Follow-up|2|||
160583534|NCT00995345|579855856|FG003|Overall Study|Lost to Follow-up|1|||
160457968|NCT03015532|579407985|FG003|Overall Study|Withdrawal by Subject|0|||
160457969|NCT03015532|579407986|FG004|Overall Study|Withdrawal by Subject|0|||
160457970|NCT03015532|579407987|FG005|Overall Study|Withdrawal by Subject|0|||
160457971|NCT03015532|579407988|FG006|Overall Study|Withdrawal by Subject|1|||
160457972|NCT03015532|579407989|FG007|Overall Study|Withdrawal by Subject|0|||
160457973|NCT04186819|579407990|FG000|Overall Study|Adverse Event|1|||
160457974|NCT04186819|579407990|FG000|Overall Study|Lost to Follow-up|1|||
160457975|NCT04186819|579407990|FG000|Overall Study|Opted for EBRT|1|||
160457976|NCT04186819|579407990|FG000|Overall Study|Opted SBRT|1|||
160457977|NCT04186819|579407990|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
160457978|NCT04186819|579407990|FG000|Overall Study|Physician Decision|1|||
160457979|NCT04186819|579407990|FG000|Overall Study|RP Delayed|1|||
160457980|NCT04186819|579407990|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
160457981|NCT04186819|579407990|FG000|Overall Study|Subject declined for financial reasons|1|||
160457982|NCT04186819|579407990|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
160583535|NCT00995345|579855857|FG004|Overall Study|Lost to Follow-up|0|||
160583536|NCT00995345|579855853|FG000|Overall Study|all other reasons combined|2|||
160457983|NCT04186819|579407990|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
160583537|NCT00995345|579855854|FG001|Overall Study|all other reasons combined|2|||
160457984|NCT04186819|579407990|FG000|Overall Study|The subject opted for other treatment option|2|||
160457985|NCT04186819|579407990|FG000|Overall Study|The subject opted for other treatment options|1|||
160457986|NCT04186819|579407990|FG000|Overall Study|Withdrawal by Subject|3|||
160457987|NCT04186819|579407990|FG000|Overall Study|Reason not specified|1|||
160457988|NCT05013385|579407994|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
160583538|NCT00995345|579855855|FG002|Overall Study|all other reasons combined|2|||
160583539|NCT00995345|579855856|FG003|Overall Study|all other reasons combined|1|||
160583540|NCT00995345|579855857|FG004|Overall Study|all other reasons combined|3|||
160583541|NCT02509598|579855865|FG000|Overall Study|Withdrawal by Subject|1|||
160583542|NCT01201798|579855866|FG000|Overall Study|Adverse Event|2|||
160583543|NCT01201798|579855867|FG001|Overall Study|Adverse Event|0|||
160583544|NCT01201798|579855866|FG000|Overall Study|Lost to Follow-up|3|||
160583545|NCT01201798|579855867|FG001|Overall Study|Lost to Follow-up|5|||
160583546|NCT01201798|579855866|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
160958387|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
160958388|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
160958389|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
160958390|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
160958391|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
160958392|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
160958393|NCT01454583|581234181|FG000|1st Year|Lost to Follow-up|1057|||
160958394|NCT01454583|581234182|FG001|1st Year|Lost to Follow-up|318|||
160958395|NCT01454583|581234183|FG002|1st Year|Lost to Follow-up|180|||
160958396|NCT01454583|581234181|FG000|2nd Year|Lost to Follow-up|3965|||
160958397|NCT01454583|581234182|FG001|2nd Year|Lost to Follow-up|1049|||
160958398|NCT01454583|581234183|FG002|2nd Year|Lost to Follow-up|737|||
160958399|NCT01454583|581234181|FG000|3rd Year|Lost to Follow-up|1959|||
160958400|NCT01454583|581234182|FG001|3rd Year|Lost to Follow-up|512|||
160958401|NCT01454583|581234183|FG002|3rd Year|Lost to Follow-up|297|||
160958402|NCT04330638|581234186|FG000|Overall Study|Adverse Event|9|||
160958403|NCT04330638|581234187|FG001|Overall Study|Adverse Event|10|||
160958404|NCT04330638|581234188|FG002|Overall Study|Adverse Event|15|||
160958405|NCT04330638|581234189|FG003|Overall Study|Adverse Event|6|||
160958406|NCT04330638|581234190|FG004|Overall Study|Adverse Event|10|||
160958407|NCT04330638|581234191|FG005|Overall Study|Adverse Event|5|||
160958408|NCT04330638|581234186|FG000|Overall Study|Other|2|||
160958409|NCT04330638|581234187|FG001|Overall Study|Other|2|||
160958410|NCT04330638|581234188|FG002|Overall Study|Other|5|||
160958411|NCT04330638|581234189|FG003|Overall Study|Other|1|||
160958412|NCT04330638|581234190|FG004|Overall Study|Other|3|||
160958413|NCT04330638|581234191|FG005|Overall Study|Other|2|||
160958414|NCT04330638|581234186|FG000|Overall Study|Withdrawal by Subject|4|||
160958415|NCT04330638|581234187|FG001|Overall Study|Withdrawal by Subject|0|||
160958416|NCT04330638|581234188|FG002|Overall Study|Withdrawal by Subject|0|||
160958417|NCT04330638|581234189|FG003|Overall Study|Withdrawal by Subject|0|||
160958418|NCT04330638|581234190|FG004|Overall Study|Withdrawal by Subject|0|||
160958419|NCT04330638|581234191|FG005|Overall Study|Withdrawal by Subject|0|||
160958420|NCT04330638|581234186|FG000|Overall Study|Lost to Follow-up|3|||
160958421|NCT04330638|581234187|FG001|Overall Study|Lost to Follow-up|2|||
160958422|NCT04330638|581234188|FG002|Overall Study|Lost to Follow-up|3|||
160958423|NCT04330638|581234189|FG003|Overall Study|Lost to Follow-up|2|||
160958424|NCT04330638|581234190|FG004|Overall Study|Lost to Follow-up|3|||
160958425|NCT04330638|581234191|FG005|Overall Study|Lost to Follow-up|0|||
160958426|NCT01967732|581234193|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
160958427|NCT01967732|581234194|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
160958428|NCT01967732|581234195|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
160958429|NCT01967732|581234196|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
160958430|NCT01967732|581234193|FG000|First Intervention (Day 1)|Poor venous access|0|||
160958431|NCT01967732|581234194|FG001|First Intervention (Day 1)|Poor venous access|1|||
160958432|NCT01967732|581234195|FG002|First Intervention (Day 1)|Poor venous access|0|||
160958433|NCT01967732|581234196|FG003|First Intervention (Day 1)|Poor venous access|0|||
160958434|NCT01988779|581234205|FG000|Overall Study|Withdrawal by Subject|2|||
160958435|NCT01988779|581234206|FG001|Overall Study|Withdrawal by Subject|2|||
160958436|NCT01988779|581234205|FG000|Overall Study|Protocol Violation|1|||
160958437|NCT01988779|581234206|FG001|Overall Study|Protocol Violation|0|||
160958438|NCT02275065|581234207|FG000|Overall Study|Randomized but not treated|1|||
160958439|NCT02275065|581234208|FG001|Overall Study|Randomized but not treated|0|||
160958440|NCT02275065|581234209|FG002|Overall Study|Randomized but not treated|1|||
160958441|NCT02275065|581234210|FG003|Overall Study|Randomized but not treated|1|||
160958442|NCT02275065|581234211|FG004|Overall Study|Randomized but not treated|0|||
160958443|NCT00377403|581234212|FG000|Overall Study|Unable to contact for telephone intervie|4|||
160958444|NCT00377403|581234213|FG001|Overall Study|Unable to contact for telephone intervie|7|||
160958445|NCT00417079|581234215|FG000|Overall Study|Disease progression|267|||
160958446|NCT00417079|581234216|FG001|Overall Study|Disease progression|180|||
160958447|NCT00417079|581234215|FG000|Overall Study|Adverse Event|32|||
160583547|NCT01201798|579855867|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
160583548|NCT01201798|579855866|FG000|Overall Study|Noncompliance|1|||
160583549|NCT01201798|579855867|FG001|Overall Study|Noncompliance|0|||
160958448|NCT00417079|581234216|FG001|Overall Study|Adverse Event|67|||
160958449|NCT00417079|581234215|FG000|Overall Study|Non-compliance to protocol|0|||
160958450|NCT00417079|581234216|FG001|Overall Study|Non-compliance to protocol|1|||
160958451|NCT00417079|581234215|FG000|Overall Study|Lost to Follow-up|2|||
160958452|NCT00417079|581234216|FG001|Overall Study|Lost to Follow-up|0|||
160958453|NCT00417079|581234215|FG000|Overall Study|Withdrawal by Subject|17|||
160958454|NCT00417079|581234216|FG001|Overall Study|Withdrawal by Subject|8|||
160958455|NCT00417079|581234215|FG000|Overall Study|Not treated|6|||
160958456|NCT00417079|581234216|FG001|Overall Study|Not treated|7|||
160958457|NCT00417079|581234215|FG000|Overall Study|Screened failure|2|||
160583550|NCT01201798|579855866|FG000|Overall Study|Protocol Violation|1|||
160583551|NCT01201798|579855867|FG001|Overall Study|Protocol Violation|1|||
161001521|NCT01123083|581390623|FG000|Overall Study|Adverse Event|1|||
161001522|NCT01123083|581390624|FG001|Overall Study|Adverse Event|0|||
161001523|NCT01123083|581390623|FG000|Overall Study|Withdrew for another reason not covered|0|||
161001524|NCT01123083|581390624|FG001|Overall Study|Withdrew for another reason not covered|1|||
161001525|NCT01123083|581390623|FG000|Overall Study|Participant/legal representative request|7|||
161001526|NCT01123083|581390624|FG001|Overall Study|Participant/legal representative request|3|||
161001527|NCT00290706|581390625|FG000|Overall Study|Withdrawal by Subject|2|||
161001528|NCT00290706|581390626|FG001|Overall Study|Withdrawal by Subject|0|||
161001529|NCT00290706|581390627|FG002|Overall Study|Withdrawal by Subject|0|||
161001530|NCT00290706|581390628|FG003|Overall Study|Withdrawal by Subject|0|||
161001531|NCT00290706|581390625|FG000|Overall Study|Progressive Disease|3|||
161001532|NCT00290706|581390626|FG001|Overall Study|Progressive Disease|5|||
161001533|NCT00290706|581390627|FG002|Overall Study|Progressive Disease|4|||
161001534|NCT00290706|581390628|FG003|Overall Study|Progressive Disease|10|||
161001535|NCT00290706|581390625|FG000|Overall Study|Adverse Event|0|||
161001536|NCT00290706|581390626|FG001|Overall Study|Adverse Event|1|||
161001537|NCT00290706|581390627|FG002|Overall Study|Adverse Event|2|||
161001538|NCT00290706|581390628|FG003|Overall Study|Adverse Event|0|||
161001539|NCT00290706|581390625|FG000|Overall Study|Receive auto transplant or radiation|0|||
161001540|NCT00290706|581390626|FG001|Overall Study|Receive auto transplant or radiation|0|||
161001541|NCT00290706|581390627|FG002|Overall Study|Receive auto transplant or radiation|0|||
161001542|NCT00290706|581390628|FG003|Overall Study|Receive auto transplant or radiation|1|||
161001543|NCT00290706|581390625|FG000|Overall Study|Physician Decision|0|||
161001544|NCT00290706|581390626|FG001|Overall Study|Physician Decision|0|||
161001545|NCT00290706|581390627|FG002|Overall Study|Physician Decision|0|||
161001546|NCT00290706|581390628|FG003|Overall Study|Physician Decision|1|||
161001547|NCT01196429|581390630|FG000|Overall Study|Ineligible - inadequate pathology|1|||
161001548|NCT01196429|581390631|FG001|Overall Study|Ineligible - inadequate pathology|0|||
161001549|NCT01196429|581390630|FG000|Overall Study|Ineligible - wrong cell type|1|||
161001550|NCT01196429|581390631|FG001|Overall Study|Ineligible - wrong cell type|0|||
161001551|NCT01196429|581390630|FG000|Overall Study|Refused - Never Treated|1|||
161001552|NCT01196429|581390631|FG001|Overall Study|Refused - Never Treated|0|||
161001553|NCT00688519|581390632|FG000|Overall Study|Adverse Event|2|||
161001554|NCT00688519|581390633|FG001|Overall Study|Adverse Event|3|||
161001555|NCT00688519|581390632|FG000|Overall Study|Lost to Follow-up|3|||
161001556|NCT00688519|581390633|FG001|Overall Study|Lost to Follow-up|3|||
161001557|NCT00688519|581390632|FG000|Overall Study|Lack of Efficacy|3|||
161001558|NCT00688519|581390633|FG001|Overall Study|Lack of Efficacy|1|||
161001559|NCT00688519|581390632|FG000|Overall Study|Withdrawal by Subject|7|||
161001560|NCT00688519|581390633|FG001|Overall Study|Withdrawal by Subject|6|||
161001561|NCT00688519|581390632|FG000|Overall Study|Prohibited medication|1|||
161001562|NCT00688519|581390633|FG001|Overall Study|Prohibited medication|0|||
161001563|NCT00688519|581390632|FG000|Overall Study|Non-compliance|0|||
161001564|NCT00688519|581390633|FG001|Overall Study|Non-compliance|1|||
161001565|NCT00688519|581390632|FG000|Overall Study|Subject moved out of state|1|||
161001566|NCT00688519|581390633|FG001|Overall Study|Subject moved out of state|0|||
161001567|NCT00688519|581390632|FG000|Overall Study|Investigator decision|1|||
161001568|NCT00688519|581390633|FG001|Overall Study|Investigator decision|0|||
161001569|NCT00688519|581390632|FG000|Overall Study|Subject moved out of area|1|||
161001570|NCT00688519|581390633|FG001|Overall Study|Subject moved out of area|0|||
161001571|NCT00688519|581390632|FG000|Overall Study|Pregnancy|0|||
161001572|NCT00688519|581390633|FG001|Overall Study|Pregnancy|1|||
161001573|NCT02551055|581390634|FG000|Overall Study|Death|2|||
161001574|NCT02551055|581390635|FG001|Overall Study|Death|4|||
161001575|NCT02551055|581390636|FG002|Overall Study|Death|2|||
161001576|NCT02551055|581390637|FG003|Overall Study|Death|2|||
161001577|NCT02551055|581390638|FG004|Overall Study|Death|2|||
161001578|NCT02551055|581390639|FG005|Overall Study|Death|1|||
161001579|NCT02551055|581390640|FG006|Overall Study|Death|2|||
161001580|NCT02551055|581390641|FG007|Overall Study|Death|0|||
161001581|NCT02551055|581390634|FG000|Overall Study|Study Terminated by Sponsor|1|||
161001582|NCT02551055|581390635|FG001|Overall Study|Study Terminated by Sponsor|1|||
161001583|NCT02551055|581390636|FG002|Overall Study|Study Terminated by Sponsor|0|||
161001584|NCT02551055|581390637|FG003|Overall Study|Study Terminated by Sponsor|2|||
161001585|NCT02551055|581390638|FG004|Overall Study|Study Terminated by Sponsor|2|||
161001586|NCT02551055|581390639|FG005|Overall Study|Study Terminated by Sponsor|0|||
161001587|NCT02551055|581390640|FG006|Overall Study|Study Terminated by Sponsor|0|||
161001588|NCT02551055|581390641|FG007|Overall Study|Study Terminated by Sponsor|0|||
161001589|NCT02551055|581390634|FG000|Overall Study|Withdrawal by Subject|1|||
161001590|NCT02551055|581390635|FG001|Overall Study|Withdrawal by Subject|1|||
161001591|NCT02551055|581390636|FG002|Overall Study|Withdrawal by Subject|0|||
160656969|NCT05097989|580124502|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161001592|NCT02551055|581390637|FG003|Overall Study|Withdrawal by Subject|1|||
161001593|NCT02551055|581390638|FG004|Overall Study|Withdrawal by Subject|2|||
161001594|NCT02551055|581390639|FG005|Overall Study|Withdrawal by Subject|0|||
161001595|NCT02551055|581390640|FG006|Overall Study|Withdrawal by Subject|0|||
161001596|NCT02551055|581390641|FG007|Overall Study|Withdrawal by Subject|0|||
160583552|NCT01201798|579855866|FG000|Overall Study|Treatment Failure|1|||
160583553|NCT01201798|579855867|FG001|Overall Study|Treatment Failure|8|||
160583554|NCT05692154|579855868|FG000|Overall Study|Adverse Event|0|||
160583555|NCT05692154|579855869|FG001|Overall Study|Adverse Event|1|||
160583556|NCT01912729|579855872|FG000|Overall Study|Withdrawal by Subject|0|||
160583557|NCT01912729|579855873|FG001|Overall Study|Withdrawal by Subject|1|||
160583558|NCT01952834|579855880|FG000|Overall Study|Adverse Event|1|||
160583559|NCT00988559|579855883|FG000|Overall Study|Withdrawal by Subject|1|||
160583560|NCT00988559|579855884|FG001|Overall Study|Withdrawal by Subject|1|||
160583561|NCT00988559|579855885|FG002|Overall Study|Withdrawal by Subject|0|||
160583562|NCT00988559|579855886|FG003|Overall Study|Withdrawal by Subject|1|||
160583563|NCT00988559|579855883|FG000|Overall Study|Pregnancy|0|||
160583564|NCT00988559|579855884|FG001|Overall Study|Pregnancy|1|||
160583565|NCT00988559|579855885|FG002|Overall Study|Pregnancy|1|||
160583566|NCT00988559|579855886|FG003|Overall Study|Pregnancy|0|||
160583567|NCT00988559|579855883|FG000|Overall Study|Lost to Follow-up|0|||
160583568|NCT00988559|579855884|FG001|Overall Study|Lost to Follow-up|0|||
160583569|NCT00988559|579855885|FG002|Overall Study|Lost to Follow-up|1|||
160583570|NCT00988559|579855886|FG003|Overall Study|Lost to Follow-up|0|||
160958458|NCT00417079|581234216|FG001|Overall Study|Screened failure|1|||
160958459|NCT00417079|581234215|FG000|Overall Study|Investigator's decision|1|||
160958460|NCT00417079|581234216|FG001|Overall Study|Investigator's decision|4|||
160958461|NCT00417079|581234215|FG000|Overall Study|Non-confirmed Disease progression|1|||
160958462|NCT00417079|581234216|FG001|Overall Study|Non-confirmed Disease progression|1|||
160958463|NCT00417079|581234215|FG000|Overall Study|Clinical deterioration|1|||
160958464|NCT00417079|581234216|FG001|Overall Study|Clinical deterioration|0|||
160583571|NCT00829166|579855887|FG000|Overall Study|Death|305|||
160583572|NCT00829166|579855888|FG001|Overall Study|Death|333|||
160583573|NCT00829166|579855887|FG000|Overall Study|Lost to Follow-up|5|||
160583574|NCT00829166|579855888|FG001|Overall Study|Lost to Follow-up|4|||
160583575|NCT00829166|579855887|FG000|Overall Study|Physician's Decision|4|||
160583576|NCT00829166|579855888|FG001|Overall Study|Physician's Decision|3|||
160583577|NCT00829166|579855887|FG000|Overall Study|Subject's Decision|41|||
160583578|NCT00829166|579855888|FG001|Overall Study|Subject's Decision|55|||
160583579|NCT00829166|579855887|FG000|Overall Study|Sponsor's Decision|137|||
160583580|NCT00829166|579855888|FG001|Overall Study|Sponsor's Decision|98|||
160583581|NCT00829166|579855887|FG000|Overall Study|Reason Not Specified|3|||
160583582|NCT00829166|579855888|FG001|Overall Study|Reason Not Specified|3|||
160583583|NCT04072146|579855892|FG000|Overall Study|Adverse Event|0|||
160583584|NCT04072146|579855893|FG001|Overall Study|Adverse Event|1|||
160583585|NCT02993224|579855894|FG000|Core Phase - Period 1|Adverse Event|4|||
160583586|NCT02993224|579855894|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
160583587|NCT02993224|579855894|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
160583588|NCT02993224|579855894|FG000|Core Phase- Period 2|Adverse Event|1|||
160583589|NCT02993224|579855894|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
160583590|NCT02993224|579855894|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
160583591|NCT02993224|579855894|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
160583592|NCT02993224|579855894|FG000|Extension Phase|Adverse Event|3|||
160583593|NCT02993224|579855894|FG000|Extension Phase|Withdrawal by Subject|3|||
160583594|NCT02993224|579855894|FG000|Extension Phase|Lost to Follow-up|2|||
160583595|NCT02993224|579855894|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
160583596|NCT05515601|579855901|FG000|Overall Study|Withdrawal by Subject|1|||
160583597|NCT05515601|579855902|FG001|Overall Study|Withdrawal by Subject|3|||
160583598|NCT05515601|579855903|FG002|Overall Study|Withdrawal by Subject|2|||
160583599|NCT05515601|579855904|FG003|Overall Study|Withdrawal by Subject|1|||
160583600|NCT05515601|579855905|FG004|Overall Study|Withdrawal by Subject|1|||
160583601|NCT05515601|579855906|FG005|Overall Study|Withdrawal by Subject|1|||
160958465|NCT00417079|581234215|FG000|Overall Study|Screening error|2|||
160958466|NCT00417079|581234216|FG001|Overall Study|Screening error|1|||
160958467|NCT00417079|581234215|FG000|Overall Study|Withdrawal by subject's family|0|||
160958468|NCT00417079|581234216|FG001|Overall Study|Withdrawal by subject's family|1|||
160958469|NCT00417079|581234215|FG000|Overall Study|Patient unable to come to the clinic|0|||
160583602|NCT05515601|579855901|FG000|Overall Study|Lost to Follow-up|0|||
160583603|NCT05515601|579855902|FG001|Overall Study|Lost to Follow-up|0|||
160583604|NCT05515601|579855903|FG002|Overall Study|Lost to Follow-up|0|||
160583605|NCT05515601|579855904|FG003|Overall Study|Lost to Follow-up|0|||
160583606|NCT05515601|579855905|FG004|Overall Study|Lost to Follow-up|1|||
160583607|NCT05515601|579855906|FG005|Overall Study|Lost to Follow-up|0|||
160583608|NCT00364845|579855907|FG000|Overall Study|Adverse Event|1|||
160583609|NCT00364845|579855908|FG001|Overall Study|Adverse Event|0|||
160958470|NCT00417079|581234216|FG001|Overall Study|Patient unable to come to the clinic|1|||
160958471|NCT00417079|581234215|FG000|Overall Study|abnormal liver function tests|0|||
160958472|NCT00417079|581234216|FG001|Overall Study|abnormal liver function tests|1|||
160583610|NCT00364845|579855907|FG000|Overall Study|Withdrawal by Subject|2|||
160583611|NCT00364845|579855908|FG001|Overall Study|Withdrawal by Subject|1|||
160583612|NCT00364845|579855907|FG000|Overall Study|Physician Decision|8|||
160958473|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
160958474|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
160958475|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
160958476|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
160958477|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
160958478|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
160958479|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
160958480|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
160958481|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
160958482|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
160958483|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
160958484|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
160958485|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
160958486|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
160958487|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
160958488|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
160958489|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
160958490|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
160958491|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
160958492|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
160958493|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
160958494|NCT00833638|581234217|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
160958495|NCT00833638|581234218|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
160958496|NCT00833638|581234219|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
160958497|NCT00833638|581234217|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
160958498|NCT00833638|581234218|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
160958499|NCT00833638|581234219|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
160958500|NCT01178086|581234220|FG000|Overall Study|Participant refusal|7|||
160958501|NCT01178086|581234220|FG000|Overall Study|Physician Decision|44|||
160958502|NCT01178086|581234220|FG000|Overall Study|Switch to other CLL therapy|113|||
160958503|NCT01178086|581234220|FG000|Overall Study|Death|59|||
160958504|NCT01178086|581234220|FG000|Overall Study|Other unspecified|89|||
160958505|NCT01178086|581234220|FG000|Overall Study|Excluded from EAS|20|||
160958506|NCT04348604|581234223|FG000|Week 8|Withdrawal by Subject|1|||
160958507|NCT04348604|581234224|FG001|Week 8|Withdrawal by Subject|1|||
160958508|NCT04348604|581234223|FG000|Week 8|Lost to Follow-up|1|||
160958509|NCT04348604|581234224|FG001|Week 8|Lost to Follow-up|2|||
160958510|NCT04348604|581234223|FG000|Week 8|Suspended|0|||
160958511|NCT04348604|581234224|FG001|Week 8|Suspended|1|||
160958512|NCT04348604|581234223|FG000|Week 12|Lost to Follow-up|1|||
160958513|NCT04348604|581234224|FG001|Week 12|Lost to Follow-up|2|||
160958514|NCT04348604|581234223|FG000|Week 12|Withdrawal by Subject|1|||
160958515|NCT04348604|581234224|FG001|Week 12|Withdrawal by Subject|0|||
160958516|NCT04348604|581234223|FG000|Week 24|Lost to Follow-up|2|||
160958517|NCT04348604|581234224|FG001|Week 24|Lost to Follow-up|1|||
160958518|NCT02097108|581234225|FG000|Overall Study|Adverse Event|1|||
160958519|NCT02097108|581234225|FG000|Overall Study|patient was abroad for 6 months|1|||
160958520|NCT00127608|581234228|FG000|Overall Study|VZV DNA negative|1|||
160958521|NCT04918784|581236041|FG000|Overall Study|Amputation - no longer eligible|1|||
160958522|NCT04918784|581236042|FG001|Overall Study|Amputation - no longer eligible|2|||
160958523|NCT04918784|581236041|FG000|Overall Study|Death|1|||
160958524|NCT04918784|581236042|FG001|Overall Study|Death|0|||
160958525|NCT04918784|581236041|FG000|Overall Study|patient non-compliance|3|||
160958526|NCT04918784|581236042|FG001|Overall Study|patient non-compliance|1|||
160958527|NCT04918784|581236041|FG000|Overall Study|Adverse Event|1|||
160958528|NCT04918784|581236042|FG001|Overall Study|Adverse Event|0|||
160958529|NCT01986881|581236043|FG000|Overall Study|Death|228|||
160958530|NCT01986881|581236044|FG001|Overall Study|Death|233|||
160958531|NCT01986881|581236045|FG002|Overall Study|Death|247|||
160958532|NCT01986881|581236043|FG000|Overall Study|Lost to Follow-up|51|||
160958533|NCT01986881|581236044|FG001|Overall Study|Lost to Follow-up|44|||
160958534|NCT01986881|581236045|FG002|Overall Study|Lost to Follow-up|55|||
160958535|NCT01986881|581236043|FG000|Overall Study|Physician Decision|7|||
160958536|NCT01986881|581236044|FG001|Overall Study|Physician Decision|4|||
160958537|NCT01986881|581236045|FG002|Overall Study|Physician Decision|6|||
160958538|NCT01986881|581236043|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
160958539|NCT01986881|581236044|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
160958540|NCT01986881|581236045|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
160958541|NCT01986881|581236043|FG000|Overall Study|Withdrawal by Subject|41|||
160958542|NCT01986881|581236044|FG001|Overall Study|Withdrawal by Subject|60|||
160958543|NCT01986881|581236045|FG002|Overall Study|Withdrawal by Subject|45|||
160958544|NCT01986881|581236043|FG000|Overall Study|Subject Moved|0|||
160958545|NCT01986881|581236044|FG001|Overall Study|Subject Moved|1|||
160958546|NCT01986881|581236045|FG002|Overall Study|Subject Moved|0|||
160583613|NCT00364845|579855908|FG001|Overall Study|Physician Decision|8|||
160583614|NCT00364845|579855907|FG000|Overall Study|Lost to Follow-up|0|||
160583615|NCT00364845|579855908|FG001|Overall Study|Lost to Follow-up|1|||
160583616|NCT00364845|579855907|FG000|Overall Study|Death|0|||
160583617|NCT00364845|579855908|FG001|Overall Study|Death|1|||
160583618|NCT03255291|579855911|FG000|Overall Study|Determined to be ineligible|10|||
160583619|NCT03255291|579855912|FG001|Overall Study|Determined to be ineligible|12|||
160583620|NCT03255291|579855913|FG002|Overall Study|Determined to be ineligible|6|||
160583621|NCT03255291|579855914|FG003|Overall Study|Determined to be ineligible|6|||
160583622|NCT03255291|579855915|FG004|Overall Study|Determined to be ineligible|5|||
160583623|NCT03255291|579855916|FG005|Overall Study|Determined to be ineligible|10|||
160583624|NCT03255291|579855911|FG000|Overall Study|Baseline data collection issues|3|||
161001597|NCT02551055|581390634|FG000|Overall Study|Reason not specified|0|||
161001598|NCT02551055|581390635|FG001|Overall Study|Reason not specified|0|||
161001599|NCT02551055|581390636|FG002|Overall Study|Reason not specified|0|||
161001600|NCT02551055|581390637|FG003|Overall Study|Reason not specified|0|||
161001601|NCT02551055|581390638|FG004|Overall Study|Reason not specified|1|||
161001602|NCT02551055|581390639|FG005|Overall Study|Reason not specified|0|||
161001603|NCT02551055|581390640|FG006|Overall Study|Reason not specified|1|||
161001604|NCT02551055|581390641|FG007|Overall Study|Reason not specified|0|||
161001605|NCT00430300|581390642|FG000|Overall Study|Adverse Event|0|||
161001606|NCT00430300|581390643|FG001|Overall Study|Adverse Event|2|||
161001607|NCT00430300|581390644|FG002|Overall Study|Adverse Event|1|||
161001608|NCT00430300|581390645|FG003|Overall Study|Adverse Event|1|||
161001609|NCT00430300|581390642|FG000|Overall Study|Withdrawal by Subject|1|||
161001610|NCT00430300|581390643|FG001|Overall Study|Withdrawal by Subject|0|||
161001611|NCT00430300|581390644|FG002|Overall Study|Withdrawal by Subject|5|||
161001612|NCT00430300|581390645|FG003|Overall Study|Withdrawal by Subject|0|||
161001613|NCT00430300|581390642|FG000|Overall Study|Laboratory abnormality|1|||
161001614|NCT00430300|581390643|FG001|Overall Study|Laboratory abnormality|0|||
161001615|NCT00430300|581390644|FG002|Overall Study|Laboratory abnormality|0|||
161001616|NCT00430300|581390645|FG003|Overall Study|Laboratory abnormality|0|||
161001617|NCT00430300|581390642|FG000|Overall Study|Other|0|||
161001618|NCT00430300|581390643|FG001|Overall Study|Other|0|||
161001619|NCT00430300|581390644|FG002|Overall Study|Other|0|||
161001620|NCT00430300|581390645|FG003|Overall Study|Other|1|||
161001621|NCT01063517|581390650|FG000|Overall Study|Consent withdrawal|1|||
161001622|NCT01063517|581390651|FG001|Overall Study|Consent withdrawal|0|||
161001623|NCT01063517|581390650|FG000|Overall Study|Study reached data cut-off|19|||
161001624|NCT01063517|581390651|FG001|Overall Study|Study reached data cut-off|7|||
161001625|NCT01063517|581390650|FG000|Overall Study|Lost to Follow-up|4|||
161001626|NCT01063517|581390651|FG001|Overall Study|Lost to Follow-up|3|||
161001627|NCT01063517|581390650|FG000|Overall Study|Withdrawal by Subject|1|||
161001628|NCT01063517|581390651|FG001|Overall Study|Withdrawal by Subject|2|||
161001629|NCT01063517|581390650|FG000|Overall Study|Death|33|||
161001630|NCT01063517|581390651|FG001|Overall Study|Death|48|||
161001631|NCT02974634|581392954|FG000|Overall Study|Advanced disease|12|||
161001632|NCT02974634|581392955|FG001|Overall Study|Advanced disease|3|||
161001633|NCT02974634|581392954|FG000|Overall Study|Noncompliance|3|||
161001634|NCT02974634|581392955|FG001|Overall Study|Noncompliance|7|||
161001635|NCT02974634|581392954|FG000|Overall Study|intervention technology related issues|5|||
161001636|NCT02974634|581392955|FG001|Overall Study|intervention technology related issues|0|||
161001637|NCT02974634|581392954|FG000|Overall Study|Death|8|||
161001638|NCT02974634|581392955|FG001|Overall Study|Death|11|||
161001639|NCT04668339|581392956|FG000|Overall Study|Physician Decision|1|||
161001640|NCT04668339|581392957|FG001|Overall Study|Physician Decision|0|||
161001641|NCT04668339|581392958|FG002|Overall Study|Physician Decision|1|||
161001642|NCT04668339|581392959|FG003|Overall Study|Physician Decision|1|||
161001643|NCT04668339|581392956|FG000|Overall Study|Lost to Follow-up|14|||
160583625|NCT03255291|579855912|FG001|Overall Study|Baseline data collection issues|0|||
161001644|NCT04668339|581392957|FG001|Overall Study|Lost to Follow-up|12|||
161001645|NCT04668339|581392958|FG002|Overall Study|Lost to Follow-up|8|||
161001646|NCT04668339|581392959|FG003|Overall Study|Lost to Follow-up|5|||
161001647|NCT04668339|581392956|FG000|Overall Study|Adverse Event|0|||
161001648|NCT04668339|581392957|FG001|Overall Study|Adverse Event|0|||
161001649|NCT04668339|581392958|FG002|Overall Study|Adverse Event|1|||
161001650|NCT04668339|581392959|FG003|Overall Study|Adverse Event|0|||
161001651|NCT04668339|581392956|FG000|Overall Study|Other than specified|3|||
161001652|NCT04668339|581392957|FG001|Overall Study|Other than specified|0|||
161001653|NCT04668339|581392958|FG002|Overall Study|Other than specified|1|||
161001654|NCT04668339|581392959|FG003|Overall Study|Other than specified|0|||
161001655|NCT04668339|581392956|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
161001656|NCT04668339|581392957|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
160583626|NCT03255291|579855913|FG002|Overall Study|Baseline data collection issues|0|||
160583627|NCT03255291|579855914|FG003|Overall Study|Baseline data collection issues|0|||
161001657|NCT04668339|581392958|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
161001658|NCT04668339|581392959|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
160958547|NCT01986881|581236043|FG000|Overall Study|Other|1|||
160958548|NCT01986881|581236044|FG001|Overall Study|Other|2|||
160958549|NCT01986881|581236045|FG002|Overall Study|Other|2|||
160958550|NCT04050865|581236046|FG000|Overall Study|Adverse Event|1|||
160958551|NCT04050865|581236047|FG001|Overall Study|Adverse Event|0|||
160958552|NCT04050865|581236046|FG000|Overall Study|no insert|1|||
160958553|NCT04050865|581236047|FG001|Overall Study|no insert|0|||
160958554|NCT04050865|581236046|FG000|Overall Study|Only 1 insert|2|||
161001659|NCT04668339|581392956|FG000|Overall Study|Vaccine not Administered|0|||
161001660|NCT04668339|581392957|FG001|Overall Study|Vaccine not Administered|0|||
161001661|NCT04668339|581392958|FG002|Overall Study|Vaccine not Administered|1|||
161001662|NCT04668339|581392959|FG003|Overall Study|Vaccine not Administered|0|||
161001663|NCT04668339|581392956|FG000|Overall Study|Protocol Violation|18|||
160583628|NCT03255291|579855915|FG004|Overall Study|Baseline data collection issues|2|||
160583629|NCT03255291|579855916|FG005|Overall Study|Baseline data collection issues|0|||
160583630|NCT01423617|579855917|FG000|Overall Study|Lost to Follow-up|0|||
160583631|NCT01423617|579855918|FG001|Overall Study|Lost to Follow-up|1|||
160583632|NCT01204658|579855921|FG000|Primary Phase|Adverse Event|0|||
160583633|NCT01204658|579855922|FG001|Primary Phase|Adverse Event|0|||
160583634|NCT01204658|579855923|FG002|Primary Phase|Adverse Event|1|||
160583635|NCT01204658|579855924|FG003|Primary Phase|Adverse Event|0|||
160583636|NCT04594239|579855929|FG000|Overall Study|Withdrawal by Subject|3|||
160583637|NCT04594239|579855930|FG001|Overall Study|Withdrawal by Subject|4|||
160583638|NCT04594239|579855931|FG002|Overall Study|Withdrawal by Subject|2|||
160583639|NCT04594239|579855932|FG003|Overall Study|Withdrawal by Subject|4|||
160583640|NCT04594239|579855929|FG000|Overall Study|Lost to Follow-up|8|||
160583641|NCT04594239|579855930|FG001|Overall Study|Lost to Follow-up|5|||
160583642|NCT04594239|579855931|FG002|Overall Study|Lost to Follow-up|4|||
160583643|NCT04594239|579855932|FG003|Overall Study|Lost to Follow-up|6|||
160583644|NCT04594239|579855929|FG000|Overall Study|Subject relocated|0|||
160583645|NCT04594239|579855930|FG001|Overall Study|Subject relocated|0|||
160583646|NCT04594239|579855931|FG002|Overall Study|Subject relocated|0|||
160583647|NCT04594239|579855932|FG003|Overall Study|Subject relocated|1|||
160583648|NCT02678780|579855933|FG000|Overall Study|Adverse Event|11|||
160583649|NCT02678780|579855934|FG001|Overall Study|Adverse Event|14|||
160583650|NCT02678780|579855933|FG000|Overall Study|Withdrawal by Subject|2|||
160583651|NCT02678780|579855934|FG001|Overall Study|Withdrawal by Subject|1|||
160583652|NCT02678780|579855933|FG000|Overall Study|Sponsor discontinuation|7|||
160583653|NCT02678780|579855934|FG001|Overall Study|Sponsor discontinuation|4|||
160583654|NCT02678780|579855933|FG000|Overall Study|Death|1|||
160583655|NCT02678780|579855934|FG001|Overall Study|Death|1|||
160583656|NCT02678780|579855933|FG000|Overall Study|Other|6|||
160583657|NCT02678780|579855934|FG001|Overall Study|Other|8|||
160583658|NCT00719732|579855947|FG000|Overall Study|Lost to Follow-up|20|||
160583659|NCT00719732|579855947|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
160583660|NCT00719732|579855947|FG000|Overall Study|Illness not associated with device|1|||
160583661|NCT00309777|579855948|FG000|Overall Study|Adverse Event|13|||
160583662|NCT00309777|579855949|FG001|Overall Study|Adverse Event|2|||
160583663|NCT00309777|579855950|FG002|Overall Study|Adverse Event|8|||
160583664|NCT00309777|579855951|FG003|Overall Study|Adverse Event|1|||
160583665|NCT00309777|579855948|FG000|Overall Study|Protocol Violation|4|||
160583666|NCT00309777|579855949|FG001|Overall Study|Protocol Violation|1|||
160583667|NCT00309777|579855950|FG002|Overall Study|Protocol Violation|3|||
160583668|NCT00309777|579855951|FG003|Overall Study|Protocol Violation|1|||
160583669|NCT00309777|579855948|FG000|Overall Study|Withdrawal by Subject|6|||
160583670|NCT00309777|579855949|FG001|Overall Study|Withdrawal by Subject|5|||
160583671|NCT00309777|579855950|FG002|Overall Study|Withdrawal by Subject|7|||
160583672|NCT00309777|579855951|FG003|Overall Study|Withdrawal by Subject|2|||
160583673|NCT00309777|579855948|FG000|Overall Study|Lost to Follow-up|0|||
160583674|NCT00309777|579855949|FG001|Overall Study|Lost to Follow-up|0|||
160583675|NCT00309777|579855950|FG002|Overall Study|Lost to Follow-up|1|||
160958555|NCT04050865|581236047|FG001|Overall Study|Only 1 insert|3|||
160958556|NCT04050865|581236046|FG000|Overall Study|Physician Decision|0|||
160958557|NCT04050865|581236047|FG001|Overall Study|Physician Decision|1|||
160583676|NCT00309777|579855951|FG003|Overall Study|Lost to Follow-up|0|||
160583677|NCT00309777|579855948|FG000|Overall Study|Death|0|||
160583678|NCT00309777|579855949|FG001|Overall Study|Death|1|||
160583679|NCT00309777|579855950|FG002|Overall Study|Death|0|||
160583680|NCT00309777|579855951|FG003|Overall Study|Death|0|||
160583681|NCT03050359|579857407|FG000|Overall Study|Randomized But Not Treated|2|||
160583682|NCT03050359|579857408|FG001|Overall Study|Randomized But Not Treated|0|||
160583683|NCT03050359|579857407|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
160583684|NCT03050359|579857408|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
160583685|NCT03050359|579857407|FG000|Overall Study|Significant Protocol Deviation|2|||
160583686|NCT03050359|579857408|FG001|Overall Study|Significant Protocol Deviation|3|||
161001664|NCT04668339|581392957|FG001|Overall Study|Protocol Violation|23|||
161001665|NCT04668339|581392958|FG002|Overall Study|Protocol Violation|12|||
161001666|NCT04668339|581392959|FG003|Overall Study|Protocol Violation|20|||
161001667|NCT04668339|581392956|FG000|Overall Study|Withdrawal by Subject|45|||
160583687|NCT03050359|579857407|FG000|Overall Study|Lost to Follow-up|2|||
160583688|NCT03050359|579857408|FG001|Overall Study|Lost to Follow-up|1|||
160583689|NCT03050359|579857407|FG000|Overall Study|Voluntary Withdrawal|4|||
160583690|NCT03050359|579857408|FG001|Overall Study|Voluntary Withdrawal|6|||
160583691|NCT03050359|579857407|FG000|Overall Study|Pregnancy|1|||
161001668|NCT04668339|581392957|FG001|Overall Study|Withdrawal by Subject|46|||
161001669|NCT04668339|581392958|FG002|Overall Study|Withdrawal by Subject|46|||
161001670|NCT04668339|581392959|FG003|Overall Study|Withdrawal by Subject|27|||
161001671|NCT04668339|581392956|FG000|Overall Study|Study Terminated by Sponsor|59|||
161001672|NCT04668339|581392957|FG001|Overall Study|Study Terminated by Sponsor|59|||
161001673|NCT04668339|581392958|FG002|Overall Study|Study Terminated by Sponsor|71|||
161001674|NCT04668339|581392959|FG003|Overall Study|Study Terminated by Sponsor|1|||
161001675|NCT03253848|581392963|FG000|Overall Study|Adverse Event|7|||
161001676|NCT03253848|581392963|FG000|Overall Study|Death|5|||
161001677|NCT03253848|581392963|FG000|Overall Study|initiation of other treatments|3|||
161001678|NCT03253848|581392963|FG000|Overall Study|Other complicating disease|1|||
161001679|NCT03253848|581392963|FG000|Overall Study|Withdrawal by Subject|1|||
161001680|NCT03253848|581392963|FG000|Overall Study|Declining health|1|||
161001681|NCT05758415|581392965|FG000|Overall Study|Subject Decision|2|||
161001682|NCT05758415|581392966|FG001|Overall Study|Subject Decision|5|||
161001683|NCT05758415|581392965|FG000|Overall Study|Lost to Follow-up|0|||
161001684|NCT05758415|581392966|FG001|Overall Study|Lost to Follow-up|1|||
161001685|NCT03622593|581392967|FG000|Overall Study|Withdrawal by Subject|11|||
161001686|NCT03622593|581392968|FG001|Overall Study|Withdrawal by Subject|9|||
161001687|NCT03622593|581392969|FG002|Overall Study|Withdrawal by Subject|13|||
161001688|NCT03622593|581392967|FG000|Overall Study|Death|12|||
161001689|NCT03622593|581392968|FG001|Overall Study|Death|9|||
161001690|NCT03622593|581392969|FG002|Overall Study|Death|10|||
161001691|NCT03622593|581392967|FG000|Overall Study|Lost to Follow-up|11|||
161001692|NCT03622593|581392968|FG001|Overall Study|Lost to Follow-up|5|||
161001693|NCT03622593|581392969|FG002|Overall Study|Lost to Follow-up|8|||
161001694|NCT03622593|581392967|FG000|Overall Study|Adverse Event|4|||
161001695|NCT03622593|581392968|FG001|Overall Study|Adverse Event|5|||
161001696|NCT03622593|581392969|FG002|Overall Study|Adverse Event|6|||
161001697|NCT03622593|581392967|FG000|Overall Study|Physician Decision|2|||
161001698|NCT03622593|581392968|FG001|Overall Study|Physician Decision|1|||
161001699|NCT03622593|581392969|FG002|Overall Study|Physician Decision|6|||
161001700|NCT03622593|581392967|FG000|Overall Study|Other|2|||
161001701|NCT03622593|581392968|FG001|Overall Study|Other|2|||
161001702|NCT03622593|581392969|FG002|Overall Study|Other|3|||
161001703|NCT03622593|581392967|FG000|Overall Study|Protocol Violation|0|||
161001704|NCT03622593|581392968|FG001|Overall Study|Protocol Violation|0|||
161001705|NCT03622593|581392969|FG002|Overall Study|Protocol Violation|1|||
161001706|NCT03622593|581392967|FG000|Overall Study|Pregnancy|0|||
161001707|NCT03622593|581392968|FG001|Overall Study|Pregnancy|0|||
161001708|NCT03622593|581392969|FG002|Overall Study|Pregnancy|1|||
161001709|NCT01393119|581392972|FG000|Overall Study|Adverse Event|1|||
161001710|NCT01393119|581392973|FG001|Overall Study|Adverse Event|1|||
161001711|NCT01393119|581392974|FG002|Overall Study|Adverse Event|0|||
161001712|NCT01393119|581392975|FG003|Overall Study|Adverse Event|1|||
161001713|NCT01393119|581392972|FG000|Overall Study|Withdrawal by Subject|0|||
160583692|NCT03050359|579857408|FG001|Overall Study|Pregnancy|0|||
160583693|NCT03050359|579857407|FG000|Overall Study|Reason Not Specified|1|||
160583694|NCT03050359|579857408|FG001|Overall Study|Reason Not Specified|0|||
160583695|NCT01830543|579857409|FG000|Overall Study|Subject Decision|19|||
160583696|NCT01830543|579857410|FG001|Overall Study|Subject Decision|21|||
160656970|NCT05097989|580124503|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161001714|NCT01393119|581392973|FG001|Overall Study|Withdrawal by Subject|1|||
161001715|NCT01393119|581392974|FG002|Overall Study|Withdrawal by Subject|1|||
161001716|NCT01393119|581392975|FG003|Overall Study|Withdrawal by Subject|0|||
161001717|NCT01393119|581392972|FG000|Overall Study|Lack of Efficacy|1|||
161001718|NCT01393119|581392973|FG001|Overall Study|Lack of Efficacy|0|||
161001719|NCT01393119|581392974|FG002|Overall Study|Lack of Efficacy|2|||
161001720|NCT01393119|581392975|FG003|Overall Study|Lack of Efficacy|1|||
161001721|NCT01393119|581392972|FG000|Overall Study|Protocol Violation|0|||
161001722|NCT01393119|581392973|FG001|Overall Study|Protocol Violation|0|||
161001723|NCT01393119|581392974|FG002|Overall Study|Protocol Violation|1|||
161001724|NCT01393119|581392975|FG003|Overall Study|Protocol Violation|0|||
161001725|NCT01393119|581392972|FG000|Overall Study|Death|0|||
161001726|NCT01393119|581392973|FG001|Overall Study|Death|0|||
161001727|NCT01393119|581392974|FG002|Overall Study|Death|0|||
161001728|NCT01393119|581392975|FG003|Overall Study|Death|1|||
160583697|NCT01830543|579857411|FG002|Overall Study|Subject Decision|57|||
161001729|NCT01393119|581392972|FG000|Overall Study|Randomized but Not treated|1|||
161001730|NCT01393119|581392973|FG001|Overall Study|Randomized but Not treated|0|||
161001731|NCT01393119|581392974|FG002|Overall Study|Randomized but Not treated|1|||
161001732|NCT01393119|581392975|FG003|Overall Study|Randomized but Not treated|1|||
161001733|NCT01393119|581392972|FG000|Overall Study|Sponsor Termination of Study|11|||
161001734|NCT01393119|581392973|FG001|Overall Study|Sponsor Termination of Study|12|||
161001735|NCT01393119|581392974|FG002|Overall Study|Sponsor Termination of Study|9|||
160583698|NCT01830543|579857409|FG000|Overall Study|Adverse Event|91|||
160583699|NCT01830543|579857410|FG001|Overall Study|Adverse Event|77|||
160583700|NCT01830543|579857411|FG002|Overall Study|Adverse Event|76|||
160583701|NCT01830543|579857409|FG000|Overall Study|Death|20|||
160583702|NCT01830543|579857410|FG001|Overall Study|Death|22|||
160583703|NCT01830543|579857411|FG002|Overall Study|Death|22|||
160583704|NCT01830543|579857409|FG000|Overall Study|Protocol Violation|3|||
160583705|NCT01830543|579857410|FG001|Overall Study|Protocol Violation|7|||
160583706|NCT01830543|579857411|FG002|Overall Study|Protocol Violation|7|||
160583707|NCT01830543|579857409|FG000|Overall Study|Physician Decision|11|||
160583708|NCT01830543|579857410|FG001|Overall Study|Physician Decision|5|||
160583709|NCT01830543|579857411|FG002|Overall Study|Physician Decision|12|||
160583710|NCT01830543|579857409|FG000|Overall Study|Withdrawal by consent|3|||
160583711|NCT01830543|579857410|FG001|Overall Study|Withdrawal by consent|3|||
160583712|NCT01830543|579857411|FG002|Overall Study|Withdrawal by consent|3|||
160583713|NCT01830543|579857409|FG000|Overall Study|Other|12|||
160583714|NCT01830543|579857410|FG001|Overall Study|Other|17|||
160583715|NCT01830543|579857411|FG002|Overall Study|Other|37|||
160958558|NCT04050865|581236046|FG000|Overall Study|Withdrawal by Subject|0|||
160583716|NCT03484923|579857418|FG000|Overall Study|Adverse Event|3|||
160583717|NCT03484923|579857419|FG001|Overall Study|Adverse Event|3|||
160583718|NCT03484923|579857420|FG002|Overall Study|Adverse Event|5|||
160583719|NCT03484923|579857421|FG003|Overall Study|Adverse Event|11|||
160583720|NCT03484923|579857422|FG004|Overall Study|Adverse Event|1|||
160583721|NCT03484923|579857418|FG000|Overall Study|Death|2|||
160583722|NCT03484923|579857419|FG001|Overall Study|Death|2|||
160583723|NCT03484923|579857420|FG002|Overall Study|Death|3|||
160583724|NCT03484923|579857421|FG003|Overall Study|Death|0|||
160583725|NCT03484923|579857422|FG004|Overall Study|Death|1|||
160583726|NCT03484923|579857418|FG000|Overall Study|Physician Decision|6|||
160583727|NCT03484923|579857419|FG001|Overall Study|Physician Decision|7|||
160583728|NCT03484923|579857420|FG002|Overall Study|Physician Decision|6|||
160583729|NCT03484923|579857421|FG003|Overall Study|Physician Decision|3|||
160583730|NCT03484923|579857422|FG004|Overall Study|Physician Decision|2|||
160583731|NCT03484923|579857418|FG000|Overall Study|Progressive disease|33|||
160583732|NCT03484923|579857419|FG001|Overall Study|Progressive disease|28|||
160583733|NCT03484923|579857420|FG002|Overall Study|Progressive disease|26|||
160583734|NCT03484923|579857421|FG003|Overall Study|Progressive disease|30|||
160583735|NCT03484923|579857422|FG004|Overall Study|Progressive disease|16|||
160583736|NCT03484923|579857418|FG000|Overall Study|Subject Decision|1|||
160583737|NCT03484923|579857419|FG001|Overall Study|Subject Decision|3|||
160583738|NCT03484923|579857420|FG002|Overall Study|Subject Decision|3|||
160583739|NCT03484923|579857421|FG003|Overall Study|Subject Decision|0|||
160583740|NCT03484923|579857422|FG004|Overall Study|Subject Decision|1|||
160583741|NCT01597557|579857425|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
160583742|NCT01597557|579857426|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
160583743|NCT00115349|579857429|FG000|Overall Study|Study closed due to low enrollment.|11|||
160583744|NCT00115349|579857430|FG001|Overall Study|Study closed due to low enrollment.|9|||
160583745|NCT01028651|579857434|FG000|Overall Study|Death|2|||
160583746|NCT01028651|579857434|FG000|Overall Study|Adverse Event|1|||
160583747|NCT00390416|579857436|FG000|Overall Study|Withdrawal by Subject|1|||
160583748|NCT00390416|579857436|FG000|Overall Study|Not treated|3|||
160583749|NCT01592409|579857437|FG000|Overall Study|Withdrawal by Subject|0|||
160583750|NCT01592409|579857438|FG001|Overall Study|Withdrawal by Subject|1|||
160583751|NCT01728584|579857441|FG000|Overall Study|Adverse Event|1|||
160583752|NCT01728584|579857442|FG001|Overall Study|Adverse Event|0|||
160583753|NCT01728584|579857443|FG002|Overall Study|Adverse Event|0|||
160583754|NCT01728584|579857444|FG003|Overall Study|Adverse Event|0|||
160583755|NCT01728584|579857441|FG000|Overall Study|Physician Decision|4|||
160583756|NCT01728584|579857442|FG001|Overall Study|Physician Decision|0|||
160583757|NCT01728584|579857443|FG002|Overall Study|Physician Decision|1|||
160583758|NCT01728584|579857444|FG003|Overall Study|Physician Decision|0|||
160583759|NCT01728584|579857441|FG000|Overall Study|Withdrawal by Subject|1|||
160958559|NCT04050865|581236047|FG001|Overall Study|Withdrawal by Subject|1|||
160656971|NCT05097989|580124504|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
160958560|NCT02035332|581236048|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
160583760|NCT01728584|579857442|FG001|Overall Study|Withdrawal by Subject|0|||
160583761|NCT01728584|579857443|FG002|Overall Study|Withdrawal by Subject|0|||
160583762|NCT01728584|579857444|FG003|Overall Study|Withdrawal by Subject|0|||
160583763|NCT01728584|579857441|FG000|Overall Study|Screen failure|1|||
160583764|NCT01728584|579857442|FG001|Overall Study|Screen failure|0|||
160583765|NCT01728584|579857443|FG002|Overall Study|Screen failure|0|||
160583766|NCT01728584|579857444|FG003|Overall Study|Screen failure|0|||
160583767|NCT01728584|579857441|FG000|Overall Study|Other reason (not specified)|1|||
160583768|NCT01728584|579857442|FG001|Overall Study|Other reason (not specified)|0|||
160583769|NCT01728584|579857443|FG002|Overall Study|Other reason (not specified)|0|||
160583770|NCT01728584|579857444|FG003|Overall Study|Other reason (not specified)|1|||
160583771|NCT02935634|579857445|FG000|Randomization|Participant withdrew consent|0|||
160583772|NCT02935634|579857446|FG001|Randomization|Participant withdrew consent|1|||
160457989|NCT01447719|579407995|FG000|Overall Study|Image acquisition failure|2|||
160583773|NCT02935634|579857447|FG002|Randomization|Participant withdrew consent|0|||
160958561|NCT01258608|581236049|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
160958562|NCT01258608|581236050|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
160958563|NCT01258608|581236049|FG000|Overall Study|Clinical progression|1|||
160958564|NCT01258608|581236050|FG001|Overall Study|Clinical progression|0|||
160958565|NCT01258608|581236049|FG000|Overall Study|Sponsor decision|0|||
160958566|NCT01258608|581236050|FG001|Overall Study|Sponsor decision|1|||
160958567|NCT01258608|581236049|FG000|Overall Study|Physician Decision|6|||
160958568|NCT01258608|581236050|FG001|Overall Study|Physician Decision|1|||
160958569|NCT01258608|581236049|FG000|Overall Study|Lost to Follow-up|0|||
160958570|NCT01258608|581236050|FG001|Overall Study|Lost to Follow-up|1|||
160583774|NCT02935634|579857448|FG003|Randomization|Participant withdrew consent|0|||
160583775|NCT02935634|579857449|FG004|Randomization|Participant withdrew consent|0|||
160583776|NCT02935634|579857450|FG005|Randomization|Participant withdrew consent|0|||
160583777|NCT02935634|579857445|FG000|Randomization|Death|2|||
160583778|NCT02935634|579857446|FG001|Randomization|Death|1|||
160583779|NCT02935634|579857447|FG002|Randomization|Death|1|||
160583780|NCT02935634|579857448|FG003|Randomization|Death|0|||
160583781|NCT02935634|579857449|FG004|Randomization|Death|0|||
160583782|NCT02935634|579857450|FG005|Randomization|Death|0|||
160583783|NCT02935634|579857445|FG000|Randomization|Other reasons|0|||
160583784|NCT02935634|579857446|FG001|Randomization|Other reasons|2|||
160583785|NCT02935634|579857447|FG002|Randomization|Other reasons|2|||
160583786|NCT02935634|579857448|FG003|Randomization|Other reasons|0|||
160583787|NCT02935634|579857449|FG004|Randomization|Other reasons|0|||
160583788|NCT02935634|579857450|FG005|Randomization|Other reasons|0|||
160583789|NCT02935634|579857445|FG000|Treatment: Track 1|Disease progression|15|||
160583790|NCT02935634|579857446|FG001|Treatment: Track 1|Disease progression|17|||
160583791|NCT02935634|579857447|FG002|Treatment: Track 1|Disease progression|28|||
160583792|NCT02935634|579857448|FG003|Treatment: Track 1|Disease progression|4|||
160583793|NCT02935634|579857449|FG004|Treatment: Track 1|Disease progression|6|||
160583794|NCT02935634|579857450|FG005|Treatment: Track 1|Disease progression|2|||
160583795|NCT02935634|579857445|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
160583796|NCT02935634|579857446|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
160583797|NCT02935634|579857447|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
160583798|NCT02935634|579857448|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
160958571|NCT01258608|581236049|FG000|Overall Study|Lack of compliance|1|||
160958572|NCT01258608|581236050|FG001|Overall Study|Lack of compliance|0|||
160958573|NCT01258608|581236049|FG000|Overall Study|Lack of Efficacy|0|||
160958574|NCT01258608|581236050|FG001|Overall Study|Lack of Efficacy|1|||
160958575|NCT01258608|581236049|FG000|Overall Study|Adverse Event|6|||
160958576|NCT01258608|581236050|FG001|Overall Study|Adverse Event|10|||
160958577|NCT01258608|581236049|FG000|Overall Study|Withdrawal by Subject|6|||
160958578|NCT01258608|581236050|FG001|Overall Study|Withdrawal by Subject|5|||
160958579|NCT04205630|581236051|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
160958580|NCT04205630|581236051|FG000|Overall Study|Disease clinical progression|7|||
160958581|NCT04205630|581236051|FG000|Overall Study|Withdrawal by Subject|2|||
160958582|NCT04205630|581236051|FG000|Overall Study|Adverse Event|17|||
160958583|NCT04205630|581236051|FG000|Overall Study|Other|1|||
160958584|NCT00160680|581236056|FG000|Overall Study|Adverse Event|0|||
160958585|NCT00160680|581236057|FG001|Overall Study|Adverse Event|1|||
160958586|NCT00160680|581236056|FG000|Overall Study|Lack of Efficacy|2|||
160958587|NCT00160680|581236057|FG001|Overall Study|Lack of Efficacy|1|||
160457990|NCT01447719|579407995|FG000|Overall Study|Invalid image or not imaged|3|||
160457991|NCT01447719|579407995|FG000|Overall Study|Subject still living at end of study|79|||
160958588|NCT00160680|581236056|FG000|Overall Study|Lost to Follow-up|3|||
160583799|NCT02935634|579857449|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
160656972|NCT05097989|580124496|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160583800|NCT02935634|579857450|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
160583801|NCT02935634|579857445|FG000|Treatment: Track 1|Lost to Follow-up|1|||
160583802|NCT02935634|579857446|FG001|Treatment: Track 1|Lost to Follow-up|0|||
160583803|NCT02935634|579857447|FG002|Treatment: Track 1|Lost to Follow-up|0|||
160583804|NCT02935634|579857448|FG003|Treatment: Track 1|Lost to Follow-up|0|||
160656973|NCT05097989|580124497|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160958589|NCT00160680|581236057|FG001|Overall Study|Lost to Follow-up|2|||
160958590|NCT00160680|581236056|FG000|Overall Study|Withdrawal by Subject|4|||
160958591|NCT00160680|581236057|FG001|Overall Study|Withdrawal by Subject|9|||
160958592|NCT04493216|581236058|FG000|Overall Study|Study terminated by sponsor|30|||
160958593|NCT04493216|581236059|FG001|Overall Study|Study terminated by sponsor|33|||
160958594|NCT04493216|581236060|FG002|Overall Study|Study terminated by sponsor|28|||
160583805|NCT02935634|579857449|FG004|Treatment: Track 1|Lost to Follow-up|0|||
160583806|NCT02935634|579857450|FG005|Treatment: Track 1|Lost to Follow-up|0|||
160958595|NCT04493216|581236061|FG003|Overall Study|Study terminated by sponsor|27|||
160958596|NCT04493216|581236058|FG000|Overall Study|Withdrawal by Subject|2|||
160958597|NCT04493216|581236059|FG001|Overall Study|Withdrawal by Subject|1|||
160958598|NCT04493216|581236060|FG002|Overall Study|Withdrawal by Subject|1|||
160958599|NCT04493216|581236061|FG003|Overall Study|Withdrawal by Subject|2|||
160958600|NCT04493216|581236058|FG000|Overall Study|Protocol Violation|1|||
160958601|NCT04493216|581236059|FG001|Overall Study|Protocol Violation|2|||
160958602|NCT04493216|581236060|FG002|Overall Study|Protocol Violation|0|||
160958603|NCT04493216|581236061|FG003|Overall Study|Protocol Violation|2|||
160958604|NCT04493216|581236058|FG000|Overall Study|Physician Decision|0|||
160958605|NCT04493216|581236059|FG001|Overall Study|Physician Decision|0|||
160958606|NCT04493216|581236060|FG002|Overall Study|Physician Decision|1|||
160958607|NCT04493216|581236061|FG003|Overall Study|Physician Decision|0|||
160958608|NCT04493216|581236058|FG000|Overall Study|Lost to Follow-up|2|||
160958609|NCT04493216|581236059|FG001|Overall Study|Lost to Follow-up|1|||
160958610|NCT04493216|581236060|FG002|Overall Study|Lost to Follow-up|0|||
160958611|NCT04493216|581236061|FG003|Overall Study|Lost to Follow-up|1|||
160958612|NCT04493216|581236058|FG000|Overall Study|Adverse Event|1|||
160958613|NCT04493216|581236059|FG001|Overall Study|Adverse Event|4|||
160958614|NCT04493216|581236060|FG002|Overall Study|Adverse Event|5|||
160457992|NCT01447719|579407995|FG000|Overall Study|Withdrawal by Subject|2|||
160958615|NCT04493216|581236061|FG003|Overall Study|Adverse Event|2|||
160958616|NCT04493216|581236058|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
160457993|NCT01447719|579407995|FG000|Overall Study|Family withdrew autopsy consent|7|||
160457994|NCT02944968|579407996|FG000|Overall Study|Subject excluded before study procedure|1|||
160457995|NCT02944968|579407996|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
160457996|NCT02542631|579408004|FG000|Overall Study|Adverse Event|1|||
160457997|NCT02542631|579408005|FG001|Overall Study|Adverse Event|1|||
160457998|NCT02542631|579408004|FG000|Overall Study|Sponsor Termination|1|||
160457999|NCT02542631|579408005|FG001|Overall Study|Sponsor Termination|0|||
160458000|NCT02542631|579408004|FG000|Overall Study|Withdrawal by Subject|11|||
160458001|NCT02542631|579408005|FG001|Overall Study|Withdrawal by Subject|16|||
160458002|NCT02542631|579408004|FG000|Overall Study|Protocol Violation|1|||
160458003|NCT02542631|579408005|FG001|Overall Study|Protocol Violation|1|||
160458004|NCT02542631|579408004|FG000|Overall Study|Physician Decision|6|||
160458005|NCT02542631|579408005|FG001|Overall Study|Physician Decision|4|||
160458006|NCT02542631|579408004|FG000|Overall Study|Lost to Follow-up|6|||
160458007|NCT02542631|579408005|FG001|Overall Study|Lost to Follow-up|5|||
160458008|NCT02542631|579408004|FG000|Overall Study|Death|1|||
160458009|NCT02542631|579408005|FG001|Overall Study|Death|2|||
160458010|NCT02542631|579408004|FG000|Overall Study|Other|2|||
160458011|NCT02542631|579408005|FG001|Overall Study|Other|1|||
160458012|NCT02542631|579408004|FG000|Overall Study|Used Prohibited Medication|2|||
160458013|NCT02542631|579408005|FG001|Overall Study|Used Prohibited Medication|1|||
160458014|NCT02326974|579408008|FG000|Overall Study|Withdrawal by Subject|2|||
160458015|NCT02326974|579408008|FG000|Overall Study|failed heterogenity evaluation|5|||
160458016|NCT04924400|579408011|FG000|Overall Study|Lost to Follow-up|3|||
160458017|NCT04924400|579408012|FG001|Overall Study|Lost to Follow-up|0|||
160458018|NCT04633538|579408013|FG000|Overall Study|Death|1|||
160458019|NCT04633538|579408013|FG000|Overall Study|Lost to Follow-up|3|||
160458020|NCT04633538|579408013|FG000|Overall Study|Withdrawal by Subject|1|||
160458021|NCT03582033|579408014|FG000|Part A|Other|0|||
160458022|NCT03582033|579408015|FG001|Part A|Other|0|||
160583807|NCT02935634|579857445|FG000|Treatment: Track 1|Study drug toxicity|2|||
160583808|NCT02935634|579857446|FG001|Treatment: Track 1|Study drug toxicity|1|||
160583809|NCT02935634|579857447|FG002|Treatment: Track 1|Study drug toxicity|3|||
160583810|NCT02935634|579857448|FG003|Treatment: Track 1|Study drug toxicity|0|||
160583811|NCT02935634|579857449|FG004|Treatment: Track 1|Study drug toxicity|0|||
160583812|NCT02935634|579857450|FG005|Treatment: Track 1|Study drug toxicity|1|||
160583813|NCT02935634|579857445|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
160583814|NCT02935634|579857446|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
160583815|NCT02935634|579857447|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
160583816|NCT02935634|579857448|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
160583817|NCT02935634|579857449|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
160583818|NCT02935634|579857450|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
160583819|NCT02935634|579857445|FG000|Treatment: Track 1|Participant withdrew consent|2|||
160583820|NCT02935634|579857446|FG001|Treatment: Track 1|Participant withdrew consent|0|||
160583821|NCT02935634|579857447|FG002|Treatment: Track 1|Participant withdrew consent|1|||
160583822|NCT02935634|579857448|FG003|Treatment: Track 1|Participant withdrew consent|0|||
160583823|NCT02935634|579857449|FG004|Treatment: Track 1|Participant withdrew consent|1|||
160583824|NCT02935634|579857450|FG005|Treatment: Track 1|Participant withdrew consent|0|||
160583825|NCT02935634|579857445|FG000|Treatment: Track 1|Other reasons|0|||
160583826|NCT02935634|579857446|FG001|Treatment: Track 1|Other reasons|0|||
160583827|NCT02935634|579857447|FG002|Treatment: Track 1|Other reasons|2|||
160583828|NCT02935634|579857448|FG003|Treatment: Track 1|Other reasons|0|||
160583829|NCT02935634|579857449|FG004|Treatment: Track 1|Other reasons|0|||
160583830|NCT02935634|579857450|FG005|Treatment: Track 1|Other reasons|0|||
160583831|NCT02935634|579857445|FG000|Treatment: Track 2|Disease progression|13|||
160583832|NCT02935634|579857446|FG001|Treatment: Track 2|Disease progression|26|||
160583833|NCT02935634|579857447|FG002|Treatment: Track 2|Disease progression|20|||
160583834|NCT02935634|579857448|FG003|Treatment: Track 2|Disease progression|5|||
160583835|NCT02935634|579857449|FG004|Treatment: Track 2|Disease progression|1|||
160958617|NCT04493216|581236059|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
160958618|NCT04493216|581236060|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
160583836|NCT02935634|579857450|FG005|Treatment: Track 2|Disease progression|4|||
160583837|NCT02935634|579857445|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
160583838|NCT02935634|579857446|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
160583839|NCT02935634|579857447|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
160583840|NCT02935634|579857448|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
160583841|NCT02935634|579857449|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
160583842|NCT02935634|579857450|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
160583843|NCT02935634|579857445|FG000|Treatment: Track 2|Study drug toxicity|7|||
160583844|NCT02935634|579857446|FG001|Treatment: Track 2|Study drug toxicity|3|||
160583845|NCT02935634|579857447|FG002|Treatment: Track 2|Study drug toxicity|0|||
160583846|NCT02935634|579857448|FG003|Treatment: Track 2|Study drug toxicity|0|||
160583847|NCT02935634|579857449|FG004|Treatment: Track 2|Study drug toxicity|0|||
160583848|NCT02935634|579857450|FG005|Treatment: Track 2|Study drug toxicity|0|||
160583849|NCT02935634|579857445|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
160583850|NCT02935634|579857446|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
160958619|NCT04493216|581236061|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
160958620|NCT04605978|581236074|FG000|Overall Study|Adverse Event|2|||
160958621|NCT04605978|581236075|FG001|Overall Study|Adverse Event|1|||
160958622|NCT04605978|581236074|FG000|Overall Study|Withdrawal nonmedical reason|1|||
160958623|NCT04605978|581236075|FG001|Overall Study|Withdrawal nonmedical reason|1|||
160958624|NCT02583425|581236076|FG000|Screening|Did not meet entry criteria|12|||
160958625|NCT02583425|581236076|FG000|Baseline|Did not meet continued criteria|5|||
160958626|NCT02583425|581236076|FG000|Treatment Period|Adverse Event|1|||
160583851|NCT02935634|579857447|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
160583852|NCT02935634|579857448|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
160583853|NCT02935634|579857449|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
160583854|NCT02935634|579857450|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
160583855|NCT02935634|579857445|FG000|Treatment: Track 2|Participant withdrew consent|0|||
160583856|NCT02935634|579857446|FG001|Treatment: Track 2|Participant withdrew consent|1|||
160583857|NCT02935634|579857447|FG002|Treatment: Track 2|Participant withdrew consent|1|||
160583858|NCT02935634|579857448|FG003|Treatment: Track 2|Participant withdrew consent|0|||
160583859|NCT02935634|579857449|FG004|Treatment: Track 2|Participant withdrew consent|1|||
160583860|NCT02935634|579857450|FG005|Treatment: Track 2|Participant withdrew consent|0|||
160583861|NCT05132569|579857452|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
160583862|NCT05132569|579857453|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
160583863|NCT05132569|579857452|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
160583864|NCT05132569|579857453|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
160583865|NCT05132569|579857452|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
160583866|NCT05132569|579857453|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
160583867|NCT06150573|579857456|FG000|Overall Study|Did not meet study criteria|1|||
160583868|NCT06150573|579857457|FG001|Overall Study|Did not meet study criteria|0|||
160583869|NCT06150573|579857456|FG000|Overall Study|Adverse Event|1|||
160583870|NCT06150573|579857457|FG001|Overall Study|Adverse Event|0|||
160583871|NCT06150573|579857456|FG000|Overall Study|Lost to Follow-up|0|||
160583872|NCT06150573|579857457|FG001|Overall Study|Lost to Follow-up|1|||
160583873|NCT06150573|579857456|FG000|Overall Study|Protocol Violation|0|||
160583874|NCT06150573|579857457|FG001|Overall Study|Protocol Violation|1|||
160583875|NCT06150573|579857456|FG000|Overall Study|Withdrawal by Subject|2|||
160583876|NCT06150573|579857457|FG001|Overall Study|Withdrawal by Subject|0|||
160958627|NCT01690130|581236077|FG000|Overall Study|Subject have cancelled visit.|1|||
160958628|NCT01690130|581236078|FG001|Overall Study|Subject have cancelled visit.|0|||
160958629|NCT01644734|581236079|FG000|Overall Study|Adverse Event|4|||
160958630|NCT01644734|581236079|FG000|Overall Study|Lost to Follow-up|17|||
160958631|NCT01644734|581236079|FG000|Overall Study|Reasons other than stated above|7|||
160458023|NCT03582033|579408016|FG002|Part A|Other|0|||
160458024|NCT03582033|579408017|FG003|Part A|Other|0|||
160458025|NCT03582033|579408018|FG004|Part A|Other|2|||
160583877|NCT00210158|579857458|FG000|Overall Study|Protocol Violation|0|||
160583878|NCT00210158|579857459|FG001|Overall Study|Protocol Violation|2|||
160583879|NCT01327651|579857460|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
160583880|NCT01327651|579857461|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
160583881|NCT01327651|579857462|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
160583882|NCT01327651|579857463|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
160583883|NCT01327651|579857464|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
160583884|NCT01327651|579857465|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
160458026|NCT03582033|579408019|FG005|Part A|Other|0|||
160458027|NCT03582033|579408020|FG006|Part A|Other|0|||
160958632|NCT01644734|581236079|FG000|Overall Study|Missing documentation|238|||
160958633|NCT02216123|581236080|FG000|Overall Study|Lost to Follow-up|4|||
160958634|NCT02216123|581236081|FG001|Overall Study|Lost to Follow-up|2|||
160958635|NCT02216123|581236080|FG000|Overall Study|Withdrawal by Subject|2|||
160958636|NCT02216123|581236081|FG001|Overall Study|Withdrawal by Subject|0|||
160958637|NCT02157779|581236086|FG000|Overall Study|Logistical|9|||
160958638|NCT02157779|581236087|FG001|Overall Study|Logistical|3|||
160958639|NCT02157779|581236086|FG000|Overall Study|Stopped attending, reason unknown|11|||
160958640|NCT02157779|581236087|FG001|Overall Study|Stopped attending, reason unknown|7|||
160958641|NCT02157779|581236086|FG000|Overall Study|No response to outreach after Baseline|1|||
160958642|NCT02157779|581236087|FG001|Overall Study|No response to outreach after Baseline|1|||
160958643|NCT02157779|581236086|FG000|Overall Study|Moved|1|||
160958644|NCT02157779|581236087|FG001|Overall Study|Moved|0|||
160958645|NCT02157779|581236086|FG000|Overall Study|Medical|1|||
160958646|NCT02157779|581236087|FG001|Overall Study|Medical|0|||
160958647|NCT02157779|581236086|FG000|Overall Study|Legal issue|1|||
160958648|NCT02157779|581236087|FG001|Overall Study|Legal issue|0|||
160958649|NCT02548455|581236088|FG000|Overall Study|Withdrawal by Subject|27|||
160958650|NCT02548455|581236088|FG000|Overall Study|Death|26|||
160958651|NCT02548455|581236088|FG000|Overall Study|Lost to Follow-up|14|||
160958652|NCT02548455|581236088|FG000|Overall Study|Visit not completed|173|||
160958653|NCT00487162|581236090|FG000|Overall Study|Adverse Event|0|||
160958654|NCT00487162|581236091|FG001|Overall Study|Adverse Event|1|||
160958655|NCT00487162|581236090|FG000|Overall Study|Physician Decision|0|||
160958656|NCT00487162|581236091|FG001|Overall Study|Physician Decision|1|||
160958657|NCT00487162|581236090|FG000|Overall Study|Withdrawal by Subject|2|||
160958658|NCT00487162|581236091|FG001|Overall Study|Withdrawal by Subject|3|||
160958659|NCT01292876|581236092|FG000|Overall Study|Physician Decision|4|||
160958660|NCT01627327|581236093|FG000|Overall Study|Adverse Event|6|||
160958661|NCT01627327|581236094|FG001|Overall Study|Adverse Event|12|||
160958662|NCT01627327|581236093|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
160958663|NCT01627327|581236094|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
160958664|NCT01627327|581236093|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
160958665|NCT01627327|581236094|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
160958666|NCT01627327|581236093|FG000|Overall Study|Protocol Violation|4|||
160958667|NCT01627327|581236094|FG001|Overall Study|Protocol Violation|10|||
160958668|NCT01627327|581236093|FG000|Overall Study|Lost to Follow-up|1|||
160958669|NCT01627327|581236094|FG001|Overall Study|Lost to Follow-up|3|||
160958670|NCT01627327|581236093|FG000|Overall Study|Physician Decision|1|||
160958671|NCT01627327|581236094|FG001|Overall Study|Physician Decision|0|||
160958672|NCT01627327|581236093|FG000|Overall Study|Withdrawal by Subject|3|||
160958673|NCT01627327|581236094|FG001|Overall Study|Withdrawal by Subject|3|||
160958674|NCT01137474|581236100|FG000|Overall Study|Adverse Event|3|||
160958675|NCT01137474|581236101|FG001|Overall Study|Adverse Event|5|||
160958676|NCT01137474|581236102|FG002|Overall Study|Adverse Event|1|||
160958677|NCT01137474|581236103|FG003|Overall Study|Adverse Event|3|||
160958678|NCT01137474|581236100|FG000|Overall Study|Withdrawal by Subject|7|||
160958679|NCT01137474|581236101|FG001|Overall Study|Withdrawal by Subject|2|||
160958680|NCT01137474|581236102|FG002|Overall Study|Withdrawal by Subject|6|||
160958681|NCT01137474|581236103|FG003|Overall Study|Withdrawal by Subject|9|||
160958682|NCT01137474|581236100|FG000|Overall Study|No longer met study criteria|6|||
160958683|NCT01137474|581236101|FG001|Overall Study|No longer met study criteria|1|||
160958684|NCT01137474|581236102|FG002|Overall Study|No longer met study criteria|0|||
160958685|NCT01137474|581236103|FG003|Overall Study|No longer met study criteria|5|||
160958686|NCT01137474|581236100|FG000|Overall Study|Lost to Follow-up|5|||
160958687|NCT01137474|581236101|FG001|Overall Study|Lost to Follow-up|1|||
160958688|NCT01137474|581236102|FG002|Overall Study|Lost to Follow-up|0|||
160958689|NCT01137474|581236103|FG003|Overall Study|Lost to Follow-up|2|||
160958690|NCT01137474|581236100|FG000|Overall Study|Lack of Efficacy|0|||
160958691|NCT01137474|581236101|FG001|Overall Study|Lack of Efficacy|0|||
160958692|NCT01137474|581236102|FG002|Overall Study|Lack of Efficacy|0|||
160958693|NCT01137474|581236103|FG003|Overall Study|Lack of Efficacy|2|||
160958694|NCT01137474|581236100|FG000|Overall Study|Other|3|||
160958695|NCT01137474|581236101|FG001|Overall Study|Other|1|||
160958696|NCT01137474|581236102|FG002|Overall Study|Other|0|||
161001736|NCT01393119|581392975|FG003|Overall Study|Sponsor Termination of Study|12|||
161001737|NCT04860258|581392976|FG000|Overall Study|Withdrawal by Subject|0|||
161001738|NCT04860258|581392977|FG001|Overall Study|Withdrawal by Subject|0|||
161001739|NCT04860258|581392978|FG002|Overall Study|Withdrawal by Subject|4|||
161001740|NCT04860258|581392979|FG003|Overall Study|Withdrawal by Subject|1|||
161001741|NCT04860258|581392980|FG004|Overall Study|Withdrawal by Subject|4|||
161001742|NCT04860258|581392981|FG005|Overall Study|Withdrawal by Subject|1|||
160958697|NCT01137474|581236103|FG003|Overall Study|Other|0|||
160958698|NCT01137474|581236100|FG000|Overall Study|Pregnancy|0|||
160958699|NCT01137474|581236101|FG001|Overall Study|Pregnancy|1|||
160458028|NCT03582033|579408021|FG007|Part A|Other|0|||
160958700|NCT01137474|581236102|FG002|Overall Study|Pregnancy|0|||
160958701|NCT01137474|581236103|FG003|Overall Study|Pregnancy|0|||
161001743|NCT04860258|581392982|FG006|Overall Study|Withdrawal by Subject|0|||
160958702|NCT01137474|581236100|FG000|Overall Study|Administrative reason by sponsor|0|||
160958703|NCT01137474|581236101|FG001|Overall Study|Administrative reason by sponsor|1|||
160958704|NCT01137474|581236102|FG002|Overall Study|Administrative reason by sponsor|0|||
160958705|NCT01137474|581236103|FG003|Overall Study|Administrative reason by sponsor|0|||
160958706|NCT02525874|581236106|FG000|Overall Study|Other|1|||
160958707|NCT02525874|581236106|FG000|Overall Study|Investigator Decision|1|||
160958708|NCT02525874|581236106|FG000|Overall Study|Consent withdrawn|22|||
160958709|NCT02525874|581236106|FG000|Overall Study|Non-compliance with study drug|3|||
160958710|NCT02525874|581236106|FG000|Overall Study|Adverse Event|17|||
160958711|NCT02525874|581236106|FG000|Overall Study|Lost to Follow-up|7|||
160958712|NCT02525874|581236106|FG000|Overall Study|Disease progression, defined by protocol|2|||
160958713|NCT02525874|581236106|FG000|Overall Study|Disease relapse|4|||
160958714|NCT02525874|581236106|FG000|Overall Study|Alternative Treatment for MS|2|||
160958715|NCT02525874|581236106|FG000|Overall Study|New lesions in Brain|1|||
160958716|NCT00675766|581236113|FG000|Overall Study|Lost to Follow-up|6|||
160958717|NCT00675766|581236114|FG001|Overall Study|Lost to Follow-up|5|||
160958718|NCT00675766|581236115|FG002|Overall Study|Lost to Follow-up|21|||
160958719|NCT00675766|581236116|FG003|Overall Study|Lost to Follow-up|26|||
160958720|NCT01207102|581236120|FG000|Overall Study|Withdrawal by Subject|5|||
160958721|NCT01207102|581236120|FG000|Overall Study|Adverse Event|2|||
160958722|NCT01207102|581236120|FG000|Overall Study|progression|2|||
160958723|NCT01207102|581236120|FG000|Overall Study|Withdrawal by Treating Physician|1|||
160958724|NCT01018394|581236121|FG000|Overall Study|Withdrawal by Subject|5|||
160958725|NCT01018394|581236122|FG001|Overall Study|Withdrawal by Subject|5|||
160958726|NCT01018394|581236121|FG000|Overall Study|Lost to Follow-up|4|||
160958727|NCT01018394|581236122|FG001|Overall Study|Lost to Follow-up|3|||
160958728|NCT03792126|581236123|FG000|Overall Study|Adverse Event|1|||
160958729|NCT03792126|581236124|FG001|Overall Study|Adverse Event|2|||
160958730|NCT03792126|581236123|FG000|Overall Study|Death|0|||
160958731|NCT03792126|581236124|FG001|Overall Study|Death|1|||
160958732|NCT03792126|581236123|FG000|Overall Study|Lost to Follow-up|1|||
160958733|NCT03792126|581236124|FG001|Overall Study|Lost to Follow-up|0|||
160958734|NCT03792126|581236123|FG000|Overall Study|Withdrawal by Subject|0|||
160958735|NCT03792126|581236124|FG001|Overall Study|Withdrawal by Subject|1|||
160958736|NCT03792126|581236123|FG000|Overall Study|COVID-19 Restrictions|1|||
160958737|NCT03792126|581236124|FG001|Overall Study|COVID-19 Restrictions|3|||
160958738|NCT03792126|581236123|FG000|Overall Study|Symptoms resolved|0|||
160958739|NCT03792126|581236124|FG001|Overall Study|Symptoms resolved|3|||
160958740|NCT00617344|581236126|FG000|Overall Study|Serious adverse event|1|||
160958741|NCT00617344|581236127|FG001|Overall Study|Serious adverse event|0|||
160958742|NCT00617344|581236128|FG002|Overall Study|Serious adverse event|0|||
160656974|NCT05097989|580124498|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160958743|NCT00617344|581236126|FG000|Overall Study|Other Adverse Event|1|||
160958744|NCT00617344|581236127|FG001|Overall Study|Other Adverse Event|1|||
160958745|NCT00617344|581236128|FG002|Overall Study|Other Adverse Event|0|||
160958746|NCT00617344|581236126|FG000|Overall Study|Protocol Violation|10|||
160958747|NCT00617344|581236127|FG001|Overall Study|Protocol Violation|8|||
160958748|NCT00617344|581236128|FG002|Overall Study|Protocol Violation|5|||
160958749|NCT00617344|581236126|FG000|Overall Study|Lost to Follow-up|5|||
160958750|NCT00617344|581236127|FG001|Overall Study|Lost to Follow-up|4|||
160958751|NCT00617344|581236128|FG002|Overall Study|Lost to Follow-up|1|||
160958752|NCT00617344|581236126|FG000|Overall Study|Withdrawal by Subject|8|||
160958753|NCT00617344|581236127|FG001|Overall Study|Withdrawal by Subject|9|||
160958754|NCT00617344|581236128|FG002|Overall Study|Withdrawal by Subject|2|||
160958755|NCT00490646|581236129|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
160958756|NCT00490646|581236130|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
160958757|NCT00490646|581236129|FG000|Overall Study|Never Treated (had an adverse event)|1|||
160958758|NCT00490646|581236130|FG001|Overall Study|Never Treated (had an adverse event)|0|||
160958759|NCT00490646|581236129|FG000|Overall Study|Never Treated (withdrew consent)|0|||
160958760|NCT00490646|581236130|FG001|Overall Study|Never Treated (withdrew consent)|1|||
160958761|NCT01400503|581236132|FG000|Overall Study|Withdrawal by Subject|1|||
160958762|NCT01400503|581236132|FG000|Overall Study|Study Terminated by Sponsor|58|||
160958763|NCT01400503|581236132|FG000|Overall Study|Other|1|||
160958764|NCT00983073|581236133|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
160958765|NCT00983073|581236133|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
160958766|NCT00983073|581236133|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
160958767|NCT00983073|581236133|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
160958768|NCT00983073|581236133|FG000|Titration and Optimal Dose Period|Other reason|4|||
160958769|NCT00983073|581236133|FG000|Maintenance Period|Adverse Event|5|||
160958770|NCT00983073|581236133|FG000|Maintenance Period|Withdrawal by Subject|2|||
160958771|NCT00983073|581236133|FG000|Maintenance Period|Lack of Efficacy|2|||
160958772|NCT00983073|581236133|FG000|Maintenance Period|Other Reason|7|||
160958773|NCT01669122|581236136|FG000|Period I|Lost to Follow-up|1|||
160958774|NCT01669122|581236136|FG000|Washout Period II|Protocol Violation|2|||
160958775|NCT02962908|581236137|FG000|Overall Study|Lost to Follow-up|0|||
160458029|NCT03582033|579408022|FG008|Part A|Other|0|||
160958776|NCT02962908|581236138|FG001|Overall Study|Lost to Follow-up|3|||
160958777|NCT02962908|581236139|FG002|Overall Study|Lost to Follow-up|0|||
160958778|NCT02962908|581236140|FG003|Overall Study|Lost to Follow-up|1|||
160958779|NCT02962908|581236137|FG000|Overall Study|Withdrawal by Subject|0|||
160958780|NCT02962908|581236138|FG001|Overall Study|Withdrawal by Subject|3|||
160958781|NCT02962908|581236139|FG002|Overall Study|Withdrawal by Subject|0|||
160958782|NCT02962908|581236140|FG003|Overall Study|Withdrawal by Subject|2|||
160958783|NCT02962908|581236137|FG000|Overall Study|Protocol Violation|0|||
160958784|NCT02962908|581236138|FG001|Overall Study|Protocol Violation|1|||
160958785|NCT02962908|581236139|FG002|Overall Study|Protocol Violation|0|||
160958786|NCT02962908|581236140|FG003|Overall Study|Protocol Violation|0|||
160958787|NCT02962908|581236137|FG000|Overall Study|Physician Decision|0|||
160958788|NCT02962908|581236138|FG001|Overall Study|Physician Decision|1|||
160958789|NCT02962908|581236139|FG002|Overall Study|Physician Decision|0|||
160958790|NCT02962908|581236140|FG003|Overall Study|Physician Decision|0|||
160958791|NCT03543254|581236141|FG000|Overall Study|Lost to Follow-up|1|||
160958792|NCT02077166|581236142|FG000|Overall Study|Death|6|||
160958793|NCT02077166|581236143|FG001|Overall Study|Death|7|||
160958794|NCT02077166|581236144|FG002|Overall Study|Death|5|||
160958795|NCT02077166|581236145|FG003|Overall Study|Death|6|||
160958796|NCT02077166|581236146|FG004|Overall Study|Death|4|||
160958797|NCT02077166|581236147|FG005|Overall Study|Death|32|||
160958798|NCT02077166|581236148|FG006|Overall Study|Death|22|||
160958799|NCT02077166|581236142|FG000|Overall Study|Study Closure by Sponsor|3|||
160958800|NCT02077166|581236143|FG001|Overall Study|Study Closure by Sponsor|0|||
160958801|NCT02077166|581236144|FG002|Overall Study|Study Closure by Sponsor|2|||
160958802|NCT02077166|581236145|FG003|Overall Study|Study Closure by Sponsor|2|||
160958803|NCT02077166|581236146|FG004|Overall Study|Study Closure by Sponsor|2|||
160958804|NCT02077166|581236147|FG005|Overall Study|Study Closure by Sponsor|12|||
160958805|NCT02077166|581236148|FG006|Overall Study|Study Closure by Sponsor|4|||
160958806|NCT02077166|581236142|FG000|Overall Study|Lost to Follow-up|0|||
160958807|NCT02077166|581236143|FG001|Overall Study|Lost to Follow-up|0|||
160958808|NCT02077166|581236144|FG002|Overall Study|Lost to Follow-up|0|||
160958809|NCT02077166|581236145|FG003|Overall Study|Lost to Follow-up|0|||
160958810|NCT02077166|581236146|FG004|Overall Study|Lost to Follow-up|0|||
160958811|NCT02077166|581236147|FG005|Overall Study|Lost to Follow-up|1|||
160958812|NCT02077166|581236148|FG006|Overall Study|Lost to Follow-up|0|||
160958813|NCT02077166|581236142|FG000|Overall Study|Withdrawal by Subject|3|||
160958814|NCT02077166|581236143|FG001|Overall Study|Withdrawal by Subject|0|||
160958815|NCT02077166|581236144|FG002|Overall Study|Withdrawal by Subject|1|||
160958816|NCT02077166|581236145|FG003|Overall Study|Withdrawal by Subject|1|||
160958817|NCT02077166|581236146|FG004|Overall Study|Withdrawal by Subject|1|||
160958818|NCT02077166|581236147|FG005|Overall Study|Withdrawal by Subject|3|||
160958819|NCT02077166|581236148|FG006|Overall Study|Withdrawal by Subject|0|||
160958820|NCT02077166|581236142|FG000|Overall Study|Other, Not Specified|0|||
160958821|NCT02077166|581236143|FG001|Overall Study|Other, Not Specified|0|||
160958822|NCT02077166|581236144|FG002|Overall Study|Other, Not Specified|1|||
160958823|NCT02077166|581236145|FG003|Overall Study|Other, Not Specified|0|||
160958824|NCT02077166|581236146|FG004|Overall Study|Other, Not Specified|1|||
160958825|NCT02077166|581236147|FG005|Overall Study|Other, Not Specified|7|||
160958826|NCT02077166|581236148|FG006|Overall Study|Other, Not Specified|8|||
161001744|NCT01266265|581392983|FG000|Overall Study|Death|95|||
161001745|NCT01266265|581392984|FG001|Overall Study|Death|73|||
161001746|NCT01266265|581392983|FG000|Overall Study|Lost to Follow-up|23|||
161001747|NCT01266265|581392984|FG001|Overall Study|Lost to Follow-up|28|||
161001748|NCT01266265|581392983|FG000|Overall Study|Withdrawal by Subject|13|||
161001749|NCT01266265|581392984|FG001|Overall Study|Withdrawal by Subject|11|||
161001750|NCT01266265|581392983|FG000|Overall Study|Respiratory-related adverse event|2|||
161001751|NCT01266265|581392984|FG001|Overall Study|Respiratory-related adverse event|1|||
161001752|NCT01266265|581392983|FG000|Overall Study|Transferred care to another provider|22|||
161001753|NCT01266265|581392984|FG001|Overall Study|Transferred care to another provider|28|||
161001754|NCT01266265|581392983|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
161001755|NCT01266265|581392984|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
161001756|NCT01266265|581392983|FG000|Overall Study|Enrolled in another clinical study|15|||
161001757|NCT01266265|581392984|FG001|Overall Study|Enrolled in another clinical study|26|||
161001758|NCT01266265|581392983|FG000|Overall Study|Non-compliance|8|||
161001759|NCT01266265|581392984|FG001|Overall Study|Non-compliance|5|||
160958827|NCT01261338|581236149|FG000|Overall Study|Withdrawal by Subject|3|||
160958828|NCT01261338|581236150|FG001|Overall Study|Withdrawal by Subject|2|||
160958829|NCT02899728|581236156|FG000|Overall Study|Withdrawal by Subject|1|||
160958830|NCT02899728|581236157|FG001|Overall Study|Withdrawal by Subject|1|||
160958831|NCT05557942|581236158|FG000|Overall Study|Death|0|||
160958832|NCT05557942|581236159|FG001|Overall Study|Death|0|||
160958833|NCT05557942|581236160|FG002|Overall Study|Death|0|||
160958834|NCT05557942|581236161|FG003|Overall Study|Death|2|||
161001760|NCT01266265|581392983|FG000|Overall Study|Lung transplant|6|||
161001761|NCT01266265|581392984|FG001|Overall Study|Lung transplant|5|||
161001762|NCT01266265|581392983|FG000|Overall Study|Site closed early|4|||
160583885|NCT01327651|579857466|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
160583886|NCT01327651|579857467|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
160583887|NCT01327651|579857468|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
160583888|NCT01327651|579857460|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
160583889|NCT01327651|579857461|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
160583890|NCT01327651|579857462|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
160583891|NCT01327651|579857463|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
160583892|NCT01327651|579857464|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
160583893|NCT01327651|579857465|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
160583894|NCT01327651|579857466|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
160583895|NCT01327651|579857467|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
160583896|NCT01327651|579857468|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
160583897|NCT01327651|579857460|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
160583898|NCT01327651|579857461|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
160583899|NCT01327651|579857462|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
160583900|NCT01327651|579857463|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
160583901|NCT01327651|579857464|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
160583902|NCT01327651|579857465|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
160583903|NCT01327651|579857466|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
160583904|NCT01327651|579857467|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
160583905|NCT01327651|579857468|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
160583906|NCT01327651|579857460|FG000|Post Study Follow-up|Lost to Follow-up|0|||
160583907|NCT01327651|579857461|FG001|Post Study Follow-up|Lost to Follow-up|1|||
160583908|NCT01327651|579857462|FG002|Post Study Follow-up|Lost to Follow-up|1|||
160583909|NCT01327651|579857463|FG003|Post Study Follow-up|Lost to Follow-up|0|||
160583910|NCT01327651|579857464|FG004|Post Study Follow-up|Lost to Follow-up|0|||
160583911|NCT01327651|579857465|FG005|Post Study Follow-up|Lost to Follow-up|0|||
160583912|NCT01327651|579857466|FG006|Post Study Follow-up|Lost to Follow-up|4|||
160583913|NCT01327651|579857467|FG007|Post Study Follow-up|Lost to Follow-up|1|||
160583914|NCT01327651|579857468|FG008|Post Study Follow-up|Lost to Follow-up|2|||
160583915|NCT02284906|579857473|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160958835|NCT05557942|581236162|FG004|Overall Study|Death|1|||
160958836|NCT05557942|581236163|FG005|Overall Study|Death|1|||
160958837|NCT05557942|581236158|FG000|Overall Study|Physician Decision|1|||
160958838|NCT05557942|581236159|FG001|Overall Study|Physician Decision|1|||
160958839|NCT05557942|581236160|FG002|Overall Study|Physician Decision|2|||
160958840|NCT05557942|581236161|FG003|Overall Study|Physician Decision|3|||
160958841|NCT05557942|581236162|FG004|Overall Study|Physician Decision|0|||
161001763|NCT01266265|581392984|FG001|Overall Study|Site closed early|3|||
160583916|NCT02284906|579857474|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
160583917|NCT02284906|579857475|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
160583918|NCT02284906|579857473|FG000|Overall Study|Major Protocol Deviation|0|||
160583919|NCT02284906|579857474|FG001|Overall Study|Major Protocol Deviation|1|||
160583920|NCT02284906|579857475|FG002|Overall Study|Major Protocol Deviation|0|||
160583921|NCT02284906|579857473|FG000|Overall Study|Voluntary Withdrawal|2|||
160583922|NCT02284906|579857474|FG001|Overall Study|Voluntary Withdrawal|4|||
160583923|NCT02284906|579857475|FG002|Overall Study|Voluntary Withdrawal|5|||
160583924|NCT02284906|579857473|FG000|Overall Study|Study Termination|0|||
160583925|NCT02284906|579857474|FG001|Overall Study|Study Termination|11|||
160583926|NCT02284906|579857475|FG002|Overall Study|Study Termination|14|||
160583927|NCT02284906|579857473|FG000|Overall Study|Reason not Specified|1|||
160583928|NCT02284906|579857474|FG001|Overall Study|Reason not Specified|1|||
160583929|NCT02284906|579857475|FG002|Overall Study|Reason not Specified|0|||
160583930|NCT01409031|579857476|FG000|Overall Study|transferred to other hosp|1|||
160583931|NCT01409031|579857477|FG001|Overall Study|transferred to other hosp|0|||
160583932|NCT00532948|579857478|FG000|Overall Study|Protocol Violation|1|||
160583933|NCT00532948|579857479|FG001|Overall Study|Protocol Violation|0|||
161001764|NCT01266265|581392983|FG000|Overall Study|Clinical worsening|1|||
161001765|NCT01266265|581392984|FG001|Overall Study|Clinical worsening|1|||
161001766|NCT01580293|581392985|FG000|Part A_Main Trial|Adverse Event|0|||
161001767|NCT01580293|581392986|FG001|Part A_Main Trial|Adverse Event|2|||
161001768|NCT01580293|581392987|FG002|Part A_Main Trial|Adverse Event|0|||
160583934|NCT00532948|579857480|FG002|Overall Study|Protocol Violation|0|||
160583935|NCT00532948|579857478|FG000|Overall Study|Death|3|||
160958842|NCT05557942|581236163|FG005|Overall Study|Physician Decision|2|||
160583936|NCT00532948|579857479|FG001|Overall Study|Death|3|||
160583937|NCT00532948|579857480|FG002|Overall Study|Death|4|||
160583938|NCT00532948|579857478|FG000|Overall Study|Violation of selection criteria at entry|0|||
160583939|NCT00532948|579857479|FG001|Overall Study|Violation of selection criteria at entry|1|||
160958843|NCT05557942|581236158|FG000|Overall Study|Study terminated by sponsor|17|||
160958844|NCT05557942|581236159|FG001|Overall Study|Study terminated by sponsor|17|||
161001769|NCT01580293|581392985|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
161001770|NCT01580293|581392986|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
160583940|NCT00532948|579857480|FG002|Overall Study|Violation of selection criteria at entry|0|||
160583941|NCT00532948|579857478|FG000|Overall Study|Failure to return|0|||
160583942|NCT00532948|579857479|FG001|Overall Study|Failure to return|1|||
160583943|NCT00532948|579857480|FG002|Overall Study|Failure to return|0|||
160583944|NCT03885726|579857481|FG000|Overall Study|Staffing issues/lost interest|1|||
160583945|NCT03885726|579857481|FG000|Overall Study|Early discharge from hospital|3|||
160583946|NCT02702193|579857485|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
160583947|NCT02702193|579857486|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
160583948|NCT02702193|579857485|FG000|4 Month Follow up|Withdrawal by Subject|1|||
160583949|NCT02702193|579857486|FG001|4 Month Follow up|Withdrawal by Subject|0|||
160583950|NCT02702193|579857485|FG000|4 Month Follow up|Lost to Follow-up|17|||
160583951|NCT02702193|579857486|FG001|4 Month Follow up|Lost to Follow-up|18|||
160583952|NCT02702193|579857485|FG000|8 Month Follow up|Withdrawal by Subject|1|||
160583953|NCT02702193|579857486|FG001|8 Month Follow up|Withdrawal by Subject|0|||
160583954|NCT02702193|579857485|FG000|8 Month Follow up|Lost to Follow-up|14|||
160583955|NCT02702193|579857486|FG001|8 Month Follow up|Lost to Follow-up|18|||
160583956|NCT02702193|579857485|FG000|12 Month Follow up|Withdrawal by Subject|1|||
160583957|NCT02702193|579857486|FG001|12 Month Follow up|Withdrawal by Subject|0|||
160583958|NCT02702193|579857485|FG000|12 Month Follow up|Lost to Follow-up|16|||
160583959|NCT02702193|579857486|FG001|12 Month Follow up|Lost to Follow-up|18|||
160583960|NCT03521687|579857487|FG000|Overall Study|Adverse Event|4|||
160583961|NCT03521687|579857487|FG000|Overall Study|Physician Decision|1|||
160583962|NCT04891770|579857497|FG000|Overall Study|Withdrew consent|1|||
160583963|NCT04891770|579857498|FG001|Overall Study|Withdrew consent|3|||
160958845|NCT05557942|581236160|FG002|Overall Study|Study terminated by sponsor|14|||
160958846|NCT05557942|581236161|FG003|Overall Study|Study terminated by sponsor|40|||
160958847|NCT05557942|581236162|FG004|Overall Study|Study terminated by sponsor|45|||
160958848|NCT05557942|581236163|FG005|Overall Study|Study terminated by sponsor|37|||
160958849|NCT05557942|581236158|FG000|Overall Study|Protocol Violation|0|||
160958850|NCT05557942|581236159|FG001|Overall Study|Protocol Violation|0|||
160958851|NCT05557942|581236160|FG002|Overall Study|Protocol Violation|0|||
160958852|NCT05557942|581236161|FG003|Overall Study|Protocol Violation|0|||
160958853|NCT05557942|581236162|FG004|Overall Study|Protocol Violation|0|||
160958854|NCT05557942|581236163|FG005|Overall Study|Protocol Violation|1|||
160958855|NCT05557942|581236158|FG000|Overall Study|Withdrawal by Subject|0|||
160958856|NCT05557942|581236159|FG001|Overall Study|Withdrawal by Subject|0|||
160583964|NCT04891770|579857499|FG002|Overall Study|Withdrew consent|0|||
160583965|NCT04891770|579857497|FG000|Overall Study|Enrolled but never treated|0|||
160583966|NCT04891770|579857498|FG001|Overall Study|Enrolled but never treated|0|||
160583967|NCT04891770|579857499|FG002|Overall Study|Enrolled but never treated|1|||
160583968|NCT04891770|579857497|FG000|Overall Study|Investigator's discretion|0|||
160583969|NCT04891770|579857498|FG001|Overall Study|Investigator's discretion|1|||
160656975|NCT05097989|580124499|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160656976|NCT05097989|580124500|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
160656977|NCT05097989|580124501|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160958857|NCT05557942|581236160|FG002|Overall Study|Withdrawal by Subject|0|||
160958858|NCT05557942|581236161|FG003|Overall Study|Withdrawal by Subject|0|||
160958859|NCT05557942|581236162|FG004|Overall Study|Withdrawal by Subject|2|||
160958860|NCT05557942|581236163|FG005|Overall Study|Withdrawal by Subject|0|||
161001771|NCT01580293|581392987|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
161001772|NCT01580293|581392985|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
161001773|NCT01580293|581392986|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
161001774|NCT01580293|581392987|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
161001775|NCT01580293|581392985|FG000|Part A_Extension|Adverse Event|0|||
161001776|NCT01580293|581392986|FG001|Part A_Extension|Adverse Event|2|||
161001777|NCT01580293|581392987|FG002|Part A_Extension|Adverse Event|0|||
161001778|NCT01580293|581392985|FG000|Part A_Extension|Withdrawal by Subject|0|||
161001779|NCT01580293|581392986|FG001|Part A_Extension|Withdrawal by Subject|3|||
161001780|NCT01580293|581392987|FG002|Part A_Extension|Withdrawal by Subject|0|||
161001781|NCT01580293|581392985|FG000|Part A_Extension|Lost to Follow-up|0|||
161001782|NCT01580293|581392986|FG001|Part A_Extension|Lost to Follow-up|1|||
161001783|NCT01580293|581392987|FG002|Part A_Extension|Lost to Follow-up|0|||
161001784|NCT01580293|581392985|FG000|Part A_Extension|Other Reason|0|||
160583970|NCT04891770|579857499|FG002|Overall Study|Investigator's discretion|0|||
160583971|NCT05122650|579857500|FG000|Overall Study|Adverse Event|4|||
160583972|NCT05122650|579857501|FG001|Overall Study|Adverse Event|16|||
160583973|NCT05122650|579857502|FG002|Overall Study|Adverse Event|11|||
160583974|NCT05122650|579857503|FG003|Overall Study|Adverse Event|12|||
160583975|NCT05122650|579857500|FG000|Overall Study|Lack of Efficacy|0|||
160583976|NCT05122650|579857501|FG001|Overall Study|Lack of Efficacy|1|||
160583977|NCT05122650|579857502|FG002|Overall Study|Lack of Efficacy|1|||
160583978|NCT05122650|579857503|FG003|Overall Study|Lack of Efficacy|2|||
160958861|NCT01962493|581236164|FG000|Overall Study|Adverse Event|1|||
161001785|NCT01580293|581392986|FG001|Part A_Extension|Other Reason|1|||
161001786|NCT01580293|581392987|FG002|Part A_Extension|Other Reason|0|||
161001787|NCT01580293|581392985|FG000|Part A_Extension|Completed Japan only|0|||
160958862|NCT01962493|581236165|FG001|Overall Study|Adverse Event|2|||
160958863|NCT01962493|581236164|FG000|Overall Study|Protocol Violation|0|||
160958864|NCT01962493|581236165|FG001|Overall Study|Protocol Violation|1|||
160583979|NCT05122650|579857500|FG000|Overall Study|Lost to Follow-up|1|||
160583980|NCT05122650|579857501|FG001|Overall Study|Lost to Follow-up|1|||
160583981|NCT05122650|579857502|FG002|Overall Study|Lost to Follow-up|3|||
160583982|NCT05122650|579857503|FG003|Overall Study|Lost to Follow-up|0|||
160583983|NCT05122650|579857500|FG000|Overall Study|Non-compliance with study intervention|0|||
160583984|NCT05122650|579857501|FG001|Overall Study|Non-compliance with study intervention|0|||
160583985|NCT05122650|579857502|FG002|Overall Study|Non-compliance with study intervention|0|||
160583986|NCT05122650|579857503|FG003|Overall Study|Non-compliance with study intervention|2|||
160583987|NCT05122650|579857500|FG000|Overall Study|Protocol Violation|0|||
160583988|NCT05122650|579857501|FG001|Overall Study|Protocol Violation|1|||
160583989|NCT05122650|579857502|FG002|Overall Study|Protocol Violation|0|||
160583990|NCT05122650|579857503|FG003|Overall Study|Protocol Violation|1|||
160583991|NCT05122650|579857500|FG000|Overall Study|Randomized by mistake|0|||
160583992|NCT05122650|579857501|FG001|Overall Study|Randomized by mistake|0|||
160583993|NCT05122650|579857502|FG002|Overall Study|Randomized by mistake|3|||
160583994|NCT05122650|579857503|FG003|Overall Study|Randomized by mistake|2|||
160583995|NCT05122650|579857500|FG000|Overall Study|Sponsor request|0|||
160583996|NCT05122650|579857501|FG001|Overall Study|Sponsor request|1|||
160583997|NCT05122650|579857502|FG002|Overall Study|Sponsor request|1|||
160583998|NCT05122650|579857503|FG003|Overall Study|Sponsor request|2|||
160583999|NCT05122650|579857500|FG000|Overall Study|Withdrawal by Subject|3|||
160584000|NCT05122650|579857501|FG001|Overall Study|Withdrawal by Subject|7|||
160584001|NCT05122650|579857502|FG002|Overall Study|Withdrawal by Subject|4|||
160584002|NCT05122650|579857503|FG003|Overall Study|Withdrawal by Subject|8|||
160584003|NCT05122650|579857500|FG000|Overall Study|Other|5|||
160584004|NCT05122650|579857501|FG001|Overall Study|Other|0|||
160584005|NCT05122650|579857502|FG002|Overall Study|Other|0|||
160584006|NCT05122650|579857503|FG003|Overall Study|Other|0|||
160584007|NCT03609359|579857507|FG000|Overall Study|Progression of primary disease (PD)|25|||
160584008|NCT03609359|579857507|FG000|Overall Study|Patient's refusal|1|||
160584009|NCT03609359|579857507|FG000|Overall Study|Physician Decision|1|||
160584010|NCT03609359|579857507|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
160584011|NCT01975272|579857510|FG000|Overall Study|Excluded after protocol amendment|1|||
160584012|NCT01975272|579857511|FG001|Overall Study|Excluded after protocol amendment|1|||
160584013|NCT01975272|579857512|FG002|Overall Study|Excluded after protocol amendment|2|||
160584014|NCT00740779|579857519|FG000|Overall Study|Adverse Event|4|||
160584015|NCT00740779|579857520|FG001|Overall Study|Adverse Event|6|||
160584016|NCT00740779|579857521|FG002|Overall Study|Adverse Event|3|||
160584017|NCT00740779|579857519|FG000|Overall Study|Protocol Violation|1|||
160584018|NCT00740779|579857520|FG001|Overall Study|Protocol Violation|1|||
160584019|NCT00740779|579857521|FG002|Overall Study|Protocol Violation|1|||
160584020|NCT00740779|579857519|FG000|Overall Study|Lack of Efficacy|0|||
160584021|NCT00740779|579857520|FG001|Overall Study|Lack of Efficacy|0|||
160584022|NCT00740779|579857521|FG002|Overall Study|Lack of Efficacy|2|||
160584023|NCT00740779|579857519|FG000|Overall Study|Withdrawal by Subject|2|||
160584024|NCT00740779|579857520|FG001|Overall Study|Withdrawal by Subject|4|||
160584025|NCT00740779|579857521|FG002|Overall Study|Withdrawal by Subject|2|||
160584026|NCT00740779|579857519|FG000|Overall Study|Lost to Follow-up|2|||
160584027|NCT00740779|579857520|FG001|Overall Study|Lost to Follow-up|3|||
160584028|NCT00740779|579857521|FG002|Overall Study|Lost to Follow-up|5|||
160584029|NCT03280550|579857525|FG000|Overall Study|Withdrawal by Subject|2|||
160584030|NCT03280550|579857526|FG001|Overall Study|Withdrawal by Subject|2|||
160584031|NCT03280550|579857525|FG000|Overall Study|Physician Decision|0|||
160958865|NCT01962493|581236164|FG000|Overall Study|Withdrawal by Subject|4|||
160958866|NCT01962493|581236165|FG001|Overall Study|Withdrawal by Subject|2|||
160584032|NCT03280550|579857526|FG001|Overall Study|Physician Decision|1|||
160584033|NCT05372575|579857527|FG000|Overall Study|Protocol Violation|7|||
160958867|NCT01951625|581236166|FG000|Treatment Period|Protocol Violation|2|||
160958868|NCT01951625|581236167|FG001|Treatment Period|Protocol Violation|0|||
160958869|NCT01951625|581236168|FG002|Treatment Period|Protocol Violation|1|||
160958870|NCT01951625|581236169|FG003|Treatment Period|Protocol Violation|3|||
160584034|NCT05372575|579857528|FG001|Overall Study|Protocol Violation|16|||
160958871|NCT01951625|581236170|FG004|Treatment Period|Protocol Violation|2|||
160584035|NCT03510663|579857529|FG000|Overall Study|Withdrawal by Subject|0|||
160584036|NCT03510663|579857530|FG001|Overall Study|Withdrawal by Subject|1|||
160584037|NCT03510663|579857531|FG002|Overall Study|Withdrawal by Subject|0|||
160584038|NCT03510663|579857532|FG003|Overall Study|Withdrawal by Subject|0|||
160584039|NCT03510663|579857533|FG004|Overall Study|Withdrawal by Subject|0|||
160584040|NCT03510663|579857534|FG005|Overall Study|Withdrawal by Subject|0|||
160584041|NCT03510663|579857535|FG006|Overall Study|Withdrawal by Subject|0|||
160584042|NCT03510663|579857536|FG007|Overall Study|Withdrawal by Subject|0|||
160584043|NCT02761993|579857539|FG000|Overall Study|Adverse Event|0|||
160584044|NCT02761993|579857540|FG001|Overall Study|Adverse Event|2|||
160958872|NCT01951625|581236166|FG000|Treatment Period|Physician Decision|0|||
160958873|NCT01951625|581236167|FG001|Treatment Period|Physician Decision|0|||
160958874|NCT01951625|581236168|FG002|Treatment Period|Physician Decision|0|||
160958875|NCT01951625|581236169|FG003|Treatment Period|Physician Decision|0|||
160958876|NCT01951625|581236170|FG004|Treatment Period|Physician Decision|1|||
160958877|NCT01951625|581236166|FG000|Treatment Period|Protocol driven decision point|0|||
160958878|NCT01951625|581236167|FG001|Treatment Period|Protocol driven decision point|5|||
160958879|NCT01951625|581236168|FG002|Treatment Period|Protocol driven decision point|0|||
160958880|NCT01951625|581236169|FG003|Treatment Period|Protocol driven decision point|2|||
160958881|NCT01951625|581236170|FG004|Treatment Period|Protocol driven decision point|1|||
160958882|NCT01951625|581236166|FG000|Treatment Period|Non compliance with study drug|1|||
160958883|NCT01951625|581236167|FG001|Treatment Period|Non compliance with study drug|2|||
160958884|NCT01951625|581236168|FG002|Treatment Period|Non compliance with study drug|2|||
160958885|NCT01951625|581236169|FG003|Treatment Period|Non compliance with study drug|0|||
160958886|NCT01951625|581236170|FG004|Treatment Period|Non compliance with study drug|0|||
160958887|NCT01951625|581236166|FG000|Treatment Period|Death|3|||
160958888|NCT01951625|581236167|FG001|Treatment Period|Death|2|||
160958889|NCT01951625|581236168|FG002|Treatment Period|Death|2|||
160958890|NCT01951625|581236169|FG003|Treatment Period|Death|1|||
160958891|NCT01951625|581236170|FG004|Treatment Period|Death|2|||
160958892|NCT01951625|581236166|FG000|Treatment Period|Adverse Event|7|||
160958893|NCT01951625|581236167|FG001|Treatment Period|Adverse Event|10|||
160958894|NCT01951625|581236168|FG002|Treatment Period|Adverse Event|9|||
160958895|NCT01951625|581236169|FG003|Treatment Period|Adverse Event|8|||
160958896|NCT01951625|581236170|FG004|Treatment Period|Adverse Event|8|||
160958897|NCT01951625|581236166|FG000|Treatment Period|Withdrawal by Subject|5|||
160958898|NCT01951625|581236167|FG001|Treatment Period|Withdrawal by Subject|2|||
160958899|NCT01951625|581236168|FG002|Treatment Period|Withdrawal by Subject|1|||
160958900|NCT01951625|581236169|FG003|Treatment Period|Withdrawal by Subject|7|||
160958901|NCT01951625|581236170|FG004|Treatment Period|Withdrawal by Subject|3|||
160958902|NCT01951625|581236166|FG000|Treatment Period|Lost to Follow-up|1|||
160958903|NCT01951625|581236167|FG001|Treatment Period|Lost to Follow-up|0|||
160958904|NCT01951625|581236168|FG002|Treatment Period|Lost to Follow-up|0|||
160958905|NCT01951625|581236169|FG003|Treatment Period|Lost to Follow-up|1|||
160958906|NCT01951625|581236170|FG004|Treatment Period|Lost to Follow-up|0|||
160958907|NCT01951625|581236166|FG000|Follow Up Period|Non-compliance with study drug|1|||
160958908|NCT01951625|581236167|FG001|Follow Up Period|Non-compliance with study drug|0|||
160958909|NCT01951625|581236168|FG002|Follow Up Period|Non-compliance with study drug|0|||
160958910|NCT01951625|581236169|FG003|Follow Up Period|Non-compliance with study drug|0|||
160958911|NCT01951625|581236170|FG004|Follow Up Period|Non-compliance with study drug|0|||
160958912|NCT01951625|581236166|FG000|Follow Up Period|Death|1|||
160958913|NCT01951625|581236167|FG001|Follow Up Period|Death|3|||
160958914|NCT01951625|581236168|FG002|Follow Up Period|Death|2|||
160958915|NCT01951625|581236169|FG003|Follow Up Period|Death|2|||
160958916|NCT01951625|581236170|FG004|Follow Up Period|Death|1|||
160958917|NCT01951625|581236166|FG000|Follow Up Period|Logistical difficulties|1|||
160958918|NCT01951625|581236167|FG001|Follow Up Period|Logistical difficulties|2|||
160958919|NCT01951625|581236168|FG002|Follow Up Period|Logistical difficulties|0|||
160958920|NCT01951625|581236169|FG003|Follow Up Period|Logistical difficulties|0|||
160958921|NCT01951625|581236170|FG004|Follow Up Period|Logistical difficulties|0|||
160958922|NCT01951625|581236166|FG000|Follow Up Period|Adverse Event|0|||
160958923|NCT01951625|581236167|FG001|Follow Up Period|Adverse Event|3|||
160958924|NCT01951625|581236168|FG002|Follow Up Period|Adverse Event|2|||
160958925|NCT01951625|581236169|FG003|Follow Up Period|Adverse Event|3|||
160958926|NCT01951625|581236170|FG004|Follow Up Period|Adverse Event|5|||
160958927|NCT01951625|581236166|FG000|Follow Up Period|Withdrawal by Subject|4|||
160958928|NCT01951625|581236167|FG001|Follow Up Period|Withdrawal by Subject|1|||
160458030|NCT03582033|579408023|FG009|Part A|Other|0|||
160458031|NCT03582033|579408014|FG000|Part A|Death|1|||
160458032|NCT03582033|579408015|FG001|Part A|Death|1|||
160458033|NCT03582033|579408016|FG002|Part A|Death|2|||
160458034|NCT03582033|579408017|FG003|Part A|Death|4|||
160458035|NCT03582033|579408018|FG004|Part A|Death|11|||
160458036|NCT03582033|579408019|FG005|Part A|Death|0|||
160458037|NCT03582033|579408020|FG006|Part A|Death|0|||
160458038|NCT03582033|579408021|FG007|Part A|Death|0|||
160458039|NCT03582033|579408022|FG008|Part A|Death|0|||
160458040|NCT03582033|579408023|FG009|Part A|Death|0|||
160458041|NCT03582033|579408014|FG000|Part A|Lost to Follow-up|0|||
160458042|NCT03582033|579408015|FG001|Part A|Lost to Follow-up|0|||
160458043|NCT03582033|579408016|FG002|Part A|Lost to Follow-up|0|||
160458044|NCT03582033|579408017|FG003|Part A|Lost to Follow-up|0|||
160458045|NCT03582033|579408018|FG004|Part A|Lost to Follow-up|1|||
160958929|NCT01951625|581236168|FG002|Follow Up Period|Withdrawal by Subject|0|||
160958930|NCT01951625|581236169|FG003|Follow Up Period|Withdrawal by Subject|5|||
160958931|NCT01951625|581236170|FG004|Follow Up Period|Withdrawal by Subject|3|||
160958932|NCT01951625|581236166|FG000|Follow Up Period|Lost to Follow-up|1|||
160458046|NCT03582033|579408019|FG005|Part A|Lost to Follow-up|0|||
160458047|NCT03582033|579408020|FG006|Part A|Lost to Follow-up|0|||
160458048|NCT03582033|579408021|FG007|Part A|Lost to Follow-up|0|||
160458049|NCT03582033|579408022|FG008|Part A|Lost to Follow-up|0|||
160958933|NCT01951625|581236167|FG001|Follow Up Period|Lost to Follow-up|0|||
160958934|NCT01951625|581236168|FG002|Follow Up Period|Lost to Follow-up|0|||
160958935|NCT01951625|581236169|FG003|Follow Up Period|Lost to Follow-up|1|||
160958936|NCT01951625|581236170|FG004|Follow Up Period|Lost to Follow-up|1|||
160958937|NCT03754803|581236177|FG000|Overall Study|Withdrawal by Subject|2|||
160958938|NCT05338333|581236178|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
160958939|NCT05338333|581236179|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
160958940|NCT05245864|581236180|FG000|Overall Study|Withdrawal by Subject|1|||
160958941|NCT05245864|581236181|FG001|Overall Study|Withdrawal by Subject|1|||
160958942|NCT01712009|581237546|FG000|Overall Study|Withdrawal by Subject|24|||
160958943|NCT01712009|581237547|FG001|Overall Study|Withdrawal by Subject|15|||
160958944|NCT01712009|581237548|FG002|Overall Study|Withdrawal by Subject|8|||
160958945|NCT01712009|581237546|FG000|Overall Study|Lost to Follow-up|2|||
160958946|NCT01712009|581237547|FG001|Overall Study|Lost to Follow-up|0|||
160958947|NCT01712009|581237548|FG002|Overall Study|Lost to Follow-up|1|||
160958948|NCT01712009|581237546|FG000|Overall Study|Decision by Sponsor|12|||
160958949|NCT01712009|581237547|FG001|Overall Study|Decision by Sponsor|14|||
160958950|NCT01712009|581237548|FG002|Overall Study|Decision by Sponsor|12|||
160958951|NCT01111123|581237550|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
160958952|NCT01111123|581237551|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
160958953|NCT01111123|581237550|FG000|Maintenance Phase|Lost to Follow-up|0|||
161001788|NCT01580293|581392986|FG001|Part A_Extension|Completed Japan only|5|||
161001789|NCT01580293|581392987|FG002|Part A_Extension|Completed Japan only|0|||
161001790|NCT01580293|581392985|FG000|Part B|Withdrawal by Subject|0|||
161001791|NCT01580293|581392986|FG001|Part B|Withdrawal by Subject|0|||
161001792|NCT01580293|581392987|FG002|Part B|Withdrawal by Subject|1|||
161001793|NCT01580293|581392985|FG000|Part B|Other reason|0|||
161001794|NCT01580293|581392986|FG001|Part B|Other reason|0|||
161001795|NCT01580293|581392987|FG002|Part B|Other reason|1|||
161001796|NCT01134562|581392988|FG000|Overall Study|Adverse Event|0|||
161001797|NCT01134562|581392989|FG001|Overall Study|Adverse Event|1|||
161001798|NCT01134562|581392990|FG002|Overall Study|Adverse Event|0|||
161001799|NCT01134562|581392991|FG003|Overall Study|Adverse Event|0|||
161001800|NCT01134562|581392992|FG004|Overall Study|Adverse Event|0|||
161001801|NCT01499134|581392995|FG000|Overall Study|Withdrawal by Subject|0|||
161001802|NCT01499134|581392996|FG001|Overall Study|Withdrawal by Subject|1|||
161001803|NCT01400776|581392997|FG000|Overall Study|Adverse Event|7|||
161001804|NCT01400776|581392998|FG001|Overall Study|Adverse Event|2|||
161001805|NCT01400776|581392999|FG002|Overall Study|Adverse Event|9|||
161001806|NCT01400776|581393000|FG003|Overall Study|Adverse Event|2|||
161001807|NCT01400776|581392997|FG000|Overall Study|Lost to Follow-up|1|||
161001808|NCT01400776|581392998|FG001|Overall Study|Lost to Follow-up|0|||
161001809|NCT01400776|581392999|FG002|Overall Study|Lost to Follow-up|4|||
161001810|NCT01400776|581393000|FG003|Overall Study|Lost to Follow-up|1|||
161001811|NCT01400776|581392997|FG000|Overall Study|Withdrew Consent|4|||
161001812|NCT01400776|581392998|FG001|Overall Study|Withdrew Consent|2|||
161001813|NCT01400776|581392999|FG002|Overall Study|Withdrew Consent|6|||
161001814|NCT01400776|581393000|FG003|Overall Study|Withdrew Consent|1|||
161001815|NCT01400776|581392997|FG000|Overall Study|Protocol Deviation|6|||
161001816|NCT01400776|581392998|FG001|Overall Study|Protocol Deviation|1|||
161001817|NCT01400776|581392999|FG002|Overall Study|Protocol Deviation|5|||
161001818|NCT01400776|581393000|FG003|Overall Study|Protocol Deviation|2|||
161001819|NCT01400776|581392997|FG000|Overall Study|Reason not Specified|3|||
160458050|NCT03582033|579408023|FG009|Part A|Lost to Follow-up|0|||
160458051|NCT03582033|579408014|FG000|Part A|Study terminated by sponsor|0|||
160458052|NCT03582033|579408015|FG001|Part A|Study terminated by sponsor|0|||
160458053|NCT03582033|579408016|FG002|Part A|Study terminated by sponsor|0|||
160458054|NCT03582033|579408017|FG003|Part A|Study terminated by sponsor|2|||
160958954|NCT01111123|581237551|FG001|Maintenance Phase|Lost to Follow-up|2|||
160958955|NCT00857207|581237560|FG000|Overall Study|Withdrawal by Subject|13|||
160958956|NCT00857207|581237561|FG001|Overall Study|Withdrawal by Subject|0|||
160458055|NCT03582033|579408018|FG004|Part A|Study terminated by sponsor|1|||
160458056|NCT03582033|579408019|FG005|Part A|Study terminated by sponsor|0|||
160958957|NCT00857207|581237560|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
161001820|NCT01400776|581392998|FG001|Overall Study|Reason not Specified|0|||
161001821|NCT01400776|581392999|FG002|Overall Study|Reason not Specified|4|||
161001822|NCT01400776|581393000|FG003|Overall Study|Reason not Specified|3|||
161001823|NCT00423098|581393001|FG000|Overall Study|Adverse Event|1|||
161001824|NCT00423098|581393002|FG001|Overall Study|Adverse Event|2|||
161001825|NCT00423098|581393001|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161001826|NCT00423098|581393002|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161001827|NCT00423098|581393001|FG000|Overall Study|Administrative problems|0|||
161001828|NCT00423098|581393002|FG001|Overall Study|Administrative problems|1|||
161001829|NCT00423098|581393001|FG000|Overall Study|Death|2|||
161001830|NCT00423098|581393002|FG001|Overall Study|Death|0|||
161001831|NCT01111526|581393009|FG000|Overall Study|GVHD Disease Progression|0|||
161001832|NCT01111526|581393010|FG001|Overall Study|GVHD Disease Progression|1|||
160958958|NCT00857207|581237561|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
160958959|NCT00857207|581237560|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
160958960|NCT00857207|581237561|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
160958961|NCT02822222|581237566|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
160958962|NCT02822222|581237567|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
160958963|NCT00833560|581237568|FG000|Overall Study|Toxicity|13|||
160958964|NCT00833560|581237568|FG000|Overall Study|Adverse Event|11|||
160958965|NCT00833560|581237568|FG000|Overall Study|Protocol Violation|6|||
160958966|NCT00833560|581237568|FG000|Overall Study|Lack of Efficacy|4|||
160958967|NCT00833560|581237568|FG000|Overall Study|Death|2|||
160958968|NCT00833560|581237568|FG000|Overall Study|Pregression of other disease|1|||
160958969|NCT00833560|581237568|FG000|Overall Study|Other|5|||
160958970|NCT00440531|581237572|FG000|Overall Study|Adverse Event|1|||
160958971|NCT00440531|581237573|FG001|Overall Study|Adverse Event|0|||
160958972|NCT00440531|581237574|FG002|Overall Study|Adverse Event|2|||
160958973|NCT00440531|581237572|FG000|Overall Study|Withdrawal by Subject|2|||
160958974|NCT00440531|581237573|FG001|Overall Study|Withdrawal by Subject|0|||
160958975|NCT00440531|581237574|FG002|Overall Study|Withdrawal by Subject|0|||
160958976|NCT00440531|581237572|FG000|Overall Study|Protocol Violation|1|||
160958977|NCT00440531|581237573|FG001|Overall Study|Protocol Violation|2|||
160958978|NCT00440531|581237574|FG002|Overall Study|Protocol Violation|0|||
160958979|NCT00440531|581237572|FG000|Overall Study|Lost to Follow-up|4|||
160958980|NCT00440531|581237573|FG001|Overall Study|Lost to Follow-up|3|||
160958981|NCT00440531|581237574|FG002|Overall Study|Lost to Follow-up|5|||
160958982|NCT00440531|581237572|FG000|Overall Study|see pre-assignment details|2|||
161001833|NCT01111526|581393011|FG002|Overall Study|GVHD Disease Progression|2|||
161001834|NCT02013830|581393012|FG000|Overall Study|Adverse Event|3|||
160584045|NCT02761993|579857541|FG002|Overall Study|Adverse Event|0|||
160584046|NCT02761993|579857539|FG000|Overall Study|Lost to Follow-up|1|||
161001835|NCT02013830|581393012|FG000|Overall Study|Death|1|||
161001836|NCT02013830|581393012|FG000|Overall Study|Insufficient therapeutic response|25|||
161001837|NCT02013830|581393012|FG000|Overall Study|Refused treatment|1|||
161001838|NCT04424641|581393013|FG000|Overall Study|Death|1|||
161001839|NCT04424641|581393014|FG001|Overall Study|Death|2|||
161001840|NCT04424641|581393015|FG002|Overall Study|Death|3|||
161001841|NCT04424641|581393016|FG003|Overall Study|Death|0|||
161001842|NCT04424641|581393017|FG004|Overall Study|Death|3|||
161001843|NCT04424641|581393018|FG005|Overall Study|Death|0|||
161001844|NCT04424641|581393019|FG006|Overall Study|Death|1|||
161001845|NCT04424641|581393020|FG007|Overall Study|Death|2|||
161001846|NCT04424641|581393013|FG000|Overall Study|Sponsor decision|0|||
161001847|NCT04424641|581393014|FG001|Overall Study|Sponsor decision|2|||
161001848|NCT04424641|581393015|FG002|Overall Study|Sponsor decision|3|||
161001849|NCT04424641|581393016|FG003|Overall Study|Sponsor decision|7|||
161001850|NCT04424641|581393017|FG004|Overall Study|Sponsor decision|2|||
161001851|NCT04424641|581393018|FG005|Overall Study|Sponsor decision|2|||
161001852|NCT04424641|581393019|FG006|Overall Study|Sponsor decision|3|||
161001853|NCT04424641|581393020|FG007|Overall Study|Sponsor decision|4|||
161001854|NCT04424641|581393013|FG000|Overall Study|Withdrawal by Subject|0|||
160584047|NCT02761993|579857540|FG001|Overall Study|Lost to Follow-up|3|||
160584048|NCT02761993|579857541|FG002|Overall Study|Lost to Follow-up|2|||
160584049|NCT02761993|579857539|FG000|Overall Study|Withdrawal by Subject|1|||
161001855|NCT04424641|581393014|FG001|Overall Study|Withdrawal by Subject|0|||
161001856|NCT04424641|581393015|FG002|Overall Study|Withdrawal by Subject|0|||
161001857|NCT04424641|581393016|FG003|Overall Study|Withdrawal by Subject|0|||
161001858|NCT04424641|581393017|FG004|Overall Study|Withdrawal by Subject|1|||
161001859|NCT04424641|581393018|FG005|Overall Study|Withdrawal by Subject|0|||
161001860|NCT04424641|581393019|FG006|Overall Study|Withdrawal by Subject|0|||
161001861|NCT04424641|581393020|FG007|Overall Study|Withdrawal by Subject|0|||
161001862|NCT04424641|581393013|FG000|Overall Study|Other|0|||
161001863|NCT04424641|581393014|FG001|Overall Study|Other|0|||
161001864|NCT04424641|581393015|FG002|Overall Study|Other|1|||
160584050|NCT02761993|579857540|FG001|Overall Study|Withdrawal by Subject|1|||
160584051|NCT02761993|579857541|FG002|Overall Study|Withdrawal by Subject|2|||
160584052|NCT01465178|579857542|FG000|Overall Study|Withdrawal by Subject|1|||
160584053|NCT01465178|579857543|FG001|Overall Study|Withdrawal by Subject|0|||
160958983|NCT00440531|581237573|FG001|Overall Study|see pre-assignment details|0|||
160958984|NCT00440531|581237574|FG002|Overall Study|see pre-assignment details|0|||
160958985|NCT01791725|581237575|FG000|Overall Study|Withdrawal by Subject|0|||
161001865|NCT04424641|581393016|FG003|Overall Study|Other|0|||
161001866|NCT04424641|581393017|FG004|Overall Study|Other|0|||
161001867|NCT04424641|581393018|FG005|Overall Study|Other|0|||
161001868|NCT04424641|581393019|FG006|Overall Study|Other|0|||
161001869|NCT04424641|581393020|FG007|Overall Study|Other|0|||
161001870|NCT01307267|581393021|FG000|Overall Study|Death|4|||
161001871|NCT01307267|581393022|FG001|Overall Study|Death|3|||
161001872|NCT01307267|581393023|FG002|Overall Study|Death|5|||
161001873|NCT01307267|581393024|FG003|Overall Study|Death|3|||
161001874|NCT01307267|581393025|FG004|Overall Study|Death|1|||
161001875|NCT01307267|581393026|FG005|Overall Study|Death|26|||
160958986|NCT01791725|581237576|FG001|Overall Study|Withdrawal by Subject|1|||
160958987|NCT01791725|581237577|FG002|Overall Study|Withdrawal by Subject|0|||
160958988|NCT02690974|581237580|FG000|Overall Study|Adverse Event|16|||
160958989|NCT02690974|581237580|FG000|Overall Study|Death|9|||
160958990|NCT02690974|581237580|FG000|Overall Study|Subject/guardian decision|4|||
160958991|NCT02690974|581237580|FG000|Overall Study|Lost to Follow-up|3|||
160958992|NCT02690974|581237580|FG000|Overall Study|Withdrawal of Informed Consent|3|||
160958993|NCT02690974|581237580|FG000|Overall Study|Physician Decision|2|||
160958994|NCT02690974|581237580|FG000|Overall Study|Non-compliance with study treatment|1|||
160958995|NCT02690974|581237580|FG000|Overall Study|Protocol-defined stopping criteria|1|||
160958996|NCT02690974|581237580|FG000|Overall Study|Protocol Deviation|1|||
160958997|NCT01666951|581237583|FG000|Overall Study|Not dosed|1|||
160958998|NCT01666951|581237584|FG001|Overall Study|Not dosed|1|||
160958999|NCT05763628|581237585|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
160959000|NCT05763628|581237586|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
160959001|NCT05763628|581237585|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
160959002|NCT05763628|581237586|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
160959003|NCT05763628|581237585|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
160959004|NCT05763628|581237586|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
160959005|NCT00868439|581237592|FG000|Overall Study|Adverse Event|4|||
160959006|NCT00868439|581237593|FG001|Overall Study|Adverse Event|3|||
160959007|NCT00868439|581237592|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
160959008|NCT00868439|581237593|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
160959009|NCT00868439|581237592|FG000|Overall Study|Death|0|||
160959010|NCT00868439|581237593|FG001|Overall Study|Death|1|||
160959011|NCT00868439|581237592|FG000|Overall Study|Protocol Violation|1|||
160959012|NCT00868439|581237593|FG001|Overall Study|Protocol Violation|1|||
160959013|NCT00868439|581237592|FG000|Overall Study|Physician Decision|1|||
160959014|NCT00868439|581237593|FG001|Overall Study|Physician Decision|0|||
160959015|NCT00868439|581237592|FG000|Overall Study|Withdrawal by Subject|0|||
160959016|NCT00868439|581237593|FG001|Overall Study|Withdrawal by Subject|1|||
160959017|NCT01132326|581237594|FG000|Overall Study|Lack of Efficacy|25|||
160959018|NCT01132326|581237594|FG000|Overall Study|Adverse Event|37|||
160959019|NCT01132326|581237594|FG000|Overall Study|Protocol Violation|1|||
160959020|NCT01132326|581237594|FG000|Overall Study|Lost to Follow-up|16|||
160959021|NCT01132326|581237594|FG000|Overall Study|Withdrawal by Subject|40|||
160959022|NCT01132326|581237594|FG000|Overall Study|Physician Decision|10|||
160959023|NCT01132326|581237594|FG000|Overall Study|Study Termination|80|||
160959024|NCT01132326|581237594|FG000|Overall Study|Declining Health|1|||
160959025|NCT01132326|581237594|FG000|Overall Study|Pregnancy|1|||
160959026|NCT01132326|581237594|FG000|Overall Study|Caregiver Withdrew Consent|1|||
160959027|NCT01132326|581237594|FG000|Overall Study|Death|5|||
160959028|NCT01132326|581237594|FG000|Overall Study|Subject Unable to Come To Visits|1|||
160959029|NCT00338884|581237597|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
160959030|NCT00338884|581237597|FG000|Overall Study|Adverse Event|14|||
160959031|NCT00338884|581237597|FG000|Overall Study|Death|8|||
160959032|NCT00338884|581237597|FG000|Overall Study|Other|4|||
160959033|NCT00338884|581237597|FG000|Overall Study|Global Deterioration of Health Status|3|||
160959034|NCT00338884|581237597|FG000|Overall Study|Withdrawal by Subject|3|||
160959035|NCT00338884|581237597|FG000|Overall Study|Lost to Follow-up|1|||
160959036|NCT00338884|581237597|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
160959037|NCT00423176|581237598|FG000|Overall Study|Adverse Event|4|||
160959038|NCT00423176|581237599|FG001|Overall Study|Adverse Event|6|||
160959039|NCT00423176|581237598|FG000|Overall Study|Treatment Failure|1|||
160959040|NCT00423176|581237599|FG001|Overall Study|Treatment Failure|6|||
160959041|NCT00423176|581237598|FG000|Overall Study|Lost to Follow-up|4|||
160959042|NCT00423176|581237599|FG001|Overall Study|Lost to Follow-up|7|||
160959043|NCT00423176|581237598|FG000|Overall Study|Withdrawal by Subject|4|||
160584054|NCT01930799|579857547|FG000|Overall Study|Withdrawal by Subject|3|||
160584055|NCT01930799|579857547|FG000|Overall Study|Lost to Follow-up|5|||
160584056|NCT00875017|579857548|FG000|First Intervention|Withdrawal by Subject|1|||
160584057|NCT00875017|579857549|FG001|First Intervention|Withdrawal by Subject|0|||
160584058|NCT00875017|579857550|FG002|First Intervention|Withdrawal by Subject|1|||
160584059|NCT00875017|579857551|FG003|First Intervention|Withdrawal by Subject|0|||
160959044|NCT00423176|581237599|FG001|Overall Study|Withdrawal by Subject|3|||
160959045|NCT00423176|581237598|FG000|Overall Study|Protocol Violation|1|||
160959046|NCT00423176|581237599|FG001|Overall Study|Protocol Violation|3|||
160959047|NCT00423176|581237598|FG000|Overall Study|Did not meet protocol eligibility|2|||
160959048|NCT00423176|581237599|FG001|Overall Study|Did not meet protocol eligibility|4|||
160959049|NCT04535947|581237600|FG000|Overall Study|Adverse Event|1|||
160959050|NCT04535947|581237601|FG001|Overall Study|Adverse Event|4|||
160959051|NCT04535947|581237600|FG000|Overall Study|Other reasons not specified|2|||
160584060|NCT00875017|579857552|FG004|First Intervention|Withdrawal by Subject|0|||
160959052|NCT04535947|581237601|FG001|Overall Study|Other reasons not specified|0|||
160959053|NCT04535947|581237600|FG000|Overall Study|Withdrawal by Subject|1|||
160959054|NCT04535947|581237601|FG001|Overall Study|Withdrawal by Subject|1|||
161001876|NCT01307267|581393027|FG006|Overall Study|Death|2|||
160959055|NCT04867369|581237607|FG000|Overall Study|Withdrawal by Subject|1|||
160959056|NCT04867369|581237608|FG001|Overall Study|Withdrawal by Subject|0|||
160959057|NCT03492281|581237614|FG000|Overall Study|Withdrawal by Subject|21|||
160959058|NCT03492281|581237615|FG001|Overall Study|Withdrawal by Subject|14|||
160959059|NCT03492281|581237616|FG002|Overall Study|Withdrawal by Subject|13|||
160959060|NCT03492281|581237614|FG000|Overall Study|Lost to Follow-up|14|||
160959061|NCT03492281|581237615|FG001|Overall Study|Lost to Follow-up|15|||
160959062|NCT03492281|581237616|FG002|Overall Study|Lost to Follow-up|10|||
160959063|NCT03492281|581237614|FG000|Overall Study|Adverse Event|6|||
160959064|NCT03492281|581237615|FG001|Overall Study|Adverse Event|8|||
160959065|NCT03492281|581237616|FG002|Overall Study|Adverse Event|13|||
160959066|NCT03492281|581237614|FG000|Overall Study|Lack of Efficacy|3|||
160959067|NCT03492281|581237615|FG001|Overall Study|Lack of Efficacy|0|||
160959068|NCT03492281|581237616|FG002|Overall Study|Lack of Efficacy|1|||
160959069|NCT03492281|581237614|FG000|Overall Study|Physician Decision|1|||
160959070|NCT03492281|581237615|FG001|Overall Study|Physician Decision|0|||
160959071|NCT03492281|581237616|FG002|Overall Study|Physician Decision|3|||
160959072|NCT03492281|581237614|FG000|Overall Study|Protocol Violation|0|||
160959073|NCT03492281|581237615|FG001|Overall Study|Protocol Violation|2|||
160959074|NCT03492281|581237616|FG002|Overall Study|Protocol Violation|1|||
160959075|NCT03492281|581237614|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
160959076|NCT03492281|581237615|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
160959077|NCT03492281|581237616|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
160959078|NCT03492281|581237614|FG000|Overall Study|Death|0|||
160959079|NCT03492281|581237615|FG001|Overall Study|Death|0|||
160959080|NCT03492281|581237616|FG002|Overall Study|Death|1|||
160959081|NCT03492281|581237614|FG000|Overall Study|Captured as Other in Database|8|||
160959082|NCT03492281|581237615|FG001|Overall Study|Captured as Other in Database|6|||
160959083|NCT03492281|581237616|FG002|Overall Study|Captured as Other in Database|3|||
160959084|NCT01749982|581237619|FG000|Overall Study|Physician Decision|0|||
160959085|NCT01749982|581237620|FG001|Overall Study|Physician Decision|0|||
160959086|NCT01749982|581237621|FG002|Overall Study|Physician Decision|0|||
160959087|NCT01749982|581237622|FG003|Overall Study|Physician Decision|1|||
160959088|NCT01749982|581237619|FG000|Overall Study|Lost to Follow-up|0|||
160959089|NCT01749982|581237620|FG001|Overall Study|Lost to Follow-up|0|||
160959090|NCT01749982|581237621|FG002|Overall Study|Lost to Follow-up|0|||
160959091|NCT01749982|581237622|FG003|Overall Study|Lost to Follow-up|1|||
160959092|NCT01749982|581237619|FG000|Overall Study|Withdrawal by Subject|0|||
160959093|NCT01749982|581237620|FG001|Overall Study|Withdrawal by Subject|0|||
160959094|NCT01749982|581237621|FG002|Overall Study|Withdrawal by Subject|0|||
160959095|NCT01749982|581237622|FG003|Overall Study|Withdrawal by Subject|1|||
160959096|NCT02677116|581237623|FG000|Overall Study|Adverse Event|0|||
160959097|NCT02677116|581237624|FG001|Overall Study|Adverse Event|1|||
160959098|NCT02677116|581237625|FG002|Overall Study|Adverse Event|0|||
161001877|NCT01307267|581393028|FG007|Overall Study|Death|2|||
161001878|NCT01307267|581393029|FG008|Overall Study|Death|21|||
161001879|NCT01307267|581393030|FG009|Overall Study|Death|2|||
161001880|NCT01307267|581393031|FG010|Overall Study|Death|3|||
161001881|NCT01307267|581393032|FG011|Overall Study|Death|9|||
161001882|NCT01307267|581393033|FG012|Overall Study|Death|0|||
161001883|NCT01307267|581393034|FG013|Overall Study|Death|0|||
161001884|NCT01307267|581393035|FG014|Overall Study|Death|0|||
161001885|NCT01307267|581393036|FG015|Overall Study|Death|0|||
161001886|NCT01307267|581393037|FG016|Overall Study|Death|1|||
161001887|NCT01307267|581393038|FG017|Overall Study|Death|1|||
161001888|NCT01307267|581393039|FG018|Overall Study|Death|2|||
161001889|NCT01307267|581393040|FG019|Overall Study|Death|8|||
161001890|NCT01307267|581393041|FG020|Overall Study|Death|1|||
160959099|NCT02677116|581237626|FG003|Overall Study|Adverse Event|0|||
160959100|NCT02677116|581237627|FG004|Overall Study|Adverse Event|0|||
160959101|NCT02677116|581237628|FG005|Overall Study|Adverse Event|1|||
160959102|NCT02677116|581237629|FG006|Overall Study|Adverse Event|1|||
160959103|NCT02677116|581237630|FG007|Overall Study|Adverse Event|0|||
160959104|NCT02677116|581237631|FG008|Overall Study|Adverse Event|0|||
160959105|NCT02677116|581237623|FG000|Overall Study|Physician Decision|0|||
160959106|NCT02677116|581237624|FG001|Overall Study|Physician Decision|2|||
160959107|NCT02677116|581237625|FG002|Overall Study|Physician Decision|3|||
160959108|NCT02677116|581237626|FG003|Overall Study|Physician Decision|2|||
160959109|NCT02677116|581237627|FG004|Overall Study|Physician Decision|1|||
160959110|NCT02677116|581237628|FG005|Overall Study|Physician Decision|3|||
161001891|NCT01307267|581393042|FG021|Overall Study|Death|2|||
160959111|NCT02677116|581237629|FG006|Overall Study|Physician Decision|1|||
160959112|NCT02677116|581237630|FG007|Overall Study|Physician Decision|1|||
160959113|NCT02677116|581237631|FG008|Overall Study|Physician Decision|2|||
160959114|NCT02677116|581237623|FG000|Overall Study|Withdrawal by parent or guardian|2|||
160959115|NCT02677116|581237624|FG001|Overall Study|Withdrawal by parent or guardian|1|||
161001892|NCT01307267|581393043|FG022|Overall Study|Death|2|||
161001893|NCT01307267|581393021|FG000|Overall Study|Lost to Follow-up|0|||
161001894|NCT01307267|581393022|FG001|Overall Study|Lost to Follow-up|0|||
161001895|NCT01307267|581393023|FG002|Overall Study|Lost to Follow-up|0|||
161001896|NCT01307267|581393024|FG003|Overall Study|Lost to Follow-up|0|||
160584061|NCT00875017|579857553|FG005|First Intervention|Withdrawal by Subject|0|||
160584062|NCT00875017|579857548|FG000|First Intervention|Adverse Event|0|||
160584063|NCT00875017|579857549|FG001|First Intervention|Adverse Event|0|||
160584064|NCT00875017|579857550|FG002|First Intervention|Adverse Event|0|||
160584065|NCT00875017|579857551|FG003|First Intervention|Adverse Event|1|||
160584066|NCT00875017|579857552|FG004|First Intervention|Adverse Event|0|||
160584067|NCT00875017|579857553|FG005|First Intervention|Adverse Event|0|||
160584068|NCT00875017|579857548|FG000|First Intervention|Problems collecting rectal effluent|1|||
160584069|NCT00875017|579857549|FG001|First Intervention|Problems collecting rectal effluent|0|||
160584070|NCT00875017|579857550|FG002|First Intervention|Problems collecting rectal effluent|0|||
160584071|NCT00875017|579857551|FG003|First Intervention|Problems collecting rectal effluent|0|||
160584072|NCT00875017|579857552|FG004|First Intervention|Problems collecting rectal effluent|0|||
160584073|NCT00875017|579857553|FG005|First Intervention|Problems collecting rectal effluent|0|||
160584074|NCT00875017|579857548|FG000|First Intervention|Intolerance to nasogastric tube|0|||
160584075|NCT00875017|579857549|FG001|First Intervention|Intolerance to nasogastric tube|0|||
160584076|NCT00875017|579857550|FG002|First Intervention|Intolerance to nasogastric tube|0|||
160959116|NCT02677116|581237625|FG002|Overall Study|Withdrawal by parent or guardian|0|||
160959117|NCT02677116|581237626|FG003|Overall Study|Withdrawal by parent or guardian|1|||
160959118|NCT02677116|581237627|FG004|Overall Study|Withdrawal by parent or guardian|0|||
160959119|NCT02677116|581237628|FG005|Overall Study|Withdrawal by parent or guardian|0|||
160959120|NCT02677116|581237629|FG006|Overall Study|Withdrawal by parent or guardian|2|||
160959121|NCT02677116|581237630|FG007|Overall Study|Withdrawal by parent or guardian|1|||
160959122|NCT02677116|581237631|FG008|Overall Study|Withdrawal by parent or guardian|0|||
160959123|NCT02677116|581237623|FG000|Overall Study|Withdrawal by Subject|1|||
160959124|NCT02677116|581237624|FG001|Overall Study|Withdrawal by Subject|0|||
160959125|NCT02677116|581237625|FG002|Overall Study|Withdrawal by Subject|0|||
160959126|NCT02677116|581237626|FG003|Overall Study|Withdrawal by Subject|0|||
160959127|NCT02677116|581237627|FG004|Overall Study|Withdrawal by Subject|0|||
160959128|NCT02677116|581237628|FG005|Overall Study|Withdrawal by Subject|0|||
160959129|NCT02677116|581237629|FG006|Overall Study|Withdrawal by Subject|0|||
160959130|NCT02677116|581237630|FG007|Overall Study|Withdrawal by Subject|0|||
160959131|NCT02677116|581237631|FG008|Overall Study|Withdrawal by Subject|0|||
160959132|NCT03342638|581237633|FG000|Overall Study|Withdrawal by Subject|1|||
160959133|NCT03342638|581237634|FG001|Overall Study|Withdrawal by Subject|0|||
160959134|NCT03342638|581237633|FG000|Overall Study|Physician Decision|0|||
160959135|NCT03342638|581237634|FG001|Overall Study|Physician Decision|1|||
160959136|NCT00113568|581237650|FG000|Overall Study|Adverse Event|97|||
160959137|NCT00113568|581237650|FG000|Overall Study|Death|1|||
160959138|NCT00113568|581237650|FG000|Overall Study|Lack of Efficacy|30|||
160959139|NCT00113568|581237650|FG000|Overall Study|Lost to Follow-up|156|||
160959140|NCT00113568|581237650|FG000|Overall Study|Protocol Violation|32|||
160959141|NCT00113568|581237650|FG000|Overall Study|Withdrawal by Subject|117|||
160959142|NCT00113568|581237650|FG000|Overall Study|Other|112|||
160959143|NCT02191267|581237652|FG000|Overall Study|Withdrawal by Subject|1|||
160959144|NCT02191267|581237653|FG001|Overall Study|Withdrawal by Subject|0|||
160959145|NCT02191267|581237654|FG002|Overall Study|Withdrawal by Subject|0|||
160959146|NCT03213158|581237657|FG000|Overall Study|Withdrawal by Subject|1|||
160959147|NCT03213158|581237657|FG000|Overall Study|Physician Decision|2|||
160959148|NCT00587964|581237661|FG000|Overall Study|Withdrawal by Subject|1|||
160959149|NCT00587964|581237661|FG000|Overall Study|Lost to Follow-up|1|||
160959150|NCT00587964|581237661|FG000|Overall Study|Patient found to be ineligible|1|||
160959151|NCT00587964|581237661|FG000|Overall Study|Patient did not receive intervention|5|||
160959152|NCT00587964|581237661|FG000|Overall Study|Progression of Disease|4|||
160959153|NCT01569438|581237663|FG000|Overall Study|Lack of Efficacy|1|||
161001897|NCT01307267|581393025|FG004|Overall Study|Lost to Follow-up|0|||
161001898|NCT01307267|581393026|FG005|Overall Study|Lost to Follow-up|7|||
161001899|NCT01307267|581393027|FG006|Overall Study|Lost to Follow-up|0|||
160959154|NCT01569438|581237664|FG001|Overall Study|Lack of Efficacy|2|||
160959155|NCT01569438|581237663|FG000|Overall Study|Withdrawal by Subject|0|||
160959156|NCT01569438|581237664|FG001|Overall Study|Withdrawal by Subject|3|||
161001900|NCT01307267|581393028|FG007|Overall Study|Lost to Follow-up|0|||
161001901|NCT01307267|581393029|FG008|Overall Study|Lost to Follow-up|1|||
161001902|NCT01307267|581393030|FG009|Overall Study|Lost to Follow-up|2|||
160458057|NCT03582033|579408020|FG006|Part A|Study terminated by sponsor|0|||
160656978|NCT05097989|580124502|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160959157|NCT01569438|581237663|FG000|Overall Study|Adverse Event|2|||
160584077|NCT00875017|579857551|FG003|First Intervention|Intolerance to nasogastric tube|0|||
160959158|NCT01569438|581237664|FG001|Overall Study|Adverse Event|15|||
160959159|NCT01569438|581237663|FG000|Overall Study|Protocol Violation|2|||
160959160|NCT01569438|581237664|FG001|Overall Study|Protocol Violation|0|||
160959161|NCT01569438|581237663|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
160959162|NCT01569438|581237664|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
160959163|NCT01569438|581237663|FG000|Overall Study|Sponsor/Physician decision|1|||
161001903|NCT01307267|581393031|FG010|Overall Study|Lost to Follow-up|1|||
161001904|NCT01307267|581393032|FG011|Overall Study|Lost to Follow-up|0|||
160584078|NCT00875017|579857552|FG004|First Intervention|Intolerance to nasogastric tube|1|||
160959164|NCT01569438|581237664|FG001|Overall Study|Sponsor/Physician decision|1|||
160959165|NCT01569438|581237663|FG000|Overall Study|Unable to adhere to study schedule|0|||
160959166|NCT01569438|581237664|FG001|Overall Study|Unable to adhere to study schedule|1|||
160959167|NCT03649230|581237666|FG000|Overall Study|Adverse Event|12|||
160959168|NCT03649230|581237666|FG000|Overall Study|Death|8|||
160959169|NCT03649230|581237666|FG000|Overall Study|Withdrawal by Subject|6|||
160959170|NCT03649230|581237666|FG000|Overall Study|Physician Decision|5|||
160959171|NCT03649230|581237666|FG000|Overall Study|Disease progression|5|||
160959172|NCT03649230|581237666|FG000|Overall Study|Switched to non-HEC|5|||
160959173|NCT03649230|581237666|FG000|Overall Study|Chemotherapy discontinued|4|||
160959174|NCT03649230|581237666|FG000|Overall Study|Received only 3 HEC cycles|4|||
160959175|NCT03649230|581237666|FG000|Overall Study|Screen Failure|3|||
160959176|NCT03649230|581237666|FG000|Overall Study|Patient stopped treatment|2|||
160959177|NCT03649230|581237666|FG000|Overall Study|Protocol Violation|1|||
160959178|NCT03649230|581237666|FG000|Overall Study|Non-compliance|1|||
160959179|NCT03649230|581237666|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
160959180|NCT01693068|581237667|FG000|Randomization Period|On-study|2|||
160959181|NCT01693068|581237668|FG001|Randomization Period|On-study|5|||
160959182|NCT01693068|581237669|FG002|Randomization Period|On-study|0|||
160959183|NCT01693068|581237667|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
160959184|NCT01693068|581237668|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
160959185|NCT01693068|581237669|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
160959186|NCT00736645|581237676|FG000|Overall Study|Adverse Event|0|||
160959187|NCT00736645|581237677|FG001|Overall Study|Adverse Event|2|||
160959188|NCT00736645|581237678|FG002|Overall Study|Adverse Event|0|||
160959189|NCT00736645|581237679|FG003|Overall Study|Adverse Event|0|||
160959190|NCT04302350|581237680|FG000|Overall Study|Physician Decision|1|||
160959191|NCT04302350|581237681|FG001|Overall Study|Physician Decision|1|||
160959192|NCT04302350|581237682|FG002|Overall Study|Physician Decision|2|||
160959193|NCT04302350|581237680|FG000|Overall Study|Lack of Efficacy|1|||
160959194|NCT04302350|581237681|FG001|Overall Study|Lack of Efficacy|1|||
160959195|NCT04302350|581237682|FG002|Overall Study|Lack of Efficacy|4|||
160959196|NCT04302350|581237680|FG000|Overall Study|Adverse Event|0|||
160959197|NCT04302350|581237681|FG001|Overall Study|Adverse Event|1|||
160959198|NCT04302350|581237682|FG002|Overall Study|Adverse Event|2|||
160959199|NCT02137369|581237685|FG000|Overall Study|Withdrawal by Subject|3|||
160959200|NCT02137369|581237686|FG001|Overall Study|Withdrawal by Subject|2|||
160959201|NCT02137369|581237685|FG000|Overall Study|Adverse Event|2|||
160959202|NCT02137369|581237686|FG001|Overall Study|Adverse Event|0|||
160959203|NCT02137369|581237685|FG000|Overall Study|Lost to Follow-up|1|||
160959204|NCT02137369|581237686|FG001|Overall Study|Lost to Follow-up|0|||
160959205|NCT02137369|581237685|FG000|Overall Study|Moved away|2|||
160959206|NCT02137369|581237686|FG001|Overall Study|Moved away|0|||
160959207|NCT01475136|581237696|FG000|Overall Study|Sponsor Decision|0|||
160959208|NCT01475136|581237697|FG001|Overall Study|Sponsor Decision|1|||
160959209|NCT01475136|581237698|FG002|Overall Study|Sponsor Decision|0|||
160959210|NCT01475136|581237699|FG003|Overall Study|Sponsor Decision|0|||
160959211|NCT01475136|581237696|FG000|Overall Study|Entry Criteria Not Met|0|||
160959212|NCT01475136|581237697|FG001|Overall Study|Entry Criteria Not Met|2|||
160959213|NCT01475136|581237698|FG002|Overall Study|Entry Criteria Not Met|3|||
160959214|NCT01475136|581237699|FG003|Overall Study|Entry Criteria Not Met|1|||
160584079|NCT00875017|579857553|FG005|First Intervention|Intolerance to nasogastric tube|0|||
160584080|NCT00875017|579857548|FG000|Washout|Problem collecting rectal effluent|0|||
160584081|NCT00875017|579857549|FG001|Washout|Problem collecting rectal effluent|0|||
160584082|NCT00875017|579857550|FG002|Washout|Problem collecting rectal effluent|1|||
160584083|NCT00875017|579857551|FG003|Washout|Problem collecting rectal effluent|0|||
160584084|NCT00875017|579857552|FG004|Washout|Problem collecting rectal effluent|0|||
160656979|NCT05097989|580124503|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160959215|NCT01475136|581237696|FG000|Overall Study|Withdrawal by Subject|0|||
160959216|NCT01475136|581237697|FG001|Overall Study|Withdrawal by Subject|0|||
160959217|NCT01475136|581237698|FG002|Overall Study|Withdrawal by Subject|0|||
160959218|NCT01475136|581237699|FG003|Overall Study|Withdrawal by Subject|2|||
160959219|NCT01475136|581237696|FG000|Overall Study|Adverse Event|1|||
160959220|NCT01475136|581237697|FG001|Overall Study|Adverse Event|0|||
160959221|NCT01475136|581237698|FG002|Overall Study|Adverse Event|0|||
160959222|NCT01475136|581237699|FG003|Overall Study|Adverse Event|1|||
160959223|NCT01475136|581237696|FG000|Overall Study|Death|0|||
160959224|NCT01475136|581237697|FG001|Overall Study|Death|0|||
160959225|NCT01475136|581237698|FG002|Overall Study|Death|0|||
160959226|NCT01475136|581237699|FG003|Overall Study|Death|1|||
160959227|NCT01329029|581237700|FG000|Overall Study|Withdrawal by Subject|117|||
160959228|NCT01329029|581237701|FG001|Overall Study|Withdrawal by Subject|87|||
160959229|NCT01329029|581237700|FG000|Overall Study|Adverse Event|82|||
160656980|NCT05097989|580124504|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160959230|NCT01329029|581237701|FG001|Overall Study|Adverse Event|29|||
160959231|NCT01329029|581237700|FG000|Overall Study|Death|16|||
160959232|NCT01329029|581237701|FG001|Overall Study|Death|19|||
160656981|NCT05097989|580124496|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161001905|NCT01307267|581393033|FG012|Overall Study|Lost to Follow-up|0|||
161001906|NCT01307267|581393034|FG013|Overall Study|Lost to Follow-up|0|||
161001907|NCT01307267|581393035|FG014|Overall Study|Lost to Follow-up|0|||
161001908|NCT01307267|581393036|FG015|Overall Study|Lost to Follow-up|0|||
161001909|NCT01307267|581393037|FG016|Overall Study|Lost to Follow-up|0|||
160458058|NCT03582033|579408021|FG007|Part A|Study terminated by sponsor|0|||
160458059|NCT03582033|579408022|FG008|Part A|Study terminated by sponsor|0|||
160458060|NCT03582033|579408023|FG009|Part A|Study terminated by sponsor|0|||
160458061|NCT03582033|579408014|FG000|Part A|Withdrawal by Subject|1|||
160458062|NCT03582033|579408015|FG001|Part A|Withdrawal by Subject|1|||
160458063|NCT03582033|579408016|FG002|Part A|Withdrawal by Subject|0|||
160458064|NCT03582033|579408017|FG003|Part A|Withdrawal by Subject|1|||
160458065|NCT03582033|579408018|FG004|Part A|Withdrawal by Subject|7|||
160458066|NCT03582033|579408019|FG005|Part A|Withdrawal by Subject|0|||
160458067|NCT03582033|579408020|FG006|Part A|Withdrawal by Subject|0|||
160458068|NCT03582033|579408021|FG007|Part A|Withdrawal by Subject|0|||
160458069|NCT03582033|579408022|FG008|Part A|Withdrawal by Subject|0|||
160458070|NCT03582033|579408023|FG009|Part A|Withdrawal by Subject|0|||
160458071|NCT03582033|579408014|FG000|Part B|Death|0|||
160458072|NCT03582033|579408015|FG001|Part B|Death|0|||
160458073|NCT03582033|579408016|FG002|Part B|Death|0|||
160458074|NCT03582033|579408017|FG003|Part B|Death|0|||
160458075|NCT03582033|579408018|FG004|Part B|Death|0|||
160458076|NCT03582033|579408019|FG005|Part B|Death|2|||
160458077|NCT03582033|579408020|FG006|Part B|Death|0|||
160458078|NCT03582033|579408021|FG007|Part B|Death|0|||
160458079|NCT03582033|579408022|FG008|Part B|Death|0|||
160458080|NCT03582033|579408023|FG009|Part B|Death|0|||
160458081|NCT03582033|579408014|FG000|Part B|Study terminated by sponsor|0|||
160458082|NCT03582033|579408015|FG001|Part B|Study terminated by sponsor|0|||
160458083|NCT03582033|579408016|FG002|Part B|Study terminated by sponsor|0|||
160458084|NCT03582033|579408017|FG003|Part B|Study terminated by sponsor|0|||
160458085|NCT03582033|579408018|FG004|Part B|Study terminated by sponsor|0|||
160458086|NCT03582033|579408019|FG005|Part B|Study terminated by sponsor|12|||
160458087|NCT03582033|579408020|FG006|Part B|Study terminated by sponsor|0|||
160458088|NCT03582033|579408021|FG007|Part B|Study terminated by sponsor|0|||
160458089|NCT03582033|579408022|FG008|Part B|Study terminated by sponsor|0|||
160458090|NCT03582033|579408023|FG009|Part B|Study terminated by sponsor|0|||
160458091|NCT03582033|579408014|FG000|Part B|Withdrawal by Subject|0|||
160458092|NCT03582033|579408015|FG001|Part B|Withdrawal by Subject|0|||
160458093|NCT03582033|579408016|FG002|Part B|Withdrawal by Subject|0|||
160458094|NCT03582033|579408017|FG003|Part B|Withdrawal by Subject|0|||
160458095|NCT03582033|579408018|FG004|Part B|Withdrawal by Subject|0|||
160458096|NCT03582033|579408019|FG005|Part B|Withdrawal by Subject|6|||
160458097|NCT03582033|579408020|FG006|Part B|Withdrawal by Subject|0|||
160458098|NCT03582033|579408021|FG007|Part B|Withdrawal by Subject|0|||
160458099|NCT03582033|579408022|FG008|Part B|Withdrawal by Subject|0|||
160458100|NCT03582033|579408023|FG009|Part B|Withdrawal by Subject|0|||
160458101|NCT03582033|579408014|FG000|Part C|Other|0|||
160458102|NCT03582033|579408015|FG001|Part C|Other|0|||
160458103|NCT03582033|579408016|FG002|Part C|Other|0|||
160458104|NCT03582033|579408017|FG003|Part C|Other|0|||
160458105|NCT03582033|579408018|FG004|Part C|Other|0|||
160458106|NCT03582033|579408019|FG005|Part C|Other|0|||
160458107|NCT03582033|579408020|FG006|Part C|Other|2|||
160458108|NCT03582033|579408021|FG007|Part C|Other|0|||
160458109|NCT03582033|579408022|FG008|Part C|Other|0|||
160458110|NCT03582033|579408023|FG009|Part C|Other|0|||
160458111|NCT03582033|579408014|FG000|Part C|Death|0|||
160458112|NCT03582033|579408015|FG001|Part C|Death|0|||
160458113|NCT03582033|579408016|FG002|Part C|Death|0|||
160458114|NCT03582033|579408017|FG003|Part C|Death|0|||
160458115|NCT03582033|579408018|FG004|Part C|Death|0|||
160458116|NCT03582033|579408019|FG005|Part C|Death|0|||
160458117|NCT03582033|579408020|FG006|Part C|Death|6|||
160458118|NCT03582033|579408021|FG007|Part C|Death|1|||
160458119|NCT03582033|579408022|FG008|Part C|Death|2|||
160458120|NCT03582033|579408023|FG009|Part C|Death|0|||
160458121|NCT03582033|579408014|FG000|Part C|Study terminated by sponsor|0|||
160458122|NCT03582033|579408015|FG001|Part C|Study terminated by sponsor|0|||
160458123|NCT03582033|579408016|FG002|Part C|Study terminated by sponsor|0|||
160458124|NCT03582033|579408017|FG003|Part C|Study terminated by sponsor|0|||
160458125|NCT03582033|579408018|FG004|Part C|Study terminated by sponsor|0|||
160458126|NCT03582033|579408019|FG005|Part C|Study terminated by sponsor|0|||
160458127|NCT03582033|579408020|FG006|Part C|Study terminated by sponsor|3|||
160458128|NCT03582033|579408021|FG007|Part C|Study terminated by sponsor|3|||
160458129|NCT03582033|579408022|FG008|Part C|Study terminated by sponsor|2|||
160458130|NCT03582033|579408023|FG009|Part C|Study terminated by sponsor|0|||
160458131|NCT03582033|579408014|FG000|Part C|Withdrawal by Subject|0|||
160458132|NCT03582033|579408015|FG001|Part C|Withdrawal by Subject|0|||
160458133|NCT03582033|579408016|FG002|Part C|Withdrawal by Subject|0|||
160458134|NCT03582033|579408017|FG003|Part C|Withdrawal by Subject|0|||
161001910|NCT01307267|581393038|FG017|Overall Study|Lost to Follow-up|0|||
160584085|NCT00875017|579857553|FG005|Washout|Problem collecting rectal effluent|0|||
160584086|NCT00875017|579857548|FG000|Second Intervention|Adverse Event|0|||
160584087|NCT00875017|579857549|FG001|Second Intervention|Adverse Event|0|||
160584088|NCT00875017|579857550|FG002|Second Intervention|Adverse Event|0|||
160584089|NCT00875017|579857551|FG003|Second Intervention|Adverse Event|1|||
160584090|NCT00875017|579857552|FG004|Second Intervention|Adverse Event|0|||
160584091|NCT00875017|579857553|FG005|Second Intervention|Adverse Event|0|||
160584092|NCT00875017|579857548|FG000|Washout|Problems collecting rectal effluent|0|||
160584093|NCT00875017|579857549|FG001|Washout|Problems collecting rectal effluent|1|||
160584094|NCT00875017|579857550|FG002|Washout|Problems collecting rectal effluent|0|||
160584095|NCT00875017|579857551|FG003|Washout|Problems collecting rectal effluent|0|||
160584096|NCT00875017|579857552|FG004|Washout|Problems collecting rectal effluent|0|||
160584097|NCT00875017|579857553|FG005|Washout|Problems collecting rectal effluent|0|||
160584098|NCT00875017|579857548|FG000|Third Intervention|Adverse Event|0|||
160584099|NCT00875017|579857549|FG001|Third Intervention|Adverse Event|1|||
160584100|NCT00875017|579857550|FG002|Third Intervention|Adverse Event|1|||
160584101|NCT00875017|579857551|FG003|Third Intervention|Adverse Event|0|||
160584102|NCT00875017|579857552|FG004|Third Intervention|Adverse Event|0|||
160584103|NCT00875017|579857553|FG005|Third Intervention|Adverse Event|0|||
160584104|NCT00875017|579857548|FG000|Washout|Withdrawal by Subject|0|||
160584105|NCT00875017|579857549|FG001|Washout|Withdrawal by Subject|0|||
160584106|NCT00875017|579857550|FG002|Washout|Withdrawal by Subject|0|||
160584107|NCT00875017|579857551|FG003|Washout|Withdrawal by Subject|0|||
160584108|NCT00875017|579857552|FG004|Washout|Withdrawal by Subject|1|||
160584109|NCT00875017|579857553|FG005|Washout|Withdrawal by Subject|0|||
160584110|NCT00875017|579857548|FG000|Fourth Intervention|Inability to comply with fasting|0|||
160584111|NCT00875017|579857549|FG001|Fourth Intervention|Inability to comply with fasting|0|||
160584112|NCT00875017|579857550|FG002|Fourth Intervention|Inability to comply with fasting|0|||
160584113|NCT00875017|579857551|FG003|Fourth Intervention|Inability to comply with fasting|0|||
160584114|NCT00875017|579857552|FG004|Fourth Intervention|Inability to comply with fasting|0|||
160584115|NCT00875017|579857553|FG005|Fourth Intervention|Inability to comply with fasting|1|||
160584116|NCT02689219|579857554|FG000|Overall Study|Death|1|||
160584117|NCT02689219|579857555|FG001|Overall Study|Death|1|||
160584118|NCT02689219|579857554|FG000|Overall Study|Disease Progression|10|||
160584119|NCT02689219|579857555|FG001|Overall Study|Disease Progression|6|||
160584120|NCT01477892|579857556|FG000|Overall Study|Withdrawal by Subject|0|||
160584121|NCT01477892|579857557|FG001|Overall Study|Withdrawal by Subject|2|||
160584122|NCT01921257|579857562|FG000|Overall Study|Adverse Event|1|||
160584123|NCT01921257|579857562|FG000|Overall Study|Protocol Violation|1|||
160584124|NCT01921257|579857562|FG000|Overall Study|Withdrawal by Subject|1|||
160584125|NCT02426658|579857563|FG000|Overall Study|Withdrawal by Subject|1|||
160584126|NCT02426658|579857563|FG000|Overall Study|Patient expired before treatment|2|||
160584127|NCT02020031|579859476|FG000|Overall Study|Physician Decision|1|||
160584128|NCT02020031|579859477|FG001|Overall Study|Physician Decision|1|||
160584129|NCT00755846|579859480|FG000|Overall Study|Adverse Event|0|||
160584130|NCT00755846|579859481|FG001|Overall Study|Adverse Event|0|||
160584131|NCT00755846|579859482|FG002|Overall Study|Adverse Event|0|||
160584132|NCT00755846|579859483|FG003|Overall Study|Adverse Event|1|||
160584133|NCT00755846|579859484|FG004|Overall Study|Adverse Event|3|||
160584134|NCT00755846|579859485|FG005|Overall Study|Adverse Event|2|||
160584135|NCT00755846|579859480|FG000|Overall Study|Protocol Violation|1|||
160584136|NCT00755846|579859481|FG001|Overall Study|Protocol Violation|1|||
160584137|NCT00755846|579859482|FG002|Overall Study|Protocol Violation|1|||
160584138|NCT00755846|579859483|FG003|Overall Study|Protocol Violation|1|||
160584139|NCT00755846|579859484|FG004|Overall Study|Protocol Violation|1|||
160584140|NCT00755846|579859485|FG005|Overall Study|Protocol Violation|1|||
160656982|NCT05097989|580124497|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161001911|NCT01307267|581393039|FG018|Overall Study|Lost to Follow-up|0|||
161001912|NCT01307267|581393040|FG019|Overall Study|Lost to Follow-up|2|||
160458135|NCT03582033|579408018|FG004|Part C|Withdrawal by Subject|0|||
160458136|NCT03582033|579408019|FG005|Part C|Withdrawal by Subject|0|||
160458137|NCT03582033|579408020|FG006|Part C|Withdrawal by Subject|1|||
160584141|NCT00755846|579859480|FG000|Overall Study|Lost to Follow-up|0|||
160584142|NCT00755846|579859481|FG001|Overall Study|Lost to Follow-up|2|||
160584143|NCT00755846|579859482|FG002|Overall Study|Lost to Follow-up|1|||
160584144|NCT00755846|579859483|FG003|Overall Study|Lost to Follow-up|0|||
160584145|NCT00755846|579859484|FG004|Overall Study|Lost to Follow-up|4|||
160584146|NCT00755846|579859485|FG005|Overall Study|Lost to Follow-up|2|||
160584147|NCT00755846|579859480|FG000|Overall Study|Withdrawal by Subject|2|||
160584148|NCT00755846|579859481|FG001|Overall Study|Withdrawal by Subject|3|||
160584149|NCT00755846|579859482|FG002|Overall Study|Withdrawal by Subject|5|||
160584150|NCT00755846|579859483|FG003|Overall Study|Withdrawal by Subject|2|||
160584151|NCT00755846|579859484|FG004|Overall Study|Withdrawal by Subject|0|||
160584152|NCT00755846|579859485|FG005|Overall Study|Withdrawal by Subject|1|||
160584153|NCT00755846|579859480|FG000|Overall Study|Hyperglycemic Rescue|21|||
160458138|NCT03582033|579408021|FG007|Part C|Withdrawal by Subject|2|||
160584154|NCT00755846|579859481|FG001|Overall Study|Hyperglycemic Rescue|7|||
160584155|NCT00755846|579859482|FG002|Overall Study|Hyperglycemic Rescue|5|||
160584156|NCT00755846|579859483|FG003|Overall Study|Hyperglycemic Rescue|8|||
160584157|NCT00755846|579859484|FG004|Overall Study|Hyperglycemic Rescue|8|||
160584158|NCT00755846|579859485|FG005|Overall Study|Hyperglycemic Rescue|7|||
160584159|NCT00755846|579859480|FG000|Overall Study|Physician Decision|1|||
160584160|NCT00755846|579859481|FG001|Overall Study|Physician Decision|3|||
160584161|NCT00755846|579859482|FG002|Overall Study|Physician Decision|0|||
160584162|NCT00755846|579859483|FG003|Overall Study|Physician Decision|1|||
160584163|NCT00755846|579859484|FG004|Overall Study|Physician Decision|0|||
160584164|NCT00755846|579859485|FG005|Overall Study|Physician Decision|1|||
160584165|NCT00755846|579859480|FG000|Overall Study|Administrative Error|0|||
160584166|NCT00755846|579859481|FG001|Overall Study|Administrative Error|1|||
160584167|NCT00755846|579859482|FG002|Overall Study|Administrative Error|0|||
160584168|NCT00755846|579859483|FG003|Overall Study|Administrative Error|0|||
160584169|NCT00755846|579859484|FG004|Overall Study|Administrative Error|0|||
160584170|NCT00755846|579859485|FG005|Overall Study|Administrative Error|0|||
160584171|NCT00755846|579859480|FG000|Overall Study|Participant Non-compliance|0|||
160584172|NCT00755846|579859481|FG001|Overall Study|Participant Non-compliance|0|||
160584173|NCT00755846|579859482|FG002|Overall Study|Participant Non-compliance|0|||
160584174|NCT00755846|579859483|FG003|Overall Study|Participant Non-compliance|0|||
160584175|NCT00755846|579859484|FG004|Overall Study|Participant Non-compliance|1|||
160584176|NCT00755846|579859485|FG005|Overall Study|Participant Non-compliance|0|||
160584177|NCT02723604|579859498|FG000|Overall Study|ineligible|1|||
160584178|NCT02723604|579859498|FG000|Overall Study|never received treatment|1|||
160584179|NCT00111475|579859499|FG000|Overall Study|Lost to Follow-up|0|||
160584180|NCT00111475|579859500|FG001|Overall Study|Lost to Follow-up|0|||
160584181|NCT00111475|579859501|FG002|Overall Study|Lost to Follow-up|0|||
160584182|NCT00111475|579859502|FG003|Overall Study|Lost to Follow-up|0|||
160584183|NCT00111475|579859503|FG004|Overall Study|Lost to Follow-up|0|||
160584184|NCT00111475|579859504|FG005|Overall Study|Lost to Follow-up|1|||
160584185|NCT00111475|579859505|FG006|Overall Study|Lost to Follow-up|0|||
160584186|NCT00111475|579859506|FG007|Overall Study|Lost to Follow-up|0|||
160584187|NCT00111475|579859507|FG008|Overall Study|Lost to Follow-up|0|||
160584188|NCT00111475|579859508|FG009|Overall Study|Lost to Follow-up|0|||
160584189|NCT03303092|579859511|FG000|Overall Study|Adverse Event|1|||
160584190|NCT03303092|579859512|FG001|Overall Study|Adverse Event|0|||
160584191|NCT03303092|579859513|FG002|Overall Study|Adverse Event|1|||
160584192|NCT03303092|579859511|FG000|Overall Study|Protocol Violation|1|||
160584193|NCT03303092|579859512|FG001|Overall Study|Protocol Violation|5|||
160584194|NCT03303092|579859513|FG002|Overall Study|Protocol Violation|1|||
160584195|NCT03303092|579859511|FG000|Overall Study|Withdrawal by Subject|1|||
160584196|NCT03303092|579859512|FG001|Overall Study|Withdrawal by Subject|1|||
160584197|NCT03303092|579859513|FG002|Overall Study|Withdrawal by Subject|3|||
160584198|NCT01995136|579859517|FG000|Overall Study|Change in residence|1|||
160584199|NCT00833248|579859521|FG000|Overall Study|Adverse Event|3|||
160584200|NCT00833248|579859522|FG001|Overall Study|Adverse Event|0|||
160584201|NCT00833248|579859521|FG000|Overall Study|Protocol Violation|1|||
160584202|NCT00833248|579859522|FG001|Overall Study|Protocol Violation|2|||
160584203|NCT00833248|579859521|FG000|Overall Study|Withdrawal by Subject|0|||
160584204|NCT00833248|579859522|FG001|Overall Study|Withdrawal by Subject|1|||
160584205|NCT01030458|579859527|FG000|Overall Study|Lost to Follow-up|9|||
160584206|NCT01030458|579859528|FG001|Overall Study|Lost to Follow-up|10|||
160584207|NCT01030458|579859527|FG000|Overall Study|Withdrawal by Subject|2|||
161001913|NCT01307267|581393041|FG020|Overall Study|Lost to Follow-up|0|||
161001914|NCT01307267|581393042|FG021|Overall Study|Lost to Follow-up|0|||
161001915|NCT01307267|581393043|FG022|Overall Study|Lost to Follow-up|0|||
161001916|NCT01307267|581393021|FG000|Overall Study|Withdrawal by Subject|0|||
161001917|NCT01307267|581393022|FG001|Overall Study|Withdrawal by Subject|0|||
161001918|NCT01307267|581393023|FG002|Overall Study|Withdrawal by Subject|0|||
160458139|NCT03582033|579408022|FG008|Part C|Withdrawal by Subject|1|||
160584208|NCT01030458|579859528|FG001|Overall Study|Withdrawal by Subject|3|||
160584209|NCT01030458|579859527|FG000|Overall Study|Logistical reasons|9|||
160584210|NCT01030458|579859528|FG001|Overall Study|Logistical reasons|5|||
160584211|NCT01030458|579859527|FG000|Overall Study|Moved or changed job|6|||
160584212|NCT01030458|579859528|FG001|Overall Study|Moved or changed job|13|||
160584213|NCT01030458|579859527|FG000|Overall Study|Side effect of medication|1|||
160584214|NCT01030458|579859528|FG001|Overall Study|Side effect of medication|1|||
160584215|NCT00839423|579859531|FG000|Overall Study|Adverse Event|4|||
160584216|NCT00839423|579859532|FG001|Overall Study|Adverse Event|3|||
160584217|NCT00839423|579859533|FG002|Overall Study|Adverse Event|7|||
160584218|NCT00839423|579859534|FG003|Overall Study|Adverse Event|16|||
161001919|NCT01307267|581393024|FG003|Overall Study|Withdrawal by Subject|0|||
160584219|NCT00839423|579859531|FG000|Overall Study|Lack of Efficacy|6|||
160584220|NCT00839423|579859532|FG001|Overall Study|Lack of Efficacy|6|||
160584221|NCT00839423|579859533|FG002|Overall Study|Lack of Efficacy|3|||
160584222|NCT00839423|579859534|FG003|Overall Study|Lack of Efficacy|2|||
160584223|NCT00839423|579859531|FG000|Overall Study|Non-compliance|0|||
160584224|NCT00839423|579859532|FG001|Overall Study|Non-compliance|0|||
161001920|NCT01307267|581393025|FG004|Overall Study|Withdrawal by Subject|0|||
160584225|NCT00839423|579859533|FG002|Overall Study|Non-compliance|0|||
160584226|NCT00839423|579859534|FG003|Overall Study|Non-compliance|1|||
160584227|NCT00839423|579859531|FG000|Overall Study|Protocol Violation|0|||
160584228|NCT00839423|579859532|FG001|Overall Study|Protocol Violation|1|||
160584229|NCT00839423|579859533|FG002|Overall Study|Protocol Violation|2|||
160584230|NCT00839423|579859534|FG003|Overall Study|Protocol Violation|0|||
160584231|NCT00839423|579859531|FG000|Overall Study|Withdrawal of consent|4|||
160584232|NCT00839423|579859532|FG001|Overall Study|Withdrawal of consent|0|||
160584233|NCT00839423|579859533|FG002|Overall Study|Withdrawal of consent|4|||
160584234|NCT00839423|579859534|FG003|Overall Study|Withdrawal of consent|1|||
160584235|NCT00839423|579859531|FG000|Overall Study|Lost to Follow-up|1|||
160584236|NCT00839423|579859532|FG001|Overall Study|Lost to Follow-up|0|||
160584237|NCT00839423|579859533|FG002|Overall Study|Lost to Follow-up|1|||
160584238|NCT00839423|579859534|FG003|Overall Study|Lost to Follow-up|0|||
160584239|NCT00839423|579859531|FG000|Overall Study|Administrative or other reasons|3|||
160584240|NCT00839423|579859532|FG001|Overall Study|Administrative or other reasons|0|||
160584241|NCT00839423|579859533|FG002|Overall Study|Administrative or other reasons|1|||
160584242|NCT00839423|579859534|FG003|Overall Study|Administrative or other reasons|0|||
160584243|NCT01071096|579859535|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
160584244|NCT01071096|579859536|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
160584245|NCT02585999|579859537|FG000|Overall Study|Lost to Follow-up|1|||
160584246|NCT02585999|579859537|FG000|Overall Study|Protocol Violation|1|||
160584247|NCT01094730|579859544|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
160584248|NCT01094730|579859545|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
160584249|NCT01094730|579859544|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
160584250|NCT01094730|579859545|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
160584251|NCT01094730|579859544|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
160959233|NCT01329029|581237700|FG000|Overall Study|Other|14|||
160959234|NCT01329029|581237701|FG001|Overall Study|Other|20|||
160959235|NCT01329029|581237700|FG000|Overall Study|COPD Exacerbation|11|||
160959236|NCT01329029|581237701|FG001|Overall Study|COPD Exacerbation|18|||
160959237|NCT01329029|581237700|FG000|Overall Study|Physician Decision|16|||
160959238|NCT01329029|581237701|FG001|Overall Study|Physician Decision|13|||
160959239|NCT01329029|581237700|FG000|Overall Study|Lost to Follow-up|8|||
160959240|NCT01329029|581237701|FG001|Overall Study|Lost to Follow-up|5|||
160959241|NCT01329029|581237700|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
160959242|NCT01329029|581237701|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
160959243|NCT01323530|581239684|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
160959244|NCT01323530|581239685|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160959245|NCT01323530|581239686|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160959246|NCT01323530|581239687|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160959247|NCT01323530|581239688|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160959248|NCT01323530|581239689|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
160959249|NCT01323530|581239690|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160959250|NCT01323530|581239684|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
160959251|NCT01323530|581239685|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
160959252|NCT01323530|581239686|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
160959253|NCT01323530|581239687|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160584252|NCT01094730|579859545|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
160584253|NCT01094730|579859544|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
160959254|NCT01323530|581239688|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
160959255|NCT01323530|581239689|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160959256|NCT01323530|581239690|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160959257|NCT01323530|581239684|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
160959258|NCT01323530|581239685|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
160959259|NCT01323530|581239686|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
160959260|NCT01323530|581239687|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
160959261|NCT01323530|581239688|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
160959262|NCT01323530|581239689|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
160959263|NCT01323530|581239690|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
160959264|NCT01323530|581239684|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160959265|NCT01323530|581239685|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160959266|NCT01323530|581239686|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160959267|NCT01323530|581239687|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160959268|NCT01323530|581239688|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160584254|NCT01094730|579859545|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
160584255|NCT01094730|579859544|FG000|Period 2 (14 Days)|Protocol Violation|2|||
160584256|NCT01094730|579859545|FG001|Period 2 (14 Days)|Protocol Violation|0|||
160584257|NCT01094730|579859544|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
160584258|NCT01094730|579859545|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
160584259|NCT01094730|579859544|FG000|Period 2 (14 Days)|Adverse Event|0|||
160584260|NCT01094730|579859545|FG001|Period 2 (14 Days)|Adverse Event|1|||
160584261|NCT01094730|579859544|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
160584262|NCT01094730|579859545|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
160584263|NCT02864940|579859546|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
160584264|NCT02864940|579859547|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
160584265|NCT02232087|579859548|FG000|Overall Study|Withdrawal by Subject|2|||
160584266|NCT02232087|579859549|FG001|Overall Study|Withdrawal by Subject|0|||
160584267|NCT02232087|579859550|FG002|Overall Study|Withdrawal by Subject|0|||
160584268|NCT02232087|579859551|FG003|Overall Study|Withdrawal by Subject|0|||
160584269|NCT02232087|579859552|FG004|Overall Study|Withdrawal by Subject|0|||
160584270|NCT02232087|579859553|FG005|Overall Study|Withdrawal by Subject|1|||
160584271|NCT02232087|579859548|FG000|Overall Study|poor inhalation technique|0|||
160584272|NCT02232087|579859549|FG001|Overall Study|poor inhalation technique|1|||
160584273|NCT02232087|579859550|FG002|Overall Study|poor inhalation technique|0|||
160584274|NCT02232087|579859551|FG003|Overall Study|poor inhalation technique|0|||
160584275|NCT02232087|579859552|FG004|Overall Study|poor inhalation technique|0|||
160584276|NCT02232087|579859553|FG005|Overall Study|poor inhalation technique|2|||
160584277|NCT02232087|579859548|FG000|Overall Study|protocol stop criteria|0|||
160584278|NCT02232087|579859549|FG001|Overall Study|protocol stop criteria|1|||
160584279|NCT02232087|579859550|FG002|Overall Study|protocol stop criteria|0|||
160584280|NCT02232087|579859551|FG003|Overall Study|protocol stop criteria|1|||
160584281|NCT02232087|579859552|FG004|Overall Study|protocol stop criteria|0|||
160584282|NCT02232087|579859553|FG005|Overall Study|protocol stop criteria|0|||
160584283|NCT02232087|579859548|FG000|Overall Study|Adverse Event|0|||
160584284|NCT02232087|579859549|FG001|Overall Study|Adverse Event|0|||
160584285|NCT02232087|579859550|FG002|Overall Study|Adverse Event|0|||
160584286|NCT02232087|579859551|FG003|Overall Study|Adverse Event|0|||
160584287|NCT02232087|579859552|FG004|Overall Study|Adverse Event|1|||
160584288|NCT02232087|579859553|FG005|Overall Study|Adverse Event|0|||
160584289|NCT01958125|579859554|FG000|Overall Study|Missing diary data|2|||
160584290|NCT01958125|579859555|FG001|Overall Study|Missing diary data|6|||
160584291|NCT01958125|579859554|FG000|Overall Study|No headache attacks|0|||
160584292|NCT01958125|579859555|FG001|Overall Study|No headache attacks|2|||
160584293|NCT01106625|579859556|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
160584294|NCT01106625|579859557|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
160584295|NCT01106625|579859558|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
160584296|NCT01106625|579859556|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
160584297|NCT01106625|579859557|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
160584298|NCT01106625|579859558|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
160584299|NCT01106625|579859556|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
160584300|NCT01106625|579859557|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
160584301|NCT01106625|579859558|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
160584302|NCT01106625|579859556|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
160584303|NCT01106625|579859557|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
160584304|NCT01106625|579859558|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
160584305|NCT01106625|579859556|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
160584306|NCT01106625|579859557|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
160584307|NCT01106625|579859558|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
160584308|NCT01106625|579859556|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
160584309|NCT01106625|579859557|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
160584310|NCT01106625|579859558|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
160584311|NCT01106625|579859556|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
160584312|NCT01106625|579859557|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
160584313|NCT01106625|579859558|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
160584314|NCT01106625|579859556|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
160584315|NCT01106625|579859557|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
160584316|NCT01106625|579859558|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
160584317|NCT01106625|579859556|FG000|Core Period: Baseline to Week 26|Other|8|||
160584318|NCT01106625|579859557|FG001|Core Period: Baseline to Week 26|Other|7|||
160584319|NCT01106625|579859558|FG002|Core Period: Baseline to Week 26|Other|4|||
160959269|NCT01323530|581239689|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160959270|NCT01323530|581239690|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
160584320|NCT01106625|579859556|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
160584321|NCT01106625|579859557|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
160584322|NCT01106625|579859558|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
160584323|NCT01106625|579859556|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
160584324|NCT01106625|579859557|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
160584325|NCT01106625|579859558|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
160584326|NCT01106625|579859556|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
160959271|NCT01323530|581239684|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959272|NCT01323530|581239685|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959273|NCT01323530|581239686|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959274|NCT01323530|581239687|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959275|NCT01323530|581239688|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959276|NCT01323530|581239689|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959277|NCT01323530|581239690|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
160959278|NCT01323530|581239684|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959279|NCT01323530|581239685|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959280|NCT01323530|581239686|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959281|NCT01323530|581239687|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959282|NCT01323530|581239688|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959283|NCT01323530|581239689|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959284|NCT01323530|581239690|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
160959285|NCT01323530|581239684|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959286|NCT01323530|581239685|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959287|NCT01323530|581239686|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959288|NCT01323530|581239687|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959289|NCT01323530|581239688|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959290|NCT01323530|581239689|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959291|NCT01323530|581239690|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
160959292|NCT01323530|581239684|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959293|NCT01323530|581239685|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959294|NCT01323530|581239686|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959295|NCT01323530|581239687|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959296|NCT01323530|581239688|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959297|NCT01323530|581239689|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959298|NCT01323530|581239690|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
160959299|NCT01194570|581239691|FG000|Overall Study|Adverse Event|22|||
160959300|NCT01194570|581239692|FG001|Overall Study|Adverse Event|40|||
160959301|NCT01194570|581239691|FG000|Overall Study|Death|6|||
160959302|NCT01194570|581239692|FG001|Overall Study|Death|20|||
160959303|NCT01194570|581239691|FG000|Overall Study|Lack of Efficacy|32|||
160959304|NCT01194570|581239692|FG001|Overall Study|Lack of Efficacy|33|||
160959305|NCT01194570|581239691|FG000|Overall Study|Lost to Follow-up|4|||
160959306|NCT01194570|581239692|FG001|Overall Study|Lost to Follow-up|15|||
160959307|NCT01194570|581239691|FG000|Overall Study|Non-Compliance|2|||
160959308|NCT01194570|581239692|FG001|Overall Study|Non-Compliance|2|||
160959309|NCT01194570|581239691|FG000|Overall Study|Non-Compliance With Study Drug|2|||
160959310|NCT01194570|581239692|FG001|Overall Study|Non-Compliance With Study Drug|2|||
160584327|NCT01106625|579859557|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
160584328|NCT01106625|579859558|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
160584329|NCT01106625|579859556|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
160584330|NCT01106625|579859557|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
160584331|NCT01106625|579859558|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
160584332|NCT01106625|579859556|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
160584333|NCT01106625|579859557|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
160584334|NCT01106625|579859558|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
160584335|NCT01106625|579859556|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
160584336|NCT01106625|579859557|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
160584337|NCT01106625|579859558|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
160584338|NCT01106625|579859556|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
160584339|NCT01106625|579859557|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
160584340|NCT01106625|579859558|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
160959311|NCT01194570|581239691|FG000|Overall Study|Other|18|||
160959312|NCT01194570|581239692|FG001|Overall Study|Other|47|||
160959313|NCT01194570|581239691|FG000|Overall Study|Physician Decision|10|||
160959314|NCT01194570|581239692|FG001|Overall Study|Physician Decision|25|||
160959315|NCT01194570|581239691|FG000|Overall Study|Protocol Violation|1|||
161001921|NCT01307267|581393026|FG005|Overall Study|Withdrawal by Subject|1|||
161001922|NCT01307267|581393027|FG006|Overall Study|Withdrawal by Subject|0|||
161001923|NCT01307267|581393028|FG007|Overall Study|Withdrawal by Subject|1|||
161001924|NCT01307267|581393029|FG008|Overall Study|Withdrawal by Subject|5|||
161001925|NCT01307267|581393030|FG009|Overall Study|Withdrawal by Subject|1|||
161001926|NCT01307267|581393031|FG010|Overall Study|Withdrawal by Subject|1|||
160584341|NCT01106625|579859556|FG000|Extension Period: Week 26 to Week 52|Other|5|||
160584342|NCT01106625|579859557|FG001|Extension Period: Week 26 to Week 52|Other|5|||
160584343|NCT01106625|579859558|FG002|Extension Period: Week 26 to Week 52|Other|4|||
160656983|NCT05097989|580124498|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
160959316|NCT01194570|581239692|FG001|Overall Study|Protocol Violation|2|||
160959317|NCT01194570|581239691|FG000|Overall Study|Study Terminated By Sponsor|0|||
160959318|NCT01194570|581239692|FG001|Overall Study|Study Terminated By Sponsor|1|||
160959319|NCT01194570|581239691|FG000|Overall Study|Withdrawal by Subject|57|||
160959320|NCT01194570|581239692|FG001|Overall Study|Withdrawal by Subject|82|||
160959321|NCT01194570|581239691|FG000|Overall Study|Pregnancy|1|||
160959322|NCT01194570|581239692|FG001|Overall Study|Pregnancy|1|||
160959323|NCT01203930|581239702|FG000|Overall Study|Disease Progression|0|||
160959324|NCT01203930|581239703|FG001|Overall Study|Disease Progression|4|||
160959325|NCT01203930|581239702|FG000|Overall Study|Death|3|||
160959326|NCT01203930|581239703|FG001|Overall Study|Death|1|||
160959327|NCT01203930|581239702|FG000|Overall Study|Withdrew Consent|1|||
160959328|NCT01203930|581239703|FG001|Overall Study|Withdrew Consent|10|||
160959329|NCT01203930|581239702|FG000|Overall Study|Investigator Request|0|||
160959330|NCT01203930|581239703|FG001|Overall Study|Investigator Request|8|||
160959331|NCT01203930|581239702|FG000|Overall Study|Study Terminated by Sponsor|0|||
160959332|NCT01203930|581239703|FG001|Overall Study|Study Terminated by Sponsor|12|||
160959333|NCT01203930|581239702|FG000|Overall Study|Poor tolerance of study drug|0|||
160959334|NCT01203930|581239703|FG001|Overall Study|Poor tolerance of study drug|1|||
160959335|NCT01203930|581239702|FG000|Overall Study|Adverse Event|17|||
160959336|NCT01203930|581239703|FG001|Overall Study|Adverse Event|5|||
160959337|NCT01266850|581239704|FG000|Overall Study|Lost to Follow-up|19|||
160959338|NCT01266850|581239705|FG001|Overall Study|Lost to Follow-up|19|||
160959339|NCT01266850|581239706|FG002|Overall Study|Lost to Follow-up|13|||
160959340|NCT01266850|581239707|FG003|Overall Study|Lost to Follow-up|13|||
160959341|NCT01266850|581239708|FG004|Overall Study|Lost to Follow-up|12|||
160959342|NCT01266850|581239704|FG000|Overall Study|Withdrawal by Subject|8|||
160959343|NCT01266850|581239705|FG001|Overall Study|Withdrawal by Subject|9|||
160959344|NCT01266850|581239706|FG002|Overall Study|Withdrawal by Subject|6|||
160959345|NCT01266850|581239707|FG003|Overall Study|Withdrawal by Subject|9|||
160959346|NCT01266850|581239708|FG004|Overall Study|Withdrawal by Subject|12|||
160959347|NCT01266850|581239704|FG000|Overall Study|Physician Decision|3|||
160959348|NCT01266850|581239705|FG001|Overall Study|Physician Decision|6|||
160959349|NCT01266850|581239706|FG002|Overall Study|Physician Decision|4|||
160959350|NCT01266850|581239707|FG003|Overall Study|Physician Decision|4|||
160959351|NCT01266850|581239708|FG004|Overall Study|Physician Decision|3|||
160959352|NCT01266850|581239704|FG000|Overall Study|Protocol Violation|0|||
160959353|NCT01266850|581239705|FG001|Overall Study|Protocol Violation|1|||
160959354|NCT01266850|581239706|FG002|Overall Study|Protocol Violation|0|||
160959355|NCT01266850|581239707|FG003|Overall Study|Protocol Violation|1|||
160959356|NCT01266850|581239708|FG004|Overall Study|Protocol Violation|2|||
160959357|NCT01266850|581239704|FG000|Overall Study|Adverse Event|0|||
160959358|NCT01266850|581239705|FG001|Overall Study|Adverse Event|0|||
160959359|NCT01266850|581239706|FG002|Overall Study|Adverse Event|0|||
160458140|NCT03582033|579408023|FG009|Part C|Withdrawal by Subject|0|||
160458141|NCT03582033|579408014|FG000|Part D|Death|0|||
160458142|NCT03582033|579408015|FG001|Part D|Death|0|||
160458143|NCT03582033|579408016|FG002|Part D|Death|0|||
160458144|NCT03582033|579408017|FG003|Part D|Death|0|||
160458145|NCT03582033|579408018|FG004|Part D|Death|0|||
160458146|NCT03582033|579408019|FG005|Part D|Death|0|||
160458147|NCT03582033|579408020|FG006|Part D|Death|0|||
160458148|NCT03582033|579408021|FG007|Part D|Death|0|||
160458149|NCT03582033|579408022|FG008|Part D|Death|0|||
160458150|NCT03582033|579408023|FG009|Part D|Death|1|||
160458151|NCT03582033|579408014|FG000|Part D|Study terminated by sponsor|0|||
160458152|NCT03582033|579408015|FG001|Part D|Study terminated by sponsor|0|||
160458153|NCT03582033|579408016|FG002|Part D|Study terminated by sponsor|0|||
160458154|NCT03582033|579408017|FG003|Part D|Study terminated by sponsor|0|||
160458155|NCT03582033|579408018|FG004|Part D|Study terminated by sponsor|0|||
160458156|NCT03582033|579408019|FG005|Part D|Study terminated by sponsor|0|||
160458157|NCT03582033|579408020|FG006|Part D|Study terminated by sponsor|0|||
160458158|NCT03582033|579408021|FG007|Part D|Study terminated by sponsor|0|||
160458159|NCT03582033|579408022|FG008|Part D|Study terminated by sponsor|0|||
160458160|NCT03582033|579408023|FG009|Part D|Study terminated by sponsor|4|||
160458161|NCT06010836|579408024|FG000|Overall Study|Lost to Follow-up|2|||
160458162|NCT06010836|579408025|FG001|Overall Study|Lost to Follow-up|2|||
160458163|NCT06010836|579408024|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
160458164|NCT06010836|579408025|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
160458165|NCT06010836|579408024|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
160458166|NCT06010836|579408025|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
160458167|NCT06010836|579408024|FG000|Overall Study|Did not receive intervention discussion|0|||
160458168|NCT06010836|579408025|FG001|Overall Study|Did not receive intervention discussion|4|||
160458169|NCT03972150|579409103|FG000|Overall Study|Adverse Event|0|||
160959360|NCT01266850|581239707|FG003|Overall Study|Adverse Event|0|||
160959361|NCT01266850|581239708|FG004|Overall Study|Adverse Event|1|||
160959362|NCT01266850|581239704|FG000|Overall Study|Site Closure|0|||
160959363|NCT01266850|581239705|FG001|Overall Study|Site Closure|1|||
160959364|NCT01266850|581239706|FG002|Overall Study|Site Closure|1|||
160959365|NCT01266850|581239707|FG003|Overall Study|Site Closure|1|||
160584344|NCT01864018|579859561|FG000|Overall Study|Ineligible|3|||
160584345|NCT01864018|579859562|FG001|Overall Study|Ineligible|1|||
160584346|NCT04056455|579859564|FG000|Overall Study|Adverse Event|1|||
160584347|NCT04056455|579859565|FG001|Overall Study|Adverse Event|0|||
160584348|NCT02512068|579859566|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
160584349|NCT02512068|579859567|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
160584350|NCT02512068|579859566|FG000|Overall Study|Major Protocol Deviation|1|||
160584351|NCT02512068|579859567|FG001|Overall Study|Major Protocol Deviation|0|||
160584352|NCT02512068|579859566|FG000|Overall Study|Voluntary Withdrawal|0|||
160584353|NCT02512068|579859567|FG001|Overall Study|Voluntary Withdrawal|1|||
160584354|NCT02512068|579859566|FG000|Overall Study|Lack of Efficacy|0|||
160584355|NCT02512068|579859567|FG001|Overall Study|Lack of Efficacy|1|||
160584356|NCT02512068|579859566|FG000|Overall Study|Reason Not Specified|3|||
160584357|NCT02512068|579859567|FG001|Overall Study|Reason Not Specified|5|||
160584358|NCT01276457|579859569|FG000|Core Study|Adverse Event|6|||
160584359|NCT01276457|579859570|FG001|Core Study|Adverse Event|3|||
160584360|NCT01276457|579859569|FG000|Core Study|Lost to Follow-up|1|||
160584361|NCT01276457|579859570|FG001|Core Study|Lost to Follow-up|2|||
160584362|NCT01276457|579859569|FG000|Core Study|Administrative problems|1|||
160584363|NCT01276457|579859570|FG001|Core Study|Administrative problems|1|||
160584364|NCT01276457|579859569|FG000|Core Study|Death|2|||
160584365|NCT01276457|579859570|FG001|Core Study|Death|2|||
160584366|NCT01276457|579859569|FG000|Core Study|Lack of Efficacy|3|||
160584367|NCT01276457|579859570|FG001|Core Study|Lack of Efficacy|12|||
160584368|NCT01276457|579859569|FG000|Extension Study|Lost to Follow-up|3|||
160584369|NCT01276457|579859570|FG001|Extension Study|Lost to Follow-up|0|||
160584370|NCT01276457|579859569|FG000|Extension Study|Death|0|||
160584371|NCT01276457|579859570|FG001|Extension Study|Death|1|||
160584372|NCT01276457|579859569|FG000|Extension Study|Lack of Efficacy|3|||
160584373|NCT01276457|579859570|FG001|Extension Study|Lack of Efficacy|1|||
160584374|NCT00830037|579859574|FG000|Overall Study|Withdrawal by Subject|2|||
160584375|NCT00830037|579859575|FG001|Overall Study|Withdrawal by Subject|3|||
160584376|NCT00830037|579859574|FG000|Overall Study|Lost to Follow-up|1|||
160584377|NCT00830037|579859575|FG001|Overall Study|Lost to Follow-up|2|||
160584378|NCT00830037|579859574|FG000|Overall Study|Active when terminated by DSMB|15|||
160959366|NCT01266850|581239708|FG004|Overall Study|Site Closure|0|||
160959367|NCT02030015|581239711|FG000|Overall Study|Withdrawal by Subject|3|||
160959368|NCT02030015|581239711|FG000|Overall Study|Death|13|||
160959369|NCT03014674|581239713|FG000|Overall Study|Withdrawal by Subject|1|||
160959370|NCT03014674|581239714|FG001|Overall Study|Withdrawal by Subject|0|||
160959371|NCT03014674|581239715|FG002|Overall Study|Withdrawal by Subject|0|||
160959372|NCT01332227|581239716|FG000|Overall Study|Adverse Event|4|||
160959373|NCT01332227|581239717|FG001|Overall Study|Adverse Event|1|||
160959374|NCT01332227|581239716|FG000|Overall Study|Withdrawal by Subject|5|||
160959375|NCT01332227|581239717|FG001|Overall Study|Withdrawal by Subject|1|||
160959376|NCT01332227|581239716|FG000|Overall Study|Lost to Follow-up|2|||
160959377|NCT01332227|581239717|FG001|Overall Study|Lost to Follow-up|0|||
160959378|NCT01332227|581239716|FG000|Overall Study|Lack of Efficacy|3|||
160959379|NCT01332227|581239717|FG001|Overall Study|Lack of Efficacy|1|||
160959380|NCT01332227|581239716|FG000|Overall Study|Poor compliance/noncompliance|1|||
160959381|NCT01332227|581239717|FG001|Overall Study|Poor compliance/noncompliance|1|||
160959382|NCT01332227|581239716|FG000|Overall Study|Patient moved from area|1|||
160959383|NCT01332227|581239717|FG001|Overall Study|Patient moved from area|0|||
160959384|NCT01332227|581239716|FG000|Overall Study|Patient began prohibited medication|0|||
160959385|NCT01332227|581239717|FG001|Overall Study|Patient began prohibited medication|1|||
160959386|NCT03382782|581239725|FG000|Cohort 1|Withdrawal by Subject|11|||
160959387|NCT03382782|581239726|FG001|Cohort 1|Withdrawal by Subject|5|||
160959388|NCT03382782|581239727|FG002|Cohort 1|Withdrawal by Subject|0|||
160959389|NCT03382782|581239725|FG000|Cohort 2|Withdrawal by Subject|1|||
160959390|NCT03382782|581239726|FG001|Cohort 2|Withdrawal by Subject|1|||
160584379|NCT00830037|579859575|FG001|Overall Study|Active when terminated by DSMB|14|||
160959391|NCT03382782|581239727|FG002|Cohort 2|Withdrawal by Subject|0|||
160959392|NCT03382782|581239725|FG000|Cohort 3|Withdrawal by Subject|1|||
160959393|NCT03382782|581239726|FG001|Cohort 3|Withdrawal by Subject|2|||
160584380|NCT02399813|579859579|FG000|Overall Study|Progressive Disease-Radiographic|2|||
160959394|NCT03382782|581239727|FG002|Cohort 3|Withdrawal by Subject|0|||
160959395|NCT00428090|581239732|FG000|Overall Study|Adverse Event|10|||
160584381|NCT02399813|579859579|FG000|Overall Study|Death|20|||
160584382|NCT02399813|579859579|FG000|Overall Study|Withdrawal by Subject|3|||
160584383|NCT02399813|579859579|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
160584384|NCT02399813|579859579|FG000|Overall Study|Lost to Follow-up|2|||
160458170|NCT03972150|579409104|FG001|Overall Study|Adverse Event|1|||
160656984|NCT05097989|580124499|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
160656985|NCT05097989|580124500|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
160959396|NCT00428090|581239733|FG001|Overall Study|Adverse Event|8|||
160584385|NCT02399813|579859579|FG000|Overall Study|Other than specified|5|||
160959397|NCT00428090|581239734|FG002|Overall Study|Adverse Event|10|||
160584386|NCT03345836|579859584|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
160584387|NCT03345836|579859585|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
160584388|NCT03345836|579859586|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
160584389|NCT03345836|579859587|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
160584390|NCT03345836|579859588|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
160584391|NCT03345836|579859589|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
160584392|NCT03345836|579859584|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
160584393|NCT03345836|579859585|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
160584394|NCT03345836|579859586|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
160584395|NCT03345836|579859587|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
160584396|NCT03345836|579859588|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
160584397|NCT03345836|579859589|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
160584398|NCT03345836|579859584|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
160584399|NCT03345836|579859585|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
160584400|NCT03345836|579859586|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
160584401|NCT03345836|579859587|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
160584402|NCT03345836|579859588|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
160584403|NCT03345836|579859589|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
160584404|NCT03345836|579859584|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
160584405|NCT03345836|579859585|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
160584406|NCT03345836|579859586|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
160584407|NCT03345836|579859587|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
160584408|NCT03345836|579859588|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
160584409|NCT03345836|579859589|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
160584410|NCT03345836|579859584|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
160584411|NCT03345836|579859585|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
160584412|NCT03345836|579859586|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
160584413|NCT03345836|579859587|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
160458171|NCT03972150|579409105|FG002|Overall Study|Adverse Event|1|||
160458172|NCT03972150|579409106|FG003|Overall Study|Adverse Event|0|||
160458173|NCT03972150|579409107|FG004|Overall Study|Adverse Event|0|||
160458174|NCT03972150|579409103|FG000|Overall Study|Progressive disease|3|||
160584414|NCT03345836|579859588|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
160584415|NCT03345836|579859589|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
160584416|NCT03345836|579859584|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
160584417|NCT03345836|579859585|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
160584418|NCT03345836|579859586|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
160584419|NCT03345836|579859587|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
160584420|NCT03345836|579859588|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
160584421|NCT03345836|579859589|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
160584422|NCT03345836|579859584|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
160584423|NCT03345836|579859585|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
160584424|NCT03345836|579859586|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
160584425|NCT03345836|579859587|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
160584426|NCT03345836|579859588|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
160584427|NCT03345836|579859589|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
160584428|NCT03345836|579859584|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
160584429|NCT03345836|579859585|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
160584430|NCT03345836|579859586|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
160584431|NCT03345836|579859587|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
160584432|NCT03345836|579859588|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
160959398|NCT00428090|581239735|FG003|Overall Study|Adverse Event|11|||
160959399|NCT00428090|581239732|FG000|Overall Study|Lost to Follow-up|3|||
160959400|NCT00428090|581239733|FG001|Overall Study|Lost to Follow-up|6|||
160959401|NCT00428090|581239734|FG002|Overall Study|Lost to Follow-up|1|||
160959402|NCT00428090|581239735|FG003|Overall Study|Lost to Follow-up|4|||
160959403|NCT00428090|581239732|FG000|Overall Study|Protocol Violation|3|||
160959404|NCT00428090|581239733|FG001|Overall Study|Protocol Violation|1|||
160458175|NCT03972150|579409104|FG001|Overall Study|Progressive disease|5|||
160458176|NCT03972150|579409105|FG002|Overall Study|Progressive disease|2|||
160959405|NCT00428090|581239734|FG002|Overall Study|Protocol Violation|3|||
160959406|NCT00428090|581239735|FG003|Overall Study|Protocol Violation|3|||
160959407|NCT00428090|581239732|FG000|Overall Study|Withdrawal by Subject|10|||
160959408|NCT00428090|581239733|FG001|Overall Study|Withdrawal by Subject|12|||
160959409|NCT00428090|581239734|FG002|Overall Study|Withdrawal by Subject|15|||
160959410|NCT00428090|581239735|FG003|Overall Study|Withdrawal by Subject|5|||
160959411|NCT00428090|581239732|FG000|Overall Study|Sponsor terminated study|0|||
160959412|NCT00428090|581239733|FG001|Overall Study|Sponsor terminated study|1|||
160584433|NCT03345836|579859589|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
160584434|NCT03345836|579859584|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
160584435|NCT03345836|579859585|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
160584436|NCT03345836|579859586|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
160584437|NCT03345836|579859587|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
160584438|NCT03345836|579859588|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
160584439|NCT03345836|579859589|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
160584440|NCT03345836|579859584|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
160584441|NCT03345836|579859585|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
160584442|NCT03345836|579859586|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
160584443|NCT03345836|579859587|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
160584444|NCT03345836|579859588|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
160584445|NCT03345836|579859589|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
160584446|NCT03345836|579859584|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161001927|NCT01307267|581393032|FG011|Overall Study|Withdrawal by Subject|1|||
161001928|NCT01307267|581393033|FG012|Overall Study|Withdrawal by Subject|0|||
161001929|NCT01307267|581393034|FG013|Overall Study|Withdrawal by Subject|0|||
161001930|NCT01307267|581393035|FG014|Overall Study|Withdrawal by Subject|0|||
161001931|NCT01307267|581393036|FG015|Overall Study|Withdrawal by Subject|0|||
161001932|NCT01307267|581393037|FG016|Overall Study|Withdrawal by Subject|0|||
161001933|NCT01307267|581393038|FG017|Overall Study|Withdrawal by Subject|0|||
161001934|NCT01307267|581393039|FG018|Overall Study|Withdrawal by Subject|0|||
161001935|NCT01307267|581393040|FG019|Overall Study|Withdrawal by Subject|3|||
161001936|NCT01307267|581393041|FG020|Overall Study|Withdrawal by Subject|0|||
161001937|NCT01307267|581393042|FG021|Overall Study|Withdrawal by Subject|0|||
161001938|NCT01307267|581393043|FG022|Overall Study|Withdrawal by Subject|0|||
161001939|NCT01307267|581393021|FG000|Overall Study|Other|0|||
161001940|NCT01307267|581393022|FG001|Overall Study|Other|0|||
161001941|NCT01307267|581393023|FG002|Overall Study|Other|0|||
161001942|NCT01307267|581393024|FG003|Overall Study|Other|0|||
161001943|NCT01307267|581393025|FG004|Overall Study|Other|0|||
161001944|NCT01307267|581393026|FG005|Overall Study|Other|7|||
161001945|NCT01307267|581393027|FG006|Overall Study|Other|0|||
161001946|NCT01307267|581393028|FG007|Overall Study|Other|1|||
161001947|NCT01307267|581393029|FG008|Overall Study|Other|3|||
161001948|NCT01307267|581393030|FG009|Overall Study|Other|0|||
161001949|NCT01307267|581393031|FG010|Overall Study|Other|1|||
161001950|NCT01307267|581393032|FG011|Overall Study|Other|1|||
161001951|NCT01307267|581393033|FG012|Overall Study|Other|1|||
161001952|NCT01307267|581393034|FG013|Overall Study|Other|0|||
161001953|NCT01307267|581393035|FG014|Overall Study|Other|2|||
161001954|NCT01307267|581393036|FG015|Overall Study|Other|1|||
161001955|NCT01307267|581393037|FG016|Overall Study|Other|0|||
161001956|NCT01307267|581393038|FG017|Overall Study|Other|0|||
161001957|NCT01307267|581393039|FG018|Overall Study|Other|0|||
161001958|NCT01307267|581393040|FG019|Overall Study|Other|19|||
161001959|NCT01307267|581393041|FG020|Overall Study|Other|2|||
161001960|NCT01307267|581393042|FG021|Overall Study|Other|3|||
161001961|NCT01307267|581393043|FG022|Overall Study|Other|2|||
161001962|NCT04956575|581393044|FG000|Overall Study|Death|1|||
161001963|NCT04956575|581393045|FG001|Overall Study|Death|0|||
161001964|NCT04956575|581393046|FG002|Overall Study|Death|0|||
161001965|NCT04956575|581393047|FG003|Overall Study|Death|0|||
161001966|NCT04956575|581393048|FG004|Overall Study|Death|0|||
161001967|NCT04956575|581393049|FG005|Overall Study|Death|0|||
161001968|NCT04956575|581393050|FG006|Overall Study|Death|0|||
160458177|NCT03972150|579409106|FG003|Overall Study|Progressive disease|2|||
160458178|NCT03972150|579409107|FG004|Overall Study|Progressive disease|3|||
160584447|NCT03345836|579859585|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161001969|NCT04956575|581393051|FG007|Overall Study|Death|1|||
161001970|NCT04956575|581393052|FG008|Overall Study|Death|0|||
161001971|NCT04956575|581393053|FG009|Overall Study|Death|1|||
161001972|NCT04956575|581393054|FG010|Overall Study|Death|0|||
161001973|NCT04956575|581393055|FG011|Overall Study|Death|0|||
161001974|NCT04956575|581393044|FG000|Overall Study|Lost to Follow-up|3|||
160458179|NCT05464069|579409110|FG000|Overall Study|Protocol Violation|3|||
161001975|NCT04956575|581393045|FG001|Overall Study|Lost to Follow-up|4|||
161001976|NCT04956575|581393046|FG002|Overall Study|Lost to Follow-up|2|||
161001977|NCT04956575|581393047|FG003|Overall Study|Lost to Follow-up|3|||
161001978|NCT04956575|581393048|FG004|Overall Study|Lost to Follow-up|1|||
161001979|NCT04956575|581393049|FG005|Overall Study|Lost to Follow-up|10|||
161001980|NCT04956575|581393050|FG006|Overall Study|Lost to Follow-up|11|||
161001981|NCT04956575|581393051|FG007|Overall Study|Lost to Follow-up|7|||
161001982|NCT04956575|581393052|FG008|Overall Study|Lost to Follow-up|4|||
161001983|NCT04956575|581393053|FG009|Overall Study|Lost to Follow-up|2|||
161001984|NCT04956575|581393054|FG010|Overall Study|Lost to Follow-up|3|||
161001985|NCT04956575|581393055|FG011|Overall Study|Lost to Follow-up|8|||
160584448|NCT03345836|579859586|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
160584449|NCT03345836|579859587|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
160584450|NCT03345836|579859588|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
160584451|NCT03345836|579859589|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
160584452|NCT00222729|579859590|FG000|Overall Study|Adverse Event|3|||
160584453|NCT01915849|579859593|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
160584454|NCT01915849|579859594|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
160584455|NCT01915849|579859595|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
160584456|NCT01915849|579859596|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
160584457|NCT01915849|579859593|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
160584458|NCT01915849|579859594|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
160584459|NCT01915849|579859595|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
160584460|NCT01915849|579859596|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
160584461|NCT01798706|579859597|FG000|Overall Study|Adverse Event|15|||
160584462|NCT01798706|579859598|FG001|Overall Study|Adverse Event|10|||
160584463|NCT01798706|579859597|FG000|Overall Study|Lack of Efficacy|0|||
160584464|NCT01798706|579859598|FG001|Overall Study|Lack of Efficacy|2|||
160584465|NCT01798706|579859597|FG000|Overall Study|Poor compliance to protocol|1|||
160584466|NCT01798706|579859598|FG001|Overall Study|Poor compliance to protocol|0|||
160584467|NCT01798706|579859597|FG000|Overall Study|Other than specified above|5|||
160584468|NCT01798706|579859598|FG001|Overall Study|Other than specified above|9|||
160584469|NCT02775864|579859599|FG000|Overall Study|Data ended end of 2010|1764|||
160584470|NCT02775864|579859600|FG001|Overall Study|Data ended end of 2010|2880|||
160584471|NCT02775864|579859601|FG002|Overall Study|Data ended end of 2010|1140|||
160584472|NCT02775864|579859602|FG003|Overall Study|Data ended end of 2010|1194|||
160584473|NCT02775864|579859599|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
160584474|NCT02775864|579859600|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
160584475|NCT02775864|579859601|FG002|Overall Study|Medicaid eligibility discontinued|720|||
160584476|NCT02775864|579859602|FG003|Overall Study|Medicaid eligibility discontinued|890|||
160584477|NCT01318083|579859603|FG000|Overall Study|Adverse Event|4|||
160584478|NCT01318083|579859604|FG001|Overall Study|Adverse Event|1|||
160584479|NCT01318083|579859605|FG002|Overall Study|Adverse Event|2|||
160584480|NCT01318083|579859603|FG000|Overall Study|Withdrawal by Subject|1|||
160584481|NCT01318083|579859604|FG001|Overall Study|Withdrawal by Subject|0|||
160584482|NCT01318083|579859605|FG002|Overall Study|Withdrawal by Subject|2|||
160584483|NCT01318083|579859603|FG000|Overall Study|Lack of Efficacy|0|||
160584484|NCT01318083|579859604|FG001|Overall Study|Lack of Efficacy|0|||
160584485|NCT01318083|579859605|FG002|Overall Study|Lack of Efficacy|1|||
160584486|NCT01318083|579859603|FG000|Overall Study|Treatment Complications|1|||
160584487|NCT01318083|579859604|FG001|Overall Study|Treatment Complications|0|||
160584488|NCT01318083|579859605|FG002|Overall Study|Treatment Complications|0|||
160584489|NCT01318083|579859603|FG000|Overall Study|Lack of Study Medication Compliance|0|||
160584490|NCT01318083|579859604|FG001|Overall Study|Lack of Study Medication Compliance|1|||
160584491|NCT01318083|579859605|FG002|Overall Study|Lack of Study Medication Compliance|0|||
160584492|NCT05896761|579859606|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
160584493|NCT05896761|579859607|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
160584494|NCT05896761|579859606|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
160584495|NCT05896761|579859607|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
160584496|NCT02028338|579859610|FG000|Overall Study|Withdrawal by Subject|3|||
160584497|NCT02028338|579859611|FG001|Overall Study|Withdrawal by Subject|1|||
160584498|NCT02028338|579859610|FG000|Overall Study|Unable to contact participant|1|||
160959413|NCT00428090|581239734|FG002|Overall Study|Sponsor terminated study|0|||
160959414|NCT00428090|581239735|FG003|Overall Study|Sponsor terminated study|0|||
160959415|NCT00428090|581239732|FG000|Overall Study|Non-compliance|4|||
160959416|NCT00428090|581239733|FG001|Overall Study|Non-compliance|0|||
160959417|NCT00428090|581239734|FG002|Overall Study|Non-compliance|1|||
160959418|NCT00428090|581239735|FG003|Overall Study|Non-compliance|3|||
160959419|NCT00428090|581239732|FG000|Overall Study|Par. did not returned to visit|1|||
160959420|NCT00428090|581239733|FG001|Overall Study|Par. did not returned to visit|0|||
160959421|NCT00428090|581239734|FG002|Overall Study|Par. did not returned to visit|0|||
160959422|NCT00428090|581239735|FG003|Overall Study|Par. did not returned to visit|1|||
160959423|NCT00428090|581239732|FG000|Overall Study|Follow-Up visit not possible|1|||
160959424|NCT00428090|581239733|FG001|Overall Study|Follow-Up visit not possible|0|||
160959425|NCT00428090|581239734|FG002|Overall Study|Follow-Up visit not possible|0|||
160959426|NCT00428090|581239735|FG003|Overall Study|Follow-Up visit not possible|0|||
160959427|NCT00428090|581239732|FG000|Overall Study|Prohibited medication used for SAE|1|||
160959428|NCT00428090|581239733|FG001|Overall Study|Prohibited medication used for SAE|0|||
160584499|NCT02028338|579859611|FG001|Overall Study|Unable to contact participant|0|||
160584500|NCT03552549|579859613|FG000|Overall Study|Disease progression|25|||
160584501|NCT03552549|579859614|FG001|Overall Study|Disease progression|17|||
160584502|NCT03552549|579859613|FG000|Overall Study|Adverse event in first 12 months|12|||
160584503|NCT03552549|579859614|FG001|Overall Study|Adverse event in first 12 months|8|||
160584504|NCT03552549|579859613|FG000|Overall Study|Withdrawal by Subject|7|||
160584505|NCT03552549|579859614|FG001|Overall Study|Withdrawal by Subject|7|||
160584506|NCT03552549|579859613|FG000|Overall Study|Unknown (no reason provided)|4|||
160584507|NCT03552549|579859614|FG001|Overall Study|Unknown (no reason provided)|2|||
160584508|NCT03552549|579859613|FG000|Overall Study|Not in participant's best interest|2|||
160584509|NCT03552549|579859614|FG001|Overall Study|Not in participant's best interest|1|||
160584510|NCT03552549|579859613|FG000|Overall Study|Did not complete study treatment|2|||
160584511|NCT03552549|579859614|FG001|Overall Study|Did not complete study treatment|3|||
160584512|NCT03552549|579859613|FG000|Overall Study|Did not meet eligibility criteria|1|||
160584513|NCT03552549|579859614|FG001|Overall Study|Did not meet eligibility criteria|0|||
160584514|NCT03552549|579859613|FG000|Overall Study|Administrative|0|||
160584515|NCT03552549|579859614|FG001|Overall Study|Administrative|14|||
160584516|NCT00256867|579859623|FG000|Overall Study|Adverse Event|0|||
160584517|NCT00256867|579859624|FG001|Overall Study|Adverse Event|1|||
160584518|NCT00256867|579859625|FG002|Overall Study|Adverse Event|1|||
160584519|NCT00256867|579859626|FG003|Overall Study|Adverse Event|1|||
160584520|NCT00256867|579859627|FG004|Overall Study|Adverse Event|2|||
160584521|NCT00256867|579859628|FG005|Overall Study|Adverse Event|2|||
160584522|NCT00256867|579859629|FG006|Overall Study|Adverse Event|1|||
160584523|NCT00256867|579859630|FG007|Overall Study|Adverse Event|4|||
160584524|NCT00256867|579859623|FG000|Overall Study|Lost to Follow-up|2|||
160584525|NCT00256867|579859624|FG001|Overall Study|Lost to Follow-up|2|||
160584526|NCT00256867|579859625|FG002|Overall Study|Lost to Follow-up|2|||
160584527|NCT00256867|579859626|FG003|Overall Study|Lost to Follow-up|3|||
160584528|NCT00256867|579859627|FG004|Overall Study|Lost to Follow-up|2|||
160584529|NCT00256867|579859628|FG005|Overall Study|Lost to Follow-up|0|||
160584530|NCT00256867|579859629|FG006|Overall Study|Lost to Follow-up|1|||
160584531|NCT00256867|579859630|FG007|Overall Study|Lost to Follow-up|2|||
160584532|NCT00256867|579859623|FG000|Overall Study|Protocol Violation|0|||
160584533|NCT00256867|579859624|FG001|Overall Study|Protocol Violation|0|||
160584534|NCT00256867|579859625|FG002|Overall Study|Protocol Violation|0|||
160584535|NCT00256867|579859626|FG003|Overall Study|Protocol Violation|1|||
160584536|NCT00256867|579859627|FG004|Overall Study|Protocol Violation|0|||
160584537|NCT00256867|579859628|FG005|Overall Study|Protocol Violation|1|||
160584538|NCT00256867|579859629|FG006|Overall Study|Protocol Violation|0|||
160584539|NCT00256867|579859630|FG007|Overall Study|Protocol Violation|1|||
160584540|NCT00256867|579859623|FG000|Overall Study|Withdrawal by Subject|0|||
160584541|NCT00256867|579859624|FG001|Overall Study|Withdrawal by Subject|0|||
160584542|NCT00256867|579859625|FG002|Overall Study|Withdrawal by Subject|1|||
160584543|NCT00256867|579859626|FG003|Overall Study|Withdrawal by Subject|1|||
160584544|NCT00256867|579859627|FG004|Overall Study|Withdrawal by Subject|2|||
160584545|NCT00256867|579859628|FG005|Overall Study|Withdrawal by Subject|2|||
160584546|NCT00256867|579859629|FG006|Overall Study|Withdrawal by Subject|3|||
160584547|NCT00256867|579859630|FG007|Overall Study|Withdrawal by Subject|2|||
160584548|NCT00256867|579859623|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
160584549|NCT00256867|579859624|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
160584550|NCT00256867|579859625|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
160584551|NCT00256867|579859626|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
160584552|NCT00256867|579859627|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
160584553|NCT00256867|579859628|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
160584554|NCT00256867|579859629|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
160584555|NCT00256867|579859630|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
160584556|NCT00256867|579859623|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
160584557|NCT00256867|579859624|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
160584558|NCT00256867|579859625|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
160584559|NCT00256867|579859626|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
160584560|NCT00256867|579859627|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
160584561|NCT00256867|579859628|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
160584562|NCT00256867|579859629|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
160584563|NCT00256867|579859630|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
160584564|NCT00256867|579859623|FG000|Overall Study|Investigator's Decision|0|||
160584565|NCT00256867|579859624|FG001|Overall Study|Investigator's Decision|0|||
160656986|NCT05097989|580124501|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
160959429|NCT00428090|581239734|FG002|Overall Study|Prohibited medication used for SAE|0|||
160959430|NCT00428090|581239735|FG003|Overall Study|Prohibited medication used for SAE|0|||
160584566|NCT00256867|579859625|FG002|Overall Study|Investigator's Decision|0|||
160584567|NCT00256867|579859626|FG003|Overall Study|Investigator's Decision|0|||
160584568|NCT00256867|579859627|FG004|Overall Study|Investigator's Decision|1|||
160584569|NCT00256867|579859628|FG005|Overall Study|Investigator's Decision|0|||
160584570|NCT00256867|579859629|FG006|Overall Study|Investigator's Decision|0|||
160584571|NCT00256867|579859630|FG007|Overall Study|Investigator's Decision|0|||
160584572|NCT00256867|579859623|FG000|Overall Study|Non-compliance with study medication|0|||
160584573|NCT00256867|579859624|FG001|Overall Study|Non-compliance with study medication|0|||
160584574|NCT00256867|579859625|FG002|Overall Study|Non-compliance with study medication|0|||
160584575|NCT00256867|579859626|FG003|Overall Study|Non-compliance with study medication|0|||
160584576|NCT00256867|579859627|FG004|Overall Study|Non-compliance with study medication|0|||
160584577|NCT00256867|579859628|FG005|Overall Study|Non-compliance with study medication|0|||
160584578|NCT00256867|579859629|FG006|Overall Study|Non-compliance with study medication|0|||
160584579|NCT00256867|579859630|FG007|Overall Study|Non-compliance with study medication|1|||
160584580|NCT00256867|579859623|FG000|Overall Study|Participant travelled Overseas|0|||
160584581|NCT00256867|579859624|FG001|Overall Study|Participant travelled Overseas|1|||
160584582|NCT00256867|579859625|FG002|Overall Study|Participant travelled Overseas|0|||
160584583|NCT00256867|579859626|FG003|Overall Study|Participant travelled Overseas|0|||
160584584|NCT00256867|579859627|FG004|Overall Study|Participant travelled Overseas|0|||
160584585|NCT00256867|579859628|FG005|Overall Study|Participant travelled Overseas|0|||
160584586|NCT00256867|579859629|FG006|Overall Study|Participant travelled Overseas|0|||
160584587|NCT00256867|579859630|FG007|Overall Study|Participant travelled Overseas|0|||
160584588|NCT00256867|579859623|FG000|Overall Study|Participant out of assessment window|0|||
160584589|NCT00256867|579859624|FG001|Overall Study|Participant out of assessment window|0|||
160584590|NCT00256867|579859625|FG002|Overall Study|Participant out of assessment window|1|||
160584591|NCT00256867|579859626|FG003|Overall Study|Participant out of assessment window|0|||
160584592|NCT00256867|579859627|FG004|Overall Study|Participant out of assessment window|0|||
160584593|NCT00256867|579859628|FG005|Overall Study|Participant out of assessment window|0|||
160584594|NCT00256867|579859629|FG006|Overall Study|Participant out of assessment window|0|||
160584595|NCT00256867|579859630|FG007|Overall Study|Participant out of assessment window|0|||
160584596|NCT00256867|579859623|FG000|Overall Study|Withdrawal by participant|0|||
160584597|NCT00256867|579859624|FG001|Overall Study|Withdrawal by participant|0|||
160584598|NCT00256867|579859625|FG002|Overall Study|Withdrawal by participant|0|||
160584599|NCT00256867|579859626|FG003|Overall Study|Withdrawal by participant|0|||
160959431|NCT00428090|581239732|FG000|Overall Study|Death of par.|1|||
160959432|NCT00428090|581239733|FG001|Overall Study|Death of par.|0|||
160959433|NCT00428090|581239734|FG002|Overall Study|Death of par.|1|||
160959434|NCT00428090|581239735|FG003|Overall Study|Death of par.|0|||
160959435|NCT00428090|581239732|FG000|Overall Study|Visit 7 exceed the visit window|0|||
160959436|NCT00428090|581239733|FG001|Overall Study|Visit 7 exceed the visit window|1|||
160959437|NCT00428090|581239734|FG002|Overall Study|Visit 7 exceed the visit window|0|||
161001986|NCT04956575|581393044|FG000|Overall Study|Withdrawal by Subject|1|||
160584600|NCT00256867|579859627|FG004|Overall Study|Withdrawal by participant|0|||
160584601|NCT00256867|579859628|FG005|Overall Study|Withdrawal by participant|1|||
160584602|NCT00256867|579859629|FG006|Overall Study|Withdrawal by participant|0|||
160584603|NCT00256867|579859630|FG007|Overall Study|Withdrawal by participant|0|||
160584604|NCT00527111|579859633|FG000|Overall Study|Adverse Event|14|||
160584605|NCT00527111|579859634|FG001|Overall Study|Adverse Event|13|||
160584606|NCT00527111|579859633|FG000|Overall Study|Death|0|||
160584607|NCT00527111|579859634|FG001|Overall Study|Death|1|||
160584608|NCT00527111|579859633|FG000|Overall Study|Investigator Request|2|||
160584609|NCT00527111|579859634|FG001|Overall Study|Investigator Request|1|||
160584610|NCT00527111|579859633|FG000|Overall Study|Patient Request|2|||
160584611|NCT00527111|579859634|FG001|Overall Study|Patient Request|5|||
160584612|NCT00527111|579859633|FG000|Overall Study|Other|2|||
160584613|NCT00527111|579859634|FG001|Overall Study|Other|2|||
160584614|NCT00634244|579859639|FG000|Overall Study|Never started treatment|0|||
160584615|NCT00634244|579859640|FG001|Overall Study|Never started treatment|1|||
160584616|NCT00634244|579859641|FG002|Overall Study|Never started treatment|0|||
160584617|NCT00634244|579859639|FG000|Overall Study|Death|1|||
160584618|NCT00634244|579859640|FG001|Overall Study|Death|6|||
160584619|NCT00634244|579859641|FG002|Overall Study|Death|0|||
160584620|NCT00634244|579859639|FG000|Overall Study|Adverse Event|0|||
160584621|NCT00634244|579859640|FG001|Overall Study|Adverse Event|2|||
160584622|NCT00634244|579859641|FG002|Overall Study|Adverse Event|0|||
160584623|NCT00634244|579859639|FG000|Overall Study|Withdrawal by Subject|0|||
160584624|NCT00634244|579859640|FG001|Overall Study|Withdrawal by Subject|1|||
160584625|NCT00634244|579859641|FG002|Overall Study|Withdrawal by Subject|0|||
160584626|NCT00634244|579859639|FG000|Overall Study|Physician Decision|0|||
160959438|NCT00428090|581239735|FG003|Overall Study|Visit 7 exceed the visit window|0|||
160959439|NCT00428090|581239732|FG000|Overall Study|Medical monitor terminated par.|0|||
160959440|NCT00428090|581239733|FG001|Overall Study|Medical monitor terminated par.|1|||
160959441|NCT00428090|581239734|FG002|Overall Study|Medical monitor terminated par.|0|||
160959442|NCT00428090|581239735|FG003|Overall Study|Medical monitor terminated par.|0|||
160959443|NCT00428090|581239732|FG000|Overall Study|Mental status of par. was|0|||
160959444|NCT00428090|581239733|FG001|Overall Study|Mental status of par. was|1|||
161001987|NCT04956575|581393045|FG001|Overall Study|Withdrawal by Subject|2|||
160959445|NCT00428090|581239734|FG002|Overall Study|Mental status of par. was|0|||
160584627|NCT00634244|579859640|FG001|Overall Study|Physician Decision|1|||
160584628|NCT00634244|579859641|FG002|Overall Study|Physician Decision|0|||
160584629|NCT00634244|579859639|FG000|Overall Study|Disease progression/relapse|0|||
160584630|NCT00634244|579859640|FG001|Overall Study|Disease progression/relapse|1|||
160584631|NCT00634244|579859641|FG002|Overall Study|Disease progression/relapse|0|||
160584632|NCT00634244|579859639|FG000|Overall Study|Other complicating disease|0|||
160584633|NCT00634244|579859640|FG001|Overall Study|Other complicating disease|1|||
160584634|NCT00634244|579859641|FG002|Overall Study|Other complicating disease|0|||
160584635|NCT03591146|579859649|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
160584636|NCT03591146|579859650|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
160584637|NCT03591146|579859651|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
160584638|NCT03591146|579859652|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
160584639|NCT03591146|579859653|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
160584640|NCT03591146|579859649|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
160584641|NCT03591146|579859650|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
160584642|NCT03591146|579859651|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
160584643|NCT03591146|579859652|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
160584644|NCT03591146|579859653|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
160584645|NCT03591146|579859649|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
160584646|NCT03591146|579859650|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
160584647|NCT03591146|579859651|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
160584648|NCT03591146|579859652|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161001988|NCT04956575|581393046|FG002|Overall Study|Withdrawal by Subject|1|||
161001989|NCT04956575|581393047|FG003|Overall Study|Withdrawal by Subject|4|||
161001990|NCT04956575|581393048|FG004|Overall Study|Withdrawal by Subject|2|||
161001991|NCT04956575|581393049|FG005|Overall Study|Withdrawal by Subject|8|||
161001992|NCT04956575|581393050|FG006|Overall Study|Withdrawal by Subject|5|||
161001993|NCT04956575|581393051|FG007|Overall Study|Withdrawal by Subject|1|||
161001994|NCT04956575|581393052|FG008|Overall Study|Withdrawal by Subject|1|||
161001995|NCT04956575|581393053|FG009|Overall Study|Withdrawal by Subject|0|||
161001996|NCT04956575|581393054|FG010|Overall Study|Withdrawal by Subject|3|||
161001997|NCT04956575|581393055|FG011|Overall Study|Withdrawal by Subject|1|||
161001998|NCT00854906|581393056|FG000|Overall Study|One person had no ocular history|1|||
160584649|NCT03591146|579859653|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
160584650|NCT03591146|579859649|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
160584651|NCT03591146|579859650|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
160584652|NCT03591146|579859651|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
160584653|NCT03591146|579859652|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
160584654|NCT03591146|579859653|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
160584655|NCT04369430|579859654|FG000|Overall Study|Adverse Event|2|||
160584656|NCT04369430|579859655|FG001|Overall Study|Adverse Event|3|||
160584657|NCT04369430|579859654|FG000|Overall Study|Death|1|||
160584658|NCT04369430|579859655|FG001|Overall Study|Death|0|||
160584659|NCT04369430|579859654|FG000|Overall Study|Withdrawal by Subject|4|||
160584660|NCT04369430|579859655|FG001|Overall Study|Withdrawal by Subject|3|||
160584661|NCT04369430|579859654|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
160584662|NCT04369430|579859655|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
160584663|NCT04369430|579859654|FG000|Overall Study|Lost to Follow-up|0|||
160584664|NCT04369430|579859655|FG001|Overall Study|Lost to Follow-up|1|||
160584665|NCT04737031|579859656|FG000|Overall Study|Patients who did not have a treatment visit|0|||
160584666|NCT04737031|579859657|FG001|Overall Study|Patients who did not have a treatment visit|31|||
160584667|NCT04737031|579859658|FG002|Overall Study|Patients who did not have a treatment visit|93|||
160584668|NCT04737031|579859659|FG003|Overall Study|Patients who did not have a treatment visit|227|||
160584669|NCT03453151|579859662|FG000|Overall Study|Withdrawal by Subject|1|||
161001999|NCT05526248|581393057|FG000|Overall Study|Lost to Follow-up|1|||
161002000|NCT05526248|581393057|FG000|Overall Study|Adverse Event|2|||
161002001|NCT05526248|581393057|FG000|Overall Study|Withdrawal by Subject|1|||
160584670|NCT03453151|579859662|FG000|Overall Study|Physician Decision|3|||
160584671|NCT00142519|579859663|FG000|Overall Study|Not Treated|7|||
160584672|NCT00142519|579859664|FG001|Overall Study|Not Treated|9|||
160584673|NCT00142519|579859663|FG000|Overall Study|Protocol Violation|1|||
160584674|NCT00142519|579859664|FG001|Overall Study|Protocol Violation|0|||
160584675|NCT00142519|579859663|FG000|Overall Study|Withdrawal by Subject|10|||
160584676|NCT00142519|579859664|FG001|Overall Study|Withdrawal by Subject|7|||
160584677|NCT01468909|579859665|FG000|Overall Study|Never Treated|2|||
160584678|NCT01468909|579859666|FG001|Overall Study|Never Treated|2|||
160458180|NCT05464069|579409111|FG001|Overall Study|Protocol Violation|2|||
160656987|NCT05097989|580124502|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
160656988|NCT05097989|580124503|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
160584679|NCT01511419|579859672|FG000|Dose 2|Physician Decision|1|||
160584680|NCT01511419|579859673|FG001|Dose 2|Physician Decision|0|||
160584681|NCT00937768|579859674|FG000|Overall Study|Refused Further Treatment|3|||
160584682|NCT00937768|579859675|FG001|Overall Study|Refused Further Treatment|2|||
160584683|NCT00937768|579859674|FG000|Overall Study|Disease Progression|1|||
160584684|NCT00937768|579859675|FG001|Overall Study|Disease Progression|1|||
161002002|NCT02459899|581393063|FG000|Overall Study|Adverse Event|1|||
161002003|NCT02459899|581393064|FG001|Overall Study|Adverse Event|1|||
161002004|NCT02459899|581393065|FG002|Overall Study|Adverse Event|0|||
160584685|NCT00937768|579859674|FG000|Overall Study|Alternate Treatment|0|||
160584686|NCT00937768|579859675|FG001|Overall Study|Alternate Treatment|1|||
160584687|NCT00937768|579859674|FG000|Overall Study|No Further Funding|4|||
160584688|NCT00937768|579859675|FG001|Overall Study|No Further Funding|4|||
160584689|NCT03229759|579859676|FG000|Overall Study|Screen Failure|30|||
160584690|NCT02669862|579861814|FG000|Overall Study|Lost to Follow-up|0|||
160584691|NCT02669862|579861815|FG001|Overall Study|Lost to Follow-up|2|||
160584692|NCT02669862|579861816|FG002|Overall Study|Lost to Follow-up|1|||
160584693|NCT02669862|579861814|FG000|Overall Study|Withdrawal by Subject|2|||
160959446|NCT00428090|581239735|FG003|Overall Study|Mental status of par. was|0|||
160959447|NCT00428090|581239732|FG000|Overall Study|Worsening of AD|0|||
160959448|NCT00428090|581239733|FG001|Overall Study|Worsening of AD|0|||
160959449|NCT00428090|581239734|FG002|Overall Study|Worsening of AD|1|||
160959450|NCT00428090|581239735|FG003|Overall Study|Worsening of AD|0|||
160959451|NCT00428090|581239732|FG000|Overall Study|Excluded for concerning QTc value|0|||
160959452|NCT00428090|581239733|FG001|Overall Study|Excluded for concerning QTc value|0|||
160959453|NCT00428090|581239734|FG002|Overall Study|Excluded for concerning QTc value|1|||
160959454|NCT00428090|581239735|FG003|Overall Study|Excluded for concerning QTc value|0|||
160959455|NCT00428090|581239732|FG000|Overall Study|Insufficient AD documentation|0|||
160959456|NCT00428090|581239733|FG001|Overall Study|Insufficient AD documentation|0|||
160959457|NCT00428090|581239734|FG002|Overall Study|Insufficient AD documentation|1|||
160959458|NCT00428090|581239735|FG003|Overall Study|Insufficient AD documentation|0|||
160959459|NCT00428090|581239732|FG000|Overall Study|High MMSE scores|0|||
160959460|NCT00428090|581239733|FG001|Overall Study|High MMSE scores|0|||
160959461|NCT00428090|581239734|FG002|Overall Study|High MMSE scores|1|||
160959462|NCT00428090|581239735|FG003|Overall Study|High MMSE scores|0|||
160959463|NCT00428090|581239732|FG000|Overall Study|Deterioration of cognitive status|0|||
160959464|NCT00428090|581239733|FG001|Overall Study|Deterioration of cognitive status|0|||
160959465|NCT00428090|581239734|FG002|Overall Study|Deterioration of cognitive status|1|||
160959466|NCT00428090|581239735|FG003|Overall Study|Deterioration of cognitive status|0|||
160959467|NCT00428090|581239732|FG000|Overall Study|Serious adverse event|0|||
160959468|NCT00428090|581239733|FG001|Overall Study|Serious adverse event|0|||
160959469|NCT00428090|581239734|FG002|Overall Study|Serious adverse event|1|||
160959470|NCT00428090|581239735|FG003|Overall Study|Serious adverse event|0|||
160959471|NCT00428090|581239732|FG000|Overall Study|Excluded for heart insufficiency|0|||
160959472|NCT00428090|581239733|FG001|Overall Study|Excluded for heart insufficiency|0|||
160959473|NCT00428090|581239734|FG002|Overall Study|Excluded for heart insufficiency|1|||
160959474|NCT00428090|581239735|FG003|Overall Study|Excluded for heart insufficiency|0|||
160959475|NCT00428090|581239732|FG000|Overall Study|Raised Creatinine Value|0|||
160959476|NCT00428090|581239733|FG001|Overall Study|Raised Creatinine Value|0|||
160959477|NCT00428090|581239734|FG002|Overall Study|Raised Creatinine Value|0|||
160959478|NCT00428090|581239735|FG003|Overall Study|Raised Creatinine Value|1|||
160959479|NCT03409666|581239736|FG000|Overall Study|Physician Decision|0|||
160959480|NCT03409666|581239737|FG001|Overall Study|Physician Decision|1|||
160959481|NCT03409666|581239736|FG000|Overall Study|Protocol Violation|0|||
160959482|NCT03409666|581239737|FG001|Overall Study|Protocol Violation|3|||
160959483|NCT00512148|581239741|FG000|Primay Study Period|Withdrawal by Subject|1|||
160959484|NCT02623322|581239742|FG000|Overall Study|Lost to Follow-up|2|||
160584694|NCT02669862|579861815|FG001|Overall Study|Withdrawal by Subject|2|||
160959485|NCT02623322|581239743|FG001|Overall Study|Lost to Follow-up|1|||
160959486|NCT02623322|581239744|FG002|Overall Study|Lost to Follow-up|0|||
160959487|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
160959488|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
160959489|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
160959490|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
160959491|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
160959492|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160959493|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
160959494|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
160959495|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
160959496|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
160959497|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
160959498|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
160959499|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Death|6|||
160959500|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Death|3|||
160959501|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Death|0|||
160959502|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Death|1|||
160959503|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Death|1|||
160959504|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Death|0|||
160959505|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
160959506|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
160959507|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
160458181|NCT03442309|579409112|FG000|Overall Study|Lost to Follow-up|1676|||
160959508|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
160584695|NCT02669862|579861816|FG002|Overall Study|Withdrawal by Subject|3|||
160584696|NCT02669862|579861814|FG000|Overall Study|moved|0|||
160584697|NCT02669862|579861815|FG001|Overall Study|moved|1|||
160584698|NCT02669862|579861816|FG002|Overall Study|moved|0|||
160959509|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
160959510|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
160959511|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
160959512|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
160959513|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
160959514|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
160959515|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
160959516|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
160959517|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
160959518|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
160959519|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
160959520|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
160959521|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
160959522|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
160959523|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
160959524|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
160959525|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
160959526|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
160959527|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
160959528|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
160959529|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
160959530|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
160959531|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
160959532|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
160959533|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
160959534|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
160959535|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160959536|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160959537|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160959538|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160959539|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160959540|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
160959541|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Death|0|||
160959542|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Death|0|||
160959543|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Death|0|||
160959544|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Death|0|||
160959545|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Death|0|||
160959546|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Death|107|||
160959547|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
160959548|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
160959549|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
160959550|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
160959551|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
160959552|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
160959553|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
160959554|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
160959555|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
160959556|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
160959557|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
160959558|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
160959559|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160959560|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160959561|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160959562|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160959563|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160959564|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
160959565|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
160959566|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
160959567|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
160959568|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
160959569|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
160959570|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
160959571|NCT02450331|581239754|FG000|Overall Study|Death|162|||
160959572|NCT02450331|581239755|FG001|Overall Study|Death|171|||
160959573|NCT02450331|581239754|FG000|Overall Study|Lost to Follow-up|14|||
160959574|NCT02450331|581239755|FG001|Overall Study|Lost to Follow-up|12|||
160959575|NCT02450331|581239754|FG000|Overall Study|Withdrawal by Subject|55|||
160959576|NCT02450331|581239755|FG001|Overall Study|Withdrawal by Subject|44|||
160959577|NCT02450331|581239754|FG000|Overall Study|Non-specified other|1|||
160959578|NCT02450331|581239755|FG001|Overall Study|Non-specified other|1|||
160959579|NCT02080871|581239756|FG000|Overall Study|Death|1|||
160584699|NCT02669862|579861814|FG000|Overall Study|Protocol Violation|0|||
160584700|NCT02669862|579861815|FG001|Overall Study|Protocol Violation|0|||
160584701|NCT02669862|579861816|FG002|Overall Study|Protocol Violation|1|||
160584702|NCT00762372|579861817|FG000|Overall Study|Adverse Event|1|||
160959580|NCT02080871|581239756|FG000|Overall Study|Lost to Follow-up|1|||
160959581|NCT01410474|581239757|FG000|Overall Study|Withdrawal by Subject|0|||
160584703|NCT00762372|579861818|FG001|Overall Study|Adverse Event|0|||
160959582|NCT01410474|581239758|FG001|Overall Study|Withdrawal by Subject|1|||
160959583|NCT02428296|581239759|FG000|Overall Study|Adverse Event|7|||
160959584|NCT02428296|581239759|FG000|Overall Study|Withdrawal by Subject|2|||
160959585|NCT04493931|581239764|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
160959586|NCT04493931|581239765|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959587|NCT04493931|581239766|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959588|NCT04493931|581239767|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959589|NCT04493931|581239768|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959590|NCT04493931|581239769|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959591|NCT04493931|581239770|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959592|NCT04493931|581239764|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959593|NCT04493931|581239765|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
160959594|NCT04493931|581239766|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959595|NCT04493931|581239767|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959596|NCT04493931|581239768|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959597|NCT04493931|581239769|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959598|NCT04493931|581239770|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959599|NCT04493931|581239764|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959600|NCT04493931|581239765|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
160959601|NCT04493931|581239766|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959602|NCT04493931|581239767|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959603|NCT04493931|581239768|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959604|NCT04493931|581239769|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959605|NCT04493931|581239770|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959606|NCT04493931|581239764|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959607|NCT04493931|581239765|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959608|NCT04493931|581239766|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
160959609|NCT04493931|581239767|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959610|NCT04493931|581239768|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959611|NCT04493931|581239769|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959612|NCT04493931|581239770|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959613|NCT03338894|581239771|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
160959614|NCT00420199|581239773|FG000|Overall Study|Participant no longer met study criteria|1|||
160959615|NCT00420199|581239774|FG001|Overall Study|Participant no longer met study criteria|0|||
160959616|NCT00254982|581239785|FG000|Overall Study|Other|2|||
160959617|NCT00254982|581239786|FG001|Overall Study|Other|1|||
160959618|NCT00254982|581239785|FG000|Overall Study|Lack of Efficacy|5|||
160959619|NCT00254982|581239786|FG001|Overall Study|Lack of Efficacy|3|||
160959620|NCT00254982|581239785|FG000|Overall Study|Lost to Follow-up|5|||
160959621|NCT00254982|581239786|FG001|Overall Study|Lost to Follow-up|3|||
160959622|NCT00254982|581239785|FG000|Overall Study|Adverse Event|18|||
160959623|NCT00254982|581239786|FG001|Overall Study|Adverse Event|16|||
160959624|NCT00254982|581239785|FG000|Overall Study|Withdrawal by Subject|1|||
160959625|NCT00254982|581239786|FG001|Overall Study|Withdrawal by Subject|1|||
160959626|NCT00254982|581239785|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
160959627|NCT00254982|581239786|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
160959628|NCT00254982|581239785|FG000|Overall Study|Protocol deviation|1|||
160959629|NCT00254982|581239786|FG001|Overall Study|Protocol deviation|1|||
160959630|NCT00254982|581239785|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
160959631|NCT00254982|581239786|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
160959632|NCT00254982|581239785|FG000|Overall Study|Malignancy|0|||
160959633|NCT00254982|581239786|FG001|Overall Study|Malignancy|2|||
160959634|NCT00254982|581239785|FG000|Overall Study|Opportunistic infection|1|||
160959635|NCT00254982|581239786|FG001|Overall Study|Opportunistic infection|0|||
160959636|NCT00254982|581239785|FG000|Overall Study|Abnormal liver function tests|2|||
160959637|NCT00254982|581239786|FG001|Overall Study|Abnormal liver function tests|1|||
160584704|NCT00762372|579861819|FG002|Overall Study|Adverse Event|0|||
160584705|NCT02616185|579861820|FG000|Overall Study|Death|0|||
160584706|NCT02616185|579861821|FG001|Overall Study|Death|0|||
160584707|NCT02616185|579861822|FG002|Overall Study|Death|0|||
160584708|NCT02616185|579861823|FG003|Overall Study|Death|1|||
160584709|NCT02616185|579861824|FG004|Overall Study|Death|2|||
160584710|NCT02616185|579861825|FG005|Overall Study|Death|0|||
160584711|NCT02616185|579861826|FG006|Overall Study|Death|0|||
160959638|NCT02261493|581239787|FG000|Overall Study|Noncompliance|0|||
160959639|NCT02261493|581239788|FG001|Overall Study|Noncompliance|0|||
160959640|NCT02261493|581239789|FG002|Overall Study|Noncompliance|2|||
160959641|NCT02261493|581239787|FG000|Overall Study|Physician Decision|0|||
160584712|NCT02616185|579861827|FG007|Overall Study|Death|2|||
160584713|NCT02616185|579861828|FG008|Overall Study|Death|1|||
160584714|NCT02616185|579861820|FG000|Overall Study|Study terminated by sponsor|0|||
160584715|NCT02616185|579861821|FG001|Overall Study|Study terminated by sponsor|0|||
160584716|NCT02616185|579861822|FG002|Overall Study|Study terminated by sponsor|1|||
160584717|NCT02616185|579861823|FG003|Overall Study|Study terminated by sponsor|0|||
160584718|NCT02616185|579861824|FG004|Overall Study|Study terminated by sponsor|0|||
160584719|NCT02616185|579861825|FG005|Overall Study|Study terminated by sponsor|0|||
160584720|NCT02616185|579861826|FG006|Overall Study|Study terminated by sponsor|5|||
160584721|NCT02616185|579861827|FG007|Overall Study|Study terminated by sponsor|2|||
160584722|NCT02616185|579861828|FG008|Overall Study|Study terminated by sponsor|0|||
160584723|NCT02616185|579861820|FG000|Overall Study|Participant refused further follow-up|1|||
160584724|NCT02616185|579861821|FG001|Overall Study|Participant refused further follow-up|1|||
160584725|NCT02616185|579861822|FG002|Overall Study|Participant refused further follow-up|2|||
160584726|NCT02616185|579861823|FG003|Overall Study|Participant refused further follow-up|3|||
160584727|NCT02616185|579861824|FG004|Overall Study|Participant refused further follow-up|4|||
160584728|NCT02616185|579861825|FG005|Overall Study|Participant refused further follow-up|0|||
160584729|NCT02616185|579861826|FG006|Overall Study|Participant refused further follow-up|3|||
160584730|NCT02616185|579861827|FG007|Overall Study|Participant refused further follow-up|4|||
160584731|NCT02616185|579861828|FG008|Overall Study|Participant refused further follow-up|3|||
160584732|NCT02616185|579861820|FG000|Overall Study|Not reported|0|||
160584733|NCT02616185|579861821|FG001|Overall Study|Not reported|0|||
160584734|NCT02616185|579861822|FG002|Overall Study|Not reported|0|||
160584735|NCT02616185|579861823|FG003|Overall Study|Not reported|1|||
160584736|NCT02616185|579861824|FG004|Overall Study|Not reported|3|||
160584737|NCT02616185|579861825|FG005|Overall Study|Not reported|1|||
160584738|NCT02616185|579861826|FG006|Overall Study|Not reported|0|||
160584739|NCT02616185|579861827|FG007|Overall Study|Not reported|5|||
160584740|NCT02616185|579861828|FG008|Overall Study|Not reported|2|||
160584741|NCT01303380|579861829|FG000|Overall Study|Lack of compliance to study procedures|1|||
160584742|NCT00487084|579861830|FG000|Overall Study|Did not receive intervention|4|||
160584743|NCT00487084|579861831|FG001|Overall Study|Did not receive intervention|3|||
160584744|NCT00487084|579861832|FG002|Overall Study|Did not receive intervention|5|||
160584745|NCT01369849|579861833|FG000|Overall Study|Ineligible prior to treatment|0|||
160584746|NCT01369849|579861834|FG001|Overall Study|Ineligible prior to treatment|0|||
160584747|NCT01369849|579861835|FG002|Overall Study|Ineligible prior to treatment|1|||
160584748|NCT01369849|579861833|FG000|Overall Study|Ineligible after receiving treatment|0|||
160584749|NCT01369849|579861834|FG001|Overall Study|Ineligible after receiving treatment|1|||
160584750|NCT01369849|579861835|FG002|Overall Study|Ineligible after receiving treatment|0|||
160584751|NCT00871377|579861836|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
160584752|NCT00871377|579861837|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
160584753|NCT00871377|579861838|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
160584754|NCT00871377|579861839|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
160584755|NCT00871377|579861840|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
160584756|NCT00871377|579861841|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
160584757|NCT00871377|579861836|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
160584758|NCT00871377|579861837|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
160584759|NCT00871377|579861838|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
160584760|NCT00871377|579861839|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
160584761|NCT00871377|579861840|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
160584762|NCT00871377|579861841|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
160584763|NCT00871377|579861836|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
160584764|NCT00871377|579861837|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
160584765|NCT00871377|579861838|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
160584766|NCT00871377|579861839|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
160584767|NCT00871377|579861840|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
160584768|NCT00871377|579861841|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
160584769|NCT00871377|579861836|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
160584770|NCT00871377|579861837|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
160584771|NCT00871377|579861838|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
160584772|NCT00871377|579861839|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
160584773|NCT00871377|579861840|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
160458182|NCT03442309|579409113|FG001|Overall Study|Lost to Follow-up|1642|||
160584774|NCT00871377|579861841|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
160584775|NCT00871377|579861836|FG000|Third Intervention (10 Weeks)|Death|0|||
160959642|NCT02261493|581239788|FG001|Overall Study|Physician Decision|1|||
160584776|NCT00871377|579861837|FG001|Third Intervention (10 Weeks)|Death|0|||
160584777|NCT00871377|579861838|FG002|Third Intervention (10 Weeks)|Death|0|||
160959643|NCT02261493|581239789|FG002|Overall Study|Physician Decision|0|||
160584778|NCT00871377|579861839|FG003|Third Intervention (10 Weeks)|Death|1|||
160584779|NCT00871377|579861840|FG004|Third Intervention (10 Weeks)|Death|0|||
160584780|NCT00871377|579861841|FG005|Third Intervention (10 Weeks)|Death|0|||
160584781|NCT00288860|579861846|FG000|Overall Study|Did not complete intake|4|||
160584782|NCT00288860|579861847|FG001|Overall Study|Did not complete intake|8|||
160584783|NCT00288860|579861846|FG000|Overall Study|Death|4|||
160584784|NCT00288860|579861847|FG001|Overall Study|Death|3|||
160584785|NCT00288860|579861846|FG000|Overall Study|Withdrawal by Subject|20|||
160584786|NCT00288860|579861847|FG001|Overall Study|Withdrawal by Subject|15|||
160584787|NCT00288860|579861846|FG000|Overall Study|Lost to Follow-up|74|||
160584788|NCT00288860|579861847|FG001|Overall Study|Lost to Follow-up|71|||
160584789|NCT05142332|579861848|FG000|Overall Study|Withdrawal by Subject|0|||
160584790|NCT05142332|579861849|FG001|Overall Study|Withdrawal by Subject|1|||
160584791|NCT05142332|579861850|FG002|Overall Study|Withdrawal by Subject|2|||
160584792|NCT05142332|579861851|FG003|Overall Study|Withdrawal by Subject|0|||
160584793|NCT05142332|579861852|FG004|Overall Study|Withdrawal by Subject|0|||
160584794|NCT05142332|579861853|FG005|Overall Study|Withdrawal by Subject|2|||
160584795|NCT05142332|579861854|FG006|Overall Study|Withdrawal by Subject|6|||
160584796|NCT05142332|579861848|FG000|Overall Study|Left ED|3|||
160584797|NCT05142332|579861849|FG001|Overall Study|Left ED|0|||
160584798|NCT05142332|579861850|FG002|Overall Study|Left ED|4|||
160584799|NCT05142332|579861851|FG003|Overall Study|Left ED|6|||
160584800|NCT05142332|579861852|FG004|Overall Study|Left ED|1|||
160584801|NCT05142332|579861853|FG005|Overall Study|Left ED|2|||
160584802|NCT05142332|579861854|FG006|Overall Study|Left ED|6|||
160584803|NCT05142332|579861848|FG000|Overall Study|Physician Decision|0|||
160584804|NCT05142332|579861849|FG001|Overall Study|Physician Decision|0|||
160584805|NCT05142332|579861850|FG002|Overall Study|Physician Decision|2|||
160584806|NCT05142332|579861851|FG003|Overall Study|Physician Decision|1|||
160584807|NCT05142332|579861852|FG004|Overall Study|Physician Decision|0|||
160584808|NCT05142332|579861853|FG005|Overall Study|Physician Decision|0|||
160584809|NCT05142332|579861854|FG006|Overall Study|Physician Decision|3|||
160584810|NCT05142332|579861848|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
160584811|NCT05142332|579861849|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
160584812|NCT05142332|579861850|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
160584813|NCT05142332|579861851|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
160584814|NCT05142332|579861852|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
160584815|NCT05142332|579861853|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
160584816|NCT05142332|579861854|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
160584817|NCT00937560|579861860|FG000|Initial Treatment|Death|6|||
160584818|NCT00937560|579861860|FG000|Initial Treatment|Withdraw consent|3|||
160584819|NCT00937560|579861860|FG000|Initial Treatment|Adverse Event|1|||
160584820|NCT00937560|579861860|FG000|Initial Treatment|Lost to Follow-up|1|||
160584821|NCT00937560|579861860|FG000|Initial Treatment|No end of study page|10|||
160584822|NCT00937560|579861860|FG000|Maintenance Treatment|Death|12|||
160584823|NCT00937560|579861860|FG000|Maintenance Treatment|Withdraw consent|5|||
160584824|NCT00937560|579861860|FG000|Maintenance Treatment|According to protocol|1|||
160584825|NCT00411788|579861861|FG000|Overall Study|Protocol Violation|1|||
160584826|NCT00411788|579861861|FG000|Overall Study|Adverse Event|1|||
160584827|NCT00848549|579861862|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
160584828|NCT00848549|579861863|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
160584829|NCT00848549|579861862|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
160584830|NCT00848549|579861863|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
160584831|NCT00848549|579861862|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
160584832|NCT00848549|579861863|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
160584833|NCT00848549|579861862|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
160584834|NCT00848549|579861863|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
160584835|NCT00848549|579861862|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
160959644|NCT02261493|581239787|FG000|Overall Study|Undisclosed alcohol abuse|0|||
160959645|NCT02261493|581239788|FG001|Overall Study|Undisclosed alcohol abuse|1|||
160959646|NCT02261493|581239789|FG002|Overall Study|Undisclosed alcohol abuse|0|||
160959647|NCT02261493|581239787|FG000|Overall Study|Protocol Violation|1|||
160584836|NCT00848549|579861863|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
160584837|NCT00848549|579861862|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
160584838|NCT00848549|579861863|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
160584839|NCT00848549|579861862|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
160584840|NCT00848549|579861863|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
160584841|NCT00848549|579861862|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
160584842|NCT00848549|579861863|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
160584843|NCT00848549|579861862|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
160584844|NCT00848549|579861863|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
160584845|NCT00848549|579861862|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
160584846|NCT00848549|579861863|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
160584847|NCT00848549|579861862|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
160584848|NCT00848549|579861863|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
160584849|NCT00848549|579861862|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
160584850|NCT00848549|579861863|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
160584851|NCT00848549|579861862|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
160584852|NCT00848549|579861863|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
160584853|NCT00848549|579861862|FG000|E2090-E044-314 (Extension Study)|Other|5|||
160584854|NCT00848549|579861863|FG001|E2090-E044-314 (Extension Study)|Other|6|||
160584855|NCT02561299|579861864|FG000|Overall Study|Death|2|||
160584856|NCT02561299|579861865|FG001|Overall Study|Death|4|||
160584857|NCT02561299|579861864|FG000|Overall Study|Lost to Follow-up|1|||
160584858|NCT02561299|579861865|FG001|Overall Study|Lost to Follow-up|0|||
160584859|NCT02561299|579861864|FG000|Overall Study|Withdrawal by Subject|2|||
160584860|NCT02561299|579861865|FG001|Overall Study|Withdrawal by Subject|2|||
160584861|NCT05631548|579861866|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
160584862|NCT05631548|579861867|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
160584863|NCT01219959|579861868|FG000|Overall Study|Adverse Event|6|||
160584864|NCT01219959|579861869|FG001|Overall Study|Adverse Event|14|||
160584865|NCT01219959|579861868|FG000|Overall Study|Physician Decision|0|||
160959648|NCT02261493|581239788|FG001|Overall Study|Protocol Violation|0|||
160959649|NCT02261493|581239789|FG002|Overall Study|Protocol Violation|0|||
160959650|NCT02261493|581239787|FG000|Overall Study|Personal Reasons|14|||
160959651|NCT02261493|581239788|FG001|Overall Study|Personal Reasons|14|||
160959652|NCT02261493|581239789|FG002|Overall Study|Personal Reasons|16|||
160959653|NCT02261493|581239787|FG000|Overall Study|Lost to Follow-up|14|||
160959654|NCT02261493|581239788|FG001|Overall Study|Lost to Follow-up|27|||
160959655|NCT02261493|581239789|FG002|Overall Study|Lost to Follow-up|8|||
160959656|NCT02261493|581239787|FG000|Overall Study|Pregnancy|1|||
160959657|NCT02261493|581239788|FG001|Overall Study|Pregnancy|2|||
160959658|NCT02261493|581239789|FG002|Overall Study|Pregnancy|0|||
160959659|NCT02261493|581239787|FG000|Overall Study|Lack of Efficacy|0|||
160959660|NCT02261493|581239788|FG001|Overall Study|Lack of Efficacy|1|||
160959661|NCT02261493|581239789|FG002|Overall Study|Lack of Efficacy|0|||
160959662|NCT02261493|581239787|FG000|Overall Study|Adverse Event|0|||
160959663|NCT02261493|581239788|FG001|Overall Study|Adverse Event|1|||
160959664|NCT02261493|581239789|FG002|Overall Study|Adverse Event|0|||
160959665|NCT00558428|581239790|FG000|Overall Study|Adverse Event|6|||
160959666|NCT00558428|581239791|FG001|Overall Study|Adverse Event|22|||
160959667|NCT00558428|581239792|FG002|Overall Study|Adverse Event|3|||
160959668|NCT00558428|581239793|FG003|Overall Study|Adverse Event|4|||
160959669|NCT00558428|581239790|FG000|Overall Study|Lost to Follow-up|0|||
160959670|NCT00558428|581239791|FG001|Overall Study|Lost to Follow-up|1|||
160959671|NCT00558428|581239792|FG002|Overall Study|Lost to Follow-up|0|||
160959672|NCT00558428|581239793|FG003|Overall Study|Lost to Follow-up|0|||
160959673|NCT00558428|581239790|FG000|Overall Study|Lack of Efficacy|0|||
160959674|NCT00558428|581239791|FG001|Overall Study|Lack of Efficacy|0|||
160959675|NCT00558428|581239792|FG002|Overall Study|Lack of Efficacy|1|||
160959676|NCT00558428|581239793|FG003|Overall Study|Lack of Efficacy|2|||
160959677|NCT00558428|581239790|FG000|Overall Study|Non compliant with protocol|1|||
160959678|NCT00558428|581239791|FG001|Overall Study|Non compliant with protocol|0|||
160959679|NCT00558428|581239792|FG002|Overall Study|Non compliant with protocol|0|||
160959680|NCT00558428|581239793|FG003|Overall Study|Non compliant with protocol|3|||
160959681|NCT00558428|581239790|FG000|Overall Study|Consent withdrawn|2|||
160959682|NCT00558428|581239791|FG001|Overall Study|Consent withdrawn|1|||
160959683|NCT00558428|581239792|FG002|Overall Study|Consent withdrawn|0|||
160959684|NCT00558428|581239793|FG003|Overall Study|Consent withdrawn|1|||
160959685|NCT00558428|581239790|FG000|Overall Study|Other|3|||
160959686|NCT00558428|581239791|FG001|Overall Study|Other|0|||
160959687|NCT00558428|581239792|FG002|Overall Study|Other|0|||
160959688|NCT00558428|581239793|FG003|Overall Study|Other|1|||
160959689|NCT02570126|581239794|FG000|Overall Study|Lost to Follow-up|2|||
160959690|NCT02570126|581239795|FG001|Overall Study|Lost to Follow-up|0|||
160959691|NCT02570126|581239794|FG000|Overall Study|Unable To Arrange Visit 3|1|||
160458183|NCT06106022|579409116|FG000|Overall Study|Lost to Follow-up|1|||
160458184|NCT06106022|579409117|FG001|Overall Study|Lost to Follow-up|0|||
160959692|NCT02570126|581239795|FG001|Overall Study|Unable To Arrange Visit 3|0|||
160458185|NCT06106022|579409116|FG000|Overall Study|Voluntary Withdrawal|0|||
160584866|NCT01219959|579861869|FG001|Overall Study|Physician Decision|4|||
160584867|NCT01219959|579861868|FG000|Overall Study|Withdrawal by Subject|0|||
160584868|NCT01219959|579861869|FG001|Overall Study|Withdrawal by Subject|2|||
160584869|NCT01219959|579861868|FG000|Overall Study|Renal Transplantation|0|||
160959693|NCT02570126|581239794|FG000|Overall Study|Violation Of Procedures GSK|0|||
160959694|NCT02570126|581239795|FG001|Overall Study|Violation Of Procedures GSK|1|||
160959695|NCT02570126|581239794|FG000|Overall Study|Protocol Violation|0|||
160959696|NCT02570126|581239795|FG001|Overall Study|Protocol Violation|1|||
160959697|NCT02570126|581239794|FG000|Overall Study|Withdrawal by Subject|3|||
160959698|NCT02570126|581239795|FG001|Overall Study|Withdrawal by Subject|7|||
160959699|NCT00626028|581239796|FG000|Overall Study|Adverse Event|1|||
160959700|NCT00626028|581239797|FG001|Overall Study|Adverse Event|1|||
160959701|NCT00626028|581239796|FG000|Overall Study|Device Failure|0|||
160959702|NCT00626028|581239797|FG001|Overall Study|Device Failure|1|||
160959703|NCT00626028|581239796|FG000|Overall Study|Physician Decision|2|||
160959704|NCT00626028|581239797|FG001|Overall Study|Physician Decision|1|||
160959705|NCT00626028|581239796|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
160959706|NCT00626028|581239797|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
160959707|NCT05224050|581239798|FG000|Overall Study|Withdrawal by Subject|9|||
160959708|NCT05224050|581239798|FG000|Overall Study|Lost to Follow-up|3|||
160959709|NCT00917579|581239800|FG000|Washout >= 2 Weeks|Adverse Event|1|||
160959710|NCT00917579|581239801|FG001|Washout >= 2 Weeks|Adverse Event|0|||
160959711|NCT00917579|581239800|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
160959712|NCT00917579|581239801|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
160959713|NCT00754338|581239802|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
160959714|NCT00754338|581239803|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
160959715|NCT00754338|581239804|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
160959716|NCT00754338|581239805|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
160959717|NCT00754338|581239802|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
160959718|NCT00754338|581239803|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
160959719|NCT00754338|581239804|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
160959720|NCT00754338|581239805|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
160959721|NCT00831779|581239808|FG000|Overall Study|Lost to Follow-up|1|||
160959722|NCT00831779|581239809|FG001|Overall Study|Lost to Follow-up|0|||
160959723|NCT00831779|581239808|FG000|Overall Study|No longer met criteria|0|||
160959724|NCT00831779|581239809|FG001|Overall Study|No longer met criteria|1|||
160959725|NCT04020341|581239810|FG000|Overall Study|Adverse Event|8|||
160959726|NCT04020341|581239811|FG001|Overall Study|Adverse Event|6|||
160959727|NCT04020341|581239810|FG000|Overall Study|Lost to Follow-up|8|||
160959728|NCT04020341|581239811|FG001|Overall Study|Lost to Follow-up|2|||
160959729|NCT04020341|581239810|FG000|Overall Study|Withdrawal by Subject|16|||
160959730|NCT04020341|581239811|FG001|Overall Study|Withdrawal by Subject|16|||
160959731|NCT04020341|581239810|FG000|Overall Study|Participant not able to swallow the tablet|1|||
160959732|NCT04020341|581239811|FG001|Overall Study|Participant not able to swallow the tablet|0|||
160959733|NCT04020341|581239810|FG000|Overall Study|Physician Decision|0|||
160959734|NCT04020341|581239811|FG001|Overall Study|Physician Decision|2|||
160959735|NCT04020341|581239810|FG000|Overall Study|Protocol Deviation|0|||
160959736|NCT04020341|581239811|FG001|Overall Study|Protocol Deviation|2|||
160959737|NCT04528069|581239812|FG000|Overall Study|Adverse Event|1|||
160959738|NCT04528069|581239812|FG000|Overall Study|Lost to Follow-up|1|||
160959739|NCT04528069|581239812|FG000|Overall Study|Patient Unable to Come|1|||
160959740|NCT04528069|581239812|FG000|Overall Study|Patient Unable to Attend|1|||
160959741|NCT01814371|581239814|FG000|Overall Study|Lost to Follow-up|30|||
160959742|NCT01814371|581239815|FG001|Overall Study|Lost to Follow-up|27|||
160959743|NCT04683926|581239816|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
160959744|NCT04683926|581239817|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
160959745|NCT04683926|581239818|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
160959746|NCT04683926|581239819|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
160959747|NCT01692782|581239821|FG000|Overall Study|Adverse Event|12|||
160959748|NCT01692782|581239822|FG001|Overall Study|Adverse Event|32|||
160959749|NCT01692782|581239823|FG002|Overall Study|Adverse Event|2|||
160959750|NCT01692782|581239821|FG000|Overall Study|Lack of Efficacy|1|||
160959751|NCT01692782|581239822|FG001|Overall Study|Lack of Efficacy|2|||
160959752|NCT01692782|581239823|FG002|Overall Study|Lack of Efficacy|0|||
160959753|NCT01692782|581239821|FG000|Overall Study|Lost to Follow-up|2|||
160959754|NCT01692782|581239822|FG001|Overall Study|Lost to Follow-up|7|||
160959755|NCT01692782|581239823|FG002|Overall Study|Lost to Follow-up|1|||
160959756|NCT01692782|581239821|FG000|Overall Study|Pregnancy|1|||
160959757|NCT01692782|581239822|FG001|Overall Study|Pregnancy|0|||
160959758|NCT01692782|581239823|FG002|Overall Study|Pregnancy|0|||
160959759|NCT01692782|581239821|FG000|Overall Study|Protocol Violation|1|||
160959760|NCT01692782|581239822|FG001|Overall Study|Protocol Violation|0|||
160959761|NCT01692782|581239823|FG002|Overall Study|Protocol Violation|2|||
160959762|NCT01692782|581239821|FG000|Overall Study|Non-complance with study drug|0|||
160959763|NCT01692782|581239822|FG001|Overall Study|Non-complance with study drug|4|||
160959764|NCT01692782|581239823|FG002|Overall Study|Non-complance with study drug|1|||
160959765|NCT01692782|581239821|FG000|Overall Study|Non-compliant with study visits|0|||
160959766|NCT01692782|581239822|FG001|Overall Study|Non-compliant with study visits|0|||
160959767|NCT01692782|581239823|FG002|Overall Study|Non-compliant with study visits|1|||
160959768|NCT01692782|581239821|FG000|Overall Study|SAE not related to study drug|0|||
160959769|NCT01692782|581239822|FG001|Overall Study|SAE not related to study drug|1|||
160959770|NCT01692782|581239823|FG002|Overall Study|SAE not related to study drug|0|||
160959771|NCT01692782|581239821|FG000|Overall Study|Withdrawal by Subject|3|||
160959772|NCT01692782|581239822|FG001|Overall Study|Withdrawal by Subject|10|||
160959773|NCT01692782|581239823|FG002|Overall Study|Withdrawal by Subject|3|||
160959774|NCT00911534|581239832|FG000|Overall Study|Adverse Event|4|||
160959775|NCT00911534|581239833|FG001|Overall Study|Adverse Event|4|||
160959776|NCT00911534|581239832|FG000|Overall Study|Lost to Follow-up|2|||
160959777|NCT00911534|581239833|FG001|Overall Study|Lost to Follow-up|4|||
160959778|NCT00911534|581239832|FG000|Overall Study|Withdrawal by Subject|2|||
160959779|NCT00911534|581239833|FG001|Overall Study|Withdrawal by Subject|1|||
160959780|NCT00911534|581239832|FG000|Overall Study|Lack of Efficacy|4|||
160959781|NCT00911534|581239833|FG001|Overall Study|Lack of Efficacy|1|||
160959782|NCT00911534|581239832|FG000|Overall Study|Withdrawal of consent|1|||
160959783|NCT00911534|581239833|FG001|Overall Study|Withdrawal of consent|4|||
160959784|NCT00911534|581239832|FG000|Overall Study|Other|2|||
160959785|NCT00911534|581239833|FG001|Overall Study|Other|2|||
160959786|NCT05072080|581239837|FG000|Overall Study|Death|0|||
160959787|NCT05072080|581239838|FG001|Overall Study|Death|0|||
160959788|NCT05072080|581239839|FG002|Overall Study|Death|1|||
160959789|NCT05072080|581239840|FG003|Overall Study|Death|0|||
160959790|NCT05072080|581239837|FG000|Overall Study|Lost to Follow-up|65|||
160959791|NCT05072080|581239838|FG001|Overall Study|Lost to Follow-up|70|||
160959792|NCT05072080|581239839|FG002|Overall Study|Lost to Follow-up|58|||
160959793|NCT05072080|581239840|FG003|Overall Study|Lost to Follow-up|23|||
160959794|NCT05072080|581239837|FG000|Overall Study|Physician Decision|2|||
160959795|NCT05072080|581239838|FG001|Overall Study|Physician Decision|1|||
160959796|NCT05072080|581239839|FG002|Overall Study|Physician Decision|1|||
160959797|NCT05072080|581239840|FG003|Overall Study|Physician Decision|0|||
160959798|NCT05072080|581239837|FG000|Overall Study|Withdrawal by Subject|45|||
160959799|NCT05072080|581239838|FG001|Overall Study|Withdrawal by Subject|30|||
160959800|NCT05072080|581239839|FG002|Overall Study|Withdrawal by Subject|27|||
160959801|NCT05072080|581239840|FG003|Overall Study|Withdrawal by Subject|7|||
160959802|NCT05072080|581239837|FG000|Overall Study|Sponsor Decision|0|||
160959803|NCT05072080|581239838|FG001|Overall Study|Sponsor Decision|1|||
160959804|NCT05072080|581239839|FG002|Overall Study|Sponsor Decision|0|||
160959805|NCT05072080|581239840|FG003|Overall Study|Sponsor Decision|0|||
160959806|NCT05072080|581239837|FG000|Overall Study|Subject moved|1|||
160959807|NCT05072080|581239838|FG001|Overall Study|Subject moved|3|||
160959808|NCT05072080|581239839|FG002|Overall Study|Subject moved|5|||
160959809|NCT05072080|581239840|FG003|Overall Study|Subject moved|2|||
160959810|NCT05072080|581239837|FG000|Overall Study|Withdrawal by parent|0|||
160959811|NCT05072080|581239838|FG001|Overall Study|Withdrawal by parent|0|||
160959812|NCT05072080|581239839|FG002|Overall Study|Withdrawal by parent|1|||
160959813|NCT05072080|581239840|FG003|Overall Study|Withdrawal by parent|0|||
160959814|NCT05072080|581239837|FG000|Overall Study|Subject was deployed|0|||
160959815|NCT05072080|581239838|FG001|Overall Study|Subject was deployed|1|||
160959816|NCT05072080|581239839|FG002|Overall Study|Subject was deployed|0|||
160959817|NCT05072080|581239840|FG003|Overall Study|Subject was deployed|0|||
160959818|NCT05072080|581239837|FG000|Overall Study|Subject left site without receiving dose|0|||
160959819|NCT05072080|581239838|FG001|Overall Study|Subject left site without receiving dose|1|||
160959820|NCT05072080|581239839|FG002|Overall Study|Subject left site without receiving dose|0|||
160959821|NCT05072080|581239840|FG003|Overall Study|Subject left site without receiving dose|0|||
160959822|NCT05072080|581239837|FG000|Overall Study|Subject incarcerated|0|||
160959823|NCT05072080|581239838|FG001|Overall Study|Subject incarcerated|1|||
160959824|NCT05072080|581239839|FG002|Overall Study|Subject incarcerated|0|||
160959825|NCT05072080|581239840|FG003|Overall Study|Subject incarcerated|1|||
160959826|NCT05072080|581239837|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
160959827|NCT05072080|581239838|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
160959828|NCT05072080|581239839|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
160959829|NCT05072080|581239840|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
160959830|NCT05072080|581239837|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
160959831|NCT05072080|581239838|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
160959832|NCT05072080|581239839|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
160959833|NCT05072080|581239840|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
160959834|NCT02747238|581239841|FG000|Overall Study|Lack of Efficacy|0|||
160959835|NCT02747238|581239842|FG001|Overall Study|Lack of Efficacy|1|||
160959836|NCT02747238|581239841|FG000|Overall Study|Data lost|3|||
160959837|NCT02747238|581239842|FG001|Overall Study|Data lost|5|||
160959838|NCT03776136|581239844|FG000|Overall Study|Death|85|||
160959839|NCT03776136|581239844|FG000|Overall Study|Withdrawal by Subject|3|||
160959840|NCT03776136|581239844|FG000|Overall Study|Sponsor Decision|15|||
160959841|NCT00680407|581239854|FG000|Overall Study|Lost to Follow-up|3|||
160959842|NCT00680407|581239855|FG001|Overall Study|Lost to Follow-up|3|||
160959843|NCT00680407|581239856|FG002|Overall Study|Lost to Follow-up|1|||
160959844|NCT00680407|581239854|FG000|Overall Study|Withdrawal by Subject|5|||
160959845|NCT00680407|581239855|FG001|Overall Study|Withdrawal by Subject|2|||
160959846|NCT00680407|581239856|FG002|Overall Study|Withdrawal by Subject|2|||
160959847|NCT01377480|581242131|FG000|Overall Study|Protocol Violation|0|||
160959848|NCT01377480|581242132|FG001|Overall Study|Protocol Violation|0|||
160959849|NCT01377480|581242133|FG002|Overall Study|Protocol Violation|0|||
160959850|NCT01377480|581242134|FG003|Overall Study|Protocol Violation|4|||
160959851|NCT01377480|581242131|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
160959852|NCT01377480|581242132|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
160959853|NCT01377480|581242133|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
160959854|NCT01377480|581242134|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
160959855|NCT01377480|581242131|FG000|Overall Study|Withdrawal by Subject|0|||
160959856|NCT01377480|581242132|FG001|Overall Study|Withdrawal by Subject|0|||
160959857|NCT01377480|581242133|FG002|Overall Study|Withdrawal by Subject|1|||
160959858|NCT01377480|581242134|FG003|Overall Study|Withdrawal by Subject|0|||
160959859|NCT01377480|581242131|FG000|Overall Study|Serious adverse event|0|||
160959860|NCT01377480|581242132|FG001|Overall Study|Serious adverse event|0|||
160959861|NCT01377480|581242133|FG002|Overall Study|Serious adverse event|1|||
160959862|NCT01377480|581242134|FG003|Overall Study|Serious adverse event|1|||
160959863|NCT01377480|581242131|FG000|Overall Study|Other|0|||
160959864|NCT01377480|581242132|FG001|Overall Study|Other|0|||
160959865|NCT01377480|581242133|FG002|Overall Study|Other|7|||
160959866|NCT01377480|581242134|FG003|Overall Study|Other|6|||
160959867|NCT01735201|581242138|FG000|Overall Study|Adverse Event|1|||
160959868|NCT01735201|581242139|FG001|Overall Study|Adverse Event|1|||
160959869|NCT01735201|581242140|FG002|Overall Study|Adverse Event|0|||
160959870|NCT01735201|581242141|FG003|Overall Study|Adverse Event|1|||
160959871|NCT01735201|581242142|FG004|Overall Study|Adverse Event|1|||
160959872|NCT01735201|581242143|FG005|Overall Study|Adverse Event|3|||
160959873|NCT01735201|581242144|FG006|Overall Study|Adverse Event|2|||
160959874|NCT01735201|581242145|FG007|Overall Study|Adverse Event|1|||
160959875|NCT01735201|581242138|FG000|Overall Study|Personal Reasons|1|||
160959876|NCT01735201|581242139|FG001|Overall Study|Personal Reasons|0|||
160959877|NCT01735201|581242140|FG002|Overall Study|Personal Reasons|0|||
160959878|NCT01735201|581242141|FG003|Overall Study|Personal Reasons|0|||
160959879|NCT01735201|581242142|FG004|Overall Study|Personal Reasons|0|||
160959880|NCT01735201|581242143|FG005|Overall Study|Personal Reasons|0|||
160959881|NCT01735201|581242144|FG006|Overall Study|Personal Reasons|0|||
160959882|NCT01735201|581242145|FG007|Overall Study|Personal Reasons|0|||
160959883|NCT01735201|581242138|FG000|Overall Study|Protocol Violation|1|||
160959884|NCT01735201|581242139|FG001|Overall Study|Protocol Violation|0|||
160959885|NCT01735201|581242140|FG002|Overall Study|Protocol Violation|0|||
160959886|NCT01735201|581242141|FG003|Overall Study|Protocol Violation|0|||
160656989|NCT05097989|580124504|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
160656990|NCT05097989|580124496|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160959887|NCT01735201|581242142|FG004|Overall Study|Protocol Violation|0|||
160959888|NCT01735201|581242143|FG005|Overall Study|Protocol Violation|0|||
160959889|NCT01735201|581242144|FG006|Overall Study|Protocol Violation|0|||
160959890|NCT01735201|581242145|FG007|Overall Study|Protocol Violation|0|||
160959891|NCT01735201|581242138|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160959892|NCT01735201|581242139|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160959893|NCT01735201|581242140|FG002|Overall Study|Other Miscellaneous Reasons|0|||
160959894|NCT01735201|581242141|FG003|Overall Study|Other Miscellaneous Reasons|1|||
160959895|NCT01735201|581242142|FG004|Overall Study|Other Miscellaneous Reasons|0|||
160959896|NCT01735201|581242143|FG005|Overall Study|Other Miscellaneous Reasons|2|||
160959897|NCT01735201|581242144|FG006|Overall Study|Other Miscellaneous Reasons|1|||
160959898|NCT01735201|581242145|FG007|Overall Study|Other Miscellaneous Reasons|1|||
160959899|NCT02178059|581242151|FG000|Washout|Physician Decision|1|||
160959900|NCT02178059|581242152|FG001|Washout|Physician Decision|0|||
160959901|NCT04128293|581242153|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
160959902|NCT04128293|581242154|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
160959903|NCT04128293|581242155|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
160959904|NCT04128293|581242156|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
160959905|NCT04098406|581242160|FG000|Overall Study|Adverse Event|2|||
160959906|NCT04098406|581242161|FG001|Overall Study|Adverse Event|1|||
160959907|NCT04098406|581242160|FG000|Overall Study|Withdrawal by Subject|1|||
160959908|NCT04098406|581242161|FG001|Overall Study|Withdrawal by Subject|0|||
160959909|NCT00514943|581242162|FG000|Stage 1|Progressive disease|4|||
160959910|NCT00514943|581242163|FG001|Stage 1|Progressive disease|8|||
160959911|NCT00514943|581242162|FG000|Stage 1|Other Adverse Event|16|||
160656991|NCT05097989|580124497|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
160959912|NCT00514943|581242163|FG001|Stage 1|Other Adverse Event|6|||
160959913|NCT00514943|581242162|FG000|Stage 1|Not treated|1|||
160959914|NCT00514943|581242163|FG001|Stage 1|Not treated|2|||
160959915|NCT00514943|581242162|FG000|Stage 1|Patient refused to continue study meds|8|||
160959916|NCT00514943|581242163|FG001|Stage 1|Patient refused to continue study meds|3|||
160959917|NCT00514943|581242162|FG000|Stage 1|Other than stated above|1|||
160959918|NCT00514943|581242163|FG001|Stage 1|Other than stated above|7|||
160959919|NCT00514943|581242162|FG000|Stage 2|Progressive disease|27|||
160959920|NCT00514943|581242163|FG001|Stage 2|Progressive disease|24|||
160959921|NCT00514943|581242162|FG000|Stage 2|Other Adverse Event|3|||
160959922|NCT00514943|581242163|FG001|Stage 2|Other Adverse Event|10|||
160959923|NCT00514943|581242162|FG000|Stage 2|Patient refused to continue study meds|2|||
160959924|NCT00514943|581242163|FG001|Stage 2|Patient refused to continue study meds|0|||
160959925|NCT00514943|581242162|FG000|Stage 2|Other than stated above|0|||
160959926|NCT00514943|581242163|FG001|Stage 2|Other than stated above|2|||
160959927|NCT00499031|581242164|FG000|Overall Study|Improper pre-protocol treatment|1|||
160959928|NCT00499031|581242164|FG000|Overall Study|Required test not done|1|||
160959929|NCT00499031|581242164|FG000|Overall Study|Never treated|1|||
160959930|NCT02001194|581242166|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
160959931|NCT02001194|581242167|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
160959932|NCT02001194|581242168|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
160959933|NCT02001194|581242169|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
160959934|NCT02001194|581242166|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
160959935|NCT02001194|581242167|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
160959936|NCT02001194|581242168|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
160959937|NCT02001194|581242169|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
160959938|NCT02366910|581242170|FG000|Overall Study|Withdrawal by Subject|2|||
160959939|NCT02366910|581242170|FG000|Overall Study|Screen Failure|3|||
160959940|NCT03284788|581242171|FG000|Overall Study|Withdrawal by Subject|2|||
160959941|NCT01786512|581242172|FG000|Overall Study|Lost to Follow-up|0|||
160959942|NCT01786512|581242173|FG001|Overall Study|Lost to Follow-up|0|||
160959943|NCT01786512|581242174|FG002|Overall Study|Lost to Follow-up|0|||
160959944|NCT01786512|581242175|FG003|Overall Study|Lost to Follow-up|0|||
160959945|NCT01786512|581242176|FG004|Overall Study|Lost to Follow-up|0|||
160959946|NCT01786512|581242177|FG005|Overall Study|Lost to Follow-up|0|||
160959947|NCT01786512|581242178|FG006|Overall Study|Lost to Follow-up|0|||
160959948|NCT01786512|581242179|FG007|Overall Study|Lost to Follow-up|0|||
160959949|NCT01786512|581242180|FG008|Overall Study|Lost to Follow-up|0|||
160959950|NCT01786512|581242181|FG009|Overall Study|Lost to Follow-up|1|||
160959951|NCT01786512|581242182|FG010|Overall Study|Lost to Follow-up|0|||
160959952|NCT01786512|581242172|FG000|Overall Study|Decision by sponsor|0|||
160959953|NCT01786512|581242173|FG001|Overall Study|Decision by sponsor|0|||
160959954|NCT01786512|581242174|FG002|Overall Study|Decision by sponsor|0|||
160959955|NCT01786512|581242175|FG003|Overall Study|Decision by sponsor|0|||
160959956|NCT01786512|581242176|FG004|Overall Study|Decision by sponsor|0|||
160959957|NCT01786512|581242177|FG005|Overall Study|Decision by sponsor|0|||
160959958|NCT01786512|581242178|FG006|Overall Study|Decision by sponsor|0|||
160959959|NCT01786512|581242179|FG007|Overall Study|Decision by sponsor|0|||
160959960|NCT01786512|581242180|FG008|Overall Study|Decision by sponsor|0|||
160959961|NCT01786512|581242181|FG009|Overall Study|Decision by sponsor|0|||
160959962|NCT01786512|581242182|FG010|Overall Study|Decision by sponsor|2|||
160959963|NCT01786512|581242172|FG000|Overall Study|Withdrawal by Subject|0|||
160959964|NCT01786512|581242173|FG001|Overall Study|Withdrawal by Subject|1|||
160959965|NCT01786512|581242174|FG002|Overall Study|Withdrawal by Subject|0|||
160959966|NCT01786512|581242175|FG003|Overall Study|Withdrawal by Subject|0|||
160959967|NCT01786512|581242176|FG004|Overall Study|Withdrawal by Subject|0|||
160959968|NCT01786512|581242177|FG005|Overall Study|Withdrawal by Subject|0|||
160959969|NCT01786512|581242178|FG006|Overall Study|Withdrawal by Subject|1|||
160959970|NCT01786512|581242179|FG007|Overall Study|Withdrawal by Subject|0|||
160959971|NCT01786512|581242180|FG008|Overall Study|Withdrawal by Subject|0|||
160959972|NCT01786512|581242181|FG009|Overall Study|Withdrawal by Subject|3|||
160959973|NCT01786512|581242182|FG010|Overall Study|Withdrawal by Subject|7|||
160959974|NCT01786512|581242172|FG000|Overall Study|Death|0|||
160959975|NCT01786512|581242173|FG001|Overall Study|Death|0|||
160959976|NCT01786512|581242174|FG002|Overall Study|Death|0|||
160959977|NCT01786512|581242175|FG003|Overall Study|Death|0|||
160959978|NCT01786512|581242176|FG004|Overall Study|Death|0|||
160959979|NCT01786512|581242177|FG005|Overall Study|Death|0|||
160959980|NCT01786512|581242178|FG006|Overall Study|Death|0|||
160959981|NCT01786512|581242179|FG007|Overall Study|Death|0|||
160959982|NCT01786512|581242180|FG008|Overall Study|Death|4|||
160959983|NCT01786512|581242181|FG009|Overall Study|Death|1|||
160959984|NCT01786512|581242182|FG010|Overall Study|Death|3|||
160959985|NCT00605293|581242183|FG000|Overall Study|Death|2|||
160959986|NCT00605293|581242184|FG001|Overall Study|Death|1|||
161002005|NCT02459899|581393066|FG003|Overall Study|Adverse Event|0|||
160959987|NCT00605293|581242183|FG000|Overall Study|Insufficient Therapeutic Response|2|||
160959988|NCT00605293|581242184|FG001|Overall Study|Insufficient Therapeutic Response|0|||
160959989|NCT00605293|581242183|FG000|Overall Study|Adverse Event|1|||
160959990|NCT00605293|581242184|FG001|Overall Study|Adverse Event|0|||
160959991|NCT00605293|581242183|FG000|Overall Study|Holidays Dialysis Out|1|||
160959992|NCT00605293|581242184|FG001|Overall Study|Holidays Dialysis Out|0|||
160959993|NCT00605293|581242183|FG000|Overall Study|Blood Transfusion|7|||
160959994|NCT00605293|581242184|FG001|Overall Study|Blood Transfusion|1|||
160959995|NCT00605293|581242183|FG000|Overall Study|Renal Transplantation|3|||
160959996|NCT00605293|581242184|FG001|Overall Study|Renal Transplantation|1|||
160959997|NCT00605293|581242183|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
160959998|NCT00605293|581242184|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
160959999|NCT00605293|581242183|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
160960000|NCT00605293|581242184|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
161002006|NCT02459899|581393063|FG000|Overall Study|Lost to Follow-up|1|||
160960001|NCT00605293|581242183|FG000|Overall Study|Principal Investigator Decision|0|||
160584870|NCT01219959|579861869|FG001|Overall Study|Renal Transplantation|3|||
160584871|NCT01219959|579861868|FG000|Overall Study|Other|1|||
160584872|NCT01219959|579861869|FG001|Overall Study|Other|0|||
160584873|NCT05906732|579861870|FG000|Overall Study|Withdrawal by Subject|1|||
160584874|NCT05906732|579861871|FG001|Overall Study|Withdrawal by Subject|0|||
160584875|NCT05906732|579861872|FG002|Overall Study|Withdrawal by Subject|0|||
160960002|NCT00605293|581242184|FG001|Overall Study|Principal Investigator Decision|1|||
160960003|NCT00234052|581242185|FG000|Treatment|Withdrawal by Subject|3|||
160960004|NCT00234052|581242185|FG000|Treatment|Adverse Event|5|||
160960005|NCT00234052|581242185|FG000|Treatment|Death|2|||
160960006|NCT00234052|581242185|FG000|Treatment|Progressive Disease|11|||
160960007|NCT00234052|581242185|FG000|Follow-up for 5 Years|Death|41|||
160960008|NCT00234052|581242185|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
160960009|NCT00234052|581242185|FG000|Follow-up for 5 Years|Other|7|||
160960010|NCT00952367|581242187|FG000|Overall Study|Withdrawal by Subject|2|||
160960011|NCT00952367|581242187|FG000|Overall Study|Noncoordination|1|||
160960012|NCT00952367|581242187|FG000|Overall Study|Protocol Violation|3|||
160960013|NCT00781391|581242190|FG000|Overall Study|never received study drug|24|||
160960014|NCT00781391|581242191|FG001|Overall Study|never received study drug|23|||
160960015|NCT00781391|581242192|FG002|Overall Study|never received study drug|32|||
160960016|NCT00781391|581242190|FG000|Overall Study|Protocol Violation|19|||
160960017|NCT00781391|581242191|FG001|Overall Study|Protocol Violation|17|||
160960018|NCT00781391|581242192|FG002|Overall Study|Protocol Violation|20|||
160960019|NCT00781391|581242190|FG000|Overall Study|Death|789|||
160960020|NCT00781391|581242191|FG001|Overall Study|Death|730|||
160960021|NCT00781391|581242192|FG002|Overall Study|Death|706|||
160960022|NCT00781391|581242190|FG000|Overall Study|Withdrawal by Subject|47|||
160960023|NCT00781391|581242191|FG001|Overall Study|Withdrawal by Subject|37|||
160960024|NCT00781391|581242192|FG002|Overall Study|Withdrawal by Subject|25|||
160960025|NCT00781391|581242190|FG000|Overall Study|Lost to Follow-up|0|||
160960026|NCT00781391|581242191|FG001|Overall Study|Lost to Follow-up|0|||
160960027|NCT00781391|581242192|FG002|Overall Study|Lost to Follow-up|1|||
160960028|NCT01984684|581242193|FG000|Overall Study|Lost to Follow-up|25|||
160960029|NCT01984684|581242194|FG001|Overall Study|Lost to Follow-up|24|||
160960030|NCT01984684|581242193|FG000|Overall Study|Adverse Event|8|||
160960031|NCT01984684|581242194|FG001|Overall Study|Adverse Event|12|||
160960032|NCT01984684|581242193|FG000|Overall Study|Withdrawal by Subject|9|||
160960033|NCT01984684|581242194|FG001|Overall Study|Withdrawal by Subject|9|||
160960034|NCT01984684|581242193|FG000|Overall Study|Lack of Efficacy|3|||
160960035|NCT01984684|581242194|FG001|Overall Study|Lack of Efficacy|6|||
160960036|NCT01984684|581242193|FG000|Overall Study|Physician Decision|4|||
160960037|NCT01984684|581242194|FG001|Overall Study|Physician Decision|2|||
160960038|NCT01984684|581242193|FG000|Overall Study|Protocol Violation|4|||
160960039|NCT01984684|581242194|FG001|Overall Study|Protocol Violation|2|||
160960040|NCT01984684|581242193|FG000|Overall Study|Death|0|||
160960041|NCT01984684|581242194|FG001|Overall Study|Death|1|||
160960042|NCT01984684|581242193|FG000|Overall Study|Noncompliance with study drug|2|||
160960043|NCT01984684|581242194|FG001|Overall Study|Noncompliance with study drug|1|||
160584876|NCT05906732|579861873|FG003|Overall Study|Withdrawal by Subject|0|||
160584877|NCT05906732|579861870|FG000|Overall Study|Physician Decision|2|||
160584878|NCT05906732|579861871|FG001|Overall Study|Physician Decision|4|||
160584879|NCT05906732|579861872|FG002|Overall Study|Physician Decision|0|||
160584880|NCT05906732|579861873|FG003|Overall Study|Physician Decision|0|||
160960044|NCT01984684|581242193|FG000|Overall Study|Subject incarcerated|1|||
160960045|NCT01984684|581242194|FG001|Overall Study|Subject incarcerated|0|||
160960046|NCT01984684|581242193|FG000|Overall Study|Study drug not available at site|1|||
160960047|NCT01984684|581242194|FG001|Overall Study|Study drug not available at site|1|||
160960048|NCT01984684|581242193|FG000|Overall Study|Subject had inadequate IV access|0|||
160960049|NCT01984684|581242194|FG001|Overall Study|Subject had inadequate IV access|1|||
160960050|NCT03205371|581242204|FG000|Overall Study|Withdrawal by Subject|4|||
160960051|NCT03205371|581242205|FG001|Overall Study|Withdrawal by Subject|1|||
160960052|NCT03205371|581242206|FG002|Overall Study|Withdrawal by Subject|0|||
160960053|NCT03205371|581242207|FG003|Overall Study|Withdrawal by Subject|0|||
160960054|NCT03205371|581242208|FG004|Overall Study|Withdrawal by Subject|0|||
160960055|NCT03205371|581242209|FG005|Overall Study|Withdrawal by Subject|0|||
160960056|NCT03205371|581242210|FG006|Overall Study|Withdrawal by Subject|4|||
160960057|NCT03205371|581242211|FG007|Overall Study|Withdrawal by Subject|0|||
160960058|NCT03205371|581242212|FG008|Overall Study|Withdrawal by Subject|2|||
160960059|NCT03205371|581242213|FG009|Overall Study|Withdrawal by Subject|0|||
160584881|NCT01248130|579861874|FG000|Overall Study|Protocol Violation|1|||
160584882|NCT01248130|579861875|FG001|Overall Study|Protocol Violation|0|||
160960060|NCT03205371|581242214|FG010|Overall Study|Withdrawal by Subject|0|||
160960061|NCT03205371|581242215|FG011|Overall Study|Withdrawal by Subject|1|||
160960062|NCT03205371|581242204|FG000|Overall Study|Lost to Follow-up|0|||
160960063|NCT03205371|581242205|FG001|Overall Study|Lost to Follow-up|0|||
160960064|NCT03205371|581242206|FG002|Overall Study|Lost to Follow-up|0|||
160584883|NCT01248130|579861874|FG000|Overall Study|Ineligible|1|||
160960065|NCT03205371|581242207|FG003|Overall Study|Lost to Follow-up|0|||
160960066|NCT03205371|581242208|FG004|Overall Study|Lost to Follow-up|0|||
160960067|NCT03205371|581242209|FG005|Overall Study|Lost to Follow-up|0|||
160960068|NCT03205371|581242210|FG006|Overall Study|Lost to Follow-up|5|||
160960069|NCT03205371|581242211|FG007|Overall Study|Lost to Follow-up|2|||
160960070|NCT03205371|581242212|FG008|Overall Study|Lost to Follow-up|3|||
160960071|NCT03205371|581242213|FG009|Overall Study|Lost to Follow-up|0|||
160960072|NCT03205371|581242214|FG010|Overall Study|Lost to Follow-up|0|||
160960073|NCT03205371|581242215|FG011|Overall Study|Lost to Follow-up|0|||
160960074|NCT03205371|581242204|FG000|Overall Study|Protocol Violation|0|||
160960075|NCT03205371|581242205|FG001|Overall Study|Protocol Violation|0|||
160960076|NCT03205371|581242206|FG002|Overall Study|Protocol Violation|0|||
160960077|NCT03205371|581242207|FG003|Overall Study|Protocol Violation|0|||
160960078|NCT03205371|581242208|FG004|Overall Study|Protocol Violation|0|||
160960079|NCT03205371|581242209|FG005|Overall Study|Protocol Violation|0|||
160960080|NCT03205371|581242210|FG006|Overall Study|Protocol Violation|1|||
160960081|NCT03205371|581242211|FG007|Overall Study|Protocol Violation|0|||
160960082|NCT03205371|581242212|FG008|Overall Study|Protocol Violation|0|||
160960083|NCT03205371|581242213|FG009|Overall Study|Protocol Violation|0|||
160960084|NCT03205371|581242214|FG010|Overall Study|Protocol Violation|0|||
160960085|NCT03205371|581242215|FG011|Overall Study|Protocol Violation|0|||
160960086|NCT03205371|581242204|FG000|Overall Study|Adverse Event|0|||
160960087|NCT03205371|581242205|FG001|Overall Study|Adverse Event|0|||
160960088|NCT03205371|581242206|FG002|Overall Study|Adverse Event|0|||
160960089|NCT03205371|581242207|FG003|Overall Study|Adverse Event|0|||
160960090|NCT03205371|581242208|FG004|Overall Study|Adverse Event|0|||
160960091|NCT03205371|581242209|FG005|Overall Study|Adverse Event|0|||
160960092|NCT03205371|581242210|FG006|Overall Study|Adverse Event|0|||
160960093|NCT03205371|581242211|FG007|Overall Study|Adverse Event|1|||
160960094|NCT03205371|581242212|FG008|Overall Study|Adverse Event|0|||
160960095|NCT03205371|581242213|FG009|Overall Study|Adverse Event|0|||
160960096|NCT03205371|581242214|FG010|Overall Study|Adverse Event|0|||
160960097|NCT03205371|581242215|FG011|Overall Study|Adverse Event|0|||
160960098|NCT02835339|581242216|FG000|Overall Study|Did not receive allocated intervention|13|||
160960099|NCT02835339|581242217|FG001|Overall Study|Did not receive allocated intervention|16|||
160960100|NCT01077544|581242218|FG000|Overall Study|New Cancer Therapy|3|||
160960101|NCT01077544|581242219|FG001|Overall Study|New Cancer Therapy|3|||
160960102|NCT01077544|581242218|FG000|Overall Study|Adverse Event|0|||
160960103|NCT01077544|581242219|FG001|Overall Study|Adverse Event|1|||
160960104|NCT01077544|581242218|FG000|Overall Study|Disease Progression|0|||
160960105|NCT01077544|581242219|FG001|Overall Study|Disease Progression|1|||
160960106|NCT03923959|581242220|FG000|Overall Study|Death|16|||
160960107|NCT03923959|581242221|FG001|Overall Study|Death|12|||
160960108|NCT03923959|581242220|FG000|Overall Study|Lost to Follow-up|56|||
160960109|NCT03923959|581242221|FG001|Overall Study|Lost to Follow-up|56|||
160960110|NCT03923959|581242220|FG000|Overall Study|Withdrawal by Subject|1|||
160960111|NCT03923959|581242221|FG001|Overall Study|Withdrawal by Subject|1|||
160960112|NCT03923959|581242220|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
160960113|NCT03923959|581242221|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
160960114|NCT04212091|581242223|FG000|Overall Study|Lost to Follow-up|0|||
160960115|NCT04212091|581242224|FG001|Overall Study|Lost to Follow-up|0|||
160960116|NCT04212091|581242225|FG002|Overall Study|Lost to Follow-up|0|||
160960117|NCT04212091|581242226|FG003|Overall Study|Lost to Follow-up|0|||
160960118|NCT04212091|581242227|FG004|Overall Study|Lost to Follow-up|1|||
160960119|NCT04212091|581242228|FG005|Overall Study|Lost to Follow-up|1|||
160960120|NCT04212091|581242223|FG000|Overall Study|Participant unable to adhere to visit|0|||
160960121|NCT04212091|581242224|FG001|Overall Study|Participant unable to adhere to visit|0|||
160960122|NCT04212091|581242225|FG002|Overall Study|Participant unable to adhere to visit|0|||
161002007|NCT02459899|581393064|FG001|Overall Study|Lost to Follow-up|2|||
161002008|NCT02459899|581393065|FG002|Overall Study|Lost to Follow-up|0|||
161002009|NCT02459899|581393066|FG003|Overall Study|Lost to Follow-up|1|||
161002010|NCT02459899|581393063|FG000|Overall Study|Non-compliance with the treatment|0|||
161002011|NCT02459899|581393064|FG001|Overall Study|Non-compliance with the treatment|0|||
161002012|NCT02459899|581393065|FG002|Overall Study|Non-compliance with the treatment|0|||
160960123|NCT04212091|581242226|FG003|Overall Study|Participant unable to adhere to visit|0|||
160960124|NCT04212091|581242227|FG004|Overall Study|Participant unable to adhere to visit|1|||
160960125|NCT04212091|581242228|FG005|Overall Study|Participant unable to adhere to visit|0|||
160960126|NCT04575051|581242229|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
160960127|NCT04575051|581242230|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
160960128|NCT04575051|581242231|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
160960129|NCT04575051|581242232|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
160960130|NCT04575051|581242233|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
160960131|NCT04575051|581242229|FG000|Time Period 1|Missing follow up|1|||
160960132|NCT04575051|581242230|FG001|Time Period 1|Missing follow up|3|||
160960133|NCT04575051|581242231|FG002|Time Period 1|Missing follow up|1|||
160960134|NCT04575051|581242232|FG003|Time Period 1|Missing follow up|3|||
160960135|NCT04575051|581242233|FG004|Time Period 1|Missing follow up|2|||
160960136|NCT04575051|581242229|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
160960137|NCT04575051|581242230|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
160960138|NCT04575051|581242231|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
160960139|NCT04575051|581242232|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
160960140|NCT04575051|581242233|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
160960141|NCT04575051|581242229|FG000|Time Period 2|Missing follow up|1|||
160960142|NCT04575051|581242230|FG001|Time Period 2|Missing follow up|8|||
160960143|NCT04575051|581242231|FG002|Time Period 2|Missing follow up|7|||
160960144|NCT04575051|581242232|FG003|Time Period 2|Missing follow up|0|||
160960145|NCT04575051|581242233|FG004|Time Period 2|Missing follow up|1|||
160960146|NCT04575051|581242229|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
160960147|NCT04575051|581242230|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
160960148|NCT04575051|581242231|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
160960149|NCT04575051|581242232|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
160960150|NCT04575051|581242233|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
160960151|NCT04575051|581242229|FG000|Time Period 3|Missing follow up|8|||
160960152|NCT04575051|581242230|FG001|Time Period 3|Missing follow up|6|||
160960153|NCT04575051|581242231|FG002|Time Period 3|Missing follow up|4|||
160960154|NCT04575051|581242232|FG003|Time Period 3|Missing follow up|3|||
160960155|NCT04575051|581242233|FG004|Time Period 3|Missing follow up|0|||
160960156|NCT04575051|581242229|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
160960157|NCT04575051|581242230|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
160960158|NCT04575051|581242231|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
160960159|NCT04575051|581242232|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
160960160|NCT04575051|581242233|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
160960161|NCT04575051|581242229|FG000|Time Period 4|Missing follow up|17|||
160960162|NCT04575051|581242230|FG001|Time Period 4|Missing follow up|3|||
160960163|NCT04575051|581242231|FG002|Time Period 4|Missing follow up|4|||
160960164|NCT04575051|581242232|FG003|Time Period 4|Missing follow up|2|||
160960165|NCT04575051|581242233|FG004|Time Period 4|Missing follow up|1|||
160960166|NCT04575051|581242229|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
160960167|NCT04575051|581242230|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
160960168|NCT04575051|581242231|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
160960169|NCT04575051|581242232|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
160960170|NCT04575051|581242233|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
160960171|NCT04575051|581242229|FG000|Time Period 5|Missing follow up|11|||
160960172|NCT04575051|581242230|FG001|Time Period 5|Missing follow up|8|||
160960173|NCT04575051|581242231|FG002|Time Period 5|Missing follow up|12|||
160960174|NCT04575051|581242232|FG003|Time Period 5|Missing follow up|3|||
160960175|NCT04575051|581242233|FG004|Time Period 5|Missing follow up|11|||
160960176|NCT03182868|581242234|FG000|Overall Study|Protocol Violation|3|||
160960177|NCT03182868|581242235|FG001|Overall Study|Protocol Violation|0|||
160960178|NCT03182868|581242236|FG002|Overall Study|Protocol Violation|4|||
160960179|NCT03182868|581242237|FG003|Overall Study|Protocol Violation|1|||
160960180|NCT03182868|581242238|FG004|Overall Study|Protocol Violation|8|||
160960181|NCT00295022|581242239|FG000|Overall Study|Adverse Event|1|||
160960182|NCT00295022|581242240|FG001|Overall Study|Adverse Event|1|||
160960183|NCT00295022|581242241|FG002|Overall Study|Adverse Event|2|||
160960184|NCT00295022|581242239|FG000|Overall Study|Lost to Follow-up|0|||
160960185|NCT00295022|581242240|FG001|Overall Study|Lost to Follow-up|0|||
160960186|NCT00295022|581242241|FG002|Overall Study|Lost to Follow-up|1|||
160960187|NCT00295022|581242239|FG000|Overall Study|Withdrawal by Subject|0|||
160584884|NCT01248130|579861875|FG001|Overall Study|Ineligible|0|||
160584885|NCT02052778|579861876|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
160584886|NCT02052778|579861877|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
160960188|NCT00295022|581242240|FG001|Overall Study|Withdrawal by Subject|0|||
160960189|NCT00295022|581242241|FG002|Overall Study|Withdrawal by Subject|2|||
160960190|NCT00734630|581242243|FG000|Overall Study|Lack of Efficacy|4|||
160960191|NCT00734630|581242244|FG001|Overall Study|Lack of Efficacy|4|||
160960192|NCT00734630|581242243|FG000|Overall Study|Withdrawal by Subject|7|||
160960193|NCT00734630|581242244|FG001|Overall Study|Withdrawal by Subject|9|||
160960194|NCT00734630|581242243|FG000|Overall Study|Lost to Follow-up|13|||
160960195|NCT00734630|581242244|FG001|Overall Study|Lost to Follow-up|7|||
160960196|NCT00734630|581242243|FG000|Overall Study|Protocol Violation|0|||
160960197|NCT00734630|581242244|FG001|Overall Study|Protocol Violation|3|||
160960198|NCT00734630|581242243|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
160960199|NCT00734630|581242244|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
160960200|NCT00734630|581242243|FG000|Overall Study|Adverse Event|3|||
161002013|NCT02459899|581393066|FG003|Overall Study|Non-compliance with the treatment|1|||
161002014|NCT02459899|581393063|FG000|Overall Study|Withdrawal by Subject|1|||
160960201|NCT00734630|581242244|FG001|Overall Study|Adverse Event|6|||
160960202|NCT00734630|581242243|FG000|Overall Study|Randomized in Error|0|||
160960203|NCT00734630|581242244|FG001|Overall Study|Randomized in Error|1|||
160960204|NCT00734630|581242243|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
160960205|NCT00734630|581242244|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
160960206|NCT00734630|581242243|FG000|Overall Study|Poor Compliance|1|||
160960207|NCT00734630|581242244|FG001|Overall Study|Poor Compliance|1|||
160960208|NCT01239030|581242245|FG000|Double Blind|Adverse Event|0|||
160960209|NCT01239030|581242246|FG001|Double Blind|Adverse Event|1|||
160960210|NCT01239030|581242247|FG002|Double Blind|Adverse Event|0|||
160960211|NCT01239030|581242248|FG003|Double Blind|Adverse Event|2|||
160960212|NCT01239030|581242249|FG004|Double Blind|Adverse Event|0|||
160960213|NCT01239030|581242245|FG000|Double Blind|Withdrawal by Subject|0|||
160960214|NCT01239030|581242246|FG001|Double Blind|Withdrawal by Subject|1|||
160960215|NCT01239030|581242247|FG002|Double Blind|Withdrawal by Subject|1|||
160960216|NCT01239030|581242248|FG003|Double Blind|Withdrawal by Subject|0|||
160960217|NCT01239030|581242249|FG004|Double Blind|Withdrawal by Subject|1|||
160960218|NCT01239030|581242245|FG000|Double Blind|Lost to Follow-up|1|||
160960219|NCT01239030|581242246|FG001|Double Blind|Lost to Follow-up|1|||
160960220|NCT01239030|581242247|FG002|Double Blind|Lost to Follow-up|0|||
160960221|NCT01239030|581242248|FG003|Double Blind|Lost to Follow-up|0|||
160960222|NCT01239030|581242249|FG004|Double Blind|Lost to Follow-up|0|||
160960223|NCT01239030|581242245|FG000|Double Blind|Physician Decision|0|||
160960224|NCT01239030|581242246|FG001|Double Blind|Physician Decision|1|||
160960225|NCT01239030|581242247|FG002|Double Blind|Physician Decision|0|||
160960226|NCT01239030|581242248|FG003|Double Blind|Physician Decision|0|||
160960227|NCT01239030|581242249|FG004|Double Blind|Physician Decision|0|||
160960228|NCT01239030|581242245|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
160960229|NCT01239030|581242246|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
160960230|NCT01239030|581242247|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
160960231|NCT01239030|581242248|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
160960232|NCT01239030|581242249|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
160960233|NCT01239030|581242245|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
160960234|NCT01239030|581242246|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
160960235|NCT01239030|581242247|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
160960236|NCT01239030|581242248|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
160960237|NCT01239030|581242249|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
160960238|NCT01239030|581242245|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
160960239|NCT01239030|581242246|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
160960240|NCT01239030|581242247|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
160960241|NCT01239030|581242248|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
160960242|NCT01239030|581242249|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
160960243|NCT01239030|581242245|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
160960244|NCT01239030|581242246|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
160960245|NCT01239030|581242247|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
160960246|NCT01239030|581242248|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
160960247|NCT01239030|581242249|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
160960248|NCT04403698|581242250|FG000|Overall Study|Adverse Event|1|||
160960249|NCT04403698|581242251|FG001|Overall Study|Adverse Event|1|||
160960250|NCT04403698|581242250|FG000|Overall Study|Lost to Follow-up|1|||
160960251|NCT04403698|581242251|FG001|Overall Study|Lost to Follow-up|0|||
160960252|NCT04403698|581242250|FG000|Overall Study|Protocol Violation|0|||
160960253|NCT04403698|581242251|FG001|Overall Study|Protocol Violation|1|||
160960254|NCT00977665|581242252|FG000|Overall Study|Withdrawal by Subject|1|||
160960255|NCT00977665|581242253|FG001|Overall Study|Withdrawal by Subject|3|||
160960256|NCT00977665|581242252|FG000|Overall Study|Physician Decision|2|||
160960257|NCT00977665|581242253|FG001|Overall Study|Physician Decision|1|||
160960258|NCT00977665|581242252|FG000|Overall Study|Sponsor requested withdrawal|0|||
160960259|NCT00977665|581242253|FG001|Overall Study|Sponsor requested withdrawal|1|||
160960260|NCT00977665|581242252|FG000|Overall Study|Lost to Follow-up|1|||
160960261|NCT00977665|581242253|FG001|Overall Study|Lost to Follow-up|0|||
160960262|NCT00977665|581242252|FG000|Overall Study|Death|3|||
161002015|NCT02459899|581393064|FG001|Overall Study|Withdrawal by Subject|3|||
161002016|NCT02459899|581393065|FG002|Overall Study|Withdrawal by Subject|0|||
160960263|NCT00977665|581242253|FG001|Overall Study|Death|2|||
160960264|NCT00977665|581242252|FG000|Overall Study|Adverse Event|14|||
160960265|NCT00977665|581242253|FG001|Overall Study|Adverse Event|7|||
160960266|NCT00977665|581242252|FG000|Overall Study|Treatment failure|0|||
160960267|NCT00977665|581242253|FG001|Overall Study|Treatment failure|1|||
160960268|NCT01330433|581242254|FG000|Overall Study|Death|1|||
160960269|NCT01330433|581242255|FG001|Overall Study|Death|3|||
160960270|NCT01330433|581242254|FG000|Overall Study|Lost to Follow-up|1|||
160960271|NCT01330433|581242255|FG001|Overall Study|Lost to Follow-up|0|||
160960272|NCT02300220|581242261|FG000|Overall Study|Lost to Follow-up|1|||
160960273|NCT02300220|581242262|FG001|Overall Study|Lost to Follow-up|2|||
160960274|NCT02300220|581242261|FG000|Overall Study|Death|1|||
160960275|NCT02300220|581242262|FG001|Overall Study|Death|1|||
160960276|NCT02300220|581242261|FG000|Overall Study|Adverse Event|1|||
160960277|NCT02300220|581242262|FG001|Overall Study|Adverse Event|1|||
160960278|NCT02300220|581242261|FG000|Overall Study|Protocol Violation|1|||
160960279|NCT02300220|581242262|FG001|Overall Study|Protocol Violation|0|||
160960280|NCT02300220|581242261|FG000|Overall Study|Withdrawal by Subject|0|||
160960281|NCT02300220|581242262|FG001|Overall Study|Withdrawal by Subject|2|||
160960282|NCT02300220|581242261|FG000|Overall Study|Did not tolerate IMP|0|||
160960283|NCT02300220|581242262|FG001|Overall Study|Did not tolerate IMP|1|||
160960284|NCT04322682|581242263|FG000|Overall Study|Withdrawal by Subject|33|||
160960285|NCT04322682|581242264|FG001|Overall Study|Withdrawal by Subject|47|||
160960286|NCT04322682|581242263|FG000|Overall Study|Death|5|||
160960287|NCT04322682|581242264|FG001|Overall Study|Death|9|||
160960288|NCT04322682|581242263|FG000|Overall Study|Lost to Follow-up|4|||
160960289|NCT04322682|581242264|FG001|Overall Study|Lost to Follow-up|8|||
160960290|NCT04322682|581242263|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
160960291|NCT04322682|581242264|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
160960292|NCT02238379|581242265|FG000|Overall Study|Lost to Follow-up|1|||
160960293|NCT02238379|581242266|FG001|Overall Study|Lost to Follow-up|0|||
160960294|NCT04123067|581242267|FG000|Overall Study|Lost to Follow-up|0|||
160960295|NCT04123067|581242268|FG001|Overall Study|Lost to Follow-up|1|||
160960296|NCT00441090|581242269|FG000|Overall Study|Adverse Event|0|||
160960297|NCT00441090|581242270|FG001|Overall Study|Adverse Event|1|||
160960298|NCT00441090|581242271|FG002|Overall Study|Adverse Event|1|||
160960299|NCT00441090|581242272|FG003|Overall Study|Adverse Event|0|||
160960300|NCT00441090|581242273|FG004|Overall Study|Adverse Event|0|||
160960301|NCT00441090|581242269|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
160960302|NCT00441090|581242270|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
160960303|NCT00441090|581242271|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
160960304|NCT00441090|581242272|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
160960305|NCT00441090|581242273|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
160960306|NCT00441090|581242269|FG000|Overall Study|Withdrawal by Subject|1|||
160960307|NCT00441090|581242270|FG001|Overall Study|Withdrawal by Subject|0|||
160960308|NCT00441090|581242271|FG002|Overall Study|Withdrawal by Subject|1|||
160960309|NCT00441090|581242272|FG003|Overall Study|Withdrawal by Subject|0|||
160960310|NCT00441090|581242273|FG004|Overall Study|Withdrawal by Subject|0|||
160960311|NCT00441090|581242269|FG000|Overall Study|Lack of Efficacy|1|||
160960312|NCT00441090|581242270|FG001|Overall Study|Lack of Efficacy|0|||
160960313|NCT00441090|581242271|FG002|Overall Study|Lack of Efficacy|0|||
160960314|NCT00441090|581242272|FG003|Overall Study|Lack of Efficacy|0|||
160960315|NCT00441090|581242273|FG004|Overall Study|Lack of Efficacy|0|||
160960316|NCT01441102|581242274|FG000|Overall Study|Adverse Event|1|||
160960317|NCT01441102|581242274|FG000|Overall Study|Withdrawal by Subject|2|||
160960318|NCT03085485|581242275|FG000|Overall Study|Death|1|||
161002017|NCT02459899|581393066|FG003|Overall Study|Withdrawal by Subject|0|||
161002018|NCT04221438|581393067|FG000|Overall Study|Adverse Event|1|||
161002019|NCT04221438|581393067|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
161002020|NCT02517307|581393072|FG000|Overall Study|Withdrawal by Subject|1|||
161002021|NCT02517307|581393073|FG001|Overall Study|Withdrawal by Subject|0|||
161002022|NCT02517307|581393074|FG002|Overall Study|Withdrawal by Subject|1|||
161002023|NCT02517307|581393075|FG003|Overall Study|Withdrawal by Subject|0|||
161002024|NCT02517307|581393072|FG000|Overall Study|Protocol Violation|0|||
161002025|NCT02517307|581393073|FG001|Overall Study|Protocol Violation|0|||
161002026|NCT02517307|581393074|FG002|Overall Study|Protocol Violation|1|||
161002027|NCT02517307|581393075|FG003|Overall Study|Protocol Violation|1|||
161002028|NCT03586544|581393076|FG000|First Intervention|Adverse Event|0|||
160584887|NCT02052778|579861878|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
160584888|NCT02052778|579861879|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
160584889|NCT02052778|579861880|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
160584890|NCT02052778|579861881|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
160584891|NCT02052778|579861882|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
160960319|NCT03085485|581242276|FG001|Overall Study|Death|0|||
160960320|NCT03085485|581242275|FG000|Overall Study|Lost to Follow-up|1|||
160960321|NCT03085485|581242276|FG001|Overall Study|Lost to Follow-up|0|||
161002029|NCT03586544|581393077|FG001|First Intervention|Adverse Event|1|||
161002030|NCT03586544|581393076|FG000|Second Intervention|Withdrawal by Subject|0|||
161002031|NCT03586544|581393077|FG001|Second Intervention|Withdrawal by Subject|1|||
161002032|NCT00539292|581393078|FG000|Overall Study|Physician Decision|1|||
161002033|NCT00539292|581393079|FG001|Overall Study|Physician Decision|0|||
160960322|NCT01022762|581242277|FG000|Overall Study|Adverse Event|3|||
160960323|NCT01022762|581242278|FG001|Overall Study|Adverse Event|1|||
160960324|NCT01022762|581242277|FG000|Overall Study|Lack of Efficacy|0|||
160960325|NCT01022762|581242278|FG001|Overall Study|Lack of Efficacy|1|||
160960326|NCT01022762|581242277|FG000|Overall Study|Protocol Violation|7|||
160960327|NCT01022762|581242278|FG001|Overall Study|Protocol Violation|6|||
160960328|NCT01022762|581242277|FG000|Overall Study|Unclassified|12|||
161002034|NCT00361283|581393090|FG000|Overall Study|Lost to Follow-up|27|||
160458186|NCT06106022|579409117|FG001|Overall Study|Voluntary Withdrawal|2|||
160458187|NCT03174275|579409120|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
160960329|NCT01022762|581242278|FG001|Overall Study|Unclassified|20|||
160960330|NCT00605280|581242279|FG000|Year 1|Protocol Violation|0|||
160960331|NCT00605280|581242280|FG001|Year 1|Protocol Violation|0|||
160960332|NCT00605280|581242281|FG002|Year 1|Protocol Violation|0|||
160960333|NCT00605280|581242282|FG003|Year 1|Protocol Violation|1|||
160960334|NCT00605280|581242279|FG000|Year 1|Adverse Event|3|||
160960335|NCT00605280|581242280|FG001|Year 1|Adverse Event|1|||
160960336|NCT00605280|581242281|FG002|Year 1|Adverse Event|1|||
160960337|NCT00605280|581242282|FG003|Year 1|Adverse Event|5|||
160960338|NCT00605280|581242279|FG000|Year 1|Physician Decision|7|||
160960339|NCT00605280|581242280|FG001|Year 1|Physician Decision|4|||
160960340|NCT00605280|581242281|FG002|Year 1|Physician Decision|0|||
160960341|NCT00605280|581242282|FG003|Year 1|Physician Decision|6|||
160960342|NCT00605280|581242279|FG000|Year 1|Withdrawal by Subject|2|||
160960343|NCT00605280|581242280|FG001|Year 1|Withdrawal by Subject|4|||
160960344|NCT00605280|581242281|FG002|Year 1|Withdrawal by Subject|0|||
160960345|NCT00605280|581242282|FG003|Year 1|Withdrawal by Subject|4|||
160960346|NCT00605280|581242279|FG000|Year 1|Other|2|||
160960347|NCT00605280|581242280|FG001|Year 1|Other|1|||
160960348|NCT00605280|581242281|FG002|Year 1|Other|0|||
160960349|NCT00605280|581242282|FG003|Year 1|Other|1|||
160960350|NCT00605280|581242279|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
160960351|NCT00605280|581242280|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
160960352|NCT00605280|581242281|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
160960353|NCT00605280|581242282|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
160960354|NCT00605280|581242279|FG000|Year 2|Adverse Event|4|||
160960355|NCT00605280|581242280|FG001|Year 2|Adverse Event|0|||
160960356|NCT00605280|581242281|FG002|Year 2|Adverse Event|2|||
160960357|NCT00605280|581242282|FG003|Year 2|Adverse Event|4|||
160960358|NCT00605280|581242279|FG000|Year 2|Physician Decision|11|||
160960359|NCT00605280|581242280|FG001|Year 2|Physician Decision|6|||
160960360|NCT00605280|581242281|FG002|Year 2|Physician Decision|4|||
160960361|NCT00605280|581242282|FG003|Year 2|Physician Decision|11|||
160960362|NCT00605280|581242279|FG000|Year 2|Withdrawal by Subject|4|||
160960363|NCT00605280|581242280|FG001|Year 2|Withdrawal by Subject|0|||
160960364|NCT00605280|581242281|FG002|Year 2|Withdrawal by Subject|0|||
160960365|NCT00605280|581242282|FG003|Year 2|Withdrawal by Subject|4|||
160960366|NCT00605280|581242279|FG000|Year 2|Other|1|||
160960367|NCT00605280|581242280|FG001|Year 2|Other|0|||
160960368|NCT00605280|581242281|FG002|Year 2|Other|0|||
160960369|NCT00605280|581242282|FG003|Year 2|Other|1|||
160960370|NCT00605280|581242279|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
160960371|NCT00605280|581242280|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
160458188|NCT03174275|579409120|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
160458189|NCT03174275|579409120|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
160458190|NCT03174275|579409120|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
160584892|NCT02052778|579861883|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
160584893|NCT02052778|579861884|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
160584894|NCT02052778|579861885|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
160584895|NCT02052778|579861886|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
160584896|NCT02052778|579861887|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
160584897|NCT02052778|579861888|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
160584898|NCT02052778|579861889|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
160584899|NCT02052778|579861890|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
160584900|NCT02052778|579861891|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
160584901|NCT02052778|579861892|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
160584902|NCT02052778|579861893|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
160960372|NCT00605280|581242281|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
160960373|NCT00605280|581242282|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
160960374|NCT00605280|581242279|FG000|Year 3 Extension|Adverse Event|2|||
160960375|NCT00605280|581242280|FG001|Year 3 Extension|Adverse Event|0|||
160458191|NCT03174275|579409120|FG000|Adjuvant Chemotherapy|Progression|1|||
160458192|NCT03174275|579409120|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
160584903|NCT02052778|579861894|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
160584904|NCT02052778|579861895|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
160584905|NCT02052778|579861896|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
160960376|NCT00605280|581242281|FG002|Year 3 Extension|Adverse Event|0|||
160960377|NCT00605280|581242282|FG003|Year 3 Extension|Adverse Event|2|||
160960378|NCT00605280|581242279|FG000|Year 3 Extension|Physician Decision|0|||
160960379|NCT00605280|581242280|FG001|Year 3 Extension|Physician Decision|0|||
160960380|NCT00605280|581242281|FG002|Year 3 Extension|Physician Decision|0|||
160960381|NCT00605280|581242282|FG003|Year 3 Extension|Physician Decision|2|||
160960382|NCT00605280|581242279|FG000|Year 3 Extension|Withdrawal by Subject|2|||
161002035|NCT01837641|581393091|FG000|Overall Study|Sponsor decision|1|||
160960383|NCT00605280|581242280|FG001|Year 3 Extension|Withdrawal by Subject|0|||
160960384|NCT00605280|581242281|FG002|Year 3 Extension|Withdrawal by Subject|0|||
160960385|NCT00605280|581242282|FG003|Year 3 Extension|Withdrawal by Subject|5|||
160960386|NCT00605280|581242279|FG000|Year 3 Extension|Other|2|||
160960387|NCT00605280|581242280|FG001|Year 3 Extension|Other|0|||
160960388|NCT00605280|581242281|FG002|Year 3 Extension|Other|0|||
160960389|NCT00605280|581242282|FG003|Year 3 Extension|Other|0|||
160960390|NCT00605280|581242279|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
160960391|NCT00605280|581242280|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
160960392|NCT00605280|581242281|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
160960393|NCT00605280|581242282|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
160960394|NCT01775904|581242286|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
160960395|NCT01775904|581242286|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
160960396|NCT00518115|581242287|FG000|Overall Study|Adverse Event|6|||
160960397|NCT00518115|581242288|FG001|Overall Study|Adverse Event|1|||
160960398|NCT00518115|581242289|FG002|Overall Study|Adverse Event|5|||
160960399|NCT00518115|581242290|FG003|Overall Study|Adverse Event|6|||
160960400|NCT00518115|581242291|FG004|Overall Study|Adverse Event|5|||
160960401|NCT00518115|581242292|FG005|Overall Study|Adverse Event|5|||
160960402|NCT00518115|581242293|FG006|Overall Study|Adverse Event|5|||
160960403|NCT00518115|581242294|FG007|Overall Study|Adverse Event|10|||
160960404|NCT00518115|581242295|FG008|Overall Study|Adverse Event|2|||
160960405|NCT00518115|581242296|FG009|Overall Study|Adverse Event|9|||
160960406|NCT00518115|581242287|FG000|Overall Study|Lost to Follow-up|0|||
160960407|NCT00518115|581242288|FG001|Overall Study|Lost to Follow-up|0|||
160960408|NCT00518115|581242289|FG002|Overall Study|Lost to Follow-up|2|||
160960409|NCT00518115|581242290|FG003|Overall Study|Lost to Follow-up|3|||
160960410|NCT00518115|581242291|FG004|Overall Study|Lost to Follow-up|1|||
160960411|NCT00518115|581242292|FG005|Overall Study|Lost to Follow-up|3|||
160960412|NCT00518115|581242293|FG006|Overall Study|Lost to Follow-up|0|||
160960413|NCT00518115|581242294|FG007|Overall Study|Lost to Follow-up|1|||
160960414|NCT00518115|581242295|FG008|Overall Study|Lost to Follow-up|1|||
160960415|NCT00518115|581242296|FG009|Overall Study|Lost to Follow-up|1|||
160960416|NCT00518115|581242287|FG000|Overall Study|Protocol Violation|1|||
160960417|NCT00518115|581242288|FG001|Overall Study|Protocol Violation|3|||
160960418|NCT00518115|581242289|FG002|Overall Study|Protocol Violation|1|||
160960419|NCT00518115|581242290|FG003|Overall Study|Protocol Violation|0|||
160960420|NCT00518115|581242291|FG004|Overall Study|Protocol Violation|0|||
160960421|NCT00518115|581242292|FG005|Overall Study|Protocol Violation|0|||
160960422|NCT00518115|581242293|FG006|Overall Study|Protocol Violation|0|||
160960423|NCT00518115|581242294|FG007|Overall Study|Protocol Violation|0|||
160960424|NCT00518115|581242295|FG008|Overall Study|Protocol Violation|0|||
160960425|NCT00518115|581242296|FG009|Overall Study|Protocol Violation|0|||
160960426|NCT00518115|581242287|FG000|Overall Study|Withdrawal by Subject|1|||
160584906|NCT02052778|579861897|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
160584907|NCT02052778|579861898|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
160584908|NCT02052778|579861876|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
160584909|NCT02052778|579861877|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
160584910|NCT02052778|579861878|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
160584911|NCT02052778|579861879|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
160584912|NCT02052778|579861880|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
160584913|NCT02052778|579861881|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
160584914|NCT02052778|579861882|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
160584915|NCT02052778|579861883|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
160584916|NCT02052778|579861884|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
160584917|NCT02052778|579861885|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160584918|NCT02052778|579861886|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160584919|NCT02052778|579861887|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
160960427|NCT00518115|581242288|FG001|Overall Study|Withdrawal by Subject|1|||
160960428|NCT00518115|581242289|FG002|Overall Study|Withdrawal by Subject|5|||
160960429|NCT00518115|581242290|FG003|Overall Study|Withdrawal by Subject|0|||
160960430|NCT00518115|581242291|FG004|Overall Study|Withdrawal by Subject|2|||
160960431|NCT00518115|581242292|FG005|Overall Study|Withdrawal by Subject|1|||
160960432|NCT00518115|581242293|FG006|Overall Study|Withdrawal by Subject|0|||
160960433|NCT00518115|581242294|FG007|Overall Study|Withdrawal by Subject|2|||
160960434|NCT00518115|581242295|FG008|Overall Study|Withdrawal by Subject|1|||
160960435|NCT00518115|581242296|FG009|Overall Study|Withdrawal by Subject|3|||
160960436|NCT00518115|581242287|FG000|Overall Study|Lack of Efficacy|1|||
160960437|NCT00518115|581242288|FG001|Overall Study|Lack of Efficacy|0|||
160960438|NCT00518115|581242289|FG002|Overall Study|Lack of Efficacy|1|||
160960439|NCT00518115|581242290|FG003|Overall Study|Lack of Efficacy|1|||
160960440|NCT00518115|581242291|FG004|Overall Study|Lack of Efficacy|0|||
160960441|NCT00518115|581242292|FG005|Overall Study|Lack of Efficacy|0|||
160960442|NCT00518115|581242293|FG006|Overall Study|Lack of Efficacy|0|||
160960443|NCT00518115|581242294|FG007|Overall Study|Lack of Efficacy|1|||
160960444|NCT00518115|581242295|FG008|Overall Study|Lack of Efficacy|0|||
160960445|NCT00518115|581242296|FG009|Overall Study|Lack of Efficacy|0|||
160960446|NCT00518115|581242287|FG000|Overall Study|Non-Compliance|1|||
160960447|NCT00518115|581242288|FG001|Overall Study|Non-Compliance|0|||
160960448|NCT00518115|581242289|FG002|Overall Study|Non-Compliance|1|||
160960449|NCT00518115|581242290|FG003|Overall Study|Non-Compliance|0|||
160960450|NCT00518115|581242291|FG004|Overall Study|Non-Compliance|1|||
160960451|NCT00518115|581242292|FG005|Overall Study|Non-Compliance|1|||
160960452|NCT00518115|581242293|FG006|Overall Study|Non-Compliance|1|||
160960453|NCT00518115|581242294|FG007|Overall Study|Non-Compliance|1|||
160960454|NCT00518115|581242295|FG008|Overall Study|Non-Compliance|0|||
160960455|NCT00518115|581242296|FG009|Overall Study|Non-Compliance|1|||
160960456|NCT00518115|581242287|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
160960457|NCT00518115|581242288|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
160960458|NCT00518115|581242289|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960459|NCT00518115|581242290|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960460|NCT00518115|581242291|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960461|NCT00518115|581242292|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
160960462|NCT00518115|581242293|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960463|NCT00518115|581242294|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960464|NCT00518115|581242295|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960465|NCT00518115|581242296|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960466|NCT00518115|581242287|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
160960467|NCT00518115|581242288|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960468|NCT00518115|581242289|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960469|NCT00518115|581242290|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960470|NCT00518115|581242291|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960471|NCT00518115|581242292|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960472|NCT00518115|581242293|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960473|NCT00518115|581242294|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960474|NCT00518115|581242295|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960475|NCT00518115|581242296|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960476|NCT00518115|581242287|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960477|NCT00518115|581242288|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960478|NCT00518115|581242289|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
160960479|NCT00518115|581242290|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960480|NCT00518115|581242291|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960481|NCT00518115|581242292|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960482|NCT00518115|581242293|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960483|NCT00518115|581242294|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960484|NCT00518115|581242295|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
160960485|NCT00518115|581242296|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960486|NCT00518115|581242287|FG000|Overall Study|Wrong Monotherapy Administered|0|||
160960487|NCT00518115|581242288|FG001|Overall Study|Wrong Monotherapy Administered|0|||
160960488|NCT00518115|581242289|FG002|Overall Study|Wrong Monotherapy Administered|1|||
160960489|NCT00518115|581242290|FG003|Overall Study|Wrong Monotherapy Administered|0|||
160960490|NCT00518115|581242291|FG004|Overall Study|Wrong Monotherapy Administered|0|||
160960491|NCT00518115|581242292|FG005|Overall Study|Wrong Monotherapy Administered|0|||
160960492|NCT00518115|581242293|FG006|Overall Study|Wrong Monotherapy Administered|1|||
160960493|NCT00518115|581242294|FG007|Overall Study|Wrong Monotherapy Administered|0|||
160960494|NCT00518115|581242295|FG008|Overall Study|Wrong Monotherapy Administered|0|||
160960495|NCT00518115|581242296|FG009|Overall Study|Wrong Monotherapy Administered|0|||
160960496|NCT00518115|581242287|FG000|Overall Study|Violation of Exclusion Criteria|0|||
160960497|NCT00518115|581242288|FG001|Overall Study|Violation of Exclusion Criteria|0|||
160960498|NCT00518115|581242289|FG002|Overall Study|Violation of Exclusion Criteria|0|||
160960499|NCT00518115|581242290|FG003|Overall Study|Violation of Exclusion Criteria|1|||
160960500|NCT00518115|581242291|FG004|Overall Study|Violation of Exclusion Criteria|0|||
160960501|NCT00518115|581242292|FG005|Overall Study|Violation of Exclusion Criteria|0|||
160960502|NCT00518115|581242293|FG006|Overall Study|Violation of Exclusion Criteria|1|||
160960503|NCT00518115|581242294|FG007|Overall Study|Violation of Exclusion Criteria|0|||
160960504|NCT00518115|581242295|FG008|Overall Study|Violation of Exclusion Criteria|0|||
160960505|NCT00518115|581242296|FG009|Overall Study|Violation of Exclusion Criteria|0|||
160960506|NCT00518115|581242287|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
160960507|NCT00518115|581242288|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
160960508|NCT00518115|581242289|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
160960509|NCT00518115|581242290|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
160960510|NCT00518115|581242291|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
160960511|NCT00518115|581242292|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
160960512|NCT00518115|581242293|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
161002036|NCT01837641|581393092|FG001|Overall Study|Sponsor decision|0|||
160960513|NCT00518115|581242294|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
160960514|NCT00518115|581242295|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
160960515|NCT00518115|581242296|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
160960516|NCT00518115|581242287|FG000|Overall Study|Withdrew Consent|0|||
160960517|NCT00518115|581242288|FG001|Overall Study|Withdrew Consent|0|||
160960518|NCT00518115|581242289|FG002|Overall Study|Withdrew Consent|0|||
160960519|NCT00518115|581242290|FG003|Overall Study|Withdrew Consent|0|||
160960520|NCT00518115|581242291|FG004|Overall Study|Withdrew Consent|0|||
160960521|NCT00518115|581242292|FG005|Overall Study|Withdrew Consent|1|||
160960522|NCT00518115|581242293|FG006|Overall Study|Withdrew Consent|0|||
160960523|NCT00518115|581242294|FG007|Overall Study|Withdrew Consent|0|||
160960524|NCT00518115|581242295|FG008|Overall Study|Withdrew Consent|0|||
160960525|NCT00518115|581242296|FG009|Overall Study|Withdrew Consent|0|||
160960526|NCT00518115|581242287|FG000|Overall Study|Moved Out of State|0|||
160960527|NCT00518115|581242288|FG001|Overall Study|Moved Out of State|0|||
160960528|NCT00518115|581242289|FG002|Overall Study|Moved Out of State|0|||
160960529|NCT00518115|581242290|FG003|Overall Study|Moved Out of State|0|||
160960530|NCT00518115|581242291|FG004|Overall Study|Moved Out of State|0|||
160960531|NCT00518115|581242292|FG005|Overall Study|Moved Out of State|0|||
160960532|NCT00518115|581242293|FG006|Overall Study|Moved Out of State|0|||
160960533|NCT00518115|581242294|FG007|Overall Study|Moved Out of State|0|||
160960534|NCT00518115|581242295|FG008|Overall Study|Moved Out of State|0|||
160960535|NCT00518115|581242296|FG009|Overall Study|Moved Out of State|1|||
160960536|NCT04891419|581242297|FG000|Overall Study|Withdrawal by Subject|4|||
160960537|NCT04891419|581242298|FG001|Overall Study|Withdrawal by Subject|0|||
160960538|NCT04891419|581242297|FG000|Overall Study|Lost to Follow-up|1|||
160960539|NCT04891419|581242298|FG001|Overall Study|Lost to Follow-up|3|||
160960540|NCT00802074|581242302|FG000|Overall Study|Adverse Event|1|||
160960541|NCT00802074|581242303|FG001|Overall Study|Adverse Event|1|||
160960542|NCT00802074|581242304|FG002|Overall Study|Adverse Event|1|||
160960543|NCT00802074|581242305|FG003|Overall Study|Adverse Event|0|||
160960544|NCT00802074|581242306|FG004|Overall Study|Adverse Event|0|||
160960545|NCT00802074|581242307|FG005|Overall Study|Adverse Event|0|||
160960546|NCT00802074|581242302|FG000|Overall Study|Withdrawal by Subject|1|||
160960547|NCT00802074|581242303|FG001|Overall Study|Withdrawal by Subject|0|||
160960548|NCT00802074|581242304|FG002|Overall Study|Withdrawal by Subject|0|||
160960549|NCT00802074|581242305|FG003|Overall Study|Withdrawal by Subject|0|||
160960550|NCT00802074|581242306|FG004|Overall Study|Withdrawal by Subject|0|||
160960551|NCT00802074|581242307|FG005|Overall Study|Withdrawal by Subject|0|||
160960552|NCT00827918|581242308|FG000|Overall Study|Adverse Event|4|||
160960553|NCT00827918|581242309|FG001|Overall Study|Adverse Event|0|||
160960554|NCT00827918|581242310|FG002|Overall Study|Adverse Event|0|||
160960555|NCT00827918|581242308|FG000|Overall Study|Lack of Efficacy|16|||
160960556|NCT00827918|581242309|FG001|Overall Study|Lack of Efficacy|4|||
160960557|NCT00827918|581242310|FG002|Overall Study|Lack of Efficacy|15|||
160960558|NCT00827918|581242308|FG000|Overall Study|Physician Decision|1|||
160960559|NCT00827918|581242309|FG001|Overall Study|Physician Decision|0|||
160960560|NCT00827918|581242310|FG002|Overall Study|Physician Decision|0|||
160960561|NCT00827918|581242308|FG000|Overall Study|Pregnancy|0|||
161002037|NCT01837641|581393093|FG002|Overall Study|Sponsor decision|0|||
161002038|NCT01837641|581393094|FG003|Overall Study|Sponsor decision|0|||
161002039|NCT01837641|581393095|FG004|Overall Study|Sponsor decision|0|||
160458193|NCT03174275|579409120|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
160458194|NCT03174275|579409120|FG000|Adjuvant Durvalumab|Progression|1|||
160458195|NCT03174275|579409120|FG000|Adjuvant Durvalumab|Adverse Event|3|||
160458196|NCT03174275|579409120|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
160458197|NCT03174275|579409120|FG000|Adjuvant Radiotherapy|Progression|1|||
160458198|NCT03174275|579409120|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
160458199|NCT03988621|579409121|FG000|Overall Study|Lost to Follow-up|16|||
160458200|NCT03988621|579409122|FG001|Overall Study|Lost to Follow-up|17|||
160458201|NCT03988621|579409121|FG000|Overall Study|Withdrawal by Subject|14|||
160458202|NCT03988621|579409122|FG001|Overall Study|Withdrawal by Subject|7|||
160458203|NCT03988621|579409121|FG000|Overall Study|Patient Lost to Follow Up|15|||
160458204|NCT03988621|579409122|FG001|Overall Study|Patient Lost to Follow Up|15|||
160960562|NCT00827918|581242309|FG001|Overall Study|Pregnancy|1|||
160960563|NCT00827918|581242310|FG002|Overall Study|Pregnancy|0|||
160960564|NCT00827918|581242308|FG000|Overall Study|Progressive Disease|1|||
160960565|NCT00827918|581242309|FG001|Overall Study|Progressive Disease|1|||
160960566|NCT00827918|581242310|FG002|Overall Study|Progressive Disease|0|||
160960567|NCT00827918|581242308|FG000|Overall Study|Protocol Violation|0|||
160960568|NCT00827918|581242309|FG001|Overall Study|Protocol Violation|1|||
160458205|NCT03988621|579409121|FG000|Overall Study|Patient death|1|||
160960569|NCT00827918|581242310|FG002|Overall Study|Protocol Violation|0|||
160960570|NCT00827918|581242308|FG000|Overall Study|Withdrawal by Subject|6|||
160960571|NCT00827918|581242309|FG001|Overall Study|Withdrawal by Subject|2|||
160960572|NCT00827918|581242310|FG002|Overall Study|Withdrawal by Subject|6|||
160960573|NCT02291614|581242313|FG000|Overall Study|Lost to Follow-up|0|||
160960574|NCT02291614|581242314|FG001|Overall Study|Lost to Follow-up|0|||
160960575|NCT02291614|581242315|FG002|Overall Study|Lost to Follow-up|0|||
160960576|NCT02291614|581242316|FG003|Overall Study|Lost to Follow-up|0|||
160960577|NCT02291614|581242317|FG004|Overall Study|Lost to Follow-up|0|||
160960578|NCT02291614|581242318|FG005|Overall Study|Lost to Follow-up|0|||
160960579|NCT02291614|581242319|FG006|Overall Study|Lost to Follow-up|0|||
160960580|NCT02291614|581242320|FG007|Overall Study|Lost to Follow-up|1|||
160960581|NCT02291614|581242321|FG008|Overall Study|Lost to Follow-up|0|||
160960582|NCT02291614|581242322|FG009|Overall Study|Lost to Follow-up|0|||
160960583|NCT02291614|581242323|FG010|Overall Study|Lost to Follow-up|0|||
160960584|NCT02291614|581242313|FG000|Overall Study|Withdrawal by Subject|0|||
160960585|NCT02291614|581242314|FG001|Overall Study|Withdrawal by Subject|1|||
160960586|NCT02291614|581242315|FG002|Overall Study|Withdrawal by Subject|0|||
160960587|NCT02291614|581242316|FG003|Overall Study|Withdrawal by Subject|0|||
160960588|NCT02291614|581242317|FG004|Overall Study|Withdrawal by Subject|0|||
160960589|NCT02291614|581242318|FG005|Overall Study|Withdrawal by Subject|0|||
160960590|NCT02291614|581242319|FG006|Overall Study|Withdrawal by Subject|0|||
160960591|NCT02291614|581242320|FG007|Overall Study|Withdrawal by Subject|0|||
160960592|NCT02291614|581242321|FG008|Overall Study|Withdrawal by Subject|0|||
160960593|NCT02291614|581242322|FG009|Overall Study|Withdrawal by Subject|2|||
160960594|NCT02291614|581242323|FG010|Overall Study|Withdrawal by Subject|2|||
160960595|NCT02291614|581242313|FG000|Overall Study|Decision by sponsor|0|||
160960596|NCT02291614|581242314|FG001|Overall Study|Decision by sponsor|0|||
160960597|NCT02291614|581242315|FG002|Overall Study|Decision by sponsor|0|||
160960598|NCT02291614|581242316|FG003|Overall Study|Decision by sponsor|1|||
160960599|NCT02291614|581242317|FG004|Overall Study|Decision by sponsor|0|||
160960600|NCT02291614|581242318|FG005|Overall Study|Decision by sponsor|0|||
160960601|NCT02291614|581242319|FG006|Overall Study|Decision by sponsor|0|||
160960602|NCT02291614|581242320|FG007|Overall Study|Decision by sponsor|0|||
160960603|NCT02291614|581242321|FG008|Overall Study|Decision by sponsor|0|||
160960604|NCT02291614|581242322|FG009|Overall Study|Decision by sponsor|0|||
160960605|NCT02291614|581242323|FG010|Overall Study|Decision by sponsor|0|||
160960606|NCT02291614|581242313|FG000|Overall Study|Death|0|||
160960607|NCT02291614|581242314|FG001|Overall Study|Death|0|||
160960608|NCT02291614|581242315|FG002|Overall Study|Death|1|||
160960609|NCT02291614|581242316|FG003|Overall Study|Death|0|||
160960610|NCT02291614|581242317|FG004|Overall Study|Death|1|||
160960611|NCT02291614|581242318|FG005|Overall Study|Death|1|||
160960612|NCT02291614|581242319|FG006|Overall Study|Death|1|||
160960613|NCT02291614|581242320|FG007|Overall Study|Death|0|||
160960614|NCT02291614|581242321|FG008|Overall Study|Death|0|||
160960615|NCT02291614|581242322|FG009|Overall Study|Death|0|||
160960616|NCT02291614|581242323|FG010|Overall Study|Death|0|||
160960617|NCT00127101|581242324|FG000|Base Protocol|Adverse Event|0|||
160960618|NCT00127101|581242325|FG001|Base Protocol|Adverse Event|2|||
160960619|NCT00127101|581242326|FG002|Base Protocol|Adverse Event|1|||
160960620|NCT00127101|581242327|FG003|Base Protocol|Adverse Event|0|||
160960621|NCT00127101|581242328|FG004|Base Protocol|Adverse Event|0|||
160960622|NCT00127101|581242329|FG005|Base Protocol|Adverse Event|0|||
160960623|NCT00127101|581242324|FG000|Base Protocol|Lack of Efficacy|1|||
160960624|NCT00127101|581242325|FG001|Base Protocol|Lack of Efficacy|0|||
160960625|NCT00127101|581242326|FG002|Base Protocol|Lack of Efficacy|0|||
160960626|NCT00127101|581242327|FG003|Base Protocol|Lack of Efficacy|0|||
160960627|NCT00127101|581242328|FG004|Base Protocol|Lack of Efficacy|2|||
160960628|NCT00127101|581242329|FG005|Base Protocol|Lack of Efficacy|0|||
160960629|NCT00127101|581242324|FG000|Base Protocol|Withdrawal by Subject|1|||
160960630|NCT00127101|581242325|FG001|Base Protocol|Withdrawal by Subject|2|||
160960631|NCT00127101|581242326|FG002|Base Protocol|Withdrawal by Subject|1|||
160960632|NCT00127101|581242327|FG003|Base Protocol|Withdrawal by Subject|0|||
160960633|NCT00127101|581242328|FG004|Base Protocol|Withdrawal by Subject|0|||
160960634|NCT00127101|581242329|FG005|Base Protocol|Withdrawal by Subject|1|||
160960635|NCT00127101|581242324|FG000|Continuation Phase|Adverse Event|0|||
160960636|NCT00127101|581242325|FG001|Continuation Phase|Adverse Event|0|||
160960637|NCT00127101|581242326|FG002|Continuation Phase|Adverse Event|0|||
160960638|NCT00127101|581242327|FG003|Continuation Phase|Adverse Event|0|||
160960639|NCT00127101|581242328|FG004|Continuation Phase|Adverse Event|1|||
160960640|NCT00127101|581242329|FG005|Continuation Phase|Adverse Event|1|||
160960641|NCT00127101|581242324|FG000|Continuation Phase|Lack of Efficacy|0|||
160960642|NCT00127101|581242325|FG001|Continuation Phase|Lack of Efficacy|0|||
160960643|NCT00127101|581242326|FG002|Continuation Phase|Lack of Efficacy|0|||
160960644|NCT00127101|581242327|FG003|Continuation Phase|Lack of Efficacy|0|||
160960645|NCT00127101|581242328|FG004|Continuation Phase|Lack of Efficacy|0|||
160960646|NCT00127101|581242329|FG005|Continuation Phase|Lack of Efficacy|1|||
160960647|NCT00127101|581242324|FG000|Continuation Phase|Withdrawal by Subject|0|||
160960648|NCT00127101|581242325|FG001|Continuation Phase|Withdrawal by Subject|0|||
160960649|NCT00127101|581242326|FG002|Continuation Phase|Withdrawal by Subject|1|||
160960650|NCT00127101|581242327|FG003|Continuation Phase|Withdrawal by Subject|0|||
160960651|NCT00127101|581242328|FG004|Continuation Phase|Withdrawal by Subject|2|||
160960652|NCT00127101|581242329|FG005|Continuation Phase|Withdrawal by Subject|1|||
160960653|NCT00843167|581242330|FG000|Treatment Period|Adverse Event|1|||
160960654|NCT00843167|581242331|FG001|Treatment Period|Adverse Event|5|||
160960655|NCT00843167|581242330|FG000|Treatment Period|Withdrawal by Subject|2|||
160960656|NCT00843167|581242331|FG001|Treatment Period|Withdrawal by Subject|3|||
160960657|NCT03743038|581242332|FG000|Overall Study|Physician Decision|1|||
160960658|NCT01830127|581242334|FG000|Overall Study|Adverse Event|1|||
160960659|NCT01830127|581242335|FG001|Overall Study|Adverse Event|6|||
160960660|NCT01830127|581242334|FG000|Overall Study|Lack of Efficacy|3|||
160960661|NCT01830127|581242335|FG001|Overall Study|Lack of Efficacy|0|||
160960662|NCT01830127|581242334|FG000|Overall Study|Withdrawal by Subject|1|||
160960663|NCT01830127|581242335|FG001|Overall Study|Withdrawal by Subject|1|||
160960664|NCT01830127|581242334|FG000|Overall Study|Other reason not defined above|0|||
160960665|NCT01830127|581242335|FG001|Overall Study|Other reason not defined above|2|||
160960666|NCT01302847|581242338|FG000|Overall Study|Death|0|||
160960667|NCT01302847|581242339|FG001|Overall Study|Death|1|||
160960668|NCT01302847|581242340|FG002|Overall Study|Death|0|||
160960669|NCT01302847|581242341|FG003|Overall Study|Death|0|||
160960670|NCT01302847|581242342|FG004|Overall Study|Death|0|||
160960671|NCT01302847|581242343|FG005|Overall Study|Death|1|||
160960672|NCT01302847|581242344|FG006|Overall Study|Death|1|||
160960673|NCT01302847|581242345|FG007|Overall Study|Death|0|||
160960674|NCT01302847|581242338|FG000|Overall Study|Pregnancy|2|||
160960675|NCT01302847|581242339|FG001|Overall Study|Pregnancy|0|||
160960676|NCT01302847|581242340|FG002|Overall Study|Pregnancy|0|||
160960677|NCT01302847|581242341|FG003|Overall Study|Pregnancy|0|||
160960678|NCT01302847|581242342|FG004|Overall Study|Pregnancy|0|||
160960679|NCT01302847|581242343|FG005|Overall Study|Pregnancy|0|||
160960680|NCT01302847|581242344|FG006|Overall Study|Pregnancy|0|||
160960681|NCT01302847|581242345|FG007|Overall Study|Pregnancy|0|||
160960682|NCT01302847|581242338|FG000|Overall Study|Virologic failure|0|||
160960683|NCT01302847|581242339|FG001|Overall Study|Virologic failure|2|||
160960684|NCT01302847|581242340|FG002|Overall Study|Virologic failure|0|||
160960685|NCT01302847|581242341|FG003|Overall Study|Virologic failure|2|||
160960686|NCT01302847|581242342|FG004|Overall Study|Virologic failure|1|||
160960687|NCT01302847|581242343|FG005|Overall Study|Virologic failure|3|||
160960688|NCT01302847|581242344|FG006|Overall Study|Virologic failure|1|||
160960689|NCT01302847|581242345|FG007|Overall Study|Virologic failure|2|||
160960690|NCT01302847|581242338|FG000|Overall Study|Severe debilitation, unable to continue|0|||
160960691|NCT01302847|581242339|FG001|Overall Study|Severe debilitation, unable to continue|0|||
160960692|NCT01302847|581242340|FG002|Overall Study|Severe debilitation, unable to continue|0|||
160960693|NCT01302847|581242341|FG003|Overall Study|Severe debilitation, unable to continue|0|||
160960694|NCT01302847|581242342|FG004|Overall Study|Severe debilitation, unable to continue|0|||
160960695|NCT01302847|581242343|FG005|Overall Study|Severe debilitation, unable to continue|1|||
160960696|NCT01302847|581242344|FG006|Overall Study|Severe debilitation, unable to continue|1|||
160960697|NCT01302847|581242345|FG007|Overall Study|Severe debilitation, unable to continue|0|||
160960698|NCT01302847|581242338|FG000|Overall Study|Not able to get to clinic|1|||
160960699|NCT01302847|581242339|FG001|Overall Study|Not able to get to clinic|1|||
160960700|NCT01302847|581242340|FG002|Overall Study|Not able to get to clinic|0|||
160960701|NCT01302847|581242341|FG003|Overall Study|Not able to get to clinic|0|||
160960702|NCT01302847|581242342|FG004|Overall Study|Not able to get to clinic|0|||
160960703|NCT01302847|581242343|FG005|Overall Study|Not able to get to clinic|0|||
160960704|NCT01302847|581242344|FG006|Overall Study|Not able to get to clinic|0|||
160960705|NCT01302847|581242345|FG007|Overall Study|Not able to get to clinic|0|||
160960706|NCT01302847|581242338|FG000|Overall Study|Site closing|2|||
160960707|NCT01302847|581242339|FG001|Overall Study|Site closing|2|||
160960708|NCT01302847|581242340|FG002|Overall Study|Site closing|0|||
160960709|NCT01302847|581242341|FG003|Overall Study|Site closing|0|||
160960710|NCT01302847|581242342|FG004|Overall Study|Site closing|0|||
160960711|NCT01302847|581242343|FG005|Overall Study|Site closing|0|||
160960712|NCT01302847|581242344|FG006|Overall Study|Site closing|0|||
160960713|NCT01302847|581242345|FG007|Overall Study|Site closing|0|||
160960714|NCT01302847|581242338|FG000|Overall Study|Withdrawal by Subject|1|||
160960715|NCT01302847|581242339|FG001|Overall Study|Withdrawal by Subject|0|||
160960716|NCT01302847|581242340|FG002|Overall Study|Withdrawal by Subject|0|||
160960717|NCT01302847|581242341|FG003|Overall Study|Withdrawal by Subject|0|||
160960718|NCT01302847|581242342|FG004|Overall Study|Withdrawal by Subject|1|||
160960719|NCT01302847|581242343|FG005|Overall Study|Withdrawal by Subject|0|||
160960720|NCT01302847|581242344|FG006|Overall Study|Withdrawal by Subject|0|||
160960721|NCT01302847|581242345|FG007|Overall Study|Withdrawal by Subject|1|||
160960722|NCT01302847|581242338|FG000|Overall Study|Not willing to adhere to requirements|5|||
160960723|NCT01302847|581242339|FG001|Overall Study|Not willing to adhere to requirements|0|||
160960724|NCT01302847|581242340|FG002|Overall Study|Not willing to adhere to requirements|1|||
160960725|NCT01302847|581242341|FG003|Overall Study|Not willing to adhere to requirements|0|||
160960726|NCT01302847|581242342|FG004|Overall Study|Not willing to adhere to requirements|0|||
160960727|NCT01302847|581242343|FG005|Overall Study|Not willing to adhere to requirements|0|||
160960728|NCT01302847|581242344|FG006|Overall Study|Not willing to adhere to requirements|0|||
160960729|NCT01302847|581242345|FG007|Overall Study|Not willing to adhere to requirements|2|||
160960730|NCT01302847|581242338|FG000|Overall Study|Site unable to contact participant|2|||
160960731|NCT01302847|581242339|FG001|Overall Study|Site unable to contact participant|1|||
160960732|NCT01302847|581242340|FG002|Overall Study|Site unable to contact participant|0|||
160960733|NCT01302847|581242341|FG003|Overall Study|Site unable to contact participant|0|||
160960734|NCT01302847|581242342|FG004|Overall Study|Site unable to contact participant|0|||
160960735|NCT01302847|581242343|FG005|Overall Study|Site unable to contact participant|0|||
160960736|NCT01302847|581242344|FG006|Overall Study|Site unable to contact participant|2|||
160960737|NCT01302847|581242345|FG007|Overall Study|Site unable to contact participant|0|||
160960738|NCT03563716|581244571|FG000|Overall Study|Death|20|||
160960739|NCT03563716|581244572|FG001|Overall Study|Death|14|||
160960740|NCT03563716|581244571|FG000|Overall Study|Withdrawal by Subject|3|||
160960741|NCT03563716|581244572|FG001|Overall Study|Withdrawal by Subject|3|||
160960742|NCT03563716|581244571|FG000|Overall Study|Still on Study|45|||
160960743|NCT03563716|581244572|FG001|Overall Study|Still on Study|50|||
160960744|NCT03813238|581244575|FG000|Overall Study|Adverse Event|0|||
160960745|NCT03813238|581244576|FG001|Overall Study|Adverse Event|6|||
160960746|NCT03813238|581244575|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160960747|NCT03813238|581244576|FG001|Overall Study|Withdrawal by parent/guardian|2|||
160960748|NCT03813238|581244575|FG000|Overall Study|Lost to Follow-up|0|||
160960749|NCT03813238|581244576|FG001|Overall Study|Lost to Follow-up|1|||
160960750|NCT03813238|581244575|FG000|Overall Study|Other than specified|1|||
160960751|NCT03813238|581244576|FG001|Overall Study|Other than specified|2|||
160960752|NCT02066402|581244577|FG000|Overall Study|Adverse Event|1|||
160960753|NCT02066402|581244578|FG001|Overall Study|Adverse Event|2|||
160960754|NCT02066402|581244577|FG000|Overall Study|Lost to Follow-up|11|||
160960755|NCT02066402|581244578|FG001|Overall Study|Lost to Follow-up|8|||
160960756|NCT02066402|581244577|FG000|Overall Study|Withdrawal by Subject|14|||
160960757|NCT02066402|581244578|FG001|Overall Study|Withdrawal by Subject|11|||
160960758|NCT02066402|581244577|FG000|Overall Study|Progressive disease-clinical progression|0|||
160960759|NCT02066402|581244578|FG001|Overall Study|Progressive disease-clinical progression|1|||
160960760|NCT02066402|581244577|FG000|Overall Study|Protocol driven decision point|0|||
160960761|NCT02066402|581244578|FG001|Overall Study|Protocol driven decision point|1|||
160960762|NCT00152464|581244579|FG000|Overall Study|Adverse Event|3|||
160960763|NCT00152464|581244580|FG001|Overall Study|Adverse Event|6|||
160960764|NCT00152464|581244579|FG000|Overall Study|Lost to Follow-up|8|||
160960765|NCT00152464|581244580|FG001|Overall Study|Lost to Follow-up|4|||
160960766|NCT00152464|581244579|FG000|Overall Study|Protocol Violation|3|||
160960767|NCT00152464|581244580|FG001|Overall Study|Protocol Violation|1|||
160960768|NCT00152464|581244579|FG000|Overall Study|Withdrawal by Subject|21|||
160960769|NCT00152464|581244580|FG001|Overall Study|Withdrawal by Subject|22|||
160960770|NCT00152464|581244579|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
160960771|NCT00152464|581244580|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
160960772|NCT00152464|581244579|FG000|Overall Study|Eczema deterioration|0|||
160960773|NCT00152464|581244580|FG001|Overall Study|Eczema deterioration|1|||
160960774|NCT00152464|581244579|FG000|Overall Study|Parent decision|1|||
160960775|NCT00152464|581244580|FG001|Overall Study|Parent decision|1|||
160960776|NCT00152464|581244579|FG000|Overall Study|Investigator decision|1|||
160960777|NCT00152464|581244580|FG001|Overall Study|Investigator decision|0|||
160960778|NCT00152464|581244579|FG000|Overall Study|Lack of Efficacy|1|||
160960779|NCT00152464|581244580|FG001|Overall Study|Lack of Efficacy|0|||
160960780|NCT00152464|581244579|FG000|Overall Study|Eczema poorly controlled|1|||
160960781|NCT00152464|581244580|FG001|Overall Study|Eczema poorly controlled|0|||
160960782|NCT00152464|581244579|FG000|Overall Study|Patient relocated|1|||
160960783|NCT00152464|581244580|FG001|Overall Study|Patient relocated|0|||
160960784|NCT02462876|581244581|FG000|Overall Study|Death|3|||
160960785|NCT02462876|581244581|FG000|Overall Study|Lost to Follow-up|7|||
161002040|NCT01837641|581393096|FG005|Overall Study|Sponsor decision|1|||
161002041|NCT01837641|581393097|FG006|Overall Study|Sponsor decision|0|||
161002042|NCT01837641|581393098|FG007|Overall Study|Sponsor decision|0|||
161002043|NCT01837641|581393091|FG000|Overall Study|Adverse Event|0|||
161002044|NCT01837641|581393092|FG001|Overall Study|Adverse Event|0|||
161002045|NCT01837641|581393093|FG002|Overall Study|Adverse Event|0|||
161002046|NCT01837641|581393094|FG003|Overall Study|Adverse Event|0|||
161002047|NCT01837641|581393095|FG004|Overall Study|Adverse Event|0|||
161002048|NCT01837641|581393096|FG005|Overall Study|Adverse Event|1|||
161002049|NCT01837641|581393097|FG006|Overall Study|Adverse Event|0|||
160960786|NCT02462876|581244581|FG000|Overall Study|Surgical Bypass|9|||
160960787|NCT02462876|581244581|FG000|Overall Study|Amputation Above the Metatarsals|1|||
160960788|NCT02462876|581244581|FG000|Overall Study|36 months follow-up visit missed|1|||
160960789|NCT02462876|581244581|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
160960790|NCT02462876|581244581|FG000|Overall Study|Patient did not come back to the vascular department|1|||
160960791|NCT02462876|581244581|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
160960792|NCT02462876|581244581|FG000|Overall Study|Patient refused to come back|1|||
160960793|NCT02462876|581244581|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
160960794|NCT02462876|581244581|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
160960795|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
161002050|NCT01837641|581393098|FG007|Overall Study|Adverse Event|0|||
160960796|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
160960797|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
160960798|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
160960799|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
160960800|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
160960801|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
160960802|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
160960803|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Other|18|||
160960804|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
160960805|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
160960806|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Other|1|||
160960807|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
160960808|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
160960809|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
160960810|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
160960811|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
160960812|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
160960813|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
160960814|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
160960815|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
160960816|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
160960817|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
160960818|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
161002051|NCT01837641|581393091|FG000|Overall Study|Withdrawal by Subject|0|||
161002052|NCT01837641|581393092|FG001|Overall Study|Withdrawal by Subject|0|||
161002053|NCT01837641|581393093|FG002|Overall Study|Withdrawal by Subject|0|||
161002054|NCT01837641|581393094|FG003|Overall Study|Withdrawal by Subject|0|||
161002055|NCT01837641|581393095|FG004|Overall Study|Withdrawal by Subject|1|||
161002056|NCT01837641|581393096|FG005|Overall Study|Withdrawal by Subject|0|||
161002057|NCT01837641|581393097|FG006|Overall Study|Withdrawal by Subject|1|||
161002058|NCT01837641|581393098|FG007|Overall Study|Withdrawal by Subject|0|||
161002059|NCT03768206|581393105|FG000|Overall Study|Lost to Follow-up|2|||
161002060|NCT03768206|581393106|FG001|Overall Study|Lost to Follow-up|1|||
161002061|NCT03768206|581393105|FG000|Overall Study|Withdrawal by Subject|0|||
161002062|NCT03768206|581393106|FG001|Overall Study|Withdrawal by Subject|1|||
161002063|NCT02106442|581393109|FG000|Overall Study|Case Report Forms Uncollected|7|||
161002064|NCT02106442|581393109|FG000|Overall Study|Protocol Deviation|30|||
161002065|NCT03516942|581393111|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
161002066|NCT03516942|581393111|FG000|Registration through baseline survey com|Death|8|||
161002067|NCT03516942|581393111|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
161002068|NCT03516942|581393111|FG000|T0: Baseline|LOST|13|||
161002069|NCT03516942|581393111|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
161002070|NCT03516942|581393111|FG000|T1: 3 Months Survey|Death|10|||
161002071|NCT03516942|581393111|FG000|T1: 3 Months Survey|Lost|163|||
161002072|NCT03516942|581393111|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
161002073|NCT03516942|581393111|FG000|T2: 6 Month Survey|Death|14|||
161002074|NCT03516942|581393111|FG000|T2: 6 Month Survey|Lost|180|||
161002075|NCT03516942|581393111|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
161002076|NCT03516942|581393111|FG000|T3: 12 Month Survey|Death|19|||
161002077|NCT03516942|581393111|FG000|T3: 12 Month Survey|Lost|209|||
161002078|NCT06269640|581394520|FG000|Overall Study|Death|1|||
161002079|NCT00711958|581394521|FG000|Overall Study|Withdrawal by Subject|6|||
161002080|NCT00711958|581394522|FG001|Overall Study|Withdrawal by Subject|8|||
161002081|NCT00711958|581394521|FG000|Overall Study|Lack of Efficacy|3|||
161002082|NCT00711958|581394522|FG001|Overall Study|Lack of Efficacy|1|||
161002083|NCT00711958|581394521|FG000|Overall Study|Clinical deterioration|1|||
161002084|NCT00711958|581394522|FG001|Overall Study|Clinical deterioration|0|||
161002085|NCT00711958|581394521|FG000|Overall Study|Adverse Event|9|||
160960819|NCT03581981|581244583|FG000|Overall Study|Withdrawal by Subject|12|||
160960820|NCT03581981|581244584|FG001|Overall Study|Withdrawal by Subject|13|||
160960821|NCT03581981|581244583|FG000|Overall Study|Physician Decision|1|||
160960822|NCT03581981|581244584|FG001|Overall Study|Physician Decision|2|||
161002086|NCT00711958|581394522|FG001|Overall Study|Adverse Event|7|||
161002087|NCT00711958|581394521|FG000|Overall Study|Protocol Violation|1|||
161002088|NCT00711958|581394522|FG001|Overall Study|Protocol Violation|0|||
161002089|NCT00711958|581394521|FG000|Overall Study|Lost to Follow-up|2|||
161002090|NCT00711958|581394522|FG001|Overall Study|Lost to Follow-up|2|||
161002091|NCT00711958|581394521|FG000|Overall Study|Death|10|||
161002092|NCT00711958|581394522|FG001|Overall Study|Death|5|||
161002093|NCT00711958|581394521|FG000|Overall Study|Progression of disease|1|||
161002094|NCT00711958|581394522|FG001|Overall Study|Progression of disease|0|||
161002095|NCT02383472|581394523|FG000|Overall Study|Withdrawal by Subject|1|||
161002096|NCT02383472|581394524|FG001|Overall Study|Withdrawal by Subject|1|||
161002097|NCT02015546|581394525|FG000|Overall Study|Withdrawal by Subject|1|||
160960823|NCT03581981|581244583|FG000|Overall Study|Lost to Follow-up|0|||
160960824|NCT03581981|581244584|FG001|Overall Study|Lost to Follow-up|4|||
160960825|NCT00828984|581244585|FG000|Overall Study|Adverse Event|2|||
160960826|NCT00828984|581244586|FG001|Overall Study|Adverse Event|3|||
160960827|NCT00828984|581244587|FG002|Overall Study|Adverse Event|0|||
160960828|NCT00828984|581244585|FG000|Overall Study|Lost to Follow-up|5|||
160960829|NCT00828984|581244586|FG001|Overall Study|Lost to Follow-up|3|||
160960830|NCT00828984|581244587|FG002|Overall Study|Lost to Follow-up|1|||
160960831|NCT00828984|581244585|FG000|Overall Study|Withdrawal by Subject|4|||
160960832|NCT00828984|581244586|FG001|Overall Study|Withdrawal by Subject|4|||
160960833|NCT00828984|581244587|FG002|Overall Study|Withdrawal by Subject|4|||
160960834|NCT00828984|581244585|FG000|Overall Study|Ineligable|1|||
160960835|NCT00828984|581244586|FG001|Overall Study|Ineligable|2|||
160960836|NCT00828984|581244587|FG002|Overall Study|Ineligable|0|||
160960837|NCT00828984|581244585|FG000|Overall Study|Medical Contraindication|0|||
160960838|NCT00828984|581244586|FG001|Overall Study|Medical Contraindication|1|||
161002098|NCT02015546|581394526|FG001|Overall Study|Withdrawal by Subject|1|||
161002099|NCT02015546|581394527|FG002|Overall Study|Withdrawal by Subject|1|||
161002100|NCT02015546|581394525|FG000|Overall Study|Screem Failure|2|||
161002101|NCT02015546|581394526|FG001|Overall Study|Screem Failure|1|||
161002102|NCT02015546|581394527|FG002|Overall Study|Screem Failure|3|||
161002103|NCT01171625|581394528|FG000|Overall Study|On-Protocol|67|||
161002104|NCT01171625|581394528|FG000|Overall Study|Death|38|||
161002105|NCT01171625|581394528|FG000|Overall Study|Withdrawal by Subject|31|||
161002106|NCT01171625|581394528|FG000|Overall Study|Explanted|10|||
161002107|NCT01171625|581394528|FG000|Overall Study|Lost to Follow-up|5|||
161002108|NCT01171625|581394528|FG000|Overall Study|Patient received valve-in-valve|3|||
161002109|NCT01171625|581394528|FG000|Overall Study|Other|1|||
161002110|NCT01171625|581394528|FG000|Overall Study|Consented but did not receive device|25|||
161002111|NCT00799396|581394529|FG000|Clopidogrel Treatment|Adverse Event|6|||
161002112|NCT00799396|581394529|FG000|Clopidogrel Treatment|Physician Decision|5|||
161002113|NCT00799396|581394529|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
161002114|NCT00799396|581394529|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
161002115|NCT00799396|581394529|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
161002116|NCT01113931|581394530|FG000|Overall Study|Adverse Event|2|||
161002117|NCT01113931|581394531|FG001|Overall Study|Adverse Event|2|||
161002118|NCT01113931|581394530|FG000|Overall Study|Physician Decision|0|||
161002119|NCT01113931|581394531|FG001|Overall Study|Physician Decision|2|||
161002120|NCT01113931|581394530|FG000|Overall Study|Lost to Follow-up|12|||
161002121|NCT01113931|581394531|FG001|Overall Study|Lost to Follow-up|9|||
161002122|NCT01113931|581394530|FG000|Overall Study|Various|2|||
161002123|NCT01113931|581394531|FG001|Overall Study|Various|4|||
161002124|NCT01113931|581394530|FG000|Overall Study|Withdrawal by Subject|3|||
161002125|NCT01113931|581394531|FG001|Overall Study|Withdrawal by Subject|0|||
161002126|NCT06119113|581394536|FG000|Overall Study|Lost to Follow-up|15|||
161002127|NCT06119113|581394537|FG001|Overall Study|Lost to Follow-up|13|||
161002128|NCT06119113|581394538|FG002|Overall Study|Lost to Follow-up|21|||
161002129|NCT00424762|581394541|FG000|Overall Study|Withdrawal by Subject|18|||
161002130|NCT00424762|581394542|FG001|Overall Study|Withdrawal by Subject|19|||
161002131|NCT00424762|581394541|FG000|Overall Study|Lost to Follow-up|2|||
161002132|NCT00424762|581394542|FG001|Overall Study|Lost to Follow-up|3|||
161002133|NCT01145885|581394543|FG000|Overall Study|Progressive Disease|7|||
161002134|NCT02950558|581394547|FG000|Overall Study|Lost to Follow-up|2|||
161002135|NCT02950558|581394548|FG001|Overall Study|Lost to Follow-up|0|||
160960839|NCT00828984|581244587|FG002|Overall Study|Medical Contraindication|0|||
160960840|NCT00828984|581244585|FG000|Overall Study|Noncompliant|1|||
160960841|NCT00828984|581244586|FG001|Overall Study|Noncompliant|2|||
160960842|NCT00828984|581244587|FG002|Overall Study|Noncompliant|3|||
160960843|NCT00828984|581244585|FG000|Overall Study|ConMed|1|||
160960844|NCT00828984|581244586|FG001|Overall Study|ConMed|1|||
160960845|NCT00828984|581244587|FG002|Overall Study|ConMed|1|||
160960846|NCT04465357|581244590|FG000|Overall Study|Adverse Event|2|||
160960847|NCT04465357|581244590|FG000|Overall Study|Lack of Efficacy|1|||
160960848|NCT04465357|581244590|FG000|Overall Study|Lost to Follow-up|2|||
160960849|NCT04465357|581244590|FG000|Overall Study|Withdrawal by Subject|6|||
160960850|NCT04465357|581244590|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
160960851|NCT00863655|581244591|FG000|Overall Study|Protocol Violation|4|||
160960852|NCT00863655|581244592|FG001|Overall Study|Protocol Violation|0|||
160960853|NCT00863655|581244591|FG000|Overall Study|Adverse Event|52|||
160960854|NCT00863655|581244592|FG001|Overall Study|Adverse Event|8|||
160960855|NCT00863655|581244591|FG000|Overall Study|Withdrawal by Subject|47|||
160960856|NCT00863655|581244592|FG001|Overall Study|Withdrawal by Subject|7|||
160960857|NCT00863655|581244591|FG000|Overall Study|Administrative problems|1|||
160960858|NCT00863655|581244592|FG001|Overall Study|Administrative problems|0|||
160960859|NCT00863655|581244591|FG000|Overall Study|Death|7|||
160960860|NCT00863655|581244592|FG001|Overall Study|Death|1|||
160960861|NCT00863655|581244591|FG000|Overall Study|New cancer therapy|5|||
160960862|NCT00863655|581244592|FG001|Overall Study|New cancer therapy|1|||
160960863|NCT00863655|581244591|FG000|Overall Study|Disease progression|364|||
160960864|NCT00863655|581244592|FG001|Overall Study|Disease progression|221|||
160960865|NCT00863655|581244591|FG000|Overall Study|Treatment completed as per protocol|5|||
160960866|NCT00863655|581244592|FG001|Overall Study|Treatment completed as per protocol|1|||
160960867|NCT00716092|581244593|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
160960868|NCT00716092|581244594|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
160960869|NCT00716092|581244595|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
160960870|NCT02436330|581244596|FG000|Cohort 1|Lost to Follow-up|5|||
160960871|NCT02436330|581244597|FG001|Cohort 1|Lost to Follow-up|2|||
160960872|NCT02436330|581244596|FG000|Cohort 1|Withdrawal by Subject|0|||
160960873|NCT02436330|581244597|FG001|Cohort 1|Withdrawal by Subject|1|||
160960874|NCT02436330|581244596|FG000|Cohort 2|Lost to Follow-up|2|||
160960875|NCT02436330|581244597|FG001|Cohort 2|Lost to Follow-up|0|||
160960876|NCT02436330|581244596|FG000|Cohort 2|Withdrawal by Subject|2|||
160960877|NCT02436330|581244597|FG001|Cohort 2|Withdrawal by Subject|3|||
160960878|NCT02436330|581244596|FG000|Cohort 3|Lost to Follow-up|1|||
160960879|NCT02436330|581244597|FG001|Cohort 3|Lost to Follow-up|0|||
160960880|NCT02436330|581244596|FG000|Cohort 3|Withdrawal by Subject|4|||
160960881|NCT02436330|581244597|FG001|Cohort 3|Withdrawal by Subject|0|||
160960882|NCT02436330|581244596|FG000|Cohort 4|Lost to Follow-up|1|||
160960883|NCT02436330|581244597|FG001|Cohort 4|Lost to Follow-up|0|||
160960884|NCT02436330|581244596|FG000|Cohort 4|Withdrawal by Subject|1|||
160960885|NCT02436330|581244597|FG001|Cohort 4|Withdrawal by Subject|0|||
160960886|NCT02436330|581244596|FG000|Cohort 5|Lost to Follow-up|3|||
160960887|NCT02436330|581244597|FG001|Cohort 5|Lost to Follow-up|2|||
160960888|NCT02436330|581244596|FG000|Cohort 5|Withdrawal by Subject|3|||
160960889|NCT02436330|581244597|FG001|Cohort 5|Withdrawal by Subject|2|||
160960890|NCT02436330|581244596|FG000|Cohort 6|Lost to Follow-up|2|||
160960891|NCT02436330|581244597|FG001|Cohort 6|Lost to Follow-up|0|||
160960892|NCT02436330|581244596|FG000|Cohort 6|Withdrawal by Subject|1|||
160960893|NCT02436330|581244597|FG001|Cohort 6|Withdrawal by Subject|1|||
160960894|NCT02054806|581244598|FG000|Overall Study|Sponsor Decision|31|||
160960895|NCT02054806|581244598|FG000|Overall Study|Withdrawal by Subject|43|||
160960896|NCT02054806|581244598|FG000|Overall Study|Protocol Violation|2|||
160960897|NCT02054806|581244598|FG000|Overall Study|Lost to Follow-up|10|||
160960898|NCT02054806|581244598|FG000|Overall Study|Death|391|||
160960899|NCT00677235|581244599|FG000|Overall Study|Withdrawal by Subject|1|||
160960900|NCT00677235|581244600|FG001|Overall Study|Withdrawal by Subject|1|||
160960901|NCT00677235|581244599|FG000|Overall Study|Lost to Follow-up|2|||
161002154|NCT01135511|581394553|FG000|Overall Study|Adverse Event|0|||
161002155|NCT01135511|581394554|FG001|Overall Study|Adverse Event|1|||
160584920|NCT02052778|579861888|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
160584921|NCT02052778|579861889|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
160584922|NCT02052778|579861890|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160960902|NCT00677235|581244600|FG001|Overall Study|Lost to Follow-up|1|||
160960903|NCT00677235|581244599|FG000|Overall Study|Death|37|||
160960904|NCT00677235|581244600|FG001|Overall Study|Death|36|||
160960905|NCT00677235|581244599|FG000|Overall Study|Adverse Experience|1|||
160960906|NCT00677235|581244600|FG001|Overall Study|Adverse Experience|0|||
160960907|NCT01040260|581244601|FG000|Overall Study|Withdrawal by Subject|12|||
161002156|NCT01135511|581394555|FG002|Overall Study|Adverse Event|2|||
161002157|NCT01135511|581394556|FG003|Overall Study|Adverse Event|0|||
160960908|NCT01040260|581244602|FG001|Overall Study|Withdrawal by Subject|6|||
160960909|NCT01040260|581244601|FG000|Overall Study|Lost to Follow-up|3|||
160960910|NCT01040260|581244602|FG001|Overall Study|Lost to Follow-up|5|||
160960911|NCT00708916|581244615|FG000|Overall Study|Subject Noncompliance|2|||
160960912|NCT00708916|581244615|FG000|Overall Study|Adverse Event|2|||
160960913|NCT00951483|581244618|FG000|Overall Study|Physician Decision|4|||
160960914|NCT00951483|581244619|FG001|Overall Study|Physician Decision|0|||
160960915|NCT00951483|581244618|FG000|Overall Study|Withdrawal by Subject|15|||
160960916|NCT00951483|581244619|FG001|Overall Study|Withdrawal by Subject|0|||
160960917|NCT03565887|581244620|FG000|Overall Study|Adverse Event|1|||
160960918|NCT03565887|581244621|FG001|Overall Study|Adverse Event|0|||
160960919|NCT03565887|581244620|FG000|Overall Study|Withdrawal by Subject|0|||
160960920|NCT03565887|581244621|FG001|Overall Study|Withdrawal by Subject|2|||
160960921|NCT00689221|581244622|FG000|Overall Study|Ongoing at cut-off date|39|||
160960922|NCT00689221|581244623|FG001|Overall Study|Ongoing at cut-off date|36|||
160960923|NCT01292239|581244624|FG000|Overall Study|Other|1|||
160960924|NCT01292239|581244625|FG001|Overall Study|Other|1|||
160960925|NCT01292239|581244624|FG000|Overall Study|Withdrawal by Subject|3|||
160960926|NCT01292239|581244625|FG001|Overall Study|Withdrawal by Subject|6|||
160960927|NCT00262821|581244626|FG000|Overall Study|Ineligible - wrong stage|0|||
160960928|NCT00262821|581244627|FG001|Overall Study|Ineligible - wrong stage|3|||
160960929|NCT00262821|581244626|FG000|Overall Study|Ineligible - wrong cell type|2|||
160960930|NCT00262821|581244627|FG001|Overall Study|Ineligible - wrong cell type|2|||
160960931|NCT00262821|581244626|FG000|Overall Study|Ineligible - wrong primary|0|||
160960932|NCT00262821|581244627|FG001|Overall Study|Ineligible - wrong primary|1|||
160960933|NCT00262821|581244626|FG000|Overall Study|Ineligible - inadequate pathology|1|||
160960934|NCT00262821|581244627|FG001|Overall Study|Ineligible - inadequate pathology|3|||
160960935|NCT00262821|581244626|FG000|Overall Study|Ineligible - elevated creatinine|0|||
160960936|NCT00262821|581244627|FG001|Overall Study|Ineligible - elevated creatinine|2|||
160960937|NCT00262821|581244626|FG000|Overall Study|Ineligible - required test not done|1|||
160960938|NCT00262821|581244627|FG001|Overall Study|Ineligible - required test not done|4|||
160960939|NCT00262821|581244626|FG000|Overall Study|Inevaluable - inadequate data|0|||
160960940|NCT00262821|581244627|FG001|Overall Study|Inevaluable - inadequate data|4|||
160960941|NCT01995461|581244628|FG000|Overall Study|Death|1|||
160960942|NCT01995461|581244628|FG000|Overall Study|Lost to Follow-up|2|||
161002158|NCT01135511|581394557|FG004|Overall Study|Adverse Event|0|||
161002159|NCT01135511|581394558|FG005|Overall Study|Adverse Event|1|||
161002160|NCT01135511|581394559|FG006|Overall Study|Adverse Event|0|||
161002161|NCT01135511|581394560|FG007|Overall Study|Adverse Event|1|||
161002162|NCT01135511|581394561|FG008|Overall Study|Adverse Event|0|||
161002163|NCT01135511|581394553|FG000|Overall Study|Lack of Efficacy|0|||
161002164|NCT01135511|581394554|FG001|Overall Study|Lack of Efficacy|1|||
161002165|NCT01135511|581394555|FG002|Overall Study|Lack of Efficacy|1|||
161002166|NCT01135511|581394556|FG003|Overall Study|Lack of Efficacy|2|||
161002167|NCT01135511|581394557|FG004|Overall Study|Lack of Efficacy|0|||
161002168|NCT01135511|581394558|FG005|Overall Study|Lack of Efficacy|0|||
161002169|NCT01135511|581394559|FG006|Overall Study|Lack of Efficacy|0|||
161002170|NCT01135511|581394560|FG007|Overall Study|Lack of Efficacy|0|||
160960943|NCT01995461|581244628|FG000|Overall Study|Withdrawal by Subject|2|||
160960944|NCT01777854|581244630|FG000|Overall Study|Physician Decision|3|||
160960945|NCT01777854|581244631|FG001|Overall Study|Physician Decision|3|||
160960946|NCT01939548|581244632|FG000|Overall Study|Non compliance|0|||
160960947|NCT01939548|581244633|FG001|Overall Study|Non compliance|2|||
160960948|NCT01939548|581244634|FG002|Overall Study|Non compliance|0|||
160960949|NCT01939548|581244632|FG000|Overall Study|Study Terminated by Sponsor|17|||
160960950|NCT01939548|581244633|FG001|Overall Study|Study Terminated by Sponsor|19|||
160960951|NCT01939548|581244634|FG002|Overall Study|Study Terminated by Sponsor|12|||
160960952|NCT01939548|581244632|FG000|Overall Study|Insufficient Clinical Response|1|||
161002171|NCT01135511|581394561|FG008|Overall Study|Lack of Efficacy|0|||
161002172|NCT01135511|581394553|FG000|Overall Study|Protocol Violation|0|||
161002173|NCT01135511|581394554|FG001|Overall Study|Protocol Violation|0|||
161002174|NCT01135511|581394555|FG002|Overall Study|Protocol Violation|3|||
161002175|NCT01135511|581394556|FG003|Overall Study|Protocol Violation|0|||
161002176|NCT01135511|581394557|FG004|Overall Study|Protocol Violation|0|||
161002177|NCT01135511|581394558|FG005|Overall Study|Protocol Violation|0|||
161002178|NCT01135511|581394559|FG006|Overall Study|Protocol Violation|0|||
161002179|NCT01135511|581394560|FG007|Overall Study|Protocol Violation|0|||
160458206|NCT03988621|579409122|FG001|Overall Study|Patient death|5|||
160458207|NCT02905331|579409123|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
160458208|NCT02905331|579409124|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
160960953|NCT01939548|581244633|FG001|Overall Study|Insufficient Clinical Response|0|||
160960954|NCT01939548|581244634|FG002|Overall Study|Insufficient Clinical Response|0|||
160960955|NCT01939548|581244632|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
160960956|NCT01939548|581244633|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
160960957|NCT01939548|581244634|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
160960958|NCT01939548|581244632|FG000|Overall Study|Withdrawal by Subject|4|||
160960959|NCT01939548|581244633|FG001|Overall Study|Withdrawal by Subject|4|||
160960960|NCT01939548|581244634|FG002|Overall Study|Withdrawal by Subject|1|||
161002180|NCT01135511|581394561|FG008|Overall Study|Protocol Violation|0|||
161002181|NCT01135511|581394553|FG000|Overall Study|Pregnancy|0|||
161002182|NCT01135511|581394554|FG001|Overall Study|Pregnancy|0|||
161002183|NCT01135511|581394555|FG002|Overall Study|Pregnancy|0|||
161002184|NCT01135511|581394556|FG003|Overall Study|Pregnancy|1|||
160960961|NCT01939548|581244632|FG000|Overall Study|Protocol Violation|7|||
161002185|NCT01135511|581394557|FG004|Overall Study|Pregnancy|0|||
161002186|NCT01135511|581394558|FG005|Overall Study|Pregnancy|0|||
161002187|NCT01135511|581394559|FG006|Overall Study|Pregnancy|0|||
160960962|NCT01939548|581244633|FG001|Overall Study|Protocol Violation|6|||
160960963|NCT01939548|581244634|FG002|Overall Study|Protocol Violation|5|||
160960964|NCT01939548|581244632|FG000|Overall Study|Lost to Follow-up|5|||
160960965|NCT01939548|581244633|FG001|Overall Study|Lost to Follow-up|5|||
160960966|NCT01939548|581244634|FG002|Overall Study|Lost to Follow-up|3|||
160960967|NCT01939548|581244632|FG000|Overall Study|Adverse Event|2|||
160960968|NCT01939548|581244633|FG001|Overall Study|Adverse Event|9|||
160960969|NCT01939548|581244634|FG002|Overall Study|Adverse Event|7|||
160960970|NCT01939548|581244632|FG000|Overall Study|Death|0|||
160960971|NCT01939548|581244633|FG001|Overall Study|Death|0|||
160960972|NCT01939548|581244634|FG002|Overall Study|Death|1|||
160960973|NCT01939548|581244632|FG000|Overall Study|Participant dropped|0|||
160960974|NCT01939548|581244633|FG001|Overall Study|Participant dropped|0|||
160960975|NCT01939548|581244634|FG002|Overall Study|Participant dropped|1|||
160960976|NCT01939548|581244632|FG000|Overall Study|Participant unwilling to continue|0|||
160960977|NCT01939548|581244633|FG001|Overall Study|Participant unwilling to continue|1|||
160960978|NCT01939548|581244634|FG002|Overall Study|Participant unwilling to continue|0|||
160960979|NCT01939548|581244632|FG000|Overall Study|Participant withdrew consent|0|||
160960980|NCT01939548|581244633|FG001|Overall Study|Participant withdrew consent|2|||
160960981|NCT01939548|581244634|FG002|Overall Study|Participant withdrew consent|0|||
160960982|NCT01939548|581244632|FG000|Overall Study|Did not complete follow-up|0|||
160960983|NCT01939548|581244633|FG001|Overall Study|Did not complete follow-up|1|||
160960984|NCT01939548|581244634|FG002|Overall Study|Did not complete follow-up|0|||
160960985|NCT03311373|581244635|FG000|Overall Study|Adverse Event|1|||
160960986|NCT03311373|581244635|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
160960987|NCT03311373|581244635|FG000|Overall Study|Lost to Follow-up|1|||
160960988|NCT03311373|581244635|FG000|Overall Study|Physician Decision|1|||
160960989|NCT03311373|581244635|FG000|Overall Study|Withdrawal by Subject|3|||
160960990|NCT01302119|581244636|FG000|Overall Study|Withdrawal by Subject|30|||
160960991|NCT01302119|581244637|FG001|Overall Study|Withdrawal by Subject|20|||
160960992|NCT01302119|581244636|FG000|Overall Study|Lost to Follow-up|10|||
160960993|NCT01302119|581244637|FG001|Overall Study|Lost to Follow-up|4|||
160960994|NCT01302119|581244636|FG000|Overall Study|Adverse Event|2|||
160960995|NCT01302119|581244637|FG001|Overall Study|Adverse Event|1|||
160960996|NCT01302119|581244636|FG000|Overall Study|Non-compliance|4|||
160960997|NCT01302119|581244637|FG001|Overall Study|Non-compliance|2|||
160960998|NCT01302119|581244636|FG000|Overall Study|Non-specific|4|||
160960999|NCT01302119|581244637|FG001|Overall Study|Non-specific|1|||
160961000|NCT01565707|581244645|FG000|Overall Study|Adverse Event|1|||
160961001|NCT01565707|581244646|FG001|Overall Study|Adverse Event|6|||
160961002|NCT01565707|581244647|FG002|Overall Study|Adverse Event|2|||
160961003|NCT01565707|581244648|FG003|Overall Study|Adverse Event|1|||
160961004|NCT01565707|581244645|FG000|Overall Study|Lost to Follow-up|1|||
160961005|NCT01565707|581244646|FG001|Overall Study|Lost to Follow-up|0|||
160961006|NCT01565707|581244647|FG002|Overall Study|Lost to Follow-up|0|||
160961007|NCT01565707|581244648|FG003|Overall Study|Lost to Follow-up|0|||
160961008|NCT01565707|581244645|FG000|Overall Study|Protocol Violation|1|||
160961009|NCT01565707|581244646|FG001|Overall Study|Protocol Violation|0|||
160961010|NCT01565707|581244647|FG002|Overall Study|Protocol Violation|0|||
160961011|NCT01565707|581244648|FG003|Overall Study|Protocol Violation|1|||
160961012|NCT01565707|581244645|FG000|Overall Study|Withdrawal by Subject|3|||
160961013|NCT01565707|581244646|FG001|Overall Study|Withdrawal by Subject|1|||
160961014|NCT01565707|581244647|FG002|Overall Study|Withdrawal by Subject|1|||
160961015|NCT01565707|581244648|FG003|Overall Study|Withdrawal by Subject|1|||
160961016|NCT01565707|581244645|FG000|Overall Study|Randomized but not evaluable|2|||
160961017|NCT01565707|581244646|FG001|Overall Study|Randomized but not evaluable|0|||
160961018|NCT01565707|581244647|FG002|Overall Study|Randomized but not evaluable|0|||
160961019|NCT01565707|581244648|FG003|Overall Study|Randomized but not evaluable|0|||
160961020|NCT01565707|581244645|FG000|Overall Study|Miscellaneous|1|||
160961021|NCT01565707|581244646|FG001|Overall Study|Miscellaneous|1|||
160961022|NCT01565707|581244647|FG002|Overall Study|Miscellaneous|0|||
160961023|NCT01565707|581244648|FG003|Overall Study|Miscellaneous|2|||
160961024|NCT01371851|581244649|FG000|Overall Study|Lost to Follow-up|5|||
160961025|NCT01371851|581244650|FG001|Overall Study|Lost to Follow-up|8|||
160961026|NCT01371851|581244649|FG000|Overall Study|was arrested and put in jail|0|||
160961027|NCT01371851|581244650|FG001|Overall Study|was arrested and put in jail|1|||
160961028|NCT01371851|581244649|FG000|Overall Study|non study related adverse event|1|||
160961029|NCT01371851|581244650|FG001|Overall Study|non study related adverse event|0|||
160961030|NCT01371851|581244649|FG000|Overall Study|Blood Pressure outside study parameters|2|||
160961031|NCT01371851|581244650|FG001|Overall Study|Blood Pressure outside study parameters|0|||
160961032|NCT00450411|581244651|FG000|Overall Study|Protocol Violation|6|||
160961033|NCT00450411|581244651|FG000|Overall Study|No protocol treatment|2|||
160961034|NCT03969719|581244662|FG000|Overall Study|Other reasons not specified|1|||
160961035|NCT03969719|581244663|FG001|Overall Study|Other reasons not specified|1|||
160961036|NCT03969719|581244664|FG002|Overall Study|Other reasons not specified|3|||
160961037|NCT03969719|581244662|FG000|Overall Study|Withdrawal by Subject|2|||
161002188|NCT01135511|581394560|FG007|Overall Study|Pregnancy|0|||
161002189|NCT01135511|581394561|FG008|Overall Study|Pregnancy|0|||
160961038|NCT03969719|581244663|FG001|Overall Study|Withdrawal by Subject|3|||
160961039|NCT03969719|581244664|FG002|Overall Study|Withdrawal by Subject|2|||
161002190|NCT01135511|581394553|FG000|Overall Study|could not visit the clinic|0|||
161002191|NCT01135511|581394554|FG001|Overall Study|could not visit the clinic|1|||
161002192|NCT01135511|581394555|FG002|Overall Study|could not visit the clinic|2|||
161002193|NCT01135511|581394556|FG003|Overall Study|could not visit the clinic|0|||
160961040|NCT03969719|581244662|FG000|Overall Study|Protocol Violation|1|||
160961041|NCT03969719|581244663|FG001|Overall Study|Protocol Violation|2|||
160961042|NCT03969719|581244664|FG002|Overall Study|Protocol Violation|0|||
160961043|NCT03969719|581244662|FG000|Overall Study|Adverse Event|0|||
160961044|NCT03969719|581244663|FG001|Overall Study|Adverse Event|2|||
160961045|NCT03969719|581244664|FG002|Overall Study|Adverse Event|0|||
160961046|NCT03969719|581244662|FG000|Overall Study|Lost to Follow-up|0|||
160961047|NCT03969719|581244663|FG001|Overall Study|Lost to Follow-up|1|||
160961048|NCT03969719|581244664|FG002|Overall Study|Lost to Follow-up|0|||
160961049|NCT05608629|581244665|FG000|Overall Study|Lost to Follow-up|2|||
160961050|NCT02130193|581244666|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
160961051|NCT02130193|581244667|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
160961052|NCT02130193|581244668|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
160961053|NCT02130193|581244666|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
160961054|NCT02130193|581244667|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
160961055|NCT02130193|581244668|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
160961056|NCT02130193|581244666|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
160961057|NCT02130193|581244667|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
160961058|NCT02130193|581244668|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
160961059|NCT02130193|581244666|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
160961060|NCT02130193|581244667|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
160961061|NCT02130193|581244668|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
160961062|NCT01297959|581244669|FG000|Overall Study|Adverse Event|0|||
160961063|NCT01297959|581244670|FG001|Overall Study|Adverse Event|1|||
160961064|NCT01297959|581244669|FG000|Overall Study|Protocol Violation|2|||
160961065|NCT01297959|581244670|FG001|Overall Study|Protocol Violation|1|||
160961066|NCT01297959|581244669|FG000|Overall Study|Withdrawal by Subject|5|||
160961067|NCT01297959|581244670|FG001|Overall Study|Withdrawal by Subject|4|||
160961068|NCT01297959|581244669|FG000|Overall Study|Physician Decision|0|||
160961069|NCT01297959|581244670|FG001|Overall Study|Physician Decision|1|||
160961070|NCT01297959|581244669|FG000|Overall Study|Unrelated medical illness / complication|0|||
160961071|NCT01297959|581244670|FG001|Overall Study|Unrelated medical illness / complication|2|||
160961072|NCT01297959|581244669|FG000|Overall Study|Other|13|||
160961073|NCT01297959|581244670|FG001|Overall Study|Other|7|||
160961074|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
160961075|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
160961076|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
160961077|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961078|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961079|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961080|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961081|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961082|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961083|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
160961084|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
160961085|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
160961086|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161002194|NCT01135511|581394557|FG004|Overall Study|could not visit the clinic|0|||
161002195|NCT01135511|581394558|FG005|Overall Study|could not visit the clinic|0|||
161002196|NCT01135511|581394559|FG006|Overall Study|could not visit the clinic|0|||
161002197|NCT01135511|581394560|FG007|Overall Study|could not visit the clinic|0|||
160961087|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160961088|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161002198|NCT01135511|581394561|FG008|Overall Study|could not visit the clinic|0|||
160584923|NCT02052778|579861891|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160584924|NCT02052778|579861892|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160584925|NCT02052778|579861893|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160961089|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160961090|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160961091|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160961092|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
160961093|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
160961094|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
160961095|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961096|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961097|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961098|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961099|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961100|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961101|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
160961102|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961103|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
160961104|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961105|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961106|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961107|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961108|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961109|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961110|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961111|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961112|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
160961113|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961114|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961115|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961116|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961117|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961118|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961119|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
160961120|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
160961121|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
160961122|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961123|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961124|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961125|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961126|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961127|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961128|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
160961129|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
160961130|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
160961131|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
160961132|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
160961133|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
160961134|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
160961135|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
160961136|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
160961137|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
160961138|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
160961139|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
160961140|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
160961141|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
160961142|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
160961143|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
160961144|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
160961145|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
160961146|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
161002199|NCT01135511|581394553|FG000|Overall Study|noncompliance with study drug taken|0|||
160584926|NCT02052778|579861894|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160584927|NCT02052778|579861895|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160584928|NCT02052778|579861896|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160584929|NCT02052778|579861897|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160584930|NCT02052778|579861898|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
160584931|NCT02052778|579861876|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584932|NCT02052778|579861877|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584933|NCT02052778|579861878|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584934|NCT02052778|579861879|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584935|NCT02052778|579861880|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584936|NCT02052778|579861881|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584937|NCT02052778|579861882|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160961147|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
160961148|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
160961149|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
160961150|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
160961151|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
160961152|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
160961153|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
160961154|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
160961155|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961156|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961157|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
160961158|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961159|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961160|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961161|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961162|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961163|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961164|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961165|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961166|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961167|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
160961168|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961169|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961170|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961171|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961172|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961173|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961174|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961175|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
160961176|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
160961177|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961178|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961179|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961180|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961181|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961182|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961183|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
160961184|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
160961185|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961186|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961187|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961188|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961189|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961190|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
160961191|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
160961192|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
160961193|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
160961194|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161002200|NCT01135511|581394554|FG001|Overall Study|noncompliance with study drug taken|0|||
161002201|NCT01135511|581394555|FG002|Overall Study|noncompliance with study drug taken|0|||
161002202|NCT01135511|581394556|FG003|Overall Study|noncompliance with study drug taken|0|||
161002203|NCT01135511|581394557|FG004|Overall Study|noncompliance with study drug taken|1|||
161002204|NCT01135511|581394558|FG005|Overall Study|noncompliance with study drug taken|0|||
161002205|NCT01135511|581394559|FG006|Overall Study|noncompliance with study drug taken|0|||
161002206|NCT01135511|581394560|FG007|Overall Study|noncompliance with study drug taken|0|||
161002207|NCT01135511|581394561|FG008|Overall Study|noncompliance with study drug taken|0|||
161002208|NCT01135511|581394553|FG000|Overall Study|Withdrawal by Subject|0|||
160584938|NCT02052778|579861883|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584939|NCT02052778|579861884|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584940|NCT02052778|579861885|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584941|NCT02052778|579861886|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160961195|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
160961196|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161002209|NCT01135511|581394554|FG001|Overall Study|Withdrawal by Subject|0|||
161002210|NCT01135511|581394555|FG002|Overall Study|Withdrawal by Subject|0|||
161002211|NCT01135511|581394556|FG003|Overall Study|Withdrawal by Subject|0|||
160961197|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
160961198|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
160961199|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
160961200|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961201|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
160961202|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961203|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961204|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961205|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961206|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961207|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961208|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961209|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160961210|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
160961211|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
160961212|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160961213|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160961214|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160961215|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160961216|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
160961217|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
160961218|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
160961219|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
160961220|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
160961221|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
160961222|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
160961223|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
160961224|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
160961225|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
160961226|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
160961227|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961228|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
160961229|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
160961230|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961231|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961232|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961233|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961234|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961235|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
160961236|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160961237|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
160961238|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
160961239|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160961240|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160961241|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160961242|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160961243|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
161002212|NCT01135511|581394557|FG004|Overall Study|Withdrawal by Subject|0|||
161002213|NCT01135511|581394558|FG005|Overall Study|Withdrawal by Subject|0|||
161002214|NCT01135511|581394559|FG006|Overall Study|Withdrawal by Subject|1|||
161002215|NCT01135511|581394560|FG007|Overall Study|Withdrawal by Subject|0|||
161002216|NCT01135511|581394561|FG008|Overall Study|Withdrawal by Subject|1|||
161002217|NCT03482011|581394568|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
161002218|NCT03482011|581394569|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
161002219|NCT03482011|581394570|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
161002220|NCT03482011|581394571|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
161002221|NCT03482011|581394572|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
161002222|NCT03482011|581394573|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
161002223|NCT03482011|581394574|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
161002224|NCT03482011|581394575|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
161002225|NCT03482011|581394568|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
161002226|NCT03482011|581394569|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
161002227|NCT03482011|581394570|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002228|NCT03482011|581394571|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002229|NCT03482011|581394572|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002230|NCT03482011|581394573|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002231|NCT03482011|581394574|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002232|NCT03482011|581394575|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002233|NCT03482011|581394568|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002234|NCT03482011|581394569|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
160458209|NCT02905331|579409125|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
160961244|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
160961245|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160458210|NCT02905331|579409123|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
160961246|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
160961247|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
160961248|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160961249|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160961250|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160961251|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160961252|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
160961253|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
160961254|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160961255|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
160961256|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
160961257|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160961258|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160961259|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160961260|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160961261|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
160961262|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
160961263|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961264|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
160961265|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961266|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961267|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961268|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961269|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961270|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961271|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961272|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961273|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961274|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961275|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961276|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961277|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961278|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961279|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
160961280|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961281|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160961282|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
160961283|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
160961284|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161002235|NCT03482011|581394570|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002236|NCT03482011|581394571|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002237|NCT03482011|581394572|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002238|NCT03482011|581394573|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002239|NCT03482011|581394574|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002240|NCT03482011|581394575|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002241|NCT03482011|581394568|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
161002242|NCT03482011|581394569|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
161002243|NCT03482011|581394570|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
161002244|NCT03482011|581394571|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
161002245|NCT03482011|581394572|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
161002246|NCT03482011|581394573|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
161002247|NCT03482011|581394574|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
161002248|NCT03482011|581394575|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
160458211|NCT02905331|579409124|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
160458212|NCT02905331|579409125|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
160961285|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160961286|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161002249|NCT03482011|581394568|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
161002250|NCT03482011|581394569|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
160458213|NCT02905331|579409123|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
160458214|NCT02905331|579409124|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
160458215|NCT02905331|579409125|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
160961287|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160961288|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
160458216|NCT02905331|579409123|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
160458217|NCT02905331|579409124|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
160458218|NCT02905331|579409125|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
160961289|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
160961290|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961291|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
160961292|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
160961293|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961294|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961295|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961296|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961297|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961298|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
160961299|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961300|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
160961301|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
160961302|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961303|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961304|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961305|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961306|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
160961307|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961308|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961309|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
160961310|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
160961311|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961312|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961313|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961314|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961315|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
160961316|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961317|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961318|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
160961319|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
160961320|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961321|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961322|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961323|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961324|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961325|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961326|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961327|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961328|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
160961329|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961330|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961331|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961332|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961333|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961334|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961335|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961336|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
160961337|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961338|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961339|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961340|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961341|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961342|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961343|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
160961344|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
160961345|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
160961346|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
160961347|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
160961348|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
160961349|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
160961350|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
160961351|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
160961352|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
160458219|NCT02905331|579409123|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
160961353|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961354|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961355|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
160961356|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961357|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961358|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961359|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961360|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961361|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961362|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961363|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961364|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
160961365|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961366|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961367|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961368|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961369|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961370|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
160961371|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961372|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961373|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
160961374|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961375|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961376|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961377|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961378|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961379|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961380|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961381|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
160961382|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
160961383|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961384|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961385|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961386|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961387|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
160961388|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961389|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Death|0|||
160961390|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Death|0|||
160961391|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Death|0|||
160961392|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Death|0|||
160961393|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Death|0|||
160961394|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Death|0|||
160961395|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Death|0|||
160961396|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Death|1|||
160961397|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Death|0|||
160961398|NCT00829387|581244682|FG000|Overall Study|Withdrawal by Subject|2|||
160961399|NCT00829387|581244683|FG001|Overall Study|Withdrawal by Subject|3|||
160961400|NCT00829387|581244682|FG000|Overall Study|Disqualified by PI|1|||
160961401|NCT00829387|581244683|FG001|Overall Study|Disqualified by PI|0|||
161002251|NCT03482011|581394570|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002252|NCT03482011|581394571|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002253|NCT03482011|581394572|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002254|NCT03482011|581394573|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002255|NCT03482011|581394574|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002256|NCT03482011|581394575|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002257|NCT03482011|581394568|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
161002258|NCT03482011|581394569|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
160961402|NCT03519854|581244684|FG000|Overall Study|Technical Error|0|||
160961403|NCT03519854|581244685|FG001|Overall Study|Technical Error|0|||
160961404|NCT03519854|581244686|FG002|Overall Study|Technical Error|1|||
160961405|NCT03519854|581244687|FG003|Overall Study|Technical Error|0|||
161002259|NCT03482011|581394570|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
161002260|NCT03482011|581394571|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
161002261|NCT03482011|581394572|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
161002262|NCT03482011|581394573|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
161002263|NCT03482011|581394574|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
161002264|NCT03482011|581394575|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
161002265|NCT03482011|581394568|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161002266|NCT03482011|581394569|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
160961406|NCT03519854|581244688|FG004|Overall Study|Technical Error|0|||
160961407|NCT03519854|581244689|FG005|Overall Study|Technical Error|0|||
160961408|NCT03519854|581244690|FG006|Overall Study|Technical Error|0|||
160961409|NCT03519854|581244691|FG007|Overall Study|Technical Error|0|||
160961410|NCT03519854|581244692|FG008|Overall Study|Technical Error|0|||
160961411|NCT03519854|581244693|FG009|Overall Study|Technical Error|0|||
160961412|NCT03519854|581244694|FG010|Overall Study|Technical Error|0|||
160961413|NCT03519854|581244695|FG011|Overall Study|Technical Error|0|||
160961414|NCT03519854|581244696|FG012|Overall Study|Technical Error|0|||
161002267|NCT03482011|581394570|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
161002268|NCT03482011|581394571|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
161002269|NCT03482011|581394572|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
161002270|NCT03482011|581394573|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
161002271|NCT03482011|581394574|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161002272|NCT03482011|581394575|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
161002273|NCT03482011|581394568|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002274|NCT03482011|581394569|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002275|NCT03482011|581394570|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002276|NCT03482011|581394571|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002277|NCT03482011|581394572|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
160961415|NCT03519854|581244697|FG013|Overall Study|Technical Error|0|||
160961416|NCT03519854|581244698|FG014|Overall Study|Technical Error|0|||
160961417|NCT03519854|581244699|FG015|Overall Study|Technical Error|0|||
161002278|NCT03482011|581394573|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002279|NCT03482011|581394574|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002280|NCT03482011|581394575|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
161002281|NCT03482011|581394568|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
161002282|NCT03482011|581394569|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
161002283|NCT03482011|581394570|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
161002284|NCT03482011|581394571|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
161002285|NCT03482011|581394572|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
161002286|NCT03482011|581394573|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
161002287|NCT03482011|581394574|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
161002288|NCT03482011|581394575|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
161002289|NCT03482011|581394568|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161002290|NCT03482011|581394569|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161002291|NCT03482011|581394570|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161002292|NCT03482011|581394571|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
161002293|NCT03482011|581394572|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161002294|NCT03482011|581394573|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
161002295|NCT03482011|581394574|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161002296|NCT03482011|581394575|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161002297|NCT03482011|581394568|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161002298|NCT03482011|581394569|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161002299|NCT03482011|581394570|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161002300|NCT03482011|581394571|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
161002301|NCT03482011|581394572|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161002302|NCT03482011|581394573|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
161002303|NCT03482011|581394574|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
161002304|NCT03482011|581394575|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
161002305|NCT03482011|581394568|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002306|NCT03482011|581394569|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002307|NCT03482011|581394570|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002308|NCT03482011|581394571|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002309|NCT03482011|581394572|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002310|NCT03482011|581394573|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002311|NCT03482011|581394574|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
161002312|NCT03482011|581394575|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
161002313|NCT03482011|581394568|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161002314|NCT03482011|581394569|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161002315|NCT03482011|581394570|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
161002316|NCT03482011|581394571|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
161002317|NCT03482011|581394572|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
160458220|NCT02905331|579409124|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
160961418|NCT03519854|581244700|FG016|Overall Study|Technical Error|0|||
161002318|NCT03482011|581394573|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
160961419|NCT03519854|581244701|FG017|Overall Study|Technical Error|0|||
161002319|NCT03482011|581394574|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161002320|NCT03482011|581394575|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
161002321|NCT03482011|581394568|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
161002322|NCT03482011|581394569|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
160961420|NCT00707031|581244702|FG000|Overall Study|Adverse Event|45|||
160961421|NCT00707031|581244703|FG001|Overall Study|Adverse Event|45|||
160961422|NCT00707031|581244702|FG000|Overall Study|Lack of Efficacy|19|||
160961423|NCT00707031|581244703|FG001|Overall Study|Lack of Efficacy|6|||
160961424|NCT00707031|581244702|FG000|Overall Study|Lost to Follow-up|2|||
160961425|NCT00707031|581244703|FG001|Overall Study|Lost to Follow-up|1|||
160961426|NCT00707031|581244702|FG000|Overall Study|Protocol Violation|1|||
160961427|NCT00707031|581244703|FG001|Overall Study|Protocol Violation|0|||
160961428|NCT00707031|581244702|FG000|Overall Study|Withdrawal by Subject|7|||
160961429|NCT00707031|581244703|FG001|Overall Study|Withdrawal by Subject|8|||
160961430|NCT00707031|581244702|FG000|Overall Study|Poor Compliance to Protocol|7|||
160961431|NCT00707031|581244703|FG001|Overall Study|Poor Compliance to Protocol|13|||
160961432|NCT00707031|581244702|FG000|Overall Study|Familial or Personal Reasons|12|||
160961433|NCT00707031|581244703|FG001|Overall Study|Familial or Personal Reasons|15|||
160961434|NCT00707031|581244702|FG000|Overall Study|Serious Noncompliance|2|||
160961435|NCT00707031|581244703|FG001|Overall Study|Serious Noncompliance|3|||
160961436|NCT00707031|581244702|FG000|Overall Study|Sponsor Decision|9|||
160961437|NCT00707031|581244703|FG001|Overall Study|Sponsor Decision|8|||
160961438|NCT00951275|581244704|FG000|Overall Study|Administrative Reason|1|||
160961439|NCT00951275|581244704|FG000|Overall Study|Adverse Event|7|||
160961440|NCT00951275|581244704|FG000|Overall Study|Withdrawal by Subject|4|||
160961441|NCT00951275|581244704|FG000|Overall Study|Protocol Violation|1|||
160961442|NCT03260868|581244709|FG000|Overall Study|Poor Compliance to Protocol|0|||
160961443|NCT03260868|581244710|FG001|Overall Study|Poor Compliance to Protocol|2|||
160961444|NCT03260868|581244709|FG000|Overall Study|Study Terminated By Sponsor|2|||
160961445|NCT03260868|581244710|FG001|Overall Study|Study Terminated By Sponsor|1|||
160961446|NCT03260868|581244709|FG000|Overall Study|Other than specified above|1|||
160961447|NCT03260868|581244710|FG001|Overall Study|Other than specified above|0|||
160961448|NCT02925676|581244711|FG000|Overall Study|Withdrawal by Subject|1|||
160961449|NCT02048072|581244712|FG000|Overall Study|Adverse Event|3|||
160961450|NCT02048072|581244712|FG000|Overall Study|Lost to Follow-up|1|||
160961451|NCT02693743|581244715|FG000|Overall Study|Physician Decision|1|||
160961452|NCT02693743|581244716|FG001|Overall Study|Physician Decision|0|||
160961453|NCT02626780|581244717|FG000|Overall Study|Withdrawal by Subject|3|||
160961454|NCT04304833|581244718|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
160961455|NCT04304833|581244719|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
160961456|NCT02858895|581244720|FG000|Overall Study|Disease progression|31|||
160961457|NCT02858895|581244720|FG000|Overall Study|Death|2|||
160961458|NCT02858895|581244720|FG000|Overall Study|Adverse Event|1|||
160961459|NCT02858895|581244720|FG000|Overall Study|Withdrawal by Subject|3|||
160961460|NCT02858895|581244720|FG000|Overall Study|hospice,|1|||
160961461|NCT02858895|581244720|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
160961462|NCT05540522|581244721|FG000|Overall Study|Adverse Event|1|||
160961463|NCT05540522|581244722|FG001|Overall Study|Adverse Event|0|||
160961464|NCT05540522|581244723|FG002|Overall Study|Adverse Event|2|||
160961465|NCT05540522|581244724|FG003|Overall Study|Adverse Event|5|||
160961466|NCT05540522|581244721|FG000|Overall Study|Lost to Follow-up|487|||
160961467|NCT05540522|581244722|FG001|Overall Study|Lost to Follow-up|427|||
160961468|NCT05540522|581244723|FG002|Overall Study|Lost to Follow-up|146|||
160961469|NCT05540522|581244724|FG003|Overall Study|Lost to Follow-up|166|||
160961470|NCT05540522|581244721|FG000|Overall Study|Physician Decision|11|||
160961471|NCT05540522|581244722|FG001|Overall Study|Physician Decision|19|||
160961472|NCT05540522|581244723|FG002|Overall Study|Physician Decision|8|||
160961473|NCT05540522|581244724|FG003|Overall Study|Physician Decision|13|||
160961474|NCT05540522|581244721|FG000|Overall Study|Pregnancy|1|||
160961475|NCT05540522|581244722|FG001|Overall Study|Pregnancy|0|||
160961476|NCT05540522|581244723|FG002|Overall Study|Pregnancy|0|||
160961477|NCT05540522|581244724|FG003|Overall Study|Pregnancy|0|||
160961478|NCT05540522|581244721|FG000|Overall Study|Protocol Violation|3|||
160961479|NCT05540522|581244722|FG001|Overall Study|Protocol Violation|1|||
160961480|NCT05540522|581244723|FG002|Overall Study|Protocol Violation|9|||
160961481|NCT05540522|581244724|FG003|Overall Study|Protocol Violation|7|||
160961482|NCT05540522|581244721|FG000|Overall Study|Withdrawal by Subject|168|||
160961483|NCT05540522|581244722|FG001|Overall Study|Withdrawal by Subject|134|||
160961484|NCT05540522|581244723|FG002|Overall Study|Withdrawal by Subject|331|||
160458221|NCT02905331|579409125|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
160961485|NCT05540522|581244724|FG003|Overall Study|Withdrawal by Subject|322|||
160458222|NCT04424316|579409129|FG000|Overall Study|Adverse Event|0|||
160458223|NCT04424316|579409130|FG001|Overall Study|Adverse Event|1|||
160458224|NCT04424316|579409131|FG002|Overall Study|Adverse Event|0|||
160961486|NCT05540522|581244721|FG000|Overall Study|Death|7|||
160961487|NCT05540522|581244722|FG001|Overall Study|Death|9|||
160961488|NCT05540522|581244723|FG002|Overall Study|Death|49|||
160961489|NCT05540522|581244724|FG003|Overall Study|Death|46|||
160961490|NCT05540522|581244721|FG000|Overall Study|Not vaccinated|34|||
160961491|NCT05540522|581244722|FG001|Overall Study|Not vaccinated|53|||
160961492|NCT05540522|581244723|FG002|Overall Study|Not vaccinated|57|||
160961493|NCT05540522|581244724|FG003|Overall Study|Not vaccinated|50|||
160961494|NCT05540522|581244721|FG000|Overall Study|No longer meets eligibility criteria|0|||
160961495|NCT05540522|581244722|FG001|Overall Study|No longer meets eligibility criteria|0|||
160961496|NCT05540522|581244723|FG002|Overall Study|No longer meets eligibility criteria|3|||
160961497|NCT05540522|581244724|FG003|Overall Study|No longer meets eligibility criteria|2|||
160961498|NCT05540522|581244721|FG000|Overall Study|Other (Unspecified)|8|||
160961499|NCT05540522|581244722|FG001|Overall Study|Other (Unspecified)|10|||
160961500|NCT05540522|581244723|FG002|Overall Study|Other (Unspecified)|4|||
160961501|NCT05540522|581244724|FG003|Overall Study|Other (Unspecified)|2|||
160961502|NCT00251745|581244731|FG000|Overall Study|Adverse Event|7|||
160961503|NCT00251745|581244732|FG001|Overall Study|Adverse Event|9|||
160961504|NCT00251745|581244733|FG002|Overall Study|Adverse Event|11|||
160961505|NCT00251745|581244731|FG000|Overall Study|Lost to Follow-up|4|||
160961506|NCT00251745|581244732|FG001|Overall Study|Lost to Follow-up|2|||
160961507|NCT00251745|581244733|FG002|Overall Study|Lost to Follow-up|5|||
160961508|NCT00251745|581244731|FG000|Overall Study|Withdrawal by Subject|13|||
160961509|NCT00251745|581244732|FG001|Overall Study|Withdrawal by Subject|7|||
160961510|NCT00251745|581244733|FG002|Overall Study|Withdrawal by Subject|3|||
160961511|NCT00251745|581244731|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
160961512|NCT00251745|581244732|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
160961513|NCT00251745|581244733|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
160961514|NCT00251745|581244731|FG000|Overall Study|Lack of Efficacy|3|||
160961515|NCT00251745|581244732|FG001|Overall Study|Lack of Efficacy|0|||
160961516|NCT00251745|581244733|FG002|Overall Study|Lack of Efficacy|0|||
160961517|NCT00251745|581244731|FG000|Overall Study|Noncompliant|0|||
160961518|NCT00251745|581244732|FG001|Overall Study|Noncompliant|2|||
160961519|NCT00251745|581244733|FG002|Overall Study|Noncompliant|2|||
160961520|NCT00251745|581244731|FG000|Overall Study|Pregnancy|0|||
160961521|NCT00251745|581244732|FG001|Overall Study|Pregnancy|1|||
160961522|NCT00251745|581244733|FG002|Overall Study|Pregnancy|0|||
160961523|NCT00251745|581244731|FG000|Overall Study|Per Subject Request|0|||
160961524|NCT00251745|581244732|FG001|Overall Study|Per Subject Request|0|||
160961525|NCT00251745|581244733|FG002|Overall Study|Per Subject Request|1|||
160961526|NCT00251745|581244731|FG000|Overall Study|Per Investigator Request|1|||
160961527|NCT00251745|581244732|FG001|Overall Study|Per Investigator Request|0|||
160961528|NCT00251745|581244733|FG002|Overall Study|Per Investigator Request|0|||
160961529|NCT04508699|581244738|FG000|Overall Study|Lack of Efficacy|2|||
160961530|NCT04508699|581244739|FG001|Overall Study|Lack of Efficacy|15|||
160961531|NCT04508699|581244738|FG000|Overall Study|Withdrawal by Subject|0|||
160961532|NCT04508699|581244739|FG001|Overall Study|Withdrawal by Subject|2|||
160961533|NCT02543658|581246366|FG000|Overall Study|Lack of Efficacy|0|||
160961534|NCT02543658|581246367|FG001|Overall Study|Lack of Efficacy|4|||
160961535|NCT00789815|581246368|FG000|Overall Study|Protocol Violation|6|||
160961536|NCT00789815|581246369|FG001|Overall Study|Protocol Violation|1|||
160961537|NCT00789815|581246368|FG000|Overall Study|Intubation due to massive bleeding|1|||
160961538|NCT00789815|581246369|FG001|Overall Study|Intubation due to massive bleeding|0|||
160961539|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
160961540|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
160961541|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
160961542|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
160961543|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
160961544|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
160961545|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Death|1|||
160961546|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Death|0|||
160961547|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Adverse Event|1|||
160961548|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Adverse Event|0|||
160961549|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Physician Decision|2|||
160961550|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Physician Decision|1|||
160961551|NCT02586025|581246378|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
160961552|NCT02586025|581246379|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
160961553|NCT02586025|581246378|FG000|Adjuvant Treatment|Recurrent Disease|4|||
160961554|NCT02586025|581246379|FG001|Adjuvant Treatment|Recurrent Disease|5|||
160961555|NCT02586025|581246378|FG000|Adjuvant Treatment|Physician Decision|0|||
160961556|NCT02586025|581246379|FG001|Adjuvant Treatment|Physician Decision|1|||
160961557|NCT02586025|581246378|FG000|Adjuvant Treatment|Pregnancy|1|||
160961558|NCT02586025|581246379|FG001|Adjuvant Treatment|Pregnancy|0|||
160961559|NCT02586025|581246378|FG000|Treatment-Free Follow-Up|Death|11|||
160961560|NCT02586025|581246379|FG001|Treatment-Free Follow-Up|Death|11|||
160458225|NCT04424316|579409132|FG003|Overall Study|Adverse Event|0|||
160961561|NCT02586025|581246378|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
160961562|NCT02586025|581246379|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
160961563|NCT02586025|581246378|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
160961564|NCT02586025|581246379|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
160961565|NCT02586025|581246378|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
160961566|NCT02586025|581246379|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
160961567|NCT02586025|581246378|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
160961568|NCT02586025|581246379|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
160961569|NCT00175825|581246380|FG000|Overall Study|Adverse Event|3|||
160961570|NCT00175825|581246381|FG001|Overall Study|Adverse Event|2|||
160961571|NCT00175825|581246382|FG002|Overall Study|Adverse Event|1|||
160961572|NCT00175825|581246383|FG003|Overall Study|Adverse Event|1|||
160961573|NCT00175825|581246380|FG000|Overall Study|Lost to Follow-up|1|||
160961574|NCT00175825|581246381|FG001|Overall Study|Lost to Follow-up|2|||
160961575|NCT00175825|581246382|FG002|Overall Study|Lost to Follow-up|0|||
160961576|NCT00175825|581246383|FG003|Overall Study|Lost to Follow-up|0|||
160961577|NCT00175825|581246380|FG000|Overall Study|Withdrawal by Subject|1|||
160961578|NCT00175825|581246381|FG001|Overall Study|Withdrawal by Subject|0|||
160961579|NCT00175825|581246382|FG002|Overall Study|Withdrawal by Subject|0|||
160961580|NCT00175825|581246383|FG003|Overall Study|Withdrawal by Subject|0|||
160961581|NCT03704584|581246384|FG000|Overall Study|Withdrawal by Subject|1|||
160961582|NCT03704584|581246385|FG001|Overall Study|Withdrawal by Subject|0|||
160961583|NCT03412812|581246386|FG000|Level 1|Death|3|||
160961584|NCT03412812|581246387|FG001|Level 1|Death|0|||
160961585|NCT03412812|581246386|FG000|Level 1|Adverse Event|0|||
160961586|NCT03412812|581246387|FG001|Level 1|Adverse Event|1|||
160961587|NCT03548207|581246390|FG000|Overall Study|Death|10|||
160961588|NCT03548207|581246391|FG001|Overall Study|Death|23|||
160961589|NCT03548207|581246392|FG002|Overall Study|Death|3|||
160961590|NCT03548207|581246390|FG000|Overall Study|Lost to Follow-up|0|||
160961591|NCT03548207|581246391|FG001|Overall Study|Lost to Follow-up|2|||
160961592|NCT03548207|581246392|FG002|Overall Study|Lost to Follow-up|0|||
160961593|NCT03548207|581246390|FG000|Overall Study|Withdrawal by Subject|0|||
160961594|NCT03548207|581246391|FG001|Overall Study|Withdrawal by Subject|3|||
160961595|NCT03548207|581246392|FG002|Overall Study|Withdrawal by Subject|0|||
160961596|NCT03548207|581246390|FG000|Overall Study|Sponsor decision|19|||
160961597|NCT03548207|581246391|FG001|Overall Study|Sponsor decision|40|||
160961598|NCT03548207|581246392|FG002|Overall Study|Sponsor decision|6|||
160961599|NCT03548207|581246390|FG000|Overall Study|Randomized but not treated|6|||
160961600|NCT03548207|581246391|FG001|Overall Study|Randomized but not treated|10|||
160961601|NCT03548207|581246392|FG002|Overall Study|Randomized but not treated|4|||
160961602|NCT03822117|581246393|FG000|Overall Study|Death|18|||
160961603|NCT03822117|581246394|FG001|Overall Study|Death|17|||
160961604|NCT03822117|581246395|FG002|Overall Study|Death|12|||
160961605|NCT03822117|581246396|FG003|Overall Study|Death|4|||
160961606|NCT03822117|581246393|FG000|Overall Study|Lost to Follow-up|1|||
160961607|NCT03822117|581246394|FG001|Overall Study|Lost to Follow-up|2|||
160961608|NCT03822117|581246395|FG002|Overall Study|Lost to Follow-up|3|||
160961609|NCT03822117|581246396|FG003|Overall Study|Lost to Follow-up|0|||
160961610|NCT03822117|581246393|FG000|Overall Study|Study Terminated by Sponsor|25|||
160961611|NCT03822117|581246394|FG001|Overall Study|Study Terminated by Sponsor|11|||
160961612|NCT03822117|581246395|FG002|Overall Study|Study Terminated by Sponsor|6|||
160961613|NCT03822117|581246396|FG003|Overall Study|Study Terminated by Sponsor|0|||
160961614|NCT03822117|581246393|FG000|Overall Study|Withdrawal by Subject|4|||
160961615|NCT03822117|581246394|FG001|Overall Study|Withdrawal by Subject|0|||
160961616|NCT03822117|581246395|FG002|Overall Study|Withdrawal by Subject|3|||
160961617|NCT03822117|581246396|FG003|Overall Study|Withdrawal by Subject|0|||
160961618|NCT03822117|581246393|FG000|Overall Study|Disease Progression|1|||
160961619|NCT03822117|581246394|FG001|Overall Study|Disease Progression|2|||
160961620|NCT03822117|581246395|FG002|Overall Study|Disease Progression|1|||
160961621|NCT03822117|581246396|FG003|Overall Study|Disease Progression|0|||
160961622|NCT03822117|581246393|FG000|Overall Study|Never Returned to Hospital|0|||
160961623|NCT03822117|581246394|FG001|Overall Study|Never Returned to Hospital|0|||
160961624|NCT03822117|581246395|FG002|Overall Study|Never Returned to Hospital|1|||
160961625|NCT03822117|581246396|FG003|Overall Study|Never Returned to Hospital|0|||
160961626|NCT00415610|581246397|FG000|Overall Study|Death|3|||
160961627|NCT00415610|581246398|FG001|Overall Study|Death|2|||
160961628|NCT00415610|581246399|FG002|Overall Study|Death|5|||
160961629|NCT01357616|581246400|FG000|Overall Study|Adverse Event|1|||
160961630|NCT01357616|581246401|FG001|Overall Study|Adverse Event|1|||
160961631|NCT01357616|581246400|FG000|Overall Study|Lost to Follow-up|4|||
160961632|NCT01357616|581246401|FG001|Overall Study|Lost to Follow-up|3|||
160961633|NCT01357616|581246400|FG000|Overall Study|Protocol Violation|0|||
160961634|NCT01357616|581246401|FG001|Overall Study|Protocol Violation|2|||
160961635|NCT01357616|581246400|FG000|Overall Study|Inadequate Control of IOP|1|||
160961636|NCT01357616|581246401|FG001|Overall Study|Inadequate Control of IOP|2|||
160961637|NCT01357616|581246400|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
160961638|NCT01357616|581246401|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
160961639|NCT01357616|581246400|FG000|Overall Study|Withdrawal by Subject|1|||
160961640|NCT01357616|581246401|FG001|Overall Study|Withdrawal by Subject|0|||
160961641|NCT03255824|581246410|FG000|Overall Study|Under-sedation|2|||
160961642|NCT03255824|581246411|FG001|Overall Study|Under-sedation|1|||
160961643|NCT03432364|581246414|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
160961644|NCT00522301|581246415|FG000|Overall Study|Withdrawal by Subject|1|||
160961645|NCT00522301|581246415|FG000|Overall Study|Adverse Event|5|||
160961646|NCT03040713|581246416|FG000|Overall Study|Positive amyloid scan|3|||
160961647|NCT01699022|581246423|FG000|Overall Study|Early discontinuation from the study|3|||
160961648|NCT04539821|581246424|FG000|Overall Study|Withdrawal by Subject|2|||
160961649|NCT04539821|581246424|FG000|Overall Study|continued care with their physician|20|||
160961650|NCT04539821|581246424|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
160961651|NCT00430248|581246439|FG000|Overall Study|Adverse Event|49|||
160961652|NCT00430248|581246440|FG001|Overall Study|Adverse Event|61|||
160961653|NCT00430248|581246441|FG002|Overall Study|Adverse Event|64|||
160961654|NCT00430248|581246439|FG000|Overall Study|Protocol Violation|10|||
160961655|NCT00430248|581246440|FG001|Overall Study|Protocol Violation|2|||
160961656|NCT00430248|581246441|FG002|Overall Study|Protocol Violation|4|||
160961657|NCT00430248|581246439|FG000|Overall Study|Personal Reasons|12|||
160961658|NCT00430248|581246440|FG001|Overall Study|Personal Reasons|24|||
160961659|NCT00430248|581246441|FG002|Overall Study|Personal Reasons|9|||
160961660|NCT00430248|581246439|FG000|Overall Study|Lost to Follow-up|28|||
160961661|NCT00430248|581246440|FG001|Overall Study|Lost to Follow-up|33|||
160961662|NCT00430248|581246441|FG002|Overall Study|Lost to Follow-up|28|||
160961663|NCT00430248|581246439|FG000|Overall Study|Therapeutic Failure|1|||
160961664|NCT00430248|581246440|FG001|Overall Study|Therapeutic Failure|1|||
160961665|NCT00430248|581246441|FG002|Overall Study|Therapeutic Failure|1|||
160961666|NCT00430248|581246439|FG000|Overall Study|Withdrawal by Subject|14|||
160961667|NCT00430248|581246440|FG001|Overall Study|Withdrawal by Subject|20|||
160961668|NCT00430248|581246441|FG002|Overall Study|Withdrawal by Subject|16|||
160961669|NCT00430248|581246439|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160961670|NCT00430248|581246440|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
160961671|NCT00430248|581246441|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160961672|NCT00430248|581246439|FG000|Overall Study|Gout Flare|3|||
160961673|NCT00430248|581246440|FG001|Overall Study|Gout Flare|7|||
160961674|NCT00430248|581246441|FG002|Overall Study|Gout Flare|2|||
160961675|NCT00430248|581246439|FG000|Overall Study|Reason Not Specified|8|||
160961676|NCT00430248|581246440|FG001|Overall Study|Reason Not Specified|8|||
160961677|NCT00430248|581246441|FG002|Overall Study|Reason Not Specified|11|||
160961678|NCT03466086|581246444|FG000|Period 1|Sponsor decision due to study timeline|1|||
160961679|NCT03466086|581246445|FG001|Period 1|Sponsor decision due to study timeline|0|||
160961680|NCT03466086|581246444|FG000|Period 1|Withdrawal by Subject|1|||
160961681|NCT03466086|581246445|FG001|Period 1|Withdrawal by Subject|0|||
160961682|NCT00002558|581246446|FG000|Overall Study|Withdrawal by Subject|0|||
160961683|NCT00002558|581246447|FG001|Overall Study|Withdrawal by Subject|1|||
160961684|NCT01260350|581246449|FG000|Overall Study|Lack of Efficacy|0|||
160961685|NCT01260350|581246450|FG001|Overall Study|Lack of Efficacy|0|||
160961686|NCT01260350|581246451|FG002|Overall Study|Lack of Efficacy|0|||
160961687|NCT01260350|581246452|FG003|Overall Study|Lack of Efficacy|0|||
160961688|NCT01260350|581246453|FG004|Overall Study|Lack of Efficacy|0|||
160961689|NCT01260350|581246454|FG005|Overall Study|Lack of Efficacy|0|||
160961690|NCT01260350|581246455|FG006|Overall Study|Lack of Efficacy|0|||
160961691|NCT01260350|581246456|FG007|Overall Study|Lack of Efficacy|0|||
160961692|NCT01260350|581246457|FG008|Overall Study|Lack of Efficacy|0|||
160961693|NCT01260350|581246458|FG009|Overall Study|Lack of Efficacy|0|||
160961694|NCT01260350|581246459|FG010|Overall Study|Lack of Efficacy|0|||
160961695|NCT01260350|581246460|FG011|Overall Study|Lack of Efficacy|0|||
160961696|NCT01260350|581246461|FG012|Overall Study|Lack of Efficacy|0|||
160961697|NCT01260350|581246462|FG013|Overall Study|Lack of Efficacy|0|||
160961698|NCT01260350|581246463|FG014|Overall Study|Lack of Efficacy|0|||
160961699|NCT01260350|581246464|FG015|Overall Study|Lack of Efficacy|0|||
160961700|NCT01260350|581246465|FG016|Overall Study|Lack of Efficacy|0|||
160961701|NCT01260350|581246466|FG017|Overall Study|Lack of Efficacy|1|||
160961702|NCT01260350|581246467|FG018|Overall Study|Lack of Efficacy|0|||
160961703|NCT01260350|581246468|FG019|Overall Study|Lack of Efficacy|0|||
160961704|NCT01260350|581246469|FG020|Overall Study|Lack of Efficacy|3|||
160961705|NCT01260350|581246470|FG021|Overall Study|Lack of Efficacy|0|||
160961706|NCT01260350|581246449|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961707|NCT01260350|581246450|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161002323|NCT03482011|581394570|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
160584942|NCT02052778|579861887|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584943|NCT02052778|579861888|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160961708|NCT01260350|581246451|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961709|NCT01260350|581246452|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961710|NCT01260350|581246453|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961711|NCT01260350|581246454|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961712|NCT01260350|581246455|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961713|NCT01260350|581246456|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961714|NCT01260350|581246457|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
160961715|NCT01260350|581246458|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961716|NCT01260350|581246459|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961717|NCT01260350|581246460|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961718|NCT01260350|581246461|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961719|NCT01260350|581246462|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961720|NCT01260350|581246463|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961721|NCT01260350|581246464|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961722|NCT01260350|581246465|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160458226|NCT04424316|579409129|FG000|Overall Study|Death|1|||
160961723|NCT01260350|581246466|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961724|NCT01260350|581246467|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961725|NCT01260350|581246468|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160584944|NCT02052778|579861889|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
160961726|NCT01260350|581246469|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961727|NCT01260350|581246470|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961728|NCT04385368|581246479|FG000|Overall Study|Death|5|||
160961729|NCT04385368|581246480|FG001|Overall Study|Death|5|||
160961730|NCT04385368|581246479|FG000|Overall Study|Physician Decision|3|||
160961731|NCT04385368|581246480|FG001|Overall Study|Physician Decision|0|||
160961732|NCT04385368|581246479|FG000|Overall Study|Withdrawal by Subject|4|||
160961733|NCT04385368|581246480|FG001|Overall Study|Withdrawal by Subject|3|||
160961734|NCT02123108|581246488|FG000|Overall Study|Death|2|||
160961735|NCT02123108|581246489|FG001|Overall Study|Death|3|||
160961736|NCT02219048|581246490|FG000|Overall Study|Adverse Event|2|||
160961737|NCT02219048|581246491|FG001|Overall Study|Adverse Event|5|||
160961738|NCT02219048|581246490|FG000|Overall Study|No longer meets eligibility criteria|1|||
160961739|NCT02219048|581246491|FG001|Overall Study|No longer meets eligibility criteria|0|||
160961740|NCT02219048|581246490|FG000|Overall Study|Study terminated by sponsor|16|||
160961741|NCT02219048|581246491|FG001|Overall Study|Study terminated by sponsor|15|||
160961742|NCT02219048|581246490|FG000|Overall Study|Withdrawal by Subject|2|||
160961743|NCT02219048|581246491|FG001|Overall Study|Withdrawal by Subject|0|||
160961744|NCT02219048|581246490|FG000|Overall Study|Other|0|||
160961745|NCT02219048|581246491|FG001|Overall Study|Other|1|||
160961746|NCT04721925|581246492|FG000|2-Month Assessment|Lost to Follow-up|5|||
160961747|NCT04721925|581246493|FG001|2-Month Assessment|Lost to Follow-up|3|||
160961748|NCT04721925|581246492|FG000|4-Month Assessment|Lost to Follow-up|3|||
160961749|NCT04721925|581246493|FG001|4-Month Assessment|Lost to Follow-up|6|||
160961750|NCT02862457|581246494|FG000|Overall Study|Death|1|||
160961751|NCT02862457|581246495|FG001|Overall Study|Death|3|||
160961752|NCT02862457|581246496|FG002|Overall Study|Death|2|||
160961753|NCT02862457|581246497|FG003|Overall Study|Death|3|||
160961754|NCT02862457|581246498|FG004|Overall Study|Death|0|||
160584945|NCT02052778|579861890|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584946|NCT02052778|579861891|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584947|NCT02052778|579861892|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160961755|NCT02862457|581246499|FG005|Overall Study|Death|2|||
160961756|NCT02862457|581246500|FG006|Overall Study|Death|1|||
160961757|NCT02862457|581246494|FG000|Overall Study|Lost to Follow-up|1|||
160961758|NCT02862457|581246495|FG001|Overall Study|Lost to Follow-up|0|||
160961759|NCT02862457|581246496|FG002|Overall Study|Lost to Follow-up|0|||
160961760|NCT02862457|581246497|FG003|Overall Study|Lost to Follow-up|1|||
160961761|NCT02862457|581246498|FG004|Overall Study|Lost to Follow-up|0|||
160961762|NCT02862457|581246499|FG005|Overall Study|Lost to Follow-up|0|||
160961763|NCT02862457|581246500|FG006|Overall Study|Lost to Follow-up|0|||
160961764|NCT02862457|581246494|FG000|Overall Study|Withdrawal by Subject|0|||
160961765|NCT02862457|581246495|FG001|Overall Study|Withdrawal by Subject|0|||
160961766|NCT02862457|581246496|FG002|Overall Study|Withdrawal by Subject|1|||
160961767|NCT02862457|581246497|FG003|Overall Study|Withdrawal by Subject|0|||
160961768|NCT02862457|581246498|FG004|Overall Study|Withdrawal by Subject|0|||
160961769|NCT02862457|581246499|FG005|Overall Study|Withdrawal by Subject|1|||
160961770|NCT02862457|581246500|FG006|Overall Study|Withdrawal by Subject|0|||
160961771|NCT03364751|581246501|FG000|Overall Study|Withdrawal by Subject|1|||
160961772|NCT03364751|581246502|FG001|Overall Study|Withdrawal by Subject|0|||
160961773|NCT03364751|581246503|FG002|Overall Study|Withdrawal by Subject|0|||
160961774|NCT03364751|581246504|FG003|Overall Study|Withdrawal by Subject|0|||
160961775|NCT03364751|581246501|FG000|Overall Study|Lost to Follow-up|0|||
160584948|NCT02052778|579861893|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160961776|NCT03364751|581246502|FG001|Overall Study|Lost to Follow-up|1|||
160961777|NCT03364751|581246503|FG002|Overall Study|Lost to Follow-up|0|||
160961778|NCT03364751|581246504|FG003|Overall Study|Lost to Follow-up|0|||
160961779|NCT00765388|581246505|FG000|Period 1|Lack of Efficacy|1|||
160961780|NCT00765388|581246506|FG001|Period 1|Lack of Efficacy|2|||
160961781|NCT00765388|581246505|FG000|Period 1|Lost to Follow-up|0|||
160961782|NCT00765388|581246506|FG001|Period 1|Lost to Follow-up|1|||
160961783|NCT00765388|581246505|FG000|Period 1|Herpes Zoster|0|||
160961784|NCT00765388|581246506|FG001|Period 1|Herpes Zoster|1|||
160961785|NCT00765388|581246505|FG000|Period 1|Hip operation|0|||
160961786|NCT00765388|581246506|FG001|Period 1|Hip operation|1|||
160961787|NCT03923933|581246507|FG000|Overall Study|Lost to Follow-up|1|||
160961788|NCT03923933|581246508|FG001|Overall Study|Lost to Follow-up|0|||
161002324|NCT03482011|581394571|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
161002325|NCT03482011|581394572|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
160961789|NCT03923933|581246507|FG000|Overall Study|Withdrawal by Subject|0|||
160961790|NCT03923933|581246508|FG001|Overall Study|Withdrawal by Subject|1|||
160961791|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
160961792|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
160961793|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
160458227|NCT04424316|579409130|FG001|Overall Study|Death|0|||
160961794|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
160961795|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
160961796|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
160961797|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
160961798|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
160961799|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
160961800|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
160961801|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
160961802|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
160961803|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
160961804|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
160961805|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
160961806|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
160961807|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
160961808|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
160961809|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
160961810|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
160961811|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
160961812|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
160961813|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
160961814|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
160961815|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
160961816|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Other|1|||
160961817|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Other|0|||
160961818|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Other|0|||
160961819|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Other|0|||
160961820|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Other|0|||
160961821|NCT01662310|581246511|FG000|Double-Blind Phase|Adverse Event|0|||
160961822|NCT01662310|581246512|FG001|Double-Blind Phase|Adverse Event|0|||
160961823|NCT01662310|581246513|FG002|Double-Blind Phase|Adverse Event|1|||
160961824|NCT01662310|581246514|FG003|Double-Blind Phase|Adverse Event|0|||
160961825|NCT01662310|581246515|FG004|Double-Blind Phase|Adverse Event|0|||
160961826|NCT01662310|581246511|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160961827|NCT01662310|581246512|FG001|Double-Blind Phase|Lost to Follow-up|3|||
160961828|NCT01662310|581246513|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160961829|NCT01662310|581246514|FG003|Double-Blind Phase|Lost to Follow-up|0|||
160961830|NCT01662310|581246515|FG004|Double-Blind Phase|Lost to Follow-up|0|||
160961831|NCT01662310|581246511|FG000|Double-Blind Phase|Pregnancy|0|||
160961832|NCT01662310|581246512|FG001|Double-Blind Phase|Pregnancy|2|||
160961833|NCT01662310|581246513|FG002|Double-Blind Phase|Pregnancy|0|||
160961834|NCT01662310|581246514|FG003|Double-Blind Phase|Pregnancy|0|||
160961835|NCT01662310|581246515|FG004|Double-Blind Phase|Pregnancy|0|||
160961836|NCT01662310|581246511|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
160961837|NCT01662310|581246512|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
160961838|NCT01662310|581246513|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
160961839|NCT01662310|581246514|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160961840|NCT01662310|581246515|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
160961841|NCT01662310|581246511|FG000|Double-Blind Phase|Other|0|||
160961842|NCT01662310|581246512|FG001|Double-Blind Phase|Other|0|||
160961843|NCT01662310|581246513|FG002|Double-Blind Phase|Other|1|||
160961844|NCT01662310|581246514|FG003|Double-Blind Phase|Other|0|||
160961845|NCT01662310|581246515|FG004|Double-Blind Phase|Other|0|||
160961846|NCT01662310|581246511|FG000|Double-Blind Phase|Randomized but not treated|0|||
160961847|NCT01662310|581246512|FG001|Double-Blind Phase|Randomized but not treated|1|||
160961848|NCT01662310|581246513|FG002|Double-Blind Phase|Randomized but not treated|0|||
160961849|NCT01662310|581246514|FG003|Double-Blind Phase|Randomized but not treated|0|||
160961850|NCT01662310|581246515|FG004|Double-Blind Phase|Randomized but not treated|0|||
160961851|NCT01662310|581246511|FG000|Open-Label Extension Phase|Adverse Event|0|||
160961852|NCT01662310|581246512|FG001|Open-Label Extension Phase|Adverse Event|0|||
160961853|NCT01662310|581246513|FG002|Open-Label Extension Phase|Adverse Event|0|||
160961854|NCT01662310|581246514|FG003|Open-Label Extension Phase|Adverse Event|3|||
160961855|NCT01662310|581246515|FG004|Open-Label Extension Phase|Adverse Event|0|||
160961856|NCT01662310|581246511|FG000|Open-Label Extension Phase|Death|0|||
160961857|NCT01662310|581246512|FG001|Open-Label Extension Phase|Death|0|||
160458228|NCT04424316|579409131|FG002|Overall Study|Death|8|||
160961858|NCT01662310|581246513|FG002|Open-Label Extension Phase|Death|0|||
160961859|NCT01662310|581246514|FG003|Open-Label Extension Phase|Death|1|||
160961860|NCT01662310|581246515|FG004|Open-Label Extension Phase|Death|0|||
160961861|NCT01662310|581246511|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
160961862|NCT01662310|581246512|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
160961863|NCT01662310|581246513|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
160961864|NCT01662310|581246514|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
160458229|NCT04424316|579409132|FG003|Overall Study|Death|14|||
160961865|NCT01662310|581246515|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
160961866|NCT01662310|581246511|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
160961867|NCT01662310|581246512|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
160961868|NCT01662310|581246513|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
160961869|NCT01662310|581246514|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
160961870|NCT01662310|581246515|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
160961871|NCT01662310|581246511|FG000|Open-Label Extension Phase|Pregnancy|0|||
160961872|NCT01662310|581246512|FG001|Open-Label Extension Phase|Pregnancy|0|||
160961873|NCT01662310|581246513|FG002|Open-Label Extension Phase|Pregnancy|0|||
160961874|NCT01662310|581246514|FG003|Open-Label Extension Phase|Pregnancy|1|||
160961875|NCT01662310|581246515|FG004|Open-Label Extension Phase|Pregnancy|0|||
160961876|NCT01662310|581246511|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
160961877|NCT01662310|581246512|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
160961878|NCT01662310|581246513|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
160961879|NCT01662310|581246514|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
160961880|NCT01662310|581246515|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
160961881|NCT02432105|581246516|FG000|Overall Study|Lost to Follow-up|1|||
160961882|NCT02432105|581246517|FG001|Overall Study|Lost to Follow-up|1|||
160961883|NCT02432105|581246518|FG002|Overall Study|Lost to Follow-up|0|||
160961884|NCT02432105|581246516|FG000|Overall Study|Withdrawal by Subject|1|||
160961885|NCT02432105|581246517|FG001|Overall Study|Withdrawal by Subject|0|||
160961886|NCT02432105|581246518|FG002|Overall Study|Withdrawal by Subject|1|||
160961887|NCT02432105|581246516|FG000|Overall Study|Culture positive for yeast|0|||
160961888|NCT02432105|581246517|FG001|Overall Study|Culture positive for yeast|1|||
160961889|NCT02432105|581246518|FG002|Overall Study|Culture positive for yeast|0|||
160961890|NCT02432105|581246516|FG000|Overall Study|Randomized in error|0|||
160961891|NCT02432105|581246517|FG001|Overall Study|Randomized in error|0|||
160961892|NCT02432105|581246518|FG002|Overall Study|Randomized in error|2|||
160961893|NCT02085252|581246521|FG000|Overall Study|Withdrawal of Consent|1|||
160961894|NCT02085252|581246522|FG001|Overall Study|Withdrawal of Consent|0|||
160961895|NCT02085252|581246521|FG000|Overall Study|Adverse Event|0|||
160961896|NCT02085252|581246522|FG001|Overall Study|Adverse Event|1|||
160961897|NCT02085252|581246521|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
160961898|NCT02085252|581246522|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
160961899|NCT02085252|581246521|FG000|Overall Study|Reason Not Specified|0|||
160961900|NCT02085252|581246522|FG001|Overall Study|Reason Not Specified|1|||
160961901|NCT02085252|581246521|FG000|Overall Study|Reason Unknown|0|||
160961902|NCT02085252|581246522|FG001|Overall Study|Reason Unknown|1|||
160961903|NCT00541450|581246523|FG000|Phase A|Adverse Event|3|||
160961904|NCT00541450|581246524|FG001|Phase A|Adverse Event|0|||
160961905|NCT00541450|581246523|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
160961906|NCT00541450|581246524|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
160961907|NCT00541450|581246523|FG000|Phase A|Hyperglycemia|0|||
160961908|NCT00541450|581246524|FG001|Phase A|Hyperglycemia|1|||
160961909|NCT00541450|581246523|FG000|Phase A|Lost to Follow-up|6|||
160961910|NCT00541450|581246524|FG001|Phase A|Lost to Follow-up|4|||
160961911|NCT00541450|581246523|FG000|Phase A|Physician Decision|2|||
160961912|NCT00541450|581246524|FG001|Phase A|Physician Decision|0|||
160961913|NCT00541450|581246523|FG000|Phase A|Protocol Violation|2|||
160961914|NCT00541450|581246524|FG001|Phase A|Protocol Violation|3|||
160961915|NCT00541450|581246523|FG000|Phase A|Withdrawal by Subject|7|||
160961916|NCT00541450|581246524|FG001|Phase A|Withdrawal by Subject|7|||
160961917|NCT00541450|581246523|FG000|Phase B|Adverse Event|6|||
160961918|NCT00541450|581246524|FG001|Phase B|Adverse Event|6|||
160961919|NCT00541450|581246523|FG000|Phase B|Hyperglycemia|10|||
160961920|NCT00541450|581246524|FG001|Phase B|Hyperglycemia|9|||
160961921|NCT00541450|581246523|FG000|Phase B|Lost to Follow-up|6|||
160961922|NCT00541450|581246524|FG001|Phase B|Lost to Follow-up|4|||
160961923|NCT00541450|581246523|FG000|Phase B|Physician Decision|4|||
160961924|NCT00541450|581246524|FG001|Phase B|Physician Decision|2|||
160961925|NCT00541450|581246523|FG000|Phase B|Pregnancy|0|||
160961926|NCT00541450|581246524|FG001|Phase B|Pregnancy|1|||
160961927|NCT00541450|581246523|FG000|Phase B|Protocol Violation|3|||
160961928|NCT00541450|581246524|FG001|Phase B|Protocol Violation|3|||
160961929|NCT00541450|581246523|FG000|Phase B|Withdrawal by Subject|8|||
160961930|NCT00541450|581246524|FG001|Phase B|Withdrawal by Subject|6|||
160961931|NCT02816138|581246525|FG000|Overall Study|Adverse Event|1|||
160961932|NCT00981084|581246526|FG000|Post Intervention (Data Analysis)|poor effort|1|||
160961933|NCT00981084|581246527|FG001|Post Intervention (Data Analysis)|poor effort|1|||
160961934|NCT00981084|581246526|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
160961935|NCT00981084|581246527|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
160961936|NCT01112579|581246528|FG000|Overall Study|Missed Visit|1|||
160961937|NCT01112579|581246529|FG001|Overall Study|Missed Visit|1|||
160961938|NCT01112579|581246528|FG000|Overall Study|Death|0|||
160961939|NCT01112579|581246529|FG001|Overall Study|Death|2|||
160961940|NCT03645759|581246533|FG000|Overall Study|Lost to Follow-up|3|||
160961941|NCT03645759|581246534|FG001|Overall Study|Lost to Follow-up|2|||
160961942|NCT01648270|581246535|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
160961943|NCT00818753|581246536|FG000|Overall Study|Protocol Violation|1|||
160961944|NCT00818753|581246537|FG001|Overall Study|Protocol Violation|0|||
160961945|NCT00818753|581246538|FG002|Overall Study|Protocol Violation|0|||
160961946|NCT00818753|581246536|FG000|Overall Study|Other reason (not specified)|0|||
160961947|NCT00818753|581246537|FG001|Overall Study|Other reason (not specified)|0|||
160961948|NCT00818753|581246538|FG002|Overall Study|Other reason (not specified)|1|||
160961949|NCT00818753|581246536|FG000|Overall Study|Randomised and not treated|2|||
160961950|NCT00818753|581246537|FG001|Overall Study|Randomised and not treated|0|||
160961951|NCT00818753|581246538|FG002|Overall Study|Randomised and not treated|0|||
160961952|NCT01389973|581246539|FG000|Overall Study|Lost to Follow-up|1|||
160961953|NCT01389973|581246539|FG000|Overall Study|Trial Stopped by Sponsor|9|||
160961954|NCT01389973|581246539|FG000|Overall Study|Other|10|||
160961955|NCT00725296|581246540|FG000|Overall Study|Adverse Event|11|||
160961956|NCT00725296|581246540|FG000|Overall Study|Lack of Efficacy|7|||
160961957|NCT00725296|581246540|FG000|Overall Study|Withdrawal by Subject|3|||
160961958|NCT00725296|581246540|FG000|Overall Study|Non-Compliance|2|||
160961959|NCT00725296|581246540|FG000|Overall Study|Lost to Follow-up|1|||
160961960|NCT00725296|581246540|FG000|Overall Study|Other|38|||
160961961|NCT03360942|581246541|FG000|Overall Study|Device explanted|2|||
160961962|NCT03360942|581246541|FG000|Overall Study|Study closure|1|||
160961963|NCT03360942|581246541|FG000|Overall Study|Withdrawal by Subject|2|||
160961964|NCT03456700|581246542|FG000|Overall Study|Withdrawal by Subject|1|||
160961965|NCT00613951|581246545|FG000|Overall Study|Adverse Event|1|||
160961966|NCT00613951|581246546|FG001|Overall Study|Adverse Event|0|||
160961967|NCT00613951|581246547|FG002|Overall Study|Adverse Event|1|||
160961968|NCT00613951|581246545|FG000|Overall Study|Lack of Efficacy|0|||
160961969|NCT00613951|581246546|FG001|Overall Study|Lack of Efficacy|1|||
160961970|NCT00613951|581246547|FG002|Overall Study|Lack of Efficacy|1|||
160961971|NCT00613951|581246545|FG000|Overall Study|Protocol Violation|1|||
160961972|NCT00613951|581246546|FG001|Overall Study|Protocol Violation|1|||
160961973|NCT00613951|581246547|FG002|Overall Study|Protocol Violation|1|||
160961974|NCT00613951|581246545|FG000|Overall Study|Unclassified|5|||
160961975|NCT00613951|581246546|FG001|Overall Study|Unclassified|3|||
160961976|NCT00613951|581246547|FG002|Overall Study|Unclassified|2|||
160961977|NCT03053050|581246549|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
160961978|NCT03053050|581246550|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
160961979|NCT03053050|581246551|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
160961980|NCT03053050|581246552|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
160961981|NCT03053050|581246549|FG000|Randomized Phase|Withdrew Consent|16|||
160961982|NCT03053050|581246550|FG001|Randomized Phase|Withdrew Consent|8|||
160961983|NCT03053050|581246551|FG002|Randomized Phase|Withdrew Consent|9|||
160961984|NCT03053050|581246552|FG003|Randomized Phase|Withdrew Consent|0|||
160961985|NCT03053050|581246549|FG000|Randomized Phase|Investigator's Discretion|6|||
160961986|NCT03053050|581246550|FG001|Randomized Phase|Investigator's Discretion|6|||
160961987|NCT03053050|581246551|FG002|Randomized Phase|Investigator's Discretion|3|||
160961988|NCT03053050|581246552|FG003|Randomized Phase|Investigator's Discretion|0|||
160961989|NCT03053050|581246549|FG000|Randomized Phase|Lost to Follow-up|5|||
160961990|NCT03053050|581246550|FG001|Randomized Phase|Lost to Follow-up|1|||
160961991|NCT03053050|581246551|FG002|Randomized Phase|Lost to Follow-up|1|||
160961992|NCT03053050|581246552|FG003|Randomized Phase|Lost to Follow-up|0|||
160961993|NCT03053050|581246549|FG000|Randomized Phase|Adverse Event|0|||
160961994|NCT03053050|581246550|FG001|Randomized Phase|Adverse Event|1|||
160961995|NCT03053050|581246551|FG002|Randomized Phase|Adverse Event|0|||
160961996|NCT03053050|581246552|FG003|Randomized Phase|Adverse Event|0|||
160961997|NCT03053050|581246549|FG000|Randomized Phase|Randomized but Never Treated|2|||
160961998|NCT03053050|581246550|FG001|Randomized Phase|Randomized but Never Treated|2|||
160961999|NCT03053050|581246551|FG002|Randomized Phase|Randomized but Never Treated|2|||
160962000|NCT03053050|581246552|FG003|Randomized Phase|Randomized but Never Treated|0|||
160962001|NCT03053050|581246549|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
160962002|NCT03053050|581246550|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
160962003|NCT03053050|581246551|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
160962004|NCT03053050|581246552|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
160962005|NCT03053050|581246549|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
160962006|NCT03053050|581246550|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
160962007|NCT03053050|581246551|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
160962008|NCT03053050|581246552|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
160962009|NCT03053050|581246549|FG000|Open-label Phase|Withdrew Consent|0|||
160962010|NCT03053050|581246550|FG001|Open-label Phase|Withdrew Consent|0|||
160962011|NCT03053050|581246551|FG002|Open-label Phase|Withdrew Consent|0|||
160962012|NCT03053050|581246552|FG003|Open-label Phase|Withdrew Consent|6|||
160962013|NCT03053050|581246549|FG000|Open-label Phase|Investigator's Discretion|0|||
160962014|NCT03053050|581246550|FG001|Open-label Phase|Investigator's Discretion|0|||
160962015|NCT03053050|581246551|FG002|Open-label Phase|Investigator's Discretion|0|||
160962016|NCT03053050|581246552|FG003|Open-label Phase|Investigator's Discretion|4|||
160962017|NCT00655980|581246553|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
160962018|NCT00655980|581246554|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
160962019|NCT00655980|581246555|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
160962020|NCT02127372|581247834|FG000|Overall Study|Withdrawal by Subject|1|||
160962021|NCT02127372|581247835|FG001|Overall Study|Withdrawal by Subject|0|||
160962022|NCT03837509|581247836|FG000|Phase 1|Death|5|||
160962023|NCT03837509|581247837|FG001|Phase 1|Death|2|||
160962024|NCT03837509|581247838|FG002|Phase 1|Death|0|||
160962025|NCT03837509|581247839|FG003|Phase 1|Death|0|||
160962026|NCT03837509|581247840|FG004|Phase 1|Death|0|||
160962027|NCT03837509|581247836|FG000|Phase 2|Death|0|||
160962028|NCT03837509|581247837|FG001|Phase 2|Death|0|||
160962029|NCT03837509|581247838|FG002|Phase 2|Death|0|||
160962030|NCT03837509|581247839|FG003|Phase 2|Death|1|||
160962031|NCT03837509|581247840|FG004|Phase 2|Death|1|||
160962032|NCT01756352|581247843|FG000|Overall Study|moved away and lost to followup|1|||
160962033|NCT02641392|581247850|FG000|Overall Study|Lost to Follow-up|0|||
160962034|NCT02641392|581247851|FG001|Overall Study|Lost to Follow-up|0|||
160962035|NCT02641392|581247852|FG002|Overall Study|Lost to Follow-up|2|||
160962036|NCT02641392|581247850|FG000|Overall Study|Withdrawal by Subject|0|||
160962037|NCT02641392|581247851|FG001|Overall Study|Withdrawal by Subject|0|||
160962038|NCT02641392|581247852|FG002|Overall Study|Withdrawal by Subject|17|||
160962039|NCT02641392|581247850|FG000|Overall Study|Adverse Event|0|||
160962040|NCT02641392|581247851|FG001|Overall Study|Adverse Event|1|||
160962041|NCT02641392|581247852|FG002|Overall Study|Adverse Event|25|||
160962042|NCT02641392|581247850|FG000|Overall Study|Study Terminated by Sponsor|4|||
160962043|NCT02641392|581247851|FG001|Overall Study|Study Terminated by Sponsor|12|||
160962044|NCT02641392|581247852|FG002|Overall Study|Study Terminated by Sponsor|144|||
160962045|NCT02641392|581247850|FG000|Overall Study|Lack of Efficacy|0|||
160962046|NCT02641392|581247851|FG001|Overall Study|Lack of Efficacy|0|||
160962047|NCT02641392|581247852|FG002|Overall Study|Lack of Efficacy|101|||
160962048|NCT02641392|581247850|FG000|Overall Study|Miscellaneous|0|||
160962049|NCT02641392|581247851|FG001|Overall Study|Miscellaneous|0|||
160962050|NCT02641392|581247852|FG002|Overall Study|Miscellaneous|3|||
160962051|NCT02641392|581247850|FG000|Overall Study|Death|0|||
160962052|NCT02641392|581247851|FG001|Overall Study|Death|0|||
160962053|NCT02641392|581247852|FG002|Overall Study|Death|1|||
160962054|NCT01113502|581247853|FG000|Overall Study|Withdrawal by Subject|1|||
160962055|NCT01113502|581247854|FG001|Overall Study|Withdrawal by Subject|0|||
160962056|NCT01113502|581247855|FG002|Overall Study|Withdrawal by Subject|1|||
160962057|NCT01113502|581247856|FG003|Overall Study|Withdrawal by Subject|1|||
160962058|NCT01113502|581247857|FG004|Overall Study|Withdrawal by Subject|0|||
160962059|NCT01113502|581247853|FG000|Overall Study|Adverse Event|0|||
160962060|NCT01113502|581247854|FG001|Overall Study|Adverse Event|0|||
160962061|NCT01113502|581247855|FG002|Overall Study|Adverse Event|3|||
160962062|NCT01113502|581247856|FG003|Overall Study|Adverse Event|2|||
160962063|NCT01113502|581247857|FG004|Overall Study|Adverse Event|0|||
160962064|NCT03802123|581247860|FG000|Overall Study|Withdrawal by Subject|3|||
160962065|NCT03802123|581247860|FG000|Overall Study|Physician Decision|1|||
160962066|NCT03802123|581247860|FG000|Overall Study|Subject moved to hospice care|1|||
160962067|NCT03802123|581247860|FG000|Overall Study|technician error|1|||
160962068|NCT03802123|581247860|FG000|Overall Study|Death|3|||
160962069|NCT01274182|581247861|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
160962070|NCT01274182|581247862|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160962071|NCT01274182|581247863|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
160962072|NCT01274182|581247861|FG000|Overall Study|Adverse Event|4|||
160962073|NCT01274182|581247862|FG001|Overall Study|Adverse Event|5|||
160962074|NCT01274182|581247863|FG002|Overall Study|Adverse Event|3|||
160962075|NCT01274182|581247861|FG000|Overall Study|Withdrawal by Subject|5|||
160962076|NCT01274182|581247862|FG001|Overall Study|Withdrawal by Subject|5|||
160962077|NCT01274182|581247863|FG002|Overall Study|Withdrawal by Subject|3|||
160962078|NCT01274182|581247861|FG000|Overall Study|Lost to Follow-up|2|||
160962079|NCT01274182|581247862|FG001|Overall Study|Lost to Follow-up|3|||
160962080|NCT01274182|581247863|FG002|Overall Study|Lost to Follow-up|1|||
160962081|NCT01274182|581247861|FG000|Overall Study|Protocol Violation|3|||
160962082|NCT01274182|581247862|FG001|Overall Study|Protocol Violation|2|||
160962083|NCT01274182|581247863|FG002|Overall Study|Protocol Violation|0|||
160962084|NCT01274182|581247861|FG000|Overall Study|Death|1|||
160962085|NCT01274182|581247862|FG001|Overall Study|Death|0|||
160962086|NCT01274182|581247863|FG002|Overall Study|Death|1|||
160458230|NCT04424316|579409129|FG000|Overall Study|Lost to Follow-up|93|||
160458231|NCT04424316|579409130|FG001|Overall Study|Lost to Follow-up|88|||
160458232|NCT04424316|579409131|FG002|Overall Study|Lost to Follow-up|224|||
160458233|NCT04424316|579409132|FG003|Overall Study|Lost to Follow-up|211|||
160458234|NCT04424316|579409129|FG000|Overall Study|No longer met eligibility criteria|1|||
160458235|NCT04424316|579409130|FG001|Overall Study|No longer met eligibility criteria|0|||
160962087|NCT01970982|581247864|FG000|Overall Study|Withdrawal by Subject|0|||
160962088|NCT01970982|581247865|FG001|Overall Study|Withdrawal by Subject|0|||
160962089|NCT01970982|581247866|FG002|Overall Study|Withdrawal by Subject|2|||
160962090|NCT04040751|581247871|FG000|Overall Study|Withdrawal by Subject|2|||
160962091|NCT04040751|581247872|FG001|Overall Study|Withdrawal by Subject|0|||
160962092|NCT04040751|581247873|FG002|Overall Study|Withdrawal by Subject|2|||
160962093|NCT04040751|581247874|FG003|Overall Study|Withdrawal by Subject|0|||
160962094|NCT03804710|581247876|FG000|Overall Study|Adverse Event|0|||
160962095|NCT03804710|581247877|FG001|Overall Study|Adverse Event|3|||
160962096|NCT03804710|581247876|FG000|Overall Study|Withdrawal by Subject|2|||
160962097|NCT03804710|581247877|FG001|Overall Study|Withdrawal by Subject|1|||
160962098|NCT03804710|581247876|FG000|Overall Study|Other|0|||
160962099|NCT03804710|581247877|FG001|Overall Study|Other|1|||
160962100|NCT04542018|581247878|FG000|Overall Study|Withdrawal by Subject|0|||
160962101|NCT04542018|581247879|FG001|Overall Study|Withdrawal by Subject|0|||
160962102|NCT04542018|581247880|FG002|Overall Study|Withdrawal by Subject|4|||
160962103|NCT04542018|581247878|FG000|Overall Study|Protocol Violation|0|||
160962104|NCT04542018|581247879|FG001|Overall Study|Protocol Violation|0|||
160962105|NCT04542018|581247880|FG002|Overall Study|Protocol Violation|2|||
160962106|NCT03583554|581247881|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
160962107|NCT03583554|581247882|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
160962108|NCT03583554|581247883|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
160962109|NCT03178266|581247884|FG000|Overall Study|Death|0|||
160962110|NCT03178266|581247885|FG001|Overall Study|Death|1|||
160962111|NCT03178266|581247884|FG000|Overall Study|Disont. Early|0|||
160962112|NCT03178266|581247885|FG001|Overall Study|Disont. Early|1|||
160962113|NCT03178266|581247884|FG000|Overall Study|Withdrawal by Subject|0|||
160962114|NCT03178266|581247885|FG001|Overall Study|Withdrawal by Subject|2|||
160962115|NCT01596582|581247897|FG000|Overall Study|Deemed ineligible after study visit|3|||
160962116|NCT01596582|581247898|FG001|Overall Study|Deemed ineligible after study visit|6|||
160962117|NCT01596582|581247897|FG000|Overall Study|Missing all outcome data|1|||
160962118|NCT01596582|581247898|FG001|Overall Study|Missing all outcome data|1|||
160962119|NCT02454101|581247902|FG000|Overall Study|Adverse Event|2|||
160962120|NCT02454101|581247903|FG001|Overall Study|Adverse Event|3|||
160962121|NCT02454101|581247902|FG000|Overall Study|Lost to Follow-up|3|||
160962122|NCT02454101|581247903|FG001|Overall Study|Lost to Follow-up|4|||
160962123|NCT02342886|581247904|FG000|Overall Study|Treatment non-compliance|1|||
160962124|NCT02342886|581247905|FG001|Overall Study|Treatment non-compliance|0|||
160962125|NCT02342886|581247906|FG002|Overall Study|Treatment non-compliance|0|||
160962126|NCT02342886|581247907|FG003|Overall Study|Treatment non-compliance|1|||
160962127|NCT02342886|581247908|FG004|Overall Study|Treatment non-compliance|0|||
160962128|NCT02342886|581247904|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
160962129|NCT02342886|581247905|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
160962130|NCT02342886|581247906|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
160962131|NCT02342886|581247907|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
160962132|NCT02342886|581247908|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
160962133|NCT02342886|581247904|FG000|Overall Study|Adverse event/specific toxicity|4|||
160962134|NCT02342886|581247905|FG001|Overall Study|Adverse event/specific toxicity|3|||
160962135|NCT02342886|581247906|FG002|Overall Study|Adverse event/specific toxicity|11|||
160962136|NCT02342886|581247907|FG003|Overall Study|Adverse event/specific toxicity|2|||
160962137|NCT02342886|581247908|FG004|Overall Study|Adverse event/specific toxicity|1|||
160962138|NCT02342886|581247904|FG000|Overall Study|Lost to Follow-up|1|||
160962139|NCT02342886|581247905|FG001|Overall Study|Lost to Follow-up|0|||
160962140|NCT02342886|581247906|FG002|Overall Study|Lost to Follow-up|0|||
160962141|NCT02342886|581247907|FG003|Overall Study|Lost to Follow-up|0|||
160962142|NCT02342886|581247908|FG004|Overall Study|Lost to Follow-up|0|||
160962143|NCT02342886|581247904|FG000|Overall Study|Death|1|||
160962144|NCT02342886|581247905|FG001|Overall Study|Death|2|||
160962145|NCT02342886|581247906|FG002|Overall Study|Death|1|||
160962146|NCT02342886|581247907|FG003|Overall Study|Death|0|||
160962147|NCT02342886|581247908|FG004|Overall Study|Death|1|||
160962148|NCT02342886|581247904|FG000|Overall Study|Withdrawal by Subject|0|||
160962149|NCT02342886|581247905|FG001|Overall Study|Withdrawal by Subject|1|||
160962150|NCT02342886|581247906|FG002|Overall Study|Withdrawal by Subject|0|||
160962151|NCT02342886|581247907|FG003|Overall Study|Withdrawal by Subject|1|||
160962152|NCT02342886|581247908|FG004|Overall Study|Withdrawal by Subject|0|||
160962153|NCT02342886|581247904|FG000|Overall Study|Investigator/sponsor decision|0|||
160962154|NCT02342886|581247905|FG001|Overall Study|Investigator/sponsor decision|2|||
160962155|NCT02342886|581247906|FG002|Overall Study|Investigator/sponsor decision|0|||
160962156|NCT02342886|581247907|FG003|Overall Study|Investigator/sponsor decision|3|||
160962157|NCT02342886|581247908|FG004|Overall Study|Investigator/sponsor decision|1|||
160962158|NCT02342886|581247904|FG000|Overall Study|Pregnancy|0|||
160458236|NCT04424316|579409131|FG002|Overall Study|No longer met eligibility criteria|0|||
160458237|NCT04424316|579409132|FG003|Overall Study|No longer met eligibility criteria|0|||
160962159|NCT02342886|581247905|FG001|Overall Study|Pregnancy|0|||
160962160|NCT02342886|581247906|FG002|Overall Study|Pregnancy|2|||
160458238|NCT04424316|579409129|FG000|Overall Study|Other|15|||
160962161|NCT02342886|581247907|FG003|Overall Study|Pregnancy|0|||
160962162|NCT02342886|581247908|FG004|Overall Study|Pregnancy|0|||
160458239|NCT04424316|579409130|FG001|Overall Study|Other|11|||
160458240|NCT04424316|579409131|FG002|Overall Study|Other|34|||
160458241|NCT04424316|579409132|FG003|Overall Study|Other|45|||
160962163|NCT02342886|581247904|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
160962164|NCT02342886|581247905|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
160962165|NCT02342886|581247906|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
160962166|NCT02342886|581247907|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
160962167|NCT02342886|581247908|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
160962168|NCT02342886|581247904|FG000|Overall Study|Protocol Violation|0|||
160962169|NCT02342886|581247905|FG001|Overall Study|Protocol Violation|0|||
160962170|NCT02342886|581247906|FG002|Overall Study|Protocol Violation|0|||
160962171|NCT02342886|581247907|FG003|Overall Study|Protocol Violation|2|||
160962172|NCT02342886|581247908|FG004|Overall Study|Protocol Violation|0|||
160962173|NCT00862134|581247912|FG000|Overall Study|Death|1|||
160962174|NCT00862134|581247913|FG001|Overall Study|Death|0|||
160962175|NCT00862134|581247912|FG000|Overall Study|Physician Decision|0|||
160962176|NCT00862134|581247913|FG001|Overall Study|Physician Decision|1|||
160962177|NCT00862134|581247912|FG000|Overall Study|Withdrawal by Subject|1|||
160962178|NCT00862134|581247913|FG001|Overall Study|Withdrawal by Subject|2|||
160962179|NCT00862134|581247912|FG000|Overall Study|Sponsor terminated study|5|||
160962180|NCT00862134|581247913|FG001|Overall Study|Sponsor terminated study|7|||
160962181|NCT00862134|581247912|FG000|Overall Study|Adverse Event|2|||
160962182|NCT00862134|581247913|FG001|Overall Study|Adverse Event|2|||
160962183|NCT00862134|581247912|FG000|Overall Study|Withdrew prior to dosing|2|||
160962184|NCT00862134|581247913|FG001|Overall Study|Withdrew prior to dosing|0|||
160962185|NCT00765674|581247914|FG000|Overall Study|Adverse Event|7|||
160962186|NCT00765674|581247915|FG001|Overall Study|Adverse Event|2|||
160962187|NCT00765674|581247916|FG002|Overall Study|Adverse Event|8|||
160962188|NCT00765674|581247917|FG003|Overall Study|Adverse Event|11|||
160962189|NCT00765674|581247914|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
160962190|NCT00765674|581247915|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
160962191|NCT00765674|581247916|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
160962192|NCT00765674|581247917|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
160962193|NCT00765674|581247914|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
160962194|NCT00765674|581247915|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
160962195|NCT00765674|581247916|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
160962196|NCT00765674|581247917|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
160962197|NCT00765674|581247914|FG000|Overall Study|Lack of Efficacy|2|||
160962198|NCT00765674|581247915|FG001|Overall Study|Lack of Efficacy|3|||
160962199|NCT00765674|581247916|FG002|Overall Study|Lack of Efficacy|1|||
160962200|NCT00765674|581247917|FG003|Overall Study|Lack of Efficacy|2|||
160962201|NCT00765674|581247914|FG000|Overall Study|Protocol Violation|2|||
160962202|NCT00765674|581247915|FG001|Overall Study|Protocol Violation|0|||
160962203|NCT00765674|581247916|FG002|Overall Study|Protocol Violation|1|||
160962204|NCT00765674|581247917|FG003|Overall Study|Protocol Violation|0|||
160962205|NCT00765674|581247914|FG000|Overall Study|Withdrawal by Subject|5|||
160962206|NCT00765674|581247915|FG001|Overall Study|Withdrawal by Subject|7|||
160962207|NCT00765674|581247916|FG002|Overall Study|Withdrawal by Subject|3|||
160962208|NCT00765674|581247917|FG003|Overall Study|Withdrawal by Subject|8|||
160962209|NCT00765674|581247914|FG000|Overall Study|Lost to Follow-up|4|||
160962210|NCT00765674|581247915|FG001|Overall Study|Lost to Follow-up|6|||
160584949|NCT02052778|579861894|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160962211|NCT00765674|581247916|FG002|Overall Study|Lost to Follow-up|2|||
160962212|NCT00765674|581247917|FG003|Overall Study|Lost to Follow-up|1|||
160962213|NCT00765674|581247914|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
160962214|NCT00765674|581247915|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
160962215|NCT00765674|581247916|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
160962216|NCT00765674|581247917|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
160962217|NCT01813474|581247923|FG000|Overall Study|Withdrawal by Subject|0|||
160962218|NCT01813474|581247924|FG001|Overall Study|Withdrawal by Subject|0|||
160962219|NCT01813474|581247925|FG002|Overall Study|Withdrawal by Subject|1|||
160962220|NCT01813474|581247923|FG000|Overall Study|Adverse Event|1|||
160962221|NCT01813474|581247924|FG001|Overall Study|Adverse Event|1|||
160962222|NCT01813474|581247925|FG002|Overall Study|Adverse Event|0|||
160962223|NCT01813474|581247923|FG000|Overall Study|Lack of Efficacy|2|||
160962224|NCT01813474|581247924|FG001|Overall Study|Lack of Efficacy|6|||
160458242|NCT04424316|579409129|FG000|Overall Study|Physician Decision|1|||
160962225|NCT01813474|581247925|FG002|Overall Study|Lack of Efficacy|9|||
160962226|NCT01813474|581247923|FG000|Overall Study|Death|0|||
160962227|NCT01813474|581247924|FG001|Overall Study|Death|0|||
160962228|NCT01813474|581247925|FG002|Overall Study|Death|1|||
160962229|NCT03015402|581247926|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
160962230|NCT03015402|581247927|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
160962231|NCT03015402|581247926|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
160458243|NCT04424316|579409130|FG001|Overall Study|Physician Decision|0|||
160962232|NCT03015402|581247927|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
160962233|NCT00316082|581247928|FG000|Overall Study|Lack of Efficacy|2|||
160962234|NCT00316082|581247929|FG001|Overall Study|Lack of Efficacy|3|||
160962235|NCT00316082|581247930|FG002|Overall Study|Lack of Efficacy|3|||
160962236|NCT00316082|581247931|FG003|Overall Study|Lack of Efficacy|4|||
160962237|NCT00316082|581247932|FG004|Overall Study|Lack of Efficacy|6|||
160962238|NCT00316082|581247928|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
160962239|NCT00316082|581247929|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
160962240|NCT00316082|581247930|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
160962241|NCT00316082|581247931|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
160962242|NCT00316082|581247932|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
160962243|NCT00316082|581247928|FG000|Overall Study|Lost to Follow-up|7|||
160962244|NCT00316082|581247929|FG001|Overall Study|Lost to Follow-up|6|||
160962245|NCT00316082|581247930|FG002|Overall Study|Lost to Follow-up|7|||
160962246|NCT00316082|581247931|FG003|Overall Study|Lost to Follow-up|8|||
160962247|NCT00316082|581247932|FG004|Overall Study|Lost to Follow-up|6|||
160962248|NCT00316082|581247928|FG000|Overall Study|Poor/noncompliance|6|||
160962249|NCT00316082|581247929|FG001|Overall Study|Poor/noncompliance|1|||
160962250|NCT00316082|581247930|FG002|Overall Study|Poor/noncompliance|4|||
160962251|NCT00316082|581247931|FG003|Overall Study|Poor/noncompliance|1|||
160962252|NCT00316082|581247932|FG004|Overall Study|Poor/noncompliance|4|||
160962253|NCT00316082|581247928|FG000|Overall Study|Adverse Event|4|||
160962254|NCT00316082|581247929|FG001|Overall Study|Adverse Event|2|||
160962255|NCT00316082|581247930|FG002|Overall Study|Adverse Event|5|||
160962256|NCT00316082|581247931|FG003|Overall Study|Adverse Event|1|||
160962257|NCT00316082|581247932|FG004|Overall Study|Adverse Event|3|||
160962258|NCT00316082|581247928|FG000|Overall Study|Subject no longer meets study criteria|3|||
160962259|NCT00316082|581247929|FG001|Overall Study|Subject no longer meets study criteria|1|||
160962260|NCT00316082|581247930|FG002|Overall Study|Subject no longer meets study criteria|2|||
160962261|NCT00316082|581247931|FG003|Overall Study|Subject no longer meets study criteria|2|||
160962262|NCT00316082|581247932|FG004|Overall Study|Subject no longer meets study criteria|1|||
160962263|NCT00316082|581247928|FG000|Overall Study|Physician Decision|1|||
160962264|NCT00316082|581247929|FG001|Overall Study|Physician Decision|1|||
160962265|NCT00316082|581247930|FG002|Overall Study|Physician Decision|2|||
160962266|NCT00316082|581247931|FG003|Overall Study|Physician Decision|1|||
160962267|NCT00316082|581247932|FG004|Overall Study|Physician Decision|1|||
160962268|NCT00316082|581247928|FG000|Overall Study|Death|0|||
160962269|NCT00316082|581247929|FG001|Overall Study|Death|0|||
160962270|NCT00316082|581247930|FG002|Overall Study|Death|1|||
160962271|NCT00316082|581247931|FG003|Overall Study|Death|0|||
160962272|NCT00316082|581247932|FG004|Overall Study|Death|0|||
160962273|NCT00316082|581247928|FG000|Overall Study|Administrative reason by sponsor|0|||
160962274|NCT00316082|581247929|FG001|Overall Study|Administrative reason by sponsor|0|||
160962275|NCT00316082|581247930|FG002|Overall Study|Administrative reason by sponsor|1|||
160962276|NCT00316082|581247931|FG003|Overall Study|Administrative reason by sponsor|0|||
160962277|NCT00316082|581247932|FG004|Overall Study|Administrative reason by sponsor|0|||
160962278|NCT02216773|581247933|FG000|Overall Study|Disease progression|4|||
160962279|NCT02216773|581247934|FG001|Overall Study|Disease progression|2|||
160962280|NCT02216773|581247933|FG000|Overall Study|Insufficient FLRV|4|||
160962281|NCT02216773|581247934|FG001|Overall Study|Insufficient FLRV|0|||
160962282|NCT02216773|581247933|FG000|Overall Study|Abandoned|4|||
160962283|NCT02216773|581247934|FG001|Overall Study|Abandoned|3|||
160962284|NCT00528775|581247937|FG000|Overall Study|Other not specified|1|||
160962285|NCT02012491|581247948|FG000|Overall Study|Lost to Follow-up|1|||
160962286|NCT02012491|581247949|FG001|Overall Study|Lost to Follow-up|0|||
160962287|NCT02012491|581247948|FG000|Overall Study|Protocol Violation|0|||
160962288|NCT02012491|581247949|FG001|Overall Study|Protocol Violation|1|||
160962289|NCT02012491|581247948|FG000|Overall Study|Withdrawal by Subject|1|||
160962290|NCT02012491|581247949|FG001|Overall Study|Withdrawal by Subject|0|||
160962291|NCT01667432|581247955|FG000|Overall Study|Premature Study Termination|26|||
160962292|NCT01667432|581247955|FG000|Overall Study|Failure to Return|10|||
160962293|NCT01667432|581247955|FG000|Overall Study|Moved to Another Center|3|||
160962294|NCT01667432|581247955|FG000|Overall Study|Lost to Follow-up|3|||
160962295|NCT01667432|581247955|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
160962296|NCT01667432|581247955|FG000|Overall Study|Insufficient Therapeutic Response|4|||
160962297|NCT01667432|581247955|FG000|Overall Study|Adverse Event|1|||
161002326|NCT03482011|581394573|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
161002327|NCT03482011|581394574|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
161002328|NCT03482011|581394575|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
161002329|NCT03482011|581394568|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161002330|NCT03482011|581394569|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161002331|NCT03482011|581394570|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
160962298|NCT01667432|581247955|FG000|Overall Study|Protocol Deviation|2|||
160962299|NCT01667432|581247955|FG000|Overall Study|Principal Investigator Decision|1|||
160962300|NCT01667432|581247955|FG000|Overall Study|Reason Not Specified|2|||
160458244|NCT04424316|579409131|FG002|Overall Study|Physician Decision|1|||
160962301|NCT01667432|581247955|FG000|Overall Study|Missing Information|4|||
160962302|NCT00344461|581247956|FG000|Overall Study|Adverse Event|6|||
160962303|NCT00344461|581247956|FG000|Overall Study|Death|1|||
160962304|NCT00344461|581247956|FG000|Overall Study|Lack of Efficacy|2|||
160962305|NCT00344461|581247956|FG000|Overall Study|Lost to Follow-up|2|||
160962306|NCT00344461|581247956|FG000|Overall Study|Physician Decision|2|||
160962307|NCT00344461|581247956|FG000|Overall Study|Protocol Violation|6|||
160962308|NCT00344461|581247956|FG000|Overall Study|Withdrawal by Subject|2|||
160962309|NCT00553696|581247963|FG000|Overall Study|Adverse Event|2|||
160962310|NCT00553696|581247964|FG001|Overall Study|Adverse Event|4|||
160962311|NCT00553696|581247965|FG002|Overall Study|Adverse Event|0|||
160962312|NCT00553696|581247966|FG003|Overall Study|Adverse Event|1|||
160962313|NCT00553696|581247963|FG000|Overall Study|Global deterioration of health status|0|||
160962314|NCT00553696|581247964|FG001|Overall Study|Global deterioration of health status|2|||
160962315|NCT00553696|581247965|FG002|Overall Study|Global deterioration of health status|0|||
160962316|NCT00553696|581247966|FG003|Overall Study|Global deterioration of health status|0|||
160962317|NCT00553696|581247963|FG000|Overall Study|Objective progression or relapse|2|||
160962318|NCT00553696|581247964|FG001|Overall Study|Objective progression or relapse|9|||
160962319|NCT00553696|581247965|FG002|Overall Study|Objective progression or relapse|6|||
160962320|NCT00553696|581247966|FG003|Overall Study|Objective progression or relapse|0|||
160962321|NCT00553696|581247963|FG000|Overall Study|Withdrawal by Subject|0|||
160962322|NCT00553696|581247964|FG001|Overall Study|Withdrawal by Subject|1|||
160962323|NCT00553696|581247965|FG002|Overall Study|Withdrawal by Subject|0|||
160962324|NCT00553696|581247966|FG003|Overall Study|Withdrawal by Subject|0|||
160962325|NCT00941330|581247969|FG000|Overall Study|Other|1|||
160962326|NCT00941330|581247970|FG001|Overall Study|Other|0|||
160962327|NCT00941330|581247969|FG000|Overall Study|Physician Decision|0|||
160962328|NCT00941330|581247970|FG001|Overall Study|Physician Decision|2|||
160962329|NCT00686881|581247971|FG000|Overall Study|Withdrawal by Subject|11|||
160962330|NCT00686881|581247972|FG001|Overall Study|Withdrawal by Subject|18|||
160962331|NCT00686881|581247971|FG000|Overall Study|Lost to Follow-up|0|||
160962332|NCT00686881|581247972|FG001|Overall Study|Lost to Follow-up|1|||
160962333|NCT00686881|581247971|FG000|Overall Study|Treatment-related adverse event|10|||
160962334|NCT00686881|581247972|FG001|Overall Study|Treatment-related adverse event|9|||
160962335|NCT00686881|581247971|FG000|Overall Study|Met discontinuation criteria|5|||
160962336|NCT00686881|581247972|FG001|Overall Study|Met discontinuation criteria|0|||
160962337|NCT00686881|581247971|FG000|Overall Study|Onset of malignant tumor|11|||
160962338|NCT00686881|581247972|FG001|Overall Study|Onset of malignant tumor|11|||
160962339|NCT00686881|581247971|FG000|Overall Study|Lack of Efficacy|4|||
160962340|NCT00686881|581247972|FG001|Overall Study|Lack of Efficacy|3|||
160962341|NCT00686881|581247971|FG000|Overall Study|Physician Decision|1|||
160962342|NCT00686881|581247972|FG001|Overall Study|Physician Decision|0|||
160962343|NCT00686881|581247971|FG000|Overall Study|Circumstances of site|1|||
160962344|NCT00686881|581247972|FG001|Overall Study|Circumstances of site|1|||
160962345|NCT00686881|581247971|FG000|Overall Study|Did not meet protocol eligibility|1|||
160962346|NCT00686881|581247972|FG001|Overall Study|Did not meet protocol eligibility|0|||
160962347|NCT00686881|581247971|FG000|Overall Study|Irregular visits|1|||
160962348|NCT00686881|581247972|FG001|Overall Study|Irregular visits|0|||
160962349|NCT00686881|581247971|FG000|Overall Study|Study discontinuation|35|||
160962350|NCT00686881|581247972|FG001|Overall Study|Study discontinuation|32|||
160962351|NCT00686881|581247971|FG000|Overall Study|Never received study drug|2|||
160962352|NCT00686881|581247972|FG001|Overall Study|Never received study drug|6|||
160962353|NCT00671931|581247975|FG000|Overall Study|Physician Decision|1|||
160962354|NCT00671931|581247976|FG001|Overall Study|Physician Decision|0|||
160962355|NCT00671931|581247977|FG002|Overall Study|Physician Decision|0|||
160962356|NCT00671931|581247978|FG003|Overall Study|Physician Decision|2|||
160962357|NCT00671931|581247979|FG004|Overall Study|Physician Decision|1|||
160962358|NCT01298999|581247980|FG000|Overall Study|Physician Decision|0|||
160962359|NCT01298999|581247981|FG001|Overall Study|Physician Decision|1|||
160962360|NCT01298999|581247980|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
160962361|NCT01298999|581247981|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
160962362|NCT00902694|581247982|FG000|Overall Study|Death|1|||
160962363|NCT00902694|581247983|FG001|Overall Study|Death|3|||
160962364|NCT00902694|581247982|FG000|Overall Study|Lost to Follow-up|1|||
160962365|NCT00902694|581247983|FG001|Overall Study|Lost to Follow-up|0|||
160962366|NCT00902694|581247982|FG000|Overall Study|Censored per protocol|3|||
160962367|NCT00902694|581247983|FG001|Overall Study|Censored per protocol|1|||
160962368|NCT00902694|581247982|FG000|Overall Study|Pregnancy|1|||
160962369|NCT00902694|581247983|FG001|Overall Study|Pregnancy|1|||
160962370|NCT00902694|581247982|FG000|Overall Study|Incarceration|1|||
160962371|NCT00902694|581247983|FG001|Overall Study|Incarceration|0|||
160962372|NCT04969263|581247984|FG000|Overall Study|Death|1|||
161002332|NCT03482011|581394571|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161002333|NCT03482011|581394572|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
160962373|NCT04969263|581247984|FG000|Overall Study|Lost to Follow-up|2|||
160962374|NCT04969263|581247984|FG000|Overall Study|Withdrawal by Subject|5|||
160962375|NCT04969263|581247984|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
160962376|NCT04154787|581247985|FG000|Overall Study|Adverse Event|0|||
160962377|NCT04154787|581247986|FG001|Overall Study|Adverse Event|1|||
160962378|NCT04154787|581247987|FG002|Overall Study|Adverse Event|0|||
160962379|NCT04154787|581247985|FG000|Overall Study|Patient Requires Other Treatment|0|||
160962380|NCT04154787|581247986|FG001|Overall Study|Patient Requires Other Treatment|1|||
160962381|NCT04154787|581247987|FG002|Overall Study|Patient Requires Other Treatment|0|||
160962382|NCT04154787|581247985|FG000|Overall Study|Study Terminated By Sponsor|0|||
160962383|NCT04154787|581247986|FG001|Overall Study|Study Terminated By Sponsor|6|||
160962384|NCT04154787|581247987|FG002|Overall Study|Study Terminated By Sponsor|1|||
160962385|NCT04154787|581247985|FG000|Overall Study|Subject Decision|0|||
160962386|NCT04154787|581247986|FG001|Overall Study|Subject Decision|1|||
160962387|NCT04154787|581247987|FG002|Overall Study|Subject Decision|0|||
160962388|NCT04154787|581247985|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
160962389|NCT04154787|581247986|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
160962390|NCT04154787|581247987|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
160962391|NCT02459574|581247988|FG000|Overall Study|Withdrawal by Subject|6|||
160962392|NCT02459574|581247989|FG001|Overall Study|Withdrawal by Subject|6|||
160962393|NCT02459574|581247990|FG002|Overall Study|Withdrawal by Subject|2|||
160962394|NCT02459574|581247988|FG000|Overall Study|Lost to Follow-up|1|||
160962395|NCT02459574|581247989|FG001|Overall Study|Lost to Follow-up|1|||
160962396|NCT02459574|581247990|FG002|Overall Study|Lost to Follow-up|0|||
160962397|NCT02459574|581247988|FG000|Overall Study|Death|0|||
160962398|NCT02459574|581247989|FG001|Overall Study|Death|1|||
160962399|NCT02459574|581247990|FG002|Overall Study|Death|0|||
160962400|NCT04866017|581247991|FG000|Overall Study|Study Terminated by Sponsor|13|||
160962401|NCT04866017|581247992|FG001|Overall Study|Study Terminated by Sponsor|14|||
160962402|NCT04866017|581247993|FG002|Overall Study|Study Terminated by Sponsor|13|||
160962403|NCT04866017|581247991|FG000|Overall Study|Death|8|||
160962404|NCT04866017|581247992|FG001|Overall Study|Death|4|||
160962405|NCT04866017|581247993|FG002|Overall Study|Death|8|||
160962406|NCT04866017|581247991|FG000|Overall Study|Withdrawal by Subject|1|||
160962407|NCT04866017|581247992|FG001|Overall Study|Withdrawal by Subject|0|||
160962408|NCT04866017|581247993|FG002|Overall Study|Withdrawal by Subject|1|||
160962409|NCT04866017|581247991|FG000|Overall Study|Physician Decision|0|||
160962410|NCT04866017|581247992|FG001|Overall Study|Physician Decision|1|||
160962411|NCT04866017|581247993|FG002|Overall Study|Physician Decision|0|||
160962412|NCT01553318|581249663|FG000|Overall Study|Protocol Violation|3|||
160962413|NCT01553318|581249664|FG001|Overall Study|Protocol Violation|2|||
160962414|NCT04244396|581249666|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
160962415|NCT04244396|581249666|FG000|Overall Study|Withdrawal by Subject|2|||
160962416|NCT04244396|581249666|FG000|Overall Study|Study termination|37|||
160962417|NCT01787097|581249667|FG000|Overall Study|Withdrawal by Subject|1|||
160962418|NCT01787097|581249668|FG001|Overall Study|Withdrawal by Subject|0|||
160962419|NCT01787097|581249669|FG002|Overall Study|Withdrawal by Subject|0|||
160962420|NCT01787097|581249670|FG003|Overall Study|Withdrawal by Subject|0|||
160962421|NCT00245102|581249671|FG000|Overall Study|Not Treated|1|||
160962422|NCT00245102|581249672|FG001|Overall Study|Not Treated|0|||
160962423|NCT00245102|581249673|FG002|Overall Study|Not Treated|1|||
160962424|NCT00245102|581249674|FG003|Overall Study|Not Treated|0|||
160962425|NCT00245102|581249675|FG004|Overall Study|Not Treated|0|||
160962426|NCT00245102|581249676|FG005|Overall Study|Not Treated|0|||
160962427|NCT00245102|581249671|FG000|Overall Study|Protocol Violation|1|||
160962428|NCT00245102|581249672|FG001|Overall Study|Protocol Violation|0|||
160962429|NCT00245102|581249673|FG002|Overall Study|Protocol Violation|0|||
160962430|NCT00245102|581249674|FG003|Overall Study|Protocol Violation|0|||
160962431|NCT00245102|581249675|FG004|Overall Study|Protocol Violation|0|||
160962432|NCT00245102|581249676|FG005|Overall Study|Protocol Violation|0|||
160962433|NCT00245102|581249671|FG000|Overall Study|Death|0|||
160962434|NCT00245102|581249672|FG001|Overall Study|Death|0|||
160962435|NCT00245102|581249673|FG002|Overall Study|Death|0|||
160962436|NCT00245102|581249674|FG003|Overall Study|Death|1|||
160962437|NCT00245102|581249675|FG004|Overall Study|Death|0|||
160962438|NCT00245102|581249676|FG005|Overall Study|Death|0|||
160962439|NCT00245102|581249671|FG000|Overall Study|Adverse Event|4|||
160962440|NCT00245102|581249672|FG001|Overall Study|Adverse Event|2|||
160962441|NCT00245102|581249673|FG002|Overall Study|Adverse Event|5|||
160962442|NCT00245102|581249674|FG003|Overall Study|Adverse Event|1|||
160962443|NCT00245102|581249675|FG004|Overall Study|Adverse Event|0|||
160962444|NCT00245102|581249676|FG005|Overall Study|Adverse Event|2|||
160962445|NCT00245102|581249671|FG000|Overall Study|Decline in performance|0|||
160962446|NCT00245102|581249672|FG001|Overall Study|Decline in performance|2|||
160962447|NCT00245102|581249673|FG002|Overall Study|Decline in performance|0|||
160962448|NCT00245102|581249674|FG003|Overall Study|Decline in performance|1|||
160962449|NCT00245102|581249675|FG004|Overall Study|Decline in performance|0|||
160962450|NCT00245102|581249676|FG005|Overall Study|Decline in performance|2|||
160962451|NCT00245102|581249671|FG000|Overall Study|Participant needed surgery|0|||
160962452|NCT00245102|581249672|FG001|Overall Study|Participant needed surgery|0|||
160962453|NCT00245102|581249673|FG002|Overall Study|Participant needed surgery|1|||
160962454|NCT00245102|581249674|FG003|Overall Study|Participant needed surgery|0|||
160962455|NCT00245102|581249675|FG004|Overall Study|Participant needed surgery|0|||
160962456|NCT00245102|581249676|FG005|Overall Study|Participant needed surgery|0|||
160962457|NCT00245102|581249671|FG000|Overall Study|Clinical progression|1|||
160962458|NCT00245102|581249672|FG001|Overall Study|Clinical progression|0|||
160962459|NCT00245102|581249673|FG002|Overall Study|Clinical progression|0|||
160962460|NCT00245102|581249674|FG003|Overall Study|Clinical progression|0|||
160962461|NCT00245102|581249675|FG004|Overall Study|Clinical progression|0|||
160962462|NCT00245102|581249676|FG005|Overall Study|Clinical progression|0|||
160962463|NCT00289887|581249677|FG000|Overall Study|Adverse Event|3|||
160962464|NCT00289887|581249678|FG001|Overall Study|Adverse Event|3|||
160962465|NCT00289887|581249677|FG000|Overall Study|Lack of Efficacy|3|||
160962466|NCT00289887|581249678|FG001|Overall Study|Lack of Efficacy|11|||
160962467|NCT00289887|581249677|FG000|Overall Study|Lost to Follow-up|3|||
160962468|NCT00289887|581249678|FG001|Overall Study|Lost to Follow-up|3|||
160962469|NCT00289887|581249677|FG000|Overall Study|Protocol Violation|3|||
160962470|NCT00289887|581249678|FG001|Overall Study|Protocol Violation|1|||
160962471|NCT00289887|581249677|FG000|Overall Study|Withdrawal by Subject|3|||
160962472|NCT00289887|581249678|FG001|Overall Study|Withdrawal by Subject|8|||
160962473|NCT00289887|581249677|FG000|Overall Study|Other|7|||
160962474|NCT00289887|581249678|FG001|Overall Study|Other|3|||
160962475|NCT02293395|581249681|FG000|Overall Study|Lost to Follow-up|1|||
160962476|NCT02293395|581249682|FG001|Overall Study|Lost to Follow-up|0|||
160962477|NCT02293395|581249681|FG000|Overall Study|Withdrawal by Subject|8|||
160962478|NCT02293395|581249682|FG001|Overall Study|Withdrawal by Subject|7|||
160962479|NCT01464021|581249683|FG000|Overall Study|Withdrawal by Subject|13|||
160962480|NCT01464021|581249683|FG000|Overall Study|Lost to Follow-up|1|||
160962481|NCT01464021|581249683|FG000|Overall Study|Lack of Efficacy|1|||
160962482|NCT01464021|581249683|FG000|Overall Study|various|11|||
160962483|NCT00224770|581249689|FG000|Overall Study|Lost to Follow-up|4|||
160962484|NCT00224770|581249690|FG001|Overall Study|Lost to Follow-up|2|||
160962485|NCT00224770|581249691|FG002|Overall Study|Lost to Follow-up|0|||
160962486|NCT01106430|581249692|FG000|Overall Study|Adverse Event|8|||
160962487|NCT01106430|581249693|FG001|Overall Study|Adverse Event|10|||
160962488|NCT01106430|581249692|FG000|Overall Study|Lack of Efficacy|2|||
160962489|NCT01106430|581249693|FG001|Overall Study|Lack of Efficacy|13|||
160962490|NCT01106430|581249692|FG000|Overall Study|Lost to Follow-up|5|||
160962491|NCT01106430|581249693|FG001|Overall Study|Lost to Follow-up|1|||
160962492|NCT01106430|581249692|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
160962493|NCT01106430|581249693|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
160962494|NCT01106430|581249692|FG000|Overall Study|Moved Out Of State|0|||
160962495|NCT01106430|581249693|FG001|Overall Study|Moved Out Of State|1|||
160962496|NCT01106430|581249692|FG000|Overall Study|Refused To Take Medication|0|||
160962497|NCT01106430|581249693|FG001|Overall Study|Refused To Take Medication|1|||
160962498|NCT01106430|581249692|FG000|Overall Study|Noncompliance|0|||
160962499|NCT01106430|581249693|FG001|Overall Study|Noncompliance|1|||
160962500|NCT01106430|581249692|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
160962501|NCT01106430|581249693|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
160962502|NCT01106430|581249692|FG000|Overall Study|Previous Use Of Marijuana|1|||
160962503|NCT01106430|581249693|FG001|Overall Study|Previous Use Of Marijuana|0|||
160962504|NCT01106430|581249692|FG000|Overall Study|Protocol Violation|7|||
160962505|NCT01106430|581249693|FG001|Overall Study|Protocol Violation|2|||
160962506|NCT01106430|581249692|FG000|Overall Study|Withdrawal by Subject|8|||
160962507|NCT01106430|581249693|FG001|Overall Study|Withdrawal by Subject|4|||
160962508|NCT00437645|581249696|FG000|Overall Study|Adverse Event|15|||
160962509|NCT00437645|581249697|FG001|Overall Study|Adverse Event|84|||
160962510|NCT00437645|581249696|FG000|Overall Study|Withdrawal by Subject|10|||
160962511|NCT00437645|581249697|FG001|Overall Study|Withdrawal by Subject|22|||
160962512|NCT00437645|581249696|FG000|Overall Study|Protocol Violation|3|||
160962513|NCT00437645|581249697|FG001|Overall Study|Protocol Violation|3|||
160962514|NCT00437645|581249696|FG000|Overall Study|Lost to Follow-up|2|||
160962515|NCT00437645|581249697|FG001|Overall Study|Lost to Follow-up|3|||
160962516|NCT00437645|581249696|FG000|Overall Study|Administrative problems|2|||
160962517|NCT00437645|581249697|FG001|Overall Study|Administrative problems|1|||
160962518|NCT00437645|581249696|FG000|Overall Study|Lack of Efficacy|2|||
160962519|NCT00437645|581249697|FG001|Overall Study|Lack of Efficacy|1|||
160962520|NCT00437645|581249696|FG000|Overall Study|Condition no longer requires study drug|1|||
160962521|NCT00437645|581249697|FG001|Overall Study|Condition no longer requires study drug|1|||
160962522|NCT00989092|581249702|FG000|Overall Study|Physician Decision|9|||
160962523|NCT00989092|581249703|FG001|Overall Study|Physician Decision|6|||
160584950|NCT02052778|579861895|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584951|NCT02052778|579861896|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160962524|NCT00989092|581249702|FG000|Overall Study|Adverse Event|20|||
160962525|NCT00989092|581249703|FG001|Overall Study|Adverse Event|1|||
160962526|NCT00989092|581249702|FG000|Overall Study|Chemotherapy initiated|12|||
160962527|NCT00989092|581249703|FG001|Overall Study|Chemotherapy initiated|4|||
160962528|NCT00989092|581249702|FG000|Overall Study|Withdrawal by Subject|17|||
160962529|NCT00989092|581249703|FG001|Overall Study|Withdrawal by Subject|9|||
160962530|NCT00989092|581249702|FG000|Overall Study|Death|14|||
160962531|NCT00989092|581249703|FG001|Overall Study|Death|2|||
160962532|NCT00989092|581249702|FG000|Overall Study|Ineligibility determined|3|||
160962533|NCT00989092|581249703|FG001|Overall Study|Ineligibility determined|3|||
160962534|NCT00989092|581249702|FG000|Overall Study|Lost to Follow-up|6|||
160962535|NCT00989092|581249703|FG001|Overall Study|Lost to Follow-up|2|||
160962536|NCT00989092|581249702|FG000|Overall Study|Other|3|||
160962537|NCT00989092|581249703|FG001|Overall Study|Other|1|||
160962538|NCT00989092|581249702|FG000|Overall Study|Protocol deviation|2|||
160962539|NCT00989092|581249703|FG001|Overall Study|Protocol deviation|0|||
160962540|NCT00989092|581249702|FG000|Overall Study|Erythropoietin therapy initiated|2|||
160962541|NCT00989092|581249703|FG001|Overall Study|Erythropoietin therapy initiated|0|||
160962542|NCT00989092|581249702|FG000|Overall Study|Did not receive study drug|2|||
160962543|NCT00989092|581249703|FG001|Overall Study|Did not receive study drug|0|||
160962544|NCT02472652|581249706|FG000|Overall Study|Lost to Follow-up|1|||
160962545|NCT03185832|581249707|FG000|Overall Study|Death|9|||
160962546|NCT03185832|581249708|FG001|Overall Study|Death|14|||
160962547|NCT03185832|581249709|FG002|Overall Study|Death|9|||
160962548|NCT03185832|581249710|FG003|Overall Study|Death|7|||
160962549|NCT03185832|581249707|FG000|Overall Study|Withdrawn - vital status available|0|||
160962550|NCT03185832|581249708|FG001|Overall Study|Withdrawn - vital status available|1|||
160962551|NCT03185832|581249709|FG002|Overall Study|Withdrawn - vital status available|1|||
160962552|NCT03185832|581249710|FG003|Overall Study|Withdrawn - vital status available|4|||
160962553|NCT02230956|581249713|FG000|Overall Study|Adverse Event|1|||
160962554|NCT02230956|581249714|FG001|Overall Study|Adverse Event|1|||
160962555|NCT02230956|581249715|FG002|Overall Study|Adverse Event|0|||
160962556|NCT02230956|581249713|FG000|Overall Study|Lack of Efficacy|1|||
160962557|NCT02230956|581249714|FG001|Overall Study|Lack of Efficacy|1|||
160962558|NCT02230956|581249715|FG002|Overall Study|Lack of Efficacy|1|||
160962559|NCT02230956|581249713|FG000|Overall Study|Lost to Follow-up|1|||
160962560|NCT02230956|581249714|FG001|Overall Study|Lost to Follow-up|1|||
160962561|NCT02230956|581249715|FG002|Overall Study|Lost to Follow-up|2|||
160962562|NCT02230956|581249713|FG000|Overall Study|Personal Reasons|2|||
160962563|NCT02230956|581249714|FG001|Overall Study|Personal Reasons|1|||
160962564|NCT02230956|581249715|FG002|Overall Study|Personal Reasons|1|||
160962565|NCT02230956|581249713|FG000|Overall Study|Protocol Violation|0|||
160458245|NCT04424316|579409132|FG003|Overall Study|Physician Decision|1|||
160458246|NCT04424316|579409129|FG000|Overall Study|Protocol Violation|0|||
160458247|NCT04424316|579409130|FG001|Overall Study|Protocol Violation|1|||
160962566|NCT02230956|581249714|FG001|Overall Study|Protocol Violation|1|||
160962567|NCT02230956|581249715|FG002|Overall Study|Protocol Violation|1|||
160962568|NCT02230956|581249713|FG000|Overall Study|Other Miscellaneous Reason|0|||
160962569|NCT02230956|581249714|FG001|Overall Study|Other Miscellaneous Reason|1|||
160962570|NCT02230956|581249715|FG002|Overall Study|Other Miscellaneous Reason|2|||
160962571|NCT01445652|581249716|FG000|Overall Study|Not comfortable in lenses|5|||
160962572|NCT01445652|581249717|FG001|Overall Study|Not comfortable in lenses|0|||
160962573|NCT01445652|581249716|FG000|Overall Study|Failed to attend scheduled visit|2|||
160962574|NCT01445652|581249717|FG001|Overall Study|Failed to attend scheduled visit|3|||
160962575|NCT01445652|581249716|FG000|Overall Study|Failed teach session|2|||
160962576|NCT01445652|581249717|FG001|Overall Study|Failed teach session|0|||
160962577|NCT01445652|581249716|FG000|Overall Study|Adverse Event|1|||
160962578|NCT01445652|581249717|FG001|Overall Study|Adverse Event|0|||
160962579|NCT03002610|581249718|FG000|Overall Study|Withdrawal by Subject|6|||
160962580|NCT03002610|581249719|FG001|Overall Study|Withdrawal by Subject|25|||
160962581|NCT03002610|581249720|FG002|Overall Study|Withdrawal by Subject|13|||
160962582|NCT01822587|581249721|FG000|Overall Study|Lost to Follow-up|7|||
160962583|NCT01822587|581249722|FG001|Overall Study|Lost to Follow-up|9|||
160962584|NCT01822587|581249723|FG002|Overall Study|Lost to Follow-up|12|||
160962585|NCT01822587|581249721|FG000|Overall Study|Physician Decision|9|||
160962586|NCT01822587|581249722|FG001|Overall Study|Physician Decision|6|||
160962587|NCT01822587|581249723|FG002|Overall Study|Physician Decision|6|||
160962588|NCT00117676|581249724|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
160962589|NCT00117676|581249725|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
160962590|NCT00117676|581249724|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
160962591|NCT00117676|581249725|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
160962592|NCT00117676|581249724|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
160962593|NCT00117676|581249725|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
160962594|NCT00117676|581249724|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
160962595|NCT00117676|581249725|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
160962596|NCT00117676|581249724|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
160962597|NCT00117676|581249725|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
160962598|NCT00117676|581249724|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
160962599|NCT00117676|581249725|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
160962600|NCT00117676|581249724|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
160962601|NCT00117676|581249725|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
160962602|NCT00117676|581249724|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
160458248|NCT04424316|579409131|FG002|Overall Study|Protocol Violation|0|||
160962603|NCT00117676|581249725|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
160458249|NCT04424316|579409132|FG003|Overall Study|Protocol Violation|0|||
160458250|NCT04424316|579409129|FG000|Overall Study|Withdrawal by Subject|71|||
160962604|NCT00117676|581249724|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
160962605|NCT00117676|581249725|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
160962606|NCT00117676|581249724|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
160962607|NCT00117676|581249725|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
160962608|NCT00117676|581249724|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
160962609|NCT00117676|581249725|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
160962610|NCT00117676|581249724|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
160962611|NCT00117676|581249725|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
160962612|NCT00117676|581249724|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
160962613|NCT00117676|581249725|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
160962614|NCT00117676|581249724|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
160962615|NCT00117676|581249725|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
160962616|NCT00117676|581249724|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
160962617|NCT00117676|581249725|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
160962618|NCT00117676|581249724|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
160962619|NCT00117676|581249725|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
160962620|NCT00117676|581249724|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
160962621|NCT00117676|581249725|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
160962622|NCT00117676|581249724|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
160962623|NCT00117676|581249725|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
160962624|NCT00117676|581249724|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
160962625|NCT00117676|581249725|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
160962626|NCT00117676|581249724|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
160962627|NCT00117676|581249725|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
160962628|NCT00117676|581249724|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
160962629|NCT00117676|581249725|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
160962630|NCT00117676|581249724|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
160962631|NCT00117676|581249725|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
160962632|NCT00117676|581249724|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
160962633|NCT00117676|581249725|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
160962634|NCT00117676|581249724|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
160962635|NCT00117676|581249725|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
160962636|NCT00117676|581249724|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
160962637|NCT00117676|581249725|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
160962638|NCT00117676|581249724|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
160962639|NCT00117676|581249725|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
160962640|NCT00117676|581249724|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
160962641|NCT00117676|581249725|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
160962642|NCT00117676|581249724|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
160962643|NCT00117676|581249725|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
160962644|NCT00117676|581249724|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
160962645|NCT00117676|581249725|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
160962646|NCT00117676|581249724|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
160962647|NCT00117676|581249725|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
160962648|NCT00117676|581249724|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
160962649|NCT00117676|581249725|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
160962650|NCT00117676|581249724|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
160962651|NCT00117676|581249725|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
160962652|NCT00117676|581249724|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
160962653|NCT00117676|581249725|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
160962654|NCT00117676|581249724|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
160962655|NCT00117676|581249725|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
160962656|NCT00117676|581249724|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
160962657|NCT00117676|581249725|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
160962658|NCT00952822|581249726|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
160962659|NCT00952822|581249727|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
160962660|NCT00952822|581249728|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
160962661|NCT00952822|581249729|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
160962662|NCT00952822|581249726|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
160962663|NCT00952822|581249727|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
160962664|NCT00952822|581249728|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
160962665|NCT00952822|581249729|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
160584952|NCT02052778|579861897|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160962666|NCT04555096|581249731|FG000|Overall Study|Death|4|||
160962667|NCT04555096|581249732|FG001|Overall Study|Death|4|||
160962668|NCT04555096|581249731|FG000|Overall Study|Withdrawal by Subject|1|||
160962669|NCT04555096|581249732|FG001|Overall Study|Withdrawal by Subject|0|||
160962670|NCT04555096|581249731|FG000|Overall Study|Other|0|||
160962671|NCT04555096|581249732|FG001|Overall Study|Other|1|||
160962672|NCT00594854|581249734|FG000|Overall Study|Study terminated|7|||
160962673|NCT00594854|581249735|FG001|Overall Study|Study terminated|10|||
160962674|NCT04918147|581249746|FG000|Overall Study|Disease flare as defined in protocol|0|||
160962675|NCT04918147|581249747|FG001|Overall Study|Disease flare as defined in protocol|2|||
160962676|NCT03292146|581249748|FG000|Baseline to 12 months|Relocation|1|||
160962677|NCT03292146|581249749|FG001|Baseline to 12 months|Relocation|0|||
160962678|NCT03292146|581249748|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
160962679|NCT03292146|581249749|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
160962680|NCT03292146|581249748|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
160962681|NCT03292146|581249749|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
160962682|NCT03292146|581249748|FG000|12 months to 24 months|Planning pregnancy|2|||
160962683|NCT03292146|581249749|FG001|12 months to 24 months|Planning pregnancy|2|||
160962684|NCT03292146|581249748|FG000|12 months to 24 months|Personal reasons|1|||
160962685|NCT03292146|581249749|FG001|12 months to 24 months|Personal reasons|0|||
160962686|NCT03292146|581249748|FG000|12 months to 24 months|Lost to Follow-up|0|||
160962687|NCT03292146|581249749|FG001|12 months to 24 months|Lost to Follow-up|1|||
160962688|NCT06134180|581249750|FG000|Overall Study|Lost to Follow-up|4|||
160962689|NCT01362439|581249751|FG000|Overall Study|Adverse Event|1|||
160962690|NCT01362439|581249751|FG000|Overall Study|Lack of Efficacy|3|||
160962691|NCT01362439|581249751|FG000|Overall Study|Lost to Follow-up|2|||
160962692|NCT01362439|581249751|FG000|Overall Study|Study medication non-compliant|1|||
160962693|NCT01362439|581249751|FG000|Overall Study|Participant who withdrew consent|8|||
160962694|NCT03575325|581249755|FG000|Overall Study|Death|1|||
160962695|NCT03440372|581249756|FG000|Treatment|Adverse Event|16|||
160962696|NCT03440372|581249757|FG001|Treatment|Adverse Event|8|||
160962697|NCT03440372|581249756|FG000|Treatment|Lack of Efficacy|4|||
160962698|NCT03440372|581249757|FG001|Treatment|Lack of Efficacy|2|||
160962699|NCT03440372|581249756|FG000|Treatment|Withdrawal by Subject|12|||
160962700|NCT03440372|581249757|FG001|Treatment|Withdrawal by Subject|8|||
160962701|NCT03440372|581249756|FG000|Treatment|Lost to Follow-up|1|||
160962702|NCT03440372|581249757|FG001|Treatment|Lost to Follow-up|0|||
160962703|NCT03440372|581249756|FG000|Treatment|Pregnancy|1|||
160962704|NCT03440372|581249757|FG001|Treatment|Pregnancy|0|||
160962705|NCT03440372|581249756|FG000|Treatment|Study Terminated by Sponsor|2|||
160962706|NCT03440372|581249757|FG001|Treatment|Study Terminated by Sponsor|1|||
160962707|NCT03440372|581249756|FG000|Treatment|Other Reason|2|||
160962708|NCT03440372|581249757|FG001|Treatment|Other Reason|3|||
160962709|NCT05711641|581249758|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
160962710|NCT05711641|581249759|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
160962711|NCT05711641|581249758|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
160962712|NCT05711641|581249759|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
160962713|NCT03574597|581249760|FG000|Overall Study|Withdrawal by Subject|67|||
160962714|NCT03574597|581249761|FG001|Overall Study|Withdrawal by Subject|96|||
160962715|NCT03574597|581249760|FG000|Overall Study|Lost to Follow-up|192|||
160962716|NCT03574597|581249761|FG001|Overall Study|Lost to Follow-up|188|||
160962717|NCT02355743|581249762|FG000|Overall Study|Withdrawal by Subject|1|||
160962718|NCT02355743|581249762|FG000|Overall Study|Lost to Follow-up|1|||
160962719|NCT02712905|581249765|FG000|Monotherapy|Death|2|||
160962720|NCT02712905|581249766|FG001|Monotherapy|Death|5|||
160962721|NCT02712905|581249767|FG002|Monotherapy|Death|0|||
160458251|NCT04424316|579409130|FG001|Overall Study|Withdrawal by Subject|77|||
160458252|NCT04424316|579409131|FG002|Overall Study|Withdrawal by Subject|0|||
160458253|NCT04424316|579409132|FG003|Overall Study|Withdrawal by Subject|0|||
160458254|NCT04424316|579409129|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160458255|NCT04424316|579409130|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160458256|NCT04424316|579409131|FG002|Overall Study|Withdrawal by parent/guardian|74|||
160458257|NCT04424316|579409132|FG003|Overall Study|Withdrawal by parent/guardian|81|||
160458258|NCT04424316|579409129|FG000|Overall Study|Randomized but not vaccinated|13|||
160962722|NCT02712905|581249768|FG003|Monotherapy|Death|3|||
160962723|NCT02712905|581249769|FG004|Monotherapy|Death|15|||
160962724|NCT02712905|581249770|FG005|Monotherapy|Death|1|||
160962725|NCT02712905|581249771|FG006|Monotherapy|Death|3|||
160962726|NCT02712905|581249772|FG007|Monotherapy|Death|3|||
160962727|NCT02712905|581249773|FG008|Monotherapy|Death|0|||
160962728|NCT02712905|581249774|FG009|Monotherapy|Death|27|||
160962729|NCT02712905|581249775|FG010|Monotherapy|Death|2|||
160962730|NCT02712905|581249776|FG011|Monotherapy|Death|5|||
160962731|NCT02712905|581249777|FG012|Monotherapy|Death|0|||
160962732|NCT02712905|581249778|FG013|Monotherapy|Death|0|||
160962733|NCT02712905|581249779|FG014|Monotherapy|Death|0|||
160962734|NCT02712905|581249780|FG015|Monotherapy|Death|0|||
160962735|NCT02712905|581249781|FG016|Monotherapy|Death|0|||
160962736|NCT02712905|581249782|FG017|Monotherapy|Death|0|||
160962737|NCT02712905|581249765|FG000|Monotherapy|Lost to Follow-up|0|||
160962738|NCT02712905|581249766|FG001|Monotherapy|Lost to Follow-up|1|||
160962739|NCT02712905|581249767|FG002|Monotherapy|Lost to Follow-up|0|||
160962740|NCT02712905|581249768|FG003|Monotherapy|Lost to Follow-up|1|||
160962741|NCT02712905|581249769|FG004|Monotherapy|Lost to Follow-up|0|||
160962742|NCT02712905|581249770|FG005|Monotherapy|Lost to Follow-up|0|||
160962743|NCT02712905|581249771|FG006|Monotherapy|Lost to Follow-up|0|||
160962744|NCT02712905|581249772|FG007|Monotherapy|Lost to Follow-up|0|||
160962745|NCT02712905|581249773|FG008|Monotherapy|Lost to Follow-up|0|||
160962746|NCT02712905|581249774|FG009|Monotherapy|Lost to Follow-up|2|||
160962747|NCT02712905|581249775|FG010|Monotherapy|Lost to Follow-up|0|||
160962748|NCT02712905|581249776|FG011|Monotherapy|Lost to Follow-up|0|||
160962749|NCT02712905|581249777|FG012|Monotherapy|Lost to Follow-up|0|||
160962750|NCT02712905|581249778|FG013|Monotherapy|Lost to Follow-up|0|||
160962751|NCT02712905|581249779|FG014|Monotherapy|Lost to Follow-up|0|||
160962752|NCT02712905|581249780|FG015|Monotherapy|Lost to Follow-up|0|||
160962753|NCT02712905|581249781|FG016|Monotherapy|Lost to Follow-up|0|||
160962754|NCT02712905|581249782|FG017|Monotherapy|Lost to Follow-up|0|||
160962755|NCT02712905|581249765|FG000|Monotherapy|Physician Decision|1|||
160962756|NCT02712905|581249766|FG001|Monotherapy|Physician Decision|0|||
160962757|NCT02712905|581249767|FG002|Monotherapy|Physician Decision|0|||
160962758|NCT02712905|581249768|FG003|Monotherapy|Physician Decision|1|||
160962759|NCT02712905|581249769|FG004|Monotherapy|Physician Decision|0|||
160962760|NCT02712905|581249770|FG005|Monotherapy|Physician Decision|0|||
160962761|NCT02712905|581249771|FG006|Monotherapy|Physician Decision|0|||
160962762|NCT02712905|581249772|FG007|Monotherapy|Physician Decision|0|||
160962763|NCT02712905|581249773|FG008|Monotherapy|Physician Decision|0|||
160962764|NCT02712905|581249774|FG009|Monotherapy|Physician Decision|1|||
160962765|NCT02712905|581249775|FG010|Monotherapy|Physician Decision|0|||
160962766|NCT02712905|581249776|FG011|Monotherapy|Physician Decision|0|||
160962767|NCT02712905|581249777|FG012|Monotherapy|Physician Decision|0|||
160962768|NCT02712905|581249778|FG013|Monotherapy|Physician Decision|0|||
160962769|NCT02712905|581249779|FG014|Monotherapy|Physician Decision|0|||
160962770|NCT02712905|581249780|FG015|Monotherapy|Physician Decision|0|||
160962771|NCT02712905|581249781|FG016|Monotherapy|Physician Decision|0|||
160962772|NCT02712905|581249782|FG017|Monotherapy|Physician Decision|0|||
160962773|NCT02712905|581249765|FG000|Monotherapy|Study Terminated by Sponsor|0|||
160962774|NCT02712905|581249766|FG001|Monotherapy|Study Terminated by Sponsor|0|||
160962775|NCT02712905|581249767|FG002|Monotherapy|Study Terminated by Sponsor|0|||
160962776|NCT02712905|581249768|FG003|Monotherapy|Study Terminated by Sponsor|0|||
160962777|NCT02712905|581249769|FG004|Monotherapy|Study Terminated by Sponsor|1|||
160962778|NCT02712905|581249770|FG005|Monotherapy|Study Terminated by Sponsor|0|||
160962779|NCT02712905|581249771|FG006|Monotherapy|Study Terminated by Sponsor|0|||
160962780|NCT02712905|581249772|FG007|Monotherapy|Study Terminated by Sponsor|0|||
160962781|NCT02712905|581249773|FG008|Monotherapy|Study Terminated by Sponsor|0|||
160962782|NCT02712905|581249774|FG009|Monotherapy|Study Terminated by Sponsor|2|||
160962783|NCT02712905|581249775|FG010|Monotherapy|Study Terminated by Sponsor|0|||
160962784|NCT02712905|581249776|FG011|Monotherapy|Study Terminated by Sponsor|0|||
160962785|NCT02712905|581249777|FG012|Monotherapy|Study Terminated by Sponsor|0|||
160962786|NCT02712905|581249778|FG013|Monotherapy|Study Terminated by Sponsor|0|||
160962787|NCT02712905|581249779|FG014|Monotherapy|Study Terminated by Sponsor|0|||
160962788|NCT02712905|581249780|FG015|Monotherapy|Study Terminated by Sponsor|0|||
160962789|NCT02712905|581249781|FG016|Monotherapy|Study Terminated by Sponsor|0|||
160962790|NCT02712905|581249782|FG017|Monotherapy|Study Terminated by Sponsor|0|||
160962791|NCT02712905|581249765|FG000|Monotherapy|Withdrawal by Subject|0|||
160962792|NCT02712905|581249766|FG001|Monotherapy|Withdrawal by Subject|0|||
160962793|NCT02712905|581249767|FG002|Monotherapy|Withdrawal by Subject|1|||
160962794|NCT02712905|581249768|FG003|Monotherapy|Withdrawal by Subject|0|||
160962795|NCT02712905|581249769|FG004|Monotherapy|Withdrawal by Subject|2|||
160962796|NCT02712905|581249770|FG005|Monotherapy|Withdrawal by Subject|0|||
160962797|NCT02712905|581249771|FG006|Monotherapy|Withdrawal by Subject|0|||
160962798|NCT02712905|581249772|FG007|Monotherapy|Withdrawal by Subject|0|||
160962799|NCT02712905|581249773|FG008|Monotherapy|Withdrawal by Subject|0|||
161002334|NCT03482011|581394573|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
160584953|NCT02052778|579861898|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
160584954|NCT02052778|579861876|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
160584955|NCT02052778|579861877|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
160584956|NCT02052778|579861878|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
160962800|NCT02712905|581249774|FG009|Monotherapy|Withdrawal by Subject|4|||
160962801|NCT02712905|581249775|FG010|Monotherapy|Withdrawal by Subject|1|||
160962802|NCT02712905|581249776|FG011|Monotherapy|Withdrawal by Subject|2|||
160962803|NCT02712905|581249777|FG012|Monotherapy|Withdrawal by Subject|0|||
161002335|NCT03482011|581394574|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
160584957|NCT02052778|579861879|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
160962804|NCT02712905|581249778|FG013|Monotherapy|Withdrawal by Subject|0|||
160962805|NCT02712905|581249779|FG014|Monotherapy|Withdrawal by Subject|0|||
160962806|NCT02712905|581249780|FG015|Monotherapy|Withdrawal by Subject|0|||
160962807|NCT02712905|581249781|FG016|Monotherapy|Withdrawal by Subject|0|||
160962808|NCT02712905|581249782|FG017|Monotherapy|Withdrawal by Subject|0|||
160584958|NCT02052778|579861880|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
160584959|NCT02052778|579861881|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
160584960|NCT02052778|579861882|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
160584961|NCT02052778|579861883|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
160584962|NCT02052778|579861884|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
160962809|NCT02712905|581249765|FG000|Monotherapy|Started New Cancer Drug|0|||
160962810|NCT02712905|581249766|FG001|Monotherapy|Started New Cancer Drug|0|||
160962811|NCT02712905|581249767|FG002|Monotherapy|Started New Cancer Drug|0|||
160962812|NCT02712905|581249768|FG003|Monotherapy|Started New Cancer Drug|0|||
160962813|NCT02712905|581249769|FG004|Monotherapy|Started New Cancer Drug|0|||
160962814|NCT02712905|581249770|FG005|Monotherapy|Started New Cancer Drug|1|||
160962815|NCT02712905|581249771|FG006|Monotherapy|Started New Cancer Drug|0|||
160962816|NCT02712905|581249772|FG007|Monotherapy|Started New Cancer Drug|0|||
160962817|NCT02712905|581249773|FG008|Monotherapy|Started New Cancer Drug|0|||
160962818|NCT02712905|581249774|FG009|Monotherapy|Started New Cancer Drug|0|||
160962819|NCT02712905|581249775|FG010|Monotherapy|Started New Cancer Drug|0|||
160962820|NCT02712905|581249776|FG011|Monotherapy|Started New Cancer Drug|0|||
160962821|NCT02712905|581249777|FG012|Monotherapy|Started New Cancer Drug|0|||
160962822|NCT02712905|581249778|FG013|Monotherapy|Started New Cancer Drug|0|||
160962823|NCT02712905|581249779|FG014|Monotherapy|Started New Cancer Drug|0|||
160962824|NCT02712905|581249780|FG015|Monotherapy|Started New Cancer Drug|0|||
160962825|NCT02712905|581249781|FG016|Monotherapy|Started New Cancer Drug|0|||
160962826|NCT02712905|581249782|FG017|Monotherapy|Started New Cancer Drug|0|||
160962827|NCT02712905|581249765|FG000|Monotherapy|Adverse Event|0|||
160962828|NCT02712905|581249766|FG001|Monotherapy|Adverse Event|0|||
160962829|NCT02712905|581249767|FG002|Monotherapy|Adverse Event|0|||
160962830|NCT02712905|581249768|FG003|Monotherapy|Adverse Event|0|||
160962831|NCT02712905|581249769|FG004|Monotherapy|Adverse Event|0|||
160962832|NCT02712905|581249770|FG005|Monotherapy|Adverse Event|0|||
160962833|NCT02712905|581249771|FG006|Monotherapy|Adverse Event|0|||
160962834|NCT02712905|581249772|FG007|Monotherapy|Adverse Event|0|||
160962835|NCT02712905|581249773|FG008|Monotherapy|Adverse Event|1|||
160962836|NCT02712905|581249774|FG009|Monotherapy|Adverse Event|0|||
160962837|NCT02712905|581249775|FG010|Monotherapy|Adverse Event|0|||
160962838|NCT02712905|581249776|FG011|Monotherapy|Adverse Event|0|||
160962839|NCT02712905|581249777|FG012|Monotherapy|Adverse Event|0|||
160962840|NCT02712905|581249778|FG013|Monotherapy|Adverse Event|0|||
160962841|NCT02712905|581249779|FG014|Monotherapy|Adverse Event|0|||
160962842|NCT02712905|581249780|FG015|Monotherapy|Adverse Event|0|||
160962843|NCT02712905|581249781|FG016|Monotherapy|Adverse Event|0|||
160962844|NCT02712905|581249782|FG017|Monotherapy|Adverse Event|0|||
160962845|NCT02712905|581249765|FG000|Combination Therapy|Death|0|||
160962846|NCT02712905|581249766|FG001|Combination Therapy|Death|0|||
160962847|NCT02712905|581249767|FG002|Combination Therapy|Death|0|||
160962848|NCT02712905|581249768|FG003|Combination Therapy|Death|0|||
160962849|NCT02712905|581249769|FG004|Combination Therapy|Death|0|||
160962850|NCT02712905|581249770|FG005|Combination Therapy|Death|0|||
160962851|NCT02712905|581249771|FG006|Combination Therapy|Death|0|||
160962852|NCT02712905|581249772|FG007|Combination Therapy|Death|0|||
160962853|NCT02712905|581249773|FG008|Combination Therapy|Death|0|||
160584963|NCT02052778|579861885|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
160584964|NCT02052778|579861886|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
160584965|NCT02052778|579861887|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
160584966|NCT02052778|579861888|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
160962854|NCT02712905|581249774|FG009|Combination Therapy|Death|0|||
160962855|NCT02712905|581249775|FG010|Combination Therapy|Death|0|||
160962856|NCT02712905|581249776|FG011|Combination Therapy|Death|0|||
160962857|NCT02712905|581249777|FG012|Combination Therapy|Death|5|||
160962858|NCT02712905|581249778|FG013|Combination Therapy|Death|6|||
160962859|NCT02712905|581249779|FG014|Combination Therapy|Death|1|||
160962860|NCT02712905|581249780|FG015|Combination Therapy|Death|3|||
160962861|NCT02712905|581249781|FG016|Combination Therapy|Death|1|||
160962862|NCT02712905|581249782|FG017|Combination Therapy|Death|3|||
160584967|NCT02052778|579861889|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
160962863|NCT02712905|581249765|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
160962864|NCT02712905|581249766|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
160962865|NCT02712905|581249767|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
160962866|NCT02712905|581249768|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
160962867|NCT02712905|581249769|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
160962868|NCT02712905|581249770|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
160962869|NCT02712905|581249771|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
160962870|NCT02712905|581249772|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
160962871|NCT02712905|581249773|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
160962872|NCT02712905|581249774|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
160962873|NCT02712905|581249775|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
160962874|NCT02712905|581249776|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
160962875|NCT02712905|581249777|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
160962876|NCT02712905|581249778|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
160962877|NCT02712905|581249779|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
160962878|NCT02712905|581249780|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
160962879|NCT02712905|581249781|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
160962880|NCT02712905|581249782|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
160962881|NCT02712905|581249765|FG000|Combination Therapy|Withdrawal by Subject|0|||
160962882|NCT02712905|581249766|FG001|Combination Therapy|Withdrawal by Subject|0|||
160962883|NCT02712905|581249767|FG002|Combination Therapy|Withdrawal by Subject|0|||
160962884|NCT02712905|581249768|FG003|Combination Therapy|Withdrawal by Subject|0|||
160962885|NCT02712905|581249769|FG004|Combination Therapy|Withdrawal by Subject|0|||
160962886|NCT02712905|581249770|FG005|Combination Therapy|Withdrawal by Subject|0|||
160962887|NCT02712905|581249771|FG006|Combination Therapy|Withdrawal by Subject|0|||
160962888|NCT02712905|581249772|FG007|Combination Therapy|Withdrawal by Subject|0|||
160962889|NCT02712905|581249773|FG008|Combination Therapy|Withdrawal by Subject|0|||
160962890|NCT02712905|581249774|FG009|Combination Therapy|Withdrawal by Subject|0|||
160962891|NCT02712905|581249775|FG010|Combination Therapy|Withdrawal by Subject|0|||
160962892|NCT02712905|581249776|FG011|Combination Therapy|Withdrawal by Subject|0|||
160962893|NCT02712905|581249777|FG012|Combination Therapy|Withdrawal by Subject|0|||
160962894|NCT02712905|581249778|FG013|Combination Therapy|Withdrawal by Subject|0|||
160962895|NCT02712905|581249779|FG014|Combination Therapy|Withdrawal by Subject|0|||
160962896|NCT02712905|581249780|FG015|Combination Therapy|Withdrawal by Subject|1|||
160962897|NCT02712905|581249781|FG016|Combination Therapy|Withdrawal by Subject|0|||
160962898|NCT02712905|581249782|FG017|Combination Therapy|Withdrawal by Subject|2|||
160962899|NCT02712905|581249765|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962900|NCT02712905|581249766|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962901|NCT02712905|581249767|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962902|NCT02712905|581249768|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962903|NCT02712905|581249769|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962904|NCT02712905|581249770|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962905|NCT02712905|581249771|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962906|NCT02712905|581249772|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962907|NCT02712905|581249773|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962908|NCT02712905|581249774|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962909|NCT02712905|581249775|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962910|NCT02712905|581249776|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962911|NCT02712905|581249777|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962912|NCT02712905|581249778|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962913|NCT02712905|581249779|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962914|NCT02712905|581249780|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
160962915|NCT02712905|581249781|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962916|NCT02712905|581249782|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962917|NCT03624504|581249783|FG000|Overall Study|Unsuccessful Implant|1|||
160962918|NCT02975973|581249786|FG000|Overall Study|Adverse Event|1|||
160962919|NCT02975973|581249787|FG001|Overall Study|Adverse Event|1|||
160962920|NCT02975973|581249788|FG002|Overall Study|Adverse Event|1|||
160962921|NCT02975973|581249789|FG003|Overall Study|Adverse Event|0|||
160962922|NCT01812655|581249790|FG000|Overall Study|Protocol Violation|1|||
160962923|NCT01812655|581249791|FG001|Overall Study|Protocol Violation|1|||
160962924|NCT01812655|581249792|FG002|Overall Study|Protocol Violation|0|||
160962925|NCT01428076|581249793|FG000|Overall Study|Adverse Event|0|||
160962926|NCT01428076|581249794|FG001|Overall Study|Adverse Event|1|||
160962927|NCT04435665|581249795|FG000|Overall Study|Lost to Follow-up|0|||
160962928|NCT04435665|581249796|FG001|Overall Study|Lost to Follow-up|0|||
160962929|NCT04435665|581249797|FG002|Overall Study|Lost to Follow-up|0|||
160962930|NCT04435665|581249798|FG003|Overall Study|Lost to Follow-up|1|||
160962931|NCT00419263|581249799|FG000|Overall Study|Lost to Follow-up|2|||
160962932|NCT00419263|581249800|FG001|Overall Study|Lost to Follow-up|1|||
160962933|NCT00419263|581249801|FG002|Overall Study|Lost to Follow-up|1|||
160962934|NCT00419263|581249799|FG000|Overall Study|Randomized in Error, Not Treated|1|||
160962935|NCT00419263|581249800|FG001|Overall Study|Randomized in Error, Not Treated|1|||
160962936|NCT00419263|581249801|FG002|Overall Study|Randomized in Error, Not Treated|0|||
160962937|NCT00419263|581249799|FG000|Overall Study|Adverse Event|0|||
161002336|NCT03482011|581394575|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
160458259|NCT04424316|579409130|FG001|Overall Study|Randomized but not vaccinated|21|||
160458260|NCT04424316|579409131|FG002|Overall Study|Randomized but not vaccinated|0|||
160458261|NCT04424316|579409132|FG003|Overall Study|Randomized but not vaccinated|0|||
160458262|NCT04424316|579409129|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
160962938|NCT00419263|581249800|FG001|Overall Study|Adverse Event|0|||
160962939|NCT00419263|581249801|FG002|Overall Study|Adverse Event|1|||
160962940|NCT00419263|581249799|FG000|Overall Study|Withdrawal by Subject|0|||
160962941|NCT00419263|581249800|FG001|Overall Study|Withdrawal by Subject|0|||
160962942|NCT00419263|581249801|FG002|Overall Study|Withdrawal by Subject|1|||
160962943|NCT00540124|581249802|FG000|Overall Study|Adverse Event|0|||
160962944|NCT00540124|581249803|FG001|Overall Study|Adverse Event|2|||
160962945|NCT00540124|581249804|FG002|Overall Study|Adverse Event|1|||
160962946|NCT00540124|581249802|FG000|Overall Study|Entry Criteria Not Met|2|||
160962947|NCT00540124|581249803|FG001|Overall Study|Entry Criteria Not Met|0|||
160962948|NCT00540124|581249804|FG002|Overall Study|Entry Criteria Not Met|0|||
160962949|NCT00540124|581249802|FG000|Overall Study|Lack of Efficacy|1|||
160962950|NCT00540124|581249803|FG001|Overall Study|Lack of Efficacy|0|||
160962951|NCT00540124|581249804|FG002|Overall Study|Lack of Efficacy|0|||
160962952|NCT00540124|581249802|FG000|Overall Study|Withdrawal by Subject|1|||
160962953|NCT00540124|581249803|FG001|Overall Study|Withdrawal by Subject|1|||
160962954|NCT00540124|581249804|FG002|Overall Study|Withdrawal by Subject|0|||
160962955|NCT02124265|581249805|FG000|Overall Study|Adverse Event|1|||
160962956|NCT00058123|581249807|FG000|Overall Study|Wrong histology|9|||
160962957|NCT00058123|581249807|FG000|Overall Study|Received >3 prior treatments|1|||
160962958|NCT04839965|581249810|FG000|Overall Study|Death|6|||
160962959|NCT04839965|581249811|FG001|Overall Study|Death|6|||
160962960|NCT04839965|581249810|FG000|Overall Study|Lost to Follow-up|1|||
160962961|NCT04839965|581249811|FG001|Overall Study|Lost to Follow-up|0|||
160962962|NCT02291679|581249812|FG000|Overall Study|Adverse Event|2|||
160962963|NCT02291679|581249813|FG001|Overall Study|Adverse Event|12|||
160962964|NCT02291679|581249814|FG002|Overall Study|Adverse Event|19|||
160962965|NCT02291679|581249812|FG000|Overall Study|Protocol Violation|5|||
160962966|NCT02291679|581249813|FG001|Overall Study|Protocol Violation|1|||
160962967|NCT02291679|581249814|FG002|Overall Study|Protocol Violation|7|||
160962968|NCT02291679|581249812|FG000|Overall Study|Withdrew Consent|18|||
160962969|NCT02291679|581249813|FG001|Overall Study|Withdrew Consent|10|||
160962970|NCT02291679|581249814|FG002|Overall Study|Withdrew Consent|15|||
160962971|NCT02291679|581249812|FG000|Overall Study|Lost to Follow-up|12|||
160962972|NCT02291679|581249813|FG001|Overall Study|Lost to Follow-up|10|||
160962973|NCT02291679|581249814|FG002|Overall Study|Lost to Follow-up|9|||
160962974|NCT02291679|581249812|FG000|Overall Study|Insufficient Therapeutic Response|5|||
160962975|NCT02291679|581249813|FG001|Overall Study|Insufficient Therapeutic Response|5|||
160962976|NCT02291679|581249814|FG002|Overall Study|Insufficient Therapeutic Response|7|||
160962977|NCT02291679|581249812|FG000|Overall Study|Other|2|||
160962978|NCT02291679|581249813|FG001|Overall Study|Other|4|||
160962979|NCT02291679|581249814|FG002|Overall Study|Other|2|||
160962980|NCT01266642|581249815|FG000|Overall Study|Protocol Violation|0|||
160962981|NCT01266642|581249816|FG001|Overall Study|Protocol Violation|1|||
160962982|NCT02532179|581251317|FG000|Overall Study|Lost to Follow-up|1|||
160962983|NCT02532179|581251317|FG000|Overall Study|Pregnancy|1|||
160962984|NCT02532179|581251317|FG000|Overall Study|Subject received depot steroid injection|1|||
160962985|NCT01337674|581251321|FG000|Treatment Period 1|Adverse Event|0|||
160962986|NCT01337674|581251322|FG001|Treatment Period 1|Adverse Event|1|||
160962987|NCT01337674|581251323|FG002|Treatment Period 1|Adverse Event|0|||
160962988|NCT01337674|581251324|FG003|Treatment Period 1|Adverse Event|0|||
161002337|NCT00468052|581394576|FG000|Overall Study|Protocol Violation|7|||
161002338|NCT00468052|581394577|FG001|Overall Study|Protocol Violation|8|||
161002339|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
161002340|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
161002341|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
160458263|NCT04424316|579409130|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
160458264|NCT04424316|579409131|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
160458265|NCT04424316|579409132|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
160962989|NCT01337674|581251321|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
160962990|NCT01337674|581251322|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
160962991|NCT01337674|581251323|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
160962992|NCT01337674|581251324|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
160962993|NCT01337674|581251321|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160962994|NCT01337674|581251322|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160962995|NCT01337674|581251323|FG002|Treatment Period 2|Withdrawal by Subject|1|||
160962996|NCT01337674|581251324|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160962997|NCT02240108|581251325|FG000|Overall Study|Other than specified|8|||
160962998|NCT02240108|581251326|FG001|Overall Study|Other than specified|6|||
160458266|NCT03812614|579409134|FG000|Intervention|Withdrawal by Subject|7|||
160962999|NCT02240108|581251325|FG000|Overall Study|Adverse Event|1|||
160963000|NCT02240108|581251326|FG001|Overall Study|Adverse Event|9|||
160963001|NCT02240108|581251325|FG000|Overall Study|Pregnancy|1|||
160963002|NCT02240108|581251326|FG001|Overall Study|Pregnancy|0|||
160963003|NCT02240108|581251325|FG000|Overall Study|Withdrawal by Subject|4|||
160963004|NCT02240108|581251326|FG001|Overall Study|Withdrawal by Subject|9|||
160963005|NCT02240108|581251325|FG000|Overall Study|StudyTerminated by Sponsor|0|||
160963006|NCT02240108|581251326|FG001|Overall Study|StudyTerminated by Sponsor|1|||
160963007|NCT00119405|581251327|FG000|Overall Study|Withdrawal by Subject|1|||
160963008|NCT00939484|581251329|FG000|Overall Study|Progression/Relapse|8|||
160963009|NCT00939484|581251330|FG001|Overall Study|Progression/Relapse|20|||
160963010|NCT00939484|581251331|FG002|Overall Study|Progression/Relapse|3|||
160963011|NCT04233372|581251332|FG000|Overall Study|Lost to Follow-up|104|||
160963012|NCT04233372|581251332|FG000|Overall Study|Adverse Event|8|||
160963013|NCT04233372|581251332|FG000|Overall Study|Withdrawal by Subject|2|||
160963014|NCT04958785|581251333|FG000|Overall Study|Study Terminated by Sponsor|4|||
160963015|NCT04958785|581251334|FG001|Overall Study|Study Terminated by Sponsor|10|||
160963016|NCT04958785|581251335|FG002|Overall Study|Study Terminated by Sponsor|7|||
160963017|NCT04958785|581251336|FG003|Overall Study|Study Terminated by Sponsor|6|||
160963018|NCT04958785|581251337|FG004|Overall Study|Study Terminated by Sponsor|34|||
160963019|NCT04958785|581251333|FG000|Overall Study|Death|2|||
160963020|NCT04958785|581251334|FG001|Overall Study|Death|3|||
160963021|NCT04958785|581251335|FG002|Overall Study|Death|4|||
160963022|NCT04958785|581251336|FG003|Overall Study|Death|5|||
160963023|NCT04958785|581251337|FG004|Overall Study|Death|5|||
160963024|NCT04958785|581251333|FG000|Overall Study|Withdrew consent|2|||
160963025|NCT04958785|581251334|FG001|Overall Study|Withdrew consent|0|||
160963026|NCT04958785|581251335|FG002|Overall Study|Withdrew consent|3|||
160963027|NCT04958785|581251336|FG003|Overall Study|Withdrew consent|1|||
160963028|NCT04958785|581251337|FG004|Overall Study|Withdrew consent|0|||
160963029|NCT04958785|581251333|FG000|Overall Study|Investigator's discretion|0|||
160963030|NCT04958785|581251334|FG001|Overall Study|Investigator's discretion|1|||
160963031|NCT04958785|581251335|FG002|Overall Study|Investigator's discretion|0|||
160963032|NCT04958785|581251336|FG003|Overall Study|Investigator's discretion|1|||
160963033|NCT04958785|581251337|FG004|Overall Study|Investigator's discretion|2|||
160963034|NCT04958785|581251333|FG000|Overall Study|Adverse Event|0|||
160963035|NCT04958785|581251334|FG001|Overall Study|Adverse Event|0|||
160963036|NCT04958785|581251335|FG002|Overall Study|Adverse Event|0|||
160963037|NCT04958785|581251336|FG003|Overall Study|Adverse Event|0|||
160963038|NCT04958785|581251337|FG004|Overall Study|Adverse Event|1|||
160963039|NCT04958785|581251333|FG000|Overall Study|Lost to Follow-up|0|||
160963040|NCT04958785|581251334|FG001|Overall Study|Lost to Follow-up|0|||
160963041|NCT04958785|581251335|FG002|Overall Study|Lost to Follow-up|0|||
160963042|NCT04958785|581251336|FG003|Overall Study|Lost to Follow-up|0|||
160963043|NCT04958785|581251337|FG004|Overall Study|Lost to Follow-up|1|||
160963047|NCT01090310|581251339|FG000|Core Study|Adverse Event|2|||
160963048|NCT01090310|581251340|FG001|Core Study|Adverse Event|2|||
160963049|NCT01090310|581251341|FG002|Core Study|Adverse Event|1|||
160963050|NCT01090310|581251342|FG003|Core Study|Adverse Event|1|||
160963051|NCT01090310|581251339|FG000|Core Study|Subject withdrew consent|0|||
160963052|NCT01090310|581251340|FG001|Core Study|Subject withdrew consent|3|||
160963053|NCT01090310|581251341|FG002|Core Study|Subject withdrew consent|1|||
160963054|NCT01090310|581251342|FG003|Core Study|Subject withdrew consent|1|||
160963055|NCT01090310|581251339|FG000|Core Study|Abnormal test procedure result|0|||
160963056|NCT01090310|581251340|FG001|Core Study|Abnormal test procedure result|0|||
160963057|NCT01090310|581251341|FG002|Core Study|Abnormal test procedure result|1|||
160963058|NCT01090310|581251342|FG003|Core Study|Abnormal test procedure result|0|||
160963059|NCT01090310|581251339|FG000|Core Study|Administrative reasons|5|||
160963060|NCT01090310|581251340|FG001|Core Study|Administrative reasons|6|||
160963061|NCT01090310|581251341|FG002|Core Study|Administrative reasons|4|||
160963062|NCT01090310|581251342|FG003|Core Study|Administrative reasons|4|||
160963063|NCT01090310|581251339|FG000|Core Study|Protocol deviation|1|||
160963064|NCT01090310|581251340|FG001|Core Study|Protocol deviation|0|||
160963065|NCT01090310|581251341|FG002|Core Study|Protocol deviation|0|||
160963066|NCT01090310|581251342|FG003|Core Study|Protocol deviation|1|||
160963067|NCT01090310|581251339|FG000|Extension Study|Aministrative problems|13|||
160458267|NCT03812614|579409135|FG001|Intervention|Withdrawal by Subject|2|||
160458268|NCT03812614|579409136|FG002|Intervention|Withdrawal by Subject|7|||
160963068|NCT01090310|581251340|FG001|Extension Study|Aministrative problems|15|||
160963069|NCT01090310|581251341|FG002|Extension Study|Aministrative problems|14|||
160963070|NCT01090310|581251342|FG003|Extension Study|Aministrative problems|18|||
160963071|NCT01090310|581251339|FG000|Extension Study|Adverse Event|0|||
160458269|NCT03812614|579409137|FG003|Intervention|Withdrawal by Subject|2|||
160458270|NCT03812614|579409134|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
160963072|NCT01090310|581251340|FG001|Extension Study|Adverse Event|0|||
160963073|NCT01090310|581251341|FG002|Extension Study|Adverse Event|0|||
160963074|NCT01090310|581251342|FG003|Extension Study|Adverse Event|1|||
160963075|NCT01090310|581251339|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
160963076|NCT01090310|581251340|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
160963077|NCT01090310|581251341|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
160963078|NCT01090310|581251342|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
160963079|NCT01090310|581251339|FG000|Extension Study|Subject withdrew consent|0|||
160963080|NCT01090310|581251340|FG001|Extension Study|Subject withdrew consent|1|||
160963081|NCT01090310|581251341|FG002|Extension Study|Subject withdrew consent|0|||
160963082|NCT01090310|581251342|FG003|Extension Study|Subject withdrew consent|0|||
160963083|NCT00695786|581251343|FG000|Overall Study|Adverse Event|0|||
160963084|NCT00695786|581251344|FG001|Overall Study|Adverse Event|3|||
160963085|NCT00695786|581251345|FG002|Overall Study|Adverse Event|4|||
160963086|NCT00695786|581251346|FG003|Overall Study|Adverse Event|2|||
160963087|NCT00695786|581251343|FG000|Overall Study|Lost to Follow-up|0|||
160963088|NCT00695786|581251344|FG001|Overall Study|Lost to Follow-up|5|||
160963089|NCT00695786|581251345|FG002|Overall Study|Lost to Follow-up|1|||
160963090|NCT00695786|581251346|FG003|Overall Study|Lost to Follow-up|1|||
160963091|NCT00695786|581251343|FG000|Overall Study|Withdrawal by Subject|0|||
160963092|NCT00695786|581251344|FG001|Overall Study|Withdrawal by Subject|4|||
160963093|NCT00695786|581251345|FG002|Overall Study|Withdrawal by Subject|3|||
160963094|NCT00695786|581251346|FG003|Overall Study|Withdrawal by Subject|1|||
160963095|NCT00695786|581251343|FG000|Overall Study|Deemed Ineligible|1|||
160963096|NCT00695786|581251344|FG001|Overall Study|Deemed Ineligible|0|||
160963097|NCT00695786|581251345|FG002|Overall Study|Deemed Ineligible|0|||
160963098|NCT00695786|581251346|FG003|Overall Study|Deemed Ineligible|0|||
160963099|NCT00695786|581251343|FG000|Overall Study|Lack of Efficacy|0|||
160963100|NCT00695786|581251344|FG001|Overall Study|Lack of Efficacy|0|||
160963101|NCT00695786|581251345|FG002|Overall Study|Lack of Efficacy|0|||
160963102|NCT00695786|581251346|FG003|Overall Study|Lack of Efficacy|4|||
160963103|NCT01224925|581251347|FG000|Overall Study|Lost to Follow-up|3|||
160963104|NCT01224925|581251348|FG001|Overall Study|Lost to Follow-up|2|||
160963105|NCT03439189|581251352|FG000|Overall Study|Protocol Violation|19|||
160963106|NCT03439189|581251352|FG000|Overall Study|Lack of Efficacy|63|||
160963107|NCT02173548|581251353|FG000|Overall Study|Lost to Follow-up|0|||
160963108|NCT02173548|581251354|FG001|Overall Study|Lost to Follow-up|2|||
160963109|NCT02173548|581251353|FG000|Overall Study|Withdrawal by Subject|1|||
160963110|NCT02173548|581251354|FG001|Overall Study|Withdrawal by Subject|0|||
160963111|NCT03597568|581251355|FG000|Overall Study|Withdrawal by Subject|1|||
160963112|NCT03597568|581251356|FG001|Overall Study|Withdrawal by Subject|1|||
160963113|NCT03597568|581251355|FG000|Overall Study|Unable to analyze vascular data|1|||
160963114|NCT03597568|581251356|FG001|Overall Study|Unable to analyze vascular data|1|||
160963115|NCT00999466|581251357|FG000|Main Part|Withdrawal by Subject|0|||
160963116|NCT00999466|581251358|FG001|Main Part|Withdrawal by Subject|0|||
160963117|NCT00999466|581251359|FG002|Main Part|Withdrawal by Subject|2|||
160963118|NCT00999466|581251357|FG000|Main Part|Adverse Event|0|||
160963119|NCT00999466|581251358|FG001|Main Part|Adverse Event|4|||
160963120|NCT00999466|581251359|FG002|Main Part|Adverse Event|2|||
160963121|NCT00526630|581251360|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
160963122|NCT00526630|581251361|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
160963123|NCT00526630|581251360|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
160963124|NCT00526630|581251361|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
160963125|NCT00337272|581251362|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
160963126|NCT00337272|581251363|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
160963127|NCT00337272|581251362|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
160963128|NCT00337272|581251363|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
160963129|NCT00337272|581251362|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
160963130|NCT00337272|581251363|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
160963131|NCT00337272|581251362|FG000|Treatment Period|Non-compliance|1|||
160963132|NCT00337272|581251363|FG001|Treatment Period|Non-compliance|1|||
160963133|NCT00337272|581251362|FG000|Treatment Period|Withdrawal by Subject|0|||
160963134|NCT00337272|581251363|FG001|Treatment Period|Withdrawal by Subject|1|||
160963135|NCT00337272|581251362|FG000|Withdrawal Period|Non-compliance|0|||
160963136|NCT00337272|581251363|FG001|Withdrawal Period|Non-compliance|1|||
160963137|NCT03320018|581251364|FG000|Treatment Period|Withdrawal by Subject|1|||
160963138|NCT03320018|581251365|FG001|Treatment Period|Withdrawal by Subject|0|||
160963139|NCT03320018|581251364|FG000|Day 90 Follow up|Death|0|||
160963140|NCT03320018|581251365|FG001|Day 90 Follow up|Death|1|||
160963141|NCT01127646|581251368|FG000|Overall Study|Entry Criteria Not Met|1|||
160963142|NCT01127646|581251369|FG001|Overall Study|Entry Criteria Not Met|0|||
160963143|NCT01127646|581251368|FG000|Overall Study|Protocol Violation|0|||
160963144|NCT01127646|581251369|FG001|Overall Study|Protocol Violation|1|||
160963145|NCT00595504|581251373|FG000|Overall Study|Withdrawal by Subject|1|||
160963146|NCT00595504|581251374|FG001|Overall Study|Withdrawal by Subject|3|||
160963147|NCT00595504|581251373|FG000|Overall Study|Physician Decision|1|||
160963148|NCT00595504|581251374|FG001|Overall Study|Physician Decision|0|||
160963149|NCT01662063|581251375|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
160963150|NCT01662063|581251376|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
160963151|NCT01662063|581251377|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
160963152|NCT01662063|581251375|FG000|Overall Study|Lack of Efficacy|1|||
160963153|NCT01662063|581251376|FG001|Overall Study|Lack of Efficacy|6|||
160963154|NCT01662063|581251377|FG002|Overall Study|Lack of Efficacy|0|||
160963155|NCT01662063|581251375|FG000|Overall Study|Lost to Follow-up|0|||
160963156|NCT01662063|581251376|FG001|Overall Study|Lost to Follow-up|4|||
160963157|NCT01662063|581251377|FG002|Overall Study|Lost to Follow-up|0|||
160963158|NCT01662063|581251375|FG000|Overall Study|Protocol Violation|1|||
160963159|NCT01662063|581251376|FG001|Overall Study|Protocol Violation|0|||
160963160|NCT01662063|581251377|FG002|Overall Study|Protocol Violation|0|||
160963161|NCT01662063|581251375|FG000|Overall Study|Withdrawal by Subject|2|||
160963162|NCT01662063|581251376|FG001|Overall Study|Withdrawal by Subject|4|||
160963163|NCT01662063|581251377|FG002|Overall Study|Withdrawal by Subject|1|||
160963164|NCT01662063|581251375|FG000|Overall Study|Physician Decision|0|||
160963165|NCT01662063|581251376|FG001|Overall Study|Physician Decision|2|||
160963166|NCT01662063|581251377|FG002|Overall Study|Physician Decision|0|||
160963167|NCT01662063|581251375|FG000|Overall Study|Other|0|||
160963168|NCT01662063|581251376|FG001|Overall Study|Other|1|||
160963169|NCT01662063|581251377|FG002|Overall Study|Other|0|||
160963170|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
160963171|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
160963172|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
160963173|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
160963174|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
160963175|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
160963176|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
160963177|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
160963178|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
160963179|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
160963180|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
160963181|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
160963182|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
160963183|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
160963184|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
160963185|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
160963186|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
160963187|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
160963188|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
160963189|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
160963190|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
160963191|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
160963192|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Death|3|||
160963193|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Death|0|||
160963194|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
160963195|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
160963196|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
160963197|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
160963198|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
160963199|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
160963200|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
160963201|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
160963202|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
160963203|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
160963204|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
160963205|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
160963206|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
160963207|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
160963208|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
160963209|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
160963210|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
160963211|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
160963212|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
160963213|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
160963214|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
160963215|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
160963216|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
160963217|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
161002342|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
161002343|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
161002344|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
161002345|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
160963218|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
160584968|NCT02052778|579861890|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
161002346|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
161002347|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
161002348|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
161002349|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
161002350|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
160963219|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
160963220|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
160963221|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
160963222|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
160963223|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
160963224|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
160963225|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
160963226|NCT01477853|581251383|FG000|Phase A|Adverse Event|1|||
160963227|NCT01477853|581251384|FG001|Phase A|Adverse Event|2|||
160963228|NCT01477853|581251385|FG002|Phase A|Adverse Event|2|||
160963229|NCT01477853|581251383|FG000|Phase A|Lost to Follow-up|4|||
160963230|NCT01477853|581251384|FG001|Phase A|Lost to Follow-up|3|||
160963231|NCT01477853|581251385|FG002|Phase A|Lost to Follow-up|2|||
160963232|NCT01477853|581251383|FG000|Phase A|Physician Decision|1|||
160963233|NCT01477853|581251384|FG001|Phase A|Physician Decision|0|||
160963234|NCT01477853|581251385|FG002|Phase A|Physician Decision|1|||
160963235|NCT01477853|581251383|FG000|Phase A|Study terminated by sponsor|37|||
160963236|NCT01477853|581251384|FG001|Phase A|Study terminated by sponsor|40|||
160963237|NCT01477853|581251385|FG002|Phase A|Study terminated by sponsor|39|||
160963238|NCT01477853|581251383|FG000|Phase B|Lost to Follow-up|0|||
160963239|NCT01477853|581251384|FG001|Phase B|Lost to Follow-up|1|||
160963240|NCT01477853|581251385|FG002|Phase B|Lost to Follow-up|0|||
160963241|NCT01477853|581251383|FG000|Phase B|Study terminated by sponsor|12|||
160963242|NCT01477853|581251384|FG001|Phase B|Study terminated by sponsor|10|||
160963243|NCT01477853|581251385|FG002|Phase B|Study terminated by sponsor|11|||
160963244|NCT01804816|581251386|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
160963245|NCT01804816|581251386|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
160963246|NCT01050816|581251387|FG000|Overall Study|Lost to Follow-up|2|||
160963247|NCT01050816|581251387|FG000|Overall Study|patient's refusal|2|||
160963248|NCT01754467|581251388|FG000|Overall Study|Lost to Follow-up|1|||
160963249|NCT01970462|581251391|FG000|Overall Study|Lost to Follow-up|0|||
160963250|NCT01970462|581251392|FG001|Overall Study|Lost to Follow-up|2|||
160963251|NCT01123382|581251393|FG000|Overall Study|Withdrawal by Subject|1|||
160963252|NCT01123382|581251394|FG001|Overall Study|Withdrawal by Subject|4|||
161002351|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
161002352|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
161002353|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
161002354|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002355|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002356|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
161002357|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002358|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002359|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002360|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002361|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002362|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002363|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002364|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002365|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
161002366|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
161002367|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
160458271|NCT03812614|579409135|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
160584969|NCT02052778|579861891|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
160584970|NCT02052778|579861892|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
160584971|NCT02052778|579861893|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
160584972|NCT02052778|579861894|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
160584973|NCT02052778|579861895|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
160584974|NCT02052778|579861896|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
160963253|NCT01123382|581251393|FG000|Overall Study|Lost to Follow-up|1|||
160963254|NCT01123382|581251394|FG001|Overall Study|Lost to Follow-up|2|||
160963255|NCT02740049|581251395|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
160963256|NCT01256411|581251396|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
161002368|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
161002369|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
160584975|NCT02052778|579861897|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
160963257|NCT01256411|581251397|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
160584976|NCT02052778|579861898|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
160584977|NCT02052778|579861876|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584978|NCT02052778|579861877|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584979|NCT02052778|579861878|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160963258|NCT01256411|581251398|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
160963259|NCT01256411|581251399|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
160963260|NCT01256411|581251400|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
160963261|NCT01256411|581251401|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
160963262|NCT01256411|581251396|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
160963263|NCT01256411|581251397|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
160963264|NCT01256411|581251398|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
160963265|NCT01256411|581251399|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
160963266|NCT01256411|581251400|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
160963267|NCT01256411|581251401|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
160963268|NCT01256411|581251396|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
160963269|NCT01256411|581251397|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
160963270|NCT01256411|581251398|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
160963271|NCT01256411|581251399|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
160963272|NCT01256411|581251400|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
160963273|NCT01256411|581251401|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
160963274|NCT01256411|581251396|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
160963275|NCT01256411|581251397|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
160963276|NCT01256411|581251398|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
160963277|NCT01256411|581251399|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
160963278|NCT01256411|581251400|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
160963279|NCT01256411|581251401|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
160963280|NCT01256411|581251396|FG000|Extension by Maximum Treatment|Adverse Event|4|||
160963281|NCT01256411|581251397|FG001|Extension by Maximum Treatment|Adverse Event|2|||
160963282|NCT01256411|581251398|FG002|Extension by Maximum Treatment|Adverse Event|1|||
160963283|NCT01256411|581251399|FG003|Extension by Maximum Treatment|Adverse Event|0|||
160963284|NCT01256411|581251400|FG004|Extension by Maximum Treatment|Adverse Event|0|||
160963285|NCT01256411|581251401|FG005|Extension by Maximum Treatment|Adverse Event|0|||
160963286|NCT01256411|581251396|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
160963287|NCT01256411|581251397|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
160963288|NCT01256411|581251398|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
160963289|NCT01256411|581251399|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
160963290|NCT01256411|581251400|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
160963291|NCT01256411|581251401|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
160963292|NCT01256411|581251396|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
160963293|NCT01256411|581251397|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
160963294|NCT01256411|581251398|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
160963295|NCT01256411|581251399|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
160963296|NCT01256411|581251400|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
160963297|NCT01256411|581251401|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
160963298|NCT01256411|581251396|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
160963299|NCT01256411|581251397|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
160963300|NCT01256411|581251398|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
160963301|NCT01256411|581251399|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
160963302|NCT01256411|581251400|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
160963303|NCT01256411|581251401|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
160963304|NCT01256411|581251396|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
160963305|NCT01256411|581251397|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
160963306|NCT01256411|581251398|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
160963307|NCT01256411|581251399|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
160963308|NCT01256411|581251400|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
160963309|NCT01256411|581251401|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
160963310|NCT01256411|581251396|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
160963311|NCT01256411|581251397|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
160963312|NCT01256411|581251398|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
160963313|NCT01256411|581251399|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
160458272|NCT03812614|579409136|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
160584980|NCT02052778|579861879|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584981|NCT02052778|579861880|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160963314|NCT01256411|581251400|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
160963315|NCT01256411|581251401|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
160963316|NCT02274857|581251402|FG000|Overall Study|Adverse Event|1|||
160963317|NCT02274857|581251403|FG001|Overall Study|Adverse Event|0|||
160963318|NCT02274857|581251402|FG000|Overall Study|Death|1|||
160963319|NCT02274857|581251403|FG001|Overall Study|Death|2|||
160458273|NCT03812614|579409137|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
160458274|NCT03812614|579409134|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
160458275|NCT03812614|579409135|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
160458276|NCT03812614|579409136|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
160458277|NCT03812614|579409137|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
160458278|NCT03812614|579409134|FG000|6-month Follow-up|Lost to Follow-up|0|||
160458279|NCT03812614|579409135|FG001|6-month Follow-up|Lost to Follow-up|0|||
160458280|NCT03812614|579409136|FG002|6-month Follow-up|Lost to Follow-up|12|||
160458281|NCT03812614|579409137|FG003|6-month Follow-up|Lost to Follow-up|8|||
160458282|NCT03812614|579409134|FG000|12-month Follow-up|Lost to Follow-up|18|||
160458283|NCT03812614|579409135|FG001|12-month Follow-up|Lost to Follow-up|17|||
160458284|NCT03812614|579409136|FG002|12-month Follow-up|Lost to Follow-up|5|||
160458285|NCT03812614|579409137|FG003|12-month Follow-up|Lost to Follow-up|2|||
160458286|NCT05652010|579409138|FG000|First Intervention|Withdrawal by Subject|0|||
160458287|NCT05652010|579409139|FG001|First Intervention|Withdrawal by Subject|1|||
160458288|NCT05652010|579409138|FG000|Second Intervention|Withdrawal by Subject|1|||
160458289|NCT05652010|579409139|FG001|Second Intervention|Withdrawal by Subject|0|||
160458290|NCT05451693|579409140|FG000|Overall Study|Withdrawal by Subject|1|||
160458291|NCT05451693|579409141|FG001|Overall Study|Withdrawal by Subject|1|||
160458292|NCT05741294|579409142|FG000|Overall Study|Lost to Follow-up|3|||
160458293|NCT05741294|579409142|FG000|Overall Study|Protocol deviation|3|||
160458294|NCT05741294|579409142|FG000|Overall Study|Withdrawal by Subject|1|||
160458295|NCT04707768|579409149|FG000|Overall Study|Adverse Event|9|||
160458296|NCT04707768|579409150|FG001|Overall Study|Adverse Event|18|||
160458297|NCT04707768|579409151|FG002|Overall Study|Adverse Event|3|||
160458298|NCT04707768|579409149|FG000|Overall Study|Investigator's Discretion|8|||
160458299|NCT04707768|579409150|FG001|Overall Study|Investigator's Discretion|4|||
160458300|NCT04707768|579409151|FG002|Overall Study|Investigator's Discretion|3|||
160458301|NCT04707768|579409149|FG000|Overall Study|Withdrawal by Subject|6|||
160963320|NCT02274857|581251402|FG000|Overall Study|Lost to Follow-up|3|||
160963321|NCT02274857|581251403|FG001|Overall Study|Lost to Follow-up|0|||
160963322|NCT02274857|581251402|FG000|Overall Study|Physician Decision|2|||
160963323|NCT02274857|581251403|FG001|Overall Study|Physician Decision|0|||
160963324|NCT02274857|581251402|FG000|Overall Study|Trial screen failure|0|||
160963325|NCT02274857|581251403|FG001|Overall Study|Trial screen failure|2|||
160963326|NCT02274857|581251402|FG000|Overall Study|Withdrawal by Subject|11|||
160963327|NCT02274857|581251403|FG001|Overall Study|Withdrawal by Subject|2|||
160963328|NCT02274857|581251402|FG000|Overall Study|Other|2|||
160963329|NCT02274857|581251403|FG001|Overall Study|Other|0|||
160963330|NCT02403180|581251406|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
160963331|NCT02403180|581251407|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
160963332|NCT02403180|581251406|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
160963333|NCT02403180|581251407|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
160963334|NCT00929162|581251409|FG000|Overall Study|Adverse Event|8|||
160963335|NCT00929162|581251410|FG001|Overall Study|Adverse Event|5|||
160963336|NCT00929162|581251409|FG000|Overall Study|Withdrawal by Subject|3|||
160963337|NCT00929162|581251410|FG001|Overall Study|Withdrawal by Subject|1|||
160963338|NCT00929162|581251409|FG000|Overall Study|Protocol Violation|32|||
160963339|NCT00929162|581251410|FG001|Overall Study|Protocol Violation|30|||
160963340|NCT00929162|581251409|FG000|Overall Study|Other termination reason|5|||
160963341|NCT00929162|581251410|FG001|Overall Study|Other termination reason|6|||
160963342|NCT00658567|581251412|FG000|Overall Study|Adverse Event|5|||
160963343|NCT00658567|581251413|FG001|Overall Study|Adverse Event|2|||
160963344|NCT00658567|581251414|FG002|Overall Study|Adverse Event|3|||
160963345|NCT00658567|581251412|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
160963346|NCT00658567|581251413|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
160963347|NCT00658567|581251414|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
160963348|NCT00658567|581251412|FG000|Overall Study|Physician Decision|0|||
160963349|NCT00658567|581251413|FG001|Overall Study|Physician Decision|1|||
160963350|NCT00658567|581251414|FG002|Overall Study|Physician Decision|0|||
160963351|NCT00658567|581251412|FG000|Overall Study|At Discretion of Sponsor|1|||
160963352|NCT00658567|581251413|FG001|Overall Study|At Discretion of Sponsor|1|||
160963353|NCT00658567|581251414|FG002|Overall Study|At Discretion of Sponsor|1|||
160963354|NCT01755702|581251415|FG000|Wash Out Period I|Other Reason|3|||
160458302|NCT04707768|579409150|FG001|Overall Study|Withdrawal by Subject|8|||
160458303|NCT04707768|579409151|FG002|Overall Study|Withdrawal by Subject|2|||
160963355|NCT01755702|581251415|FG000|Washout Period II|Other Reason|5|||
160963356|NCT00691938|581251416|FG000|Overall Study|QTc prolongation|1|||
160963357|NCT00691938|581251417|FG001|Overall Study|QTc prolongation|0|||
160963358|NCT00691938|581251418|FG002|Overall Study|QTc prolongation|0|||
160584982|NCT02052778|579861881|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584983|NCT02052778|579861882|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584984|NCT02052778|579861883|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584985|NCT02052778|579861884|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
160963359|NCT00691938|581251419|FG003|Overall Study|QTc prolongation|0|||
160963360|NCT00691938|581251420|FG004|Overall Study|QTc prolongation|0|||
160963361|NCT00691938|581251421|FG005|Overall Study|QTc prolongation|0|||
160963362|NCT00691938|581251422|FG006|Overall Study|QTc prolongation|0|||
160963363|NCT04860518|581251424|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
160963364|NCT04860518|581251425|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
160963365|NCT03172702|581251429|FG000|Overall Study|Adverse Event|9|||
160963366|NCT03172702|581251429|FG000|Overall Study|Death|2|||
160963367|NCT03172702|581251429|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
160963368|NCT03172702|581251429|FG000|Overall Study|Withdrawal by Subject|5|||
160963369|NCT03172702|581251429|FG000|Overall Study|Other|2|||
160963370|NCT02355028|581251430|FG000|Overall Study|Adverse Event|2|||
160963371|NCT02355028|581251431|FG001|Overall Study|Adverse Event|0|||
160963372|NCT02355028|581251430|FG000|Overall Study|Withdrawal by Subject|1|||
160963373|NCT02355028|581251431|FG001|Overall Study|Withdrawal by Subject|1|||
160963374|NCT02355028|581251430|FG000|Overall Study|Deemed ineligible after randomization|8|||
160963375|NCT02355028|581251431|FG001|Overall Study|Deemed ineligible after randomization|4|||
160963376|NCT02276222|581251432|FG000|Overall Study|Adverse Event|62|||
160963377|NCT02276222|581251433|FG001|Overall Study|Adverse Event|11|||
160963378|NCT02276222|581251432|FG000|Overall Study|Death|3|||
160963379|NCT02276222|581251433|FG001|Overall Study|Death|4|||
160963380|NCT02276222|581251432|FG000|Overall Study|Lack of Efficacy|13|||
160963381|NCT02276222|581251433|FG001|Overall Study|Lack of Efficacy|3|||
160963382|NCT02276222|581251432|FG000|Overall Study|Protocol Violation|3|||
160963383|NCT02276222|581251433|FG001|Overall Study|Protocol Violation|2|||
160963384|NCT02276222|581251432|FG000|Overall Study|Withdrawal by Subject|79|||
160963385|NCT02276222|581251433|FG001|Overall Study|Withdrawal by Subject|33|||
160963386|NCT02276222|581251432|FG000|Overall Study|non compliance with study medication|6|||
160963387|NCT02276222|581251433|FG001|Overall Study|non compliance with study medication|2|||
160963388|NCT02276222|581251432|FG000|Overall Study|sponsor decision|0|||
160963389|NCT02276222|581251433|FG001|Overall Study|sponsor decision|3|||
160963390|NCT02276222|581251432|FG000|Overall Study|Lost to Follow-up|15|||
160963391|NCT02276222|581251433|FG001|Overall Study|Lost to Follow-up|5|||
160963392|NCT02276222|581251432|FG000|Overall Study|Physician Decision|2|||
160963393|NCT02276222|581251433|FG001|Overall Study|Physician Decision|1|||
160963394|NCT02276222|581251432|FG000|Overall Study|sheduling conflict|1|||
160963395|NCT02276222|581251433|FG001|Overall Study|sheduling conflict|0|||
160963396|NCT02276222|581251432|FG000|Overall Study|subject withdrew after randomization|1|||
160963397|NCT02276222|581251433|FG001|Overall Study|subject withdrew after randomization|0|||
160963398|NCT04102579|581251434|FG000|Overall Study|Withdrawal by Subject|3|||
160963399|NCT04102579|581251435|FG001|Overall Study|Withdrawal by Subject|4|||
160963400|NCT04102579|581251434|FG000|Overall Study|Lost to Follow-up|0|||
160963401|NCT04102579|581251435|FG001|Overall Study|Lost to Follow-up|1|||
160963402|NCT04102579|581251434|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
160963403|NCT04102579|581251435|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
160963404|NCT04102579|581251434|FG000|Overall Study|Other than Specified|1|||
160963405|NCT04102579|581251435|FG001|Overall Study|Other than Specified|0|||
160963406|NCT04102579|581251434|FG000|Overall Study|Not Dosed with Study Drug|0|||
160963407|NCT04102579|581251435|FG001|Overall Study|Not Dosed with Study Drug|1|||
160963408|NCT05899686|581251436|FG000|Overall Study|Protocol Violation|1|||
160963409|NCT02170025|581251437|FG000|Overall Study|Adverse Event|2|||
160963410|NCT02170025|581251438|FG001|Overall Study|Adverse Event|0|||
160963411|NCT01525602|581251439|FG000|Overall Study|Adverse Event|1|||
160963412|NCT01525602|581251440|FG001|Overall Study|Adverse Event|0|||
160963413|NCT01525602|581251441|FG002|Overall Study|Adverse Event|1|||
160963414|NCT01525602|581251442|FG003|Overall Study|Adverse Event|1|||
160963415|NCT01525602|581251443|FG004|Overall Study|Adverse Event|3|||
160963416|NCT01525602|581251444|FG005|Overall Study|Adverse Event|3|||
160963417|NCT01525602|581251445|FG006|Overall Study|Adverse Event|0|||
160963418|NCT01525602|581251446|FG007|Overall Study|Adverse Event|1|||
160963419|NCT01525602|581251439|FG000|Overall Study|Disease progression|6|||
160963420|NCT01525602|581251440|FG001|Overall Study|Disease progression|3|||
160963421|NCT01525602|581251441|FG002|Overall Study|Disease progression|2|||
160963422|NCT01525602|581251442|FG003|Overall Study|Disease progression|5|||
160963423|NCT01525602|581251443|FG004|Overall Study|Disease progression|22|||
160963424|NCT01525602|581251444|FG005|Overall Study|Disease progression|2|||
160963425|NCT01525602|581251445|FG006|Overall Study|Disease progression|3|||
160963426|NCT01525602|581251446|FG007|Overall Study|Disease progression|3|||
160963427|NCT01525602|581251439|FG000|Overall Study|Clinical progression|2|||
160963428|NCT01525602|581251440|FG001|Overall Study|Clinical progression|0|||
160963429|NCT01525602|581251441|FG002|Overall Study|Clinical progression|0|||
160963430|NCT01525602|581251442|FG003|Overall Study|Clinical progression|0|||
160963431|NCT01525602|581251443|FG004|Overall Study|Clinical progression|0|||
160963432|NCT01525602|581251444|FG005|Overall Study|Clinical progression|0|||
160963433|NCT01525602|581251445|FG006|Overall Study|Clinical progression|1|||
160963434|NCT01525602|581251446|FG007|Overall Study|Clinical progression|1|||
160963435|NCT01525602|581251439|FG000|Overall Study|Non-compliance|0|||
160963436|NCT01525602|581251440|FG001|Overall Study|Non-compliance|0|||
160963437|NCT01525602|581251441|FG002|Overall Study|Non-compliance|0|||
160963438|NCT01525602|581251442|FG003|Overall Study|Non-compliance|0|||
160963439|NCT01525602|581251443|FG004|Overall Study|Non-compliance|1|||
160963440|NCT01525602|581251444|FG005|Overall Study|Non-compliance|0|||
160963441|NCT01525602|581251445|FG006|Overall Study|Non-compliance|0|||
160963442|NCT01525602|581251446|FG007|Overall Study|Non-compliance|0|||
160963443|NCT01525602|581251439|FG000|Overall Study|Withdrawal by Subject|0|||
160963444|NCT01525602|581251440|FG001|Overall Study|Withdrawal by Subject|0|||
160963445|NCT01525602|581251441|FG002|Overall Study|Withdrawal by Subject|0|||
160963446|NCT01525602|581251442|FG003|Overall Study|Withdrawal by Subject|0|||
160963447|NCT01525602|581251443|FG004|Overall Study|Withdrawal by Subject|3|||
160963448|NCT01525602|581251444|FG005|Overall Study|Withdrawal by Subject|1|||
160963449|NCT01525602|581251445|FG006|Overall Study|Withdrawal by Subject|0|||
160963450|NCT01525602|581251446|FG007|Overall Study|Withdrawal by Subject|1|||
160963451|NCT01525602|581251439|FG000|Overall Study|Physician Decision|0|||
160963452|NCT01525602|581251440|FG001|Overall Study|Physician Decision|0|||
160963453|NCT01525602|581251441|FG002|Overall Study|Physician Decision|0|||
160963454|NCT01525602|581251442|FG003|Overall Study|Physician Decision|0|||
160963455|NCT01525602|581251443|FG004|Overall Study|Physician Decision|3|||
160963456|NCT01525602|581251444|FG005|Overall Study|Physician Decision|0|||
160963457|NCT01525602|581251445|FG006|Overall Study|Physician Decision|1|||
160963458|NCT01525602|581251446|FG007|Overall Study|Physician Decision|0|||
160963459|NCT01525602|581251439|FG000|Overall Study|Death|0|||
160963460|NCT01525602|581251440|FG001|Overall Study|Death|0|||
160963461|NCT01525602|581251441|FG002|Overall Study|Death|0|||
160963462|NCT01525602|581251442|FG003|Overall Study|Death|0|||
160963463|NCT01525602|581251443|FG004|Overall Study|Death|1|||
160963464|NCT01525602|581251444|FG005|Overall Study|Death|1|||
160963465|NCT01525602|581251445|FG006|Overall Study|Death|0|||
160963466|NCT01525602|581251446|FG007|Overall Study|Death|0|||
160963467|NCT01525602|581251439|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963468|NCT01525602|581251440|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963469|NCT01525602|581251441|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963470|NCT01525602|581251442|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963471|NCT01525602|581251443|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963472|NCT01525602|581251444|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963473|NCT01525602|581251445|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
160963474|NCT01525602|581251446|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
160963475|NCT03703466|581251452|FG000|Overall Study|Death|2|||
160963476|NCT03703466|581251453|FG001|Overall Study|Death|1|||
160963477|NCT03703466|581251454|FG002|Overall Study|Death|0|||
160963478|NCT03703466|581251452|FG000|Overall Study|Withdrawal by Subject|0|||
160963479|NCT03703466|581251453|FG001|Overall Study|Withdrawal by Subject|3|||
160963480|NCT03703466|581251454|FG002|Overall Study|Withdrawal by Subject|0|||
160963481|NCT03703466|581251452|FG000|Overall Study|Completed < 3 Cycles|2|||
160963482|NCT03703466|581251453|FG001|Overall Study|Completed < 3 Cycles|2|||
160963483|NCT03703466|581251454|FG002|Overall Study|Completed < 3 Cycles|2|||
160963484|NCT02412137|581251455|FG000|Overall Study|Withdrawal by Subject|2|||
160963485|NCT02412137|581251456|FG001|Overall Study|Withdrawal by Subject|0|||
160963486|NCT02412137|581251455|FG000|Overall Study|Lost to Follow-up|21|||
160963487|NCT02412137|581251456|FG001|Overall Study|Lost to Follow-up|14|||
160963488|NCT02412137|581251455|FG000|Overall Study|Physician Decision|28|||
160963489|NCT02412137|581251456|FG001|Overall Study|Physician Decision|9|||
160963490|NCT00506493|581251459|FG000|Overall Study|Death|6|||
160963491|NCT00506493|581251459|FG000|Overall Study|Withdrawal by Subject|5|||
160963492|NCT03076970|581253269|FG000|Washout Period 2|Adverse Event|0|||
160963493|NCT03076970|581253270|FG001|Washout Period 2|Adverse Event|0|||
160584986|NCT02052778|579861885|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160963494|NCT03076970|581253271|FG002|Washout Period 2|Adverse Event|0|||
160963495|NCT03076970|581253272|FG003|Washout Period 2|Adverse Event|0|||
160963496|NCT03076970|581253273|FG004|Washout Period 2|Adverse Event|1|||
160963497|NCT03076970|581253274|FG005|Washout Period 2|Adverse Event|0|||
160963498|NCT03076970|581253269|FG000|Period 3|Withdrawal by Subject|0|||
160963499|NCT03076970|581253270|FG001|Period 3|Withdrawal by Subject|0|||
160963500|NCT03076970|581253271|FG002|Period 3|Withdrawal by Subject|0|||
160963501|NCT03076970|581253272|FG003|Period 3|Withdrawal by Subject|0|||
160963502|NCT03076970|581253273|FG004|Period 3|Withdrawal by Subject|0|||
160963503|NCT03076970|581253274|FG005|Period 3|Withdrawal by Subject|1|||
160963504|NCT03076970|581253269|FG000|Period 3|Failure to meet I/E criteria|0|||
160963505|NCT03076970|581253270|FG001|Period 3|Failure to meet I/E criteria|0|||
160963506|NCT03076970|581253271|FG002|Period 3|Failure to meet I/E criteria|0|||
160963507|NCT03076970|581253272|FG003|Period 3|Failure to meet I/E criteria|0|||
160584987|NCT02052778|579861886|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584988|NCT02052778|579861887|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584989|NCT02052778|579861888|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584990|NCT02052778|579861889|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
160963508|NCT03076970|581253273|FG004|Period 3|Failure to meet I/E criteria|1|||
160963509|NCT03076970|581253274|FG005|Period 3|Failure to meet I/E criteria|0|||
160963510|NCT05178121|581253280|FG000|Overall Study|Other|4|||
160963511|NCT05178121|581253280|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
160963512|NCT00949884|581253281|FG000|Overall Study|Adverse Event|14|||
160963513|NCT00949884|581253282|FG001|Overall Study|Adverse Event|3|||
160963514|NCT00949884|581253283|FG002|Overall Study|Adverse Event|12|||
160963515|NCT00949884|581253281|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
160963516|NCT00949884|581253282|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
160963517|NCT00949884|581253283|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
160963518|NCT00949884|581253281|FG000|Overall Study|Lost to Follow-up|7|||
160963519|NCT00949884|581253282|FG001|Overall Study|Lost to Follow-up|5|||
160963520|NCT00949884|581253283|FG002|Overall Study|Lost to Follow-up|5|||
160963521|NCT00949884|581253281|FG000|Overall Study|Physician Decision|5|||
160963522|NCT00949884|581253282|FG001|Overall Study|Physician Decision|0|||
160963523|NCT00949884|581253283|FG002|Overall Study|Physician Decision|6|||
160963524|NCT00949884|581253281|FG000|Overall Study|Treatment non-compliance|5|||
160963525|NCT00949884|581253282|FG001|Overall Study|Treatment non-compliance|0|||
160963526|NCT00949884|581253283|FG002|Overall Study|Treatment non-compliance|8|||
160963527|NCT00949884|581253281|FG000|Overall Study|Withdrawal by Subject|13|||
160963528|NCT00949884|581253282|FG001|Overall Study|Withdrawal by Subject|4|||
160963529|NCT00949884|581253283|FG002|Overall Study|Withdrawal by Subject|16|||
160963530|NCT00949884|581253281|FG000|Overall Study|Lack of Efficacy|4|||
160963531|NCT00949884|581253282|FG001|Overall Study|Lack of Efficacy|2|||
160963532|NCT00949884|581253283|FG002|Overall Study|Lack of Efficacy|7|||
160963533|NCT00949884|581253281|FG000|Overall Study|Study terminated by sponsor|0|||
160963534|NCT00949884|581253282|FG001|Overall Study|Study terminated by sponsor|0|||
160963535|NCT00949884|581253283|FG002|Overall Study|Study terminated by sponsor|1|||
160963536|NCT01953003|581253284|FG000|Overall Study|Not treated|0|||
160963537|NCT01953003|581253285|FG001|Overall Study|Not treated|1|||
160963538|NCT01953003|581253284|FG000|Overall Study|Progressive disease|35|||
160963539|NCT01953003|581253285|FG001|Overall Study|Progressive disease|45|||
160963540|NCT01953003|581253284|FG000|Overall Study|Related Adverse events|7|||
160963541|NCT01953003|581253285|FG001|Overall Study|Related Adverse events|2|||
160963542|NCT01953003|581253284|FG000|Overall Study|Non-related adverse events|0|||
160963543|NCT01953003|581253285|FG001|Overall Study|Non-related adverse events|2|||
160963544|NCT01953003|581253284|FG000|Overall Study|Protocol Violation|0|||
160963545|NCT01953003|581253285|FG001|Overall Study|Protocol Violation|1|||
160963546|NCT01953003|581253284|FG000|Overall Study|Withdrawal by Subject|14|||
160963547|NCT01953003|581253285|FG001|Overall Study|Withdrawal by Subject|4|||
160963548|NCT03391765|581253291|FG000|Overall Study|Adverse Event|2|||
160963549|NCT03391765|581253292|FG001|Overall Study|Adverse Event|0|||
160963550|NCT03391765|581253293|FG002|Overall Study|Adverse Event|0|||
160963551|NCT03391765|581253294|FG003|Overall Study|Adverse Event|2|||
160963552|NCT03391765|581253291|FG000|Overall Study|Withdrew consent|5|||
160963553|NCT03391765|581253292|FG001|Overall Study|Withdrew consent|7|||
160963554|NCT03391765|581253293|FG002|Overall Study|Withdrew consent|2|||
160963555|NCT03391765|581253294|FG003|Overall Study|Withdrew consent|5|||
160963556|NCT03391765|581253291|FG000|Overall Study|Other, not specified|44|||
160963557|NCT03391765|581253292|FG001|Overall Study|Other, not specified|38|||
160963558|NCT03391765|581253293|FG002|Overall Study|Other, not specified|21|||
160963559|NCT03391765|581253294|FG003|Overall Study|Other, not specified|16|||
160963560|NCT00662857|581253299|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
160963561|NCT00662857|581253300|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
160963562|NCT00662857|581253299|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
160963563|NCT00662857|581253300|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
160963564|NCT00662857|581253299|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
160963565|NCT00662857|581253300|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
160963566|NCT03966053|581253301|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
160963567|NCT02832622|581253303|FG000|Overall Study|MPP not programmed|1259|||
160963568|NCT02832622|581253303|FG000|Overall Study|Withdrawal by Subject|123|||
160963569|NCT02832622|581253303|FG000|Overall Study|Death|119|||
160963570|NCT02832622|581253303|FG000|Overall Study|Unsuccessful CRT implant|93|||
160963571|NCT02832622|581253303|FG000|Overall Study|Lost to Follow-up|45|||
160963572|NCT02832622|581253303|FG000|Overall Study|Patient non-compliance|42|||
160963573|NCT02832622|581253303|FG000|Overall Study|Withdrawal by other reasons|25|||
160963574|NCT02832622|581253303|FG000|Overall Study|System explant|24|||
160963575|NCT02832622|581253303|FG000|Overall Study|Physician Decision|6|||
160963576|NCT04586569|581253304|FG000|Overall Study|Withdrawal by Subject|0|||
160963577|NCT04586569|581253305|FG001|Overall Study|Withdrawal by Subject|2|||
161002370|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
160963578|NCT04586569|581253304|FG000|Overall Study|No longer eligible|2|||
160963579|NCT04586569|581253305|FG001|Overall Study|No longer eligible|3|||
160963580|NCT04586569|581253304|FG000|Overall Study|Physician Decision|1|||
160963581|NCT04586569|581253305|FG001|Overall Study|Physician Decision|0|||
160963582|NCT00998400|581253306|FG000|Overall Study|Lack of interest/motivation|1|||
160963583|NCT00998400|581253307|FG001|Overall Study|Lack of interest/motivation|2|||
160963584|NCT00998400|581253306|FG000|Overall Study|Logistical problems|1|||
160963585|NCT00998400|581253307|FG001|Overall Study|Logistical problems|0|||
160963586|NCT01083641|581253309|FG000|Overall Study|Withdrawal by Subject|2|||
160963587|NCT01777321|581253310|FG000|Overall Study|Withdrawal by Subject|0|||
160963588|NCT01777321|581253311|FG001|Overall Study|Withdrawal by Subject|1|||
160963589|NCT05131165|581253314|FG000|Overall Study|Death|1|||
160963590|NCT05131165|581253315|FG001|Overall Study|Death|1|||
160963591|NCT05131165|581253316|FG002|Overall Study|Death|0|||
160963592|NCT05131165|581253314|FG000|Overall Study|Lost to Follow-up|2|||
160963593|NCT05131165|581253315|FG001|Overall Study|Lost to Follow-up|2|||
160584991|NCT02052778|579861890|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584992|NCT02052778|579861891|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584993|NCT02052778|579861892|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160963594|NCT05131165|581253316|FG002|Overall Study|Lost to Follow-up|5|||
160963595|NCT05131165|581253314|FG000|Overall Study|Transferred out of clinic|1|||
160963596|NCT05131165|581253315|FG001|Overall Study|Transferred out of clinic|0|||
160963597|NCT05131165|581253316|FG002|Overall Study|Transferred out of clinic|3|||
160963598|NCT05131165|581253314|FG000|Overall Study|Dropped out|1|||
160963599|NCT05131165|581253315|FG001|Overall Study|Dropped out|2|||
160963600|NCT05131165|581253316|FG002|Overall Study|Dropped out|0|||
160963601|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
160963602|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
160963603|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
160963604|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
160963605|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
160963606|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
160963607|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
160963608|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
160963609|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
160963610|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
160963611|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
160963612|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
160963613|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
160963614|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
160963615|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
160963616|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
160963617|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
160963618|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
160963619|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
160963620|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
160963621|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
160963622|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
160963623|NCT00549757|581253322|FG000|Extension Period (in Average 9 Months)|Death|143|||
161002371|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
161002372|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
161002373|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
161002374|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161002375|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161002376|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161002377|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
160584994|NCT02052778|579861893|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584995|NCT02052778|579861894|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160963624|NCT00549757|581253323|FG001|Extension Period (in Average 9 Months)|Death|136|||
160963625|NCT00549757|581253322|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
160963626|NCT00549757|581253323|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
160963627|NCT00549757|581253322|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
161002378|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002379|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
160963628|NCT00549757|581253323|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
160963629|NCT00549757|581253322|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
161002380|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
161002381|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
160963630|NCT00549757|581253323|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
160963631|NCT02691182|581253326|FG000|Overall Study|Withdrawal by Subject|4|||
160963632|NCT02691182|581253327|FG001|Overall Study|Withdrawal by Subject|7|||
160963633|NCT02691182|581253328|FG002|Overall Study|Withdrawal by Subject|6|||
160963634|NCT02691182|581253329|FG003|Overall Study|Withdrawal by Subject|8|||
160963635|NCT02691182|581253326|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
160963636|NCT02691182|581253327|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
160963637|NCT02691182|581253328|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
160963638|NCT02691182|581253329|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
160963639|NCT02691182|581253326|FG000|Overall Study|Lost to Follow-up|8|||
160963640|NCT02691182|581253327|FG001|Overall Study|Lost to Follow-up|33|||
160963641|NCT02691182|581253328|FG002|Overall Study|Lost to Follow-up|19|||
160963642|NCT02691182|581253329|FG003|Overall Study|Lost to Follow-up|22|||
160963643|NCT02691182|581253326|FG000|Overall Study|Adverse Event|3|||
160963644|NCT02691182|581253327|FG001|Overall Study|Adverse Event|10|||
160963645|NCT02691182|581253328|FG002|Overall Study|Adverse Event|10|||
160963646|NCT02691182|581253329|FG003|Overall Study|Adverse Event|11|||
160963647|NCT02691182|581253326|FG000|Overall Study|Physician Decision|3|||
160963648|NCT02691182|581253327|FG001|Overall Study|Physician Decision|7|||
160963649|NCT02691182|581253328|FG002|Overall Study|Physician Decision|14|||
160963650|NCT02691182|581253329|FG003|Overall Study|Physician Decision|8|||
160963651|NCT02691182|581253326|FG000|Overall Study|Lack of Efficacy|0|||
160963652|NCT02691182|581253327|FG001|Overall Study|Lack of Efficacy|0|||
160963653|NCT02691182|581253328|FG002|Overall Study|Lack of Efficacy|0|||
160963654|NCT02691182|581253329|FG003|Overall Study|Lack of Efficacy|4|||
160963655|NCT02691182|581253326|FG000|Overall Study|Protocol Violation|2|||
160963656|NCT02691182|581253327|FG001|Overall Study|Protocol Violation|6|||
160963657|NCT02691182|581253328|FG002|Overall Study|Protocol Violation|6|||
160963658|NCT02691182|581253329|FG003|Overall Study|Protocol Violation|8|||
160963659|NCT02691182|581253326|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
160963660|NCT02691182|581253327|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
160963661|NCT02691182|581253328|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
160963662|NCT02691182|581253329|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
160963663|NCT02691182|581253326|FG000|Overall Study|Missing|0|||
160963664|NCT02691182|581253327|FG001|Overall Study|Missing|5|||
160963665|NCT02691182|581253328|FG002|Overall Study|Missing|1|||
160963666|NCT02691182|581253329|FG003|Overall Study|Missing|5|||
160963667|NCT00105235|581253330|FG000|Overall Study|Death|4|||
160963668|NCT00105235|581253330|FG000|Overall Study|Physician Decision|1|||
160963669|NCT00105235|581253330|FG000|Overall Study|Withdrawal by Subject|2|||
160963670|NCT02052310|581253331|FG000|Overall Study|Death|64|||
160963671|NCT02052310|581253332|FG001|Overall Study|Death|54|||
160963672|NCT02052310|581253331|FG000|Overall Study|Withdrawal by Subject|37|||
160963673|NCT02052310|581253332|FG001|Overall Study|Withdrawal by Subject|49|||
160963674|NCT02052310|581253331|FG000|Overall Study|Other than specified|32|||
160963675|NCT02052310|581253332|FG001|Overall Study|Other than specified|29|||
160963676|NCT02052310|581253331|FG000|Overall Study|Adverse Event|29|||
160963677|NCT02052310|581253332|FG001|Overall Study|Adverse Event|22|||
160963678|NCT02052310|581253331|FG000|Overall Study|Kidney Transplant|23|||
160963679|NCT02052310|581253332|FG001|Overall Study|Kidney Transplant|29|||
160963680|NCT02052310|581253331|FG000|Overall Study|Physician Decision|14|||
160963681|NCT02052310|581253332|FG001|Overall Study|Physician Decision|7|||
160963682|NCT02052310|581253331|FG000|Overall Study|Lack of Efficacy|6|||
160963683|NCT02052310|581253332|FG001|Overall Study|Lack of Efficacy|1|||
160963684|NCT02052310|581253331|FG000|Overall Study|Site Terminated by Sponsor|5|||
160963685|NCT02052310|581253332|FG001|Overall Study|Site Terminated by Sponsor|13|||
160963686|NCT02052310|581253331|FG000|Overall Study|Lost to Follow-up|4|||
160963687|NCT02052310|581253332|FG001|Overall Study|Lost to Follow-up|2|||
160963688|NCT02052310|581253331|FG000|Overall Study|Protocol Violation|1|||
160963689|NCT02052310|581253332|FG001|Overall Study|Protocol Violation|6|||
160584996|NCT02052778|579861895|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160963690|NCT01964326|581253333|FG000|Overall Study|Adverse Event|48|||
160963691|NCT01964326|581253333|FG000|Overall Study|Death|2|||
160963692|NCT01964326|581253333|FG000|Overall Study|Protocol Violation|4|||
160963693|NCT01964326|581253333|FG000|Overall Study|Lost to Follow-up|88|||
160963694|NCT01964326|581253333|FG000|Overall Study|Withdrawal by Subject|87|||
160963695|NCT01964326|581253333|FG000|Overall Study|Pregnancy|1|||
160963696|NCT01964326|581253333|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
160963697|NCT01964326|581253333|FG000|Overall Study|Physician Decision|55|||
160963698|NCT01964326|581253333|FG000|Overall Study|Investigator Discretion|1|||
160963699|NCT01964326|581253333|FG000|Overall Study|Other|9|||
160963700|NCT01964326|581253333|FG000|Overall Study|Did not meet eligibility criteria|1|||
160963701|NCT03518125|581253342|FG000|Overall Study|Lost to Follow-up|0|||
160963702|NCT03518125|581253343|FG001|Overall Study|Lost to Follow-up|2|||
160963703|NCT03518125|581253344|FG002|Overall Study|Lost to Follow-up|0|||
160963704|NCT03518125|581253345|FG003|Overall Study|Lost to Follow-up|0|||
160584997|NCT02052778|579861896|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584998|NCT02052778|579861897|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160584999|NCT02052778|579861898|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
160585000|NCT02052778|579861876|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160963705|NCT03518125|581253346|FG004|Overall Study|Lost to Follow-up|3|||
160963706|NCT03518125|581253347|FG005|Overall Study|Lost to Follow-up|5|||
160963707|NCT03518125|581253342|FG000|Overall Study|Physician Decision|0|||
160963708|NCT03518125|581253343|FG001|Overall Study|Physician Decision|1|||
160963709|NCT03518125|581253344|FG002|Overall Study|Physician Decision|0|||
160963710|NCT03518125|581253345|FG003|Overall Study|Physician Decision|0|||
160963711|NCT03518125|581253346|FG004|Overall Study|Physician Decision|0|||
160963712|NCT03518125|581253347|FG005|Overall Study|Physician Decision|0|||
160963713|NCT03518125|581253342|FG000|Overall Study|Withdrawal by Subject|1|||
160963714|NCT03518125|581253343|FG001|Overall Study|Withdrawal by Subject|1|||
160963715|NCT03518125|581253344|FG002|Overall Study|Withdrawal by Subject|0|||
160963716|NCT03518125|581253345|FG003|Overall Study|Withdrawal by Subject|1|||
160963717|NCT03518125|581253346|FG004|Overall Study|Withdrawal by Subject|1|||
160963718|NCT03518125|581253347|FG005|Overall Study|Withdrawal by Subject|3|||
160963719|NCT03518125|581253342|FG000|Overall Study|Missed Day 394 Visit|1|||
160963720|NCT03518125|581253343|FG001|Overall Study|Missed Day 394 Visit|0|||
160963721|NCT03518125|581253344|FG002|Overall Study|Missed Day 394 Visit|0|||
160963722|NCT03518125|581253345|FG003|Overall Study|Missed Day 394 Visit|0|||
160963723|NCT03518125|581253346|FG004|Overall Study|Missed Day 394 Visit|0|||
160963724|NCT03518125|581253347|FG005|Overall Study|Missed Day 394 Visit|0|||
160963725|NCT02093663|581253352|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
160963726|NCT02093663|581253353|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
160963727|NCT02093663|581253354|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
160963728|NCT02093663|581253355|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
160963729|NCT02093663|581253356|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
160963730|NCT02093663|581253352|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
160963731|NCT02093663|581253353|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963732|NCT02093663|581253354|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963733|NCT02093663|581253355|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963734|NCT02093663|581253356|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963735|NCT02093663|581253352|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
160963736|NCT02093663|581253353|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
160963737|NCT02093663|581253354|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
160963738|NCT02093663|581253355|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
160963739|NCT02093663|581253356|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
160963740|NCT02093663|581253352|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
160963741|NCT02093663|581253353|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
160963742|NCT02093663|581253354|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
160963743|NCT02093663|581253355|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
160963744|NCT02093663|581253356|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
160963745|NCT02093663|581253352|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963746|NCT02093663|581253353|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963747|NCT02093663|581253354|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
160963748|NCT02093663|581253355|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963749|NCT02093663|581253356|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963750|NCT02093663|581253352|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
160963751|NCT02093663|581253353|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
160585001|NCT02052778|579861877|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160963752|NCT02093663|581253354|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
160963753|NCT02093663|581253355|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
160963754|NCT02093663|581253356|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
160963755|NCT02093663|581253352|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
160963756|NCT02093663|581253353|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
160963757|NCT02093663|581253354|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
160963758|NCT02093663|581253355|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
160963759|NCT02093663|581253356|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
160963760|NCT02093663|581253352|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
160963761|NCT02093663|581253353|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
160963762|NCT02093663|581253354|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
160585002|NCT02052778|579861878|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585003|NCT02052778|579861879|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160963763|NCT02093663|581253355|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
160963764|NCT02093663|581253356|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
160963765|NCT02093663|581253352|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
160963766|NCT02093663|581253353|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
160963767|NCT02093663|581253354|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
160963768|NCT02093663|581253355|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
160963769|NCT02093663|581253356|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
160963775|NCT00508404|581253362|FG000|Overall Study|Ongoing at Data Cut-off|12|||
160963776|NCT00508404|581253362|FG000|Overall Study|Adverse Event|2|||
160963777|NCT00508404|581253362|FG000|Overall Study|Death|16|||
160963778|NCT00508404|581253362|FG000|Overall Study|Physician Decision|2|||
160963779|NCT00508404|581253362|FG000|Overall Study|Withdrawal by Subject|3|||
160963780|NCT00508404|581253362|FG000|Overall Study|Protocol-specified Criteria|2|||
160963781|NCT00508404|581253362|FG000|Overall Study|Lost to Follow-up|2|||
160963782|NCT00508404|581253362|FG000|Overall Study|Other - Not Specified|3|||
160963783|NCT05453110|581253363|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
160963784|NCT05453110|581253364|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
160963785|NCT05453110|581253365|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
160963786|NCT05906368|581253366|FG000|Overall Study|Withdrawal by Subject|1|||
160963787|NCT05906368|581253367|FG001|Overall Study|Withdrawal by Subject|1|||
160963788|NCT05906368|581253366|FG000|Overall Study|Ineligibility criteria identified|2|||
160963789|NCT05906368|581253367|FG001|Overall Study|Ineligibility criteria identified|0|||
160963790|NCT00266825|581253368|FG000|Completed Follow-Up|Lost to Follow-up|14|||
160963791|NCT00266825|581253369|FG001|Completed Follow-Up|Lost to Follow-up|19|||
160963792|NCT00266825|581253368|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
160963793|NCT00266825|581253369|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
160963794|NCT02799784|581253372|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
160963795|NCT02799784|581253373|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
160963796|NCT02799784|581253372|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
160963797|NCT02799784|581253373|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
160963798|NCT02799784|581253372|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
160963799|NCT02799784|581253373|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
160963800|NCT02799784|581253372|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
160963801|NCT02799784|581253373|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
160963802|NCT02799784|581253372|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
160963803|NCT02799784|581253373|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
160963804|NCT02799784|581253372|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
160963805|NCT02799784|581253373|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
160963806|NCT01949870|581253374|FG000|Overall Study|Lack of Efficacy|2|||
160963807|NCT01949870|581253374|FG000|Overall Study|Adverse Event|1|||
160963808|NCT01949870|581253374|FG000|Overall Study|Study termination|1|||
160963809|NCT01949870|581253374|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
160963810|NCT01235546|581253375|FG000|Overall Study|Staff error, medication not administered|1|||
160963811|NCT01235546|581253376|FG001|Overall Study|Staff error, medication not administered|0|||
160963812|NCT01235546|581253375|FG000|Overall Study|Protocol Violation|1|||
160963813|NCT01235546|581253376|FG001|Overall Study|Protocol Violation|1|||
160963814|NCT02954354|581253377|FG000|Overall Study|Adverse Event|2|||
160963815|NCT02954354|581253378|FG001|Overall Study|Adverse Event|2|||
160963816|NCT02954354|581253379|FG002|Overall Study|Adverse Event|4|||
160963817|NCT02954354|581253377|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
160963818|NCT02954354|581253378|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
160963819|NCT02954354|581253379|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
160963820|NCT02954354|581253377|FG000|Overall Study|Lack of Efficacy|0|||
160963821|NCT02954354|581253378|FG001|Overall Study|Lack of Efficacy|2|||
160963822|NCT02954354|581253379|FG002|Overall Study|Lack of Efficacy|0|||
161002382|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
161002383|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
160656992|NCT05097989|580124498|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160963823|NCT02954354|581253377|FG000|Overall Study|Withdrawal by Subject|17|||
160963824|NCT02954354|581253378|FG001|Overall Study|Withdrawal by Subject|9|||
160963825|NCT02954354|581253379|FG002|Overall Study|Withdrawal by Subject|11|||
160963826|NCT02954354|581253377|FG000|Overall Study|Lost to Follow-up|12|||
160963827|NCT02954354|581253378|FG001|Overall Study|Lost to Follow-up|5|||
160963828|NCT02954354|581253379|FG002|Overall Study|Lost to Follow-up|0|||
160963829|NCT02954354|581253377|FG000|Overall Study|Miscellaneous|2|||
160963830|NCT02954354|581253378|FG001|Overall Study|Miscellaneous|2|||
160963831|NCT02954354|581253379|FG002|Overall Study|Miscellaneous|1|||
160963832|NCT02279043|581253390|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
160963833|NCT02279043|581253391|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
160963834|NCT02279043|581253392|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
160585004|NCT02052778|579861880|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585005|NCT02052778|579861881|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
160585006|NCT02052778|579861882|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585007|NCT02052778|579861883|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585008|NCT02052778|579861884|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585009|NCT02052778|579861885|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160963835|NCT02279043|581253390|FG000|Overall Study|Lost to Follow-up|46|||
160963836|NCT02279043|581253391|FG001|Overall Study|Lost to Follow-up|88|||
160963837|NCT02279043|581253392|FG002|Overall Study|Lost to Follow-up|0|||
160963838|NCT00490282|581253393|FG000|Overall Study|Withdrawal by Subject|3|||
160963839|NCT01494584|581253400|FG000|Overall Study|Study Closed/Terminated|1|||
160963840|NCT01256567|581253407|FG000|Overall Study|Withdrawal by Subject|1|||
160963841|NCT00567190|581253413|FG000|Overall Study|Death|235|||
160963842|NCT00567190|581253414|FG001|Overall Study|Death|280|||
160963843|NCT00567190|581253413|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
160963844|NCT00567190|581253414|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
160963845|NCT00374322|581253418|FG000|Overall Study|Lost to Follow-up|92|||
160963846|NCT00374322|581253419|FG001|Overall Study|Lost to Follow-up|90|||
160963847|NCT00374322|581253418|FG000|Overall Study|Protocol Violation|8|||
160963848|NCT00374322|581253419|FG001|Overall Study|Protocol Violation|3|||
160963849|NCT00374322|581253418|FG000|Overall Study|Withdrawal by Subject|235|||
160963850|NCT00374322|581253419|FG001|Overall Study|Withdrawal by Subject|167|||
160963851|NCT00374322|581253418|FG000|Overall Study|Sponsor Terminated Study|866|||
160963852|NCT00374322|581253419|FG001|Overall Study|Sponsor Terminated Study|990|||
160963853|NCT00374322|581253418|FG000|Overall Study|Physician Decision|36|||
160963854|NCT00374322|581253419|FG001|Overall Study|Physician Decision|32|||
160458304|NCT04707768|579409149|FG000|Overall Study|Lack of Efficacy|1|||
160963855|NCT00374322|581253418|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
160963856|NCT00374322|581253419|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
160963857|NCT00374322|581253418|FG000|Overall Study|Sponsor Decision|2|||
160963858|NCT00374322|581253419|FG001|Overall Study|Sponsor Decision|3|||
160963859|NCT00374322|581253418|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
160963860|NCT00374322|581253419|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
160963861|NCT00374322|581253418|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
160963862|NCT00374322|581253419|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
160963863|NCT00374322|581253418|FG000|Overall Study|Severe Toxicity|1|||
160963864|NCT00374322|581253419|FG001|Overall Study|Severe Toxicity|0|||
160963865|NCT00374322|581253418|FG000|Overall Study|Site Closed|2|||
160963866|NCT00374322|581253419|FG001|Overall Study|Site Closed|2|||
160963867|NCT00374322|581253418|FG000|Overall Study|Participant Changed Physician|1|||
160963868|NCT00374322|581253419|FG001|Overall Study|Participant Changed Physician|0|||
160963869|NCT00374322|581253418|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
160963870|NCT00374322|581253419|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
160963871|NCT00374322|581253418|FG000|Overall Study|Noncompliance with Study Requirements|0|||
160963872|NCT00374322|581253419|FG001|Overall Study|Noncompliance with Study Requirements|1|||
160963873|NCT00374322|581253418|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
160963874|NCT00374322|581253419|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
160963875|NCT00374322|581253418|FG000|Overall Study|Did Not Receive Study Medication|8|||
160963876|NCT00374322|581253419|FG001|Overall Study|Did Not Receive Study Medication|6|||
160963877|NCT00636610|581253423|FG000|Overall Study|Adverse Event|4|||
160963878|NCT00636610|581253424|FG001|Overall Study|Adverse Event|4|||
160963879|NCT00636610|581253423|FG000|Overall Study|Death|6|||
160963880|NCT00636610|581253424|FG001|Overall Study|Death|3|||
160963881|NCT00636610|581253423|FG000|Overall Study|Physician decision to withdraw patient|15|||
160963882|NCT00636610|581253424|FG001|Overall Study|Physician decision to withdraw patient|9|||
160963883|NCT00636610|581253423|FG000|Overall Study|Subject decision to withdraw|15|||
160963884|NCT00636610|581253424|FG001|Overall Study|Subject decision to withdraw|11|||
160963885|NCT00636610|581253423|FG000|Overall Study|Disease progression - radiographic|41|||
160585010|NCT02052778|579861886|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585011|NCT02052778|579861887|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585012|NCT02052778|579861888|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
160585013|NCT02052778|579861889|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585014|NCT02052778|579861890|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160963886|NCT00636610|581253424|FG001|Overall Study|Disease progression - radiographic|51|||
160963887|NCT00636610|581253423|FG000|Overall Study|Disease progression - clinical|8|||
160963888|NCT00636610|581253424|FG001|Overall Study|Disease progression - clinical|3|||
160585015|NCT02052778|579861891|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160963889|NCT00636610|581253423|FG000|Overall Study|Reason for discontinuation not available|3|||
160963890|NCT00636610|581253424|FG001|Overall Study|Reason for discontinuation not available|2|||
160458305|NCT04707768|579409150|FG001|Overall Study|Lack of Efficacy|3|||
160963891|NCT02495025|581253425|FG000|Overall Study|Lost to Follow-up|21|||
160458306|NCT04707768|579409151|FG002|Overall Study|Lack of Efficacy|0|||
160963892|NCT02495025|581253426|FG001|Overall Study|Lost to Follow-up|14|||
160963893|NCT02495025|581253425|FG000|Overall Study|Withdrawal by Subject|5|||
160963894|NCT02495025|581253426|FG001|Overall Study|Withdrawal by Subject|0|||
160963895|NCT02151266|581253431|FG000|Overall Study|Lost to Follow-up|1|||
160963896|NCT02151266|581253432|FG001|Overall Study|Lost to Follow-up|4|||
160963897|NCT02151266|581253433|FG002|Overall Study|Lost to Follow-up|1|||
160963898|NCT02151266|581253431|FG000|Overall Study|Did NOT receive intervention|3|||
160963899|NCT02151266|581253432|FG001|Overall Study|Did NOT receive intervention|6|||
160963900|NCT02151266|581253433|FG002|Overall Study|Did NOT receive intervention|2|||
160963901|NCT02151266|581253431|FG000|Overall Study|Not able to exercise|4|||
160963902|NCT02151266|581253432|FG001|Overall Study|Not able to exercise|5|||
160963903|NCT02151266|581253433|FG002|Overall Study|Not able to exercise|4|||
160963904|NCT01169675|581253434|FG000|Overall Study|Progressive disease|13|||
160963905|NCT01169675|581253435|FG001|Overall Study|Progressive disease|2|||
160963906|NCT01169675|581253436|FG002|Overall Study|Progressive disease|5|||
160963907|NCT01169675|581253437|FG003|Overall Study|Progressive disease|15|||
160963908|NCT01169675|581253438|FG004|Overall Study|Progressive disease|1|||
160963909|NCT01169675|581253434|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160963910|NCT01169675|581253435|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160963911|NCT01169675|581253436|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160963912|NCT01169675|581253437|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160963913|NCT01169675|581253438|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
160963914|NCT01169675|581253434|FG000|Overall Study|Adverse Event|5|||
160963915|NCT01169675|581253435|FG001|Overall Study|Adverse Event|1|||
160963916|NCT01169675|581253436|FG002|Overall Study|Adverse Event|2|||
160963917|NCT01169675|581253437|FG003|Overall Study|Adverse Event|0|||
160963918|NCT01169675|581253438|FG004|Overall Study|Adverse Event|0|||
160963919|NCT01169675|581253434|FG000|Overall Study|Withdrawal by Subject|1|||
160963920|NCT01169675|581253435|FG001|Overall Study|Withdrawal by Subject|0|||
160963921|NCT01169675|581253436|FG002|Overall Study|Withdrawal by Subject|0|||
160963922|NCT01169675|581253437|FG003|Overall Study|Withdrawal by Subject|1|||
160963923|NCT01169675|581253438|FG004|Overall Study|Withdrawal by Subject|2|||
160963924|NCT01169675|581253434|FG000|Overall Study|Other Reason Not Defined Above|0|||
160963925|NCT01169675|581253435|FG001|Overall Study|Other Reason Not Defined Above|0|||
160963926|NCT01169675|581253436|FG002|Overall Study|Other Reason Not Defined Above|0|||
160963927|NCT01169675|581253437|FG003|Overall Study|Other Reason Not Defined Above|1|||
160963928|NCT01169675|581253438|FG004|Overall Study|Other Reason Not Defined Above|1|||
160963929|NCT00572195|581253441|FG000|Overall Study|Withdrawal by Subject|50|||
160963930|NCT00572195|581253441|FG000|Overall Study|Death|9|||
160963931|NCT00572195|581253441|FG000|Overall Study|Adverse Event|4|||
160963932|NCT00572195|581253441|FG000|Overall Study|Lost to Follow-up|5|||
160963933|NCT01984697|581255598|FG000|Overall Study|Adverse Event|0|||
160963934|NCT01984697|581255599|FG001|Overall Study|Adverse Event|0|||
160963935|NCT01984697|581255600|FG002|Overall Study|Adverse Event|2|||
160963936|NCT01984697|581255601|FG003|Overall Study|Adverse Event|0|||
160963937|NCT01984697|581255602|FG004|Overall Study|Adverse Event|0|||
160963938|NCT01984697|581255598|FG000|Overall Study|Lost to Follow-up|14|||
160963939|NCT01984697|581255599|FG001|Overall Study|Lost to Follow-up|5|||
160963940|NCT01984697|581255600|FG002|Overall Study|Lost to Follow-up|10|||
160963941|NCT01984697|581255601|FG003|Overall Study|Lost to Follow-up|6|||
160963942|NCT01984697|581255602|FG004|Overall Study|Lost to Follow-up|21|||
160963943|NCT01984697|581255598|FG000|Overall Study|Physician Decision|3|||
160963944|NCT01984697|581255599|FG001|Overall Study|Physician Decision|0|||
160963945|NCT01984697|581255600|FG002|Overall Study|Physician Decision|0|||
160963946|NCT01984697|581255601|FG003|Overall Study|Physician Decision|1|||
160963947|NCT01984697|581255602|FG004|Overall Study|Physician Decision|0|||
160963948|NCT01984697|581255598|FG000|Overall Study|Protocol Violation|8|||
160963949|NCT01984697|581255599|FG001|Overall Study|Protocol Violation|5|||
160963950|NCT01984697|581255600|FG002|Overall Study|Protocol Violation|3|||
160963951|NCT01984697|581255601|FG003|Overall Study|Protocol Violation|2|||
160963952|NCT01984697|581255602|FG004|Overall Study|Protocol Violation|0|||
160963953|NCT01984697|581255598|FG000|Overall Study|Withdrawal by Subject|15|||
160963954|NCT01984697|581255599|FG001|Overall Study|Withdrawal by Subject|21|||
160963955|NCT01984697|581255600|FG002|Overall Study|Withdrawal by Subject|13|||
160963956|NCT01984697|581255601|FG003|Overall Study|Withdrawal by Subject|11|||
160963957|NCT01984697|581255602|FG004|Overall Study|Withdrawal by Subject|13|||
160963958|NCT01984697|581255598|FG000|Overall Study|Missed last follow-up visit|1|||
160963959|NCT01984697|581255599|FG001|Overall Study|Missed last follow-up visit|0|||
160963960|NCT01984697|581255600|FG002|Overall Study|Missed last follow-up visit|0|||
160963961|NCT01984697|581255601|FG003|Overall Study|Missed last follow-up visit|0|||
160963962|NCT01984697|581255602|FG004|Overall Study|Missed last follow-up visit|0|||
160963963|NCT01984697|581255598|FG000|Overall Study|Death|0|||
160963964|NCT01984697|581255599|FG001|Overall Study|Death|0|||
160963965|NCT01984697|581255600|FG002|Overall Study|Death|0|||
160963966|NCT01984697|581255601|FG003|Overall Study|Death|1|||
160963967|NCT01984697|581255602|FG004|Overall Study|Death|0|||
160963968|NCT01984697|581255598|FG000|Overall Study|Pregnancy|2|||
160458307|NCT04707768|579409149|FG000|Overall Study|Lost to Follow-up|0|||
160458308|NCT04707768|579409150|FG001|Overall Study|Lost to Follow-up|0|||
160458309|NCT04707768|579409151|FG002|Overall Study|Lost to Follow-up|3|||
160458310|NCT04707768|579409149|FG000|Overall Study|Death|13|||
160963969|NCT01984697|581255599|FG001|Overall Study|Pregnancy|0|||
160963970|NCT01984697|581255600|FG002|Overall Study|Pregnancy|1|||
160963971|NCT01984697|581255601|FG003|Overall Study|Pregnancy|0|||
160963972|NCT01984697|581255602|FG004|Overall Study|Pregnancy|1|||
160963973|NCT01345630|581255603|FG000|Overall Study|Adverse Event|22|||
160963974|NCT01345630|581255604|FG001|Overall Study|Adverse Event|23|||
160963975|NCT01345630|581255603|FG000|Overall Study|Lost to Follow-up|17|||
160963976|NCT01345630|581255604|FG001|Overall Study|Lost to Follow-up|16|||
160963977|NCT01345630|581255603|FG000|Overall Study|Protocol Violation|4|||
160963978|NCT01345630|581255604|FG001|Overall Study|Protocol Violation|1|||
160963979|NCT01345630|581255603|FG000|Overall Study|Medication error without associated AE|0|||
160963980|NCT01345630|581255604|FG001|Overall Study|Medication error without associated AE|1|||
160963981|NCT01345630|581255603|FG000|Overall Study|Study terminated by sponsor|254|||
160963982|NCT01345630|581255604|FG001|Overall Study|Study terminated by sponsor|285|||
160963983|NCT01345630|581255603|FG000|Overall Study|Other reasons|6|||
160963984|NCT01345630|581255604|FG001|Overall Study|Other reasons|8|||
160963985|NCT01345630|581255603|FG000|Overall Study|Withdrawn due to pregnancy|1|||
160963986|NCT01345630|581255604|FG001|Overall Study|Withdrawn due to pregnancy|2|||
160963987|NCT01345630|581255603|FG000|Overall Study|No longer willing to participate|9|||
160963988|NCT01345630|581255604|FG001|Overall Study|No longer willing to participate|12|||
160963989|NCT01345630|581255603|FG000|Overall Study|Insufficient clinical response|48|||
160963990|NCT01345630|581255604|FG001|Overall Study|Insufficient clinical response|11|||
160963991|NCT01364922|581255607|FG000|Open-label (OL) Period|Adverse Event|7|||
160963992|NCT01364922|581255608|FG001|Open-label (OL) Period|Adverse Event|0|||
160963993|NCT01364922|581255609|FG002|Open-label (OL) Period|Adverse Event|0|||
160963994|NCT01364922|581255607|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
160963995|NCT01364922|581255608|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
160963996|NCT01364922|581255609|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
160963997|NCT01364922|581255607|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
160963998|NCT01364922|581255608|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
160963999|NCT01364922|581255609|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
160964000|NCT01364922|581255607|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
160964001|NCT01364922|581255608|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
160964002|NCT01364922|581255609|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
160964003|NCT01364922|581255607|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
160964004|NCT01364922|581255608|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
160458311|NCT04707768|579409150|FG001|Overall Study|Death|11|||
160964005|NCT01364922|581255609|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
160964006|NCT01364922|581255607|FG000|Open-label (OL) Period|Other, Unspecified|1|||
160964007|NCT01364922|581255608|FG001|Open-label (OL) Period|Other, Unspecified|0|||
160964008|NCT01364922|581255609|FG002|Open-label (OL) Period|Other, Unspecified|0|||
160964009|NCT01364922|581255607|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
160964010|NCT01364922|581255608|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
160964011|NCT01364922|581255609|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
160964012|NCT01364922|581255607|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
160964013|NCT01364922|581255608|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
160964014|NCT01364922|581255609|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
160964015|NCT01364922|581255607|FG000|Double-Blind (DB) Period|Adverse Event|0|||
160964016|NCT01364922|581255608|FG001|Double-Blind (DB) Period|Adverse Event|0|||
160964017|NCT01364922|581255609|FG002|Double-Blind (DB) Period|Adverse Event|1|||
160964018|NCT01364922|581255607|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
160964019|NCT01364922|581255608|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
160964020|NCT01364922|581255609|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
160964021|NCT01582789|581255613|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
160964022|NCT01582789|581255614|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
160964023|NCT00800202|581255615|FG000|Overall Study|Adverse Event|7|||
160458312|NCT04707768|579409151|FG002|Overall Study|Death|13|||
160458313|NCT04707768|579409149|FG000|Overall Study|Protocol Violation|2|||
160458314|NCT04707768|579409150|FG001|Overall Study|Protocol Violation|1|||
160964024|NCT00800202|581255616|FG001|Overall Study|Adverse Event|6|||
160964025|NCT00800202|581255615|FG000|Overall Study|Death|1|||
160964026|NCT00800202|581255616|FG001|Overall Study|Death|0|||
160964027|NCT00800202|581255615|FG000|Overall Study|Other|5|||
161002384|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
160458315|NCT04707768|579409151|FG002|Overall Study|Protocol Violation|0|||
160458316|NCT04707768|579409149|FG000|Overall Study|Non Compliance with Study Drug|1|||
160458317|NCT04707768|579409150|FG001|Overall Study|Non Compliance with Study Drug|0|||
160964028|NCT00800202|581255616|FG001|Overall Study|Other|0|||
160964029|NCT00800202|581255615|FG000|Overall Study|Disease Progression|54|||
160964030|NCT00800202|581255616|FG001|Overall Study|Disease Progression|18|||
160458318|NCT04707768|579409151|FG002|Overall Study|Non Compliance with Study Drug|0|||
160964031|NCT05674890|581255619|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
160964032|NCT05674890|581255620|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
160964033|NCT05674890|581255619|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
160964034|NCT05674890|581255620|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
160964035|NCT05674890|581255619|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
160964036|NCT05674890|581255620|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
160964037|NCT02563002|581255623|FG000|Overall Study|Death|72|||
160964038|NCT02563002|581255624|FG001|Overall Study|Death|87|||
160964039|NCT02563002|581255623|FG000|Overall Study|Lost to Follow-up|5|||
160964040|NCT02563002|581255624|FG001|Overall Study|Lost to Follow-up|0|||
160964041|NCT02563002|581255623|FG000|Overall Study|Physician Decision|0|||
160964042|NCT02563002|581255624|FG001|Overall Study|Physician Decision|2|||
160964043|NCT02563002|581255623|FG000|Overall Study|Withdrawal by Subject|2|||
160964044|NCT02563002|581255624|FG001|Overall Study|Withdrawal by Subject|10|||
160964045|NCT02563002|581255623|FG000|Overall Study|Sponsor decision|74|||
160964046|NCT02563002|581255624|FG001|Overall Study|Sponsor decision|55|||
160964047|NCT01505387|581255625|FG000|Overall Study|Protocol Violation|1|||
160964048|NCT01505387|581255626|FG001|Overall Study|Protocol Violation|0|||
160964049|NCT01505387|581255625|FG000|Overall Study|Withdrawal by Subject|1|||
160964050|NCT01505387|581255626|FG001|Overall Study|Withdrawal by Subject|1|||
160964051|NCT01197508|581255627|FG000|Overall Study|Withdrawal by Subject|8|||
160964052|NCT01197508|581255628|FG001|Overall Study|Withdrawal by Subject|7|||
160964053|NCT01197508|581255629|FG002|Overall Study|Withdrawal by Subject|15|||
160964054|NCT01197508|581255630|FG003|Overall Study|Withdrawal by Subject|4|||
160964055|NCT01197508|581255627|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
160964056|NCT01197508|581255628|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
160964057|NCT01197508|581255629|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
160964058|NCT01197508|581255630|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
160964059|NCT01197508|581255627|FG000|Overall Study|Adverse Event|10|||
160964060|NCT01197508|581255628|FG001|Overall Study|Adverse Event|13|||
160964061|NCT01197508|581255629|FG002|Overall Study|Adverse Event|23|||
160964062|NCT01197508|581255630|FG003|Overall Study|Adverse Event|3|||
160964063|NCT01197508|581255627|FG000|Overall Study|Severe non-compliance to protocol|0|||
160964064|NCT01197508|581255628|FG001|Overall Study|Severe non-compliance to protocol|3|||
160964065|NCT01197508|581255629|FG002|Overall Study|Severe non-compliance to protocol|1|||
160964066|NCT01197508|581255630|FG003|Overall Study|Severe non-compliance to protocol|3|||
160964067|NCT01197508|581255627|FG000|Overall Study|Condition under investigation worsened|1|||
160964068|NCT01197508|581255628|FG001|Overall Study|Condition under investigation worsened|1|||
160964069|NCT01197508|581255629|FG002|Overall Study|Condition under investigation worsened|1|||
160964070|NCT01197508|581255630|FG003|Overall Study|Condition under investigation worsened|1|||
160964071|NCT01197508|581255627|FG000|Overall Study|Lack of Efficacy|1|||
160964072|NCT01197508|581255628|FG001|Overall Study|Lack of Efficacy|2|||
160964073|NCT01197508|581255629|FG002|Overall Study|Lack of Efficacy|2|||
160964074|NCT01197508|581255630|FG003|Overall Study|Lack of Efficacy|1|||
160964075|NCT01197508|581255627|FG000|Overall Study|Study-specific withdrawal criteria|0|||
160964076|NCT01197508|581255628|FG001|Overall Study|Study-specific withdrawal criteria|0|||
160964077|NCT01197508|581255629|FG002|Overall Study|Study-specific withdrawal criteria|1|||
160964078|NCT01197508|581255630|FG003|Overall Study|Study-specific withdrawal criteria|2|||
160964079|NCT01197508|581255627|FG000|Overall Study|Lost to Follow-up|1|||
160964080|NCT01197508|581255628|FG001|Overall Study|Lost to Follow-up|1|||
160964081|NCT01197508|581255629|FG002|Overall Study|Lost to Follow-up|2|||
160964082|NCT01197508|581255630|FG003|Overall Study|Lost to Follow-up|0|||
160964083|NCT01197508|581255627|FG000|Overall Study|Other|2|||
160964084|NCT01197508|581255628|FG001|Overall Study|Other|3|||
161002385|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002386|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002387|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002388|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002389|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002390|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002391|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
161002392|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
161002393|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
161002394|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
161002395|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
161002396|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
160964085|NCT01197508|581255629|FG002|Overall Study|Other|2|||
160964086|NCT01197508|581255630|FG003|Overall Study|Other|2|||
160964087|NCT03086330|581255631|FG000|Overall Study|Withdrawal by Subject|3|||
160964088|NCT03086330|581255632|FG001|Overall Study|Withdrawal by Subject|2|||
160964089|NCT03086330|581255631|FG000|Overall Study|Lost to Follow-up|1|||
160964090|NCT03086330|581255632|FG001|Overall Study|Lost to Follow-up|2|||
160964091|NCT00330174|581255634|FG000|Overall Study|Withdrawal by Subject|7|||
160964092|NCT00330174|581255635|FG001|Overall Study|Withdrawal by Subject|7|||
160964093|NCT00330174|581255634|FG000|Overall Study|Lost to Follow-up|4|||
160964094|NCT00330174|581255635|FG001|Overall Study|Lost to Follow-up|1|||
160964095|NCT00330174|581255634|FG000|Overall Study|Clinical deterioration|1|||
160964096|NCT00330174|581255635|FG001|Overall Study|Clinical deterioration|2|||
160964097|NCT00330174|581255634|FG000|Overall Study|Excessive missed visits|3|||
160964098|NCT00330174|581255635|FG001|Overall Study|Excessive missed visits|8|||
160964099|NCT00330174|581255634|FG000|Overall Study|Miscellaneous reasons|7|||
160964100|NCT00330174|581255635|FG001|Overall Study|Miscellaneous reasons|1|||
160964101|NCT02316769|581255638|FG000|Overall Study|Physician Decision|1|||
160964102|NCT02316769|581255639|FG001|Overall Study|Physician Decision|0|||
160964103|NCT02316769|581255638|FG000|Overall Study|Withdrawal by Subject|1|||
160964104|NCT02316769|581255639|FG001|Overall Study|Withdrawal by Subject|0|||
160964105|NCT04570436|581255640|FG000|Overall Study|Adverse Event|0|||
160964106|NCT04570436|581255641|FG001|Overall Study|Adverse Event|0|||
160964107|NCT04570436|581255642|FG002|Overall Study|Adverse Event|1|||
160964108|NCT04570436|581255643|FG003|Overall Study|Adverse Event|0|||
160964109|NCT04570436|581255644|FG004|Overall Study|Adverse Event|0|||
160964110|NCT04570436|581255645|FG005|Overall Study|Adverse Event|0|||
160964111|NCT04570436|581255646|FG006|Overall Study|Adverse Event|0|||
160964112|NCT04570436|581255647|FG007|Overall Study|Adverse Event|0|||
160964113|NCT04570436|581255648|FG008|Overall Study|Adverse Event|0|||
160964114|NCT04570436|581255649|FG009|Overall Study|Adverse Event|0|||
160964115|NCT04570436|581255640|FG000|Overall Study|Physician Decision|1|||
160964116|NCT04570436|581255641|FG001|Overall Study|Physician Decision|0|||
160964117|NCT04570436|581255642|FG002|Overall Study|Physician Decision|0|||
160964118|NCT04570436|581255643|FG003|Overall Study|Physician Decision|0|||
160964119|NCT04570436|581255644|FG004|Overall Study|Physician Decision|0|||
160964120|NCT04570436|581255645|FG005|Overall Study|Physician Decision|0|||
160964121|NCT04570436|581255646|FG006|Overall Study|Physician Decision|0|||
160964122|NCT04570436|581255647|FG007|Overall Study|Physician Decision|0|||
160964123|NCT04570436|581255648|FG008|Overall Study|Physician Decision|0|||
160964124|NCT04570436|581255649|FG009|Overall Study|Physician Decision|0|||
160964125|NCT00645164|581255650|FG000|Overall Study|Lost to Follow-up|2|||
160964126|NCT00645164|581255650|FG000|Overall Study|Withdrawal by Subject|4|||
160964127|NCT00645164|581255650|FG000|Overall Study|Protocol Violation|1|||
160964128|NCT03039023|581255651|FG000|Overall Study|Withdrawal by Subject|1|||
160964129|NCT03039023|581255652|FG001|Overall Study|Withdrawal by Subject|0|||
160964130|NCT03039023|581255653|FG002|Overall Study|Withdrawal by Subject|1|||
160964131|NCT03039023|581255654|FG003|Overall Study|Withdrawal by Subject|1|||
160964132|NCT03039023|581255655|FG004|Overall Study|Withdrawal by Subject|0|||
160964133|NCT03039023|581255651|FG000|Overall Study|Physician Decision|0|||
160964134|NCT03039023|581255652|FG001|Overall Study|Physician Decision|0|||
160964135|NCT03039023|581255653|FG002|Overall Study|Physician Decision|0|||
160964136|NCT03039023|581255654|FG003|Overall Study|Physician Decision|1|||
160964137|NCT03039023|581255655|FG004|Overall Study|Physician Decision|0|||
160964138|NCT03338829|581255656|FG000|Overall Study|Lost to Follow-up|4|||
160964139|NCT03338829|581255657|FG001|Overall Study|Lost to Follow-up|2|||
160964140|NCT03338829|581255658|FG002|Overall Study|Lost to Follow-up|4|||
160964141|NCT03338829|581255656|FG000|Overall Study|Pregnancy loss|1|||
160964142|NCT03338829|581255657|FG001|Overall Study|Pregnancy loss|1|||
160964143|NCT03338829|581255658|FG002|Overall Study|Pregnancy loss|0|||
160964144|NCT03338829|581255656|FG000|Overall Study|Protocol Violation|0|||
160964145|NCT03338829|581255657|FG001|Overall Study|Protocol Violation|1|||
160964146|NCT03338829|581255658|FG002|Overall Study|Protocol Violation|0|||
160964147|NCT03701399|581255662|FG000|Overall Study|Adverse Event|3|||
160964148|NCT03701399|581255663|FG001|Overall Study|Adverse Event|5|||
160964149|NCT03701399|581255662|FG000|Overall Study|Withdrawal by Subject|6|||
160964150|NCT03701399|581255663|FG001|Overall Study|Withdrawal by Subject|3|||
160964151|NCT03701399|581255662|FG000|Overall Study|Investigators decision|1|||
160964152|NCT03701399|581255663|FG001|Overall Study|Investigators decision|2|||
160964153|NCT03701399|581255662|FG000|Overall Study|Lost to Follow-up|1|||
161002397|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002398|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002399|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
160964154|NCT03701399|581255663|FG001|Overall Study|Lost to Follow-up|2|||
160964155|NCT03701399|581255662|FG000|Overall Study|Death|1|||
160964156|NCT03701399|581255663|FG001|Overall Study|Death|1|||
160964157|NCT03701399|581255662|FG000|Overall Study|Randomized but not treated|1|||
160964158|NCT03701399|581255663|FG001|Overall Study|Randomized but not treated|0|||
160964159|NCT04179032|581255664|FG000|Part B (Up to Week 52)|Adverse Event|1|||
160964160|NCT04179032|581255664|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
160964161|NCT04179032|581255664|FG000|Access Extension Phase|Ongoing|11|||
160964162|NCT00448448|581255665|FG000|Overall Study|Withdrawal by Subject|13|||
160964163|NCT00448448|581255666|FG001|Overall Study|Withdrawal by Subject|2|||
160964164|NCT00448448|581255665|FG000|Overall Study|On protocol when study ended|83|||
160964165|NCT00448448|581255666|FG001|Overall Study|On protocol when study ended|36|||
160964166|NCT00448448|581255665|FG000|Overall Study|Lost to Follow-up|2|||
160964167|NCT00448448|581255666|FG001|Overall Study|Lost to Follow-up|1|||
160964168|NCT00448448|581255665|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
160964169|NCT00448448|581255666|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
160964170|NCT00448448|581255665|FG000|Overall Study|Signed consent lost|0|||
160964171|NCT00448448|581255666|FG001|Overall Study|Signed consent lost|1|||
160964172|NCT02340026|581255667|FG000|Treatment Phase|Withdrawal by Subject|2|||
160964173|NCT02340026|581255668|FG001|Treatment Phase|Withdrawal by Subject|2|||
160964174|NCT02340026|581255667|FG000|Follow-up Phase|Lost to Follow-up|1|||
160964175|NCT02340026|581255668|FG001|Follow-up Phase|Lost to Follow-up|0|||
160964176|NCT03945292|581255669|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
160964177|NCT03945292|581255670|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964178|NCT03945292|581255671|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
160964179|NCT03945292|581255672|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964180|NCT03945292|581255673|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964181|NCT03945292|581255674|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964182|NCT03945292|581255675|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964183|NCT03945292|581255676|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964184|NCT03945292|581255669|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964185|NCT03945292|581255670|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964186|NCT03945292|581255671|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
160964187|NCT03945292|581255672|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964188|NCT03945292|581255673|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964189|NCT03945292|581255674|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964190|NCT03945292|581255675|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964191|NCT03945292|581255676|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964192|NCT03945292|581255669|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964193|NCT03945292|581255670|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964194|NCT03945292|581255671|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964195|NCT03945292|581255672|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964196|NCT03945292|581255673|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964197|NCT03945292|581255674|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964198|NCT03945292|581255675|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964199|NCT03945292|581255676|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
160964200|NCT02684006|581255677|FG000|Overall Study|Other|18|||
160964201|NCT02684006|581255678|FG001|Overall Study|Other|6|||
160964202|NCT02684006|581255677|FG000|Overall Study|Protocol Violation|2|||
160964203|NCT02684006|581255678|FG001|Overall Study|Protocol Violation|1|||
160964204|NCT02684006|581255677|FG000|Overall Study|Non-compliance with study drug|1|||
160964205|NCT02684006|581255678|FG001|Overall Study|Non-compliance with study drug|1|||
160964206|NCT02684006|581255677|FG000|Overall Study|No longer met eligibility criteria|6|||
160964207|NCT02684006|581255678|FG001|Overall Study|No longer met eligibility criteria|2|||
160964208|NCT02684006|581255677|FG000|Overall Study|Lost to Follow-up|0|||
160964209|NCT02684006|581255678|FG001|Overall Study|Lost to Follow-up|1|||
160964210|NCT02684006|581255677|FG000|Overall Study|Death|25|||
160964211|NCT02684006|581255678|FG001|Overall Study|Death|22|||
160964212|NCT02684006|581255677|FG000|Overall Study|Global deterioration of health status|18|||
160964213|NCT02684006|581255678|FG001|Overall Study|Global deterioration of health status|20|||
160964214|NCT02684006|581255677|FG000|Overall Study|Physician Decision|15|||
160964215|NCT02684006|581255678|FG001|Overall Study|Physician Decision|8|||
160964216|NCT02684006|581255677|FG000|Overall Study|Adverse Event|86|||
160964217|NCT02684006|581255678|FG001|Overall Study|Adverse Event|65|||
160964218|NCT02684006|581255677|FG000|Overall Study|Withdrawal by Subject|29|||
160964219|NCT02684006|581255678|FG001|Overall Study|Withdrawal by Subject|43|||
160964220|NCT02684006|581255677|FG000|Overall Study|Progressive disease|236|||
160964221|NCT02684006|581255678|FG001|Overall Study|Progressive disease|266|||
160964222|NCT02684006|581255677|FG000|Overall Study|Participation terminated by sponsor|6|||
160964223|NCT02684006|581255678|FG001|Overall Study|Participation terminated by sponsor|9|||
160964224|NCT04642898|581255679|FG000|Overall Study|Withdrawal by Subject|2|||
160964225|NCT04642898|581255680|FG001|Overall Study|Withdrawal by Subject|4|||
160964226|NCT04642898|581255681|FG002|Overall Study|Withdrawal by Subject|4|||
160964227|NCT04642898|581255682|FG003|Overall Study|Withdrawal by Subject|6|||
160964228|NCT04642898|581255683|FG004|Overall Study|Withdrawal by Subject|2|||
160964229|NCT04642898|581255684|FG005|Overall Study|Withdrawal by Subject|6|||
160964230|NCT04642898|581255679|FG000|Overall Study|Lost to Follow-up|0|||
160964231|NCT04642898|581255680|FG001|Overall Study|Lost to Follow-up|0|||
160964232|NCT04642898|581255681|FG002|Overall Study|Lost to Follow-up|0|||
160964233|NCT04642898|581255682|FG003|Overall Study|Lost to Follow-up|2|||
160964234|NCT04642898|581255683|FG004|Overall Study|Lost to Follow-up|0|||
160964235|NCT04642898|581255684|FG005|Overall Study|Lost to Follow-up|1|||
160964236|NCT04642898|581255679|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
160964237|NCT04642898|581255680|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
161002400|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002401|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002402|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002403|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002404|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
161002405|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002406|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002407|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002408|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002409|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
161002410|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
161002411|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
161002412|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002413|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002414|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002415|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002416|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002417|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
161002418|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
161002419|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
161002420|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
161002421|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
161002422|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
161002423|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
161002424|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
161002425|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
161002426|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
161002427|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
160964238|NCT04642898|581255681|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
160964239|NCT04642898|581255682|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
160964240|NCT04642898|581255683|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
160964241|NCT04642898|581255684|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
160964242|NCT04642898|581255679|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
160964243|NCT04642898|581255680|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
160964244|NCT04642898|581255681|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
160964245|NCT04642898|581255682|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
160964246|NCT04642898|581255683|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
160964247|NCT04642898|581255684|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
160964248|NCT04495179|581255685|FG000|Overall Study|Lost to Follow-up|0|||
160964249|NCT04495179|581255686|FG001|Overall Study|Lost to Follow-up|1|||
160964250|NCT04495179|581255685|FG000|Overall Study|Withdrawal by Subject|2|||
160964251|NCT04495179|581255686|FG001|Overall Study|Withdrawal by Subject|4|||
160964252|NCT04495179|581255685|FG000|Overall Study|Study terminated by sponsor|0|||
160964253|NCT04495179|581255686|FG001|Overall Study|Study terminated by sponsor|18|||
160964254|NCT04495179|581255685|FG000|Overall Study|Death|0|||
160964255|NCT04495179|581255686|FG001|Overall Study|Death|4|||
160964256|NCT04495179|581255685|FG000|Overall Study|Adverse Event|0|||
160964257|NCT04495179|581255686|FG001|Overall Study|Adverse Event|1|||
160964258|NCT04280562|581255687|FG000|Study|Adverse Event|2|||
160964259|NCT04280562|581255688|FG001|Study|Adverse Event|0|||
160964260|NCT04280562|581255687|FG000|Study|Lost to Follow-up|3|||
160964261|NCT04280562|581255688|FG001|Study|Lost to Follow-up|3|||
160964262|NCT00946296|581255689|FG000|Overall Study|Physician Decision|3|||
160964263|NCT00946296|581255690|FG001|Overall Study|Physician Decision|0|||
160964264|NCT03434678|581255693|FG000|Overall Study|Withdrawal by Subject|13|||
160964265|NCT03434678|581255694|FG001|Overall Study|Withdrawal by Subject|13|||
160964266|NCT03434678|581255693|FG000|Overall Study|Found to be ineligible post randomization|2|||
160964267|NCT03434678|581255694|FG001|Overall Study|Found to be ineligible post randomization|1|||
161002428|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
161002429|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
161002430|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002431|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002432|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
161002433|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
160964268|NCT01368965|581255698|FG000|Overall Study|Lost to Follow-up|12|||
160964269|NCT06060457|581255699|FG000|Overall Study|Adverse Event|1|||
160964270|NCT06060457|581255700|FG001|Overall Study|Adverse Event|1|||
160964271|NCT06060457|581255699|FG000|Overall Study|Death|2|||
160964272|NCT06060457|581255700|FG001|Overall Study|Death|2|||
160458319|NCT04707768|579409149|FG000|Overall Study|Transplant|4|||
160458320|NCT04707768|579409150|FG001|Overall Study|Transplant|4|||
160458321|NCT04707768|579409151|FG002|Overall Study|Transplant|8|||
160458322|NCT04707768|579409149|FG000|Overall Study|Other|9|||
160458323|NCT04707768|579409150|FG001|Overall Study|Other|5|||
160458324|NCT04707768|579409151|FG002|Overall Study|Other|2|||
160964273|NCT06060457|581255699|FG000|Overall Study|Lost to Follow-up|17|||
160964274|NCT06060457|581255700|FG001|Overall Study|Lost to Follow-up|19|||
160964275|NCT06060457|581255699|FG000|Overall Study|Physician Decision|0|||
160964276|NCT06060457|581255700|FG001|Overall Study|Physician Decision|1|||
160964277|NCT06060457|581255699|FG000|Overall Study|Protocol Violation|1|||
160964278|NCT06060457|581255700|FG001|Overall Study|Protocol Violation|1|||
160964279|NCT06060457|581255699|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
160964280|NCT06060457|581255700|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
160964281|NCT06060457|581255699|FG000|Overall Study|Withdrawal by Subject|12|||
160964282|NCT06060457|581255700|FG001|Overall Study|Withdrawal by Subject|15|||
160964283|NCT06060457|581255699|FG000|Overall Study|Other Than Specified|2|||
160964284|NCT06060457|581255700|FG001|Overall Study|Other Than Specified|1|||
160964285|NCT02061202|581255701|FG000|Overall Study|Lost to Follow-up|1|||
160964286|NCT02061202|581255702|FG001|Overall Study|Lost to Follow-up|1|||
160964287|NCT00162370|581255703|FG000|Efficacy Population|Lost to Follow-up|51|||
160964288|NCT00569582|581255714|FG000|Overall Study|Withdrawal by Subject|5|||
160964289|NCT00569582|581255714|FG000|Overall Study|Death|2|||
160964290|NCT00569582|581255714|FG000|Overall Study|Adverse Event|7|||
160964291|NCT00569582|581255714|FG000|Overall Study|Subject was too ill to travel.|1|||
160964292|NCT00569582|581255714|FG000|Overall Study|Subject was non-compliant.|1|||
160964293|NCT04559568|581255718|FG000|Overall Study|Physician Decision|0|||
160964294|NCT04559568|581255719|FG001|Overall Study|Physician Decision|0|||
160964295|NCT04559568|581255720|FG002|Overall Study|Physician Decision|0|||
160964296|NCT04559568|581255721|FG003|Overall Study|Physician Decision|0|||
160964297|NCT04559568|581255722|FG004|Overall Study|Physician Decision|0|||
160964298|NCT04559568|581255723|FG005|Overall Study|Physician Decision|0|||
160964299|NCT04559568|581255724|FG006|Overall Study|Physician Decision|0|||
160964300|NCT04559568|581255725|FG007|Overall Study|Physician Decision|0|||
160964301|NCT04559568|581255726|FG008|Overall Study|Physician Decision|0|||
160964302|NCT04559568|581255727|FG009|Overall Study|Physician Decision|1|||
160964303|NCT04559568|581255728|FG010|Overall Study|Physician Decision|0|||
160964304|NCT04559568|581255718|FG000|Overall Study|Withdrawal by Subject|0|||
160964305|NCT04559568|581255719|FG001|Overall Study|Withdrawal by Subject|0|||
160964306|NCT04559568|581255720|FG002|Overall Study|Withdrawal by Subject|0|||
160964307|NCT04559568|581255721|FG003|Overall Study|Withdrawal by Subject|0|||
160964308|NCT04559568|581255722|FG004|Overall Study|Withdrawal by Subject|0|||
160964309|NCT04559568|581255723|FG005|Overall Study|Withdrawal by Subject|0|||
160964310|NCT04559568|581255724|FG006|Overall Study|Withdrawal by Subject|0|||
160964311|NCT04559568|581255725|FG007|Overall Study|Withdrawal by Subject|0|||
160964312|NCT04559568|581255726|FG008|Overall Study|Withdrawal by Subject|0|||
160964313|NCT04559568|581255727|FG009|Overall Study|Withdrawal by Subject|0|||
160964314|NCT04559568|581255728|FG010|Overall Study|Withdrawal by Subject|1|||
160964315|NCT04085328|581255730|FG000|Overall Study|Witihdrew Consent|16|||
160964316|NCT04085328|581255731|FG001|Overall Study|Witihdrew Consent|16|||
160964317|NCT04085328|581255730|FG000|Overall Study|Adverse Event|8|||
160964318|NCT04085328|581255731|FG001|Overall Study|Adverse Event|7|||
160964319|NCT04085328|581255730|FG000|Overall Study|Lost to Follow-up|7|||
160964320|NCT04085328|581255731|FG001|Overall Study|Lost to Follow-up|2|||
160964321|NCT04085328|581255730|FG000|Overall Study|Physician Decision|0|||
160964322|NCT04085328|581255731|FG001|Overall Study|Physician Decision|1|||
160964323|NCT04085328|581255730|FG000|Overall Study|Pregnancy|0|||
160964324|NCT04085328|581255731|FG001|Overall Study|Pregnancy|1|||
160964325|NCT04085328|581255730|FG000|Overall Study|Reasons Related to COVID-19|5|||
160964326|NCT04085328|581255731|FG001|Overall Study|Reasons Related to COVID-19|8|||
160964327|NCT04085328|581255730|FG000|Overall Study|Did not meet inclusion criteria|1|||
160964328|NCT04085328|581255731|FG001|Overall Study|Did not meet inclusion criteria|1|||
160964329|NCT04085328|581255730|FG000|Overall Study|Early termination|1|||
160964330|NCT04085328|581255731|FG001|Overall Study|Early termination|0|||
160964331|NCT01422408|581255732|FG000|Overall Study|Adverse Event|1|||
160458325|NCT04490109|579409152|FG000|Overall Study|Lost to Follow-up|3|||
160458326|NCT04490109|579409153|FG001|Overall Study|Lost to Follow-up|10|||
160458327|NCT04490109|579409154|FG002|Overall Study|Lost to Follow-up|4|||
160458328|NCT04490109|579409152|FG000|Overall Study|Withdrawal by Subject|8|||
160458329|NCT04490109|579409153|FG001|Overall Study|Withdrawal by Subject|6|||
160458330|NCT04490109|579409154|FG002|Overall Study|Withdrawal by Subject|9|||
160458331|NCT04490109|579409152|FG000|Overall Study|Physician Decision|0|||
160458332|NCT04490109|579409153|FG001|Overall Study|Physician Decision|2|||
160964332|NCT01422408|581255732|FG000|Overall Study|Withdrawal by Subject|3|||
160964333|NCT00724152|581255736|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
160458333|NCT04490109|579409154|FG002|Overall Study|Physician Decision|3|||
160458334|NCT04490109|579409152|FG000|Overall Study|Adverse Event|2|||
160458335|NCT04490109|579409153|FG001|Overall Study|Adverse Event|1|||
160964334|NCT00724152|581255737|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
160585016|NCT02052778|579861892|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585017|NCT02052778|579861893|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160964335|NCT00724152|581255738|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
160964336|NCT00724152|581255736|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
160964337|NCT00724152|581255737|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
160964338|NCT00724152|581255738|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
160964339|NCT01328080|581255739|FG000|Overall Study|Lost to Follow-up|5|||
160964340|NCT03266770|581255740|FG000|Overall Study|Physician Decision|3|||
160964341|NCT03266770|581255740|FG000|Overall Study|Insufficient study supplies|1|||
160964342|NCT03266770|581255740|FG000|Overall Study|Adverse Event|1|||
160964343|NCT04274894|581255741|FG000|Overall Study|Adverse Event|7|||
160964344|NCT04274894|581255741|FG000|Overall Study|Withdrew consent|5|||
160964345|NCT04274894|581255741|FG000|Overall Study|Lost to Follow-up|9|||
160964346|NCT04274894|581255741|FG000|Overall Study|COVID-19 infection|1|||
160964347|NCT04274894|581255741|FG000|Overall Study|Other, not specified|20|||
160964348|NCT01936857|581255742|FG000|Overall Study|Sent to prison or 06 center|11|||
160964349|NCT01936857|581255743|FG001|Overall Study|Sent to prison or 06 center|12|||
160964350|NCT01936857|581255742|FG000|Overall Study|Lost to Follow-up|10|||
160964351|NCT01936857|581255743|FG001|Overall Study|Lost to Follow-up|7|||
160964352|NCT01936857|581255742|FG000|Overall Study|Death|7|||
160964353|NCT01936857|581255743|FG001|Overall Study|Death|3|||
160964354|NCT01936857|581255742|FG000|Overall Study|Moved|2|||
160964355|NCT01936857|581255743|FG001|Overall Study|Moved|1|||
160964356|NCT01936857|581255742|FG000|Overall Study|Withdrawal by Subject|1|||
160964357|NCT01936857|581255743|FG001|Overall Study|Withdrawal by Subject|0|||
160964358|NCT01936857|581255742|FG000|Overall Study|Side effect of medication|1|||
160964359|NCT01936857|581255743|FG001|Overall Study|Side effect of medication|0|||
160964360|NCT01936857|581255742|FG000|Overall Study|Other|2|||
160964361|NCT01936857|581255743|FG001|Overall Study|Other|2|||
160964362|NCT04510675|581255744|FG000|Overall Study|Withdrawal by Subject|5|||
160964363|NCT01499082|581255747|FG000|Overall Study|Randomized but not Treated|0|||
160964364|NCT01499082|581255748|FG001|Overall Study|Randomized but not Treated|1|||
160964365|NCT01499082|581255747|FG000|Overall Study|Adverse Event|12|||
160964366|NCT01499082|581255748|FG001|Overall Study|Adverse Event|16|||
160964367|NCT01499082|581255747|FG000|Overall Study|Lack of Efficacy|1|||
160964368|NCT01499082|581255748|FG001|Overall Study|Lack of Efficacy|1|||
160964369|NCT01499082|581255747|FG000|Overall Study|Protocol Violation|6|||
160964370|NCT01499082|581255748|FG001|Overall Study|Protocol Violation|8|||
160964371|NCT01499082|581255747|FG000|Overall Study|Diverse Reasons|18|||
160964372|NCT01499082|581255748|FG001|Overall Study|Diverse Reasons|14|||
160964373|NCT01499082|581255747|FG000|Overall Study|Site Closure for Noncompliance|5|||
160964374|NCT01499082|581255748|FG001|Overall Study|Site Closure for Noncompliance|2|||
160964375|NCT01499082|581255747|FG000|Overall Study|Hypoglycemia|2|||
160964376|NCT01499082|581255748|FG001|Overall Study|Hypoglycemia|3|||
160964377|NCT01499082|581255747|FG000|Overall Study|Lost to Follow-up|1|||
160964378|NCT01499082|581255748|FG001|Overall Study|Lost to Follow-up|3|||
160964379|NCT01218126|581255749|FG000|Overall Study|Adverse Event|8|||
160964380|NCT01218126|581255750|FG001|Overall Study|Adverse Event|10|||
160964381|NCT01218126|581255751|FG002|Overall Study|Adverse Event|12|||
160964382|NCT01218126|581255752|FG003|Overall Study|Adverse Event|16|||
160964383|NCT01218126|581255749|FG000|Overall Study|Lack of Efficacy|7|||
160964384|NCT01218126|581255750|FG001|Overall Study|Lack of Efficacy|2|||
160964385|NCT01218126|581255751|FG002|Overall Study|Lack of Efficacy|2|||
160964386|NCT01218126|581255752|FG003|Overall Study|Lack of Efficacy|6|||
160964387|NCT01218126|581255749|FG000|Overall Study|Protocol Violation|5|||
160964388|NCT01218126|581255750|FG001|Overall Study|Protocol Violation|2|||
160964389|NCT01218126|581255751|FG002|Overall Study|Protocol Violation|2|||
160964390|NCT01218126|581255752|FG003|Overall Study|Protocol Violation|3|||
160964391|NCT01218126|581255749|FG000|Overall Study|Protocol-defined stopping criteria|1|||
160964392|NCT01218126|581255750|FG001|Overall Study|Protocol-defined stopping criteria|1|||
160964393|NCT01218126|581255751|FG002|Overall Study|Protocol-defined stopping criteria|0|||
160964394|NCT01218126|581255752|FG003|Overall Study|Protocol-defined stopping criteria|0|||
160964395|NCT01218126|581255749|FG000|Overall Study|Lost to Follow-up|0|||
160964396|NCT01218126|581255750|FG001|Overall Study|Lost to Follow-up|0|||
160964397|NCT01218126|581255751|FG002|Overall Study|Lost to Follow-up|0|||
160964398|NCT01218126|581255752|FG003|Overall Study|Lost to Follow-up|2|||
160964399|NCT01218126|581255749|FG000|Overall Study|Physician Decision|1|||
160964400|NCT01218126|581255750|FG001|Overall Study|Physician Decision|2|||
160964401|NCT01218126|581255751|FG002|Overall Study|Physician Decision|4|||
160964402|NCT01218126|581255752|FG003|Overall Study|Physician Decision|2|||
160964403|NCT01218126|581255749|FG000|Overall Study|Withdrawal by Subject|2|||
160964404|NCT01218126|581255750|FG001|Overall Study|Withdrawal by Subject|5|||
160964405|NCT01218126|581255751|FG002|Overall Study|Withdrawal by Subject|4|||
160964406|NCT01218126|581255752|FG003|Overall Study|Withdrawal by Subject|6|||
160964407|NCT05380947|581255753|FG000|Washout Period 1|Not attend visit|1|||
160964408|NCT05380947|581255754|FG001|Washout Period 1|Not attend visit|0|||
160964409|NCT05380947|581255755|FG002|Washout Period 1|Not attend visit|0|||
160964410|NCT05380947|581255756|FG003|Washout Period 1|Not attend visit|0|||
160964411|NCT05380947|581255753|FG000|Washout Period 2|Adverse Event|1|||
160964412|NCT05380947|581255754|FG001|Washout Period 2|Adverse Event|0|||
160964413|NCT05380947|581255755|FG002|Washout Period 2|Adverse Event|0|||
160964414|NCT05380947|581255756|FG003|Washout Period 2|Adverse Event|0|||
160964415|NCT05380947|581255753|FG000|Washout Period 3|Adverse Event|0|||
160964416|NCT05380947|581255754|FG001|Washout Period 3|Adverse Event|1|||
160964417|NCT05380947|581255755|FG002|Washout Period 3|Adverse Event|0|||
160964418|NCT05380947|581255756|FG003|Washout Period 3|Adverse Event|0|||
160964419|NCT05380947|581255753|FG000|Washout Period 3|Not attend visit|0|||
160964420|NCT05380947|581255754|FG001|Washout Period 3|Not attend visit|1|||
160964421|NCT05380947|581255755|FG002|Washout Period 3|Not attend visit|0|||
160964422|NCT05380947|581255756|FG003|Washout Period 3|Not attend visit|1|||
160964423|NCT01563536|581255757|FG000|Overall Study|Withdrawal by Subject|0|||
160964424|NCT01563536|581255758|FG001|Overall Study|Withdrawal by Subject|2|||
160964425|NCT01563536|581255757|FG000|Overall Study|Lost to Follow-up|1|||
160964426|NCT01563536|581255758|FG001|Overall Study|Lost to Follow-up|0|||
160964427|NCT01860703|581255759|FG000|Overall Study|Adverse Event|1|||
160964428|NCT01860703|581255760|FG001|Overall Study|Adverse Event|4|||
160964429|NCT01860703|581255761|FG002|Overall Study|Adverse Event|0|||
160964430|NCT01860703|581255762|FG003|Overall Study|Adverse Event|2|||
160964431|NCT01860703|581255759|FG000|Overall Study|Withdrawal by Subject|0|||
160964432|NCT01860703|581255760|FG001|Overall Study|Withdrawal by Subject|1|||
160964433|NCT01860703|581255761|FG002|Overall Study|Withdrawal by Subject|0|||
160964434|NCT01860703|581255762|FG003|Overall Study|Withdrawal by Subject|0|||
160964435|NCT01860703|581255759|FG000|Overall Study|Personal reason|1|||
160964436|NCT01860703|581255760|FG001|Overall Study|Personal reason|0|||
160964437|NCT01860703|581255761|FG002|Overall Study|Personal reason|1|||
160964438|NCT01860703|581255762|FG003|Overall Study|Personal reason|0|||
160964439|NCT06213701|581255766|FG000|Overall Study|Withdrawal by Subject|2|||
160964440|NCT06213701|581255767|FG001|Overall Study|Withdrawal by Subject|1|||
160964441|NCT06213701|581255768|FG002|Overall Study|Withdrawal by Subject|0|||
160964442|NCT00538590|581255769|FG000|Overall Study|Death|1|||
160964443|NCT00538590|581255770|FG001|Overall Study|Death|0|||
160964444|NCT03184792|581255775|FG000|Overall Study|Pandemic|2|||
160964445|NCT03184792|581255776|FG001|Overall Study|Pandemic|2|||
160964446|NCT00313820|581255777|FG000|Assigned to Treatment|Other|1|||
160964447|NCT00313820|581255778|FG001|Assigned to Treatment|Other|0|||
160964448|NCT00313820|581255777|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
160964449|NCT00313820|581255778|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
160964450|NCT00313820|581255777|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
160964451|NCT00313820|581255778|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
160964452|NCT00313820|581255777|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
160964453|NCT00313820|581255778|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
160964454|NCT00313820|581255777|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
160964455|NCT00313820|581255778|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
160964456|NCT00313820|581255777|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
160964457|NCT00313820|581255778|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
160964458|NCT02453685|581255779|FG000|Overall Study|Adverse Event|0|||
160964459|NCT02453685|581255780|FG001|Overall Study|Adverse Event|1|||
160964460|NCT02453685|581255779|FG000|Overall Study|Protocol Violation|7|||
160964461|NCT02453685|581255780|FG001|Overall Study|Protocol Violation|4|||
160964462|NCT02453685|581255779|FG000|Overall Study|Lost to Follow-up|0|||
160964463|NCT02453685|581255780|FG001|Overall Study|Lost to Follow-up|1|||
160964464|NCT02453685|581255779|FG000|Overall Study|Withdrawal by Subject|8|||
160964465|NCT02453685|581255780|FG001|Overall Study|Withdrawal by Subject|4|||
160964466|NCT02453685|581255779|FG000|Overall Study|Unclassified|4|||
160964467|NCT02453685|581255780|FG001|Overall Study|Unclassified|2|||
160964468|NCT02778100|581255781|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
160964469|NCT02778100|581255782|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
160964470|NCT01515748|581255783|FG000|Overall Study|Withdrawal by Subject|32|||
160964471|NCT01515748|581255784|FG001|Overall Study|Withdrawal by Subject|41|||
160964472|NCT01515748|581255783|FG000|Overall Study|Lost to Follow-up|2|||
160964473|NCT01515748|581255784|FG001|Overall Study|Lost to Follow-up|4|||
160964474|NCT01515748|581255783|FG000|Overall Study|Other than specified above|5|||
160964475|NCT01515748|581255784|FG001|Overall Study|Other than specified above|10|||
160964476|NCT05809596|581255787|FG000|Overall Study|Death|16|||
160964477|NCT05809596|581255787|FG000|Overall Study|Withdrawal by Subject|4|||
160964478|NCT05809596|581255787|FG000|Overall Study|Physician Decision|1|||
160964479|NCT05809596|581255787|FG000|Overall Study|Missed Visit|2|||
160964480|NCT05809596|581255787|FG000|Overall Study|Other|3|||
160964481|NCT03770494|581255788|FG000|Overall Study|Lost to Follow-up|0|||
160964482|NCT03770494|581255789|FG001|Overall Study|Lost to Follow-up|0|||
160964483|NCT03770494|581255790|FG002|Overall Study|Lost to Follow-up|1|||
160964484|NCT03770494|581255791|FG003|Overall Study|Lost to Follow-up|1|||
160964485|NCT03770494|581255792|FG004|Overall Study|Lost to Follow-up|1|||
160964486|NCT03770494|581255793|FG005|Overall Study|Lost to Follow-up|0|||
160964487|NCT03770494|581255794|FG006|Overall Study|Lost to Follow-up|0|||
160964488|NCT03770494|581255795|FG007|Overall Study|Lost to Follow-up|0|||
161002434|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002435|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002436|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002437|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
161002438|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002439|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002440|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002441|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002442|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002443|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002444|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002445|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002446|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002447|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002448|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002449|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002450|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
160964489|NCT03770494|581255796|FG008|Overall Study|Lost to Follow-up|0|||
160964490|NCT03770494|581255797|FG009|Overall Study|Lost to Follow-up|0|||
160964491|NCT03770494|581255798|FG010|Overall Study|Lost to Follow-up|0|||
160964492|NCT03770494|581255799|FG011|Overall Study|Lost to Follow-up|0|||
160964493|NCT03770494|581255800|FG012|Overall Study|Lost to Follow-up|0|||
160964494|NCT03770494|581255801|FG013|Overall Study|Lost to Follow-up|0|||
160964495|NCT03770494|581255788|FG000|Overall Study|Study terminated by sponsor|1|||
160964496|NCT03770494|581255789|FG001|Overall Study|Study terminated by sponsor|2|||
160964497|NCT03770494|581255790|FG002|Overall Study|Study terminated by sponsor|1|||
160964498|NCT03770494|581255791|FG003|Overall Study|Study terminated by sponsor|1|||
160964499|NCT03770494|581255792|FG004|Overall Study|Study terminated by sponsor|1|||
160964500|NCT03770494|581255793|FG005|Overall Study|Study terminated by sponsor|2|||
160964501|NCT03770494|581255794|FG006|Overall Study|Study terminated by sponsor|1|||
160964502|NCT03770494|581255795|FG007|Overall Study|Study terminated by sponsor|2|||
160964503|NCT03770494|581255796|FG008|Overall Study|Study terminated by sponsor|1|||
160964504|NCT03770494|581255797|FG009|Overall Study|Study terminated by sponsor|2|||
160964505|NCT03770494|581255798|FG010|Overall Study|Study terminated by sponsor|1|||
160964506|NCT03770494|581255799|FG011|Overall Study|Study terminated by sponsor|2|||
160964507|NCT03770494|581255800|FG012|Overall Study|Study terminated by sponsor|0|||
160964508|NCT03770494|581255801|FG013|Overall Study|Study terminated by sponsor|0|||
160964509|NCT03770494|581255788|FG000|Overall Study|Withdrawal by Subject|1|||
160964510|NCT03770494|581255789|FG001|Overall Study|Withdrawal by Subject|1|||
160964511|NCT03770494|581255790|FG002|Overall Study|Withdrawal by Subject|0|||
160964512|NCT03770494|581255791|FG003|Overall Study|Withdrawal by Subject|0|||
160964513|NCT03770494|581255792|FG004|Overall Study|Withdrawal by Subject|2|||
160964514|NCT03770494|581255793|FG005|Overall Study|Withdrawal by Subject|2|||
160964515|NCT03770494|581255794|FG006|Overall Study|Withdrawal by Subject|2|||
160964516|NCT03770494|581255795|FG007|Overall Study|Withdrawal by Subject|0|||
160964517|NCT03770494|581255796|FG008|Overall Study|Withdrawal by Subject|2|||
160964518|NCT03770494|581255797|FG009|Overall Study|Withdrawal by Subject|3|||
160964519|NCT03770494|581255798|FG010|Overall Study|Withdrawal by Subject|1|||
160964520|NCT03770494|581255799|FG011|Overall Study|Withdrawal by Subject|0|||
160964521|NCT03770494|581255800|FG012|Overall Study|Withdrawal by Subject|0|||
160964522|NCT03770494|581255801|FG013|Overall Study|Withdrawal by Subject|0|||
160964523|NCT00553501|581257168|FG000|Overall Study|Adverse Event|2|||
160964524|NCT00553501|581257168|FG000|Overall Study|Death|1|||
160964525|NCT00553501|581257168|FG000|Overall Study|Progression|1|||
160964526|NCT00949715|581257171|FG000|Overall Study|Physician Decision|1|||
160964527|NCT00949715|581257172|FG001|Overall Study|Physician Decision|0|||
160964528|NCT00949715|581257171|FG000|Overall Study|Lost to Follow-up|1|||
160964529|NCT00949715|581257172|FG001|Overall Study|Lost to Follow-up|0|||
160964530|NCT00949715|581257171|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
161002451|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002452|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
160964531|NCT00949715|581257172|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
160964532|NCT00840801|581257176|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
160964533|NCT00840801|581257177|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
160585018|NCT02052778|579861894|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160964534|NCT00840801|581257178|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
160964535|NCT00840801|581257176|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
160964536|NCT00840801|581257177|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
160964537|NCT00840801|581257178|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
160964538|NCT00840801|581257176|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
160964539|NCT00840801|581257177|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
160964540|NCT00840801|581257178|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
161002453|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
161002454|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
161002455|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
161002456|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002457|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002458|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002459|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002460|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002461|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002462|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002463|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002464|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002465|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
161002466|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
161002467|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
161002468|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002469|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002470|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002471|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002472|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002473|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002474|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002475|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002476|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002477|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002478|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
161002479|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
161002480|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
161002481|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
161002482|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002483|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002484|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002485|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002486|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002487|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002488|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002489|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002490|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002491|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002492|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
161002493|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002494|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
161002495|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002496|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002497|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
160964541|NCT00840801|581257176|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
160964542|NCT00840801|581257177|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
160964543|NCT00840801|581257178|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
160964544|NCT00335452|581257179|FG000|Overall Study|Death|156|||
160964545|NCT00335452|581257180|FG001|Overall Study|Death|144|||
160964546|NCT00335452|581257181|FG002|Overall Study|Death|158|||
160964547|NCT00335452|581257182|FG003|Overall Study|Death|129|||
160964548|NCT00335452|581257179|FG000|Overall Study|Lost to Follow-up|2|||
160964549|NCT00335452|581257180|FG001|Overall Study|Lost to Follow-up|3|||
160964550|NCT00335452|581257181|FG002|Overall Study|Lost to Follow-up|1|||
160964551|NCT00335452|581257182|FG003|Overall Study|Lost to Follow-up|2|||
160964552|NCT02421666|581257185|FG000|6-month Follow-up|Lost to Follow-up|8|||
160964553|NCT02421666|581257186|FG001|6-month Follow-up|Lost to Follow-up|7|||
160964554|NCT02421666|581257185|FG000|6-month Follow-up|Withdrawal by Subject|5|||
160964555|NCT02421666|581257186|FG001|6-month Follow-up|Withdrawal by Subject|6|||
160964556|NCT02421666|581257185|FG000|12-month Follow-up|Lost to Follow-up|5|||
160964557|NCT02421666|581257186|FG001|12-month Follow-up|Lost to Follow-up|5|||
160964558|NCT02421666|581257185|FG000|12-month Follow-up|Withdrawal by Subject|6|||
160964559|NCT02421666|581257186|FG001|12-month Follow-up|Withdrawal by Subject|11|||
160964560|NCT01078155|581257188|FG000|Overall Study|Adverse Event|7|||
160964561|NCT01078155|581257188|FG000|Overall Study|Lack of Efficacy|16|||
160964562|NCT01078155|581257188|FG000|Overall Study|Participant's Decision|6|||
160964563|NCT01078155|581257188|FG000|Overall Study|Lost to Follow-up|15|||
161002498|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002499|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002500|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
160964564|NCT01621880|581257189|FG000|Overall Study|Adverse Event|5|||
160964565|NCT01621880|581257190|FG001|Overall Study|Adverse Event|1|||
160964566|NCT01621880|581257189|FG000|Overall Study|Withdrawal by Subject|5|||
160964567|NCT01621880|581257190|FG001|Overall Study|Withdrawal by Subject|4|||
160964568|NCT04044456|581257200|FG000|Overall Study|Lost to Follow-up|4|||
160964569|NCT04044456|581257201|FG001|Overall Study|Lost to Follow-up|1|||
160964570|NCT04044456|581257200|FG000|Overall Study|Withdrawal by Subject|1|||
160964571|NCT04044456|581257201|FG001|Overall Study|Withdrawal by Subject|0|||
160964572|NCT04209725|581257211|FG000|Overall Study|Adverse Event|1|||
160964573|NCT01281644|581257214|FG000|Overall Study|Lost to Follow-up|3|||
160964574|NCT01281644|581257214|FG000|Overall Study|Withdrawal by Subject|2|||
160964575|NCT03721965|581257222|FG000|Overall Study|Death|1|||
160964576|NCT03721965|581257222|FG000|Overall Study|Study Terminated by Sponsor|1|||
160964577|NCT05103384|581257223|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
160964578|NCT02612311|581257224|FG000|Overall Study|Adverse Event|16|||
160964579|NCT02612311|581257225|FG001|Overall Study|Adverse Event|12|||
160964580|NCT02612311|581257226|FG002|Overall Study|Adverse Event|7|||
160964581|NCT02612311|581257227|FG003|Overall Study|Adverse Event|13|||
160964582|NCT02612311|581257224|FG000|Overall Study|Death|29|||
160964583|NCT02612311|581257225|FG001|Overall Study|Death|10|||
160964584|NCT02612311|581257226|FG002|Overall Study|Death|11|||
160964585|NCT02612311|581257227|FG003|Overall Study|Death|11|||
160964586|NCT02612311|581257224|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
160964587|NCT02612311|581257225|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
160964588|NCT02612311|581257226|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
160964589|NCT02612311|581257227|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
160964590|NCT02612311|581257224|FG000|Overall Study|Investigator's Decision|11|||
160964591|NCT02612311|581257225|FG001|Overall Study|Investigator's Decision|15|||
160964592|NCT02612311|581257226|FG002|Overall Study|Investigator's Decision|6|||
160964593|NCT02612311|581257227|FG003|Overall Study|Investigator's Decision|6|||
160964594|NCT02612311|581257224|FG000|Overall Study|Lack of Efficacy|0|||
160964595|NCT02612311|581257225|FG001|Overall Study|Lack of Efficacy|0|||
160964596|NCT02612311|581257226|FG002|Overall Study|Lack of Efficacy|1|||
160964597|NCT02612311|581257227|FG003|Overall Study|Lack of Efficacy|1|||
160964598|NCT02612311|581257224|FG000|Overall Study|Lost to Follow-up|2|||
160964599|NCT02612311|581257225|FG001|Overall Study|Lost to Follow-up|2|||
160964600|NCT02612311|581257226|FG002|Overall Study|Lost to Follow-up|1|||
160964601|NCT02612311|581257227|FG003|Overall Study|Lost to Follow-up|2|||
160964602|NCT02612311|581257224|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
160964603|NCT02612311|581257225|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
160964604|NCT02612311|581257226|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
160964605|NCT02612311|581257227|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
160964606|NCT02612311|581257224|FG000|Overall Study|Site Terminated by Sponsor|29|||
160964607|NCT02612311|581257225|FG001|Overall Study|Site Terminated by Sponsor|12|||
160964608|NCT02612311|581257226|FG002|Overall Study|Site Terminated by Sponsor|13|||
160964609|NCT02612311|581257227|FG003|Overall Study|Site Terminated by Sponsor|5|||
160964610|NCT02612311|581257224|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
160964611|NCT02612311|581257225|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
160964612|NCT02612311|581257226|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
160964613|NCT02612311|581257227|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
160964614|NCT02612311|581257224|FG000|Overall Study|Reason Not Specified|3|||
160964615|NCT02612311|581257225|FG001|Overall Study|Reason Not Specified|7|||
160964616|NCT02612311|581257226|FG002|Overall Study|Reason Not Specified|4|||
160964617|NCT02612311|581257227|FG003|Overall Study|Reason Not Specified|5|||
160964618|NCT02612311|581257224|FG000|Overall Study|Unknown/Missing|10|||
160964619|NCT02612311|581257225|FG001|Overall Study|Unknown/Missing|13|||
160964620|NCT02612311|581257226|FG002|Overall Study|Unknown/Missing|4|||
160964621|NCT02612311|581257227|FG003|Overall Study|Unknown/Missing|0|||
160964622|NCT02612311|581257224|FG000|Overall Study|Non-Compliance with Study|1|||
160964623|NCT02612311|581257225|FG001|Overall Study|Non-Compliance with Study|0|||
160964624|NCT02612311|581257226|FG002|Overall Study|Non-Compliance with Study|0|||
160964625|NCT02612311|581257227|FG003|Overall Study|Non-Compliance with Study|0|||
160964626|NCT05608499|581257231|FG000|Overall Study|Lack of Efficacy|1|||
160964627|NCT05608499|581257232|FG001|Overall Study|Lack of Efficacy|0|||
160964628|NCT05608499|581257231|FG000|Overall Study|Lost to Follow-up|0|||
160964629|NCT05608499|581257232|FG001|Overall Study|Lost to Follow-up|1|||
160964630|NCT00514735|581257233|FG000|Overall Study|Withdrawal by Subject|13|||
160458336|NCT04490109|579409154|FG002|Overall Study|Adverse Event|0|||
160458337|NCT04490109|579409152|FG000|Overall Study|Significant Non-Compliance|2|||
160585019|NCT02052778|579861895|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160964631|NCT00514735|581257234|FG001|Overall Study|Withdrawal by Subject|5|||
160964632|NCT00514735|581257233|FG000|Overall Study|Death|1|||
160964633|NCT00514735|581257234|FG001|Overall Study|Death|0|||
160964634|NCT00514735|581257233|FG000|Overall Study|Lost to Follow-up|0|||
160964635|NCT00514735|581257234|FG001|Overall Study|Lost to Follow-up|1|||
160964636|NCT04751942|581257238|FG000|Overall Study|Lost to Follow-up|9|||
160964637|NCT04751942|581257239|FG001|Overall Study|Lost to Follow-up|6|||
161002501|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002502|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002503|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002504|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
160458338|NCT04490109|579409153|FG001|Overall Study|Significant Non-Compliance|4|||
160458339|NCT04490109|579409154|FG002|Overall Study|Significant Non-Compliance|4|||
160458340|NCT04490109|579409152|FG000|Overall Study|Significant Clinical Event|0|||
160458341|NCT04490109|579409153|FG001|Overall Study|Significant Clinical Event|1|||
160458342|NCT04490109|579409154|FG002|Overall Study|Significant Clinical Event|0|||
160458343|NCT04490109|579409152|FG000|Overall Study|Other Reason|4|||
160458344|NCT04490109|579409153|FG001|Overall Study|Other Reason|1|||
160458345|NCT04490109|579409154|FG002|Overall Study|Other Reason|1|||
160458346|NCT03372057|579409155|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
160458347|NCT03372057|579409156|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
160458348|NCT03372057|579409157|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
160458349|NCT03372057|579409155|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
160458350|NCT03372057|579409156|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
160458351|NCT03372057|579409157|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
160458352|NCT03372057|579409155|FG000|Dose Optimization Phase|Death|16|||
160458353|NCT03372057|579409156|FG001|Dose Optimization Phase|Death|11|||
160458354|NCT03372057|579409157|FG002|Dose Optimization Phase|Death|0|||
160458355|NCT03372057|579409155|FG000|Expansion Phase|Withdrawal by Subject|0|||
160458356|NCT03372057|579409156|FG001|Expansion Phase|Withdrawal by Subject|0|||
160458357|NCT03372057|579409157|FG002|Expansion Phase|Withdrawal by Subject|4|||
160458358|NCT03372057|579409155|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
160458359|NCT03372057|579409156|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
160458360|NCT03372057|579409157|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
160458361|NCT03372057|579409155|FG000|Expansion Phase|Death|0|||
160585020|NCT02052778|579861896|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585021|NCT02052778|579861897|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585022|NCT02052778|579861898|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
160585023|NCT02052778|579861876|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585024|NCT02052778|579861877|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585025|NCT02052778|579861878|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585026|NCT02052778|579861879|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160964638|NCT00045305|581257244|FG000|Overall Study|Lack of Efficacy|6|||
160964639|NCT00045305|581257244|FG000|Overall Study|Adverse Event|3|||
160964640|NCT00045305|581257244|FG000|Overall Study|Death|3|||
160964641|NCT00045305|581257244|FG000|Overall Study|site error|2|||
160964642|NCT03848403|581257245|FG000|Period 2 (Day 8)|Adverse Event|1|||
160964643|NCT03848403|581257246|FG001|Period 2 (Day 8)|Adverse Event|2|||
160964644|NCT03848403|581257247|FG002|Period 2 (Day 8)|Adverse Event|2|||
160964645|NCT03848403|581257245|FG000|Period 2 (Day 8)|Physician Decision|0|||
160964646|NCT03848403|581257246|FG001|Period 2 (Day 8)|Physician Decision|1|||
160964647|NCT03848403|581257247|FG002|Period 2 (Day 8)|Physician Decision|0|||
160964648|NCT03848403|581257245|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
160964649|NCT03848403|581257246|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
160964650|NCT03848403|581257247|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
160964651|NCT00168038|581257248|FG000|Overall Study|Adverse Event|1|||
160964652|NCT00168038|581257248|FG000|Overall Study|Therapy failure|1|||
160964653|NCT03221387|581257274|FG000|Overall Study|Lost to Follow-up|1|||
160964654|NCT03221387|581257274|FG000|Overall Study|Lung transplant|1|||
160964655|NCT00522626|581257275|FG000|Overall Study|Lost to Follow-up|7|||
160964656|NCT00803452|581257276|FG000|Overall Study|Adverse Event|0|||
160964657|NCT00803452|581257277|FG001|Overall Study|Adverse Event|2|||
160964658|NCT00803452|581257276|FG000|Overall Study|Lost to Follow-up|0|||
160964659|NCT00803452|581257277|FG001|Overall Study|Lost to Follow-up|3|||
160964660|NCT02365519|581257279|FG000|Randomized and Treated|Adverse Event|0|||
160964661|NCT02365519|581257280|FG001|Randomized and Treated|Adverse Event|1|||
160964662|NCT02365519|581257281|FG002|Randomized and Treated|Adverse Event|0|||
160964663|NCT02365519|581257279|FG000|Randomized and Treated|Withdrawal by Subject|0|||
160964664|NCT02365519|581257280|FG001|Randomized and Treated|Withdrawal by Subject|1|||
160964665|NCT02365519|581257281|FG002|Randomized and Treated|Withdrawal by Subject|1|||
160964666|NCT01971723|581257282|FG000|Overall Study|Withdrawal by Subject|1|||
160964667|NCT01971723|581257283|FG001|Overall Study|Withdrawal by Subject|1|||
160964668|NCT01971723|581257282|FG000|Overall Study|Protocol Violation|1|||
160964669|NCT01971723|581257283|FG001|Overall Study|Protocol Violation|2|||
160458362|NCT03372057|579409156|FG001|Expansion Phase|Death|0|||
160458363|NCT03372057|579409157|FG002|Expansion Phase|Death|78|||
160458364|NCT03372057|579409155|FG000|Expansion Phase|Progressive Disease|0|||
160964670|NCT03017079|581257287|FG000|Overall Study|Physician Decision|1|||
160458365|NCT03372057|579409156|FG001|Expansion Phase|Progressive Disease|0|||
160458366|NCT03372057|579409157|FG002|Expansion Phase|Progressive Disease|1|||
160458367|NCT03372057|579409155|FG000|Expansion Phase|Adverse Event|0|||
160585027|NCT02052778|579861880|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585028|NCT02052778|579861881|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585029|NCT02052778|579861882|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585030|NCT02052778|579861883|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585031|NCT02052778|579861884|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585032|NCT02052778|579861885|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160964671|NCT03017079|581257288|FG001|Overall Study|Physician Decision|1|||
160964672|NCT03017079|581257287|FG000|Overall Study|Death|3|||
160964673|NCT03017079|581257288|FG001|Overall Study|Death|2|||
160964674|NCT03017079|581257287|FG000|Overall Study|Lack of Efficacy|2|||
160964675|NCT03017079|581257288|FG001|Overall Study|Lack of Efficacy|2|||
160964676|NCT03017079|581257287|FG000|Overall Study|Protocol Violation|0|||
160964677|NCT03017079|581257288|FG001|Overall Study|Protocol Violation|1|||
160964678|NCT04120233|581257294|FG000|Overall Study|Adverse Event|0|||
160964679|NCT04120233|581257295|FG001|Overall Study|Adverse Event|0|||
160964680|NCT04120233|581257296|FG002|Overall Study|Adverse Event|0|||
160964681|NCT04120233|581257297|FG003|Overall Study|Adverse Event|0|||
160964682|NCT04120233|581257298|FG004|Overall Study|Adverse Event|1|||
160964683|NCT04120233|581257299|FG005|Overall Study|Adverse Event|0|||
160964684|NCT06223373|581257300|FG000|Overall Study|Lost to Follow-up|1|||
160964685|NCT06223373|581257301|FG001|Overall Study|Lost to Follow-up|2|||
160964686|NCT03355326|581257309|FG000|Overall Study|Protocol Violation|3|||
160964687|NCT03355326|581257310|FG001|Overall Study|Protocol Violation|3|||
160964688|NCT00608582|581257315|FG000|Overall Study|Lost to Follow-up|2|||
160964689|NCT00608582|581257316|FG001|Overall Study|Lost to Follow-up|0|||
160964690|NCT00608582|581257315|FG000|Overall Study|No Best Response in Phase 1 located|1|||
160964691|NCT00608582|581257316|FG001|Overall Study|No Best Response in Phase 1 located|1|||
160964692|NCT00608582|581257315|FG000|Overall Study|Illicit Drug Use|1|||
160964693|NCT00608582|581257316|FG001|Overall Study|Illicit Drug Use|0|||
160964694|NCT00608582|581257315|FG000|Overall Study|Early stage Design Change|0|||
160964695|NCT00608582|581257316|FG001|Overall Study|Early stage Design Change|3|||
160964696|NCT04922554|581257317|FG000|Overall Study|Adverse Event|4|||
160964697|NCT04922554|581257318|FG001|Overall Study|Adverse Event|0|||
160964698|NCT04922554|581257317|FG000|Overall Study|Withdrawal by Subject|1|||
160964699|NCT04922554|581257318|FG001|Overall Study|Withdrawal by Subject|0|||
160964700|NCT00861614|581259339|FG000|Overall Study|Disease Progression|182|||
160964701|NCT00861614|581259340|FG001|Overall Study|Disease Progression|263|||
160964702|NCT00861614|581259339|FG000|Overall Study|Study Drug Toxicity|79|||
160964703|NCT00861614|581259340|FG001|Overall Study|Study Drug Toxicity|6|||
160964704|NCT00861614|581259339|FG000|Overall Study|Death|32|||
160964705|NCT00861614|581259340|FG001|Overall Study|Death|19|||
160964706|NCT00861614|581259339|FG000|Overall Study|Adverse Event|27|||
160964707|NCT00861614|581259340|FG001|Overall Study|Adverse Event|23|||
160964708|NCT00861614|581259339|FG000|Overall Study|Withdrawal by Subject|34|||
160964709|NCT00861614|581259340|FG001|Overall Study|Withdrawal by Subject|35|||
160964710|NCT00861614|581259339|FG000|Overall Study|Other|17|||
160964711|NCT00861614|581259340|FG001|Overall Study|Other|22|||
160964712|NCT00944658|581259341|FG000|Treatment 12 Weeks|Adverse Event|0|||
160964713|NCT00944658|581259342|FG001|Treatment 12 Weeks|Adverse Event|2|||
160964714|NCT01255592|581259343|FG000|Overall Study|Adverse Event|5|||
160964715|NCT01255592|581259344|FG001|Overall Study|Adverse Event|0|||
160964716|NCT01255592|581259343|FG000|Overall Study|Withdrawal by Subject|1|||
160964717|NCT01255592|581259344|FG001|Overall Study|Withdrawal by Subject|0|||
160964718|NCT01255592|581259343|FG000|Overall Study|Other|0|||
160964719|NCT01255592|581259344|FG001|Overall Study|Other|1|||
160964720|NCT02259517|581259345|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
160964721|NCT02259517|581259346|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
160964722|NCT02259517|581259347|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
160964723|NCT02259517|581259345|FG000|Overall Study|Withdrawal by Subject|0|||
160964724|NCT02259517|581259346|FG001|Overall Study|Withdrawal by Subject|0|||
160964725|NCT02259517|581259347|FG002|Overall Study|Withdrawal by Subject|3|||
160964726|NCT01289418|581259351|FG000|Day 8 Survey|email address invalid|283|||
160964727|NCT01289418|581259351|FG000|Day 8 Survey|participants did not complete the survey|1935|||
160964728|NCT01289418|581259351|FG000|Day 29 Survey|email address invalid|283|||
160964729|NCT01289418|581259351|FG000|Day 29 Survey|participants did not complete the survey|2185|||
160964730|NCT01352585|581259352|FG000|Overall Study|Adverse Event|2|||
160964731|NCT01352585|581259353|FG001|Overall Study|Adverse Event|1|||
160964732|NCT01352585|581259352|FG000|Overall Study|Lost to Follow-up|1|||
161002505|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
160964733|NCT01352585|581259353|FG001|Overall Study|Lost to Follow-up|0|||
160964734|NCT01352585|581259352|FG000|Overall Study|Other|5|||
160964735|NCT01352585|581259353|FG001|Overall Study|Other|2|||
160964736|NCT00838682|581259356|FG000|Overall Study|Lost to Follow-up|21|||
160964737|NCT00838682|581259357|FG001|Overall Study|Lost to Follow-up|14|||
160964738|NCT00838682|581259356|FG000|Overall Study|detection of exclusion criteria|4|||
160964739|NCT00838682|581259357|FG001|Overall Study|detection of exclusion criteria|3|||
161002506|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
160458368|NCT03372057|579409156|FG001|Expansion Phase|Adverse Event|0|||
160458369|NCT03372057|579409157|FG002|Expansion Phase|Adverse Event|1|||
160458370|NCT02518048|579409158|FG000|Overall Study|Withdrawal by Subject|1|||
160458371|NCT05890105|579409159|FG000|Overall Study|Adverse Event|1|||
160585033|NCT02052778|579861886|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160964740|NCT00838682|581259356|FG000|Overall Study|Protocol Violation|0|||
160964741|NCT00838682|581259357|FG001|Overall Study|Protocol Violation|1|||
160964742|NCT00838682|581259356|FG000|Overall Study|Withdrawal by Subject|0|||
160964743|NCT00838682|581259357|FG001|Overall Study|Withdrawal by Subject|1|||
160964744|NCT05050578|581259358|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
160964745|NCT05050578|581259359|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
160964746|NCT05050578|581259358|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
160964747|NCT05050578|581259359|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
160964748|NCT05050578|581259358|FG000|Period 2, 30 Days|Protocol Violation|0|||
160964749|NCT05050578|581259359|FG001|Period 2, 30 Days|Protocol Violation|1|||
160964750|NCT02243280|581259360|FG000|Treated|Adverse Event|1|||
160964751|NCT02243280|581259361|FG001|Treated|Adverse Event|0|||
160964752|NCT02243280|581259362|FG002|Treated|Adverse Event|0|||
160964753|NCT02243280|581259363|FG003|Treated|Adverse Event|0|||
160964754|NCT02243280|581259364|FG004|Treated|Adverse Event|0|||
160964755|NCT02243280|581259365|FG005|Treated|Adverse Event|0|||
160964756|NCT02243280|581259366|FG006|Treated|Adverse Event|0|||
160964757|NCT02243280|581259367|FG007|Treated|Adverse Event|0|||
160964758|NCT02243280|581259368|FG008|Treated|Adverse Event|0|||
160964759|NCT02243280|581259369|FG009|Treated|Adverse Event|0|||
160964760|NCT02243280|581259370|FG010|Treated|Adverse Event|1|||
160964761|NCT02243280|581259360|FG000|Treated|Lost to Follow-up|0|||
160964762|NCT02243280|581259361|FG001|Treated|Lost to Follow-up|0|||
160964763|NCT02243280|581259362|FG002|Treated|Lost to Follow-up|0|||
160964764|NCT02243280|581259363|FG003|Treated|Lost to Follow-up|0|||
160964765|NCT02243280|581259364|FG004|Treated|Lost to Follow-up|0|||
160964766|NCT02243280|581259365|FG005|Treated|Lost to Follow-up|0|||
160964767|NCT02243280|581259366|FG006|Treated|Lost to Follow-up|0|||
160964768|NCT02243280|581259367|FG007|Treated|Lost to Follow-up|0|||
160964769|NCT02243280|581259368|FG008|Treated|Lost to Follow-up|1|||
160964770|NCT02243280|581259369|FG009|Treated|Lost to Follow-up|0|||
160964771|NCT02243280|581259370|FG010|Treated|Lost to Follow-up|2|||
160964772|NCT03386032|581259379|FG000|Overall Study|Lack of Efficacy|6|||
160964773|NCT03386032|581259380|FG001|Overall Study|Lack of Efficacy|2|||
160964774|NCT03386032|581259381|FG002|Overall Study|Lack of Efficacy|0|||
160964775|NCT03386032|581259379|FG000|Overall Study|Adverse Event|2|||
160964776|NCT03386032|581259380|FG001|Overall Study|Adverse Event|2|||
160964777|NCT03386032|581259381|FG002|Overall Study|Adverse Event|0|||
160964778|NCT03386032|581259379|FG000|Overall Study|Withdrawal by Subject|1|||
160964779|NCT03386032|581259380|FG001|Overall Study|Withdrawal by Subject|0|||
160964780|NCT03386032|581259381|FG002|Overall Study|Withdrawal by Subject|0|||
160964781|NCT03386032|581259379|FG000|Overall Study|Lost to Follow-up|9|||
160964782|NCT03386032|581259380|FG001|Overall Study|Lost to Follow-up|3|||
160964783|NCT03386032|581259381|FG002|Overall Study|Lost to Follow-up|0|||
160964784|NCT01807156|581259386|FG000|Overall Study|Physician Decision|1|||
160964785|NCT03928028|581259391|FG000|Overall Study|Physician Decision|9|||
160964786|NCT03928028|581259392|FG001|Overall Study|Physician Decision|6|||
160964787|NCT03928028|581259393|FG002|Overall Study|Physician Decision|3|||
160964788|NCT03928028|581259391|FG000|Overall Study|Withdrawal by Subject|12|||
160964789|NCT03928028|581259392|FG001|Overall Study|Withdrawal by Subject|3|||
160964790|NCT03928028|581259393|FG002|Overall Study|Withdrawal by Subject|3|||
160964791|NCT02710292|581259399|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
160964792|NCT02710292|581259400|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
160964793|NCT02710292|581259399|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
160964794|NCT02710292|581259400|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
160964795|NCT04525547|581259401|FG000|Overall Study|Not treated with Ofev|2|||
160964796|NCT04525547|581259401|FG000|Overall Study|Off-label use|2|||
160964797|NCT04525547|581259401|FG000|Overall Study|Lost to Follow-up|1|||
160458372|NCT05890105|579409160|FG001|Overall Study|Adverse Event|0|||
160964798|NCT03122119|581259402|FG000|Overall Study|Did not meet eligibility critria|1|||
160964799|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
160964800|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
160964801|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
160964802|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
160964803|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
160964804|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
160964805|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
160964806|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
160964807|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
160458373|NCT05890105|579409161|FG002|Overall Study|Adverse Event|0|||
160458374|NCT05890105|579409159|FG000|Overall Study|Other|1|||
160964808|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
160964809|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
160964810|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
160964811|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
160964812|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
160964813|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
160964814|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
160964815|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
160964816|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
160964817|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
160964818|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
160964819|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
160964820|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
160964821|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
160964822|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
160964823|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
160964824|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
160964825|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
160964826|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
160964827|NCT01493687|581259415|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
160964828|NCT01493687|581259416|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
160964829|NCT02364180|581259419|FG000|Overall Study|Screen Fail|1|||
160964830|NCT02323646|581259420|FG000|Treatment Course 1|Adverse Event|1|||
160964831|NCT02323646|581259421|FG001|Treatment Course 1|Adverse Event|0|||
160964832|NCT02323646|581259422|FG002|Treatment Course 1|Adverse Event|1|||
160964833|NCT02323646|581259420|FG000|Treatment Course 1|Heavy Bleeding|1|||
160964834|NCT02323646|581259421|FG001|Treatment Course 1|Heavy Bleeding|1|||
160964835|NCT02323646|581259422|FG002|Treatment Course 1|Heavy Bleeding|0|||
160964836|NCT02323646|581259420|FG000|Treatment Course 1|Lost to Follow-up|1|||
160964837|NCT02323646|581259421|FG001|Treatment Course 1|Lost to Follow-up|0|||
160964838|NCT02323646|581259422|FG002|Treatment Course 1|Lost to Follow-up|2|||
160964839|NCT02323646|581259420|FG000|Treatment Course 1|Withdrawal by Subject|0|||
160964840|NCT02323646|581259421|FG001|Treatment Course 1|Withdrawal by Subject|2|||
160964841|NCT02323646|581259422|FG002|Treatment Course 1|Withdrawal by Subject|0|||
160964842|NCT02323646|581259420|FG000|Treatment Course 2|Adverse Event|1|||
160964843|NCT02323646|581259421|FG001|Treatment Course 2|Adverse Event|0|||
160964844|NCT02323646|581259422|FG002|Treatment Course 2|Adverse Event|1|||
160964845|NCT02323646|581259420|FG000|Treatment Course 2|Lost to Follow-up|0|||
160964846|NCT02323646|581259421|FG001|Treatment Course 2|Lost to Follow-up|0|||
160964847|NCT02323646|581259422|FG002|Treatment Course 2|Lost to Follow-up|1|||
160458375|NCT05890105|579409160|FG001|Overall Study|Other|2|||
160458376|NCT05890105|579409161|FG002|Overall Study|Other|0|||
160458377|NCT04206787|579409162|FG000|Overall Study|Other than listed|2|||
160458378|NCT04206787|579409162|FG000|Overall Study|Investigator decision|1|||
160458379|NCT04206787|579409162|FG000|Overall Study|Death|25|||
160458380|NCT04206787|579409162|FG000|Overall Study|Lost to Follow-up|9|||
160458381|NCT04206787|579409162|FG000|Overall Study|Withdrawal of consent|9|||
160458382|NCT05123027|579409164|FG000|Overall Study|Lost to Follow-up|17|||
160458383|NCT05123027|579409165|FG001|Overall Study|Lost to Follow-up|22|||
160458384|NCT05123027|579409164|FG000|Overall Study|Incarceration|3|||
160458385|NCT05123027|579409165|FG001|Overall Study|Incarceration|4|||
160458386|NCT05123027|579409164|FG000|Overall Study|Death|2|||
160458387|NCT05123027|579409165|FG001|Overall Study|Death|2|||
160458388|NCT05123027|579409164|FG000|Overall Study|Other|2|||
160458389|NCT05123027|579409165|FG001|Overall Study|Other|0|||
160458390|NCT04330040|579409166|FG000|Overall Study|Other: Adverse event|5|||
160458391|NCT04330040|579409167|FG001|Overall Study|Other: Adverse event|0|||
160458392|NCT04330040|579409168|FG002|Overall Study|Other: Adverse event|0|||
160458393|NCT04330040|579409166|FG000|Overall Study|Disease progression|38|||
160458394|NCT04330040|579409167|FG001|Overall Study|Disease progression|10|||
160458395|NCT04330040|579409168|FG002|Overall Study|Disease progression|0|||
160458396|NCT04330040|579409166|FG000|Overall Study|Physician Decision|5|||
160458397|NCT04330040|579409167|FG001|Overall Study|Physician Decision|3|||
160458398|NCT04330040|579409168|FG002|Overall Study|Physician Decision|0|||
160458399|NCT04330040|579409166|FG000|Overall Study|Lost to Follow-up|1|||
160458400|NCT04330040|579409167|FG001|Overall Study|Lost to Follow-up|1|||
160458401|NCT04330040|579409168|FG002|Overall Study|Lost to Follow-up|0|||
160458402|NCT04330040|579409166|FG000|Overall Study|Death|2|||
160458403|NCT04330040|579409167|FG001|Overall Study|Death|1|||
160458404|NCT04330040|579409168|FG002|Overall Study|Death|0|||
160458405|NCT04330040|579409166|FG000|Overall Study|Withdrawal by Subject|3|||
160458406|NCT04330040|579409167|FG001|Overall Study|Withdrawal by Subject|3|||
160458407|NCT04330040|579409168|FG002|Overall Study|Withdrawal by Subject|0|||
160458408|NCT04330040|579409166|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
160458409|NCT04330040|579409167|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
160458410|NCT04330040|579409168|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
160964848|NCT02323646|581259420|FG000|Treatment Course 2|Non-compliance|0|||
160964849|NCT02323646|581259421|FG001|Treatment Course 2|Non-compliance|1|||
160964850|NCT02323646|581259422|FG002|Treatment Course 2|Non-compliance|1|||
160964851|NCT01783418|581259423|FG000|Overall Study|Withdrawal by Subject|1|||
160964852|NCT01783418|581259424|FG001|Overall Study|Withdrawal by Subject|0|||
160964853|NCT00521144|581259425|FG000|Overall Study|Not Treated|0|||
160964854|NCT00521144|581259426|FG001|Overall Study|Not Treated|0|||
160964855|NCT00521144|581259427|FG002|Overall Study|Not Treated|0|||
160964856|NCT00521144|581259428|FG003|Overall Study|Not Treated|1|||
160964857|NCT00521144|581259429|FG004|Overall Study|Not Treated|0|||
160964858|NCT00521144|581259425|FG000|Overall Study|Adverse Event|0|||
160964859|NCT00521144|581259426|FG001|Overall Study|Adverse Event|1|||
160964860|NCT00521144|581259427|FG002|Overall Study|Adverse Event|0|||
160964861|NCT00521144|581259428|FG003|Overall Study|Adverse Event|0|||
160964862|NCT00521144|581259429|FG004|Overall Study|Adverse Event|1|||
160964863|NCT00521144|581259425|FG000|Overall Study|Progressive Disease|4|||
160964864|NCT00521144|581259426|FG001|Overall Study|Progressive Disease|2|||
160964865|NCT00521144|581259427|FG002|Overall Study|Progressive Disease|2|||
160964866|NCT00521144|581259428|FG003|Overall Study|Progressive Disease|0|||
160964867|NCT00521144|581259429|FG004|Overall Study|Progressive Disease|6|||
160964868|NCT00089141|581259431|FG000|Overall Study|Termination of trial|18|||
160964869|NCT00089141|581259432|FG001|Overall Study|Termination of trial|24|||
160964870|NCT00508261|581259435|FG000|Overall Study|Other|0|||
160964871|NCT00508261|581259436|FG001|Overall Study|Other|1|||
160964872|NCT00508261|581259437|FG002|Overall Study|Other|1|||
160964873|NCT00508261|581259438|FG003|Overall Study|Other|0|||
160964874|NCT00508261|581259435|FG000|Overall Study|Serious Adverse Event|0|||
160964875|NCT00508261|581259436|FG001|Overall Study|Serious Adverse Event|1|||
160964876|NCT00508261|581259437|FG002|Overall Study|Serious Adverse Event|0|||
160964877|NCT00508261|581259438|FG003|Overall Study|Serious Adverse Event|0|||
160964878|NCT00508261|581259435|FG000|Overall Study|Withdrawal by Subject|3|||
160964879|NCT00508261|581259436|FG001|Overall Study|Withdrawal by Subject|4|||
160964880|NCT00508261|581259437|FG002|Overall Study|Withdrawal by Subject|4|||
160964881|NCT00508261|581259438|FG003|Overall Study|Withdrawal by Subject|0|||
160964882|NCT00508261|581259435|FG000|Overall Study|Migrated/ moved from study area|0|||
160964883|NCT00508261|581259436|FG001|Overall Study|Migrated/ moved from study area|1|||
160964884|NCT00508261|581259437|FG002|Overall Study|Migrated/ moved from study area|0|||
160964885|NCT00508261|581259438|FG003|Overall Study|Migrated/ moved from study area|0|||
160964886|NCT00508261|581259435|FG000|Overall Study|Lost to Follow-up|0|||
160964887|NCT00508261|581259436|FG001|Overall Study|Lost to Follow-up|1|||
160964888|NCT00508261|581259437|FG002|Overall Study|Lost to Follow-up|1|||
160964889|NCT00508261|581259438|FG003|Overall Study|Lost to Follow-up|1|||
160964890|NCT00180479|581259439|FG000|Overall Study|Death|4|||
160964891|NCT00180479|581259440|FG001|Overall Study|Death|2|||
160964892|NCT00180479|581259439|FG000|Overall Study|Lost to Follow-up|9|||
160964893|NCT00180479|581259440|FG001|Overall Study|Lost to Follow-up|7|||
160964894|NCT00180479|581259439|FG000|Overall Study|Withdrawal by Subject|3|||
160964895|NCT00180479|581259440|FG001|Overall Study|Withdrawal by Subject|3|||
160964896|NCT00180479|581259439|FG000|Overall Study|Informed consent not signed|0|||
160964897|NCT00180479|581259440|FG001|Overall Study|Informed consent not signed|1|||
160964898|NCT03315143|581259445|FG000|Overall Study|Death|240|||
160964899|NCT03315143|581259446|FG001|Overall Study|Death|246|||
160964900|NCT03315143|581259445|FG000|Overall Study|Withdrawal by Subject|57|||
160964901|NCT03315143|581259446|FG001|Overall Study|Withdrawal by Subject|68|||
160964902|NCT03315143|581259445|FG000|Overall Study|Site Terminated by Sponsor|256|||
160964903|NCT03315143|581259446|FG001|Overall Study|Site Terminated by Sponsor|282|||
160964904|NCT03315143|581259445|FG000|Overall Study|Study Terminated by Sponsor|4723|||
160964905|NCT03315143|581259446|FG001|Overall Study|Study Terminated by Sponsor|4664|||
160964906|NCT03315143|581259445|FG000|Overall Study|Reason not Specified|16|||
160964907|NCT03315143|581259446|FG001|Overall Study|Reason not Specified|32|||
160964908|NCT02459262|581259447|FG000|Overall Study|Withdrawal by Subject|0|||
160964909|NCT02459262|581259448|FG001|Overall Study|Withdrawal by Subject|0|||
160585034|NCT02052778|579861887|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585035|NCT02052778|579861888|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160964910|NCT02459262|581259449|FG002|Overall Study|Withdrawal by Subject|0|||
160964911|NCT02459262|581259450|FG003|Overall Study|Withdrawal by Subject|0|||
160964912|NCT02459262|581259451|FG004|Overall Study|Withdrawal by Subject|0|||
160964913|NCT02459262|581259452|FG005|Overall Study|Withdrawal by Subject|0|||
160964914|NCT02459262|581259453|FG006|Overall Study|Withdrawal by Subject|0|||
160964915|NCT02459262|581259454|FG007|Overall Study|Withdrawal by Subject|0|||
160964916|NCT02459262|581259455|FG008|Overall Study|Withdrawal by Subject|0|||
160964917|NCT02459262|581259456|FG009|Overall Study|Withdrawal by Subject|1|||
160964918|NCT02459262|581259457|FG010|Overall Study|Withdrawal by Subject|0|||
160964919|NCT05168579|581259458|FG000|Overall Study|Lack of Consent|1|||
160964920|NCT05168579|581259459|FG001|Overall Study|Lack of Consent|0|||
160964921|NCT05168579|581259458|FG000|Overall Study|Conflicts with time|2|||
160964922|NCT05168579|581259459|FG001|Overall Study|Conflicts with time|0|||
160964923|NCT05168579|581259458|FG000|Overall Study|Time slots were full|3|||
161002507|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002508|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002509|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002510|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002511|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002512|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002513|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002514|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002515|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002516|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002517|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
161002518|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
161002519|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
161002520|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
161002521|NCT02739035|581394592|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
161002522|NCT02739035|581394593|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
161002523|NCT02739035|581394592|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
161002524|NCT02739035|581394593|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
161002525|NCT02739035|581394592|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
161002526|NCT02739035|581394593|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
161002527|NCT02739035|581394592|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
161002528|NCT02739035|581394593|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
161002529|NCT00940992|581394596|FG000|Overall Study|Adverse Event|2|||
161002530|NCT00940992|581394597|FG001|Overall Study|Adverse Event|0|||
161002531|NCT00940992|581394598|FG002|Overall Study|Adverse Event|1|||
161002532|NCT00940992|581394596|FG000|Overall Study|subject request|2|||
161002533|NCT00940992|581394597|FG001|Overall Study|subject request|1|||
161002534|NCT00940992|581394598|FG002|Overall Study|subject request|0|||
161002535|NCT00940992|581394596|FG000|Overall Study|Lost to Follow-up|0|||
161002536|NCT00940992|581394597|FG001|Overall Study|Lost to Follow-up|1|||
161002537|NCT00940992|581394598|FG002|Overall Study|Lost to Follow-up|1|||
161002538|NCT04446117|581394599|FG000|Overall Study|No Study Treatment Given|4|||
161002539|NCT04446117|581394600|FG001|Overall Study|No Study Treatment Given|3|||
161002540|NCT04446117|581394599|FG000|Overall Study|Radiographic Disease Progression|132|||
161002541|NCT04446117|581394600|FG001|Overall Study|Radiographic Disease Progression|158|||
161002542|NCT04446117|581394599|FG000|Overall Study|Adverse Event|79|||
161002543|NCT04446117|581394600|FG001|Overall Study|Adverse Event|43|||
161002544|NCT04446117|581394599|FG000|Overall Study|Lack of Clinical Benefit|1|||
161002545|NCT04446117|581394600|FG001|Overall Study|Lack of Clinical Benefit|1|||
161002546|NCT04446117|581394599|FG000|Overall Study|Withdrawal by Subject|24|||
161002547|NCT04446117|581394600|FG001|Overall Study|Withdrawal by Subject|22|||
161002548|NCT04446117|581394599|FG000|Overall Study|Lost to Follow-up|0|||
161002549|NCT04446117|581394600|FG001|Overall Study|Lost to Follow-up|3|||
161002550|NCT04446117|581394599|FG000|Overall Study|Miscellaneous|26|||
161002551|NCT04446117|581394600|FG001|Overall Study|Miscellaneous|36|||
161002552|NCT04446117|581394599|FG000|Overall Study|Missing Data/Data not yet Received|1|||
161002553|NCT04446117|581394600|FG001|Overall Study|Missing Data/Data not yet Received|0|||
161002554|NCT00843882|581394604|FG000|Step 1|Lack of Efficacy|14|||
161002555|NCT00843882|581394605|FG001|Step 1|Lack of Efficacy|10|||
161002556|NCT00843882|581394606|FG002|Step 1|Lack of Efficacy|21|||
161002557|NCT00843882|581394604|FG000|Step 1|Adverse Event|8|||
161002558|NCT00843882|581394605|FG001|Step 1|Adverse Event|17|||
161002559|NCT00843882|581394606|FG002|Step 1|Adverse Event|20|||
161002560|NCT00843882|581394604|FG000|Step 1|Death|1|||
161002561|NCT00843882|581394605|FG001|Step 1|Death|2|||
161002562|NCT00843882|581394606|FG002|Step 1|Death|4|||
161002563|NCT00843882|581394604|FG000|Step 1|Withdrawal by Subject|6|||
161002564|NCT00843882|581394605|FG001|Step 1|Withdrawal by Subject|12|||
161002565|NCT00843882|581394606|FG002|Step 1|Withdrawal by Subject|9|||
161002566|NCT00843882|581394604|FG000|Step 1|Physician Decision|0|||
161002567|NCT00843882|581394605|FG001|Step 1|Physician Decision|5|||
161002568|NCT00843882|581394606|FG002|Step 1|Physician Decision|1|||
161002569|NCT00843882|581394604|FG000|Step 1|Patient and physician's decision|0|||
161002570|NCT00843882|581394605|FG001|Step 1|Patient and physician's decision|0|||
161002571|NCT00843882|581394606|FG002|Step 1|Patient and physician's decision|1|||
161002572|NCT00843882|581394604|FG000|Step 1|Other complicating disease|1|||
161002573|NCT00843882|581394605|FG001|Step 1|Other complicating disease|3|||
161002574|NCT00843882|581394606|FG002|Step 1|Other complicating disease|4|||
161002575|NCT00843882|581394604|FG000|Step 1|Alternative therapy|0|||
161002576|NCT00843882|581394605|FG001|Step 1|Alternative therapy|1|||
161002577|NCT00843882|581394606|FG002|Step 1|Alternative therapy|1|||
161002578|NCT00843882|581394604|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
161002579|NCT00843882|581394605|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
161002580|NCT00843882|581394606|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
161002581|NCT00843882|581394604|FG000|Step 1|Off treatment reason unknown|0|||
161002582|NCT00843882|581394605|FG001|Step 1|Off treatment reason unknown|1|||
160964924|NCT05168579|581259459|FG001|Overall Study|Time slots were full|0|||
160964925|NCT05168579|581259458|FG000|Overall Study|Lost to Follow-up|0|||
160964926|NCT05168579|581259459|FG001|Overall Study|Lost to Follow-up|15|||
160964927|NCT01242748|581259460|FG000|Overall Study|Adverse Event|10|||
160964928|NCT01242748|581259461|FG001|Overall Study|Adverse Event|5|||
160964929|NCT01242748|581259460|FG000|Overall Study|Lost to Follow-up|6|||
160964930|NCT01242748|581259461|FG001|Overall Study|Lost to Follow-up|2|||
160964931|NCT01242748|581259460|FG000|Overall Study|Physician Decision|3|||
160964932|NCT01242748|581259461|FG001|Overall Study|Physician Decision|2|||
160964933|NCT01242748|581259460|FG000|Overall Study|Protocol Violation|1|||
160964934|NCT01242748|581259461|FG001|Overall Study|Protocol Violation|0|||
160964935|NCT01242748|581259460|FG000|Overall Study|Withdrawal by Subject|10|||
160964936|NCT01242748|581259461|FG001|Overall Study|Withdrawal by Subject|2|||
160964937|NCT01242748|581259460|FG000|Overall Study|Miscellaneous reasons|8|||
160964938|NCT01242748|581259461|FG001|Overall Study|Miscellaneous reasons|3|||
160964939|NCT02736825|581259462|FG000|Overall Study|Lost to Follow-up|10|||
160964940|NCT02736825|581259463|FG001|Overall Study|Lost to Follow-up|11|||
160964941|NCT02736825|581259462|FG000|Overall Study|Early Termination|0|||
160964942|NCT02736825|581259463|FG001|Overall Study|Early Termination|1|||
160964943|NCT00790452|581259464|FG000|Overall Study|Drug supply issue|1|||
160964944|NCT00790452|581259465|FG001|Overall Study|Drug supply issue|0|||
160964945|NCT02901626|581259466|FG000|Overall Study|Lost to Follow-up|1|||
160964946|NCT02901626|581259467|FG001|Overall Study|Lost to Follow-up|1|||
160964947|NCT04082884|581259468|FG000|Overall Study|Withdrawal by Subject|1|||
160964948|NCT00387894|581259469|FG000|Overall Study|Withdrawal by Subject|1|||
160964949|NCT00659490|581259472|FG000|Overall Study|Lost to Follow-up|2|||
160964950|NCT00659490|581259473|FG001|Overall Study|Lost to Follow-up|0|||
160964951|NCT00659490|581259474|FG002|Overall Study|Lost to Follow-up|1|||
160964952|NCT00827541|581259475|FG000|Overall Study|Exitus|1|||
160964953|NCT00827541|581259476|FG001|Overall Study|Exitus|8|||
160964954|NCT00827541|581259475|FG000|Overall Study|Other|1|||
160964955|NCT00827541|581259476|FG001|Overall Study|Other|3|||
160964956|NCT00827541|581259475|FG000|Overall Study|Pathogen not susceptible|1|||
160964957|NCT00827541|581259476|FG001|Overall Study|Pathogen not susceptible|0|||
160964958|NCT00827541|581259475|FG000|Overall Study|Lack of effectiveness|1|||
160964959|NCT00827541|581259476|FG001|Overall Study|Lack of effectiveness|0|||
160964960|NCT01649232|581259477|FG000|Overall Study|Physician Decision|2|||
160964961|NCT01649232|581259478|FG001|Overall Study|Physician Decision|0|||
160964962|NCT01750879|581259479|FG000|Overall Study|Adverse Event|8|||
160964963|NCT01750879|581259480|FG001|Overall Study|Adverse Event|0|||
160964964|NCT01750879|581259479|FG000|Overall Study|Lack of Efficacy|1|||
160964965|NCT01750879|581259480|FG001|Overall Study|Lack of Efficacy|0|||
160964966|NCT01750879|581259479|FG000|Overall Study|Withdrawal by Subject|1|||
160964967|NCT01750879|581259480|FG001|Overall Study|Withdrawal by Subject|0|||
160964968|NCT01750879|581259479|FG000|Overall Study|Did not complete per protocol|0|||
160964969|NCT01750879|581259480|FG001|Overall Study|Did not complete per protocol|3|||
160964970|NCT02347657|581259481|FG000|Overall Study|Physician Decision|0|||
160964971|NCT02347657|581259482|FG001|Overall Study|Physician Decision|1|||
160964972|NCT02347657|581259481|FG000|Overall Study|Adverse Event|8|||
160964973|NCT02347657|581259482|FG001|Overall Study|Adverse Event|4|||
160964974|NCT02347657|581259481|FG000|Overall Study|Withdrawal by Subject|6|||
160964975|NCT02347657|581259482|FG001|Overall Study|Withdrawal by Subject|7|||
160964976|NCT02347657|581259481|FG000|Overall Study|Randomized but not treated|1|||
160964977|NCT02347657|581259482|FG001|Overall Study|Randomized but not treated|0|||
160964978|NCT02347657|581259481|FG000|Overall Study|Other|3|||
160964979|NCT02347657|581259482|FG001|Overall Study|Other|3|||
160964980|NCT03033225|581259489|FG000|Overall Study|Withdrawal by Subject|5|||
160964981|NCT02618967|581259490|FG000|Overall Study|Lost to Follow-up|0|||
160964982|NCT02618967|581259491|FG001|Overall Study|Lost to Follow-up|0|||
160964983|NCT02618967|581259492|FG002|Overall Study|Lost to Follow-up|1|||
160585036|NCT02052778|579861889|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585037|NCT02052778|579861890|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
160585038|NCT02052778|579861891|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
160964984|NCT02618967|581259493|FG003|Overall Study|Lost to Follow-up|0|||
160964985|NCT02618967|581259494|FG004|Overall Study|Lost to Follow-up|2|||
160964986|NCT02618967|581259495|FG005|Overall Study|Lost to Follow-up|0|||
160964987|NCT02618967|581259496|FG006|Overall Study|Lost to Follow-up|0|||
160964988|NCT02618967|581259497|FG007|Overall Study|Lost to Follow-up|0|||
160964989|NCT02618967|581259490|FG000|Overall Study|Withdrawal by Subject|1|||
160964990|NCT02618967|581259491|FG001|Overall Study|Withdrawal by Subject|0|||
160964991|NCT02618967|581259492|FG002|Overall Study|Withdrawal by Subject|0|||
160964992|NCT02618967|581259493|FG003|Overall Study|Withdrawal by Subject|0|||
160964993|NCT02618967|581259494|FG004|Overall Study|Withdrawal by Subject|0|||
160964994|NCT02618967|581259495|FG005|Overall Study|Withdrawal by Subject|0|||
160964995|NCT02618967|581259496|FG006|Overall Study|Withdrawal by Subject|0|||
160964996|NCT02618967|581259497|FG007|Overall Study|Withdrawal by Subject|0|||
160964997|NCT05614089|581259498|FG000|Overall Study|Pregnancy|5|||
160964998|NCT05614089|581259499|FG001|Overall Study|Pregnancy|2|||
161002583|NCT00843882|581394606|FG002|Step 1|Off treatment reason unknown|4|||
161002584|NCT00843882|581394604|FG000|Step 1|Never started treatment|2|||
161002585|NCT00843882|581394605|FG001|Step 1|Never started treatment|0|||
161002586|NCT00843882|581394606|FG002|Step 1|Never started treatment|0|||
161002587|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
161002588|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
161002589|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
161002590|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
161002591|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
161002592|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
161002593|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
161002594|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
161002595|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
161002596|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
161002597|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
161002598|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
161002599|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
161002600|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
161002601|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
161002602|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
161002603|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
161002604|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
161002605|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
161002606|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
161002607|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
161002608|NCT02248480|581394607|FG000|Overall Study|Lack of Efficacy|4|||
161002609|NCT02248480|581394608|FG001|Overall Study|Lack of Efficacy|6|||
161002610|NCT02248480|581394607|FG000|Overall Study|Adverse Event|11|||
161002611|NCT02248480|581394608|FG001|Overall Study|Adverse Event|2|||
161002612|NCT02248480|581394607|FG000|Overall Study|Withdrawal by Subject|2|||
161002613|NCT02248480|581394608|FG001|Overall Study|Withdrawal by Subject|4|||
161002614|NCT02248480|581394607|FG000|Overall Study|Entry Criteria Not Met|0|||
161002615|NCT02248480|581394608|FG001|Overall Study|Entry Criteria Not Met|1|||
161002616|NCT02248480|581394607|FG000|Overall Study|Other:Physician Decision|0|||
161002617|NCT02248480|581394608|FG001|Overall Study|Other:Physician Decision|1|||
161002618|NCT00630786|581394609|FG000|Overall Study|Physician Decision|0|||
161002619|NCT00630786|581394610|FG001|Overall Study|Physician Decision|0|||
161002620|NCT00630786|581394611|FG002|Overall Study|Physician Decision|1|||
161002621|NCT00630786|581394609|FG000|Overall Study|Withdrawal by Subject|0|||
161002622|NCT00630786|581394610|FG001|Overall Study|Withdrawal by Subject|1|||
161002623|NCT00630786|581394611|FG002|Overall Study|Withdrawal by Subject|1|||
161002624|NCT00630786|581394609|FG000|Overall Study|Lost to Follow-up|0|||
161002625|NCT00630786|581394610|FG001|Overall Study|Lost to Follow-up|1|||
161002626|NCT00630786|581394611|FG002|Overall Study|Lost to Follow-up|0|||
161002627|NCT00630786|581394609|FG000|Overall Study|Other|1|||
161002628|NCT00630786|581394610|FG001|Overall Study|Other|0|||
161002629|NCT00630786|581394611|FG002|Overall Study|Other|0|||
161002630|NCT01582269|581394612|FG000|Overall Study|Withdrawal by Subject|1|||
161002631|NCT01582269|581394613|FG001|Overall Study|Withdrawal by Subject|0|||
161002632|NCT01582269|581394614|FG002|Overall Study|Withdrawal by Subject|0|||
161002633|NCT02770248|581394616|FG000|Overall Study|Adverse Event|0|||
161002634|NCT02770248|581394617|FG001|Overall Study|Adverse Event|1|||
161002635|NCT02770248|581394616|FG000|Overall Study|Randomized in error, prior to treatment|0|||
161002636|NCT02770248|581394617|FG001|Overall Study|Randomized in error, prior to treatment|1|||
161002637|NCT05076266|581394618|FG000|Overall Study|Survey not complete - Participant refusal|2|||
161002638|NCT05076266|581394619|FG001|Overall Study|Survey not complete - Participant refusal|0|||
161002639|NCT02486588|581394624|FG000|Overall Study|Randomized in error- ineligible|738|||
161002640|NCT02486588|581394625|FG001|Overall Study|Randomized in error- ineligible|750|||
161002641|NCT02486588|581394626|FG002|Overall Study|Randomized in error- ineligible|755|||
161002642|NCT02486588|581394627|FG003|Overall Study|Randomized in error- ineligible|738|||
161002643|NCT02486588|581394628|FG004|Overall Study|Randomized in error- ineligible|746|||
161002644|NCT02486588|581394629|FG005|Overall Study|Randomized in error- ineligible|746|||
161002645|NCT00546871|581394630|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
161002646|NCT00546871|581394631|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
161002647|NCT00546871|581394630|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
161002648|NCT00546871|581394631|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
161002649|NCT00546871|581394630|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
161002650|NCT00546871|581394631|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
161002651|NCT00546871|581394630|FG000|Study Extension Period|Protocol Violation|1|||
161002652|NCT00546871|581394631|FG001|Study Extension Period|Protocol Violation|0|||
161002653|NCT00546871|581394630|FG000|Study Extension Period|Withdrawal by Subject|0|||
161002654|NCT00546871|581394631|FG001|Study Extension Period|Withdrawal by Subject|1|||
161002655|NCT05136443|581395420|FG000|Overall Study|Lost to Follow-up|2|||
160585039|NCT02052778|579861892|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
160585040|NCT02052778|579861893|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
160585041|NCT02052778|579861894|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
160585042|NCT02052778|579861895|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
160585043|NCT02052778|579861896|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
160585044|NCT02052778|579861897|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
160585045|NCT02052778|579861898|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
160585046|NCT02052778|579861876|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585047|NCT02052778|579861877|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585048|NCT02052778|579861878|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585049|NCT02052778|579861879|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160964999|NCT05614089|581259498|FG000|Overall Study|Lost to Follow-up|5|||
160965000|NCT05614089|581259499|FG001|Overall Study|Lost to Follow-up|1|||
160965001|NCT05614089|581259498|FG000|Overall Study|Death|0|||
160965002|NCT05614089|581259499|FG001|Overall Study|Death|1|||
160965003|NCT05614089|581259498|FG000|Overall Study|Adverse Event|1|||
160965004|NCT05614089|581259499|FG001|Overall Study|Adverse Event|0|||
160965005|NCT04393441|581259500|FG000|Overall Study|Adverse Event|0|||
160965006|NCT04393441|581259501|FG001|Overall Study|Adverse Event|3|||
160965007|NCT04393441|581259500|FG000|Overall Study|Withdrawal by Subject|5|||
160965008|NCT04393441|581259501|FG001|Overall Study|Withdrawal by Subject|7|||
160965009|NCT04393441|581259500|FG000|Overall Study|Lost to Follow-up|0|||
160965010|NCT04393441|581259501|FG001|Overall Study|Lost to Follow-up|2|||
160965011|NCT04393441|581259500|FG000|Overall Study|Protocol Deviation|2|||
160965012|NCT04393441|581259501|FG001|Overall Study|Protocol Deviation|1|||
160965013|NCT04393441|581259500|FG000|Overall Study|Reason not Specified|1|||
160965014|NCT04393441|581259501|FG001|Overall Study|Reason not Specified|1|||
160965015|NCT02782169|581259502|FG000|Overall Study|Lost to Follow-up|1|||
160965016|NCT02782169|581259503|FG001|Overall Study|Lost to Follow-up|2|||
160965017|NCT00771810|581259504|FG000|Overall Study|Adverse Event|3|||
160965018|NCT00771810|581259505|FG001|Overall Study|Adverse Event|0|||
160965019|NCT00771810|581259506|FG002|Overall Study|Adverse Event|2|||
160965020|NCT00771810|581259504|FG000|Overall Study|Lost to Follow-up|0|||
160965021|NCT00771810|581259505|FG001|Overall Study|Lost to Follow-up|0|||
160965022|NCT00771810|581259506|FG002|Overall Study|Lost to Follow-up|1|||
160965023|NCT00771810|581259504|FG000|Overall Study|Physician Decision|1|||
160965024|NCT00771810|581259505|FG001|Overall Study|Physician Decision|2|||
160965025|NCT00771810|581259506|FG002|Overall Study|Physician Decision|2|||
160965026|NCT00771810|581259504|FG000|Overall Study|Protocol Violation|0|||
160965027|NCT00771810|581259505|FG001|Overall Study|Protocol Violation|1|||
160965028|NCT00771810|581259506|FG002|Overall Study|Protocol Violation|1|||
160965029|NCT00771810|581259504|FG000|Overall Study|Withdrawal by Subject|1|||
160965030|NCT00771810|581259505|FG001|Overall Study|Withdrawal by Subject|2|||
160965031|NCT00771810|581259506|FG002|Overall Study|Withdrawal by Subject|0|||
160965032|NCT00771810|581259504|FG000|Overall Study|Other|0|||
160965033|NCT00771810|581259505|FG001|Overall Study|Other|0|||
160965034|NCT00771810|581259506|FG002|Overall Study|Other|1|||
160965035|NCT02660827|581259511|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
160965036|NCT02660827|581259511|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
160965037|NCT02660827|581259511|FG000|From Study to End of Continued Access|Adverse Event|3|||
160965038|NCT02660827|581259511|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
160965039|NCT02660827|581259511|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
160965040|NCT02660827|581259511|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
160965041|NCT02660827|581259511|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
160965042|NCT02660827|581259511|FG000|Period 2: Continued Access Period|Adverse Event|3|||
160965043|NCT02953938|581259512|FG000|Overall Study|Adverse Event|0|||
160965044|NCT02953938|581259513|FG001|Overall Study|Adverse Event|1|||
160965045|NCT02953938|581259512|FG000|Overall Study|Withdrawal by Subject|1|||
160965046|NCT02953938|581259513|FG001|Overall Study|Withdrawal by Subject|1|||
160965047|NCT02657031|581259517|FG000|Overall Study|Adverse Event|1|||
160965048|NCT02657031|581259518|FG001|Overall Study|Adverse Event|2|||
160965049|NCT04198805|581259519|FG000|Overall Study|Death|0|||
160965050|NCT04198805|581259520|FG001|Overall Study|Death|0|||
160965051|NCT04198805|581259521|FG002|Overall Study|Death|0|||
160965052|NCT04198805|581259522|FG003|Overall Study|Death|1|||
160965053|NCT04198805|581259519|FG000|Overall Study|Early Termination|8|||
160965054|NCT04198805|581259520|FG001|Overall Study|Early Termination|4|||
160965055|NCT04198805|581259521|FG002|Overall Study|Early Termination|6|||
160965056|NCT04198805|581259522|FG003|Overall Study|Early Termination|9|||
160965057|NCT03599349|581259523|FG000|Overall Study|Lost to Follow-up|1|||
160965058|NCT00810264|581259526|FG000|Overall Study|Lost to Follow-up|191|||
160965059|NCT00810264|581259526|FG000|Overall Study|Withdrawal by subject or physician|721|||
160965060|NCT00810264|581259526|FG000|Overall Study|Death|641|||
161002656|NCT05136443|581395420|FG000|Overall Study|Adverse Event|2|||
161002657|NCT01786564|581395425|FG000|Overall Study|Lost to Follow-up|47|||
161002658|NCT01786564|581395425|FG000|Overall Study|Ineligible|17|||
160585050|NCT02052778|579861880|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585051|NCT02052778|579861881|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585052|NCT02052778|579861882|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585053|NCT02052778|579861883|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161002659|NCT05299606|581395428|FG000|Overall Study|Death|1|||
161002660|NCT03460756|581395430|FG000|Overall Study|Adverse Event|0|||
161002661|NCT03460756|581395431|FG001|Overall Study|Adverse Event|0|||
161002662|NCT03460756|581395432|FG002|Overall Study|Adverse Event|0|||
161002663|NCT03460756|581395433|FG003|Overall Study|Adverse Event|1|||
161002664|NCT03460756|581395430|FG000|Overall Study|Lack of Efficacy|0|||
161002665|NCT03460756|581395431|FG001|Overall Study|Lack of Efficacy|0|||
161002666|NCT03460756|581395432|FG002|Overall Study|Lack of Efficacy|0|||
161002667|NCT03460756|581395433|FG003|Overall Study|Lack of Efficacy|2|||
161002668|NCT03460756|581395430|FG000|Overall Study|Lost to Follow-up|0|||
161002669|NCT03460756|581395431|FG001|Overall Study|Lost to Follow-up|1|||
161002670|NCT03460756|581395432|FG002|Overall Study|Lost to Follow-up|2|||
161002671|NCT03460756|581395433|FG003|Overall Study|Lost to Follow-up|1|||
161002672|NCT03460756|581395430|FG000|Overall Study|Pregnancy|0|||
161002673|NCT03460756|581395431|FG001|Overall Study|Pregnancy|0|||
161002674|NCT03460756|581395432|FG002|Overall Study|Pregnancy|0|||
161002675|NCT03460756|581395433|FG003|Overall Study|Pregnancy|1|||
161002676|NCT03460756|581395430|FG000|Overall Study|Protocol Violation|0|||
161002677|NCT03460756|581395431|FG001|Overall Study|Protocol Violation|0|||
161002678|NCT03460756|581395432|FG002|Overall Study|Protocol Violation|0|||
161002679|NCT03460756|581395433|FG003|Overall Study|Protocol Violation|1|||
161002680|NCT03460756|581395430|FG000|Overall Study|Withdrawal by Subject|0|||
161002681|NCT03460756|581395431|FG001|Overall Study|Withdrawal by Subject|4|||
161002682|NCT03460756|581395432|FG002|Overall Study|Withdrawal by Subject|7|||
161002683|NCT03460756|581395433|FG003|Overall Study|Withdrawal by Subject|3|||
161002684|NCT00723450|581395435|FG000|Open-Label Phase|Adverse Event|26|||
161002685|NCT00723450|581395436|FG001|Open-Label Phase|Adverse Event|0|||
161002686|NCT00723450|581395437|FG002|Open-Label Phase|Adverse Event|0|||
161002687|NCT00723450|581395435|FG000|Open-Label Phase|Lack of Efficacy|18|||
161002688|NCT00723450|581395436|FG001|Open-Label Phase|Lack of Efficacy|0|||
161002689|NCT00723450|581395437|FG002|Open-Label Phase|Lack of Efficacy|0|||
161002690|NCT00723450|581395435|FG000|Open-Label Phase|Protocol Violation|35|||
161002691|NCT00723450|581395436|FG001|Open-Label Phase|Protocol Violation|0|||
161002692|NCT00723450|581395437|FG002|Open-Label Phase|Protocol Violation|0|||
161002693|NCT00723450|581395435|FG000|Open-Label Phase|Lost to Follow-up|7|||
161002694|NCT00723450|581395436|FG001|Open-Label Phase|Lost to Follow-up|0|||
161002695|NCT00723450|581395437|FG002|Open-Label Phase|Lost to Follow-up|0|||
161002696|NCT00723450|581395435|FG000|Open-Label Phase|Physician Decision|2|||
161002697|NCT00723450|581395436|FG001|Open-Label Phase|Physician Decision|0|||
161002698|NCT00723450|581395437|FG002|Open-Label Phase|Physician Decision|0|||
161002699|NCT00723450|581395435|FG000|Open-Label Phase|Withdrawal by Subject|37|||
161002700|NCT00723450|581395436|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161002701|NCT00723450|581395437|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161002702|NCT00723450|581395435|FG000|Randomized Phase|Adverse Event|0|||
161002703|NCT00723450|581395436|FG001|Randomized Phase|Adverse Event|26|||
161002704|NCT00723450|581395437|FG002|Randomized Phase|Adverse Event|17|||
161002705|NCT00723450|581395435|FG000|Randomized Phase|Lack of Efficacy|0|||
161002706|NCT00723450|581395436|FG001|Randomized Phase|Lack of Efficacy|11|||
161002707|NCT00723450|581395437|FG002|Randomized Phase|Lack of Efficacy|11|||
160585054|NCT02052778|579861884|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161002708|NCT00723450|581395435|FG000|Randomized Phase|Protocol Violation|0|||
161002709|NCT00723450|581395436|FG001|Randomized Phase|Protocol Violation|9|||
161002710|NCT00723450|581395437|FG002|Randomized Phase|Protocol Violation|13|||
161002711|NCT00723450|581395435|FG000|Randomized Phase|Lost to Follow-up|0|||
161002712|NCT00723450|581395436|FG001|Randomized Phase|Lost to Follow-up|2|||
161002713|NCT00723450|581395437|FG002|Randomized Phase|Lost to Follow-up|3|||
161002714|NCT00723450|581395435|FG000|Randomized Phase|Physician Decision|0|||
161002715|NCT00723450|581395436|FG001|Randomized Phase|Physician Decision|3|||
161002716|NCT00723450|581395437|FG002|Randomized Phase|Physician Decision|1|||
161002717|NCT00723450|581395435|FG000|Randomized Phase|Withdrawal by Subject|0|||
161002718|NCT00723450|581395436|FG001|Randomized Phase|Withdrawal by Subject|14|||
161002719|NCT00723450|581395437|FG002|Randomized Phase|Withdrawal by Subject|22|||
161002720|NCT02537522|581395443|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
161002721|NCT02537522|581395444|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
160632902|NCT02858076|580036101|FG001|Overall Study|Withdrawal by Subject|5|||
161002722|NCT02537522|581395445|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
161002723|NCT02537522|581395446|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
161002724|NCT02537522|581395443|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
161002725|NCT02537522|581395444|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
160458411|NCT04330040|579409166|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
160585055|NCT02052778|579861885|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585056|NCT02052778|579861886|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585057|NCT02052778|579861887|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585058|NCT02052778|579861888|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585059|NCT02052778|579861889|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585060|NCT02052778|579861890|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
160585061|NCT02052778|579861891|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
160585062|NCT02052778|579861892|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585063|NCT02052778|579861893|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
160585064|NCT02052778|579861894|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
160585065|NCT02052778|579861895|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
160585066|NCT02052778|579861896|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
160965061|NCT00696410|581259527|FG000|Overall Study|Lost to Follow-up|2|||
160965062|NCT00696410|581259528|FG001|Overall Study|Lost to Follow-up|0|||
160965063|NCT00696410|581259527|FG000|Overall Study|Withdrawal by Subject|8|||
160965064|NCT00696410|581259528|FG001|Overall Study|Withdrawal by Subject|0|||
160965065|NCT00696410|581259527|FG000|Overall Study|Physician Decision|3|||
160965066|NCT00696410|581259528|FG001|Overall Study|Physician Decision|0|||
160965067|NCT00453986|581259530|FG000|Overall Study|Lost to Follow-up|6|||
160965068|NCT00453986|581259531|FG001|Overall Study|Lost to Follow-up|5|||
160965069|NCT00453986|581259532|FG002|Overall Study|Lost to Follow-up|6|||
160965070|NCT00453986|581259533|FG003|Overall Study|Lost to Follow-up|2|||
160965071|NCT00453986|581259534|FG004|Overall Study|Lost to Follow-up|0|||
160965072|NCT03419364|581259536|FG000|Overall Study|Delivery due to maternal condition|2|||
160965073|NCT03419364|581259537|FG001|Overall Study|Delivery due to maternal condition|0|||
160965074|NCT03419364|581259538|FG002|Overall Study|Delivery due to maternal condition|0|||
160965075|NCT03559218|581261037|FG000|Overall Study|Withdrawal by Subject|1|||
160965076|NCT03559218|581261038|FG001|Overall Study|Withdrawal by Subject|0|||
160965077|NCT04737109|581261048|FG000|Study Treatment|Disease Progression|5|||
160965078|NCT04737109|581261049|FG001|Study Treatment|Disease Progression|0|||
160965079|NCT04737109|581261050|FG002|Study Treatment|Disease Progression|0|||
160965080|NCT04737109|581261051|FG003|Study Treatment|Disease Progression|0|||
160965081|NCT04737109|581261048|FG000|Study Treatment|Death on study|1|||
160965082|NCT04737109|581261049|FG001|Study Treatment|Death on study|0|||
160965083|NCT04737109|581261050|FG002|Study Treatment|Death on study|0|||
160965084|NCT04737109|581261051|FG003|Study Treatment|Death on study|0|||
160965085|NCT03092375|581261052|FG000|Overall Study|Lack of Efficacy|0|||
160965086|NCT03092375|581261053|FG001|Overall Study|Lack of Efficacy|1|||
160965087|NCT03092375|581261054|FG002|Overall Study|Lack of Efficacy|1|||
160965088|NCT03092375|581261055|FG003|Overall Study|Lack of Efficacy|0|||
160965089|NCT01679301|581261056|FG000|Screening Period|screen failure|3|||
160965090|NCT01679301|581261057|FG001|Screening Period|screen failure|0|||
160965091|NCT01679301|581261058|FG002|Screening Period|screen failure|0|||
160965092|NCT02305381|581261062|FG000|Overall Study|Unclassified|5|||
160965093|NCT02305381|581261063|FG001|Overall Study|Unclassified|5|||
160458412|NCT04330040|579409167|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
160458413|NCT04330040|579409168|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
160458414|NCT04330040|579409166|FG000|Overall Study|Other: Disease progression|1|||
160965094|NCT02305381|581261064|FG002|Overall Study|Unclassified|7|||
160965095|NCT02276066|581261065|FG000|Overall Study|Lost to Follow-up|21|||
160965096|NCT02276066|581261066|FG001|Overall Study|Lost to Follow-up|11|||
160965097|NCT02882282|581261067|FG000|Overall Study|Adverse Event|1|||
160965098|NCT02882282|581261068|FG001|Overall Study|Adverse Event|0|||
160965099|NCT03642938|581261073|FG000|Overall Study|Withdrawal by Subject|0|||
160965100|NCT03642938|581261074|FG001|Overall Study|Withdrawal by Subject|0|||
160965101|NCT03642938|581261075|FG002|Overall Study|Withdrawal by Subject|0|||
160965102|NCT03642938|581261076|FG003|Overall Study|Withdrawal by Subject|1|||
160965103|NCT01424930|581261077|FG000|Overall Study|Adverse Event|0|||
160965104|NCT01424930|581261078|FG001|Overall Study|Adverse Event|1|||
160965105|NCT01424930|581261077|FG000|Overall Study|Death|1|||
160965106|NCT01424930|581261078|FG001|Overall Study|Death|0|||
160965107|NCT01424930|581261077|FG000|Overall Study|Progressive Disease|3|||
160965108|NCT01424930|581261078|FG001|Overall Study|Progressive Disease|6|||
160965109|NCT01424930|581261077|FG000|Overall Study|Screen Failure|0|||
160965110|NCT01424930|581261078|FG001|Overall Study|Screen Failure|1|||
160965111|NCT01424930|581261077|FG000|Overall Study|Reason not specified|0|||
160965112|NCT01424930|581261078|FG001|Overall Study|Reason not specified|6|||
160965113|NCT03286751|581261083|FG000|Washout Period 1|Withdrawal by Subject|0|||
160965114|NCT03286751|581261084|FG001|Washout Period 1|Withdrawal by Subject|0|||
160965115|NCT03286751|581261085|FG002|Washout Period 1|Withdrawal by Subject|0|||
160965116|NCT03286751|581261086|FG003|Washout Period 1|Withdrawal by Subject|0|||
160965117|NCT03286751|581261087|FG004|Washout Period 1|Withdrawal by Subject|1|||
161002726|NCT02537522|581395445|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
161002727|NCT02537522|581395446|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
161002728|NCT02537522|581395443|FG000|Phase I - Contralateral|incorrect randomization|0|||
161002729|NCT02537522|581395444|FG001|Phase I - Contralateral|incorrect randomization|1|||
161002730|NCT02537522|581395445|FG002|Phase I - Contralateral|incorrect randomization|0|||
161002731|NCT02537522|581395446|FG003|Phase I - Contralateral|incorrect randomization|0|||
161002732|NCT02537522|581395443|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
161002733|NCT02537522|581395444|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
161002734|NCT02537522|581395445|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
161002735|NCT02537522|581395446|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
161002736|NCT02537522|581395443|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
161002737|NCT02537522|581395444|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
161002738|NCT02537522|581395445|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
161002739|NCT02537522|581395446|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
161002740|NCT03920215|581395448|FG000|Overall Study|Lost to Follow-up|1|||
161002741|NCT03920215|581395449|FG001|Overall Study|Lost to Follow-up|2|||
161002742|NCT03920215|581395450|FG002|Overall Study|Lost to Follow-up|0|||
161002743|NCT03920215|581395451|FG003|Overall Study|Lost to Follow-up|0|||
161002744|NCT03920215|581395448|FG000|Overall Study|Death|0|||
161002745|NCT03920215|581395449|FG001|Overall Study|Death|0|||
161002746|NCT03920215|581395450|FG002|Overall Study|Death|0|||
161002747|NCT03920215|581395451|FG003|Overall Study|Death|1|||
161002748|NCT02425111|581395454|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
161002749|NCT02425111|581395454|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
161002750|NCT02425111|581395454|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
161002751|NCT02425111|581395454|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
161002752|NCT02425111|581395454|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
161002753|NCT02425111|581395454|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
161002754|NCT00585533|581395455|FG000|Overall Study|objective or symptomatic progression|9|||
161002755|NCT02798835|581395456|FG000|Overall Study|Protocol Violation|0|||
161002756|NCT02798835|581395457|FG001|Overall Study|Protocol Violation|0|||
161002757|NCT02798835|581395458|FG002|Overall Study|Protocol Violation|3|||
161002758|NCT03024606|581395463|FG000|Overall Study|Withdrawal by Subject|9|||
161002759|NCT03024606|581395464|FG001|Overall Study|Withdrawal by Subject|10|||
161002760|NCT02547922|581395474|FG000|Overall Study|Withdrawal by Subject|9|||
161002761|NCT02547922|581395475|FG001|Overall Study|Withdrawal by Subject|6|||
161002762|NCT02547922|581395476|FG002|Overall Study|Withdrawal by Subject|10|||
161002763|NCT02547922|581395474|FG000|Overall Study|Adverse Event|3|||
161002764|NCT02547922|581395475|FG001|Overall Study|Adverse Event|1|||
161002765|NCT02547922|581395476|FG002|Overall Study|Adverse Event|2|||
161002766|NCT02547922|581395474|FG000|Overall Study|Lost to Follow-up|1|||
161002767|NCT02547922|581395475|FG001|Overall Study|Lost to Follow-up|0|||
161002768|NCT02547922|581395476|FG002|Overall Study|Lost to Follow-up|0|||
161002769|NCT02547922|581395474|FG000|Overall Study|Lack of Efficacy|5|||
161002770|NCT02547922|581395475|FG001|Overall Study|Lack of Efficacy|7|||
161002771|NCT02547922|581395476|FG002|Overall Study|Lack of Efficacy|4|||
161002772|NCT02547922|581395474|FG000|Overall Study|Death|1|||
161002773|NCT02547922|581395475|FG001|Overall Study|Death|0|||
161002774|NCT02547922|581395476|FG002|Overall Study|Death|0|||
161002775|NCT02547922|581395474|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
161002776|NCT02547922|581395475|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
161002777|NCT02547922|581395476|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
161002778|NCT02547922|581395474|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
161002779|NCT02547922|581395475|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
161002780|NCT02547922|581395476|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
161002781|NCT02547922|581395474|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
161002782|NCT02547922|581395475|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
161002783|NCT02547922|581395476|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
161002784|NCT02547922|581395474|FG000|Overall Study|Physician Decision|2|||
161002785|NCT02547922|581395475|FG001|Overall Study|Physician Decision|1|||
160458415|NCT04330040|579409167|FG001|Overall Study|Other: Disease progression|0|||
160458416|NCT04330040|579409168|FG002|Overall Study|Other: Disease progression|0|||
160458417|NCT04330040|579409166|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
161002786|NCT02547922|581395476|FG002|Overall Study|Physician Decision|2|||
161002787|NCT02547922|581395474|FG000|Overall Study|Patients did not receive IP|1|||
161002788|NCT02547922|581395475|FG001|Overall Study|Patients did not receive IP|1|||
161002789|NCT02547922|581395476|FG002|Overall Study|Patients did not receive IP|0|||
161002790|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
161002791|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161002792|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161002793|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161002794|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161002795|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
161002796|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161002797|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161002798|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161002799|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161002800|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
161002801|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161002802|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161002803|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161002804|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161002805|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
161002806|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161002807|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161002808|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161002809|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161002810|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
161002811|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161002812|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161002813|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161002814|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161002815|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
161002816|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161002817|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161002818|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161002819|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161002820|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
161002821|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161002822|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161002823|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161002824|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161002825|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
161002826|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161002827|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161002828|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161002829|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161002830|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
161002831|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161002832|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
160656993|NCT05097989|580124499|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
160656994|NCT05097989|580124500|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160965118|NCT03286751|581261088|FG005|Washout Period 1|Withdrawal by Subject|0|||
160965119|NCT03286751|581261083|FG000|Washout Period 2|Personal Reasons|0|||
160965120|NCT03286751|581261084|FG001|Washout Period 2|Personal Reasons|1|||
160965121|NCT03286751|581261085|FG002|Washout Period 2|Personal Reasons|0|||
160965122|NCT03286751|581261086|FG003|Washout Period 2|Personal Reasons|0|||
160965123|NCT03286751|581261087|FG004|Washout Period 2|Personal Reasons|0|||
160965124|NCT03286751|581261088|FG005|Washout Period 2|Personal Reasons|0|||
160965125|NCT03286751|581261083|FG000|Washout Period 5|Adverse Event|0|||
160965126|NCT03286751|581261084|FG001|Washout Period 5|Adverse Event|0|||
160965127|NCT03286751|581261085|FG002|Washout Period 5|Adverse Event|0|||
160965128|NCT03286751|581261086|FG003|Washout Period 5|Adverse Event|0|||
160965129|NCT03286751|581261087|FG004|Washout Period 5|Adverse Event|1|||
160965130|NCT03286751|581261088|FG005|Washout Period 5|Adverse Event|0|||
160965131|NCT01119768|581261089|FG000|Treatment Period|Lack of Efficacy|18|||
160965132|NCT01119768|581261090|FG001|Treatment Period|Lack of Efficacy|25|||
160965133|NCT01301391|581261091|FG000|Overall Study|Death|13|||
161002833|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161002834|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161002835|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
161002836|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
161002837|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
161002838|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
161002839|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
161002840|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
161002841|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
160458418|NCT04330040|579409167|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
160965134|NCT01301391|581261091|FG000|Overall Study|Lost to Follow-up|3|||
160965135|NCT01301391|581261091|FG000|Overall Study|Physician Decision|2|||
160965136|NCT01301391|581261091|FG000|Overall Study|Sponsor's decision|8|||
160656995|NCT05097989|580124501|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161002842|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
161002843|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
161002844|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
161002845|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
161002846|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
161002847|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
161002848|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
161002849|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
161002850|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161002851|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
161002852|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161002853|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161002854|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161002855|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
161002856|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
161002857|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
161002858|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
161002859|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
161002860|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
161002861|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
161002862|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
161002863|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
161002864|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
161002865|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
161002866|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
161002867|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
161002868|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
161002869|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
161002870|NCT00102063|581395483|FG000|Overall Study|Lack of Efficacy|5|||
161002871|NCT00102063|581395484|FG001|Overall Study|Lack of Efficacy|1|||
161002872|NCT00102063|581395485|FG002|Overall Study|Lack of Efficacy|1|||
161002873|NCT00102063|581395483|FG000|Overall Study|Adverse Event|7|||
161002874|NCT00102063|581395484|FG001|Overall Study|Adverse Event|4|||
161002875|NCT00102063|581395485|FG002|Overall Study|Adverse Event|2|||
161002876|NCT00102063|581395483|FG000|Overall Study|Withdrawal by Subject|4|||
161002877|NCT00102063|581395484|FG001|Overall Study|Withdrawal by Subject|12|||
161002878|NCT00102063|581395485|FG002|Overall Study|Withdrawal by Subject|5|||
161002879|NCT00102063|581395483|FG000|Overall Study|Lost to Follow-up|0|||
161002880|NCT00102063|581395484|FG001|Overall Study|Lost to Follow-up|0|||
161002881|NCT00102063|581395485|FG002|Overall Study|Lost to Follow-up|1|||
161002882|NCT00102063|581395483|FG000|Overall Study|Protocol Violation|0|||
161002883|NCT00102063|581395484|FG001|Overall Study|Protocol Violation|1|||
161002884|NCT00102063|581395485|FG002|Overall Study|Protocol Violation|1|||
161002885|NCT00857649|581395486|FG000|Overall Study|Adverse Event|15|||
161002886|NCT00857649|581395487|FG001|Overall Study|Adverse Event|10|||
161002887|NCT00857649|581395486|FG000|Overall Study|Non-compliance|1|||
161002888|NCT00857649|581395487|FG001|Overall Study|Non-compliance|1|||
161002889|NCT00857649|581395486|FG000|Overall Study|Protocol Violation|2|||
161002890|NCT00857649|581395487|FG001|Overall Study|Protocol Violation|2|||
161002891|NCT00857649|581395486|FG000|Overall Study|Withdrawal of Consent|10|||
161002892|NCT00857649|581395487|FG001|Overall Study|Withdrawal of Consent|7|||
161002893|NCT00857649|581395486|FG000|Overall Study|Nursing Home Placement|2|||
161002894|NCT00857649|581395487|FG001|Overall Study|Nursing Home Placement|9|||
161002895|NCT00857649|581395486|FG000|Overall Study|Other Reasons|1|||
161002896|NCT00857649|581395487|FG001|Overall Study|Other Reasons|3|||
161002897|NCT01713946|581395494|FG000|Overall Study|Death|0|||
161002898|NCT01713946|581395495|FG001|Overall Study|Death|2|||
160585067|NCT02052778|579861897|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
160585068|NCT02052778|579861898|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
160585069|NCT02052778|579861876|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585070|NCT02052778|579861877|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161002899|NCT01713946|581395496|FG002|Overall Study|Death|2|||
161002900|NCT01713946|581395494|FG000|Overall Study|Adverse Event|19|||
161002901|NCT01713946|581395495|FG001|Overall Study|Adverse Event|14|||
161002902|NCT01713946|581395496|FG002|Overall Study|Adverse Event|13|||
161002903|NCT01713946|581395494|FG000|Overall Study|Withdrawal by Subject|12|||
161002904|NCT01713946|581395495|FG001|Overall Study|Withdrawal by Subject|12|||
161002905|NCT01713946|581395496|FG002|Overall Study|Withdrawal by Subject|8|||
161002906|NCT01713946|581395494|FG000|Overall Study|Lack of Efficacy|8|||
161002907|NCT01713946|581395495|FG001|Overall Study|Lack of Efficacy|8|||
161002908|NCT01713946|581395496|FG002|Overall Study|Lack of Efficacy|14|||
161002909|NCT01713946|581395494|FG000|Overall Study|Protocol Violation|2|||
161002910|NCT01713946|581395495|FG001|Overall Study|Protocol Violation|4|||
161002911|NCT01713946|581395496|FG002|Overall Study|Protocol Violation|1|||
160585071|NCT02052778|579861878|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585072|NCT02052778|579861879|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585073|NCT02052778|579861880|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585074|NCT02052778|579861881|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585075|NCT02052778|579861882|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585076|NCT02052778|579861883|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585077|NCT02052778|579861884|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161002912|NCT01713946|581395494|FG000|Overall Study|Lost to Follow-up|0|||
161002913|NCT01713946|581395495|FG001|Overall Study|Lost to Follow-up|0|||
161002914|NCT01713946|581395496|FG002|Overall Study|Lost to Follow-up|1|||
161002915|NCT01713946|581395494|FG000|Overall Study|Administrative problems|1|||
161002916|NCT01713946|581395495|FG001|Overall Study|Administrative problems|0|||
161002917|NCT01713946|581395496|FG002|Overall Study|Administrative problems|0|||
161002918|NCT01713946|581395494|FG000|Overall Study|Did not continue in Ext|0|||
161002919|NCT01713946|581395495|FG001|Overall Study|Did not continue in Ext|3|||
161002920|NCT01713946|581395496|FG002|Overall Study|Did not continue in Ext|0|||
161002921|NCT01713946|581395494|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
161002922|NCT01713946|581395495|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
161002923|NCT01713946|581395496|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
161002924|NCT01713946|581395494|FG000|Overall Study|Patients never switched to everolimus|0|||
161002925|NCT01713946|581395495|FG001|Overall Study|Patients never switched to everolimus|0|||
161002926|NCT01713946|581395496|FG002|Overall Study|Patients never switched to everolimus|5|||
161002927|NCT03723616|581396541|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
161002928|NCT03723616|581396542|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
161002929|NCT03723616|581396543|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
161002930|NCT03723616|581396544|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
161002931|NCT03723616|581396545|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
161002932|NCT03723616|581396546|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
161002933|NCT06001177|581396549|FG000|Treatment Phase|Adverse Event|1|||
161002934|NCT06001177|581396550|FG001|Treatment Phase|Adverse Event|0|||
161002935|NCT06001177|581396549|FG000|Treatment Phase|Withdrawal by Subject|1|||
161002936|NCT06001177|581396550|FG001|Treatment Phase|Withdrawal by Subject|0|||
161002937|NCT06001177|581396549|FG000|Observation Phase|Adverse Event|1|||
161002938|NCT06001177|581396550|FG001|Observation Phase|Adverse Event|1|||
161002939|NCT06001177|581396549|FG000|Observation Phase|Withdrawal by Subject|0|||
161002940|NCT06001177|581396550|FG001|Observation Phase|Withdrawal by Subject|1|||
161002941|NCT03593876|581396553|FG000|Overall Study|Withdrawal by Subject|1|||
161002942|NCT03593876|581396553|FG000|Overall Study|Discharged home before intervention completion|2|||
161002943|NCT05309668|581396554|FG000|Overall Study|Ongoing at data cut-off|14|||
161002944|NCT05309668|581396555|FG001|Overall Study|Ongoing at data cut-off|17|||
161002945|NCT05309668|581396556|FG002|Overall Study|Ongoing at data cut-off|4|||
161002946|NCT02696707|581396557|FG000|Per Protocol Population|Physician Decision|2|||
161002947|NCT02696707|581396558|FG001|Per Protocol Population|Physician Decision|1|||
161002948|NCT02696707|581396557|FG000|Per Protocol Population|Participant Decision|0|||
161002949|NCT02696707|581396558|FG001|Per Protocol Population|Participant Decision|2|||
161002950|NCT02696707|581396557|FG000|Completed Study as Planned|Reason = LVEF|2|||
161002951|NCT02696707|581396558|FG001|Completed Study as Planned|Reason = LVEF|2|||
161002952|NCT02696707|581396557|FG000|Completed Study as Planned|Protocol Violation|2|||
161002953|NCT02696707|581396558|FG001|Completed Study as Planned|Protocol Violation|6|||
161002954|NCT02696707|581396557|FG000|Completed Study as Planned|Metastatic disease|3|||
161002955|NCT02696707|581396558|FG001|Completed Study as Planned|Metastatic disease|0|||
160585078|NCT02052778|579861885|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585079|NCT02052778|579861886|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585080|NCT02052778|579861887|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585081|NCT02052778|579861888|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585082|NCT02052778|579861889|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585083|NCT02052778|579861890|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
161002956|NCT02696707|581396557|FG000|Completed Study as Planned|Location|1|||
161002957|NCT02696707|581396558|FG001|Completed Study as Planned|Location|1|||
161002958|NCT00071799|581396559|FG000|Overall Study|Adverse Event|19|||
161002959|NCT00071799|581396560|FG001|Overall Study|Adverse Event|10|||
161002960|NCT00071799|581396559|FG000|Overall Study|Protocol Violation|1|||
161002961|NCT00071799|581396560|FG001|Overall Study|Protocol Violation|7|||
161002962|NCT00071799|581396559|FG000|Overall Study|Lost to Follow-up|1|||
161002963|NCT00071799|581396560|FG001|Overall Study|Lost to Follow-up|1|||
161002964|NCT00071799|581396559|FG000|Overall Study|Withdrawal by Subject|15|||
161002965|NCT00071799|581396560|FG001|Overall Study|Withdrawal by Subject|37|||
161002966|NCT00071799|581396559|FG000|Overall Study|Physician Decision|0|||
161002967|NCT00071799|581396560|FG001|Overall Study|Physician Decision|2|||
161002968|NCT00071799|581396559|FG000|Overall Study|Lack of Efficacy|11|||
160585084|NCT02052778|579861891|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
160585085|NCT02052778|579861892|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
160585086|NCT02052778|579861893|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160965137|NCT01059643|581261092|FG000|Overall Study|Adverse Event|3|||
160965138|NCT01059643|581261092|FG000|Overall Study|Withdrawal by Subject|2|||
160965139|NCT01059643|581261092|FG000|Overall Study|Physician Decision|1|||
160965140|NCT00677352|581261101|FG000|Treatment Phase|Adverse Event|14|||
160965141|NCT00677352|581261102|FG001|Treatment Phase|Adverse Event|22|||
160965142|NCT00677352|581261101|FG000|Treatment Phase|Lack of Efficacy|2|||
160965143|NCT00677352|581261102|FG001|Treatment Phase|Lack of Efficacy|3|||
160965144|NCT00677352|581261101|FG000|Treatment Phase|Lost to Follow-up|0|||
160965145|NCT00677352|581261102|FG001|Treatment Phase|Lost to Follow-up|1|||
160965146|NCT00677352|581261101|FG000|Treatment Phase|Withdrawal by Subject|7|||
160965147|NCT00677352|581261102|FG001|Treatment Phase|Withdrawal by Subject|7|||
160965148|NCT00677352|581261101|FG000|Treatment Phase|Physician Decision|1|||
160965149|NCT00677352|581261102|FG001|Treatment Phase|Physician Decision|0|||
160965150|NCT00677352|581261101|FG000|Treatment Phase|Pregnancy|0|||
160965151|NCT00677352|581261102|FG001|Treatment Phase|Pregnancy|1|||
160965152|NCT00677352|581261101|FG000|Treatment Phase|Protocol Violation|1|||
160965153|NCT00677352|581261102|FG001|Treatment Phase|Protocol Violation|1|||
160965154|NCT00677352|581261101|FG000|Treatment Phase|Transference or work related matter|0|||
160965155|NCT00677352|581261102|FG001|Treatment Phase|Transference or work related matter|5|||
160965156|NCT00677352|581261101|FG000|Treatment Phase|Not treated|0|||
160965157|NCT00677352|581261102|FG001|Treatment Phase|Not treated|2|||
160965158|NCT00677352|581261101|FG000|Tapering Phase|Adverse Event|1|||
160965159|NCT00677352|581261102|FG001|Tapering Phase|Adverse Event|5|||
160965160|NCT00677352|581261101|FG000|Tapering Phase|Withdrawal by Subject|5|||
160965161|NCT00677352|581261102|FG001|Tapering Phase|Withdrawal by Subject|3|||
160965162|NCT00677352|581261101|FG000|Tapering Phase|Pregnancy|0|||
160965163|NCT00677352|581261102|FG001|Tapering Phase|Pregnancy|1|||
160965164|NCT00677352|581261101|FG000|Tapering Phase|Job transfer|0|||
160965165|NCT00677352|581261102|FG001|Tapering Phase|Job transfer|1|||
160965166|NCT02182973|581261105|FG000|Overall Study|Withdrawal by Subject|3|||
160965167|NCT02182973|581261106|FG001|Overall Study|Withdrawal by Subject|0|||
160965168|NCT00238433|581261107|FG000|Overall Study|Screen failure|1|||
160965169|NCT00238433|581261107|FG000|Overall Study|Lost to Follow-up|1|||
160965170|NCT00238433|581261107|FG000|Overall Study|Death|1|||
160965171|NCT01814748|581261108|FG000|Overall Study|Lost to Follow-up|1|||
160965172|NCT01814748|581261109|FG001|Overall Study|Lost to Follow-up|2|||
160965173|NCT01814748|581261108|FG000|Overall Study|Study site terminated by sponsor|1|||
160965174|NCT01814748|581261109|FG001|Overall Study|Study site terminated by sponsor|1|||
160965175|NCT01814748|581261108|FG000|Overall Study|Withdrawal by Subject|6|||
160965176|NCT01814748|581261109|FG001|Overall Study|Withdrawal by Subject|4|||
160965177|NCT00409682|581261116|FG000|Open-label Induction Period|Adverse Event|1|||
160965178|NCT00409682|581261117|FG001|Open-label Induction Period|Adverse Event|0|||
160965179|NCT00409682|581261118|FG002|Open-label Induction Period|Adverse Event|0|||
160965180|NCT00409682|581261116|FG000|Open-label Induction Period|Lack of Efficacy|1|||
160965181|NCT00409682|581261117|FG001|Open-label Induction Period|Lack of Efficacy|0|||
160965182|NCT00409682|581261118|FG002|Open-label Induction Period|Lack of Efficacy|0|||
160965183|NCT00409682|581261116|FG000|Open-label Induction Period|Protocol Violation|1|||
160965184|NCT00409682|581261117|FG001|Open-label Induction Period|Protocol Violation|0|||
160965185|NCT00409682|581261118|FG002|Open-label Induction Period|Protocol Violation|0|||
160965186|NCT00409682|581261116|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
160965187|NCT00409682|581261117|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
160965188|NCT00409682|581261118|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
160965189|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
160965190|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
160965191|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
160965192|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
160965193|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
160965194|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
160965195|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
160965196|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
160965197|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
160965198|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
160965199|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
160965200|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
160965201|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
160965202|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
160965203|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
160965204|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
160965205|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
160965206|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
160458419|NCT04330040|579409168|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
160458420|NCT04330040|579409166|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
160585087|NCT02052778|579861894|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
160585088|NCT02052778|579861895|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
161002969|NCT00071799|581396560|FG001|Overall Study|Lack of Efficacy|18|||
161002970|NCT00071799|581396559|FG000|Overall Study|Disease Progression|23|||
161002971|NCT00071799|581396560|FG001|Overall Study|Disease Progression|20|||
161002972|NCT00071799|581396559|FG000|Overall Study|Different Central+Local Pathology Review|0|||
161002973|NCT00071799|581396560|FG001|Overall Study|Different Central+Local Pathology Review|1|||
161002974|NCT00071799|581396559|FG000|Overall Study|Not Documented|0|||
161002975|NCT00071799|581396560|FG001|Overall Study|Not Documented|2|||
161002976|NCT04527549|581396563|FG000|Overall Study|Withdrawal by Subject|1|||
161002977|NCT04527549|581396564|FG001|Overall Study|Withdrawal by Subject|1|||
161002978|NCT00814346|581396565|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
161002979|NCT00814346|581396566|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
161002980|NCT00814346|581396565|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
161002981|NCT00814346|581396566|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
161002982|NCT00814346|581396565|FG000|Open Phase (17 Months)|Adverse Event|5|||
161002983|NCT00814346|581396566|FG001|Open Phase (17 Months)|Adverse Event|0|||
161002984|NCT00814346|581396565|FG000|Open Phase (17 Months)|Consent|2|||
161002985|NCT00814346|581396566|FG001|Open Phase (17 Months)|Consent|0|||
161002986|NCT00814346|581396565|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
161002987|NCT00814346|581396566|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
161002988|NCT00814346|581396565|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
161002989|NCT00814346|581396566|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
161002990|NCT05764161|581396568|FG000|12-week DBVC Period|Lack of Efficacy|2|||
161002991|NCT05764161|581396569|FG001|12-week DBVC Period|Lack of Efficacy|1|||
161002992|NCT05764161|581396568|FG000|12-week DBVC Period|Lost to Follow-up|0|||
161002993|NCT05764161|581396569|FG001|12-week DBVC Period|Lost to Follow-up|2|||
161002994|NCT05764161|581396568|FG000|12-week DBVC Period|Protocol Violation|2|||
161002995|NCT05764161|581396569|FG001|12-week DBVC Period|Protocol Violation|4|||
161002996|NCT05764161|581396568|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
161002997|NCT05764161|581396569|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
161002998|NCT05764161|581396568|FG000|40-week OLE Period|Lack of Efficacy|0|||
161002999|NCT05764161|581396569|FG001|40-week OLE Period|Lack of Efficacy|1|||
161003000|NCT05764161|581396568|FG000|40-week OLE Period|Lost to Follow-up|1|||
161003001|NCT05764161|581396569|FG001|40-week OLE Period|Lost to Follow-up|4|||
161003002|NCT05764161|581396568|FG000|40-week OLE Period|Withdrawal by Subject|2|||
161003003|NCT05764161|581396569|FG001|40-week OLE Period|Withdrawal by Subject|7|||
161003004|NCT05764161|581396568|FG000|40-week OLE Period|Extended Travel|0|||
161003005|NCT05764161|581396569|FG001|40-week OLE Period|Extended Travel|1|||
161003006|NCT05764161|581396568|FG000|40-week OLE Period|Ongoing|66|||
161003007|NCT05764161|581396569|FG001|40-week OLE Period|Ongoing|59|||
161003008|NCT00507689|581396576|FG000|Pre-Randomization Period|Adverse Event|1|||
161003009|NCT00507689|581396577|FG001|Pre-Randomization Period|Adverse Event|0|||
161003010|NCT00507689|581396576|FG000|Pre-Randomization Period|Physician Decision|1|||
161003011|NCT00507689|581396577|FG001|Pre-Randomization Period|Physician Decision|0|||
161003012|NCT00507689|581396576|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
161003013|NCT00507689|581396577|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
161003014|NCT00507689|581396576|FG000|Randomized Period|Adverse Event|1|||
161003015|NCT00507689|581396577|FG001|Randomized Period|Adverse Event|1|||
161003016|NCT00507689|581396576|FG000|Randomized Period|Withdrawal by Subject|0|||
161003017|NCT00507689|581396577|FG001|Randomized Period|Withdrawal by Subject|1|||
160585089|NCT02052778|579861896|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160585090|NCT02052778|579861897|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161003018|NCT01241292|581396578|FG000|Overall Study|Administrative Reason by Sponsor|1|||
161003019|NCT01241292|581396579|FG001|Overall Study|Administrative Reason by Sponsor|0|||
161003020|NCT01241292|581396578|FG000|Overall Study|Disease Progression|2|||
161003021|NCT01241292|581396579|FG001|Overall Study|Disease Progression|0|||
160585091|NCT02052778|579861898|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
160632903|NCT02858076|580036100|FG000|Overall Study|Lost to Follow-up|2|||
161003022|NCT01241292|581396578|FG000|Overall Study|Study Drug Toxicity|0|||
161003023|NCT01241292|581396579|FG001|Overall Study|Study Drug Toxicity|1|||
161003024|NCT01241292|581396578|FG000|Overall Study|Participant Discontinued Treatment|0|||
161003025|NCT01241292|581396579|FG001|Overall Study|Participant Discontinued Treatment|2|||
161003026|NCT03034915|581396582|FG000|Overall Study|Adverse Event|29|||
160458421|NCT04330040|579409167|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
161003027|NCT03034915|581396583|FG001|Overall Study|Adverse Event|32|||
161003028|NCT03034915|581396584|FG002|Overall Study|Adverse Event|22|||
161003029|NCT03034915|581396582|FG000|Overall Study|Lost to Follow-up|5|||
161003030|NCT03034915|581396583|FG001|Overall Study|Lost to Follow-up|13|||
161003031|NCT03034915|581396584|FG002|Overall Study|Lost to Follow-up|3|||
161003032|NCT03034915|581396582|FG000|Overall Study|Withdrawal by Subject|29|||
161003033|NCT03034915|581396583|FG001|Overall Study|Withdrawal by Subject|46|||
161003034|NCT03034915|581396584|FG002|Overall Study|Withdrawal by Subject|41|||
161003035|NCT03034915|581396582|FG000|Overall Study|Protocol Deviation|2|||
161003036|NCT03034915|581396583|FG001|Overall Study|Protocol Deviation|14|||
161003037|NCT03034915|581396584|FG002|Overall Study|Protocol Deviation|7|||
161003038|NCT03034915|581396582|FG000|Overall Study|Lack of Efficacy|8|||
161003039|NCT03034915|581396583|FG001|Overall Study|Lack of Efficacy|16|||
161003040|NCT03034915|581396584|FG002|Overall Study|Lack of Efficacy|18|||
161003041|NCT03034915|581396582|FG000|Overall Study|Site closed|2|||
161003042|NCT03034915|581396583|FG001|Overall Study|Site closed|2|||
161003043|NCT03034915|581396584|FG002|Overall Study|Site closed|4|||
161003044|NCT03034915|581396582|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
161003045|NCT03034915|581396583|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
161003046|NCT03034915|581396584|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
161003047|NCT03034915|581396582|FG000|Overall Study|Physician Decision|1|||
161003048|NCT03034915|581396583|FG001|Overall Study|Physician Decision|5|||
161003049|NCT03034915|581396584|FG002|Overall Study|Physician Decision|2|||
161003050|NCT03861767|581396585|FG000|Overall Study|Withdrawal by Subject|2|||
161003051|NCT03861767|581396586|FG001|Overall Study|Withdrawal by Subject|1|||
161003052|NCT03861767|581396587|FG002|Overall Study|Withdrawal by Subject|0|||
161003053|NCT03861767|581396588|FG003|Overall Study|Withdrawal by Subject|5|||
161003054|NCT03861767|581396589|FG004|Overall Study|Withdrawal by Subject|2|||
161003055|NCT03861767|581396590|FG005|Overall Study|Withdrawal by Subject|1|||
161003056|NCT03861767|581396591|FG006|Overall Study|Withdrawal by Subject|3|||
161003057|NCT03861767|581396592|FG007|Overall Study|Withdrawal by Subject|1|||
161003058|NCT03861767|581396593|FG008|Overall Study|Withdrawal by Subject|0|||
161003059|NCT03861767|581396594|FG009|Overall Study|Withdrawal by Subject|5|||
161003060|NCT00346333|581396595|FG000|Overall Study|Death|1|||
161003061|NCT00346333|581396596|FG001|Overall Study|Death|0|||
161003062|NCT00346333|581396595|FG000|Overall Study|unwilling or unable to continue|4|||
161003063|NCT00346333|581396596|FG001|Overall Study|unwilling or unable to continue|8|||
161003064|NCT00117286|581396602|FG000|Overall Study|Adverse Event|12|||
161003065|NCT00117286|581396603|FG001|Overall Study|Adverse Event|6|||
161003066|NCT00117286|581396602|FG000|Overall Study|Lost to Follow-up|2|||
161003067|NCT00117286|581396603|FG001|Overall Study|Lost to Follow-up|0|||
160458422|NCT04330040|579409168|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
160458423|NCT04330040|579409166|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
160458424|NCT04330040|579409167|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
161003068|NCT00117286|581396602|FG000|Overall Study|Protocol Violation|3|||
161003069|NCT00117286|581396603|FG001|Overall Study|Protocol Violation|3|||
161003070|NCT00117286|581396602|FG000|Overall Study|Withdrawal by Subject|6|||
161003071|NCT00117286|581396603|FG001|Overall Study|Withdrawal by Subject|2|||
161003072|NCT00117286|581396602|FG000|Overall Study|Physician Decision|3|||
161003073|NCT00117286|581396603|FG001|Overall Study|Physician Decision|7|||
161003074|NCT00117286|581396602|FG000|Overall Study|Lack of Efficacy|2|||
161003075|NCT00117286|581396603|FG001|Overall Study|Lack of Efficacy|1|||
161003076|NCT00117286|581396602|FG000|Overall Study|Research site closing|0|||
161003077|NCT00117286|581396603|FG001|Overall Study|Research site closing|2|||
161003078|NCT00189202|581396604|FG000|Overall Study|Physician Decision|5|||
161003079|NCT01595061|581396609|FG000|Overall Study|Never Treated|3|||
161003080|NCT01595061|581396609|FG000|Overall Study|Inadequate Pathology|1|||
161003081|NCT03388632|581396613|FG000|Triplet C|Clinical progression|0|||
161003082|NCT03388632|581396614|FG001|Triplet C|Clinical progression|0|||
161003083|NCT03388632|581396615|FG002|Triplet C|Clinical progression|0|||
161003084|NCT03388632|581396616|FG003|Triplet C|Clinical progression|0|||
161003085|NCT03388632|581396617|FG004|Triplet C|Clinical progression|1|||
161003086|NCT03388632|581396618|FG005|Triplet C|Clinical progression|0|||
161003087|NCT03388632|581396619|FG006|Triplet C|Clinical progression|0|||
161003088|NCT03388632|581396620|FG007|Triplet C|Clinical progression|0|||
161003089|NCT03388632|581396621|FG008|Triplet C|Clinical progression|0|||
160458425|NCT04330040|579409168|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
160585092|NCT02052778|579861876|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161003090|NCT03388632|581396613|FG000|Triplet C|42-day lapse in tx|0|||
161003091|NCT03388632|581396614|FG001|Triplet C|42-day lapse in tx|0|||
161003092|NCT03388632|581396615|FG002|Triplet C|42-day lapse in tx|0|||
160585093|NCT02052778|579861877|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161003093|NCT03388632|581396616|FG003|Triplet C|42-day lapse in tx|0|||
161003094|NCT03388632|581396617|FG004|Triplet C|42-day lapse in tx|1|||
161003095|NCT03388632|581396618|FG005|Triplet C|42-day lapse in tx|0|||
161003096|NCT03388632|581396619|FG006|Triplet C|42-day lapse in tx|0|||
161003097|NCT03388632|581396620|FG007|Triplet C|42-day lapse in tx|0|||
161003098|NCT03388632|581396621|FG008|Triplet C|42-day lapse in tx|0|||
161003099|NCT03388632|581396613|FG000|Triplet C|Adverse Event|0|||
161003100|NCT03388632|581396614|FG001|Triplet C|Adverse Event|0|||
161003101|NCT03388632|581396615|FG002|Triplet C|Adverse Event|0|||
161003102|NCT03388632|581396616|FG003|Triplet C|Adverse Event|0|||
161003103|NCT03388632|581396617|FG004|Triplet C|Adverse Event|0|||
160965207|NCT01896869|581261119|FG000|Overall Study|Withdrawal by Subject|0|||
160965208|NCT01896869|581261120|FG001|Overall Study|Withdrawal by Subject|6|||
160965209|NCT01896869|581261119|FG000|Overall Study|Lost to Follow-up|1|||
160965210|NCT01896869|581261120|FG001|Overall Study|Lost to Follow-up|0|||
160965211|NCT02436811|581261124|FG000|Overall Study|Lost to Follow-up|2|||
160965212|NCT02436811|581261125|FG001|Overall Study|Lost to Follow-up|9|||
160965213|NCT02436811|581261126|FG002|Overall Study|Lost to Follow-up|7|||
160965214|NCT02831257|581261127|FG000|Overall Study|Lack of Efficacy|3|||
160965215|NCT02831257|581261127|FG000|Overall Study|Adverse Event|2|||
160965216|NCT02831257|581261127|FG000|Overall Study|Physician Decision|1|||
160965217|NCT02831257|581261127|FG000|Overall Study|Withdrawal by Subject|6|||
160965218|NCT02496767|581261129|FG000|Open-label Lead-in Phase|Adverse Event|176|||
160965219|NCT02496767|581261130|FG001|Open-label Lead-in Phase|Adverse Event|0|||
160965220|NCT02496767|581261131|FG002|Open-label Lead-in Phase|Adverse Event|0|||
160965221|NCT02496767|581261132|FG003|Open-label Lead-in Phase|Adverse Event|0|||
160965222|NCT02496767|581261133|FG004|Open-label Lead-in Phase|Adverse Event|0|||
160965223|NCT02496767|581261134|FG005|Open-label Lead-in Phase|Adverse Event|0|||
160965224|NCT02496767|581261135|FG006|Open-label Lead-in Phase|Adverse Event|0|||
160965225|NCT02496767|581261136|FG007|Open-label Lead-in Phase|Adverse Event|0|||
160965226|NCT02496767|581261129|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
160965227|NCT02496767|581261130|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
160965228|NCT02496767|581261131|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
160965229|NCT02496767|581261132|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
160965230|NCT02496767|581261133|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
160965231|NCT02496767|581261134|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
160965232|NCT02496767|581261135|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
160965233|NCT02496767|581261136|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
160965234|NCT02496767|581261129|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
160965235|NCT02496767|581261130|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965236|NCT02496767|581261131|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965237|NCT02496767|581261132|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965238|NCT02496767|581261133|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965239|NCT02496767|581261134|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965240|NCT02496767|581261135|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965241|NCT02496767|581261136|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965242|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
160965243|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
160965244|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
160965245|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
160965246|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
160965247|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
160965248|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
160965249|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
160965250|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
160965251|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
160965252|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
160965253|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
160965254|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
160965255|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
160965256|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
160965257|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
160965258|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
160965259|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
160965260|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
160965261|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
160965262|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
160965263|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
160965264|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
160965265|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
160965266|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
160965267|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
160965268|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
160965269|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
160458426|NCT04761198|579409171|FG000|Overall Study|Progressive Disease|1|||
160965270|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
160965271|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
160965272|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
160965273|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
160458427|NCT04761198|579409172|FG001|Overall Study|Progressive Disease|0|||
160458428|NCT04761198|579409173|FG002|Overall Study|Progressive Disease|0|||
161003104|NCT03388632|581396618|FG005|Triplet C|Adverse Event|0|||
161003105|NCT03388632|581396619|FG006|Triplet C|Adverse Event|0|||
161003106|NCT03388632|581396620|FG007|Triplet C|Adverse Event|0|||
161003107|NCT03388632|581396621|FG008|Triplet C|Adverse Event|1|||
161003108|NCT03388632|581396613|FG000|Triplet C|Switched to alternative treatment|0|||
161003109|NCT03388632|581396614|FG001|Triplet C|Switched to alternative treatment|0|||
161003110|NCT03388632|581396615|FG002|Triplet C|Switched to alternative treatment|0|||
161003111|NCT03388632|581396616|FG003|Triplet C|Switched to alternative treatment|0|||
161003112|NCT03388632|581396617|FG004|Triplet C|Switched to alternative treatment|0|||
161003113|NCT03388632|581396618|FG005|Triplet C|Switched to alternative treatment|0|||
161003114|NCT03388632|581396619|FG006|Triplet C|Switched to alternative treatment|0|||
161003115|NCT03388632|581396620|FG007|Triplet C|Switched to alternative treatment|1|||
161003116|NCT03388632|581396621|FG008|Triplet C|Switched to alternative treatment|0|||
161003117|NCT03388632|581396613|FG000|Triplet C|Participant choice|0|||
161003118|NCT03388632|581396614|FG001|Triplet C|Participant choice|0|||
161003119|NCT03388632|581396615|FG002|Triplet C|Participant choice|0|||
161003120|NCT03388632|581396616|FG003|Triplet C|Participant choice|0|||
161003121|NCT03388632|581396617|FG004|Triplet C|Participant choice|0|||
161003122|NCT03388632|581396618|FG005|Triplet C|Participant choice|1|||
161003123|NCT03388632|581396619|FG006|Triplet C|Participant choice|0|||
161003124|NCT03388632|581396620|FG007|Triplet C|Participant choice|0|||
161003125|NCT03388632|581396621|FG008|Triplet C|Participant choice|0|||
161003126|NCT02115282|581396622|FG000|Overall Study|Disease progression during treatment|216|||
161003127|NCT02115282|581396623|FG001|Overall Study|Disease progression during treatment|229|||
161003128|NCT02115282|581396622|FG000|Overall Study|Adverse Event|49|||
161003129|NCT02115282|581396623|FG001|Overall Study|Adverse Event|23|||
161003130|NCT02115282|581396622|FG000|Overall Study|Death|1|||
161003131|NCT02115282|581396623|FG001|Overall Study|Death|3|||
161003132|NCT02115282|581396622|FG000|Overall Study|Alternative therapy|1|||
161003133|NCT02115282|581396623|FG001|Overall Study|Alternative therapy|1|||
161003134|NCT02115282|581396622|FG000|Overall Study|Complicating disease|0|||
161003135|NCT02115282|581396623|FG001|Overall Study|Complicating disease|3|||
161003136|NCT02115282|581396622|FG000|Overall Study|Withdrawal by Subject|12|||
161003137|NCT02115282|581396623|FG001|Overall Study|Withdrawal by Subject|10|||
161003138|NCT02115282|581396622|FG000|Overall Study|Symptomatic progression/deterioration|7|||
161003139|NCT02115282|581396623|FG001|Overall Study|Symptomatic progression/deterioration|18|||
161003140|NCT02115282|581396622|FG000|Overall Study|Non-compliance|5|||
161003141|NCT02115282|581396623|FG001|Overall Study|Non-compliance|1|||
161003142|NCT02115282|581396622|FG000|Overall Study|Protocol Violation|2|||
161003143|NCT02115282|581396623|FG001|Overall Study|Protocol Violation|2|||
161003144|NCT02115282|581396622|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
161003145|NCT02115282|581396623|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
161003146|NCT02115282|581396622|FG000|Overall Study|Not start protocol therapy|9|||
161003147|NCT02115282|581396623|FG001|Overall Study|Not start protocol therapy|10|||
161003148|NCT06218251|581396626|FG000|Overall Study|Lost to Follow-up|4|||
161003149|NCT00997386|581396629|FG000|Overall Study|Death|7|||
161003150|NCT03492177|581396630|FG000|Overall Study|Adverse Event|1|||
161003151|NCT03492177|581396631|FG001|Overall Study|Adverse Event|0|||
161003152|NCT03492177|581396632|FG002|Overall Study|Adverse Event|0|||
161003153|NCT03492177|581396630|FG000|Overall Study|Death|3|||
161003154|NCT03492177|581396631|FG001|Overall Study|Death|0|||
161003155|NCT03492177|581396632|FG002|Overall Study|Death|3|||
161003156|NCT03492177|581396630|FG000|Overall Study|Lack of Efficacy|1|||
161003157|NCT03492177|581396631|FG001|Overall Study|Lack of Efficacy|2|||
161003158|NCT03492177|581396632|FG002|Overall Study|Lack of Efficacy|0|||
161003159|NCT03492177|581396630|FG000|Overall Study|Other|1|||
161003160|NCT03492177|581396631|FG001|Overall Study|Other|0|||
161003161|NCT03492177|581396632|FG002|Overall Study|Other|0|||
161003162|NCT03492177|581396630|FG000|Overall Study|Ongoing|16|||
161003163|NCT03492177|581396631|FG001|Overall Study|Ongoing|19|||
161003164|NCT03492177|581396632|FG002|Overall Study|Ongoing|17|||
161003165|NCT03889925|581397969|FG000|Overall Study|Lost to Follow-up|11|||
161003166|NCT03889925|581397970|FG001|Overall Study|Lost to Follow-up|10|||
160585094|NCT02052778|579861878|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585095|NCT02052778|579861879|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161003167|NCT05777785|581397971|FG000|Overall Study|Withdrawal by Subject|5|||
161003168|NCT05777785|581397971|FG000|Overall Study|Lost to Follow-up|1|||
161003169|NCT05644444|581397976|FG000|Tolerance Phase|Adverse Event|0|||
161003170|NCT05644444|581397977|FG001|Tolerance Phase|Adverse Event|2|||
161003171|NCT05644444|581397976|FG000|Treatment Phase|Adverse Event|0|||
161003172|NCT05644444|581397977|FG001|Treatment Phase|Adverse Event|2|||
161003173|NCT00493649|581397978|FG000|Overall Study|Adverse Event|44|||
161003174|NCT00493649|581397978|FG000|Overall Study|Patient Request|21|||
161003175|NCT00493649|581397978|FG000|Overall Study|Investigator Request|2|||
161003176|NCT00493649|581397978|FG000|Overall Study|Disease Progression|1|||
161003177|NCT00493649|581397978|FG000|Overall Study|Lost to Follow-up|1|||
161003178|NCT00493649|581397978|FG000|Overall Study|Other|13|||
161003179|NCT00925899|581397981|FG000|Part 1|Death|1|||
161003180|NCT00925899|581397982|FG001|Part 1|Death|2|||
161003181|NCT00925899|581397981|FG000|Part 1|Withdrawal by Subject|10|||
161003182|NCT00925899|581397982|FG001|Part 1|Withdrawal by Subject|9|||
161003183|NCT00683696|581397983|FG000|Overall Study|Withdrawn due to study closure|337|||
161003184|NCT00683696|581397984|FG001|Overall Study|Withdrawn due to study closure|338|||
161003185|NCT00683696|581397983|FG000|Overall Study|Withdrawn prior to study closure|13|||
161003186|NCT00683696|581397984|FG001|Overall Study|Withdrawn prior to study closure|28|||
161003187|NCT00683696|581397983|FG000|Overall Study|Lost to Follow-up|5|||
161003188|NCT00683696|581397984|FG001|Overall Study|Lost to Follow-up|6|||
161003189|NCT00683696|581397983|FG000|Overall Study|Vital status follow-up only|3|||
161003190|NCT00683696|581397984|FG001|Overall Study|Vital status follow-up only|3|||
161003191|NCT00683696|581397983|FG000|Overall Study|Death|46|||
161003192|NCT00683696|581397984|FG001|Overall Study|Death|30|||
161003193|NCT00089544|581397985|FG000|Overall Study|Ineligible|1|||
161003194|NCT00089544|581397986|FG001|Overall Study|Ineligible|0|||
161003195|NCT02396316|581397989|FG000|Overall Study|Physician Decision|1|||
161003196|NCT02396316|581397990|FG001|Overall Study|Physician Decision|0|||
161003197|NCT02396316|581397989|FG000|Overall Study|Progressive disease|6|||
161003198|NCT02396316|581397990|FG001|Overall Study|Progressive disease|3|||
161003199|NCT02396316|581397989|FG000|Overall Study|Protocol Violation|0|||
161003200|NCT02396316|581397990|FG001|Overall Study|Protocol Violation|1|||
161003201|NCT02396316|581397989|FG000|Overall Study|Treatment unblinded|0|||
161003202|NCT02396316|581397990|FG001|Overall Study|Treatment unblinded|1|||
161003203|NCT01823536|581397991|FG000|Overall Study|Lost to Follow-up|1|||
161003204|NCT01823536|581397992|FG001|Overall Study|Lost to Follow-up|0|||
161003205|NCT01823536|581397993|FG002|Overall Study|Lost to Follow-up|0|||
161003206|NCT01823536|581397994|FG003|Overall Study|Lost to Follow-up|1|||
161003207|NCT01823536|581397995|FG004|Overall Study|Lost to Follow-up|1|||
161003208|NCT01823536|581397996|FG005|Overall Study|Lost to Follow-up|0|||
161003209|NCT01823536|581397991|FG000|Overall Study|Protocol Violation|0|||
161003210|NCT01823536|581397992|FG001|Overall Study|Protocol Violation|1|||
161003211|NCT01823536|581397993|FG002|Overall Study|Protocol Violation|0|||
161003212|NCT01823536|581397994|FG003|Overall Study|Protocol Violation|0|||
161003213|NCT01823536|581397995|FG004|Overall Study|Protocol Violation|0|||
161003214|NCT01823536|581397996|FG005|Overall Study|Protocol Violation|0|||
161003215|NCT01823536|581397991|FG000|Overall Study|Withdrawal by Subject|1|||
161003216|NCT01823536|581397992|FG001|Overall Study|Withdrawal by Subject|1|||
161003217|NCT01823536|581397993|FG002|Overall Study|Withdrawal by Subject|0|||
161003218|NCT01823536|581397994|FG003|Overall Study|Withdrawal by Subject|0|||
161003219|NCT01823536|581397995|FG004|Overall Study|Withdrawal by Subject|0|||
161003220|NCT01823536|581397996|FG005|Overall Study|Withdrawal by Subject|0|||
161003221|NCT01823536|581397991|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161003222|NCT01823536|581397992|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161003223|NCT01823536|581397993|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
161003224|NCT01823536|581397994|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161003225|NCT01823536|581397995|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161003226|NCT01823536|581397996|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161003227|NCT01823536|581397991|FG000|Overall Study|Met exclusion criterion No 6|0|||
161003228|NCT01823536|581397992|FG001|Overall Study|Met exclusion criterion No 6|0|||
161003229|NCT01823536|581397993|FG002|Overall Study|Met exclusion criterion No 6|0|||
161003230|NCT01823536|581397994|FG003|Overall Study|Met exclusion criterion No 6|1|||
161003231|NCT01823536|581397995|FG004|Overall Study|Met exclusion criterion No 6|0|||
161003232|NCT01823536|581397996|FG005|Overall Study|Met exclusion criterion No 6|0|||
161003233|NCT01823536|581397991|FG000|Overall Study|Subject moved out of the state|0|||
161003234|NCT01823536|581397992|FG001|Overall Study|Subject moved out of the state|0|||
161003235|NCT01823536|581397993|FG002|Overall Study|Subject moved out of the state|0|||
161003236|NCT01823536|581397994|FG003|Overall Study|Subject moved out of the state|0|||
161003237|NCT01823536|581397995|FG004|Overall Study|Subject moved out of the state|1|||
161003238|NCT01823536|581397996|FG005|Overall Study|Subject moved out of the state|0|||
161003239|NCT03648762|581397997|FG000|Overall Study|Lost to Follow-up|1|||
161003240|NCT03648762|581397998|FG001|Overall Study|Lost to Follow-up|2|||
161003241|NCT03648762|581397999|FG002|Overall Study|Lost to Follow-up|0|||
161003242|NCT03648762|581397997|FG000|Overall Study|Withdrawal by Subject|5|||
161003243|NCT03648762|581397998|FG001|Overall Study|Withdrawal by Subject|2|||
161003244|NCT03648762|581397999|FG002|Overall Study|Withdrawal by Subject|1|||
161003245|NCT01662336|581398012|FG000|Overall Study|Adverse Event|1|||
161003246|NCT01662336|581398012|FG000|Overall Study|No longer on LPV/r|30|||
161003247|NCT01662336|581398012|FG000|Overall Study|Other|29|||
161003248|NCT01662336|581398012|FG000|Overall Study|Withdrawal by Subject|6|||
161003249|NCT02189252|581398013|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
161003250|NCT02189252|581398014|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
161003251|NCT02189252|581398015|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
161003252|NCT02189252|581398016|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
161003253|NCT02189252|581398013|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
161003254|NCT02189252|581398014|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
161003255|NCT02189252|581398015|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
160458429|NCT04761198|579409174|FG003|Overall Study|Progressive Disease|1|||
160458430|NCT04761198|579409175|FG004|Overall Study|Progressive Disease|4|||
160458431|NCT04761198|579409176|FG005|Overall Study|Progressive Disease|1|||
160458432|NCT04761198|579409177|FG006|Overall Study|Progressive Disease|2|||
160965274|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160965275|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
160965276|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
160965277|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
160965278|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
160965279|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160965280|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160965281|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160965282|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965283|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
160965284|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
160965285|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965286|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965287|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965288|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965289|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965290|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160965291|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
160965292|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160965293|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
160965294|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
160965295|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160965296|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160965297|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160965298|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965299|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
160965300|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965301|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965302|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965303|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965304|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965305|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965306|NCT02496767|581261129|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965307|NCT02496767|581261130|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965308|NCT02496767|581261131|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965309|NCT02496767|581261132|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965310|NCT02496767|581261133|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965311|NCT02496767|581261134|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
160965312|NCT02496767|581261135|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965313|NCT02496767|581261136|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
160965314|NCT02496767|581261129|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
160965315|NCT02496767|581261130|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
160965316|NCT02496767|581261131|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
160965317|NCT02496767|581261132|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
160965318|NCT02496767|581261133|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
160965319|NCT02496767|581261134|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
160965320|NCT02496767|581261135|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
160965321|NCT02496767|581261136|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
160965322|NCT02496767|581261129|FG000|Double-blind, Withdrawal Phase|Death|0|||
160965323|NCT02496767|581261130|FG001|Double-blind, Withdrawal Phase|Death|0|||
160965324|NCT02496767|581261131|FG002|Double-blind, Withdrawal Phase|Death|0|||
160965325|NCT02496767|581261132|FG003|Double-blind, Withdrawal Phase|Death|0|||
160965326|NCT02496767|581261133|FG004|Double-blind, Withdrawal Phase|Death|0|||
160965327|NCT02496767|581261134|FG005|Double-blind, Withdrawal Phase|Death|0|||
160965328|NCT02496767|581261135|FG006|Double-blind, Withdrawal Phase|Death|1|||
160965329|NCT02496767|581261136|FG007|Double-blind, Withdrawal Phase|Death|2|||
160965330|NCT02496767|581261129|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
160965331|NCT02496767|581261130|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
160965332|NCT02496767|581261131|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
160458433|NCT04761198|579409171|FG000|Overall Study|Protocol Violation|0|||
160458434|NCT04761198|579409172|FG001|Overall Study|Protocol Violation|0|||
160458435|NCT04761198|579409173|FG002|Overall Study|Protocol Violation|0|||
160458436|NCT04761198|579409174|FG003|Overall Study|Protocol Violation|0|||
160458437|NCT04761198|579409175|FG004|Overall Study|Protocol Violation|1|||
161003256|NCT02189252|581398016|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
161003257|NCT00566735|581398017|FG000|Overall Study|Withdrawal by Subject|0|||
161003258|NCT00566735|581398018|FG001|Overall Study|Withdrawal by Subject|1|||
161003259|NCT00566735|581398017|FG000|Overall Study|Refused neuropsychological testing|2|||
161003260|NCT00566735|581398018|FG001|Overall Study|Refused neuropsychological testing|5|||
161003261|NCT00566735|581398017|FG000|Overall Study|Switched into a manic episode|0|||
161003262|NCT00566735|581398018|FG001|Overall Study|Switched into a manic episode|1|||
161003263|NCT00768664|581398019|FG000|Overall Study|Death|57|||
161003264|NCT00768664|581398019|FG000|Overall Study|Lost to Follow-up|2|||
161003265|NCT00768664|581398019|FG000|Overall Study|Other|9|||
161003266|NCT00768664|581398019|FG000|Overall Study|Participant refused|1|||
161003267|NCT02544152|581398020|FG000|Overall Study|Adverse Event|0|||
161003268|NCT02544152|581398021|FG001|Overall Study|Adverse Event|4|||
161003269|NCT02544152|581398020|FG000|Overall Study|Withdrawal by Subject|0|||
161003270|NCT02544152|581398021|FG001|Overall Study|Withdrawal by Subject|3|||
161003271|NCT02544152|581398020|FG000|Overall Study|Other|1|||
161003272|NCT02544152|581398021|FG001|Overall Study|Other|0|||
161003273|NCT02320123|581398022|FG000|Overall Study|Lost to Follow-up|4|||
161003274|NCT02320123|581398023|FG001|Overall Study|Lost to Follow-up|6|||
161003275|NCT02320123|581398022|FG000|Overall Study|Death|6|||
161003276|NCT02320123|581398023|FG001|Overall Study|Death|5|||
161003277|NCT04480827|581398024|FG000|Overall Study|Adverse Event|0|||
161003278|NCT04480827|581398025|FG001|Overall Study|Adverse Event|0|||
161003279|NCT04480827|581398026|FG002|Overall Study|Adverse Event|0|||
161003280|NCT04480827|581398027|FG003|Overall Study|Adverse Event|0|||
161003281|NCT04480827|581398028|FG004|Overall Study|Adverse Event|0|||
161003282|NCT04480827|581398029|FG005|Overall Study|Adverse Event|1|||
161003283|NCT04480827|581398030|FG006|Overall Study|Adverse Event|0|||
161003284|NCT00465816|581398031|FG000|Overall Study|Lost to Follow-up|0|||
161003285|NCT00465816|581398032|FG001|Overall Study|Lost to Follow-up|0|||
161003286|NCT00465816|581398033|FG002|Overall Study|Lost to Follow-up|2|||
161003287|NCT03194958|581398034|FG000|Overall Study|Death|0|||
161003288|NCT03194958|581398035|FG001|Overall Study|Death|1|||
161003289|NCT03194958|581398036|FG002|Overall Study|Death|1|||
161003290|NCT03194958|581398037|FG003|Overall Study|Death|1|||
161003291|NCT03194958|581398034|FG000|Overall Study|Withdrawal by Subject|24|||
161003292|NCT03194958|581398035|FG001|Overall Study|Withdrawal by Subject|27|||
161003293|NCT03194958|581398036|FG002|Overall Study|Withdrawal by Subject|7|||
161003294|NCT03194958|581398037|FG003|Overall Study|Withdrawal by Subject|22|||
161003295|NCT03194958|581398034|FG000|Overall Study|Lost to Follow-up|168|||
161003296|NCT03194958|581398035|FG001|Overall Study|Lost to Follow-up|196|||
161003297|NCT03194958|581398036|FG002|Overall Study|Lost to Follow-up|174|||
161003298|NCT03194958|581398037|FG003|Overall Study|Lost to Follow-up|186|||
161003299|NCT01179334|581398040|FG000|Treatment Period|Adverse Event|1|||
161003300|NCT01179334|581398041|FG001|Treatment Period|Adverse Event|0|||
161003301|NCT01179334|581398040|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
161003302|NCT01179334|581398041|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
161003303|NCT01179334|581398040|FG000|Long-term Extension (LTE) Period|Death|3|||
161003304|NCT01179334|581398041|FG001|Long-term Extension (LTE) Period|Death|0|||
161003305|NCT01179334|581398040|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
161003306|NCT01179334|581398041|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
161003307|NCT03654768|581398044|FG000|Overall Study|Adverse Event|1|||
161003308|NCT03654768|581398045|FG001|Overall Study|Adverse Event|6|||
161003309|NCT03654768|581398044|FG000|Overall Study|Loss of response|2|||
161003310|NCT03654768|581398045|FG001|Overall Study|Loss of response|2|||
161003311|NCT03654768|581398044|FG000|Overall Study|Non-compliance|0|||
161003312|NCT03654768|581398045|FG001|Overall Study|Non-compliance|1|||
161003313|NCT03654768|581398044|FG000|Overall Study|Refusal not related to toxicity|1|||
161003314|NCT03654768|581398045|FG001|Overall Study|Refusal not related to toxicity|5|||
161003315|NCT03654768|581398044|FG000|Overall Study|Did not receive protocol therapy|1|||
161003316|NCT03654768|581398045|FG001|Overall Study|Did not receive protocol therapy|1|||
161003317|NCT00588770|581398046|FG000|Overall Study|Disease progression|85|||
161003318|NCT00588770|581398047|FG001|Overall Study|Disease progression|68|||
161003319|NCT00588770|581398046|FG000|Overall Study|Adverse Event|29|||
161003320|NCT00588770|581398047|FG001|Overall Study|Adverse Event|58|||
161003321|NCT00588770|581398046|FG000|Overall Study|Death|13|||
161003322|NCT00588770|581398047|FG001|Overall Study|Death|22|||
161003323|NCT00588770|581398046|FG000|Overall Study|Withdrawal by Subject|15|||
161003324|NCT00588770|581398047|FG001|Overall Study|Withdrawal by Subject|25|||
161003325|NCT00588770|581398046|FG000|Overall Study|Alternative therapy|2|||
161003326|NCT00588770|581398047|FG001|Overall Study|Alternative therapy|4|||
160585096|NCT02052778|579861880|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585097|NCT02052778|579861881|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160632904|NCT02858076|580036101|FG001|Overall Study|Lost to Follow-up|7|||
161003327|NCT00588770|581398046|FG000|Overall Study|Other complicating disease|3|||
161003328|NCT00588770|581398047|FG001|Overall Study|Other complicating disease|2|||
161003329|NCT00588770|581398046|FG000|Overall Study|Not start protocol therapy|0|||
161003330|NCT00588770|581398047|FG001|Overall Study|Not start protocol therapy|9|||
161003331|NCT00588770|581398046|FG000|Overall Study|Lack of Efficacy|8|||
161003332|NCT00588770|581398047|FG001|Overall Study|Lack of Efficacy|10|||
161003333|NCT00588770|581398046|FG000|Overall Study|Physician discretion|2|||
161003334|NCT00588770|581398047|FG001|Overall Study|Physician discretion|0|||
161003335|NCT00588770|581398046|FG000|Overall Study|Patient non-compliance|2|||
161003336|NCT00588770|581398047|FG001|Overall Study|Patient non-compliance|2|||
161003337|NCT04697628|581398048|FG000|Overall Study|Withdrawal by Subject|17|||
161003338|NCT04697628|581398049|FG001|Overall Study|Withdrawal by Subject|23|||
161003339|NCT04697628|581398048|FG000|Overall Study|Lost to Follow-up|0|||
161003340|NCT04697628|581398049|FG001|Overall Study|Lost to Follow-up|4|||
161003341|NCT04697628|581398048|FG000|Overall Study|On-going in study|122|||
161003342|NCT04697628|581398049|FG001|Overall Study|On-going in study|91|||
161003343|NCT04177394|581398052|FG000|Overall Study|Death|16|||
161003344|NCT04177394|581398052|FG000|Overall Study|Withdrawal by Subject|19|||
161003345|NCT04177394|581398052|FG000|Overall Study|Missed visits|61|||
161003346|NCT04177394|581398052|FG000|Overall Study|Expected Visits|15|||
161003347|NCT00256243|581398053|FG000|Overall Study|Lost to Follow-up|2|||
161003348|NCT00256243|581398053|FG000|Overall Study|Death|7|||
161003349|NCT00256243|581398053|FG000|Overall Study|Not treated|1|||
161003350|NCT01152190|581398054|FG000|Overall Study|Adverse Event|2|||
161003351|NCT01152190|581398055|FG001|Overall Study|Adverse Event|4|||
161003352|NCT01152190|581398054|FG000|Overall Study|Death|1|||
161003353|NCT01152190|581398055|FG001|Overall Study|Death|0|||
161003354|NCT01152190|581398054|FG000|Overall Study|Protocol Violation|1|||
161003355|NCT01152190|581398055|FG001|Overall Study|Protocol Violation|1|||
161003356|NCT01152190|581398054|FG000|Overall Study|Withdrawal by Subject|1|||
161003357|NCT01152190|581398055|FG001|Overall Study|Withdrawal by Subject|3|||
161003358|NCT06129045|581398056|FG000|Overall Study|Lost to Follow-up|1|||
161003359|NCT06129045|581398057|FG001|Overall Study|Lost to Follow-up|1|||
161003360|NCT06129045|581398058|FG002|Overall Study|Lost to Follow-up|4|||
161003361|NCT02031471|581398059|FG000|24 Week Treatment Period|Adverse Event|6|||
161003362|NCT02031471|581398059|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
161003363|NCT02031471|581398059|FG000|24 Week Treatment Period|Protocol Violation|1|||
161003364|NCT02031471|581398059|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
161003365|NCT02031471|581398059|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
161003366|NCT02031471|581398059|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
161003367|NCT02031471|581398059|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
161003368|NCT03070483|581398060|FG000|Overall Study|Lost to Follow-up|2|||
161003369|NCT05797155|581398061|FG000|Overall Study|Lost to Follow-up|33|||
161003370|NCT05797155|581398062|FG001|Overall Study|Lost to Follow-up|12|||
161003371|NCT00617201|581398068|FG000|Overall Study|Lost to Follow-up|9|||
161003372|NCT00617201|581398069|FG001|Overall Study|Lost to Follow-up|13|||
161003373|NCT01350804|581398070|FG000|Core Study|Withdrawal by Subject|11|||
161003374|NCT01350804|581398071|FG001|Core Study|Withdrawal by Subject|17|||
161003375|NCT01350804|581398072|FG002|Core Study|Withdrawal by Subject|16|||
161003376|NCT01350804|581398073|FG003|Core Study|Withdrawal by Subject|7|||
161003377|NCT01350804|581398070|FG000|Core Study|Study terminated by Sponsor|0|||
161003378|NCT01350804|581398071|FG001|Core Study|Study terminated by Sponsor|0|||
161003379|NCT01350804|581398072|FG002|Core Study|Study terminated by Sponsor|0|||
161003380|NCT01350804|581398073|FG003|Core Study|Study terminated by Sponsor|2|||
161003381|NCT01350804|581398070|FG000|Core Study|Protocol deviation|1|||
161003382|NCT01350804|581398071|FG001|Core Study|Protocol deviation|0|||
161003383|NCT01350804|581398072|FG002|Core Study|Protocol deviation|1|||
161003384|NCT01350804|581398073|FG003|Core Study|Protocol deviation|0|||
161003385|NCT01350804|581398070|FG000|Core Study|Physician Decision|1|||
161003386|NCT01350804|581398071|FG001|Core Study|Physician Decision|0|||
161003387|NCT01350804|581398072|FG002|Core Study|Physician Decision|1|||
161003388|NCT01350804|581398073|FG003|Core Study|Physician Decision|3|||
161003389|NCT01350804|581398070|FG000|Core Study|Lost to Follow-up|3|||
161003390|NCT01350804|581398071|FG001|Core Study|Lost to Follow-up|0|||
161003391|NCT01350804|581398072|FG002|Core Study|Lost to Follow-up|2|||
161003392|NCT01350804|581398073|FG003|Core Study|Lost to Follow-up|1|||
161003393|NCT01350804|581398070|FG000|Core Study|Lack of Efficacy|16|||
160585098|NCT02052778|579861882|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161003394|NCT01350804|581398071|FG001|Core Study|Lack of Efficacy|19|||
161003395|NCT01350804|581398072|FG002|Core Study|Lack of Efficacy|18|||
161003396|NCT01350804|581398073|FG003|Core Study|Lack of Efficacy|5|||
161003397|NCT01350804|581398070|FG000|Core Study|Death|1|||
161003398|NCT01350804|581398071|FG001|Core Study|Death|1|||
160585099|NCT02052778|579861883|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161003399|NCT01350804|581398072|FG002|Core Study|Death|1|||
161003400|NCT01350804|581398073|FG003|Core Study|Death|0|||
161003401|NCT01350804|581398070|FG000|Core Study|Adverse Event|8|||
161003402|NCT01350804|581398071|FG001|Core Study|Adverse Event|10|||
161003403|NCT01350804|581398072|FG002|Core Study|Adverse Event|8|||
161003404|NCT01350804|581398073|FG003|Core Study|Adverse Event|8|||
161003405|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
161003406|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
161003407|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
160585100|NCT02052778|579861884|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585101|NCT02052778|579861885|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585102|NCT02052778|579861886|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585103|NCT02052778|579861887|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585104|NCT02052778|579861888|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585105|NCT02052778|579861889|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585106|NCT02052778|579861890|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
160585107|NCT02052778|579861891|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
160585108|NCT02052778|579861892|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585109|NCT02052778|579861893|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585110|NCT02052778|579861894|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585111|NCT02052778|579861895|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585112|NCT02052778|579861896|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585113|NCT02052778|579861897|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585114|NCT02052778|579861898|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
160585115|NCT02052778|579861876|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585116|NCT02052778|579861877|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585117|NCT02052778|579861878|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160965333|NCT02496767|581261132|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
160965334|NCT02496767|581261133|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
160965335|NCT02496767|581261134|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
160965336|NCT02496767|581261135|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
160965337|NCT02496767|581261136|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
160965338|NCT03641313|581261145|FG000|Overall Study|Death|1|||
160965339|NCT03641313|581261145|FG000|Overall Study|Withdrawal by Subject|2|||
160965340|NCT03641313|581261145|FG000|Overall Study|Declining health|1|||
160965341|NCT03641313|581261145|FG000|Overall Study|Adverse Event|1|||
160965342|NCT01533493|581261148|FG000|Overall Study|Adverse Event|2|||
160965343|NCT01533493|581261149|FG001|Overall Study|Adverse Event|1|||
160965344|NCT01533493|581261148|FG000|Overall Study|Withdrawal by Subject|1|||
160965345|NCT01533493|581261149|FG001|Overall Study|Withdrawal by Subject|2|||
160965346|NCT01533493|581261148|FG000|Overall Study|Lost to Follow-up|2|||
160965347|NCT01533493|581261149|FG001|Overall Study|Lost to Follow-up|0|||
160965348|NCT02521285|581261153|FG000|Overall Study|Lost to Follow-up|1|||
160965349|NCT02521285|581261154|FG001|Overall Study|Lost to Follow-up|1|||
160965350|NCT02521285|581261153|FG000|Overall Study|Withdrawal by Subject|1|||
160965351|NCT02521285|581261154|FG001|Overall Study|Withdrawal by Subject|1|||
160965352|NCT02521285|581261153|FG000|Overall Study|Adverse Event|0|||
160965353|NCT02521285|581261154|FG001|Overall Study|Adverse Event|1|||
160965354|NCT05701995|581261156|FG000|Pre-Treatment|Randomization Error|1|||
160965355|NCT05701995|581261157|FG001|Pre-Treatment|Randomization Error|1|||
160965356|NCT05701995|581261156|FG000|Treatment|Withdrawal by Subject|8|||
160965357|NCT05701995|581261157|FG001|Treatment|Withdrawal by Subject|4|||
160965358|NCT05701995|581261156|FG000|Treatment|Lost to Follow-up|2|||
160965359|NCT05701995|581261157|FG001|Treatment|Lost to Follow-up|3|||
160965360|NCT05701995|581261156|FG000|Treatment|Adverse Event|3|||
160965361|NCT05701995|581261157|FG001|Treatment|Adverse Event|1|||
160965362|NCT05701995|581261156|FG000|Treatment|Other Reason|1|||
160965363|NCT05701995|581261157|FG001|Treatment|Other Reason|1|||
160965364|NCT05701995|581261156|FG000|Treatment|Death|1|||
160965365|NCT05701995|581261157|FG001|Treatment|Death|0|||
160965366|NCT05701995|581261156|FG000|Treatment|Physician Decision|0|||
160965367|NCT05701995|581261157|FG001|Treatment|Physician Decision|1|||
160965368|NCT00715429|581261158|FG000|Overall Study|Did not complete the study diary|0|||
160965369|NCT00715429|581261159|FG001|Overall Study|Did not complete the study diary|1|||
160965370|NCT04899245|581261164|FG000|Overall Study|Withdrawal by Subject|3|||
160965371|NCT04899245|581261165|FG001|Overall Study|Withdrawal by Subject|5|||
160965372|NCT04899245|581261166|FG002|Overall Study|Withdrawal by Subject|2|||
160965373|NCT04899245|581261164|FG000|Overall Study|No longer eligible - Left staff position|0|||
160965374|NCT04899245|581261165|FG001|Overall Study|No longer eligible - Left staff position|0|||
160965375|NCT04899245|581261166|FG002|Overall Study|No longer eligible - Left staff position|1|||
160965376|NCT04899245|581261164|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
160965377|NCT04899245|581261165|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
160965378|NCT04899245|581261166|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
161003408|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
160965379|NCT04899245|581261164|FG000|Overall Study|No longer eligible - Moved away from area|2|||
160965380|NCT04899245|581261165|FG001|Overall Study|No longer eligible - Moved away from area|2|||
160965381|NCT04899245|581261166|FG002|Overall Study|No longer eligible - Moved away from area|0|||
161003409|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
160965382|NCT03937219|581261175|FG000|Overall Study|Death|223|||
160965383|NCT03937219|581261176|FG001|Overall Study|Death|211|||
160656996|NCT05097989|580124502|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160656997|NCT05097989|580124503|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160965384|NCT03937219|581261175|FG000|Overall Study|Withdrawal by Subject|17|||
160965385|NCT03937219|581261176|FG001|Overall Study|Withdrawal by Subject|25|||
160965386|NCT03937219|581261175|FG000|Overall Study|Lost to Follow-up|3|||
160965387|NCT03937219|581261176|FG001|Overall Study|Lost to Follow-up|4|||
160965388|NCT04003610|581261177|FG000|Overall Study|Lost to Follow-up|0|||
160965389|NCT04003610|581261178|FG001|Overall Study|Lost to Follow-up|1|||
160965390|NCT04003610|581261179|FG002|Overall Study|Lost to Follow-up|0|||
160965391|NCT04003610|581261177|FG000|Overall Study|Death|0|||
160965392|NCT04003610|581261178|FG001|Overall Study|Death|0|||
160965393|NCT04003610|581261179|FG002|Overall Study|Death|3|||
160965394|NCT04003610|581261177|FG000|Overall Study|Study Terminated by Sponsor|0|||
160965395|NCT04003610|581261178|FG001|Overall Study|Study Terminated by Sponsor|0|||
160965396|NCT04003610|581261179|FG002|Overall Study|Study Terminated by Sponsor|3|||
160965397|NCT03078816|581261183|FG000|Overall Study|Withdrawal by Subject|1|||
160965398|NCT02114151|581261184|FG000|Overall Study|Death|1|||
160965399|NCT02114151|581261184|FG000|Overall Study|Lost to Follow-up|1|||
160965400|NCT02114151|581261184|FG000|Overall Study|Withdrawal by Subject|5|||
160965401|NCT00500903|581261185|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
160965402|NCT00500903|581261186|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
160965403|NCT00500903|581261187|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
160965404|NCT00500903|581261185|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
160965405|NCT00500903|581261186|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
160965406|NCT00500903|581261187|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
160965407|NCT00500903|581261185|FG000|Overall Study|Progressive Disease|41|||
160965408|NCT00500903|581261186|FG001|Overall Study|Progressive Disease|2|||
160965409|NCT00500903|581261187|FG002|Overall Study|Progressive Disease|15|||
160965410|NCT00500903|581261185|FG000|Overall Study|Patient Declined Further Treatment|0|||
160965411|NCT00500903|581261186|FG001|Overall Study|Patient Declined Further Treatment|0|||
160965412|NCT00500903|581261187|FG002|Overall Study|Patient Declined Further Treatment|3|||
160965413|NCT00500903|581261185|FG000|Overall Study|Symptomatic Deterioration|2|||
160965414|NCT00500903|581261186|FG001|Overall Study|Symptomatic Deterioration|0|||
160965415|NCT00500903|581261187|FG002|Overall Study|Symptomatic Deterioration|0|||
160965416|NCT00500903|581261185|FG000|Overall Study|Reason Not Specified|10|||
160965417|NCT00500903|581261186|FG001|Overall Study|Reason Not Specified|0|||
160965418|NCT00500903|581261187|FG002|Overall Study|Reason Not Specified|2|||
160965419|NCT01648348|581261190|FG000|Overall Study|Cancel|1|||
160965420|NCT01648348|581261191|FG001|Overall Study|Cancel|0|||
160965421|NCT01648348|581261192|FG002|Overall Study|Cancel|0|||
160965422|NCT01648348|581261193|FG003|Overall Study|Cancel|0|||
160965423|NCT01648348|581261194|FG004|Overall Study|Cancel|3|||
160965424|NCT01648348|581261195|FG005|Overall Study|Cancel|6|||
160965425|NCT01648348|581261190|FG000|Overall Study|Replaced for MTD analysis|1|||
160965426|NCT01648348|581261191|FG001|Overall Study|Replaced for MTD analysis|0|||
160965427|NCT01648348|581261192|FG002|Overall Study|Replaced for MTD analysis|1|||
160965428|NCT01648348|581261193|FG003|Overall Study|Replaced for MTD analysis|0|||
160965429|NCT01648348|581261194|FG004|Overall Study|Replaced for MTD analysis|0|||
160965430|NCT01648348|581261195|FG005|Overall Study|Replaced for MTD analysis|0|||
160965431|NCT00265889|581261199|FG000|Overall Study|Physician Decision|1|||
160965432|NCT00265889|581261199|FG000|Overall Study|Protocol Violation|1|||
160965433|NCT00265889|581261199|FG000|Overall Study|Insurance denied the request|3|||
160965434|NCT02134587|581261200|FG000|Overall Study|Did not completed all meetings|30|||
160965435|NCT03308825|581262905|FG000|Overall Study|Lost to Follow-up|2|||
160965436|NCT03308825|581262906|FG001|Overall Study|Lost to Follow-up|2|||
160965437|NCT03308825|581262907|FG002|Overall Study|Lost to Follow-up|1|||
160965438|NCT03308825|581262908|FG003|Overall Study|Lost to Follow-up|0|||
160965439|NCT03308825|581262905|FG000|Overall Study|Protocol Violation|0|||
160965440|NCT03308825|581262906|FG001|Overall Study|Protocol Violation|2|||
160965441|NCT03308825|581262907|FG002|Overall Study|Protocol Violation|0|||
160965442|NCT03308825|581262908|FG003|Overall Study|Protocol Violation|0|||
160965443|NCT02790073|581262909|FG000|Overall Study|Death|1|||
160965444|NCT02790073|581262909|FG000|Overall Study|Withdrawal from HD|1|||
160965445|NCT02790073|581262909|FG000|Overall Study|Withdrawal by Subject|1|||
160965446|NCT03328143|581262910|FG000|Overall Study|Declined|3|||
160965447|NCT03328143|581262910|FG000|Overall Study|Required increased sedation|4|||
160965448|NCT03328143|581262910|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
160965449|NCT03328143|581262910|FG000|Overall Study|Surgery cancelled|1|||
160965450|NCT01370525|581262911|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
160965451|NCT01370525|581262912|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
160965452|NCT01370525|581262911|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
160965453|NCT01370525|581262912|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160965454|NCT01370525|581262911|FG000|Overall Study|Adverse Event|0|||
160965455|NCT01370525|581262912|FG001|Overall Study|Adverse Event|1|||
160965456|NCT01370525|581262911|FG000|Overall Study|Protocol Violation|2|||
160965457|NCT01370525|581262912|FG001|Overall Study|Protocol Violation|1|||
160965458|NCT01370525|581262911|FG000|Overall Study|Lost to follow up|2|||
160585118|NCT02052778|579861879|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585119|NCT02052778|579861880|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585120|NCT02052778|579861881|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585121|NCT02052778|579861882|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585122|NCT02052778|579861883|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160965459|NCT01370525|581262912|FG001|Overall Study|Lost to follow up|6|||
160965460|NCT00106184|581262913|FG000|Overall Study|Withdrawal by Subject|3|||
160965461|NCT00106184|581262914|FG001|Overall Study|Withdrawal by Subject|2|||
160965462|NCT05292534|581262915|FG000|Overall Study|Protocol Violation|3|||
160965463|NCT05292534|581262916|FG001|Overall Study|Protocol Violation|4|||
160965464|NCT05292534|581262915|FG000|Overall Study|Withdrawal by Subject|0|||
160965465|NCT05292534|581262916|FG001|Overall Study|Withdrawal by Subject|1|||
160965466|NCT04710927|581262919|FG000|Overall Study|Lost to Follow-up|7|||
160965467|NCT04710927|581262920|FG001|Overall Study|Lost to Follow-up|6|||
160965468|NCT04710927|581262921|FG002|Overall Study|Lost to Follow-up|5|||
160965469|NCT01376323|581262925|FG000|Overall Study|Adverse Event|1|||
160965470|NCT01376323|581262926|FG001|Overall Study|Adverse Event|0|||
160965471|NCT01376323|581262927|FG002|Overall Study|Adverse Event|0|||
160965472|NCT01376323|581262928|FG003|Overall Study|Adverse Event|2|||
160965473|NCT01376323|581262929|FG004|Overall Study|Adverse Event|0|||
160965474|NCT01376323|581262925|FG000|Overall Study|Lost to Follow-up|0|||
160965475|NCT01376323|581262926|FG001|Overall Study|Lost to Follow-up|0|||
160965476|NCT01376323|581262927|FG002|Overall Study|Lost to Follow-up|0|||
160965477|NCT01376323|581262928|FG003|Overall Study|Lost to Follow-up|2|||
160965478|NCT01376323|581262929|FG004|Overall Study|Lost to Follow-up|0|||
160965479|NCT01376323|581262925|FG000|Overall Study|Physician Decision|1|||
160965480|NCT01376323|581262926|FG001|Overall Study|Physician Decision|0|||
160965481|NCT01376323|581262927|FG002|Overall Study|Physician Decision|2|||
160965482|NCT01376323|581262928|FG003|Overall Study|Physician Decision|1|||
160965483|NCT01376323|581262929|FG004|Overall Study|Physician Decision|1|||
160965484|NCT01376323|581262925|FG000|Overall Study|Withdrawal by Subject|0|||
160965485|NCT01376323|581262926|FG001|Overall Study|Withdrawal by Subject|1|||
160965486|NCT01376323|581262927|FG002|Overall Study|Withdrawal by Subject|1|||
160965487|NCT01376323|581262928|FG003|Overall Study|Withdrawal by Subject|0|||
160965488|NCT01376323|581262929|FG004|Overall Study|Withdrawal by Subject|0|||
160965489|NCT00454571|581262930|FG000|Overall Study|Adverse Event|2|||
160965490|NCT00454571|581262931|FG001|Overall Study|Adverse Event|0|||
160965491|NCT00454571|581262930|FG000|Overall Study|Physician Decision|0|||
160965492|NCT00454571|581262931|FG001|Overall Study|Physician Decision|1|||
160965493|NCT00454571|581262930|FG000|Overall Study|Protocol Violation|1|||
160965494|NCT00454571|581262931|FG001|Overall Study|Protocol Violation|0|||
160965495|NCT00454571|581262930|FG000|Overall Study|Withdrawal by Subject|10|||
160965496|NCT00454571|581262931|FG001|Overall Study|Withdrawal by Subject|5|||
160965497|NCT04681729|581262932|FG000|Overall Study|Lack of Efficacy|2|||
160965498|NCT04681729|581262933|FG001|Overall Study|Lack of Efficacy|2|||
160965499|NCT04681729|581262932|FG000|Overall Study|Withdrawal by Subject|8|||
160965500|NCT04681729|581262933|FG001|Overall Study|Withdrawal by Subject|9|||
160965501|NCT03595332|581262934|FG000|Overall Study|Lost to Follow-up|16|||
160965502|NCT03595332|581262935|FG001|Overall Study|Lost to Follow-up|22|||
160965503|NCT03595332|581262934|FG000|Overall Study|Unable to retrieve ID from school|0|||
160965504|NCT03595332|581262935|FG001|Overall Study|Unable to retrieve ID from school|2|||
160965505|NCT00792103|581262936|FG000|Overall Study|Enrolled, not treated|15|||
160965506|NCT00792103|581262936|FG000|Overall Study|Lost to Follow-up|17|||
160965507|NCT00792103|581262936|FG000|Overall Study|Adverse Event|25|||
160965508|NCT00792103|581262936|FG000|Overall Study|Withdrawal by Subject|52|||
160965509|NCT00792103|581262936|FG000|Overall Study|Protocol Violation|10|||
160965510|NCT00792103|581262936|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
160965511|NCT02227875|581262937|FG000|Overall Study|Protocol Violation|10|||
160965512|NCT02227875|581262938|FG001|Overall Study|Protocol Violation|7|||
160965513|NCT02227875|581262937|FG000|Overall Study|Other|1|||
160965514|NCT02227875|581262938|FG001|Overall Study|Other|3|||
160965515|NCT02227875|581262937|FG000|Overall Study|Physician Decision|1|||
160965516|NCT02227875|581262938|FG001|Overall Study|Physician Decision|0|||
160965517|NCT02227875|581262937|FG000|Overall Study|Adverse Event|3|||
160965518|NCT02227875|581262938|FG001|Overall Study|Adverse Event|0|||
160965519|NCT02227875|581262937|FG000|Overall Study|Withdrawal by Subject|12|||
160965520|NCT02227875|581262938|FG001|Overall Study|Withdrawal by Subject|13|||
160965521|NCT02227875|581262937|FG000|Overall Study|Lost to Follow-up|10|||
160965522|NCT02227875|581262938|FG001|Overall Study|Lost to Follow-up|10|||
160965523|NCT01201811|581262939|FG000|Overall Study|Adverse Event|6|||
160965524|NCT01201811|581262939|FG000|Overall Study|Disease progression|3|||
160965525|NCT01201811|581262939|FG000|Overall Study|Withdrawal by Subject|3|||
160965526|NCT01201811|581262939|FG000|Overall Study|Death|4|||
160965527|NCT01201811|581262939|FG000|Overall Study|Treatment Failure|2|||
160965528|NCT01201811|581262939|FG000|Overall Study|Physician Decision|1|||
160965529|NCT02856113|581262940|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
160965530|NCT02856113|581262941|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
160585123|NCT02052778|579861884|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585124|NCT02052778|579861885|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585125|NCT02052778|579861886|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585126|NCT02052778|579861887|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585127|NCT02052778|579861888|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585128|NCT02052778|579861889|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585129|NCT02052778|579861890|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
160585130|NCT02052778|579861891|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
160585131|NCT02052778|579861892|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585132|NCT02052778|579861893|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585133|NCT02052778|579861894|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585134|NCT02052778|579861895|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
160585135|NCT02052778|579861896|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585136|NCT02052778|579861897|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585137|NCT02052778|579861898|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
160585138|NCT02052778|579861876|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
160585139|NCT02052778|579861877|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
160585140|NCT02052778|579861878|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
160965531|NCT02856113|581262940|FG000|Overall Study|Significant Protocol Deviation|1|||
160965532|NCT02856113|581262941|FG001|Overall Study|Significant Protocol Deviation|0|||
160965533|NCT02856113|581262940|FG000|Overall Study|Lost to Follow-up|3|||
160965534|NCT02856113|581262941|FG001|Overall Study|Lost to Follow-up|5|||
160965535|NCT02856113|581262940|FG000|Overall Study|Voluntary Withdrawal|3|||
160965536|NCT02856113|581262941|FG001|Overall Study|Voluntary Withdrawal|5|||
160965537|NCT02856113|581262940|FG000|Overall Study|Pregnancy|0|||
160965538|NCT02856113|581262941|FG001|Overall Study|Pregnancy|1|||
160965539|NCT02856113|581262940|FG000|Overall Study|Principal Investigator Discretion|2|||
160965540|NCT02856113|581262941|FG001|Overall Study|Principal Investigator Discretion|1|||
160965541|NCT02856113|581262940|FG000|Overall Study|Randomized but not Treated|1|||
160965542|NCT02856113|581262941|FG001|Overall Study|Randomized but not Treated|0|||
160965543|NCT02856113|581262940|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
160965544|NCT02856113|581262941|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
160965545|NCT03494166|581262942|FG000|Overall Study|Death|0|||
160965546|NCT03494166|581262943|FG001|Overall Study|Death|0|||
160965547|NCT03494166|581262944|FG002|Overall Study|Death|0|||
160965548|NCT03494166|581262945|FG003|Overall Study|Death|1|||
160965549|NCT03494166|581262946|FG004|Overall Study|Death|3|||
160965550|NCT03494166|581262947|FG005|Overall Study|Death|0|||
160965551|NCT03494166|581262942|FG000|Overall Study|Lost to Follow-up|2|||
160965552|NCT03494166|581262943|FG001|Overall Study|Lost to Follow-up|2|||
160965553|NCT03494166|581262944|FG002|Overall Study|Lost to Follow-up|2|||
160965554|NCT03494166|581262945|FG003|Overall Study|Lost to Follow-up|2|||
160965555|NCT03494166|581262946|FG004|Overall Study|Lost to Follow-up|14|||
160965556|NCT03494166|581262947|FG005|Overall Study|Lost to Follow-up|0|||
160965557|NCT03494166|581262942|FG000|Overall Study|Withdrawal by Subject|10|||
160965558|NCT03494166|581262943|FG001|Overall Study|Withdrawal by Subject|7|||
160965559|NCT03494166|581262944|FG002|Overall Study|Withdrawal by Subject|0|||
160965560|NCT03494166|581262945|FG003|Overall Study|Withdrawal by Subject|5|||
160965561|NCT03494166|581262946|FG004|Overall Study|Withdrawal by Subject|3|||
160965562|NCT03494166|581262947|FG005|Overall Study|Withdrawal by Subject|17|||
160965563|NCT03494166|581262942|FG000|Overall Study|Screen failure|1|||
160965564|NCT03494166|581262943|FG001|Overall Study|Screen failure|0|||
160965565|NCT03494166|581262944|FG002|Overall Study|Screen failure|0|||
160965566|NCT03494166|581262945|FG003|Overall Study|Screen failure|0|||
160965567|NCT03494166|581262946|FG004|Overall Study|Screen failure|1|||
160965568|NCT03494166|581262947|FG005|Overall Study|Screen failure|0|||
160965569|NCT02857426|581262948|FG000|Overall Study|Disease progression|34|||
160965570|NCT02857426|581262949|FG001|Overall Study|Disease progression|13|||
160965571|NCT02857426|581262948|FG000|Overall Study|Study drug toxicity|4|||
160965572|NCT02857426|581262949|FG001|Overall Study|Study drug toxicity|1|||
160965573|NCT02857426|581262948|FG000|Overall Study|Death|1|||
160965574|NCT02857426|581262949|FG001|Overall Study|Death|0|||
160965575|NCT02857426|581262948|FG000|Overall Study|Adverse event unrelated to study drug|6|||
160965576|NCT02857426|581262949|FG001|Overall Study|Adverse event unrelated to study drug|2|||
160585141|NCT02052778|579861879|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
160965577|NCT02857426|581262948|FG000|Overall Study|Participant withdrew consent|1|||
160965578|NCT02857426|581262949|FG001|Overall Study|Participant withdrew consent|1|||
160965579|NCT02857426|581262948|FG000|Overall Study|Maximum clinical benefit|1|||
160965580|NCT02857426|581262949|FG001|Overall Study|Maximum clinical benefit|0|||
160965581|NCT02857426|581262948|FG000|Overall Study|Completed treatment|0|||
160965582|NCT02857426|581262949|FG001|Overall Study|Completed treatment|2|||
160965583|NCT01960725|581262950|FG000|Overall Study|Lost to Follow-up|4|||
160965584|NCT01960725|581262951|FG001|Overall Study|Lost to Follow-up|3|||
161003410|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
161003411|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
161003412|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
161003413|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
161003414|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
160458438|NCT04761198|579409176|FG005|Overall Study|Protocol Violation|0|||
160458439|NCT04761198|579409177|FG006|Overall Study|Protocol Violation|0|||
160458440|NCT04761198|579409171|FG000|Overall Study|Death|2|||
160458441|NCT04761198|579409172|FG001|Overall Study|Death|1|||
160458442|NCT04761198|579409173|FG002|Overall Study|Death|2|||
160458443|NCT04761198|579409174|FG003|Overall Study|Death|5|||
160458444|NCT04761198|579409175|FG004|Overall Study|Death|14|||
160458445|NCT04761198|579409176|FG005|Overall Study|Death|2|||
160458446|NCT04761198|579409177|FG006|Overall Study|Death|5|||
160458447|NCT04761198|579409171|FG000|Overall Study|Lost to Follow-up|0|||
160458448|NCT04761198|579409172|FG001|Overall Study|Lost to Follow-up|0|||
160458449|NCT04761198|579409173|FG002|Overall Study|Lost to Follow-up|0|||
160458450|NCT04761198|579409174|FG003|Overall Study|Lost to Follow-up|0|||
160458451|NCT04761198|579409175|FG004|Overall Study|Lost to Follow-up|1|||
160458452|NCT04761198|579409176|FG005|Overall Study|Lost to Follow-up|0|||
160458453|NCT04761198|579409177|FG006|Overall Study|Lost to Follow-up|0|||
160458454|NCT04761198|579409171|FG000|Overall Study|Withdrawal by Subject|2|||
160458455|NCT04761198|579409172|FG001|Overall Study|Withdrawal by Subject|0|||
160458456|NCT04761198|579409173|FG002|Overall Study|Withdrawal by Subject|1|||
160458457|NCT04761198|579409174|FG003|Overall Study|Withdrawal by Subject|0|||
160458458|NCT04761198|579409175|FG004|Overall Study|Withdrawal by Subject|2|||
160458459|NCT04761198|579409176|FG005|Overall Study|Withdrawal by Subject|0|||
160458460|NCT04761198|579409177|FG006|Overall Study|Withdrawal by Subject|1|||
160458461|NCT04761198|579409171|FG000|Overall Study|Study Terminated by Sponsor|6|||
160458462|NCT04761198|579409172|FG001|Overall Study|Study Terminated by Sponsor|0|||
160458463|NCT04761198|579409173|FG002|Overall Study|Study Terminated by Sponsor|5|||
160458464|NCT04761198|579409174|FG003|Overall Study|Study Terminated by Sponsor|3|||
160458465|NCT04761198|579409175|FG004|Overall Study|Study Terminated by Sponsor|10|||
160458466|NCT04761198|579409176|FG005|Overall Study|Study Terminated by Sponsor|1|||
160585142|NCT02052778|579861880|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
160585143|NCT02052778|579861881|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
160585144|NCT02052778|579861882|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
160585145|NCT02052778|579861883|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
160585146|NCT02052778|579861884|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
160585147|NCT02052778|579861885|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
161003415|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
161003416|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
161003417|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
161003418|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
161003419|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
161003420|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
161003421|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
161003422|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
161003423|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
161003424|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
161003425|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
160458467|NCT04761198|579409177|FG006|Overall Study|Study Terminated by Sponsor|2|||
160458468|NCT02994927|579409178|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160458469|NCT02994927|579409179|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160585148|NCT02052778|579861886|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
160585149|NCT02052778|579861887|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
160458470|NCT02994927|579409178|FG000|Overall Study|Did not meet eligibility criteria|0|||
160458471|NCT02994927|579409179|FG001|Overall Study|Did not meet eligibility criteria|1|||
160965585|NCT01960725|581262950|FG000|Overall Study|Withdrawal by Subject|1|||
160965586|NCT01960725|581262951|FG001|Overall Study|Withdrawal by Subject|0|||
160965587|NCT01960725|581262950|FG000|Overall Study|unable to obtain blood sample|1|||
160965588|NCT01960725|581262951|FG001|Overall Study|unable to obtain blood sample|2|||
160965589|NCT00611858|581262956|FG000|Overall Study|Adverse Event|2|||
160965590|NCT00611858|581262956|FG000|Overall Study|Withdrawal by Subject|2|||
160965591|NCT01844284|581262957|FG000|Overall Study|Lost to Follow-up|12|||
160965592|NCT01844284|581262958|FG001|Overall Study|Lost to Follow-up|7|||
160965593|NCT01058304|581262959|FG000|Overall Study|Withdrawal by Subject|8|||
160965594|NCT01058304|581262960|FG001|Overall Study|Withdrawal by Subject|5|||
160965595|NCT01058304|581262959|FG000|Overall Study|Lost to Follow-up|13|||
160965596|NCT01058304|581262960|FG001|Overall Study|Lost to Follow-up|16|||
160965597|NCT01058304|581262959|FG000|Overall Study|Developed exclusion criterion|6|||
160458472|NCT02994927|579409178|FG000|Overall Study|Physician Decision|4|||
160458473|NCT02994927|579409179|FG001|Overall Study|Physician Decision|3|||
160458474|NCT02994927|579409178|FG000|Overall Study|Death|4|||
160458475|NCT02994927|579409179|FG001|Overall Study|Death|2|||
160458476|NCT02994927|579409178|FG000|Overall Study|Adverse Event|2|||
160458477|NCT02994927|579409179|FG001|Overall Study|Adverse Event|1|||
160458478|NCT02994927|579409178|FG000|Overall Study|Withdrawal by Subject|3|||
160458479|NCT02994927|579409179|FG001|Overall Study|Withdrawal by Subject|6|||
160458480|NCT02994927|579409178|FG000|Overall Study|Lost to Follow-up|2|||
160458481|NCT02994927|579409179|FG001|Overall Study|Lost to Follow-up|1|||
160458482|NCT03533257|579409180|FG000|Overall Study|Adverse Event|4|||
160585150|NCT02052778|579861888|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
160965598|NCT01058304|581262960|FG001|Overall Study|Developed exclusion criterion|12|||
160965599|NCT01820559|581262961|FG000|Overall Study|Adverse Event|4|||
160965600|NCT01820559|581262962|FG001|Overall Study|Adverse Event|6|||
160965601|NCT01820559|581262963|FG002|Overall Study|Adverse Event|13|||
160965602|NCT01820559|581262961|FG000|Overall Study|Withdrawal by Subject|1|||
160965603|NCT01820559|581262962|FG001|Overall Study|Withdrawal by Subject|2|||
160965604|NCT01820559|581262963|FG002|Overall Study|Withdrawal by Subject|5|||
160965605|NCT01820559|581262961|FG000|Overall Study|Protocol Violation|2|||
160965606|NCT01820559|581262962|FG001|Overall Study|Protocol Violation|1|||
160965607|NCT01820559|581262963|FG002|Overall Study|Protocol Violation|3|||
160965608|NCT01820559|581262961|FG000|Overall Study|Subject's non-compliance|1|||
160965609|NCT01820559|581262962|FG001|Overall Study|Subject's non-compliance|0|||
160965610|NCT01820559|581262963|FG002|Overall Study|Subject's non-compliance|2|||
160965611|NCT01820559|581262961|FG000|Overall Study|Lost to Follow-up|3|||
160965612|NCT01820559|581262962|FG001|Overall Study|Lost to Follow-up|2|||
160965613|NCT01820559|581262963|FG002|Overall Study|Lost to Follow-up|2|||
160965614|NCT01820559|581262961|FG000|Overall Study|At sponsor request|0|||
160965615|NCT01820559|581262962|FG001|Overall Study|At sponsor request|0|||
160965616|NCT01820559|581262963|FG002|Overall Study|At sponsor request|1|||
160965617|NCT01820559|581262961|FG000|Overall Study|Lack of Efficacy|3|||
160965618|NCT01820559|581262962|FG001|Overall Study|Lack of Efficacy|2|||
160965619|NCT01820559|581262963|FG002|Overall Study|Lack of Efficacy|3|||
160965620|NCT00166296|581262965|FG000|Overall Study|Withdrawal by Subject|1|||
160965621|NCT00166296|581262966|FG001|Overall Study|Withdrawal by Subject|3|||
160965622|NCT00166296|581262965|FG000|Overall Study|Adverse Event|2|||
160965623|NCT00166296|581262966|FG001|Overall Study|Adverse Event|4|||
160965624|NCT00166296|581262965|FG000|Overall Study|Lost to Follow-up|4|||
160965625|NCT00166296|581262966|FG001|Overall Study|Lost to Follow-up|2|||
160965626|NCT04035200|581262967|FG000|Overall Study|Lost to Follow-up|0|||
160965627|NCT04035200|581262968|FG001|Overall Study|Lost to Follow-up|1|||
160965628|NCT04035200|581262969|FG002|Overall Study|Lost to Follow-up|0|||
160965629|NCT04035200|581262967|FG000|Overall Study|Withdrawal by Subject|1|||
160965630|NCT04035200|581262968|FG001|Overall Study|Withdrawal by Subject|4|||
160965631|NCT04035200|581262969|FG002|Overall Study|Withdrawal by Subject|4|||
160965632|NCT04035200|581262967|FG000|Overall Study|COVID-19|1|||
160965633|NCT04035200|581262968|FG001|Overall Study|COVID-19|0|||
160965634|NCT04035200|581262969|FG002|Overall Study|COVID-19|0|||
160965635|NCT04035200|581262967|FG000|Overall Study|Early Termination|0|||
160965636|NCT04035200|581262968|FG001|Overall Study|Early Termination|1|||
160965637|NCT04035200|581262969|FG002|Overall Study|Early Termination|0|||
160965638|NCT04035200|581262967|FG000|Overall Study|Non-compliance|0|||
160965639|NCT04035200|581262968|FG001|Overall Study|Non-compliance|1|||
160965640|NCT04035200|581262969|FG002|Overall Study|Non-compliance|0|||
160965641|NCT02277990|581262970|FG000|Overall Study|Death|170|||
160965642|NCT02277990|581262971|FG001|Overall Study|Death|188|||
160965643|NCT02277990|581262970|FG000|Overall Study|Withdrawal by Subject|64|||
160965644|NCT02277990|581262971|FG001|Overall Study|Withdrawal by Subject|53|||
160965645|NCT02277990|581262970|FG000|Overall Study|Physician Decision|40|||
160965646|NCT02277990|581262971|FG001|Overall Study|Physician Decision|34|||
160965647|NCT02277990|581262970|FG000|Overall Study|Lost to Follow-up|66|||
160965648|NCT02277990|581262971|FG001|Overall Study|Lost to Follow-up|69|||
160965649|NCT02277990|581262970|FG000|Overall Study|Had other reason|26|||
160965650|NCT02277990|581262971|FG001|Overall Study|Had other reason|32|||
160965651|NCT03351738|581262972|FG000|Overall Study|Withdrawal by Subject|0|||
160965652|NCT03351738|581262973|FG001|Overall Study|Withdrawal by Subject|1|||
160965653|NCT03351738|581262974|FG002|Overall Study|Withdrawal by Subject|0|||
160965654|NCT03351738|581262975|FG003|Overall Study|Withdrawal by Subject|1|||
160965655|NCT03351738|581262976|FG004|Overall Study|Withdrawal by Subject|0|||
160965656|NCT03351738|581262977|FG005|Overall Study|Withdrawal by Subject|0|||
160965657|NCT03138733|581262982|FG000|Overall Study|Death|17|||
160965658|NCT03138733|581262983|FG001|Overall Study|Death|18|||
160965659|NCT03138733|581262982|FG000|Overall Study|Withdrawal by Subject|11|||
160965660|NCT03138733|581262983|FG001|Overall Study|Withdrawal by Subject|6|||
160965661|NCT03138733|581262982|FG000|Overall Study|Lost to Follow-up|3|||
160965662|NCT03138733|581262983|FG001|Overall Study|Lost to Follow-up|2|||
160965663|NCT03138733|581262982|FG000|Overall Study|Adverse Event|1|||
160965664|NCT03138733|581262983|FG001|Overall Study|Adverse Event|0|||
161003426|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
160458483|NCT03533257|579409181|FG001|Overall Study|Adverse Event|2|||
160965665|NCT03138733|581262982|FG000|Overall Study|Protocol Violation|1|||
160965666|NCT03138733|581262983|FG001|Overall Study|Protocol Violation|3|||
161003427|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
161003428|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
161003429|NCT02445391|581398074|FG000|Overall Study|No active protocol treatment|3|||
161003430|NCT02445391|581398075|FG001|Overall Study|No active protocol treatment|0|||
161003431|NCT02445391|581398076|FG002|Overall Study|No active protocol treatment|0|||
161003432|NCT02445391|581398074|FG000|Overall Study|Adverse Event|0|||
161003433|NCT02445391|581398075|FG001|Overall Study|Adverse Event|21|||
161003434|NCT02445391|581398076|FG002|Overall Study|Adverse Event|12|||
161003435|NCT02445391|581398074|FG000|Overall Study|Alternative therapy|0|||
161003436|NCT02445391|581398075|FG001|Overall Study|Alternative therapy|0|||
161003437|NCT02445391|581398076|FG002|Overall Study|Alternative therapy|1|||
161003438|NCT02445391|581398074|FG000|Overall Study|Disease progression|0|||
161003439|NCT02445391|581398075|FG001|Overall Study|Disease progression|7|||
161003440|NCT02445391|581398076|FG002|Overall Study|Disease progression|22|||
161003441|NCT02445391|581398074|FG000|Overall Study|Complicating disease|0|||
161003442|NCT02445391|581398075|FG001|Overall Study|Complicating disease|2|||
161003443|NCT02445391|581398076|FG002|Overall Study|Complicating disease|1|||
161003444|NCT02445391|581398074|FG000|Overall Study|Withdrawal by Subject|0|||
161003445|NCT02445391|581398075|FG001|Overall Study|Withdrawal by Subject|4|||
161003446|NCT02445391|581398076|FG002|Overall Study|Withdrawal by Subject|9|||
161003447|NCT02445391|581398074|FG000|Overall Study|Financial issue|0|||
161003448|NCT02445391|581398075|FG001|Overall Study|Financial issue|0|||
161003449|NCT02445391|581398076|FG002|Overall Study|Financial issue|2|||
161003450|NCT02445391|581398074|FG000|Overall Study|Still on treatment|0|||
161003451|NCT02445391|581398075|FG001|Overall Study|Still on treatment|7|||
161003452|NCT02445391|581398076|FG002|Overall Study|Still on treatment|16|||
161003453|NCT02445391|581398074|FG000|Overall Study|Not start protocol therapy|0|||
161003454|NCT02445391|581398075|FG001|Overall Study|Not start protocol therapy|12|||
161003455|NCT02445391|581398076|FG002|Overall Study|Not start protocol therapy|9|||
161003456|NCT02611037|581398077|FG000|Overall Study|Withdrawal prior to treatment|2|||
161003457|NCT02611037|581398078|FG001|Overall Study|Withdrawal prior to treatment|0|||
161003458|NCT05850520|581398080|FG000|Overall Study|Withdrawal by Subject|8|||
161003459|NCT05850520|581398081|FG001|Overall Study|Withdrawal by Subject|8|||
161003460|NCT05850520|581398082|FG002|Overall Study|Withdrawal by Subject|16|||
161003461|NCT05850520|581398080|FG000|Overall Study|Lost to Follow-up|2|||
161003462|NCT05850520|581398081|FG001|Overall Study|Lost to Follow-up|2|||
161003463|NCT05850520|581398082|FG002|Overall Study|Lost to Follow-up|2|||
161003464|NCT05850520|581398080|FG000|Overall Study|Death|2|||
161003465|NCT05850520|581398081|FG001|Overall Study|Death|2|||
161003466|NCT05850520|581398082|FG002|Overall Study|Death|3|||
161003467|NCT05850520|581398080|FG000|Overall Study|Adverse Event|2|||
161003468|NCT05850520|581398081|FG001|Overall Study|Adverse Event|0|||
161003469|NCT05850520|581398082|FG002|Overall Study|Adverse Event|1|||
161003470|NCT05850520|581398080|FG000|Overall Study|Physician Decision|0|||
161003471|NCT05850520|581398081|FG001|Overall Study|Physician Decision|1|||
161003472|NCT05850520|581398082|FG002|Overall Study|Physician Decision|0|||
161003473|NCT05850520|581398080|FG000|Overall Study|Protocol deviation|0|||
161003474|NCT05850520|581398081|FG001|Overall Study|Protocol deviation|0|||
161003475|NCT05850520|581398082|FG002|Overall Study|Protocol deviation|1|||
161003476|NCT05850520|581398080|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
161003477|NCT05850520|581398081|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
161003478|NCT05850520|581398082|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
161003479|NCT03785782|581399019|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
161003480|NCT03785782|581399020|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
161003481|NCT03785782|581399019|FG000|Overall Study|Withdrawal by Subject|1|||
161003482|NCT03785782|581399020|FG001|Overall Study|Withdrawal by Subject|1|||
161003483|NCT03785782|581399019|FG000|Overall Study|insufficient image quality.|3|||
161003484|NCT03785782|581399020|FG001|Overall Study|insufficient image quality.|0|||
161003485|NCT04817670|581399021|FG000|Overall Study|Withdrawal by Subject|1|||
161003486|NCT04817670|581399022|FG001|Overall Study|Withdrawal by Subject|0|||
161003487|NCT04817670|581399023|FG002|Overall Study|Withdrawal by Subject|0|||
161003488|NCT04817670|581399024|FG003|Overall Study|Withdrawal by Subject|0|||
161003489|NCT04817670|581399025|FG004|Overall Study|Withdrawal by Subject|0|||
161003490|NCT04817670|581399021|FG000|Overall Study|Lost to Follow-up|0|||
161003491|NCT04817670|581399022|FG001|Overall Study|Lost to Follow-up|0|||
161003492|NCT04817670|581399023|FG002|Overall Study|Lost to Follow-up|1|||
160458484|NCT03533257|579409180|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
160656998|NCT05097989|580124504|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161003493|NCT04817670|581399024|FG003|Overall Study|Lost to Follow-up|0|||
160458485|NCT03533257|579409181|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
160656999|NCT05097989|580124496|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
161003494|NCT04817670|581399025|FG004|Overall Study|Lost to Follow-up|0|||
161003495|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
160458486|NCT05525104|579409183|FG000|Overall Study|Failed caudal analgesia|1|||
161003496|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
161003497|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
161003498|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
161003499|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
161003500|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
161003501|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
161003502|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
161003503|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
161003504|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
161003505|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
161003506|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
161003507|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
161003508|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
161003509|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
161003510|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
161003511|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
161003512|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
161003513|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
161003514|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
161003515|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
161003516|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
161003517|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
161003518|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
161003519|NCT00304031|581399027|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
161003520|NCT00304031|581399028|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
161003521|NCT00304031|581399029|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
161003522|NCT01188655|581399033|FG000|Overall Study|Lack of Efficacy|1|||
161003523|NCT01188655|581399033|FG000|Overall Study|Lost to Follow-up|1|||
161003524|NCT01188655|581399033|FG000|Overall Study|Other|11|||
161003525|NCT04603924|581399034|FG000|Overall Study|Not Dosed|2|||
161003526|NCT04603924|581399035|FG001|Overall Study|Not Dosed|1|||
161003527|NCT04603924|581399034|FG000|Overall Study|Withdrawal by Subject|6|||
161003528|NCT04603924|581399035|FG001|Overall Study|Withdrawal by Subject|6|||
161003529|NCT04603924|581399034|FG000|Overall Study|Adverse Event|2|||
161003530|NCT04603924|581399035|FG001|Overall Study|Adverse Event|2|||
161003531|NCT03762668|581399038|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
161003532|NCT03762668|581399039|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
161003533|NCT02731755|581399045|FG000|First Intervention|Withdrawal by Subject|0|||
161003534|NCT02731755|581399046|FG001|First Intervention|Withdrawal by Subject|2|||
161003535|NCT02139046|581399047|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
161003536|NCT02139046|581399048|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
161003537|NCT02139046|581399049|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
161003538|NCT02139046|581399050|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
161003539|NCT02139046|581399051|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
161003540|NCT02139046|581399047|FG000|Overall Study|Major Protocol Deviation|9|||
161003541|NCT02139046|581399048|FG001|Overall Study|Major Protocol Deviation|10|||
161003542|NCT02139046|581399049|FG002|Overall Study|Major Protocol Deviation|16|||
161003543|NCT02139046|581399050|FG003|Overall Study|Major Protocol Deviation|12|||
161003544|NCT02139046|581399051|FG004|Overall Study|Major Protocol Deviation|6|||
161003545|NCT02139046|581399047|FG000|Overall Study|Lost to Follow-up|13|||
161003546|NCT02139046|581399048|FG001|Overall Study|Lost to Follow-up|16|||
161003547|NCT02139046|581399049|FG002|Overall Study|Lost to Follow-up|16|||
161003548|NCT02139046|581399050|FG003|Overall Study|Lost to Follow-up|18|||
160657000|NCT05097989|580124497|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
160657001|NCT05097989|580124498|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
161003549|NCT02139046|581399051|FG004|Overall Study|Lost to Follow-up|13|||
161003550|NCT02139046|581399047|FG000|Overall Study|Voluntary Withdrawal|20|||
161003551|NCT02139046|581399048|FG001|Overall Study|Voluntary Withdrawal|8|||
161003552|NCT02139046|581399049|FG002|Overall Study|Voluntary Withdrawal|10|||
161003553|NCT02139046|581399050|FG003|Overall Study|Voluntary Withdrawal|15|||
161003554|NCT02139046|581399051|FG004|Overall Study|Voluntary Withdrawal|16|||
161003555|NCT02139046|581399047|FG000|Overall Study|Lack of Efficacy|0|||
161003556|NCT02139046|581399048|FG001|Overall Study|Lack of Efficacy|1|||
161003557|NCT02139046|581399049|FG002|Overall Study|Lack of Efficacy|2|||
161003558|NCT02139046|581399050|FG003|Overall Study|Lack of Efficacy|1|||
161003559|NCT02139046|581399051|FG004|Overall Study|Lack of Efficacy|2|||
161003560|NCT02139046|581399047|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
161003561|NCT02139046|581399048|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
161003562|NCT02139046|581399049|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
161003563|NCT02139046|581399050|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
160965667|NCT03138733|581262982|FG000|Overall Study|Administrative or logistical reason|1|||
160965668|NCT03138733|581262983|FG001|Overall Study|Administrative or logistical reason|0|||
160965669|NCT03138733|581262982|FG000|Overall Study|The patient was transferred to another hospital|1|||
160965670|NCT03138733|581262983|FG001|Overall Study|The patient was transferred to another hospital|0|||
160965671|NCT01089374|581262985|FG000|Overall Study|Lost to Follow-up|3|||
160965672|NCT01089374|581262986|FG001|Overall Study|Lost to Follow-up|0|||
160965673|NCT01089374|581262985|FG000|Overall Study|Withdrawal by Subject|1|||
160965674|NCT01089374|581262986|FG001|Overall Study|Withdrawal by Subject|0|||
160965675|NCT01089374|581262985|FG000|Overall Study|Study closed early - low accrual|6|||
160965676|NCT01089374|581262986|FG001|Overall Study|Study closed early - low accrual|0|||
160965677|NCT02597036|581262997|FG000|Overall Study|Progressive Disease|0|||
160965678|NCT02597036|581262998|FG001|Overall Study|Progressive Disease|0|||
160965679|NCT02597036|581262999|FG002|Overall Study|Progressive Disease|0|||
160965680|NCT02597036|581263000|FG003|Overall Study|Progressive Disease|0|||
160965681|NCT02597036|581263001|FG004|Overall Study|Progressive Disease|1|||
160965682|NCT02597036|581263002|FG005|Overall Study|Progressive Disease|1|||
160965683|NCT02597036|581263003|FG006|Overall Study|Progressive Disease|1|||
160965684|NCT02597036|581263004|FG007|Overall Study|Progressive Disease|0|||
160965685|NCT02597036|581263005|FG008|Overall Study|Progressive Disease|0|||
160965686|NCT02597036|581263006|FG009|Overall Study|Progressive Disease|0|||
160965687|NCT02597036|581263007|FG010|Overall Study|Progressive Disease|0|||
160965688|NCT02597036|581263008|FG011|Overall Study|Progressive Disease|0|||
160965689|NCT02597036|581262997|FG000|Overall Study|Adverse Event|0|||
160965690|NCT02597036|581262998|FG001|Overall Study|Adverse Event|0|||
160965691|NCT02597036|581262999|FG002|Overall Study|Adverse Event|0|||
160965692|NCT02597036|581263000|FG003|Overall Study|Adverse Event|0|||
160965693|NCT02597036|581263001|FG004|Overall Study|Adverse Event|0|||
160965694|NCT02597036|581263002|FG005|Overall Study|Adverse Event|0|||
160965695|NCT02597036|581263003|FG006|Overall Study|Adverse Event|0|||
160965696|NCT02597036|581263004|FG007|Overall Study|Adverse Event|1|||
160965697|NCT02597036|581263005|FG008|Overall Study|Adverse Event|0|||
160965698|NCT02597036|581263006|FG009|Overall Study|Adverse Event|0|||
160965699|NCT02597036|581263007|FG010|Overall Study|Adverse Event|0|||
160965700|NCT02597036|581263008|FG011|Overall Study|Adverse Event|1|||
160965701|NCT02597036|581262997|FG000|Overall Study|Death|0|||
160965702|NCT02597036|581262998|FG001|Overall Study|Death|0|||
160965703|NCT02597036|581262999|FG002|Overall Study|Death|0|||
160965704|NCT02597036|581263000|FG003|Overall Study|Death|0|||
160965705|NCT02597036|581263001|FG004|Overall Study|Death|0|||
160965706|NCT02597036|581263002|FG005|Overall Study|Death|0|||
160965707|NCT02597036|581263003|FG006|Overall Study|Death|0|||
160965708|NCT02597036|581263004|FG007|Overall Study|Death|0|||
160965709|NCT02597036|581263005|FG008|Overall Study|Death|0|||
160965710|NCT02597036|581263006|FG009|Overall Study|Death|1|||
160965711|NCT02597036|581263007|FG010|Overall Study|Death|1|||
160965712|NCT02597036|581263008|FG011|Overall Study|Death|0|||
160965713|NCT02597036|581262997|FG000|Overall Study|Lost to Follow-up|0|||
160965714|NCT02597036|581262998|FG001|Overall Study|Lost to Follow-up|0|||
160965715|NCT02597036|581262999|FG002|Overall Study|Lost to Follow-up|0|||
160965716|NCT02597036|581263000|FG003|Overall Study|Lost to Follow-up|0|||
160965717|NCT02597036|581263001|FG004|Overall Study|Lost to Follow-up|0|||
160965718|NCT02597036|581263002|FG005|Overall Study|Lost to Follow-up|0|||
160965719|NCT02597036|581263003|FG006|Overall Study|Lost to Follow-up|0|||
160965720|NCT02597036|581263004|FG007|Overall Study|Lost to Follow-up|0|||
160965721|NCT02597036|581263005|FG008|Overall Study|Lost to Follow-up|0|||
160965722|NCT02597036|581263006|FG009|Overall Study|Lost to Follow-up|0|||
160965723|NCT02597036|581263007|FG010|Overall Study|Lost to Follow-up|1|||
160965724|NCT02597036|581263008|FG011|Overall Study|Lost to Follow-up|0|||
160965725|NCT02597036|581262997|FG000|Overall Study|Withdrawal by Subject|0|||
160965726|NCT02597036|581262998|FG001|Overall Study|Withdrawal by Subject|0|||
160965727|NCT02597036|581262999|FG002|Overall Study|Withdrawal by Subject|0|||
160965728|NCT02597036|581263000|FG003|Overall Study|Withdrawal by Subject|0|||
160965729|NCT02597036|581263001|FG004|Overall Study|Withdrawal by Subject|0|||
160965730|NCT02597036|581263002|FG005|Overall Study|Withdrawal by Subject|0|||
160965731|NCT02597036|581263003|FG006|Overall Study|Withdrawal by Subject|0|||
160965732|NCT02597036|581263004|FG007|Overall Study|Withdrawal by Subject|0|||
160965733|NCT02597036|581263005|FG008|Overall Study|Withdrawal by Subject|0|||
160965734|NCT02597036|581263006|FG009|Overall Study|Withdrawal by Subject|0|||
160965735|NCT02597036|581263007|FG010|Overall Study|Withdrawal by Subject|0|||
160965736|NCT02597036|581263008|FG011|Overall Study|Withdrawal by Subject|1|||
160965737|NCT05163522|581263011|FG000|Overall Study|Withdrawal by Subject|0|||
160965738|NCT05163522|581263012|FG001|Overall Study|Withdrawal by Subject|0|||
160965739|NCT05163522|581263013|FG002|Overall Study|Withdrawal by Subject|1|||
160965740|NCT05163522|581263014|FG003|Overall Study|Withdrawal by Subject|0|||
160965741|NCT05163522|581263015|FG004|Overall Study|Withdrawal by Subject|0|||
161003564|NCT02139046|581399051|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
160965742|NCT05163522|581263016|FG005|Overall Study|Withdrawal by Subject|0|||
160965743|NCT05163522|581263017|FG006|Overall Study|Withdrawal by Subject|0|||
160965744|NCT05163522|581263018|FG007|Overall Study|Withdrawal by Subject|0|||
160585151|NCT02052778|579861889|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
160585152|NCT02052778|579861890|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
160585153|NCT02052778|579861891|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
160585154|NCT02052778|579861892|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
160585155|NCT02052778|579861893|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
160585156|NCT02052778|579861894|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
160585157|NCT02052778|579861895|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
160585158|NCT02052778|579861896|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
160965745|NCT05163522|581263019|FG008|Overall Study|Withdrawal by Subject|0|||
160965746|NCT05163522|581263020|FG009|Overall Study|Withdrawal by Subject|0|||
160965747|NCT05163522|581263021|FG010|Overall Study|Withdrawal by Subject|0|||
160965748|NCT04672941|581263026|FG000|Overall Study|Investigator decision|1|||
160965749|NCT04672941|581263026|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
160965750|NCT04672941|581263026|FG000|Overall Study|COVID-19 related but no adverse event|1|||
160965751|NCT04672941|581263026|FG000|Overall Study|Adverse Event|2|||
160965752|NCT04672941|581263026|FG000|Overall Study|Lost to Follow-up|2|||
160965753|NCT00386022|581263032|FG000|Plus Estrogen|Lost to Follow-up|2|||
160965754|NCT00386022|581263033|FG001|Plus Estrogen|Lost to Follow-up|0|||
160965755|NCT00386022|581263032|FG000|Plus Estrogen|Adverse Event|0|||
160965756|NCT00386022|581263033|FG001|Plus Estrogen|Adverse Event|1|||
160965757|NCT03988166|581263038|FG000|Overall Study|Lost to Follow-up|2|||
160965758|NCT03988166|581263038|FG000|Overall Study|Death|1|||
160965759|NCT03933826|581263039|FG000|Overall Study|Withdrawal by Subject|8|||
160965760|NCT03933826|581263040|FG001|Overall Study|Withdrawal by Subject|1|||
160965761|NCT03933826|581263039|FG000|Overall Study|Death|19|||
160965762|NCT03933826|581263040|FG001|Overall Study|Death|11|||
160965763|NCT03933826|581263039|FG000|Overall Study|Lost to Follow-up|41|||
160965764|NCT03933826|581263040|FG001|Overall Study|Lost to Follow-up|13|||
160965765|NCT02638948|581263041|FG000|Overall Study|Withdrawal by Subject|4|||
160965766|NCT02638948|581263042|FG001|Overall Study|Withdrawal by Subject|5|||
160965767|NCT02638948|581263043|FG002|Overall Study|Withdrawal by Subject|3|||
160965768|NCT02638948|581263044|FG003|Overall Study|Withdrawal by Subject|1|||
160965769|NCT02638948|581263041|FG000|Overall Study|Administrative Reason by Sponsor|0|||
160965770|NCT02638948|581263042|FG001|Overall Study|Administrative Reason by Sponsor|1|||
160965771|NCT02638948|581263043|FG002|Overall Study|Administrative Reason by Sponsor|0|||
160965772|NCT02638948|581263044|FG003|Overall Study|Administrative Reason by Sponsor|4|||
160965773|NCT02638948|581263041|FG000|Overall Study|Adverse Event|0|||
160965774|NCT02638948|581263042|FG001|Overall Study|Adverse Event|0|||
160965775|NCT02638948|581263043|FG002|Overall Study|Adverse Event|1|||
160965776|NCT02638948|581263044|FG003|Overall Study|Adverse Event|1|||
160965777|NCT02638948|581263041|FG000|Overall Study|Lack of Efficacy|1|||
160965778|NCT02638948|581263042|FG001|Overall Study|Lack of Efficacy|1|||
160965779|NCT02638948|581263043|FG002|Overall Study|Lack of Efficacy|0|||
160965780|NCT02638948|581263044|FG003|Overall Study|Lack of Efficacy|0|||
160965781|NCT02638948|581263041|FG000|Overall Study|Lost to Follow-up|0|||
160965782|NCT02638948|581263042|FG001|Overall Study|Lost to Follow-up|0|||
160965783|NCT02638948|581263043|FG002|Overall Study|Lost to Follow-up|1|||
160965784|NCT02638948|581263044|FG003|Overall Study|Lost to Follow-up|1|||
160965785|NCT02638948|581263041|FG000|Overall Study|Poor/Non-Compliance|0|||
160965786|NCT02638948|581263042|FG001|Overall Study|Poor/Non-Compliance|2|||
160965787|NCT02638948|581263043|FG002|Overall Study|Poor/Non-Compliance|1|||
160965788|NCT02638948|581263044|FG003|Overall Study|Poor/Non-Compliance|0|||
160965789|NCT02638948|581263041|FG000|Overall Study|Participant no longer met study criteria|0|||
160965790|NCT02638948|581263042|FG001|Overall Study|Participant no longer met study criteria|1|||
160965791|NCT02638948|581263043|FG002|Overall Study|Participant no longer met study criteria|0|||
160965792|NCT02638948|581263044|FG003|Overall Study|Participant no longer met study criteria|0|||
160965793|NCT02638948|581263041|FG000|Overall Study|Other than specified above|4|||
160965794|NCT02638948|581263042|FG001|Overall Study|Other than specified above|1|||
160965795|NCT02638948|581263043|FG002|Overall Study|Other than specified above|1|||
160965796|NCT02638948|581263044|FG003|Overall Study|Other than specified above|1|||
160965797|NCT04992546|581263045|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
160965798|NCT04992546|581263045|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
160965799|NCT04992546|581263045|FG000|Open-Label Treatment Period|Adverse Event|3|||
160965800|NCT04992546|581263045|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
160965801|NCT05007392|581263047|FG000|Overall Study|Randomized but not treated|1|||
160965802|NCT05007392|581263048|FG001|Overall Study|Randomized but not treated|2|||
160657002|NCT05097989|580124499|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
160965803|NCT05007392|581263047|FG000|Overall Study|Other|5|||
160965804|NCT05007392|581263048|FG001|Overall Study|Other|4|||
160657003|NCT05097989|580124500|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
160965805|NCT05007392|581263047|FG000|Overall Study|Lost to Follow-up|1|||
160965806|NCT05007392|581263048|FG001|Overall Study|Lost to Follow-up|2|||
160657004|NCT05097989|580124501|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
160965807|NCT05007392|581263047|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
160965808|NCT05007392|581263048|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
160965809|NCT05007392|581263047|FG000|Overall Study|Use of prohibited concomitant drug|1|||
160657005|NCT05097989|580124502|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
160965810|NCT05007392|581263048|FG001|Overall Study|Use of prohibited concomitant drug|1|||
160965811|NCT05007392|581263047|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
160965812|NCT05007392|581263048|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
160965813|NCT05007392|581263047|FG000|Overall Study|Adverse Event|10|||
160965814|NCT05007392|581263048|FG001|Overall Study|Adverse Event|6|||
160965815|NCT05007392|581263047|FG000|Overall Study|Participant choice|5|||
160965816|NCT05007392|581263048|FG001|Overall Study|Participant choice|10|||
160965817|NCT05007392|581263047|FG000|Overall Study|Withdrawal of consent|5|||
160965818|NCT05007392|581263048|FG001|Overall Study|Withdrawal of consent|4|||
160965819|NCT02703922|581263049|FG000|Overall Study|Death|5|||
160965820|NCT02703922|581263050|FG001|Overall Study|Death|8|||
160965821|NCT02703922|581263049|FG000|Overall Study|Lost to Follow-up|10|||
160965822|NCT02703922|581263050|FG001|Overall Study|Lost to Follow-up|10|||
160965823|NCT05805657|581263055|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
160965824|NCT05805657|581263056|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
160965825|NCT04058353|581263057|FG000|Overall Study|Adverse Event|2|||
160965826|NCT04058353|581263058|FG001|Overall Study|Adverse Event|1|||
160965827|NCT04058353|581263057|FG000|Overall Study|Physician Decision|1|||
160965828|NCT04058353|581263058|FG001|Overall Study|Physician Decision|0|||
160965829|NCT04058353|581263057|FG000|Overall Study|Other|1|||
160965830|NCT04058353|581263058|FG001|Overall Study|Other|0|||
160965831|NCT00316173|581263062|FG000|Run-in Phase|Adverse Event|1|||
160965832|NCT00316173|581263063|FG001|Run-in Phase|Adverse Event|0|||
160965833|NCT00316173|581263062|FG000|Run-in Phase|Protocol Violation|1|||
160965834|NCT00316173|581263063|FG001|Run-in Phase|Protocol Violation|0|||
160965835|NCT00316173|581263062|FG000|Run-in Phase|Study Follow-up Stopped|5|||
160965836|NCT00316173|581263063|FG001|Run-in Phase|Study Follow-up Stopped|0|||
160965837|NCT00316173|581263062|FG000|Treatment Phase|Adverse Event|0|||
160965838|NCT00316173|581263063|FG001|Treatment Phase|Adverse Event|1|||
160965839|NCT00316173|581263062|FG000|Treatment Phase|Lack of Efficacy|0|||
160965840|NCT00316173|581263063|FG001|Treatment Phase|Lack of Efficacy|3|||
160965841|NCT00316173|581263062|FG000|Treatment Phase|Lost to Follow-up|0|||
160965842|NCT00316173|581263063|FG001|Treatment Phase|Lost to Follow-up|3|||
160965843|NCT00316173|581263062|FG000|Treatment Phase|Withdrawal by Subject|0|||
160965844|NCT00316173|581263063|FG001|Treatment Phase|Withdrawal by Subject|1|||
160965845|NCT00316173|581263062|FG000|Treatment Phase|Study Follow-up Stopped|0|||
160965846|NCT00316173|581263063|FG001|Treatment Phase|Study Follow-up Stopped|34|||
160965847|NCT01338025|581263067|FG000|Overall Study|Unexpected closure of study|10|||
160965848|NCT01338025|581263068|FG001|Overall Study|Unexpected closure of study|9|||
160965849|NCT01338025|581263067|FG000|Overall Study|Withdrawal by Subject|0|||
160965850|NCT01338025|581263068|FG001|Overall Study|Withdrawal by Subject|2|||
160965851|NCT01338025|581263067|FG000|Overall Study|Found ineligible after starting|1|||
160965852|NCT01338025|581263068|FG001|Overall Study|Found ineligible after starting|0|||
160965853|NCT03188055|581263069|FG000|Overall Study|Unavailable for training|0|||
160965854|NCT03188055|581263070|FG001|Overall Study|Unavailable for training|0|||
160965855|NCT03188055|581263071|FG002|Overall Study|Unavailable for training|19|||
160965856|NCT03188055|581263072|FG003|Overall Study|Unavailable for training|0|||
160965857|NCT03188055|581263073|FG004|Overall Study|Unavailable for training|0|||
160965858|NCT03188055|581263074|FG005|Overall Study|Unavailable for training|0|||
160965859|NCT03188055|581263069|FG000|Overall Study|Lost to Follow-up|0|||
160965860|NCT03188055|581263070|FG001|Overall Study|Lost to Follow-up|18|||
160965861|NCT03188055|581263071|FG002|Overall Study|Lost to Follow-up|0|||
160965862|NCT03188055|581263072|FG003|Overall Study|Lost to Follow-up|11|||
160965863|NCT03188055|581263073|FG004|Overall Study|Lost to Follow-up|0|||
160965864|NCT03188055|581263074|FG005|Overall Study|Lost to Follow-up|0|||
160965865|NCT03188055|581263069|FG000|Overall Study|Withdrawal by Subject|0|||
160965866|NCT03188055|581263070|FG001|Overall Study|Withdrawal by Subject|1|||
160965867|NCT03188055|581263071|FG002|Overall Study|Withdrawal by Subject|0|||
160965868|NCT03188055|581263072|FG003|Overall Study|Withdrawal by Subject|1|||
160965869|NCT03188055|581263073|FG004|Overall Study|Withdrawal by Subject|0|||
160965870|NCT03188055|581263074|FG005|Overall Study|Withdrawal by Subject|0|||
160965871|NCT03657277|581263075|FG000|Overall Study|Physician Decision|2|||
160965872|NCT03657277|581263075|FG000|Overall Study|Lost to Follow-up|1|||
160965873|NCT03657277|581263075|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
160965874|NCT01024608|581263078|FG000|Overall Study|Adverse Event|1|||
160965875|NCT01024608|581263079|FG001|Overall Study|Adverse Event|0|||
160965876|NCT01024608|581263078|FG000|Overall Study|Withdrawal by Subject|1|||
160965877|NCT01024608|581263079|FG001|Overall Study|Withdrawal by Subject|0|||
160965878|NCT01024608|581263078|FG000|Overall Study|Lost to Follow-up|0|||
160965879|NCT01024608|581263079|FG001|Overall Study|Lost to Follow-up|1|||
160965880|NCT01024608|581263078|FG000|Overall Study|Protocol Violation|0|||
160965881|NCT01024608|581263079|FG001|Overall Study|Protocol Violation|3|||
160965882|NCT01024608|581263078|FG000|Overall Study|Never received study treatment|2|||
161003565|NCT02139046|581399047|FG000|Overall Study|Other Miscellaneous Reasons|10|||
161003566|NCT02139046|581399048|FG001|Overall Study|Other Miscellaneous Reasons|9|||
161003567|NCT02139046|581399049|FG002|Overall Study|Other Miscellaneous Reasons|4|||
161003568|NCT02139046|581399050|FG003|Overall Study|Other Miscellaneous Reasons|9|||
161003569|NCT02139046|581399051|FG004|Overall Study|Other Miscellaneous Reasons|12|||
161003570|NCT00818454|581399054|FG000|Treatment Period 1|Adverse Event|0|||
161003571|NCT00818454|581399055|FG001|Treatment Period 1|Adverse Event|1|||
161003572|NCT00818454|581399056|FG002|Treatment Period 1|Adverse Event|0|||
161003573|NCT00818454|581399057|FG003|Treatment Period 1|Adverse Event|0|||
161003574|NCT00818454|581399054|FG000|Treatment Period 1|Other|3|||
161003575|NCT00818454|581399055|FG001|Treatment Period 1|Other|0|||
161003576|NCT00818454|581399056|FG002|Treatment Period 1|Other|0|||
161003577|NCT00818454|581399057|FG003|Treatment Period 1|Other|0|||
161003578|NCT00818454|581399054|FG000|Washout Period of 1 Week|Adverse Event|1|||
161003579|NCT00818454|581399055|FG001|Washout Period of 1 Week|Adverse Event|1|||
161003580|NCT00818454|581399056|FG002|Washout Period of 1 Week|Adverse Event|0|||
161003581|NCT00818454|581399057|FG003|Washout Period of 1 Week|Adverse Event|0|||
161003582|NCT00818454|581399054|FG000|Washout Period of 1 Week|Protocol Violation|2|||
161003583|NCT00818454|581399055|FG001|Washout Period of 1 Week|Protocol Violation|0|||
161003584|NCT00818454|581399056|FG002|Washout Period of 1 Week|Protocol Violation|0|||
161003585|NCT00818454|581399057|FG003|Washout Period of 1 Week|Protocol Violation|0|||
161003586|NCT00818454|581399054|FG000|Washout Period of 1 Week|Other|1|||
161003587|NCT00818454|581399055|FG001|Washout Period of 1 Week|Other|2|||
161003588|NCT00818454|581399056|FG002|Washout Period of 1 Week|Other|0|||
161003589|NCT00818454|581399057|FG003|Washout Period of 1 Week|Other|0|||
161003590|NCT00818454|581399054|FG000|Treatment Period 2|Other|2|||
161003591|NCT00818454|581399055|FG001|Treatment Period 2|Other|1|||
161003592|NCT00818454|581399056|FG002|Treatment Period 2|Other|0|||
161003593|NCT00818454|581399057|FG003|Treatment Period 2|Other|0|||
161003594|NCT00818454|581399054|FG000|Treatment Period 3|Adverse Event|0|||
161003595|NCT00818454|581399055|FG001|Treatment Period 3|Adverse Event|0|||
161003596|NCT00818454|581399056|FG002|Treatment Period 3|Adverse Event|0|||
161003597|NCT00818454|581399057|FG003|Treatment Period 3|Adverse Event|1|||
161003598|NCT01765543|581399064|FG000|Overall Study|Death|1|||
161003599|NCT01765543|581399064|FG000|Overall Study|Withdrawal by Subject|2|||
161003600|NCT03454529|581399065|FG000|Overall Study|Did not receive treatment|6|||
161003601|NCT03454529|581399065|FG000|Overall Study|Received < 80% doses|1|||
161003602|NCT01040689|581399070|FG000|Overall Study|Adverse Event|0|||
161003603|NCT01040689|581399071|FG001|Overall Study|Adverse Event|0|||
161003604|NCT01040689|581399072|FG002|Overall Study|Adverse Event|2|||
161003605|NCT01040689|581399073|FG003|Overall Study|Adverse Event|4|||
161003606|NCT01040689|581399070|FG000|Overall Study|Lack of Efficacy|0|||
161003607|NCT01040689|581399071|FG001|Overall Study|Lack of Efficacy|0|||
161003608|NCT01040689|581399072|FG002|Overall Study|Lack of Efficacy|1|||
161003609|NCT01040689|581399073|FG003|Overall Study|Lack of Efficacy|0|||
161003610|NCT01040689|581399070|FG000|Overall Study|Lost to Follow-up|1|||
161003611|NCT01040689|581399071|FG001|Overall Study|Lost to Follow-up|0|||
161003612|NCT01040689|581399072|FG002|Overall Study|Lost to Follow-up|0|||
161003613|NCT01040689|581399073|FG003|Overall Study|Lost to Follow-up|0|||
161003614|NCT01040689|581399070|FG000|Overall Study|Withdrawal by Subject|2|||
161003615|NCT01040689|581399071|FG001|Overall Study|Withdrawal by Subject|1|||
161003616|NCT01040689|581399072|FG002|Overall Study|Withdrawal by Subject|1|||
161003617|NCT01040689|581399073|FG003|Overall Study|Withdrawal by Subject|0|||
161003618|NCT01040689|581399070|FG000|Overall Study|Other reasons not listed above|0|||
161003619|NCT01040689|581399071|FG001|Overall Study|Other reasons not listed above|1|||
161003620|NCT01040689|581399072|FG002|Overall Study|Other reasons not listed above|0|||
161003621|NCT01040689|581399073|FG003|Overall Study|Other reasons not listed above|0|||
161003622|NCT02755805|581399076|FG000|Overall Study|Lost to Follow-up|1|||
161003623|NCT02755805|581399077|FG001|Overall Study|Lost to Follow-up|2|||
161003624|NCT02755805|581399076|FG000|Overall Study|Refused assessments|1|||
161003625|NCT02755805|581399077|FG001|Overall Study|Refused assessments|0|||
161003626|NCT02755805|581399076|FG000|Overall Study|Withdrawal by Subject|0|||
161003627|NCT02755805|581399077|FG001|Overall Study|Withdrawal by Subject|2|||
161003628|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
161003629|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
161003630|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
161003631|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
161003632|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
161003633|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
161003634|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
161003635|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
161003636|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
161003637|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
161003638|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
161003639|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
161003640|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
161003641|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
161003642|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
161003643|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
161003644|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
161003645|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
161003646|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
161003647|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
161003648|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
161003649|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
161003650|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
161003651|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
161003652|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
161003653|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
161003654|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
161003655|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
161003656|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
161003657|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
161003658|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
161003659|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
161003660|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
161003661|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
161003662|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
161003663|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
161003664|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
161003665|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
161003666|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
161003667|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
161003668|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
161003669|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
161003670|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
161003671|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
161003672|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
161003673|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
161003674|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
161003675|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
161003676|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
161003677|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
161003678|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
161003679|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
161003680|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
161003681|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
161003682|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
161003683|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
161003684|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
161003685|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
161003686|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
161003687|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
161003688|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
161003689|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
161003690|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
161003691|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
161003692|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
161003693|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
161003694|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
161003695|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
161003696|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
161003697|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
161003698|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
161003699|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
161003700|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
161003701|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
161003702|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
161003703|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
161003704|NCT03184558|581399084|FG000|Overall Study|Withdrawal by Subject|2|||
161003705|NCT03184558|581399084|FG000|Overall Study|Death|16|||
161003706|NCT03184558|581399084|FG000|Overall Study|Lost to Follow-up|2|||
161003707|NCT03184558|581399084|FG000|Overall Study|Other|9|||
161003708|NCT01831791|581399085|FG000|Overall Study|Withdrawal by Subject|10|||
161003709|NCT01190007|581399086|FG000|Overall Study|Withdrawal by Subject|4|||
161003710|NCT01190007|581399086|FG000|Overall Study|Adverse Event|8|||
161003711|NCT01190007|581399086|FG000|Overall Study|Difficulty of visit for complications|1|||
161003712|NCT01190007|581399086|FG000|Overall Study|Participant was arrested|1|||
161003713|NCT02880241|581399090|FG000|Overall Study|Lack of Efficacy|1|||
161003714|NCT02880241|581399091|FG001|Overall Study|Lack of Efficacy|0|||
161003715|NCT02880241|581399092|FG002|Overall Study|Lack of Efficacy|0|||
161003716|NCT02880241|581399093|FG003|Overall Study|Lack of Efficacy|0|||
161003717|NCT02880241|581399094|FG004|Overall Study|Lack of Efficacy|0|||
161003718|NCT02880241|581399095|FG005|Overall Study|Lack of Efficacy|0|||
161003719|NCT00356265|581399097|FG000|Overall Study|Withdrawal by Subject|0|||
161003720|NCT00356265|581399098|FG001|Overall Study|Withdrawal by Subject|0|||
161003721|NCT00356265|581399099|FG002|Overall Study|Withdrawal by Subject|1|||
161003722|NCT00373529|581399103|FG000|Overall Study|Physician Decision|19|||
161003723|NCT00373529|581399103|FG000|Overall Study|Withdrawal by Subject|7|||
161003724|NCT00373529|581399103|FG000|Overall Study|Adverse Event|7|||
161003725|NCT00373529|581399103|FG000|Overall Study|Treatment failure|36|||
161003726|NCT00373529|581399103|FG000|Overall Study|Disease recurrence|10|||
161003727|NCT00373529|581399103|FG000|Overall Study|Death|16|||
161003728|NCT00373529|581399103|FG000|Overall Study|Need for treatment prohibited by study|1|||
161003729|NCT00373529|581399103|FG000|Overall Study|Other|8|||
161003730|NCT00373529|581399103|FG000|Overall Study|Failed independent confirmation of AML|3|||
161003731|NCT00373529|581399103|FG000|Overall Study|Consent violation|1|||
161003732|NCT04795752|581399104|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
161003733|NCT04795752|581399105|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
161003734|NCT04795752|581399104|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
161003735|NCT04795752|581399105|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
161003736|NCT04795752|581399104|FG000|Primary Endpoint Phase|Physician Decision|2|||
161003737|NCT04795752|581399105|FG001|Primary Endpoint Phase|Physician Decision|0|||
161003738|NCT04795752|581399104|FG000|Primary Endpoint Phase|Other|4|||
161003739|NCT04795752|581399105|FG001|Primary Endpoint Phase|Other|1|||
161003740|NCT04795752|581399104|FG000|Primary Endpoint Phase|Protocol Violation|1|||
161003741|NCT04795752|581399105|FG001|Primary Endpoint Phase|Protocol Violation|0|||
161003742|NCT04795752|581399104|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
161003743|NCT04795752|581399105|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
161003744|NCT04795752|581399104|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
161003745|NCT04795752|581399105|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
161003746|NCT04795752|581399104|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
161003747|NCT04795752|581399105|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
161003748|NCT04795752|581399104|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
161003749|NCT04795752|581399105|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
161003750|NCT04795752|581399104|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
161003751|NCT04795752|581399105|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
161003752|NCT00792948|581399106|FG000|Overall Study|Adverse Event|6|||
161003753|NCT00792948|581399106|FG000|Overall Study|Death|4|||
161003754|NCT00792948|581399106|FG000|Overall Study|Withdrawal by Subject|3|||
161003755|NCT00792948|581399106|FG000|Overall Study|Ineligible|2|||
161003756|NCT00792948|581399106|FG000|Overall Study|Insurance denial - not treated|1|||
160458487|NCT05525104|579409184|FG001|Overall Study|Failed caudal analgesia|3|||
160458488|NCT05525104|579409183|FG000|Overall Study|Premedication needed|0|||
160458489|NCT05525104|579409184|FG001|Overall Study|Premedication needed|1|||
160585159|NCT02052778|579861897|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
160585160|NCT02052778|579861898|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
160585161|NCT02052778|579861876|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161003757|NCT00792948|581399106|FG000|Overall Study|Physician Decision|11|||
161003758|NCT00792948|581399106|FG000|Overall Study|Protocol Violation|1|||
161003759|NCT01585558|581399113|FG000|Overall Study|Withdrawal by Subject|4|||
161003760|NCT01585558|581399114|FG001|Overall Study|Withdrawal by Subject|5|||
161003761|NCT01585558|581399115|FG002|Overall Study|Withdrawal by Subject|8|||
161003762|NCT01585558|581399113|FG000|Overall Study|Lost to Follow-up|2|||
161003763|NCT01585558|581399114|FG001|Overall Study|Lost to Follow-up|0|||
161003764|NCT01585558|581399115|FG002|Overall Study|Lost to Follow-up|3|||
161003765|NCT01585558|581399113|FG000|Overall Study|Adverse Event|3|||
161003766|NCT01585558|581399114|FG001|Overall Study|Adverse Event|4|||
161003767|NCT01585558|581399115|FG002|Overall Study|Adverse Event|1|||
161003768|NCT01585558|581399113|FG000|Overall Study|Protocol Violation|4|||
160458490|NCT05525104|579409183|FG000|Overall Study|Protocol Violation|10|||
160458491|NCT05525104|579409184|FG001|Overall Study|Protocol Violation|0|||
161003769|NCT01585558|581399114|FG001|Overall Study|Protocol Violation|3|||
161003770|NCT01585558|581399115|FG002|Overall Study|Protocol Violation|2|||
161003771|NCT01585558|581399113|FG000|Overall Study|Lack of Efficacy|0|||
161003772|NCT01585558|581399114|FG001|Overall Study|Lack of Efficacy|0|||
161003773|NCT01585558|581399115|FG002|Overall Study|Lack of Efficacy|1|||
161003774|NCT01390402|581399124|FG000|Overall Study|Death|1|||
161003775|NCT01390402|581399124|FG000|Overall Study|Disease Progression|4|||
161003776|NCT01170026|581400037|FG000|Overall Study|Lost to Follow-up|4|||
161003777|NCT01170026|581400038|FG001|Overall Study|Lost to Follow-up|2|||
161003778|NCT00686855|581400044|FG000|Overall Study|Lost to Follow-up|1|||
161003779|NCT00686855|581400045|FG001|Overall Study|Lost to Follow-up|0|||
161003780|NCT00686855|581400044|FG000|Overall Study|Progressive GVHD|0|||
161003781|NCT00686855|581400045|FG001|Overall Study|Progressive GVHD|1|||
161003782|NCT05876949|581400048|FG000|Overall Study|Withdrawal by Subject|1|||
161003783|NCT05876949|581400049|FG001|Overall Study|Withdrawal by Subject|3|||
161003784|NCT05876949|581400048|FG000|Overall Study|Physician Decision|0|||
161003785|NCT05876949|581400049|FG001|Overall Study|Physician Decision|2|||
161003786|NCT05876949|581400048|FG000|Overall Study|Death|0|||
161003787|NCT05876949|581400049|FG001|Overall Study|Death|1|||
161003788|NCT03718767|581400057|FG000|Overall Study|Declined to participate (before treatment started)|0|||
161003789|NCT03718767|581400058|FG001|Overall Study|Declined to participate (before treatment started)|0|||
161003790|NCT03718767|581400059|FG002|Overall Study|Declined to participate (before treatment started)|7|||
161003791|NCT03718767|581400057|FG000|Overall Study|Ineligible|0|||
161003792|NCT03718767|581400058|FG001|Overall Study|Ineligible|0|||
161003793|NCT03718767|581400059|FG002|Overall Study|Ineligible|17|||
161003794|NCT00494442|581400060|FG000|Overall Study|Death|1|||
161003795|NCT00494442|581400061|FG001|Overall Study|Death|1|||
161003796|NCT00494442|581400060|FG000|Overall Study|Lack of Efficacy|16|||
161003797|NCT00494442|581400061|FG001|Overall Study|Lack of Efficacy|10|||
161003798|NCT00494442|581400060|FG000|Overall Study|Adverse Event|0|||
161003799|NCT00494442|581400061|FG001|Overall Study|Adverse Event|2|||
161003800|NCT00494442|581400060|FG000|Overall Study|Physician Decision|0|||
161003801|NCT00494442|581400061|FG001|Overall Study|Physician Decision|1|||
161003802|NCT00494442|581400060|FG000|Overall Study|Non-compliance|0|||
161003803|NCT00494442|581400061|FG001|Overall Study|Non-compliance|1|||
161003804|NCT00494442|581400060|FG000|Overall Study|Intercurrent illness|0|||
161003805|NCT00494442|581400061|FG001|Overall Study|Intercurrent illness|1|||
161003806|NCT03691428|581400066|FG000|Overall Study|Withdrawal by Subject|6|||
161003807|NCT03691428|581400067|FG001|Overall Study|Withdrawal by Subject|8|||
161003808|NCT01460290|581400068|FG000|Overall Study|Adverse Event|3|||
161003809|NCT01460290|581400068|FG000|Overall Study|Elevated liver function|1|||
161003810|NCT01254019|581400073|FG000|Overall Study|Adverse Event|0|||
161003811|NCT01254019|581400074|FG001|Overall Study|Adverse Event|2|||
161003812|NCT01254019|581400073|FG000|Overall Study|Protocol Violation|1|||
161003813|NCT01254019|581400074|FG001|Overall Study|Protocol Violation|0|||
161003814|NCT01254019|581400073|FG000|Overall Study|Withdrawal by Subject|0|||
161003815|NCT01254019|581400074|FG001|Overall Study|Withdrawal by Subject|2|||
161003816|NCT03061474|581400075|FG000|Overall Study|Adverse Event|2|||
161003817|NCT03061474|581400076|FG001|Overall Study|Adverse Event|0|||
161003818|NCT03061474|581400075|FG000|Overall Study|Safety Risk|0|||
161003819|NCT03061474|581400076|FG001|Overall Study|Safety Risk|1|||
161003820|NCT03061474|581400075|FG000|Overall Study|Participant unwilling or unable to participate|0|||
161003821|NCT03061474|581400076|FG001|Overall Study|Participant unwilling or unable to participate|2|||
161003822|NCT03061474|581400075|FG000|Overall Study|Lost to Follow-up|0|||
161003823|NCT03061474|581400076|FG001|Overall Study|Lost to Follow-up|1|||
161003824|NCT00845832|581400079|FG000|Treatment Period|Adverse Event|0|||
161003825|NCT00845832|581400080|FG001|Treatment Period|Adverse Event|2|||
161003826|NCT00845832|581400081|FG002|Treatment Period|Adverse Event|0|||
161003827|NCT00845832|581400079|FG000|Treatment Period|Protocol Violation|1|||
161003828|NCT00845832|581400080|FG001|Treatment Period|Protocol Violation|1|||
161003829|NCT00845832|581400081|FG002|Treatment Period|Protocol Violation|0|||
161003830|NCT00845832|581400079|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
161003831|NCT00845832|581400080|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
160458492|NCT05525104|579409183|FG000|Overall Study|Cancelled operation|1|||
160458493|NCT05525104|579409184|FG001|Overall Study|Cancelled operation|0|||
160458494|NCT02039401|579409185|FG000|Overall Study|Adverse Event|0|||
161003832|NCT00845832|581400081|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
161003833|NCT00845832|581400079|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
161003834|NCT00845832|581400080|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
160458495|NCT02039401|579409186|FG001|Overall Study|Adverse Event|1|||
161003835|NCT00845832|581400081|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
161003836|NCT01391130|581400082|FG000|Overall Study|Withdrawal by Subject|3|||
161003837|NCT01391130|581400083|FG001|Overall Study|Withdrawal by Subject|2|||
161003838|NCT01391130|581400082|FG000|Overall Study|Physician Decision|2|||
160458496|NCT04427007|579410815|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
161003839|NCT01391130|581400083|FG001|Overall Study|Physician Decision|3|||
161003840|NCT01391130|581400082|FG000|Overall Study|Did not Receive Drug|1|||
161003841|NCT01391130|581400083|FG001|Overall Study|Did not Receive Drug|1|||
161003842|NCT03520413|581400090|FG000|Overall Study|Lost to Follow-up|1|||
161003843|NCT03520413|581400091|FG001|Overall Study|Lost to Follow-up|1|||
161003844|NCT03520413|581400090|FG000|Overall Study|Withdrawal by Subject|1|||
161003845|NCT03520413|581400091|FG001|Overall Study|Withdrawal by Subject|2|||
161003846|NCT03520413|581400090|FG000|Overall Study|Death|0|||
161003847|NCT03520413|581400091|FG001|Overall Study|Death|1|||
161003848|NCT03520413|581400090|FG000|Overall Study|Physician Decision|3|||
161003849|NCT03520413|581400091|FG001|Overall Study|Physician Decision|3|||
161003850|NCT03520413|581400090|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
161003851|NCT03520413|581400091|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
161003852|NCT00869323|581400092|FG000|Maintenance Therapy|concurrent illness|1|||
161003853|NCT00638963|581400093|FG000|Overall Study|Withdrawal by Subject|1|||
161003854|NCT00638963|581400094|FG001|Overall Study|Withdrawal by Subject|0|||
161003855|NCT00959946|581400099|FG000|Overall Study|Adverse Event|0|||
161003856|NCT00959946|581400100|FG001|Overall Study|Adverse Event|0|||
161003857|NCT00959946|581400101|FG002|Overall Study|Adverse Event|2|||
161003858|NCT00959946|581400102|FG003|Overall Study|Adverse Event|1|||
161003859|NCT00959946|581400103|FG004|Overall Study|Adverse Event|0|||
161003860|NCT00959946|581400104|FG005|Overall Study|Adverse Event|1|||
161003861|NCT00959946|581400105|FG006|Overall Study|Adverse Event|0|||
161003862|NCT00959946|581400106|FG007|Overall Study|Adverse Event|0|||
161003863|NCT00959946|581400099|FG000|Overall Study|Death|0|||
161003864|NCT00959946|581400100|FG001|Overall Study|Death|0|||
161003865|NCT00959946|581400101|FG002|Overall Study|Death|0|||
161003866|NCT00959946|581400102|FG003|Overall Study|Death|0|||
161003867|NCT00959946|581400103|FG004|Overall Study|Death|0|||
161003868|NCT00959946|581400104|FG005|Overall Study|Death|1|||
161003869|NCT00959946|581400105|FG006|Overall Study|Death|0|||
161003870|NCT00959946|581400106|FG007|Overall Study|Death|0|||
161003871|NCT00959946|581400099|FG000|Overall Study|Disease Progression|2|||
161003872|NCT00959946|581400100|FG001|Overall Study|Disease Progression|4|||
161003873|NCT00959946|581400101|FG002|Overall Study|Disease Progression|2|||
161003874|NCT00959946|581400102|FG003|Overall Study|Disease Progression|4|||
161003875|NCT00959946|581400103|FG004|Overall Study|Disease Progression|4|||
161003876|NCT00959946|581400104|FG005|Overall Study|Disease Progression|6|||
161003877|NCT00959946|581400105|FG006|Overall Study|Disease Progression|2|||
161003878|NCT00959946|581400106|FG007|Overall Study|Disease Progression|2|||
161003879|NCT00959946|581400099|FG000|Overall Study|Withdrawal by Subject|0|||
161003880|NCT00959946|581400100|FG001|Overall Study|Withdrawal by Subject|0|||
161003881|NCT00959946|581400101|FG002|Overall Study|Withdrawal by Subject|0|||
161003882|NCT00959946|581400102|FG003|Overall Study|Withdrawal by Subject|0|||
161003883|NCT00959946|581400103|FG004|Overall Study|Withdrawal by Subject|0|||
161003884|NCT00959946|581400104|FG005|Overall Study|Withdrawal by Subject|1|||
161003885|NCT00959946|581400105|FG006|Overall Study|Withdrawal by Subject|0|||
161003886|NCT00959946|581400106|FG007|Overall Study|Withdrawal by Subject|0|||
161003887|NCT00457743|581400107|FG000|Overall Study|Adverse Event|0|||
161003888|NCT00457743|581400108|FG001|Overall Study|Adverse Event|4|||
161003889|NCT00457743|581400109|FG002|Overall Study|Adverse Event|0|||
161003890|NCT00457743|581400107|FG000|Overall Study|Lack of Efficacy|3|||
161003891|NCT00457743|581400108|FG001|Overall Study|Lack of Efficacy|23|||
161003892|NCT00457743|581400109|FG002|Overall Study|Lack of Efficacy|3|||
161003893|NCT00566527|581400110|FG000|Overall Study|Reason not provided|3|||
161003894|NCT00566527|581400111|FG001|Overall Study|Reason not provided|11|||
161003895|NCT00566527|581400112|FG002|Overall Study|Reason not provided|10|||
161003896|NCT00566527|581400110|FG000|Overall Study|Adverse Event|2|||
161003897|NCT00566527|581400111|FG001|Overall Study|Adverse Event|0|||
161003898|NCT00566527|581400112|FG002|Overall Study|Adverse Event|1|||
161003899|NCT00566527|581400110|FG000|Overall Study|Physician Decision|3|||
161003900|NCT00566527|581400111|FG001|Overall Study|Physician Decision|8|||
161003901|NCT00566527|581400112|FG002|Overall Study|Physician Decision|20|||
161003902|NCT00566527|581400110|FG000|Overall Study|Lost to Follow-up|3|||
161003903|NCT00566527|581400111|FG001|Overall Study|Lost to Follow-up|4|||
161003904|NCT00566527|581400112|FG002|Overall Study|Lost to Follow-up|4|||
161003905|NCT00566527|581400110|FG000|Overall Study|Withdrawal by Subject|6|||
161003906|NCT00566527|581400111|FG001|Overall Study|Withdrawal by Subject|43|||
160585162|NCT02052778|579861877|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161003907|NCT00566527|581400112|FG002|Overall Study|Withdrawal by Subject|43|||
161003908|NCT01837966|581400114|FG000|Overall Study|Withdrawal by Subject|2|||
161003909|NCT01837966|581400115|FG001|Overall Study|Withdrawal by Subject|1|||
161003910|NCT04975308|581400119|FG000|Overall Study|Withdrawal by Subject|6|||
161003911|NCT04975308|581400120|FG001|Overall Study|Withdrawal by Subject|16|||
161003912|NCT04975308|581400121|FG002|Overall Study|Withdrawal by Subject|6|||
161003913|NCT04975308|581400119|FG000|Overall Study|Physician Decision|0|||
161003914|NCT04975308|581400120|FG001|Overall Study|Physician Decision|3|||
161003915|NCT04975308|581400121|FG002|Overall Study|Physician Decision|1|||
161003916|NCT04975308|581400119|FG000|Overall Study|Adverse Event|10|||
161003917|NCT04975308|581400120|FG001|Overall Study|Adverse Event|1|||
161003918|NCT04975308|581400121|FG002|Overall Study|Adverse Event|12|||
161003919|NCT04975308|581400119|FG000|Overall Study|On study treatment (Ongoing)|65|||
161003920|NCT04975308|581400120|FG001|Overall Study|On study treatment (Ongoing)|43|||
161003921|NCT04975308|581400121|FG002|Overall Study|On study treatment (Ongoing)|75|||
161003922|NCT04975308|581400119|FG000|Overall Study|Protocol Deviation|4|||
161003923|NCT04975308|581400120|FG001|Overall Study|Protocol Deviation|3|||
161003924|NCT04975308|581400121|FG002|Overall Study|Protocol Deviation|2|||
161003925|NCT01943916|581400124|FG000|Overall Study|Technically invalid images|10|||
161003926|NCT01943916|581400124|FG000|Overall Study|Enrollment Failure|23|||
161003927|NCT01943916|581400124|FG000|Overall Study|Pilot Phase exclusion|100|||
161003928|NCT01943916|581400124|FG000|Overall Study|Quality Assurance Reader Fail|130|||
161003929|NCT01943916|581400124|FG000|Overall Study|Technical Failure|39|||
161003930|NCT01943916|581400124|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
161003931|NCT01943916|581400124|FG000|Overall Study|No Truth Panel Review|38|||
161003932|NCT01943916|581400124|FG000|Overall Study|Protocol Deviation|1|||
161003933|NCT00547118|581400126|FG000|Overall Study|Did not qualify prior to starting drug|1|||
161003934|NCT00547118|581400127|FG001|Overall Study|Did not qualify prior to starting drug|1|||
161003935|NCT00547118|581400126|FG000|Overall Study|Study suspended|7|||
161003936|NCT00547118|581400127|FG001|Overall Study|Study suspended|8|||
161003937|NCT01595321|581400128|FG000|Overall Study|Adverse Event|1|||
161003938|NCT01595321|581400129|FG001|Overall Study|Adverse Event|1|||
161003939|NCT01595321|581400130|FG002|Overall Study|Adverse Event|1|||
161003940|NCT01595321|581400128|FG000|Overall Study|Lack of Efficacy|0|||
161003941|NCT01595321|581400129|FG001|Overall Study|Lack of Efficacy|0|||
161003942|NCT01595321|581400130|FG002|Overall Study|Lack of Efficacy|4|||
161003943|NCT00834834|581400131|FG000|Overall Study|Withdrawal by Subject|4|||
161003944|NCT00834834|581400132|FG001|Overall Study|Withdrawal by Subject|3|||
161003945|NCT01810263|581400137|FG000|Overall Study|Lost to Follow-up|8|||
161003946|NCT01810263|581400138|FG001|Overall Study|Lost to Follow-up|7|||
161003947|NCT00026312|581400141|FG000|Overall Study|Adverse Event|0|||
161003948|NCT00026312|581400142|FG001|Overall Study|Adverse Event|32|||
161003949|NCT00026312|581400141|FG000|Overall Study|Death|1|||
161003950|NCT00026312|581400142|FG001|Overall Study|Death|7|||
161003951|NCT00026312|581400141|FG000|Overall Study|Lack of Efficacy|19|||
161003952|NCT00026312|581400142|FG001|Overall Study|Lack of Efficacy|114|||
161003953|NCT00026312|581400141|FG000|Overall Study|Lost to Follow-up|0|||
161003954|NCT00026312|581400142|FG001|Overall Study|Lost to Follow-up|5|||
161003955|NCT00026312|581400141|FG000|Overall Study|Physician Decision|1|||
161003956|NCT00026312|581400142|FG001|Overall Study|Physician Decision|37|||
161003957|NCT00026312|581400141|FG000|Overall Study|Protocol Violation|0|||
161003958|NCT00026312|581400142|FG001|Overall Study|Protocol Violation|3|||
161003959|NCT00026312|581400141|FG000|Overall Study|Withdrawal by Subject|1|||
161003960|NCT00026312|581400142|FG001|Overall Study|Withdrawal by Subject|6|||
161003961|NCT00026312|581400141|FG000|Overall Study|Ineligible|4|||
161003962|NCT00026312|581400142|FG001|Overall Study|Ineligible|5|||
161003963|NCT00026312|581400141|FG000|Overall Study|Entry onto another COG study|0|||
161003964|NCT00026312|581400142|FG001|Overall Study|Entry onto another COG study|1|||
161003965|NCT00026312|581400141|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
161003966|NCT00026312|581400142|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
161003967|NCT01185561|581401110|FG000|Overall Study|Lost to Follow-up|0|||
161003968|NCT01185561|581401111|FG001|Overall Study|Lost to Follow-up|4|||
161003969|NCT01185561|581401110|FG000|Overall Study|Withdrawal by Subject|2|||
161003970|NCT01185561|581401111|FG001|Overall Study|Withdrawal by Subject|8|||
161003971|NCT01078116|581401114|FG000|Overall Study|Lost to Follow-up|17|||
161003972|NCT01078116|581401114|FG000|Overall Study|Adverse Event|5|||
161003973|NCT01078116|581401114|FG000|Overall Study|Withdrawal by Subject|8|||
161003974|NCT01078116|581401114|FG000|Overall Study|Lack of effectiveness|15|||
161003975|NCT01078116|581401114|FG000|Overall Study|Case report form not completed|3|||
161003976|NCT00585052|581401115|FG000|Overall Study|Withdrawal by Subject|1|||
161003977|NCT02616900|581401116|FG000|Overall Study|Lack of Efficacy|7|||
161003978|NCT02616900|581401116|FG000|Overall Study|Lost to Follow-up|2|||
160585163|NCT02052778|579861878|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585164|NCT02052778|579861879|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585165|NCT02052778|579861880|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585166|NCT02052778|579861881|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161003979|NCT02616900|581401116|FG000|Overall Study|Protocol Violation|5|||
160585167|NCT02052778|579861882|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161003980|NCT02616900|581401116|FG000|Overall Study|Withdrawal by Subject|3|||
160585168|NCT02052778|579861883|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161003981|NCT02616900|581401116|FG000|Overall Study|Incomplete data|6|||
161003982|NCT02613871|581401117|FG000|Overall Study|Death|2|||
161003983|NCT02613871|581401117|FG000|Overall Study|Withdrew Consent|1|||
161003984|NCT02527148|581401118|FG000|Overall Study|Did not receive study intervention|1|||
161003985|NCT02527148|581401119|FG001|Overall Study|Did not receive study intervention|0|||
161003986|NCT00309907|581401120|FG000|Overall Study|Death|4|||
161003987|NCT00309907|581401120|FG000|Overall Study|Physician Decision|1|||
161003988|NCT00309907|581401120|FG000|Overall Study|Ineligible|11|||
161003989|NCT00309907|581401120|FG000|Overall Study|Major infectious event|4|||
161003990|NCT00494780|581401121|FG000|Overall Study|Adverse Event|1|||
161003991|NCT00494780|581401122|FG001|Overall Study|Adverse Event|0|||
161003992|NCT00494780|581401121|FG000|Overall Study|Withdrew before Dosed|0|||
160585169|NCT02052778|579861884|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585170|NCT02052778|579861885|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161003993|NCT00494780|581401122|FG001|Overall Study|Withdrew before Dosed|1|||
161003994|NCT00494780|581401121|FG000|Overall Study|Progression of Study Disease|7|||
161003995|NCT00494780|581401122|FG001|Overall Study|Progression of Study Disease|8|||
161003996|NCT00494780|581401121|FG000|Overall Study|New Treatment|2|||
161003997|NCT00494780|581401122|FG001|Overall Study|New Treatment|2|||
161003998|NCT00494780|581401121|FG000|Overall Study|Non-compliance|1|||
161003999|NCT00494780|581401122|FG001|Overall Study|Non-compliance|0|||
161004000|NCT00494780|581401121|FG000|Overall Study|Residual Tumour Mass|0|||
161004001|NCT00494780|581401122|FG001|Overall Study|Residual Tumour Mass|1|||
161004002|NCT00494780|581401121|FG000|Overall Study|Insurance Issues|0|||
161004003|NCT00494780|581401122|FG001|Overall Study|Insurance Issues|1|||
161004004|NCT02448446|581401123|FG000|Overall Study|Withdrawal by Subject|1|||
161004005|NCT02448446|581401124|FG001|Overall Study|Withdrawal by Subject|0|||
161004006|NCT03260140|581401125|FG000|Overall Study|Death|4|||
161004007|NCT03260140|581401126|FG001|Overall Study|Death|1|||
161004008|NCT03260140|581401125|FG000|Overall Study|Withdrawal by Subject|1|||
161004009|NCT03260140|581401126|FG001|Overall Study|Withdrawal by Subject|4|||
161004010|NCT00463788|581401127|FG000|Overall Study|Progressive Disease|86|||
161004011|NCT00463788|581401128|FG001|Overall Study|Progressive Disease|42|||
161004012|NCT00463788|581401127|FG000|Overall Study|Adverse Event|6|||
161004013|NCT00463788|581401128|FG001|Overall Study|Adverse Event|2|||
161004014|NCT00463788|581401127|FG000|Overall Study|Withdrawal by Subject|6|||
161004015|NCT00463788|581401128|FG001|Overall Study|Withdrawal by Subject|2|||
161004016|NCT00463788|581401127|FG000|Overall Study|Death|4|||
161004017|NCT00463788|581401128|FG001|Overall Study|Death|3|||
161004018|NCT00463788|581401127|FG000|Overall Study|Symptomatic Deterioration|2|||
161004019|NCT00463788|581401128|FG001|Overall Study|Symptomatic Deterioration|3|||
161004020|NCT00463788|581401127|FG000|Overall Study|Lost to Follow-up|1|||
161004021|NCT00463788|581401128|FG001|Overall Study|Lost to Follow-up|0|||
161004022|NCT00463788|581401127|FG000|Overall Study|Protocol Violation|0|||
161004023|NCT00463788|581401128|FG001|Overall Study|Protocol Violation|1|||
161004024|NCT00463788|581401127|FG000|Overall Study|Other|3|||
161004025|NCT00463788|581401128|FG001|Overall Study|Other|0|||
161004026|NCT00463788|581401127|FG000|Overall Study|Randomized but not treated|1|||
161004027|NCT00463788|581401128|FG001|Overall Study|Randomized but not treated|1|||
161004028|NCT00360698|581401129|FG000|Run-In|Physician Decision|0|||
161004029|NCT00360698|581401130|FG001|Run-In|Physician Decision|1|||
161004030|NCT00360698|581401129|FG000|Run-In|Withdrawal by Subject|0|||
161004031|NCT00360698|581401130|FG001|Run-In|Withdrawal by Subject|2|||
161004032|NCT00360698|581401129|FG000|Run-In|Non compliance with treatment procedure|0|||
161004033|NCT00360698|581401130|FG001|Run-In|Non compliance with treatment procedure|1|||
161004034|NCT00360698|581401129|FG000|Run-In|Sponsor request|0|||
161004035|NCT00360698|581401130|FG001|Run-In|Sponsor request|2|||
161004036|NCT00360698|581401129|FG000|Run-In|Patient did not meet inclusion criteria|0|||
161004037|NCT00360698|581401130|FG001|Run-In|Patient did not meet inclusion criteria|1|||
161004038|NCT00360698|581401129|FG000|Run-In|Patient personal reasons|0|||
161004039|NCT00360698|581401130|FG001|Run-In|Patient personal reasons|2|||
161004040|NCT00360698|581401129|FG000|Run-In|Need of insulin with meals|0|||
161004041|NCT00360698|581401130|FG001|Run-In|Need of insulin with meals|1|||
161004042|NCT00360698|581401129|FG000|Treatment Period|Non compliance with treatment procedure|1|||
161004043|NCT00360698|581401130|FG001|Treatment Period|Non compliance with treatment procedure|0|||
161004044|NCT00360698|581401129|FG000|Treatment Period|Early termination by error|0|||
161004045|NCT00360698|581401130|FG001|Treatment Period|Early termination by error|1|||
161004046|NCT01692938|581401139|FG000|Overall Study|Protocol Deviation|1|||
160585171|NCT02052778|579861886|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585172|NCT02052778|579861887|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585173|NCT02052778|579861888|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585174|NCT02052778|579861889|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585175|NCT02052778|579861890|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161004047|NCT01692938|581401140|FG001|Overall Study|Protocol Deviation|1|||
161004048|NCT01692938|581401139|FG000|Overall Study|Study completed prior to site completion|3|||
161004049|NCT01692938|581401140|FG001|Overall Study|Study completed prior to site completion|3|||
161004050|NCT02423291|581401144|FG000|Overall Study|Lack of Efficacy|14|||
161004051|NCT02423291|581401144|FG000|Overall Study|Adverse Event|1|||
161004052|NCT05283395|581401147|FG000|Overall Study|Adverse Event|4|||
161004053|NCT05283395|581401148|FG001|Overall Study|Adverse Event|4|||
160585176|NCT02052778|579861891|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161004054|NCT05283395|581401149|FG002|Overall Study|Adverse Event|0|||
161004055|NCT05283395|581401147|FG000|Overall Study|Patient Lost to Follow-Up|0|||
161004056|NCT05283395|581401148|FG001|Overall Study|Patient Lost to Follow-Up|0|||
160458497|NCT04427007|579410816|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
161004057|NCT05283395|581401149|FG002|Overall Study|Patient Lost to Follow-Up|1|||
161004058|NCT05283395|581401147|FG000|Overall Study|Patient Withdrawal|2|||
161004059|NCT05283395|581401148|FG001|Overall Study|Patient Withdrawal|4|||
161004060|NCT05283395|581401149|FG002|Overall Study|Patient Withdrawal|2|||
161004061|NCT05283395|581401147|FG000|Overall Study|Investigator Decision|1|||
161004062|NCT05283395|581401148|FG001|Overall Study|Investigator Decision|0|||
161004063|NCT05283395|581401149|FG002|Overall Study|Investigator Decision|1|||
161004064|NCT05283395|581401147|FG000|Overall Study|Enrolled in error|0|||
161004065|NCT05283395|581401148|FG001|Overall Study|Enrolled in error|0|||
161004066|NCT05283395|581401149|FG002|Overall Study|Enrolled in error|1|||
161004067|NCT00712335|581401151|FG000|Overall Study|Withdrawal by Subject|0|||
161004068|NCT00712335|581401152|FG001|Overall Study|Withdrawal by Subject|7|||
161004069|NCT00712335|581401153|FG002|Overall Study|Withdrawal by Subject|2|||
161004070|NCT00712335|581401154|FG003|Overall Study|Withdrawal by Subject|3|||
161004071|NCT00712335|581401155|FG004|Overall Study|Withdrawal by Subject|0|||
161004072|NCT00712335|581401151|FG000|Overall Study|Lost to Follow-up|2|||
160458498|NCT05524116|579410828|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
160458499|NCT05524116|579410829|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
160458500|NCT05524116|579410828|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
160458501|NCT05524116|579410829|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
160458502|NCT05524116|579410828|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
160458503|NCT05524116|579410829|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
160458504|NCT05524116|579410828|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
160458505|NCT05524116|579410829|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
160458506|NCT05524116|579410828|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
160458507|NCT05524116|579410829|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
160458508|NCT04389957|579410830|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
160458509|NCT04389957|579410831|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
160458510|NCT04389957|579410832|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
160458511|NCT04389957|579410833|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
160458512|NCT04389957|579410834|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
160458513|NCT04247802|579410838|FG000|Overall Study|Withdrawal by Subject|1|||
160458514|NCT04247802|579410839|FG001|Overall Study|Withdrawal by Subject|3|||
160458515|NCT04247802|579410838|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
160458516|NCT04247802|579410839|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
160458517|NCT01385202|579410851|FG000|Overall Study|Lost to Follow-up|6|||
160458518|NCT01385202|579410851|FG000|Overall Study|Not Eligible|11|||
160458519|NCT01385202|579410851|FG000|Overall Study|Withdrawn|1|||
160458520|NCT03691298|579410858|FG000|Overall Study|Lost to Follow-up|8|||
160458521|NCT03691298|579410858|FG000|Overall Study|Sponsor terminated study|2|||
160458522|NCT02577354|579410859|FG000|Overall Study|Lack of Efficacy|4|||
160458523|NCT02577354|579410860|FG001|Overall Study|Lack of Efficacy|4|||
160458524|NCT02577354|579410859|FG000|Overall Study|Lost to Follow-up|3|||
160458525|NCT02577354|579410860|FG001|Overall Study|Lost to Follow-up|1|||
160458526|NCT02577354|579410859|FG000|Overall Study|Missed Visit|4|||
160458527|NCT02577354|579410860|FG001|Overall Study|Missed Visit|3|||
160458528|NCT02577354|579410859|FG000|Overall Study|Adverse Event|4|||
160458529|NCT02577354|579410860|FG001|Overall Study|Adverse Event|5|||
160458530|NCT05070741|579410868|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
160458531|NCT03245840|579410869|FG000|Overall Study|Adverse Event|6|||
160458532|NCT03245840|579410870|FG001|Overall Study|Adverse Event|0|||
160458533|NCT03245840|579410869|FG000|Overall Study|Death|2|||
160458534|NCT03245840|579410870|FG001|Overall Study|Death|0|||
160458535|NCT03245840|579410869|FG000|Overall Study|Withdrawal by Subject|31|||
160458536|NCT03245840|579410870|FG001|Overall Study|Withdrawal by Subject|1|||
160458537|NCT03245840|579410869|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160458538|NCT03245840|579410870|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160458539|NCT03245840|579410869|FG000|Overall Study|Physician Decision|4|||
160458540|NCT03245840|579410870|FG001|Overall Study|Physician Decision|1|||
160458541|NCT03245840|579410869|FG000|Overall Study|Study Terminated by Sponsor|56|||
160657006|NCT05097989|580124503|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
160657007|NCT05097989|580124504|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
160458542|NCT03245840|579410870|FG001|Overall Study|Study Terminated by Sponsor|6|||
160458543|NCT03245840|579410869|FG000|Overall Study|Site Terminated by Sponsor|4|||
160458544|NCT03245840|579410870|FG001|Overall Study|Site Terminated by Sponsor|0|||
161004073|NCT00712335|581401152|FG001|Overall Study|Lost to Follow-up|5|||
161004074|NCT00712335|581401153|FG002|Overall Study|Lost to Follow-up|0|||
161004075|NCT00712335|581401154|FG003|Overall Study|Lost to Follow-up|1|||
160458545|NCT03245840|579410869|FG000|Overall Study|Lost to Follow-up|12|||
160458546|NCT03245840|579410870|FG001|Overall Study|Lost to Follow-up|2|||
160458547|NCT03245840|579410869|FG000|Overall Study|Pregnancy|2|||
160458548|NCT03245840|579410870|FG001|Overall Study|Pregnancy|0|||
161004076|NCT00712335|581401155|FG004|Overall Study|Lost to Follow-up|0|||
161004077|NCT00712335|581401151|FG000|Overall Study|Protocol Violation|1|||
161004078|NCT00712335|581401152|FG001|Overall Study|Protocol Violation|2|||
161004079|NCT00712335|581401153|FG002|Overall Study|Protocol Violation|1|||
161004080|NCT00712335|581401154|FG003|Overall Study|Protocol Violation|0|||
161004081|NCT00712335|581401155|FG004|Overall Study|Protocol Violation|0|||
161004082|NCT00712335|581401151|FG000|Overall Study|Lack of Efficacy|0|||
161004083|NCT00712335|581401152|FG001|Overall Study|Lack of Efficacy|0|||
161004084|NCT00712335|581401153|FG002|Overall Study|Lack of Efficacy|1|||
161004085|NCT00712335|581401154|FG003|Overall Study|Lack of Efficacy|1|||
161004086|NCT00712335|581401155|FG004|Overall Study|Lack of Efficacy|0|||
161004087|NCT00712335|581401151|FG000|Overall Study|Other Reason|0|||
161004088|NCT00712335|581401152|FG001|Overall Study|Other Reason|3|||
161004089|NCT00712335|581401153|FG002|Overall Study|Other Reason|1|||
161004090|NCT00712335|581401154|FG003|Overall Study|Other Reason|0|||
161004091|NCT00712335|581401155|FG004|Overall Study|Other Reason|0|||
161004092|NCT03401112|581401156|FG000|Overall Study|Adverse Event|1|||
161004093|NCT03401112|581401157|FG001|Overall Study|Adverse Event|2|||
161004094|NCT03401112|581401158|FG002|Overall Study|Adverse Event|3|||
161004095|NCT03401112|581401159|FG003|Overall Study|Adverse Event|2|||
161004096|NCT03401112|581401160|FG004|Overall Study|Adverse Event|0|||
161004097|NCT03401112|581401156|FG000|Overall Study|Lost to Follow-up|1|||
161004098|NCT03401112|581401157|FG001|Overall Study|Lost to Follow-up|0|||
161004099|NCT03401112|581401158|FG002|Overall Study|Lost to Follow-up|0|||
161004100|NCT03401112|581401159|FG003|Overall Study|Lost to Follow-up|0|||
161004101|NCT03401112|581401160|FG004|Overall Study|Lost to Follow-up|0|||
161004102|NCT03401112|581401156|FG000|Overall Study|Noncompliance|1|||
161004103|NCT03401112|581401157|FG001|Overall Study|Noncompliance|2|||
161004104|NCT03401112|581401158|FG002|Overall Study|Noncompliance|3|||
161004105|NCT03401112|581401159|FG003|Overall Study|Noncompliance|0|||
161004106|NCT03401112|581401160|FG004|Overall Study|Noncompliance|0|||
161004107|NCT03401112|581401156|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
161004108|NCT03401112|581401157|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
161004109|NCT03401112|581401158|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
161004110|NCT03401112|581401159|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
161004111|NCT03401112|581401160|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
161004112|NCT03401112|581401156|FG000|Overall Study|Withdrawal by Subject|0|||
161004113|NCT03401112|581401157|FG001|Overall Study|Withdrawal by Subject|3|||
161004114|NCT03401112|581401158|FG002|Overall Study|Withdrawal by Subject|2|||
161004115|NCT03401112|581401159|FG003|Overall Study|Withdrawal by Subject|1|||
161004116|NCT03401112|581401160|FG004|Overall Study|Withdrawal by Subject|0|||
161004117|NCT03401112|581401156|FG000|Overall Study|Physician Decision|0|||
161004118|NCT03401112|581401157|FG001|Overall Study|Physician Decision|0|||
161004119|NCT03401112|581401158|FG002|Overall Study|Physician Decision|0|||
161004120|NCT03401112|581401159|FG003|Overall Study|Physician Decision|2|||
161004121|NCT03401112|581401160|FG004|Overall Study|Physician Decision|0|||
161004122|NCT03401112|581401156|FG000|Overall Study|Study was Terminated by Sponsor|0|||
161004123|NCT03401112|581401157|FG001|Overall Study|Study was Terminated by Sponsor|0|||
161004124|NCT03401112|581401158|FG002|Overall Study|Study was Terminated by Sponsor|0|||
161004125|NCT03401112|581401159|FG003|Overall Study|Study was Terminated by Sponsor|1|||
161004126|NCT03401112|581401160|FG004|Overall Study|Study was Terminated by Sponsor|0|||
161004127|NCT03401112|581401156|FG000|Overall Study|Day 1 Assessment not Done|1|||
161004128|NCT03401112|581401157|FG001|Overall Study|Day 1 Assessment not Done|0|||
161004129|NCT03401112|581401158|FG002|Overall Study|Day 1 Assessment not Done|0|||
161004130|NCT03401112|581401159|FG003|Overall Study|Day 1 Assessment not Done|0|||
161004131|NCT03401112|581401160|FG004|Overall Study|Day 1 Assessment not Done|0|||
161004132|NCT03401112|581401156|FG000|Overall Study|Not Dosed|0|||
161004133|NCT03401112|581401157|FG001|Overall Study|Not Dosed|0|||
161004134|NCT03401112|581401158|FG002|Overall Study|Not Dosed|1|||
161004135|NCT03401112|581401159|FG003|Overall Study|Not Dosed|0|||
161004136|NCT03401112|581401160|FG004|Overall Study|Not Dosed|0|||
161004137|NCT03401112|581401156|FG000|Overall Study|Missed Clinical Visit|0|||
161004138|NCT03401112|581401157|FG001|Overall Study|Missed Clinical Visit|0|||
161004139|NCT03401112|581401158|FG002|Overall Study|Missed Clinical Visit|1|||
160585177|NCT02052778|579861892|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161004140|NCT03401112|581401159|FG003|Overall Study|Missed Clinical Visit|0|||
161004141|NCT03401112|581401160|FG004|Overall Study|Missed Clinical Visit|0|||
161004142|NCT03401112|581401156|FG000|Overall Study|Missed Doses|0|||
161004143|NCT03401112|581401157|FG001|Overall Study|Missed Doses|0|||
161004144|NCT03401112|581401158|FG002|Overall Study|Missed Doses|1|||
161004145|NCT03401112|581401159|FG003|Overall Study|Missed Doses|0|||
161004146|NCT03401112|581401160|FG004|Overall Study|Missed Doses|0|||
160585178|NCT02052778|579861893|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585179|NCT02052778|579861894|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161004147|NCT01264679|581401161|FG000|Overall Study|Participation in Another Clinical Trial|1|||
161004148|NCT01264679|581401161|FG000|Overall Study|Physician Decision|1|||
161004149|NCT01264679|581401161|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
161004150|NCT01264679|581401161|FG000|Overall Study|Withdrawal by Subject|1|||
161004151|NCT03475316|581401162|FG000|6 Month Intervention|Adverse Event|2|||
161004152|NCT03475316|581401163|FG001|6 Month Intervention|Adverse Event|1|||
161004153|NCT03475316|581401162|FG000|6 Month Intervention|Withdrawal by Subject|2|||
161004154|NCT03475316|581401163|FG001|6 Month Intervention|Withdrawal by Subject|0|||
161004155|NCT03475316|581401162|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
161004156|NCT03475316|581401163|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
161004157|NCT03475316|581401162|FG000|9 Months|Study stopped due to COVID pandemic|3|||
161004158|NCT03475316|581401163|FG001|9 Months|Study stopped due to COVID pandemic|4|||
161004159|NCT00424645|581401168|FG000|Overall Study|Death|1|||
161004160|NCT00424645|581401169|FG001|Overall Study|Death|0|||
161004161|NCT02555215|581401170|FG000|Overall Study|Other|1|||
161004162|NCT02555215|581401170|FG000|Overall Study|Investigator Decision|2|||
161004163|NCT00529789|581401171|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
161004164|NCT00529789|581401171|FG000|Study Period II/III|Adverse Event|3|||
161004165|NCT00529789|581401171|FG000|Study Period II/III|Lack of Efficacy|2|||
161004166|NCT00529789|581401171|FG000|Study Period II/III|Withdrawal by Subject|1|||
161004167|NCT00529789|581401171|FG000|Study Period II/III|Protocol Violation|3|||
161004168|NCT00529789|581401171|FG000|Study Period II/III|Physician Decision|3|||
161004169|NCT00529789|581401171|FG000|Study Period II/III|Lost to Follow-up|3|||
161004170|NCT00529789|581401171|FG000|Study Period IV|Parent/Caregiver Decision|1|||
161004171|NCT00529789|581401171|FG000|Study Period IV|Adverse Event|1|||
161004172|NCT00529789|581401171|FG000|Study Period IV|Lack of Efficacy|1|||
161004173|NCT00529789|581401171|FG000|Study Period IV|Lost to Follow-up|3|||
161004174|NCT00468910|581401172|FG000|Overall Study|Lost to Follow-up|2|||
161004175|NCT00468910|581401173|FG001|Overall Study|Lost to Follow-up|1|||
161004176|NCT00468910|581401172|FG000|Overall Study|Withdrawal by Subject|2|||
161004177|NCT00468910|581401173|FG001|Overall Study|Withdrawal by Subject|1|||
161004178|NCT00468910|581401172|FG000|Overall Study|Medical Contraindication|0|||
161004179|NCT00468910|581401173|FG001|Overall Study|Medical Contraindication|1|||
161004180|NCT01909778|581401174|FG000|Overall Study|failed screening|1|||
161004181|NCT05323734|581401175|FG000|Overall Study|Adverse Event|5|||
161004182|NCT05323734|581401176|FG001|Overall Study|Adverse Event|2|||
161004183|NCT05323734|581401175|FG000|Overall Study|Physician Decision|1|||
161004184|NCT05323734|581401176|FG001|Overall Study|Physician Decision|0|||
161004185|NCT05323734|581401175|FG000|Overall Study|Lack of Efficacy|1|||
161004186|NCT05323734|581401176|FG001|Overall Study|Lack of Efficacy|2|||
161004187|NCT05323734|581401175|FG000|Overall Study|Withdrawal by Subject|2|||
161004188|NCT05323734|581401176|FG001|Overall Study|Withdrawal by Subject|0|||
161004189|NCT05323734|581401175|FG000|Overall Study|Participant Withdrawn Due|0|||
161004190|NCT05323734|581401176|FG001|Overall Study|Participant Withdrawn Due|1|||
161004191|NCT00841035|581401181|FG000|Phase 1 Overall Study|Physician Decision|13|||
161004192|NCT00433199|581401186|FG000|Double-Blind Period|Adverse Event|0|||
161004193|NCT00433199|581401187|FG001|Double-Blind Period|Adverse Event|25|||
161004194|NCT00433199|581401186|FG000|Double-Blind Period|Lack of Efficacy|0|||
161004195|NCT00433199|581401187|FG001|Double-Blind Period|Lack of Efficacy|2|||
161004196|NCT00433199|581401186|FG000|Double-Blind Period|Lost to Follow-up|2|||
161004197|NCT00433199|581401187|FG001|Double-Blind Period|Lost to Follow-up|5|||
161004198|NCT00433199|581401186|FG000|Double-Blind Period|Withdrawal by Subject|8|||
161004199|NCT00433199|581401187|FG001|Double-Blind Period|Withdrawal by Subject|19|||
161004200|NCT00433199|581401186|FG000|Double-Blind Period|Protocol Violation|1|||
161004201|NCT00433199|581401187|FG001|Double-Blind Period|Protocol Violation|10|||
161004202|NCT00433199|581401186|FG000|Double-Blind Period|Administrative|1|||
161004203|NCT00433199|581401187|FG001|Double-Blind Period|Administrative|5|||
161004204|NCT00433199|581401186|FG000|Open-Label Period|Adverse Event|0|||
161004205|NCT00433199|581401187|FG001|Open-Label Period|Adverse Event|19|||
161004206|NCT00433199|581401186|FG000|Open-Label Period|Lack of Efficacy|0|||
161004207|NCT00433199|581401187|FG001|Open-Label Period|Lack of Efficacy|2|||
161004208|NCT00433199|581401186|FG000|Open-Label Period|Lost to Follow-up|0|||
161004209|NCT00433199|581401187|FG001|Open-Label Period|Lost to Follow-up|3|||
161004210|NCT00433199|581401186|FG000|Open-Label Period|Withdrawal by Subject|0|||
161004211|NCT00433199|581401187|FG001|Open-Label Period|Withdrawal by Subject|7|||
161004212|NCT00433199|581401186|FG000|Open-Label Period|Protocol Violation|0|||
161004213|NCT00433199|581401187|FG001|Open-Label Period|Protocol Violation|2|||
161004214|NCT00433199|581401186|FG000|Open-Label Period|Administrative|0|||
161004215|NCT00433199|581401187|FG001|Open-Label Period|Administrative|1|||
161004216|NCT00357097|581401188|FG000|Overall Study|Did not meet inclusion criteria|5|||
161004217|NCT00357097|581401189|FG001|Overall Study|Did not meet inclusion criteria|3|||
161004218|NCT00357097|581401188|FG000|Overall Study|Adverse Event|34|||
161004219|NCT00357097|581401189|FG001|Overall Study|Adverse Event|6|||
161004220|NCT00357097|581401188|FG000|Overall Study|Withdrawal by Subject|8|||
161004221|NCT00357097|581401189|FG001|Overall Study|Withdrawal by Subject|7|||
161004222|NCT00357097|581401188|FG000|Overall Study|Non-compliance|1|||
161004223|NCT00357097|581401189|FG001|Overall Study|Non-compliance|2|||
161004224|NCT00357097|581401188|FG000|Overall Study|Lack of Efficacy|2|||
161004225|NCT00357097|581401189|FG001|Overall Study|Lack of Efficacy|8|||
161004226|NCT00357097|581401188|FG000|Overall Study|Met Exclusion Criteria|3|||
161004227|NCT00357097|581401189|FG001|Overall Study|Met Exclusion Criteria|1|||
161004228|NCT00357097|581401188|FG000|Overall Study|Other|1|||
160585180|NCT02052778|579861895|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585181|NCT02052778|579861896|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585182|NCT02052778|579861897|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585183|NCT02052778|579861898|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
160585184|NCT02052778|579861876|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585185|NCT02052778|579861877|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585186|NCT02052778|579861878|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585187|NCT02052778|579861879|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585188|NCT02052778|579861880|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161004229|NCT00357097|581401189|FG001|Overall Study|Other|1|||
161004230|NCT00357097|581401188|FG000|Overall Study|Increase of RLS Symptoms|0|||
161004231|NCT00357097|581401189|FG001|Overall Study|Increase of RLS Symptoms|1|||
161004232|NCT00658996|581401190|FG000|First Intervention|Positive slit lamp finding|1|||
161004233|NCT00658996|581401191|FG001|First Intervention|Positive slit lamp finding|0|||
161004234|NCT00658996|581401190|FG000|First Intervention|Lack of lenses|0|||
161004235|NCT00658996|581401191|FG001|First Intervention|Lack of lenses|1|||
161004236|NCT00658996|581401190|FG000|Crossover Period|Physician Decision|1|||
161004237|NCT00658996|581401191|FG001|Crossover Period|Physician Decision|0|||
161004238|NCT00658996|581401190|FG000|Crossover Period|Ineligible|1|||
161004239|NCT00658996|581401191|FG001|Crossover Period|Ineligible|1|||
161004240|NCT00658996|581401190|FG000|Second Intervention|Developed a stye on upper lid|1|||
161004241|NCT00658996|581401191|FG001|Second Intervention|Developed a stye on upper lid|0|||
161004242|NCT00658996|581401190|FG000|Second Intervention|Positive slit lamp finding|0|||
161004243|NCT00658996|581401191|FG001|Second Intervention|Positive slit lamp finding|1|||
161004244|NCT02994654|581401194|FG000|Overall Study|Lost to Follow-up|1|||
161004245|NCT03603717|581401201|FG000|Overall Study|Lost to Follow-up|20|||
161004246|NCT03603717|581401202|FG001|Overall Study|Lost to Follow-up|20|||
161004247|NCT03603717|581401201|FG000|Overall Study|Withdrawal by Subject|16|||
161004248|NCT03603717|581401202|FG001|Overall Study|Withdrawal by Subject|10|||
161004249|NCT00732381|581401205|FG000|Overall Study|Adverse Event|1|||
161004250|NCT00732381|581401206|FG001|Overall Study|Adverse Event|0|||
161004251|NCT00732381|581401205|FG000|Overall Study|Treatment Failure|1|||
161004252|NCT00732381|581401206|FG001|Overall Study|Treatment Failure|1|||
161004253|NCT00457691|581401207|FG000|Overall Study|Adverse Event|4|||
161004254|NCT00457691|581401208|FG001|Overall Study|Adverse Event|1|||
161004255|NCT00457691|581401207|FG000|Overall Study|Death|163|||
161004256|NCT00457691|581401208|FG001|Overall Study|Death|148|||
161004257|NCT00457691|581401207|FG000|Overall Study|Protocol Violation|1|||
161004258|NCT00457691|581401208|FG001|Overall Study|Protocol Violation|3|||
161004259|NCT00457691|581401207|FG000|Overall Study|Lost to Follow-up|23|||
161004260|NCT00457691|581401208|FG001|Overall Study|Lost to Follow-up|14|||
161004261|NCT00457691|581401207|FG000|Overall Study|Study terminated by Sponsor|1|||
161004262|NCT00457691|581401208|FG001|Overall Study|Study terminated by Sponsor|1|||
161004263|NCT00457691|581401207|FG000|Overall Study|Subject refused (reason other than AE)|14|||
161004264|NCT00457691|581401208|FG001|Overall Study|Subject refused (reason other than AE)|19|||
161004265|NCT00457691|581401207|FG000|Overall Study|Disease progression, study terminated|180|||
161004266|NCT00457691|581401208|FG001|Overall Study|Disease progression, study terminated|196|||
161004267|NCT01460446|581402742|FG000|Overall Study|Non-compliance|2|||
161004268|NCT01460446|581402743|FG001|Overall Study|Non-compliance|9|||
161004269|NCT01460446|581402742|FG000|Overall Study|Consent Withdrawn|0|||
161004270|NCT01460446|581402743|FG001|Overall Study|Consent Withdrawn|4|||
161004271|NCT01460446|581402742|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
161004272|NCT01460446|581402743|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
161004273|NCT01460446|581402742|FG000|Overall Study|Surgery/Illness|1|||
161004274|NCT01460446|581402743|FG001|Overall Study|Surgery/Illness|1|||
161004275|NCT01460446|581402742|FG000|Overall Study|Pregnancy|1|||
161004276|NCT01460446|581402743|FG001|Overall Study|Pregnancy|0|||
161004277|NCT01460446|581402742|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
161004278|NCT01460446|581402743|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
161004279|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
161004280|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
161004281|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
161004282|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
161004283|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
161004284|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
161004285|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
161004286|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
161004287|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
161004288|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
161004289|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
161004290|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
161004291|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
160585189|NCT02052778|579861881|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161004292|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
161004293|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
161004294|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
161004295|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
161004296|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
161004297|NCT00516321|581402744|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
161004298|NCT00516321|581402745|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
161004299|NCT00516321|581402746|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
161004300|NCT00516321|581402744|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
161004301|NCT00516321|581402745|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
161004302|NCT00516321|581402746|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
161004303|NCT00516321|581402744|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
161004304|NCT00516321|581402745|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
161004305|NCT00516321|581402746|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
161004306|NCT00516321|581402744|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
161004307|NCT00516321|581402745|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
161004308|NCT00516321|581402746|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
161004309|NCT00516321|581402744|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
161004310|NCT00516321|581402745|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
161004311|NCT00516321|581402746|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
161004312|NCT00414544|581402747|FG000|Overall Study|Lost to Follow-up|14|||
161004313|NCT01318382|581402749|FG000|Overall Study|Physician Decision|2|||
161004314|NCT01318382|581402749|FG000|Overall Study|Device Malfunction|10|||
161004315|NCT01318382|581402749|FG000|Overall Study|Protocol Violation|1|||
161004316|NCT01599104|581402752|FG000|Overall Study|Withdrawal by Subject|1|||
160585190|NCT02052778|579861882|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585191|NCT02052778|579861883|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585192|NCT02052778|579861884|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161004317|NCT01599104|581402753|FG001|Overall Study|Withdrawal by Subject|1|||
161004318|NCT01599104|581402754|FG002|Overall Study|Withdrawal by Subject|2|||
161004319|NCT01599104|581402752|FG000|Overall Study|Technical Problems|1|||
161004320|NCT01599104|581402753|FG001|Overall Study|Technical Problems|0|||
161004321|NCT01599104|581402754|FG002|Overall Study|Technical Problems|0|||
161004322|NCT01599104|581402752|FG000|Overall Study|Physician Decision|3|||
161004323|NCT01599104|581402753|FG001|Overall Study|Physician Decision|2|||
161004324|NCT01599104|581402754|FG002|Overall Study|Physician Decision|2|||
161004325|NCT01599104|581402752|FG000|Overall Study|Non-compliance with study treatment|0|||
161004326|NCT01599104|581402753|FG001|Overall Study|Non-compliance with study treatment|1|||
161004327|NCT01599104|581402754|FG002|Overall Study|Non-compliance with study treatment|0|||
161004328|NCT01599104|581402752|FG000|Overall Study|Lack of Efficacy|4|||
161004329|NCT01599104|581402753|FG001|Overall Study|Lack of Efficacy|4|||
161004330|NCT01599104|581402754|FG002|Overall Study|Lack of Efficacy|10|||
161004331|NCT01599104|581402752|FG000|Overall Study|Adverse Event|7|||
161004332|NCT01599104|581402753|FG001|Overall Study|Adverse Event|6|||
161004333|NCT01599104|581402754|FG002|Overall Study|Adverse Event|12|||
161004334|NCT00714714|581402757|FG000|Overall Study|Adverse Event|1|||
161004335|NCT02271854|581402760|FG000|Overall Study|Withdrawal by Subject|2|||
161004336|NCT02271854|581402760|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
161004337|NCT02271854|581402760|FG000|Overall Study|Lost to Follow-up|1|||
161004338|NCT01308567|581402761|FG000|Overall Study|Lost to Follow-up|2|||
161004339|NCT01308567|581402762|FG001|Overall Study|Lost to Follow-up|4|||
161004340|NCT01308567|581402763|FG002|Overall Study|Lost to Follow-up|4|||
161004341|NCT01582100|581402764|FG000|Overall Study|Adverse Event|1|||
161004342|NCT01582100|581402764|FG000|Overall Study|Withdrawal by Subject|1|||
161004343|NCT04425863|581402765|FG000|Overall Study|Death|0|||
161004344|NCT04425863|581402766|FG001|Overall Study|Death|0|||
161004345|NCT04425863|581402767|FG002|Overall Study|Death|1|||
161004346|NCT02242487|581402768|FG000|Overall Study|Adverse Event|13|||
161004347|NCT02242487|581402769|FG001|Overall Study|Adverse Event|15|||
160585193|NCT02052778|579861885|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161004348|NCT02242487|581402768|FG000|Overall Study|Lack of Efficacy|4|||
161004349|NCT02242487|581402769|FG001|Overall Study|Lack of Efficacy|6|||
161004350|NCT02242487|581402768|FG000|Overall Study|Protocol Violation|2|||
160585194|NCT02052778|579861886|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585195|NCT02052778|579861887|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585196|NCT02052778|579861888|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585197|NCT02052778|579861889|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161004351|NCT02242487|581402769|FG001|Overall Study|Protocol Violation|0|||
161004352|NCT02242487|581402768|FG000|Overall Study|Lost to Follow-up|2|||
161004353|NCT02242487|581402769|FG001|Overall Study|Lost to Follow-up|1|||
161004354|NCT02242487|581402768|FG000|Overall Study|Other - Miscellaneous|4|||
161004355|NCT02242487|581402769|FG001|Overall Study|Other - Miscellaneous|6|||
161004356|NCT02242487|581402768|FG000|Overall Study|Withdrawal by Subject|37|||
161004357|NCT02242487|581402769|FG001|Overall Study|Withdrawal by Subject|19|||
161004358|NCT02564744|581402771|FG000|Overall Study|Investigator decision|0|||
161004359|NCT02564744|581402772|FG001|Overall Study|Investigator decision|0|||
161004360|NCT02564744|581402773|FG002|Overall Study|Investigator decision|0|||
161004361|NCT02564744|581402774|FG003|Overall Study|Investigator decision|0|||
161004362|NCT02564744|581402775|FG004|Overall Study|Investigator decision|1|||
161004363|NCT02564744|581402771|FG000|Overall Study|Death|10|||
161004364|NCT02564744|581402772|FG001|Overall Study|Death|5|||
161004365|NCT02564744|581402773|FG002|Overall Study|Death|4|||
161004366|NCT02564744|581402774|FG003|Overall Study|Death|16|||
161004367|NCT02564744|581402775|FG004|Overall Study|Death|16|||
161004368|NCT02564744|581402771|FG000|Overall Study|End of study Page Missing|0|||
161004369|NCT02564744|581402772|FG001|Overall Study|End of study Page Missing|0|||
161004370|NCT02564744|581402773|FG002|Overall Study|End of study Page Missing|3|||
161004371|NCT02564744|581402774|FG003|Overall Study|End of study Page Missing|3|||
161004372|NCT02564744|581402775|FG004|Overall Study|End of study Page Missing|0|||
161004373|NCT02564744|581402771|FG000|Overall Study|Subject Withdrew Consent|1|||
161004374|NCT02564744|581402772|FG001|Overall Study|Subject Withdrew Consent|1|||
161004375|NCT02564744|581402773|FG002|Overall Study|Subject Withdrew Consent|1|||
161004376|NCT02564744|581402774|FG003|Overall Study|Subject Withdrew Consent|0|||
161004377|NCT02564744|581402775|FG004|Overall Study|Subject Withdrew Consent|2|||
161004378|NCT02564744|581402771|FG000|Overall Study|Lost to Follow-up|0|||
161004379|NCT02564744|581402772|FG001|Overall Study|Lost to Follow-up|1|||
161004380|NCT02564744|581402773|FG002|Overall Study|Lost to Follow-up|0|||
161004381|NCT02564744|581402774|FG003|Overall Study|Lost to Follow-up|0|||
161004382|NCT02564744|581402775|FG004|Overall Study|Lost to Follow-up|1|||
161004383|NCT02564744|581402771|FG000|Overall Study|Reason not specified|1|||
161004384|NCT02564744|581402772|FG001|Overall Study|Reason not specified|0|||
161004385|NCT02564744|581402773|FG002|Overall Study|Reason not specified|0|||
161004386|NCT02564744|581402774|FG003|Overall Study|Reason not specified|0|||
161004387|NCT02564744|581402775|FG004|Overall Study|Reason not specified|0|||
161004388|NCT02918279|581402786|FG000|Overall Study|Lost to Follow-up|3|||
161004389|NCT02918279|581402787|FG001|Overall Study|Lost to Follow-up|6|||
161004390|NCT02918279|581402786|FG000|Overall Study|Withdrawal by Subject|5|||
161004391|NCT02918279|581402787|FG001|Overall Study|Withdrawal by Subject|15|||
161004392|NCT02918279|581402786|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161004393|NCT02918279|581402787|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161004394|NCT02918279|581402786|FG000|Overall Study|Other|3|||
161004395|NCT02918279|581402787|FG001|Overall Study|Other|1|||
161004396|NCT01140048|581402788|FG000|Overall Study|Physician Decision|1|||
161004397|NCT01140048|581402788|FG000|Overall Study|Withdrawal by Subject|13|||
160585198|NCT02052778|579861890|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585199|NCT02052778|579861891|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585200|NCT02052778|579861892|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585201|NCT02052778|579861893|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585202|NCT02052778|579861894|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585203|NCT02052778|579861895|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585204|NCT02052778|579861896|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160585205|NCT02052778|579861897|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
160657008|NCT05097989|580124496|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
161004398|NCT01140048|581402788|FG000|Overall Study|Lost to Follow-up|31|||
161004399|NCT02888080|581402789|FG000|Overall Study|Subject / Guardian decision|1|||
161004400|NCT02888080|581402790|FG001|Overall Study|Subject / Guardian decision|3|||
161004401|NCT02888080|581402789|FG000|Overall Study|New Therapy for study indication|1|||
161004402|NCT02888080|581402790|FG001|Overall Study|New Therapy for study indication|0|||
161004403|NCT02888080|581402789|FG000|Overall Study|Lack of Efficacy|0|||
161004404|NCT02888080|581402790|FG001|Overall Study|Lack of Efficacy|1|||
160657009|NCT05097989|580124497|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
161004405|NCT02888080|581402789|FG000|Overall Study|Adverse Event|0|||
161004406|NCT02888080|581402790|FG001|Overall Study|Adverse Event|1|||
161004407|NCT01641198|581402791|FG000|After 12 Months of Function|Lost to Follow-up|3|||
161004408|NCT01641198|581402792|FG001|After 12 Months of Function|Lost to Follow-up|2|||
161004409|NCT01641198|581402793|FG002|After 12 Months of Function|Lost to Follow-up|2|||
161004410|NCT01641198|581402791|FG000|After 12 Months of Function|Protocol Violation|1|||
161004411|NCT01641198|581402792|FG001|After 12 Months of Function|Protocol Violation|0|||
161004412|NCT01641198|581402793|FG002|After 12 Months of Function|Protocol Violation|0|||
161004413|NCT01641198|581402791|FG000|After 12 Months of Function|Adverse Event|0|||
161004414|NCT01641198|581402792|FG001|After 12 Months of Function|Adverse Event|1|||
161004415|NCT01641198|581402793|FG002|After 12 Months of Function|Adverse Event|0|||
161004416|NCT01641198|581402791|FG000|After 24 Months of Function|Lost to Follow-up|4|||
161004417|NCT01641198|581402792|FG001|After 24 Months of Function|Lost to Follow-up|9|||
161004418|NCT01641198|581402793|FG002|After 24 Months of Function|Lost to Follow-up|6|||
161004419|NCT01641198|581402791|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
161004420|NCT01641198|581402792|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
161004421|NCT01641198|581402793|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
161004422|NCT01641198|581402791|FG000|At 15-20 Years of Function|Death|1|||
161004423|NCT01641198|581402792|FG001|At 15-20 Years of Function|Death|0|||
161004424|NCT01641198|581402793|FG002|At 15-20 Years of Function|Death|1|||
161004425|NCT01039688|581402794|FG000|Overall Study|Adverse Event|38|||
161004426|NCT01039688|581402795|FG001|Overall Study|Adverse Event|39|||
161004427|NCT01039688|581402796|FG002|Overall Study|Adverse Event|24|||
161004428|NCT01039688|581402794|FG000|Overall Study|Lack of Efficacy|20|||
161004429|NCT01039688|581402795|FG001|Overall Study|Lack of Efficacy|11|||
161004430|NCT01039688|581402796|FG002|Overall Study|Lack of Efficacy|26|||
161004431|NCT01039688|581402794|FG000|Overall Study|Lost to Follow-up|11|||
161004432|NCT01039688|581402795|FG001|Overall Study|Lost to Follow-up|9|||
161004433|NCT01039688|581402796|FG002|Overall Study|Lost to Follow-up|5|||
161004434|NCT01039688|581402794|FG000|Overall Study|Other|13|||
161004435|NCT01039688|581402795|FG001|Overall Study|Other|25|||
161004436|NCT01039688|581402796|FG002|Overall Study|Other|12|||
161004437|NCT01039688|581402794|FG000|Overall Study|Withdrawal by Subject|23|||
161004438|NCT01039688|581402795|FG001|Overall Study|Withdrawal by Subject|27|||
161004439|NCT01039688|581402796|FG002|Overall Study|Withdrawal by Subject|13|||
161004440|NCT01039688|581402794|FG000|Overall Study|Death|2|||
161004441|NCT01039688|581402795|FG001|Overall Study|Death|0|||
161004442|NCT01039688|581402796|FG002|Overall Study|Death|0|||
161004443|NCT00346151|581402800|FG000|Overall Study|Withdrawal by Subject|3|||
161004444|NCT01075217|581402801|FG000|Overall Study|Adverse Event|1|||
161004445|NCT01075217|581402802|FG001|Overall Study|Adverse Event|1|||
161004446|NCT01075217|581402801|FG000|Overall Study|Physician Decision|1|||
161004447|NCT01075217|581402802|FG001|Overall Study|Physician Decision|0|||
161004448|NCT03737240|581402805|FG000|Overall Study|Lost to Follow-up|16|||
161004449|NCT03737240|581402806|FG001|Overall Study|Lost to Follow-up|15|||
161004450|NCT00891930|581402807|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
161004451|NCT00891930|581402807|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
161004452|NCT00891930|581402807|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
161004453|NCT00891930|581402807|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
161004454|NCT00891930|581402807|FG000|Part 2 Panitumumab + AMG479|Death|30|||
161004455|NCT02512965|581402810|FG000|Overall Study|Withdrawal by Subject|0|||
161004456|NCT02512965|581402811|FG001|Overall Study|Withdrawal by Subject|4|||
161004457|NCT01444417|581402814|FG000|Overall Study|Ineligibility Determined|0|||
161004458|NCT01444417|581402815|FG001|Overall Study|Ineligibility Determined|1|||
161004459|NCT01444417|581402814|FG000|Overall Study|Withdrawal by Subject|2|||
161004460|NCT01444417|581402815|FG001|Overall Study|Withdrawal by Subject|0|||
161004461|NCT02755116|581402817|FG000|Overall Study|surgery converted to open, pt admitted|3|||
161004462|NCT02755116|581402818|FG001|Overall Study|surgery converted to open, pt admitted|1|||
161004463|NCT02200770|581402819|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
161004464|NCT02200770|581402820|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
161004465|NCT02200770|581402819|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
161004466|NCT02200770|581402820|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
161004467|NCT02200770|581402819|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
161004468|NCT02200770|581402820|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
161004469|NCT02200770|581402819|FG000|Randomized-controlled Period (RCP)|Other|1|||
161004470|NCT02200770|581402820|FG001|Randomized-controlled Period (RCP)|Other|2|||
161004471|NCT02200770|581402819|FG000|Open-label Period (OLP)|Adverse Event|1|||
161004472|NCT02200770|581402820|FG001|Open-label Period (OLP)|Adverse Event|2|||
161004473|NCT02200770|581402819|FG000|Open-label Period (OLP)|Death|1|||
161004474|NCT02200770|581402820|FG001|Open-label Period (OLP)|Death|2|||
161004475|NCT02200770|581402819|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
161004476|NCT02200770|581402820|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
161004477|NCT02200770|581402819|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
161004478|NCT02200770|581402820|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
161004479|NCT02200770|581402819|FG000|Open-label Period (OLP)|Other|6|||
161004480|NCT02200770|581402820|FG001|Open-label Period (OLP)|Other|15|||
161004481|NCT02214160|581402823|FG000|Overall Study|Withdrawal by Subject|1|||
161004482|NCT02214160|581402824|FG001|Overall Study|Withdrawal by Subject|0|||
161004483|NCT02214160|581402825|FG002|Overall Study|Withdrawal by Subject|6|||
161004484|NCT02214160|581402823|FG000|Overall Study|Death|2|||
161004485|NCT02214160|581402824|FG001|Overall Study|Death|2|||
161004486|NCT02214160|581402825|FG002|Overall Study|Death|1|||
161004487|NCT02214160|581402823|FG000|Overall Study|Subject Non-Compliance|0|||
160585206|NCT02052778|579861898|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
160585207|NCT02052778|579861876|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004488|NCT02214160|581402824|FG001|Overall Study|Subject Non-Compliance|3|||
160585208|NCT02052778|579861877|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004489|NCT02214160|581402825|FG002|Overall Study|Subject Non-Compliance|1|||
161004490|NCT02214160|581402823|FG000|Overall Study|Adverse Event|0|||
161004491|NCT02214160|581402824|FG001|Overall Study|Adverse Event|1|||
161004492|NCT02214160|581402825|FG002|Overall Study|Adverse Event|1|||
161004493|NCT02214160|581402823|FG000|Overall Study|Sponsor Decision|0|||
161004494|NCT02214160|581402824|FG001|Overall Study|Sponsor Decision|2|||
161004495|NCT02214160|581402825|FG002|Overall Study|Sponsor Decision|0|||
161004496|NCT02214160|581402823|FG000|Overall Study|Protocol Violation|1|||
161004497|NCT02214160|581402824|FG001|Overall Study|Protocol Violation|0|||
161004498|NCT02214160|581402825|FG002|Overall Study|Protocol Violation|0|||
161004499|NCT02214160|581402823|FG000|Overall Study|Physician Decision|0|||
161004500|NCT02214160|581402824|FG001|Overall Study|Physician Decision|0|||
161004501|NCT02214160|581402825|FG002|Overall Study|Physician Decision|1|||
161004502|NCT01063972|581402826|FG000|Overall Study|Death|12|||
161004503|NCT01063972|581402827|FG001|Overall Study|Death|11|||
161004504|NCT01063972|581402826|FG000|Overall Study|Incarcerated|2|||
161004505|NCT01063972|581402827|FG001|Overall Study|Incarcerated|1|||
161004506|NCT01510717|581402828|FG000|Overall Study|Adverse Event|1|||
161004507|NCT01510717|581402829|FG001|Overall Study|Adverse Event|2|||
161004508|NCT01510717|581402828|FG000|Overall Study|Death|1|||
161004509|NCT01510717|581402829|FG001|Overall Study|Death|0|||
161004510|NCT01510717|581402828|FG000|Overall Study|Lost to Follow-up|0|||
161004511|NCT01510717|581402829|FG001|Overall Study|Lost to Follow-up|1|||
161004512|NCT01510717|581402828|FG000|Overall Study|Withdrawal by Subject|0|||
161004513|NCT01510717|581402829|FG001|Overall Study|Withdrawal by Subject|2|||
161004514|NCT01430611|581402831|FG000|Overall Study|Adverse Event|0|||
161004515|NCT01430611|581402832|FG001|Overall Study|Adverse Event|1|||
161004516|NCT01430611|581402831|FG000|Overall Study|Protocol Violation|1|||
161004517|NCT01430611|581402832|FG001|Overall Study|Protocol Violation|0|||
161004518|NCT01430611|581402831|FG000|Overall Study|Lost to Follow-up|1|||
161004519|NCT01430611|581402832|FG001|Overall Study|Lost to Follow-up|0|||
161004520|NCT01430611|581402831|FG000|Overall Study|Withdrawal by Subject|15|||
161004521|NCT01430611|581402832|FG001|Overall Study|Withdrawal by Subject|14|||
161004522|NCT02204982|581402833|FG000|Overall Study|Patient ineligible-medical monitor|1|||
161004523|NCT02204982|581402834|FG001|Overall Study|Patient ineligible-medical monitor|0|||
161004524|NCT02204982|581402833|FG000|Overall Study|Withdrawal by Subject|1|||
161004525|NCT02204982|581402834|FG001|Overall Study|Withdrawal by Subject|0|||
161004526|NCT02204982|581402833|FG000|Overall Study|Adverse Event|1|||
161004527|NCT02204982|581402834|FG001|Overall Study|Adverse Event|0|||
161004528|NCT02204982|581402833|FG000|Overall Study|Adverse Event and Investigator decision|1|||
161004529|NCT02204982|581402834|FG001|Overall Study|Adverse Event and Investigator decision|0|||
161004530|NCT02204982|581402833|FG000|Overall Study|Physician Decision|0|||
161004531|NCT02204982|581402834|FG001|Overall Study|Physician Decision|2|||
161004532|NCT02204982|581402833|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
161004533|NCT02204982|581402834|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
161004534|NCT02204982|581402833|FG000|Overall Study|Termination of Study bySponsor|0|||
161004535|NCT02204982|581402834|FG001|Overall Study|Termination of Study bySponsor|1|||
161004536|NCT01968226|581402835|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
161004537|NCT00919763|581402836|FG000|Overall Study|Adverse Event|7|||
161004538|NCT00919763|581402837|FG001|Overall Study|Adverse Event|1|||
161004539|NCT00919763|581402836|FG000|Overall Study|Lost to Follow-up|1|||
161004540|NCT00919763|581402837|FG001|Overall Study|Lost to Follow-up|0|||
161004541|NCT00919763|581402836|FG000|Overall Study|Protocol Violation|1|||
161004542|NCT00919763|581402837|FG001|Overall Study|Protocol Violation|1|||
161004543|NCT00919763|581402836|FG000|Overall Study|Withdrawal by Subject|3|||
161004544|NCT00919763|581402837|FG001|Overall Study|Withdrawal by Subject|1|||
161004545|NCT00919763|581402836|FG000|Overall Study|Non-compliance|0|||
161004546|NCT00919763|581402837|FG001|Overall Study|Non-compliance|1|||
161004547|NCT04740164|581402838|FG000|Overall Study|Lack of Efficacy|4|||
161004548|NCT04740164|581402839|FG001|Overall Study|Lack of Efficacy|0|||
161004549|NCT04740164|581402838|FG000|Overall Study|Physician Decision|3|||
161004550|NCT04740164|581402839|FG001|Overall Study|Physician Decision|3|||
161004551|NCT00258895|581402845|FG000|Overall Study|Lost to Follow-up|3|||
161004552|NCT00258895|581402846|FG001|Overall Study|Lost to Follow-up|1|||
161004553|NCT00258895|581402845|FG000|Overall Study|Protocol Violation|6|||
161004554|NCT00258895|581402846|FG001|Overall Study|Protocol Violation|2|||
161004555|NCT00258895|581402845|FG000|Overall Study|Withdrawal by Subject|1|||
161004556|NCT00258895|581402846|FG001|Overall Study|Withdrawal by Subject|0|||
161004557|NCT00442117|581402847|FG000|Overall Study|Adverse Event|3|||
161004558|NCT00442117|581402848|FG001|Overall Study|Adverse Event|2|||
161004559|NCT00442117|581402847|FG000|Overall Study|Lack of Efficacy|2|||
161004560|NCT00442117|581402848|FG001|Overall Study|Lack of Efficacy|6|||
160585209|NCT02052778|579861878|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004561|NCT00442117|581402847|FG000|Overall Study|Lost to Follow-up|1|||
161004562|NCT00442117|581402848|FG001|Overall Study|Lost to Follow-up|2|||
161004563|NCT00442117|581402847|FG000|Overall Study|Withdrawal by Subject|2|||
161004564|NCT00442117|581402848|FG001|Overall Study|Withdrawal by Subject|2|||
160585210|NCT02052778|579861879|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160585211|NCT02052778|579861880|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004565|NCT00442117|581402847|FG000|Overall Study|Major Deviation|25|||
161004566|NCT00442117|581402848|FG001|Overall Study|Major Deviation|20|||
161004567|NCT00442117|581402847|FG000|Overall Study|Non compliance with protocol|3|||
161004568|NCT00442117|581402848|FG001|Overall Study|Non compliance with protocol|5|||
161004569|NCT00442117|581402847|FG000|Overall Study|Met Withdrawal Criteria|2|||
161004570|NCT00442117|581402848|FG001|Overall Study|Met Withdrawal Criteria|1|||
161004571|NCT01121549|581402854|FG000|Overall Study|Adverse Event|10|||
161004572|NCT01121549|581402854|FG000|Overall Study|Lack of Efficacy|11|||
161004573|NCT01121549|581402854|FG000|Overall Study|Lost to Follow-up|12|||
161004574|NCT01121549|581402854|FG000|Overall Study|Did not meet entrance criteria|9|||
161004575|NCT01121549|581402854|FG000|Overall Study|Study terminated by sponsor|197|||
161004576|NCT01121549|581402854|FG000|Overall Study|Pregnancy|1|||
161004577|NCT01121549|581402854|FG000|Overall Study|Protocol Violation|33|||
161004578|NCT01121549|581402854|FG000|Overall Study|Withdrawal by Subject|16|||
161004579|NCT01121549|581402854|FG000|Overall Study|Other|58|||
161004580|NCT03073941|581404619|FG000|Overall Study|Received non-study device intraoperatively|0|||
161004581|NCT03073941|581404620|FG001|Overall Study|Received non-study device intraoperatively|2|||
161004582|NCT03073941|581404619|FG000|Overall Study|Death|1|||
161004583|NCT03073941|581404620|FG001|Overall Study|Death|0|||
161004584|NCT03073941|581404619|FG000|Overall Study|Withdrawal by Subject|1|||
161004585|NCT03073941|581404620|FG001|Overall Study|Withdrawal by Subject|3|||
161004586|NCT03073941|581404619|FG000|Overall Study|Lost to Follow-up|5|||
161004587|NCT03073941|581404620|FG001|Overall Study|Lost to Follow-up|4|||
161004588|NCT03073941|581404619|FG000|Overall Study|Adverse Event|4|||
161004589|NCT03073941|581404620|FG001|Overall Study|Adverse Event|2|||
161004590|NCT03073941|581404619|FG000|Overall Study|Met an exclusion criterion|0|||
161004591|NCT03073941|581404620|FG001|Overall Study|Met an exclusion criterion|1|||
161004592|NCT04250883|581404622|FG000|Overall Study|Lost to Follow-up|1|||
161004593|NCT04250883|581404623|FG001|Overall Study|Lost to Follow-up|0|||
161004594|NCT02763319|581404624|FG000|Overall Study|Adverse Event|12|||
161004595|NCT02763319|581404625|FG001|Overall Study|Adverse Event|3|||
161004596|NCT02763319|581404624|FG000|Overall Study|Death|123|||
161004597|NCT02763319|581404625|FG001|Overall Study|Death|123|||
161004598|NCT02763319|581404624|FG000|Overall Study|Lost to Follow-up|6|||
161004599|NCT02763319|581404625|FG001|Overall Study|Lost to Follow-up|7|||
161004600|NCT02763319|581404624|FG000|Overall Study|Noncompliance with Study Drug|2|||
161004601|NCT02763319|581404625|FG001|Overall Study|Noncompliance with Study Drug|0|||
161004602|NCT02763319|581404624|FG000|Overall Study|"Captured as Other in Database"|29|||
161004603|NCT02763319|581404625|FG001|Overall Study|"Captured as Other in Database"|34|||
161004604|NCT02763319|581404624|FG000|Overall Study|Physician Decision|1|||
161004605|NCT02763319|581404625|FG001|Overall Study|Physician Decision|7|||
161004606|NCT02763319|581404624|FG000|Overall Study|Progressive Disease|24|||
161004607|NCT02763319|581404625|FG001|Overall Study|Progressive Disease|27|||
161004608|NCT02763319|581404624|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
161004609|NCT02763319|581404625|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
161004610|NCT02763319|581404624|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
161004611|NCT02763319|581404625|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
161004612|NCT02763319|581404624|FG000|Overall Study|Withdrawal by Subject|26|||
161004613|NCT02763319|581404625|FG001|Overall Study|Withdrawal by Subject|25|||
161004614|NCT03936660|581404627|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
161004615|NCT03936660|581404628|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
161004616|NCT00722046|581404629|FG000|Overall Study|Adverse Event|0|||
161004617|NCT00722046|581404630|FG001|Overall Study|Adverse Event|1|||
161004618|NCT00722046|581404631|FG002|Overall Study|Adverse Event|2|||
161004619|NCT00722046|581404632|FG003|Overall Study|Adverse Event|1|||
161004620|NCT00722046|581404633|FG004|Overall Study|Adverse Event|2|||
161004621|NCT00722046|581404634|FG005|Overall Study|Adverse Event|1|||
161004622|NCT00722046|581404635|FG006|Overall Study|Adverse Event|0|||
161004623|NCT00722046|581404629|FG000|Overall Study|Death|0|||
161004624|NCT00722046|581404630|FG001|Overall Study|Death|1|||
161004625|NCT00722046|581404631|FG002|Overall Study|Death|0|||
161004626|NCT00722046|581404632|FG003|Overall Study|Death|0|||
161004627|NCT00722046|581404633|FG004|Overall Study|Death|0|||
161004628|NCT00722046|581404634|FG005|Overall Study|Death|0|||
161004629|NCT00722046|581404635|FG006|Overall Study|Death|2|||
161004630|NCT00722046|581404629|FG000|Overall Study|Protocol Violation|1|||
161004631|NCT00722046|581404630|FG001|Overall Study|Protocol Violation|0|||
161004632|NCT00722046|581404631|FG002|Overall Study|Protocol Violation|0|||
161004633|NCT00722046|581404632|FG003|Overall Study|Protocol Violation|0|||
160585212|NCT02052778|579861881|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004634|NCT00722046|581404633|FG004|Overall Study|Protocol Violation|0|||
161004635|NCT00722046|581404634|FG005|Overall Study|Protocol Violation|1|||
161004636|NCT00722046|581404635|FG006|Overall Study|Protocol Violation|0|||
161004637|NCT00722046|581404629|FG000|Overall Study|Withdrawal by Subject|3|||
161004638|NCT00722046|581404630|FG001|Overall Study|Withdrawal by Subject|3|||
161004639|NCT00722046|581404631|FG002|Overall Study|Withdrawal by Subject|4|||
161004640|NCT00722046|581404632|FG003|Overall Study|Withdrawal by Subject|4|||
161004641|NCT00722046|581404633|FG004|Overall Study|Withdrawal by Subject|4|||
161004642|NCT00722046|581404634|FG005|Overall Study|Withdrawal by Subject|7|||
161004643|NCT00722046|581404635|FG006|Overall Study|Withdrawal by Subject|3|||
161004644|NCT00722046|581404629|FG000|Overall Study|Randomized, but not treated|1|||
160585213|NCT02052778|579861882|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004645|NCT00722046|581404630|FG001|Overall Study|Randomized, but not treated|1|||
161004646|NCT00722046|581404631|FG002|Overall Study|Randomized, but not treated|0|||
160585214|NCT02052778|579861883|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004647|NCT00722046|581404632|FG003|Overall Study|Randomized, but not treated|2|||
161004648|NCT00722046|581404633|FG004|Overall Study|Randomized, but not treated|0|||
161004649|NCT00722046|581404634|FG005|Overall Study|Randomized, but not treated|0|||
161004650|NCT00722046|581404635|FG006|Overall Study|Randomized, but not treated|0|||
161004651|NCT00722046|581404629|FG000|Overall Study|Other|0|||
161004652|NCT00722046|581404630|FG001|Overall Study|Other|0|||
161004653|NCT00722046|581404631|FG002|Overall Study|Other|1|||
161004654|NCT00722046|581404632|FG003|Overall Study|Other|1|||
161004655|NCT00722046|581404633|FG004|Overall Study|Other|3|||
161004656|NCT00722046|581404634|FG005|Overall Study|Other|2|||
161004657|NCT00722046|581404635|FG006|Overall Study|Other|1|||
161004658|NCT00925587|581404636|FG000|Overall Study|Protocol Specified Criteria|6|||
161004659|NCT00925587|581404637|FG001|Overall Study|Protocol Specified Criteria|6|||
161004660|NCT00925587|581404636|FG000|Overall Study|Physician Decision|4|||
161004661|NCT00925587|581404637|FG001|Overall Study|Physician Decision|1|||
161004662|NCT00925587|581404636|FG000|Overall Study|Protocol Violation|6|||
161004663|NCT00925587|581404637|FG001|Overall Study|Protocol Violation|4|||
161004664|NCT00925587|581404636|FG000|Overall Study|Withdrawal by Subject|9|||
161004665|NCT00925587|581404637|FG001|Overall Study|Withdrawal by Subject|6|||
161004666|NCT00925587|581404636|FG000|Overall Study|Death|5|||
161004667|NCT00925587|581404637|FG001|Overall Study|Death|5|||
161004668|NCT00925587|581404636|FG000|Overall Study|Adverse Event|6|||
161004669|NCT00925587|581404637|FG001|Overall Study|Adverse Event|2|||
161004670|NCT00925587|581404636|FG000|Overall Study|Lost to Follow-up|0|||
161004671|NCT00925587|581404637|FG001|Overall Study|Lost to Follow-up|1|||
161004672|NCT01571596|581404647|FG000|Overall Study|Adverse Event|2|||
161004673|NCT01571596|581404648|FG001|Overall Study|Adverse Event|0|||
161004674|NCT01571596|581404649|FG002|Overall Study|Adverse Event|0|||
161004675|NCT01571596|581404647|FG000|Overall Study|Study Terminated by the Sponsor|0|||
161004676|NCT01571596|581404648|FG001|Overall Study|Study Terminated by the Sponsor|1|||
161004677|NCT01571596|581404649|FG002|Overall Study|Study Terminated by the Sponsor|1|||
161004678|NCT00774397|581404654|FG000|Overall Study|Adverse Event|1|||
161004679|NCT00774397|581404655|FG001|Overall Study|Adverse Event|3|||
161004680|NCT00774397|581404656|FG002|Overall Study|Adverse Event|16|||
161004681|NCT00774397|581404657|FG003|Overall Study|Adverse Event|8|||
161004682|NCT00774397|581404658|FG004|Overall Study|Adverse Event|8|||
161004683|NCT00774397|581404659|FG005|Overall Study|Adverse Event|3|||
161004684|NCT00774397|581404660|FG006|Overall Study|Adverse Event|16|||
161004685|NCT00774397|581404654|FG000|Overall Study|Lack of Efficacy|11|||
161004686|NCT00774397|581404655|FG001|Overall Study|Lack of Efficacy|4|||
161004687|NCT00774397|581404656|FG002|Overall Study|Lack of Efficacy|5|||
161004688|NCT00774397|581404657|FG003|Overall Study|Lack of Efficacy|3|||
161004689|NCT00774397|581404658|FG004|Overall Study|Lack of Efficacy|27|||
161004690|NCT00774397|581404659|FG005|Overall Study|Lack of Efficacy|15|||
161004691|NCT00774397|581404660|FG006|Overall Study|Lack of Efficacy|9|||
161004692|NCT00774397|581404654|FG000|Overall Study|Protocol Violation|0|||
161004693|NCT00774397|581404655|FG001|Overall Study|Protocol Violation|1|||
161004694|NCT00774397|581404656|FG002|Overall Study|Protocol Violation|3|||
161004695|NCT00774397|581404657|FG003|Overall Study|Protocol Violation|1|||
161004696|NCT00774397|581404658|FG004|Overall Study|Protocol Violation|2|||
161004697|NCT00774397|581404659|FG005|Overall Study|Protocol Violation|1|||
161004698|NCT00774397|581404660|FG006|Overall Study|Protocol Violation|0|||
161004699|NCT00774397|581404654|FG000|Overall Study|Lost to Follow-up|0|||
161004700|NCT00774397|581404655|FG001|Overall Study|Lost to Follow-up|1|||
161004701|NCT00774397|581404656|FG002|Overall Study|Lost to Follow-up|1|||
161004702|NCT00774397|581404657|FG003|Overall Study|Lost to Follow-up|1|||
161004703|NCT00774397|581404658|FG004|Overall Study|Lost to Follow-up|0|||
161004704|NCT00774397|581404659|FG005|Overall Study|Lost to Follow-up|1|||
161004705|NCT00774397|581404660|FG006|Overall Study|Lost to Follow-up|0|||
161004706|NCT00774397|581404654|FG000|Overall Study|Refused to continue trial medication|1|||
160585215|NCT02052778|579861884|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160585216|NCT02052778|579861885|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004707|NCT00774397|581404655|FG001|Overall Study|Refused to continue trial medication|3|||
161004708|NCT00774397|581404656|FG002|Overall Study|Refused to continue trial medication|2|||
161004709|NCT00774397|581404657|FG003|Overall Study|Refused to continue trial medication|2|||
161004710|NCT00774397|581404658|FG004|Overall Study|Refused to continue trial medication|6|||
161004711|NCT00774397|581404659|FG005|Overall Study|Refused to continue trial medication|2|||
161004712|NCT00774397|581404660|FG006|Overall Study|Refused to continue trial medication|3|||
161004713|NCT00774397|581404654|FG000|Overall Study|Not treated|0|||
161004714|NCT00774397|581404655|FG001|Overall Study|Not treated|0|||
161004715|NCT00774397|581404656|FG002|Overall Study|Not treated|0|||
160585217|NCT02052778|579861886|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004716|NCT00774397|581404657|FG003|Overall Study|Not treated|0|||
161004717|NCT00774397|581404658|FG004|Overall Study|Not treated|1|||
161004718|NCT00774397|581404659|FG005|Overall Study|Not treated|0|||
161004719|NCT00774397|581404660|FG006|Overall Study|Not treated|1|||
161004720|NCT00774397|581404654|FG000|Overall Study|Other than those stated above|1|||
161004721|NCT00774397|581404655|FG001|Overall Study|Other than those stated above|1|||
161004722|NCT00774397|581404656|FG002|Overall Study|Other than those stated above|3|||
161004723|NCT00774397|581404657|FG003|Overall Study|Other than those stated above|2|||
161004724|NCT00774397|581404658|FG004|Overall Study|Other than those stated above|2|||
161004725|NCT00774397|581404659|FG005|Overall Study|Other than those stated above|0|||
161004726|NCT00774397|581404660|FG006|Overall Study|Other than those stated above|1|||
161004727|NCT02499159|581404661|FG000|Randomization|Protocol Violation|1|||
161004728|NCT02499159|581404662|FG001|Randomization|Protocol Violation|1|||
161004729|NCT02499159|581404661|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
161004730|NCT02499159|581404662|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
161004731|NCT02499159|581404661|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
161004732|NCT02499159|581404662|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
161004733|NCT02499159|581404661|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
161004734|NCT02499159|581404662|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
161004735|NCT02499159|581404661|FG000|30-Day Follow-Up Phone Call|Other|1|||
161004736|NCT02499159|581404662|FG001|30-Day Follow-Up Phone Call|Other|0|||
161004737|NCT03644849|581404663|FG000|Overall Study|Lost to Follow-up|1|||
161004738|NCT03644849|581404664|FG001|Overall Study|Lost to Follow-up|3|||
161004739|NCT00979992|581404665|FG000|Overall Study|Ineligible - inadequate pathology|1|||
161004740|NCT00979992|581404665|FG000|Overall Study|Ineligible - wrong cell type|2|||
161004741|NCT00979992|581404665|FG000|Overall Study|Refused - Never Treated|2|||
161004742|NCT00869258|581404666|FG000|Overall Study|Physician Decision|1|||
161004743|NCT00980330|581404668|FG000|Overall Study|Adverse Event|0|||
161004744|NCT00980330|581404669|FG001|Overall Study|Adverse Event|0|||
161004745|NCT00980330|581404670|FG002|Overall Study|Adverse Event|0|||
161004746|NCT00980330|581404671|FG003|Overall Study|Adverse Event|1|||
161004747|NCT00980330|581404672|FG004|Overall Study|Adverse Event|0|||
161004748|NCT00980330|581404673|FG005|Overall Study|Adverse Event|0|||
161004749|NCT00980330|581404674|FG006|Overall Study|Adverse Event|0|||
161004750|NCT00980330|581404668|FG000|Overall Study|Lost to Follow-up|1|||
161004751|NCT00980330|581404669|FG001|Overall Study|Lost to Follow-up|1|||
161004752|NCT00980330|581404670|FG002|Overall Study|Lost to Follow-up|4|||
161004753|NCT00980330|581404671|FG003|Overall Study|Lost to Follow-up|2|||
161004754|NCT00980330|581404672|FG004|Overall Study|Lost to Follow-up|1|||
161004755|NCT00980330|581404673|FG005|Overall Study|Lost to Follow-up|1|||
161004756|NCT00980330|581404674|FG006|Overall Study|Lost to Follow-up|2|||
161004757|NCT00980330|581404668|FG000|Overall Study|Withdrawal by Subject|2|||
161004758|NCT00980330|581404669|FG001|Overall Study|Withdrawal by Subject|4|||
161004759|NCT00980330|581404670|FG002|Overall Study|Withdrawal by Subject|4|||
161004760|NCT00980330|581404671|FG003|Overall Study|Withdrawal by Subject|1|||
161004761|NCT00980330|581404672|FG004|Overall Study|Withdrawal by Subject|3|||
161004762|NCT00980330|581404673|FG005|Overall Study|Withdrawal by Subject|2|||
161004763|NCT00980330|581404674|FG006|Overall Study|Withdrawal by Subject|5|||
161004764|NCT00980330|581404668|FG000|Overall Study|(not specified)|2|||
161004765|NCT00980330|581404669|FG001|Overall Study|(not specified)|0|||
161004766|NCT00980330|581404670|FG002|Overall Study|(not specified)|0|||
161004767|NCT00980330|581404671|FG003|Overall Study|(not specified)|1|||
161004768|NCT00980330|581404672|FG004|Overall Study|(not specified)|1|||
161004769|NCT00980330|581404673|FG005|Overall Study|(not specified)|1|||
161004770|NCT00980330|581404674|FG006|Overall Study|(not specified)|0|||
161004771|NCT03844269|581404679|FG000|Overall Study|Withdrawal pre-intervention|1|||
161004772|NCT03844269|581404679|FG000|Overall Study|Did not complete the intervention|2|||
161004773|NCT02570711|581404686|FG000|Overall Study|Death|1|||
161004774|NCT02570711|581404687|FG001|Overall Study|Death|0|||
161004775|NCT02570711|581404686|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
161004776|NCT02570711|581404687|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
161004777|NCT05001945|581404688|FG000|Overall Study|Adverse Event|0|||
161004778|NCT05001945|581404689|FG001|Overall Study|Adverse Event|0|||
161004779|NCT05001945|581404690|FG002|Overall Study|Adverse Event|0|||
161004780|NCT05001945|581404691|FG003|Overall Study|Adverse Event|1|||
161004781|NCT05001945|581404692|FG004|Overall Study|Adverse Event|0|||
161004782|NCT05001945|581404693|FG005|Overall Study|Adverse Event|0|||
161004783|NCT05001945|581404694|FG006|Overall Study|Adverse Event|0|||
161004784|NCT05001945|581404695|FG007|Overall Study|Adverse Event|0|||
161004785|NCT05001945|581404688|FG000|Overall Study|Lost to Follow-up|0|||
161004786|NCT05001945|581404689|FG001|Overall Study|Lost to Follow-up|1|||
161004787|NCT05001945|581404690|FG002|Overall Study|Lost to Follow-up|1|||
160458549|NCT03245840|579410869|FG000|Overall Study|Non-Compliance with Study Drug|2|||
160458550|NCT03245840|579410870|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161004788|NCT05001945|581404691|FG003|Overall Study|Lost to Follow-up|2|||
161004789|NCT05001945|581404692|FG004|Overall Study|Lost to Follow-up|0|||
161004790|NCT05001945|581404693|FG005|Overall Study|Lost to Follow-up|1|||
160458551|NCT03245840|579410869|FG000|Overall Study|Not treated|1|||
160585218|NCT02052778|579861887|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004791|NCT05001945|581404694|FG006|Overall Study|Lost to Follow-up|0|||
161004792|NCT05001945|581404695|FG007|Overall Study|Lost to Follow-up|0|||
160458552|NCT03245840|579410870|FG001|Overall Study|Not treated|1|||
160585219|NCT02052778|579861888|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160585220|NCT02052778|579861889|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160965883|NCT01024608|581263079|FG001|Overall Study|Never received study treatment|0|||
160965884|NCT04349280|581263080|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
160965885|NCT04349280|581263081|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
160965886|NCT04349280|581263080|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
160965887|NCT04349280|581263081|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
160965888|NCT04349280|581263080|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
160965889|NCT04349280|581263081|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
160965890|NCT00657618|581263084|FG000|Overall Study|Adverse Event|32|||
160965891|NCT00657618|581263084|FG000|Overall Study|Withdrawal by Subject|8|||
160965892|NCT00657618|581263084|FG000|Overall Study|negative for leishmaniasis|2|||
160965893|NCT00657618|581263084|FG000|Overall Study|didn't start due to schedule conflicts|1|||
160965894|NCT00045708|581264747|FG000|Phase 1|early progressive disease|0|||
160965895|NCT00045708|581264748|FG001|Phase 1|early progressive disease|1|||
160965896|NCT00045708|581264749|FG002|Phase 1|early progressive disease|0|||
160965897|NCT00685945|581264751|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
160965898|NCT00847405|581264753|FG000|First Intervention|Adverse Event|0|||
160965899|NCT00847405|581264754|FG001|First Intervention|Adverse Event|1|||
160965900|NCT00847405|581264753|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
160965901|NCT00847405|581264754|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
160965902|NCT01728792|581264755|FG000|Overall Study|Withdrawal of Consent|1|||
160965903|NCT01728792|581264756|FG001|Overall Study|Withdrawal of Consent|1|||
160965904|NCT01728792|581264757|FG002|Overall Study|Withdrawal of Consent|0|||
160965905|NCT01728792|581264758|FG003|Overall Study|Withdrawal of Consent|1|||
160965906|NCT01728792|581264759|FG004|Overall Study|Withdrawal of Consent|0|||
160965907|NCT01728792|581264755|FG000|Overall Study|Lost to Follow-up|2|||
160965908|NCT01728792|581264756|FG001|Overall Study|Lost to Follow-up|1|||
160965909|NCT01728792|581264757|FG002|Overall Study|Lost to Follow-up|4|||
160965910|NCT01728792|581264758|FG003|Overall Study|Lost to Follow-up|2|||
160965911|NCT01728792|581264759|FG004|Overall Study|Lost to Follow-up|0|||
160965912|NCT04277455|581264760|FG000|Overall Study|Lost to Follow-up|1|||
160965913|NCT04791761|581264762|FG000|Overall Study|Lost to Follow-up|8|||
160965914|NCT04791761|581264763|FG001|Overall Study|Lost to Follow-up|6|||
160965915|NCT04791761|581264764|FG002|Overall Study|Lost to Follow-up|10|||
160965916|NCT04791761|581264762|FG000|Overall Study|Withdrawal by Subject|0|||
160965917|NCT04791761|581264763|FG001|Overall Study|Withdrawal by Subject|1|||
160965918|NCT04791761|581264764|FG002|Overall Study|Withdrawal by Subject|1|||
160965919|NCT04791761|581264762|FG000|Overall Study|Protocol Violation|0|||
160965920|NCT04791761|581264763|FG001|Overall Study|Protocol Violation|1|||
160965921|NCT04791761|581264764|FG002|Overall Study|Protocol Violation|1|||
160965922|NCT00514683|581264765|FG000|Overall Study|Not treated|2|||
160965923|NCT00514683|581264766|FG001|Overall Study|Not treated|1|||
160965924|NCT00514683|581264767|FG002|Overall Study|Not treated|0|||
160965925|NCT00514683|581264768|FG003|Overall Study|Not treated|0|||
160965926|NCT00514683|581264769|FG004|Overall Study|Not treated|1|||
160965927|NCT00514683|581264765|FG000|Overall Study|Adverse Event|21|||
160965928|NCT00514683|581264766|FG001|Overall Study|Adverse Event|20|||
160965929|NCT00514683|581264767|FG002|Overall Study|Adverse Event|15|||
160965930|NCT00514683|581264768|FG003|Overall Study|Adverse Event|13|||
160965931|NCT00514683|581264769|FG004|Overall Study|Adverse Event|27|||
160965932|NCT00514683|581264765|FG000|Overall Study|Protocol Violation|1|||
160965933|NCT00514683|581264766|FG001|Overall Study|Protocol Violation|1|||
160965934|NCT00514683|581264767|FG002|Overall Study|Protocol Violation|0|||
160965935|NCT00514683|581264768|FG003|Overall Study|Protocol Violation|1|||
160965936|NCT00514683|581264769|FG004|Overall Study|Protocol Violation|0|||
160965937|NCT00514683|581264765|FG000|Overall Study|Withdrawal by Subject|2|||
160965938|NCT00514683|581264766|FG001|Overall Study|Withdrawal by Subject|2|||
160965939|NCT00514683|581264767|FG002|Overall Study|Withdrawal by Subject|1|||
160965940|NCT00514683|581264768|FG003|Overall Study|Withdrawal by Subject|0|||
160965941|NCT00514683|581264769|FG004|Overall Study|Withdrawal by Subject|4|||
160585221|NCT02052778|579861890|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160585222|NCT02052778|579861891|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160585223|NCT02052778|579861892|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160585224|NCT02052778|579861893|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160965942|NCT00514683|581264765|FG000|Overall Study|Reason other than listed above|0|||
160965943|NCT00514683|581264766|FG001|Overall Study|Reason other than listed above|1|||
160965944|NCT00514683|581264767|FG002|Overall Study|Reason other than listed above|2|||
161004793|NCT05001945|581404688|FG000|Overall Study|Protocol Violation|1|||
160585225|NCT02052778|579861894|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160965945|NCT00514683|581264768|FG003|Overall Study|Reason other than listed above|0|||
160965946|NCT00514683|581264769|FG004|Overall Study|Reason other than listed above|1|||
160965947|NCT02487498|581264770|FG000|Period: Period 1|Adverse Event|2|||
160965948|NCT02487498|581264771|FG001|Period: Period 1|Adverse Event|4|||
160965949|NCT02487498|581264770|FG000|Period: Period 1|Subject/guardian decision|2|||
160965950|NCT02487498|581264771|FG001|Period: Period 1|Subject/guardian decision|4|||
161004794|NCT05001945|581404689|FG001|Overall Study|Protocol Violation|0|||
161004795|NCT05001945|581404690|FG002|Overall Study|Protocol Violation|1|||
161004796|NCT05001945|581404691|FG003|Overall Study|Protocol Violation|1|||
161004797|NCT05001945|581404692|FG004|Overall Study|Protocol Violation|0|||
161004798|NCT05001945|581404693|FG005|Overall Study|Protocol Violation|1|||
161004799|NCT05001945|581404694|FG006|Overall Study|Protocol Violation|0|||
161004800|NCT05001945|581404695|FG007|Overall Study|Protocol Violation|0|||
161004801|NCT05001945|581404688|FG000|Overall Study|Withdrawal by Subject|0|||
161004802|NCT05001945|581404689|FG001|Overall Study|Withdrawal by Subject|0|||
161004803|NCT05001945|581404690|FG002|Overall Study|Withdrawal by Subject|0|||
161004804|NCT05001945|581404691|FG003|Overall Study|Withdrawal by Subject|1|||
161004805|NCT05001945|581404692|FG004|Overall Study|Withdrawal by Subject|1|||
161004806|NCT05001945|581404693|FG005|Overall Study|Withdrawal by Subject|1|||
161004807|NCT05001945|581404694|FG006|Overall Study|Withdrawal by Subject|0|||
161004808|NCT05001945|581404695|FG007|Overall Study|Withdrawal by Subject|1|||
161004809|NCT05001945|581404688|FG000|Overall Study|Not specified by Investigator|0|||
161004810|NCT05001945|581404689|FG001|Overall Study|Not specified by Investigator|3|||
161004811|NCT05001945|581404690|FG002|Overall Study|Not specified by Investigator|0|||
161004812|NCT05001945|581404691|FG003|Overall Study|Not specified by Investigator|0|||
161004813|NCT05001945|581404692|FG004|Overall Study|Not specified by Investigator|1|||
161004814|NCT05001945|581404693|FG005|Overall Study|Not specified by Investigator|0|||
161004815|NCT05001945|581404694|FG006|Overall Study|Not specified by Investigator|0|||
161004816|NCT05001945|581404695|FG007|Overall Study|Not specified by Investigator|0|||
161004817|NCT01369498|581404697|FG000|Overall Study|Lack of Efficacy|9|||
161004818|NCT01369498|581404698|FG001|Overall Study|Lack of Efficacy|9|||
161004819|NCT01369498|581404699|FG002|Overall Study|Lack of Efficacy|1|||
161004820|NCT01369498|581404700|FG003|Overall Study|Lack of Efficacy|3|||
161004821|NCT01369498|581404697|FG000|Overall Study|Adverse Event|1|||
161004822|NCT01369498|581404698|FG001|Overall Study|Adverse Event|2|||
161004823|NCT01369498|581404699|FG002|Overall Study|Adverse Event|0|||
161004824|NCT01369498|581404700|FG003|Overall Study|Adverse Event|1|||
161004825|NCT01369498|581404697|FG000|Overall Study|Withdrawal of Consent|0|||
161004826|NCT01369498|581404698|FG001|Overall Study|Withdrawal of Consent|1|||
161004827|NCT01369498|581404699|FG002|Overall Study|Withdrawal of Consent|1|||
161004828|NCT01369498|581404700|FG003|Overall Study|Withdrawal of Consent|1|||
161004829|NCT01369498|581404697|FG000|Overall Study|Death|0|||
161004830|NCT01369498|581404698|FG001|Overall Study|Death|0|||
161004831|NCT01369498|581404699|FG002|Overall Study|Death|1|||
161004832|NCT01369498|581404700|FG003|Overall Study|Death|0|||
161004833|NCT01369498|581404697|FG000|Overall Study|Investigator's Discretion|1|||
161004834|NCT01369498|581404698|FG001|Overall Study|Investigator's Discretion|0|||
161004835|NCT01369498|581404699|FG002|Overall Study|Investigator's Discretion|1|||
161004836|NCT01369498|581404700|FG003|Overall Study|Investigator's Discretion|3|||
161004837|NCT01369498|581404697|FG000|Overall Study|Unknown Reason|1|||
161004838|NCT01369498|581404698|FG001|Overall Study|Unknown Reason|0|||
161004839|NCT01369498|581404699|FG002|Overall Study|Unknown Reason|11|||
161004840|NCT01369498|581404700|FG003|Overall Study|Unknown Reason|6|||
161004841|NCT01369498|581404697|FG000|Overall Study|Disease Progression|0|||
161004842|NCT01369498|581404698|FG001|Overall Study|Disease Progression|0|||
161004843|NCT01369498|581404699|FG002|Overall Study|Disease Progression|0|||
161004844|NCT01369498|581404700|FG003|Overall Study|Disease Progression|1|||
161004845|NCT00545077|581404701|FG000|Overall Study|Treatment not received|5|||
161004846|NCT00545077|581404702|FG001|Overall Study|Treatment not received|1|||
161004847|NCT00545077|581404701|FG000|Overall Study|Disease Progression|131|||
161004848|NCT00545077|581404702|FG001|Overall Study|Disease Progression|98|||
161004849|NCT00545077|581404701|FG000|Overall Study|Withdrawal by Subject|3|||
161004850|NCT00545077|581404702|FG001|Overall Study|Withdrawal by Subject|14|||
161004851|NCT00545077|581404701|FG000|Overall Study|Physician Decision|6|||
161004852|NCT00545077|581404702|FG001|Overall Study|Physician Decision|3|||
161004853|NCT00545077|581404701|FG000|Overall Study|Lost to Follow-up|2|||
161004854|NCT00545077|581404702|FG001|Overall Study|Lost to Follow-up|0|||
161004855|NCT00545077|581404701|FG000|Overall Study|Protocol Violation|1|||
161004856|NCT00545077|581404702|FG001|Overall Study|Protocol Violation|0|||
161004857|NCT00545077|581404701|FG000|Overall Study|Adverse Event|0|||
161004858|NCT00545077|581404702|FG001|Overall Study|Adverse Event|31|||
161004859|NCT00545077|581404701|FG000|Overall Study|Death|0|||
161004860|NCT00545077|581404702|FG001|Overall Study|Death|8|||
161004861|NCT02202499|581404703|FG000|Overall Study|Cancer diagnosis|0|||
161004862|NCT02202499|581404704|FG001|Overall Study|Cancer diagnosis|0|||
161004863|NCT02202499|581404705|FG002|Overall Study|Cancer diagnosis|1|||
161004864|NCT02202499|581404703|FG000|Overall Study|Moved from area|0|||
161004865|NCT02202499|581404704|FG001|Overall Study|Moved from area|0|||
161004866|NCT02202499|581404705|FG002|Overall Study|Moved from area|1|||
161004867|NCT02202499|581404703|FG000|Overall Study|Declined before randomization|1|||
161004868|NCT02202499|581404704|FG001|Overall Study|Declined before randomization|0|||
161004869|NCT02202499|581404705|FG002|Overall Study|Declined before randomization|0|||
161004870|NCT02202499|581404703|FG000|Overall Study|Auto accident|1|||
161004871|NCT02202499|581404704|FG001|Overall Study|Auto accident|0|||
161004872|NCT02202499|581404705|FG002|Overall Study|Auto accident|0|||
161004873|NCT00535145|581404709|FG000|Phase I|Adverse Event|3|||
161004874|NCT00535145|581404709|FG000|Phase I|Lost to Follow-up|7|||
161004875|NCT00535145|581404709|FG000|Phase I|Withdrawal by Subject|6|||
161004876|NCT00535145|581404709|FG000|Phase I|(eligibility)|8|||
161004877|NCT00535145|581404709|FG000|Phase I|(protocol violation)|1|||
161004878|NCT00535145|581404709|FG000|Phase I|(PI decision)|1|||
161004879|NCT00535145|581404709|FG000|Phase I|(diagnosis)|3|||
161004880|NCT00535145|581404709|FG000|Phase II|Adverse Event|2|||
161004881|NCT00535145|581404709|FG000|Phase II|Lack of Efficacy|1|||
161004882|NCT00535145|581404709|FG000|Phase II|Lost to Follow-up|5|||
161004883|NCT00535145|581404709|FG000|Phase II|Withdrawal by Subject|5|||
161004884|NCT00535145|581404709|FG000|Phase II|Subject non-compliance|2|||
161004885|NCT05082935|581404716|FG000|Overall Study|Lost to Follow-up|549|||
161004886|NCT05082935|581404717|FG001|Overall Study|Lost to Follow-up|631|||
161004887|NCT05082935|581404716|FG000|Overall Study|Withdrawal by Subject|27|||
161004888|NCT05082935|581404717|FG001|Overall Study|Withdrawal by Subject|58|||
161004889|NCT02957136|581404718|FG000|Overall Study|Withdrawal by Subject|2|||
161004890|NCT02957136|581404719|FG001|Overall Study|Withdrawal by Subject|1|||
161004891|NCT00439569|581404720|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
161004892|NCT00439569|581404720|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
161004893|NCT00439569|581404720|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
161004894|NCT01124734|581404722|FG000|Overall Study|Disease progression|13|||
161004895|NCT01124734|581404722|FG000|Overall Study|Adverse Event|1|||
161004896|NCT01124734|581404722|FG000|Overall Study|Withdrawal by Subject|1|||
161004897|NCT01124734|581404722|FG000|Overall Study|Elected for alternative treatment|2|||
161004898|NCT02423798|581404723|FG000|Overall Study|Withdrawal by Subject|3|||
161004899|NCT02928224|581404727|FG000|Overall Study|Lost to Follow-up|1|||
161004900|NCT02928224|581404728|FG001|Overall Study|Lost to Follow-up|1|||
161004901|NCT02928224|581404729|FG002|Overall Study|Lost to Follow-up|3|||
161004902|NCT02928224|581404730|FG003|Overall Study|Lost to Follow-up|0|||
161004903|NCT02928224|581404727|FG000|Overall Study|Death|30|||
161004904|NCT02928224|581404728|FG001|Overall Study|Death|209|||
161004905|NCT02928224|581404729|FG002|Overall Study|Death|193|||
161004906|NCT02928224|581404730|FG003|Overall Study|Death|198|||
161004907|NCT02928224|581404727|FG000|Overall Study|Withdrawal by Subject|0|||
161004908|NCT02928224|581404728|FG001|Overall Study|Withdrawal by Subject|3|||
161004909|NCT02928224|581404729|FG002|Overall Study|Withdrawal by Subject|7|||
161004910|NCT02928224|581404730|FG003|Overall Study|Withdrawal by Subject|20|||
161004911|NCT02928224|581404727|FG000|Overall Study|Study participation terminated by sponsor|3|||
161004912|NCT02928224|581404728|FG001|Overall Study|Study participation terminated by sponsor|8|||
161004913|NCT02928224|581404729|FG002|Overall Study|Study participation terminated by sponsor|12|||
161004914|NCT02928224|581404730|FG003|Overall Study|Study participation terminated by sponsor|3|||
161004915|NCT02928224|581404727|FG000|Overall Study|Other|3|||
161004916|NCT02928224|581404728|FG001|Overall Study|Other|3|||
161004917|NCT02928224|581404729|FG002|Overall Study|Other|5|||
161004918|NCT02928224|581404730|FG003|Overall Study|Other|0|||
161004919|NCT02538107|581404731|FG000|Overall Study|Did not receive any Mircera dose|11|||
161004920|NCT02538107|581404731|FG000|Overall Study|Missing|5|||
161004921|NCT02538107|581404731|FG000|Overall Study|Necessity of dialysis|20|||
161004922|NCT02538107|581404731|FG000|Overall Study|Administration of other ESA|11|||
161004923|NCT02538107|581404731|FG000|Overall Study|No further treatment necessary|18|||
161004924|NCT02538107|581404731|FG000|Overall Study|Withdrawal by Subject|17|||
161004925|NCT02538107|581404731|FG000|Overall Study|Death|4|||
161004926|NCT02538107|581404731|FG000|Overall Study|Administrative reason|5|||
161004927|NCT02538107|581404731|FG000|Overall Study|Adverse Event|4|||
161004928|NCT02538107|581404731|FG000|Overall Study|Surgery|1|||
161004929|NCT02538107|581404731|FG000|Overall Study|Other|7|||
161004930|NCT02538107|581404731|FG000|Overall Study|Not recorded|7|||
161004931|NCT01278394|581404732|FG000|Overall Study|Lost to Follow-up|1|||
161004932|NCT02115139|581404733|FG000|Overall Study|Protocol Violation|1|||
161004933|NCT02115139|581404733|FG000|Overall Study|treatment discontinuation|6|||
160585226|NCT02052778|579861895|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160585227|NCT02052778|579861896|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
160585228|NCT02052778|579861897|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161004934|NCT02471755|581404734|FG000|Overall Study|Withdrawal by Subject|1|||
161004935|NCT02471755|581404735|FG001|Overall Study|Withdrawal by Subject|0|||
161004936|NCT02471755|581404734|FG000|Overall Study|Lost to Follow-up|0|||
161004937|NCT02471755|581404735|FG001|Overall Study|Lost to Follow-up|1|||
161004938|NCT00305695|581404741|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
161004939|NCT00305695|581404742|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
161004940|NCT00305695|581404741|FG000|Overall Study|Did not have baseline scan|1|||
161004941|NCT00305695|581404742|FG001|Overall Study|Did not have baseline scan|1|||
161004942|NCT01597258|581404745|FG000|Overall Study|No Drug Administration|1|||
161004943|NCT04789408|581404746|FG000|Overall Study|Death|4|||
161004944|NCT04789408|581404747|FG001|Overall Study|Death|3|||
161004945|NCT04789408|581404748|FG002|Overall Study|Death|6|||
161004946|NCT04789408|581404746|FG000|Overall Study|Did not meet eligibility criteria|1|||
161004947|NCT04789408|581404747|FG001|Overall Study|Did not meet eligibility criteria|0|||
161004948|NCT04789408|581404748|FG002|Overall Study|Did not meet eligibility criteria|0|||
161004949|NCT04789408|581404746|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
161004950|NCT04789408|581404747|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
161004951|NCT04789408|581404748|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
161004952|NCT05938413|581406174|FG000|Overall Study|Lost to Follow-up|1|||
161004953|NCT05938413|581406175|FG001|Overall Study|Lost to Follow-up|7|||
161004954|NCT05938413|581406174|FG000|Overall Study|Withdrawal by Subject|1|||
161004955|NCT05938413|581406175|FG001|Overall Study|Withdrawal by Subject|1|||
161004956|NCT03312907|581406176|FG000|Overall Study|Adverse Event|1|||
161004957|NCT03312907|581406177|FG001|Overall Study|Adverse Event|6|||
161004958|NCT03312907|581406178|FG002|Overall Study|Adverse Event|1|||
161004959|NCT03312907|581406176|FG000|Overall Study|Protocol Violation|2|||
161004960|NCT03312907|581406177|FG001|Overall Study|Protocol Violation|3|||
161004961|NCT03312907|581406178|FG002|Overall Study|Protocol Violation|4|||
161004962|NCT03312907|581406176|FG000|Overall Study|Lost to Follow-up|2|||
161004963|NCT03312907|581406177|FG001|Overall Study|Lost to Follow-up|3|||
161004964|NCT03312907|581406178|FG002|Overall Study|Lost to Follow-up|2|||
161004965|NCT03312907|581406176|FG000|Overall Study|Physician Decision|3|||
161004966|NCT03312907|581406177|FG001|Overall Study|Physician Decision|4|||
161004967|NCT03312907|581406178|FG002|Overall Study|Physician Decision|2|||
161004968|NCT03312907|581406176|FG000|Overall Study|Withdrawal by Subject|9|||
161004969|NCT03312907|581406177|FG001|Overall Study|Withdrawal by Subject|14|||
161004970|NCT03312907|581406178|FG002|Overall Study|Withdrawal by Subject|10|||
161004971|NCT01780298|581406184|FG000|Overall Study|Physician Decision|1|||
161004972|NCT01780298|581406185|FG001|Overall Study|Physician Decision|5|||
161004973|NCT01780298|581406186|FG002|Overall Study|Physician Decision|1|||
161004974|NCT01780298|581406187|FG003|Overall Study|Physician Decision|1|||
161004975|NCT01780298|581406184|FG000|Overall Study|Subject not matched|1|||
161004976|NCT01780298|581406185|FG001|Overall Study|Subject not matched|0|||
161004977|NCT01780298|581406186|FG002|Overall Study|Subject not matched|1|||
161004978|NCT01780298|581406187|FG003|Overall Study|Subject not matched|0|||
161004979|NCT01780298|581406184|FG000|Overall Study|Adverse Event|0|||
161004980|NCT01780298|581406185|FG001|Overall Study|Adverse Event|0|||
161004981|NCT01780298|581406186|FG002|Overall Study|Adverse Event|2|||
161004982|NCT01780298|581406187|FG003|Overall Study|Adverse Event|0|||
161004983|NCT02407249|581406204|FG000|Overall Study|Did not complete 12-month follow-up|13|||
161004984|NCT02407249|581406204|FG000|Overall Study|Not treated|13|||
161004985|NCT00840177|581406205|FG000|Overall Study|Adverse Event|5|||
161004986|NCT00840177|581406206|FG001|Overall Study|Adverse Event|1|||
161004987|NCT00840177|581406207|FG002|Overall Study|Adverse Event|1|||
161004988|NCT00840177|581406205|FG000|Overall Study|Refusal unrelated to adverse events|1|||
161004989|NCT00840177|581406206|FG001|Overall Study|Refusal unrelated to adverse events|0|||
161004990|NCT00840177|581406207|FG002|Overall Study|Refusal unrelated to adverse events|1|||
161004991|NCT00840177|581406205|FG000|Overall Study|Progression/relapse|2|||
161004992|NCT00840177|581406206|FG001|Overall Study|Progression/relapse|0|||
161004993|NCT00840177|581406207|FG002|Overall Study|Progression/relapse|0|||
161004994|NCT00840177|581406205|FG000|Overall Study|Death|4|||
161004995|NCT00840177|581406206|FG001|Overall Study|Death|5|||
161004996|NCT00840177|581406207|FG002|Overall Study|Death|5|||
161004997|NCT00840177|581406205|FG000|Overall Study|not protocol specified|6|||
161004998|NCT00840177|581406206|FG001|Overall Study|not protocol specified|3|||
161004999|NCT00840177|581406207|FG002|Overall Study|not protocol specified|0|||
161005000|NCT00840177|581406205|FG000|Overall Study|Ineligible|0|||
161005001|NCT00840177|581406206|FG001|Overall Study|Ineligible|0|||
161005002|NCT00840177|581406207|FG002|Overall Study|Ineligible|3|||
161005003|NCT00840177|581406205|FG000|Overall Study|Did not start treatment|0|||
161005004|NCT00840177|581406206|FG001|Overall Study|Did not start treatment|0|||
161005005|NCT00840177|581406207|FG002|Overall Study|Did not start treatment|1|||
161005006|NCT01391832|581406208|FG000|Overall Study|Withdrawal by Subject|21|||
161005007|NCT01391832|581406209|FG001|Overall Study|Withdrawal by Subject|22|||
161005008|NCT01391832|581406208|FG000|Overall Study|Lost to Follow-up|0|||
161005009|NCT01391832|581406209|FG001|Overall Study|Lost to Follow-up|1|||
161005010|NCT03345901|581406215|FG000|Overall Study|The study was terminated|18|||
161005011|NCT01599793|581406216|FG000|Overall Study|Adverse Event|2|||
161005012|NCT01972724|581406217|FG000|Double-Blind|Rescue Criteria Met|1|||
161005013|NCT01972724|581406218|FG001|Double-Blind|Rescue Criteria Met|0|||
161005014|NCT01972724|581406219|FG002|Double-Blind|Rescue Criteria Met|0|||
161005015|NCT01972724|581406217|FG000|Double-Blind|Adverse Event|1|||
161005016|NCT01972724|581406218|FG001|Double-Blind|Adverse Event|0|||
161005017|NCT01972724|581406219|FG002|Double-Blind|Adverse Event|0|||
161005018|NCT01972724|581406217|FG000|Double-Blind|Withdrawal of Consent|2|||
161005019|NCT01972724|581406218|FG001|Double-Blind|Withdrawal of Consent|1|||
161005020|NCT01972724|581406219|FG002|Double-Blind|Withdrawal of Consent|0|||
161005021|NCT01972724|581406217|FG000|Double-Blind|Significant Protocol Deviation|5|||
161005022|NCT01972724|581406218|FG001|Double-Blind|Significant Protocol Deviation|8|||
161005023|NCT01972724|581406219|FG002|Double-Blind|Significant Protocol Deviation|0|||
161005024|NCT01972724|581406217|FG000|Open-Label|Withdrew Consent|0|||
160585229|NCT02052778|579861898|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
160585230|NCT02052778|579861876|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585231|NCT02052778|579861877|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161005025|NCT01972724|581406218|FG001|Open-Label|Withdrew Consent|0|||
161005026|NCT01972724|581406219|FG002|Open-Label|Withdrew Consent|3|||
161005027|NCT01972724|581406217|FG000|Open-Label|Significant Protocol Deviation|0|||
161005028|NCT01972724|581406218|FG001|Open-Label|Significant Protocol Deviation|0|||
161005029|NCT01972724|581406219|FG002|Open-Label|Significant Protocol Deviation|2|||
161005030|NCT00277355|581406227|FG000|Overall Study|Withdrawal by Subject|3|||
161005031|NCT00277355|581406228|FG001|Overall Study|Withdrawal by Subject|3|||
161005032|NCT00277355|581406227|FG000|Overall Study|Lost to Follow-up|2|||
161005033|NCT00277355|581406228|FG001|Overall Study|Lost to Follow-up|2|||
161005034|NCT00277355|581406227|FG000|Overall Study|Adverse Event|5|||
161005035|NCT00277355|581406228|FG001|Overall Study|Adverse Event|0|||
161005036|NCT00277355|581406227|FG000|Overall Study|Death|3|||
161005037|NCT00277355|581406228|FG001|Overall Study|Death|0|||
161005038|NCT00277355|581406227|FG000|Overall Study|Physician Decision|1|||
161005039|NCT00277355|581406228|FG001|Overall Study|Physician Decision|0|||
161005040|NCT02675244|581406233|FG000|Overall Study|Death|9|||
161005041|NCT02675244|581406234|FG001|Overall Study|Death|6|||
161005042|NCT02675244|581406233|FG000|Overall Study|Withdrawal by Subject|3|||
161005043|NCT02675244|581406234|FG001|Overall Study|Withdrawal by Subject|6|||
161005044|NCT02675244|581406233|FG000|Overall Study|Lost to Follow-up|1|||
161005045|NCT02675244|581406234|FG001|Overall Study|Lost to Follow-up|1|||
161005046|NCT02675244|581406233|FG000|Overall Study|Ongoing at 2 Years|190|||
161005047|NCT02675244|581406234|FG001|Overall Study|Ongoing at 2 Years|185|||
161005048|NCT02652442|581406238|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
161005049|NCT02252042|581406239|FG000|Overall Study|Adverse Event|9|||
161005050|NCT02252042|581406240|FG001|Overall Study|Adverse Event|6|||
161005051|NCT02252042|581406239|FG000|Overall Study|Death|209|||
161005052|NCT02252042|581406240|FG001|Overall Study|Death|217|||
161005053|NCT02252042|581406239|FG000|Overall Study|Physician Decision|0|||
161005054|NCT02252042|581406240|FG001|Overall Study|Physician Decision|2|||
161005055|NCT02252042|581406239|FG000|Overall Study|Transferred to Extension Study|7|||
161005056|NCT02252042|581406240|FG001|Overall Study|Transferred to Extension Study|1|||
161005057|NCT02252042|581406239|FG000|Overall Study|Did Not Continue on Extension Study|7|||
161005058|NCT02252042|581406240|FG001|Overall Study|Did Not Continue on Extension Study|2|||
161005059|NCT02252042|581406239|FG000|Overall Study|Withdrawal by Subject|15|||
161005060|NCT02252042|581406240|FG001|Overall Study|Withdrawal by Subject|20|||
161005061|NCT02593149|581406243|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
161005062|NCT02593149|581406244|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
161005063|NCT02593149|581406243|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
161005064|NCT02593149|581406244|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
161005065|NCT01177670|581406245|FG000|Overall Study|Study Terminated|115|||
161005066|NCT01177670|581406245|FG000|Overall Study|Physician Decision|50|||
161005067|NCT01177670|581406245|FG000|Overall Study|Withdrawal by Subject|4|||
161005068|NCT01636687|581406246|FG000|Induction Period|Withdrawal by Subject|1|||
161005069|NCT01636687|581406247|FG001|Induction Period|Withdrawal by Subject|0|||
161005070|NCT01636687|581406248|FG002|Induction Period|Withdrawal by Subject|0|||
161005071|NCT01636687|581406249|FG003|Induction Period|Withdrawal by Subject|0|||
161005072|NCT01636687|581406250|FG004|Induction Period|Withdrawal by Subject|0|||
161005073|NCT01636687|581406246|FG000|Induction Period|Adverse Event|1|||
161005074|NCT01636687|581406247|FG001|Induction Period|Adverse Event|0|||
161005075|NCT01636687|581406248|FG002|Induction Period|Adverse Event|0|||
161005076|NCT01636687|581406249|FG003|Induction Period|Adverse Event|0|||
161005077|NCT01636687|581406250|FG004|Induction Period|Adverse Event|1|||
161005078|NCT01636687|581406246|FG000|Induction Period|Lack of Efficacy|0|||
161005079|NCT01636687|581406247|FG001|Induction Period|Lack of Efficacy|0|||
161005080|NCT01636687|581406248|FG002|Induction Period|Lack of Efficacy|0|||
161005081|NCT01636687|581406249|FG003|Induction Period|Lack of Efficacy|0|||
161005082|NCT01636687|581406250|FG004|Induction Period|Lack of Efficacy|1|||
161005083|NCT01636687|581406246|FG000|Induction Period|Physician Decision|1|||
161005084|NCT01636687|581406247|FG001|Induction Period|Physician Decision|0|||
161005085|NCT01636687|581406248|FG002|Induction Period|Physician Decision|0|||
161005086|NCT01636687|581406249|FG003|Induction Period|Physician Decision|0|||
161005087|NCT01636687|581406250|FG004|Induction Period|Physician Decision|0|||
161005088|NCT01636687|581406246|FG000|Maintenance Period|Withdrawal by Subject|2|||
161005089|NCT01636687|581406247|FG001|Maintenance Period|Withdrawal by Subject|0|||
161005090|NCT01636687|581406248|FG002|Maintenance Period|Withdrawal by Subject|2|||
161005091|NCT01636687|581406249|FG003|Maintenance Period|Withdrawal by Subject|0|||
161005092|NCT01636687|581406250|FG004|Maintenance Period|Withdrawal by Subject|0|||
161005093|NCT01636687|581406246|FG000|Maintenance Period|Adverse Event|1|||
161005094|NCT01636687|581406247|FG001|Maintenance Period|Adverse Event|0|||
161005095|NCT01636687|581406248|FG002|Maintenance Period|Adverse Event|0|||
161005096|NCT01636687|581406249|FG003|Maintenance Period|Adverse Event|0|||
161005097|NCT01636687|581406250|FG004|Maintenance Period|Adverse Event|0|||
161005098|NCT01636687|581406246|FG000|Maintenance Period|Lack of Efficacy|4|||
161005099|NCT01636687|581406247|FG001|Maintenance Period|Lack of Efficacy|1|||
161005100|NCT01636687|581406248|FG002|Maintenance Period|Lack of Efficacy|0|||
161005101|NCT01636687|581406249|FG003|Maintenance Period|Lack of Efficacy|0|||
161005102|NCT01636687|581406250|FG004|Maintenance Period|Lack of Efficacy|0|||
161005103|NCT01636687|581406246|FG000|Maintenance Period|Lost to Follow-up|1|||
161005104|NCT01636687|581406247|FG001|Maintenance Period|Lost to Follow-up|1|||
161005105|NCT01636687|581406248|FG002|Maintenance Period|Lost to Follow-up|0|||
161005106|NCT01636687|581406249|FG003|Maintenance Period|Lost to Follow-up|0|||
161005107|NCT01636687|581406250|FG004|Maintenance Period|Lost to Follow-up|1|||
161005108|NCT01636687|581406246|FG000|Maintenance Period|Physician Decision|0|||
161005109|NCT01636687|581406247|FG001|Maintenance Period|Physician Decision|0|||
161005110|NCT01636687|581406248|FG002|Maintenance Period|Physician Decision|0|||
161005111|NCT01636687|581406249|FG003|Maintenance Period|Physician Decision|0|||
161005112|NCT01636687|581406250|FG004|Maintenance Period|Physician Decision|1|||
161005113|NCT01636687|581406246|FG000|Extension Period|technical problems|0|||
161005114|NCT01636687|581406247|FG001|Extension Period|technical problems|1|||
161005115|NCT01636687|581406248|FG002|Extension Period|technical problems|2|||
161005116|NCT01636687|581406249|FG003|Extension Period|technical problems|1|||
161005117|NCT01636687|581406250|FG004|Extension Period|technical problems|0|||
161005118|NCT01636687|581406246|FG000|Extension Period|Adverse Event|4|||
161005119|NCT01636687|581406247|FG001|Extension Period|Adverse Event|3|||
160585232|NCT02052778|579861878|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160965951|NCT02487498|581264770|FG000|Period: Period 1|Lost to Follow-up|0|||
160965952|NCT02487498|581264771|FG001|Period: Period 1|Lost to Follow-up|2|||
160965953|NCT02487498|581264770|FG000|Period: Period 1|Lack of Efficacy|1|||
160965954|NCT02487498|581264771|FG001|Period: Period 1|Lack of Efficacy|0|||
160965955|NCT02487498|581264770|FG000|Period: Period 1|Physician Decision|0|||
160965956|NCT02487498|581264771|FG001|Period: Period 1|Physician Decision|1|||
160965957|NCT02487498|581264770|FG000|Period: Period 1|Protocol deviation|1|||
160965958|NCT02487498|581264771|FG001|Period: Period 1|Protocol deviation|0|||
160965959|NCT02487498|581264770|FG000|Period: Washout|Subject/guardian decision|0|||
160965960|NCT02487498|581264771|FG001|Period: Washout|Subject/guardian decision|5|||
160965961|NCT02487498|581264770|FG000|Period: Washout|Lack of Efficacy|1|||
160965962|NCT02487498|581264771|FG001|Period: Washout|Lack of Efficacy|1|||
160965963|NCT02487498|581264770|FG000|Period: Washout|Physician Decision|1|||
160965964|NCT02487498|581264771|FG001|Period: Washout|Physician Decision|0|||
160965965|NCT02487498|581264770|FG000|Period: Washout|Non-compliance with study treatment|0|||
160965966|NCT02487498|581264771|FG001|Period: Washout|Non-compliance with study treatment|1|||
160965967|NCT02487498|581264770|FG000|Period: Period 2|Adverse Event|2|||
160965968|NCT02487498|581264771|FG001|Period: Period 2|Adverse Event|2|||
160965969|NCT02487498|581264770|FG000|Period: Period 2|Subject/guardian decision|2|||
160965970|NCT02487498|581264771|FG001|Period: Period 2|Subject/guardian decision|1|||
160965971|NCT02487498|581264770|FG000|Period: Period 2|Lost to Follow-up|1|||
160965972|NCT02487498|581264771|FG001|Period: Period 2|Lost to Follow-up|1|||
160965973|NCT02487498|581264770|FG000|Period: Period 2|Death|0|||
160965974|NCT02487498|581264771|FG001|Period: Period 2|Death|1|||
160965975|NCT02487498|581264770|FG000|Period: Period 2|Physician Decision|1|||
160965976|NCT02487498|581264771|FG001|Period: Period 2|Physician Decision|0|||
160965977|NCT00676130|581264778|FG000|Overall Study|Lost to Follow-up|0|||
160965978|NCT00676130|581264779|FG001|Overall Study|Lost to Follow-up|1|||
160965979|NCT00676130|581264778|FG000|Overall Study|Found ineligible|3|||
160965980|NCT00676130|581264779|FG001|Overall Study|Found ineligible|2|||
160965981|NCT00676130|581264778|FG000|Overall Study|Withdrawal by Subject|0|||
160965982|NCT00676130|581264779|FG001|Overall Study|Withdrawal by Subject|1|||
160965983|NCT01564368|581264780|FG000|Overall Study|Ineligible|18|||
160965984|NCT01564368|581264780|FG000|Overall Study|Not Randomized in Parent study|116|||
160965985|NCT01564368|581264780|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
160965986|NCT01564368|581264780|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
160965987|NCT02940574|581264782|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
160965988|NCT02940574|581264783|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
161005120|NCT01636687|581406248|FG002|Extension Period|Adverse Event|2|||
161005121|NCT01636687|581406249|FG003|Extension Period|Adverse Event|1|||
161005122|NCT01636687|581406250|FG004|Extension Period|Adverse Event|0|||
161005123|NCT01636687|581406246|FG000|Extension Period|Lack of Efficacy|7|||
161005124|NCT01636687|581406247|FG001|Extension Period|Lack of Efficacy|0|||
161005125|NCT01636687|581406248|FG002|Extension Period|Lack of Efficacy|2|||
161005126|NCT01636687|581406249|FG003|Extension Period|Lack of Efficacy|1|||
161005127|NCT01636687|581406250|FG004|Extension Period|Lack of Efficacy|0|||
161005128|NCT01636687|581406246|FG000|Extension Period|Lost to Follow-up|1|||
161005129|NCT01636687|581406247|FG001|Extension Period|Lost to Follow-up|0|||
160585233|NCT02052778|579861879|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160965989|NCT02940574|581264782|FG000|1-year Follow-up|Lost to Follow-up|3|||
160965990|NCT02940574|581264783|FG001|1-year Follow-up|Lost to Follow-up|4|||
160965991|NCT00520975|581264784|FG000|Overall Study|Disease progression|31|||
160965992|NCT00520975|581264785|FG001|Overall Study|Disease progression|23|||
160965993|NCT00520975|581264784|FG000|Overall Study|Adverse Event|7|||
161005130|NCT01636687|581406248|FG002|Extension Period|Lost to Follow-up|1|||
161005131|NCT01636687|581406249|FG003|Extension Period|Lost to Follow-up|0|||
161005132|NCT01636687|581406250|FG004|Extension Period|Lost to Follow-up|0|||
161005133|NCT01636687|581406246|FG000|Extension Period|Physician Decision|1|||
161005134|NCT01636687|581406247|FG001|Extension Period|Physician Decision|0|||
161005135|NCT01636687|581406248|FG002|Extension Period|Physician Decision|0|||
161005136|NCT01636687|581406249|FG003|Extension Period|Physician Decision|1|||
161005137|NCT01636687|581406250|FG004|Extension Period|Physician Decision|0|||
161005138|NCT01636687|581406246|FG000|Extension Period|study terminated by sponsor|33|||
161005139|NCT01636687|581406247|FG001|Extension Period|study terminated by sponsor|50|||
161005140|NCT01636687|581406248|FG002|Extension Period|study terminated by sponsor|17|||
161005141|NCT01636687|581406249|FG003|Extension Period|study terminated by sponsor|23|||
161005142|NCT01636687|581406250|FG004|Extension Period|study terminated by sponsor|0|||
161005143|NCT01636687|581406246|FG000|Extension Period|Withdrawal by Subject|1|||
161005144|NCT01636687|581406247|FG001|Extension Period|Withdrawal by Subject|0|||
161005145|NCT01636687|581406248|FG002|Extension Period|Withdrawal by Subject|1|||
161005146|NCT01636687|581406249|FG003|Extension Period|Withdrawal by Subject|1|||
161005147|NCT01636687|581406250|FG004|Extension Period|Withdrawal by Subject|0|||
161005148|NCT01636687|581406246|FG000|Follow-up Period|Withdrawal by Subject|1|||
161005149|NCT01636687|581406247|FG001|Follow-up Period|Withdrawal by Subject|0|||
161005150|NCT01636687|581406248|FG002|Follow-up Period|Withdrawal by Subject|0|||
161005151|NCT01636687|581406249|FG003|Follow-up Period|Withdrawal by Subject|0|||
161005152|NCT01636687|581406250|FG004|Follow-up Period|Withdrawal by Subject|1|||
161005153|NCT00666276|581406253|FG000|Overall Study|Protocol Violation|34|||
161005154|NCT02594735|581406254|FG000|Overall Study|Adverse Event|1|||
161005155|NCT00101010|581406255|FG000|Overall Study|Physician Decision|1|||
161005156|NCT00364013|581406262|FG000|Overall Study|Ineligibility determined|4|||
161005157|NCT00364013|581406263|FG001|Overall Study|Ineligibility determined|2|||
161005158|NCT00364013|581406262|FG000|Overall Study|Adverse Event|4|||
161005159|NCT00364013|581406263|FG001|Overall Study|Adverse Event|3|||
161005160|NCT00364013|581406262|FG000|Overall Study|Withdrawal by Subject|13|||
161005161|NCT00364013|581406263|FG001|Overall Study|Withdrawal by Subject|18|||
161005162|NCT00364013|581406262|FG000|Overall Study|Physician Decision|3|||
161005163|NCT00364013|581406263|FG001|Overall Study|Physician Decision|3|||
161005164|NCT00364013|581406262|FG000|Overall Study|Lost to Follow-up|10|||
161005165|NCT00364013|581406263|FG001|Overall Study|Lost to Follow-up|3|||
161005166|NCT00364013|581406262|FG000|Overall Study|Protocol-specified criteria|6|||
161005167|NCT00364013|581406263|FG001|Overall Study|Protocol-specified criteria|6|||
161005168|NCT00364013|581406262|FG000|Overall Study|Other|41|||
161005169|NCT00364013|581406263|FG001|Overall Study|Other|47|||
161005170|NCT00364013|581406262|FG000|Overall Study|Ongoing|20|||
161005171|NCT00364013|581406263|FG001|Overall Study|Ongoing|13|||
161005172|NCT00835770|581406264|FG000|Overall Study|MS Relapse|17|||
161005173|NCT00835770|581406265|FG001|Overall Study|MS Relapse|23|||
161005174|NCT00835770|581406264|FG000|Overall Study|MS Progression|14|||
161005175|NCT00835770|581406265|FG001|Overall Study|MS Progression|9|||
161005176|NCT00835770|581406264|FG000|Overall Study|Adverse Event|113|||
161005177|NCT00835770|581406265|FG001|Overall Study|Adverse Event|124|||
161005178|NCT00835770|581406264|FG000|Overall Study|Lost to Follow-up|22|||
161005179|NCT00835770|581406265|FG001|Overall Study|Lost to Follow-up|19|||
161005180|NCT00835770|581406264|FG000|Overall Study|Consent Withdrawn|144|||
161005181|NCT00835770|581406265|FG001|Overall Study|Consent Withdrawn|156|||
161005182|NCT00835770|581406264|FG000|Overall Study|Investigator Decision|42|||
161005183|NCT00835770|581406265|FG001|Overall Study|Investigator Decision|42|||
161005184|NCT00835770|581406264|FG000|Overall Study|Participant Non-Compliance|11|||
161005185|NCT00835770|581406265|FG001|Overall Study|Participant Non-Compliance|9|||
161005186|NCT00835770|581406264|FG000|Overall Study|Death|4|||
161005187|NCT00835770|581406265|FG001|Overall Study|Death|6|||
161005188|NCT00835770|581406264|FG000|Overall Study|Other|115|||
161005189|NCT00835770|581406265|FG001|Overall Study|Other|104|||
161005190|NCT00835770|581406264|FG000|Overall Study|Other|2|||
161005191|NCT00835770|581406265|FG001|Overall Study|Other|1|||
161005192|NCT00939510|581406269|FG000|Overall Study|Withdrawal by Subject|1|||
161005193|NCT01202955|581406270|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
160458553|NCT04369911|579410876|FG000|Overall Study|Lost to Follow-up|3|||
161005194|NCT01202955|581406271|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
161005195|NCT00159783|581406276|FG000|Overall Study|Adverse Event|5|||
161005196|NCT00159783|581406277|FG001|Overall Study|Adverse Event|7|||
161005197|NCT00159783|581406278|FG002|Overall Study|Adverse Event|9|||
161005198|NCT00159783|581406276|FG000|Overall Study|Lack of Efficacy|1|||
161005199|NCT00159783|581406277|FG001|Overall Study|Lack of Efficacy|2|||
161005200|NCT00159783|581406278|FG002|Overall Study|Lack of Efficacy|3|||
161005201|NCT00159783|581406276|FG000|Overall Study|Withdrawal by Subject|7|||
161005202|NCT00159783|581406277|FG001|Overall Study|Withdrawal by Subject|11|||
161005203|NCT00159783|581406278|FG002|Overall Study|Withdrawal by Subject|12|||
161005204|NCT00159783|581406276|FG000|Overall Study|Lost to Follow-up|6|||
161005205|NCT00159783|581406277|FG001|Overall Study|Lost to Follow-up|5|||
161005206|NCT00159783|581406278|FG002|Overall Study|Lost to Follow-up|11|||
161005207|NCT00159783|581406276|FG000|Overall Study|Other|0|||
161005208|NCT00159783|581406277|FG001|Overall Study|Other|2|||
161005209|NCT00159783|581406278|FG002|Overall Study|Other|4|||
161005210|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
161005211|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
161005212|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
161005213|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
161005214|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
161005215|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
161005216|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
161005217|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
161005218|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
161005219|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
161005220|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
161005221|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
161005222|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
161005223|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
161005224|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
161005225|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
161005226|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
161005227|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
161005228|NCT00958633|581406279|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
161005229|NCT00958633|581406280|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
161005230|NCT00958633|581406281|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
161005231|NCT00094575|581406284|FG000|Overall Study|Death|146|||
161005232|NCT00094575|581406285|FG001|Overall Study|Death|146|||
161005233|NCT00794118|581406286|FG000|Overall Study|Lost to Follow-up|16|||
161005234|NCT00794118|581406286|FG000|Overall Study|Withdrawal by Subject|9|||
161005235|NCT00794118|581406286|FG000|Overall Study|Changed hospital center|2|||
161005236|NCT00206375|581406287|FG000|Overall Study|Lost to Follow-up|1|||
161005237|NCT00206375|581406288|FG001|Overall Study|Lost to Follow-up|0|||
161005238|NCT00206375|581406289|FG002|Overall Study|Lost to Follow-up|0|||
161005239|NCT00206375|581406287|FG000|Overall Study|Withdrawal by Subject|2|||
161005240|NCT00206375|581406288|FG001|Overall Study|Withdrawal by Subject|1|||
161005241|NCT00206375|581406289|FG002|Overall Study|Withdrawal by Subject|3|||
161005242|NCT00206375|581406287|FG000|Overall Study|Study terminated due to lack of funds|0|||
161005243|NCT00206375|581406288|FG001|Overall Study|Study terminated due to lack of funds|1|||
161005244|NCT00206375|581406289|FG002|Overall Study|Study terminated due to lack of funds|1|||
161005245|NCT00837616|581406292|FG000|Overall Study|Withdrawal by Subject|0|||
161005246|NCT00837616|581406293|FG001|Overall Study|Withdrawal by Subject|1|||
161005247|NCT03512756|581406301|FG000|Part 1|Death|23|||
161005248|NCT03512756|581406302|FG001|Part 1|Death|18|||
161005249|NCT03512756|581406303|FG002|Part 1|Death|0|||
161005250|NCT03512756|581406304|FG003|Part 1|Death|0|||
161005251|NCT03512756|581406301|FG000|Part 1|Lost to Follow-up|0|||
161005252|NCT03512756|581406302|FG001|Part 1|Lost to Follow-up|3|||
161005253|NCT03512756|581406303|FG002|Part 1|Lost to Follow-up|0|||
161005254|NCT03512756|581406304|FG003|Part 1|Lost to Follow-up|0|||
160965994|NCT00520975|581264785|FG001|Overall Study|Adverse Event|10|||
160965995|NCT00520975|581264784|FG000|Overall Study|Death|0|||
160965996|NCT00520975|581264785|FG001|Overall Study|Death|2|||
160965997|NCT00520975|581264784|FG000|Overall Study|Withdrawal by Subject|3|||
160965998|NCT00520975|581264785|FG001|Overall Study|Withdrawal by Subject|5|||
160965999|NCT00520975|581264784|FG000|Overall Study|Other therapy|2|||
160966000|NCT00520975|581264785|FG001|Overall Study|Other therapy|4|||
160966001|NCT00520975|581264784|FG000|Overall Study|Other reasons|4|||
160966002|NCT00520975|581264785|FG001|Overall Study|Other reasons|2|||
160966003|NCT00520975|581264784|FG000|Overall Study|Not start protocol therapy|1|||
160966004|NCT00520975|581264785|FG001|Overall Study|Not start protocol therapy|2|||
160966005|NCT04810221|581264786|FG000|Overall Study|Physician Decision|3|||
160966006|NCT01181726|581264787|FG000|First Intervention|Adverse Event|1|||
160966007|NCT01181726|581264788|FG001|First Intervention|Adverse Event|0|||
160966008|NCT00642902|581264789|FG000|Overall Study|Adverse Event|0|||
160966009|NCT00642902|581264790|FG001|Overall Study|Adverse Event|1|||
160966010|NCT00642902|581264791|FG002|Overall Study|Adverse Event|3|||
160966011|NCT00642902|581264792|FG003|Overall Study|Adverse Event|1|||
160966012|NCT00642902|581264789|FG000|Overall Study|Lost to Follow-up|1|||
160966013|NCT00642902|581264790|FG001|Overall Study|Lost to Follow-up|1|||
160966014|NCT00642902|581264791|FG002|Overall Study|Lost to Follow-up|0|||
161005255|NCT03512756|581406301|FG000|Part 1|Physician Decision|0|||
161005256|NCT03512756|581406302|FG001|Part 1|Physician Decision|1|||
161005257|NCT03512756|581406303|FG002|Part 1|Physician Decision|0|||
161005258|NCT03512756|581406304|FG003|Part 1|Physician Decision|0|||
161005259|NCT03512756|581406301|FG000|Part 1|Withdrawal by Subject|2|||
160966015|NCT00642902|581264792|FG003|Overall Study|Lost to Follow-up|0|||
160966016|NCT00642902|581264789|FG000|Overall Study|Lack of Efficacy|0|||
161005260|NCT03512756|581406302|FG001|Part 1|Withdrawal by Subject|2|||
161005261|NCT03512756|581406303|FG002|Part 1|Withdrawal by Subject|0|||
161005262|NCT03512756|581406304|FG003|Part 1|Withdrawal by Subject|0|||
161005263|NCT03512756|581406301|FG000|Part 2|Death|0|||
161005264|NCT03512756|581406302|FG001|Part 2|Death|0|||
161005265|NCT03512756|581406303|FG002|Part 2|Death|32|||
161005266|NCT03512756|581406304|FG003|Part 2|Death|21|||
161005267|NCT03512756|581406301|FG000|Part 2|Lost to Follow-up|0|||
161005268|NCT03512756|581406302|FG001|Part 2|Lost to Follow-up|0|||
161005269|NCT03512756|581406303|FG002|Part 2|Lost to Follow-up|1|||
161005270|NCT03512756|581406304|FG003|Part 2|Lost to Follow-up|0|||
161005271|NCT03512756|581406301|FG000|Part 2|Physician Decision|0|||
161005272|NCT03512756|581406302|FG001|Part 2|Physician Decision|0|||
161005273|NCT03512756|581406303|FG002|Part 2|Physician Decision|2|||
161005274|NCT03512756|581406304|FG003|Part 2|Physician Decision|4|||
161005275|NCT03512756|581406301|FG000|Part 2|Study Terminated by Sponsor|0|||
161005276|NCT03512756|581406302|FG001|Part 2|Study Terminated by Sponsor|0|||
161005277|NCT03512756|581406303|FG002|Part 2|Study Terminated by Sponsor|2|||
161005278|NCT03512756|581406304|FG003|Part 2|Study Terminated by Sponsor|6|||
161005279|NCT03512756|581406301|FG000|Part 2|Protocol Violation|0|||
161005280|NCT03512756|581406302|FG001|Part 2|Protocol Violation|0|||
161005281|NCT03512756|581406303|FG002|Part 2|Protocol Violation|1|||
161005282|NCT03512756|581406304|FG003|Part 2|Protocol Violation|0|||
161005283|NCT03512756|581406301|FG000|Part 2|Withdrawal by Subject|0|||
161005284|NCT03512756|581406302|FG001|Part 2|Withdrawal by Subject|0|||
161005285|NCT03512756|581406303|FG002|Part 2|Withdrawal by Subject|3|||
161005286|NCT03512756|581406304|FG003|Part 2|Withdrawal by Subject|9|||
161005287|NCT01212991|581406305|FG000|Double-blind|Lost to Follow-up|8|||
161005288|NCT01212991|581406306|FG001|Double-blind|Lost to Follow-up|4|||
161005289|NCT01212991|581406307|FG002|Double-blind|Lost to Follow-up|0|||
161005290|NCT01212991|581406305|FG000|Double-blind|Death|699|||
161005291|NCT01212991|581406306|FG001|Double-blind|Death|550|||
161005292|NCT01212991|581406307|FG002|Double-blind|Death|0|||
161005293|NCT01212991|581406305|FG000|Double-blind|Withdrawal by Subject|16|||
161005294|NCT01212991|581406306|FG001|Double-blind|Withdrawal by Subject|19|||
161005295|NCT01212991|581406307|FG002|Double-blind|Withdrawal by Subject|0|||
161005296|NCT01212991|581406305|FG000|Double-blind|Other|7|||
161005297|NCT01212991|581406306|FG001|Double-blind|Other|0|||
161005298|NCT01212991|581406307|FG002|Double-blind|Other|0|||
161005299|NCT01212991|581406305|FG000|Double-blind|Sponsor decision|142|||
161005300|NCT01212991|581406306|FG001|Double-blind|Sponsor decision|38|||
161005301|NCT01212991|581406307|FG002|Double-blind|Sponsor decision|0|||
161005302|NCT01212991|581406305|FG000|Open-label|Death|0|||
161005303|NCT01212991|581406306|FG001|Open-label|Death|0|||
161005304|NCT01212991|581406307|FG002|Open-label|Death|166|||
161005305|NCT01212991|581406305|FG000|Open-label|Lost to Follow-up|0|||
161005306|NCT01212991|581406306|FG001|Open-label|Lost to Follow-up|0|||
161005307|NCT01212991|581406307|FG002|Open-label|Lost to Follow-up|5|||
161005308|NCT01212991|581406305|FG000|Open-label|Withdrawal by Subject|0|||
161005309|NCT01212991|581406306|FG001|Open-label|Withdrawal by Subject|0|||
161005310|NCT01212991|581406307|FG002|Open-label|Withdrawal by Subject|7|||
161005311|NCT01212991|581406305|FG000|Open-label|Sponsor decision|0|||
161005312|NCT01212991|581406306|FG001|Open-label|Sponsor decision|0|||
161005313|NCT01212991|581406307|FG002|Open-label|Sponsor decision|53|||
161005314|NCT01212991|581406305|FG000|Open-label|Other|0|||
161005315|NCT01212991|581406306|FG001|Open-label|Other|0|||
161005316|NCT01212991|581406307|FG002|Open-label|Other|3|||
161005317|NCT04411056|581407822|FG000|Overall Study|surgery cancelled|1|||
161005318|NCT04411056|581407823|FG001|Overall Study|surgery cancelled|0|||
161005319|NCT04411056|581407822|FG000|Overall Study|Equipment problem during intubation|0|||
161005320|NCT04411056|581407823|FG001|Overall Study|Equipment problem during intubation|1|||
161005321|NCT04623008|581407824|FG000|Baseline to T2|Withdrawal by Subject|4|||
161005322|NCT04623008|581407825|FG001|Baseline to T2|Withdrawal by Subject|2|||
161005323|NCT04623008|581407824|FG000|Baseline to T3|Withdrawal by Subject|4|||
161005324|NCT04623008|581407825|FG001|Baseline to T3|Withdrawal by Subject|2|||
160458554|NCT04369911|579410877|FG001|Overall Study|Lost to Follow-up|3|||
161005325|NCT04688450|581407834|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
161005326|NCT04688450|581407834|FG000|Overall Study|Withdrawal by Subject|1|||
161005327|NCT03481777|581407835|FG000|Overall Study|Withdrawal by Subject|36|||
161005328|NCT03481777|581407836|FG001|Overall Study|Withdrawal by Subject|31|||
160458555|NCT04369911|579410876|FG000|Overall Study|Withdrawal by Subject|1|||
160458556|NCT04369911|579410877|FG001|Overall Study|Withdrawal by Subject|2|||
161005329|NCT03481777|581407835|FG000|Overall Study|Non stroke = non target population|277|||
161005330|NCT03481777|581407836|FG001|Overall Study|Non stroke = non target population|254|||
161005331|NCT03189524|581407837|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
161005332|NCT03189524|581407838|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
161005333|NCT03189524|581407839|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
161005334|NCT03189524|581407837|FG000|Overall Study|Death|2|||
161005335|NCT03189524|581407838|FG001|Overall Study|Death|2|||
160458557|NCT04163991|579410878|FG000|Overall Study|Adverse Event|0|||
161005336|NCT03189524|581407839|FG002|Overall Study|Death|1|||
161005337|NCT03189524|581407837|FG000|Overall Study|Lost to Follow-up|1|||
161005338|NCT03189524|581407838|FG001|Overall Study|Lost to Follow-up|0|||
161005339|NCT03189524|581407839|FG002|Overall Study|Lost to Follow-up|8|||
161005340|NCT03189524|581407837|FG000|Overall Study|Withdrawal by Subject|1|||
161005341|NCT03189524|581407838|FG001|Overall Study|Withdrawal by Subject|1|||
161005342|NCT03189524|581407839|FG002|Overall Study|Withdrawal by Subject|3|||
161005343|NCT03189524|581407837|FG000|Overall Study|Progressive Disease|0|||
161005344|NCT03189524|581407838|FG001|Overall Study|Progressive Disease|2|||
161005345|NCT03189524|581407839|FG002|Overall Study|Progressive Disease|0|||
161005346|NCT04252586|581407840|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161005347|NCT04252586|581407840|FG000|Overall Study|Adverse Event|1|||
161005348|NCT04252586|581407840|FG000|Overall Study|Death|2|||
161005349|NCT04252586|581407840|FG000|Overall Study|Study terminated by sponsor|4|||
161005350|NCT04252586|581407840|FG000|Overall Study|Sponsor request|10|||
161005351|NCT04252586|581407840|FG000|Overall Study|Did not complete treatment period|1|||
161005352|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Death|186|||
161005353|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Death|222|||
161005354|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Death|0|||
161005355|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
161005356|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
161005357|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
161005358|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
161005359|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
161005360|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
161005361|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
161005362|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
161005363|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
161005364|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Adverse Event|83|||
161005365|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Adverse Event|100|||
161005366|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Adverse Event|0|||
161005367|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Other|70|||
161005368|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Other|75|||
161005369|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Other|0|||
161005370|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
161005371|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
161005372|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
161005373|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
161005374|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
161005375|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
161005376|NCT00232180|581407841|FG000|Open Label Phase|Death|0|||
161005377|NCT00232180|581407842|FG001|Open Label Phase|Death|0|||
161005378|NCT00232180|581407843|FG002|Open Label Phase|Death|48|||
161005379|NCT00232180|581407841|FG000|Open Label Phase|Lost to Follow-up|0|||
161005380|NCT00232180|581407842|FG001|Open Label Phase|Lost to Follow-up|0|||
161005381|NCT00232180|581407843|FG002|Open Label Phase|Lost to Follow-up|5|||
161005382|NCT00232180|581407841|FG000|Open Label Phase|Protocol Violation|0|||
161005383|NCT00232180|581407842|FG001|Open Label Phase|Protocol Violation|0|||
161005384|NCT00232180|581407843|FG002|Open Label Phase|Protocol Violation|3|||
161005385|NCT00232180|581407841|FG000|Open Label Phase|Study terminated by sponsor|0|||
161005386|NCT00232180|581407842|FG001|Open Label Phase|Study terminated by sponsor|0|||
161005387|NCT00232180|581407843|FG002|Open Label Phase|Study terminated by sponsor|3|||
161005388|NCT00232180|581407841|FG000|Open Label Phase|Withdrawal by Subject|0|||
161005389|NCT00232180|581407842|FG001|Open Label Phase|Withdrawal by Subject|0|||
161005390|NCT00232180|581407843|FG002|Open Label Phase|Withdrawal by Subject|37|||
161005391|NCT00232180|581407841|FG000|Open Label Phase|Other|0|||
161005392|NCT00232180|581407842|FG001|Open Label Phase|Other|0|||
161005393|NCT00232180|581407843|FG002|Open Label Phase|Other|16|||
161005394|NCT00232180|581407841|FG000|Open Label Phase|Adverse Event|0|||
161005395|NCT00232180|581407842|FG001|Open Label Phase|Adverse Event|0|||
161005396|NCT00232180|581407843|FG002|Open Label Phase|Adverse Event|25|||
161005397|NCT00232180|581407841|FG000|Open Label Phase|Laboratory abnormality|0|||
161005398|NCT00232180|581407842|FG001|Open Label Phase|Laboratory abnormality|0|||
161005399|NCT00232180|581407843|FG002|Open Label Phase|Laboratory abnormality|10|||
161005400|NCT00232180|581407841|FG000|Open Label Phase|Randomized but not treated|0|||
161005401|NCT00232180|581407842|FG001|Open Label Phase|Randomized but not treated|0|||
161005402|NCT00232180|581407843|FG002|Open Label Phase|Randomized but not treated|1|||
161005403|NCT02748317|581407844|FG000|Overall Study|Withdrawal by Subject|14|||
161005404|NCT02748317|581407844|FG000|Overall Study|Lost to Follow-up|8|||
161005405|NCT02748317|581407844|FG000|Overall Study|Death|1|||
161005406|NCT00434304|581407845|FG000|Overall Study|Adverse Event|14|||
161005407|NCT00434304|581407845|FG000|Overall Study|Lack of Efficacy|2|||
161005408|NCT00434304|581407845|FG000|Overall Study|Withdrawal by Subject|4|||
161005409|NCT05262738|581407846|FG000|Overall Study|Withdrawal by Subject|1|||
161005410|NCT05262738|581407847|FG001|Overall Study|Withdrawal by Subject|0|||
161005411|NCT01149369|581407851|FG000|Overall Study|Adverse Event|6|||
161005412|NCT01149369|581407852|FG001|Overall Study|Adverse Event|3|||
161005413|NCT01424397|581407853|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005414|NCT01424397|581407854|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005415|NCT01424397|581407855|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
161005416|NCT01424397|581407856|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005417|NCT01424397|581407857|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005418|NCT01424397|581407858|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005419|NCT01424397|581407859|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005420|NCT01424397|581407860|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005421|NCT01424397|581407861|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005422|NCT01424397|581407862|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005423|NCT01424397|581407863|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005424|NCT01424397|581407864|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005425|NCT02767765|581407865|FG000|Overall Study|Adverse Event|4|||
161005426|NCT02767765|581407865|FG000|Overall Study|Death|1|||
161005427|NCT02767765|581407865|FG000|Overall Study|Insufficient response|1|||
161005428|NCT02767765|581407865|FG000|Overall Study|Lost to Follow-up|2|||
161005429|NCT02767765|581407865|FG000|Overall Study|Investigator decision|1|||
161005430|NCT02767765|581407865|FG000|Overall Study|Non-Compliance|1|||
161005431|NCT02767765|581407865|FG000|Overall Study|Withdrawal by Subject|1|||
161005432|NCT00636207|581407871|FG000|Overall Study|Adverse Event|1|||
161005433|NCT00636207|581407872|FG001|Overall Study|Adverse Event|0|||
161005434|NCT00636207|581407873|FG002|Overall Study|Adverse Event|0|||
161005435|NCT00636207|581407874|FG003|Overall Study|Adverse Event|0|||
161005436|NCT00636207|581407875|FG004|Overall Study|Adverse Event|0|||
161005437|NCT00636207|581407876|FG005|Overall Study|Adverse Event|0|||
161005438|NCT00636207|581407877|FG006|Overall Study|Adverse Event|0|||
161005439|NCT00636207|581407871|FG000|Overall Study|Withdrawal by Subject|0|||
161005440|NCT00636207|581407872|FG001|Overall Study|Withdrawal by Subject|1|||
161005441|NCT00636207|581407873|FG002|Overall Study|Withdrawal by Subject|0|||
161005442|NCT00636207|581407874|FG003|Overall Study|Withdrawal by Subject|0|||
161005443|NCT00636207|581407875|FG004|Overall Study|Withdrawal by Subject|1|||
161005444|NCT00636207|581407876|FG005|Overall Study|Withdrawal by Subject|0|||
161005445|NCT00636207|581407877|FG006|Overall Study|Withdrawal by Subject|0|||
161005446|NCT04054635|581407878|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
161005447|NCT04054635|581407879|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
161005448|NCT04054635|581407880|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
161005449|NCT04054635|581407878|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
161005450|NCT04054635|581407879|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
161005451|NCT04054635|581407880|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
161005452|NCT01185782|581407887|FG000|Overall Study|Adverse Event|0|||
161005453|NCT01185782|581407888|FG001|Overall Study|Adverse Event|1|||
161005454|NCT01185782|581407887|FG000|Overall Study|Protocol Violation|1|||
161005455|NCT01185782|581407888|FG001|Overall Study|Protocol Violation|0|||
161005456|NCT01185782|581407887|FG000|Overall Study|Poor Response to Treatment|3|||
161005457|NCT01185782|581407888|FG001|Overall Study|Poor Response to Treatment|1|||
161005458|NCT01185782|581407887|FG000|Overall Study|Other|2|||
161005459|NCT01185782|581407888|FG001|Overall Study|Other|5|||
161005460|NCT01185782|581407887|FG000|Overall Study|Randomized but not treated|0|||
161005461|NCT01185782|581407888|FG001|Overall Study|Randomized but not treated|4|||
161005462|NCT02507752|581407889|FG000|Overall Study|Adverse Event|1|||
161005463|NCT02507752|581407889|FG000|Overall Study|Protocol Violation|6|||
161005464|NCT02507752|581407889|FG000|Overall Study|Lost to Follow-up|7|||
161005465|NCT02507752|581407889|FG000|Overall Study|Infusion reaction at first infusion|1|||
161005466|NCT02507752|581407889|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
161005467|NCT02507752|581407889|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
161005468|NCT01254188|581407895|FG000|Overall Study|Disease Progression|6|||
161005469|NCT01254188|581407895|FG000|Overall Study|Protocol Violation|6|||
161005470|NCT01254188|581407895|FG000|Overall Study|Pregnancy|2|||
161005471|NCT01254188|581407895|FG000|Overall Study|Death|4|||
161005472|NCT01254188|581407895|FG000|Overall Study|Lost to Follow-up|5|||
161005473|NCT01254188|581407895|FG000|Overall Study|Withdrawal by Subject|7|||
161005474|NCT01254188|581407895|FG000|Overall Study|Adverse Event|43|||
161005475|NCT01254188|581407895|FG000|Overall Study|per investigator discretion|20|||
161005476|NCT04530747|581407896|FG000|Overall Study|Withdrawal by Subject|1|||
161005477|NCT04530747|581407897|FG001|Overall Study|Withdrawal by Subject|0|||
161005478|NCT03292913|581407898|FG000|Overall Study|Death|9|||
161005479|NCT03292913|581407899|FG001|Overall Study|Death|3|||
161005480|NCT03292913|581407898|FG000|Overall Study|Lost to Follow-up|49|||
161005481|NCT03292913|581407899|FG001|Overall Study|Lost to Follow-up|49|||
161005482|NCT03292913|581407898|FG000|Overall Study|Withdrawal by Subject|2|||
161005483|NCT03292913|581407899|FG001|Overall Study|Withdrawal by Subject|0|||
161005484|NCT03292913|581407898|FG000|Overall Study|Clinic closed due to COVID|22|||
161005485|NCT03292913|581407899|FG001|Overall Study|Clinic closed due to COVID|36|||
161005486|NCT03950622|581407900|FG000|Overall Study|Withdrawal by Subject|1|||
161005487|NCT03950622|581407901|FG001|Overall Study|Withdrawal by Subject|0|||
161005488|NCT03950622|581407900|FG000|Overall Study|Protocol Deviation|0|||
161005489|NCT03950622|581407901|FG001|Overall Study|Protocol Deviation|1|||
161005490|NCT03950622|581407900|FG000|Overall Study|Physician Decision|1|||
160585234|NCT02052778|579861880|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585235|NCT02052778|579861881|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585236|NCT02052778|579861882|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161005491|NCT03950622|581407901|FG001|Overall Study|Physician Decision|0|||
161005492|NCT03950622|581407900|FG000|Overall Study|Lost to Follow-up|5|||
161005493|NCT03950622|581407901|FG001|Overall Study|Lost to Follow-up|5|||
161005494|NCT03950622|581407900|FG000|Overall Study|Death|1|||
161005495|NCT03950622|581407901|FG001|Overall Study|Death|1|||
161005496|NCT03531840|581407905|FG000|Overall Study|Death on study|3|||
161005497|NCT03531840|581407906|FG001|Overall Study|Death on study|2|||
161005498|NCT03531840|581407907|FG002|Overall Study|Death on study|1|||
161005499|NCT03531840|581407908|FG003|Overall Study|Death on study|2|||
161005500|NCT03531840|581407905|FG000|Overall Study|Death during follow up|2|||
161005501|NCT03531840|581407906|FG001|Overall Study|Death during follow up|3|||
161005502|NCT03531840|581407907|FG002|Overall Study|Death during follow up|4|||
161005503|NCT03531840|581407908|FG003|Overall Study|Death during follow up|1|||
161005504|NCT02267824|581407910|FG000|Overall Study|Pregnancy|1|||
161005505|NCT02267824|581407911|FG001|Overall Study|Pregnancy|1|||
161005506|NCT02267824|581407910|FG000|Overall Study|Lost to Follow-up|4|||
161005507|NCT02267824|581407911|FG001|Overall Study|Lost to Follow-up|0|||
161005508|NCT02267824|581407910|FG000|Overall Study|Protocol Violation|3|||
161005509|NCT02267824|581407911|FG001|Overall Study|Protocol Violation|0|||
161005510|NCT02267824|581407910|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
161005511|NCT02267824|581407911|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
161005512|NCT01546753|581407912|FG000|Overall Study|anxiety|1|||
161005513|NCT01546753|581407913|FG001|Overall Study|anxiety|1|||
161005514|NCT01546753|581407912|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
161005515|NCT01546753|581407913|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
161005516|NCT01236560|581407921|FG000|Overall Study|Adverse Event|0|||
161005517|NCT01236560|581407922|FG001|Overall Study|Adverse Event|2|||
161005518|NCT01236560|581407923|FG002|Overall Study|Adverse Event|1|||
161005519|NCT01236560|581407924|FG003|Overall Study|Adverse Event|3|||
161005520|NCT01236560|581407925|FG004|Overall Study|Adverse Event|0|||
161005521|NCT01236560|581407926|FG005|Overall Study|Adverse Event|0|||
161005522|NCT01236560|581407921|FG000|Overall Study|Death|0|||
161005523|NCT01236560|581407922|FG001|Overall Study|Death|1|||
161005524|NCT01236560|581407923|FG002|Overall Study|Death|0|||
161005525|NCT01236560|581407924|FG003|Overall Study|Death|1|||
161005526|NCT01236560|581407925|FG004|Overall Study|Death|0|||
161005527|NCT01236560|581407926|FG005|Overall Study|Death|0|||
161005528|NCT01236560|581407921|FG000|Overall Study|Lost to Follow-up|0|||
161005529|NCT01236560|581407922|FG001|Overall Study|Lost to Follow-up|1|||
161005530|NCT01236560|581407923|FG002|Overall Study|Lost to Follow-up|1|||
161005531|NCT01236560|581407924|FG003|Overall Study|Lost to Follow-up|0|||
161005532|NCT01236560|581407925|FG004|Overall Study|Lost to Follow-up|0|||
161005533|NCT01236560|581407926|FG005|Overall Study|Lost to Follow-up|0|||
161005534|NCT01236560|581407921|FG000|Overall Study|Physician Decision|0|||
161005535|NCT01236560|581407922|FG001|Overall Study|Physician Decision|1|||
161005536|NCT01236560|581407923|FG002|Overall Study|Physician Decision|8|||
161005537|NCT01236560|581407924|FG003|Overall Study|Physician Decision|0|||
161005538|NCT01236560|581407925|FG004|Overall Study|Physician Decision|0|||
161005539|NCT01236560|581407926|FG005|Overall Study|Physician Decision|0|||
161005540|NCT01236560|581407921|FG000|Overall Study|Withdrawal by Subject|0|||
161005541|NCT01236560|581407922|FG001|Overall Study|Withdrawal by Subject|0|||
161005542|NCT01236560|581407923|FG002|Overall Study|Withdrawal by Subject|1|||
161005543|NCT01236560|581407924|FG003|Overall Study|Withdrawal by Subject|2|||
161005544|NCT01236560|581407925|FG004|Overall Study|Withdrawal by Subject|0|||
161005545|NCT01236560|581407926|FG005|Overall Study|Withdrawal by Subject|0|||
161005546|NCT01236560|581407921|FG000|Overall Study|Progressive disease|5|||
161005547|NCT01236560|581407922|FG001|Overall Study|Progressive disease|19|||
161005548|NCT01236560|581407923|FG002|Overall Study|Progressive disease|9|||
161005549|NCT01236560|581407924|FG003|Overall Study|Progressive disease|16|||
161005550|NCT01236560|581407925|FG004|Overall Study|Progressive disease|0|||
161005551|NCT01236560|581407926|FG005|Overall Study|Progressive disease|0|||
161005552|NCT01576484|581407929|FG000|Overall Study|Adverse Event|1|||
161005553|NCT01576484|581407930|FG001|Overall Study|Adverse Event|1|||
161005554|NCT01576484|581407929|FG000|Overall Study|Protocol Violation|0|||
161005555|NCT01576484|581407930|FG001|Overall Study|Protocol Violation|2|||
161005556|NCT01576484|581407929|FG000|Overall Study|Sponsor Decision|2|||
161005557|NCT01576484|581407930|FG001|Overall Study|Sponsor Decision|8|||
161005558|NCT01576484|581407929|FG000|Overall Study|Withdrawal by Subject|0|||
161005559|NCT01576484|581407930|FG001|Overall Study|Withdrawal by Subject|3|||
161005560|NCT01576484|581407929|FG000|Overall Study|Other|2|||
161005561|NCT01576484|581407930|FG001|Overall Study|Other|5|||
160458558|NCT04163991|579410879|FG001|Overall Study|Adverse Event|0|||
161005562|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
161005563|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
161005564|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
161005565|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
160585237|NCT02052778|579861883|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585238|NCT02052778|579861884|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585239|NCT02052778|579861885|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585240|NCT02052778|579861886|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585241|NCT02052778|579861887|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160966017|NCT00642902|581264790|FG001|Overall Study|Lack of Efficacy|3|||
160966018|NCT00642902|581264791|FG002|Overall Study|Lack of Efficacy|3|||
160966019|NCT00642902|581264792|FG003|Overall Study|Lack of Efficacy|0|||
160966020|NCT00642902|581264789|FG000|Overall Study|Death|1|||
160966021|NCT00642902|581264790|FG001|Overall Study|Death|0|||
160966022|NCT00642902|581264791|FG002|Overall Study|Death|0|||
160966023|NCT00642902|581264792|FG003|Overall Study|Death|0|||
160966024|NCT00642902|581264789|FG000|Overall Study|Premature termination of clinical trial|37|||
160966025|NCT00642902|581264790|FG001|Overall Study|Premature termination of clinical trial|32|||
160966026|NCT00642902|581264791|FG002|Overall Study|Premature termination of clinical trial|35|||
160966027|NCT00642902|581264792|FG003|Overall Study|Premature termination of clinical trial|35|||
160966028|NCT00642902|581264789|FG000|Overall Study|Randomized, but not treated|0|||
160966029|NCT00642902|581264790|FG001|Overall Study|Randomized, but not treated|0|||
160966030|NCT00642902|581264791|FG002|Overall Study|Randomized, but not treated|1|||
160966031|NCT00642902|581264792|FG003|Overall Study|Randomized, but not treated|0|||
160966032|NCT00642902|581264789|FG000|Overall Study|Other|1|||
160966033|NCT00642902|581264790|FG001|Overall Study|Other|5|||
160966034|NCT00642902|581264791|FG002|Overall Study|Other|1|||
160966035|NCT00642902|581264792|FG003|Overall Study|Other|4|||
160966036|NCT03953898|581264793|FG000|Overall Study|Lack of Efficacy|8|||
160966037|NCT03953898|581264793|FG000|Overall Study|Death|3|||
160966038|NCT03953898|581264793|FG000|Overall Study|Withdrawal by Subject|2|||
160966039|NCT03953898|581264793|FG000|Overall Study|Adverse Event|1|||
160966040|NCT01226511|581264796|FG000|Acute Treatment Period|Adverse Event|7|||
160966041|NCT01226511|581264797|FG001|Acute Treatment Period|Adverse Event|6|||
160966042|NCT01226511|581264796|FG000|Acute Treatment Period|Lack of Efficacy|2|||
160966043|NCT01226511|581264797|FG001|Acute Treatment Period|Lack of Efficacy|1|||
160966044|NCT01226511|581264796|FG000|Acute Treatment Period|Lost to Follow-up|3|||
160966045|NCT01226511|581264797|FG001|Acute Treatment Period|Lost to Follow-up|6|||
160966046|NCT01226511|581264796|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
160966047|NCT01226511|581264797|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
160966048|NCT01226511|581264796|FG000|Acute Treatment Period|Protocol Violation|5|||
160966049|NCT01226511|581264797|FG001|Acute Treatment Period|Protocol Violation|5|||
160966050|NCT01226511|581264796|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
160966051|NCT01226511|581264797|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
160966052|NCT01226511|581264796|FG000|Extension Treatment Period|Adverse Event|8|||
160966053|NCT01226511|581264797|FG001|Extension Treatment Period|Adverse Event|8|||
160966054|NCT01226511|581264796|FG000|Extension Treatment Period|Lack of Efficacy|3|||
160966055|NCT01226511|581264797|FG001|Extension Treatment Period|Lack of Efficacy|2|||
160966056|NCT01226511|581264796|FG000|Extension Treatment Period|Lost to Follow-up|4|||
160966057|NCT01226511|581264797|FG001|Extension Treatment Period|Lost to Follow-up|3|||
160966058|NCT01226511|581264796|FG000|Extension Treatment Period|Protocol Violation|2|||
160966059|NCT01226511|581264797|FG001|Extension Treatment Period|Protocol Violation|2|||
160966060|NCT01226511|581264796|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
160966061|NCT01226511|581264797|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
160966062|NCT01226511|581264796|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
160966063|NCT01226511|581264797|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
160966064|NCT01226511|581264796|FG000|Extension Treatment Period|Sponsor Decision|1|||
160966065|NCT01226511|581264797|FG001|Extension Treatment Period|Sponsor Decision|1|||
160966066|NCT01226511|581264796|FG000|Taper Period|Adverse Event|1|||
160966067|NCT01226511|581264797|FG001|Taper Period|Adverse Event|0|||
160966068|NCT01226511|581264796|FG000|Taper Period|Lost to Follow-up|2|||
160966069|NCT01226511|581264797|FG001|Taper Period|Lost to Follow-up|2|||
160966070|NCT01226511|581264796|FG000|Taper Period|Protocol Violation|1|||
160966071|NCT01226511|581264797|FG001|Taper Period|Protocol Violation|0|||
160966072|NCT01226511|581264796|FG000|Taper Period|Parent/Caregiver Decision|1|||
160966073|NCT01226511|581264797|FG001|Taper Period|Parent/Caregiver Decision|1|||
160966074|NCT05267600|581264802|FG000|Overall Study|Adverse Event|1|||
161005566|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
160585242|NCT02052778|579861888|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585243|NCT02052778|579861889|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585244|NCT02052778|579861890|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160966075|NCT05267600|581264803|FG001|Overall Study|Adverse Event|4|||
160966076|NCT05267600|581264802|FG000|Overall Study|Death|1|||
160966077|NCT05267600|581264803|FG001|Overall Study|Death|2|||
160966078|NCT05267600|581264802|FG000|Overall Study|Lack of Efficacy|1|||
160966079|NCT05267600|581264803|FG001|Overall Study|Lack of Efficacy|2|||
160966080|NCT05267600|581264802|FG000|Overall Study|Lost to Follow-up|3|||
160966081|NCT05267600|581264803|FG001|Overall Study|Lost to Follow-up|0|||
160966082|NCT05267600|581264802|FG000|Overall Study|Physician Decision|4|||
160966083|NCT05267600|581264803|FG001|Overall Study|Physician Decision|0|||
160966084|NCT05267600|581264802|FG000|Overall Study|Treatment Unblinded|0|||
160966085|NCT05267600|581264803|FG001|Overall Study|Treatment Unblinded|1|||
160966086|NCT05267600|581264802|FG000|Overall Study|Withdrawal by Subject|5|||
160966087|NCT05267600|581264803|FG001|Overall Study|Withdrawal by Subject|4|||
160966088|NCT01520402|581264806|FG000|Overall Study|Withdrawal by Subject|2|||
160966089|NCT01520402|581264806|FG000|Overall Study|Physician Decision|3|||
160966090|NCT01722162|581264814|FG000|Overall Study|Withdrawal by Subject|1|||
160966091|NCT01722162|581264815|FG001|Overall Study|Withdrawal by Subject|1|||
160966092|NCT01722162|581264814|FG000|Overall Study|Found ineligible|1|||
160966093|NCT01722162|581264815|FG001|Overall Study|Found ineligible|0|||
160966094|NCT01722162|581264814|FG000|Overall Study|Unrelated to study adverse event|2|||
160966095|NCT01722162|581264815|FG001|Overall Study|Unrelated to study adverse event|2|||
160966096|NCT01722162|581264814|FG000|Overall Study|Adverse Event|1|||
160966097|NCT01722162|581264815|FG001|Overall Study|Adverse Event|1|||
160966098|NCT01722162|581264814|FG000|Overall Study|Insurance denial post enrollment|0|||
160966099|NCT01722162|581264815|FG001|Overall Study|Insurance denial post enrollment|1|||
160966100|NCT01722162|581264814|FG000|Overall Study|Noncompliance|0|||
160966101|NCT01722162|581264815|FG001|Overall Study|Noncompliance|1|||
160966102|NCT00643123|581264816|FG000|Overall Study|Lost to Follow-up|4|||
160966103|NCT00643123|581264817|FG001|Overall Study|Lost to Follow-up|0|||
160966104|NCT00643123|581264816|FG000|Overall Study|Withdrawal by Subject|1|||
160966105|NCT00643123|581264817|FG001|Overall Study|Withdrawal by Subject|1|||
160966106|NCT01538472|581264818|FG000|Overall Study|Disease Progression|3|||
160966107|NCT01538472|581264818|FG000|Overall Study|Death|1|||
160966108|NCT02133872|581264819|FG000|Overall Study|Withdrawal by Subject|5|||
160966109|NCT02133872|581264820|FG001|Overall Study|Withdrawal by Subject|3|||
160966110|NCT02133872|581264821|FG002|Overall Study|Withdrawal by Subject|0|||
160966111|NCT02923739|581264822|FG000|Overall Study|Withdrawal by Subject|2|||
160966112|NCT02923739|581264823|FG001|Overall Study|Withdrawal by Subject|0|||
160966113|NCT02923739|581264824|FG002|Overall Study|Withdrawal by Subject|0|||
160966114|NCT02923739|581264825|FG003|Overall Study|Withdrawal by Subject|0|||
160966115|NCT02923739|581264822|FG000|Overall Study|Failed Screening|3|||
160966116|NCT02923739|581264823|FG001|Overall Study|Failed Screening|0|||
160966117|NCT02923739|581264824|FG002|Overall Study|Failed Screening|0|||
160966118|NCT02923739|581264825|FG003|Overall Study|Failed Screening|0|||
160966119|NCT01972529|581264828|FG000|Overall Study|Adverse Event|0|||
160966120|NCT01972529|581264829|FG001|Overall Study|Adverse Event|1|||
160966121|NCT01972529|581264830|FG002|Overall Study|Adverse Event|0|||
160966122|NCT01972529|581264831|FG003|Overall Study|Adverse Event|0|||
160966123|NCT01972529|581264828|FG000|Overall Study|Lost to Follow-up|1|||
160966124|NCT01972529|581264829|FG001|Overall Study|Lost to Follow-up|0|||
160966125|NCT01972529|581264830|FG002|Overall Study|Lost to Follow-up|0|||
160966126|NCT01972529|581264831|FG003|Overall Study|Lost to Follow-up|0|||
160966127|NCT01972529|581264828|FG000|Overall Study|Participant Choice|0|||
160966128|NCT01972529|581264829|FG001|Overall Study|Participant Choice|1|||
160966129|NCT01972529|581264830|FG002|Overall Study|Participant Choice|0|||
160966130|NCT01972529|581264831|FG003|Overall Study|Participant Choice|0|||
160966131|NCT01972529|581264828|FG000|Overall Study|Withdrawl of Consent|1|||
160966132|NCT01972529|581264829|FG001|Overall Study|Withdrawl of Consent|2|||
160966133|NCT01972529|581264830|FG002|Overall Study|Withdrawl of Consent|0|||
160966134|NCT01972529|581264831|FG003|Overall Study|Withdrawl of Consent|1|||
160966135|NCT01972529|581264828|FG000|Overall Study|Other|0|||
160966136|NCT01972529|581264829|FG001|Overall Study|Other|0|||
160966137|NCT01972529|581264830|FG002|Overall Study|Other|0|||
160966138|NCT01972529|581264831|FG003|Overall Study|Other|2|||
160966139|NCT01972529|581264828|FG000|Overall Study|Not treated|0|||
160966140|NCT01972529|581264829|FG001|Overall Study|Not treated|1|||
160966141|NCT01972529|581264830|FG002|Overall Study|Not treated|2|||
160966142|NCT01972529|581264831|FG003|Overall Study|Not treated|1|||
160966143|NCT01889186|581264832|FG000|Overall Study|Adverse event- not related to progression|18|||
160966144|NCT01889186|581264833|FG001|Overall Study|Adverse event- not related to progression|5|||
160966145|NCT01889186|581264832|FG000|Overall Study|Adverse event- related to progression|7|||
160966146|NCT01889186|581264833|FG001|Overall Study|Adverse event- related to progression|2|||
160966147|NCT01889186|581264832|FG000|Overall Study|COVID-19 logistical restrictions|1|||
160966148|NCT01889186|581264833|FG001|Overall Study|COVID-19 logistical restrictions|0|||
160966149|NCT01889186|581264832|FG000|Overall Study|Investigator request|1|||
160966150|NCT01889186|581264833|FG001|Overall Study|Investigator request|1|||
160966151|NCT01889186|581264832|FG000|Overall Study|Progressive disease- Richter's|12|||
160966152|NCT01889186|581264833|FG001|Overall Study|Progressive disease- Richter's|7|||
160966153|NCT01889186|581264832|FG000|Overall Study|Progressive disease per protocol|46|||
160966154|NCT01889186|581264833|FG001|Overall Study|Progressive disease per protocol|17|||
160966155|NCT01889186|581264832|FG000|Overall Study|Stem cell transplant|2|||
160966156|NCT01889186|581264833|FG001|Overall Study|Stem cell transplant|1|||
160966157|NCT01889186|581264832|FG000|Overall Study|Withdrew consent|2|||
160966158|NCT01889186|581264833|FG001|Overall Study|Withdrew consent|3|||
160966159|NCT01889186|581264832|FG000|Overall Study|Other, not specified|18|||
161005567|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
161005568|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
161005569|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
161005570|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
161005571|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
161005572|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
161005573|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
161005574|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
161005575|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
161005576|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
161005577|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
161005578|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
161005579|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
161005580|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
161005581|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
161005582|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
161005583|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
161005584|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
161005585|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
161005586|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Death|1|||
161005587|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Death|0|||
161005588|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Death|0|||
161005589|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
161005590|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
161005591|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
161005592|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
161005593|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
161005594|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
161005595|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
161005596|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
161005597|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
161005598|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
161005599|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
161005600|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
161005601|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
161005602|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
161005603|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
161005604|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
161005605|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
161005606|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
161005607|NCT00396084|581407936|FG000|Overall Study|Adverse Event|0|||
161005608|NCT00396084|581407937|FG001|Overall Study|Adverse Event|0|||
161005609|NCT00396084|581407938|FG002|Overall Study|Adverse Event|0|||
161005610|NCT00396084|581407939|FG003|Overall Study|Adverse Event|0|||
161005611|NCT00396084|581407940|FG004|Overall Study|Adverse Event|1|||
161005612|NCT00396084|581407941|FG005|Overall Study|Adverse Event|2|||
161005613|NCT00396084|581407936|FG000|Overall Study|Withdrawal by Subject|0|||
161005614|NCT00396084|581407937|FG001|Overall Study|Withdrawal by Subject|0|||
161005615|NCT00396084|581407938|FG002|Overall Study|Withdrawal by Subject|0|||
161005616|NCT00396084|581407939|FG003|Overall Study|Withdrawal by Subject|1|||
161005617|NCT00396084|581407940|FG004|Overall Study|Withdrawal by Subject|0|||
161005618|NCT00396084|581407941|FG005|Overall Study|Withdrawal by Subject|0|||
161005619|NCT04009577|581407942|FG000|Core Study|Adverse Event|1|||
161005620|NCT04009577|581407943|FG001|Core Study|Adverse Event|0|||
161005621|NCT04009577|581407944|FG002|Core Study|Adverse Event|2|||
161005622|NCT04009577|581407945|FG003|Core Study|Adverse Event|4|||
161005623|NCT04009577|581407942|FG000|Core Study|Withdrawal by Subject|0|||
161005624|NCT04009577|581407943|FG001|Core Study|Withdrawal by Subject|0|||
161005625|NCT04009577|581407944|FG002|Core Study|Withdrawal by Subject|2|||
160458559|NCT04163991|579410880|FG002|Overall Study|Adverse Event|0|||
161005626|NCT04009577|581407945|FG003|Core Study|Withdrawal by Subject|0|||
161005627|NCT04009577|581407942|FG000|Core Study|Other|0|||
161005628|NCT04009577|581407943|FG001|Core Study|Other|0|||
161005629|NCT04009577|581407944|FG002|Core Study|Other|0|||
161005630|NCT04009577|581407945|FG003|Core Study|Other|1|||
161005631|NCT04009577|581407942|FG000|Extension Phase|Adverse Event|0|||
161005632|NCT04009577|581407943|FG001|Extension Phase|Adverse Event|0|||
161005633|NCT04009577|581407944|FG002|Extension Phase|Adverse Event|0|||
161005634|NCT04009577|581407945|FG003|Extension Phase|Adverse Event|1|||
161005635|NCT04009577|581407942|FG000|Extension Phase|Inadequate therapeutic effect|0|||
161005636|NCT04009577|581407943|FG001|Extension Phase|Inadequate therapeutic effect|0|||
161005637|NCT04009577|581407944|FG002|Extension Phase|Inadequate therapeutic effect|1|||
161005638|NCT04009577|581407945|FG003|Extension Phase|Inadequate therapeutic effect|0|||
161005639|NCT04009577|581407942|FG000|Extension Phase|Withdrawal by Subject|0|||
161005640|NCT04009577|581407943|FG001|Extension Phase|Withdrawal by Subject|0|||
161005641|NCT04009577|581407944|FG002|Extension Phase|Withdrawal by Subject|1|||
161005642|NCT04009577|581407945|FG003|Extension Phase|Withdrawal by Subject|0|||
161005643|NCT04009577|581407942|FG000|Extension Phase|Not Treated|0|||
161005644|NCT04009577|581407943|FG001|Extension Phase|Not Treated|0|||
161005645|NCT04009577|581407944|FG002|Extension Phase|Not Treated|2|||
161005646|NCT04009577|581407945|FG003|Extension Phase|Not Treated|0|||
161005647|NCT01832480|581407946|FG000|Overall Study|Lost to Follow-up|33|||
161005648|NCT01832480|581407947|FG001|Overall Study|Lost to Follow-up|30|||
161005649|NCT01832480|581407946|FG000|Overall Study|Withdrawal by Subject|0|||
161005650|NCT01832480|581407947|FG001|Overall Study|Withdrawal by Subject|2|||
161005651|NCT01832480|581407946|FG000|Overall Study|post randomization ineligible|8|||
161005652|NCT01832480|581407947|FG001|Overall Study|post randomization ineligible|10|||
161005653|NCT02674750|581407952|FG000|Overall Study|Death|4|||
161005654|NCT02674750|581407953|FG001|Overall Study|Death|5|||
161005655|NCT02674750|581407954|FG002|Overall Study|Death|8|||
161005656|NCT02674750|581407952|FG000|Overall Study|Lost to Follow-up|0|||
161005657|NCT02674750|581407953|FG001|Overall Study|Lost to Follow-up|8|||
161005658|NCT02674750|581407954|FG002|Overall Study|Lost to Follow-up|0|||
161005659|NCT02674750|581407952|FG000|Overall Study|Lack of Efficacy|1|||
161005660|NCT02674750|581407953|FG001|Overall Study|Lack of Efficacy|17|||
161005661|NCT02674750|581407954|FG002|Overall Study|Lack of Efficacy|3|||
161005662|NCT02674750|581407952|FG000|Overall Study|Withdrawal by Subject|0|||
161005663|NCT02674750|581407953|FG001|Overall Study|Withdrawal by Subject|7|||
161005664|NCT02674750|581407954|FG002|Overall Study|Withdrawal by Subject|1|||
161005665|NCT02674750|581407952|FG000|Overall Study|Other|0|||
161005666|NCT02674750|581407953|FG001|Overall Study|Other|8|||
161005667|NCT02674750|581407954|FG002|Overall Study|Other|0|||
161005668|NCT01685606|581407957|FG000|Overall Study|Withdrawal by Subject|1|||
161005669|NCT01353963|581407958|FG000|Overall Study|Adverse Event|2|||
161005670|NCT02079844|581407959|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
161005671|NCT02079844|581407960|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
161005672|NCT02079844|581407961|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
161005673|NCT02079844|581407959|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
161005674|NCT02079844|581407960|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
161005675|NCT02079844|581407961|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
161005676|NCT01420549|581407962|FG000|Overall Study|Adverse Event|1|||
161005677|NCT01420549|581407963|FG001|Overall Study|Adverse Event|1|||
161005678|NCT01420549|581407962|FG000|Overall Study|Lost to Follow-up|2|||
161005679|NCT01420549|581407963|FG001|Overall Study|Lost to Follow-up|2|||
161005680|NCT01420549|581407962|FG000|Overall Study|Protocol Violation|0|||
161005681|NCT01420549|581407963|FG001|Overall Study|Protocol Violation|1|||
161005682|NCT01420549|581407962|FG000|Overall Study|Non-adherence to medication|4|||
161005683|NCT01420549|581407963|FG001|Overall Study|Non-adherence to medication|1|||
161005684|NCT03394885|581407964|FG000|Overall Study|Adverse Event|4|||
161005685|NCT03394885|581407964|FG000|Overall Study|Lack of Efficacy|1|||
161005686|NCT03394885|581407964|FG000|Overall Study|Physician Decision|1|||
161005687|NCT03394885|581407964|FG000|Overall Study|Withdrawal by Subject|8|||
161005688|NCT03394885|581407964|FG000|Overall Study|Alternative Therapy|1|||
161005689|NCT00203411|581407965|FG000|Follow-up|Progressive Disease|4|||
161005690|NCT04980755|581407966|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
161005691|NCT04980755|581407966|FG000|Body Reprogramming Courses|Work commitment|2|||
161005692|NCT04980755|581407966|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
161005693|NCT04980755|581407966|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
161005694|NCT00632424|581407971|FG000|Overall Study|Disease Progression|17|||
161005695|NCT00632424|581407971|FG000|Overall Study|Study Drug Toxicity|1|||
161005696|NCT05985044|581409164|FG000|Overall Study|Death|6|||
161005697|NCT05985044|581409164|FG000|Overall Study|Lost to Follow-up|4|||
161005698|NCT05985044|581409164|FG000|Overall Study|Incapacitation|3|||
161005699|NCT05985044|581409164|FG000|Overall Study|Withdrawal by Subject|2|||
161005700|NCT02279095|581409167|FG000|Overall Study|Non-Compliance|1|||
161005701|NCT02279095|581409167|FG000|Overall Study|Withdrawal by Subject|8|||
161005702|NCT02279095|581409167|FG000|Overall Study|Adverse Event|2|||
161005703|NCT02279095|581409167|FG000|Overall Study|Other|7|||
161005704|NCT02279095|581409167|FG000|Overall Study|Lost to Follow-up|1|||
161005705|NCT05672667|581409171|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
161005706|NCT04524390|581409172|FG000|Double Blind|Consent Withdrawal by subject|2|||
161005707|NCT04524390|581409173|FG001|Double Blind|Consent Withdrawal by subject|1|||
161005708|NCT04524390|581409174|FG002|Double Blind|Consent Withdrawal by subject|0|||
161005709|NCT04524390|581409172|FG000|Double Blind|Adverse Event|5|||
161005710|NCT04524390|581409173|FG001|Double Blind|Adverse Event|3|||
161005711|NCT04524390|581409174|FG002|Double Blind|Adverse Event|0|||
161005712|NCT04524390|581409172|FG000|Double Blind|Liver Transplant|5|||
161005713|NCT04524390|581409173|FG001|Double Blind|Liver Transplant|6|||
161005714|NCT04524390|581409174|FG002|Double Blind|Liver Transplant|0|||
161005715|NCT04524390|581409172|FG000|Double Blind|Disease Progression|0|||
161005716|NCT04524390|581409173|FG001|Double Blind|Disease Progression|1|||
161005717|NCT04524390|581409174|FG002|Double Blind|Disease Progression|0|||
161005718|NCT04524390|581409172|FG000|Open-Label|Drug interruption criteria|0|||
161005719|NCT04524390|581409173|FG001|Open-Label|Drug interruption criteria|0|||
161005720|NCT04524390|581409174|FG002|Open-Label|Drug interruption criteria|1|||
161005721|NCT04524390|581409172|FG000|Open-Label|Liver Transplant|0|||
161005722|NCT04524390|581409173|FG001|Open-Label|Liver Transplant|0|||
161005723|NCT04524390|581409174|FG002|Open-Label|Liver Transplant|1|||
161005724|NCT04524390|581409172|FG000|Open-Label|Disease Progression|0|||
161005725|NCT04524390|581409173|FG001|Open-Label|Disease Progression|0|||
161005726|NCT04524390|581409174|FG002|Open-Label|Disease Progression|1|||
161005727|NCT04524390|581409172|FG000|Open-Label|Adverse Event|0|||
161005728|NCT04524390|581409173|FG001|Open-Label|Adverse Event|0|||
161005729|NCT04524390|581409174|FG002|Open-Label|Adverse Event|3|||
161005730|NCT04524390|581409172|FG000|Open-Label|Study Termination by sponsor|0|||
161005731|NCT04524390|581409173|FG001|Open-Label|Study Termination by sponsor|0|||
161005732|NCT04524390|581409174|FG002|Open-Label|Study Termination by sponsor|45|||
161005733|NCT03613740|581409175|FG000|Overall Study|Lost to Follow-up|1|||
161005734|NCT03613740|581409176|FG001|Overall Study|Lost to Follow-up|1|||
161005735|NCT01693120|581409177|FG000|Enrollment|Lost to Follow-up|1|||
161005736|NCT01693120|581409177|FG000|Enrollment|Withdrawal by Subject|10|||
161005737|NCT01693120|581409177|FG000|Enrollment|Protocol Violation|46|||
161005738|NCT01693120|581409177|FG000|Enrollment|Physician Decision|3|||
161005739|NCT01693120|581409177|FG000|Enrollment|Adverse Event|1|||
161005740|NCT01693120|581409177|FG000|Enrollment|Study closed|8|||
161005741|NCT01693120|581409177|FG000|Enrollment|Other|1|||
161005742|NCT01693120|581409177|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
161005743|NCT01693120|581409177|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
161005744|NCT01693120|581409177|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
161005745|NCT01693120|581409177|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
161005746|NCT01693120|581409177|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
161005747|NCT02300298|581409181|FG000|Disposition for Nintedanib|Progressive disease|10|||
161005748|NCT02300298|581409182|FG001|Disposition for Nintedanib|Progressive disease|0|||
161005749|NCT02300298|581409181|FG000|Disposition for Docetaxel|Progressive disease|0|||
161005750|NCT02300298|581409182|FG001|Disposition for Docetaxel|Progressive disease|6|||
161005751|NCT02300298|581409181|FG000|Disposition for Docetaxel|other adverse event|0|||
161005752|NCT02300298|581409182|FG001|Disposition for Docetaxel|other adverse event|4|||
161005753|NCT03452189|581409184|FG000|First Intervention (3 Months)|Adverse Event|1|||
161005754|NCT03452189|581409185|FG001|First Intervention (3 Months)|Adverse Event|0|||
161005755|NCT03452189|581409184|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
161005756|NCT03452189|581409185|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
161005757|NCT02724592|581409186|FG000|Overall Study|Lost to Follow-up|4|||
161005758|NCT02724592|581409187|FG001|Overall Study|Lost to Follow-up|1|||
161005759|NCT01951170|581409188|FG000|Overall Study|Investigator decision|1|||
161005760|NCT04723394|581409199|FG000|Overall Study|Adverse Event|0|||
161005761|NCT04723394|581409200|FG001|Overall Study|Adverse Event|3|||
161005762|NCT04723394|581409199|FG000|Overall Study|Death|8|||
161005763|NCT04723394|581409200|FG001|Overall Study|Death|8|||
161005764|NCT04723394|581409199|FG000|Overall Study|Lost to Follow-up|20|||
161005765|NCT04723394|581409200|FG001|Overall Study|Lost to Follow-up|17|||
161005766|NCT04723394|581409199|FG000|Overall Study|Physician Decision|1|||
161005767|NCT04723394|581409200|FG001|Overall Study|Physician Decision|0|||
161005768|NCT04723394|581409199|FG000|Overall Study|Withdrawal by Subject|20|||
161005769|NCT04723394|581409200|FG001|Overall Study|Withdrawal by Subject|34|||
161005770|NCT04723394|581409199|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
161005771|NCT04723394|581409200|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
161005772|NCT00077675|581409202|FG000|Overall Study|Adverse Event|1|||
161005773|NCT00077675|581409203|FG001|Overall Study|Adverse Event|2|||
160585245|NCT02052778|579861891|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585246|NCT02052778|579861892|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161005774|NCT00077675|581409202|FG000|Overall Study|Lost to Follow-up|6|||
161005775|NCT00077675|581409203|FG001|Overall Study|Lost to Follow-up|3|||
161005776|NCT00077675|581409202|FG000|Overall Study|Withdrawal by Subject|1|||
161005777|NCT00077675|581409203|FG001|Overall Study|Withdrawal by Subject|0|||
161005778|NCT00077675|581409202|FG000|Overall Study|Other|0|||
161005779|NCT00077675|581409203|FG001|Overall Study|Other|1|||
161005780|NCT00077675|581409202|FG000|Overall Study|Never received study treatment|3|||
161005781|NCT00077675|581409203|FG001|Overall Study|Never received study treatment|3|||
161005782|NCT02597920|581409205|FG000|Overall Study|Worsening of other pre-existing disease|0|||
161005783|NCT02597920|581409206|FG001|Overall Study|Worsening of other pre-existing disease|1|||
161005784|NCT02597920|581409207|FG002|Overall Study|Worsening of other pre-existing disease|0|||
161005785|NCT02597920|581409205|FG000|Overall Study|Other adverse event|20|||
161005786|NCT02597920|581409206|FG001|Overall Study|Other adverse event|30|||
161005787|NCT02597920|581409207|FG002|Overall Study|Other adverse event|0|||
161005788|NCT02597920|581409205|FG000|Overall Study|Lost to Follow-up|7|||
160585247|NCT02052778|579861893|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585248|NCT02052778|579861894|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161005789|NCT02597920|581409206|FG001|Overall Study|Lost to Follow-up|9|||
161005790|NCT02597920|581409207|FG002|Overall Study|Lost to Follow-up|0|||
161005791|NCT02597920|581409205|FG000|Overall Study|Refuse to continue in the study|3|||
161005792|NCT02597920|581409206|FG001|Overall Study|Refuse to continue in the study|13|||
161005793|NCT02597920|581409207|FG002|Overall Study|Refuse to continue in the study|1|||
161005794|NCT02597920|581409205|FG000|Overall Study|Other than specified|10|||
161005795|NCT02597920|581409206|FG001|Overall Study|Other than specified|31|||
161005796|NCT02597920|581409207|FG002|Overall Study|Other than specified|5|||
161005797|NCT02597920|581409205|FG000|Overall Study|Other|1|||
161005798|NCT02597920|581409206|FG001|Overall Study|Other|0|||
161005799|NCT02597920|581409207|FG002|Overall Study|Other|0|||
161005800|NCT04532528|581409211|FG000|Overall Study|Adverse Event|12|||
161005801|NCT04532528|581409212|FG001|Overall Study|Adverse Event|17|||
161005802|NCT04532528|581409211|FG000|Overall Study|Withdrawal of consent|16|||
161005803|NCT04532528|581409212|FG001|Overall Study|Withdrawal of consent|17|||
161005804|NCT04532528|581409211|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
161005805|NCT04532528|581409212|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
161005806|NCT04532528|581409211|FG000|Overall Study|Lost to Follow-up|69|||
161005807|NCT04532528|581409212|FG001|Overall Study|Lost to Follow-up|68|||
161005808|NCT04532528|581409211|FG000|Overall Study|Administrative problems|12|||
161005809|NCT04532528|581409212|FG001|Overall Study|Administrative problems|14|||
161005810|NCT04532528|581409211|FG000|Overall Study|Death|3|||
161005811|NCT04532528|581409212|FG001|Overall Study|Death|3|||
161005812|NCT04532528|581409211|FG000|Overall Study|Other|38|||
161005813|NCT04532528|581409212|FG001|Overall Study|Other|46|||
161005814|NCT00668863|581409217|FG000|Overall Study|Objective Progression or Relapse|42|||
161005815|NCT00668863|581409217|FG000|Overall Study|Adverse Event|13|||
161005816|NCT00668863|581409217|FG000|Overall Study|Study Terminated by Sponsor|8|||
161005817|NCT00668863|581409217|FG000|Overall Study|Global Deterioration of Health Status|4|||
161005818|NCT00668863|581409217|FG000|Overall Study|Withdrawal by Subject|1|||
161005819|NCT00668863|581409217|FG000|Overall Study|Surgery|1|||
161005820|NCT00668863|581409217|FG000|Overall Study|Subject's work scheduling problem|1|||
161005821|NCT00668863|581409217|FG000|Overall Study|Physician Decision|1|||
161005822|NCT00665444|581409218|FG000|Overall Study|Physician Decision|1|||
161005823|NCT00665444|581409218|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
161005824|NCT01068743|581409221|FG000|Period 3|Adverse Event|0|||
161005825|NCT01068743|581409222|FG001|Period 3|Adverse Event|1|||
161005826|NCT01068743|581409223|FG002|Period 3|Adverse Event|0|||
161005827|NCT01068743|581409224|FG003|Period 3|Adverse Event|0|||
161005828|NCT00293293|581409225|FG000|Overall Study|Withdrawal by Subject|1|||
161005829|NCT00293293|581409226|FG001|Overall Study|Withdrawal by Subject|1|||
161005830|NCT00293293|581409225|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
161005831|NCT00293293|581409226|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
161005832|NCT00293293|581409225|FG000|Overall Study|Patient discontinued chemotherapy|0|||
161005833|NCT00293293|581409226|FG001|Overall Study|Patient discontinued chemotherapy|1|||
161005834|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
161005835|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
161005836|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
161005837|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
161005838|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
160585249|NCT02052778|579861895|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585250|NCT02052778|579861896|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585251|NCT02052778|579861897|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
160585252|NCT02052778|579861898|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
160585253|NCT02052778|579861876|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161005839|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
161005840|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
161005841|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
161005842|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
161005843|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
161005844|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
161005845|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
161005846|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
161005847|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
161005848|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
161005849|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
161005850|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
161005851|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
161005852|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
161005853|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
161005854|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
161005855|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
161005856|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
161005857|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
161005858|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
161005859|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
161005860|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
161005861|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
161005862|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
161005863|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
161005864|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
161005865|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
161005866|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
161005867|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
161005868|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
161005869|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
161005870|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
161005871|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
161005872|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
161005873|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
161005874|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
161005875|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
161005876|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
161005877|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
161005878|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
161005879|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
161005880|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
160585254|NCT02052778|579861877|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585255|NCT02052778|579861878|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585256|NCT02052778|579861879|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161005881|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
161005882|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
161005883|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
161005884|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
161005885|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
161005886|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
161005887|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
161005888|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
161005889|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
160585257|NCT02052778|579861880|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585258|NCT02052778|579861881|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160458560|NCT04163991|579410881|FG003|Overall Study|Adverse Event|1|||
160585259|NCT02052778|579861882|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585260|NCT02052778|579861883|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585261|NCT02052778|579861884|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585262|NCT02052778|579861885|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585263|NCT02052778|579861886|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585264|NCT02052778|579861887|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585265|NCT02052778|579861888|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585266|NCT02052778|579861889|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585267|NCT02052778|579861890|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585268|NCT02052778|579861891|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585269|NCT02052778|579861892|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160458561|NCT04163991|579410882|FG004|Overall Study|Adverse Event|0|||
160458562|NCT04163991|579410878|FG000|Overall Study|Death|0|||
160458563|NCT04163991|579410879|FG001|Overall Study|Death|0|||
160458564|NCT04163991|579410880|FG002|Overall Study|Death|1|||
160458565|NCT04163991|579410881|FG003|Overall Study|Death|0|||
160458566|NCT04163991|579410882|FG004|Overall Study|Death|0|||
160458567|NCT04163991|579410878|FG000|Overall Study|Lost to Follow-up|0|||
160458568|NCT04163991|579410879|FG001|Overall Study|Lost to Follow-up|1|||
160458569|NCT04163991|579410880|FG002|Overall Study|Lost to Follow-up|0|||
160585270|NCT02052778|579861893|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585271|NCT02052778|579861894|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585272|NCT02052778|579861895|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585273|NCT02052778|579861896|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585274|NCT02052778|579861897|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
160585275|NCT02052778|579861898|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
160585276|NCT02052778|579861876|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160966160|NCT01889186|581264833|FG001|Overall Study|Other, not specified|15|||
160966161|NCT00118716|581264835|FG000|Overall Study|Adverse Event|2|||
160966162|NCT00118716|581264836|FG001|Overall Study|Adverse Event|7|||
160966163|NCT00118716|581264835|FG000|Overall Study|Protocol Violation|5|||
160966164|NCT00118716|581264836|FG001|Overall Study|Protocol Violation|4|||
160966165|NCT00118716|581264835|FG000|Overall Study|Withdrawal by Subject|0|||
160966166|NCT00118716|581264836|FG001|Overall Study|Withdrawal by Subject|1|||
160966167|NCT00118716|581264835|FG000|Overall Study|Exacerbation|2|||
160966168|NCT00118716|581264836|FG001|Overall Study|Exacerbation|2|||
160966169|NCT00118716|581264835|FG000|Overall Study|Discontinued by sponsor|1|||
160966170|NCT00118716|581264836|FG001|Overall Study|Discontinued by sponsor|1|||
160966171|NCT00118716|581264835|FG000|Overall Study|Non-compliance|1|||
160966172|NCT00118716|581264836|FG001|Overall Study|Non-compliance|3|||
160966173|NCT00118716|581264835|FG000|Overall Study|misrandomized|1|||
160966174|NCT00118716|581264836|FG001|Overall Study|misrandomized|1|||
160966175|NCT00118716|581264835|FG000|Overall Study|Expired drug use|1|||
160966176|NCT00118716|581264836|FG001|Overall Study|Expired drug use|2|||
160966177|NCT00118716|581264835|FG000|Overall Study|Investigator discretion|0|||
160966178|NCT00118716|581264836|FG001|Overall Study|Investigator discretion|1|||
160966179|NCT00855062|581264838|FG000|Step1|Early Study Closure|5|||
160966180|NCT00855062|581264839|FG001|Step1|Early Study Closure|7|||
160966181|NCT00855062|581264838|FG000|Step1|Adverse Event|1|||
160966182|NCT00855062|581264839|FG001|Step1|Adverse Event|1|||
160966183|NCT00855062|581264838|FG000|Step1|Protocol Violation|1|||
160966184|NCT00855062|581264839|FG001|Step1|Protocol Violation|0|||
160966185|NCT00855062|581264838|FG000|Step1|Pregnancy|1|||
160966186|NCT00855062|581264839|FG001|Step1|Pregnancy|0|||
160966187|NCT00855062|581264838|FG000|Step1|Withdrawal by Subject|2|||
160966188|NCT00855062|581264839|FG001|Step1|Withdrawal by Subject|3|||
160966189|NCT00855062|581264838|FG000|Step2|Early Study Closure|6|||
160966190|NCT00855062|581264839|FG001|Step2|Early Study Closure|2|||
160966191|NCT00855062|581264838|FG000|Step2|Adverse Event|0|||
160966192|NCT00855062|581264839|FG001|Step2|Adverse Event|3|||
160966193|NCT00855062|581264838|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
160966194|NCT00855062|581264839|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
160966195|NCT02110901|581264840|FG000|Overall Study|Death|6|||
160966196|NCT02110901|581264841|FG001|Overall Study|Death|3|||
160966197|NCT02110901|581264840|FG000|Overall Study|Lost to Follow-up|12|||
160966198|NCT02110901|581264841|FG001|Overall Study|Lost to Follow-up|8|||
160966199|NCT02110901|581264840|FG000|Overall Study|Withdrawal by Subject|7|||
160966200|NCT02110901|581264841|FG001|Overall Study|Withdrawal by Subject|3|||
160966201|NCT02110901|581264840|FG000|Overall Study|received a kidney transplant|5|||
160966202|NCT02110901|581264841|FG001|Overall Study|received a kidney transplant|0|||
160966203|NCT00855595|581264843|FG000|Overall Study|Withdrawal by Subject|1|||
160966204|NCT00855595|581264844|FG001|Overall Study|Withdrawal by Subject|2|||
160966205|NCT00855595|581264843|FG000|Overall Study|Lost to Follow-up|3|||
160966206|NCT00855595|581264844|FG001|Overall Study|Lost to Follow-up|3|||
160966207|NCT00855595|581264843|FG000|Overall Study|Adverse Event|1|||
160966208|NCT00855595|581264844|FG001|Overall Study|Adverse Event|1|||
160966209|NCT00855595|581264843|FG000|Overall Study|patient moved out of state|1|||
160966210|NCT00855595|581264844|FG001|Overall Study|patient moved out of state|0|||
160966211|NCT00855595|581264843|FG000|Overall Study|patient left country|0|||
161005890|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
160966212|NCT00855595|581264844|FG001|Overall Study|patient left country|1|||
160966213|NCT02755597|581264845|FG000|Overall Study|Withdrew consent|27|||
160966214|NCT02755597|581264846|FG001|Overall Study|Withdrew consent|11|||
160966215|NCT02755597|581264845|FG000|Overall Study|Lost to Follow-up|1|||
160966216|NCT02755597|581264846|FG001|Overall Study|Lost to Follow-up|0|||
161005891|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
160966217|NCT02755597|581264845|FG000|Overall Study|Death|78|||
160966218|NCT02755597|581264846|FG001|Overall Study|Death|36|||
160966219|NCT02755597|581264845|FG000|Overall Study|Study terminated by Sponsor|67|||
160966220|NCT02755597|581264846|FG001|Overall Study|Study terminated by Sponsor|47|||
160966221|NCT02755597|581264845|FG000|Overall Study|Other, not specified|20|||
160966222|NCT02755597|581264846|FG001|Overall Study|Other, not specified|3|||
160966223|NCT02755597|581264845|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
160966224|NCT02755597|581264846|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
160966225|NCT04581200|581264847|FG000|Overall Study|Lost to Follow-up|6|||
160966226|NCT04581200|581264848|FG001|Overall Study|Lost to Follow-up|5|||
160966227|NCT04711603|581264849|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
161005892|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
161005893|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
161005894|NCT03740009|581409231|FG000|Overall Study|Physician Decision|9|||
161005895|NCT03740009|581409231|FG000|Overall Study|Lost to Follow-up|1|||
161005896|NCT00960141|581409236|FG000|Overall Study|Adverse Event|4|||
161005897|NCT00960141|581409237|FG001|Overall Study|Adverse Event|8|||
161005898|NCT00960141|581409238|FG002|Overall Study|Adverse Event|2|||
161005899|NCT00960141|581409236|FG000|Overall Study|Lack of Efficacy|3|||
161005900|NCT00960141|581409237|FG001|Overall Study|Lack of Efficacy|4|||
161005901|NCT00960141|581409238|FG002|Overall Study|Lack of Efficacy|2|||
161005902|NCT00960141|581409236|FG000|Overall Study|Lost to Follow-up|1|||
161005903|NCT00960141|581409237|FG001|Overall Study|Lost to Follow-up|0|||
161005904|NCT00960141|581409238|FG002|Overall Study|Lost to Follow-up|0|||
161005905|NCT00960141|581409236|FG000|Overall Study|Protocol Violation|1|||
161005906|NCT00960141|581409237|FG001|Overall Study|Protocol Violation|3|||
161005907|NCT00960141|581409238|FG002|Overall Study|Protocol Violation|2|||
161005908|NCT00960141|581409236|FG000|Overall Study|Withdrawal by Subject|1|||
161005909|NCT00960141|581409237|FG001|Overall Study|Withdrawal by Subject|2|||
161005910|NCT00960141|581409238|FG002|Overall Study|Withdrawal by Subject|1|||
161005911|NCT03036813|581409239|FG000|Overall Study|Adverse Event|6|||
161005912|NCT03036813|581409240|FG001|Overall Study|Adverse Event|11|||
161005913|NCT03036813|581409241|FG002|Overall Study|Adverse Event|6|||
161005914|NCT03036813|581409239|FG000|Overall Study|Withdrawal by Subject|12|||
161005915|NCT03036813|581409240|FG001|Overall Study|Withdrawal by Subject|6|||
161005916|NCT03036813|581409241|FG002|Overall Study|Withdrawal by Subject|10|||
161005917|NCT03036813|581409239|FG000|Overall Study|Lost to Follow-up|1|||
161005918|NCT03036813|581409240|FG001|Overall Study|Lost to Follow-up|1|||
161005919|NCT03036813|581409241|FG002|Overall Study|Lost to Follow-up|0|||
160458570|NCT04163991|579410881|FG003|Overall Study|Lost to Follow-up|0|||
160458571|NCT04163991|579410882|FG004|Overall Study|Lost to Follow-up|0|||
160458572|NCT04163991|579410878|FG000|Overall Study|Withdrawal by Subject|1|||
160458573|NCT04163991|579410879|FG001|Overall Study|Withdrawal by Subject|1|||
160458574|NCT04163991|579410880|FG002|Overall Study|Withdrawal by Subject|3|||
160458575|NCT04163991|579410881|FG003|Overall Study|Withdrawal by Subject|1|||
160458576|NCT04163991|579410882|FG004|Overall Study|Withdrawal by Subject|1|||
160458577|NCT04163991|579410878|FG000|Overall Study|Other, Not Specified|0|||
160458578|NCT04163991|579410879|FG001|Overall Study|Other, Not Specified|1|||
160458579|NCT04163991|579410880|FG002|Overall Study|Other, Not Specified|1|||
160458580|NCT04163991|579410881|FG003|Overall Study|Other, Not Specified|1|||
160458581|NCT04163991|579410882|FG004|Overall Study|Other, Not Specified|0|||
160458582|NCT05953740|579410883|FG000|Period 1|Physician Decision|0|||
160458583|NCT05953740|579410884|FG001|Period 1|Physician Decision|1|||
160458584|NCT05953740|579410885|FG002|Period 1|Physician Decision|0|||
160458585|NCT05953740|579410886|FG003|Period 1|Physician Decision|0|||
160458586|NCT05953740|579410887|FG004|Period 1|Physician Decision|0|||
160458587|NCT05953740|579410888|FG005|Period 1|Physician Decision|0|||
160458588|NCT05953740|579410889|FG006|Period 1|Physician Decision|0|||
160458589|NCT05953740|579410890|FG007|Period 1|Physician Decision|0|||
160458590|NCT05953740|579410883|FG000|Period 2|Withdrawal by Subject|0|||
160458591|NCT05953740|579410884|FG001|Period 2|Withdrawal by Subject|1|||
160458592|NCT05953740|579410885|FG002|Period 2|Withdrawal by Subject|1|||
160458593|NCT05953740|579410886|FG003|Period 2|Withdrawal by Subject|0|||
160458594|NCT05953740|579410887|FG004|Period 2|Withdrawal by Subject|0|||
160458595|NCT05953740|579410888|FG005|Period 2|Withdrawal by Subject|0|||
160458596|NCT05953740|579410889|FG006|Period 2|Withdrawal by Subject|0|||
160458597|NCT05953740|579410890|FG007|Period 2|Withdrawal by Subject|0|||
160458598|NCT03880955|579410891|FG000|Overall Study|Adverse Event|1|||
160458599|NCT03880955|579410891|FG000|Overall Study|Death|1|||
160458600|NCT03880955|579410891|FG000|Overall Study|Lost to Follow-up|12|||
160458601|NCT03880955|579410891|FG000|Overall Study|Withdrawal by Subject|4|||
160458602|NCT03880955|579410891|FG000|Overall Study|Missing- Study Site Closed|27|||
160458603|NCT02510235|579410893|FG000|Overall Study|Withdrawal by Subject|1|||
161005920|NCT03036813|581409239|FG000|Overall Study|Physician Decision|2|||
161005921|NCT03036813|581409240|FG001|Overall Study|Physician Decision|1|||
161005922|NCT03036813|581409241|FG002|Overall Study|Physician Decision|1|||
161005923|NCT03036813|581409239|FG000|Overall Study|Non-Compliance|1|||
161005924|NCT03036813|581409240|FG001|Overall Study|Non-Compliance|5|||
160458604|NCT02510235|579410894|FG001|Overall Study|Withdrawal by Subject|0|||
160458605|NCT00450216|579410895|FG000|Overall Study|Adverse Event|38|||
160458606|NCT00450216|579410896|FG001|Overall Study|Adverse Event|23|||
160458607|NCT00450216|579410895|FG000|Overall Study|Withdrawal by Subject|48|||
160585277|NCT02052778|579861877|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161005925|NCT03036813|581409241|FG002|Overall Study|Non-Compliance|3|||
160458608|NCT00450216|579410896|FG001|Overall Study|Withdrawal by Subject|26|||
160458609|NCT00450216|579410895|FG000|Overall Study|Lost to Follow-up|16|||
160458610|NCT00450216|579410896|FG001|Overall Study|Lost to Follow-up|9|||
160458611|NCT00450216|579410895|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
160458612|NCT00450216|579410896|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
161005926|NCT03036813|581409239|FG000|Overall Study|Pregnancy|0|||
160966228|NCT04711603|581264850|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
160966229|NCT04711603|581264851|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
160966230|NCT04711603|581264852|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
160966231|NCT04711603|581264849|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
160966232|NCT04711603|581264850|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
160966233|NCT04711603|581264851|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
161005927|NCT03036813|581409240|FG001|Overall Study|Pregnancy|0|||
161005928|NCT03036813|581409241|FG002|Overall Study|Pregnancy|1|||
161005929|NCT03036813|581409239|FG000|Overall Study|Other|0|||
161005930|NCT03036813|581409240|FG001|Overall Study|Other|3|||
161005931|NCT03036813|581409241|FG002|Overall Study|Other|5|||
161005932|NCT01102231|581409242|FG000|Overall Study|Protocol Violation|3|||
161005933|NCT01102231|581409242|FG000|Overall Study|Lack of Efficacy|2|||
161005934|NCT01102231|581409242|FG000|Overall Study|Death|2|||
161005935|NCT01102231|581409242|FG000|Overall Study|Adverse Event|3|||
161005936|NCT01102231|581409242|FG000|Overall Study|Withdrawal by Subject|1|||
161005937|NCT01102231|581409242|FG000|Overall Study|Did not received the treatment|4|||
161005938|NCT00546754|581409243|FG000|Overall Study|Serious Adverse Event|1|||
161005939|NCT00546754|581409244|FG001|Overall Study|Serious Adverse Event|1|||
161005940|NCT00546754|581409243|FG000|Overall Study|Adverse Event|11|||
161005941|NCT00546754|581409244|FG001|Overall Study|Adverse Event|16|||
161005942|NCT00546754|581409243|FG000|Overall Study|Lack of Efficacy|1|||
161005943|NCT00546754|581409244|FG001|Overall Study|Lack of Efficacy|1|||
161005944|NCT00546754|581409243|FG000|Overall Study|Lost to Follow-up|9|||
161005945|NCT00546754|581409244|FG001|Overall Study|Lost to Follow-up|15|||
161005946|NCT00546754|581409243|FG000|Overall Study|Protocol Violation|3|||
161005947|NCT00546754|581409244|FG001|Overall Study|Protocol Violation|0|||
161005948|NCT00546754|581409243|FG000|Overall Study|Withdrawal by Subject|6|||
161005949|NCT00546754|581409244|FG001|Overall Study|Withdrawal by Subject|7|||
161005950|NCT00546754|581409243|FG000|Overall Study|Dyspnea|1|||
161005951|NCT00546754|581409244|FG001|Overall Study|Dyspnea|0|||
161005952|NCT00546754|581409243|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
161005953|NCT00546754|581409244|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
161005954|NCT00546754|581409243|FG000|Overall Study|Hip Replacement|1|||
161005955|NCT00546754|581409244|FG001|Overall Study|Hip Replacement|0|||
161005956|NCT00546754|581409243|FG000|Overall Study|Suicide|1|||
161005957|NCT00546754|581409244|FG001|Overall Study|Suicide|0|||
161005958|NCT00546754|581409243|FG000|Overall Study|Missing Cooperation|1|||
161005959|NCT00546754|581409244|FG001|Overall Study|Missing Cooperation|0|||
161005960|NCT00546754|581409243|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
161005961|NCT00546754|581409244|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
161005962|NCT00546754|581409243|FG000|Overall Study|Patient's Decision|0|||
161005963|NCT00546754|581409244|FG001|Overall Study|Patient's Decision|1|||
161005964|NCT00546754|581409243|FG000|Overall Study|Missing|14|||
161005965|NCT00546754|581409244|FG001|Overall Study|Missing|7|||
161005966|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
161005967|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
161005968|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
161005969|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005970|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005971|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005972|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
160966234|NCT04711603|581264852|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
160966235|NCT04711603|581264849|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
160966236|NCT04711603|581264850|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
160966237|NCT04711603|581264851|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
160966238|NCT04711603|581264852|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
160966239|NCT04711603|581264849|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
161005973|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005974|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005975|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005976|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005977|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005978|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
161005979|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
161005980|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
161005981|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
161005982|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
161005983|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
161005984|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
161005985|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
161005986|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
160966240|NCT04711603|581264850|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
160585278|NCT02052778|579861878|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585279|NCT02052778|579861879|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585280|NCT02052778|579861880|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585281|NCT02052778|579861881|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585282|NCT02052778|579861882|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585283|NCT02052778|579861883|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585284|NCT02052778|579861884|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585285|NCT02052778|579861885|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585286|NCT02052778|579861886|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585287|NCT02052778|579861887|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160966241|NCT04711603|581264851|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
160966242|NCT04711603|581264852|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
160966243|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
160966244|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
160966245|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
160966246|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
160966247|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
160966248|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
160966249|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
160966250|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
160966251|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
160966252|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
160966253|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
160966254|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
160966255|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
160966256|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
160966257|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
160966258|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
160966259|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
160966260|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
160966261|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
160966262|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
160966263|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
160966264|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
160966265|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
160966266|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
160966267|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
160966268|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
160966269|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
160966270|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
160966271|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
160966272|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
160966273|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
160966274|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
160966275|NCT03759834|581264853|FG000|Overall Study|Withdrawal by Subject|1|||
160966276|NCT00504426|581264856|FG000|Overall Study|Adverse Event|0|||
160966277|NCT00504426|581264857|FG001|Overall Study|Adverse Event|0|||
160966278|NCT00504426|581264858|FG002|Overall Study|Adverse Event|2|||
160966279|NCT00504426|581264859|FG003|Overall Study|Adverse Event|0|||
160966280|NCT00504426|581264856|FG000|Overall Study|Protocol Violation|1|||
160966281|NCT00504426|581264857|FG001|Overall Study|Protocol Violation|1|||
160966282|NCT00504426|581264858|FG002|Overall Study|Protocol Violation|2|||
160966283|NCT00504426|581264859|FG003|Overall Study|Protocol Violation|0|||
160966284|NCT00504426|581264856|FG000|Overall Study|Withdrawal by Subject|2|||
160966285|NCT00504426|581264857|FG001|Overall Study|Withdrawal by Subject|0|||
160966286|NCT00504426|581264858|FG002|Overall Study|Withdrawal by Subject|0|||
160966287|NCT00504426|581264859|FG003|Overall Study|Withdrawal by Subject|0|||
160966288|NCT03685591|581264863|FG000|Overall Study|Global Deterioration of Health Status|0|||
160966289|NCT03685591|581264864|FG001|Overall Study|Global Deterioration of Health Status|0|||
160966290|NCT03685591|581264865|FG002|Overall Study|Global Deterioration of Health Status|0|||
160966291|NCT03685591|581264866|FG003|Overall Study|Global Deterioration of Health Status|1|||
160966292|NCT03685591|581264867|FG004|Overall Study|Global Deterioration of Health Status|2|||
160966293|NCT03685591|581264868|FG005|Overall Study|Global Deterioration of Health Status|4|||
160966294|NCT03685591|581264869|FG006|Overall Study|Global Deterioration of Health Status|1|||
160966295|NCT03685591|581264870|FG007|Overall Study|Global Deterioration of Health Status|1|||
160585288|NCT02052778|579861888|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585289|NCT02052778|579861889|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585290|NCT02052778|579861890|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585291|NCT02052778|579861891|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585292|NCT02052778|579861892|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585293|NCT02052778|579861893|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585294|NCT02052778|579861894|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585295|NCT02052778|579861895|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585296|NCT02052778|579861896|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585297|NCT02052778|579861897|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
160585298|NCT02052778|579861898|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
161005987|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
161005988|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
161005989|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
161005990|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
161005991|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005992|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005993|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005994|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005995|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005996|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005997|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005998|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005999|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161006000|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161006001|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161006002|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006003|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006004|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
161006005|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006006|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006007|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006008|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006009|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006010|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006011|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006012|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006013|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006014|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
161006015|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
161006016|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
161006017|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
161006018|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006019|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006020|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006021|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006022|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006023|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006024|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006025|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006026|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
161006027|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
161006028|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
161006029|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
161006030|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006031|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006032|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006033|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006034|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006035|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006036|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006037|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006038|NCT05061693|581409251|FG000|24-week Extension Period|Adverse Event|0|||
161006039|NCT05061693|581409252|FG001|24-week Extension Period|Adverse Event|0|||
160458613|NCT00450216|579410895|FG000|Overall Study|misc|21|||
161006040|NCT05061693|581409253|FG002|24-week Extension Period|Adverse Event|0|||
161006041|NCT05061693|581409254|FG003|24-week Extension Period|Adverse Event|0|||
161006042|NCT05061693|581409255|FG004|24-week Extension Period|Adverse Event|0|||
161006043|NCT05061693|581409256|FG005|24-week Extension Period|Adverse Event|0|||
161006044|NCT05061693|581409257|FG006|24-week Extension Period|Adverse Event|0|||
161006045|NCT05061693|581409258|FG007|24-week Extension Period|Adverse Event|2|||
161006046|NCT05061693|581409259|FG008|24-week Extension Period|Adverse Event|2|||
161006047|NCT05061693|581409260|FG009|24-week Extension Period|Adverse Event|0|||
161006048|NCT05061693|581409261|FG010|24-week Extension Period|Adverse Event|1|||
161006049|NCT05061693|581409262|FG011|24-week Extension Period|Adverse Event|3|||
161006050|NCT05061693|581409251|FG000|24-week Extension Period|Lack of Efficacy|0|||
161006051|NCT05061693|581409252|FG001|24-week Extension Period|Lack of Efficacy|0|||
161006052|NCT05061693|581409253|FG002|24-week Extension Period|Lack of Efficacy|0|||
161006053|NCT05061693|581409254|FG003|24-week Extension Period|Lack of Efficacy|0|||
161006054|NCT05061693|581409255|FG004|24-week Extension Period|Lack of Efficacy|0|||
161006055|NCT05061693|581409256|FG005|24-week Extension Period|Lack of Efficacy|0|||
161006056|NCT05061693|581409257|FG006|24-week Extension Period|Lack of Efficacy|0|||
161006057|NCT05061693|581409258|FG007|24-week Extension Period|Lack of Efficacy|0|||
161006058|NCT05061693|581409259|FG008|24-week Extension Period|Lack of Efficacy|0|||
161006059|NCT05061693|581409260|FG009|24-week Extension Period|Lack of Efficacy|0|||
161006060|NCT05061693|581409261|FG010|24-week Extension Period|Lack of Efficacy|2|||
161006061|NCT05061693|581409262|FG011|24-week Extension Period|Lack of Efficacy|0|||
161006062|NCT05061693|581409251|FG000|24-week Extension Period|Lost to Follow-up|0|||
161006063|NCT05061693|581409252|FG001|24-week Extension Period|Lost to Follow-up|0|||
161006064|NCT05061693|581409253|FG002|24-week Extension Period|Lost to Follow-up|0|||
161006065|NCT05061693|581409254|FG003|24-week Extension Period|Lost to Follow-up|0|||
161006066|NCT05061693|581409255|FG004|24-week Extension Period|Lost to Follow-up|0|||
161006067|NCT05061693|581409256|FG005|24-week Extension Period|Lost to Follow-up|0|||
161006068|NCT05061693|581409257|FG006|24-week Extension Period|Lost to Follow-up|1|||
161006069|NCT05061693|581409258|FG007|24-week Extension Period|Lost to Follow-up|0|||
161006070|NCT05061693|581409259|FG008|24-week Extension Period|Lost to Follow-up|1|||
161006071|NCT05061693|581409260|FG009|24-week Extension Period|Lost to Follow-up|1|||
161006072|NCT05061693|581409261|FG010|24-week Extension Period|Lost to Follow-up|0|||
161006073|NCT05061693|581409262|FG011|24-week Extension Period|Lost to Follow-up|0|||
161006074|NCT05061693|581409251|FG000|24-week Extension Period|Withdrawal by Subject|0|||
161006075|NCT05061693|581409252|FG001|24-week Extension Period|Withdrawal by Subject|0|||
161006076|NCT05061693|581409253|FG002|24-week Extension Period|Withdrawal by Subject|0|||
161006077|NCT05061693|581409254|FG003|24-week Extension Period|Withdrawal by Subject|0|||
161006078|NCT05061693|581409255|FG004|24-week Extension Period|Withdrawal by Subject|0|||
161006079|NCT05061693|581409256|FG005|24-week Extension Period|Withdrawal by Subject|0|||
161006080|NCT05061693|581409257|FG006|24-week Extension Period|Withdrawal by Subject|0|||
161006081|NCT05061693|581409258|FG007|24-week Extension Period|Withdrawal by Subject|0|||
161006082|NCT05061693|581409259|FG008|24-week Extension Period|Withdrawal by Subject|1|||
161006083|NCT05061693|581409260|FG009|24-week Extension Period|Withdrawal by Subject|2|||
161006084|NCT05061693|581409261|FG010|24-week Extension Period|Withdrawal by Subject|2|||
161006085|NCT05061693|581409262|FG011|24-week Extension Period|Withdrawal by Subject|1|||
161006086|NCT05061693|581409251|FG000|24-week Extension Period|Sponsor Decision|0|||
161006087|NCT05061693|581409252|FG001|24-week Extension Period|Sponsor Decision|0|||
161006088|NCT05061693|581409253|FG002|24-week Extension Period|Sponsor Decision|0|||
161006089|NCT05061693|581409254|FG003|24-week Extension Period|Sponsor Decision|0|||
161006090|NCT05061693|581409255|FG004|24-week Extension Period|Sponsor Decision|0|||
161006091|NCT05061693|581409256|FG005|24-week Extension Period|Sponsor Decision|0|||
161006092|NCT05061693|581409257|FG006|24-week Extension Period|Sponsor Decision|0|||
161006093|NCT05061693|581409258|FG007|24-week Extension Period|Sponsor Decision|1|||
161006094|NCT05061693|581409259|FG008|24-week Extension Period|Sponsor Decision|0|||
161006095|NCT05061693|581409260|FG009|24-week Extension Period|Sponsor Decision|0|||
161006096|NCT05061693|581409261|FG010|24-week Extension Period|Sponsor Decision|0|||
161006097|NCT05061693|581409262|FG011|24-week Extension Period|Sponsor Decision|0|||
161006098|NCT05061693|581409251|FG000|24-week Extension Period|Site Closure|0|||
161006099|NCT05061693|581409252|FG001|24-week Extension Period|Site Closure|0|||
161006100|NCT05061693|581409253|FG002|24-week Extension Period|Site Closure|0|||
160458614|NCT00450216|579410896|FG001|Overall Study|misc|20|||
160458615|NCT03011034|579410901|FG000|Overall Study|Adverse Event|1|||
160458616|NCT03011034|579410902|FG001|Overall Study|Adverse Event|0|||
161006101|NCT05061693|581409254|FG003|24-week Extension Period|Site Closure|0|||
161006102|NCT05061693|581409255|FG004|24-week Extension Period|Site Closure|0|||
161006103|NCT05061693|581409256|FG005|24-week Extension Period|Site Closure|0|||
161006104|NCT05061693|581409257|FG006|24-week Extension Period|Site Closure|0|||
161006105|NCT05061693|581409258|FG007|24-week Extension Period|Site Closure|0|||
161006106|NCT05061693|581409259|FG008|24-week Extension Period|Site Closure|1|||
161006107|NCT05061693|581409260|FG009|24-week Extension Period|Site Closure|0|||
160458617|NCT03735979|579410911|FG000|Overall Study|Lost to Follow-up|1|||
161006108|NCT05061693|581409261|FG010|24-week Extension Period|Site Closure|0|||
161006109|NCT05061693|581409262|FG011|24-week Extension Period|Site Closure|1|||
160585299|NCT02052778|579861876|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
160585300|NCT02052778|579861877|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
160585301|NCT02052778|579861878|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
160585302|NCT02052778|579861879|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
160585303|NCT02052778|579861880|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
160966296|NCT03685591|581264871|FG008|Overall Study|Global Deterioration of Health Status|0|||
160966297|NCT03685591|581264863|FG000|Overall Study|Progressive Disease|1|||
160966298|NCT03685591|581264864|FG001|Overall Study|Progressive Disease|1|||
160966299|NCT03685591|581264865|FG002|Overall Study|Progressive Disease|0|||
160966300|NCT03685591|581264866|FG003|Overall Study|Progressive Disease|3|||
160966301|NCT03685591|581264867|FG004|Overall Study|Progressive Disease|5|||
160966302|NCT03685591|581264868|FG005|Overall Study|Progressive Disease|4|||
160966303|NCT03685591|581264869|FG006|Overall Study|Progressive Disease|3|||
160966304|NCT03685591|581264870|FG007|Overall Study|Progressive Disease|2|||
160966305|NCT03685591|581264871|FG008|Overall Study|Progressive Disease|1|||
160966306|NCT03685591|581264863|FG000|Overall Study|Other|0|||
160966307|NCT03685591|581264864|FG001|Overall Study|Other|0|||
160966308|NCT03685591|581264865|FG002|Overall Study|Other|1|||
160966309|NCT03685591|581264866|FG003|Overall Study|Other|0|||
160966310|NCT03685591|581264867|FG004|Overall Study|Other|2|||
160966311|NCT03685591|581264868|FG005|Overall Study|Other|3|||
160966312|NCT03685591|581264869|FG006|Overall Study|Other|0|||
160966313|NCT03685591|581264870|FG007|Overall Study|Other|0|||
160966314|NCT03685591|581264871|FG008|Overall Study|Other|0|||
160966315|NCT03685591|581264863|FG000|Overall Study|Withdrawal by Subject|0|||
160966316|NCT03685591|581264864|FG001|Overall Study|Withdrawal by Subject|0|||
160966317|NCT03685591|581264865|FG002|Overall Study|Withdrawal by Subject|0|||
160966318|NCT03685591|581264866|FG003|Overall Study|Withdrawal by Subject|0|||
160966319|NCT03685591|581264867|FG004|Overall Study|Withdrawal by Subject|3|||
160966320|NCT03685591|581264868|FG005|Overall Study|Withdrawal by Subject|2|||
160966321|NCT03685591|581264869|FG006|Overall Study|Withdrawal by Subject|0|||
160966322|NCT03685591|581264870|FG007|Overall Study|Withdrawal by Subject|0|||
160966323|NCT03685591|581264871|FG008|Overall Study|Withdrawal by Subject|1|||
160966324|NCT03685591|581264863|FG000|Overall Study|Adverse Event|0|||
160966325|NCT03685591|581264864|FG001|Overall Study|Adverse Event|0|||
160966326|NCT03685591|581264865|FG002|Overall Study|Adverse Event|0|||
160966327|NCT03685591|581264866|FG003|Overall Study|Adverse Event|1|||
160966328|NCT03685591|581264867|FG004|Overall Study|Adverse Event|1|||
160966329|NCT03685591|581264868|FG005|Overall Study|Adverse Event|4|||
160966330|NCT03685591|581264869|FG006|Overall Study|Adverse Event|0|||
160966331|NCT03685591|581264870|FG007|Overall Study|Adverse Event|1|||
160966332|NCT03685591|581264871|FG008|Overall Study|Adverse Event|1|||
160966333|NCT00689026|581264874|FG000|Overall Study|Withdrawal by Subject|13|||
160966334|NCT00689026|581264875|FG001|Overall Study|Withdrawal by Subject|6|||
160966335|NCT02390531|581264879|FG000|Overall Study|Death|0|||
160966336|NCT02390531|581264880|FG001|Overall Study|Death|2|||
160966337|NCT02390531|581264881|FG002|Overall Study|Death|0|||
160966338|NCT02390531|581264882|FG003|Overall Study|Death|1|||
160966339|NCT02390531|581264883|FG004|Overall Study|Death|0|||
160966340|NCT02390531|581264884|FG005|Overall Study|Death|0|||
160966341|NCT02390531|581264885|FG006|Overall Study|Death|0|||
160966342|NCT02390531|581264886|FG007|Overall Study|Death|1|||
160966343|NCT02390531|581264879|FG000|Overall Study|Protocol Violation|0|||
160966344|NCT02390531|581264880|FG001|Overall Study|Protocol Violation|0|||
160966345|NCT02390531|581264881|FG002|Overall Study|Protocol Violation|0|||
160966346|NCT02390531|581264882|FG003|Overall Study|Protocol Violation|0|||
160966347|NCT02390531|581264883|FG004|Overall Study|Protocol Violation|1|||
160966348|NCT02390531|581264884|FG005|Overall Study|Protocol Violation|0|||
160966349|NCT02390531|581264885|FG006|Overall Study|Protocol Violation|2|||
160966350|NCT02390531|581264886|FG007|Overall Study|Protocol Violation|0|||
160966351|NCT01951638|581264887|FG000|Treatment Period|Protocol Violation|0|||
160966352|NCT01951638|581264888|FG001|Treatment Period|Protocol Violation|0|||
160966353|NCT01951638|581264889|FG002|Treatment Period|Protocol Violation|0|||
160966354|NCT01951638|581264890|FG003|Treatment Period|Protocol Violation|2|||
160966355|NCT01951638|581264891|FG004|Treatment Period|Protocol Violation|0|||
160966356|NCT01951638|581264887|FG000|Treatment Period|Protocol-driven decision point|1|||
160966357|NCT01951638|581264888|FG001|Treatment Period|Protocol-driven decision point|3|||
160966358|NCT01951638|581264889|FG002|Treatment Period|Protocol-driven decision point|0|||
160966359|NCT01951638|581264890|FG003|Treatment Period|Protocol-driven decision point|0|||
160966360|NCT01951638|581264891|FG004|Treatment Period|Protocol-driven decision point|0|||
160966361|NCT01951638|581264887|FG000|Treatment Period|Logistical difficulties|0|||
160966362|NCT01951638|581264888|FG001|Treatment Period|Logistical difficulties|1|||
160966363|NCT01951638|581264889|FG002|Treatment Period|Logistical difficulties|1|||
160585304|NCT02052778|579861881|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
160966364|NCT01951638|581264890|FG003|Treatment Period|Logistical difficulties|0|||
160585305|NCT02052778|579861882|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
160585306|NCT02052778|579861883|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
160966365|NCT01951638|581264891|FG004|Treatment Period|Logistical difficulties|0|||
160966366|NCT01951638|581264887|FG000|Treatment Period|Withdrawal by Subject|9|||
161006110|NCT03823911|581409263|FG000|Overall Study|Lost to Follow-up|1|||
161006111|NCT03823911|581409264|FG001|Overall Study|Lost to Follow-up|5|||
161006112|NCT03823911|581409265|FG002|Overall Study|Lost to Follow-up|2|||
161006113|NCT03823911|581409263|FG000|Overall Study|Did not meet eligibility criteria|13|||
161006114|NCT03823911|581409264|FG001|Overall Study|Did not meet eligibility criteria|7|||
161006115|NCT03823911|581409265|FG002|Overall Study|Did not meet eligibility criteria|4|||
161006116|NCT03823911|581409263|FG000|Overall Study|Death|0|||
161006117|NCT03823911|581409264|FG001|Overall Study|Death|1|||
161006118|NCT03823911|581409265|FG002|Overall Study|Death|0|||
161006119|NCT02261467|581409269|FG000|Overall Study|Enrolled in Error|1|||
161006120|NCT02261467|581409270|FG001|Overall Study|Enrolled in Error|0|||
161006121|NCT02261467|581409269|FG000|Overall Study|Protocol Violation|0|||
161006122|NCT02261467|581409270|FG001|Overall Study|Protocol Violation|1|||
161006123|NCT02261467|581409269|FG000|Overall Study|Personal Reasons|17|||
161006124|NCT02261467|581409270|FG001|Overall Study|Personal Reasons|22|||
161006125|NCT02261467|581409269|FG000|Overall Study|Lost to Follow-up|2|||
161006126|NCT02261467|581409270|FG001|Overall Study|Lost to Follow-up|13|||
161006127|NCT02261467|581409269|FG000|Overall Study|Adverse Event|1|||
161006128|NCT02261467|581409270|FG001|Overall Study|Adverse Event|1|||
161006129|NCT04305405|581409273|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161006130|NCT04305405|581409274|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161006131|NCT01787760|581409275|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
161006132|NCT01787760|581409276|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
161006133|NCT01787760|581409277|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
161006134|NCT01787760|581409275|FG000|Overall Study|Decompensated on left exotropia|0|||
161006135|NCT01787760|581409276|FG001|Overall Study|Decompensated on left exotropia|0|||
161006136|NCT01787760|581409277|FG002|Overall Study|Decompensated on left exotropia|1|||
161006137|NCT01787760|581409275|FG000|Overall Study|Dryness|0|||
161006138|NCT01787760|581409276|FG001|Overall Study|Dryness|1|||
161006139|NCT01787760|581409277|FG002|Overall Study|Dryness|0|||
161006140|NCT01787760|581409275|FG000|Overall Study|Relocation|1|||
161006141|NCT01787760|581409276|FG001|Overall Study|Relocation|1|||
161006142|NCT01787760|581409277|FG002|Overall Study|Relocation|0|||
161006143|NCT01787760|581409275|FG000|Overall Study|Lens discomfort|3|||
161006144|NCT01787760|581409276|FG001|Overall Study|Lens discomfort|0|||
161006145|NCT01787760|581409277|FG002|Overall Study|Lens discomfort|0|||
161006146|NCT01787760|581409275|FG000|Overall Study|Lens handling difficulty|1|||
161006147|NCT01787760|581409276|FG001|Overall Study|Lens handling difficulty|2|||
161006148|NCT01787760|581409277|FG002|Overall Study|Lens handling difficulty|0|||
161006149|NCT01787760|581409275|FG000|Overall Study|Protocol Violation|6|||
161006150|NCT01787760|581409276|FG001|Overall Study|Protocol Violation|0|||
161006151|NCT01787760|581409277|FG002|Overall Study|Protocol Violation|1|||
161006152|NCT01787760|581409275|FG000|Overall Study|Withdrawal by Subject|5|||
161006153|NCT01787760|581409276|FG001|Overall Study|Withdrawal by Subject|1|||
161006154|NCT01787760|581409277|FG002|Overall Study|Withdrawal by Subject|2|||
161006155|NCT01787760|581409275|FG000|Overall Study|Lost to Follow-up|1|||
161006156|NCT01787760|581409276|FG001|Overall Study|Lost to Follow-up|0|||
161006157|NCT01787760|581409277|FG002|Overall Study|Lost to Follow-up|1|||
161006158|NCT01787760|581409275|FG000|Overall Study|Stroke|1|||
161006159|NCT01787760|581409276|FG001|Overall Study|Stroke|0|||
161006160|NCT01787760|581409277|FG002|Overall Study|Stroke|0|||
161006161|NCT01787760|581409275|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
161006162|NCT01787760|581409276|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
161006163|NCT01787760|581409277|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
161006164|NCT01787760|581409275|FG000|Overall Study|Unsatisfactory physiological response|2|||
161006165|NCT01787760|581409276|FG001|Overall Study|Unsatisfactory physiological response|4|||
161006166|NCT01787760|581409277|FG002|Overall Study|Unsatisfactory physiological response|0|||
161006167|NCT01787760|581409275|FG000|Overall Study|Unsatisfactory visual response|1|||
161006168|NCT01787760|581409276|FG001|Overall Study|Unsatisfactory visual response|1|||
161006169|NCT01787760|581409277|FG002|Overall Study|Unsatisfactory visual response|0|||
161006170|NCT01787760|581409275|FG000|Overall Study|Near vision blur|1|||
161006171|NCT01787760|581409276|FG001|Overall Study|Near vision blur|0|||
161006172|NCT01787760|581409277|FG002|Overall Study|Near vision blur|0|||
161006173|NCT03473340|581409278|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
161006174|NCT03473340|581409279|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
161006175|NCT03473340|581409278|FG000|Overall Study|Withdrawal by Subject|1|||
161006176|NCT03473340|581409279|FG001|Overall Study|Withdrawal by Subject|0|||
161006177|NCT03473340|581409278|FG000|Overall Study|Lost to Follow-up|1|||
161006178|NCT03473340|581409279|FG001|Overall Study|Lost to Follow-up|2|||
161006179|NCT02531113|581409282|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
161006180|NCT02531113|581409282|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
161006181|NCT02531113|581409282|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
161006182|NCT02531113|581409282|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
161006183|NCT02531113|581409282|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
161006184|NCT02531113|581409282|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
161006185|NCT02531113|581409282|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
161006186|NCT02531113|581409282|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
161006187|NCT00801983|581409283|FG000|Period 1|Lost to Follow-up|2|||
161006188|NCT00801983|581409284|FG001|Period 1|Lost to Follow-up|0|||
161006189|NCT00801983|581409283|FG000|Period 1|Withdrawal by Subject|2|||
161006190|NCT00801983|581409284|FG001|Period 1|Withdrawal by Subject|8|||
161006191|NCT00801983|581409283|FG000|Period 2|Withdrawal by Subject|2|||
161006192|NCT00801983|581409284|FG001|Period 2|Withdrawal by Subject|1|||
161006193|NCT03122886|581410636|FG000|Overall Study|Withdrawal by Subject|1|||
161006194|NCT03122886|581410637|FG001|Overall Study|Withdrawal by Subject|2|||
161006195|NCT03237481|581410642|FG000|Overall Study|Lost to Follow-up|1|||
161006196|NCT03237481|581410643|FG001|Overall Study|Lost to Follow-up|0|||
161006197|NCT03237481|581410644|FG002|Overall Study|Lost to Follow-up|0|||
161006198|NCT03237481|581410642|FG000|Overall Study|Protocol Violation|1|||
161006199|NCT03237481|581410643|FG001|Overall Study|Protocol Violation|0|||
161006200|NCT03237481|581410644|FG002|Overall Study|Protocol Violation|0|||
161006201|NCT03237481|581410642|FG000|Overall Study|Withdrawal by Subject|3|||
161006202|NCT03237481|581410643|FG001|Overall Study|Withdrawal by Subject|2|||
161006203|NCT03237481|581410644|FG002|Overall Study|Withdrawal by Subject|1|||
161006204|NCT02544074|581410645|FG000|Overall Study|Withdrawal by Subject|0|||
161006205|NCT02544074|581410646|FG001|Overall Study|Withdrawal by Subject|1|||
161006206|NCT02544074|581410647|FG002|Overall Study|Withdrawal by Subject|0|||
161006207|NCT02544074|581410648|FG003|Overall Study|Withdrawal by Subject|0|||
161006208|NCT02544074|581410649|FG004|Overall Study|Withdrawal by Subject|0|||
161006209|NCT02544074|581410650|FG005|Overall Study|Withdrawal by Subject|0|||
161006210|NCT02544074|581410651|FG006|Overall Study|Withdrawal by Subject|0|||
161006211|NCT02544074|581410652|FG007|Overall Study|Withdrawal by Subject|0|||
161006212|NCT02544074|581410653|FG008|Overall Study|Withdrawal by Subject|0|||
161006213|NCT02544074|581410654|FG009|Overall Study|Withdrawal by Subject|0|||
161006214|NCT02544074|581410655|FG010|Overall Study|Withdrawal by Subject|0|||
161006215|NCT02544074|581410656|FG011|Overall Study|Withdrawal by Subject|0|||
161006216|NCT02544074|581410657|FG012|Overall Study|Withdrawal by Subject|0|||
161006217|NCT02544074|581410658|FG013|Overall Study|Withdrawal by Subject|0|||
161006218|NCT02544074|581410659|FG014|Overall Study|Withdrawal by Subject|0|||
161006219|NCT02544074|581410660|FG015|Overall Study|Withdrawal by Subject|0|||
161006220|NCT02544074|581410661|FG016|Overall Study|Withdrawal by Subject|0|||
161006221|NCT02544074|581410662|FG017|Overall Study|Withdrawal by Subject|0|||
161006222|NCT02544074|581410663|FG018|Overall Study|Withdrawal by Subject|0|||
161006223|NCT02544074|581410664|FG019|Overall Study|Withdrawal by Subject|0|||
161006224|NCT02544074|581410665|FG020|Overall Study|Withdrawal by Subject|0|||
161006225|NCT02544074|581410645|FG000|Overall Study|Tablet error|0|||
161006226|NCT02544074|581410646|FG001|Overall Study|Tablet error|0|||
161006227|NCT02544074|581410647|FG002|Overall Study|Tablet error|0|||
161006228|NCT02544074|581410648|FG003|Overall Study|Tablet error|0|||
161006229|NCT02544074|581410649|FG004|Overall Study|Tablet error|0|||
161006230|NCT02544074|581410650|FG005|Overall Study|Tablet error|1|||
161006231|NCT02544074|581410651|FG006|Overall Study|Tablet error|0|||
161006232|NCT02544074|581410652|FG007|Overall Study|Tablet error|0|||
161006233|NCT02544074|581410653|FG008|Overall Study|Tablet error|0|||
161006234|NCT02544074|581410654|FG009|Overall Study|Tablet error|1|||
161006235|NCT02544074|581410655|FG010|Overall Study|Tablet error|0|||
161006236|NCT02544074|581410656|FG011|Overall Study|Tablet error|0|||
161006237|NCT02544074|581410657|FG012|Overall Study|Tablet error|0|||
161006238|NCT02544074|581410658|FG013|Overall Study|Tablet error|0|||
161006239|NCT02544074|581410659|FG014|Overall Study|Tablet error|0|||
161006240|NCT02544074|581410660|FG015|Overall Study|Tablet error|0|||
161006241|NCT02544074|581410661|FG016|Overall Study|Tablet error|0|||
161006242|NCT02544074|581410662|FG017|Overall Study|Tablet error|0|||
161006243|NCT02544074|581410663|FG018|Overall Study|Tablet error|0|||
161006244|NCT02544074|581410664|FG019|Overall Study|Tablet error|0|||
161006245|NCT02544074|581410665|FG020|Overall Study|Tablet error|0|||
161006246|NCT04714320|581410670|FG000|Overall Study|Voluntary Withdrawal|4|||
161006247|NCT04714320|581410671|FG001|Overall Study|Voluntary Withdrawal|1|||
161006248|NCT04714320|581410672|FG002|Overall Study|Voluntary Withdrawal|2|||
161006249|NCT04714320|581410670|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
161006250|NCT04714320|581410671|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
161006251|NCT04714320|581410672|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
161006252|NCT04714320|581410670|FG000|Overall Study|Reason Not Specified|1|||
161006253|NCT04714320|581410671|FG001|Overall Study|Reason Not Specified|3|||
161006254|NCT04714320|581410672|FG002|Overall Study|Reason Not Specified|3|||
161006255|NCT03873779|581410673|FG000|Overall Study|Withdrawal by Subject|1|||
161006256|NCT02581215|581410674|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
161006257|NCT02581215|581410675|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
161006258|NCT02581215|581410674|FG000|Overall Study|Eligibility Criteria Not Met|0|||
161006259|NCT02581215|581410675|FG001|Overall Study|Eligibility Criteria Not Met|1|||
161006260|NCT04153565|581410676|FG000|Overall Study|Death|13|||
160585307|NCT02052778|579861884|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
160585308|NCT02052778|579861885|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
160585309|NCT02052778|579861886|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
160585310|NCT02052778|579861887|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
160585311|NCT02052778|579861888|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
160585312|NCT02052778|579861889|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
160585313|NCT02052778|579861890|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
160585314|NCT02052778|579861891|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
161006261|NCT02374463|581410686|FG000|Overall Study|Withdrawal by Subject|3|||
161006262|NCT02374463|581410687|FG001|Overall Study|Withdrawal by Subject|3|||
161006263|NCT00446459|581410690|FG000|8 Months|Protocol Violation|12|||
161006264|NCT00446459|581410690|FG000|12 Months|Protocol Violation|4|||
161006265|NCT00446459|581410690|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
161006266|NCT00858117|581410691|FG000|Treatment on Study|Adverse Event|2|||
161006267|NCT00858117|581410691|FG000|Follow up for 5 Years|Death|4|||
161006268|NCT00858117|581410691|FG000|Follow up for 5 Years|No further data collected for study|9|||
161006269|NCT00371787|581410692|FG000|Overall Study|Withdrawal by Subject|3|||
161006270|NCT00371787|581410693|FG001|Overall Study|Withdrawal by Subject|1|||
161006271|NCT02601820|581410694|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
161006272|NCT02601820|581410694|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
161006273|NCT02601820|581410694|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
161006274|NCT02601820|581410694|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
161006275|NCT01414738|581410708|FG000|Overall Study|Death|26|||
161006276|NCT01414738|581410708|FG000|Overall Study|Refused testing|5|||
161006277|NCT01414738|581410708|FG000|Overall Study|Lost to Follow-up|2|||
161006278|NCT01414738|581410708|FG000|Overall Study|Refused, disease progression|8|||
161006279|NCT01414738|581410708|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
161006280|NCT01266122|581410709|FG000|Overall Study|Lost to Follow-up|6|||
161006281|NCT01266122|581410710|FG001|Overall Study|Lost to Follow-up|6|||
161006282|NCT03756571|581410711|FG000|Overall Study|Lost to Follow-up|1|||
161006283|NCT03756571|581410712|FG001|Overall Study|Lost to Follow-up|1|||
161006284|NCT02379819|581410713|FG000|Overall Study|Withdrawal by Subject|10|||
161006285|NCT02379819|581410713|FG000|Overall Study|Death|2|||
161006286|NCT02379819|581410713|FG000|Overall Study|Lack of Efficacy|1|||
161006287|NCT02379819|581410713|FG000|Overall Study|Lost to Follow-up|1|||
161006288|NCT03752151|581410714|FG000|Overall Study|Withdrawal by Subject|1|||
161006289|NCT03752151|581410714|FG000|Overall Study|Protocol Violation|1|||
161006290|NCT00529516|581410715|FG000|Overall Study|Adverse Event|2|||
161006291|NCT00529516|581410716|FG001|Overall Study|Adverse Event|1|||
161006292|NCT00529516|581410717|FG002|Overall Study|Adverse Event|0|||
161006293|NCT00529516|581410715|FG000|Overall Study|Withdrawal by Subject|1|||
161006294|NCT00529516|581410716|FG001|Overall Study|Withdrawal by Subject|1|||
161006295|NCT00529516|581410717|FG002|Overall Study|Withdrawal by Subject|0|||
161006296|NCT00529516|581410715|FG000|Overall Study|Lost to Follow-up|0|||
161006297|NCT00529516|581410716|FG001|Overall Study|Lost to Follow-up|0|||
161006298|NCT00529516|581410717|FG002|Overall Study|Lost to Follow-up|1|||
161006299|NCT04056624|581410718|FG000|Overall Study|Withdrawal by Subject|0|||
161006300|NCT04056624|581410719|FG001|Overall Study|Withdrawal by Subject|0|||
161006301|NCT04056624|581410720|FG002|Overall Study|Withdrawal by Subject|1|||
161006302|NCT04056624|581410718|FG000|Overall Study|Protocol Violation|1|||
161006303|NCT04056624|581410719|FG001|Overall Study|Protocol Violation|2|||
161006304|NCT04056624|581410720|FG002|Overall Study|Protocol Violation|0|||
161006305|NCT00703820|581410724|FG000|Overall Study|Adverse Event|12|||
161006306|NCT00703820|581410725|FG001|Overall Study|Adverse Event|17|||
161006307|NCT00703820|581410724|FG000|Overall Study|Death|5|||
161006308|NCT00703820|581410725|FG001|Overall Study|Death|0|||
161006309|NCT00703820|581410724|FG000|Overall Study|Lack of Efficacy|11|||
161006310|NCT00703820|581410725|FG001|Overall Study|Lack of Efficacy|11|||
160585315|NCT02052778|579861892|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
160585316|NCT02052778|579861893|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
160585317|NCT02052778|579861894|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
160585318|NCT02052778|579861895|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
160585319|NCT02052778|579861896|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
160585320|NCT02052778|579861897|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
161006311|NCT00703820|581410724|FG000|Overall Study|Received non-protocol therapy|1|||
160585321|NCT02052778|579861898|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
161006312|NCT00703820|581410725|FG001|Overall Study|Received non-protocol therapy|0|||
161006313|NCT00703820|581410724|FG000|Overall Study|Physician Decision|4|||
161006314|NCT00703820|581410725|FG001|Overall Study|Physician Decision|5|||
161006315|NCT00703820|581410724|FG000|Overall Study|Withdrawal by Subject|2|||
161006316|NCT00703820|581410725|FG001|Overall Study|Withdrawal by Subject|1|||
161006317|NCT02092116|581410729|FG000|Overall Study|Withdrawal by Subject|0|||
160585322|NCT02052778|579861876|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
161006318|NCT02092116|581410730|FG001|Overall Study|Withdrawal by Subject|3|||
161006319|NCT02092116|581410729|FG000|Overall Study|Adverse Event|0|||
161006320|NCT02092116|581410730|FG001|Overall Study|Adverse Event|1|||
161006321|NCT01007396|581410731|FG000|Overall Study|Lost to Follow-up|47|||
161006322|NCT01792830|581410732|FG000|Overall Study|Withdrawal by Subject|22|||
161006323|NCT01792830|581410733|FG001|Overall Study|Withdrawal by Subject|0|||
161006324|NCT01792830|581410734|FG002|Overall Study|Withdrawal by Subject|0|||
161006325|NCT01792830|581410735|FG003|Overall Study|Withdrawal by Subject|2|||
161006326|NCT01792830|581410736|FG004|Overall Study|Withdrawal by Subject|1|||
161006327|NCT01792830|581410737|FG005|Overall Study|Withdrawal by Subject|1|||
161006328|NCT01792830|581410738|FG006|Overall Study|Withdrawal by Subject|1|||
161006329|NCT01792830|581410739|FG007|Overall Study|Withdrawal by Subject|1|||
161006330|NCT01792830|581410740|FG008|Overall Study|Withdrawal by Subject|7|||
161006331|NCT01792830|581410741|FG009|Overall Study|Withdrawal by Subject|0|||
161006332|NCT01792830|581410742|FG010|Overall Study|Withdrawal by Subject|2|||
161006333|NCT01792830|581410732|FG000|Overall Study|Death|3|||
161006334|NCT01792830|581410733|FG001|Overall Study|Death|0|||
161006335|NCT01792830|581410734|FG002|Overall Study|Death|0|||
161006336|NCT01792830|581410735|FG003|Overall Study|Death|1|||
161006337|NCT01792830|581410736|FG004|Overall Study|Death|0|||
161006338|NCT01792830|581410737|FG005|Overall Study|Death|0|||
161006339|NCT01792830|581410738|FG006|Overall Study|Death|1|||
161006340|NCT01792830|581410739|FG007|Overall Study|Death|0|||
161006341|NCT01792830|581410740|FG008|Overall Study|Death|1|||
161006342|NCT01792830|581410741|FG009|Overall Study|Death|0|||
161006343|NCT01792830|581410742|FG010|Overall Study|Death|1|||
161006344|NCT01792830|581410732|FG000|Overall Study|Adverse Event|0|||
161006345|NCT01792830|581410733|FG001|Overall Study|Adverse Event|0|||
161006346|NCT01792830|581410734|FG002|Overall Study|Adverse Event|0|||
161006347|NCT01792830|581410735|FG003|Overall Study|Adverse Event|0|||
161006348|NCT01792830|581410736|FG004|Overall Study|Adverse Event|0|||
161006349|NCT01792830|581410737|FG005|Overall Study|Adverse Event|0|||
161006350|NCT01792830|581410738|FG006|Overall Study|Adverse Event|0|||
161006351|NCT01792830|581410739|FG007|Overall Study|Adverse Event|0|||
161006352|NCT01792830|581410740|FG008|Overall Study|Adverse Event|1|||
161006353|NCT01792830|581410741|FG009|Overall Study|Adverse Event|0|||
161006354|NCT01792830|581410742|FG010|Overall Study|Adverse Event|0|||
161006355|NCT05274217|581410758|FG000|Overall Study|Study terminated.|11|||
161006356|NCT05274217|581410759|FG001|Overall Study|Study terminated.|0|||
161006357|NCT03811574|581410760|FG000|Overall Study|Withdrawal by Subject|2|||
161006358|NCT03811574|581410761|FG001|Overall Study|Withdrawal by Subject|4|||
161006359|NCT03811574|581410762|FG002|Overall Study|Withdrawal by Subject|0|||
161006360|NCT01697969|581410765|FG000|Overall Study|Did not meet inc/exc criteria|3|||
161006361|NCT00736853|581410768|FG000|Open-Label Period|Physician Decision|2|||
161006362|NCT00736853|581410769|FG001|Open-Label Period|Physician Decision|0|||
161006363|NCT00736853|581410770|FG002|Open-Label Period|Physician Decision|0|||
161006364|NCT00736853|581410768|FG000|Open-Label Period|Adverse Event|31|||
161006365|NCT00736853|581410769|FG001|Open-Label Period|Adverse Event|0|||
161006366|NCT00736853|581410770|FG002|Open-Label Period|Adverse Event|0|||
161006367|NCT00736853|581410768|FG000|Open-Label Period|Withdrawal by Subject|16|||
161006368|NCT00736853|581410769|FG001|Open-Label Period|Withdrawal by Subject|0|||
161006369|NCT00736853|581410770|FG002|Open-Label Period|Withdrawal by Subject|0|||
161006370|NCT00736853|581410768|FG000|Open-Label Period|Started but not treated|42|||
161006371|NCT00736853|581410769|FG001|Open-Label Period|Started but not treated|0|||
161006372|NCT00736853|581410770|FG002|Open-Label Period|Started but not treated|0|||
161006373|NCT00736853|581410768|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
161006374|NCT00736853|581410769|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
161006375|NCT00736853|581410770|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
161006376|NCT00736853|581410768|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
161006377|NCT00736853|581410769|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
161006378|NCT00736853|581410770|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
161006379|NCT00736853|581410768|FG000|Double-Blind Period|Lack of Efficacy|0|||
161006380|NCT00736853|581410769|FG001|Double-Blind Period|Lack of Efficacy|19|||
161006381|NCT00736853|581410770|FG002|Double-Blind Period|Lack of Efficacy|42|||
160585323|NCT02052778|579861877|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585324|NCT02052778|579861878|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585325|NCT02052778|579861879|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
161006382|NCT00736853|581410768|FG000|Double-Blind Period|Adverse Event|0|||
160585326|NCT02052778|579861880|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585327|NCT02052778|579861881|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585328|NCT02052778|579861882|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
161006383|NCT00736853|581410769|FG001|Double-Blind Period|Adverse Event|3|||
161006384|NCT00736853|581410770|FG002|Double-Blind Period|Adverse Event|2|||
161006385|NCT00736853|581410768|FG000|Double-Blind Period|Withdrawal by Subject|0|||
161006386|NCT00736853|581410769|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161006387|NCT00736853|581410770|FG002|Double-Blind Period|Withdrawal by Subject|4|||
160585329|NCT02052778|579861883|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
161006388|NCT00736853|581410768|FG000|Double-Blind Period|Ineligible to participate the study|0|||
161006389|NCT00736853|581410769|FG001|Double-Blind Period|Ineligible to participate the study|1|||
161006390|NCT00736853|581410770|FG002|Double-Blind Period|Ineligible to participate the study|0|||
160585330|NCT02052778|579861884|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585331|NCT02052778|579861885|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585332|NCT02052778|579861886|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585333|NCT02052778|579861887|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585334|NCT02052778|579861888|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585335|NCT02052778|579861889|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585336|NCT02052778|579861890|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585337|NCT02052778|579861891|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585338|NCT02052778|579861892|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585339|NCT02052778|579861893|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585340|NCT02052778|579861894|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585341|NCT02052778|579861895|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585342|NCT02052778|579861896|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585343|NCT02052778|579861897|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
160585344|NCT02052778|579861898|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
160585345|NCT02345252|579861911|FG000|Double-Blind Phase|Adverse Event|2|||
160585346|NCT02345252|579861912|FG001|Double-Blind Phase|Adverse Event|3|||
160585347|NCT02345252|579861911|FG000|Double-Blind Phase|Death|1|||
160585348|NCT02345252|579861912|FG001|Double-Blind Phase|Death|2|||
160966367|NCT01951638|581264888|FG001|Treatment Period|Withdrawal by Subject|6|||
160966368|NCT01951638|581264889|FG002|Treatment Period|Withdrawal by Subject|4|||
160966369|NCT01951638|581264890|FG003|Treatment Period|Withdrawal by Subject|5|||
160966370|NCT01951638|581264891|FG004|Treatment Period|Withdrawal by Subject|4|||
160966371|NCT01951638|581264887|FG000|Treatment Period|Death|0|||
160966372|NCT01951638|581264888|FG001|Treatment Period|Death|0|||
160966373|NCT01951638|581264889|FG002|Treatment Period|Death|0|||
160966374|NCT01951638|581264890|FG003|Treatment Period|Death|3|||
160966375|NCT01951638|581264891|FG004|Treatment Period|Death|1|||
160966376|NCT01951638|581264887|FG000|Treatment Period|Adverse Event|3|||
160966377|NCT01951638|581264888|FG001|Treatment Period|Adverse Event|4|||
160966378|NCT01951638|581264889|FG002|Treatment Period|Adverse Event|8|||
160966379|NCT01951638|581264890|FG003|Treatment Period|Adverse Event|6|||
160966380|NCT01951638|581264891|FG004|Treatment Period|Adverse Event|5|||
160966381|NCT01951638|581264887|FG000|Follow-up Period|Protocol Violation|0|||
160966382|NCT01951638|581264888|FG001|Follow-up Period|Protocol Violation|0|||
160966383|NCT01951638|581264889|FG002|Follow-up Period|Protocol Violation|0|||
160966384|NCT01951638|581264890|FG003|Follow-up Period|Protocol Violation|1|||
160966385|NCT01951638|581264891|FG004|Follow-up Period|Protocol Violation|0|||
160966386|NCT01951638|581264887|FG000|Follow-up Period|Logistical difficulties|0|||
160966387|NCT01951638|581264888|FG001|Follow-up Period|Logistical difficulties|2|||
160966388|NCT01951638|581264889|FG002|Follow-up Period|Logistical difficulties|0|||
160966389|NCT01951638|581264890|FG003|Follow-up Period|Logistical difficulties|0|||
160966390|NCT01951638|581264891|FG004|Follow-up Period|Logistical difficulties|1|||
160966391|NCT01951638|581264887|FG000|Follow-up Period|Withdrawal by Subject|1|||
160966392|NCT01951638|581264888|FG001|Follow-up Period|Withdrawal by Subject|5|||
160966393|NCT01951638|581264889|FG002|Follow-up Period|Withdrawal by Subject|2|||
160966394|NCT01951638|581264890|FG003|Follow-up Period|Withdrawal by Subject|1|||
160966395|NCT01951638|581264891|FG004|Follow-up Period|Withdrawal by Subject|2|||
160966396|NCT01951638|581264887|FG000|Follow-up Period|Lost to Follow-up|0|||
160966397|NCT01951638|581264888|FG001|Follow-up Period|Lost to Follow-up|1|||
160966398|NCT01951638|581264889|FG002|Follow-up Period|Lost to Follow-up|0|||
160966399|NCT01951638|581264890|FG003|Follow-up Period|Lost to Follow-up|1|||
160966400|NCT01951638|581264891|FG004|Follow-up Period|Lost to Follow-up|0|||
160966401|NCT01951638|581264887|FG000|Follow-up Period|Death|1|||
160966402|NCT01951638|581264888|FG001|Follow-up Period|Death|0|||
160966403|NCT01951638|581264889|FG002|Follow-up Period|Death|1|||
160966404|NCT01951638|581264890|FG003|Follow-up Period|Death|4|||
160966405|NCT01951638|581264891|FG004|Follow-up Period|Death|1|||
160966406|NCT01951638|581264887|FG000|Follow-up Period|Adverse Event|0|||
160966407|NCT01951638|581264888|FG001|Follow-up Period|Adverse Event|1|||
160966408|NCT01951638|581264889|FG002|Follow-up Period|Adverse Event|2|||
160966409|NCT01951638|581264890|FG003|Follow-up Period|Adverse Event|1|||
160966410|NCT01951638|581264891|FG004|Follow-up Period|Adverse Event|1|||
160966411|NCT03764072|581264892|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
160966412|NCT03764072|581264893|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
160966413|NCT03764072|581264894|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
160966414|NCT03764072|581264895|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
160585349|NCT02345252|579861911|FG000|Double-Blind Phase|Lack of Efficacy|1|||
160966415|NCT03764072|581264896|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
160966416|NCT03764072|581264897|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
160966417|NCT03764072|581264892|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
160966418|NCT03764072|581264893|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
160966419|NCT03764072|581264894|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
160585350|NCT02345252|579861912|FG001|Double-Blind Phase|Lack of Efficacy|0|||
160585351|NCT02345252|579861911|FG000|Double-Blind Phase|Investigator's Discretion|4|||
160458618|NCT03735979|579410912|FG001|Overall Study|Lost to Follow-up|12|||
160966420|NCT03764072|581264895|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
160966421|NCT03764072|581264896|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
160966422|NCT03764072|581264897|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
160966423|NCT03764072|581264892|FG000|Overall Study|Lost to Follow-up|0|||
160966424|NCT03764072|581264893|FG001|Overall Study|Lost to Follow-up|0|||
160966425|NCT03764072|581264894|FG002|Overall Study|Lost to Follow-up|0|||
160966426|NCT03764072|581264895|FG003|Overall Study|Lost to Follow-up|0|||
160966427|NCT03764072|581264896|FG004|Overall Study|Lost to Follow-up|1|||
160966428|NCT03764072|581264897|FG005|Overall Study|Lost to Follow-up|0|||
160966429|NCT00552084|581264898|FG000|Overall Study|Adverse Event|2|||
160966430|NCT00552084|581264899|FG001|Overall Study|Adverse Event|3|||
160966431|NCT00552084|581264898|FG000|Overall Study|Withdrawal by Subject|4|||
160966432|NCT00552084|581264899|FG001|Overall Study|Withdrawal by Subject|5|||
160966433|NCT00552084|581264898|FG000|Overall Study|Protocol Violation|1|||
160966434|NCT00552084|581264899|FG001|Overall Study|Protocol Violation|0|||
160966435|NCT00552084|581264898|FG000|Overall Study|change in anti-arrythmic drug|1|||
160966436|NCT00552084|581264899|FG001|Overall Study|change in anti-arrythmic drug|1|||
160966437|NCT02286089|581264900|FG000|Overall Study|Ongoing in Study|1|||
160966438|NCT02286089|581264901|FG001|Overall Study|Ongoing in Study|1|||
160966439|NCT02286089|581264902|FG002|Overall Study|Ongoing in Study|4|||
160966440|NCT02286089|581264903|FG003|Overall Study|Ongoing in Study|10|||
160966441|NCT02286089|581264900|FG000|Overall Study|Withdrawal by Subject|0|||
160966442|NCT02286089|581264901|FG001|Overall Study|Withdrawal by Subject|0|||
160966443|NCT02286089|581264902|FG002|Overall Study|Withdrawal by Subject|2|||
160966444|NCT02286089|581264903|FG003|Overall Study|Withdrawal by Subject|2|||
160966445|NCT04981678|581264905|FG000|Overall Study|Lost to Follow-up|0|||
160966446|NCT04981678|581264906|FG001|Overall Study|Lost to Follow-up|1|||
160966447|NCT03779906|581264907|FG000|Overall Study|Lost to Follow-up|7|||
160966448|NCT03779906|581264907|FG000|Overall Study|COVID pandemic|1|||
160966449|NCT02044848|581266691|FG000|Overall Study|Administrative Problems|2|||
160966450|NCT02044848|581266692|FG001|Overall Study|Administrative Problems|3|||
160966451|NCT03183388|581266693|FG000|Overall Study|Lost to Follow-up|3|||
160966452|NCT03183388|581266694|FG001|Overall Study|Lost to Follow-up|5|||
160966453|NCT03183388|581266693|FG000|Overall Study|Physician Decision|1|||
160966454|NCT03183388|581266694|FG001|Overall Study|Physician Decision|4|||
160966455|NCT03183388|581266693|FG000|Overall Study|Withdrawal by Subject|4|||
160966456|NCT03183388|581266694|FG001|Overall Study|Withdrawal by Subject|1|||
160966457|NCT03183388|581266693|FG000|Overall Study|Moved|1|||
160966458|NCT03183388|581266694|FG001|Overall Study|Moved|0|||
160966459|NCT03183388|581266693|FG000|Overall Study|Met Exclusion Criteria|2|||
160966460|NCT03183388|581266694|FG001|Overall Study|Met Exclusion Criteria|2|||
160966461|NCT03183388|581266693|FG000|Overall Study|COVID Pandemic Related|2|||
160966462|NCT03183388|581266694|FG001|Overall Study|COVID Pandemic Related|4|||
160966463|NCT00284141|581266699|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
160966464|NCT00284141|581266699|FG000|Overall Study|Adverse Event|19|||
160966465|NCT00284141|581266699|FG000|Overall Study|Participant's request|9|||
160966466|NCT00284141|581266699|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
160966467|NCT00284141|581266699|FG000|Overall Study|Clinical deterioration / death|2|||
160966468|NCT00284141|581266699|FG000|Overall Study|General decline|1|||
160966469|NCT00284141|581266699|FG000|Overall Study|Pneumonia|1|||
160966470|NCT00284141|581266699|FG000|Overall Study|Did not take study medication|2|||
160966471|NCT00284141|581266699|FG000|Overall Study|Ongoing treatment|2|||
160966472|NCT01782742|581266702|FG000|Double-blind Treatment Phase|Adverse Event|1|||
160966473|NCT01782742|581266703|FG001|Double-blind Treatment Phase|Adverse Event|0|||
160966474|NCT00803101|581266704|FG000|Overall Study|Death / Serious Adverse Event|4|||
160966475|NCT00803101|581266705|FG001|Overall Study|Death / Serious Adverse Event|6|||
160966476|NCT00803101|581266704|FG000|Overall Study|Withdrawal by Subject|6|||
160966477|NCT00803101|581266705|FG001|Overall Study|Withdrawal by Subject|4|||
160966478|NCT00803101|581266704|FG000|Overall Study|Lost to Follow-up|2|||
160966479|NCT00803101|581266705|FG001|Overall Study|Lost to Follow-up|2|||
160966480|NCT00803101|581266704|FG000|Overall Study|Protocol Violation|1|||
160966481|NCT00803101|581266705|FG001|Overall Study|Protocol Violation|7|||
160966482|NCT00803101|581266704|FG000|Overall Study|Surgery finished outside protocol window|1|||
160966483|NCT00803101|581266705|FG001|Overall Study|Surgery finished outside protocol window|1|||
160966484|NCT00803101|581266704|FG000|Overall Study|Patient died outside SAE report period|1|||
160966485|NCT00803101|581266705|FG001|Overall Study|Patient died outside SAE report period|0|||
160458619|NCT03735979|579410913|FG002|Overall Study|Lost to Follow-up|14|||
160966486|NCT00803101|581266704|FG000|Overall Study|Patient did not attend scheduled visit|2|||
160966487|NCT00803101|581266705|FG001|Overall Study|Patient did not attend scheduled visit|1|||
160966488|NCT00803101|581266704|FG000|Overall Study|Patient did not have surgery|1|||
160966489|NCT00803101|581266705|FG001|Overall Study|Patient did not have surgery|1|||
160966490|NCT01529008|581266706|FG000|Bone Marrow Harvesting|Physician Decision|1|||
160966491|NCT01529008|581266707|FG001|Bone Marrow Harvesting|Physician Decision|1|||
160966492|NCT01529008|581266706|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
160966493|NCT01529008|581266707|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
160966494|NCT01529008|581266706|FG000|Treatment|Adverse Event|6|||
160966495|NCT01529008|581266707|FG001|Treatment|Adverse Event|0|||
160966496|NCT01529008|581266706|FG000|Treatment|Other|3|||
160966497|NCT01529008|581266707|FG001|Treatment|Other|1|||
160966498|NCT01529008|581266706|FG000|Efficacy Analysis|Protocol Violation|2|||
160966499|NCT01529008|581266707|FG001|Efficacy Analysis|Protocol Violation|0|||
160966500|NCT01529008|581266706|FG000|Efficacy Analysis|Physician Decision|0|||
160966501|NCT01529008|581266707|FG001|Efficacy Analysis|Physician Decision|1|||
160966502|NCT01529008|581266706|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
160966503|NCT01529008|581266707|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
160966504|NCT04170686|581266708|FG000|Screening|Physician Decision|12|||
160966505|NCT04170686|581266709|FG001|Screening|Physician Decision|13|||
160966506|NCT04170686|581266708|FG000|Randomization and Treatment|Lost to Follow-up|26|||
160966507|NCT04170686|581266709|FG001|Randomization and Treatment|Lost to Follow-up|15|||
160966508|NCT04425902|581266712|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
160966509|NCT01191840|581266713|FG000|Overall Study|withdrew consent|2|||
160966510|NCT01191840|581266714|FG001|Overall Study|withdrew consent|1|||
160966511|NCT01191840|581266713|FG000|Overall Study|Subject discontinued treatment|1|||
160966512|NCT01191840|581266714|FG001|Overall Study|Subject discontinued treatment|2|||
160966513|NCT01191840|581266713|FG000|Overall Study|Lost to Follow-up|4|||
160966514|NCT01191840|581266714|FG001|Overall Study|Lost to Follow-up|6|||
160966515|NCT01191840|581266713|FG000|Overall Study|Non Staph Infection|4|||
160966516|NCT01191840|581266714|FG001|Overall Study|Non Staph Infection|3|||
160966517|NCT01191840|581266713|FG000|Overall Study|ineligible at enrollment|1|||
160966518|NCT01191840|581266714|FG001|Overall Study|ineligible at enrollment|0|||
160966519|NCT01191840|581266713|FG000|Overall Study|IRB approval lapse|0|||
160966520|NCT01191840|581266714|FG001|Overall Study|IRB approval lapse|2|||
160966521|NCT01191840|581266713|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
160966522|NCT01191840|581266714|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
160966523|NCT01191840|581266713|FG000|Overall Study|Withdrawal by Subject|2|||
160966524|NCT01191840|581266714|FG001|Overall Study|Withdrawal by Subject|0|||
160966525|NCT04669600|581266715|FG000|Overall Study|Withdrawal by Subject|1|||
160966526|NCT04669600|581266715|FG000|Overall Study|Other|6|||
160966527|NCT01802437|581266721|FG000|Overall Study|Lost to Follow-up|1|||
160966528|NCT01802437|581266722|FG001|Overall Study|Lost to Follow-up|0|||
160966529|NCT01802437|581266721|FG000|Overall Study|Withdrawal by Subject|3|||
160966530|NCT01802437|581266722|FG001|Overall Study|Withdrawal by Subject|4|||
160966531|NCT04857034|581266727|FG000|Placebo-Controlled Period|Request to discontinue|2|||
160966532|NCT04857034|581266728|FG001|Placebo-Controlled Period|Request to discontinue|2|||
160966533|NCT04857034|581266729|FG002|Placebo-Controlled Period|Request to discontinue|0|||
160966534|NCT04857034|581266730|FG003|Placebo-Controlled Period|Request to discontinue|0|||
160966535|NCT04857034|581266731|FG004|Placebo-Controlled Period|Request to discontinue|0|||
160966536|NCT04857034|581266727|FG000|Placebo-Controlled Period|withdrew consent|1|||
160966537|NCT04857034|581266728|FG001|Placebo-Controlled Period|withdrew consent|1|||
160966538|NCT04857034|581266729|FG002|Placebo-Controlled Period|withdrew consent|2|||
160966539|NCT04857034|581266730|FG003|Placebo-Controlled Period|withdrew consent|0|||
160966540|NCT04857034|581266731|FG004|Placebo-Controlled Period|withdrew consent|0|||
160966541|NCT04857034|581266727|FG000|Placebo-Controlled Period|Pregnancy|1|||
160966542|NCT04857034|581266728|FG001|Placebo-Controlled Period|Pregnancy|1|||
160966543|NCT04857034|581266729|FG002|Placebo-Controlled Period|Pregnancy|0|||
160966544|NCT04857034|581266730|FG003|Placebo-Controlled Period|Pregnancy|0|||
160966545|NCT04857034|581266731|FG004|Placebo-Controlled Period|Pregnancy|0|||
160966546|NCT04857034|581266727|FG000|Placebo-Controlled Period|Ongoing study period|0|||
160966547|NCT04857034|581266728|FG001|Placebo-Controlled Period|Ongoing study period|1|||
160966548|NCT04857034|581266729|FG002|Placebo-Controlled Period|Ongoing study period|0|||
160966549|NCT04857034|581266730|FG003|Placebo-Controlled Period|Ongoing study period|0|||
160966550|NCT04857034|581266731|FG004|Placebo-Controlled Period|Ongoing study period|0|||
160966551|NCT04857034|581266727|FG000|Active Treatment Period|Lack of Efficacy|1|||
160966552|NCT04857034|581266728|FG001|Active Treatment Period|Lack of Efficacy|0|||
160966553|NCT04857034|581266729|FG002|Active Treatment Period|Lack of Efficacy|0|||
160966554|NCT04857034|581266730|FG003|Active Treatment Period|Lack of Efficacy|0|||
160966555|NCT04857034|581266731|FG004|Active Treatment Period|Lack of Efficacy|0|||
160966556|NCT04857034|581266727|FG000|Active Treatment Period|request to discontinue|0|||
160966557|NCT04857034|581266728|FG001|Active Treatment Period|request to discontinue|1|||
160966558|NCT04857034|581266729|FG002|Active Treatment Period|request to discontinue|0|||
161006391|NCT01764464|581410771|FG000|First Intervention|Withdrawal by Subject|1|||
160966559|NCT04857034|581266730|FG003|Active Treatment Period|request to discontinue|1|||
160966560|NCT04857034|581266731|FG004|Active Treatment Period|request to discontinue|0|||
160966561|NCT04857034|581266727|FG000|Active Treatment Period|administrative reason by sponsor|1|||
160966562|NCT04857034|581266728|FG001|Active Treatment Period|administrative reason by sponsor|5|||
160966563|NCT04857034|581266729|FG002|Active Treatment Period|administrative reason by sponsor|0|||
160966564|NCT04857034|581266730|FG003|Active Treatment Period|administrative reason by sponsor|2|||
160966565|NCT04857034|581266731|FG004|Active Treatment Period|administrative reason by sponsor|2|||
161006392|NCT01764464|581410772|FG001|First Intervention|Withdrawal by Subject|0|||
161006393|NCT01764464|581410771|FG000|First Intervention|Lost to Follow-up|1|||
161006394|NCT01764464|581410772|FG001|First Intervention|Lost to Follow-up|0|||
161006395|NCT01764464|581410771|FG000|First Intervention|Adverse Event|0|||
161006396|NCT01764464|581410772|FG001|First Intervention|Adverse Event|2|||
161006397|NCT01764464|581410771|FG000|First Intervention|did not receive study drug|0|||
161006398|NCT01764464|581410772|FG001|First Intervention|did not receive study drug|1|||
161006399|NCT01764464|581410771|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
161006400|NCT01764464|581410772|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
161006401|NCT01616459|581410777|FG000|Overall Study|Adverse Event|1|||
161006402|NCT01616459|581410778|FG001|Overall Study|Adverse Event|1|||
161006403|NCT01616459|581410779|FG002|Overall Study|Adverse Event|2|||
161006404|NCT01616459|581410780|FG003|Overall Study|Adverse Event|0|||
161006405|NCT01616459|581410777|FG000|Overall Study|Lost to Follow-up|1|||
160966566|NCT04857034|581266727|FG000|Active Treatment Period|other reasons|1|||
160966567|NCT04857034|581266728|FG001|Active Treatment Period|other reasons|1|||
160966568|NCT04857034|581266729|FG002|Active Treatment Period|other reasons|0|||
160966569|NCT04857034|581266730|FG003|Active Treatment Period|other reasons|0|||
160966570|NCT04857034|581266731|FG004|Active Treatment Period|other reasons|1|||
160966571|NCT04857034|581266727|FG000|Active Treatment Period|Ongoing Study Period|2|||
160966572|NCT04857034|581266728|FG001|Active Treatment Period|Ongoing Study Period|4|||
160966573|NCT04857034|581266729|FG002|Active Treatment Period|Ongoing Study Period|0|||
160966574|NCT04857034|581266730|FG003|Active Treatment Period|Ongoing Study Period|1|||
160966575|NCT04857034|581266731|FG004|Active Treatment Period|Ongoing Study Period|0|||
160966576|NCT01682213|581266734|FG000|Overall Study|Withdrawal by Subject|2|||
160966577|NCT01264380|581266735|FG000|Period C|Disease Progression|0|||
160966578|NCT01264380|581266736|FG001|Period C|Disease Progression|0|||
160966579|NCT01264380|581266737|FG002|Period C|Disease Progression|4|||
160966580|NCT01264380|581266735|FG000|Period C|Death|0|||
160966581|NCT01264380|581266736|FG001|Period C|Death|0|||
160966582|NCT01264380|581266737|FG002|Period C|Death|2|||
160966583|NCT01264380|581266735|FG000|Period C|Follow-up for survival status|0|||
160966584|NCT01264380|581266736|FG001|Period C|Follow-up for survival status|0|||
160966585|NCT01264380|581266737|FG002|Period C|Follow-up for survival status|6|||
160966586|NCT01264380|581266735|FG000|Period C|Withdrawal by Subject|0|||
160966587|NCT01264380|581266736|FG001|Period C|Withdrawal by Subject|0|||
160966588|NCT01264380|581266737|FG002|Period C|Withdrawal by Subject|1|||
160966589|NCT01264380|581266735|FG000|Period C|Adverse Event|0|||
160966590|NCT01264380|581266736|FG001|Period C|Adverse Event|0|||
160966591|NCT01264380|581266737|FG002|Period C|Adverse Event|1|||
160966592|NCT04382924|581266739|FG000|Overall Study|Death|2|||
160966593|NCT04382924|581266740|FG001|Overall Study|Death|5|||
160966594|NCT04382924|581266741|FG002|Overall Study|Death|4|||
160966595|NCT04382924|581266739|FG000|Overall Study|Protocol Violation|0|||
160966596|NCT04382924|581266740|FG001|Overall Study|Protocol Violation|1|||
160966597|NCT04382924|581266741|FG002|Overall Study|Protocol Violation|1|||
160966598|NCT04382924|581266739|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
160966599|NCT04382924|581266740|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
160966600|NCT04382924|581266741|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
160966601|NCT04382924|581266739|FG000|Overall Study|Withdrawal by Subject|6|||
160966602|NCT04382924|581266740|FG001|Overall Study|Withdrawal by Subject|3|||
160966603|NCT04382924|581266741|FG002|Overall Study|Withdrawal by Subject|6|||
160966604|NCT04998604|581266742|FG000|Overall Study|Adverse Event|3|||
160966605|NCT04998604|581266743|FG001|Overall Study|Adverse Event|2|||
160966606|NCT04998604|581266742|FG000|Overall Study|Withdrawal by Subject|2|||
160966607|NCT04998604|581266743|FG001|Overall Study|Withdrawal by Subject|4|||
160966608|NCT04998604|581266742|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
160966609|NCT04998604|581266743|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
160966610|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
160966611|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
160966612|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
160966613|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
160966614|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
160966615|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
160966616|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
160966617|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
161006406|NCT01616459|581410778|FG001|Overall Study|Lost to Follow-up|11|||
161006407|NCT01616459|581410779|FG002|Overall Study|Lost to Follow-up|3|||
161006408|NCT01616459|581410780|FG003|Overall Study|Lost to Follow-up|2|||
160966618|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
160966619|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
160966620|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
160966621|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
160966622|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
160966623|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
161006409|NCT01616459|581410777|FG000|Overall Study|Protocol Violation|0|||
161006410|NCT01616459|581410778|FG001|Overall Study|Protocol Violation|0|||
161006411|NCT01616459|581410779|FG002|Overall Study|Protocol Violation|0|||
161006412|NCT01616459|581410780|FG003|Overall Study|Protocol Violation|2|||
161006413|NCT01616459|581410777|FG000|Overall Study|Withdrawal by Subject|2|||
161006414|NCT01616459|581410778|FG001|Overall Study|Withdrawal by Subject|4|||
161006415|NCT01616459|581410779|FG002|Overall Study|Withdrawal by Subject|4|||
161006416|NCT01616459|581410780|FG003|Overall Study|Withdrawal by Subject|4|||
161006417|NCT01616459|581410777|FG000|Overall Study|Other reason|0|||
161006418|NCT01616459|581410778|FG001|Overall Study|Other reason|1|||
161006419|NCT01616459|581410779|FG002|Overall Study|Other reason|1|||
161006420|NCT01616459|581410780|FG003|Overall Study|Other reason|0|||
161006421|NCT04755660|581412378|FG000|Overall Study|Lost to Follow-up|1|||
161006422|NCT04755660|581412379|FG001|Overall Study|Lost to Follow-up|1|||
161006423|NCT04755660|581412380|FG002|Overall Study|Lost to Follow-up|0|||
161006424|NCT04755660|581412378|FG000|Overall Study|Withdrawal by Subject|0|||
161006425|NCT04755660|581412379|FG001|Overall Study|Withdrawal by Subject|1|||
161006426|NCT04755660|581412380|FG002|Overall Study|Withdrawal by Subject|1|||
161006427|NCT04755660|581412378|FG000|Overall Study|Physician Decision|0|||
161006428|NCT04755660|581412379|FG001|Overall Study|Physician Decision|0|||
161006429|NCT04755660|581412380|FG002|Overall Study|Physician Decision|1|||
160585352|NCT02345252|579861912|FG001|Double-Blind Phase|Investigator's Discretion|6|||
160585353|NCT02345252|579861911|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
160585354|NCT02345252|579861912|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
160585355|NCT02345252|579861911|FG000|Double-Blind Phase|Protocol Violation|2|||
160585356|NCT02345252|579861912|FG001|Double-Blind Phase|Protocol Violation|1|||
160585357|NCT02345252|579861911|FG000|Double-Blind Phase|Withdrew Consent|21|||
160966624|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
160966625|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
160966626|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
160966627|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
160966628|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
160966629|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
160966630|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
160966631|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
160966632|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
160966633|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
160966634|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
160966635|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
160966636|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
160966637|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
160966638|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
160966639|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
160966640|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
160966641|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
160966642|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
160966643|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
160966644|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
160966645|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
160966646|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160966647|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
160966648|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
160966649|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
160966650|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
160966651|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
160966652|NCT00429663|581266750|FG000|Overall Study|Lost to Follow-up|24|||
160966653|NCT00429663|581266751|FG001|Overall Study|Lost to Follow-up|31|||
160966654|NCT00429663|581266750|FG000|Overall Study|Physician Decision|6|||
160966655|NCT00429663|581266751|FG001|Overall Study|Physician Decision|3|||
160966656|NCT00429663|581266750|FG000|Overall Study|Withdrawal by Subject|2|||
160966657|NCT00429663|581266751|FG001|Overall Study|Withdrawal by Subject|5|||
160966658|NCT00429663|581266750|FG000|Overall Study|Death|4|||
160966659|NCT00429663|581266751|FG001|Overall Study|Death|0|||
160966660|NCT04207840|581266752|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
160966661|NCT04207840|581266753|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
160966662|NCT04207840|581266754|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
160966663|NCT04207840|581266752|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
161006430|NCT04279574|581412383|FG000|Overall Study|Death|1|||
161006431|NCT04279574|581412384|FG001|Overall Study|Death|0|||
161006432|NCT04279574|581412383|FG000|Overall Study|lost restoration, tooth fracture|1|||
161006433|NCT04279574|581412384|FG001|Overall Study|lost restoration, tooth fracture|0|||
161006434|NCT04279574|581412383|FG000|Overall Study|Lost to Follow-up|0|||
161006435|NCT04279574|581412384|FG001|Overall Study|Lost to Follow-up|1|||
161006436|NCT02991807|581412386|FG000|Overall Study|Withdrawal by Subject|2|||
161006437|NCT02991807|581412387|FG001|Overall Study|Withdrawal by Subject|1|||
161006438|NCT02991807|581412386|FG000|Overall Study|Physician Decision|0|||
161006439|NCT02991807|581412387|FG001|Overall Study|Physician Decision|1|||
161006440|NCT02991807|581412386|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
161006441|NCT02991807|581412387|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
161006442|NCT02566902|581412388|FG000|Overall Study|Protocol Violation|2|||
161006443|NCT02566902|581412389|FG001|Overall Study|Protocol Violation|1|||
161006444|NCT01875848|581412390|FG000|Overall Study|Withdrawal by Subject|2|||
161006445|NCT01875848|581412391|FG001|Overall Study|Withdrawal by Subject|0|||
161006446|NCT02411084|581412392|FG000|Overall Study|Lack of Efficacy|6|||
161006447|NCT02411084|581412393|FG001|Overall Study|Lack of Efficacy|3|||
161006448|NCT02411084|581412392|FG000|Overall Study|Death|5|||
161006449|NCT02411084|581412393|FG001|Overall Study|Death|4|||
161006450|NCT02411084|581412392|FG000|Overall Study|Adverse Event|2|||
161006451|NCT02411084|581412393|FG001|Overall Study|Adverse Event|1|||
161006452|NCT02411084|581412392|FG000|Overall Study|Other reasons|0|||
161006453|NCT02411084|581412393|FG001|Overall Study|Other reasons|5|||
161006454|NCT01622868|581412394|FG000|Overall Study|Protocol Violation|7|||
161006455|NCT01622868|581412395|FG001|Overall Study|Protocol Violation|0|||
161006456|NCT03285763|581412397|FG000|Overall Study|Death|470|||
161006457|NCT03285763|581412397|FG000|Overall Study|Lost to Follow-up|18|||
161006458|NCT03285763|581412397|FG000|Overall Study|Physician Decision|2|||
161006459|NCT03285763|581412397|FG000|Overall Study|Study Terminated By Sponsor|79|||
161006460|NCT03285763|581412397|FG000|Overall Study|Withdrawal by Subject|33|||
161006461|NCT04425629|581412398|FG000|Overall Study|Adverse Event|0|||
161006462|NCT04425629|581412399|FG001|Overall Study|Adverse Event|0|||
161006463|NCT04425629|581412400|FG002|Overall Study|Adverse Event|0|||
161006464|NCT04425629|581412401|FG003|Overall Study|Adverse Event|0|||
161006465|NCT04425629|581412402|FG004|Overall Study|Adverse Event|1|||
161006466|NCT04425629|581412403|FG005|Overall Study|Adverse Event|0|||
161006467|NCT04425629|581412404|FG006|Overall Study|Adverse Event|0|||
161006468|NCT04425629|581412405|FG007|Overall Study|Adverse Event|0|||
161006469|NCT04425629|581412406|FG008|Overall Study|Adverse Event|0|||
161006470|NCT04425629|581412407|FG009|Overall Study|Adverse Event|3|||
161006471|NCT04425629|581412408|FG010|Overall Study|Adverse Event|2|||
161006472|NCT04425629|581412409|FG011|Overall Study|Adverse Event|1|||
161006473|NCT04425629|581412410|FG012|Overall Study|Adverse Event|1|||
161006474|NCT04425629|581412411|FG013|Overall Study|Adverse Event|0|||
161006475|NCT04425629|581412412|FG014|Overall Study|Adverse Event|0|||
161006476|NCT04425629|581412413|FG015|Overall Study|Adverse Event|0|||
161006477|NCT04425629|581412414|FG016|Overall Study|Adverse Event|0|||
161006478|NCT04425629|581412415|FG017|Overall Study|Adverse Event|0|||
161006479|NCT04425629|581412416|FG018|Overall Study|Adverse Event|0|||
161006480|NCT04425629|581412398|FG000|Overall Study|Lost to Follow-up|1|||
161006481|NCT04425629|581412399|FG001|Overall Study|Lost to Follow-up|3|||
161006482|NCT04425629|581412400|FG002|Overall Study|Lost to Follow-up|1|||
161006483|NCT04425629|581412401|FG003|Overall Study|Lost to Follow-up|7|||
161006484|NCT04425629|581412402|FG004|Overall Study|Lost to Follow-up|1|||
161006485|NCT04425629|581412403|FG005|Overall Study|Lost to Follow-up|2|||
161006486|NCT04425629|581412404|FG006|Overall Study|Lost to Follow-up|1|||
161006487|NCT04425629|581412405|FG007|Overall Study|Lost to Follow-up|0|||
161006488|NCT04425629|581412406|FG008|Overall Study|Lost to Follow-up|1|||
161006489|NCT04425629|581412407|FG009|Overall Study|Lost to Follow-up|64|||
161006490|NCT04425629|581412408|FG010|Overall Study|Lost to Follow-up|70|||
161006491|NCT04425629|581412409|FG011|Overall Study|Lost to Follow-up|98|||
161006492|NCT04425629|581412410|FG012|Overall Study|Lost to Follow-up|30|||
161006493|NCT04425629|581412411|FG013|Overall Study|Lost to Follow-up|0|||
161006494|NCT04425629|581412412|FG014|Overall Study|Lost to Follow-up|5|||
161006495|NCT04425629|581412413|FG015|Overall Study|Lost to Follow-up|4|||
161006496|NCT04425629|581412414|FG016|Overall Study|Lost to Follow-up|0|||
161006497|NCT04425629|581412415|FG017|Overall Study|Lost to Follow-up|3|||
161006498|NCT04425629|581412416|FG018|Overall Study|Lost to Follow-up|1|||
161006499|NCT04425629|581412398|FG000|Overall Study|Subject Decision|0|||
161006500|NCT04425629|581412399|FG001|Overall Study|Subject Decision|2|||
161006501|NCT04425629|581412400|FG002|Overall Study|Subject Decision|1|||
161006502|NCT04425629|581412401|FG003|Overall Study|Subject Decision|3|||
161006503|NCT04425629|581412402|FG004|Overall Study|Subject Decision|6|||
161006504|NCT04425629|581412403|FG005|Overall Study|Subject Decision|6|||
161006505|NCT04425629|581412404|FG006|Overall Study|Subject Decision|3|||
161006506|NCT04425629|581412405|FG007|Overall Study|Subject Decision|3|||
161006507|NCT04425629|581412406|FG008|Overall Study|Subject Decision|1|||
161006508|NCT04425629|581412407|FG009|Overall Study|Subject Decision|70|||
161006509|NCT04425629|581412408|FG010|Overall Study|Subject Decision|95|||
161006510|NCT04425629|581412409|FG011|Overall Study|Subject Decision|124|||
161006511|NCT04425629|581412410|FG012|Overall Study|Subject Decision|25|||
161006512|NCT04425629|581412411|FG013|Overall Study|Subject Decision|0|||
161006513|NCT04425629|581412412|FG014|Overall Study|Subject Decision|1|||
161006514|NCT04425629|581412413|FG015|Overall Study|Subject Decision|4|||
161006515|NCT04425629|581412414|FG016|Overall Study|Subject Decision|1|||
161006516|NCT04425629|581412415|FG017|Overall Study|Subject Decision|0|||
161006517|NCT04425629|581412416|FG018|Overall Study|Subject Decision|2|||
161006518|NCT04425629|581412398|FG000|Overall Study|Death|0|||
161006519|NCT04425629|581412399|FG001|Overall Study|Death|0|||
161006520|NCT04425629|581412400|FG002|Overall Study|Death|0|||
161006521|NCT04425629|581412401|FG003|Overall Study|Death|0|||
161006522|NCT04425629|581412402|FG004|Overall Study|Death|0|||
161006523|NCT04425629|581412403|FG005|Overall Study|Death|0|||
161006524|NCT04425629|581412404|FG006|Overall Study|Death|0|||
161006525|NCT04425629|581412405|FG007|Overall Study|Death|0|||
161006526|NCT04425629|581412406|FG008|Overall Study|Death|0|||
161006527|NCT04425629|581412407|FG009|Overall Study|Death|11|||
161006528|NCT04425629|581412408|FG010|Overall Study|Death|2|||
161006529|NCT04425629|581412409|FG011|Overall Study|Death|4|||
161006530|NCT04425629|581412410|FG012|Overall Study|Death|0|||
161006531|NCT04425629|581412411|FG013|Overall Study|Death|0|||
161006532|NCT04425629|581412412|FG014|Overall Study|Death|0|||
161006533|NCT04425629|581412413|FG015|Overall Study|Death|0|||
161006534|NCT04425629|581412414|FG016|Overall Study|Death|0|||
161006535|NCT04425629|581412415|FG017|Overall Study|Death|0|||
161006536|NCT04425629|581412416|FG018|Overall Study|Death|0|||
161006537|NCT04425629|581412398|FG000|Overall Study|Sponsor Request|0|||
161006538|NCT04425629|581412399|FG001|Overall Study|Sponsor Request|0|||
161006539|NCT04425629|581412400|FG002|Overall Study|Sponsor Request|0|||
161006540|NCT04425629|581412401|FG003|Overall Study|Sponsor Request|2|||
161006541|NCT04425629|581412402|FG004|Overall Study|Sponsor Request|2|||
161006542|NCT04425629|581412403|FG005|Overall Study|Sponsor Request|2|||
161006543|NCT04425629|581412404|FG006|Overall Study|Sponsor Request|1|||
161006544|NCT04425629|581412405|FG007|Overall Study|Sponsor Request|0|||
161006545|NCT04425629|581412406|FG008|Overall Study|Sponsor Request|0|||
161006546|NCT04425629|581412407|FG009|Overall Study|Sponsor Request|9|||
161006547|NCT04425629|581412408|FG010|Overall Study|Sponsor Request|9|||
161006548|NCT04425629|581412409|FG011|Overall Study|Sponsor Request|10|||
161006549|NCT04425629|581412410|FG012|Overall Study|Sponsor Request|8|||
161006550|NCT04425629|581412411|FG013|Overall Study|Sponsor Request|0|||
161006551|NCT04425629|581412412|FG014|Overall Study|Sponsor Request|0|||
161006552|NCT04425629|581412413|FG015|Overall Study|Sponsor Request|1|||
161006553|NCT04425629|581412414|FG016|Overall Study|Sponsor Request|0|||
161006554|NCT04425629|581412415|FG017|Overall Study|Sponsor Request|0|||
161006555|NCT04425629|581412416|FG018|Overall Study|Sponsor Request|0|||
161006556|NCT04425629|581412398|FG000|Overall Study|Physician Decision|0|||
161006557|NCT04425629|581412399|FG001|Overall Study|Physician Decision|0|||
161006558|NCT04425629|581412400|FG002|Overall Study|Physician Decision|0|||
161006559|NCT04425629|581412401|FG003|Overall Study|Physician Decision|0|||
161006560|NCT04425629|581412402|FG004|Overall Study|Physician Decision|0|||
161006561|NCT04425629|581412403|FG005|Overall Study|Physician Decision|0|||
161006562|NCT04425629|581412404|FG006|Overall Study|Physician Decision|0|||
161006563|NCT04425629|581412405|FG007|Overall Study|Physician Decision|0|||
160585358|NCT02345252|579861912|FG001|Double-Blind Phase|Withdrew Consent|23|||
160585359|NCT02345252|579861911|FG000|Double-Blind Phase|Lost to Follow-up|8|||
160585360|NCT02345252|579861912|FG001|Double-Blind Phase|Lost to Follow-up|10|||
160585361|NCT02345252|579861911|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
160585362|NCT02345252|579861912|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
160585363|NCT00471536|579861923|FG000|Overall Study|Withdrawal by Subject|1|||
160585364|NCT02651194|579861924|FG000|Overall Study|Lost to Follow-up|3|||
160966664|NCT04207840|581266753|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
160966665|NCT04207840|581266754|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
160966666|NCT03243422|581266755|FG000|Overall Study|Death|20|||
160966667|NCT03243422|581266756|FG001|Overall Study|Death|21|||
160966668|NCT03243422|581266755|FG000|Overall Study|Lost to Follow-up|9|||
160966669|NCT03243422|581266756|FG001|Overall Study|Lost to Follow-up|21|||
160966670|NCT03243422|581266755|FG000|Overall Study|Withdrawal by Subject|22|||
160966671|NCT03243422|581266756|FG001|Overall Study|Withdrawal by Subject|8|||
160966672|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
160966673|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
160966674|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
161006564|NCT04425629|581412406|FG008|Overall Study|Physician Decision|0|||
161006565|NCT04425629|581412407|FG009|Overall Study|Physician Decision|4|||
161006566|NCT04425629|581412408|FG010|Overall Study|Physician Decision|3|||
161006567|NCT04425629|581412409|FG011|Overall Study|Physician Decision|5|||
161006568|NCT04425629|581412410|FG012|Overall Study|Physician Decision|1|||
161006569|NCT04425629|581412411|FG013|Overall Study|Physician Decision|0|||
161006570|NCT04425629|581412412|FG014|Overall Study|Physician Decision|0|||
161006571|NCT04425629|581412413|FG015|Overall Study|Physician Decision|1|||
161006572|NCT04425629|581412414|FG016|Overall Study|Physician Decision|0|||
161006573|NCT04425629|581412415|FG017|Overall Study|Physician Decision|0|||
161006574|NCT04425629|581412416|FG018|Overall Study|Physician Decision|0|||
161006575|NCT04425629|581412398|FG000|Overall Study|Lack of Efficacy|0|||
161006576|NCT04425629|581412399|FG001|Overall Study|Lack of Efficacy|0|||
161006577|NCT04425629|581412400|FG002|Overall Study|Lack of Efficacy|0|||
161006578|NCT04425629|581412401|FG003|Overall Study|Lack of Efficacy|0|||
161006579|NCT04425629|581412402|FG004|Overall Study|Lack of Efficacy|0|||
161006580|NCT04425629|581412403|FG005|Overall Study|Lack of Efficacy|0|||
161006581|NCT04425629|581412404|FG006|Overall Study|Lack of Efficacy|0|||
161006582|NCT04425629|581412405|FG007|Overall Study|Lack of Efficacy|0|||
161006583|NCT04425629|581412406|FG008|Overall Study|Lack of Efficacy|0|||
161006584|NCT04425629|581412407|FG009|Overall Study|Lack of Efficacy|0|||
161006585|NCT04425629|581412408|FG010|Overall Study|Lack of Efficacy|1|||
161006586|NCT04425629|581412409|FG011|Overall Study|Lack of Efficacy|0|||
161006587|NCT04425629|581412410|FG012|Overall Study|Lack of Efficacy|0|||
161006588|NCT04425629|581412411|FG013|Overall Study|Lack of Efficacy|0|||
161006589|NCT04425629|581412412|FG014|Overall Study|Lack of Efficacy|0|||
161006590|NCT04425629|581412413|FG015|Overall Study|Lack of Efficacy|0|||
161006591|NCT04425629|581412414|FG016|Overall Study|Lack of Efficacy|0|||
161006592|NCT04425629|581412415|FG017|Overall Study|Lack of Efficacy|0|||
161006593|NCT04425629|581412416|FG018|Overall Study|Lack of Efficacy|0|||
161006594|NCT00610649|581412419|FG000|Overall Study|Adverse Event|1|||
161006595|NCT00610649|581412420|FG001|Overall Study|Adverse Event|0|||
161006596|NCT00610649|581412421|FG002|Overall Study|Adverse Event|0|||
161006597|NCT00610649|581412422|FG003|Overall Study|Adverse Event|0|||
161006598|NCT00610649|581412423|FG004|Overall Study|Adverse Event|0|||
161006599|NCT00610649|581412424|FG005|Overall Study|Adverse Event|0|||
161006600|NCT00610649|581412425|FG006|Overall Study|Adverse Event|0|||
161006601|NCT00610649|581412426|FG007|Overall Study|Adverse Event|0|||
161006602|NCT00610649|581412427|FG008|Overall Study|Adverse Event|0|||
161006603|NCT00610649|581412428|FG009|Overall Study|Adverse Event|0|||
161006604|NCT00610649|581412429|FG010|Overall Study|Adverse Event|1|||
161006605|NCT00610649|581412419|FG000|Overall Study|Family Emergency|0|||
161006606|NCT00610649|581412420|FG001|Overall Study|Family Emergency|1|||
161006607|NCT00610649|581412421|FG002|Overall Study|Family Emergency|0|||
161006608|NCT00610649|581412422|FG003|Overall Study|Family Emergency|0|||
161006609|NCT00610649|581412423|FG004|Overall Study|Family Emergency|0|||
161006610|NCT00610649|581412424|FG005|Overall Study|Family Emergency|0|||
161006611|NCT00610649|581412425|FG006|Overall Study|Family Emergency|0|||
161006612|NCT00610649|581412426|FG007|Overall Study|Family Emergency|0|||
161006613|NCT00610649|581412427|FG008|Overall Study|Family Emergency|0|||
161006614|NCT00610649|581412428|FG009|Overall Study|Family Emergency|0|||
161006615|NCT00610649|581412429|FG010|Overall Study|Family Emergency|0|||
161006616|NCT00610649|581412419|FG000|Overall Study|Withdrawal by Subject|0|||
161006617|NCT00610649|581412420|FG001|Overall Study|Withdrawal by Subject|0|||
161006618|NCT00610649|581412421|FG002|Overall Study|Withdrawal by Subject|0|||
161006619|NCT00610649|581412422|FG003|Overall Study|Withdrawal by Subject|0|||
161006620|NCT00610649|581412423|FG004|Overall Study|Withdrawal by Subject|0|||
161006621|NCT00610649|581412424|FG005|Overall Study|Withdrawal by Subject|0|||
161006622|NCT00610649|581412425|FG006|Overall Study|Withdrawal by Subject|0|||
161006623|NCT00610649|581412426|FG007|Overall Study|Withdrawal by Subject|0|||
161006624|NCT00610649|581412427|FG008|Overall Study|Withdrawal by Subject|0|||
161006625|NCT00610649|581412428|FG009|Overall Study|Withdrawal by Subject|1|||
161006626|NCT00610649|581412429|FG010|Overall Study|Withdrawal by Subject|0|||
161006627|NCT04259450|581412430|FG000|Overall Study|Adverse event/ Toxicity|0|||
161006628|NCT04259450|581412431|FG001|Overall Study|Adverse event/ Toxicity|3|||
161006629|NCT04259450|581412432|FG002|Overall Study|Adverse event/ Toxicity|0|||
161006630|NCT04259450|581412433|FG003|Overall Study|Adverse event/ Toxicity|1|||
161006631|NCT04259450|581412434|FG004|Overall Study|Adverse event/ Toxicity|0|||
161006632|NCT04259450|581412435|FG005|Overall Study|Adverse event/ Toxicity|0|||
161006633|NCT04259450|581412436|FG006|Overall Study|Adverse event/ Toxicity|0|||
161006634|NCT04259450|581412437|FG007|Overall Study|Adverse event/ Toxicity|1|||
161006635|NCT04259450|581412438|FG008|Overall Study|Adverse event/ Toxicity|0|||
161006636|NCT04259450|581412439|FG009|Overall Study|Adverse event/ Toxicity|3|||
161006637|NCT04259450|581412430|FG000|Overall Study|Disease progression|2|||
161006638|NCT04259450|581412431|FG001|Overall Study|Disease progression|3|||
160585365|NCT02651194|579861924|FG000|Overall Study|Other|2|||
160585366|NCT01980706|579861925|FG000|Overall Study|Withdrawal by Subject|9|||
160585367|NCT01980706|579861926|FG001|Overall Study|Withdrawal by Subject|6|||
160585368|NCT01980706|579861927|FG002|Overall Study|Withdrawal by Subject|2|||
160585369|NCT01980706|579861925|FG000|Overall Study|Adverse Event|1|||
160585370|NCT01980706|579861926|FG001|Overall Study|Adverse Event|2|||
161006639|NCT04259450|581412432|FG002|Overall Study|Disease progression|4|||
161006640|NCT04259450|581412433|FG003|Overall Study|Disease progression|4|||
161006641|NCT04259450|581412434|FG004|Overall Study|Disease progression|6|||
161006642|NCT04259450|581412435|FG005|Overall Study|Disease progression|6|||
161006643|NCT04259450|581412436|FG006|Overall Study|Disease progression|6|||
161006644|NCT04259450|581412437|FG007|Overall Study|Disease progression|15|||
161006645|NCT04259450|581412438|FG008|Overall Study|Disease progression|6|||
161006646|NCT04259450|581412439|FG009|Overall Study|Disease progression|18|||
161006647|NCT04259450|581412430|FG000|Overall Study|Death|0|||
161006648|NCT04259450|581412431|FG001|Overall Study|Death|0|||
161006649|NCT04259450|581412432|FG002|Overall Study|Death|0|||
161006650|NCT04259450|581412433|FG003|Overall Study|Death|0|||
161006651|NCT04259450|581412434|FG004|Overall Study|Death|0|||
161006652|NCT04259450|581412435|FG005|Overall Study|Death|0|||
161006653|NCT04259450|581412436|FG006|Overall Study|Death|0|||
161006654|NCT04259450|581412437|FG007|Overall Study|Death|1|||
161006655|NCT04259450|581412438|FG008|Overall Study|Death|1|||
161006656|NCT04259450|581412439|FG009|Overall Study|Death|0|||
161006657|NCT04259450|581412430|FG000|Overall Study|Withdrawal by Subject|0|||
161006658|NCT04259450|581412431|FG001|Overall Study|Withdrawal by Subject|0|||
161006659|NCT04259450|581412432|FG002|Overall Study|Withdrawal by Subject|0|||
161006660|NCT04259450|581412433|FG003|Overall Study|Withdrawal by Subject|0|||
161006661|NCT04259450|581412434|FG004|Overall Study|Withdrawal by Subject|0|||
161006662|NCT04259450|581412435|FG005|Overall Study|Withdrawal by Subject|0|||
161006663|NCT04259450|581412436|FG006|Overall Study|Withdrawal by Subject|0|||
160966675|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
160966676|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
160966677|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
160966678|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
160966679|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
161006664|NCT04259450|581412437|FG007|Overall Study|Withdrawal by Subject|1|||
161006665|NCT04259450|581412438|FG008|Overall Study|Withdrawal by Subject|0|||
161006666|NCT04259450|581412439|FG009|Overall Study|Withdrawal by Subject|0|||
161006667|NCT04259450|581412430|FG000|Overall Study|Other than listed|0|||
161006668|NCT04259450|581412431|FG001|Overall Study|Other than listed|0|||
160966680|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
160966681|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
160966682|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
160966683|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
160966684|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
160966685|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
160966686|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
160966687|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
160966688|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
160966689|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
160966690|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
160966691|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
160966692|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Death|2|||
160966693|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Death|2|||
160966694|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Death|0|||
160966695|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Death|0|||
160966696|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Death|0|||
160966697|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
160966698|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
160966699|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
160966700|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
160966701|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
160966702|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
160966703|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
160966704|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
160966705|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
160966706|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
160966707|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
160966708|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
160966709|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
160966710|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
160966711|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
160966712|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
160966713|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
160966714|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
160966715|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
160966716|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
160966717|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
160966718|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
160966719|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
161006669|NCT04259450|581412432|FG002|Overall Study|Other than listed|0|||
160585371|NCT01980706|579861927|FG002|Overall Study|Adverse Event|5|||
160966720|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
161006670|NCT04259450|581412433|FG003|Overall Study|Other than listed|0|||
161006671|NCT04259450|581412434|FG004|Overall Study|Other than listed|0|||
161006672|NCT04259450|581412435|FG005|Overall Study|Other than listed|0|||
161006673|NCT04259450|581412436|FG006|Overall Study|Other than listed|0|||
161006674|NCT04259450|581412437|FG007|Overall Study|Other than listed|1|||
160585372|NCT01980706|579861925|FG000|Overall Study|Lost to Follow-up|3|||
160585373|NCT01980706|579861926|FG001|Overall Study|Lost to Follow-up|4|||
161006675|NCT04259450|581412438|FG008|Overall Study|Other than listed|1|||
161006676|NCT04259450|581412439|FG009|Overall Study|Other than listed|2|||
161006677|NCT00332241|581412440|FG000|Overall Study|Lack of Efficacy|6|||
161006678|NCT00332241|581412441|FG001|Overall Study|Lack of Efficacy|1|||
161006679|NCT00332241|581412440|FG000|Overall Study|Adverse Event|3|||
161006680|NCT00332241|581412441|FG001|Overall Study|Adverse Event|5|||
161006681|NCT00332241|581412440|FG000|Overall Study|Withdrawal by Subject|2|||
161006682|NCT00332241|581412441|FG001|Overall Study|Withdrawal by Subject|1|||
161006683|NCT00332241|581412440|FG000|Overall Study|Lost to Follow-up|4|||
161006684|NCT00332241|581412441|FG001|Overall Study|Lost to Follow-up|1|||
161006685|NCT00542789|581412443|FG000|Overall Study|Adverse Event|18|||
161006686|NCT00542789|581412444|FG001|Overall Study|Adverse Event|17|||
161006687|NCT00542789|581412443|FG000|Overall Study|Withdrawal by Subject|7|||
161006688|NCT00542789|581412444|FG001|Overall Study|Withdrawal by Subject|3|||
161006689|NCT00542789|581412443|FG000|Overall Study|Protocol Violation|8|||
161006690|NCT00542789|581412444|FG001|Overall Study|Protocol Violation|1|||
161006691|NCT00542789|581412443|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
161006692|NCT00542789|581412444|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
161006693|NCT02584829|581412445|FG000|Overall Study|Physician Decision|1|||
161006694|NCT02584829|581412446|FG001|Overall Study|Physician Decision|0|||
161006695|NCT02584829|581412445|FG000|Overall Study|Withdrawal by Subject|0|||
161006696|NCT02584829|581412446|FG001|Overall Study|Withdrawal by Subject|1|||
161006697|NCT02584829|581412445|FG000|Overall Study|Progressive Disease|0|||
161006698|NCT02584829|581412446|FG001|Overall Study|Progressive Disease|3|||
161006699|NCT02765100|581412452|FG000|Overall Study|subject found ineligible after baseline|1|||
161006700|NCT02765100|581412453|FG001|Overall Study|subject found ineligible after baseline|1|||
161006701|NCT02765100|581412452|FG000|Overall Study|Lost to Follow-up|0|||
161006702|NCT02765100|581412453|FG001|Overall Study|Lost to Follow-up|1|||
161006703|NCT00244855|581412459|FG000|Overall Study|Withdrawal by Subject|0|||
161006704|NCT00244855|581412460|FG001|Overall Study|Withdrawal by Subject|1|||
161006705|NCT00106080|581412461|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
161006706|NCT00106080|581412462|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
161006707|NCT01236001|581412463|FG000|Overall Study|Adverse Event|5|||
161006708|NCT01236001|581412464|FG001|Overall Study|Adverse Event|14|||
161006709|NCT01236001|581412463|FG000|Overall Study|Lack of Efficacy|6|||
161006710|NCT01236001|581412464|FG001|Overall Study|Lack of Efficacy|6|||
161006711|NCT01236001|581412463|FG000|Overall Study|Lost to Follow-up|6|||
161006712|NCT01236001|581412464|FG001|Overall Study|Lost to Follow-up|1|||
161006713|NCT01236001|581412463|FG000|Overall Study|Incompliance|1|||
161006714|NCT01236001|581412464|FG001|Overall Study|Incompliance|0|||
161006715|NCT01236001|581412463|FG000|Overall Study|Planned Visit After End of Study|0|||
161006716|NCT01236001|581412464|FG001|Overall Study|Planned Visit After End of Study|1|||
161006717|NCT01839331|581412465|FG000|Overall Study|Early Termination|3|||
161006718|NCT01839331|581412466|FG001|Overall Study|Early Termination|0|||
161006719|NCT01839331|581412467|FG002|Overall Study|Early Termination|1|||
161006720|NCT01839331|581412468|FG003|Overall Study|Early Termination|2|||
161006721|NCT01839331|581412465|FG000|Overall Study|Protocol Violation|1|||
161006722|NCT01839331|581412466|FG001|Overall Study|Protocol Violation|6|||
161006723|NCT01839331|581412467|FG002|Overall Study|Protocol Violation|4|||
161006724|NCT01839331|581412468|FG003|Overall Study|Protocol Violation|3|||
161006725|NCT00761605|581412469|FG000|Overall Study|Adverse Event|26|||
161006726|NCT00761605|581412469|FG000|Overall Study|Death|2|||
161006727|NCT00761605|581412469|FG000|Overall Study|Lack of Efficacy|26|||
161006728|NCT00761605|581412469|FG000|Overall Study|Lost to Follow-up|29|||
161006729|NCT00761605|581412469|FG000|Overall Study|Withdrawal by Subject|37|||
161006730|NCT00761605|581412469|FG000|Overall Study|Other|21|||
161006731|NCT03074331|581412470|FG000|Overall Study|Enrolled but Not Treated|1|||
161006732|NCT03074331|581412470|FG000|Overall Study|Lost to Follow-up|5|||
161006733|NCT03074331|581412470|FG000|Overall Study|Withdrew Consent|1|||
161006734|NCT03451721|581412471|FG000|Overall Study|Death|1|||
161006735|NCT03283371|581412474|FG000|Placebo-controlled|Adverse Event|1|||
161006736|NCT03283371|581412475|FG001|Placebo-controlled|Adverse Event|1|||
161006737|NCT03283371|581412476|FG002|Placebo-controlled|Adverse Event|0|||
161006738|NCT03283371|581412477|FG003|Placebo-controlled|Adverse Event|0|||
161006739|NCT03283371|581412474|FG000|Placebo-controlled|Lack of Efficacy|1|||
161006740|NCT03283371|581412475|FG001|Placebo-controlled|Lack of Efficacy|0|||
161006741|NCT03283371|581412476|FG002|Placebo-controlled|Lack of Efficacy|0|||
161006742|NCT03283371|581412477|FG003|Placebo-controlled|Lack of Efficacy|0|||
161006743|NCT03283371|581412474|FG000|Placebo-controlled|Withdrawal by Subject|1|||
161006744|NCT03283371|581412475|FG001|Placebo-controlled|Withdrawal by Subject|1|||
161006745|NCT03283371|581412476|FG002|Placebo-controlled|Withdrawal by Subject|0|||
161006746|NCT03283371|581412477|FG003|Placebo-controlled|Withdrawal by Subject|0|||
161006747|NCT03283371|581412474|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
161006748|NCT03283371|581412475|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
161006749|NCT03283371|581412476|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
161006750|NCT03283371|581412477|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
161006751|NCT03283371|581412474|FG000|Open-label Phase|Adverse Event|0|||
161006752|NCT03283371|581412475|FG001|Open-label Phase|Adverse Event|0|||
161006753|NCT03283371|581412476|FG002|Open-label Phase|Adverse Event|2|||
161006754|NCT03283371|581412477|FG003|Open-label Phase|Adverse Event|0|||
161006755|NCT03283371|581412474|FG000|Open-label Phase|Withdrawal by Subject|0|||
161006756|NCT03283371|581412475|FG001|Open-label Phase|Withdrawal by Subject|0|||
161006757|NCT03283371|581412476|FG002|Open-label Phase|Withdrawal by Subject|1|||
161006758|NCT03283371|581412477|FG003|Open-label Phase|Withdrawal by Subject|0|||
161006759|NCT03283371|581412474|FG000|Open-label Phase|Other|0|||
161006760|NCT03283371|581412475|FG001|Open-label Phase|Other|0|||
161006761|NCT03283371|581412476|FG002|Open-label Phase|Other|1|||
161006762|NCT03283371|581412477|FG003|Open-label Phase|Other|1|||
161006763|NCT01290341|581412478|FG000|Overall Study|Protocol Violation|7|||
161006764|NCT01290341|581412479|FG001|Overall Study|Protocol Violation|3|||
161006765|NCT01290341|581412478|FG000|Overall Study|Adverse Event|1|||
161006766|NCT01290341|581412479|FG001|Overall Study|Adverse Event|0|||
161006767|NCT01290341|581412478|FG000|Overall Study|Lost to Follow-up|21|||
161006768|NCT01290341|581412479|FG001|Overall Study|Lost to Follow-up|10|||
161006769|NCT01290341|581412478|FG000|Overall Study|Withdrawal by Subject|19|||
161006770|NCT01290341|581412479|FG001|Overall Study|Withdrawal by Subject|5|||
161006771|NCT01290341|581412478|FG000|Overall Study|Negative baseline culture and others|44|||
161006772|NCT01290341|581412479|FG001|Overall Study|Negative baseline culture and others|11|||
161006773|NCT01943799|581412481|FG000|Overall Study|Lost to Follow-up|0|||
161006774|NCT01943799|581412482|FG001|Overall Study|Lost to Follow-up|1|||
161006775|NCT01943799|581412483|FG002|Overall Study|Lost to Follow-up|1|||
161006776|NCT01943799|581412484|FG003|Overall Study|Lost to Follow-up|0|||
161006777|NCT01943799|581412481|FG000|Overall Study|Protocol Violation|1|||
161006778|NCT01943799|581412482|FG001|Overall Study|Protocol Violation|0|||
161006779|NCT01943799|581412483|FG002|Overall Study|Protocol Violation|0|||
161006780|NCT01943799|581412484|FG003|Overall Study|Protocol Violation|0|||
161006781|NCT01943799|581412481|FG000|Overall Study|Withdrawal by Subject|4|||
161006782|NCT01943799|581412482|FG001|Overall Study|Withdrawal by Subject|2|||
161006783|NCT01943799|581412483|FG002|Overall Study|Withdrawal by Subject|1|||
161006784|NCT01943799|581412484|FG003|Overall Study|Withdrawal by Subject|0|||
161006785|NCT04594759|581412485|FG000|Overall Study|Lost to Follow-up|3|||
161006786|NCT04556981|581412489|FG000|Overall Study|Death|0|||
161006787|NCT04556981|581412490|FG001|Overall Study|Death|1|||
161006788|NCT04556981|581412489|FG000|Overall Study|Lost to Follow-up|2|||
161006789|NCT04556981|581412490|FG001|Overall Study|Lost to Follow-up|11|||
161006790|NCT04556981|581412489|FG000|Overall Study|Moved from the study area|1|||
161006791|NCT04556981|581412490|FG001|Overall Study|Moved from the study area|4|||
161006792|NCT04556981|581412489|FG000|Overall Study|Withdrawal by Subject|2|||
161006793|NCT04556981|581412490|FG001|Overall Study|Withdrawal by Subject|2|||
161006794|NCT04556981|581412489|FG000|Overall Study|Other|2|||
161006795|NCT04556981|581412490|FG001|Overall Study|Other|1|||
161006796|NCT03764475|581412491|FG000|Overall Study|Adverse Event|11|||
161006797|NCT03764475|581412492|FG001|Overall Study|Adverse Event|2|||
161006798|NCT03764475|581412491|FG000|Overall Study|Lost to Follow-up|24|||
161006799|NCT03764475|581412492|FG001|Overall Study|Lost to Follow-up|10|||
161006800|NCT03764475|581412491|FG000|Overall Study|Withdrawal by Subject|26|||
161006801|NCT03764475|581412492|FG001|Overall Study|Withdrawal by Subject|10|||
161006802|NCT03764475|581412491|FG000|Overall Study|Lack of Efficacy|3|||
161006803|NCT03764475|581412492|FG001|Overall Study|Lack of Efficacy|0|||
161006804|NCT03764475|581412491|FG000|Overall Study|COVID-19 Disruption|2|||
161006805|NCT03764475|581412492|FG001|Overall Study|COVID-19 Disruption|0|||
161006806|NCT00580866|581412493|FG000|Overall Study|Lost to Follow-up|2|||
161006807|NCT00580866|581412494|FG001|Overall Study|Lost to Follow-up|2|||
161006808|NCT02574455|581412498|FG000|Overall Study|Death|197|||
161006809|NCT02574455|581412499|FG001|Overall Study|Death|210|||
161006810|NCT02574455|581412498|FG000|Overall Study|Withdrawal of Consent|11|||
160458620|NCT03735979|579410911|FG000|Overall Study|Withdrawal by Subject|1|||
160458621|NCT03735979|579410912|FG001|Overall Study|Withdrawal by Subject|5|||
160458622|NCT03735979|579410913|FG002|Overall Study|Withdrawal by Subject|2|||
160458623|NCT03735979|579410911|FG000|Overall Study|Not due to the above reasons|1|||
160458624|NCT03735979|579410912|FG001|Overall Study|Not due to the above reasons|0|||
160458625|NCT03735979|579410913|FG002|Overall Study|Not due to the above reasons|0|||
160458626|NCT00319111|579410916|FG000|Overall Study|Adverse Event|20|||
160458627|NCT00319111|579410916|FG000|Overall Study|Withdrawal of consent|11|||
160458628|NCT00319111|579410916|FG000|Overall Study|Death|9|||
160458629|NCT00319111|579410916|FG000|Overall Study|Lack of clinical improvement|4|||
161006811|NCT02574455|581412499|FG001|Overall Study|Withdrawal of Consent|28|||
161006812|NCT02574455|581412498|FG000|Overall Study|Lost to Follow-up|4|||
161006813|NCT02574455|581412499|FG001|Overall Study|Lost to Follow-up|4|||
161006814|NCT02574455|581412498|FG000|Overall Study|Sponsor's Decision|55|||
161006815|NCT02574455|581412499|FG001|Overall Study|Sponsor's Decision|20|||
161006816|NCT03144674|581412508|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
161006817|NCT03144674|581412509|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
161006818|NCT03144674|581412510|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
161006819|NCT03144674|581412511|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
161006820|NCT03144674|581412508|FG000|Overall Study|Death|3|||
161006821|NCT03144674|581412509|FG001|Overall Study|Death|2|||
161006822|NCT03144674|581412510|FG002|Overall Study|Death|6|||
161006823|NCT03144674|581412511|FG003|Overall Study|Death|24|||
161006824|NCT03144674|581412508|FG000|Overall Study|Lost to Follow-up|0|||
161006825|NCT03144674|581412509|FG001|Overall Study|Lost to Follow-up|1|||
161006826|NCT03144674|581412510|FG002|Overall Study|Lost to Follow-up|0|||
161006827|NCT03144674|581412511|FG003|Overall Study|Lost to Follow-up|4|||
161006828|NCT03144674|581412508|FG000|Overall Study|Withdrawal by Participant|0|||
161006829|NCT03144674|581412509|FG001|Overall Study|Withdrawal by Participant|0|||
161006830|NCT03144674|581412510|FG002|Overall Study|Withdrawal by Participant|2|||
161006831|NCT03144674|581412511|FG003|Overall Study|Withdrawal by Participant|6|||
161006832|NCT03144674|581412508|FG000|Overall Study|Discharged from the Trust|0|||
161006833|NCT03144674|581412509|FG001|Overall Study|Discharged from the Trust|0|||
161006834|NCT03144674|581412510|FG002|Overall Study|Discharged from the Trust|1|||
161006835|NCT03144674|581412511|FG003|Overall Study|Discharged from the Trust|0|||
161006836|NCT03144674|581412508|FG000|Overall Study|Exclusion Criteria Met|0|||
161006837|NCT03144674|581412509|FG001|Overall Study|Exclusion Criteria Met|0|||
161006838|NCT03144674|581412510|FG002|Overall Study|Exclusion Criteria Met|1|||
161006839|NCT03144674|581412511|FG003|Overall Study|Exclusion Criteria Met|0|||
161006840|NCT03144674|581412508|FG000|Overall Study|Changed Physicians|0|||
161006841|NCT03144674|581412509|FG001|Overall Study|Changed Physicians|0|||
161006842|NCT03144674|581412510|FG002|Overall Study|Changed Physicians|0|||
161006843|NCT03144674|581412511|FG003|Overall Study|Changed Physicians|1|||
161006844|NCT03144674|581412508|FG000|Overall Study|Removed for Safety|0|||
161006845|NCT03144674|581412509|FG001|Overall Study|Removed for Safety|0|||
161006846|NCT03144674|581412510|FG002|Overall Study|Removed for Safety|0|||
161006847|NCT03144674|581412511|FG003|Overall Study|Removed for Safety|1|||
161006848|NCT03144674|581412508|FG000|Overall Study|Site Closed|0|||
161006849|NCT03144674|581412509|FG001|Overall Study|Site Closed|0|||
161006850|NCT03144674|581412510|FG002|Overall Study|Site Closed|0|||
161006851|NCT03144674|581412511|FG003|Overall Study|Site Closed|1|||
161006852|NCT03144674|581412508|FG000|Overall Study|Histological Criteria Not Met|0|||
161006853|NCT03144674|581412509|FG001|Overall Study|Histological Criteria Not Met|0|||
161006854|NCT03144674|581412510|FG002|Overall Study|Histological Criteria Not Met|0|||
161006855|NCT03144674|581412511|FG003|Overall Study|Histological Criteria Not Met|1|||
161006856|NCT03144674|581412508|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
161006857|NCT03144674|581412509|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
161006858|NCT03144674|581412510|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
161006859|NCT03144674|581412511|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
160966721|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
160966722|NCT03420781|581266759|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
160966723|NCT03420781|581266760|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
160966724|NCT03420781|581266761|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
160966725|NCT03420781|581266762|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
160966726|NCT03420781|581266763|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
160966727|NCT03420781|581266759|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
160966728|NCT03420781|581266760|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
160966729|NCT03420781|581266761|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
160966730|NCT03420781|581266762|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
160966731|NCT03420781|581266763|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
160966732|NCT03420781|581266759|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
160966733|NCT03420781|581266760|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
160966734|NCT03420781|581266761|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
160966735|NCT03420781|581266762|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
160966736|NCT03420781|581266763|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
160966737|NCT01330316|581266764|FG000|Overall Study|Adverse Event|2|||
160966738|NCT01330316|581266765|FG001|Overall Study|Adverse Event|2|||
160966739|NCT01330316|581266764|FG000|Overall Study|Lack of Efficacy|0|||
160966740|NCT01330316|581266765|FG001|Overall Study|Lack of Efficacy|10|||
160966741|NCT01330316|581266764|FG000|Overall Study|Lost to Follow-up|0|||
160966742|NCT01330316|581266765|FG001|Overall Study|Lost to Follow-up|1|||
160966743|NCT01330316|581266764|FG000|Overall Study|Withdrawal by Subject|0|||
160966744|NCT01330316|581266765|FG001|Overall Study|Withdrawal by Subject|1|||
160966745|NCT01330316|581266764|FG000|Overall Study|other than above|0|||
160966746|NCT01330316|581266765|FG001|Overall Study|other than above|1|||
160966747|NCT00246337|581266768|FG000|Overall Study|Lost to Follow-up|3|||
160966748|NCT00246337|581266769|FG001|Overall Study|Lost to Follow-up|0|||
160966749|NCT00246337|581266770|FG002|Overall Study|Lost to Follow-up|0|||
161006860|NCT03144674|581412508|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
161006861|NCT03144674|581412509|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
161006862|NCT03144674|581412510|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
161006863|NCT03144674|581412511|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
161006864|NCT05510245|581412512|FG000|Overall Study|Withdrawal by Subject|1|||
161006865|NCT05510245|581412513|FG001|Overall Study|Withdrawal by Subject|0|||
161006866|NCT05510245|581412514|FG002|Overall Study|Withdrawal by Subject|0|||
161006867|NCT01373346|581412515|FG000|Overall Study|Death|1|||
161006868|NCT01198028|581412516|FG000|Overall Study|Adverse Event|5|||
161006869|NCT01198028|581412516|FG000|Overall Study|Death|3|||
161006870|NCT01198028|581412516|FG000|Overall Study|Physician Decision|2|||
161006871|NCT01395758|581412518|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
161006872|NCT01395758|581412519|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161006873|NCT01395758|581412520|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
161006874|NCT01565148|581412521|FG000|Overall Study|Withdrawal by Subject|1|||
161006875|NCT01565148|581412522|FG001|Overall Study|Withdrawal by Subject|1|||
161006876|NCT01565148|581412523|FG002|Overall Study|Withdrawal by Subject|1|||
161006877|NCT01565148|581412524|FG003|Overall Study|Withdrawal by Subject|2|||
161006878|NCT01565148|581412521|FG000|Overall Study|Lost to Follow-up|4|||
161006879|NCT01565148|581412522|FG001|Overall Study|Lost to Follow-up|4|||
161006880|NCT01565148|581412523|FG002|Overall Study|Lost to Follow-up|0|||
161006881|NCT01565148|581412524|FG003|Overall Study|Lost to Follow-up|3|||
161006882|NCT01565148|581412521|FG000|Overall Study|Rescue Therapy|8|||
161006883|NCT01565148|581412522|FG001|Overall Study|Rescue Therapy|5|||
161006884|NCT01565148|581412523|FG002|Overall Study|Rescue Therapy|5|||
161006885|NCT01565148|581412524|FG003|Overall Study|Rescue Therapy|8|||
161006886|NCT01565148|581412521|FG000|Overall Study|Death|0|||
161006887|NCT01565148|581412522|FG001|Overall Study|Death|0|||
161006888|NCT01565148|581412523|FG002|Overall Study|Death|1|||
161006889|NCT01565148|581412524|FG003|Overall Study|Death|0|||
161006890|NCT01565148|581412521|FG000|Overall Study|Physician Decision|2|||
161006891|NCT01565148|581412522|FG001|Overall Study|Physician Decision|5|||
161006892|NCT01565148|581412523|FG002|Overall Study|Physician Decision|0|||
161006893|NCT01565148|581412524|FG003|Overall Study|Physician Decision|0|||
161006894|NCT01759771|581412525|FG000|Overall Study|Withdrawal by Subject|1|||
161006895|NCT01759771|581412526|FG001|Overall Study|Withdrawal by Subject|1|||
161006896|NCT00529659|581412529|FG000|Overall Study|Adverse Event|8|||
161006897|NCT00529659|581412530|FG001|Overall Study|Adverse Event|7|||
161006898|NCT00529659|581412529|FG000|Overall Study|Lost to Follow-up|0|||
161006899|NCT00529659|581412530|FG001|Overall Study|Lost to Follow-up|2|||
161006900|NCT00529659|581412529|FG000|Overall Study|Physician Decision|0|||
161006901|NCT00529659|581412530|FG001|Overall Study|Physician Decision|2|||
161006902|NCT00529659|581412529|FG000|Overall Study|Protocol Violation|2|||
161006903|NCT00529659|581412530|FG001|Overall Study|Protocol Violation|6|||
161006904|NCT00529659|581412529|FG000|Overall Study|Withdrawal by Subject|1|||
161006905|NCT00529659|581412530|FG001|Overall Study|Withdrawal by Subject|6|||
161006906|NCT01692730|581412533|FG000|Overall Study|Lost to Follow-up|225|||
161006907|NCT01692730|581412534|FG001|Overall Study|Lost to Follow-up|227|||
161006908|NCT01415349|581412535|FG000|Treatment Period 1|Adverse Event|0|||
161006909|NCT01415349|581412536|FG001|Treatment Period 1|Adverse Event|1|||
161006910|NCT01415349|581412535|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161006911|NCT01415349|581412536|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161006912|NCT02139943|581412537|FG000|Overall Study|Adverse Event|0|||
161006913|NCT02139943|581412538|FG001|Overall Study|Adverse Event|1|||
161006914|NCT02139943|581412539|FG002|Overall Study|Adverse Event|2|||
161006915|NCT02139943|581412537|FG000|Overall Study|Lost to Follow-up|3|||
161006916|NCT02139943|581412538|FG001|Overall Study|Lost to Follow-up|2|||
161006917|NCT02139943|581412539|FG002|Overall Study|Lost to Follow-up|2|||
161006918|NCT02139943|581412537|FG000|Overall Study|Withdrawal by Subject|4|||
161006919|NCT02139943|581412538|FG001|Overall Study|Withdrawal by Subject|3|||
161006920|NCT02139943|581412539|FG002|Overall Study|Withdrawal by Subject|0|||
161006921|NCT02139943|581412537|FG000|Overall Study|Other|0|||
161006922|NCT02139943|581412538|FG001|Overall Study|Other|0|||
161006923|NCT02139943|581412539|FG002|Overall Study|Other|1|||
161006924|NCT02139943|581412537|FG000|Overall Study|Participant wishes to discontinue|2|||
161006925|NCT02139943|581412538|FG001|Overall Study|Participant wishes to discontinue|0|||
161006926|NCT02139943|581412539|FG002|Overall Study|Participant wishes to discontinue|0|||
161006927|NCT02139943|581412537|FG000|Overall Study|Participant in Poor Compliance|1|||
161006928|NCT02139943|581412538|FG001|Overall Study|Participant in Poor Compliance|0|||
161006929|NCT02139943|581412539|FG002|Overall Study|Participant in Poor Compliance|1|||
161006930|NCT02139943|581412537|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
161006931|NCT02139943|581412538|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
161006932|NCT02139943|581412539|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
161006933|NCT01041417|581412540|FG000|Overall Study|Adverse Event|5|||
161006934|NCT01041417|581412541|FG001|Overall Study|Adverse Event|2|||
161006935|NCT01041417|581412540|FG000|Overall Study|Lost to Follow-up|1|||
161006936|NCT01041417|581412541|FG001|Overall Study|Lost to Follow-up|1|||
161006937|NCT01041417|581412540|FG000|Overall Study|Death|1|||
161006938|NCT01041417|581412541|FG001|Overall Study|Death|0|||
161006939|NCT02918071|581412547|FG000|Overall Study|Withdrawal by Subject|2|||
161006940|NCT02918071|581412547|FG000|Overall Study|Lost to Follow-up|1|||
161006941|NCT03960463|581414277|FG000|Overall Study|Withdrawal by Subject|2|||
161006942|NCT03960463|581414278|FG001|Overall Study|Withdrawal by Subject|0|||
161006943|NCT03422276|581414279|FG000|Overall Study|Withdrawal by Subject|21|||
161006944|NCT03422276|581414280|FG001|Overall Study|Withdrawal by Subject|25|||
161006945|NCT03422276|581414281|FG002|Overall Study|Withdrawal by Subject|14|||
161006946|NCT03422276|581414282|FG003|Overall Study|Withdrawal by Subject|16|||
161006947|NCT03422276|581414279|FG000|Overall Study|Death|14|||
161006948|NCT03422276|581414280|FG001|Overall Study|Death|21|||
161006949|NCT03422276|581414281|FG002|Overall Study|Death|3|||
161006950|NCT03422276|581414282|FG003|Overall Study|Death|1|||
161006951|NCT03422276|581414279|FG000|Overall Study|Discontinued, ineligible|4|||
161006952|NCT03422276|581414280|FG001|Overall Study|Discontinued, ineligible|3|||
161006953|NCT03422276|581414281|FG002|Overall Study|Discontinued, ineligible|0|||
161006954|NCT03422276|581414282|FG003|Overall Study|Discontinued, ineligible|0|||
161006955|NCT03422276|581414279|FG000|Overall Study|Lost to Follow-up|15|||
161006956|NCT03422276|581414280|FG001|Overall Study|Lost to Follow-up|8|||
161006957|NCT03422276|581414281|FG002|Overall Study|Lost to Follow-up|13|||
161006958|NCT03422276|581414282|FG003|Overall Study|Lost to Follow-up|4|||
161006959|NCT03422276|581414279|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
161006960|NCT03422276|581414280|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
161006961|NCT03422276|581414281|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
161006962|NCT03422276|581414282|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
161006963|NCT03422276|581414279|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
161006964|NCT03422276|581414280|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
161006965|NCT03422276|581414281|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
161006966|NCT03422276|581414282|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
161006967|NCT03422276|581414279|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
161006968|NCT03422276|581414280|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
161006969|NCT03422276|581414281|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
161006970|NCT03422276|581414282|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
161006971|NCT03422276|581414279|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
161006972|NCT03422276|581414280|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
161006973|NCT03422276|581414281|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
161006974|NCT03422276|581414282|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
161006975|NCT03422276|581414279|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
161006976|NCT03422276|581414280|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
161006977|NCT03422276|581414281|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
161006978|NCT03422276|581414282|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
161006979|NCT05194917|581414283|FG000|Overall Study|Lost to Follow-up|7|||
161006980|NCT05194917|581414284|FG001|Overall Study|Lost to Follow-up|5|||
161006981|NCT05194917|581414285|FG002|Overall Study|Lost to Follow-up|6|||
161006982|NCT05194917|581414286|FG003|Overall Study|Lost to Follow-up|5|||
161006983|NCT04922021|581414287|FG000|Overall Study|Withdrawal by Subject|4|||
161006984|NCT04922021|581414288|FG001|Overall Study|Withdrawal by Subject|10|||
161006985|NCT04922021|581414287|FG000|Overall Study|Adverse Event|2|||
161006986|NCT04922021|581414288|FG001|Overall Study|Adverse Event|2|||
161006987|NCT04922021|581414287|FG000|Overall Study|Lack of Efficacy|0|||
161006988|NCT04922021|581414288|FG001|Overall Study|Lack of Efficacy|1|||
161006989|NCT04922021|581414287|FG000|Overall Study|Multiple reasons|1|||
161006990|NCT04922021|581414288|FG001|Overall Study|Multiple reasons|0|||
161006991|NCT04941287|581414298|FG000|Overall Study|Rapid decline before starting treatment|3|||
161006992|NCT04941287|581414299|FG001|Overall Study|Rapid decline before starting treatment|1|||
161006993|NCT01998984|581414304|FG000|Overall Study|Adverse Event|0|||
161006994|NCT01998984|581414305|FG001|Overall Study|Adverse Event|0|||
161006995|NCT01998984|581414306|FG002|Overall Study|Adverse Event|0|||
161006996|NCT01998984|581414307|FG003|Overall Study|Adverse Event|1|||
161006997|NCT01998984|581414304|FG000|Overall Study|Lost to Follow-up|0|||
161006998|NCT01998984|581414305|FG001|Overall Study|Lost to Follow-up|1|||
161006999|NCT01998984|581414306|FG002|Overall Study|Lost to Follow-up|0|||
160458630|NCT00319111|579410916|FG000|Overall Study|Administrative|2|||
160458631|NCT00319111|579410916|FG000|Overall Study|Treatment failure|1|||
160458632|NCT01475786|579410917|FG000|Overall Study|Adverse Event|0|||
160458633|NCT01475786|579410918|FG001|Overall Study|Adverse Event|1|||
160458634|NCT01475786|579410919|FG002|Overall Study|Adverse Event|0|||
160458635|NCT01475786|579410917|FG000|Overall Study|Lost to Follow-up|1|||
161007000|NCT01998984|581414307|FG003|Overall Study|Lost to Follow-up|1|||
161007001|NCT01998984|581414304|FG000|Overall Study|Withdrawal by Subject|0|||
161007002|NCT01998984|581414305|FG001|Overall Study|Withdrawal by Subject|0|||
161007003|NCT01998984|581414306|FG002|Overall Study|Withdrawal by Subject|1|||
161007004|NCT01998984|581414307|FG003|Overall Study|Withdrawal by Subject|0|||
160458636|NCT01475786|579410918|FG001|Overall Study|Lost to Follow-up|2|||
161007005|NCT01998984|581414304|FG000|Overall Study|Other|0|||
161007006|NCT01998984|581414305|FG001|Overall Study|Other|0|||
161007007|NCT01998984|581414306|FG002|Overall Study|Other|0|||
161007008|NCT01998984|581414307|FG003|Overall Study|Other|1|||
161007009|NCT04300647|581414308|FG000|Pre-Crossover|Death|19|||
161007010|NCT04300647|581414309|FG001|Pre-Crossover|Death|58|||
161007011|NCT04300647|581414310|FG002|Pre-Crossover|Death|0|||
161007012|NCT04300647|581414308|FG000|Pre-Crossover|Lost to Follow-up|0|||
161007013|NCT04300647|581414309|FG001|Pre-Crossover|Lost to Follow-up|3|||
161007014|NCT04300647|581414310|FG002|Pre-Crossover|Lost to Follow-up|0|||
161007015|NCT04300647|581414308|FG000|Pre-Crossover|Withdrawal by Subject|2|||
161007016|NCT04300647|581414309|FG001|Pre-Crossover|Withdrawal by Subject|4|||
161007017|NCT04300647|581414310|FG002|Pre-Crossover|Withdrawal by Subject|0|||
161007018|NCT04300647|581414308|FG000|Pre-Crossover|On-going in Study|24|||
161007019|NCT04300647|581414309|FG001|Pre-Crossover|On-going in Study|61|||
161007020|NCT04300647|581414310|FG002|Pre-Crossover|On-going in Study|0|||
161007021|NCT04300647|581414308|FG000|Post-Crossover|Death|0|||
161007022|NCT04300647|581414309|FG001|Post-Crossover|Death|0|||
161007023|NCT04300647|581414310|FG002|Post-Crossover|Death|3|||
161007024|NCT04300647|581414308|FG000|Post-Crossover|Lost to Follow-up|0|||
161007025|NCT04300647|581414309|FG001|Post-Crossover|Lost to Follow-up|0|||
161007026|NCT04300647|581414310|FG002|Post-Crossover|Lost to Follow-up|1|||
161007027|NCT04300647|581414308|FG000|Post-Crossover|Withdrawal by Subject|0|||
161007028|NCT04300647|581414309|FG001|Post-Crossover|Withdrawal by Subject|0|||
161007029|NCT04300647|581414310|FG002|Post-Crossover|Withdrawal by Subject|1|||
161007030|NCT04300647|581414308|FG000|Post-Crossover|On-going in Study|0|||
161007031|NCT04300647|581414309|FG001|Post-Crossover|On-going in Study|0|||
161007032|NCT04300647|581414310|FG002|Post-Crossover|On-going in Study|8|||
161007033|NCT05386238|581414311|FG000|Overall Study|Lost to Follow-up|3|||
161007034|NCT05386238|581414312|FG001|Overall Study|Lost to Follow-up|2|||
161007035|NCT05386238|581414311|FG000|Overall Study|Withdrawal by Subject|0|||
161007036|NCT05386238|581414312|FG001|Overall Study|Withdrawal by Subject|1|||
161007037|NCT04907474|581414313|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
161007038|NCT04907474|581414314|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
161007039|NCT01353313|581414317|FG000|Overall Study|Lost to Follow-up|22|||
161007040|NCT01353313|581414318|FG001|Overall Study|Lost to Follow-up|23|||
161007041|NCT01353313|581414317|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
161007042|NCT01353313|581414318|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
161007043|NCT02647905|581414332|FG000|Overall Study|Lost to Follow-up|1|||
161007044|NCT02647905|581414332|FG000|Overall Study|Withdrawal by Subject|2|||
161007045|NCT05119855|581414333|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
161007046|NCT05119855|581414334|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
161007047|NCT05119855|581414333|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
161007048|NCT05119855|581414334|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
161007049|NCT05119855|581414333|FG000|Overall Study|Lost to Follow-up|6|||
161007050|NCT05119855|581414334|FG001|Overall Study|Lost to Follow-up|8|||
161007051|NCT00642850|581414339|FG000|Overall Study|Death|7|||
161007052|NCT00642850|581414339|FG000|Overall Study|Adverse Event|2|||
161007053|NCT00642850|581414339|FG000|Overall Study|Lack of Efficacy|1|||
161007054|NCT00642850|581414339|FG000|Overall Study|Protocol Violation|2|||
161007055|NCT00642850|581414339|FG000|Overall Study|Kidney transplantation|8|||
161007056|NCT00642850|581414339|FG000|Overall Study|Blood transfusion|6|||
161007057|NCT00642850|581414339|FG000|Overall Study|Other reasons|7|||
161007058|NCT00391898|581414340|FG000|Overall Study|Adverse Event|3|||
161007059|NCT00391898|581414341|FG001|Overall Study|Adverse Event|0|||
161007060|NCT00391898|581414340|FG000|Overall Study|Other|8|||
161007061|NCT00391898|581414341|FG001|Overall Study|Other|10|||
161007062|NCT05489484|581414342|FG000|Overall Study|withdrawn|1|||
160458637|NCT01475786|579410919|FG002|Overall Study|Lost to Follow-up|1|||
160585374|NCT01980706|579861927|FG002|Overall Study|Lost to Follow-up|3|||
160585375|NCT01980706|579861925|FG000|Overall Study|miscellaneous|4|||
160585376|NCT01980706|579861926|FG001|Overall Study|miscellaneous|5|||
160585377|NCT01980706|579861927|FG002|Overall Study|miscellaneous|3|||
161007063|NCT00444600|581414345|FG000|Overall Study|Death|7|||
161007064|NCT00444600|581414346|FG001|Overall Study|Death|5|||
161007065|NCT00444600|581414347|FG002|Overall Study|Death|3|||
161007066|NCT00444600|581414348|FG003|Overall Study|Death|2|||
161007067|NCT00444600|581414345|FG000|Overall Study|Dropped|11|||
161007068|NCT00444600|581414346|FG001|Overall Study|Dropped|11|||
161007069|NCT00444600|581414347|FG002|Overall Study|Dropped|7|||
161007070|NCT00444600|581414348|FG003|Overall Study|Dropped|7|||
161007071|NCT00444600|581414345|FG000|Overall Study|Missed visit|1|||
161007072|NCT00444600|581414346|FG001|Overall Study|Missed visit|0|||
161007073|NCT00444600|581414347|FG002|Overall Study|Missed visit|0|||
161007074|NCT00444600|581414348|FG003|Overall Study|Missed visit|1|||
160585378|NCT02546674|579861928|FG000|Overall Study|Adverse Event|19|||
161007075|NCT02988817|581414349|FG000|Overall Study|Withdrawal by Subject|1|||
161007076|NCT02988817|581414350|FG001|Overall Study|Withdrawal by Subject|0|||
161007077|NCT02988817|581414351|FG002|Overall Study|Withdrawal by Subject|0|||
161007078|NCT02988817|581414352|FG003|Overall Study|Withdrawal by Subject|1|||
161007079|NCT02988817|581414353|FG004|Overall Study|Withdrawal by Subject|3|||
161007080|NCT02988817|581414354|FG005|Overall Study|Withdrawal by Subject|1|||
161007081|NCT02988817|581414355|FG006|Overall Study|Withdrawal by Subject|2|||
161007082|NCT02988817|581414356|FG007|Overall Study|Withdrawal by Subject|1|||
161007083|NCT02988817|581414357|FG008|Overall Study|Withdrawal by Subject|1|||
161007084|NCT02988817|581414358|FG009|Overall Study|Withdrawal by Subject|1|||
161007085|NCT02988817|581414359|FG010|Overall Study|Withdrawal by Subject|1|||
161007086|NCT02988817|581414360|FG011|Overall Study|Withdrawal by Subject|12|||
161007087|NCT02988817|581414361|FG012|Overall Study|Withdrawal by Subject|6|||
161007088|NCT02988817|581414362|FG013|Overall Study|Withdrawal by Subject|6|||
161007089|NCT02988817|581414363|FG014|Overall Study|Withdrawal by Subject|4|||
161007090|NCT02988817|581414364|FG015|Overall Study|Withdrawal by Subject|5|||
161007091|NCT02988817|581414365|FG016|Overall Study|Withdrawal by Subject|4|||
161007092|NCT02988817|581414366|FG017|Overall Study|Withdrawal by Subject|11|||
161007093|NCT02988817|581414367|FG018|Overall Study|Withdrawal by Subject|4|||
161007094|NCT02988817|581414368|FG019|Overall Study|Withdrawal by Subject|2|||
161007095|NCT02988817|581414349|FG000|Overall Study|Death|0|||
161007096|NCT02988817|581414350|FG001|Overall Study|Death|1|||
161007097|NCT02988817|581414351|FG002|Overall Study|Death|3|||
161007098|NCT02988817|581414352|FG003|Overall Study|Death|1|||
161007099|NCT02988817|581414353|FG004|Overall Study|Death|6|||
161007100|NCT02988817|581414354|FG005|Overall Study|Death|10|||
161007101|NCT02988817|581414355|FG006|Overall Study|Death|1|||
161007102|NCT02988817|581414356|FG007|Overall Study|Death|2|||
161007103|NCT02988817|581414357|FG008|Overall Study|Death|1|||
161007104|NCT02988817|581414358|FG009|Overall Study|Death|5|||
161007105|NCT02988817|581414359|FG010|Overall Study|Death|1|||
161007106|NCT02988817|581414360|FG011|Overall Study|Death|8|||
161007107|NCT02988817|581414361|FG012|Overall Study|Death|9|||
161007108|NCT02988817|581414362|FG013|Overall Study|Death|17|||
161007109|NCT02988817|581414363|FG014|Overall Study|Death|18|||
161007110|NCT02988817|581414364|FG015|Overall Study|Death|30|||
161007111|NCT02988817|581414365|FG016|Overall Study|Death|17|||
161007112|NCT02988817|581414366|FG017|Overall Study|Death|38|||
161007113|NCT02988817|581414367|FG018|Overall Study|Death|14|||
161007114|NCT02988817|581414368|FG019|Overall Study|Death|16|||
161007115|NCT02988817|581414349|FG000|Overall Study|Other|0|||
161007116|NCT02988817|581414350|FG001|Overall Study|Other|0|||
161007117|NCT02988817|581414351|FG002|Overall Study|Other|0|||
161007118|NCT02988817|581414352|FG003|Overall Study|Other|1|||
161007119|NCT02988817|581414353|FG004|Overall Study|Other|1|||
161007120|NCT02988817|581414354|FG005|Overall Study|Other|0|||
161007121|NCT02988817|581414355|FG006|Overall Study|Other|0|||
161007122|NCT02988817|581414356|FG007|Overall Study|Other|0|||
161007123|NCT02988817|581414357|FG008|Overall Study|Other|0|||
161007124|NCT02988817|581414358|FG009|Overall Study|Other|0|||
161007125|NCT02988817|581414359|FG010|Overall Study|Other|0|||
161007126|NCT02988817|581414360|FG011|Overall Study|Other|0|||
161007127|NCT02988817|581414361|FG012|Overall Study|Other|0|||
161007128|NCT02988817|581414362|FG013|Overall Study|Other|0|||
161007129|NCT02988817|581414363|FG014|Overall Study|Other|0|||
161007130|NCT02988817|581414364|FG015|Overall Study|Other|1|||
161007131|NCT02988817|581414365|FG016|Overall Study|Other|0|||
161007132|NCT02988817|581414366|FG017|Overall Study|Other|0|||
161007133|NCT02988817|581414367|FG018|Overall Study|Other|0|||
161007134|NCT02988817|581414368|FG019|Overall Study|Other|0|||
161007135|NCT02988817|581414349|FG000|Overall Study|Lost to Follow-up|0|||
161007136|NCT02988817|581414350|FG001|Overall Study|Lost to Follow-up|0|||
161007137|NCT02988817|581414351|FG002|Overall Study|Lost to Follow-up|0|||
161007138|NCT02988817|581414352|FG003|Overall Study|Lost to Follow-up|0|||
161007139|NCT02988817|581414353|FG004|Overall Study|Lost to Follow-up|0|||
161007140|NCT02988817|581414354|FG005|Overall Study|Lost to Follow-up|0|||
161007141|NCT02988817|581414355|FG006|Overall Study|Lost to Follow-up|0|||
161007142|NCT02988817|581414356|FG007|Overall Study|Lost to Follow-up|0|||
161007143|NCT02988817|581414357|FG008|Overall Study|Lost to Follow-up|1|||
161007144|NCT02988817|581414358|FG009|Overall Study|Lost to Follow-up|0|||
161007145|NCT02988817|581414359|FG010|Overall Study|Lost to Follow-up|1|||
161007146|NCT02988817|581414360|FG011|Overall Study|Lost to Follow-up|1|||
161007147|NCT02988817|581414361|FG012|Overall Study|Lost to Follow-up|0|||
161007148|NCT02988817|581414362|FG013|Overall Study|Lost to Follow-up|0|||
161007149|NCT02988817|581414363|FG014|Overall Study|Lost to Follow-up|1|||
161007150|NCT02988817|581414364|FG015|Overall Study|Lost to Follow-up|1|||
161007151|NCT02988817|581414365|FG016|Overall Study|Lost to Follow-up|2|||
161007152|NCT02988817|581414366|FG017|Overall Study|Lost to Follow-up|3|||
161007153|NCT02988817|581414367|FG018|Overall Study|Lost to Follow-up|0|||
161007154|NCT02988817|581414368|FG019|Overall Study|Lost to Follow-up|0|||
161007155|NCT02988817|581414349|FG000|Overall Study|Sponsor decision|0|||
161007156|NCT02988817|581414350|FG001|Overall Study|Sponsor decision|0|||
161007157|NCT02988817|581414351|FG002|Overall Study|Sponsor decision|0|||
161007158|NCT02988817|581414352|FG003|Overall Study|Sponsor decision|0|||
161007159|NCT02988817|581414353|FG004|Overall Study|Sponsor decision|0|||
161007160|NCT02988817|581414354|FG005|Overall Study|Sponsor decision|0|||
161007161|NCT02988817|581414355|FG006|Overall Study|Sponsor decision|0|||
161007162|NCT02988817|581414356|FG007|Overall Study|Sponsor decision|0|||
161007163|NCT02988817|581414357|FG008|Overall Study|Sponsor decision|0|||
161007164|NCT02988817|581414358|FG009|Overall Study|Sponsor decision|0|||
161007165|NCT02988817|581414359|FG010|Overall Study|Sponsor decision|0|||
161007166|NCT02988817|581414360|FG011|Overall Study|Sponsor decision|1|||
161007167|NCT02988817|581414361|FG012|Overall Study|Sponsor decision|1|||
161007168|NCT02988817|581414362|FG013|Overall Study|Sponsor decision|2|||
161007169|NCT02988817|581414363|FG014|Overall Study|Sponsor decision|2|||
161007170|NCT02988817|581414364|FG015|Overall Study|Sponsor decision|6|||
161007171|NCT02988817|581414365|FG016|Overall Study|Sponsor decision|2|||
161007172|NCT02988817|581414366|FG017|Overall Study|Sponsor decision|3|||
161007173|NCT02988817|581414367|FG018|Overall Study|Sponsor decision|2|||
161007174|NCT02988817|581414368|FG019|Overall Study|Sponsor decision|7|||
161007175|NCT02988817|581414349|FG000|Overall Study|Physician Decision|0|||
161007176|NCT02988817|581414350|FG001|Overall Study|Physician Decision|0|||
161007177|NCT02988817|581414351|FG002|Overall Study|Physician Decision|0|||
161007178|NCT02988817|581414352|FG003|Overall Study|Physician Decision|0|||
161007179|NCT02988817|581414353|FG004|Overall Study|Physician Decision|0|||
161007180|NCT02988817|581414354|FG005|Overall Study|Physician Decision|0|||
161007181|NCT02988817|581414355|FG006|Overall Study|Physician Decision|0|||
161007182|NCT02988817|581414356|FG007|Overall Study|Physician Decision|0|||
161007183|NCT02988817|581414357|FG008|Overall Study|Physician Decision|0|||
161007184|NCT02988817|581414358|FG009|Overall Study|Physician Decision|0|||
161007185|NCT02988817|581414359|FG010|Overall Study|Physician Decision|0|||
161007186|NCT02988817|581414360|FG011|Overall Study|Physician Decision|0|||
161007187|NCT02988817|581414361|FG012|Overall Study|Physician Decision|0|||
161007188|NCT02988817|581414362|FG013|Overall Study|Physician Decision|0|||
161007189|NCT02988817|581414363|FG014|Overall Study|Physician Decision|0|||
161007190|NCT02988817|581414364|FG015|Overall Study|Physician Decision|1|||
161007191|NCT02988817|581414365|FG016|Overall Study|Physician Decision|0|||
161007192|NCT02988817|581414366|FG017|Overall Study|Physician Decision|0|||
160585379|NCT02546674|579861928|FG000|Overall Study|Death|1|||
160585380|NCT02546674|579861928|FG000|Overall Study|Lost to Follow-up|1|||
160585381|NCT02546674|579861928|FG000|Overall Study|Physician Decision|13|||
160585382|NCT02546674|579861928|FG000|Overall Study|Pregnancy|1|||
160585383|NCT02546674|579861928|FG000|Overall Study|Progressive Disease|2|||
160585384|NCT02546674|579861928|FG000|Overall Study|Protocol Deviation|2|||
160585385|NCT02546674|579861928|FG000|Overall Study|Subject/Guardian Decision|6|||
160585386|NCT02546674|579861928|FG000|Overall Study|Withdrawal of Informed Consent|3|||
160585387|NCT01188564|579861929|FG000|Double-blind Phase|randomized not treated|1|||
160585388|NCT01188564|579861930|FG001|Double-blind Phase|randomized not treated|0|||
160585389|NCT04171037|579861931|FG000|Overall Study|Lost to Follow-up|1|||
160585390|NCT04171037|579861932|FG001|Overall Study|Lost to Follow-up|0|||
160585391|NCT04171037|579861931|FG000|Overall Study|Physician Decision|3|||
160585392|NCT04171037|579861932|FG001|Overall Study|Physician Decision|3|||
160585393|NCT01934894|579861933|FG000|Overall Study|Adverse Event|1|||
160585394|NCT01934894|579861934|FG001|Overall Study|Adverse Event|2|||
160585395|NCT01934894|579861933|FG000|Overall Study|Death|2|||
160585396|NCT01934894|579861934|FG001|Overall Study|Death|0|||
160585397|NCT01934894|579861933|FG000|Overall Study|Withdrawal by Subject|0|||
160966750|NCT00246337|581266771|FG003|Overall Study|Lost to Follow-up|0|||
160966751|NCT00246337|581266772|FG004|Overall Study|Lost to Follow-up|2|||
160966752|NCT00246337|581266773|FG005|Overall Study|Lost to Follow-up|2|||
160966753|NCT00246337|581266774|FG006|Overall Study|Lost to Follow-up|1|||
160966754|NCT00246337|581266775|FG007|Overall Study|Lost to Follow-up|2|||
160966755|NCT00246337|581266776|FG008|Overall Study|Lost to Follow-up|0|||
160966756|NCT00246337|581266768|FG000|Overall Study|Protocol Violation|1|||
160966757|NCT00246337|581266769|FG001|Overall Study|Protocol Violation|0|||
160966758|NCT00246337|581266770|FG002|Overall Study|Protocol Violation|0|||
160966759|NCT00246337|581266771|FG003|Overall Study|Protocol Violation|0|||
160966760|NCT00246337|581266772|FG004|Overall Study|Protocol Violation|1|||
160966761|NCT00246337|581266773|FG005|Overall Study|Protocol Violation|0|||
160966762|NCT00246337|581266774|FG006|Overall Study|Protocol Violation|1|||
160966763|NCT00246337|581266775|FG007|Overall Study|Protocol Violation|1|||
160966764|NCT00246337|581266776|FG008|Overall Study|Protocol Violation|0|||
160966765|NCT00246337|581266768|FG000|Overall Study|Withdrawal by Subject|2|||
161007193|NCT02988817|581414367|FG018|Overall Study|Physician Decision|1|||
161007194|NCT02988817|581414368|FG019|Overall Study|Physician Decision|1|||
161007195|NCT00350792|581414373|FG000|Overall Study|Adverse Event|11|||
161007196|NCT00350792|581414373|FG000|Overall Study|Death from Study Disease|1|||
161007197|NCT00350792|581414373|FG000|Overall Study|Death from Study Drug Toxicity|1|||
161007198|NCT00350792|581414373|FG000|Overall Study|Death Not Study Drug Related|2|||
161007199|NCT00350792|581414373|FG000|Overall Study|Protocol Violation|1|||
161007200|NCT00350792|581414373|FG000|Overall Study|Withdrawal by Subject|4|||
160585398|NCT01934894|579861934|FG001|Overall Study|Withdrawal by Subject|1|||
160585399|NCT01934894|579861933|FG000|Overall Study|Progressive Disease|3|||
160966766|NCT00246337|581266769|FG001|Overall Study|Withdrawal by Subject|0|||
161007201|NCT00350792|581414373|FG000|Overall Study|Physician Decision|2|||
161007202|NCT00350792|581414373|FG000|Overall Study|Lack of Efficacy|11|||
161007203|NCT03076515|581414380|FG000|Overall Study|DMC decision based on interim analysis|25|||
161007204|NCT03076515|581414381|FG001|Overall Study|DMC decision based on interim analysis|29|||
161007205|NCT00174382|581414382|FG000|Overall Study|Death|2|||
161007206|NCT00174382|581414382|FG000|Overall Study|Adverse Event|19|||
161007207|NCT00174382|581414382|FG000|Overall Study|Withdrawal by Subject|6|||
161007208|NCT00174382|581414382|FG000|Overall Study|Protocol Violation|3|||
161007209|NCT00174382|581414382|FG000|Overall Study|Arrived early for last visit in error|1|||
161007210|NCT00174382|581414382|FG000|Overall Study|Subject felt pill not effective enough|1|||
161007211|NCT00174382|581414382|FG000|Overall Study|Lost to Follow-up|1|||
161007212|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
161007213|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
161007214|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
161007215|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
161007216|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
161007217|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
161007218|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
161007219|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
161007220|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161007221|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161007222|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161007223|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161007224|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
161007225|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
161007226|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
160966767|NCT00246337|581266770|FG002|Overall Study|Withdrawal by Subject|0|||
160966768|NCT00246337|581266771|FG003|Overall Study|Withdrawal by Subject|0|||
160966769|NCT00246337|581266772|FG004|Overall Study|Withdrawal by Subject|0|||
160966770|NCT00246337|581266773|FG005|Overall Study|Withdrawal by Subject|0|||
160966771|NCT00246337|581266774|FG006|Overall Study|Withdrawal by Subject|1|||
160966772|NCT00246337|581266775|FG007|Overall Study|Withdrawal by Subject|1|||
160966773|NCT00246337|581266776|FG008|Overall Study|Withdrawal by Subject|0|||
160966774|NCT00246337|581266768|FG000|Overall Study|Lack of Qualifying Event|8|||
160966775|NCT00246337|581266769|FG001|Overall Study|Lack of Qualifying Event|2|||
160966776|NCT00246337|581266770|FG002|Overall Study|Lack of Qualifying Event|1|||
160966777|NCT00246337|581266771|FG003|Overall Study|Lack of Qualifying Event|1|||
160966778|NCT00246337|581266772|FG004|Overall Study|Lack of Qualifying Event|1|||
160966779|NCT00246337|581266773|FG005|Overall Study|Lack of Qualifying Event|3|||
160966780|NCT00246337|581266774|FG006|Overall Study|Lack of Qualifying Event|3|||
160966781|NCT00246337|581266775|FG007|Overall Study|Lack of Qualifying Event|2|||
160966782|NCT00246337|581266776|FG008|Overall Study|Lack of Qualifying Event|5|||
160966783|NCT00246337|581266768|FG000|Overall Study|Site Terminated|10|||
160966784|NCT00246337|581266769|FG001|Overall Study|Site Terminated|0|||
160966785|NCT00246337|581266770|FG002|Overall Study|Site Terminated|0|||
160966786|NCT00246337|581266771|FG003|Overall Study|Site Terminated|0|||
160966787|NCT00246337|581266772|FG004|Overall Study|Site Terminated|0|||
160966788|NCT00246337|581266773|FG005|Overall Study|Site Terminated|7|||
160966789|NCT00246337|581266774|FG006|Overall Study|Site Terminated|1|||
160966790|NCT00246337|581266775|FG007|Overall Study|Site Terminated|6|||
160966791|NCT00246337|581266776|FG008|Overall Study|Site Terminated|2|||
160966792|NCT00246337|581266768|FG000|Overall Study|Abnormal baseline lab values|7|||
160966793|NCT00246337|581266769|FG001|Overall Study|Abnormal baseline lab values|0|||
160966794|NCT00246337|581266770|FG002|Overall Study|Abnormal baseline lab values|2|||
160966795|NCT00246337|581266771|FG003|Overall Study|Abnormal baseline lab values|0|||
160966796|NCT00246337|581266772|FG004|Overall Study|Abnormal baseline lab values|0|||
160966797|NCT00246337|581266773|FG005|Overall Study|Abnormal baseline lab values|2|||
160966798|NCT00246337|581266774|FG006|Overall Study|Abnormal baseline lab values|2|||
160966799|NCT00246337|581266775|FG007|Overall Study|Abnormal baseline lab values|0|||
160966800|NCT00246337|581266776|FG008|Overall Study|Abnormal baseline lab values|4|||
160966801|NCT00246337|581266768|FG000|Overall Study|Overwhelmed|0|||
160966802|NCT00246337|581266769|FG001|Overall Study|Overwhelmed|0|||
160966803|NCT00246337|581266770|FG002|Overall Study|Overwhelmed|0|||
160966804|NCT00246337|581266771|FG003|Overall Study|Overwhelmed|0|||
160966805|NCT00246337|581266772|FG004|Overall Study|Overwhelmed|0|||
160966806|NCT00246337|581266773|FG005|Overall Study|Overwhelmed|1|||
160966807|NCT00246337|581266774|FG006|Overall Study|Overwhelmed|0|||
160966808|NCT00246337|581266775|FG007|Overall Study|Overwhelmed|0|||
161007227|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161007228|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161007229|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
160966809|NCT00246337|581266776|FG008|Overall Study|Overwhelmed|0|||
160966810|NCT00246337|581266768|FG000|Overall Study|Protocol Violator|1|||
160966811|NCT00246337|581266769|FG001|Overall Study|Protocol Violator|0|||
160966812|NCT00246337|581266770|FG002|Overall Study|Protocol Violator|0|||
160966813|NCT00246337|581266771|FG003|Overall Study|Protocol Violator|0|||
160966814|NCT00246337|581266772|FG004|Overall Study|Protocol Violator|0|||
160966815|NCT00246337|581266773|FG005|Overall Study|Protocol Violator|0|||
161007230|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161007231|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161007232|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161007233|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161007234|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
161007235|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
161007236|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007237|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
161007238|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007239|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007240|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007241|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007242|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007243|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007244|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007245|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007246|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007247|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
161007248|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
161007249|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007250|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007251|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007252|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007253|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007254|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007255|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
161007256|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007257|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007258|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007259|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007260|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161007261|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
161007262|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161007263|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161007264|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
161007265|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161007266|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
161007267|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
161007268|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
161007269|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007270|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007271|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007272|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007273|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
161007274|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007275|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007276|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Other|2|||
161007277|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Other|1|||
161007278|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Other|0|||
161007279|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Other|0|||
161007280|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Other|1|||
161007281|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Other|1|||
161007282|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Other|0|||
161007283|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Other|0|||
161007284|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
161007285|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
161007286|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
161007287|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
161007288|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
160585400|NCT01934894|579861934|FG001|Overall Study|Progressive Disease|2|||
160585401|NCT01954251|579861935|FG000|Overall Study|Adverse Event|5|||
160585402|NCT01954251|579861936|FG001|Overall Study|Adverse Event|7|||
160585403|NCT01954251|579861935|FG000|Overall Study|Lost to Follow-up|6|||
160585404|NCT01954251|579861936|FG001|Overall Study|Lost to Follow-up|6|||
160585405|NCT01954251|579861935|FG000|Overall Study|Withdrawal by Subject|2|||
160585406|NCT01954251|579861936|FG001|Overall Study|Withdrawal by Subject|6|||
161007289|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
161007290|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
161007291|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
160585407|NCT04096326|579861937|FG000|Overall Study|Withdrawal by Subject|0|||
161007292|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
160585408|NCT04096326|579861938|FG001|Overall Study|Withdrawal by Subject|0|||
161007293|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007294|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007295|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007296|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
161007297|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007298|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007299|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007300|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
161007301|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161007302|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161007303|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161007304|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161007305|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161007306|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
161007307|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
161007308|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007309|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007310|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007311|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
160458638|NCT01475786|579410917|FG000|Overall Study|Withdrawal by Subject|0|||
160458639|NCT01475786|579410918|FG001|Overall Study|Withdrawal by Subject|1|||
160458640|NCT01475786|579410919|FG002|Overall Study|Withdrawal by Subject|1|||
160458641|NCT01475786|579410917|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
161007312|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
161007313|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007314|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007315|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007316|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161007317|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
161007318|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
161007319|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161007320|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161007321|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161007322|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
161007323|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
161007324|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007325|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007326|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007327|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007328|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007329|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
161007330|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007331|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007332|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Other|1|||
161007333|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Other|1|||
161007334|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Other|0|||
161007335|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Other|0|||
161007336|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Other|0|||
161007337|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Other|0|||
161007338|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Other|0|||
161007339|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Other|0|||
161007340|NCT00296036|581414391|FG000|Overall Study|Withdrawal by Subject|1|||
161007341|NCT00296036|581414392|FG001|Overall Study|Withdrawal by Subject|0|||
161007342|NCT00296036|581414393|FG002|Overall Study|Withdrawal by Subject|2|||
161007343|NCT00296036|581414394|FG003|Overall Study|Withdrawal by Subject|1|||
161007344|NCT00296036|581414395|FG004|Overall Study|Withdrawal by Subject|2|||
160458642|NCT01475786|579410918|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
160458643|NCT01475786|579410919|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
160458644|NCT03165955|579410921|FG000|Treatment|Withdrawal by Subject|3|||
160458645|NCT03165955|579410921|FG000|Treatment|Death|1|||
160458646|NCT03165955|579410921|FG000|Treatment|Adverse Event|1|||
160458647|NCT03165955|579410921|FG000|Treatment|Progressive disease|3|||
160458648|NCT02865538|579410922|FG000|Overall Study|Withdrawal by Subject|0|||
161007345|NCT00296036|581414396|FG005|Overall Study|Withdrawal by Subject|1|||
160458649|NCT02865538|579410923|FG001|Overall Study|Withdrawal by Subject|0|||
160458650|NCT02865538|579410924|FG002|Overall Study|Withdrawal by Subject|1|||
160458651|NCT02865538|579410925|FG003|Overall Study|Withdrawal by Subject|0|||
161007346|NCT00296036|581414391|FG000|Overall Study|Protocol Violation|0|||
161007347|NCT00296036|581414392|FG001|Overall Study|Protocol Violation|0|||
161007348|NCT00296036|581414393|FG002|Overall Study|Protocol Violation|0|||
160458652|NCT02865538|579410926|FG004|Overall Study|Withdrawal by Subject|0|||
160458653|NCT02865538|579410922|FG000|Overall Study|Lost to Follow-up|1|||
161007349|NCT00296036|581414394|FG003|Overall Study|Protocol Violation|0|||
161007350|NCT00296036|581414395|FG004|Overall Study|Protocol Violation|0|||
161007351|NCT00296036|581414396|FG005|Overall Study|Protocol Violation|3|||
161007352|NCT00785512|581414399|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
161007353|NCT00785512|581414400|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
161007354|NCT00785512|581414399|FG000|Overall Study|Adverse Event|0|||
161007355|NCT00785512|581414400|FG001|Overall Study|Adverse Event|0|||
161007356|NCT00785512|581414399|FG000|Overall Study|Lack of Efficacy|0|||
161007357|NCT00785512|581414400|FG001|Overall Study|Lack of Efficacy|2|||
161007358|NCT00785512|581414399|FG000|Overall Study|Withdrawal by Subject|0|||
161007359|NCT00785512|581414400|FG001|Overall Study|Withdrawal by Subject|1|||
161007360|NCT00785512|581414399|FG000|Overall Study|Lost to Follow-up|3|||
161007361|NCT00785512|581414400|FG001|Overall Study|Lost to Follow-up|0|||
161007362|NCT00785512|581414399|FG000|Overall Study|Precedure Refused|0|||
161007363|NCT00785512|581414400|FG001|Overall Study|Precedure Refused|0|||
161007364|NCT00785512|581414399|FG000|Overall Study|IVRS Programing Error|0|||
161007365|NCT00785512|581414400|FG001|Overall Study|IVRS Programing Error|0|||
161007366|NCT00785512|581414399|FG000|Overall Study|Physician Decision|0|||
161007367|NCT00785512|581414400|FG001|Overall Study|Physician Decision|0|||
161007368|NCT00785512|581414399|FG000|Overall Study|Lack of compliance|0|||
161007369|NCT00785512|581414400|FG001|Overall Study|Lack of compliance|1|||
161007370|NCT02477605|581414401|FG000|Overall Study|Discontinued prior to treatment|1|||
161007371|NCT02477605|581414402|FG001|Overall Study|Discontinued prior to treatment|0|||
161007372|NCT02477605|581414401|FG000|Overall Study|Lost to Follow-up|0|||
161007373|NCT02477605|581414402|FG001|Overall Study|Lost to Follow-up|2|||
161007374|NCT02477605|581414401|FG000|Overall Study|Withdrawal by Subject|0|||
161007375|NCT02477605|581414402|FG001|Overall Study|Withdrawal by Subject|1|||
161007376|NCT02477605|581414401|FG000|Overall Study|Administered gas during surgery|0|||
161007377|NCT02477605|581414402|FG001|Overall Study|Administered gas during surgery|1|||
161007378|NCT00970359|581414404|FG000|Overall Study|Not Treated|4|||
161007379|NCT01388361|581414405|FG000|Overall Study|Adverse Event|0|||
161007380|NCT01388361|581414406|FG001|Overall Study|Adverse Event|5|||
161007381|NCT01388361|581414407|FG002|Overall Study|Adverse Event|1|||
161007382|NCT01388361|581414405|FG000|Overall Study|Protocol Violation|0|||
161007383|NCT01388361|581414406|FG001|Overall Study|Protocol Violation|0|||
161007384|NCT01388361|581414407|FG002|Overall Study|Protocol Violation|2|||
161007385|NCT01388361|581414405|FG000|Overall Study|Withdrawal criteria|12|||
161007386|NCT01388361|581414406|FG001|Overall Study|Withdrawal criteria|7|||
161007387|NCT01388361|581414407|FG002|Overall Study|Withdrawal criteria|10|||
161007388|NCT01388361|581414405|FG000|Overall Study|Unclassified|0|||
161007389|NCT01388361|581414406|FG001|Overall Study|Unclassified|0|||
161007390|NCT01388361|581414407|FG002|Overall Study|Unclassified|1|||
161007391|NCT03942042|581414408|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
161007392|NCT03942042|581414409|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
161007393|NCT03942042|581414408|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
161007394|NCT03942042|581414409|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
161007395|NCT01499199|581414412|FG000|Overall Study|Adverse Event|1|||
161007396|NCT01499199|581414412|FG000|Overall Study|Lack of Efficacy|1|||
161007397|NCT01199705|581414413|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
161007398|NCT00933400|581414414|FG000|Overall Study|Withdrawal by Subject|21|||
161007399|NCT00933400|581414415|FG001|Overall Study|Withdrawal by Subject|1|||
161007400|NCT01849055|581414416|FG000|Overall Study|Withdrawal by Subject|0|||
161007401|NCT01849055|581414417|FG001|Overall Study|Withdrawal by Subject|0|||
161007402|NCT01849055|581414418|FG002|Overall Study|Withdrawal by Subject|1|||
161007403|NCT01849055|581414419|FG003|Overall Study|Withdrawal by Subject|0|||
161007404|NCT01849055|581414420|FG004|Overall Study|Withdrawal by Subject|0|||
161007405|NCT01849055|581414421|FG005|Overall Study|Withdrawal by Subject|0|||
161007406|NCT00223795|581414422|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
161007407|NCT00223795|581414423|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
161007408|NCT00223795|581414422|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
161007409|NCT00223795|581414423|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
161007410|NCT00716859|581414426|FG000|Overall Study|Adverse Event|4|||
161007411|NCT00716859|581414427|FG001|Overall Study|Adverse Event|1|||
161007412|NCT00716859|581414426|FG000|Overall Study|Lack of Efficacy|3|||
160458654|NCT02865538|579410923|FG001|Overall Study|Lost to Follow-up|0|||
161007413|NCT00716859|581414427|FG001|Overall Study|Lack of Efficacy|0|||
161007414|NCT00716859|581414426|FG000|Overall Study|Withdrawal by Subject|1|||
161007415|NCT00716859|581414427|FG001|Overall Study|Withdrawal by Subject|3|||
161007416|NCT00716859|581414426|FG000|Overall Study|Not treated|1|||
161007417|NCT00716859|581414427|FG001|Overall Study|Not treated|1|||
161007418|NCT03783026|581416659|FG000|Treatment Phase|Adverse Event|15|||
161007419|NCT03783026|581416659|FG000|Treatment Phase|Lack of Efficacy|11|||
161007420|NCT03783026|581416659|FG000|Treatment Phase|Withdrawal by Subject|6|||
161007421|NCT03783026|581416659|FG000|Treatment Phase|Lost to Follow-up|2|||
161007422|NCT03783026|581416659|FG000|Treatment Phase|Protocol Deviation|8|||
161007423|NCT03783026|581416659|FG000|Treatment Phase|Did Not Receive Treatment|1|||
161007424|NCT03783026|581416659|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
161007425|NCT04814186|581416660|FG000|Treatment Phase|Adverse Event|1|||
161007426|NCT04814186|581416660|FG000|Treatment Phase|Death|6|||
161007427|NCT04814186|581416660|FG000|Treatment Phase|Withdrawal by Subject|2|||
161007428|NCT04814186|581416660|FG000|Treatment Phase|Other|1|||
161007429|NCT04814186|581416660|FG000|Follow-Up Phase|Adverse Event|1|||
161007430|NCT04814186|581416660|FG000|Follow-Up Phase|Death|6|||
161007431|NCT04814186|581416660|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
161007432|NCT04814186|581416660|FG000|Follow-Up Phase|Other|1|||
161007433|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
161007434|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
161007435|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
161007436|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
161007437|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
161007438|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
161007439|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
161007440|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
161007441|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
161007442|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
161007443|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
161007444|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
161007445|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161007446|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
161007447|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
161007448|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161007449|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161007450|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161007451|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
161007452|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
161007453|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
161007454|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
161007455|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
161007456|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
161007457|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161007458|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
161007459|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161007460|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161007461|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161007462|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161007463|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
161007464|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161007465|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161007466|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161007467|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161007468|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161007469|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161007470|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
161007471|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161007472|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161007473|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161007474|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161007475|NCT04043455|581416665|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
161007476|NCT04043455|581416666|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
161007477|NCT04043455|581416667|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
161007478|NCT04043455|581416668|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
161007479|NCT04043455|581416669|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
161007480|NCT04043455|581416670|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
161007481|NCT04043455|581416665|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161007482|NCT04043455|581416666|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161007483|NCT04043455|581416667|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161007484|NCT04043455|581416668|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161007485|NCT04043455|581416669|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
161007486|NCT04043455|581416670|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
161007487|NCT04043455|581416665|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
160585409|NCT04096326|579861939|FG002|Overall Study|Withdrawal by Subject|0|||
160966816|NCT00246337|581266774|FG006|Overall Study|Protocol Violator|0|||
160966817|NCT00246337|581266775|FG007|Overall Study|Protocol Violator|0|||
160966818|NCT00246337|581266776|FG008|Overall Study|Protocol Violator|0|||
160966819|NCT00246337|581266768|FG000|Overall Study|Reported as completing trial in error|0|||
160966820|NCT00246337|581266769|FG001|Overall Study|Reported as completing trial in error|0|||
160966821|NCT00246337|581266770|FG002|Overall Study|Reported as completing trial in error|0|||
160966822|NCT00246337|581266771|FG003|Overall Study|Reported as completing trial in error|0|||
160966823|NCT00246337|581266772|FG004|Overall Study|Reported as completing trial in error|0|||
160966824|NCT00246337|581266773|FG005|Overall Study|Reported as completing trial in error|0|||
160966825|NCT00246337|581266774|FG006|Overall Study|Reported as completing trial in error|0|||
160966826|NCT00246337|581266775|FG007|Overall Study|Reported as completing trial in error|1|||
160966827|NCT00246337|581266776|FG008|Overall Study|Reported as completing trial in error|0|||
160966828|NCT02696564|581266779|FG000|Overall Study|Death|1|||
160966829|NCT02696564|581266780|FG001|Overall Study|Death|2|||
160966830|NCT02696564|581266779|FG000|Overall Study|Withdrawal by Subject|3|||
160966831|NCT02696564|581266780|FG001|Overall Study|Withdrawal by Subject|2|||
160966832|NCT02696564|581266779|FG000|Overall Study|Lost to Follow-up|3|||
160966833|NCT02696564|581266780|FG001|Overall Study|Lost to Follow-up|3|||
160966834|NCT02696564|581266779|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
160966835|NCT02696564|581266780|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
160966836|NCT02696564|581266779|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
160966837|NCT02696564|581266780|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
160966838|NCT02696564|581266779|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
160966839|NCT02696564|581266780|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
160966840|NCT02696564|581266779|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
160966841|NCT02696564|581266780|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
160966842|NCT02696564|581266779|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
160966843|NCT02696564|581266780|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
160966844|NCT04067401|581266781|FG000|Overall Study|Withdrawal by Subject|7|||
160966845|NCT04067401|581266782|FG001|Overall Study|Withdrawal by Subject|0|||
160966846|NCT04067401|581266781|FG000|Overall Study|no data provided|1|||
160966847|NCT04067401|581266782|FG001|Overall Study|no data provided|0|||
160966848|NCT03633929|581266783|FG000|Overall Study|Lost to Follow-up|1|||
160966849|NCT03633929|581266783|FG000|Overall Study|Did not login to software. Did not participate|3|||
160966850|NCT02287584|581266785|FG000|the Double-blind Phase|Adverse Event|17|||
160966851|NCT02287584|581266786|FG001|the Double-blind Phase|Adverse Event|17|||
160966852|NCT02287584|581266787|FG002|the Double-blind Phase|Adverse Event|12|||
160966853|NCT02287584|581266788|FG003|the Double-blind Phase|Adverse Event|0|||
160966854|NCT02287584|581266789|FG004|the Double-blind Phase|Adverse Event|0|||
160966855|NCT02287584|581266790|FG005|the Double-blind Phase|Adverse Event|0|||
160966856|NCT02287584|581266785|FG000|the Double-blind Phase|Lack of Efficacy|18|||
160966857|NCT02287584|581266786|FG001|the Double-blind Phase|Lack of Efficacy|8|||
160966858|NCT02287584|581266787|FG002|the Double-blind Phase|Lack of Efficacy|8|||
160966859|NCT02287584|581266788|FG003|the Double-blind Phase|Lack of Efficacy|0|||
160966860|NCT02287584|581266789|FG004|the Double-blind Phase|Lack of Efficacy|0|||
160966861|NCT02287584|581266790|FG005|the Double-blind Phase|Lack of Efficacy|0|||
160966862|NCT02287584|581266785|FG000|the Double-blind Phase|Lost to Follow-up|0|||
160966863|NCT02287584|581266786|FG001|the Double-blind Phase|Lost to Follow-up|1|||
160966864|NCT02287584|581266787|FG002|the Double-blind Phase|Lost to Follow-up|1|||
160966865|NCT02287584|581266788|FG003|the Double-blind Phase|Lost to Follow-up|0|||
160966866|NCT02287584|581266789|FG004|the Double-blind Phase|Lost to Follow-up|0|||
160966867|NCT02287584|581266790|FG005|the Double-blind Phase|Lost to Follow-up|0|||
160966868|NCT02287584|581266785|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
160966869|NCT02287584|581266786|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
160966870|NCT02287584|581266787|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
160966871|NCT02287584|581266788|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
160966872|NCT02287584|581266789|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
160966873|NCT02287584|581266790|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
160966874|NCT02287584|581266785|FG000|the Double-blind Phase|Pregnancy|0|||
160966875|NCT02287584|581266786|FG001|the Double-blind Phase|Pregnancy|1|||
160966876|NCT02287584|581266787|FG002|the Double-blind Phase|Pregnancy|0|||
160966877|NCT02287584|581266788|FG003|the Double-blind Phase|Pregnancy|0|||
160966878|NCT02287584|581266789|FG004|the Double-blind Phase|Pregnancy|0|||
160966879|NCT02287584|581266790|FG005|the Double-blind Phase|Pregnancy|0|||
160966880|NCT02287584|581266785|FG000|the Double-blind Phase|Protocol Violation|0|||
160966881|NCT02287584|581266786|FG001|the Double-blind Phase|Protocol Violation|3|||
160966882|NCT02287584|581266787|FG002|the Double-blind Phase|Protocol Violation|0|||
160966883|NCT02287584|581266788|FG003|the Double-blind Phase|Protocol Violation|0|||
160966884|NCT02287584|581266789|FG004|the Double-blind Phase|Protocol Violation|0|||
160966885|NCT02287584|581266790|FG005|the Double-blind Phase|Protocol Violation|0|||
160585410|NCT04096326|579861940|FG003|Overall Study|Withdrawal by Subject|0|||
161007488|NCT04043455|581416666|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161007489|NCT04043455|581416667|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161007490|NCT04043455|581416668|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161007491|NCT04043455|581416669|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
161007492|NCT04043455|581416670|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161007493|NCT04043455|581416665|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161007494|NCT04043455|581416666|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161007495|NCT04043455|581416667|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161007496|NCT04043455|581416668|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161007497|NCT04043455|581416669|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
161007498|NCT04043455|581416670|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
161007499|NCT01643070|581416671|FG000|Overall Study|Withdrawal by Subject|3|||
161007500|NCT01643070|581416672|FG001|Overall Study|Withdrawal by Subject|1|||
161007501|NCT01643070|581416671|FG000|Overall Study|Death|1|||
161007502|NCT01643070|581416672|FG001|Overall Study|Death|0|||
161007503|NCT01643070|581416671|FG000|Overall Study|Pregressive disease|0|||
160585411|NCT04096326|579861941|FG004|Overall Study|Withdrawal by Subject|0|||
160585412|NCT04096326|579861942|FG005|Overall Study|Withdrawal by Subject|0|||
160585413|NCT04096326|579861943|FG006|Overall Study|Withdrawal by Subject|1|||
160585414|NCT04096326|579861944|FG007|Overall Study|Withdrawal by Subject|0|||
160585415|NCT04096326|579861945|FG008|Overall Study|Withdrawal by Subject|0|||
160585416|NCT04096326|579861946|FG009|Overall Study|Withdrawal by Subject|0|||
160585417|NCT04096326|579861937|FG000|Overall Study|Lost to Follow-up|0|||
160585418|NCT04096326|579861938|FG001|Overall Study|Lost to Follow-up|1|||
160585419|NCT04096326|579861939|FG002|Overall Study|Lost to Follow-up|0|||
160585420|NCT04096326|579861940|FG003|Overall Study|Lost to Follow-up|0|||
160585421|NCT04096326|579861941|FG004|Overall Study|Lost to Follow-up|0|||
160585422|NCT04096326|579861942|FG005|Overall Study|Lost to Follow-up|0|||
160585423|NCT04096326|579861943|FG006|Overall Study|Lost to Follow-up|0|||
160585424|NCT04096326|579861944|FG007|Overall Study|Lost to Follow-up|0|||
160585425|NCT04096326|579861945|FG008|Overall Study|Lost to Follow-up|0|||
160585426|NCT04096326|579861946|FG009|Overall Study|Lost to Follow-up|0|||
160585427|NCT04096326|579861937|FG000|Overall Study|COVID-19-related reasons|0|||
160585428|NCT04096326|579861938|FG001|Overall Study|COVID-19-related reasons|0|||
160585429|NCT04096326|579861939|FG002|Overall Study|COVID-19-related reasons|0|||
160966886|NCT02287584|581266785|FG000|the Double-blind Phase|other reasons|0|||
160966887|NCT02287584|581266786|FG001|the Double-blind Phase|other reasons|0|||
160966888|NCT02287584|581266787|FG002|the Double-blind Phase|other reasons|1|||
160966889|NCT02287584|581266788|FG003|the Double-blind Phase|other reasons|0|||
160966890|NCT02287584|581266789|FG004|the Double-blind Phase|other reasons|0|||
160966891|NCT02287584|581266790|FG005|the Double-blind Phase|other reasons|0|||
160966892|NCT02287584|581266785|FG000|the Open-label Phase|Did not receive drug|0|||
160966893|NCT02287584|581266786|FG001|the Open-label Phase|Did not receive drug|0|||
160966894|NCT02287584|581266787|FG002|the Open-label Phase|Did not receive drug|0|||
160966895|NCT02287584|581266788|FG003|the Open-label Phase|Did not receive drug|7|||
160966896|NCT02287584|581266789|FG004|the Open-label Phase|Did not receive drug|6|||
160966897|NCT02287584|581266790|FG005|the Open-label Phase|Did not receive drug|4|||
160966898|NCT02287584|581266785|FG000|the Open-label Phase|Adverse Event|0|||
160966899|NCT02287584|581266786|FG001|the Open-label Phase|Adverse Event|0|||
160966900|NCT02287584|581266787|FG002|the Open-label Phase|Adverse Event|0|||
160966901|NCT02287584|581266788|FG003|the Open-label Phase|Adverse Event|15|||
160966902|NCT02287584|581266789|FG004|the Open-label Phase|Adverse Event|12|||
160966903|NCT02287584|581266790|FG005|the Open-label Phase|Adverse Event|16|||
160966904|NCT02287584|581266785|FG000|the Open-label Phase|Lack of Efficacy|0|||
160966905|NCT02287584|581266786|FG001|the Open-label Phase|Lack of Efficacy|0|||
160966906|NCT02287584|581266787|FG002|the Open-label Phase|Lack of Efficacy|0|||
160966907|NCT02287584|581266788|FG003|the Open-label Phase|Lack of Efficacy|8|||
160966908|NCT02287584|581266789|FG004|the Open-label Phase|Lack of Efficacy|3|||
160966909|NCT02287584|581266790|FG005|the Open-label Phase|Lack of Efficacy|7|||
160966910|NCT02287584|581266785|FG000|the Open-label Phase|Lost to Follow-up|0|||
160966911|NCT02287584|581266786|FG001|the Open-label Phase|Lost to Follow-up|0|||
160966912|NCT02287584|581266787|FG002|the Open-label Phase|Lost to Follow-up|0|||
160966913|NCT02287584|581266788|FG003|the Open-label Phase|Lost to Follow-up|4|||
160966914|NCT02287584|581266789|FG004|the Open-label Phase|Lost to Follow-up|1|||
160966915|NCT02287584|581266790|FG005|the Open-label Phase|Lost to Follow-up|2|||
160966916|NCT02287584|581266785|FG000|the Open-label Phase|Withdrawal by Subject|0|||
160966917|NCT02287584|581266786|FG001|the Open-label Phase|Withdrawal by Subject|0|||
160966918|NCT02287584|581266787|FG002|the Open-label Phase|Withdrawal by Subject|0|||
160966919|NCT02287584|581266788|FG003|the Open-label Phase|Withdrawal by Subject|18|||
160966920|NCT02287584|581266789|FG004|the Open-label Phase|Withdrawal by Subject|29|||
160585430|NCT04096326|579861940|FG003|Overall Study|COVID-19-related reasons|0|||
160585431|NCT04096326|579861941|FG004|Overall Study|COVID-19-related reasons|1|||
160585432|NCT04096326|579861942|FG005|Overall Study|COVID-19-related reasons|5|||
161007504|NCT01643070|581416672|FG001|Overall Study|Pregressive disease|2|||
161007505|NCT02652260|581416674|FG000|Base Study|Pregnancy|0|||
161007506|NCT02652260|581416675|FG001|Base Study|Pregnancy|1|||
161007507|NCT02652260|581416674|FG000|Base Study|Withdrawal by Subject|0|||
161007508|NCT02652260|581416675|FG001|Base Study|Withdrawal by Subject|1|||
161007509|NCT02652260|581416674|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
161007510|NCT02652260|581416675|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
161007511|NCT02652260|581416674|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
161007512|NCT02652260|581416675|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
161007513|NCT02652260|581416674|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
161007514|NCT02652260|581416675|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
161007515|NCT02652260|581416674|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
161007516|NCT02652260|581416675|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
161007517|NCT02652260|581416674|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
161007518|NCT02652260|581416675|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
161007519|NCT02652260|581416674|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
161007520|NCT02652260|581416675|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
161007521|NCT02652260|581416674|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
161007522|NCT02652260|581416675|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
161007523|NCT02652260|581416674|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
161007524|NCT02652260|581416675|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
161007525|NCT02652260|581416674|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
161007526|NCT02652260|581416675|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
161007527|NCT02652260|581416674|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
161007528|NCT02652260|581416675|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
161007529|NCT02652260|581416674|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
161007530|NCT02652260|581416675|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
161007531|NCT02652260|581416674|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
161007532|NCT02652260|581416675|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
161007533|NCT04999085|581416678|FG000|Overall Study|Death|1|||
161007534|NCT05056246|581416679|FG000|Overall Study|Adverse Event|0|||
161007535|NCT05056246|581416680|FG001|Overall Study|Adverse Event|0|||
161007536|NCT05056246|581416681|FG002|Overall Study|Adverse Event|0|||
161007537|NCT05056246|581416682|FG003|Overall Study|Adverse Event|0|||
161007538|NCT05056246|581416683|FG004|Overall Study|Adverse Event|1|||
161007539|NCT05056246|581416679|FG000|Overall Study|Lost to Follow-up|0|||
161007540|NCT05056246|581416680|FG001|Overall Study|Lost to Follow-up|0|||
161007541|NCT05056246|581416681|FG002|Overall Study|Lost to Follow-up|0|||
161007542|NCT05056246|581416682|FG003|Overall Study|Lost to Follow-up|2|||
161007543|NCT05056246|581416683|FG004|Overall Study|Lost to Follow-up|0|||
161007544|NCT05056246|581416679|FG000|Overall Study|Withdrawal by Subject|0|||
161007545|NCT05056246|581416680|FG001|Overall Study|Withdrawal by Subject|1|||
161007546|NCT05056246|581416681|FG002|Overall Study|Withdrawal by Subject|0|||
161007547|NCT05056246|581416682|FG003|Overall Study|Withdrawal by Subject|0|||
161007548|NCT05056246|581416683|FG004|Overall Study|Withdrawal by Subject|0|||
161007549|NCT02824029|581416684|FG000|Overall Study|Didn't receive treatment|2|||
161007550|NCT02824029|581416684|FG000|Overall Study|Patient decision to discontinue treatment|3|||
161007551|NCT02824029|581416684|FG000|Overall Study|Non-compliant|5|||
161007552|NCT02824029|581416684|FG000|Overall Study|Progression of disease|15|||
161007553|NCT02824029|581416684|FG000|Overall Study|Inadequate response to therapy|2|||
161007554|NCT02824029|581416684|FG000|Overall Study|Possible progression per treating physician|1|||
161007555|NCT04440176|581416686|FG000|Overall Study|Withdrawal by Subject|5|||
161007556|NCT04440176|581416687|FG001|Overall Study|Withdrawal by Subject|3|||
161007557|NCT04440176|581416686|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161007558|NCT04440176|581416687|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161007559|NCT04440176|581416686|FG000|Overall Study|Adverse Event|2|||
161007560|NCT04440176|581416687|FG001|Overall Study|Adverse Event|6|||
161007561|NCT04440176|581416686|FG000|Overall Study|Lost to Follow-up|22|||
161007562|NCT04440176|581416687|FG001|Overall Study|Lost to Follow-up|23|||
161007563|NCT04440176|581416686|FG000|Overall Study|Medication error without associated adverse event|0|||
161007564|NCT04440176|581416687|FG001|Overall Study|Medication error without associated adverse event|1|||
161007565|NCT04440176|581416686|FG000|Overall Study|No longer met eligibility criteria|7|||
161007566|NCT04440176|581416687|FG001|Overall Study|No longer met eligibility criteria|1|||
161007567|NCT04440176|581416686|FG000|Overall Study|Other|1|||
161007568|NCT04440176|581416687|FG001|Overall Study|Other|2|||
161007569|NCT04440176|581416686|FG000|Overall Study|Protocol deviation|6|||
161007570|NCT04440176|581416687|FG001|Overall Study|Protocol deviation|8|||
161007571|NCT04440176|581416686|FG000|Overall Study|Randomized but not vaccinated|6|||
161007572|NCT04440176|581416687|FG001|Overall Study|Randomized but not vaccinated|3|||
161007573|NCT01631214|581416691|FG000|Overall Study|Withdrawal by Subject|276|||
161007574|NCT01631214|581416692|FG001|Overall Study|Withdrawal by Subject|290|||
161007575|NCT01631214|581416691|FG000|Overall Study|Death|113|||
161007576|NCT01631214|581416692|FG001|Overall Study|Death|106|||
161007577|NCT01631214|581416691|FG000|Overall Study|Lost to Follow-up|54|||
161007578|NCT01631214|581416692|FG001|Overall Study|Lost to Follow-up|40|||
161007579|NCT01631214|581416691|FG000|Overall Study|Adverse Event|45|||
161007580|NCT01631214|581416692|FG001|Overall Study|Adverse Event|45|||
161007581|NCT01631214|581416691|FG000|Overall Study|Other|22|||
161007582|NCT01631214|581416692|FG001|Overall Study|Other|19|||
161007583|NCT01631214|581416691|FG000|Overall Study|Noncompliance|16|||
161007584|NCT01631214|581416692|FG001|Overall Study|Noncompliance|15|||
161007585|NCT01631214|581416691|FG000|Overall Study|Requirement for Alternative Therapy|8|||
161007586|NCT01631214|581416692|FG001|Overall Study|Requirement for Alternative Therapy|3|||
161007587|NCT01631214|581416691|FG000|Overall Study|Protocol Deviation|4|||
161007588|NCT01631214|581416692|FG001|Overall Study|Protocol Deviation|3|||
161007589|NCT01631214|581416691|FG000|Overall Study|Ineligibility determined|5|||
161007590|NCT01631214|581416692|FG001|Overall Study|Ineligibility determined|2|||
160458655|NCT02865538|579410924|FG002|Overall Study|Lost to Follow-up|0|||
160458656|NCT02865538|579410925|FG003|Overall Study|Lost to Follow-up|0|||
160458657|NCT02865538|579410926|FG004|Overall Study|Lost to Follow-up|0|||
160458658|NCT04108130|579412600|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
160458659|NCT04108130|579412601|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
161007591|NCT01631214|581416691|FG000|Overall Study|Administrative Decision|1|||
161007592|NCT01631214|581416692|FG001|Overall Study|Administrative Decision|0|||
161007593|NCT03575052|581416693|FG000|Overall Study|Adverse Event|6|||
161007594|NCT03575052|581416694|FG001|Overall Study|Adverse Event|10|||
160458660|NCT04108130|579412600|FG000|Overall Study|Consent Withdrawn|9|||
160458661|NCT04108130|579412601|FG001|Overall Study|Consent Withdrawn|6|||
160458662|NCT04108130|579412600|FG000|Overall Study|Surgery Cancelled|4|||
160458663|NCT04108130|579412601|FG001|Overall Study|Surgery Cancelled|4|||
160458664|NCT04108130|579412600|FG000|Overall Study|Found Ineligible for Study|4|||
160458665|NCT04108130|579412601|FG001|Overall Study|Found Ineligible for Study|3|||
160458666|NCT04108130|579412600|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
160458667|NCT04108130|579412601|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
160458668|NCT04108130|579412600|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
160458669|NCT04108130|579412601|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
160458670|NCT04244175|579412602|FG000|Overall Study|Adverse Event|3|||
160458671|NCT04244175|579412603|FG001|Overall Study|Adverse Event|2|||
160458672|NCT04244175|579412604|FG002|Overall Study|Adverse Event|5|||
160458673|NCT04244175|579412602|FG000|Overall Study|Lack of Efficacy|1|||
160458674|NCT04244175|579412603|FG001|Overall Study|Lack of Efficacy|0|||
160458675|NCT04244175|579412604|FG002|Overall Study|Lack of Efficacy|1|||
160458676|NCT04244175|579412602|FG000|Overall Study|Lost to Follow-up|1|||
160458677|NCT04244175|579412603|FG001|Overall Study|Lost to Follow-up|0|||
160458678|NCT04244175|579412604|FG002|Overall Study|Lost to Follow-up|0|||
160458679|NCT04244175|579412602|FG000|Overall Study|Non-compliance with study drug|1|||
160458680|NCT04244175|579412603|FG001|Overall Study|Non-compliance with study drug|0|||
160458681|NCT04244175|579412604|FG002|Overall Study|Non-compliance with study drug|1|||
160458682|NCT04244175|579412602|FG000|Overall Study|Protocol deviation|0|||
160458683|NCT04244175|579412603|FG001|Overall Study|Protocol deviation|1|||
160458684|NCT04244175|579412604|FG002|Overall Study|Protocol deviation|0|||
160458685|NCT04244175|579412602|FG000|Overall Study|Withdrawal by Subject|1|||
160458686|NCT04244175|579412603|FG001|Overall Study|Withdrawal by Subject|3|||
161007595|NCT03575052|581416693|FG000|Overall Study|Not further specified|5|||
161007596|NCT03575052|581416694|FG001|Overall Study|Not further specified|7|||
161007597|NCT03575052|581416693|FG000|Overall Study|Withdrawal by Subject|5|||
161007598|NCT03575052|581416694|FG001|Overall Study|Withdrawal by Subject|6|||
160458687|NCT04244175|579412604|FG002|Overall Study|Withdrawal by Subject|1|||
160458688|NCT04244175|579412602|FG000|Overall Study|Other, not specified|0|||
160458689|NCT04244175|579412603|FG001|Overall Study|Other, not specified|1|||
160458690|NCT04244175|579412604|FG002|Overall Study|Other, not specified|2|||
160585433|NCT04096326|579861943|FG006|Overall Study|COVID-19-related reasons|0|||
160966921|NCT02287584|581266790|FG005|the Open-label Phase|Withdrawal by Subject|21|||
160966922|NCT02287584|581266785|FG000|the Open-label Phase|non-compliance|0|||
160966923|NCT02287584|581266786|FG001|the Open-label Phase|non-compliance|0|||
160966924|NCT02287584|581266787|FG002|the Open-label Phase|non-compliance|0|||
160966925|NCT02287584|581266788|FG003|the Open-label Phase|non-compliance|2|||
160966926|NCT02287584|581266789|FG004|the Open-label Phase|non-compliance|5|||
160966927|NCT02287584|581266790|FG005|the Open-label Phase|non-compliance|1|||
160966928|NCT02287584|581266785|FG000|the Open-label Phase|other reasons|0|||
160966929|NCT02287584|581266786|FG001|the Open-label Phase|other reasons|0|||
160966930|NCT02287584|581266787|FG002|the Open-label Phase|other reasons|0|||
160966931|NCT02287584|581266788|FG003|the Open-label Phase|other reasons|3|||
160966932|NCT02287584|581266789|FG004|the Open-label Phase|other reasons|6|||
161007599|NCT03575052|581416693|FG000|Overall Study|Lost to Follow-up|3|||
160458691|NCT03417284|579412605|FG000|Overall Study|Inadequate supply on study drug|1|||
160458692|NCT03417284|579412606|FG001|Overall Study|Inadequate supply on study drug|0|||
160458693|NCT03417284|579412607|FG002|Overall Study|Inadequate supply on study drug|0|||
161007600|NCT03575052|581416694|FG001|Overall Study|Lost to Follow-up|0|||
161007601|NCT03575052|581416693|FG000|Overall Study|Death|2|||
161007602|NCT03575052|581416694|FG001|Overall Study|Death|1|||
161007603|NCT03575052|581416693|FG000|Overall Study|Lack of Efficacy|2|||
161007604|NCT03575052|581416694|FG001|Overall Study|Lack of Efficacy|1|||
161007605|NCT03575052|581416693|FG000|Overall Study|Study drug noncompliance|1|||
161007606|NCT03575052|581416694|FG001|Overall Study|Study drug noncompliance|2|||
161007607|NCT03575052|581416693|FG000|Overall Study|Protocol Violation|0|||
161007608|NCT03575052|581416694|FG001|Overall Study|Protocol Violation|2|||
161007609|NCT03575052|581416693|FG000|Overall Study|Physician Decision|1|||
161007610|NCT03575052|581416694|FG001|Overall Study|Physician Decision|0|||
161007611|NCT03624972|581416704|FG000|Overall Study|Lost to Follow-up|2|||
161007612|NCT03624972|581416705|FG001|Overall Study|Lost to Follow-up|0|||
161007613|NCT03624972|581416706|FG002|Overall Study|Lost to Follow-up|0|||
161007614|NCT03624972|581416704|FG000|Overall Study|Withdrawal by Subject|0|||
161007615|NCT03624972|581416705|FG001|Overall Study|Withdrawal by Subject|2|||
161007616|NCT03624972|581416706|FG002|Overall Study|Withdrawal by Subject|0|||
161007617|NCT03112174|581416707|FG000|Overall Study|Withdrawal by Subject|3|||
161007618|NCT03112174|581416708|FG001|Overall Study|Withdrawal by Subject|0|||
161007619|NCT03112174|581416709|FG002|Overall Study|Withdrawal by Subject|11|||
161007620|NCT03112174|581416710|FG003|Overall Study|Withdrawal by Subject|9|||
161007621|NCT03112174|581416711|FG004|Overall Study|Withdrawal by Subject|7|||
161007622|NCT03112174|581416707|FG000|Overall Study|Lost to Follow-up|1|||
161007623|NCT03112174|581416708|FG001|Overall Study|Lost to Follow-up|1|||
161007624|NCT03112174|581416709|FG002|Overall Study|Lost to Follow-up|2|||
161007625|NCT03112174|581416710|FG003|Overall Study|Lost to Follow-up|3|||
161007626|NCT03112174|581416711|FG004|Overall Study|Lost to Follow-up|2|||
161007627|NCT03112174|581416707|FG000|Overall Study|Death|8|||
161007628|NCT03112174|581416708|FG001|Overall Study|Death|3|||
161007629|NCT03112174|581416709|FG002|Overall Study|Death|67|||
161007630|NCT03112174|581416710|FG003|Overall Study|Death|73|||
161007631|NCT03112174|581416711|FG004|Overall Study|Death|18|||
161007632|NCT03112174|581416707|FG000|Overall Study|Other, Not Specified|1|||
161007633|NCT03112174|581416708|FG001|Overall Study|Other, Not Specified|0|||
161007634|NCT03112174|581416709|FG002|Overall Study|Other, Not Specified|1|||
161007635|NCT03112174|581416710|FG003|Overall Study|Other, Not Specified|2|||
161007636|NCT03112174|581416711|FG004|Overall Study|Other, Not Specified|0|||
161007637|NCT04512482|581416712|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
161007638|NCT04512482|581416713|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
161007639|NCT02529995|581416714|FG000|Part A|Ongoing Study at Data Cut-off|14|||
161007640|NCT02529995|581416715|FG001|Part A|Ongoing Study at Data Cut-off|16|||
161007641|NCT02529995|581416714|FG000|Part A|Discontinued Study|1|||
161007642|NCT02529995|581416715|FG001|Part A|Discontinued Study|0|||
161007643|NCT02529995|581416714|FG000|Part B|Ongoing Study at Data Cut-off|0|||
161007644|NCT02529995|581416715|FG001|Part B|Ongoing Study at Data Cut-off|7|||
161007645|NCT02529995|581416714|FG000|Part B|Discontinued Study|6|||
161007646|NCT02529995|581416715|FG001|Part B|Discontinued Study|5|||
161007647|NCT05132478|581416716|FG000|Overall Study|did not complete survey after consent|1|||
161007648|NCT05132478|581416717|FG001|Overall Study|did not complete survey after consent|1|||
161007649|NCT05132478|581416716|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
161007650|NCT05132478|581416717|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
161007651|NCT02549170|581416718|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
161007652|NCT02549170|581416719|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
161007653|NCT02549170|581416720|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
161007654|NCT02549170|581416721|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
161007655|NCT02549170|581416722|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
161007656|NCT02549170|581416718|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
161007657|NCT02549170|581416719|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
161007658|NCT02549170|581416720|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
161007659|NCT02549170|581416721|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
161007660|NCT02549170|581416722|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
161007661|NCT02549170|581416718|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
161007662|NCT02549170|581416719|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
161007663|NCT02549170|581416720|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
161007664|NCT02549170|581416721|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
161007665|NCT02549170|581416722|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
161007666|NCT00421889|581416723|FG000|Overall Study|Adverse Event|1|||
160585434|NCT04096326|579861944|FG007|Overall Study|COVID-19-related reasons|0|||
160585435|NCT04096326|579861945|FG008|Overall Study|COVID-19-related reasons|0|||
160585436|NCT04096326|579861946|FG009|Overall Study|COVID-19-related reasons|0|||
160585437|NCT04804033|579861947|FG000|Period 1: DBT Phase|Adverse Event|1|||
161007667|NCT00421889|581416724|FG001|Overall Study|Adverse Event|0|||
161007668|NCT00421889|581416725|FG002|Overall Study|Adverse Event|1|||
160585438|NCT04804033|579861948|FG001|Period 1: DBT Phase|Adverse Event|5|||
161007669|NCT00421889|581416726|FG003|Overall Study|Adverse Event|1|||
161007670|NCT00421889|581416727|FG004|Overall Study|Adverse Event|1|||
161007671|NCT00421889|581416728|FG005|Overall Study|Adverse Event|4|||
161007672|NCT00421889|581416729|FG006|Overall Study|Adverse Event|1|||
161007673|NCT00421889|581416730|FG007|Overall Study|Adverse Event|0|||
161007674|NCT00421889|581416731|FG008|Overall Study|Adverse Event|2|||
161007675|NCT00421889|581416723|FG000|Overall Study|Withdrawal by Subject|1|||
161007676|NCT00421889|581416724|FG001|Overall Study|Withdrawal by Subject|3|||
161007677|NCT00421889|581416725|FG002|Overall Study|Withdrawal by Subject|0|||
161007678|NCT00421889|581416726|FG003|Overall Study|Withdrawal by Subject|0|||
161007679|NCT00421889|581416727|FG004|Overall Study|Withdrawal by Subject|2|||
161007680|NCT00421889|581416728|FG005|Overall Study|Withdrawal by Subject|0|||
161007681|NCT00421889|581416729|FG006|Overall Study|Withdrawal by Subject|0|||
161007682|NCT00421889|581416730|FG007|Overall Study|Withdrawal by Subject|0|||
161007683|NCT00421889|581416731|FG008|Overall Study|Withdrawal by Subject|0|||
161007684|NCT00421889|581416723|FG000|Overall Study|Death|0|||
161007685|NCT00421889|581416724|FG001|Overall Study|Death|0|||
161007686|NCT00421889|581416725|FG002|Overall Study|Death|0|||
161007687|NCT00421889|581416726|FG003|Overall Study|Death|0|||
161007688|NCT00421889|581416727|FG004|Overall Study|Death|1|||
161007689|NCT00421889|581416728|FG005|Overall Study|Death|1|||
161007690|NCT00421889|581416729|FG006|Overall Study|Death|0|||
161007691|NCT00421889|581416730|FG007|Overall Study|Death|0|||
161007692|NCT00421889|581416731|FG008|Overall Study|Death|0|||
161007693|NCT00421889|581416723|FG000|Overall Study|Progressive disease|3|||
161007694|NCT00421889|581416724|FG001|Overall Study|Progressive disease|2|||
161007695|NCT00421889|581416725|FG002|Overall Study|Progressive disease|2|||
161007696|NCT00421889|581416726|FG003|Overall Study|Progressive disease|3|||
161007697|NCT00421889|581416727|FG004|Overall Study|Progressive disease|2|||
161007698|NCT00421889|581416728|FG005|Overall Study|Progressive disease|21|||
161007699|NCT00421889|581416729|FG006|Overall Study|Progressive disease|3|||
161007700|NCT00421889|581416730|FG007|Overall Study|Progressive disease|1|||
161007701|NCT00421889|581416731|FG008|Overall Study|Progressive disease|5|||
161007702|NCT00421889|581416723|FG000|Overall Study|Patient/Investigator request|0|||
161007703|NCT00421889|581416724|FG001|Overall Study|Patient/Investigator request|0|||
161007704|NCT00421889|581416725|FG002|Overall Study|Patient/Investigator request|0|||
161007705|NCT00421889|581416726|FG003|Overall Study|Patient/Investigator request|0|||
161007706|NCT00421889|581416727|FG004|Overall Study|Patient/Investigator request|0|||
161007707|NCT00421889|581416728|FG005|Overall Study|Patient/Investigator request|9|||
161007708|NCT00421889|581416729|FG006|Overall Study|Patient/Investigator request|0|||
161007709|NCT00421889|581416730|FG007|Overall Study|Patient/Investigator request|1|||
161007710|NCT00421889|581416731|FG008|Overall Study|Patient/Investigator request|3|||
161007711|NCT00421889|581416723|FG000|Overall Study|Lost to Follow-up|0|||
161007712|NCT00421889|581416724|FG001|Overall Study|Lost to Follow-up|0|||
161007713|NCT00421889|581416725|FG002|Overall Study|Lost to Follow-up|0|||
161007714|NCT00421889|581416726|FG003|Overall Study|Lost to Follow-up|0|||
161007715|NCT00421889|581416727|FG004|Overall Study|Lost to Follow-up|0|||
161007716|NCT00421889|581416728|FG005|Overall Study|Lost to Follow-up|0|||
161007717|NCT00421889|581416729|FG006|Overall Study|Lost to Follow-up|0|||
161007718|NCT00421889|581416730|FG007|Overall Study|Lost to Follow-up|0|||
161007719|NCT00421889|581416731|FG008|Overall Study|Lost to Follow-up|1|||
161007720|NCT03051165|581416732|FG000|Overall Study|Withdrawal by Subject|1|||
161007721|NCT03051165|581416732|FG000|Overall Study|Early termination of study|12|||
161007722|NCT03684044|581416737|FG000|Overall Study|Adverse Event|3|||
160585439|NCT04804033|579861949|FG002|Period 1: DBT Phase|Adverse Event|3|||
160585440|NCT04804033|579861950|FG003|Period 1: DBT Phase|Adverse Event|4|||
160585441|NCT04804033|579861947|FG000|Period 1: DBT Phase|Death|1|||
161007723|NCT03684044|581416738|FG001|Overall Study|Adverse Event|0|||
161007724|NCT03684044|581416737|FG000|Overall Study|Death|4|||
161007725|NCT03684044|581416738|FG001|Overall Study|Death|7|||
161007726|NCT03684044|581416737|FG000|Overall Study|Lost to Follow-up|3|||
161007727|NCT03684044|581416738|FG001|Overall Study|Lost to Follow-up|2|||
161007728|NCT03684044|581416737|FG000|Overall Study|Patient Not Available|0|||
160585442|NCT04804033|579861948|FG001|Period 1: DBT Phase|Death|0|||
161007729|NCT03684044|581416738|FG001|Overall Study|Patient Not Available|2|||
160585443|NCT04804033|579861949|FG002|Period 1: DBT Phase|Death|0|||
161007730|NCT03684044|581416737|FG000|Overall Study|Physician Decision|1|||
161007731|NCT03684044|581416738|FG001|Overall Study|Physician Decision|0|||
161007732|NCT03684044|581416737|FG000|Overall Study|Withdrawal by Subject|11|||
161007733|NCT03684044|581416738|FG001|Overall Study|Withdrawal by Subject|9|||
161007734|NCT03703336|581416739|FG000|Overall Study|Parent withdrew consent|29|||
161007735|NCT03703336|581416740|FG001|Overall Study|Parent withdrew consent|8|||
161007736|NCT03703336|581416739|FG000|Overall Study|Migration|3|||
161007737|NCT03703336|581416740|FG001|Overall Study|Migration|3|||
161007738|NCT03703336|581416739|FG000|Overall Study|Protocol Violation|3|||
160585444|NCT04804033|579861950|FG003|Period 1: DBT Phase|Death|0|||
161007739|NCT03703336|581416740|FG001|Overall Study|Protocol Violation|1|||
161007740|NCT03703336|581416739|FG000|Overall Study|Physician Decision|2|||
161007741|NCT03703336|581416740|FG001|Overall Study|Physician Decision|0|||
161007742|NCT03703336|581416739|FG000|Overall Study|Adverse Event|0|||
161007743|NCT03703336|581416740|FG001|Overall Study|Adverse Event|2|||
161007744|NCT03703336|581416739|FG000|Overall Study|Lost to Follow-up|1|||
161007745|NCT03703336|581416740|FG001|Overall Study|Lost to Follow-up|0|||
161007746|NCT00595413|581416741|FG000|Overall Study|Adverse Event|0|||
161007747|NCT00595413|581416742|FG001|Overall Study|Adverse Event|2|||
161007748|NCT00595413|581416743|FG002|Overall Study|Adverse Event|1|||
161007749|NCT00595413|581416744|FG003|Overall Study|Adverse Event|1|||
161007750|NCT00595413|581416741|FG000|Overall Study|Lost to Follow-up|2|||
161007751|NCT00595413|581416742|FG001|Overall Study|Lost to Follow-up|2|||
161007752|NCT00595413|581416743|FG002|Overall Study|Lost to Follow-up|1|||
161007753|NCT00595413|581416744|FG003|Overall Study|Lost to Follow-up|3|||
161007754|NCT00595413|581416741|FG000|Overall Study|Death|0|||
161007755|NCT00595413|581416742|FG001|Overall Study|Death|0|||
161007756|NCT00595413|581416743|FG002|Overall Study|Death|1|||
160585445|NCT04804033|579861947|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
160585446|NCT04804033|579861948|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
160585447|NCT04804033|579861949|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
160585448|NCT04804033|579861950|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
160585449|NCT04804033|579861947|FG000|Period 1: DBT Phase|Non-compliance|1|||
160585450|NCT04804033|579861948|FG001|Period 1: DBT Phase|Non-compliance|0|||
160585451|NCT04804033|579861949|FG002|Period 1: DBT Phase|Non-compliance|1|||
160585452|NCT04804033|579861950|FG003|Period 1: DBT Phase|Non-compliance|2|||
160585453|NCT04804033|579861947|FG000|Period 1: DBT Phase|Other|0|||
160585454|NCT04804033|579861948|FG001|Period 1: DBT Phase|Other|1|||
160585455|NCT04804033|579861949|FG002|Period 1: DBT Phase|Other|0|||
160585456|NCT04804033|579861950|FG003|Period 1: DBT Phase|Other|0|||
160585457|NCT04804033|579861947|FG000|Period 1: DBT Phase|Pregnancy|2|||
160585458|NCT04804033|579861948|FG001|Period 1: DBT Phase|Pregnancy|0|||
160585459|NCT04804033|579861949|FG002|Period 1: DBT Phase|Pregnancy|0|||
160585460|NCT04804033|579861950|FG003|Period 1: DBT Phase|Pregnancy|0|||
161007757|NCT00595413|581416744|FG003|Overall Study|Death|0|||
161007758|NCT00595413|581416741|FG000|Overall Study|Other|5|||
161007759|NCT00595413|581416742|FG001|Overall Study|Other|1|||
161007760|NCT00595413|581416743|FG002|Overall Study|Other|5|||
161007761|NCT00595413|581416744|FG003|Overall Study|Other|0|||
161007762|NCT00807937|581416745|FG000|Overall Study|Adverse Event|12|||
161007763|NCT00807937|581416746|FG001|Overall Study|Adverse Event|12|||
161007764|NCT00807937|581416747|FG002|Overall Study|Adverse Event|5|||
161007765|NCT00807937|581416748|FG003|Overall Study|Adverse Event|4|||
161007766|NCT00807937|581416745|FG000|Overall Study|Protocol Violation|4|||
161007767|NCT00807937|581416746|FG001|Overall Study|Protocol Violation|5|||
161007768|NCT00807937|581416747|FG002|Overall Study|Protocol Violation|3|||
161007769|NCT00807937|581416748|FG003|Overall Study|Protocol Violation|3|||
161007770|NCT00807937|581416745|FG000|Overall Study|Withdrawal by Subject|5|||
161007771|NCT00807937|581416746|FG001|Overall Study|Withdrawal by Subject|4|||
161007772|NCT00807937|581416747|FG002|Overall Study|Withdrawal by Subject|1|||
161007773|NCT00807937|581416748|FG003|Overall Study|Withdrawal by Subject|4|||
161007774|NCT00807937|581416745|FG000|Overall Study|Lost to Follow-up|4|||
161007775|NCT00807937|581416746|FG001|Overall Study|Lost to Follow-up|0|||
161007776|NCT00807937|581416747|FG002|Overall Study|Lost to Follow-up|2|||
161007777|NCT00807937|581416748|FG003|Overall Study|Lost to Follow-up|1|||
161007778|NCT00807937|581416745|FG000|Overall Study|Lack of Efficacy|0|||
161007779|NCT00807937|581416746|FG001|Overall Study|Lack of Efficacy|0|||
161007780|NCT00807937|581416747|FG002|Overall Study|Lack of Efficacy|1|||
160585461|NCT04804033|579861947|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
160585462|NCT04804033|579861948|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
160585463|NCT04804033|579861949|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
160585464|NCT04804033|579861950|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
160585465|NCT04804033|579861947|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
160585466|NCT04804033|579861948|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
160585467|NCT04804033|579861949|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
161007781|NCT00807937|581416748|FG003|Overall Study|Lack of Efficacy|2|||
161007782|NCT00807937|581416745|FG000|Overall Study|Intake of prohibited medicine|0|||
161007783|NCT00807937|581416746|FG001|Overall Study|Intake of prohibited medicine|0|||
161007784|NCT00807937|581416747|FG002|Overall Study|Intake of prohibited medicine|2|||
160585468|NCT04804033|579861950|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
160585469|NCT04804033|579861947|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
160585470|NCT04804033|579861948|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
161007785|NCT00807937|581416748|FG003|Overall Study|Intake of prohibited medicine|0|||
161007786|NCT00807937|581416745|FG000|Overall Study|All other reasons (not provided)|2|||
161007787|NCT00807937|581416746|FG001|Overall Study|All other reasons (not provided)|4|||
161007788|NCT00807937|581416747|FG002|Overall Study|All other reasons (not provided)|0|||
161007789|NCT00807937|581416748|FG003|Overall Study|All other reasons (not provided)|1|||
161007790|NCT04629950|581416751|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
161007791|NCT04629950|581416752|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
161007792|NCT04629950|581416753|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
161007793|NCT04629950|581416754|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
161007794|NCT04629950|581416751|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
161007795|NCT04629950|581416752|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
161007796|NCT04629950|581416753|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
161007797|NCT04629950|581416754|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
161007798|NCT04629950|581416751|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
161007799|NCT04629950|581416752|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
161007800|NCT04629950|581416753|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
161007801|NCT04629950|581416754|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
161007802|NCT04629950|581416751|FG000|Extension Study|Withdrawal by Subject|0|||
161007803|NCT04629950|581416752|FG001|Extension Study|Withdrawal by Subject|0|||
161007804|NCT04629950|581416753|FG002|Extension Study|Withdrawal by Subject|1|||
161007805|NCT04629950|581416754|FG003|Extension Study|Withdrawal by Subject|0|||
161007806|NCT04629950|581416751|FG000|Extension Study|Adverse Event|0|||
161007807|NCT04629950|581416752|FG001|Extension Study|Adverse Event|0|||
161007808|NCT04629950|581416753|FG002|Extension Study|Adverse Event|0|||
161007809|NCT04629950|581416754|FG003|Extension Study|Adverse Event|1|||
161007810|NCT03233633|581416755|FG000|Overall Study|Adverse Event|2|||
161007811|NCT03233633|581416755|FG000|Overall Study|Less Than 3 Days of Data|6|||
161007812|NCT02708108|581416756|FG000|Overall Study|Death|1|||
161007813|NCT02708108|581416757|FG001|Overall Study|Death|2|||
161007814|NCT02708108|581416756|FG000|Overall Study|Regimen change|1|||
161007815|NCT02708108|581416757|FG001|Overall Study|Regimen change|0|||
161007816|NCT02708108|581416756|FG000|Overall Study|No MRD and no imaging available|0|||
161007817|NCT02708108|581416757|FG001|Overall Study|No MRD and no imaging available|1|||
161007818|NCT02568683|581416759|FG000|Overall Study|Death|0|||
161007819|NCT02568683|581416760|FG001|Overall Study|Death|2|||
161007820|NCT02568683|581416759|FG000|Overall Study|Withdrew Consent|1|||
161007821|NCT02568683|581416760|FG001|Overall Study|Withdrew Consent|0|||
161007822|NCT02568683|581416759|FG000|Overall Study|Study Terminated By Sponsor|5|||
161007823|NCT02568683|581416760|FG001|Overall Study|Study Terminated By Sponsor|2|||
161007824|NCT01561989|581416763|FG000|Overall Study|accural target not met.|5|||
161007825|NCT01561989|581416764|FG001|Overall Study|accural target not met.|6|||
161007826|NCT03485950|581416765|FG000|Overall Study|Adverse Event|1|||
161007827|NCT03485950|581416766|FG001|Overall Study|Adverse Event|0|||
161007828|NCT03485950|581416765|FG000|Overall Study|Death|3|||
161007829|NCT03485950|581416766|FG001|Overall Study|Death|2|||
161007830|NCT03485950|581416765|FG000|Overall Study|Withdrawal by Subject|3|||
161007831|NCT03485950|581416766|FG001|Overall Study|Withdrawal by Subject|0|||
161007832|NCT05368831|581416777|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
161007833|NCT03565315|581416779|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
161007834|NCT03565315|581416780|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
161007835|NCT03565315|581416781|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
161007836|NCT03565315|581416782|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
161007837|NCT03887650|581416783|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
161007838|NCT03887650|581416784|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
161007839|NCT03887650|581416783|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
161007840|NCT03887650|581416784|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
161007841|NCT03887650|581416783|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
161007842|NCT03887650|581416784|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
161007843|NCT01170962|581416785|FG000|Treatment Period|Lack of Efficacy|96|||
161007844|NCT01170962|581416786|FG001|Treatment Period|Lack of Efficacy|91|||
161007845|NCT01170962|581416787|FG002|Treatment Period|Lack of Efficacy|7|||
161007846|NCT01170962|581416785|FG000|Treatment Period|Adverse Event|11|||
161007847|NCT01170962|581416786|FG001|Treatment Period|Adverse Event|12|||
161007848|NCT01170962|581416787|FG002|Treatment Period|Adverse Event|3|||
161007849|NCT01170962|581416785|FG000|Treatment Period|Withdrawal by Subject|2|||
161007850|NCT01170962|581416786|FG001|Treatment Period|Withdrawal by Subject|1|||
161007851|NCT01170962|581416787|FG002|Treatment Period|Withdrawal by Subject|0|||
161007852|NCT01170962|581416785|FG000|Treatment Period|Lost to Follow-up|1|||
161007853|NCT01170962|581416786|FG001|Treatment Period|Lost to Follow-up|1|||
161007854|NCT01170962|581416787|FG002|Treatment Period|Lost to Follow-up|1|||
161007855|NCT01170962|581416785|FG000|Treatment Period|Participant no longer meets criteria|0|||
161007856|NCT01170962|581416786|FG001|Treatment Period|Participant no longer meets criteria|1|||
161007857|NCT01170962|581416787|FG002|Treatment Period|Participant no longer meets criteria|0|||
161007858|NCT01170962|581416785|FG000|Treatment Period|Request to discontinue treatment|7|||
161007859|NCT01170962|581416786|FG001|Treatment Period|Request to discontinue treatment|3|||
161007860|NCT01170962|581416787|FG002|Treatment Period|Request to discontinue treatment|1|||
161007861|NCT01170962|581416785|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
161007862|NCT01170962|581416786|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
161007863|NCT01170962|581416787|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
161007864|NCT01170962|581416785|FG000|Follow up Period|Withdrawal by Subject|14|||
161007865|NCT01170962|581416786|FG001|Follow up Period|Withdrawal by Subject|10|||
161007866|NCT01170962|581416787|FG002|Follow up Period|Withdrawal by Subject|2|||
161007867|NCT01170962|581416785|FG000|Follow up Period|Lost to Follow-up|13|||
161007868|NCT01170962|581416786|FG001|Follow up Period|Lost to Follow-up|8|||
161007869|NCT01170962|581416787|FG002|Follow up Period|Lost to Follow-up|1|||
161007870|NCT01170962|581416785|FG000|Follow up Period|Death|2|||
161007871|NCT01170962|581416786|FG001|Follow up Period|Death|2|||
160585471|NCT04804033|579861949|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
160585472|NCT04804033|579861950|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
160585473|NCT04804033|579861947|FG000|Period 2: OLE Phase|Adverse Event|3|||
160585474|NCT04804033|579861948|FG001|Period 2: OLE Phase|Adverse Event|4|||
160585475|NCT04804033|579861949|FG002|Period 2: OLE Phase|Adverse Event|2|||
160585476|NCT04804033|579861950|FG003|Period 2: OLE Phase|Adverse Event|0|||
160585477|NCT04804033|579861947|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
161007872|NCT01170962|581416787|FG002|Follow up Period|Death|0|||
161007873|NCT01170962|581416785|FG000|Follow up Period|Others|10|||
161007874|NCT01170962|581416786|FG001|Follow up Period|Others|7|||
160585478|NCT04804033|579861948|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
161007875|NCT01170962|581416787|FG002|Follow up Period|Others|3|||
161007876|NCT01083316|581416788|FG000|Overall Study|Adverse Event|2|||
161007877|NCT01083316|581416788|FG000|Overall Study|Withdrawal by Subject|1|||
161007878|NCT04200365|581416789|FG000|Overall Study|Adverse Event|2|||
161007879|NCT04200365|581416789|FG000|Overall Study|Progressive Disease|4|||
161007880|NCT04200365|581416789|FG000|Overall Study|Lack of Efficacy|1|||
161007881|NCT04200365|581416789|FG000|Overall Study|Study Closure|4|||
161007882|NCT01199575|581416790|FG000|Overall Study|Withdrawal by Subject|5|||
161007883|NCT00704184|581416795|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
161007884|NCT00704184|581416796|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
161007885|NCT00704184|581416797|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
161007886|NCT00704184|581416798|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
161007887|NCT00704184|581416799|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
161007888|NCT00704184|581416795|FG000|Open-Label Treatment|Adverse Event|0|||
161007889|NCT00704184|581416796|FG001|Open-Label Treatment|Adverse Event|0|||
161007890|NCT00704184|581416797|FG002|Open-Label Treatment|Adverse Event|2|||
160585479|NCT04804033|579861949|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
160585480|NCT04804033|579861950|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
160585481|NCT04804033|579861947|FG000|Period 2: OLE Phase|Non-compliance|2|||
160585482|NCT04804033|579861948|FG001|Period 2: OLE Phase|Non-compliance|2|||
160585483|NCT04804033|579861949|FG002|Period 2: OLE Phase|Non-compliance|0|||
160585484|NCT04804033|579861950|FG003|Period 2: OLE Phase|Non-compliance|1|||
160585485|NCT04804033|579861947|FG000|Period 2: OLE Phase|Other|0|||
160657010|NCT05097989|580124498|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
160657011|NCT05097989|580124499|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
160657012|NCT05097989|580124500|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
160657013|NCT05097989|580124501|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
160657014|NCT05097989|580124502|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
160966933|NCT02287584|581266790|FG005|the Open-label Phase|other reasons|6|||
160966934|NCT03124199|581266791|FG000|Overall Study|Lost to Follow-up|4|||
160966935|NCT03086018|581266793|FG000|Final Testing for End of Trial|Adverse Event|1|||
160966936|NCT03086018|581266793|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
160966937|NCT02309112|581266794|FG000|Overall Study|Withdrawal by Subject|1|||
160966938|NCT02309112|581266795|FG001|Overall Study|Withdrawal by Subject|0|||
160966939|NCT02309112|581266796|FG002|Overall Study|Withdrawal by Subject|1|||
160966940|NCT02309112|581266794|FG000|Overall Study|Lost to Follow-up|0|||
160966941|NCT02309112|581266795|FG001|Overall Study|Lost to Follow-up|1|||
160966942|NCT02309112|581266796|FG002|Overall Study|Lost to Follow-up|0|||
160966943|NCT01892345|581266797|FG000|Overall Study|Adverse Event|0|||
160966944|NCT01892345|581266798|FG001|Overall Study|Adverse Event|2|||
160966945|NCT01892345|581266797|FG000|Overall Study|Death|1|||
160966946|NCT01892345|581266798|FG001|Overall Study|Death|0|||
160966947|NCT01892345|581266797|FG000|Overall Study|Lost to Follow-up|3|||
160966948|NCT01892345|581266798|FG001|Overall Study|Lost to Follow-up|0|||
160966949|NCT01892345|581266797|FG000|Overall Study|Withdrawal by Subject|12|||
160966950|NCT01892345|581266798|FG001|Overall Study|Withdrawal by Subject|1|||
160966951|NCT00659984|581266802|FG000|Overall Study|Adverse Event|1|||
160966952|NCT00948974|581266805|FG000|Overall Study|Lost to Follow-up|23|||
160966953|NCT00948974|581266806|FG001|Overall Study|Lost to Follow-up|20|||
160966954|NCT02487810|581266807|FG000|Overall Study|Withdrawal by Subject|1|||
160966955|NCT02487810|581266808|FG001|Overall Study|Withdrawal by Subject|0|||
161007891|NCT00704184|581416798|FG003|Open-Label Treatment|Adverse Event|0|||
161007892|NCT00704184|581416799|FG004|Open-Label Treatment|Adverse Event|1|||
161007893|NCT00704184|581416795|FG000|Open-Label Treatment|Lack of Efficacy|0|||
161007894|NCT00704184|581416796|FG001|Open-Label Treatment|Lack of Efficacy|2|||
161007895|NCT00704184|581416797|FG002|Open-Label Treatment|Lack of Efficacy|2|||
161007896|NCT00704184|581416798|FG003|Open-Label Treatment|Lack of Efficacy|2|||
160585486|NCT04804033|579861948|FG001|Period 2: OLE Phase|Other|2|||
160966956|NCT00621543|581266811|FG000|Overall Study|Lost to Follow-up|23|||
160966957|NCT04252742|581266812|FG000|Overall Study|Decision by sponsor|0|||
160966958|NCT04252742|581266813|FG001|Overall Study|Decision by sponsor|2|||
161007897|NCT00704184|581416799|FG004|Open-Label Treatment|Lack of Efficacy|1|||
161007898|NCT00704184|581416795|FG000|Open-Label Treatment|Physician Decision|0|||
161007899|NCT00704184|581416796|FG001|Open-Label Treatment|Physician Decision|0|||
161007900|NCT00704184|581416797|FG002|Open-Label Treatment|Physician Decision|0|||
161007901|NCT00704184|581416798|FG003|Open-Label Treatment|Physician Decision|0|||
161007902|NCT00704184|581416799|FG004|Open-Label Treatment|Physician Decision|1|||
161007903|NCT00704184|581416795|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
161007904|NCT00704184|581416796|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
161007905|NCT00704184|581416797|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
161007906|NCT00704184|581416798|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
161007907|NCT00704184|581416799|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
161007908|NCT02178098|581416800|FG000|Overall Study|Withdrawal by Subject|0|||
161007909|NCT02178098|581416801|FG001|Overall Study|Withdrawal by Subject|6|||
161007910|NCT02178098|581416800|FG000|Overall Study|Adverse Event|1|||
161007911|NCT02178098|581416801|FG001|Overall Study|Adverse Event|2|||
161007912|NCT02178098|581416800|FG000|Overall Study|Protocol Violation|1|||
161007913|NCT02178098|581416801|FG001|Overall Study|Protocol Violation|1|||
161007914|NCT02178098|581416800|FG000|Overall Study|Lost to Follow-up|0|||
161007915|NCT02178098|581416801|FG001|Overall Study|Lost to Follow-up|1|||
161007916|NCT02178098|581416800|FG000|Overall Study|Sponsor Request|1|||
161007917|NCT02178098|581416801|FG001|Overall Study|Sponsor Request|0|||
161007918|NCT02178098|581416800|FG000|Overall Study|Other|2|||
161007919|NCT02178098|581416801|FG001|Overall Study|Other|2|||
161007920|NCT01109524|581416807|FG000|Overall Study|Disease Progression|29|||
161007921|NCT01109524|581416807|FG000|Overall Study|Study Drug toxicity|6|||
161007922|NCT01109524|581416807|FG000|Overall Study|Adverse Event|4|||
161007923|NCT01109524|581416807|FG000|Overall Study|Withdrawal by Subject|2|||
161007924|NCT01109524|581416807|FG000|Overall Study|Maximum clinical benefit|3|||
161007925|NCT01109524|581416807|FG000|Overall Study|Death|2|||
161007926|NCT01109524|581416807|FG000|Overall Study|No longer meets criteria|2|||
161007927|NCT01109524|581416807|FG000|Overall Study|Participant requested to end treatment|4|||
161007928|NCT01109524|581416807|FG000|Overall Study|Other|5|||
161007929|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
161007930|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161007931|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161007932|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161007933|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161007934|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
161007935|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161007936|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161007937|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161007938|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161007939|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
161007940|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161007941|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161007942|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161007943|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161007944|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
161007945|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161007946|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161007947|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161007948|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161007949|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
161007950|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161007951|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161007952|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161007953|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161007954|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
160585487|NCT04804033|579861949|FG002|Period 2: OLE Phase|Other|0|||
160585488|NCT04804033|579861950|FG003|Period 2: OLE Phase|Other|0|||
160585489|NCT04804033|579861947|FG000|Period 2: OLE Phase|Physician Decision|1|||
160585490|NCT04804033|579861948|FG001|Period 2: OLE Phase|Physician Decision|1|||
160585491|NCT04804033|579861949|FG002|Period 2: OLE Phase|Physician Decision|0|||
161007955|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161007956|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161007957|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
160585492|NCT04804033|579861950|FG003|Period 2: OLE Phase|Physician Decision|0|||
160585493|NCT04804033|579861947|FG000|Period 2: OLE Phase|Pregnancy|0|||
160585494|NCT04804033|579861948|FG001|Period 2: OLE Phase|Pregnancy|0|||
161007958|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161007959|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
161007960|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161007961|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161007962|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161007963|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161007964|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
161007965|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161007966|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161007967|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161007968|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161007969|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
161007970|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161007971|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161007972|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161007973|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161007974|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
161007975|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
161007976|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
161007977|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
161007978|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
161007979|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161007980|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161007981|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161007982|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
161007983|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161007984|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
161007985|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
161007986|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
161007987|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
161007988|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
161007989|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
161007990|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
161007991|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
161007992|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
161007993|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
161007994|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
161007995|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
161007996|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
161007997|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
161007998|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
161007999|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
161008000|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
161008001|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
161008002|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
161008003|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
161008004|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161008005|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161008006|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
161008007|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161008008|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161008009|NCT01925339|581416813|FG000|Overall Study|Adverse Event|2|||
161008010|NCT01925339|581416814|FG001|Overall Study|Adverse Event|0|||
161008011|NCT04992390|581416829|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
160458694|NCT03417284|579412608|FG003|Overall Study|Inadequate supply on study drug|0|||
160458695|NCT03417284|579412605|FG000|Overall Study|Disease Progression|0|||
160458696|NCT03417284|579412606|FG001|Overall Study|Disease Progression|0|||
160458697|NCT03417284|579412607|FG002|Overall Study|Disease Progression|1|||
160458698|NCT03417284|579412608|FG003|Overall Study|Disease Progression|0|||
160458699|NCT02585323|579412611|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
160458700|NCT02585323|579412612|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
160458701|NCT02585323|579412611|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
160458702|NCT02585323|579412612|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
160458703|NCT02585323|579412611|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
160458704|NCT02585323|579412612|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
161008012|NCT04992390|581416830|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
161008013|NCT04992390|581416831|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
161008014|NCT04992390|581416829|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
161008015|NCT04992390|581416830|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
161008016|NCT04992390|581416831|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
161008017|NCT04992390|581416829|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
161008018|NCT04992390|581416830|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
161008019|NCT04992390|581416831|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
161008020|NCT04992390|581416829|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
161008021|NCT04992390|581416830|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
161008022|NCT04992390|581416831|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
161008023|NCT04992390|581416829|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
161008024|NCT04992390|581416830|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
161008025|NCT04992390|581416831|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
161008026|NCT04992390|581416829|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
161008027|NCT04992390|581416830|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
161008028|NCT04992390|581416831|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
161008029|NCT04992390|581416829|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
161008030|NCT04992390|581416830|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
161008031|NCT04992390|581416831|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
160585495|NCT04804033|579861949|FG002|Period 2: OLE Phase|Pregnancy|2|||
160585496|NCT04804033|579861950|FG003|Period 2: OLE Phase|Pregnancy|0|||
160585497|NCT04804033|579861947|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
160585498|NCT04804033|579861948|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
160966959|NCT04252742|581266812|FG000|Overall Study|Withdrawal by Subject|15|||
160966960|NCT04252742|581266813|FG001|Overall Study|Withdrawal by Subject|9|||
160966961|NCT04252742|581266812|FG000|Overall Study|Lost to Follow-up|0|||
160966962|NCT04252742|581266813|FG001|Overall Study|Lost to Follow-up|1|||
160966963|NCT00031486|581266816|FG000|Overall Study|Adverse Event|1|||
160966964|NCT00031486|581266817|FG001|Overall Study|Adverse Event|0|||
160966965|NCT00031486|581266816|FG000|Overall Study|Lost to Follow-up|0|||
160966966|NCT00031486|581266817|FG001|Overall Study|Lost to Follow-up|1|||
160966967|NCT00031486|581266816|FG000|Overall Study|Withdrawal by Subject|3|||
160966968|NCT00031486|581266817|FG001|Overall Study|Withdrawal by Subject|2|||
160966969|NCT00031486|581266816|FG000|Overall Study|Death|0|||
160966970|NCT00031486|581266817|FG001|Overall Study|Death|3|||
160966971|NCT00031486|581266816|FG000|Overall Study|Non-compliant|0|||
160966972|NCT00031486|581266817|FG001|Overall Study|Non-compliant|4|||
160966973|NCT00031486|581266816|FG000|Overall Study|Did not meet eligibility requirement|2|||
160966974|NCT00031486|581266817|FG001|Overall Study|Did not meet eligibility requirement|1|||
160966975|NCT00031486|581266816|FG000|Overall Study|Other|1|||
160966976|NCT00031486|581266817|FG001|Overall Study|Other|1|||
160966977|NCT01685138|581266818|FG000|Overall Study|Lost to Follow-up|1|||
160966978|NCT01685138|581266818|FG000|Overall Study|Protocol Violation|1|||
160966979|NCT01685138|581266818|FG000|Overall Study|No longer requires treatment|1|||
160966980|NCT01685138|581266818|FG000|Overall Study|Subject/guardian decision|2|||
160966981|NCT01685138|581266818|FG000|Overall Study|Physician Decision|6|||
160966982|NCT01685138|581266818|FG000|Overall Study|Death|10|||
160966983|NCT01685138|581266818|FG000|Overall Study|Adverse Event|18|||
160966984|NCT01685138|581266818|FG000|Overall Study|Progressive disease|53|||
160966985|NCT03996291|581266823|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
160966986|NCT03996291|581266824|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
160966987|NCT03996291|581266825|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
160966988|NCT03996291|581266826|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
160966989|NCT03996291|581266827|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
160966990|NCT03996291|581266828|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
160966991|NCT03996291|581266829|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
160966992|NCT03996291|581266830|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
160966993|NCT03996291|581266823|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160966994|NCT03996291|581266824|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160966995|NCT03996291|581266825|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160966996|NCT03996291|581266826|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160966997|NCT03996291|581266827|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160966998|NCT03996291|581266828|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
160966999|NCT03996291|581266829|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
160967000|NCT03996291|581266830|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160967001|NCT03996291|581266823|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
160967002|NCT03996291|581266824|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
160967003|NCT03996291|581266825|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
160967004|NCT03996291|581266826|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
160967005|NCT03996291|581266827|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
160967006|NCT03996291|581266828|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
161008032|NCT04992390|581416829|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
161008033|NCT04992390|581416830|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
161008034|NCT04992390|581416831|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
161008035|NCT04992390|581416829|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
161008036|NCT04992390|581416830|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
161008037|NCT04992390|581416831|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
161008038|NCT04992390|581416829|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
161008039|NCT04992390|581416830|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
161008040|NCT04992390|581416831|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
161008041|NCT04992390|581416829|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
161008042|NCT04992390|581416830|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
161008043|NCT04992390|581416831|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
161008044|NCT04992390|581416829|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
161008045|NCT04992390|581416830|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
161008046|NCT04992390|581416831|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
161008047|NCT04992390|581416829|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
161008048|NCT04992390|581416830|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
161008049|NCT04992390|581416831|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
161008050|NCT04992390|581416829|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
161008051|NCT04992390|581416830|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
161008052|NCT04992390|581416831|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
161008053|NCT04992390|581416829|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
161008054|NCT04992390|581416830|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
161008055|NCT04992390|581416831|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
161008056|NCT04992390|581416829|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
161008057|NCT04992390|581416830|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
160967007|NCT03996291|581266829|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
160967008|NCT03996291|581266830|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
160967009|NCT03996291|581266823|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
160967010|NCT03996291|581266824|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
160967011|NCT03996291|581266825|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
160967012|NCT03996291|581266826|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
160967013|NCT03996291|581266827|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
160967014|NCT03996291|581266828|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
160967015|NCT03996291|581266829|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
160967016|NCT03996291|581266830|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
160967017|NCT03996291|581266823|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967018|NCT03996291|581266824|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967019|NCT03996291|581266825|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967020|NCT03996291|581266826|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967021|NCT03996291|581266827|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
160967022|NCT03996291|581266828|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967023|NCT03996291|581266829|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967024|NCT03996291|581266830|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967025|NCT01659151|581266833|FG000|Overall Study|Inadequate TIL growth|1|||
160967026|NCT05774197|581266834|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
160967027|NCT05073133|581266837|FG000|Overall Study|Death|2|||
160967028|NCT05002218|581266841|FG000|Overall Study|Lost to Follow-up|5|||
160967029|NCT05002218|581266842|FG001|Overall Study|Lost to Follow-up|6|||
160967030|NCT03421808|581266843|FG000|Overall Study|COVID related problems|2|||
160967031|NCT03421808|581266844|FG001|Overall Study|COVID related problems|0|||
160967032|NCT03421808|581266843|FG000|Overall Study|Withdrawal by Subject|1|||
160967033|NCT03421808|581266844|FG001|Overall Study|Withdrawal by Subject|0|||
160967034|NCT03421808|581266843|FG000|Overall Study|Protocol Violation|0|||
160967035|NCT03421808|581266844|FG001|Overall Study|Protocol Violation|1|||
160967036|NCT03764774|581266847|FG000|Overall Study|Withdrawal by Subject|0|||
160967037|NCT03764774|581266848|FG001|Overall Study|Withdrawal by Subject|0|||
160967038|NCT03764774|581266849|FG002|Overall Study|Withdrawal by Subject|0|||
160967039|NCT03764774|581266850|FG003|Overall Study|Withdrawal by Subject|0|||
160967040|NCT03764774|581266851|FG004|Overall Study|Withdrawal by Subject|0|||
160967041|NCT03764774|581266852|FG005|Overall Study|Withdrawal by Subject|0|||
160967042|NCT03764774|581266853|FG006|Overall Study|Withdrawal by Subject|0|||
160967043|NCT03764774|581266854|FG007|Overall Study|Withdrawal by Subject|0|||
160967044|NCT03764774|581266855|FG008|Overall Study|Withdrawal by Subject|0|||
161008058|NCT04992390|581416831|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
160967045|NCT03764774|581266856|FG009|Overall Study|Withdrawal by Subject|0|||
160967046|NCT03764774|581266857|FG010|Overall Study|Withdrawal by Subject|1|||
161008059|NCT02769858|581416834|FG000|Overall Study|Withdrawal by Subject|2|||
161008066|NCT04939246|581416837|FG000|After Treatment|Death|4|||
161008067|NCT04939246|581416837|FG000|After Treatment|Lost to Follow-up|1|||
161008068|NCT04939246|581416837|FG000|After Treatment|Discharged to hospice|2|||
161008069|NCT01853748|581418711|FG000|Allocation|Withdrawal by Subject|1|||
161008070|NCT01853748|581418712|FG001|Allocation|Withdrawal by Subject|13|||
161008071|NCT01853748|581418711|FG000|Allocation|not sufficient to receive intervention|0|||
161008072|NCT01853748|581418712|FG001|Allocation|not sufficient to receive intervention|1|||
161008073|NCT01853748|581418711|FG000|Follow-Up|Withdrawal by Subject|7|||
161008074|NCT01853748|581418712|FG001|Follow-Up|Withdrawal by Subject|6|||
161008075|NCT01853748|581418711|FG000|Follow-Up|Adverse Event|67|||
161008076|NCT01853748|581418712|FG001|Follow-Up|Adverse Event|7|||
161008077|NCT01853748|581418711|FG000|Follow-Up|not available for data collection|16|||
161008078|NCT01853748|581418712|FG001|Follow-Up|not available for data collection|4|||
161008079|NCT05505045|581418713|FG000|Overall Study|Withdrawal by Subject|2|||
161008080|NCT05505045|581418714|FG001|Overall Study|Withdrawal by Subject|1|||
161008081|NCT04201834|581418718|FG000|Overall Study|Screen fail|1|||
161008082|NCT04104321|581418722|FG000|Overall Study|didn't take the study drug|3|||
161008083|NCT04842500|581418723|FG000|Overall Study|Withdrawal by Subject|4|||
161008084|NCT04842500|581418724|FG001|Overall Study|Withdrawal by Subject|1|||
161008085|NCT04842500|581418725|FG002|Overall Study|Withdrawal by Subject|2|||
161008086|NCT04842500|581418726|FG003|Overall Study|Withdrawal by Subject|3|||
161008087|NCT04842500|581418723|FG000|Overall Study|Protocol Violation|1|||
161008088|NCT04842500|581418724|FG001|Overall Study|Protocol Violation|0|||
161008089|NCT04842500|581418725|FG002|Overall Study|Protocol Violation|0|||
161008090|NCT04842500|581418726|FG003|Overall Study|Protocol Violation|1|||
161008091|NCT02980276|581418727|FG000|Overall Study|Withdrawal by Subject|4|||
161008092|NCT02980276|581418728|FG001|Overall Study|Withdrawal by Subject|4|||
161008093|NCT02980276|581418727|FG000|Overall Study|Physician Decision|0|||
161008094|NCT02980276|581418728|FG001|Overall Study|Physician Decision|1|||
161008095|NCT02980276|581418727|FG000|Overall Study|Lost to Follow-up|18|||
161008096|NCT02980276|581418728|FG001|Overall Study|Lost to Follow-up|18|||
161008097|NCT02980276|581418727|FG000|Overall Study|Death|1|||
161008098|NCT02980276|581418728|FG001|Overall Study|Death|0|||
161008099|NCT02980276|581418727|FG000|Overall Study|Miscellaneous other|10|||
161008100|NCT02980276|581418728|FG001|Overall Study|Miscellaneous other|4|||
161008101|NCT04139668|581418729|FG000|Overall Study|Withdrawal by Subject|1|||
161008102|NCT03554265|581418730|FG000|Overall Study|Withdrawal by Subject|2|||
161008103|NCT03554265|581418731|FG001|Overall Study|Withdrawal by Subject|2|||
161008104|NCT03554265|581418732|FG002|Overall Study|Withdrawal by Subject|3|||
161008105|NCT03554265|581418730|FG000|Overall Study|Physician Decision|0|||
161008106|NCT03554265|581418731|FG001|Overall Study|Physician Decision|0|||
161008107|NCT03554265|581418732|FG002|Overall Study|Physician Decision|1|||
161008108|NCT03025789|581418733|FG000|Overall Study|Lack of Efficacy|6|||
161008109|NCT03025789|581418734|FG001|Overall Study|Lack of Efficacy|1|||
161008110|NCT03025789|581418733|FG000|Overall Study|Death|1|||
161008111|NCT03025789|581418734|FG001|Overall Study|Death|0|||
161008112|NCT03025789|581418733|FG000|Overall Study|Withdrawal by Subject|0|||
161008113|NCT03025789|581418734|FG001|Overall Study|Withdrawal by Subject|2|||
161008114|NCT05057897|581418735|FG000|Overall Study|Site closure|2|||
161008115|NCT05057897|581418736|FG001|Overall Study|Site closure|2|||
161008116|NCT05057897|581418735|FG000|Overall Study|Death|1|||
161008117|NCT05057897|581418736|FG001|Overall Study|Death|0|||
161008118|NCT01903811|581418748|FG000|Overall Study|No measurable disease|1|||
161008119|NCT01903811|581418749|FG001|Overall Study|No measurable disease|1|||
161008120|NCT01903811|581418748|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
161008121|NCT01903811|581418749|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
161008122|NCT01903811|581418748|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
161008123|NCT01903811|581418749|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
161008124|NCT01903811|581418748|FG000|Overall Study|Withdrawal by Subject|0|||
161008125|NCT01903811|581418749|FG001|Overall Study|Withdrawal by Subject|1|||
161008126|NCT04188379|581418750|FG000|Overall Study|Withdrawal by Subject|10|||
161008127|NCT04188379|581418751|FG001|Overall Study|Withdrawal by Subject|3|||
161008128|NCT04188379|581418750|FG000|Overall Study|Physician Decision|0|||
161008129|NCT04188379|581418751|FG001|Overall Study|Physician Decision|1|||
161008130|NCT04188379|581418750|FG000|Overall Study|Adverse Event|3|||
161008131|NCT04188379|581418751|FG001|Overall Study|Adverse Event|1|||
161008132|NCT04188379|581418750|FG000|Overall Study|Pregnancy|1|||
161008133|NCT04188379|581418751|FG001|Overall Study|Pregnancy|0|||
161008134|NCT04188379|581418750|FG000|Overall Study|Lack of Efficacy|8|||
161008135|NCT04188379|581418751|FG001|Overall Study|Lack of Efficacy|5|||
161008136|NCT04188379|581418750|FG000|Overall Study|Other|0|||
161008137|NCT04188379|581418751|FG001|Overall Study|Other|3|||
161008138|NCT02932579|581418760|FG000|Overall Study|Withdrawal by Subject|4|||
161008139|NCT02932579|581418761|FG001|Overall Study|Withdrawal by Subject|1|||
161008140|NCT02706717|581418762|FG000|Overall Study|Withdrawal by Subject|1|||
161008141|NCT02706717|581418763|FG001|Overall Study|Withdrawal by Subject|8|||
161008142|NCT02706717|581418762|FG000|Overall Study|Lost to Follow-up|0|||
161008143|NCT02706717|581418763|FG001|Overall Study|Lost to Follow-up|1|||
161008144|NCT02706717|581418762|FG000|Overall Study|Physician Decision|0|||
161008145|NCT02706717|581418763|FG001|Overall Study|Physician Decision|1|||
161008146|NCT02706717|581418762|FG000|Overall Study|Death|0|||
161008147|NCT02706717|581418763|FG001|Overall Study|Death|1|||
161008148|NCT00978042|581418768|FG000|Initial Treatment Period|Treated in Error|0|||
161008149|NCT00978042|581418769|FG001|Initial Treatment Period|Treated in Error|3|||
161008150|NCT00978042|581418768|FG000|Initial Treatment Period|Ineligibility|1|||
161008151|NCT00978042|581418769|FG001|Initial Treatment Period|Ineligibility|0|||
161008152|NCT00978042|581418768|FG000|Initial Treatment Period|Lost to Follow-up|21|||
161008153|NCT00978042|581418769|FG001|Initial Treatment Period|Lost to Follow-up|3|||
161008154|NCT00978042|581418768|FG000|Initial Treatment Period|Adverse Event|2|||
161008155|NCT00978042|581418769|FG001|Initial Treatment Period|Adverse Event|0|||
161008156|NCT00978042|581418768|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
161008157|NCT00978042|581418769|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
161008158|NCT00978042|581418768|FG000|Initial Treatment Period|Consent withdrawn|22|||
161008159|NCT00978042|581418769|FG001|Initial Treatment Period|Consent withdrawn|9|||
161008160|NCT00978042|581418768|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
161008161|NCT00978042|581418769|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
161008162|NCT00111813|581418770|FG000|Overall Study|Adverse Event|1|||
161008163|NCT00111813|581418771|FG001|Overall Study|Adverse Event|2|||
161008164|NCT00111813|581418772|FG002|Overall Study|Adverse Event|4|||
161008165|NCT00111813|581418773|FG003|Overall Study|Adverse Event|2|||
161008166|NCT00111813|581418774|FG004|Overall Study|Adverse Event|2|||
161008167|NCT00111813|581418775|FG005|Overall Study|Adverse Event|2|||
161008168|NCT00111813|581418770|FG000|Overall Study|Progressive disease|2|||
161008169|NCT00111813|581418771|FG001|Overall Study|Progressive disease|1|||
161008170|NCT00111813|581418772|FG002|Overall Study|Progressive disease|5|||
161008171|NCT00111813|581418773|FG003|Overall Study|Progressive disease|3|||
161008172|NCT00111813|581418774|FG004|Overall Study|Progressive disease|4|||
161008173|NCT00111813|581418775|FG005|Overall Study|Progressive disease|3|||
161008174|NCT00111813|581418770|FG000|Overall Study|Lack of Efficacy|0|||
161008175|NCT00111813|581418771|FG001|Overall Study|Lack of Efficacy|0|||
161008176|NCT00111813|581418772|FG002|Overall Study|Lack of Efficacy|0|||
161008177|NCT00111813|581418773|FG003|Overall Study|Lack of Efficacy|0|||
161008178|NCT00111813|581418774|FG004|Overall Study|Lack of Efficacy|0|||
161008179|NCT00111813|581418775|FG005|Overall Study|Lack of Efficacy|1|||
161008180|NCT00111813|581418770|FG000|Overall Study|Other|0|||
161008181|NCT00111813|581418771|FG001|Overall Study|Other|0|||
161008182|NCT00111813|581418772|FG002|Overall Study|Other|1|||
161008183|NCT00111813|581418773|FG003|Overall Study|Other|0|||
161008184|NCT00111813|581418774|FG004|Overall Study|Other|0|||
161008185|NCT00111813|581418775|FG005|Overall Study|Other|0|||
161008186|NCT01610297|581418776|FG000|Overall Study|Lost to Follow-up|1|||
161008187|NCT00818246|581418777|FG000|Overall Study|Impossible to match pictures|5|||
161008188|NCT02121002|581418778|FG000|Overall Study|Physician Decision|2|||
161008189|NCT02121002|581418779|FG001|Overall Study|Physician Decision|0|||
161008190|NCT02121002|581418780|FG002|Overall Study|Physician Decision|0|||
161008191|NCT02121002|581418778|FG000|Overall Study|Withdrawal by Subject|3|||
160585499|NCT04804033|579861949|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
160585500|NCT04804033|579861950|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
161008192|NCT02121002|581418779|FG001|Overall Study|Withdrawal by Subject|1|||
161008193|NCT02121002|581418780|FG002|Overall Study|Withdrawal by Subject|4|||
161008194|NCT02121002|581418778|FG000|Overall Study|Protocol Violation|1|||
161008195|NCT02121002|581418779|FG001|Overall Study|Protocol Violation|2|||
161008196|NCT02121002|581418780|FG002|Overall Study|Protocol Violation|4|||
161008197|NCT02121002|581418778|FG000|Overall Study|Concomitant therapy|0|||
161008198|NCT02121002|581418779|FG001|Overall Study|Concomitant therapy|1|||
160585501|NCT04804033|579861947|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
161008199|NCT02121002|581418780|FG002|Overall Study|Concomitant therapy|1|||
161008200|NCT02121002|581418778|FG000|Overall Study|Others|1|||
161008201|NCT02121002|581418779|FG001|Overall Study|Others|0|||
161008202|NCT02121002|581418780|FG002|Overall Study|Others|1|||
161008203|NCT02590432|581418781|FG000|Open-label Treatment Period|Adverse Event|97|||
161008204|NCT02590432|581418782|FG001|Open-label Treatment Period|Adverse Event|79|||
161008205|NCT02590432|581418783|FG002|Open-label Treatment Period|Adverse Event|0|||
161008206|NCT02590432|581418784|FG003|Open-label Treatment Period|Adverse Event|0|||
161008207|NCT02590432|581418785|FG004|Open-label Treatment Period|Adverse Event|0|||
161008208|NCT02590432|581418786|FG005|Open-label Treatment Period|Adverse Event|0|||
161008209|NCT02590432|581418787|FG006|Open-label Treatment Period|Adverse Event|0|||
161008210|NCT02590432|581418788|FG007|Open-label Treatment Period|Adverse Event|0|||
161008211|NCT02590432|581418789|FG008|Open-label Treatment Period|Adverse Event|0|||
161008212|NCT02590432|581418781|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
161008213|NCT02590432|581418782|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
161008214|NCT02590432|581418783|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
161008215|NCT02590432|581418784|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
161008216|NCT02590432|581418785|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
161008217|NCT02590432|581418786|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
161008218|NCT02590432|581418787|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
161008219|NCT02590432|581418788|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
161008220|NCT02590432|581418789|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
161008221|NCT02590432|581418781|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
161008222|NCT02590432|581418782|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
161008223|NCT02590432|581418783|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
161008224|NCT02590432|581418784|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
161008225|NCT02590432|581418785|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
161008226|NCT02590432|581418786|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
161008227|NCT02590432|581418787|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
161008228|NCT02590432|581418788|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
161008229|NCT02590432|581418789|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
161008230|NCT02590432|581418781|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
161008231|NCT02590432|581418782|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
161008232|NCT02590432|581418783|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
161008233|NCT02590432|581418784|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
161008234|NCT02590432|581418785|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
161008235|NCT02590432|581418786|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
161008236|NCT02590432|581418787|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
161008237|NCT02590432|581418788|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
161008238|NCT02590432|581418789|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
161008239|NCT02590432|581418781|FG000|Open-label Treatment Period|Protocol Violation|10|||
161008240|NCT02590432|581418782|FG001|Open-label Treatment Period|Protocol Violation|4|||
161008241|NCT02590432|581418783|FG002|Open-label Treatment Period|Protocol Violation|0|||
161008242|NCT02590432|581418784|FG003|Open-label Treatment Period|Protocol Violation|0|||
161008243|NCT02590432|581418785|FG004|Open-label Treatment Period|Protocol Violation|0|||
161008244|NCT02590432|581418786|FG005|Open-label Treatment Period|Protocol Violation|0|||
161008245|NCT02590432|581418787|FG006|Open-label Treatment Period|Protocol Violation|0|||
161008246|NCT02590432|581418788|FG007|Open-label Treatment Period|Protocol Violation|0|||
161008247|NCT02590432|581418789|FG008|Open-label Treatment Period|Protocol Violation|0|||
161008248|NCT02590432|581418781|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
161008249|NCT02590432|581418782|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
161008250|NCT02590432|581418783|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008251|NCT02590432|581418784|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008252|NCT02590432|581418785|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008253|NCT02590432|581418786|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008254|NCT02590432|581418787|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008255|NCT02590432|581418788|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008256|NCT02590432|581418789|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008257|NCT02590432|581418781|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
161008258|NCT02590432|581418782|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
161008259|NCT02590432|581418783|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008260|NCT02590432|581418784|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008261|NCT02590432|581418785|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008262|NCT02590432|581418786|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008263|NCT02590432|581418787|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008264|NCT02590432|581418788|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008265|NCT02590432|581418789|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008266|NCT02590432|581418781|FG000|Double-blind Treatment Period|Adverse Event|0|||
161008267|NCT02590432|581418782|FG001|Double-blind Treatment Period|Adverse Event|0|||
161008268|NCT02590432|581418783|FG002|Double-blind Treatment Period|Adverse Event|14|||
161008269|NCT02590432|581418784|FG003|Double-blind Treatment Period|Adverse Event|12|||
161008270|NCT02590432|581418785|FG004|Double-blind Treatment Period|Adverse Event|6|||
161008271|NCT02590432|581418786|FG005|Double-blind Treatment Period|Adverse Event|22|||
161008272|NCT02590432|581418787|FG006|Double-blind Treatment Period|Adverse Event|20|||
161008273|NCT02590432|581418788|FG007|Double-blind Treatment Period|Adverse Event|0|||
161008274|NCT02590432|581418789|FG008|Double-blind Treatment Period|Adverse Event|0|||
161008275|NCT02590432|581418781|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161008276|NCT02590432|581418782|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161008277|NCT02590432|581418783|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
160458705|NCT02585323|579412611|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
160458706|NCT02585323|579412612|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
160458707|NCT01130883|579412613|FG000|Overall Study|Patient Noncompliance|6|||
161008278|NCT02590432|581418784|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
161008279|NCT02590432|581418785|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
161008280|NCT02590432|581418786|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
161008281|NCT02590432|581418787|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
161008282|NCT02590432|581418788|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
161008283|NCT02590432|581418789|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
161008284|NCT02590432|581418781|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
161008285|NCT02590432|581418782|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
161008286|NCT02590432|581418783|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
161008287|NCT02590432|581418784|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
161008288|NCT02590432|581418785|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
161008289|NCT02590432|581418786|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
161008290|NCT02590432|581418787|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
161008291|NCT02590432|581418788|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
161008292|NCT02590432|581418789|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
161008293|NCT02590432|581418781|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161008294|NCT02590432|581418782|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161008295|NCT02590432|581418783|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161008296|NCT02590432|581418784|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161008297|NCT02590432|581418785|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
161008298|NCT02590432|581418786|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
161008299|NCT02590432|581418787|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
161008300|NCT02590432|581418788|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
161008301|NCT02590432|581418789|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
161008302|NCT02590432|581418781|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008303|NCT02590432|581418782|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008304|NCT02590432|581418783|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008305|NCT02590432|581418784|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008306|NCT02590432|581418785|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008307|NCT02590432|581418786|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
161008308|NCT02590432|581418787|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008309|NCT02590432|581418788|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008310|NCT02590432|581418789|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008311|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008312|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008313|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008314|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008315|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008316|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008317|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008318|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
161008319|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
161008320|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008321|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008322|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008323|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008324|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008325|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008326|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008327|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
161008328|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008329|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008330|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008331|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008332|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008333|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008334|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008335|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008336|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
161008337|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
161008338|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008339|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008340|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008341|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
160458708|NCT01130883|579412613|FG000|Overall Study|Reason Unknown|1|||
161008342|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008343|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008344|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008345|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008346|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
161008347|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008348|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008349|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008350|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008351|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008352|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008353|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008354|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008355|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
161008356|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008357|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008358|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008359|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008360|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008361|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008362|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008363|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
161008364|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008365|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008366|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008367|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008368|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008369|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008370|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008371|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008372|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
161008373|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008374|NCT00409838|581418790|FG000|Short-term Period|Adverse Event|0|||
161008375|NCT00409838|581418791|FG001|Short-term Period|Adverse Event|1|||
161008376|NCT00409838|581418790|FG000|Short-term Period|Lost to Follow-up|0|||
161008377|NCT00409838|581418791|FG001|Short-term Period|Lost to Follow-up|1|||
161008378|NCT00409838|581418790|FG000|Short-term Period|Withdrawal by Subject|2|||
161008379|NCT00409838|581418791|FG001|Short-term Period|Withdrawal by Subject|3|||
161008380|NCT00409838|581418790|FG000|Short-term Period|Never Treated|1|||
161008381|NCT00409838|581418791|FG001|Short-term Period|Never Treated|0|||
161008382|NCT00409838|581418790|FG000|Long-term Extension Period|Adverse Event|10|||
161008383|NCT00409838|581418791|FG001|Long-term Extension Period|Adverse Event|0|||
161008384|NCT00409838|581418790|FG000|Long-term Extension Period|Death|1|||
161008385|NCT00409838|581418791|FG001|Long-term Extension Period|Death|0|||
161008386|NCT00409838|581418790|FG000|Long-term Extension Period|Lack of Efficacy|2|||
161008387|NCT00409838|581418791|FG001|Long-term Extension Period|Lack of Efficacy|0|||
161008388|NCT00409838|581418790|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
161008389|NCT00409838|581418791|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
161008390|NCT00409838|581418790|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
161008391|NCT00409838|581418791|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
161008392|NCT00409838|581418790|FG000|Long-term Extension Period|Pregnancy|1|||
161008393|NCT00409838|581418791|FG001|Long-term Extension Period|Pregnancy|0|||
161008394|NCT04788641|581418793|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
161008395|NCT04788641|581418794|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
161008396|NCT04788641|581418795|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
161008397|NCT04788641|581418796|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
161008398|NCT04788641|581418793|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
161008399|NCT04788641|581418794|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
161008400|NCT04788641|581418795|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
161008401|NCT04788641|581418796|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
160585502|NCT04804033|579861948|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
160585503|NCT04804033|579861949|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
160458709|NCT01130883|579412613|FG000|Overall Study|Adverse Event|3|||
160585504|NCT04804033|579861950|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
161008402|NCT04788641|581418793|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
161008403|NCT04788641|581418794|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
161008404|NCT04788641|581418795|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
161008405|NCT04788641|581418796|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
161008406|NCT01250769|581418797|FG000|Overall Study|Withdrawal by Subject|0|||
161008407|NCT01250769|581418798|FG001|Overall Study|Withdrawal by Subject|1|||
161008408|NCT01250769|581418799|FG002|Overall Study|Withdrawal by Subject|1|||
161008409|NCT01250769|581418800|FG003|Overall Study|Withdrawal by Subject|0|||
161008410|NCT01250769|581418797|FG000|Overall Study|Adverse Event|0|||
161008411|NCT01250769|581418798|FG001|Overall Study|Adverse Event|0|||
161008412|NCT01250769|581418799|FG002|Overall Study|Adverse Event|1|||
161008413|NCT01250769|581418800|FG003|Overall Study|Adverse Event|0|||
161008414|NCT01985334|581418801|FG000|Overall Study|Administrative problems|1|||
161008415|NCT01985334|581418802|FG001|Overall Study|Administrative problems|1|||
161008416|NCT01985334|581418803|FG002|Overall Study|Administrative problems|0|||
161008417|NCT01985334|581418804|FG003|Overall Study|Administrative problems|2|||
161008418|NCT01985334|581418805|FG004|Overall Study|Administrative problems|0|||
161008419|NCT01985334|581418806|FG005|Overall Study|Administrative problems|1|||
161008420|NCT01985334|581418807|FG006|Overall Study|Administrative problems|1|||
161008421|NCT01985334|581418808|FG007|Overall Study|Administrative problems|3|||
161008422|NCT01985334|581418801|FG000|Overall Study|Death|1|||
161008423|NCT01985334|581418802|FG001|Overall Study|Death|0|||
161008424|NCT01985334|581418803|FG002|Overall Study|Death|0|||
161008425|NCT01985334|581418804|FG003|Overall Study|Death|3|||
161008426|NCT01985334|581418805|FG004|Overall Study|Death|0|||
161008427|NCT01985334|581418806|FG005|Overall Study|Death|0|||
161008428|NCT01985334|581418807|FG006|Overall Study|Death|1|||
161008429|NCT01985334|581418808|FG007|Overall Study|Death|2|||
161008430|NCT01985334|581418801|FG000|Overall Study|Worsening of disease|0|||
161008431|NCT01985334|581418802|FG001|Overall Study|Worsening of disease|0|||
161008432|NCT01985334|581418803|FG002|Overall Study|Worsening of disease|0|||
161008433|NCT01985334|581418804|FG003|Overall Study|Worsening of disease|1|||
161008434|NCT01985334|581418805|FG004|Overall Study|Worsening of disease|0|||
161008435|NCT01985334|581418806|FG005|Overall Study|Worsening of disease|3|||
161008436|NCT01985334|581418807|FG006|Overall Study|Worsening of disease|0|||
161008437|NCT01985334|581418808|FG007|Overall Study|Worsening of disease|1|||
161008438|NCT01985334|581418801|FG000|Overall Study|Other|2|||
161008439|NCT01985334|581418802|FG001|Overall Study|Other|9|||
161008440|NCT01985334|581418803|FG002|Overall Study|Other|7|||
161008441|NCT01985334|581418804|FG003|Overall Study|Other|17|||
161008442|NCT01985334|581418805|FG004|Overall Study|Other|4|||
161008443|NCT01985334|581418806|FG005|Overall Study|Other|8|||
161008444|NCT01985334|581418807|FG006|Overall Study|Other|4|||
161008445|NCT01985334|581418808|FG007|Overall Study|Other|7|||
161008446|NCT01985334|581418801|FG000|Overall Study|Protocol deviation|6|||
161008447|NCT01985334|581418802|FG001|Overall Study|Protocol deviation|31|||
161008448|NCT01985334|581418803|FG002|Overall Study|Protocol deviation|25|||
161008449|NCT01985334|581418804|FG003|Overall Study|Protocol deviation|84|||
161008450|NCT01985334|581418805|FG004|Overall Study|Protocol deviation|17|||
161008451|NCT01985334|581418806|FG005|Overall Study|Protocol deviation|47|||
161008452|NCT01985334|581418807|FG006|Overall Study|Protocol deviation|15|||
161008453|NCT01985334|581418808|FG007|Overall Study|Protocol deviation|42|||
161008454|NCT01985334|581418801|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
161008455|NCT01985334|581418802|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
161008456|NCT01985334|581418803|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
161008457|NCT01985334|581418804|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
161008458|NCT01985334|581418805|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
161008459|NCT01985334|581418806|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
161008460|NCT01985334|581418807|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
161008461|NCT01985334|581418808|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
161008462|NCT01985334|581418801|FG000|Overall Study|Subject withdrawal of consent|3|||
161008463|NCT01985334|581418802|FG001|Overall Study|Subject withdrawal of consent|6|||
161008464|NCT01985334|581418803|FG002|Overall Study|Subject withdrawal of consent|2|||
161008465|NCT01985334|581418804|FG003|Overall Study|Subject withdrawal of consent|28|||
160458710|NCT04089865|579412620|FG000|Overall Study|Withdrawal by Subject|2|||
161008466|NCT01985334|581418805|FG004|Overall Study|Subject withdrawal of consent|4|||
161008467|NCT01985334|581418806|FG005|Overall Study|Subject withdrawal of consent|19|||
161008468|NCT01985334|581418807|FG006|Overall Study|Subject withdrawal of consent|0|||
161008469|NCT01985334|581418808|FG007|Overall Study|Subject withdrawal of consent|20|||
161008470|NCT01985334|581418801|FG000|Overall Study|Adverse Event|0|||
161008471|NCT01985334|581418802|FG001|Overall Study|Adverse Event|8|||
160458711|NCT04089865|579412621|FG001|Overall Study|Withdrawal by Subject|2|||
160458712|NCT04089865|579412622|FG002|Overall Study|Withdrawal by Subject|7|||
160458713|NCT04089865|579412623|FG003|Overall Study|Withdrawal by Subject|2|||
161008472|NCT01985334|581418803|FG002|Overall Study|Adverse Event|2|||
161008473|NCT01985334|581418804|FG003|Overall Study|Adverse Event|26|||
161008474|NCT01985334|581418805|FG004|Overall Study|Adverse Event|3|||
161008475|NCT01985334|581418806|FG005|Overall Study|Adverse Event|18|||
161008476|NCT01985334|581418807|FG006|Overall Study|Adverse Event|3|||
161008477|NCT01985334|581418808|FG007|Overall Study|Adverse Event|15|||
161008478|NCT01985334|581418801|FG000|Overall Study|Other|4|||
161008479|NCT01985334|581418802|FG001|Overall Study|Other|2|||
161008480|NCT01985334|581418803|FG002|Overall Study|Other|3|||
161008481|NCT01985334|581418804|FG003|Overall Study|Other|10|||
161008482|NCT01985334|581418805|FG004|Overall Study|Other|1|||
161008483|NCT01985334|581418806|FG005|Overall Study|Other|6|||
161008484|NCT01985334|581418807|FG006|Overall Study|Other|2|||
161008485|NCT01985334|581418808|FG007|Overall Study|Other|2|||
161008486|NCT01985334|581418801|FG000|Overall Study|Medication non-compliance|0|||
161008487|NCT01985334|581418802|FG001|Overall Study|Medication non-compliance|4|||
161008488|NCT01985334|581418803|FG002|Overall Study|Medication non-compliance|1|||
161008489|NCT01985334|581418804|FG003|Overall Study|Medication non-compliance|6|||
161008490|NCT01985334|581418805|FG004|Overall Study|Medication non-compliance|2|||
161008491|NCT01985334|581418806|FG005|Overall Study|Medication non-compliance|3|||
161008492|NCT01985334|581418807|FG006|Overall Study|Medication non-compliance|1|||
161008493|NCT01985334|581418808|FG007|Overall Study|Medication non-compliance|3|||
161008494|NCT01985334|581418801|FG000|Overall Study|Use of prohibited treatment|1|||
161008495|NCT01985334|581418802|FG001|Overall Study|Use of prohibited treatment|4|||
161008496|NCT01985334|581418803|FG002|Overall Study|Use of prohibited treatment|1|||
161008497|NCT01985334|581418804|FG003|Overall Study|Use of prohibited treatment|2|||
161008498|NCT01985334|581418805|FG004|Overall Study|Use of prohibited treatment|1|||
161008499|NCT01985334|581418806|FG005|Overall Study|Use of prohibited treatment|6|||
161008500|NCT01985334|581418807|FG006|Overall Study|Use of prohibited treatment|2|||
161008501|NCT01985334|581418808|FG007|Overall Study|Use of prohibited treatment|0|||
161008502|NCT01985334|581418801|FG000|Overall Study|Investigator decision|0|||
161008503|NCT01985334|581418802|FG001|Overall Study|Investigator decision|3|||
161008504|NCT01985334|581418803|FG002|Overall Study|Investigator decision|0|||
161008505|NCT01985334|581418804|FG003|Overall Study|Investigator decision|7|||
161008506|NCT01985334|581418805|FG004|Overall Study|Investigator decision|1|||
161008507|NCT01985334|581418806|FG005|Overall Study|Investigator decision|1|||
161008508|NCT01985334|581418807|FG006|Overall Study|Investigator decision|0|||
161008509|NCT01985334|581418808|FG007|Overall Study|Investigator decision|4|||
161008510|NCT01985334|581418801|FG000|Overall Study|Lost to Follow-up|0|||
161008511|NCT01985334|581418802|FG001|Overall Study|Lost to Follow-up|2|||
161008512|NCT01985334|581418803|FG002|Overall Study|Lost to Follow-up|0|||
161008513|NCT01985334|581418804|FG003|Overall Study|Lost to Follow-up|3|||
161008514|NCT01985334|581418805|FG004|Overall Study|Lost to Follow-up|1|||
161008515|NCT01985334|581418806|FG005|Overall Study|Lost to Follow-up|4|||
161008516|NCT01985334|581418807|FG006|Overall Study|Lost to Follow-up|0|||
161008517|NCT01985334|581418808|FG007|Overall Study|Lost to Follow-up|3|||
161008518|NCT00093015|581418809|FG000|Overall Study|Withdrawal by Subject|194|||
161008519|NCT00093015|581418810|FG001|Overall Study|Withdrawal by Subject|171|||
161008520|NCT00093015|581418809|FG000|Overall Study|Lost to Follow-up|96|||
161008521|NCT00093015|581418810|FG001|Overall Study|Lost to Follow-up|108|||
161008522|NCT00093015|581418809|FG000|Overall Study|Death|375|||
161008523|NCT00093015|581418810|FG001|Overall Study|Death|385|||
161008524|NCT03951805|581418815|FG000|Overall Study|Adverse Event|1|||
161008525|NCT03951805|581418816|FG001|Overall Study|Adverse Event|0|||
161008526|NCT03951805|581418817|FG002|Overall Study|Adverse Event|0|||
161008527|NCT03951805|581418818|FG003|Overall Study|Adverse Event|0|||
161008528|NCT01198145|581418821|FG000|Overall Study|Withdrawal by Subject|1|||
161008529|NCT01198145|581418822|FG001|Overall Study|Withdrawal by Subject|1|||
161008530|NCT00603954|581418823|FG000|Overall Study|Protocol Violation|1|||
161008531|NCT00603954|581418824|FG001|Overall Study|Protocol Violation|2|||
161008532|NCT02528188|581418825|FG000|Overall Study|Adverse Event|23|||
161008533|NCT02528188|581418826|FG001|Overall Study|Adverse Event|22|||
161008534|NCT02528188|581418827|FG002|Overall Study|Adverse Event|8|||
161008535|NCT02528188|581418825|FG000|Overall Study|Protocol Violation|4|||
161008536|NCT02528188|581418826|FG001|Overall Study|Protocol Violation|6|||
161008537|NCT02528188|581418827|FG002|Overall Study|Protocol Violation|4|||
161008538|NCT02528188|581418825|FG000|Overall Study|Lack of Efficacy|19|||
161008539|NCT02528188|581418826|FG001|Overall Study|Lack of Efficacy|21|||
161008540|NCT02528188|581418827|FG002|Overall Study|Lack of Efficacy|22|||
161008541|NCT02528188|581418825|FG000|Overall Study|Withdrawal by Subject|97|||
161008542|NCT02528188|581418826|FG001|Overall Study|Withdrawal by Subject|104|||
161008543|NCT02528188|581418827|FG002|Overall Study|Withdrawal by Subject|100|||
161008544|NCT02528188|581418825|FG000|Overall Study|Lost to Follow-up|25|||
161008545|NCT02528188|581418826|FG001|Overall Study|Lost to Follow-up|21|||
160585505|NCT04804033|579861947|FG000|Period 2: OLE Phase|Not reported|0|||
161008546|NCT02528188|581418827|FG002|Overall Study|Lost to Follow-up|31|||
161008547|NCT02528188|581418825|FG000|Overall Study|Death|4|||
161008548|NCT02528188|581418826|FG001|Overall Study|Death|4|||
161008549|NCT02528188|581418827|FG002|Overall Study|Death|0|||
161008550|NCT02528188|581418825|FG000|Overall Study|Other|89|||
161008551|NCT02528188|581418826|FG001|Overall Study|Other|91|||
161008552|NCT02528188|581418827|FG002|Overall Study|Other|74|||
161008553|NCT02528188|581418825|FG000|Overall Study|Randomized but not treated|6|||
161008554|NCT02528188|581418826|FG001|Overall Study|Randomized but not treated|7|||
161008555|NCT02528188|581418827|FG002|Overall Study|Randomized but not treated|12|||
161008556|NCT01239316|581418833|FG000|Overall Study|Progression/Relapse|11|||
161008557|NCT01239316|581418833|FG000|Overall Study|Adverse Event|1|||
161008558|NCT02299375|581418839|FG000|Overall Study|Adverse Event, serious fatal|1|||
161008559|NCT02299375|581418840|FG001|Overall Study|Adverse Event, serious fatal|3|||
161008560|NCT02299375|581418839|FG000|Overall Study|Adverse Event, non-fatal|8|||
161008561|NCT02299375|581418840|FG001|Overall Study|Adverse Event, non-fatal|9|||
161008562|NCT02299375|581418839|FG000|Overall Study|Lack of Efficacy|1|||
161008563|NCT02299375|581418840|FG001|Overall Study|Lack of Efficacy|3|||
161008564|NCT02299375|581418839|FG000|Overall Study|Protocol Violation|1|||
161008565|NCT02299375|581418840|FG001|Overall Study|Protocol Violation|3|||
161008566|NCT02299375|581418839|FG000|Overall Study|Other: Met stopping criteria|1|||
161008567|NCT02299375|581418840|FG001|Overall Study|Other: Met stopping criteria|0|||
161008568|NCT02299375|581418839|FG000|Overall Study|Other: Study closed/terminated|66|||
161008569|NCT02299375|581418840|FG001|Overall Study|Other: Study closed/terminated|55|||
161008570|NCT02299375|581418839|FG000|Overall Study|Lost to Follow-up|0|||
161008571|NCT02299375|581418840|FG001|Overall Study|Lost to Follow-up|2|||
161008572|NCT02299375|581418839|FG000|Overall Study|Physician Decision|1|||
161008573|NCT02299375|581418840|FG001|Overall Study|Physician Decision|1|||
161008574|NCT02299375|581418839|FG000|Overall Study|Withdrawal by Subject|1|||
161008575|NCT02299375|581418840|FG001|Overall Study|Withdrawal by Subject|4|||
161008576|NCT00411216|581418844|FG000|Overall Study|Ten participants were entered into the c|0|||
161008577|NCT00411216|581418845|FG001|Overall Study|Ten participants were entered into the c|2|||
161008578|NCT01205048|581418846|FG000|Overall Study|Withdrawal by Subject|14|||
161008579|NCT01205048|581418846|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
161008580|NCT01205048|581418846|FG000|Overall Study|Lost to Follow-up|4|||
161008581|NCT01205048|581418846|FG000|Overall Study|Other|2|||
161008582|NCT00823472|581418847|FG000|Overall Study|Physician Decision|24|||
161008583|NCT00823472|581418848|FG001|Overall Study|Physician Decision|28|||
161008584|NCT01251354|581418850|FG000|Overall Study|Adverse Event|1|||
161008585|NCT01251354|581418850|FG000|Overall Study|Investigator's Decision|1|||
161008586|NCT01251354|581418850|FG000|Overall Study|Disease Progression|4|||
161008587|NCT03997916|581418854|FG000|Overall Study|Protocol Violation|35|||
161008588|NCT00780416|581421294|FG000|Overall Study|Physician Decision|3|||
161008589|NCT00780416|581421295|FG001|Overall Study|Physician Decision|3|||
161008590|NCT00780416|581421294|FG000|Overall Study|Protocol Violation|1|||
161008591|NCT00780416|581421295|FG001|Overall Study|Protocol Violation|0|||
161008592|NCT00780416|581421294|FG000|Overall Study|Withdrawal by Subject|8|||
161008593|NCT00780416|581421295|FG001|Overall Study|Withdrawal by Subject|6|||
161008594|NCT02916706|581421296|FG000|Overall Study|Adverse Event|0|||
161008595|NCT02916706|581421297|FG001|Overall Study|Adverse Event|1|||
161008596|NCT02916706|581421296|FG000|Overall Study|Lost to Follow-up|0|||
161008597|NCT02916706|581421297|FG001|Overall Study|Lost to Follow-up|1|||
161008598|NCT02916706|581421296|FG000|Overall Study|Physician Decision|1|||
161008599|NCT02916706|581421297|FG001|Overall Study|Physician Decision|0|||
161008600|NCT02916706|581421296|FG000|Overall Study|Protocol Violation|3|||
161008601|NCT02916706|581421297|FG001|Overall Study|Protocol Violation|1|||
161008602|NCT02916706|581421296|FG000|Overall Study|Withdrawal by Subject|6|||
161008603|NCT02916706|581421297|FG001|Overall Study|Withdrawal by Subject|9|||
161008604|NCT02916706|581421296|FG000|Overall Study|Other|5|||
161008605|NCT02916706|581421297|FG001|Overall Study|Other|19|||
161008606|NCT02723955|581421298|FG000|Escalation Phase|Death|1|||
161008607|NCT02723955|581421299|FG001|Escalation Phase|Death|1|||
161008608|NCT02723955|581421300|FG002|Escalation Phase|Death|2|||
161008609|NCT02723955|581421301|FG003|Escalation Phase|Death|7|||
161008610|NCT02723955|581421302|FG004|Escalation Phase|Death|18|||
161008611|NCT02723955|581421303|FG005|Escalation Phase|Death|17|||
161008612|NCT02723955|581421304|FG006|Escalation Phase|Death|11|||
161008613|NCT02723955|581421305|FG007|Escalation Phase|Death|21|||
161008614|NCT02723955|581421306|FG008|Escalation Phase|Death|3|||
161008615|NCT02723955|581421307|FG009|Escalation Phase|Death|0|||
161008616|NCT02723955|581421308|FG010|Escalation Phase|Death|0|||
161008617|NCT02723955|581421309|FG011|Escalation Phase|Death|0|||
161008618|NCT02723955|581421310|FG012|Escalation Phase|Death|2|||
161008619|NCT02723955|581421311|FG013|Escalation Phase|Death|4|||
160585506|NCT04804033|579861948|FG001|Period 2: OLE Phase|Not reported|2|||
161008620|NCT02723955|581421312|FG014|Escalation Phase|Death|5|||
161008621|NCT02723955|581421313|FG015|Escalation Phase|Death|6|||
161008622|NCT02723955|581421314|FG016|Escalation Phase|Death|6|||
161008623|NCT02723955|581421315|FG017|Escalation Phase|Death|7|||
161008624|NCT02723955|581421316|FG018|Escalation Phase|Death|1|||
161008625|NCT02723955|581421317|FG019|Escalation Phase|Death|3|||
161008626|NCT02723955|581421318|FG020|Escalation Phase|Death|13|||
161008627|NCT02723955|581421319|FG021|Escalation Phase|Death|3|||
161008628|NCT02723955|581421320|FG022|Escalation Phase|Death|2|||
161008629|NCT02723955|581421321|FG023|Escalation Phase|Death|4|||
161008630|NCT02723955|581421322|FG024|Escalation Phase|Death|31|||
161008631|NCT02723955|581421323|FG025|Escalation Phase|Death|7|||
161008632|NCT02723955|581421324|FG026|Escalation Phase|Death|13|||
161008633|NCT02723955|581421325|FG027|Escalation Phase|Death|0|||
161008634|NCT02723955|581421326|FG028|Escalation Phase|Death|1|||
161008635|NCT02723955|581421327|FG029|Escalation Phase|Death|0|||
161008636|NCT02723955|581421328|FG030|Escalation Phase|Death|0|||
161008637|NCT02723955|581421329|FG031|Escalation Phase|Death|0|||
161008638|NCT02723955|581421330|FG032|Escalation Phase|Death|0|||
161008639|NCT02723955|581421331|FG033|Escalation Phase|Death|0|||
161008640|NCT02723955|581421332|FG034|Escalation Phase|Death|0|||
161008641|NCT02723955|581421333|FG035|Escalation Phase|Death|0|||
161008642|NCT02723955|581421334|FG036|Escalation Phase|Death|0|||
161008643|NCT02723955|581421335|FG037|Escalation Phase|Death|0|||
161008644|NCT02723955|581421336|FG038|Escalation Phase|Death|0|||
161008645|NCT02723955|581421337|FG039|Escalation Phase|Death|0|||
161008646|NCT02723955|581421338|FG040|Escalation Phase|Death|0|||
161008647|NCT02723955|581421339|FG041|Escalation Phase|Death|0|||
161008648|NCT02723955|581421340|FG042|Escalation Phase|Death|0|||
161008649|NCT02723955|581421298|FG000|Escalation Phase|Lost to Follow-up|0|||
161008650|NCT02723955|581421299|FG001|Escalation Phase|Lost to Follow-up|0|||
161008651|NCT02723955|581421300|FG002|Escalation Phase|Lost to Follow-up|0|||
161008652|NCT02723955|581421301|FG003|Escalation Phase|Lost to Follow-up|0|||
161008653|NCT02723955|581421302|FG004|Escalation Phase|Lost to Follow-up|0|||
161008654|NCT02723955|581421303|FG005|Escalation Phase|Lost to Follow-up|2|||
161008655|NCT02723955|581421304|FG006|Escalation Phase|Lost to Follow-up|1|||
161008656|NCT02723955|581421305|FG007|Escalation Phase|Lost to Follow-up|1|||
161008657|NCT02723955|581421306|FG008|Escalation Phase|Lost to Follow-up|1|||
161008658|NCT02723955|581421307|FG009|Escalation Phase|Lost to Follow-up|0|||
161008659|NCT02723955|581421308|FG010|Escalation Phase|Lost to Follow-up|0|||
161008660|NCT02723955|581421309|FG011|Escalation Phase|Lost to Follow-up|0|||
161008661|NCT02723955|581421310|FG012|Escalation Phase|Lost to Follow-up|1|||
161008662|NCT02723955|581421311|FG013|Escalation Phase|Lost to Follow-up|0|||
161008663|NCT02723955|581421312|FG014|Escalation Phase|Lost to Follow-up|0|||
161008664|NCT02723955|581421313|FG015|Escalation Phase|Lost to Follow-up|0|||
161008665|NCT02723955|581421314|FG016|Escalation Phase|Lost to Follow-up|1|||
161008666|NCT02723955|581421315|FG017|Escalation Phase|Lost to Follow-up|2|||
161008667|NCT02723955|581421316|FG018|Escalation Phase|Lost to Follow-up|0|||
161008668|NCT02723955|581421317|FG019|Escalation Phase|Lost to Follow-up|1|||
161008669|NCT02723955|581421318|FG020|Escalation Phase|Lost to Follow-up|2|||
161008670|NCT02723955|581421319|FG021|Escalation Phase|Lost to Follow-up|1|||
161008671|NCT02723955|581421320|FG022|Escalation Phase|Lost to Follow-up|0|||
161008672|NCT02723955|581421321|FG023|Escalation Phase|Lost to Follow-up|0|||
161008673|NCT02723955|581421322|FG024|Escalation Phase|Lost to Follow-up|1|||
161008674|NCT02723955|581421323|FG025|Escalation Phase|Lost to Follow-up|1|||
161008675|NCT02723955|581421324|FG026|Escalation Phase|Lost to Follow-up|3|||
161008676|NCT02723955|581421325|FG027|Escalation Phase|Lost to Follow-up|0|||
161008677|NCT02723955|581421326|FG028|Escalation Phase|Lost to Follow-up|1|||
161008678|NCT02723955|581421327|FG029|Escalation Phase|Lost to Follow-up|0|||
161008679|NCT02723955|581421328|FG030|Escalation Phase|Lost to Follow-up|0|||
161008680|NCT02723955|581421329|FG031|Escalation Phase|Lost to Follow-up|0|||
161008681|NCT02723955|581421330|FG032|Escalation Phase|Lost to Follow-up|0|||
161008682|NCT02723955|581421331|FG033|Escalation Phase|Lost to Follow-up|0|||
161008683|NCT02723955|581421332|FG034|Escalation Phase|Lost to Follow-up|0|||
161008684|NCT02723955|581421333|FG035|Escalation Phase|Lost to Follow-up|0|||
161008685|NCT02723955|581421334|FG036|Escalation Phase|Lost to Follow-up|0|||
161008686|NCT02723955|581421335|FG037|Escalation Phase|Lost to Follow-up|0|||
161008687|NCT02723955|581421336|FG038|Escalation Phase|Lost to Follow-up|0|||
161008688|NCT02723955|581421337|FG039|Escalation Phase|Lost to Follow-up|0|||
161008689|NCT02723955|581421338|FG040|Escalation Phase|Lost to Follow-up|0|||
161008690|NCT02723955|581421339|FG041|Escalation Phase|Lost to Follow-up|0|||
161008691|NCT02723955|581421340|FG042|Escalation Phase|Lost to Follow-up|0|||
161008692|NCT02723955|581421298|FG000|Escalation Phase|Physician Decision|0|||
161008693|NCT02723955|581421299|FG001|Escalation Phase|Physician Decision|0|||
160458714|NCT04282980|579412626|FG000|Overall Study|Remained on treatment|6|||
160458715|NCT04282980|579412626|FG000|Overall Study|Survival follow-up|11|||
160458716|NCT04282980|579412626|FG000|Overall Study|Withdrawal of informed consent|1|||
160458717|NCT04282980|579412626|FG000|Overall Study|Lost to Follow-up|1|||
160458718|NCT01917084|579412628|FG000|Overall Study|Withdrawal by Subject|1|||
160458719|NCT03571386|579412629|FG000|Overall Study|scheduling conflict|4|||
160458720|NCT03571386|579412630|FG001|Overall Study|scheduling conflict|0|||
160458721|NCT03571386|579412629|FG000|Overall Study|Withdrawal by Subject|15|||
160458722|NCT03571386|579412630|FG001|Overall Study|Withdrawal by Subject|5|||
161008694|NCT02723955|581421300|FG002|Escalation Phase|Physician Decision|0|||
161008695|NCT02723955|581421301|FG003|Escalation Phase|Physician Decision|0|||
161008696|NCT02723955|581421302|FG004|Escalation Phase|Physician Decision|0|||
161008697|NCT02723955|581421303|FG005|Escalation Phase|Physician Decision|2|||
161008698|NCT02723955|581421304|FG006|Escalation Phase|Physician Decision|0|||
161008699|NCT02723955|581421305|FG007|Escalation Phase|Physician Decision|0|||
161008700|NCT02723955|581421306|FG008|Escalation Phase|Physician Decision|0|||
161008701|NCT02723955|581421307|FG009|Escalation Phase|Physician Decision|0|||
161008702|NCT02723955|581421308|FG010|Escalation Phase|Physician Decision|0|||
161008703|NCT02723955|581421309|FG011|Escalation Phase|Physician Decision|0|||
161008704|NCT02723955|581421310|FG012|Escalation Phase|Physician Decision|0|||
161008705|NCT02723955|581421311|FG013|Escalation Phase|Physician Decision|0|||
161008706|NCT02723955|581421312|FG014|Escalation Phase|Physician Decision|0|||
161008707|NCT02723955|581421313|FG015|Escalation Phase|Physician Decision|0|||
161008708|NCT02723955|581421314|FG016|Escalation Phase|Physician Decision|0|||
161008709|NCT02723955|581421315|FG017|Escalation Phase|Physician Decision|0|||
161008710|NCT02723955|581421316|FG018|Escalation Phase|Physician Decision|0|||
161008711|NCT02723955|581421317|FG019|Escalation Phase|Physician Decision|0|||
161008712|NCT02723955|581421318|FG020|Escalation Phase|Physician Decision|0|||
161008713|NCT02723955|581421319|FG021|Escalation Phase|Physician Decision|0|||
161008714|NCT02723955|581421320|FG022|Escalation Phase|Physician Decision|0|||
161008715|NCT02723955|581421321|FG023|Escalation Phase|Physician Decision|0|||
161008716|NCT02723955|581421322|FG024|Escalation Phase|Physician Decision|0|||
161008717|NCT02723955|581421323|FG025|Escalation Phase|Physician Decision|0|||
161008718|NCT02723955|581421324|FG026|Escalation Phase|Physician Decision|2|||
161008719|NCT02723955|581421325|FG027|Escalation Phase|Physician Decision|0|||
161008720|NCT02723955|581421326|FG028|Escalation Phase|Physician Decision|0|||
161008721|NCT02723955|581421327|FG029|Escalation Phase|Physician Decision|0|||
161008722|NCT02723955|581421328|FG030|Escalation Phase|Physician Decision|0|||
161008723|NCT02723955|581421329|FG031|Escalation Phase|Physician Decision|0|||
161008724|NCT02723955|581421330|FG032|Escalation Phase|Physician Decision|0|||
161008725|NCT02723955|581421331|FG033|Escalation Phase|Physician Decision|0|||
161008726|NCT02723955|581421332|FG034|Escalation Phase|Physician Decision|0|||
161008727|NCT02723955|581421333|FG035|Escalation Phase|Physician Decision|0|||
161008728|NCT02723955|581421334|FG036|Escalation Phase|Physician Decision|0|||
161008729|NCT02723955|581421335|FG037|Escalation Phase|Physician Decision|0|||
161008730|NCT02723955|581421336|FG038|Escalation Phase|Physician Decision|0|||
161008731|NCT02723955|581421337|FG039|Escalation Phase|Physician Decision|0|||
161008732|NCT02723955|581421338|FG040|Escalation Phase|Physician Decision|0|||
161008733|NCT02723955|581421339|FG041|Escalation Phase|Physician Decision|0|||
161008734|NCT02723955|581421340|FG042|Escalation Phase|Physician Decision|0|||
161008735|NCT02723955|581421298|FG000|Escalation Phase|Withdrawal by Subject|0|||
161008736|NCT02723955|581421299|FG001|Escalation Phase|Withdrawal by Subject|0|||
161008737|NCT02723955|581421300|FG002|Escalation Phase|Withdrawal by Subject|0|||
161008738|NCT02723955|581421301|FG003|Escalation Phase|Withdrawal by Subject|0|||
161008739|NCT02723955|581421302|FG004|Escalation Phase|Withdrawal by Subject|1|||
161008740|NCT02723955|581421303|FG005|Escalation Phase|Withdrawal by Subject|1|||
161008741|NCT02723955|581421304|FG006|Escalation Phase|Withdrawal by Subject|1|||
161008742|NCT02723955|581421305|FG007|Escalation Phase|Withdrawal by Subject|1|||
161008743|NCT02723955|581421306|FG008|Escalation Phase|Withdrawal by Subject|0|||
161008744|NCT02723955|581421307|FG009|Escalation Phase|Withdrawal by Subject|0|||
161008745|NCT02723955|581421308|FG010|Escalation Phase|Withdrawal by Subject|0|||
161008746|NCT02723955|581421309|FG011|Escalation Phase|Withdrawal by Subject|0|||
161008747|NCT02723955|581421310|FG012|Escalation Phase|Withdrawal by Subject|1|||
161008748|NCT02723955|581421311|FG013|Escalation Phase|Withdrawal by Subject|0|||
161008749|NCT02723955|581421312|FG014|Escalation Phase|Withdrawal by Subject|0|||
161008750|NCT02723955|581421313|FG015|Escalation Phase|Withdrawal by Subject|0|||
161008751|NCT02723955|581421314|FG016|Escalation Phase|Withdrawal by Subject|1|||
161008752|NCT02723955|581421315|FG017|Escalation Phase|Withdrawal by Subject|0|||
161008753|NCT02723955|581421316|FG018|Escalation Phase|Withdrawal by Subject|0|||
161008754|NCT02723955|581421317|FG019|Escalation Phase|Withdrawal by Subject|0|||
161008755|NCT02723955|581421318|FG020|Escalation Phase|Withdrawal by Subject|0|||
161008756|NCT02723955|581421319|FG021|Escalation Phase|Withdrawal by Subject|0|||
161008757|NCT02723955|581421320|FG022|Escalation Phase|Withdrawal by Subject|0|||
161008758|NCT02723955|581421321|FG023|Escalation Phase|Withdrawal by Subject|2|||
161008759|NCT02723955|581421322|FG024|Escalation Phase|Withdrawal by Subject|0|||
161008760|NCT02723955|581421323|FG025|Escalation Phase|Withdrawal by Subject|1|||
161008761|NCT02723955|581421324|FG026|Escalation Phase|Withdrawal by Subject|0|||
161008762|NCT02723955|581421325|FG027|Escalation Phase|Withdrawal by Subject|0|||
161008763|NCT02723955|581421326|FG028|Escalation Phase|Withdrawal by Subject|1|||
161008764|NCT02723955|581421327|FG029|Escalation Phase|Withdrawal by Subject|0|||
161008765|NCT02723955|581421328|FG030|Escalation Phase|Withdrawal by Subject|0|||
160657015|NCT05097989|580124503|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
160657016|NCT05097989|580124504|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
160657017|NCT05097989|580124496|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
161008766|NCT02723955|581421329|FG031|Escalation Phase|Withdrawal by Subject|0|||
160657018|NCT05097989|580124497|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
161008767|NCT02723955|581421330|FG032|Escalation Phase|Withdrawal by Subject|0|||
161008768|NCT02723955|581421331|FG033|Escalation Phase|Withdrawal by Subject|0|||
161008769|NCT02723955|581421332|FG034|Escalation Phase|Withdrawal by Subject|0|||
161008770|NCT02723955|581421333|FG035|Escalation Phase|Withdrawal by Subject|0|||
161008771|NCT02723955|581421334|FG036|Escalation Phase|Withdrawal by Subject|0|||
160657019|NCT05097989|580124498|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
160585507|NCT04804033|579861949|FG002|Period 2: OLE Phase|Not reported|0|||
160585508|NCT04804033|579861950|FG003|Period 2: OLE Phase|Not reported|0|||
160585509|NCT04804033|579861947|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
160585510|NCT04804033|579861948|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
160585511|NCT04804033|579861949|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
161008772|NCT02723955|581421335|FG037|Escalation Phase|Withdrawal by Subject|0|||
161008773|NCT02723955|581421336|FG038|Escalation Phase|Withdrawal by Subject|0|||
161008774|NCT02723955|581421337|FG039|Escalation Phase|Withdrawal by Subject|0|||
161008775|NCT02723955|581421338|FG040|Escalation Phase|Withdrawal by Subject|0|||
161008776|NCT02723955|581421339|FG041|Escalation Phase|Withdrawal by Subject|0|||
161008777|NCT02723955|581421340|FG042|Escalation Phase|Withdrawal by Subject|0|||
161008778|NCT02723955|581421298|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008779|NCT02723955|581421299|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008780|NCT02723955|581421300|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008781|NCT02723955|581421301|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008782|NCT02723955|581421302|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
161008783|NCT02723955|581421303|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
161008784|NCT02723955|581421304|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
161008785|NCT02723955|581421305|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
161008786|NCT02723955|581421306|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
161008787|NCT02723955|581421307|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008788|NCT02723955|581421308|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008789|NCT02723955|581421309|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008790|NCT02723955|581421310|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008791|NCT02723955|581421311|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008792|NCT02723955|581421312|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008793|NCT02723955|581421313|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008794|NCT02723955|581421314|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008795|NCT02723955|581421315|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008796|NCT02723955|581421316|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008797|NCT02723955|581421317|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008798|NCT02723955|581421318|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008799|NCT02723955|581421319|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008800|NCT02723955|581421320|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008801|NCT02723955|581421321|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008802|NCT02723955|581421322|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008803|NCT02723955|581421323|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008804|NCT02723955|581421324|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008805|NCT02723955|581421325|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008806|NCT02723955|581421326|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008807|NCT02723955|581421327|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008808|NCT02723955|581421328|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008809|NCT02723955|581421329|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008810|NCT02723955|581421330|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008811|NCT02723955|581421331|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008812|NCT02723955|581421332|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
160585512|NCT04804033|579861950|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
160585513|NCT04804033|579861947|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
160585514|NCT04804033|579861948|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
160585515|NCT04804033|579861949|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
160585516|NCT04804033|579861950|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
160585517|NCT04804033|579861947|FG000|Period 3: Follow-up Phase|Other|0|||
160585518|NCT04804033|579861948|FG001|Period 3: Follow-up Phase|Other|1|||
160585519|NCT04804033|579861949|FG002|Period 3: Follow-up Phase|Other|2|||
160585520|NCT04804033|579861950|FG003|Period 3: Follow-up Phase|Other|1|||
160585521|NCT04804033|579861947|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
160657020|NCT05097989|580124499|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
160458723|NCT02909686|579412638|FG000|Overall Study|Physician Decision|3|||
160458724|NCT02909686|579412638|FG000|Overall Study|Withdrawal by Subject|2|||
161008813|NCT02723955|581421333|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008814|NCT02723955|581421334|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008815|NCT02723955|581421335|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008816|NCT02723955|581421336|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008817|NCT02723955|581421337|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008818|NCT02723955|581421338|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008819|NCT02723955|581421339|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008820|NCT02723955|581421340|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008821|NCT02723955|581421298|FG000|Escalation Phase|Site Closed|0|||
161008822|NCT02723955|581421299|FG001|Escalation Phase|Site Closed|0|||
161008823|NCT02723955|581421300|FG002|Escalation Phase|Site Closed|0|||
161008824|NCT02723955|581421301|FG003|Escalation Phase|Site Closed|0|||
161008825|NCT02723955|581421302|FG004|Escalation Phase|Site Closed|0|||
161008826|NCT02723955|581421303|FG005|Escalation Phase|Site Closed|0|||
161008827|NCT02723955|581421304|FG006|Escalation Phase|Site Closed|0|||
161008828|NCT02723955|581421305|FG007|Escalation Phase|Site Closed|0|||
161008829|NCT02723955|581421306|FG008|Escalation Phase|Site Closed|0|||
161008830|NCT02723955|581421307|FG009|Escalation Phase|Site Closed|0|||
161008831|NCT02723955|581421308|FG010|Escalation Phase|Site Closed|0|||
161008832|NCT02723955|581421309|FG011|Escalation Phase|Site Closed|0|||
161008833|NCT02723955|581421310|FG012|Escalation Phase|Site Closed|0|||
161008834|NCT02723955|581421311|FG013|Escalation Phase|Site Closed|0|||
161008835|NCT02723955|581421312|FG014|Escalation Phase|Site Closed|0|||
161008836|NCT02723955|581421313|FG015|Escalation Phase|Site Closed|1|||
161008837|NCT02723955|581421314|FG016|Escalation Phase|Site Closed|0|||
161008838|NCT02723955|581421315|FG017|Escalation Phase|Site Closed|2|||
161008839|NCT02723955|581421316|FG018|Escalation Phase|Site Closed|0|||
161008840|NCT02723955|581421317|FG019|Escalation Phase|Site Closed|0|||
161008841|NCT02723955|581421318|FG020|Escalation Phase|Site Closed|1|||
161008842|NCT02723955|581421319|FG021|Escalation Phase|Site Closed|0|||
161008843|NCT02723955|581421320|FG022|Escalation Phase|Site Closed|0|||
161008844|NCT02723955|581421321|FG023|Escalation Phase|Site Closed|0|||
161008845|NCT02723955|581421322|FG024|Escalation Phase|Site Closed|3|||
161008846|NCT02723955|581421323|FG025|Escalation Phase|Site Closed|1|||
161008847|NCT02723955|581421324|FG026|Escalation Phase|Site Closed|3|||
161008848|NCT02723955|581421325|FG027|Escalation Phase|Site Closed|1|||
161008849|NCT02723955|581421326|FG028|Escalation Phase|Site Closed|1|||
161008850|NCT02723955|581421327|FG029|Escalation Phase|Site Closed|0|||
161008851|NCT02723955|581421328|FG030|Escalation Phase|Site Closed|0|||
161008852|NCT02723955|581421329|FG031|Escalation Phase|Site Closed|0|||
161008853|NCT02723955|581421330|FG032|Escalation Phase|Site Closed|0|||
161008854|NCT02723955|581421331|FG033|Escalation Phase|Site Closed|0|||
161008855|NCT02723955|581421332|FG034|Escalation Phase|Site Closed|0|||
161008856|NCT02723955|581421333|FG035|Escalation Phase|Site Closed|0|||
161008857|NCT02723955|581421334|FG036|Escalation Phase|Site Closed|0|||
161008858|NCT02723955|581421335|FG037|Escalation Phase|Site Closed|0|||
161008859|NCT02723955|581421336|FG038|Escalation Phase|Site Closed|0|||
161008860|NCT02723955|581421337|FG039|Escalation Phase|Site Closed|0|||
161008861|NCT02723955|581421338|FG040|Escalation Phase|Site Closed|0|||
161008862|NCT02723955|581421339|FG041|Escalation Phase|Site Closed|0|||
161008863|NCT02723955|581421340|FG042|Escalation Phase|Site Closed|0|||
161008864|NCT02723955|581421298|FG000|Expansion Phase|Death|0|||
161008865|NCT02723955|581421299|FG001|Expansion Phase|Death|0|||
161008866|NCT02723955|581421300|FG002|Expansion Phase|Death|0|||
161008867|NCT02723955|581421301|FG003|Expansion Phase|Death|0|||
161008868|NCT02723955|581421302|FG004|Expansion Phase|Death|0|||
161008869|NCT02723955|581421303|FG005|Expansion Phase|Death|0|||
161008870|NCT02723955|581421304|FG006|Expansion Phase|Death|0|||
161008871|NCT02723955|581421305|FG007|Expansion Phase|Death|0|||
161008872|NCT02723955|581421306|FG008|Expansion Phase|Death|0|||
161008873|NCT02723955|581421307|FG009|Expansion Phase|Death|25|||
161008874|NCT02723955|581421308|FG010|Expansion Phase|Death|69|||
161008875|NCT02723955|581421309|FG011|Expansion Phase|Death|48|||
161008876|NCT02723955|581421310|FG012|Expansion Phase|Death|0|||
161008877|NCT02723955|581421311|FG013|Expansion Phase|Death|0|||
161008878|NCT02723955|581421312|FG014|Expansion Phase|Death|0|||
161008879|NCT02723955|581421313|FG015|Expansion Phase|Death|0|||
161008880|NCT02723955|581421314|FG016|Expansion Phase|Death|0|||
161008881|NCT02723955|581421315|FG017|Expansion Phase|Death|0|||
161008882|NCT02723955|581421316|FG018|Expansion Phase|Death|0|||
161008883|NCT02723955|581421317|FG019|Expansion Phase|Death|0|||
161008884|NCT02723955|581421318|FG020|Expansion Phase|Death|0|||
161008885|NCT02723955|581421319|FG021|Expansion Phase|Death|0|||
161008886|NCT02723955|581421320|FG022|Expansion Phase|Death|0|||
161008887|NCT02723955|581421321|FG023|Expansion Phase|Death|0|||
161008888|NCT02723955|581421322|FG024|Expansion Phase|Death|0|||
161008889|NCT02723955|581421323|FG025|Expansion Phase|Death|0|||
161008890|NCT02723955|581421324|FG026|Expansion Phase|Death|0|||
161008891|NCT02723955|581421325|FG027|Expansion Phase|Death|0|||
161008892|NCT02723955|581421326|FG028|Expansion Phase|Death|0|||
161008893|NCT02723955|581421327|FG029|Expansion Phase|Death|12|||
161008894|NCT02723955|581421328|FG030|Expansion Phase|Death|202|||
161008895|NCT02723955|581421329|FG031|Expansion Phase|Death|31|||
161008896|NCT02723955|581421330|FG032|Expansion Phase|Death|17|||
161008897|NCT02723955|581421331|FG033|Expansion Phase|Death|2|||
161008898|NCT02723955|581421332|FG034|Expansion Phase|Death|3|||
161008899|NCT02723955|581421333|FG035|Expansion Phase|Death|3|||
161008900|NCT02723955|581421334|FG036|Expansion Phase|Death|1|||
161008901|NCT02723955|581421335|FG037|Expansion Phase|Death|0|||
161008902|NCT02723955|581421336|FG038|Expansion Phase|Death|0|||
161008903|NCT02723955|581421337|FG039|Expansion Phase|Death|0|||
161008904|NCT02723955|581421338|FG040|Expansion Phase|Death|0|||
161008905|NCT02723955|581421339|FG041|Expansion Phase|Death|0|||
161008906|NCT02723955|581421340|FG042|Expansion Phase|Death|0|||
161008907|NCT02723955|581421298|FG000|Expansion Phase|Lost to Follow-up|0|||
161008908|NCT02723955|581421299|FG001|Expansion Phase|Lost to Follow-up|0|||
161008909|NCT02723955|581421300|FG002|Expansion Phase|Lost to Follow-up|0|||
161008910|NCT02723955|581421301|FG003|Expansion Phase|Lost to Follow-up|0|||
161008911|NCT02723955|581421302|FG004|Expansion Phase|Lost to Follow-up|0|||
161008912|NCT02723955|581421303|FG005|Expansion Phase|Lost to Follow-up|0|||
161008913|NCT02723955|581421304|FG006|Expansion Phase|Lost to Follow-up|0|||
161008914|NCT02723955|581421305|FG007|Expansion Phase|Lost to Follow-up|0|||
161008915|NCT02723955|581421306|FG008|Expansion Phase|Lost to Follow-up|0|||
161008916|NCT02723955|581421307|FG009|Expansion Phase|Lost to Follow-up|0|||
161008917|NCT02723955|581421308|FG010|Expansion Phase|Lost to Follow-up|4|||
161008918|NCT02723955|581421309|FG011|Expansion Phase|Lost to Follow-up|1|||
161008919|NCT02723955|581421310|FG012|Expansion Phase|Lost to Follow-up|0|||
161008920|NCT02723955|581421311|FG013|Expansion Phase|Lost to Follow-up|0|||
161008921|NCT02723955|581421312|FG014|Expansion Phase|Lost to Follow-up|0|||
161008922|NCT02723955|581421313|FG015|Expansion Phase|Lost to Follow-up|0|||
161008923|NCT02723955|581421314|FG016|Expansion Phase|Lost to Follow-up|0|||
161008924|NCT02723955|581421315|FG017|Expansion Phase|Lost to Follow-up|0|||
161008925|NCT02723955|581421316|FG018|Expansion Phase|Lost to Follow-up|0|||
161008926|NCT02723955|581421317|FG019|Expansion Phase|Lost to Follow-up|0|||
161008927|NCT02723955|581421318|FG020|Expansion Phase|Lost to Follow-up|0|||
161008928|NCT02723955|581421319|FG021|Expansion Phase|Lost to Follow-up|0|||
161008929|NCT02723955|581421320|FG022|Expansion Phase|Lost to Follow-up|0|||
161008930|NCT02723955|581421321|FG023|Expansion Phase|Lost to Follow-up|0|||
161008931|NCT02723955|581421322|FG024|Expansion Phase|Lost to Follow-up|0|||
161008932|NCT02723955|581421323|FG025|Expansion Phase|Lost to Follow-up|0|||
161008933|NCT02723955|581421324|FG026|Expansion Phase|Lost to Follow-up|0|||
161008934|NCT02723955|581421325|FG027|Expansion Phase|Lost to Follow-up|0|||
161008935|NCT02723955|581421326|FG028|Expansion Phase|Lost to Follow-up|0|||
161008936|NCT02723955|581421327|FG029|Expansion Phase|Lost to Follow-up|1|||
161008937|NCT02723955|581421328|FG030|Expansion Phase|Lost to Follow-up|19|||
161008938|NCT02723955|581421329|FG031|Expansion Phase|Lost to Follow-up|2|||
161008939|NCT02723955|581421330|FG032|Expansion Phase|Lost to Follow-up|1|||
161008940|NCT02723955|581421331|FG033|Expansion Phase|Lost to Follow-up|0|||
161008941|NCT02723955|581421332|FG034|Expansion Phase|Lost to Follow-up|0|||
161008942|NCT02723955|581421333|FG035|Expansion Phase|Lost to Follow-up|0|||
161008943|NCT02723955|581421334|FG036|Expansion Phase|Lost to Follow-up|0|||
161008944|NCT02723955|581421335|FG037|Expansion Phase|Lost to Follow-up|0|||
161008945|NCT02723955|581421336|FG038|Expansion Phase|Lost to Follow-up|0|||
161008946|NCT02723955|581421337|FG039|Expansion Phase|Lost to Follow-up|0|||
161008947|NCT02723955|581421338|FG040|Expansion Phase|Lost to Follow-up|0|||
161008948|NCT02723955|581421339|FG041|Expansion Phase|Lost to Follow-up|0|||
161008949|NCT02723955|581421340|FG042|Expansion Phase|Lost to Follow-up|0|||
161008950|NCT02723955|581421298|FG000|Expansion Phase|Physician Decision|0|||
161008951|NCT02723955|581421299|FG001|Expansion Phase|Physician Decision|0|||
161008952|NCT02723955|581421300|FG002|Expansion Phase|Physician Decision|0|||
161008953|NCT02723955|581421301|FG003|Expansion Phase|Physician Decision|0|||
161008954|NCT02723955|581421302|FG004|Expansion Phase|Physician Decision|0|||
161008955|NCT02723955|581421303|FG005|Expansion Phase|Physician Decision|0|||
161008956|NCT02723955|581421304|FG006|Expansion Phase|Physician Decision|0|||
161008957|NCT02723955|581421305|FG007|Expansion Phase|Physician Decision|0|||
161008958|NCT02723955|581421306|FG008|Expansion Phase|Physician Decision|0|||
160657021|NCT05097989|580124500|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
160657022|NCT05097989|580124501|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
161008959|NCT02723955|581421307|FG009|Expansion Phase|Physician Decision|0|||
161008960|NCT02723955|581421308|FG010|Expansion Phase|Physician Decision|0|||
161008961|NCT02723955|581421309|FG011|Expansion Phase|Physician Decision|0|||
161008962|NCT02723955|581421310|FG012|Expansion Phase|Physician Decision|0|||
161008963|NCT02723955|581421311|FG013|Expansion Phase|Physician Decision|0|||
161008964|NCT02723955|581421312|FG014|Expansion Phase|Physician Decision|0|||
161008965|NCT02723955|581421313|FG015|Expansion Phase|Physician Decision|0|||
161008966|NCT02723955|581421314|FG016|Expansion Phase|Physician Decision|0|||
161008967|NCT02723955|581421315|FG017|Expansion Phase|Physician Decision|0|||
161008968|NCT02723955|581421316|FG018|Expansion Phase|Physician Decision|0|||
161008969|NCT02723955|581421317|FG019|Expansion Phase|Physician Decision|0|||
161008970|NCT02723955|581421318|FG020|Expansion Phase|Physician Decision|0|||
161008971|NCT02723955|581421319|FG021|Expansion Phase|Physician Decision|0|||
161008972|NCT02723955|581421320|FG022|Expansion Phase|Physician Decision|0|||
161008973|NCT02723955|581421321|FG023|Expansion Phase|Physician Decision|0|||
161008974|NCT02723955|581421322|FG024|Expansion Phase|Physician Decision|0|||
161008975|NCT02723955|581421323|FG025|Expansion Phase|Physician Decision|0|||
161008976|NCT02723955|581421324|FG026|Expansion Phase|Physician Decision|0|||
161008977|NCT02723955|581421325|FG027|Expansion Phase|Physician Decision|0|||
161008978|NCT02723955|581421326|FG028|Expansion Phase|Physician Decision|0|||
161008979|NCT02723955|581421327|FG029|Expansion Phase|Physician Decision|0|||
161008980|NCT02723955|581421328|FG030|Expansion Phase|Physician Decision|1|||
161008981|NCT02723955|581421329|FG031|Expansion Phase|Physician Decision|1|||
161008982|NCT02723955|581421330|FG032|Expansion Phase|Physician Decision|0|||
161008983|NCT02723955|581421331|FG033|Expansion Phase|Physician Decision|0|||
161008984|NCT02723955|581421332|FG034|Expansion Phase|Physician Decision|0|||
161008985|NCT02723955|581421333|FG035|Expansion Phase|Physician Decision|0|||
161008986|NCT02723955|581421334|FG036|Expansion Phase|Physician Decision|0|||
161008987|NCT02723955|581421335|FG037|Expansion Phase|Physician Decision|0|||
161008988|NCT02723955|581421336|FG038|Expansion Phase|Physician Decision|0|||
161008989|NCT02723955|581421337|FG039|Expansion Phase|Physician Decision|0|||
161008990|NCT02723955|581421338|FG040|Expansion Phase|Physician Decision|0|||
161008991|NCT02723955|581421339|FG041|Expansion Phase|Physician Decision|0|||
161008992|NCT02723955|581421340|FG042|Expansion Phase|Physician Decision|0|||
161008993|NCT02723955|581421298|FG000|Expansion Phase|Withdrawal by Subject|0|||
161008994|NCT02723955|581421299|FG001|Expansion Phase|Withdrawal by Subject|0|||
161008995|NCT02723955|581421300|FG002|Expansion Phase|Withdrawal by Subject|0|||
161008996|NCT02723955|581421301|FG003|Expansion Phase|Withdrawal by Subject|0|||
161008997|NCT02723955|581421302|FG004|Expansion Phase|Withdrawal by Subject|0|||
161008998|NCT02723955|581421303|FG005|Expansion Phase|Withdrawal by Subject|0|||
161008999|NCT02723955|581421304|FG006|Expansion Phase|Withdrawal by Subject|0|||
161009000|NCT02723955|581421305|FG007|Expansion Phase|Withdrawal by Subject|0|||
161009001|NCT02723955|581421306|FG008|Expansion Phase|Withdrawal by Subject|0|||
161009002|NCT02723955|581421307|FG009|Expansion Phase|Withdrawal by Subject|2|||
161009003|NCT02723955|581421308|FG010|Expansion Phase|Withdrawal by Subject|1|||
161009004|NCT02723955|581421309|FG011|Expansion Phase|Withdrawal by Subject|0|||
161009005|NCT02723955|581421310|FG012|Expansion Phase|Withdrawal by Subject|0|||
161009006|NCT02723955|581421311|FG013|Expansion Phase|Withdrawal by Subject|0|||
161009007|NCT02723955|581421312|FG014|Expansion Phase|Withdrawal by Subject|0|||
161009008|NCT02723955|581421313|FG015|Expansion Phase|Withdrawal by Subject|0|||
161009009|NCT02723955|581421314|FG016|Expansion Phase|Withdrawal by Subject|0|||
161009010|NCT02723955|581421315|FG017|Expansion Phase|Withdrawal by Subject|0|||
161009011|NCT02723955|581421316|FG018|Expansion Phase|Withdrawal by Subject|0|||
161009012|NCT02723955|581421317|FG019|Expansion Phase|Withdrawal by Subject|0|||
161009013|NCT02723955|581421318|FG020|Expansion Phase|Withdrawal by Subject|0|||
161009014|NCT02723955|581421319|FG021|Expansion Phase|Withdrawal by Subject|0|||
161009015|NCT02723955|581421320|FG022|Expansion Phase|Withdrawal by Subject|0|||
161009016|NCT02723955|581421321|FG023|Expansion Phase|Withdrawal by Subject|0|||
161009017|NCT02723955|581421322|FG024|Expansion Phase|Withdrawal by Subject|0|||
161009018|NCT02723955|581421323|FG025|Expansion Phase|Withdrawal by Subject|0|||
161009019|NCT02723955|581421324|FG026|Expansion Phase|Withdrawal by Subject|0|||
161009020|NCT02723955|581421325|FG027|Expansion Phase|Withdrawal by Subject|0|||
161009021|NCT02723955|581421326|FG028|Expansion Phase|Withdrawal by Subject|0|||
161009022|NCT02723955|581421327|FG029|Expansion Phase|Withdrawal by Subject|0|||
161009023|NCT02723955|581421328|FG030|Expansion Phase|Withdrawal by Subject|8|||
161009024|NCT02723955|581421329|FG031|Expansion Phase|Withdrawal by Subject|4|||
161009025|NCT02723955|581421330|FG032|Expansion Phase|Withdrawal by Subject|0|||
161009026|NCT02723955|581421331|FG033|Expansion Phase|Withdrawal by Subject|0|||
161009027|NCT02723955|581421332|FG034|Expansion Phase|Withdrawal by Subject|0|||
161009028|NCT02723955|581421333|FG035|Expansion Phase|Withdrawal by Subject|1|||
161009029|NCT02723955|581421334|FG036|Expansion Phase|Withdrawal by Subject|0|||
161009030|NCT02723955|581421335|FG037|Expansion Phase|Withdrawal by Subject|0|||
161009031|NCT02723955|581421336|FG038|Expansion Phase|Withdrawal by Subject|0|||
161009032|NCT02723955|581421337|FG039|Expansion Phase|Withdrawal by Subject|0|||
161009033|NCT02723955|581421338|FG040|Expansion Phase|Withdrawal by Subject|0|||
161009034|NCT02723955|581421339|FG041|Expansion Phase|Withdrawal by Subject|0|||
161009035|NCT02723955|581421340|FG042|Expansion Phase|Withdrawal by Subject|0|||
161009036|NCT02723955|581421298|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
160458725|NCT03858517|579412639|FG000|Overall Study|Adverse Event|1|||
161009037|NCT02723955|581421299|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009038|NCT02723955|581421300|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009039|NCT02723955|581421301|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009040|NCT02723955|581421302|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009041|NCT02723955|581421303|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009042|NCT02723955|581421304|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009043|NCT02723955|581421305|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009044|NCT02723955|581421306|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009045|NCT02723955|581421307|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
161009046|NCT02723955|581421308|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
161009047|NCT02723955|581421309|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
161009048|NCT02723955|581421310|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009049|NCT02723955|581421311|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009050|NCT02723955|581421312|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009051|NCT02723955|581421313|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009052|NCT02723955|581421314|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009053|NCT02723955|581421315|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009054|NCT02723955|581421316|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009055|NCT02723955|581421317|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009056|NCT02723955|581421318|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009057|NCT02723955|581421319|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009058|NCT02723955|581421320|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009059|NCT02723955|581421321|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009060|NCT02723955|581421322|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009061|NCT02723955|581421323|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009062|NCT02723955|581421324|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009063|NCT02723955|581421325|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009064|NCT02723955|581421326|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009065|NCT02723955|581421327|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009066|NCT02723955|581421328|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
161009067|NCT02723955|581421329|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009068|NCT02723955|581421330|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009069|NCT02723955|581421331|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009070|NCT02723955|581421332|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009071|NCT02723955|581421333|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009072|NCT02723955|581421334|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009073|NCT02723955|581421335|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009074|NCT02723955|581421336|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009075|NCT02723955|581421337|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009076|NCT02723955|581421338|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009077|NCT02723955|581421339|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009078|NCT02723955|581421340|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009079|NCT02723955|581421298|FG000|Expansion Phase|Site Closed|0|||
161009080|NCT02723955|581421299|FG001|Expansion Phase|Site Closed|0|||
161009081|NCT02723955|581421300|FG002|Expansion Phase|Site Closed|0|||
161009082|NCT02723955|581421301|FG003|Expansion Phase|Site Closed|0|||
161009083|NCT02723955|581421302|FG004|Expansion Phase|Site Closed|0|||
161009084|NCT02723955|581421303|FG005|Expansion Phase|Site Closed|0|||
161009085|NCT02723955|581421304|FG006|Expansion Phase|Site Closed|0|||
161009086|NCT02723955|581421305|FG007|Expansion Phase|Site Closed|0|||
161009087|NCT02723955|581421306|FG008|Expansion Phase|Site Closed|0|||
161009088|NCT02723955|581421307|FG009|Expansion Phase|Site Closed|1|||
161009089|NCT02723955|581421308|FG010|Expansion Phase|Site Closed|2|||
161009090|NCT02723955|581421309|FG011|Expansion Phase|Site Closed|6|||
161009091|NCT02723955|581421310|FG012|Expansion Phase|Site Closed|0|||
161009092|NCT02723955|581421311|FG013|Expansion Phase|Site Closed|0|||
161009093|NCT02723955|581421312|FG014|Expansion Phase|Site Closed|0|||
161009094|NCT02723955|581421313|FG015|Expansion Phase|Site Closed|0|||
161009095|NCT02723955|581421314|FG016|Expansion Phase|Site Closed|0|||
161009096|NCT02723955|581421315|FG017|Expansion Phase|Site Closed|0|||
161009097|NCT02723955|581421316|FG018|Expansion Phase|Site Closed|0|||
161009098|NCT02723955|581421317|FG019|Expansion Phase|Site Closed|0|||
161009099|NCT02723955|581421318|FG020|Expansion Phase|Site Closed|0|||
161009100|NCT02723955|581421319|FG021|Expansion Phase|Site Closed|0|||
161009101|NCT02723955|581421320|FG022|Expansion Phase|Site Closed|0|||
161009102|NCT02723955|581421321|FG023|Expansion Phase|Site Closed|0|||
161009103|NCT02723955|581421322|FG024|Expansion Phase|Site Closed|0|||
161009104|NCT02723955|581421323|FG025|Expansion Phase|Site Closed|0|||
161009105|NCT02723955|581421324|FG026|Expansion Phase|Site Closed|0|||
161009106|NCT02723955|581421325|FG027|Expansion Phase|Site Closed|0|||
161009107|NCT02723955|581421326|FG028|Expansion Phase|Site Closed|0|||
161009108|NCT02723955|581421327|FG029|Expansion Phase|Site Closed|0|||
161009109|NCT02723955|581421328|FG030|Expansion Phase|Site Closed|8|||
161009110|NCT02723955|581421329|FG031|Expansion Phase|Site Closed|4|||
161009111|NCT02723955|581421330|FG032|Expansion Phase|Site Closed|2|||
161009112|NCT02723955|581421331|FG033|Expansion Phase|Site Closed|2|||
161009113|NCT02723955|581421332|FG034|Expansion Phase|Site Closed|0|||
161009114|NCT02723955|581421333|FG035|Expansion Phase|Site Closed|0|||
161009115|NCT02723955|581421334|FG036|Expansion Phase|Site Closed|0|||
161009116|NCT02723955|581421335|FG037|Expansion Phase|Site Closed|0|||
161009117|NCT02723955|581421336|FG038|Expansion Phase|Site Closed|0|||
161009118|NCT02723955|581421337|FG039|Expansion Phase|Site Closed|0|||
161009119|NCT02723955|581421338|FG040|Expansion Phase|Site Closed|0|||
161009120|NCT02723955|581421339|FG041|Expansion Phase|Site Closed|0|||
161009121|NCT02723955|581421340|FG042|Expansion Phase|Site Closed|0|||
161009122|NCT02723955|581421298|FG000|Crossover/ Re-treatment Phase|Death|0|||
161009123|NCT02723955|581421299|FG001|Crossover/ Re-treatment Phase|Death|0|||
161009124|NCT02723955|581421300|FG002|Crossover/ Re-treatment Phase|Death|0|||
161009125|NCT02723955|581421301|FG003|Crossover/ Re-treatment Phase|Death|0|||
161009126|NCT02723955|581421302|FG004|Crossover/ Re-treatment Phase|Death|0|||
161009127|NCT02723955|581421303|FG005|Crossover/ Re-treatment Phase|Death|0|||
161009128|NCT02723955|581421304|FG006|Crossover/ Re-treatment Phase|Death|0|||
161009129|NCT02723955|581421305|FG007|Crossover/ Re-treatment Phase|Death|0|||
161009130|NCT02723955|581421306|FG008|Crossover/ Re-treatment Phase|Death|0|||
161009131|NCT02723955|581421307|FG009|Crossover/ Re-treatment Phase|Death|0|||
161009132|NCT02723955|581421308|FG010|Crossover/ Re-treatment Phase|Death|0|||
161009133|NCT02723955|581421309|FG011|Crossover/ Re-treatment Phase|Death|0|||
161009134|NCT02723955|581421310|FG012|Crossover/ Re-treatment Phase|Death|0|||
161009135|NCT02723955|581421311|FG013|Crossover/ Re-treatment Phase|Death|0|||
161009136|NCT02723955|581421312|FG014|Crossover/ Re-treatment Phase|Death|0|||
161009137|NCT02723955|581421313|FG015|Crossover/ Re-treatment Phase|Death|0|||
161009138|NCT02723955|581421314|FG016|Crossover/ Re-treatment Phase|Death|0|||
161009139|NCT02723955|581421315|FG017|Crossover/ Re-treatment Phase|Death|0|||
161009140|NCT02723955|581421316|FG018|Crossover/ Re-treatment Phase|Death|0|||
161009141|NCT02723955|581421317|FG019|Crossover/ Re-treatment Phase|Death|0|||
161009142|NCT02723955|581421318|FG020|Crossover/ Re-treatment Phase|Death|0|||
161009143|NCT02723955|581421319|FG021|Crossover/ Re-treatment Phase|Death|0|||
161009144|NCT02723955|581421320|FG022|Crossover/ Re-treatment Phase|Death|0|||
161009145|NCT02723955|581421321|FG023|Crossover/ Re-treatment Phase|Death|0|||
161009146|NCT02723955|581421322|FG024|Crossover/ Re-treatment Phase|Death|0|||
161009147|NCT02723955|581421323|FG025|Crossover/ Re-treatment Phase|Death|0|||
161009148|NCT02723955|581421324|FG026|Crossover/ Re-treatment Phase|Death|0|||
161009149|NCT02723955|581421325|FG027|Crossover/ Re-treatment Phase|Death|0|||
161009150|NCT02723955|581421326|FG028|Crossover/ Re-treatment Phase|Death|0|||
161009151|NCT02723955|581421327|FG029|Crossover/ Re-treatment Phase|Death|0|||
160458726|NCT03858517|579412639|FG000|Overall Study|Lost to Follow-up|1|||
161009152|NCT02723955|581421328|FG030|Crossover/ Re-treatment Phase|Death|0|||
161009153|NCT02723955|581421329|FG031|Crossover/ Re-treatment Phase|Death|0|||
161009154|NCT02723955|581421330|FG032|Crossover/ Re-treatment Phase|Death|0|||
161009155|NCT02723955|581421331|FG033|Crossover/ Re-treatment Phase|Death|0|||
161009156|NCT02723955|581421332|FG034|Crossover/ Re-treatment Phase|Death|0|||
161009157|NCT02723955|581421333|FG035|Crossover/ Re-treatment Phase|Death|0|||
161009158|NCT02723955|581421334|FG036|Crossover/ Re-treatment Phase|Death|0|||
161009159|NCT02723955|581421335|FG037|Crossover/ Re-treatment Phase|Death|1|||
161009160|NCT02723955|581421336|FG038|Crossover/ Re-treatment Phase|Death|14|||
161009161|NCT02723955|581421337|FG039|Crossover/ Re-treatment Phase|Death|32|||
161009162|NCT02723955|581421338|FG040|Crossover/ Re-treatment Phase|Death|2|||
161009163|NCT02723955|581421339|FG041|Crossover/ Re-treatment Phase|Death|1|||
161009164|NCT02723955|581421340|FG042|Crossover/ Re-treatment Phase|Death|0|||
161009165|NCT02723955|581421298|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009166|NCT02723955|581421299|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009167|NCT02723955|581421300|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009168|NCT02723955|581421301|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
160458727|NCT03858517|579412639|FG000|Overall Study|removed for being incarcerated|1|||
160458728|NCT03858517|579412639|FG000|Overall Study|Sponsor Closure|48|||
161009169|NCT02723955|581421302|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009170|NCT02723955|581421303|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009171|NCT02723955|581421304|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009172|NCT02723955|581421305|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009173|NCT02723955|581421306|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
160458729|NCT06037668|579412640|FG000|Overall Study|Lost to Follow-up|1|||
161009174|NCT02723955|581421307|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009175|NCT02723955|581421308|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009176|NCT02723955|581421309|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009177|NCT02723955|581421310|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009178|NCT02723955|581421311|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009179|NCT02723955|581421312|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009180|NCT02723955|581421313|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009181|NCT02723955|581421314|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009182|NCT02723955|581421315|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009183|NCT02723955|581421316|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009184|NCT02723955|581421317|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009185|NCT02723955|581421318|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009186|NCT02723955|581421319|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009187|NCT02723955|581421320|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009188|NCT02723955|581421321|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009189|NCT02723955|581421322|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009190|NCT02723955|581421323|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009191|NCT02723955|581421324|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009192|NCT02723955|581421325|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009193|NCT02723955|581421326|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009194|NCT02723955|581421327|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009195|NCT02723955|581421328|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009196|NCT02723955|581421329|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009197|NCT02723955|581421330|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009198|NCT02723955|581421331|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009199|NCT02723955|581421332|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009200|NCT02723955|581421333|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009201|NCT02723955|581421334|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009202|NCT02723955|581421335|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009203|NCT02723955|581421336|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009204|NCT02723955|581421337|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
161009205|NCT02723955|581421338|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009206|NCT02723955|581421339|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009207|NCT02723955|581421340|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009208|NCT02723955|581421298|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009209|NCT02723955|581421299|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009210|NCT02723955|581421300|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009211|NCT02723955|581421301|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009212|NCT02723955|581421302|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009213|NCT02723955|581421303|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009214|NCT02723955|581421304|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009215|NCT02723955|581421305|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009216|NCT02723955|581421306|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009217|NCT02723955|581421307|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009218|NCT02723955|581421308|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009219|NCT02723955|581421309|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009220|NCT02723955|581421310|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009221|NCT02723955|581421311|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009222|NCT02723955|581421312|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009223|NCT02723955|581421313|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009224|NCT02723955|581421314|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009225|NCT02723955|581421315|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009226|NCT02723955|581421316|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009227|NCT02723955|581421317|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009228|NCT02723955|581421318|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009229|NCT02723955|581421319|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009230|NCT02723955|581421320|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009231|NCT02723955|581421321|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009232|NCT02723955|581421322|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009233|NCT02723955|581421323|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009234|NCT02723955|581421324|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009235|NCT02723955|581421325|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009236|NCT02723955|581421326|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009237|NCT02723955|581421327|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009238|NCT02723955|581421328|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009239|NCT02723955|581421329|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009240|NCT02723955|581421330|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009241|NCT02723955|581421331|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009242|NCT02723955|581421332|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009243|NCT02723955|581421333|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009244|NCT02723955|581421334|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009245|NCT02723955|581421335|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009246|NCT02723955|581421336|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
161009247|NCT02723955|581421337|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
161009248|NCT02723955|581421338|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009249|NCT02723955|581421339|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009250|NCT02723955|581421340|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
161009251|NCT02723955|581421298|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
161009252|NCT02723955|581421299|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
161009253|NCT02723955|581421300|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
161009254|NCT02723955|581421301|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
161009255|NCT02723955|581421302|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
161009256|NCT02723955|581421303|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
161009257|NCT02723955|581421304|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
161009258|NCT02723955|581421305|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
161009259|NCT02723955|581421306|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
161009260|NCT02723955|581421307|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
161009261|NCT02723955|581421308|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
161009262|NCT02723955|581421309|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
161009263|NCT02723955|581421310|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
161009264|NCT02723955|581421311|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
161009265|NCT02723955|581421312|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
161009266|NCT02723955|581421313|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
161009267|NCT02723955|581421314|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
161009268|NCT02723955|581421315|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
161009269|NCT02723955|581421316|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
161009270|NCT02723955|581421317|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
161009271|NCT02723955|581421318|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
161009272|NCT02723955|581421319|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
161009273|NCT02723955|581421320|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
161009274|NCT02723955|581421321|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
161009275|NCT02723955|581421322|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
161009276|NCT02723955|581421323|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
161009277|NCT02723955|581421324|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
161009278|NCT02723955|581421325|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
161009279|NCT02723955|581421326|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
161009280|NCT02723955|581421327|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
161009281|NCT02723955|581421328|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
161009282|NCT02723955|581421329|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
161009283|NCT02723955|581421330|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
161009284|NCT02723955|581421331|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
161009285|NCT02723955|581421332|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
161009286|NCT02723955|581421333|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
161009287|NCT02723955|581421334|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
161009288|NCT02723955|581421335|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
161009289|NCT02723955|581421336|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
160585522|NCT04804033|579861948|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
161009290|NCT02723955|581421337|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
161009291|NCT02723955|581421338|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
161009292|NCT02723955|581421339|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
161009293|NCT02723955|581421340|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
161009294|NCT03088813|581421343|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
161009295|NCT03088813|581421344|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
161009296|NCT03088813|581421345|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
161009297|NCT03088813|581421346|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
161009298|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
161009299|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
161009300|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
161009301|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
161009302|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
161009303|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
161009304|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
161009305|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
161009306|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
161009307|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
161009308|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
161009309|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
161009310|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
161009311|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
160585523|NCT04804033|579861949|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
160585524|NCT04804033|579861950|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
160585525|NCT04804033|579861947|FG000|Period 3: Follow-up Phase|Not reported|18|||
160585526|NCT04804033|579861948|FG001|Period 3: Follow-up Phase|Not reported|15|||
160585527|NCT04804033|579861949|FG002|Period 3: Follow-up Phase|Not reported|1|||
160585528|NCT04804033|579861950|FG003|Period 3: Follow-up Phase|Not reported|4|||
160585529|NCT02496585|579861953|FG000|Overall Study|Death|3|||
160585530|NCT02496585|579861954|FG001|Overall Study|Death|0|||
160585531|NCT02496585|579861953|FG000|Overall Study|Lost to Follow-up|2|||
160585532|NCT02496585|579861954|FG001|Overall Study|Lost to Follow-up|0|||
160585533|NCT02496585|579861953|FG000|Overall Study|Withdrawal by Subject|1|||
160585534|NCT02496585|579861954|FG001|Overall Study|Withdrawal by Subject|2|||
160585535|NCT02496585|579861953|FG000|Overall Study|Progression of Malignancy|4|||
160967047|NCT03764774|581266858|FG011|Overall Study|Withdrawal by Subject|0|||
160967048|NCT03764774|581266859|FG012|Overall Study|Withdrawal by Subject|0|||
160967049|NCT03764774|581266860|FG013|Overall Study|Withdrawal by Subject|0|||
160967050|NCT03764774|581266847|FG000|Overall Study|Adverse Event|0|||
160967051|NCT03764774|581266848|FG001|Overall Study|Adverse Event|0|||
160967052|NCT03764774|581266849|FG002|Overall Study|Adverse Event|0|||
160967053|NCT03764774|581266850|FG003|Overall Study|Adverse Event|0|||
160967054|NCT03764774|581266851|FG004|Overall Study|Adverse Event|0|||
160967055|NCT03764774|581266852|FG005|Overall Study|Adverse Event|0|||
160967056|NCT03764774|581266853|FG006|Overall Study|Adverse Event|0|||
160967057|NCT03764774|581266854|FG007|Overall Study|Adverse Event|0|||
160967058|NCT03764774|581266855|FG008|Overall Study|Adverse Event|0|||
160967059|NCT03764774|581266856|FG009|Overall Study|Adverse Event|0|||
160967060|NCT03764774|581266857|FG010|Overall Study|Adverse Event|0|||
160967061|NCT03764774|581266858|FG011|Overall Study|Adverse Event|0|||
160967062|NCT03764774|581266859|FG012|Overall Study|Adverse Event|2|||
160967063|NCT03764774|581266860|FG013|Overall Study|Adverse Event|0|||
160967064|NCT03764774|581266847|FG000|Overall Study|Lost to Follow-up|0|||
160967065|NCT03764774|581266848|FG001|Overall Study|Lost to Follow-up|0|||
160967066|NCT03764774|581266849|FG002|Overall Study|Lost to Follow-up|0|||
160967067|NCT03764774|581266850|FG003|Overall Study|Lost to Follow-up|0|||
160967068|NCT03764774|581266851|FG004|Overall Study|Lost to Follow-up|0|||
160967069|NCT03764774|581266852|FG005|Overall Study|Lost to Follow-up|0|||
160967070|NCT03764774|581266853|FG006|Overall Study|Lost to Follow-up|0|||
160967071|NCT03764774|581266854|FG007|Overall Study|Lost to Follow-up|0|||
160967072|NCT03764774|581266855|FG008|Overall Study|Lost to Follow-up|0|||
160967073|NCT03764774|581266856|FG009|Overall Study|Lost to Follow-up|0|||
160967074|NCT03764774|581266857|FG010|Overall Study|Lost to Follow-up|0|||
160967075|NCT03764774|581266858|FG011|Overall Study|Lost to Follow-up|0|||
160967076|NCT03764774|581266859|FG012|Overall Study|Lost to Follow-up|0|||
160967077|NCT03764774|581266860|FG013|Overall Study|Lost to Follow-up|1|||
160967078|NCT03764774|581266847|FG000|Overall Study|Physician Decision|0|||
160967079|NCT03764774|581266848|FG001|Overall Study|Physician Decision|0|||
160967080|NCT03764774|581266849|FG002|Overall Study|Physician Decision|0|||
160967081|NCT03764774|581266850|FG003|Overall Study|Physician Decision|0|||
160967082|NCT03764774|581266851|FG004|Overall Study|Physician Decision|0|||
160967083|NCT03764774|581266852|FG005|Overall Study|Physician Decision|0|||
160967084|NCT03764774|581266853|FG006|Overall Study|Physician Decision|0|||
160967085|NCT03764774|581266854|FG007|Overall Study|Physician Decision|0|||
160967086|NCT03764774|581266855|FG008|Overall Study|Physician Decision|0|||
160967087|NCT03764774|581266856|FG009|Overall Study|Physician Decision|4|||
160967088|NCT03764774|581266857|FG010|Overall Study|Physician Decision|1|||
160967089|NCT03764774|581266858|FG011|Overall Study|Physician Decision|4|||
160967090|NCT03764774|581266859|FG012|Overall Study|Physician Decision|9|||
160967091|NCT03764774|581266860|FG013|Overall Study|Physician Decision|0|||
160967092|NCT03764774|581266847|FG000|Overall Study|Study Termination|0|||
160967093|NCT03764774|581266848|FG001|Overall Study|Study Termination|0|||
160967094|NCT03764774|581266849|FG002|Overall Study|Study Termination|0|||
160967095|NCT03764774|581266850|FG003|Overall Study|Study Termination|0|||
160967096|NCT03764774|581266851|FG004|Overall Study|Study Termination|0|||
160967097|NCT03764774|581266852|FG005|Overall Study|Study Termination|0|||
160458730|NCT06037668|579412641|FG001|Overall Study|Lost to Follow-up|1|||
160458731|NCT06037668|579412640|FG000|Overall Study|Protocol Violation|1|||
160458732|NCT06037668|579412641|FG001|Overall Study|Protocol Violation|0|||
160967098|NCT03764774|581266853|FG006|Overall Study|Study Termination|0|||
160967099|NCT03764774|581266854|FG007|Overall Study|Study Termination|0|||
160967100|NCT03764774|581266855|FG008|Overall Study|Study Termination|0|||
160967101|NCT03764774|581266856|FG009|Overall Study|Study Termination|1|||
160967102|NCT03764774|581266857|FG010|Overall Study|Study Termination|0|||
160967103|NCT03764774|581266858|FG011|Overall Study|Study Termination|0|||
160585536|NCT02496585|579861954|FG001|Overall Study|Progression of Malignancy|1|||
160585537|NCT01401010|579861955|FG000|Overall Study|Could not interpret assay results|1|||
160967104|NCT03764774|581266859|FG012|Overall Study|Study Termination|0|||
160967105|NCT03764774|581266860|FG013|Overall Study|Study Termination|2|||
160967106|NCT00755222|581268146|FG000|Overall Study|Withdrawal by Subject|4|||
160967107|NCT00755222|581268147|FG001|Overall Study|Withdrawal by Subject|2|||
160967108|NCT00755222|581268146|FG000|Overall Study|Adverse Event|2|||
160967109|NCT00755222|581268147|FG001|Overall Study|Adverse Event|0|||
161009312|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
161009313|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
161009314|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
161009315|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
161009316|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
161009317|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
161009318|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
161009319|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
161009320|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
161009321|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
161009322|NCT04878354|581421347|FG000|Overall Study|Adverse Event|4|||
161009323|NCT04878354|581421348|FG001|Overall Study|Adverse Event|13|||
161009324|NCT04878354|581421347|FG000|Overall Study|Withdrawal by Subject|14|||
161009325|NCT04878354|581421348|FG001|Overall Study|Withdrawal by Subject|12|||
161009326|NCT04878354|581421347|FG000|Overall Study|Lost to Follow-up|4|||
161009327|NCT04878354|581421348|FG001|Overall Study|Lost to Follow-up|1|||
161009328|NCT04878354|581421347|FG000|Overall Study|Lack of Efficacy|1|||
161009329|NCT04878354|581421348|FG001|Overall Study|Lack of Efficacy|0|||
161009330|NCT04878354|581421347|FG000|Overall Study|Protocol Violation|0|||
161009331|NCT04878354|581421348|FG001|Overall Study|Protocol Violation|1|||
161009332|NCT04878354|581421347|FG000|Overall Study|"Reason stated as other in CRF"|2|||
161009333|NCT04878354|581421348|FG001|Overall Study|"Reason stated as other in CRF"|3|||
161009334|NCT04540913|581421349|FG000|Overall Study|Withdrawal by Subject|14|||
161009335|NCT04540913|581421350|FG001|Overall Study|Withdrawal by Subject|3|||
161009336|NCT02118961|581421351|FG000|Overall Study|Withdrawal by Subject|1|||
161009337|NCT02118961|581421352|FG001|Overall Study|Withdrawal by Subject|0|||
161009338|NCT05288283|581421353|FG000|Overall Study|Study Terminated Early|1|||
161009339|NCT05288283|581421354|FG001|Overall Study|Study Terminated Early|1|||
161009340|NCT02992925|581421355|FG000|Cohort 2|Physician Decision|0|||
161009341|NCT02992925|581421356|FG001|Cohort 2|Physician Decision|0|||
161009342|NCT02992925|581421357|FG002|Cohort 2|Physician Decision|1|||
161009343|NCT02992925|581421358|FG003|Cohort 2|Physician Decision|0|||
161009344|NCT02992925|581421355|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
161009345|NCT02992925|581421356|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
161009346|NCT02992925|581421357|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
161009347|NCT02992925|581421358|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
161009348|NCT05678998|581421359|FG000|Overall Study|Withdrawal by Subject|1|||
161009349|NCT05678998|581421360|FG001|Overall Study|Withdrawal by Subject|1|||
161009350|NCT05678998|581421361|FG002|Overall Study|Withdrawal by Subject|3|||
161009351|NCT05678998|581421362|FG003|Overall Study|Withdrawal by Subject|0|||
161009352|NCT05678998|581421363|FG004|Overall Study|Withdrawal by Subject|1|||
161009353|NCT05678998|581421359|FG000|Overall Study|Lost to Follow-up|0|||
161009354|NCT05678998|581421360|FG001|Overall Study|Lost to Follow-up|0|||
161009355|NCT05678998|581421361|FG002|Overall Study|Lost to Follow-up|0|||
161009356|NCT05678998|581421362|FG003|Overall Study|Lost to Follow-up|0|||
161009357|NCT05678998|581421363|FG004|Overall Study|Lost to Follow-up|1|||
161009358|NCT05678998|581421359|FG000|Overall Study|Death|0|||
161009359|NCT05678998|581421360|FG001|Overall Study|Death|0|||
161009360|NCT05678998|581421361|FG002|Overall Study|Death|0|||
161009361|NCT05678998|581421362|FG003|Overall Study|Death|3|||
161009362|NCT05678998|581421363|FG004|Overall Study|Death|4|||
161009363|NCT05678998|581421359|FG000|Overall Study|Other|0|||
161009364|NCT05678998|581421360|FG001|Overall Study|Other|0|||
161009365|NCT05678998|581421361|FG002|Overall Study|Other|0|||
161009366|NCT05678998|581421362|FG003|Overall Study|Other|2|||
161009367|NCT05678998|581421363|FG004|Overall Study|Other|1|||
161009368|NCT03990649|581421366|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
161009369|NCT03990649|581421367|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
161009370|NCT03990649|581421368|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
161009371|NCT03990649|581421366|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
161009372|NCT03990649|581421367|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
161009373|NCT03990649|581421368|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
161009374|NCT03990649|581421366|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
161009375|NCT03990649|581421367|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
161009376|NCT03990649|581421368|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
161009377|NCT03990649|581421366|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
161009378|NCT03990649|581421367|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
161009379|NCT03990649|581421368|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
161009380|NCT03990649|581421366|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
161009381|NCT03990649|581421367|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
161009382|NCT03990649|581421368|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
161009383|NCT03990649|581421366|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
161009384|NCT03990649|581421367|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
161009385|NCT03990649|581421368|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
161009386|NCT03990649|581421366|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
161009387|NCT03990649|581421367|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
161009388|NCT03990649|581421368|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
161009389|NCT05773313|581421369|FG000|Overall Study|Lost to Follow-up|3|||
161009390|NCT03050814|581421370|FG000|Overall Study|Screen failures|0|||
161009391|NCT03050814|581421371|FG001|Overall Study|Screen failures|0|||
161009392|NCT03050814|581421372|FG002|Overall Study|Screen failures|4|||
161009393|NCT05137236|581421373|FG000|Part A|Other than Specified|1|||
161009394|NCT05137236|581421374|FG001|Part A|Other than Specified|0|||
161009395|NCT05137236|581421375|FG002|Part A|Other than Specified|0|||
161009396|NCT05137236|581421376|FG003|Part A|Other than Specified|0|||
161009397|NCT05137236|581421377|FG004|Part A|Other than Specified|0|||
161009398|NCT05137236|581421378|FG005|Part A|Other than Specified|0|||
161009399|NCT05137236|581421379|FG006|Part A|Other than Specified|0|||
161009400|NCT05137236|581421380|FG007|Part A|Other than Specified|0|||
161009401|NCT05137236|581421373|FG000|Part A|Withdrawal by Subject|0|||
161009402|NCT05137236|581421374|FG001|Part A|Withdrawal by Subject|4|||
161009403|NCT05137236|581421375|FG002|Part A|Withdrawal by Subject|1|||
161009404|NCT05137236|581421376|FG003|Part A|Withdrawal by Subject|1|||
161009405|NCT05137236|581421377|FG004|Part A|Withdrawal by Subject|3|||
161009406|NCT05137236|581421378|FG005|Part A|Withdrawal by Subject|2|||
161009407|NCT05137236|581421379|FG006|Part A|Withdrawal by Subject|0|||
161009408|NCT05137236|581421380|FG007|Part A|Withdrawal by Subject|0|||
161009409|NCT05137236|581421373|FG000|Part A|Lost to Follow-up|5|||
161009410|NCT05137236|581421374|FG001|Part A|Lost to Follow-up|7|||
161009411|NCT05137236|581421375|FG002|Part A|Lost to Follow-up|1|||
161009412|NCT05137236|581421376|FG003|Part A|Lost to Follow-up|3|||
161009413|NCT05137236|581421377|FG004|Part A|Lost to Follow-up|3|||
161009414|NCT05137236|581421378|FG005|Part A|Lost to Follow-up|8|||
161009415|NCT05137236|581421379|FG006|Part A|Lost to Follow-up|0|||
161009416|NCT05137236|581421380|FG007|Part A|Lost to Follow-up|0|||
161009417|NCT05137236|581421373|FG000|Part B|Withdrawal by Subject|0|||
161009418|NCT05137236|581421374|FG001|Part B|Withdrawal by Subject|0|||
161009419|NCT05137236|581421375|FG002|Part B|Withdrawal by Subject|0|||
161009420|NCT05137236|581421376|FG003|Part B|Withdrawal by Subject|0|||
161009421|NCT05137236|581421377|FG004|Part B|Withdrawal by Subject|0|||
161009422|NCT05137236|581421378|FG005|Part B|Withdrawal by Subject|0|||
161009423|NCT05137236|581421379|FG006|Part B|Withdrawal by Subject|0|||
161009424|NCT05137236|581421380|FG007|Part B|Withdrawal by Subject|2|||
161009425|NCT05137236|581421373|FG000|Part B|Lost to Follow-up|0|||
161009426|NCT05137236|581421374|FG001|Part B|Lost to Follow-up|0|||
161009427|NCT05137236|581421375|FG002|Part B|Lost to Follow-up|0|||
161009428|NCT05137236|581421376|FG003|Part B|Lost to Follow-up|0|||
161009429|NCT05137236|581421377|FG004|Part B|Lost to Follow-up|0|||
161009430|NCT05137236|581421378|FG005|Part B|Lost to Follow-up|0|||
161009431|NCT05137236|581421379|FG006|Part B|Lost to Follow-up|5|||
161009432|NCT05137236|581421380|FG007|Part B|Lost to Follow-up|5|||
161009433|NCT05137236|581421373|FG000|Part B|Death|0|||
161009434|NCT05137236|581421374|FG001|Part B|Death|0|||
161009435|NCT05137236|581421375|FG002|Part B|Death|0|||
161009436|NCT05137236|581421376|FG003|Part B|Death|0|||
161009437|NCT05137236|581421377|FG004|Part B|Death|0|||
161009438|NCT05137236|581421378|FG005|Part B|Death|0|||
161009439|NCT05137236|581421379|FG006|Part B|Death|0|||
161009440|NCT05137236|581421380|FG007|Part B|Death|2|||
161009441|NCT01534494|581421381|FG000|Overall Study|Withdrawal by Subject|1|||
161009442|NCT00802464|581421382|FG000|Month 0 - Month 8|Adverse Event|0|||
161009443|NCT00802464|581421383|FG001|Month 0 - Month 8|Adverse Event|1|||
161009444|NCT00802464|581421384|FG002|Month 0 - Month 8|Adverse Event|1|||
161009445|NCT00802464|581421385|FG003|Month 0 - Month 8|Adverse Event|2|||
161009446|NCT00802464|581421382|FG000|Month 0 - Month 8|Protocol Violation|0|||
161009447|NCT00802464|581421383|FG001|Month 0 - Month 8|Protocol Violation|0|||
161009448|NCT00802464|581421384|FG002|Month 0 - Month 8|Protocol Violation|1|||
160458733|NCT06037668|579412640|FG000|Overall Study|Withdrawal by Subject|1|||
161009449|NCT00802464|581421385|FG003|Month 0 - Month 8|Protocol Violation|0|||
161009450|NCT00802464|581421382|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
161009451|NCT00802464|581421383|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
161009452|NCT00802464|581421384|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
161009453|NCT00802464|581421385|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
161009454|NCT00802464|581421382|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
161009455|NCT00802464|581421383|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
161009456|NCT00802464|581421384|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
160458734|NCT06037668|579412641|FG001|Overall Study|Withdrawal by Subject|0|||
161009457|NCT00802464|581421385|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
161009458|NCT00802464|581421382|FG000|Month 0 - Month 8|Other|0|||
161009459|NCT00802464|581421383|FG001|Month 0 - Month 8|Other|0|||
161009460|NCT00802464|581421384|FG002|Month 0 - Month 8|Other|1|||
161009461|NCT00802464|581421385|FG003|Month 0 - Month 8|Other|0|||
161009462|NCT00802464|581421382|FG000|Month 8 - Month 14|Adverse Event|0|||
161009463|NCT00802464|581421383|FG001|Month 8 - Month 14|Adverse Event|1|||
161009464|NCT00802464|581421384|FG002|Month 8 - Month 14|Adverse Event|0|||
161009465|NCT00802464|581421385|FG003|Month 8 - Month 14|Adverse Event|0|||
161009466|NCT00802464|581421382|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
161009467|NCT00802464|581421383|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
161009468|NCT00802464|581421384|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
161009469|NCT00802464|581421385|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
161009470|NCT00802464|581421382|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
161009471|NCT00802464|581421383|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
161009472|NCT00802464|581421384|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
161009473|NCT00802464|581421385|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
161009474|NCT00402246|581421386|FG000|Overall Study|Death|62|||
161009475|NCT00402246|581421387|FG001|Overall Study|Death|58|||
161009476|NCT00402246|581421386|FG000|Overall Study|Lost to Follow-up|20|||
161009477|NCT00402246|581421387|FG001|Overall Study|Lost to Follow-up|28|||
161009478|NCT00402246|581421386|FG000|Overall Study|Withdrawal by Subject|72|||
161009479|NCT00402246|581421387|FG001|Overall Study|Withdrawal by Subject|87|||
161009480|NCT00402246|581421386|FG000|Overall Study|Physician Decision|24|||
161009481|NCT00402246|581421387|FG001|Overall Study|Physician Decision|26|||
161009482|NCT00402246|581421386|FG000|Overall Study|Protocol Violation|25|||
161009483|NCT00402246|581421387|FG001|Overall Study|Protocol Violation|24|||
161009484|NCT00402246|581421386|FG000|Overall Study|Missed Final Visit|1|||
161009485|NCT00402246|581421387|FG001|Overall Study|Missed Final Visit|2|||
161009486|NCT00402246|581421386|FG000|Overall Study|Insurance Issues|2|||
161009487|NCT00402246|581421387|FG001|Overall Study|Insurance Issues|1|||
161009488|NCT00402246|581421386|FG000|Overall Study|Heart Transplant|0|||
161009489|NCT00402246|581421387|FG001|Overall Study|Heart Transplant|1|||
161009490|NCT00402246|581421386|FG000|Overall Study|Patient's device explanted|6|||
161009491|NCT00402246|581421387|FG001|Overall Study|Patient's device explanted|2|||
161009492|NCT00402246|581421386|FG000|Overall Study|Center Closure|5|||
161009493|NCT00402246|581421387|FG001|Overall Study|Center Closure|3|||
161009494|NCT00402246|581421386|FG000|Overall Study|Deterioriating Condition|3|||
161009495|NCT00402246|581421387|FG001|Overall Study|Deterioriating Condition|2|||
161009496|NCT02622568|581421397|FG000|Overall Study|Lost to Follow-up|5|||
161009497|NCT02622568|581421398|FG001|Overall Study|Lost to Follow-up|5|||
161009498|NCT01939899|581421399|FG000|Lead-in Dose Finding Phase|Death|0|||
161009499|NCT01939899|581421400|FG001|Lead-in Dose Finding Phase|Death|3|||
161009500|NCT01939899|581421401|FG002|Lead-in Dose Finding Phase|Death|1|||
161009501|NCT01939899|581421402|FG003|Lead-in Dose Finding Phase|Death|0|||
161009502|NCT01939899|581421403|FG004|Lead-in Dose Finding Phase|Death|0|||
161009503|NCT01939899|581421399|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
161009504|NCT01939899|581421400|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
161009505|NCT01939899|581421401|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
161009506|NCT01939899|581421402|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
161009507|NCT01939899|581421403|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
161009508|NCT01939899|581421399|FG000|Lead-in Dose Finding Phase|Other|0|||
161009509|NCT01939899|581421400|FG001|Lead-in Dose Finding Phase|Other|0|||
161009510|NCT01939899|581421401|FG002|Lead-in Dose Finding Phase|Other|1|||
161009511|NCT01939899|581421402|FG003|Lead-in Dose Finding Phase|Other|0|||
161009512|NCT01939899|581421403|FG004|Lead-in Dose Finding Phase|Other|0|||
161009513|NCT01939899|581421399|FG000|Phase 2|Withdrawal by Subject|0|||
161009514|NCT01939899|581421400|FG001|Phase 2|Withdrawal by Subject|0|||
161009515|NCT01939899|581421401|FG002|Phase 2|Withdrawal by Subject|0|||
161009516|NCT01939899|581421402|FG003|Phase 2|Withdrawal by Subject|2|||
161009517|NCT01939899|581421403|FG004|Phase 2|Withdrawal by Subject|0|||
161009518|NCT01939899|581421399|FG000|Phase 2|Disease Progression|0|||
161009519|NCT01939899|581421400|FG001|Phase 2|Disease Progression|0|||
161009520|NCT01939899|581421401|FG002|Phase 2|Disease Progression|0|||
161009521|NCT01939899|581421402|FG003|Phase 2|Disease Progression|9|||
161009522|NCT01939899|581421403|FG004|Phase 2|Disease Progression|1|||
161009523|NCT02015520|581421406|FG000|Overall Study|Lack of Efficacy|1|||
161009524|NCT02015520|581421407|FG001|Overall Study|Lack of Efficacy|0|||
161009525|NCT02015520|581421408|FG002|Overall Study|Lack of Efficacy|3|||
161009526|NCT02015520|581421409|FG003|Overall Study|Lack of Efficacy|2|||
161009527|NCT02015520|581421406|FG000|Overall Study|Adverse Event|0|||
161009528|NCT02015520|581421407|FG001|Overall Study|Adverse Event|0|||
160458735|NCT06037668|579412640|FG000|Overall Study|Other Study Discontinuation Reason|1|||
160458736|NCT06037668|579412641|FG001|Overall Study|Other Study Discontinuation Reason|0|||
160458737|NCT04804540|579412642|FG000|Overall Study|Adverse Event|26|||
161009529|NCT02015520|581421408|FG002|Overall Study|Adverse Event|0|||
161009530|NCT02015520|581421409|FG003|Overall Study|Adverse Event|1|||
161009531|NCT02015520|581421406|FG000|Overall Study|Withdrawal by Subject|2|||
161009532|NCT02015520|581421407|FG001|Overall Study|Withdrawal by Subject|2|||
161009533|NCT02015520|581421408|FG002|Overall Study|Withdrawal by Subject|1|||
161009534|NCT02015520|581421409|FG003|Overall Study|Withdrawal by Subject|0|||
161009535|NCT02015520|581421406|FG000|Overall Study|Death|1|||
161009536|NCT02015520|581421407|FG001|Overall Study|Death|0|||
161009537|NCT02015520|581421408|FG002|Overall Study|Death|0|||
161009538|NCT02015520|581421409|FG003|Overall Study|Death|0|||
161009539|NCT02015520|581421406|FG000|Overall Study|Lost to Follow-up|0|||
161009540|NCT02015520|581421407|FG001|Overall Study|Lost to Follow-up|0|||
161009541|NCT02015520|581421408|FG002|Overall Study|Lost to Follow-up|1|||
161009542|NCT02015520|581421409|FG003|Overall Study|Lost to Follow-up|0|||
161009543|NCT02015520|581421406|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
161009544|NCT02015520|581421407|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
160458738|NCT04804540|579412643|FG001|Overall Study|Adverse Event|13|||
160458739|NCT05172232|579412644|FG000|Overall Study|Lost to Follow-up|3|||
160458740|NCT02473445|579412645|FG000|Overall Study|Withdrawal by Subject|2|||
160458741|NCT02473445|579412645|FG000|Overall Study|Sponsor Decision|20|||
160458742|NCT04881461|579412646|FG000|Overall Study|Adverse Event|2|||
161009545|NCT02015520|581421408|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
161009546|NCT02015520|581421409|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
161009547|NCT02015520|581421406|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
161009548|NCT02015520|581421407|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
161009549|NCT02015520|581421408|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
161009550|NCT02015520|581421409|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
161009551|NCT01854385|581421411|FG000|Pre-Treatment|Withdrawal by Subject|4|||
161009552|NCT01854385|581421411|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
161009553|NCT01854385|581421411|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
161009554|NCT01854385|581421411|FG000|Pre-Treatment|Unable to come for study visits|1|||
161009555|NCT01854385|581421411|FG000|Treatment|Lost to Follow-up|1|||
161009556|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
161009557|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
161009558|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
161009559|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
161009560|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
161009561|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161009562|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161009563|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
161009564|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161009565|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161009566|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
161009567|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
161009568|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
161009569|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
161009570|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
161009571|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
161009572|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
161009573|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
161009574|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
161009575|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
161009576|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
161009577|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
161009578|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
161009579|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
161009580|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
161009581|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161009582|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161009583|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
161009584|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161009585|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161009586|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161009587|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
161009588|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161009589|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161009590|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161009591|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
161009592|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
161009593|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
161009594|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
161009595|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
161009596|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
160585538|NCT01401010|579861956|FG001|Overall Study|Could not interpret assay results|0|||
160458743|NCT04881461|579412647|FG001|Overall Study|Adverse Event|4|||
160458744|NCT04881461|579412646|FG000|Overall Study|Withdrawal by Subject|19|||
161009597|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
160585539|NCT04285346|579861957|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
160585540|NCT04285346|579861958|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
160585541|NCT04285346|579861957|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
160585542|NCT04285346|579861958|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161009598|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
161009599|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
161009600|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
161009601|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
161009602|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
161009603|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
161009604|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
161009605|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
161009606|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
161009607|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
161009608|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
161009609|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
161009610|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
161009611|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
161009612|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
161009613|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
161009614|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
161009615|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
161009616|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
161009617|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
161009618|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
161009619|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
161009620|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
161009621|NCT00508924|581421419|FG000|Overall Study|Protocol Violation|0|||
161009622|NCT00508924|581421420|FG001|Overall Study|Protocol Violation|0|||
161009623|NCT00508924|581421421|FG002|Overall Study|Protocol Violation|1|||
161009624|NCT00508924|581421422|FG003|Overall Study|Protocol Violation|1|||
161009625|NCT00630058|581421423|FG000|Overall Study|Adverse Event|1|||
161009626|NCT00630058|581421424|FG001|Overall Study|Adverse Event|1|||
161009627|NCT00630058|581421423|FG000|Overall Study|Withdrawal by Subject|0|||
161009628|NCT00630058|581421424|FG001|Overall Study|Withdrawal by Subject|1|||
161009629|NCT00630058|581421423|FG000|Overall Study|stopping criteria|3|||
161009630|NCT00630058|581421424|FG001|Overall Study|stopping criteria|2|||
161009631|NCT00415519|581421429|FG000|Overall Study|Adverse Event|1|||
161009632|NCT00415519|581421430|FG001|Overall Study|Adverse Event|0|||
161009633|NCT00415519|581421429|FG000|Overall Study|Withdrawal by Subject|2|||
161009634|NCT00415519|581421430|FG001|Overall Study|Withdrawal by Subject|0|||
161009635|NCT00415519|581421429|FG000|Overall Study|Patient's convenience|1|||
161009636|NCT00415519|581421430|FG001|Overall Study|Patient's convenience|0|||
161009637|NCT04163718|581421431|FG000|Overall Study|Study terminated|12|||
161009638|NCT04872738|581421432|FG000|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|152|||
161009639|NCT04872738|581421433|FG001|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|15|||
161009640|NCT02924064|581421436|FG000|Overall Study|Adverse Event|2|||
161009641|NCT02924064|581421437|FG001|Overall Study|Adverse Event|2|||
161009642|NCT02924064|581421436|FG000|Overall Study|Lost to Follow-up|0|||
161009643|NCT02924064|581421437|FG001|Overall Study|Lost to Follow-up|2|||
161009644|NCT02924064|581421436|FG000|Overall Study|Physician Decision|0|||
161009645|NCT02924064|581421437|FG001|Overall Study|Physician Decision|2|||
161009646|NCT02924064|581421436|FG000|Overall Study|Protocol Violation|1|||
161009647|NCT02924064|581421437|FG001|Overall Study|Protocol Violation|3|||
161009648|NCT02924064|581421436|FG000|Overall Study|Withdrawal by Subject|4|||
161009649|NCT02924064|581421437|FG001|Overall Study|Withdrawal by Subject|5|||
161009650|NCT02924064|581421436|FG000|Overall Study|Other|17|||
161009651|NCT02924064|581421437|FG001|Overall Study|Other|29|||
161009652|NCT00529100|581421440|FG000|Overall Study|Adverse Event|0|||
161009653|NCT00529100|581421441|FG001|Overall Study|Adverse Event|5|||
161009654|NCT00529100|581421440|FG000|Overall Study|Protocol Violation|0|||
160585543|NCT04285346|579861957|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
161009655|NCT00529100|581421441|FG001|Overall Study|Protocol Violation|1|||
161009656|NCT00529100|581421440|FG000|Overall Study|Progressive Disease|0|||
161009657|NCT00529100|581421441|FG001|Overall Study|Progressive Disease|1|||
161009658|NCT00529100|581421440|FG000|Overall Study|Withdrawal by Subject|0|||
161009659|NCT00529100|581421441|FG001|Overall Study|Withdrawal by Subject|1|||
161009660|NCT00529100|581421440|FG000|Overall Study|Participant Ineligibility|0|||
161009661|NCT00529100|581421441|FG001|Overall Study|Participant Ineligibility|1|||
161009662|NCT05524454|581421443|FG000|Overall Study|Withdrawal by Subject|1|||
161009663|NCT05999435|581421444|FG000|Overall Study|Adverse Event|1|||
161009664|NCT05999435|581421445|FG001|Overall Study|Adverse Event|0|||
161009665|NCT05999435|581421446|FG002|Overall Study|Adverse Event|0|||
161009666|NCT05999435|581421444|FG000|Overall Study|Withdrawal by Subject|2|||
161009667|NCT05999435|581421445|FG001|Overall Study|Withdrawal by Subject|1|||
161009668|NCT05999435|581421446|FG002|Overall Study|Withdrawal by Subject|0|||
161009669|NCT05054725|581421450|FG000|Overall Study|Withdrawal by Subject|3|||
161009670|NCT05054725|581421451|FG001|Overall Study|Withdrawal by Subject|4|||
161009671|NCT05054725|581421450|FG000|Overall Study|Sponsor's Decision to Terminate the Study|0|||
161009672|NCT05054725|581421451|FG001|Overall Study|Sponsor's Decision to Terminate the Study|3|||
161009673|NCT05054725|581421450|FG000|Overall Study|Death|1|||
161009674|NCT05054725|581421451|FG001|Overall Study|Death|21|||
161009675|NCT05054725|581421450|FG000|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|0|||
161009676|NCT05054725|581421451|FG001|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|3|||
161009677|NCT05054725|581421450|FG000|Overall Study|PI's decision that there is no benefit from LTFU|0|||
161009678|NCT05054725|581421451|FG001|Overall Study|PI's decision that there is no benefit from LTFU|6|||
161009679|NCT05054725|581421450|FG000|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|0|||
161009680|NCT05054725|581421451|FG001|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|1|||
161009681|NCT05054725|581421450|FG000|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|0|||
161009682|NCT05054725|581421451|FG001|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|1|||
161009683|NCT05054725|581421450|FG000|Overall Study|Physician discretion due to subject progression|0|||
161009684|NCT05054725|581421451|FG001|Overall Study|Physician discretion due to subject progression|1|||
161009685|NCT03674411|581421452|FG000|Overall Study|Non-treatment|4|||
161009686|NCT03674411|581421453|FG001|Overall Study|Non-treatment|0|||
161009687|NCT00781274|581421455|FG000|Overall Study|Withdrawal by Subject|2|||
161009688|NCT04705480|581421457|FG000|Overall Study|Withdrawal by Subject|1|||
160458745|NCT04881461|579412647|FG001|Overall Study|Withdrawal by Subject|19|||
160458746|NCT04881461|579412646|FG000|Overall Study|Lost to Follow-up|4|||
160458747|NCT04881461|579412647|FG001|Overall Study|Lost to Follow-up|4|||
160458748|NCT04881461|579412646|FG000|Overall Study|Lack of Efficacy|1|||
160458749|NCT04881461|579412647|FG001|Overall Study|Lack of Efficacy|0|||
160458750|NCT04881461|579412646|FG000|Overall Study|"Reason stated as other in CRF"|1|||
160458751|NCT04881461|579412647|FG001|Overall Study|"Reason stated as other in CRF"|2|||
160585544|NCT04285346|579861958|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
160585545|NCT00610935|579861959|FG000|Overall Study|Lost to Follow-up|0|||
160967110|NCT00755222|581268146|FG000|Overall Study|Protocol Violation|2|||
160967111|NCT00755222|581268147|FG001|Overall Study|Protocol Violation|0|||
160967112|NCT01337986|581268150|FG000|Overall Study|Adverse Event|2|||
160967113|NCT01337986|581268151|FG001|Overall Study|Adverse Event|2|||
160967114|NCT01337986|581268150|FG000|Overall Study|Lost to Follow-up|1|||
160967115|NCT01337986|581268151|FG001|Overall Study|Lost to Follow-up|0|||
160967116|NCT01337986|581268150|FG000|Overall Study|Protocol Violation|0|||
160967117|NCT01337986|581268151|FG001|Overall Study|Protocol Violation|3|||
160967118|NCT03430063|581268152|FG000|Overall Study|Adverse Event|0|||
160967119|NCT03430063|581268153|FG001|Overall Study|Adverse Event|1|||
160967120|NCT03430063|581268154|FG002|Overall Study|Adverse Event|0|||
160967121|NCT03430063|581268152|FG000|Overall Study|Death|3|||
160967122|NCT03430063|581268153|FG001|Overall Study|Death|2|||
160967123|NCT03430063|581268154|FG002|Overall Study|Death|3|||
160967124|NCT03430063|581268152|FG000|Overall Study|Lost to Follow-up|0|||
160967125|NCT03430063|581268153|FG001|Overall Study|Lost to Follow-up|1|||
160967126|NCT03430063|581268154|FG002|Overall Study|Lost to Follow-up|0|||
160967127|NCT03430063|581268152|FG000|Overall Study|Withdrawal by Subject|0|||
160967128|NCT03430063|581268153|FG001|Overall Study|Withdrawal by Subject|0|||
160967129|NCT03430063|581268154|FG002|Overall Study|Withdrawal by Subject|1|||
160967130|NCT03430063|581268152|FG000|Overall Study|Withdrawal of consent|3|||
160967131|NCT03430063|581268153|FG001|Overall Study|Withdrawal of consent|1|||
160967132|NCT03430063|581268154|FG002|Overall Study|Withdrawal of consent|2|||
160967133|NCT03430063|581268152|FG000|Overall Study|Progressive disease|1|||
160967134|NCT03430063|581268153|FG001|Overall Study|Progressive disease|2|||
161009689|NCT04705480|581421458|FG001|Overall Study|Withdrawal by Subject|0|||
161009690|NCT04705480|581421459|FG002|Overall Study|Withdrawal by Subject|1|||
161009691|NCT04705480|581421457|FG000|Overall Study|Protocol Violation|2|||
161009692|NCT04705480|581421458|FG001|Overall Study|Protocol Violation|0|||
161009693|NCT04705480|581421459|FG002|Overall Study|Protocol Violation|2|||
161009694|NCT04705480|581421457|FG000|Overall Study|Decision to discharge before intervention|2|||
161009695|NCT04705480|581421458|FG001|Overall Study|Decision to discharge before intervention|0|||
161009696|NCT04705480|581421459|FG002|Overall Study|Decision to discharge before intervention|0|||
161009697|NCT00861692|581421460|FG000|Overall Study|Death|6|||
161009698|NCT06429163|581421461|FG000|Overall Study|uterine fibroid type 7|1|||
161009699|NCT06429163|581421462|FG001|Overall Study|uterine fibroid type 7|1|||
161009700|NCT06429163|581421463|FG002|Overall Study|uterine fibroid type 7|1|||
161009701|NCT06429163|581421461|FG000|Overall Study|severe adhesions|1|||
161009702|NCT06429163|581421462|FG001|Overall Study|severe adhesions|2|||
161009703|NCT06429163|581421463|FG002|Overall Study|severe adhesions|1|||
161009704|NCT06429163|581421461|FG000|Overall Study|conversion to laparotomy|0|||
161009705|NCT06429163|581421462|FG001|Overall Study|conversion to laparotomy|1|||
161009706|NCT06429163|581421463|FG002|Overall Study|conversion to laparotomy|0|||
161009707|NCT06429163|581421461|FG000|Overall Study|concomitant procedure|1|||
161009708|NCT06429163|581421462|FG001|Overall Study|concomitant procedure|0|||
161009709|NCT06429163|581421463|FG002|Overall Study|concomitant procedure|0|||
161009710|NCT04970654|581421464|FG000|Overall Study|Withdrawal by parents/guardian|1|||
161009711|NCT04970654|581421465|FG001|Overall Study|Withdrawal by parents/guardian|2|||
161009712|NCT04970654|581421464|FG000|Overall Study|Unclassified|2|||
161009713|NCT04970654|581421465|FG001|Overall Study|Unclassified|1|||
161009714|NCT04970654|581421464|FG000|Overall Study|Lost to Follow-up|1|||
161009715|NCT04970654|581421465|FG001|Overall Study|Lost to Follow-up|0|||
161009716|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Adverse Event|1|||
161009717|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Adverse Event|6|||
161009718|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Adverse Event|2|||
161009719|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Adverse Event|1|||
161009720|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Adverse Event|0|||
161009721|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Adverse Event|0|||
161009722|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Withdrawal by Subject|0|||
161009723|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Withdrawal by Subject|3|||
161009724|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Withdrawal by Subject|3|||
161009725|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Withdrawal by Subject|3|||
161009726|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Withdrawal by Subject|0|||
161009727|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Withdrawal by Subject|0|||
161009728|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Lost to Follow-up|0|||
161009729|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Lost to Follow-up|2|||
161009730|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Lost to Follow-up|0|||
161009731|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Lost to Follow-up|2|||
161009732|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Lost to Follow-up|0|||
161009733|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Lost to Follow-up|0|||
161009734|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Physician Decision|0|||
161009735|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Physician Decision|2|||
161009736|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Physician Decision|0|||
161009737|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Physician Decision|0|||
161009738|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Physician Decision|0|||
161009739|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Physician Decision|0|||
161009740|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Protocol Violation|0|||
161009741|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Protocol Violation|0|||
161009742|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Protocol Violation|1|||
161009743|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Protocol Violation|0|||
161009744|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Protocol Violation|0|||
161009745|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Protocol Violation|0|||
161009746|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Randomized in error|0|||
161009747|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Randomized in error|1|||
161009748|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Randomized in error|0|||
161009749|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Randomized in error|2|||
161009750|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Randomized in error|0|||
161009751|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Randomized in error|0|||
161009752|NCT04929483|581421466|FG000|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161009753|NCT04929483|581421467|FG001|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161009754|NCT04929483|581421468|FG002|Extension Study (24 Weeks)|Withdrawal by Subject|3|||
161009755|NCT04929483|581421469|FG003|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161009756|NCT04929483|581421470|FG004|Extension Study (24 Weeks)|Withdrawal by Subject|2|||
161009757|NCT04929483|581421471|FG005|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161009758|NCT04929483|581421466|FG000|Extension Study (24 Weeks)|Lost to Follow-up|0|||
161009759|NCT04929483|581421467|FG001|Extension Study (24 Weeks)|Lost to Follow-up|1|||
161009760|NCT04929483|581421468|FG002|Extension Study (24 Weeks)|Lost to Follow-up|1|||
161009761|NCT04929483|581421469|FG003|Extension Study (24 Weeks)|Lost to Follow-up|0|||
161009762|NCT04929483|581421470|FG004|Extension Study (24 Weeks)|Lost to Follow-up|1|||
161009763|NCT04929483|581421471|FG005|Extension Study (24 Weeks)|Lost to Follow-up|0|||
161009764|NCT04929483|581421466|FG000|Extension Study (24 Weeks)|Other than specified|1|||
161009765|NCT04929483|581421467|FG001|Extension Study (24 Weeks)|Other than specified|0|||
161009766|NCT04929483|581421468|FG002|Extension Study (24 Weeks)|Other than specified|1|||
161009767|NCT04929483|581421469|FG003|Extension Study (24 Weeks)|Other than specified|0|||
161009768|NCT04929483|581421470|FG004|Extension Study (24 Weeks)|Other than specified|1|||
161009769|NCT04929483|581421471|FG005|Extension Study (24 Weeks)|Other than specified|0|||
161009770|NCT04929483|581421466|FG000|Extension Study (24 Weeks)|Adverse Event|0|||
161009771|NCT04929483|581421467|FG001|Extension Study (24 Weeks)|Adverse Event|2|||
161009772|NCT04929483|581421468|FG002|Extension Study (24 Weeks)|Adverse Event|3|||
161009773|NCT04929483|581421469|FG003|Extension Study (24 Weeks)|Adverse Event|0|||
161009774|NCT04929483|581421470|FG004|Extension Study (24 Weeks)|Adverse Event|0|||
161009775|NCT04929483|581421471|FG005|Extension Study (24 Weeks)|Adverse Event|0|||
161009776|NCT01626885|581421472|FG000|Overall Study|Adverse Event|8|||
161009777|NCT01626885|581421472|FG000|Overall Study|Withdrawal by Subject|4|||
161009778|NCT04083781|581421479|FG000|Main Part|Physician Decision|0|||
161009779|NCT04083781|581421480|FG001|Main Part|Physician Decision|1|||
161009780|NCT04083781|581421481|FG002|Main Part|Physician Decision|2|||
161009781|NCT04083781|581421482|FG003|Main Part|Physician Decision|0|||
161009782|NCT04083781|581421479|FG000|Main Part|Death|1|||
161009783|NCT04083781|581421480|FG001|Main Part|Death|3|||
161009784|NCT04083781|581421481|FG002|Main Part|Death|1|||
161009785|NCT04083781|581421482|FG003|Main Part|Death|0|||
161009786|NCT04083781|581421479|FG000|Main Part|Withdrawal by Subject|5|||
161009787|NCT04083781|581421480|FG001|Main Part|Withdrawal by Subject|2|||
161009788|NCT04083781|581421481|FG002|Main Part|Withdrawal by Subject|3|||
161009789|NCT04083781|581421482|FG003|Main Part|Withdrawal by Subject|7|||
161009790|NCT04083781|581421479|FG000|Extension Part|Physician Decision|0|||
161009791|NCT04083781|581421480|FG001|Extension Part|Physician Decision|0|||
161009792|NCT04083781|581421481|FG002|Extension Part|Physician Decision|0|||
161009793|NCT04083781|581421482|FG003|Extension Part|Physician Decision|1|||
161009794|NCT04083781|581421479|FG000|Extension Part|Death|0|||
161009795|NCT04083781|581421480|FG001|Extension Part|Death|1|||
161009796|NCT04083781|581421481|FG002|Extension Part|Death|0|||
161009797|NCT04083781|581421482|FG003|Extension Part|Death|1|||
161009798|NCT04083781|581421479|FG000|Extension Part|Withdrawal by Subject|0|||
161009799|NCT04083781|581421480|FG001|Extension Part|Withdrawal by Subject|1|||
161009800|NCT04083781|581421481|FG002|Extension Part|Withdrawal by Subject|0|||
161009801|NCT04083781|581421482|FG003|Extension Part|Withdrawal by Subject|0|||
161009802|NCT04083781|581421479|FG000|Extension Part|Ongoing|13|||
161009803|NCT04083781|581421480|FG001|Extension Part|Ongoing|25|||
161009804|NCT04083781|581421481|FG002|Extension Part|Ongoing|15|||
161009805|NCT04083781|581421482|FG003|Extension Part|Ongoing|51|||
161009806|NCT01466192|581421483|FG000|Overall Study|Physician Decision|1|||
161009807|NCT01466192|581421483|FG000|Overall Study|Withdrawal by Subject|3|||
161009808|NCT05600283|581421484|FG000|Overall Study|Withdrawal by Subject|3|||
161009809|NCT05600283|581421485|FG001|Overall Study|Withdrawal by Subject|8|||
161009810|NCT05600283|581421484|FG000|Overall Study|Invalid Vaginal Swab|2|||
161009811|NCT05600283|581421485|FG001|Overall Study|Invalid Vaginal Swab|2|||
161009812|NCT05600283|581421484|FG000|Overall Study|Missing Clinician Collection|3|||
161009813|NCT05600283|581421485|FG001|Overall Study|Missing Clinician Collection|6|||
161009814|NCT05600283|581421484|FG000|Overall Study|Screen Failure|1|||
161009815|NCT05600283|581421485|FG001|Overall Study|Screen Failure|2|||
161009816|NCT05600283|581421484|FG000|Overall Study|Sample Lost in Transit|1|||
161009817|NCT05600283|581421485|FG001|Overall Study|Sample Lost in Transit|0|||
161009818|NCT00068601|581421486|FG000|Overall Study|Ineligible|11|||
161009819|NCT00068601|581421487|FG001|Overall Study|Ineligible|13|||
161009820|NCT00068601|581421486|FG000|Overall Study|Not evaluable: withdrew consent|5|||
161009821|NCT00068601|581421487|FG001|Overall Study|Not evaluable: withdrew consent|4|||
161009822|NCT00068601|581421486|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
161009823|NCT00068601|581421487|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
161009824|NCT00068601|581421486|FG000|Overall Study|Death|11|||
161009825|NCT00068601|581421487|FG001|Overall Study|Death|3|||
161009826|NCT00068601|581421486|FG000|Overall Study|Lost to Follow-up|3|||
161009827|NCT00068601|581421487|FG001|Overall Study|Lost to Follow-up|2|||
161009828|NCT00068601|581421486|FG000|Overall Study|Missing primary outcome data|30|||
161009829|NCT00068601|581421487|FG001|Overall Study|Missing primary outcome data|34|||
161009830|NCT02468128|581421488|FG000|Overall Study|Protocol Violation|6|||
161009831|NCT02468128|581421489|FG001|Overall Study|Protocol Violation|6|||
161009832|NCT00440011|581421493|FG000|Overall Study|Adverse Event|2|||
161009833|NCT00440011|581421494|FG001|Overall Study|Adverse Event|0|||
161009834|NCT00440011|581421493|FG000|Overall Study|Lost to Follow-up|0|||
161009835|NCT00440011|581421494|FG001|Overall Study|Lost to Follow-up|2|||
161009836|NCT00440011|581421493|FG000|Overall Study|Protocol Violation|1|||
160458752|NCT04629339|579412651|FG000|Overall Study|Death|1|||
161009837|NCT00440011|581421494|FG001|Overall Study|Protocol Violation|1|||
161009838|NCT00440011|581421493|FG000|Overall Study|Withdrawal by Subject|1|||
160458753|NCT04629339|579412652|FG001|Overall Study|Death|0|||
160458754|NCT04629339|579412653|FG002|Overall Study|Death|2|||
161009839|NCT00440011|581421494|FG001|Overall Study|Withdrawal by Subject|0|||
161009840|NCT00621296|581421495|FG000|Overall Study|Adverse Event|2|||
161009841|NCT00621296|581421495|FG000|Overall Study|Lack of Efficacy|1|||
161009842|NCT00621296|581421495|FG000|Overall Study|Physician Decision|7|||
161009843|NCT00621296|581421495|FG000|Overall Study|Unmatch Criteria|1|||
161009844|NCT00621296|581421495|FG000|Overall Study|Stopping Criteria|3|||
161009845|NCT04166058|581421496|FG000|Overall Study|Adverse Event|1|||
161009846|NCT04166058|581421497|FG001|Overall Study|Adverse Event|1|||
161009847|NCT04166058|581421498|FG002|Overall Study|Adverse Event|0|||
161009848|NCT04166058|581421499|FG003|Overall Study|Adverse Event|0|||
161009849|NCT04166058|581421496|FG000|Overall Study|Withdrawal by Subject|4|||
160458755|NCT04629339|579412654|FG003|Overall Study|Death|2|||
161009850|NCT04166058|581421497|FG001|Overall Study|Withdrawal by Subject|4|||
161009851|NCT04166058|581421498|FG002|Overall Study|Withdrawal by Subject|1|||
161009852|NCT04166058|581421499|FG003|Overall Study|Withdrawal by Subject|10|||
161009853|NCT04166058|581421496|FG000|Overall Study|Lost to Follow-up|9|||
161009854|NCT04166058|581421497|FG001|Overall Study|Lost to Follow-up|2|||
161009855|NCT04166058|581421498|FG002|Overall Study|Lost to Follow-up|1|||
161009856|NCT04166058|581421499|FG003|Overall Study|Lost to Follow-up|1|||
161009857|NCT04166058|581421496|FG000|Overall Study|Pregnancy|1|||
161009858|NCT04166058|581421497|FG001|Overall Study|Pregnancy|0|||
161009859|NCT04166058|581421498|FG002|Overall Study|Pregnancy|0|||
161009860|NCT04166058|581421499|FG003|Overall Study|Pregnancy|0|||
161009861|NCT04166058|581421496|FG000|Overall Study|Physician Decision|2|||
161009862|NCT04166058|581421497|FG001|Overall Study|Physician Decision|0|||
161009863|NCT04166058|581421498|FG002|Overall Study|Physician Decision|0|||
161009864|NCT04166058|581421499|FG003|Overall Study|Physician Decision|2|||
161009865|NCT04166058|581421496|FG000|Overall Study|Protocol Violation|1|||
161009866|NCT04166058|581421497|FG001|Overall Study|Protocol Violation|0|||
161009867|NCT04166058|581421498|FG002|Overall Study|Protocol Violation|0|||
161009868|NCT04166058|581421499|FG003|Overall Study|Protocol Violation|0|||
161009869|NCT04166058|581421496|FG000|Overall Study|Lack of Efficacy|2|||
161009870|NCT04166058|581421497|FG001|Overall Study|Lack of Efficacy|0|||
161009871|NCT04166058|581421498|FG002|Overall Study|Lack of Efficacy|0|||
161009872|NCT04166058|581421499|FG003|Overall Study|Lack of Efficacy|0|||
161009873|NCT04166058|581421496|FG000|Overall Study|Other|1|||
161009874|NCT04166058|581421497|FG001|Overall Study|Other|0|||
161009875|NCT04166058|581421498|FG002|Overall Study|Other|0|||
161009876|NCT04166058|581421499|FG003|Overall Study|Other|1|||
161009877|NCT04166058|581421496|FG000|Overall Study|Non-compliance with study drug|0|||
161009878|NCT04166058|581421497|FG001|Overall Study|Non-compliance with study drug|0|||
161009879|NCT04166058|581421498|FG002|Overall Study|Non-compliance with study drug|0|||
161009880|NCT04166058|581421499|FG003|Overall Study|Non-compliance with study drug|2|||
161009881|NCT02998528|581421500|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
161009882|NCT02998528|581421501|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
161009883|NCT02998528|581421502|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
161009884|NCT02998528|581421500|FG000|Randomization Period|Participant withdrew consent|0|||
161009885|NCT02998528|581421501|FG001|Randomization Period|Participant withdrew consent|3|||
161009886|NCT02998528|581421502|FG002|Randomization Period|Participant withdrew consent|0|||
161009887|NCT02998528|581421500|FG000|Randomization Period|Participant no longer meets study criteria|1|||
161009888|NCT02998528|581421501|FG001|Randomization Period|Participant no longer meets study criteria|3|||
161009889|NCT02998528|581421502|FG002|Randomization Period|Participant no longer meets study criteria|2|||
161009890|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
161009891|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
161009892|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
161009893|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
161009894|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
161009895|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
161009896|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
161009897|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
161009898|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
161009899|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
161009900|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
161009901|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
160585546|NCT00610935|579861960|FG001|Overall Study|Lost to Follow-up|1|||
160585547|NCT00610935|579861959|FG000|Overall Study|Withdrawal by Subject|0|||
160967135|NCT03430063|581268154|FG002|Overall Study|Progressive disease|1|||
160967136|NCT03430063|581268152|FG000|Overall Study|Other un-specified|1|||
160967137|NCT03430063|581268153|FG001|Overall Study|Other un-specified|1|||
160967138|NCT03430063|581268154|FG002|Overall Study|Other un-specified|0|||
160967139|NCT03430063|581268152|FG000|Overall Study|Randomized, but never treated|0|||
160967140|NCT03430063|581268153|FG001|Overall Study|Randomized, but never treated|0|||
160967141|NCT03430063|581268154|FG002|Overall Study|Randomized, but never treated|1|||
160967142|NCT01287611|581268156|FG000|Overall Study|Lost to Follow-up|29|||
160967143|NCT01287611|581268157|FG001|Overall Study|Lost to Follow-up|16|||
160967144|NCT01287611|581268156|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
160967145|NCT01287611|581268157|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
160967146|NCT02192970|581268160|FG000|Overall Study|Lost to Follow-up|6|||
160967147|NCT02192970|581268161|FG001|Overall Study|Lost to Follow-up|0|||
161009902|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
161009903|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
161009904|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
161009905|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Death|1|||
161009906|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Death|0|||
161009907|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Death|0|||
161009908|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
160585548|NCT00610935|579861960|FG001|Overall Study|Withdrawal by Subject|2|||
160585549|NCT00610935|579861959|FG000|Overall Study|Sponsor Discontinuation|1|||
160585550|NCT00610935|579861960|FG001|Overall Study|Sponsor Discontinuation|0|||
160585551|NCT04360187|579861963|FG000|Double-Blind Treatment|Adverse Event|9|||
160585552|NCT04360187|579861964|FG001|Double-Blind Treatment|Adverse Event|11|||
160585553|NCT04360187|579861963|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
160585554|NCT04360187|579861964|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
160585555|NCT04360187|579861963|FG000|Double-Blind Treatment|Physician Decision|1|||
160585556|NCT04360187|579861964|FG001|Double-Blind Treatment|Physician Decision|0|||
160585557|NCT04360187|579861963|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
160585558|NCT04360187|579861964|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
160585559|NCT04360187|579861963|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
160585560|NCT04360187|579861964|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
160585561|NCT04360187|579861963|FG000|Follow-Up|Lost to Follow-up|1|||
160585562|NCT04360187|579861964|FG001|Follow-Up|Lost to Follow-up|0|||
160585563|NCT02203838|579861965|FG000|Overall Study|Lack of Efficacy|7|||
161009909|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
161009910|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
161009911|NCT02998528|581421500|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
161009912|NCT02998528|581421501|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
161009913|NCT02998528|581421502|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
161009914|NCT02998528|581421500|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
161009915|NCT02998528|581421501|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
161009916|NCT02998528|581421502|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
161009917|NCT02998528|581421500|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
161009918|NCT02998528|581421501|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
161009919|NCT02998528|581421502|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
161009920|NCT02998528|581421500|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
161009921|NCT02998528|581421501|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
161009922|NCT02998528|581421502|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
161009923|NCT02998528|581421500|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
161009924|NCT02998528|581421501|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
161009925|NCT02998528|581421502|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
161009926|NCT00591214|581421503|FG000|Overall Study|Physician Decision|7|||
161009927|NCT00591214|581421503|FG000|Overall Study|Withdrawal by Subject|1|||
161009928|NCT01753570|581421504|FG000|Overall Study|Adverse Event|1|||
161009929|NCT01753570|581421505|FG001|Overall Study|Adverse Event|0|||
161009930|NCT01753570|581421506|FG002|Overall Study|Adverse Event|1|||
161009931|NCT01753570|581421504|FG000|Overall Study|Physician Decision|0|||
161009932|NCT01753570|581421505|FG001|Overall Study|Physician Decision|1|||
161009933|NCT01753570|581421506|FG002|Overall Study|Physician Decision|0|||
161009934|NCT01753570|581421504|FG000|Overall Study|Withdrawal by Subject|1|||
161009935|NCT01753570|581421505|FG001|Overall Study|Withdrawal by Subject|4|||
161009936|NCT01753570|581421506|FG002|Overall Study|Withdrawal by Subject|0|||
161009937|NCT05308316|581421507|FG000|Overall Study|Withdrawal by Subject|2|||
161009938|NCT05308316|581421507|FG000|Overall Study|Physician Decision|1|||
161009939|NCT03103321|581422711|FG000|Overall Study|Protocol Violation|1|||
161009940|NCT03103321|581422712|FG001|Overall Study|Protocol Violation|1|||
161009941|NCT03103321|581422713|FG002|Overall Study|Protocol Violation|1|||
161009942|NCT03103321|581422714|FG003|Overall Study|Protocol Violation|0|||
161009943|NCT06375421|581422716|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
161009944|NCT06375421|581422717|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
161009945|NCT06375421|581422718|FG002|First Intervention (1 Week)|Withdrawal by Subject|1|||
161009946|NCT06375421|581422719|FG003|First Intervention (1 Week)|Withdrawal by Subject|0|||
161009947|NCT05760313|581422725|FG000|Overall Study|Withdrawal by Subject|0|||
161009948|NCT05760313|581422726|FG001|Overall Study|Withdrawal by Subject|0|||
161009949|NCT05760313|581422727|FG002|Overall Study|Withdrawal by Subject|1|||
161009950|NCT05760313|581422725|FG000|Overall Study|Other|1|||
161009951|NCT05760313|581422726|FG001|Overall Study|Other|0|||
161009952|NCT05760313|581422727|FG002|Overall Study|Other|0|||
160585564|NCT02203838|579861966|FG001|Overall Study|Lack of Efficacy|0|||
160585565|NCT02203838|579861967|FG002|Overall Study|Lack of Efficacy|1|||
160585566|NCT02203838|579861968|FG003|Overall Study|Lack of Efficacy|1|||
160585567|NCT02203838|579861965|FG000|Overall Study|Adverse Event|46|||
160585568|NCT02203838|579861966|FG001|Overall Study|Adverse Event|6|||
160585569|NCT02203838|579861967|FG002|Overall Study|Adverse Event|3|||
161009953|NCT00956007|581422728|FG000|Overall Study|Protocol Violation|27|||
161009954|NCT00956007|581422729|FG001|Overall Study|Protocol Violation|23|||
161009955|NCT05228470|581422730|FG000|Overall Study|Death|6|||
161009956|NCT05228470|581422731|FG001|Overall Study|Death|11|||
161009957|NCT05228470|581422730|FG000|Overall Study|Withdrawal by Subject|1|||
161009958|NCT05228470|581422731|FG001|Overall Study|Withdrawal by Subject|8|||
161009959|NCT05228470|581422730|FG000|Overall Study|Ongoing|1|||
161009960|NCT05228470|581422731|FG001|Overall Study|Ongoing|11|||
161009961|NCT03885037|581422732|FG000|Overall Study|Protocol Violation|16|||
161009962|NCT01492686|581422733|FG000|Double-blind Phase|Adverse Event|0|||
161009963|NCT01492686|581422734|FG001|Double-blind Phase|Adverse Event|2|||
161009964|NCT01492686|581422733|FG000|Double-blind Phase|Physician Decision|0|||
161009965|NCT01492686|581422734|FG001|Double-blind Phase|Physician Decision|1|||
161009966|NCT01492686|581422733|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161009967|NCT01492686|581422734|FG001|Double-blind Phase|Withdrawal by Subject|2|||
161009968|NCT01492686|581422733|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
161009969|NCT01492686|581422734|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
161009970|NCT01492686|581422733|FG000|Open-label Phase|Adverse Event|1|||
161009971|NCT01492686|581422734|FG001|Open-label Phase|Adverse Event|2|||
161009972|NCT01492686|581422733|FG000|Open-label Phase|Physician Decision|1|||
161009973|NCT01492686|581422734|FG001|Open-label Phase|Physician Decision|0|||
161009974|NCT01492686|581422733|FG000|Open-label Phase|Withdrawal by Subject|6|||
161009975|NCT01492686|581422734|FG001|Open-label Phase|Withdrawal by Subject|7|||
161009976|NCT01492686|581422733|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
161009977|NCT01492686|581422734|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
161009978|NCT03314987|581422737|FG000|Overall Study|Lost to Follow-up|13|||
161009979|NCT03314987|581422738|FG001|Overall Study|Lost to Follow-up|13|||
161009980|NCT05552963|581422739|FG000|Overall Study|Lost to Follow-up|1|||
161009981|NCT05552963|581422739|FG000|Overall Study|Study catheter was inserted, but PF energy was not delivered due to ECG interference|1|||
161009982|NCT00431834|581422742|FG000|Overall Study|Withdrawal by Subject|7|||
161009983|NCT00431834|581422742|FG000|Overall Study|Death|3|||
161009984|NCT00431834|581422742|FG000|Overall Study|Missed Endpoint Visit|2|||
161009985|NCT00431834|581422742|FG000|Overall Study|Lost to Follow-up|1|||
161009986|NCT05529979|581422745|FG000|Overall Study|Lost to Follow-up|6|||
161009987|NCT05529979|581422745|FG000|Overall Study|Physician Decision|1|||
161009988|NCT05529979|581422745|FG000|Overall Study|non-feasibility cases|4|||
161009989|NCT05529979|581422745|FG000|Overall Study|Lack of Efficacy|3|||
161009990|NCT05529979|581422745|FG000|Overall Study|ablation not performed|1|||
161009991|NCT04191499|581422746|FG000|Overall Study|Adverse Event|1|||
161009992|NCT04191499|581422747|FG001|Overall Study|Adverse Event|0|||
161009993|NCT04191499|581422746|FG000|Overall Study|Death|42|||
161009994|NCT04191499|581422747|FG001|Overall Study|Death|55|||
161009995|NCT04191499|581422746|FG000|Overall Study|Lost to Follow-up|4|||
161009996|NCT04191499|581422747|FG001|Overall Study|Lost to Follow-up|1|||
161009997|NCT04191499|581422746|FG000|Overall Study|Physician Decision|1|||
161009998|NCT04191499|581422747|FG001|Overall Study|Physician Decision|0|||
161009999|NCT04191499|581422746|FG000|Overall Study|Progressive Disease|1|||
161010000|NCT04191499|581422747|FG001|Overall Study|Progressive Disease|0|||
161010001|NCT04191499|581422746|FG000|Overall Study|Symptomatic Deterioration|1|||
161010002|NCT04191499|581422747|FG001|Overall Study|Symptomatic Deterioration|0|||
161010003|NCT04191499|581422746|FG000|Overall Study|Withdrawal by Subject|7|||
161010004|NCT04191499|581422747|FG001|Overall Study|Withdrawal by Subject|11|||
161010005|NCT04191499|581422746|FG000|Overall Study|Ongoing in the study|104|||
161010006|NCT04191499|581422747|FG001|Overall Study|Ongoing in the study|97|||
161010007|NCT03403413|581422748|FG000|Overall Study|Lack of Efficacy|2|||
161010008|NCT04982315|581422749|FG000|Overall Study|Death|1|||
161010009|NCT04982315|581422750|FG001|Overall Study|Death|0|||
161010010|NCT04982315|581422751|FG002|Overall Study|Death|1|||
161010011|NCT04982315|581422749|FG000|Overall Study|Lack of Efficacy|0|||
161010012|NCT04982315|581422750|FG001|Overall Study|Lack of Efficacy|0|||
161010013|NCT04982315|581422751|FG002|Overall Study|Lack of Efficacy|2|||
161010014|NCT04982315|581422749|FG000|Overall Study|Withdrawal by Subject|24|||
161010015|NCT04982315|581422750|FG001|Overall Study|Withdrawal by Subject|1|||
161010016|NCT04982315|581422751|FG002|Overall Study|Withdrawal by Subject|2|||
161010017|NCT04982315|581422749|FG000|Overall Study|Dealing with health/life issues|3|||
161010018|NCT04982315|581422750|FG001|Overall Study|Dealing with health/life issues|4|||
161010019|NCT04982315|581422751|FG002|Overall Study|Dealing with health/life issues|7|||
161010020|NCT04982315|581422749|FG000|Overall Study|Privacy concerns|1|||
161010021|NCT04982315|581422750|FG001|Overall Study|Privacy concerns|0|||
161010022|NCT04982315|581422751|FG002|Overall Study|Privacy concerns|0|||
160458756|NCT04629339|579412655|FG004|Overall Study|Death|0|||
161010023|NCT04982315|581422749|FG000|Overall Study|Withdrawal by research team|0|||
161010024|NCT04982315|581422750|FG001|Overall Study|Withdrawal by research team|0|||
161010025|NCT04982315|581422751|FG002|Overall Study|Withdrawal by research team|1|||
161010026|NCT00780910|581422752|FG000|Overall Study|Adverse Event|2|||
161010027|NCT01143337|581422757|FG000|Overall Study|Adverse Event|3|||
161010028|NCT01143337|581422758|FG001|Overall Study|Adverse Event|9|||
161010029|NCT01143337|581422759|FG002|Overall Study|Adverse Event|5|||
161010030|NCT01143337|581422757|FG000|Overall Study|Lack of Efficacy|6|||
161010031|NCT01143337|581422758|FG001|Overall Study|Lack of Efficacy|2|||
161010032|NCT01143337|581422759|FG002|Overall Study|Lack of Efficacy|1|||
161010033|NCT01143337|581422757|FG000|Overall Study|Protocol Violation|1|||
161010034|NCT01143337|581422758|FG001|Overall Study|Protocol Violation|0|||
161010035|NCT01143337|581422759|FG002|Overall Study|Protocol Violation|0|||
160458757|NCT04629339|579412651|FG000|Overall Study|Disease Progression|0|||
161010036|NCT01143337|581422757|FG000|Overall Study|Withdrawal by Subject|0|||
161010037|NCT01143337|581422758|FG001|Overall Study|Withdrawal by Subject|0|||
161010038|NCT01143337|581422759|FG002|Overall Study|Withdrawal by Subject|1|||
161010039|NCT01143337|581422757|FG000|Overall Study|Other reason|0|||
161010040|NCT01143337|581422758|FG001|Overall Study|Other reason|0|||
161010041|NCT01143337|581422759|FG002|Overall Study|Other reason|5|||
161010042|NCT03671811|581422761|FG000|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|4|||
161010043|NCT03671811|581422762|FG001|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|3|||
161010044|NCT00424463|581422770|FG000|Overall Study|Adverse Event|2|||
161010045|NCT00424463|581422771|FG001|Overall Study|Adverse Event|3|||
161010046|NCT00424463|581422772|FG002|Overall Study|Adverse Event|2|||
161010047|NCT00424463|581422770|FG000|Overall Study|Physician Decision|0|||
161010048|NCT00424463|581422771|FG001|Overall Study|Physician Decision|2|||
161010049|NCT00424463|581422772|FG002|Overall Study|Physician Decision|2|||
161010050|NCT00424463|581422770|FG000|Overall Study|Withdrawal by Subject|4|||
161010051|NCT00424463|581422771|FG001|Overall Study|Withdrawal by Subject|2|||
161010052|NCT00424463|581422772|FG002|Overall Study|Withdrawal by Subject|5|||
161010053|NCT00424463|581422770|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
161010054|NCT00424463|581422771|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
161010055|NCT00424463|581422772|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
161010056|NCT00424463|581422770|FG000|Overall Study|Patient's convenience|0|||
161010057|NCT00424463|581422771|FG001|Overall Study|Patient's convenience|0|||
161010058|NCT00424463|581422772|FG002|Overall Study|Patient's convenience|1|||
161010059|NCT03570892|581422773|FG000|Overall Study|Death|51|||
161010060|NCT03570892|581422774|FG001|Overall Study|Death|45|||
161010061|NCT03570892|581422773|FG000|Overall Study|Subject decision|5|||
161010062|NCT03570892|581422774|FG001|Overall Study|Subject decision|3|||
161010063|NCT03570892|581422773|FG000|Overall Study|Protocol Violation|1|||
161010064|NCT03570892|581422774|FG001|Overall Study|Protocol Violation|4|||
161010065|NCT03570892|581422773|FG000|Overall Study|Physician Decision|0|||
161010066|NCT03570892|581422774|FG001|Overall Study|Physician Decision|2|||
161010067|NCT03891758|581422775|FG000|Overall Study|Adverse Event|2|||
161010068|NCT03891758|581422776|FG001|Overall Study|Adverse Event|0|||
161010069|NCT03891758|581422775|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161010070|NCT03891758|581422776|FG001|Overall Study|Withdrawal by parent/guardian|2|||
161010071|NCT04434729|581422779|FG000|Overall Study|Adverse Event|1|||
161010072|NCT04434729|581422779|FG000|Overall Study|Physician Decision|1|||
161010073|NCT00975819|581422780|FG000|Overall Study|Lack of Efficacy|8|||
161010074|NCT00975819|581422780|FG000|Overall Study|Adverse Event|2|||
161010075|NCT00975819|581422780|FG000|Overall Study|Physician Decision|2|||
161010076|NCT00975819|581422780|FG000|Overall Study|Withdrawal by Subject|2|||
161010077|NCT00975819|581422780|FG000|Overall Study|Protocol Violation|1|||
161010078|NCT01968109|581422781|FG000|Overall Study|DISEASE PROGRESSION|4|||
161010079|NCT01968109|581422782|FG001|Overall Study|DISEASE PROGRESSION|4|||
161010080|NCT01968109|581422783|FG002|Overall Study|DISEASE PROGRESSION|3|||
161010081|NCT01968109|581422784|FG003|Overall Study|DISEASE PROGRESSION|9|||
161010082|NCT01968109|581422785|FG004|Overall Study|DISEASE PROGRESSION|5|||
161010083|NCT01968109|581422786|FG005|Overall Study|DISEASE PROGRESSION|6|||
161010084|NCT01968109|581422787|FG006|Overall Study|DISEASE PROGRESSION|6|||
161010085|NCT01968109|581422788|FG007|Overall Study|DISEASE PROGRESSION|6|||
161010086|NCT01968109|581422789|FG008|Overall Study|DISEASE PROGRESSION|4|||
161010087|NCT01968109|581422790|FG009|Overall Study|DISEASE PROGRESSION|5|||
161010088|NCT01968109|581422791|FG010|Overall Study|DISEASE PROGRESSION|8|||
161010089|NCT01968109|581422792|FG011|Overall Study|DISEASE PROGRESSION|4|||
161010090|NCT01968109|581422793|FG012|Overall Study|DISEASE PROGRESSION|7|||
161010091|NCT01968109|581422794|FG013|Overall Study|DISEASE PROGRESSION|14|||
161010092|NCT01968109|581422795|FG014|Overall Study|DISEASE PROGRESSION|14|||
161010093|NCT01968109|581422796|FG015|Overall Study|DISEASE PROGRESSION|13|||
161010094|NCT01968109|581422797|FG016|Overall Study|DISEASE PROGRESSION|34|||
161010095|NCT01968109|581422798|FG017|Overall Study|DISEASE PROGRESSION|20|||
161010096|NCT01968109|581422799|FG018|Overall Study|DISEASE PROGRESSION|54|||
160657023|NCT05097989|580124502|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
161010097|NCT01968109|581422800|FG019|Overall Study|DISEASE PROGRESSION|46|||
161010098|NCT01968109|581422801|FG020|Overall Study|DISEASE PROGRESSION|77|||
161010099|NCT01968109|581422802|FG021|Overall Study|DISEASE PROGRESSION|25|||
161010100|NCT01968109|581422803|FG022|Overall Study|DISEASE PROGRESSION|47|||
161010101|NCT01968109|581422804|FG023|Overall Study|DISEASE PROGRESSION|125|||
161010102|NCT01968109|581422805|FG024|Overall Study|DISEASE PROGRESSION|155|||
161010103|NCT01968109|581422806|FG025|Overall Study|DISEASE PROGRESSION|63|||
161010104|NCT01968109|581422807|FG026|Overall Study|DISEASE PROGRESSION|65|||
161010105|NCT01968109|581422808|FG027|Overall Study|DISEASE PROGRESSION|137|||
161010106|NCT01968109|581422809|FG028|Overall Study|DISEASE PROGRESSION|35|||
161010107|NCT01968109|581422810|FG029|Overall Study|DISEASE PROGRESSION|23|||
161010108|NCT01968109|581422811|FG030|Overall Study|DISEASE PROGRESSION|71|||
161010109|NCT01968109|581422781|FG000|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010110|NCT01968109|581422782|FG001|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010111|NCT01968109|581422783|FG002|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010112|NCT01968109|581422784|FG003|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010113|NCT01968109|581422785|FG004|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010114|NCT01968109|581422786|FG005|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010115|NCT01968109|581422787|FG006|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010116|NCT01968109|581422788|FG007|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010117|NCT01968109|581422789|FG008|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010118|NCT01968109|581422790|FG009|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010119|NCT01968109|581422791|FG010|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010120|NCT01968109|581422792|FG011|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010121|NCT01968109|581422793|FG012|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010122|NCT01968109|581422794|FG013|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010123|NCT01968109|581422795|FG014|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010124|NCT01968109|581422796|FG015|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010125|NCT01968109|581422797|FG016|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010126|NCT01968109|581422798|FG017|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010127|NCT01968109|581422799|FG018|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010128|NCT01968109|581422800|FG019|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010129|NCT01968109|581422801|FG020|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161010130|NCT01968109|581422802|FG021|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010131|NCT01968109|581422803|FG022|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161010132|NCT01968109|581422804|FG023|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|4|||
161010133|NCT01968109|581422805|FG024|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|7|||
161010134|NCT01968109|581422806|FG025|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161010135|NCT01968109|581422807|FG026|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161010136|NCT01968109|581422808|FG027|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161010137|NCT01968109|581422809|FG028|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|8|||
161010138|NCT01968109|581422810|FG029|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|12|||
161010139|NCT01968109|581422811|FG030|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161010140|NCT01968109|581422781|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
161010141|NCT01968109|581422782|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
161010142|NCT01968109|581422783|FG002|Overall Study|STUDY DRUG TOXICITY|1|||
161010143|NCT01968109|581422784|FG003|Overall Study|STUDY DRUG TOXICITY|2|||
161010144|NCT01968109|581422785|FG004|Overall Study|STUDY DRUG TOXICITY|1|||
161010145|NCT01968109|581422786|FG005|Overall Study|STUDY DRUG TOXICITY|1|||
161010146|NCT01968109|581422787|FG006|Overall Study|STUDY DRUG TOXICITY|1|||
161010147|NCT01968109|581422788|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
161010148|NCT01968109|581422789|FG008|Overall Study|STUDY DRUG TOXICITY|2|||
161010149|NCT01968109|581422790|FG009|Overall Study|STUDY DRUG TOXICITY|1|||
161010150|NCT01968109|581422791|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
161010151|NCT01968109|581422792|FG011|Overall Study|STUDY DRUG TOXICITY|2|||
161010152|NCT01968109|581422793|FG012|Overall Study|STUDY DRUG TOXICITY|0|||
161010153|NCT01968109|581422794|FG013|Overall Study|STUDY DRUG TOXICITY|2|||
161010154|NCT01968109|581422795|FG014|Overall Study|STUDY DRUG TOXICITY|2|||
161010155|NCT01968109|581422796|FG015|Overall Study|STUDY DRUG TOXICITY|4|||
161010156|NCT01968109|581422797|FG016|Overall Study|STUDY DRUG TOXICITY|11|||
161010157|NCT01968109|581422798|FG017|Overall Study|STUDY DRUG TOXICITY|3|||
161010158|NCT01968109|581422799|FG018|Overall Study|STUDY DRUG TOXICITY|4|||
161010159|NCT01968109|581422800|FG019|Overall Study|STUDY DRUG TOXICITY|9|||
161010160|NCT01968109|581422801|FG020|Overall Study|STUDY DRUG TOXICITY|6|||
161010161|NCT01968109|581422802|FG021|Overall Study|STUDY DRUG TOXICITY|4|||
161010162|NCT01968109|581422803|FG022|Overall Study|STUDY DRUG TOXICITY|3|||
161010163|NCT01968109|581422804|FG023|Overall Study|STUDY DRUG TOXICITY|8|||
161010164|NCT01968109|581422805|FG024|Overall Study|STUDY DRUG TOXICITY|9|||
161010165|NCT01968109|581422806|FG025|Overall Study|STUDY DRUG TOXICITY|8|||
161010166|NCT01968109|581422807|FG026|Overall Study|STUDY DRUG TOXICITY|3|||
161010167|NCT01968109|581422808|FG027|Overall Study|STUDY DRUG TOXICITY|9|||
161010168|NCT01968109|581422809|FG028|Overall Study|STUDY DRUG TOXICITY|14|||
161010169|NCT01968109|581422810|FG029|Overall Study|STUDY DRUG TOXICITY|21|||
161010170|NCT01968109|581422811|FG030|Overall Study|STUDY DRUG TOXICITY|9|||
161010171|NCT01968109|581422781|FG000|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010172|NCT01968109|581422782|FG001|Overall Study|SUBJECT WITHDREW CONSENT|0|||
160585570|NCT02203838|579861968|FG003|Overall Study|Adverse Event|2|||
161010173|NCT01968109|581422783|FG002|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010174|NCT01968109|581422784|FG003|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010175|NCT01968109|581422785|FG004|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010176|NCT01968109|581422786|FG005|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010177|NCT01968109|581422787|FG006|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010178|NCT01968109|581422788|FG007|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010179|NCT01968109|581422789|FG008|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010180|NCT01968109|581422790|FG009|Overall Study|SUBJECT WITHDREW CONSENT|0|||
160458758|NCT04629339|579412652|FG001|Overall Study|Disease Progression|0|||
161010181|NCT01968109|581422791|FG010|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010182|NCT01968109|581422792|FG011|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010183|NCT01968109|581422793|FG012|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010184|NCT01968109|581422794|FG013|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010185|NCT01968109|581422795|FG014|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010186|NCT01968109|581422796|FG015|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010187|NCT01968109|581422797|FG016|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010188|NCT01968109|581422798|FG017|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010189|NCT01968109|581422799|FG018|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010190|NCT01968109|581422800|FG019|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010191|NCT01968109|581422801|FG020|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010192|NCT01968109|581422802|FG021|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010193|NCT01968109|581422803|FG022|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010194|NCT01968109|581422804|FG023|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010195|NCT01968109|581422805|FG024|Overall Study|SUBJECT WITHDREW CONSENT|3|||
161010196|NCT01968109|581422806|FG025|Overall Study|SUBJECT WITHDREW CONSENT|2|||
161010197|NCT01968109|581422807|FG026|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010198|NCT01968109|581422808|FG027|Overall Study|SUBJECT WITHDREW CONSENT|4|||
161010199|NCT01968109|581422809|FG028|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010200|NCT01968109|581422810|FG029|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010201|NCT01968109|581422811|FG030|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010202|NCT01968109|581422781|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010203|NCT01968109|581422782|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010204|NCT01968109|581422783|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010205|NCT01968109|581422784|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010206|NCT01968109|581422785|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010207|NCT01968109|581422786|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010208|NCT01968109|581422787|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010209|NCT01968109|581422788|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010210|NCT01968109|581422789|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161010211|NCT01968109|581422790|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161010212|NCT01968109|581422791|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010213|NCT01968109|581422792|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161010214|NCT01968109|581422793|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010215|NCT01968109|581422794|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161010216|NCT01968109|581422795|FG014|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010217|NCT01968109|581422796|FG015|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161010218|NCT01968109|581422797|FG016|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161010219|NCT01968109|581422798|FG017|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010220|NCT01968109|581422799|FG018|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161010221|NCT01968109|581422800|FG019|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161010222|NCT01968109|581422801|FG020|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161010223|NCT01968109|581422802|FG021|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161010224|NCT01968109|581422803|FG022|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161010225|NCT01968109|581422804|FG023|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161010226|NCT01968109|581422805|FG024|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|5|||
161010227|NCT01968109|581422806|FG025|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|6|||
161010228|NCT01968109|581422807|FG026|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161010229|NCT01968109|581422808|FG027|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161010230|NCT01968109|581422809|FG028|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
160585571|NCT02203838|579861965|FG000|Overall Study|Lost to Follow-up|39|||
160585572|NCT02203838|579861966|FG001|Overall Study|Lost to Follow-up|3|||
160585573|NCT02203838|579861967|FG002|Overall Study|Lost to Follow-up|2|||
160585574|NCT02203838|579861968|FG003|Overall Study|Lost to Follow-up|1|||
160585575|NCT02203838|579861965|FG000|Overall Study|Protocol Violation|7|||
160585576|NCT02203838|579861966|FG001|Overall Study|Protocol Violation|3|||
160585577|NCT02203838|579861967|FG002|Overall Study|Protocol Violation|0|||
160585578|NCT02203838|579861968|FG003|Overall Study|Protocol Violation|0|||
161010231|NCT01968109|581422810|FG029|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161010232|NCT01968109|581422811|FG030|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161010233|NCT01968109|581422781|FG000|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010234|NCT01968109|581422782|FG001|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010235|NCT01968109|581422783|FG002|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010236|NCT01968109|581422784|FG003|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010237|NCT01968109|581422785|FG004|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010238|NCT01968109|581422786|FG005|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010239|NCT01968109|581422787|FG006|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010240|NCT01968109|581422788|FG007|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
160585579|NCT02203838|579861965|FG000|Overall Study|Withdrawal by Subject|83|||
160657024|NCT05097989|580124503|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
161010241|NCT01968109|581422789|FG008|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010242|NCT01968109|581422790|FG009|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010243|NCT01968109|581422791|FG010|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010244|NCT01968109|581422792|FG011|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010245|NCT01968109|581422793|FG012|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010246|NCT01968109|581422794|FG013|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010247|NCT01968109|581422795|FG014|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010248|NCT01968109|581422796|FG015|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
161010249|NCT01968109|581422797|FG016|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
161010250|NCT01968109|581422798|FG017|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010251|NCT01968109|581422799|FG018|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010252|NCT01968109|581422800|FG019|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010253|NCT01968109|581422801|FG020|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
161010254|NCT01968109|581422802|FG021|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010255|NCT01968109|581422803|FG022|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010256|NCT01968109|581422804|FG023|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
161010257|NCT01968109|581422805|FG024|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|5|||
161010258|NCT01968109|581422806|FG025|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010259|NCT01968109|581422807|FG026|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010260|NCT01968109|581422808|FG027|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|2|||
161010261|NCT01968109|581422809|FG028|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010262|NCT01968109|581422810|FG029|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010263|NCT01968109|581422811|FG030|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010264|NCT01968109|581422781|FG000|Overall Study|OTHER REASONS|0|||
161010265|NCT01968109|581422782|FG001|Overall Study|OTHER REASONS|0|||
161010266|NCT01968109|581422783|FG002|Overall Study|OTHER REASONS|0|||
161010267|NCT01968109|581422784|FG003|Overall Study|OTHER REASONS|1|||
161010268|NCT01968109|581422785|FG004|Overall Study|OTHER REASONS|0|||
161010269|NCT01968109|581422786|FG005|Overall Study|OTHER REASONS|0|||
161010270|NCT01968109|581422787|FG006|Overall Study|OTHER REASONS|0|||
161010271|NCT01968109|581422788|FG007|Overall Study|OTHER REASONS|0|||
161010272|NCT01968109|581422789|FG008|Overall Study|OTHER REASONS|0|||
161010273|NCT01968109|581422790|FG009|Overall Study|OTHER REASONS|0|||
161010274|NCT01968109|581422791|FG010|Overall Study|OTHER REASONS|0|||
161010275|NCT01968109|581422792|FG011|Overall Study|OTHER REASONS|1|||
161010276|NCT01968109|581422793|FG012|Overall Study|OTHER REASONS|0|||
161010277|NCT01968109|581422794|FG013|Overall Study|OTHER REASONS|0|||
161010278|NCT01968109|581422795|FG014|Overall Study|OTHER REASONS|1|||
161010279|NCT01968109|581422796|FG015|Overall Study|OTHER REASONS|1|||
161010280|NCT01968109|581422797|FG016|Overall Study|OTHER REASONS|1|||
161010281|NCT01968109|581422798|FG017|Overall Study|OTHER REASONS|0|||
161010282|NCT01968109|581422799|FG018|Overall Study|OTHER REASONS|0|||
161010283|NCT01968109|581422800|FG019|Overall Study|OTHER REASONS|0|||
161010284|NCT01968109|581422801|FG020|Overall Study|OTHER REASONS|0|||
161010285|NCT01968109|581422802|FG021|Overall Study|OTHER REASONS|2|||
161010286|NCT01968109|581422803|FG022|Overall Study|OTHER REASONS|0|||
161010287|NCT01968109|581422804|FG023|Overall Study|OTHER REASONS|0|||
161010288|NCT01968109|581422805|FG024|Overall Study|OTHER REASONS|3|||
161010289|NCT01968109|581422806|FG025|Overall Study|OTHER REASONS|0|||
161010290|NCT01968109|581422807|FG026|Overall Study|OTHER REASONS|3|||
161010291|NCT01968109|581422808|FG027|Overall Study|OTHER REASONS|3|||
161010292|NCT01968109|581422809|FG028|Overall Study|OTHER REASONS|6|||
160458759|NCT04629339|579412653|FG002|Overall Study|Disease Progression|1|||
160585580|NCT02203838|579861966|FG001|Overall Study|Withdrawal by Subject|10|||
160585581|NCT02203838|579861967|FG002|Overall Study|Withdrawal by Subject|8|||
160585582|NCT02203838|579861968|FG003|Overall Study|Withdrawal by Subject|11|||
160585583|NCT02203838|579861965|FG000|Overall Study|Physician Decision|27|||
160585584|NCT02203838|579861966|FG001|Overall Study|Physician Decision|0|||
160585585|NCT02203838|579861967|FG002|Overall Study|Physician Decision|2|||
160585586|NCT02203838|579861968|FG003|Overall Study|Physician Decision|3|||
160585587|NCT02203838|579861965|FG000|Overall Study|Other|1|||
160585588|NCT02203838|579861966|FG001|Overall Study|Other|0|||
160585589|NCT02203838|579861967|FG002|Overall Study|Other|0|||
160585590|NCT02203838|579861968|FG003|Overall Study|Other|0|||
161010293|NCT01968109|581422810|FG029|Overall Study|OTHER REASONS|7|||
160585591|NCT05091060|579861969|FG000|Overall Study|Lost to Follow-up|1|||
160585592|NCT02739594|579861970|FG000|Overall Study|Undesired Event|3|||
160585593|NCT02739594|579861971|FG001|Overall Study|Undesired Event|4|||
160585594|NCT02739594|579861970|FG000|Overall Study|Violation of Eligibility Criteria|1|||
161010294|NCT01968109|581422811|FG030|Overall Study|OTHER REASONS|3|||
161010295|NCT01968109|581422781|FG000|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010296|NCT01968109|581422782|FG001|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010297|NCT01968109|581422783|FG002|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010298|NCT01968109|581422784|FG003|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010299|NCT01968109|581422785|FG004|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
160458760|NCT04629339|579412654|FG003|Overall Study|Disease Progression|1|||
160585595|NCT02739594|579861971|FG001|Overall Study|Violation of Eligibility Criteria|2|||
161010300|NCT01968109|581422786|FG005|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010301|NCT01968109|581422787|FG006|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010302|NCT01968109|581422788|FG007|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010303|NCT01968109|581422789|FG008|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010304|NCT01968109|581422790|FG009|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010305|NCT01968109|581422791|FG010|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010306|NCT01968109|581422792|FG011|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010307|NCT01968109|581422793|FG012|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010308|NCT01968109|581422794|FG013|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010309|NCT01968109|581422795|FG014|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010310|NCT01968109|581422796|FG015|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010311|NCT01968109|581422797|FG016|Overall Study|MAXIMUM CLINICAL BENEFIT|5|||
161010312|NCT01968109|581422798|FG017|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
161010313|NCT01968109|581422799|FG018|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010314|NCT01968109|581422800|FG019|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161010315|NCT01968109|581422801|FG020|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
161010316|NCT01968109|581422802|FG021|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010317|NCT01968109|581422803|FG022|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010318|NCT01968109|581422804|FG023|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010319|NCT01968109|581422805|FG024|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
161010320|NCT01968109|581422806|FG025|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010321|NCT01968109|581422807|FG026|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161010322|NCT01968109|581422808|FG027|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161010323|NCT01968109|581422809|FG028|Overall Study|MAXIMUM CLINICAL BENEFIT|3|||
161010324|NCT01968109|581422810|FG029|Overall Study|MAXIMUM CLINICAL BENEFIT|6|||
161010325|NCT01968109|581422811|FG030|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161010326|NCT01968109|581422781|FG000|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010327|NCT01968109|581422782|FG001|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010328|NCT01968109|581422783|FG002|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010329|NCT01968109|581422784|FG003|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010330|NCT01968109|581422785|FG004|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010331|NCT01968109|581422786|FG005|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010332|NCT01968109|581422787|FG006|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010333|NCT01968109|581422788|FG007|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010334|NCT01968109|581422789|FG008|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010335|NCT01968109|581422790|FG009|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010336|NCT01968109|581422791|FG010|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010337|NCT01968109|581422792|FG011|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010338|NCT01968109|581422793|FG012|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010339|NCT01968109|581422794|FG013|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010340|NCT01968109|581422795|FG014|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010341|NCT01968109|581422796|FG015|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010342|NCT01968109|581422797|FG016|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010343|NCT01968109|581422798|FG017|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010344|NCT01968109|581422799|FG018|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010345|NCT01968109|581422800|FG019|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010346|NCT01968109|581422801|FG020|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|1|||
161010347|NCT01968109|581422802|FG021|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010348|NCT01968109|581422803|FG022|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010349|NCT01968109|581422804|FG023|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|3|||
161010350|NCT01968109|581422805|FG024|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010351|NCT01968109|581422806|FG025|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010352|NCT01968109|581422807|FG026|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010353|NCT01968109|581422808|FG027|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010354|NCT01968109|581422809|FG028|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010355|NCT01968109|581422810|FG029|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010356|NCT01968109|581422811|FG030|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010357|NCT01968109|581422781|FG000|Overall Study|Death|0|||
161010358|NCT01968109|581422782|FG001|Overall Study|Death|0|||
161010359|NCT01968109|581422783|FG002|Overall Study|Death|0|||
161010360|NCT01968109|581422784|FG003|Overall Study|Death|0|||
161010361|NCT01968109|581422785|FG004|Overall Study|Death|0|||
161010362|NCT01968109|581422786|FG005|Overall Study|Death|0|||
161010363|NCT01968109|581422787|FG006|Overall Study|Death|0|||
161010364|NCT01968109|581422788|FG007|Overall Study|Death|0|||
161010365|NCT01968109|581422789|FG008|Overall Study|Death|0|||
161010366|NCT01968109|581422790|FG009|Overall Study|Death|0|||
161010367|NCT01968109|581422791|FG010|Overall Study|Death|0|||
161010368|NCT01968109|581422792|FG011|Overall Study|Death|0|||
161010369|NCT01968109|581422793|FG012|Overall Study|Death|0|||
161010370|NCT01968109|581422794|FG013|Overall Study|Death|0|||
161010371|NCT01968109|581422795|FG014|Overall Study|Death|0|||
161010372|NCT01968109|581422796|FG015|Overall Study|Death|0|||
161010373|NCT01968109|581422797|FG016|Overall Study|Death|0|||
161010374|NCT01968109|581422798|FG017|Overall Study|Death|0|||
161010375|NCT01968109|581422799|FG018|Overall Study|Death|0|||
161010376|NCT01968109|581422800|FG019|Overall Study|Death|0|||
161010377|NCT01968109|581422801|FG020|Overall Study|Death|0|||
161010378|NCT01968109|581422802|FG021|Overall Study|Death|1|||
161010379|NCT01968109|581422803|FG022|Overall Study|Death|0|||
161010380|NCT01968109|581422804|FG023|Overall Study|Death|0|||
161010381|NCT01968109|581422805|FG024|Overall Study|Death|0|||
161010382|NCT01968109|581422806|FG025|Overall Study|Death|0|||
161010383|NCT01968109|581422807|FG026|Overall Study|Death|0|||
161010384|NCT01968109|581422808|FG027|Overall Study|Death|0|||
161010385|NCT01968109|581422809|FG028|Overall Study|Death|0|||
161010386|NCT01968109|581422810|FG029|Overall Study|Death|0|||
161010387|NCT01968109|581422811|FG030|Overall Study|Death|1|||
161010388|NCT03899792|581422812|FG000|Phase 2|Ongoing Treatment|0|||
161010389|NCT03899792|581422813|FG001|Phase 2|Ongoing Treatment|13|||
161010390|NCT03899792|581422814|FG002|Phase 2|Ongoing Treatment|14|||
161010391|NCT03899792|581422815|FG003|Phase 2|Ongoing Treatment|2|||
161010392|NCT03899792|581422812|FG000|Phase 2|Death|0|||
161010393|NCT03899792|581422813|FG001|Phase 2|Death|0|||
161010394|NCT03899792|581422814|FG002|Phase 2|Death|0|||
161010395|NCT03899792|581422815|FG003|Phase 2|Death|4|||
161010396|NCT03899792|581422812|FG000|Phase 2|Lost to Follow-up|0|||
161010397|NCT03899792|581422813|FG001|Phase 2|Lost to Follow-up|1|||
161010398|NCT03899792|581422814|FG002|Phase 2|Lost to Follow-up|1|||
161010399|NCT03899792|581422815|FG003|Phase 2|Lost to Follow-up|0|||
161010400|NCT03899792|581422812|FG000|Phase 2|Withdrawal by Subject|0|||
161010401|NCT03899792|581422813|FG001|Phase 2|Withdrawal by Subject|1|||
161010402|NCT03899792|581422814|FG002|Phase 2|Withdrawal by Subject|0|||
161010403|NCT03899792|581422815|FG003|Phase 2|Withdrawal by Subject|0|||
161010404|NCT02152137|581423894|FG000|Overall Study|Withdrawal by Subject|1|||
161010405|NCT02152137|581423894|FG000|Overall Study|Originally assigned to Arm B|3|||
161010406|NCT03358875|581423895|FG000|Overall Study|Death|409|||
161010407|NCT03358875|581423896|FG001|Overall Study|Death|223|||
161010408|NCT03358875|581423895|FG000|Overall Study|Study Closed by Sponsor|66|||
161010409|NCT03358875|581423896|FG001|Overall Study|Study Closed by Sponsor|29|||
161010410|NCT03358875|581423895|FG000|Overall Study|Withdrawal by Subject|13|||
161010411|NCT03358875|581423896|FG001|Overall Study|Withdrawal by Subject|16|||
161010412|NCT03358875|581423895|FG000|Overall Study|Lost to Follow-up|13|||
161010413|NCT03358875|581423896|FG001|Overall Study|Lost to Follow-up|2|||
161010414|NCT03358875|581423895|FG000|Overall Study|Miscellaneous|33|||
161010415|NCT03358875|581423896|FG001|Overall Study|Miscellaneous|0|||
161010416|NCT03358875|581423895|FG000|Overall Study|Remained on Study|1|||
161010417|NCT03358875|581423896|FG001|Overall Study|Remained on Study|0|||
161010418|NCT03460236|581423911|FG000|Overall Study|failed radiographic screening|16|||
161010419|NCT03460236|581423911|FG000|Overall Study|Withdrawal by Subject|11|||
161010420|NCT06194214|581423912|FG000|Overall Study|Adverse Event|1|||
161010421|NCT05613205|581423913|FG000|Overall Study|Lost to Follow-up|0|||
161010422|NCT05613205|581423914|FG001|Overall Study|Lost to Follow-up|0|||
161010423|NCT05613205|581423915|FG002|Overall Study|Lost to Follow-up|1|||
161010424|NCT05613205|581423916|FG003|Overall Study|Lost to Follow-up|1|||
161010425|NCT05613205|581423917|FG004|Overall Study|Lost to Follow-up|0|||
161010426|NCT05613205|581423913|FG000|Overall Study|Withdrawal by Subject|0|||
161010427|NCT05613205|581423914|FG001|Overall Study|Withdrawal by Subject|0|||
161010428|NCT05613205|581423915|FG002|Overall Study|Withdrawal by Subject|1|||
161010429|NCT05613205|581423916|FG003|Overall Study|Withdrawal by Subject|1|||
161010430|NCT05613205|581423917|FG004|Overall Study|Withdrawal by Subject|0|||
161010431|NCT04608045|581423921|FG000|Overall Study|Physician Decision|1|||
161010432|NCT04847999|581423922|FG000|Overall Study|Lost to Follow-up|0|||
161010433|NCT04847999|581423923|FG001|Overall Study|Lost to Follow-up|1|||
161010434|NCT03602014|581423925|FG000|Overall Study|Lost to Follow-up|2|||
161010435|NCT03602014|581423926|FG001|Overall Study|Lost to Follow-up|0|||
161010436|NCT03602014|581423927|FG002|Overall Study|Lost to Follow-up|0|||
161010437|NCT04300231|581423928|FG000|Overall Study|Protocol Violation|4|||
160458761|NCT04629339|579412655|FG004|Overall Study|Disease Progression|0|||
160585596|NCT02739594|579861970|FG000|Overall Study|Protocol Violation|5|||
161010438|NCT04300231|581423929|FG001|Overall Study|Protocol Violation|3|||
161010439|NCT04300231|581423930|FG002|Overall Study|Protocol Violation|0|||
161010440|NCT04300231|581423931|FG003|Overall Study|Protocol Violation|2|||
161010441|NCT05846646|581423937|FG000|Overall Study|Physician Decision|1|||
161010442|NCT05846646|581423938|FG001|Overall Study|Physician Decision|0|||
161010443|NCT05846646|581423939|FG002|Overall Study|Physician Decision|0|||
161010444|NCT05846646|581423937|FG000|Overall Study|Lack of Efficacy|1|||
161010445|NCT05846646|581423938|FG001|Overall Study|Lack of Efficacy|1|||
161010446|NCT05846646|581423939|FG002|Overall Study|Lack of Efficacy|0|||
161010447|NCT05846646|581423937|FG000|Overall Study|Early Study Termination|1|||
161010448|NCT05846646|581423938|FG001|Overall Study|Early Study Termination|2|||
161010449|NCT05846646|581423939|FG002|Overall Study|Early Study Termination|0|||
161010450|NCT03733119|581423942|FG000|Overall Study|Physician Decision|2|||
161010451|NCT03733119|581423943|FG001|Overall Study|Physician Decision|1|||
161010452|NCT03733119|581423942|FG000|Overall Study|ineligible to treat per protocol|0|||
161010453|NCT03733119|581423943|FG001|Overall Study|ineligible to treat per protocol|1|||
161010454|NCT05052996|581423944|FG000|Overall Study|Still on study|0|||
161010455|NCT05052996|581423945|FG001|Overall Study|Still on study|0|||
161010456|NCT05052996|581423946|FG002|Overall Study|Still on study|47|||
161010457|NCT05052996|581423947|FG003|Overall Study|Still on study|44|||
161010458|NCT05052996|581423944|FG000|Overall Study|Cohort terminated by sponsor|21|||
161010459|NCT05052996|581423945|FG001|Overall Study|Cohort terminated by sponsor|12|||
161010460|NCT05052996|581423946|FG002|Overall Study|Cohort terminated by sponsor|0|||
161010461|NCT05052996|581423947|FG003|Overall Study|Cohort terminated by sponsor|0|||
161010462|NCT05052996|581423944|FG000|Overall Study|Withdrew consent|1|||
160967148|NCT04074590|581268162|FG000|Overall Study|Adverse Event|1|||
160967149|NCT04074590|581268163|FG001|Overall Study|Adverse Event|0|||
160967150|NCT04074590|581268162|FG000|Overall Study|Physician Decision|1|||
160967151|NCT04074590|581268163|FG001|Overall Study|Physician Decision|0|||
160967152|NCT04074590|581268162|FG000|Overall Study|Withdrawal by Subject|2|||
160967153|NCT04074590|581268163|FG001|Overall Study|Withdrawal by Subject|0|||
160967154|NCT03745222|581268166|FG000|Overall Study|Withdrawal by Subject|0|||
160967155|NCT03745222|581268167|FG001|Overall Study|Withdrawal by Subject|1|||
160967156|NCT03745222|581268168|FG002|Overall Study|Withdrawal by Subject|0|||
160967157|NCT02657317|581268169|FG000|Overall Study|Withdrawal by Subject|2|||
160967158|NCT02657317|581268170|FG001|Overall Study|Withdrawal by Subject|0|||
160967159|NCT02657317|581268169|FG000|Overall Study|Lost to Follow-up|3|||
160967160|NCT02657317|581268170|FG001|Overall Study|Lost to Follow-up|3|||
160967161|NCT02634788|581268171|FG000|Overall Study|Adverse Event|0|||
160967162|NCT02634788|581268172|FG001|Overall Study|Adverse Event|8|||
160967163|NCT02634788|581268173|FG002|Overall Study|Adverse Event|3|||
160967164|NCT02634788|581268174|FG003|Overall Study|Adverse Event|1|||
160967165|NCT02634788|581268171|FG000|Overall Study|Lack of Efficacy|4|||
160967166|NCT02634788|581268172|FG001|Overall Study|Lack of Efficacy|0|||
160967167|NCT02634788|581268173|FG002|Overall Study|Lack of Efficacy|1|||
160967168|NCT02634788|581268174|FG003|Overall Study|Lack of Efficacy|4|||
160967169|NCT02634788|581268171|FG000|Overall Study|Lost to Follow-up|0|||
160967170|NCT02634788|581268172|FG001|Overall Study|Lost to Follow-up|1|||
160967171|NCT02634788|581268173|FG002|Overall Study|Lost to Follow-up|0|||
160967172|NCT02634788|581268174|FG003|Overall Study|Lost to Follow-up|0|||
160967173|NCT02634788|581268171|FG000|Overall Study|Withdrawal by Subject|0|||
160967174|NCT02634788|581268172|FG001|Overall Study|Withdrawal by Subject|1|||
160967175|NCT02634788|581268173|FG002|Overall Study|Withdrawal by Subject|1|||
160967176|NCT02634788|581268174|FG003|Overall Study|Withdrawal by Subject|0|||
160967177|NCT00758459|581268175|FG000|Overall Study|Adverse Event|3|||
160967178|NCT00758459|581268176|FG001|Overall Study|Adverse Event|2|||
160967179|NCT00758459|581268175|FG000|Overall Study|Protocol Violation|0|||
160967180|NCT00758459|581268176|FG001|Overall Study|Protocol Violation|1|||
160967181|NCT00758459|581268175|FG000|Overall Study|Withdrawal by Subject|0|||
160967182|NCT00758459|581268176|FG001|Overall Study|Withdrawal by Subject|1|||
160967183|NCT01780935|581268180|FG000|Overall Study|Admin problems due to early termination|321|||
160967184|NCT01780935|581268181|FG001|Overall Study|Admin problems due to early termination|309|||
160967185|NCT01780935|581268180|FG000|Overall Study|Adverse Event|2|||
160967186|NCT01780935|581268181|FG001|Overall Study|Adverse Event|4|||
160967187|NCT01780935|581268180|FG000|Overall Study|Death|1|||
160967188|NCT01780935|581268181|FG001|Overall Study|Death|6|||
160967189|NCT01780935|581268180|FG000|Overall Study|Lost to Follow-up|2|||
160967190|NCT01780935|581268181|FG001|Overall Study|Lost to Follow-up|6|||
160967191|NCT01780935|581268180|FG000|Overall Study|Physician Decision|1|||
160967192|NCT01780935|581268181|FG001|Overall Study|Physician Decision|1|||
160967193|NCT01780935|581268180|FG000|Overall Study|Protocol deviation|0|||
160967194|NCT01780935|581268181|FG001|Overall Study|Protocol deviation|1|||
160967195|NCT01780935|581268180|FG000|Overall Study|Patient withdrew consent|8|||
160967196|NCT01780935|581268181|FG001|Overall Study|Patient withdrew consent|9|||
160967197|NCT01281202|581268182|FG000|Overall Study|Adverse Event|2|||
160967198|NCT01281202|581268183|FG001|Overall Study|Adverse Event|0|||
160967199|NCT01281202|581268182|FG000|Overall Study|Withdrawal by Subject|2|||
160967200|NCT01281202|581268183|FG001|Overall Study|Withdrawal by Subject|2|||
160967201|NCT01281202|581268182|FG000|Overall Study|Protocol Violation|11|||
160967202|NCT01281202|581268183|FG001|Overall Study|Protocol Violation|10|||
160967203|NCT01281202|581268182|FG000|Overall Study|Administrative|2|||
160967204|NCT01281202|581268183|FG001|Overall Study|Administrative|8|||
160967205|NCT01281202|581268182|FG000|Overall Study|Lost to Follow-up|11|||
160967206|NCT01281202|581268183|FG001|Overall Study|Lost to Follow-up|13|||
160967207|NCT01281202|581268182|FG000|Overall Study|Incarceration|0|||
160967208|NCT01281202|581268183|FG001|Overall Study|Incarceration|3|||
160967209|NCT01215357|581268184|FG000|Overall Study|Withdrawal by Subject|3|||
160967210|NCT01215357|581268184|FG000|Overall Study|Protocol Violation|9|||
160967211|NCT05479604|581268185|FG000|Overall Study|Lost to Follow-up|1|||
160967212|NCT05479604|581268186|FG001|Overall Study|Lost to Follow-up|5|||
160967213|NCT01591382|581268187|FG000|Overall Study|Discharged Prior to Study Completion|2|||
161010463|NCT05052996|581423945|FG001|Overall Study|Withdrew consent|0|||
161010464|NCT05052996|581423946|FG002|Overall Study|Withdrew consent|1|||
161010465|NCT05052996|581423947|FG003|Overall Study|Withdrew consent|2|||
161010466|NCT05052996|581423944|FG000|Overall Study|Lost to Follow-up|1|||
161010467|NCT05052996|581423945|FG001|Overall Study|Lost to Follow-up|0|||
161010468|NCT05052996|581423946|FG002|Overall Study|Lost to Follow-up|0|||
161010469|NCT05052996|581423947|FG003|Overall Study|Lost to Follow-up|2|||
161010470|NCT05052996|581423944|FG000|Overall Study|Adverse Event|0|||
161010471|NCT05052996|581423945|FG001|Overall Study|Adverse Event|0|||
161010472|NCT05052996|581423946|FG002|Overall Study|Adverse Event|2|||
161010473|NCT05052996|581423947|FG003|Overall Study|Adverse Event|0|||
161010474|NCT05052996|581423944|FG000|Overall Study|Randomized but never treated|0|||
161010475|NCT05052996|581423945|FG001|Overall Study|Randomized but never treated|0|||
161010476|NCT05052996|581423946|FG002|Overall Study|Randomized but never treated|1|||
161010477|NCT05052996|581423947|FG003|Overall Study|Randomized but never treated|1|||
161010478|NCT05052996|581423944|FG000|Overall Study|Protocol Violation|1|||
161010479|NCT05052996|581423945|FG001|Overall Study|Protocol Violation|0|||
161010480|NCT05052996|581423946|FG002|Overall Study|Protocol Violation|0|||
161010481|NCT05052996|581423947|FG003|Overall Study|Protocol Violation|0|||
161010482|NCT02088853|581423948|FG000|Overall Study|Pregnancy|1|||
161010483|NCT02088853|581423949|FG001|Overall Study|Pregnancy|0|||
161010484|NCT04704284|581423950|FG000|Overall Study|Withdrawal by Subject|1|||
161010485|NCT01061671|581423958|FG000|Overall Study|Withdrawal by Subject|16|||
161010486|NCT01061671|581423959|FG001|Overall Study|Withdrawal by Subject|20|||
161010487|NCT01061671|581423958|FG000|Overall Study|Lost to Follow-up|3|||
161010488|NCT01061671|581423959|FG001|Overall Study|Lost to Follow-up|5|||
161010489|NCT01061671|581423958|FG000|Overall Study|Death|28|||
161010490|NCT01061671|581423959|FG001|Overall Study|Death|30|||
161010491|NCT00419341|581423970|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
161010492|NCT00419341|581423970|FG000|Wash in/Wash Out Period|Adverse Event|2|||
161010493|NCT00419341|581423970|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
161010494|NCT00419341|581423970|FG000|Efficacy Period|Withdrawal by Subject|6|||
161010495|NCT00419341|581423970|FG000|Efficacy Period|Protocol Violation|1|||
161010496|NCT00419341|581423970|FG000|Efficacy Period|Lost to Follow-up|1|||
161010497|NCT00419341|581423970|FG000|Efficacy Period|Non-compliance|1|||
161010498|NCT00419341|581423970|FG000|Efficacy Period|Termination of study site|1|||
161010499|NCT00331136|581423971|FG000|Overall Study|Adverse Event|3|||
161010500|NCT00331136|581423972|FG001|Overall Study|Adverse Event|5|||
161010501|NCT00331136|581423973|FG002|Overall Study|Adverse Event|0|||
161010502|NCT00331136|581423974|FG003|Overall Study|Adverse Event|1|||
161010503|NCT00331136|581423971|FG000|Overall Study|Withdrawal by Subject|0|||
161010504|NCT00331136|581423972|FG001|Overall Study|Withdrawal by Subject|1|||
161010505|NCT00331136|581423973|FG002|Overall Study|Withdrawal by Subject|0|||
161010506|NCT00331136|581423974|FG003|Overall Study|Withdrawal by Subject|0|||
161010507|NCT00331136|581423971|FG000|Overall Study|Lost to Follow-up|0|||
161010508|NCT00331136|581423972|FG001|Overall Study|Lost to Follow-up|1|||
161010509|NCT00331136|581423973|FG002|Overall Study|Lost to Follow-up|0|||
161010510|NCT00331136|581423974|FG003|Overall Study|Lost to Follow-up|0|||
160458762|NCT04629339|579412651|FG000|Overall Study|Lost to Follow-up|0|||
160458763|NCT04629339|579412652|FG001|Overall Study|Lost to Follow-up|0|||
160458764|NCT04629339|579412653|FG002|Overall Study|Lost to Follow-up|0|||
160458765|NCT04629339|579412654|FG003|Overall Study|Lost to Follow-up|1|||
160458766|NCT04629339|579412655|FG004|Overall Study|Lost to Follow-up|0|||
160458767|NCT04629339|579412651|FG000|Overall Study|Physician Decision|0|||
160458768|NCT04629339|579412652|FG001|Overall Study|Physician Decision|1|||
160458769|NCT04629339|579412653|FG002|Overall Study|Physician Decision|0|||
160458770|NCT04629339|579412654|FG003|Overall Study|Physician Decision|0|||
160458771|NCT04629339|579412655|FG004|Overall Study|Physician Decision|0|||
160458772|NCT04629339|579412651|FG000|Overall Study|Study Terminated by Sponsor|0|||
161010511|NCT00331136|581423971|FG000|Overall Study|Protocol Violation|1|||
161010512|NCT00331136|581423972|FG001|Overall Study|Protocol Violation|0|||
161010513|NCT00331136|581423973|FG002|Overall Study|Protocol Violation|0|||
161010514|NCT00331136|581423974|FG003|Overall Study|Protocol Violation|0|||
160458773|NCT04629339|579412652|FG001|Overall Study|Study Terminated by Sponsor|0|||
160458774|NCT04629339|579412653|FG002|Overall Study|Study Terminated by Sponsor|0|||
160458775|NCT04629339|579412654|FG003|Overall Study|Study Terminated by Sponsor|1|||
160458776|NCT04629339|579412655|FG004|Overall Study|Study Terminated by Sponsor|0|||
161010515|NCT00331136|581423971|FG000|Overall Study|Not treated|1|||
161010516|NCT00331136|581423972|FG001|Overall Study|Not treated|0|||
161010517|NCT00331136|581423973|FG002|Overall Study|Not treated|0|||
161010518|NCT00331136|581423974|FG003|Overall Study|Not treated|0|||
161010519|NCT02321514|581423975|FG000|Overall Study|Death|15|||
161010520|NCT02321514|581423975|FG000|Overall Study|Missed Visit|7|||
161010521|NCT02321514|581423975|FG000|Overall Study|Study Exit|3|||
161010522|NCT04578106|581423985|FG000|Follow-up after 1 year|Lost to Follow-up|1|||
161010523|NCT01207492|581423986|FG000|Overall Study|Still on study|1|||
161010524|NCT01207492|581423986|FG000|Overall Study|Withdrawal by Subject|9|||
161010525|NCT01207492|581423986|FG000|Overall Study|Physician Decision|1|||
161010526|NCT01207492|581423986|FG000|Overall Study|Progressive disease|3|||
161010527|NCT01207492|581423986|FG000|Overall Study|Toxicity|1|||
161010528|NCT04690556|581423987|FG000|Overall Study|Adverse Event|6|||
161010529|NCT04690556|581423988|FG001|Overall Study|Adverse Event|4|||
161010530|NCT04690556|581423987|FG000|Overall Study|Death|3|||
161010531|NCT04690556|581423988|FG001|Overall Study|Death|4|||
161010532|NCT04690556|581423987|FG000|Overall Study|Lost to Follow-up|3|||
161010533|NCT04690556|581423988|FG001|Overall Study|Lost to Follow-up|2|||
161010534|NCT04690556|581423987|FG000|Overall Study|Protocol Violation|1|||
161010535|NCT04690556|581423988|FG001|Overall Study|Protocol Violation|4|||
161010536|NCT04690556|581423987|FG000|Overall Study|Physician Decision|2|||
161010537|NCT04690556|581423988|FG001|Overall Study|Physician Decision|0|||
161010538|NCT04690556|581423987|FG000|Overall Study|Withdrawal by Subject|25|||
161010539|NCT04690556|581423988|FG001|Overall Study|Withdrawal by Subject|17|||
161010540|NCT04690556|581423987|FG000|Overall Study|Prohibited medications and other reasons|3|||
161010541|NCT04690556|581423988|FG001|Overall Study|Prohibited medications and other reasons|1|||
161010542|NCT00497198|581423989|FG000|Overall Study|Adverse Event|4|||
161010543|NCT00497198|581423990|FG001|Overall Study|Adverse Event|2|||
161010544|NCT00497198|581423989|FG000|Overall Study|Physician Decision|1|||
161010545|NCT00497198|581423990|FG001|Overall Study|Physician Decision|2|||
161010546|NCT00497198|581423989|FG000|Overall Study|Withdrawal by Subject|0|||
161010547|NCT00497198|581423990|FG001|Overall Study|Withdrawal by Subject|1|||
161010548|NCT05028582|581423992|FG000|Overall Study|Lost to Follow-up|11|||
161010549|NCT05028582|581423993|FG001|Overall Study|Lost to Follow-up|9|||
161010550|NCT05028582|581423992|FG000|Overall Study|Withdrawal by Subject|9|||
161010551|NCT05028582|581423993|FG001|Overall Study|Withdrawal by Subject|10|||
161010552|NCT05028582|581423992|FG000|Overall Study|Adverse Event|5|||
161010553|NCT05028582|581423993|FG001|Overall Study|Adverse Event|2|||
161010554|NCT05028582|581423992|FG000|Overall Study|Miscellaneous|3|||
161010555|NCT05028582|581423993|FG001|Overall Study|Miscellaneous|2|||
161010556|NCT05028582|581423992|FG000|Overall Study|Lack of Efficacy|3|||
161010557|NCT05028582|581423993|FG001|Overall Study|Lack of Efficacy|1|||
161010558|NCT05028582|581423992|FG000|Overall Study|Physician Decision|0|||
161010559|NCT05028582|581423993|FG001|Overall Study|Physician Decision|1|||
161010560|NCT06938230|581423997|FG000|Overall Study|Lost to Follow-up|56|||
161010561|NCT06938230|581423998|FG001|Overall Study|Lost to Follow-up|18|||
161010562|NCT00330681|581424002|FG000|Overall Study|Adverse Event|3|||
161010563|NCT00330681|581424003|FG001|Overall Study|Adverse Event|6|||
161010564|NCT00330681|581424002|FG000|Overall Study|Protocol Violation|0|||
161010565|NCT00330681|581424003|FG001|Overall Study|Protocol Violation|1|||
161010566|NCT00330681|581424002|FG000|Overall Study|Withdrawal by Subject|5|||
161010567|NCT00330681|581424003|FG001|Overall Study|Withdrawal by Subject|5|||
161010568|NCT00330681|581424002|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
161010569|NCT00330681|581424003|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
161010570|NCT04310735|581425444|FG000|Overall Study|Withdrawal by Subject|1|||
161010571|NCT04310735|581425445|FG001|Overall Study|Withdrawal by Subject|3|||
161010572|NCT04310735|581425446|FG002|Overall Study|Withdrawal by Subject|8|||
161010573|NCT04310735|581425444|FG000|Overall Study|Equipment malfunction|0|||
161010574|NCT04310735|581425445|FG001|Overall Study|Equipment malfunction|1|||
161010575|NCT04310735|581425446|FG002|Overall Study|Equipment malfunction|0|||
161010576|NCT03012841|581425447|FG000|Overall Study|Protocol Violation|0|||
161010577|NCT03012841|581425448|FG001|Overall Study|Protocol Violation|10|||
161010578|NCT03012841|581425447|FG000|Overall Study|Lost to Follow-up|6|||
161010579|NCT03012841|581425448|FG001|Overall Study|Lost to Follow-up|1|||
161010580|NCT03012841|581425447|FG000|Overall Study|Withdrawal by Subject|6|||
161010581|NCT03012841|581425448|FG001|Overall Study|Withdrawal by Subject|0|||
161010582|NCT03012841|581425447|FG000|Overall Study|Unable to complete 12 month visit|6|||
161010583|NCT03012841|581425448|FG001|Overall Study|Unable to complete 12 month visit|0|||
161010584|NCT03012841|581425447|FG000|Overall Study|Subject relocation|1|||
161010585|NCT03012841|581425448|FG001|Overall Study|Subject relocation|0|||
161010586|NCT03012841|581425447|FG000|Overall Study|Seasonal winter travel|1|||
161010587|NCT03012841|581425448|FG001|Overall Study|Seasonal winter travel|0|||
161010588|NCT03012841|581425447|FG000|Overall Study|Physician Decision|0|||
161010589|NCT03012841|581425448|FG001|Overall Study|Physician Decision|2|||
161010590|NCT03012841|581425447|FG000|Overall Study|No ablation performed|0|||
161010591|NCT03012841|581425448|FG001|Overall Study|No ablation performed|2|||
161010592|NCT03012841|581425447|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
160585597|NCT02739594|579861971|FG001|Overall Study|Protocol Violation|6|||
160585598|NCT02739594|579861970|FG000|Overall Study|Death|4|||
161010593|NCT03012841|581425448|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
161010594|NCT03012841|581425447|FG000|Overall Study|Insurance change|0|||
161010595|NCT03012841|581425448|FG001|Overall Study|Insurance change|1|||
161010596|NCT05696080|581425449|FG000|Overall Study|Lost to Follow-up|2|||
161010597|NCT05696080|581425450|FG001|Overall Study|Lost to Follow-up|1|||
161010598|NCT05696080|581425449|FG000|Overall Study|Physician Decision|1|||
161010599|NCT05696080|581425450|FG001|Overall Study|Physician Decision|0|||
161010600|NCT05696080|581425449|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161010601|NCT05696080|581425450|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161010602|NCT05696080|581425449|FG000|Overall Study|Withdrawal by Subject|12|||
161010603|NCT05696080|581425450|FG001|Overall Study|Withdrawal by Subject|0|||
161010604|NCT03398200|581425451|FG000|Overall Study|Withdrawal by Subject|0|||
161010605|NCT03398200|581425452|FG001|Overall Study|Withdrawal by Subject|1|||
161010606|NCT04065048|581425453|FG000|Overall Study|Withdrawal by Subject|1|||
161010607|NCT04065048|581425454|FG001|Overall Study|Withdrawal by Subject|2|||
161010608|NCT04065048|581425455|FG002|Overall Study|Withdrawal by Subject|1|||
161010609|NCT04065048|581425456|FG003|Overall Study|Withdrawal by Subject|1|||
161010610|NCT04065048|581425453|FG000|Overall Study|Adverse Event|1|||
161010611|NCT04065048|581425454|FG001|Overall Study|Adverse Event|0|||
161010612|NCT04065048|581425455|FG002|Overall Study|Adverse Event|1|||
161010613|NCT04065048|581425456|FG003|Overall Study|Adverse Event|0|||
161010614|NCT03397108|581425457|FG000|Overall Study|Lost to Follow-up|15|||
161010615|NCT03397108|581425458|FG001|Overall Study|Lost to Follow-up|0|||
161010616|NCT03397108|581425457|FG000|Overall Study|Insufficient milk production|3|||
161010617|NCT03397108|581425458|FG001|Overall Study|Insufficient milk production|2|||
161010618|NCT03397108|581425457|FG000|Overall Study|Withdrawal by Subject|2|||
161010619|NCT03397108|581425458|FG001|Overall Study|Withdrawal by Subject|0|||
161010620|NCT05096819|581425461|FG000|Overall Study|Withdrawal by Subject|3|||
161010621|NCT05096819|581425462|FG001|Overall Study|Withdrawal by Subject|0|||
161010622|NCT03324984|581425463|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
161010623|NCT03324984|581425464|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
161010624|NCT04607044|581425465|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
161010625|NCT04607044|581425465|FG000|Overall Study|Adverse Event|1|||
161010626|NCT04607044|581425465|FG000|Overall Study|Did not receive study device|3|||
161010627|NCT04607044|581425465|FG000|Overall Study|Death|1|||
161010628|NCT04337372|581425469|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
161010629|NCT04337372|581425470|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
161010630|NCT04337372|581425471|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
161010631|NCT04337372|581425472|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
161010632|NCT04337372|581425469|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
161010633|NCT04337372|581425470|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
161010634|NCT04337372|581425471|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
161010635|NCT04337372|581425472|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
161010636|NCT04337372|581425469|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
161010637|NCT04337372|581425470|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
161010638|NCT04337372|581425471|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
161010639|NCT04337372|581425472|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
161010640|NCT04337372|581425469|FG000|Day 2: EEG Measures|Protocol Violation|6|||
161010641|NCT04337372|581425470|FG001|Day 2: EEG Measures|Protocol Violation|6|||
161010642|NCT04337372|581425471|FG002|Day 2: EEG Measures|Protocol Violation|5|||
161010643|NCT04337372|581425472|FG003|Day 2: EEG Measures|Protocol Violation|17|||
161010644|NCT05307783|581425473|FG000|Overall Study|Death|7|||
161010645|NCT05307783|581425473|FG000|Overall Study|Lost to Follow-up|4|||
161010646|NCT04883645|581425474|FG000|Overall Study|Death|1|||
161010647|NCT04869982|581425479|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
161010648|NCT04869982|581425480|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
161010649|NCT04869982|581425479|FG000|Overall Study|Migrated / moved from the study area|1|||
161010650|NCT04869982|581425480|FG001|Overall Study|Migrated / moved from the study area|1|||
161010651|NCT04869982|581425479|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
161010652|NCT04869982|581425480|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
161010653|NCT04869982|581425479|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
161010654|NCT04869982|581425480|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
161010655|NCT04869982|581425479|FG000|Overall Study|Solicited adverse event|2|||
161010656|NCT04869982|581425480|FG001|Overall Study|Solicited adverse event|1|||
161010657|NCT02473250|581425482|FG000|Overall Study|Lost to Follow-up|10|||
161010658|NCT02473250|581425482|FG000|Overall Study|Physician Decision|5|||
161010659|NCT02473250|581425482|FG000|Overall Study|Did not tolerate medication washout|3|||
161010660|NCT02473250|581425482|FG000|Overall Study|Antidepressant effect of divalproex|2|||
161010661|NCT01704079|581425486|FG000|Overall Study|Withdrawal by Subject|5|||
161010662|NCT01704079|581425487|FG001|Overall Study|Withdrawal by Subject|7|||
161010663|NCT01704079|581425486|FG000|Overall Study|Lost to Follow-up|2|||
161010664|NCT01704079|581425487|FG001|Overall Study|Lost to Follow-up|5|||
161010665|NCT01704079|581425486|FG000|Overall Study|Adverse Event|4|||
161010666|NCT01704079|581425487|FG001|Overall Study|Adverse Event|7|||
161010667|NCT01704079|581425486|FG000|Overall Study|Protocol Violation|1|||
161010668|NCT01704079|581425487|FG001|Overall Study|Protocol Violation|0|||
161010669|NCT01704079|581425486|FG000|Overall Study|Subject noncompliance|2|||
161010670|NCT01704079|581425487|FG001|Overall Study|Subject noncompliance|3|||
160458777|NCT04629339|579412651|FG000|Overall Study|Withdrawal by Subject|0|||
161010671|NCT01704079|581425486|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
161010672|NCT01704079|581425487|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
161010673|NCT03584516|581425488|FG000|Part 1|Death|2|||
161010674|NCT03584516|581425489|FG001|Part 1|Death|3|||
161010675|NCT03584516|581425490|FG002|Part 1|Death|0|||
160967214|NCT01591382|581268188|FG001|Overall Study|Discharged Prior to Study Completion|1|||
160967215|NCT01591382|581268187|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
160967216|NCT01591382|581268188|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
160967217|NCT01784068|581268192|FG000|NTCS Phase|Adverse Event|5|||
160967218|NCT01784068|581268193|FG001|NTCS Phase|Adverse Event|0|||
160967219|NCT01784068|581268192|FG000|NTCS Phase|Physician Decision|2|||
160967220|NCT01784068|581268193|FG001|NTCS Phase|Physician Decision|0|||
160967221|NCT01784068|581268192|FG000|NTCS Phase|Patient/guardian decision|3|||
160967222|NCT01784068|581268193|FG001|NTCS Phase|Patient/guardian decision|0|||
160967223|NCT01784068|581268192|FG000|NTCS Phase|Death|2|||
160967224|NCT01784068|581268193|FG001|NTCS Phase|Death|0|||
160967225|NCT01784068|581268192|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
160967226|NCT01784068|581268193|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
160967227|NCT01784068|581268192|FG000|TFR Phase|Physician Decision|0|||
160967228|NCT01784068|581268193|FG001|TFR Phase|Physician Decision|1|||
160967229|NCT01784068|581268192|FG000|TFR Phase|Patient/guardian decision|0|||
160967230|NCT01784068|581268193|FG001|TFR Phase|Patient/guardian decision|3|||
160967231|NCT01784068|581268192|FG000|TFR Phase|Death|0|||
160967232|NCT01784068|581268193|FG001|TFR Phase|Death|1|||
160967233|NCT01784068|581268192|FG000|TFR Phase|Lack of Efficacy|0|||
160967234|NCT01784068|581268193|FG001|TFR Phase|Lack of Efficacy|88|||
160967235|NCT06351371|581268194|FG000|Overall Study|Mutation Status Not Confirmed|9|||
160967236|NCT06351371|581268194|FG000|Overall Study|Ineligible|1|||
160967237|NCT06351371|581268194|FG000|Overall Study|Adverse Event|4|||
160967238|NCT06351371|581268194|FG000|Overall Study|Death|1|||
160967239|NCT06351371|581268194|FG000|Overall Study|Disease progression|14|||
160967240|NCT06351371|581268194|FG000|Overall Study|Withdrawal by Subject|3|||
160967241|NCT06351371|581268194|FG000|Overall Study|Physician Decision|3|||
160967242|NCT04359784|581268195|FG000|Overall Study|Death|2|||
160967243|NCT02063828|581268196|FG000|Overall Study|Withdrawal by Subject|4|||
160967244|NCT02063828|581268197|FG001|Overall Study|Withdrawal by Subject|6|||
160967245|NCT02063828|581268198|FG002|Overall Study|Withdrawal by Subject|3|||
160967246|NCT02063828|581268196|FG000|Overall Study|Death|0|||
160967247|NCT02063828|581268197|FG001|Overall Study|Death|0|||
160967248|NCT02063828|581268198|FG002|Overall Study|Death|1|||
160967249|NCT02753595|581268199|FG000|Overall Study|Sponsor termination|2|||
160967250|NCT02753595|581268200|FG001|Overall Study|Sponsor termination|2|||
160967251|NCT02515279|581268204|FG000|Overall Study|Adverse Event|7|||
160967252|NCT02515279|581268204|FG000|Overall Study|Lack of Efficacy|31|||
160967253|NCT02515279|581268204|FG000|Overall Study|Lost to Follow-up|9|||
160967254|NCT02515279|581268204|FG000|Overall Study|Withdrawal by Subject|18|||
160967255|NCT02515279|581268204|FG000|Overall Study|End-of-treatment visit not attended|17|||
160967256|NCT02515279|581268204|FG000|Overall Study|Other|22|||
160967257|NCT01800968|581268205|FG000|Overall Study|Death|23|||
160967258|NCT01800968|581268206|FG001|Overall Study|Death|16|||
160967259|NCT01800968|581268205|FG000|Overall Study|Lost to Follow-up|5|||
160967260|NCT01800968|581268206|FG001|Overall Study|Lost to Follow-up|7|||
160967261|NCT01800968|581268205|FG000|Overall Study|Withdrawal by Subject|7|||
160967262|NCT01800968|581268206|FG001|Overall Study|Withdrawal by Subject|9|||
160967263|NCT01800968|581268205|FG000|Overall Study|Physician Decision|1|||
160967264|NCT01800968|581268206|FG001|Overall Study|Physician Decision|0|||
160967265|NCT04987762|581268208|FG000|Overall Study|Study was Terminated by Sponsor|103|||
160967266|NCT03185481|581268209|FG000|Overall Study|Adverse Event|1|||
160967267|NCT03185481|581268209|FG000|Overall Study|Study Terminated by Sponsor|4|||
160967268|NCT00701038|581268215|FG000|Overall Study|study amended pilot group of patients|4|||
160967269|NCT00701038|581268216|FG001|Overall Study|study amended pilot group of patients|4|||
160967270|NCT03371940|581268219|FG000|Overall Study|Withdrawal by Subject|8|||
160967271|NCT03371940|581268220|FG001|Overall Study|Withdrawal by Subject|1|||
160967272|NCT03371940|581268221|FG002|Overall Study|Withdrawal by Subject|3|||
160967273|NCT03371940|581268222|FG003|Overall Study|Withdrawal by Subject|4|||
160967274|NCT05099926|581268225|FG000|Overall Study|Lost to Follow-up|1|||
160967275|NCT02068495|581268231|FG000|Overall Study|Case Report Forms Uncollected|60|||
160967276|NCT02068495|581268231|FG000|Overall Study|Protocol Deviation|49|||
160967277|NCT01666808|581268234|FG000|Overall Study|Lost to Follow-up|9|||
160967278|NCT01666808|581268235|FG001|Overall Study|Lost to Follow-up|15|||
160967279|NCT01666808|581268234|FG000|Overall Study|Withdrawal by Subject|3|||
160967280|NCT01666808|581268235|FG001|Overall Study|Withdrawal by Subject|1|||
160967281|NCT01666808|581268234|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
160967282|NCT01666808|581268235|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
160967283|NCT02220894|581268236|FG000|Overall Study|Adverse Event|127|||
160967284|NCT02220894|581268237|FG001|Overall Study|Adverse Event|74|||
160967285|NCT02220894|581268236|FG000|Overall Study|Death|418|||
160585599|NCT02739594|579861971|FG001|Overall Study|Death|2|||
160585600|NCT02739594|579861970|FG000|Overall Study|Renal Insufficiency|4|||
160585601|NCT02739594|579861971|FG001|Overall Study|Renal Insufficiency|6|||
160967286|NCT02220894|581268237|FG001|Overall Study|Death|508|||
160967287|NCT02220894|581268236|FG000|Overall Study|Lost to Follow-up|0|||
160967288|NCT02220894|581268237|FG001|Overall Study|Lost to Follow-up|4|||
161010676|NCT03584516|581425491|FG003|Part 1|Death|0|||
161010677|NCT03584516|581425492|FG004|Part 1|Death|0|||
161010678|NCT03584516|581425493|FG005|Part 1|Death|0|||
161010679|NCT03584516|581425488|FG000|Part 1|Withdrawal by Subject|2|||
161010680|NCT03584516|581425489|FG001|Part 1|Withdrawal by Subject|0|||
161010681|NCT03584516|581425490|FG002|Part 1|Withdrawal by Subject|0|||
161010682|NCT03584516|581425491|FG003|Part 1|Withdrawal by Subject|0|||
161010683|NCT03584516|581425492|FG004|Part 1|Withdrawal by Subject|0|||
161010684|NCT03584516|581425493|FG005|Part 1|Withdrawal by Subject|0|||
161010685|NCT03584516|581425488|FG000|Part 1|Lost to Follow-up|1|||
161010686|NCT03584516|581425489|FG001|Part 1|Lost to Follow-up|0|||
161010687|NCT03584516|581425490|FG002|Part 1|Lost to Follow-up|0|||
161010688|NCT03584516|581425491|FG003|Part 1|Lost to Follow-up|0|||
161010689|NCT03584516|581425492|FG004|Part 1|Lost to Follow-up|0|||
161010690|NCT03584516|581425493|FG005|Part 1|Lost to Follow-up|0|||
161010691|NCT03584516|581425488|FG000|Part 1|Study Terminated by Sponsor|0|||
161010692|NCT03584516|581425489|FG001|Part 1|Study Terminated by Sponsor|2|||
161010693|NCT03584516|581425490|FG002|Part 1|Study Terminated by Sponsor|0|||
161010694|NCT03584516|581425491|FG003|Part 1|Study Terminated by Sponsor|0|||
161010695|NCT03584516|581425492|FG004|Part 1|Study Terminated by Sponsor|0|||
161010696|NCT03584516|581425493|FG005|Part 1|Study Terminated by Sponsor|0|||
161010697|NCT03584516|581425488|FG000|Part 1 Expansion|Death|0|||
161010698|NCT03584516|581425489|FG001|Part 1 Expansion|Death|0|||
161010699|NCT03584516|581425490|FG002|Part 1 Expansion|Death|9|||
161010700|NCT03584516|581425491|FG003|Part 1 Expansion|Death|8|||
161010701|NCT03584516|581425492|FG004|Part 1 Expansion|Death|4|||
161010702|NCT03584516|581425493|FG005|Part 1 Expansion|Death|5|||
161010703|NCT03584516|581425488|FG000|Part 1 Expansion|Lost to Follow-up|0|||
161010704|NCT03584516|581425489|FG001|Part 1 Expansion|Lost to Follow-up|0|||
161010705|NCT03584516|581425490|FG002|Part 1 Expansion|Lost to Follow-up|0|||
161010706|NCT03584516|581425491|FG003|Part 1 Expansion|Lost to Follow-up|1|||
161010707|NCT03584516|581425492|FG004|Part 1 Expansion|Lost to Follow-up|0|||
161010708|NCT03584516|581425493|FG005|Part 1 Expansion|Lost to Follow-up|0|||
161010709|NCT03584516|581425488|FG000|Part 1 Expansion|Physician Decision|0|||
161010710|NCT03584516|581425489|FG001|Part 1 Expansion|Physician Decision|0|||
161010711|NCT03584516|581425490|FG002|Part 1 Expansion|Physician Decision|4|||
161010712|NCT03584516|581425491|FG003|Part 1 Expansion|Physician Decision|3|||
161010713|NCT03584516|581425492|FG004|Part 1 Expansion|Physician Decision|2|||
161010714|NCT03584516|581425493|FG005|Part 1 Expansion|Physician Decision|3|||
161010715|NCT03584516|581425488|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
161010716|NCT03584516|581425489|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
161010717|NCT03584516|581425490|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
161010718|NCT03584516|581425491|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
161010719|NCT03584516|581425492|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
161010720|NCT03584516|581425493|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
161010721|NCT03584516|581425488|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
161010722|NCT03584516|581425489|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
161010723|NCT03584516|581425490|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
161010724|NCT03584516|581425491|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
161010725|NCT03584516|581425492|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
161010726|NCT03584516|581425493|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
161010727|NCT03584516|581425488|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161010728|NCT03584516|581425489|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161010729|NCT03584516|581425490|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161010730|NCT03584516|581425491|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
161010731|NCT03584516|581425492|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
160458778|NCT04629339|579412652|FG001|Overall Study|Withdrawal by Subject|0|||
161010732|NCT03584516|581425493|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161010733|NCT03584516|581425488|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161010734|NCT03584516|581425489|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161010735|NCT03584516|581425490|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
160458779|NCT04629339|579412653|FG002|Overall Study|Withdrawal by Subject|2|||
160458780|NCT04629339|579412654|FG003|Overall Study|Withdrawal by Subject|2|||
160458781|NCT04629339|579412655|FG004|Overall Study|Withdrawal by Subject|0|||
160458782|NCT04158739|579412658|FG000|Overall Study|Adverse Event|1|||
160458783|NCT04158739|579412659|FG001|Overall Study|Adverse Event|0|||
160458784|NCT04158739|579412658|FG000|Overall Study|Death|0|||
160458785|NCT04158739|579412659|FG001|Overall Study|Death|1|||
160458786|NCT04158739|579412658|FG000|Overall Study|Lack of Efficacy|3|||
160458787|NCT04158739|579412659|FG001|Overall Study|Lack of Efficacy|7|||
160458788|NCT04158739|579412658|FG000|Overall Study|Physician Decision|0|||
161010736|NCT03584516|581425491|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161010737|NCT03584516|581425492|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
160458789|NCT04158739|579412659|FG001|Overall Study|Physician Decision|1|||
161010738|NCT03584516|581425493|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
161010739|NCT01443845|581425500|FG000|Overall Study|Protocol Violation|43|||
161010740|NCT01443845|581425501|FG001|Overall Study|Protocol Violation|45|||
161010741|NCT01443845|581425500|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
161010742|NCT01443845|581425501|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
161010743|NCT01443845|581425500|FG000|Overall Study|Deterioration in pulmonary function|1|||
161010744|NCT01443845|581425501|FG001|Overall Study|Deterioration in pulmonary function|4|||
161010745|NCT01443845|581425500|FG000|Overall Study|Lack of Efficacy|10|||
161010746|NCT01443845|581425501|FG001|Overall Study|Lack of Efficacy|5|||
161010747|NCT01443845|581425500|FG000|Overall Study|Adverse Event|64|||
161010748|NCT01443845|581425501|FG001|Overall Study|Adverse Event|138|||
161010749|NCT01443845|581425500|FG000|Overall Study|Withdrawal by Subject|63|||
161010750|NCT01443845|581425501|FG001|Overall Study|Withdrawal by Subject|67|||
161010751|NCT01443845|581425500|FG000|Overall Study|Military Conflict - Site Terminated|20|||
161010752|NCT01443845|581425501|FG001|Overall Study|Military Conflict - Site Terminated|21|||
161010753|NCT01443845|581425500|FG000|Overall Study|Lost to Follow-up|9|||
161010754|NCT01443845|581425501|FG001|Overall Study|Lost to Follow-up|13|||
161010755|NCT01471691|581425504|FG000|Overall Study|Lack of Efficacy|0|||
161010756|NCT01471691|581425505|FG001|Overall Study|Lack of Efficacy|1|||
161010757|NCT01808339|581425506|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010758|NCT01808339|581425507|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010759|NCT01808339|581425508|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010760|NCT01808339|581425509|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
161010761|NCT01808339|581425510|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
161010762|NCT01808339|581425511|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
161010763|NCT01808339|581425506|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161010764|NCT01808339|581425507|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161010765|NCT01808339|581425508|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161010766|NCT01808339|581425509|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161010767|NCT01808339|581425510|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161010768|NCT01808339|581425511|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161010769|NCT01808339|581425506|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010770|NCT01808339|581425507|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010771|NCT01808339|581425508|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
161010772|NCT01808339|581425509|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010773|NCT01808339|581425510|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010774|NCT01808339|581425511|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010775|NCT02461628|581425512|FG000|Overall Study|Refused to complete survey|4|||
161010776|NCT02461628|581425513|FG001|Overall Study|Refused to complete survey|7|||
161010777|NCT02462759|581425516|FG000|Part 1: Double Blind|Death|1|||
161010778|NCT02462759|581425517|FG001|Part 1: Double Blind|Death|0|||
161010779|NCT02462759|581425518|FG002|Part 1: Double Blind|Death|0|||
161010780|NCT00243503|581425519|FG000|Overall Study|Adverse Event|11|||
161010781|NCT00243503|581425519|FG000|Overall Study|Withdrawal by Subject|1|||
161010782|NCT00243503|581425519|FG000|Overall Study|Lack of Efficacy|44|||
161010783|NCT00243503|581425519|FG000|Overall Study|Death|1|||
161010784|NCT00243503|581425519|FG000|Overall Study|Other|1|||
161010785|NCT00520546|581425523|FG000|Overall Study|Withdrawal by Subject|1|||
161010786|NCT00520546|581425523|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
161010787|NCT03988023|581425525|FG000|Overall Study|Non-compliance|3|||
161010788|NCT03988023|581425526|FG001|Overall Study|Non-compliance|0|||
161010789|NCT03988023|581425525|FG000|Overall Study|Withdrawal by Subject|39|||
161010790|NCT03988023|581425526|FG001|Overall Study|Withdrawal by Subject|37|||
161010791|NCT03988023|581425525|FG000|Overall Study|Adverse Event|0|||
161010792|NCT03988023|581425526|FG001|Overall Study|Adverse Event|2|||
161010793|NCT03988023|581425525|FG000|Overall Study|Physician Decision|0|||
161010794|NCT03988023|581425526|FG001|Overall Study|Physician Decision|1|||
161010795|NCT03988023|581425525|FG000|Overall Study|Lost to Follow-up|5|||
161010796|NCT03988023|581425526|FG001|Overall Study|Lost to Follow-up|8|||
161010797|NCT03988023|581425525|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
161010798|NCT03988023|581425526|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
161010799|NCT03988023|581425525|FG000|Overall Study|Lack of Efficacy|3|||
161010800|NCT03988023|581425526|FG001|Overall Study|Lack of Efficacy|1|||
161010801|NCT03988023|581425525|FG000|Overall Study|COVID-19 pandemic|225|||
161010802|NCT03988023|581425526|FG001|Overall Study|COVID-19 pandemic|227|||
160585602|NCT02739594|579861970|FG000|Overall Study|Administrative Reasons|1|||
160585603|NCT02739594|579861971|FG001|Overall Study|Administrative Reasons|3|||
160585604|NCT02739594|579861970|FG000|Overall Study|Withdrawal by Subject|1|||
161010803|NCT02101281|581425527|FG000|Overall Study|Adverse Event|0|||
161010804|NCT02101281|581425528|FG001|Overall Study|Adverse Event|1|||
161010805|NCT02554786|581425531|FG000|Overall Study|Subject/guardian decision|29|||
161010806|NCT02554786|581425532|FG001|Overall Study|Subject/guardian decision|17|||
161010807|NCT02554786|581425533|FG002|Overall Study|Subject/guardian decision|18|||
160585605|NCT02739594|579861971|FG001|Overall Study|Withdrawal by Subject|1|||
160585606|NCT02739594|579861970|FG000|Overall Study|Lost to Follow-up|0|||
160585607|NCT02739594|579861971|FG001|Overall Study|Lost to Follow-up|1|||
160585608|NCT02739594|579861970|FG000|Overall Study|Elevated Serum Creatinine|0|||
160585609|NCT02739594|579861971|FG001|Overall Study|Elevated Serum Creatinine|1|||
160585610|NCT02739594|579861970|FG000|Overall Study|Other|6|||
160585611|NCT02739594|579861971|FG001|Overall Study|Other|2|||
160585612|NCT00952289|579861972|FG000|All Participants|Death|9|||
160585613|NCT00952289|579861973|FG001|All Participants|Death|9|||
161010808|NCT02554786|581425534|FG003|Overall Study|Subject/guardian decision|30|||
161010809|NCT02554786|581425535|FG004|Overall Study|Subject/guardian decision|20|||
161010810|NCT02554786|581425531|FG000|Overall Study|Lost to Follow-up|4|||
161010811|NCT02554786|581425532|FG001|Overall Study|Lost to Follow-up|3|||
161010812|NCT02554786|581425533|FG002|Overall Study|Lost to Follow-up|4|||
161010813|NCT02554786|581425534|FG003|Overall Study|Lost to Follow-up|2|||
161010814|NCT02554786|581425535|FG004|Overall Study|Lost to Follow-up|2|||
161010815|NCT02554786|581425531|FG000|Overall Study|Protocol deviation|1|||
161010816|NCT02554786|581425532|FG001|Overall Study|Protocol deviation|3|||
161010817|NCT02554786|581425533|FG002|Overall Study|Protocol deviation|3|||
161010818|NCT02554786|581425534|FG003|Overall Study|Protocol deviation|4|||
161010819|NCT02554786|581425535|FG004|Overall Study|Protocol deviation|2|||
161010820|NCT02554786|581425531|FG000|Overall Study|Technical problems|1|||
161010821|NCT02554786|581425532|FG001|Overall Study|Technical problems|1|||
161010822|NCT02554786|581425533|FG002|Overall Study|Technical problems|0|||
161010823|NCT02554786|581425534|FG003|Overall Study|Technical problems|2|||
161010824|NCT02554786|581425535|FG004|Overall Study|Technical problems|1|||
161010825|NCT02554786|581425531|FG000|Overall Study|Adverse Event|0|||
161010826|NCT02554786|581425532|FG001|Overall Study|Adverse Event|0|||
161010827|NCT02554786|581425533|FG002|Overall Study|Adverse Event|0|||
161010828|NCT02554786|581425534|FG003|Overall Study|Adverse Event|0|||
161010829|NCT02554786|581425535|FG004|Overall Study|Adverse Event|2|||
161010830|NCT02554786|581425531|FG000|Overall Study|Death|0|||
161010831|NCT02554786|581425532|FG001|Overall Study|Death|0|||
161010832|NCT02554786|581425533|FG002|Overall Study|Death|0|||
161010833|NCT02554786|581425534|FG003|Overall Study|Death|1|||
161010834|NCT02554786|581425535|FG004|Overall Study|Death|0|||
161010835|NCT02554786|581425531|FG000|Overall Study|Non-compliance with study treatment|0|||
161010836|NCT02554786|581425532|FG001|Overall Study|Non-compliance with study treatment|1|||
161010837|NCT02554786|581425533|FG002|Overall Study|Non-compliance with study treatment|1|||
161010838|NCT02554786|581425534|FG003|Overall Study|Non-compliance with study treatment|0|||
161010839|NCT02554786|581425535|FG004|Overall Study|Non-compliance with study treatment|1|||
161010840|NCT02554786|581425531|FG000|Overall Study|Physician Decision|0|||
161010841|NCT02554786|581425532|FG001|Overall Study|Physician Decision|1|||
161010842|NCT02554786|581425533|FG002|Overall Study|Physician Decision|4|||
161010843|NCT02554786|581425534|FG003|Overall Study|Physician Decision|1|||
161010844|NCT02554786|581425535|FG004|Overall Study|Physician Decision|1|||
161010845|NCT02554786|581425531|FG000|Overall Study|Pregnancy|0|||
161010846|NCT02554786|581425532|FG001|Overall Study|Pregnancy|0|||
161010847|NCT02554786|581425533|FG002|Overall Study|Pregnancy|0|||
161010848|NCT02554786|581425534|FG003|Overall Study|Pregnancy|1|||
161010849|NCT02554786|581425535|FG004|Overall Study|Pregnancy|1|||
161010850|NCT01695954|581425536|FG000|Overall Study|Withdrawal by Subject|4|||
161010851|NCT01695954|581425537|FG001|Overall Study|Withdrawal by Subject|0|||
161010852|NCT01695954|581425536|FG000|Overall Study|Adverse Event|0|||
160585614|NCT00952289|579861972|FG000|All Participants|Adverse Event|8|||
161010853|NCT01695954|581425537|FG001|Overall Study|Adverse Event|2|||
161010854|NCT01248936|581425548|FG000|Overall Study|Sponsor Decision|259|||
161010855|NCT01248936|581425548|FG000|Overall Study|Progression of Disease|50|||
161010856|NCT01248936|581425548|FG000|Overall Study|Death|26|||
161010857|NCT01248936|581425548|FG000|Overall Study|Withdrawal of Consent|20|||
161010858|NCT01248936|581425548|FG000|Overall Study|Adverse Event|8|||
161010859|NCT01248936|581425548|FG000|Overall Study|Lost to Follow-up|7|||
161010860|NCT01248936|581425548|FG000|Overall Study|Refused Treatment|1|||
161010861|NCT01248936|581425548|FG000|Overall Study|Other reason|3|||
161010862|NCT03930420|581425549|FG000|Overall Study|Withdrawal by Subject|7|||
160585615|NCT00952289|579861973|FG001|All Participants|Adverse Event|8|||
160585616|NCT00952289|579861972|FG000|All Participants|Disease progression|3|||
161010863|NCT03930420|581425550|FG001|Overall Study|Withdrawal by Subject|9|||
161010864|NCT05609032|581425551|FG000|Overall Study|Lost to Follow-up|3|||
161010865|NCT05609032|581425552|FG001|Overall Study|Lost to Follow-up|1|||
161010866|NCT05609032|581425551|FG000|Overall Study|Withdrawal by Subject|1|||
161010867|NCT05609032|581425552|FG001|Overall Study|Withdrawal by Subject|0|||
161010868|NCT00609336|581425553|FG000|Overall Study|Protocol Violation|3|||
161010869|NCT00609336|581425553|FG000|Overall Study|Death|1|||
160585617|NCT00952289|579861973|FG001|All Participants|Disease progression|12|||
161010870|NCT00609336|581425553|FG000|Overall Study|LA or Met at Surgery|9|||
161010871|NCT00567489|581425554|FG000|Overall Study|Adverse Event|6|||
161010872|NCT00567489|581425555|FG001|Overall Study|Adverse Event|14|||
161010873|NCT00567489|581425554|FG000|Overall Study|Physician Decision|0|||
161010874|NCT00567489|581425555|FG001|Overall Study|Physician Decision|4|||
161010875|NCT00567489|581425554|FG000|Overall Study|Withdrawal by Subject|0|||
161010876|NCT00567489|581425555|FG001|Overall Study|Withdrawal by Subject|2|||
161010877|NCT00567489|581425554|FG000|Overall Study|Renal Transplantation|0|||
161010878|NCT00567489|581425555|FG001|Overall Study|Renal Transplantation|3|||
161010879|NCT00567489|581425554|FG000|Overall Study|Other|1|||
161010880|NCT00567489|581425555|FG001|Overall Study|Other|0|||
161010881|NCT02692417|581425558|FG000|Overall Study|Withdrawal by Subject|5|||
161010882|NCT02692417|581425559|FG001|Overall Study|Withdrawal by Subject|1|||
161010883|NCT02692417|581425558|FG000|Overall Study|Adverse Event|1|||
161010884|NCT02692417|581425559|FG001|Overall Study|Adverse Event|0|||
161010885|NCT01551355|581425582|FG000|Overall Study|Lost to Follow-up|51|||
161010886|NCT01551355|581425583|FG001|Overall Study|Lost to Follow-up|49|||
161010887|NCT01551355|581425584|FG002|Overall Study|Lost to Follow-up|34|||
161010888|NCT01551355|581425585|FG003|Overall Study|Lost to Follow-up|24|||
161010889|NCT01551355|581425586|FG004|Overall Study|Lost to Follow-up|9|||
161010890|NCT01551355|581425587|FG005|Overall Study|Lost to Follow-up|6|||
161010891|NCT00031694|581425588|FG000|Overall Study|Adverse Event|12|||
161010892|NCT00031694|581425588|FG000|Overall Study|Death|2|||
161010893|NCT00031694|581425588|FG000|Overall Study|Withdrawal by Subject|5|||
161010894|NCT01255670|581425591|FG000|Overall Study|Adverse Event|10|||
161010895|NCT01255670|581425592|FG001|Overall Study|Adverse Event|10|||
161010896|NCT01255670|581425591|FG000|Overall Study|Lost to Follow-up|16|||
161010897|NCT01255670|581425592|FG001|Overall Study|Lost to Follow-up|10|||
161010898|NCT03892564|581425593|FG000|Overall Study|Withdrawal by Subject|2|||
161010899|NCT03664960|581425594|FG000|Overall Study|Adverse Event|0|||
161010900|NCT03664960|581425595|FG001|Overall Study|Adverse Event|3|||
161010901|NCT03664960|581425594|FG000|Overall Study|Lost to Follow-up|3|||
161010902|NCT03664960|581425595|FG001|Overall Study|Lost to Follow-up|2|||
161010903|NCT03664960|581425594|FG000|Overall Study|Physician Decision|1|||
161010904|NCT03664960|581425595|FG001|Overall Study|Physician Decision|0|||
161010905|NCT03664960|581425594|FG000|Overall Study|Withdrawal by Subject|3|||
161010906|NCT03664960|581425595|FG001|Overall Study|Withdrawal by Subject|14|||
161010907|NCT03664960|581425594|FG000|Overall Study|Sponsor Decision|1|||
161010908|NCT03664960|581425595|FG001|Overall Study|Sponsor Decision|1|||
161010909|NCT03664960|581425594|FG000|Overall Study|Other|1|||
161010910|NCT03664960|581425595|FG001|Overall Study|Other|2|||
161010911|NCT04019444|581425596|FG000|Overall Study|Withdrawal by Subject|0|||
161010912|NCT04019444|581425597|FG001|Overall Study|Withdrawal by Subject|1|||
161010913|NCT04019444|581425598|FG002|Overall Study|Withdrawal by Subject|0|||
161010914|NCT04019444|581425599|FG003|Overall Study|Withdrawal by Subject|1|||
161010915|NCT04019444|581425596|FG000|Overall Study|Solicited Event|0|||
161010916|NCT04019444|581425597|FG001|Overall Study|Solicited Event|0|||
161010917|NCT04019444|581425598|FG002|Overall Study|Solicited Event|2|||
161010918|NCT04019444|581425599|FG003|Overall Study|Solicited Event|0|||
161010919|NCT03807778|581425600|FG000|Overall Study|Adverse Event|0|||
161010920|NCT03807778|581425601|FG001|Overall Study|Adverse Event|0|||
161010921|NCT03807778|581425602|FG002|Overall Study|Adverse Event|3|||
161010922|NCT03807778|581425603|FG003|Overall Study|Adverse Event|5|||
161010923|NCT03807778|581425600|FG000|Overall Study|Progressive Disease|4|||
161010924|NCT03807778|581425601|FG001|Overall Study|Progressive Disease|2|||
161010925|NCT03807778|581425602|FG002|Overall Study|Progressive Disease|8|||
161010926|NCT03807778|581425603|FG003|Overall Study|Progressive Disease|15|||
161010927|NCT03807778|581425600|FG000|Overall Study|Symptomatic Deterioration|0|||
161010928|NCT03807778|581425601|FG001|Overall Study|Symptomatic Deterioration|1|||
161010929|NCT03807778|581425602|FG002|Overall Study|Symptomatic Deterioration|0|||
160458790|NCT04158739|579412658|FG000|Overall Study|Withdrawal by Subject|3|||
160458791|NCT04158739|579412659|FG001|Overall Study|Withdrawal by Subject|0|||
160458792|NCT04778410|579412660|FG000|Safety Run-in Period|Death|5|||
160458793|NCT04778410|579412661|FG001|Safety Run-in Period|Death|6|||
160458794|NCT04778410|579412662|FG002|Safety Run-in Period|Death|0|||
160458795|NCT04778410|579412663|FG003|Safety Run-in Period|Death|0|||
160458796|NCT04778410|579412664|FG004|Safety Run-in Period|Death|0|||
160458797|NCT04778410|579412665|FG005|Safety Run-in Period|Death|0|||
161010930|NCT03807778|581425603|FG003|Overall Study|Symptomatic Deterioration|1|||
160458798|NCT04778410|579412660|FG000|Phase 2 Period|Death|0|||
160458799|NCT04778410|579412661|FG001|Phase 2 Period|Death|0|||
160458800|NCT04778410|579412662|FG002|Phase 2 Period|Death|0|||
161010931|NCT03807778|581425600|FG000|Overall Study|Withdrawal by Subject|0|||
161010932|NCT03807778|581425601|FG001|Overall Study|Withdrawal by Subject|1|||
161010933|NCT03807778|581425602|FG002|Overall Study|Withdrawal by Subject|0|||
161010934|NCT03807778|581425603|FG003|Overall Study|Withdrawal by Subject|1|||
161010935|NCT03807778|581425600|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
161010936|NCT03807778|581425601|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
161010937|NCT03807778|581425602|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
161010938|NCT03807778|581425603|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
161010939|NCT04278586|581427273|FG000|Overall Study|Withdrawal by Subject|13|||
161010940|NCT04278586|581427274|FG001|Overall Study|Withdrawal by Subject|6|||
161010941|NCT04278586|581427273|FG000|Overall Study|Lost to Follow-up|37|||
161010942|NCT04278586|581427274|FG001|Overall Study|Lost to Follow-up|24|||
161010943|NCT03954184|581427281|FG000|Overall Study|Lost to Follow-up|500|||
160585618|NCT00952289|579861972|FG000|All Participants|Withdrawal by Subject|1|||
160585619|NCT00952289|579861973|FG001|All Participants|Withdrawal by Subject|10|||
160585620|NCT00952289|579861972|FG000|All Participants|Data lost during site relocation|0|||
160585621|NCT00952289|579861973|FG001|All Participants|Data lost during site relocation|1|||
160585622|NCT00952289|579861972|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
160585623|NCT00952289|579861973|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
160585624|NCT00952289|579861972|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
160585625|NCT00952289|579861973|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
160967289|NCT02220894|581268236|FG000|Overall Study|Site Terminated by Sponsor|2|||
160967290|NCT02220894|581268237|FG001|Overall Study|Site Terminated by Sponsor|0|||
160967291|NCT02220894|581268236|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
160967292|NCT02220894|581268237|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
160967293|NCT02220894|581268236|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160967294|NCT02220894|581268237|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160967295|NCT02220894|581268236|FG000|Overall Study|Withdrawal by Subject|10|||
160967296|NCT02220894|581268237|FG001|Overall Study|Withdrawal by Subject|9|||
160967297|NCT03217747|581268238|FG000|Overall Study|Adverse Event|0|||
160967298|NCT03217747|581268239|FG001|Overall Study|Adverse Event|1|||
160967299|NCT03217747|581268240|FG002|Overall Study|Adverse Event|0|||
160967300|NCT03217747|581268241|FG003|Overall Study|Adverse Event|0|||
160967301|NCT03217747|581268242|FG004|Overall Study|Adverse Event|0|||
160967302|NCT03217747|581268243|FG005|Overall Study|Adverse Event|0|||
160967303|NCT03217747|581268244|FG006|Overall Study|Adverse Event|0|||
160967304|NCT03217747|581268245|FG007|Overall Study|Adverse Event|0|||
160967305|NCT03217747|581268246|FG008|Overall Study|Adverse Event|0|||
160967306|NCT03217747|581268247|FG009|Overall Study|Adverse Event|0|||
160967307|NCT03217747|581268248|FG010|Overall Study|Adverse Event|0|||
160967308|NCT03217747|581268249|FG011|Overall Study|Adverse Event|0|||
160967309|NCT03217747|581268250|FG012|Overall Study|Adverse Event|1|||
160967310|NCT03217747|581268251|FG013|Overall Study|Adverse Event|1|||
160967311|NCT03217747|581268238|FG000|Overall Study|Death|0|||
160967312|NCT03217747|581268239|FG001|Overall Study|Death|0|||
160967313|NCT03217747|581268240|FG002|Overall Study|Death|0|||
160967314|NCT03217747|581268241|FG003|Overall Study|Death|0|||
160967315|NCT03217747|581268242|FG004|Overall Study|Death|0|||
160967316|NCT03217747|581268243|FG005|Overall Study|Death|0|||
160967317|NCT03217747|581268244|FG006|Overall Study|Death|0|||
160967318|NCT03217747|581268245|FG007|Overall Study|Death|0|||
160967319|NCT03217747|581268246|FG008|Overall Study|Death|1|||
160967320|NCT03217747|581268247|FG009|Overall Study|Death|0|||
160967321|NCT03217747|581268248|FG010|Overall Study|Death|0|||
160967322|NCT03217747|581268249|FG011|Overall Study|Death|0|||
160967323|NCT03217747|581268250|FG012|Overall Study|Death|0|||
160967324|NCT03217747|581268251|FG013|Overall Study|Death|0|||
160967325|NCT03217747|581268238|FG000|Overall Study|Lack of Efficacy|12|||
160967326|NCT03217747|581268239|FG001|Overall Study|Lack of Efficacy|6|||
160967327|NCT03217747|581268240|FG002|Overall Study|Lack of Efficacy|15|||
160967328|NCT03217747|581268241|FG003|Overall Study|Lack of Efficacy|11|||
160967329|NCT03217747|581268242|FG004|Overall Study|Lack of Efficacy|3|||
160967330|NCT03217747|581268243|FG005|Overall Study|Lack of Efficacy|14|||
160967331|NCT03217747|581268244|FG006|Overall Study|Lack of Efficacy|10|||
160967332|NCT03217747|581268245|FG007|Overall Study|Lack of Efficacy|4|||
160967333|NCT03217747|581268246|FG008|Overall Study|Lack of Efficacy|2|||
160967334|NCT03217747|581268247|FG009|Overall Study|Lack of Efficacy|7|||
160967335|NCT03217747|581268248|FG010|Overall Study|Lack of Efficacy|3|||
160967336|NCT03217747|581268249|FG011|Overall Study|Lack of Efficacy|1|||
160967337|NCT03217747|581268250|FG012|Overall Study|Lack of Efficacy|3|||
160967338|NCT03217747|581268251|FG013|Overall Study|Lack of Efficacy|1|||
160967339|NCT03217747|581268238|FG000|Overall Study|Withdrawal by Subject|2|||
160967340|NCT03217747|581268239|FG001|Overall Study|Withdrawal by Subject|1|||
160967341|NCT03217747|581268240|FG002|Overall Study|Withdrawal by Subject|1|||
160967342|NCT03217747|581268241|FG003|Overall Study|Withdrawal by Subject|1|||
160585626|NCT00952289|579861972|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
160585627|NCT00952289|579861973|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
160585628|NCT00952289|579861972|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
160967343|NCT03217747|581268242|FG004|Overall Study|Withdrawal by Subject|1|||
160967344|NCT03217747|581268243|FG005|Overall Study|Withdrawal by Subject|2|||
160967345|NCT03217747|581268244|FG006|Overall Study|Withdrawal by Subject|1|||
160967346|NCT03217747|581268245|FG007|Overall Study|Withdrawal by Subject|0|||
160967347|NCT03217747|581268246|FG008|Overall Study|Withdrawal by Subject|0|||
160967348|NCT03217747|581268247|FG009|Overall Study|Withdrawal by Subject|0|||
160967349|NCT03217747|581268248|FG010|Overall Study|Withdrawal by Subject|0|||
160967350|NCT03217747|581268249|FG011|Overall Study|Withdrawal by Subject|1|||
160967351|NCT03217747|581268250|FG012|Overall Study|Withdrawal by Subject|0|||
160967352|NCT03217747|581268251|FG013|Overall Study|Withdrawal by Subject|1|||
160967353|NCT03217747|581268238|FG000|Overall Study|Toxicity and progression|1|||
160967354|NCT03217747|581268239|FG001|Overall Study|Toxicity and progression|0|||
160458801|NCT04778410|579412663|FG003|Phase 2 Period|Death|5|||
160458802|NCT04778410|579412664|FG004|Phase 2 Period|Death|18|||
160458803|NCT04778410|579412665|FG005|Phase 2 Period|Death|0|||
160458804|NCT04778410|579412660|FG000|Phase 2 Period|Lost to Follow-up|0|||
160967355|NCT03217747|581268240|FG002|Overall Study|Toxicity and progression|0|||
160967356|NCT03217747|581268241|FG003|Overall Study|Toxicity and progression|0|||
160967357|NCT03217747|581268242|FG004|Overall Study|Toxicity and progression|0|||
160967358|NCT03217747|581268243|FG005|Overall Study|Toxicity and progression|0|||
160967359|NCT03217747|581268244|FG006|Overall Study|Toxicity and progression|0|||
160967360|NCT03217747|581268245|FG007|Overall Study|Toxicity and progression|0|||
160967361|NCT03217747|581268246|FG008|Overall Study|Toxicity and progression|0|||
160967362|NCT03217747|581268247|FG009|Overall Study|Toxicity and progression|0|||
160967363|NCT03217747|581268248|FG010|Overall Study|Toxicity and progression|0|||
160967364|NCT03217747|581268249|FG011|Overall Study|Toxicity and progression|0|||
160967365|NCT03217747|581268250|FG012|Overall Study|Toxicity and progression|0|||
160967366|NCT03217747|581268251|FG013|Overall Study|Toxicity and progression|0|||
160967367|NCT03217747|581268238|FG000|Overall Study|Removal of sole target lesion|1|||
160967368|NCT03217747|581268239|FG001|Overall Study|Removal of sole target lesion|0|||
160967369|NCT03217747|581268240|FG002|Overall Study|Removal of sole target lesion|0|||
160967370|NCT03217747|581268241|FG003|Overall Study|Removal of sole target lesion|0|||
160967371|NCT03217747|581268242|FG004|Overall Study|Removal of sole target lesion|0|||
160967372|NCT03217747|581268243|FG005|Overall Study|Removal of sole target lesion|0|||
160967373|NCT03217747|581268244|FG006|Overall Study|Removal of sole target lesion|0|||
160967374|NCT03217747|581268245|FG007|Overall Study|Removal of sole target lesion|0|||
160967375|NCT03217747|581268246|FG008|Overall Study|Removal of sole target lesion|0|||
160967376|NCT03217747|581268247|FG009|Overall Study|Removal of sole target lesion|0|||
160967377|NCT03217747|581268248|FG010|Overall Study|Removal of sole target lesion|0|||
160967378|NCT03217747|581268249|FG011|Overall Study|Removal of sole target lesion|0|||
160967379|NCT03217747|581268250|FG012|Overall Study|Removal of sole target lesion|0|||
160967380|NCT03217747|581268251|FG013|Overall Study|Removal of sole target lesion|0|||
160967381|NCT03217747|581268238|FG000|Overall Study|Stroke|0|||
160967382|NCT03217747|581268239|FG001|Overall Study|Stroke|0|||
160967383|NCT03217747|581268240|FG002|Overall Study|Stroke|0|||
160967384|NCT03217747|581268241|FG003|Overall Study|Stroke|0|||
160967385|NCT03217747|581268242|FG004|Overall Study|Stroke|0|||
160967386|NCT03217747|581268243|FG005|Overall Study|Stroke|1|||
160967387|NCT03217747|581268244|FG006|Overall Study|Stroke|0|||
160967388|NCT03217747|581268245|FG007|Overall Study|Stroke|0|||
160967389|NCT03217747|581268246|FG008|Overall Study|Stroke|0|||
160967390|NCT03217747|581268247|FG009|Overall Study|Stroke|0|||
160967391|NCT03217747|581268248|FG010|Overall Study|Stroke|0|||
160967392|NCT03217747|581268249|FG011|Overall Study|Stroke|1|||
160967393|NCT03217747|581268250|FG012|Overall Study|Stroke|0|||
160967394|NCT03217747|581268251|FG013|Overall Study|Stroke|0|||
160967395|NCT03248375|581268252|FG000|Overall Study|Lost to Follow-up|5|||
160967396|NCT00394355|581268253|FG000|Overall Study|Adverse Event|10|||
160967397|NCT00394355|581268254|FG001|Overall Study|Adverse Event|6|||
160967398|NCT00394355|581268255|FG002|Overall Study|Adverse Event|7|||
160967399|NCT00394355|581268256|FG003|Overall Study|Adverse Event|8|||
160967400|NCT00394355|581268253|FG000|Overall Study|Did not meet protocol eligibility|1|||
160967401|NCT00394355|581268254|FG001|Overall Study|Did not meet protocol eligibility|5|||
160967402|NCT00394355|581268255|FG002|Overall Study|Did not meet protocol eligibility|4|||
160967403|NCT00394355|581268256|FG003|Overall Study|Did not meet protocol eligibility|2|||
160967404|NCT00394355|581268253|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
160967405|NCT00394355|581268254|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
160967406|NCT00394355|581268255|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
160967407|NCT00394355|581268256|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
160967408|NCT00394355|581268253|FG000|Overall Study|Subject withdrawal - related to drug|1|||
160967409|NCT00394355|581268254|FG001|Overall Study|Subject withdrawal - related to drug|0|||
160967410|NCT00394355|581268255|FG002|Overall Study|Subject withdrawal - related to drug|0|||
160967411|NCT00394355|581268256|FG003|Overall Study|Subject withdrawal - related to drug|0|||
160967412|NCT00394355|581268253|FG000|Overall Study|Lost to Follow-up|7|||
160967413|NCT00394355|581268254|FG001|Overall Study|Lost to Follow-up|5|||
160967414|NCT00394355|581268255|FG002|Overall Study|Lost to Follow-up|4|||
160967415|NCT00394355|581268256|FG003|Overall Study|Lost to Follow-up|3|||
160967416|NCT00394355|581268253|FG000|Overall Study|Noncompliance with protocol|4|||
160967417|NCT00394355|581268254|FG001|Overall Study|Noncompliance with protocol|3|||
160967418|NCT00394355|581268255|FG002|Overall Study|Noncompliance with protocol|10|||
160967419|NCT00394355|581268256|FG003|Overall Study|Noncompliance with protocol|8|||
160967420|NCT00394355|581268253|FG000|Overall Study|Administrative|0|||
160967421|NCT00394355|581268254|FG001|Overall Study|Administrative|1|||
160967422|NCT00394355|581268255|FG002|Overall Study|Administrative|1|||
160967423|NCT00394355|581268256|FG003|Overall Study|Administrative|1|||
160967424|NCT00394355|581268253|FG000|Overall Study|Lack of Efficacy|0|||
160458805|NCT04778410|579412661|FG001|Phase 2 Period|Lost to Follow-up|0|||
160458806|NCT04778410|579412662|FG002|Phase 2 Period|Lost to Follow-up|0|||
161010944|NCT03954184|581427282|FG001|Overall Study|Lost to Follow-up|0|||
161010945|NCT05403801|581427285|FG000|Overall Study|Withdrawal by Subject|2|||
161010946|NCT02879448|581427286|FG000|Overall Study|Death|251|||
161010947|NCT02879448|581427287|FG001|Overall Study|Death|263|||
161010948|NCT02879448|581427286|FG000|Overall Study|Lost to Follow-up|23|||
161010949|NCT02879448|581427287|FG001|Overall Study|Lost to Follow-up|28|||
161010950|NCT02879448|581427286|FG000|Overall Study|Withdrawal by Subject|42|||
161010951|NCT02879448|581427287|FG001|Overall Study|Withdrawal by Subject|79|||
161010952|NCT02879448|581427286|FG000|Overall Study|Other Reasons|8|||
161010953|NCT02879448|581427287|FG001|Overall Study|Other Reasons|12|||
161010954|NCT02819843|581427290|FG000|Overall Study|Disease progression before RT|0|||
161010955|NCT02819843|581427291|FG001|Overall Study|Disease progression before RT|1|||
161010956|NCT02728557|581427292|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
161010957|NCT02728557|581427293|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
161010958|NCT02728557|581427292|FG000|Overall Study|Dissatisfaction with research tasks|0|||
161010959|NCT02728557|581427293|FG001|Overall Study|Dissatisfaction with research tasks|1|||
161010960|NCT02728557|581427292|FG000|Overall Study|Scheduling or change in availability|1|||
161010961|NCT02728557|581427293|FG001|Overall Study|Scheduling or change in availability|1|||
161010962|NCT01718743|581427294|FG000|Overall Study|Physician Decision|7|||
161010963|NCT01718743|581427294|FG000|Overall Study|Withdrawal by Subject|14|||
161010964|NCT01718743|581427294|FG000|Overall Study|Progressive Disease|22|||
161010965|NCT01718743|581427294|FG000|Overall Study|Toxicity|1|||
161010966|NCT01718743|581427294|FG000|Overall Study|Malignancy|1|||
161010967|NCT03416010|581427295|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
161010968|NCT03416010|581427296|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
161010969|NCT03416010|581427295|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
161010970|NCT03416010|581427296|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
161010971|NCT03416010|581427295|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
161010972|NCT03416010|581427296|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
161010973|NCT03416010|581427295|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
161010974|NCT03416010|581427296|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
161010975|NCT03416010|581427295|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
161010976|NCT03416010|581427296|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
161010977|NCT03416010|581427295|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
161010978|NCT03416010|581427296|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
161010979|NCT03416010|581427295|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
161010980|NCT03416010|581427296|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
161010981|NCT03948763|581427300|FG000|Overall Study|Sponsor's decision|0|||
161010982|NCT03948763|581427301|FG001|Overall Study|Sponsor's decision|2|||
161010983|NCT03948763|581427302|FG002|Overall Study|Sponsor's decision|6|||
161010984|NCT03948763|581427303|FG003|Overall Study|Sponsor's decision|4|||
161010985|NCT03948763|581427304|FG004|Overall Study|Sponsor's decision|0|||
161010986|NCT03948763|581427300|FG000|Overall Study|Physician Decision|0|||
161010987|NCT03948763|581427301|FG001|Overall Study|Physician Decision|0|||
161010988|NCT03948763|581427302|FG002|Overall Study|Physician Decision|1|||
161010989|NCT03948763|581427303|FG003|Overall Study|Physician Decision|0|||
161010990|NCT03948763|581427304|FG004|Overall Study|Physician Decision|0|||
161010991|NCT03948763|581427300|FG000|Overall Study|Lost to Follow-up|0|||
161010992|NCT03948763|581427301|FG001|Overall Study|Lost to Follow-up|0|||
161010993|NCT03948763|581427302|FG002|Overall Study|Lost to Follow-up|0|||
161010994|NCT03948763|581427303|FG003|Overall Study|Lost to Follow-up|0|||
161010995|NCT03948763|581427304|FG004|Overall Study|Lost to Follow-up|1|||
161010996|NCT03948763|581427300|FG000|Overall Study|Death|2|||
161010997|NCT03948763|581427301|FG001|Overall Study|Death|12|||
161010998|NCT03948763|581427302|FG002|Overall Study|Death|13|||
161010999|NCT03948763|581427303|FG003|Overall Study|Death|10|||
161011000|NCT03948763|581427304|FG004|Overall Study|Death|11|||
161011001|NCT03948763|581427300|FG000|Overall Study|Withdrawal by Subject|1|||
161011002|NCT03948763|581427301|FG001|Overall Study|Withdrawal by Subject|1|||
161011003|NCT03948763|581427302|FG002|Overall Study|Withdrawal by Subject|0|||
161011004|NCT03948763|581427303|FG003|Overall Study|Withdrawal by Subject|2|||
161011005|NCT03948763|581427304|FG004|Overall Study|Withdrawal by Subject|4|||
161011006|NCT06629454|581427305|FG000|Overall Study|Withdraw by Clinician Decision|1|||
161011007|NCT06023082|581427306|FG000|Overall Study|Withdrawal by Subject|2|||
161011008|NCT06023082|581427306|FG000|Overall Study|Lost to Follow-up|15|||
161011009|NCT06023082|581427306|FG000|Overall Study|Side effects|5|||
161011010|NCT05986565|581427307|FG000|Overall Study|Lost to Follow-up|8|||
161011011|NCT05986565|581427308|FG001|Overall Study|Lost to Follow-up|3|||
161011012|NCT05986565|581427307|FG000|Overall Study|Withdrawal by Subject|0|||
161011013|NCT05986565|581427308|FG001|Overall Study|Withdrawal by Subject|1|||
161011014|NCT00670046|581427309|FG000|Overall Study|Lost to Follow-up|1|||
161011015|NCT00670046|581427310|FG001|Overall Study|Lost to Follow-up|1|||
161011016|NCT00670046|581427309|FG000|Overall Study|Withdrawal by Subject|0|||
161011017|NCT00670046|581427310|FG001|Overall Study|Withdrawal by Subject|1|||
161011018|NCT02006758|581427324|FG000|Overall Study|Protocol Violation|1|||
161011019|NCT02006758|581427324|FG000|Overall Study|Death|1|||
161011020|NCT02006758|581427324|FG000|Overall Study|Lost to Follow-up|4|||
161011021|NCT02006758|581427324|FG000|Overall Study|Withdrawal by Subject|4|||
161011022|NCT02006758|581427324|FG000|Overall Study|Procedurally excluded|1|||
161011023|NCT02006758|581427324|FG000|Overall Study|Other|2|||
161011024|NCT02740231|581427325|FG000|Overall Study|Withdrawal by Subject|1|||
161011025|NCT02740231|581427326|FG001|Overall Study|Withdrawal by Subject|1|||
161011026|NCT02740231|581427327|FG002|Overall Study|Withdrawal by Subject|1|||
161011027|NCT02740231|581427328|FG003|Overall Study|Withdrawal by Subject|0|||
161011028|NCT02740231|581427325|FG000|Overall Study|Lack of Efficacy|0|||
161011029|NCT02740231|581427326|FG001|Overall Study|Lack of Efficacy|1|||
161011030|NCT02740231|581427327|FG002|Overall Study|Lack of Efficacy|0|||
161011031|NCT02740231|581427328|FG003|Overall Study|Lack of Efficacy|4|||
161011032|NCT02740231|581427325|FG000|Overall Study|Lost to Follow-up|1|||
161011033|NCT02740231|581427326|FG001|Overall Study|Lost to Follow-up|3|||
161011034|NCT02740231|581427327|FG002|Overall Study|Lost to Follow-up|0|||
161011035|NCT02740231|581427328|FG003|Overall Study|Lost to Follow-up|3|||
161011036|NCT02740231|581427325|FG000|Overall Study|Adverse Event|0|||
161011037|NCT02740231|581427326|FG001|Overall Study|Adverse Event|1|||
161011038|NCT02740231|581427327|FG002|Overall Study|Adverse Event|0|||
161011039|NCT02740231|581427328|FG003|Overall Study|Adverse Event|1|||
161011040|NCT00914589|581427329|FG000|Overall Study|Adverse Event|1|||
161011041|NCT00914589|581427330|FG001|Overall Study|Adverse Event|0|||
161011042|NCT00914589|581427331|FG002|Overall Study|Adverse Event|1|||
161011043|NCT00914589|581427329|FG000|Overall Study|Protocol Violation|8|||
161011044|NCT00914589|581427330|FG001|Overall Study|Protocol Violation|6|||
161011045|NCT00914589|581427331|FG002|Overall Study|Protocol Violation|3|||
161011046|NCT00914589|581427329|FG000|Overall Study|unclassified|16|||
161011047|NCT00914589|581427330|FG001|Overall Study|unclassified|9|||
161011048|NCT00914589|581427331|FG002|Overall Study|unclassified|7|||
161011049|NCT00914589|581427329|FG000|Overall Study|Death|0|||
161011050|NCT00914589|581427330|FG001|Overall Study|Death|1|||
161011051|NCT00914589|581427331|FG002|Overall Study|Death|1|||
161011052|NCT04110054|581427332|FG000|Overall Study|COVID-19 reason other than AE|0|||
161011053|NCT04110054|581427333|FG001|Overall Study|COVID-19 reason other than AE|0|||
161011054|NCT04110054|581427334|FG002|Overall Study|COVID-19 reason other than AE|2|||
161011055|NCT04110054|581427335|FG003|Overall Study|COVID-19 reason other than AE|0|||
161011056|NCT04110054|581427332|FG000|Overall Study|Withdrawal by Subject|0|||
161011057|NCT04110054|581427333|FG001|Overall Study|Withdrawal by Subject|3|||
161011058|NCT04110054|581427334|FG002|Overall Study|Withdrawal by Subject|2|||
161011059|NCT04110054|581427335|FG003|Overall Study|Withdrawal by Subject|0|||
161011060|NCT04110054|581427332|FG000|Overall Study|Adverse Event|1|||
161011061|NCT04110054|581427333|FG001|Overall Study|Adverse Event|1|||
161011062|NCT04110054|581427334|FG002|Overall Study|Adverse Event|4|||
161011063|NCT04110054|581427335|FG003|Overall Study|Adverse Event|3|||
161011064|NCT04149002|581427343|FG000|Overall Study|Lost to Follow-up|1|||
161011065|NCT04149002|581427344|FG001|Overall Study|Lost to Follow-up|0|||
161011066|NCT04149002|581427343|FG000|Overall Study|Withdrawal by Subject|1|||
161011067|NCT04149002|581427344|FG001|Overall Study|Withdrawal by Subject|0|||
161011068|NCT04583423|581427349|FG000|Overall Study|Lost to Follow-up|0|||
161011069|NCT04583423|581427350|FG001|Overall Study|Lost to Follow-up|1|||
161011070|NCT04583423|581427351|FG002|Overall Study|Lost to Follow-up|0|||
161011071|NCT04583423|581427352|FG003|Overall Study|Lost to Follow-up|2|||
161011072|NCT04583423|581427349|FG000|Overall Study|Study Terminated by Sponsor|32|||
161011073|NCT04583423|581427350|FG001|Overall Study|Study Terminated by Sponsor|35|||
161011074|NCT04583423|581427351|FG002|Overall Study|Study Terminated by Sponsor|36|||
161011075|NCT04583423|581427352|FG003|Overall Study|Study Terminated by Sponsor|33|||
161011076|NCT04583423|581427349|FG000|Overall Study|Withdrawal by Subject|3|||
161011077|NCT04583423|581427350|FG001|Overall Study|Withdrawal by Subject|1|||
161011078|NCT04583423|581427351|FG002|Overall Study|Withdrawal by Subject|2|||
161011079|NCT04583423|581427352|FG003|Overall Study|Withdrawal by Subject|1|||
161011080|NCT06061081|581427353|FG000|Overall Study|Withdrawal by Subject|1|||
161011081|NCT06061081|581427354|FG001|Overall Study|Withdrawal by Subject|0|||
161011082|NCT06061081|581427355|FG002|Overall Study|Withdrawal by Subject|0|||
161011083|NCT06061081|581427356|FG003|Overall Study|Withdrawal by Subject|0|||
161011084|NCT06061081|581427357|FG004|Overall Study|Withdrawal by Subject|0|||
161011085|NCT00510887|581427358|FG000|Overall Study|Lost to Follow-up|1|||
161011086|NCT01736215|581427359|FG000|Overall Study|Early termination of erythropoietin use|1|||
161011087|NCT01736215|581427359|FG000|Overall Study|Adverse Event|4|||
161011088|NCT01736215|581427359|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
161011089|NCT01736215|581427359|FG000|Overall Study|Insufficient data to perform analysis|8|||
161011090|NCT03447249|581427362|FG000|Overall Study|Adverse Event|1|||
161011091|NCT03447249|581427363|FG001|Overall Study|Adverse Event|0|||
161011092|NCT03447249|581427362|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
161011093|NCT03447249|581427363|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
161011094|NCT03447249|581427362|FG000|Overall Study|Other|3|||
161011095|NCT03447249|581427363|FG001|Overall Study|Other|0|||
161011096|NCT02372253|581427367|FG000|Overall Study|Non Compliance|2|||
160585629|NCT00952289|579861973|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
160967425|NCT00394355|581268254|FG001|Overall Study|Lack of Efficacy|0|||
160967426|NCT00394355|581268255|FG002|Overall Study|Lack of Efficacy|2|||
160967427|NCT00394355|581268256|FG003|Overall Study|Lack of Efficacy|3|||
160967428|NCT02618616|581268259|FG000|Overall Study|Lack of Efficacy|4|||
160967429|NCT02618616|581268260|FG001|Overall Study|Lack of Efficacy|0|||
160967430|NCT02618616|581268259|FG000|Overall Study|Pregnancy|0|||
160967431|NCT02618616|581268260|FG001|Overall Study|Pregnancy|1|||
160967432|NCT02618616|581268259|FG000|Overall Study|Adverse Event|8|||
160967433|NCT02618616|581268260|FG001|Overall Study|Adverse Event|0|||
160967434|NCT02618616|581268259|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
160967435|NCT02618616|581268260|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
160967436|NCT02618616|581268259|FG000|Overall Study|Consent withdrawn by subject|8|||
160967437|NCT02618616|581268260|FG001|Overall Study|Consent withdrawn by subject|5|||
160967438|NCT02618616|581268259|FG000|Overall Study|Lost to Follow-up|0|||
160967439|NCT02618616|581268260|FG001|Overall Study|Lost to Follow-up|1|||
160967440|NCT00459342|581268263|FG000|Overall Study|Not eligible|1|||
160967441|NCT02686034|581268264|FG000|Run-In Period 1|Eligibility|12|||
160967442|NCT02686034|581268265|FG001|Run-In Period 1|Eligibility|10|||
160967443|NCT02686034|581268264|FG000|Run-In Period 1|Withdrawal by Subject|4|||
160967444|NCT02686034|581268265|FG001|Run-In Period 1|Withdrawal by Subject|3|||
160967445|NCT02686034|581268264|FG000|Run-In Period 1|Lost to Follow-up|4|||
160967446|NCT02686034|581268265|FG001|Run-In Period 1|Lost to Follow-up|4|||
160967447|NCT02686034|581268264|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
160967448|NCT02686034|581268265|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
160967449|NCT02686034|581268264|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
160967450|NCT02686034|581268265|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
160967451|NCT02686034|581268264|FG000|Randomized Controlled Period 2|Adverse Event|0|||
160967452|NCT02686034|581268265|FG001|Randomized Controlled Period 2|Adverse Event|2|||
160967453|NCT02686034|581268264|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
160967454|NCT02686034|581268265|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
160967455|NCT02686034|581268264|FG000|Open Label Period 3|Lost to Follow-up|0|||
160967456|NCT02686034|581268265|FG001|Open Label Period 3|Lost to Follow-up|1|||
160967457|NCT01678131|581268266|FG000|Overall Study|Adverse Event|0|||
160967458|NCT01678131|581268267|FG001|Overall Study|Adverse Event|1|||
160967459|NCT01678131|581268268|FG002|Overall Study|Adverse Event|0|||
160967460|NCT01678131|581268266|FG000|Overall Study|Withdrawal by Subject|0|||
160967461|NCT01678131|581268267|FG001|Overall Study|Withdrawal by Subject|0|||
160967462|NCT01678131|581268268|FG002|Overall Study|Withdrawal by Subject|2|||
160967463|NCT00558064|581268270|FG000|Overall Study|Adverse Event|3|||
160967464|NCT00558064|581268271|FG001|Overall Study|Adverse Event|2|||
160967465|NCT00558064|581268270|FG000|Overall Study|Lack of Efficacy|0|||
160967466|NCT00558064|581268271|FG001|Overall Study|Lack of Efficacy|1|||
160967467|NCT00558064|581268270|FG000|Overall Study|Protocol Violation|1|||
160967468|NCT00558064|581268271|FG001|Overall Study|Protocol Violation|0|||
160967469|NCT00558064|581268270|FG000|Overall Study|Lost to Follow-up|0|||
160967470|NCT00558064|581268271|FG001|Overall Study|Lost to Follow-up|1|||
160967471|NCT00558064|581268270|FG000|Overall Study|Withdrawal by Subject|0|||
160967472|NCT00558064|581268271|FG001|Overall Study|Withdrawal by Subject|1|||
160967473|NCT00558064|581268270|FG000|Overall Study|No visit within allowance period|1|||
160967474|NCT00558064|581268271|FG001|Overall Study|No visit within allowance period|0|||
160967475|NCT02027402|581268272|FG000|Overall Study|Withdrawal by Subject|4|||
160967476|NCT02027402|581268273|FG001|Overall Study|Withdrawal by Subject|1|||
160967477|NCT00941798|581268274|FG000|Overall Study|Withdrawal by Subject|72|||
160967478|NCT00941798|581268275|FG001|Overall Study|Withdrawal by Subject|74|||
160967479|NCT00941798|581268274|FG000|Overall Study|Adverse Event|43|||
160967480|NCT00941798|581268275|FG001|Overall Study|Adverse Event|23|||
160967481|NCT00941798|581268274|FG000|Overall Study|Lost to Follow-up|29|||
160967482|NCT00941798|581268275|FG001|Overall Study|Lost to Follow-up|23|||
160967483|NCT00941798|581268274|FG000|Overall Study|Protocol Violation|17|||
160967484|NCT00941798|581268275|FG001|Overall Study|Protocol Violation|20|||
160967485|NCT00941798|581268274|FG000|Overall Study|Administrative problems|13|||
160967486|NCT00941798|581268275|FG001|Overall Study|Administrative problems|23|||
160585630|NCT00952289|579861972|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
160585631|NCT00952289|579861973|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
160967487|NCT00941798|581268274|FG000|Overall Study|Lack of Efficacy|10|||
160967488|NCT00941798|581268275|FG001|Overall Study|Lack of Efficacy|17|||
160967489|NCT00941798|581268274|FG000|Overall Study|Patient's inability to use device|6|||
160967490|NCT00941798|581268275|FG001|Overall Study|Patient's inability to use device|1|||
160967491|NCT00941798|581268274|FG000|Overall Study|Abnormal test procedure results|3|||
160967492|NCT00941798|581268275|FG001|Overall Study|Abnormal test procedure results|1|||
160967493|NCT00941798|581268274|FG000|Overall Study|Abnormal laboratory values|1|||
160967494|NCT00941798|581268275|FG001|Overall Study|Abnormal laboratory values|2|||
161011097|NCT02372253|581427368|FG001|Overall Study|Non Compliance|0|||
161011098|NCT03201562|581427369|FG000|Overall Study|Physician Decision|0|||
160585632|NCT03259334|579861974|FG000|Overall Study|Adverse Event|3|||
160585633|NCT03259334|579861975|FG001|Overall Study|Adverse Event|8|||
160585634|NCT03259334|579861976|FG002|Overall Study|Adverse Event|5|||
160585635|NCT03259334|579861974|FG000|Overall Study|Withdrawal by Subject|4|||
160585636|NCT03259334|579861975|FG001|Overall Study|Withdrawal by Subject|2|||
160585637|NCT03259334|579861976|FG002|Overall Study|Withdrawal by Subject|4|||
160585638|NCT03259334|579861974|FG000|Overall Study|Physician Decision|1|||
160585639|NCT03259334|579861975|FG001|Overall Study|Physician Decision|0|||
160585640|NCT03259334|579861976|FG002|Overall Study|Physician Decision|0|||
160585641|NCT03259334|579861974|FG000|Overall Study|Lost to Follow-up|0|||
160657025|NCT05097989|580124504|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
160967495|NCT00941798|581268274|FG000|Overall Study|Death|0|||
160967496|NCT00941798|581268275|FG001|Overall Study|Death|1|||
160967497|NCT05597722|581268278|FG000|Overall Study|Study was terminated|6|||
160967498|NCT05597722|581268279|FG001|Overall Study|Study was terminated|1|||
160967499|NCT00404495|581268280|FG000|Overall Study|Death|37|||
160967500|NCT00404495|581268281|FG001|Overall Study|Death|11|||
160967501|NCT00404495|581268280|FG000|Overall Study|Lost to Follow-up|5|||
160967502|NCT00404495|581268281|FG001|Overall Study|Lost to Follow-up|0|||
160967503|NCT00404495|581268280|FG000|Overall Study|Other|1|||
160967504|NCT00404495|581268281|FG001|Overall Study|Other|0|||
160967505|NCT00404495|581268280|FG000|Overall Study|Withdrawal by Subject|1|||
160967506|NCT00404495|581268281|FG001|Overall Study|Withdrawal by Subject|0|||
160967507|NCT04108000|581268282|FG000|Overall Study|Death of patient|1|||
160967508|NCT04108000|581268283|FG001|Overall Study|Death of patient|0|||
160967509|NCT04108000|581268284|FG002|Overall Study|Death of patient|1|||
160967510|NCT04108000|581268285|FG003|Overall Study|Death of patient|0|||
160967511|NCT04108000|581268282|FG000|Overall Study|Withdrawal by Subject|2|||
160967512|NCT04108000|581268283|FG001|Overall Study|Withdrawal by Subject|2|||
160967513|NCT04108000|581268284|FG002|Overall Study|Withdrawal by Subject|0|||
160967514|NCT04108000|581268285|FG003|Overall Study|Withdrawal by Subject|0|||
160967515|NCT04108000|581268282|FG000|Overall Study|Death of surrogate partner|0|||
160967516|NCT04108000|581268283|FG001|Overall Study|Death of surrogate partner|1|||
160967517|NCT04108000|581268284|FG002|Overall Study|Death of surrogate partner|0|||
160967518|NCT04108000|581268285|FG003|Overall Study|Death of surrogate partner|1|||
160967519|NCT03904043|581268288|FG000|Overall Study|Adverse Event|1|||
160967520|NCT03904043|581268289|FG001|Overall Study|Adverse Event|1|||
160967521|NCT03904043|581268288|FG000|Overall Study|Withdrawal by Subject|1|||
160967522|NCT03904043|581268289|FG001|Overall Study|Withdrawal by Subject|0|||
160967523|NCT03904043|581268288|FG000|Overall Study|Non-compliance|1|||
160967524|NCT03904043|581268289|FG001|Overall Study|Non-compliance|0|||
160967525|NCT03904043|581268288|FG000|Overall Study|Did not start treatment|1|||
160967526|NCT03904043|581268289|FG001|Overall Study|Did not start treatment|0|||
160967527|NCT03750006|581268290|FG000|Overall Study|Withdrawal by Subject|8|||
160967528|NCT03750006|581268290|FG000|Overall Study|COVID PANDEMIC|11|||
160967529|NCT00766675|581269998|FG000|Overall Study|Adverse Event|16|||
160967530|NCT00766675|581269998|FG000|Overall Study|Lost to Follow-up|2|||
160967531|NCT00766675|581269998|FG000|Overall Study|Withdrawal by Subject|11|||
160967532|NCT00766675|581269998|FG000|Overall Study|Protocol Violation|8|||
160967533|NCT00766675|581269998|FG000|Overall Study|Participant took prohibited medication|1|||
160967534|NCT00766675|581269998|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
160967535|NCT00766675|581269998|FG000|Overall Study|Insufficient therapy|1|||
160967536|NCT01679236|581269999|FG000|Overall Study|Lost to Follow-up|15|||
160967537|NCT01679236|581270000|FG001|Overall Study|Lost to Follow-up|15|||
160967538|NCT03935217|581270003|FG000|Overall Study|Adverse Event|1|||
160967539|NCT03935217|581270004|FG001|Overall Study|Adverse Event|0|||
160967540|NCT03935217|581270003|FG000|Overall Study|Lost to Follow-up|0|||
160967541|NCT03935217|581270004|FG001|Overall Study|Lost to Follow-up|1|||
160967542|NCT03935217|581270003|FG000|Overall Study|Withdrawal by Subject|0|||
160967543|NCT03935217|581270004|FG001|Overall Study|Withdrawal by Subject|2|||
160967544|NCT01160484|581270011|FG000|Overall Study|Lack of Efficacy|9|||
160967545|NCT01160484|581270011|FG000|Overall Study|Adverse Event|6|||
160967546|NCT01160484|581270011|FG000|Overall Study|Withdrawal by Subject|2|||
160967547|NCT01160484|581270011|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
160967548|NCT02026232|581270014|FG000|Overall Study|incomplete visit/missing data|3|||
160967549|NCT02026232|581270015|FG001|Overall Study|incomplete visit/missing data|2|||
160967550|NCT01382602|581270016|FG000|Overall Study|Protocol Violation|0|||
160967551|NCT01382602|581270017|FG001|Overall Study|Protocol Violation|3|||
160967552|NCT01382602|581270016|FG000|Overall Study|Withdrawal by Subject|0|||
160967553|NCT01382602|581270017|FG001|Overall Study|Withdrawal by Subject|1|||
160585642|NCT03259334|579861975|FG001|Overall Study|Lost to Follow-up|2|||
160967554|NCT00331344|581270023|FG000|Phase I|Adverse Event|0|||
160967555|NCT00331344|581270024|FG001|Phase I|Adverse Event|0|||
160967556|NCT00331344|581270025|FG002|Phase I|Adverse Event|0|||
160967557|NCT00331344|581270026|FG003|Phase I|Adverse Event|1|||
160585643|NCT03259334|579861976|FG002|Overall Study|Lost to Follow-up|1|||
160967558|NCT00331344|581270027|FG004|Phase I|Adverse Event|2|||
160967559|NCT00331344|581270028|FG005|Phase I|Adverse Event|2|||
160967560|NCT00331344|581270029|FG006|Phase I|Adverse Event|0|||
160585644|NCT03259334|579861974|FG000|Overall Study|Protocol Deviation|0|||
160585645|NCT03259334|579861975|FG001|Overall Study|Protocol Deviation|3|||
160585646|NCT03259334|579861976|FG002|Overall Study|Protocol Deviation|2|||
160585647|NCT03259334|579861974|FG000|Overall Study|Lack of Efficacy|2|||
160585648|NCT03259334|579861975|FG001|Overall Study|Lack of Efficacy|0|||
160585649|NCT03259334|579861976|FG002|Overall Study|Lack of Efficacy|1|||
160585650|NCT03259334|579861974|FG000|Overall Study|Randomized but never treated|0|||
160585651|NCT03259334|579861975|FG001|Overall Study|Randomized but never treated|2|||
160585652|NCT03259334|579861976|FG002|Overall Study|Randomized but never treated|0|||
160585653|NCT00777491|579861977|FG000|Overall Study|Protocol Violation|0|||
160585654|NCT00777491|579861978|FG001|Overall Study|Protocol Violation|2|||
160585655|NCT00777491|579861977|FG000|Overall Study|Did not receive any protocol treatment|2|||
160585656|NCT00777491|579861978|FG001|Overall Study|Did not receive any protocol treatment|0|||
160585657|NCT01689207|579861979|FG000|Overall Study|Adverse Event|0|||
160585658|NCT01689207|579861980|FG001|Overall Study|Adverse Event|1|||
160585659|NCT01689207|579861981|FG002|Overall Study|Adverse Event|0|||
160585660|NCT01689207|579861982|FG003|Overall Study|Adverse Event|0|||
161011099|NCT03201562|581427370|FG001|Overall Study|Physician Decision|0|||
161011100|NCT03201562|581427371|FG002|Overall Study|Physician Decision|1|||
161011101|NCT03201562|581427369|FG000|Overall Study|Adverse Event|0|||
161011102|NCT03201562|581427370|FG001|Overall Study|Adverse Event|0|||
161011103|NCT03201562|581427371|FG002|Overall Study|Adverse Event|1|||
161011104|NCT03201562|581427369|FG000|Overall Study|Lost to Follow-up|0|||
161011105|NCT03201562|581427370|FG001|Overall Study|Lost to Follow-up|1|||
160585661|NCT01689207|579861983|FG004|Overall Study|Adverse Event|2|||
160967561|NCT00331344|581270030|FG007|Phase I|Adverse Event|1|||
160585662|NCT01689207|579861984|FG005|Overall Study|Adverse Event|1|||
160585663|NCT01689207|579861985|FG006|Overall Study|Adverse Event|0|||
160585664|NCT01689207|579861986|FG007|Overall Study|Adverse Event|0|||
160585665|NCT01689207|579861987|FG008|Overall Study|Adverse Event|1|||
160585666|NCT01689207|579861988|FG009|Overall Study|Adverse Event|0|||
160585667|NCT01689207|579861989|FG010|Overall Study|Adverse Event|0|||
160967562|NCT00331344|581270031|FG008|Phase I|Adverse Event|0|||
160967563|NCT00331344|581270023|FG000|Phase II|Death|0|||
160967564|NCT00331344|581270024|FG001|Phase II|Death|0|||
160967565|NCT00331344|581270025|FG002|Phase II|Death|0|||
160967566|NCT00331344|581270026|FG003|Phase II|Death|0|||
160967567|NCT00331344|581270027|FG004|Phase II|Death|0|||
160967568|NCT00331344|581270028|FG005|Phase II|Death|0|||
160967569|NCT00331344|581270029|FG006|Phase II|Death|0|||
160967570|NCT00331344|581270030|FG007|Phase II|Death|0|||
160967571|NCT00331344|581270031|FG008|Phase II|Death|4|||
160967572|NCT04538144|581270037|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
160967573|NCT04538144|581270038|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
160967574|NCT04538144|581270039|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
160967575|NCT04538144|581270040|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
160967576|NCT02228967|581270041|FG000|Overall Study|Lost to Follow-up|146|||
160967577|NCT02228967|581270042|FG001|Overall Study|Lost to Follow-up|142|||
160967578|NCT02228967|581270041|FG000|Overall Study|Withdrawal by Subject|13|||
160967579|NCT02228967|581270042|FG001|Overall Study|Withdrawal by Subject|18|||
160967580|NCT01995539|581270045|FG000|Overall Study|Screening Failure|1|||
160967581|NCT01995539|581270045|FG000|Overall Study|Withdrawal by Investigator|15|||
160967582|NCT01995539|581270045|FG000|Overall Study|Withdrawal by Subject|11|||
160967583|NCT01995539|581270045|FG000|Overall Study|Lost to Follow-up|5|||
160967584|NCT01995539|581270045|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
160967585|NCT03261271|581270049|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
160967586|NCT03261271|581270050|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
160967587|NCT02173054|581270051|FG000|Overall Study|lack of compliance|1|||
160967588|NCT02173054|581270052|FG001|Overall Study|lack of compliance|0|||
160967589|NCT02173054|581270053|FG002|Overall Study|lack of compliance|0|||
160967590|NCT02173054|581270051|FG000|Overall Study|Withdrawal by Subject|0|||
160967591|NCT02173054|581270052|FG001|Overall Study|Withdrawal by Subject|0|||
160967592|NCT02173054|581270053|FG002|Overall Study|Withdrawal by Subject|1|||
160967593|NCT01932697|581270054|FG000|Overall Study|Received a different amount of tx|1|||
160967594|NCT01932697|581270055|FG001|Overall Study|Received a different amount of tx|0|||
160967595|NCT01932697|581270054|FG000|Overall Study|Ineligible|1|||
160967596|NCT01932697|581270055|FG001|Overall Study|Ineligible|0|||
160967597|NCT00215540|581270060|FG000|Overall Study|Withdrew from study medication|1|||
160967598|NCT00215540|581270061|FG001|Overall Study|Withdrew from study medication|0|||
160967599|NCT00215540|581270062|FG002|Overall Study|Withdrew from study medication|0|||
160967600|NCT00674570|581270064|FG000|Overall Study|Withdrawal by Subject|0|||
160967601|NCT00674570|581270065|FG001|Overall Study|Withdrawal by Subject|2|||
160967602|NCT00674570|581270066|FG002|Overall Study|Withdrawal by Subject|0|||
160967603|NCT02313909|581270067|FG000|Overall Study|Consent withdrawn by participant|33|||
160967604|NCT02313909|581270068|FG001|Overall Study|Consent withdrawn by participant|33|||
160967605|NCT02313909|581270067|FG000|Overall Study|Lost to Follow-up|24|||
160967606|NCT02313909|581270068|FG001|Overall Study|Lost to Follow-up|17|||
161011106|NCT03201562|581427371|FG002|Overall Study|Lost to Follow-up|2|||
161011107|NCT01803555|581427372|FG000|Overall Study|Adverse Event|3|||
161011108|NCT01803555|581427373|FG001|Overall Study|Adverse Event|2|||
161011109|NCT01803555|581427372|FG000|Overall Study|Withdrawal by Subject|3|||
161011110|NCT01803555|581427373|FG001|Overall Study|Withdrawal by Subject|3|||
161011111|NCT01803555|581427372|FG000|Overall Study|Non-compliance|1|||
161011112|NCT01803555|581427373|FG001|Overall Study|Non-compliance|1|||
161011113|NCT01803555|581427372|FG000|Overall Study|Protocol Violation|3|||
161011114|NCT01803555|581427373|FG001|Overall Study|Protocol Violation|5|||
161011115|NCT01803555|581427372|FG000|Overall Study|Lost to Follow-up|0|||
161011116|NCT01803555|581427373|FG001|Overall Study|Lost to Follow-up|2|||
161011117|NCT01803555|581427372|FG000|Overall Study|Other than specified|3|||
161011118|NCT01803555|581427373|FG001|Overall Study|Other than specified|5|||
161011119|NCT00393484|581427374|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
161011120|NCT00393484|581427375|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
161011121|NCT00393484|581427374|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
161011122|NCT00393484|581427375|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
161011123|NCT00393484|581427374|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
161011124|NCT00393484|581427375|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
161011125|NCT00393484|581427374|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
161011126|NCT00393484|581427375|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
161011127|NCT00393484|581427374|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
161011128|NCT00393484|581427375|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
161011129|NCT00393484|581427374|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
161011130|NCT00393484|581427375|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
161011131|NCT00393484|581427374|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
160458807|NCT04778410|579412663|FG003|Phase 2 Period|Lost to Follow-up|1|||
160458808|NCT04778410|579412664|FG004|Phase 2 Period|Lost to Follow-up|1|||
160458809|NCT04778410|579412665|FG005|Phase 2 Period|Lost to Follow-up|0|||
160458810|NCT04778410|579412660|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
160458811|NCT04778410|579412661|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
160458812|NCT04778410|579412662|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
160657026|NCT05097989|580124496|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
160458813|NCT04778410|579412663|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
160458814|NCT04778410|579412664|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
160657027|NCT05097989|580124497|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
160967607|NCT02798211|581270069|FG000|Period 1|Adverse Event|1|||
160967608|NCT02798211|581270070|FG001|Period 1|Adverse Event|1|||
160967609|NCT02798211|581270071|FG002|Period 1|Adverse Event|0|||
160967610|NCT02798211|581270072|FG003|Period 1|Adverse Event|0|||
160967611|NCT02798211|581270073|FG004|Period 1|Adverse Event|0|||
160967612|NCT02798211|581270074|FG005|Period 1|Adverse Event|0|||
160967613|NCT02798211|581270069|FG000|Period 1|Lost to Follow-up|2|||
160967614|NCT02798211|581270070|FG001|Period 1|Lost to Follow-up|1|||
160967615|NCT02798211|581270071|FG002|Period 1|Lost to Follow-up|0|||
160967616|NCT02798211|581270072|FG003|Period 1|Lost to Follow-up|0|||
160967617|NCT02798211|581270073|FG004|Period 1|Lost to Follow-up|0|||
160967618|NCT02798211|581270074|FG005|Period 1|Lost to Follow-up|0|||
160967619|NCT02798211|581270069|FG000|Period 1|Protocol Violation|0|||
160967620|NCT02798211|581270070|FG001|Period 1|Protocol Violation|0|||
160967621|NCT02798211|581270071|FG002|Period 1|Protocol Violation|2|||
160967622|NCT02798211|581270072|FG003|Period 1|Protocol Violation|0|||
160967623|NCT02798211|581270073|FG004|Period 1|Protocol Violation|0|||
160967624|NCT02798211|581270074|FG005|Period 1|Protocol Violation|0|||
160967625|NCT02798211|581270069|FG000|Period 1|Withdrawal by Subject|1|||
160967626|NCT02798211|581270070|FG001|Period 1|Withdrawal by Subject|1|||
160967627|NCT02798211|581270071|FG002|Period 1|Withdrawal by Subject|0|||
160967628|NCT02798211|581270072|FG003|Period 1|Withdrawal by Subject|0|||
160967629|NCT02798211|581270073|FG004|Period 1|Withdrawal by Subject|0|||
160967630|NCT02798211|581270074|FG005|Period 1|Withdrawal by Subject|0|||
160967631|NCT02798211|581270069|FG000|Period 1|Death|0|||
160967632|NCT02798211|581270070|FG001|Period 1|Death|0|||
160967633|NCT02798211|581270071|FG002|Period 1|Death|1|||
160967634|NCT02798211|581270072|FG003|Period 1|Death|0|||
160967635|NCT02798211|581270073|FG004|Period 1|Death|0|||
160967636|NCT02798211|581270074|FG005|Period 1|Death|0|||
160967637|NCT02798211|581270069|FG000|Period 1|Withdrawal of Informed Consent|2|||
160967638|NCT02798211|581270070|FG001|Period 1|Withdrawal of Informed Consent|7|||
160967639|NCT02798211|581270071|FG002|Period 1|Withdrawal of Informed Consent|3|||
160967640|NCT02798211|581270072|FG003|Period 1|Withdrawal of Informed Consent|0|||
160967641|NCT02798211|581270073|FG004|Period 1|Withdrawal of Informed Consent|0|||
160967642|NCT02798211|581270074|FG005|Period 1|Withdrawal of Informed Consent|0|||
160967643|NCT02798211|581270069|FG000|Period 2|Withdrawal by Subject|2|||
160967644|NCT02798211|581270070|FG001|Period 2|Withdrawal by Subject|0|||
160967645|NCT02798211|581270071|FG002|Period 2|Withdrawal by Subject|0|||
160967646|NCT02798211|581270072|FG003|Period 2|Withdrawal by Subject|0|||
161011132|NCT00393484|581427375|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
161011133|NCT00393484|581427374|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
161011134|NCT00393484|581427375|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
161011135|NCT00393484|581427374|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
161011136|NCT00393484|581427375|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
161011137|NCT00393484|581427374|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
160585668|NCT01912768|579861990|FG000|Overall Study|Adverse Event|2|||
160585669|NCT01912768|579861991|FG001|Overall Study|Adverse Event|0|||
160585670|NCT01912768|579861990|FG000|Overall Study|Lost to Follow-up|2|||
160585671|NCT01912768|579861991|FG001|Overall Study|Lost to Follow-up|1|||
161011138|NCT00393484|581427375|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
161011139|NCT03101371|581427378|FG000|Overall Study|Physician Decision|0|||
161011140|NCT03101371|581427379|FG001|Overall Study|Physician Decision|1|||
161011141|NCT03101371|581427378|FG000|Overall Study|Lost to Follow-up|1|||
161011142|NCT03101371|581427379|FG001|Overall Study|Lost to Follow-up|4|||
161011143|NCT03101371|581427378|FG000|Overall Study|Did not meet eligibility criteria|2|||
161011144|NCT03101371|581427379|FG001|Overall Study|Did not meet eligibility criteria|1|||
161011145|NCT02318134|581427383|FG000|Overall Study|Withdrawal by Subject|2|||
161011146|NCT02318134|581427384|FG001|Overall Study|Withdrawal by Subject|1|||
161011147|NCT01094184|581427385|FG000|Overall Study|Death|35|||
161011148|NCT01094184|581427386|FG001|Overall Study|Death|11|||
161011149|NCT03988842|581427387|FG000|Overall Study|Death|1|||
161011150|NCT04766034|581427388|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161011151|NCT04766034|581427389|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161011152|NCT04766034|581427390|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161011153|NCT04766034|581427391|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161011154|NCT04766034|581427392|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
161011155|NCT04766034|581427388|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161011156|NCT04766034|581427389|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161011157|NCT04766034|581427390|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161011158|NCT04766034|581427391|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161011159|NCT04766034|581427392|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
161011160|NCT04766034|581427388|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
161011161|NCT04766034|581427389|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
161011162|NCT04766034|581427390|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
161011163|NCT04766034|581427391|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
161011164|NCT04766034|581427392|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
161011165|NCT04766034|581427388|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
161011166|NCT04766034|581427389|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
161011167|NCT04766034|581427390|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
161011168|NCT04766034|581427391|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
161011169|NCT04766034|581427392|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
161011170|NCT01976312|581427393|FG000|Overall Study|Pregnancy|0|||
161011171|NCT01976312|581427394|FG001|Overall Study|Pregnancy|1|||
161011172|NCT01976312|581427393|FG000|Overall Study|Lost to Follow-up|2|||
161011173|NCT01976312|581427394|FG001|Overall Study|Lost to Follow-up|0|||
161011174|NCT01976312|581427393|FG000|Overall Study|Withdrawal by Subject|7|||
161011175|NCT01976312|581427394|FG001|Overall Study|Withdrawal by Subject|2|||
161011176|NCT01976312|581427393|FG000|Overall Study|Adverse Event|6|||
161011177|NCT01976312|581427394|FG001|Overall Study|Adverse Event|6|||
161011178|NCT01976312|581427393|FG000|Overall Study|Protocol Violation|2|||
161011179|NCT01976312|581427394|FG001|Overall Study|Protocol Violation|0|||
161011180|NCT01538719|581427399|FG000|Overall Study|Lost to Follow-up|2|||
161011181|NCT01538719|581427400|FG001|Overall Study|Lost to Follow-up|0|||
160585672|NCT01912768|579861990|FG000|Overall Study|Withdrawal by Subject|5|||
160585673|NCT01912768|579861991|FG001|Overall Study|Withdrawal by Subject|3|||
161011182|NCT02807779|581427401|FG000|Overall Study|Lost to Follow-up|1|||
161011183|NCT02807779|581427402|FG001|Overall Study|Lost to Follow-up|0|||
161011184|NCT02807779|581427403|FG002|Overall Study|Lost to Follow-up|0|||
160585674|NCT01912768|579861990|FG000|Overall Study|Randomized in error|1|||
160585675|NCT01912768|579861991|FG001|Overall Study|Randomized in error|0|||
160585676|NCT00524316|579861992|FG000|Overall Study|Withdrawal by Subject|2|||
161011185|NCT02807779|581427401|FG000|Overall Study|Physician Decision|2|||
161011186|NCT02807779|581427402|FG001|Overall Study|Physician Decision|0|||
160585677|NCT00524316|579861992|FG000|Overall Study|Adverse Event|7|||
160585678|NCT00524316|579861992|FG000|Overall Study|Disease Progression|7|||
160585679|NCT01199263|579861993|FG000|Overall Study|Ineligible|0|||
160585680|NCT01199263|579861994|FG001|Overall Study|Ineligible|2|||
160585681|NCT01199263|579861993|FG000|Overall Study|Never Treated|6|||
160585682|NCT01199263|579861994|FG001|Overall Study|Never Treated|0|||
160585683|NCT01687413|579861997|FG000|Overall Study|Withdrawal by Subject|0|||
160585684|NCT01687413|579861998|FG001|Overall Study|Withdrawal by Subject|2|||
160585685|NCT01687413|579861997|FG000|Overall Study|Not eligible|0|||
160585686|NCT01687413|579861998|FG001|Overall Study|Not eligible|2|||
160585687|NCT01687413|579861997|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
160585688|NCT01687413|579861998|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
160585689|NCT04973228|579862001|FG000|Overall Study|Adverse Event|2|||
160585690|NCT04973228|579862002|FG001|Overall Study|Adverse Event|3|||
160585691|NCT04973228|579862001|FG000|Overall Study|Lack of Efficacy|1|||
160585692|NCT04973228|579862002|FG001|Overall Study|Lack of Efficacy|3|||
160585693|NCT04973228|579862001|FG000|Overall Study|Lost to Follow-up|12|||
160585694|NCT04973228|579862002|FG001|Overall Study|Lost to Follow-up|4|||
160585695|NCT04973228|579862001|FG000|Overall Study|Withdrawal by Subject|11|||
160585696|NCT04973228|579862002|FG001|Overall Study|Withdrawal by Subject|4|||
160585697|NCT04973228|579862001|FG000|Overall Study|Did not tolerate application|1|||
160585698|NCT04973228|579862002|FG001|Overall Study|Did not tolerate application|0|||
160585699|NCT04973228|579862001|FG000|Overall Study|Wanted to early terminate and use own product|0|||
160585700|NCT04973228|579862002|FG001|Overall Study|Wanted to early terminate and use own product|1|||
160585701|NCT04973228|579862001|FG000|Overall Study|Missed visits due to new work schedule|1|||
160585702|NCT04973228|579862002|FG001|Overall Study|Missed visits due to new work schedule|0|||
160585703|NCT00091390|579862008|FG000|Overall Study|Protocol Violation|1|||
160585704|NCT00091390|579862008|FG000|Overall Study|No protocol treatment|3|||
160585705|NCT00406640|579862013|FG000|Acute Phase|Adverse Event|18|||
160585706|NCT00406640|579862014|FG001|Acute Phase|Adverse Event|13|||
160585707|NCT00406640|579862013|FG000|Acute Phase|Failed to Return|5|||
160585708|NCT00406640|579862014|FG001|Acute Phase|Failed to Return|1|||
160585709|NCT00406640|579862013|FG000|Acute Phase|Physician Decision|0|||
160585710|NCT00406640|579862014|FG001|Acute Phase|Physician Decision|1|||
160585711|NCT00406640|579862013|FG000|Acute Phase|Lost to Follow-up|7|||
160585712|NCT00406640|579862014|FG001|Acute Phase|Lost to Follow-up|4|||
160585713|NCT00406640|579862013|FG000|Acute Phase|Protocol deviation|4|||
160585714|NCT00406640|579862014|FG001|Acute Phase|Protocol deviation|10|||
160585715|NCT00406640|579862013|FG000|Acute Phase|Protocol Violation|3|||
160585716|NCT00406640|579862014|FG001|Acute Phase|Protocol Violation|2|||
160585717|NCT00406640|579862013|FG000|Acute Phase|Withdrawal by Subject|11|||
160585718|NCT00406640|579862014|FG001|Acute Phase|Withdrawal by Subject|9|||
160967647|NCT02798211|581270073|FG004|Period 2|Withdrawal by Subject|2|||
160967648|NCT02798211|581270074|FG005|Period 2|Withdrawal by Subject|2|||
160967649|NCT02798211|581270069|FG000|Period 2|Adverse Event|5|||
160967650|NCT02798211|581270070|FG001|Period 2|Adverse Event|0|||
160967651|NCT02798211|581270071|FG002|Period 2|Adverse Event|0|||
160967652|NCT02798211|581270072|FG003|Period 2|Adverse Event|0|||
160967653|NCT02798211|581270073|FG004|Period 2|Adverse Event|1|||
160967654|NCT02798211|581270074|FG005|Period 2|Adverse Event|0|||
160967655|NCT02798211|581270069|FG000|Period 2|Lack of Efficacy|1|||
160967656|NCT02798211|581270070|FG001|Period 2|Lack of Efficacy|0|||
160967657|NCT02798211|581270071|FG002|Period 2|Lack of Efficacy|0|||
160967658|NCT02798211|581270072|FG003|Period 2|Lack of Efficacy|1|||
160967659|NCT02798211|581270073|FG004|Period 2|Lack of Efficacy|0|||
160967660|NCT02798211|581270074|FG005|Period 2|Lack of Efficacy|1|||
160967661|NCT02798211|581270069|FG000|Period 2|Lost to Follow-up|3|||
160967662|NCT02798211|581270070|FG001|Period 2|Lost to Follow-up|0|||
160967663|NCT02798211|581270071|FG002|Period 2|Lost to Follow-up|0|||
160967664|NCT02798211|581270072|FG003|Period 2|Lost to Follow-up|0|||
160967665|NCT02798211|581270073|FG004|Period 2|Lost to Follow-up|2|||
160967666|NCT02798211|581270074|FG005|Period 2|Lost to Follow-up|0|||
160967667|NCT02798211|581270069|FG000|Period 2|Physician Decision|1|||
160967668|NCT02798211|581270070|FG001|Period 2|Physician Decision|0|||
160967669|NCT02798211|581270071|FG002|Period 2|Physician Decision|0|||
160967670|NCT02798211|581270072|FG003|Period 2|Physician Decision|1|||
160967671|NCT02798211|581270073|FG004|Period 2|Physician Decision|1|||
160967672|NCT02798211|581270074|FG005|Period 2|Physician Decision|0|||
160967673|NCT02798211|581270069|FG000|Period 2|Pregnancy|0|||
160967674|NCT02798211|581270070|FG001|Period 2|Pregnancy|0|||
160967675|NCT02798211|581270071|FG002|Period 2|Pregnancy|0|||
160967676|NCT02798211|581270072|FG003|Period 2|Pregnancy|2|||
160967677|NCT02798211|581270073|FG004|Period 2|Pregnancy|0|||
160967678|NCT02798211|581270074|FG005|Period 2|Pregnancy|0|||
160967679|NCT02798211|581270069|FG000|Period 2|Technical problems|1|||
160967680|NCT02798211|581270070|FG001|Period 2|Technical problems|0|||
160967681|NCT02798211|581270071|FG002|Period 2|Technical problems|0|||
160967682|NCT02798211|581270072|FG003|Period 2|Technical problems|1|||
160967683|NCT02798211|581270073|FG004|Period 2|Technical problems|0|||
160967684|NCT02798211|581270074|FG005|Period 2|Technical problems|0|||
160967685|NCT02798211|581270069|FG000|Period 2|Withdrawal of Informed Consent|1|||
160967686|NCT02798211|581270070|FG001|Period 2|Withdrawal of Informed Consent|0|||
160967687|NCT02798211|581270071|FG002|Period 2|Withdrawal of Informed Consent|0|||
161011187|NCT02807779|581427403|FG002|Overall Study|Physician Decision|1|||
160585719|NCT00406640|579862013|FG000|Acute Phase|Lack of Efficacy|3|||
160585720|NCT00406640|579862014|FG001|Acute Phase|Lack of Efficacy|3|||
160585721|NCT00406640|579862013|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
160585722|NCT00406640|579862014|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
160585723|NCT00406640|579862013|FG000|DB Continuation Phase for Responders|Death|1|||
161011188|NCT02807779|581427401|FG000|Overall Study|Death|1|||
161011189|NCT02807779|581427402|FG001|Overall Study|Death|1|||
161011190|NCT02807779|581427403|FG002|Overall Study|Death|0|||
161011191|NCT03582722|581427404|FG000|Overall Study|Lost to Follow-up|1|||
161011192|NCT03582722|581427405|FG001|Overall Study|Lost to Follow-up|4|||
161011193|NCT03582722|581427404|FG000|Overall Study|Withdrawal by Subject|3|||
161011194|NCT03582722|581427405|FG001|Overall Study|Withdrawal by Subject|3|||
161011195|NCT01216176|581428705|FG000|Overall Study|Adverse Event|0|||
161011196|NCT01216176|581428706|FG001|Overall Study|Adverse Event|8|||
161011197|NCT01216176|581428707|FG002|Overall Study|Adverse Event|0|||
161011198|NCT01216176|581428705|FG000|Overall Study|Physician Decision|0|||
161011199|NCT01216176|581428706|FG001|Overall Study|Physician Decision|0|||
161011200|NCT01216176|581428707|FG002|Overall Study|Physician Decision|1|||
161011201|NCT03481660|581428710|FG000|Overall Study|Adverse Event|5|||
161011202|NCT03481660|581428711|FG001|Overall Study|Adverse Event|4|||
161011203|NCT03481660|581428710|FG000|Overall Study|Death|13|||
161011204|NCT03481660|581428711|FG001|Overall Study|Death|9|||
161011205|NCT03481660|581428710|FG000|Overall Study|Lost to Follow-up|2|||
161011206|NCT03481660|581428711|FG001|Overall Study|Lost to Follow-up|2|||
161011207|NCT03481660|581428710|FG000|Overall Study|Physician Decision|2|||
161011208|NCT03481660|581428711|FG001|Overall Study|Physician Decision|3|||
161011209|NCT03481660|581428710|FG000|Overall Study|Withdrawal by Subject|14|||
161011210|NCT03481660|581428711|FG001|Overall Study|Withdrawal by Subject|7|||
161011211|NCT05687903|581428714|FG000|Overall Study|Protocol Deviation|1|||
161011212|NCT05687903|581428715|FG001|Overall Study|Protocol Deviation|1|||
161011213|NCT05687903|581428716|FG002|Overall Study|Protocol Deviation|0|||
161011214|NCT05687903|581428717|FG003|Overall Study|Protocol Deviation|1|||
161011215|NCT05687903|581428718|FG004|Overall Study|Protocol Deviation|0|||
161011216|NCT05215847|581428719|FG000|Overall Study|Lost to Follow-up|1|||
161011217|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161011218|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161011219|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161011220|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161011221|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
161011222|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161011223|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161011224|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161011225|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161011226|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
161011227|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161011228|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161011229|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161011230|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161011231|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
161011232|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161011233|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161011234|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161011235|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161011236|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
161011237|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161011238|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161011239|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161011240|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161011241|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
160458815|NCT04778410|579412665|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
160458816|NCT04778410|579412660|FG000|Phase 2 Period|Withdrew Consent|0|||
160458817|NCT04778410|579412661|FG001|Phase 2 Period|Withdrew Consent|0|||
161011242|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161011243|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161011244|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161011245|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161011246|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
160458818|NCT04778410|579412662|FG002|Phase 2 Period|Withdrew Consent|0|||
160458819|NCT04778410|579412663|FG003|Phase 2 Period|Withdrew Consent|0|||
160458820|NCT04778410|579412664|FG004|Phase 2 Period|Withdrew Consent|2|||
160585724|NCT00406640|579862014|FG001|DB Continuation Phase for Responders|Death|0|||
160585725|NCT00406640|579862013|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
160585726|NCT00406640|579862014|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
161011247|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161011248|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161011249|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161011250|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161011251|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
161011252|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161011253|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161011254|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161011255|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161011256|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
161011257|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
161011258|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
161011259|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
161011260|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
161011261|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
161011262|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
161011263|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
161011264|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
161011265|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
161011266|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
161011267|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
161011268|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
161011269|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
161011270|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
161011271|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
161011272|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161011273|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
161011274|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161011275|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161011276|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161011277|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161011278|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161011279|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
161011280|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161011281|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161011282|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
161011283|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
161011284|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
161011285|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
161011286|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
161011287|NCT04732494|581428735|FG000|Overall Study|Death|39|||
161011288|NCT04732494|581428736|FG001|Overall Study|Death|36|||
161011289|NCT04732494|581428735|FG000|Overall Study|Study Closed by Sponsor|20|||
161011290|NCT04732494|581428736|FG001|Overall Study|Study Closed by Sponsor|15|||
161011291|NCT04732494|581428735|FG000|Overall Study|Withdrawal by Subject|2|||
161011292|NCT04732494|581428736|FG001|Overall Study|Withdrawal by Subject|7|||
161011293|NCT04732494|581428735|FG000|Overall Study|Lost to Follow-up|1|||
161011294|NCT04732494|581428736|FG001|Overall Study|Lost to Follow-up|5|||
161011295|NCT03055858|581428737|FG000|Overall Study|Death|9|||
161011296|NCT03055858|581428737|FG000|Overall Study|Withdrawal by Subject|11|||
161011297|NCT03055858|581428737|FG000|Overall Study|Lost to Follow-up|6|||
161011298|NCT03055858|581428737|FG000|Overall Study|Missed Follow-Up Visits|18|||
161011299|NCT05136404|581428738|FG000|Period 1|Adverse Event|0|||
161011300|NCT05136404|581428739|FG001|Period 1|Adverse Event|1|||
161011301|NCT05136404|581428740|FG002|Period 1|Adverse Event|1|||
161011302|NCT05136404|581428738|FG000|Period 2|Inappropriate Behavior|0|||
161011303|NCT05136404|581428739|FG001|Period 2|Inappropriate Behavior|0|||
161011304|NCT05136404|581428740|FG002|Period 2|Inappropriate Behavior|1|||
161011305|NCT05136404|581428738|FG000|Period 3|Adverse Event|0|||
161011306|NCT05136404|581428739|FG001|Period 3|Adverse Event|0|||
161011307|NCT05136404|581428740|FG002|Period 3|Adverse Event|1|||
161011308|NCT02553642|581428746|FG000|Overall Study|Withdrawal by Subject|0|||
161011309|NCT02553642|581428747|FG001|Overall Study|Withdrawal by Subject|3|||
161011310|NCT02553642|581428746|FG000|Overall Study|Physician Decision|0|||
161011311|NCT02553642|581428747|FG001|Overall Study|Physician Decision|1|||
161011312|NCT02553642|581428746|FG000|Overall Study|Additional cancer dx|0|||
161011313|NCT02553642|581428747|FG001|Overall Study|Additional cancer dx|1|||
161011314|NCT02553642|581428746|FG000|Overall Study|Never started treatment|0|||
161011315|NCT02553642|581428747|FG001|Overall Study|Never started treatment|1|||
161011316|NCT01820260|581428753|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011317|NCT01820260|581428754|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011318|NCT01820260|581428755|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
160585727|NCT00406640|579862013|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
160585728|NCT00406640|579862014|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
161011319|NCT01820260|581428756|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011320|NCT01820260|581428757|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011321|NCT01820260|581428758|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011322|NCT01820260|581428759|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
161011323|NCT01820260|581428760|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011324|NCT01820260|581428761|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011325|NCT01820260|581428762|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011326|NCT01820260|581428763|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011327|NCT01820260|581428764|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011328|NCT01820260|581428765|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011329|NCT01820260|581428766|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011330|NCT01820260|581428753|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011331|NCT01820260|581428754|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011332|NCT01820260|581428755|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011333|NCT01820260|581428756|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011334|NCT01820260|581428757|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011335|NCT01820260|581428758|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011336|NCT01820260|581428759|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011337|NCT01820260|581428760|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011338|NCT01820260|581428761|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011339|NCT01820260|581428762|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
161011340|NCT01820260|581428763|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011341|NCT01820260|581428764|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011342|NCT01820260|581428765|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011343|NCT01820260|581428766|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011344|NCT05444192|581428767|FG000|Overall Study|Lost to Follow-up|1|||
161011345|NCT05444192|581428768|FG001|Overall Study|Lost to Follow-up|0|||
161011346|NCT04424927|581428772|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
161011347|NCT04424927|581428773|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
161011348|NCT04424927|581428774|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
161011349|NCT04424927|581428775|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
161011350|NCT04424927|581428776|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
161011351|NCT04424927|581428772|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
161011352|NCT04424927|581428773|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
161011353|NCT04424927|581428774|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
161011354|NCT04424927|581428775|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
161011355|NCT04424927|581428776|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
161011356|NCT04424927|581428772|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
161011357|NCT04424927|581428773|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161011358|NCT04424927|581428774|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161011359|NCT04424927|581428775|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161011360|NCT04424927|581428776|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161011361|NCT04424927|581428772|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
161011362|NCT04424927|581428773|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161011363|NCT04424927|581428774|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161011364|NCT04424927|581428775|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161011365|NCT04424927|581428776|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161011366|NCT04424927|581428772|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
161011367|NCT04424927|581428773|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
161011368|NCT04424927|581428774|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
161011369|NCT04424927|581428775|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
161011370|NCT04424927|581428776|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
161011371|NCT04424927|581428772|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
161011372|NCT04424927|581428773|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
161011373|NCT04424927|581428774|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
161011374|NCT04424927|581428775|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
161011375|NCT04424927|581428776|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
161011376|NCT04424927|581428772|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
161011377|NCT04424927|581428773|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
160458821|NCT04778410|579412665|FG005|Phase 2 Period|Withdrew Consent|0|||
161011378|NCT04424927|581428774|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
161011379|NCT04424927|581428775|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
161011380|NCT04424927|581428776|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
160458822|NCT05422885|579412672|FG000|Overall Study|Lost to Follow-up|1|||
161011381|NCT04424927|581428772|FG000|Double-blind Period (24 Weeks)|Other|0|||
161011382|NCT04424927|581428773|FG001|Double-blind Period (24 Weeks)|Other|1|||
161011383|NCT04424927|581428774|FG002|Double-blind Period (24 Weeks)|Other|3|||
161011384|NCT04424927|581428775|FG003|Double-blind Period (24 Weeks)|Other|1|||
161011385|NCT04424927|581428776|FG004|Double-blind Period (24 Weeks)|Other|0|||
161011386|NCT00505934|581428777|FG000|Overall Study|Adverse Event|1|||
161011387|NCT00505934|581428777|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
161011388|NCT00505934|581428777|FG000|Overall Study|Other: IV dose needed to be changed|1|||
161011389|NCT01121991|581428780|FG000|Overall Study|Lack of Ovarian Response|2|||
161011390|NCT01121991|581428780|FG000|Overall Study|No Oocytes Retrieved|3|||
161011391|NCT01121991|581428780|FG000|Overall Study|No Fertilization|1|||
161011392|NCT01619410|581428781|FG000|Overall Study|Lost to Follow-up|7|||
161011393|NCT01619410|581428782|FG001|Overall Study|Lost to Follow-up|4|||
161011394|NCT01000480|581428783|FG000|Induction Phase|Adverse Event|2|||
161011395|NCT01000480|581428783|FG000|Induction Phase|Lost to Follow-up|1|||
161011396|NCT01000480|581428783|FG000|Induction Phase|Physician Decision|1|||
161011397|NCT01000480|581428783|FG000|Induction Phase|Entry Criteria Not Met|3|||
161011398|NCT01000480|581428783|FG000|Concurrent Therapy Phase|Adverse Event|4|||
161011399|NCT01000480|581428783|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
161011400|NCT01000480|581428783|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
161011401|NCT01000480|581428783|FG000|Concurrent Therapy Phase|Physician Decision|1|||
161011402|NCT03655262|581428788|FG000|Overall Study|Withdrawal by Subject|0|||
161011403|NCT03655262|581428789|FG001|Overall Study|Withdrawal by Subject|0|||
161011404|NCT03655262|581428790|FG002|Overall Study|Withdrawal by Subject|1|||
161011408|NCT03330795|581428797|FG000|Overall Study|Death|3|||
161011409|NCT03330795|581428797|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
161011410|NCT05782231|581428798|FG000|Overall Study|Withdrawal by Subject|1|||
161011411|NCT02252172|581428799|FG000|Overall Study|Lost to Follow-up|9|||
161011412|NCT02252172|581428800|FG001|Overall Study|Lost to Follow-up|6|||
161011413|NCT02252172|581428799|FG000|Overall Study|Death|218|||
161011414|NCT02252172|581428800|FG001|Overall Study|Death|175|||
160458823|NCT05422885|579412672|FG000|Overall Study|Withdrawal by Subject|2|||
160458824|NCT04084574|579412673|FG000|Overall Study|Lost to Follow-up|1|||
160585729|NCT00406640|579862013|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
160585730|NCT00406640|579862014|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
160585731|NCT00406640|579862013|FG000|DB Continuation Phase for Responders|non-compliance|7|||
160585732|NCT00406640|579862014|FG001|DB Continuation Phase for Responders|non-compliance|5|||
160585733|NCT00406640|579862013|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
160585734|NCT00406640|579862014|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
160585735|NCT00406640|579862013|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
160585736|NCT00406640|579862014|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
160585737|NCT00406640|579862013|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
160585738|NCT00406640|579862014|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
160585739|NCT00406640|579862013|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
161011415|NCT02252172|581428799|FG000|Overall Study|Withdrawal by Subject|20|||
161011416|NCT02252172|581428800|FG001|Overall Study|Withdrawal by Subject|15|||
161011417|NCT02252172|581428799|FG000|Overall Study|Physician Decision|0|||
161011418|NCT02252172|581428800|FG001|Overall Study|Physician Decision|1|||
161011419|NCT02252172|581428799|FG000|Overall Study|End of data collection|122|||
161011420|NCT02252172|581428800|FG001|Overall Study|End of data collection|170|||
161011421|NCT02252172|581428799|FG000|Overall Study|Site closure|0|||
161011422|NCT02252172|581428800|FG001|Overall Study|Site closure|1|||
161011423|NCT05575076|581428801|FG000|Overall Study|Adverse Event|24|||
161011424|NCT05575076|581428801|FG000|Overall Study|Death|7|||
161011425|NCT05575076|581428801|FG000|Overall Study|Lost to Follow-up|16|||
161011426|NCT05575076|581428801|FG000|Overall Study|Non-Compliance|3|||
161011427|NCT05575076|581428801|FG000|Overall Study|Physician Decision|6|||
161011428|NCT05575076|581428801|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
160585740|NCT00406640|579862014|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
161011429|NCT05575076|581428801|FG000|Overall Study|Withdrawal by Subject|71|||
161011430|NCT05575076|581428801|FG000|Overall Study|Study Terminated by Sponsor|630|||
161011431|NCT05575076|581428801|FG000|Overall Study|Other|17|||
161011432|NCT03830866|581428802|FG000|Overall Study|Death|90|||
161011433|NCT03830866|581428803|FG001|Overall Study|Death|111|||
161011434|NCT03830866|581428802|FG000|Overall Study|Lost to Follow-up|7|||
161011435|NCT03830866|581428803|FG001|Overall Study|Lost to Follow-up|7|||
161011436|NCT03830866|581428802|FG000|Overall Study|Withdrawal by Subject|19|||
161011437|NCT03830866|581428803|FG001|Overall Study|Withdrawal by Subject|16|||
161011438|NCT03830866|581428802|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
161011439|NCT03830866|581428803|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
161011440|NCT03830866|581428802|FG000|Overall Study|Other|1|||
161011441|NCT03830866|581428803|FG001|Overall Study|Other|1|||
161011442|NCT02376790|581428813|FG000|Overall Study|Withdrawal by Subject|43|||
161011443|NCT02376790|581428814|FG001|Overall Study|Withdrawal by Subject|36|||
161011444|NCT02376790|581428815|FG002|Overall Study|Withdrawal by Subject|37|||
161011445|NCT02376790|581428813|FG000|Overall Study|Decision by Sponsor|2|||
161011446|NCT02376790|581428814|FG001|Overall Study|Decision by Sponsor|1|||
161011447|NCT02376790|581428815|FG002|Overall Study|Decision by Sponsor|4|||
161011448|NCT02376790|581428813|FG000|Overall Study|Lost to Follow-up|15|||
161011449|NCT02376790|581428814|FG001|Overall Study|Lost to Follow-up|10|||
161011450|NCT02376790|581428815|FG002|Overall Study|Lost to Follow-up|12|||
161011451|NCT00988858|581428816|FG000|Overall Study|Adverse Event|7|||
161011452|NCT00988858|581428816|FG000|Overall Study|Death|1|||
161011453|NCT00988858|581428816|FG000|Overall Study|Physician Decision|1|||
161011454|NCT00988858|581428816|FG000|Overall Study|Sponsor Decision|1|||
161011455|NCT03014453|581428817|FG000|Overall Study|Lost to Follow-up|12|||
161011456|NCT03014453|581428817|FG000|Overall Study|Discontinued GER|3|||
161011457|NCT03014453|581428817|FG000|Overall Study|Excluded|19|||
161011458|NCT03014453|581428817|FG000|Overall Study|Refused to take part in|37|||
161011459|NCT02238483|581428818|FG000|Overall Study|Withdrawal by Subject|2|||
161011460|NCT02238483|581428819|FG001|Overall Study|Withdrawal by Subject|7|||
161011461|NCT02238483|581428818|FG000|Overall Study|Lost to Follow-up|1|||
160458825|NCT04084574|579412674|FG001|Overall Study|Lost to Follow-up|0|||
160458826|NCT04084574|579412673|FG000|Overall Study|Physician Decision|1|||
160458827|NCT04084574|579412674|FG001|Overall Study|Physician Decision|0|||
160458828|NCT04084574|579412673|FG000|Overall Study|Relocated out of state|1|||
160458829|NCT04084574|579412674|FG001|Overall Study|Relocated out of state|0|||
160458830|NCT00942877|579412675|FG000|Overall Study|Refused further treatment|1|||
160458831|NCT00942877|579412676|FG001|Overall Study|Refused further treatment|1|||
160458832|NCT00942877|579412675|FG000|Overall Study|Patient was not treated|1|||
160458833|NCT00942877|579412676|FG001|Overall Study|Patient was not treated|0|||
160458834|NCT00942877|579412675|FG000|Overall Study|Adverse Event|1|||
160458835|NCT00942877|579412676|FG001|Overall Study|Adverse Event|0|||
160458836|NCT00942877|579412675|FG000|Overall Study|Progressive disease|42|||
160458837|NCT00942877|579412676|FG001|Overall Study|Progressive disease|3|||
160458838|NCT02095691|579412679|FG000|Overall Study|Physician Decision|1|||
160458839|NCT03681262|579412680|FG000|Overall Study|Continuing on study|3|||
160458840|NCT03681262|579412681|FG001|Overall Study|Continuing on study|3|||
160458841|NCT03681262|579412680|FG000|Overall Study|Lost to Follow-up|1|||
160458842|NCT03681262|579412681|FG001|Overall Study|Lost to Follow-up|0|||
160458843|NCT00887198|579412683|FG000|Randomized Period|Ongoing|42|||
160458844|NCT00887198|579412684|FG001|Randomized Period|Ongoing|0|||
160458845|NCT00887198|579412685|FG002|Randomized Period|Ongoing|0|||
160458846|NCT00887198|579412683|FG000|Randomized Period|Adverse Event|50|||
160458847|NCT00887198|579412684|FG001|Randomized Period|Adverse Event|33|||
160458848|NCT00887198|579412685|FG002|Randomized Period|Adverse Event|0|||
160458849|NCT00887198|579412683|FG000|Randomized Period|Lost to Follow-up|1|||
160458850|NCT00887198|579412684|FG001|Randomized Period|Lost to Follow-up|0|||
160458851|NCT00887198|579412685|FG002|Randomized Period|Lost to Follow-up|0|||
160458852|NCT00887198|579412683|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
160458853|NCT00887198|579412684|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
160458854|NCT00887198|579412685|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
160458855|NCT00887198|579412683|FG000|Randomized Period|Withdrawal by Subject|41|||
160458856|NCT00887198|579412684|FG001|Randomized Period|Withdrawal by Subject|56|||
160458857|NCT00887198|579412685|FG002|Randomized Period|Withdrawal by Subject|0|||
160458858|NCT00887198|579412683|FG000|Randomized Period|Progressive disease|366|||
160458859|NCT00887198|579412684|FG001|Randomized Period|Progressive disease|370|||
160458860|NCT00887198|579412685|FG002|Randomized Period|Progressive disease|0|||
160458861|NCT00887198|579412683|FG000|Randomized Period|Other|42|||
160458862|NCT00887198|579412684|FG001|Randomized Period|Other|30|||
161011462|NCT02238483|581428819|FG001|Overall Study|Lost to Follow-up|1|||
161011463|NCT02238483|581428818|FG000|Overall Study|Protocol Violation|1|||
161011464|NCT02238483|581428819|FG001|Overall Study|Protocol Violation|2|||
161011465|NCT02238483|581428818|FG000|Overall Study|Death|1|||
161011466|NCT02238483|581428819|FG001|Overall Study|Death|0|||
161011467|NCT02238483|581428818|FG000|Overall Study|Adverse Event|7|||
161011468|NCT02238483|581428819|FG001|Overall Study|Adverse Event|3|||
161011469|NCT02238483|581428818|FG000|Overall Study|Withdrawn due to physician decision|1|||
160458863|NCT00887198|579412685|FG002|Randomized Period|Other|0|||
160458864|NCT00887198|579412683|FG000|Randomized Period|Randomized, Not treated|4|||
160458865|NCT00887198|579412684|FG001|Randomized Period|Randomized, Not treated|2|||
160458866|NCT00887198|579412685|FG002|Randomized Period|Randomized, Not treated|0|||
160458867|NCT00887198|579412683|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
160458868|NCT00887198|579412684|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
160458869|NCT00887198|579412685|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
160458870|NCT00887198|579412683|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
160458871|NCT00887198|579412684|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
160458872|NCT00887198|579412685|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
161011470|NCT02238483|581428819|FG001|Overall Study|Withdrawn due to physician decision|0|||
161011471|NCT02238483|581428818|FG000|Overall Study|Completion status not recorded|1|||
161011472|NCT02238483|581428819|FG001|Overall Study|Completion status not recorded|1|||
161011473|NCT02238483|581428818|FG000|Overall Study|Illness in family member|1|||
161011474|NCT02238483|581428819|FG001|Overall Study|Illness in family member|0|||
161011475|NCT02538341|581428827|FG000|Overall Study|Lost to Follow-up|51|||
161011476|NCT02538341|581428828|FG001|Overall Study|Lost to Follow-up|46|||
161011477|NCT02538341|581428827|FG000|Overall Study|Withdrawal by Subject|3|||
161011478|NCT02538341|581428828|FG001|Overall Study|Withdrawal by Subject|1|||
161011479|NCT02538341|581428827|FG000|Overall Study|Death|2|||
161011480|NCT02538341|581428828|FG001|Overall Study|Death|0|||
161011481|NCT03750968|581428829|FG000|Overall Study|Adverse Event|2|||
161011482|NCT03750968|581428830|FG001|Overall Study|Adverse Event|0|||
161011483|NCT03750968|581428829|FG000|Overall Study|Lost to Follow-up|1|||
161011484|NCT03750968|581428830|FG001|Overall Study|Lost to Follow-up|3|||
161011485|NCT02539225|581428833|FG000|Part A|Adverse Event|13|||
161011486|NCT02539225|581428834|FG001|Part A|Adverse Event|4|||
161011487|NCT02539225|581428833|FG000|Part A|Withdrawal by Subject|2|||
161011488|NCT02539225|581428834|FG001|Part A|Withdrawal by Subject|4|||
161011489|NCT02539225|581428833|FG000|Part A|Physician Decision|4|||
161011490|NCT02539225|581428834|FG001|Part A|Physician Decision|7|||
161011491|NCT02539225|581428833|FG000|Part A|Did Not Receive study Drug|1|||
161011492|NCT02539225|581428834|FG001|Part A|Did Not Receive study Drug|1|||
161011493|NCT02539225|581428833|FG000|Pre Treatment for Part B|Progressive disease|1|||
161011494|NCT02539225|581428834|FG001|Pre Treatment for Part B|Progressive disease|1|||
161011495|NCT02539225|581428833|FG000|Pre Treatment for Part B|Adverse Event|1|||
161011496|NCT02539225|581428834|FG001|Pre Treatment for Part B|Adverse Event|1|||
161011497|NCT02539225|581428833|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
161011498|NCT02539225|581428834|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
161011499|NCT02539225|581428833|FG000|Pre Treatment for Part B|Physician Decision|2|||
161011500|NCT02539225|581428834|FG001|Pre Treatment for Part B|Physician Decision|0|||
161011501|NCT02539225|581428833|FG000|Part B|Adverse Event|4|||
161011502|NCT02539225|581428834|FG001|Part B|Adverse Event|4|||
161011503|NCT02539225|581428833|FG000|Part B|Withdrawal by Subject|0|||
161011504|NCT02539225|581428834|FG001|Part B|Withdrawal by Subject|3|||
161011505|NCT02539225|581428833|FG000|Part B|Physician Decision|0|||
161011506|NCT02539225|581428834|FG001|Part B|Physician Decision|9|||
161011507|NCT02759016|581428835|FG000|Overall Study|Not treated with BI 836826|1|||
161011508|NCT02759016|581428836|FG001|Overall Study|Not treated with BI 836826|0|||
161011509|NCT02759016|581428835|FG000|Overall Study|Progressive disease|1|||
161011510|NCT02759016|581428836|FG001|Overall Study|Progressive disease|0|||
161011511|NCT02759016|581428835|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
161011512|NCT02759016|581428836|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
161011513|NCT02759016|581428835|FG000|Overall Study|Other not defined above|2|||
161011514|NCT02759016|581428836|FG001|Overall Study|Other not defined above|1|||
161011515|NCT02891915|581428841|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
161011516|NCT02891915|581428842|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
161011517|NCT02891915|581428841|FG000|Overall Study|Withdrawal by Subject|3|||
161011518|NCT02891915|581428842|FG001|Overall Study|Withdrawal by Subject|3|||
161011519|NCT02891915|581428841|FG000|Overall Study|Became Ineligible After Enrollment|2|||
161011520|NCT02891915|581428842|FG001|Overall Study|Became Ineligible After Enrollment|1|||
161011521|NCT02891915|581428841|FG000|Overall Study|Lost to Follow-up|1|||
161011522|NCT02891915|581428842|FG001|Overall Study|Lost to Follow-up|4|||
161011523|NCT02891915|581428841|FG000|Overall Study|Physician Decision|1|||
161011524|NCT02891915|581428842|FG001|Overall Study|Physician Decision|0|||
161011525|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
161011526|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
161011527|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
161011528|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
161011529|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
161011530|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
161011531|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
161011532|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
161011533|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
161011534|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
161011535|NCT03939312|581428843|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
161011536|NCT03939312|581428843|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
161011537|NCT01609218|581428845|FG000|Period 1|Adverse Event|3|||
161011538|NCT01609218|581428846|FG001|Period 1|Adverse Event|5|||
161011539|NCT01609218|581428845|FG000|Period 1|Sponsor Decision|0|||
161011540|NCT01609218|581428846|FG001|Period 1|Sponsor Decision|1|||
161011541|NCT01609218|581428845|FG000|Period 2|Adverse Event|1|||
160585741|NCT00406640|579862013|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
160585742|NCT00406640|579862014|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
161011542|NCT01609218|581428846|FG001|Period 2|Adverse Event|0|||
161011543|NCT02576509|581430660|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
161011544|NCT02576509|581430661|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
161011545|NCT02576509|581430660|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
161011546|NCT02576509|581430661|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
160585743|NCT00406640|579862013|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
160585744|NCT00406640|579862014|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
160585745|NCT00406640|579862013|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
160585746|NCT00406640|579862014|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
160585747|NCT00406640|579862013|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
160585748|NCT00406640|579862014|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
161011547|NCT02576509|581430660|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
161011548|NCT02576509|581430661|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
161011549|NCT02576509|581430660|FG000|Treatment Period|Disease progression|263|||
161011550|NCT02576509|581430661|FG001|Treatment Period|Disease progression|244|||
161011551|NCT02576509|581430660|FG000|Treatment Period|Study drug toxicity|37|||
161011552|NCT02576509|581430661|FG001|Treatment Period|Study drug toxicity|41|||
161011553|NCT02576509|581430660|FG000|Treatment Period|Death|1|||
161011554|NCT02576509|581430661|FG001|Treatment Period|Death|1|||
161011555|NCT02576509|581430660|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
161011556|NCT02576509|581430661|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
161011557|NCT02576509|581430660|FG000|Treatment Period|Participant request to stop treatment|8|||
161011558|NCT02576509|581430661|FG001|Treatment Period|Participant request to stop treatment|18|||
161011559|NCT02576509|581430660|FG000|Treatment Period|Participant withdrew consent|3|||
161011560|NCT02576509|581430661|FG001|Treatment Period|Participant withdrew consent|7|||
161011561|NCT02576509|581430660|FG000|Treatment Period|Lost to Follow-up|0|||
161011562|NCT02576509|581430661|FG001|Treatment Period|Lost to Follow-up|1|||
161011563|NCT02576509|581430660|FG000|Treatment Period|Maximum clinical benefit|1|||
161011564|NCT02576509|581430661|FG001|Treatment Period|Maximum clinical benefit|0|||
161011565|NCT02576509|581430660|FG000|Treatment Period|Poor/non-compliance|1|||
161011566|NCT02576509|581430661|FG001|Treatment Period|Poor/non-compliance|1|||
161011567|NCT02576509|581430660|FG000|Treatment Period|Participant no longer meets criteria|1|||
161011568|NCT02576509|581430661|FG001|Treatment Period|Participant no longer meets criteria|0|||
161011569|NCT02576509|581430660|FG000|Treatment Period|Other reason|12|||
161011570|NCT02576509|581430661|FG001|Treatment Period|Other reason|8|||
161011571|NCT02576509|581430660|FG000|Treatment Period|NOT REPORTED|1|||
161011572|NCT02576509|581430661|FG001|Treatment Period|NOT REPORTED|0|||
160458873|NCT00887198|579412683|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
160458874|NCT00887198|579412684|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
160458875|NCT00887198|579412685|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
160458876|NCT00887198|579412683|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
160458877|NCT00887198|579412684|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
160458878|NCT00887198|579412685|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
160458879|NCT00887198|579412683|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
160458880|NCT00887198|579412684|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
160458881|NCT00887198|579412685|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
160458882|NCT00887198|579412683|FG000|Cross Over (Placebo to AA)|Other|0|||
160458883|NCT00887198|579412684|FG001|Cross Over (Placebo to AA)|Other|0|||
160458884|NCT00887198|579412685|FG002|Cross Over (Placebo to AA)|Other|19|||
160458885|NCT02782676|579412686|FG000|Overall Study|Lost to Follow-up|0|||
160458886|NCT02782676|579412687|FG001|Overall Study|Lost to Follow-up|1|||
160458887|NCT05007080|579412688|FG000|Overall Study|Lost to Follow-up|0|||
160458888|NCT05007080|579412689|FG001|Overall Study|Lost to Follow-up|1|||
160458889|NCT05007080|579412690|FG002|Overall Study|Lost to Follow-up|0|||
160458890|NCT05007080|579412691|FG003|Overall Study|Lost to Follow-up|1|||
160458891|NCT05007080|579412692|FG004|Overall Study|Lost to Follow-up|1|||
160458892|NCT05007080|579412693|FG005|Overall Study|Lost to Follow-up|1|||
160458893|NCT05007080|579412688|FG000|Overall Study|Death|0|||
160458894|NCT05007080|579412689|FG001|Overall Study|Death|1|||
160458895|NCT05007080|579412690|FG002|Overall Study|Death|0|||
160458896|NCT05007080|579412691|FG003|Overall Study|Death|0|||
160458897|NCT05007080|579412692|FG004|Overall Study|Death|0|||
160458898|NCT05007080|579412693|FG005|Overall Study|Death|0|||
160585749|NCT00406640|579862013|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
160657028|NCT05097989|580124498|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161011573|NCT02576509|581430660|FG000|Treatment Period|Administrative reason by sponsor|0|||
161011574|NCT02576509|581430661|FG001|Treatment Period|Administrative reason by sponsor|1|||
161011575|NCT00212355|581430662|FG000|Overall Study|Adverse Event|1|||
161011576|NCT00212355|581430662|FG000|Overall Study|Withdrawal by Subject|1|||
160458899|NCT05007080|579412688|FG000|Overall Study|Withdrawal by Subject|1|||
160458900|NCT05007080|579412689|FG001|Overall Study|Withdrawal by Subject|2|||
160458901|NCT05007080|579412690|FG002|Overall Study|Withdrawal by Subject|0|||
160458902|NCT05007080|579412691|FG003|Overall Study|Withdrawal by Subject|2|||
160458903|NCT05007080|579412692|FG004|Overall Study|Withdrawal by Subject|1|||
160458904|NCT05007080|579412693|FG005|Overall Study|Withdrawal by Subject|1|||
160458905|NCT05007080|579412688|FG000|Overall Study|Other|1|||
160458906|NCT05007080|579412689|FG001|Overall Study|Other|0|||
161011577|NCT00212355|581430662|FG000|Overall Study|A change of address|1|||
161011578|NCT00186992|581430668|FG000|Overall Study|Withdrawal by Subject|5|||
161011579|NCT00186992|581430668|FG000|Overall Study|Physician's discretion|13|||
161011580|NCT00186992|581430668|FG000|Overall Study|PI Discretion|4|||
161011581|NCT00186992|581430668|FG000|Overall Study|Ineligible|2|||
161011582|NCT00186992|581430668|FG000|Overall Study|Lost to Follow-up|2|||
161011583|NCT00186992|581430668|FG000|Overall Study|Still on Study|9|||
161011584|NCT05104697|581430669|FG000|Overall Study|Withdrawal by Subject|0|||
161011585|NCT05104697|581430670|FG001|Overall Study|Withdrawal by Subject|1|||
161011586|NCT03913195|581430671|FG000|Overall Study|Adverse Event|0|||
161011587|NCT03913195|581430672|FG001|Overall Study|Adverse Event|0|||
161011588|NCT03913195|581430673|FG002|Overall Study|Adverse Event|1|||
161011589|NCT03913195|581430674|FG003|Overall Study|Adverse Event|1|||
161011590|NCT03913195|581430675|FG004|Overall Study|Adverse Event|0|||
161011591|NCT03913195|581430671|FG000|Overall Study|Withdrawal by Subject|0|||
161011592|NCT03913195|581430672|FG001|Overall Study|Withdrawal by Subject|0|||
161011593|NCT03913195|581430673|FG002|Overall Study|Withdrawal by Subject|1|||
161011594|NCT03913195|581430674|FG003|Overall Study|Withdrawal by Subject|0|||
161011595|NCT03913195|581430675|FG004|Overall Study|Withdrawal by Subject|1|||
161011596|NCT03913195|581430671|FG000|Overall Study|non adherence to study|0|||
161011597|NCT03913195|581430672|FG001|Overall Study|non adherence to study|0|||
161011598|NCT03913195|581430673|FG002|Overall Study|non adherence to study|1|||
161011599|NCT03913195|581430674|FG003|Overall Study|non adherence to study|0|||
161011600|NCT03913195|581430675|FG004|Overall Study|non adherence to study|0|||
161011601|NCT03899961|581430676|FG000|Overall Study|-delivery prior to|2|||
161011602|NCT03899961|581430677|FG001|Overall Study|-delivery prior to|7|||
161011603|NCT03899961|581430676|FG000|Overall Study|req general anesth|1|||
161011604|NCT03899961|581430677|FG001|Overall Study|req general anesth|2|||
161011605|NCT03899961|581430676|FG000|Overall Study|capacity|5|||
161011606|NCT03899961|581430677|FG001|Overall Study|capacity|6|||
161011607|NCT03899961|581430676|FG000|Overall Study|Withdrawal by Subject|1|||
161011608|NCT03899961|581430677|FG001|Overall Study|Withdrawal by Subject|1|||
161011609|NCT05307978|581430678|FG000|Overall Study|Lost to Follow-up|0|||
161011610|NCT05307978|581430679|FG001|Overall Study|Lost to Follow-up|1|||
161011611|NCT05307978|581430680|FG002|Overall Study|Lost to Follow-up|0|||
161011612|NCT05307978|581430681|FG003|Overall Study|Lost to Follow-up|4|||
161011613|NCT05307978|581430682|FG004|Overall Study|Lost to Follow-up|0|||
161011614|NCT05307978|581430683|FG005|Overall Study|Lost to Follow-up|0|||
161011615|NCT05307978|581430684|FG006|Overall Study|Lost to Follow-up|1|||
161011616|NCT03416023|581430685|FG000|Overall Study|Exclusion criteria failure|1|||
161011617|NCT03416023|581430685|FG000|Overall Study|Withdrawal by Subject|6|||
161011618|NCT03416023|581430685|FG000|Overall Study|Explanted|7|||
161011619|NCT03416023|581430685|FG000|Overall Study|Physician Decision|1|||
161011620|NCT03416023|581430685|FG000|Overall Study|Lost to Follow-up|1|||
161011621|NCT03416023|581430685|FG000|Overall Study|Death|1|||
161011622|NCT03651895|581430686|FG000|First Drug Assignment|Adverse Event|4|||
161011623|NCT03651895|581430687|FG001|First Drug Assignment|Adverse Event|5|||
161011624|NCT03651895|581430686|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
161011625|NCT03651895|581430687|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
161011626|NCT02837510|581430688|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
161011627|NCT02837510|581430689|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
161011628|NCT02837510|581430688|FG000|Washout (2 Weeks)|Adverse Event|0|||
161011629|NCT02837510|581430689|FG001|Washout (2 Weeks)|Adverse Event|1|||
161011630|NCT02837510|581430688|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
161011631|NCT02837510|581430689|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
161011632|NCT02837510|581430688|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
161011633|NCT02837510|581430689|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
161011634|NCT02837510|581430688|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
161011635|NCT02837510|581430689|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
161011636|NCT02837510|581430688|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
161011637|NCT02837510|581430689|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
161011638|NCT05510232|581430690|FG000|Overall Study|Withdrawal by Subject|2|||
161011639|NCT05510232|581430691|FG001|Overall Study|Withdrawal by Subject|7|||
161011640|NCT05510232|581430692|FG002|Overall Study|Withdrawal by Subject|6|||
161011641|NCT04468776|581430702|FG000|Overall Study|Lost to Follow-up|4|||
161011642|NCT04468776|581430703|FG001|Overall Study|Lost to Follow-up|3|||
161011643|NCT04468776|581430704|FG002|Overall Study|Lost to Follow-up|4|||
161011644|NCT04468776|581430702|FG000|Overall Study|Withdrawal by Subject|1|||
161011645|NCT04468776|581430703|FG001|Overall Study|Withdrawal by Subject|10|||
160657029|NCT05097989|580124499|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161011646|NCT04468776|581430704|FG002|Overall Study|Withdrawal by Subject|4|||
161011647|NCT04468776|581430702|FG000|Overall Study|Physician Decision|0|||
161011648|NCT04468776|581430703|FG001|Overall Study|Physician Decision|1|||
161011649|NCT04468776|581430704|FG002|Overall Study|Physician Decision|1|||
161011650|NCT03857620|581430708|FG000|Overall Study|Death|4|||
161011651|NCT03857620|581430709|FG001|Overall Study|Death|5|||
161011652|NCT03857620|581430710|FG002|Overall Study|Death|7|||
161011653|NCT03857620|581430708|FG000|Overall Study|Lost to Follow-up|2|||
161011654|NCT03857620|581430709|FG001|Overall Study|Lost to Follow-up|5|||
161011655|NCT03857620|581430710|FG002|Overall Study|Lost to Follow-up|3|||
161011656|NCT03857620|581430708|FG000|Overall Study|Disease progression or relapse after study registration|1|||
161011657|NCT03857620|581430709|FG001|Overall Study|Disease progression or relapse after study registration|5|||
161011658|NCT03857620|581430710|FG002|Overall Study|Disease progression or relapse after study registration|1|||
161011659|NCT03857620|581430708|FG000|Overall Study|Ineligible|5|||
161011660|NCT03857620|581430709|FG001|Overall Study|Ineligible|0|||
161011661|NCT03857620|581430710|FG002|Overall Study|Ineligible|2|||
161011662|NCT03857620|581430708|FG000|Overall Study|No malignancy|1|||
161011663|NCT03857620|581430709|FG001|Overall Study|No malignancy|0|||
161011664|NCT03857620|581430710|FG002|Overall Study|No malignancy|1|||
161011665|NCT03857620|581430708|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
161011666|NCT03857620|581430709|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
161011667|NCT03857620|581430710|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
161011668|NCT03857620|581430708|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
161011669|NCT03857620|581430709|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
161011670|NCT03857620|581430710|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
161011671|NCT03857620|581430708|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
161011672|NCT03857620|581430709|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
161011673|NCT03857620|581430710|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
161011674|NCT03857620|581430708|FG000|Overall Study|Surgery not performed, patient decision|0|||
161011675|NCT03857620|581430709|FG001|Overall Study|Surgery not performed, patient decision|3|||
161011676|NCT03857620|581430710|FG002|Overall Study|Surgery not performed, patient decision|1|||
161011677|NCT03857620|581430708|FG000|Overall Study|Surgery not performed, other reason|3|||
161011678|NCT03857620|581430709|FG001|Overall Study|Surgery not performed, other reason|1|||
161011679|NCT03857620|581430710|FG002|Overall Study|Surgery not performed, other reason|4|||
161011680|NCT03857620|581430708|FG000|Overall Study|Worsening performance status after surgery performed|0|||
161011681|NCT03857620|581430709|FG001|Overall Study|Worsening performance status after surgery performed|1|||
161011682|NCT03857620|581430710|FG002|Overall Study|Worsening performance status after surgery performed|1|||
161011683|NCT04118452|581430711|FG000|Overall Study|Lost to Follow-up|5|||
161011684|NCT04118452|581430712|FG001|Overall Study|Lost to Follow-up|5|||
161011685|NCT04118452|581430711|FG000|Overall Study|Withdrawal by Subject|17|||
161011686|NCT04118452|581430712|FG001|Overall Study|Withdrawal by Subject|17|||
161011687|NCT03433339|581430713|FG000|Overall Study|Lost to Follow-up|2|||
160585750|NCT00406640|579862014|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
161011688|NCT03433339|581430714|FG001|Overall Study|Lost to Follow-up|0|||
161011689|NCT03433339|581430713|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
161011690|NCT03433339|581430714|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
161011691|NCT03433339|581430713|FG000|Overall Study|Withdrawal by Subject|0|||
161011692|NCT03433339|581430714|FG001|Overall Study|Withdrawal by Subject|2|||
161011693|NCT04905407|581430719|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
161011694|NCT04905407|581430720|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
161011695|NCT04905407|581430721|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
161011696|NCT04905407|581430722|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
161011697|NCT04905407|581430719|FG000|Part 1 and Part 2|Death|7|||
161011698|NCT04905407|581430720|FG001|Part 1 and Part 2|Death|7|||
161011699|NCT04905407|581430721|FG002|Part 1 and Part 2|Death|7|||
161011700|NCT04905407|581430722|FG003|Part 1 and Part 2|Death|0|||
161011701|NCT04905407|581430719|FG000|Part 1 and Part 2|Other than specified|0|||
161011702|NCT04905407|581430720|FG001|Part 1 and Part 2|Other than specified|0|||
161011703|NCT04905407|581430721|FG002|Part 1 and Part 2|Other than specified|1|||
161011704|NCT04905407|581430722|FG003|Part 1 and Part 2|Other than specified|0|||
161011705|NCT04905407|581430719|FG000|Part 3|Death|0|||
161011706|NCT04905407|581430720|FG001|Part 3|Death|0|||
161011707|NCT04905407|581430721|FG002|Part 3|Death|0|||
161011708|NCT04905407|581430722|FG003|Part 3|Death|2|||
161011709|NCT04868110|581430729|FG000|Overall Study|Withdrawal by Subject|3|||
161011710|NCT04868110|581430730|FG001|Overall Study|Withdrawal by Subject|4|||
161011711|NCT01046136|581430735|FG000|Overall Study|Withdrawal by Subject|0|||
161011712|NCT01046136|581430736|FG001|Overall Study|Withdrawal by Subject|4|||
160585751|NCT00406640|579862013|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
161011713|NCT01046136|581430735|FG000|Overall Study|Physician Decision|1|||
161011714|NCT01046136|581430736|FG001|Overall Study|Physician Decision|1|||
161011715|NCT01046136|581430735|FG000|Overall Study|Lost to Follow-up|3|||
161011716|NCT01046136|581430736|FG001|Overall Study|Lost to Follow-up|3|||
161011717|NCT02058108|581430737|FG000|Overall Study|Abnormal Laboratory Values|0|||
161011718|NCT02058108|581430738|FG001|Overall Study|Abnormal Laboratory Values|1|||
161011719|NCT02058108|581430737|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
161011720|NCT02058108|581430738|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161011721|NCT02058108|581430737|FG000|Overall Study|No longer requires study drug|0|||
161011722|NCT02058108|581430738|FG001|Overall Study|No longer requires study drug|1|||
161011723|NCT02058108|581430737|FG000|Overall Study|Withdrawal by Subject|1|||
161011724|NCT02058108|581430738|FG001|Overall Study|Withdrawal by Subject|0|||
161011725|NCT02058108|581430737|FG000|Overall Study|Administrative problems|3|||
161011726|NCT02058108|581430738|FG001|Overall Study|Administrative problems|3|||
161011727|NCT02058108|581430737|FG000|Overall Study|Protocol Violation|0|||
161011728|NCT02058108|581430738|FG001|Overall Study|Protocol Violation|1|||
161011729|NCT01376700|581430742|FG000|Overall Study|Sponsor terminated study early|8|||
160585752|NCT00406640|579862014|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
160585753|NCT00311181|579863894|FG000|Overall Study|Final DFTs were not obtained|96|||
160585754|NCT02294318|579863895|FG000|Overall Study|Worsening of drinking|3|||
160585755|NCT02294318|579863896|FG001|Overall Study|Worsening of drinking|0|||
160585756|NCT02294318|579863895|FG000|Overall Study|Not exposed to intervention|0|||
160585757|NCT02294318|579863896|FG001|Overall Study|Not exposed to intervention|2|||
161011730|NCT01376700|581430742|FG000|Overall Study|Low or high titer inhibitor|8|||
161011731|NCT00727909|581430743|FG000|Overall Study|Withdrawal by Subject|5|||
161011732|NCT00727909|581430744|FG001|Overall Study|Withdrawal by Subject|11|||
161011733|NCT00727909|581430745|FG002|Overall Study|Withdrawal by Subject|8|||
161011734|NCT00727909|581430746|FG003|Overall Study|Withdrawal by Subject|5|||
161011735|NCT00727909|581430743|FG000|Overall Study|Death|0|||
161011736|NCT00727909|581430744|FG001|Overall Study|Death|0|||
161011737|NCT00727909|581430745|FG002|Overall Study|Death|1|||
161011738|NCT00727909|581430746|FG003|Overall Study|Death|0|||
161011739|NCT01696773|581430747|FG000|Days 15-27, Washout|Adverse Event|1|||
161011740|NCT01696773|581430748|FG001|Days 15-27, Washout|Adverse Event|0|||
161011741|NCT03446157|581430749|FG000|Overall Study|Death|11|||
161011742|NCT03446157|581430750|FG001|Overall Study|Death|9|||
161011743|NCT03446157|581430749|FG000|Overall Study|Lost to Follow-up|0|||
161011744|NCT03446157|581430750|FG001|Overall Study|Lost to Follow-up|1|||
161011745|NCT03446157|581430749|FG000|Overall Study|Withdrawal by Subject|2|||
161011746|NCT03446157|581430750|FG001|Overall Study|Withdrawal by Subject|1|||
161011747|NCT02386553|581430751|FG000|Overall Study|Reason Not Specified|1|||
161011748|NCT02386553|581430752|FG001|Overall Study|Reason Not Specified|1|||
161011749|NCT02386553|581430751|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
161011750|NCT02386553|581430752|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
160458907|NCT05007080|579412690|FG002|Overall Study|Other|1|||
160458908|NCT05007080|579412691|FG003|Overall Study|Other|1|||
160458909|NCT05007080|579412692|FG004|Overall Study|Other|0|||
160458910|NCT05007080|579412693|FG005|Overall Study|Other|2|||
160458911|NCT05007080|579412688|FG000|Overall Study|Randomized not vaccinated|0|||
160458912|NCT05007080|579412689|FG001|Overall Study|Randomized not vaccinated|0|||
160458913|NCT05007080|579412690|FG002|Overall Study|Randomized not vaccinated|0|||
160458914|NCT05007080|579412691|FG003|Overall Study|Randomized not vaccinated|0|||
160458915|NCT05007080|579412692|FG004|Overall Study|Randomized not vaccinated|0|||
160458916|NCT05007080|579412693|FG005|Overall Study|Randomized not vaccinated|1|||
160458917|NCT02874742|579412695|FG000|Overall Study|Death|0|||
160458918|NCT02874742|579412696|FG001|Overall Study|Death|1|||
160458919|NCT02874742|579412697|FG002|Overall Study|Death|0|||
160458920|NCT02874742|579412695|FG000|Overall Study|Lost to Follow-up|5|||
160458921|NCT02874742|579412696|FG001|Overall Study|Lost to Follow-up|4|||
160458922|NCT02874742|579412697|FG002|Overall Study|Lost to Follow-up|1|||
160458923|NCT02874742|579412695|FG000|Overall Study|Withdrawal by Subject|17|||
160458924|NCT02874742|579412696|FG001|Overall Study|Withdrawal by Subject|8|||
160458925|NCT02874742|579412697|FG002|Overall Study|Withdrawal by Subject|0|||
160585758|NCT01694420|579863900|FG000|Overall Study|Lost to Follow-up|3|||
160585759|NCT00506948|579863901|FG000|Overall Study|Death|4|||
160967688|NCT02798211|581270072|FG003|Period 2|Withdrawal of Informed Consent|2|||
160967689|NCT02798211|581270073|FG004|Period 2|Withdrawal of Informed Consent|2|||
160967690|NCT02798211|581270074|FG005|Period 2|Withdrawal of Informed Consent|3|||
160967691|NCT01782872|581270075|FG000|Overall Study|Protocol Violation|0|||
160967692|NCT01782872|581270076|FG001|Overall Study|Protocol Violation|0|||
160967693|NCT01782872|581270077|FG002|Overall Study|Protocol Violation|0|||
160967694|NCT01782872|581270078|FG003|Overall Study|Protocol Violation|1|||
160967695|NCT01782872|581270075|FG000|Overall Study|Withdrawal by Subject|0|||
160967696|NCT01782872|581270076|FG001|Overall Study|Withdrawal by Subject|1|||
160967697|NCT01782872|581270077|FG002|Overall Study|Withdrawal by Subject|0|||
160967698|NCT01782872|581270078|FG003|Overall Study|Withdrawal by Subject|0|||
160967699|NCT03505476|581270079|FG000|Overall Study|Physician Decision|18|||
161011751|NCT05623345|581430761|FG000|Overall Study|Withdrawal by Subject|14|||
161011752|NCT05623345|581430762|FG001|Overall Study|Withdrawal by Subject|0|||
161011753|NCT05623345|581430763|FG002|Overall Study|Withdrawal by Subject|9|||
161011754|NCT05623345|581430764|FG003|Overall Study|Withdrawal by Subject|20|||
160458926|NCT02874742|579412695|FG000|Overall Study|Other|4|||
160585760|NCT00506948|579863901|FG000|Overall Study|Adverse Event|5|||
160967700|NCT03505476|581270079|FG000|Overall Study|Device Malfunctioned|101|||
160458927|NCT02874742|579412696|FG001|Overall Study|Other|1|||
160458928|NCT02874742|579412697|FG002|Overall Study|Other|0|||
161011755|NCT05623345|581430761|FG000|Overall Study|Lost to Follow-up|3|||
160458929|NCT02874742|579412695|FG000|Overall Study|Progressive Disease|1|||
160458930|NCT02874742|579412696|FG001|Overall Study|Progressive Disease|0|||
160967701|NCT03505476|581270079|FG000|Overall Study|Data Corrupt|6|||
161011756|NCT05623345|581430762|FG001|Overall Study|Lost to Follow-up|0|||
161011757|NCT05623345|581430763|FG002|Overall Study|Lost to Follow-up|7|||
161011758|NCT05623345|581430764|FG003|Overall Study|Lost to Follow-up|2|||
161011759|NCT05623345|581430761|FG000|Overall Study|Termination of Study By Sponsor|37|||
161011760|NCT05623345|581430762|FG001|Overall Study|Termination of Study By Sponsor|4|||
161011761|NCT05623345|581430763|FG002|Overall Study|Termination of Study By Sponsor|40|||
161011762|NCT05623345|581430764|FG003|Overall Study|Termination of Study By Sponsor|38|||
161011763|NCT05384730|581430765|FG000|Overall Study|Adverse Event|1|||
161011764|NCT05384730|581430766|FG001|Overall Study|Adverse Event|0|||
161011765|NCT05384730|581430765|FG000|Overall Study|Lack of social support|2|||
161011766|NCT05384730|581430766|FG001|Overall Study|Lack of social support|0|||
161011767|NCT05384730|581430765|FG000|Overall Study|Hospital readmission|2|||
161011768|NCT05384730|581430766|FG001|Overall Study|Hospital readmission|0|||
161011769|NCT05384730|581430765|FG000|Overall Study|Disease progression|5|||
161011770|NCT05384730|581430766|FG001|Overall Study|Disease progression|0|||
161011771|NCT05384730|581430765|FG000|Overall Study|Overwhelmed with College commitments|0|||
161011772|NCT05384730|581430766|FG001|Overall Study|Overwhelmed with College commitments|2|||
161011773|NCT02886286|581430775|FG000|Overall Study|pump motor stall|0|||
161011774|NCT02886286|581430776|FG001|Overall Study|pump motor stall|1|||
161011775|NCT01426412|581430777|FG000|Overall Study|Withdrawal by Subject|1|||
161011776|NCT01426412|581430778|FG001|Overall Study|Withdrawal by Subject|0|||
161011777|NCT01426412|581430779|FG002|Overall Study|Withdrawal by Subject|0|||
161011778|NCT01426412|581430780|FG003|Overall Study|Withdrawal by Subject|0|||
161011779|NCT01426412|581430781|FG004|Overall Study|Withdrawal by Subject|1|||
161011780|NCT01426412|581430782|FG005|Overall Study|Withdrawal by Subject|0|||
161011781|NCT01426412|581430783|FG006|Overall Study|Withdrawal by Subject|0|||
161011782|NCT01426412|581430784|FG007|Overall Study|Withdrawal by Subject|3|||
161011783|NCT01426412|581430785|FG008|Overall Study|Withdrawal by Subject|1|||
161011784|NCT00262301|581430788|FG000|Double-blind Phase|Lost to Follow-up|1|||
161011785|NCT00262301|581430789|FG001|Double-blind Phase|Lost to Follow-up|0|||
161011786|NCT00262301|581430790|FG002|Double-blind Phase|Lost to Follow-up|0|||
161011787|NCT00262301|581430788|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
161011788|NCT00262301|581430789|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
161011789|NCT00262301|581430790|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
161011790|NCT01017146|581430791|FG000|Overall Study|Adverse Event|11|||
161011791|NCT01017146|581430792|FG001|Overall Study|Adverse Event|1|||
161011792|NCT01017146|581430791|FG000|Overall Study|Lost to Follow-up|14|||
161011793|NCT01017146|581430792|FG001|Overall Study|Lost to Follow-up|14|||
161011794|NCT01017146|581430791|FG000|Overall Study|Noncompliance with Study Product|1|||
161011795|NCT01017146|581430792|FG001|Overall Study|Noncompliance with Study Product|1|||
161011796|NCT01017146|581430791|FG000|Overall Study|Withdrawal by Subject|32|||
161011797|NCT01017146|581430792|FG001|Overall Study|Withdrawal by Subject|16|||
161011798|NCT01017146|581430791|FG000|Overall Study|Relocation|0|||
161011799|NCT01017146|581430792|FG001|Overall Study|Relocation|4|||
161011800|NCT01017146|581430791|FG000|Overall Study|Pregnancy|2|||
161011801|NCT01017146|581430792|FG001|Overall Study|Pregnancy|1|||
161011802|NCT01017146|581430791|FG000|Overall Study|Protocol Violation|2|||
161011803|NCT01017146|581430792|FG001|Overall Study|Protocol Violation|0|||
161011804|NCT01017146|581430791|FG000|Overall Study|Took Excluded Medication|2|||
161011805|NCT01017146|581430792|FG001|Overall Study|Took Excluded Medication|0|||
161011806|NCT01017146|581430791|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
161011807|NCT01017146|581430792|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
161011808|NCT01017146|581430791|FG000|Overall Study|Change in Work Situation|1|||
161011809|NCT01017146|581430792|FG001|Overall Study|Change in Work Situation|0|||
161011810|NCT00976495|581430793|FG000|Overall Study|Withdrawal by Subject|0|||
161011811|NCT00976495|581430794|FG001|Overall Study|Withdrawal by Subject|1|||
161011812|NCT00976495|581430795|FG002|Overall Study|Withdrawal by Subject|0|||
161011813|NCT04154384|581430796|FG000|Overall Study|Lost to Follow-up|24|||
161011814|NCT04154384|581430797|FG001|Overall Study|Lost to Follow-up|33|||
161011815|NCT04154384|581430798|FG002|Overall Study|Lost to Follow-up|0|||
161011816|NCT04154384|581430796|FG000|Overall Study|Withdrawal by Subject|7|||
161011817|NCT04154384|581430797|FG001|Overall Study|Withdrawal by Subject|18|||
161011818|NCT04154384|581430798|FG002|Overall Study|Withdrawal by Subject|0|||
161011819|NCT04154384|581430796|FG000|Overall Study|Missing outcome data|1|||
161011820|NCT04154384|581430797|FG001|Overall Study|Missing outcome data|0|||
161011821|NCT04154384|581430798|FG002|Overall Study|Missing outcome data|0|||
161011822|NCT04732338|581430803|FG000|Overall Study|Lost to Follow-up|3|||
161011823|NCT04732338|581430804|FG001|Overall Study|Lost to Follow-up|3|||
161011824|NCT04484935|581430806|FG000|Overall Study|Other|0|||
161011825|NCT04484935|581430807|FG001|Overall Study|Other|1|||
161011826|NCT04484935|581430806|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161011827|NCT04484935|581430807|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161011828|NCT04484935|581430806|FG000|Overall Study|Lost to Follow-up|1|||
161011829|NCT04484935|581430807|FG001|Overall Study|Lost to Follow-up|0|||
161011830|NCT04484935|581430806|FG000|Overall Study|Death|2|||
161011831|NCT04484935|581430807|FG001|Overall Study|Death|1|||
161011832|NCT02556138|581430811|FG000|Overall Study|Withdrawal by Subject|1|||
161011833|NCT05094141|581430816|FG000|Overall Study|Death|0|||
161011834|NCT05094141|581430817|FG001|Overall Study|Death|0|||
161011835|NCT05094141|581430818|FG002|Overall Study|Death|1|||
160458931|NCT02874742|579412697|FG002|Overall Study|Progressive Disease|0|||
160458932|NCT02874742|579412695|FG000|Overall Study|Screen Failure|0|||
160458933|NCT02874742|579412696|FG001|Overall Study|Screen Failure|2|||
160458934|NCT02874742|579412697|FG002|Overall Study|Screen Failure|0|||
160458935|NCT04583280|579412703|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
160458936|NCT04583280|579412704|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
160458937|NCT00964392|579412705|FG000|Overall Study|Withdrawal by Subject|4|||
160458938|NCT00964392|579412706|FG001|Overall Study|Withdrawal by Subject|6|||
160458939|NCT00964392|579412705|FG000|Overall Study|Lost to Follow-up|4|||
160458940|NCT00964392|579412706|FG001|Overall Study|Lost to Follow-up|10|||
160458941|NCT00964392|579412705|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
160458942|NCT00964392|579412706|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
160458943|NCT00964392|579412705|FG000|Overall Study|Not completed|44|||
160458944|NCT00964392|579412706|FG001|Overall Study|Not completed|168|||
160458945|NCT00303459|579412707|FG000|Overall Study|Death|33|||
160458946|NCT00303459|579412708|FG001|Overall Study|Death|44|||
160458947|NCT00303459|579412707|FG000|Overall Study|Withdrawal of consent|32|||
160458948|NCT00303459|579412708|FG001|Overall Study|Withdrawal of consent|26|||
160458949|NCT00303459|579412707|FG000|Overall Study|Lost to Follow-up|5|||
160458950|NCT00303459|579412708|FG001|Overall Study|Lost to Follow-up|4|||
160458951|NCT00303459|579412707|FG000|Overall Study|Administrative reason|7|||
160458952|NCT00303459|579412708|FG001|Overall Study|Administrative reason|7|||
160458953|NCT00303459|579412707|FG000|Overall Study|Decision by the investigator|5|||
160458954|NCT00303459|579412708|FG001|Overall Study|Decision by the investigator|7|||
160458955|NCT00303459|579412707|FG000|Overall Study|Lung transplantation|1|||
160458956|NCT00303459|579412708|FG001|Overall Study|Lung transplantation|1|||
160458957|NCT04173247|579412717|FG000|Overall Study|Withdrawal by Subject|0|||
160458958|NCT04173247|579412718|FG001|Overall Study|Withdrawal by Subject|2|||
160458959|NCT04173247|579412717|FG000|Overall Study|Death|1|||
160458960|NCT04173247|579412718|FG001|Overall Study|Death|0|||
160458961|NCT04173247|579412717|FG000|Overall Study|Physician Decision|1|||
160967702|NCT03505476|581270079|FG000|Overall Study|Device application insufficiant|3|||
160967703|NCT01059630|581270082|FG000|Overall Study|Death|100|||
160967704|NCT01059630|581270083|FG001|Overall Study|Death|84|||
160967705|NCT01059630|581270082|FG000|Overall Study|Lost to Follow-up|4|||
160967706|NCT01059630|581270083|FG001|Overall Study|Lost to Follow-up|1|||
160967707|NCT01059630|581270082|FG000|Overall Study|Physician Decision|2|||
160967708|NCT01059630|581270083|FG001|Overall Study|Physician Decision|4|||
160967709|NCT01059630|581270082|FG000|Overall Study|Withdrawal by Subject|21|||
160967710|NCT01059630|581270083|FG001|Overall Study|Withdrawal by Subject|14|||
160967711|NCT02569437|581270084|FG000|Overall Study|Lost to Follow-up|12|||
160967712|NCT02569437|581270085|FG001|Overall Study|Lost to Follow-up|14|||
160967713|NCT00441701|581270086|FG000|Overall Study|Adverse Event|3|||
160967714|NCT00441701|581270087|FG001|Overall Study|Adverse Event|2|||
160967715|NCT00441701|581270088|FG002|Overall Study|Adverse Event|1|||
160967716|NCT00441701|581270089|FG003|Overall Study|Adverse Event|0|||
160967717|NCT00441701|581270090|FG004|Overall Study|Adverse Event|2|||
160967718|NCT00441701|581270091|FG005|Overall Study|Adverse Event|2|||
160967719|NCT00441701|581270092|FG006|Overall Study|Adverse Event|0|||
160967720|NCT00441701|581270093|FG007|Overall Study|Adverse Event|0|||
160967721|NCT00441701|581270094|FG008|Overall Study|Adverse Event|0|||
160967722|NCT00441701|581270095|FG009|Overall Study|Adverse Event|0|||
160967723|NCT00441701|581270086|FG000|Overall Study|Lack of Efficacy|2|||
160967724|NCT00441701|581270087|FG001|Overall Study|Lack of Efficacy|0|||
160967725|NCT00441701|581270088|FG002|Overall Study|Lack of Efficacy|2|||
160967726|NCT00441701|581270089|FG003|Overall Study|Lack of Efficacy|2|||
160967727|NCT00441701|581270090|FG004|Overall Study|Lack of Efficacy|0|||
160967728|NCT00441701|581270091|FG005|Overall Study|Lack of Efficacy|1|||
160967729|NCT00441701|581270092|FG006|Overall Study|Lack of Efficacy|0|||
160967730|NCT00441701|581270093|FG007|Overall Study|Lack of Efficacy|0|||
160967731|NCT00441701|581270094|FG008|Overall Study|Lack of Efficacy|0|||
160967732|NCT00441701|581270095|FG009|Overall Study|Lack of Efficacy|0|||
161011836|NCT05094141|581430816|FG000|Overall Study|Withdrawal by Subject|0|||
160458962|NCT04173247|579412718|FG001|Overall Study|Physician Decision|0|||
160967733|NCT00441701|581270086|FG000|Overall Study|Withdrawal by Subject|0|||
160967734|NCT00441701|581270087|FG001|Overall Study|Withdrawal by Subject|2|||
160967735|NCT00441701|581270088|FG002|Overall Study|Withdrawal by Subject|1|||
160458963|NCT04214834|579412723|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
160458964|NCT04214834|579412724|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
160458965|NCT04109066|579412729|FG000|Pre-treatment|Participant withdrew consent|2|||
160458966|NCT04109066|579412730|FG001|Pre-treatment|Participant withdrew consent|0|||
160585761|NCT00506948|579863901|FG000|Overall Study|Physician Decision|1|||
160967736|NCT00441701|581270089|FG003|Overall Study|Withdrawal by Subject|1|||
160967737|NCT00441701|581270090|FG004|Overall Study|Withdrawal by Subject|0|||
160967738|NCT00441701|581270091|FG005|Overall Study|Withdrawal by Subject|0|||
161011837|NCT05094141|581430817|FG001|Overall Study|Withdrawal by Subject|0|||
161011838|NCT05094141|581430818|FG002|Overall Study|Withdrawal by Subject|1|||
161011839|NCT05094141|581430816|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
161011840|NCT05094141|581430817|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
161011841|NCT05094141|581430818|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
161011842|NCT05094141|581430816|FG000|Overall Study|Did not participate in randomization|0|||
161011843|NCT05094141|581430817|FG001|Overall Study|Did not participate in randomization|0|||
161011844|NCT05094141|581430818|FG002|Overall Study|Did not participate in randomization|33|||
161011845|NCT03725722|581432619|FG000|Overall Study|Lack of Efficacy|2|||
161011846|NCT03725722|581432620|FG001|Overall Study|Lack of Efficacy|1|||
161011847|NCT03725722|581432621|FG002|Overall Study|Lack of Efficacy|2|||
161011848|NCT03725722|581432622|FG003|Overall Study|Lack of Efficacy|0|||
161011849|NCT03725722|581432623|FG004|Overall Study|Lack of Efficacy|2|||
161011850|NCT03725722|581432619|FG000|Overall Study|Adverse Event|2|||
161011851|NCT03725722|581432620|FG001|Overall Study|Adverse Event|2|||
161011852|NCT03725722|581432621|FG002|Overall Study|Adverse Event|1|||
161011853|NCT03725722|581432622|FG003|Overall Study|Adverse Event|0|||
161011854|NCT03725722|581432623|FG004|Overall Study|Adverse Event|6|||
161011855|NCT03725722|581432619|FG000|Overall Study|Withdrawal by Subject|4|||
161011856|NCT03725722|581432620|FG001|Overall Study|Withdrawal by Subject|1|||
161011857|NCT03725722|581432621|FG002|Overall Study|Withdrawal by Subject|0|||
161011858|NCT03725722|581432622|FG003|Overall Study|Withdrawal by Subject|4|||
161011859|NCT03725722|581432623|FG004|Overall Study|Withdrawal by Subject|4|||
161011860|NCT03725722|581432619|FG000|Overall Study|Lost to Follow-up|3|||
161011861|NCT03725722|581432620|FG001|Overall Study|Lost to Follow-up|1|||
161011862|NCT03725722|581432621|FG002|Overall Study|Lost to Follow-up|2|||
161011863|NCT03725722|581432622|FG003|Overall Study|Lost to Follow-up|2|||
161011864|NCT03725722|581432623|FG004|Overall Study|Lost to Follow-up|1|||
161011865|NCT03725722|581432619|FG000|Overall Study|Personal reasons|0|||
161011866|NCT03725722|581432620|FG001|Overall Study|Personal reasons|0|||
161011867|NCT03725722|581432621|FG002|Overall Study|Personal reasons|1|||
161011868|NCT03725722|581432622|FG003|Overall Study|Personal reasons|0|||
161011869|NCT03725722|581432623|FG004|Overall Study|Personal reasons|1|||
161011870|NCT03725722|581432619|FG000|Overall Study|COVID-19 situation|0|||
161011871|NCT03725722|581432620|FG001|Overall Study|COVID-19 situation|1|||
161011872|NCT03725722|581432621|FG002|Overall Study|COVID-19 situation|0|||
161011873|NCT03725722|581432622|FG003|Overall Study|COVID-19 situation|0|||
161011874|NCT03725722|581432623|FG004|Overall Study|COVID-19 situation|0|||
161011875|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
161011876|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
161011877|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
161011878|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
161011879|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
161011880|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
161011881|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
161011882|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
161011883|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
161011884|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
161011885|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
161011886|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
161011887|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
161011888|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
161011889|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
161011890|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
161011891|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
161011892|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
161011893|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
161011894|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
161011895|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
161011896|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
161011897|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
161011898|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
161011899|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
161011900|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
161011901|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
161011902|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
161011903|NCT01600014|581432624|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
161011904|NCT01600014|581432625|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
160657030|NCT05097989|580124500|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161011905|NCT01600014|581432624|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
160585762|NCT02395653|579863902|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
160585763|NCT02395653|579863902|FG000|Overall Study|Consent Withdrawn at Screening|1|||
160585764|NCT02395653|579863902|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
160585765|NCT02395653|579863902|FG000|Overall Study|Investigator Decision at Screening|1|||
160585766|NCT02395653|579863902|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
161011906|NCT01600014|581432625|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
161011907|NCT01600014|581432624|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
161011908|NCT01600014|581432625|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
161011909|NCT03398148|581432629|FG000|Substudy 1 Period 1|Adverse Event|5|||
161011910|NCT03398148|581432630|FG001|Substudy 1 Period 1|Adverse Event|2|||
161011911|NCT03398148|581432631|FG002|Substudy 1 Period 1|Adverse Event|2|||
161011912|NCT03398148|581432632|FG003|Substudy 1 Period 1|Adverse Event|0|||
161011913|NCT03398148|581432633|FG004|Substudy 1 Period 1|Adverse Event|8|||
161011914|NCT03398148|581432634|FG005|Substudy 1 Period 1|Adverse Event|0|||
161011915|NCT03398148|581432635|FG006|Substudy 1 Period 1|Adverse Event|0|||
161011916|NCT03398148|581432636|FG007|Substudy 1 Period 1|Adverse Event|0|||
161011917|NCT03398148|581432637|FG008|Substudy 1 Period 1|Adverse Event|0|||
161011918|NCT03398148|581432638|FG009|Substudy 1 Period 1|Adverse Event|0|||
161011919|NCT03398148|581432639|FG010|Substudy 1 Period 1|Adverse Event|0|||
161011920|NCT03398148|581432640|FG011|Substudy 1 Period 1|Adverse Event|0|||
161011921|NCT03398148|581432641|FG012|Substudy 1 Period 1|Adverse Event|0|||
161011922|NCT03398148|581432642|FG013|Substudy 1 Period 1|Adverse Event|0|||
161011923|NCT03398148|581432643|FG014|Substudy 1 Period 1|Adverse Event|0|||
161011924|NCT03398148|581432629|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
161011925|NCT03398148|581432630|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
161011926|NCT03398148|581432631|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011927|NCT03398148|581432632|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
161011928|NCT03398148|581432633|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
161011929|NCT03398148|581432634|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011930|NCT03398148|581432635|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011931|NCT03398148|581432636|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011932|NCT03398148|581432637|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011933|NCT03398148|581432638|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011934|NCT03398148|581432639|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011935|NCT03398148|581432640|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011936|NCT03398148|581432641|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011937|NCT03398148|581432642|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011938|NCT03398148|581432643|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011939|NCT03398148|581432629|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
161011940|NCT03398148|581432630|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
161011941|NCT03398148|581432631|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
161011942|NCT03398148|581432632|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
161011943|NCT03398148|581432633|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
161011944|NCT03398148|581432634|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
161011945|NCT03398148|581432635|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
161011946|NCT03398148|581432636|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
161011947|NCT03398148|581432637|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
161011948|NCT03398148|581432638|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
161011949|NCT03398148|581432639|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
161011950|NCT03398148|581432640|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
161011951|NCT03398148|581432641|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
161011952|NCT03398148|581432642|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
161011953|NCT03398148|581432643|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
161011954|NCT03398148|581432629|FG000|Substudy 1 Period 1|Other|0|||
161011955|NCT03398148|581432630|FG001|Substudy 1 Period 1|Other|1|||
161011956|NCT03398148|581432631|FG002|Substudy 1 Period 1|Other|0|||
161011957|NCT03398148|581432632|FG003|Substudy 1 Period 1|Other|0|||
161011958|NCT03398148|581432633|FG004|Substudy 1 Period 1|Other|3|||
161011959|NCT03398148|581432634|FG005|Substudy 1 Period 1|Other|0|||
161011960|NCT03398148|581432635|FG006|Substudy 1 Period 1|Other|0|||
161011961|NCT03398148|581432636|FG007|Substudy 1 Period 1|Other|0|||
161011962|NCT03398148|581432637|FG008|Substudy 1 Period 1|Other|0|||
161011963|NCT03398148|581432638|FG009|Substudy 1 Period 1|Other|0|||
161011964|NCT03398148|581432639|FG010|Substudy 1 Period 1|Other|0|||
161011965|NCT03398148|581432640|FG011|Substudy 1 Period 1|Other|0|||
161011966|NCT03398148|581432641|FG012|Substudy 1 Period 1|Other|0|||
161011967|NCT03398148|581432642|FG013|Substudy 1 Period 1|Other|0|||
161011968|NCT03398148|581432643|FG014|Substudy 1 Period 1|Other|0|||
161011969|NCT03398148|581432629|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011970|NCT03398148|581432630|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011971|NCT03398148|581432631|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011972|NCT03398148|581432632|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
160585767|NCT02395653|579863902|FG000|Overall Study|Withdrawal by Subject|1|||
160585768|NCT02395653|579863902|FG000|Overall Study|Lost to Follow-up|1|||
161011973|NCT03398148|581432633|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
161011974|NCT03398148|581432634|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011975|NCT03398148|581432635|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011976|NCT03398148|581432636|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011977|NCT03398148|581432637|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011978|NCT03398148|581432638|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011979|NCT03398148|581432639|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011980|NCT03398148|581432640|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011981|NCT03398148|581432641|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011982|NCT03398148|581432642|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011983|NCT03398148|581432643|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011984|NCT03398148|581432629|FG000|Substudy 1 Period 2|Adverse Event|0|||
161011985|NCT03398148|581432630|FG001|Substudy 1 Period 2|Adverse Event|0|||
161011986|NCT03398148|581432631|FG002|Substudy 1 Period 2|Adverse Event|0|||
161011987|NCT03398148|581432632|FG003|Substudy 1 Period 2|Adverse Event|0|||
161011988|NCT03398148|581432633|FG004|Substudy 1 Period 2|Adverse Event|0|||
161011989|NCT03398148|581432634|FG005|Substudy 1 Period 2|Adverse Event|2|||
161011990|NCT03398148|581432635|FG006|Substudy 1 Period 2|Adverse Event|4|||
161011991|NCT03398148|581432636|FG007|Substudy 1 Period 2|Adverse Event|0|||
161011992|NCT03398148|581432637|FG008|Substudy 1 Period 2|Adverse Event|0|||
161011993|NCT03398148|581432638|FG009|Substudy 1 Period 2|Adverse Event|0|||
161011994|NCT03398148|581432639|FG010|Substudy 1 Period 2|Adverse Event|0|||
161011995|NCT03398148|581432640|FG011|Substudy 1 Period 2|Adverse Event|0|||
161011996|NCT03398148|581432641|FG012|Substudy 1 Period 2|Adverse Event|0|||
161011997|NCT03398148|581432642|FG013|Substudy 1 Period 2|Adverse Event|0|||
161011998|NCT03398148|581432643|FG014|Substudy 1 Period 2|Adverse Event|0|||
161011999|NCT03398148|581432629|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012000|NCT03398148|581432630|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012001|NCT03398148|581432631|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012002|NCT03398148|581432632|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012003|NCT03398148|581432633|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012004|NCT03398148|581432634|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012005|NCT03398148|581432635|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
161012006|NCT03398148|581432636|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
161012007|NCT03398148|581432637|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012008|NCT03398148|581432638|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012009|NCT03398148|581432639|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012010|NCT03398148|581432640|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012011|NCT03398148|581432641|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012012|NCT03398148|581432642|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012013|NCT03398148|581432643|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012014|NCT03398148|581432629|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
161012015|NCT03398148|581432630|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
161012016|NCT03398148|581432631|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
161012017|NCT03398148|581432632|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
161012018|NCT03398148|581432633|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
161012019|NCT03398148|581432634|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
161012020|NCT03398148|581432635|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
161012021|NCT03398148|581432636|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
161012022|NCT03398148|581432637|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
161012023|NCT03398148|581432638|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
161012024|NCT03398148|581432639|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
161012025|NCT03398148|581432640|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
161012026|NCT03398148|581432641|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
161012027|NCT03398148|581432642|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
161012028|NCT03398148|581432643|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
161012029|NCT03398148|581432629|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012030|NCT03398148|581432630|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012031|NCT03398148|581432631|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012032|NCT03398148|581432632|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012033|NCT03398148|581432633|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012034|NCT03398148|581432634|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012035|NCT03398148|581432635|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
161012036|NCT03398148|581432636|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012037|NCT03398148|581432637|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012038|NCT03398148|581432638|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012039|NCT03398148|581432639|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012040|NCT03398148|581432640|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012041|NCT03398148|581432641|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012042|NCT03398148|581432642|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012043|NCT03398148|581432643|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012044|NCT03398148|581432629|FG000|Substudy 1 Period 2|Other|0|||
161012045|NCT03398148|581432630|FG001|Substudy 1 Period 2|Other|0|||
161012046|NCT03398148|581432631|FG002|Substudy 1 Period 2|Other|0|||
161012047|NCT03398148|581432632|FG003|Substudy 1 Period 2|Other|0|||
161012048|NCT03398148|581432633|FG004|Substudy 1 Period 2|Other|0|||
161012049|NCT03398148|581432634|FG005|Substudy 1 Period 2|Other|0|||
161012050|NCT03398148|581432635|FG006|Substudy 1 Period 2|Other|1|||
161012051|NCT03398148|581432636|FG007|Substudy 1 Period 2|Other|0|||
161012052|NCT03398148|581432637|FG008|Substudy 1 Period 2|Other|0|||
161012053|NCT03398148|581432638|FG009|Substudy 1 Period 2|Other|0|||
161012054|NCT03398148|581432639|FG010|Substudy 1 Period 2|Other|0|||
161012055|NCT03398148|581432640|FG011|Substudy 1 Period 2|Other|0|||
161012056|NCT03398148|581432641|FG012|Substudy 1 Period 2|Other|0|||
161012057|NCT03398148|581432642|FG013|Substudy 1 Period 2|Other|0|||
161012058|NCT03398148|581432643|FG014|Substudy 1 Period 2|Other|0|||
161012059|NCT03398148|581432629|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012060|NCT03398148|581432630|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012061|NCT03398148|581432631|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012062|NCT03398148|581432632|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012063|NCT03398148|581432633|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012064|NCT03398148|581432634|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012065|NCT03398148|581432635|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
161012066|NCT03398148|581432636|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012067|NCT03398148|581432637|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012068|NCT03398148|581432638|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012069|NCT03398148|581432639|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012070|NCT03398148|581432640|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012071|NCT03398148|581432641|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012072|NCT03398148|581432642|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012073|NCT03398148|581432643|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012074|NCT03398148|581432629|FG000|Substudy 2 Period 1|Adverse Event|0|||
161012075|NCT03398148|581432630|FG001|Substudy 2 Period 1|Adverse Event|0|||
161012076|NCT03398148|581432631|FG002|Substudy 2 Period 1|Adverse Event|0|||
161012077|NCT03398148|581432632|FG003|Substudy 2 Period 1|Adverse Event|0|||
161012078|NCT03398148|581432633|FG004|Substudy 2 Period 1|Adverse Event|0|||
161012079|NCT03398148|581432634|FG005|Substudy 2 Period 1|Adverse Event|0|||
161012080|NCT03398148|581432635|FG006|Substudy 2 Period 1|Adverse Event|0|||
161012081|NCT03398148|581432636|FG007|Substudy 2 Period 1|Adverse Event|0|||
161012082|NCT03398148|581432637|FG008|Substudy 2 Period 1|Adverse Event|0|||
161012083|NCT03398148|581432638|FG009|Substudy 2 Period 1|Adverse Event|12|||
161012084|NCT03398148|581432639|FG010|Substudy 2 Period 1|Adverse Event|2|||
161012085|NCT03398148|581432640|FG011|Substudy 2 Period 1|Adverse Event|0|||
161012086|NCT03398148|581432641|FG012|Substudy 2 Period 1|Adverse Event|0|||
161012087|NCT03398148|581432642|FG013|Substudy 2 Period 1|Adverse Event|0|||
161012088|NCT03398148|581432643|FG014|Substudy 2 Period 1|Adverse Event|0|||
161012089|NCT03398148|581432629|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
160585769|NCT01194804|579863903|FG000|Overall Study|Withdrawal by Subject|1|||
160585770|NCT02670915|579863904|FG000|Overall Study|Withdrawal by Subject|0|||
160585771|NCT02670915|579863905|FG001|Overall Study|Withdrawal by Subject|1|||
160585772|NCT02670915|579863906|FG002|Overall Study|Withdrawal by Subject|4|||
160585773|NCT02670915|579863904|FG000|Overall Study|Withdrawal by parent/guardian|4|||
160585774|NCT02670915|579863905|FG001|Overall Study|Withdrawal by parent/guardian|4|||
160585775|NCT02670915|579863906|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161012090|NCT03398148|581432630|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012091|NCT03398148|581432631|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012092|NCT03398148|581432632|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012093|NCT03398148|581432633|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012094|NCT03398148|581432634|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012095|NCT03398148|581432635|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012096|NCT03398148|581432636|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012097|NCT03398148|581432637|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012098|NCT03398148|581432638|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
161012099|NCT03398148|581432639|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
161012100|NCT03398148|581432640|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012101|NCT03398148|581432641|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012102|NCT03398148|581432642|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012103|NCT03398148|581432643|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012104|NCT03398148|581432629|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
161012105|NCT03398148|581432630|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
161012106|NCT03398148|581432631|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
161012107|NCT03398148|581432632|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
161012108|NCT03398148|581432633|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
161012109|NCT03398148|581432634|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
161012110|NCT03398148|581432635|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
161012111|NCT03398148|581432636|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
160585776|NCT02670915|579863904|FG000|Overall Study|Unclassified|0|||
160585777|NCT02670915|579863905|FG001|Overall Study|Unclassified|3|||
161012112|NCT03398148|581432637|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
161012113|NCT03398148|581432638|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
161012114|NCT03398148|581432639|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
161012115|NCT03398148|581432640|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
161012116|NCT03398148|581432641|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
161012117|NCT03398148|581432642|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
161012118|NCT03398148|581432643|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
161012119|NCT03398148|581432629|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012120|NCT03398148|581432630|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012121|NCT03398148|581432631|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012122|NCT03398148|581432632|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012123|NCT03398148|581432633|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012124|NCT03398148|581432634|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012125|NCT03398148|581432635|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012126|NCT03398148|581432636|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012127|NCT03398148|581432637|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012128|NCT03398148|581432638|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012129|NCT03398148|581432639|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
161012130|NCT03398148|581432640|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012131|NCT03398148|581432641|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012132|NCT03398148|581432642|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012133|NCT03398148|581432643|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012134|NCT03398148|581432629|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012135|NCT03398148|581432630|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012136|NCT03398148|581432631|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012137|NCT03398148|581432632|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012138|NCT03398148|581432633|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012139|NCT03398148|581432634|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012140|NCT03398148|581432635|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012141|NCT03398148|581432636|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012142|NCT03398148|581432637|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012143|NCT03398148|581432638|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012144|NCT03398148|581432639|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
161012145|NCT03398148|581432640|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012146|NCT03398148|581432641|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012147|NCT03398148|581432642|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012148|NCT03398148|581432643|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
160458967|NCT04109066|579412729|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
160458968|NCT04109066|579412730|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
160458969|NCT04109066|579412729|FG000|Treatment|Lack of Efficacy|2|||
160585778|NCT02670915|579863906|FG002|Overall Study|Unclassified|0|||
160585779|NCT00818207|579863907|FG000|Overall Study|Adverse Event|6|||
160585780|NCT00818207|579863908|FG001|Overall Study|Adverse Event|0|||
160585781|NCT00818207|579863907|FG000|Overall Study|Lost to Follow-up|160|||
160585782|NCT00818207|579863908|FG001|Overall Study|Lost to Follow-up|146|||
160585783|NCT00818207|579863907|FG000|Overall Study|Multiple reasons|11|||
160585784|NCT00818207|579863908|FG001|Overall Study|Multiple reasons|12|||
160585785|NCT00818207|579863907|FG000|Overall Study|Withdrawal by Subject|42|||
160585786|NCT00818207|579863908|FG001|Overall Study|Withdrawal by Subject|104|||
160585787|NCT00818207|579863907|FG000|Overall Study|Death|3|||
160585788|NCT00818207|579863908|FG001|Overall Study|Death|5|||
160585789|NCT02494778|579863909|FG000|Overall Study|Death|3|||
160585790|NCT02494778|579863909|FG000|Overall Study|Other|173|||
160585791|NCT02494778|579863909|FG000|Overall Study|Lack of Efficacy|4|||
160585792|NCT02494778|579863909|FG000|Overall Study|Adverse Event|18|||
160585793|NCT02494778|579863909|FG000|Overall Study|Withdrawal by Subject|20|||
160585794|NCT02494778|579863909|FG000|Overall Study|Lost to Follow-up|2|||
160585795|NCT02494778|579863909|FG000|Overall Study|Noncompliant with study drug admin.|1|||
160585796|NCT03621943|579863910|FG000|First Randomized Intervention|Lost to Follow-up|51|||
160585797|NCT03621943|579863911|FG001|First Randomized Intervention|Lost to Follow-up|54|||
160585798|NCT03621943|579863910|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
160585799|NCT03621943|579863911|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
160585800|NCT03621943|579863910|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
160585801|NCT03621943|579863911|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
160585802|NCT03621943|579863910|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
160585803|NCT03621943|579863911|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
160585804|NCT00967226|579863912|FG000|Overall Study|Adverse Event|0|||
160585805|NCT00967226|579863913|FG001|Overall Study|Adverse Event|5|||
160585806|NCT00967226|579863912|FG000|Overall Study|Protocol Violation|2|||
160585807|NCT00967226|579863913|FG001|Overall Study|Protocol Violation|0|||
161012149|NCT03398148|581432629|FG000|Substudy 2 Period 1|Other|0|||
161012150|NCT03398148|581432630|FG001|Substudy 2 Period 1|Other|0|||
161012151|NCT03398148|581432631|FG002|Substudy 2 Period 1|Other|0|||
160458970|NCT04109066|579412730|FG001|Treatment|Lack of Efficacy|4|||
160458971|NCT04109066|579412729|FG000|Treatment|Adverse Event|23|||
160458972|NCT04109066|579412730|FG001|Treatment|Adverse Event|7|||
160585808|NCT00967226|579863912|FG000|Overall Study|Physician Decision|0|||
160585809|NCT00967226|579863913|FG001|Overall Study|Physician Decision|1|||
161012152|NCT03398148|581432632|FG003|Substudy 2 Period 1|Other|0|||
161012153|NCT03398148|581432633|FG004|Substudy 2 Period 1|Other|0|||
161012154|NCT03398148|581432634|FG005|Substudy 2 Period 1|Other|0|||
161012155|NCT03398148|581432635|FG006|Substudy 2 Period 1|Other|0|||
161012156|NCT03398148|581432636|FG007|Substudy 2 Period 1|Other|0|||
161012157|NCT03398148|581432637|FG008|Substudy 2 Period 1|Other|0|||
161012158|NCT03398148|581432638|FG009|Substudy 2 Period 1|Other|4|||
161012159|NCT03398148|581432639|FG010|Substudy 2 Period 1|Other|4|||
161012160|NCT03398148|581432640|FG011|Substudy 2 Period 1|Other|0|||
161012161|NCT03398148|581432641|FG012|Substudy 2 Period 1|Other|0|||
161012162|NCT03398148|581432642|FG013|Substudy 2 Period 1|Other|0|||
161012163|NCT03398148|581432643|FG014|Substudy 2 Period 1|Other|0|||
161012164|NCT03398148|581432629|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012165|NCT03398148|581432630|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012166|NCT03398148|581432631|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012167|NCT03398148|581432632|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012168|NCT03398148|581432633|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012169|NCT03398148|581432634|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012170|NCT03398148|581432635|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012171|NCT03398148|581432636|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012172|NCT03398148|581432637|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012173|NCT03398148|581432638|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012174|NCT03398148|581432639|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
161012175|NCT03398148|581432640|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012176|NCT03398148|581432641|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
160585810|NCT02174861|579863914|FG000|Overall Study|Decision by sponsor|8|||
160585811|NCT02174861|579863914|FG000|Overall Study|Withdrawal by Subject|124|||
160585812|NCT02174861|579863914|FG000|Overall Study|Lost to Follow-up|26|||
160585813|NCT01215734|579863915|FG000|Overall Study|Death|0|||
160585814|NCT01215734|579863916|FG001|Overall Study|Death|1|||
160585815|NCT00315705|579863917|FG000|Phase 1|Refused further treatment|1|||
161012177|NCT03398148|581432642|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012178|NCT03398148|581432643|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012179|NCT03398148|581432629|FG000|Substudy 2 Period 2|Adverse Event|0|||
161012180|NCT03398148|581432630|FG001|Substudy 2 Period 2|Adverse Event|0|||
161012181|NCT03398148|581432631|FG002|Substudy 2 Period 2|Adverse Event|0|||
161012182|NCT03398148|581432632|FG003|Substudy 2 Period 2|Adverse Event|0|||
161012183|NCT03398148|581432633|FG004|Substudy 2 Period 2|Adverse Event|0|||
161012184|NCT03398148|581432634|FG005|Substudy 2 Period 2|Adverse Event|0|||
161012185|NCT03398148|581432635|FG006|Substudy 2 Period 2|Adverse Event|0|||
161012186|NCT03398148|581432636|FG007|Substudy 2 Period 2|Adverse Event|0|||
161012187|NCT03398148|581432637|FG008|Substudy 2 Period 2|Adverse Event|0|||
161012188|NCT03398148|581432638|FG009|Substudy 2 Period 2|Adverse Event|0|||
161012189|NCT03398148|581432639|FG010|Substudy 2 Period 2|Adverse Event|0|||
161012190|NCT03398148|581432640|FG011|Substudy 2 Period 2|Adverse Event|0|||
161012191|NCT03398148|581432641|FG012|Substudy 2 Period 2|Adverse Event|0|||
161012192|NCT03398148|581432642|FG013|Substudy 2 Period 2|Adverse Event|1|||
161012193|NCT03398148|581432643|FG014|Substudy 2 Period 2|Adverse Event|3|||
161012194|NCT03398148|581432629|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
161012195|NCT03398148|581432630|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
161012196|NCT03398148|581432631|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
161012197|NCT03398148|581432632|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
161012198|NCT03398148|581432633|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
161012199|NCT03398148|581432634|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
161012200|NCT03398148|581432635|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
161012201|NCT03398148|581432636|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
161012202|NCT03398148|581432637|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
161012203|NCT03398148|581432638|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
161012204|NCT03398148|581432639|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
161012205|NCT03398148|581432640|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
161012206|NCT03398148|581432641|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
160458973|NCT04109066|579412729|FG000|Treatment|Participant request to discontinue Study treatment|15|||
160458974|NCT04109066|579412730|FG001|Treatment|Participant request to discontinue Study treatment|14|||
160458975|NCT04109066|579412729|FG000|Treatment|Withdrawal by Subject|8|||
160585816|NCT00315705|579863917|FG000|Phase 1|Failure to achieve response|8|||
160585817|NCT00315705|579863917|FG000|Phase 1|Disease relapse|4|||
161012207|NCT03398148|581432642|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
161012208|NCT03398148|581432643|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
160458976|NCT04109066|579412730|FG001|Treatment|Withdrawal by Subject|8|||
160657031|NCT05097989|580124501|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161012209|NCT03398148|581432629|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012210|NCT03398148|581432630|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012211|NCT03398148|581432631|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
160585818|NCT00315705|579863917|FG000|Phase 1|Scheduled for transplant|9|||
160585819|NCT00315705|579863917|FG000|Phase 1|Death|3|||
161012212|NCT03398148|581432632|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012213|NCT03398148|581432633|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012214|NCT03398148|581432634|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012215|NCT03398148|581432635|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012216|NCT03398148|581432636|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012217|NCT03398148|581432637|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012218|NCT03398148|581432638|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012219|NCT03398148|581432639|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012220|NCT03398148|581432640|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
161012221|NCT03398148|581432641|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012222|NCT03398148|581432642|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
161012223|NCT03398148|581432643|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
161012224|NCT03398148|581432629|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
160585820|NCT00315705|579863917|FG000|Phase 2|Physician Decision|4|||
161012225|NCT03398148|581432630|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
161012226|NCT03398148|581432631|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
161012227|NCT03398148|581432632|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
161012228|NCT03398148|581432633|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
161012229|NCT03398148|581432634|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
161012230|NCT03398148|581432635|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
161012231|NCT03398148|581432636|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
161012232|NCT03398148|581432637|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
161012233|NCT03398148|581432638|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
161012234|NCT03398148|581432639|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
161012235|NCT03398148|581432640|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
161012236|NCT03398148|581432641|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
161012237|NCT03398148|581432642|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
161012238|NCT03398148|581432643|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
161012239|NCT03398148|581432629|FG000|Substudy 2 Period 2|Other|0|||
161012240|NCT03398148|581432630|FG001|Substudy 2 Period 2|Other|0|||
161012241|NCT03398148|581432631|FG002|Substudy 2 Period 2|Other|0|||
161012242|NCT03398148|581432632|FG003|Substudy 2 Period 2|Other|0|||
161012243|NCT03398148|581432633|FG004|Substudy 2 Period 2|Other|0|||
161012244|NCT03398148|581432634|FG005|Substudy 2 Period 2|Other|0|||
161012245|NCT03398148|581432635|FG006|Substudy 2 Period 2|Other|0|||
161012246|NCT03398148|581432636|FG007|Substudy 2 Period 2|Other|0|||
161012247|NCT03398148|581432637|FG008|Substudy 2 Period 2|Other|0|||
161012248|NCT03398148|581432638|FG009|Substudy 2 Period 2|Other|0|||
161012249|NCT03398148|581432639|FG010|Substudy 2 Period 2|Other|0|||
161012250|NCT03398148|581432640|FG011|Substudy 2 Period 2|Other|0|||
161012251|NCT03398148|581432641|FG012|Substudy 2 Period 2|Other|0|||
161012252|NCT03398148|581432642|FG013|Substudy 2 Period 2|Other|1|||
161012253|NCT03398148|581432643|FG014|Substudy 2 Period 2|Other|1|||
161012254|NCT03398148|581432629|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012255|NCT03398148|581432630|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012256|NCT03398148|581432631|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012257|NCT03398148|581432632|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012258|NCT03398148|581432633|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012259|NCT03398148|581432634|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012260|NCT03398148|581432635|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012261|NCT03398148|581432636|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012262|NCT03398148|581432637|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012263|NCT03398148|581432638|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012264|NCT03398148|581432639|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012265|NCT03398148|581432640|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
160585821|NCT00315705|579863917|FG000|Phase 2|Adverse Event|1|||
160585822|NCT00315705|579863917|FG000|Phase 2|Failure to achieve response|3|||
160585823|NCT00315705|579863917|FG000|Phase 2|Disease relapse|1|||
160585824|NCT00315705|579863917|FG000|Phase 2|Scheduled for transplant|8|||
160585825|NCT00315705|579863917|FG000|Phase 2|Other|1|||
160585826|NCT00315705|579863917|FG000|Phase 2|Death|7|||
160585827|NCT01346371|579863918|FG000|Overall Study|Lost to Follow-up|2|||
160585828|NCT01346371|579863919|FG001|Overall Study|Lost to Follow-up|0|||
161012266|NCT03398148|581432641|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
161012267|NCT03398148|581432642|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012268|NCT03398148|581432643|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
161012269|NCT02791230|581432644|FG000|Overall Study|Adverse Event|10|||
161012270|NCT02791230|581432645|FG001|Overall Study|Adverse Event|9|||
161012271|NCT02791230|581432646|FG002|Overall Study|Adverse Event|66|||
161012272|NCT02791230|581432644|FG000|Overall Study|Death|38|||
160585829|NCT01716533|579863923|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
161012273|NCT02791230|581432645|FG001|Overall Study|Death|25|||
161012274|NCT02791230|581432646|FG002|Overall Study|Death|184|||
161012275|NCT02791230|581432644|FG000|Overall Study|Lack of Efficacy|1|||
161012276|NCT02791230|581432645|FG001|Overall Study|Lack of Efficacy|0|||
161012277|NCT02791230|581432646|FG002|Overall Study|Lack of Efficacy|3|||
161012278|NCT02791230|581432644|FG000|Overall Study|Lost to Follow-up|0|||
161012279|NCT02791230|581432645|FG001|Overall Study|Lost to Follow-up|0|||
161012280|NCT02791230|581432646|FG002|Overall Study|Lost to Follow-up|10|||
161012281|NCT02791230|581432644|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
160585830|NCT01716533|579863924|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
160585831|NCT01716533|579863925|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
160585832|NCT01716533|579863926|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
160585833|NCT01716533|579863923|FG000|Overall Study|Withdrawal by Subject|0|||
160585834|NCT01716533|579863924|FG001|Overall Study|Withdrawal by Subject|0|||
160585835|NCT01716533|579863925|FG002|Overall Study|Withdrawal by Subject|0|||
160585836|NCT01716533|579863926|FG003|Overall Study|Withdrawal by Subject|5|||
160585837|NCT01716533|579863923|FG000|Overall Study|Death|0|||
160585838|NCT01716533|579863924|FG001|Overall Study|Death|0|||
160585839|NCT01716533|579863925|FG002|Overall Study|Death|0|||
160585840|NCT01716533|579863926|FG003|Overall Study|Death|2|||
160585841|NCT01716533|579863923|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
160585842|NCT01716533|579863924|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
160585843|NCT01716533|579863925|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
160585844|NCT01716533|579863926|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
160585845|NCT01670656|579863933|FG000|Overall Study|Non-compliance with study drug|0|||
160585846|NCT01670656|579863934|FG001|Overall Study|Non-compliance with study drug|0|||
160585847|NCT01670656|579863935|FG002|Overall Study|Non-compliance with study drug|3|||
160585848|NCT01670656|579863936|FG003|Overall Study|Non-compliance with study drug|0|||
161012282|NCT02791230|581432645|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
161012283|NCT02791230|581432646|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
161012284|NCT02791230|581432644|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
161012285|NCT02791230|581432645|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
161012286|NCT02791230|581432646|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
161012287|NCT02791230|581432644|FG000|Overall Study|Study sites terminated by sponsor|1|||
161012288|NCT02791230|581432645|FG001|Overall Study|Study sites terminated by sponsor|0|||
161012289|NCT02791230|581432646|FG002|Overall Study|Study sites terminated by sponsor|5|||
161012290|NCT02791230|581432644|FG000|Overall Study|Other|9|||
161012291|NCT02791230|581432645|FG001|Overall Study|Other|1|||
161012292|NCT02791230|581432646|FG002|Overall Study|Other|28|||
161012293|NCT02791230|581432644|FG000|Overall Study|Protocol Violation|0|||
161012294|NCT02791230|581432645|FG001|Overall Study|Protocol Violation|0|||
161012295|NCT02791230|581432646|FG002|Overall Study|Protocol Violation|4|||
161012296|NCT02791230|581432644|FG000|Overall Study|Withdrawal by Subject|24|||
161012297|NCT02791230|581432645|FG001|Overall Study|Withdrawal by Subject|13|||
161012298|NCT02791230|581432646|FG002|Overall Study|Withdrawal by Subject|172|||
161012299|NCT02791230|581432644|FG000|Overall Study|Enrolled but not treated|0|||
161012300|NCT02791230|581432645|FG001|Overall Study|Enrolled but not treated|0|||
161012301|NCT02791230|581432646|FG002|Overall Study|Enrolled but not treated|5|||
161012302|NCT03683069|581432649|FG000|Overall Study|see limitations|12|||
161012303|NCT03683069|581432650|FG001|Overall Study|see limitations|13|||
161012304|NCT05478525|581432651|FG000|Overall Study|Withdrawal by Subject|0|||
161012305|NCT05478525|581432652|FG001|Overall Study|Withdrawal by Subject|1|||
161012306|NCT05478525|581432653|FG002|Overall Study|Withdrawal by Subject|2|||
161012307|NCT05478525|581432654|FG003|Overall Study|Withdrawal by Subject|0|||
161012308|NCT05478525|581432651|FG000|Overall Study|COVID-19 Infection|2|||
161012309|NCT05478525|581432652|FG001|Overall Study|COVID-19 Infection|0|||
161012310|NCT05478525|581432653|FG002|Overall Study|COVID-19 Infection|1|||
161012311|NCT05478525|581432654|FG003|Overall Study|COVID-19 Infection|1|||
160585849|NCT01670656|579863937|FG004|Overall Study|Non-compliance with study drug|1|||
160585850|NCT01670656|579863933|FG000|Overall Study|Pregnancy|0|||
160585851|NCT01670656|579863934|FG001|Overall Study|Pregnancy|0|||
160585852|NCT01670656|579863935|FG002|Overall Study|Pregnancy|0|||
160585853|NCT01670656|579863936|FG003|Overall Study|Pregnancy|0|||
160585854|NCT01670656|579863937|FG004|Overall Study|Pregnancy|1|||
160585855|NCT01670656|579863933|FG000|Overall Study|Withdrawal by Subject|1|||
160585856|NCT01670656|579863934|FG001|Overall Study|Withdrawal by Subject|1|||
160585857|NCT01670656|579863935|FG002|Overall Study|Withdrawal by Subject|0|||
160585858|NCT01670656|579863936|FG003|Overall Study|Withdrawal by Subject|0|||
161012312|NCT01649271|581432655|FG000|Overall Study|Progressive disease|4|||
161012313|NCT01649271|581432656|FG001|Overall Study|Progressive disease|5|||
161012314|NCT01649271|581432655|FG000|Overall Study|Other Adverse Event|0|||
161012315|NCT01649271|581432656|FG001|Overall Study|Other Adverse Event|2|||
161012316|NCT01649271|581432655|FG000|Overall Study|Withdrawal by Subject|1|||
161012317|NCT01649271|581432656|FG001|Overall Study|Withdrawal by Subject|0|||
161012318|NCT01649271|581432655|FG000|Overall Study|Other than stated above|1|||
161012319|NCT01649271|581432656|FG001|Overall Study|Other than stated above|0|||
161012320|NCT05644002|581432659|FG000|Overall Study|Lost to Follow-up|1|||
161012321|NCT05644002|581432660|FG001|Overall Study|Lost to Follow-up|2|||
160585859|NCT01670656|579863937|FG004|Overall Study|Withdrawal by Subject|0|||
160585860|NCT01670656|579863933|FG000|Overall Study|Non-compliance with protocol|0|||
160585861|NCT01670656|579863934|FG001|Overall Study|Non-compliance with protocol|3|||
160585862|NCT01670656|579863935|FG002|Overall Study|Non-compliance with protocol|1|||
161012322|NCT05644002|581432659|FG000|Overall Study|Withdrawal by Subject|0|||
161012323|NCT05644002|581432660|FG001|Overall Study|Withdrawal by Subject|1|||
161012324|NCT04038957|581432664|FG000|Overall Study|Withdrawal by Subject|1|||
160585863|NCT01670656|579863936|FG003|Overall Study|Non-compliance with protocol|1|||
160585864|NCT01670656|579863937|FG004|Overall Study|Non-compliance with protocol|2|||
160585865|NCT01670656|579863933|FG000|Overall Study|Adverse Event|2|||
160585866|NCT01670656|579863934|FG001|Overall Study|Adverse Event|2|||
160585867|NCT01670656|579863935|FG002|Overall Study|Adverse Event|2|||
160585868|NCT01670656|579863936|FG003|Overall Study|Adverse Event|3|||
160585869|NCT01670656|579863937|FG004|Overall Study|Adverse Event|3|||
160585870|NCT01670656|579863933|FG000|Overall Study|Subject withdrew consent|0|||
160585871|NCT01670656|579863934|FG001|Overall Study|Subject withdrew consent|1|||
160585872|NCT01670656|579863935|FG002|Overall Study|Subject withdrew consent|2|||
160585873|NCT01670656|579863936|FG003|Overall Study|Subject withdrew consent|1|||
160585874|NCT01670656|579863937|FG004|Overall Study|Subject withdrew consent|1|||
160585875|NCT01670656|579863933|FG000|Overall Study|Lost to Follow-up|0|||
160585876|NCT01670656|579863934|FG001|Overall Study|Lost to Follow-up|0|||
160585877|NCT01670656|579863935|FG002|Overall Study|Lost to Follow-up|0|||
161012325|NCT04038957|581432664|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
161012326|NCT03821844|581432665|FG000|Overall Study|Death|37|||
161012327|NCT03821844|581432666|FG001|Overall Study|Death|31|||
161012328|NCT03821844|581432665|FG000|Overall Study|Discharged|10|||
161012329|NCT03821844|581432666|FG001|Overall Study|Discharged|14|||
161012330|NCT03821844|581432665|FG000|Overall Study|Not present in facility at followup|2|||
161012331|NCT03821844|581432666|FG001|Overall Study|Not present in facility at followup|3|||
161012332|NCT02605837|581432667|FG000|Overall Study|Adverse Event|3|||
161012333|NCT02605837|581432668|FG001|Overall Study|Adverse Event|1|||
161012334|NCT02605837|581432667|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161012335|NCT02605837|581432668|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161012336|NCT02605837|581432667|FG000|Overall Study|Withdrawal by Subject|8|||
161012337|NCT02605837|581432668|FG001|Overall Study|Withdrawal by Subject|8|||
161012338|NCT02605837|581432667|FG000|Overall Study|Physician Decision|0|||
161012339|NCT02605837|581432668|FG001|Overall Study|Physician Decision|1|||
161012340|NCT05656911|581432671|FG000|Treatment Phase|Physician Decision|2|||
161012341|NCT05656911|581432672|FG001|Treatment Phase|Physician Decision|0|||
161012342|NCT05656911|581432671|FG000|Treatment Phase|Lack of Efficacy|6|||
161012343|NCT05656911|581432672|FG001|Treatment Phase|Lack of Efficacy|3|||
161012344|NCT05656911|581432671|FG000|Treatment Phase|Subject Decision|4|||
161012345|NCT05656911|581432672|FG001|Treatment Phase|Subject Decision|2|||
161012346|NCT05656911|581432671|FG000|Treatment Phase|Other Reasons|1|||
161012347|NCT05656911|581432672|FG001|Treatment Phase|Other Reasons|0|||
161012348|NCT05656911|581432671|FG000|Treatment Phase|Adverse Event|3|||
161012349|NCT05656911|581432672|FG001|Treatment Phase|Adverse Event|1|||
161012350|NCT05656911|581432671|FG000|Follow-up Phase|Subject Decision|0|||
161012351|NCT05656911|581432672|FG001|Follow-up Phase|Subject Decision|1|||
161012352|NCT05656911|581432671|FG000|Follow-up Phase|Missing|1|||
161012353|NCT05656911|581432672|FG001|Follow-up Phase|Missing|0|||
161012354|NCT05075408|581432679|FG000|Overall Study|Withdrawal by Subject|5|||
161012355|NCT05075408|581432680|FG001|Overall Study|Withdrawal by Subject|3|||
161012356|NCT05075408|581432681|FG002|Overall Study|Withdrawal by Subject|4|||
161012357|NCT05075408|581432679|FG000|Overall Study|Adverse Event|5|||
161012358|NCT05075408|581432680|FG001|Overall Study|Adverse Event|7|||
161012359|NCT05075408|581432681|FG002|Overall Study|Adverse Event|8|||
161012360|NCT05075408|581432679|FG000|Overall Study|Protocol Violation|0|||
161012361|NCT05075408|581432680|FG001|Overall Study|Protocol Violation|1|||
161012362|NCT05075408|581432681|FG002|Overall Study|Protocol Violation|0|||
161012363|NCT05075408|581432679|FG000|Overall Study|Lost to Follow-up|2|||
161012364|NCT05075408|581432680|FG001|Overall Study|Lost to Follow-up|1|||
161012365|NCT05075408|581432681|FG002|Overall Study|Lost to Follow-up|1|||
161012366|NCT05075408|581432679|FG000|Overall Study|Physician Decision|1|||
161012367|NCT05075408|581432680|FG001|Overall Study|Physician Decision|0|||
161012368|NCT05075408|581432681|FG002|Overall Study|Physician Decision|0|||
160585878|NCT01670656|579863936|FG003|Overall Study|Lost to Follow-up|0|||
160585879|NCT01670656|579863937|FG004|Overall Study|Lost to Follow-up|3|||
160585880|NCT01670656|579863933|FG000|Overall Study|Subject moved|0|||
160585881|NCT01670656|579863934|FG001|Overall Study|Subject moved|0|||
161012369|NCT05075408|581432679|FG000|Overall Study|Other-unspecified|3|||
161012370|NCT05075408|581432680|FG001|Overall Study|Other-unspecified|2|||
161012371|NCT05075408|581432681|FG002|Overall Study|Other-unspecified|0|||
161012372|NCT05419505|581432683|FG000|Overall Study|Adverse Event|0|||
161012373|NCT05419505|581432684|FG001|Overall Study|Adverse Event|0|||
161012374|NCT05419505|581432685|FG002|Overall Study|Adverse Event|0|||
161012375|NCT05419505|581432686|FG003|Overall Study|Adverse Event|1|||
161012376|NCT05419505|581432687|FG004|Overall Study|Adverse Event|0|||
160585882|NCT01670656|579863935|FG002|Overall Study|Subject moved|0|||
160585883|NCT01670656|579863936|FG003|Overall Study|Subject moved|1|||
160585884|NCT01670656|579863937|FG004|Overall Study|Subject moved|0|||
160585885|NCT00789958|579863938|FG000|Overall Study|Adverse Event|3|||
161012377|NCT05419505|581432688|FG005|Overall Study|Adverse Event|0|||
161012378|NCT05419505|581432689|FG006|Overall Study|Adverse Event|0|||
161012379|NCT05419505|581432690|FG007|Overall Study|Adverse Event|0|||
161012380|NCT05419505|581432683|FG000|Overall Study|Withdrawal by Subject|1|||
161012381|NCT05419505|581432684|FG001|Overall Study|Withdrawal by Subject|2|||
161012382|NCT05419505|581432685|FG002|Overall Study|Withdrawal by Subject|0|||
161012383|NCT05419505|581432686|FG003|Overall Study|Withdrawal by Subject|0|||
161012384|NCT05419505|581432687|FG004|Overall Study|Withdrawal by Subject|0|||
161012385|NCT05419505|581432688|FG005|Overall Study|Withdrawal by Subject|0|||
161012386|NCT05419505|581432689|FG006|Overall Study|Withdrawal by Subject|1|||
161012387|NCT05419505|581432690|FG007|Overall Study|Withdrawal by Subject|0|||
161012388|NCT05419505|581432683|FG000|Overall Study|Lost to Follow-up|2|||
161012389|NCT05419505|581432684|FG001|Overall Study|Lost to Follow-up|1|||
161012390|NCT05419505|581432685|FG002|Overall Study|Lost to Follow-up|0|||
161012391|NCT05419505|581432686|FG003|Overall Study|Lost to Follow-up|0|||
161012392|NCT05419505|581432687|FG004|Overall Study|Lost to Follow-up|1|||
161012393|NCT05419505|581432688|FG005|Overall Study|Lost to Follow-up|2|||
161012394|NCT05419505|581432689|FG006|Overall Study|Lost to Follow-up|0|||
161012395|NCT05419505|581432690|FG007|Overall Study|Lost to Follow-up|1|||
161012396|NCT02780388|581432693|FG000|Overall Study|Lost to Follow-up|0|||
161012397|NCT02780388|581432694|FG001|Overall Study|Lost to Follow-up|1|||
161012398|NCT02780388|581432695|FG002|Overall Study|Lost to Follow-up|0|||
161012399|NCT02780388|581432696|FG003|Overall Study|Lost to Follow-up|0|||
161012400|NCT02780388|581432697|FG004|Overall Study|Lost to Follow-up|0|||
161012401|NCT02780388|581432693|FG000|Overall Study|Withdrawal by Subject|1|||
161012402|NCT02780388|581432694|FG001|Overall Study|Withdrawal by Subject|1|||
161012403|NCT02780388|581432695|FG002|Overall Study|Withdrawal by Subject|0|||
161012404|NCT02780388|581432696|FG003|Overall Study|Withdrawal by Subject|0|||
161012405|NCT02780388|581432697|FG004|Overall Study|Withdrawal by Subject|0|||
161012406|NCT04527146|581432698|FG000|Overall Study|Withdrawal by Subject|12|||
161012407|NCT04527146|581432699|FG001|Overall Study|Withdrawal by Subject|15|||
161012408|NCT04527146|581432700|FG002|Overall Study|Withdrawal by Subject|7|||
161012409|NCT04527146|581432701|FG003|Overall Study|Withdrawal by Subject|16|||
161012410|NCT04527146|581432698|FG000|Overall Study|Lost to Follow-up|13|||
161012411|NCT04527146|581432699|FG001|Overall Study|Lost to Follow-up|9|||
161012412|NCT04527146|581432700|FG002|Overall Study|Lost to Follow-up|16|||
161012413|NCT04527146|581432701|FG003|Overall Study|Lost to Follow-up|13|||
161012414|NCT04527146|581432698|FG000|Overall Study|Death|0|||
161012415|NCT04527146|581432699|FG001|Overall Study|Death|1|||
161012416|NCT04527146|581432700|FG002|Overall Study|Death|1|||
161012417|NCT04527146|581432701|FG003|Overall Study|Death|0|||
161012418|NCT04527146|581432698|FG000|Overall Study|Adverse Event|0|||
161012419|NCT04527146|581432699|FG001|Overall Study|Adverse Event|0|||
161012420|NCT04527146|581432700|FG002|Overall Study|Adverse Event|1|||
161012421|NCT04527146|581432701|FG003|Overall Study|Adverse Event|0|||
161012422|NCT04527146|581432698|FG000|Overall Study|Ineligible after randomization|2|||
161012423|NCT04527146|581432699|FG001|Overall Study|Ineligible after randomization|0|||
161012424|NCT04527146|581432700|FG002|Overall Study|Ineligible after randomization|2|||
161012425|NCT04527146|581432701|FG003|Overall Study|Ineligible after randomization|2|||
161012426|NCT04527146|581432698|FG000|Overall Study|Moved to a different group|6|||
161012427|NCT04527146|581432699|FG001|Overall Study|Moved to a different group|3|||
161012428|NCT04527146|581432700|FG002|Overall Study|Moved to a different group|0|||
161012429|NCT04527146|581432701|FG003|Overall Study|Moved to a different group|2|||
161012430|NCT05107401|581432702|FG000|Overall Study|Lost to Follow-up|13|||
161012431|NCT05107401|581432703|FG001|Overall Study|Lost to Follow-up|12|||
161012432|NCT04855760|581432704|FG000|Overall Study|Adverse Event|21|||
161012433|NCT04855760|581432704|FG000|Overall Study|Withdrawal by Subject|116|||
160458977|NCT04109066|579412729|FG000|Treatment|Death|3|||
160458978|NCT04109066|579412730|FG001|Treatment|Death|0|||
160458979|NCT04109066|579412729|FG000|Treatment|Participant no longer meets study criteria|2|||
160458980|NCT04109066|579412730|FG001|Treatment|Participant no longer meets study criteria|2|||
160458981|NCT04109066|579412729|FG000|Treatment|Administrative reasons by sponsor|2|||
160585886|NCT00789958|579863938|FG000|Overall Study|Withdrawal by Subject|4|||
160458982|NCT04109066|579412730|FG001|Treatment|Administrative reasons by sponsor|3|||
161012434|NCT04855760|581432704|FG000|Overall Study|Lack of Efficacy|21|||
161012435|NCT04855760|581432704|FG000|Overall Study|Lost to Follow-up|49|||
161012436|NCT04855760|581432704|FG000|Overall Study|Protocol Violation|2|||
161012437|NCT04855760|581432704|FG000|Overall Study|Physician Decision|5|||
161012438|NCT04855760|581432704|FG000|Overall Study|Pregnancy|1|||
161012439|NCT04855760|581432704|FG000|Overall Study|Non-Compliance with Study Drug|11|||
161012440|NCT04855760|581432704|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
160458983|NCT04109066|579412729|FG000|Treatment|Other reasons|17|||
161012441|NCT04855760|581432704|FG000|Overall Study|Study Completed by Sponsor|202|||
161012442|NCT04855760|581432704|FG000|Overall Study|Other|13|||
161012443|NCT04840199|581432707|FG000|Overall Study|Study Terminated by Sponsor|8|||
161012444|NCT04840199|581432708|FG001|Overall Study|Study Terminated by Sponsor|9|||
161012445|NCT04840199|581432707|FG000|Overall Study|Lost to Follow-up|0|||
160458984|NCT04109066|579412730|FG001|Treatment|Other reasons|23|||
160585887|NCT00789958|579863938|FG000|Overall Study|Progression|3|||
161012446|NCT04840199|581432708|FG001|Overall Study|Lost to Follow-up|2|||
161012447|NCT04840199|581432707|FG000|Overall Study|Withdrawal by Subject|2|||
161012448|NCT04840199|581432708|FG001|Overall Study|Withdrawal by Subject|0|||
160585888|NCT00789958|579863938|FG000|Overall Study|not protocol specified|1|||
160585889|NCT00789958|579863938|FG000|Overall Study|Not eligible/not analyzable|26|||
160585890|NCT02622724|579863939|FG000|Overall Study|Death|51|||
160585891|NCT02622724|579863940|FG001|Overall Study|Death|53|||
160585892|NCT02622724|579863939|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
160585893|NCT02622724|579863940|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
160585894|NCT02622724|579863939|FG000|Overall Study|Early termination of study|38|||
160585895|NCT02622724|579863940|FG001|Overall Study|Early termination of study|43|||
160585896|NCT00254293|579863941|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
160585897|NCT00254293|579863942|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
160585898|NCT00254293|579863943|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
160585899|NCT00254293|579863944|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
160585900|NCT00254293|579863945|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
160585901|NCT00254293|579863946|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
160585902|NCT00254293|579863947|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
160585903|NCT00254293|579863941|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
160585904|NCT00254293|579863942|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
160585905|NCT00254293|579863943|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
160458985|NCT04109066|579412729|FG000|Treatment|Disease Progression|4|||
160458986|NCT04109066|579412730|FG001|Treatment|Disease Progression|7|||
160585906|NCT00254293|579863944|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
160585907|NCT00254293|579863945|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
160585908|NCT00254293|579863946|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161012449|NCT04840199|581432707|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
161012450|NCT04840199|581432708|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
161012451|NCT05952076|581432709|FG000|Overall Study|Death|1|||
161012452|NCT05952076|581432710|FG001|Overall Study|Death|1|||
161012453|NCT05952076|581432709|FG000|Overall Study|Lost to Follow-up|0|||
161012454|NCT05952076|581432710|FG001|Overall Study|Lost to Follow-up|1|||
161012455|NCT00150813|581432711|FG000|Overall Study|Adverse Event|1|||
161012456|NCT00150813|581432711|FG000|Overall Study|Lack of Efficacy|1|||
161012457|NCT00150813|581432711|FG000|Overall Study|Lost to Follow-up|5|||
161012458|NCT00150813|581432711|FG000|Overall Study|Withdrawal by Subject|5|||
161012459|NCT00150813|581432711|FG000|Overall Study|Remission|3|||
161012460|NCT00150813|581432711|FG000|Overall Study|Planned pregancy|1|||
161012461|NCT00150813|581432711|FG000|Overall Study|Switch to commercially available LEV|2|||
161012462|NCT00894543|581432712|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
161012463|NCT00894543|581432713|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
161012464|NCT00894543|581432712|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
161012465|NCT00894543|581432713|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
161012466|NCT04048681|581432714|FG000|Overall Study|family emergency|0|||
161012467|NCT04048681|581432715|FG001|Overall Study|family emergency|0|||
161012468|NCT04048681|581432716|FG002|Overall Study|family emergency|0|||
161012469|NCT04048681|581432717|FG003|Overall Study|family emergency|1|||
161012470|NCT04048681|581432718|FG004|Overall Study|family emergency|0|||
161012471|NCT04579250|581432719|FG000|Overall Study|Withdrawal by Subject|1|||
161012472|NCT04579250|581432720|FG001|Overall Study|Withdrawal by Subject|1|||
161012473|NCT04579250|581432721|FG002|Overall Study|Withdrawal by Subject|0|||
161012474|NCT04579250|581432719|FG000|Overall Study|Lost to Follow-up|1|||
161012475|NCT04579250|581432720|FG001|Overall Study|Lost to Follow-up|1|||
161012476|NCT04579250|581432721|FG002|Overall Study|Lost to Follow-up|0|||
161012477|NCT04579250|581432719|FG000|Overall Study|Moved from area|0|||
161012478|NCT04579250|581432720|FG001|Overall Study|Moved from area|1|||
161012479|NCT04579250|581432721|FG002|Overall Study|Moved from area|2|||
161012480|NCT02919449|581432722|FG000|Overall Study|Withdrawal by Subject|1|||
161012481|NCT02919449|581432722|FG000|Overall Study|Investigator decision|1|||
161012482|NCT00411151|581432723|FG000|Overall Study|Death|38|||
161012483|NCT00411151|581432723|FG000|Overall Study|Withdrawal by Subject|2|||
161012484|NCT00411151|581432723|FG000|Overall Study|Lost to Follow-up|2|||
161012485|NCT00411151|581432723|FG000|Overall Study|Protocol Violation|1|||
161012486|NCT00411151|581432723|FG000|Overall Study|Trial prematurely closed|4|||
160458987|NCT04109066|579412729|FG000|Treatment|Study drug toxicity|12|||
160585909|NCT00254293|579863947|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
160585910|NCT00254293|579863941|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161012487|NCT04452318|581432727|FG000|Overall Study|Physician Decision|1|||
161012488|NCT04452318|581432728|FG001|Overall Study|Physician Decision|2|||
161012489|NCT04452318|581432729|FG002|Overall Study|Physician Decision|0|||
160585911|NCT00254293|579863942|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161012490|NCT04452318|581432730|FG003|Overall Study|Physician Decision|2|||
161012491|NCT04452318|581432731|FG004|Overall Study|Physician Decision|0|||
161012492|NCT04452318|581432732|FG005|Overall Study|Physician Decision|2|||
161012493|NCT04452318|581432733|FG006|Overall Study|Physician Decision|5|||
161012494|NCT04452318|581432727|FG000|Overall Study|Death|2|||
161012495|NCT04452318|581432728|FG001|Overall Study|Death|3|||
160585912|NCT00254293|579863943|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
160585913|NCT00254293|579863944|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
160585914|NCT00254293|579863945|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
160585915|NCT00254293|579863946|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
160585916|NCT00254293|579863947|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
160585917|NCT00254293|579863941|FG000|LTE Open Label Variable SC Dosing|Death|0|||
160585918|NCT00254293|579863942|FG001|LTE Open Label Variable SC Dosing|Death|0|||
160585919|NCT00254293|579863943|FG002|LTE Open Label Variable SC Dosing|Death|1|||
160585920|NCT00254293|579863944|FG003|LTE Open Label Variable SC Dosing|Death|0|||
160585921|NCT00254293|579863945|FG004|LTE Open Label Variable SC Dosing|Death|0|||
160585922|NCT00254293|579863946|FG005|LTE Open Label Variable SC Dosing|Death|0|||
160585923|NCT00254293|579863947|FG006|LTE Open Label Variable SC Dosing|Death|0|||
160585924|NCT00254293|579863941|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
160585925|NCT00254293|579863942|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
160585926|NCT00254293|579863943|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
160585927|NCT00254293|579863944|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
160585928|NCT00254293|579863945|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
160585929|NCT00254293|579863946|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
160585930|NCT00254293|579863947|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
160585931|NCT00254293|579863941|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
160585932|NCT00254293|579863942|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
160585933|NCT00254293|579863943|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
160585934|NCT00254293|579863944|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
160585935|NCT00254293|579863945|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
160585936|NCT00254293|579863946|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
160585937|NCT00254293|579863947|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
160585938|NCT00254293|579863941|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
160585939|NCT00254293|579863942|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
160585940|NCT00254293|579863943|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
160967739|NCT00441701|581270092|FG006|Overall Study|Withdrawal by Subject|0|||
160967740|NCT00441701|581270093|FG007|Overall Study|Withdrawal by Subject|0|||
160967741|NCT00441701|581270094|FG008|Overall Study|Withdrawal by Subject|0|||
160967742|NCT00441701|581270095|FG009|Overall Study|Withdrawal by Subject|0|||
160967743|NCT00985985|581270099|FG000|Overall Study|Adverse Event|4|||
160967744|NCT00985985|581270100|FG001|Overall Study|Adverse Event|2|||
160967745|NCT00985985|581270101|FG002|Overall Study|Adverse Event|2|||
160967746|NCT00985985|581270102|FG003|Overall Study|Adverse Event|2|||
160967747|NCT00985985|581270099|FG000|Overall Study|Lost to Follow-up|4|||
160967748|NCT00985985|581270100|FG001|Overall Study|Lost to Follow-up|11|||
160967749|NCT00985985|581270101|FG002|Overall Study|Lost to Follow-up|2|||
160967750|NCT00985985|581270102|FG003|Overall Study|Lost to Follow-up|3|||
160967751|NCT00985985|581270099|FG000|Overall Study|Protocol Violation|1|||
160967752|NCT00985985|581270100|FG001|Overall Study|Protocol Violation|2|||
160967753|NCT00985985|581270101|FG002|Overall Study|Protocol Violation|0|||
160967754|NCT00985985|581270102|FG003|Overall Study|Protocol Violation|1|||
160967755|NCT00985985|581270099|FG000|Overall Study|Lack of Efficacy|5|||
160967756|NCT00985985|581270100|FG001|Overall Study|Lack of Efficacy|6|||
160967757|NCT00985985|581270101|FG002|Overall Study|Lack of Efficacy|1|||
160967758|NCT00985985|581270102|FG003|Overall Study|Lack of Efficacy|3|||
160967759|NCT00985985|581270099|FG000|Overall Study|Withdrawal by Subject|4|||
160967760|NCT00985985|581270100|FG001|Overall Study|Withdrawal by Subject|2|||
160967761|NCT00985985|581270101|FG002|Overall Study|Withdrawal by Subject|2|||
160967762|NCT00985985|581270102|FG003|Overall Study|Withdrawal by Subject|2|||
160967763|NCT00985985|581270099|FG000|Overall Study|Other Reason|6|||
160967764|NCT00985985|581270100|FG001|Overall Study|Other Reason|1|||
160967765|NCT00985985|581270101|FG002|Overall Study|Other Reason|4|||
160967766|NCT00985985|581270102|FG003|Overall Study|Other Reason|2|||
160967767|NCT02255357|581270106|FG000|Overall Study|Physician Decision|10|||
160967768|NCT02255357|581270107|FG001|Overall Study|Physician Decision|24|||
160967769|NCT00509236|581270112|FG000|Overall Study|Adverse Event|7|||
160967770|NCT00509236|581270113|FG001|Overall Study|Adverse Event|9|||
160967771|NCT00509236|581270112|FG000|Overall Study|Withdrawal by Subject|5|||
160967772|NCT00509236|581270113|FG001|Overall Study|Withdrawal by Subject|10|||
160967773|NCT00509236|581270112|FG000|Overall Study|Protocol Violation|3|||
160967774|NCT00509236|581270113|FG001|Overall Study|Protocol Violation|0|||
160967775|NCT00509236|581270112|FG000|Overall Study|Excluded Medication|1|||
160967776|NCT00509236|581270113|FG001|Overall Study|Excluded Medication|1|||
160967777|NCT00509236|581270112|FG000|Overall Study|Scheduled Kidney Transplant|1|||
160967778|NCT00509236|581270113|FG001|Overall Study|Scheduled Kidney Transplant|0|||
160967779|NCT02709005|581270125|FG000|Overall Study|Lost to Follow-up|1|||
160967780|NCT02709005|581270126|FG001|Overall Study|Lost to Follow-up|1|||
160967781|NCT02709005|581270125|FG000|Overall Study|Withdrawal by Subject|3|||
160967782|NCT02709005|581270126|FG001|Overall Study|Withdrawal by Subject|0|||
160967783|NCT01572389|581270127|FG000|Overall Study|Death|1|||
160585941|NCT00254293|579863944|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
160585942|NCT00254293|579863945|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
160585943|NCT00254293|579863946|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
160585944|NCT00254293|579863947|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
160585945|NCT00254293|579863941|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
160585946|NCT00254293|579863942|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
160585947|NCT00254293|579863943|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
160585948|NCT00254293|579863944|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
160585949|NCT00254293|579863945|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
160585950|NCT00254293|579863946|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
160585951|NCT00254293|579863947|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
160585952|NCT00254293|579863941|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
160585953|NCT00254293|579863942|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
160585954|NCT00254293|579863943|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
160585955|NCT00254293|579863944|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
160585956|NCT00254293|579863945|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
160967784|NCT01572389|581270128|FG001|Overall Study|Death|3|||
160967785|NCT01572389|581270127|FG000|Overall Study|Withdrawal by Subject|14|||
160967786|NCT01572389|581270128|FG001|Overall Study|Withdrawal by Subject|2|||
160967787|NCT01572389|581270127|FG000|Overall Study|Lost to Follow-up|25|||
160967788|NCT01572389|581270128|FG001|Overall Study|Lost to Follow-up|14|||
160967789|NCT01572389|581270127|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
160967790|NCT01572389|581270128|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
160967791|NCT00499863|581270133|FG000|Overall Study|Lack of Efficacy|21|||
160967792|NCT00499863|581270134|FG001|Overall Study|Lack of Efficacy|27|||
160967793|NCT00499863|581270133|FG000|Overall Study|Protocol Violation|12|||
160967794|NCT00499863|581270134|FG001|Overall Study|Protocol Violation|7|||
160967795|NCT00499863|581270133|FG000|Overall Study|Withdrawal by Subject|6|||
160967796|NCT00499863|581270134|FG001|Overall Study|Withdrawal by Subject|4|||
160967797|NCT00499863|581270133|FG000|Overall Study|Adverse Event|8|||
160967798|NCT00499863|581270134|FG001|Overall Study|Adverse Event|2|||
160967799|NCT00499863|581270133|FG000|Overall Study|Sponsor decision|2|||
160967800|NCT00499863|581270134|FG001|Overall Study|Sponsor decision|2|||
160967801|NCT00499863|581270133|FG000|Overall Study|Lost to Follow-up|1|||
160967802|NCT00499863|581270134|FG001|Overall Study|Lost to Follow-up|1|||
160967803|NCT02535364|581270135|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
160967804|NCT02535364|581270135|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
160967805|NCT02535364|581270135|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
160967806|NCT02535364|581270135|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
160967807|NCT02535364|581270135|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
160967808|NCT02535364|581270135|FG000|Part B Screening|Death|2|||
160967809|NCT02535364|581270135|FG000|Part B Screening|Physician Decision|1|||
160967810|NCT02535364|581270135|FG000|Part B Screening|Withdrawal by Subject|1|||
160967811|NCT02535364|581270135|FG000|Part B Screening|Adverse Event|1|||
160967812|NCT02535364|581270135|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
160967813|NCT02535364|581270135|FG000|Study Treatment|Death|1|||
160967814|NCT02535364|581270135|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
160967815|NCT02535364|581270135|FG000|12-Month Follow-up Period|Disease progression|22|||
160967816|NCT02535364|581270135|FG000|12-Month Follow-up Period|Death|5|||
160967817|NCT02535364|581270135|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
160967818|NCT02535364|581270135|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
160967819|NCT02535364|581270135|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
160967820|NCT00571701|581270136|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
160967821|NCT00571701|581270137|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
160967822|NCT00571701|581270136|FG000|First Intervention 12 Months|Death|1|||
160967823|NCT00571701|581270137|FG001|First Intervention 12 Months|Death|0|||
160967824|NCT00571701|581270136|FG000|Second Intervention 12 Months|Adverse Event|0|||
160967825|NCT00571701|581270137|FG001|Second Intervention 12 Months|Adverse Event|1|||
160967826|NCT00571701|581270136|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
160967827|NCT00571701|581270137|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
160967828|NCT00691132|581270138|FG000|Overall Study|Adverse Event|2|||
160967829|NCT00691132|581270139|FG001|Overall Study|Adverse Event|3|||
160967830|NCT00691132|581270138|FG000|Overall Study|Withdrawal by Subject|10|||
160967831|NCT00691132|581270139|FG001|Overall Study|Withdrawal by Subject|10|||
160967832|NCT01959347|581270150|FG000|Overall Study|Protocol Violation|9|||
160967833|NCT01959347|581270151|FG001|Overall Study|Protocol Violation|7|||
160967834|NCT01282801|581270152|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
160967835|NCT01282801|581270153|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
160967836|NCT01375205|581270161|FG000|Overall Study|Lost to Follow-up|15|||
160967837|NCT01375205|581270162|FG001|Overall Study|Lost to Follow-up|12|||
160967838|NCT01375205|581270161|FG000|Overall Study|Withdrawal by Subject|6|||
161012496|NCT04452318|581432729|FG002|Overall Study|Death|0|||
161012497|NCT04452318|581432730|FG003|Overall Study|Death|0|||
161012498|NCT04452318|581432731|FG004|Overall Study|Death|0|||
161012499|NCT04452318|581432732|FG005|Overall Study|Death|0|||
161012500|NCT04452318|581432733|FG006|Overall Study|Death|0|||
161012501|NCT04452318|581432727|FG000|Overall Study|Lost to Follow-up|38|||
161012502|NCT04452318|581432728|FG001|Overall Study|Lost to Follow-up|28|||
161012503|NCT04452318|581432729|FG002|Overall Study|Lost to Follow-up|0|||
161012504|NCT04452318|581432730|FG003|Overall Study|Lost to Follow-up|3|||
161012505|NCT04452318|581432731|FG004|Overall Study|Lost to Follow-up|3|||
161012506|NCT04452318|581432732|FG005|Overall Study|Lost to Follow-up|2|||
161012507|NCT04452318|581432733|FG006|Overall Study|Lost to Follow-up|1|||
161012508|NCT04452318|581432727|FG000|Overall Study|Withdrawal by Subject|46|||
161012509|NCT04452318|581432728|FG001|Overall Study|Withdrawal by Subject|40|||
161012510|NCT04452318|581432729|FG002|Overall Study|Withdrawal by Subject|0|||
161012511|NCT04452318|581432730|FG003|Overall Study|Withdrawal by Subject|18|||
161012512|NCT04452318|581432731|FG004|Overall Study|Withdrawal by Subject|6|||
161012513|NCT04452318|581432732|FG005|Overall Study|Withdrawal by Subject|8|||
161012514|NCT04452318|581432733|FG006|Overall Study|Withdrawal by Subject|6|||
161012515|NCT03380390|581432738|FG000|Overall Study|Adverse Event|3|||
161012516|NCT05494788|581432740|FG000|Initial Treatment Period|Adverse Event|2|||
161012517|NCT05494788|581432740|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
161012518|NCT05494788|581432740|FG000|Extension Period|Adverse Event|1|||
161012519|NCT05494788|581432740|FG000|Extension Period|Withdrawal by Subject|1|||
161012520|NCT00073749|581432741|FG000|Overall Study|Disease Progression|2|||
161012521|NCT00073749|581432742|FG001|Overall Study|Disease Progression|0|||
161012522|NCT00073749|581432743|FG002|Overall Study|Disease Progression|3|||
161012523|NCT00073749|581432744|FG003|Overall Study|Disease Progression|2|||
161012524|NCT00073749|581432745|FG004|Overall Study|Disease Progression|3|||
161012525|NCT00073749|581432746|FG005|Overall Study|Disease Progression|1|||
161012526|NCT00073749|581432747|FG006|Overall Study|Disease Progression|3|||
161012527|NCT00073749|581432741|FG000|Overall Study|Death|0|||
160458988|NCT04109066|579412730|FG001|Treatment|Study drug toxicity|5|||
160458989|NCT04109066|579412729|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
160967839|NCT01375205|581270162|FG001|Overall Study|Withdrawal by Subject|1|||
160967840|NCT01859793|581270163|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
160967841|NCT01859793|581270164|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
160967842|NCT01859793|581270163|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
160967843|NCT01859793|581270164|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
160967844|NCT01859793|581270163|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
160967845|NCT01859793|581270164|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
160967846|NCT01859793|581270163|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
160967847|NCT01859793|581270164|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
160967848|NCT01064297|581270171|FG000|Overall Study|Lost to Follow-up|791|||
160967849|NCT01064297|581270172|FG001|Overall Study|Lost to Follow-up|48|||
160967850|NCT01064297|581270173|FG002|Overall Study|Lost to Follow-up|133|||
160967851|NCT00542880|581270181|FG000|Period 1|Eligibility criteria not fulfilled|2|||
160967852|NCT00542880|581270182|FG001|Period 1|Eligibility criteria not fulfilled|6|||
160967853|NCT00542880|581270181|FG000|Period 1|Adverse Event|2|||
160967854|NCT00542880|581270182|FG001|Period 1|Adverse Event|2|||
160967855|NCT00542880|581270181|FG000|Period 1|Development of study-specific criteria|1|||
160967856|NCT00542880|581270182|FG001|Period 1|Development of study-specific criteria|2|||
160967857|NCT00542880|581270181|FG000|Period 1|Withdrawal by Subject|1|||
160967858|NCT00542880|581270182|FG001|Period 1|Withdrawal by Subject|1|||
160967859|NCT00542880|581270181|FG000|Period 1|Protocol Violation|0|||
160967860|NCT00542880|581270182|FG001|Period 1|Protocol Violation|1|||
160967861|NCT00542880|581270181|FG000|Period 2|Adverse Event|5|||
160967862|NCT00542880|581270182|FG001|Period 2|Adverse Event|7|||
160967863|NCT00542880|581270181|FG000|Period 2|Eligibility not fulfilled|0|||
160967864|NCT00542880|581270182|FG001|Period 2|Eligibility not fulfilled|1|||
160967865|NCT00542880|581270181|FG000|Period 2|Discontinuation criteria|2|||
160967866|NCT00542880|581270182|FG001|Period 2|Discontinuation criteria|0|||
160967867|NCT00542880|581270181|FG000|Period 2|Severe non-compliance|0|||
160967868|NCT00542880|581270182|FG001|Period 2|Severe non-compliance|1|||
160967869|NCT00542880|581270181|FG000|Period 2|Other|0|||
160967870|NCT00542880|581270182|FG001|Period 2|Other|1|||
160967871|NCT00542880|581270181|FG000|Period 3|Adverse Event|0|||
160967872|NCT00542880|581270182|FG001|Period 3|Adverse Event|2|||
160967873|NCT00982930|581270187|FG000|Overall Study|Adverse Event|1|||
160967874|NCT00982930|581270187|FG000|Overall Study|Withdrawal by Subject|1|||
160967875|NCT00982930|581270187|FG000|Overall Study|Administrative Problems|2|||
160967876|NCT04179721|581270188|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
160967877|NCT04179721|581270189|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
160967878|NCT04179721|581270188|FG000|Overall Study|Lost to Follow-up|0|||
161012528|NCT00073749|581432742|FG001|Overall Study|Death|1|||
161012529|NCT00073749|581432743|FG002|Overall Study|Death|1|||
161012530|NCT00073749|581432744|FG003|Overall Study|Death|0|||
161012531|NCT00073749|581432745|FG004|Overall Study|Death|0|||
161012532|NCT00073749|581432746|FG005|Overall Study|Death|0|||
161012533|NCT00073749|581432747|FG006|Overall Study|Death|29|||
161012534|NCT00073749|581432741|FG000|Overall Study|Adverse Event|0|||
161012535|NCT00073749|581432742|FG001|Overall Study|Adverse Event|3|||
161012536|NCT00073749|581432743|FG002|Overall Study|Adverse Event|6|||
161012537|NCT00073749|581432744|FG003|Overall Study|Adverse Event|4|||
161012538|NCT00073749|581432745|FG004|Overall Study|Adverse Event|2|||
161012539|NCT00073749|581432746|FG005|Overall Study|Adverse Event|1|||
161012540|NCT00073749|581432747|FG006|Overall Study|Adverse Event|0|||
161012541|NCT00073749|581432741|FG000|Overall Study|Physician Decision|0|||
161012542|NCT00073749|581432742|FG001|Overall Study|Physician Decision|0|||
161012543|NCT00073749|581432743|FG002|Overall Study|Physician Decision|1|||
161012544|NCT00073749|581432744|FG003|Overall Study|Physician Decision|0|||
161012545|NCT00073749|581432745|FG004|Overall Study|Physician Decision|0|||
161012546|NCT00073749|581432746|FG005|Overall Study|Physician Decision|2|||
161012547|NCT00073749|581432747|FG006|Overall Study|Physician Decision|0|||
161012548|NCT00073749|581432741|FG000|Overall Study|Withdrawal by Subject|0|||
161012549|NCT00073749|581432742|FG001|Overall Study|Withdrawal by Subject|1|||
161012550|NCT00073749|581432743|FG002|Overall Study|Withdrawal by Subject|0|||
161012551|NCT00073749|581432744|FG003|Overall Study|Withdrawal by Subject|0|||
161012552|NCT00073749|581432745|FG004|Overall Study|Withdrawal by Subject|1|||
161012553|NCT00073749|581432746|FG005|Overall Study|Withdrawal by Subject|0|||
161012554|NCT00073749|581432747|FG006|Overall Study|Withdrawal by Subject|2|||
161012555|NCT00073749|581432741|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
161012556|NCT00073749|581432742|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161012557|NCT00073749|581432743|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
161012558|NCT00073749|581432744|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161012559|NCT00073749|581432745|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
161012560|NCT00073749|581432746|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
160585957|NCT00254293|579863946|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
160585958|NCT00254293|579863947|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
160585959|NCT00254293|579863941|FG000|LTE Open Label Variable SC Dosing|Other|0|||
161012561|NCT00073749|581432747|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
161012562|NCT00073749|581432741|FG000|Overall Study|Lost to Follow-up|0|||
161012563|NCT00073749|581432742|FG001|Overall Study|Lost to Follow-up|0|||
161012564|NCT00073749|581432743|FG002|Overall Study|Lost to Follow-up|0|||
161012565|NCT00073749|581432744|FG003|Overall Study|Lost to Follow-up|0|||
161012566|NCT00073749|581432745|FG004|Overall Study|Lost to Follow-up|0|||
161012567|NCT00073749|581432746|FG005|Overall Study|Lost to Follow-up|0|||
161012568|NCT00073749|581432747|FG006|Overall Study|Lost to Follow-up|2|||
161012569|NCT00073749|581432741|FG000|Overall Study|Other|0|||
161012570|NCT00073749|581432742|FG001|Overall Study|Other|0|||
161012571|NCT00073749|581432743|FG002|Overall Study|Other|0|||
161012572|NCT00073749|581432744|FG003|Overall Study|Other|0|||
161012573|NCT00073749|581432745|FG004|Overall Study|Other|0|||
161012574|NCT00073749|581432746|FG005|Overall Study|Other|2|||
161012575|NCT00073749|581432747|FG006|Overall Study|Other|0|||
161012576|NCT02272816|581432748|FG000|Overall Study|Adverse Event|1|||
161012577|NCT00065260|581432752|FG000|Overall Study|Death|0|||
161012578|NCT00065260|581432753|FG001|Overall Study|Death|1|||
161012579|NCT00001277|581432754|FG000|Overall Study|Adverse Event|0|||
161012580|NCT00001277|581432755|FG001|Overall Study|Adverse Event|0|||
161012581|NCT00001277|581432756|FG002|Overall Study|Adverse Event|1|||
161012582|NCT00001277|581432754|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
161012583|NCT00001277|581432755|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
161012584|NCT00001277|581432756|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
161012585|NCT00088413|581432759|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
161012586|NCT00088413|581432760|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
160458990|NCT04109066|579412730|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
160458991|NCT04109066|579412729|FG000|Treatment|Disease Recurrence|0|||
160585960|NCT00254293|579863942|FG001|LTE Open Label Variable SC Dosing|Other|0|||
160585961|NCT00254293|579863943|FG002|LTE Open Label Variable SC Dosing|Other|2|||
160585962|NCT00254293|579863944|FG003|LTE Open Label Variable SC Dosing|Other|0|||
160585963|NCT00254293|579863945|FG004|LTE Open Label Variable SC Dosing|Other|0|||
161012587|NCT00088413|581432761|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
161012588|NCT00088413|581432762|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
161012589|NCT00088413|581432759|FG000|Overall Study|Adverse Events/Side Effects|0|||
161012590|NCT00088413|581432760|FG001|Overall Study|Adverse Events/Side Effects|1|||
161012591|NCT00088413|581432761|FG002|Overall Study|Adverse Events/Side Effects|1|||
161012592|NCT00088413|581432762|FG003|Overall Study|Adverse Events/Side Effects|0|||
161012593|NCT00088413|581432759|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
161012594|NCT00088413|581432760|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
161012595|NCT00088413|581432761|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
161012596|NCT00088413|581432762|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
161012597|NCT00088413|581432759|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
160458992|NCT04109066|579412730|FG001|Treatment|Disease Recurrence|2|||
161012598|NCT00088413|581432760|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
161012599|NCT00088413|581432761|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
161012600|NCT00088413|581432762|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
161012601|NCT00088413|581432759|FG000|Overall Study|Death|0|||
161012602|NCT00088413|581432760|FG001|Overall Study|Death|1|||
161012603|NCT00088413|581432761|FG002|Overall Study|Death|0|||
161012604|NCT00088413|581432762|FG003|Overall Study|Death|0|||
161012605|NCT00088413|581432759|FG000|Overall Study|Progressive disease|9|||
161012606|NCT00088413|581432760|FG001|Overall Study|Progressive disease|11|||
161012607|NCT00088413|581432761|FG002|Overall Study|Progressive disease|8|||
161012608|NCT00088413|581432762|FG003|Overall Study|Progressive disease|14|||
161012609|NCT00088413|581432759|FG000|Overall Study|Other|0|||
161012610|NCT00088413|581432760|FG001|Overall Study|Other|1|||
161012611|NCT00088413|581432761|FG002|Overall Study|Other|0|||
161012612|NCT00088413|581432762|FG003|Overall Study|Other|0|||
161012613|NCT00088413|581432759|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
161012614|NCT00088413|581432760|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
161012615|NCT00088413|581432761|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
161012616|NCT00088413|581432762|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
161012617|NCT04820686|581432763|FG000|Overall Study|Withdrawal by Subject|5|||
161012618|NCT04820686|581432764|FG001|Overall Study|Withdrawal by Subject|2|||
161012619|NCT04820686|581432765|FG002|Overall Study|Withdrawal by Subject|3|||
161012620|NCT04820686|581432763|FG000|Overall Study|Study Termination|25|||
161012621|NCT04820686|581432764|FG001|Overall Study|Study Termination|13|||
161012622|NCT04820686|581432765|FG002|Overall Study|Study Termination|14|||
161012623|NCT04820686|581432763|FG000|Overall Study|Adverse Event|0|||
161012624|NCT04820686|581432764|FG001|Overall Study|Adverse Event|1|||
161012625|NCT04820686|581432765|FG002|Overall Study|Adverse Event|0|||
161012626|NCT04048382|581432766|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
161012627|NCT04048382|581432767|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
161012628|NCT04048382|581432766|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
161012629|NCT04048382|581432767|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
161012630|NCT04048382|581432766|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
161012631|NCT04048382|581432767|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
161012632|NCT02119650|581432771|FG000|Overall Study|Adverse Event|3|||
161012633|NCT02119650|581432772|FG001|Overall Study|Adverse Event|4|||
161012634|NCT02119650|581432771|FG000|Overall Study|Subject decision|2|||
161012635|NCT02119650|581432772|FG001|Overall Study|Subject decision|3|||
161012636|NCT02119650|581432771|FG000|Overall Study|Disease progression|11|||
161012637|NCT02119650|581432772|FG001|Overall Study|Disease progression|14|||
161012638|NCT02119650|581432771|FG000|Overall Study|Death|5|||
161012639|NCT02119650|581432772|FG001|Overall Study|Death|1|||
161012640|NCT02119650|581432771|FG000|Overall Study|Noncompliance with study treatment|1|||
161012641|NCT02119650|581432772|FG001|Overall Study|Noncompliance with study treatment|1|||
161012642|NCT02119650|581432771|FG000|Overall Study|Study terminated by the sponsor|1|||
161012643|NCT02119650|581432772|FG001|Overall Study|Study terminated by the sponsor|0|||
161012644|NCT02119650|581432771|FG000|Overall Study|Physician Decision|0|||
161012645|NCT02119650|581432772|FG001|Overall Study|Physician Decision|2|||
161012646|NCT02119650|581432771|FG000|Overall Study|Multiple reasons for termination|2|||
161012647|NCT02119650|581432772|FG001|Overall Study|Multiple reasons for termination|1|||
161012648|NCT01037985|581432774|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
161012649|NCT01037985|581432775|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
161012650|NCT01037985|581432774|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
161012651|NCT01037985|581432775|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
161012652|NCT01037985|581432774|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
161012653|NCT01037985|581432775|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
161012654|NCT01037985|581432774|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
161012655|NCT01037985|581432775|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
161012656|NCT02269475|581432776|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
161012657|NCT02269475|581432777|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
161012658|NCT02269475|581432776|FG000|Overall Study|Withdrawal by Subject|0|||
160458993|NCT04109066|579412729|FG000|Treatment|Not reported|4|||
160458994|NCT04109066|579412730|FG001|Treatment|Not reported|8|||
161012659|NCT02269475|581432777|FG001|Overall Study|Withdrawal by Subject|1|||
161012660|NCT03481816|581432778|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
161012661|NCT03481816|581432779|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
161012662|NCT03481816|581432778|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
161012663|NCT03481816|581432779|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
161012664|NCT03481816|581432778|FG000|Dose Expansion|Withdrawal by Subject|0|||
161012665|NCT03481816|581432779|FG001|Dose Expansion|Withdrawal by Subject|2|||
161012666|NCT03481816|581432778|FG000|Dose Expansion|Physician Decision|0|||
161012667|NCT03481816|581432779|FG001|Dose Expansion|Physician Decision|5|||
161012668|NCT02730871|581432782|FG000|Overall Study|Adverse Event|6|||
161012669|NCT02730871|581432783|FG001|Overall Study|Adverse Event|0|||
161012670|NCT05368558|581432785|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
161012671|NCT05368558|581432786|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
161012672|NCT05368558|581432787|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
161012673|NCT05368558|581432788|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012674|NCT05368558|581432789|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012675|NCT05368558|581432790|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012676|NCT05368558|581432791|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012677|NCT05368558|581432792|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012678|NCT05368558|581432793|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012679|NCT05368558|581432794|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012680|NCT05368558|581432795|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012681|NCT05368558|581432796|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012682|NCT05368558|581432785|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012683|NCT05368558|581432786|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012684|NCT05368558|581432787|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012685|NCT05368558|581432788|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
161012686|NCT05368558|581432789|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
160967879|NCT04179721|581270189|FG001|Overall Study|Lost to Follow-up|1|||
160967880|NCT01392300|581271338|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
160967881|NCT01392300|581271339|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
160967882|NCT01392300|581271340|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
160967883|NCT01392300|581271338|FG000|Main Period (MP)|Withdrawal by Subject|5|||
160967884|NCT01392300|581271339|FG001|Main Period (MP)|Withdrawal by Subject|1|||
160967885|NCT01392300|581271340|FG002|Main Period (MP)|Withdrawal by Subject|0|||
160967886|NCT01392300|581271338|FG000|Main Period (MP)|Lost to Follow-up|3|||
160967887|NCT01392300|581271339|FG001|Main Period (MP)|Lost to Follow-up|3|||
160967888|NCT01392300|581271340|FG002|Main Period (MP)|Lost to Follow-up|0|||
160967889|NCT01392300|581271338|FG000|Main Period (MP)|Non-compliance|1|||
160967890|NCT01392300|581271339|FG001|Main Period (MP)|Non-compliance|0|||
160967891|NCT01392300|581271340|FG002|Main Period (MP)|Non-compliance|0|||
160967892|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
160967893|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
160967894|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
160967895|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
160967896|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
160967897|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
160967898|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
160967899|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
160967900|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
160967901|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Death|0|||
160967902|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Death|0|||
160967903|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Death|4|||
160967904|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
160967905|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
160967906|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
160967907|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
160967908|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
160967909|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
160967910|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
160967911|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
160967912|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
160967913|NCT01147822|581271345|FG000|Overall Study|Lost to Follow-up|14|||
160967914|NCT01147822|581271346|FG001|Overall Study|Lost to Follow-up|6|||
160967915|NCT01147822|581271345|FG000|Overall Study|Withdrawal by Subject|10|||
160967916|NCT01147822|581271346|FG001|Overall Study|Withdrawal by Subject|16|||
160967917|NCT01147822|581271345|FG000|Overall Study|Physician Decision|9|||
160967918|NCT01147822|581271346|FG001|Overall Study|Physician Decision|8|||
160967919|NCT01147822|581271345|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
160967920|NCT01147822|581271346|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
160967921|NCT01147822|581271345|FG000|Overall Study|Protocol Violation|1|||
160967922|NCT01147822|581271346|FG001|Overall Study|Protocol Violation|1|||
160967923|NCT03010462|581271350|FG000|Overall Study|Withdrawal by Subject|3|||
160967924|NCT03010462|581271351|FG001|Overall Study|Withdrawal by Subject|1|||
160967925|NCT01966003|581271352|FG000|Overall Study|Death|43|||
160967926|NCT01966003|581271353|FG001|Overall Study|Death|36|||
160967927|NCT01966003|581271352|FG000|Overall Study|Protocol Violation|6|||
160967928|NCT01966003|581271353|FG001|Overall Study|Protocol Violation|4|||
160967929|NCT01966003|581271352|FG000|Overall Study|Lost to Follow-up|4|||
160967930|NCT01966003|581271353|FG001|Overall Study|Lost to Follow-up|3|||
161012687|NCT05368558|581432790|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
161012688|NCT05368558|581432791|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012689|NCT05368558|581432792|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012690|NCT05368558|581432793|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012691|NCT05368558|581432794|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012692|NCT05368558|581432795|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012693|NCT05368558|581432796|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
160657032|NCT05097989|580124502|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161012694|NCT05368558|581432785|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012695|NCT05368558|581432786|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012696|NCT05368558|581432787|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012697|NCT05368558|581432788|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
161012698|NCT05368558|581432789|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012699|NCT05368558|581432790|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012700|NCT05368558|581432791|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012701|NCT05368558|581432792|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012702|NCT05368558|581432793|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012703|NCT05368558|581432794|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012704|NCT05368558|581432795|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012705|NCT05368558|581432796|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012706|NCT05368558|581432785|FG000|Blinded Extension Period (BEP)|other|0|||
161012707|NCT05368558|581432786|FG001|Blinded Extension Period (BEP)|other|0|||
161012708|NCT05368558|581432787|FG002|Blinded Extension Period (BEP)|other|0|||
161012709|NCT05368558|581432788|FG003|Blinded Extension Period (BEP)|other|0|||
161012710|NCT05368558|581432789|FG004|Blinded Extension Period (BEP)|other|0|||
161012711|NCT05368558|581432790|FG005|Blinded Extension Period (BEP)|other|1|||
161012712|NCT05368558|581432791|FG006|Blinded Extension Period (BEP)|other|0|||
161012713|NCT05368558|581432792|FG007|Blinded Extension Period (BEP)|other|0|||
161012714|NCT05368558|581432793|FG008|Blinded Extension Period (BEP)|other|0|||
161012715|NCT05368558|581432794|FG009|Blinded Extension Period (BEP)|other|0|||
161012716|NCT05368558|581432795|FG010|Blinded Extension Period (BEP)|other|0|||
161012717|NCT05368558|581432796|FG011|Blinded Extension Period (BEP)|other|0|||
161012718|NCT00774852|581432797|FG000|Overall Study|Adverse Event|9|||
161012719|NCT00774852|581432798|FG001|Overall Study|Adverse Event|6|||
161012720|NCT00774852|581432797|FG000|Overall Study|Death|2|||
161012721|NCT00774852|581432798|FG001|Overall Study|Death|1|||
161012722|NCT00774852|581432797|FG000|Overall Study|Lack of Efficacy|3|||
161012723|NCT00774852|581432798|FG001|Overall Study|Lack of Efficacy|7|||
161012724|NCT00774852|581432797|FG000|Overall Study|Lost to Follow-up|9|||
161012725|NCT00774852|581432798|FG001|Overall Study|Lost to Follow-up|5|||
161012726|NCT00774852|581432797|FG000|Overall Study|Physician Decision|2|||
161012727|NCT00774852|581432798|FG001|Overall Study|Physician Decision|6|||
161012728|NCT00774852|581432797|FG000|Overall Study|Pregnancy|1|||
161012729|NCT00774852|581432798|FG001|Overall Study|Pregnancy|2|||
161012730|NCT00774852|581432797|FG000|Overall Study|Withdrawal by Subject|2|||
161012731|NCT00774852|581432798|FG001|Overall Study|Withdrawal by Subject|2|||
161012732|NCT00774852|581432797|FG000|Overall Study|Non-responder|15|||
161012733|NCT00774852|581432798|FG001|Overall Study|Non-responder|11|||
161012734|NCT00774852|581432797|FG000|Overall Study|Subject non-compliance|0|||
161012735|NCT00774852|581432798|FG001|Overall Study|Subject non-compliance|1|||
161012736|NCT00774852|581432797|FG000|Overall Study|Protocol Violation|1|||
161012737|NCT00774852|581432798|FG001|Overall Study|Protocol Violation|0|||
161012738|NCT00774852|581432797|FG000|Overall Study|Subject received prohibited medication|1|||
161012739|NCT00774852|581432798|FG001|Overall Study|Subject received prohibited medication|0|||
161012740|NCT04428112|581432799|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
161012741|NCT04428112|581432800|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
161012742|NCT04428112|581432799|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
161012743|NCT04428112|581432800|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
161012744|NCT04428112|581432799|FG000|Overall Study|Withdrawal by Subject|9|||
161012745|NCT04428112|581432800|FG001|Overall Study|Withdrawal by Subject|4|||
161012746|NCT04428112|581432799|FG000|Overall Study|Lost to Follow-up|27|||
161012747|NCT04428112|581432800|FG001|Overall Study|Lost to Follow-up|7|||
161012748|NCT01303445|581432803|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
161012749|NCT01303445|581432804|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
161012750|NCT01303445|581432803|FG000|Second Intervention (7 Days)|Adverse Event|0|||
161012751|NCT01303445|581432804|FG001|Second Intervention (7 Days)|Adverse Event|2|||
161012752|NCT01303445|581432803|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
161012753|NCT01303445|581432804|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
161012754|NCT01303445|581432803|FG000|Washout (14 Days)|Protocol Violation|1|||
161012755|NCT01303445|581432804|FG001|Washout (14 Days)|Protocol Violation|0|||
161012756|NCT01303445|581432803|FG000|Washout (14 Days)|Lost to Follow-up|0|||
161012757|NCT01303445|581432804|FG001|Washout (14 Days)|Lost to Follow-up|2|||
161012758|NCT01303445|581432803|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
161012759|NCT01303445|581432804|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
161012760|NCT01303445|581432803|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
161012761|NCT01303445|581432804|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
161012762|NCT04459416|581434881|FG000|Overall Study|Lost to Follow-up|2|||
161012763|NCT04459416|581434882|FG001|Overall Study|Lost to Follow-up|0|||
161012764|NCT04459416|581434881|FG000|Overall Study|Withdrawal by Subject|8|||
161012765|NCT04459416|581434882|FG001|Overall Study|Withdrawal by Subject|10|||
161012766|NCT04459416|581434881|FG000|Overall Study|Disease progression|0|||
161012767|NCT04459416|581434882|FG001|Overall Study|Disease progression|3|||
161012768|NCT03744312|581434883|FG000|Overall Study|Withdrawal by Subject|0|||
161012769|NCT03744312|581434884|FG001|Overall Study|Withdrawal by Subject|1|||
161012770|NCT03744312|581434883|FG000|Overall Study|Screen fail|0|||
161012771|NCT03744312|581434884|FG001|Overall Study|Screen fail|1|||
161012772|NCT05134337|581434885|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
161012773|NCT05134337|581434886|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
161012774|NCT04923347|581434887|FG000|Overall Study|Withdrawal by Subject|14|||
161012775|NCT01259401|581434888|FG000|4-month Follow-up|Death|0|||
161012776|NCT01259401|581434889|FG001|4-month Follow-up|Death|1|||
161012777|NCT01259401|581434888|FG000|4-month Follow-up|Lost to Follow-up|0|||
161012778|NCT01259401|581434889|FG001|4-month Follow-up|Lost to Follow-up|1|||
161012779|NCT05756075|581434894|FG000|Overall Study|Withdrawal by Subject|16|||
161012780|NCT05756075|581434895|FG001|Overall Study|Withdrawal by Subject|9|||
161012781|NCT01991977|581434896|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
161012782|NCT01991977|581434896|FG000|Overall Study|Withdrew after start of treatment|5|||
161012783|NCT02201108|581434898|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
161012784|NCT02201108|581434899|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
161012785|NCT02201108|581434900|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
161012786|NCT02201108|581434898|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
161012787|NCT02201108|581434899|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
161012788|NCT02201108|581434900|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
161012789|NCT02201108|581434898|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
161012790|NCT02201108|581434899|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
161012791|NCT02201108|581434900|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
161012792|NCT02201108|581434898|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
161012793|NCT02201108|581434899|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
161012794|NCT02201108|581434900|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
161012795|NCT02201108|581434898|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
161012796|NCT02201108|581434899|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
161012797|NCT02201108|581434900|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
161012798|NCT02201108|581434898|FG000|Open Label Period (up to Week 192)|Other reason|4|||
161012799|NCT02201108|581434899|FG001|Open Label Period (up to Week 192)|Other reason|7|||
161012800|NCT02201108|581434900|FG002|Open Label Period (up to Week 192)|Other reason|0|||
161012801|NCT02201108|581434898|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
161012802|NCT02201108|581434899|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
161012803|NCT02201108|581434900|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
161012804|NCT02201108|581434898|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
161012805|NCT02201108|581434899|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
161012806|NCT02201108|581434900|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
161012807|NCT02201108|581434898|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
161012808|NCT02201108|581434899|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
161012809|NCT02201108|581434900|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
161012810|NCT03055377|581434901|FG000|Treatment Phase|Lost to Follow-up|28|||
161012811|NCT03055377|581434902|FG001|Treatment Phase|Lost to Follow-up|24|||
161012812|NCT03055377|581434901|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
161012813|NCT03055377|581434902|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
161012814|NCT04143061|581434903|FG000|Overall Study|Protocol Deviation|0|||
161012815|NCT04143061|581434904|FG001|Overall Study|Protocol Deviation|0|||
161012816|NCT04143061|581434905|FG002|Overall Study|Protocol Deviation|0|||
161012817|NCT04143061|581434906|FG003|Overall Study|Protocol Deviation|0|||
160458995|NCT05205161|579412731|FG000|Overall Study|Study terminated by sponsor|3|||
160458996|NCT05205161|579412732|FG001|Overall Study|Study terminated by sponsor|3|||
160458997|NCT05205161|579412733|FG002|Overall Study|Study terminated by sponsor|1|||
161012818|NCT04143061|581434907|FG004|Overall Study|Protocol Deviation|0|||
161012819|NCT04143061|581434908|FG005|Overall Study|Protocol Deviation|0|||
160458998|NCT03817983|579412737|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
161012820|NCT04143061|581434909|FG006|Overall Study|Protocol Deviation|5|||
161012821|NCT04143061|581434910|FG007|Overall Study|Protocol Deviation|5|||
161012822|NCT04143061|581434903|FG000|Overall Study|Withdrawal by Subject|2|||
161012823|NCT04143061|581434904|FG001|Overall Study|Withdrawal by Subject|0|||
161012824|NCT04143061|581434905|FG002|Overall Study|Withdrawal by Subject|0|||
161012825|NCT04143061|581434906|FG003|Overall Study|Withdrawal by Subject|0|||
161012826|NCT04143061|581434907|FG004|Overall Study|Withdrawal by Subject|0|||
161012827|NCT04143061|581434908|FG005|Overall Study|Withdrawal by Subject|1|||
161012828|NCT04143061|581434909|FG006|Overall Study|Withdrawal by Subject|0|||
161012829|NCT04143061|581434910|FG007|Overall Study|Withdrawal by Subject|0|||
160585964|NCT00254293|579863946|FG005|LTE Open Label Variable SC Dosing|Other|0|||
160585965|NCT00254293|579863947|FG006|LTE Open Label Variable SC Dosing|Other|0|||
160585966|NCT00254293|579863941|FG000|LTE Open Label Fixed Dosing|Death|0|||
161012830|NCT04143061|581434903|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161012831|NCT04143061|581434904|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161012832|NCT04143061|581434905|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161012833|NCT04143061|581434906|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161012834|NCT04143061|581434907|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
161012835|NCT04143061|581434908|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
161012836|NCT04143061|581434909|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
161012837|NCT04143061|581434910|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
161012838|NCT03289039|581434911|FG000|Overall Study|Withdrawal by Subject|0|||
161012839|NCT03289039|581434912|FG001|Overall Study|Withdrawal by Subject|1|||
161012840|NCT03289039|581434911|FG000|Overall Study|Became ineligible prior to treatment start|0|||
161012841|NCT03289039|581434912|FG001|Overall Study|Became ineligible prior to treatment start|1|||
161012842|NCT03289039|581434911|FG000|Overall Study|progressed before treatment start|1|||
161012843|NCT03289039|581434912|FG001|Overall Study|progressed before treatment start|0|||
161012844|NCT04586920|581434913|FG000|Overall Study|Lost to Follow-up|0|||
161012845|NCT04586920|581434914|FG001|Overall Study|Lost to Follow-up|0|||
161012846|NCT04586920|581434915|FG002|Overall Study|Lost to Follow-up|0|||
161012847|NCT04586920|581434916|FG003|Overall Study|Lost to Follow-up|0|||
161012848|NCT04586920|581434917|FG004|Overall Study|Lost to Follow-up|0|||
161012849|NCT04586920|581434918|FG005|Overall Study|Lost to Follow-up|0|||
161012850|NCT04586920|581434919|FG006|Overall Study|Lost to Follow-up|1|||
161012851|NCT04586920|581434920|FG007|Overall Study|Lost to Follow-up|1|||
161012852|NCT04586920|581434921|FG008|Overall Study|Lost to Follow-up|0|||
161012853|NCT04586920|581434922|FG009|Overall Study|Lost to Follow-up|1|||
161012854|NCT04586920|581434923|FG010|Overall Study|Lost to Follow-up|0|||
161012855|NCT04586920|581434924|FG011|Overall Study|Lost to Follow-up|0|||
161012856|NCT04586920|581434925|FG012|Overall Study|Lost to Follow-up|0|||
161012857|NCT04586920|581434926|FG013|Overall Study|Lost to Follow-up|1|||
161012858|NCT04586920|581434927|FG014|Overall Study|Lost to Follow-up|0|||
161012859|NCT04586920|581434928|FG015|Overall Study|Lost to Follow-up|0|||
161012860|NCT04586920|581434929|FG016|Overall Study|Lost to Follow-up|0|||
161012861|NCT04586920|581434930|FG017|Overall Study|Lost to Follow-up|0|||
161012862|NCT04586920|581434913|FG000|Overall Study|Withdrawal by Subject|0|||
161012863|NCT04586920|581434914|FG001|Overall Study|Withdrawal by Subject|0|||
161012864|NCT04586920|581434915|FG002|Overall Study|Withdrawal by Subject|0|||
161012865|NCT04586920|581434916|FG003|Overall Study|Withdrawal by Subject|0|||
161012866|NCT04586920|581434917|FG004|Overall Study|Withdrawal by Subject|0|||
161012867|NCT04586920|581434918|FG005|Overall Study|Withdrawal by Subject|0|||
161012868|NCT04586920|581434919|FG006|Overall Study|Withdrawal by Subject|0|||
161012869|NCT04586920|581434920|FG007|Overall Study|Withdrawal by Subject|1|||
161012870|NCT04586920|581434921|FG008|Overall Study|Withdrawal by Subject|0|||
161012871|NCT04586920|581434922|FG009|Overall Study|Withdrawal by Subject|1|||
161012872|NCT04586920|581434923|FG010|Overall Study|Withdrawal by Subject|0|||
161012873|NCT04586920|581434924|FG011|Overall Study|Withdrawal by Subject|1|||
161012874|NCT04586920|581434925|FG012|Overall Study|Withdrawal by Subject|0|||
161012875|NCT04586920|581434926|FG013|Overall Study|Withdrawal by Subject|0|||
161012876|NCT04586920|581434927|FG014|Overall Study|Withdrawal by Subject|0|||
161012877|NCT04586920|581434928|FG015|Overall Study|Withdrawal by Subject|0|||
161012878|NCT04586920|581434929|FG016|Overall Study|Withdrawal by Subject|0|||
161012879|NCT04586920|581434930|FG017|Overall Study|Withdrawal by Subject|0|||
161012880|NCT02287311|581434931|FG000|Cohort 1: Dose Level 1|Death|2|||
160585967|NCT00254293|579863942|FG001|LTE Open Label Fixed Dosing|Death|0|||
160585968|NCT00254293|579863943|FG002|LTE Open Label Fixed Dosing|Death|0|||
161012881|NCT02287311|581434932|FG001|Cohort 1: Dose Level 1|Death|0|||
161012882|NCT02287311|581434933|FG002|Cohort 1: Dose Level 1|Death|0|||
161012883|NCT02287311|581434934|FG003|Cohort 1: Dose Level 1|Death|3|||
161012884|NCT02287311|581434935|FG004|Cohort 1: Dose Level 1|Death|0|||
161012885|NCT02287311|581434936|FG005|Cohort 1: Dose Level 1|Death|0|||
161012886|NCT02287311|581434937|FG006|Cohort 1: Dose Level 1|Death|1|||
161012887|NCT02287311|581434938|FG007|Cohort 1: Dose Level 1|Death|0|||
160585969|NCT00254293|579863944|FG003|LTE Open Label Fixed Dosing|Death|0|||
161012888|NCT02287311|581434939|FG008|Cohort 1: Dose Level 1|Death|0|||
161012889|NCT02287311|581434931|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012890|NCT02287311|581434932|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012891|NCT02287311|581434933|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012892|NCT02287311|581434934|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
161012893|NCT02287311|581434935|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012894|NCT02287311|581434936|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012895|NCT02287311|581434937|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
161012896|NCT02287311|581434938|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012897|NCT02287311|581434939|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012898|NCT02287311|581434931|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
161012899|NCT02287311|581434932|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
161012900|NCT02287311|581434933|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
161012901|NCT02287311|581434934|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
161012902|NCT02287311|581434935|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
161012903|NCT02287311|581434936|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
161012904|NCT02287311|581434937|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
161012905|NCT02287311|581434938|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
161012906|NCT02287311|581434939|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
161012907|NCT02287311|581434931|FG000|Cohort 2: Dose Level 2|Death|0|||
161012908|NCT02287311|581434932|FG001|Cohort 2: Dose Level 2|Death|2|||
161012909|NCT02287311|581434933|FG002|Cohort 2: Dose Level 2|Death|0|||
161012910|NCT02287311|581434934|FG003|Cohort 2: Dose Level 2|Death|0|||
161012911|NCT02287311|581434935|FG004|Cohort 2: Dose Level 2|Death|2|||
161012912|NCT02287311|581434936|FG005|Cohort 2: Dose Level 2|Death|0|||
161012913|NCT02287311|581434937|FG006|Cohort 2: Dose Level 2|Death|0|||
161012914|NCT02287311|581434938|FG007|Cohort 2: Dose Level 2|Death|2|||
161012915|NCT02287311|581434939|FG008|Cohort 2: Dose Level 2|Death|0|||
161012916|NCT02287311|581434931|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012917|NCT02287311|581434932|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012918|NCT02287311|581434933|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012919|NCT02287311|581434934|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012920|NCT02287311|581434935|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
161012921|NCT02287311|581434936|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012922|NCT02287311|581434937|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012923|NCT02287311|581434938|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012924|NCT02287311|581434939|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012925|NCT02287311|581434931|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012926|NCT02287311|581434932|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
161012927|NCT02287311|581434933|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012928|NCT02287311|581434934|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012929|NCT02287311|581434935|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012930|NCT02287311|581434936|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012931|NCT02287311|581434937|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012932|NCT02287311|581434938|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012933|NCT02287311|581434939|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012934|NCT02287311|581434931|FG000|Cohort 3: Dose Level 3|Death|0|||
161012935|NCT02287311|581434932|FG001|Cohort 3: Dose Level 3|Death|0|||
161012936|NCT02287311|581434933|FG002|Cohort 3: Dose Level 3|Death|4|||
161012937|NCT02287311|581434934|FG003|Cohort 3: Dose Level 3|Death|0|||
161012938|NCT02287311|581434935|FG004|Cohort 3: Dose Level 3|Death|0|||
161012939|NCT02287311|581434936|FG005|Cohort 3: Dose Level 3|Death|4|||
161012940|NCT02287311|581434937|FG006|Cohort 3: Dose Level 3|Death|0|||
161012941|NCT02287311|581434938|FG007|Cohort 3: Dose Level 3|Death|0|||
161012942|NCT02287311|581434939|FG008|Cohort 3: Dose Level 3|Death|2|||
161012943|NCT02287311|581434931|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012944|NCT02287311|581434932|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012945|NCT02287311|581434933|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
161012946|NCT02287311|581434934|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012947|NCT02287311|581434935|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012948|NCT02287311|581434936|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
161012949|NCT02287311|581434937|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012950|NCT02287311|581434938|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012951|NCT02287311|581434939|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012952|NCT02287311|581434931|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012953|NCT02287311|581434932|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012954|NCT02287311|581434933|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012955|NCT02287311|581434934|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012956|NCT02287311|581434935|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012957|NCT02287311|581434936|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
160458999|NCT03817983|579412738|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
160459000|NCT03817983|579412739|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
161012958|NCT02287311|581434937|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012959|NCT02287311|581434938|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
160459001|NCT03744676|579412740|FG000|Pre-Treatment Phase|Disease related complications|2|||
160459002|NCT03744676|579412740|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
161012960|NCT02287311|581434939|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
161012961|NCT02724956|581434944|FG000|Overall Study|Physician Decision|1|||
161012962|NCT02724956|581434945|FG001|Overall Study|Physician Decision|0|||
161012963|NCT02724956|581434944|FG000|Overall Study|Lack of Efficacy|0|||
161012964|NCT02724956|581434945|FG001|Overall Study|Lack of Efficacy|1|||
161012965|NCT02724956|581434944|FG000|Overall Study|Withdrawal by Subject|0|||
161012966|NCT02724956|581434945|FG001|Overall Study|Withdrawal by Subject|1|||
161012967|NCT04436107|581434951|FG000|Overall Study|Sponsor Ended Study|2|||
161012968|NCT04436107|581434952|FG001|Overall Study|Sponsor Ended Study|4|||
161012969|NCT04436107|581434953|FG002|Overall Study|Sponsor Ended Study|8|||
161012970|NCT04436107|581434954|FG003|Overall Study|Sponsor Ended Study|20|||
161012971|NCT04436107|581434951|FG000|Overall Study|Death|3|||
161012972|NCT04436107|581434952|FG001|Overall Study|Death|5|||
161012973|NCT04436107|581434953|FG002|Overall Study|Death|3|||
161012974|NCT04436107|581434954|FG003|Overall Study|Death|18|||
161012975|NCT04436107|581434951|FG000|Overall Study|Withdrawal by Subject|1|||
161012976|NCT04436107|581434952|FG001|Overall Study|Withdrawal by Subject|1|||
161012977|NCT04436107|581434953|FG002|Overall Study|Withdrawal by Subject|0|||
161012978|NCT04436107|581434954|FG003|Overall Study|Withdrawal by Subject|1|||
161012979|NCT01095796|581434955|FG000|Overall Study|Randomized but Not Treated|5|||
161012980|NCT01095796|581434956|FG001|Overall Study|Randomized but Not Treated|2|||
161012981|NCT01095796|581434955|FG000|Overall Study|Adverse Event|9|||
161012982|NCT01095796|581434956|FG001|Overall Study|Adverse Event|19|||
161012983|NCT01095796|581434955|FG000|Overall Study|Death|3|||
161012984|NCT01095796|581434956|FG001|Overall Study|Death|2|||
161012985|NCT01095796|581434955|FG000|Overall Study|Pregnancy|2|||
161012986|NCT01095796|581434956|FG001|Overall Study|Pregnancy|0|||
161012987|NCT01095796|581434955|FG000|Overall Study|Lack of Efficacy|5|||
161012988|NCT01095796|581434956|FG001|Overall Study|Lack of Efficacy|3|||
161012989|NCT01095796|581434955|FG000|Overall Study|Investigator's Discretion|7|||
161012990|NCT01095796|581434956|FG001|Overall Study|Investigator's Discretion|2|||
161012991|NCT01095796|581434955|FG000|Overall Study|Withdrew Consent|16|||
161012992|NCT01095796|581434956|FG001|Overall Study|Withdrew Consent|22|||
161012993|NCT01095796|581434955|FG000|Overall Study|Lost to Follow-up|27|||
161012994|NCT01095796|581434956|FG001|Overall Study|Lost to Follow-up|29|||
161012995|NCT01095796|581434955|FG000|Overall Study|Participant Noncompliance|5|||
161012996|NCT01095796|581434956|FG001|Overall Study|Participant Noncompliance|10|||
161012997|NCT01095796|581434955|FG000|Overall Study|Protocol Violation|1|||
161012998|NCT01095796|581434956|FG001|Overall Study|Protocol Violation|0|||
161012999|NCT01095796|581434955|FG000|Overall Study|Participant Transferred to Another Study|215|||
161013000|NCT01095796|581434956|FG001|Overall Study|Participant Transferred to Another Study|200|||
161013001|NCT02374307|581434959|FG000|3-months Follow-up|Lost to Follow-up|1|||
161013002|NCT02374307|581434960|FG001|3-months Follow-up|Lost to Follow-up|2|||
161013003|NCT02374307|581434959|FG000|3-months Follow-up|Withdrawal by Subject|1|||
161013004|NCT02374307|581434960|FG001|3-months Follow-up|Withdrawal by Subject|4|||
161013005|NCT02374307|581434959|FG000|3-months Follow-up|Death|1|||
161013006|NCT02374307|581434960|FG001|3-months Follow-up|Death|2|||
161013007|NCT02374307|581434959|FG000|3-months Follow-up|Missed first follow-up|5|||
161013008|NCT02374307|581434960|FG001|3-months Follow-up|Missed first follow-up|1|||
161013009|NCT02374307|581434959|FG000|6-months Follow-up|Lost to Follow-up|1|||
161013010|NCT02374307|581434960|FG001|6-months Follow-up|Lost to Follow-up|2|||
161013011|NCT02374307|581434959|FG000|6-months Follow-up|Death|2|||
161013012|NCT02374307|581434960|FG001|6-months Follow-up|Death|1|||
161013013|NCT02374307|581434959|FG000|6-months Follow-up|Withdrawal by Subject|0|||
161013014|NCT02374307|581434960|FG001|6-months Follow-up|Withdrawal by Subject|3|||
161013015|NCT01989455|581434961|FG000|Overall Study|Adverse Event|0|||
161013016|NCT01989455|581434962|FG001|Overall Study|Adverse Event|1|||
161013017|NCT01989455|581434963|FG002|Overall Study|Adverse Event|0|||
161013018|NCT01989455|581434964|FG003|Overall Study|Adverse Event|0|||
161013019|NCT01989455|581434965|FG004|Overall Study|Adverse Event|0|||
161013020|NCT01989455|581434961|FG000|Overall Study|Withdrawal by Subject|0|||
161013021|NCT01989455|581434962|FG001|Overall Study|Withdrawal by Subject|1|||
161013022|NCT01989455|581434963|FG002|Overall Study|Withdrawal by Subject|0|||
160459003|NCT03744676|579412740|FG000|Pre-Treatment Phase|Death|7|||
160459004|NCT03744676|579412740|FG000|Pre-Treatment Phase|Other Reasons|7|||
160459005|NCT03744676|579412740|FG000|Treatment Phase|Participant withdrew consent|8|||
160459006|NCT03744676|579412740|FG000|Treatment Phase|Death|33|||
160459007|NCT03744676|579412740|FG000|Treatment Phase|other reasons|6|||
160459008|NCT05008055|579412743|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
160459009|NCT05008055|579412744|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
160459010|NCT05008055|579412745|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
160585970|NCT00254293|579863945|FG004|LTE Open Label Fixed Dosing|Death|0|||
161013023|NCT01989455|581434964|FG003|Overall Study|Withdrawal by Subject|0|||
161013024|NCT01989455|581434965|FG004|Overall Study|Withdrawal by Subject|0|||
161013025|NCT01989455|581434961|FG000|Overall Study|Technical problems with infusion|0|||
161013026|NCT01989455|581434962|FG001|Overall Study|Technical problems with infusion|0|||
161013027|NCT01989455|581434963|FG002|Overall Study|Technical problems with infusion|1|||
161013028|NCT01989455|581434964|FG003|Overall Study|Technical problems with infusion|0|||
161013029|NCT01989455|581434965|FG004|Overall Study|Technical problems with infusion|1|||
161013030|NCT00632203|581434966|FG000|Overall Study|Did not start study treatment|1|||
161013031|NCT00632203|581434967|FG001|Overall Study|Did not start study treatment|0|||
161013032|NCT00448669|581434973|FG000|Overall Study|Lost to Follow-up|52|||
160585971|NCT00254293|579863946|FG005|LTE Open Label Fixed Dosing|Death|0|||
160585972|NCT00254293|579863947|FG006|LTE Open Label Fixed Dosing|Death|3|||
160585973|NCT00254293|579863941|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
160585974|NCT00254293|579863942|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
160585975|NCT00254293|579863943|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
160585976|NCT00254293|579863944|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
160585977|NCT00254293|579863945|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
160585978|NCT00254293|579863946|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
160585979|NCT00254293|579863947|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
160585980|NCT00254293|579863941|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
160585981|NCT00254293|579863942|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
160585982|NCT00254293|579863943|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
160585983|NCT00254293|579863944|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
160585984|NCT00254293|579863945|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
160585985|NCT00254293|579863946|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
160585986|NCT00254293|579863947|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
160585987|NCT00254293|579863941|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
160585988|NCT00254293|579863942|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
160585989|NCT00254293|579863943|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
160585990|NCT00254293|579863944|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
160585991|NCT00254293|579863945|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
160585992|NCT00254293|579863946|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
160585993|NCT00254293|579863947|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
160585994|NCT00254293|579863941|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
160585995|NCT00254293|579863942|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
160585996|NCT00254293|579863943|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
160585997|NCT00254293|579863944|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
160585998|NCT00254293|579863945|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
160585999|NCT00254293|579863946|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
160586000|NCT00254293|579863947|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
160586001|NCT00254293|579863941|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
160586002|NCT00254293|579863942|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
160586003|NCT00254293|579863943|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
160586004|NCT00254293|579863944|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
160586005|NCT00254293|579863945|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161013033|NCT00448669|581434974|FG001|Overall Study|Lost to Follow-up|63|||
161013034|NCT00448669|581434973|FG000|Overall Study|Withdrawal by Subject|90|||
161013035|NCT00448669|581434974|FG001|Overall Study|Withdrawal by Subject|74|||
161013036|NCT00448669|581434973|FG000|Overall Study|Relocated|49|||
161013037|NCT00448669|581434974|FG001|Overall Study|Relocated|36|||
161013038|NCT00448669|581434973|FG000|Overall Study|Were withdrawn by investigator|10|||
161013039|NCT00448669|581434974|FG001|Overall Study|Were withdrawn by investigator|6|||
161013040|NCT00448669|581434973|FG000|Overall Study|Death|2|||
161013041|NCT00448669|581434974|FG001|Overall Study|Death|4|||
161013042|NCT00448669|581434973|FG000|Overall Study|Had other reasons|5|||
161013043|NCT00448669|581434974|FG001|Overall Study|Had other reasons|6|||
161013044|NCT00448669|581434973|FG000|Overall Study|HIV-infected at enrollment|1|||
161013045|NCT00448669|581434974|FG001|Overall Study|HIV-infected at enrollment|2|||
161013046|NCT00448669|581434973|FG000|Overall Study|Never started drug|9|||
161013047|NCT00448669|581434974|FG001|Overall Study|Never started drug|7|||
161013048|NCT04287985|581434975|FG000|Overall Study|Adverse Event|1|||
161013049|NCT04287985|581434976|FG001|Overall Study|Adverse Event|0|||
161013050|NCT04287985|581434977|FG002|Overall Study|Adverse Event|0|||
161013051|NCT04287985|581434978|FG003|Overall Study|Adverse Event|0|||
161013052|NCT04287985|581434975|FG000|Overall Study|Protocol Violation|0|||
161013053|NCT04287985|581434976|FG001|Overall Study|Protocol Violation|1|||
161013054|NCT04287985|581434977|FG002|Overall Study|Protocol Violation|0|||
161013055|NCT04287985|581434978|FG003|Overall Study|Protocol Violation|0|||
161013056|NCT04287985|581434975|FG000|Overall Study|Physician Decision|0|||
161013057|NCT04287985|581434976|FG001|Overall Study|Physician Decision|0|||
161013058|NCT04287985|581434977|FG002|Overall Study|Physician Decision|0|||
161013059|NCT04287985|581434978|FG003|Overall Study|Physician Decision|1|||
161013060|NCT04287985|581434975|FG000|Overall Study|Withdrawal by Subject|2|||
161013061|NCT04287985|581434976|FG001|Overall Study|Withdrawal by Subject|1|||
161013062|NCT04287985|581434977|FG002|Overall Study|Withdrawal by Subject|1|||
161013063|NCT04287985|581434978|FG003|Overall Study|Withdrawal by Subject|2|||
160586006|NCT00254293|579863946|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
160586007|NCT00254293|579863947|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
160586008|NCT00254293|579863941|FG000|LTE Open Label Fixed Dosing|Other|0|||
160586009|NCT00254293|579863942|FG001|LTE Open Label Fixed Dosing|Other|0|||
160586010|NCT00254293|579863943|FG002|LTE Open Label Fixed Dosing|Other|0|||
160586011|NCT00254293|579863944|FG003|LTE Open Label Fixed Dosing|Other|0|||
161013064|NCT02638337|581434983|FG000|Overall Study|Adverse Event|6|||
161013065|NCT02638337|581434984|FG001|Overall Study|Adverse Event|10|||
161013066|NCT02638337|581434983|FG000|Overall Study|Protocol Violation|3|||
161013067|NCT02638337|581434984|FG001|Overall Study|Protocol Violation|0|||
161013068|NCT02638337|581434983|FG000|Overall Study|Withdrawal by Subject|13|||
161013069|NCT02638337|581434984|FG001|Overall Study|Withdrawal by Subject|16|||
161013070|NCT02638337|581434983|FG000|Overall Study|Lost to Follow-up|7|||
161013071|NCT02638337|581434984|FG001|Overall Study|Lost to Follow-up|7|||
161013072|NCT02638337|581434983|FG000|Overall Study|Other - Miscellaneous|4|||
161013073|NCT02638337|581434984|FG001|Overall Study|Other - Miscellaneous|3|||
161013074|NCT00604669|581434985|FG000|Overall Study|lack of information in chart|7|||
161013075|NCT01340066|581434986|FG000|Placebo Run in Period|Screen Failures|27|||
161013076|NCT01340066|581434987|FG001|Placebo Run in Period|Screen Failures|0|||
161013077|NCT01340066|581434988|FG002|Placebo Run in Period|Screen Failures|0|||
161013078|NCT01340066|581434986|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
161013079|NCT01340066|581434987|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
161013080|NCT01340066|581434988|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
161013081|NCT01340066|581434986|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
161013082|NCT01340066|581434987|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
161013083|NCT01340066|581434988|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
161013084|NCT01340066|581434986|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
161013085|NCT01340066|581434987|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
161013086|NCT01340066|581434988|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
161013087|NCT03771352|581434996|FG000|Overall Study|Screen failure|2|||
161013088|NCT03771352|581434996|FG000|Overall Study|Withdrawal by Subject|2|||
161013089|NCT04315181|581434997|FG000|Overall Study|Non-responsive to drug conditions.|1|||
161013090|NCT01948661|581434998|FG000|Overall Study|Withdrawal by Subject|2|||
161013091|NCT01948661|581434999|FG001|Overall Study|Withdrawal by Subject|4|||
161013092|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Adverse Event|4|||
161013093|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Adverse Event|1|||
161013094|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
161013095|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
161013096|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
161013097|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
161013098|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
161013099|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
161013100|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
161013101|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
161013102|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Other|6|||
161013103|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Other|1|||
161013104|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Missing|1|||
161013105|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Missing|0|||
161013106|NCT03271489|581435000|FG000|Open-Label (OL) Period|Adverse Event|2|||
161013107|NCT03271489|581435001|FG001|Open-Label (OL) Period|Adverse Event|0|||
161013108|NCT03271489|581435000|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
161013109|NCT03271489|581435001|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
161013110|NCT03271489|581435000|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
161013111|NCT03271489|581435001|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
161013112|NCT03271489|581435000|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
161013113|NCT03271489|581435001|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
161013114|NCT03271489|581435000|FG000|Open-Label (OL) Period|No Specified|2|||
161013115|NCT03271489|581435001|FG001|Open-Label (OL) Period|No Specified|2|||
161013116|NCT03271489|581435000|FG000|Open-Label (OL) Period|Missing|2|||
161013117|NCT03271489|581435001|FG001|Open-Label (OL) Period|Missing|0|||
161013118|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
161013119|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
161013120|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
161013121|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
161013122|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
161013123|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
161013124|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
161013125|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
161013126|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
161013127|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
161013128|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
161013129|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
161013130|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
160459011|NCT03636490|579413504|FG000|Overall Study|Dropped out or incomplete data|141|||
160459012|NCT04165213|579413514|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
160459013|NCT04165213|579413515|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
161013131|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
161013132|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
161013133|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
161013134|NCT01127373|581435002|FG000|Overall Study|Not Treated|3|||
161013135|NCT01127373|581435002|FG000|Overall Study|Lost to Follow-up|7|||
161013136|NCT01127373|581435002|FG000|Overall Study|Withdrawal by Subject|1|||
161013137|NCT01127373|581435002|FG000|Overall Study|Disease progression|1|||
161013138|NCT00522951|581435005|FG000|Period 1|body motion|0|||
161013139|NCT00522951|581435006|FG001|Period 1|body motion|1|||
161013140|NCT00522951|581435005|FG000|Washout Period|Adverse Event|0|||
161013141|NCT00522951|581435006|FG001|Washout Period|Adverse Event|1|||
161013142|NCT00522951|581435005|FG000|Washout Period|Death|0|||
161013143|NCT00522951|581435006|FG001|Washout Period|Death|1|||
161013144|NCT00522951|581435005|FG000|Period 2|Withdrawal by Subject|1|||
161013145|NCT00522951|581435006|FG001|Period 2|Withdrawal by Subject|0|||
161013146|NCT00522951|581435005|FG000|Period 2|residual contrast medium|1|||
161013147|NCT00522951|581435006|FG001|Period 2|residual contrast medium|1|||
161013148|NCT00136435|581435010|FG000|Overall Study|Ineligible|8|||
161013149|NCT00136435|581435010|FG000|Overall Study|Induction Death|1|||
161013150|NCT00136435|581435010|FG000|Overall Study|Induction Failure|10|||
161013151|NCT00136435|581435010|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
161013152|NCT00136435|581435010|FG000|Overall Study|Withdrawal by Subject|3|||
161013153|NCT00136435|581435010|FG000|Overall Study|Adverse Event|19|||
161013154|NCT00136435|581435010|FG000|Overall Study|Relapse|4|||
161013155|NCT00136435|581435010|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
161013156|NCT00390299|581435015|FG000|Overall Study|Cancellation|1|||
161013157|NCT00390299|581435016|FG001|Overall Study|Cancellation|0|||
161013158|NCT00390299|581435017|FG002|Overall Study|Cancellation|0|||
161013159|NCT00390299|581435018|FG003|Overall Study|Cancellation|0|||
161013160|NCT00390299|581435019|FG004|Overall Study|Cancellation|0|||
161013161|NCT00539734|581435021|FG000|Overall Study|Protocol Violation|1|||
161013162|NCT01070069|581435022|FG000|Overall Study|Death|1|||
161013163|NCT01070069|581435023|FG001|Overall Study|Death|0|||
161013164|NCT01070069|581435024|FG002|Overall Study|Death|2|||
161013165|NCT01070069|581435025|FG003|Overall Study|Death|0|||
161013166|NCT01070069|581435026|FG004|Overall Study|Death|1|||
161013167|NCT01070069|581435022|FG000|Overall Study|Withdrawal by Subject|1|||
161013168|NCT01070069|581435023|FG001|Overall Study|Withdrawal by Subject|1|||
161013169|NCT01070069|581435024|FG002|Overall Study|Withdrawal by Subject|4|||
161013170|NCT01070069|581435025|FG003|Overall Study|Withdrawal by Subject|0|||
161013171|NCT01070069|581435026|FG004|Overall Study|Withdrawal by Subject|0|||
161013172|NCT01070069|581435022|FG000|Overall Study|Lost to Follow-up|4|||
161013173|NCT01070069|581435023|FG001|Overall Study|Lost to Follow-up|1|||
161013174|NCT01070069|581435024|FG002|Overall Study|Lost to Follow-up|0|||
161013175|NCT01070069|581435025|FG003|Overall Study|Lost to Follow-up|0|||
161013176|NCT01070069|581435026|FG004|Overall Study|Lost to Follow-up|3|||
161013177|NCT03101930|581435027|FG000|Overall Study|Withdrawal by Subject|2|||
161013178|NCT03101930|581435028|FG001|Overall Study|Withdrawal by Subject|1|||
161013179|NCT03101930|581435029|FG002|Overall Study|Withdrawal by Subject|2|||
161013180|NCT02814838|581435030|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
161013181|NCT02814838|581435031|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
161013182|NCT02814838|581435030|FG000|Overall Study|Consent withdrawal|1|||
161013183|NCT02814838|581435031|FG001|Overall Study|Consent withdrawal|1|||
161013184|NCT01771731|581435035|FG000|Overall Study|Physician Decision|1|||
161013185|NCT01771731|581435036|FG001|Overall Study|Physician Decision|0|||
161013186|NCT01771731|581435035|FG000|Overall Study|Protocol Violation|0|||
161013187|NCT01771731|581435036|FG001|Overall Study|Protocol Violation|1|||
161013188|NCT01771731|581435035|FG000|Overall Study|Adverse event: Pain Crisis|1|||
161013189|NCT01771731|581435036|FG001|Overall Study|Adverse event: Pain Crisis|1|||
161013190|NCT00087139|581435037|FG000|Overall Study|Adverse Event|18|||
161013191|NCT00087139|581435038|FG001|Overall Study|Adverse Event|17|||
161013192|NCT00087139|581435039|FG002|Overall Study|Adverse Event|13|||
161013193|NCT00087139|581435037|FG000|Overall Study|Death|2|||
161013194|NCT00087139|581435038|FG001|Overall Study|Death|1|||
161013195|NCT00087139|581435039|FG002|Overall Study|Death|0|||
161013196|NCT00087139|581435037|FG000|Overall Study|Withdrawal by Subject|3|||
161013197|NCT00087139|581435038|FG001|Overall Study|Withdrawal by Subject|2|||
161013198|NCT00087139|581435039|FG002|Overall Study|Withdrawal by Subject|2|||
161013199|NCT00087139|581435037|FG000|Overall Study|Physician Decision|1|||
161013200|NCT00087139|581435038|FG001|Overall Study|Physician Decision|1|||
161013201|NCT00087139|581435039|FG002|Overall Study|Physician Decision|1|||
161013202|NCT00087139|581435037|FG000|Overall Study|Disease progression|9|||
161013203|NCT00087139|581435038|FG001|Overall Study|Disease progression|19|||
161013204|NCT00087139|581435039|FG002|Overall Study|Disease progression|12|||
161013205|NCT00087139|581435037|FG000|Overall Study|Ineligible|4|||
161013206|NCT00087139|581435038|FG001|Overall Study|Ineligible|7|||
160459014|NCT04165213|579413514|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
161013207|NCT00087139|581435039|FG002|Overall Study|Ineligible|4|||
161013208|NCT00087139|581435037|FG000|Overall Study|Symptomatic deterioration|1|||
161013209|NCT00087139|581435038|FG001|Overall Study|Symptomatic deterioration|1|||
160586012|NCT00254293|579863945|FG004|LTE Open Label Fixed Dosing|Other|0|||
160586013|NCT00254293|579863946|FG005|LTE Open Label Fixed Dosing|Other|0|||
160586014|NCT00254293|579863947|FG006|LTE Open Label Fixed Dosing|Other|1|||
160586015|NCT01697267|579863951|FG000|Overall Study|Death|3|||
160586016|NCT01697267|579863952|FG001|Overall Study|Death|1|||
160586017|NCT01697267|579863951|FG000|Overall Study|Withdrawal by Subject|5|||
160586018|NCT01697267|579863952|FG001|Overall Study|Withdrawal by Subject|5|||
160586019|NCT01697267|579863951|FG000|Overall Study|Adverse Event|2|||
160586020|NCT01697267|579863952|FG001|Overall Study|Adverse Event|1|||
160586021|NCT01697267|579863951|FG000|Overall Study|Lost to Follow-up|2|||
160586022|NCT01697267|579863952|FG001|Overall Study|Lost to Follow-up|4|||
160586023|NCT01697267|579863951|FG000|Overall Study|Physician Decision|2|||
160586024|NCT01697267|579863952|FG001|Overall Study|Physician Decision|4|||
160586025|NCT03544268|579863953|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
161013210|NCT00087139|581435039|FG002|Overall Study|Symptomatic deterioration|3|||
161013211|NCT00087139|581435037|FG000|Overall Study|Use of coumadin|1|||
161013212|NCT00087139|581435038|FG001|Overall Study|Use of coumadin|0|||
161013213|NCT00087139|581435039|FG002|Overall Study|Use of coumadin|0|||
161013214|NCT00087139|581435037|FG000|Overall Study|Response achieved|0|||
161013215|NCT00087139|581435038|FG001|Overall Study|Response achieved|1|||
161013216|NCT00087139|581435039|FG002|Overall Study|Response achieved|0|||
161013217|NCT00087139|581435037|FG000|Overall Study|Extradural disease|0|||
161013218|NCT00087139|581435038|FG001|Overall Study|Extradural disease|0|||
161013219|NCT00087139|581435039|FG002|Overall Study|Extradural disease|1|||
161013220|NCT04095104|581435047|FG000|Overall Study|Withdrawal by Subject|0|||
161013221|NCT04095104|581435048|FG001|Overall Study|Withdrawal by Subject|1|||
161013222|NCT01136876|581435049|FG000|Overall Study|Lost to Follow-up|0|||
161013223|NCT01136876|581435050|FG001|Overall Study|Lost to Follow-up|1|||
161013224|NCT01136876|581435049|FG000|Overall Study|Physician Decision|3|||
161013225|NCT01136876|581435050|FG001|Overall Study|Physician Decision|5|||
161013226|NCT01136876|581435049|FG000|Overall Study|Missing NGAL measurement|2|||
161013227|NCT01136876|581435050|FG001|Overall Study|Missing NGAL measurement|5|||
161013228|NCT05321069|581435051|FG000|Overall Study|Adverse Event|52|||
161013229|NCT05321069|581435052|FG001|Overall Study|Adverse Event|52|||
161013230|NCT05321069|581435053|FG002|Overall Study|Adverse Event|64|||
161013231|NCT05321069|581435051|FG000|Overall Study|Protocol Violation|1|||
161013232|NCT05321069|581435052|FG001|Overall Study|Protocol Violation|1|||
161013233|NCT05321069|581435053|FG002|Overall Study|Protocol Violation|0|||
161013234|NCT05321069|581435051|FG000|Overall Study|Withdrawal by Subject|23|||
161013235|NCT05321069|581435052|FG001|Overall Study|Withdrawal by Subject|18|||
161013236|NCT05321069|581435053|FG002|Overall Study|Withdrawal by Subject|12|||
161013237|NCT05321069|581435051|FG000|Overall Study|Lost to Follow-up|1|||
161013238|NCT05321069|581435052|FG001|Overall Study|Lost to Follow-up|0|||
161013239|NCT05321069|581435053|FG002|Overall Study|Lost to Follow-up|1|||
161013240|NCT05321069|581435051|FG000|Overall Study|No reason stated by the participants|23|||
161013241|NCT05321069|581435052|FG001|Overall Study|No reason stated by the participants|22|||
161013242|NCT05321069|581435053|FG002|Overall Study|No reason stated by the participants|16|||
161013243|NCT05321069|581435051|FG000|Overall Study|Lack of Efficacy|1|||
161013244|NCT05321069|581435052|FG001|Overall Study|Lack of Efficacy|1|||
161013245|NCT05321069|581435053|FG002|Overall Study|Lack of Efficacy|0|||
161013246|NCT05048186|581435056|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
161013247|NCT05048186|581435057|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
161013248|NCT05048186|581435056|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
161013249|NCT05048186|581435057|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
161013250|NCT02412748|581435060|FG000|Overall Study|Lost to Follow-up|38|||
161013251|NCT02412748|581435061|FG001|Overall Study|Lost to Follow-up|39|||
161013252|NCT00976937|581435062|FG000|Overall Study|Adverse Event|4|||
161013253|NCT00976937|581435063|FG001|Overall Study|Adverse Event|5|||
161013254|NCT00976937|581435062|FG000|Overall Study|Lost to Follow-up|2|||
161013255|NCT00976937|581435063|FG001|Overall Study|Lost to Follow-up|1|||
161013256|NCT00976937|581435062|FG000|Overall Study|Withdrawal by Subject|5|||
161013257|NCT00976937|581435063|FG001|Overall Study|Withdrawal by Subject|3|||
161013258|NCT00976937|581435062|FG000|Overall Study|Poor compliance to protocol|3|||
161013259|NCT00976937|581435063|FG001|Overall Study|Poor compliance to protocol|0|||
161013260|NCT00976937|581435062|FG000|Overall Study|Personal and Familial Reason|2|||
161013261|NCT00976937|581435063|FG001|Overall Study|Personal and Familial Reason|2|||
161013262|NCT04218266|581435064|FG000|Overall Study|Death|1|||
161013263|NCT04218266|581435065|FG001|Overall Study|Death|2|||
160586026|NCT03544268|579863954|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
160586027|NCT02796391|579863960|FG000|Overall Study|Lost to Follow-up|2|||
160657033|NCT05097989|580124503|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161013264|NCT04218266|581435066|FG002|Overall Study|Death|3|||
161013265|NCT04218266|581435064|FG000|Overall Study|Adverse Event|13|||
161013266|NCT04218266|581435065|FG001|Overall Study|Adverse Event|14|||
160586028|NCT02796391|579863961|FG001|Overall Study|Lost to Follow-up|2|||
161013267|NCT04218266|581435066|FG002|Overall Study|Adverse Event|11|||
160586029|NCT02796391|579863962|FG002|Overall Study|Lost to Follow-up|13|||
160586030|NCT02796391|579863963|FG003|Overall Study|Lost to Follow-up|8|||
160586031|NCT02796391|579863964|FG004|Overall Study|Lost to Follow-up|14|||
160586032|NCT02796391|579863965|FG005|Overall Study|Lost to Follow-up|13|||
161013268|NCT04218266|581435064|FG000|Overall Study|Other|7|||
161013269|NCT04218266|581435065|FG001|Overall Study|Other|5|||
161013270|NCT04218266|581435066|FG002|Overall Study|Other|14|||
161013271|NCT04218266|581435064|FG000|Overall Study|Physician Decision|1|||
161013272|NCT04218266|581435065|FG001|Overall Study|Physician Decision|3|||
161013273|NCT04218266|581435066|FG002|Overall Study|Physician Decision|2|||
161013274|NCT04218266|581435064|FG000|Overall Study|Non-compliance with study drug|0|||
161013275|NCT04218266|581435065|FG001|Overall Study|Non-compliance with study drug|0|||
161013276|NCT04218266|581435066|FG002|Overall Study|Non-compliance with study drug|1|||
161013277|NCT04218266|581435064|FG000|Overall Study|Withdrawal by Subject|1|||
161013278|NCT04218266|581435065|FG001|Overall Study|Withdrawal by Subject|3|||
161013279|NCT04218266|581435066|FG002|Overall Study|Withdrawal by Subject|1|||
161013280|NCT04218266|581435064|FG000|Overall Study|Study drug never administered|2|||
161013281|NCT04218266|581435065|FG001|Overall Study|Study drug never administered|0|||
161013282|NCT04218266|581435066|FG002|Overall Study|Study drug never administered|0|||
161013283|NCT01044303|581435067|FG000|Overall Study|Lost to Follow-up|2|||
161013284|NCT01424670|581435068|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
161013285|NCT01424670|581435069|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
161013286|NCT01424670|581435068|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
161013287|NCT01424670|581435069|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
161013288|NCT01424670|581435068|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
161013289|NCT01424670|581435069|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
161013290|NCT01424670|581435068|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
161013291|NCT01424670|581435069|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
161013292|NCT01424670|581435068|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
161013293|NCT01424670|581435069|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
161013294|NCT01424670|581435068|FG000|Continuation Period|Adverse Event|13|||
161013295|NCT01424670|581435069|FG001|Continuation Period|Adverse Event|5|||
161013296|NCT01424670|581435068|FG000|Continuation Period|Lost to Follow-up|2|||
161013297|NCT01424670|581435069|FG001|Continuation Period|Lost to Follow-up|0|||
161013298|NCT01424670|581435068|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
161013299|NCT01424670|581435069|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
161013300|NCT01424670|581435068|FG000|Continuation Period|Physician Decision|5|||
161013301|NCT01424670|581435069|FG001|Continuation Period|Physician Decision|4|||
161013302|NCT01424670|581435068|FG000|Continuation Period|Withdrawal by Subject|13|||
161013303|NCT01424670|581435069|FG001|Continuation Period|Withdrawal by Subject|4|||
161013304|NCT00761189|581435070|FG000|Overall Study|Adverse Event|42|||
161013305|NCT00761189|581435070|FG000|Overall Study|Lack of Efficacy|45|||
161013306|NCT00761189|581435070|FG000|Overall Study|Lost to Follow-up|36|||
161013307|NCT00761189|581435070|FG000|Overall Study|Withdrawal by Subject|49|||
161013308|NCT00761189|581435070|FG000|Overall Study|Other|13|||
161013309|NCT04377308|581435071|FG000|Overall Study|Withdrawal by Subject|0|||
161013310|NCT04377308|581435072|FG001|Overall Study|Withdrawal by Subject|1|||
161013311|NCT01494922|581435073|FG000|Overall Study|Adverse Event|1|||
161013312|NCT00709098|581435081|FG000|Double-blind Period|Withdrawal of consent|3|||
161013313|NCT00709098|581435082|FG001|Double-blind Period|Withdrawal of consent|3|||
161013314|NCT00709098|581435083|FG002|Double-blind Period|Withdrawal of consent|0|||
161013315|NCT00709098|581435081|FG000|Double-blind Period|Administrative reason|1|||
161013316|NCT00709098|581435082|FG001|Double-blind Period|Administrative reason|3|||
161013317|NCT00709098|581435083|FG002|Double-blind Period|Administrative reason|0|||
161013318|NCT00709098|581435081|FG000|Double-blind Period|Death|1|||
161013319|NCT00709098|581435082|FG001|Double-blind Period|Death|1|||
161013320|NCT00709098|581435083|FG002|Double-blind Period|Death|0|||
161013321|NCT00709098|581435081|FG000|Double-blind Period|Lost to Follow-up|1|||
161013322|NCT00709098|581435082|FG001|Double-blind Period|Lost to Follow-up|1|||
160459015|NCT04165213|579413515|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
160459016|NCT04165213|579413514|FG000|Clinician Enrollment|Termination from site|0|||
160586033|NCT02796391|579863960|FG000|Overall Study|COVID|0|||
160586034|NCT02796391|579863961|FG001|Overall Study|COVID|0|||
160586035|NCT02796391|579863962|FG002|Overall Study|COVID|5|||
160586036|NCT02796391|579863963|FG003|Overall Study|COVID|5|||
160586037|NCT02796391|579863964|FG004|Overall Study|COVID|2|||
160586038|NCT02796391|579863965|FG005|Overall Study|COVID|4|||
161013323|NCT00709098|581435083|FG002|Double-blind Period|Lost to Follow-up|0|||
161013324|NCT00709098|581435081|FG000|Open-label Period|Withdrawal of consent|0|||
160459017|NCT04165213|579413515|FG001|Clinician Enrollment|Termination from site|1|||
160586039|NCT02796391|579863960|FG000|Overall Study|Participant did not like study cigarettes|0|||
160586040|NCT02796391|579863961|FG001|Overall Study|Participant did not like study cigarettes|0|||
161013325|NCT00709098|581435082|FG001|Open-label Period|Withdrawal of consent|0|||
161013326|NCT00709098|581435083|FG002|Open-label Period|Withdrawal of consent|7|||
161013327|NCT00709098|581435081|FG000|Open-label Period|Administrative reason|0|||
161013328|NCT00709098|581435082|FG001|Open-label Period|Administrative reason|0|||
161013329|NCT00709098|581435083|FG002|Open-label Period|Administrative reason|5|||
161013330|NCT00709098|581435081|FG000|Open-label Period|Death|0|||
161013331|NCT00709098|581435082|FG001|Open-label Period|Death|0|||
161013332|NCT00709098|581435083|FG002|Open-label Period|Death|1|||
161013333|NCT00709098|581435081|FG000|Open-label Period|Lost to Follow-up|0|||
161013334|NCT00709098|581435082|FG001|Open-label Period|Lost to Follow-up|0|||
161013335|NCT00709098|581435083|FG002|Open-label Period|Lost to Follow-up|1|||
161013336|NCT01227265|581435084|FG000|Overall Study|Did Not Receive Treatment|1|||
161013337|NCT01227265|581435085|FG001|Overall Study|Did Not Receive Treatment|2|||
161013338|NCT01227265|581435086|FG002|Overall Study|Did Not Receive Treatment|0|||
161013339|NCT01227265|581435084|FG000|Overall Study|Administrative|1|||
161013340|NCT01227265|581435085|FG001|Overall Study|Administrative|0|||
161013341|NCT01227265|581435086|FG002|Overall Study|Administrative|2|||
161013342|NCT01227265|581435084|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161013343|NCT01227265|581435085|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
161013344|NCT01227265|581435086|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
161013345|NCT01227265|581435084|FG000|Overall Study|Protocol Violation|2|||
161013346|NCT01227265|581435085|FG001|Overall Study|Protocol Violation|1|||
161013347|NCT01227265|581435086|FG002|Overall Study|Protocol Violation|0|||
161013348|NCT01227265|581435084|FG000|Overall Study|Withdrawal by Subject|7|||
161013349|NCT01227265|581435085|FG001|Overall Study|Withdrawal by Subject|7|||
161013350|NCT01227265|581435086|FG002|Overall Study|Withdrawal by Subject|3|||
161013351|NCT01227265|581435084|FG000|Overall Study|Lost to Follow-up|2|||
161013352|NCT01227265|581435085|FG001|Overall Study|Lost to Follow-up|0|||
161013353|NCT01227265|581435086|FG002|Overall Study|Lost to Follow-up|3|||
161013354|NCT01227265|581435084|FG000|Overall Study|Adverse Event|6|||
161013355|NCT01227265|581435085|FG001|Overall Study|Adverse Event|10|||
161013356|NCT01227265|581435086|FG002|Overall Study|Adverse Event|5|||
161013357|NCT06024174|581435088|FG000|Overall Study|Other Reasons|1|||
161013358|NCT06024174|581435088|FG000|Overall Study|Study terminated by Sponsor|4|||
161013359|NCT04994509|581435089|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
161013360|NCT04994509|581435090|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
161013361|NCT04994509|581435091|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
161013362|NCT04994509|581435089|FG000|Overall Study|Withdrew Consent|73|||
161013363|NCT04994509|581435090|FG001|Overall Study|Withdrew Consent|72|||
161013364|NCT04994509|581435091|FG002|Overall Study|Withdrew Consent|46|||
161013365|NCT04994509|581435089|FG000|Overall Study|Lost to Follow-up|39|||
161013366|NCT04994509|581435090|FG001|Overall Study|Lost to Follow-up|36|||
161013367|NCT04994509|581435091|FG002|Overall Study|Lost to Follow-up|26|||
161013368|NCT04994509|581435089|FG000|Overall Study|HIV-1 Infection|4|||
161013369|NCT04994509|581435090|FG001|Overall Study|HIV-1 Infection|20|||
161013370|NCT04994509|581435091|FG002|Overall Study|HIV-1 Infection|12|||
161013371|NCT04994509|581435089|FG000|Overall Study|Investigator's Discretion|9|||
161013372|NCT04994509|581435090|FG001|Overall Study|Investigator's Discretion|8|||
161013373|NCT04994509|581435091|FG002|Overall Study|Investigator's Discretion|11|||
161013374|NCT04994509|581435089|FG000|Overall Study|Randomized but Never Treated|10|||
161013375|NCT04994509|581435090|FG001|Overall Study|Randomized but Never Treated|10|||
161013376|NCT04994509|581435091|FG002|Overall Study|Randomized but Never Treated|3|||
161013377|NCT04994509|581435089|FG000|Overall Study|Pregnancy|5|||
161013378|NCT04994509|581435090|FG001|Overall Study|Pregnancy|5|||
161013379|NCT04994509|581435091|FG002|Overall Study|Pregnancy|0|||
161013380|NCT04994509|581435089|FG000|Overall Study|Death|0|||
161013381|NCT04994509|581435090|FG001|Overall Study|Death|5|||
161013382|NCT04994509|581435091|FG002|Overall Study|Death|0|||
161013383|NCT04994509|581435089|FG000|Overall Study|Adverse Event|2|||
161013384|NCT04994509|581435090|FG001|Overall Study|Adverse Event|1|||
161013385|NCT04994509|581435091|FG002|Overall Study|Adverse Event|0|||
161013386|NCT04994509|581435089|FG000|Overall Study|Non-compliance With Study Drug|1|||
161013387|NCT04994509|581435090|FG001|Overall Study|Non-compliance With Study Drug|1|||
161013388|NCT04994509|581435091|FG002|Overall Study|Non-compliance With Study Drug|1|||
161013389|NCT04994509|581435089|FG000|Overall Study|Withdrew Assent|3|||
161013390|NCT04994509|581435090|FG001|Overall Study|Withdrew Assent|0|||
161013391|NCT04994509|581435091|FG002|Overall Study|Withdrew Assent|0|||
161013392|NCT04994509|581435089|FG000|Overall Study|Protocol Violation|1|||
161013393|NCT04994509|581435090|FG001|Overall Study|Protocol Violation|0|||
161013394|NCT04994509|581435091|FG002|Overall Study|Protocol Violation|0|||
161013395|NCT04402294|581435093|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
161013396|NCT04402294|581435094|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
161013397|NCT04402294|581435093|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
161013398|NCT04402294|581435094|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
161013399|NCT04924062|581437598|FG000|Overall Study|Death|49|||
161013400|NCT04924062|581437599|FG001|Overall Study|Death|63|||
161013401|NCT04924062|581437598|FG000|Overall Study|Participant On-going|26|||
161013402|NCT04924062|581437599|FG001|Overall Study|Participant On-going|20|||
161013403|NCT03845465|581437600|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
161013404|NCT03845465|581437601|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
161013405|NCT03845465|581437600|FG000|6-month Data Collection|Withdrawal by Subject|0|||
161013406|NCT03845465|581437601|FG001|6-month Data Collection|Withdrawal by Subject|2|||
161013407|NCT03845465|581437600|FG000|12-month Data Collection|Withdrawal by Subject|0|||
161013408|NCT03845465|581437601|FG001|12-month Data Collection|Withdrawal by Subject|2|||
161013409|NCT03547908|581437604|FG000|Blinded Phase|Lost to Follow-up|3|||
161013410|NCT03547908|581437605|FG001|Blinded Phase|Lost to Follow-up|3|||
161013411|NCT03547908|581437606|FG002|Blinded Phase|Lost to Follow-up|0|||
161013412|NCT03547908|581437607|FG003|Blinded Phase|Lost to Follow-up|0|||
161013413|NCT03547908|581437604|FG000|Blinded Phase|Withdrew Consent|2|||
161013414|NCT03547908|581437605|FG001|Blinded Phase|Withdrew Consent|3|||
161013415|NCT03547908|581437606|FG002|Blinded Phase|Withdrew Consent|0|||
161013416|NCT03547908|581437607|FG003|Blinded Phase|Withdrew Consent|0|||
161013417|NCT03547908|581437604|FG000|Blinded Phase|Investigator's Discretion|2|||
161013418|NCT03547908|581437605|FG001|Blinded Phase|Investigator's Discretion|1|||
161013419|NCT03547908|581437606|FG002|Blinded Phase|Investigator's Discretion|0|||
161013420|NCT03547908|581437607|FG003|Blinded Phase|Investigator's Discretion|0|||
161013421|NCT03547908|581437604|FG000|Blinded Phase|Death|2|||
161013422|NCT03547908|581437605|FG001|Blinded Phase|Death|0|||
161013423|NCT03547908|581437606|FG002|Blinded Phase|Death|0|||
161013424|NCT03547908|581437607|FG003|Blinded Phase|Death|0|||
161013425|NCT03547908|581437604|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
161013426|NCT03547908|581437605|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
161013427|NCT03547908|581437606|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
161013428|NCT03547908|581437607|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
161013429|NCT03547908|581437604|FG000|Blinded Phase|Adverse Event|1|||
161013430|NCT03547908|581437605|FG001|Blinded Phase|Adverse Event|0|||
161013431|NCT03547908|581437606|FG002|Blinded Phase|Adverse Event|0|||
161013432|NCT03547908|581437607|FG003|Blinded Phase|Adverse Event|0|||
161013433|NCT03547908|581437604|FG000|Blinded Phase|Randomized But Never Treated|1|||
161013434|NCT03547908|581437605|FG001|Blinded Phase|Randomized But Never Treated|0|||
161013435|NCT03547908|581437606|FG002|Blinded Phase|Randomized But Never Treated|0|||
161013436|NCT03547908|581437607|FG003|Blinded Phase|Randomized But Never Treated|0|||
161013437|NCT03547908|581437604|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
161013438|NCT03547908|581437605|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
161013439|NCT03547908|581437606|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
161013440|NCT03547908|581437607|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
161013441|NCT03547908|581437604|FG000|Open-label Extension Phase|Death|0|||
161013442|NCT03547908|581437605|FG001|Open-label Extension Phase|Death|0|||
161013443|NCT03547908|581437606|FG002|Open-label Extension Phase|Death|1|||
161013444|NCT03547908|581437607|FG003|Open-label Extension Phase|Death|0|||
161013445|NCT04059354|581437610|FG000|Overall Study|COVID-19 pandemic|3|||
161013446|NCT02349412|581437612|FG000|Overall Study|Withdrawal by Subject|7|||
161013447|NCT02349412|581437613|FG001|Overall Study|Withdrawal by Subject|7|||
161013448|NCT00979576|581437616|FG000|Combination Treatment Phase|Progressive disease|3|||
161013449|NCT00979576|581437617|FG001|Combination Treatment Phase|Progressive disease|1|||
161013450|NCT00979576|581437618|FG002|Combination Treatment Phase|Progressive disease|5|||
161013451|NCT00979576|581437616|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
161013452|NCT00979576|581437617|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
161013453|NCT00979576|581437618|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
161013454|NCT00979576|581437616|FG000|Combination Treatment Phase|Adverse Event|0|||
161013455|NCT00979576|581437617|FG001|Combination Treatment Phase|Adverse Event|2|||
161013456|NCT00979576|581437618|FG002|Combination Treatment Phase|Adverse Event|2|||
161013457|NCT00979576|581437616|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
161013458|NCT00979576|581437617|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
161013459|NCT00979576|581437618|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
161013460|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
161013461|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161013462|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161013463|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161013464|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
160459018|NCT04165213|579413514|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
160459019|NCT04165213|579413515|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
161013465|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
161013466|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
161013467|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
161013468|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
161013469|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
161013470|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
161013471|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
161013472|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
160459020|NCT04165213|579413514|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
161013473|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
161013474|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
161013475|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
161013476|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161013477|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161013478|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161013479|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161013480|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
161013481|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
161013482|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
161013483|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
161013484|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
161013485|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
161013486|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
161013487|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
161013488|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
161013489|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
161013490|NCT05338086|581437619|FG000|Transition Period (M12 to M18)|Death|0|||
161013491|NCT05338086|581437620|FG001|Transition Period (M12 to M18)|Death|0|||
161013492|NCT05338086|581437621|FG002|Transition Period (M12 to M18)|Death|1|||
161013493|NCT05338086|581437622|FG003|Transition Period (M12 to M18)|Death|0|||
161013494|NCT05338086|581437623|FG004|Transition Period (M12 to M18)|Death|0|||
161013495|NCT05338086|581437619|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
161013496|NCT05338086|581437620|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
161013497|NCT05338086|581437621|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
161013498|NCT05338086|581437622|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
161013499|NCT05338086|581437623|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
161013500|NCT05338086|581437619|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
161013501|NCT05338086|581437620|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
161013502|NCT05338086|581437621|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
161013503|NCT05338086|581437622|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
161013504|NCT05338086|581437623|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
161013505|NCT05338086|581437619|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
161013506|NCT05338086|581437620|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
161013507|NCT05338086|581437621|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
161013508|NCT05338086|581437622|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
161013509|NCT05338086|581437623|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
161013510|NCT03424811|581437628|FG000|Overall Study|Lost to Follow-up|9|||
161013511|NCT03424811|581437629|FG001|Overall Study|Lost to Follow-up|0|||
161013512|NCT00567398|581437631|FG000|Overall Study|Adverse Event|6|||
161013513|NCT00567398|581437632|FG001|Overall Study|Adverse Event|14|||
161013514|NCT00567398|581437631|FG000|Overall Study|Physician Decision|0|||
161013515|NCT00567398|581437632|FG001|Overall Study|Physician Decision|4|||
161013516|NCT00567398|581437631|FG000|Overall Study|Withdrawal by Subject|0|||
161013517|NCT00567398|581437632|FG001|Overall Study|Withdrawal by Subject|2|||
161013518|NCT00567398|581437631|FG000|Overall Study|Renal Transplantation|0|||
161013519|NCT00567398|581437632|FG001|Overall Study|Renal Transplantation|3|||
161013520|NCT00567398|581437631|FG000|Overall Study|Other|1|||
161013521|NCT00567398|581437632|FG001|Overall Study|Other|0|||
161013522|NCT03517553|581437633|FG000|Overall Study|Withdrawal by Subject|2|||
161013523|NCT03271151|581437634|FG000|Overall Study|Lost to Follow-up|1|||
161013524|NCT03271151|581437635|FG001|Overall Study|Lost to Follow-up|3|||
161013525|NCT03271151|581437634|FG000|Overall Study|Withdrawal by Subject|1|||
160459021|NCT04165213|579413515|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
160459022|NCT04165213|579413514|FG000|Caregiver Enrollment|Physician Decision|1|||
160459023|NCT04165213|579413515|FG001|Caregiver Enrollment|Physician Decision|0|||
160459024|NCT04165213|579413514|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
160459025|NCT04165213|579413515|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
160459026|NCT04165213|579413514|FG000|Caregiver Enrollment|PLWD death|2|||
160459027|NCT04165213|579413515|FG001|Caregiver Enrollment|PLWD death|0|||
160459028|NCT04165213|579413514|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
160459029|NCT04165213|579413515|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
160459030|NCT04165213|579413514|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
160459031|NCT04165213|579413515|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
160459032|NCT04165213|579413514|FG000|PLWD Enrollment|Lost to Follow-up|1|||
160459033|NCT04165213|579413515|FG001|PLWD Enrollment|Lost to Follow-up|1|||
160657034|NCT05097989|580124504|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161013526|NCT03271151|581437635|FG001|Overall Study|Withdrawal by Subject|0|||
161013527|NCT04093362|581437638|FG000|Overall Study|Study Termination|1|||
161013528|NCT04093362|581437639|FG001|Overall Study|Study Termination|1|||
161013529|NCT04093362|581437638|FG000|Overall Study|Withdrawal of Consent|1|||
161013530|NCT04093362|581437639|FG001|Overall Study|Withdrawal of Consent|0|||
161013531|NCT04093362|581437638|FG000|Overall Study|Death|1|||
161013532|NCT04093362|581437639|FG001|Overall Study|Death|3|||
161013533|NCT04093362|581437638|FG000|Overall Study|Reason not Specified|1|||
161013534|NCT04093362|581437639|FG001|Overall Study|Reason not Specified|2|||
161013535|NCT03438188|581437651|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
161013536|NCT03438188|581437652|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
161013537|NCT03438188|581437653|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
161013538|NCT03438188|581437651|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
161013539|NCT03438188|581437652|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
161013540|NCT03438188|581437653|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
161013541|NCT03438188|581437651|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
161013542|NCT03438188|581437652|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
161013543|NCT03438188|581437653|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
161013544|NCT03438188|581437651|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
161013545|NCT03438188|581437652|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
161013546|NCT03438188|581437653|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
161013547|NCT03438188|581437651|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
161013548|NCT03438188|581437652|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
161013549|NCT03438188|581437653|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
161013550|NCT04823611|581437658|FG000|Overall Study|Adverse Event|2|||
161013551|NCT04823611|581437659|FG001|Overall Study|Adverse Event|0|||
161013552|NCT04823611|581437660|FG002|Overall Study|Adverse Event|1|||
161013553|NCT04823611|581437661|FG003|Overall Study|Adverse Event|0|||
161013554|NCT04823611|581437662|FG004|Overall Study|Adverse Event|0|||
161013555|NCT04823611|581437663|FG005|Overall Study|Adverse Event|0|||
161013556|NCT04823611|581437664|FG006|Overall Study|Adverse Event|0|||
161013557|NCT01673984|581437666|FG000|Overall Study|Adverse Event|1|||
161013558|NCT01673984|581437667|FG001|Overall Study|Adverse Event|0|||
161013559|NCT01673984|581437666|FG000|Overall Study|Study termination|9|||
161013560|NCT01673984|581437667|FG001|Overall Study|Study termination|6|||
161013561|NCT02651324|581437670|FG000|Overall Study|drug not administered, due dispensing issue|1|||
161013562|NCT02651324|581437671|FG001|Overall Study|drug not administered, due dispensing issue|0|||
161013563|NCT04437433|581437674|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
161013564|NCT04437433|581437675|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
161013565|NCT04437433|581437674|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
161013566|NCT04437433|581437675|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
161013567|NCT04437433|581437674|FG000|Overall Study|Adverse Event|9|||
161013568|NCT04437433|581437675|FG001|Overall Study|Adverse Event|0|||
161013569|NCT04437433|581437674|FG000|Overall Study|Lack of Efficacy|4|||
161013570|NCT04437433|581437675|FG001|Overall Study|Lack of Efficacy|0|||
161013571|NCT04437433|581437674|FG000|Overall Study|Withdrawal by Subject|4|||
161013572|NCT04437433|581437675|FG001|Overall Study|Withdrawal by Subject|1|||
161013573|NCT04437433|581437674|FG000|Overall Study|Protocol Deviation|0|||
161013574|NCT04437433|581437675|FG001|Overall Study|Protocol Deviation|1|||
161013575|NCT04437433|581437674|FG000|Overall Study|Other, not specified|0|||
161013576|NCT04437433|581437675|FG001|Overall Study|Other, not specified|1|||
161013577|NCT02365766|581437676|FG000|Overall Study|Withdrawal by Subject|0|||
161013578|NCT02365766|581437677|FG001|Overall Study|Withdrawal by Subject|0|||
160459034|NCT04165213|579413514|FG000|PLWD Enrollment|Physician Decision|1|||
160459035|NCT04165213|579413515|FG001|PLWD Enrollment|Physician Decision|0|||
160459036|NCT04165213|579413514|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
160459037|NCT04165213|579413515|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
160459038|NCT04165213|579413514|FG000|PLWD Enrollment|Death|2|||
160459039|NCT04165213|579413515|FG001|PLWD Enrollment|Death|0|||
160459040|NCT04165213|579413514|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
160657035|NCT05097989|580124496|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
160657036|NCT05097989|580124497|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
161013579|NCT02365766|581437678|FG002|Overall Study|Withdrawal by Subject|1|||
161013580|NCT02365766|581437676|FG000|Overall Study|Eligibility Criteria Not Met|0|||
161013581|NCT02365766|581437677|FG001|Overall Study|Eligibility Criteria Not Met|0|||
161013582|NCT02365766|581437678|FG002|Overall Study|Eligibility Criteria Not Met|1|||
161013583|NCT03385629|581437682|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
161013584|NCT03385629|581437683|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
161013585|NCT03385629|581437682|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
161013586|NCT03385629|581437683|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
161013587|NCT03385629|581437682|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
160459041|NCT04165213|579413515|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
161013588|NCT03385629|581437683|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
161013589|NCT04711135|581437687|FG000|Overall Study|Physician Decision|0|||
161013590|NCT04711135|581437688|FG001|Overall Study|Physician Decision|1|||
161013591|NCT04711135|581437687|FG000|Overall Study|Ongoing treatment|0|||
161013592|NCT04711135|581437688|FG001|Overall Study|Ongoing treatment|1|||
161013593|NCT02538900|581437696|FG000|Overall Study|Death|2|||
161013594|NCT02538900|581437697|FG001|Overall Study|Death|2|||
161013595|NCT02538900|581437698|FG002|Overall Study|Death|2|||
161013596|NCT02538900|581437696|FG000|Overall Study|Withdrawal by Subject|18|||
161013597|NCT02538900|581437697|FG001|Overall Study|Withdrawal by Subject|16|||
161013598|NCT02538900|581437698|FG002|Overall Study|Withdrawal by Subject|15|||
161013599|NCT04600752|581437699|FG000|Overall Study|Physician Decision|0|||
161013600|NCT04600752|581437700|FG001|Overall Study|Physician Decision|0|||
161013601|NCT04600752|581437701|FG002|Overall Study|Physician Decision|1|||
161013602|NCT04600752|581437699|FG000|Overall Study|Adverse Event|0|||
161013603|NCT04600752|581437700|FG001|Overall Study|Adverse Event|1|||
161013604|NCT04600752|581437701|FG002|Overall Study|Adverse Event|0|||
161013605|NCT04600752|581437699|FG000|Overall Study|Withdrawal by Subject|2|||
161013606|NCT04600752|581437700|FG001|Overall Study|Withdrawal by Subject|1|||
161013607|NCT04600752|581437701|FG002|Overall Study|Withdrawal by Subject|0|||
161013608|NCT04600752|581437699|FG000|Overall Study|Lack of Efficacy|1|||
161013609|NCT04600752|581437700|FG001|Overall Study|Lack of Efficacy|0|||
161013610|NCT04600752|581437701|FG002|Overall Study|Lack of Efficacy|0|||
161013611|NCT04431726|581437702|FG000|Overall Study|Ongoing in the Study|55|||
161013612|NCT03732820|581437703|FG000|Overall Study|Death|168|||
161013613|NCT03732820|581437704|FG001|Overall Study|Death|203|||
161013614|NCT03732820|581437703|FG000|Overall Study|Other|2|||
161013615|NCT03732820|581437704|FG001|Overall Study|Other|2|||
161013616|NCT03732820|581437703|FG000|Overall Study|Failure to meet randomisation criteria|1|||
161013617|NCT03732820|581437704|FG001|Overall Study|Failure to meet randomisation criteria|1|||
161013618|NCT03732820|581437703|FG000|Overall Study|Patient decision|14|||
161013619|NCT03732820|581437704|FG001|Overall Study|Patient decision|10|||
161013620|NCT03732820|581437703|FG000|Overall Study|Screen failure|0|||
161013621|NCT03732820|581437704|FG001|Overall Study|Screen failure|1|||
161013622|NCT03732820|581437703|FG000|Overall Study|Patients ongoing study at data cut off|210|||
161013623|NCT03732820|581437704|FG001|Overall Study|Patients ongoing study at data cut off|178|||
161013624|NCT03732820|581437703|FG000|Overall Study|Lost to Follow-up|4|||
161013625|NCT03732820|581437704|FG001|Overall Study|Lost to Follow-up|2|||
161013626|NCT00999167|581437707|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
161013627|NCT00999167|581437708|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
161013628|NCT00999167|581437709|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
161013629|NCT00999167|581437707|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
161013630|NCT00999167|581437708|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
161013631|NCT00999167|581437709|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
161013632|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
161013633|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
161013634|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
161013635|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
161013636|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
161013637|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
161013638|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
161013639|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
161013640|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
161013641|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
161013642|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
161013643|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
161013644|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
161013645|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
161013646|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
161013647|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
161013648|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
161013649|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
161013650|NCT02789020|581437712|FG000|Overall Study|Withdrawal by Subject|6|||
161013651|NCT02789020|581437713|FG001|Overall Study|Withdrawal by Subject|5|||
161013652|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
161013653|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
161013654|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
161013655|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
161013656|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
161013657|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
161013658|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
161013659|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
161013660|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
161013661|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
161013662|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
161013663|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
161013664|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
161013665|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
161013666|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
161013667|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
161013668|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
161013669|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
160459042|NCT04464564|579413516|FG000|Period A (Placebo lead-in)|Other|5|||
160459043|NCT04464564|579413517|FG001|Period A (Placebo lead-in)|Other|0|||
160459044|NCT04464564|579413518|FG002|Period A (Placebo lead-in)|Other|0|||
160459045|NCT04464564|579413519|FG003|Period A (Placebo lead-in)|Other|0|||
160459046|NCT04464564|579413516|FG000|Period B (Randomization Period)|Adverse Event|0|||
160459047|NCT04464564|579413517|FG001|Period B (Randomization Period)|Adverse Event|1|||
160459048|NCT04464564|579413518|FG002|Period B (Randomization Period)|Adverse Event|2|||
160459049|NCT04464564|579413519|FG003|Period B (Randomization Period)|Adverse Event|8|||
160459050|NCT04464564|579413516|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
160459051|NCT04464564|579413517|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
160459052|NCT04464564|579413518|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
160459053|NCT04464564|579413519|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
160459054|NCT04464564|579413516|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
160459055|NCT04464564|579413517|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
160459056|NCT04464564|579413518|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
160459057|NCT04464564|579413519|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
160459058|NCT04464564|579413516|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
160459059|NCT04464564|579413517|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
160459060|NCT04464564|579413518|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
160459061|NCT04464564|579413519|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
160459062|NCT04464564|579413516|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
160459063|NCT04464564|579413517|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
160459064|NCT04464564|579413518|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
160459065|NCT04464564|579413519|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
160459066|NCT04464564|579413516|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
160459067|NCT04464564|579413517|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
160459068|NCT04464564|579413518|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
160459069|NCT04464564|579413519|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
160459070|NCT04464564|579413516|FG000|Period B (Randomization Period)|Reason not Specified|0|||
160459071|NCT04464564|579413517|FG001|Period B (Randomization Period)|Reason not Specified|3|||
160459072|NCT04464564|579413518|FG002|Period B (Randomization Period)|Reason not Specified|3|||
160459073|NCT04464564|579413519|FG003|Period B (Randomization Period)|Reason not Specified|3|||
160459074|NCT02278211|579413524|FG000|Overall Study|Unable to analyse PET scan|2|||
160459075|NCT01828021|579413527|FG000|Overall Study|Adverse Event|5|||
160459076|NCT01828021|579413527|FG000|Overall Study|Lack of Efficacy|17|||
160459077|NCT01828021|579413527|FG000|Overall Study|Withdrawal by Subject|2|||
160459078|NCT01828021|579413527|FG000|Overall Study|Ileal obstruction, unrelated|1|||
160459079|NCT02997202|579413528|FG000|Overall Study|Miscellaneous|2|||
160459080|NCT02997202|579413529|FG001|Overall Study|Miscellaneous|2|||
160459081|NCT02997202|579413528|FG000|Overall Study|Withdrawal by Subject|8|||
160459082|NCT02997202|579413529|FG001|Overall Study|Withdrawal by Subject|12|||
160459083|NCT02997202|579413528|FG000|Overall Study|Lost to Follow-up|5|||
160459084|NCT02997202|579413529|FG001|Overall Study|Lost to Follow-up|3|||
160459085|NCT02997202|579413528|FG000|Overall Study|Death|41|||
160459086|NCT02997202|579413529|FG001|Overall Study|Death|45|||
160459087|NCT01121588|579413532|FG000|Overall Study|Death|5|||
160459088|NCT01121588|579413533|FG001|Overall Study|Death|3|||
160459089|NCT01121588|579413534|FG002|Overall Study|Death|13|||
160459090|NCT01121588|579413532|FG000|Overall Study|Study Terminated by Sponsor|1|||
160459091|NCT01121588|579413533|FG001|Overall Study|Study Terminated by Sponsor|1|||
160459092|NCT01121588|579413534|FG002|Overall Study|Study Terminated by Sponsor|0|||
160459093|NCT01121588|579413532|FG000|Overall Study|Participant Refused Further Followup|2|||
160459094|NCT01121588|579413533|FG001|Overall Study|Participant Refused Further Followup|0|||
161013670|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
160459095|NCT01121588|579413534|FG002|Overall Study|Participant Refused Further Followup|2|||
160459096|NCT01121588|579413532|FG000|Overall Study|Lost to Follow-up|0|||
160459097|NCT01121588|579413533|FG001|Overall Study|Lost to Follow-up|1|||
160459098|NCT01121588|579413534|FG002|Overall Study|Lost to Follow-up|1|||
161013671|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
161013672|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
161013673|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
161013674|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
161013675|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
161013676|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
161013677|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
161013678|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
161013679|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
161013680|NCT04238247|581437725|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
161013681|NCT04238247|581437726|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
161013682|NCT04238247|581437727|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
161013683|NCT04238247|581437728|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
161013684|NCT04238247|581437725|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
161013685|NCT04238247|581437726|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
161013686|NCT04238247|581437727|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
161013687|NCT04238247|581437728|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
161013688|NCT04238247|581437725|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
161013689|NCT04238247|581437726|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
161013690|NCT04238247|581437727|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
161013691|NCT04238247|581437728|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
161013692|NCT04238247|581437725|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
161013693|NCT04238247|581437726|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
161013694|NCT04238247|581437727|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
161013695|NCT04238247|581437728|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
161013696|NCT05512962|581437729|FG000|Overall Study|Withdrawal by Subject|1|||
161013697|NCT05512962|581437730|FG001|Overall Study|Withdrawal by Subject|0|||
161013698|NCT04950127|581437731|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
161013699|NCT04950127|581437732|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
161013700|NCT04950127|581437733|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
161013701|NCT04950127|581437734|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
161013702|NCT04950127|581437735|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
161013703|NCT04950127|581437736|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
161013704|NCT04950127|581437731|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
161013705|NCT04950127|581437732|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
161013706|NCT04950127|581437733|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
161013707|NCT04950127|581437734|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
161013708|NCT04950127|581437735|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
161013709|NCT04950127|581437736|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
161013710|NCT04950127|581437731|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
161013711|NCT04950127|581437732|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
161013712|NCT04950127|581437733|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161013713|NCT04950127|581437734|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161013714|NCT04950127|581437735|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161013715|NCT04950127|581437736|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161013716|NCT04950127|581437731|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
160459099|NCT01121588|579413532|FG000|Overall Study|Non-Specified Reasons|9|||
160459100|NCT01121588|579413533|FG001|Overall Study|Non-Specified Reasons|4|||
160459101|NCT01121588|579413534|FG002|Overall Study|Non-Specified Reasons|2|||
160459102|NCT00631475|579413537|FG000|Overall Study|Death|18|||
160459103|NCT00631475|579413537|FG000|Overall Study|Adverse Event|14|||
160459104|NCT00631475|579413537|FG000|Overall Study|Withdrew consent|5|||
161013717|NCT04950127|581437732|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161013718|NCT04950127|581437733|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161013719|NCT04950127|581437734|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161013720|NCT04950127|581437735|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161013721|NCT04950127|581437736|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
161013722|NCT04950127|581437731|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
161013723|NCT04950127|581437732|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
161013724|NCT04950127|581437733|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
161013725|NCT04950127|581437734|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
161013726|NCT04950127|581437735|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
161013727|NCT04950127|581437736|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
161013728|NCT01711632|581437737|FG000|Overall Study|Adverse Event|4|||
161013729|NCT01711632|581437737|FG000|Overall Study|Death|3|||
160459105|NCT00631475|579413537|FG000|Overall Study|Preparation for lung transplant|8|||
160657037|NCT05097989|580124498|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
161013730|NCT01711632|581437737|FG000|Overall Study|Lost to Follow-up|3|||
161013731|NCT01711632|581437737|FG000|Overall Study|Withdrawal by Subject|4|||
160586041|NCT02796391|579863962|FG002|Overall Study|Participant did not like study cigarettes|3|||
160586042|NCT02796391|579863963|FG003|Overall Study|Participant did not like study cigarettes|0|||
161013732|NCT01711632|581437737|FG000|Overall Study|Progressive disease|2|||
161013733|NCT01711632|581437737|FG000|Overall Study|No follow up required in re-treatment|3|||
161013734|NCT01711632|581437737|FG000|Overall Study|No follow up required in re-treatment|3|||
161013735|NCT03517969|581437738|FG000|Overall Study|Never started protocol treatment|3|||
161013736|NCT03517969|581437739|FG001|Overall Study|Never started protocol treatment|5|||
161013737|NCT03517969|581437738|FG000|Overall Study|Disease progression|11|||
161013738|NCT03517969|581437739|FG001|Overall Study|Disease progression|16|||
161013739|NCT03517969|581437738|FG000|Overall Study|PSA progression|8|||
161013740|NCT03517969|581437739|FG001|Overall Study|PSA progression|1|||
161013741|NCT03517969|581437738|FG000|Overall Study|Clinical progression|4|||
161013742|NCT03517969|581437739|FG001|Overall Study|Clinical progression|2|||
161013743|NCT03517969|581437738|FG000|Overall Study|Adverse Event|5|||
161013744|NCT03517969|581437739|FG001|Overall Study|Adverse Event|4|||
161013745|NCT03517969|581437738|FG000|Overall Study|Intercurrent illness|1|||
161013746|NCT03517969|581437739|FG001|Overall Study|Intercurrent illness|2|||
161013747|NCT03517969|581437738|FG000|Overall Study|Death|1|||
161013748|NCT03517969|581437739|FG001|Overall Study|Death|1|||
161013749|NCT03517969|581437738|FG000|Overall Study|Withdrawal by Subject|1|||
161013750|NCT03517969|581437739|FG001|Overall Study|Withdrawal by Subject|2|||
161013751|NCT03517969|581437738|FG000|Overall Study|Physician Decision|1|||
161013752|NCT03517969|581437739|FG001|Overall Study|Physician Decision|1|||
161013753|NCT03517969|581437738|FG000|Overall Study|No clinical benefit|1|||
161013754|NCT03517969|581437739|FG001|Overall Study|No clinical benefit|0|||
161013755|NCT03517969|581437738|FG000|Overall Study|Delayed treatment for dental treatment|1|||
161013756|NCT03517969|581437739|FG001|Overall Study|Delayed treatment for dental treatment|0|||
161013757|NCT03517969|581437738|FG000|Overall Study|Difficult to maintain appointment|0|||
161013758|NCT03517969|581437739|FG001|Overall Study|Difficult to maintain appointment|1|||
161013759|NCT03517969|581437738|FG000|Overall Study|Protocol Violation|0|||
161013760|NCT03517969|581437739|FG001|Overall Study|Protocol Violation|1|||
161013761|NCT02860130|581437740|FG000|Overall Study|Adverse Event|2|||
161013762|NCT02860130|581437741|FG001|Overall Study|Adverse Event|3|||
161013763|NCT02860130|581437740|FG000|Overall Study|Protocol Violation|1|||
161013764|NCT02860130|581437741|FG001|Overall Study|Protocol Violation|1|||
161013765|NCT02860130|581437740|FG000|Overall Study|Withdrawal by Subject|0|||
161013766|NCT02860130|581437741|FG001|Overall Study|Withdrawal by Subject|2|||
161013767|NCT02860130|581437740|FG000|Overall Study|Physician Decision|2|||
161013768|NCT02860130|581437741|FG001|Overall Study|Physician Decision|2|||
161013769|NCT02860130|581437740|FG000|Overall Study|Other|2|||
161013770|NCT02860130|581437741|FG001|Overall Study|Other|1|||
161013771|NCT02140645|581437746|FG000|Overall Study|Not linked|5489|||
161013772|NCT02140645|581437747|FG001|Overall Study|Not linked|61654|||
161013773|NCT02140645|581437748|FG002|Overall Study|Not linked|4236|||
161013774|NCT02140645|581437749|FG003|Overall Study|Not linked|13833|||
161013775|NCT02140645|581437750|FG004|Overall Study|Not linked|3286|||
161013776|NCT02140645|581437751|FG005|Overall Study|Not linked|70896|||
161013777|NCT05450458|581437752|FG000|Overall Study|Lost to Follow-up|4|||
161013778|NCT01101451|581437753|FG000|Overall Study|Eligible and never treated|0|||
161013779|NCT01101451|581437754|FG001|Overall Study|Eligible and never treated|5|||
161013780|NCT01101451|581437753|FG000|Overall Study|Ineligible and treated|12|||
161013781|NCT01101451|581437754|FG001|Overall Study|Ineligible and treated|8|||
161013782|NCT01101451|581437753|FG000|Overall Study|Ineligible and never treated|2|||
161013783|NCT01101451|581437754|FG001|Overall Study|Ineligible and never treated|2|||
161013784|NCT05480943|581437755|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
161013785|NCT05480943|581437755|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
161013786|NCT05480943|581437755|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
161013787|NCT05480943|581437755|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
161013788|NCT02965846|581437756|FG000|Overall Study|Lost to Follow-up|1|||
161013789|NCT02965846|581437757|FG001|Overall Study|Lost to Follow-up|0|||
161013790|NCT02965846|581437758|FG002|Overall Study|Lost to Follow-up|0|||
161013791|NCT02965846|581437756|FG000|Overall Study|Withdrawal by Subject|0|||
161013792|NCT02965846|581437757|FG001|Overall Study|Withdrawal by Subject|1|||
160586043|NCT02796391|579863964|FG004|Overall Study|Participant did not like study cigarettes|0|||
161013793|NCT02965846|581437758|FG002|Overall Study|Withdrawal by Subject|0|||
161013794|NCT02965846|581437756|FG000|Overall Study|Study Terminated By Sponsor|4|||
161013795|NCT02965846|581437757|FG001|Overall Study|Study Terminated By Sponsor|4|||
161013796|NCT02965846|581437758|FG002|Overall Study|Study Terminated By Sponsor|0|||
161013797|NCT02965846|581437756|FG000|Overall Study|Participants not randomized|0|||
161013798|NCT02965846|581437757|FG001|Overall Study|Participants not randomized|0|||
161013799|NCT02965846|581437758|FG002|Overall Study|Participants not randomized|33|||
161013800|NCT02794480|581437759|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
161013801|NCT02794480|581437760|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
161013802|NCT02794480|581437761|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
161013803|NCT02794480|581437762|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
161013804|NCT02794480|581437759|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
160459106|NCT04055012|579413538|FG000|Overall Study|Withdrawal by Subject|1|||
160459107|NCT04055012|579413539|FG001|Overall Study|Withdrawal by Subject|3|||
160459108|NCT04055012|579413540|FG002|Overall Study|Withdrawal by Subject|1|||
160459109|NCT04055012|579413541|FG003|Overall Study|Withdrawal by Subject|0|||
160586044|NCT02796391|579863965|FG005|Overall Study|Participant did not like study cigarettes|0|||
161013805|NCT02794480|581437760|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
161013806|NCT02794480|581437761|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
161013807|NCT02794480|581437762|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
161013808|NCT02794480|581437759|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161013809|NCT02794480|581437760|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161013810|NCT02794480|581437761|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161013811|NCT02794480|581437762|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
161013812|NCT02794480|581437759|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161013813|NCT02794480|581437760|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
161013814|NCT02794480|581437761|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161013815|NCT02794480|581437762|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161013816|NCT02794480|581437759|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
161013817|NCT02794480|581437760|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161013818|NCT02794480|581437761|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161013819|NCT02794480|581437762|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
161013820|NCT01747486|581437763|FG000|Stage 1|Physician Decision|3|||
161013821|NCT01747486|581437764|FG001|Stage 1|Physician Decision|0|||
161013822|NCT01747486|581437763|FG000|Stage 1|Withdrawal by Subject|4|||
161013823|NCT01747486|581437764|FG001|Stage 1|Withdrawal by Subject|3|||
161013824|NCT01747486|581437763|FG000|Stage 1|Disease progression|4|||
161013825|NCT01747486|581437764|FG001|Stage 1|Disease progression|9|||
161013826|NCT01747486|581437763|FG000|Stage 1|Death|1|||
161013827|NCT01747486|581437764|FG001|Stage 1|Death|1|||
161013828|NCT01747486|581437763|FG000|Stage 2|Physician Decision|2|||
161013829|NCT01747486|581437764|FG001|Stage 2|Physician Decision|0|||
161013830|NCT01747486|581437763|FG000|Stage 2|Withdrawal by Subject|1|||
161013831|NCT01747486|581437764|FG001|Stage 2|Withdrawal by Subject|0|||
161013832|NCT01747486|581437763|FG000|Stage 2|New Cancer Therapy|3|||
161013833|NCT01747486|581437764|FG001|Stage 2|New Cancer Therapy|0|||
161013834|NCT01747486|581437763|FG000|Stage 2|Disease Progression|3|||
161013835|NCT01747486|581437764|FG001|Stage 2|Disease Progression|0|||
161013836|NCT00632749|581437765|FG000|Overall Study|Progressive disease|3|||
161013837|NCT00632749|581437766|FG001|Overall Study|Progressive disease|2|||
161013838|NCT00632749|581437767|FG002|Overall Study|Progressive disease|2|||
161013839|NCT00632749|581437768|FG003|Overall Study|Progressive disease|2|||
161013840|NCT00632749|581437769|FG004|Overall Study|Progressive disease|4|||
161013841|NCT00632749|581437770|FG005|Overall Study|Progressive disease|4|||
161013842|NCT00632749|581437771|FG006|Overall Study|Progressive disease|3|||
161013843|NCT00632749|581437772|FG007|Overall Study|Progressive disease|2|||
161013844|NCT00632749|581437773|FG008|Overall Study|Progressive disease|3|||
161013845|NCT00632749|581437774|FG009|Overall Study|Progressive disease|2|||
161013846|NCT00632749|581437775|FG010|Overall Study|Progressive disease|4|||
161013847|NCT00632749|581437776|FG011|Overall Study|Progressive disease|3|||
161013848|NCT00632749|581437777|FG012|Overall Study|Progressive disease|2|||
161013849|NCT00632749|581437778|FG013|Overall Study|Progressive disease|4|||
161013850|NCT00632749|581437765|FG000|Overall Study|Other Adverse event|1|||
161013851|NCT00632749|581437766|FG001|Overall Study|Other Adverse event|1|||
161013852|NCT00632749|581437767|FG002|Overall Study|Other Adverse event|1|||
161013853|NCT00632749|581437768|FG003|Overall Study|Other Adverse event|1|||
161013854|NCT00632749|581437769|FG004|Overall Study|Other Adverse event|2|||
161013855|NCT00632749|581437770|FG005|Overall Study|Other Adverse event|4|||
161013856|NCT00632749|581437771|FG006|Overall Study|Other Adverse event|1|||
161013857|NCT00632749|581437772|FG007|Overall Study|Other Adverse event|2|||
161013858|NCT00632749|581437773|FG008|Overall Study|Other Adverse event|2|||
161013859|NCT00632749|581437774|FG009|Overall Study|Other Adverse event|0|||
161013860|NCT00632749|581437775|FG010|Overall Study|Other Adverse event|1|||
161013861|NCT00632749|581437776|FG011|Overall Study|Other Adverse event|0|||
160459110|NCT04055012|579413538|FG000|Overall Study|Metformin Recall|1|||
160586045|NCT02796391|579863960|FG000|Overall Study|Withdrawal by Subject|1|||
160586046|NCT02796391|579863961|FG001|Overall Study|Withdrawal by Subject|1|||
161013862|NCT00632749|581437777|FG012|Overall Study|Other Adverse event|1|||
161013863|NCT00632749|581437778|FG013|Overall Study|Other Adverse event|0|||
161013864|NCT00632749|581437765|FG000|Overall Study|Refuse to continue medication|0|||
161013865|NCT00632749|581437766|FG001|Overall Study|Refuse to continue medication|0|||
161013866|NCT00632749|581437767|FG002|Overall Study|Refuse to continue medication|0|||
161013867|NCT00632749|581437768|FG003|Overall Study|Refuse to continue medication|1|||
160586047|NCT02796391|579863962|FG002|Overall Study|Withdrawal by Subject|4|||
161013868|NCT00632749|581437769|FG004|Overall Study|Refuse to continue medication|0|||
161013869|NCT00632749|581437770|FG005|Overall Study|Refuse to continue medication|0|||
161013870|NCT00632749|581437771|FG006|Overall Study|Refuse to continue medication|0|||
161013871|NCT00632749|581437772|FG007|Overall Study|Refuse to continue medication|0|||
161013872|NCT00632749|581437773|FG008|Overall Study|Refuse to continue medication|0|||
161013873|NCT00632749|581437774|FG009|Overall Study|Refuse to continue medication|1|||
161013874|NCT00632749|581437775|FG010|Overall Study|Refuse to continue medication|0|||
161013875|NCT00632749|581437776|FG011|Overall Study|Refuse to continue medication|0|||
161013876|NCT00632749|581437777|FG012|Overall Study|Refuse to continue medication|0|||
161013877|NCT00632749|581437778|FG013|Overall Study|Refuse to continue medication|0|||
161013878|NCT00632749|581437765|FG000|Overall Study|Reason other than those specified above|0|||
161013879|NCT00632749|581437766|FG001|Overall Study|Reason other than those specified above|2|||
161013880|NCT00632749|581437767|FG002|Overall Study|Reason other than those specified above|0|||
161013881|NCT00632749|581437768|FG003|Overall Study|Reason other than those specified above|0|||
161013882|NCT00632749|581437769|FG004|Overall Study|Reason other than those specified above|1|||
161013883|NCT00632749|581437770|FG005|Overall Study|Reason other than those specified above|0|||
161013884|NCT00632749|581437771|FG006|Overall Study|Reason other than those specified above|1|||
161013885|NCT00632749|581437772|FG007|Overall Study|Reason other than those specified above|0|||
161013886|NCT00632749|581437773|FG008|Overall Study|Reason other than those specified above|0|||
161013887|NCT00632749|581437774|FG009|Overall Study|Reason other than those specified above|0|||
161013888|NCT00632749|581437775|FG010|Overall Study|Reason other than those specified above|2|||
161013889|NCT00632749|581437776|FG011|Overall Study|Reason other than those specified above|1|||
161013890|NCT00632749|581437777|FG012|Overall Study|Reason other than those specified above|0|||
161013891|NCT00632749|581437778|FG013|Overall Study|Reason other than those specified above|2|||
161013892|NCT00611559|581437779|FG000|Overall Study|Lost to Follow-up|0|||
161013893|NCT00611559|581437780|FG001|Overall Study|Lost to Follow-up|1|||
161013894|NCT00611559|581437781|FG002|Overall Study|Lost to Follow-up|0|||
161013895|NCT00611559|581437779|FG000|Overall Study|Protocol Violation|1|||
161013896|NCT00611559|581437780|FG001|Overall Study|Protocol Violation|0|||
161013897|NCT00611559|581437781|FG002|Overall Study|Protocol Violation|1|||
161013898|NCT00879333|581437782|FG000|Overall Study|Adverse Event|94|||
161013899|NCT00879333|581437783|FG001|Overall Study|Adverse Event|34|||
161013900|NCT00879333|581437782|FG000|Overall Study|Abnormal Laboratory Value|1|||
161013901|NCT00879333|581437783|FG001|Overall Study|Abnormal Laboratory Value|0|||
161013902|NCT00879333|581437782|FG000|Overall Study|Withdrawal by Subject|20|||
161013903|NCT00879333|581437783|FG001|Overall Study|Withdrawal by Subject|7|||
161013904|NCT00879333|581437782|FG000|Overall Study|Lost to Follow-up|2|||
161013905|NCT00879333|581437783|FG001|Overall Study|Lost to Follow-up|1|||
161013906|NCT00879333|581437782|FG000|Overall Study|Administrative Problems|2|||
161013907|NCT00879333|581437783|FG001|Overall Study|Administrative Problems|0|||
161013908|NCT00879333|581437782|FG000|Overall Study|Death|16|||
161013909|NCT00879333|581437783|FG001|Overall Study|Death|5|||
161013910|NCT00879333|581437782|FG000|Overall Study|Disease Progression|292|||
161013911|NCT00879333|581437783|FG001|Overall Study|Disease Progression|169|||
161013912|NCT00879333|581437782|FG000|Overall Study|Protocol Violation|1|||
161013913|NCT00879333|581437783|FG001|Overall Study|Protocol Violation|1|||
161013914|NCT04999592|581437784|FG000|Overall Study|Withdrawal by Subject|1|||
161013915|NCT04999592|581437785|FG001|Overall Study|Withdrawal by Subject|0|||
161013916|NCT02671435|581437786|FG000|Overall Study|Death|1|||
161013917|NCT02671435|581437787|FG001|Overall Study|Death|3|||
161013918|NCT02671435|581437788|FG002|Overall Study|Death|0|||
161013919|NCT02671435|581437789|FG003|Overall Study|Death|16|||
161013920|NCT02671435|581437790|FG004|Overall Study|Death|14|||
161013921|NCT02671435|581437791|FG005|Overall Study|Death|29|||
161013922|NCT02671435|581437792|FG006|Overall Study|Death|34|||
161013923|NCT02671435|581437793|FG007|Overall Study|Death|28|||
161013924|NCT02671435|581437794|FG008|Overall Study|Death|19|||
161013925|NCT02671435|581437795|FG009|Overall Study|Death|10|||
161013926|NCT02671435|581437796|FG010|Overall Study|Death|8|||
161013927|NCT02671435|581437797|FG011|Overall Study|Death|29|||
161013928|NCT02671435|581437798|FG012|Overall Study|Death|29|||
161013929|NCT02671435|581437799|FG013|Overall Study|Death|29|||
161013930|NCT02671435|581437800|FG014|Overall Study|Death|27|||
161013931|NCT02671435|581437786|FG000|Overall Study|Lost to Follow-up|0|||
161013932|NCT02671435|581437787|FG001|Overall Study|Lost to Follow-up|0|||
161013933|NCT02671435|581437788|FG002|Overall Study|Lost to Follow-up|1|||
161013934|NCT02671435|581437789|FG003|Overall Study|Lost to Follow-up|0|||
161013935|NCT02671435|581437790|FG004|Overall Study|Lost to Follow-up|1|||
161013936|NCT02671435|581437791|FG005|Overall Study|Lost to Follow-up|1|||
161013937|NCT02671435|581437792|FG006|Overall Study|Lost to Follow-up|2|||
161013938|NCT02671435|581437793|FG007|Overall Study|Lost to Follow-up|2|||
161013939|NCT02671435|581437794|FG008|Overall Study|Lost to Follow-up|0|||
161013940|NCT02671435|581437795|FG009|Overall Study|Lost to Follow-up|2|||
161013941|NCT02671435|581437796|FG010|Overall Study|Lost to Follow-up|0|||
161013942|NCT02671435|581437797|FG011|Overall Study|Lost to Follow-up|3|||
161013943|NCT02671435|581437798|FG012|Overall Study|Lost to Follow-up|3|||
161013944|NCT02671435|581437799|FG013|Overall Study|Lost to Follow-up|2|||
161013945|NCT02671435|581437800|FG014|Overall Study|Lost to Follow-up|0|||
161013946|NCT02671435|581437786|FG000|Overall Study|Withdrawal by Subject|2|||
161013947|NCT02671435|581437787|FG001|Overall Study|Withdrawal by Subject|0|||
161013948|NCT02671435|581437788|FG002|Overall Study|Withdrawal by Subject|2|||
161013949|NCT02671435|581437789|FG003|Overall Study|Withdrawal by Subject|2|||
161013950|NCT02671435|581437790|FG004|Overall Study|Withdrawal by Subject|2|||
161013951|NCT02671435|581437791|FG005|Overall Study|Withdrawal by Subject|7|||
161013952|NCT02671435|581437792|FG006|Overall Study|Withdrawal by Subject|2|||
161013953|NCT02671435|581437793|FG007|Overall Study|Withdrawal by Subject|7|||
161013954|NCT02671435|581437794|FG008|Overall Study|Withdrawal by Subject|1|||
161013955|NCT02671435|581437795|FG009|Overall Study|Withdrawal by Subject|1|||
161013956|NCT02671435|581437796|FG010|Overall Study|Withdrawal by Subject|2|||
161013957|NCT02671435|581437797|FG011|Overall Study|Withdrawal by Subject|4|||
161013958|NCT02671435|581437798|FG012|Overall Study|Withdrawal by Subject|4|||
161013959|NCT02671435|581437799|FG013|Overall Study|Withdrawal by Subject|4|||
161013960|NCT02671435|581437800|FG014|Overall Study|Withdrawal by Subject|2|||
161013961|NCT02671435|581437786|FG000|Overall Study|Un-specified|0|||
161013962|NCT02671435|581437787|FG001|Overall Study|Un-specified|0|||
161013963|NCT02671435|581437788|FG002|Overall Study|Un-specified|0|||
161013964|NCT02671435|581437789|FG003|Overall Study|Un-specified|0|||
161013965|NCT02671435|581437790|FG004|Overall Study|Un-specified|1|||
161013966|NCT02671435|581437791|FG005|Overall Study|Un-specified|3|||
161013967|NCT02671435|581437792|FG006|Overall Study|Un-specified|2|||
161013968|NCT02671435|581437793|FG007|Overall Study|Un-specified|3|||
161013969|NCT02671435|581437794|FG008|Overall Study|Un-specified|0|||
161013970|NCT02671435|581437795|FG009|Overall Study|Un-specified|5|||
161013971|NCT02671435|581437796|FG010|Overall Study|Un-specified|8|||
161013972|NCT02671435|581437797|FG011|Overall Study|Un-specified|4|||
161013973|NCT02671435|581437798|FG012|Overall Study|Un-specified|5|||
161013974|NCT02671435|581437799|FG013|Overall Study|Un-specified|9|||
161013975|NCT02671435|581437800|FG014|Overall Study|Un-specified|8|||
161013976|NCT04128319|581437801|FG000|Overall Study|Death|3|||
161013977|NCT02910713|581437804|FG000|Overall Study|Protocol Violation|2|||
161013978|NCT02910713|581437804|FG000|Overall Study|Subject Choice|4|||
161013979|NCT02910713|581437804|FG000|Overall Study|Received One Application|10|||
161013980|NCT02910713|581437804|FG000|Overall Study|Received Neither Application|18|||
161013981|NCT02910713|581437804|FG000|Overall Study|Enrollment cap|7|||
161013982|NCT02910713|581437804|FG000|Overall Study|Investigator Discretion|1|||
161013983|NCT04442126|581437808|FG000|Overall Study|Withdrawal by Subject|0|||
161013984|NCT04442126|581437809|FG001|Overall Study|Withdrawal by Subject|0|||
161013985|NCT04442126|581437810|FG002|Overall Study|Withdrawal by Subject|0|||
161013986|NCT04442126|581437811|FG003|Overall Study|Withdrawal by Subject|2|||
161013987|NCT04442126|581437812|FG004|Overall Study|Withdrawal by Subject|1|||
161013988|NCT04442126|581437813|FG005|Overall Study|Withdrawal by Subject|0|||
161013989|NCT04442126|581437814|FG006|Overall Study|Withdrawal by Subject|1|||
161013990|NCT04442126|581437815|FG007|Overall Study|Withdrawal by Subject|1|||
161013991|NCT04442126|581437816|FG008|Overall Study|Withdrawal by Subject|3|||
161013992|NCT04442126|581437808|FG000|Overall Study|Death|1|||
161013993|NCT04442126|581437809|FG001|Overall Study|Death|0|||
161013994|NCT04442126|581437810|FG002|Overall Study|Death|0|||
161013995|NCT04442126|581437811|FG003|Overall Study|Death|1|||
161013996|NCT04442126|581437812|FG004|Overall Study|Death|2|||
161013997|NCT04442126|581437813|FG005|Overall Study|Death|2|||
161013998|NCT04442126|581437814|FG006|Overall Study|Death|4|||
161013999|NCT04442126|581437815|FG007|Overall Study|Death|1|||
161014000|NCT04442126|581437816|FG008|Overall Study|Death|5|||
161014001|NCT04442126|581437808|FG000|Overall Study|Study Terminated by Sponsor|0|||
161014002|NCT04442126|581437809|FG001|Overall Study|Study Terminated by Sponsor|0|||
161014003|NCT04442126|581437810|FG002|Overall Study|Study Terminated by Sponsor|0|||
161014004|NCT04442126|581437811|FG003|Overall Study|Study Terminated by Sponsor|0|||
161014005|NCT04442126|581437812|FG004|Overall Study|Study Terminated by Sponsor|0|||
161014006|NCT04442126|581437813|FG005|Overall Study|Study Terminated by Sponsor|1|||
161014007|NCT04442126|581437814|FG006|Overall Study|Study Terminated by Sponsor|4|||
161014008|NCT04442126|581437815|FG007|Overall Study|Study Terminated by Sponsor|2|||
161014009|NCT04442126|581437816|FG008|Overall Study|Study Terminated by Sponsor|10|||
161014010|NCT04442126|581437808|FG000|Overall Study|Lost to Follow-up|0|||
161014011|NCT04442126|581437809|FG001|Overall Study|Lost to Follow-up|0|||
161014012|NCT04442126|581437810|FG002|Overall Study|Lost to Follow-up|0|||
160459111|NCT04055012|579413539|FG001|Overall Study|Metformin Recall|1|||
160459112|NCT04055012|579413540|FG002|Overall Study|Metformin Recall|1|||
160459113|NCT04055012|579413541|FG003|Overall Study|Metformin Recall|0|||
160657038|NCT05097989|580124499|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
161014013|NCT04442126|581437811|FG003|Overall Study|Lost to Follow-up|0|||
161014014|NCT04442126|581437812|FG004|Overall Study|Lost to Follow-up|0|||
161014015|NCT04442126|581437813|FG005|Overall Study|Lost to Follow-up|0|||
161014016|NCT04442126|581437814|FG006|Overall Study|Lost to Follow-up|0|||
161014017|NCT04442126|581437815|FG007|Overall Study|Lost to Follow-up|1|||
161014018|NCT04442126|581437816|FG008|Overall Study|Lost to Follow-up|2|||
161014019|NCT04442126|581437808|FG000|Overall Study|Progressive Disease|0|||
160459114|NCT02492711|579413542|FG000|Overall Study|Adverse Event|9|||
161014020|NCT04442126|581437809|FG001|Overall Study|Progressive Disease|1|||
161014021|NCT04442126|581437810|FG002|Overall Study|Progressive Disease|3|||
160586048|NCT02796391|579863963|FG003|Overall Study|Withdrawal by Subject|3|||
160586049|NCT02796391|579863964|FG004|Overall Study|Withdrawal by Subject|4|||
160586050|NCT02796391|579863965|FG005|Overall Study|Withdrawal by Subject|3|||
160586051|NCT02796391|579863960|FG000|Overall Study|Adverse Event|0|||
160586052|NCT02796391|579863961|FG001|Overall Study|Adverse Event|0|||
160586053|NCT02796391|579863962|FG002|Overall Study|Adverse Event|0|||
160586054|NCT02796391|579863963|FG003|Overall Study|Adverse Event|1|||
160586055|NCT02796391|579863964|FG004|Overall Study|Adverse Event|0|||
160586056|NCT02796391|579863965|FG005|Overall Study|Adverse Event|0|||
160586057|NCT02796391|579863960|FG000|Overall Study|Protocol Violation|0|||
160586058|NCT02796391|579863961|FG001|Overall Study|Protocol Violation|0|||
160586059|NCT02796391|579863962|FG002|Overall Study|Protocol Violation|0|||
160586060|NCT02796391|579863963|FG003|Overall Study|Protocol Violation|1|||
160586061|NCT02796391|579863964|FG004|Overall Study|Protocol Violation|0|||
160586062|NCT02796391|579863965|FG005|Overall Study|Protocol Violation|0|||
160586063|NCT02681055|579863966|FG000|Weeks 5-12|Adverse Event|1|||
160586064|NCT02695524|579863967|FG000|Overall Study|Lost to Follow-up|3|||
160586065|NCT02695524|579863968|FG001|Overall Study|Lost to Follow-up|2|||
160586066|NCT02695524|579863967|FG000|Overall Study|Death|0|||
160586067|NCT02695524|579863968|FG001|Overall Study|Death|1|||
160586068|NCT00377611|579863971|FG000|Overall Study|Adverse Event|2|||
160586069|NCT00377611|579863972|FG001|Overall Study|Adverse Event|9|||
160586070|NCT00377611|579863971|FG000|Overall Study|Protocol Violation|2|||
160586071|NCT00377611|579863972|FG001|Overall Study|Protocol Violation|0|||
160586072|NCT00377611|579863971|FG000|Overall Study|Withdrawal by Subject|0|||
160586073|NCT00377611|579863972|FG001|Overall Study|Withdrawal by Subject|5|||
160586074|NCT00377611|579863971|FG000|Overall Study|Lost to Follow-up|18|||
160586075|NCT00377611|579863972|FG001|Overall Study|Lost to Follow-up|16|||
160586076|NCT00377611|579863971|FG000|Overall Study|Other|0|||
160586077|NCT00377611|579863972|FG001|Overall Study|Other|3|||
160586078|NCT00798655|579863978|FG000|Overall Study|Did not receive at least one dose of pan|2|||
160586079|NCT03446651|579863979|FG000|Overall Study|Lost to Follow-up|4|||
160586080|NCT03446651|579863980|FG001|Overall Study|Lost to Follow-up|0|||
160586081|NCT03446651|579863979|FG000|Overall Study|Open Label Participants|5|||
160967931|NCT01966003|581271352|FG000|Overall Study|Physician Decision|12|||
160967932|NCT01966003|581271353|FG001|Overall Study|Physician Decision|13|||
160967933|NCT01966003|581271352|FG000|Overall Study|Withdrawal by Subject|29|||
160967934|NCT01966003|581271353|FG001|Overall Study|Withdrawal by Subject|19|||
160967935|NCT01966003|581271352|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
160967936|NCT01966003|581271353|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
160967937|NCT01966003|581271352|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
160967938|NCT01966003|581271353|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
160967939|NCT01966003|581271352|FG000|Overall Study|Other|1|||
160967940|NCT01966003|581271353|FG001|Overall Study|Other|1|||
160967941|NCT02748694|581271358|FG000|Overall Study|Voluntary Withdrawal|0|||
160967942|NCT02748694|581271359|FG001|Overall Study|Voluntary Withdrawal|0|||
160967943|NCT02748694|581271360|FG002|Overall Study|Voluntary Withdrawal|0|||
160967944|NCT02748694|581271361|FG003|Overall Study|Voluntary Withdrawal|0|||
160967945|NCT02748694|581271362|FG004|Overall Study|Voluntary Withdrawal|0|||
160967946|NCT02748694|581271363|FG005|Overall Study|Voluntary Withdrawal|0|||
160967947|NCT02748694|581271364|FG006|Overall Study|Voluntary Withdrawal|0|||
160967948|NCT02748694|581271365|FG007|Overall Study|Voluntary Withdrawal|0|||
160967949|NCT02748694|581271366|FG008|Overall Study|Voluntary Withdrawal|0|||
160967950|NCT02748694|581271367|FG009|Overall Study|Voluntary Withdrawal|0|||
160967951|NCT02748694|581271368|FG010|Overall Study|Voluntary Withdrawal|0|||
160967952|NCT02748694|581271369|FG011|Overall Study|Voluntary Withdrawal|0|||
160967953|NCT02748694|581271370|FG012|Overall Study|Voluntary Withdrawal|0|||
160967954|NCT02748694|581271371|FG013|Overall Study|Voluntary Withdrawal|0|||
160967955|NCT02748694|581271372|FG014|Overall Study|Voluntary Withdrawal|2|||
160967956|NCT04026165|581271375|FG000|Run-in Placebo Period|Enrollment Error|13|||
160967957|NCT04026165|581271376|FG001|Run-in Placebo Period|Enrollment Error|0|||
160967958|NCT04026165|581271377|FG002|Run-in Placebo Period|Enrollment Error|0|||
160967959|NCT04026165|581271378|FG003|Run-in Placebo Period|Enrollment Error|0|||
160967960|NCT04026165|581271375|FG000|Run-in Placebo Period|Run-in Failure|4|||
160967961|NCT04026165|581271376|FG001|Run-in Placebo Period|Run-in Failure|0|||
160967962|NCT04026165|581271377|FG002|Run-in Placebo Period|Run-in Failure|0|||
160967963|NCT04026165|581271378|FG003|Run-in Placebo Period|Run-in Failure|0|||
160967964|NCT04026165|581271375|FG000|Run-in Placebo Period|Protocol Violation|2|||
160967965|NCT04026165|581271376|FG001|Run-in Placebo Period|Protocol Violation|0|||
160586082|NCT03446651|579863980|FG001|Overall Study|Open Label Participants|0|||
160586083|NCT00343291|579863981|FG000|Overall Study|Adverse Event|13|||
160586084|NCT00343291|579863982|FG001|Overall Study|Adverse Event|13|||
160586085|NCT00343291|579863981|FG000|Overall Study|Death|3|||
160967966|NCT04026165|581271377|FG002|Run-in Placebo Period|Protocol Violation|0|||
160967967|NCT04026165|581271378|FG003|Run-in Placebo Period|Protocol Violation|0|||
160967968|NCT04026165|581271375|FG000|Run-in Placebo Period|Withdrew Consent|2|||
160967969|NCT04026165|581271376|FG001|Run-in Placebo Period|Withdrew Consent|0|||
160586086|NCT00343291|579863982|FG001|Overall Study|Death|2|||
161014022|NCT04442126|581437811|FG003|Overall Study|Progressive Disease|0|||
161014023|NCT04442126|581437812|FG004|Overall Study|Progressive Disease|3|||
161014024|NCT04442126|581437813|FG005|Overall Study|Progressive Disease|0|||
161014025|NCT04442126|581437814|FG006|Overall Study|Progressive Disease|0|||
161014026|NCT04442126|581437815|FG007|Overall Study|Progressive Disease|0|||
161014027|NCT04442126|581437816|FG008|Overall Study|Progressive Disease|0|||
161014028|NCT04442126|581437808|FG000|Overall Study|Other|0|||
161014029|NCT04442126|581437809|FG001|Overall Study|Other|0|||
161014030|NCT04442126|581437810|FG002|Overall Study|Other|0|||
161014031|NCT04442126|581437811|FG003|Overall Study|Other|0|||
161014032|NCT04442126|581437812|FG004|Overall Study|Other|0|||
161014033|NCT04442126|581437813|FG005|Overall Study|Other|0|||
161014034|NCT04442126|581437814|FG006|Overall Study|Other|0|||
161014035|NCT04442126|581437815|FG007|Overall Study|Other|0|||
161014036|NCT04442126|581437816|FG008|Overall Study|Other|1|||
161014037|NCT06450405|581437817|FG000|Overall Study|Study funding terminated.|0|||
161014038|NCT06450405|581437818|FG001|Overall Study|Study funding terminated.|2|||
161014039|NCT03152786|581438866|FG000|Overall Study|Withdrawal by Subject|2|||
161014040|NCT03152786|581438867|FG001|Overall Study|Withdrawal by Subject|1|||
161014041|NCT02525692|581438868|FG000|Overall Study|Withdrawal by Subject|1|||
161014042|NCT02525692|581438869|FG001|Overall Study|Withdrawal by Subject|1|||
161014043|NCT02525692|581438870|FG002|Overall Study|Withdrawal by Subject|0|||
161014044|NCT02525692|581438871|FG003|Overall Study|Withdrawal by Subject|5|||
161014045|NCT02525692|581438872|FG004|Overall Study|Withdrawal by Subject|0|||
161014046|NCT02525692|581438873|FG005|Overall Study|Withdrawal by Subject|1|||
161014047|NCT02525692|581438868|FG000|Overall Study|Death|16|||
161014048|NCT02525692|581438869|FG001|Overall Study|Death|18|||
161014049|NCT02525692|581438870|FG002|Overall Study|Death|7|||
161014050|NCT02525692|581438871|FG003|Overall Study|Death|20|||
161014051|NCT02525692|581438872|FG004|Overall Study|Death|3|||
161014052|NCT02525692|581438873|FG005|Overall Study|Death|6|||
161014053|NCT02525692|581438868|FG000|Overall Study|Lost to Follow-up|0|||
161014054|NCT02525692|581438869|FG001|Overall Study|Lost to Follow-up|0|||
161014055|NCT02525692|581438870|FG002|Overall Study|Lost to Follow-up|1|||
161014056|NCT02525692|581438871|FG003|Overall Study|Lost to Follow-up|5|||
161014057|NCT02525692|581438872|FG004|Overall Study|Lost to Follow-up|0|||
161014058|NCT02525692|581438873|FG005|Overall Study|Lost to Follow-up|0|||
161014059|NCT02396199|581438874|FG000|Overall Study|Lost to Follow-up|1|||
161014060|NCT02396199|581438874|FG000|Overall Study|Death|4|||
161014061|NCT04247542|581438877|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
161014062|NCT04247542|581438878|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
161014063|NCT04247542|581438879|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
161014064|NCT04247542|581438877|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
161014065|NCT04247542|581438878|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
161014066|NCT04247542|581438879|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
161014067|NCT06066541|581438880|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
161014068|NCT06066541|581438881|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
161014069|NCT06066541|581438882|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
161014070|NCT06066541|581438883|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
161014071|NCT06066541|581438884|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
161014072|NCT06066541|581438885|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
161014073|NCT06066541|581438886|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
161014074|NCT06066541|581438880|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
161014075|NCT06066541|581438881|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
160657039|NCT05097989|580124500|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
161014076|NCT06066541|581438882|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
161014077|NCT06066541|581438883|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
161014078|NCT06066541|581438884|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
161014079|NCT06066541|581438885|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
161014080|NCT06066541|581438886|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
161014081|NCT04533022|581438887|FG000|Overall Study|Withdrawal by Subject|15|||
161014082|NCT04533022|581438887|FG000|Overall Study|Adverse Event|6|||
160459115|NCT02492711|579413543|FG001|Overall Study|Adverse Event|9|||
161014083|NCT04533022|581438887|FG000|Overall Study|Death|1|||
161014084|NCT04533022|581438887|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
161014085|NCT04533022|581438887|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
160459116|NCT02492711|579413544|FG002|Overall Study|Adverse Event|2|||
160657040|NCT05097989|580124501|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
161014086|NCT02163447|581438888|FG000|Overall Study|Withdrawal by Subject|2|||
160657041|NCT05097989|580124502|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
160459117|NCT02492711|579413542|FG000|Overall Study|Death|3|||
161014087|NCT02163447|581438889|FG001|Overall Study|Withdrawal by Subject|0|||
161014088|NCT02163447|581438890|FG002|Overall Study|Withdrawal by Subject|1|||
161014089|NCT02163447|581438888|FG000|Overall Study|Lost to Follow-up|1|||
161014090|NCT02163447|581438889|FG001|Overall Study|Lost to Follow-up|3|||
161014091|NCT02163447|581438890|FG002|Overall Study|Lost to Follow-up|0|||
161014092|NCT02163447|581438888|FG000|Overall Study|Moved out of study area|2|||
161014093|NCT02163447|581438889|FG001|Overall Study|Moved out of study area|3|||
161014094|NCT02163447|581438890|FG002|Overall Study|Moved out of study area|2|||
161014095|NCT02163447|581438888|FG000|Overall Study|Became HIV infected at time of delivery|1|||
161014096|NCT02163447|581438889|FG001|Overall Study|Became HIV infected at time of delivery|0|||
161014097|NCT02163447|581438890|FG002|Overall Study|Became HIV infected at time of delivery|0|||
161014098|NCT03157167|581438891|FG000|Overall Study|Withdrawal by Subject|1|||
161014099|NCT03157167|581438892|FG001|Overall Study|Withdrawal by Subject|0|||
161014100|NCT03157167|581438893|FG002|Overall Study|Withdrawal by Subject|0|||
161014101|NCT02597946|581438895|FG000|Overall Study|Withdrawal by Subject|1|||
161014102|NCT02597946|581438895|FG000|Overall Study|Progressive disease|16|||
161014103|NCT02597946|581438895|FG000|Overall Study|Other than above|1|||
161014104|NCT03263026|581438896|FG000|Overall Study|Withdrawal by Subject|1|||
161014105|NCT03263026|581438897|FG001|Overall Study|Withdrawal by Subject|0|||
161014106|NCT03263026|581438896|FG000|Overall Study|Death|1|||
161014107|NCT03263026|581438897|FG001|Overall Study|Death|0|||
161014108|NCT03263026|581438896|FG000|Overall Study|Other/ Various|41|||
161014109|NCT03263026|581438897|FG001|Overall Study|Other/ Various|29|||
161014110|NCT01938547|581438906|FG000|Overall Study|Physician Decision|1|||
161014111|NCT05320432|581438911|FG000|Overall Study|Withdrawal by Subject|0|||
161014112|NCT05320432|581438912|FG001|Overall Study|Withdrawal by Subject|2|||
161014113|NCT05038566|581438913|FG000|Overall Study|Technical Difficulties with the Device|0|||
160657042|NCT05097989|580124503|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
160967970|NCT04026165|581271377|FG002|Run-in Placebo Period|Withdrew Consent|0|||
160967971|NCT04026165|581271378|FG003|Run-in Placebo Period|Withdrew Consent|0|||
160967972|NCT04026165|581271375|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
160967973|NCT04026165|581271376|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
160967974|NCT04026165|581271377|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
160967975|NCT04026165|581271378|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
160967976|NCT04026165|581271375|FG000|Run-in SEL Period|Run-in Failure|0|||
160967977|NCT04026165|581271376|FG001|Run-in SEL Period|Run-in Failure|26|||
160967978|NCT04026165|581271377|FG002|Run-in SEL Period|Run-in Failure|0|||
160967979|NCT04026165|581271378|FG003|Run-in SEL Period|Run-in Failure|0|||
160967980|NCT04026165|581271375|FG000|Run-in SEL Period|Withdrew Consent|0|||
160967981|NCT04026165|581271376|FG001|Run-in SEL Period|Withdrew Consent|10|||
160967982|NCT04026165|581271377|FG002|Run-in SEL Period|Withdrew Consent|0|||
160967983|NCT04026165|581271378|FG003|Run-in SEL Period|Withdrew Consent|0|||
160967984|NCT04026165|581271375|FG000|Run-in SEL Period|Enrollment Error|0|||
160967985|NCT04026165|581271376|FG001|Run-in SEL Period|Enrollment Error|4|||
160967986|NCT04026165|581271377|FG002|Run-in SEL Period|Enrollment Error|0|||
160967987|NCT04026165|581271378|FG003|Run-in SEL Period|Enrollment Error|0|||
160967988|NCT04026165|581271375|FG000|Run-in SEL Period|Protocol Violation|0|||
160967989|NCT04026165|581271376|FG001|Run-in SEL Period|Protocol Violation|3|||
160967990|NCT04026165|581271377|FG002|Run-in SEL Period|Protocol Violation|0|||
160967991|NCT04026165|581271378|FG003|Run-in SEL Period|Protocol Violation|0|||
160967992|NCT04026165|581271375|FG000|Run-in SEL Period|Investigator's Discretion|0|||
160967993|NCT04026165|581271376|FG001|Run-in SEL Period|Investigator's Discretion|2|||
160967994|NCT04026165|581271377|FG002|Run-in SEL Period|Investigator's Discretion|0|||
160967995|NCT04026165|581271378|FG003|Run-in SEL Period|Investigator's Discretion|0|||
160967996|NCT04026165|581271375|FG000|Run-in SEL Period|Death|0|||
160967997|NCT04026165|581271376|FG001|Run-in SEL Period|Death|1|||
160967998|NCT04026165|581271377|FG002|Run-in SEL Period|Death|0|||
160967999|NCT04026165|581271378|FG003|Run-in SEL Period|Death|0|||
160968000|NCT04026165|581271375|FG000|Randomized Period|Withdrew Consent|0|||
160968001|NCT04026165|581271376|FG001|Randomized Period|Withdrew Consent|0|||
160968002|NCT04026165|581271377|FG002|Randomized Period|Withdrew Consent|5|||
160968003|NCT04026165|581271378|FG003|Randomized Period|Withdrew Consent|8|||
160968004|NCT04026165|581271375|FG000|Randomized Period|Death|0|||
160968005|NCT04026165|581271376|FG001|Randomized Period|Death|0|||
160968006|NCT04026165|581271377|FG002|Randomized Period|Death|5|||
160968007|NCT04026165|581271378|FG003|Randomized Period|Death|7|||
160968008|NCT04026165|581271375|FG000|Randomized Period|Investigator's Discretion|0|||
160968009|NCT04026165|581271376|FG001|Randomized Period|Investigator's Discretion|0|||
160968010|NCT04026165|581271377|FG002|Randomized Period|Investigator's Discretion|2|||
160968011|NCT04026165|581271378|FG003|Randomized Period|Investigator's Discretion|2|||
160968012|NCT04026165|581271375|FG000|Randomized Period|Lost to Follow-up|0|||
160968013|NCT04026165|581271376|FG001|Randomized Period|Lost to Follow-up|0|||
160459118|NCT02492711|579413543|FG001|Overall Study|Death|3|||
160459119|NCT02492711|579413544|FG002|Overall Study|Death|0|||
160968014|NCT04026165|581271377|FG002|Randomized Period|Lost to Follow-up|2|||
160459120|NCT02492711|579413542|FG000|Overall Study|Withdrawal by Subject|10|||
160459121|NCT02492711|579413543|FG001|Overall Study|Withdrawal by Subject|16|||
160968015|NCT04026165|581271378|FG003|Randomized Period|Lost to Follow-up|2|||
160968016|NCT03170375|581271379|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
160968017|NCT03170375|581271380|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
160968018|NCT03170375|581271381|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
160968019|NCT03170375|581271379|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
160968020|NCT03170375|581271380|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
160968021|NCT03170375|581271381|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
160968022|NCT00077064|581271382|FG000|Overall Study|Adverse Event|0|||
160968023|NCT00077064|581271383|FG001|Overall Study|Adverse Event|4|||
160968024|NCT00077064|581271382|FG000|Overall Study|Patient refusal|0|||
160968025|NCT00077064|581271383|FG001|Overall Study|Patient refusal|2|||
160968026|NCT02007434|581271384|FG000|Overall Study|Lost to Follow-up|0|||
160968027|NCT02007434|581271385|FG001|Overall Study|Lost to Follow-up|1|||
160968028|NCT02007434|581271386|FG002|Overall Study|Lost to Follow-up|0|||
160968029|NCT02007434|581271387|FG003|Overall Study|Lost to Follow-up|0|||
160968030|NCT02007434|581271388|FG004|Overall Study|Lost to Follow-up|0|||
160968031|NCT02007434|581271389|FG005|Overall Study|Lost to Follow-up|0|||
160968032|NCT02007434|581271390|FG006|Overall Study|Lost to Follow-up|0|||
160968033|NCT02007434|581271391|FG007|Overall Study|Lost to Follow-up|0|||
160968034|NCT02007434|581271384|FG000|Overall Study|Non-compliance|1|||
160968035|NCT02007434|581271385|FG001|Overall Study|Non-compliance|0|||
160968036|NCT02007434|581271386|FG002|Overall Study|Non-compliance|1|||
160968037|NCT02007434|581271387|FG003|Overall Study|Non-compliance|0|||
160968038|NCT02007434|581271388|FG004|Overall Study|Non-compliance|0|||
160968039|NCT02007434|581271389|FG005|Overall Study|Non-compliance|0|||
160968040|NCT02007434|581271390|FG006|Overall Study|Non-compliance|0|||
160968041|NCT02007434|581271391|FG007|Overall Study|Non-compliance|0|||
160968042|NCT00763958|581271392|FG000|Overall Study|did not meet final criteria|4|||
160968043|NCT00763958|581271393|FG001|Overall Study|did not meet final criteria|4|||
160968044|NCT00763958|581271392|FG000|Overall Study|Lost to Follow-up|10|||
160968045|NCT00763958|581271393|FG001|Overall Study|Lost to Follow-up|2|||
160968046|NCT00763958|581271392|FG000|Overall Study|Believed they were receiving placebo|0|||
160968047|NCT00763958|581271393|FG001|Overall Study|Believed they were receiving placebo|5|||
160968048|NCT00927355|581271394|FG000|Overall Study|Adverse Event|1|||
160968049|NCT00927355|581271395|FG001|Overall Study|Adverse Event|1|||
160968050|NCT03299686|581271396|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
160968051|NCT03299686|581271397|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
160968052|NCT03299686|581271396|FG000|Treatment Epoch|Physician Decision|1|||
160968053|NCT03299686|581271397|FG001|Treatment Epoch|Physician Decision|0|||
160968054|NCT03299686|581271396|FG000|Treatment Epoch|Adverse Event|8|||
160968055|NCT03299686|581271397|FG001|Treatment Epoch|Adverse Event|4|||
160968056|NCT03299686|581271396|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
160968057|NCT03299686|581271397|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
160968058|NCT02889133|581271399|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
160968059|NCT02889133|581271400|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
160968060|NCT02889133|581271399|FG000|Completed Primary Outcome|Manufacturing error|3|||
160968061|NCT02889133|581271400|FG001|Completed Primary Outcome|Manufacturing error|8|||
160968062|NCT02889133|581271399|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
160968063|NCT02889133|581271400|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
160968064|NCT02889133|581271399|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
160968065|NCT02889133|581271400|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
160968066|NCT02889133|581271399|FG000|Completed Primary Outcome|Protocol Violation|1|||
160968067|NCT02889133|581271400|FG001|Completed Primary Outcome|Protocol Violation|0|||
160968068|NCT02889133|581271399|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
160968069|NCT02889133|581271400|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
160968070|NCT02889133|581271399|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
160968071|NCT02889133|581271400|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
160968072|NCT02889133|581271399|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
160968073|NCT02889133|581271400|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
160968074|NCT02889133|581271399|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
160968075|NCT02889133|581271400|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
160968076|NCT02889133|581271399|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
160968077|NCT02889133|581271400|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
160968078|NCT01060553|581271401|FG000|Overall Study|Lost to Follow-up|3|||
160968079|NCT01060553|581271402|FG001|Overall Study|Lost to Follow-up|5|||
160968080|NCT01060553|581271401|FG000|Overall Study|Withdrawal by Subject|5|||
160968081|NCT01060553|581271402|FG001|Overall Study|Withdrawal by Subject|5|||
160968082|NCT01060553|581271401|FG000|Overall Study|Lack of Efficacy|1|||
160968083|NCT01060553|581271402|FG001|Overall Study|Lack of Efficacy|0|||
160968084|NCT01781390|581271406|FG000|Overall Study|Withdrawal of Consent|0|||
160968085|NCT01781390|581271407|FG001|Overall Study|Withdrawal of Consent|3|||
160968086|NCT01781390|581271408|FG002|Overall Study|Withdrawal of Consent|1|||
160968087|NCT01781390|581271406|FG000|Overall Study|Lost to Follow-up|1|||
161014114|NCT05038566|581438914|FG001|Overall Study|Technical Difficulties with the Device|1|||
161014115|NCT05387447|581438923|FG000|Overall Study|Participants changed their minds about study participation.|3|||
161014116|NCT05387447|581438924|FG001|Overall Study|Participants changed their minds about study participation.|5|||
161014117|NCT04178733|581438925|FG000|Overall Study|Investigator Decision|0|||
161014118|NCT04178733|581438926|FG001|Overall Study|Investigator Decision|0|||
161014119|NCT04178733|581438927|FG002|Overall Study|Investigator Decision|0|||
161014120|NCT04178733|581438928|FG003|Overall Study|Investigator Decision|1|||
161014121|NCT04178733|581438929|FG004|Overall Study|Investigator Decision|2|||
161014122|NCT03655132|581438932|FG000|Overall Study|Lost to Follow-up|2|||
161014123|NCT03655132|581438933|FG001|Overall Study|Lost to Follow-up|1|||
161014124|NCT03655132|581438932|FG000|Overall Study|Withdrawal by Subject|0|||
161014125|NCT03655132|581438933|FG001|Overall Study|Withdrawal by Subject|1|||
161014126|NCT03655132|581438932|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
161014127|NCT03655132|581438933|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
161014128|NCT05919082|581438937|FG000|Overall Study|Adverse Event|3|||
160586087|NCT00343291|579863981|FG000|Overall Study|Progressive disease|33|||
160586088|NCT00343291|579863982|FG001|Overall Study|Progressive disease|34|||
160586089|NCT00343291|579863981|FG000|Overall Study|Withdrawal by Subject|0|||
160586090|NCT00343291|579863982|FG001|Overall Study|Withdrawal by Subject|2|||
160586091|NCT00343291|579863981|FG000|Overall Study|Other|8|||
160586092|NCT00343291|579863982|FG001|Overall Study|Other|5|||
160586093|NCT01332019|579863987|FG000|Overall Study|Was Not Dosed|1|||
160586094|NCT01332019|579863988|FG001|Overall Study|Was Not Dosed|0|||
160586095|NCT01332019|579863987|FG000|Overall Study|Other|16|||
160586096|NCT01332019|579863988|FG001|Overall Study|Other|18|||
160586097|NCT01332019|579863987|FG000|Overall Study|Death|2|||
160586098|NCT01332019|579863988|FG001|Overall Study|Death|1|||
160586099|NCT01332019|579863987|FG000|Overall Study|Physician Decision|4|||
160586100|NCT01332019|579863988|FG001|Overall Study|Physician Decision|3|||
160586101|NCT01332019|579863987|FG000|Overall Study|Withdrawal by Subject|73|||
160586102|NCT01332019|579863988|FG001|Overall Study|Withdrawal by Subject|71|||
160586103|NCT01332019|579863987|FG000|Overall Study|Lost to Follow-up|4|||
160586104|NCT01332019|579863988|FG001|Overall Study|Lost to Follow-up|7|||
160586105|NCT01332019|579863987|FG000|Overall Study|Adverse Event|13|||
160586106|NCT01332019|579863988|FG001|Overall Study|Adverse Event|22|||
160586107|NCT00756886|579863991|FG000|Overall Study|Lost to Follow-up|1|||
160586108|NCT00756886|579863992|FG001|Overall Study|Lost to Follow-up|0|||
160586109|NCT00756886|579863991|FG000|Overall Study|Adverse Event|0|||
160586110|NCT00756886|579863992|FG001|Overall Study|Adverse Event|3|||
160586111|NCT00756886|579863991|FG000|Overall Study|Lack of Efficacy|1|||
160586112|NCT00756886|579863992|FG001|Overall Study|Lack of Efficacy|0|||
160586113|NCT00756886|579863991|FG000|Overall Study|Ineligible|9|||
160586114|NCT00756886|579863992|FG001|Overall Study|Ineligible|4|||
160586115|NCT04348656|579863997|FG000|Overall Study|Withdrawal by Subject|2|||
160586116|NCT04348656|579863998|FG001|Overall Study|Withdrawal by Subject|0|||
160586117|NCT04348656|579863997|FG000|Overall Study|Lost to Follow-up|11|||
160586118|NCT04348656|579863998|FG001|Overall Study|Lost to Follow-up|6|||
160586119|NCT04281030|579863999|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
160586120|NCT04281030|579864000|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
160586121|NCT04281030|579863999|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
160586122|NCT04281030|579864000|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
160586123|NCT01395368|579864001|FG000|Overall Study|Physician Decision|14|||
160586124|NCT01395368|579864001|FG000|Overall Study|Withdrawal by Subject|2|||
160586125|NCT00310388|579864002|FG000|Primary Reporting Phase|Adverse Event|101|||
160586126|NCT00310388|579864003|FG001|Primary Reporting Phase|Adverse Event|0|||
160586127|NCT00310388|579864002|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
160586128|NCT00310388|579864003|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
160586129|NCT00310388|579864002|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
160586130|NCT00310388|579864003|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
160586131|NCT00310388|579864002|FG000|Primary Reporting Phase|Protocol Violation|10|||
160586132|NCT00310388|579864003|FG001|Primary Reporting Phase|Protocol Violation|0|||
160586133|NCT00310388|579864002|FG000|Primary Reporting Phase|Pregnancy|3|||
160586134|NCT00310388|579864003|FG001|Primary Reporting Phase|Pregnancy|0|||
160586135|NCT00310388|579864002|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
160586136|NCT00310388|579864003|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
160586137|NCT00310388|579864002|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
160586138|NCT00310388|579864003|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
160586139|NCT00310388|579864002|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
160586140|NCT00310388|579864003|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
160586141|NCT00310388|579864002|FG000|Primary Reporting Phase|Physician Decision|2|||
160586142|NCT00310388|579864003|FG001|Primary Reporting Phase|Physician Decision|0|||
160586143|NCT00310388|579864002|FG000|Primary Reporting Phase|Request of the sponsor|19|||
161014129|NCT05919082|581438938|FG001|Overall Study|Adverse Event|0|||
161014130|NCT05919082|581438937|FG000|Overall Study|Lost to Follow-up|0|||
161014131|NCT05919082|581438938|FG001|Overall Study|Lost to Follow-up|1|||
161014132|NCT05919082|581438937|FG000|Overall Study|Withdrawal by Subject|8|||
161014133|NCT05919082|581438938|FG001|Overall Study|Withdrawal by Subject|9|||
161014134|NCT05919082|581438937|FG000|Overall Study|Lack of Efficacy|0|||
161014135|NCT05919082|581438938|FG001|Overall Study|Lack of Efficacy|1|||
161014136|NCT05919082|581438937|FG000|Overall Study|Investigator Decision|1|||
161014137|NCT05919082|581438938|FG001|Overall Study|Investigator Decision|0|||
161014138|NCT05439603|581438939|FG000|Overall Study|met withdrawal criteria|2|||
161014139|NCT03896516|581438943|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
161014140|NCT03896516|581438944|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
161014141|NCT03896516|581438943|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
161014142|NCT03896516|581438944|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
161014143|NCT03896516|581438943|FG000|Washout Period|Physician Decision|3|||
161014144|NCT03896516|581438944|FG001|Washout Period|Physician Decision|1|||
161014145|NCT03896516|581438943|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
161014146|NCT03896516|581438944|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
161014147|NCT05461131|581438945|FG000|Overall Study|Lost to Follow-up|0|||
161014148|NCT05461131|581438946|FG001|Overall Study|Lost to Follow-up|2|||
161014149|NCT04549168|581438952|FG000|Randomization Phase|Adverse Event|0|||
161014150|NCT04549168|581438953|FG001|Randomization Phase|Adverse Event|0|||
161014151|NCT04549168|581438954|FG002|Randomization Phase|Adverse Event|1|||
161014152|NCT04549168|581438952|FG000|Randomization Phase|Other|0|||
161014153|NCT04549168|581438953|FG001|Randomization Phase|Other|2|||
161014154|NCT04549168|581438954|FG002|Randomization Phase|Other|0|||
161014155|NCT04549168|581438952|FG000|Randomization Phase|Withdrawal by Subject|0|||
161014156|NCT04549168|581438953|FG001|Randomization Phase|Withdrawal by Subject|2|||
161014157|NCT04549168|581438954|FG002|Randomization Phase|Withdrawal by Subject|1|||
161014158|NCT04791709|581438963|FG000|Overall Study|Withdrawal by Subject|3|||
161014159|NCT03578536|581438964|FG000|Overall Study|Lost to Follow-up|1|||
161014160|NCT00274469|581438965|FG000|Overall Study|Death|63|||
161014161|NCT00274469|581438966|FG001|Overall Study|Death|74|||
161014162|NCT00274469|581438965|FG000|Overall Study|Did not consent to OS follow-up|16|||
161014163|NCT00274469|581438966|FG001|Overall Study|Did not consent to OS follow-up|19|||
161014164|NCT04623775|581438975|FG000|Randomization|No Longer Meets Study Criteria|2|||
161014165|NCT04623775|581438976|FG001|Randomization|No Longer Meets Study Criteria|1|||
161014166|NCT04623775|581438977|FG002|Randomization|No Longer Meets Study Criteria|0|||
161014167|NCT04623775|581438978|FG003|Randomization|No Longer Meets Study Criteria|0|||
161014168|NCT04623775|581438975|FG000|Randomization|Withdrew Consent|0|||
161014169|NCT04623775|581438976|FG001|Randomization|Withdrew Consent|0|||
161014170|NCT04623775|581438977|FG002|Randomization|Withdrew Consent|0|||
161014171|NCT04623775|581438978|FG003|Randomization|Withdrew Consent|1|||
161014172|NCT04623775|581438975|FG000|Randomization|Other Reasons|0|||
161014173|NCT04623775|581438976|FG001|Randomization|Other Reasons|0|||
161014174|NCT04623775|581438977|FG002|Randomization|Other Reasons|0|||
161014175|NCT04623775|581438978|FG003|Randomization|Other Reasons|1|||
161014176|NCT04623775|581438975|FG000|Treatment Period|participant withdrew consent|4|||
161014177|NCT04623775|581438976|FG001|Treatment Period|participant withdrew consent|0|||
161014178|NCT04623775|581438977|FG002|Treatment Period|participant withdrew consent|1|||
161014179|NCT04623775|581438978|FG003|Treatment Period|participant withdrew consent|2|||
161014180|NCT04623775|581438975|FG000|Treatment Period|Death|3|||
161014181|NCT04623775|581438976|FG001|Treatment Period|Death|1|||
161014182|NCT04623775|581438977|FG002|Treatment Period|Death|4|||
161014183|NCT04623775|581438978|FG003|Treatment Period|Death|2|||
161014184|NCT04623775|581438975|FG000|Treatment Period|Lost to Follow-up|0|||
161014185|NCT04623775|581438976|FG001|Treatment Period|Lost to Follow-up|2|||
161014186|NCT04623775|581438977|FG002|Treatment Period|Lost to Follow-up|0|||
161014187|NCT04623775|581438978|FG003|Treatment Period|Lost to Follow-up|0|||
161014188|NCT04623775|581438975|FG000|Treatment Period|poor/non compliance|0|||
161014189|NCT04623775|581438976|FG001|Treatment Period|poor/non compliance|0|||
161014190|NCT04623775|581438977|FG002|Treatment Period|poor/non compliance|1|||
161014191|NCT04623775|581438978|FG003|Treatment Period|poor/non compliance|0|||
161014192|NCT04623775|581438975|FG000|Treatment Period|participant no longer meets study criteria|0|||
161014193|NCT04623775|581438976|FG001|Treatment Period|participant no longer meets study criteria|1|||
161014194|NCT04623775|581438977|FG002|Treatment Period|participant no longer meets study criteria|0|||
160459122|NCT02492711|579413544|FG002|Overall Study|Withdrawal by Subject|5|||
160586144|NCT00310388|579864003|FG001|Primary Reporting Phase|Request of the sponsor|0|||
160586145|NCT00310388|579864002|FG000|Primary Reporting Phase|Failed to return|8|||
161014195|NCT04623775|581438978|FG003|Treatment Period|participant no longer meets study criteria|0|||
161014196|NCT04623775|581438975|FG000|Treatment Period|administrative reasons by sponsor|3|||
161014197|NCT04623775|581438976|FG001|Treatment Period|administrative reasons by sponsor|2|||
161014198|NCT04623775|581438977|FG002|Treatment Period|administrative reasons by sponsor|0|||
161014199|NCT04623775|581438978|FG003|Treatment Period|administrative reasons by sponsor|0|||
161014200|NCT04623775|581438975|FG000|Treatment Period|other reasons|2|||
161014201|NCT04623775|581438976|FG001|Treatment Period|other reasons|0|||
161014202|NCT04623775|581438977|FG002|Treatment Period|other reasons|1|||
161014203|NCT04623775|581438978|FG003|Treatment Period|other reasons|1|||
161014204|NCT04623775|581438975|FG000|Treatment Period|disease progression|40|||
161014205|NCT04623775|581438976|FG001|Treatment Period|disease progression|35|||
161014206|NCT04623775|581438977|FG002|Treatment Period|disease progression|63|||
161014207|NCT04623775|581438978|FG003|Treatment Period|disease progression|63|||
161014208|NCT04623775|581438975|FG000|Treatment Period|study drug toxicity|12|||
161014209|NCT04623775|581438976|FG001|Treatment Period|study drug toxicity|15|||
161014210|NCT04623775|581438977|FG002|Treatment Period|study drug toxicity|13|||
161014211|NCT04623775|581438978|FG003|Treatment Period|study drug toxicity|12|||
161014212|NCT04623775|581438975|FG000|Treatment Period|AE unrelated to study drug|4|||
161014213|NCT04623775|581438976|FG001|Treatment Period|AE unrelated to study drug|9|||
161014214|NCT04623775|581438977|FG002|Treatment Period|AE unrelated to study drug|12|||
161014215|NCT04623775|581438978|FG003|Treatment Period|AE unrelated to study drug|9|||
161014216|NCT04623775|581438975|FG000|Treatment Period|participant request to discontinue treatment|0|||
161014217|NCT04623775|581438976|FG001|Treatment Period|participant request to discontinue treatment|2|||
161014218|NCT04623775|581438977|FG002|Treatment Period|participant request to discontinue treatment|2|||
161014219|NCT04623775|581438978|FG003|Treatment Period|participant request to discontinue treatment|0|||
161014220|NCT03767517|581438979|FG000|Overall Study|Lost to Follow-up|16|||
161014221|NCT03767517|581438980|FG001|Overall Study|Lost to Follow-up|10|||
161014222|NCT03767517|581438979|FG000|Overall Study|Death|2|||
161014223|NCT03767517|581438980|FG001|Overall Study|Death|3|||
161014224|NCT04112316|581440079|FG000|First Period (8 Weeks)|Protocol Violation|1|||
161014225|NCT04112316|581440080|FG001|First Period (8 Weeks)|Protocol Violation|0|||
161014226|NCT04112316|581440079|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
161014227|NCT04112316|581440080|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
161014228|NCT03775109|581440096|FG000|Overall Study|Adverse Event|1|||
161014229|NCT03775109|581440097|FG001|Overall Study|Adverse Event|0|||
161014230|NCT03775109|581440096|FG000|Overall Study|COVID-19 outbreak|2|||
161014231|NCT03775109|581440097|FG001|Overall Study|COVID-19 outbreak|0|||
161014232|NCT03775109|581440096|FG000|Overall Study|Lost to Follow-up|0|||
161014233|NCT03775109|581440097|FG001|Overall Study|Lost to Follow-up|2|||
161014234|NCT03775109|581440096|FG000|Overall Study|Withdrawal by Subject|1|||
161014235|NCT03775109|581440097|FG001|Overall Study|Withdrawal by Subject|1|||
161014236|NCT03775109|581440096|FG000|Overall Study|Death|0|||
161014237|NCT03775109|581440097|FG001|Overall Study|Death|1|||
161014238|NCT03775109|581440096|FG000|Overall Study|Lack of Efficacy|1|||
161014239|NCT03775109|581440097|FG001|Overall Study|Lack of Efficacy|0|||
161014240|NCT04850807|581440107|FG000|Overall Study|Death|50|||
161014241|NCT04850807|581440108|FG001|Overall Study|Death|55|||
161014242|NCT04850807|581440107|FG000|Overall Study|Discharged|17|||
161014243|NCT04850807|581440108|FG001|Overall Study|Discharged|13|||
160586146|NCT00310388|579864003|FG001|Primary Reporting Phase|Failed to return|0|||
160586147|NCT00310388|579864002|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
160586148|NCT00310388|579864003|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
160586149|NCT00310388|579864002|FG000|Primary Reporting Phase|Participant request|2|||
160586150|NCT00310388|579864003|FG001|Primary Reporting Phase|Participant request|0|||
160586151|NCT00310388|579864002|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
160586152|NCT00310388|579864003|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
160586153|NCT00310388|579864002|FG000|Primary Reporting Phase|Discontinuation of study|1|||
160586154|NCT00310388|579864003|FG001|Primary Reporting Phase|Discontinuation of study|0|||
160586155|NCT00310388|579864002|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
160586156|NCT00310388|579864003|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
160586157|NCT00310388|579864002|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
160586158|NCT00310388|579864003|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
160586159|NCT00310388|579864002|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
160586160|NCT00310388|579864003|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
160586161|NCT00310388|579864002|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
160586162|NCT00310388|579864003|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
160657043|NCT05097989|580124504|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
161014244|NCT04850807|581440107|FG000|Overall Study|Incomplete baseline data|3|||
161014245|NCT04850807|581440108|FG001|Overall Study|Incomplete baseline data|2|||
161014246|NCT03739996|581440115|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
161014247|NCT03739996|581440115|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
161014248|NCT03739996|581440115|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
161014249|NCT03739996|581440115|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
161014250|NCT03739996|581440115|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
161014251|NCT03739996|581440115|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
161014252|NCT03739996|581440115|FG000|Step 3 (SOC ART)|Death|1|||
161014253|NCT03739996|581440115|FG000|Step 3 (SOC ART)|Participant moved|1|||
161014254|NCT05141903|581440116|FG000|Overall Study|Withdrawal by Subject|0|||
161014255|NCT05141903|581440117|FG001|Overall Study|Withdrawal by Subject|1|||
161014256|NCT05141903|581440118|FG002|Overall Study|Withdrawal by Subject|1|||
161014257|NCT05141903|581440119|FG003|Overall Study|Withdrawal by Subject|0|||
161014258|NCT05141903|581440120|FG004|Overall Study|Withdrawal by Subject|0|||
161014259|NCT05141903|581440116|FG000|Overall Study|Other|1|||
161014260|NCT05141903|581440117|FG001|Overall Study|Other|1|||
161014261|NCT05141903|581440118|FG002|Overall Study|Other|0|||
161014262|NCT05141903|581440119|FG003|Overall Study|Other|0|||
161014263|NCT05141903|581440120|FG004|Overall Study|Other|0|||
161014264|NCT04737772|581440123|FG000|Phase 2 Study|Lost to Follow-up|15|||
161014265|NCT04737772|581440124|FG001|Phase 2 Study|Lost to Follow-up|15|||
161014266|NCT04737772|581440123|FG000|Phase 2 Study|Withdrawal by Subject|0|||
161014267|NCT04737772|581440124|FG001|Phase 2 Study|Withdrawal by Subject|1|||
161014268|NCT04737772|581440123|FG000|Phase 2 Study|Did not take any coaching calls|4|||
161014269|NCT04737772|581440124|FG001|Phase 2 Study|Did not take any coaching calls|0|||
161014270|NCT04737772|581440123|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
161014271|NCT04737772|581440124|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
161014272|NCT04737772|581440123|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
161014273|NCT04737772|581440124|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
161014274|NCT02549339|581440125|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
161014275|NCT02549339|581440126|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
161014276|NCT02549339|581440125|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
161014277|NCT02549339|581440126|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
161014278|NCT02549339|581440125|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
161014279|NCT02549339|581440126|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
161014280|NCT02549339|581440125|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
161014281|NCT02549339|581440126|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
161014282|NCT02549339|581440125|FG000|12-month Follow-up|Lack of Efficacy|0|||
161014283|NCT02549339|581440126|FG001|12-month Follow-up|Lack of Efficacy|2|||
161014284|NCT02549339|581440125|FG000|12-month Follow-up|Withdrawal by Subject|8|||
161014285|NCT02549339|581440126|FG001|12-month Follow-up|Withdrawal by Subject|3|||
161014286|NCT02549339|581440125|FG000|12-month Follow-up|Lost to Follow-up|1|||
161014287|NCT02549339|581440126|FG001|12-month Follow-up|Lost to Follow-up|3|||
161014288|NCT02549339|581440125|FG000|12-month Follow-up|Other|0|||
161014289|NCT02549339|581440126|FG001|12-month Follow-up|Other|3|||
161014290|NCT02728076|581440127|FG000|Overall Study|Physician Decision|4|||
161014291|NCT05054374|581440144|FG000|Overall Study|Withdrawal by Subject|1|||
161014292|NCT05054374|581440145|FG001|Overall Study|Withdrawal by Subject|0|||
161014293|NCT05054374|581440146|FG002|Overall Study|Withdrawal by Subject|0|||
161014294|NCT05054374|581440147|FG003|Overall Study|Withdrawal by Subject|0|||
161014295|NCT05054374|581440144|FG000|Overall Study|Progressive Disease|5|||
161014296|NCT05054374|581440145|FG001|Overall Study|Progressive Disease|0|||
161014297|NCT05054374|581440146|FG002|Overall Study|Progressive Disease|0|||
161014298|NCT05054374|581440147|FG003|Overall Study|Progressive Disease|0|||
161014299|NCT05691309|581440148|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
161014300|NCT05691309|581440148|FG000|Overall Study|vancomycin levels not evaluable|2|||
161014301|NCT01707030|581440149|FG000|Overall Study|Death|1|||
161014302|NCT01707030|581440150|FG001|Overall Study|Death|1|||
161014303|NCT01707030|581440149|FG000|Overall Study|Withdrawal by Subject|2|||
161014304|NCT01707030|581440150|FG001|Overall Study|Withdrawal by Subject|3|||
161014305|NCT01707030|581440149|FG000|Overall Study|Lost to Follow-up|8|||
161014306|NCT01707030|581440150|FG001|Overall Study|Lost to Follow-up|13|||
161014307|NCT05415410|581440152|FG000|Overall Study|Death|3|||
161014308|NCT05415410|581440153|FG001|Overall Study|Death|6|||
161014309|NCT05415410|581440154|FG002|Overall Study|Death|1|||
161014310|NCT05415410|581440152|FG000|Overall Study|Trial Terminated by Sponsor|1|||
161014311|NCT05415410|581440153|FG001|Overall Study|Trial Terminated by Sponsor|5|||
161014312|NCT05415410|581440154|FG002|Overall Study|Trial Terminated by Sponsor|0|||
161014313|NCT05415410|581440152|FG000|Overall Study|Adverse Event|2|||
161014314|NCT05415410|581440153|FG001|Overall Study|Adverse Event|1|||
161014315|NCT05415410|581440154|FG002|Overall Study|Adverse Event|0|||
161014316|NCT05415410|581440152|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
161014317|NCT05415410|581440153|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
161014318|NCT05415410|581440154|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
161014319|NCT05415410|581440152|FG000|Overall Study|Withdrawal by Subject|1|||
161014320|NCT05415410|581440153|FG001|Overall Study|Withdrawal by Subject|0|||
161014321|NCT05415410|581440154|FG002|Overall Study|Withdrawal by Subject|0|||
161014322|NCT05415410|581440152|FG000|Overall Study|Pregnancy|5|||
161014323|NCT05415410|581440153|FG001|Overall Study|Pregnancy|2|||
161014324|NCT05415410|581440154|FG002|Overall Study|Pregnancy|0|||
161014325|NCT02927769|581440155|FG000|Induction Phase|Study drug toxicity|1|||
161014326|NCT02927769|581440156|FG001|Induction Phase|Study drug toxicity|1|||
161014327|NCT02927769|581440155|FG000|Induction Phase|Disease progression|0|||
161014328|NCT02927769|581440156|FG001|Induction Phase|Disease progression|1|||
161014329|NCT02927769|581440155|FG000|Intensification Phase|Study drug toxicity|1|||
161014330|NCT02927769|581440156|FG001|Intensification Phase|Study drug toxicity|0|||
161014331|NCT01532388|581440161|FG000|3-month Follow-up|Lost to Follow-up|68|||
161014332|NCT01532388|581440162|FG001|3-month Follow-up|Lost to Follow-up|68|||
161014333|NCT01532388|581440161|FG000|6-month Follow-up|Lost to Follow-up|74|||
161014334|NCT01532388|581440162|FG001|6-month Follow-up|Lost to Follow-up|66|||
161014335|NCT01532388|581440161|FG000|12-month Follow-up|Lost to Follow-up|69|||
161014336|NCT01532388|581440162|FG001|12-month Follow-up|Lost to Follow-up|67|||
161014337|NCT00792636|581440163|FG000|Overall Study|Protocol Violation|17|||
161014338|NCT00792636|581440164|FG001|Overall Study|Protocol Violation|23|||
161014339|NCT00792636|581440165|FG002|Overall Study|Protocol Violation|20|||
161014340|NCT00792636|581440163|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
161014341|NCT00792636|581440164|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
161014342|NCT00792636|581440165|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
161014343|NCT00792636|581440163|FG000|Overall Study|Lost to Follow-up|13|||
161014344|NCT00792636|581440164|FG001|Overall Study|Lost to Follow-up|19|||
161014345|NCT00792636|581440165|FG002|Overall Study|Lost to Follow-up|14|||
161014346|NCT00792636|581440163|FG000|Overall Study|Withdrew Consent|10|||
161014347|NCT00792636|581440164|FG001|Overall Study|Withdrew Consent|13|||
161014348|NCT00792636|581440165|FG002|Overall Study|Withdrew Consent|9|||
161014349|NCT00792636|581440163|FG000|Overall Study|Lack of Efficacy|3|||
161014350|NCT00792636|581440164|FG001|Overall Study|Lack of Efficacy|4|||
161014351|NCT00792636|581440165|FG002|Overall Study|Lack of Efficacy|13|||
161014352|NCT00792636|581440163|FG000|Overall Study|Adverse Event|4|||
161014353|NCT00792636|581440164|FG001|Overall Study|Adverse Event|2|||
161014354|NCT00792636|581440165|FG002|Overall Study|Adverse Event|3|||
161014355|NCT00792636|581440163|FG000|Overall Study|Investigator Discretion|2|||
161014356|NCT00792636|581440164|FG001|Overall Study|Investigator Discretion|0|||
161014357|NCT00792636|581440165|FG002|Overall Study|Investigator Discretion|2|||
161014358|NCT00593489|581440166|FG000|Allocation|did not attend workshop; allocation not|2|||
161014359|NCT00593489|581440167|FG001|Allocation|did not attend workshop; allocation not|1|||
161014360|NCT03069313|581440168|FG000|Overall Study|Adverse Event|5|||
161014361|NCT01011946|581440169|FG000|Overall Study|Transferred to another hospital|2|||
161014362|NCT01011946|581440169|FG000|Overall Study|No pathological lab value|1|||
161014363|NCT03912831|581440171|FG000|Overall Study|Death|1|||
161014364|NCT03912831|581440172|FG001|Overall Study|Death|1|||
161014365|NCT03912831|581440173|FG002|Overall Study|Death|1|||
161014366|NCT03912831|581440174|FG003|Overall Study|Death|1|||
161014367|NCT03912831|581440175|FG004|Overall Study|Death|1|||
161014368|NCT03912831|581440176|FG005|Overall Study|Death|1|||
161014369|NCT03912831|581440171|FG000|Overall Study|Reason not Specified|0|||
161014370|NCT03912831|581440172|FG001|Overall Study|Reason not Specified|0|||
161014371|NCT03912831|581440173|FG002|Overall Study|Reason not Specified|0|||
161014372|NCT03912831|581440174|FG003|Overall Study|Reason not Specified|0|||
161014373|NCT03912831|581440175|FG004|Overall Study|Reason not Specified|1|||
161014374|NCT03912831|581440176|FG005|Overall Study|Reason not Specified|0|||
161014375|NCT03912831|581440171|FG000|Overall Study|Withdrawal by Participant|0|||
161014376|NCT03912831|581440172|FG001|Overall Study|Withdrawal by Participant|0|||
161014377|NCT03912831|581440173|FG002|Overall Study|Withdrawal by Participant|0|||
161014378|NCT03912831|581440174|FG003|Overall Study|Withdrawal by Participant|0|||
161014379|NCT03912831|581440175|FG004|Overall Study|Withdrawal by Participant|1|||
161014380|NCT03912831|581440176|FG005|Overall Study|Withdrawal by Participant|0|||
161014381|NCT03580369|581440177|FG000|Overall Study|No treatment due to mis-randomization|1|||
161014382|NCT03580369|581440178|FG001|Overall Study|No treatment due to mis-randomization|0|||
161014383|NCT03580369|581440179|FG002|Overall Study|No treatment due to mis-randomization|0|||
161014384|NCT03580369|581440180|FG003|Overall Study|No treatment due to mis-randomization|0|||
161014385|NCT03580369|581440181|FG004|Overall Study|No treatment due to mis-randomization|3|||
161014386|NCT03580369|581440182|FG005|Overall Study|No treatment due to mis-randomization|0|||
161014387|NCT03580369|581440183|FG006|Overall Study|No treatment due to mis-randomization|0|||
161014388|NCT03580369|581440184|FG007|Overall Study|No treatment due to mis-randomization|0|||
161014389|NCT03580369|581440177|FG000|Overall Study|Reason unknown|0|||
161014390|NCT03580369|581440178|FG001|Overall Study|Reason unknown|0|||
161014391|NCT03580369|581440179|FG002|Overall Study|Reason unknown|1|||
160459123|NCT02492711|579413542|FG000|Overall Study|Physician Decision|10|||
161014392|NCT03580369|581440180|FG003|Overall Study|Reason unknown|0|||
161014393|NCT03580369|581440181|FG004|Overall Study|Reason unknown|0|||
160586163|NCT00310388|579864002|FG000|Primary Reporting Phase|Participant passed away|1|||
161014394|NCT03580369|581440182|FG005|Overall Study|Reason unknown|0|||
161014395|NCT03580369|581440183|FG006|Overall Study|Reason unknown|0|||
161014396|NCT03580369|581440184|FG007|Overall Study|Reason unknown|0|||
161014397|NCT03580369|581440177|FG000|Overall Study|Technical problems|0|||
161014398|NCT03580369|581440178|FG001|Overall Study|Technical problems|0|||
160586164|NCT00310388|579864003|FG001|Primary Reporting Phase|Participant passed away|0|||
161014399|NCT03580369|581440179|FG002|Overall Study|Technical problems|0|||
160459124|NCT02492711|579413543|FG001|Overall Study|Physician Decision|6|||
160459125|NCT02492711|579413544|FG002|Overall Study|Physician Decision|4|||
161014400|NCT03580369|581440180|FG003|Overall Study|Technical problems|0|||
161014401|NCT03580369|581440181|FG004|Overall Study|Technical problems|1|||
161014402|NCT03580369|581440182|FG005|Overall Study|Technical problems|0|||
161014403|NCT03580369|581440183|FG006|Overall Study|Technical problems|2|||
161014404|NCT03580369|581440184|FG007|Overall Study|Technical problems|0|||
161014405|NCT03580369|581440177|FG000|Overall Study|Pregnancy|2|||
161014406|NCT03580369|581440178|FG001|Overall Study|Pregnancy|0|||
161014407|NCT03580369|581440179|FG002|Overall Study|Pregnancy|3|||
161014408|NCT03580369|581440180|FG003|Overall Study|Pregnancy|0|||
161014409|NCT03580369|581440181|FG004|Overall Study|Pregnancy|2|||
161014410|NCT03580369|581440182|FG005|Overall Study|Pregnancy|0|||
161014411|NCT03580369|581440183|FG006|Overall Study|Pregnancy|0|||
161014412|NCT03580369|581440184|FG007|Overall Study|Pregnancy|0|||
161014413|NCT03580369|581440177|FG000|Overall Study|Lost to Follow-up|2|||
161014414|NCT03580369|581440178|FG001|Overall Study|Lost to Follow-up|0|||
161014415|NCT03580369|581440179|FG002|Overall Study|Lost to Follow-up|2|||
161014416|NCT03580369|581440180|FG003|Overall Study|Lost to Follow-up|0|||
161014417|NCT03580369|581440181|FG004|Overall Study|Lost to Follow-up|3|||
161014418|NCT03580369|581440182|FG005|Overall Study|Lost to Follow-up|0|||
161014419|NCT03580369|581440183|FG006|Overall Study|Lost to Follow-up|1|||
161014420|NCT03580369|581440184|FG007|Overall Study|Lost to Follow-up|0|||
161014421|NCT03580369|581440177|FG000|Overall Study|Physician Decision|4|||
161014422|NCT03580369|581440178|FG001|Overall Study|Physician Decision|0|||
161014423|NCT03580369|581440179|FG002|Overall Study|Physician Decision|4|||
161014424|NCT03580369|581440180|FG003|Overall Study|Physician Decision|1|||
161014425|NCT03580369|581440181|FG004|Overall Study|Physician Decision|1|||
161014426|NCT03580369|581440182|FG005|Overall Study|Physician Decision|0|||
161014427|NCT03580369|581440183|FG006|Overall Study|Physician Decision|0|||
161014428|NCT03580369|581440184|FG007|Overall Study|Physician Decision|0|||
161014429|NCT03580369|581440177|FG000|Overall Study|Lack of Efficacy|3|||
161014430|NCT03580369|581440178|FG001|Overall Study|Lack of Efficacy|0|||
161014431|NCT03580369|581440179|FG002|Overall Study|Lack of Efficacy|7|||
161014432|NCT03580369|581440180|FG003|Overall Study|Lack of Efficacy|0|||
161014433|NCT03580369|581440181|FG004|Overall Study|Lack of Efficacy|2|||
161014434|NCT03580369|581440182|FG005|Overall Study|Lack of Efficacy|0|||
161014435|NCT03580369|581440183|FG006|Overall Study|Lack of Efficacy|3|||
161014436|NCT03580369|581440184|FG007|Overall Study|Lack of Efficacy|0|||
161014437|NCT03580369|581440177|FG000|Overall Study|Protocol Violation|6|||
161014438|NCT03580369|581440178|FG001|Overall Study|Protocol Violation|0|||
161014439|NCT03580369|581440179|FG002|Overall Study|Protocol Violation|6|||
161014440|NCT03580369|581440180|FG003|Overall Study|Protocol Violation|1|||
161014441|NCT03580369|581440181|FG004|Overall Study|Protocol Violation|8|||
161014442|NCT03580369|581440182|FG005|Overall Study|Protocol Violation|2|||
161014443|NCT03580369|581440183|FG006|Overall Study|Protocol Violation|1|||
161014444|NCT03580369|581440184|FG007|Overall Study|Protocol Violation|0|||
161014445|NCT03580369|581440177|FG000|Overall Study|Adverse Event|7|||
161014446|NCT03580369|581440178|FG001|Overall Study|Adverse Event|0|||
161014447|NCT03580369|581440179|FG002|Overall Study|Adverse Event|14|||
161014448|NCT03580369|581440180|FG003|Overall Study|Adverse Event|1|||
161014449|NCT03580369|581440181|FG004|Overall Study|Adverse Event|6|||
161014450|NCT03580369|581440182|FG005|Overall Study|Adverse Event|0|||
161014451|NCT03580369|581440183|FG006|Overall Study|Adverse Event|1|||
161014452|NCT03580369|581440184|FG007|Overall Study|Adverse Event|0|||
161014453|NCT03580369|581440177|FG000|Overall Study|Withdrawal by Subject|19|||
161014454|NCT03580369|581440178|FG001|Overall Study|Withdrawal by Subject|0|||
161014455|NCT03580369|581440179|FG002|Overall Study|Withdrawal by Subject|17|||
161014456|NCT03580369|581440180|FG003|Overall Study|Withdrawal by Subject|0|||
161014457|NCT03580369|581440181|FG004|Overall Study|Withdrawal by Subject|16|||
161014458|NCT03580369|581440182|FG005|Overall Study|Withdrawal by Subject|1|||
161014459|NCT03580369|581440183|FG006|Overall Study|Withdrawal by Subject|7|||
161014460|NCT03580369|581440184|FG007|Overall Study|Withdrawal by Subject|0|||
161014461|NCT05239039|581440186|FG000|Overall Study|Withdrawal by Subject|0|||
161014462|NCT05239039|581440187|FG001|Overall Study|Withdrawal by Subject|1|||
161014463|NCT03897686|581441621|FG000|Overall Study|Protocol Violation|1|||
161014464|NCT03897686|581441622|FG001|Overall Study|Protocol Violation|1|||
161014465|NCT03897686|581441621|FG000|Overall Study|Withdrawal by Subject|1|||
161014466|NCT03897686|581441622|FG001|Overall Study|Withdrawal by Subject|1|||
161014467|NCT05415436|581441623|FG000|Overall Study|Surgeon cancelled procedure|1|||
161014468|NCT05415436|581441624|FG001|Overall Study|Surgeon cancelled procedure|0|||
161014469|NCT05415436|581441623|FG000|Overall Study|Death|1|||
161014470|NCT05415436|581441624|FG001|Overall Study|Death|0|||
161014471|NCT05386355|581441633|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161014472|NCT05386355|581441634|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161014473|NCT05386355|581441635|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161014474|NCT05386355|581441636|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161014475|NCT05691452|581441639|FG000|Overall Study|Withdrawal by Subject|1|||
161014476|NCT05691452|581441640|FG001|Overall Study|Withdrawal by Subject|1|||
160459126|NCT02492711|579413542|FG000|Overall Study|Lost to Follow-up|0|||
160459127|NCT02492711|579413543|FG001|Overall Study|Lost to Follow-up|0|||
161014477|NCT05691452|581441641|FG002|Overall Study|Withdrawal by Subject|0|||
161014478|NCT05691452|581441639|FG000|Overall Study|Physician Decision|1|||
161014479|NCT05691452|581441640|FG001|Overall Study|Physician Decision|0|||
161014480|NCT05691452|581441641|FG002|Overall Study|Physician Decision|0|||
161014481|NCT05691452|581441639|FG000|Overall Study|Lost to Follow-up|0|||
161014482|NCT05691452|581441640|FG001|Overall Study|Lost to Follow-up|0|||
161014483|NCT05691452|581441641|FG002|Overall Study|Lost to Follow-up|1|||
161014484|NCT05691452|581441639|FG000|Overall Study|Adverse Event|0|||
161014485|NCT05691452|581441640|FG001|Overall Study|Adverse Event|0|||
161014486|NCT05691452|581441641|FG002|Overall Study|Adverse Event|1|||
161014487|NCT03484702|581441642|FG000|Treatment Period|Death|3|||
161014488|NCT03484702|581441643|FG001|Treatment Period|Death|1|||
161014489|NCT03484702|581441644|FG002|Treatment Period|Death|0|||
161014490|NCT03484702|581441645|FG003|Treatment Period|Death|0|||
161014491|NCT03484702|581441646|FG004|Treatment Period|Death|0|||
161014492|NCT03484702|581441647|FG005|Treatment Period|Death|0|||
161014493|NCT03484702|581441642|FG000|Treatment Period|Adverse Event|1|||
161014494|NCT03484702|581441643|FG001|Treatment Period|Adverse Event|0|||
161014495|NCT03484702|581441644|FG002|Treatment Period|Adverse Event|0|||
161014496|NCT03484702|581441645|FG003|Treatment Period|Adverse Event|0|||
161014497|NCT03484702|581441646|FG004|Treatment Period|Adverse Event|0|||
161014498|NCT03484702|581441647|FG005|Treatment Period|Adverse Event|0|||
161014499|NCT03484702|581441642|FG000|Treatment Period|Participant Withdrew from Study|0|||
161014500|NCT03484702|581441643|FG001|Treatment Period|Participant Withdrew from Study|1|||
161014501|NCT03484702|581441644|FG002|Treatment Period|Participant Withdrew from Study|0|||
160586165|NCT00310388|579864002|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
160586166|NCT00310388|579864003|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
160459128|NCT02492711|579413544|FG002|Overall Study|Lost to Follow-up|1|||
160459129|NCT02492711|579413542|FG000|Overall Study|study treatment delay|2|||
160586167|NCT00310388|579864002|FG000|Primary Reporting Phase|Missing|1|||
160586168|NCT00310388|579864003|FG001|Primary Reporting Phase|Missing|0|||
160586169|NCT00310388|579864002|FG000|Primary Reporting Phase|Other|1|||
160586170|NCT00310388|579864003|FG001|Primary Reporting Phase|Other|0|||
160586171|NCT00310388|579864002|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
160586172|NCT00310388|579864003|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
160586173|NCT00310388|579864002|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
160586174|NCT00310388|579864003|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
160586175|NCT00310388|579864002|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
160586176|NCT00310388|579864003|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
160586177|NCT00310388|579864002|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
160586178|NCT00310388|579864003|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
160586179|NCT02116660|579864010|FG000|Overall Study|Deteriorating renal function|0|||
160586180|NCT02116660|579864011|FG001|Overall Study|Deteriorating renal function|1|||
160586181|NCT02116660|579864010|FG000|Overall Study|Adverse Event|1|||
160586182|NCT02116660|579864011|FG001|Overall Study|Adverse Event|1|||
160586183|NCT02116660|579864010|FG000|Overall Study|Withdrawal by Subject|0|||
160586184|NCT02116660|579864011|FG001|Overall Study|Withdrawal by Subject|2|||
160586185|NCT02116660|579864010|FG000|Overall Study|Organization reason|1|||
160586186|NCT02116660|579864011|FG001|Overall Study|Organization reason|0|||
160586187|NCT01718509|579864012|FG000|Overall Study|Lost to Follow-up|18|||
160586188|NCT01718509|579864013|FG001|Overall Study|Lost to Follow-up|15|||
160586189|NCT01718509|579864012|FG000|Overall Study|Withdrawal by Subject|7|||
160586190|NCT01718509|579864013|FG001|Overall Study|Withdrawal by Subject|13|||
160586191|NCT01718509|579864012|FG000|Overall Study|Adverse Event|5|||
160586192|NCT01718509|579864013|FG001|Overall Study|Adverse Event|7|||
160586193|NCT01718509|579864012|FG000|Overall Study|Other|13|||
160586194|NCT01718509|579864013|FG001|Overall Study|Other|11|||
160586195|NCT01718509|579864012|FG000|Overall Study|Protocol Violation|4|||
160586196|NCT01718509|579864013|FG001|Overall Study|Protocol Violation|2|||
160586197|NCT01718509|579864012|FG000|Overall Study|Lack of Efficacy|1|||
160586198|NCT01718509|579864013|FG001|Overall Study|Lack of Efficacy|0|||
160586199|NCT01757405|579864018|FG000|Overall Study|Lost to Follow-up|1|||
160586200|NCT01757405|579864019|FG001|Overall Study|Lost to Follow-up|1|||
160586201|NCT01757405|579864018|FG000|Overall Study|Withdrawal by Subject|0|||
160586202|NCT01757405|579864019|FG001|Overall Study|Withdrawal by Subject|1|||
160586203|NCT02175771|579864025|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
160586204|NCT02175771|579864026|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160586205|NCT02175771|579864027|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160586206|NCT02175771|579864028|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161014502|NCT03484702|581441645|FG003|Treatment Period|Participant Withdrew from Study|0|||
161014503|NCT03484702|581441646|FG004|Treatment Period|Participant Withdrew from Study|0|||
161014504|NCT03484702|581441647|FG005|Treatment Period|Participant Withdrew from Study|0|||
161014505|NCT03484702|581441642|FG000|Treatment Period|Physician Decision|0|||
161014506|NCT03484702|581441643|FG001|Treatment Period|Physician Decision|1|||
161014507|NCT03484702|581441644|FG002|Treatment Period|Physician Decision|0|||
161014508|NCT03484702|581441645|FG003|Treatment Period|Physician Decision|0|||
161014509|NCT03484702|581441646|FG004|Treatment Period|Physician Decision|0|||
161014510|NCT03484702|581441647|FG005|Treatment Period|Physician Decision|1|||
161014511|NCT01894061|581441651|FG000|Overall Study|Screen failure|1|||
161014512|NCT01894061|581441651|FG000|Overall Study|Withdrawal by Subject|1|||
161014513|NCT00739648|581441652|FG000|Overall Study|Adverse Event|3|||
161014514|NCT00739648|581441653|FG001|Overall Study|Adverse Event|15|||
161014515|NCT00739648|581441652|FG000|Overall Study|Withdrawal by Subject|13|||
161014516|NCT00739648|581441653|FG001|Overall Study|Withdrawal by Subject|25|||
161014517|NCT00739648|581441652|FG000|Overall Study|Lost to Follow-up|4|||
161014518|NCT00739648|581441653|FG001|Overall Study|Lost to Follow-up|7|||
161014519|NCT00739648|581441652|FG000|Overall Study|Death|2|||
161014520|NCT00739648|581441653|FG001|Overall Study|Death|0|||
161014521|NCT00739648|581441652|FG000|Overall Study|Do not know|4|||
161014522|NCT00739648|581441653|FG001|Overall Study|Do not know|6|||
161014523|NCT05110495|581441654|FG000|Overall Study|Lost to Follow-up|1|||
161014524|NCT05110495|581441654|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
161014525|NCT04173663|581441655|FG000|Overall Study|Withdrawal by Subject|1|||
161014526|NCT04173663|581441656|FG001|Overall Study|Withdrawal by Subject|6|||
161014527|NCT04173663|581441655|FG000|Overall Study|Lost to Follow-up|17|||
161014528|NCT04173663|581441656|FG001|Overall Study|Lost to Follow-up|24|||
161014529|NCT02840474|581441658|FG000|Overall Study|Lost to Follow-up|1|||
160459130|NCT02492711|579413543|FG001|Overall Study|study treatment delay|1|||
160459131|NCT02492711|579413544|FG002|Overall Study|study treatment delay|0|||
160459132|NCT02492711|579413542|FG000|Overall Study|change in chemotherapy|0|||
161014530|NCT02840474|581441659|FG001|Overall Study|Lost to Follow-up|0|||
161014531|NCT04716634|581441660|FG000|Overall Study|Death|24|||
161014532|NCT04716634|581441661|FG001|Overall Study|Death|24|||
160459133|NCT02492711|579413543|FG001|Overall Study|change in chemotherapy|1|||
160459134|NCT02492711|579413544|FG002|Overall Study|change in chemotherapy|0|||
160459135|NCT02492711|579413542|FG000|Overall Study|never treated|2|||
160459136|NCT02492711|579413543|FG001|Overall Study|never treated|4|||
160459137|NCT02492711|579413544|FG002|Overall Study|never treated|0|||
160459138|NCT02492711|579413542|FG000|Overall Study|Other|0|||
160459139|NCT02492711|579413543|FG001|Overall Study|Other|0|||
160459140|NCT02492711|579413544|FG002|Overall Study|Other|1|||
160459141|NCT05830799|579413545|FG000|Overall Study|Withdrawal by Subject|1|||
160459142|NCT03652272|579413546|FG000|3 Month|Withdrawal by Subject|1|||
160459143|NCT03652272|579413547|FG001|3 Month|Withdrawal by Subject|1|||
160459144|NCT03652272|579413546|FG000|3 Month|Lost to Follow-up|16|||
160459145|NCT03652272|579413547|FG001|3 Month|Lost to Follow-up|14|||
160459146|NCT04967599|579413552|FG000|Overall Study|Lost to Follow-up|35|||
160459147|NCT04967599|579413553|FG001|Overall Study|Lost to Follow-up|19|||
160459148|NCT04967599|579413554|FG002|Overall Study|Lost to Follow-up|23|||
160459149|NCT02919917|579413558|FG000|Overall Study|Withdrawal by Subject|4|||
160459150|NCT02919917|579413559|FG001|Overall Study|Withdrawal by Subject|8|||
160459151|NCT03418740|579413560|FG000|Overall Study|Lost to Follow-up|13|||
160459152|NCT03418740|579413560|FG000|Overall Study|Scheduling Issues|7|||
160459153|NCT03418740|579413560|FG000|Overall Study|Withdrawal by Subject|2|||
160459154|NCT03418740|579413560|FG000|Overall Study|Unable to Continue Consent|1|||
160459155|NCT04743973|579413561|FG000|Overall Study|Withdrawal by Subject|5|||
160459156|NCT02461134|579413566|FG000|Overall Study|Adverse Event|1|||
160459157|NCT00626795|579413567|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
160459158|NCT00626795|579413568|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
160459159|NCT00626795|579413569|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
160459160|NCT00626795|579413567|FG000|Blinded Treatment|Lack of Efficacy|2|||
160459161|NCT00626795|579413568|FG001|Blinded Treatment|Lack of Efficacy|0|||
160459162|NCT00626795|579413569|FG002|Blinded Treatment|Lack of Efficacy|0|||
160459163|NCT00626795|579413567|FG000|Blinded Treatment|Unacceptable adverse event|0|||
160459164|NCT00626795|579413568|FG001|Blinded Treatment|Unacceptable adverse event|0|||
160459165|NCT00626795|579413569|FG002|Blinded Treatment|Unacceptable adverse event|1|||
160459166|NCT00626795|579413567|FG000|Blinded Treatment|Protocol Violation|0|||
160459167|NCT00626795|579413568|FG001|Blinded Treatment|Protocol Violation|1|||
160459168|NCT00626795|579413569|FG002|Blinded Treatment|Protocol Violation|1|||
160459169|NCT00626795|579413567|FG000|Blinded Treatment|Withdrawal by Subject|1|||
160459170|NCT00626795|579413568|FG001|Blinded Treatment|Withdrawal by Subject|1|||
160459171|NCT00626795|579413569|FG002|Blinded Treatment|Withdrawal by Subject|0|||
160459172|NCT00626795|579413567|FG000|Blinded Treatment|Other reasons|2|||
160459173|NCT00626795|579413568|FG001|Blinded Treatment|Other reasons|0|||
160459174|NCT00626795|579413569|FG002|Blinded Treatment|Other reasons|2|||
161014533|NCT04716634|581441662|FG002|Overall Study|Death|8|||
161014534|NCT04716634|581441660|FG000|Overall Study|Closed by Sponsor|4|||
161014535|NCT04716634|581441661|FG001|Overall Study|Closed by Sponsor|4|||
161014536|NCT04716634|581441662|FG002|Overall Study|Closed by Sponsor|5|||
161014537|NCT04716634|581441660|FG000|Overall Study|Lost to Follow-up|1|||
161014538|NCT04716634|581441661|FG001|Overall Study|Lost to Follow-up|0|||
160459175|NCT00626795|579413567|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
161014539|NCT04716634|581441662|FG002|Overall Study|Lost to Follow-up|1|||
160586207|NCT02175771|579864029|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160586208|NCT02175771|579864030|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160586209|NCT02175771|579864031|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160586210|NCT02175771|579864032|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160586211|NCT02175771|579864033|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160586212|NCT02175771|579864025|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
160586213|NCT02175771|579864026|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160586214|NCT02175771|579864027|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160586215|NCT02175771|579864028|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160586216|NCT02175771|579864029|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160586217|NCT02175771|579864030|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160586218|NCT02175771|579864031|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160586219|NCT02175771|579864032|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160586220|NCT02175771|579864033|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160586221|NCT02175771|579864025|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
160586222|NCT02175771|579864026|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160586223|NCT02175771|579864027|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160586224|NCT02175771|579864028|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160459176|NCT00626795|579413568|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
160459177|NCT00626795|579413569|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
160459178|NCT04499521|579413570|FG000|Overall Study|Disease Progression|1|||
160459179|NCT04499521|579413571|FG001|Overall Study|Disease Progression|0|||
160459180|NCT05412004|579414201|FG000|Overall Study|Adverse Event|0|||
160459181|NCT05412004|579414202|FG001|Overall Study|Adverse Event|2|||
160459182|NCT05412004|579414203|FG002|Overall Study|Adverse Event|1|||
160459183|NCT05412004|579414204|FG003|Overall Study|Adverse Event|5|||
160459184|NCT05412004|579414201|FG000|Overall Study|Assigned Treatment by Mistake|5|||
160459185|NCT05412004|579414202|FG001|Overall Study|Assigned Treatment by Mistake|10|||
160459186|NCT05412004|579414203|FG002|Overall Study|Assigned Treatment by Mistake|2|||
160459187|NCT05412004|579414204|FG003|Overall Study|Assigned Treatment by Mistake|5|||
160459188|NCT05412004|579414201|FG000|Overall Study|Lost to Follow-up|3|||
160459189|NCT05412004|579414202|FG001|Overall Study|Lost to Follow-up|0|||
160459190|NCT05412004|579414203|FG002|Overall Study|Lost to Follow-up|0|||
160459191|NCT05412004|579414204|FG003|Overall Study|Lost to Follow-up|0|||
160459192|NCT05412004|579414201|FG000|Overall Study|Patient could not travel to site|0|||
160459193|NCT05412004|579414202|FG001|Overall Study|Patient could not travel to site|1|||
160459194|NCT05412004|579414203|FG002|Overall Study|Patient could not travel to site|0|||
160459195|NCT05412004|579414204|FG003|Overall Study|Patient could not travel to site|0|||
160459196|NCT05412004|579414201|FG000|Overall Study|Physician Decision|0|||
160459197|NCT05412004|579414202|FG001|Overall Study|Physician Decision|1|||
160459198|NCT05412004|579414203|FG002|Overall Study|Physician Decision|0|||
160459199|NCT05412004|579414204|FG003|Overall Study|Physician Decision|0|||
160459200|NCT05412004|579414201|FG000|Overall Study|Pregnancy|0|||
160459201|NCT05412004|579414202|FG001|Overall Study|Pregnancy|1|||
160459202|NCT05412004|579414203|FG002|Overall Study|Pregnancy|0|||
160459203|NCT05412004|579414204|FG003|Overall Study|Pregnancy|0|||
160459204|NCT05412004|579414201|FG000|Overall Study|Protocol Violation|1|||
160459205|NCT05412004|579414202|FG001|Overall Study|Protocol Violation|0|||
160459206|NCT05412004|579414203|FG002|Overall Study|Protocol Violation|0|||
160459207|NCT05412004|579414204|FG003|Overall Study|Protocol Violation|0|||
160459208|NCT05412004|579414201|FG000|Overall Study|Withdrawal by Subject|4|||
160459209|NCT05412004|579414202|FG001|Overall Study|Withdrawal by Subject|19|||
160459210|NCT05412004|579414203|FG002|Overall Study|Withdrawal by Subject|4|||
160459211|NCT05412004|579414204|FG003|Overall Study|Withdrawal by Subject|14|||
160459212|NCT05412004|579414201|FG000|Overall Study|Screen Failure|0|||
160459213|NCT05412004|579414202|FG001|Overall Study|Screen Failure|0|||
160459214|NCT05412004|579414203|FG002|Overall Study|Screen Failure|0|||
160459215|NCT05412004|579414204|FG003|Overall Study|Screen Failure|1|||
160459216|NCT05412004|579414201|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
160459217|NCT05412004|579414202|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
160459218|NCT05412004|579414203|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
160459219|NCT05412004|579414204|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
160459220|NCT03781089|579414205|FG000|Overall Study|Constipation|1|||
160459221|NCT03781089|579414206|FG001|Overall Study|Constipation|0|||
160459222|NCT03781089|579414205|FG000|Overall Study|Positive pregnancy test|0|||
160459223|NCT03781089|579414206|FG001|Overall Study|Positive pregnancy test|1|||
160586225|NCT02175771|579864029|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160459224|NCT04644029|579414207|FG000|Overall Study|Death|1|||
160459225|NCT04644029|579414208|FG001|Overall Study|Death|0|||
160459226|NCT04644029|579414207|FG000|Overall Study|Physician Decision|1|||
160459227|NCT04644029|579414208|FG001|Overall Study|Physician Decision|2|||
161014540|NCT04716634|581441660|FG000|Overall Study|Withdrawal by Subject|0|||
161014541|NCT04716634|581441661|FG001|Overall Study|Withdrawal by Subject|0|||
161014542|NCT04716634|581441662|FG002|Overall Study|Withdrawal by Subject|1|||
161014543|NCT05418296|581441678|FG000|Overall Study|Withdrawal by Subject|4|||
161014544|NCT05418296|581441679|FG001|Overall Study|Withdrawal by Subject|1|||
161014545|NCT04703322|581441681|FG000|Overall Study|Ongoing|8|||
161014546|NCT04703322|581441681|FG000|Overall Study|Withdrawal by Subject|1|||
161014547|NCT04638998|581441682|FG000|Overall Study|Withdrawal by Subject|1|||
161014548|NCT04638998|581441683|FG001|Overall Study|Withdrawal by Subject|3|||
161014549|NCT04419168|581441686|FG000|Overall Study|Protocol Violation|1|||
161014550|NCT04419168|581441687|FG001|Overall Study|Protocol Violation|1|||
161014551|NCT04419168|581441686|FG000|Overall Study|Lost to Follow-up|7|||
161014552|NCT04419168|581441687|FG001|Overall Study|Lost to Follow-up|7|||
161014553|NCT04419168|581441686|FG000|Overall Study|Missed 6-month Visit|48|||
161014554|NCT04419168|581441687|FG001|Overall Study|Missed 6-month Visit|45|||
161014555|NCT03713086|581441691|FG000|Overall Study|Withdrawal by Subject|0|||
161014556|NCT03713086|581441692|FG001|Overall Study|Withdrawal by Subject|2|||
161014557|NCT03713086|581441693|FG002|Overall Study|Withdrawal by Subject|1|||
161014558|NCT03713086|581441694|FG003|Overall Study|Withdrawal by Subject|0|||
161014559|NCT03713086|581441691|FG000|Overall Study|Lost to Follow-up|0|||
161014560|NCT03713086|581441692|FG001|Overall Study|Lost to Follow-up|1|||
161014561|NCT03713086|581441693|FG002|Overall Study|Lost to Follow-up|0|||
161014562|NCT03713086|581441694|FG003|Overall Study|Lost to Follow-up|1|||
161014563|NCT05009251|581441695|FG000|Overall Study|Protocol Violation|100|||
161014564|NCT05009251|581441696|FG001|Overall Study|Protocol Violation|105|||
161014565|NCT05009251|581441697|FG002|Overall Study|Protocol Violation|119|||
161014566|NCT05009251|581441698|FG003|Overall Study|Protocol Violation|120|||
161014567|NCT05009251|581441699|FG004|Overall Study|Protocol Violation|119|||
161014568|NCT05009251|581441695|FG000|Overall Study|Death|25|||
161014569|NCT05009251|581441696|FG001|Overall Study|Death|22|||
161014570|NCT05009251|581441697|FG002|Overall Study|Death|24|||
161014571|NCT05009251|581441698|FG003|Overall Study|Death|19|||
161014572|NCT05009251|581441699|FG004|Overall Study|Death|15|||
161014573|NCT05374837|581441705|FG000|Overall Study|Lost to Follow-up|17|||
161014574|NCT05374837|581441706|FG001|Overall Study|Lost to Follow-up|18|||
161014575|NCT05406921|581441709|FG000|Overall Study|Withdrawal by Subject|25|||
161014576|NCT05406921|581441710|FG001|Overall Study|Withdrawal by Subject|0|||
161014577|NCT05406921|581441711|FG002|Overall Study|Withdrawal by Subject|25|||
161014578|NCT05406921|581441709|FG000|Overall Study|Protocol Violation|0|||
161014579|NCT05406921|581441710|FG001|Overall Study|Protocol Violation|12|||
161014580|NCT05406921|581441711|FG002|Overall Study|Protocol Violation|0|||
161014581|NCT04831281|581441714|FG000|Overall Study|Adverse Event|1|||
161014582|NCT04831281|581441715|FG001|Overall Study|Adverse Event|0|||
161014583|NCT04831281|581441716|FG002|Overall Study|Adverse Event|3|||
161014584|NCT04831281|581441714|FG000|Overall Study|Withdrawal by Subject|0|||
161014585|NCT04831281|581441715|FG001|Overall Study|Withdrawal by Subject|1|||
161014586|NCT04831281|581441716|FG002|Overall Study|Withdrawal by Subject|2|||
161014587|NCT04831281|581441714|FG000|Overall Study|Undetermined|1|||
161014588|NCT04831281|581441715|FG001|Overall Study|Undetermined|1|||
161014589|NCT04831281|581441716|FG002|Overall Study|Undetermined|0|||
161014590|NCT02249949|581441717|FG000|Overall Study|Cancelled prior to treatment|2|||
161014591|NCT02097420|581441720|FG000|Overall Study|Death|6|||
161014592|NCT02097420|581441720|FG000|Overall Study|Valve explanted|13|||
161014593|NCT02097420|581441720|FG000|Overall Study|Other Reason|1|||
161014594|NCT04263311|581441721|FG000|Overall Study|Lost to Follow-up|1|||
161014595|NCT04263311|581441722|FG001|Overall Study|Lost to Follow-up|2|||
161014596|NCT04263311|581441723|FG002|Overall Study|Lost to Follow-up|0|||
161014597|NCT04263311|581441721|FG000|Overall Study|Health Issues|1|||
161014598|NCT04263311|581441722|FG001|Overall Study|Health Issues|0|||
161014599|NCT04263311|581441723|FG002|Overall Study|Health Issues|0|||
161014600|NCT04263311|581441721|FG000|Overall Study|Left the country|1|||
161014601|NCT04263311|581441722|FG001|Overall Study|Left the country|0|||
161014602|NCT04263311|581441723|FG002|Overall Study|Left the country|0|||
161014603|NCT04263311|581441721|FG000|Overall Study|Unable to maintain time commitment|1|||
161014604|NCT04263311|581441722|FG001|Overall Study|Unable to maintain time commitment|0|||
161014605|NCT04263311|581441723|FG002|Overall Study|Unable to maintain time commitment|0|||
161014606|NCT04263311|581441721|FG000|Overall Study|No longer interested|1|||
161014607|NCT04263311|581441722|FG001|Overall Study|No longer interested|0|||
161014608|NCT04263311|581441723|FG002|Overall Study|No longer interested|0|||
161014609|NCT04263311|581441721|FG000|Overall Study|Ineligible post consent|0|||
161014610|NCT04263311|581441722|FG001|Overall Study|Ineligible post consent|0|||
161014611|NCT04263311|581441723|FG002|Overall Study|Ineligible post consent|5|||
161014612|NCT04820855|581441724|FG000|Overall Study|Lost to Follow-up|6|||
161014613|NCT04820855|581441725|FG001|Overall Study|Lost to Follow-up|9|||
161014614|NCT04838262|581441726|FG000|Overall Study|Withdrawal by Subject|9|||
161014615|NCT04838262|581441727|FG001|Overall Study|Withdrawal by Subject|4|||
161014616|NCT05524233|581441730|FG000|Overall Study|Lost to Follow-up|2|||
161014617|NCT05524233|581441730|FG000|Overall Study|Adverse Event|2|||
161014618|NCT05524233|581441730|FG000|Overall Study|Withdrawal by Subject|1|||
161014619|NCT02307565|581441731|FG000|Overall Study|Adverse Event|3|||
161014620|NCT02307565|581441732|FG001|Overall Study|Adverse Event|2|||
161014621|NCT02307565|581441731|FG000|Overall Study|Withdrawal by Subject|2|||
161014622|NCT02307565|581441732|FG001|Overall Study|Withdrawal by Subject|2|||
161014623|NCT00650104|581441733|FG000|Overall Study|Adverse Event|17|||
161014624|NCT00650104|581441733|FG000|Overall Study|Death|2|||
161014625|NCT00650104|581441733|FG000|Overall Study|Withdrawal by Subject|11|||
161014626|NCT00650104|581441733|FG000|Overall Study|Physician Decision|7|||
161014627|NCT00650104|581441733|FG000|Overall Study|Lost to Follow-up|1|||
161014628|NCT00650104|581441733|FG000|Overall Study|Non-compliance|2|||
161014629|NCT00650104|581441733|FG000|Overall Study|Sponsor Terminated Dosing|1|||
161014630|NCT02697136|581441740|FG000|Overall Study|Adverse Event|3|||
161014631|NCT02697136|581441741|FG001|Overall Study|Adverse Event|0|||
161014632|NCT05633407|581441745|FG000|Overall Study|Physician Decision|2|||
161014633|NCT05633407|581441746|FG001|Overall Study|Physician Decision|0|||
161014634|NCT05633407|581441745|FG000|Overall Study|Adverse Event|1|||
161014635|NCT05633407|581441746|FG001|Overall Study|Adverse Event|0|||
161014636|NCT05633407|581441745|FG000|Overall Study|Withdrawal by Subject|1|||
161014637|NCT05633407|581441746|FG001|Overall Study|Withdrawal by Subject|0|||
161014638|NCT05633407|581441745|FG000|Overall Study|Other|1|||
161014639|NCT05633407|581441746|FG001|Overall Study|Other|1|||
161014640|NCT03527160|581441747|FG000|Overall Study|No urine collected|13|||
161014641|NCT03527160|581441747|FG000|Overall Study|No clinical serum creatinine collected|6|||
161014642|NCT03527160|581441747|FG000|Overall Study|Did not meet inclusion|2|||
161014643|NCT01721291|581441749|FG000|Overall Study|Withdrawal by Subject|1|||
161014644|NCT01721291|581441750|FG001|Overall Study|Withdrawal by Subject|0|||
161014645|NCT01721291|581441749|FG000|Overall Study|did not like the treatment|1|||
161014646|NCT01721291|581441750|FG001|Overall Study|did not like the treatment|0|||
161014647|NCT03690206|581441752|FG000|Overall Study|Withdrawal by Subject|2|||
161014648|NCT03690206|581441753|FG001|Overall Study|Withdrawal by Subject|0|||
161014649|NCT03690206|581441754|FG002|Overall Study|Withdrawal by Subject|0|||
161014650|NCT03690206|581441752|FG000|Overall Study|ICF withdrawal|2|||
161014651|NCT03690206|581441753|FG001|Overall Study|ICF withdrawal|0|||
161014652|NCT03690206|581441754|FG002|Overall Study|ICF withdrawal|0|||
161014653|NCT04833777|581443407|FG000|Overall Study|Lost to Follow-up|1|||
161014654|NCT04833777|581443408|FG001|Overall Study|Lost to Follow-up|0|||
161014655|NCT03089398|581443409|FG000|Overall Study|Death|4|||
161014656|NCT03089398|581443410|FG001|Overall Study|Death|9|||
161014657|NCT03089398|581443409|FG000|Overall Study|Lost to Follow-up|21|||
161014658|NCT03089398|581443410|FG001|Overall Study|Lost to Follow-up|30|||
161014659|NCT03089398|581443409|FG000|Overall Study|Withdrawal by Subject|2|||
161014660|NCT03089398|581443410|FG001|Overall Study|Withdrawal by Subject|2|||
161014661|NCT05249439|581443411|FG000|Overall Study|Withdrawal by Subject|2|||
161014662|NCT05249439|581443412|FG001|Overall Study|Withdrawal by Subject|5|||
161014663|NCT05249439|581443411|FG000|Overall Study|Physician Decision|3|||
161014664|NCT05249439|581443412|FG001|Overall Study|Physician Decision|1|||
161014665|NCT00616967|581443413|FG000|Overall Study|Withdrawal by Subject|0|||
161014666|NCT00616967|581443414|FG001|Overall Study|Withdrawal by Subject|0|||
161014667|NCT00616967|581443415|FG002|Overall Study|Withdrawal by Subject|1|||
161014668|NCT02910583|581443416|FG000|Overall Study|Death|7|||
161014669|NCT02910583|581443417|FG001|Overall Study|Death|3|||
161014670|NCT02910583|581443416|FG000|Overall Study|Lost to Follow-up|1|||
161014671|NCT02910583|581443417|FG001|Overall Study|Lost to Follow-up|0|||
161014672|NCT02910583|581443416|FG000|Overall Study|Withdrawal by Subject|12|||
161014673|NCT02910583|581443417|FG001|Overall Study|Withdrawal by Subject|8|||
161014674|NCT02910583|581443416|FG000|Overall Study|Other, Not Specified|6|||
161014675|NCT02910583|581443417|FG001|Overall Study|Other, Not Specified|3|||
161014676|NCT05059262|581443418|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
161014677|NCT05059262|581443419|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
161014678|NCT05059262|581443418|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
161014679|NCT05059262|581443419|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
161014680|NCT05059262|581443418|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
161014681|NCT05059262|581443419|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
161014682|NCT05059262|581443418|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
161014683|NCT05059262|581443419|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
161014684|NCT05059262|581443418|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
161014685|NCT05059262|581443419|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
161014686|NCT05059262|581443418|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
161014687|NCT05059262|581443419|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
161014688|NCT05059262|581443418|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
161014689|NCT05059262|581443419|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
161014690|NCT05059262|581443418|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
161014691|NCT05059262|581443419|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
161014692|NCT05059262|581443418|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
161014693|NCT05059262|581443419|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
160586226|NCT02175771|579864030|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160586227|NCT02175771|579864031|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160586228|NCT02175771|579864032|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160586229|NCT02175771|579864033|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160968088|NCT01781390|581271407|FG001|Overall Study|Lost to Follow-up|1|||
160968089|NCT01781390|581271408|FG002|Overall Study|Lost to Follow-up|1|||
160968090|NCT01781390|581271406|FG000|Overall Study|Adverse Event|1|||
160968091|NCT01781390|581271407|FG001|Overall Study|Adverse Event|2|||
160968092|NCT01781390|581271408|FG002|Overall Study|Adverse Event|1|||
160968093|NCT01781390|581271406|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
160968094|NCT01781390|581271407|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
160968095|NCT01781390|581271408|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
160968096|NCT01862796|581271411|FG000|Overall Study|Prohibited medications|0|||
160968097|NCT01862796|581271412|FG001|Overall Study|Prohibited medications|0|||
160968098|NCT01862796|581271413|FG002|Overall Study|Prohibited medications|1|||
160968099|NCT02612064|581271421|FG000|Overall Study|Withdrawal by Subject|1|||
160968100|NCT02612064|581271422|FG001|Overall Study|Withdrawal by Subject|1|||
160968101|NCT02612064|581271421|FG000|Overall Study|Other|0|||
160968102|NCT02612064|581271422|FG001|Overall Study|Other|2|||
160968103|NCT05918978|581271425|FG000|Overall Study|Study Terminated by Sponsor|17|||
160968104|NCT05918978|581271426|FG001|Overall Study|Study Terminated by Sponsor|11|||
160968105|NCT05918978|581271425|FG000|Overall Study|Withdrawal by Subject|1|||
160968106|NCT05918978|581271426|FG001|Overall Study|Withdrawal by Subject|1|||
160968107|NCT05918978|581271425|FG000|Overall Study|Adverse Event|1|||
160968108|NCT05918978|581271426|FG001|Overall Study|Adverse Event|0|||
160968109|NCT05918978|581271425|FG000|Overall Study|Other|0|||
160968110|NCT05918978|581271426|FG001|Overall Study|Other|1|||
160968111|NCT00622180|581271427|FG000|Overall Study|Lost to Follow-up|1|||
160968112|NCT00622180|581271428|FG001|Overall Study|Lost to Follow-up|2|||
160968113|NCT00511875|581271434|FG000|Overall Study|Lost to Follow-up|4|||
160968114|NCT00511875|581271435|FG001|Overall Study|Lost to Follow-up|0|||
160968115|NCT00511875|581271434|FG000|Overall Study|Missing variables|1|||
160968116|NCT00511875|581271435|FG001|Overall Study|Missing variables|0|||
160968117|NCT05559866|581271438|FG000|Overall Study|Withdrawal by Subject|1|||
160968118|NCT05559866|581271439|FG001|Overall Study|Withdrawal by Subject|0|||
160968119|NCT03538951|581271440|FG000|Overall Study|Withdrawal by Subject|1|||
160968120|NCT03538951|581271441|FG001|Overall Study|Withdrawal by Subject|2|||
160968121|NCT03444376|581271443|FG000|Part A|Disease relapse or Progression|1|||
160968122|NCT03444376|581271443|FG000|Part A|Withdrawal by Subject|2|||
160968123|NCT03444376|581271443|FG000|Part A|Adverse Event|1|||
160968124|NCT03444376|581271443|FG000|Part B|Disease relapse or Progression|18|||
160968125|NCT03444376|581271443|FG000|Part B|Withdrawal by Subject|2|||
160968126|NCT03444376|581271443|FG000|Part B|Adverse Event|2|||
160968127|NCT03444376|581271443|FG000|Part B|Physician Decision|1|||
160968128|NCT03444376|581271443|FG000|Part C|Disease relapse or Progression|43|||
160968129|NCT03444376|581271443|FG000|Part C|Withdrawal by Subject|5|||
160968130|NCT03444376|581271443|FG000|Part C|Adverse Event|2|||
160968131|NCT03444376|581271443|FG000|Part C|Physician Decision|2|||
160968132|NCT03444376|581271443|FG000|Part C|Death|1|||
160968133|NCT06027619|581271447|FG000|Overall Study|Adverse Event|0|||
160968134|NCT06027619|581271448|FG001|Overall Study|Adverse Event|0|||
160968135|NCT06027619|581271449|FG002|Overall Study|Adverse Event|1|||
160968136|NCT01493960|581273302|FG000|Overall Study|Adverse Event|0|||
160968137|NCT01493960|581273303|FG001|Overall Study|Adverse Event|1|||
160968138|NCT01493960|581273302|FG000|Overall Study|Lack of Efficacy|15|||
160968139|NCT01493960|581273303|FG001|Overall Study|Lack of Efficacy|9|||
160968140|NCT01493960|581273302|FG000|Overall Study|Protocol Violation|3|||
160968141|NCT01493960|581273303|FG001|Overall Study|Protocol Violation|0|||
160968142|NCT01493960|581273302|FG000|Overall Study|Withdrawal by Subject|10|||
160968143|NCT01493960|581273303|FG001|Overall Study|Withdrawal by Subject|4|||
160968144|NCT01493960|581273302|FG000|Overall Study|Non-specified|4|||
160586230|NCT02175771|579864025|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
160968145|NCT01493960|581273303|FG001|Overall Study|Non-specified|4|||
160968146|NCT00871403|581273306|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
160968147|NCT00871403|581273307|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
160968148|NCT00871403|581273308|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
160968149|NCT00871403|581273306|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
160968150|NCT00871403|581273307|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
160968151|NCT00871403|581273308|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
160968152|NCT00871403|581273306|FG000|Combination Treatment Phase|Adverse Event|0|||
160968153|NCT00871403|581273307|FG001|Combination Treatment Phase|Adverse Event|17|||
160968154|NCT00871403|581273308|FG002|Combination Treatment Phase|Adverse Event|2|||
160968155|NCT00871403|581273306|FG000|Combination Treatment Phase|Disease Progression|0|||
160968156|NCT00871403|581273307|FG001|Combination Treatment Phase|Disease Progression|8|||
160968157|NCT00871403|581273308|FG002|Combination Treatment Phase|Disease Progression|5|||
160968158|NCT00871403|581273306|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
161014694|NCT05021640|581443422|FG000|Overall Study|Lost to Follow-up|0|||
160968159|NCT00871403|581273307|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
160968160|NCT00871403|581273308|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
160968161|NCT00871403|581273306|FG000|Combination Treatment Phase|Physician Decision|0|||
160968162|NCT00871403|581273307|FG001|Combination Treatment Phase|Physician Decision|1|||
160968163|NCT00871403|581273308|FG002|Combination Treatment Phase|Physician Decision|3|||
160968164|NCT00871403|581273306|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
160968165|NCT00871403|581273307|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
160968166|NCT00871403|581273308|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
160968167|NCT00871403|581273306|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
160968168|NCT00871403|581273307|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
160968169|NCT00871403|581273308|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
160968170|NCT01446796|581273309|FG000|Overall Study|Withdrawal by Subject|1|||
160968171|NCT01446796|581273310|FG001|Overall Study|Withdrawal by Subject|0|||
160968172|NCT00954733|581273312|FG000|Overall Study|blood gas machine did not work|1|||
160968173|NCT03131960|581273313|FG000|Overall Study|Adverse Event|0|||
160968174|NCT03131960|581273314|FG001|Overall Study|Adverse Event|1|||
160968175|NCT04707196|581273315|FG000|Overall Study|Withdrawal by Subject|9|||
160968176|NCT04707196|581273316|FG001|Overall Study|Withdrawal by Subject|6|||
160968177|NCT04707196|581273315|FG000|Overall Study|Lost to Follow-up|1|||
160968178|NCT04707196|581273316|FG001|Overall Study|Lost to Follow-up|0|||
160968179|NCT04707196|581273315|FG000|Overall Study|Protocol Violation|4|||
160968180|NCT04707196|581273316|FG001|Overall Study|Protocol Violation|1|||
160968181|NCT04707196|581273315|FG000|Overall Study|Adverse Event|2|||
160968182|NCT04707196|581273316|FG001|Overall Study|Adverse Event|2|||
160968183|NCT04707196|581273315|FG000|Overall Study|Death|3|||
160968184|NCT04707196|581273316|FG001|Overall Study|Death|1|||
160968185|NCT04707196|581273315|FG000|Overall Study|Non-compliance with study drug|1|||
160968186|NCT04707196|581273316|FG001|Overall Study|Non-compliance with study drug|0|||
160968187|NCT04707196|581273315|FG000|Overall Study|Progressive disease|9|||
160968188|NCT04707196|581273316|FG001|Overall Study|Progressive disease|10|||
160968189|NCT01462162|581273318|FG000|Overall Study|Adverse Event|5|||
160968190|NCT01462162|581273318|FG000|Overall Study|Lack of Efficacy|4|||
160968191|NCT01462162|581273318|FG000|Overall Study|Abnormal laboratory parameters|1|||
160968192|NCT01462162|581273318|FG000|Overall Study|Other|2|||
160968193|NCT03485911|581273319|FG000|Part 1|Perceived lack of efficacy|1|||
160968194|NCT03485911|581273320|FG001|Part 1|Perceived lack of efficacy|1|||
160968195|NCT03485911|581273321|FG002|Part 1|Perceived lack of efficacy|2|||
160968196|NCT03485911|581273322|FG003|Part 1|Perceived lack of efficacy|0|||
160968197|NCT03485911|581273319|FG000|Part 1|Subject withdrew consent|0|||
160968198|NCT03485911|581273320|FG001|Part 1|Subject withdrew consent|1|||
160968199|NCT03485911|581273321|FG002|Part 1|Subject withdrew consent|0|||
160968200|NCT03485911|581273322|FG003|Part 1|Subject withdrew consent|1|||
160968201|NCT03485911|581273319|FG000|Part 1|Lab abnormalities/AEs|3|||
160968202|NCT03485911|581273320|FG001|Part 1|Lab abnormalities/AEs|1|||
160968203|NCT03485911|581273321|FG002|Part 1|Lab abnormalities/AEs|1|||
160968204|NCT03485911|581273322|FG003|Part 1|Lab abnormalities/AEs|0|||
160968205|NCT03485911|581273319|FG000|Part 1|Withdrew Consent prior to dosing|0|||
160968206|NCT03485911|581273320|FG001|Part 1|Withdrew Consent prior to dosing|0|||
160968207|NCT03485911|581273321|FG002|Part 1|Withdrew Consent prior to dosing|0|||
160968208|NCT03485911|581273322|FG003|Part 1|Withdrew Consent prior to dosing|1|||
160968209|NCT03485911|581273319|FG000|Part 1|Other NOS|0|||
160968210|NCT03485911|581273320|FG001|Part 1|Other NOS|0|||
160968211|NCT03485911|581273321|FG002|Part 1|Other NOS|0|||
160968212|NCT03485911|581273322|FG003|Part 1|Other NOS|1|||
160968213|NCT03485911|581273319|FG000|Part 2|Perceived lack of efficacy|5|||
160968214|NCT03485911|581273320|FG001|Part 2|Perceived lack of efficacy|3|||
160968215|NCT03485911|581273321|FG002|Part 2|Perceived lack of efficacy|0|||
160968216|NCT03485911|581273322|FG003|Part 2|Perceived lack of efficacy|2|||
160968217|NCT03485911|581273319|FG000|Part 2|Subject withdrew consent|1|||
160968218|NCT03485911|581273320|FG001|Part 2|Subject withdrew consent|0|||
160968219|NCT03485911|581273321|FG002|Part 2|Subject withdrew consent|2|||
160968220|NCT03485911|581273322|FG003|Part 2|Subject withdrew consent|1|||
160968221|NCT03485911|581273319|FG000|Part 2|Lab abnormalities/AEs|1|||
160968222|NCT03485911|581273320|FG001|Part 2|Lab abnormalities/AEs|2|||
160968223|NCT03485911|581273321|FG002|Part 2|Lab abnormalities/AEs|0|||
160968224|NCT03485911|581273322|FG003|Part 2|Lab abnormalities/AEs|0|||
160968225|NCT03485911|581273319|FG000|Part 2|Other NOS|0|||
160968226|NCT03485911|581273320|FG001|Part 2|Other NOS|1|||
160968227|NCT03485911|581273321|FG002|Part 2|Other NOS|0|||
160968228|NCT03485911|581273322|FG003|Part 2|Other NOS|0|||
160968229|NCT03485911|581273319|FG000|Part 2|Intercurrent illness/new medical condition|1|||
160968230|NCT03485911|581273320|FG001|Part 2|Intercurrent illness/new medical condition|0|||
161014695|NCT05021640|581443423|FG001|Overall Study|Lost to Follow-up|0|||
160968231|NCT03485911|581273321|FG002|Part 2|Intercurrent illness/new medical condition|0|||
160968232|NCT03485911|581273322|FG003|Part 2|Intercurrent illness/new medical condition|0|||
160968233|NCT03485911|581273319|FG000|Part 2|Investigator judgement|1|||
160968234|NCT03485911|581273320|FG001|Part 2|Investigator judgement|0|||
160968235|NCT03485911|581273321|FG002|Part 2|Investigator judgement|0|||
161014696|NCT05021640|581443424|FG002|Overall Study|Lost to Follow-up|0|||
161014697|NCT05021640|581443425|FG003|Overall Study|Lost to Follow-up|0|||
160586231|NCT02175771|579864026|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
160586232|NCT02175771|579864027|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
160586233|NCT02175771|579864028|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
160586234|NCT02175771|579864029|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
160586235|NCT02175771|579864030|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
160586236|NCT02175771|579864031|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
160586237|NCT02175771|579864032|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
160586238|NCT02175771|579864033|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
160586239|NCT02175771|579864025|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
160586240|NCT02175771|579864026|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160586241|NCT02175771|579864027|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160586242|NCT02175771|579864028|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160586243|NCT02175771|579864029|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160586244|NCT02175771|579864030|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160586245|NCT02175771|579864031|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160586246|NCT02175771|579864032|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160586247|NCT02175771|579864033|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160586248|NCT02175771|579864025|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
160586249|NCT02175771|579864026|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160586250|NCT02175771|579864027|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160586251|NCT02175771|579864028|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160586252|NCT02175771|579864029|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160586253|NCT02175771|579864030|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160586254|NCT02175771|579864031|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160586255|NCT02175771|579864032|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160586256|NCT02175771|579864033|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160586257|NCT02175771|579864025|FG000|Run-In Period (Pre-assignment)|Other|8|||
160586258|NCT02175771|579864026|FG001|Run-In Period (Pre-assignment)|Other|0|||
160586259|NCT02175771|579864027|FG002|Run-In Period (Pre-assignment)|Other|0|||
160586260|NCT02175771|579864028|FG003|Run-In Period (Pre-assignment)|Other|0|||
160586261|NCT02175771|579864029|FG004|Run-In Period (Pre-assignment)|Other|0|||
160586262|NCT02175771|579864030|FG005|Run-In Period (Pre-assignment)|Other|0|||
160586263|NCT02175771|579864031|FG006|Run-In Period (Pre-assignment)|Other|0|||
160586264|NCT02175771|579864032|FG007|Run-In Period (Pre-assignment)|Other|0|||
160586265|NCT02175771|579864033|FG008|Run-In Period (Pre-assignment)|Other|0|||
160586266|NCT02175771|579864025|FG000|Treatment Period|Adverse Event|0|||
160586267|NCT02175771|579864026|FG001|Treatment Period|Adverse Event|2|||
160586268|NCT02175771|579864027|FG002|Treatment Period|Adverse Event|1|||
160586269|NCT02175771|579864028|FG003|Treatment Period|Adverse Event|1|||
160586270|NCT02175771|579864029|FG004|Treatment Period|Adverse Event|1|||
160586271|NCT02175771|579864030|FG005|Treatment Period|Adverse Event|3|||
160586272|NCT02175771|579864031|FG006|Treatment Period|Adverse Event|2|||
160586273|NCT02175771|579864032|FG007|Treatment Period|Adverse Event|0|||
160586274|NCT02175771|579864033|FG008|Treatment Period|Adverse Event|1|||
160586275|NCT02175771|579864025|FG000|Treatment Period|Withdrawal by Subject|0|||
160586276|NCT02175771|579864026|FG001|Treatment Period|Withdrawal by Subject|9|||
160586277|NCT02175771|579864027|FG002|Treatment Period|Withdrawal by Subject|3|||
160586278|NCT02175771|579864028|FG003|Treatment Period|Withdrawal by Subject|6|||
160586279|NCT02175771|579864029|FG004|Treatment Period|Withdrawal by Subject|2|||
160586280|NCT02175771|579864030|FG005|Treatment Period|Withdrawal by Subject|4|||
160586281|NCT02175771|579864031|FG006|Treatment Period|Withdrawal by Subject|2|||
160586282|NCT02175771|579864032|FG007|Treatment Period|Withdrawal by Subject|9|||
160586283|NCT02175771|579864033|FG008|Treatment Period|Withdrawal by Subject|2|||
160586284|NCT02175771|579864025|FG000|Treatment Period|Noncompliance|0|||
160586285|NCT02175771|579864026|FG001|Treatment Period|Noncompliance|1|||
160586286|NCT02175771|579864027|FG002|Treatment Period|Noncompliance|2|||
160586287|NCT02175771|579864028|FG003|Treatment Period|Noncompliance|0|||
160586288|NCT02175771|579864029|FG004|Treatment Period|Noncompliance|0|||
160586289|NCT02175771|579864030|FG005|Treatment Period|Noncompliance|0|||
160586290|NCT02175771|579864031|FG006|Treatment Period|Noncompliance|0|||
160586291|NCT02175771|579864032|FG007|Treatment Period|Noncompliance|0|||
161014698|NCT05021640|581443426|FG004|Overall Study|Lost to Follow-up|1|||
160586292|NCT02175771|579864033|FG008|Treatment Period|Noncompliance|1|||
161014699|NCT02312960|581443427|FG000|Overall Study|Death|24|||
160586293|NCT02175771|579864025|FG000|Treatment Period|Protocol Violation|0|||
160586294|NCT02175771|579864026|FG001|Treatment Period|Protocol Violation|0|||
160586295|NCT02175771|579864027|FG002|Treatment Period|Protocol Violation|0|||
160586296|NCT02175771|579864028|FG003|Treatment Period|Protocol Violation|0|||
160586297|NCT02175771|579864029|FG004|Treatment Period|Protocol Violation|0|||
160586298|NCT02175771|579864030|FG005|Treatment Period|Protocol Violation|0|||
160586299|NCT02175771|579864031|FG006|Treatment Period|Protocol Violation|0|||
161014700|NCT02312960|581443428|FG001|Overall Study|Death|32|||
161014701|NCT02312960|581443429|FG002|Overall Study|Death|25|||
161014702|NCT02312960|581443430|FG003|Overall Study|Death|11|||
161014703|NCT02312960|581443431|FG004|Overall Study|Death|5|||
161014704|NCT02312960|581443432|FG005|Overall Study|Death|5|||
161014705|NCT02312960|581443433|FG006|Overall Study|Death|8|||
161014706|NCT02312960|581443434|FG007|Overall Study|Death|5|||
161014707|NCT02312960|581443435|FG008|Overall Study|Death|7|||
161014708|NCT02312960|581443436|FG009|Overall Study|Death|3|||
161014709|NCT02312960|581443437|FG010|Overall Study|Death|3|||
161014710|NCT02312960|581443438|FG011|Overall Study|Death|1|||
161014711|NCT02312960|581443439|FG012|Overall Study|Death|25|||
161014712|NCT02312960|581443440|FG013|Overall Study|Death|19|||
161014713|NCT02312960|581443427|FG000|Overall Study|Missing|0|||
161014714|NCT02312960|581443428|FG001|Overall Study|Missing|0|||
161014715|NCT02312960|581443429|FG002|Overall Study|Missing|2|||
161014716|NCT02312960|581443430|FG003|Overall Study|Missing|0|||
161014717|NCT02312960|581443431|FG004|Overall Study|Missing|0|||
161014718|NCT02312960|581443432|FG005|Overall Study|Missing|0|||
161014719|NCT02312960|581443433|FG006|Overall Study|Missing|0|||
161014720|NCT02312960|581443434|FG007|Overall Study|Missing|0|||
161014721|NCT02312960|581443435|FG008|Overall Study|Missing|0|||
161014722|NCT02312960|581443436|FG009|Overall Study|Missing|0|||
161014723|NCT02312960|581443437|FG010|Overall Study|Missing|0|||
161014724|NCT02312960|581443438|FG011|Overall Study|Missing|0|||
161014725|NCT02312960|581443439|FG012|Overall Study|Missing|0|||
161014726|NCT02312960|581443440|FG013|Overall Study|Missing|0|||
161014727|NCT02312960|581443427|FG000|Overall Study|Lost to Follow-up|0|||
161014728|NCT02312960|581443428|FG001|Overall Study|Lost to Follow-up|0|||
161014729|NCT02312960|581443429|FG002|Overall Study|Lost to Follow-up|1|||
161014730|NCT02312960|581443430|FG003|Overall Study|Lost to Follow-up|0|||
161014731|NCT02312960|581443431|FG004|Overall Study|Lost to Follow-up|0|||
161014732|NCT02312960|581443432|FG005|Overall Study|Lost to Follow-up|0|||
161014733|NCT02312960|581443433|FG006|Overall Study|Lost to Follow-up|1|||
161014734|NCT02312960|581443434|FG007|Overall Study|Lost to Follow-up|1|||
161014735|NCT02312960|581443435|FG008|Overall Study|Lost to Follow-up|0|||
161014736|NCT02312960|581443436|FG009|Overall Study|Lost to Follow-up|1|||
161014737|NCT02312960|581443437|FG010|Overall Study|Lost to Follow-up|0|||
161014738|NCT02312960|581443438|FG011|Overall Study|Lost to Follow-up|0|||
161014739|NCT02312960|581443439|FG012|Overall Study|Lost to Follow-up|1|||
161014740|NCT02312960|581443440|FG013|Overall Study|Lost to Follow-up|0|||
161014741|NCT02312960|581443427|FG000|Overall Study|Withdrawal by Subject|1|||
161014742|NCT02312960|581443428|FG001|Overall Study|Withdrawal by Subject|2|||
161014743|NCT02312960|581443429|FG002|Overall Study|Withdrawal by Subject|0|||
161014744|NCT02312960|581443430|FG003|Overall Study|Withdrawal by Subject|0|||
161014745|NCT02312960|581443431|FG004|Overall Study|Withdrawal by Subject|1|||
161014746|NCT02312960|581443432|FG005|Overall Study|Withdrawal by Subject|0|||
161014747|NCT02312960|581443433|FG006|Overall Study|Withdrawal by Subject|1|||
161014748|NCT02312960|581443434|FG007|Overall Study|Withdrawal by Subject|2|||
161014749|NCT02312960|581443435|FG008|Overall Study|Withdrawal by Subject|2|||
161014750|NCT02312960|581443436|FG009|Overall Study|Withdrawal by Subject|3|||
161014751|NCT02312960|581443437|FG010|Overall Study|Withdrawal by Subject|0|||
161014752|NCT02312960|581443438|FG011|Overall Study|Withdrawal by Subject|0|||
161014753|NCT02312960|581443439|FG012|Overall Study|Withdrawal by Subject|2|||
161014754|NCT02312960|581443440|FG013|Overall Study|Withdrawal by Subject|0|||
161014755|NCT03131648|581443441|FG000|Initial Treatment Period|Not dosed|2|||
161014756|NCT03131648|581443442|FG001|Initial Treatment Period|Not dosed|2|||
161014757|NCT03131648|581443443|FG002|Initial Treatment Period|Not dosed|0|||
161014758|NCT03131648|581443444|FG003|Initial Treatment Period|Not dosed|0|||
161014759|NCT03131648|581443445|FG004|Initial Treatment Period|Not dosed|0|||
160459228|NCT04644029|579414207|FG000|Overall Study|Withdrawal by Subject|21|||
160459229|NCT04644029|579414208|FG001|Overall Study|Withdrawal by Subject|19|||
160459230|NCT04644029|579414207|FG000|Overall Study|Lost to Follow-up|31|||
160459231|NCT04644029|579414208|FG001|Overall Study|Lost to Follow-up|34|||
161014760|NCT03131648|581443446|FG005|Initial Treatment Period|Not dosed|0|||
161014761|NCT03131648|581443447|FG006|Initial Treatment Period|Not dosed|0|||
161014762|NCT03131648|581443448|FG007|Initial Treatment Period|Not dosed|0|||
161014763|NCT03131648|581443441|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
161014764|NCT03131648|581443442|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
161014765|NCT03131648|581443443|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014766|NCT03131648|581443444|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014767|NCT03131648|581443445|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014768|NCT03131648|581443446|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014769|NCT03131648|581443447|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014770|NCT03131648|581443448|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014771|NCT03131648|581443441|FG000|Open-label Treatment|Discontinued IMP|0|||
161014772|NCT03131648|581443442|FG001|Open-label Treatment|Discontinued IMP|0|||
160459232|NCT04644029|579414207|FG000|Overall Study|Study Terminated by Sponsor|308|||
161014773|NCT03131648|581443443|FG002|Open-label Treatment|Discontinued IMP|0|||
161014774|NCT03131648|581443444|FG003|Open-label Treatment|Discontinued IMP|0|||
161014775|NCT03131648|581443445|FG004|Open-label Treatment|Discontinued IMP|0|||
161014776|NCT03131648|581443446|FG005|Open-label Treatment|Discontinued IMP|0|||
161014777|NCT03131648|581443447|FG006|Open-label Treatment|Discontinued IMP|112|||
161014778|NCT03131648|581443448|FG007|Open-label Treatment|Discontinued IMP|0|||
161014779|NCT03131648|581443441|FG000|Open-label Treatment|Completed Week 50|0|||
161014780|NCT03131648|581443442|FG001|Open-label Treatment|Completed Week 50|0|||
161014781|NCT03131648|581443443|FG002|Open-label Treatment|Completed Week 50|0|||
161014782|NCT03131648|581443444|FG003|Open-label Treatment|Completed Week 50|0|||
161014783|NCT03131648|581443445|FG004|Open-label Treatment|Completed Week 50|0|||
161014784|NCT03131648|581443446|FG005|Open-label Treatment|Completed Week 50|0|||
161014785|NCT03131648|581443447|FG006|Open-label Treatment|Completed Week 50|6|||
161014786|NCT03131648|581443448|FG007|Open-label Treatment|Completed Week 50|0|||
161014787|NCT03131648|581443441|FG000|Maintenance Treatment Period|Not dosed|0|||
161014788|NCT03131648|581443442|FG001|Maintenance Treatment Period|Not dosed|0|||
161014789|NCT03131648|581443443|FG002|Maintenance Treatment Period|Not dosed|3|||
161014790|NCT03131648|581443444|FG003|Maintenance Treatment Period|Not dosed|2|||
161014791|NCT03131648|581443445|FG004|Maintenance Treatment Period|Not dosed|1|||
161014792|NCT03131648|581443446|FG005|Maintenance Treatment Period|Not dosed|0|||
161014793|NCT03131648|581443447|FG006|Maintenance Treatment Period|Not dosed|0|||
161014794|NCT03131648|581443448|FG007|Maintenance Treatment Period|Not dosed|0|||
161014795|NCT03131648|581443441|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
161014796|NCT03131648|581443442|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
161014797|NCT03131648|581443443|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
161014798|NCT03131648|581443444|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
161014799|NCT03131648|581443445|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
161014800|NCT03131648|581443446|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
161014801|NCT03131648|581443447|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
161014802|NCT03131648|581443448|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
161014803|NCT03131648|581443441|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161014804|NCT03131648|581443442|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161014805|NCT03131648|581443443|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
161014806|NCT03131648|581443444|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
161014807|NCT03131648|581443445|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
161014808|NCT03131648|581443446|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
161014809|NCT03131648|581443447|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161014810|NCT03131648|581443448|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161014811|NCT03131648|581443441|FG000|Maintenance Treatment Period|Completed Week 50|0|||
161014812|NCT03131648|581443442|FG001|Maintenance Treatment Period|Completed Week 50|0|||
161014813|NCT03131648|581443443|FG002|Maintenance Treatment Period|Completed Week 50|0|||
161014814|NCT03131648|581443444|FG003|Maintenance Treatment Period|Completed Week 50|0|||
161014815|NCT03131648|581443445|FG004|Maintenance Treatment Period|Completed Week 50|1|||
161014816|NCT03131648|581443446|FG005|Maintenance Treatment Period|Completed Week 50|0|||
161014817|NCT03131648|581443447|FG006|Maintenance Treatment Period|Completed Week 50|0|||
161014818|NCT03131648|581443448|FG007|Maintenance Treatment Period|Completed Week 50|0|||
161014819|NCT03131648|581443441|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014820|NCT03131648|581443442|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014821|NCT03131648|581443443|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014822|NCT03131648|581443444|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014823|NCT03131648|581443445|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014824|NCT03131648|581443446|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014825|NCT03131648|581443447|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014826|NCT03131648|581443448|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
161014827|NCT02724878|581443449|FG000|Overall Study|Still on Active Therapy|15|||
161014828|NCT02724878|581443449|FG000|Overall Study|Disease Progression|31|||
161014829|NCT02724878|581443449|FG000|Overall Study|Toxicity|5|||
161014830|NCT02724878|581443449|FG000|Overall Study|Death|1|||
161014831|NCT02724878|581443449|FG000|Overall Study|Withdrawal by Subject|4|||
161014832|NCT02724878|581443449|FG000|Overall Study|Lost to Follow-up|2|||
161014833|NCT02724878|581443449|FG000|Overall Study|Protocol Violation|1|||
160459233|NCT04644029|579414208|FG001|Overall Study|Study Terminated by Sponsor|309|||
160459234|NCT04644029|579414207|FG000|Overall Study|Randomized in Error|2|||
160459235|NCT04644029|579414208|FG001|Overall Study|Randomized in Error|1|||
160459236|NCT04644029|579414207|FG000|Overall Study|Other|0|||
160459237|NCT04644029|579414208|FG001|Overall Study|Other|1|||
161014834|NCT02724878|581443449|FG000|Overall Study|Ineligible for Study Drug|5|||
161014835|NCT02724878|581443449|FG000|Overall Study|not started|1|||
161014836|NCT02954341|581443450|FG000|Overall Study|Attempted Implant unsuccessful|5|||
161014837|NCT02954341|581443450|FG000|Overall Study|Death|90|||
161014838|NCT02954341|581443450|FG000|Overall Study|Withdrawal by Subject|4|||
160459238|NCT02246127|579414209|FG000|First Course Treatment|Adverse Event|9|||
160459239|NCT02246127|579414210|FG001|First Course Treatment|Adverse Event|7|||
160586300|NCT02175771|579864032|FG007|Treatment Period|Protocol Violation|1|||
160586301|NCT02175771|579864033|FG008|Treatment Period|Protocol Violation|0|||
161014839|NCT02954341|581443450|FG000|Overall Study|Physician Decision|13|||
161014840|NCT02954341|581443450|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
161014841|NCT02954341|581443450|FG000|Overall Study|Not implanted due to physician's decision|1|||
161014842|NCT02954341|581443450|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
161014843|NCT05227209|581443451|FG000|Overall Study|Adverse Event|11|||
161014844|NCT05227209|581443451|FG000|Overall Study|Lost to Follow-up|1|||
161014845|NCT05227209|581443451|FG000|Overall Study|Withdrawal by Subject|7|||
161014846|NCT05227209|581443451|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
161014847|NCT05633953|581443452|FG000|Overall Study|Adverse Event|7|||
161014848|NCT05633953|581443452|FG000|Overall Study|Death|30|||
161014849|NCT05633953|581443452|FG000|Overall Study|Lost to Follow-up|1|||
161014850|NCT05633953|581443452|FG000|Overall Study|Osilodrostat discontinued|4|||
161014851|NCT05633953|581443452|FG000|Overall Study|Physician Decision|1|||
161014852|NCT05633953|581443452|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
161014853|NCT05633953|581443452|FG000|Overall Study|Progressive disease|2|||
161014854|NCT04245501|581443455|FG000|Overall Study|Adverse Event|2|||
161014855|NCT04245501|581443456|FG001|Overall Study|Adverse Event|0|||
161014856|NCT04245501|581443455|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
161014857|NCT04245501|581443456|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
160459240|NCT02246127|579414209|FG000|First Course Treatment|Withdrawal by Subject|6|||
160459241|NCT02246127|579414210|FG001|First Course Treatment|Withdrawal by Subject|7|||
160657044|NCT01974141|580124520|FG000|Overall Study|Other Reasons|28|||
160657045|NCT01974141|580124521|FG001|Overall Study|Other Reasons|18|||
160968236|NCT03485911|581273322|FG003|Part 2|Investigator judgement|0|||
160968237|NCT03485911|581273319|FG000|Part 3|Perceived lack of efficacy|2|||
160968238|NCT03485911|581273320|FG001|Part 3|Perceived lack of efficacy|2|||
160968239|NCT03485911|581273321|FG002|Part 3|Perceived lack of efficacy|2|||
160968240|NCT03485911|581273322|FG003|Part 3|Perceived lack of efficacy|0|||
160968241|NCT03485911|581273319|FG000|Part 3|Subject withdrew consent|1|||
160968242|NCT03485911|581273320|FG001|Part 3|Subject withdrew consent|4|||
160968243|NCT03485911|581273321|FG002|Part 3|Subject withdrew consent|0|||
160968244|NCT03485911|581273322|FG003|Part 3|Subject withdrew consent|1|||
160968245|NCT03485911|581273319|FG000|Part 3|Lab abnormalities/AEs|1|||
160968246|NCT03485911|581273320|FG001|Part 3|Lab abnormalities/AEs|1|||
160968247|NCT03485911|581273321|FG002|Part 3|Lab abnormalities/AEs|0|||
160968248|NCT03485911|581273322|FG003|Part 3|Lab abnormalities/AEs|2|||
160968249|NCT03485911|581273319|FG000|Part 3|Other NOS|1|||
160968250|NCT03485911|581273320|FG001|Part 3|Other NOS|1|||
160968251|NCT03485911|581273321|FG002|Part 3|Other NOS|0|||
160968252|NCT03485911|581273322|FG003|Part 3|Other NOS|0|||
160968253|NCT03485911|581273319|FG000|Part 3|Intercurrent illness/new medical condition|0|||
160968254|NCT03485911|581273320|FG001|Part 3|Intercurrent illness/new medical condition|1|||
160968255|NCT03485911|581273321|FG002|Part 3|Intercurrent illness/new medical condition|1|||
160968256|NCT03485911|581273322|FG003|Part 3|Intercurrent illness/new medical condition|0|||
160968257|NCT03485911|581273319|FG000|Part 3|Sponsor discontinuation|1|||
160968258|NCT03485911|581273320|FG001|Part 3|Sponsor discontinuation|0|||
160968259|NCT03485911|581273321|FG002|Part 3|Sponsor discontinuation|0|||
160968260|NCT03485911|581273322|FG003|Part 3|Sponsor discontinuation|0|||
160968261|NCT03485911|581273319|FG000|Part 3|Berotralstat provided by alternative means|13|||
160968262|NCT03485911|581273320|FG001|Part 3|Berotralstat provided by alternative means|13|||
160968263|NCT03485911|581273321|FG002|Part 3|Berotralstat provided by alternative means|7|||
160968264|NCT03485911|581273322|FG003|Part 3|Berotralstat provided by alternative means|7|||
160968265|NCT03333928|581273323|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
160968266|NCT03333928|581273324|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
160968267|NCT03333928|581273325|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
160968268|NCT03333928|581273323|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
160968269|NCT03333928|581273324|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
160968270|NCT03333928|581273325|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
160968271|NCT03333928|581273323|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
160968272|NCT03333928|581273324|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
160968273|NCT03333928|581273325|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
160968274|NCT03333928|581273323|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
160968275|NCT03333928|581273324|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
160968276|NCT03333928|581273325|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
160968277|NCT03333928|581273323|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
160968278|NCT03333928|581273324|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
160968279|NCT03333928|581273325|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
160968280|NCT03333928|581273323|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
160968281|NCT03333928|581273324|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
161014858|NCT01772472|581443457|FG000|Overall Study|Death|126|||
161014859|NCT01772472|581443458|FG001|Overall Study|Death|94|||
161014860|NCT01772472|581443457|FG000|Overall Study|Lost to Follow-up|51|||
160657046|NCT01974141|580124520|FG000|Overall Study|Protocol Violation|2|||
161014861|NCT01772472|581443458|FG001|Overall Study|Lost to Follow-up|50|||
161014862|NCT01772472|581443457|FG000|Overall Study|Other|9|||
161014863|NCT01772472|581443458|FG001|Overall Study|Other|7|||
161014864|NCT01772472|581443457|FG000|Overall Study|Physician Decision|1|||
161014865|NCT01772472|581443458|FG001|Overall Study|Physician Decision|7|||
161014866|NCT01772472|581443457|FG000|Overall Study|Withdrawal by Subject|115|||
161014867|NCT01772472|581443458|FG001|Overall Study|Withdrawal by Subject|90|||
161014868|NCT01772472|581443457|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
161014869|NCT01772472|581443458|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
161014870|NCT04391894|581443459|FG000|Overall Study|Adverse Event|1|||
161014871|NCT04391894|581443460|FG001|Overall Study|Adverse Event|1|||
161014872|NCT04391894|581443461|FG002|Overall Study|Adverse Event|1|||
161014873|NCT04391894|581443462|FG003|Overall Study|Adverse Event|1|||
161014874|NCT04391894|581443463|FG004|Overall Study|Adverse Event|1|||
161014875|NCT04391894|581443459|FG000|Overall Study|Lost to Follow-up|1|||
161014876|NCT04391894|581443460|FG001|Overall Study|Lost to Follow-up|0|||
161014877|NCT04391894|581443461|FG002|Overall Study|Lost to Follow-up|0|||
161014878|NCT04391894|581443462|FG003|Overall Study|Lost to Follow-up|0|||
161014879|NCT04391894|581443463|FG004|Overall Study|Lost to Follow-up|0|||
161014880|NCT04391894|581443459|FG000|Overall Study|Protocol Violation|0|||
161014881|NCT04391894|581443460|FG001|Overall Study|Protocol Violation|0|||
161014882|NCT04391894|581443461|FG002|Overall Study|Protocol Violation|0|||
161014883|NCT04391894|581443462|FG003|Overall Study|Protocol Violation|1|||
161014884|NCT04391894|581443463|FG004|Overall Study|Protocol Violation|0|||
161014885|NCT04391894|581443459|FG000|Overall Study|Withdrawal by Subject|2|||
161014886|NCT04391894|581443460|FG001|Overall Study|Withdrawal by Subject|0|||
161014887|NCT04391894|581443461|FG002|Overall Study|Withdrawal by Subject|3|||
161014888|NCT04391894|581443462|FG003|Overall Study|Withdrawal by Subject|0|||
160586302|NCT02175771|579864025|FG000|Treatment Period|Disease progression|0|||
160586303|NCT02175771|579864026|FG001|Treatment Period|Disease progression|0|||
160586304|NCT02175771|579864027|FG002|Treatment Period|Disease progression|0|||
160586305|NCT02175771|579864028|FG003|Treatment Period|Disease progression|0|||
160586306|NCT02175771|579864029|FG004|Treatment Period|Disease progression|0|||
160586307|NCT02175771|579864030|FG005|Treatment Period|Disease progression|0|||
160586308|NCT02175771|579864031|FG006|Treatment Period|Disease progression|0|||
160586309|NCT02175771|579864032|FG007|Treatment Period|Disease progression|2|||
160586310|NCT02175771|579864033|FG008|Treatment Period|Disease progression|0|||
160586311|NCT02175771|579864025|FG000|Treatment Period|Lost to Follow-up|0|||
160586312|NCT02175771|579864026|FG001|Treatment Period|Lost to Follow-up|3|||
160586313|NCT02175771|579864027|FG002|Treatment Period|Lost to Follow-up|1|||
160586314|NCT02175771|579864028|FG003|Treatment Period|Lost to Follow-up|3|||
160586315|NCT02175771|579864029|FG004|Treatment Period|Lost to Follow-up|1|||
160586316|NCT02175771|579864030|FG005|Treatment Period|Lost to Follow-up|2|||
160586317|NCT02175771|579864031|FG006|Treatment Period|Lost to Follow-up|1|||
160586318|NCT02175771|579864032|FG007|Treatment Period|Lost to Follow-up|2|||
160586319|NCT02175771|579864033|FG008|Treatment Period|Lost to Follow-up|2|||
160586320|NCT02175771|579864025|FG000|Treatment Period|Lack of Efficacy|0|||
160586321|NCT02175771|579864026|FG001|Treatment Period|Lack of Efficacy|0|||
160586322|NCT02175771|579864027|FG002|Treatment Period|Lack of Efficacy|0|||
160586323|NCT02175771|579864028|FG003|Treatment Period|Lack of Efficacy|0|||
160586324|NCT02175771|579864029|FG004|Treatment Period|Lack of Efficacy|0|||
160586325|NCT02175771|579864030|FG005|Treatment Period|Lack of Efficacy|1|||
160586326|NCT02175771|579864031|FG006|Treatment Period|Lack of Efficacy|0|||
160586327|NCT02175771|579864032|FG007|Treatment Period|Lack of Efficacy|1|||
160586328|NCT02175771|579864033|FG008|Treatment Period|Lack of Efficacy|0|||
160586329|NCT02175771|579864025|FG000|Treatment Period|Other|0|||
160586330|NCT02175771|579864026|FG001|Treatment Period|Other|1|||
160586331|NCT02175771|579864027|FG002|Treatment Period|Other|0|||
160586332|NCT02175771|579864028|FG003|Treatment Period|Other|3|||
160586333|NCT02175771|579864029|FG004|Treatment Period|Other|1|||
160586334|NCT02175771|579864030|FG005|Treatment Period|Other|0|||
160586335|NCT02175771|579864031|FG006|Treatment Period|Other|0|||
161014889|NCT04391894|581443463|FG004|Overall Study|Withdrawal by Subject|1|||
160586336|NCT02175771|579864032|FG007|Treatment Period|Other|2|||
160586337|NCT02175771|579864033|FG008|Treatment Period|Other|0|||
160586338|NCT02208024|579864034|FG000|Overall Study|Withdrawal by Subject|1|||
160586339|NCT03375112|579864037|FG000|Overall Study|Withdrawal by Subject|3|||
160586340|NCT03375112|579864038|FG001|Overall Study|Withdrawal by Subject|0|||
160586341|NCT03599141|579864039|FG000|Overall Study|Lost to Follow-up|3|||
160586342|NCT03599141|579864040|FG001|Overall Study|Lost to Follow-up|1|||
161014890|NCT04391894|581443459|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
160586343|NCT00786032|579865636|FG000|Overall Study|Death|4|||
160586344|NCT00786032|579865636|FG000|Overall Study|Withdrawal by Subject|14|||
160586345|NCT00786032|579865636|FG000|Overall Study|Did not complete in the timeframe|6|||
161014891|NCT04391894|581443460|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
161014892|NCT04391894|581443461|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
161014893|NCT04391894|581443462|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
161014894|NCT04391894|581443463|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
161014895|NCT02323321|581443467|FG000|Overall Study|Re-Transplant|1|||
161014896|NCT02323321|581443467|FG000|Overall Study|Death|12|||
161014897|NCT00446225|581443468|FG000|Overall Study|Protocol Violation|1|||
161014898|NCT00446225|581443469|FG001|Overall Study|Protocol Violation|0|||
161014899|NCT02500758|581443472|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
161014900|NCT02500758|581443473|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
161014901|NCT02500758|581443472|FG000|Washout (1 Week)|Lost to Follow-up|2|||
161014902|NCT02500758|581443473|FG001|Washout (1 Week)|Lost to Follow-up|2|||
161014903|NCT02500758|581443472|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
161014904|NCT02500758|581443473|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
161014905|NCT02500758|581443472|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
161014906|NCT02500758|581443473|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
161014907|NCT02500758|581443472|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
161014908|NCT02500758|581443473|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
161014909|NCT00220740|581443474|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
161014910|NCT00220740|581443475|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
161014911|NCT00220740|581443474|FG000|Efficacy Period|Adverse Event|1|||
161014912|NCT00220740|581443475|FG001|Efficacy Period|Adverse Event|1|||
161014913|NCT00220740|581443474|FG000|Efficacy Period|Withdrawal by Subject|1|||
161014914|NCT00220740|581443475|FG001|Efficacy Period|Withdrawal by Subject|0|||
161014915|NCT00220740|581443474|FG000|Efficacy Period|Protocol Violation|1|||
161014916|NCT00220740|581443475|FG001|Efficacy Period|Protocol Violation|0|||
161014917|NCT00220740|581443474|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
161014918|NCT00220740|581443475|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
161014919|NCT01057433|581443476|FG000|Overall Study|Adverse Event|1|||
161014920|NCT02874534|581443478|FG000|Overall Study|Withdrawal by Subject|5|||
161014921|NCT02874534|581443479|FG001|Overall Study|Withdrawal by Subject|8|||
161014922|NCT02874534|581443478|FG000|Overall Study|Lost to Follow-up|2|||
161014923|NCT02874534|581443479|FG001|Overall Study|Lost to Follow-up|2|||
161014924|NCT02874534|581443478|FG000|Overall Study|Ongoing in study|1|||
161014925|NCT02874534|581443479|FG001|Overall Study|Ongoing in study|1|||
161014926|NCT05198310|581443480|FG000|Overall Study|Lost to Follow-up|0|||
161014927|NCT05198310|581443481|FG001|Overall Study|Lost to Follow-up|1|||
161014928|NCT05198310|581443482|FG002|Overall Study|Lost to Follow-up|0|||
161014929|NCT05198310|581443483|FG003|Overall Study|Lost to Follow-up|0|||
161014930|NCT05198310|581443484|FG004|Overall Study|Lost to Follow-up|0|||
161014931|NCT05198310|581443485|FG005|Overall Study|Lost to Follow-up|0|||
161014932|NCT05198310|581443486|FG006|Overall Study|Lost to Follow-up|0|||
161014933|NCT05198310|581443487|FG007|Overall Study|Lost to Follow-up|0|||
161014934|NCT05198310|581443480|FG000|Overall Study|Withdrawal by Subject|0|||
161014935|NCT05198310|581443481|FG001|Overall Study|Withdrawal by Subject|0|||
161014936|NCT05198310|581443482|FG002|Overall Study|Withdrawal by Subject|0|||
161014937|NCT05198310|581443483|FG003|Overall Study|Withdrawal by Subject|2|||
161014938|NCT05198310|581443484|FG004|Overall Study|Withdrawal by Subject|0|||
161014939|NCT05198310|581443485|FG005|Overall Study|Withdrawal by Subject|2|||
161014940|NCT05198310|581443486|FG006|Overall Study|Withdrawal by Subject|1|||
161014941|NCT05198310|581443487|FG007|Overall Study|Withdrawal by Subject|3|||
161014942|NCT04116736|581443490|FG000|Overall Study|Withdrew consent during study|3|||
161014943|NCT04116736|581443491|FG001|Overall Study|Withdrew consent during study|1|||
161014944|NCT04116736|581443490|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
161014945|NCT04116736|581443491|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
161014946|NCT04116736|581443490|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
161014947|NCT04116736|581443491|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
161014948|NCT04116736|581443490|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
161014949|NCT04116736|581443491|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
161014950|NCT04116736|581443490|FG000|Overall Study|Subject was enrolled in error|2|||
161014951|NCT04116736|581443491|FG001|Overall Study|Subject was enrolled in error|0|||
161014952|NCT04116736|581443490|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
161014953|NCT04116736|581443491|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
161014954|NCT04116736|581443490|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
161014955|NCT04116736|581443491|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
161014956|NCT04116736|581443490|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
160586346|NCT02457182|579865637|FG000|Overall Study|Lost to Follow-up|1|||
160586347|NCT02457182|579865638|FG001|Overall Study|Lost to Follow-up|0|||
160586348|NCT01116687|579865641|FG000|Overall Study|Withdrawal by Subject|4|||
161014957|NCT04116736|581443491|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
161014958|NCT03941860|581443498|FG000|Overall Study|Withdrawal by Subject|0|||
161014959|NCT03941860|581443499|FG001|Overall Study|Withdrawal by Subject|1|||
161014960|NCT03361748|581443500|FG000|Overall Study|Death|77|||
160586349|NCT00424528|579865642|FG000|Overall Study|Adverse Event|2|||
161014961|NCT03361748|581443500|FG000|Overall Study|Lost to Follow-up|4|||
160586350|NCT00424528|579865643|FG001|Overall Study|Adverse Event|1|||
161014962|NCT03361748|581443500|FG000|Overall Study|Withdrawal by Subject|20|||
161014963|NCT04093752|581443501|FG000|Overall Study|Adverse Event|7|||
161014964|NCT04093752|581443502|FG001|Overall Study|Adverse Event|19|||
161014965|NCT04093752|581443503|FG002|Overall Study|Adverse Event|18|||
161014966|NCT04093752|581443504|FG003|Overall Study|Adverse Event|4|||
161014967|NCT04093752|581443501|FG000|Overall Study|Withdrawal by Subject|6|||
161014968|NCT04093752|581443502|FG001|Overall Study|Withdrawal by Subject|6|||
161014969|NCT04093752|581443503|FG002|Overall Study|Withdrawal by Subject|8|||
161014970|NCT04093752|581443504|FG003|Overall Study|Withdrawal by Subject|20|||
161014971|NCT04093752|581443501|FG000|Overall Study|Lost to Follow-up|2|||
160586351|NCT00424528|579865644|FG002|Overall Study|Adverse Event|2|||
160586352|NCT00424528|579865642|FG000|Overall Study|Protocol Violation|1|||
160586353|NCT00424528|579865643|FG001|Overall Study|Protocol Violation|1|||
160586354|NCT00424528|579865644|FG002|Overall Study|Protocol Violation|0|||
160586355|NCT00424528|579865642|FG000|Overall Study|Lost to Follow-up|0|||
160586356|NCT00424528|579865643|FG001|Overall Study|Lost to Follow-up|1|||
160586357|NCT00424528|579865644|FG002|Overall Study|Lost to Follow-up|0|||
160586358|NCT00424528|579865642|FG000|Overall Study|noncompliance with study requirements|2|||
160586359|NCT00424528|579865643|FG001|Overall Study|noncompliance with study requirements|1|||
160586360|NCT00424528|579865644|FG002|Overall Study|noncompliance with study requirements|2|||
160586361|NCT00165841|579865647|FG000|Overall Study|Adverse Event|2|||
160586362|NCT00165841|579865648|FG001|Overall Study|Adverse Event|3|||
160586363|NCT00165841|579865647|FG000|Overall Study|Lack of Efficacy|6|||
160968282|NCT03333928|581273325|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
160968283|NCT03333928|581273323|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
160968284|NCT03333928|581273324|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
160968285|NCT03333928|581273325|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
160968286|NCT03333928|581273323|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
160968287|NCT03333928|581273324|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
160968288|NCT03333928|581273325|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
160968289|NCT01674621|581273326|FG000|Overall Study|Adverse Event|3|||
160968290|NCT01674621|581273327|FG001|Overall Study|Adverse Event|2|||
160968291|NCT01674621|581273328|FG002|Overall Study|Adverse Event|5|||
160968292|NCT01674621|581273329|FG003|Overall Study|Adverse Event|5|||
160968293|NCT01674621|581273330|FG004|Overall Study|Adverse Event|1|||
160968294|NCT01674621|581273326|FG000|Overall Study|Inability to Complete Study Procedures|0|||
160968295|NCT01674621|581273327|FG001|Overall Study|Inability to Complete Study Procedures|0|||
160968296|NCT01674621|581273328|FG002|Overall Study|Inability to Complete Study Procedures|0|||
160968297|NCT01674621|581273329|FG003|Overall Study|Inability to Complete Study Procedures|0|||
160968298|NCT01674621|581273330|FG004|Overall Study|Inability to Complete Study Procedures|2|||
160968299|NCT01674621|581273326|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
160968300|NCT01674621|581273327|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
160968301|NCT01674621|581273328|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
160968302|NCT01674621|581273329|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
160968303|NCT01674621|581273330|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
160968304|NCT01674621|581273326|FG000|Overall Study|Withdrawal by Subject|2|||
160968305|NCT01674621|581273327|FG001|Overall Study|Withdrawal by Subject|5|||
160968306|NCT01674621|581273328|FG002|Overall Study|Withdrawal by Subject|2|||
160968307|NCT01674621|581273329|FG003|Overall Study|Withdrawal by Subject|0|||
160968308|NCT01674621|581273330|FG004|Overall Study|Withdrawal by Subject|1|||
160968309|NCT01674621|581273326|FG000|Overall Study|Other than specified|0|||
160968310|NCT01674621|581273327|FG001|Overall Study|Other than specified|1|||
160968311|NCT01674621|581273328|FG002|Overall Study|Other than specified|0|||
160968312|NCT01674621|581273329|FG003|Overall Study|Other than specified|0|||
160968313|NCT01674621|581273330|FG004|Overall Study|Other than specified|2|||
160968314|NCT04543188|581273331|FG000|Phase 1a|Adverse Event|0|||
160968315|NCT04543188|581273332|FG001|Phase 1a|Adverse Event|0|||
160968316|NCT04543188|581273333|FG002|Phase 1a|Adverse Event|0|||
160968317|NCT04543188|581273334|FG003|Phase 1a|Adverse Event|1|||
160968318|NCT04543188|581273335|FG004|Phase 1a|Adverse Event|0|||
160968319|NCT04543188|581273336|FG005|Phase 1a|Adverse Event|0|||
160968320|NCT04543188|581273337|FG006|Phase 1a|Adverse Event|1|||
160968321|NCT04543188|581273338|FG007|Phase 1a|Adverse Event|0|||
160968322|NCT04543188|581273339|FG008|Phase 1a|Adverse Event|0|||
160968323|NCT04543188|581273340|FG009|Phase 1a|Adverse Event|0|||
160968324|NCT04543188|581273341|FG010|Phase 1a|Adverse Event|0|||
160968325|NCT04543188|581273342|FG011|Phase 1a|Adverse Event|0|||
160968326|NCT04543188|581273343|FG012|Phase 1a|Adverse Event|0|||
160968327|NCT04543188|581273344|FG013|Phase 1a|Adverse Event|0|||
160968328|NCT04543188|581273345|FG014|Phase 1a|Adverse Event|0|||
160968329|NCT04543188|581273331|FG000|Phase 1a|Other (Death)|0|||
160968330|NCT04543188|581273332|FG001|Phase 1a|Other (Death)|1|||
160968331|NCT04543188|581273333|FG002|Phase 1a|Other (Death)|0|||
160968332|NCT04543188|581273334|FG003|Phase 1a|Other (Death)|0|||
160968333|NCT04543188|581273335|FG004|Phase 1a|Other (Death)|1|||
160968334|NCT04543188|581273336|FG005|Phase 1a|Other (Death)|0|||
160968335|NCT04543188|581273337|FG006|Phase 1a|Other (Death)|0|||
161014972|NCT04093752|581443502|FG001|Overall Study|Lost to Follow-up|1|||
161014973|NCT04093752|581443503|FG002|Overall Study|Lost to Follow-up|1|||
161014974|NCT04093752|581443504|FG003|Overall Study|Lost to Follow-up|1|||
161014975|NCT04093752|581443501|FG000|Overall Study|Death|0|||
161014976|NCT04093752|581443502|FG001|Overall Study|Death|0|||
161014977|NCT04093752|581443503|FG002|Overall Study|Death|1|||
161014978|NCT04093752|581443504|FG003|Overall Study|Death|2|||
161014979|NCT04093752|581443501|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
161014980|NCT04093752|581443502|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
161014981|NCT04093752|581443503|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
161014982|NCT04093752|581443504|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
160968336|NCT04543188|581273338|FG007|Phase 1a|Other (Death)|0|||
160968337|NCT04543188|581273339|FG008|Phase 1a|Other (Death)|0|||
160968338|NCT04543188|581273340|FG009|Phase 1a|Other (Death)|1|||
160968339|NCT04543188|581273341|FG010|Phase 1a|Other (Death)|0|||
160968340|NCT04543188|581273342|FG011|Phase 1a|Other (Death)|0|||
160968341|NCT04543188|581273343|FG012|Phase 1a|Other (Death)|0|||
160968342|NCT04543188|581273344|FG013|Phase 1a|Other (Death)|0|||
160968343|NCT04543188|581273345|FG014|Phase 1a|Other (Death)|0|||
160968344|NCT04543188|581273331|FG000|Phase 1a|Lost to Follow-up|0|||
160968345|NCT04543188|581273332|FG001|Phase 1a|Lost to Follow-up|0|||
160968346|NCT04543188|581273333|FG002|Phase 1a|Lost to Follow-up|0|||
160968347|NCT04543188|581273334|FG003|Phase 1a|Lost to Follow-up|0|||
160968348|NCT04543188|581273335|FG004|Phase 1a|Lost to Follow-up|0|||
160968349|NCT04543188|581273336|FG005|Phase 1a|Lost to Follow-up|0|||
160968350|NCT04543188|581273337|FG006|Phase 1a|Lost to Follow-up|0|||
160968351|NCT04543188|581273338|FG007|Phase 1a|Lost to Follow-up|0|||
160968352|NCT04543188|581273339|FG008|Phase 1a|Lost to Follow-up|0|||
160968353|NCT04543188|581273340|FG009|Phase 1a|Lost to Follow-up|0|||
160968354|NCT04543188|581273341|FG010|Phase 1a|Lost to Follow-up|1|||
160968355|NCT04543188|581273342|FG011|Phase 1a|Lost to Follow-up|0|||
160968356|NCT04543188|581273343|FG012|Phase 1a|Lost to Follow-up|0|||
160968357|NCT04543188|581273344|FG013|Phase 1a|Lost to Follow-up|0|||
160968358|NCT04543188|581273345|FG014|Phase 1a|Lost to Follow-up|0|||
160968359|NCT04543188|581273331|FG000|Phase 1a|Progressive Disease|2|||
160968360|NCT04543188|581273332|FG001|Phase 1a|Progressive Disease|2|||
160968361|NCT04543188|581273333|FG002|Phase 1a|Progressive Disease|3|||
160968362|NCT04543188|581273334|FG003|Phase 1a|Progressive Disease|1|||
160968363|NCT04543188|581273335|FG004|Phase 1a|Progressive Disease|4|||
160968364|NCT04543188|581273336|FG005|Phase 1a|Progressive Disease|2|||
160968365|NCT04543188|581273337|FG006|Phase 1a|Progressive Disease|3|||
160968366|NCT04543188|581273338|FG007|Phase 1a|Progressive Disease|4|||
160968367|NCT04543188|581273339|FG008|Phase 1a|Progressive Disease|1|||
160968368|NCT04543188|581273340|FG009|Phase 1a|Progressive Disease|0|||
160968369|NCT04543188|581273341|FG010|Phase 1a|Progressive Disease|4|||
160968370|NCT04543188|581273342|FG011|Phase 1a|Progressive Disease|0|||
160968371|NCT04543188|581273343|FG012|Phase 1a|Progressive Disease|0|||
160968372|NCT04543188|581273344|FG013|Phase 1a|Progressive Disease|0|||
160968373|NCT04543188|581273345|FG014|Phase 1a|Progressive Disease|0|||
160968374|NCT04543188|581273331|FG000|Phase 1a|Study terminated by sponsor|0|||
160968375|NCT04543188|581273332|FG001|Phase 1a|Study terminated by sponsor|0|||
160968376|NCT04543188|581273333|FG002|Phase 1a|Study terminated by sponsor|0|||
160968377|NCT04543188|581273334|FG003|Phase 1a|Study terminated by sponsor|0|||
160968378|NCT04543188|581273335|FG004|Phase 1a|Study terminated by sponsor|1|||
160968379|NCT04543188|581273336|FG005|Phase 1a|Study terminated by sponsor|0|||
160968380|NCT04543188|581273337|FG006|Phase 1a|Study terminated by sponsor|0|||
160968381|NCT04543188|581273338|FG007|Phase 1a|Study terminated by sponsor|0|||
160968382|NCT04543188|581273339|FG008|Phase 1a|Study terminated by sponsor|0|||
160968383|NCT04543188|581273340|FG009|Phase 1a|Study terminated by sponsor|0|||
160968384|NCT04543188|581273341|FG010|Phase 1a|Study terminated by sponsor|1|||
160968385|NCT04543188|581273342|FG011|Phase 1a|Study terminated by sponsor|0|||
160968386|NCT04543188|581273343|FG012|Phase 1a|Study terminated by sponsor|0|||
160968387|NCT04543188|581273344|FG013|Phase 1a|Study terminated by sponsor|0|||
160968388|NCT04543188|581273345|FG014|Phase 1a|Study terminated by sponsor|0|||
160968389|NCT04543188|581273331|FG000|Phase 1a|Withdrawal by Subject|0|||
160968390|NCT04543188|581273332|FG001|Phase 1a|Withdrawal by Subject|0|||
160968391|NCT04543188|581273333|FG002|Phase 1a|Withdrawal by Subject|0|||
160968392|NCT04543188|581273334|FG003|Phase 1a|Withdrawal by Subject|0|||
160968393|NCT04543188|581273335|FG004|Phase 1a|Withdrawal by Subject|3|||
160968394|NCT04543188|581273336|FG005|Phase 1a|Withdrawal by Subject|0|||
160968395|NCT04543188|581273337|FG006|Phase 1a|Withdrawal by Subject|0|||
160968396|NCT04543188|581273338|FG007|Phase 1a|Withdrawal by Subject|0|||
160968397|NCT04543188|581273339|FG008|Phase 1a|Withdrawal by Subject|1|||
160968398|NCT04543188|581273340|FG009|Phase 1a|Withdrawal by Subject|1|||
160968399|NCT04543188|581273341|FG010|Phase 1a|Withdrawal by Subject|2|||
160968400|NCT04543188|581273342|FG011|Phase 1a|Withdrawal by Subject|0|||
160968401|NCT04543188|581273343|FG012|Phase 1a|Withdrawal by Subject|0|||
160968402|NCT04543188|581273344|FG013|Phase 1a|Withdrawal by Subject|0|||
160968403|NCT04543188|581273345|FG014|Phase 1a|Withdrawal by Subject|0|||
160586364|NCT00165841|579865648|FG001|Overall Study|Lack of Efficacy|33|||
160586365|NCT00165841|579865647|FG000|Overall Study|Lost to Follow-up|4|||
160586366|NCT00165841|579865648|FG001|Overall Study|Lost to Follow-up|4|||
160586367|NCT00165841|579865647|FG000|Overall Study|Withdrawal by Subject|7|||
160586368|NCT00165841|579865648|FG001|Overall Study|Withdrawal by Subject|8|||
160586369|NCT00165841|579865647|FG000|Overall Study|Physician Decision|1|||
160586370|NCT00165841|579865648|FG001|Overall Study|Physician Decision|0|||
160586371|NCT00165841|579865647|FG000|Overall Study|Protocol Violation|6|||
160586372|NCT00165841|579865648|FG001|Overall Study|Protocol Violation|8|||
160586373|NCT00165841|579865647|FG000|Overall Study|Other|3|||
160586374|NCT00165841|579865648|FG001|Overall Study|Other|5|||
160586375|NCT00165841|579865647|FG000|Overall Study|Medication Noncompliance|1|||
160586376|NCT00165841|579865648|FG001|Overall Study|Medication Noncompliance|1|||
160968404|NCT04543188|581273331|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
160968405|NCT04543188|581273332|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
160968406|NCT04543188|581273333|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
160968407|NCT04543188|581273334|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
160968408|NCT04543188|581273335|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
160968409|NCT04543188|581273336|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
160968410|NCT04543188|581273337|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
160968411|NCT04543188|581273338|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
160968412|NCT04543188|581273339|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
160968413|NCT04543188|581273340|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
160968414|NCT04543188|581273341|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
160968415|NCT04543188|581273342|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
160968416|NCT04543188|581273343|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
160968417|NCT04543188|581273344|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
160968418|NCT04543188|581273345|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
160968419|NCT04543188|581273331|FG000|Phase 1a|Other|0|||
160968420|NCT04543188|581273332|FG001|Phase 1a|Other|0|||
160968421|NCT04543188|581273333|FG002|Phase 1a|Other|0|||
160968422|NCT04543188|581273334|FG003|Phase 1a|Other|0|||
160968423|NCT04543188|581273335|FG004|Phase 1a|Other|0|||
160968424|NCT04543188|581273336|FG005|Phase 1a|Other|0|||
160968425|NCT04543188|581273337|FG006|Phase 1a|Other|0|||
160968426|NCT04543188|581273338|FG007|Phase 1a|Other|0|||
160968427|NCT04543188|581273339|FG008|Phase 1a|Other|0|||
160968428|NCT04543188|581273340|FG009|Phase 1a|Other|1|||
160968429|NCT04543188|581273341|FG010|Phase 1a|Other|0|||
160968430|NCT04543188|581273342|FG011|Phase 1a|Other|0|||
160968431|NCT04543188|581273343|FG012|Phase 1a|Other|0|||
160968432|NCT04543188|581273344|FG013|Phase 1a|Other|0|||
160968433|NCT04543188|581273345|FG014|Phase 1a|Other|0|||
160968434|NCT04543188|581273331|FG000|Phase 1b|Adverse Event|0|||
160968435|NCT04543188|581273332|FG001|Phase 1b|Adverse Event|0|||
160968436|NCT04543188|581273333|FG002|Phase 1b|Adverse Event|0|||
160968437|NCT04543188|581273334|FG003|Phase 1b|Adverse Event|0|||
160968438|NCT04543188|581273335|FG004|Phase 1b|Adverse Event|0|||
160968439|NCT04543188|581273336|FG005|Phase 1b|Adverse Event|0|||
160968440|NCT04543188|581273337|FG006|Phase 1b|Adverse Event|0|||
160968441|NCT04543188|581273338|FG007|Phase 1b|Adverse Event|0|||
160968442|NCT04543188|581273339|FG008|Phase 1b|Adverse Event|0|||
160968443|NCT04543188|581273340|FG009|Phase 1b|Adverse Event|0|||
160968444|NCT04543188|581273341|FG010|Phase 1b|Adverse Event|0|||
160968445|NCT04543188|581273342|FG011|Phase 1b|Adverse Event|0|||
160968446|NCT04543188|581273343|FG012|Phase 1b|Adverse Event|0|||
160968447|NCT04543188|581273344|FG013|Phase 1b|Adverse Event|0|||
160968448|NCT04543188|581273345|FG014|Phase 1b|Adverse Event|2|||
160968449|NCT04543188|581273331|FG000|Phase 1b|Other (Death)|0|||
160968450|NCT04543188|581273332|FG001|Phase 1b|Other (Death)|0|||
160968451|NCT04543188|581273333|FG002|Phase 1b|Other (Death)|0|||
160968452|NCT04543188|581273334|FG003|Phase 1b|Other (Death)|0|||
160968453|NCT04543188|581273335|FG004|Phase 1b|Other (Death)|0|||
160968454|NCT04543188|581273336|FG005|Phase 1b|Other (Death)|0|||
160968455|NCT04543188|581273337|FG006|Phase 1b|Other (Death)|0|||
160968456|NCT04543188|581273338|FG007|Phase 1b|Other (Death)|0|||
160968457|NCT04543188|581273339|FG008|Phase 1b|Other (Death)|0|||
161014983|NCT04093752|581443501|FG000|Overall Study|Covid 19|0|||
160586377|NCT01575197|579865649|FG000|Overall Study|Migration out of study area|1|||
160968458|NCT04543188|581273340|FG009|Phase 1b|Other (Death)|0|||
160968459|NCT04543188|581273341|FG010|Phase 1b|Other (Death)|0|||
160968460|NCT04543188|581273342|FG011|Phase 1b|Other (Death)|0|||
160968461|NCT04543188|581273343|FG012|Phase 1b|Other (Death)|1|||
160968462|NCT04543188|581273344|FG013|Phase 1b|Other (Death)|0|||
160968463|NCT04543188|581273345|FG014|Phase 1b|Other (Death)|1|||
160968464|NCT04543188|581273331|FG000|Phase 1b|Progressive Disease|0|||
160968465|NCT04543188|581273332|FG001|Phase 1b|Progressive Disease|0|||
160968466|NCT04543188|581273333|FG002|Phase 1b|Progressive Disease|0|||
160968467|NCT04543188|581273334|FG003|Phase 1b|Progressive Disease|0|||
160968468|NCT04543188|581273335|FG004|Phase 1b|Progressive Disease|0|||
160968469|NCT04543188|581273336|FG005|Phase 1b|Progressive Disease|0|||
160968470|NCT04543188|581273337|FG006|Phase 1b|Progressive Disease|0|||
160968471|NCT04543188|581273338|FG007|Phase 1b|Progressive Disease|0|||
161014984|NCT04093752|581443502|FG001|Overall Study|Covid 19|0|||
161014985|NCT04093752|581443503|FG002|Overall Study|Covid 19|0|||
161014986|NCT04093752|581443504|FG003|Overall Study|Covid 19|1|||
161014987|NCT04093752|581443501|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
161014988|NCT04093752|581443502|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
161014989|NCT04093752|581443503|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
161014990|NCT04093752|581443504|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
161014991|NCT04093752|581443501|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
161014992|NCT04093752|581443502|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
161014993|NCT04093752|581443503|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
161014994|NCT04093752|581443504|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
161014995|NCT04093752|581443501|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
160459242|NCT02246127|579414209|FG000|First Course Treatment|Physician Decision|9|||
160459243|NCT02246127|579414210|FG001|First Course Treatment|Physician Decision|9|||
160459244|NCT02246127|579414209|FG000|First Course Treatment|Death|3|||
160459245|NCT02246127|579414210|FG001|First Course Treatment|Death|3|||
160459246|NCT02246127|579414209|FG000|First Course Treatment|Not reported reasons|6|||
160586378|NCT01575197|579865650|FG001|Overall Study|Migration out of study area|5|||
160586379|NCT01575197|579865651|FG002|Overall Study|Migration out of study area|4|||
160586380|NCT01575197|579865649|FG000|Overall Study|SAE|0|||
160968472|NCT04543188|581273339|FG008|Phase 1b|Progressive Disease|0|||
160968473|NCT04543188|581273340|FG009|Phase 1b|Progressive Disease|0|||
160968474|NCT04543188|581273341|FG010|Phase 1b|Progressive Disease|0|||
160968475|NCT04543188|581273342|FG011|Phase 1b|Progressive Disease|0|||
160968476|NCT04543188|581273343|FG012|Phase 1b|Progressive Disease|2|||
160968477|NCT04543188|581273344|FG013|Phase 1b|Progressive Disease|1|||
160968478|NCT04543188|581273345|FG014|Phase 1b|Progressive Disease|5|||
160968479|NCT04543188|581273331|FG000|Phase 1b|Study Terminated By Sponsor|0|||
160968480|NCT04543188|581273332|FG001|Phase 1b|Study Terminated By Sponsor|0|||
160968481|NCT04543188|581273333|FG002|Phase 1b|Study Terminated By Sponsor|0|||
160968482|NCT04543188|581273334|FG003|Phase 1b|Study Terminated By Sponsor|0|||
160968483|NCT04543188|581273335|FG004|Phase 1b|Study Terminated By Sponsor|0|||
160968484|NCT04543188|581273336|FG005|Phase 1b|Study Terminated By Sponsor|0|||
160968485|NCT04543188|581273337|FG006|Phase 1b|Study Terminated By Sponsor|0|||
160968486|NCT04543188|581273338|FG007|Phase 1b|Study Terminated By Sponsor|0|||
160968487|NCT04543188|581273339|FG008|Phase 1b|Study Terminated By Sponsor|0|||
160968488|NCT04543188|581273340|FG009|Phase 1b|Study Terminated By Sponsor|0|||
160968489|NCT04543188|581273341|FG010|Phase 1b|Study Terminated By Sponsor|0|||
160968490|NCT04543188|581273342|FG011|Phase 1b|Study Terminated By Sponsor|1|||
160968491|NCT04543188|581273343|FG012|Phase 1b|Study Terminated By Sponsor|1|||
160968492|NCT04543188|581273344|FG013|Phase 1b|Study Terminated By Sponsor|0|||
160968493|NCT04543188|581273345|FG014|Phase 1b|Study Terminated By Sponsor|1|||
160968494|NCT04543188|581273331|FG000|Phase 1b|Withdrawal by Subject|0|||
160968495|NCT04543188|581273332|FG001|Phase 1b|Withdrawal by Subject|0|||
160968496|NCT04543188|581273333|FG002|Phase 1b|Withdrawal by Subject|0|||
160968497|NCT04543188|581273334|FG003|Phase 1b|Withdrawal by Subject|0|||
160968498|NCT04543188|581273335|FG004|Phase 1b|Withdrawal by Subject|0|||
160968499|NCT04543188|581273336|FG005|Phase 1b|Withdrawal by Subject|0|||
160968500|NCT04543188|581273337|FG006|Phase 1b|Withdrawal by Subject|0|||
160968501|NCT04543188|581273338|FG007|Phase 1b|Withdrawal by Subject|0|||
160968502|NCT04543188|581273339|FG008|Phase 1b|Withdrawal by Subject|0|||
160968503|NCT04543188|581273340|FG009|Phase 1b|Withdrawal by Subject|0|||
160968504|NCT04543188|581273341|FG010|Phase 1b|Withdrawal by Subject|0|||
160968505|NCT04543188|581273342|FG011|Phase 1b|Withdrawal by Subject|0|||
160968506|NCT04543188|581273343|FG012|Phase 1b|Withdrawal by Subject|0|||
160968507|NCT04543188|581273344|FG013|Phase 1b|Withdrawal by Subject|0|||
160968508|NCT04543188|581273345|FG014|Phase 1b|Withdrawal by Subject|2|||
160968509|NCT03815019|581273346|FG000|Overall Study|Withdrawal by Subject|6|||
160968510|NCT03815019|581273347|FG001|Overall Study|Withdrawal by Subject|8|||
160968511|NCT04270747|581273349|FG000|Through Week 16|Adverse Event|1|||
160968512|NCT04270747|581273350|FG001|Through Week 16|Adverse Event|2|||
160968513|NCT04270747|581273351|FG002|Through Week 16|Adverse Event|0|||
160968514|NCT04270747|581273349|FG000|Through Week 16|Death|0|||
160968515|NCT04270747|581273350|FG001|Through Week 16|Death|2|||
160968516|NCT04270747|581273351|FG002|Through Week 16|Death|0|||
160968517|NCT04270747|581273349|FG000|Through Week 16|Consent Withdrawn|3|||
160968518|NCT04270747|581273350|FG001|Through Week 16|Consent Withdrawn|3|||
160968519|NCT04270747|581273351|FG002|Through Week 16|Consent Withdrawn|0|||
160968520|NCT04270747|581273349|FG000|Through Week 16|Physician Decision|1|||
160968521|NCT04270747|581273350|FG001|Through Week 16|Physician Decision|1|||
160459247|NCT02246127|579414210|FG001|First Course Treatment|Not reported reasons|7|||
160459248|NCT02246127|579414209|FG000|First Course Treatment|Not treated|3|||
160459249|NCT02246127|579414210|FG001|First Course Treatment|Not treated|3|||
160459250|NCT05157841|579414211|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
160586381|NCT01575197|579865650|FG001|Overall Study|SAE|1|||
160968522|NCT04270747|581273351|FG002|Through Week 16|Physician Decision|0|||
160968523|NCT04270747|581273349|FG000|Through Week 16|Lost to Follow-up|2|||
161014996|NCT04093752|581443502|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
161014997|NCT04093752|581443503|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
161014998|NCT04093752|581443504|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
161014999|NCT04838613|581443508|FG000|Overall Study|Withdrawal by Subject|3|||
161015000|NCT04838613|581443509|FG001|Overall Study|Withdrawal by Subject|6|||
161015001|NCT04838613|581443508|FG000|Overall Study|Protocol Deviation|3|||
161015002|NCT04838613|581443509|FG001|Overall Study|Protocol Deviation|2|||
161015003|NCT04838613|581443508|FG000|Overall Study|Technical Problems|0|||
161015004|NCT04838613|581443509|FG001|Overall Study|Technical Problems|5|||
161015005|NCT04838613|581443508|FG000|Overall Study|Physician Decision|2|||
161015006|NCT04838613|581443509|FG001|Overall Study|Physician Decision|0|||
161015007|NCT04854096|581443510|FG000|Overall Study|Adverse Event|1|||
161015008|NCT04854096|581443511|FG001|Overall Study|Adverse Event|0|||
161015009|NCT04854096|581443510|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
161015010|NCT04854096|581443511|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
161015011|NCT04854096|581443510|FG000|Overall Study|Withdrawal by Subject|1|||
161015012|NCT04854096|581443511|FG001|Overall Study|Withdrawal by Subject|0|||
161015013|NCT04854096|581443510|FG000|Overall Study|Other reasons|1|||
161015014|NCT04854096|581443511|FG001|Overall Study|Other reasons|0|||
161015015|NCT04757610|581443512|FG000|Overall Study|Adverse Event|13|||
161015016|NCT04757610|581443513|FG001|Overall Study|Adverse Event|10|||
161015017|NCT04757610|581443514|FG002|Overall Study|Adverse Event|5|||
161015018|NCT04757610|581443512|FG000|Overall Study|Death|5|||
161015019|NCT04757610|581443513|FG001|Overall Study|Death|13|||
161015020|NCT04757610|581443514|FG002|Overall Study|Death|8|||
161015021|NCT04757610|581443512|FG000|Overall Study|Lack of Efficacy|1|||
161015022|NCT04757610|581443513|FG001|Overall Study|Lack of Efficacy|2|||
161015023|NCT04757610|581443514|FG002|Overall Study|Lack of Efficacy|3|||
161015024|NCT04757610|581443512|FG000|Overall Study|Lost to Follow-up|7|||
161015025|NCT04757610|581443513|FG001|Overall Study|Lost to Follow-up|2|||
161015026|NCT04757610|581443514|FG002|Overall Study|Lost to Follow-up|7|||
161015027|NCT04757610|581443512|FG000|Overall Study|Physician Decision|4|||
161015028|NCT04757610|581443513|FG001|Overall Study|Physician Decision|1|||
161015029|NCT04757610|581443514|FG002|Overall Study|Physician Decision|2|||
161015030|NCT04757610|581443512|FG000|Overall Study|Withdrawal by Subject|26|||
161015031|NCT04757610|581443513|FG001|Overall Study|Withdrawal by Subject|25|||
161015032|NCT04757610|581443514|FG002|Overall Study|Withdrawal by Subject|25|||
161015033|NCT04757610|581443512|FG000|Overall Study|Study Terminated by Sponsor|105|||
161015034|NCT04757610|581443513|FG001|Overall Study|Study Terminated by Sponsor|105|||
161015035|NCT04757610|581443514|FG002|Overall Study|Study Terminated by Sponsor|110|||
161015036|NCT04757610|581443512|FG000|Overall Study|Randomized in Error|1|||
161015037|NCT04757610|581443513|FG001|Overall Study|Randomized in Error|0|||
161015038|NCT04757610|581443514|FG002|Overall Study|Randomized in Error|0|||
161015039|NCT00901901|581443519|FG000|Treatment Period|Adverse Event|120|||
161015040|NCT00901901|581443520|FG001|Treatment Period|Adverse Event|128|||
161015041|NCT00901901|581443519|FG000|Treatment Period|Withdrawal by Subject|26|||
161015042|NCT00901901|581443520|FG001|Treatment Period|Withdrawal by Subject|24|||
161015043|NCT00901901|581443519|FG000|Treatment Period|Physician Decision|2|||
161015044|NCT00901901|581443520|FG001|Treatment Period|Physician Decision|2|||
161015045|NCT00901901|581443519|FG000|Treatment Period|Lost to Follow-up|3|||
161015046|NCT00901901|581443520|FG001|Treatment Period|Lost to Follow-up|5|||
161015047|NCT00901901|581443519|FG000|Treatment Period|Noncompliance with study medication|4|||
161015048|NCT00901901|581443520|FG001|Treatment Period|Noncompliance with study medication|1|||
161015049|NCT00901901|581443519|FG000|Treatment Period|Missing|1|||
161015050|NCT00901901|581443520|FG001|Treatment Period|Missing|0|||
161015051|NCT00901901|581443519|FG000|Treatment Period|Never treated|0|||
161015052|NCT00901901|581443520|FG001|Treatment Period|Never treated|3|||
161015053|NCT00901901|581443519|FG000|Treatment Period|Protocol driven decision point|0|||
161015054|NCT00901901|581443520|FG001|Treatment Period|Protocol driven decision point|2|||
161015055|NCT00901901|581443519|FG000|Treatment Period|Study terminated by sponsor|2|||
161015056|NCT00901901|581443520|FG001|Treatment Period|Study terminated by sponsor|0|||
161015057|NCT00901901|581443519|FG000|Treatment Period|Protocol Violation|5|||
161015058|NCT00901901|581443520|FG001|Treatment Period|Protocol Violation|9|||
161015059|NCT00901901|581443519|FG000|Treatment Period|Switch to commercial drug|1|||
161015060|NCT00901901|581443520|FG001|Treatment Period|Switch to commercial drug|1|||
161015061|NCT00901901|581443519|FG000|Treatment Period|Transfer to treatment continuation study|5|||
161015062|NCT00901901|581443520|FG001|Treatment Period|Transfer to treatment continuation study|2|||
161015063|NCT00901901|581443519|FG000|Follow-up Period|Death|181|||
161015064|NCT00901901|581443520|FG001|Follow-up Period|Death|208|||
161015065|NCT00901901|581443519|FG000|Follow-up Period|Protocol driven decision point|47|||
161015066|NCT00901901|581443520|FG001|Follow-up Period|Protocol driven decision point|36|||
161015067|NCT00901901|581443519|FG000|Follow-up Period|Withdrawal by Subject|6|||
161015068|NCT00901901|581443520|FG001|Follow-up Period|Withdrawal by Subject|9|||
161015069|NCT00901901|581443519|FG000|Follow-up Period|Lost to Follow-up|12|||
161015070|NCT00901901|581443520|FG001|Follow-up Period|Lost to Follow-up|8|||
161015071|NCT00901901|581443519|FG000|Follow-up Period|Missing|94|||
160586382|NCT01575197|579865651|FG002|Overall Study|SAE|0|||
160586383|NCT01575197|579865649|FG000|Overall Study|Lost to Follow-up|0|||
160586384|NCT01575197|579865650|FG001|Overall Study|Lost to Follow-up|1|||
160586385|NCT01575197|579865651|FG002|Overall Study|Lost to Follow-up|0|||
160586386|NCT01575197|579865649|FG000|Overall Study|Withdrawal by Subject|0|||
160586387|NCT01575197|579865650|FG001|Overall Study|Withdrawal by Subject|1|||
160586388|NCT01575197|579865651|FG002|Overall Study|Withdrawal by Subject|1|||
160586389|NCT01575197|579865649|FG000|Overall Study|Protocol Violation|2|||
160586390|NCT01575197|579865650|FG001|Overall Study|Protocol Violation|1|||
160586391|NCT01575197|579865651|FG002|Overall Study|Protocol Violation|1|||
160586392|NCT01000727|579865652|FG000|Overall Study|Lost to Follow-up|41|||
160586393|NCT01000727|579865653|FG001|Overall Study|Lost to Follow-up|43|||
160586394|NCT01000727|579865652|FG000|Overall Study|Withdrawal by Subject|111|||
160586395|NCT01000727|579865653|FG001|Overall Study|Withdrawal by Subject|109|||
160586396|NCT01000727|579865652|FG000|Overall Study|Study closed/terminated|23|||
160586397|NCT01000727|579865653|FG001|Overall Study|Study closed/terminated|24|||
160586398|NCT03196193|579865654|FG000|Overall Study|Adverse Event|1|||
160586399|NCT03196193|579865655|FG001|Overall Study|Adverse Event|0|||
160586400|NCT03196193|579865654|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
160586401|NCT03196193|579865655|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
160586402|NCT02709083|579865656|FG000|Overall Study|Original PI left institution|7|||
160586403|NCT01026389|579865657|FG000|Overall Study|Withdrawal by Subject|1|||
160586404|NCT01026389|579865658|FG001|Overall Study|Withdrawal by Subject|3|||
160586405|NCT01026389|579865657|FG000|Overall Study|change of treatment, patient moved|4|||
160586406|NCT01026389|579865658|FG001|Overall Study|change of treatment, patient moved|2|||
160586407|NCT04410198|579865659|FG000|Overall Study|Death|10|||
160586408|NCT04410198|579865659|FG000|Overall Study|Withdrawal by Subject|7|||
160586409|NCT04410198|579865659|FG000|Overall Study|Transferred/Relocation|4|||
160968524|NCT04270747|581273350|FG001|Through Week 16|Lost to Follow-up|0|||
160968525|NCT04270747|581273351|FG002|Through Week 16|Lost to Follow-up|0|||
160968526|NCT04270747|581273349|FG000|Through Week 16|Protocol Violation|1|||
160968527|NCT04270747|581273350|FG001|Through Week 16|Protocol Violation|2|||
160968528|NCT04270747|581273351|FG002|Through Week 16|Protocol Violation|0|||
160968529|NCT04270747|581273349|FG000|Through Week 16|Protocol Specified Criteria|6|||
160968530|NCT04270747|581273350|FG001|Through Week 16|Protocol Specified Criteria|7|||
160968531|NCT04270747|581273351|FG002|Through Week 16|Protocol Specified Criteria|0|||
160968532|NCT04270747|581273349|FG000|Through Week 16|Miscellaneous|1|||
160968533|NCT04270747|581273350|FG001|Through Week 16|Miscellaneous|1|||
160968534|NCT04270747|581273351|FG002|Through Week 16|Miscellaneous|0|||
160968535|NCT04270747|581273349|FG000|Post Week 16|Adverse Event|7|||
160968536|NCT04270747|581273350|FG001|Post Week 16|Adverse Event|5|||
160968537|NCT04270747|581273351|FG002|Post Week 16|Adverse Event|1|||
160968538|NCT04270747|581273349|FG000|Post Week 16|Death|2|||
160968539|NCT04270747|581273350|FG001|Post Week 16|Death|0|||
160968540|NCT04270747|581273351|FG002|Post Week 16|Death|2|||
160968541|NCT04270747|581273349|FG000|Post Week 16|Consent Withdrawn|4|||
160968542|NCT04270747|581273350|FG001|Post Week 16|Consent Withdrawn|3|||
160968543|NCT04270747|581273351|FG002|Post Week 16|Consent Withdrawn|6|||
160968544|NCT04270747|581273349|FG000|Post Week 16|Physician Decision|3|||
160968545|NCT04270747|581273350|FG001|Post Week 16|Physician Decision|1|||
160968546|NCT04270747|581273351|FG002|Post Week 16|Physician Decision|1|||
160968547|NCT04270747|581273349|FG000|Post Week 16|Lost to Follow-up|2|||
160968548|NCT04270747|581273350|FG001|Post Week 16|Lost to Follow-up|1|||
160968549|NCT04270747|581273351|FG002|Post Week 16|Lost to Follow-up|0|||
160968550|NCT04270747|581273349|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
160968551|NCT04270747|581273350|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
160968552|NCT04270747|581273351|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
160968553|NCT04270747|581273349|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
160968554|NCT04270747|581273350|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
160968555|NCT04270747|581273351|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
160968556|NCT04270747|581273349|FG000|Post Week 16|Miscellaneous|1|||
160968557|NCT04270747|581273350|FG001|Post Week 16|Miscellaneous|0|||
160968558|NCT04270747|581273351|FG002|Post Week 16|Miscellaneous|1|||
160968559|NCT05960097|581273352|FG000|Overall Study|Lost to Follow-up|3|||
160968560|NCT05960097|581273353|FG001|Overall Study|Lost to Follow-up|1|||
160968561|NCT05960097|581273354|FG002|Overall Study|Lost to Follow-up|1|||
161015072|NCT00901901|581443520|FG001|Follow-up Period|Missing|80|||
160586410|NCT04410198|579865659|FG000|Overall Study|Kidney Transplant|9|||
160968562|NCT05960097|581273355|FG003|Overall Study|Lost to Follow-up|2|||
160968563|NCT05960097|581273356|FG004|Overall Study|Lost to Follow-up|1|||
160968564|NCT05960097|581273357|FG005|Overall Study|Lost to Follow-up|1|||
160968565|NCT05960097|581273358|FG006|Overall Study|Lost to Follow-up|2|||
160968566|NCT05960097|581273359|FG007|Overall Study|Lost to Follow-up|3|||
160968567|NCT05960097|581273352|FG000|Overall Study|Physician Decision|0|||
160968568|NCT05960097|581273353|FG001|Overall Study|Physician Decision|0|||
160968569|NCT05960097|581273354|FG002|Overall Study|Physician Decision|0|||
160586411|NCT04410198|579865659|FG000|Overall Study|Adverse Event|4|||
160586412|NCT04410198|579865659|FG000|Overall Study|Physician Decision|2|||
161015073|NCT00951379|581443521|FG000|Overall Study|Adverse Event|4|||
161015074|NCT00951379|581443522|FG001|Overall Study|Adverse Event|1|||
161015075|NCT00951379|581443521|FG000|Overall Study|Withdrawal by Subject|1|||
161015076|NCT00951379|581443522|FG001|Overall Study|Withdrawal by Subject|0|||
161015077|NCT00951379|581443521|FG000|Overall Study|Noncompliance|1|||
161015078|NCT00951379|581443522|FG001|Overall Study|Noncompliance|0|||
161015079|NCT00951379|581443521|FG000|Overall Study|Disease Progression|0|||
161015080|NCT00951379|581443522|FG001|Overall Study|Disease Progression|1|||
161015081|NCT02742519|581443525|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
161015082|NCT02742519|581443526|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
161015083|NCT02742519|581443527|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
161015084|NCT02742519|581443525|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
161015085|NCT02742519|581443526|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
161015086|NCT02742519|581443527|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
161015087|NCT02742519|581443525|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
161015088|NCT02742519|581443526|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
161015089|NCT02742519|581443527|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
161015090|NCT03432858|581443529|FG000|Overall Study|Protocol Violation|2|||
161015091|NCT03432858|581443530|FG001|Overall Study|Protocol Violation|1|||
161015092|NCT03432858|581443531|FG002|Overall Study|Protocol Violation|9|||
161015093|NCT03432858|581443529|FG000|Overall Study|Withdrawal by Subject|0|||
161015094|NCT03432858|581443530|FG001|Overall Study|Withdrawal by Subject|1|||
161015095|NCT03432858|581443531|FG002|Overall Study|Withdrawal by Subject|1|||
161015096|NCT03432858|581443529|FG000|Overall Study|Procedure canceled/rescheduled|0|||
161015097|NCT03432858|581443530|FG001|Overall Study|Procedure canceled/rescheduled|9|||
161015098|NCT03432858|581443531|FG002|Overall Study|Procedure canceled/rescheduled|6|||
161015099|NCT03432858|581443529|FG000|Overall Study|Required postop mobilization with splinting|0|||
161015100|NCT03432858|581443530|FG001|Overall Study|Required postop mobilization with splinting|0|||
161015101|NCT03432858|581443531|FG002|Overall Study|Required postop mobilization with splinting|1|||
161015102|NCT01872078|581443533|FG000|Overall Study|Adverse Event|0|||
161015103|NCT01872078|581443534|FG001|Overall Study|Adverse Event|0|||
161015104|NCT01872078|581443535|FG002|Overall Study|Adverse Event|1|||
161015105|NCT01872078|581443536|FG003|Overall Study|Adverse Event|0|||
161015106|NCT01872078|581443533|FG000|Overall Study|Dose administration non-compliance|0|||
161015107|NCT01872078|581443534|FG001|Overall Study|Dose administration non-compliance|0|||
161015108|NCT01872078|581443535|FG002|Overall Study|Dose administration non-compliance|0|||
161015109|NCT01872078|581443536|FG003|Overall Study|Dose administration non-compliance|1|||
161015110|NCT01872078|581443533|FG000|Overall Study|Protocol Violation|0|||
161015111|NCT01872078|581443534|FG001|Overall Study|Protocol Violation|0|||
161015112|NCT01872078|581443535|FG002|Overall Study|Protocol Violation|1|||
161015113|NCT01872078|581443536|FG003|Overall Study|Protocol Violation|0|||
161015114|NCT01872078|581443533|FG000|Overall Study|Withdrawal by Subject|0|||
161015115|NCT01872078|581443534|FG001|Overall Study|Withdrawal by Subject|0|||
161015116|NCT01872078|581443535|FG002|Overall Study|Withdrawal by Subject|1|||
161015117|NCT01872078|581443536|FG003|Overall Study|Withdrawal by Subject|0|||
161015118|NCT01872078|581443533|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
161015119|NCT01872078|581443534|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
161015120|NCT01872078|581443535|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
161015121|NCT01872078|581443536|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
161015122|NCT03978637|581443542|FG000|Overall Study|Death|0|||
161015123|NCT03978637|581443543|FG001|Overall Study|Death|2|||
161015124|NCT03978637|581443544|FG002|Overall Study|Death|2|||
161015125|NCT03978637|581443545|FG003|Overall Study|Death|0|||
161015126|NCT03978637|581443542|FG000|Overall Study|Withdrawal by Subject|0|||
161015127|NCT03978637|581443543|FG001|Overall Study|Withdrawal by Subject|0|||
161015128|NCT03978637|581443544|FG002|Overall Study|Withdrawal by Subject|1|||
161015129|NCT03978637|581443545|FG003|Overall Study|Withdrawal by Subject|0|||
161015130|NCT03978637|581443542|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
161015131|NCT03978637|581443543|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
161015132|NCT03978637|581443544|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
161015133|NCT03978637|581443545|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
161015134|NCT01959698|581443546|FG000|Overall Study|Adverse Event|0|||
160657047|NCT01974141|580124521|FG001|Overall Study|Protocol Violation|6|||
160459251|NCT05157841|579414212|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
161015135|NCT01959698|581443547|FG001|Overall Study|Adverse Event|0|||
161015136|NCT01959698|581443548|FG002|Overall Study|Adverse Event|0|||
161015137|NCT01959698|581443549|FG003|Overall Study|Adverse Event|0|||
161015138|NCT01959698|581443550|FG004|Overall Study|Adverse Event|0|||
161015139|NCT01959698|581443551|FG005|Overall Study|Adverse Event|0|||
161015140|NCT01959698|581443552|FG006|Overall Study|Adverse Event|1|||
161015141|NCT01959698|581443546|FG000|Overall Study|Physician Decision|1|||
161015142|NCT01959698|581443547|FG001|Overall Study|Physician Decision|0|||
160459252|NCT05157841|579414213|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
160459253|NCT05157841|579414211|FG000|Part A (14 Days)|Adverse Event|1|||
160586413|NCT04410198|579865659|FG000|Overall Study|Other than specified|1|||
160586414|NCT01626352|579865660|FG000|Overall Study|Disease Progression|3|||
160586415|NCT01626352|579865660|FG000|Overall Study|Intercurrent Illness|2|||
160586416|NCT01626352|579865660|FG000|Overall Study|Death|2|||
160586417|NCT01626352|579865660|FG000|Overall Study|Withdrawal by Subject|1|||
160586418|NCT01626352|579865660|FG000|Overall Study|Non-Compliance|1|||
160586419|NCT01626352|579865660|FG000|Overall Study|Never Treated|1|||
160586420|NCT03583372|579865663|FG000|Overall Study|Withdrawal by Subject|6|||
160586421|NCT03583372|579865664|FG001|Overall Study|Withdrawal by Subject|11|||
160586422|NCT03583372|579865665|FG002|Overall Study|Withdrawal by Subject|7|||
160586423|NCT03583372|579865666|FG003|Overall Study|Withdrawal by Subject|8|||
160586424|NCT03583372|579865663|FG000|Overall Study|Lost to Follow-up|4|||
160586425|NCT03583372|579865664|FG001|Overall Study|Lost to Follow-up|6|||
160586426|NCT03583372|579865665|FG002|Overall Study|Lost to Follow-up|3|||
160586427|NCT03583372|579865666|FG003|Overall Study|Lost to Follow-up|2|||
160586428|NCT03583372|579865663|FG000|Overall Study|Adverse Event|1|||
160586429|NCT03583372|579865664|FG001|Overall Study|Adverse Event|3|||
160586430|NCT03583372|579865665|FG002|Overall Study|Adverse Event|4|||
160586431|NCT03583372|579865666|FG003|Overall Study|Adverse Event|4|||
160586432|NCT03583372|579865663|FG000|Overall Study|Physician Decision|0|||
160586433|NCT03583372|579865664|FG001|Overall Study|Physician Decision|1|||
160586434|NCT03583372|579865665|FG002|Overall Study|Physician Decision|1|||
160586435|NCT03583372|579865666|FG003|Overall Study|Physician Decision|1|||
160586436|NCT03583372|579865663|FG000|Overall Study|Lack of Efficacy|0|||
161015143|NCT01959698|581443548|FG002|Overall Study|Physician Decision|1|||
161015144|NCT01959698|581443549|FG003|Overall Study|Physician Decision|2|||
161015145|NCT01959698|581443550|FG004|Overall Study|Physician Decision|0|||
161015146|NCT01959698|581443551|FG005|Overall Study|Physician Decision|3|||
161015147|NCT01959698|581443552|FG006|Overall Study|Physician Decision|3|||
161015148|NCT03819686|581445250|FG000|Overall Study|Lost to Follow-up|2|||
161015149|NCT03819686|581445251|FG001|Overall Study|Lost to Follow-up|3|||
161015150|NCT06143670|581445252|FG000|Overall Study|Lost to Follow-up|0|||
161015151|NCT06143670|581445253|FG001|Overall Study|Lost to Follow-up|1|||
161015152|NCT06143670|581445252|FG000|Overall Study|Withdrawal by Subject|3|||
161015153|NCT06143670|581445253|FG001|Overall Study|Withdrawal by Subject|0|||
161015154|NCT03747484|581445254|FG000|Overall Study|Lack of Efficacy|0|||
161015155|NCT03747484|581445255|FG001|Overall Study|Lack of Efficacy|1|||
161015156|NCT03747484|581445256|FG002|Overall Study|Lack of Efficacy|1|||
161015157|NCT03747484|581445257|FG003|Overall Study|Lack of Efficacy|2|||
161015158|NCT03747484|581445258|FG004|Overall Study|Lack of Efficacy|2|||
161015159|NCT03625882|581445261|FG000|Overall Study|Protocol Violation|3|||
161015160|NCT05058391|581445262|FG000|Overall Study|Adverse Event|1|||
161015161|NCT03833245|581445265|FG000|Overall Study|Death|0|||
161015162|NCT03833245|581445266|FG001|Overall Study|Death|1|||
161015163|NCT03347383|581445267|FG000|Overall Study|Death|39|||
161015164|NCT03347383|581445267|FG000|Overall Study|Withdrawal by Subject|3|||
160586437|NCT03583372|579865664|FG001|Overall Study|Lack of Efficacy|1|||
160586438|NCT03583372|579865665|FG002|Overall Study|Lack of Efficacy|0|||
160586439|NCT03583372|579865666|FG003|Overall Study|Lack of Efficacy|1|||
160586440|NCT03583372|579865663|FG000|Overall Study|Death|1|||
160586441|NCT03583372|579865664|FG001|Overall Study|Death|0|||
161015165|NCT03347383|581445267|FG000|Overall Study|Lost to Follow-up|9|||
161015166|NCT04842643|581445269|FG000|Overall Study|Physician Decision|1|||
161015167|NCT04842643|581445269|FG000|Overall Study|Other|1|||
160586442|NCT03583372|579865665|FG002|Overall Study|Death|0|||
160586443|NCT03583372|579865666|FG003|Overall Study|Death|0|||
160586444|NCT03583372|579865663|FG000|Overall Study|Protocol Violation|0|||
160586445|NCT03583372|579865664|FG001|Overall Study|Protocol Violation|1|||
160586446|NCT03583372|579865665|FG002|Overall Study|Protocol Violation|0|||
160586447|NCT03583372|579865666|FG003|Overall Study|Protocol Violation|0|||
160586448|NCT03583372|579865663|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
160586449|NCT03583372|579865664|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
161015168|NCT02662062|581445271|FG000|Overall Study|Withdrawal by Subject|1|||
161015169|NCT00676715|581445272|FG000|Treatment Period (TP)|Adverse Event|0|||
161015170|NCT00676715|581445273|FG001|Treatment Period (TP)|Adverse Event|3|||
161015171|NCT00676715|581445274|FG002|Treatment Period (TP)|Adverse Event|2|||
161015172|NCT00676715|581445275|FG003|Treatment Period (TP)|Adverse Event|2|||
161015173|NCT00676715|581445272|FG000|Treatment Period (TP)|Death|0|||
161015174|NCT00676715|581445273|FG001|Treatment Period (TP)|Death|0|||
161015175|NCT00676715|581445274|FG002|Treatment Period (TP)|Death|1|||
161015176|NCT00676715|581445275|FG003|Treatment Period (TP)|Death|0|||
161015177|NCT00676715|581445272|FG000|Treatment Period (TP)|Failure to return|1|||
161015178|NCT00676715|581445273|FG001|Treatment Period (TP)|Failure to return|0|||
160459254|NCT05157841|579414212|FG001|Part A (14 Days)|Adverse Event|0|||
160586450|NCT03583372|579865665|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
160586451|NCT03583372|579865666|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
160586452|NCT03583372|579865663|FG000|Overall Study|Did Not Receive Study Drug|0|||
160586453|NCT03583372|579865664|FG001|Overall Study|Did Not Receive Study Drug|1|||
160657048|NCT01974141|580124520|FG000|Overall Study|Personal Reasons|21|||
161015179|NCT00676715|581445274|FG002|Treatment Period (TP)|Failure to return|0|||
160586454|NCT03583372|579865665|FG002|Overall Study|Did Not Receive Study Drug|0|||
160586455|NCT03583372|579865666|FG003|Overall Study|Did Not Receive Study Drug|0|||
161015180|NCT00676715|581445275|FG003|Treatment Period (TP)|Failure to return|0|||
161015181|NCT00676715|581445272|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
161015182|NCT00676715|581445273|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
161015183|NCT00676715|581445274|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
161015184|NCT00676715|581445275|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
161015185|NCT00676715|581445272|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
161015186|NCT00676715|581445273|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
161015187|NCT00676715|581445274|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
161015188|NCT00676715|581445275|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
161015189|NCT00676715|581445272|FG000|Treatment Period (TP)|Withdrew consent|3|||
161015190|NCT00676715|581445273|FG001|Treatment Period (TP)|Withdrew consent|3|||
161015191|NCT00676715|581445274|FG002|Treatment Period (TP)|Withdrew consent|3|||
161015192|NCT00676715|581445275|FG003|Treatment Period (TP)|Withdrew consent|3|||
161015193|NCT00676715|581445272|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
161015194|NCT00676715|581445273|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
161015195|NCT00676715|581445274|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
161015196|NCT00676715|581445275|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
161015197|NCT00676715|581445272|FG000|Treatment Period (TP)|Administrative|0|||
161015198|NCT00676715|581445273|FG001|Treatment Period (TP)|Administrative|0|||
161015199|NCT00676715|581445274|FG002|Treatment Period (TP)|Administrative|0|||
161015200|NCT00676715|581445275|FG003|Treatment Period (TP)|Administrative|1|||
161015201|NCT00676715|581445272|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
161015202|NCT00676715|581445273|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
161015203|NCT00676715|581445274|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
161015204|NCT00676715|581445275|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
161015205|NCT00676715|581445272|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
161015206|NCT00676715|581445273|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
161015207|NCT00676715|581445274|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
161015208|NCT00676715|581445275|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
161015209|NCT00676715|581445272|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
161015210|NCT00676715|581445273|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
161015211|NCT00676715|581445274|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
161015212|NCT00676715|581445275|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
161015213|NCT00676715|581445272|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
161015214|NCT00676715|581445273|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
161015215|NCT00676715|581445274|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
161015216|NCT00676715|581445275|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
161015217|NCT00676715|581445272|FG000|Treatment-free Period (TFP)|Death|1|||
161015218|NCT00676715|581445273|FG001|Treatment-free Period (TFP)|Death|1|||
161015219|NCT00676715|581445274|FG002|Treatment-free Period (TFP)|Death|1|||
161015220|NCT00676715|581445275|FG003|Treatment-free Period (TFP)|Death|0|||
161015221|NCT00676715|581445272|FG000|Open Label Extension (OLE)|Reason not provided|3|||
160459255|NCT05157841|579414213|FG002|Part A (14 Days)|Adverse Event|0|||
160586456|NCT03583372|579865663|FG000|Overall Study|Captured as Other in the Database|1|||
160586457|NCT03583372|579865664|FG001|Overall Study|Captured as Other in the Database|2|||
160586458|NCT03583372|579865665|FG002|Overall Study|Captured as Other in the Database|4|||
160586459|NCT03583372|579865666|FG003|Overall Study|Captured as Other in the Database|1|||
160586460|NCT04831515|579865669|FG000|First Intervention|Adverse Event|0|||
161015222|NCT00676715|581445273|FG001|Open Label Extension (OLE)|Reason not provided|4|||
161015223|NCT00676715|581445274|FG002|Open Label Extension (OLE)|Reason not provided|1|||
161015224|NCT00676715|581445275|FG003|Open Label Extension (OLE)|Reason not provided|4|||
161015225|NCT00676715|581445272|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
161015226|NCT00676715|581445273|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
161015227|NCT00676715|581445274|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
161015228|NCT00676715|581445275|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
161015229|NCT00676715|581445272|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
161015230|NCT00676715|581445273|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
161015231|NCT00676715|581445274|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
161015232|NCT00676715|581445275|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
161015233|NCT00676715|581445272|FG000|Open Label Extension (OLE)|Adverse Event|0|||
161015234|NCT00676715|581445273|FG001|Open Label Extension (OLE)|Adverse Event|3|||
161015235|NCT00676715|581445274|FG002|Open Label Extension (OLE)|Adverse Event|1|||
161015236|NCT00676715|581445275|FG003|Open Label Extension (OLE)|Adverse Event|0|||
161015237|NCT00676715|581445272|FG000|Open Label Extension (OLE)|Death|2|||
161015238|NCT00676715|581445273|FG001|Open Label Extension (OLE)|Death|0|||
161015239|NCT00676715|581445274|FG002|Open Label Extension (OLE)|Death|2|||
161015240|NCT00676715|581445275|FG003|Open Label Extension (OLE)|Death|2|||
160586461|NCT04831515|579865670|FG001|First Intervention|Adverse Event|1|||
160657049|NCT01974141|580124521|FG001|Overall Study|Personal Reasons|20|||
160586462|NCT03712345|579865671|FG000|Overall Study|Failure to meet randomization criteria|0|||
160586463|NCT03712345|579865672|FG001|Overall Study|Failure to meet randomization criteria|0|||
160586464|NCT03712345|579865673|FG002|Overall Study|Failure to meet randomization criteria|1|||
160586465|NCT00960934|579865674|FG000|Overall Study|Adverse Event|2|||
160586466|NCT00960934|579865675|FG001|Overall Study|Adverse Event|3|||
160586467|NCT00960934|579865676|FG002|Overall Study|Adverse Event|3|||
160586468|NCT00960934|579865677|FG003|Overall Study|Adverse Event|2|||
160586469|NCT00960934|579865678|FG004|Overall Study|Adverse Event|4|||
160586470|NCT00960934|579865679|FG005|Overall Study|Adverse Event|3|||
160586471|NCT00960934|579865674|FG000|Overall Study|Lack of Efficacy|1|||
160586472|NCT00960934|579865675|FG001|Overall Study|Lack of Efficacy|0|||
160586473|NCT00960934|579865676|FG002|Overall Study|Lack of Efficacy|0|||
160586474|NCT00960934|579865677|FG003|Overall Study|Lack of Efficacy|0|||
160586475|NCT00960934|579865678|FG004|Overall Study|Lack of Efficacy|0|||
160586476|NCT00960934|579865679|FG005|Overall Study|Lack of Efficacy|0|||
160586477|NCT00960934|579865674|FG000|Overall Study|Lost to Follow-up|0|||
160586478|NCT00960934|579865675|FG001|Overall Study|Lost to Follow-up|1|||
160586479|NCT00960934|579865676|FG002|Overall Study|Lost to Follow-up|0|||
160586480|NCT00960934|579865677|FG003|Overall Study|Lost to Follow-up|0|||
160586481|NCT00960934|579865678|FG004|Overall Study|Lost to Follow-up|0|||
160586482|NCT00960934|579865679|FG005|Overall Study|Lost to Follow-up|0|||
160586483|NCT00960934|579865674|FG000|Overall Study|Other|2|||
160586484|NCT00960934|579865675|FG001|Overall Study|Other|1|||
160586485|NCT00960934|579865676|FG002|Overall Study|Other|5|||
160657050|NCT01974141|580124520|FG000|Overall Study|Lost to Follow-up|38|||
160657051|NCT01974141|580124521|FG001|Overall Study|Lost to Follow-up|29|||
161015241|NCT03315754|581445291|FG000|Overall Study|COVID-19 complications leading to death|1|||
161015242|NCT03315754|581445291|FG000|Overall Study|insurance coverage issue|1|||
161015243|NCT03526861|581445306|FG000|Initial Treatment Period|Not dosed|1|||
161015244|NCT03526861|581445307|FG001|Initial Treatment Period|Not dosed|1|||
161015245|NCT03526861|581445308|FG002|Initial Treatment Period|Not dosed|1|||
161015246|NCT03526861|581445309|FG003|Initial Treatment Period|Not dosed|0|||
161015247|NCT03526861|581445310|FG004|Initial Treatment Period|Not dosed|0|||
161015248|NCT03526861|581445311|FG005|Initial Treatment Period|Not dosed|0|||
161015249|NCT03526861|581445312|FG006|Initial Treatment Period|Not dosed|0|||
161015250|NCT03526861|581445313|FG007|Initial Treatment Period|Not dosed|0|||
161015251|NCT03526861|581445314|FG008|Initial Treatment Period|Not dosed|0|||
161015252|NCT03526861|581445306|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
161015253|NCT03526861|581445307|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
161015254|NCT03526861|581445308|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
161015255|NCT03526861|581445309|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015256|NCT03526861|581445310|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015257|NCT03526861|581445311|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015258|NCT03526861|581445312|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015259|NCT03526861|581445313|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015260|NCT03526861|581445314|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015261|NCT03526861|581445306|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
161015262|NCT03526861|581445307|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
161015263|NCT03526861|581445308|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
161015264|NCT03526861|581445309|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015265|NCT03526861|581445310|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015266|NCT03526861|581445311|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015267|NCT03526861|581445312|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015268|NCT03526861|581445313|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015269|NCT03526861|581445314|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015270|NCT03526861|581445306|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015271|NCT03526861|581445307|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015272|NCT03526861|581445308|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015273|NCT03526861|581445309|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
161015274|NCT03526861|581445310|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
160586486|NCT00960934|579865677|FG003|Overall Study|Other|4|||
160586487|NCT00960934|579865678|FG004|Overall Study|Other|2|||
160586488|NCT00960934|579865679|FG005|Overall Study|Other|2|||
160657052|NCT01974141|580124520|FG000|Overall Study|Pregnancy|3|||
160586489|NCT00960934|579865674|FG000|Overall Study|Physician Decision|0|||
160586490|NCT00960934|579865675|FG001|Overall Study|Physician Decision|1|||
160586491|NCT00960934|579865676|FG002|Overall Study|Physician Decision|0|||
160459256|NCT05157841|579414211|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
160459257|NCT05157841|579414212|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
160657053|NCT01974141|580124521|FG001|Overall Study|Pregnancy|3|||
160657054|NCT01974141|580124520|FG000|Overall Study|Lack of Efficacy|0|||
161015275|NCT03526861|581445311|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015276|NCT03526861|581445312|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
161015277|NCT03526861|581445313|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015278|NCT03526861|581445314|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015279|NCT03526861|581445306|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161015280|NCT03526861|581445307|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161015281|NCT03526861|581445308|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161015282|NCT03526861|581445309|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
161015283|NCT03526861|581445310|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
161015284|NCT03526861|581445311|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
161015285|NCT03526861|581445312|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
161015286|NCT03526861|581445313|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
161015287|NCT03526861|581445314|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161015288|NCT03526861|581445306|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015289|NCT03526861|581445307|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015290|NCT03526861|581445308|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015291|NCT03526861|581445309|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
161015292|NCT03526861|581445310|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015293|NCT03526861|581445311|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015294|NCT03526861|581445312|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015295|NCT03526861|581445313|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015296|NCT03526861|581445314|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015297|NCT03526861|581445306|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015298|NCT03526861|581445307|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015299|NCT03526861|581445308|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015300|NCT03526861|581445309|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015301|NCT03526861|581445310|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015302|NCT03526861|581445311|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015303|NCT03526861|581445312|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015304|NCT03526861|581445313|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015305|NCT03526861|581445314|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
161015306|NCT03526861|581445306|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015307|NCT03526861|581445307|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015308|NCT03526861|581445308|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015309|NCT03526861|581445309|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015310|NCT03526861|581445310|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015311|NCT03526861|581445311|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015312|NCT03526861|581445312|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015313|NCT03526861|581445313|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015314|NCT03526861|581445314|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
160459258|NCT05157841|579414213|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
160459259|NCT03884101|579414222|FG000|Overall Study|Participant Ongoing in Study|202|||
160459260|NCT03884101|579414223|FG001|Overall Study|Participant Ongoing in Study|186|||
160459261|NCT03884101|579414222|FG000|Overall Study|Death|212|||
160459262|NCT03884101|579414223|FG001|Overall Study|Death|224|||
160459263|NCT03884101|579414222|FG000|Overall Study|Lost to Follow-up|0|||
160459264|NCT03884101|579414223|FG001|Overall Study|Lost to Follow-up|1|||
160657055|NCT01974141|580124521|FG001|Overall Study|Lack of Efficacy|1|||
160657056|NCT01974141|580124520|FG000|Overall Study|Adverse Event|4|||
161015315|NCT03526861|581445306|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015316|NCT03526861|581445307|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015317|NCT03526861|581445308|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015318|NCT03526861|581445309|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015319|NCT03526861|581445310|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015320|NCT03526861|581445311|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015321|NCT03526861|581445312|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015322|NCT03526861|581445313|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015323|NCT03526861|581445314|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
161015324|NCT02506959|581445316|FG000|Overall Study|Physician Decision|2|||
161015325|NCT02506959|581445317|FG001|Overall Study|Physician Decision|1|||
161015326|NCT03453619|581445319|FG000|Core Study (Part A)|Physician Decision|0|||
161015327|NCT03453619|581445320|FG001|Core Study (Part A)|Physician Decision|0|||
161015328|NCT03453619|581445321|FG002|Core Study (Part A)|Physician Decision|2|||
161015329|NCT03453619|581445322|FG003|Core Study (Part A)|Physician Decision|0|||
161015330|NCT03453619|581445319|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
161015331|NCT03453619|581445320|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
161015332|NCT03453619|581445321|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
161015333|NCT03453619|581445322|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
161015334|NCT03453619|581445319|FG000|Core Study (Part A)|Other|0|||
161015335|NCT03453619|581445320|FG001|Core Study (Part A)|Other|1|||
161015336|NCT03453619|581445321|FG002|Core Study (Part A)|Other|0|||
161015337|NCT03453619|581445322|FG003|Core Study (Part A)|Other|0|||
161015338|NCT03453619|581445319|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
161015339|NCT03453619|581445320|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
161015340|NCT03453619|581445321|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
161015341|NCT03453619|581445322|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
161015342|NCT03453619|581445319|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
161015343|NCT03453619|581445320|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
161015344|NCT03453619|581445321|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
161015345|NCT03453619|581445322|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
161015346|NCT03453619|581445319|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
161015347|NCT03453619|581445320|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
161015348|NCT03453619|581445321|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
161015349|NCT03453619|581445322|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
161015350|NCT03453619|581445319|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
161015351|NCT03453619|581445320|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
161015352|NCT03453619|581445321|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
161015353|NCT03453619|581445322|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
161015354|NCT03932682|581445323|FG000|Overall Study|Death|1|||
161015355|NCT03932682|581445324|FG001|Overall Study|Death|2|||
161015356|NCT03932682|581445323|FG000|Overall Study|Withdrawal by Subject|37|||
161015357|NCT03932682|581445324|FG001|Overall Study|Withdrawal by Subject|45|||
161015358|NCT03932682|581445323|FG000|Overall Study|Lost to Follow-up|19|||
161015359|NCT03932682|581445324|FG001|Overall Study|Lost to Follow-up|25|||
161015360|NCT03932682|581445323|FG000|Overall Study|Protocol Violation|0|||
161015361|NCT03932682|581445324|FG001|Overall Study|Protocol Violation|2|||
161015362|NCT03932682|581445323|FG000|Overall Study|Other|9|||
161015363|NCT03932682|581445324|FG001|Overall Study|Other|23|||
161015364|NCT05470400|581445325|FG000|Overall Study|Lost to Follow-up|0|||
161015365|NCT05470400|581445326|FG001|Overall Study|Lost to Follow-up|0|||
161015366|NCT05470400|581445327|FG002|Overall Study|Lost to Follow-up|0|||
161015367|NCT05470400|581445328|FG003|Overall Study|Lost to Follow-up|0|||
161015368|NCT05470400|581445329|FG004|Overall Study|Lost to Follow-up|0|||
161015369|NCT05470400|581445330|FG005|Overall Study|Lost to Follow-up|0|||
161015370|NCT05470400|581445331|FG006|Overall Study|Lost to Follow-up|0|||
161015371|NCT05470400|581445332|FG007|Overall Study|Lost to Follow-up|1|||
161015372|NCT05470400|581445325|FG000|Overall Study|Withdrawal by Subject|1|||
161015373|NCT05470400|581445326|FG001|Overall Study|Withdrawal by Subject|0|||
161015374|NCT05470400|581445327|FG002|Overall Study|Withdrawal by Subject|0|||
161015375|NCT05470400|581445328|FG003|Overall Study|Withdrawal by Subject|0|||
161015376|NCT05470400|581445329|FG004|Overall Study|Withdrawal by Subject|0|||
160459265|NCT03884101|579414222|FG000|Overall Study|Withdrawal by Subject|6|||
160459266|NCT03884101|579414223|FG001|Overall Study|Withdrawal by Subject|11|||
160657057|NCT01974141|580124521|FG001|Overall Study|Adverse Event|5|||
160459267|NCT04631016|579414224|FG000|Overall Study|Adverse Event|3|||
161015377|NCT05470400|581445330|FG005|Overall Study|Withdrawal by Subject|1|||
161015378|NCT05470400|581445331|FG006|Overall Study|Withdrawal by Subject|0|||
161015379|NCT05470400|581445332|FG007|Overall Study|Withdrawal by Subject|2|||
160968570|NCT05960097|581273355|FG003|Overall Study|Physician Decision|0|||
161015380|NCT05956002|581445333|FG000|Treatment Period 3|Adverse Event|0|||
161015381|NCT05956002|581445334|FG001|Treatment Period 3|Adverse Event|0|||
161015382|NCT05956002|581445335|FG002|Treatment Period 3|Adverse Event|1|||
161015383|NCT05956002|581445336|FG003|Treatment Period 3|Adverse Event|0|||
161015384|NCT05323084|581445340|FG000|Period 2 - Washout|Lost to Follow-up|0|||
161015385|NCT05323084|581445341|FG001|Period 2 - Washout|Lost to Follow-up|1|||
161015386|NCT04294225|581445342|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
161015387|NCT04294225|581445342|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
160968571|NCT05960097|581273356|FG004|Overall Study|Physician Decision|0|||
160968572|NCT05960097|581273357|FG005|Overall Study|Physician Decision|0|||
160968573|NCT05960097|581273358|FG006|Overall Study|Physician Decision|1|||
160968574|NCT05960097|581273359|FG007|Overall Study|Physician Decision|0|||
160968575|NCT05960097|581273352|FG000|Overall Study|Withdrawal by Subject|1|||
160968576|NCT05960097|581273353|FG001|Overall Study|Withdrawal by Subject|0|||
160968577|NCT05960097|581273354|FG002|Overall Study|Withdrawal by Subject|0|||
160968578|NCT05960097|581273355|FG003|Overall Study|Withdrawal by Subject|1|||
160968579|NCT05960097|581273356|FG004|Overall Study|Withdrawal by Subject|1|||
160968580|NCT05960097|581273357|FG005|Overall Study|Withdrawal by Subject|0|||
160968581|NCT05960097|581273358|FG006|Overall Study|Withdrawal by Subject|0|||
160968582|NCT05960097|581273359|FG007|Overall Study|Withdrawal by Subject|0|||
160968583|NCT05960097|581273352|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968584|NCT05960097|581273353|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968585|NCT05960097|581273354|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
160968586|NCT05960097|581273355|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968587|NCT05960097|581273356|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968588|NCT05960097|581273357|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968589|NCT05960097|581273358|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968590|NCT05960097|581273359|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968591|NCT00728962|581273360|FG000|Implant Placement Surgery|Adverse Event|8|||
160968592|NCT00728962|581273360|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
160968593|NCT00728962|581273360|FG000|Implant Placement Surgery|Protocol Violation|1|||
160968594|NCT00728962|581273360|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
160968595|NCT00728962|581273360|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
160968596|NCT04954586|581273361|FG000|Overall Study|Withdrawal by Subject|5|||
160968597|NCT01987817|581273373|FG000|Overall Study|Adverse Event|4|||
160968598|NCT01987817|581273374|FG001|Overall Study|Adverse Event|0|||
160968599|NCT01987817|581273373|FG000|Overall Study|Withdrawal by Subject|1|||
160968600|NCT01987817|581273374|FG001|Overall Study|Withdrawal by Subject|1|||
160968601|NCT01987817|581273373|FG000|Overall Study|Physician Decision|1|||
160968602|NCT01987817|581273374|FG001|Overall Study|Physician Decision|0|||
160968603|NCT04098250|581273377|FG000|Overall Study|Withdrawal by Subject|1|||
160968604|NCT04098250|581273378|FG001|Overall Study|Withdrawal by Subject|0|||
160968605|NCT04098250|581273377|FG000|Overall Study|Lost to Follow-up|0|||
160968606|NCT04098250|581273378|FG001|Overall Study|Lost to Follow-up|1|||
160968607|NCT00633464|581273379|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
160968608|NCT00633464|581273380|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
160968609|NCT00633464|581273379|FG000|Overall Study|Never Treated (Randomized in error)|0|||
160968610|NCT00633464|581273380|FG001|Overall Study|Never Treated (Randomized in error)|1|||
160968611|NCT06387472|581273381|FG000|Overall Study|Withdrawal by Subject|1|||
160968612|NCT06387472|581273381|FG000|Overall Study|Lost to Follow-up|2|||
160968613|NCT06387472|581273381|FG000|Overall Study|Physician Decision|1|||
160968614|NCT04182880|581273382|FG000|Overall Study|Pregnancy|1|||
160968615|NCT04182880|581273383|FG001|Overall Study|Pregnancy|0|||
160968616|NCT02036645|581273384|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968617|NCT02036645|581273385|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968618|NCT02036645|581273386|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968619|NCT02036645|581273387|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968620|NCT02036645|581273388|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968621|NCT02036645|581273389|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968622|NCT02036645|581273390|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
160968623|NCT02036645|581273391|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968624|NCT02036645|581273392|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968625|NCT02036645|581273393|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968626|NCT02036645|581273394|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968627|NCT02036645|581273395|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968628|NCT02036645|581273384|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968629|NCT02036645|581273385|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968630|NCT02036645|581273386|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968631|NCT02036645|581273387|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
161015388|NCT04294225|581445342|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
161015389|NCT04294225|581445342|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
160586492|NCT00960934|579865677|FG003|Overall Study|Physician Decision|0|||
160586493|NCT00960934|579865678|FG004|Overall Study|Physician Decision|0|||
160586494|NCT00960934|579865679|FG005|Overall Study|Physician Decision|0|||
160586495|NCT00960934|579865674|FG000|Overall Study|Progressive Disease|1|||
160586496|NCT00960934|579865675|FG001|Overall Study|Progressive Disease|1|||
161015390|NCT04294225|581445342|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
161015391|NCT04812535|581445350|FG000|Overall Study|Withdrawal by Subject|0|||
161015392|NCT04812535|581445351|FG001|Overall Study|Withdrawal by Subject|0|||
161015393|NCT04812535|581445352|FG002|Overall Study|Withdrawal by Subject|0|||
161015394|NCT04812535|581445353|FG003|Overall Study|Withdrawal by Subject|1|||
161015395|NCT04812535|581445350|FG000|Overall Study|Death|7|||
161015396|NCT04812535|581445351|FG001|Overall Study|Death|2|||
161015397|NCT04812535|581445352|FG002|Overall Study|Death|4|||
161015398|NCT04812535|581445353|FG003|Overall Study|Death|1|||
161015399|NCT04812535|581445350|FG000|Overall Study|Due to premature study termination by sponsor|2|||
161015400|NCT04812535|581445351|FG001|Overall Study|Due to premature study termination by sponsor|0|||
161015401|NCT04812535|581445352|FG002|Overall Study|Due to premature study termination by sponsor|1|||
161015402|NCT04812535|581445353|FG003|Overall Study|Due to premature study termination by sponsor|3|||
161015403|NCT03436745|581445354|FG000|Overall Study|Ineligible|0|||
161015404|NCT03436745|581445355|FG001|Overall Study|Ineligible|0|||
161015405|NCT03436745|581445356|FG002|Overall Study|Ineligible|1|||
161015406|NCT04401800|581445359|FG000|Overall Study|Death|17|||
161015407|NCT04401800|581445359|FG000|Overall Study|Lost to Follow-up|5|||
161015408|NCT04401800|581445359|FG000|Overall Study|Withdrawal by Subject|4|||
161015409|NCT04927065|581445360|FG000|First Booster|Adverse Event|1|||
161015410|NCT04927065|581445361|FG001|First Booster|Adverse Event|0|||
161015411|NCT04927065|581445362|FG002|First Booster|Adverse Event|0|||
161015412|NCT04927065|581445363|FG003|First Booster|Adverse Event|0|||
161015413|NCT04927065|581445364|FG004|First Booster|Adverse Event|0|||
161015414|NCT04927065|581445365|FG005|First Booster|Adverse Event|0|||
161015415|NCT04927065|581445366|FG006|First Booster|Adverse Event|0|||
161015416|NCT04927065|581445367|FG007|First Booster|Adverse Event|1|||
161015417|NCT04927065|581445368|FG008|First Booster|Adverse Event|0|||
161015418|NCT04927065|581445369|FG009|First Booster|Adverse Event|0|||
161015419|NCT04927065|581445370|FG010|First Booster|Adverse Event|0|||
161015420|NCT04927065|581445371|FG011|First Booster|Adverse Event|0|||
161015421|NCT04927065|581445372|FG012|First Booster|Adverse Event|0|||
161015422|NCT04927065|581445373|FG013|First Booster|Adverse Event|0|||
161015423|NCT04927065|581445374|FG014|First Booster|Adverse Event|0|||
161015424|NCT04927065|581445375|FG015|First Booster|Adverse Event|0|||
161015425|NCT04927065|581445360|FG000|First Booster|Death|1|||
161015426|NCT04927065|581445361|FG001|First Booster|Death|0|||
161015427|NCT04927065|581445362|FG002|First Booster|Death|0|||
161015428|NCT04927065|581445363|FG003|First Booster|Death|1|||
161015429|NCT04927065|581445364|FG004|First Booster|Death|0|||
161015430|NCT04927065|581445365|FG005|First Booster|Death|1|||
161015431|NCT04927065|581445366|FG006|First Booster|Death|0|||
161015432|NCT04927065|581445367|FG007|First Booster|Death|0|||
161015433|NCT04927065|581445368|FG008|First Booster|Death|0|||
161015434|NCT04927065|581445369|FG009|First Booster|Death|0|||
161015435|NCT04927065|581445370|FG010|First Booster|Death|0|||
161015436|NCT04927065|581445371|FG011|First Booster|Death|0|||
161015437|NCT04927065|581445372|FG012|First Booster|Death|0|||
161015438|NCT04927065|581445373|FG013|First Booster|Death|0|||
161015439|NCT04927065|581445374|FG014|First Booster|Death|0|||
161015440|NCT04927065|581445375|FG015|First Booster|Death|0|||
161015441|NCT04927065|581445360|FG000|First Booster|Lost to Follow-up|8|||
161015442|NCT04927065|581445361|FG001|First Booster|Lost to Follow-up|20|||
161015443|NCT04927065|581445362|FG002|First Booster|Lost to Follow-up|0|||
161015444|NCT04927065|581445363|FG003|First Booster|Lost to Follow-up|11|||
161015445|NCT04927065|581445364|FG004|First Booster|Lost to Follow-up|43|||
160586497|NCT00960934|579865676|FG002|Overall Study|Progressive Disease|0|||
160459268|NCT04631016|579414225|FG001|Overall Study|Adverse Event|0|||
160459269|NCT04631016|579414224|FG000|Overall Study|Withdrawal by Subject|5|||
161015446|NCT04927065|581445365|FG005|First Booster|Lost to Follow-up|30|||
160459270|NCT04631016|579414225|FG001|Overall Study|Withdrawal by Subject|4|||
160459271|NCT04631016|579414224|FG000|Overall Study|Reason unspecified|1|||
160586498|NCT00960934|579865677|FG003|Overall Study|Progressive Disease|0|||
161015447|NCT04927065|581445366|FG006|First Booster|Lost to Follow-up|28|||
161015448|NCT04927065|581445367|FG007|First Booster|Lost to Follow-up|23|||
161015449|NCT04927065|581445368|FG008|First Booster|Lost to Follow-up|4|||
161015450|NCT04927065|581445369|FG009|First Booster|Lost to Follow-up|15|||
161015451|NCT04927065|581445370|FG010|First Booster|Lost to Follow-up|0|||
161015452|NCT04927065|581445371|FG011|First Booster|Lost to Follow-up|0|||
161015453|NCT04927065|581445372|FG012|First Booster|Lost to Follow-up|0|||
161015454|NCT04927065|581445373|FG013|First Booster|Lost to Follow-up|0|||
161015455|NCT04927065|581445374|FG014|First Booster|Lost to Follow-up|0|||
161015456|NCT04927065|581445375|FG015|First Booster|Lost to Follow-up|0|||
161015457|NCT04927065|581445360|FG000|First Booster|Physician Decision|1|||
161015458|NCT04927065|581445361|FG001|First Booster|Physician Decision|0|||
161015459|NCT04927065|581445362|FG002|First Booster|Physician Decision|0|||
160586499|NCT00960934|579865678|FG004|Overall Study|Progressive Disease|1|||
160586500|NCT00960934|579865679|FG005|Overall Study|Progressive Disease|1|||
160586501|NCT00960934|579865674|FG000|Overall Study|Protocol Violation|3|||
160586502|NCT00960934|579865675|FG001|Overall Study|Protocol Violation|4|||
160586503|NCT00960934|579865676|FG002|Overall Study|Protocol Violation|0|||
160586504|NCT00960934|579865677|FG003|Overall Study|Protocol Violation|3|||
160586505|NCT00960934|579865678|FG004|Overall Study|Protocol Violation|3|||
160586506|NCT00960934|579865679|FG005|Overall Study|Protocol Violation|2|||
160968632|NCT02036645|581273388|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968633|NCT02036645|581273389|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968634|NCT02036645|581273390|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968635|NCT02036645|581273391|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968636|NCT02036645|581273392|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968637|NCT02036645|581273393|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968638|NCT02036645|581273394|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968639|NCT02036645|581273395|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968640|NCT00717860|581273396|FG000|Overall Study|Clinical adverse experience|5|||
160968641|NCT00717860|581273397|FG001|Overall Study|Clinical adverse experience|9|||
160968642|NCT00717860|581273396|FG000|Overall Study|Laboratory adverse experience|2|||
160968643|NCT00717860|581273397|FG001|Overall Study|Laboratory adverse experience|2|||
160968644|NCT00717860|581273396|FG000|Overall Study|Lack of Efficacy|7|||
160968645|NCT00717860|581273397|FG001|Overall Study|Lack of Efficacy|13|||
160968646|NCT00717860|581273396|FG000|Overall Study|Discontinued for other reason|6|||
160968647|NCT00717860|581273397|FG001|Overall Study|Discontinued for other reason|1|||
160968648|NCT00717860|581273396|FG000|Overall Study|Withdrew consent|7|||
160968649|NCT00717860|581273397|FG001|Overall Study|Withdrew consent|3|||
160968650|NCT00698646|581273398|FG000|Overall Study|Adverse Event|8|||
160968651|NCT00698646|581273399|FG001|Overall Study|Adverse Event|7|||
160968652|NCT00698646|581273400|FG002|Overall Study|Adverse Event|8|||
160968653|NCT00698646|581273398|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
160968654|NCT00698646|581273399|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
160968655|NCT00698646|581273400|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
160968656|NCT00698646|581273398|FG000|Overall Study|Protocol Deviation|6|||
160968657|NCT00698646|581273399|FG001|Overall Study|Protocol Deviation|2|||
160968658|NCT00698646|581273400|FG002|Overall Study|Protocol Deviation|3|||
160968659|NCT00698646|581273398|FG000|Overall Study|Withdrawal by Subject|10|||
160968660|NCT00698646|581273399|FG001|Overall Study|Withdrawal by Subject|11|||
160968661|NCT00698646|581273400|FG002|Overall Study|Withdrawal by Subject|8|||
160968662|NCT00698646|581273398|FG000|Overall Study|Lost to Follow-up|0|||
160968663|NCT00698646|581273399|FG001|Overall Study|Lost to Follow-up|0|||
160968664|NCT00698646|581273400|FG002|Overall Study|Lost to Follow-up|2|||
160968665|NCT00698646|581273398|FG000|Overall Study|Administrative problems|1|||
160968666|NCT00698646|581273399|FG001|Overall Study|Administrative problems|0|||
160968667|NCT00698646|581273400|FG002|Overall Study|Administrative problems|1|||
160968668|NCT00279201|581273403|FG000|Initiation|Death|1|||
160968669|NCT00279201|581273404|FG001|Initiation|Death|5|||
160968670|NCT00279201|581273405|FG002|Initiation|Death|0|||
160968671|NCT00279201|581273406|FG003|Initiation|Death|0|||
160968672|NCT00279201|581273407|FG004|Initiation|Death|0|||
160968673|NCT00279201|581273408|FG005|Initiation|Death|0|||
160968674|NCT00279201|581273403|FG000|Initiation|Adverse Event|6|||
160968675|NCT00279201|581273404|FG001|Initiation|Adverse Event|15|||
160968676|NCT00279201|581273405|FG002|Initiation|Adverse Event|0|||
160968677|NCT00279201|581273406|FG003|Initiation|Adverse Event|0|||
160968678|NCT00279201|581273407|FG004|Initiation|Adverse Event|0|||
160968679|NCT00279201|581273408|FG005|Initiation|Adverse Event|0|||
160968680|NCT00279201|581273403|FG000|Initiation|Lost to Follow-up|42|||
160968681|NCT00279201|581273404|FG001|Initiation|Lost to Follow-up|41|||
160968682|NCT00279201|581273405|FG002|Initiation|Lost to Follow-up|0|||
160968683|NCT00279201|581273406|FG003|Initiation|Lost to Follow-up|0|||
160968684|NCT00279201|581273407|FG004|Initiation|Lost to Follow-up|0|||
160968685|NCT00279201|581273408|FG005|Initiation|Lost to Follow-up|0|||
160968686|NCT00279201|581273403|FG000|Initiation|Entry Criteria Exclusion|7|||
160968687|NCT00279201|581273404|FG001|Initiation|Entry Criteria Exclusion|9|||
160968688|NCT00279201|581273405|FG002|Initiation|Entry Criteria Exclusion|0|||
160968689|NCT00279201|581273406|FG003|Initiation|Entry Criteria Exclusion|0|||
160968690|NCT00279201|581273407|FG004|Initiation|Entry Criteria Exclusion|0|||
160968691|NCT00279201|581273408|FG005|Initiation|Entry Criteria Exclusion|0|||
160968692|NCT00279201|581273403|FG000|Initiation|Protocol Violation|9|||
160968693|NCT00279201|581273404|FG001|Initiation|Protocol Violation|10|||
160968694|NCT00279201|581273405|FG002|Initiation|Protocol Violation|0|||
160968695|NCT00279201|581273406|FG003|Initiation|Protocol Violation|0|||
160968696|NCT00279201|581273407|FG004|Initiation|Protocol Violation|0|||
160968697|NCT00279201|581273408|FG005|Initiation|Protocol Violation|0|||
160968698|NCT00279201|581273403|FG000|Initiation|Withdrawal by Subject|35|||
160968699|NCT00279201|581273404|FG001|Initiation|Withdrawal by Subject|41|||
160586507|NCT00960934|579865674|FG000|Overall Study|Withdrawal by Subject|5|||
160586508|NCT00960934|579865675|FG001|Overall Study|Withdrawal by Subject|6|||
160968700|NCT00279201|581273405|FG002|Initiation|Withdrawal by Subject|0|||
161015460|NCT04927065|581445363|FG003|First Booster|Physician Decision|3|||
161015461|NCT04927065|581445364|FG004|First Booster|Physician Decision|1|||
161015462|NCT04927065|581445365|FG005|First Booster|Physician Decision|1|||
161015463|NCT04927065|581445366|FG006|First Booster|Physician Decision|0|||
161015464|NCT04927065|581445367|FG007|First Booster|Physician Decision|3|||
161015465|NCT04927065|581445368|FG008|First Booster|Physician Decision|0|||
161015466|NCT04927065|581445369|FG009|First Booster|Physician Decision|0|||
161015467|NCT04927065|581445370|FG010|First Booster|Physician Decision|0|||
161015468|NCT04927065|581445371|FG011|First Booster|Physician Decision|0|||
161015469|NCT04927065|581445372|FG012|First Booster|Physician Decision|0|||
161015470|NCT04927065|581445373|FG013|First Booster|Physician Decision|0|||
161015471|NCT04927065|581445374|FG014|First Booster|Physician Decision|0|||
161015472|NCT04927065|581445375|FG015|First Booster|Physician Decision|0|||
161015473|NCT04927065|581445360|FG000|First Booster|Protocol Violation|4|||
161015474|NCT04927065|581445361|FG001|First Booster|Protocol Violation|4|||
161015475|NCT04927065|581445362|FG002|First Booster|Protocol Violation|0|||
161015476|NCT04927065|581445363|FG003|First Booster|Protocol Violation|3|||
161015477|NCT04927065|581445364|FG004|First Booster|Protocol Violation|0|||
161015478|NCT04927065|581445365|FG005|First Booster|Protocol Violation|0|||
161015479|NCT04927065|581445366|FG006|First Booster|Protocol Violation|0|||
161015480|NCT04927065|581445367|FG007|First Booster|Protocol Violation|2|||
161015481|NCT04927065|581445368|FG008|First Booster|Protocol Violation|0|||
161015482|NCT04927065|581445369|FG009|First Booster|Protocol Violation|0|||
161015483|NCT04927065|581445370|FG010|First Booster|Protocol Violation|0|||
161015484|NCT04927065|581445371|FG011|First Booster|Protocol Violation|0|||
161015485|NCT04927065|581445372|FG012|First Booster|Protocol Violation|0|||
161015486|NCT04927065|581445373|FG013|First Booster|Protocol Violation|0|||
161015487|NCT04927065|581445374|FG014|First Booster|Protocol Violation|0|||
161015488|NCT04927065|581445375|FG015|First Booster|Protocol Violation|0|||
161015489|NCT04927065|581445360|FG000|First Booster|Withdrawal by Subject|8|||
161015490|NCT04927065|581445361|FG001|First Booster|Withdrawal by Subject|23|||
161015491|NCT04927065|581445362|FG002|First Booster|Withdrawal by Subject|0|||
161015492|NCT04927065|581445363|FG003|First Booster|Withdrawal by Subject|19|||
161015493|NCT04927065|581445364|FG004|First Booster|Withdrawal by Subject|20|||
161015494|NCT04927065|581445365|FG005|First Booster|Withdrawal by Subject|15|||
161015495|NCT04927065|581445366|FG006|First Booster|Withdrawal by Subject|6|||
161015496|NCT04927065|581445367|FG007|First Booster|Withdrawal by Subject|24|||
161015497|NCT04927065|581445368|FG008|First Booster|Withdrawal by Subject|0|||
161015498|NCT04927065|581445369|FG009|First Booster|Withdrawal by Subject|4|||
161015499|NCT04927065|581445370|FG010|First Booster|Withdrawal by Subject|0|||
161015500|NCT04927065|581445371|FG011|First Booster|Withdrawal by Subject|0|||
161015501|NCT04927065|581445372|FG012|First Booster|Withdrawal by Subject|0|||
161015502|NCT04927065|581445373|FG013|First Booster|Withdrawal by Subject|0|||
161015503|NCT04927065|581445374|FG014|First Booster|Withdrawal by Subject|0|||
161015504|NCT04927065|581445375|FG015|First Booster|Withdrawal by Subject|0|||
161015505|NCT04927065|581445360|FG000|First Booster|Other Than Specified|1|||
161015506|NCT04927065|581445361|FG001|First Booster|Other Than Specified|1|||
161015507|NCT04927065|581445362|FG002|First Booster|Other Than Specified|0|||
161015508|NCT04927065|581445363|FG003|First Booster|Other Than Specified|1|||
161015509|NCT04927065|581445364|FG004|First Booster|Other Than Specified|2|||
161015510|NCT04927065|581445365|FG005|First Booster|Other Than Specified|3|||
161015511|NCT04927065|581445366|FG006|First Booster|Other Than Specified|2|||
161015512|NCT04927065|581445367|FG007|First Booster|Other Than Specified|6|||
161015513|NCT04927065|581445368|FG008|First Booster|Other Than Specified|0|||
161015514|NCT04927065|581445369|FG009|First Booster|Other Than Specified|4|||
161015515|NCT04927065|581445370|FG010|First Booster|Other Than Specified|0|||
161015516|NCT04927065|581445371|FG011|First Booster|Other Than Specified|0|||
161015517|NCT04927065|581445372|FG012|First Booster|Other Than Specified|0|||
161015518|NCT04927065|581445373|FG013|First Booster|Other Than Specified|0|||
160586509|NCT00960934|579865676|FG002|Overall Study|Withdrawal by Subject|4|||
160586510|NCT00960934|579865677|FG003|Overall Study|Withdrawal by Subject|5|||
161015519|NCT04927065|581445374|FG014|First Booster|Other Than Specified|0|||
161015520|NCT04927065|581445375|FG015|First Booster|Other Than Specified|0|||
161015521|NCT04927065|581445360|FG000|Second Booster|Death|0|||
161015522|NCT04927065|581445361|FG001|Second Booster|Death|0|||
161015523|NCT04927065|581445362|FG002|Second Booster|Death|0|||
161015524|NCT04927065|581445363|FG003|Second Booster|Death|0|||
161015525|NCT04927065|581445364|FG004|Second Booster|Death|0|||
161015526|NCT04927065|581445365|FG005|Second Booster|Death|0|||
161015527|NCT04927065|581445366|FG006|Second Booster|Death|0|||
161015528|NCT04927065|581445367|FG007|Second Booster|Death|0|||
161015529|NCT04927065|581445368|FG008|Second Booster|Death|0|||
161015530|NCT04927065|581445369|FG009|Second Booster|Death|0|||
161015531|NCT04927065|581445370|FG010|Second Booster|Death|2|||
161015532|NCT04927065|581445371|FG011|Second Booster|Death|0|||
161015533|NCT04927065|581445372|FG012|Second Booster|Death|2|||
161015534|NCT04927065|581445373|FG013|Second Booster|Death|2|||
161015535|NCT04927065|581445374|FG014|Second Booster|Death|0|||
161015536|NCT04927065|581445375|FG015|Second Booster|Death|0|||
161015537|NCT04927065|581445360|FG000|Second Booster|Lost to Follow-up|0|||
160586511|NCT00960934|579865678|FG004|Overall Study|Withdrawal by Subject|5|||
160586512|NCT00960934|579865679|FG005|Overall Study|Withdrawal by Subject|7|||
160586513|NCT00960934|579865674|FG000|Overall Study|Study Terminated by Sponsor|50|||
160586514|NCT00960934|579865675|FG001|Overall Study|Study Terminated by Sponsor|46|||
160586515|NCT00960934|579865676|FG002|Overall Study|Study Terminated by Sponsor|52|||
160586516|NCT00960934|579865677|FG003|Overall Study|Study Terminated by Sponsor|50|||
160586517|NCT00960934|579865678|FG004|Overall Study|Study Terminated by Sponsor|49|||
160586518|NCT00960934|579865679|FG005|Overall Study|Study Terminated by Sponsor|49|||
160586519|NCT02338492|579865692|FG000|Overall Study|Death|32|||
160586520|NCT02338492|579865692|FG000|Overall Study|Adverse Event|3|||
160586521|NCT02338492|579865692|FG000|Overall Study|Lost to Follow-up|4|||
160586522|NCT02338492|579865692|FG000|Overall Study|Reason not captured above|6|||
160586523|NCT02179515|579865695|FG000|Overall Study|switched to alternative treatment|0|||
160586524|NCT02179515|579865696|FG001|Overall Study|switched to alternative treatment|1|||
160586525|NCT02179515|579865697|FG002|Overall Study|switched to alternative treatment|1|||
161015538|NCT04927065|581445361|FG001|Second Booster|Lost to Follow-up|0|||
161015539|NCT04927065|581445362|FG002|Second Booster|Lost to Follow-up|3|||
161015540|NCT04927065|581445363|FG003|Second Booster|Lost to Follow-up|0|||
161015541|NCT04927065|581445364|FG004|Second Booster|Lost to Follow-up|0|||
161015542|NCT04927065|581445365|FG005|Second Booster|Lost to Follow-up|0|||
161015543|NCT04927065|581445366|FG006|Second Booster|Lost to Follow-up|0|||
161015544|NCT04927065|581445367|FG007|Second Booster|Lost to Follow-up|0|||
161015545|NCT04927065|581445368|FG008|Second Booster|Lost to Follow-up|0|||
161015546|NCT04927065|581445369|FG009|Second Booster|Lost to Follow-up|0|||
161015547|NCT04927065|581445370|FG010|Second Booster|Lost to Follow-up|14|||
161015548|NCT04927065|581445371|FG011|Second Booster|Lost to Follow-up|10|||
161015549|NCT04927065|581445372|FG012|Second Booster|Lost to Follow-up|13|||
161015550|NCT04927065|581445373|FG013|Second Booster|Lost to Follow-up|16|||
161015551|NCT04927065|581445374|FG014|Second Booster|Lost to Follow-up|0|||
161015552|NCT04927065|581445375|FG015|Second Booster|Lost to Follow-up|0|||
161015553|NCT04927065|581445360|FG000|Second Booster|Physician Decision|0|||
161015554|NCT04927065|581445361|FG001|Second Booster|Physician Decision|0|||
161015555|NCT04927065|581445362|FG002|Second Booster|Physician Decision|0|||
161015556|NCT04927065|581445363|FG003|Second Booster|Physician Decision|0|||
161015557|NCT04927065|581445364|FG004|Second Booster|Physician Decision|0|||
161015558|NCT04927065|581445365|FG005|Second Booster|Physician Decision|0|||
161015559|NCT04927065|581445366|FG006|Second Booster|Physician Decision|0|||
161015560|NCT04927065|581445367|FG007|Second Booster|Physician Decision|0|||
161015561|NCT04927065|581445368|FG008|Second Booster|Physician Decision|0|||
161015562|NCT04927065|581445369|FG009|Second Booster|Physician Decision|0|||
161015563|NCT04927065|581445370|FG010|Second Booster|Physician Decision|0|||
161015564|NCT04927065|581445371|FG011|Second Booster|Physician Decision|3|||
161015565|NCT04927065|581445372|FG012|Second Booster|Physician Decision|0|||
161015566|NCT04927065|581445373|FG013|Second Booster|Physician Decision|1|||
161015567|NCT04927065|581445374|FG014|Second Booster|Physician Decision|0|||
161015568|NCT04927065|581445375|FG015|Second Booster|Physician Decision|0|||
161015569|NCT04927065|581445360|FG000|Second Booster|Withdrawal by Subject|0|||
161015570|NCT04927065|581445361|FG001|Second Booster|Withdrawal by Subject|0|||
161015571|NCT04927065|581445362|FG002|Second Booster|Withdrawal by Subject|4|||
161015572|NCT04927065|581445363|FG003|Second Booster|Withdrawal by Subject|0|||
161015573|NCT04927065|581445364|FG004|Second Booster|Withdrawal by Subject|0|||
161015574|NCT04927065|581445365|FG005|Second Booster|Withdrawal by Subject|0|||
161015575|NCT04927065|581445366|FG006|Second Booster|Withdrawal by Subject|0|||
161015576|NCT04927065|581445367|FG007|Second Booster|Withdrawal by Subject|0|||
161015577|NCT04927065|581445368|FG008|Second Booster|Withdrawal by Subject|0|||
161015578|NCT04927065|581445369|FG009|Second Booster|Withdrawal by Subject|0|||
161015579|NCT04927065|581445370|FG010|Second Booster|Withdrawal by Subject|3|||
161015580|NCT04927065|581445371|FG011|Second Booster|Withdrawal by Subject|16|||
161015581|NCT04927065|581445372|FG012|Second Booster|Withdrawal by Subject|13|||
161015582|NCT04927065|581445373|FG013|Second Booster|Withdrawal by Subject|9|||
161015583|NCT04927065|581445374|FG014|Second Booster|Withdrawal by Subject|0|||
161015584|NCT04927065|581445375|FG015|Second Booster|Withdrawal by Subject|0|||
161015585|NCT04927065|581445360|FG000|Second Booster|Other Than Specified|0|||
161015586|NCT04927065|581445361|FG001|Second Booster|Other Than Specified|0|||
161015587|NCT04927065|581445362|FG002|Second Booster|Other Than Specified|0|||
161015588|NCT04927065|581445363|FG003|Second Booster|Other Than Specified|0|||
161015589|NCT04927065|581445364|FG004|Second Booster|Other Than Specified|0|||
161015590|NCT04927065|581445365|FG005|Second Booster|Other Than Specified|0|||
161015591|NCT04927065|581445366|FG006|Second Booster|Other Than Specified|0|||
161015592|NCT04927065|581445367|FG007|Second Booster|Other Than Specified|0|||
161015593|NCT04927065|581445368|FG008|Second Booster|Other Than Specified|0|||
161015594|NCT04927065|581445369|FG009|Second Booster|Other Than Specified|0|||
160586526|NCT02179515|579865695|FG000|Overall Study|Death|0|||
160586527|NCT02179515|579865696|FG001|Overall Study|Death|1|||
160586528|NCT02179515|579865697|FG002|Overall Study|Death|1|||
160586529|NCT02179515|579865695|FG000|Overall Study|refused further treatment|0|||
161015595|NCT04927065|581445370|FG010|Second Booster|Other Than Specified|1|||
161015596|NCT04927065|581445371|FG011|Second Booster|Other Than Specified|1|||
160586530|NCT02179515|579865696|FG001|Overall Study|refused further treatment|3|||
160586531|NCT02179515|579865697|FG002|Overall Study|refused further treatment|4|||
160968701|NCT00279201|581273406|FG003|Initiation|Withdrawal by Subject|0|||
160968702|NCT00279201|581273407|FG004|Initiation|Withdrawal by Subject|0|||
160968703|NCT00279201|581273408|FG005|Initiation|Withdrawal by Subject|0|||
160968704|NCT00279201|581273403|FG000|Initiation|Physician Decision|15|||
160968705|NCT00279201|581273404|FG001|Initiation|Physician Decision|18|||
160968706|NCT00279201|581273405|FG002|Initiation|Physician Decision|0|||
160968707|NCT00279201|581273406|FG003|Initiation|Physician Decision|0|||
160968708|NCT00279201|581273407|FG004|Initiation|Physician Decision|0|||
160968709|NCT00279201|581273408|FG005|Initiation|Physician Decision|0|||
160968710|NCT00279201|581273403|FG000|Initiation|Sponsor Decision|13|||
160968711|NCT00279201|581273404|FG001|Initiation|Sponsor Decision|5|||
160968712|NCT00279201|581273405|FG002|Initiation|Sponsor Decision|0|||
160968713|NCT00279201|581273406|FG003|Initiation|Sponsor Decision|0|||
160968714|NCT00279201|581273407|FG004|Initiation|Sponsor Decision|0|||
160968715|NCT00279201|581273408|FG005|Initiation|Sponsor Decision|0|||
160968716|NCT00279201|581273403|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
160968717|NCT00279201|581273404|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
160968718|NCT00279201|581273405|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
160968719|NCT00279201|581273406|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
160968720|NCT00279201|581273407|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
160968721|NCT00279201|581273408|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
160968722|NCT00279201|581273403|FG000|Maintenance|Lack of Efficacy|32|||
160968723|NCT00279201|581273404|FG001|Maintenance|Lack of Efficacy|30|||
160968724|NCT00279201|581273405|FG002|Maintenance|Lack of Efficacy|0|||
160968725|NCT00279201|581273406|FG003|Maintenance|Lack of Efficacy|0|||
160968726|NCT00279201|581273407|FG004|Maintenance|Lack of Efficacy|0|||
160968727|NCT00279201|581273408|FG005|Maintenance|Lack of Efficacy|0|||
160968728|NCT00279201|581273403|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
160968729|NCT00279201|581273404|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
160968730|NCT00279201|581273405|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
160968731|NCT00279201|581273406|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
160968732|NCT00279201|581273407|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
160968733|NCT00279201|581273408|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
160968734|NCT00279201|581273403|FG000|Maintenance|Adverse Event|4|||
160968735|NCT00279201|581273404|FG001|Maintenance|Adverse Event|4|||
160968736|NCT00279201|581273405|FG002|Maintenance|Adverse Event|0|||
160968737|NCT00279201|581273406|FG003|Maintenance|Adverse Event|0|||
160968738|NCT00279201|581273407|FG004|Maintenance|Adverse Event|0|||
160968739|NCT00279201|581273408|FG005|Maintenance|Adverse Event|0|||
160968740|NCT00279201|581273403|FG000|Maintenance|Death|4|||
160968741|NCT00279201|581273404|FG001|Maintenance|Death|4|||
160968742|NCT00279201|581273405|FG002|Maintenance|Death|0|||
160968743|NCT00279201|581273406|FG003|Maintenance|Death|0|||
160968744|NCT00279201|581273407|FG004|Maintenance|Death|0|||
160968745|NCT00279201|581273408|FG005|Maintenance|Death|0|||
160968746|NCT00279201|581273403|FG000|Maintenance|Lost to Follow-up|17|||
160968747|NCT00279201|581273404|FG001|Maintenance|Lost to Follow-up|13|||
160968748|NCT00279201|581273405|FG002|Maintenance|Lost to Follow-up|0|||
160968749|NCT00279201|581273406|FG003|Maintenance|Lost to Follow-up|0|||
160968750|NCT00279201|581273407|FG004|Maintenance|Lost to Follow-up|0|||
160968751|NCT00279201|581273408|FG005|Maintenance|Lost to Follow-up|0|||
160968752|NCT00279201|581273403|FG000|Maintenance|Entry Criteria Exclusion|1|||
160968753|NCT00279201|581273404|FG001|Maintenance|Entry Criteria Exclusion|4|||
160968754|NCT00279201|581273405|FG002|Maintenance|Entry Criteria Exclusion|0|||
160968755|NCT00279201|581273406|FG003|Maintenance|Entry Criteria Exclusion|0|||
160968756|NCT00279201|581273407|FG004|Maintenance|Entry Criteria Exclusion|0|||
160968757|NCT00279201|581273408|FG005|Maintenance|Entry Criteria Exclusion|0|||
160968758|NCT00279201|581273403|FG000|Maintenance|Protocol Violation|16|||
160968759|NCT00279201|581273404|FG001|Maintenance|Protocol Violation|24|||
160968760|NCT00279201|581273405|FG002|Maintenance|Protocol Violation|0|||
160968761|NCT00279201|581273406|FG003|Maintenance|Protocol Violation|0|||
160968762|NCT00279201|581273407|FG004|Maintenance|Protocol Violation|0|||
160968763|NCT00279201|581273408|FG005|Maintenance|Protocol Violation|0|||
160968764|NCT00279201|581273403|FG000|Maintenance|Withdrawal by Subject|18|||
160968765|NCT00279201|581273404|FG001|Maintenance|Withdrawal by Subject|18|||
160968766|NCT00279201|581273405|FG002|Maintenance|Withdrawal by Subject|0|||
160968767|NCT00279201|581273406|FG003|Maintenance|Withdrawal by Subject|0|||
160968768|NCT00279201|581273407|FG004|Maintenance|Withdrawal by Subject|0|||
160968769|NCT00279201|581273408|FG005|Maintenance|Withdrawal by Subject|0|||
160968770|NCT00279201|581273403|FG000|Maintenance|Physician Decision|9|||
160968771|NCT00279201|581273404|FG001|Maintenance|Physician Decision|9|||
160968772|NCT00279201|581273405|FG002|Maintenance|Physician Decision|0|||
160968773|NCT00279201|581273406|FG003|Maintenance|Physician Decision|0|||
160968774|NCT00279201|581273407|FG004|Maintenance|Physician Decision|0|||
160459272|NCT04631016|579414225|FG001|Overall Study|Reason unspecified|0|||
160459273|NCT04631016|579414224|FG000|Overall Study|Failure to meet randomization criteria|2|||
160459274|NCT04631016|579414225|FG001|Overall Study|Failure to meet randomization criteria|1|||
160459275|NCT05112900|579414228|FG000|Overall Study|Withdrawal by Subject|960|||
160459276|NCT05112900|579414229|FG001|Overall Study|Withdrawal by Subject|921|||
160459277|NCT05112900|579414230|FG002|Overall Study|Withdrawal by Subject|968|||
160459278|NCT05541484|579414231|FG000|Overall Study|Withdrawal by Subject|1|||
160459279|NCT05541484|579414232|FG001|Overall Study|Withdrawal by Subject|0|||
160459280|NCT01438853|579414238|FG000|Overall Study|Death|0|||
160459281|NCT01438853|579414239|FG001|Overall Study|Death|0|||
160459282|NCT01438853|579414240|FG002|Overall Study|Death|0|||
160459283|NCT01438853|579414241|FG003|Overall Study|Death|1|||
160459284|NCT01438853|579414238|FG000|Overall Study|Withdrawal by Subject|0|||
160968775|NCT00279201|581273408|FG005|Maintenance|Physician Decision|0|||
160968776|NCT00279201|581273403|FG000|Maintenance|Sponsor Decision|4|||
160968777|NCT00279201|581273404|FG001|Maintenance|Sponsor Decision|0|||
160968778|NCT00279201|581273405|FG002|Maintenance|Sponsor Decision|0|||
160968779|NCT00279201|581273406|FG003|Maintenance|Sponsor Decision|0|||
160968780|NCT00279201|581273407|FG004|Maintenance|Sponsor Decision|0|||
160968781|NCT00279201|581273408|FG005|Maintenance|Sponsor Decision|0|||
160968782|NCT00279201|581273403|FG000|Maintenance|HbA1c>7.5%|123|||
160968783|NCT00279201|581273404|FG001|Maintenance|HbA1c>7.5%|126|||
160968784|NCT00279201|581273405|FG002|Maintenance|HbA1c>7.5%|0|||
160968785|NCT00279201|581273406|FG003|Maintenance|HbA1c>7.5%|0|||
160968786|NCT00279201|581273407|FG004|Maintenance|HbA1c>7.5%|0|||
160968787|NCT00279201|581273408|FG005|Maintenance|HbA1c>7.5%|0|||
160968788|NCT00279201|581273403|FG000|Intensification Addendum|Withdrawal by Subject|0|||
160968789|NCT00279201|581273404|FG001|Intensification Addendum|Withdrawal by Subject|0|||
160968790|NCT00279201|581273405|FG002|Intensification Addendum|Withdrawal by Subject|12|||
160968791|NCT00279201|581273406|FG003|Intensification Addendum|Withdrawal by Subject|14|||
160968792|NCT00279201|581273407|FG004|Intensification Addendum|Withdrawal by Subject|9|||
160968793|NCT00279201|581273408|FG005|Intensification Addendum|Withdrawal by Subject|18|||
160968794|NCT00279201|581273403|FG000|Intensification Addendum|Lost to Follow-up|0|||
160968795|NCT00279201|581273404|FG001|Intensification Addendum|Lost to Follow-up|0|||
160968796|NCT00279201|581273405|FG002|Intensification Addendum|Lost to Follow-up|4|||
160968797|NCT00279201|581273406|FG003|Intensification Addendum|Lost to Follow-up|6|||
160968798|NCT00279201|581273407|FG004|Intensification Addendum|Lost to Follow-up|7|||
160968799|NCT00279201|581273408|FG005|Intensification Addendum|Lost to Follow-up|7|||
160968800|NCT00279201|581273403|FG000|Intensification Addendum|Protocol Violation|0|||
160968801|NCT00279201|581273404|FG001|Intensification Addendum|Protocol Violation|0|||
160968802|NCT00279201|581273405|FG002|Intensification Addendum|Protocol Violation|2|||
160968803|NCT00279201|581273406|FG003|Intensification Addendum|Protocol Violation|2|||
160968804|NCT00279201|581273407|FG004|Intensification Addendum|Protocol Violation|6|||
160968805|NCT00279201|581273408|FG005|Intensification Addendum|Protocol Violation|6|||
160968806|NCT00279201|581273403|FG000|Intensification Addendum|Adverse Event|0|||
160968807|NCT00279201|581273404|FG001|Intensification Addendum|Adverse Event|0|||
160968808|NCT00279201|581273405|FG002|Intensification Addendum|Adverse Event|0|||
160968809|NCT00279201|581273406|FG003|Intensification Addendum|Adverse Event|4|||
160968810|NCT00279201|581273407|FG004|Intensification Addendum|Adverse Event|1|||
160968811|NCT00279201|581273408|FG005|Intensification Addendum|Adverse Event|3|||
160968812|NCT00279201|581273403|FG000|Intensification Addendum|Physician Decision|0|||
160968813|NCT00279201|581273404|FG001|Intensification Addendum|Physician Decision|0|||
160968814|NCT00279201|581273405|FG002|Intensification Addendum|Physician Decision|4|||
160968815|NCT00279201|581273406|FG003|Intensification Addendum|Physician Decision|1|||
160968816|NCT00279201|581273407|FG004|Intensification Addendum|Physician Decision|3|||
160968817|NCT00279201|581273408|FG005|Intensification Addendum|Physician Decision|2|||
160968818|NCT00279201|581273403|FG000|Intensification Addendum|Sponsor Decision|0|||
160968819|NCT00279201|581273404|FG001|Intensification Addendum|Sponsor Decision|0|||
160968820|NCT00279201|581273405|FG002|Intensification Addendum|Sponsor Decision|0|||
160968821|NCT00279201|581273406|FG003|Intensification Addendum|Sponsor Decision|0|||
160968822|NCT00279201|581273407|FG004|Intensification Addendum|Sponsor Decision|1|||
160968823|NCT00279201|581273408|FG005|Intensification Addendum|Sponsor Decision|1|||
160968824|NCT00279201|581273403|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
160968825|NCT00279201|581273404|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
160968826|NCT00279201|581273405|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
160968827|NCT00279201|581273406|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
160968828|NCT00279201|581273407|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
160968829|NCT00279201|581273408|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
160968830|NCT00279201|581273403|FG000|Intensification Addendum|Lack of Efficacy|0|||
160968831|NCT00279201|581273404|FG001|Intensification Addendum|Lack of Efficacy|0|||
160968832|NCT00279201|581273405|FG002|Intensification Addendum|Lack of Efficacy|0|||
160968833|NCT00279201|581273406|FG003|Intensification Addendum|Lack of Efficacy|1|||
161015597|NCT04927065|581445372|FG012|Second Booster|Other Than Specified|4|||
161015598|NCT04927065|581445373|FG013|Second Booster|Other Than Specified|0|||
161015599|NCT04927065|581445374|FG014|Second Booster|Other Than Specified|0|||
161015600|NCT04927065|581445375|FG015|Second Booster|Other Than Specified|0|||
161015601|NCT04927065|581445360|FG000|Third Booster|Lost to Follow-up|0|||
161015602|NCT04927065|581445361|FG001|Third Booster|Lost to Follow-up|0|||
161015603|NCT04927065|581445362|FG002|Third Booster|Lost to Follow-up|0|||
161015604|NCT04927065|581445363|FG003|Third Booster|Lost to Follow-up|0|||
161015605|NCT04927065|581445364|FG004|Third Booster|Lost to Follow-up|0|||
161015606|NCT04927065|581445365|FG005|Third Booster|Lost to Follow-up|0|||
161015607|NCT04927065|581445366|FG006|Third Booster|Lost to Follow-up|0|||
161015608|NCT04927065|581445367|FG007|Third Booster|Lost to Follow-up|0|||
161015609|NCT04927065|581445368|FG008|Third Booster|Lost to Follow-up|0|||
161015610|NCT04927065|581445369|FG009|Third Booster|Lost to Follow-up|0|||
161015611|NCT04927065|581445370|FG010|Third Booster|Lost to Follow-up|0|||
161015612|NCT04927065|581445371|FG011|Third Booster|Lost to Follow-up|0|||
161015613|NCT04927065|581445372|FG012|Third Booster|Lost to Follow-up|0|||
161015614|NCT04927065|581445373|FG013|Third Booster|Lost to Follow-up|0|||
161015615|NCT04927065|581445374|FG014|Third Booster|Lost to Follow-up|0|||
161015616|NCT04927065|581445375|FG015|Third Booster|Lost to Follow-up|1|||
161015617|NCT04927065|581445360|FG000|Third Booster|Withdrawal by Subject|0|||
161015618|NCT04927065|581445361|FG001|Third Booster|Withdrawal by Subject|0|||
161015619|NCT04927065|581445362|FG002|Third Booster|Withdrawal by Subject|0|||
161015620|NCT04927065|581445363|FG003|Third Booster|Withdrawal by Subject|0|||
161015621|NCT04927065|581445364|FG004|Third Booster|Withdrawal by Subject|0|||
161015622|NCT04927065|581445365|FG005|Third Booster|Withdrawal by Subject|0|||
161015623|NCT04927065|581445366|FG006|Third Booster|Withdrawal by Subject|0|||
161015624|NCT04927065|581445367|FG007|Third Booster|Withdrawal by Subject|0|||
161015625|NCT04927065|581445368|FG008|Third Booster|Withdrawal by Subject|0|||
161015626|NCT04927065|581445369|FG009|Third Booster|Withdrawal by Subject|0|||
161015627|NCT04927065|581445370|FG010|Third Booster|Withdrawal by Subject|0|||
161015628|NCT04927065|581445371|FG011|Third Booster|Withdrawal by Subject|0|||
161015629|NCT04927065|581445372|FG012|Third Booster|Withdrawal by Subject|0|||
161015630|NCT04927065|581445373|FG013|Third Booster|Withdrawal by Subject|0|||
161015631|NCT04927065|581445374|FG014|Third Booster|Withdrawal by Subject|0|||
161015632|NCT04927065|581445375|FG015|Third Booster|Withdrawal by Subject|1|||
161015633|NCT03846505|581445376|FG000|Treatment Phase|Withdrawal by Subject|9|||
161015634|NCT03846505|581445377|FG001|Treatment Phase|Withdrawal by Subject|11|||
161015635|NCT03846505|581445376|FG000|Treatment Phase|Lost to Follow-up|6|||
161015636|NCT03846505|581445377|FG001|Treatment Phase|Lost to Follow-up|2|||
161015637|NCT03846505|581445376|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
161015638|NCT03846505|581445377|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
161015639|NCT03846505|581445376|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
161015640|NCT03846505|581445377|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
161015641|NCT04021602|581445384|FG000|Overall Study|Lost to Follow-up|3|||
161015642|NCT04021602|581445385|FG001|Overall Study|Lost to Follow-up|3|||
161015643|NCT04021602|581445386|FG002|Overall Study|Lost to Follow-up|1|||
161015644|NCT04021602|581445384|FG000|Overall Study|Adverse Event|1|||
161015645|NCT04021602|581445385|FG001|Overall Study|Adverse Event|0|||
161015646|NCT04021602|581445386|FG002|Overall Study|Adverse Event|1|||
161015647|NCT05592418|581445387|FG000|Overall Study|Adverse Event|1|||
161015648|NCT05592418|581445388|FG001|Overall Study|Adverse Event|0|||
161015649|NCT05592418|581445387|FG000|Overall Study|Lost to Follow-up|1|||
161015650|NCT05592418|581445388|FG001|Overall Study|Lost to Follow-up|3|||
161015651|NCT05592418|581445387|FG000|Overall Study|Withdrawal by Subject|2|||
161015652|NCT05592418|581445388|FG001|Overall Study|Withdrawal by Subject|7|||
161015653|NCT04450342|581445391|FG000|Overall Study|Adverse Event|1|||
161015654|NCT04450342|581445392|FG001|Overall Study|Adverse Event|1|||
161015655|NCT04450342|581445393|FG002|Overall Study|Adverse Event|0|||
161015656|NCT04450342|581445391|FG000|Overall Study|Device not used|1|||
161015657|NCT04450342|581445392|FG001|Overall Study|Device not used|0|||
161015658|NCT04450342|581445393|FG002|Overall Study|Device not used|0|||
161015659|NCT04450342|581445391|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
161015660|NCT04450342|581445392|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
161015661|NCT04450342|581445393|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
161015662|NCT04450342|581445391|FG000|Overall Study|Physician Decision|1|||
161015663|NCT04450342|581445392|FG001|Overall Study|Physician Decision|0|||
161015664|NCT04450342|581445393|FG002|Overall Study|Physician Decision|1|||
161015665|NCT04450342|581445391|FG000|Overall Study|Protocol Deviation|0|||
160586532|NCT02179515|579865695|FG000|Overall Study|Disease progression on study|2|||
161015666|NCT04450342|581445392|FG001|Overall Study|Protocol Deviation|1|||
161015667|NCT04450342|581445393|FG002|Overall Study|Protocol Deviation|0|||
161015668|NCT04450342|581445391|FG000|Overall Study|Reoperation|1|||
161015669|NCT04450342|581445392|FG001|Overall Study|Reoperation|1|||
161015670|NCT04450342|581445393|FG002|Overall Study|Reoperation|0|||
161015671|NCT04450342|581445391|FG000|Overall Study|Screen Failures|0|||
161015672|NCT04450342|581445392|FG001|Overall Study|Screen Failures|0|||
161015673|NCT04450342|581445393|FG002|Overall Study|Screen Failures|2|||
161015674|NCT04450342|581445391|FG000|Overall Study|Site Terminated by Sponsor|1|||
161015675|NCT04450342|581445392|FG001|Overall Study|Site Terminated by Sponsor|1|||
161015676|NCT04450342|581445393|FG002|Overall Study|Site Terminated by Sponsor|1|||
161015677|NCT04450342|581445391|FG000|Overall Study|Study Terminated by Sponsor|31|||
161015678|NCT04450342|581445392|FG001|Overall Study|Study Terminated by Sponsor|29|||
161015679|NCT04450342|581445393|FG002|Overall Study|Study Terminated by Sponsor|6|||
161015680|NCT04450342|581445391|FG000|Overall Study|Withdrawal by Subject|0|||
161015681|NCT04450342|581445392|FG001|Overall Study|Withdrawal by Subject|1|||
161015682|NCT04450342|581445393|FG002|Overall Study|Withdrawal by Subject|2|||
161015683|NCT05481320|581445394|FG000|Overall Study|Withdrawal by Subject|1|||
161015684|NCT05481320|581445395|FG001|Overall Study|Withdrawal by Subject|1|||
161015685|NCT05481320|581445394|FG000|Overall Study|Care recipent passed away|0|||
161015686|NCT05481320|581445395|FG001|Overall Study|Care recipent passed away|1|||
161015687|NCT05481320|581445394|FG000|Overall Study|Out-of-window assessment|0|||
161015688|NCT05481320|581445395|FG001|Overall Study|Out-of-window assessment|1|||
161015689|NCT05481320|581445394|FG000|Overall Study|No longer a primary caregiver|3|||
161015690|NCT05481320|581445395|FG001|Overall Study|No longer a primary caregiver|0|||
161015691|NCT05481320|581445394|FG000|Overall Study|Unable to contact|1|||
161015692|NCT05481320|581445395|FG001|Overall Study|Unable to contact|0|||
161015693|NCT02923180|581445396|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
161015694|NCT02923180|581445396|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
161015695|NCT01084707|581445400|FG000|Overall Study|Withdrawal by Subject|6|||
161015696|NCT03930342|581445404|FG000|Overall Study|Lost to Follow-up|70|||
161015697|NCT03930342|581445405|FG001|Overall Study|Lost to Follow-up|77|||
161015698|NCT01091168|581445406|FG000|Overall Study|Progressive disease|250|||
161015699|NCT01091168|581445407|FG001|Overall Study|Progressive disease|234|||
161015700|NCT01091168|581445406|FG000|Overall Study|Adverse Event|21|||
161015701|NCT01091168|581445407|FG001|Overall Study|Adverse Event|24|||
161015702|NCT01091168|581445406|FG000|Overall Study|Lost to Follow-up|0|||
161015703|NCT01091168|581445407|FG001|Overall Study|Lost to Follow-up|1|||
161015704|NCT01091168|581445406|FG000|Overall Study|Physician, patient's decision, other|27|||
161015705|NCT01091168|581445407|FG001|Overall Study|Physician, patient's decision, other|37|||
161015706|NCT04774237|581445410|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
161015707|NCT04774237|581445411|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
161015708|NCT04774237|581445412|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
161015709|NCT04774237|581445413|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
161015710|NCT04774237|581445414|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
161015711|NCT04774237|581445415|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
161015712|NCT05792423|581445416|FG000|Overall Study|Withdrawal by Subject|2|||
161015713|NCT04052516|581447710|FG000|Overall Study|Withdrawal by Subject|4|||
161015714|NCT04052516|581447711|FG001|Overall Study|Withdrawal by Subject|5|||
161015715|NCT04052516|581447712|FG002|Overall Study|Withdrawal by Subject|6|||
161015716|NCT04052516|581447710|FG000|Overall Study|Adverse Event|3|||
161015717|NCT04052516|581447711|FG001|Overall Study|Adverse Event|2|||
161015718|NCT04052516|581447712|FG002|Overall Study|Adverse Event|8|||
161015719|NCT04052516|581447710|FG000|Overall Study|Lost to Follow-up|2|||
161015720|NCT04052516|581447711|FG001|Overall Study|Lost to Follow-up|5|||
161015721|NCT04052516|581447712|FG002|Overall Study|Lost to Follow-up|3|||
161015722|NCT04052516|581447710|FG000|Overall Study|Protocol Violation|1|||
161015723|NCT04052516|581447711|FG001|Overall Study|Protocol Violation|1|||
161015724|NCT04052516|581447712|FG002|Overall Study|Protocol Violation|0|||
161015725|NCT04052516|581447710|FG000|Overall Study|Death|1|||
161015726|NCT04052516|581447711|FG001|Overall Study|Death|0|||
161015727|NCT04052516|581447712|FG002|Overall Study|Death|0|||
161015728|NCT04052516|581447710|FG000|Overall Study|Physician Decision|0|||
161015729|NCT04052516|581447711|FG001|Overall Study|Physician Decision|1|||
161015730|NCT04052516|581447712|FG002|Overall Study|Physician Decision|0|||
161015731|NCT04052516|581447710|FG000|Overall Study|Pregnancy|1|||
160586533|NCT02179515|579865696|FG001|Overall Study|Disease progression on study|11|||
161015732|NCT04052516|581447711|FG001|Overall Study|Pregnancy|0|||
161015733|NCT04052516|581447712|FG002|Overall Study|Pregnancy|0|||
161015734|NCT04052516|581447710|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
161015735|NCT04052516|581447711|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
161015736|NCT04052516|581447712|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
161015737|NCT04052516|581447710|FG000|Overall Study|Reason not recorded|0|||
161015738|NCT04052516|581447711|FG001|Overall Study|Reason not recorded|1|||
161015739|NCT04052516|581447712|FG002|Overall Study|Reason not recorded|0|||
161015758|NCT05062265|581447727|FG000|Overall Study|Withdrawal by Subject|1|||
161015759|NCT05062265|581447728|FG001|Overall Study|Withdrawal by Subject|0|||
161015760|NCT03101904|581447732|FG000|Wash Out (10 Days)|Adverse Event|1|||
161015761|NCT03101904|581447733|FG001|Wash Out (10 Days)|Adverse Event|0|||
161015762|NCT03101904|581447732|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
161015763|NCT03101904|581447733|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
161015764|NCT04538417|581447734|FG000|Overall Study|Withdrawal by Subject|2|||
161015765|NCT01331005|581447736|FG000|Overall Study|Lost to Follow-up|2|||
161015766|NCT01331005|581447737|FG001|Overall Study|Lost to Follow-up|1|||
161015767|NCT01331005|581447736|FG000|Overall Study|Withdrawal by Subject|2|||
161015768|NCT01331005|581447737|FG001|Overall Study|Withdrawal by Subject|3|||
161015769|NCT03161379|581447738|FG000|Overall Study|Withdrawal by Subject|4|||
161015770|NCT03161379|581447738|FG000|Overall Study|disease progression during chemotherapy|5|||
161015771|NCT03161379|581447738|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
161015772|NCT03161379|581447738|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
161015773|NCT03393975|581447739|FG000|Urgent Treatment Period|Physician Decision|0|||
161015774|NCT03393975|581447740|FG001|Urgent Treatment Period|Physician Decision|0|||
160586534|NCT02179515|579865697|FG002|Overall Study|Disease progression on study|8|||
160586535|NCT00782418|579865698|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
160586536|NCT00782418|579865699|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
160586537|NCT00782418|579865700|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
160586538|NCT00782418|579865701|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
160586539|NCT00782418|579865702|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
160586540|NCT00782418|579865703|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
160586541|NCT00782418|579865704|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
160586542|NCT00782418|579865698|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
160586543|NCT00782418|579865699|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
160586544|NCT00782418|579865700|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161015775|NCT03393975|581447741|FG002|Urgent Treatment Period|Physician Decision|0|||
161015776|NCT03393975|581447742|FG003|Urgent Treatment Period|Physician Decision|1|||
161015777|NCT03393975|581447739|FG000|Prophylaxis Period 1|Reason not Specified|0|||
161015778|NCT03393975|581447740|FG001|Prophylaxis Period 1|Reason not Specified|1|||
161015779|NCT03393975|581447741|FG002|Prophylaxis Period 1|Reason not Specified|0|||
161015780|NCT03393975|581447742|FG003|Prophylaxis Period 1|Reason not Specified|0|||
161015781|NCT03393975|581447739|FG000|Prophylaxis Period 2|Reason not Specified|0|||
161015782|NCT03393975|581447740|FG001|Prophylaxis Period 2|Reason not Specified|1|||
161015783|NCT03393975|581447741|FG002|Prophylaxis Period 2|Reason not Specified|0|||
161015784|NCT03393975|581447742|FG003|Prophylaxis Period 2|Reason not Specified|0|||
161015785|NCT01140880|581447745|FG000|Overall Study|Death|0|||
161015786|NCT01140880|581447746|FG001|Overall Study|Death|1|||
161015787|NCT01140880|581447745|FG000|Overall Study|Withdrawal by Subject|6|||
161015788|NCT01140880|581447746|FG001|Overall Study|Withdrawal by Subject|3|||
160459285|NCT01438853|579414239|FG001|Overall Study|Withdrawal by Subject|0|||
160459286|NCT01438853|579414240|FG002|Overall Study|Withdrawal by Subject|1|||
160459287|NCT01438853|579414241|FG003|Overall Study|Withdrawal by Subject|0|||
160459288|NCT03279978|579414243|FG000|Overall Study|Withdrawal by Subject|0|||
160459289|NCT03279978|579414244|FG001|Overall Study|Withdrawal by Subject|1|||
160459290|NCT03279978|579414245|FG002|Overall Study|Withdrawal by Subject|0|||
160459291|NCT03279978|579414246|FG003|Overall Study|Withdrawal by Subject|0|||
160459292|NCT03279978|579414247|FG004|Overall Study|Withdrawal by Subject|0|||
160459293|NCT03279978|579414248|FG005|Overall Study|Withdrawal by Subject|0|||
160459294|NCT03279978|579414249|FG006|Overall Study|Withdrawal by Subject|0|||
160459295|NCT03279978|579414250|FG007|Overall Study|Withdrawal by Subject|0|||
160459296|NCT03279978|579414251|FG008|Overall Study|Withdrawal by Subject|0|||
160459297|NCT03279978|579414252|FG009|Overall Study|Withdrawal by Subject|1|||
160459298|NCT03279978|579414243|FG000|Overall Study|Lost to Follow-up|1|||
160459299|NCT03279978|579414244|FG001|Overall Study|Lost to Follow-up|0|||
160459300|NCT03279978|579414245|FG002|Overall Study|Lost to Follow-up|1|||
160586545|NCT00782418|579865701|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161015789|NCT01140880|581447745|FG000|Overall Study|Lost to Follow-up|8|||
161015790|NCT01140880|581447746|FG001|Overall Study|Lost to Follow-up|10|||
161015791|NCT01140880|581447745|FG000|Overall Study|Protocol Violation|0|||
161015792|NCT01140880|581447746|FG001|Overall Study|Protocol Violation|30|||
160459301|NCT03279978|579414246|FG003|Overall Study|Lost to Follow-up|0|||
161015793|NCT03779204|581447747|FG000|Overall Study|Lost to Follow-up|2|||
161015794|NCT03779204|581447748|FG001|Overall Study|Lost to Follow-up|0|||
161015795|NCT04258709|581447749|FG000|Overall Study|Lost to Follow-up|10|||
161015796|NCT04258709|581447750|FG001|Overall Study|Lost to Follow-up|4|||
161015797|NCT04258709|581447749|FG000|Overall Study|Withdrawal by Subject|1|||
161015798|NCT04258709|581447750|FG001|Overall Study|Withdrawal by Subject|0|||
161015799|NCT04258709|581447749|FG000|Overall Study|Fetal demise|0|||
161015800|NCT04258709|581447750|FG001|Overall Study|Fetal demise|1|||
161015801|NCT04258709|581447749|FG000|Overall Study|Protocol Violation|1|||
161015802|NCT04258709|581447750|FG001|Overall Study|Protocol Violation|1|||
161015803|NCT02592330|581447751|FG000|Overall Study|Withdrawal by Subject|1|||
161015804|NCT02592330|581447752|FG001|Overall Study|Withdrawal by Subject|0|||
161015805|NCT02592330|581447751|FG000|Overall Study|Failed Biopsy|1|||
161015806|NCT02592330|581447752|FG001|Overall Study|Failed Biopsy|0|||
161015807|NCT03958955|581447753|FG000|Overall Study|Adverse Event|1|||
161015808|NCT02807636|581447754|FG000|Overall Study|Lost to Follow-up|10|||
161015809|NCT02807636|581447755|FG001|Overall Study|Lost to Follow-up|13|||
161015810|NCT02807636|581447756|FG002|Overall Study|Lost to Follow-up|6|||
161015811|NCT02807636|581447754|FG000|Overall Study|Protocol Deviation|1|||
161015812|NCT02807636|581447755|FG001|Overall Study|Protocol Deviation|0|||
161015813|NCT02807636|581447756|FG002|Overall Study|Protocol Deviation|0|||
161015814|NCT02807636|581447754|FG000|Overall Study|Symptomatic Deterioration|0|||
161015815|NCT02807636|581447755|FG001|Overall Study|Symptomatic Deterioration|1|||
161015816|NCT02807636|581447756|FG002|Overall Study|Symptomatic Deterioration|0|||
161015817|NCT02807636|581447754|FG000|Overall Study|Withdrawal by Subject|39|||
161015818|NCT02807636|581447755|FG001|Overall Study|Withdrawal by Subject|28|||
161015819|NCT02807636|581447756|FG002|Overall Study|Withdrawal by Subject|24|||
161015820|NCT02807636|581447754|FG000|Overall Study|Death|303|||
161015821|NCT02807636|581447755|FG001|Overall Study|Death|332|||
161015822|NCT02807636|581447756|FG002|Overall Study|Death|272|||
161015823|NCT02807636|581447754|FG000|Overall Study|Study Terminated By Sponsor|47|||
161015824|NCT02807636|581447755|FG001|Overall Study|Study Terminated By Sponsor|76|||
161015825|NCT02807636|581447756|FG002|Overall Study|Study Terminated By Sponsor|60|||
161015826|NCT02807636|581447754|FG000|Overall Study|Physician Decision|0|||
161015827|NCT02807636|581447755|FG001|Overall Study|Physician Decision|1|||
161015828|NCT02807636|581447756|FG002|Overall Study|Physician Decision|0|||
161015829|NCT05337748|581447760|FG000|Overall Study|Withdrawal by Subject|1|||
161015830|NCT05337748|581447761|FG001|Overall Study|Withdrawal by Subject|0|||
161015831|NCT05337748|581447760|FG000|Overall Study|Death|1|||
161015832|NCT05337748|581447761|FG001|Overall Study|Death|0|||
161015833|NCT04089371|581447764|FG000|Overall Study|Withdrawal by Subject|0|||
161015834|NCT04089371|581447765|FG001|Overall Study|Withdrawal by Subject|1|||
161015835|NCT04089371|581447764|FG000|Overall Study|Study terminated early|0|||
161015836|NCT04089371|581447765|FG001|Overall Study|Study terminated early|9|||
161015837|NCT04382898|581447766|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
161015838|NCT04382898|581447767|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
161015839|NCT04382898|581447768|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
161015840|NCT04382898|581447769|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
161015841|NCT04382898|581447770|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
161015842|NCT04382898|581447766|FG000|Part 1: Dose Titration|Death|6|||
161015843|NCT04382898|581447767|FG001|Part 1: Dose Titration|Death|0|||
161015844|NCT04382898|581447768|FG002|Part 1: Dose Titration|Death|0|||
161015845|NCT04382898|581447769|FG003|Part 1: Dose Titration|Death|0|||
161015846|NCT04382898|581447770|FG004|Part 1: Dose Titration|Death|0|||
161015847|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161015848|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161015849|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161015850|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161015851|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161015852|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
161015853|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
161015854|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
161015855|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
161015856|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
161015857|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Death|0|||
161015858|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Death|17|||
161015859|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Death|13|||
161015860|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Death|1|||
161015861|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Death|0|||
160657058|NCT02327130|580124522|FG000|Overall Study|Discharged in less than 5 days|5|||
161015862|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
161015863|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
161015864|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
161015865|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
161015866|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
161015867|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
161015868|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
161015869|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
161015870|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
161015871|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
161015872|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Other|0|||
161015873|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Other|0|||
161015874|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Other|1|||
161015875|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Other|0|||
161015876|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Other|0|||
161015877|NCT05229120|581447771|FG000|Overall Study|Withdrawal by Subject|8|||
161015878|NCT04321031|581447774|FG000|Overall Study|Adverse Event|0|||
161015879|NCT04321031|581447775|FG001|Overall Study|Adverse Event|2|||
161015880|NCT04321031|581447776|FG002|Overall Study|Adverse Event|2|||
161015881|NCT04321031|581447777|FG003|Overall Study|Adverse Event|2|||
161015882|NCT04321031|581447778|FG004|Overall Study|Adverse Event|2|||
161015883|NCT04321031|581447779|FG005|Overall Study|Adverse Event|2|||
161015884|NCT04321031|581447780|FG006|Overall Study|Adverse Event|0|||
161015885|NCT04321031|581447774|FG000|Overall Study|Lost to Follow-up|0|||
161015886|NCT04321031|581447775|FG001|Overall Study|Lost to Follow-up|0|||
161015887|NCT04321031|581447776|FG002|Overall Study|Lost to Follow-up|0|||
161015888|NCT04321031|581447777|FG003|Overall Study|Lost to Follow-up|1|||
161015889|NCT04321031|581447778|FG004|Overall Study|Lost to Follow-up|0|||
161015890|NCT04321031|581447779|FG005|Overall Study|Lost to Follow-up|2|||
161015891|NCT04321031|581447780|FG006|Overall Study|Lost to Follow-up|1|||
161015892|NCT04321031|581447774|FG000|Overall Study|Withdrawal by Subject|2|||
161015893|NCT04321031|581447775|FG001|Overall Study|Withdrawal by Subject|2|||
161015894|NCT04321031|581447776|FG002|Overall Study|Withdrawal by Subject|1|||
161015895|NCT04321031|581447777|FG003|Overall Study|Withdrawal by Subject|3|||
161015896|NCT04321031|581447778|FG004|Overall Study|Withdrawal by Subject|1|||
161015897|NCT04321031|581447779|FG005|Overall Study|Withdrawal by Subject|0|||
161015898|NCT04321031|581447780|FG006|Overall Study|Withdrawal by Subject|1|||
161015899|NCT04321031|581447774|FG000|Overall Study|Non-compliance with study drug|0|||
161015900|NCT04321031|581447775|FG001|Overall Study|Non-compliance with study drug|0|||
161015901|NCT04321031|581447776|FG002|Overall Study|Non-compliance with study drug|0|||
161015902|NCT04321031|581447777|FG003|Overall Study|Non-compliance with study drug|0|||
161015903|NCT04321031|581447778|FG004|Overall Study|Non-compliance with study drug|0|||
161015904|NCT04321031|581447779|FG005|Overall Study|Non-compliance with study drug|1|||
161015905|NCT04321031|581447780|FG006|Overall Study|Non-compliance with study drug|0|||
161015906|NCT04321031|581447774|FG000|Overall Study|Other|0|||
161015907|NCT04321031|581447775|FG001|Overall Study|Other|0|||
161015908|NCT04321031|581447776|FG002|Overall Study|Other|0|||
161015909|NCT04321031|581447777|FG003|Overall Study|Other|1|||
161015910|NCT04321031|581447778|FG004|Overall Study|Other|0|||
161015911|NCT04321031|581447779|FG005|Overall Study|Other|0|||
161015912|NCT04321031|581447780|FG006|Overall Study|Other|0|||
161015913|NCT04237298|581447781|FG000|Overall Study|Lost to Follow-up|4|||
161015914|NCT04237298|581447782|FG001|Overall Study|Lost to Follow-up|5|||
161015915|NCT04556656|581447786|FG000|Overall Study|Withdrawal by Subject|14|||
161015916|NCT04556656|581447787|FG001|Overall Study|Withdrawal by Subject|12|||
161015917|NCT04556656|581447786|FG000|Overall Study|Physician Decision|1|||
161015918|NCT04556656|581447787|FG001|Overall Study|Physician Decision|0|||
161015919|NCT04556656|581447786|FG000|Overall Study|Adverse Event|4|||
161015920|NCT04556656|581447787|FG001|Overall Study|Adverse Event|7|||
161015921|NCT04556656|581447786|FG000|Overall Study|Death|4|||
161015922|NCT04556656|581447787|FG001|Overall Study|Death|0|||
161015923|NCT04556656|581447786|FG000|Overall Study|Lost to Follow-up|3|||
161015924|NCT04556656|581447787|FG001|Overall Study|Lost to Follow-up|2|||
161015925|NCT04556656|581447786|FG000|Overall Study|Not further specified|2|||
161015926|NCT04556656|581447787|FG001|Overall Study|Not further specified|1|||
161015927|NCT04541706|581447788|FG000|Overall Study|Withdrawal by Subject|3|||
161015928|NCT04541706|581447788|FG000|Overall Study|Progressive disease|33|||
161015929|NCT04541706|581447788|FG000|Overall Study|Physician Decision|1|||
161015930|NCT04541706|581447788|FG000|Overall Study|Lost to Follow-up|2|||
161015931|NCT04541706|581447788|FG000|Overall Study|Death|5|||
161015932|NCT04541706|581447788|FG000|Overall Study|Adverse Event|1|||
161015933|NCT05536440|581447789|FG000|Overall Study|Adverse Event|0|||
161015934|NCT05536440|581447790|FG001|Overall Study|Adverse Event|0|||
161015935|NCT05536440|581447791|FG002|Overall Study|Adverse Event|0|||
161015936|NCT05536440|581447792|FG003|Overall Study|Adverse Event|0|||
161015937|NCT05536440|581447793|FG004|Overall Study|Adverse Event|0|||
160459302|NCT03279978|579414247|FG004|Overall Study|Lost to Follow-up|0|||
160632905|NCT02858076|580036100|FG000|Overall Study|Completed Out of Window|1|||
161015938|NCT05536440|581447794|FG005|Overall Study|Adverse Event|0|||
161015939|NCT05536440|581447795|FG006|Overall Study|Adverse Event|0|||
161015940|NCT05536440|581447796|FG007|Overall Study|Adverse Event|0|||
161015941|NCT05536440|581447797|FG008|Overall Study|Adverse Event|1|||
161015942|NCT01566695|581447800|FG000|Overall Study|Lack of Efficacy|1|||
161015943|NCT01566695|581447801|FG001|Overall Study|Lack of Efficacy|0|||
161015944|NCT01566695|581447800|FG000|Overall Study|Adverse Event|3|||
161015945|NCT01566695|581447801|FG001|Overall Study|Adverse Event|0|||
161015946|NCT01566695|581447800|FG000|Overall Study|Death|79|||
161015947|NCT01566695|581447801|FG001|Overall Study|Death|86|||
161015948|NCT01566695|581447800|FG000|Overall Study|Withdrawal by Subject|13|||
161015949|NCT01566695|581447801|FG001|Overall Study|Withdrawal by Subject|12|||
161015950|NCT01566695|581447800|FG000|Overall Study|Lost to Follow-up|0|||
161015951|NCT01566695|581447801|FG001|Overall Study|Lost to Follow-up|3|||
161015952|NCT01566695|581447800|FG000|Overall Study|Other reasons|11|||
161015953|NCT01566695|581447801|FG001|Overall Study|Other reasons|8|||
161015954|NCT01416831|581447803|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
161015955|NCT01416831|581447804|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
161015956|NCT04784559|581447805|FG000|Overall Study|Withdrawal by Subject|3|||
161015957|NCT04784559|581447806|FG001|Overall Study|Withdrawal by Subject|2|||
161015958|NCT04784559|581447807|FG002|Overall Study|Withdrawal by Subject|1|||
161015959|NCT04784559|581447805|FG000|Overall Study|Death|2|||
161015960|NCT04784559|581447806|FG001|Overall Study|Death|1|||
161015961|NCT04784559|581447807|FG002|Overall Study|Death|2|||
161015962|NCT04784559|581447805|FG000|Overall Study|Lost to Follow-up|0|||
161015963|NCT04784559|581447806|FG001|Overall Study|Lost to Follow-up|0|||
161015964|NCT04784559|581447807|FG002|Overall Study|Lost to Follow-up|2|||
161015965|NCT04784559|581447805|FG000|Overall Study|Participant worsened, PI decision|1|||
161015966|NCT04784559|581447806|FG001|Overall Study|Participant worsened, PI decision|0|||
161015967|NCT04784559|581447807|FG002|Overall Study|Participant worsened, PI decision|0|||
161015968|NCT04784559|581447805|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
161015969|NCT04784559|581447806|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
161015970|NCT04784559|581447807|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
161015971|NCT04784559|581447805|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
161015972|NCT04784559|581447806|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
161015973|NCT04784559|581447807|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
161015974|NCT04784559|581447805|FG000|Overall Study|Did not meet all inclusion criteria|0|||
161015975|NCT04784559|581447806|FG001|Overall Study|Did not meet all inclusion criteria|1|||
161015976|NCT04784559|581447807|FG002|Overall Study|Did not meet all inclusion criteria|0|||
161015977|NCT04784559|581447805|FG000|Overall Study|The participant was transferred to IRCU|0|||
161015978|NCT04784559|581447806|FG001|Overall Study|The participant was transferred to IRCU|1|||
161015979|NCT04784559|581447807|FG002|Overall Study|The participant was transferred to IRCU|0|||
161015980|NCT04784559|581447805|FG000|Overall Study|SAE|0|||
161015981|NCT04784559|581447806|FG001|Overall Study|SAE|1|||
161015982|NCT04784559|581447807|FG002|Overall Study|SAE|0|||
161015983|NCT04784559|581447805|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
161015984|NCT04784559|581447806|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
161015985|NCT04784559|581447807|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
161015986|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
161015987|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
161015988|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
161015989|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015990|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015991|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015992|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015993|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015994|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015995|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015996|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015997|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015998|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015999|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
161016000|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
161016001|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016002|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016003|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016004|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016005|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016006|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016007|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016008|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016009|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016010|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016011|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016012|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
161016013|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
161016014|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016015|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016016|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016017|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016018|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016019|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016020|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016021|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016022|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016023|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016024|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016025|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
161016026|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
161016027|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016028|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016029|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016030|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016031|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016032|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016033|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016034|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016035|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016036|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016037|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016038|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
161016039|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
161016040|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
161016041|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016042|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016043|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016044|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016045|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016046|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016047|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016048|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016049|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016050|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016051|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
161016052|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
161016053|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
161016054|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016055|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016056|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016057|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016058|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016059|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016060|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016061|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016062|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016063|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016064|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
161016065|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016066|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
161016067|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016068|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016069|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016070|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016071|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016072|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016073|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016074|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016075|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016076|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016077|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016078|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016079|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016080|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
161016081|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
161016082|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
161016083|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016084|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016085|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016086|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016087|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016088|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016089|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016090|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016091|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016092|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016093|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016094|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
161016095|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
161016096|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016097|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016098|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016099|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016100|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016101|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016102|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016103|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016104|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016105|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016106|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016107|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
161016108|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
161016109|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016110|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016111|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016112|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016113|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016114|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016115|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016116|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016117|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016118|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016119|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
161016120|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
161016121|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
161016122|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016123|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016124|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016125|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016126|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016127|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016128|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016129|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016130|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016131|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016132|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016133|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016134|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
161016135|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016136|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016137|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016138|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016139|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016140|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016141|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016142|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016143|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016144|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016145|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
161016146|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
161016147|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
161016148|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016149|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016150|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016151|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016152|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016153|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016154|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016155|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016156|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016157|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016158|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
161016159|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
161016160|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
161016161|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016162|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016163|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016164|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016165|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016166|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016167|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016168|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016169|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016170|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016171|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016172|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016173|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016174|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
161016175|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
161016176|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
161016177|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016178|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016179|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016180|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016181|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016182|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016183|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016184|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016185|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016186|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016187|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016188|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
161016189|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
161016190|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016191|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016192|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016193|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016194|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016195|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016196|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016197|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016198|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016199|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016200|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
161016201|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
161016202|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
161016203|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016204|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016205|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016206|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016207|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
161016208|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
161016209|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
161016210|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
161016211|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
160632906|NCT02858076|580036101|FG001|Overall Study|Completed Out of Window|3|||
161016212|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
161016213|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
161016214|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
161016215|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
161016216|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
160657059|NCT02327130|580124522|FG000|Overall Study|Physician Decision|2|||
161016217|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
161016218|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
161016219|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
161016220|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016221|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016222|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016223|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016224|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016225|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016226|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
161016227|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
161016228|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
161016229|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016230|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016231|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016232|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016233|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016234|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016235|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016236|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016237|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016238|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016239|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
161016240|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
161016241|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
161016242|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016243|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016244|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016245|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016246|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016247|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016248|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016249|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016250|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016251|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016252|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
161016253|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
161016254|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
161016255|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016256|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016257|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016258|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016259|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016260|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016261|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016262|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016263|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016264|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016265|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016266|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016267|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016268|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
161016269|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
161016270|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
161016271|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
161016272|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016273|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
160459303|NCT03279978|579414248|FG005|Overall Study|Lost to Follow-up|0|||
161016274|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016275|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016276|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016277|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016278|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016279|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016280|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016281|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
161016282|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016283|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
161016284|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
161016285|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016286|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016287|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016288|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016289|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016290|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016291|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016292|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016293|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016294|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
161016295|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
161016296|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
161016297|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
161016298|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016299|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016300|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016301|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016302|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016303|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016304|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016305|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016306|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016307|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
161016308|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
161016309|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
161016310|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
161016311|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016312|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016313|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016314|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016315|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016316|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016317|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016318|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016319|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016320|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
161016321|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
161016322|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
161016323|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
161016324|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016325|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016326|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016327|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016328|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016329|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016330|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
160586546|NCT00782418|579865702|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
160586547|NCT00782418|579865703|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
160586548|NCT00782418|579865704|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
160586549|NCT00882999|579865705|FG000|Overall Study|Adverse Event|0|||
160586550|NCT00882999|579865706|FG001|Overall Study|Adverse Event|0|||
160586551|NCT00882999|579865707|FG002|Overall Study|Adverse Event|0|||
160459304|NCT03279978|579414249|FG006|Overall Study|Lost to Follow-up|0|||
160586552|NCT00882999|579865708|FG003|Overall Study|Adverse Event|0|||
161016331|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016332|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016333|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
161016334|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
161016335|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
161016336|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
161016337|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016338|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016339|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016340|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016341|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016342|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016343|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016344|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016345|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016346|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
161016347|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
161016348|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
161016349|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
161016350|NCT03336333|581447821|FG000|Overall Study|Remained on study at time of data cut-off|202|||
161016351|NCT03336333|581447822|FG001|Overall Study|Remained on study at time of data cut-off|219|||
161016352|NCT03336333|581447823|FG002|Overall Study|Remained on study at time of data cut-off|102|||
161016353|NCT03336333|581447821|FG000|Overall Study|Death|14|||
161016354|NCT03336333|581447822|FG001|Overall Study|Death|16|||
161016355|NCT03336333|581447823|FG002|Overall Study|Death|8|||
161016356|NCT03336333|581447821|FG000|Overall Study|Withdrawal by Subject|16|||
161016357|NCT03336333|581447822|FG001|Overall Study|Withdrawal by Subject|5|||
161016358|NCT03336333|581447823|FG002|Overall Study|Withdrawal by Subject|1|||
161016359|NCT03336333|581447821|FG000|Overall Study|Physician Decision|5|||
161016360|NCT03336333|581447822|FG001|Overall Study|Physician Decision|1|||
161016361|NCT03336333|581447823|FG002|Overall Study|Physician Decision|0|||
161016362|NCT03336333|581447821|FG000|Overall Study|Lost to Follow-up|1|||
161016363|NCT03336333|581447822|FG001|Overall Study|Lost to Follow-up|0|||
161016364|NCT03336333|581447823|FG002|Overall Study|Lost to Follow-up|0|||
161016365|NCT00931710|581447826|FG000|Overall Study|Adverse Event|16|||
161016366|NCT00931710|581447827|FG001|Overall Study|Adverse Event|10|||
161016367|NCT00931710|581447826|FG000|Overall Study|Abnormal test procedure results|2|||
161016368|NCT00931710|581447827|FG001|Overall Study|Abnormal test procedure results|0|||
161016369|NCT00931710|581447826|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
161016370|NCT00931710|581447827|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
161016371|NCT00931710|581447826|FG000|Overall Study|Patient withdrew consent|4|||
161016372|NCT00931710|581447827|FG001|Overall Study|Patient withdrew consent|9|||
161016373|NCT00931710|581447826|FG000|Overall Study|Lost to Follow-up|6|||
161016374|NCT00931710|581447827|FG001|Overall Study|Lost to Follow-up|5|||
161016375|NCT00931710|581447826|FG000|Overall Study|Protocol deviation|1|||
161016376|NCT00931710|581447827|FG001|Overall Study|Protocol deviation|2|||
161016377|NCT03338790|581447833|FG000|Overall Study|Disease Progression|65|||
161016378|NCT03338790|581447834|FG001|Overall Study|Disease Progression|43|||
161016379|NCT03338790|581447835|FG002|Overall Study|Disease Progression|50|||
161016380|NCT03338790|581447836|FG003|Overall Study|Disease Progression|37|||
161016381|NCT03338790|581447833|FG000|Overall Study|Study Drug Toxicity|9|||
161016382|NCT03338790|581447834|FG001|Overall Study|Study Drug Toxicity|8|||
161016383|NCT03338790|581447835|FG002|Overall Study|Study Drug Toxicity|15|||
161016384|NCT03338790|581447836|FG003|Overall Study|Study Drug Toxicity|0|||
161016385|NCT03338790|581447833|FG000|Overall Study|Death|1|||
161016386|NCT03338790|581447834|FG001|Overall Study|Death|1|||
161016387|NCT03338790|581447835|FG002|Overall Study|Death|1|||
161016388|NCT03338790|581447836|FG003|Overall Study|Death|0|||
161016389|NCT03338790|581447833|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
161016390|NCT03338790|581447834|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
161016391|NCT03338790|581447835|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
161016392|NCT03338790|581447836|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
161016393|NCT03338790|581447833|FG000|Overall Study|Participant request to discontinue study treatment|3|||
161016394|NCT03338790|581447834|FG001|Overall Study|Participant request to discontinue study treatment|3|||
161016395|NCT03338790|581447835|FG002|Overall Study|Participant request to discontinue study treatment|2|||
161016396|NCT03338790|581447836|FG003|Overall Study|Participant request to discontinue study treatment|1|||
161016397|NCT03338790|581447833|FG000|Overall Study|Poor/non-compliance|0|||
161016398|NCT03338790|581447834|FG001|Overall Study|Poor/non-compliance|1|||
161016399|NCT03338790|581447835|FG002|Overall Study|Poor/non-compliance|0|||
161016400|NCT03338790|581447836|FG003|Overall Study|Poor/non-compliance|0|||
161016401|NCT03338790|581447833|FG000|Overall Study|Participant withdrew consent|1|||
161016402|NCT03338790|581447834|FG001|Overall Study|Participant withdrew consent|0|||
161016403|NCT03338790|581447835|FG002|Overall Study|Participant withdrew consent|1|||
161016404|NCT03338790|581447836|FG003|Overall Study|Participant withdrew consent|1|||
161016405|NCT03338790|581447833|FG000|Overall Study|Other reasons|0|||
161016406|NCT03338790|581447834|FG001|Overall Study|Other reasons|5|||
161016407|NCT03338790|581447835|FG002|Overall Study|Other reasons|0|||
161016408|NCT03338790|581447836|FG003|Overall Study|Other reasons|2|||
161016409|NCT03338790|581447833|FG000|Overall Study|Not reported|0|||
161016410|NCT03338790|581447834|FG001|Overall Study|Not reported|0|||
161016411|NCT03338790|581447835|FG002|Overall Study|Not reported|1|||
161016412|NCT03338790|581447836|FG003|Overall Study|Not reported|0|||
161016413|NCT03338790|581447833|FG000|Overall Study|Completed treatment period|1|||
161016414|NCT03338790|581447834|FG001|Overall Study|Completed treatment period|2|||
161016415|NCT03338790|581447835|FG002|Overall Study|Completed treatment period|0|||
161016416|NCT03338790|581447836|FG003|Overall Study|Completed treatment period|0|||
161016417|NCT04588298|581447837|FG000|Overall Study|Adverse Event|0|||
161016418|NCT04588298|581447838|FG001|Overall Study|Adverse Event|0|||
161016419|NCT04588298|581447839|FG002|Overall Study|Adverse Event|1|||
161016420|NCT04588298|581447840|FG003|Overall Study|Adverse Event|0|||
161016421|NCT04588298|581447841|FG004|Overall Study|Adverse Event|2|||
161016422|NCT04588298|581447837|FG000|Overall Study|Withdrawal by Subject|1|||
161016423|NCT04588298|581447838|FG001|Overall Study|Withdrawal by Subject|0|||
161016424|NCT04588298|581447839|FG002|Overall Study|Withdrawal by Subject|0|||
161016425|NCT04588298|581447840|FG003|Overall Study|Withdrawal by Subject|1|||
161016426|NCT04588298|581447841|FG004|Overall Study|Withdrawal by Subject|0|||
161016427|NCT02281955|581447842|FG000|Overall Study|Death|1|||
161016428|NCT03892616|581447843|FG000|Washout Period 2|Met discontinuation criterion|0|||
161016429|NCT03892616|581447844|FG001|Washout Period 2|Met discontinuation criterion|0|||
161016430|NCT03892616|581447845|FG002|Washout Period 2|Met discontinuation criterion|0|||
160459305|NCT03279978|579414250|FG007|Overall Study|Lost to Follow-up|0|||
160459306|NCT03279978|579414251|FG008|Overall Study|Lost to Follow-up|0|||
160459307|NCT03279978|579414252|FG009|Overall Study|Lost to Follow-up|0|||
160459308|NCT03279978|579414243|FG000|Overall Study|Other than stated above|0|||
160459309|NCT03279978|579414244|FG001|Overall Study|Other than stated above|0|||
160459310|NCT03279978|579414245|FG002|Overall Study|Other than stated above|0|||
160459311|NCT03279978|579414246|FG003|Overall Study|Other than stated above|0|||
160459312|NCT03279978|579414247|FG004|Overall Study|Other than stated above|0|||
160459313|NCT03279978|579414248|FG005|Overall Study|Other than stated above|0|||
160459314|NCT03279978|579414249|FG006|Overall Study|Other than stated above|1|||
160459315|NCT03279978|579414250|FG007|Overall Study|Other than stated above|0|||
160459316|NCT03279978|579414251|FG008|Overall Study|Other than stated above|0|||
160459317|NCT03279978|579414252|FG009|Overall Study|Other than stated above|0|||
160459318|NCT04159519|579414253|FG000|Overall Study|Adverse Event|1|||
160459319|NCT04159519|579414254|FG001|Overall Study|Adverse Event|1|||
160459320|NCT04159519|579414253|FG000|Overall Study|Lack of Efficacy|1|||
160459321|NCT04159519|579414254|FG001|Overall Study|Lack of Efficacy|0|||
160459322|NCT04159519|579414253|FG000|Overall Study|Discontinued from study|1|||
161016431|NCT03892616|581447846|FG003|Washout Period 2|Met discontinuation criterion|0|||
161016432|NCT03892616|581447847|FG004|Washout Period 2|Met discontinuation criterion|0|||
161016433|NCT03892616|581447848|FG005|Washout Period 2|Met discontinuation criterion|0|||
161016434|NCT03892616|581447849|FG006|Washout Period 2|Met discontinuation criterion|0|||
161016435|NCT03892616|581447850|FG007|Washout Period 2|Met discontinuation criterion|0|||
161016436|NCT03892616|581447851|FG008|Washout Period 2|Met discontinuation criterion|1|||
161016437|NCT03892616|581447852|FG009|Washout Period 2|Met discontinuation criterion|0|||
161016438|NCT03892616|581447853|FG010|Washout Period 2|Met discontinuation criterion|0|||
161016439|NCT03892616|581447854|FG011|Washout Period 2|Met discontinuation criterion|0|||
161016440|NCT03683719|581447855|FG000|Overall Study|Lack of Efficacy|1|||
161016441|NCT03683719|581447856|FG001|Overall Study|Lack of Efficacy|3|||
161016442|NCT03683719|581447857|FG002|Overall Study|Lack of Efficacy|4|||
161016443|NCT03683719|581447858|FG003|Overall Study|Lack of Efficacy|0|||
161016444|NCT03683719|581447859|FG004|Overall Study|Lack of Efficacy|4|||
161016445|NCT03683719|581447855|FG000|Overall Study|Adverse Event|6|||
161016446|NCT03683719|581447856|FG001|Overall Study|Adverse Event|6|||
161016447|NCT03683719|581447857|FG002|Overall Study|Adverse Event|0|||
161016448|NCT03683719|581447858|FG003|Overall Study|Adverse Event|1|||
161016449|NCT03683719|581447859|FG004|Overall Study|Adverse Event|3|||
161016450|NCT03683719|581447855|FG000|Overall Study|Withdrawal by Subject|4|||
161016451|NCT03683719|581447856|FG001|Overall Study|Withdrawal by Subject|4|||
160459323|NCT04159519|579414254|FG001|Overall Study|Discontinued from study|0|||
160459324|NCT04159519|579414253|FG000|Overall Study|Protocol Violation|1|||
160459325|NCT04159519|579414254|FG001|Overall Study|Protocol Violation|1|||
160459326|NCT04159519|579414253|FG000|Overall Study|Withdrawal by Subject|4|||
160459327|NCT04159519|579414254|FG001|Overall Study|Withdrawal by Subject|4|||
161016452|NCT03683719|581447857|FG002|Overall Study|Withdrawal by Subject|3|||
161016453|NCT03683719|581447858|FG003|Overall Study|Withdrawal by Subject|5|||
161016454|NCT03683719|581447859|FG004|Overall Study|Withdrawal by Subject|5|||
161016455|NCT03683719|581447855|FG000|Overall Study|Lost to Follow-up|1|||
161016456|NCT03683719|581447856|FG001|Overall Study|Lost to Follow-up|0|||
161016457|NCT03683719|581447857|FG002|Overall Study|Lost to Follow-up|0|||
161016458|NCT03683719|581447858|FG003|Overall Study|Lost to Follow-up|1|||
161016459|NCT03683719|581447859|FG004|Overall Study|Lost to Follow-up|1|||
161016460|NCT03683719|581447855|FG000|Overall Study|Other personal reasons|0|||
161016461|NCT03683719|581447856|FG001|Overall Study|Other personal reasons|0|||
161016462|NCT03683719|581447857|FG002|Overall Study|Other personal reasons|1|||
161016463|NCT03683719|581447858|FG003|Overall Study|Other personal reasons|0|||
161016464|NCT03683719|581447859|FG004|Overall Study|Other personal reasons|1|||
161016465|NCT00601900|581447860|FG000|Overall Study|Withdrawal by Subject|0|||
161016466|NCT00601900|581447861|FG001|Overall Study|Withdrawal by Subject|3|||
161016467|NCT03924986|581447862|FG000|Overall Study|Death|57|||
161016468|NCT03924986|581447863|FG001|Overall Study|Death|66|||
161016469|NCT03924986|581447862|FG000|Overall Study|Study Concluded by Sponsor|51|||
161016470|NCT03924986|581447863|FG001|Overall Study|Study Concluded by Sponsor|41|||
161016471|NCT03924986|581447862|FG000|Overall Study|Withdrawal by Subject|15|||
161016472|NCT03924986|581447863|FG001|Overall Study|Withdrawal by Subject|20|||
161016473|NCT03924986|581447862|FG000|Overall Study|Lost to Follow-up|7|||
161016474|NCT03924986|581447863|FG001|Overall Study|Lost to Follow-up|5|||
161016475|NCT03924986|581447862|FG000|Overall Study|Miscellaneous|1|||
161016476|NCT03924986|581447863|FG001|Overall Study|Miscellaneous|0|||
161016477|NCT02689284|581447869|FG000|Overall Study|Adverse Event|1|||
161016478|NCT02689284|581447870|FG001|Overall Study|Adverse Event|8|||
161016479|NCT02689284|581447869|FG000|Overall Study|Death|0|||
161016480|NCT02689284|581447870|FG001|Overall Study|Death|1|||
161016481|NCT02689284|581447869|FG000|Overall Study|Physician Decision|1|||
161016482|NCT02689284|581447870|FG001|Overall Study|Physician Decision|2|||
161016483|NCT02689284|581447869|FG000|Overall Study|Withdrawal by Subject|0|||
161016484|NCT02689284|581447870|FG001|Overall Study|Withdrawal by Subject|1|||
161016485|NCT02689284|581447869|FG000|Overall Study|progression of cancer|1|||
161016486|NCT02689284|581447870|FG001|Overall Study|progression of cancer|72|||
161016487|NCT02689284|581447869|FG000|Overall Study|decreased heart function|0|||
161016488|NCT02689284|581447870|FG001|Overall Study|decreased heart function|1|||
161016489|NCT02689284|581447869|FG000|Overall Study|concern for anemia|0|||
161016490|NCT02689284|581447870|FG001|Overall Study|concern for anemia|1|||
161016491|NCT02689284|581447869|FG000|Overall Study|no measurable cancer for evaluation|0|||
161016492|NCT02689284|581447870|FG001|Overall Study|no measurable cancer for evaluation|1|||
161016493|NCT05569252|581447871|FG000|Overall Study|Adverse event (central vision loss)|1|||
161016494|NCT05569252|581447872|FG001|Overall Study|Adverse event (central vision loss)|0|||
161016495|NCT05569252|581447873|FG002|Overall Study|Adverse event (central vision loss)|0|||
161016496|NCT05569252|581447874|FG003|Overall Study|Adverse event (central vision loss)|0|||
161016497|NCT03665597|581447875|FG000|Period 1|Adverse Event|1|||
161016498|NCT03665597|581447876|FG001|Period 1|Adverse Event|0|||
161016499|NCT03665597|581447877|FG002|Period 1|Adverse Event|0|||
161016500|NCT03665597|581447878|FG003|Period 1|Adverse Event|1|||
160459328|NCT03493542|579414257|FG000|Base Study|Withdrawal by Subject|0|||
160459329|NCT03493542|579414258|FG001|Base Study|Withdrawal by Subject|4|||
160459330|NCT03493542|579414259|FG002|Base Study|Withdrawal by Subject|0|||
160459331|NCT03493542|579414257|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
160459332|NCT03493542|579414258|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
160459333|NCT03493542|579414259|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
160459334|NCT03493542|579414257|FG000|Extension Study|Withdrawal by Subject|0|||
160459335|NCT03493542|579414258|FG001|Extension Study|Withdrawal by Subject|0|||
160459336|NCT03493542|579414259|FG002|Extension Study|Withdrawal by Subject|25|||
160459337|NCT01651000|579414263|FG000|Overall Study|Adverse Event|2|||
160459338|NCT01651000|579414264|FG001|Overall Study|Adverse Event|8|||
160459339|NCT01651000|579414263|FG000|Overall Study|Lost to Follow-up|3|||
160459340|NCT01651000|579414264|FG001|Overall Study|Lost to Follow-up|2|||
160459341|NCT01651000|579414263|FG000|Overall Study|Protocol Violation|0|||
160459342|NCT01651000|579414264|FG001|Overall Study|Protocol Violation|3|||
160459343|NCT01651000|579414263|FG000|Overall Study|Withdrawal by Subject|2|||
160459344|NCT01651000|579414264|FG001|Overall Study|Withdrawal by Subject|10|||
160459345|NCT01651000|579414263|FG000|Overall Study|Subject noncompliance|0|||
160459346|NCT01651000|579414264|FG001|Overall Study|Subject noncompliance|3|||
160657060|NCT02327130|580124522|FG000|Overall Study|Unable to provide breath sample|1|||
160459347|NCT01651000|579414263|FG000|Overall Study|Lack of Efficacy|1|||
160459348|NCT01651000|579414264|FG001|Overall Study|Lack of Efficacy|1|||
160459349|NCT01651000|579414263|FG000|Overall Study|Physician Decision|1|||
160459350|NCT01651000|579414264|FG001|Overall Study|Physician Decision|0|||
161016501|NCT03665597|581447879|FG004|Period 1|Adverse Event|0|||
161016502|NCT03665597|581447880|FG005|Period 1|Adverse Event|0|||
161016503|NCT03665597|581447881|FG006|Period 1|Adverse Event|0|||
161016504|NCT03665597|581447875|FG000|Period 1|Screen Failure|0|||
161016505|NCT03665597|581447876|FG001|Period 1|Screen Failure|0|||
161016506|NCT03665597|581447877|FG002|Period 1|Screen Failure|0|||
161016507|NCT03665597|581447878|FG003|Period 1|Screen Failure|1|||
161016508|NCT03665597|581447879|FG004|Period 1|Screen Failure|0|||
161016509|NCT03665597|581447880|FG005|Period 1|Screen Failure|0|||
161016510|NCT03665597|581447881|FG006|Period 1|Screen Failure|0|||
161016511|NCT03665597|581447875|FG000|Period 1|Death|0|||
161016512|NCT03665597|581447876|FG001|Period 1|Death|0|||
161016513|NCT03665597|581447877|FG002|Period 1|Death|0|||
161016514|NCT03665597|581447878|FG003|Period 1|Death|0|||
161016515|NCT03665597|581447879|FG004|Period 1|Death|0|||
161016516|NCT03665597|581447880|FG005|Period 1|Death|0|||
161016517|NCT03665597|581447881|FG006|Period 1|Death|45|||
161016518|NCT03665597|581447875|FG000|Period 1|Withdrawal by Subject|0|||
161016519|NCT03665597|581447876|FG001|Period 1|Withdrawal by Subject|0|||
161016520|NCT03665597|581447877|FG002|Period 1|Withdrawal by Subject|0|||
161016521|NCT03665597|581447878|FG003|Period 1|Withdrawal by Subject|0|||
161016522|NCT03665597|581447879|FG004|Period 1|Withdrawal by Subject|0|||
161016523|NCT03665597|581447880|FG005|Period 1|Withdrawal by Subject|0|||
161016524|NCT03665597|581447881|FG006|Period 1|Withdrawal by Subject|5|||
161016525|NCT03665597|581447875|FG000|Period 2|Adverse Event|0|||
161016526|NCT03665597|581447876|FG001|Period 2|Adverse Event|0|||
161016527|NCT03665597|581447877|FG002|Period 2|Adverse Event|0|||
161016528|NCT03665597|581447878|FG003|Period 2|Adverse Event|0|||
161016529|NCT03665597|581447879|FG004|Period 2|Adverse Event|0|||
161016530|NCT03665597|581447880|FG005|Period 2|Adverse Event|1|||
161016531|NCT03665597|581447881|FG006|Period 2|Adverse Event|0|||
161016532|NCT03665597|581447875|FG000|Period 3|Adverse Event|0|||
161016533|NCT03665597|581447876|FG001|Period 3|Adverse Event|1|||
161016534|NCT03665597|581447877|FG002|Period 3|Adverse Event|0|||
161016535|NCT03665597|581447878|FG003|Period 3|Adverse Event|0|||
161016536|NCT03665597|581447879|FG004|Period 3|Adverse Event|0|||
161016537|NCT03665597|581447880|FG005|Period 3|Adverse Event|0|||
161016538|NCT03665597|581447881|FG006|Period 3|Adverse Event|0|||
161016539|NCT03665597|581447875|FG000|Period 3|Death|0|||
161016540|NCT03665597|581447876|FG001|Period 3|Death|0|||
161016541|NCT03665597|581447877|FG002|Period 3|Death|0|||
161016542|NCT03665597|581447878|FG003|Period 3|Death|0|||
161016543|NCT03665597|581447879|FG004|Period 3|Death|1|||
161016544|NCT03665597|581447880|FG005|Period 3|Death|0|||
161016545|NCT03665597|581447881|FG006|Period 3|Death|0|||
161016546|NCT03665597|581447875|FG000|Period 4|Adverse Event|2|||
161016547|NCT03665597|581447876|FG001|Period 4|Adverse Event|2|||
161016548|NCT03665597|581447877|FG002|Period 4|Adverse Event|2|||
161016549|NCT03665597|581447878|FG003|Period 4|Adverse Event|2|||
161016550|NCT03665597|581447879|FG004|Period 4|Adverse Event|1|||
161016551|NCT03665597|581447880|FG005|Period 4|Adverse Event|0|||
161016552|NCT03665597|581447881|FG006|Period 4|Adverse Event|0|||
161016553|NCT03665597|581447875|FG000|Period 4|Death|0|||
161016554|NCT03665597|581447876|FG001|Period 4|Death|0|||
161016555|NCT03665597|581447877|FG002|Period 4|Death|2|||
161016556|NCT03665597|581447878|FG003|Period 4|Death|0|||
161016557|NCT03665597|581447879|FG004|Period 4|Death|0|||
161016558|NCT03665597|581447880|FG005|Period 4|Death|0|||
161016559|NCT03665597|581447881|FG006|Period 4|Death|0|||
161016560|NCT03665597|581447875|FG000|Period 4|Physician Decision|1|||
161016561|NCT03665597|581447876|FG001|Period 4|Physician Decision|2|||
161016562|NCT03665597|581447877|FG002|Period 4|Physician Decision|0|||
161016563|NCT03665597|581447878|FG003|Period 4|Physician Decision|0|||
161016564|NCT03665597|581447879|FG004|Period 4|Physician Decision|0|||
161016565|NCT03665597|581447880|FG005|Period 4|Physician Decision|0|||
161016566|NCT03665597|581447881|FG006|Period 4|Physician Decision|0|||
161016567|NCT05516147|581447882|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
161016568|NCT05371652|581447886|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
161016569|NCT05371652|581447886|FG000|Overall Study|Withdrawal by Subject|12|||
161016570|NCT05371652|581447886|FG000|Overall Study|Adverse Event|1|||
161016571|NCT05371652|581447886|FG000|Overall Study|Other|11|||
161016572|NCT05256706|581447887|FG000|Overall Study|Lost to Follow-up|9|||
161016573|NCT05256706|581447888|FG001|Overall Study|Lost to Follow-up|3|||
161016574|NCT05256706|581447887|FG000|Overall Study|Withdrawal by Subject|7|||
161016575|NCT05256706|581447888|FG001|Overall Study|Withdrawal by Subject|11|||
161016576|NCT05256706|581447887|FG000|Overall Study|Screen Failures|3|||
161016577|NCT05256706|581447888|FG001|Overall Study|Screen Failures|0|||
161016578|NCT04410042|581447890|FG000|Overall Study|Not Eligible|1|||
161016579|NCT04410042|581447891|FG001|Overall Study|Not Eligible|1|||
161016580|NCT01494662|581447892|FG000|Overall Study|Withdrawal by Subject|0|||
161016581|NCT01494662|581447893|FG001|Overall Study|Withdrawal by Subject|0|||
161016582|NCT01494662|581447894|FG002|Overall Study|Withdrawal by Subject|1|||
161016583|NCT01494662|581447895|FG003|Overall Study|Withdrawal by Subject|0|||
161016584|NCT01494662|581447896|FG004|Overall Study|Withdrawal by Subject|0|||
161016585|NCT01494662|581447897|FG005|Overall Study|Withdrawal by Subject|0|||
161016586|NCT01494662|581447898|FG006|Overall Study|Withdrawal by Subject|0|||
161016587|NCT01494662|581447892|FG000|Overall Study|Physician Decision|0|||
161016588|NCT01494662|581447893|FG001|Overall Study|Physician Decision|0|||
161016589|NCT01494662|581447894|FG002|Overall Study|Physician Decision|1|||
161016590|NCT01494662|581447895|FG003|Overall Study|Physician Decision|0|||
161016591|NCT01494662|581447896|FG004|Overall Study|Physician Decision|0|||
161016592|NCT01494662|581447897|FG005|Overall Study|Physician Decision|0|||
161016593|NCT01494662|581447898|FG006|Overall Study|Physician Decision|0|||
161016594|NCT03302494|581447899|FG000|Overall Study|Other|7|||
161016595|NCT03302494|581447900|FG001|Overall Study|Other|4|||
161016596|NCT03302494|581447901|FG002|Overall Study|Other|6|||
161016597|NCT03302494|581447899|FG000|Overall Study|Withdrawal by Subject|10|||
161016598|NCT03302494|581447900|FG001|Overall Study|Withdrawal by Subject|2|||
161016599|NCT03302494|581447901|FG002|Overall Study|Withdrawal by Subject|9|||
161016600|NCT03302494|581447899|FG000|Overall Study|Study Terminated by Sponsor|32|||
161016601|NCT03302494|581447900|FG001|Overall Study|Study Terminated by Sponsor|29|||
161016602|NCT03302494|581447901|FG002|Overall Study|Study Terminated by Sponsor|30|||
161016603|NCT03302494|581447899|FG000|Overall Study|Physician Decision|1|||
161016604|NCT03302494|581447900|FG001|Overall Study|Physician Decision|0|||
161016605|NCT03302494|581447901|FG002|Overall Study|Physician Decision|1|||
161016606|NCT03302494|581447899|FG000|Overall Study|Lost to Follow-up|1|||
161016607|NCT03302494|581447900|FG001|Overall Study|Lost to Follow-up|3|||
161016608|NCT03302494|581447901|FG002|Overall Study|Lost to Follow-up|3|||
161016609|NCT03302494|581447899|FG000|Overall Study|Death|13|||
161016610|NCT03302494|581447900|FG001|Overall Study|Death|11|||
161016611|NCT03302494|581447901|FG002|Overall Study|Death|4|||
161016612|NCT03302494|581447899|FG000|Overall Study|Adverse Event|1|||
161016613|NCT03302494|581447900|FG001|Overall Study|Adverse Event|2|||
161016614|NCT03302494|581447901|FG002|Overall Study|Adverse Event|0|||
161016615|NCT03302494|581447899|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
161016616|NCT03302494|581447900|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
161016617|NCT03302494|581447901|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
161016618|NCT02596126|581447910|FG000|Overall Study|Lost to Follow-up|12|||
161016619|NCT02596126|581447911|FG001|Overall Study|Lost to Follow-up|21|||
161016620|NCT02596126|581447910|FG000|Overall Study|Protocol Violation|7|||
161016621|NCT02596126|581447911|FG001|Overall Study|Protocol Violation|9|||
161016622|NCT00753090|581449444|FG000|Overall Study|Withdrawal by Subject|10|||
161016623|NCT00753090|581449445|FG001|Overall Study|Withdrawal by Subject|10|||
161016624|NCT00753090|581449444|FG000|Overall Study|Death|17|||
161016625|NCT00753090|581449445|FG001|Overall Study|Death|6|||
161016626|NCT00753090|581449444|FG000|Overall Study|Study Prosthesis Removed|12|||
161016627|NCT00753090|581449445|FG001|Overall Study|Study Prosthesis Removed|3|||
161016628|NCT00753090|581449444|FG000|Overall Study|Lost to Follow-up|2|||
161016629|NCT00753090|581449445|FG001|Overall Study|Lost to Follow-up|2|||
161016630|NCT00753090|581449444|FG000|Overall Study|Other|127|||
161016631|NCT00753090|581449445|FG001|Overall Study|Other|75|||
161016632|NCT05113966|581449448|FG000|Overall Study|Death|21|||
161016633|NCT05113966|581449448|FG000|Overall Study|Study Terminated by Sponsor|9|||
161016634|NCT04521478|581449449|FG000|Overall Study|Protocol Violation|2|||
161016635|NCT04521478|581449450|FG001|Overall Study|Protocol Violation|0|||
161016636|NCT04521478|581449451|FG002|Overall Study|Protocol Violation|1|||
161016637|NCT04521478|581449452|FG003|Overall Study|Protocol Violation|0|||
161016638|NCT04521478|581449453|FG004|Overall Study|Protocol Violation|0|||
161016639|NCT04521478|581449454|FG005|Overall Study|Protocol Violation|0|||
161016640|NCT04521478|581449449|FG000|Overall Study|Technical Problems|0|||
161016641|NCT04521478|581449450|FG001|Overall Study|Technical Problems|0|||
161016642|NCT04521478|581449451|FG002|Overall Study|Technical Problems|0|||
161016643|NCT04521478|581449452|FG003|Overall Study|Technical Problems|1|||
161016644|NCT04521478|581449453|FG004|Overall Study|Technical Problems|0|||
161016645|NCT04521478|581449454|FG005|Overall Study|Technical Problems|0|||
161016646|NCT04521478|581449449|FG000|Overall Study|Burden of Study Procedures|1|||
161016647|NCT04521478|581449450|FG001|Overall Study|Burden of Study Procedures|0|||
161016648|NCT04521478|581449451|FG002|Overall Study|Burden of Study Procedures|0|||
161016649|NCT04521478|581449452|FG003|Overall Study|Burden of Study Procedures|1|||
161016650|NCT04521478|581449453|FG004|Overall Study|Burden of Study Procedures|0|||
160459351|NCT01651000|579414263|FG000|Overall Study|Administrative reason|1|||
160459352|NCT01651000|579414264|FG001|Overall Study|Administrative reason|0|||
160459353|NCT01651000|579414263|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
160459354|NCT01651000|579414264|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
160459355|NCT04595331|579414969|FG000|Overall Study|Withdrawal by Subject|0|||
161016651|NCT04521478|581449454|FG005|Overall Study|Burden of Study Procedures|1|||
161016652|NCT04521478|581449449|FG000|Overall Study|Lack of Efficacy|0|||
161016653|NCT04521478|581449450|FG001|Overall Study|Lack of Efficacy|0|||
161016654|NCT04521478|581449451|FG002|Overall Study|Lack of Efficacy|0|||
161016655|NCT04521478|581449452|FG003|Overall Study|Lack of Efficacy|0|||
161016656|NCT04521478|581449453|FG004|Overall Study|Lack of Efficacy|1|||
161016657|NCT04521478|581449454|FG005|Overall Study|Lack of Efficacy|1|||
161016658|NCT04521478|581449449|FG000|Overall Study|Adverse Event|7|||
161016659|NCT04521478|581449450|FG001|Overall Study|Adverse Event|0|||
161016660|NCT04521478|581449451|FG002|Overall Study|Adverse Event|2|||
161016661|NCT04521478|581449452|FG003|Overall Study|Adverse Event|1|||
161016662|NCT04521478|581449453|FG004|Overall Study|Adverse Event|2|||
161016663|NCT04521478|581449454|FG005|Overall Study|Adverse Event|7|||
161016664|NCT04521478|581449449|FG000|Overall Study|No Reason Available|0|||
161016665|NCT04521478|581449450|FG001|Overall Study|No Reason Available|2|||
161016666|NCT04521478|581449451|FG002|Overall Study|No Reason Available|0|||
161016667|NCT04521478|581449452|FG003|Overall Study|No Reason Available|0|||
161016668|NCT04521478|581449453|FG004|Overall Study|No Reason Available|1|||
161016669|NCT04521478|581449454|FG005|Overall Study|No Reason Available|0|||
161016670|NCT04521478|581449449|FG000|Overall Study|Other than listed|3|||
161016671|NCT04521478|581449450|FG001|Overall Study|Other than listed|3|||
161016672|NCT04521478|581449451|FG002|Overall Study|Other than listed|3|||
161016673|NCT04521478|581449452|FG003|Overall Study|Other than listed|2|||
161016674|NCT04521478|581449453|FG004|Overall Study|Other than listed|3|||
161016675|NCT04521478|581449454|FG005|Overall Study|Other than listed|3|||
161016676|NCT04521478|581449449|FG000|Overall Study|Not treated|0|||
161016677|NCT04521478|581449450|FG001|Overall Study|Not treated|0|||
161016678|NCT04521478|581449451|FG002|Overall Study|Not treated|0|||
161016679|NCT04521478|581449452|FG003|Overall Study|Not treated|0|||
161016680|NCT04521478|581449453|FG004|Overall Study|Not treated|0|||
161016681|NCT04521478|581449454|FG005|Overall Study|Not treated|1|||
161016682|NCT02630823|581449469|FG000|Overall Study|Withdrawal by Subject|1|||
161016683|NCT02630823|581449469|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
161016684|NCT02682316|581449483|FG000|Overall Study|Benign Final Pathology|27|||
161016685|NCT02682316|581449484|FG001|Overall Study|Benign Final Pathology|26|||
161016686|NCT02682316|581449483|FG000|Overall Study|Reoperation before 30 days|7|||
161016687|NCT02682316|581449484|FG001|Overall Study|Reoperation before 30 days|6|||
161016688|NCT02682316|581449483|FG000|Overall Study|Ineligible|1|||
161016689|NCT02682316|581449484|FG001|Overall Study|Ineligible|0|||
161016690|NCT02682316|581449483|FG000|Overall Study|Death|1|||
161016691|NCT02682316|581449484|FG001|Overall Study|Death|0|||
161016692|NCT02682316|581449483|FG000|Overall Study|Lost to Follow-up|7|||
161016693|NCT02682316|581449484|FG001|Overall Study|Lost to Follow-up|3|||
161016694|NCT04630262|581449486|FG000|Overall Study|Intraoperative Screen Failure|5|||
161016695|NCT04630262|581449486|FG000|Overall Study|Study terminated prematurely|71|||
161016696|NCT04630262|581449486|FG000|Overall Study|Withdrawal by Subject|2|||
161016697|NCT04630262|581449486|FG000|Overall Study|Physician Decision|2|||
161016698|NCT03692676|581449488|FG000|Overall Study|exclude patients with prior use|4424|||
161016699|NCT03692676|581449489|FG001|Overall Study|exclude patients with prior use|24726|||
161016700|NCT03692676|581449490|FG002|Overall Study|exclude patients with prior use|0|||
161016701|NCT03692676|581449491|FG003|Overall Study|exclude patients with prior use|0|||
161016702|NCT03692676|581449488|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
161016703|NCT03692676|581449489|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
161016704|NCT03692676|581449490|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
161016705|NCT03692676|581449491|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
161016706|NCT03692676|581449488|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
161016707|NCT03692676|581449489|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
161016708|NCT03692676|581449490|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
161016709|NCT03692676|581449491|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
161016710|NCT03692676|581449488|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
161016711|NCT03692676|581449489|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
161016712|NCT03692676|581449490|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
161016713|NCT03692676|581449491|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
161016714|NCT03692676|581449488|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
161016715|NCT03692676|581449489|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
161016716|NCT03692676|581449490|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
161016717|NCT03692676|581449491|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
161016718|NCT03692676|581449488|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
161016719|NCT03692676|581449489|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
161016720|NCT03692676|581449490|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
161016721|NCT03692676|581449491|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
161016722|NCT03692676|581449488|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
161016723|NCT03692676|581449489|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
161016724|NCT03692676|581449490|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
161016725|NCT03692676|581449491|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
161016726|NCT03692676|581449488|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
161016727|NCT03692676|581449489|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
161016728|NCT03692676|581449490|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
160459356|NCT04595331|579414970|FG001|Overall Study|Withdrawal by Subject|1|||
160459357|NCT04595331|579414969|FG000|Overall Study|Lost to Follow-up|0|||
160586553|NCT00882999|579865709|FG004|Overall Study|Adverse Event|1|||
160586554|NCT00882999|579865710|FG005|Overall Study|Adverse Event|0|||
161016729|NCT03692676|581449491|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
161016730|NCT03692676|581449488|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
160459358|NCT04595331|579414970|FG001|Overall Study|Lost to Follow-up|5|||
161016731|NCT03692676|581449489|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
161016732|NCT03692676|581449490|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
161016733|NCT03692676|581449491|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
161016734|NCT03692676|581449488|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
161016735|NCT03692676|581449489|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
161016736|NCT03692676|581449490|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
161016737|NCT03692676|581449491|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
161016738|NCT03692676|581449488|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
161016739|NCT03692676|581449489|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
161016740|NCT03692676|581449490|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
161016741|NCT03692676|581449491|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
161016742|NCT03692676|581449488|FG000|Overall Study|Other|0|||
161016743|NCT03692676|581449489|FG001|Overall Study|Other|805|||
161016744|NCT03692676|581449490|FG002|Overall Study|Other|758|||
161016745|NCT03692676|581449491|FG003|Overall Study|Other|277|||
161016746|NCT03692676|581449488|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
161016747|NCT03692676|581449489|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
161016748|NCT03692676|581449490|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
161016749|NCT03692676|581449491|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
161016750|NCT01180634|581449492|FG000|Overall Study|Adverse Event|4|||
161016751|NCT01180634|581449493|FG001|Overall Study|Adverse Event|1|||
161016752|NCT01180634|581449492|FG000|Overall Study|Miscellaneous|2|||
161016753|NCT01180634|581449493|FG001|Overall Study|Miscellaneous|0|||
161016754|NCT01180634|581449492|FG000|Overall Study|Withdrawal by Subject|4|||
161016755|NCT01180634|581449493|FG001|Overall Study|Withdrawal by Subject|0|||
161016756|NCT03692611|581449494|FG000|Overall Study|Found to be ineligible postrandomization|3|||
161016757|NCT03692611|581449495|FG001|Overall Study|Found to be ineligible postrandomization|0|||
161016758|NCT06311084|581449496|FG000|Overall Study|Lost to Follow-up|14|||
161016759|NCT03988634|581449497|FG000|Double-Blind|Adverse Event|4|||
161016760|NCT03988634|581449498|FG001|Double-Blind|Adverse Event|0|||
161016761|NCT03988634|581449499|FG002|Double-Blind|Adverse Event|0|||
161016762|NCT03988634|581449497|FG000|Double-Blind|Death|18|||
161016763|NCT03988634|581449498|FG001|Double-Blind|Death|26|||
161016764|NCT03988634|581449499|FG002|Double-Blind|Death|0|||
161016765|NCT03988634|581449497|FG000|Double-Blind|Lost to Follow-up|6|||
161016766|NCT03988634|581449498|FG001|Double-Blind|Lost to Follow-up|7|||
161016767|NCT03988634|581449499|FG002|Double-Blind|Lost to Follow-up|0|||
161016768|NCT03988634|581449497|FG000|Double-Blind|Physician Decision|9|||
161016769|NCT03988634|581449498|FG001|Double-Blind|Physician Decision|5|||
161016770|NCT03988634|581449499|FG002|Double-Blind|Physician Decision|0|||
161016771|NCT03988634|581449497|FG000|Double-Blind|Subject decision|24|||
161016772|NCT03988634|581449498|FG001|Double-Blind|Subject decision|13|||
161016773|NCT03988634|581449499|FG002|Double-Blind|Subject decision|0|||
161016774|NCT03988634|581449497|FG000|Open-Label|Adverse Event|0|||
161016775|NCT03988634|581449498|FG001|Open-Label|Adverse Event|0|||
161016776|NCT03988634|581449499|FG002|Open-Label|Adverse Event|7|||
161016777|NCT03988634|581449497|FG000|Open-Label|Physician Decision|0|||
161016778|NCT03988634|581449498|FG001|Open-Label|Physician Decision|0|||
161016779|NCT03988634|581449499|FG002|Open-Label|Physician Decision|1|||
161016780|NCT03988634|581449497|FG000|Open-Label|Technical problems|0|||
161016781|NCT03988634|581449498|FG001|Open-Label|Technical problems|0|||
161016782|NCT03988634|581449499|FG002|Open-Label|Technical problems|1|||
161016783|NCT04725240|581449500|FG000|Overall Study|Adverse Event|2|||
161016784|NCT04083235|581449519|FG000|Overall Study|Death|252|||
161016785|NCT04083235|581449520|FG001|Overall Study|Death|277|||
161016786|NCT04083235|581449519|FG000|Overall Study|Withdrawal by Subject|13|||
161016787|NCT04083235|581449520|FG001|Overall Study|Withdrawal by Subject|17|||
161016788|NCT04083235|581449519|FG000|Overall Study|Lost to Follow-up|1|||
161016789|NCT04083235|581449520|FG001|Overall Study|Lost to Follow-up|1|||
161016790|NCT04083235|581449519|FG000|Overall Study|Does not meet entry criteria|1|||
161016791|NCT04083235|581449520|FG001|Overall Study|Does not meet entry criteria|0|||
161016792|NCT04083235|581449519|FG000|Overall Study|Did not receive treatment|13|||
161016793|NCT04083235|581449520|FG001|Overall Study|Did not receive treatment|8|||
161016794|NCT04083235|581449519|FG000|Overall Study|Ongoing at the time of DCO|44|||
161016795|NCT04083235|581449520|FG001|Overall Study|Ongoing at the time of DCO|7|||
161016796|NCT03016169|581449523|FG000|Overall Study|Lost to Follow-up|4|||
161016797|NCT03016169|581449523|FG000|Overall Study|Death|54|||
161016798|NCT03016169|581449523|FG000|Overall Study|Device Explant|11|||
161016799|NCT03016169|581449523|FG000|Overall Study|Withdrawal by Subject|19|||
161016800|NCT03016169|581449523|FG000|Overall Study|Other Reasons|1|||
161016801|NCT04060355|581449524|FG000|Overall Study|Lost to Follow-up|41|||
160586555|NCT00882999|579865711|FG006|Overall Study|Adverse Event|0|||
160586556|NCT00882999|579865705|FG000|Overall Study|Death|0|||
160586557|NCT00882999|579865706|FG001|Overall Study|Death|1|||
160586558|NCT00882999|579865707|FG002|Overall Study|Death|0|||
160586559|NCT00882999|579865708|FG003|Overall Study|Death|0|||
160586560|NCT00882999|579865709|FG004|Overall Study|Death|0|||
160586561|NCT00882999|579865710|FG005|Overall Study|Death|0|||
160586562|NCT00882999|579865711|FG006|Overall Study|Death|0|||
160586563|NCT00882999|579865705|FG000|Overall Study|Withdrawal by Subject|7|||
160586564|NCT00882999|579865706|FG001|Overall Study|Withdrawal by Subject|6|||
160586565|NCT00882999|579865707|FG002|Overall Study|Withdrawal by Subject|3|||
160586566|NCT00882999|579865708|FG003|Overall Study|Withdrawal by Subject|3|||
160586567|NCT00882999|579865709|FG004|Overall Study|Withdrawal by Subject|6|||
160586568|NCT00882999|579865710|FG005|Overall Study|Withdrawal by Subject|5|||
160586569|NCT00882999|579865711|FG006|Overall Study|Withdrawal by Subject|5|||
160586570|NCT00882999|579865705|FG000|Overall Study|Lost to Follow-up|0|||
160586571|NCT00882999|579865706|FG001|Overall Study|Lost to Follow-up|1|||
160586572|NCT00882999|579865707|FG002|Overall Study|Lost to Follow-up|1|||
160586573|NCT00882999|579865708|FG003|Overall Study|Lost to Follow-up|2|||
160586574|NCT00882999|579865709|FG004|Overall Study|Lost to Follow-up|1|||
160586575|NCT00882999|579865710|FG005|Overall Study|Lost to Follow-up|1|||
160586576|NCT00882999|579865711|FG006|Overall Study|Lost to Follow-up|2|||
160586577|NCT00882999|579865705|FG000|Overall Study|Physician Decision|1|||
160586578|NCT00882999|579865706|FG001|Overall Study|Physician Decision|0|||
160586579|NCT00882999|579865707|FG002|Overall Study|Physician Decision|0|||
160586580|NCT00882999|579865708|FG003|Overall Study|Physician Decision|0|||
160968834|NCT00279201|581273407|FG004|Intensification Addendum|Lack of Efficacy|1|||
160968835|NCT00279201|581273408|FG005|Intensification Addendum|Lack of Efficacy|0|||
160968836|NCT00279201|581273403|FG000|Intensification Addendum|Death|0|||
160968837|NCT00279201|581273404|FG001|Intensification Addendum|Death|0|||
160968838|NCT00279201|581273405|FG002|Intensification Addendum|Death|0|||
160968839|NCT00279201|581273406|FG003|Intensification Addendum|Death|0|||
160968840|NCT00279201|581273407|FG004|Intensification Addendum|Death|1|||
160968841|NCT00279201|581273408|FG005|Intensification Addendum|Death|0|||
160968842|NCT00696384|581273419|FG000|Open Label Phase|Adverse Event|27|||
160968843|NCT00696384|581273420|FG001|Open Label Phase|Adverse Event|0|||
160968844|NCT00696384|581273421|FG002|Open Label Phase|Adverse Event|0|||
160968845|NCT00696384|581273419|FG000|Open Label Phase|Protocol Violation|18|||
160968846|NCT00696384|581273420|FG001|Open Label Phase|Protocol Violation|0|||
160968847|NCT00696384|581273421|FG002|Open Label Phase|Protocol Violation|0|||
160968848|NCT00696384|581273419|FG000|Open Label Phase|Lost to Follow-up|24|||
160968849|NCT00696384|581273420|FG001|Open Label Phase|Lost to Follow-up|0|||
160968850|NCT00696384|581273421|FG002|Open Label Phase|Lost to Follow-up|0|||
160968851|NCT00696384|581273419|FG000|Open Label Phase|Withdrawal by Subject|37|||
160968852|NCT00696384|581273420|FG001|Open Label Phase|Withdrawal by Subject|0|||
160968853|NCT00696384|581273421|FG002|Open Label Phase|Withdrawal by Subject|0|||
160968854|NCT00696384|581273419|FG000|Open Label Phase|Other|6|||
160968855|NCT00696384|581273420|FG001|Open Label Phase|Other|0|||
160968856|NCT00696384|581273421|FG002|Open Label Phase|Other|0|||
160968857|NCT00696384|581273419|FG000|Open Label Phase|Lack of Efficacy|3|||
160968858|NCT00696384|581273420|FG001|Open Label Phase|Lack of Efficacy|0|||
160968859|NCT00696384|581273421|FG002|Open Label Phase|Lack of Efficacy|0|||
160968860|NCT00696384|581273419|FG000|Open Label Phase|Physician Decision|4|||
160968861|NCT00696384|581273420|FG001|Open Label Phase|Physician Decision|0|||
160968862|NCT00696384|581273421|FG002|Open Label Phase|Physician Decision|0|||
160968863|NCT00696384|581273419|FG000|Double Blind Phase|Adverse Event|0|||
160968864|NCT00696384|581273420|FG001|Double Blind Phase|Adverse Event|2|||
160968865|NCT00696384|581273421|FG002|Double Blind Phase|Adverse Event|2|||
160968866|NCT00696384|581273419|FG000|Double Blind Phase|Lost to Follow-up|0|||
160968867|NCT00696384|581273420|FG001|Double Blind Phase|Lost to Follow-up|2|||
160968868|NCT00696384|581273421|FG002|Double Blind Phase|Lost to Follow-up|1|||
160968869|NCT00696384|581273419|FG000|Double Blind Phase|Withdrawal by Subject|0|||
160968870|NCT00696384|581273420|FG001|Double Blind Phase|Withdrawal by Subject|4|||
160968871|NCT00696384|581273421|FG002|Double Blind Phase|Withdrawal by Subject|3|||
160968872|NCT00696384|581273419|FG000|Double Blind Phase|Lack of Efficacy|0|||
160968873|NCT00696384|581273420|FG001|Double Blind Phase|Lack of Efficacy|1|||
160968874|NCT00696384|581273421|FG002|Double Blind Phase|Lack of Efficacy|0|||
160968875|NCT00696384|581273419|FG000|Double Blind Phase|Physician Decision|0|||
160968876|NCT00696384|581273420|FG001|Double Blind Phase|Physician Decision|2|||
160968877|NCT00696384|581273421|FG002|Double Blind Phase|Physician Decision|0|||
160968878|NCT03995784|581273425|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
160968879|NCT01489189|581273426|FG000|Overall Study|Withdrawal by Subject|20|||
160968880|NCT01489189|581273427|FG001|Overall Study|Withdrawal by Subject|23|||
160586581|NCT00882999|579865709|FG004|Overall Study|Physician Decision|0|||
160586582|NCT00882999|579865710|FG005|Overall Study|Physician Decision|1|||
160586583|NCT00882999|579865711|FG006|Overall Study|Physician Decision|1|||
160586584|NCT00082758|579865712|FG000|Overall Study|Adverse Event|0|||
160586585|NCT00082758|579865713|FG001|Overall Study|Adverse Event|2|||
161016802|NCT04421378|581449529|FG000|Overall Study|Adverse Event|2|||
161016803|NCT04421378|581449530|FG001|Overall Study|Adverse Event|7|||
161016804|NCT04421378|581449531|FG002|Overall Study|Adverse Event|0|||
161016805|NCT04421378|581449532|FG003|Overall Study|Adverse Event|1|||
161016806|NCT04421378|581449533|FG004|Overall Study|Adverse Event|0|||
161016807|NCT04421378|581449529|FG000|Overall Study|Physician Decision|1|||
161016808|NCT04421378|581449530|FG001|Overall Study|Physician Decision|2|||
161016809|NCT04421378|581449531|FG002|Overall Study|Physician Decision|0|||
161016810|NCT04421378|581449532|FG003|Overall Study|Physician Decision|0|||
161016811|NCT04421378|581449533|FG004|Overall Study|Physician Decision|0|||
161016812|NCT04421378|581449529|FG000|Overall Study|Progressive Disease|16|||
161016813|NCT04421378|581449530|FG001|Overall Study|Progressive Disease|4|||
161016814|NCT04421378|581449531|FG002|Overall Study|Progressive Disease|18|||
161016815|NCT04421378|581449532|FG003|Overall Study|Progressive Disease|11|||
161016816|NCT04421378|581449533|FG004|Overall Study|Progressive Disease|3|||
161016817|NCT04421378|581449529|FG000|Overall Study|Study Terminated by Sponsor|0|||
161016818|NCT04421378|581449530|FG001|Overall Study|Study Terminated by Sponsor|1|||
161016819|NCT04421378|581449531|FG002|Overall Study|Study Terminated by Sponsor|1|||
161016820|NCT04421378|581449532|FG003|Overall Study|Study Terminated by Sponsor|0|||
161016821|NCT04421378|581449533|FG004|Overall Study|Study Terminated by Sponsor|0|||
161016822|NCT04421378|581449529|FG000|Overall Study|Withdrawal by Subject|3|||
161016823|NCT04421378|581449530|FG001|Overall Study|Withdrawal by Subject|1|||
161016824|NCT04421378|581449531|FG002|Overall Study|Withdrawal by Subject|0|||
161016825|NCT04421378|581449532|FG003|Overall Study|Withdrawal by Subject|2|||
161016826|NCT04421378|581449533|FG004|Overall Study|Withdrawal by Subject|0|||
161016827|NCT04421378|581449529|FG000|Overall Study|Other|1|||
161016828|NCT04421378|581449530|FG001|Overall Study|Other|0|||
161016829|NCT04421378|581449531|FG002|Overall Study|Other|0|||
161016830|NCT04421378|581449532|FG003|Overall Study|Other|0|||
161016831|NCT04421378|581449533|FG004|Overall Study|Other|0|||
161016832|NCT03090152|581449534|FG000|Overall Study|Withdrawal by Subject|0|||
161016833|NCT03090152|581449535|FG001|Overall Study|Withdrawal by Subject|2|||
161016834|NCT03090152|581449536|FG002|Overall Study|Withdrawal by Subject|1|||
161016835|NCT03090152|581449534|FG000|Overall Study|Surgery Canceled|1|||
161016836|NCT03090152|581449535|FG001|Overall Study|Surgery Canceled|0|||
161016837|NCT03090152|581449536|FG002|Overall Study|Surgery Canceled|0|||
161016838|NCT03090152|581449534|FG000|Overall Study|Epidural catheter could not be placed|0|||
161016839|NCT03090152|581449535|FG001|Overall Study|Epidural catheter could not be placed|2|||
161016840|NCT03090152|581449536|FG002|Overall Study|Epidural catheter could not be placed|0|||
161016841|NCT04673929|581449537|FG000|Overall Study|Death|73|||
161016842|NCT04673929|581449537|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
161016843|NCT05082909|581449541|FG000|Overall Study|Protocol Violation|0|||
161016844|NCT05082909|581449542|FG001|Overall Study|Protocol Violation|0|||
161016845|NCT05082909|581449543|FG002|Overall Study|Protocol Violation|1|||
161016846|NCT05082909|581449544|FG003|Overall Study|Protocol Violation|0|||
161016847|NCT05082909|581449545|FG004|Overall Study|Protocol Violation|0|||
161016848|NCT05082909|581449546|FG005|Overall Study|Protocol Violation|0|||
161016849|NCT04088630|581449547|FG000|Overall Study|Lost to Follow-up|3|||
161016850|NCT04088630|581449548|FG001|Overall Study|Lost to Follow-up|2|||
161016851|NCT04088630|581449549|FG002|Overall Study|Lost to Follow-up|6|||
161016852|NCT04088630|581449547|FG000|Overall Study|Death|3|||
161016853|NCT04088630|581449548|FG001|Overall Study|Death|1|||
161016854|NCT04088630|581449549|FG002|Overall Study|Death|1|||
161016855|NCT04088630|581449547|FG000|Overall Study|Physician Decision|0|||
161016856|NCT04088630|581449548|FG001|Overall Study|Physician Decision|1|||
161016857|NCT04088630|581449549|FG002|Overall Study|Physician Decision|1|||
161016858|NCT03175029|581449550|FG000|Overall Study|Withdrawal by Subject|2|||
161016859|NCT03175029|581449551|FG001|Overall Study|Withdrawal by Subject|1|||
160586586|NCT00082758|579865714|FG002|Overall Study|Adverse Event|0|||
160586587|NCT00082758|579865712|FG000|Overall Study|Lack of Efficacy|12|||
160586588|NCT00082758|579865713|FG001|Overall Study|Lack of Efficacy|13|||
160586589|NCT00082758|579865714|FG002|Overall Study|Lack of Efficacy|0|||
160586590|NCT00082758|579865712|FG000|Overall Study|Physician Decision|0|||
161016860|NCT03175029|581449550|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
161016861|NCT03175029|581449551|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
161016862|NCT04024813|581449557|FG000|Overall Study|Study terminated by Sponsor|1|||
161016863|NCT03047928|581449558|FG000|Overall Study|Adverse Event|0|||
161016864|NCT03047928|581449559|FG001|Overall Study|Adverse Event|2|||
161016865|NCT03047928|581449560|FG002|Overall Study|Adverse Event|0|||
161016866|NCT03047928|581449558|FG000|Overall Study|Protocol Violation|0|||
161016867|NCT03047928|581449559|FG001|Overall Study|Protocol Violation|1|||
161016868|NCT03047928|581449560|FG002|Overall Study|Protocol Violation|0|||
161016869|NCT03047928|581449558|FG000|Overall Study|included in another protocol|0|||
161016870|NCT03047928|581449559|FG001|Overall Study|included in another protocol|1|||
160586591|NCT00082758|579865713|FG001|Overall Study|Physician Decision|1|||
160586592|NCT00082758|579865714|FG002|Overall Study|Physician Decision|0|||
160586593|NCT00082758|579865712|FG000|Overall Study|Withdrawal by Subject|3|||
160586594|NCT00082758|579865713|FG001|Overall Study|Withdrawal by Subject|0|||
160586595|NCT00082758|579865714|FG002|Overall Study|Withdrawal by Subject|0|||
160586596|NCT00082758|579865712|FG000|Overall Study|Protocol Violation|0|||
160586597|NCT00082758|579865713|FG001|Overall Study|Protocol Violation|1|||
161016871|NCT03047928|581449560|FG002|Overall Study|included in another protocol|0|||
161016872|NCT02729311|581449561|FG000|Overall Study|Withdrawal by Subject|8|||
161016873|NCT02729311|581449562|FG001|Overall Study|Withdrawal by Subject|2|||
161016874|NCT05324124|581449563|FG000|Period 1|Withdrawal by Subject|1|||
161016875|NCT05324124|581449564|FG001|Period 1|Withdrawal by Subject|0|||
161016876|NCT05324124|581449563|FG000|Period 1|Physician Decision|0|||
161016877|NCT05324124|581449564|FG001|Period 1|Physician Decision|1|||
161016878|NCT04950660|581449565|FG000|Overall Study|Protocol Violation|4|||
161016879|NCT04950660|581449566|FG001|Overall Study|Protocol Violation|2|||
161016880|NCT04950660|581449565|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
161016881|NCT04950660|581449566|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
161016882|NCT04950660|581449565|FG000|Overall Study|Withdrawal by Subject|0|||
161016883|NCT04950660|581449566|FG001|Overall Study|Withdrawal by Subject|1|||
161016884|NCT04950660|581449565|FG000|Overall Study|Hypotension|1|||
161016885|NCT04950660|581449566|FG001|Overall Study|Hypotension|0|||
161016886|NCT04783935|581449569|FG000|Overall Study|Withdrawal by Subject|6|||
161016887|NCT04783935|581449569|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
161016888|NCT04783935|581449569|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
161016889|NCT04783935|581449569|FG000|Overall Study|Lost to Follow-up|3|||
161016890|NCT04783935|581449569|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
161016891|NCT02437318|581449570|FG000|Overall Study|Progressive disease|207|||
161016892|NCT02437318|581449571|FG001|Overall Study|Progressive disease|240|||
161016893|NCT02437318|581449570|FG000|Overall Study|Subject/guardian decision|24|||
161016894|NCT02437318|581449571|FG001|Overall Study|Subject/guardian decision|11|||
161016895|NCT02437318|581449570|FG000|Overall Study|Physician Decision|29|||
161016896|NCT02437318|581449571|FG001|Overall Study|Physician Decision|22|||
161016897|NCT02437318|581449570|FG000|Overall Study|Adverse Event|14|||
161016898|NCT02437318|581449571|FG001|Overall Study|Adverse Event|4|||
161016899|NCT02437318|581449570|FG000|Overall Study|Death|4|||
161016900|NCT02437318|581449571|FG001|Overall Study|Death|4|||
161016901|NCT02437318|581449570|FG000|Overall Study|Protocol deviation|5|||
161016902|NCT02437318|581449571|FG001|Overall Study|Protocol deviation|7|||
161016903|NCT02437318|581449570|FG000|Overall Study|Sponsor decision|1|||
161016904|NCT02437318|581449571|FG001|Overall Study|Sponsor decision|0|||
161016905|NCT00920621|581449575|FG000|Overall Study|Lost to Follow-up|16|||
161016906|NCT00920621|581449576|FG001|Overall Study|Lost to Follow-up|17|||
161016907|NCT00920621|581449577|FG002|Overall Study|Lost to Follow-up|19|||
161016908|NCT00920621|581449578|FG003|Overall Study|Lost to Follow-up|21|||
161016909|NCT00920621|581449575|FG000|Overall Study|Fetal/neonatal deaths|16|||
161016910|NCT00920621|581449576|FG001|Overall Study|Fetal/neonatal deaths|14|||
161016911|NCT00920621|581449577|FG002|Overall Study|Fetal/neonatal deaths|16|||
161016912|NCT00920621|581449578|FG003|Overall Study|Fetal/neonatal deaths|14|||
161016913|NCT00920621|581449575|FG000|Overall Study|Blood sample not collected|22|||
161016914|NCT00920621|581449576|FG001|Overall Study|Blood sample not collected|14|||
161016915|NCT00920621|581449577|FG002|Overall Study|Blood sample not collected|0|||
161016916|NCT00920621|581449578|FG003|Overall Study|Blood sample not collected|0|||
161016917|NCT06074523|581449579|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
161016918|NCT06074523|581449579|FG000|Overall Study|Withdrawal by Subject|1|||
161016919|NCT01195831|581450918|FG000|Overall Study|Lost to Follow-up|2|||
161016920|NCT01195831|581450919|FG001|Overall Study|Lost to Follow-up|4|||
161016921|NCT01195831|581450918|FG000|Overall Study|Withdrawal by Subject|2|||
161016922|NCT01195831|581450919|FG001|Overall Study|Withdrawal by Subject|2|||
161016923|NCT01195831|581450918|FG000|Overall Study|Adverse Event|4|||
161016924|NCT01195831|581450919|FG001|Overall Study|Adverse Event|2|||
161016925|NCT01195831|581450918|FG000|Overall Study|Protocol Violation|0|||
161016926|NCT01195831|581450919|FG001|Overall Study|Protocol Violation|2|||
161016927|NCT04490915|581450921|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161016928|NCT04490915|581450922|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161016929|NCT04490915|581450921|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161016930|NCT04490915|581450922|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161016931|NCT04490915|581450921|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160586598|NCT00082758|579865714|FG002|Overall Study|Protocol Violation|0|||
161016932|NCT04490915|581450922|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
161016933|NCT04490915|581450921|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
161016934|NCT04490915|581450922|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
161016935|NCT04490915|581450921|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
161016936|NCT04490915|581450922|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
161016937|NCT04490915|581450921|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
161016938|NCT04490915|581450922|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
161016939|NCT04490915|581450921|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
161016940|NCT04490915|581450922|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
161016941|NCT02287610|581450924|FG000|Overall Study|Lost to Follow-up|3|||
161016942|NCT02287610|581450924|FG000|Overall Study|Withdrawal by Subject|8|||
161016943|NCT02287610|581450924|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
161016944|NCT01426425|581450925|FG000|Overall Study|Exited prior to EP study|22|||
161016945|NCT01426425|581450925|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
161016946|NCT01426425|581450925|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
161016947|NCT03281291|581450931|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
161016948|NCT03281291|581450932|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
161016949|NCT03281291|581450933|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
161016950|NCT03281291|581450934|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
161016951|NCT03281291|581450935|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
161016952|NCT03281291|581450931|FG000|Overall Study|Protocol Deviation|2|||
161016953|NCT03281291|581450932|FG001|Overall Study|Protocol Deviation|0|||
161016954|NCT03281291|581450933|FG002|Overall Study|Protocol Deviation|1|||
161016955|NCT03281291|581450934|FG003|Overall Study|Protocol Deviation|2|||
161016956|NCT03281291|581450935|FG004|Overall Study|Protocol Deviation|1|||
161016957|NCT03281291|581450931|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
161016958|NCT03281291|581450932|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161016959|NCT03281291|581450933|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
161016960|NCT03281291|581450934|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161016961|NCT03281291|581450935|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
161016962|NCT03281291|581450931|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
161016963|NCT03281291|581450932|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
161016964|NCT03281291|581450933|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
161016965|NCT03281291|581450934|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
161016966|NCT03281291|581450935|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
161016967|NCT03281291|581450931|FG000|Overall Study|Lost to Follow-up|10|||
161016968|NCT03281291|581450932|FG001|Overall Study|Lost to Follow-up|10|||
161016969|NCT03281291|581450933|FG002|Overall Study|Lost to Follow-up|4|||
161016970|NCT03281291|581450934|FG003|Overall Study|Lost to Follow-up|6|||
161016971|NCT03281291|581450935|FG004|Overall Study|Lost to Follow-up|10|||
161016972|NCT03281291|581450931|FG000|Overall Study|Other|0|||
161016973|NCT03281291|581450932|FG001|Overall Study|Other|2|||
161016974|NCT03281291|581450933|FG002|Overall Study|Other|0|||
161016975|NCT03281291|581450934|FG003|Overall Study|Other|2|||
161016976|NCT03281291|581450935|FG004|Overall Study|Other|1|||
161016977|NCT00512070|581450936|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
161016978|NCT00512070|581450937|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
161016979|NCT00512070|581450938|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
161016980|NCT00512070|581450936|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
161016981|NCT00512070|581450937|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
161016982|NCT00512070|581450938|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
161016983|NCT04956861|581450939|FG000|Overall Study|Withdrawal by Subject|4|||
161016984|NCT04956861|581450940|FG001|Overall Study|Withdrawal by Subject|4|||
161016985|NCT04956861|581450941|FG002|Overall Study|Withdrawal by Subject|2|||
161016986|NCT04956861|581450939|FG000|Overall Study|Physician Decision|4|||
161016987|NCT04956861|581450940|FG001|Overall Study|Physician Decision|5|||
161016988|NCT04956861|581450941|FG002|Overall Study|Physician Decision|1|||
161016989|NCT00961571|581450942|FG000|Overall Study|Physician Decision|39|||
161016990|NCT05862870|581450946|FG000|Overall Study|Lost to Follow-up|3|||
161016991|NCT02900924|581450947|FG000|Overall Study|Death|52|||
161016992|NCT02900924|581450947|FG000|Overall Study|Lost to Follow-up|4|||
161016993|NCT02900924|581450947|FG000|Overall Study|Withdrawal by Subject|20|||
161016994|NCT02900924|581450947|FG000|Overall Study|Missed Visit|33|||
161016995|NCT03143153|581450950|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
161016996|NCT03143153|581450951|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
161016997|NCT03143153|581450952|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
161016998|NCT03143153|581450950|FG000|Pre-Treatment|Participant withdrew consent|0|||
160459359|NCT04595331|579414969|FG000|Overall Study|Medical reason|0|||
160459360|NCT04595331|579414970|FG001|Overall Study|Medical reason|1|||
161016999|NCT03143153|581450951|FG001|Pre-Treatment|Participant withdrew consent|1|||
161017000|NCT03143153|581450952|FG002|Pre-Treatment|Participant withdrew consent|12|||
161017001|NCT03143153|581450950|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
161017002|NCT03143153|581450951|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
161017003|NCT03143153|581450952|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
161017004|NCT03143153|581450950|FG000|Pre-Treatment|Other Reasons|1|||
161017005|NCT03143153|581450951|FG001|Pre-Treatment|Other Reasons|2|||
161017006|NCT03143153|581450952|FG002|Pre-Treatment|Other Reasons|1|||
161017007|NCT03143153|581450950|FG000|Pre-Treatment|Disease Progression|1|||
161017008|NCT03143153|581450951|FG001|Pre-Treatment|Disease Progression|1|||
161017009|NCT03143153|581450952|FG002|Pre-Treatment|Disease Progression|2|||
160586599|NCT00238303|579865715|FG000|Overall Study|Withdrawal by Subject|11|||
161017010|NCT03143153|581450950|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
161017011|NCT03143153|581450951|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
161017012|NCT03143153|581450952|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
161017013|NCT03143153|581450950|FG000|Treatment|Disease progression|174|||
161017014|NCT03143153|581450951|FG001|Treatment|Disease progression|184|||
161017015|NCT03143153|581450952|FG002|Treatment|Disease progression|193|||
161017016|NCT03143153|581450950|FG000|Treatment|Study drug toxicity|59|||
161017017|NCT03143153|581450951|FG001|Treatment|Study drug toxicity|33|||
161017018|NCT03143153|581450952|FG002|Treatment|Study drug toxicity|40|||
161017019|NCT03143153|581450950|FG000|Treatment|Death|5|||
161017020|NCT03143153|581450951|FG001|Treatment|Death|3|||
161017021|NCT03143153|581450952|FG002|Treatment|Death|4|||
161017022|NCT03143153|581450950|FG000|Treatment|Adverse event unrelated to study drug|19|||
161017023|NCT03143153|581450951|FG001|Treatment|Adverse event unrelated to study drug|28|||
161017024|NCT03143153|581450952|FG002|Treatment|Adverse event unrelated to study drug|12|||
161017025|NCT03143153|581450950|FG000|Treatment|Participant request to discontinue study treatment|13|||
161017026|NCT03143153|581450951|FG001|Treatment|Participant request to discontinue study treatment|15|||
161017027|NCT03143153|581450952|FG002|Treatment|Participant request to discontinue study treatment|20|||
161017028|NCT03143153|581450950|FG000|Treatment|Participant withdrew consent|3|||
161017029|NCT03143153|581450951|FG001|Treatment|Participant withdrew consent|4|||
161017030|NCT03143153|581450952|FG002|Treatment|Participant withdrew consent|12|||
161017031|NCT03143153|581450950|FG000|Treatment|Pregnancy|1|||
161017032|NCT03143153|581450951|FG001|Treatment|Pregnancy|0|||
161017033|NCT03143153|581450952|FG002|Treatment|Pregnancy|0|||
161017034|NCT03143153|581450950|FG000|Treatment|Maximum clinical benefit|1|||
161017035|NCT03143153|581450951|FG001|Treatment|Maximum clinical benefit|3|||
161017036|NCT03143153|581450952|FG002|Treatment|Maximum clinical benefit|4|||
161017037|NCT03143153|581450950|FG000|Treatment|Completed treatment as per Protocol|13|||
161017038|NCT03143153|581450951|FG001|Treatment|Completed treatment as per Protocol|8|||
161017039|NCT03143153|581450952|FG002|Treatment|Completed treatment as per Protocol|0|||
161017040|NCT03143153|581450950|FG000|Treatment|Other reasons|12|||
161017041|NCT03143153|581450951|FG001|Treatment|Other reasons|7|||
161017042|NCT03143153|581450952|FG002|Treatment|Other reasons|15|||
161017043|NCT03143153|581450950|FG000|Treatment|Not reported|1|||
161017044|NCT03143153|581450951|FG001|Treatment|Not reported|0|||
161017045|NCT03143153|581450952|FG002|Treatment|Not reported|0|||
161017046|NCT02736409|581450953|FG000|Overall Study|Withdrawal by Subject|4|||
161017047|NCT02736409|581450954|FG001|Overall Study|Withdrawal by Subject|2|||
161017048|NCT02736409|581450955|FG002|Overall Study|Withdrawal by Subject|17|||
161017049|NCT02736409|581450956|FG003|Overall Study|Withdrawal by Subject|3|||
161017050|NCT02736409|581450953|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161017051|NCT02736409|581450954|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161017052|NCT02736409|581450955|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161017053|NCT02736409|581450956|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161017054|NCT02736409|581450953|FG000|Overall Study|Adverse Event|0|||
161017055|NCT02736409|581450954|FG001|Overall Study|Adverse Event|1|||
161017056|NCT02736409|581450955|FG002|Overall Study|Adverse Event|5|||
161017057|NCT02736409|581450956|FG003|Overall Study|Adverse Event|4|||
161017058|NCT02736409|581450953|FG000|Overall Study|Other|0|||
161017059|NCT02736409|581450954|FG001|Overall Study|Other|0|||
161017060|NCT02736409|581450955|FG002|Overall Study|Other|1|||
161017061|NCT02736409|581450956|FG003|Overall Study|Other|1|||
161017062|NCT02736409|581450953|FG000|Overall Study|Pregnancy|0|||
161017063|NCT02736409|581450954|FG001|Overall Study|Pregnancy|0|||
161017064|NCT02736409|581450955|FG002|Overall Study|Pregnancy|1|||
161017065|NCT02736409|581450956|FG003|Overall Study|Pregnancy|0|||
161017066|NCT02736409|581450953|FG000|Overall Study|Lost to Follow-up|0|||
161017067|NCT02736409|581450954|FG001|Overall Study|Lost to Follow-up|0|||
161017068|NCT02736409|581450955|FG002|Overall Study|Lost to Follow-up|2|||
161017069|NCT02736409|581450956|FG003|Overall Study|Lost to Follow-up|1|||
161017070|NCT02736409|581450953|FG000|Overall Study|Physician Decision|0|||
161017071|NCT02736409|581450954|FG001|Overall Study|Physician Decision|0|||
161017072|NCT02736409|581450955|FG002|Overall Study|Physician Decision|0|||
161017073|NCT02736409|581450956|FG003|Overall Study|Physician Decision|2|||
161017074|NCT01415154|581450957|FG000|Overall Study|Lack of Efficacy|4|||
161017075|NCT01415154|581450958|FG001|Overall Study|Lack of Efficacy|5|||
161017076|NCT01415154|581450957|FG000|Overall Study|Withdrawal by Subject|7|||
161017077|NCT01415154|581450958|FG001|Overall Study|Withdrawal by Subject|8|||
161017078|NCT01415154|581450957|FG000|Overall Study|Lost to Follow-up|1|||
161017079|NCT01415154|581450958|FG001|Overall Study|Lost to Follow-up|4|||
161017080|NCT01415154|581450957|FG000|Overall Study|Protocol Violation|0|||
161017081|NCT01415154|581450958|FG001|Overall Study|Protocol Violation|1|||
161017082|NCT01415154|581450957|FG000|Overall Study|Satisfactory Response|0|||
161017083|NCT01415154|581450958|FG001|Overall Study|Satisfactory Response|1|||
161017084|NCT01415154|581450957|FG000|Overall Study|Adverse Event|1|||
161017085|NCT01415154|581450958|FG001|Overall Study|Adverse Event|1|||
161017086|NCT03763708|581450962|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
161017087|NCT03763708|581450963|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017088|NCT03763708|581450964|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017089|NCT03763708|581450965|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017090|NCT03763708|581450966|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017091|NCT03763708|581450967|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017092|NCT03763708|581450968|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017093|NCT03763708|581450969|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017094|NCT03763708|581450970|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017095|NCT03763708|581450962|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017096|NCT03763708|581450963|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017097|NCT03763708|581450964|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
161017098|NCT03763708|581450965|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017099|NCT03763708|581450966|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017100|NCT03763708|581450967|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017101|NCT03763708|581450968|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017102|NCT03763708|581450969|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017103|NCT03763708|581450970|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017104|NCT03763708|581450962|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017105|NCT03763708|581450963|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017106|NCT03763708|581450964|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017107|NCT03763708|581450965|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
161017108|NCT03763708|581450966|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017109|NCT03763708|581450967|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017110|NCT03763708|581450968|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017111|NCT03763708|581450969|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017112|NCT03763708|581450970|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017113|NCT03763708|581450962|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017114|NCT03763708|581450963|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017115|NCT03763708|581450964|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017116|NCT03763708|581450965|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017117|NCT03763708|581450966|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
161017118|NCT03763708|581450967|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017119|NCT03763708|581450968|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017120|NCT03763708|581450969|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017121|NCT03763708|581450970|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017122|NCT03763708|581450962|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017123|NCT03763708|581450963|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017124|NCT03763708|581450964|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017125|NCT03763708|581450965|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017126|NCT03763708|581450966|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017127|NCT03763708|581450967|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
161017128|NCT03763708|581450968|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017129|NCT03763708|581450969|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017130|NCT03763708|581450970|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017131|NCT03763708|581450962|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017132|NCT03763708|581450963|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017133|NCT03763708|581450964|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017134|NCT03763708|581450965|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017135|NCT03763708|581450966|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017136|NCT03763708|581450967|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017137|NCT03763708|581450968|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
161017138|NCT03763708|581450969|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017139|NCT03763708|581450970|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017140|NCT03763708|581450962|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
161017141|NCT03763708|581450963|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
161017142|NCT03763708|581450964|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
161017143|NCT03763708|581450965|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
161017144|NCT03763708|581450966|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
161017145|NCT03763708|581450967|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
161017146|NCT03763708|581450968|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
161017147|NCT03763708|581450969|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
161017148|NCT03763708|581450970|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
161017149|NCT03763708|581450962|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
161017150|NCT03763708|581450963|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
160459361|NCT05132400|579414974|FG000|Overall Study|Withdrawal by Subject|14|||
160459362|NCT05132400|579414975|FG001|Overall Study|Withdrawal by Subject|8|||
160459363|NCT05132400|579414974|FG000|Overall Study|Lost to Follow-up|132|||
161017151|NCT03763708|581450964|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
161017152|NCT03763708|581450965|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
160586600|NCT00238303|579865716|FG001|Overall Study|Withdrawal by Subject|1|||
160586601|NCT00238303|579865717|FG002|Overall Study|Withdrawal by Subject|2|||
160586602|NCT00238303|579865715|FG000|Overall Study|Death|1|||
160586603|NCT00238303|579865716|FG001|Overall Study|Death|0|||
160586604|NCT00238303|579865717|FG002|Overall Study|Death|1|||
160586605|NCT00238303|579865715|FG000|Overall Study|Other Medical Problems|2|||
160586606|NCT00238303|579865716|FG001|Overall Study|Other Medical Problems|0|||
161017153|NCT03763708|581450966|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
161017154|NCT03763708|581450967|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
161017155|NCT03763708|581450968|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
161017156|NCT03763708|581450969|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
161017157|NCT03763708|581450970|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
161017158|NCT03763708|581450962|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
161017159|NCT03763708|581450963|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
161017160|NCT03763708|581450964|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
161017161|NCT03763708|581450965|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
161017162|NCT03763708|581450966|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
161017163|NCT03763708|581450967|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
161017164|NCT03763708|581450968|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
161017165|NCT03763708|581450969|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
161017166|NCT03763708|581450970|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
161017167|NCT04382404|581450973|FG000|Overall Study|Adverse Event|1|||
161017168|NCT04382404|581450973|FG000|Overall Study|Lost to Follow-up|2|||
161017169|NCT05687916|581450977|FG000|Overall Study|Adverse Event|1|||
161017170|NCT05687916|581450978|FG001|Overall Study|Adverse Event|2|||
161017171|NCT05687916|581450979|FG002|Overall Study|Adverse Event|0|||
161017172|NCT05687916|581450977|FG000|Overall Study|Withdrawal by Subject|1|||
161017173|NCT05687916|581450978|FG001|Overall Study|Withdrawal by Subject|0|||
161017174|NCT05687916|581450979|FG002|Overall Study|Withdrawal by Subject|1|||
161017175|NCT05687916|581450977|FG000|Overall Study|Protocol Violation|0|||
161017176|NCT05687916|581450978|FG001|Overall Study|Protocol Violation|2|||
161017177|NCT05687916|581450979|FG002|Overall Study|Protocol Violation|1|||
161017178|NCT05687916|581450977|FG000|Overall Study|Reason not Specified|1|||
161017179|NCT05687916|581450978|FG001|Overall Study|Reason not Specified|0|||
161017180|NCT05687916|581450979|FG002|Overall Study|Reason not Specified|0|||
161017181|NCT03406871|581450987|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
161017182|NCT03406871|581450988|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
161017183|NCT03406871|581450989|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
161017184|NCT03406871|581450987|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
161017185|NCT03406871|581450988|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
161017186|NCT03406871|581450989|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
161017187|NCT03406871|581450987|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
161017188|NCT03406871|581450988|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
161017189|NCT03406871|581450989|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
161017190|NCT03406871|581450987|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
161017191|NCT03406871|581450988|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
161017192|NCT03406871|581450989|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
161017193|NCT03406871|581450987|FG000|Expansion Cohort(Final Analysis)|Death|0|||
161017194|NCT03406871|581450988|FG001|Expansion Cohort(Final Analysis)|Death|1|||
161017195|NCT03406871|581450989|FG002|Expansion Cohort(Final Analysis)|Death|0|||
161017196|NCT03406871|581450987|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
161017197|NCT03406871|581450988|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
161017198|NCT03406871|581450989|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
161017199|NCT02243709|581451000|FG000|Phase 1|Lost to Follow-up|0|||
161017200|NCT02243709|581451001|FG001|Phase 1|Lost to Follow-up|1|||
161017201|NCT02243709|581451000|FG000|Phase 1|Withdrawal by Subject|1|||
161017202|NCT02243709|581451001|FG001|Phase 1|Withdrawal by Subject|0|||
161017203|NCT02243709|581451000|FG000|Phase 1|Protocol Violation|0|||
161017204|NCT02243709|581451001|FG001|Phase 1|Protocol Violation|1|||
161017205|NCT02243709|581451000|FG000|Phase 1|Adverse Event|0|||
161017206|NCT02243709|581451001|FG001|Phase 1|Adverse Event|1|||
161017207|NCT04177823|581451002|FG000|Overall Study|Physician Decision|1|||
161017208|NCT04177823|581451002|FG000|Overall Study|Withdrawal by Subject|1|||
161017209|NCT01748448|581451004|FG000|Treatment Period|Consent withdrawn by subject|1|||
161017210|NCT01748448|581451005|FG001|Treatment Period|Consent withdrawn by subject|0|||
161017211|NCT01748448|581451004|FG000|Treatment Period|Adverse Event|1|||
161017212|NCT01748448|581451005|FG001|Treatment Period|Adverse Event|0|||
161017213|NCT01748448|581451004|FG000|Treatment Period|Personal|0|||
161017214|NCT01748448|581451005|FG001|Treatment Period|Personal|1|||
161017215|NCT02913872|581451006|FG000|Overall Study|Withdrawal by Subject|1|||
161017216|NCT03110315|581451009|FG000|Overall Study|Withdrawal by Subject|1|||
161017217|NCT03110315|581451010|FG001|Overall Study|Withdrawal by Subject|0|||
161017218|NCT03978871|581451011|FG000|Overall Study|Lost to Follow-up|11|||
161017219|NCT03978871|581451012|FG001|Overall Study|Lost to Follow-up|12|||
161017220|NCT05710107|581451013|FG000|Overall Study|Withdrawal by Subject|1|||
161017221|NCT05710107|581451014|FG001|Overall Study|Withdrawal by Subject|1|||
161017222|NCT05710107|581451013|FG000|Overall Study|Lost to Follow-up|8|||
161017223|NCT05710107|581451014|FG001|Overall Study|Lost to Follow-up|9|||
161017224|NCT05710107|581451013|FG000|Overall Study|Unable to place assigned block|2|||
161017225|NCT05710107|581451014|FG001|Overall Study|Unable to place assigned block|0|||
161017226|NCT05710107|581451013|FG000|Overall Study|Withdrawn by study team|0|||
161017227|NCT05710107|581451014|FG001|Overall Study|Withdrawn by study team|1|||
161017228|NCT04166773|581451015|FG000|Overall Study|Adverse Event|2|||
161017229|NCT04166773|581451016|FG001|Overall Study|Adverse Event|0|||
161017230|NCT04166773|581451017|FG002|Overall Study|Adverse Event|2|||
161017231|NCT04166773|581451018|FG003|Overall Study|Adverse Event|1|||
161017232|NCT04166773|581451015|FG000|Overall Study|Lost to Follow-up|4|||
161017233|NCT04166773|581451016|FG001|Overall Study|Lost to Follow-up|2|||
161017234|NCT04166773|581451017|FG002|Overall Study|Lost to Follow-up|1|||
161017235|NCT04166773|581451018|FG003|Overall Study|Lost to Follow-up|3|||
160586607|NCT00238303|579865717|FG002|Overall Study|Other Medical Problems|2|||
160586608|NCT00238303|579865715|FG000|Overall Study|Poor tolerance of study treatment|1|||
160586609|NCT00238303|579865716|FG001|Overall Study|Poor tolerance of study treatment|0|||
160586610|NCT00238303|579865717|FG002|Overall Study|Poor tolerance of study treatment|1|||
160586611|NCT00238303|579865715|FG000|Overall Study|Adverse Event|0|||
160586612|NCT00238303|579865716|FG001|Overall Study|Adverse Event|1|||
161017236|NCT04166773|581451015|FG000|Overall Study|Physician Decision|0|||
161017237|NCT04166773|581451016|FG001|Overall Study|Physician Decision|0|||
161017238|NCT04166773|581451017|FG002|Overall Study|Physician Decision|0|||
161017239|NCT04166773|581451018|FG003|Overall Study|Physician Decision|1|||
161017240|NCT04166773|581451015|FG000|Overall Study|Withdrawal by Subject|1|||
161017241|NCT04166773|581451016|FG001|Overall Study|Withdrawal by Subject|1|||
161017242|NCT04166773|581451017|FG002|Overall Study|Withdrawal by Subject|2|||
161017243|NCT04166773|581451018|FG003|Overall Study|Withdrawal by Subject|5|||
161017244|NCT04072822|581451019|FG000|Treatment|Adverse Event|9|||
161017245|NCT04072822|581451020|FG001|Treatment|Adverse Event|5|||
161017246|NCT04072822|581451019|FG000|Treatment|Met Stopping Criteria|13|||
161017247|NCT04072822|581451020|FG001|Treatment|Met Stopping Criteria|24|||
161017248|NCT04072822|581451019|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
161017249|NCT04072822|581451020|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
161017250|NCT04072822|581451019|FG000|Treatment|Withdrawal by Subject|0|||
161017251|NCT04072822|581451020|FG001|Treatment|Withdrawal by Subject|2|||
161017252|NCT04072822|581451019|FG000|Treatment|Death|0|||
161017253|NCT04072822|581451020|FG001|Treatment|Death|2|||
161017254|NCT04072822|581451019|FG000|Treatment|Lost to Follow-up|11|||
161017255|NCT04072822|581451020|FG001|Treatment|Lost to Follow-up|3|||
161017256|NCT04072822|581451019|FG000|Treatment|Physician Decision|1|||
161017257|NCT04072822|581451020|FG001|Treatment|Physician Decision|0|||
161017258|NCT04072822|581451019|FG000|Treatment|Other|7|||
161017259|NCT04072822|581451020|FG001|Treatment|Other|9|||
161017260|NCT04072822|581451019|FG000|Follow-up|Withdrawal by Subject|1|||
161017261|NCT04072822|581451020|FG001|Follow-up|Withdrawal by Subject|0|||
161017262|NCT04072822|581451019|FG000|Follow-up|Lost to Follow-up|5|||
161017263|NCT04072822|581451020|FG001|Follow-up|Lost to Follow-up|4|||
161017264|NCT03033576|581451021|FG000|Overall Study|Ineligible|1|||
161017265|NCT03033576|581451022|FG001|Overall Study|Ineligible|1|||
161017266|NCT03033576|581451021|FG000|Overall Study|Adverse Event|4|||
161017267|NCT03033576|581451022|FG001|Overall Study|Adverse Event|20|||
161017268|NCT03033576|581451021|FG000|Overall Study|Progression/relapse|9|||
161017269|NCT03033576|581451022|FG001|Overall Study|Progression/relapse|36|||
161017270|NCT03033576|581451021|FG000|Overall Study|Death|1|||
161017271|NCT03033576|581451022|FG001|Overall Study|Death|1|||
161017272|NCT03033576|581451021|FG000|Overall Study|Patient refusal|1|||
161017273|NCT03033576|581451022|FG001|Overall Study|Patient refusal|6|||
161017274|NCT03033576|581451021|FG000|Overall Study|Other, unspecified reasons|0|||
161017275|NCT03033576|581451022|FG001|Overall Study|Other, unspecified reasons|4|||
161017276|NCT03033576|581451021|FG000|Overall Study|Currently on protocol therapy|0|||
161017277|NCT03033576|581451022|FG001|Overall Study|Currently on protocol therapy|2|||
161017278|NCT01214616|581451023|FG000|Overall Study|Progressive disease|2|||
161017279|NCT01214616|581451024|FG001|Overall Study|Progressive disease|2|||
161017280|NCT01214616|581451025|FG002|Overall Study|Progressive disease|2|||
161017281|NCT01214616|581451026|FG003|Overall Study|Progressive disease|4|||
161017282|NCT01214616|581451023|FG000|Overall Study|Dose limiting toxicity|0|||
161017283|NCT01214616|581451024|FG001|Overall Study|Dose limiting toxicity|2|||
161017284|NCT01214616|581451025|FG002|Overall Study|Dose limiting toxicity|0|||
161017285|NCT01214616|581451026|FG003|Overall Study|Dose limiting toxicity|0|||
161017286|NCT01214616|581451023|FG000|Overall Study|Other adverse events|0|||
161017287|NCT01214616|581451024|FG001|Overall Study|Other adverse events|1|||
161017288|NCT01214616|581451025|FG002|Overall Study|Other adverse events|1|||
161017289|NCT01214616|581451026|FG003|Overall Study|Other adverse events|1|||
161017290|NCT01214616|581451023|FG000|Overall Study|Withdrawal by Subject|1|||
161017291|NCT01214616|581451024|FG001|Overall Study|Withdrawal by Subject|0|||
161017292|NCT01214616|581451025|FG002|Overall Study|Withdrawal by Subject|0|||
161017293|NCT01214616|581451026|FG003|Overall Study|Withdrawal by Subject|1|||
161017294|NCT02949362|581451027|FG000|Retrospective Period|Inform consent not signed by participant|4|||
161017295|NCT02949362|581451028|FG001|Retrospective Period|Inform consent not signed by participant|1|||
161017296|NCT02949362|581451029|FG002|Retrospective Period|Inform consent not signed by participant|0|||
161017297|NCT02949362|581451030|FG003|Retrospective Period|Inform consent not signed by participant|0|||
161017298|NCT02949362|581451027|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
161017299|NCT02949362|581451028|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
161017300|NCT02949362|581451029|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
161017301|NCT02949362|581451030|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
161017302|NCT02949362|581451027|FG000|Prospective Period|Other|0|||
161017303|NCT02949362|581451028|FG001|Prospective Period|Other|0|||
161017304|NCT02949362|581451029|FG002|Prospective Period|Other|0|||
161017305|NCT02949362|581451030|FG003|Prospective Period|Other|4|||
161017306|NCT05268302|581451031|FG000|Overall Study|Death|0|||
161017307|NCT05268302|581451032|FG001|Overall Study|Death|1|||
161017308|NCT02811679|581451033|FG000|Overall Study|Adverse Event|1|||
161017309|NCT02811679|581451033|FG000|Overall Study|Lack of Efficacy|6|||
161017310|NCT02811679|581451033|FG000|Overall Study|Early study closure due to slow accrual|3|||
161017311|NCT05319860|581451034|FG000|Overall Study|Death|1|||
161017312|NCT05319860|581451035|FG001|Overall Study|Death|1|||
161017313|NCT05319860|581451034|FG000|Overall Study|Lost to Follow-up|3|||
161017314|NCT05319860|581451035|FG001|Overall Study|Lost to Follow-up|1|||
161017315|NCT05319860|581451034|FG000|Overall Study|Withdrawal by Subject|1|||
161017316|NCT05319860|581451035|FG001|Overall Study|Withdrawal by Subject|7|||
161017317|NCT04314895|581451036|FG000|Overall Study|Lost to Follow-up|1|||
161017318|NCT04314895|581451036|FG000|Overall Study|Death|10|||
161017319|NCT04314895|581451036|FG000|Overall Study|Physician Decision|2|||
161017320|NCT01361711|581451037|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
161017321|NCT01361711|581451037|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
161017322|NCT01361711|581451037|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
161017323|NCT01361711|581451037|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
161017324|NCT01361711|581451037|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
161017325|NCT01361711|581451037|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
161017326|NCT01361711|581451037|FG000|Completed Week 18 of Treatment|Other|9|||
161017327|NCT01361711|581451037|FG000|10 Year Follow-up|Still in follow-up|22|||
161017328|NCT01361711|581451037|FG000|10 Year Follow-up|Death|7|||
161017329|NCT01361711|581451037|FG000|10 Year Follow-up|Developed new cancer|1|||
161017330|NCT01361711|581451037|FG000|10 Year Follow-up|Lost to Follow-up|2|||
161017331|NCT01361711|581451037|FG000|10 Year Follow-up|New treatment started|6|||
161017332|NCT01361711|581451037|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
161017333|NCT01361711|581451037|FG000|10 Year Follow-up|Progressive Disease|1|||
161017334|NCT02187003|581453098|FG000|Overall Study|Adverse Event|2|||
161017335|NCT02187003|581453099|FG001|Overall Study|Adverse Event|0|||
161017336|NCT02187003|581453098|FG000|Overall Study|Lost to Follow-up|14|||
161017337|NCT02187003|581453099|FG001|Overall Study|Lost to Follow-up|10|||
161017338|NCT02187003|581453098|FG000|Overall Study|Withdrawal by Subject|3|||
161017339|NCT02187003|581453099|FG001|Overall Study|Withdrawal by Subject|7|||
161017340|NCT02187003|581453098|FG000|Overall Study|Protocol Violation|2|||
161017341|NCT02187003|581453099|FG001|Overall Study|Protocol Violation|4|||
161017342|NCT02187003|581453098|FG000|Overall Study|Other|5|||
161017343|NCT02187003|581453099|FG001|Overall Study|Other|5|||
161017344|NCT02187003|581453098|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161017345|NCT02187003|581453099|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
161017346|NCT05816551|581453100|FG000|Overall Study|Withdrawal by Subject|0|||
161017347|NCT05816551|581453101|FG001|Overall Study|Withdrawal by Subject|1|||
161017348|NCT05816551|581453100|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
161017349|NCT05816551|581453101|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
161017350|NCT04593472|581453104|FG000|Overall Study|Death|31|||
161017351|NCT04593472|581453105|FG001|Overall Study|Death|27|||
161017352|NCT04593472|581453104|FG000|Overall Study|Withdrawal by Subject|12|||
161017353|NCT04593472|581453105|FG001|Overall Study|Withdrawal by Subject|12|||
161017354|NCT04593472|581453104|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
161017355|NCT04593472|581453105|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
161017356|NCT04593472|581453104|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
161017357|NCT04593472|581453105|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
161017358|NCT04593472|581453104|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
161017359|NCT04593472|581453105|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
161017360|NCT04593472|581453104|FG000|Overall Study|Lost to Follow-up|0|||
161017361|NCT04593472|581453105|FG001|Overall Study|Lost to Follow-up|2|||
161017362|NCT04593472|581453104|FG000|Overall Study|Still collecting 24-month assessment|17|||
161017363|NCT04593472|581453105|FG001|Overall Study|Still collecting 24-month assessment|10|||
161017364|NCT03648840|581453108|FG000|First IV Infusion Session|Adverse Event|0|||
161017365|NCT03648840|581453109|FG001|First IV Infusion Session|Adverse Event|2|||
161017366|NCT03648840|581453108|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
161017367|NCT03648840|581453109|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
161017368|NCT03648840|581453108|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
161017369|NCT03648840|581453109|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
161017370|NCT03648840|581453108|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
161017371|NCT03648840|581453109|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
161017372|NCT05382936|581453110|FG000|Overall Study|Progressive Disease|3|||
161017373|NCT05382936|581453111|FG001|Overall Study|Progressive Disease|5|||
161017374|NCT05382936|581453112|FG002|Overall Study|Progressive Disease|2|||
161017375|NCT05382936|581453113|FG003|Overall Study|Progressive Disease|5|||
161017376|NCT05382936|581453110|FG000|Overall Study|Adverse Event|0|||
161017377|NCT05382936|581453111|FG001|Overall Study|Adverse Event|1|||
161017378|NCT05382936|581453112|FG002|Overall Study|Adverse Event|1|||
161017379|NCT05382936|581453113|FG003|Overall Study|Adverse Event|0|||
161017380|NCT05382936|581453110|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
161017381|NCT05382936|581453111|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
161017382|NCT05382936|581453112|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
161017383|NCT05382936|581453113|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
161017384|NCT05382936|581453110|FG000|Overall Study|Withdrawal by Subject|0|||
161017385|NCT05382936|581453111|FG001|Overall Study|Withdrawal by Subject|0|||
161017386|NCT05382936|581453112|FG002|Overall Study|Withdrawal by Subject|1|||
161017387|NCT05382936|581453113|FG003|Overall Study|Withdrawal by Subject|1|||
161017388|NCT05063994|581453114|FG000|Cortef Run-In|Withdrawal of Consent|1|||
161017389|NCT05063994|581453115|FG001|Cortef Run-In|Withdrawal of Consent|0|||
161017390|NCT05063994|581453116|FG002|Cortef Run-In|Withdrawal of Consent|0|||
161017391|NCT05063994|581453114|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
161017392|NCT05063994|581453115|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
161017393|NCT05063994|581453116|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
161017394|NCT05063994|581453114|FG000|Treatment|Physician Decision|0|||
161017395|NCT05063994|581453115|FG001|Treatment|Physician Decision|0|||
161017396|NCT05063994|581453116|FG002|Treatment|Physician Decision|1|||
161017397|NCT05063994|581453114|FG000|Treatment|Withdrawal by Subject|0|||
161017398|NCT05063994|581453115|FG001|Treatment|Withdrawal by Subject|0|||
161017399|NCT05063994|581453116|FG002|Treatment|Withdrawal by Subject|1|||
161017400|NCT05063994|581453114|FG000|Treatment|Withdrawal of Consent|0|||
161017401|NCT05063994|581453115|FG001|Treatment|Withdrawal of Consent|0|||
161017402|NCT05063994|581453116|FG002|Treatment|Withdrawal of Consent|1|||
161017403|NCT00667251|581453120|FG000|Overall Study|Disease progression|232|||
161017404|NCT00667251|581453121|FG001|Overall Study|Disease progression|203|||
161017405|NCT00667251|581453120|FG000|Overall Study|Toxicity|44|||
161017406|NCT00667251|581453121|FG001|Overall Study|Toxicity|23|||
161017407|NCT00667251|581453120|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
161017408|NCT00667251|581453121|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
161017409|NCT00667251|581453120|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
161017410|NCT00667251|581453121|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
161017411|NCT00667251|581453120|FG000|Overall Study|Symptomatic progression|8|||
161017412|NCT00667251|581453121|FG001|Overall Study|Symptomatic progression|4|||
161017413|NCT00667251|581453120|FG000|Overall Study|Death|6|||
161017414|NCT00667251|581453121|FG001|Overall Study|Death|11|||
161017415|NCT00667251|581453120|FG000|Overall Study|Intercurrent illness|5|||
161017416|NCT00667251|581453121|FG001|Overall Study|Intercurrent illness|6|||
161017417|NCT00667251|581453120|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
161017418|NCT00667251|581453121|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
161017419|NCT00667251|581453120|FG000|Overall Study|Randomized not Treated|4|||
161017420|NCT00667251|581453121|FG001|Overall Study|Randomized not Treated|1|||
161017421|NCT02995434|581453122|FG000|Overall Study|Adverse Event|1|||
161017422|NCT02995434|581453123|FG001|Overall Study|Adverse Event|0|||
161017423|NCT02995434|581453122|FG000|Overall Study|Withdrawal by Subject|6|||
161017424|NCT02995434|581453123|FG001|Overall Study|Withdrawal by Subject|3|||
161017425|NCT04150718|581453129|FG000|Overall Study|Withdrawal by Subject|2|||
161017426|NCT04150718|581453130|FG001|Overall Study|Withdrawal by Subject|7|||
160459364|NCT05132400|579414975|FG001|Overall Study|Lost to Follow-up|121|||
160586613|NCT00238303|579865717|FG002|Overall Study|Adverse Event|3|||
160586614|NCT01994226|579865720|FG000|Overall Study|Protocol Violation|13|||
160586615|NCT01994226|579865721|FG001|Overall Study|Protocol Violation|10|||
160586616|NCT01994226|579865720|FG000|Overall Study|Early Cessation of treatment|6|||
160586617|NCT01994226|579865721|FG001|Overall Study|Early Cessation of treatment|11|||
161017427|NCT04150718|581453131|FG002|Overall Study|Withdrawal by Subject|1|||
161017428|NCT04150718|581453129|FG000|Overall Study|Lost to Follow-up|1|||
160586618|NCT02488551|579865722|FG000|Overall Study|Lost to Follow-up|4|||
160586619|NCT02488551|579865723|FG001|Overall Study|Lost to Follow-up|7|||
160586620|NCT02488551|579865724|FG002|Overall Study|Lost to Follow-up|0|||
160657061|NCT02327130|580124522|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
160657062|NCT02327130|580124522|FG000|Overall Study|Met exclusion criteria|3|||
160586621|NCT02488551|579865725|FG003|Overall Study|Lost to Follow-up|0|||
161017429|NCT04150718|581453130|FG001|Overall Study|Lost to Follow-up|2|||
161017430|NCT04150718|581453131|FG002|Overall Study|Lost to Follow-up|0|||
161017431|NCT04150718|581453129|FG000|Overall Study|Ineligible|1|||
161017432|NCT04150718|581453130|FG001|Overall Study|Ineligible|0|||
161017433|NCT04150718|581453131|FG002|Overall Study|Ineligible|10|||
161017434|NCT04034251|581453132|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
161017435|NCT04034251|581453133|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
161017436|NCT04034251|581453134|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
161017437|NCT05034952|581453135|FG000|Overall Study|Adverse Event|1|||
161017438|NCT05034952|581453136|FG001|Overall Study|Adverse Event|0|||
161017439|NCT05034952|581453137|FG002|Overall Study|Adverse Event|0|||
161017440|NCT05034952|581453138|FG003|Overall Study|Adverse Event|0|||
161017441|NCT05034952|581453135|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
161017442|NCT05034952|581453136|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
161017443|NCT05034952|581453137|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
161017444|NCT05034952|581453138|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
161017445|NCT05034952|581453135|FG000|Overall Study|Lost to Follow-up|1|||
161017446|NCT05034952|581453136|FG001|Overall Study|Lost to Follow-up|4|||
160459365|NCT03934931|579414976|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
160459366|NCT03934931|579414977|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
160459367|NCT03934931|579414978|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
160459368|NCT03635567|579414981|FG000|Overall Study|Lost to Follow-up|4|||
160459369|NCT03635567|579414982|FG001|Overall Study|Lost to Follow-up|1|||
160459370|NCT03635567|579414981|FG000|Overall Study|Withdrawal by Subject|11|||
160459371|NCT03635567|579414982|FG001|Overall Study|Withdrawal by Subject|16|||
160459372|NCT03635567|579414981|FG000|Overall Study|Sponsor Decision|99|||
160459373|NCT03635567|579414982|FG001|Overall Study|Sponsor Decision|57|||
160459374|NCT03635567|579414981|FG000|Overall Study|Death|194|||
160459375|NCT03635567|579414982|FG001|Overall Study|Death|235|||
160459376|NCT00739908|579414983|FG000|Overall Study|Adverse Event|5|||
160459377|NCT00739908|579414984|FG001|Overall Study|Adverse Event|6|||
160459378|NCT00739908|579414983|FG000|Overall Study|Withdrawal by Subject|4|||
160459379|NCT00739908|579414984|FG001|Overall Study|Withdrawal by Subject|2|||
160459380|NCT00739908|579414983|FG000|Overall Study|Lost to Follow-up|14|||
160459381|NCT00739908|579414984|FG001|Overall Study|Lost to Follow-up|9|||
160459382|NCT00739908|579414983|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
160459383|NCT00739908|579414984|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
160459384|NCT00739908|579414983|FG000|Overall Study|Non-Compliance With Study Medication|0|||
160459385|NCT00739908|579414984|FG001|Overall Study|Non-Compliance With Study Medication|3|||
160459386|NCT00739908|579414983|FG000|Overall Study|Lack of Efficacy|0|||
160459387|NCT00739908|579414984|FG001|Overall Study|Lack of Efficacy|1|||
160459388|NCT00739908|579414983|FG000|Overall Study|Relocation|0|||
160459389|NCT00739908|579414984|FG001|Overall Study|Relocation|1|||
160459390|NCT02076009|579414985|FG000|Overall Study|Death|172|||
160459391|NCT02076009|579414986|FG001|Overall Study|Death|153|||
160459392|NCT02076009|579414985|FG000|Overall Study|Withdrawal by Subject|16|||
160459393|NCT02076009|579414986|FG001|Overall Study|Withdrawal by Subject|12|||
160459394|NCT02076009|579414985|FG000|Overall Study|Lost to Follow-up|4|||
160459395|NCT02076009|579414986|FG001|Overall Study|Lost to Follow-up|2|||
160459396|NCT02076009|579414985|FG000|Overall Study|Progressive Disease|1|||
160968881|NCT01489189|581273426|FG000|Overall Study|Death|10|||
160968882|NCT01489189|581273427|FG001|Overall Study|Death|8|||
160968883|NCT01489189|581273426|FG000|Overall Study|Missed Visit|1|||
160968884|NCT01489189|581273427|FG001|Overall Study|Missed Visit|4|||
160968885|NCT04225988|581273428|FG000|Overall Study|Withdrawal by Subject|2|||
160968886|NCT04225988|581273429|FG001|Overall Study|Withdrawal by Subject|0|||
160968887|NCT00112580|581273430|FG000|Overall Study|Adverse Event|1|||
160968888|NCT00112580|581273431|FG001|Overall Study|Adverse Event|2|||
160968889|NCT00112580|581273430|FG000|Overall Study|Disease progression|5|||
160968890|NCT00112580|581273431|FG001|Overall Study|Disease progression|16|||
160968891|NCT00112580|581273430|FG000|Overall Study|Participant withdrew consent|2|||
160968892|NCT00112580|581273431|FG001|Overall Study|Participant withdrew consent|1|||
160968893|NCT05619003|581273434|FG000|Overall Study|Adverse Event|1|||
160968894|NCT07018999|581273439|FG000|Overall Study|Protocol Violation|0|||
160968895|NCT07018999|581273440|FG001|Overall Study|Protocol Violation|1|||
160968896|NCT07018999|581273439|FG000|Overall Study|Incomplete data entry|4|||
160968897|NCT07018999|581273440|FG001|Overall Study|Incomplete data entry|7|||
160968898|NCT04739761|581273442|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
160968899|NCT04739761|581273443|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
160968900|NCT04739761|581273442|FG000|Overall Study|By complete response from the participant|1|||
160968901|NCT04739761|581273443|FG001|Overall Study|By complete response from the participant|0|||
160968902|NCT04739761|581273442|FG000|Overall Study|Lost to Follow-up|3|||
160968903|NCT04739761|581273443|FG001|Overall Study|Lost to Follow-up|3|||
160968904|NCT04739761|581273442|FG000|Overall Study|Death|13|||
160968905|NCT04739761|581273443|FG001|Overall Study|Death|13|||
160586622|NCT02488551|579865722|FG000|Overall Study|Military Deployment|1|||
160586623|NCT02488551|579865723|FG001|Overall Study|Military Deployment|1|||
160586624|NCT02488551|579865724|FG002|Overall Study|Military Deployment|0|||
160586625|NCT02488551|579865725|FG003|Overall Study|Military Deployment|0|||
160586626|NCT00436566|579865726|FG000|Overall Study|Withdrawal by Subject|2|||
160586627|NCT00436566|579865726|FG000|Overall Study|Protocol Violation|1|||
160586628|NCT01860534|579865727|FG000|ROP #1|Needed treatment for ROP|0|||
160586629|NCT01860534|579865728|FG001|ROP #1|Needed treatment for ROP|1|||
160586630|NCT01860534|579865727|FG000|ROP #2|discharged prior to ROP #2|1|||
160586631|NCT01860534|579865728|FG001|ROP #2|discharged prior to ROP #2|0|||
160586632|NCT00779324|579865733|FG000|Overall Study|Lost to Follow-up|2|||
160586633|NCT00779324|579865734|FG001|Overall Study|Lost to Follow-up|1|||
160586634|NCT00779324|579865733|FG000|Overall Study|Withdrawal by Subject|4|||
160586635|NCT00779324|579865734|FG001|Overall Study|Withdrawal by Subject|2|||
160586636|NCT00779324|579865733|FG000|Overall Study|Missed visit|1|||
160586637|NCT00779324|579865734|FG001|Overall Study|Missed visit|1|||
160586638|NCT02207556|579865735|FG000|Overall Study|Physician Decision|1|||
160586639|NCT02207556|579865736|FG001|Overall Study|Physician Decision|0|||
160586640|NCT02207556|579865735|FG000|Overall Study|Withdrawal by Subject|1|||
160586641|NCT02207556|579865736|FG001|Overall Study|Withdrawal by Subject|0|||
160586642|NCT02207556|579865735|FG000|Overall Study|Death|0|||
160586643|NCT02207556|579865736|FG001|Overall Study|Death|5|||
160586644|NCT03558555|579865737|FG000|Overall Study|Lost to Follow-up|2|||
160586645|NCT03558555|579865738|FG001|Overall Study|Lost to Follow-up|1|||
160586646|NCT02841787|579865748|FG000|Overall Study|Lost to Follow-up|1|||
160586647|NCT02841787|579865749|FG001|Overall Study|Lost to Follow-up|0|||
160586648|NCT02841787|579865750|FG002|Overall Study|Lost to Follow-up|0|||
160586649|NCT02841787|579865748|FG000|Overall Study|Symptoms dropped below threshold|1|||
160968906|NCT04739761|581273442|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
160968907|NCT04739761|581273443|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
160968908|NCT04739761|581273442|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
160968909|NCT04739761|581273443|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
160968910|NCT04739761|581273442|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
160968911|NCT04739761|581273443|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
160968912|NCT04739761|581273442|FG000|Overall Study|Adverse Event|0|||
160968913|NCT04739761|581273443|FG001|Overall Study|Adverse Event|3|||
160968914|NCT04739761|581273442|FG000|Overall Study|Participant decision|1|||
160968915|NCT04739761|581273443|FG001|Overall Study|Participant decision|0|||
160968916|NCT04739761|581273442|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
160968917|NCT04739761|581273443|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
160968918|NCT04739761|581273442|FG000|Overall Study|Participant immediately started next line of treatment|1|||
160968919|NCT04739761|581273443|FG001|Overall Study|Participant immediately started next line of treatment|0|||
160968920|NCT04739761|581273442|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
160968921|NCT04739761|581273443|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
160968922|NCT04739761|581273442|FG000|Overall Study|Lack of clinical benefit|1|||
160968923|NCT04739761|581273443|FG001|Overall Study|Lack of clinical benefit|0|||
160968924|NCT04739761|581273442|FG000|Overall Study|Disease progression|5|||
160968925|NCT04739761|581273443|FG001|Overall Study|Disease progression|5|||
160968926|NCT04739761|581273442|FG000|Overall Study|Withdrawal by Subject|14|||
160968927|NCT04739761|581273443|FG001|Overall Study|Withdrawal by Subject|13|||
160968928|NCT04739761|581273442|FG000|Overall Study|Protocol Violation|1|||
160968929|NCT04739761|581273443|FG001|Overall Study|Protocol Violation|0|||
160968930|NCT04739761|581273442|FG000|Overall Study|Physician Decision|2|||
160968931|NCT04739761|581273443|FG001|Overall Study|Physician Decision|0|||
160968932|NCT03881696|581273447|FG000|Overall Study|Adverse Event|2|||
160968933|NCT03881696|581273448|FG001|Overall Study|Adverse Event|0|||
160968934|NCT03881696|581273447|FG000|Overall Study|Withdrawal by Subject|2|||
160968935|NCT03881696|581273448|FG001|Overall Study|Withdrawal by Subject|0|||
160968936|NCT03881696|581273447|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
160968937|NCT03881696|581273448|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
160968938|NCT03881696|581273447|FG000|Overall Study|Failure to meet continuation criteria|1|||
160968939|NCT03881696|581273448|FG001|Overall Study|Failure to meet continuation criteria|0|||
160968940|NCT00856167|581273450|FG000|Period 1|Withdrawal by Subject|1|||
160968941|NCT00856167|581273451|FG001|Period 1|Withdrawal by Subject|4|||
160968942|NCT00856167|581273452|FG002|Period 1|Withdrawal by Subject|0|||
160968943|NCT00856167|581273453|FG003|Period 1|Withdrawal by Subject|0|||
161017447|NCT05034952|581453137|FG002|Overall Study|Lost to Follow-up|3|||
160586650|NCT02841787|579865749|FG001|Overall Study|Symptoms dropped below threshold|0|||
160968944|NCT00856167|581273450|FG000|Period 1|Lost to Follow-up|2|||
160968945|NCT00856167|581273451|FG001|Period 1|Lost to Follow-up|1|||
160968946|NCT00856167|581273452|FG002|Period 1|Lost to Follow-up|0|||
160586651|NCT02841787|579865750|FG002|Overall Study|Symptoms dropped below threshold|0|||
160586652|NCT02841787|579865748|FG000|Overall Study|Withdrawal by Subject|1|||
160586653|NCT02841787|579865749|FG001|Overall Study|Withdrawal by Subject|4|||
160586654|NCT02841787|579865750|FG002|Overall Study|Withdrawal by Subject|0|||
160586655|NCT01474746|579865751|FG000|Overall Study|Lost to Follow-up|1|||
160586656|NCT01474746|579865752|FG001|Overall Study|Lost to Follow-up|1|||
160586657|NCT01474746|579865751|FG000|Overall Study|Withdrawal by Subject|2|||
160586658|NCT01474746|579865752|FG001|Overall Study|Withdrawal by Subject|1|||
160586659|NCT01766336|579865756|FG000|Overall Study|Adverse Event|11|||
160586660|NCT01766336|579865757|FG001|Overall Study|Adverse Event|8|||
160586661|NCT01766336|579865756|FG000|Overall Study|Death|4|||
160586662|NCT01766336|579865757|FG001|Overall Study|Death|3|||
160586663|NCT01766336|579865756|FG000|Overall Study|Lost to Follow-up|1|||
160586664|NCT01766336|579865757|FG001|Overall Study|Lost to Follow-up|3|||
160586665|NCT01766336|579865756|FG000|Overall Study|Physician Decision|4|||
160586666|NCT01766336|579865757|FG001|Overall Study|Physician Decision|2|||
160586667|NCT01766336|579865756|FG000|Overall Study|Protocol Violation|0|||
160586668|NCT01766336|579865757|FG001|Overall Study|Protocol Violation|1|||
160586669|NCT01766336|579865756|FG000|Overall Study|Sponsor Decision|52|||
160586670|NCT01766336|579865757|FG001|Overall Study|Sponsor Decision|43|||
160586671|NCT01766336|579865756|FG000|Overall Study|Withdrawal by Subject|18|||
160586672|NCT01766336|579865757|FG001|Overall Study|Withdrawal by Subject|15|||
160586673|NCT03029650|579865758|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
160586674|NCT03029650|579865759|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
160586675|NCT03029650|579865758|FG000|Washout (1 Week)|Physician Decision|0|||
160586676|NCT03029650|579865759|FG001|Washout (1 Week)|Physician Decision|1|||
160586677|NCT04544709|579865760|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
160586678|NCT03135028|579865761|FG000|Overall Study|Death|6|||
160586679|NCT03135028|579865761|FG000|Overall Study|Study Terminated by Sponsor|2|||
160586680|NCT03135028|579865761|FG000|Overall Study|Withdrew Consent|1|||
160586681|NCT00496873|579865762|FG000|Overall Study|Ineligible|2|||
160586682|NCT00496873|579865762|FG000|Overall Study|Death|2|||
160586683|NCT00496873|579865762|FG000|Overall Study|Withdrawal by Subject|3|||
160586684|NCT02065869|579865763|FG000|Overall Study|Death|7|||
160586685|NCT02065869|579865763|FG000|Overall Study|Disease relapse|16|||
160586686|NCT02065869|579865763|FG000|Overall Study|Lost to Follow-up|4|||
160586687|NCT02065869|579865763|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
160586688|NCT02065869|579865763|FG000|Overall Study|Withdrawal by Subject|1|||
160586689|NCT01842620|579865764|FG000|Period 1|Withdrawal by Subject|1|||
160586690|NCT01842620|579865765|FG001|Period 1|Withdrawal by Subject|0|||
160586691|NCT02371759|579865768|FG000|Overall Study|Protocol Violation|3|||
160586692|NCT02371759|579865769|FG001|Overall Study|Protocol Violation|1|||
160586693|NCT02371759|579865770|FG002|Overall Study|Protocol Violation|1|||
160586694|NCT02371759|579865771|FG003|Overall Study|Protocol Violation|0|||
160586695|NCT02371759|579865772|FG004|Overall Study|Protocol Violation|3|||
160586696|NCT02371759|579865773|FG005|Overall Study|Protocol Violation|1|||
160586697|NCT02371759|579865774|FG006|Overall Study|Protocol Violation|0|||
160586698|NCT02371759|579865775|FG007|Overall Study|Protocol Violation|3|||
160586699|NCT02371759|579865768|FG000|Overall Study|Withdrawal by Subject|0|||
160586700|NCT02371759|579865769|FG001|Overall Study|Withdrawal by Subject|0|||
160586701|NCT02371759|579865770|FG002|Overall Study|Withdrawal by Subject|0|||
160968947|NCT00856167|581273453|FG003|Period 1|Lost to Follow-up|0|||
160968948|NCT00856167|581273450|FG000|Period 2|Lost to Follow-up|0|||
160968949|NCT00856167|581273451|FG001|Period 2|Lost to Follow-up|0|||
160968950|NCT00856167|581273452|FG002|Period 2|Lost to Follow-up|3|||
160968951|NCT00856167|581273453|FG003|Period 2|Lost to Follow-up|1|||
160968952|NCT00856167|581273450|FG000|Period 2|Withdrawal by Subject|0|||
160968953|NCT00856167|581273451|FG001|Period 2|Withdrawal by Subject|0|||
160968954|NCT00856167|581273452|FG002|Period 2|Withdrawal by Subject|2|||
160968955|NCT00856167|581273453|FG003|Period 2|Withdrawal by Subject|4|||
160968956|NCT01061333|581273454|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
160968957|NCT01061333|581273455|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
160968958|NCT01816763|581275061|FG000|Overall Study|The main reason for an incomplete survey|4|||
160968959|NCT01816763|581275062|FG001|Overall Study|The main reason for an incomplete survey|15|||
160968960|NCT01816763|581275063|FG002|Overall Study|The main reason for an incomplete survey|11|||
160968961|NCT01186328|581275068|FG000|Overall Study|Death|1|||
160968962|NCT01186328|581275069|FG001|Overall Study|Death|0|||
160586702|NCT02371759|579865771|FG003|Overall Study|Withdrawal by Subject|0|||
160586703|NCT02371759|579865772|FG004|Overall Study|Withdrawal by Subject|0|||
160586704|NCT02371759|579865773|FG005|Overall Study|Withdrawal by Subject|0|||
160586705|NCT02371759|579865774|FG006|Overall Study|Withdrawal by Subject|0|||
160586706|NCT02371759|579865775|FG007|Overall Study|Withdrawal by Subject|1|||
160968963|NCT01186328|581275070|FG002|Overall Study|Death|0|||
160968964|NCT02202434|581275071|FG000|Overall Study|Death|70|||
160586707|NCT03136185|579865778|FG000|Overall Study|Adverse Event|0|||
160586708|NCT03136185|579865779|FG001|Overall Study|Adverse Event|1|||
160968965|NCT02202434|581275072|FG001|Overall Study|Death|39|||
160586709|NCT03136185|579865780|FG002|Overall Study|Adverse Event|3|||
160586710|NCT03136185|579865781|FG003|Overall Study|Adverse Event|1|||
160586711|NCT03136185|579865782|FG004|Overall Study|Adverse Event|2|||
160586712|NCT03136185|579865783|FG005|Overall Study|Adverse Event|2|||
160586713|NCT03136185|579865784|FG006|Overall Study|Adverse Event|5|||
161017448|NCT05034952|581453138|FG003|Overall Study|Lost to Follow-up|3|||
161017449|NCT05034952|581453135|FG000|Overall Study|Other|0|||
161017450|NCT05034952|581453136|FG001|Overall Study|Other|0|||
161017451|NCT05034952|581453137|FG002|Overall Study|Other|0|||
161017452|NCT05034952|581453138|FG003|Overall Study|Other|1|||
161017453|NCT05273749|581453145|FG000|Overall Study|Adverse Event|14|||
161017454|NCT05273749|581453146|FG001|Overall Study|Adverse Event|8|||
161017455|NCT05273749|581453145|FG000|Overall Study|Lack of Efficacy|2|||
161017456|NCT05273749|581453146|FG001|Overall Study|Lack of Efficacy|8|||
161017457|NCT05273749|581453145|FG000|Overall Study|Physician Decision|0|||
161017458|NCT05273749|581453146|FG001|Overall Study|Physician Decision|2|||
161017459|NCT05273749|581453145|FG000|Overall Study|Withdrawal by Subject|14|||
161017460|NCT05273749|581453146|FG001|Overall Study|Withdrawal by Subject|16|||
161017461|NCT05273749|581453145|FG000|Overall Study|Lost to Follow-up|10|||
161017462|NCT05273749|581453146|FG001|Overall Study|Lost to Follow-up|10|||
161017463|NCT05273749|581453145|FG000|Overall Study|Pregnancy|1|||
161017464|NCT05273749|581453146|FG001|Overall Study|Pregnancy|0|||
161017465|NCT05273749|581453145|FG000|Overall Study|Non-Compliance|3|||
161017466|NCT05273749|581453146|FG001|Overall Study|Non-Compliance|2|||
161017467|NCT05273749|581453145|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
161017468|NCT05273749|581453146|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
161017469|NCT02543281|581453153|FG000|Overall Study|Lost to Follow-up|0|||
161017470|NCT02543281|581453154|FG001|Overall Study|Lost to Follow-up|0|||
161017471|NCT02543281|581453155|FG002|Overall Study|Lost to Follow-up|1|||
161017472|NCT02530671|581453156|FG000|Overall Study|Lost to Follow-up|2|||
161017473|NCT02530671|581453157|FG001|Overall Study|Lost to Follow-up|0|||
161017474|NCT02530671|581453156|FG000|Overall Study|Withdrawal by Subject|1|||
161017475|NCT02530671|581453157|FG001|Overall Study|Withdrawal by Subject|0|||
161017476|NCT05247489|581453158|FG000|Overall Study|Lost to Follow-up|5|||
161017477|NCT05247489|581453159|FG001|Overall Study|Lost to Follow-up|1|||
161017478|NCT05247489|581453158|FG000|Overall Study|Withdrawal by Subject|6|||
161017479|NCT05247489|581453159|FG001|Overall Study|Withdrawal by Subject|7|||
161017480|NCT05247489|581453158|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
161017481|NCT05247489|581453159|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
161017482|NCT05247489|581453158|FG000|Overall Study|Left Country|1|||
161017483|NCT05247489|581453159|FG001|Overall Study|Left Country|0|||
161017484|NCT05247489|581453158|FG000|Overall Study|Noncompliance with Investigational Product|1|||
161017485|NCT05247489|581453159|FG001|Overall Study|Noncompliance with Investigational Product|0|||
161017486|NCT05247489|581453158|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
161017487|NCT05247489|581453159|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
161017488|NCT03126019|581453160|FG000|Overall Study|Death|5|||
161017489|NCT03126019|581453161|FG001|Overall Study|Death|27|||
161017490|NCT03126019|581453160|FG000|Overall Study|Lost to Follow-up|2|||
161017491|NCT03126019|581453161|FG001|Overall Study|Lost to Follow-up|4|||
161017492|NCT03126019|581453160|FG000|Overall Study|Withdrawal by Subject|1|||
161017493|NCT03126019|581453161|FG001|Overall Study|Withdrawal by Subject|9|||
161017494|NCT03126019|581453160|FG000|Overall Study|Physician Decision|1|||
161017495|NCT03126019|581453161|FG001|Overall Study|Physician Decision|0|||
161017496|NCT03126019|581453160|FG000|Overall Study|Transitioned to Rollover Study|0|||
161017497|NCT03126019|581453161|FG001|Overall Study|Transitioned to Rollover Study|11|||
161017498|NCT03126019|581453160|FG000|Overall Study|Did Not Return to Site for Care|0|||
160586714|NCT03136185|579865785|FG007|Overall Study|Adverse Event|1|||
160586715|NCT03136185|579865786|FG008|Overall Study|Adverse Event|1|||
160586716|NCT03136185|579865778|FG000|Overall Study|Death|0|||
160586717|NCT03136185|579865779|FG001|Overall Study|Death|0|||
160586718|NCT03136185|579865780|FG002|Overall Study|Death|0|||
160586719|NCT03136185|579865781|FG003|Overall Study|Death|1|||
160586720|NCT03136185|579865782|FG004|Overall Study|Death|1|||
161017499|NCT03126019|581453161|FG001|Overall Study|Did Not Return to Site for Care|1|||
161017500|NCT03126019|581453160|FG000|Overall Study|Site Closed|0|||
161017501|NCT03126019|581453161|FG001|Overall Study|Site Closed|1|||
161017502|NCT00170573|581453165|FG000|Overall Study|Violation of inclusion criteria|13|||
161017503|NCT05563246|581453211|FG000|Overall Study|Withdrawal by Subject|1|||
161017504|NCT05563246|581453212|FG001|Overall Study|Withdrawal by Subject|2|||
161017505|NCT05563246|581453213|FG002|Overall Study|Withdrawal by Subject|0|||
161017506|NCT05563246|581453214|FG003|Overall Study|Withdrawal by Subject|0|||
161017507|NCT05563246|581453211|FG000|Overall Study|Protocol Deviation|0|||
161017508|NCT05563246|581453212|FG001|Overall Study|Protocol Deviation|1|||
161017509|NCT05563246|581453213|FG002|Overall Study|Protocol Deviation|0|||
161017510|NCT05563246|581453214|FG003|Overall Study|Protocol Deviation|0|||
161017511|NCT05563246|581453211|FG000|Overall Study|Physician Decision|0|||
161017512|NCT05563246|581453212|FG001|Overall Study|Physician Decision|1|||
161017513|NCT05563246|581453213|FG002|Overall Study|Physician Decision|0|||
161017514|NCT05563246|581453214|FG003|Overall Study|Physician Decision|0|||
160586721|NCT03136185|579865783|FG005|Overall Study|Death|0|||
160586722|NCT03136185|579865784|FG006|Overall Study|Death|1|||
160586723|NCT03136185|579865785|FG007|Overall Study|Death|0|||
161017515|NCT05563246|581453211|FG000|Overall Study|Adverse Event|0|||
161017516|NCT05563246|581453212|FG001|Overall Study|Adverse Event|0|||
161017517|NCT05563246|581453213|FG002|Overall Study|Adverse Event|2|||
161017518|NCT05563246|581453214|FG003|Overall Study|Adverse Event|0|||
161017519|NCT05563246|581453211|FG000|Overall Study|Lost to Follow-up|0|||
161017520|NCT05563246|581453212|FG001|Overall Study|Lost to Follow-up|0|||
161017521|NCT05563246|581453213|FG002|Overall Study|Lost to Follow-up|1|||
161017522|NCT05563246|581453214|FG003|Overall Study|Lost to Follow-up|0|||
161017523|NCT03332017|581453216|FG000|Overall Study|Lost to Follow-up|1|||
161017524|NCT03332017|581453217|FG001|Overall Study|Lost to Follow-up|2|||
161017525|NCT03332017|581453216|FG000|Overall Study|Death|17|||
161017526|NCT03332017|581453217|FG001|Overall Study|Death|16|||
161017527|NCT03332017|581453216|FG000|Overall Study|Withdrawal by Subject|6|||
161017528|NCT03332017|581453217|FG001|Overall Study|Withdrawal by Subject|14|||
161017529|NCT03332017|581453216|FG000|Overall Study|Other|1|||
161017530|NCT03332017|581453217|FG001|Overall Study|Other|3|||
161017531|NCT03332017|581453216|FG000|Overall Study|Remained in Study (Ongoing)|47|||
161017532|NCT03332017|581453217|FG001|Overall Study|Remained in Study (Ongoing)|110|||
161017533|NCT01580488|581453218|FG000|Overall Study|Withdrawal by Subject|1|||
161017534|NCT03699709|581453222|FG000|Overall Study|Death|1|||
161017535|NCT03699709|581453223|FG001|Overall Study|Death|2|||
161017536|NCT03699709|581453222|FG000|Overall Study|Lost to Follow-up|10|||
161017537|NCT03699709|581453223|FG001|Overall Study|Lost to Follow-up|3|||
161017538|NCT03699709|581453222|FG000|Overall Study|Withdrawal by Subject|5|||
161017539|NCT03699709|581453223|FG001|Overall Study|Withdrawal by Subject|0|||
161017540|NCT03699709|581453222|FG000|Overall Study|incarcerated|1|||
161017541|NCT03699709|581453223|FG001|Overall Study|incarcerated|0|||
161017542|NCT03699709|581453222|FG000|Overall Study|scheduled, but no show|0|||
161017543|NCT03699709|581453223|FG001|Overall Study|scheduled, but no show|1|||
161017544|NCT02907099|581453224|FG000|Overall Study|Adverse Event|1|||
161017545|NCT02907099|581453224|FG000|Overall Study|Withdrawal by Subject|2|||
161017546|NCT02907099|581453224|FG000|Overall Study|Screen Fail|2|||
161017547|NCT05784662|581453225|FG000|Overall Study|Lost to Follow-up|21|||
161017548|NCT05784662|581453226|FG001|Overall Study|Lost to Follow-up|17|||
161017549|NCT04831216|581453230|FG000|Overall Study|Lost to Follow-up|32|||
161017550|NCT04739956|581453237|FG000|Overall Study|Withdrawal by Subject|1|||
161017551|NCT04739956|581453238|FG001|Overall Study|Withdrawal by Subject|1|||
161017552|NCT03920111|581453239|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
161017553|NCT03920111|581453240|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
161017554|NCT03920111|581453241|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
161017555|NCT03519581|581453242|FG000|Overall Study|Lost to Follow-up|3|||
161017556|NCT03519581|581453243|FG001|Overall Study|Lost to Follow-up|2|||
161017557|NCT03519581|581453242|FG000|Overall Study|Adverse Event|5|||
161017558|NCT03519581|581453243|FG001|Overall Study|Adverse Event|2|||
161017559|NCT03519581|581453242|FG000|Overall Study|Withdrawal by Subject|2|||
161017560|NCT03519581|581453243|FG001|Overall Study|Withdrawal by Subject|0|||
161017561|NCT03519581|581453242|FG000|Overall Study|Change to insurance|2|||
161017562|NCT03519581|581453243|FG001|Overall Study|Change to insurance|1|||
161017563|NCT03519581|581453242|FG000|Overall Study|Other|2|||
161017564|NCT03519581|581453243|FG001|Overall Study|Other|4|||
161017565|NCT05177848|581453244|FG000|Overall Study|Lost to Follow-up|1|||
161017566|NCT05177848|581453245|FG001|Overall Study|Lost to Follow-up|4|||
161017567|NCT05177848|581453244|FG000|Overall Study|Discontinued|2|||
161017568|NCT05177848|581453245|FG001|Overall Study|Discontinued|1|||
161017569|NCT06414213|581453246|FG000|Overall Study|Lost to Follow-up|1|||
161017570|NCT06414213|581453247|FG001|Overall Study|Lost to Follow-up|1|||
161017571|NCT06414213|581453248|FG002|Overall Study|Lost to Follow-up|3|||
161017572|NCT03720795|581453254|FG000|Phase 1|Lost to Follow-up|4|||
161017573|NCT03720795|581453254|FG000|Phase 1|Withdrawal by Subject|6|||
161017574|NCT03720795|581453254|FG000|Phase 1|Protocol Violation|1|||
161017575|NCT03720795|581453254|FG000|Phase 1|Other|1|||
161017576|NCT03720795|581453254|FG000|Phase 2|Lost to Follow-up|5|||
160586724|NCT03136185|579865786|FG008|Overall Study|Death|0|||
161017577|NCT03720795|581453254|FG000|Phase 2|Withdrawal by Subject|10|||
161017578|NCT03720795|581453254|FG000|Phase 2|Protocol Violation|2|||
161017579|NCT03720795|581453254|FG000|3 Month Follow Up|Lost to Follow-up|2|||
161017580|NCT04322643|581453255|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
161017581|NCT05486078|581453258|FG000|Overall Study|4 drop out and one withdrawn|5|||
161017582|NCT05134233|581453259|FG000|Overall Study|Pregnancy|1|||
161017583|NCT05134233|581453259|FG000|Overall Study|MEP value too low|2|||
161017584|NCT05134233|581453259|FG000|Overall Study|Lost to Follow-up|1|||
161017585|NCT04763265|581453262|FG000|Overall Study|Adverse Event|1|||
161017586|NCT04763265|581453263|FG001|Overall Study|Adverse Event|0|||
161017587|NCT04763265|581453262|FG000|Overall Study|Lost to Follow-up|2|||
161017588|NCT04763265|581453263|FG001|Overall Study|Lost to Follow-up|4|||
161017589|NCT04763265|581453262|FG000|Overall Study|Withdrawal by Subject|0|||
161017590|NCT04763265|581453263|FG001|Overall Study|Withdrawal by Subject|1|||
161017591|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Other|0|||
161017592|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Other|0|||
161017593|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Other|0|||
161017594|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Other|0|||
161017595|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Other|0|||
161017596|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Other|0|||
161017597|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Other|0|||
161017598|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Other|0|||
161017599|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Other|0|||
161017600|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Other|0|||
161017601|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Other|1|||
161017602|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Other|1|||
161017603|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Other|1|||
161017604|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Other|0|||
161017605|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Other|3|||
161017606|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Other|1|||
161017607|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Other|1|||
161017608|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Other|0|||
161017609|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017610|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017611|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017612|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017613|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017614|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017615|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
161017616|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017617|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
161017618|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017619|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017620|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017621|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
161017622|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017623|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017624|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017625|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017626|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017627|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017628|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017629|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017630|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017631|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017632|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017633|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017634|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
161017635|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017636|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017637|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017638|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017639|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017640|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017641|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017642|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017643|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017644|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017645|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017646|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017647|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017648|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017649|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017650|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017651|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017652|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017653|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017654|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
161017655|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017656|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017657|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017658|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017659|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017660|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017661|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017662|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017663|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Death|0|||
161017664|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Death|0|||
160586725|NCT03136185|579865778|FG000|Overall Study|Physician Decision|3|||
160586726|NCT03136185|579865779|FG001|Overall Study|Physician Decision|1|||
160586727|NCT03136185|579865780|FG002|Overall Study|Physician Decision|1|||
160586728|NCT03136185|579865781|FG003|Overall Study|Physician Decision|2|||
160586729|NCT03136185|579865782|FG004|Overall Study|Physician Decision|1|||
160586730|NCT03136185|579865783|FG005|Overall Study|Physician Decision|2|||
160586731|NCT03136185|579865784|FG006|Overall Study|Physician Decision|1|||
160586732|NCT03136185|579865785|FG007|Overall Study|Physician Decision|0|||
160586733|NCT03136185|579865786|FG008|Overall Study|Physician Decision|1|||
160586734|NCT03136185|579865778|FG000|Overall Study|Protocol Defined Disease Progression|0|||
160586735|NCT03136185|579865779|FG001|Overall Study|Protocol Defined Disease Progression|0|||
160586736|NCT03136185|579865780|FG002|Overall Study|Protocol Defined Disease Progression|1|||
160586737|NCT03136185|579865781|FG003|Overall Study|Protocol Defined Disease Progression|0|||
160586738|NCT03136185|579865782|FG004|Overall Study|Protocol Defined Disease Progression|0|||
160586739|NCT03136185|579865783|FG005|Overall Study|Protocol Defined Disease Progression|1|||
160586740|NCT03136185|579865784|FG006|Overall Study|Protocol Defined Disease Progression|0|||
160586741|NCT03136185|579865785|FG007|Overall Study|Protocol Defined Disease Progression|1|||
160586742|NCT03136185|579865786|FG008|Overall Study|Protocol Defined Disease Progression|1|||
160586743|NCT03136185|579865778|FG000|Overall Study|Withdrawal by Subject|1|||
160586744|NCT03136185|579865779|FG001|Overall Study|Withdrawal by Subject|0|||
160586745|NCT03136185|579865780|FG002|Overall Study|Withdrawal by Subject|1|||
160586746|NCT03136185|579865781|FG003|Overall Study|Withdrawal by Subject|1|||
160586747|NCT03136185|579865782|FG004|Overall Study|Withdrawal by Subject|1|||
160586748|NCT03136185|579865783|FG005|Overall Study|Withdrawal by Subject|1|||
160586749|NCT03136185|579865784|FG006|Overall Study|Withdrawal by Subject|2|||
160586750|NCT03136185|579865785|FG007|Overall Study|Withdrawal by Subject|3|||
160586751|NCT03136185|579865786|FG008|Overall Study|Withdrawal by Subject|3|||
160968966|NCT02202434|581275073|FG002|Overall Study|Death|13|||
160968967|NCT02202434|581275074|FG003|Overall Study|Death|27|||
160968968|NCT02202434|581275071|FG000|Overall Study|Lost to Follow-up|1|||
160968969|NCT02202434|581275072|FG001|Overall Study|Lost to Follow-up|1|||
160968970|NCT02202434|581275073|FG002|Overall Study|Lost to Follow-up|1|||
160968971|NCT02202434|581275074|FG003|Overall Study|Lost to Follow-up|0|||
160968972|NCT02202434|581275071|FG000|Overall Study|Physician Decision|2|||
160968973|NCT02202434|581275072|FG001|Overall Study|Physician Decision|3|||
160968974|NCT02202434|581275073|FG002|Overall Study|Physician Decision|0|||
160968975|NCT02202434|581275074|FG003|Overall Study|Physician Decision|0|||
160968976|NCT02202434|581275071|FG000|Overall Study|Withdrawal by Subject|13|||
160968977|NCT02202434|581275072|FG001|Overall Study|Withdrawal by Subject|14|||
160968978|NCT02202434|581275073|FG002|Overall Study|Withdrawal by Subject|1|||
160968979|NCT02202434|581275074|FG003|Overall Study|Withdrawal by Subject|4|||
160968980|NCT02202434|581275071|FG000|Overall Study|Completed Study|1|||
160968981|NCT02202434|581275072|FG001|Overall Study|Completed Study|0|||
160968982|NCT02202434|581275073|FG002|Overall Study|Completed Study|0|||
160968983|NCT02202434|581275074|FG003|Overall Study|Completed Study|0|||
160968984|NCT02202434|581275071|FG000|Overall Study|Visit Missed|21|||
160968985|NCT02202434|581275072|FG001|Overall Study|Visit Missed|12|||
160968986|NCT02202434|581275073|FG002|Overall Study|Visit Missed|0|||
160968987|NCT02202434|581275074|FG003|Overall Study|Visit Missed|5|||
160968988|NCT02202434|581275071|FG000|Overall Study|Other|1|||
160968989|NCT02202434|581275072|FG001|Overall Study|Other|0|||
160968990|NCT02202434|581275073|FG002|Overall Study|Other|0|||
160968991|NCT02202434|581275074|FG003|Overall Study|Other|1|||
160968992|NCT03237858|581275075|FG000|Overall Study|Death|19|||
160968993|NCT03237858|581275075|FG000|Overall Study|Withdrawal by Subject|37|||
160968994|NCT00332332|581275076|FG000|Overall Study|Adverse Event|13|||
160968995|NCT00332332|581275076|FG000|Overall Study|Death|1|||
160968996|NCT00332332|581275076|FG000|Overall Study|Withdrawal by Subject|8|||
160968997|NCT00332332|581275076|FG000|Overall Study|Physician Decision|1|||
160968998|NCT00332332|581275076|FG000|Overall Study|Lost to Follow-up|3|||
160968999|NCT00332332|581275076|FG000|Overall Study|Protocol deviation|4|||
160969000|NCT00332332|581275076|FG000|Overall Study|Noncompliance|2|||
160969001|NCT00332332|581275076|FG000|Overall Study|Disease progression|2|||
160969002|NCT00332332|581275076|FG000|Overall Study|Other|18|||
160969003|NCT00332332|581275076|FG000|Overall Study|Did not receive study treatment|16|||
160969004|NCT01108458|581275077|FG000|Overall Study|Withdrawal by Subject|1|||
160969005|NCT03075501|581275079|FG000|Overall Study|Scheduling difficulties|15|||
160969006|NCT03075501|581275080|FG001|Overall Study|Scheduling difficulties|9|||
160586752|NCT03136185|579865778|FG000|Overall Study|Not Reported|4|||
160969007|NCT03610737|581275085|FG000|Overall Study|Withdrawal by Subject|1|||
160969008|NCT03610737|581275086|FG001|Overall Study|Withdrawal by Subject|5|||
160969009|NCT03610737|581275085|FG000|Overall Study|Death|1|||
160969010|NCT03610737|581275086|FG001|Overall Study|Death|0|||
160586753|NCT03136185|579865779|FG001|Overall Study|Not Reported|1|||
160586754|NCT03136185|579865780|FG002|Overall Study|Not Reported|0|||
160586755|NCT03136185|579865781|FG003|Overall Study|Not Reported|1|||
160586756|NCT03136185|579865782|FG004|Overall Study|Not Reported|0|||
160969011|NCT03610737|581275085|FG000|Overall Study|Not treated|5|||
160586757|NCT03136185|579865783|FG005|Overall Study|Not Reported|2|||
160586758|NCT03136185|579865784|FG006|Overall Study|Not Reported|1|||
160586759|NCT03136185|579865785|FG007|Overall Study|Not Reported|1|||
161017665|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Death|0|||
161017666|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Death|0|||
161017667|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Death|0|||
161017668|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Death|0|||
161017669|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Death|0|||
161017670|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Death|0|||
161017671|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Death|0|||
161017672|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Death|1|||
161017673|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Death|0|||
161017674|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Death|1|||
161017675|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Death|0|||
161017676|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Death|1|||
161017677|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Death|0|||
161017678|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Death|0|||
161017679|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Death|2|||
161017680|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Death|0|||
161017681|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
161017682|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
161017683|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
161017684|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
161017685|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
161017686|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
161017687|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
161017688|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
161017689|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
161017690|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
161017691|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
161017692|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
161017693|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
161017694|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
161017695|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
161017696|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
161017697|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
161017698|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
161017699|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Adverse Event|0|||
161017700|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Adverse Event|0|||
161017701|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Adverse Event|0|||
161017702|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Adverse Event|0|||
161017703|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Adverse Event|0|||
161017704|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Adverse Event|0|||
161017705|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Adverse Event|2|||
161017706|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Adverse Event|0|||
161017707|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Adverse Event|0|||
161017708|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Adverse Event|0|||
161017709|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Adverse Event|1|||
161017710|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Adverse Event|2|||
161017711|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Adverse Event|0|||
161017712|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Adverse Event|1|||
161017713|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Adverse Event|0|||
161017714|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Adverse Event|0|||
161017715|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Adverse Event|1|||
161017716|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Adverse Event|0|||
161017717|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
161017718|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
160586760|NCT03136185|579865786|FG008|Overall Study|Not Reported|0|||
160586761|NCT00303108|579865792|FG000|Overall Study|Adverse Event|5|||
160586762|NCT00303108|579865793|FG001|Overall Study|Adverse Event|6|||
161017719|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
161017720|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
161017721|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
161017722|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
161017723|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
161017724|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
161017725|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
161017726|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
161017727|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
161017728|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
160586763|NCT00303108|579865794|FG002|Overall Study|Adverse Event|7|||
161017729|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
160586764|NCT00303108|579865792|FG000|Overall Study|Patient Request|4|||
160586765|NCT00303108|579865793|FG001|Overall Study|Patient Request|2|||
160586766|NCT00303108|579865794|FG002|Overall Study|Patient Request|8|||
161017730|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
161017731|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
161017732|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
161017733|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
161017734|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
161017735|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017736|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017737|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017738|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017739|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017740|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017741|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017742|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017743|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017744|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017745|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017746|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017747|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161017748|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161017749|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161017750|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017751|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161017752|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017753|NCT03269136|581453266|FG000|Part 2A: Dose Expansion|Other|0|||
161017754|NCT03269136|581453267|FG001|Part 2A: Dose Expansion|Other|0|||
161017755|NCT03269136|581453268|FG002|Part 2A: Dose Expansion|Other|0|||
161017756|NCT03269136|581453269|FG003|Part 2A: Dose Expansion|Other|0|||
161017757|NCT03269136|581453270|FG004|Part 2A: Dose Expansion|Other|0|||
161017758|NCT03269136|581453271|FG005|Part 2A: Dose Expansion|Other|0|||
161017759|NCT03269136|581453272|FG006|Part 2A: Dose Expansion|Other|0|||
161017760|NCT03269136|581453273|FG007|Part 2A: Dose Expansion|Other|0|||
161017761|NCT03269136|581453274|FG008|Part 2A: Dose Expansion|Other|0|||
161017762|NCT03269136|581453275|FG009|Part 2A: Dose Expansion|Other|0|||
161017763|NCT03269136|581453276|FG010|Part 2A: Dose Expansion|Other|0|||
161017764|NCT03269136|581453277|FG011|Part 2A: Dose Expansion|Other|0|||
161017765|NCT03269136|581453278|FG012|Part 2A: Dose Expansion|Other|0|||
161017766|NCT03269136|581453279|FG013|Part 2A: Dose Expansion|Other|0|||
161017767|NCT03269136|581453280|FG014|Part 2A: Dose Expansion|Other|0|||
161017768|NCT03269136|581453281|FG015|Part 2A: Dose Expansion|Other|0|||
161017769|NCT03269136|581453282|FG016|Part 2A: Dose Expansion|Other|0|||
161017770|NCT03269136|581453283|FG017|Part 2A: Dose Expansion|Other|1|||
161017771|NCT03269136|581453266|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017772|NCT03269136|581453267|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017773|NCT03269136|581453268|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017774|NCT03269136|581453269|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017775|NCT03269136|581453270|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017776|NCT03269136|581453271|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017777|NCT03269136|581453272|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017778|NCT03269136|581453273|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017779|NCT03269136|581453274|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017780|NCT03269136|581453275|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017781|NCT03269136|581453276|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017782|NCT03269136|581453277|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017783|NCT03269136|581453278|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017784|NCT03269136|581453279|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017785|NCT03269136|581453280|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017786|NCT03269136|581453281|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017787|NCT03269136|581453282|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017788|NCT03269136|581453283|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
161017789|NCT03269136|581453266|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
161017790|NCT03269136|581453267|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
161017791|NCT03269136|581453268|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
160459397|NCT02076009|579414986|FG001|Overall Study|Progressive Disease|0|||
160586767|NCT00303108|579865792|FG000|Overall Study|Failed Entry|1|||
160586768|NCT00303108|579865793|FG001|Overall Study|Failed Entry|0|||
160586769|NCT00303108|579865794|FG002|Overall Study|Failed Entry|1|||
160586770|NCT00303108|579865792|FG000|Overall Study|ineligible|2|||
160586771|NCT00303108|579865793|FG001|Overall Study|ineligible|1|||
161017792|NCT03269136|581453269|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
161017793|NCT03269136|581453270|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
161017794|NCT03269136|581453271|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
161017795|NCT03269136|581453272|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
160586772|NCT00303108|579865794|FG002|Overall Study|ineligible|0|||
160586773|NCT01067508|579865797|FG000|Overall Study|Physician Decision|0|||
160586774|NCT01067508|579865798|FG001|Overall Study|Physician Decision|1|||
161017796|NCT03269136|581453273|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
161017797|NCT03269136|581453274|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
161017798|NCT03269136|581453275|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
161017799|NCT03269136|581453276|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
161017800|NCT03269136|581453277|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
161017801|NCT03269136|581453278|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
161017802|NCT03269136|581453279|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
161017803|NCT03269136|581453280|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
161017804|NCT03269136|581453281|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
161017805|NCT03269136|581453282|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
161017806|NCT03269136|581453283|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
161017807|NCT03269136|581453266|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
161017808|NCT03269136|581453267|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
161017809|NCT03269136|581453268|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
161017810|NCT03269136|581453269|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
161017811|NCT03269136|581453270|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
161017812|NCT03269136|581453271|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
161017813|NCT03269136|581453272|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
161017814|NCT03269136|581453273|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
161017815|NCT03269136|581453274|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
161017816|NCT03269136|581453275|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
161017817|NCT03269136|581453276|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
161017818|NCT03269136|581453277|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
161017819|NCT03269136|581453278|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
161017820|NCT03269136|581453279|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
161017821|NCT03269136|581453280|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
161017822|NCT03269136|581453281|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
161017823|NCT03269136|581453282|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
161017824|NCT03269136|581453283|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
161017825|NCT03269136|581453266|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
161017826|NCT03269136|581453267|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
161017827|NCT03269136|581453268|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
161017828|NCT03269136|581453269|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
161017829|NCT03269136|581453270|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
161017830|NCT03269136|581453271|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
161017831|NCT03269136|581453272|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
161017832|NCT03269136|581453273|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
161017833|NCT03269136|581453274|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
161017834|NCT03269136|581453275|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
161017835|NCT03269136|581453276|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
161017836|NCT03269136|581453277|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
161017837|NCT03269136|581453278|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
161017838|NCT03269136|581453279|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
161017839|NCT03269136|581453280|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
161017840|NCT03269136|581453281|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
161017841|NCT03269136|581453282|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
161017842|NCT03269136|581453283|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
161017843|NCT04856163|581453290|FG000|Overall Study|Lost to Follow-up|97|||
161017844|NCT04856163|581453291|FG001|Overall Study|Lost to Follow-up|100|||
161017845|NCT03468218|581453294|FG000|Overall Study|Adverse Event|5|||
161017846|NCT03468218|581453294|FG000|Overall Study|Progressive Disease|16|||
161017847|NCT03468218|581453294|FG000|Overall Study|Death|1|||
160459398|NCT02076009|579414985|FG000|Overall Study|Physician Decision|0|||
160586775|NCT01067508|579865797|FG000|Overall Study|Withdrawal by Subject|0|||
160586776|NCT01067508|579865798|FG001|Overall Study|Withdrawal by Subject|1|||
160586777|NCT00444626|579865799|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
160586778|NCT00444626|579865799|FG000|Initial Treatment Period|Adverse Event|1|||
160586779|NCT00444626|579865799|FG000|Initial Treatment Period|Lost to Follow-up|9|||
160586780|NCT00008138|579865802|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
160586781|NCT00008138|579865802|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
160586782|NCT00008138|579865802|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
160586783|NCT00008138|579865802|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
160657063|NCT04028843|580124524|FG000|Overall Study|Lost to Follow-up|32|||
160657064|NCT04028843|580124525|FG001|Overall Study|Lost to Follow-up|39|||
161017848|NCT03468218|581453294|FG000|Overall Study|Alternate therapy|1|||
161017849|NCT03468218|581453294|FG000|Overall Study|Withdrawal by Subject|2|||
161017850|NCT03719443|581453295|FG000|Overall Study|Lost to Follow-up|0|||
161017851|NCT03719443|581453296|FG001|Overall Study|Lost to Follow-up|0|||
161017852|NCT03719443|581453297|FG002|Overall Study|Lost to Follow-up|1|||
161017853|NCT03719443|581453298|FG003|Overall Study|Lost to Follow-up|0|||
161017854|NCT03719443|581453299|FG004|Overall Study|Lost to Follow-up|1|||
161017855|NCT03719443|581453300|FG005|Overall Study|Lost to Follow-up|0|||
161017856|NCT03719443|581453301|FG006|Overall Study|Lost to Follow-up|1|||
161017857|NCT03719443|581453295|FG000|Overall Study|Withdrawal by Subject|0|||
161017858|NCT03719443|581453296|FG001|Overall Study|Withdrawal by Subject|0|||
160586784|NCT00008138|579865802|FG000|Interval Debulking|Withdrawal by Subject|2|||
160586785|NCT00008138|579865802|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
160586786|NCT00008138|579865802|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
160586787|NCT00008138|579865802|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
160586788|NCT02635737|579865806|FG000|Overall Study|Protocol Violation|1|||
161017859|NCT03719443|581453297|FG002|Overall Study|Withdrawal by Subject|1|||
161017860|NCT03719443|581453298|FG003|Overall Study|Withdrawal by Subject|0|||
161017861|NCT03719443|581453299|FG004|Overall Study|Withdrawal by Subject|0|||
161017862|NCT03719443|581453300|FG005|Overall Study|Withdrawal by Subject|0|||
161017863|NCT03719443|581453301|FG006|Overall Study|Withdrawal by Subject|0|||
161017864|NCT03447470|581453306|FG000|Overall Study|Death|0|||
161017865|NCT03447470|581453307|FG001|Overall Study|Death|1|||
161017866|NCT03447470|581453308|FG002|Overall Study|Death|3|||
161017867|NCT03447470|581453309|FG003|Overall Study|Death|0|||
161017868|NCT03447470|581453310|FG004|Overall Study|Death|1|||
161017869|NCT03447470|581453311|FG005|Overall Study|Death|0|||
161017870|NCT03447470|581453312|FG006|Overall Study|Death|3|||
161017871|NCT03447470|581453313|FG007|Overall Study|Death|3|||
161017872|NCT03447470|581453314|FG008|Overall Study|Death|1|||
161017873|NCT03447470|581453306|FG000|Overall Study|Withdrawal by Subject|1|||
161017874|NCT03447470|581453307|FG001|Overall Study|Withdrawal by Subject|0|||
161017875|NCT03447470|581453308|FG002|Overall Study|Withdrawal by Subject|0|||
161017876|NCT03447470|581453309|FG003|Overall Study|Withdrawal by Subject|0|||
161017877|NCT03447470|581453310|FG004|Overall Study|Withdrawal by Subject|1|||
161017878|NCT03447470|581453311|FG005|Overall Study|Withdrawal by Subject|0|||
161017879|NCT03447470|581453312|FG006|Overall Study|Withdrawal by Subject|1|||
161017880|NCT03447470|581453313|FG007|Overall Study|Withdrawal by Subject|1|||
161017881|NCT03447470|581453314|FG008|Overall Study|Withdrawal by Subject|3|||
161017882|NCT03447470|581453306|FG000|Overall Study|Treatment discontinued|3|||
161017883|NCT03447470|581453307|FG001|Overall Study|Treatment discontinued|2|||
161017884|NCT03447470|581453308|FG002|Overall Study|Treatment discontinued|4|||
161017885|NCT03447470|581453309|FG003|Overall Study|Treatment discontinued|6|||
161017886|NCT03447470|581453310|FG004|Overall Study|Treatment discontinued|2|||
161017887|NCT03447470|581453311|FG005|Overall Study|Treatment discontinued|1|||
161017888|NCT03447470|581453312|FG006|Overall Study|Treatment discontinued|2|||
161017889|NCT03447470|581453313|FG007|Overall Study|Treatment discontinued|4|||
161017890|NCT03447470|581453314|FG008|Overall Study|Treatment discontinued|3|||
161017891|NCT02471638|581453323|FG000|Overall Study|Early Term Withdrawal|10|||
160459399|NCT02076009|579414986|FG001|Overall Study|Physician Decision|1|||
160459400|NCT02076009|579414985|FG000|Overall Study|End of data collection|90|||
160459401|NCT02076009|579414986|FG001|Overall Study|End of data collection|118|||
160459402|NCT03786926|579414989|FG000|Overall Study|Adverse Event|0|||
160459403|NCT03786926|579414990|FG001|Overall Study|Adverse Event|0|||
160459404|NCT03786926|579414991|FG002|Overall Study|Adverse Event|0|||
160459405|NCT03786926|579414992|FG003|Overall Study|Adverse Event|0|||
160459406|NCT03786926|579414993|FG004|Overall Study|Adverse Event|0|||
160459407|NCT03786926|579414994|FG005|Overall Study|Adverse Event|0|||
160459408|NCT03786926|579414995|FG006|Overall Study|Adverse Event|0|||
160459409|NCT03786926|579414996|FG007|Overall Study|Adverse Event|1|||
160459410|NCT03786926|579414997|FG008|Overall Study|Adverse Event|1|||
160459411|NCT03786926|579414998|FG009|Overall Study|Adverse Event|0|||
160459412|NCT03786926|579414999|FG010|Overall Study|Adverse Event|1|||
160459413|NCT03786926|579414989|FG000|Overall Study|Progressive disease|3|||
160459414|NCT03786926|579414990|FG001|Overall Study|Progressive disease|0|||
160459415|NCT03786926|579414991|FG002|Overall Study|Progressive disease|3|||
160459416|NCT03786926|579414992|FG003|Overall Study|Progressive disease|1|||
160459417|NCT03786926|579414993|FG004|Overall Study|Progressive disease|2|||
160586789|NCT02349789|579867540|FG000|Overall Study|Withdrawal by Subject|2|||
160586790|NCT01009983|579867544|FG000|Overall Study|necessary scans not completed|1|||
160969012|NCT03610737|581275086|FG001|Overall Study|Not treated|2|||
160969013|NCT03610737|581275085|FG000|Overall Study|Missed Visit|1|||
160969014|NCT03610737|581275086|FG001|Overall Study|Missed Visit|2|||
160969015|NCT00710606|581275093|FG000|Overall Study|Adverse Event|0|||
160969016|NCT00710606|581275094|FG001|Overall Study|Adverse Event|2|||
160969017|NCT02670538|581275099|FG000|Overall Study|Withdrawal of Consent|8|||
160969018|NCT02670538|581275100|FG001|Overall Study|Withdrawal of Consent|6|||
160969019|NCT02670538|581275101|FG002|Overall Study|Withdrawal of Consent|5|||
160969020|NCT02670538|581275099|FG000|Overall Study|Lost to Follow-up|8|||
161017892|NCT04353661|581455735|FG000|Overall Study|Protocol Violation|0|||
160586791|NCT03497429|579867545|FG000|Overall Study|Progressive disease|3|||
160586792|NCT03497429|579867546|FG001|Overall Study|Progressive disease|4|||
161017893|NCT04353661|581455736|FG001|Overall Study|Protocol Violation|0|||
161017894|NCT04353661|581455737|FG002|Overall Study|Protocol Violation|1|||
161017895|NCT04353661|581455735|FG000|Overall Study|Study termination by the Sponsor|1|||
161017896|NCT04353661|581455736|FG001|Overall Study|Study termination by the Sponsor|1|||
161017897|NCT04353661|581455737|FG002|Overall Study|Study termination by the Sponsor|1|||
161017898|NCT03376321|581455743|FG000|Overall Study|Other|5|||
160459418|NCT03786926|579414994|FG005|Overall Study|Progressive disease|2|||
161017899|NCT03376321|581455744|FG001|Overall Study|Other|1|||
161017900|NCT03376321|581455743|FG000|Overall Study|Withdrawal by Subject|8|||
161017901|NCT03376321|581455744|FG001|Overall Study|Withdrawal by Subject|14|||
161017902|NCT03376321|581455743|FG000|Overall Study|Lost to Follow-up|1|||
161017903|NCT03376321|581455744|FG001|Overall Study|Lost to Follow-up|7|||
161017904|NCT03376321|581455743|FG000|Overall Study|Death|4|||
161017905|NCT03376321|581455744|FG001|Overall Study|Death|0|||
161017906|NCT03376321|581455743|FG000|Overall Study|Randomized, not treated|5|||
161017907|NCT03376321|581455744|FG001|Overall Study|Randomized, not treated|3|||
161017908|NCT02671903|581455745|FG000|Period 0 (Run-In)|Death|0|||
160586793|NCT03497429|579867545|FG000|Overall Study|Adverse Event|0|||
161017909|NCT02671903|581455746|FG001|Period 0 (Run-In)|Death|0|||
161017910|NCT02671903|581455747|FG002|Period 0 (Run-In)|Death|3|||
161017911|NCT02671903|581455745|FG000|Period 0 (Run-In)|Physician Decision|0|||
161017912|NCT02671903|581455746|FG001|Period 0 (Run-In)|Physician Decision|0|||
161017913|NCT02671903|581455747|FG002|Period 0 (Run-In)|Physician Decision|4|||
161017914|NCT02671903|581455745|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
161017915|NCT02671903|581455746|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
161017916|NCT02671903|581455747|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
161017917|NCT02671903|581455745|FG000|Period 0 (Run-In)|Protocol Violation|0|||
161017918|NCT02671903|581455746|FG001|Period 0 (Run-In)|Protocol Violation|0|||
161017919|NCT02671903|581455747|FG002|Period 0 (Run-In)|Protocol Violation|1|||
161017920|NCT02671903|581455745|FG000|Period 0 (Run-In)|Adverse Event|0|||
161017921|NCT02671903|581455746|FG001|Period 0 (Run-In)|Adverse Event|0|||
161017922|NCT02671903|581455747|FG002|Period 0 (Run-In)|Adverse Event|1|||
161017923|NCT02671903|581455745|FG000|Period 0 (Run-In)|Implantation Failure|0|||
161017924|NCT02671903|581455746|FG001|Period 0 (Run-In)|Implantation Failure|0|||
161017925|NCT02671903|581455747|FG002|Period 0 (Run-In)|Implantation Failure|2|||
161017926|NCT02671903|581455745|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
161017927|NCT02671903|581455746|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
161017928|NCT02671903|581455747|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
161017929|NCT03673111|581455767|FG000|Overall Study|Protocol Violation|0|||
161017930|NCT03673111|581455768|FG001|Overall Study|Protocol Violation|0|||
161017931|NCT03673111|581455769|FG002|Overall Study|Protocol Violation|0|||
161017932|NCT03673111|581455770|FG003|Overall Study|Protocol Violation|0|||
161017933|NCT03673111|581455771|FG004|Overall Study|Protocol Violation|0|||
161017934|NCT03673111|581455772|FG005|Overall Study|Protocol Violation|0|||
161017935|NCT03673111|581455773|FG006|Overall Study|Protocol Violation|0|||
161017936|NCT03673111|581455774|FG007|Overall Study|Protocol Violation|0|||
161017937|NCT03673111|581455775|FG008|Overall Study|Protocol Violation|0|||
161017938|NCT03673111|581455776|FG009|Overall Study|Protocol Violation|0|||
161017939|NCT03673111|581455777|FG010|Overall Study|Protocol Violation|1|||
161017940|NCT03673111|581455778|FG011|Overall Study|Protocol Violation|0|||
161017941|NCT03673111|581455779|FG012|Overall Study|Protocol Violation|0|||
161017942|NCT03673111|581455780|FG013|Overall Study|Protocol Violation|0|||
161017943|NCT03673111|581455767|FG000|Overall Study|Adverse Event|1|||
161017944|NCT03673111|581455768|FG001|Overall Study|Adverse Event|0|||
161017945|NCT03673111|581455769|FG002|Overall Study|Adverse Event|0|||
161017946|NCT03673111|581455770|FG003|Overall Study|Adverse Event|0|||
161017947|NCT03673111|581455771|FG004|Overall Study|Adverse Event|0|||
161017948|NCT03673111|581455772|FG005|Overall Study|Adverse Event|0|||
161017949|NCT03673111|581455773|FG006|Overall Study|Adverse Event|0|||
161017950|NCT03673111|581455774|FG007|Overall Study|Adverse Event|0|||
160586794|NCT03497429|579867546|FG001|Overall Study|Adverse Event|2|||
160586795|NCT02006667|579867549|FG000|Overall Study|Adverse Event|3|||
161017951|NCT03673111|581455775|FG008|Overall Study|Adverse Event|0|||
161017952|NCT03673111|581455776|FG009|Overall Study|Adverse Event|0|||
161017953|NCT03673111|581455777|FG010|Overall Study|Adverse Event|0|||
161017954|NCT03673111|581455778|FG011|Overall Study|Adverse Event|0|||
161017955|NCT03673111|581455779|FG012|Overall Study|Adverse Event|0|||
160586796|NCT02006667|579867549|FG000|Overall Study|Death|2|||
160586797|NCT02006667|579867549|FG000|Overall Study|Withdrawal by Subject|1|||
160586798|NCT00174785|579867558|FG000|Overall Study|Adverse Event|293|||
161017956|NCT03673111|581455780|FG013|Overall Study|Adverse Event|0|||
160586799|NCT00174785|579867559|FG001|Overall Study|Adverse Event|191|||
161017957|NCT04485039|581455784|FG000|TPOXX Only|Adverse Event|2|||
161017958|NCT04485039|581455784|FG000|TPOXX Only|Physician Decision|1|||
161017959|NCT04485039|581455784|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
161017960|NCT04485039|581455784|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
161017961|NCT04005716|581455788|FG000|Overall Study|Death|175|||
160586800|NCT00174785|579867558|FG000|Overall Study|Protocol Violation|14|||
160586801|NCT00174785|579867559|FG001|Overall Study|Protocol Violation|14|||
161017962|NCT04005716|581455789|FG001|Overall Study|Death|196|||
161017963|NCT04005716|581455788|FG000|Overall Study|Withdrawal by Subject|1|||
161017964|NCT04005716|581455789|FG001|Overall Study|Withdrawal by Subject|6|||
161017965|NCT04005716|581455788|FG000|Overall Study|Lost to Follow-up|2|||
161017966|NCT04005716|581455789|FG001|Overall Study|Lost to Follow-up|2|||
160586802|NCT00174785|579867558|FG000|Overall Study|Withdrawal by Subject|173|||
160586803|NCT00174785|579867559|FG001|Overall Study|Withdrawal by Subject|175|||
160586804|NCT00174785|579867558|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
160586805|NCT00174785|579867559|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
160586806|NCT00174785|579867558|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
160586807|NCT00174785|579867559|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
160586808|NCT00174785|579867558|FG000|Overall Study|Other prohibited medication|5|||
160586809|NCT00174785|579867559|FG001|Overall Study|Other prohibited medication|3|||
160586810|NCT00174785|579867558|FG000|Overall Study|Family request|6|||
160586811|NCT00174785|579867559|FG001|Overall Study|Family request|8|||
160586812|NCT00174785|579867558|FG000|Overall Study|Not pre-specified/Not coded|56|||
160586813|NCT00174785|579867559|FG001|Overall Study|Not pre-specified/Not coded|70|||
160586814|NCT00120289|579867560|FG000|Overall Study|Death|96|||
160586815|NCT00120289|579867561|FG001|Overall Study|Death|82|||
160586816|NCT00120289|579867560|FG000|Overall Study|Lost to Follow-up|11|||
160586817|NCT00120289|579867561|FG001|Overall Study|Lost to Follow-up|14|||
160586818|NCT00120289|579867560|FG000|Overall Study|Withdrawal by Subject|14|||
160586819|NCT00120289|579867561|FG001|Overall Study|Withdrawal by Subject|13|||
160586820|NCT04507867|579867568|FG000|Overall Study|Death|7|||
160586821|NCT04507867|579867569|FG001|Overall Study|Death|1|||
160586822|NCT03364673|579867573|FG000|Overall Study|Withdrawal by Subject|2|||
160586823|NCT03364673|579867573|FG000|Overall Study|Injury unrelated to study|3|||
160586824|NCT00194025|579867575|FG000|Overall Study|Adverse Event|1|||
160586825|NCT00194025|579867575|FG000|Overall Study|non-adherence with study medication|4|||
160586826|NCT00543569|579867576|FG000|Overall Study|Death|2|||
160586827|NCT00543569|579867577|FG001|Overall Study|Death|2|||
160586828|NCT00543569|579867578|FG002|Overall Study|Death|3|||
160586829|NCT00543569|579867579|FG003|Overall Study|Death|1|||
161017967|NCT02783300|581455790|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017968|NCT02783300|581455791|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017969|NCT02783300|581455792|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017970|NCT02783300|581455793|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017971|NCT02783300|581455794|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017972|NCT02783300|581455795|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017973|NCT02783300|581455796|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
161017974|NCT02783300|581455797|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017975|NCT02783300|581455798|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017976|NCT02783300|581455799|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017977|NCT02783300|581455800|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017978|NCT02783300|581455801|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017979|NCT02783300|581455802|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017980|NCT02783300|581455803|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017981|NCT02783300|581455804|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017982|NCT02783300|581455805|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017983|NCT02783300|581455806|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017984|NCT02783300|581455807|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017985|NCT02783300|581455808|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017986|NCT02783300|581455809|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017987|NCT02783300|581455810|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017988|NCT02783300|581455811|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017989|NCT02783300|581455812|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017990|NCT02783300|581455813|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017991|NCT02783300|581455814|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017992|NCT02783300|581455815|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017993|NCT02783300|581455816|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017994|NCT02783300|581455790|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161017995|NCT02783300|581455791|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161017996|NCT02783300|581455792|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161017997|NCT02783300|581455793|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
160586830|NCT00543569|579867576|FG000|Overall Study|Lost to Follow-up|0|||
160586831|NCT00543569|579867577|FG001|Overall Study|Lost to Follow-up|0|||
161017998|NCT02783300|581455794|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161017999|NCT02783300|581455795|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018000|NCT02783300|581455796|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
160586832|NCT00543569|579867578|FG002|Overall Study|Lost to Follow-up|1|||
160586833|NCT00543569|579867579|FG003|Overall Study|Lost to Follow-up|1|||
160586834|NCT00543569|579867576|FG000|Overall Study|Miscellaneous Reasons|7|||
160586835|NCT00543569|579867577|FG001|Overall Study|Miscellaneous Reasons|3|||
160657065|NCT04028843|580124524|FG000|Overall Study|Adverse Event|1|||
160586836|NCT00543569|579867578|FG002|Overall Study|Miscellaneous Reasons|11|||
160586837|NCT00543569|579867579|FG003|Overall Study|Miscellaneous Reasons|4|||
160586838|NCT00543569|579867576|FG000|Overall Study|Randomized but never received study drug|3|||
160586839|NCT00543569|579867577|FG001|Overall Study|Randomized but never received study drug|3|||
161018001|NCT02783300|581455797|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018002|NCT02783300|581455798|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018003|NCT02783300|581455799|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018004|NCT02783300|581455800|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018005|NCT02783300|581455801|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018006|NCT02783300|581455802|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018007|NCT02783300|581455803|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018008|NCT02783300|581455804|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018009|NCT02783300|581455805|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018010|NCT02783300|581455806|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018011|NCT02783300|581455807|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018012|NCT02783300|581455808|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018013|NCT02783300|581455809|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018014|NCT02783300|581455810|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018015|NCT02783300|581455811|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018016|NCT02783300|581455812|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018017|NCT02783300|581455813|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018018|NCT02783300|581455814|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018019|NCT02783300|581455815|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018020|NCT02783300|581455816|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018021|NCT02783300|581455790|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
161018022|NCT02783300|581455791|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
161018023|NCT02783300|581455792|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
161018024|NCT02783300|581455793|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
161018025|NCT02783300|581455794|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
161018026|NCT02783300|581455795|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
161018027|NCT02783300|581455796|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
161018028|NCT02783300|581455797|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
161018029|NCT02783300|581455798|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
161018030|NCT02783300|581455799|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
161018031|NCT02783300|581455800|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
161018032|NCT02783300|581455801|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
161018033|NCT02783300|581455802|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
160586840|NCT00543569|579867578|FG002|Overall Study|Randomized but never received study drug|5|||
160586841|NCT00543569|579867579|FG003|Overall Study|Randomized but never received study drug|3|||
160586842|NCT00862849|579867580|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
160586843|NCT00862849|579867581|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
160586844|NCT00862849|579867582|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
160586845|NCT00862849|579867583|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
160586846|NCT00862849|579867584|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
160586847|NCT00862849|579867585|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
160586848|NCT00862849|579867580|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
160657066|NCT04028843|580124525|FG001|Overall Study|Adverse Event|0|||
160657067|NCT04028843|580124524|FG000|Overall Study|Non-viable Pregnancy|0|||
160969021|NCT02670538|581275100|FG001|Overall Study|Lost to Follow-up|12|||
160969022|NCT02670538|581275101|FG002|Overall Study|Lost to Follow-up|7|||
160969023|NCT02670538|581275099|FG000|Overall Study|Adverse Event|5|||
160969024|NCT02670538|581275100|FG001|Overall Study|Adverse Event|5|||
160969025|NCT02670538|581275101|FG002|Overall Study|Adverse Event|11|||
160969026|NCT02670538|581275099|FG000|Overall Study|Lack of Efficacy|7|||
160969027|NCT02670538|581275100|FG001|Overall Study|Lack of Efficacy|1|||
160969028|NCT02670538|581275101|FG002|Overall Study|Lack of Efficacy|2|||
160969029|NCT02670538|581275099|FG000|Overall Study|Protocol Violation|3|||
160969030|NCT02670538|581275100|FG001|Overall Study|Protocol Violation|4|||
160969031|NCT02670538|581275101|FG002|Overall Study|Protocol Violation|1|||
160969032|NCT02670538|581275099|FG000|Overall Study|Noncompliance with Study Drug|1|||
160969033|NCT02670538|581275100|FG001|Overall Study|Noncompliance with Study Drug|3|||
160969034|NCT02670538|581275101|FG002|Overall Study|Noncompliance with Study Drug|2|||
160969035|NCT02670538|581275099|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160969036|NCT02670538|581275100|FG001|Overall Study|Other Miscellaneous Reasons|1|||
160969037|NCT02670538|581275101|FG002|Overall Study|Other Miscellaneous Reasons|2|||
160969038|NCT02243202|581275102|FG000|Overall Study|Adverse Event|5|||
160969039|NCT02243202|581275103|FG001|Overall Study|Adverse Event|6|||
160969040|NCT02243202|581275104|FG002|Overall Study|Adverse Event|10|||
160969041|NCT02243202|581275105|FG003|Overall Study|Adverse Event|4|||
160969042|NCT02243202|581275102|FG000|Overall Study|Lost to Follow-up|9|||
160969043|NCT02243202|581275103|FG001|Overall Study|Lost to Follow-up|9|||
160969044|NCT02243202|581275104|FG002|Overall Study|Lost to Follow-up|14|||
160969045|NCT02243202|581275105|FG003|Overall Study|Lost to Follow-up|11|||
160969046|NCT02243202|581275102|FG000|Overall Study|Protocol Violation|3|||
160969047|NCT02243202|581275103|FG001|Overall Study|Protocol Violation|1|||
160969048|NCT02243202|581275104|FG002|Overall Study|Protocol Violation|2|||
161018034|NCT02783300|581455803|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
161018035|NCT02783300|581455804|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
161018036|NCT02783300|581455805|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
161018037|NCT02783300|581455806|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
161018038|NCT02783300|581455807|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
161018039|NCT02783300|581455808|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
161018040|NCT02783300|581455809|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
161018041|NCT02783300|581455810|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
161018042|NCT02783300|581455811|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
161018043|NCT02783300|581455812|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
161018044|NCT02783300|581455813|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
161018045|NCT02783300|581455814|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
161018046|NCT02783300|581455815|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
161018047|NCT02783300|581455816|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
161018048|NCT02783300|581455790|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018049|NCT02783300|581455791|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018050|NCT02783300|581455792|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018051|NCT02783300|581455793|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018052|NCT02783300|581455794|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018053|NCT02783300|581455795|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018054|NCT02783300|581455796|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
161018055|NCT02783300|581455797|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018056|NCT02783300|581455798|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018057|NCT02783300|581455799|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018058|NCT02783300|581455800|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018059|NCT02783300|581455801|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018060|NCT02783300|581455802|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
161018061|NCT02783300|581455803|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018062|NCT02783300|581455804|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018063|NCT02783300|581455805|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018064|NCT02783300|581455806|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018065|NCT02783300|581455807|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018066|NCT02783300|581455808|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018067|NCT02783300|581455809|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018068|NCT02783300|581455810|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018069|NCT02783300|581455811|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018070|NCT02783300|581455812|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018071|NCT02783300|581455813|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018072|NCT02783300|581455814|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018073|NCT02783300|581455815|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018074|NCT02783300|581455816|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018075|NCT02783300|581455790|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018076|NCT02783300|581455791|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018077|NCT02783300|581455792|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018078|NCT02783300|581455793|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018079|NCT02783300|581455794|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
161018080|NCT02783300|581455795|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018081|NCT02783300|581455796|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
161018082|NCT02783300|581455797|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018083|NCT02783300|581455798|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018084|NCT02783300|581455799|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
161018085|NCT02783300|581455800|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018086|NCT02783300|581455801|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018087|NCT02783300|581455802|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
161018088|NCT02783300|581455803|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018089|NCT02783300|581455804|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018090|NCT02783300|581455805|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018091|NCT02783300|581455806|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018092|NCT02783300|581455807|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018093|NCT02783300|581455808|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018094|NCT02783300|581455809|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
160459419|NCT03786926|579414995|FG006|Overall Study|Progressive disease|1|||
161018095|NCT02783300|581455810|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018096|NCT02783300|581455811|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
160459420|NCT03786926|579414996|FG007|Overall Study|Progressive disease|6|||
160586849|NCT00862849|579867581|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
161018097|NCT02783300|581455812|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018098|NCT02783300|581455813|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018099|NCT02783300|581455814|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018100|NCT02783300|581455815|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018101|NCT02783300|581455816|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018102|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018103|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018104|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018105|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018106|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018107|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018108|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018109|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018110|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018111|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018112|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018113|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018114|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018115|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018116|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018117|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
161018118|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018119|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
161018120|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
161018121|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
161018122|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018123|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018124|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018125|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018126|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
161018127|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018128|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018129|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018130|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018131|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018132|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018133|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018134|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018135|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018136|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018137|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018138|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018139|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018140|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018141|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018142|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018143|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018144|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018145|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
161018146|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018147|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
161018148|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
161018149|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018150|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
160586850|NCT00862849|579867582|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
160586851|NCT00862849|579867583|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
160586852|NCT00862849|579867584|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
160586853|NCT00862849|579867585|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
160586854|NCT00617409|579867586|FG000|Overall Study|Withdrawal by Subject|4|||
160586855|NCT00617409|579867587|FG001|Overall Study|Withdrawal by Subject|1|||
160586856|NCT00617409|579867588|FG002|Overall Study|Withdrawal by Subject|2|||
161018151|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018152|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018153|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018154|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018155|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018156|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018157|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018158|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018159|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018160|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018161|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018162|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018163|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018164|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018165|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018166|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018167|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018168|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018169|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018170|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018171|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018172|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
161018173|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018174|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
161018175|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
161018176|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
161018177|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018178|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018179|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018180|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018181|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018182|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018183|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018184|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018185|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018186|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018187|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018188|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018189|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018190|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018191|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018192|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018193|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018194|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018195|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018196|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018197|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018198|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
161018199|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018200|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018201|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018202|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018203|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018204|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018205|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
161018206|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018207|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018208|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018209|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018210|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018211|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018212|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018213|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018214|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018215|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018216|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018217|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018218|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018219|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018220|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018221|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018222|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018223|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
161018224|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
161018225|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
161018226|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
161018227|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018228|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
161018229|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
161018230|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018231|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018232|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018233|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018234|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018235|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018236|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018237|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018238|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018239|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018240|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018241|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018242|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018243|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018244|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018245|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018246|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018247|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018248|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018249|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018250|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
161018251|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161018252|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161018253|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161018254|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161018255|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161018256|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
161018257|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161018258|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161018259|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
161018260|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161018261|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161018262|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
161018263|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018264|NCT02783300|581455790|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018265|NCT02783300|581455791|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018266|NCT02783300|581455792|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018267|NCT02783300|581455793|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018268|NCT02783300|581455794|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018269|NCT02783300|581455795|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018270|NCT02783300|581455796|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
160459421|NCT03786926|579414997|FG008|Overall Study|Progressive disease|1|||
160586857|NCT00617409|579867586|FG000|Overall Study|Adverse Event|0|||
160586858|NCT00617409|579867587|FG001|Overall Study|Adverse Event|2|||
160586859|NCT00617409|579867588|FG002|Overall Study|Adverse Event|3|||
160586860|NCT00617409|579867586|FG000|Overall Study|Disease Progression|8|||
160586861|NCT00617409|579867587|FG001|Overall Study|Disease Progression|8|||
161018271|NCT02783300|581455797|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018272|NCT02783300|581455798|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018273|NCT02783300|581455799|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018274|NCT02783300|581455800|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018275|NCT02783300|581455801|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018276|NCT02783300|581455802|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018277|NCT02783300|581455803|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018278|NCT02783300|581455804|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018279|NCT02783300|581455805|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018280|NCT02783300|581455806|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018281|NCT02783300|581455807|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018282|NCT02783300|581455808|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018283|NCT02783300|581455809|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018284|NCT02783300|581455810|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018285|NCT02783300|581455811|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018286|NCT02783300|581455812|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018287|NCT02783300|581455813|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018288|NCT02783300|581455814|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018289|NCT02783300|581455815|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018290|NCT02783300|581455816|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
161018291|NCT02783300|581455790|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018292|NCT02783300|581455791|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018293|NCT02783300|581455792|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018294|NCT02783300|581455793|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018295|NCT02783300|581455794|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018296|NCT02783300|581455795|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018297|NCT02783300|581455796|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018298|NCT02783300|581455797|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018299|NCT02783300|581455798|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018300|NCT02783300|581455799|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018301|NCT02783300|581455800|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018302|NCT02783300|581455801|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018303|NCT02783300|581455802|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018304|NCT02783300|581455803|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018305|NCT02783300|581455804|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018306|NCT02783300|581455805|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018307|NCT02783300|581455806|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018308|NCT02783300|581455807|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018309|NCT02783300|581455808|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018310|NCT02783300|581455809|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018311|NCT02783300|581455810|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018312|NCT02783300|581455811|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018313|NCT02783300|581455812|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018314|NCT02783300|581455813|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018315|NCT02783300|581455814|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018316|NCT02783300|581455815|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018317|NCT02783300|581455816|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
161018318|NCT03535272|581455817|FG000|Overall Study|Lost to Follow-up|71|||
161018319|NCT03535272|581455818|FG001|Overall Study|Lost to Follow-up|73|||
161018320|NCT01744782|581455819|FG000|Overall Study|Death|1|||
161018321|NCT00378105|581455820|FG000|Overall Study|Adverse Event|3|||
161018322|NCT00378105|581455821|FG001|Overall Study|Adverse Event|1|||
161018323|NCT00378105|581455820|FG000|Overall Study|Withdrawal by Subject|3|||
161018324|NCT00378105|581455821|FG001|Overall Study|Withdrawal by Subject|3|||
161018325|NCT00378105|581455820|FG000|Overall Study|Death|1|||
161018326|NCT00378105|581455821|FG001|Overall Study|Death|0|||
161018327|NCT00378105|581455820|FG000|Overall Study|Going to transplant|7|||
161018328|NCT00378105|581455821|FG001|Overall Study|Going to transplant|8|||
161018329|NCT00378105|581455820|FG000|Overall Study|Progressive disease|3|||
161018330|NCT00378105|581455821|FG001|Overall Study|Progressive disease|3|||
161018331|NCT00378105|581455820|FG000|Overall Study|remain on study|3|||
161018332|NCT00378105|581455821|FG001|Overall Study|remain on study|11|||
161018333|NCT00378105|581455820|FG000|Overall Study|Physician Decision|0|||
161018334|NCT00378105|581455821|FG001|Overall Study|Physician Decision|2|||
161018335|NCT00378105|581455820|FG000|Overall Study|Going non-protocol therapy|0|||
161018336|NCT00378105|581455821|FG001|Overall Study|Going non-protocol therapy|1|||
161018337|NCT00378105|581455820|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
161018338|NCT00378105|581455821|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
161018339|NCT03623321|581455822|FG000|Overall Study|Adverse Event|32|||
160586862|NCT00617409|579867588|FG002|Overall Study|Disease Progression|18|||
160586863|NCT00617409|579867586|FG000|Overall Study|Death|3|||
160586864|NCT00617409|579867587|FG001|Overall Study|Death|5|||
160586865|NCT00617409|579867588|FG002|Overall Study|Death|4|||
161018340|NCT03623321|581455822|FG000|Overall Study|Death|9|||
161018341|NCT03623321|581455822|FG000|Overall Study|Lack of Efficacy|9|||
161018342|NCT03623321|581455822|FG000|Overall Study|Lost to Follow-up|6|||
160586866|NCT00617409|579867586|FG000|Overall Study|Alternative Therapy|1|||
160586867|NCT00617409|579867587|FG001|Overall Study|Alternative Therapy|2|||
160586868|NCT00617409|579867588|FG002|Overall Study|Alternative Therapy|0|||
160586869|NCT02124707|579867594|FG000|Overall Study|Adverse Event|5|||
160586870|NCT02124707|579867594|FG000|Overall Study|Physician Decision|1|||
160586871|NCT02124707|579867594|FG000|Overall Study|Death|1|||
160586872|NCT00511342|579867603|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
160586873|NCT00511342|579867604|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
160586874|NCT00511342|579867603|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
160586875|NCT00511342|579867604|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
160586876|NCT00511342|579867603|FG000|Overall Study|Pregnancy|0|||
160586877|NCT00511342|579867604|FG001|Overall Study|Pregnancy|1|||
160586878|NCT00511342|579867603|FG000|Overall Study|Pregnancy wish|0|||
160586879|NCT00511342|579867604|FG001|Overall Study|Pregnancy wish|1|||
160586880|NCT00511342|579867603|FG000|Overall Study|Lost to Follow-up|1|||
160586881|NCT00511342|579867604|FG001|Overall Study|Lost to Follow-up|5|||
160586882|NCT00511342|579867603|FG000|Overall Study|Other Reason|2|||
160586883|NCT00511342|579867604|FG001|Overall Study|Other Reason|2|||
160586884|NCT02432040|579867605|FG000|Overall Study|Lack of Efficacy|3|||
160586885|NCT02432040|579867606|FG001|Overall Study|Lack of Efficacy|0|||
160586886|NCT02432040|579867605|FG000|Overall Study|Lost to Follow-up|4|||
160586887|NCT02432040|579867606|FG001|Overall Study|Lost to Follow-up|5|||
160586888|NCT02432040|579867605|FG000|Overall Study|Physician Decision|1|||
160586889|NCT02432040|579867606|FG001|Overall Study|Physician Decision|1|||
160586890|NCT03198754|579867607|FG000|Overall Study|Withdrawal by Subject|5|||
160586891|NCT03198754|579867608|FG001|Overall Study|Withdrawal by Subject|4|||
160586892|NCT03198754|579867607|FG000|Overall Study|Lost to Follow-up|4|||
160586893|NCT03198754|579867608|FG001|Overall Study|Lost to Follow-up|3|||
160586894|NCT03198754|579867607|FG000|Overall Study|Ineligible|2|||
160586895|NCT03198754|579867608|FG001|Overall Study|Ineligible|1|||
160586896|NCT03247413|579867614|FG000|Overall Study|Lost to Follow-up|28|||
160586897|NCT00642746|579867615|FG000|Overall Study|Patient unevaluable|1|||
160586898|NCT00642746|579867616|FG001|Overall Study|Patient unevaluable|0|||
160586899|NCT01496430|579867620|FG000|Overall Study|Adverse Event|0|||
160586900|NCT01496430|579867621|FG001|Overall Study|Adverse Event|0|||
160586901|NCT01496430|579867622|FG002|Overall Study|Adverse Event|1|||
160586902|NCT01496430|579867620|FG000|Overall Study|Major Protocol Deviation|0|||
160586903|NCT01496430|579867621|FG001|Overall Study|Major Protocol Deviation|0|||
160586904|NCT01496430|579867622|FG002|Overall Study|Major Protocol Deviation|1|||
160586905|NCT01496430|579867620|FG000|Overall Study|Lost to Follow-up|2|||
160586906|NCT01496430|579867621|FG001|Overall Study|Lost to Follow-up|3|||
160969049|NCT02243202|581275105|FG003|Overall Study|Protocol Violation|1|||
160969050|NCT02243202|581275102|FG000|Overall Study|Withdrawal by Subject|7|||
160969051|NCT02243202|581275103|FG001|Overall Study|Withdrawal by Subject|6|||
160969052|NCT02243202|581275104|FG002|Overall Study|Withdrawal by Subject|4|||
160969053|NCT02243202|581275105|FG003|Overall Study|Withdrawal by Subject|4|||
160969054|NCT02243202|581275102|FG000|Overall Study|Other|1|||
160969055|NCT02243202|581275103|FG001|Overall Study|Other|3|||
160969056|NCT02243202|581275104|FG002|Overall Study|Other|1|||
160969057|NCT02243202|581275105|FG003|Overall Study|Other|2|||
160969058|NCT02243202|581275102|FG000|Overall Study|Randomized but not received treatment|0|||
160969059|NCT02243202|581275103|FG001|Overall Study|Randomized but not received treatment|0|||
160969060|NCT02243202|581275104|FG002|Overall Study|Randomized but not received treatment|0|||
160969061|NCT02243202|581275105|FG003|Overall Study|Randomized but not received treatment|1|||
160969062|NCT02801669|581275108|FG000|Overall Study|Death|66|||
160969063|NCT02801669|581275109|FG001|Overall Study|Death|69|||
160969064|NCT02801669|581275108|FG000|Overall Study|Withdrawal by Subject|81|||
160969065|NCT02801669|581275109|FG001|Overall Study|Withdrawal by Subject|77|||
160969066|NCT02801669|581275108|FG000|Overall Study|Other|4|||
160969067|NCT02801669|581275109|FG001|Overall Study|Other|6|||
160969068|NCT00615264|581275110|FG000|Overall Study|Withdrawal by Subject|17|||
160969069|NCT00615264|581275111|FG001|Overall Study|Withdrawal by Subject|19|||
160969070|NCT00615264|581275110|FG000|Overall Study|Lost to Follow-up|6|||
160969071|NCT00615264|581275111|FG001|Overall Study|Lost to Follow-up|13|||
161018343|NCT03623321|581455822|FG000|Overall Study|Noncompliance with study drug|6|||
160586907|NCT01496430|579867622|FG002|Overall Study|Lost to Follow-up|1|||
160586908|NCT01496430|579867620|FG000|Overall Study|Voluntary Withdrawal|2|||
160586909|NCT01496430|579867621|FG001|Overall Study|Voluntary Withdrawal|1|||
160586910|NCT01496430|579867622|FG002|Overall Study|Voluntary Withdrawal|6|||
161018344|NCT03623321|581455822|FG000|Overall Study|Use of prohibited medication|3|||
160586911|NCT01496430|579867620|FG000|Overall Study|Principal Investigator Discretion|0|||
160969072|NCT00615264|581275110|FG000|Overall Study|Adverse Event|8|||
160586912|NCT01496430|579867621|FG001|Overall Study|Principal Investigator Discretion|1|||
160586913|NCT01496430|579867622|FG002|Overall Study|Principal Investigator Discretion|1|||
160586914|NCT01496430|579867620|FG000|Overall Study|Other|2|||
161018345|NCT03623321|581455822|FG000|Overall Study|Physician Decision|5|||
161018346|NCT03623321|581455822|FG000|Overall Study|Protocol Violation|1|||
161018347|NCT03623321|581455822|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
161018348|NCT03623321|581455822|FG000|Overall Study|Not further specified|43|||
161018349|NCT04241068|581455825|FG000|Core Treatment Period|Adverse Event|91|||
161018350|NCT04241068|581455825|FG000|Core Treatment Period|Change of Treatment|4|||
161018351|NCT04241068|581455825|FG000|Core Treatment Period|Consent Withdrawn|143|||
161018352|NCT04241068|581455825|FG000|Core Treatment Period|Death|26|||
161018353|NCT04241068|581455825|FG000|Core Treatment Period|Disease Progression|67|||
161018354|NCT04241068|581455825|FG000|Core Treatment Period|Investigator Decision|40|||
161018355|NCT04241068|581455825|FG000|Core Treatment Period|Loss of Capacity|9|||
161018356|NCT04241068|581455825|FG000|Core Treatment Period|Lost to Follow-up|11|||
161018357|NCT04241068|581455825|FG000|Core Treatment Period|Relocation|4|||
161018358|NCT04241068|581455825|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
161018359|NCT04241068|581455825|FG000|Core Treatment Period|Study Visit Burden|40|||
161018360|NCT04241068|581455825|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
161018361|NCT04241068|581455825|FG000|Core Treatment Period|Missing|2|||
161018362|NCT04241068|581455825|FG000|Core Treatment Period|Reason Not Specified|41|||
161018363|NCT04241068|581455825|FG000|LTE Period|Adverse Event|19|||
161018364|NCT04241068|581455825|FG000|LTE Period|Change of Treatment|1|||
161018365|NCT04241068|581455825|FG000|LTE Period|Consent Withdrawn|71|||
161018366|NCT04241068|581455825|FG000|LTE Period|Death|8|||
161018367|NCT04241068|581455825|FG000|LTE Period|Disease Progression|11|||
161018368|NCT04241068|581455825|FG000|LTE Period|Investigator Decision|12|||
161018369|NCT04241068|581455825|FG000|LTE Period|Loss of Capacity|2|||
161018370|NCT04241068|581455825|FG000|LTE Period|Lost to Follow-up|7|||
161018371|NCT04241068|581455825|FG000|LTE Period|Relocation|6|||
161018372|NCT04241068|581455825|FG000|LTE Period|Site Terminated by Sponsor|26|||
161018373|NCT04241068|581455825|FG000|LTE Period|Study Terminated by Sponsor|276|||
161018374|NCT04241068|581455825|FG000|LTE Period|Study Visit Burden|10|||
161018375|NCT04241068|581455825|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
161018376|NCT04241068|581455825|FG000|LTE Period|Reason Not Specified|65|||
161018377|NCT04229992|581455835|FG000|Overall Study|Withdrawal by Subject|0|||
161018378|NCT04229992|581455836|FG001|Overall Study|Withdrawal by Subject|2|||
161018379|NCT04229992|581455837|FG002|Overall Study|Withdrawal by Subject|1|||
161018380|NCT04229992|581455838|FG003|Overall Study|Withdrawal by Subject|1|||
161018381|NCT04229992|581455835|FG000|Overall Study|Adverse Event|1|||
161018382|NCT04229992|581455836|FG001|Overall Study|Adverse Event|1|||
161018383|NCT04229992|581455837|FG002|Overall Study|Adverse Event|3|||
161018384|NCT04229992|581455838|FG003|Overall Study|Adverse Event|1|||
161018385|NCT04229992|581455835|FG000|Overall Study|Lost to Follow-up|0|||
161018386|NCT04229992|581455836|FG001|Overall Study|Lost to Follow-up|0|||
161018387|NCT04229992|581455837|FG002|Overall Study|Lost to Follow-up|0|||
161018388|NCT04229992|581455838|FG003|Overall Study|Lost to Follow-up|1|||
161018389|NCT05178316|581455839|FG000|Overall Study|Adverse Event|5|||
161018390|NCT05178316|581455840|FG001|Overall Study|Adverse Event|4|||
161018391|NCT05178316|581455841|FG002|Overall Study|Adverse Event|9|||
161018392|NCT05178316|581455839|FG000|Overall Study|Enrolled in Error|1|||
161018393|NCT05178316|581455840|FG001|Overall Study|Enrolled in Error|2|||
161018394|NCT05178316|581455841|FG002|Overall Study|Enrolled in Error|1|||
160586915|NCT01496430|579867621|FG001|Overall Study|Other|0|||
160586916|NCT01496430|579867622|FG002|Overall Study|Other|0|||
161018395|NCT05178316|581455839|FG000|Overall Study|Lost to Follow-up|3|||
161018396|NCT05178316|581455840|FG001|Overall Study|Lost to Follow-up|15|||
161018397|NCT05178316|581455841|FG002|Overall Study|Lost to Follow-up|11|||
160586917|NCT00718666|579867623|FG000|Booster Phase Year 5|No active participation request|0|||
160586918|NCT00718666|579867624|FG001|Booster Phase Year 5|No active participation request|0|||
160586919|NCT00718666|579867625|FG002|Booster Phase Year 5|No active participation request|1|||
161018398|NCT05178316|581455839|FG000|Overall Study|Noncompliance|1|||
161018399|NCT05178316|581455840|FG001|Overall Study|Noncompliance|3|||
161018400|NCT05178316|581455841|FG002|Overall Study|Noncompliance|1|||
161018401|NCT05178316|581455839|FG000|Overall Study|Other|0|||
161018402|NCT05178316|581455840|FG001|Overall Study|Other|1|||
161018403|NCT05178316|581455841|FG002|Overall Study|Other|0|||
161018404|NCT05178316|581455839|FG000|Overall Study|Physician Decision|0|||
161018405|NCT05178316|581455840|FG001|Overall Study|Physician Decision|3|||
161018406|NCT05178316|581455841|FG002|Overall Study|Physician Decision|2|||
161018407|NCT05178316|581455839|FG000|Overall Study|Protocol deviation|1|||
161018408|NCT05178316|581455840|FG001|Overall Study|Protocol deviation|0|||
161018409|NCT05178316|581455841|FG002|Overall Study|Protocol deviation|1|||
161018410|NCT05178316|581455839|FG000|Overall Study|Sponsor decision|1|||
160586920|NCT00718666|579867623|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
161018411|NCT05178316|581455840|FG001|Overall Study|Sponsor decision|0|||
161018412|NCT05178316|581455841|FG002|Overall Study|Sponsor decision|1|||
161018413|NCT05178316|581455839|FG000|Overall Study|Withdrawal by Subject|5|||
161018414|NCT05178316|581455840|FG001|Overall Study|Withdrawal by Subject|11|||
161018415|NCT05178316|581455841|FG002|Overall Study|Withdrawal by Subject|5|||
161018416|NCT04347161|581455842|FG000|Overall Study|Death|0|||
161018417|NCT04347161|581455843|FG001|Overall Study|Death|2|||
161018418|NCT04347161|581455842|FG000|Overall Study|Withdrawal by Subject|1|||
161018419|NCT04347161|581455843|FG001|Overall Study|Withdrawal by Subject|0|||
161018420|NCT04347161|581455842|FG000|Overall Study|Lost to Follow-up|0|||
161018421|NCT04347161|581455843|FG001|Overall Study|Lost to Follow-up|1|||
161018422|NCT04347161|581455842|FG000|Overall Study|No longer on study medication|1|||
161018423|NCT04347161|581455843|FG001|Overall Study|No longer on study medication|1|||
161018424|NCT04169373|581455844|FG000|Week 1 to Week 14|Adverse Event|1|||
161018425|NCT04169373|581455845|FG001|Week 1 to Week 14|Adverse Event|0|||
161018426|NCT04169373|581455846|FG002|Week 1 to Week 14|Adverse Event|1|||
161018427|NCT04169373|581455847|FG003|Week 1 to Week 14|Adverse Event|2|||
161018428|NCT04169373|581455844|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
161018429|NCT04169373|581455845|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
161018430|NCT04169373|581455846|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
161018431|NCT04169373|581455847|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
161018432|NCT04169373|581455844|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
161018433|NCT04169373|581455845|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
161018434|NCT04169373|581455846|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
161018435|NCT04169373|581455847|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
161018436|NCT04169373|581455844|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
161018437|NCT04169373|581455845|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
161018438|NCT04169373|581455846|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
161018439|NCT04169373|581455847|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
161018440|NCT04169373|581455844|FG000|Week 1 to Week 14|Other|1|||
160586921|NCT00718666|579867624|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
160586922|NCT00718666|579867625|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
160586923|NCT00718666|579867623|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
160586924|NCT00718666|579867624|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
161018441|NCT04169373|581455845|FG001|Week 1 to Week 14|Other|3|||
161018442|NCT04169373|581455846|FG002|Week 1 to Week 14|Other|3|||
161018443|NCT04169373|581455847|FG003|Week 1 to Week 14|Other|5|||
161018444|NCT04169373|581455844|FG000|Week 14 to Week 52|Adverse Event|1|||
161018445|NCT04169373|581455845|FG001|Week 14 to Week 52|Adverse Event|0|||
161018446|NCT04169373|581455846|FG002|Week 14 to Week 52|Adverse Event|0|||
161018447|NCT04169373|581455847|FG003|Week 14 to Week 52|Adverse Event|1|||
161018448|NCT04169373|581455844|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
161018449|NCT04169373|581455845|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
161018450|NCT04169373|581455846|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
161018451|NCT04169373|581455847|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
161018452|NCT04169373|581455844|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
161018453|NCT04169373|581455845|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
161018454|NCT04169373|581455846|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
161018455|NCT04169373|581455847|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
161018456|NCT04169373|581455844|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
161018457|NCT04169373|581455845|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
161018458|NCT04169373|581455846|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
161018459|NCT04169373|581455847|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
161018460|NCT04169373|581455844|FG000|Week 14 to Week 52|Other|4|||
161018461|NCT04169373|581455845|FG001|Week 14 to Week 52|Other|5|||
161018462|NCT04169373|581455846|FG002|Week 14 to Week 52|Other|4|||
161018463|NCT04169373|581455847|FG003|Week 14 to Week 52|Other|5|||
161018464|NCT04169373|581455844|FG000|Week 14 to Week 52|Ongoing|0|||
161018465|NCT04169373|581455845|FG001|Week 14 to Week 52|Ongoing|1|||
161018466|NCT04169373|581455846|FG002|Week 14 to Week 52|Ongoing|0|||
161018467|NCT04169373|581455847|FG003|Week 14 to Week 52|Ongoing|0|||
161018468|NCT04610892|581455848|FG000|Overall Study|Adverse Event|1|||
161018469|NCT04610892|581455849|FG001|Overall Study|Adverse Event|0|||
161018470|NCT04610892|581455850|FG002|Overall Study|Adverse Event|0|||
161018471|NCT04610892|581455851|FG003|Overall Study|Adverse Event|1|||
161018472|NCT04610892|581455852|FG004|Overall Study|Adverse Event|3|||
160459422|NCT03786926|579414998|FG009|Overall Study|Progressive disease|1|||
160459423|NCT03786926|579414999|FG010|Overall Study|Progressive disease|1|||
161018473|NCT04610892|581455848|FG000|Overall Study|Death|0|||
161018474|NCT04610892|581455849|FG001|Overall Study|Death|1|||
161018475|NCT04610892|581455850|FG002|Overall Study|Death|0|||
161018476|NCT04610892|581455851|FG003|Overall Study|Death|1|||
161018477|NCT04610892|581455852|FG004|Overall Study|Death|0|||
161018478|NCT04610892|581455848|FG000|Overall Study|Withdrawal by Subject|3|||
161018479|NCT04610892|581455849|FG001|Overall Study|Withdrawal by Subject|2|||
161018480|NCT04610892|581455850|FG002|Overall Study|Withdrawal by Subject|0|||
161018481|NCT04610892|581455851|FG003|Overall Study|Withdrawal by Subject|6|||
161018482|NCT04610892|581455852|FG004|Overall Study|Withdrawal by Subject|6|||
161018483|NCT04610892|581455848|FG000|Overall Study|Subjects who did not receive treatment|1|||
160586925|NCT00718666|579867625|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
160586926|NCT00718666|579867623|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
160586927|NCT00718666|579867624|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
160586928|NCT00718666|579867625|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
160586929|NCT02196038|579867628|FG000|Overall Study|Death|16|||
160586930|NCT02196038|579867629|FG001|Overall Study|Death|21|||
160586931|NCT02196038|579867628|FG000|Overall Study|Withdrawal by Subject|0|||
160586932|NCT02196038|579867629|FG001|Overall Study|Withdrawal by Subject|1|||
160586933|NCT02196038|579867628|FG000|Overall Study|Lost to Follow-up|1|||
160586934|NCT02196038|579867629|FG001|Overall Study|Lost to Follow-up|0|||
160586935|NCT00608530|579867637|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
160586936|NCT00608530|579867638|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
160586937|NCT00608530|579867639|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
160586938|NCT00608530|579867640|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
160586939|NCT00608530|579867637|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
160586940|NCT00608530|579867638|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
160969073|NCT00615264|581275111|FG001|Overall Study|Adverse Event|5|||
160969074|NCT00615264|581275110|FG000|Overall Study|Death|1|||
160969075|NCT00615264|581275111|FG001|Overall Study|Death|1|||
160969076|NCT00615264|581275110|FG000|Overall Study|Protocol Violation|11|||
160969077|NCT00615264|581275111|FG001|Overall Study|Protocol Violation|7|||
160969078|NCT00615264|581275110|FG000|Overall Study|Not defined|7|||
160969079|NCT00615264|581275111|FG001|Overall Study|Not defined|4|||
160969080|NCT00615264|581275110|FG000|Overall Study|Dermal Hypersensitivity|0|||
160969081|NCT00615264|581275111|FG001|Overall Study|Dermal Hypersensitivity|3|||
160969082|NCT00633932|581275112|FG000|Overall Study|Adverse Event|1|||
160969083|NCT00633932|581275113|FG001|Overall Study|Adverse Event|3|||
160969084|NCT00633932|581275114|FG002|Overall Study|Adverse Event|4|||
160969085|NCT00633932|581275112|FG000|Overall Study|Withdrawal by Subject|3|||
160969086|NCT00633932|581275113|FG001|Overall Study|Withdrawal by Subject|9|||
160969087|NCT00633932|581275114|FG002|Overall Study|Withdrawal by Subject|1|||
160969088|NCT00633932|581275112|FG000|Overall Study|Lost to Follow-up|1|||
160969089|NCT00633932|581275113|FG001|Overall Study|Lost to Follow-up|0|||
160969090|NCT00633932|581275114|FG002|Overall Study|Lost to Follow-up|2|||
160969091|NCT00633932|581275112|FG000|Overall Study|Protocol Violation|5|||
160969092|NCT00633932|581275113|FG001|Overall Study|Protocol Violation|2|||
160969093|NCT00633932|581275114|FG002|Overall Study|Protocol Violation|3|||
160969094|NCT00633932|581275112|FG000|Overall Study|Physician Decision|0|||
160969095|NCT00633932|581275113|FG001|Overall Study|Physician Decision|0|||
160969096|NCT00633932|581275114|FG002|Overall Study|Physician Decision|1|||
160969097|NCT00633932|581275112|FG000|Overall Study|Doctor's judgement|1|||
160969098|NCT00633932|581275113|FG001|Overall Study|Doctor's judgement|0|||
160969099|NCT00633932|581275114|FG002|Overall Study|Doctor's judgement|0|||
160969100|NCT00633932|581275112|FG000|Overall Study|Moved Away|1|||
160969101|NCT00633932|581275113|FG001|Overall Study|Moved Away|0|||
160969102|NCT00633932|581275114|FG002|Overall Study|Moved Away|0|||
160969103|NCT04836858|581275115|FG000|Overall Study|Adverse Event|0|||
160969104|NCT04836858|581275116|FG001|Overall Study|Adverse Event|0|||
160969105|NCT04836858|581275117|FG002|Overall Study|Adverse Event|0|||
160969106|NCT04836858|581275118|FG003|Overall Study|Adverse Event|1|||
160969107|NCT04836858|581275115|FG000|Overall Study|Lost to Follow-up|1|||
160969108|NCT04836858|581275116|FG001|Overall Study|Lost to Follow-up|0|||
160969109|NCT04836858|581275117|FG002|Overall Study|Lost to Follow-up|0|||
160969110|NCT04836858|581275118|FG003|Overall Study|Lost to Follow-up|0|||
160969111|NCT04836858|581275115|FG000|Overall Study|Subject/Guardian decision|3|||
160969112|NCT04836858|581275116|FG001|Overall Study|Subject/Guardian decision|0|||
160969113|NCT04836858|581275117|FG002|Overall Study|Subject/Guardian decision|0|||
160969114|NCT04836858|581275118|FG003|Overall Study|Subject/Guardian decision|1|||
160969115|NCT04836858|581275115|FG000|Overall Study|Randomized but not treated|4|||
160969116|NCT04836858|581275116|FG001|Overall Study|Randomized but not treated|0|||
160969117|NCT04836858|581275117|FG002|Overall Study|Randomized but not treated|0|||
160969118|NCT04836858|581275118|FG003|Overall Study|Randomized but not treated|0|||
160969119|NCT00708435|581275120|FG000|Overall Study|Death / Serious Adverse Event|10|||
160969120|NCT00708435|581275121|FG001|Overall Study|Death / Serious Adverse Event|5|||
160969121|NCT00708435|581275120|FG000|Overall Study|Lost to Follow-up|9|||
160969122|NCT00708435|581275121|FG001|Overall Study|Lost to Follow-up|4|||
160969123|NCT00708435|581275120|FG000|Overall Study|Withdrawal by Subject|3|||
160586941|NCT00608530|579867639|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
160586942|NCT00608530|579867640|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
160586943|NCT00608530|579867637|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
160969124|NCT00708435|581275121|FG001|Overall Study|Withdrawal by Subject|7|||
160969125|NCT00708435|581275120|FG000|Overall Study|Adverse Event|1|||
160969126|NCT00708435|581275121|FG001|Overall Study|Adverse Event|0|||
160969127|NCT00708435|581275120|FG000|Overall Study|Protocol Violation|0|||
160969128|NCT00708435|581275121|FG001|Overall Study|Protocol Violation|1|||
160969129|NCT00708435|581275120|FG000|Overall Study|Intervention by primary care physician|1|||
160969130|NCT00708435|581275121|FG001|Overall Study|Intervention by primary care physician|0|||
160586944|NCT00608530|579867638|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
160586945|NCT00608530|579867639|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
160586946|NCT00608530|579867640|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
160586947|NCT00608530|579867637|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
160586948|NCT00608530|579867638|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
160586949|NCT00608530|579867639|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
160586950|NCT00608530|579867640|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
160586951|NCT00608530|579867637|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
160586952|NCT00608530|579867638|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
160586953|NCT00608530|579867639|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
160586954|NCT00608530|579867640|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
160586955|NCT00608530|579867637|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
160586956|NCT00608530|579867638|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
160969131|NCT00708435|581275120|FG000|Overall Study|Refused hospitalization|1|||
160969132|NCT00708435|581275121|FG001|Overall Study|Refused hospitalization|0|||
160969133|NCT04766086|581275124|FG000|Overall Study|Lost to Follow-up|3|||
160969134|NCT04766086|581275125|FG001|Overall Study|Lost to Follow-up|5|||
160969135|NCT04766086|581275126|FG002|Overall Study|Lost to Follow-up|3|||
160969136|NCT04766086|581275124|FG000|Overall Study|Withdrawal by Subject|1|||
160969137|NCT04766086|581275125|FG001|Overall Study|Withdrawal by Subject|1|||
160969138|NCT04766086|581275126|FG002|Overall Study|Withdrawal by Subject|2|||
160969139|NCT04766086|581275124|FG000|Overall Study|Other|0|||
160969140|NCT04766086|581275125|FG001|Overall Study|Other|0|||
160969141|NCT04766086|581275126|FG002|Overall Study|Other|1|||
160969142|NCT01691521|581275127|FG000|Overall Study|Adverse Event|4|||
160969143|NCT01691521|581275128|FG001|Overall Study|Adverse Event|0|||
160969144|NCT01691521|581275129|FG002|Overall Study|Adverse Event|1|||
160969145|NCT01691521|581275127|FG000|Overall Study|Lack of Efficacy|1|||
160969146|NCT01691521|581275128|FG001|Overall Study|Lack of Efficacy|1|||
160969147|NCT01691521|581275129|FG002|Overall Study|Lack of Efficacy|2|||
160969148|NCT01691521|581275127|FG000|Overall Study|Protocol Violation|0|||
160969149|NCT01691521|581275128|FG001|Overall Study|Protocol Violation|3|||
160969150|NCT01691521|581275129|FG002|Overall Study|Protocol Violation|0|||
160969151|NCT01691521|581275127|FG000|Overall Study|Lost to Follow-up|0|||
160969152|NCT01691521|581275128|FG001|Overall Study|Lost to Follow-up|2|||
160969153|NCT01691521|581275129|FG002|Overall Study|Lost to Follow-up|2|||
160969154|NCT01691521|581275127|FG000|Overall Study|Physician Decision|2|||
160969155|NCT01691521|581275128|FG001|Overall Study|Physician Decision|1|||
160969156|NCT01691521|581275129|FG002|Overall Study|Physician Decision|0|||
160969157|NCT01691521|581275127|FG000|Overall Study|Withdrawal by Subject|5|||
160969158|NCT01691521|581275128|FG001|Overall Study|Withdrawal by Subject|9|||
160969159|NCT01691521|581275129|FG002|Overall Study|Withdrawal by Subject|4|||
160969160|NCT02343003|581275130|FG000|Overall Study|Withdrawal by Subject|9|||
160969161|NCT02343003|581275131|FG001|Overall Study|Withdrawal by Subject|4|||
160969162|NCT02343003|581275130|FG000|Overall Study|Lost to Follow-up|5|||
160969163|NCT02343003|581275131|FG001|Overall Study|Lost to Follow-up|1|||
160969164|NCT02343003|581275130|FG000|Overall Study|Protocol Violation|1|||
160969165|NCT02343003|581275131|FG001|Overall Study|Protocol Violation|0|||
160969166|NCT02343003|581275130|FG000|Overall Study|Death|0|||
160969167|NCT02343003|581275131|FG001|Overall Study|Death|1|||
160969168|NCT02343003|581275130|FG000|Overall Study|exclusion criteria met|1|||
160969169|NCT02343003|581275131|FG001|Overall Study|exclusion criteria met|1|||
160969170|NCT02343003|581275130|FG000|Overall Study|terminated by sponsor|2|||
160969171|NCT02343003|581275131|FG001|Overall Study|terminated by sponsor|0|||
160969172|NCT02635724|581275134|FG000|Overall Study|Withdrawal by Subject|0|||
160969173|NCT02635724|581275135|FG001|Overall Study|Withdrawal by Subject|1|||
160969174|NCT02635724|581275136|FG002|Overall Study|Withdrawal by Subject|0|||
160969175|NCT03579290|581275139|FG000|Overall Study|Lost to Follow-up|9|||
160969176|NCT00622713|581275140|FG000|Overall Study|Adverse Event|35|||
160969177|NCT00622713|581275140|FG000|Overall Study|Administrative problems|4|||
160969178|NCT00622713|581275140|FG000|Overall Study|Withdrawal by Subject|11|||
160969179|NCT00622713|581275140|FG000|Overall Study|Lost to Follow-up|5|||
160969180|NCT00622713|581275140|FG000|Overall Study|Death|2|||
160969181|NCT00622713|581275140|FG000|Overall Study|Subject no longer required study drug|1|||
160969182|NCT00622713|581275140|FG000|Overall Study|Did not meet eligibility criteria|1|||
160969183|NCT04404478|581275141|FG000|Overall Study|Withdrawal by Subject|1|||
160969184|NCT04404478|581275142|FG001|Overall Study|Withdrawal by Subject|3|||
160969185|NCT01725386|581275155|FG000|Overall Study|Death|84|||
160969186|NCT01725386|581275156|FG001|Overall Study|Death|40|||
160969187|NCT01725386|581275155|FG000|Overall Study|Lost to Follow-up|81|||
160969188|NCT01725386|581275156|FG001|Overall Study|Lost to Follow-up|6|||
160969189|NCT01725386|581275155|FG000|Overall Study|Withdrawal by Subject|10|||
160969190|NCT01725386|581275156|FG001|Overall Study|Withdrawal by Subject|0|||
160969191|NCT00879996|581275160|FG000|Overall Study|Lost to Follow-up|7|||
160969192|NCT00879996|581275161|FG001|Overall Study|Lost to Follow-up|6|||
160969193|NCT00879996|581275160|FG000|Overall Study|non-compliance|6|||
161018484|NCT04610892|581455849|FG001|Overall Study|Subjects who did not receive treatment|0|||
161018485|NCT04610892|581455850|FG002|Overall Study|Subjects who did not receive treatment|0|||
161018486|NCT04610892|581455851|FG003|Overall Study|Subjects who did not receive treatment|0|||
161018487|NCT04610892|581455852|FG004|Overall Study|Subjects who did not receive treatment|2|||
161018488|NCT01413100|581455853|FG000|Overall Study|Withdrawal by Subject|1|||
161018489|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
161018490|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
161018491|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
161018492|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
161018493|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
161018494|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
161018495|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
161018496|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
161018497|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
161018498|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
161018499|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
161018500|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
161018501|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
161018502|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
161018503|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
161018504|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
161018505|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
161018506|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
161018507|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
160459424|NCT03786926|579414989|FG000|Overall Study|Death|0|||
160459425|NCT03786926|579414990|FG001|Overall Study|Death|1|||
160459426|NCT03786926|579414991|FG002|Overall Study|Death|1|||
160459427|NCT03786926|579414992|FG003|Overall Study|Death|0|||
160459428|NCT03786926|579414993|FG004|Overall Study|Death|0|||
160459429|NCT03786926|579414994|FG005|Overall Study|Death|0|||
160459430|NCT03786926|579414995|FG006|Overall Study|Death|0|||
160459431|NCT03786926|579414996|FG007|Overall Study|Death|0|||
160459432|NCT03786926|579414997|FG008|Overall Study|Death|0|||
160459433|NCT03786926|579414998|FG009|Overall Study|Death|1|||
160459434|NCT03786926|579414999|FG010|Overall Study|Death|2|||
160459435|NCT03786926|579414989|FG000|Overall Study|Physician Decision|0|||
160459436|NCT03786926|579414990|FG001|Overall Study|Physician Decision|1|||
160459437|NCT03786926|579414991|FG002|Overall Study|Physician Decision|0|||
160459438|NCT03786926|579414992|FG003|Overall Study|Physician Decision|1|||
160459439|NCT03786926|579414993|FG004|Overall Study|Physician Decision|2|||
160459440|NCT03786926|579414994|FG005|Overall Study|Physician Decision|0|||
160459441|NCT03786926|579414995|FG006|Overall Study|Physician Decision|0|||
160459442|NCT03786926|579414996|FG007|Overall Study|Physician Decision|2|||
160459443|NCT03786926|579414997|FG008|Overall Study|Physician Decision|1|||
160459444|NCT03786926|579414998|FG009|Overall Study|Physician Decision|1|||
160459445|NCT03786926|579414999|FG010|Overall Study|Physician Decision|0|||
160459446|NCT03786926|579414989|FG000|Overall Study|Withdrawal by Subject|0|||
160459447|NCT03786926|579414990|FG001|Overall Study|Withdrawal by Subject|1|||
160459448|NCT03786926|579414991|FG002|Overall Study|Withdrawal by Subject|1|||
160459449|NCT03786926|579414992|FG003|Overall Study|Withdrawal by Subject|0|||
160459450|NCT03786926|579414993|FG004|Overall Study|Withdrawal by Subject|0|||
160459451|NCT03786926|579414994|FG005|Overall Study|Withdrawal by Subject|0|||
160459452|NCT03786926|579414995|FG006|Overall Study|Withdrawal by Subject|1|||
160459453|NCT03786926|579414996|FG007|Overall Study|Withdrawal by Subject|0|||
160459454|NCT03786926|579414997|FG008|Overall Study|Withdrawal by Subject|1|||
160459455|NCT03786926|579414998|FG009|Overall Study|Withdrawal by Subject|0|||
160459456|NCT03786926|579414999|FG010|Overall Study|Withdrawal by Subject|1|||
160459457|NCT03786926|579414989|FG000|Overall Study|Study terminated by Sponsor|0|||
160459458|NCT03786926|579414990|FG001|Overall Study|Study terminated by Sponsor|0|||
160459459|NCT03786926|579414991|FG002|Overall Study|Study terminated by Sponsor|0|||
160459460|NCT03786926|579414992|FG003|Overall Study|Study terminated by Sponsor|0|||
160459461|NCT03786926|579414993|FG004|Overall Study|Study terminated by Sponsor|1|||
160459462|NCT03786926|579414994|FG005|Overall Study|Study terminated by Sponsor|0|||
160459463|NCT03786926|579414995|FG006|Overall Study|Study terminated by Sponsor|0|||
160459464|NCT03786926|579414996|FG007|Overall Study|Study terminated by Sponsor|4|||
160459465|NCT03786926|579414997|FG008|Overall Study|Study terminated by Sponsor|0|||
160459466|NCT03786926|579414998|FG009|Overall Study|Study terminated by Sponsor|0|||
160459467|NCT03786926|579414999|FG010|Overall Study|Study terminated by Sponsor|0|||
160459468|NCT03786926|579414989|FG000|Overall Study|Anti-neoplasm treatment|0|||
160459469|NCT03786926|579414990|FG001|Overall Study|Anti-neoplasm treatment|0|||
160459470|NCT03786926|579414991|FG002|Overall Study|Anti-neoplasm treatment|0|||
160459471|NCT03786926|579414992|FG003|Overall Study|Anti-neoplasm treatment|0|||
160459472|NCT03786926|579414993|FG004|Overall Study|Anti-neoplasm treatment|1|||
160632907|NCT02575807|580036104|FG000|Overall Study|Death|8|||
161018508|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
161018509|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
161018510|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
161018511|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
161018512|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
161018513|NCT05369403|581455854|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
161018514|NCT05369403|581455855|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
161018515|NCT05369403|581455856|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
161018516|NCT05369403|581455854|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
161018517|NCT05369403|581455855|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
161018518|NCT05369403|581455856|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
161018519|NCT05369403|581455854|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
161018520|NCT05369403|581455855|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
161018521|NCT05369403|581455856|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
161018522|NCT03792256|581455857|FG000|Overall Study|Death|0|||
161018523|NCT03792256|581455858|FG001|Overall Study|Death|1|||
161018524|NCT03792256|581455857|FG000|Overall Study|Lack of Efficacy|0|||
161018525|NCT03792256|581455858|FG001|Overall Study|Lack of Efficacy|1|||
161018526|NCT03792256|581455857|FG000|Overall Study|Withdrawal by Subject|0|||
161018527|NCT03792256|581455858|FG001|Overall Study|Withdrawal by Subject|1|||
161018528|NCT04760678|581455861|FG000|Overall Study|Death|13|||
161018529|NCT04760678|581455861|FG000|Overall Study|Lost to Follow-up|48|||
161018530|NCT04760678|581455861|FG000|Overall Study|Withdrawal by Subject|1|||
161018531|NCT01997840|581455870|FG000|Overall Study|Lost to Follow-up|0|||
161018532|NCT01997840|581455871|FG001|Overall Study|Lost to Follow-up|0|||
161018533|NCT01997840|581455872|FG002|Overall Study|Lost to Follow-up|1|||
161018534|NCT01997840|581455873|FG003|Overall Study|Lost to Follow-up|0|||
161018535|NCT01997840|581455870|FG000|Overall Study|Withdrawal by participant|0|||
161018536|NCT01997840|581455871|FG001|Overall Study|Withdrawal by participant|0|||
161018537|NCT01997840|581455872|FG002|Overall Study|Withdrawal by participant|8|||
161018538|NCT01997840|581455873|FG003|Overall Study|Withdrawal by participant|1|||
161018539|NCT01997840|581455870|FG000|Overall Study|Physician Decision|0|||
161018540|NCT01997840|581455871|FG001|Overall Study|Physician Decision|0|||
161018541|NCT01997840|581455872|FG002|Overall Study|Physician Decision|3|||
161018542|NCT01997840|581455873|FG003|Overall Study|Physician Decision|0|||
161018543|NCT01997840|581455870|FG000|Overall Study|Progressive disease|3|||
161018544|NCT01997840|581455871|FG001|Overall Study|Progressive disease|4|||
161018545|NCT01997840|581455872|FG002|Overall Study|Progressive disease|57|||
161018546|NCT01997840|581455873|FG003|Overall Study|Progressive disease|8|||
160459473|NCT03786926|579414994|FG005|Overall Study|Anti-neoplasm treatment|0|||
160459474|NCT03786926|579414995|FG006|Overall Study|Anti-neoplasm treatment|1|||
160459475|NCT03786926|579414996|FG007|Overall Study|Anti-neoplasm treatment|0|||
161018547|NCT01997840|581455870|FG000|Overall Study|Other reasons|0|||
161018548|NCT01997840|581455871|FG001|Overall Study|Other reasons|0|||
161018549|NCT01997840|581455872|FG002|Overall Study|Other reasons|1|||
161018550|NCT01997840|581455873|FG003|Overall Study|Other reasons|0|||
161018551|NCT01997840|581455870|FG000|Overall Study|Adverse Event|0|||
161018552|NCT01997840|581455871|FG001|Overall Study|Adverse Event|0|||
161018553|NCT01997840|581455872|FG002|Overall Study|Adverse Event|15|||
161018554|NCT01997840|581455873|FG003|Overall Study|Adverse Event|2|||
161018555|NCT01573442|581455878|FG000|Overall Study|Cancels|9|||
161018556|NCT01573442|581455879|FG001|Overall Study|Cancels|10|||
160459476|NCT03786926|579414997|FG008|Overall Study|Anti-neoplasm treatment|0|||
160459477|NCT03786926|579414998|FG009|Overall Study|Anti-neoplasm treatment|0|||
160459478|NCT03786926|579414999|FG010|Overall Study|Anti-neoplasm treatment|0|||
160459479|NCT03786926|579414989|FG000|Overall Study|Other|0|||
160459480|NCT03786926|579414990|FG001|Overall Study|Other|0|||
160459481|NCT03786926|579414991|FG002|Overall Study|Other|0|||
160586957|NCT00608530|579867639|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
161018557|NCT04952909|581455890|FG000|Overall Study|Death|3|||
161018558|NCT05308004|581455891|FG000|Overall Study|Not seen by Palliative Care NP|0|||
161018559|NCT05308004|581455892|FG001|Overall Study|Not seen by Palliative Care NP|1|||
161018560|NCT04552223|581455893|FG000|Overall Study|Withdrawal by Subject|1|||
161018561|NCT00881621|581455896|FG000|Overall Study|Physician Decision|34|||
161018562|NCT04359108|581455900|FG000|Overall Study|Withdrawal by Subject|1|||
161018563|NCT04359108|581455901|FG001|Overall Study|Withdrawal by Subject|0|||
161018564|NCT04359108|581455900|FG000|Overall Study|Unable or too feeble to walk independently|0|||
161018565|NCT04359108|581455901|FG001|Overall Study|Unable or too feeble to walk independently|2|||
161018566|NCT04359108|581455900|FG000|Overall Study|Argus II system stopped functioning|0|||
161018567|NCT04359108|581455901|FG001|Overall Study|Argus II system stopped functioning|1|||
160459482|NCT03786926|579414992|FG003|Overall Study|Other|1|||
160586958|NCT00608530|579867640|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
160459483|NCT03786926|579414993|FG004|Overall Study|Other|0|||
161018568|NCT04359108|581455900|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
161018569|NCT04359108|581455901|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
161018570|NCT02515773|581455902|FG000|Overall Study|Withdrawal by Subject|12|||
161018571|NCT02515773|581455903|FG001|Overall Study|Withdrawal by Subject|2|||
161018572|NCT02515773|581455902|FG000|Overall Study|Lost to Follow-up|119|||
161018573|NCT02515773|581455903|FG001|Overall Study|Lost to Follow-up|126|||
161018574|NCT02515773|581455902|FG000|Overall Study|Discharged from Clinic Services|53|||
161018575|NCT02515773|581455903|FG001|Overall Study|Discharged from Clinic Services|84|||
161018576|NCT02515773|581455902|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
161018577|NCT02515773|581455903|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
161018578|NCT02515773|581455902|FG000|Overall Study|Follow-up at non-study site|8|||
161018579|NCT02515773|581455903|FG001|Overall Study|Follow-up at non-study site|16|||
161018580|NCT02515773|581455902|FG000|Overall Study|Moved from area|9|||
161018581|NCT02515773|581455903|FG001|Overall Study|Moved from area|14|||
161018582|NCT04176965|581455904|FG000|Overall Study|Death|1|||
161018583|NCT04176965|581455905|FG001|Overall Study|Death|2|||
161018584|NCT04176965|581455904|FG000|Overall Study|Lost to Follow-up|10|||
161018585|NCT04176965|581455905|FG001|Overall Study|Lost to Follow-up|2|||
161018586|NCT04176965|581455904|FG000|Overall Study|Withdrawal by Subject|6|||
161018587|NCT04176965|581455905|FG001|Overall Study|Withdrawal by Subject|1|||
161018588|NCT05434078|581455907|FG000|Overall Study|Lost to Follow-up|2|||
160459484|NCT03786926|579414994|FG005|Overall Study|Other|1|||
160459485|NCT03786926|579414995|FG006|Overall Study|Other|0|||
160459486|NCT03786926|579414996|FG007|Overall Study|Other|0|||
160459487|NCT03786926|579414997|FG008|Overall Study|Other|2|||
160459488|NCT03786926|579414998|FG009|Overall Study|Other|0|||
160459489|NCT03786926|579414999|FG010|Overall Study|Other|0|||
160459490|NCT05988398|579415003|FG000|Overall Study|Lack of time|21|||
160459491|NCT05988398|579415004|FG001|Overall Study|Lack of time|0|||
160459492|NCT05988398|579415003|FG000|Overall Study|Absent from school|0|||
160459493|NCT05988398|579415004|FG001|Overall Study|Absent from school|38|||
160459494|NCT05988398|579415003|FG000|Overall Study|Chose not to participate|0|||
160459495|NCT05988398|579415004|FG001|Overall Study|Chose not to participate|42|||
160459496|NCT05988398|579415003|FG000|Overall Study|Other commitments (e.g., sports)|0|||
160459497|NCT05988398|579415004|FG001|Overall Study|Other commitments (e.g., sports)|25|||
160459498|NCT00942734|579415006|FG000|Overall Study|Adverse Event|2|||
160459499|NCT00942734|579415006|FG000|Overall Study|Protocol Violation|3|||
160459500|NCT00942734|579415006|FG000|Overall Study|Disease Progression|2|||
160459501|NCT00942734|579415006|FG000|Overall Study|Physician Decision|1|||
160459502|NCT05147584|579415007|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
160459503|NCT02163694|579415013|FG000|Overall Study|Adverse event- related to progression|4|||
160459504|NCT02163694|579415014|FG001|Overall Study|Adverse event- related to progression|10|||
160459505|NCT02163694|579415013|FG000|Overall Study|Adverse event- not related to progression|7|||
160459506|NCT02163694|579415014|FG001|Overall Study|Adverse event- not related to progression|22|||
160459507|NCT02163694|579415013|FG000|Overall Study|Withdrew consent|13|||
160459508|NCT02163694|579415014|FG001|Overall Study|Withdrew consent|28|||
160459509|NCT02163694|579415013|FG000|Overall Study|Lost to Follow-up|2|||
160459510|NCT02163694|579415014|FG001|Overall Study|Lost to Follow-up|2|||
160459511|NCT02163694|579415013|FG000|Overall Study|Sponsor discontinued study|3|||
160459512|NCT02163694|579415014|FG001|Overall Study|Sponsor discontinued study|29|||
160459513|NCT02163694|579415013|FG000|Overall Study|Progressive disease per protocol|125|||
160459514|NCT02163694|579415014|FG001|Overall Study|Progressive disease per protocol|224|||
160459515|NCT02163694|579415013|FG000|Overall Study|Other, not specified|17|||
160459516|NCT02163694|579415014|FG001|Overall Study|Other, not specified|22|||
160459517|NCT02163694|579415013|FG000|Overall Study|Randomized but Not Treated|1|||
160459518|NCT02163694|579415014|FG001|Overall Study|Randomized but Not Treated|0|||
160459519|NCT02163694|579415013|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
160459520|NCT02163694|579415014|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
160459521|NCT03370913|579415015|FG000|Overall Study|Death|1|||
160459522|NCT03370913|579415015|FG000|Overall Study|Lost to Follow-up|1|||
160459523|NCT04560179|579415020|FG000|Overall Study|Physician Decision|1|||
160459524|NCT04560179|579415021|FG001|Overall Study|Physician Decision|0|||
160459525|NCT04560179|579415022|FG002|Overall Study|Physician Decision|0|||
160459526|NCT04560179|579415023|FG003|Overall Study|Physician Decision|0|||
160459527|NCT04560179|579415024|FG004|Overall Study|Physician Decision|0|||
161018589|NCT05434078|581455908|FG001|Overall Study|Lost to Follow-up|1|||
161018590|NCT05434078|581455907|FG000|Overall Study|Withdrawal by Subject|1|||
161018591|NCT05434078|581455908|FG001|Overall Study|Withdrawal by Subject|0|||
160459528|NCT04560179|579415020|FG000|Overall Study|Adverse Event|0|||
160459529|NCT04560179|579415021|FG001|Overall Study|Adverse Event|0|||
160459530|NCT04560179|579415022|FG002|Overall Study|Adverse Event|0|||
160459531|NCT04560179|579415023|FG003|Overall Study|Adverse Event|1|||
161018592|NCT03652688|581455909|FG000|Baseline|Withdrawal by Subject|0|||
161018593|NCT03652688|581455910|FG001|Baseline|Withdrawal by Subject|3|||
161018594|NCT03652688|581455909|FG000|Follow-up|Lost to Follow-up|56|||
161018595|NCT03652688|581455910|FG001|Follow-up|Lost to Follow-up|54|||
161018596|NCT04072380|581455911|FG000|Overall Study|Adverse Event|4|||
161018597|NCT04072380|581455912|FG001|Overall Study|Adverse Event|6|||
161018598|NCT04072380|581455913|FG002|Overall Study|Adverse Event|0|||
161018599|NCT04072380|581455911|FG000|Overall Study|Withdrawal by Subject|3|||
161018600|NCT04072380|581455912|FG001|Overall Study|Withdrawal by Subject|1|||
161018601|NCT04072380|581455913|FG002|Overall Study|Withdrawal by Subject|1|||
161018602|NCT04072380|581455911|FG000|Overall Study|Physician Decision|2|||
161018603|NCT04072380|581455912|FG001|Overall Study|Physician Decision|0|||
161018604|NCT04072380|581455913|FG002|Overall Study|Physician Decision|0|||
161018605|NCT04072380|581455911|FG000|Overall Study|Protocol Violation|0|||
161018606|NCT04072380|581455912|FG001|Overall Study|Protocol Violation|2|||
161018607|NCT04072380|581455913|FG002|Overall Study|Protocol Violation|3|||
161018608|NCT04072380|581455911|FG000|Overall Study|Intercurrent Illness and Others|3|||
161018609|NCT04072380|581455912|FG001|Overall Study|Intercurrent Illness and Others|5|||
161018610|NCT04072380|581455913|FG002|Overall Study|Intercurrent Illness and Others|6|||
161018611|NCT00554788|581455919|FG000|Overall Study|Adverse Event|0|||
161018612|NCT00554788|581455920|FG001|Overall Study|Adverse Event|1|||
161018613|NCT00554788|581455921|FG002|Overall Study|Adverse Event|2|||
161018614|NCT00554788|581455919|FG000|Overall Study|Lost to Follow-up|4|||
161018615|NCT00554788|581455920|FG001|Overall Study|Lost to Follow-up|3|||
161018616|NCT00554788|581455921|FG002|Overall Study|Lost to Follow-up|3|||
161018617|NCT00554788|581455919|FG000|Overall Study|Physician Decision|1|||
161018618|NCT00554788|581455920|FG001|Overall Study|Physician Decision|1|||
161018619|NCT00554788|581455921|FG002|Overall Study|Physician Decision|3|||
161018620|NCT00554788|581455919|FG000|Overall Study|Withdrawal by Subject|0|||
161018621|NCT00554788|581455920|FG001|Overall Study|Withdrawal by Subject|0|||
161018622|NCT00554788|581455921|FG002|Overall Study|Withdrawal by Subject|1|||
161018623|NCT00554788|581455919|FG000|Overall Study|Refusal of further protocol therapy|0|||
161018624|NCT00554788|581455920|FG001|Overall Study|Refusal of further protocol therapy|1|||
161018625|NCT00554788|581455921|FG002|Overall Study|Refusal of further protocol therapy|1|||
161018626|NCT00554788|581455919|FG000|Overall Study|Progressive disease|0|||
161018627|NCT00554788|581455920|FG001|Overall Study|Progressive disease|0|||
161018628|NCT00554788|581455921|FG002|Overall Study|Progressive disease|3|||
161018629|NCT00554788|581455919|FG000|Overall Study|Ineligible|2|||
161018630|NCT00554788|581455920|FG001|Overall Study|Ineligible|0|||
161018631|NCT00554788|581455921|FG002|Overall Study|Ineligible|1|||
161018632|NCT03640312|581455932|FG000|Overall Study|Lost to Follow-up|3|||
161018633|NCT03640312|581455933|FG001|Overall Study|Lost to Follow-up|6|||
161018634|NCT05008835|581455937|FG000|Overall Study|Adverse Event|5|||
161018635|NCT05008835|581455938|FG001|Overall Study|Adverse Event|2|||
161018636|NCT05008835|581455939|FG002|Overall Study|Adverse Event|1|||
161018637|NCT05008835|581455937|FG000|Overall Study|Lack of Efficacy|0|||
161018638|NCT05008835|581455938|FG001|Overall Study|Lack of Efficacy|0|||
161018639|NCT05008835|581455939|FG002|Overall Study|Lack of Efficacy|1|||
161018640|NCT05008835|581455937|FG000|Overall Study|Study terminated by sponsor|0|||
160459532|NCT04560179|579415024|FG004|Overall Study|Adverse Event|0|||
160459533|NCT05454514|579415025|FG000|Overall Study|Withdrawal by Subject|4|||
160459534|NCT02624050|579415026|FG000|Overall Study|Physician Decision|4|||
160459535|NCT02624050|579415027|FG001|Overall Study|Physician Decision|0|||
160459536|NCT02624050|579415026|FG000|Overall Study|Protocol Violation|2|||
160459537|NCT02624050|579415027|FG001|Overall Study|Protocol Violation|0|||
160459538|NCT04795245|579415028|FG000|Overall Study|Unkown reason|7|||
160459539|NCT04795245|579415028|FG000|Overall Study|Death|17|||
160459540|NCT04795245|579415028|FG000|Overall Study|Other than listed|19|||
160459541|NCT04795245|579415028|FG000|Overall Study|Adverse Event|143|||
160459542|NCT04795245|579415028|FG000|Overall Study|Progressive disease|512|||
160459543|NCT04795245|579415028|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
160459544|NCT01756300|579415029|FG000|Overall Study|Death|1|||
160459545|NCT01756300|579415029|FG000|Overall Study|Withdrawal by Subject|1|||
160459546|NCT03734029|579415030|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
160459547|NCT03734029|579415031|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
160459548|NCT03734029|579415030|FG000|Overall Study|Adverse Event|60|||
160459549|NCT03734029|579415031|FG001|Overall Study|Adverse Event|14|||
161018641|NCT05008835|581455938|FG001|Overall Study|Study terminated by sponsor|0|||
161018642|NCT05008835|581455939|FG002|Overall Study|Study terminated by sponsor|1|||
161018643|NCT05008835|581455937|FG000|Overall Study|Not further specified|3|||
161018644|NCT05008835|581455938|FG001|Overall Study|Not further specified|2|||
161018645|NCT05008835|581455939|FG002|Overall Study|Not further specified|1|||
161018646|NCT04876118|581455940|FG000|Overall Study|Pregnancy|1|||
160459550|NCT03734029|579415030|FG000|Overall Study|Withdrawal by Subject|12|||
160459551|NCT03734029|579415031|FG001|Overall Study|Withdrawal by Subject|11|||
160459552|NCT03734029|579415030|FG000|Overall Study|Clinical progression by investigator|10|||
161018647|NCT04876118|581455940|FG000|Overall Study|Withdrawal by Subject|14|||
160459553|NCT03734029|579415031|FG001|Overall Study|Clinical progression by investigator|8|||
161018648|NCT05089734|581455941|FG000|Overall Study|Still on study|122|||
161018649|NCT05089734|581455942|FG001|Overall Study|Still on study|101|||
161018650|NCT05089734|581455941|FG000|Overall Study|Death|161|||
161018651|NCT05089734|581455942|FG001|Overall Study|Death|179|||
161018652|NCT05089734|581455941|FG000|Overall Study|Withdrew consent|11|||
161018653|NCT05089734|581455942|FG001|Overall Study|Withdrew consent|24|||
161018654|NCT05089734|581455941|FG000|Overall Study|Lost to Follow-up|5|||
161018655|NCT05089734|581455942|FG001|Overall Study|Lost to Follow-up|0|||
161018656|NCT05215314|581457686|FG000|Overall Study|Lost to Follow-up|2|||
161018657|NCT05215314|581457687|FG001|Overall Study|Lost to Follow-up|2|||
161018658|NCT05215314|581457686|FG000|Overall Study|Withdrawal by Subject|2|||
161018659|NCT05215314|581457687|FG001|Overall Study|Withdrawal by Subject|0|||
161018660|NCT05215314|581457686|FG000|Overall Study|Physician Decision|1|||
161018661|NCT05215314|581457687|FG001|Overall Study|Physician Decision|0|||
161018662|NCT04179500|581457688|FG000|Treatment|Withdrawal by Subject|1|||
161018663|NCT04179500|581457688|FG000|Treatment|Adverse Event|2|||
161018664|NCT04179500|581457688|FG000|Treatment|pyrazinamide resistance|1|||
161018665|NCT03792555|581457691|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
161018666|NCT03792555|581457692|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
161018667|NCT03792555|581457693|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
161018668|NCT03792555|581457691|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
161018669|NCT03792555|581457692|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
161018670|NCT03792555|581457693|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
161018671|NCT03792555|581457691|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
161018672|NCT03792555|581457692|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
161018673|NCT03792555|581457693|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
161018674|NCT04492007|581457694|FG000|Overall Study|Lost to Follow-up|1|||
161018675|NCT04492007|581457695|FG001|Overall Study|Lost to Follow-up|1|||
161018676|NCT04492007|581457696|FG002|Overall Study|Lost to Follow-up|2|||
161018677|NCT04492007|581457697|FG003|Overall Study|Lost to Follow-up|2|||
161018678|NCT04492007|581457694|FG000|Overall Study|Protocol Violation|1|||
161018679|NCT04492007|581457695|FG001|Overall Study|Protocol Violation|1|||
161018680|NCT04492007|581457696|FG002|Overall Study|Protocol Violation|1|||
161018681|NCT04492007|581457697|FG003|Overall Study|Protocol Violation|1|||
161018682|NCT04492007|581457694|FG000|Overall Study|Withdrawal by Subject|0|||
161018683|NCT04492007|581457695|FG001|Overall Study|Withdrawal by Subject|0|||
161018684|NCT04492007|581457696|FG002|Overall Study|Withdrawal by Subject|1|||
161018685|NCT04492007|581457697|FG003|Overall Study|Withdrawal by Subject|1|||
161018686|NCT03457142|581457702|FG000|Overall Study|Death|1|||
161018687|NCT03770273|581457703|FG000|Overall Study|Adverse Event|2|||
161018688|NCT03770273|581457704|FG001|Overall Study|Adverse Event|0|||
161018689|NCT03770273|581457703|FG000|Overall Study|Lost to Follow-up|1|||
161018690|NCT03770273|581457704|FG001|Overall Study|Lost to Follow-up|1|||
161018691|NCT00418886|581457705|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
161018692|NCT00418886|581457706|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
161018693|NCT00418886|581457705|FG000|Randomized Period|Death|122|||
161018694|NCT00418886|581457706|FG001|Randomized Period|Death|147|||
161018695|NCT00418886|581457705|FG000|Randomized Period|Withdrawal by Subject|9|||
161018696|NCT00418886|581457706|FG001|Randomized Period|Withdrawal by Subject|10|||
161018697|NCT00418886|581457705|FG000|Randomized Period|Lost to Follow-up|4|||
161018698|NCT00418886|581457706|FG001|Randomized Period|Lost to Follow-up|6|||
161018699|NCT00418886|581457705|FG000|Randomized Period|withdrawn due to other reason|1|||
161018700|NCT00418886|581457706|FG001|Randomized Period|withdrawn due to other reason|0|||
161018701|NCT00418886|581457705|FG000|Randomized Period|randomised but no treatment received|0|||
161018702|NCT00418886|581457706|FG001|Randomized Period|randomised but no treatment received|1|||
161018703|NCT04060654|581457707|FG000|Overall Study|Withdrawal by Subject|1|||
161018704|NCT04060654|581457707|FG000|Overall Study|Lost to Follow-up|5|||
161018705|NCT03707951|581457708|FG000|Overall Study|Lost to Follow-up|8|||
161018706|NCT03707951|581457709|FG001|Overall Study|Lost to Follow-up|17|||
161018707|NCT03707951|581457708|FG000|Overall Study|Withdrawal by Subject|6|||
161018708|NCT03707951|581457709|FG001|Overall Study|Withdrawal by Subject|6|||
161018709|NCT04887129|581457710|FG000|Overall Study|Lost to Follow-up|0|||
161018710|NCT04887129|581457711|FG001|Overall Study|Lost to Follow-up|24|||
161018711|NCT04887129|581457710|FG000|Overall Study|Withdrawal by Subject|9|||
161018712|NCT04887129|581457711|FG001|Overall Study|Withdrawal by Subject|57|||
161018713|NCT04887129|581457710|FG000|Overall Study|Other|2|||
161018714|NCT04887129|581457711|FG001|Overall Study|Other|9|||
161018715|NCT04533347|581457713|FG000|Overall Study|Adverse Event|1|||
161018716|NCT04533347|581457714|FG001|Overall Study|Adverse Event|2|||
161018717|NCT04533347|581457713|FG000|Overall Study|Lost to Follow-up|2|||
161018718|NCT04533347|581457714|FG001|Overall Study|Lost to Follow-up|0|||
161018719|NCT04533347|581457713|FG000|Overall Study|Withdrawal by Subject|1|||
161018720|NCT04533347|581457714|FG001|Overall Study|Withdrawal by Subject|0|||
161018721|NCT05520190|581457715|FG000|Overall Study|Lost to Follow-up|7|||
161018722|NCT05520190|581457715|FG000|Overall Study|Withdrawal by Subject|2|||
161018723|NCT01999075|581457716|FG000|Overall Study|Lost to Follow-up|0|||
161018724|NCT01999075|581457717|FG001|Overall Study|Lost to Follow-up|2|||
161018725|NCT01999075|581457716|FG000|Overall Study|Withdrawal by Subject|2|||
161018726|NCT01999075|581457717|FG001|Overall Study|Withdrawal by Subject|7|||
161018727|NCT01999075|581457716|FG000|Overall Study|Enrolled in drug trial|3|||
161018728|NCT01999075|581457717|FG001|Overall Study|Enrolled in drug trial|1|||
161018729|NCT01999075|581457716|FG000|Overall Study|Became ineligible|0|||
161018730|NCT01999075|581457717|FG001|Overall Study|Became ineligible|2|||
161018731|NCT03907397|581457720|FG000|Overall Study|Lost to Follow-up|0|||
161018732|NCT03907397|581457721|FG001|Overall Study|Lost to Follow-up|1|||
161018733|NCT03907397|581457720|FG000|Overall Study|Physician Decision|2|||
161018734|NCT03907397|581457721|FG001|Overall Study|Physician Decision|1|||
161018735|NCT03907397|581457720|FG000|Overall Study|Withdrawal by Subject|5|||
161018736|NCT03907397|581457721|FG001|Overall Study|Withdrawal by Subject|4|||
161018737|NCT03907397|581457720|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
161018738|NCT03907397|581457721|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
161018739|NCT04896476|581457733|FG000|Overall Study|Withdrawal by Subject|1|||
161018740|NCT04896476|581457733|FG000|Overall Study|Lost to Follow-up|2|||
161018741|NCT03476187|581457734|FG000|Overall Study|Protocol Violation|7|||
161018742|NCT03476187|581457734|FG000|Overall Study|Physician Decision|5|||
161018743|NCT05948670|581457736|FG000|Overall Study|Protocol Violation|6|||
161018744|NCT05948670|581457737|FG001|Overall Study|Protocol Violation|8|||
161018745|NCT05948670|581457736|FG000|Overall Study|Withdrawal by Subject|0|||
161018746|NCT05948670|581457737|FG001|Overall Study|Withdrawal by Subject|1|||
161018747|NCT04562649|581457739|FG000|Overall Study|Withdrawal by Subject|11|||
161018748|NCT04562649|581457740|FG001|Overall Study|Withdrawal by Subject|8|||
161018749|NCT04562649|581457739|FG000|Overall Study|Lost to Follow-up|26|||
161018750|NCT04562649|581457740|FG001|Overall Study|Lost to Follow-up|20|||
161018751|NCT05368103|581457741|FG000|Overall Study|Withdrawal by Subject|4|||
161018752|NCT05368103|581457741|FG000|Overall Study|Lost to Follow-up|1|||
161018753|NCT05368103|581457741|FG000|Overall Study|Lack of Efficacy|3|||
161018754|NCT03675282|581457744|FG000|Overall Study|Lost to Follow-up|4|||
161018755|NCT03675282|581457745|FG001|Overall Study|Lost to Follow-up|8|||
161018756|NCT03675282|581457746|FG002|Overall Study|Lost to Follow-up|1|||
161018757|NCT03675282|581457747|FG003|Overall Study|Lost to Follow-up|0|||
161018758|NCT03675282|581457748|FG004|Overall Study|Lost to Follow-up|2|||
161018759|NCT03675282|581457749|FG005|Overall Study|Lost to Follow-up|7|||
161018760|NCT03675282|581457744|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
161018761|NCT03675282|581457745|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
161018762|NCT03675282|581457746|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
161018763|NCT03675282|581457747|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
161018764|NCT03675282|581457748|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
161018765|NCT03675282|581457749|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
161018766|NCT03675282|581457744|FG000|Overall Study|Physician Decision|1|||
161018767|NCT03675282|581457745|FG001|Overall Study|Physician Decision|0|||
161018768|NCT03675282|581457746|FG002|Overall Study|Physician Decision|0|||
161018769|NCT03675282|581457747|FG003|Overall Study|Physician Decision|0|||
161018770|NCT03675282|581457748|FG004|Overall Study|Physician Decision|0|||
161018771|NCT03675282|581457749|FG005|Overall Study|Physician Decision|0|||
161018772|NCT03056040|581457750|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
161018773|NCT03056040|581457751|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
161018774|NCT03056040|581457750|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
161018775|NCT03056040|581457751|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
161018776|NCT03056040|581457750|FG000|Primary Evaluation Period|Pregnancy|0|||
161018777|NCT03056040|581457751|FG001|Primary Evaluation Period|Pregnancy|1|||
161018778|NCT03056040|581457750|FG000|Primary Evaluation Period|Randomized, not treated|1|||
161018779|NCT03056040|581457751|FG001|Primary Evaluation Period|Randomized, not treated|1|||
161018780|NCT03056040|581457750|FG000|Extension Period|Physician Decision|3|||
161018781|NCT03056040|581457751|FG001|Extension Period|Physician Decision|3|||
161018782|NCT03056040|581457750|FG000|Extension Period|Lost to Follow-up|0|||
160586959|NCT00077610|579867641|FG000|Overall Study|Adverse Event|9|||
160586960|NCT00077610|579867642|FG001|Overall Study|Adverse Event|7|||
161018783|NCT03056040|581457751|FG001|Extension Period|Lost to Follow-up|1|||
161018784|NCT03056040|581457750|FG000|Extension Period|Death|0|||
161018785|NCT03056040|581457751|FG001|Extension Period|Death|3|||
161018786|NCT03056040|581457750|FG000|Extension Period|Withdrawal by Subject|1|||
161018787|NCT03056040|581457751|FG001|Extension Period|Withdrawal by Subject|0|||
161018788|NCT03232138|581457757|FG000|Overall Study|Physician Decision|1|||
161018789|NCT03232138|581457758|FG001|Overall Study|Physician Decision|0|||
160586961|NCT00077610|579867643|FG002|Overall Study|Adverse Event|1|||
161018790|NCT03232138|581457757|FG000|Overall Study|Adverse Event|2|||
161018791|NCT03232138|581457758|FG001|Overall Study|Adverse Event|0|||
161018792|NCT03232138|581457757|FG000|Overall Study|Withdrawal by Subject|1|||
161018793|NCT03232138|581457758|FG001|Overall Study|Withdrawal by Subject|2|||
161018794|NCT03853746|581457760|FG000|Overall Study|Withdrawal by Subject|1|||
161018795|NCT05028634|581457761|FG000|Overall Study|Withdrawal by Subject|0|||
161018796|NCT05028634|581457762|FG001|Overall Study|Withdrawal by Subject|1|||
160586962|NCT00077610|579867641|FG000|Overall Study|Lost to Follow-up|0|||
161018797|NCT03850678|581457763|FG000|Overall Study|Withdrawal by Subject|3|||
161018798|NCT03850678|581457764|FG001|Overall Study|Withdrawal by Subject|0|||
161018799|NCT03850678|581457763|FG000|Overall Study|Experimenter Error|1|||
161018800|NCT03850678|581457764|FG001|Overall Study|Experimenter Error|1|||
161018801|NCT03850678|581457763|FG000|Overall Study|Did Not Condition To Experiment|7|||
161018802|NCT03850678|581457764|FG001|Overall Study|Did Not Condition To Experiment|2|||
161018803|NCT02724631|581457772|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
161018804|NCT02908477|581457773|FG000|Overall Study|Withdrawal by Subject|8|||
161018805|NCT02908477|581457774|FG001|Overall Study|Withdrawal by Subject|28|||
161018806|NCT03766009|581457779|FG000|Usual Care|Death|0|||
161018807|NCT03766009|581457780|FG001|Usual Care|Death|0|||
161018808|NCT03766009|581457781|FG002|Usual Care|Death|0|||
161018809|NCT03766009|581457782|FG003|Usual Care|Death|1|||
161018810|NCT03766009|581457783|FG004|Usual Care|Death|0|||
161018811|NCT03766009|581457784|FG005|Usual Care|Death|0|||
161018812|NCT03766009|581457779|FG000|Usual Care|Lost to Follow-up|0|||
161018813|NCT03766009|581457780|FG001|Usual Care|Lost to Follow-up|0|||
161018814|NCT03766009|581457781|FG002|Usual Care|Lost to Follow-up|0|||
161018815|NCT03766009|581457782|FG003|Usual Care|Lost to Follow-up|1|||
161018816|NCT03766009|581457783|FG004|Usual Care|Lost to Follow-up|0|||
161018817|NCT03766009|581457784|FG005|Usual Care|Lost to Follow-up|0|||
161018818|NCT03766009|581457779|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
161018819|NCT03766009|581457780|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
161018820|NCT03766009|581457781|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
161018821|NCT03766009|581457782|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
160459554|NCT03734029|579415030|FG000|Overall Study|Death|5|||
160459555|NCT03734029|579415031|FG001|Overall Study|Death|2|||
160459556|NCT03734029|579415030|FG000|Overall Study|Physician Decision|4|||
160459557|NCT03734029|579415031|FG001|Overall Study|Physician Decision|3|||
160459558|NCT03734029|579415030|FG000|Overall Study|Other|2|||
160459559|NCT03734029|579415031|FG001|Overall Study|Other|0|||
160459560|NCT03734029|579415030|FG000|Overall Study|Lost to Follow-up|0|||
160459561|NCT03734029|579415031|FG001|Overall Study|Lost to Follow-up|1|||
160459562|NCT03734029|579415030|FG000|Overall Study|Randomized, but not treated|2|||
160459563|NCT03734029|579415031|FG001|Overall Study|Randomized, but not treated|12|||
160459564|NCT02611687|579415686|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
160459565|NCT02611687|579415687|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
160459566|NCT02075554|579415688|FG000|Overall Study|Lost to Follow-up|7|||
160459567|NCT02075554|579415688|FG000|Overall Study|Withdrawal by Subject|5|||
160459568|NCT02075554|579415688|FG000|Overall Study|Physician Decision|3|||
160459569|NCT04933474|579415694|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
160459570|NCT04933474|579415695|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
160459571|NCT04933474|579415694|FG000|Overall Study|Lost to Follow-up|19|||
161018822|NCT03766009|581457783|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
161018823|NCT03766009|581457784|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
161018824|NCT03766009|581457779|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161018825|NCT03766009|581457780|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
161018826|NCT03766009|581457781|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161018827|NCT03766009|581457782|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
161018828|NCT03766009|581457783|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161018829|NCT03766009|581457784|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161018830|NCT03766009|581457779|FG000|Usual Care|No treatment or declined surgery|0|||
161018831|NCT03766009|581457780|FG001|Usual Care|No treatment or declined surgery|0|||
161018832|NCT03766009|581457781|FG002|Usual Care|No treatment or declined surgery|0|||
161018833|NCT03766009|581457782|FG003|Usual Care|No treatment or declined surgery|2|||
161018834|NCT03766009|581457783|FG004|Usual Care|No treatment or declined surgery|0|||
161018835|NCT03766009|581457784|FG005|Usual Care|No treatment or declined surgery|0|||
161018836|NCT03766009|581457779|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
161018837|NCT03766009|581457780|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
161018838|NCT03766009|581457781|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
160459572|NCT04933474|579415695|FG001|Overall Study|Lost to Follow-up|9|||
160459573|NCT04933474|579415694|FG000|Overall Study|Life Burden - unable to participate|6|||
160459574|NCT04933474|579415695|FG001|Overall Study|Life Burden - unable to participate|2|||
160459575|NCT04933474|579415694|FG000|Overall Study|Disease Burden - unable to participate|4|||
160459576|NCT04933474|579415695|FG001|Overall Study|Disease Burden - unable to participate|1|||
160459577|NCT04933474|579415694|FG000|Overall Study|Surgery/Hospitalization|1|||
161018839|NCT03766009|581457782|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
161018840|NCT03766009|581457783|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
160459578|NCT04933474|579415695|FG001|Overall Study|Surgery/Hospitalization|2|||
160459579|NCT04933474|579415694|FG000|Overall Study|Dissatisfied with Intervention|1|||
160586963|NCT00077610|579867642|FG001|Overall Study|Lost to Follow-up|1|||
161018841|NCT03766009|581457784|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
161018842|NCT03766009|581457779|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161018843|NCT03766009|581457780|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
161018844|NCT03766009|581457781|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161018845|NCT03766009|581457782|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161018846|NCT03766009|581457783|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161018847|NCT03766009|581457784|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161018848|NCT03766009|581457779|FG000|Usual Care|Ineligible|0|||
161018849|NCT03766009|581457780|FG001|Usual Care|Ineligible|1|||
161018850|NCT03766009|581457781|FG002|Usual Care|Ineligible|0|||
161018851|NCT03766009|581457782|FG003|Usual Care|Ineligible|0|||
161018852|NCT03766009|581457783|FG004|Usual Care|Ineligible|0|||
161018853|NCT03766009|581457784|FG005|Usual Care|Ineligible|0|||
161018854|NCT03766009|581457779|FG000|Usual Care|Other: Staff turnover|0|||
161018855|NCT03766009|581457780|FG001|Usual Care|Other: Staff turnover|0|||
161018856|NCT03766009|581457781|FG002|Usual Care|Other: Staff turnover|0|||
161018857|NCT03766009|581457782|FG003|Usual Care|Other: Staff turnover|0|||
160459580|NCT04933474|579415695|FG001|Overall Study|Dissatisfied with Intervention|1|||
160459581|NCT04933474|579415694|FG000|Overall Study|Withdrew interest in participation|1|||
160459582|NCT04933474|579415695|FG001|Overall Study|Withdrew interest in participation|0|||
160459583|NCT04933474|579415694|FG000|Overall Study|Had previously enrolled in the study|0|||
160459584|NCT04933474|579415695|FG001|Overall Study|Had previously enrolled in the study|1|||
160459585|NCT04757753|579415698|FG000|Overall Study|Lost to Follow-up|7|||
160459586|NCT04757753|579415699|FG001|Overall Study|Lost to Follow-up|7|||
160459587|NCT04757753|579415698|FG000|Overall Study|Withdrawal by Subject|0|||
160459588|NCT04757753|579415699|FG001|Overall Study|Withdrawal by Subject|3|||
160459589|NCT04757753|579415698|FG000|Overall Study|Endodontic treatment failure|1|||
160459590|NCT04757753|579415699|FG001|Overall Study|Endodontic treatment failure|2|||
160459591|NCT04757753|579415698|FG000|Overall Study|Tooth fracture/extraction|3|||
160459592|NCT04757753|579415699|FG001|Overall Study|Tooth fracture/extraction|0|||
160459593|NCT03733626|579415706|FG000|Overall Study|Physician Decision|4|||
160459594|NCT03733626|579415707|FG001|Overall Study|Physician Decision|4|||
160459595|NCT00319046|579415708|FG000|Overall Study|withdrawal of subject's consent|7|||
160459596|NCT00319046|579415708|FG000|Overall Study|administrative reason|1|||
160459597|NCT03816397|579415709|FG000|Overall Study|Censored at interim analysis date.|13|||
160459598|NCT03816397|579415710|FG001|Overall Study|Censored at interim analysis date.|6|||
160459599|NCT03816397|579415709|FG000|Overall Study|Withdrawal by Subject|1|||
160459600|NCT03816397|579415710|FG001|Overall Study|Withdrawal by Subject|1|||
160459601|NCT04496752|579415711|FG000|Second Assessment|Lost to Follow-up|3|||
160459602|NCT04496752|579415712|FG001|Second Assessment|Lost to Follow-up|3|||
160459603|NCT04496752|579415711|FG000|Second Assessment|Adverse Event|2|||
160459604|NCT04496752|579415712|FG001|Second Assessment|Adverse Event|0|||
160459605|NCT04214418|579415713|FG000|Overall Study|Withdrawal by Subject|1|||
160459606|NCT04214418|579415714|FG001|Overall Study|Withdrawal by Subject|0|||
160459607|NCT04214418|579415715|FG002|Overall Study|Withdrawal by Subject|0|||
160459608|NCT04214418|579415716|FG003|Overall Study|Withdrawal by Subject|0|||
160459609|NCT04214418|579415717|FG004|Overall Study|Withdrawal by Subject|0|||
160459610|NCT04214418|579415718|FG005|Overall Study|Withdrawal by Subject|0|||
160459611|NCT04214418|579415713|FG000|Overall Study|Adverse Event|0|||
160459612|NCT04214418|579415714|FG001|Overall Study|Adverse Event|2|||
160459613|NCT04214418|579415715|FG002|Overall Study|Adverse Event|0|||
160459614|NCT04214418|579415716|FG003|Overall Study|Adverse Event|0|||
160459615|NCT04214418|579415717|FG004|Overall Study|Adverse Event|0|||
160459616|NCT04214418|579415718|FG005|Overall Study|Adverse Event|0|||
160459617|NCT04214418|579415713|FG000|Overall Study|Death|1|||
160459618|NCT04214418|579415714|FG001|Overall Study|Death|0|||
160459619|NCT04214418|579415715|FG002|Overall Study|Death|0|||
160459620|NCT04214418|579415716|FG003|Overall Study|Death|0|||
160459621|NCT04214418|579415717|FG004|Overall Study|Death|0|||
160459622|NCT04214418|579415718|FG005|Overall Study|Death|0|||
161018858|NCT03766009|581457783|FG004|Usual Care|Other: Staff turnover|0|||
161018859|NCT03766009|581457784|FG005|Usual Care|Other: Staff turnover|2|||
160459623|NCT04078152|579415719|FG000|Overall Study|Other|83|||
160459624|NCT04078152|579415720|FG001|Overall Study|Other|22|||
160459625|NCT04078152|579415721|FG002|Overall Study|Other|25|||
160459626|NCT04078152|579415719|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
160459627|NCT04078152|579415720|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
160459628|NCT04078152|579415721|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
160459629|NCT04078152|579415719|FG000|Overall Study|Withdrawal by Subject|5|||
160459630|NCT04078152|579415720|FG001|Overall Study|Withdrawal by Subject|0|||
160459631|NCT04078152|579415721|FG002|Overall Study|Withdrawal by Subject|1|||
160459632|NCT04078152|579415719|FG000|Overall Study|Death|10|||
160459633|NCT04078152|579415720|FG001|Overall Study|Death|2|||
161018860|NCT05071807|581457788|FG000|Overall Study|Withdrawal by Subject|4|||
161018861|NCT05071807|581457789|FG001|Overall Study|Withdrawal by Subject|0|||
160459634|NCT04078152|579415721|FG002|Overall Study|Death|12|||
160459635|NCT04078152|579415719|FG000|Overall Study|Adverse Event|1|||
160459636|NCT04078152|579415720|FG001|Overall Study|Adverse Event|0|||
160459637|NCT04078152|579415721|FG002|Overall Study|Adverse Event|0|||
160459638|NCT04908930|579415725|FG000|Overall Study|Lost to Follow-up|1|||
160459639|NCT04908930|579415726|FG001|Overall Study|Lost to Follow-up|1|||
160459640|NCT04908930|579415727|FG002|Overall Study|Lost to Follow-up|0|||
160459641|NCT04908930|579415728|FG003|Overall Study|Lost to Follow-up|0|||
160459642|NCT04908930|579415729|FG004|Overall Study|Lost to Follow-up|0|||
160459643|NCT04908930|579415725|FG000|Overall Study|hardware in mouth|1|||
160459644|NCT04908930|579415726|FG001|Overall Study|hardware in mouth|1|||
160459645|NCT04908930|579415727|FG002|Overall Study|hardware in mouth|0|||
160459646|NCT04908930|579415728|FG003|Overall Study|hardware in mouth|0|||
160459647|NCT04908930|579415729|FG004|Overall Study|hardware in mouth|0|||
160459648|NCT04908930|579415725|FG000|Overall Study|wrong team|1|||
160459649|NCT04908930|579415726|FG001|Overall Study|wrong team|0|||
160459650|NCT04908930|579415727|FG002|Overall Study|wrong team|0|||
160459651|NCT04908930|579415728|FG003|Overall Study|wrong team|0|||
160459652|NCT04908930|579415729|FG004|Overall Study|wrong team|0|||
160459653|NCT04908930|579415725|FG000|Overall Study|quit team|2|||
160459654|NCT04908930|579415726|FG001|Overall Study|quit team|4|||
160459655|NCT04908930|579415727|FG002|Overall Study|quit team|0|||
160459656|NCT04908930|579415728|FG003|Overall Study|quit team|0|||
160459657|NCT04908930|579415729|FG004|Overall Study|quit team|0|||
160459658|NCT04908930|579415725|FG000|Overall Study|Withdrawal by Subject|1|||
160459659|NCT04908930|579415726|FG001|Overall Study|Withdrawal by Subject|2|||
160459660|NCT04908930|579415727|FG002|Overall Study|Withdrawal by Subject|0|||
160459661|NCT04908930|579415728|FG003|Overall Study|Withdrawal by Subject|0|||
160459662|NCT04908930|579415729|FG004|Overall Study|Withdrawal by Subject|0|||
160459663|NCT04908930|579415725|FG000|Overall Study|parent not liking program|0|||
160459664|NCT04908930|579415726|FG001|Overall Study|parent not liking program|1|||
160459665|NCT04908930|579415727|FG002|Overall Study|parent not liking program|0|||
160459666|NCT04908930|579415728|FG003|Overall Study|parent not liking program|0|||
160459667|NCT04908930|579415729|FG004|Overall Study|parent not liking program|0|||
160459668|NCT04679389|579415730|FG000|Overall Study|Adverse Event|1|||
160459669|NCT04679389|579415731|FG001|Overall Study|Adverse Event|0|||
160459670|NCT04679389|579415730|FG000|Overall Study|Protocol Violation|2|||
160459671|NCT04679389|579415731|FG001|Overall Study|Protocol Violation|0|||
160459672|NCT04679389|579415730|FG000|Overall Study|Physician Decision|3|||
160459673|NCT04679389|579415731|FG001|Overall Study|Physician Decision|5|||
161018862|NCT05071807|581457788|FG000|Overall Study|Unrelated medical issues|3|||
161018863|NCT05071807|581457789|FG001|Overall Study|Unrelated medical issues|0|||
161018864|NCT05071807|581457788|FG000|Overall Study|Relocated|0|||
161018865|NCT05071807|581457789|FG001|Overall Study|Relocated|1|||
161018866|NCT03903146|581457794|FG000|Overall Study|Lost to Follow-up|6|||
161018867|NCT03903146|581457795|FG001|Overall Study|Lost to Follow-up|4|||
161018868|NCT03903146|581457794|FG000|Overall Study|Withdrawal by Subject|0|||
161018869|NCT03903146|581457795|FG001|Overall Study|Withdrawal by Subject|1|||
161018870|NCT05551637|581457796|FG000|Overall Study|Lack of Efficacy|0|||
161018871|NCT05551637|581457797|FG001|Overall Study|Lack of Efficacy|6|||
161018872|NCT05551637|581457796|FG000|Overall Study|Lost to Follow-up|1|||
161018873|NCT05551637|581457797|FG001|Overall Study|Lost to Follow-up|1|||
161018874|NCT05179837|581457800|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
161018875|NCT05179837|581457800|FG000|Overall Study|Device malfunctioned|1|||
161018876|NCT05179837|581457800|FG000|Overall Study|Image quality too low|2|||
161018877|NCT04924660|581457801|FG000|United States|Death|29|||
161018878|NCT04924660|581457802|FG001|United States|Death|32|||
161018879|NCT04924660|581457803|FG002|United States|Death|34|||
161018880|NCT04924660|581457804|FG003|United States|Death|25|||
161018881|NCT04924660|581457805|FG004|United States|Death|26|||
160459674|NCT04679389|579415730|FG000|Overall Study|Withdrawal by Subject|5|||
160459675|NCT04679389|579415731|FG001|Overall Study|Withdrawal by Subject|7|||
160459676|NCT03904576|579415750|FG000|Washout Period|Protocol Violation|1|||
160459677|NCT03904576|579415751|FG001|Washout Period|Protocol Violation|1|||
161018882|NCT04924660|581457806|FG005|United States|Death|23|||
161018883|NCT04924660|581457801|FG000|United States|Lost to Follow-up|15|||
161018884|NCT04924660|581457802|FG001|United States|Lost to Follow-up|10|||
161018885|NCT04924660|581457803|FG002|United States|Lost to Follow-up|13|||
160459678|NCT04780581|579415754|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
160459679|NCT04780581|579415755|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
160459680|NCT04780581|579415754|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
160586964|NCT00077610|579867643|FG002|Overall Study|Lost to Follow-up|2|||
161018886|NCT04924660|581457804|FG003|United States|Lost to Follow-up|5|||
161018887|NCT04924660|581457805|FG004|United States|Lost to Follow-up|19|||
161018888|NCT04924660|581457806|FG005|United States|Lost to Follow-up|20|||
161018889|NCT04924660|581457801|FG000|United States|Withdrawal by Subject|8|||
160459681|NCT04780581|579415755|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
160459682|NCT02765412|579415756|FG000|Overall Study|Death|482|||
160459683|NCT02765412|579415757|FG001|Overall Study|Death|855|||
160632908|NCT02575807|580036105|FG001|Overall Study|Death|3|||
161018890|NCT04924660|581457802|FG001|United States|Withdrawal by Subject|3|||
161018891|NCT04924660|581457803|FG002|United States|Withdrawal by Subject|3|||
161018892|NCT04924660|581457804|FG003|United States|Withdrawal by Subject|3|||
161018893|NCT04924660|581457805|FG004|United States|Withdrawal by Subject|8|||
161018894|NCT04924660|581457806|FG005|United States|Withdrawal by Subject|4|||
161018895|NCT04924660|581457801|FG000|Spain|Death|0|||
161018896|NCT04924660|581457802|FG001|Spain|Death|0|||
161018897|NCT04924660|581457803|FG002|Spain|Death|0|||
161018898|NCT04924660|581457804|FG003|Spain|Death|0|||
161018899|NCT04924660|581457805|FG004|Spain|Death|0|||
161018900|NCT04924660|581457806|FG005|Spain|Death|2|||
161018901|NCT04924660|581457801|FG000|Spain|Lost to Follow-up|0|||
160459684|NCT03990883|579415758|FG000|Blinded Treatment Phase|Adverse Event|1|||
160459685|NCT03990883|579415759|FG001|Blinded Treatment Phase|Adverse Event|1|||
160459686|NCT03990883|579415760|FG002|Blinded Treatment Phase|Adverse Event|0|||
160459687|NCT03990883|579415758|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
160459688|NCT03990883|579415759|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
160459689|NCT03990883|579415760|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
160459690|NCT03990883|579415758|FG000|Blinded Treatment Phase|Physician Decision|1|||
160459691|NCT03990883|579415759|FG001|Blinded Treatment Phase|Physician Decision|0|||
160459692|NCT03990883|579415760|FG002|Blinded Treatment Phase|Physician Decision|0|||
160459693|NCT03990883|579415758|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
160459694|NCT03990883|579415759|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
160459695|NCT03990883|579415760|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
160459696|NCT03990883|579415758|FG000|Blinded Treatment Phase|COVID-19|3|||
160459697|NCT03990883|579415759|FG001|Blinded Treatment Phase|COVID-19|2|||
160459698|NCT03990883|579415760|FG002|Blinded Treatment Phase|COVID-19|0|||
160459699|NCT03990883|579415758|FG000|Blinded Treatment Phase|Personal Reasons|6|||
160459700|NCT03990883|579415759|FG001|Blinded Treatment Phase|Personal Reasons|3|||
160459701|NCT03990883|579415760|FG002|Blinded Treatment Phase|Personal Reasons|0|||
160459702|NCT03990883|579415758|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
160586965|NCT00077610|579867641|FG000|Overall Study|Withdrawal by Subject|4|||
160586966|NCT00077610|579867642|FG001|Overall Study|Withdrawal by Subject|10|||
160586967|NCT00077610|579867643|FG002|Overall Study|Withdrawal by Subject|6|||
160586968|NCT00077610|579867641|FG000|Overall Study|Death|17|||
160586969|NCT00077610|579867642|FG001|Overall Study|Death|13|||
160586970|NCT00077610|579867643|FG002|Overall Study|Death|13|||
160586971|NCT00077610|579867641|FG000|Overall Study|Renal transplant|12|||
160586972|NCT00077610|579867642|FG001|Overall Study|Renal transplant|15|||
160969194|NCT00879996|581275161|FG001|Overall Study|non-compliance|4|||
160969195|NCT00879996|581275160|FG000|Overall Study|Physician Decision|1|||
160969196|NCT00879996|581275161|FG001|Overall Study|Physician Decision|2|||
160969197|NCT00879996|581275160|FG000|Overall Study|psychiatric problem|0|||
160969198|NCT00879996|581275161|FG001|Overall Study|psychiatric problem|1|||
160969199|NCT00879996|581275160|FG000|Overall Study|put on parole|1|||
160969200|NCT00879996|581275161|FG001|Overall Study|put on parole|0|||
160969201|NCT01216163|581275166|FG000|Overall Study|Withdrawal by Subject|1|||
160969202|NCT01216163|581275167|FG001|Overall Study|Withdrawal by Subject|1|||
160969203|NCT01216163|581275168|FG002|Overall Study|Withdrawal by Subject|0|||
160969204|NCT02914314|581275169|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
160969205|NCT02914314|581275170|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
160969206|NCT02914314|581275171|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
160969207|NCT02914314|581275172|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
160969208|NCT02914314|581275169|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
160969209|NCT02914314|581275170|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
160969210|NCT02914314|581275171|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
160969211|NCT02914314|581275172|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
160969212|NCT02914314|581275169|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
160969213|NCT02914314|581275170|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
160969214|NCT02914314|581275171|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
160969215|NCT02914314|581275172|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
160969216|NCT02914314|581275169|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
160969217|NCT02914314|581275170|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
160969218|NCT02914314|581275171|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
161018902|NCT04924660|581457802|FG001|Spain|Lost to Follow-up|0|||
161018903|NCT04924660|581457803|FG002|Spain|Lost to Follow-up|0|||
161018904|NCT04924660|581457804|FG003|Spain|Lost to Follow-up|0|||
160459703|NCT03990883|579415759|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
160459704|NCT03990883|579415760|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
160586973|NCT00077610|579867643|FG002|Overall Study|Renal transplant|11|||
160969219|NCT02914314|581275172|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
160969220|NCT02914314|581275169|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
161018905|NCT04924660|581457805|FG004|Spain|Lost to Follow-up|1|||
161018906|NCT04924660|581457806|FG005|Spain|Lost to Follow-up|0|||
161018907|NCT04924660|581457801|FG000|Brazil|Death|0|||
160459705|NCT03990883|579415758|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
160459706|NCT03990883|579415759|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
160459707|NCT03990883|579415760|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
160459708|NCT03990883|579415758|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
160459709|NCT03990883|579415759|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
160459710|NCT03990883|579415760|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
160459711|NCT04678856|579415761|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
160459712|NCT04678856|579415762|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
160459713|NCT04678856|579415761|FG000|Overall Study|Withdrawal by Subject|5|||
160459714|NCT04678856|579415762|FG001|Overall Study|Withdrawal by Subject|1|||
160459715|NCT05020353|579416525|FG000|Overall Study|Protocol Violation|7|||
160459716|NCT05020353|579416525|FG000|Overall Study|Withdrawal by Subject|33|||
160459717|NCT06655818|579416530|FG000|Overall Study|Withdrawal by Subject|1|||
160459718|NCT05836012|579416539|FG000|Overall Study|Lost to Follow-up|1|||
160459719|NCT05836012|579416540|FG001|Overall Study|Lost to Follow-up|0|||
160459720|NCT05836012|579416539|FG000|Overall Study|Withdrawal by Subject|1|||
160459721|NCT05836012|579416540|FG001|Overall Study|Withdrawal by Subject|3|||
160459722|NCT05836012|579416539|FG000|Overall Study|Reason not included in pre-specified categories|2|||
160459723|NCT05836012|579416540|FG001|Overall Study|Reason not included in pre-specified categories|1|||
160459724|NCT02777593|579416545|FG000|Overall Study|Still in study|1|||
160459725|NCT02777593|579416546|FG001|Overall Study|Still in study|32|||
160459726|NCT02777593|579416547|FG002|Overall Study|Still in study|3|||
160459727|NCT02777593|579416548|FG003|Overall Study|Still in study|6|||
160459728|NCT02777593|579416549|FG004|Overall Study|Still in study|5|||
160459729|NCT02777593|579416545|FG000|Overall Study|Death|21|||
160459730|NCT02777593|579416546|FG001|Overall Study|Death|28|||
160459731|NCT02777593|579416547|FG002|Overall Study|Death|0|||
160459732|NCT02777593|579416548|FG003|Overall Study|Death|5|||
160459733|NCT02777593|579416549|FG004|Overall Study|Death|0|||
160459734|NCT02777593|579416545|FG000|Overall Study|Withdrawal by Subject|8|||
160459735|NCT02777593|579416546|FG001|Overall Study|Withdrawal by Subject|4|||
160459736|NCT02777593|579416547|FG002|Overall Study|Withdrawal by Subject|1|||
160459737|NCT02777593|579416548|FG003|Overall Study|Withdrawal by Subject|1|||
160459738|NCT02777593|579416549|FG004|Overall Study|Withdrawal by Subject|0|||
160459739|NCT02777593|579416545|FG000|Overall Study|Lost to Follow-up|8|||
160459740|NCT02777593|579416546|FG001|Overall Study|Lost to Follow-up|16|||
160459741|NCT02777593|579416547|FG002|Overall Study|Lost to Follow-up|5|||
160459742|NCT02777593|579416548|FG003|Overall Study|Lost to Follow-up|0|||
160459743|NCT02777593|579416549|FG004|Overall Study|Lost to Follow-up|1|||
161018908|NCT04924660|581457802|FG001|Brazil|Death|0|||
161018909|NCT04924660|581457803|FG002|Brazil|Death|0|||
161018910|NCT04924660|581457804|FG003|Brazil|Death|0|||
161018911|NCT04924660|581457805|FG004|Brazil|Death|1|||
161018912|NCT04924660|581457806|FG005|Brazil|Death|0|||
161018913|NCT04924660|581457801|FG000|Italy|Lost to Follow-up|0|||
161018914|NCT04924660|581457802|FG001|Italy|Lost to Follow-up|0|||
161018915|NCT04924660|581457803|FG002|Italy|Lost to Follow-up|0|||
161018916|NCT04924660|581457804|FG003|Italy|Lost to Follow-up|0|||
161018917|NCT04924660|581457805|FG004|Italy|Lost to Follow-up|0|||
161018918|NCT04924660|581457806|FG005|Italy|Lost to Follow-up|1|||
161018919|NCT04924660|581457801|FG000|South Africa|Death|0|||
161018920|NCT04924660|581457802|FG001|South Africa|Death|0|||
161018921|NCT04924660|581457803|FG002|South Africa|Death|0|||
161018922|NCT04924660|581457804|FG003|South Africa|Death|0|||
161018923|NCT04924660|581457805|FG004|South Africa|Death|0|||
161018924|NCT04924660|581457806|FG005|South Africa|Death|1|||
161018925|NCT04924660|581457801|FG000|South Africa|Lost to Follow-up|0|||
161018926|NCT04924660|581457802|FG001|South Africa|Lost to Follow-up|0|||
161018927|NCT04924660|581457803|FG002|South Africa|Lost to Follow-up|0|||
161018928|NCT04924660|581457804|FG003|South Africa|Lost to Follow-up|0|||
161018929|NCT04924660|581457805|FG004|South Africa|Lost to Follow-up|0|||
161018930|NCT04924660|581457806|FG005|South Africa|Lost to Follow-up|1|||
160459744|NCT02777593|579416545|FG000|Overall Study|Physician Decision|2|||
161018931|NCT03557697|581457807|FG000|Overall Study|Withdrawal by Subject|2|||
161018932|NCT03557697|581457808|FG001|Overall Study|Withdrawal by Subject|4|||
160459745|NCT02777593|579416546|FG001|Overall Study|Physician Decision|2|||
161018933|NCT03197662|581457809|FG000|Overall Study|Withdrawn by family|0|||
160459746|NCT02777593|579416547|FG002|Overall Study|Physician Decision|0|||
160459747|NCT02777593|579416548|FG003|Overall Study|Physician Decision|0|||
160459748|NCT02777593|579416549|FG004|Overall Study|Physician Decision|0|||
160586974|NCT00077610|579867641|FG000|Overall Study|Withdrew from dialysis care|5|||
161018934|NCT03197662|581457810|FG001|Overall Study|Withdrawn by family|2|||
161018935|NCT03721952|581457811|FG000|Overall Study|Lost to Follow-up|0|||
161018936|NCT03721952|581457812|FG001|Overall Study|Lost to Follow-up|0|||
161018937|NCT03721952|581457813|FG002|Overall Study|Lost to Follow-up|2|||
160459749|NCT02777593|579416545|FG000|Overall Study|Discontinued due to Other|1|||
160459750|NCT02777593|579416546|FG001|Overall Study|Discontinued due to Other|0|||
160459751|NCT02777593|579416547|FG002|Overall Study|Discontinued due to Other|0|||
161018938|NCT03721952|581457814|FG003|Overall Study|Lost to Follow-up|0|||
161018939|NCT03721952|581457815|FG004|Overall Study|Lost to Follow-up|0|||
161018940|NCT03721952|581457811|FG000|Overall Study|Protocol Violation|0|||
160586975|NCT00077610|579867642|FG001|Overall Study|Withdrew from dialysis care|0|||
160586976|NCT00077610|579867643|FG002|Overall Study|Withdrew from dialysis care|3|||
160586977|NCT00077610|579867641|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160586978|NCT00077610|579867642|FG001|Overall Study|Insufficient Therapeutic Response|0|||
160586979|NCT00077610|579867643|FG002|Overall Study|Insufficient Therapeutic Response|0|||
160586980|NCT00077610|579867641|FG000|Overall Study|Multiple blood transfusions|0|||
160586981|NCT00077610|579867642|FG001|Overall Study|Multiple blood transfusions|0|||
160586982|NCT00077610|579867643|FG002|Overall Study|Multiple blood transfusions|1|||
160586983|NCT00077610|579867641|FG000|Overall Study|Principal Investigator's decision|1|||
160586984|NCT00077610|579867642|FG001|Overall Study|Principal Investigator's decision|0|||
160586985|NCT00077610|579867643|FG002|Overall Study|Principal Investigator's decision|1|||
160586986|NCT00077610|579867641|FG000|Overall Study|Worsening of health condition|1|||
160586987|NCT00077610|579867642|FG001|Overall Study|Worsening of health condition|1|||
160586988|NCT00077610|579867643|FG002|Overall Study|Worsening of health condition|0|||
160586989|NCT00077610|579867641|FG000|Overall Study|Given Epogen in hospital|1|||
160586990|NCT00077610|579867642|FG001|Overall Study|Given Epogen in hospital|0|||
160586991|NCT00077610|579867643|FG002|Overall Study|Given Epogen in hospital|0|||
160586992|NCT00077610|579867641|FG000|Overall Study|Transferred to other unit|0|||
160586993|NCT00077610|579867642|FG001|Overall Study|Transferred to other unit|0|||
160586994|NCT00077610|579867643|FG002|Overall Study|Transferred to other unit|1|||
160586995|NCT00077610|579867641|FG000|Overall Study|Transferred to nursing home|0|||
160586996|NCT00077610|579867642|FG001|Overall Study|Transferred to nursing home|0|||
160586997|NCT00077610|579867643|FG002|Overall Study|Transferred to nursing home|1|||
160586998|NCT00077610|579867641|FG000|Overall Study|Transfer to satellite unit|1|||
160586999|NCT00077610|579867642|FG001|Overall Study|Transfer to satellite unit|0|||
160587000|NCT00077610|579867643|FG002|Overall Study|Transfer to satellite unit|0|||
160587001|NCT00077610|579867641|FG000|Overall Study|Transfer to other center for surgery|1|||
160587002|NCT00077610|579867642|FG001|Overall Study|Transfer to other center for surgery|0|||
160587003|NCT00077610|579867643|FG002|Overall Study|Transfer to other center for surgery|0|||
160587004|NCT00077610|579867641|FG000|Overall Study|Change in dialysis modality|1|||
160587005|NCT00077610|579867642|FG001|Overall Study|Change in dialysis modality|0|||
160587006|NCT00077610|579867643|FG002|Overall Study|Change in dialysis modality|0|||
160587007|NCT00077610|579867641|FG000|Overall Study|Relocation|0|||
160587008|NCT00077610|579867642|FG001|Overall Study|Relocation|8|||
160587009|NCT00077610|579867643|FG002|Overall Study|Relocation|5|||
160587010|NCT00077610|579867641|FG000|Overall Study|Financial issues|0|||
160587011|NCT00077610|579867642|FG001|Overall Study|Financial issues|1|||
160587012|NCT00077610|579867643|FG002|Overall Study|Financial issues|0|||
160587013|NCT00077610|579867641|FG000|Overall Study|Sponsors decision to withdraw|0|||
160587014|NCT00077610|579867642|FG001|Overall Study|Sponsors decision to withdraw|0|||
160587015|NCT00077610|579867643|FG002|Overall Study|Sponsors decision to withdraw|1|||
160587016|NCT01153763|579867647|FG000|Overall Study|Study Closed|16|||
160587017|NCT01153763|579867647|FG000|Overall Study|Lost to Follow-up|1|||
160587018|NCT01153763|579867647|FG000|Overall Study|Physician Decision|2|||
160587019|NCT01153763|579867647|FG000|Overall Study|Withdrawal by Subject|2|||
160587020|NCT01814800|579867648|FG000|Overall Study|Adverse Event|2|||
160587021|NCT01814800|579867648|FG000|Overall Study|Pregnancy|1|||
160587022|NCT01814800|579867648|FG000|Overall Study|Sponsor decision|1|||
160587023|NCT01814800|579867648|FG000|Overall Study|Subject relocation|1|||
160587024|NCT02402218|579867649|FG000|Overall Study|Did not pickup study medication|12|||
160587025|NCT02402218|579867650|FG001|Overall Study|Did not pickup study medication|9|||
160587026|NCT02402218|579867651|FG002|Overall Study|Did not pickup study medication|13|||
160587027|NCT02402218|579867649|FG000|Overall Study|Lack of Efficacy|0|||
160587028|NCT02402218|579867650|FG001|Overall Study|Lack of Efficacy|1|||
160587029|NCT02402218|579867651|FG002|Overall Study|Lack of Efficacy|1|||
160587030|NCT02402218|579867649|FG000|Overall Study|Death|1|||
160587031|NCT02402218|579867650|FG001|Overall Study|Death|0|||
160587032|NCT02402218|579867651|FG002|Overall Study|Death|0|||
160587033|NCT02402218|579867649|FG000|Overall Study|Reinfection|0|||
160587034|NCT02402218|579867650|FG001|Overall Study|Reinfection|0|||
160587035|NCT02402218|579867651|FG002|Overall Study|Reinfection|1|||
160587036|NCT02402218|579867649|FG000|Overall Study|Adverse Event|0|||
160587037|NCT02402218|579867650|FG001|Overall Study|Adverse Event|2|||
160587038|NCT02402218|579867651|FG002|Overall Study|Adverse Event|1|||
160587039|NCT02402218|579867649|FG000|Overall Study|Withdrawal by Subject|1|||
160587040|NCT02402218|579867650|FG001|Overall Study|Withdrawal by Subject|1|||
160587041|NCT02402218|579867651|FG002|Overall Study|Withdrawal by Subject|1|||
160587042|NCT03827473|579867652|FG000|Overall Study|Withdrawal by Subject|1|||
160969221|NCT02914314|581275170|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
160969222|NCT02914314|581275171|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
160969223|NCT02914314|581275172|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
160969224|NCT01148862|581275177|FG000|Second Intervention|Withdrawal by Subject|0|||
160969225|NCT01148862|581275178|FG001|Second Intervention|Withdrawal by Subject|2|||
160969226|NCT03056534|581275179|FG000|Overall Study|Participant withdrew consent|8|||
160969227|NCT03056534|581275179|FG000|Overall Study|Participant not able to return|6|||
160969228|NCT03056534|581275179|FG000|Overall Study|Lost to Follow-up|37|||
161018941|NCT03721952|581457812|FG001|Overall Study|Protocol Violation|1|||
161018942|NCT03721952|581457813|FG002|Overall Study|Protocol Violation|0|||
161018943|NCT03721952|581457814|FG003|Overall Study|Protocol Violation|0|||
161018944|NCT03721952|581457815|FG004|Overall Study|Protocol Violation|0|||
161018945|NCT03721952|581457811|FG000|Overall Study|Withdrawal by Subject|1|||
161018946|NCT03721952|581457812|FG001|Overall Study|Withdrawal by Subject|0|||
161018947|NCT03721952|581457813|FG002|Overall Study|Withdrawal by Subject|40|||
161018948|NCT03721952|581457814|FG003|Overall Study|Withdrawal by Subject|28|||
161018949|NCT03721952|581457815|FG004|Overall Study|Withdrawal by Subject|0|||
161018950|NCT03364647|581457816|FG000|Overall Study|Withdrawal by Subject|3|||
161018951|NCT03364647|581457817|FG001|Overall Study|Withdrawal by Subject|1|||
161018952|NCT03476460|581457818|FG000|Overall Study|Withdrawal by Subject|3|||
161018953|NCT03476460|581457819|FG001|Overall Study|Withdrawal by Subject|2|||
161018954|NCT03476460|581457818|FG000|Overall Study|Non-compliance with treatment|3|||
161018955|NCT03476460|581457819|FG001|Overall Study|Non-compliance with treatment|0|||
161018956|NCT03476460|581457818|FG000|Overall Study|Missing laboratory tests|5|||
161018957|NCT03476460|581457819|FG001|Overall Study|Missing laboratory tests|5|||
161018958|NCT03476460|581457818|FG000|Overall Study|Adverse Event|0|||
161018959|NCT03476460|581457819|FG001|Overall Study|Adverse Event|1|||
161018960|NCT04624633|581457823|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
161018961|NCT04624633|581457824|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
161018962|NCT04624633|581457823|FG000|Overall Study|Death|1|||
161018963|NCT04624633|581457824|FG001|Overall Study|Death|0|||
161018964|NCT01902173|581457825|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
161018965|NCT01902173|581457826|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161018966|NCT01902173|581457827|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161018967|NCT01902173|581457828|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161018968|NCT01902173|581457829|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161018969|NCT01902173|581457830|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161018970|NCT01902173|581457825|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
161018971|NCT01902173|581457826|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161018972|NCT01902173|581457827|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161018973|NCT01902173|581457828|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161018974|NCT01902173|581457829|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161018975|NCT01902173|581457830|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161018976|NCT01902173|581457825|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161018977|NCT01902173|581457826|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
161018978|NCT01902173|581457827|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161018979|NCT01902173|581457828|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161018980|NCT01902173|581457829|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161018981|NCT01902173|581457830|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161018982|NCT01902173|581457825|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161018983|NCT01902173|581457826|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
161018984|NCT01902173|581457827|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161018985|NCT01902173|581457828|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161018986|NCT01902173|581457829|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161018987|NCT01902173|581457830|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161018988|NCT01902173|581457825|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161018989|NCT01902173|581457826|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
161018990|NCT01902173|581457827|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161018991|NCT01902173|581457828|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161018992|NCT01902173|581457829|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161018993|NCT01902173|581457830|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161018994|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161018995|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161018996|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
161018997|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161018998|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161018999|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161019000|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161019001|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161019002|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
161019003|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
160459752|NCT02777593|579416548|FG003|Overall Study|Discontinued due to Other|0|||
160459753|NCT02777593|579416549|FG004|Overall Study|Discontinued due to Other|0|||
161019004|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161019005|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161019006|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161019007|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161019008|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
160969229|NCT03056534|581275179|FG000|Overall Study|Investigator judgment|1|||
160969230|NCT03056534|581275179|FG000|Overall Study|Death|4|||
160969231|NCT03056534|581275179|FG000|Overall Study|Adverse Event|1|||
160969232|NCT03056534|581275179|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
160969233|NCT05398796|581275182|FG000|Overall Study|Participant moved from the area|0|||
160969234|NCT05398796|581275183|FG001|Overall Study|Participant moved from the area|1|||
160969235|NCT05398796|581275184|FG002|Overall Study|Participant moved from the area|0|||
160969236|NCT05398796|581275185|FG003|Overall Study|Participant moved from the area|0|||
160969237|NCT05004688|581275186|FG000|Overall Study|Protocol Violation|7|||
160969238|NCT05004688|581275186|FG000|Overall Study|Physician Decision|2|||
160969239|NCT05004688|581275186|FG000|Overall Study|Withdrawal by Subject|2|||
160969240|NCT02134925|581275187|FG000|Overall Study|Withdrawal by Subject|1|||
160969241|NCT02134925|581275188|FG001|Overall Study|Withdrawal by Subject|0|||
160969242|NCT02134925|581275187|FG000|Overall Study|Cancel|1|||
160969243|NCT02134925|581275188|FG001|Overall Study|Cancel|6|||
160969244|NCT02158884|581275189|FG000|Baseline Assessment|Missed performance assessment|3|||
160969245|NCT02158884|581275189|FG000|Baseline Assessment|Missed SMFA|1|||
160969246|NCT02158884|581275189|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
160969247|NCT02158884|581275189|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
160969248|NCT02158884|581275189|FG000|6 Month Assessment|Missed SMFA|20|||
160969249|NCT02158884|581275189|FG000|12 Month Assessment|Missed SMFA|17|||
160969250|NCT05158296|581275190|FG000|Overall Study|Sponsor Decision|2|||
160969251|NCT05158296|581275191|FG001|Overall Study|Sponsor Decision|3|||
160969252|NCT05158296|581275192|FG002|Overall Study|Sponsor Decision|2|||
160969253|NCT02552238|581275193|FG000|Overall Study|Withdrawal by Subject|2|||
160969254|NCT02552238|581275193|FG000|Overall Study|Adverse Event|2|||
160969255|NCT01576718|581275196|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
160969256|NCT01576718|581275197|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969257|NCT01576718|581275198|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969258|NCT01576718|581275199|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969259|NCT01576718|581275200|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969260|NCT01576718|581275201|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969261|NCT01576718|581275202|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969262|NCT01576718|581275196|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
160969263|NCT01576718|581275197|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969264|NCT01576718|581275198|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969265|NCT01576718|581275199|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969266|NCT01576718|581275200|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969267|NCT01576718|581275201|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969268|NCT01576718|581275202|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969269|NCT01576718|581275196|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
160969270|NCT01576718|581275197|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969271|NCT01576718|581275198|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969272|NCT01576718|581275199|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969273|NCT01576718|581275200|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969274|NCT01576718|581275201|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969275|NCT01576718|581275202|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969276|NCT01576718|581275196|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
160969277|NCT01576718|581275197|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969278|NCT01576718|581275198|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969279|NCT01576718|581275199|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969280|NCT01576718|581275200|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969281|NCT01576718|581275201|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969282|NCT01576718|581275202|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969283|NCT01576718|581275196|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
160969284|NCT01576718|581275197|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160969285|NCT01576718|581275198|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160969286|NCT01576718|581275199|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160969287|NCT01576718|581275200|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160969288|NCT01576718|581275201|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160632909|NCT02575807|580036106|FG002|Overall Study|Death|7|||
160969289|NCT01576718|581275202|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160969290|NCT01576718|581275196|FG000|Treatment Period|Adverse Event|0|||
160969291|NCT01576718|581275197|FG001|Treatment Period|Adverse Event|1|||
160969292|NCT01576718|581275198|FG002|Treatment Period|Adverse Event|1|||
160969293|NCT01576718|581275199|FG003|Treatment Period|Adverse Event|1|||
160969294|NCT01576718|581275200|FG004|Treatment Period|Adverse Event|1|||
160969295|NCT01576718|581275201|FG005|Treatment Period|Adverse Event|1|||
160587043|NCT03827473|579867653|FG001|Overall Study|Withdrawal by Subject|0|||
161019009|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
161019010|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161019011|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161019012|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161019013|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161019014|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161019015|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
161019016|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161019017|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161019018|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161019019|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161019020|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161019021|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161019022|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
161019023|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161019024|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161019025|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161019026|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161019027|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161019028|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
161019029|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161019030|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161019031|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161019032|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161019033|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161019034|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161019035|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
161019036|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161019037|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161019038|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161019039|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161019040|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161019041|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
161019042|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161019043|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161019044|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161019045|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161019046|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161019047|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
161019048|NCT03536754|581457833|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
161019049|NCT03536754|581457834|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
161019050|NCT03536754|581457835|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
161019051|NCT03536754|581457836|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
161019052|NCT03536754|581457837|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
161019053|NCT03536754|581457833|FG000|Open Label Extension|Other|0|||
161019054|NCT03536754|581457834|FG001|Open Label Extension|Other|0|||
161019055|NCT03536754|581457835|FG002|Open Label Extension|Other|0|||
161019056|NCT03536754|581457836|FG003|Open Label Extension|Other|0|||
161019057|NCT03536754|581457837|FG004|Open Label Extension|Other|1|||
161019058|NCT03382652|581457840|FG000|Overall Study|Lost to Follow-up|6|||
161019059|NCT03382652|581457840|FG000|Overall Study|Death|4|||
161019060|NCT03382652|581457840|FG000|Overall Study|Revision|5|||
161019061|NCT03382652|581457840|FG000|Overall Study|Patient withdrew|3|||
161019062|NCT03382652|581457840|FG000|Overall Study|Other reasons|21|||
161019063|NCT04806594|581459595|FG000|Overall Study|Withdrawal by Subject|2|||
160587044|NCT04436822|579867654|FG000|Overall Study|Physician Decision|2|||
160587045|NCT04436822|579867655|FG001|Overall Study|Physician Decision|0|||
160587046|NCT04436822|579867654|FG000|Overall Study|Sponsor request|1|||
160587047|NCT04436822|579867655|FG001|Overall Study|Sponsor request|0|||
160587048|NCT04436822|579867654|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160587049|NCT04436822|579867655|FG001|Overall Study|Withdrawal by parent/guardian|3|||
160587050|NCT04436822|579867654|FG000|Overall Study|Unsuccessful procedure|0|||
160587051|NCT04436822|579867655|FG001|Overall Study|Unsuccessful procedure|1|||
161019064|NCT04806594|581459595|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
161019065|NCT04390048|581459596|FG000|Overall Study|Withdrawal by Subject|1|||
160587052|NCT04436822|579867654|FG000|Overall Study|Withdrawal due to Covid-19|8|||
160587053|NCT04436822|579867655|FG001|Overall Study|Withdrawal due to Covid-19|1|||
161019066|NCT04390048|581459597|FG001|Overall Study|Withdrawal by Subject|3|||
161019067|NCT06283173|581459598|FG000|Overall Study|Did not show for first visit|10|||
161019068|NCT06283173|581459598|FG000|Overall Study|Lost to Follow-up|12|||
161019069|NCT06283173|581459598|FG000|Overall Study|Physician Decision|7|||
161019070|NCT03138512|581459599|FG000|Randomization|Participants withdrew consent|0|||
161019071|NCT03138512|581459600|FG001|Randomization|Participants withdrew consent|1|||
161019072|NCT03138512|581459601|FG002|Randomization|Participants withdrew consent|1|||
161019073|NCT03138512|581459602|FG003|Randomization|Participants withdrew consent|0|||
161019074|NCT03138512|581459603|FG004|Randomization|Participants withdrew consent|0|||
161019075|NCT03138512|581459599|FG000|Randomization|Participant no longer meets study criteria|0|||
161019076|NCT03138512|581459600|FG001|Randomization|Participant no longer meets study criteria|3|||
161019077|NCT03138512|581459601|FG002|Randomization|Participant no longer meets study criteria|1|||
161019078|NCT03138512|581459602|FG003|Randomization|Participant no longer meets study criteria|1|||
161019079|NCT03138512|581459603|FG004|Randomization|Participant no longer meets study criteria|3|||
161019080|NCT03138512|581459599|FG000|Randomization|Other reasons|1|||
161019081|NCT03138512|581459600|FG001|Randomization|Other reasons|0|||
161019082|NCT03138512|581459601|FG002|Randomization|Other reasons|0|||
161019083|NCT03138512|581459602|FG003|Randomization|Other reasons|0|||
161019084|NCT03138512|581459603|FG004|Randomization|Other reasons|0|||
161019085|NCT03138512|581459599|FG000|Treatment Part A|Disease recurrence|10|||
161019086|NCT03138512|581459600|FG001|Treatment Part A|Disease recurrence|20|||
161019087|NCT03138512|581459601|FG002|Treatment Part A|Disease recurrence|0|||
161019088|NCT03138512|581459602|FG003|Treatment Part A|Disease recurrence|0|||
161019089|NCT03138512|581459603|FG004|Treatment Part A|Disease recurrence|0|||
161019090|NCT03138512|581459599|FG000|Treatment Part A|Study Drug Toxicity|132|||
161019091|NCT03138512|581459600|FG001|Treatment Part A|Study Drug Toxicity|5|||
161019092|NCT03138512|581459601|FG002|Treatment Part A|Study Drug Toxicity|0|||
161019093|NCT03138512|581459602|FG003|Treatment Part A|Study Drug Toxicity|0|||
161019094|NCT03138512|581459603|FG004|Treatment Part A|Study Drug Toxicity|0|||
161019095|NCT03138512|581459599|FG000|Treatment Part A|Death|1|||
161019096|NCT03138512|581459600|FG001|Treatment Part A|Death|0|||
161019097|NCT03138512|581459601|FG002|Treatment Part A|Death|0|||
161019098|NCT03138512|581459602|FG003|Treatment Part A|Death|0|||
161019099|NCT03138512|581459603|FG004|Treatment Part A|Death|0|||
161019100|NCT03138512|581459599|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
160459754|NCT05785130|579416553|FG000|Overall Study|Withdrawal by Subject|1|||
160459755|NCT05785130|579416554|FG001|Overall Study|Withdrawal by Subject|0|||
160459756|NCT05785130|579416553|FG000|Overall Study|Lack of Efficacy|0|||
160459757|NCT05785130|579416554|FG001|Overall Study|Lack of Efficacy|1|||
160459758|NCT03547271|579416558|FG000|Overall Study|Adverse Event|1|||
160459759|NCT03547271|579416559|FG001|Overall Study|Adverse Event|1|||
160459760|NCT03547271|579416560|FG002|Overall Study|Adverse Event|0|||
160459761|NCT03547271|579416561|FG003|Overall Study|Adverse Event|0|||
160459762|NCT03547271|579416558|FG000|Overall Study|Protocol deviation|5|||
160459763|NCT03547271|579416559|FG001|Overall Study|Protocol deviation|7|||
161019101|NCT03138512|581459600|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
161019102|NCT03138512|581459601|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
161019103|NCT03138512|581459602|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
161019104|NCT03138512|581459603|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
161019105|NCT03138512|581459599|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
161019106|NCT03138512|581459600|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
161019107|NCT03138512|581459601|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
161019108|NCT03138512|581459602|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
161019109|NCT03138512|581459603|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
161019110|NCT03138512|581459599|FG000|Treatment Part A|Participant withdrew consent|2|||
161019111|NCT03138512|581459600|FG001|Treatment Part A|Participant withdrew consent|4|||
161019112|NCT03138512|581459601|FG002|Treatment Part A|Participant withdrew consent|0|||
161019113|NCT03138512|581459602|FG003|Treatment Part A|Participant withdrew consent|0|||
161019114|NCT03138512|581459603|FG004|Treatment Part A|Participant withdrew consent|0|||
161019115|NCT03138512|581459599|FG000|Treatment Part A|Lost to Follow-up|0|||
161019116|NCT03138512|581459600|FG001|Treatment Part A|Lost to Follow-up|1|||
161019117|NCT03138512|581459601|FG002|Treatment Part A|Lost to Follow-up|0|||
161019118|NCT03138512|581459602|FG003|Treatment Part A|Lost to Follow-up|0|||
161019119|NCT03138512|581459603|FG004|Treatment Part A|Lost to Follow-up|0|||
161019120|NCT03138512|581459599|FG000|Treatment Part A|Poor/non-compliance|1|||
161019121|NCT03138512|581459600|FG001|Treatment Part A|Poor/non-compliance|0|||
161019122|NCT03138512|581459601|FG002|Treatment Part A|Poor/non-compliance|0|||
161019123|NCT03138512|581459602|FG003|Treatment Part A|Poor/non-compliance|0|||
161019124|NCT03138512|581459603|FG004|Treatment Part A|Poor/non-compliance|0|||
161019125|NCT03138512|581459599|FG000|Treatment Part A|Pregnancy|0|||
160459764|NCT03547271|579416560|FG002|Overall Study|Protocol deviation|3|||
161019126|NCT03138512|581459600|FG001|Treatment Part A|Pregnancy|1|||
161019127|NCT03138512|581459601|FG002|Treatment Part A|Pregnancy|0|||
161019128|NCT03138512|581459602|FG003|Treatment Part A|Pregnancy|0|||
161019129|NCT03138512|581459603|FG004|Treatment Part A|Pregnancy|0|||
160459765|NCT03547271|579416561|FG003|Overall Study|Protocol deviation|0|||
160459766|NCT03547271|579416558|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
160459767|NCT03547271|579416559|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
161019130|NCT03138512|581459599|FG000|Treatment Part A|Other reasons|11|||
161019131|NCT03138512|581459600|FG001|Treatment Part A|Other reasons|8|||
161019132|NCT03138512|581459601|FG002|Treatment Part A|Other reasons|0|||
161019133|NCT03138512|581459602|FG003|Treatment Part A|Other reasons|0|||
161019134|NCT03138512|581459603|FG004|Treatment Part A|Other reasons|0|||
161019135|NCT03138512|581459599|FG000|Treatment Part B|Disease recurrence|0|||
161019136|NCT03138512|581459600|FG001|Treatment Part B|Disease recurrence|0|||
161019137|NCT03138512|581459601|FG002|Treatment Part B|Disease recurrence|6|||
161019138|NCT03138512|581459602|FG003|Treatment Part B|Disease recurrence|12|||
161019139|NCT03138512|581459603|FG004|Treatment Part B|Disease recurrence|10|||
161019140|NCT03138512|581459599|FG000|Treatment Part B|Study drug toxicity|0|||
161019141|NCT03138512|581459600|FG001|Treatment Part B|Study drug toxicity|0|||
161019142|NCT03138512|581459601|FG002|Treatment Part B|Study drug toxicity|63|||
161019143|NCT03138512|581459602|FG003|Treatment Part B|Study drug toxicity|3|||
161019144|NCT03138512|581459603|FG004|Treatment Part B|Study drug toxicity|45|||
161019145|NCT03138512|581459599|FG000|Treatment Part B|Death|0|||
161019146|NCT03138512|581459600|FG001|Treatment Part B|Death|0|||
161019147|NCT03138512|581459601|FG002|Treatment Part B|Death|1|||
161019148|NCT03138512|581459602|FG003|Treatment Part B|Death|0|||
161019149|NCT03138512|581459603|FG004|Treatment Part B|Death|0|||
161019150|NCT03138512|581459599|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
161019151|NCT03138512|581459600|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
161019152|NCT03138512|581459601|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
161019153|NCT03138512|581459602|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
161019154|NCT03138512|581459603|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
161019155|NCT03138512|581459599|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
161019156|NCT03138512|581459600|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
161019157|NCT03138512|581459601|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
161019158|NCT03138512|581459602|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
161019159|NCT03138512|581459603|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
161019160|NCT03138512|581459599|FG000|Treatment Part B|Participant withdrew consent|0|||
161019161|NCT03138512|581459600|FG001|Treatment Part B|Participant withdrew consent|0|||
161019162|NCT03138512|581459601|FG002|Treatment Part B|Participant withdrew consent|1|||
161019163|NCT03138512|581459602|FG003|Treatment Part B|Participant withdrew consent|1|||
161019164|NCT03138512|581459603|FG004|Treatment Part B|Participant withdrew consent|2|||
161019165|NCT03138512|581459599|FG000|Treatment Part B|Lost to Follow-up|0|||
161019166|NCT03138512|581459600|FG001|Treatment Part B|Lost to Follow-up|0|||
161019167|NCT03138512|581459601|FG002|Treatment Part B|Lost to Follow-up|0|||
161019168|NCT03138512|581459602|FG003|Treatment Part B|Lost to Follow-up|1|||
161019169|NCT03138512|581459603|FG004|Treatment Part B|Lost to Follow-up|0|||
161019170|NCT03138512|581459599|FG000|Treatment Part B|Poor/non-compliance|0|||
161019171|NCT03138512|581459600|FG001|Treatment Part B|Poor/non-compliance|0|||
161019172|NCT03138512|581459601|FG002|Treatment Part B|Poor/non-compliance|1|||
161019173|NCT03138512|581459602|FG003|Treatment Part B|Poor/non-compliance|1|||
161019174|NCT03138512|581459603|FG004|Treatment Part B|Poor/non-compliance|1|||
161019175|NCT03138512|581459599|FG000|Treatment Part B|Other reasons|0|||
161019176|NCT03138512|581459600|FG001|Treatment Part B|Other reasons|0|||
161019177|NCT03138512|581459601|FG002|Treatment Part B|Other reasons|3|||
161019178|NCT03138512|581459602|FG003|Treatment Part B|Other reasons|1|||
161019179|NCT03138512|581459603|FG004|Treatment Part B|Other reasons|5|||
161019180|NCT02120456|581459608|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019181|NCT02120456|581459609|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019182|NCT02120456|581459610|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019183|NCT02120456|581459611|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019184|NCT02120456|581459612|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019185|NCT02120456|581459613|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019186|NCT02120456|581459614|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
161019187|NCT02120456|581459615|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019188|NCT02120456|581459616|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019189|NCT02120456|581459608|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019190|NCT02120456|581459609|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019191|NCT02120456|581459610|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019192|NCT02120456|581459611|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019193|NCT02120456|581459612|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019194|NCT02120456|581459613|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019195|NCT02120456|581459614|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
161019196|NCT02120456|581459615|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019197|NCT02120456|581459616|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019198|NCT02120456|581459608|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
160587054|NCT04436822|579867654|FG000|Overall Study|Withdrawal by Subject|1|||
160587055|NCT04436822|579867655|FG001|Overall Study|Withdrawal by Subject|0|||
160632910|NCT02575807|580036107|FG003|Overall Study|Death|0|||
161019199|NCT02120456|581459609|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019200|NCT02120456|581459610|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019201|NCT02120456|581459611|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019202|NCT02120456|581459612|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019203|NCT02120456|581459613|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019204|NCT02120456|581459614|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019205|NCT02120456|581459615|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019206|NCT02120456|581459616|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
161019207|NCT05192200|581459617|FG000|Treatment Period|Other|1|||
161019208|NCT05192200|581459617|FG000|Treatment Period|Lack of Efficacy|1|||
161019209|NCT05192200|581459617|FG000|Treatment Period|Withdrawal by Subject|1|||
161019210|NCT05192200|581459617|FG000|Follow-up|Withdrawal by Subject|1|||
161019211|NCT03443323|581459620|FG000|Overall Study|Lost to Follow-up|2|||
161019212|NCT03443323|581459621|FG001|Overall Study|Lost to Follow-up|2|||
161019213|NCT03443323|581459620|FG000|Overall Study|PI withdrawal|1|||
161019214|NCT03443323|581459621|FG001|Overall Study|PI withdrawal|0|||
161019215|NCT02921230|581459622|FG000|Overall Study|Withdrawal by Subject|20|||
161019216|NCT02921230|581459623|FG001|Overall Study|Withdrawal by Subject|8|||
161019217|NCT02921230|581459622|FG000|Overall Study|Death|12|||
161019218|NCT02921230|581459623|FG001|Overall Study|Death|3|||
161019219|NCT02921230|581459622|FG000|Overall Study|Protocol Violation|17|||
161019220|NCT02921230|581459623|FG001|Overall Study|Protocol Violation|6|||
161019221|NCT02921230|581459622|FG000|Overall Study|Early completion|5|||
161019222|NCT02921230|581459623|FG001|Overall Study|Early completion|1|||
161019223|NCT02921230|581459622|FG000|Overall Study|Pending data entry|1|||
161019224|NCT02921230|581459623|FG001|Overall Study|Pending data entry|0|||
161019225|NCT04274764|581459624|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
161019226|NCT04274764|581459625|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
161019227|NCT04142788|581459630|FG000|Overall Study|Trial terminated prematurely|2|||
161019228|NCT04142788|581459631|FG001|Overall Study|Trial terminated prematurely|2|||
161019229|NCT05268393|581459635|FG000|Overall Study|Withdrawal by Subject|2|||
161019230|NCT05268393|581459636|FG001|Overall Study|Withdrawal by Subject|1|||
161019231|NCT03396926|581459637|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
161019232|NCT03396926|581459638|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
161019233|NCT02035787|581459639|FG000|Overall Study- 12 Months|Adverse Event|3|||
161019234|NCT02035787|581459640|FG001|Overall Study- 12 Months|Adverse Event|0|||
161019235|NCT02035787|581459639|FG000|Overall Study- 12 Months|Complete response|4|||
161019236|NCT02035787|581459640|FG001|Overall Study- 12 Months|Complete response|1|||
161019237|NCT02035787|581459639|FG000|Overall Study- 12 Months|Protocol Violation|1|||
161019238|NCT02035787|581459640|FG001|Overall Study- 12 Months|Protocol Violation|1|||
161019239|NCT01396278|581459642|FG000|Overall Study|Adverse Event|0|||
161019240|NCT01396278|581459643|FG001|Overall Study|Adverse Event|0|||
161019241|NCT01396278|581459644|FG002|Overall Study|Adverse Event|0|||
161019242|NCT01396278|581459645|FG003|Overall Study|Adverse Event|2|||
161019243|NCT01396278|581459646|FG004|Overall Study|Adverse Event|0|||
161019244|NCT01396278|581459642|FG000|Overall Study|Withdraw due to trial termination|2|||
161019245|NCT01396278|581459643|FG001|Overall Study|Withdraw due to trial termination|1|||
161019246|NCT01396278|581459644|FG002|Overall Study|Withdraw due to trial termination|1|||
161019247|NCT01396278|581459645|FG003|Overall Study|Withdraw due to trial termination|0|||
161019248|NCT01396278|581459646|FG004|Overall Study|Withdraw due to trial termination|2|||
161019249|NCT00450658|581459647|FG000|Overall Study|Adverse Event|24|||
161019250|NCT00450658|581459648|FG001|Overall Study|Adverse Event|15|||
161019251|NCT00450658|581459647|FG000|Overall Study|Withdrawal by Subject|43|||
161019252|NCT00450658|581459648|FG001|Overall Study|Withdrawal by Subject|26|||
161019253|NCT00450658|581459647|FG000|Overall Study|Lost to Follow-up|22|||
161019254|NCT00450658|581459648|FG001|Overall Study|Lost to Follow-up|5|||
161019255|NCT00450658|581459647|FG000|Overall Study|UGI ulcer|33|||
161019256|NCT00450658|581459648|FG001|Overall Study|UGI ulcer|34|||
161019257|NCT00450658|581459647|FG000|Overall Study|misc|21|||
161019258|NCT00450658|581459648|FG001|Overall Study|misc|10|||
161019259|NCT04727554|581459650|FG000|Overall Study|Lost to Follow-up|0|||
161019260|NCT04727554|581459651|FG001|Overall Study|Lost to Follow-up|1|||
161019261|NCT04727554|581459650|FG000|Overall Study|Death|2|||
161019262|NCT04727554|581459651|FG001|Overall Study|Death|6|||
161019263|NCT04727554|581459650|FG000|Overall Study|Withdrawal by Subject|1|||
161019264|NCT04727554|581459651|FG001|Overall Study|Withdrawal by Subject|0|||
161019265|NCT05763823|581459652|FG000|Overall Study|Death|6|||
161019266|NCT05763823|581459652|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161019267|NCT05763823|581459652|FG000|Overall Study|Withdrawal by Subject|6|||
161019268|NCT00999804|581459655|FG000|Overall Study|Lack of Efficacy|9|||
161019269|NCT00999804|581459656|FG001|Overall Study|Lack of Efficacy|2|||
161019270|NCT00999804|581459655|FG000|Overall Study|Adverse Event|4|||
161019271|NCT00999804|581459656|FG001|Overall Study|Adverse Event|3|||
161019272|NCT00999804|581459655|FG000|Overall Study|Withdrawal by Subject|4|||
161019273|NCT00999804|581459656|FG001|Overall Study|Withdrawal by Subject|0|||
161019274|NCT00999804|581459655|FG000|Overall Study|Death|1|||
161019275|NCT00999804|581459656|FG001|Overall Study|Death|0|||
161019276|NCT00999804|581459655|FG000|Overall Study|Ineligible|3|||
161019277|NCT00999804|581459656|FG001|Overall Study|Ineligible|0|||
161019278|NCT05311384|581459667|FG000|Overall Study|Uncontrolled health conditions|2|||
161019279|NCT05311384|581459667|FG000|Overall Study|Withdrawal by Subject|1|||
161019280|NCT05076708|581459668|FG000|Overall Study|Withdrawal by Subject|4|||
161019281|NCT05076708|581459668|FG000|Overall Study|Lost to study during switch phase|8|||
161019282|NCT05590403|581459669|FG000|Overall Study|Lost to Follow-up|13|||
161019283|NCT05590403|581459670|FG001|Overall Study|Lost to Follow-up|1|||
161019284|NCT05590403|581459671|FG002|Overall Study|Lost to Follow-up|7|||
161019285|NCT05590403|581459672|FG003|Overall Study|Lost to Follow-up|3|||
161019286|NCT05590403|581459673|FG004|Overall Study|Lost to Follow-up|4|||
161019287|NCT05590403|581459669|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
161019288|NCT05590403|581459670|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
161019289|NCT05590403|581459671|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
161019290|NCT05590403|581459672|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
161019291|NCT05590403|581459673|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
161019292|NCT05590403|581459669|FG000|Overall Study|Other|2|||
161019293|NCT05590403|581459670|FG001|Overall Study|Other|0|||
161019294|NCT05590403|581459671|FG002|Overall Study|Other|2|||
161019295|NCT05590403|581459672|FG003|Overall Study|Other|2|||
161019296|NCT05590403|581459673|FG004|Overall Study|Other|0|||
161019297|NCT05590403|581459669|FG000|Overall Study|Migrated / moved from the study area|1|||
161019298|NCT05590403|581459670|FG001|Overall Study|Migrated / moved from the study area|1|||
161019299|NCT05590403|581459671|FG002|Overall Study|Migrated / moved from the study area|0|||
161019300|NCT05590403|581459672|FG003|Overall Study|Migrated / moved from the study area|3|||
161019301|NCT05590403|581459673|FG004|Overall Study|Migrated / moved from the study area|1|||
161019302|NCT05590403|581459669|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
161019303|NCT05590403|581459670|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
161019304|NCT05590403|581459671|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
161019305|NCT05590403|581459672|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
161019306|NCT05590403|581459673|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
161019307|NCT04717492|581459674|FG000|Overall Study|Withdrawal by Subject|2|||
161019308|NCT04717492|581459675|FG001|Overall Study|Withdrawal by Subject|13|||
161019309|NCT04717492|581459674|FG000|Overall Study|Lost to Follow-up|2|||
161019310|NCT04717492|581459675|FG001|Overall Study|Lost to Follow-up|9|||
161019311|NCT02924272|581459676|FG000|Overall Study|Site Terminated by Sponsor|4|||
161019312|NCT02924272|581459677|FG001|Overall Study|Site Terminated by Sponsor|1|||
161019313|NCT02924272|581459676|FG000|Overall Study|Withdrawal by Subject|2|||
161019314|NCT02924272|581459677|FG001|Overall Study|Withdrawal by Subject|0|||
161019315|NCT02924272|581459676|FG000|Overall Study|Adverse Event|3|||
161019316|NCT02924272|581459677|FG001|Overall Study|Adverse Event|0|||
161019317|NCT02924272|581459676|FG000|Overall Study|Progressive Disease|11|||
161019318|NCT02924272|581459677|FG001|Overall Study|Progressive Disease|8|||
161019319|NCT02924272|581459676|FG000|Overall Study|Clinical Deterioration|1|||
161019320|NCT02924272|581459677|FG001|Overall Study|Clinical Deterioration|0|||
160459768|NCT03547271|579416560|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
160459769|NCT03547271|579416561|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
160459770|NCT03547271|579416558|FG000|Overall Study|Lost to Follow-up|3|||
160459771|NCT03547271|579416559|FG001|Overall Study|Lost to Follow-up|3|||
160459772|NCT03547271|579416560|FG002|Overall Study|Lost to Follow-up|1|||
160459773|NCT03547271|579416561|FG003|Overall Study|Lost to Follow-up|0|||
160459774|NCT05718687|579416564|FG000|Overall Study|Withdrawal by Subject|3|||
160459775|NCT05215054|579416567|FG000|Overall Study|Lost to Follow-up|1|||
160459776|NCT05215054|579416568|FG001|Overall Study|Lost to Follow-up|1|||
160459777|NCT05215054|579416567|FG000|Overall Study|Protocol Violation|1|||
160459778|NCT05215054|579416568|FG001|Overall Study|Protocol Violation|1|||
160459779|NCT05215054|579416567|FG000|Overall Study|Withdrawal by Subject|4|||
160459780|NCT05215054|579416568|FG001|Overall Study|Withdrawal by Subject|4|||
160459781|NCT01897441|579416569|FG000|Overall Study|Lost to Follow-up|0|||
160459782|NCT01897441|579416570|FG001|Overall Study|Lost to Follow-up|0|||
160459783|NCT01897441|579416571|FG002|Overall Study|Lost to Follow-up|1|||
160459784|NCT01897441|579416572|FG003|Overall Study|Lost to Follow-up|0|||
160459785|NCT01897441|579416573|FG004|Overall Study|Lost to Follow-up|0|||
160459786|NCT01897441|579416574|FG005|Overall Study|Lost to Follow-up|0|||
160459787|NCT01897441|579416569|FG000|Overall Study|Withdrawal by Subject|0|||
160459788|NCT01897441|579416570|FG001|Overall Study|Withdrawal by Subject|0|||
160459789|NCT01897441|579416571|FG002|Overall Study|Withdrawal by Subject|0|||
160459790|NCT01897441|579416572|FG003|Overall Study|Withdrawal by Subject|0|||
160459791|NCT01897441|579416573|FG004|Overall Study|Withdrawal by Subject|1|||
160459792|NCT01897441|579416574|FG005|Overall Study|Withdrawal by Subject|0|||
160459793|NCT01897441|579416569|FG000|Overall Study|Withdrawn by Provider|0|||
160459794|NCT01897441|579416570|FG001|Overall Study|Withdrawn by Provider|2|||
160459795|NCT01897441|579416571|FG002|Overall Study|Withdrawn by Provider|0|||
161019321|NCT02924272|581459676|FG000|Overall Study|Death|1|||
161019322|NCT02924272|581459677|FG001|Overall Study|Death|0|||
161019323|NCT02924272|581459676|FG000|Overall Study|Reason Not Specified|1|||
161019324|NCT02924272|581459677|FG001|Overall Study|Reason Not Specified|0|||
161019325|NCT03575897|581459680|FG000|Overall Study|Lost to Follow-up|12|||
161019326|NCT03575897|581459681|FG001|Overall Study|Lost to Follow-up|13|||
161019327|NCT03150810|581459683|FG000|Overall Study|Death|4|||
161019328|NCT03150810|581459684|FG001|Overall Study|Death|8|||
161019329|NCT03150810|581459685|FG002|Overall Study|Death|7|||
161019330|NCT03150810|581459686|FG003|Overall Study|Death|2|||
161019331|NCT03150810|581459687|FG004|Overall Study|Death|2|||
161019332|NCT03150810|581459688|FG005|Overall Study|Death|10|||
161019333|NCT03150810|581459689|FG006|Overall Study|Death|8|||
161019334|NCT03150810|581459690|FG007|Overall Study|Death|6|||
161019335|NCT03150810|581459691|FG008|Overall Study|Death|18|||
161019336|NCT03150810|581459692|FG009|Overall Study|Death|3|||
161019337|NCT03150810|581459693|FG010|Overall Study|Death|19|||
161019338|NCT03150810|581459694|FG011|Overall Study|Death|1|||
161019339|NCT03150810|581459695|FG012|Overall Study|Death|19|||
161019340|NCT03150810|581459683|FG000|Overall Study|Withdrawal by Subject|0|||
161019341|NCT03150810|581459684|FG001|Overall Study|Withdrawal by Subject|1|||
161019342|NCT03150810|581459685|FG002|Overall Study|Withdrawal by Subject|1|||
161019343|NCT03150810|581459686|FG003|Overall Study|Withdrawal by Subject|1|||
161019344|NCT03150810|581459687|FG004|Overall Study|Withdrawal by Subject|0|||
161019345|NCT03150810|581459688|FG005|Overall Study|Withdrawal by Subject|0|||
161019346|NCT03150810|581459689|FG006|Overall Study|Withdrawal by Subject|2|||
161019347|NCT03150810|581459690|FG007|Overall Study|Withdrawal by Subject|0|||
161019348|NCT03150810|581459691|FG008|Overall Study|Withdrawal by Subject|2|||
161019349|NCT03150810|581459692|FG009|Overall Study|Withdrawal by Subject|0|||
161019350|NCT03150810|581459693|FG010|Overall Study|Withdrawal by Subject|1|||
161019351|NCT03150810|581459694|FG011|Overall Study|Withdrawal by Subject|0|||
161019352|NCT03150810|581459695|FG012|Overall Study|Withdrawal by Subject|1|||
161019353|NCT03150810|581459683|FG000|Overall Study|Sponsor Decision|0|||
161019354|NCT03150810|581459684|FG001|Overall Study|Sponsor Decision|2|||
161019355|NCT03150810|581459685|FG002|Overall Study|Sponsor Decision|0|||
161019356|NCT03150810|581459686|FG003|Overall Study|Sponsor Decision|0|||
161019357|NCT03150810|581459687|FG004|Overall Study|Sponsor Decision|1|||
161019358|NCT03150810|581459688|FG005|Overall Study|Sponsor Decision|1|||
161019359|NCT03150810|581459689|FG006|Overall Study|Sponsor Decision|0|||
161019360|NCT03150810|581459690|FG007|Overall Study|Sponsor Decision|0|||
161019361|NCT03150810|581459691|FG008|Overall Study|Sponsor Decision|1|||
161019362|NCT03150810|581459692|FG009|Overall Study|Sponsor Decision|0|||
161019363|NCT03150810|581459693|FG010|Overall Study|Sponsor Decision|0|||
161019364|NCT03150810|581459694|FG011|Overall Study|Sponsor Decision|0|||
161019365|NCT03150810|581459695|FG012|Overall Study|Sponsor Decision|5|||
161019366|NCT03150810|581459683|FG000|Overall Study|Lost to Follow-up|0|||
161019367|NCT03150810|581459684|FG001|Overall Study|Lost to Follow-up|1|||
161019368|NCT03150810|581459685|FG002|Overall Study|Lost to Follow-up|1|||
161019369|NCT03150810|581459686|FG003|Overall Study|Lost to Follow-up|0|||
161019370|NCT03150810|581459687|FG004|Overall Study|Lost to Follow-up|0|||
161019371|NCT03150810|581459688|FG005|Overall Study|Lost to Follow-up|0|||
161019372|NCT03150810|581459689|FG006|Overall Study|Lost to Follow-up|1|||
161019373|NCT03150810|581459690|FG007|Overall Study|Lost to Follow-up|0|||
161019374|NCT03150810|581459691|FG008|Overall Study|Lost to Follow-up|0|||
161019375|NCT03150810|581459692|FG009|Overall Study|Lost to Follow-up|0|||
161019376|NCT03150810|581459693|FG010|Overall Study|Lost to Follow-up|1|||
161019377|NCT03150810|581459694|FG011|Overall Study|Lost to Follow-up|0|||
161019378|NCT03150810|581459695|FG012|Overall Study|Lost to Follow-up|0|||
161019379|NCT03150810|581459683|FG000|Overall Study|Physician Decision|0|||
160459796|NCT01897441|579416572|FG003|Overall Study|Withdrawn by Provider|0|||
160459797|NCT01897441|579416573|FG004|Overall Study|Withdrawn by Provider|0|||
160459798|NCT01897441|579416574|FG005|Overall Study|Withdrawn by Provider|0|||
160459799|NCT02933489|579416575|FG000|Overall Study|Ineligible|3|||
160459800|NCT02933489|579416576|FG001|Overall Study|Ineligible|3|||
160459801|NCT02933489|579416575|FG000|Overall Study|Withdrawal by Subject|27|||
160459802|NCT02933489|579416576|FG001|Overall Study|Withdrawal by Subject|18|||
160459803|NCT02933489|579416575|FG000|Overall Study|Unable to complete exams (other)|14|||
161019380|NCT03150810|581459684|FG001|Overall Study|Physician Decision|0|||
161019381|NCT03150810|581459685|FG002|Overall Study|Physician Decision|0|||
161019382|NCT03150810|581459686|FG003|Overall Study|Physician Decision|0|||
160459804|NCT02933489|579416576|FG001|Overall Study|Unable to complete exams (other)|7|||
161019383|NCT03150810|581459687|FG004|Overall Study|Physician Decision|0|||
160459805|NCT05485935|579416577|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
160459806|NCT05485935|579416578|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
160459807|NCT05485935|579416577|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
161019384|NCT03150810|581459688|FG005|Overall Study|Physician Decision|1|||
161019385|NCT03150810|581459689|FG006|Overall Study|Physician Decision|1|||
161019386|NCT03150810|581459690|FG007|Overall Study|Physician Decision|0|||
161019387|NCT03150810|581459691|FG008|Overall Study|Physician Decision|0|||
161019388|NCT03150810|581459692|FG009|Overall Study|Physician Decision|0|||
161019389|NCT03150810|581459693|FG010|Overall Study|Physician Decision|0|||
161019390|NCT03150810|581459694|FG011|Overall Study|Physician Decision|0|||
161019391|NCT03150810|581459695|FG012|Overall Study|Physician Decision|0|||
161019392|NCT03150810|581459683|FG000|Overall Study|Site withdrawal from study|0|||
161019393|NCT03150810|581459684|FG001|Overall Study|Site withdrawal from study|1|||
161019394|NCT03150810|581459685|FG002|Overall Study|Site withdrawal from study|0|||
161019395|NCT03150810|581459686|FG003|Overall Study|Site withdrawal from study|0|||
161019396|NCT03150810|581459687|FG004|Overall Study|Site withdrawal from study|0|||
161019397|NCT03150810|581459688|FG005|Overall Study|Site withdrawal from study|0|||
161019398|NCT03150810|581459689|FG006|Overall Study|Site withdrawal from study|0|||
161019399|NCT03150810|581459690|FG007|Overall Study|Site withdrawal from study|0|||
161019400|NCT03150810|581459691|FG008|Overall Study|Site withdrawal from study|0|||
161019401|NCT03150810|581459692|FG009|Overall Study|Site withdrawal from study|1|||
161019402|NCT03150810|581459693|FG010|Overall Study|Site withdrawal from study|1|||
161019403|NCT03150810|581459694|FG011|Overall Study|Site withdrawal from study|0|||
161019404|NCT03150810|581459695|FG012|Overall Study|Site withdrawal from study|0|||
161019405|NCT03150810|581459683|FG000|Overall Study|Hospice|0|||
161019406|NCT03150810|581459684|FG001|Overall Study|Hospice|0|||
161019407|NCT03150810|581459685|FG002|Overall Study|Hospice|0|||
161019408|NCT03150810|581459686|FG003|Overall Study|Hospice|0|||
161019409|NCT03150810|581459687|FG004|Overall Study|Hospice|0|||
161019410|NCT03150810|581459688|FG005|Overall Study|Hospice|1|||
161019411|NCT03150810|581459689|FG006|Overall Study|Hospice|0|||
161019412|NCT03150810|581459690|FG007|Overall Study|Hospice|0|||
161019413|NCT03150810|581459691|FG008|Overall Study|Hospice|0|||
161019414|NCT03150810|581459692|FG009|Overall Study|Hospice|0|||
161019415|NCT03150810|581459693|FG010|Overall Study|Hospice|0|||
161019416|NCT03150810|581459694|FG011|Overall Study|Hospice|0|||
161019417|NCT03150810|581459695|FG012|Overall Study|Hospice|0|||
161019418|NCT03150810|581459683|FG000|Overall Study|Participant relocated abroad.|0|||
161019419|NCT03150810|581459684|FG001|Overall Study|Participant relocated abroad.|0|||
161019420|NCT03150810|581459685|FG002|Overall Study|Participant relocated abroad.|0|||
161019421|NCT03150810|581459686|FG003|Overall Study|Participant relocated abroad.|0|||
161019422|NCT03150810|581459687|FG004|Overall Study|Participant relocated abroad.|0|||
161019423|NCT03150810|581459688|FG005|Overall Study|Participant relocated abroad.|1|||
161019424|NCT03150810|581459689|FG006|Overall Study|Participant relocated abroad.|0|||
161019425|NCT03150810|581459690|FG007|Overall Study|Participant relocated abroad.|0|||
161019426|NCT03150810|581459691|FG008|Overall Study|Participant relocated abroad.|0|||
161019427|NCT03150810|581459692|FG009|Overall Study|Participant relocated abroad.|0|||
161019428|NCT03150810|581459693|FG010|Overall Study|Participant relocated abroad.|0|||
161019429|NCT03150810|581459694|FG011|Overall Study|Participant relocated abroad.|0|||
161019430|NCT03150810|581459695|FG012|Overall Study|Participant relocated abroad.|0|||
161019431|NCT03150810|581459683|FG000|Overall Study|Transferred care to oncologist|0|||
161019432|NCT03150810|581459684|FG001|Overall Study|Transferred care to oncologist|0|||
161019433|NCT03150810|581459685|FG002|Overall Study|Transferred care to oncologist|0|||
161019434|NCT03150810|581459686|FG003|Overall Study|Transferred care to oncologist|0|||
161019435|NCT03150810|581459687|FG004|Overall Study|Transferred care to oncologist|0|||
161019436|NCT03150810|581459688|FG005|Overall Study|Transferred care to oncologist|0|||
161019437|NCT03150810|581459689|FG006|Overall Study|Transferred care to oncologist|2|||
161019438|NCT03150810|581459690|FG007|Overall Study|Transferred care to oncologist|0|||
161019439|NCT03150810|581459691|FG008|Overall Study|Transferred care to oncologist|0|||
161019440|NCT03150810|581459692|FG009|Overall Study|Transferred care to oncologist|0|||
161019441|NCT03150810|581459693|FG010|Overall Study|Transferred care to oncologist|0|||
161019442|NCT03150810|581459694|FG011|Overall Study|Transferred care to oncologist|0|||
161019443|NCT03150810|581459695|FG012|Overall Study|Transferred care to oncologist|0|||
161019444|NCT04526704|581459696|FG000|Overall Study|Adverse Event|1|||
161019445|NCT04526704|581459697|FG001|Overall Study|Adverse Event|0|||
161019446|NCT04526704|581459696|FG000|Overall Study|Physician Decision|1|||
161019447|NCT04526704|581459697|FG001|Overall Study|Physician Decision|0|||
161019448|NCT04526704|581459696|FG000|Overall Study|Withdrawal by Subject|2|||
161019449|NCT04526704|581459697|FG001|Overall Study|Withdrawal by Subject|0|||
161019450|NCT03936322|581459698|FG000|Overall Study|Lost to Follow-up|1|||
161019451|NCT03936322|581459698|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
161019452|NCT06393088|581459699|FG000|Overall Study|Withdrawal by Subject|0|||
161019453|NCT06393088|581459700|FG001|Overall Study|Withdrawal by Subject|2|||
160587056|NCT04436822|579867654|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
161019454|NCT05051124|581459701|FG000|Overall Study|Lost to Follow-up|2|||
161019455|NCT05051124|581459701|FG000|Overall Study|Withdrawal by Subject|1|||
161019456|NCT05051124|581459701|FG000|Overall Study|Residential relocation|2|||
161019457|NCT05051124|581459701|FG000|Overall Study|Death|1|||
161019458|NCT04782973|581459702|FG000|Overall Study|Withdrawal by Subject|5|||
161019459|NCT04782973|581459702|FG000|Overall Study|Protocol Violation|6|||
161019460|NCT04782973|581459702|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
161019461|NCT04495894|581459718|FG000|Overall Study|Withdrawal by Subject|2|||
160587057|NCT04436822|579867655|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
161019462|NCT04495894|581459719|FG001|Overall Study|Withdrawal by Subject|0|||
161019463|NCT04495894|581459720|FG002|Overall Study|Withdrawal by Subject|2|||
161019464|NCT04495894|581459721|FG003|Overall Study|Withdrawal by Subject|3|||
161019465|NCT04495894|581459718|FG000|Overall Study|Early termination|0|||
161019466|NCT04495894|581459719|FG001|Overall Study|Early termination|0|||
161019467|NCT04495894|581459720|FG002|Overall Study|Early termination|3|||
161019468|NCT04495894|581459721|FG003|Overall Study|Early termination|0|||
161019469|NCT01000961|581459722|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
161019470|NCT01000961|581459723|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161019471|NCT01000961|581459722|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
161019472|NCT01000961|581459723|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
161019473|NCT05746455|581459726|FG000|Overall Study|Discharged from Clinical Service|1|||
161019474|NCT05746455|581459726|FG000|Overall Study|Lost to Follow-up|1|||
161019475|NCT02023866|581459727|FG000|Overall Study|Non-compliance|2|||
161019476|NCT02023866|581459727|FG000|Overall Study|Adverse Event|3|||
161019477|NCT02023866|581459727|FG000|Overall Study|Withdrawal by Subject|1|||
161019478|NCT03307343|581459728|FG000|Overall Study|Withdrawal by Subject|1|||
161019479|NCT03307343|581459729|FG001|Overall Study|Withdrawal by Subject|2|||
161019480|NCT03307343|581459728|FG000|Overall Study|Pregnancy|0|||
161019481|NCT03307343|581459729|FG001|Overall Study|Pregnancy|2|||
161019482|NCT03307343|581459728|FG000|Overall Study|Physician Decision|1|||
161019483|NCT03307343|581459729|FG001|Overall Study|Physician Decision|0|||
161019484|NCT03307343|581459728|FG000|Overall Study|Lost to Follow-up|0|||
161019485|NCT03307343|581459729|FG001|Overall Study|Lost to Follow-up|2|||
161019486|NCT04683744|581459731|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
161019487|NCT04683744|581459732|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
161019488|NCT04683744|581459733|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
161019489|NCT05184192|581459736|FG000|Overall Study|Lost to Follow-up|4|||
161019490|NCT05184192|581459737|FG001|Overall Study|Lost to Follow-up|7|||
161019491|NCT05184192|581459736|FG000|Overall Study|Adverse Event|1|||
161019492|NCT05184192|581459737|FG001|Overall Study|Adverse Event|4|||
161019493|NCT05184192|581459736|FG000|Overall Study|PI withdrawal|1|||
161019494|NCT05184192|581459737|FG001|Overall Study|PI withdrawal|2|||
161019495|NCT05184192|581459736|FG000|Overall Study|Withdrew due to adverse effect|1|||
161019496|NCT05184192|581459737|FG001|Overall Study|Withdrew due to adverse effect|0|||
161019497|NCT05184192|581459736|FG000|Overall Study|Medication schedule|1|||
161019498|NCT05184192|581459737|FG001|Overall Study|Medication schedule|0|||
161019499|NCT05184192|581459736|FG000|Overall Study|Concern for adverse effects|0|||
161019500|NCT05184192|581459737|FG001|Overall Study|Concern for adverse effects|4|||
161019501|NCT01824394|581459743|FG000|Overall Study|Early Termination|1|||
161019502|NCT01824394|581459744|FG001|Overall Study|Early Termination|1|||
161019503|NCT01824394|581459745|FG002|Overall Study|Early Termination|3|||
161019504|NCT01824394|581459743|FG000|Overall Study|Withdrawn due to Study Termination|91|||
161019505|NCT01824394|581459744|FG001|Overall Study|Withdrawn due to Study Termination|83|||
161019506|NCT01824394|581459745|FG002|Overall Study|Withdrawn due to Study Termination|41|||
161019507|NCT01824394|581459743|FG000|Overall Study|Lost to Follow-up|0|||
161019508|NCT01824394|581459744|FG001|Overall Study|Lost to Follow-up|9|||
161019509|NCT01824394|581459745|FG002|Overall Study|Lost to Follow-up|3|||
160459808|NCT05485935|579416578|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
160459809|NCT05485935|579416577|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
160459810|NCT05485935|579416578|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
160459811|NCT05485935|579416577|FG000|Period 2 (T2 and V3)|loss of contact|0|||
160459812|NCT05485935|579416578|FG001|Period 2 (T2 and V3)|loss of contact|1|||
160459813|NCT04093869|579416579|FG000|Overall Study|Death|0|||
160459814|NCT04093869|579416580|FG001|Overall Study|Death|1|||
160459815|NCT04093869|579416579|FG000|Overall Study|Withdrawal by Subject|1|||
160459816|NCT04093869|579416580|FG001|Overall Study|Withdrawal by Subject|0|||
160459817|NCT02806726|579416581|FG000|Overall Study|Lost to Follow-up|1|||
160459818|NCT03250676|579416582|FG000|Overall Study|Adverse Event|0|||
160459819|NCT03250676|579416583|FG001|Overall Study|Adverse Event|0|||
160459820|NCT03250676|579416584|FG002|Overall Study|Adverse Event|0|||
160459821|NCT03250676|579416585|FG003|Overall Study|Adverse Event|1|||
160459822|NCT03250676|579416586|FG004|Overall Study|Adverse Event|2|||
160459823|NCT03250676|579416587|FG005|Overall Study|Adverse Event|9|||
160459824|NCT03250676|579416582|FG000|Overall Study|Withdrawal by Subject|1|||
161019510|NCT01824394|581459743|FG000|Overall Study|Death|3|||
160459825|NCT03250676|579416583|FG001|Overall Study|Withdrawal by Subject|0|||
160459826|NCT03250676|579416584|FG002|Overall Study|Withdrawal by Subject|0|||
161019511|NCT01824394|581459744|FG001|Overall Study|Death|2|||
161019512|NCT01824394|581459745|FG002|Overall Study|Death|4|||
161019513|NCT01824394|581459743|FG000|Overall Study|Discontinued Subjects|1|||
161019514|NCT01824394|581459744|FG001|Overall Study|Discontinued Subjects|1|||
161019515|NCT01824394|581459745|FG002|Overall Study|Discontinued Subjects|2|||
161019516|NCT01824394|581459743|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
161019517|NCT01824394|581459744|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
161019518|NCT01824394|581459745|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
160587058|NCT03807739|579867656|FG000|Overall Study|Adverse Event|1|||
161019519|NCT05364671|581459747|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
161019520|NCT05364671|581459748|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
161019521|NCT05364671|581459747|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
161019522|NCT05364671|581459748|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
161019523|NCT05364671|581459747|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
161019524|NCT05364671|581459748|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
161019525|NCT05364671|581459747|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
161019526|NCT05364671|581459748|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
161019527|NCT05364671|581459747|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
161019528|NCT05364671|581459748|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
161019529|NCT04015167|581459749|FG000|Overall Study|Lost to Follow-up|40|||
161019530|NCT04015167|581459749|FG000|Overall Study|Adverse Event|5|||
161019531|NCT04015167|581459749|FG000|Overall Study|Withdrawal by Subject|2|||
161019532|NCT04015167|581459749|FG000|Overall Study|Subject went to jail|1|||
161019533|NCT04810650|581459751|FG000|Overall Study|Disenrolled in error|0|||
161019534|NCT04810650|581459752|FG001|Overall Study|Disenrolled in error|0|||
161019535|NCT04810650|581459753|FG002|Overall Study|Disenrolled in error|0|||
161019536|NCT04810650|581459754|FG003|Overall Study|Disenrolled in error|0|||
161019537|NCT04810650|581459755|FG004|Overall Study|Disenrolled in error|0|||
161019538|NCT04810650|581459756|FG005|Overall Study|Disenrolled in error|0|||
161019539|NCT04810650|581459757|FG006|Overall Study|Disenrolled in error|0|||
161019540|NCT04810650|581459758|FG007|Overall Study|Disenrolled in error|0|||
161019541|NCT04810650|581459759|FG008|Overall Study|Disenrolled in error|1|||
161019542|NCT04810650|581459760|FG009|Overall Study|Disenrolled in error|0|||
161019543|NCT04810650|581459761|FG010|Overall Study|Disenrolled in error|0|||
161019544|NCT04810650|581459762|FG011|Overall Study|Disenrolled in error|0|||
161019545|NCT04810650|581459763|FG012|Overall Study|Disenrolled in error|0|||
160587059|NCT03807739|579867657|FG001|Overall Study|Adverse Event|0|||
160587060|NCT03807739|579867658|FG002|Overall Study|Adverse Event|0|||
160587061|NCT03807739|579867659|FG003|Overall Study|Adverse Event|0|||
160587062|NCT03807739|579867656|FG000|Overall Study|Withdrawal by Subject|1|||
160587063|NCT03807739|579867657|FG001|Overall Study|Withdrawal by Subject|0|||
160587064|NCT03807739|579867658|FG002|Overall Study|Withdrawal by Subject|0|||
160587065|NCT03807739|579867659|FG003|Overall Study|Withdrawal by Subject|0|||
160587066|NCT05118386|579867670|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
160587067|NCT05118386|579867671|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
160587068|NCT05118386|579867672|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
160587069|NCT05118386|579867673|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
160587070|NCT05118386|579867674|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
160587071|NCT05118386|579867675|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
160587072|NCT05118386|579867670|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
160587073|NCT05118386|579867671|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
160587074|NCT05118386|579867672|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
160587075|NCT05118386|579867673|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
160587076|NCT05118386|579867674|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
160587077|NCT05118386|579867675|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
160587078|NCT00488033|579867676|FG000|Overall Study|Withdrawal by Subject|1|||
160587079|NCT00488033|579867677|FG001|Overall Study|Withdrawal by Subject|0|||
160587080|NCT00369668|579867678|FG000|Overall Study|Lack of Efficacy|4|||
160587081|NCT00369668|579867679|FG001|Overall Study|Lack of Efficacy|5|||
160587082|NCT00369668|579867680|FG002|Overall Study|Lack of Efficacy|7|||
160587083|NCT00894413|579867681|FG000|Overall Study|Physician Decision|0|||
160587084|NCT00894413|579867682|FG001|Overall Study|Physician Decision|2|||
161019546|NCT04810650|581459764|FG013|Overall Study|Disenrolled in error|0|||
161019547|NCT04810650|581459751|FG000|Overall Study|Death|0|||
161019548|NCT04810650|581459752|FG001|Overall Study|Death|0|||
161019549|NCT04810650|581459753|FG002|Overall Study|Death|0|||
161019550|NCT04810650|581459754|FG003|Overall Study|Death|0|||
161019551|NCT04810650|581459755|FG004|Overall Study|Death|0|||
161019552|NCT04810650|581459756|FG005|Overall Study|Death|0|||
161019553|NCT04810650|581459757|FG006|Overall Study|Death|2|||
160587085|NCT00894413|579867681|FG000|Overall Study|Adverse Event|0|||
160587086|NCT00894413|579867682|FG001|Overall Study|Adverse Event|2|||
160587087|NCT00894413|579867681|FG000|Overall Study|Withdrawal by Subject|0|||
160587088|NCT00894413|579867682|FG001|Overall Study|Withdrawal by Subject|4|||
161019554|NCT04810650|581459758|FG007|Overall Study|Death|2|||
161019555|NCT04810650|581459759|FG008|Overall Study|Death|0|||
161019556|NCT04810650|581459760|FG009|Overall Study|Death|1|||
161019557|NCT04810650|581459761|FG010|Overall Study|Death|0|||
161019558|NCT04810650|581459762|FG011|Overall Study|Death|0|||
161019559|NCT04810650|581459763|FG012|Overall Study|Death|2|||
161019560|NCT04810650|581459764|FG013|Overall Study|Death|1|||
161019561|NCT04810650|581459751|FG000|Overall Study|Moved/transferred care|0|||
161019562|NCT04810650|581459752|FG001|Overall Study|Moved/transferred care|0|||
161019563|NCT04810650|581459753|FG002|Overall Study|Moved/transferred care|0|||
161019564|NCT04810650|581459754|FG003|Overall Study|Moved/transferred care|0|||
161019565|NCT04810650|581459755|FG004|Overall Study|Moved/transferred care|0|||
161019566|NCT04810650|581459756|FG005|Overall Study|Moved/transferred care|0|||
161019567|NCT04810650|581459757|FG006|Overall Study|Moved/transferred care|0|||
161019568|NCT04810650|581459758|FG007|Overall Study|Moved/transferred care|1|||
160587089|NCT03855137|579867687|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
160587090|NCT03855137|579867688|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
160587091|NCT03855137|579867689|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
160587092|NCT03855137|579867687|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
160587093|NCT03855137|579867688|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
160587094|NCT03855137|579867689|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
160587095|NCT03855137|579867687|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
160587096|NCT03855137|579867688|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
160587097|NCT03855137|579867689|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
160587098|NCT03855137|579867687|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
160587099|NCT03855137|579867688|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
160587100|NCT03855137|579867689|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
160587101|NCT03855137|579867687|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
160587102|NCT03855137|579867688|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
160587103|NCT03855137|579867689|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
161019569|NCT04810650|581459759|FG008|Overall Study|Moved/transferred care|12|||
161019570|NCT04810650|581459760|FG009|Overall Study|Moved/transferred care|10|||
161019571|NCT04810650|581459761|FG010|Overall Study|Moved/transferred care|0|||
161019572|NCT04810650|581459762|FG011|Overall Study|Moved/transferred care|0|||
161019573|NCT04810650|581459763|FG012|Overall Study|Moved/transferred care|0|||
161019574|NCT04810650|581459764|FG013|Overall Study|Moved/transferred care|0|||
161019575|NCT04810650|581459751|FG000|Overall Study|Lost to Follow-up|15|||
161019576|NCT04810650|581459752|FG001|Overall Study|Lost to Follow-up|12|||
161019577|NCT04810650|581459753|FG002|Overall Study|Lost to Follow-up|7|||
161019578|NCT04810650|581459754|FG003|Overall Study|Lost to Follow-up|9|||
161019579|NCT04810650|581459755|FG004|Overall Study|Lost to Follow-up|10|||
161019580|NCT04810650|581459756|FG005|Overall Study|Lost to Follow-up|6|||
161019581|NCT04810650|581459757|FG006|Overall Study|Lost to Follow-up|0|||
161019582|NCT04810650|581459758|FG007|Overall Study|Lost to Follow-up|0|||
161019583|NCT04810650|581459759|FG008|Overall Study|Lost to Follow-up|0|||
161019584|NCT04810650|581459760|FG009|Overall Study|Lost to Follow-up|0|||
161019585|NCT04810650|581459761|FG010|Overall Study|Lost to Follow-up|1|||
161019586|NCT04810650|581459762|FG011|Overall Study|Lost to Follow-up|0|||
161019587|NCT04810650|581459763|FG012|Overall Study|Lost to Follow-up|3|||
161019588|NCT04810650|581459764|FG013|Overall Study|Lost to Follow-up|9|||
161019589|NCT04810650|581459751|FG000|Overall Study|Participant declined|0|||
161019590|NCT04810650|581459752|FG001|Overall Study|Participant declined|0|||
161019591|NCT04810650|581459753|FG002|Overall Study|Participant declined|0|||
161019592|NCT04810650|581459754|FG003|Overall Study|Participant declined|0|||
161019593|NCT04810650|581459755|FG004|Overall Study|Participant declined|0|||
161019594|NCT04810650|581459756|FG005|Overall Study|Participant declined|0|||
161019595|NCT04810650|581459757|FG006|Overall Study|Participant declined|0|||
161019596|NCT04810650|581459758|FG007|Overall Study|Participant declined|0|||
161019597|NCT04810650|581459759|FG008|Overall Study|Participant declined|0|||
161019598|NCT04810650|581459760|FG009|Overall Study|Participant declined|0|||
161019599|NCT04810650|581459761|FG010|Overall Study|Participant declined|2|||
161019600|NCT04810650|581459762|FG011|Overall Study|Participant declined|0|||
161019601|NCT04810650|581459763|FG012|Overall Study|Participant declined|0|||
161019602|NCT04810650|581459764|FG013|Overall Study|Participant declined|0|||
161019603|NCT05794243|581459765|FG000|Overall Study|Withdrawal by Subject|1|||
161019604|NCT05794243|581459766|FG001|Overall Study|Withdrawal by Subject|0|||
160587104|NCT03855137|579867687|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
160587105|NCT03855137|579867688|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
161019605|NCT05794243|581459767|FG002|Overall Study|Withdrawal by Subject|1|||
160587106|NCT03855137|579867689|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
160587107|NCT03855137|579867687|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
161019606|NCT05794243|581459765|FG000|Overall Study|Physician Decision|0|||
161019607|NCT05794243|581459766|FG001|Overall Study|Physician Decision|3|||
161019608|NCT05794243|581459767|FG002|Overall Study|Physician Decision|1|||
161019609|NCT02761057|581459771|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
161019610|NCT02761057|581459772|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
161019611|NCT02761057|581459773|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
161019612|NCT02761057|581459774|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
161019613|NCT02761057|581459771|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
160587108|NCT03855137|579867688|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
160587109|NCT03855137|579867689|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
160587110|NCT03855137|579867687|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
161019614|NCT02761057|581459772|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
161019615|NCT02761057|581459773|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
161019616|NCT02761057|581459774|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
161019617|NCT02761057|581459771|FG000|Overall Study|Currently On Study Treatment|0|||
161019618|NCT02761057|581459772|FG001|Overall Study|Currently On Study Treatment|3|||
161019619|NCT02761057|581459773|FG002|Overall Study|Currently On Study Treatment|0|||
161019620|NCT02761057|581459774|FG003|Overall Study|Currently On Study Treatment|0|||
161019621|NCT02761057|581459771|FG000|Overall Study|Adverse Event|11|||
160587111|NCT03855137|579867688|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
160587112|NCT03855137|579867689|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
160587113|NCT03855137|579867687|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
160587114|NCT03855137|579867688|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
160587115|NCT03855137|579867689|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
160587116|NCT03855137|579867687|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
160587117|NCT03855137|579867688|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
160587118|NCT03855137|579867689|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
160587119|NCT02427477|579867690|FG000|Period 1|Adverse Event|1|||
160587120|NCT02427477|579867691|FG001|Period 1|Adverse Event|0|||
160587121|NCT02435277|579867692|FG000|Overall Study|Adverse Event|1|||
161019622|NCT02761057|581459772|FG001|Overall Study|Adverse Event|9|||
161019623|NCT02761057|581459773|FG002|Overall Study|Adverse Event|5|||
161019624|NCT02761057|581459774|FG003|Overall Study|Adverse Event|3|||
161019625|NCT02761057|581459771|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
161019626|NCT02761057|581459772|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
161019627|NCT02761057|581459773|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
161019628|NCT02761057|581459774|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
161019629|NCT02761057|581459771|FG000|Overall Study|Progression/Relapse|29|||
160587122|NCT02435277|579867693|FG001|Overall Study|Adverse Event|1|||
160587123|NCT02435277|579867694|FG002|Overall Study|Adverse Event|0|||
160587124|NCT02435277|579867695|FG003|Overall Study|Adverse Event|0|||
160587125|NCT02435277|579867692|FG000|Overall Study|Withdrawal by Subject|1|||
160587126|NCT02435277|579867693|FG001|Overall Study|Withdrawal by Subject|0|||
160587127|NCT02435277|579867694|FG002|Overall Study|Withdrawal by Subject|0|||
160587128|NCT02435277|579867695|FG003|Overall Study|Withdrawal by Subject|0|||
160587129|NCT03213626|579867696|FG000|Overall Study|Adverse Event|1|||
160587130|NCT03213626|579867696|FG000|Overall Study|Progressive Disease|6|||
160587131|NCT01005732|579867697|FG000|Overall Study|Lost to Follow-up|10|||
160587132|NCT01005732|579867697|FG000|Overall Study|Death|1|||
160587133|NCT01552928|579867698|FG000|Period 3|Adverse Event|0|||
160587134|NCT01552928|579867699|FG001|Period 3|Adverse Event|0|||
160587135|NCT01552928|579867700|FG002|Period 3|Adverse Event|1|||
160587136|NCT01552928|579867701|FG003|Period 3|Adverse Event|0|||
160587137|NCT00632463|579867702|FG000|Overall Study|Adverse Event|0|||
160587138|NCT00632463|579867703|FG001|Overall Study|Adverse Event|1|||
160587139|NCT00632463|579867704|FG002|Overall Study|Adverse Event|0|||
160587140|NCT02065622|579867705|FG000|Induction Study|Adverse Event|13|||
160587141|NCT02065622|579867706|FG001|Induction Study|Adverse Event|19|||
160587142|NCT02065622|579867707|FG002|Induction Study|Adverse Event|0|||
160587143|NCT02065622|579867708|FG003|Induction Study|Adverse Event|0|||
160587144|NCT02065622|579867709|FG004|Induction Study|Adverse Event|0|||
160587145|NCT02065622|579867705|FG000|Induction Study|Withdrawal by Subject|3|||
160587146|NCT02065622|579867706|FG001|Induction Study|Withdrawal by Subject|5|||
160587147|NCT02065622|579867707|FG002|Induction Study|Withdrawal by Subject|0|||
161019630|NCT02761057|581459772|FG001|Overall Study|Progression/Relapse|27|||
160459827|NCT03250676|579416585|FG003|Overall Study|Withdrawal by Subject|1|||
160587148|NCT02065622|579867708|FG003|Induction Study|Withdrawal by Subject|0|||
160587149|NCT02065622|579867709|FG004|Induction Study|Withdrawal by Subject|0|||
160587150|NCT02065622|579867705|FG000|Induction Study|Lost to Follow-up|1|||
160587151|NCT02065622|579867706|FG001|Induction Study|Lost to Follow-up|0|||
160587152|NCT02065622|579867707|FG002|Induction Study|Lost to Follow-up|0|||
160587153|NCT02065622|579867708|FG003|Induction Study|Lost to Follow-up|0|||
160587154|NCT02065622|579867709|FG004|Induction Study|Lost to Follow-up|0|||
160587155|NCT02065622|579867705|FG000|Induction Study|Lack of Efficacy|22|||
160587156|NCT02065622|579867706|FG001|Induction Study|Lack of Efficacy|27|||
160587157|NCT02065622|579867707|FG002|Induction Study|Lack of Efficacy|0|||
160587158|NCT02065622|579867708|FG003|Induction Study|Lack of Efficacy|0|||
160587159|NCT02065622|579867709|FG004|Induction Study|Lack of Efficacy|0|||
160587160|NCT02065622|579867705|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
160587161|NCT02065622|579867706|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
161019631|NCT02761057|581459773|FG002|Overall Study|Progression/Relapse|20|||
161019632|NCT02761057|581459774|FG003|Overall Study|Progression/Relapse|23|||
161019633|NCT02761057|581459771|FG000|Overall Study|Death|2|||
161019634|NCT02761057|581459772|FG001|Overall Study|Death|2|||
161019635|NCT02761057|581459773|FG002|Overall Study|Death|1|||
161019636|NCT02761057|581459774|FG003|Overall Study|Death|1|||
161019637|NCT02761057|581459771|FG000|Overall Study|Other - Not Protocol Specified|2|||
161019638|NCT02761057|581459772|FG001|Overall Study|Other - Not Protocol Specified|1|||
161019639|NCT02761057|581459773|FG002|Overall Study|Other - Not Protocol Specified|2|||
161019640|NCT02761057|581459774|FG003|Overall Study|Other - Not Protocol Specified|0|||
161019641|NCT05609760|581459781|FG000|Overall Study|Lost to Follow-up|0|||
161019642|NCT05609760|581459782|FG001|Overall Study|Lost to Follow-up|1|||
161019643|NCT05609760|581459781|FG000|Overall Study|Withdrawal by Subject|1|||
161019644|NCT05609760|581459782|FG001|Overall Study|Withdrawal by Subject|0|||
161019645|NCT05179395|581459783|FG000|Overall Study|Lack of Efficacy|1|||
161019646|NCT00812461|581459785|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
161019647|NCT00812461|581459786|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
161019648|NCT00812461|581459785|FG000|All Treated Patients|Adverse Event|8|||
161019649|NCT00812461|581459786|FG001|All Treated Patients|Adverse Event|15|||
161019650|NCT00812461|581459785|FG000|All Treated Patients|Lack of Efficacy|13|||
161019651|NCT00812461|581459786|FG001|All Treated Patients|Lack of Efficacy|7|||
161019652|NCT00812461|581459785|FG000|All Treated Patients|Non-compliance|6|||
161019653|NCT00812461|581459786|FG001|All Treated Patients|Non-compliance|9|||
161019654|NCT00812461|581459785|FG000|All Treated Patients|Protocol Violation|36|||
161019655|NCT00812461|581459786|FG001|All Treated Patients|Protocol Violation|27|||
161019656|NCT00812461|581459785|FG000|All Treated Patients|Withdrawal by Subject|45|||
161019657|NCT00812461|581459786|FG001|All Treated Patients|Withdrawal by Subject|54|||
161019658|NCT00812461|581459785|FG000|All Treated Patients|Lost to Follow-up|11|||
161019659|NCT00812461|581459786|FG001|All Treated Patients|Lost to Follow-up|14|||
161019660|NCT00812461|581459785|FG000|All Treated Patients|Other Reason|13|||
161019661|NCT00812461|581459786|FG001|All Treated Patients|Other Reason|21|||
161019662|NCT05093829|581459788|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161019663|NCT05093829|581459789|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161019664|NCT05093829|581459790|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
161019665|NCT05093829|581459791|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161019666|NCT05093829|581459792|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161019667|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Physician Decision|1|||
161019668|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Physician Decision|0|||
161019669|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
161019670|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
161019671|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
161019672|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
161019673|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Pregnancy|0|||
161019674|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Pregnancy|2|||
161019675|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
161019676|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
161019677|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
161019678|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
161019679|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
161019680|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
161019681|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
161019682|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
161019683|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
161019684|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
161019685|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
161019686|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
161019687|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
161019688|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
161019689|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
161019690|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
161019691|NCT01785719|581461609|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
161019692|NCT01785719|581461610|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
161019693|NCT01785719|581461609|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
161019694|NCT01785719|581461610|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
161019695|NCT01785719|581461609|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
161019696|NCT01785719|581461610|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
161019697|NCT04977947|581461611|FG000|Overall Study|Lost to Follow-up|1|||
161019698|NCT04977947|581461612|FG001|Overall Study|Lost to Follow-up|1|||
161019699|NCT03445988|581461613|FG000|Overall Study|Lost to Follow-up|14|||
161019700|NCT03445988|581461614|FG001|Overall Study|Lost to Follow-up|26|||
161019701|NCT03445988|581461615|FG002|Overall Study|Lost to Follow-up|27|||
161019702|NCT03445988|581461616|FG003|Overall Study|Lost to Follow-up|66|||
161019703|NCT03445988|581461613|FG000|Overall Study|Withdrawal by Subject|7|||
161019704|NCT03445988|581461614|FG001|Overall Study|Withdrawal by Subject|4|||
161019705|NCT03445988|581461615|FG002|Overall Study|Withdrawal by Subject|3|||
161019706|NCT03445988|581461616|FG003|Overall Study|Withdrawal by Subject|5|||
161019707|NCT03445988|581461613|FG000|Overall Study|Death (unrelated to study)|5|||
161019708|NCT03445988|581461614|FG001|Overall Study|Death (unrelated to study)|1|||
161019709|NCT03445988|581461615|FG002|Overall Study|Death (unrelated to study)|2|||
161019710|NCT03445988|581461616|FG003|Overall Study|Death (unrelated to study)|4|||
161019711|NCT05875142|581461617|FG000|Overall Study|Lost to Follow-up|0|||
161019712|NCT05875142|581461618|FG001|Overall Study|Lost to Follow-up|1|||
161019713|NCT05875142|581461619|FG002|Overall Study|Lost to Follow-up|1|||
161019714|NCT02677298|581461630|FG000|Double Blind Phase|Adverse Event|2|||
161019715|NCT02677298|581461631|FG001|Double Blind Phase|Adverse Event|1|||
161019716|NCT02677298|581461632|FG002|Double Blind Phase|Adverse Event|0|||
161019717|NCT02677298|581461630|FG000|Double Blind Phase|Physician Decision|5|||
161019718|NCT02677298|581461631|FG001|Double Blind Phase|Physician Decision|0|||
161019719|NCT02677298|581461632|FG002|Double Blind Phase|Physician Decision|0|||
161019720|NCT02677298|581461630|FG000|Double Blind Phase|Lost to Follow-up|11|||
161019721|NCT02677298|581461631|FG001|Double Blind Phase|Lost to Follow-up|7|||
161019722|NCT02677298|581461632|FG002|Double Blind Phase|Lost to Follow-up|0|||
161019723|NCT02677298|581461630|FG000|Double Blind Phase|Withdrawal by Subject|11|||
161019724|NCT02677298|581461631|FG001|Double Blind Phase|Withdrawal by Subject|8|||
161019725|NCT02677298|581461632|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161019726|NCT02677298|581461630|FG000|Double Blind Phase|No study drug available at site|0|||
161019727|NCT02677298|581461631|FG001|Double Blind Phase|No study drug available at site|1|||
161019728|NCT02677298|581461632|FG002|Double Blind Phase|No study drug available at site|0|||
161019729|NCT02677298|581461630|FG000|Open Label Phase|Adverse Event|0|||
161019730|NCT02677298|581461631|FG001|Open Label Phase|Adverse Event|0|||
161019731|NCT02677298|581461632|FG002|Open Label Phase|Adverse Event|4|||
161019732|NCT02677298|581461630|FG000|Open Label Phase|Physician Decision|0|||
161019733|NCT02677298|581461631|FG001|Open Label Phase|Physician Decision|0|||
161019734|NCT02677298|581461632|FG002|Open Label Phase|Physician Decision|1|||
161019735|NCT02677298|581461630|FG000|Open Label Phase|Lost to Follow-up|0|||
161019736|NCT02677298|581461631|FG001|Open Label Phase|Lost to Follow-up|0|||
161019737|NCT02677298|581461632|FG002|Open Label Phase|Lost to Follow-up|17|||
161019738|NCT02677298|581461630|FG000|Open Label Phase|Withdrawal by Subject|0|||
161019739|NCT02677298|581461631|FG001|Open Label Phase|Withdrawal by Subject|0|||
161019740|NCT02677298|581461632|FG002|Open Label Phase|Withdrawal by Subject|38|||
161019741|NCT03611621|581461633|FG000|Overall Study|Graft loss|3|||
161019742|NCT03611621|581461633|FG000|Overall Study|Death|3|||
161019743|NCT03611621|581461633|FG000|Overall Study|Lost to Follow-up|1|||
161019744|NCT05653427|581461636|FG000|Overall Study|Study Terminated by Sponsor|13|||
161019745|NCT03891667|581461639|FG000|Overall Study|Physician Decision|1|||
161019746|NCT03891667|581461640|FG001|Overall Study|Physician Decision|1|||
161019747|NCT03891667|581461639|FG000|Overall Study|COVID related pause|1|||
161019748|NCT03891667|581461640|FG001|Overall Study|COVID related pause|0|||
161019749|NCT03891667|581461639|FG000|Overall Study|Withdrawal by Subject|0|||
161019750|NCT03891667|581461640|FG001|Overall Study|Withdrawal by Subject|1|||
161019751|NCT03891667|581461639|FG000|Overall Study|Adverse Event|0|||
161019752|NCT03891667|581461640|FG001|Overall Study|Adverse Event|1|||
161019753|NCT05659537|581461641|FG000|Overall Study|Adverse Event|5|||
161019754|NCT05659537|581461641|FG000|Overall Study|Lost to Follow-up|4|||
161019755|NCT05659537|581461641|FG000|Overall Study|Withdrawal by Subject|13|||
161019756|NCT05659537|581461641|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
161019757|NCT05659537|581461641|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
161019758|NCT05659537|581461641|FG000|Overall Study|Participant was suffering from anaemia|1|||
161019759|NCT04971395|581461642|FG000|Overall Study|Withdrawal by Subject|0|||
161019760|NCT04971395|581461643|FG001|Overall Study|Withdrawal by Subject|1|||
161019761|NCT04971395|581461644|FG002|Overall Study|Withdrawal by Subject|0|||
161019762|NCT00506519|581461651|FG000|Overall Study|Death|4|||
161019763|NCT00506519|581461652|FG001|Overall Study|Death|6|||
161019764|NCT00506519|581461653|FG002|Overall Study|Death|0|||
161019765|NCT00506519|581461651|FG000|Overall Study|Adverse Event|1|||
161019766|NCT00506519|581461652|FG001|Overall Study|Adverse Event|0|||
161019767|NCT00506519|581461653|FG002|Overall Study|Adverse Event|0|||
161019768|NCT02975882|581461654|FG000|Overall Study|Adverse Event|1|||
161019769|NCT02975882|581461655|FG001|Overall Study|Adverse Event|2|||
161019770|NCT02975882|581461656|FG002|Overall Study|Adverse Event|1|||
161019771|NCT02975882|581461657|FG003|Overall Study|Adverse Event|1|||
161019772|NCT02975882|581461654|FG000|Overall Study|Death|0|||
161019773|NCT02975882|581461655|FG001|Overall Study|Death|1|||
161019774|NCT02975882|581461656|FG002|Overall Study|Death|0|||
161019775|NCT02975882|581461657|FG003|Overall Study|Death|0|||
161019776|NCT02975882|581461654|FG000|Overall Study|Lack of Efficacy|3|||
161019777|NCT02975882|581461655|FG001|Overall Study|Lack of Efficacy|7|||
161019778|NCT02975882|581461656|FG002|Overall Study|Lack of Efficacy|4|||
161019779|NCT02975882|581461657|FG003|Overall Study|Lack of Efficacy|3|||
161019780|NCT02975882|581461654|FG000|Overall Study|Physician Decision|0|||
161019781|NCT02975882|581461655|FG001|Overall Study|Physician Decision|2|||
161019782|NCT02975882|581461656|FG002|Overall Study|Physician Decision|4|||
161019783|NCT02975882|581461657|FG003|Overall Study|Physician Decision|2|||
161019784|NCT02975882|581461654|FG000|Overall Study|Ineligible|0|||
161019785|NCT02975882|581461655|FG001|Overall Study|Ineligible|1|||
161019786|NCT02975882|581461656|FG002|Overall Study|Ineligible|0|||
161019787|NCT02975882|581461657|FG003|Overall Study|Ineligible|0|||
161019788|NCT05116787|581461658|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
161019789|NCT05116787|581461659|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
161019790|NCT05116787|581461658|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
161019791|NCT05116787|581461659|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
161019792|NCT05116787|581461658|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
161019793|NCT05116787|581461659|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
161019794|NCT05116787|581461658|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
161019795|NCT05116787|581461659|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
161019796|NCT02737436|581461660|FG000|Washout Period|Lost to Follow-up|5|||
161019797|NCT02737436|581461661|FG001|Washout Period|Lost to Follow-up|11|||
161019798|NCT02737436|581461660|FG000|Data Analysis|Scanning data problems|5|||
161019799|NCT02737436|581461661|FG001|Data Analysis|Scanning data problems|8|||
161019800|NCT02919683|581461662|FG000|Post-Surgery Follow-Up|Death|2|||
161019801|NCT02919683|581461663|FG001|Post-Surgery Follow-Up|Death|2|||
161019802|NCT02919683|581461662|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
161019803|NCT02919683|581461663|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
161019804|NCT01160211|581461665|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
161019805|NCT01160211|581461666|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
161019806|NCT01160211|581461667|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
161019807|NCT01160211|581461665|FG000|Overall Study|Lost to Follow-up|4|||
161019808|NCT01160211|581461666|FG001|Overall Study|Lost to Follow-up|8|||
161019809|NCT01160211|581461667|FG002|Overall Study|Lost to Follow-up|4|||
161019810|NCT01160211|581461665|FG000|Overall Study|Physician Decision|1|||
161019811|NCT01160211|581461666|FG001|Overall Study|Physician Decision|0|||
161019812|NCT01160211|581461667|FG002|Overall Study|Physician Decision|0|||
161019813|NCT01160211|581461665|FG000|Overall Study|Withdrawal by Subject|4|||
161019814|NCT01160211|581461666|FG001|Overall Study|Withdrawal by Subject|2|||
161019815|NCT01160211|581461667|FG002|Overall Study|Withdrawal by Subject|2|||
161019816|NCT01160211|581461665|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
161019817|NCT01160211|581461666|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
161019818|NCT01160211|581461667|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
161019819|NCT02734290|581461668|FG000|Overall Study|Adverse Event|1|||
161019820|NCT02734290|581461669|FG001|Overall Study|Adverse Event|0|||
161019821|NCT02734290|581461668|FG000|Overall Study|Death|1|||
161019822|NCT02734290|581461669|FG001|Overall Study|Death|0|||
161019823|NCT03829410|581461671|FG000|Overall Study|Adverse Event|1|||
161019824|NCT03829410|581461672|FG001|Overall Study|Adverse Event|0|||
161019825|NCT03829410|581461673|FG002|Overall Study|Adverse Event|1|||
161019826|NCT03829410|581461674|FG003|Overall Study|Adverse Event|4|||
161019827|NCT03829410|581461671|FG000|Overall Study|Physician Decision|0|||
161019828|NCT03829410|581461672|FG001|Overall Study|Physician Decision|0|||
161019829|NCT03829410|581461673|FG002|Overall Study|Physician Decision|0|||
161019830|NCT03829410|581461674|FG003|Overall Study|Physician Decision|2|||
161019831|NCT03829410|581461671|FG000|Overall Study|Disease Progressing|3|||
161019832|NCT03829410|581461672|FG001|Overall Study|Disease Progressing|4|||
161019833|NCT03829410|581461673|FG002|Overall Study|Disease Progressing|2|||
161019834|NCT03829410|581461674|FG003|Overall Study|Disease Progressing|31|||
161019835|NCT03829410|581461671|FG000|Overall Study|Miscellaneous|2|||
161019836|NCT03829410|581461672|FG001|Overall Study|Miscellaneous|4|||
161019837|NCT03829410|581461673|FG002|Overall Study|Miscellaneous|3|||
161019838|NCT03829410|581461674|FG003|Overall Study|Miscellaneous|10|||
161019839|NCT03158129|581461675|FG000|Overall Study|Adverse Event|0|||
161019840|NCT03158129|581461676|FG001|Overall Study|Adverse Event|1|||
161019841|NCT03158129|581461677|FG002|Overall Study|Adverse Event|0|||
161019842|NCT03158129|581461678|FG003|Overall Study|Adverse Event|0|||
161019843|NCT03158129|581461675|FG000|Overall Study|Death|0|||
161019844|NCT03158129|581461676|FG001|Overall Study|Death|0|||
161019845|NCT03158129|581461677|FG002|Overall Study|Death|0|||
161019846|NCT03158129|581461678|FG003|Overall Study|Death|1|||
161019847|NCT03158129|581461675|FG000|Overall Study|High surgical risk|1|||
161019848|NCT03158129|581461676|FG001|Overall Study|High surgical risk|1|||
161019849|NCT03158129|581461677|FG002|Overall Study|High surgical risk|0|||
161019850|NCT03158129|581461678|FG003|Overall Study|High surgical risk|0|||
161019851|NCT03158129|581461675|FG000|Overall Study|Progression|1|||
161019852|NCT03158129|581461676|FG001|Overall Study|Progression|1|||
161019853|NCT03158129|581461677|FG002|Overall Study|Progression|0|||
161019854|NCT03158129|581461678|FG003|Overall Study|Progression|0|||
161019855|NCT03158129|581461675|FG000|Overall Study|Lack of resectability|0|||
161019856|NCT03158129|581461676|FG001|Overall Study|Lack of resectability|1|||
161019857|NCT03158129|581461677|FG002|Overall Study|Lack of resectability|0|||
161019858|NCT03158129|581461678|FG003|Overall Study|Lack of resectability|0|||
161019859|NCT03158129|581461675|FG000|Overall Study|Declined surgery|0|||
161019860|NCT03158129|581461676|FG001|Overall Study|Declined surgery|1|||
161019861|NCT03158129|581461677|FG002|Overall Study|Declined surgery|0|||
161019862|NCT03158129|581461678|FG003|Overall Study|Declined surgery|0|||
161019863|NCT03158129|581461675|FG000|Overall Study|No longer surgical candidate|0|||
161019864|NCT03158129|581461676|FG001|Overall Study|No longer surgical candidate|0|||
161019865|NCT03158129|581461677|FG002|Overall Study|No longer surgical candidate|0|||
161019866|NCT03158129|581461678|FG003|Overall Study|No longer surgical candidate|1|||
161019867|NCT02105766|581461683|FG000|Overall Study|Physician Decision|1|||
161019868|NCT02105766|581461684|FG001|Overall Study|Physician Decision|1|||
161019869|NCT02105766|581461685|FG002|Overall Study|Physician Decision|0|||
161019870|NCT02105766|581461683|FG000|Overall Study|Lost to Follow-up|2|||
161019871|NCT02105766|581461684|FG001|Overall Study|Lost to Follow-up|0|||
161019872|NCT02105766|581461685|FG002|Overall Study|Lost to Follow-up|0|||
161019873|NCT02105766|581461683|FG000|Overall Study|Death|1|||
161019874|NCT02105766|581461684|FG001|Overall Study|Death|1|||
161019875|NCT02105766|581461685|FG002|Overall Study|Death|0|||
161019876|NCT06205407|581461686|FG000|Period 2|Withdrawal by Subject|0|||
161019877|NCT06205407|581461687|FG001|Period 2|Withdrawal by Subject|1|||
161019878|NCT06205407|581461686|FG000|Period 2|Adverse Event|2|||
161019879|NCT06205407|581461687|FG001|Period 2|Adverse Event|1|||
161019880|NCT06491433|581461688|FG000|Overall Study|Protocol Violation|51|||
161019881|NCT06491433|581461688|FG000|Overall Study|consent withdrawal|2|||
161019882|NCT06491433|581461688|FG000|Overall Study|screen failure|1|||
161019883|NCT04676022|581461692|FG000|Overall Study|Screen Failure/|1|||
161019884|NCT04676022|581461693|FG001|Overall Study|Screen Failure/|1|||
161019885|NCT04676022|581461694|FG002|Overall Study|Screen Failure/|85|||
161019886|NCT04676022|581461692|FG000|Overall Study|Lost to Follow-up|1|||
161019887|NCT04676022|581461693|FG001|Overall Study|Lost to Follow-up|1|||
161019888|NCT04676022|581461694|FG002|Overall Study|Lost to Follow-up|0|||
161019889|NCT04676022|581461692|FG000|Overall Study|Adverse Event|2|||
161019890|NCT04676022|581461693|FG001|Overall Study|Adverse Event|0|||
161019891|NCT04676022|581461694|FG002|Overall Study|Adverse Event|1|||
161019892|NCT04676022|581461692|FG000|Overall Study|Physician Decision|2|||
161019893|NCT04676022|581461693|FG001|Overall Study|Physician Decision|0|||
161019894|NCT04676022|581461694|FG002|Overall Study|Physician Decision|1|||
161019895|NCT04676022|581461692|FG000|Overall Study|Withdrawal by Subject|3|||
161019896|NCT04676022|581461693|FG001|Overall Study|Withdrawal by Subject|1|||
161019897|NCT04676022|581461694|FG002|Overall Study|Withdrawal by Subject|6|||
161019898|NCT04676022|581461692|FG000|Overall Study|Will not move forward with permanent implant|6|||
161019899|NCT04676022|581461693|FG001|Overall Study|Will not move forward with permanent implant|0|||
161019900|NCT04676022|581461694|FG002|Overall Study|Will not move forward with permanent implant|0|||
161019901|NCT04676022|581461692|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
161019902|NCT04676022|581461693|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
161019903|NCT04676022|581461694|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
161019904|NCT05409183|581461709|FG000|Complete Study|Adverse Event|1|||
161019905|NCT05409183|581461710|FG001|Complete Study|Adverse Event|2|||
161019906|NCT05409183|581461709|FG000|Complete Study|Withdrawal by Subject|3|||
161019907|NCT05409183|581461710|FG001|Complete Study|Withdrawal by Subject|0|||
161019908|NCT02274662|581461711|FG000|Overall Study|Death|1|||
161019909|NCT02274662|581461711|FG000|Overall Study|Lost to Follow-up|3|||
161019910|NCT04806451|581461712|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
161019911|NCT04806451|581461713|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
161019912|NCT04806451|581461712|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
161019913|NCT04806451|581461713|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
161019914|NCT04806451|581461712|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
161019915|NCT04806451|581461713|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
161019916|NCT02936752|581461714|FG000|Overall Study|Death|2|||
161019917|NCT02936752|581461715|FG001|Overall Study|Death|1|||
161019918|NCT02936752|581461714|FG000|Overall Study|Physician Decision|4|||
161019919|NCT02936752|581461715|FG001|Overall Study|Physician Decision|0|||
161019920|NCT02936752|581461714|FG000|Overall Study|Withdrawal by Subject|0|||
161019921|NCT02936752|581461715|FG001|Overall Study|Withdrawal by Subject|2|||
161019922|NCT05292365|581461720|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
161019923|NCT05292365|581461721|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
161019924|NCT05292365|581461722|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
161019925|NCT05292365|581461723|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
161019926|NCT05282173|581461724|FG000|Overall Study|Missed|3|||
161019927|NCT05282173|581461725|FG001|Overall Study|Missed|2|||
161019928|NCT05282173|581461726|FG002|Overall Study|Missed|4|||
161019929|NCT03134196|581461731|FG000|Overall Study|Death|2|||
161019930|NCT03134196|581461732|FG001|Overall Study|Death|1|||
161019931|NCT03134196|581461731|FG000|Overall Study|Lost to Follow-up|13|||
161019932|NCT03134196|581461732|FG001|Overall Study|Lost to Follow-up|15|||
161019933|NCT03134196|581461731|FG000|Overall Study|Physician Decision|0|||
161019934|NCT03134196|581461732|FG001|Overall Study|Physician Decision|1|||
161019935|NCT03134196|581461731|FG000|Overall Study|Withdrawal by Subject|19|||
161019936|NCT03134196|581461732|FG001|Overall Study|Withdrawal by Subject|12|||
161019937|NCT03134196|581461731|FG000|Overall Study|Site Unable to Contact Participant|2|||
161019938|NCT03134196|581461732|FG001|Overall Study|Site Unable to Contact Participant|0|||
161019939|NCT03134196|581461731|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
161019940|NCT03134196|581461732|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
161019941|NCT03134196|581461731|FG000|Overall Study|Scheduling Conflict|1|||
161019942|NCT03134196|581461732|FG001|Overall Study|Scheduling Conflict|0|||
161019943|NCT01798498|581461745|FG000|Overall Study|Lost to Follow-up|1|||
161019944|NCT04592549|581461750|FG000|Overall Study|Withdrawal by Subject|0|||
161019945|NCT04592549|581461751|FG001|Overall Study|Withdrawal by Subject|1|||
161019946|NCT04592549|581461752|FG002|Overall Study|Withdrawal by Subject|0|||
161019947|NCT04592549|581461753|FG003|Overall Study|Withdrawal by Subject|1|||
161019948|NCT04592549|581461754|FG004|Overall Study|Withdrawal by Subject|1|||
161019949|NCT04592549|581461755|FG005|Overall Study|Withdrawal by Subject|0|||
161019950|NCT04592549|581461750|FG000|Overall Study|Lost to Follow-up|2|||
161019951|NCT04592549|581461751|FG001|Overall Study|Lost to Follow-up|0|||
161019952|NCT04592549|581461752|FG002|Overall Study|Lost to Follow-up|0|||
161019953|NCT04592549|581461753|FG003|Overall Study|Lost to Follow-up|1|||
161019954|NCT04592549|581461754|FG004|Overall Study|Lost to Follow-up|1|||
161019955|NCT04592549|581461755|FG005|Overall Study|Lost to Follow-up|1|||
161019956|NCT04295798|581461758|FG000|Overall Study|Lost to Follow-up|1|||
161019957|NCT04625283|581461762|FG000|Overall Study|post randomization exclusion|28|||
161019958|NCT04625283|581461763|FG001|Overall Study|post randomization exclusion|20|||
161019959|NCT04137289|581461766|FG000|Overall Study|Death|0|||
161019960|NCT04137289|581461767|FG001|Overall Study|Death|0|||
161019961|NCT04137289|581461768|FG002|Overall Study|Death|0|||
161019962|NCT04137289|581461769|FG003|Overall Study|Death|0|||
161019963|NCT04137289|581461770|FG004|Overall Study|Death|0|||
161019964|NCT04137289|581461771|FG005|Overall Study|Death|0|||
161019965|NCT04137289|581461772|FG006|Overall Study|Death|1|||
161019966|NCT04137289|581461773|FG007|Overall Study|Death|0|||
161019967|NCT04137289|581461774|FG008|Overall Study|Death|0|||
161019968|NCT04137289|581461766|FG000|Overall Study|Clinical disease progression|0|||
161019969|NCT04137289|581461767|FG001|Overall Study|Clinical disease progression|0|||
161019970|NCT04137289|581461768|FG002|Overall Study|Clinical disease progression|0|||
161019971|NCT04137289|581461769|FG003|Overall Study|Clinical disease progression|4|||
161019972|NCT04137289|581461770|FG004|Overall Study|Clinical disease progression|4|||
161019973|NCT04137289|581461771|FG005|Overall Study|Clinical disease progression|2|||
161019974|NCT04137289|581461772|FG006|Overall Study|Clinical disease progression|5|||
161019975|NCT04137289|581461773|FG007|Overall Study|Clinical disease progression|1|||
161019976|NCT04137289|581461774|FG008|Overall Study|Clinical disease progression|0|||
161019977|NCT04137289|581461766|FG000|Overall Study|Lost to Follow-up|0|||
161019978|NCT04137289|581461767|FG001|Overall Study|Lost to Follow-up|0|||
161019979|NCT04137289|581461768|FG002|Overall Study|Lost to Follow-up|0|||
161019980|NCT04137289|581461769|FG003|Overall Study|Lost to Follow-up|1|||
161019981|NCT04137289|581461770|FG004|Overall Study|Lost to Follow-up|0|||
161019982|NCT04137289|581461771|FG005|Overall Study|Lost to Follow-up|0|||
161019983|NCT04137289|581461772|FG006|Overall Study|Lost to Follow-up|0|||
161019984|NCT04137289|581461773|FG007|Overall Study|Lost to Follow-up|0|||
161019985|NCT04137289|581461774|FG008|Overall Study|Lost to Follow-up|0|||
161019986|NCT04137289|581461766|FG000|Overall Study|Adverse Event|0|||
161019987|NCT04137289|581461767|FG001|Overall Study|Adverse Event|0|||
161019988|NCT04137289|581461768|FG002|Overall Study|Adverse Event|1|||
161019989|NCT04137289|581461769|FG003|Overall Study|Adverse Event|0|||
161019990|NCT04137289|581461770|FG004|Overall Study|Adverse Event|0|||
160587162|NCT02065622|579867707|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
160587163|NCT02065622|579867708|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
160587164|NCT02065622|579867709|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
160587165|NCT02065622|579867705|FG000|Induction Study|Subject Noncompliance|1|||
160587166|NCT02065622|579867706|FG001|Induction Study|Subject Noncompliance|1|||
161019991|NCT04137289|581461771|FG005|Overall Study|Adverse Event|1|||
161019992|NCT04137289|581461772|FG006|Overall Study|Adverse Event|0|||
161019993|NCT04137289|581461773|FG007|Overall Study|Adverse Event|0|||
161019994|NCT04137289|581461774|FG008|Overall Study|Adverse Event|0|||
161019995|NCT04137289|581461766|FG000|Overall Study|Lack of clinical benefit|0|||
161019996|NCT04137289|581461767|FG001|Overall Study|Lack of clinical benefit|0|||
161019997|NCT04137289|581461768|FG002|Overall Study|Lack of clinical benefit|0|||
161019998|NCT04137289|581461769|FG003|Overall Study|Lack of clinical benefit|0|||
161019999|NCT04137289|581461770|FG004|Overall Study|Lack of clinical benefit|0|||
161020000|NCT04137289|581461771|FG005|Overall Study|Lack of clinical benefit|0|||
161020001|NCT04137289|581461772|FG006|Overall Study|Lack of clinical benefit|0|||
161020002|NCT04137289|581461773|FG007|Overall Study|Lack of clinical benefit|0|||
161020003|NCT04137289|581461774|FG008|Overall Study|Lack of clinical benefit|1|||
161020004|NCT04137289|581461766|FG000|Overall Study|Objective disease progression|1|||
161020005|NCT04137289|581461767|FG001|Overall Study|Objective disease progression|1|||
161020006|NCT04137289|581461768|FG002|Overall Study|Objective disease progression|6|||
161020007|NCT04137289|581461769|FG003|Overall Study|Objective disease progression|18|||
161020008|NCT04137289|581461770|FG004|Overall Study|Objective disease progression|12|||
161020009|NCT04137289|581461771|FG005|Overall Study|Objective disease progression|20|||
161020010|NCT04137289|581461772|FG006|Overall Study|Objective disease progression|18|||
161020011|NCT04137289|581461773|FG007|Overall Study|Objective disease progression|7|||
161020012|NCT04137289|581461774|FG008|Overall Study|Objective disease progression|6|||
161020013|NCT03396588|581461775|FG000|Overall Study|Physician Decision|2|||
161020014|NCT03396588|581461776|FG001|Overall Study|Physician Decision|3|||
161020015|NCT02727699|581463376|FG000|Overall Study|Adverse Event|2|||
161020016|NCT02727699|581463377|FG001|Overall Study|Adverse Event|0|||
161020017|NCT02727699|581463376|FG000|Overall Study|Withdrawal by Subject|5|||
161020018|NCT02727699|581463377|FG001|Overall Study|Withdrawal by Subject|3|||
161020019|NCT02727699|581463376|FG000|Overall Study|Protocol Violation|0|||
161020020|NCT02727699|581463377|FG001|Overall Study|Protocol Violation|1|||
161020021|NCT02727699|581463376|FG000|Overall Study|Physician Decision|0|||
161020022|NCT02727699|581463377|FG001|Overall Study|Physician Decision|1|||
161020023|NCT02727699|581463376|FG000|Overall Study|Lost to Follow-up|1|||
161020024|NCT02727699|581463377|FG001|Overall Study|Lost to Follow-up|0|||
161020025|NCT02727699|581463376|FG000|Overall Study|Sponsor Decision|1|||
161020026|NCT02727699|581463377|FG001|Overall Study|Sponsor Decision|0|||
161020027|NCT04318548|581463386|FG000|Overall Study|Adverse Event|0|||
161020028|NCT04318548|581463387|FG001|Overall Study|Adverse Event|0|||
161020029|NCT04318548|581463388|FG002|Overall Study|Adverse Event|1|||
161020030|NCT04318548|581463386|FG000|Overall Study|Lost to Follow-up|6|||
161020031|NCT04318548|581463387|FG001|Overall Study|Lost to Follow-up|13|||
161020032|NCT04318548|581463388|FG002|Overall Study|Lost to Follow-up|9|||
161020033|NCT04318548|581463386|FG000|Overall Study|Protocol Violation|1|||
161020034|NCT04318548|581463387|FG001|Overall Study|Protocol Violation|0|||
161020035|NCT04318548|581463388|FG002|Overall Study|Protocol Violation|2|||
161020036|NCT04318548|581463386|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
161020037|NCT04318548|581463387|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
161020038|NCT04318548|581463388|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
161020039|NCT04318548|581463386|FG000|Overall Study|Migrated / moved from the study area|0|||
161020040|NCT04318548|581463387|FG001|Overall Study|Migrated / moved from the study area|0|||
161020041|NCT04318548|581463388|FG002|Overall Study|Migrated / moved from the study area|1|||
161020042|NCT04318548|581463386|FG000|Overall Study|Other|1|||
161020043|NCT04318548|581463387|FG001|Overall Study|Other|2|||
161020044|NCT04318548|581463388|FG002|Overall Study|Other|3|||
161020045|NCT03366649|581463389|FG000|Overall Study|Failed preoperative screening|4|||
161020046|NCT03366649|581463390|FG001|Overall Study|Failed preoperative screening|0|||
161020047|NCT03366649|581463391|FG002|Overall Study|Failed preoperative screening|0|||
161020048|NCT03366649|581463389|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
161020049|NCT03366649|581463390|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
161020050|NCT03366649|581463391|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
161020051|NCT04029688|581463401|FG000|Overall Study|Death|8|||
161020052|NCT04029688|581463402|FG001|Overall Study|Death|3|||
161020053|NCT04029688|581463403|FG002|Overall Study|Death|6|||
161020054|NCT04029688|581463404|FG003|Overall Study|Death|2|||
161020055|NCT04029688|581463405|FG004|Overall Study|Death|5|||
161020056|NCT04029688|581463406|FG005|Overall Study|Death|0|||
161020057|NCT04029688|581463407|FG006|Overall Study|Death|2|||
161020058|NCT04029688|581463408|FG007|Overall Study|Death|3|||
161020059|NCT04029688|581463401|FG000|Overall Study|Study Terminated by Sponsor|0|||
161020060|NCT04029688|581463402|FG001|Overall Study|Study Terminated by Sponsor|0|||
161020061|NCT04029688|581463403|FG002|Overall Study|Study Terminated by Sponsor|0|||
161020062|NCT04029688|581463404|FG003|Overall Study|Study Terminated by Sponsor|0|||
161020063|NCT04029688|581463405|FG004|Overall Study|Study Terminated by Sponsor|1|||
161020064|NCT04029688|581463406|FG005|Overall Study|Study Terminated by Sponsor|3|||
161020065|NCT04029688|581463407|FG006|Overall Study|Study Terminated by Sponsor|1|||
161020066|NCT04029688|581463408|FG007|Overall Study|Study Terminated by Sponsor|3|||
161020067|NCT04029688|581463401|FG000|Overall Study|Withdrawal by Subject|0|||
161020068|NCT04029688|581463402|FG001|Overall Study|Withdrawal by Subject|0|||
161020069|NCT04029688|581463403|FG002|Overall Study|Withdrawal by Subject|0|||
161020070|NCT04029688|581463404|FG003|Overall Study|Withdrawal by Subject|1|||
161020071|NCT04029688|581463405|FG004|Overall Study|Withdrawal by Subject|0|||
161020072|NCT04029688|581463406|FG005|Overall Study|Withdrawal by Subject|0|||
161020073|NCT04029688|581463407|FG006|Overall Study|Withdrawal by Subject|0|||
161020074|NCT04029688|581463408|FG007|Overall Study|Withdrawal by Subject|0|||
161020075|NCT03436290|581463409|FG000|Overall Study|Post-randomization Exclusion|1|||
161020076|NCT03436290|581463410|FG001|Overall Study|Post-randomization Exclusion|0|||
161020077|NCT03436290|581463409|FG000|Overall Study|Death|6|||
161020078|NCT03436290|581463410|FG001|Overall Study|Death|0|||
160969296|NCT01576718|581275202|FG006|Treatment Period|Adverse Event|0|||
160969297|NCT01576718|581275196|FG000|Treatment Period|Withdrawal by Subject|0|||
160969298|NCT01576718|581275197|FG001|Treatment Period|Withdrawal by Subject|1|||
160969299|NCT01576718|581275198|FG002|Treatment Period|Withdrawal by Subject|1|||
160969300|NCT01576718|581275199|FG003|Treatment Period|Withdrawal by Subject|0|||
160969301|NCT01576718|581275200|FG004|Treatment Period|Withdrawal by Subject|2|||
160969302|NCT01576718|581275201|FG005|Treatment Period|Withdrawal by Subject|4|||
160969303|NCT01576718|581275202|FG006|Treatment Period|Withdrawal by Subject|2|||
160969304|NCT01576718|581275196|FG000|Treatment Period|Physician Decision|0|||
160969305|NCT01576718|581275197|FG001|Treatment Period|Physician Decision|1|||
160969306|NCT01576718|581275198|FG002|Treatment Period|Physician Decision|1|||
160969307|NCT01576718|581275199|FG003|Treatment Period|Physician Decision|1|||
160969308|NCT01576718|581275200|FG004|Treatment Period|Physician Decision|1|||
160969309|NCT01576718|581275201|FG005|Treatment Period|Physician Decision|0|||
160969310|NCT01576718|581275202|FG006|Treatment Period|Physician Decision|0|||
160969311|NCT01576718|581275196|FG000|Treatment Period|Protocol Violation|0|||
160969312|NCT01576718|581275197|FG001|Treatment Period|Protocol Violation|5|||
160969313|NCT01576718|581275198|FG002|Treatment Period|Protocol Violation|4|||
160969314|NCT01576718|581275199|FG003|Treatment Period|Protocol Violation|10|||
160969315|NCT01576718|581275200|FG004|Treatment Period|Protocol Violation|6|||
160969316|NCT01576718|581275201|FG005|Treatment Period|Protocol Violation|8|||
160969317|NCT01576718|581275202|FG006|Treatment Period|Protocol Violation|12|||
160969318|NCT01576718|581275196|FG000|Treatment Period|Sponsor request|0|||
160969319|NCT01576718|581275197|FG001|Treatment Period|Sponsor request|1|||
160969320|NCT01576718|581275198|FG002|Treatment Period|Sponsor request|0|||
160969321|NCT01576718|581275199|FG003|Treatment Period|Sponsor request|0|||
160969322|NCT01576718|581275200|FG004|Treatment Period|Sponsor request|0|||
160969323|NCT01576718|581275201|FG005|Treatment Period|Sponsor request|1|||
160969324|NCT01576718|581275202|FG006|Treatment Period|Sponsor request|0|||
160969325|NCT01576718|581275196|FG000|Treatment Period|Met stopping criteria|0|||
160969326|NCT01576718|581275197|FG001|Treatment Period|Met stopping criteria|16|||
160969327|NCT01576718|581275198|FG002|Treatment Period|Met stopping criteria|13|||
160969328|NCT01576718|581275199|FG003|Treatment Period|Met stopping criteria|19|||
160969329|NCT01576718|581275200|FG004|Treatment Period|Met stopping criteria|16|||
160969330|NCT01576718|581275201|FG005|Treatment Period|Met stopping criteria|33|||
160969331|NCT01576718|581275202|FG006|Treatment Period|Met stopping criteria|15|||
160969332|NCT01576718|581275196|FG000|Treatment Period|Lost to Follow-up|0|||
160969333|NCT01576718|581275197|FG001|Treatment Period|Lost to Follow-up|0|||
160969334|NCT01576718|581275198|FG002|Treatment Period|Lost to Follow-up|0|||
160969335|NCT01576718|581275199|FG003|Treatment Period|Lost to Follow-up|0|||
160969336|NCT01576718|581275200|FG004|Treatment Period|Lost to Follow-up|1|||
160969337|NCT01576718|581275201|FG005|Treatment Period|Lost to Follow-up|0|||
160969338|NCT01576718|581275202|FG006|Treatment Period|Lost to Follow-up|0|||
160969339|NCT01576718|581275196|FG000|Treatment Period|Noncompliance to study medication|0|||
160969340|NCT01576718|581275197|FG001|Treatment Period|Noncompliance to study medication|0|||
160969341|NCT01576718|581275198|FG002|Treatment Period|Noncompliance to study medication|0|||
160969342|NCT01576718|581275199|FG003|Treatment Period|Noncompliance to study medication|0|||
160969343|NCT01576718|581275200|FG004|Treatment Period|Noncompliance to study medication|0|||
160969344|NCT01576718|581275201|FG005|Treatment Period|Noncompliance to study medication|1|||
160969345|NCT01576718|581275202|FG006|Treatment Period|Noncompliance to study medication|1|||
160969346|NCT02070484|581275203|FG000|Overall Study|Withdrawal by Subject|1|||
160969347|NCT02070484|581275204|FG001|Overall Study|Withdrawal by Subject|0|||
160969348|NCT02821819|581275209|FG000|Overall Study|Protocol Violation|1|||
160969349|NCT01669798|581275210|FG000|Overall Study|Physician Decision|5|||
160969350|NCT02272725|581275218|FG000|Overall Study|equipment malfunction|2|||
160969351|NCT02272725|581275219|FG001|Overall Study|equipment malfunction|0|||
160969352|NCT02764775|581276761|FG000|Overall Study|Death|1|||
160969353|NCT02764775|581276761|FG000|Overall Study|Lost to Follow-up|2|||
160969354|NCT02764775|581276761|FG000|Overall Study|Withdrawal by Subject|3|||
160969355|NCT05056870|581276762|FG000|Period 1|Site COVID-19 Related|3|||
160969356|NCT05056870|581276763|FG001|Period 1|Site COVID-19 Related|3|||
160969357|NCT05056870|581276762|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160969358|NCT05056870|581276763|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
160969359|NCT05056870|581276762|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
160969360|NCT05056870|581276763|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160969361|NCT05056870|581276762|FG000|Period 2|COVID-19 Related|1|||
160969362|NCT05056870|581276763|FG001|Period 2|COVID-19 Related|0|||
160969363|NCT05056870|581276762|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
160969364|NCT05056870|581276763|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
160969365|NCT05044325|581276766|FG000|Part A:Treatment Period 1|Adverse Event|0|||
160969366|NCT05044325|581276767|FG001|Part A:Treatment Period 1|Adverse Event|0|||
160969367|NCT05044325|581276768|FG002|Part A:Treatment Period 1|Adverse Event|0|||
160969368|NCT05044325|581276769|FG003|Part A:Treatment Period 1|Adverse Event|0|||
160969369|NCT05044325|581276770|FG004|Part A:Treatment Period 1|Adverse Event|0|||
161020079|NCT03436290|581463409|FG000|Overall Study|Withdrawal by Subject|4|||
161020080|NCT03436290|581463410|FG001|Overall Study|Withdrawal by Subject|0|||
161020081|NCT03436290|581463409|FG000|Overall Study|Protocol Violation|30|||
161020082|NCT03436290|581463410|FG001|Overall Study|Protocol Violation|0|||
161020083|NCT03812679|581463432|FG000|Overall Study|Adverse Event|2|||
161020084|NCT03812679|581463432|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
161020085|NCT03812679|581463432|FG000|Overall Study|Renal transplant|1|||
161020086|NCT03812679|581463432|FG000|Overall Study|Withdrawal by Subject|1|||
161020087|NCT03812679|581463432|FG000|Overall Study|Termination of study|2|||
161020088|NCT03812679|581463432|FG000|Overall Study|Water device replacement|1|||
161020089|NCT02140554|581463444|FG000|Overall Study|Withdrawal of consent|1|||
161020090|NCT02140554|581463445|FG001|Overall Study|Withdrawal of consent|0|||
161020091|NCT02140554|581463446|FG002|Overall Study|Withdrawal of consent|4|||
161020092|NCT02140554|581463444|FG000|Overall Study|Physician Decision|1|||
161020093|NCT02140554|581463445|FG001|Overall Study|Physician Decision|0|||
161020094|NCT02140554|581463446|FG002|Overall Study|Physician Decision|2|||
161020095|NCT02140554|581463444|FG000|Overall Study|Death|0|||
161020096|NCT02140554|581463445|FG001|Overall Study|Death|0|||
161020097|NCT02140554|581463446|FG002|Overall Study|Death|1|||
161020098|NCT02140554|581463444|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
161020099|NCT02140554|581463445|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
161020100|NCT02140554|581463446|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
161020101|NCT03953508|581463448|FG000|Baseline|Lost to Follow-up|3|||
161020102|NCT03953508|581463449|FG001|Baseline|Lost to Follow-up|2|||
161020103|NCT03953508|581463448|FG000|6-month Follow-up|Lost to Follow-up|62|||
161020104|NCT03953508|581463449|FG001|6-month Follow-up|Lost to Follow-up|70|||
161020105|NCT03771417|581463450|FG000|Overall Study|Withdrawal by Subject|1|||
161020106|NCT03771417|581463451|FG001|Overall Study|Withdrawal by Subject|0|||
161020107|NCT03771417|581463452|FG002|Overall Study|Withdrawal by Subject|0|||
161020108|NCT03771417|581463450|FG000|Overall Study|Covid-19 Shutdown|0|||
161020109|NCT03771417|581463451|FG001|Overall Study|Covid-19 Shutdown|1|||
161020110|NCT03771417|581463452|FG002|Overall Study|Covid-19 Shutdown|0|||
161020111|NCT04456517|581463453|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
161020112|NCT04456517|581463454|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
161020113|NCT02100813|581463455|FG000|Overall Study|Adverse Event|0|||
161020114|NCT02100813|581463456|FG001|Overall Study|Adverse Event|0|||
160459828|NCT03250676|579416586|FG004|Overall Study|Withdrawal by Subject|1|||
160459829|NCT03250676|579416587|FG005|Overall Study|Withdrawal by Subject|2|||
160459830|NCT03250676|579416582|FG000|Overall Study|Physician Decision|0|||
160459831|NCT03250676|579416583|FG001|Overall Study|Physician Decision|0|||
160459832|NCT03250676|579416584|FG002|Overall Study|Physician Decision|0|||
160459833|NCT03250676|579416585|FG003|Overall Study|Physician Decision|2|||
160459834|NCT03250676|579416586|FG004|Overall Study|Physician Decision|0|||
160459835|NCT03250676|579416587|FG005|Overall Study|Physician Decision|3|||
160587167|NCT02065622|579867707|FG002|Induction Study|Subject Noncompliance|0|||
160587168|NCT02065622|579867708|FG003|Induction Study|Subject Noncompliance|0|||
160587169|NCT02065622|579867709|FG004|Induction Study|Subject Noncompliance|0|||
160587170|NCT02065622|579867705|FG000|Induction Study|Other, Not Specified|3|||
160587171|NCT02065622|579867706|FG001|Induction Study|Other, Not Specified|2|||
160587172|NCT02065622|579867707|FG002|Induction Study|Other, Not Specified|0|||
160587173|NCT02065622|579867708|FG003|Induction Study|Other, Not Specified|0|||
160587174|NCT02065622|579867709|FG004|Induction Study|Other, Not Specified|0|||
160587175|NCT02065622|579867705|FG000|Maintenance Study|Adverse Event|0|||
160587176|NCT02065622|579867706|FG001|Maintenance Study|Adverse Event|0|||
160587177|NCT02065622|579867707|FG002|Maintenance Study|Adverse Event|25|||
160587178|NCT02065622|579867708|FG003|Maintenance Study|Adverse Event|22|||
161020115|NCT02100813|581463457|FG002|Overall Study|Adverse Event|0|||
161020116|NCT02100813|581463458|FG003|Overall Study|Adverse Event|0|||
161020117|NCT02100813|581463459|FG004|Overall Study|Adverse Event|0|||
161020118|NCT02100813|581463460|FG005|Overall Study|Adverse Event|0|||
161020119|NCT02100813|581463461|FG006|Overall Study|Adverse Event|0|||
161020120|NCT02100813|581463462|FG007|Overall Study|Adverse Event|1|||
161020121|NCT01186367|581463463|FG000|Overall Study|Lost to Follow-up|7|||
161020122|NCT01186367|581463464|FG001|Overall Study|Lost to Follow-up|4|||
160459836|NCT03250676|579416582|FG000|Overall Study|Withdrawal of consent|0|||
160459837|NCT03250676|579416583|FG001|Overall Study|Withdrawal of consent|0|||
160587179|NCT02065622|579867709|FG004|Maintenance Study|Adverse Event|11|||
160587180|NCT02065622|579867705|FG000|Maintenance Study|Withdrawal by Subject|0|||
160587181|NCT02065622|579867706|FG001|Maintenance Study|Withdrawal by Subject|0|||
160587182|NCT02065622|579867707|FG002|Maintenance Study|Withdrawal by Subject|11|||
161020123|NCT01186367|581463465|FG002|Overall Study|Lost to Follow-up|7|||
161020124|NCT01186367|581463463|FG000|Overall Study|Did not receive study treatment|0|||
161020125|NCT01186367|581463464|FG001|Overall Study|Did not receive study treatment|1|||
161020126|NCT01186367|581463465|FG002|Overall Study|Did not receive study treatment|0|||
161020127|NCT03867500|581463467|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
161020128|NCT04749615|581463468|FG000|Overall Study|Lost to Follow-up|6|||
161020129|NCT04749615|581463469|FG001|Overall Study|Lost to Follow-up|10|||
161020130|NCT03611491|581463470|FG000|Overall Study|Lost to Follow-up|1|||
161020131|NCT05894577|581463471|FG000|Overall Study|No receipt of study drug|14|||
161020132|NCT05894577|581463472|FG001|Overall Study|No receipt of study drug|13|||
161020133|NCT05894577|581463471|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
161020134|NCT05894577|581463472|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
161020135|NCT05894577|581463471|FG000|Overall Study|Screen Fail|2|||
161020136|NCT05894577|581463472|FG001|Overall Study|Screen Fail|0|||
161020137|NCT05894577|581463471|FG000|Overall Study|Study drug recall|86|||
161020138|NCT05894577|581463472|FG001|Overall Study|Study drug recall|63|||
161020139|NCT04064164|581463475|FG000|Overall Study|Withdrawal by Subject|8|||
161020140|NCT04064164|581463476|FG001|Overall Study|Withdrawal by Subject|8|||
161020141|NCT04650269|581463484|FG000|Overall Study|Death|3|||
161020142|NCT04650269|581463484|FG000|Overall Study|Lost to Follow-up|6|||
161020143|NCT04091750|581463485|FG000|Overall Study|Adverse Event|4|||
161020144|NCT04091750|581463485|FG000|Overall Study|Withdrawal by Subject|1|||
161020145|NCT02619838|581463486|FG000|Overall Study|Lost to Follow-up|9|||
161020146|NCT02619838|581463486|FG000|Overall Study|Withdrawal by Subject|15|||
161020147|NCT05020249|581463487|FG000|Overall Study|Protocol Violation|1|||
161020148|NCT05020249|581463488|FG001|Overall Study|Protocol Violation|0|||
161020149|NCT04971681|581463499|FG000|Followup|Lost to Follow-up|1|||
161020150|NCT04971681|581463500|FG001|Followup|Lost to Follow-up|0|||
161020151|NCT00686335|581463501|FG000|Run-in Period|Adverse Event|1|||
161020152|NCT00686335|581463501|FG000|Run-in Period|asthma exacerbation|1|||
161020153|NCT00686335|581463501|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
161020154|NCT04376502|581463502|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
161020155|NCT05603143|581463503|FG000|Overall Study|Withdrew consent|6|||
161020156|NCT05603143|581463504|FG001|Overall Study|Withdrew consent|2|||
161020157|NCT05603143|581463503|FG000|Overall Study|Randomized but never treated|0|||
161020158|NCT05603143|581463504|FG001|Overall Study|Randomized but never treated|3|||
161020159|NCT05603143|581463503|FG000|Overall Study|Adverse Event|2|||
161020160|NCT05603143|581463504|FG001|Overall Study|Adverse Event|0|||
161020161|NCT05603143|581463503|FG000|Overall Study|Death|0|||
161020162|NCT05603143|581463504|FG001|Overall Study|Death|1|||
161020163|NCT05603143|581463503|FG000|Overall Study|Investigator's discretion|1|||
161020164|NCT05603143|581463504|FG001|Overall Study|Investigator's discretion|0|||
161020165|NCT05603143|581463503|FG000|Overall Study|Lost to Follow-up|0|||
161020166|NCT05603143|581463504|FG001|Overall Study|Lost to Follow-up|1|||
161020167|NCT05603143|581463503|FG000|Overall Study|Protocol Violation|0|||
161020168|NCT05603143|581463504|FG001|Overall Study|Protocol Violation|1|||
161020169|NCT04171999|581463505|FG000|Overall Study|deemed ineligible after randomization|2|||
160969370|NCT05044325|581276771|FG005|Part A:Treatment Period 1|Adverse Event|1|||
160969371|NCT05044325|581276772|FG006|Part A:Treatment Period 1|Adverse Event|0|||
160969372|NCT05044325|581276773|FG007|Part A:Treatment Period 1|Adverse Event|1|||
160969373|NCT05044325|581276774|FG008|Part A:Treatment Period 1|Adverse Event|0|||
160969374|NCT05044325|581276775|FG009|Part A:Treatment Period 1|Adverse Event|0|||
160969375|NCT05044325|581276766|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969376|NCT05044325|581276767|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969377|NCT05044325|581276768|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969378|NCT05044325|581276769|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
160969379|NCT05044325|581276770|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
160969380|NCT05044325|581276771|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
160969381|NCT05044325|581276772|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969382|NCT05044325|581276773|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969383|NCT05044325|581276774|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969384|NCT05044325|581276775|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969385|NCT05044325|581276766|FG000|Part A:Treatment Period 1|Physician Decision|0|||
160969386|NCT05044325|581276767|FG001|Part A:Treatment Period 1|Physician Decision|0|||
160969387|NCT05044325|581276768|FG002|Part A:Treatment Period 1|Physician Decision|0|||
160969388|NCT05044325|581276769|FG003|Part A:Treatment Period 1|Physician Decision|0|||
160969389|NCT05044325|581276770|FG004|Part A:Treatment Period 1|Physician Decision|0|||
160969390|NCT05044325|581276771|FG005|Part A:Treatment Period 1|Physician Decision|0|||
160969391|NCT05044325|581276772|FG006|Part A:Treatment Period 1|Physician Decision|1|||
160969392|NCT05044325|581276773|FG007|Part A:Treatment Period 1|Physician Decision|0|||
160969393|NCT05044325|581276774|FG008|Part A:Treatment Period 1|Physician Decision|0|||
160969394|NCT05044325|581276775|FG009|Part A:Treatment Period 1|Physician Decision|0|||
160969395|NCT05044325|581276766|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969396|NCT05044325|581276767|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969397|NCT05044325|581276768|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
160969398|NCT05044325|581276769|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969399|NCT05044325|581276770|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969400|NCT05044325|581276771|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969401|NCT05044325|581276772|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161020170|NCT04171999|581463506|FG001|Overall Study|deemed ineligible after randomization|1|||
160459838|NCT03250676|579416584|FG002|Overall Study|Withdrawal of consent|2|||
160459839|NCT03250676|579416585|FG003|Overall Study|Withdrawal of consent|0|||
160459840|NCT03250676|579416586|FG004|Overall Study|Withdrawal of consent|0|||
160459841|NCT03250676|579416587|FG005|Overall Study|Withdrawal of consent|2|||
160459842|NCT03250676|579416582|FG000|Overall Study|Other|1|||
160459843|NCT03250676|579416583|FG001|Overall Study|Other|0|||
160459844|NCT03250676|579416584|FG002|Overall Study|Other|0|||
160459845|NCT03250676|579416585|FG003|Overall Study|Other|0|||
160459846|NCT03250676|579416586|FG004|Overall Study|Other|0|||
160459847|NCT03250676|579416587|FG005|Overall Study|Other|0|||
160587183|NCT02065622|579867708|FG003|Maintenance Study|Withdrawal by Subject|5|||
160969402|NCT05044325|581276773|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969403|NCT05044325|581276774|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969404|NCT05044325|581276775|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969405|NCT05044325|581276766|FG000|Part A:Treatment Period 2|Adverse Event|0|||
160969406|NCT05044325|581276767|FG001|Part A:Treatment Period 2|Adverse Event|1|||
160969407|NCT05044325|581276768|FG002|Part A:Treatment Period 2|Adverse Event|0|||
160969408|NCT05044325|581276769|FG003|Part A:Treatment Period 2|Adverse Event|0|||
160969409|NCT05044325|581276770|FG004|Part A:Treatment Period 2|Adverse Event|1|||
160969410|NCT05044325|581276771|FG005|Part A:Treatment Period 2|Adverse Event|1|||
160969411|NCT05044325|581276772|FG006|Part A:Treatment Period 2|Adverse Event|0|||
160969412|NCT05044325|581276773|FG007|Part A:Treatment Period 2|Adverse Event|0|||
160969413|NCT05044325|581276774|FG008|Part A:Treatment Period 2|Adverse Event|0|||
160969414|NCT05044325|581276775|FG009|Part A:Treatment Period 2|Adverse Event|0|||
160969415|NCT05044325|581276766|FG000|Part A:Treatment Period 2|Physician Decision|0|||
160969416|NCT05044325|581276767|FG001|Part A:Treatment Period 2|Physician Decision|0|||
160969417|NCT05044325|581276768|FG002|Part A:Treatment Period 2|Physician Decision|0|||
160969418|NCT05044325|581276769|FG003|Part A:Treatment Period 2|Physician Decision|0|||
160969419|NCT05044325|581276770|FG004|Part A:Treatment Period 2|Physician Decision|0|||
160969420|NCT05044325|581276771|FG005|Part A:Treatment Period 2|Physician Decision|1|||
160969421|NCT05044325|581276772|FG006|Part A:Treatment Period 2|Physician Decision|0|||
160969422|NCT05044325|581276773|FG007|Part A:Treatment Period 2|Physician Decision|0|||
160969423|NCT05044325|581276774|FG008|Part A:Treatment Period 2|Physician Decision|0|||
160969424|NCT05044325|581276775|FG009|Part A:Treatment Period 2|Physician Decision|0|||
160969425|NCT05044325|581276766|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969426|NCT05044325|581276767|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969427|NCT05044325|581276768|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969428|NCT05044325|581276769|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
160969429|NCT05044325|581276770|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
160969430|NCT05044325|581276771|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969431|NCT05044325|581276772|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969432|NCT05044325|581276773|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969433|NCT05044325|581276774|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969434|NCT05044325|581276775|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969435|NCT01373931|581276778|FG000|Lead-in Period|Adverse Event|2|||
160969436|NCT01373931|581276779|FG001|Lead-in Period|Adverse Event|0|||
160969437|NCT01373931|581276778|FG000|Period 1|Adverse Event|2|||
160969438|NCT01373931|581276779|FG001|Period 1|Adverse Event|0|||
160969439|NCT01373931|581276778|FG000|Period 1|Withdrawal by Subject|0|||
160969440|NCT01373931|581276779|FG001|Period 1|Withdrawal by Subject|2|||
160969441|NCT00674323|581276780|FG000|Overall Study|Adverse Event|0|||
160969442|NCT00674323|581276781|FG001|Overall Study|Adverse Event|1|||
160969443|NCT00674323|581276782|FG002|Overall Study|Adverse Event|0|||
160969444|NCT00674323|581276780|FG000|Overall Study|Protocol Violation|1|||
160969445|NCT00674323|581276781|FG001|Overall Study|Protocol Violation|0|||
160969446|NCT00674323|581276782|FG002|Overall Study|Protocol Violation|0|||
160969447|NCT00742079|581276783|FG000|Overall Study|Lost to Follow-up|0|||
160969448|NCT00742079|581276784|FG001|Overall Study|Lost to Follow-up|1|||
160969449|NCT01114204|581276793|FG000|Overall Study|Adverse Event|3|||
160969450|NCT01114204|581276794|FG001|Overall Study|Adverse Event|2|||
160969451|NCT01114204|581276793|FG000|Overall Study|Lost to Follow-up|1|||
160969452|NCT01114204|581276794|FG001|Overall Study|Lost to Follow-up|0|||
160969453|NCT01114204|581276793|FG000|Overall Study|Withdrawal by Subject|10|||
160969454|NCT01114204|581276794|FG001|Overall Study|Withdrawal by Subject|6|||
160459848|NCT03250676|579416582|FG000|Overall Study|Disease progression|4|||
160969455|NCT01114204|581276793|FG000|Overall Study|Death|1|||
160969456|NCT01114204|581276794|FG001|Overall Study|Death|0|||
160969457|NCT01114204|581276793|FG000|Overall Study|Other-Personal reasons|2|||
160969458|NCT01114204|581276794|FG001|Overall Study|Other-Personal reasons|0|||
160969459|NCT01114204|581276793|FG000|Overall Study|Other-Medical monitor request|1|||
160969460|NCT01114204|581276794|FG001|Overall Study|Other-Medical monitor request|0|||
160969461|NCT01114204|581276793|FG000|Overall Study|Other-Participant request|2|||
160969462|NCT01114204|581276794|FG001|Overall Study|Other-Participant request|0|||
160969463|NCT01114204|581276793|FG000|Overall Study|Other-Protocol Violation|1|||
160969464|NCT01114204|581276794|FG001|Overall Study|Other-Protocol Violation|0|||
160459849|NCT03250676|579416583|FG001|Overall Study|Disease progression|12|||
160459850|NCT03250676|579416584|FG002|Overall Study|Disease progression|9|||
160459851|NCT03250676|579416585|FG003|Overall Study|Disease progression|7|||
160657068|NCT04028843|580124525|FG001|Overall Study|Non-viable Pregnancy|1|||
160969465|NCT00991341|581276799|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
160969466|NCT00991341|581276800|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
160969467|NCT00991341|581276799|FG000|Overall Study|Death|3|||
160969468|NCT00991341|581276800|FG001|Overall Study|Death|0|||
160969469|NCT00991341|581276799|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
160969470|NCT00991341|581276800|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
160969471|NCT00991341|581276799|FG000|Overall Study|Physician Decision|1|||
160969472|NCT00991341|581276800|FG001|Overall Study|Physician Decision|2|||
160969473|NCT00991341|581276799|FG000|Overall Study|Withdrawal by Subject|3|||
160969474|NCT00991341|581276800|FG001|Overall Study|Withdrawal by Subject|4|||
160969475|NCT02207725|581276812|FG000|Overall Study|Did Not Receive Treatment|0|||
160969476|NCT02207725|581276813|FG001|Overall Study|Did Not Receive Treatment|1|||
160969477|NCT02207725|581276814|FG002|Overall Study|Did Not Receive Treatment|1|||
160969478|NCT02207725|581276815|FG003|Overall Study|Did Not Receive Treatment|1|||
160969479|NCT02799472|581276818|FG000|Overall Study|Withdrawal by Subject|2|||
160969480|NCT02799472|581276819|FG001|Overall Study|Withdrawal by Subject|4|||
160969481|NCT02799472|581276818|FG000|Overall Study|Lack of Efficacy|2|||
160969482|NCT02799472|581276819|FG001|Overall Study|Lack of Efficacy|0|||
160969483|NCT02799472|581276818|FG000|Overall Study|Lost to Follow-up|0|||
160969484|NCT02799472|581276819|FG001|Overall Study|Lost to Follow-up|1|||
160969485|NCT04461795|581276820|FG000|Overall Study|Lost to Follow-up|2|||
160969486|NCT04461795|581276820|FG000|Overall Study|Withdrawal by Subject|2|||
160969487|NCT04461795|581276820|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
160969488|NCT00058422|581276822|FG000|Overall Study|Not treated|2|||
160969489|NCT00185640|581276823|FG000|Overall Study|Not Eligible|4|||
160969490|NCT00185640|581276823|FG000|Overall Study|Withdrawal by Subject|3|||
160969491|NCT00185640|581276823|FG000|Overall Study|Death|138|||
160969492|NCT01982435|581276826|FG000|Overall Study|Adverse Event|1|||
160969493|NCT01982435|581276827|FG001|Overall Study|Adverse Event|0|||
160969494|NCT03954743|581276828|FG000|Overall Study|Adverse Event|1|||
160969495|NCT03954743|581276829|FG001|Overall Study|Adverse Event|0|||
160969496|NCT03954743|581276828|FG000|Overall Study|Lost to Follow-up|6|||
160969497|NCT03954743|581276829|FG001|Overall Study|Lost to Follow-up|4|||
160969498|NCT03954743|581276828|FG000|Overall Study|Protocol Violation|1|||
160969499|NCT03954743|581276829|FG001|Overall Study|Protocol Violation|0|||
160969500|NCT03954743|581276828|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
160969501|NCT03954743|581276829|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
160969502|NCT03954743|581276828|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
160969503|NCT03954743|581276829|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160969504|NCT03541044|581276830|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
160969505|NCT03541044|581276831|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
160969506|NCT03541044|581276830|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
160969507|NCT03541044|581276831|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
160969508|NCT01153269|581276832|FG000|Overall Study|Withdrawal by Subject|1|||
160969509|NCT01153269|581276832|FG000|Overall Study|Antiretroviral therapy break|1|||
160969510|NCT00860067|581276843|FG000|Overall Study|Lost to Follow-up|46|||
160969511|NCT00860067|581276844|FG001|Overall Study|Lost to Follow-up|9|||
160969512|NCT00860067|581276845|FG002|Overall Study|Lost to Follow-up|9|||
160969513|NCT00860067|581276843|FG000|Overall Study|Withdrawal by Subject|4|||
160969514|NCT00860067|581276844|FG001|Overall Study|Withdrawal by Subject|0|||
160969515|NCT00860067|581276845|FG002|Overall Study|Withdrawal by Subject|0|||
160969516|NCT00860067|581276843|FG000|Overall Study|Pregnancy|1|||
160969517|NCT00860067|581276844|FG001|Overall Study|Pregnancy|0|||
160969518|NCT00860067|581276845|FG002|Overall Study|Pregnancy|0|||
160969519|NCT02387996|581276846|FG000|Overall Study|Disease Progression|167|||
160969520|NCT02387996|581276846|FG000|Overall Study|Study Drug Toxicity|31|||
160969521|NCT02387996|581276846|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
160969522|NCT02387996|581276846|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
160969523|NCT02387996|581276846|FG000|Overall Study|Subject Withdrew Consent|5|||
160969524|NCT02387996|581276846|FG000|Overall Study|Lost to Follow-up|1|||
160969525|NCT02387996|581276846|FG000|Overall Study|Poor/Non-Compliance|1|||
160969526|NCT02387996|581276846|FG000|Overall Study|Other Reasons|5|||
160969527|NCT02387996|581276846|FG000|Overall Study|Death|1|||
160969528|NCT00770432|581276847|FG000|Overall Study|Other|4|||
160969529|NCT00770432|581276848|FG001|Overall Study|Other|6|||
160969530|NCT00770432|581276847|FG000|Overall Study|Non-compliance|0|||
160969531|NCT00770432|581276848|FG001|Overall Study|Non-compliance|1|||
160969532|NCT00312702|581276849|FG000|Immunization Phase|Lost to Follow-up|0|||
160969533|NCT00312702|581276850|FG001|Immunization Phase|Lost to Follow-up|1|||
160969534|NCT00312702|581276851|FG002|Immunization Phase|Lost to Follow-up|0|||
160969535|NCT03592277|581276853|FG000|Overall Study|Withdrawal by Subject|6|||
160969536|NCT03592277|581276854|FG001|Overall Study|Withdrawal by Subject|8|||
160969537|NCT03787680|581276864|FG000|Overall Study|Physician Decision|2|||
161020171|NCT04505904|581463507|FG000|Overall Study|Withdrawal by Subject|1|||
161020172|NCT04505904|581463508|FG001|Overall Study|Withdrawal by Subject|2|||
161020173|NCT04505904|581463509|FG002|Overall Study|Withdrawal by Subject|0|||
161020174|NCT04505904|581463510|FG003|Overall Study|Withdrawal by Subject|0|||
161020175|NCT04505904|581463507|FG000|Overall Study|Physician Decision|1|||
161020176|NCT04505904|581463508|FG001|Overall Study|Physician Decision|0|||
161020177|NCT04505904|581463509|FG002|Overall Study|Physician Decision|0|||
161020178|NCT04505904|581463510|FG003|Overall Study|Physician Decision|0|||
161020179|NCT04505904|581463507|FG000|Overall Study|Adverse Event|0|||
161020180|NCT04505904|581463508|FG001|Overall Study|Adverse Event|1|||
161020181|NCT04505904|581463509|FG002|Overall Study|Adverse Event|0|||
161020182|NCT04505904|581463510|FG003|Overall Study|Adverse Event|0|||
161020183|NCT04277442|581463513|FG000|Overall Study|Death|1|||
161020184|NCT03092518|581463514|FG000|Overall Study|Ineligible|2|||
161020185|NCT01824537|581463515|FG000|Overall Study|Lost to Follow-up|78|||
161020186|NCT01824537|581463516|FG001|Overall Study|Lost to Follow-up|87|||
161020187|NCT02547987|581463517|FG000|Overall Study|Withdrawal by Subject|1|||
161020188|NCT02547987|581463517|FG000|Overall Study|Adverse Event|2|||
161020189|NCT04938492|581463529|FG000|Overall Study|Lost to Follow-up|17|||
161020190|NCT04938492|581463530|FG001|Overall Study|Lost to Follow-up|18|||
161020191|NCT03865498|581463531|FG000|Overall Study|Lack of Efficacy|12|||
161020192|NCT03865498|581463532|FG001|Overall Study|Lack of Efficacy|11|||
161020193|NCT03865498|581463531|FG000|Overall Study|Lost to Follow-up|125|||
161020194|NCT03865498|581463532|FG001|Overall Study|Lost to Follow-up|133|||
161020195|NCT03865498|581463531|FG000|Overall Study|Withdrawal by Subject|2|||
161020196|NCT03865498|581463532|FG001|Overall Study|Withdrawal by Subject|4|||
161020197|NCT01648023|581463533|FG000|Overall Study|Screen Fail Post Randomization|1|||
161020198|NCT01648023|581463534|FG001|Overall Study|Screen Fail Post Randomization|2|||
161020199|NCT05084508|581463535|FG000|Overall Study|Lost to Follow-up|6|||
161020200|NCT05084508|581463536|FG001|Overall Study|Lost to Follow-up|3|||
161020201|NCT05084508|581463537|FG002|Overall Study|Lost to Follow-up|7|||
161020202|NCT05084508|581463538|FG003|Overall Study|Lost to Follow-up|3|||
161020203|NCT05084508|581463535|FG000|Overall Study|Withdrawal by Subject|0|||
161020204|NCT05084508|581463536|FG001|Overall Study|Withdrawal by Subject|2|||
161020205|NCT05084508|581463537|FG002|Overall Study|Withdrawal by Subject|3|||
161020206|NCT05084508|581463538|FG003|Overall Study|Withdrawal by Subject|1|||
161020207|NCT05084508|581463535|FG000|Overall Study|Other|0|||
161020208|NCT05084508|581463536|FG001|Overall Study|Other|0|||
161020209|NCT05084508|581463537|FG002|Overall Study|Other|0|||
161020210|NCT05084508|581463538|FG003|Overall Study|Other|1|||
161020211|NCT05296525|581463539|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
161020212|NCT05296525|581463540|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
161020213|NCT05296525|581463541|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
161020214|NCT05296525|581463542|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
161020215|NCT02547363|581463549|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
161020216|NCT02547363|581463550|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
161020217|NCT02547363|581463549|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
161020218|NCT02547363|581463550|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
160459852|NCT03250676|579416586|FG004|Overall Study|Disease progression|4|||
160459853|NCT03250676|579416587|FG005|Overall Study|Disease progression|88|||
160459854|NCT01499368|579416588|FG000|Overall Study|Did not meet I/E criteria|8|||
160459855|NCT01499368|579416589|FG001|Overall Study|Did not meet I/E criteria|4|||
160459856|NCT01499368|579416590|FG002|Overall Study|Did not meet I/E criteria|4|||
160459857|NCT01499368|579416588|FG000|Overall Study|Prohibited Concomitant medication|1|||
160459858|NCT01499368|579416589|FG001|Overall Study|Prohibited Concomitant medication|1|||
160459859|NCT01499368|579416590|FG002|Overall Study|Prohibited Concomitant medication|0|||
160459860|NCT01499368|579416588|FG000|Overall Study|Withdrawal by Subject|11|||
160459861|NCT01499368|579416589|FG001|Overall Study|Withdrawal by Subject|10|||
160459862|NCT01499368|579416590|FG002|Overall Study|Withdrawal by Subject|8|||
160459863|NCT01499368|579416588|FG000|Overall Study|Lost to Follow-up|3|||
160459864|NCT01499368|579416589|FG001|Overall Study|Lost to Follow-up|2|||
160459865|NCT01499368|579416590|FG002|Overall Study|Lost to Follow-up|5|||
161020219|NCT02547363|581463549|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
161020220|NCT02547363|581463550|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
161020221|NCT02547363|581463549|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
161020222|NCT02547363|581463550|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
160459866|NCT01499368|579416588|FG000|Overall Study|Adverse Event|4|||
161020223|NCT02547363|581463549|FG000|12-month Follow-up|Withdrawal by Subject|4|||
161020224|NCT02547363|581463550|FG001|12-month Follow-up|Withdrawal by Subject|3|||
161020225|NCT02547363|581463549|FG000|12-month Follow-up|Lost to Follow-up|4|||
161020226|NCT02547363|581463550|FG001|12-month Follow-up|Lost to Follow-up|1|||
161020227|NCT02547363|581463549|FG000|12-month Follow-up|Lack of Efficacy|1|||
161020228|NCT02547363|581463550|FG001|12-month Follow-up|Lack of Efficacy|1|||
161020229|NCT02547363|581463549|FG000|12-month Follow-up|Other|1|||
161020230|NCT02547363|581463550|FG001|12-month Follow-up|Other|0|||
161020231|NCT03931174|581463551|FG000|Providers|Staff left organization|26|||
161020232|NCT03931174|581463552|FG001|Providers|Staff left organization|25|||
161020233|NCT03931174|581463551|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
161020234|NCT03931174|581463552|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
161020235|NCT03931174|581463551|FG000|Providers|Lost to Follow-up|4|||
161020236|NCT03931174|581463552|FG001|Providers|Lost to Follow-up|4|||
161020237|NCT03931174|581463551|FG000|Patients|Post-consent screening failure|1|||
161020238|NCT03931174|581463552|FG001|Patients|Post-consent screening failure|1|||
161020239|NCT03931174|581463551|FG000|Patients|Death|1|||
161020240|NCT03931174|581463552|FG001|Patients|Death|1|||
161020241|NCT03931174|581463551|FG000|Patients|Lost to Follow-up|60|||
161020242|NCT03931174|581463552|FG001|Patients|Lost to Follow-up|89|||
161020243|NCT05386030|581463553|FG000|Overall Study|Death|1|||
161020244|NCT05386030|581463554|FG001|Overall Study|Death|0|||
161020245|NCT05386030|581463553|FG000|Overall Study|Physician Decision|2|||
161020246|NCT05386030|581463554|FG001|Overall Study|Physician Decision|1|||
161020247|NCT05386030|581463553|FG000|Overall Study|Lost to Follow-up|19|||
161020248|NCT05386030|581463554|FG001|Overall Study|Lost to Follow-up|7|||
161020249|NCT05386030|581463553|FG000|Overall Study|Withdrawal by Subject|20|||
161020250|NCT05386030|581463554|FG001|Overall Study|Withdrawal by Subject|10|||
161020251|NCT05386030|581463553|FG000|Overall Study|Eligibility criteria violation|1|||
161020252|NCT05386030|581463554|FG001|Overall Study|Eligibility criteria violation|1|||
161020253|NCT05386030|581463553|FG000|Overall Study|Personal Reasons|1|||
161020254|NCT05386030|581463554|FG001|Overall Study|Personal Reasons|0|||
161020255|NCT03213691|581463555|FG000|Overall Study|Adverse Event|2|||
161020256|NCT03213691|581463555|FG000|Overall Study|Death|3|||
161020257|NCT03213691|581463555|FG000|Overall Study|Physician Decision|1|||
161020258|NCT03213691|581463555|FG000|Overall Study|Progressive Disease|14|||
161020259|NCT03213691|581463555|FG000|Overall Study|Ineligible|1|||
161020260|NCT03161028|581463558|FG000|Overall Study|Withdrawal by Subject|6|||
161020261|NCT03161028|581463559|FG001|Overall Study|Withdrawal by Subject|4|||
161020262|NCT03161028|581463558|FG000|Overall Study|Adverse Event|5|||
161020263|NCT03161028|581463559|FG001|Overall Study|Adverse Event|1|||
161020264|NCT03161028|581463558|FG000|Overall Study|Study drug side effects|2|||
161020265|NCT03161028|581463559|FG001|Overall Study|Study drug side effects|2|||
161020266|NCT03161028|581463558|FG000|Overall Study|Administrative PD/UP|4|||
161020267|NCT03161028|581463559|FG001|Overall Study|Administrative PD/UP|2|||
161020268|NCT03161028|581463558|FG000|Overall Study|Lost to Follow-up|2|||
161020269|NCT03161028|581463559|FG001|Overall Study|Lost to Follow-up|0|||
161020270|NCT03161028|581463558|FG000|Overall Study|Unable to comply with procedures|1|||
161020271|NCT03161028|581463559|FG001|Overall Study|Unable to comply with procedures|1|||
161020272|NCT00736723|581463560|FG000|Overall Study|Withdrawal by Subject|4|||
161020273|NCT00736723|581463561|FG001|Overall Study|Withdrawal by Subject|3|||
161020274|NCT03492216|581463562|FG000|Overall Study|Death|1|||
161020275|NCT03492216|581463563|FG001|Overall Study|Death|0|||
161020276|NCT03492216|581463564|FG002|Overall Study|Death|4|||
161020277|NCT03492216|581463565|FG003|Overall Study|Death|0|||
161020278|NCT03492216|581463562|FG000|Overall Study|Withdrawal by Subject|5|||
161020279|NCT03492216|581463563|FG001|Overall Study|Withdrawal by Subject|3|||
161020280|NCT03492216|581463564|FG002|Overall Study|Withdrawal by Subject|1|||
161020281|NCT03492216|581463565|FG003|Overall Study|Withdrawal by Subject|1|||
161020282|NCT03492216|581463562|FG000|Overall Study|Lost to Follow-up|9|||
161020283|NCT03492216|581463563|FG001|Overall Study|Lost to Follow-up|2|||
161020284|NCT03492216|581463564|FG002|Overall Study|Lost to Follow-up|7|||
161020285|NCT03492216|581463565|FG003|Overall Study|Lost to Follow-up|8|||
161020286|NCT03492216|581463562|FG000|Overall Study|Moved|5|||
161020287|NCT03492216|581463563|FG001|Overall Study|Moved|3|||
161020288|NCT03492216|581463564|FG002|Overall Study|Moved|3|||
161020289|NCT03492216|581463565|FG003|Overall Study|Moved|5|||
161020290|NCT03492216|581463562|FG000|Overall Study|Too ill|0|||
161020291|NCT03492216|581463563|FG001|Overall Study|Too ill|1|||
161020292|NCT03492216|581463564|FG002|Overall Study|Too ill|0|||
161020293|NCT03492216|581463565|FG003|Overall Study|Too ill|0|||
160459867|NCT01499368|579416589|FG001|Overall Study|Adverse Event|0|||
161020294|NCT03492216|581463562|FG000|Overall Study|Incarcerated|0|||
161020295|NCT03492216|581463563|FG001|Overall Study|Incarcerated|0|||
161020296|NCT03492216|581463564|FG002|Overall Study|Incarcerated|2|||
161020297|NCT03492216|581463565|FG003|Overall Study|Incarcerated|0|||
161020298|NCT05351554|581463566|FG000|Overall Study|Study terminated by sponsor|1|||
161020299|NCT05030233|581463567|FG000|Overall Study|withdrawn for transfer|1|||
161020300|NCT05030233|581463568|FG001|Overall Study|withdrawn for transfer|0|||
161020301|NCT04256941|581465536|FG000|Overall Study|Withdrawal by Subject|0|||
161020302|NCT04256941|581465537|FG001|Overall Study|Withdrawal by Subject|1|||
161020303|NCT04256941|581465536|FG000|Overall Study|Death|1|||
161020304|NCT04256941|581465537|FG001|Overall Study|Death|0|||
160459868|NCT01499368|579416590|FG002|Overall Study|Adverse Event|2|||
161020305|NCT04256941|581465536|FG000|Overall Study|Disease Progession|0|||
161020306|NCT04256941|581465537|FG001|Overall Study|Disease Progession|2|||
161020307|NCT04185298|581465543|FG000|Overall Study|Lost to Follow-up|1|||
161020308|NCT04185298|581465544|FG001|Overall Study|Lost to Follow-up|3|||
161020309|NCT04185298|581465543|FG000|Overall Study|Withdrawal by Subject|0|||
160587184|NCT02065622|579867709|FG004|Maintenance Study|Withdrawal by Subject|7|||
160587185|NCT02065622|579867705|FG000|Maintenance Study|Lost to Follow-up|0|||
160587186|NCT02065622|579867706|FG001|Maintenance Study|Lost to Follow-up|0|||
160587187|NCT02065622|579867707|FG002|Maintenance Study|Lost to Follow-up|4|||
160587188|NCT02065622|579867708|FG003|Maintenance Study|Lost to Follow-up|1|||
160587189|NCT02065622|579867709|FG004|Maintenance Study|Lost to Follow-up|1|||
160587190|NCT02065622|579867705|FG000|Maintenance Study|Lack of Efficacy|0|||
160587191|NCT02065622|579867706|FG001|Maintenance Study|Lack of Efficacy|0|||
160459869|NCT01499368|579416588|FG000|Overall Study|Physician Decision|0|||
160459870|NCT01499368|579416589|FG001|Overall Study|Physician Decision|1|||
160459871|NCT01499368|579416590|FG002|Overall Study|Physician Decision|0|||
160459872|NCT01499368|579416588|FG000|Overall Study|Deviation from visit window|0|||
160459873|NCT01499368|579416589|FG001|Overall Study|Deviation from visit window|0|||
160459874|NCT01499368|579416590|FG002|Overall Study|Deviation from visit window|1|||
160459875|NCT01499368|579416588|FG000|Overall Study|Error of Prescriptions|0|||
160587192|NCT02065622|579867707|FG002|Maintenance Study|Lack of Efficacy|70|||
160587193|NCT02065622|579867708|FG003|Maintenance Study|Lack of Efficacy|55|||
160969538|NCT03787680|581276865|FG001|Overall Study|Physician Decision|3|||
160969539|NCT03787680|581276864|FG000|Overall Study|Adverse Event|7|||
160969540|NCT03787680|581276865|FG001|Overall Study|Adverse Event|3|||
160969541|NCT03787680|581276864|FG000|Overall Study|Withdrawal by Subject|2|||
160969542|NCT03787680|581276865|FG001|Overall Study|Withdrawal by Subject|1|||
160969543|NCT05454410|581276868|FG000|Overall Study|Withdrawal by Subject|0|||
160969544|NCT05454410|581276869|FG001|Overall Study|Withdrawal by Subject|0|||
160969545|NCT05454410|581276870|FG002|Overall Study|Withdrawal by Subject|1|||
160969546|NCT05454410|581276871|FG003|Overall Study|Withdrawal by Subject|1|||
160969547|NCT00895622|581276872|FG000|Overall Study|Protocol Violation|5|||
160969548|NCT00895622|581276873|FG001|Overall Study|Protocol Violation|4|||
160969549|NCT00895622|581276874|FG002|Overall Study|Protocol Violation|4|||
160969550|NCT00532155|581276882|FG000|Overall Study|Adverse Event|66|||
160969551|NCT00532155|581276883|FG001|Overall Study|Adverse Event|123|||
160969552|NCT00532155|581276882|FG000|Overall Study|Lack of Efficacy|332|||
160969553|NCT00532155|581276883|FG001|Overall Study|Lack of Efficacy|255|||
160969554|NCT00532155|581276882|FG000|Overall Study|Protocol Violation|1|||
160969555|NCT00532155|581276883|FG001|Overall Study|Protocol Violation|3|||
160969556|NCT00532155|581276882|FG000|Overall Study|Lost to Follow-up|2|||
160969557|NCT00532155|581276883|FG001|Overall Study|Lost to Follow-up|0|||
160969558|NCT00532155|581276882|FG000|Overall Study|Physician Decision|16|||
160969559|NCT00532155|581276883|FG001|Overall Study|Physician Decision|15|||
160969560|NCT00532155|581276882|FG000|Overall Study|Withdrawal by Subject|23|||
160969561|NCT00532155|581276883|FG001|Overall Study|Withdrawal by Subject|44|||
160969562|NCT00532155|581276882|FG000|Overall Study|Consent withdrawn|5|||
160969563|NCT00532155|581276883|FG001|Overall Study|Consent withdrawn|7|||
160969564|NCT00532155|581276882|FG000|Overall Study|Moved|1|||
160969565|NCT00532155|581276883|FG001|Overall Study|Moved|0|||
160969566|NCT00532155|581276882|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
160969567|NCT00532155|581276883|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
160969568|NCT00532155|581276882|FG000|Overall Study|Occurence of a second cancer|0|||
160969569|NCT00532155|581276883|FG001|Overall Study|Occurence of a second cancer|1|||
160969570|NCT00532155|581276882|FG000|Overall Study|Occurence of a secondary cancer|0|||
160969571|NCT00532155|581276883|FG001|Overall Study|Occurence of a secondary cancer|1|||
160969572|NCT00532155|581276882|FG000|Overall Study|Promotor ended study|1|||
160969573|NCT00532155|581276883|FG001|Overall Study|Promotor ended study|0|||
160969574|NCT00532155|581276882|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
160969575|NCT00532155|581276883|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
160969576|NCT00532155|581276882|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
160969577|NCT00532155|581276883|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
160969578|NCT00532155|581276882|FG000|Overall Study|Study stopped|1|||
160969579|NCT00532155|581276883|FG001|Overall Study|Study stopped|0|||
160969580|NCT00532155|581276882|FG000|Overall Study|Study terminated by sponsor|1|||
160969581|NCT00532155|581276883|FG001|Overall Study|Study terminated by sponsor|0|||
160969582|NCT00532155|581276882|FG000|Overall Study|Study termination stop further treatment|4|||
160969583|NCT00532155|581276883|FG001|Overall Study|Study termination stop further treatment|0|||
160969584|NCT00532155|581276882|FG000|Overall Study|Did not receive study medication|2|||
160969585|NCT00532155|581276883|FG001|Overall Study|Did not receive study medication|6|||
160969586|NCT03483038|581276884|FG000|Overall Study|Subjects still in follow-up|18|||
160969587|NCT03635489|581276885|FG000|Overall Study|Death|19|||
160969588|NCT03635489|581276886|FG001|Overall Study|Death|13|||
160969589|NCT03635489|581276885|FG000|Overall Study|Lost to Follow-up|1|||
160969590|NCT03635489|581276886|FG001|Overall Study|Lost to Follow-up|2|||
160969591|NCT03635489|581276885|FG000|Overall Study|Withdrawal by Subject|1|||
160969592|NCT03635489|581276886|FG001|Overall Study|Withdrawal by Subject|2|||
160969593|NCT03635489|581276885|FG000|Overall Study|Study Ended by Sponsor|28|||
160969594|NCT03635489|581276886|FG001|Overall Study|Study Ended by Sponsor|34|||
160969595|NCT01368900|581276887|FG000|Overall Study|Lost to Follow-up|7|||
160969596|NCT04027348|581276892|FG000|Overall Study|Adverse Event|2|||
161020310|NCT04185298|581465544|FG001|Overall Study|Withdrawal by Subject|3|||
161020311|NCT03896789|581465545|FG000|Baseline|Lost to Follow-up|1|||
161020312|NCT03896789|581465546|FG001|Baseline|Lost to Follow-up|2|||
161020313|NCT03896789|581465545|FG000|Baseline|Death|3|||
161020314|NCT03896789|581465546|FG001|Baseline|Death|6|||
161020315|NCT03896789|581465545|FG000|Post-Randomization|Lost to Follow-up|12|||
161020316|NCT03896789|581465546|FG001|Post-Randomization|Lost to Follow-up|11|||
161020317|NCT03896789|581465545|FG000|Post-Randomization|Death|12|||
161020318|NCT03896789|581465546|FG001|Post-Randomization|Death|13|||
161020319|NCT01606215|581465547|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
161020320|NCT01606215|581465548|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
161020321|NCT03524118|581465550|FG000|Overall Study|Lost to Follow-up|0|||
161020322|NCT03524118|581465551|FG001|Overall Study|Lost to Follow-up|0|||
161020323|NCT03524118|581465552|FG002|Overall Study|Lost to Follow-up|0|||
161020324|NCT03524118|581465553|FG003|Overall Study|Lost to Follow-up|0|||
161020325|NCT03524118|581465554|FG004|Overall Study|Lost to Follow-up|1|||
161020326|NCT03524118|581465555|FG005|Overall Study|Lost to Follow-up|0|||
161020327|NCT03524118|581465550|FG000|Overall Study|Other|0|||
161020328|NCT03524118|581465551|FG001|Overall Study|Other|1|||
161020329|NCT03524118|581465552|FG002|Overall Study|Other|0|||
161020330|NCT03524118|581465553|FG003|Overall Study|Other|0|||
161020331|NCT03524118|581465554|FG004|Overall Study|Other|1|||
161020332|NCT03524118|581465555|FG005|Overall Study|Other|1|||
161020333|NCT03524118|581465550|FG000|Overall Study|Physician Decision|0|||
161020334|NCT03524118|581465551|FG001|Overall Study|Physician Decision|0|||
161020335|NCT03524118|581465552|FG002|Overall Study|Physician Decision|0|||
161020336|NCT03524118|581465553|FG003|Overall Study|Physician Decision|0|||
161020337|NCT03524118|581465554|FG004|Overall Study|Physician Decision|1|||
161020338|NCT03524118|581465555|FG005|Overall Study|Physician Decision|0|||
161020339|NCT03524118|581465550|FG000|Overall Study|Protocol Violation|0|||
161020340|NCT03524118|581465551|FG001|Overall Study|Protocol Violation|0|||
161020341|NCT03524118|581465552|FG002|Overall Study|Protocol Violation|1|||
161020342|NCT03524118|581465553|FG003|Overall Study|Protocol Violation|0|||
161020343|NCT03524118|581465554|FG004|Overall Study|Protocol Violation|1|||
161020344|NCT03524118|581465555|FG005|Overall Study|Protocol Violation|0|||
161020345|NCT03524118|581465550|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161020346|NCT03524118|581465551|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161020347|NCT03524118|581465552|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161020348|NCT03524118|581465553|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
161020349|NCT03524118|581465554|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
161020350|NCT03524118|581465555|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161020351|NCT01437709|581465558|FG000|Overall Study|Adverse Event|0|||
161020352|NCT01437709|581465559|FG001|Overall Study|Adverse Event|1|||
161020353|NCT01437709|581465560|FG002|Overall Study|Adverse Event|0|||
161020354|NCT01437709|581465558|FG000|Overall Study|Pt trasnferred care|0|||
161020355|NCT01437709|581465559|FG001|Overall Study|Pt trasnferred care|1|||
161020356|NCT01437709|581465560|FG002|Overall Study|Pt trasnferred care|0|||
161020357|NCT01842542|581465561|FG000|Overall Study|Withdrawal by Subject|2|||
161020358|NCT01842542|581465561|FG000|Overall Study|Lack of Efficacy|1|||
161020359|NCT01842542|581465561|FG000|Overall Study|Protocol Non-compliance|2|||
161020360|NCT01842542|581465561|FG000|Overall Study|Lost to Follow-up|1|||
161020361|NCT02919306|581465562|FG000|Overall Study|Withdrawal by Subject|1|||
161020362|NCT02919306|581465563|FG001|Overall Study|Withdrawal by Subject|0|||
161020363|NCT02919306|581465562|FG000|Overall Study|Protocol Violation|1|||
161020364|NCT02919306|581465563|FG001|Overall Study|Protocol Violation|0|||
161020365|NCT04293055|581465564|FG000|Overall Study|Lost to Follow-up|1|||
161020366|NCT04293055|581465565|FG001|Overall Study|Lost to Follow-up|1|||
161020367|NCT04293055|581465564|FG000|Overall Study|Did not trigger randomization|6|||
161020368|NCT04293055|581465565|FG001|Overall Study|Did not trigger randomization|5|||
161020369|NCT02262728|581465566|FG000|Follow-up Phase (3 Years)|Death|0|||
161020370|NCT02262728|581465567|FG001|Follow-up Phase (3 Years)|Death|1|||
161020371|NCT02262728|581465566|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
161020372|NCT02262728|581465567|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
161020373|NCT02262728|581465566|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
161020374|NCT02262728|581465567|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
161020375|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
161020376|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
161020377|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
161020378|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
161020379|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
161020380|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
161020381|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
161020382|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
161020383|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
161020384|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
160587194|NCT02065622|579867709|FG004|Maintenance Study|Lack of Efficacy|19|||
160587195|NCT02065622|579867705|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
160587196|NCT02065622|579867706|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
160587197|NCT02065622|579867707|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
161020385|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
161020386|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
161020387|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
161020388|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
161020389|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
161020390|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
161020391|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
161020392|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
161020393|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
161020394|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
161020395|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
161020396|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
161020397|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
161020398|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
161020399|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
161020400|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
161020401|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
161020402|NCT01715285|581465568|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
161020403|NCT01715285|581465569|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
161020404|NCT01715285|581465570|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
161020405|NCT01715285|581465568|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
161020406|NCT01715285|581465569|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
161020407|NCT01715285|581465570|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
161020408|NCT01715285|581465568|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
161020409|NCT01715285|581465569|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
161020410|NCT01715285|581465570|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
161020411|NCT01715285|581465568|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
161020412|NCT01715285|581465569|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
161020413|NCT01715285|581465570|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
161020414|NCT01715285|581465568|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
161020415|NCT01715285|581465569|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
161020416|NCT01715285|581465570|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
161020417|NCT02573493|581465581|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
161020418|NCT02573493|581465582|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
161020419|NCT02573493|581465583|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
161020420|NCT02573493|581465584|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
161020421|NCT04149704|581465588|FG000|Three Month Follow-up|Death|2|||
161020422|NCT04149704|581465589|FG001|Three Month Follow-up|Death|0|||
161020423|NCT04149704|581465590|FG002|Three Month Follow-up|Death|0|||
161020424|NCT04149704|581465591|FG003|Three Month Follow-up|Death|0|||
161020425|NCT04149704|581465588|FG000|Three Month Follow-up|Lost to Follow-up|1|||
161020426|NCT04149704|581465589|FG001|Three Month Follow-up|Lost to Follow-up|4|||
161020427|NCT04149704|581465590|FG002|Three Month Follow-up|Lost to Follow-up|5|||
161020428|NCT04149704|581465591|FG003|Three Month Follow-up|Lost to Follow-up|5|||
161020429|NCT04149704|581465588|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
161020430|NCT04149704|581465589|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
161020431|NCT04149704|581465590|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
161020432|NCT04149704|581465591|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
161020433|NCT04149704|581465588|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
161020434|NCT04149704|581465589|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
161020435|NCT04149704|581465590|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
161020436|NCT04149704|581465591|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
160587198|NCT02065622|579867708|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
160587199|NCT02065622|579867709|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
160587200|NCT02065622|579867705|FG000|Maintenance Study|Subject Non-Compliance|0|||
160587201|NCT02065622|579867706|FG001|Maintenance Study|Subject Non-Compliance|0|||
161020437|NCT04332926|581465592|FG000|Overall Study|Withdrawal by Subject|6|||
161020438|NCT04332926|581465592|FG000|Overall Study|Physician Decision|6|||
161020439|NCT04632992|581465602|FG000|Overall Study|Adverse Event|0|||
161020440|NCT04632992|581465603|FG001|Overall Study|Adverse Event|0|||
160587202|NCT02065622|579867707|FG002|Maintenance Study|Subject Non-Compliance|1|||
160587203|NCT02065622|579867708|FG003|Maintenance Study|Subject Non-Compliance|3|||
161020441|NCT04632992|581465604|FG002|Overall Study|Adverse Event|0|||
161020442|NCT04632992|581465605|FG003|Overall Study|Adverse Event|0|||
161020443|NCT04632992|581465606|FG004|Overall Study|Adverse Event|0|||
161020444|NCT04632992|581465607|FG005|Overall Study|Adverse Event|0|||
161020445|NCT04632992|581465608|FG006|Overall Study|Adverse Event|0|||
161020446|NCT04632992|581465609|FG007|Overall Study|Adverse Event|0|||
161020447|NCT04632992|581465610|FG008|Overall Study|Adverse Event|0|||
161020448|NCT04632992|581465611|FG009|Overall Study|Adverse Event|0|||
161020449|NCT04632992|581465612|FG010|Overall Study|Adverse Event|0|||
161020450|NCT04632992|581465613|FG011|Overall Study|Adverse Event|0|||
161020451|NCT04632992|581465614|FG012|Overall Study|Adverse Event|1|||
161020452|NCT04632992|581465615|FG013|Overall Study|Adverse Event|0|||
161020453|NCT04632992|581465602|FG000|Overall Study|Death|17|||
161020454|NCT04632992|581465603|FG001|Overall Study|Death|1|||
161020455|NCT04632992|581465604|FG002|Overall Study|Death|14|||
161020456|NCT04632992|581465605|FG003|Overall Study|Death|14|||
161020457|NCT04632992|581465606|FG004|Overall Study|Death|13|||
161020458|NCT04632992|581465607|FG005|Overall Study|Death|6|||
161020459|NCT04632992|581465608|FG006|Overall Study|Death|7|||
161020460|NCT04632992|581465609|FG007|Overall Study|Death|12|||
161020461|NCT04632992|581465610|FG008|Overall Study|Death|15|||
161020462|NCT04632992|581465611|FG009|Overall Study|Death|20|||
161020463|NCT04632992|581465612|FG010|Overall Study|Death|8|||
161020464|NCT04632992|581465613|FG011|Overall Study|Death|2|||
161020465|NCT04632992|581465614|FG012|Overall Study|Death|10|||
161020466|NCT04632992|581465615|FG013|Overall Study|Death|1|||
161020467|NCT04632992|581465602|FG000|Overall Study|Lost to Follow-up|1|||
161020468|NCT04632992|581465603|FG001|Overall Study|Lost to Follow-up|0|||
161020469|NCT04632992|581465604|FG002|Overall Study|Lost to Follow-up|1|||
161020470|NCT04632992|581465605|FG003|Overall Study|Lost to Follow-up|0|||
161020471|NCT04632992|581465606|FG004|Overall Study|Lost to Follow-up|2|||
161020472|NCT04632992|581465607|FG005|Overall Study|Lost to Follow-up|0|||
161020473|NCT04632992|581465608|FG006|Overall Study|Lost to Follow-up|1|||
161020474|NCT04632992|581465609|FG007|Overall Study|Lost to Follow-up|1|||
161020475|NCT04632992|581465610|FG008|Overall Study|Lost to Follow-up|1|||
161020476|NCT04632992|581465611|FG009|Overall Study|Lost to Follow-up|1|||
161020477|NCT04632992|581465612|FG010|Overall Study|Lost to Follow-up|2|||
161020478|NCT04632992|581465613|FG011|Overall Study|Lost to Follow-up|0|||
161020479|NCT04632992|581465614|FG012|Overall Study|Lost to Follow-up|0|||
161020480|NCT04632992|581465615|FG013|Overall Study|Lost to Follow-up|0|||
161020481|NCT04632992|581465602|FG000|Overall Study|Reason not Specified|2|||
161020482|NCT04632992|581465603|FG001|Overall Study|Reason not Specified|0|||
160587204|NCT02065622|579867709|FG004|Maintenance Study|Subject Non-Compliance|2|||
161020483|NCT04632992|581465604|FG002|Overall Study|Reason not Specified|1|||
161020484|NCT04632992|581465605|FG003|Overall Study|Reason not Specified|1|||
161020485|NCT04632992|581465606|FG004|Overall Study|Reason not Specified|0|||
161020486|NCT04632992|581465607|FG005|Overall Study|Reason not Specified|0|||
161020487|NCT04632992|581465608|FG006|Overall Study|Reason not Specified|0|||
161020488|NCT04632992|581465609|FG007|Overall Study|Reason not Specified|0|||
161020489|NCT04632992|581465610|FG008|Overall Study|Reason not Specified|0|||
161020490|NCT04632992|581465611|FG009|Overall Study|Reason not Specified|0|||
161020491|NCT04632992|581465612|FG010|Overall Study|Reason not Specified|1|||
161020492|NCT04632992|581465613|FG011|Overall Study|Reason not Specified|0|||
161020493|NCT04632992|581465614|FG012|Overall Study|Reason not Specified|0|||
161020494|NCT04632992|581465615|FG013|Overall Study|Reason not Specified|0|||
161020495|NCT04632992|581465602|FG000|Overall Study|Physician Decision|0|||
161020496|NCT04632992|581465603|FG001|Overall Study|Physician Decision|0|||
161020497|NCT04632992|581465604|FG002|Overall Study|Physician Decision|0|||
160587205|NCT02065622|579867705|FG000|Maintenance Study|Other, Not Specified|0|||
161020498|NCT04632992|581465605|FG003|Overall Study|Physician Decision|2|||
161020499|NCT04632992|581465606|FG004|Overall Study|Physician Decision|1|||
161020500|NCT04632992|581465607|FG005|Overall Study|Physician Decision|0|||
161020501|NCT04632992|581465608|FG006|Overall Study|Physician Decision|0|||
160587206|NCT02065622|579867706|FG001|Maintenance Study|Other, Not Specified|0|||
161020502|NCT04632992|581465609|FG007|Overall Study|Physician Decision|0|||
161020503|NCT04632992|581465610|FG008|Overall Study|Physician Decision|0|||
161020504|NCT04632992|581465611|FG009|Overall Study|Physician Decision|0|||
161020505|NCT04632992|581465612|FG010|Overall Study|Physician Decision|0|||
161020506|NCT04632992|581465613|FG011|Overall Study|Physician Decision|0|||
161020507|NCT04632992|581465614|FG012|Overall Study|Physician Decision|3|||
161020508|NCT04632992|581465615|FG013|Overall Study|Physician Decision|0|||
161020509|NCT04632992|581465602|FG000|Overall Study|Progressive Disease|0|||
161020510|NCT04632992|581465603|FG001|Overall Study|Progressive Disease|0|||
161020511|NCT04632992|581465604|FG002|Overall Study|Progressive Disease|0|||
160587207|NCT02065622|579867707|FG002|Maintenance Study|Other, Not Specified|6|||
161020512|NCT04632992|581465605|FG003|Overall Study|Progressive Disease|0|||
161020513|NCT04632992|581465606|FG004|Overall Study|Progressive Disease|1|||
161020514|NCT04632992|581465607|FG005|Overall Study|Progressive Disease|0|||
161020515|NCT04632992|581465608|FG006|Overall Study|Progressive Disease|0|||
161020516|NCT04632992|581465609|FG007|Overall Study|Progressive Disease|0|||
161020517|NCT04632992|581465610|FG008|Overall Study|Progressive Disease|0|||
161020518|NCT04632992|581465611|FG009|Overall Study|Progressive Disease|1|||
161020519|NCT04632992|581465612|FG010|Overall Study|Progressive Disease|1|||
161020520|NCT04632992|581465613|FG011|Overall Study|Progressive Disease|0|||
161020521|NCT04632992|581465614|FG012|Overall Study|Progressive Disease|2|||
161020522|NCT04632992|581465615|FG013|Overall Study|Progressive Disease|0|||
161020523|NCT04632992|581465602|FG000|Overall Study|Withdrawal by Subject|4|||
161020524|NCT04632992|581465603|FG001|Overall Study|Withdrawal by Subject|1|||
161020525|NCT04632992|581465604|FG002|Overall Study|Withdrawal by Subject|5|||
161020526|NCT04632992|581465605|FG003|Overall Study|Withdrawal by Subject|4|||
161020527|NCT04632992|581465606|FG004|Overall Study|Withdrawal by Subject|3|||
161020528|NCT04632992|581465607|FG005|Overall Study|Withdrawal by Subject|3|||
161020529|NCT04632992|581465608|FG006|Overall Study|Withdrawal by Subject|0|||
161020530|NCT04632992|581465609|FG007|Overall Study|Withdrawal by Subject|5|||
161020531|NCT04632992|581465610|FG008|Overall Study|Withdrawal by Subject|0|||
161020532|NCT04632992|581465611|FG009|Overall Study|Withdrawal by Subject|2|||
161020533|NCT04632992|581465612|FG010|Overall Study|Withdrawal by Subject|8|||
161020534|NCT04632992|581465613|FG011|Overall Study|Withdrawal by Subject|0|||
161020535|NCT04632992|581465614|FG012|Overall Study|Withdrawal by Subject|1|||
161020536|NCT04632992|581465615|FG013|Overall Study|Withdrawal by Subject|1|||
161020537|NCT02677805|581465616|FG000|Double Blind Phase|Lost to Follow-up|8|||
161020538|NCT02677805|581465617|FG001|Double Blind Phase|Lost to Follow-up|3|||
161020539|NCT02677805|581465618|FG002|Double Blind Phase|Lost to Follow-up|0|||
161020540|NCT02677805|581465616|FG000|Double Blind Phase|Withdrawal by Subject|5|||
161020541|NCT02677805|581465617|FG001|Double Blind Phase|Withdrawal by Subject|2|||
161020542|NCT02677805|581465618|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161020543|NCT02677805|581465616|FG000|Open Label Phase|Lost to Follow-up|0|||
161020544|NCT02677805|581465617|FG001|Open Label Phase|Lost to Follow-up|0|||
161020545|NCT02677805|581465618|FG002|Open Label Phase|Lost to Follow-up|10|||
161020546|NCT02677805|581465616|FG000|Open Label Phase|Withdrawal by Subject|0|||
161020547|NCT02677805|581465617|FG001|Open Label Phase|Withdrawal by Subject|0|||
161020548|NCT02677805|581465618|FG002|Open Label Phase|Withdrawal by Subject|6|||
161020549|NCT04111536|581465623|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
161020550|NCT04111536|581465624|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161020551|NCT04111536|581465623|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
161020552|NCT04111536|581465624|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
161020553|NCT04111536|581465623|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
161020554|NCT04111536|581465624|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
161020555|NCT04111536|581465623|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
161020556|NCT04111536|581465624|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
161020557|NCT04350463|581465625|FG000|Overall Study|Other reason|0|||
161020558|NCT04350463|581465626|FG001|Overall Study|Other reason|0|||
161020559|NCT04350463|581465627|FG002|Overall Study|Other reason|0|||
161020560|NCT04350463|581465628|FG003|Overall Study|Other reason|1|||
161020561|NCT04350463|581465625|FG000|Overall Study|Lost to Follow-up|0|||
161020562|NCT04350463|581465626|FG001|Overall Study|Lost to Follow-up|0|||
161020563|NCT04350463|581465627|FG002|Overall Study|Lost to Follow-up|0|||
161020564|NCT04350463|581465628|FG003|Overall Study|Lost to Follow-up|2|||
161020565|NCT04350463|581465625|FG000|Overall Study|Withdrawal by Subject|4|||
161020566|NCT04350463|581465626|FG001|Overall Study|Withdrawal by Subject|0|||
161020567|NCT04350463|581465627|FG002|Overall Study|Withdrawal by Subject|1|||
161020568|NCT04350463|581465628|FG003|Overall Study|Withdrawal by Subject|4|||
161020569|NCT04350463|581465625|FG000|Overall Study|Adverse Event|0|||
161020570|NCT04350463|581465626|FG001|Overall Study|Adverse Event|0|||
161020571|NCT04350463|581465627|FG002|Overall Study|Adverse Event|0|||
161020572|NCT04350463|581465628|FG003|Overall Study|Adverse Event|2|||
161020573|NCT04350463|581465625|FG000|Overall Study|Death|27|||
161020574|NCT04350463|581465626|FG001|Overall Study|Death|2|||
161020575|NCT04350463|581465627|FG002|Overall Study|Death|13|||
161020576|NCT04350463|581465628|FG003|Overall Study|Death|26|||
161020577|NCT04652700|581465629|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
161020578|NCT04652700|581465630|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
161020579|NCT04652700|581465629|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
161020580|NCT04652700|581465630|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
160459876|NCT01499368|579416589|FG001|Overall Study|Error of Prescriptions|0|||
161020581|NCT04652700|581465629|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
161020582|NCT04652700|581465630|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
161020583|NCT04652700|581465629|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
160459877|NCT01499368|579416590|FG002|Overall Study|Error of Prescriptions|1|||
160459878|NCT03092674|579416591|FG000|Overall Study|Adverse Event or Side Effects|1|||
161020584|NCT04652700|581465630|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
161020585|NCT04652700|581465629|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
161020586|NCT04652700|581465630|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
160459879|NCT03092674|579416592|FG001|Overall Study|Adverse Event or Side Effects|4|||
160632911|NCT02575807|580036108|FG004|Overall Study|Death|1|||
161020587|NCT04652700|581465629|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
161020588|NCT04652700|581465630|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
161020589|NCT04652700|581465629|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
161020590|NCT04652700|581465630|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
161020591|NCT04652700|581465629|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
161020592|NCT04652700|581465630|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
161020593|NCT04652700|581465629|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
161020594|NCT04652700|581465630|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
161020595|NCT04187833|581465631|FG000|Overall Study|Withdrawal by Subject|1|||
161020596|NCT06037369|581465635|FG000|Overall Study|Lost to Follow-up|0|||
161020597|NCT06037369|581465636|FG001|Overall Study|Lost to Follow-up|1|||
161020598|NCT04209465|581465637|FG000|Overall Study|Adverse Event|0|||
161020599|NCT04209465|581465638|FG001|Overall Study|Adverse Event|0|||
161020600|NCT04209465|581465639|FG002|Overall Study|Adverse Event|0|||
161020601|NCT04209465|581465640|FG003|Overall Study|Adverse Event|0|||
161020602|NCT04209465|581465641|FG004|Overall Study|Adverse Event|0|||
161020603|NCT04209465|581465642|FG005|Overall Study|Adverse Event|1|||
161020604|NCT04209465|581465643|FG006|Overall Study|Adverse Event|0|||
161020605|NCT04209465|581465644|FG007|Overall Study|Adverse Event|0|||
161020606|NCT04209465|581465645|FG008|Overall Study|Adverse Event|1|||
161020607|NCT04209465|581465646|FG009|Overall Study|Adverse Event|0|||
161020608|NCT04209465|581465647|FG010|Overall Study|Adverse Event|2|||
161020609|NCT04209465|581465648|FG011|Overall Study|Adverse Event|1|||
161020610|NCT04209465|581465649|FG012|Overall Study|Adverse Event|1|||
161020611|NCT04209465|581465637|FG000|Overall Study|Death|1|||
161020612|NCT04209465|581465638|FG001|Overall Study|Death|0|||
161020613|NCT04209465|581465639|FG002|Overall Study|Death|0|||
161020614|NCT04209465|581465640|FG003|Overall Study|Death|0|||
161020615|NCT04209465|581465641|FG004|Overall Study|Death|2|||
161020616|NCT04209465|581465642|FG005|Overall Study|Death|7|||
161020617|NCT04209465|581465643|FG006|Overall Study|Death|2|||
161020618|NCT04209465|581465644|FG007|Overall Study|Death|2|||
161020619|NCT04209465|581465645|FG008|Overall Study|Death|1|||
161020620|NCT04209465|581465646|FG009|Overall Study|Death|1|||
161020621|NCT04209465|581465647|FG010|Overall Study|Death|1|||
161020622|NCT04209465|581465648|FG011|Overall Study|Death|0|||
161020623|NCT04209465|581465649|FG012|Overall Study|Death|10|||
161020624|NCT04209465|581465637|FG000|Overall Study|Physician Decision|0|||
161020625|NCT04209465|581465638|FG001|Overall Study|Physician Decision|1|||
161020626|NCT04209465|581465639|FG002|Overall Study|Physician Decision|0|||
161020627|NCT04209465|581465640|FG003|Overall Study|Physician Decision|0|||
161020628|NCT04209465|581465641|FG004|Overall Study|Physician Decision|0|||
161020629|NCT04209465|581465642|FG005|Overall Study|Physician Decision|0|||
161020630|NCT04209465|581465643|FG006|Overall Study|Physician Decision|0|||
161020631|NCT04209465|581465644|FG007|Overall Study|Physician Decision|0|||
161020632|NCT04209465|581465645|FG008|Overall Study|Physician Decision|0|||
161020633|NCT04209465|581465646|FG009|Overall Study|Physician Decision|0|||
161020634|NCT04209465|581465647|FG010|Overall Study|Physician Decision|0|||
161020635|NCT04209465|581465648|FG011|Overall Study|Physician Decision|0|||
161020636|NCT04209465|581465649|FG012|Overall Study|Physician Decision|0|||
161020637|NCT04209465|581465637|FG000|Overall Study|Progressive Disease|0|||
161020638|NCT04209465|581465638|FG001|Overall Study|Progressive Disease|0|||
161020639|NCT04209465|581465639|FG002|Overall Study|Progressive Disease|1|||
161020640|NCT04209465|581465640|FG003|Overall Study|Progressive Disease|2|||
161020641|NCT04209465|581465641|FG004|Overall Study|Progressive Disease|8|||
161020642|NCT04209465|581465642|FG005|Overall Study|Progressive Disease|5|||
161020643|NCT04209465|581465643|FG006|Overall Study|Progressive Disease|3|||
161020644|NCT04209465|581465644|FG007|Overall Study|Progressive Disease|4|||
161020645|NCT04209465|581465645|FG008|Overall Study|Progressive Disease|1|||
161020646|NCT04209465|581465646|FG009|Overall Study|Progressive Disease|3|||
161020647|NCT04209465|581465647|FG010|Overall Study|Progressive Disease|2|||
161020648|NCT04209465|581465648|FG011|Overall Study|Progressive Disease|1|||
161020649|NCT04209465|581465649|FG012|Overall Study|Progressive Disease|0|||
160587208|NCT02065622|579867708|FG003|Maintenance Study|Other, Not Specified|14|||
160587209|NCT02065622|579867709|FG004|Maintenance Study|Other, Not Specified|2|||
160587210|NCT02065622|579867705|FG000|Maintenance Study|Unknown Reason|0|||
161020650|NCT04209465|581465637|FG000|Overall Study|Withdrawal by Subject|0|||
161020651|NCT04209465|581465638|FG001|Overall Study|Withdrawal by Subject|0|||
161020652|NCT04209465|581465639|FG002|Overall Study|Withdrawal by Subject|0|||
161020653|NCT04209465|581465640|FG003|Overall Study|Withdrawal by Subject|0|||
161020654|NCT04209465|581465641|FG004|Overall Study|Withdrawal by Subject|0|||
161020655|NCT04209465|581465642|FG005|Overall Study|Withdrawal by Subject|1|||
160587211|NCT02065622|579867706|FG001|Maintenance Study|Unknown Reason|0|||
160587212|NCT02065622|579867707|FG002|Maintenance Study|Unknown Reason|0|||
161020656|NCT04209465|581465643|FG006|Overall Study|Withdrawal by Subject|2|||
160587213|NCT02065622|579867708|FG003|Maintenance Study|Unknown Reason|1|||
161020657|NCT04209465|581465644|FG007|Overall Study|Withdrawal by Subject|0|||
161020658|NCT04209465|581465645|FG008|Overall Study|Withdrawal by Subject|1|||
161020659|NCT04209465|581465646|FG009|Overall Study|Withdrawal by Subject|0|||
161020660|NCT04209465|581465647|FG010|Overall Study|Withdrawal by Subject|0|||
161020661|NCT04209465|581465648|FG011|Overall Study|Withdrawal by Subject|2|||
161020662|NCT04209465|581465649|FG012|Overall Study|Withdrawal by Subject|2|||
161020663|NCT04209465|581465637|FG000|Overall Study|Lost to Follow-up|0|||
161020664|NCT04209465|581465638|FG001|Overall Study|Lost to Follow-up|0|||
161020665|NCT04209465|581465639|FG002|Overall Study|Lost to Follow-up|0|||
161020666|NCT04209465|581465640|FG003|Overall Study|Lost to Follow-up|0|||
161020667|NCT04209465|581465641|FG004|Overall Study|Lost to Follow-up|0|||
161020668|NCT04209465|581465642|FG005|Overall Study|Lost to Follow-up|1|||
161020669|NCT04209465|581465643|FG006|Overall Study|Lost to Follow-up|0|||
161020670|NCT04209465|581465644|FG007|Overall Study|Lost to Follow-up|0|||
161020671|NCT04209465|581465645|FG008|Overall Study|Lost to Follow-up|1|||
161020672|NCT04209465|581465646|FG009|Overall Study|Lost to Follow-up|0|||
161020673|NCT04209465|581465647|FG010|Overall Study|Lost to Follow-up|0|||
161020674|NCT04209465|581465648|FG011|Overall Study|Lost to Follow-up|1|||
161020675|NCT04209465|581465649|FG012|Overall Study|Lost to Follow-up|0|||
161020676|NCT04209465|581465637|FG000|Overall Study|Started new therapy|0|||
161020677|NCT04209465|581465638|FG001|Overall Study|Started new therapy|0|||
161020678|NCT04209465|581465639|FG002|Overall Study|Started new therapy|0|||
161020679|NCT04209465|581465640|FG003|Overall Study|Started new therapy|0|||
161020680|NCT04209465|581465641|FG004|Overall Study|Started new therapy|0|||
161020681|NCT04209465|581465642|FG005|Overall Study|Started new therapy|1|||
161020682|NCT04209465|581465643|FG006|Overall Study|Started new therapy|0|||
161020683|NCT04209465|581465644|FG007|Overall Study|Started new therapy|0|||
161020684|NCT04209465|581465645|FG008|Overall Study|Started new therapy|0|||
161020685|NCT04209465|581465646|FG009|Overall Study|Started new therapy|0|||
161020686|NCT04209465|581465647|FG010|Overall Study|Started new therapy|0|||
161020687|NCT04209465|581465648|FG011|Overall Study|Started new therapy|0|||
161020688|NCT04209465|581465649|FG012|Overall Study|Started new therapy|0|||
161020689|NCT04209465|581465637|FG000|Overall Study|Study terminated early by sponsor|0|||
161020690|NCT04209465|581465638|FG001|Overall Study|Study terminated early by sponsor|0|||
161020691|NCT04209465|581465639|FG002|Overall Study|Study terminated early by sponsor|0|||
161020692|NCT04209465|581465640|FG003|Overall Study|Study terminated early by sponsor|0|||
161020693|NCT04209465|581465641|FG004|Overall Study|Study terminated early by sponsor|0|||
161020694|NCT04209465|581465642|FG005|Overall Study|Study terminated early by sponsor|0|||
161020695|NCT04209465|581465643|FG006|Overall Study|Study terminated early by sponsor|3|||
161020696|NCT04209465|581465644|FG007|Overall Study|Study terminated early by sponsor|0|||
161020697|NCT04209465|581465645|FG008|Overall Study|Study terminated early by sponsor|0|||
161020698|NCT04209465|581465646|FG009|Overall Study|Study terminated early by sponsor|0|||
161020699|NCT04209465|581465647|FG010|Overall Study|Study terminated early by sponsor|0|||
161020700|NCT04209465|581465648|FG011|Overall Study|Study terminated early by sponsor|0|||
161020701|NCT04209465|581465649|FG012|Overall Study|Study terminated early by sponsor|3|||
161020702|NCT04209465|581465637|FG000|Overall Study|Other|0|||
161020703|NCT04209465|581465638|FG001|Overall Study|Other|0|||
161020704|NCT04209465|581465639|FG002|Overall Study|Other|0|||
161020705|NCT04209465|581465640|FG003|Overall Study|Other|0|||
161020706|NCT04209465|581465641|FG004|Overall Study|Other|0|||
161020707|NCT04209465|581465642|FG005|Overall Study|Other|0|||
161020708|NCT04209465|581465643|FG006|Overall Study|Other|0|||
161020709|NCT04209465|581465644|FG007|Overall Study|Other|0|||
161020710|NCT04209465|581465645|FG008|Overall Study|Other|1|||
161020711|NCT04209465|581465646|FG009|Overall Study|Other|0|||
161020712|NCT04209465|581465647|FG010|Overall Study|Other|0|||
161020713|NCT04209465|581465648|FG011|Overall Study|Other|0|||
161020714|NCT04209465|581465649|FG012|Overall Study|Other|0|||
161020715|NCT03097549|581465650|FG000|Overall Study|Withdrawal by Subject|1|||
161020716|NCT03097549|581465651|FG001|Overall Study|Withdrawal by Subject|0|||
161020717|NCT03097549|581465650|FG000|Overall Study|Lost to Follow-up|1|||
161020718|NCT03097549|581465651|FG001|Overall Study|Lost to Follow-up|0|||
161020719|NCT05783102|581465652|FG000|Overall Study|Lost to Follow-up|1|||
161020720|NCT05783102|581465652|FG000|Overall Study|Withdrawal by Subject|2|||
161020721|NCT05647304|581465653|FG000|Overall Study|Withdrawal by Subject|1|||
161020722|NCT05647304|581465654|FG001|Overall Study|Withdrawal by Subject|0|||
161020723|NCT04282148|581465657|FG000|Overall Study|Death|7|||
160587214|NCT02065622|579867709|FG004|Maintenance Study|Unknown Reason|0|||
161020724|NCT04282148|581465657|FG000|Overall Study|Withdrawal by Subject|1|||
161020725|NCT04282148|581465657|FG000|Overall Study|Physician Decision|1|||
161020726|NCT02146378|581465658|FG000|Overall Study|No information of administration|2|||
161020727|NCT06215521|581465659|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
161020728|NCT06215521|581465660|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
161020729|NCT06215521|581465661|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
161020730|NCT06215521|581465662|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
161020731|NCT06215521|581465663|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
161020732|NCT06215521|581465664|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
161020733|NCT04096040|581465665|FG000|Overall Study|Protocol Violation|12|||
161020734|NCT04096040|581465665|FG000|Overall Study|Non-compliant site|4|||
161020735|NCT04973254|581465666|FG000|Overall Study|Not adherent|0|||
161020736|NCT04973254|581465667|FG001|Overall Study|Not adherent|1|||
161020737|NCT04973254|581465668|FG002|Overall Study|Not adherent|0|||
160587215|NCT02198651|579869818|FG000|Lead-in Period|Withdrew consent|13|||
160587216|NCT02198651|579869819|FG001|Lead-in Period|Withdrew consent|0|||
160587217|NCT02198651|579869820|FG002|Lead-in Period|Withdrew consent|0|||
160587218|NCT02198651|579869821|FG003|Lead-in Period|Withdrew consent|0|||
160587219|NCT02198651|579869822|FG004|Lead-in Period|Withdrew consent|0|||
160587220|NCT02198651|579869818|FG000|Lead-in Period|Adverse Event|2|||
160587221|NCT02198651|579869819|FG001|Lead-in Period|Adverse Event|0|||
160587222|NCT02198651|579869820|FG002|Lead-in Period|Adverse Event|0|||
160587223|NCT02198651|579869821|FG003|Lead-in Period|Adverse Event|0|||
160587224|NCT02198651|579869822|FG004|Lead-in Period|Adverse Event|0|||
160587225|NCT02198651|579869818|FG000|Lead-in Period|Other, not specified|22|||
160587226|NCT02198651|579869819|FG001|Lead-in Period|Other, not specified|0|||
160587227|NCT02198651|579869820|FG002|Lead-in Period|Other, not specified|0|||
160587228|NCT02198651|579869821|FG003|Lead-in Period|Other, not specified|0|||
160587229|NCT02198651|579869822|FG004|Lead-in Period|Other, not specified|0|||
160587230|NCT02198651|579869818|FG000|Double-blind Period|Withdrew consent|0|||
160587231|NCT02198651|579869819|FG001|Double-blind Period|Withdrew consent|4|||
160587232|NCT02198651|579869820|FG002|Double-blind Period|Withdrew consent|0|||
160587233|NCT02198651|579869821|FG003|Double-blind Period|Withdrew consent|0|||
160587234|NCT02198651|579869822|FG004|Double-blind Period|Withdrew consent|0|||
160587235|NCT02198651|579869818|FG000|Double-blind Period|Adverse Event|0|||
160587236|NCT02198651|579869819|FG001|Double-blind Period|Adverse Event|1|||
160587237|NCT02198651|579869820|FG002|Double-blind Period|Adverse Event|0|||
160587238|NCT02198651|579869821|FG003|Double-blind Period|Adverse Event|0|||
160587239|NCT02198651|579869822|FG004|Double-blind Period|Adverse Event|0|||
160587240|NCT02198651|579869818|FG000|Double-blind Period|Other, not specified|0|||
160587241|NCT02198651|579869819|FG001|Double-blind Period|Other, not specified|4|||
160587242|NCT02198651|579869820|FG002|Double-blind Period|Other, not specified|1|||
160587243|NCT02198651|579869821|FG003|Double-blind Period|Other, not specified|0|||
160587244|NCT02198651|579869822|FG004|Double-blind Period|Other, not specified|0|||
160587245|NCT02198651|579869818|FG000|Open-label Rescue Period|Withdrew consent|0|||
160587246|NCT02198651|579869819|FG001|Open-label Rescue Period|Withdrew consent|0|||
160587247|NCT02198651|579869820|FG002|Open-label Rescue Period|Withdrew consent|0|||
160587248|NCT02198651|579869821|FG003|Open-label Rescue Period|Withdrew consent|2|||
160587249|NCT02198651|579869822|FG004|Open-label Rescue Period|Withdrew consent|0|||
160587250|NCT02198651|579869818|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
160587251|NCT02198651|579869819|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
160587252|NCT02198651|579869820|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
160587253|NCT02198651|579869821|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
160587254|NCT02198651|579869822|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
160587255|NCT02922634|579869825|FG000|Overall Study|Withdrawal by Subject|5|||
161020738|NCT04044768|581465669|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
161020739|NCT04044768|581465670|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
161020740|NCT05089019|581465671|FG000|Period 1|Withdrawal by Subject|0|||
161020741|NCT05089019|581465672|FG001|Period 1|Withdrawal by Subject|1|||
161020742|NCT05089019|581465671|FG000|Washout Period|Adverse Event|3|||
161020743|NCT05089019|581465672|FG001|Washout Period|Adverse Event|4|||
161020744|NCT05089019|581465671|FG000|Washout Period|Lost to Follow-up|1|||
161020745|NCT05089019|581465672|FG001|Washout Period|Lost to Follow-up|0|||
161020746|NCT05089019|581465671|FG000|Washout Period|Physician Decision|2|||
161020747|NCT05089019|581465672|FG001|Washout Period|Physician Decision|0|||
161020748|NCT05089019|581465671|FG000|Washout Period|Withdrawal by Subject|6|||
161020749|NCT05089019|581465672|FG001|Washout Period|Withdrawal by Subject|3|||
161020750|NCT05089019|581465671|FG000|Period 2|Adverse Event|4|||
161020751|NCT05089019|581465672|FG001|Period 2|Adverse Event|2|||
161020752|NCT05089019|581465671|FG000|Period 2|Lost to Follow-up|1|||
161020753|NCT05089019|581465672|FG001|Period 2|Lost to Follow-up|0|||
161020754|NCT05089019|581465671|FG000|Period 2|Withdrawal by Subject|0|||
161020755|NCT05089019|581465672|FG001|Period 2|Withdrawal by Subject|1|||
161020756|NCT05170009|581465673|FG000|Overall Study|Physician Decision|0|||
161020757|NCT05170009|581465674|FG001|Overall Study|Physician Decision|1|||
161020758|NCT04925986|581465675|FG000|Overall Study|Death|0|||
160587256|NCT02922634|579869825|FG000|Overall Study|Did not have their surgery|5|||
161020759|NCT04925986|581465676|FG001|Overall Study|Death|0|||
161020760|NCT04925986|581465677|FG002|Overall Study|Death|2|||
160587257|NCT02625324|579869826|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
160587258|NCT02625324|579869826|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
160587259|NCT02625324|579869826|FG000|6-Month Follow-up Subject Accountability|Death|5|||
160587260|NCT02625324|579869826|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
160587261|NCT02625324|579869826|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
160587262|NCT02625324|579869826|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
161020761|NCT04925986|581465678|FG003|Overall Study|Death|0|||
160587263|NCT02625324|579869826|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
161020762|NCT04925986|581465675|FG000|Overall Study|Lack of Efficacy|1|||
161020763|NCT04925986|581465676|FG001|Overall Study|Lack of Efficacy|2|||
161020764|NCT04925986|581465677|FG002|Overall Study|Lack of Efficacy|0|||
160587264|NCT02625324|579869826|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
160587265|NCT02625324|579869826|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
160587266|NCT02625324|579869826|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
160587267|NCT02625324|579869826|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
160587268|NCT02625324|579869826|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
160587269|NCT02625324|579869826|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
160587270|NCT02625324|579869826|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
160587271|NCT02625324|579869826|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
160587272|NCT02625324|579869826|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
160587273|NCT02625324|579869826|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
160587274|NCT00352755|579869827|FG000|Overall Study|Physician Decision|1|||
160587275|NCT00352755|579869827|FG000|Overall Study|Adverse Event|1|||
160587276|NCT02397694|579869830|FG000|Double-Blinded Phase|Adverse Event|1|||
160587277|NCT02397694|579869831|FG001|Double-Blinded Phase|Adverse Event|0|||
160587278|NCT02397694|579869830|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
160587279|NCT02397694|579869831|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
160587280|NCT02397694|579869830|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
160587281|NCT02397694|579869831|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
160587282|NCT02397694|579869830|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
160587283|NCT02397694|579869831|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
160587284|NCT02397694|579869830|FG000|Open Label Extension Phase|Protocol Violation|1|||
160587285|NCT02397694|579869831|FG001|Open Label Extension Phase|Protocol Violation|0|||
160587286|NCT02397694|579869830|FG000|Open Label Extension Phase|Withdrew Consent|3|||
160587287|NCT02397694|579869831|FG001|Open Label Extension Phase|Withdrew Consent|1|||
160587288|NCT02397694|579869830|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
160587289|NCT02397694|579869831|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
160587290|NCT02115113|579869832|FG000|Participants in Run-in Period|Death|0|||
160587291|NCT02115113|579869833|FG001|Participants in Run-in Period|Death|0|||
160587292|NCT02115113|579869834|FG002|Participants in Run-in Period|Death|1|||
160587293|NCT02115113|579869832|FG000|Participants in Run-in Period|Administrative problems|0|||
160587294|NCT02115113|579869833|FG001|Participants in Run-in Period|Administrative problems|0|||
160587295|NCT02115113|579869834|FG002|Participants in Run-in Period|Administrative problems|1|||
160587296|NCT02115113|579869832|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
160587297|NCT02115113|579869833|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
160587298|NCT02115113|579869834|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
161020765|NCT04925986|581465678|FG003|Overall Study|Lack of Efficacy|1|||
161020766|NCT04925986|581465675|FG000|Overall Study|Withdrawal by Subject|0|||
161020767|NCT04925986|581465676|FG001|Overall Study|Withdrawal by Subject|0|||
161020768|NCT04925986|581465677|FG002|Overall Study|Withdrawal by Subject|1|||
161020769|NCT04925986|581465678|FG003|Overall Study|Withdrawal by Subject|2|||
161020770|NCT03858634|581465679|FG000|Overall Study|Withdrawal by Subject|1|||
161020771|NCT03858634|581465680|FG001|Overall Study|Withdrawal by Subject|0|||
161020772|NCT03858634|581465679|FG000|Overall Study|Adverse Event|1|||
161020773|NCT03858634|581465680|FG001|Overall Study|Adverse Event|0|||
161020774|NCT03858634|581465679|FG000|Overall Study|Lost to Follow-up|0|||
161020775|NCT03858634|581465680|FG001|Overall Study|Lost to Follow-up|1|||
161020776|NCT03858634|581465679|FG000|Overall Study|Other, Not Specified|1|||
161020777|NCT03858634|581465680|FG001|Overall Study|Other, Not Specified|1|||
161020778|NCT03808818|581465681|FG000|Overall Study|Death|6|||
161020779|NCT03808818|581465682|FG001|Overall Study|Death|6|||
161020780|NCT03808818|581465681|FG000|Overall Study|Withdrawal by Subject|7|||
161020781|NCT03808818|581465682|FG001|Overall Study|Withdrawal by Subject|18|||
161020782|NCT03808818|581465681|FG000|Overall Study|Lost to Follow-up|31|||
161020783|NCT03808818|581465682|FG001|Overall Study|Lost to Follow-up|33|||
161020784|NCT06181760|581465683|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
161020785|NCT06181760|581465684|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
161020786|NCT06181760|581465685|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
161020787|NCT06181760|581465686|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
161020788|NCT05415722|581465688|FG000|Overall Study|Lost to Follow-up|0|||
161020789|NCT05415722|581465689|FG001|Overall Study|Lost to Follow-up|2|||
161020790|NCT05415722|581465690|FG002|Overall Study|Lost to Follow-up|0|||
160587299|NCT02115113|579869832|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
161020791|NCT05415722|581465691|FG003|Overall Study|Lost to Follow-up|1|||
161020792|NCT05415722|581465692|FG004|Overall Study|Lost to Follow-up|0|||
161020793|NCT05415722|581465693|FG005|Overall Study|Lost to Follow-up|0|||
161020794|NCT05415722|581465694|FG006|Overall Study|Lost to Follow-up|1|||
161020795|NCT05415722|581465688|FG000|Overall Study|Physician Decision|0|||
161020796|NCT05415722|581465689|FG001|Overall Study|Physician Decision|0|||
160587300|NCT02115113|579869833|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
161020797|NCT05415722|581465690|FG002|Overall Study|Physician Decision|0|||
161020798|NCT05415722|581465691|FG003|Overall Study|Physician Decision|1|||
161020799|NCT05415722|581465692|FG004|Overall Study|Physician Decision|0|||
161020800|NCT05415722|581465693|FG005|Overall Study|Physician Decision|0|||
161020801|NCT05415722|581465694|FG006|Overall Study|Physician Decision|1|||
161020802|NCT05415722|581465688|FG000|Overall Study|Protocol Violation|0|||
161020803|NCT05415722|581465689|FG001|Overall Study|Protocol Violation|0|||
161020804|NCT05415722|581465690|FG002|Overall Study|Protocol Violation|0|||
161020805|NCT05415722|581465691|FG003|Overall Study|Protocol Violation|1|||
161020806|NCT05415722|581465692|FG004|Overall Study|Protocol Violation|0|||
161020807|NCT05415722|581465693|FG005|Overall Study|Protocol Violation|0|||
161020808|NCT05415722|581465694|FG006|Overall Study|Protocol Violation|0|||
161020809|NCT05415722|581465688|FG000|Overall Study|Sponsor Discretion|0|||
161020810|NCT05415722|581465689|FG001|Overall Study|Sponsor Discretion|0|||
161020811|NCT05415722|581465690|FG002|Overall Study|Sponsor Discretion|0|||
161020812|NCT05415722|581465691|FG003|Overall Study|Sponsor Discretion|0|||
161020813|NCT05415722|581465692|FG004|Overall Study|Sponsor Discretion|1|||
161020814|NCT05415722|581465693|FG005|Overall Study|Sponsor Discretion|1|||
161020815|NCT05415722|581465694|FG006|Overall Study|Sponsor Discretion|0|||
161020816|NCT05415722|581465688|FG000|Overall Study|Withdrawal by Subject|0|||
161020817|NCT05415722|581465689|FG001|Overall Study|Withdrawal by Subject|1|||
161020818|NCT05415722|581465690|FG002|Overall Study|Withdrawal by Subject|0|||
161020819|NCT05415722|581465691|FG003|Overall Study|Withdrawal by Subject|1|||
161020820|NCT05415722|581465692|FG004|Overall Study|Withdrawal by Subject|1|||
161020821|NCT05415722|581465693|FG005|Overall Study|Withdrawal by Subject|0|||
161020822|NCT05415722|581465694|FG006|Overall Study|Withdrawal by Subject|1|||
161020823|NCT04629716|581465695|FG000|Overall Study|Lost to Follow-up|7|||
161020824|NCT04629716|581465696|FG001|Overall Study|Lost to Follow-up|3|||
161020825|NCT03524612|581465697|FG000|Overall Study|Lack of Efficacy|10|||
161020826|NCT03524612|581465697|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
161020827|NCT03524612|581465697|FG000|Overall Study|Adverse Event|10|||
161020828|NCT03524612|581465697|FG000|Overall Study|Withdrawal by Subject|7|||
161020829|NCT03524612|581465697|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
161020830|NCT03524612|581465697|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
161020831|NCT03524612|581465697|FG000|Overall Study|New therapy for study indication|6|||
161020832|NCT03524612|581465697|FG000|Overall Study|Death|3|||
161020833|NCT03524612|581465697|FG000|Overall Study|Lost to Follow-up|2|||
161020834|NCT03524612|581465697|FG000|Overall Study|Protocol Violation|1|||
161020835|NCT04537715|581465699|FG000|Overall Study|Death|3|||
161020836|NCT04537715|581465700|FG001|Overall Study|Death|1|||
161020837|NCT04537715|581465699|FG000|Overall Study|Withdrawal by Subject|3|||
161020838|NCT04537715|581465700|FG001|Overall Study|Withdrawal by Subject|1|||
161020839|NCT04537715|581465699|FG000|Overall Study|Other|4|||
161020840|NCT04537715|581465700|FG001|Overall Study|Other|3|||
161020841|NCT04537715|581465699|FG000|Overall Study|Progressive disease|1|||
161020842|NCT04537715|581465700|FG001|Overall Study|Progressive disease|0|||
161020843|NCT05457647|581465702|FG000|Overall Study|Lost to Follow-up|3|||
161020844|NCT03448107|581465703|FG000|Overall Study|Lost to Follow-up|229|||
161020845|NCT03448107|581465704|FG001|Overall Study|Lost to Follow-up|258|||
161020846|NCT03115476|581465705|FG000|LP0084-1369|Death|1|||
161020847|NCT03115476|581465706|FG001|LP0084-1369|Death|0|||
161020848|NCT03115476|581465707|FG002|LP0084-1369|Death|2|||
161020849|NCT03115476|581465705|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
161020850|NCT03115476|581465706|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
161020851|NCT03115476|581465707|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
161020852|NCT05228457|581465711|FG000|Overall Study|Withdrawal by Subject|1|||
161020853|NCT05228457|581465712|FG001|Overall Study|Withdrawal by Subject|1|||
161020854|NCT05302596|581465728|FG000|Overall Study|Withdrawal by Subject|1|||
161020855|NCT05302596|581465729|FG001|Overall Study|Withdrawal by Subject|1|||
161020856|NCT03287817|581468040|FG000|Overall Study|Progressive disease|4|||
161020857|NCT03287817|581468041|FG001|Overall Study|Progressive disease|2|||
161020858|NCT03287817|581468042|FG002|Overall Study|Progressive disease|3|||
161020859|NCT03287817|581468043|FG003|Overall Study|Progressive disease|10|||
161020860|NCT03287817|581468044|FG004|Overall Study|Progressive disease|8|||
161020861|NCT03287817|581468040|FG000|Overall Study|Death|0|||
161020862|NCT03287817|581468041|FG001|Overall Study|Death|0|||
161020863|NCT03287817|581468042|FG002|Overall Study|Death|2|||
161020864|NCT03287817|581468043|FG003|Overall Study|Death|3|||
161020865|NCT03287817|581468044|FG004|Overall Study|Death|4|||
161020866|NCT03287817|581468040|FG000|Overall Study|Physician Decision|0|||
161020867|NCT03287817|581468041|FG001|Overall Study|Physician Decision|0|||
161020868|NCT03287817|581468042|FG002|Overall Study|Physician Decision|0|||
160459880|NCT03092674|579416593|FG002|Overall Study|Adverse Event or Side Effects|4|||
160459881|NCT03092674|579416591|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
160459882|NCT03092674|579416592|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
160459883|NCT03092674|579416593|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
161020869|NCT03287817|581468043|FG003|Overall Study|Physician Decision|1|||
161020870|NCT03287817|581468044|FG004|Overall Study|Physician Decision|0|||
161020871|NCT03287817|581468040|FG000|Overall Study|Withdrawal by Subject|0|||
161020872|NCT03287817|581468041|FG001|Overall Study|Withdrawal by Subject|0|||
161020873|NCT03287817|581468042|FG002|Overall Study|Withdrawal by Subject|0|||
161020874|NCT03287817|581468043|FG003|Overall Study|Withdrawal by Subject|0|||
161020875|NCT03287817|581468044|FG004|Overall Study|Withdrawal by Subject|4|||
160587301|NCT02115113|579869834|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
160587302|NCT02115113|579869832|FG000|Participants Randomized|Lost to Follow-up|1|||
160587303|NCT02115113|579869833|FG001|Participants Randomized|Lost to Follow-up|0|||
160587304|NCT02115113|579869834|FG002|Participants Randomized|Lost to Follow-up|0|||
160587305|NCT02115113|579869832|FG000|Participants Randomized|Death|1|||
160587306|NCT02115113|579869833|FG001|Participants Randomized|Death|0|||
160587307|NCT02115113|579869834|FG002|Participants Randomized|Death|0|||
160587308|NCT00789191|579869836|FG000|Overall Study|Adverse Event|2|||
160587309|NCT00789191|579869837|FG001|Overall Study|Adverse Event|4|||
160587310|NCT00789191|579869836|FG000|Overall Study|Lack of Efficacy|0|||
160587311|NCT00789191|579869837|FG001|Overall Study|Lack of Efficacy|5|||
160587312|NCT00789191|579869836|FG000|Overall Study|Protocol Violation|5|||
160587313|NCT00789191|579869837|FG001|Overall Study|Protocol Violation|3|||
160587314|NCT00789191|579869836|FG000|Overall Study|Withdrawal Criteria|2|||
160587315|NCT00789191|579869837|FG001|Overall Study|Withdrawal Criteria|4|||
160587316|NCT00789191|579869836|FG000|Overall Study|Unclassified|5|||
160587317|NCT00789191|579869837|FG001|Overall Study|Unclassified|3|||
160587318|NCT00296725|579869845|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
160587319|NCT00296725|579869845|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
160969597|NCT02487472|581276893|FG000|Overall Study|Did not complete telephonic interviews|9|||
160969598|NCT02487472|581276893|FG000|Overall Study|Other|2|||
160969599|NCT01313286|581276894|FG000|Period 1|Withdrawal by Subject|2|||
160969600|NCT01313286|581276895|FG001|Period 1|Withdrawal by Subject|0|||
160969601|NCT00654901|581276896|FG000|Overall Study|Lost to Follow-up|1|||
160969602|NCT00654901|581276897|FG001|Overall Study|Lost to Follow-up|0|||
160969603|NCT00654901|581276898|FG002|Overall Study|Lost to Follow-up|1|||
160969604|NCT00654901|581276899|FG003|Overall Study|Lost to Follow-up|0|||
160969605|NCT00654901|581276896|FG000|Overall Study|Withdrawal by Subject|3|||
160969606|NCT00654901|581276897|FG001|Overall Study|Withdrawal by Subject|0|||
160969607|NCT00654901|581276898|FG002|Overall Study|Withdrawal by Subject|1|||
160969608|NCT00654901|581276899|FG003|Overall Study|Withdrawal by Subject|0|||
160969609|NCT04843930|581276901|FG000|Randomization|Withdrawal by Subject|6|||
160969610|NCT04843930|581276902|FG001|Randomization|Withdrawal by Subject|6|||
160969611|NCT04843930|581276903|FG002|Randomization|Withdrawal by Subject|0|||
160969612|NCT04843930|581276904|FG003|Randomization|Withdrawal by Subject|0|||
160969613|NCT04843930|581276901|FG000|Week 6 Assessment|Adverse Event|3|||
160969614|NCT04843930|581276902|FG001|Week 6 Assessment|Adverse Event|0|||
160969615|NCT04843930|581276903|FG002|Week 6 Assessment|Adverse Event|0|||
160969616|NCT04843930|581276904|FG003|Week 6 Assessment|Adverse Event|0|||
160969617|NCT04843930|581276901|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
160969618|NCT04843930|581276902|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
160969619|NCT04843930|581276903|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
160969620|NCT04843930|581276904|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
160969621|NCT04843930|581276901|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
160969622|NCT04843930|581276902|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
160969623|NCT04843930|581276903|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
160969624|NCT04843930|581276904|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
160969625|NCT04631705|581276905|FG000|Overall Study|Withdrawal by Subject|0|||
160969626|NCT04631705|581276906|FG001|Overall Study|Withdrawal by Subject|0|||
160969627|NCT04631705|581276907|FG002|Overall Study|Withdrawal by Subject|0|||
160969628|NCT04631705|581276908|FG003|Overall Study|Withdrawal by Subject|0|||
160969629|NCT04631705|581276909|FG004|Overall Study|Withdrawal by Subject|0|||
160969630|NCT04631705|581276910|FG005|Overall Study|Withdrawal by Subject|0|||
160969631|NCT04631705|581276911|FG006|Overall Study|Withdrawal by Subject|1|||
160969632|NCT04631705|581276912|FG007|Overall Study|Withdrawal by Subject|0|||
160969633|NCT04631705|581276913|FG008|Overall Study|Withdrawal by Subject|0|||
160969634|NCT01521884|581276915|FG000|Overall Study|Non Responders|10|||
160969635|NCT01521884|581276915|FG000|Overall Study|Adverse Event|5|||
160969636|NCT01521884|581276915|FG000|Overall Study|Pregnancy|1|||
160969637|NCT01521884|581276915|FG000|Overall Study|Withdrawal by Subject|1|||
160969638|NCT01521884|581276915|FG000|Overall Study|Physician Decision|2|||
160969639|NCT01521884|581276915|FG000|Overall Study|Protocol Violation|3|||
160969640|NCT01521884|581276915|FG000|Overall Study|Participant non-eligible|1|||
160969641|NCT01521884|581276915|FG000|Overall Study|Lost to Follow-up|4|||
160969642|NCT04241094|581276916|FG000|Overall Study|Dropped out of treatment|4|||
160969643|NCT04241094|581276916|FG000|Overall Study|Ineligible after clinical assessment|2|||
160969644|NCT04241094|581276916|FG000|Overall Study|Lost to Follow-up|2|||
160969645|NCT02332590|581276917|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
160969646|NCT02332590|581276918|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
160969647|NCT02332590|581276917|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
160969648|NCT02332590|581276918|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
160969649|NCT02332590|581276917|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
160969650|NCT02332590|581276918|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
160969651|NCT02332590|581276917|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
160969652|NCT02332590|581276918|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
160969653|NCT02332590|581276917|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
160969654|NCT02332590|581276918|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
160969655|NCT02332590|581276917|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
160969656|NCT02332590|581276918|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
160969657|NCT02332590|581276917|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
160969658|NCT02332590|581276918|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
160969659|NCT02332590|581276917|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
160969660|NCT02332590|581276918|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
161020876|NCT05251909|581468049|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
161020877|NCT05251909|581468050|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
161020878|NCT04130438|581468051|FG000|Overall Study|Lost to Follow-up|0|||
161020879|NCT04130438|581468052|FG001|Overall Study|Lost to Follow-up|0|||
161020880|NCT04130438|581468053|FG002|Overall Study|Lost to Follow-up|1|||
161020881|NCT03338933|581468055|FG000|Screening Visit|Lost to Follow-up|1|||
161020882|NCT03338933|581468056|FG001|Screening Visit|Lost to Follow-up|3|||
161020883|NCT03338933|581468057|FG002|Screening Visit|Lost to Follow-up|1|||
161020884|NCT03338933|581468058|FG003|Screening Visit|Lost to Follow-up|4|||
161020885|NCT03338933|581468055|FG000|Screening Visit|Screen fail after consent|2|||
161020886|NCT03338933|581468056|FG001|Screening Visit|Screen fail after consent|7|||
161020887|NCT03338933|581468057|FG002|Screening Visit|Screen fail after consent|1|||
161020888|NCT03338933|581468058|FG003|Screening Visit|Screen fail after consent|4|||
161020889|NCT03338933|581468055|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
161020890|NCT03338933|581468056|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
161020891|NCT03338933|581468057|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
161020892|NCT03338933|581468058|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
161020893|NCT03338933|581468055|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
161020894|NCT03338933|581468056|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
161020895|NCT03338933|581468057|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
161020896|NCT03338933|581468058|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
161020897|NCT03338933|581468055|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
161020898|NCT03338933|581468056|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
161020899|NCT03338933|581468057|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
161020900|NCT03338933|581468058|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
161020901|NCT04764448|581468059|FG000|Overall Study|Study terminated by sponsor|2|||
161020902|NCT04764448|581468060|FG001|Overall Study|Study terminated by sponsor|2|||
161020903|NCT04764448|581468061|FG002|Overall Study|Study terminated by sponsor|5|||
161020904|NCT04764448|581468059|FG000|Overall Study|Withdrawal by Subject|3|||
161020905|NCT04764448|581468060|FG001|Overall Study|Withdrawal by Subject|3|||
161020906|NCT04764448|581468061|FG002|Overall Study|Withdrawal by Subject|1|||
161020907|NCT01084876|581468062|FG000|Main Study Treatment Period|Adverse Event|12|||
161020908|NCT01084876|581468063|FG001|Main Study Treatment Period|Adverse Event|7|||
161020909|NCT01084876|581468062|FG000|Main Study Treatment Period|Disease Progression|41|||
161020910|NCT01084876|581468063|FG001|Main Study Treatment Period|Disease Progression|24|||
161020911|NCT01084876|581468062|FG000|Main Study Treatment Period|Physician Decision|2|||
161020912|NCT01084876|581468063|FG001|Main Study Treatment Period|Physician Decision|0|||
161020913|NCT01084876|581468062|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
161020914|NCT01084876|581468063|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
160587320|NCT00296725|579869845|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
160587321|NCT00356863|579869848|FG000|Overall Study|Death|16|||
160587322|NCT00356863|579869849|FG001|Overall Study|Death|32|||
160587323|NCT00356863|579869848|FG000|Overall Study|Lost to Follow-up|76|||
160587324|NCT00356863|579869849|FG001|Overall Study|Lost to Follow-up|43|||
160587325|NCT03137121|579869856|FG000|Overall Study|Withdrawal by Subject|0|||
160587326|NCT03137121|579869857|FG001|Overall Study|Withdrawal by Subject|1|||
161020915|NCT01084876|581468062|FG000|Main Study Treatment Period|Other Reason|0|||
161020916|NCT01084876|581468063|FG001|Main Study Treatment Period|Other Reason|1|||
161020917|NCT01084876|581468062|FG000|Main Study Treatment Period|Other|0|||
161020918|NCT01084876|581468063|FG001|Main Study Treatment Period|Other|1|||
161020919|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
161020920|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
161020921|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
161020922|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
161020923|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
160459884|NCT03092674|579416591|FG000|Overall Study|Progression/Relapse|5|||
160587327|NCT00836277|579869861|FG000|Overall Study|Not evaluable for response|6|||
161020924|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
160459885|NCT03092674|579416592|FG001|Overall Study|Progression/Relapse|4|||
161020925|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
161020926|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
161020927|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
161020928|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
161020929|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Other|6|||
161020930|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Other|9|||
161020931|NCT04515576|581468064|FG000|Overall Study|Withdrawal by Subject|0|||
161020932|NCT04515576|581468065|FG001|Overall Study|Withdrawal by Subject|0|||
161020933|NCT04515576|581468066|FG002|Overall Study|Withdrawal by Subject|0|||
161020934|NCT04515576|581468067|FG003|Overall Study|Withdrawal by Subject|0|||
161020935|NCT04515576|581468068|FG004|Overall Study|Withdrawal by Subject|0|||
161020936|NCT04515576|581468069|FG005|Overall Study|Withdrawal by Subject|1|||
161020937|NCT02577835|581468070|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
161020938|NCT04342494|581468071|FG000|Overall Study|Questionnaire partially completed|1|||
161020939|NCT04342494|581468072|FG001|Overall Study|Questionnaire partially completed|0|||
161020940|NCT04342494|581468073|FG002|Overall Study|Questionnaire partially completed|2|||
161020941|NCT04342494|581468074|FG003|Overall Study|Questionnaire partially completed|0|||
161020942|NCT04342494|581468075|FG004|Overall Study|Questionnaire partially completed|1|||
161020943|NCT04342494|581468071|FG000|Overall Study|Lost to Follow-up|49|||
161020944|NCT04342494|581468072|FG001|Overall Study|Lost to Follow-up|38|||
161020945|NCT04342494|581468073|FG002|Overall Study|Lost to Follow-up|34|||
161020946|NCT04342494|581468074|FG003|Overall Study|Lost to Follow-up|34|||
161020947|NCT04342494|581468075|FG004|Overall Study|Lost to Follow-up|35|||
161020948|NCT05119023|581468077|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
161020949|NCT05119023|581468077|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
161020950|NCT05119023|581468077|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
161020951|NCT03194217|581468078|FG000|Overall Study|Adverse Event|0|||
161020952|NCT03194217|581468079|FG001|Overall Study|Adverse Event|2|||
161020953|NCT03194217|581468080|FG002|Overall Study|Adverse Event|3|||
161020954|NCT03194217|581468081|FG003|Overall Study|Adverse Event|3|||
161020955|NCT03194217|581468078|FG000|Overall Study|Failure to meet randomisation criteria|0|||
161020956|NCT03194217|581468079|FG001|Overall Study|Failure to meet randomisation criteria|0|||
161020957|NCT03194217|581468080|FG002|Overall Study|Failure to meet randomisation criteria|0|||
161020958|NCT03194217|581468081|FG003|Overall Study|Failure to meet randomisation criteria|1|||
161020959|NCT03194217|581468078|FG000|Overall Study|Other|0|||
161020960|NCT03194217|581468079|FG001|Overall Study|Other|1|||
161020961|NCT03194217|581468080|FG002|Overall Study|Other|1|||
161020962|NCT03194217|581468081|FG003|Overall Study|Other|0|||
161020963|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
161020964|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
161020965|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
161020966|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161020967|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161020968|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161020969|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161020970|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020971|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
161020972|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020973|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020974|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020975|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020976|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020977|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161020978|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
161020979|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
161020980|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161020981|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161020982|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161020983|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161020984|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
161020985|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020986|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020987|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020988|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020989|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020990|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020991|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020992|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
161020993|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020994|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020995|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020996|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020997|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020998|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161020999|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161021000|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161021001|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
161021002|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161021003|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161021004|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161021005|NCT02962895|581468082|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021006|NCT02962895|581468083|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021007|NCT02962895|581468084|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021008|NCT02962895|581468085|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021009|NCT02962895|581468086|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021010|NCT02962895|581468087|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021011|NCT02962895|581468088|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
161021012|NCT02962895|581468082|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161021013|NCT02962895|581468083|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161021014|NCT02962895|581468084|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161021015|NCT02962895|581468085|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161021016|NCT02962895|581468086|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
161021017|NCT02962895|581468087|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161021018|NCT02962895|581468088|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
161021019|NCT02962895|581468082|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021020|NCT02962895|581468083|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021021|NCT02962895|581468084|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021022|NCT02962895|581468085|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021023|NCT02962895|581468086|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021024|NCT02962895|581468087|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021025|NCT02962895|581468088|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
161021026|NCT02962895|581468082|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021027|NCT02962895|581468083|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
161021028|NCT02962895|581468084|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021029|NCT02962895|581468085|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021030|NCT02962895|581468086|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021031|NCT02962895|581468087|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021032|NCT02962895|581468088|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021033|NCT02962895|581468082|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021034|NCT02962895|581468083|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021035|NCT02962895|581468084|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021036|NCT02962895|581468085|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021037|NCT02962895|581468086|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
161021038|NCT02962895|581468087|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021039|NCT02962895|581468088|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021040|NCT02962895|581468082|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021041|NCT02962895|581468083|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021042|NCT02962895|581468084|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021043|NCT02962895|581468085|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021044|NCT02962895|581468086|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
161021045|NCT02962895|581468087|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021046|NCT02962895|581468088|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021047|NCT02962895|581468082|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161021048|NCT02962895|581468083|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
161021049|NCT02962895|581468084|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
161021050|NCT02962895|581468085|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
161021051|NCT02962895|581468086|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161021052|NCT02962895|581468087|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
160459886|NCT03092674|579416593|FG002|Overall Study|Progression/Relapse|8|||
160459887|NCT03092674|579416591|FG000|Overall Study|Death|4|||
161021053|NCT02962895|581468088|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161021054|NCT02962895|581468082|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
161021055|NCT02962895|581468083|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
161021056|NCT02962895|581468084|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
161021057|NCT02962895|581468085|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
161021058|NCT02962895|581468086|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
161021059|NCT02962895|581468087|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
161021060|NCT02962895|581468088|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
161021061|NCT04509674|581468091|FG000|Overall Study|Not treated|33|||
161021062|NCT04509674|581468092|FG001|Overall Study|Not treated|26|||
161021063|NCT04509674|581468091|FG000|Overall Study|Protocol Violation|9|||
161021064|NCT04509674|581468092|FG001|Overall Study|Protocol Violation|10|||
161021065|NCT04509674|581468091|FG000|Overall Study|Lost to Follow-up|31|||
161021066|NCT04509674|581468092|FG001|Overall Study|Lost to Follow-up|39|||
161021067|NCT04509674|581468091|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
161021068|NCT04509674|581468092|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
161021069|NCT04509674|581468091|FG000|Overall Study|Adverse event, serious fatal event|11|||
161021070|NCT04509674|581468092|FG001|Overall Study|Adverse event, serious fatal event|4|||
161021071|NCT04509674|581468091|FG000|Overall Study|Adverse event, non-fatal event|107|||
161021072|NCT04509674|581468092|FG001|Overall Study|Adverse event, non-fatal event|118|||
161021073|NCT04509674|581468091|FG000|Overall Study|Other reason than listed|106|||
161021074|NCT04509674|581468092|FG001|Overall Study|Other reason than listed|95|||
161021075|NCT06190691|581468102|FG000|Overall Study|Adverse Event|2|||
161021076|NCT06190691|581468103|FG001|Overall Study|Adverse Event|0|||
161021077|NCT06190691|581468104|FG002|Overall Study|Adverse Event|0|||
161021078|NCT06190691|581468105|FG003|Overall Study|Adverse Event|0|||
161021079|NCT03016754|581468107|FG000|Overall Study|Death|5|||
161021080|NCT03016754|581468108|FG001|Overall Study|Death|4|||
161021081|NCT03016754|581468109|FG002|Overall Study|Death|5|||
160459888|NCT03092674|579416592|FG001|Overall Study|Death|8|||
160459889|NCT03092674|579416593|FG002|Overall Study|Death|2|||
160587328|NCT00280150|579869862|FG000|Overall Study|Adverse Event|0|||
160587329|NCT00280150|579869863|FG001|Overall Study|Adverse Event|1|||
160587330|NCT00280150|579869864|FG002|Overall Study|Adverse Event|2|||
160587331|NCT00280150|579869865|FG003|Overall Study|Adverse Event|3|||
160587332|NCT00280150|579869862|FG000|Overall Study|Lack of Efficacy|0|||
160587333|NCT00280150|579869863|FG001|Overall Study|Lack of Efficacy|0|||
160587334|NCT00280150|579869864|FG002|Overall Study|Lack of Efficacy|0|||
160587335|NCT00280150|579869865|FG003|Overall Study|Lack of Efficacy|3|||
160587336|NCT00280150|579869862|FG000|Overall Study|Physician Decision|0|||
160587337|NCT00280150|579869863|FG001|Overall Study|Physician Decision|0|||
160587338|NCT00280150|579869864|FG002|Overall Study|Physician Decision|0|||
160587339|NCT00280150|579869865|FG003|Overall Study|Physician Decision|1|||
160587340|NCT00280150|579869862|FG000|Overall Study|Protocol Violation|0|||
160587341|NCT00280150|579869863|FG001|Overall Study|Protocol Violation|0|||
160587342|NCT00280150|579869864|FG002|Overall Study|Protocol Violation|0|||
160587343|NCT00280150|579869865|FG003|Overall Study|Protocol Violation|1|||
160587344|NCT00280150|579869862|FG000|Overall Study|Withdrawal by Subject|0|||
160587345|NCT00280150|579869863|FG001|Overall Study|Withdrawal by Subject|0|||
160587346|NCT00280150|579869864|FG002|Overall Study|Withdrawal by Subject|0|||
160587347|NCT00280150|579869865|FG003|Overall Study|Withdrawal by Subject|1|||
160587348|NCT00280150|579869862|FG000|Overall Study|Did not get consolidation therapy|3|||
160587349|NCT00280150|579869863|FG001|Overall Study|Did not get consolidation therapy|0|||
160587350|NCT00280150|579869864|FG002|Overall Study|Did not get consolidation therapy|3|||
160587351|NCT00280150|579869865|FG003|Overall Study|Did not get consolidation therapy|0|||
160587352|NCT00280150|579869862|FG000|Overall Study|Declining Performance Status|0|||
160587353|NCT00280150|579869863|FG001|Overall Study|Declining Performance Status|0|||
160587354|NCT00280150|579869864|FG002|Overall Study|Declining Performance Status|0|||
160587355|NCT00280150|579869865|FG003|Overall Study|Declining Performance Status|1|||
160657069|NCT04028843|580124524|FG000|Overall Study|Withdrawal by Subject|4|||
161021082|NCT03016754|581468110|FG003|Overall Study|Death|1|||
161021083|NCT03016754|581468107|FG000|Overall Study|Lost to Follow-up|23|||
160459890|NCT03092674|579416591|FG000|Overall Study|Other - Not Protocol Specified|11|||
160459891|NCT03092674|579416592|FG001|Overall Study|Other - Not Protocol Specified|8|||
160459892|NCT03092674|579416593|FG002|Overall Study|Other - Not Protocol Specified|8|||
160657070|NCT04028843|580124525|FG001|Overall Study|Withdrawal by Subject|2|||
160587356|NCT02871401|579869873|FG000|Overall Study|Adverse Event|1|||
160587357|NCT02871401|579869874|FG001|Overall Study|Adverse Event|0|||
160587358|NCT02282982|579869875|FG000|Overall Study|Lost to Follow-up|15|||
160587359|NCT02282982|579869875|FG000|Overall Study|Withdrew consent|2|||
160587360|NCT02282982|579869875|FG000|Overall Study|Death|4|||
160587361|NCT02282982|579869875|FG000|Overall Study|Lack of product|156|||
160587362|NCT02282982|579869875|FG000|Overall Study|Palivizumab is ended|11|||
160657071|NCT02879643|580124529|FG000|Overall Study|Adverse Event|0|||
161021084|NCT03016754|581468108|FG001|Overall Study|Lost to Follow-up|17|||
161021085|NCT03016754|581468109|FG002|Overall Study|Lost to Follow-up|4|||
161021086|NCT03016754|581468110|FG003|Overall Study|Lost to Follow-up|2|||
161021087|NCT03016754|581468107|FG000|Overall Study|Withdrawal by Subject|6|||
161021088|NCT03016754|581468108|FG001|Overall Study|Withdrawal by Subject|6|||
161021089|NCT03016754|581468109|FG002|Overall Study|Withdrawal by Subject|2|||
161021090|NCT03016754|581468110|FG003|Overall Study|Withdrawal by Subject|2|||
161021091|NCT03016754|581468107|FG000|Overall Study|Other/Unknown|2|||
161021092|NCT03016754|581468108|FG001|Overall Study|Other/Unknown|4|||
161021093|NCT03016754|581468109|FG002|Overall Study|Other/Unknown|2|||
161021094|NCT03016754|581468110|FG003|Overall Study|Other/Unknown|1|||
161021095|NCT03016754|581468107|FG000|Overall Study|Protocol Violation|0|||
161021096|NCT03016754|581468108|FG001|Overall Study|Protocol Violation|0|||
161021097|NCT03016754|581468109|FG002|Overall Study|Protocol Violation|0|||
161021098|NCT03016754|581468110|FG003|Overall Study|Protocol Violation|4|||
161021099|NCT04019873|581468111|FG000|Overall Study|Discontinued from the treatment|1|||
161021100|NCT04019873|581468112|FG001|Overall Study|Discontinued from the treatment|39|||
161021101|NCT04019873|581468113|FG002|Overall Study|Discontinued from the treatment|2|||
161021102|NCT04316871|581468124|FG000|Overall Study|Protocol Violation|2|||
161021103|NCT04316871|581468125|FG001|Overall Study|Protocol Violation|2|||
161021104|NCT04316871|581468126|FG002|Overall Study|Protocol Violation|2|||
161021105|NCT04316871|581468127|FG003|Overall Study|Protocol Violation|2|||
161021106|NCT05087992|581468128|FG000|Overall Study|Adverse Event|0|||
161021107|NCT05087992|581468129|FG001|Overall Study|Adverse Event|1|||
161021108|NCT05087992|581468130|FG002|Overall Study|Adverse Event|0|||
161021109|NCT05087992|581468128|FG000|Overall Study|Withdrawal by Subject|2|||
161021110|NCT05087992|581468129|FG001|Overall Study|Withdrawal by Subject|0|||
161021111|NCT05087992|581468130|FG002|Overall Study|Withdrawal by Subject|0|||
161021112|NCT05087992|581468128|FG000|Overall Study|clinical disease progression|3|||
161021113|NCT05087992|581468129|FG001|Overall Study|clinical disease progression|1|||
161021114|NCT05087992|581468130|FG002|Overall Study|clinical disease progression|0|||
161021115|NCT05087992|581468128|FG000|Overall Study|objective disease progression|4|||
161021116|NCT05087992|581468129|FG001|Overall Study|objective disease progression|1|||
161021117|NCT05087992|581468130|FG002|Overall Study|objective disease progression|0|||
161021118|NCT04473222|581468131|FG000|Overall Study|Lost to Follow-up|13|||
161021119|NCT04473222|581468132|FG001|Overall Study|Lost to Follow-up|13|||
161021120|NCT04473222|581468131|FG000|Overall Study|Withdrawal by Subject|0|||
161021121|NCT04473222|581468132|FG001|Overall Study|Withdrawal by Subject|1|||
161021122|NCT04473222|581468131|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
161021123|NCT04473222|581468132|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
161021124|NCT01098812|581468141|FG000|Overall Study|Death|2|||
161021125|NCT01098812|581468142|FG001|Overall Study|Death|0|||
161021126|NCT01098812|581468143|FG002|Overall Study|Death|1|||
161021127|NCT01098812|581468141|FG000|Overall Study|Lost to Follow-up|0|||
161021128|NCT01098812|581468142|FG001|Overall Study|Lost to Follow-up|1|||
161021129|NCT01098812|581468143|FG002|Overall Study|Lost to Follow-up|0|||
161021130|NCT02319759|581468144|FG000|Week 0 - 16|Lack of Efficacy|1|||
161021131|NCT02319759|581468145|FG001|Week 0 - 16|Lack of Efficacy|0|||
161021132|NCT02319759|581468146|FG002|Week 0 - 16|Lack of Efficacy|0|||
161021133|NCT02319759|581468147|FG003|Week 0 - 16|Lack of Efficacy|0|||
161021134|NCT02319759|581468148|FG004|Week 0 - 16|Lack of Efficacy|0|||
161021135|NCT02319759|581468144|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
161021136|NCT02319759|581468145|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
161021137|NCT02319759|581468146|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
161021138|NCT02319759|581468147|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
161021139|NCT02319759|581468148|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
161021140|NCT02319759|581468144|FG000|Week 16 - 24|Lack of Efficacy|1|||
161021141|NCT02319759|581468145|FG001|Week 16 - 24|Lack of Efficacy|0|||
161021142|NCT02319759|581468146|FG002|Week 16 - 24|Lack of Efficacy|1|||
161021143|NCT02319759|581468147|FG003|Week 16 - 24|Lack of Efficacy|0|||
161021144|NCT02319759|581468148|FG004|Week 16 - 24|Lack of Efficacy|0|||
161021145|NCT02319759|581468144|FG000|Week 16 - 24|Lost to Follow-up|1|||
161021146|NCT02319759|581468145|FG001|Week 16 - 24|Lost to Follow-up|0|||
161021147|NCT02319759|581468146|FG002|Week 16 - 24|Lost to Follow-up|0|||
161021148|NCT02319759|581468147|FG003|Week 16 - 24|Lost to Follow-up|0|||
161021149|NCT02319759|581468148|FG004|Week 16 - 24|Lost to Follow-up|0|||
161021150|NCT02319759|581468144|FG000|Week 16 - 24|Withdrawal by Subject|0|||
161021151|NCT02319759|581468145|FG001|Week 16 - 24|Withdrawal by Subject|0|||
161021152|NCT02319759|581468146|FG002|Week 16 - 24|Withdrawal by Subject|2|||
161021153|NCT02319759|581468147|FG003|Week 16 - 24|Withdrawal by Subject|0|||
161021154|NCT02319759|581468148|FG004|Week 16 - 24|Withdrawal by Subject|0|||
161021155|NCT02319759|581468144|FG000|Week 24 - 56|Adverse Event|0|||
160587363|NCT02282982|579869875|FG000|Overall Study|Other, not specified|18|||
160587364|NCT02939937|579869876|FG000|Overall Study|Adverse Event|5|||
160587365|NCT02939937|579869877|FG001|Overall Study|Adverse Event|0|||
160587366|NCT02939937|579869876|FG000|Overall Study|Lost to Follow-up|1|||
160587367|NCT02939937|579869877|FG001|Overall Study|Lost to Follow-up|3|||
160587368|NCT00568958|579869879|FG000|Allocation|Withdrawal by Subject|7|||
160587369|NCT00568958|579869880|FG001|Allocation|Withdrawal by Subject|3|||
160587370|NCT00568958|579869879|FG000|Allocation|Physician Decision|2|||
161021156|NCT02319759|581468145|FG001|Week 24 - 56|Adverse Event|0|||
161021157|NCT02319759|581468146|FG002|Week 24 - 56|Adverse Event|2|||
161021158|NCT02319759|581468147|FG003|Week 24 - 56|Adverse Event|0|||
161021159|NCT02319759|581468148|FG004|Week 24 - 56|Adverse Event|0|||
161021160|NCT02319759|581468144|FG000|Week 24 - 56|Lack of Efficacy|0|||
161021161|NCT02319759|581468145|FG001|Week 24 - 56|Lack of Efficacy|0|||
161021162|NCT02319759|581468146|FG002|Week 24 - 56|Lack of Efficacy|0|||
161021163|NCT02319759|581468147|FG003|Week 24 - 56|Lack of Efficacy|2|||
161021164|NCT02319759|581468148|FG004|Week 24 - 56|Lack of Efficacy|1|||
161021165|NCT02319759|581468144|FG000|Week 24 - 56|Withdrawal by Subject|0|||
161021166|NCT02319759|581468145|FG001|Week 24 - 56|Withdrawal by Subject|1|||
161021167|NCT02319759|581468146|FG002|Week 24 - 56|Withdrawal by Subject|0|||
161021168|NCT02319759|581468147|FG003|Week 24 - 56|Withdrawal by Subject|0|||
161021169|NCT02319759|581468148|FG004|Week 24 - 56|Withdrawal by Subject|0|||
161021170|NCT02319759|581468144|FG000|Week 24 - 56|Lost to Follow-up|0|||
161021171|NCT02319759|581468145|FG001|Week 24 - 56|Lost to Follow-up|0|||
161021172|NCT02319759|581468146|FG002|Week 24 - 56|Lost to Follow-up|0|||
161021173|NCT02319759|581468147|FG003|Week 24 - 56|Lost to Follow-up|0|||
161021174|NCT02319759|581468148|FG004|Week 24 - 56|Lost to Follow-up|1|||
161021175|NCT03452579|581468151|FG000|Overall Study|Death|0|||
161021176|NCT03452579|581468152|FG001|Overall Study|Death|1|||
161021177|NCT03452579|581468151|FG000|Overall Study|Withdrawal by Subject|2|||
161021178|NCT03452579|581468152|FG001|Overall Study|Withdrawal by Subject|0|||
161021179|NCT03452579|581468151|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
161021180|NCT03452579|581468152|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
161021181|NCT03452579|581468151|FG000|Overall Study|Physician Decision|1|||
161021182|NCT03452579|581468152|FG001|Overall Study|Physician Decision|1|||
161021183|NCT03452579|581468151|FG000|Overall Study|Adverse Event|1|||
161021184|NCT03452579|581468152|FG001|Overall Study|Adverse Event|4|||
161021185|NCT04858321|581468153|FG000|Overall Study|Withdrawal by Subject|3|||
161021186|NCT05006872|581468156|FG000|Overall Study|Lost to Follow-up|37|||
161021187|NCT05006872|581468157|FG001|Overall Study|Lost to Follow-up|31|||
161021188|NCT04025554|581468158|FG000|Overall Study|Adverse Event|3|||
161021189|NCT04700163|581468159|FG000|Overall Study|Lost to Follow-up|0|||
161021190|NCT04700163|581468160|FG001|Overall Study|Lost to Follow-up|0|||
161021191|NCT04700163|581468161|FG002|Overall Study|Lost to Follow-up|0|||
161021192|NCT04700163|581468162|FG003|Overall Study|Lost to Follow-up|0|||
161021193|NCT04700163|581468163|FG004|Overall Study|Lost to Follow-up|0|||
161021194|NCT04700163|581468164|FG005|Overall Study|Lost to Follow-up|1|||
161021195|NCT03848065|581468167|FG000|Overall Study|Death|0|||
161021196|NCT03848065|581468168|FG001|Overall Study|Death|1|||
161021197|NCT03848065|581468169|FG002|Overall Study|Death|0|||
161021198|NCT03848065|581468167|FG000|Overall Study|Lost to Follow-up|0|||
161021199|NCT03848065|581468168|FG001|Overall Study|Lost to Follow-up|0|||
161021200|NCT03848065|581468169|FG002|Overall Study|Lost to Follow-up|1|||
161021201|NCT03848065|581468167|FG000|Overall Study|Physician Decision|0|||
161021202|NCT03848065|581468168|FG001|Overall Study|Physician Decision|0|||
161021203|NCT03848065|581468169|FG002|Overall Study|Physician Decision|1|||
161021204|NCT05543629|581468172|FG000|Overall Study|Death|1|||
161021205|NCT05543629|581468173|FG001|Overall Study|Death|0|||
161021206|NCT05543629|581468174|FG002|Overall Study|Death|1|||
161021207|NCT05543629|581468175|FG003|Overall Study|Death|0|||
161021208|NCT05543629|581468176|FG004|Overall Study|Death|0|||
161021209|NCT05543629|581468177|FG005|Overall Study|Death|1|||
160587371|NCT00568958|579869880|FG001|Allocation|Physician Decision|0|||
160587372|NCT00568958|579869879|FG000|Follow-Up|Withdrawal by Subject|6|||
160587373|NCT00568958|579869880|FG001|Follow-Up|Withdrawal by Subject|6|||
160587374|NCT00568958|579869879|FG000|Follow-Up|Physician Decision|1|||
161021210|NCT05543629|581468178|FG006|Overall Study|Death|2|||
161021211|NCT05543629|581468179|FG007|Overall Study|Death|2|||
161021212|NCT05543629|581468172|FG000|Overall Study|Other Reasons|0|||
161021213|NCT05543629|581468173|FG001|Overall Study|Other Reasons|0|||
161021214|NCT05543629|581468174|FG002|Overall Study|Other Reasons|0|||
161021215|NCT05543629|581468175|FG003|Overall Study|Other Reasons|0|||
161021216|NCT05543629|581468176|FG004|Overall Study|Other Reasons|1|||
161021217|NCT05543629|581468177|FG005|Overall Study|Other Reasons|0|||
161021218|NCT05543629|581468178|FG006|Overall Study|Other Reasons|0|||
161021219|NCT05543629|581468179|FG007|Overall Study|Other Reasons|0|||
160459893|NCT02325154|579416594|FG000|Overall Study|Physician Decision|1|||
160587375|NCT00568958|579869880|FG001|Follow-Up|Physician Decision|1|||
160587376|NCT00568958|579869879|FG000|Follow-Up|Family Emergency|1|||
161021220|NCT05543629|581468172|FG000|Overall Study|Physician Decision|0|||
161021221|NCT05543629|581468173|FG001|Overall Study|Physician Decision|0|||
161021222|NCT05543629|581468174|FG002|Overall Study|Physician Decision|3|||
160459894|NCT04633278|579417490|FG000|Overall Study|Adverse Event|1|||
161021223|NCT05543629|581468175|FG003|Overall Study|Physician Decision|0|||
161021224|NCT05543629|581468176|FG004|Overall Study|Physician Decision|0|||
161021225|NCT05543629|581468177|FG005|Overall Study|Physician Decision|0|||
161021226|NCT05543629|581468178|FG006|Overall Study|Physician Decision|1|||
161021227|NCT05543629|581468179|FG007|Overall Study|Physician Decision|0|||
161021228|NCT05543629|581468172|FG000|Overall Study|Study terminated by Sponsor|1|||
160587377|NCT00568958|579869880|FG001|Follow-Up|Family Emergency|0|||
161021229|NCT05543629|581468173|FG001|Overall Study|Study terminated by Sponsor|0|||
161021230|NCT05543629|581468174|FG002|Overall Study|Study terminated by Sponsor|0|||
161021231|NCT05543629|581468175|FG003|Overall Study|Study terminated by Sponsor|1|||
161021232|NCT05543629|581468176|FG004|Overall Study|Study terminated by Sponsor|0|||
161021233|NCT05543629|581468177|FG005|Overall Study|Study terminated by Sponsor|4|||
161021234|NCT05543629|581468178|FG006|Overall Study|Study terminated by Sponsor|1|||
161021235|NCT05543629|581468179|FG007|Overall Study|Study terminated by Sponsor|0|||
161021236|NCT05543629|581468172|FG000|Overall Study|Withdrawal by Subject|1|||
161021237|NCT05543629|581468173|FG001|Overall Study|Withdrawal by Subject|1|||
161021238|NCT05543629|581468174|FG002|Overall Study|Withdrawal by Subject|0|||
161021239|NCT05543629|581468175|FG003|Overall Study|Withdrawal by Subject|2|||
161021240|NCT05543629|581468176|FG004|Overall Study|Withdrawal by Subject|1|||
161021241|NCT05543629|581468177|FG005|Overall Study|Withdrawal by Subject|1|||
161021242|NCT05543629|581468178|FG006|Overall Study|Withdrawal by Subject|1|||
161021243|NCT05543629|581468179|FG007|Overall Study|Withdrawal by Subject|1|||
161021244|NCT05543629|581468172|FG000|Overall Study|Not Reported|2|||
161021245|NCT05543629|581468173|FG001|Overall Study|Not Reported|2|||
161021246|NCT05543629|581468174|FG002|Overall Study|Not Reported|0|||
161021247|NCT05543629|581468175|FG003|Overall Study|Not Reported|0|||
161021248|NCT05543629|581468176|FG004|Overall Study|Not Reported|1|||
161021249|NCT05543629|581468177|FG005|Overall Study|Not Reported|1|||
161021250|NCT05543629|581468178|FG006|Overall Study|Not Reported|3|||
161021251|NCT05543629|581468179|FG007|Overall Study|Not Reported|0|||
161021252|NCT04568603|581468180|FG000|Overall Study|Physician Decision|1|||
161021253|NCT03270501|581468181|FG000|Overall Study|Screen failure|6|||
161021254|NCT03270501|581468181|FG000|Overall Study|Lost to Follow-up|2|||
161021255|NCT03270501|581468181|FG000|Overall Study|Adverse Event|1|||
161021256|NCT00764751|581468186|FG000|Overall Study|Adverse Event|1|||
161021257|NCT00764751|581468187|FG001|Overall Study|Adverse Event|1|||
161021258|NCT00764751|581468186|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
161021259|NCT00764751|581468187|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
161021260|NCT05270408|581468196|FG000|Started Treatment|Withdrawal by Subject|0|||
161021261|NCT05270408|581468197|FG001|Started Treatment|Withdrawal by Subject|0|||
161021262|NCT05270408|581468198|FG002|Started Treatment|Withdrawal by Subject|3|||
161021263|NCT05270408|581468196|FG000|Started Treatment|Adverse Event|0|||
161021264|NCT05270408|581468197|FG001|Started Treatment|Adverse Event|0|||
161021265|NCT05270408|581468198|FG002|Started Treatment|Adverse Event|1|||
161021266|NCT05270408|581468196|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
161021267|NCT05270408|581468197|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
161021268|NCT05270408|581468198|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
161021269|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
161021270|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
161021271|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
161021272|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
161021273|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
161021274|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
161021275|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
161021276|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
161021277|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
161021278|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
161021279|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
161021280|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
161021281|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
161021282|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
161021283|NCT04338061|581468199|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
161021284|NCT04338061|581468200|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
161021285|NCT04338061|581468199|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
161021286|NCT04338061|581468200|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
161021287|NCT04338061|581468199|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
161021288|NCT04338061|581468200|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
161021289|NCT04338061|581468199|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
161021290|NCT04338061|581468200|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
161021291|NCT04338061|581468199|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
161021292|NCT04338061|581468200|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
161021293|NCT04074759|581468201|FG000|Overall Study|Withdrawal by Subject|0|||
161021294|NCT04074759|581468202|FG001|Overall Study|Withdrawal by Subject|0|||
161021295|NCT04074759|581468203|FG002|Overall Study|Withdrawal by Subject|0|||
161021296|NCT04074759|581468204|FG003|Overall Study|Withdrawal by Subject|0|||
160459895|NCT04633278|579417491|FG001|Overall Study|Adverse Event|0|||
160587378|NCT00568958|579869879|FG000|Follow-Up|Adverse Event|1|||
160587379|NCT00568958|579869880|FG001|Follow-Up|Adverse Event|0|||
160587380|NCT05254613|579869881|FG000|Overall Study|Lost to Follow-up|0|||
161021297|NCT04074759|581468205|FG004|Overall Study|Withdrawal by Subject|0|||
161021298|NCT04074759|581468206|FG005|Overall Study|Withdrawal by Subject|2|||
161021299|NCT04074759|581468207|FG006|Overall Study|Withdrawal by Subject|0|||
161021300|NCT04074759|581468208|FG007|Overall Study|Withdrawal by Subject|2|||
161021301|NCT04074759|581468209|FG008|Overall Study|Withdrawal by Subject|1|||
161021302|NCT04074759|581468210|FG009|Overall Study|Withdrawal by Subject|2|||
161021303|NCT04074759|581468211|FG010|Overall Study|Withdrawal by Subject|9|||
161021304|NCT04074759|581468212|FG011|Overall Study|Withdrawal by Subject|2|||
161021305|NCT04074759|581468213|FG012|Overall Study|Withdrawal by Subject|1|||
161021306|NCT04074759|581468214|FG013|Overall Study|Withdrawal by Subject|3|||
161021307|NCT04074759|581468215|FG014|Overall Study|Withdrawal by Subject|2|||
161021308|NCT04074759|581468216|FG015|Overall Study|Withdrawal by Subject|0|||
161021309|NCT04074759|581468217|FG016|Overall Study|Withdrawal by Subject|0|||
161021310|NCT04074759|581468218|FG017|Overall Study|Withdrawal by Subject|3|||
161021311|NCT04074759|581468219|FG018|Overall Study|Withdrawal by Subject|1|||
161021312|NCT04074759|581468201|FG000|Overall Study|Death|1|||
161021313|NCT04074759|581468202|FG001|Overall Study|Death|0|||
161021314|NCT04074759|581468203|FG002|Overall Study|Death|1|||
161021315|NCT04074759|581468204|FG003|Overall Study|Death|1|||
161021316|NCT04074759|581468205|FG004|Overall Study|Death|2|||
161021317|NCT04074759|581468206|FG005|Overall Study|Death|0|||
161021318|NCT04074759|581468207|FG006|Overall Study|Death|1|||
161021319|NCT04074759|581468208|FG007|Overall Study|Death|0|||
161021320|NCT04074759|581468209|FG008|Overall Study|Death|3|||
161021321|NCT04074759|581468210|FG009|Overall Study|Death|2|||
161021322|NCT04074759|581468211|FG010|Overall Study|Death|4|||
161021323|NCT04074759|581468212|FG011|Overall Study|Death|1|||
161021324|NCT04074759|581468213|FG012|Overall Study|Death|0|||
161021325|NCT04074759|581468214|FG013|Overall Study|Death|2|||
161021326|NCT04074759|581468215|FG014|Overall Study|Death|1|||
161021327|NCT04074759|581468216|FG015|Overall Study|Death|0|||
161021328|NCT04074759|581468217|FG016|Overall Study|Death|1|||
161021329|NCT04074759|581468218|FG017|Overall Study|Death|0|||
161021330|NCT04074759|581468219|FG018|Overall Study|Death|1|||
161021331|NCT04074759|581468201|FG000|Overall Study|Lost to Follow-up|0|||
161021332|NCT04074759|581468202|FG001|Overall Study|Lost to Follow-up|0|||
161021333|NCT04074759|581468203|FG002|Overall Study|Lost to Follow-up|0|||
161021334|NCT04074759|581468204|FG003|Overall Study|Lost to Follow-up|0|||
161021335|NCT04074759|581468205|FG004|Overall Study|Lost to Follow-up|0|||
161021336|NCT04074759|581468206|FG005|Overall Study|Lost to Follow-up|0|||
161021337|NCT04074759|581468207|FG006|Overall Study|Lost to Follow-up|0|||
161021338|NCT04074759|581468208|FG007|Overall Study|Lost to Follow-up|0|||
161021339|NCT04074759|581468209|FG008|Overall Study|Lost to Follow-up|0|||
161021340|NCT04074759|581468210|FG009|Overall Study|Lost to Follow-up|0|||
161021341|NCT04074759|581468211|FG010|Overall Study|Lost to Follow-up|1|||
161021342|NCT04074759|581468212|FG011|Overall Study|Lost to Follow-up|0|||
161021343|NCT04074759|581468213|FG012|Overall Study|Lost to Follow-up|0|||
161021344|NCT04074759|581468214|FG013|Overall Study|Lost to Follow-up|0|||
161021345|NCT04074759|581468215|FG014|Overall Study|Lost to Follow-up|0|||
161021346|NCT04074759|581468216|FG015|Overall Study|Lost to Follow-up|0|||
161021347|NCT04074759|581468217|FG016|Overall Study|Lost to Follow-up|1|||
161021348|NCT04074759|581468218|FG017|Overall Study|Lost to Follow-up|0|||
161021349|NCT04074759|581468219|FG018|Overall Study|Lost to Follow-up|1|||
161021350|NCT04074759|581468201|FG000|Overall Study|Other|0|||
161021351|NCT04074759|581468202|FG001|Overall Study|Other|1|||
161021352|NCT04074759|581468203|FG002|Overall Study|Other|1|||
161021353|NCT04074759|581468204|FG003|Overall Study|Other|0|||
161021354|NCT04074759|581468205|FG004|Overall Study|Other|2|||
161021355|NCT04074759|581468206|FG005|Overall Study|Other|1|||
161021356|NCT04074759|581468207|FG006|Overall Study|Other|2|||
161021357|NCT04074759|581468208|FG007|Overall Study|Other|1|||
161021358|NCT04074759|581468209|FG008|Overall Study|Other|1|||
161021359|NCT04074759|581468210|FG009|Overall Study|Other|4|||
161021360|NCT04074759|581468211|FG010|Overall Study|Other|4|||
161021361|NCT04074759|581468212|FG011|Overall Study|Other|2|||
161021362|NCT04074759|581468213|FG012|Overall Study|Other|0|||
161021363|NCT04074759|581468214|FG013|Overall Study|Other|0|||
161021364|NCT04074759|581468215|FG014|Overall Study|Other|0|||
161021365|NCT04074759|581468216|FG015|Overall Study|Other|1|||
161021366|NCT04074759|581468217|FG016|Overall Study|Other|0|||
161021367|NCT04074759|581468218|FG017|Overall Study|Other|0|||
161021368|NCT04074759|581468219|FG018|Overall Study|Other|0|||
161021369|NCT04074759|581468201|FG000|Overall Study|Missing end of study status|0|||
161021370|NCT04074759|581468202|FG001|Overall Study|Missing end of study status|0|||
161021371|NCT04074759|581468203|FG002|Overall Study|Missing end of study status|0|||
161021372|NCT04074759|581468204|FG003|Overall Study|Missing end of study status|0|||
161021373|NCT04074759|581468205|FG004|Overall Study|Missing end of study status|0|||
161021374|NCT04074759|581468206|FG005|Overall Study|Missing end of study status|0|||
161021375|NCT04074759|581468207|FG006|Overall Study|Missing end of study status|0|||
161021376|NCT04074759|581468208|FG007|Overall Study|Missing end of study status|0|||
161021377|NCT04074759|581468209|FG008|Overall Study|Missing end of study status|0|||
161021378|NCT04074759|581468210|FG009|Overall Study|Missing end of study status|0|||
161021379|NCT04074759|581468211|FG010|Overall Study|Missing end of study status|2|||
161021380|NCT04074759|581468212|FG011|Overall Study|Missing end of study status|0|||
161021381|NCT04074759|581468213|FG012|Overall Study|Missing end of study status|0|||
161021382|NCT04074759|581468214|FG013|Overall Study|Missing end of study status|0|||
161021383|NCT04074759|581468215|FG014|Overall Study|Missing end of study status|0|||
161021384|NCT04074759|581468216|FG015|Overall Study|Missing end of study status|0|||
161021385|NCT04074759|581468217|FG016|Overall Study|Missing end of study status|1|||
161021386|NCT04074759|581468218|FG017|Overall Study|Missing end of study status|0|||
161021387|NCT04074759|581468219|FG018|Overall Study|Missing end of study status|0|||
161021388|NCT03631784|581468220|FG000|Overall Study|Participants Ongoing|1|||
161021389|NCT03631784|581468221|FG001|Overall Study|Participants Ongoing|0|||
161021390|NCT03631784|581468220|FG000|Overall Study|Withdrawal by Subject|3|||
161021391|NCT03631784|581468221|FG001|Overall Study|Withdrawal by Subject|3|||
161021392|NCT03631784|581468220|FG000|Overall Study|Sponsor's Decision|36|||
161021393|NCT03631784|581468221|FG001|Overall Study|Sponsor's Decision|52|||
161021394|NCT03631784|581468220|FG000|Overall Study|Lost to Follow-up|1|||
161021395|NCT03631784|581468221|FG001|Overall Study|Lost to Follow-up|0|||
161021396|NCT03631784|581468220|FG000|Overall Study|Death|71|||
161021397|NCT03631784|581468221|FG001|Overall Study|Death|49|||
161021398|NCT02465268|581468223|FG000|Overall Study|Withdrawal by Subject|4|||
161021399|NCT02465268|581468224|FG001|Overall Study|Withdrawal by Subject|3|||
161021400|NCT02465268|581468225|FG002|Overall Study|Withdrawal by Subject|1|||
161021401|NCT02465268|581468223|FG000|Overall Study|Not evaluable per protocol criteria|3|||
161021402|NCT02465268|581468224|FG001|Overall Study|Not evaluable per protocol criteria|2|||
161021403|NCT02465268|581468225|FG002|Overall Study|Not evaluable per protocol criteria|1|||
161021404|NCT02465268|581468223|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
161021405|NCT02465268|581468224|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
161021406|NCT02465268|581468225|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
161021407|NCT02465268|581468223|FG000|Overall Study|Study drug did not pass QA/QC|1|||
161021408|NCT02465268|581468224|FG001|Overall Study|Study drug did not pass QA/QC|0|||
161021409|NCT02465268|581468225|FG002|Overall Study|Study drug did not pass QA/QC|0|||
161021410|NCT02465268|581468223|FG000|Overall Study|Adverse Event|0|||
161021411|NCT02465268|581468224|FG001|Overall Study|Adverse Event|1|||
161021412|NCT02465268|581468225|FG002|Overall Study|Adverse Event|0|||
161021413|NCT02465268|581468223|FG000|Overall Study|Physician Decision|0|||
161021414|NCT02465268|581468224|FG001|Overall Study|Physician Decision|1|||
161021415|NCT02465268|581468225|FG002|Overall Study|Physician Decision|0|||
161021416|NCT03322267|581468227|FG000|Overall Study|Lack of Efficacy|11|||
161021417|NCT03322267|581468227|FG000|Overall Study|Adverse Event|1|||
161021418|NCT03322267|581468227|FG000|Overall Study|Withdrawal by Subject|2|||
161021419|NCT04719832|581468231|FG000|Overall Study|Adverse Event|2|||
161021420|NCT04719832|581468232|FG001|Overall Study|Adverse Event|0|||
161021421|NCT04719832|581468231|FG000|Overall Study|Lack of Efficacy|2|||
161021422|NCT04719832|581468232|FG001|Overall Study|Lack of Efficacy|4|||
161021423|NCT04719832|581468231|FG000|Overall Study|Lost to Follow-up|0|||
161021424|NCT04719832|581468232|FG001|Overall Study|Lost to Follow-up|2|||
161021425|NCT04719832|581468231|FG000|Overall Study|Physician Decision|0|||
161021426|NCT04719832|581468232|FG001|Overall Study|Physician Decision|1|||
161021427|NCT04719832|581468231|FG000|Overall Study|Pregnancy|1|||
161021428|NCT04719832|581468232|FG001|Overall Study|Pregnancy|1|||
161021429|NCT04719832|581468231|FG000|Overall Study|Withdrawal by Subject|5|||
161021430|NCT04719832|581468232|FG001|Overall Study|Withdrawal by Subject|5|||
160459896|NCT04633278|579417490|FG000|Overall Study|Withdrawal by Subject|1|||
160459897|NCT04633278|579417491|FG001|Overall Study|Withdrawal by Subject|0|||
160459898|NCT04633278|579417490|FG000|Overall Study|Death|11|||
160459899|NCT04633278|579417491|FG001|Overall Study|Death|7|||
160459900|NCT04633278|579417490|FG000|Overall Study|Sponsor Decision|3|||
160459901|NCT04633278|579417491|FG001|Overall Study|Sponsor Decision|0|||
160459902|NCT04633278|579417490|FG000|Overall Study|Not Listed|1|||
160587381|NCT05254613|579869882|FG001|Overall Study|Lost to Follow-up|0|||
161021431|NCT04719832|581468231|FG000|Overall Study|Randomized, not treated|0|||
161021432|NCT04719832|581468232|FG001|Overall Study|Randomized, not treated|2|||
161021433|NCT04719832|581468231|FG000|Overall Study|GCP violations|4|||
161021434|NCT04719832|581468232|FG001|Overall Study|GCP violations|7|||
161021435|NCT01799265|581468237|FG000|Overall Study|Lost to Follow-up|1|||
161021436|NCT01799265|581468238|FG001|Overall Study|Lost to Follow-up|0|||
161021437|NCT01799265|581468237|FG000|Overall Study|Protocol Violation|2|||
161021438|NCT01799265|581468238|FG001|Overall Study|Protocol Violation|1|||
161021439|NCT01799265|581468237|FG000|Overall Study|inadequate sleep study|0|||
161021440|NCT01799265|581468238|FG001|Overall Study|inadequate sleep study|2|||
161021441|NCT03084536|581468242|FG000|Overall Study|Determined to be ineligible|0|||
161021442|NCT03084536|581468243|FG001|Overall Study|Determined to be ineligible|0|||
160459903|NCT04633278|579417491|FG001|Overall Study|Not Listed|0|||
160587382|NCT05254613|579869883|FG002|Overall Study|Lost to Follow-up|1|||
161021443|NCT03084536|581468244|FG002|Overall Study|Determined to be ineligible|16|||
161021444|NCT03084536|581468242|FG000|Overall Study|Withdrawal by Subject|0|||
161021445|NCT03084536|581468243|FG001|Overall Study|Withdrawal by Subject|0|||
161021446|NCT03084536|581468244|FG002|Overall Study|Withdrawal by Subject|4|||
161021447|NCT03084536|581468242|FG000|Overall Study|Physician Decision|0|||
161021448|NCT03084536|581468243|FG001|Overall Study|Physician Decision|0|||
161021449|NCT03084536|581468244|FG002|Overall Study|Physician Decision|3|||
161021450|NCT03084536|581468242|FG000|Overall Study|Death|0|||
161021451|NCT03084536|581468243|FG001|Overall Study|Death|0|||
161021452|NCT03084536|581468244|FG002|Overall Study|Death|1|||
161021453|NCT03084536|581468242|FG000|Overall Study|Lost to Follow-up|0|||
161021454|NCT03084536|581468243|FG001|Overall Study|Lost to Follow-up|0|||
161021455|NCT03084536|581468244|FG002|Overall Study|Lost to Follow-up|1|||
161021456|NCT03084536|581468242|FG000|Overall Study|Protocol Violation|0|||
161021457|NCT03084536|581468243|FG001|Overall Study|Protocol Violation|0|||
161021458|NCT03084536|581468244|FG002|Overall Study|Protocol Violation|1|||
161021459|NCT03084536|581468242|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
161021460|NCT03084536|581468243|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
161021461|NCT03084536|581468244|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
161021462|NCT05704543|581468245|FG000|Overall Study|Withdrawal by Subject|1|||
161021463|NCT05704543|581468246|FG001|Overall Study|Withdrawal by Subject|1|||
161021464|NCT05704543|581468247|FG002|Overall Study|Withdrawal by Subject|0|||
161021465|NCT05704543|581468248|FG003|Overall Study|Withdrawal by Subject|2|||
161021466|NCT05704543|581468245|FG000|Overall Study|Lost to Follow-up|1|||
161021467|NCT05704543|581468246|FG001|Overall Study|Lost to Follow-up|2|||
161021468|NCT05704543|581468247|FG002|Overall Study|Lost to Follow-up|0|||
161021469|NCT05704543|581468248|FG003|Overall Study|Lost to Follow-up|0|||
161021470|NCT04830800|581468252|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
161021471|NCT04830800|581468253|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
161021472|NCT04830800|581468254|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
161021473|NCT04830800|581468255|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
161021474|NCT04830800|581468256|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
161021475|NCT05192109|581468261|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161021476|NCT05192109|581468262|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161021477|NCT05192109|581468263|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161021478|NCT05192109|581468264|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161021479|NCT05192109|581468261|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161021480|NCT05192109|581468262|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161021481|NCT05192109|581468263|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161021482|NCT05192109|581468264|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161021483|NCT04728347|581470718|FG000|Overall Study|Sponsor decision|0|||
161021484|NCT04728347|581470719|FG001|Overall Study|Sponsor decision|0|||
161021485|NCT04728347|581470720|FG002|Overall Study|Sponsor decision|1|||
161021486|NCT04728347|581470721|FG003|Overall Study|Sponsor decision|0|||
161021487|NCT03869866|581470724|FG000|Overall Study|Protocol Violation|1|||
161021488|NCT03869866|581470724|FG000|Overall Study|Withdrawal by Subject|3|||
161021489|NCT06181227|581470725|FG000|Overall Study|Study terminated by sponsor|7|||
161021490|NCT06181227|581470726|FG001|Overall Study|Study terminated by sponsor|9|||
161021491|NCT05543915|581470727|FG000|Overall Study|Lost to Follow-up|0|||
161021492|NCT05543915|581470728|FG001|Overall Study|Lost to Follow-up|1|||
161021493|NCT06516705|581470733|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
161021494|NCT06516705|581470734|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
161021495|NCT06516705|581470733|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
161021496|NCT06516705|581470734|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
161021497|NCT06516705|581470733|FG000|T3 ( 3 Month After Education)|covid-19|1|||
161021498|NCT06516705|581470734|FG001|T3 ( 3 Month After Education)|covid-19|2|||
161021499|NCT06516705|581470733|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
161021500|NCT06516705|581470734|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
161021501|NCT06516705|581470733|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
161021502|NCT06516705|581470734|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
161021503|NCT06516705|581470733|FG000|T4 ( 6 Month After Education)|covid-19|3|||
161021504|NCT06516705|581470734|FG001|T4 ( 6 Month After Education)|covid-19|2|||
161021505|NCT06516705|581470733|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
161021506|NCT06516705|581470734|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
161021507|NCT04292223|581470736|FG000|Overall Study|Adverse Event|1|||
161021508|NCT04292223|581470736|FG000|Overall Study|Lost to Follow-up|1|||
161021509|NCT04292223|581470736|FG000|Overall Study|Noncompliance with study drug|2|||
161021510|NCT04292223|581470736|FG000|Overall Study|Patient moved out of the state|1|||
161021511|NCT04719390|581470737|FG000|Overall Study|Withdrawal by Subject|1|||
161021512|NCT04633122|581470738|FG000|Overall Study|Remained on treatment|19|||
161021513|NCT04633122|581470739|FG001|Overall Study|Remained on treatment|14|||
161021514|NCT04633122|581470738|FG000|Overall Study|Survival follow-up stopped|22|||
161021515|NCT04633122|581470739|FG001|Overall Study|Survival follow-up stopped|25|||
161021516|NCT02561247|581470740|FG000|Overall Study|Protocol Violation|1|||
161021517|NCT02561247|581470740|FG000|Overall Study|Withdrawal by Subject|1|||
161021518|NCT02561247|581470740|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
161021519|NCT04963270|581470741|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
161021520|NCT04963270|581470742|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
161021521|NCT04963270|581470743|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
161021522|NCT04963270|581470744|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
161021523|NCT04963270|581470741|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161021524|NCT04963270|581470742|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
161021525|NCT04963270|581470743|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161021526|NCT04963270|581470744|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161021527|NCT04963270|581470741|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
161021528|NCT04963270|581470742|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161021529|NCT04963270|581470743|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161021530|NCT04963270|581470744|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161021531|NCT04963270|581470741|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
161021532|NCT04963270|581470742|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
161021533|NCT04963270|581470743|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
161021534|NCT04963270|581470744|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
161021535|NCT04963270|581470741|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
161021536|NCT04963270|581470742|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
161021537|NCT04963270|581470743|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
161021538|NCT04963270|581470744|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
161021539|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
161021540|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
161021541|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
161021542|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
161021543|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
161021544|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
161021545|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
161021546|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
161021547|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
161021548|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
161021549|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
161021550|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
161021551|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
161021552|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
161021553|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
161021554|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
161021555|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
161021556|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
161021557|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
161021558|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
161021559|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
161021560|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
161021561|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
161021562|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
161021563|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
161021564|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
161021565|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
161021566|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
161021567|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
161021568|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
161021569|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
161021570|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
161021571|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
161021572|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
161021573|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
161021574|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
160587383|NCT02387372|579869884|FG000|Overall Study|Not Treated|1|||
161021575|NCT03560609|581470745|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
161021576|NCT03560609|581470746|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
161021577|NCT04908722|581470749|FG000|Overall Study|Protocol deviation|1|||
161021578|NCT04908722|581470750|FG001|Overall Study|Protocol deviation|0|||
161021579|NCT04908722|581470751|FG002|Overall Study|Protocol deviation|0|||
161021580|NCT04908722|581470752|FG003|Overall Study|Protocol deviation|0|||
161021581|NCT04908722|581470753|FG004|Overall Study|Protocol deviation|0|||
161021582|NCT04908722|581470754|FG005|Overall Study|Protocol deviation|1|||
161021583|NCT04908722|581470749|FG000|Overall Study|Lost to Follow-up|33|||
161021584|NCT04908722|581470750|FG001|Overall Study|Lost to Follow-up|33|||
161021585|NCT04908722|581470751|FG002|Overall Study|Lost to Follow-up|36|||
161021586|NCT04908722|581470752|FG003|Overall Study|Lost to Follow-up|30|||
161021587|NCT04908722|581470753|FG004|Overall Study|Lost to Follow-up|32|||
161021588|NCT04908722|581470754|FG005|Overall Study|Lost to Follow-up|34|||
160657072|NCT02879643|580124530|FG001|Overall Study|Adverse Event|0|||
161021589|NCT04908722|581470749|FG000|Overall Study|Physician Decision|1|||
161021590|NCT04908722|581470750|FG001|Overall Study|Physician Decision|1|||
161021591|NCT04908722|581470751|FG002|Overall Study|Physician Decision|1|||
161021592|NCT04908722|581470752|FG003|Overall Study|Physician Decision|2|||
161021593|NCT04908722|581470753|FG004|Overall Study|Physician Decision|0|||
161021594|NCT04908722|581470754|FG005|Overall Study|Physician Decision|0|||
161021595|NCT04908722|581470749|FG000|Overall Study|Death|1|||
161021596|NCT04908722|581470750|FG001|Overall Study|Death|0|||
161021597|NCT04908722|581470751|FG002|Overall Study|Death|0|||
161021598|NCT04908722|581470752|FG003|Overall Study|Death|0|||
161021599|NCT04908722|581470753|FG004|Overall Study|Death|0|||
161021600|NCT04908722|581470754|FG005|Overall Study|Death|1|||
161021601|NCT04908722|581470749|FG000|Overall Study|Withdrawal by Subject|12|||
161021602|NCT04908722|581470750|FG001|Overall Study|Withdrawal by Subject|8|||
161021603|NCT04908722|581470751|FG002|Overall Study|Withdrawal by Subject|7|||
161021604|NCT04908722|581470752|FG003|Overall Study|Withdrawal by Subject|6|||
161021605|NCT04908722|581470753|FG004|Overall Study|Withdrawal by Subject|12|||
161021606|NCT04908722|581470754|FG005|Overall Study|Withdrawal by Subject|14|||
161021607|NCT04908722|581470749|FG000|Overall Study|Other|3|||
161021608|NCT04908722|581470750|FG001|Overall Study|Other|1|||
161021609|NCT04908722|581470751|FG002|Overall Study|Other|3|||
161021610|NCT04908722|581470752|FG003|Overall Study|Other|2|||
161021611|NCT04908722|581470753|FG004|Overall Study|Other|4|||
161021612|NCT04908722|581470754|FG005|Overall Study|Other|1|||
161021613|NCT04908722|581470749|FG000|Overall Study|Initiated prohibited medication|0|||
161021614|NCT04908722|581470750|FG001|Overall Study|Initiated prohibited medication|0|||
161021615|NCT04908722|581470751|FG002|Overall Study|Initiated prohibited medication|0|||
161021616|NCT04908722|581470752|FG003|Overall Study|Initiated prohibited medication|1|||
161021617|NCT04908722|581470753|FG004|Overall Study|Initiated prohibited medication|0|||
161021618|NCT04908722|581470754|FG005|Overall Study|Initiated prohibited medication|1|||
161021619|NCT04908722|581470749|FG000|Overall Study|Randomized but not vaccinated|3|||
161021620|NCT04908722|581470750|FG001|Overall Study|Randomized but not vaccinated|1|||
161021621|NCT04908722|581470751|FG002|Overall Study|Randomized but not vaccinated|2|||
161021622|NCT04908722|581470752|FG003|Overall Study|Randomized but not vaccinated|2|||
161021623|NCT04908722|581470753|FG004|Overall Study|Randomized but not vaccinated|3|||
161021624|NCT04908722|581470754|FG005|Overall Study|Randomized but not vaccinated|4|||
161021625|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
161021626|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
161021627|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
161021628|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
161021629|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
161021630|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
161021631|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
161021632|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
161021633|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
161021634|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
161021635|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
161021636|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
161021637|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
161021638|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
161021639|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
161021640|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
161021641|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
161021642|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
161021643|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161021644|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
161021645|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
161021646|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161021647|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161021648|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
161021649|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161021650|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
160459904|NCT03705793|579417495|FG000|Overall Study|Lost to Follow-up|3|||
161021651|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161021652|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
161021653|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161021654|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
161021655|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
161021656|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
161021657|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
161021658|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161021659|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161021660|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161021661|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
161021662|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
161021663|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
161021664|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
161021665|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
161021666|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
161021667|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
161021668|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
161021669|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
161021670|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
161021671|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
161021672|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
161021673|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
161021674|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
161021675|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
161021676|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
161021677|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
161021678|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
161021679|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021680|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021681|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021682|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021683|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021684|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021685|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
161021686|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
161021687|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
161021688|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Death|0|||
161021689|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Death|0|||
161021690|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Death|0|||
161021691|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Death|0|||
161021692|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Death|0|||
161021693|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Death|0|||
161021694|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Death|0|||
161021695|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Death|1|||
161021696|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Death|3|||
161021697|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021698|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021699|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021700|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021701|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021702|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021703|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
161021704|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
161021705|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
161021706|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021707|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021708|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021709|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
160587384|NCT02387372|579869885|FG001|Overall Study|Not Treated|0|||
160587385|NCT01911845|579869887|FG000|Overall Study|Adverse Event|2|||
161021710|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021711|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021712|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021713|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
161021714|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
161021715|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
161021716|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
161021717|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
160587386|NCT01911845|579869887|FG000|Overall Study|Lost to Follow-up|1|||
160587387|NCT01911845|579869887|FG000|Overall Study|Other (not specified)|3|||
160587388|NCT01576016|579869888|FG000|Lead Safety|Death|132|||
160587389|NCT01576016|579869889|FG001|Lead Safety|Death|0|||
161021718|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
161021719|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
161021720|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
161021721|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
161021722|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
161021723|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
161021724|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021725|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021726|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021727|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021728|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021729|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021730|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
161021731|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
161021732|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
161021733|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021734|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021735|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021736|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021737|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021738|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021739|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
161021740|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
161021741|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
161021742|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Other|0|||
161021743|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Other|0|||
161021744|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Other|0|||
161021745|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Other|0|||
161021746|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Other|0|||
161021747|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Other|0|||
161021748|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Other|110|||
161021749|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Other|9|||
161021750|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Other|17|||
161021751|NCT06424236|581470770|FG000|Overall Study|Adverse Event|0|||
161021752|NCT06424236|581470771|FG001|Overall Study|Adverse Event|1|||
161021753|NCT06424236|581470772|FG002|Overall Study|Adverse Event|0|||
161021754|NCT06424236|581470770|FG000|Overall Study|Withdrawal by Subject|3|||
161021755|NCT06424236|581470771|FG001|Overall Study|Withdrawal by Subject|1|||
161021756|NCT06424236|581470772|FG002|Overall Study|Withdrawal by Subject|2|||
161021757|NCT06424236|581470770|FG000|Overall Study|Physician Decision|0|||
161021758|NCT06424236|581470771|FG001|Overall Study|Physician Decision|1|||
161021759|NCT06424236|581470772|FG002|Overall Study|Physician Decision|0|||
161021760|NCT06424236|581470770|FG000|Overall Study|Study Terminated by Sponsor|11|||
161021761|NCT06424236|581470771|FG001|Overall Study|Study Terminated by Sponsor|20|||
161021762|NCT06424236|581470772|FG002|Overall Study|Study Terminated by Sponsor|16|||
161021763|NCT06424236|581470770|FG000|Overall Study|Lost to Follow-up|0|||
161021764|NCT06424236|581470771|FG001|Overall Study|Lost to Follow-up|1|||
161021765|NCT06424236|581470772|FG002|Overall Study|Lost to Follow-up|0|||
161021766|NCT06424236|581470770|FG000|Overall Study|Disease Progression|0|||
161021767|NCT06424236|581470771|FG001|Overall Study|Disease Progression|1|||
161021768|NCT06424236|581470772|FG002|Overall Study|Disease Progression|2|||
161021769|NCT06424236|581470770|FG000|Overall Study|Other|0|||
161021770|NCT06424236|581470771|FG001|Overall Study|Other|0|||
161021771|NCT06424236|581470772|FG002|Overall Study|Other|1|||
161021772|NCT01959425|581470776|FG000|Overall Study|Withdrawal by Subject|5|||
161021773|NCT01959425|581470777|FG001|Overall Study|Withdrawal by Subject|4|||
161021774|NCT01959425|581470776|FG000|Overall Study|Lost to Follow-up|1|||
161021775|NCT01959425|581470777|FG001|Overall Study|Lost to Follow-up|0|||
161021776|NCT01959425|581470776|FG000|Overall Study|Discontinued Subjects|6|||
161021777|NCT01959425|581470777|FG001|Overall Study|Discontinued Subjects|4|||
161021778|NCT00227344|581470779|FG000|Overall Study|study terminated early|12|||
161021779|NCT00227344|581470780|FG001|Overall Study|study terminated early|5|||
161021780|NCT01987895|581470781|FG000|Overall Study|Withdrawal by Subject|12|||
161021781|NCT01987895|581470782|FG001|Overall Study|Withdrawal by Subject|7|||
161021782|NCT01987895|581470781|FG000|Overall Study|Physician Decision|8|||
161021783|NCT01987895|581470782|FG001|Overall Study|Physician Decision|10|||
161021784|NCT01987895|581470781|FG000|Overall Study|Death|7|||
160587390|NCT01576016|579869888|FG000|Lead Safety|Withdrawal by Subject|81|||
160587391|NCT01576016|579869889|FG001|Lead Safety|Withdrawal by Subject|0|||
160587392|NCT01576016|579869888|FG000|Lead Safety|System Explanted without Replacement|24|||
161021785|NCT01987895|581470782|FG001|Overall Study|Death|7|||
161021786|NCT01987895|581470781|FG000|Overall Study|Lost to Follow-up|3|||
161021787|NCT01987895|581470782|FG001|Overall Study|Lost to Follow-up|5|||
161021788|NCT01987895|581470781|FG000|Overall Study|randomized before giving IC|0|||
160587393|NCT01576016|579869889|FG001|Lead Safety|System Explanted without Replacement|0|||
160587394|NCT01576016|579869888|FG000|Lead Safety|Physician Decision|14|||
161021789|NCT01987895|581470782|FG001|Overall Study|randomized before giving IC|1|||
161021790|NCT02979327|581470783|FG000|First Intervention|Protocol Violation|1|||
161021791|NCT02979327|581470784|FG001|First Intervention|Protocol Violation|0|||
161021792|NCT01073566|581470790|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
161021793|NCT01073566|581470791|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
161021794|NCT05780437|581470792|FG000|Overall Study|Withdrawal by Subject|22|||
161021795|NCT05780437|581470793|FG001|Overall Study|Withdrawal by Subject|16|||
161021796|NCT03474679|581470802|FG000|Overall Study|Death|7|||
161021797|NCT03474679|581470802|FG000|Overall Study|Withdrawal by Subject|1|||
161021798|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
161021799|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
161021800|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
161021801|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
161021802|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
161021803|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
161021804|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Death|6|||
161021805|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Death|0|||
161021806|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Death|0|||
161021807|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
161021808|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
161021809|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
161021810|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
161021811|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
161021812|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
161021813|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
161021814|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
161021815|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
161021816|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Other|5|||
161021817|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Other|0|||
161021818|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Other|0|||
161021819|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
161021820|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
161021821|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
161021822|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Other|0|||
161021823|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Other|1|||
161021824|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Other|1|||
161021825|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
161021826|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
161021827|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
161021828|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
161021829|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
161021830|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
161021831|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
161021832|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
161021833|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
161021834|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
161021835|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
161021836|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
161021837|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Death|0|||
161021838|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Death|6|||
161021839|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Death|11|||
161021840|NCT05499377|581470813|FG000|Overall Study|Withdrawal by Subject|2|||
161021841|NCT05499377|581470814|FG001|Overall Study|Withdrawal by Subject|0|||
161021842|NCT05499377|581470813|FG000|Overall Study|Physician Decision|1|||
161021843|NCT05499377|581470814|FG001|Overall Study|Physician Decision|0|||
161021844|NCT03544281|581470817|FG000|Main Study Phase|Death|3|||
161021845|NCT03544281|581470818|FG001|Main Study Phase|Death|2|||
160587395|NCT01576016|579869889|FG001|Lead Safety|Physician Decision|0|||
160587396|NCT01576016|579869888|FG000|Lead Safety|Lost to Follow-up|13|||
160587397|NCT01576016|579869889|FG001|Lead Safety|Lost to Follow-up|0|||
160587398|NCT01576016|579869888|FG000|Lead Safety|Unsuccessful implant|2|||
160587399|NCT01576016|579869889|FG001|Lead Safety|Unsuccessful implant|0|||
160587400|NCT01576016|579869888|FG000|Lead Safety|Sponsor request|1|||
161021846|NCT03544281|581470819|FG002|Main Study Phase|Death|6|||
161021847|NCT03544281|581470820|FG003|Main Study Phase|Death|8|||
161021848|NCT03544281|581470821|FG004|Main Study Phase|Death|4|||
161021849|NCT03544281|581470822|FG005|Main Study Phase|Death|2|||
161021850|NCT03544281|581470823|FG006|Main Study Phase|Death|4|||
161021851|NCT03544281|581470824|FG007|Main Study Phase|Death|5|||
161021852|NCT03544281|581470825|FG008|Main Study Phase|Death|5|||
161021853|NCT03544281|581470826|FG009|Main Study Phase|Death|8|||
161021854|NCT03544281|581470827|FG010|Main Study Phase|Death|6|||
161021855|NCT03544281|581470828|FG011|Main Study Phase|Death|4|||
161021856|NCT03544281|581470829|FG012|Main Study Phase|Death|0|||
161021857|NCT03544281|581470830|FG013|Main Study Phase|Death|0|||
161021858|NCT03544281|581470831|FG014|Main Study Phase|Death|0|||
161021859|NCT03544281|581470832|FG015|Main Study Phase|Death|0|||
161021860|NCT03544281|581470833|FG016|Main Study Phase|Death|0|||
161021861|NCT03544281|581470834|FG017|Main Study Phase|Death|0|||
161021862|NCT03544281|581470835|FG018|Main Study Phase|Death|0|||
161021863|NCT03544281|581470836|FG019|Main Study Phase|Death|0|||
161021864|NCT03544281|581470837|FG020|Main Study Phase|Death|0|||
161021865|NCT03544281|581470838|FG021|Main Study Phase|Death|0|||
161021866|NCT03544281|581470817|FG000|Main Study Phase|Lost to Follow-up|0|||
161021867|NCT03544281|581470818|FG001|Main Study Phase|Lost to Follow-up|0|||
161021868|NCT03544281|581470819|FG002|Main Study Phase|Lost to Follow-up|0|||
161021869|NCT03544281|581470820|FG003|Main Study Phase|Lost to Follow-up|0|||
161021870|NCT03544281|581470821|FG004|Main Study Phase|Lost to Follow-up|0|||
161021871|NCT03544281|581470822|FG005|Main Study Phase|Lost to Follow-up|0|||
161021872|NCT03544281|581470823|FG006|Main Study Phase|Lost to Follow-up|0|||
161021873|NCT03544281|581470824|FG007|Main Study Phase|Lost to Follow-up|0|||
161021874|NCT03544281|581470825|FG008|Main Study Phase|Lost to Follow-up|0|||
161021875|NCT03544281|581470826|FG009|Main Study Phase|Lost to Follow-up|0|||
161021876|NCT03544281|581470827|FG010|Main Study Phase|Lost to Follow-up|1|||
161021877|NCT03544281|581470828|FG011|Main Study Phase|Lost to Follow-up|0|||
161021878|NCT03544281|581470829|FG012|Main Study Phase|Lost to Follow-up|0|||
161021879|NCT03544281|581470830|FG013|Main Study Phase|Lost to Follow-up|0|||
161021880|NCT03544281|581470831|FG014|Main Study Phase|Lost to Follow-up|0|||
161021881|NCT03544281|581470832|FG015|Main Study Phase|Lost to Follow-up|0|||
161021882|NCT03544281|581470833|FG016|Main Study Phase|Lost to Follow-up|0|||
161021883|NCT03544281|581470834|FG017|Main Study Phase|Lost to Follow-up|0|||
161021884|NCT03544281|581470835|FG018|Main Study Phase|Lost to Follow-up|0|||
161021885|NCT03544281|581470836|FG019|Main Study Phase|Lost to Follow-up|0|||
161021886|NCT03544281|581470837|FG020|Main Study Phase|Lost to Follow-up|0|||
161021887|NCT03544281|581470838|FG021|Main Study Phase|Lost to Follow-up|0|||
161021888|NCT03544281|581470817|FG000|Main Study Phase|Physician Decision|0|||
161021889|NCT03544281|581470818|FG001|Main Study Phase|Physician Decision|0|||
161021890|NCT03544281|581470819|FG002|Main Study Phase|Physician Decision|0|||
161021891|NCT03544281|581470820|FG003|Main Study Phase|Physician Decision|0|||
161021892|NCT03544281|581470821|FG004|Main Study Phase|Physician Decision|0|||
161021893|NCT03544281|581470822|FG005|Main Study Phase|Physician Decision|0|||
161021894|NCT03544281|581470823|FG006|Main Study Phase|Physician Decision|0|||
161021895|NCT03544281|581470824|FG007|Main Study Phase|Physician Decision|1|||
161021896|NCT03544281|581470825|FG008|Main Study Phase|Physician Decision|0|||
161021897|NCT03544281|581470826|FG009|Main Study Phase|Physician Decision|0|||
161021898|NCT03544281|581470827|FG010|Main Study Phase|Physician Decision|0|||
161021899|NCT03544281|581470828|FG011|Main Study Phase|Physician Decision|0|||
161021900|NCT03544281|581470829|FG012|Main Study Phase|Physician Decision|0|||
161021901|NCT03544281|581470830|FG013|Main Study Phase|Physician Decision|0|||
161021902|NCT03544281|581470831|FG014|Main Study Phase|Physician Decision|0|||
161021903|NCT03544281|581470832|FG015|Main Study Phase|Physician Decision|0|||
161021904|NCT03544281|581470833|FG016|Main Study Phase|Physician Decision|0|||
161021905|NCT03544281|581470834|FG017|Main Study Phase|Physician Decision|0|||
161021906|NCT03544281|581470835|FG018|Main Study Phase|Physician Decision|0|||
161021907|NCT03544281|581470836|FG019|Main Study Phase|Physician Decision|0|||
161021908|NCT03544281|581470837|FG020|Main Study Phase|Physician Decision|0|||
161021909|NCT03544281|581470838|FG021|Main Study Phase|Physician Decision|0|||
161021910|NCT03544281|581470817|FG000|Main Study Phase|Withdrawal by Subject|2|||
161021911|NCT03544281|581470818|FG001|Main Study Phase|Withdrawal by Subject|0|||
161021912|NCT03544281|581470819|FG002|Main Study Phase|Withdrawal by Subject|1|||
161021913|NCT03544281|581470820|FG003|Main Study Phase|Withdrawal by Subject|2|||
161021914|NCT03544281|581470821|FG004|Main Study Phase|Withdrawal by Subject|0|||
161021915|NCT03544281|581470822|FG005|Main Study Phase|Withdrawal by Subject|0|||
161021916|NCT03544281|581470823|FG006|Main Study Phase|Withdrawal by Subject|0|||
161021917|NCT03544281|581470824|FG007|Main Study Phase|Withdrawal by Subject|0|||
161021918|NCT03544281|581470825|FG008|Main Study Phase|Withdrawal by Subject|2|||
161021919|NCT03544281|581470826|FG009|Main Study Phase|Withdrawal by Subject|3|||
161021920|NCT03544281|581470827|FG010|Main Study Phase|Withdrawal by Subject|0|||
161021921|NCT03544281|581470828|FG011|Main Study Phase|Withdrawal by Subject|4|||
161021922|NCT03544281|581470829|FG012|Main Study Phase|Withdrawal by Subject|0|||
161021923|NCT03544281|581470830|FG013|Main Study Phase|Withdrawal by Subject|0|||
161021924|NCT03544281|581470831|FG014|Main Study Phase|Withdrawal by Subject|0|||
161021925|NCT03544281|581470832|FG015|Main Study Phase|Withdrawal by Subject|0|||
161021926|NCT03544281|581470833|FG016|Main Study Phase|Withdrawal by Subject|0|||
161021927|NCT03544281|581470834|FG017|Main Study Phase|Withdrawal by Subject|0|||
161021928|NCT03544281|581470835|FG018|Main Study Phase|Withdrawal by Subject|0|||
161021929|NCT03544281|581470836|FG019|Main Study Phase|Withdrawal by Subject|0|||
161021930|NCT03544281|581470837|FG020|Main Study Phase|Withdrawal by Subject|0|||
161021931|NCT03544281|581470838|FG021|Main Study Phase|Withdrawal by Subject|0|||
161021932|NCT03544281|581470817|FG000|Main Study Phase|Ongoing|3|||
161021933|NCT03544281|581470818|FG001|Main Study Phase|Ongoing|1|||
161021934|NCT03544281|581470819|FG002|Main Study Phase|Ongoing|2|||
161021935|NCT03544281|581470820|FG003|Main Study Phase|Ongoing|4|||
161021936|NCT03544281|581470821|FG004|Main Study Phase|Ongoing|2|||
161021937|NCT03544281|581470822|FG005|Main Study Phase|Ongoing|4|||
161021938|NCT03544281|581470823|FG006|Main Study Phase|Ongoing|4|||
161021939|NCT03544281|581470824|FG007|Main Study Phase|Ongoing|0|||
161021940|NCT03544281|581470825|FG008|Main Study Phase|Ongoing|2|||
161021941|NCT03544281|581470826|FG009|Main Study Phase|Ongoing|2|||
161021942|NCT03544281|581470827|FG010|Main Study Phase|Ongoing|1|||
161021943|NCT03544281|581470828|FG011|Main Study Phase|Ongoing|0|||
161021944|NCT03544281|581470829|FG012|Main Study Phase|Ongoing|0|||
161021945|NCT03544281|581470830|FG013|Main Study Phase|Ongoing|0|||
161021946|NCT03544281|581470831|FG014|Main Study Phase|Ongoing|0|||
161021947|NCT03544281|581470832|FG015|Main Study Phase|Ongoing|0|||
161021948|NCT03544281|581470833|FG016|Main Study Phase|Ongoing|0|||
161021949|NCT03544281|581470834|FG017|Main Study Phase|Ongoing|0|||
161021950|NCT03544281|581470835|FG018|Main Study Phase|Ongoing|0|||
161021951|NCT03544281|581470836|FG019|Main Study Phase|Ongoing|0|||
161021952|NCT03544281|581470837|FG020|Main Study Phase|Ongoing|0|||
161021953|NCT03544281|581470838|FG021|Main Study Phase|Ongoing|0|||
161021954|NCT03544281|581470817|FG000|Main Study Phase|Investigator Site Closed|0|||
161021955|NCT03544281|581470818|FG001|Main Study Phase|Investigator Site Closed|0|||
161021956|NCT03544281|581470819|FG002|Main Study Phase|Investigator Site Closed|0|||
161021957|NCT03544281|581470820|FG003|Main Study Phase|Investigator Site Closed|0|||
161021958|NCT03544281|581470821|FG004|Main Study Phase|Investigator Site Closed|0|||
161021959|NCT03544281|581470822|FG005|Main Study Phase|Investigator Site Closed|0|||
161021960|NCT03544281|581470823|FG006|Main Study Phase|Investigator Site Closed|0|||
161021961|NCT03544281|581470824|FG007|Main Study Phase|Investigator Site Closed|0|||
161021962|NCT03544281|581470825|FG008|Main Study Phase|Investigator Site Closed|0|||
161021963|NCT03544281|581470826|FG009|Main Study Phase|Investigator Site Closed|1|||
161021964|NCT03544281|581470827|FG010|Main Study Phase|Investigator Site Closed|0|||
161021965|NCT03544281|581470828|FG011|Main Study Phase|Investigator Site Closed|0|||
161021966|NCT03544281|581470829|FG012|Main Study Phase|Investigator Site Closed|0|||
161021967|NCT03544281|581470830|FG013|Main Study Phase|Investigator Site Closed|0|||
161021968|NCT03544281|581470831|FG014|Main Study Phase|Investigator Site Closed|0|||
161021969|NCT03544281|581470832|FG015|Main Study Phase|Investigator Site Closed|0|||
161021970|NCT03544281|581470833|FG016|Main Study Phase|Investigator Site Closed|0|||
161021971|NCT03544281|581470834|FG017|Main Study Phase|Investigator Site Closed|0|||
161021972|NCT03544281|581470835|FG018|Main Study Phase|Investigator Site Closed|0|||
161021973|NCT03544281|581470836|FG019|Main Study Phase|Investigator Site Closed|0|||
161021974|NCT03544281|581470837|FG020|Main Study Phase|Investigator Site Closed|0|||
161021975|NCT03544281|581470838|FG021|Main Study Phase|Investigator Site Closed|0|||
161021976|NCT03544281|581470817|FG000|Main Study Phase|Did not receive study treatment|0|||
161021977|NCT03544281|581470818|FG001|Main Study Phase|Did not receive study treatment|0|||
161021978|NCT03544281|581470819|FG002|Main Study Phase|Did not receive study treatment|0|||
161021979|NCT03544281|581470820|FG003|Main Study Phase|Did not receive study treatment|0|||
161021980|NCT03544281|581470821|FG004|Main Study Phase|Did not receive study treatment|0|||
161021981|NCT03544281|581470822|FG005|Main Study Phase|Did not receive study treatment|0|||
161021982|NCT03544281|581470823|FG006|Main Study Phase|Did not receive study treatment|1|||
161021983|NCT03544281|581470824|FG007|Main Study Phase|Did not receive study treatment|0|||
161021984|NCT03544281|581470825|FG008|Main Study Phase|Did not receive study treatment|0|||
161021985|NCT03544281|581470826|FG009|Main Study Phase|Did not receive study treatment|0|||
161021986|NCT03544281|581470827|FG010|Main Study Phase|Did not receive study treatment|0|||
161021987|NCT03544281|581470828|FG011|Main Study Phase|Did not receive study treatment|0|||
161021988|NCT03544281|581470829|FG012|Main Study Phase|Did not receive study treatment|0|||
161021989|NCT03544281|581470830|FG013|Main Study Phase|Did not receive study treatment|0|||
161021990|NCT03544281|581470831|FG014|Main Study Phase|Did not receive study treatment|0|||
161021991|NCT03544281|581470832|FG015|Main Study Phase|Did not receive study treatment|0|||
161021992|NCT03544281|581470833|FG016|Main Study Phase|Did not receive study treatment|0|||
161021993|NCT03544281|581470834|FG017|Main Study Phase|Did not receive study treatment|0|||
161021994|NCT03544281|581470835|FG018|Main Study Phase|Did not receive study treatment|0|||
161021995|NCT03544281|581470836|FG019|Main Study Phase|Did not receive study treatment|0|||
161021996|NCT03544281|581470837|FG020|Main Study Phase|Did not receive study treatment|0|||
161021997|NCT03544281|581470838|FG021|Main Study Phase|Did not receive study treatment|0|||
161021998|NCT03544281|581470817|FG000|PACT Phase|Adverse Event|0|||
161021999|NCT03544281|581470818|FG001|PACT Phase|Adverse Event|0|||
161022000|NCT03544281|581470819|FG002|PACT Phase|Adverse Event|0|||
161022001|NCT03544281|581470820|FG003|PACT Phase|Adverse Event|0|||
161022002|NCT03544281|581470821|FG004|PACT Phase|Adverse Event|0|||
161022003|NCT03544281|581470822|FG005|PACT Phase|Adverse Event|0|||
161022004|NCT03544281|581470823|FG006|PACT Phase|Adverse Event|0|||
161022005|NCT03544281|581470824|FG007|PACT Phase|Adverse Event|0|||
161022006|NCT03544281|581470825|FG008|PACT Phase|Adverse Event|0|||
161022007|NCT03544281|581470826|FG009|PACT Phase|Adverse Event|0|||
161022008|NCT03544281|581470827|FG010|PACT Phase|Adverse Event|0|||
161022009|NCT03544281|581470828|FG011|PACT Phase|Adverse Event|0|||
160459905|NCT03705793|579417496|FG001|Overall Study|Lost to Follow-up|4|||
160459906|NCT03705793|579417495|FG000|Overall Study|Withdrawal by Subject|2|||
161022010|NCT03544281|581470829|FG012|PACT Phase|Adverse Event|1|||
161022011|NCT03544281|581470830|FG013|PACT Phase|Adverse Event|0|||
161022012|NCT03544281|581470831|FG014|PACT Phase|Adverse Event|0|||
161022013|NCT03544281|581470832|FG015|PACT Phase|Adverse Event|0|||
161022014|NCT03544281|581470833|FG016|PACT Phase|Adverse Event|0|||
161022015|NCT03544281|581470834|FG017|PACT Phase|Adverse Event|1|||
161022016|NCT03544281|581470835|FG018|PACT Phase|Adverse Event|1|||
161022017|NCT03544281|581470836|FG019|PACT Phase|Adverse Event|0|||
161022018|NCT03544281|581470837|FG020|PACT Phase|Adverse Event|0|||
161022019|NCT03544281|581470838|FG021|PACT Phase|Adverse Event|0|||
161022020|NCT06019559|581470839|FG000|Overall Study|Withdrawal by Subject|7|||
161022021|NCT06019559|581470840|FG001|Overall Study|Withdrawal by Subject|6|||
161022022|NCT06019559|581470841|FG002|Overall Study|Withdrawal by Subject|5|||
161022023|NCT06019559|581470839|FG000|Overall Study|Lost to Follow-up|2|||
161022024|NCT06019559|581470840|FG001|Overall Study|Lost to Follow-up|0|||
161022025|NCT06019559|581470841|FG002|Overall Study|Lost to Follow-up|3|||
161022026|NCT04623671|581470847|FG000|Overall Study|Adverse Event|0|||
161022027|NCT04623671|581470848|FG001|Overall Study|Adverse Event|1|||
161022028|NCT04623671|581470847|FG000|Overall Study|Lost to Follow-up|2|||
161022029|NCT04623671|581470848|FG001|Overall Study|Lost to Follow-up|1|||
161022030|NCT04623671|581470847|FG000|Overall Study|Death|5|||
161022031|NCT04623671|581470848|FG001|Overall Study|Death|5|||
161022032|NCT01802788|581470852|FG000|Overall Study|Withdrawal by Subject|102|||
161022033|NCT01802788|581470853|FG001|Overall Study|Withdrawal by Subject|5|||
161022034|NCT01802788|581470852|FG000|Overall Study|Death|382|||
161022035|NCT01802788|581470853|FG001|Overall Study|Death|18|||
161022036|NCT01802788|581470852|FG000|Overall Study|Lost to Follow-up|31|||
161022037|NCT01802788|581470853|FG001|Overall Study|Lost to Follow-up|2|||
161022038|NCT01802788|581470852|FG000|Overall Study|Physician Decision|3|||
161022039|NCT01802788|581470853|FG001|Overall Study|Physician Decision|0|||
161022040|NCT01802788|581470852|FG000|Overall Study|Patient Non-Compliance|1|||
161022041|NCT01802788|581470853|FG001|Overall Study|Patient Non-Compliance|0|||
161022042|NCT01802788|581470852|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
161022043|NCT01802788|581470853|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
161022044|NCT01802788|581470852|FG000|Overall Study|Other Reasons|19|||
161022045|NCT01802788|581470853|FG001|Overall Study|Other Reasons|0|||
161022046|NCT05257486|581470854|FG000|Overall Study|Protocol Violation|3|||
161022047|NCT04542317|581470855|FG000|Overall Study|Care recipients passed away|18|||
161022048|NCT04542317|581470856|FG001|Overall Study|Care recipients passed away|13|||
161022049|NCT04542317|581470855|FG000|Overall Study|No longer a primary caregiver|5|||
161022050|NCT04542317|581470856|FG001|Overall Study|No longer a primary caregiver|1|||
161022051|NCT04542317|581470855|FG000|Overall Study|Withdrawal by Subject|4|||
161022052|NCT04542317|581470856|FG001|Overall Study|Withdrawal by Subject|2|||
161022053|NCT04542317|581470855|FG000|Overall Study|Caregivers passed away|0|||
161022054|NCT04542317|581470856|FG001|Overall Study|Caregivers passed away|2|||
161022055|NCT04564742|581470861|FG000|Overall Study|Lost to Follow-up|1|||
161022056|NCT04564742|581470862|FG001|Overall Study|Lost to Follow-up|0|||
161022057|NCT04564742|581470861|FG000|Overall Study|Consent Withdrawal|4|||
161022058|NCT04564742|581470862|FG001|Overall Study|Consent Withdrawal|4|||
161022059|NCT03313076|581470866|FG000|Overall Study|Withdrawal by Subject|2|||
161022060|NCT03313076|581470867|FG001|Overall Study|Withdrawal by Subject|0|||
161022061|NCT03313076|581470868|FG002|Overall Study|Withdrawal by Subject|0|||
161022062|NCT03313076|581470869|FG003|Overall Study|Withdrawal by Subject|0|||
161022063|NCT03313076|581470866|FG000|Overall Study|Lost to Follow-up|0|||
161022064|NCT03313076|581470867|FG001|Overall Study|Lost to Follow-up|2|||
161022065|NCT03313076|581470868|FG002|Overall Study|Lost to Follow-up|2|||
161022066|NCT03313076|581470869|FG003|Overall Study|Lost to Follow-up|2|||
161022067|NCT05869383|581470870|FG000|Overall Study|Withdrawal by Subject|2|||
161022068|NCT05869383|581470871|FG001|Overall Study|Withdrawal by Subject|0|||
161022069|NCT04137367|581470880|FG000|Overall Study|Lost to Follow-up|8|||
160459907|NCT03705793|579417496|FG001|Overall Study|Withdrawal by Subject|1|||
160459908|NCT00447980|579417497|FG000|Overall Study|Withdrawal by Subject|1|||
160459909|NCT00447980|579417498|FG001|Overall Study|Withdrawal by Subject|1|||
160459910|NCT00447980|579417499|FG002|Overall Study|Withdrawal by Subject|4|||
160459911|NCT00447980|579417500|FG003|Overall Study|Withdrawal by Subject|4|||
160459912|NCT00447980|579417497|FG000|Overall Study|Lost to Follow-up|1|||
161022070|NCT04137367|581470881|FG001|Overall Study|Lost to Follow-up|6|||
161022071|NCT04137367|581470882|FG002|Overall Study|Lost to Follow-up|4|||
161022072|NCT05144009|581470883|FG000|Overall Study|Lost to Follow-up|0|||
161022073|NCT05144009|581470884|FG001|Overall Study|Lost to Follow-up|1|||
161022074|NCT05144009|581470883|FG000|Overall Study|Study Termination by the Sponsor|11|||
161022075|NCT05144009|581470884|FG001|Overall Study|Study Termination by the Sponsor|11|||
161022076|NCT05144009|581470883|FG000|Overall Study|Disease Progression|1|||
161022077|NCT05144009|581470884|FG001|Overall Study|Disease Progression|0|||
161022078|NCT05144009|581470883|FG000|Overall Study|Participant Decision|0|||
160459913|NCT00447980|579417498|FG001|Overall Study|Lost to Follow-up|1|||
160459914|NCT00447980|579417499|FG002|Overall Study|Lost to Follow-up|0|||
160587401|NCT01576016|579869889|FG001|Lead Safety|Sponsor request|0|||
160587402|NCT01576016|579869888|FG000|Lead Safety|Device replaced with CRT-D|1|||
160587403|NCT01576016|579869889|FG001|Lead Safety|Device replaced with CRT-D|0|||
160587404|NCT01576016|579869888|FG000|Lead Safety|Patient on Palliative Care|1|||
160587405|NCT01576016|579869889|FG001|Lead Safety|Patient on Palliative Care|0|||
161022079|NCT05144009|581470884|FG001|Overall Study|Participant Decision|2|||
161022080|NCT05144009|581470883|FG000|Overall Study|Death|5|||
161022081|NCT05144009|581470884|FG001|Overall Study|Death|10|||
161022082|NCT04065841|581470885|FG000|Overall Study|Adverse Event|4|||
161022083|NCT04065841|581470886|FG001|Overall Study|Adverse Event|2|||
161022084|NCT04065841|581470887|FG002|Overall Study|Adverse Event|10|||
161022085|NCT04065841|581470888|FG003|Overall Study|Adverse Event|1|||
161022086|NCT04065841|581470885|FG000|Overall Study|Lost to Follow-up|1|||
161022087|NCT04065841|581470886|FG001|Overall Study|Lost to Follow-up|2|||
161022088|NCT04065841|581470887|FG002|Overall Study|Lost to Follow-up|2|||
161022089|NCT04065841|581470888|FG003|Overall Study|Lost to Follow-up|2|||
161022090|NCT04065841|581470885|FG000|Overall Study|Physician Decision|1|||
161022091|NCT04065841|581470886|FG001|Overall Study|Physician Decision|0|||
161022092|NCT04065841|581470887|FG002|Overall Study|Physician Decision|0|||
161022093|NCT04065841|581470888|FG003|Overall Study|Physician Decision|0|||
161022094|NCT04065841|581470885|FG000|Overall Study|Protocol Violation|0|||
161022095|NCT04065841|581470886|FG001|Overall Study|Protocol Violation|1|||
161022096|NCT04065841|581470887|FG002|Overall Study|Protocol Violation|0|||
161022097|NCT04065841|581470888|FG003|Overall Study|Protocol Violation|0|||
161022098|NCT04065841|581470885|FG000|Overall Study|Study terminated by Sponsor|22|||
161022099|NCT04065841|581470886|FG001|Overall Study|Study terminated by Sponsor|16|||
161022100|NCT04065841|581470887|FG002|Overall Study|Study terminated by Sponsor|28|||
161022101|NCT04065841|581470888|FG003|Overall Study|Study terminated by Sponsor|17|||
161022102|NCT04065841|581470885|FG000|Overall Study|Withdrawal by Subject|1|||
161022103|NCT04065841|581470886|FG001|Overall Study|Withdrawal by Subject|1|||
161022104|NCT04065841|581470887|FG002|Overall Study|Withdrawal by Subject|2|||
161022105|NCT04065841|581470888|FG003|Overall Study|Withdrawal by Subject|0|||
161022106|NCT01420237|581470891|FG000|Overall Study|Death|13|||
161022107|NCT01420237|581470891|FG000|Overall Study|Withdrawal by Subject|41|||
161022108|NCT01420237|581470891|FG000|Overall Study|Lost to Follow-up|32|||
161022109|NCT01420237|581470891|FG000|Overall Study|Adverse Event|10|||
161022110|NCT01420237|581470891|FG000|Overall Study|Investigative Site Termination|43|||
161022111|NCT01420237|581470891|FG000|Overall Study|Censored because study device not implanted|21|||
161022112|NCT01420237|581470891|FG000|Overall Study|Censored because surgery not performed|2|||
161022113|NCT01420237|581470891|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
161022114|NCT01420237|581470891|FG000|Overall Study|Sponsor terminated study early|127|||
161022115|NCT05269667|581470892|FG000|Overall Study|Study Terminated by Sponsor|4|||
161022116|NCT02815566|581470895|FG000|Overall Study|Adverse Event|1|||
161022117|NCT02815566|581470896|FG001|Overall Study|Adverse Event|1|||
161022118|NCT02815566|581470895|FG000|Overall Study|Withdrawal by Subject|1|||
161022119|NCT02815566|581470896|FG001|Overall Study|Withdrawal by Subject|0|||
161022120|NCT02815566|581470895|FG000|Overall Study|Lost to Follow-up|0|||
161022121|NCT02815566|581470896|FG001|Overall Study|Lost to Follow-up|1|||
161022122|NCT04492722|581470898|FG000|Overall Study|Adverse Event|7|||
161022123|NCT04492722|581470899|FG001|Overall Study|Adverse Event|2|||
161022124|NCT04492722|581470900|FG002|Overall Study|Adverse Event|3|||
161022125|NCT04492722|581470901|FG003|Overall Study|Adverse Event|0|||
161022126|NCT04492722|581470898|FG000|Overall Study|Death|0|||
161022127|NCT04492722|581470899|FG001|Overall Study|Death|0|||
161022128|NCT04492722|581470900|FG002|Overall Study|Death|0|||
161022129|NCT04492722|581470901|FG003|Overall Study|Death|1|||
160587406|NCT01576016|579869888|FG000|Lead Safety|Patient noncompliance|1|||
160587407|NCT01576016|579869889|FG001|Lead Safety|Patient noncompliance|0|||
161022130|NCT04492722|581470898|FG000|Overall Study|Lost to Follow-up|0|||
161022131|NCT04492722|581470899|FG001|Overall Study|Lost to Follow-up|1|||
161022132|NCT04492722|581470900|FG002|Overall Study|Lost to Follow-up|0|||
161022133|NCT04492722|581470901|FG003|Overall Study|Lost to Follow-up|1|||
161022134|NCT04492722|581470898|FG000|Overall Study|Physician Decision|0|||
161022135|NCT04492722|581470899|FG001|Overall Study|Physician Decision|3|||
161022136|NCT04492722|581470900|FG002|Overall Study|Physician Decision|1|||
161022137|NCT04492722|581470901|FG003|Overall Study|Physician Decision|1|||
160587408|NCT01576016|579869888|FG000|Lead Safety|Too far from study site|1|||
160587409|NCT01576016|579869889|FG001|Lead Safety|Too far from study site|0|||
160587410|NCT01576016|579869888|FG000|Lead Safety|System deactivated|1|||
161022138|NCT04492722|581470898|FG000|Overall Study|Withdrawal by Subject|6|||
161022139|NCT04492722|581470899|FG001|Overall Study|Withdrawal by Subject|6|||
161022140|NCT04492722|581470900|FG002|Overall Study|Withdrawal by Subject|0|||
161022141|NCT04492722|581470901|FG003|Overall Study|Withdrawal by Subject|3|||
161022142|NCT04492722|581470898|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
161022143|NCT04492722|581470899|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
161022144|NCT04492722|581470900|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
161022145|NCT04492722|581470901|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
161022146|NCT04492722|581470898|FG000|Overall Study|Due to Covid-19 pandemic|7|||
161022147|NCT04492722|581470899|FG001|Overall Study|Due to Covid-19 pandemic|3|||
161022148|NCT04492722|581470900|FG002|Overall Study|Due to Covid-19 pandemic|7|||
161022149|NCT04492722|581470901|FG003|Overall Study|Due to Covid-19 pandemic|6|||
161022150|NCT04492722|581470898|FG000|Overall Study|Failure to meet randomisation criteria|2|||
161022151|NCT04492722|581470899|FG001|Overall Study|Failure to meet randomisation criteria|3|||
161022152|NCT04492722|581470900|FG002|Overall Study|Failure to meet randomisation criteria|4|||
161022153|NCT04492722|581470901|FG003|Overall Study|Failure to meet randomisation criteria|2|||
161022154|NCT04492722|581470898|FG000|Overall Study|Early termination from the study|54|||
161022155|NCT04492722|581470899|FG001|Overall Study|Early termination from the study|51|||
161022156|NCT04492722|581470900|FG002|Overall Study|Early termination from the study|50|||
161022157|NCT04492722|581470901|FG003|Overall Study|Early termination from the study|50|||
161022158|NCT04492722|581470898|FG000|Overall Study|Missing|3|||
161022159|NCT04492722|581470899|FG001|Overall Study|Missing|0|||
161022160|NCT04492722|581470900|FG002|Overall Study|Missing|0|||
161022161|NCT04492722|581470901|FG003|Overall Study|Missing|5|||
161022162|NCT04492722|581470898|FG000|Overall Study|Participants who did not receive treatment|0|||
161022163|NCT04492722|581470899|FG001|Overall Study|Participants who did not receive treatment|1|||
161022164|NCT04492722|581470900|FG002|Overall Study|Participants who did not receive treatment|4|||
161022165|NCT04492722|581470901|FG003|Overall Study|Participants who did not receive treatment|0|||
161022166|NCT05329220|581470905|FG000|Active Trial Period|Adverse Event|0|||
161022167|NCT05329220|581470906|FG001|Active Trial Period|Adverse Event|0|||
161022168|NCT05329220|581470907|FG002|Active Trial Period|Adverse Event|0|||
161022169|NCT05329220|581470908|FG003|Active Trial Period|Adverse Event|0|||
161022170|NCT05329220|581470909|FG004|Active Trial Period|Adverse Event|1|||
161022171|NCT05329220|581470910|FG005|Active Trial Period|Adverse Event|0|||
161022172|NCT05329220|581470905|FG000|Active Trial Period|Lost to Follow-up|0|||
161022173|NCT05329220|581470906|FG001|Active Trial Period|Lost to Follow-up|0|||
161022174|NCT05329220|581470907|FG002|Active Trial Period|Lost to Follow-up|0|||
161022175|NCT05329220|581470908|FG003|Active Trial Period|Lost to Follow-up|0|||
161022176|NCT05329220|581470909|FG004|Active Trial Period|Lost to Follow-up|32|||
161022177|NCT05329220|581470910|FG005|Active Trial Period|Lost to Follow-up|28|||
161022178|NCT05329220|581470905|FG000|Active Trial Period|Physician Decision|0|||
161022179|NCT05329220|581470906|FG001|Active Trial Period|Physician Decision|0|||
161022180|NCT05329220|581470907|FG002|Active Trial Period|Physician Decision|0|||
161022181|NCT05329220|581470908|FG003|Active Trial Period|Physician Decision|0|||
161022182|NCT05329220|581470909|FG004|Active Trial Period|Physician Decision|2|||
161022183|NCT05329220|581470910|FG005|Active Trial Period|Physician Decision|0|||
161022184|NCT05329220|581470905|FG000|Active Trial Period|Protocol Violation|0|||
161022185|NCT05329220|581470906|FG001|Active Trial Period|Protocol Violation|0|||
161022186|NCT05329220|581470907|FG002|Active Trial Period|Protocol Violation|0|||
161022187|NCT05329220|581470908|FG003|Active Trial Period|Protocol Violation|0|||
161022188|NCT05329220|581470909|FG004|Active Trial Period|Protocol Violation|1|||
161022189|NCT05329220|581470910|FG005|Active Trial Period|Protocol Violation|3|||
161022190|NCT05329220|581470905|FG000|Active Trial Period|Withdrawal by Subject|0|||
161022191|NCT05329220|581470906|FG001|Active Trial Period|Withdrawal by Subject|0|||
161022192|NCT05329220|581470907|FG002|Active Trial Period|Withdrawal by Subject|0|||
161022193|NCT05329220|581470908|FG003|Active Trial Period|Withdrawal by Subject|1|||
161022194|NCT05329220|581470909|FG004|Active Trial Period|Withdrawal by Subject|12|||
161022195|NCT05329220|581470910|FG005|Active Trial Period|Withdrawal by Subject|13|||
161022196|NCT05329220|581470905|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161022197|NCT05329220|581470906|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161022198|NCT05329220|581470907|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161022199|NCT05329220|581470908|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161022200|NCT05329220|581470909|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161022201|NCT05329220|581470910|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
161022202|NCT05329220|581470905|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161022203|NCT05329220|581470906|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161022204|NCT05329220|581470907|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161022205|NCT05329220|581470908|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161022206|NCT05329220|581470909|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161022207|NCT05329220|581470910|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
161022208|NCT05329220|581470905|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
161022209|NCT05329220|581470906|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
160459915|NCT00447980|579417500|FG003|Overall Study|Lost to Follow-up|0|||
160587411|NCT01576016|579869889|FG001|Lead Safety|System deactivated|0|||
160587412|NCT01576016|579869888|FG000|Lead Safety|Patient no longer followed by study PI|1|||
161022210|NCT05329220|581470907|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
161022211|NCT05329220|581470908|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
161022212|NCT05329220|581470909|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
161022213|NCT05329220|581470910|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
161022214|NCT05329220|581470905|FG000|Follow-up Period|Adverse Event|0|||
161022215|NCT05329220|581470906|FG001|Follow-up Period|Adverse Event|0|||
161022216|NCT05329220|581470907|FG002|Follow-up Period|Adverse Event|0|||
161022217|NCT05329220|581470908|FG003|Follow-up Period|Adverse Event|0|||
161022218|NCT05329220|581470909|FG004|Follow-up Period|Adverse Event|2|||
161022219|NCT05329220|581470910|FG005|Follow-up Period|Adverse Event|1|||
161022220|NCT05329220|581470905|FG000|Follow-up Period|Death|0|||
161022221|NCT05329220|581470906|FG001|Follow-up Period|Death|0|||
161022222|NCT05329220|581470907|FG002|Follow-up Period|Death|1|||
161022223|NCT05329220|581470908|FG003|Follow-up Period|Death|1|||
161022224|NCT05329220|581470909|FG004|Follow-up Period|Death|0|||
161022225|NCT05329220|581470910|FG005|Follow-up Period|Death|1|||
161022226|NCT05329220|581470905|FG000|Follow-up Period|Lost to Follow-up|0|||
161022227|NCT05329220|581470906|FG001|Follow-up Period|Lost to Follow-up|1|||
161022228|NCT05329220|581470907|FG002|Follow-up Period|Lost to Follow-up|2|||
161022229|NCT05329220|581470908|FG003|Follow-up Period|Lost to Follow-up|2|||
161022230|NCT05329220|581470909|FG004|Follow-up Period|Lost to Follow-up|113|||
161022231|NCT05329220|581470910|FG005|Follow-up Period|Lost to Follow-up|89|||
161022232|NCT05329220|581470905|FG000|Follow-up Period|Physician Decision|0|||
161022233|NCT05329220|581470906|FG001|Follow-up Period|Physician Decision|0|||
161022234|NCT05329220|581470907|FG002|Follow-up Period|Physician Decision|0|||
161022235|NCT05329220|581470908|FG003|Follow-up Period|Physician Decision|0|||
161022236|NCT05329220|581470909|FG004|Follow-up Period|Physician Decision|2|||
161022237|NCT05329220|581470910|FG005|Follow-up Period|Physician Decision|2|||
161022238|NCT05329220|581470905|FG000|Follow-up Period|Protocol Violation|0|||
161022239|NCT05329220|581470906|FG001|Follow-up Period|Protocol Violation|0|||
161022240|NCT05329220|581470907|FG002|Follow-up Period|Protocol Violation|0|||
161022241|NCT05329220|581470908|FG003|Follow-up Period|Protocol Violation|0|||
161022242|NCT05329220|581470909|FG004|Follow-up Period|Protocol Violation|0|||
161022243|NCT05329220|581470910|FG005|Follow-up Period|Protocol Violation|1|||
161022244|NCT05329220|581470905|FG000|Follow-up Period|Withdrawal by Subject|0|||
161022245|NCT05329220|581470906|FG001|Follow-up Period|Withdrawal by Subject|0|||
161022246|NCT05329220|581470907|FG002|Follow-up Period|Withdrawal by Subject|1|||
161022247|NCT05329220|581470908|FG003|Follow-up Period|Withdrawal by Subject|1|||
161022248|NCT05329220|581470909|FG004|Follow-up Period|Withdrawal by Subject|34|||
161022249|NCT05329220|581470910|FG005|Follow-up Period|Withdrawal by Subject|35|||
161022250|NCT05329220|581470905|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161022251|NCT05329220|581470906|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161022252|NCT05329220|581470907|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
161022253|NCT05329220|581470908|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161022254|NCT05329220|581470909|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161022255|NCT05329220|581470910|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161022256|NCT05329220|581470905|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161022257|NCT05329220|581470906|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161022258|NCT05329220|581470907|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161022259|NCT05329220|581470908|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161022260|NCT05329220|581470909|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
161022261|NCT05329220|581470910|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161022262|NCT05329220|581470905|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161022263|NCT05329220|581470906|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161022264|NCT05329220|581470907|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161022265|NCT05329220|581470908|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161022266|NCT05329220|581470909|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
161022267|NCT05329220|581470910|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161022268|NCT05329220|581470905|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161022269|NCT05329220|581470906|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161022270|NCT05329220|581470907|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161022271|NCT05329220|581470908|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161022272|NCT05329220|581470909|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161022273|NCT05329220|581470910|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
161022274|NCT05329220|581470905|FG000|Follow-up Period|EARLY TERMINATION|0|||
161022275|NCT05329220|581470906|FG001|Follow-up Period|EARLY TERMINATION|0|||
161022276|NCT05329220|581470907|FG002|Follow-up Period|EARLY TERMINATION|0|||
161022277|NCT05329220|581470908|FG003|Follow-up Period|EARLY TERMINATION|0|||
161022278|NCT05329220|581470909|FG004|Follow-up Period|EARLY TERMINATION|0|||
161022279|NCT05329220|581470910|FG005|Follow-up Period|EARLY TERMINATION|1|||
161022280|NCT05329220|581470905|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161022281|NCT05329220|581470906|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161022282|NCT05329220|581470907|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161022283|NCT05329220|581470908|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161022284|NCT05329220|581470909|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161022285|NCT05329220|581470910|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
161022286|NCT05329220|581470905|FG000|Follow-up Period|DROPPED|0|||
161022287|NCT05329220|581470906|FG001|Follow-up Period|DROPPED|0|||
161022288|NCT05329220|581470907|FG002|Follow-up Period|DROPPED|0|||
161022289|NCT05329220|581470908|FG003|Follow-up Period|DROPPED|0|||
161022290|NCT05329220|581470909|FG004|Follow-up Period|DROPPED|0|||
161022291|NCT05329220|581470910|FG005|Follow-up Period|DROPPED|1|||
161022292|NCT05329220|581470905|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161022293|NCT05329220|581470906|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161022294|NCT05329220|581470907|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161022295|NCT05329220|581470908|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161022296|NCT05329220|581470909|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161022297|NCT05329220|581470910|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
161022298|NCT05835336|581472788|FG000|Overall Study|Withdrawal by Subject|5|||
161022299|NCT05835336|581472788|FG000|Overall Study|Did not complete the personalization process|3|||
161022300|NCT04489771|581472789|FG000|Overall Study|Death|27|||
161022301|NCT04489771|581472790|FG001|Overall Study|Death|25|||
161022302|NCT04489771|581472789|FG000|Overall Study|Withdrawal by Subject|1|||
161022303|NCT04489771|581472790|FG001|Overall Study|Withdrawal by Subject|0|||
161022304|NCT04489771|581472789|FG000|Overall Study|Participants Ongoing in Study|50|||
161022305|NCT04489771|581472790|FG001|Overall Study|Participants Ongoing in Study|51|||
161022306|NCT04059484|581472796|FG000|Overall Study|Adverse Event|2|||
161022307|NCT04059484|581472797|FG001|Overall Study|Adverse Event|5|||
161022308|NCT04059484|581472796|FG000|Overall Study|Withdrawal by Subject|5|||
161022309|NCT04059484|581472797|FG001|Overall Study|Withdrawal by Subject|3|||
161022310|NCT04059484|581472796|FG000|Overall Study|Progressive disease|112|||
161022311|NCT04059484|581472797|FG001|Overall Study|Progressive disease|112|||
161022312|NCT04059484|581472796|FG000|Overall Study|Other|8|||
161022313|NCT04059484|581472797|FG001|Overall Study|Other|3|||
161022314|NCT04059484|581472796|FG000|Overall Study|Ongoing|20|||
161022315|NCT04059484|581472797|FG001|Overall Study|Ongoing|20|||
161022316|NCT00753545|581472798|FG000|Overall Study|Death|98|||
161022317|NCT00753545|581472799|FG001|Overall Study|Death|112|||
161022318|NCT00753545|581472798|FG000|Overall Study|Lost to Follow-up|2|||
161022319|NCT00753545|581472799|FG001|Overall Study|Lost to Follow-up|3|||
161022320|NCT00753545|581472798|FG000|Overall Study|Protocol Violation|1|||
161022321|NCT00753545|581472799|FG001|Overall Study|Protocol Violation|0|||
161022322|NCT00753545|581472798|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
161022323|NCT00753545|581472799|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
161022324|NCT05453773|581472800|FG000|Overall Study|Withdrawal by Subject|3|||
161022325|NCT05453773|581472800|FG000|Overall Study|Lost to Follow-up|3|||
161022326|NCT05453773|581472800|FG000|Overall Study|Difficult Blood Draw|3|||
161022327|NCT02485938|581472803|FG000|Overall Study|Withdrawal of consent|2|||
161022328|NCT02485938|581472804|FG001|Overall Study|Withdrawal of consent|0|||
161022329|NCT03839940|581472805|FG000|Overall Study|Withdrawal by Subject|3|||
161022330|NCT03839940|581472806|FG001|Overall Study|Withdrawal by Subject|0|||
161022331|NCT03839940|581472805|FG000|Overall Study|Protocol Violation|0|||
161022332|NCT03839940|581472806|FG001|Overall Study|Protocol Violation|1|||
161022333|NCT03839940|581472805|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
161022334|NCT03839940|581472806|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
161022335|NCT03241745|581472807|FG000|Overall Study|Adverse Event|7|||
161022336|NCT03241745|581472807|FG000|Overall Study|Death|1|||
161022337|NCT03241745|581472807|FG000|Overall Study|Withdrawal by Subject|5|||
161022338|NCT03241745|581472807|FG000|Overall Study|Treatment delay >28 days|2|||
161022339|NCT03241745|581472807|FG000|Overall Study|Lack of Efficacy|14|||
161022340|NCT00470704|581472808|FG000|Overall Study|Withdrawal by Subject|4|||
161022341|NCT00470704|581472809|FG001|Overall Study|Withdrawal by Subject|3|||
161022342|NCT00470704|581472808|FG000|Overall Study|Relapse/Progression|37|||
161022343|NCT00470704|581472809|FG001|Overall Study|Relapse/Progression|42|||
161022344|NCT00470704|581472808|FG000|Overall Study|toxicity|0|||
161022345|NCT00470704|581472809|FG001|Overall Study|toxicity|1|||
161022346|NCT04802967|581472811|FG000|Part B|Withdrawal by Subject|0|||
161022347|NCT04802967|581472812|FG001|Part B|Withdrawal by Subject|0|||
161022348|NCT04802967|581472813|FG002|Part B|Withdrawal by Subject|0|||
161022349|NCT04802967|581472814|FG003|Part B|Withdrawal by Subject|0|||
161022350|NCT04802967|581472815|FG004|Part B|Withdrawal by Subject|0|||
161022351|NCT04802967|581472816|FG005|Part B|Withdrawal by Subject|1|||
161022352|NCT04802967|581472817|FG006|Part B|Withdrawal by Subject|0|||
161022353|NCT04802967|581472818|FG007|Part B|Withdrawal by Subject|0|||
161022354|NCT04802967|581472819|FG008|Part B|Withdrawal by Subject|0|||
161022355|NCT04802967|581472820|FG009|Part B|Withdrawal by Subject|0|||
161022356|NCT02547233|581472826|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
161022357|NCT02547233|581472827|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
161022358|NCT02547233|581472826|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
161022359|NCT02547233|581472827|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
161022360|NCT02547233|581472826|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
161022361|NCT02547233|581472827|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
161022362|NCT02547233|581472826|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
161022363|NCT02547233|581472827|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
161022364|NCT02547233|581472826|FG000|12-month Follow-up|Withdrawal by Subject|10|||
161022365|NCT02547233|581472827|FG001|12-month Follow-up|Withdrawal by Subject|10|||
161022366|NCT02547233|581472826|FG000|12-month Follow-up|Lost to Follow-up|3|||
161022367|NCT02547233|581472827|FG001|12-month Follow-up|Lost to Follow-up|3|||
161022368|NCT02547233|581472826|FG000|12-month Follow-up|Lack of Efficacy|1|||
161022369|NCT02547233|581472827|FG001|12-month Follow-up|Lack of Efficacy|2|||
161022370|NCT02547233|581472826|FG000|12-month Follow-up|Protocol Violation|0|||
161022371|NCT02547233|581472827|FG001|12-month Follow-up|Protocol Violation|1|||
161022372|NCT02547233|581472826|FG000|12-month Follow-up|Other|0|||
161022373|NCT02547233|581472827|FG001|12-month Follow-up|Other|1|||
161022374|NCT05362487|581472829|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
161022375|NCT03603600|581472831|FG000|Overall Study|Withdrawal by Subject|5|||
161022376|NCT03603600|581472832|FG001|Overall Study|Withdrawal by Subject|7|||
161022377|NCT03603600|581472831|FG000|Overall Study|Lost to Follow-up|2|||
161022378|NCT03603600|581472832|FG001|Overall Study|Lost to Follow-up|3|||
161022379|NCT03603600|581472831|FG000|Overall Study|Death|3|||
161022380|NCT03603600|581472832|FG001|Overall Study|Death|1|||
161022381|NCT03603600|581472831|FG000|Overall Study|Physician Decision|2|||
161022382|NCT03603600|581472832|FG001|Overall Study|Physician Decision|1|||
161022383|NCT03603600|581472831|FG000|Overall Study|Other reason|1|||
161022384|NCT03603600|581472832|FG001|Overall Study|Other reason|0|||
161022385|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
161022386|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
161022387|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
161022388|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
161022389|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
161022390|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
161022391|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
161022392|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
161022393|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
161022394|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
161022395|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
161022396|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
161022397|NCT03461276|581472833|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
161022398|NCT03461276|581472834|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
161022399|NCT03461276|581472833|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
161022400|NCT03461276|581472834|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
161022401|NCT03461276|581472833|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
161022402|NCT03461276|581472834|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
161022403|NCT03461276|581472833|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
161022404|NCT03461276|581472834|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
161022405|NCT01943409|581472838|FG000|Overall Study|resumed oral/entral|24|||
161022406|NCT01943409|581472839|FG001|Overall Study|resumed oral/entral|20|||
161022407|NCT01943409|581472838|FG000|Overall Study|Protocol Violation|14|||
161022408|NCT01943409|581472839|FG001|Overall Study|Protocol Violation|24|||
161022409|NCT01943409|581472838|FG000|Overall Study|Death|3|||
161022410|NCT01943409|581472839|FG001|Overall Study|Death|1|||
161022411|NCT01943409|581472838|FG000|Overall Study|Withdrawal by Subject|4|||
161022412|NCT01943409|581472839|FG001|Overall Study|Withdrawal by Subject|3|||
160587413|NCT01576016|579869889|FG001|Lead Safety|Patient no longer followed by study PI|0|||
160587414|NCT01576016|579869888|FG000|MRI Safety|Withdrawal by Subject|0|||
160587415|NCT01576016|579869889|FG001|MRI Safety|Withdrawal by Subject|10|||
160587416|NCT01576016|579869888|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
161022413|NCT02310646|581472840|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
160587417|NCT01576016|579869889|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
160587418|NCT01576016|579869888|FG000|MRI Safety|Has not yet completed MRI scan|0|||
161022414|NCT02310646|581472841|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
161022415|NCT02310646|581472840|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
161022416|NCT02310646|581472841|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
161022417|NCT00613106|581472848|FG000|Overall Study|Adverse Event|3|||
161022418|NCT00613106|581472849|FG001|Overall Study|Adverse Event|1|||
160587419|NCT01576016|579869889|FG001|MRI Safety|Has not yet completed MRI scan|56|||
161022419|NCT00613106|581472848|FG000|Overall Study|Withdrawal by Subject|6|||
161022420|NCT00613106|581472849|FG001|Overall Study|Withdrawal by Subject|3|||
161022421|NCT00613106|581472848|FG000|Overall Study|Lost to Follow-up|7|||
161022422|NCT00613106|581472849|FG001|Overall Study|Lost to Follow-up|2|||
161022423|NCT00613106|581472848|FG000|Overall Study|misc|4|||
161022424|NCT00613106|581472849|FG001|Overall Study|misc|3|||
161022425|NCT03496168|581472850|FG000|Overall Study|Other Reasons|1|||
161022426|NCT03496168|581472850|FG000|Overall Study|Adverse Event|1|||
161022427|NCT02043678|581472855|FG000|Overall Study|Never treated|11|||
161022428|NCT02043678|581472856|FG001|Overall Study|Never treated|9|||
161022429|NCT02043678|581472855|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
161022430|NCT02043678|581472856|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
161022431|NCT02043678|581472855|FG000|Overall Study|AE without clinical PD|54|||
161022432|NCT02043678|581472856|FG001|Overall Study|AE without clinical PD|36|||
161022433|NCT02043678|581472855|FG000|Overall Study|Lost to Follow-up|1|||
161022434|NCT02043678|581472856|FG001|Overall Study|Lost to Follow-up|1|||
161022435|NCT02043678|581472855|FG000|Overall Study|Other|10|||
161022436|NCT02043678|581472856|FG001|Overall Study|Other|14|||
161022437|NCT02043678|581472855|FG000|Overall Study|Clinical PD|114|||
161022438|NCT02043678|581472856|FG001|Overall Study|Clinical PD|148|||
161022439|NCT02043678|581472855|FG000|Overall Study|Radiological PD|100|||
161022440|NCT02043678|581472856|FG001|Overall Study|Radiological PD|90|||
161022441|NCT02043678|581472855|FG000|Overall Study|Protocol-driven decision point|59|||
161022442|NCT02043678|581472856|FG001|Overall Study|Protocol-driven decision point|58|||
161022443|NCT02043678|581472855|FG000|Overall Study|Withdrawal by Subject|16|||
161022444|NCT02043678|581472856|FG001|Overall Study|Withdrawal by Subject|20|||
161022445|NCT02043678|581472855|FG000|Overall Study|Protocol Violation|1|||
161022446|NCT02043678|581472856|FG001|Overall Study|Protocol Violation|0|||
161022447|NCT02043678|581472855|FG000|Overall Study|Deterioration of general conditions|1|||
161022448|NCT02043678|581472856|FG001|Overall Study|Deterioration of general conditions|1|||
161022449|NCT02043678|581472855|FG000|Overall Study|Logistical difficulties|2|||
161022450|NCT02043678|581472856|FG001|Overall Study|Logistical difficulties|0|||
161022451|NCT02043678|581472855|FG000|Overall Study|Non-compliance with study drug|3|||
161022452|NCT02043678|581472856|FG001|Overall Study|Non-compliance with study drug|1|||
161022453|NCT02043678|581472855|FG000|Overall Study|Physician Decision|4|||
161022454|NCT02043678|581472856|FG001|Overall Study|Physician Decision|3|||
161022455|NCT02043678|581472855|FG000|Overall Study|Subject decision|0|||
161022456|NCT02043678|581472856|FG001|Overall Study|Subject decision|1|||
161022457|NCT02043678|581472855|FG000|Overall Study|Switching to other therapy|3|||
161022458|NCT02043678|581472856|FG001|Overall Study|Switching to other therapy|2|||
161022459|NCT02043678|581472855|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
161022460|NCT02043678|581472856|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
161022461|NCT02043678|581472855|FG000|Overall Study|Missing|1|||
161022462|NCT02043678|581472856|FG001|Overall Study|Missing|0|||
161022463|NCT02043678|581472855|FG000|Overall Study|Adverse Event|0|||
161022464|NCT02043678|581472856|FG001|Overall Study|Adverse Event|1|||
161022465|NCT05126433|581472857|FG000|Overall Study|Withdrawal by Subject|3|||
161022466|NCT05126433|581472858|FG001|Overall Study|Withdrawal by Subject|0|||
161022467|NCT05126433|581472859|FG002|Overall Study|Withdrawal by Subject|4|||
161022468|NCT05126433|581472857|FG000|Overall Study|Death|9|||
161022469|NCT05126433|581472858|FG001|Overall Study|Death|3|||
161022470|NCT05126433|581472859|FG002|Overall Study|Death|5|||
161022471|NCT05126433|581472857|FG000|Overall Study|Study Terminated by sponsor|0|||
161022472|NCT05126433|581472858|FG001|Overall Study|Study Terminated by sponsor|1|||
161022473|NCT05126433|581472859|FG002|Overall Study|Study Terminated by sponsor|2|||
161022474|NCT05126433|581472857|FG000|Overall Study|Progressive Disease|1|||
161022475|NCT05126433|581472858|FG001|Overall Study|Progressive Disease|4|||
161022476|NCT05126433|581472859|FG002|Overall Study|Progressive Disease|3|||
161022477|NCT05126433|581472857|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
161022478|NCT05126433|581472858|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
161022479|NCT05126433|581472859|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
161022480|NCT03907878|581472860|FG000|Treatment Period|Withdrawal by Subject|5|||
161022481|NCT03907878|581472860|FG000|Treatment Period|Adverse Event|4|||
161022482|NCT03907878|581472860|FG000|Treatment Period|Lack of Efficacy|1|||
161022483|NCT03907878|581472860|FG000|Treatment Period|Protocol Violation|1|||
161022484|NCT03907878|581472860|FG000|Follow-up Period|Adverse Event|3|||
161022485|NCT03907878|581472860|FG000|Follow-up Period|Withdrawal by Subject|3|||
161022486|NCT04307355|581472869|FG000|Overall Study|Non-Compliance|3|||
161022487|NCT04307355|581472870|FG001|Overall Study|Non-Compliance|3|||
161022488|NCT04307355|581472871|FG002|Overall Study|Non-Compliance|0|||
161022489|NCT04313972|581472876|FG000|Overall Study|Withdrawal by Subject|0|||
161022490|NCT04313972|581472877|FG001|Overall Study|Withdrawal by Subject|1|||
161022491|NCT05201079|581472891|FG000|Overall Study|Adverse Event|7|||
161022492|NCT05201079|581472892|FG001|Overall Study|Adverse Event|11|||
160459916|NCT00447980|579417497|FG000|Overall Study|Did not proceed with surgery|3|||
160657073|NCT02879643|580124531|FG002|Overall Study|Adverse Event|1|||
161022493|NCT05201079|581472891|FG000|Overall Study|Death|1|||
161022494|NCT05201079|581472892|FG001|Overall Study|Death|1|||
161022495|NCT05201079|581472891|FG000|Overall Study|Lack of Efficacy|0|||
161022496|NCT05201079|581472892|FG001|Overall Study|Lack of Efficacy|2|||
161022497|NCT05201079|581472891|FG000|Overall Study|Lost to Follow-up|0|||
161022498|NCT05201079|581472892|FG001|Overall Study|Lost to Follow-up|1|||
161022499|NCT05201079|581472891|FG000|Overall Study|Physician Decision|1|||
161022500|NCT05201079|581472892|FG001|Overall Study|Physician Decision|1|||
161022501|NCT05201079|581472891|FG000|Overall Study|Protocol Violation|1|||
161022502|NCT05201079|581472892|FG001|Overall Study|Protocol Violation|0|||
161022503|NCT05201079|581472891|FG000|Overall Study|Withdrawal by Subject|1|||
161022504|NCT05201079|581472892|FG001|Overall Study|Withdrawal by Subject|0|||
161022505|NCT05201079|581472891|FG000|Overall Study|Forbidden medication|9|||
161022506|NCT05201079|581472892|FG001|Overall Study|Forbidden medication|5|||
160459917|NCT00447980|579417498|FG001|Overall Study|Did not proceed with surgery|3|||
160459918|NCT00447980|579417499|FG002|Overall Study|Did not proceed with surgery|2|||
160459919|NCT00447980|579417500|FG003|Overall Study|Did not proceed with surgery|2|||
160459920|NCT02720068|579417501|FG000|Overall Study|Adverse Event|0|||
160459921|NCT02720068|579417502|FG001|Overall Study|Adverse Event|0|||
160459922|NCT02720068|579417503|FG002|Overall Study|Adverse Event|0|||
160459923|NCT02720068|579417504|FG003|Overall Study|Adverse Event|0|||
160459924|NCT02720068|579417505|FG004|Overall Study|Adverse Event|0|||
160459925|NCT02720068|579417506|FG005|Overall Study|Adverse Event|0|||
160459926|NCT02720068|579417507|FG006|Overall Study|Adverse Event|0|||
160459927|NCT02720068|579417508|FG007|Overall Study|Adverse Event|0|||
160459928|NCT02720068|579417509|FG008|Overall Study|Adverse Event|0|||
160459929|NCT02720068|579417510|FG009|Overall Study|Adverse Event|0|||
160459930|NCT02720068|579417511|FG010|Overall Study|Adverse Event|0|||
160459931|NCT02720068|579417512|FG011|Overall Study|Adverse Event|1|||
160459932|NCT02720068|579417513|FG012|Overall Study|Adverse Event|0|||
160459933|NCT02720068|579417514|FG013|Overall Study|Adverse Event|0|||
160459934|NCT02720068|579417515|FG014|Overall Study|Adverse Event|0|||
160459935|NCT02720068|579417516|FG015|Overall Study|Adverse Event|0|||
160459936|NCT02720068|579417517|FG016|Overall Study|Adverse Event|0|||
160459937|NCT02720068|579417518|FG017|Overall Study|Adverse Event|0|||
160459938|NCT02720068|579417501|FG000|Overall Study|Death|1|||
160459939|NCT02720068|579417502|FG001|Overall Study|Death|3|||
160459940|NCT02720068|579417503|FG002|Overall Study|Death|2|||
160459941|NCT02720068|579417504|FG003|Overall Study|Death|1|||
160459942|NCT02720068|579417505|FG004|Overall Study|Death|2|||
160459943|NCT02720068|579417506|FG005|Overall Study|Death|1|||
160459944|NCT02720068|579417507|FG006|Overall Study|Death|2|||
160459945|NCT02720068|579417508|FG007|Overall Study|Death|2|||
160459946|NCT02720068|579417509|FG008|Overall Study|Death|3|||
160459947|NCT02720068|579417510|FG009|Overall Study|Death|1|||
160459948|NCT02720068|579417511|FG010|Overall Study|Death|20|||
160459949|NCT02720068|579417512|FG011|Overall Study|Death|166|||
160459950|NCT02720068|579417513|FG012|Overall Study|Death|34|||
160459951|NCT02720068|579417514|FG013|Overall Study|Death|30|||
160459952|NCT02720068|579417515|FG014|Overall Study|Death|45|||
160459953|NCT02720068|579417516|FG015|Overall Study|Death|16|||
160459954|NCT02720068|579417517|FG016|Overall Study|Death|20|||
160459955|NCT02720068|579417518|FG017|Overall Study|Death|28|||
160459956|NCT02720068|579417501|FG000|Overall Study|Lost to Follow-up|0|||
160459957|NCT02720068|579417502|FG001|Overall Study|Lost to Follow-up|0|||
160459958|NCT02720068|579417503|FG002|Overall Study|Lost to Follow-up|0|||
160459959|NCT02720068|579417504|FG003|Overall Study|Lost to Follow-up|0|||
160459960|NCT02720068|579417505|FG004|Overall Study|Lost to Follow-up|0|||
160459961|NCT02720068|579417506|FG005|Overall Study|Lost to Follow-up|0|||
160459962|NCT02720068|579417507|FG006|Overall Study|Lost to Follow-up|0|||
160459963|NCT02720068|579417508|FG007|Overall Study|Lost to Follow-up|0|||
160459964|NCT02720068|579417509|FG008|Overall Study|Lost to Follow-up|0|||
160459965|NCT02720068|579417510|FG009|Overall Study|Lost to Follow-up|0|||
160459966|NCT02720068|579417511|FG010|Overall Study|Lost to Follow-up|0|||
160459967|NCT02720068|579417512|FG011|Overall Study|Lost to Follow-up|1|||
160459968|NCT02720068|579417513|FG012|Overall Study|Lost to Follow-up|0|||
160459969|NCT02720068|579417514|FG013|Overall Study|Lost to Follow-up|1|||
160459970|NCT02720068|579417515|FG014|Overall Study|Lost to Follow-up|2|||
160459971|NCT02720068|579417516|FG015|Overall Study|Lost to Follow-up|0|||
160459972|NCT02720068|579417517|FG016|Overall Study|Lost to Follow-up|0|||
160459973|NCT02720068|579417518|FG017|Overall Study|Lost to Follow-up|1|||
160459974|NCT02720068|579417501|FG000|Overall Study|Physician Decision|0|||
160459975|NCT02720068|579417502|FG001|Overall Study|Physician Decision|0|||
161022507|NCT05201079|581472891|FG000|Overall Study|Transfer to another hospital|0|||
160459976|NCT02720068|579417503|FG002|Overall Study|Physician Decision|0|||
160459977|NCT02720068|579417504|FG003|Overall Study|Physician Decision|1|||
160459978|NCT02720068|579417505|FG004|Overall Study|Physician Decision|0|||
160459979|NCT02720068|579417506|FG005|Overall Study|Physician Decision|0|||
160459980|NCT02720068|579417507|FG006|Overall Study|Physician Decision|0|||
161022508|NCT05201079|581472892|FG001|Overall Study|Transfer to another hospital|1|||
161022509|NCT05201079|581472891|FG000|Overall Study|Clinical condition|1|||
161022510|NCT05201079|581472892|FG001|Overall Study|Clinical condition|0|||
160459981|NCT02720068|579417508|FG007|Overall Study|Physician Decision|0|||
161022511|NCT05201079|581472891|FG000|Overall Study|SAE and sepsis|1|||
161022512|NCT05201079|581472892|FG001|Overall Study|SAE and sepsis|0|||
161022513|NCT05281562|581472899|FG000|Overall Study|Ineligible patient|1|||
161022514|NCT05281562|581472900|FG001|Overall Study|Ineligible patient|0|||
161022515|NCT05792085|581472901|FG000|Overall Study|Death|0|||
161022516|NCT05792085|581472902|FG001|Overall Study|Death|0|||
161022517|NCT05792085|581472903|FG002|Overall Study|Death|0|||
161022518|NCT05792085|581472904|FG003|Overall Study|Death|0|||
161022519|NCT05792085|581472905|FG004|Overall Study|Death|1|||
161022520|NCT05977530|581472912|FG000|Overall Study|Withdrawal by Subject|1|||
161022521|NCT05977530|581472912|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
160587420|NCT01576016|579869888|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
161022522|NCT04524442|581472915|FG000|Overall Study|Subject Decision|1|||
161022523|NCT04898673|581472918|FG000|Overall Study|Screenfail|1|||
161022524|NCT04898673|581472919|FG001|Overall Study|Screenfail|0|||
161022525|NCT04797897|581472920|FG000|Overall Study|Study Termination by Sponsor|1|||
161022526|NCT04797897|581472921|FG001|Overall Study|Study Termination by Sponsor|1|||
161022527|NCT05526430|581472926|FG000|Overall Study|Withdrawal by Subject|0|||
161022528|NCT05526430|581472927|FG001|Overall Study|Withdrawal by Subject|2|||
161022529|NCT05526430|581472928|FG002|Overall Study|Withdrawal by Subject|0|||
161022530|NCT05526430|581472929|FG003|Overall Study|Withdrawal by Subject|0|||
161022531|NCT02601313|581472930|FG000|Overall Study|Death|2|||
161022532|NCT02601313|581472931|FG001|Overall Study|Death|41|||
161022533|NCT02601313|581472932|FG002|Overall Study|Death|6|||
161022534|NCT02601313|581472930|FG000|Overall Study|Enrolled but never treated|0|||
161022535|NCT02601313|581472931|FG001|Overall Study|Enrolled but never treated|6|||
161022536|NCT02601313|581472932|FG002|Overall Study|Enrolled but never treated|3|||
161022537|NCT02601313|581472930|FG000|Overall Study|Enrolled, did not initiate AC|4|||
161022538|NCT02601313|581472931|FG001|Overall Study|Enrolled, did not initiate AC|0|||
161022539|NCT02601313|581472932|FG002|Overall Study|Enrolled, did not initiate AC|0|||
161022540|NCT02601313|581472930|FG000|Overall Study|Full consent withdrawal|0|||
161022541|NCT02601313|581472931|FG001|Overall Study|Full consent withdrawal|3|||
161022542|NCT02601313|581472932|FG002|Overall Study|Full consent withdrawal|2|||
161022543|NCT02601313|581472930|FG000|Overall Study|Lost to Follow-up|0|||
161022544|NCT02601313|581472931|FG001|Overall Study|Lost to Follow-up|1|||
161022545|NCT02601313|581472932|FG002|Overall Study|Lost to Follow-up|1|||
161022546|NCT03701763|581472938|FG000|Placebo-controlled Phase|Adverse Event|1|||
161022547|NCT03701763|581472939|FG001|Placebo-controlled Phase|Adverse Event|5|||
161022548|NCT03701763|581472940|FG002|Placebo-controlled Phase|Adverse Event|0|||
161022549|NCT03701763|581472941|FG003|Placebo-controlled Phase|Adverse Event|0|||
161022550|NCT03701763|581472938|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
161022551|NCT03701763|581472939|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
160587421|NCT01576016|579869889|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
160587422|NCT01774344|579869890|FG000|Overall Study|Withdrawal by Subject|3|||
160587423|NCT01774344|579869891|FG001|Overall Study|Withdrawal by Subject|10|||
160587424|NCT01774344|579869890|FG000|Overall Study|Protocol Violation|0|||
160587425|NCT01774344|579869891|FG001|Overall Study|Protocol Violation|1|||
160587426|NCT01774344|579869890|FG000|Overall Study|Lost to Follow-up|4|||
160587427|NCT01774344|579869891|FG001|Overall Study|Lost to Follow-up|10|||
160587428|NCT01774344|579869890|FG000|Overall Study|End of survival follow-up not available|2|||
160587429|NCT01774344|579869891|FG001|Overall Study|End of survival follow-up not available|2|||
160587430|NCT01774344|579869890|FG000|Overall Study|Data collection finished|4|||
160587431|NCT01774344|579869891|FG001|Overall Study|Data collection finished|14|||
160587432|NCT01774344|579869890|FG000|Overall Study|Other|0|||
160587433|NCT01774344|579869891|FG001|Overall Study|Other|1|||
160587434|NCT01774344|579869890|FG000|Overall Study|Did not enter Survival Follow up|49|||
160587435|NCT01774344|579869891|FG001|Overall Study|Did not enter Survival Follow up|83|||
160587436|NCT00502320|579869900|FG000|Overall Study|Lost to Follow-up|1|||
160587437|NCT00502320|579869901|FG001|Overall Study|Lost to Follow-up|1|||
160587438|NCT00502320|579869900|FG000|Overall Study|Withdrew Consent|1|||
160587439|NCT00502320|579869901|FG001|Overall Study|Withdrew Consent|0|||
161022552|NCT03701763|581472940|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
161022553|NCT03701763|581472941|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
161022554|NCT03701763|581472938|FG000|Placebo-controlled Phase|Miscellaneous|2|||
161022555|NCT03701763|581472939|FG001|Placebo-controlled Phase|Miscellaneous|0|||
161022556|NCT03701763|581472940|FG002|Placebo-controlled Phase|Miscellaneous|0|||
161022557|NCT03701763|581472941|FG003|Placebo-controlled Phase|Miscellaneous|0|||
161022558|NCT03701763|581472938|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
161022559|NCT03701763|581472939|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
161022560|NCT03701763|581472940|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
161022561|NCT03701763|581472941|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
160587440|NCT00502320|579869900|FG000|Overall Study|No longer met criteria|1|||
160587441|NCT00502320|579869901|FG001|Overall Study|No longer met criteria|0|||
160587442|NCT00502320|579869900|FG000|Overall Study|Screen Failure|0|||
160587443|NCT00502320|579869901|FG001|Overall Study|Screen Failure|1|||
161022562|NCT03701763|581472938|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
161022563|NCT03701763|581472939|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
161022564|NCT03701763|581472940|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
161022565|NCT03701763|581472941|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
161022566|NCT03701763|581472938|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
161022567|NCT03701763|581472939|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
161022568|NCT03701763|581472940|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
161022569|NCT03701763|581472941|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
161022570|NCT03701763|581472938|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
161022571|NCT03701763|581472939|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
161022572|NCT03701763|581472940|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
161022573|NCT03701763|581472941|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
161022574|NCT03701763|581472938|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
161022575|NCT03701763|581472939|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
161022576|NCT03701763|581472940|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
161022577|NCT03701763|581472941|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
161022578|NCT03701763|581472938|FG000|Apremilast Extension Phase|Adverse Event|0|||
161022579|NCT03701763|581472939|FG001|Apremilast Extension Phase|Adverse Event|0|||
161022580|NCT03701763|581472940|FG002|Apremilast Extension Phase|Adverse Event|3|||
161022581|NCT03701763|581472941|FG003|Apremilast Extension Phase|Adverse Event|1|||
161022582|NCT03701763|581472938|FG000|Apremilast Extension Phase|Miscellaneous|0|||
161022583|NCT03701763|581472939|FG001|Apremilast Extension Phase|Miscellaneous|0|||
161022584|NCT03701763|581472940|FG002|Apremilast Extension Phase|Miscellaneous|2|||
161022585|NCT03701763|581472941|FG003|Apremilast Extension Phase|Miscellaneous|1|||
161022586|NCT03701763|581472938|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
161022587|NCT03701763|581472939|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
161022588|NCT03701763|581472940|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
161022589|NCT03701763|581472941|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
161022590|NCT03701763|581472938|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
161022591|NCT03701763|581472939|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
161022592|NCT03701763|581472940|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
161022593|NCT03701763|581472941|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
161022594|NCT03701763|581472938|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
161022595|NCT03701763|581472939|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
161022596|NCT03701763|581472940|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
161022597|NCT03701763|581472941|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
161022598|NCT03701763|581472938|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
161022599|NCT03701763|581472939|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
161022600|NCT03701763|581472940|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
161022601|NCT03701763|581472941|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
161022602|NCT03701763|581472938|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
161022603|NCT03701763|581472939|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
161022604|NCT03701763|581472940|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
161022605|NCT03701763|581472941|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
161022606|NCT03701763|581472938|FG000|14-Week Observational Follow-up Phase|Other|0|||
161022607|NCT03701763|581472939|FG001|14-Week Observational Follow-up Phase|Other|0|||
161022608|NCT03701763|581472940|FG002|14-Week Observational Follow-up Phase|Other|1|||
161022609|NCT03701763|581472941|FG003|14-Week Observational Follow-up Phase|Other|0|||
161022610|NCT03701763|581472938|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
161022611|NCT03701763|581472939|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
161022612|NCT03701763|581472940|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
161022613|NCT03701763|581472941|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
161022614|NCT03701763|581472938|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
161022615|NCT03701763|581472939|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
161022616|NCT03701763|581472940|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
161022617|NCT03701763|581472941|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
161022618|NCT03365882|581472948|FG000|Randomization|Still Receiving Protocol Treatment|2|||
161022619|NCT03365882|581472949|FG001|Randomization|Still Receiving Protocol Treatment|0|||
161022620|NCT03365882|581472948|FG000|Randomization|Adverse Event|1|||
161022621|NCT03365882|581472949|FG001|Randomization|Adverse Event|2|||
160587444|NCT00502320|579869900|FG000|Overall Study|Adverse Event|3|||
160587445|NCT00502320|579869901|FG001|Overall Study|Adverse Event|5|||
160587446|NCT01363713|579869910|FG000|Overall Study|Adverse Event|1|||
160587447|NCT01363713|579869910|FG000|Overall Study|Protocol Violation|3|||
160587448|NCT01363713|579869910|FG000|Overall Study|Withdrawal by Subject|2|||
161022622|NCT03365882|581472948|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
160459982|NCT02720068|579417509|FG008|Overall Study|Physician Decision|0|||
160459983|NCT02720068|579417510|FG009|Overall Study|Physician Decision|0|||
160459984|NCT02720068|579417511|FG010|Overall Study|Physician Decision|0|||
160587449|NCT01199055|579869911|FG000|Overall Study|Death|0|||
161022623|NCT03365882|581472949|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
161022624|NCT03365882|581472948|FG000|Randomization|Progression/Relapse|21|||
161022625|NCT03365882|581472949|FG001|Randomization|Progression/Relapse|3|||
161022626|NCT03365882|581472948|FG000|Randomization|Death|1|||
161022627|NCT03365882|581472949|FG001|Randomization|Death|0|||
161022628|NCT03365882|581472948|FG000|Randomization|Other - Not Protocol Specified|1|||
161022629|NCT03365882|581472949|FG001|Randomization|Other - Not Protocol Specified|1|||
161022630|NCT03365882|581472948|FG000|Randomization|Major Protocol Deviation|0|||
161022631|NCT03365882|581472949|FG001|Randomization|Major Protocol Deviation|1|||
161022632|NCT03365882|581472948|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
161022633|NCT03365882|581472949|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
161022634|NCT03365882|581472948|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
161022635|NCT03365882|581472949|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
161022636|NCT03365882|581472948|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
161022637|NCT03365882|581472949|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
161022638|NCT03365882|581472948|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
161022639|NCT03365882|581472949|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
161022640|NCT04437615|581472950|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
161022641|NCT04828005|581472951|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
161022642|NCT04828005|581472952|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
161022643|NCT04828005|581472953|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
161022644|NCT04828005|581472954|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
161022645|NCT04828005|581472951|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
161022646|NCT04828005|581472952|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
161022647|NCT04828005|581472953|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
161022648|NCT04828005|581472954|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
161022649|NCT04828005|581472951|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
161022650|NCT04828005|581472952|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
161022651|NCT04828005|581472953|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
161022652|NCT04828005|581472954|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
161022653|NCT04828005|581472951|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
161022654|NCT04828005|581472952|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
161022655|NCT04828005|581472953|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
161022656|NCT04828005|581472954|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
161022657|NCT04828005|581472951|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
161022658|NCT04828005|581472952|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
161022659|NCT04828005|581472953|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
161022660|NCT04828005|581472954|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
161022661|NCT04828005|581472951|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
161022662|NCT04828005|581472952|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
161022663|NCT04828005|581472953|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
161022664|NCT04828005|581472954|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
161022665|NCT04828005|581472951|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
161022666|NCT04828005|581472952|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
161022667|NCT04828005|581472953|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
161022668|NCT04828005|581472954|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
161022669|NCT04828005|581472951|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
161022670|NCT04828005|581472952|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
161022671|NCT04828005|581472953|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
161022672|NCT04828005|581472954|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
161022673|NCT04828005|581472951|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
161022674|NCT04828005|581472952|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
161022675|NCT04828005|581472953|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
161022676|NCT04828005|581472954|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
161022677|NCT05579899|581474495|FG000|Overall Study|Lost to Follow-up|3|||
161022678|NCT05579899|581474496|FG001|Overall Study|Lost to Follow-up|1|||
161022679|NCT05579899|581474495|FG000|Overall Study|Adverse Event|0|||
161022680|NCT05579899|581474496|FG001|Overall Study|Adverse Event|3|||
161022681|NCT05579899|581474495|FG000|Overall Study|Pregnancy|0|||
161022682|NCT05579899|581474496|FG001|Overall Study|Pregnancy|1|||
161022683|NCT05579899|581474495|FG000|Overall Study|Withdrawal by Subject|0|||
161022684|NCT05579899|581474496|FG001|Overall Study|Withdrawal by Subject|3|||
161022685|NCT04799899|581474497|FG000|Overall Study|Lost to Follow-up|2|||
161022686|NCT04799899|581474498|FG001|Overall Study|Lost to Follow-up|4|||
161022687|NCT03339713|581474502|FG000|Overall Study|Lost to Follow-up|2|||
161022688|NCT03339713|581474503|FG001|Overall Study|Lost to Follow-up|1|||
161022689|NCT03339713|581474502|FG000|Overall Study|Protocol Violation|1|||
161022690|NCT03339713|581474503|FG001|Overall Study|Protocol Violation|0|||
161022691|NCT03339713|581474502|FG000|Overall Study|Withdrawal by Subject|1|||
161022692|NCT03339713|581474503|FG001|Overall Study|Withdrawal by Subject|1|||
161022693|NCT05540665|581474504|FG000|Overall Study|Study terminated by sponsor|6|||
161022694|NCT05540665|581474505|FG001|Overall Study|Study terminated by sponsor|6|||
161022695|NCT05540665|581474506|FG002|Overall Study|Study terminated by sponsor|7|||
161022696|NCT03462030|581474507|FG000|Overall Study|Withdrawal by Subject|1|||
161022697|NCT03462030|581474508|FG001|Overall Study|Withdrawal by Subject|1|||
161022698|NCT03381196|581474509|FG000|Overall Study|Withdrawal by Subject|7|||
160587450|NCT01199055|579869912|FG001|Overall Study|Death|1|||
160587451|NCT01199055|579869913|FG002|Overall Study|Death|0|||
160587452|NCT01199055|579869911|FG000|Overall Study|Physician Decision|0|||
160587453|NCT01199055|579869912|FG001|Overall Study|Physician Decision|1|||
161022699|NCT03381196|581474510|FG001|Overall Study|Withdrawal by Subject|7|||
161022700|NCT03381196|581474509|FG000|Overall Study|Other|0|||
161022701|NCT03381196|581474510|FG001|Overall Study|Other|1|||
161022702|NCT03381196|581474509|FG000|Overall Study|Lost to Follow-up|5|||
161022703|NCT03381196|581474510|FG001|Overall Study|Lost to Follow-up|4|||
161022704|NCT03381196|581474509|FG000|Overall Study|Death|0|||
161022705|NCT03381196|581474510|FG001|Overall Study|Death|1|||
161022706|NCT03381196|581474509|FG000|Overall Study|Adverse Event|1|||
161022707|NCT03381196|581474510|FG001|Overall Study|Adverse Event|0|||
161022708|NCT03381196|581474509|FG000|Overall Study|Randomized, not treated|3|||
161022709|NCT03381196|581474510|FG001|Overall Study|Randomized, not treated|6|||
161022710|NCT02675751|581474511|FG000|Overall Study|Lost to Follow-up|16|||
161022711|NCT03371381|581474512|FG000|Overall Study|Death|5|||
161022712|NCT03371381|581474512|FG000|Overall Study|Study terminated by sponsor|3|||
161022713|NCT03371381|581474512|FG000|Overall Study|Other|4|||
161022714|NCT03628924|581474514|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
161022715|NCT03628924|581474515|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022716|NCT03628924|581474516|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022717|NCT03628924|581474517|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022718|NCT03628924|581474518|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022719|NCT03628924|581474519|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022720|NCT03628924|581474520|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022721|NCT03628924|581474514|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022722|NCT03628924|581474515|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022723|NCT03628924|581474516|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
161022724|NCT03628924|581474517|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022725|NCT03628924|581474518|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022726|NCT03628924|581474519|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022727|NCT03628924|581474520|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022728|NCT03628924|581474514|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
161022729|NCT03628924|581474515|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
161022730|NCT03628924|581474516|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
161022731|NCT03628924|581474517|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161022732|NCT03628924|581474518|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161022733|NCT03628924|581474519|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161022734|NCT03628924|581474520|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161022735|NCT03628924|581474514|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022736|NCT03628924|581474515|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
161022737|NCT03628924|581474516|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022738|NCT03628924|581474517|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022739|NCT03628924|581474518|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022740|NCT03628924|581474519|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022741|NCT03628924|581474520|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022742|NCT03628924|581474514|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
161022743|NCT03628924|581474515|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161022744|NCT03628924|581474516|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
161022745|NCT03628924|581474517|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161022746|NCT03628924|581474518|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161022747|NCT03628924|581474519|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161022748|NCT03628924|581474520|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161022749|NCT03628924|581474514|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
161022750|NCT03628924|581474515|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
161022751|NCT03628924|581474516|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
161022752|NCT03628924|581474517|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
161022753|NCT03628924|581474518|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
160587454|NCT01199055|579869913|FG002|Overall Study|Physician Decision|1|||
161022754|NCT03628924|581474519|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
161022755|NCT03628924|581474520|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
161022756|NCT03628924|581474514|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161022757|NCT03628924|581474515|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
160587455|NCT01199055|579869911|FG000|Overall Study|Progressive disease|2|||
161022758|NCT03628924|581474516|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161022759|NCT03628924|581474517|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
161022760|NCT03628924|581474518|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161022761|NCT03628924|581474519|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
161022762|NCT03628924|581474520|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
161022763|NCT03628924|581474514|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161022764|NCT03628924|581474515|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161022765|NCT03628924|581474516|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161022766|NCT03628924|581474517|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
161022767|NCT03628924|581474518|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
161022768|NCT03628924|581474519|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161022769|NCT03628924|581474520|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
161022770|NCT03628924|581474514|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
161022771|NCT03628924|581474515|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
161022772|NCT03628924|581474516|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
161022773|NCT03628924|581474517|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
161022774|NCT03628924|581474518|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
161022775|NCT03628924|581474519|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
161022776|NCT03628924|581474520|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
161022777|NCT03628924|581474514|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161022778|NCT03628924|581474515|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161022779|NCT03628924|581474516|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161022780|NCT03628924|581474517|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161022781|NCT03628924|581474518|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
161022782|NCT03628924|581474519|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
161022783|NCT03628924|581474520|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
161022784|NCT02268253|581474521|FG000|Stage 1|Withdrawal by Subject|1|||
161022785|NCT02268253|581474522|FG001|Stage 1|Withdrawal by Subject|0|||
161022786|NCT02268253|581474523|FG002|Stage 1|Withdrawal by Subject|0|||
161022787|NCT02268253|581474524|FG003|Stage 1|Withdrawal by Subject|0|||
161022788|NCT02268253|581474525|FG004|Stage 1|Withdrawal by Subject|0|||
161022789|NCT02268253|581474526|FG005|Stage 1|Withdrawal by Subject|0|||
161022790|NCT02268253|581474527|FG006|Stage 1|Withdrawal by Subject|0|||
161022791|NCT02268253|581474521|FG000|Stage 1|Death|0|||
161022792|NCT02268253|581474522|FG001|Stage 1|Death|2|||
161022793|NCT02268253|581474523|FG002|Stage 1|Death|2|||
161022794|NCT02268253|581474524|FG003|Stage 1|Death|2|||
161022795|NCT02268253|581474525|FG004|Stage 1|Death|1|||
161022796|NCT02268253|581474526|FG005|Stage 1|Death|1|||
161022797|NCT02268253|581474527|FG006|Stage 1|Death|0|||
161022798|NCT02268253|581474521|FG000|Stage 2|Disease Recurrence/ Progression|0|||
161022799|NCT02268253|581474522|FG001|Stage 2|Disease Recurrence/ Progression|0|||
161022800|NCT02268253|581474523|FG002|Stage 2|Disease Recurrence/ Progression|1|||
161022801|NCT02268253|581474524|FG003|Stage 2|Disease Recurrence/ Progression|0|||
161022802|NCT02268253|581474525|FG004|Stage 2|Disease Recurrence/ Progression|0|||
161022803|NCT02268253|581474526|FG005|Stage 2|Disease Recurrence/ Progression|0|||
161022804|NCT02268253|581474527|FG006|Stage 2|Disease Recurrence/ Progression|0|||
161022805|NCT02268253|581474521|FG000|Stage 2|Withdrawal by Subject|0|||
161022806|NCT02268253|581474522|FG001|Stage 2|Withdrawal by Subject|0|||
161022807|NCT02268253|581474523|FG002|Stage 2|Withdrawal by Subject|2|||
161022808|NCT02268253|581474524|FG003|Stage 2|Withdrawal by Subject|0|||
161022809|NCT02268253|581474525|FG004|Stage 2|Withdrawal by Subject|0|||
161022810|NCT02268253|581474526|FG005|Stage 2|Withdrawal by Subject|2|||
161022811|NCT02268253|581474527|FG006|Stage 2|Withdrawal by Subject|0|||
161022812|NCT02268253|581474521|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
160587456|NCT01199055|579869912|FG001|Overall Study|Progressive disease|1|||
161022813|NCT02268253|581474522|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161022814|NCT02268253|581474523|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
161022815|NCT02268253|581474524|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161022816|NCT02268253|581474525|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161022817|NCT02268253|581474526|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
161022818|NCT02268253|581474527|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161022819|NCT02268253|581474521|FG000|Stage 2|Death|0|||
160587457|NCT01199055|579869913|FG002|Overall Study|Progressive disease|2|||
160587458|NCT01199055|579869911|FG000|Overall Study|Withdrawal by Subject|0|||
161022820|NCT02268253|581474522|FG001|Stage 2|Death|0|||
161022821|NCT02268253|581474523|FG002|Stage 2|Death|19|||
161022822|NCT02268253|581474524|FG003|Stage 2|Death|0|||
161022823|NCT02268253|581474525|FG004|Stage 2|Death|0|||
161022824|NCT02268253|581474526|FG005|Stage 2|Death|20|||
161022825|NCT02268253|581474527|FG006|Stage 2|Death|1|||
161022826|NCT02268253|581474521|FG000|Stage 2|Lost to Follow-up|0|||
161022827|NCT02268253|581474522|FG001|Stage 2|Lost to Follow-up|0|||
160587459|NCT01199055|579869912|FG001|Overall Study|Withdrawal by Subject|0|||
161022828|NCT02268253|581474523|FG002|Stage 2|Lost to Follow-up|0|||
161022829|NCT02268253|581474524|FG003|Stage 2|Lost to Follow-up|0|||
161022830|NCT02268253|581474525|FG004|Stage 2|Lost to Follow-up|0|||
161022831|NCT02268253|581474526|FG005|Stage 2|Lost to Follow-up|4|||
161022832|NCT02268253|581474527|FG006|Stage 2|Lost to Follow-up|0|||
161022833|NCT02268253|581474521|FG000|Stage 2|Transferred to Hospice|0|||
161022834|NCT02268253|581474522|FG001|Stage 2|Transferred to Hospice|0|||
161022835|NCT02268253|581474523|FG002|Stage 2|Transferred to Hospice|0|||
161022836|NCT02268253|581474524|FG003|Stage 2|Transferred to Hospice|0|||
161022837|NCT02268253|581474525|FG004|Stage 2|Transferred to Hospice|0|||
161022838|NCT02268253|581474526|FG005|Stage 2|Transferred to Hospice|2|||
161022839|NCT02268253|581474527|FG006|Stage 2|Transferred to Hospice|0|||
161022840|NCT02268253|581474521|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
161022841|NCT02268253|581474522|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
161022842|NCT02268253|581474523|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
161022843|NCT02268253|581474524|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
161022844|NCT02268253|581474525|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
161022845|NCT02268253|581474526|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
161022846|NCT02268253|581474527|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
161022847|NCT02268253|581474521|FG000|Stage 3A|Withdrawal by Subject|0|||
161022848|NCT02268253|581474522|FG001|Stage 3A|Withdrawal by Subject|0|||
161022849|NCT02268253|581474523|FG002|Stage 3A|Withdrawal by Subject|2|||
161022850|NCT02268253|581474524|FG003|Stage 3A|Withdrawal by Subject|0|||
161022851|NCT02268253|581474525|FG004|Stage 3A|Withdrawal by Subject|0|||
161022852|NCT02268253|581474526|FG005|Stage 3A|Withdrawal by Subject|0|||
161022853|NCT02268253|581474527|FG006|Stage 3A|Withdrawal by Subject|0|||
161022854|NCT02268253|581474521|FG000|Stage 3A|Physician Decision|0|||
161022855|NCT02268253|581474522|FG001|Stage 3A|Physician Decision|0|||
161022856|NCT02268253|581474523|FG002|Stage 3A|Physician Decision|2|||
161022857|NCT02268253|581474524|FG003|Stage 3A|Physician Decision|0|||
161022858|NCT02268253|581474525|FG004|Stage 3A|Physician Decision|0|||
161022859|NCT02268253|581474526|FG005|Stage 3A|Physician Decision|0|||
161022860|NCT02268253|581474527|FG006|Stage 3A|Physician Decision|0|||
161022861|NCT02268253|581474521|FG000|Stage 3A|Study Terminated by Sponsor|0|||
161022862|NCT02268253|581474522|FG001|Stage 3A|Study Terminated by Sponsor|0|||
161022863|NCT02268253|581474523|FG002|Stage 3A|Study Terminated by Sponsor|2|||
161022864|NCT02268253|581474524|FG003|Stage 3A|Study Terminated by Sponsor|0|||
161022865|NCT02268253|581474525|FG004|Stage 3A|Study Terminated by Sponsor|0|||
161022866|NCT02268253|581474526|FG005|Stage 3A|Study Terminated by Sponsor|0|||
161022867|NCT02268253|581474527|FG006|Stage 3A|Study Terminated by Sponsor|0|||
161022868|NCT02268253|581474521|FG000|Stage 3A|Lost to Follow-up|0|||
161022869|NCT02268253|581474522|FG001|Stage 3A|Lost to Follow-up|0|||
161022870|NCT02268253|581474523|FG002|Stage 3A|Lost to Follow-up|1|||
161022871|NCT02268253|581474524|FG003|Stage 3A|Lost to Follow-up|0|||
161022872|NCT02268253|581474525|FG004|Stage 3A|Lost to Follow-up|0|||
161022873|NCT02268253|581474526|FG005|Stage 3A|Lost to Follow-up|0|||
161022874|NCT02268253|581474527|FG006|Stage 3A|Lost to Follow-up|0|||
161022875|NCT02268253|581474521|FG000|Stage 3A|Death|0|||
161022876|NCT02268253|581474522|FG001|Stage 3A|Death|0|||
161022877|NCT02268253|581474523|FG002|Stage 3A|Death|5|||
161022878|NCT02268253|581474524|FG003|Stage 3A|Death|0|||
161022879|NCT02268253|581474525|FG004|Stage 3A|Death|0|||
161022880|NCT02268253|581474526|FG005|Stage 3A|Death|0|||
161022881|NCT02268253|581474527|FG006|Stage 3A|Death|0|||
161022882|NCT05714761|581474528|FG000|Overall Study|Lost to Follow-up|3|||
161022883|NCT05714761|581474528|FG000|Overall Study|Withdrawal by Subject|3|||
161022884|NCT05714761|581474528|FG000|Overall Study|unblinding of sensor data|1|||
161022885|NCT05714761|581474528|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
161022886|NCT05714761|581474528|FG000|Overall Study|did not return second CGM sensor|4|||
161022887|NCT05672069|581474529|FG000|Overall Study|Implant removal|1|||
161022888|NCT05672069|581474529|FG000|Overall Study|Lost to Follow-up|2|||
161022889|NCT05949788|581474530|FG000|Overall Study|severe birth deformity|2|||
161022890|NCT05949788|581474531|FG001|Overall Study|severe birth deformity|7|||
161022891|NCT05949788|581474530|FG000|Overall Study|twin-twin transfusion syndrome|2|||
161022892|NCT05949788|581474531|FG001|Overall Study|twin-twin transfusion syndrome|7|||
161022893|NCT05949788|581474530|FG000|Overall Study|neonatal hemolytic disease|3|||
161022894|NCT05949788|581474531|FG001|Overall Study|neonatal hemolytic disease|8|||
161022895|NCT05949788|581474530|FG000|Overall Study|death within 14 days after birth|2|||
161022896|NCT05949788|581474531|FG001|Overall Study|death within 14 days after birth|6|||
161022897|NCT05949788|581474530|FG000|Overall Study|transfer to another hospital|2|||
161022898|NCT05949788|581474531|FG001|Overall Study|transfer to another hospital|6|||
161022899|NCT05213390|581474532|FG000|Overall Study|Withdrawal by Subject|2|||
161022900|NCT05213390|581474532|FG000|Overall Study|Lost to Follow-up|12|||
161022901|NCT05213390|581474532|FG000|Overall Study|Protocol Violation|9|||
161022902|NCT02191618|581474540|FG000|Overall Study|Withdrawal by Subject|3|||
161022903|NCT02191618|581474540|FG000|Overall Study|Missed Visit|4|||
161022904|NCT03031470|581474542|FG000|Overall Study|Adverse Event|3|||
161022905|NCT03031470|581474543|FG001|Overall Study|Adverse Event|0|||
161022906|NCT03031470|581474542|FG000|Overall Study|Death|3|||
161022907|NCT03031470|581474543|FG001|Overall Study|Death|1|||
161022908|NCT03031470|581474542|FG000|Overall Study|Lost to Follow-up|1|||
161022909|NCT03031470|581474543|FG001|Overall Study|Lost to Follow-up|1|||
161022910|NCT03031470|581474542|FG000|Overall Study|Withdrawal by Subject|1|||
161022911|NCT03031470|581474543|FG001|Overall Study|Withdrawal by Subject|0|||
161022912|NCT03031470|581474542|FG000|Overall Study|Protocol entry criteria not met|0|||
161022913|NCT03031470|581474543|FG001|Overall Study|Protocol entry criteria not met|1|||
161022914|NCT03031470|581474542|FG000|Overall Study|Cancel the operation|0|||
161022915|NCT03031470|581474543|FG001|Overall Study|Cancel the operation|1|||
161022916|NCT01593917|581474544|FG000|Overall Study|Death|67|||
161022917|NCT01593917|581474544|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
161022918|NCT01593917|581474544|FG000|Overall Study|Withdrawal by Subject|23|||
161022919|NCT01593917|581474544|FG000|Overall Study|Lost to Follow-up|12|||
161022920|NCT01593917|581474544|FG000|Overall Study|Protocol Violation|5|||
161022921|NCT01593917|581474544|FG000|Overall Study|Physician Decision|3|||
161022922|NCT03021096|581474546|FG000|Overall Study|Lost to Follow-up|4|||
161022923|NCT03021096|581474546|FG000|Overall Study|Protocol Violation|2|||
161022924|NCT03216057|581474547|FG000|Overall Study|Lost to Follow-up|2|||
161022925|NCT03216057|581474548|FG001|Overall Study|Lost to Follow-up|2|||
161022926|NCT03768505|581474549|FG000|Overall Study|sponsor decision|76|||
161022927|NCT03768505|581474549|FG000|Overall Study|Death|35|||
161022928|NCT03768505|581474549|FG000|Overall Study|Other -Various|30|||
161022929|NCT03768505|581474549|FG000|Overall Study|Withdrawal by Subject|22|||
161022930|NCT03768505|581474549|FG000|Overall Study|Lost to Follow-up|6|||
161022931|NCT02861300|581474553|FG000|Overall Study|Death|0|||
161022932|NCT02861300|581474554|FG001|Overall Study|Death|0|||
161022933|NCT02861300|581474555|FG002|Overall Study|Death|0|||
161022934|NCT02861300|581474556|FG003|Overall Study|Death|0|||
161022935|NCT02861300|581474557|FG004|Overall Study|Death|0|||
161022936|NCT02861300|581474558|FG005|Overall Study|Death|0|||
161022937|NCT02861300|581474559|FG006|Overall Study|Death|24|||
161022938|NCT02861300|581474553|FG000|Overall Study|Delay in treatment|0|||
161022939|NCT02861300|581474554|FG001|Overall Study|Delay in treatment|0|||
161022940|NCT02861300|581474555|FG002|Overall Study|Delay in treatment|0|||
161022941|NCT02861300|581474556|FG003|Overall Study|Delay in treatment|0|||
161022942|NCT02861300|581474557|FG004|Overall Study|Delay in treatment|0|||
161022943|NCT02861300|581474558|FG005|Overall Study|Delay in treatment|1|||
161022944|NCT02861300|581474559|FG006|Overall Study|Delay in treatment|0|||
161022945|NCT02861300|581474553|FG000|Overall Study|Disease Progression|0|||
161022946|NCT02861300|581474554|FG001|Overall Study|Disease Progression|1|||
161022947|NCT02861300|581474555|FG002|Overall Study|Disease Progression|0|||
161022948|NCT02861300|581474556|FG003|Overall Study|Disease Progression|0|||
161022949|NCT02861300|581474557|FG004|Overall Study|Disease Progression|0|||
161022950|NCT02861300|581474558|FG005|Overall Study|Disease Progression|0|||
161022951|NCT02861300|581474559|FG006|Overall Study|Disease Progression|2|||
161022952|NCT02861300|581474553|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
161022953|NCT02861300|581474554|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
161022954|NCT02861300|581474555|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
161022955|NCT02861300|581474556|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
161022956|NCT02861300|581474557|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
161022957|NCT02861300|581474558|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
161022958|NCT02861300|581474559|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
161022959|NCT02861300|581474553|FG000|Overall Study|Clinical Complications|0|||
161022960|NCT02861300|581474554|FG001|Overall Study|Clinical Complications|0|||
161022961|NCT02861300|581474555|FG002|Overall Study|Clinical Complications|0|||
161022962|NCT02861300|581474556|FG003|Overall Study|Clinical Complications|0|||
161022963|NCT02861300|581474557|FG004|Overall Study|Clinical Complications|0|||
161022964|NCT02861300|581474558|FG005|Overall Study|Clinical Complications|0|||
161022965|NCT02861300|581474559|FG006|Overall Study|Clinical Complications|1|||
161022966|NCT03133546|581474566|FG000|Overall Study|Death|46|||
161022967|NCT03133546|581474567|FG001|Overall Study|Death|43|||
161022968|NCT03133546|581474566|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
161022969|NCT03133546|581474567|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
161022970|NCT02993159|581474569|FG000|Overall Study|Withdrawal by Subject|1|||
161022971|NCT02993159|581474570|FG001|Overall Study|Withdrawal by Subject|3|||
161022972|NCT02993159|581474569|FG000|Overall Study|Protocol Violation|1|||
161022973|NCT02993159|581474570|FG001|Overall Study|Protocol Violation|0|||
161022974|NCT02993159|581474569|FG000|Overall Study|Opted out of surgery|2|||
161022975|NCT02993159|581474570|FG001|Overall Study|Opted out of surgery|0|||
161022976|NCT02993159|581474569|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
161022977|NCT02993159|581474570|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
161022978|NCT02993159|581474569|FG000|Overall Study|Physician Decision|0|||
161022979|NCT02993159|581474570|FG001|Overall Study|Physician Decision|1|||
161022980|NCT05034328|581474571|FG000|Overall Study|Protocol Violation|1|||
161022981|NCT05034328|581474572|FG001|Overall Study|Protocol Violation|0|||
161022982|NCT05034328|581474571|FG000|Overall Study|Lost to Follow-up|0|||
161022983|NCT05034328|581474572|FG001|Overall Study|Lost to Follow-up|10|||
161022984|NCT05399459|581474575|FG000|Overall Study|Randomized but not treated|29|||
161022985|NCT05399459|581474576|FG001|Overall Study|Randomized but not treated|30|||
161022986|NCT05399459|581474577|FG002|Overall Study|Randomized but not treated|38|||
161022987|NCT05399459|581474575|FG000|Overall Study|Lost to Follow-up|1|||
161022988|NCT05399459|581474576|FG001|Overall Study|Lost to Follow-up|0|||
161022989|NCT05399459|581474577|FG002|Overall Study|Lost to Follow-up|0|||
161022990|NCT04992520|581474578|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
161022991|NCT04992520|581474579|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
161022992|NCT04992520|581474580|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
161022993|NCT04992520|581474581|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
161022994|NCT04992520|581474582|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
161022995|NCT04992520|581474583|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
161022996|NCT04992520|581474578|FG000|Part A: First Challenge|Non-compliance|0|||
161022997|NCT04992520|581474579|FG001|Part A: First Challenge|Non-compliance|0|||
161022998|NCT04992520|581474580|FG002|Part A: First Challenge|Non-compliance|0|||
161022999|NCT04992520|581474581|FG003|Part A: First Challenge|Non-compliance|1|||
161023000|NCT04992520|581474582|FG004|Part A: First Challenge|Non-compliance|0|||
161023001|NCT04992520|581474583|FG005|Part A: First Challenge|Non-compliance|0|||
161023002|NCT04992520|581474578|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161023003|NCT04992520|581474579|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161023004|NCT04992520|581474580|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
161023005|NCT04992520|581474581|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161023006|NCT04992520|581474582|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161023007|NCT04992520|581474583|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
161023008|NCT04992520|581474578|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161023009|NCT04992520|581474579|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161023010|NCT04992520|581474580|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
161023011|NCT04992520|581474581|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161023012|NCT04992520|581474582|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161023013|NCT04992520|581474583|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161023014|NCT03625167|581474585|FG000|Overall Study|Protocol Violation|5|||
161023015|NCT02231164|581474586|FG000|Overall Study|Adverse Event|1|||
161023016|NCT02231164|581474587|FG001|Overall Study|Adverse Event|1|||
161023017|NCT02231164|581474586|FG000|Overall Study|Lack of Efficacy|4|||
161023018|NCT02231164|581474587|FG001|Overall Study|Lack of Efficacy|3|||
161023019|NCT02231164|581474586|FG000|Overall Study|Withdrawal by Subject|1|||
161023020|NCT02231164|581474587|FG001|Overall Study|Withdrawal by Subject|2|||
161023021|NCT06103188|581474588|FG000|Overall Study|Lost to Follow-up|1|||
161023022|NCT06103188|581474589|FG001|Overall Study|Lost to Follow-up|6|||
161023023|NCT06103188|581474590|FG002|Overall Study|Lost to Follow-up|4|||
161023024|NCT02969707|581474593|FG000|Overall Study|Withdrawal by Subject|6|||
161023025|NCT02969707|581474594|FG001|Overall Study|Withdrawal by Subject|5|||
161023026|NCT02969707|581474593|FG000|Overall Study|Severe anxiety|0|||
161023027|NCT02969707|581474594|FG001|Overall Study|Severe anxiety|1|||
161023028|NCT02969707|581474593|FG000|Overall Study|Positive toxicology screen|0|||
161023029|NCT02969707|581474594|FG001|Overall Study|Positive toxicology screen|2|||
161023030|NCT02969707|581474593|FG000|Overall Study|Claustrophobia|2|||
161023031|NCT02969707|581474594|FG001|Overall Study|Claustrophobia|2|||
161023032|NCT02969707|581474593|FG000|Overall Study|Non-compliance|1|||
161023033|NCT02969707|581474594|FG001|Overall Study|Non-compliance|2|||
161023034|NCT01175356|581474595|FG000|Overall Study|Death|1|||
161023035|NCT01175356|581474595|FG000|Overall Study|Lack of Efficacy|12|||
161023036|NCT01175356|581474595|FG000|Overall Study|Lost to Follow-up|1|||
161023037|NCT01175356|581474595|FG000|Overall Study|Physician Decision|23|||
161023038|NCT01175356|581474595|FG000|Overall Study|Ineligible|1|||
161023039|NCT01175356|581474595|FG000|Overall Study|Treatment Slot Not Available|18|||
161023040|NCT01175356|581474595|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
161023041|NCT01175356|581474595|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
161023042|NCT01175356|581474595|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
161023043|NCT01175356|581474595|FG000|Overall Study|Inadequate stem cell for transplant|1|||
161023044|NCT01175356|581474595|FG000|Overall Study|Initiation other tx prior to completion|9|||
161023045|NCT03020199|581474602|FG000|Treatment Period|Adverse Event|0|||
161023046|NCT03020199|581474603|FG001|Treatment Period|Adverse Event|2|||
161023047|NCT03020199|581474602|FG000|Treatment Period|Lack of Efficacy|1|||
161023048|NCT03020199|581474603|FG001|Treatment Period|Lack of Efficacy|6|||
161023049|NCT03020199|581474602|FG000|Treatment Period|Lost to Follow-up|1|||
161023050|NCT03020199|581474603|FG001|Treatment Period|Lost to Follow-up|6|||
161023051|NCT03020199|581474602|FG000|Treatment Period|Physician Decision|0|||
161023052|NCT03020199|581474603|FG001|Treatment Period|Physician Decision|1|||
161023053|NCT03020199|581474602|FG000|Treatment Period|Subject/guardian decision|8|||
161023054|NCT03020199|581474603|FG001|Treatment Period|Subject/guardian decision|15|||
161023055|NCT03020199|581474602|FG000|Treatment Period|Subjects not treated|3|||
161023056|NCT03020199|581474603|FG001|Treatment Period|Subjects not treated|4|||
161023057|NCT03020199|581474602|FG000|Follow-up Period|Disease relapse|32|||
161023058|NCT03020199|581474603|FG001|Follow-up Period|Disease relapse|7|||
161023059|NCT03020199|581474602|FG000|Follow-up Period|Lack of Efficacy|1|||
161023060|NCT03020199|581474603|FG001|Follow-up Period|Lack of Efficacy|2|||
161023061|NCT03020199|581474602|FG000|Follow-up Period|Lost to Follow-up|4|||
161023062|NCT03020199|581474603|FG001|Follow-up Period|Lost to Follow-up|6|||
160587460|NCT01199055|579869913|FG002|Overall Study|Withdrawal by Subject|1|||
160587461|NCT00668200|579869915|FG000|Overall Study|Withdrawal by Subject|2|||
160587462|NCT00668200|579869915|FG000|Overall Study|Lost to Follow-up|1|||
160587463|NCT01100307|579869916|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
160587464|NCT01100307|579869917|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
160587465|NCT01100307|579869916|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
160587466|NCT01100307|579869917|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
160587467|NCT01100307|579869916|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
160587468|NCT01100307|579869917|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
160587469|NCT01100307|579869916|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
160587470|NCT01100307|579869917|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
160587471|NCT01100307|579869916|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
160587472|NCT01100307|579869917|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
160587473|NCT01100307|579869916|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
160587474|NCT01100307|579869917|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
160587475|NCT00997321|579869918|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
160587476|NCT00997321|579869919|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
160587477|NCT01151579|579869928|FG000|Overall Study|Physician Decision|3|||
160587478|NCT01151579|579869929|FG001|Overall Study|Physician Decision|1|||
160587479|NCT01151579|579869928|FG000|Overall Study|Withdrawal by Subject|3|||
160587480|NCT01151579|579869929|FG001|Overall Study|Withdrawal by Subject|2|||
160587481|NCT01151579|579869928|FG000|Overall Study|Not meet inclusion criteria|6|||
160587482|NCT01151579|579869929|FG001|Overall Study|Not meet inclusion criteria|4|||
160587483|NCT01357915|579869930|FG000|Overall Study|Lost to Follow-up|3|||
160587484|NCT01357915|579869931|FG001|Overall Study|Lost to Follow-up|0|||
160587485|NCT00305253|579869932|FG000|Overall Study|Withdrawal by Subject|0|||
160587486|NCT00305253|579869933|FG001|Overall Study|Withdrawal by Subject|1|||
160587487|NCT03491553|579869938|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
160587488|NCT03491553|579869939|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
160587489|NCT03491553|579869940|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
160587490|NCT03491553|579869941|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
160587491|NCT03491553|579869942|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
161023063|NCT03020199|581474602|FG000|Follow-up Period|Physician Decision|2|||
161023064|NCT03020199|581474603|FG001|Follow-up Period|Physician Decision|2|||
161023065|NCT03020199|581474602|FG000|Follow-up Period|Protocol Violation|1|||
161023066|NCT03020199|581474603|FG001|Follow-up Period|Protocol Violation|2|||
161023067|NCT03020199|581474602|FG000|Follow-up Period|Study terminated by Sponsor|6|||
161023068|NCT03020199|581474603|FG001|Follow-up Period|Study terminated by Sponsor|3|||
161023069|NCT03020199|581474602|FG000|Follow-up Period|Subject/guardian decision|14|||
161023070|NCT03020199|581474603|FG001|Follow-up Period|Subject/guardian decision|9|||
161023071|NCT05583578|581474604|FG000|Overall Study|Withdrawal by Subject|2|||
161023072|NCT05583578|581474605|FG001|Overall Study|Withdrawal by Subject|0|||
161023073|NCT00248287|581474608|FG000|Overall Study|Adverse Event|11|||
161023074|NCT00248287|581474609|FG001|Overall Study|Adverse Event|10|||
161023075|NCT00248287|581474608|FG000|Overall Study|Death|1|||
161023076|NCT00248287|581474609|FG001|Overall Study|Death|0|||
161023077|NCT00248287|581474608|FG000|Overall Study|Lost to Follow-up|0|||
161023078|NCT00248287|581474609|FG001|Overall Study|Lost to Follow-up|1|||
161023079|NCT00248287|581474608|FG000|Overall Study|Investigator Request|4|||
161023080|NCT00248287|581474609|FG001|Overall Study|Investigator Request|3|||
161023081|NCT00248287|581474608|FG000|Overall Study|Patient Request|5|||
161023082|NCT00248287|581474609|FG001|Overall Study|Patient Request|3|||
161023083|NCT00248287|581474608|FG000|Overall Study|Other|3|||
161023084|NCT00248287|581474609|FG001|Overall Study|Other|2|||
160587492|NCT03491553|579869943|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
160587493|NCT03491553|579869938|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
161023085|NCT02714257|581474610|FG000|Overall Study|Withdrawal by Subject|6|||
161023086|NCT02714257|581474611|FG001|Overall Study|Withdrawal by Subject|11|||
161023087|NCT02714257|581474610|FG000|Overall Study|Death|3|||
161023088|NCT02714257|581474611|FG001|Overall Study|Death|4|||
161023089|NCT02714257|581474610|FG000|Overall Study|Lost to Follow-up|1|||
161023090|NCT02714257|581474611|FG001|Overall Study|Lost to Follow-up|6|||
161023091|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
161023092|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
161023093|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
161023094|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
160587494|NCT03491553|579869939|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
160587495|NCT03491553|579869940|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
161023095|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
161023096|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
161023097|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
161023098|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
161023099|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
161023100|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
161023101|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Other|3|||
161023102|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Other|3|||
161023103|NCT04103580|581474612|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
161023104|NCT04103580|581474613|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
161023105|NCT04103580|581474612|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
161023106|NCT04103580|581474613|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
161023107|NCT04103580|581474612|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
161023108|NCT04103580|581474613|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
161023109|NCT04103580|581474612|FG000|Phase 2 Bereavement|Other|8|||
161023110|NCT04103580|581474613|FG001|Phase 2 Bereavement|Other|6|||
161023111|NCT04568486|581474614|FG000|Overall Study|Withdrawal by Subject|26|||
161023112|NCT04568486|581474614|FG000|Overall Study|Lost to Follow-up|7|||
161023113|NCT04042233|581474615|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
161023114|NCT04042233|581474616|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
161023115|NCT04042233|581474615|FG000|Overall Study|Protocol Violation|0|||
161023116|NCT04042233|581474616|FG001|Overall Study|Protocol Violation|2|||
161023117|NCT01210807|581474626|FG000|Overall Study|Lost to Follow-up|1|||
161023118|NCT01210807|581474627|FG001|Overall Study|Lost to Follow-up|2|||
161023119|NCT01210807|581474626|FG000|Overall Study|Not implanted bilaterally|2|||
161023120|NCT01210807|581474627|FG001|Overall Study|Not implanted bilaterally|1|||
161023121|NCT00324805|581474633|FG000|Overall Study|Adverse Event|62|||
161023122|NCT00324805|581474634|FG001|Overall Study|Adverse Event|203|||
161023123|NCT00324805|581474633|FG000|Overall Study|Progression|7|||
161023124|NCT00324805|581474634|FG001|Overall Study|Progression|35|||
161023125|NCT00324805|581474633|FG000|Overall Study|Withdrawal by Subject|51|||
161023126|NCT00324805|581474634|FG001|Overall Study|Withdrawal by Subject|174|||
161023127|NCT00324805|581474633|FG000|Overall Study|Death|6|||
161023128|NCT00324805|581474634|FG001|Overall Study|Death|9|||
161023129|NCT00324805|581474633|FG000|Overall Study|Alternative therapy|4|||
161023130|NCT00324805|581474634|FG001|Overall Study|Alternative therapy|8|||
161023131|NCT00324805|581474633|FG000|Overall Study|Other complicating disease|1|||
161023132|NCT00324805|581474634|FG001|Overall Study|Other complicating disease|9|||
161023133|NCT00324805|581474633|FG000|Overall Study|Other reasons|7|||
161023134|NCT00324805|581474634|FG001|Overall Study|Other reasons|26|||
161023135|NCT00324805|581474633|FG000|Overall Study|Other|0|||
161023136|NCT00324805|581474634|FG001|Overall Study|Other|2|||
161023137|NCT00324805|581474633|FG000|Overall Study|Did not start therapy|12|||
161023138|NCT00324805|581474634|FG001|Overall Study|Did not start therapy|17|||
161023139|NCT05496231|581474636|FG000|Overall Study|Adverse Event|1|||
161023140|NCT05496231|581474637|FG001|Overall Study|Adverse Event|1|||
161023141|NCT05496231|581474638|FG002|Overall Study|Adverse Event|0|||
161023142|NCT05496231|581474639|FG003|Overall Study|Adverse Event|4|||
161023143|NCT05496231|581474636|FG000|Overall Study|Withdrawal by Subject|5|||
161023144|NCT05496231|581474637|FG001|Overall Study|Withdrawal by Subject|5|||
161023145|NCT05496231|581474638|FG002|Overall Study|Withdrawal by Subject|4|||
161023146|NCT05496231|581474639|FG003|Overall Study|Withdrawal by Subject|11|||
161023147|NCT05496231|581474636|FG000|Overall Study|Migrated/moved from the study area|3|||
161023148|NCT05496231|581474637|FG001|Overall Study|Migrated/moved from the study area|5|||
161023149|NCT05496231|581474638|FG002|Overall Study|Migrated/moved from the study area|3|||
161023150|NCT05496231|581474639|FG003|Overall Study|Migrated/moved from the study area|3|||
161023151|NCT05496231|581474636|FG000|Overall Study|Lost to Follow-up|13|||
161023152|NCT05496231|581474637|FG001|Overall Study|Lost to Follow-up|6|||
161023153|NCT05496231|581474638|FG002|Overall Study|Lost to Follow-up|11|||
161023154|NCT05496231|581474639|FG003|Overall Study|Lost to Follow-up|6|||
161023155|NCT05496231|581474636|FG000|Overall Study|Other|9|||
161023156|NCT05496231|581474637|FG001|Overall Study|Other|7|||
161023157|NCT05496231|581474638|FG002|Overall Study|Other|7|||
161023158|NCT05496231|581474639|FG003|Overall Study|Other|8|||
161023159|NCT03085810|581474654|FG000|Main Study|Withdrawal by Subject|77|||
161023160|NCT03085810|581474655|FG001|Main Study|Withdrawal by Subject|0|||
161023161|NCT03085810|581474656|FG002|Main Study|Withdrawal by Subject|0|||
161023162|NCT03085810|581474654|FG000|Main Study|Terminated By Sponsor|14|||
161023163|NCT03085810|581474655|FG001|Main Study|Terminated By Sponsor|0|||
161023164|NCT03085810|581474656|FG002|Main Study|Terminated By Sponsor|0|||
161023165|NCT03085810|581474654|FG000|Main Study|Protocol Violation|15|||
161023166|NCT03085810|581474655|FG001|Main Study|Protocol Violation|0|||
161023167|NCT03085810|581474656|FG002|Main Study|Protocol Violation|0|||
161023168|NCT03085810|581474654|FG000|Main Study|Physician Decision|13|||
161023169|NCT03085810|581474655|FG001|Main Study|Physician Decision|0|||
161023170|NCT03085810|581474656|FG002|Main Study|Physician Decision|0|||
161023171|NCT03085810|581474654|FG000|Main Study|Lost to Follow-up|17|||
161023172|NCT03085810|581474655|FG001|Main Study|Lost to Follow-up|0|||
161023173|NCT03085810|581474656|FG002|Main Study|Lost to Follow-up|0|||
161023174|NCT03085810|581474654|FG000|Main Study|Adverse Event|25|||
161023175|NCT03085810|581474655|FG001|Main Study|Adverse Event|0|||
161023176|NCT03085810|581474656|FG002|Main Study|Adverse Event|0|||
161023177|NCT03085810|581474654|FG000|Main Study|Pregnancy|7|||
161023178|NCT03085810|581474655|FG001|Main Study|Pregnancy|0|||
161023179|NCT03085810|581474656|FG002|Main Study|Pregnancy|0|||
161023180|NCT03085810|581474654|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
161023181|NCT03085810|581474655|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
161023182|NCT03085810|581474656|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
161023183|NCT03085810|581474654|FG000|Main Study|Lack of Efficacy|10|||
161023184|NCT03085810|581474655|FG001|Main Study|Lack of Efficacy|0|||
161023185|NCT03085810|581474656|FG002|Main Study|Lack of Efficacy|0|||
161023186|NCT03085810|581474654|FG000|Main Study|Death|12|||
161023187|NCT03085810|581474655|FG001|Main Study|Death|0|||
161023188|NCT03085810|581474656|FG002|Main Study|Death|0|||
161023189|NCT03085810|581474654|FG000|Main Study|Disease progression|1|||
161023190|NCT03085810|581474655|FG001|Main Study|Disease progression|0|||
161023191|NCT03085810|581474656|FG002|Main Study|Disease progression|0|||
161023192|NCT03085810|581474654|FG000|Main Study|Site Closure|3|||
161023193|NCT03085810|581474655|FG001|Main Study|Site Closure|0|||
161023194|NCT03085810|581474656|FG002|Main Study|Site Closure|0|||
161023195|NCT03085810|581474654|FG000|Main Study|Planned pregnancy|17|||
161023196|NCT03085810|581474655|FG001|Main Study|Planned pregnancy|0|||
161023197|NCT03085810|581474656|FG002|Main Study|Planned pregnancy|0|||
161023198|NCT03085810|581474654|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
161023199|NCT03085810|581474655|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
161023200|NCT03085810|581474656|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
161023201|NCT03085810|581474654|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
161023202|NCT03085810|581474655|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
161023203|NCT03085810|581474656|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
161023204|NCT03085810|581474654|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
161023205|NCT03085810|581474655|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
161023206|NCT03085810|581474656|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
161023207|NCT03085810|581474654|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
161023208|NCT03085810|581474655|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
161023209|NCT03085810|581474656|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
161023210|NCT05239455|581474657|FG000|Overall Study|Adverse Event|1|||
161023211|NCT05239455|581474657|FG000|Overall Study|Sponsor Decision|5|||
161023212|NCT05239455|581474657|FG000|Overall Study|Incomplete Blood Collection|1|||
161023213|NCT03023410|581477188|FG000|Overall Study|study termination|0|||
161023214|NCT03023410|581477189|FG001|Overall Study|study termination|1|||
161023215|NCT04987320|581477195|FG000|Overall Study|Withdrawal by Subject|0|||
161023216|NCT04987320|581477196|FG001|Overall Study|Withdrawal by Subject|1|||
161023217|NCT00085735|581477197|FG000|Overall Study|Adverse Event|1|||
161023218|NCT00085735|581477198|FG001|Overall Study|Adverse Event|0|||
161023219|NCT00085735|581477199|FG002|Overall Study|Adverse Event|0|||
161023220|NCT00085735|581477200|FG003|Overall Study|Adverse Event|0|||
161023221|NCT00085735|581477201|FG004|Overall Study|Adverse Event|0|||
161023222|NCT00085735|581477202|FG005|Overall Study|Adverse Event|0|||
161023223|NCT00085735|581477197|FG000|Overall Study|Lack of Efficacy|2|||
161023224|NCT00085735|581477198|FG001|Overall Study|Lack of Efficacy|4|||
161023225|NCT00085735|581477199|FG002|Overall Study|Lack of Efficacy|6|||
161023226|NCT00085735|581477200|FG003|Overall Study|Lack of Efficacy|3|||
161023227|NCT00085735|581477201|FG004|Overall Study|Lack of Efficacy|4|||
161023228|NCT00085735|581477202|FG005|Overall Study|Lack of Efficacy|3|||
161023229|NCT00085735|581477197|FG000|Overall Study|Lost to Follow-up|0|||
161023230|NCT00085735|581477198|FG001|Overall Study|Lost to Follow-up|1|||
160459985|NCT02720068|579417512|FG011|Overall Study|Physician Decision|1|||
160459986|NCT02720068|579417513|FG012|Overall Study|Physician Decision|0|||
160459987|NCT02720068|579417514|FG013|Overall Study|Physician Decision|0|||
160459988|NCT02720068|579417515|FG014|Overall Study|Physician Decision|0|||
161023231|NCT00085735|581477199|FG002|Overall Study|Lost to Follow-up|0|||
161023232|NCT00085735|581477200|FG003|Overall Study|Lost to Follow-up|0|||
161023233|NCT00085735|581477201|FG004|Overall Study|Lost to Follow-up|1|||
161023234|NCT00085735|581477202|FG005|Overall Study|Lost to Follow-up|0|||
161023235|NCT00085735|581477197|FG000|Overall Study|Physician Decision|2|||
161023236|NCT00085735|581477198|FG001|Overall Study|Physician Decision|3|||
160459989|NCT02720068|579417516|FG015|Overall Study|Physician Decision|0|||
160459990|NCT02720068|579417517|FG016|Overall Study|Physician Decision|0|||
160459991|NCT02720068|579417518|FG017|Overall Study|Physician Decision|1|||
160459992|NCT02720068|579417501|FG000|Overall Study|Progressive Disease|2|||
161023237|NCT00085735|581477199|FG002|Overall Study|Physician Decision|2|||
161023238|NCT00085735|581477200|FG003|Overall Study|Physician Decision|3|||
161023239|NCT00085735|581477201|FG004|Overall Study|Physician Decision|11|||
161023240|NCT00085735|581477202|FG005|Overall Study|Physician Decision|8|||
160459993|NCT02720068|579417502|FG001|Overall Study|Progressive Disease|3|||
161023241|NCT00085735|581477197|FG000|Overall Study|Protocol Violation|1|||
161023242|NCT00085735|581477198|FG001|Overall Study|Protocol Violation|0|||
161023243|NCT00085735|581477199|FG002|Overall Study|Protocol Violation|0|||
161023244|NCT00085735|581477200|FG003|Overall Study|Protocol Violation|0|||
161023245|NCT00085735|581477201|FG004|Overall Study|Protocol Violation|0|||
161023246|NCT00085735|581477202|FG005|Overall Study|Protocol Violation|0|||
161023247|NCT00085735|581477197|FG000|Overall Study|Withdrawal by Subject|1|||
161023248|NCT00085735|581477198|FG001|Overall Study|Withdrawal by Subject|0|||
161023249|NCT00085735|581477199|FG002|Overall Study|Withdrawal by Subject|4|||
161023250|NCT00085735|581477200|FG003|Overall Study|Withdrawal by Subject|5|||
161023251|NCT00085735|581477201|FG004|Overall Study|Withdrawal by Subject|7|||
161023252|NCT00085735|581477202|FG005|Overall Study|Withdrawal by Subject|8|||
161023253|NCT00085735|581477197|FG000|Overall Study|Patient ineligible|1|||
161023254|NCT00085735|581477198|FG001|Overall Study|Patient ineligible|0|||
161023255|NCT00085735|581477199|FG002|Overall Study|Patient ineligible|3|||
160587496|NCT03491553|579869941|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
160587497|NCT03491553|579869942|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
160587498|NCT03491553|579869943|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
160587499|NCT03633227|579869944|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
160587500|NCT03633227|579869945|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
160587501|NCT03633227|579869944|FG000|Double Blind (DB), up to Week 48|Death|2|||
160587502|NCT03633227|579869945|FG001|Double Blind (DB), up to Week 48|Death|1|||
160587503|NCT03633227|579869944|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
160587504|NCT03633227|579869945|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
160587505|NCT03633227|579869944|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
160587506|NCT03633227|579869945|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
160587507|NCT03633227|579869944|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
160587508|NCT03633227|579869945|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
160587509|NCT03633227|579869944|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
160587510|NCT03633227|579869945|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
160587511|NCT03633227|579869944|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
160587512|NCT03633227|579869945|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
160587513|NCT03633227|579869944|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
160587514|NCT03633227|579869945|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
160587515|NCT03633227|579869944|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
160587516|NCT03633227|579869945|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
160587517|NCT03633227|579869944|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
160587518|NCT03633227|579869945|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
160587519|NCT03633227|579869944|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
160587520|NCT03633227|579869945|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
160587521|NCT03633227|579869944|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
160587522|NCT03633227|579869945|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
160587523|NCT01479374|579869953|FG000|Overall Study|Adverse Event|2|||
160587524|NCT01479374|579869954|FG001|Overall Study|Adverse Event|1|||
160587525|NCT01479374|579869955|FG002|Overall Study|Adverse Event|0|||
160587526|NCT01479374|579869953|FG000|Overall Study|Lost to Follow-up|1|||
160587527|NCT01479374|579869954|FG001|Overall Study|Lost to Follow-up|2|||
160587528|NCT01479374|579869955|FG002|Overall Study|Lost to Follow-up|0|||
160587529|NCT01479374|579869953|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
160587530|NCT01479374|579869954|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
160587531|NCT01479374|579869955|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
161023256|NCT00085735|581477200|FG003|Overall Study|Patient ineligible|7|||
161023257|NCT00085735|581477201|FG004|Overall Study|Patient ineligible|17|||
161023258|NCT00085735|581477202|FG005|Overall Study|Patient ineligible|8|||
161023259|NCT00085735|581477197|FG000|Overall Study|Excess residual disease|2|||
161023260|NCT00085735|581477198|FG001|Overall Study|Excess residual disease|2|||
161023261|NCT00085735|581477199|FG002|Overall Study|Excess residual disease|1|||
161023262|NCT00085735|581477200|FG003|Overall Study|Excess residual disease|1|||
161023263|NCT00085735|581477201|FG004|Overall Study|Excess residual disease|1|||
160587532|NCT01479374|579869953|FG000|Overall Study|Other|0|||
160587533|NCT01479374|579869954|FG001|Overall Study|Other|4|||
161023264|NCT00085735|581477202|FG005|Overall Study|Excess residual disease|4|||
161023265|NCT00085735|581477197|FG000|Overall Study|Reason not documented|1|||
161023266|NCT00085735|581477198|FG001|Overall Study|Reason not documented|0|||
161023267|NCT00085735|581477199|FG002|Overall Study|Reason not documented|1|||
161023268|NCT00085735|581477200|FG003|Overall Study|Reason not documented|0|||
161023269|NCT00085735|581477201|FG004|Overall Study|Reason not documented|1|||
160587534|NCT01479374|579869955|FG002|Overall Study|Other|5|||
160587535|NCT01606761|579869956|FG000|Prior to Week 24|Lost to Follow-up|0|||
160587536|NCT01606761|579869957|FG001|Prior to Week 24|Lost to Follow-up|3|||
161023270|NCT00085735|581477202|FG005|Overall Study|Reason not documented|0|||
161023271|NCT00085735|581477197|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
161023272|NCT00085735|581477198|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
161023273|NCT00085735|581477199|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
161023274|NCT00085735|581477200|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
161023275|NCT00085735|581477201|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
161023276|NCT00085735|581477202|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
161023277|NCT01824875|581477203|FG000|Overall Study|Disease progression|22|||
161023278|NCT01824875|581477204|FG001|Overall Study|Disease progression|15|||
161023279|NCT01824875|581477203|FG000|Overall Study|Withdrawal by Subject|5|||
161023280|NCT01824875|581477204|FG001|Overall Study|Withdrawal by Subject|4|||
161023281|NCT01824875|581477203|FG000|Overall Study|Adverse Event|4|||
161023282|NCT01824875|581477204|FG001|Overall Study|Adverse Event|10|||
161023283|NCT01824875|581477203|FG000|Overall Study|Alternative therapy|3|||
161023284|NCT01824875|581477204|FG001|Overall Study|Alternative therapy|0|||
161023285|NCT01824875|581477203|FG000|Overall Study|Complicating disease|1|||
161023286|NCT01824875|581477204|FG001|Overall Study|Complicating disease|0|||
161023287|NCT01824875|581477203|FG000|Overall Study|Physician Decision|0|||
161023288|NCT01824875|581477204|FG001|Overall Study|Physician Decision|1|||
161023289|NCT01824875|581477203|FG000|Overall Study|Non-compliance|1|||
161023290|NCT01824875|581477204|FG001|Overall Study|Non-compliance|1|||
161023291|NCT01824875|581477203|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
161023292|NCT01824875|581477204|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
161023293|NCT01824875|581477203|FG000|Overall Study|Administrative issues|0|||
161023294|NCT01824875|581477204|FG001|Overall Study|Administrative issues|2|||
161023295|NCT01824875|581477203|FG000|Overall Study|Ineligible or never started treatment|9|||
161023296|NCT01824875|581477204|FG001|Overall Study|Ineligible or never started treatment|5|||
161023297|NCT01824875|581477203|FG000|Overall Study|Other|0|||
161023298|NCT01824875|581477204|FG001|Overall Study|Other|2|||
161023299|NCT04195698|581477207|FG000|Overall Study|Adverse Event|4|||
161023300|NCT04195698|581477208|FG001|Overall Study|Adverse Event|11|||
161023301|NCT04195698|581477207|FG000|Overall Study|Withdrawal by Subject|9|||
161023302|NCT04195698|581477208|FG001|Overall Study|Withdrawal by Subject|10|||
161023303|NCT04195698|581477207|FG000|Overall Study|Lost to Follow-up|5|||
161023304|NCT04195698|581477208|FG001|Overall Study|Lost to Follow-up|4|||
161023305|NCT04195698|581477207|FG000|Overall Study|Lack of Efficacy|2|||
161023306|NCT04195698|581477208|FG001|Overall Study|Lack of Efficacy|10|||
161023307|NCT04195698|581477207|FG000|Overall Study|Other|5|||
161023308|NCT04195698|581477208|FG001|Overall Study|Other|4|||
161023309|NCT00433329|581477209|FG000|Overall Study|Adverse Event|9|||
161023310|NCT00433329|581477209|FG000|Overall Study|Death|4|||
161023311|NCT00433329|581477209|FG000|Overall Study|Withdrew consent|3|||
161023312|NCT00433329|581477209|FG000|Overall Study|Discontinued sildenafil|2|||
161023313|NCT00433329|581477209|FG000|Overall Study|Moved out of state|1|||
161023314|NCT00433329|581477209|FG000|Overall Study|Lost to Follow-up|1|||
161023315|NCT00433329|581477209|FG000|Overall Study|Physician Decision|1|||
161023316|NCT05459688|581477210|FG000|Overall Study|Lost to Follow-up|6|||
161023317|NCT05459688|581477210|FG000|Overall Study|Physician Decision|1|||
161023318|NCT05459688|581477210|FG000|Overall Study|Withdrawal by Subject|19|||
161023319|NCT05459688|581477210|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
161023320|NCT01129102|581477211|FG000|Overall Study|No study drug treatment|2|||
161023321|NCT01129102|581477212|FG001|Overall Study|No study drug treatment|3|||
161023322|NCT01129102|581477213|FG002|Overall Study|No study drug treatment|1|||
161023323|NCT01129102|581477211|FG000|Overall Study|Withdrawal by Subject|2|||
161023324|NCT01129102|581477212|FG001|Overall Study|Withdrawal by Subject|0|||
161023325|NCT01129102|581477213|FG002|Overall Study|Withdrawal by Subject|3|||
161023326|NCT01129102|581477211|FG000|Overall Study|Protocol Violation|0|||
161023327|NCT01129102|581477212|FG001|Overall Study|Protocol Violation|1|||
161023328|NCT01129102|581477213|FG002|Overall Study|Protocol Violation|1|||
161023329|NCT01129102|581477211|FG000|Overall Study|Pregnancy|0|||
161023330|NCT01129102|581477212|FG001|Overall Study|Pregnancy|0|||
161023331|NCT01129102|581477213|FG002|Overall Study|Pregnancy|1|||
161023332|NCT01129102|581477211|FG000|Overall Study|Adverse Event|2|||
161023333|NCT01129102|581477212|FG001|Overall Study|Adverse Event|2|||
161023334|NCT01129102|581477213|FG002|Overall Study|Adverse Event|1|||
161023335|NCT01129102|581477211|FG000|Overall Study|Lost to Follow-up|2|||
161023336|NCT01129102|581477212|FG001|Overall Study|Lost to Follow-up|0|||
161023337|NCT01129102|581477213|FG002|Overall Study|Lost to Follow-up|0|||
161023338|NCT03379675|581477216|FG000|Overall Study|Lost to Follow-up|0|||
161023339|NCT03379675|581477217|FG001|Overall Study|Lost to Follow-up|1|||
161023340|NCT03379675|581477218|FG002|Overall Study|Lost to Follow-up|0|||
161023341|NCT03379675|581477216|FG000|Overall Study|Adverse Event|2|||
161023342|NCT03379675|581477217|FG001|Overall Study|Adverse Event|0|||
161023343|NCT03379675|581477218|FG002|Overall Study|Adverse Event|0|||
161023344|NCT03379675|581477216|FG000|Overall Study|Withdrawal by Subject|2|||
161023345|NCT03379675|581477217|FG001|Overall Study|Withdrawal by Subject|1|||
161023346|NCT03379675|581477218|FG002|Overall Study|Withdrawal by Subject|2|||
161023347|NCT02817776|581477219|FG000|Overall Study|Excluded|33|||
161023348|NCT02817776|581477219|FG000|Overall Study|Lost to Follow-up|20|||
160459994|NCT02720068|579417503|FG002|Overall Study|Progressive Disease|1|||
161023349|NCT02817776|581477219|FG000|Overall Study|Withdrawal by Subject|33|||
161023350|NCT02817776|581477219|FG000|Overall Study|Death|2|||
161023351|NCT02359890|581477220|FG000|Overall Study|Not meeting eligibility|4|||
161023352|NCT02359890|581477220|FG000|Overall Study|Never treated with study catheter|6|||
161023353|NCT02683447|581477225|FG000|Overall Study|Lost to Follow-up|2|||
161023354|NCT04663737|581477226|FG000|Overall Study|Withdrawal by Subject|2|||
161023355|NCT04663737|581477227|FG001|Overall Study|Withdrawal by Subject|0|||
161023356|NCT04016662|581477228|FG000|Run-In Phase|Death|1|||
161023357|NCT04016662|581477228|FG000|Run-In Phase|Withdrawal by Subject|11|||
161023358|NCT04016662|581477228|FG000|Run-In Phase|Not meeting screening eligibility|9|||
161023359|NCT04016662|581477228|FG000|Run-In Phase|Physician Decision|3|||
161023360|NCT04016662|581477228|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
161023361|NCT04016662|581477228|FG000|PLGS (12 Weeks)|Death|1|||
161023362|NCT04016662|581477228|FG000|SAP (12 Weeks)|Death|1|||
161023363|NCT02489903|581477232|FG000|Screening|Screen Failure|24|||
161023364|NCT02489903|581477233|FG001|Screening|Screen Failure|0|||
161023365|NCT02489903|581477234|FG002|Screening|Screen Failure|0|||
161023366|NCT02489903|581477235|FG003|Screening|Screen Failure|8|||
161023367|NCT02489903|581477232|FG000|Randomized and Received Treatment|Protocol Violation|0|||
161023368|NCT02489903|581477233|FG001|Randomized and Received Treatment|Protocol Violation|1|||
161023369|NCT02489903|581477234|FG002|Randomized and Received Treatment|Protocol Violation|0|||
161023370|NCT02489903|581477235|FG003|Randomized and Received Treatment|Protocol Violation|0|||
161023371|NCT02489903|581477232|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
161023372|NCT02489903|581477233|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
161023373|NCT02489903|581477234|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
161023374|NCT02489903|581477235|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
161023375|NCT02489903|581477232|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
161023376|NCT02489903|581477233|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
161023377|NCT02489903|581477234|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
161023378|NCT02489903|581477235|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
161023379|NCT02489903|581477232|FG000|Randomized and Received Treatment|Death|10|||
161023380|NCT02489903|581477233|FG001|Randomized and Received Treatment|Death|1|||
161023381|NCT02489903|581477234|FG002|Randomized and Received Treatment|Death|0|||
161023382|NCT02489903|581477235|FG003|Randomized and Received Treatment|Death|0|||
161023383|NCT03904147|581477240|FG000|Overall Study|Death|15|||
161023384|NCT03904147|581477241|FG001|Overall Study|Death|13|||
161023385|NCT03904147|581477242|FG002|Overall Study|Death|15|||
161023386|NCT03904147|581477240|FG000|Overall Study|Withdrawal by Subject|7|||
161023387|NCT03904147|581477241|FG001|Overall Study|Withdrawal by Subject|12|||
161023388|NCT03904147|581477242|FG002|Overall Study|Withdrawal by Subject|1|||
161023389|NCT03904147|581477240|FG000|Overall Study|1Y visit completed after 365 days|1|||
161023390|NCT03904147|581477241|FG001|Overall Study|1Y visit completed after 365 days|1|||
161023391|NCT03904147|581477242|FG002|Overall Study|1Y visit completed after 365 days|0|||
161023392|NCT04413708|581477243|FG000|Overall Study|Lost to Follow-up|1|||
161023393|NCT04413708|581477244|FG001|Overall Study|Lost to Follow-up|2|||
161023394|NCT04948697|581477245|FG000|Overall Study|Progressive disease|27|||
161023395|NCT04948697|581477246|FG001|Overall Study|Progressive disease|18|||
161023396|NCT04948697|581477245|FG000|Overall Study|Adverse Event|14|||
161023397|NCT04948697|581477246|FG001|Overall Study|Adverse Event|4|||
161023398|NCT04948697|581477245|FG000|Overall Study|Participant moved to long term extension study|7|||
161023399|NCT04948697|581477246|FG001|Overall Study|Participant moved to long term extension study|4|||
161023400|NCT04948697|581477245|FG000|Overall Study|Withdrawal by Subject|10|||
161023401|NCT04948697|581477246|FG001|Overall Study|Withdrawal by Subject|0|||
161023402|NCT04948697|581477245|FG000|Overall Study|Closed by Sponsor|3|||
161023403|NCT04948697|581477246|FG001|Overall Study|Closed by Sponsor|2|||
161023404|NCT04948697|581477245|FG000|Overall Study|Physician Decision|0|||
161023405|NCT04948697|581477246|FG001|Overall Study|Physician Decision|2|||
161023406|NCT04948697|581477245|FG000|Overall Study|Lost to Follow-up|0|||
161023407|NCT04948697|581477246|FG001|Overall Study|Lost to Follow-up|1|||
161023408|NCT04948697|581477245|FG000|Overall Study|Other-Miscellaneous|1|||
160587537|NCT01606761|579869958|FG002|Prior to Week 24|Lost to Follow-up|2|||
161023409|NCT04948697|581477246|FG001|Overall Study|Other-Miscellaneous|0|||
161023410|NCT04948697|581477245|FG000|Overall Study|Randomized but not treated|0|||
161023411|NCT04948697|581477246|FG001|Overall Study|Randomized but not treated|1|||
161023412|NCT04599062|581477247|FG000|Overall Study|Physician Decision|1|||
160459995|NCT02720068|579417504|FG003|Overall Study|Progressive Disease|1|||
161023413|NCT04599062|581477248|FG001|Overall Study|Physician Decision|0|||
161023414|NCT04032704|581477249|FG000|Part A|Withdrawal by Subject|0|||
161023415|NCT04032704|581477250|FG001|Part A|Withdrawal by Subject|0|||
161023416|NCT04032704|581477251|FG002|Part A|Withdrawal by Subject|3|||
161023417|NCT04032704|581477252|FG003|Part A|Withdrawal by Subject|0|||
161023418|NCT04032704|581477253|FG004|Part A|Withdrawal by Subject|1|||
161023419|NCT04032704|581477254|FG005|Part A|Withdrawal by Subject|7|||
161023420|NCT04032704|581477255|FG006|Part A|Withdrawal by Subject|0|||
161023421|NCT04032704|581477256|FG007|Part A|Withdrawal by Subject|0|||
160587538|NCT01606761|579869959|FG003|Prior to Week 24|Lost to Follow-up|0|||
161023422|NCT04032704|581477257|FG008|Part A|Withdrawal by Subject|0|||
161023423|NCT04032704|581477258|FG009|Part A|Withdrawal by Subject|0|||
161023424|NCT04032704|581477259|FG010|Part A|Withdrawal by Subject|0|||
161023425|NCT04032704|581477260|FG011|Part A|Withdrawal by Subject|0|||
161023426|NCT04032704|581477261|FG012|Part A|Withdrawal by Subject|0|||
161023427|NCT04032704|581477262|FG013|Part A|Withdrawal by Subject|0|||
161023428|NCT04032704|581477263|FG014|Part A|Withdrawal by Subject|0|||
161023429|NCT04032704|581477264|FG015|Part A|Withdrawal by Subject|0|||
161023430|NCT04032704|581477265|FG016|Part A|Withdrawal by Subject|0|||
161023431|NCT04032704|581477266|FG017|Part A|Withdrawal by Subject|0|||
161023432|NCT04032704|581477249|FG000|Part A|Lost to Follow-up|1|||
161023433|NCT04032704|581477250|FG001|Part A|Lost to Follow-up|0|||
161023434|NCT04032704|581477251|FG002|Part A|Lost to Follow-up|0|||
161023435|NCT04032704|581477252|FG003|Part A|Lost to Follow-up|0|||
161023436|NCT04032704|581477253|FG004|Part A|Lost to Follow-up|0|||
161023437|NCT04032704|581477254|FG005|Part A|Lost to Follow-up|0|||
161023438|NCT04032704|581477255|FG006|Part A|Lost to Follow-up|0|||
161023439|NCT04032704|581477256|FG007|Part A|Lost to Follow-up|0|||
161023440|NCT04032704|581477257|FG008|Part A|Lost to Follow-up|0|||
161023441|NCT04032704|581477258|FG009|Part A|Lost to Follow-up|0|||
161023442|NCT04032704|581477259|FG010|Part A|Lost to Follow-up|0|||
161023443|NCT04032704|581477260|FG011|Part A|Lost to Follow-up|0|||
161023444|NCT04032704|581477261|FG012|Part A|Lost to Follow-up|0|||
161023445|NCT04032704|581477262|FG013|Part A|Lost to Follow-up|0|||
161023446|NCT04032704|581477263|FG014|Part A|Lost to Follow-up|0|||
161023447|NCT04032704|581477264|FG015|Part A|Lost to Follow-up|0|||
161023448|NCT04032704|581477265|FG016|Part A|Lost to Follow-up|0|||
161023449|NCT04032704|581477266|FG017|Part A|Lost to Follow-up|0|||
161023450|NCT04032704|581477249|FG000|Part A|Death|9|||
161023451|NCT04032704|581477250|FG001|Part A|Death|2|||
161023452|NCT04032704|581477251|FG002|Part A|Death|10|||
161023453|NCT04032704|581477252|FG003|Part A|Death|7|||
160459996|NCT02720068|579417505|FG004|Overall Study|Progressive Disease|1|||
160459997|NCT02720068|579417506|FG005|Overall Study|Progressive Disease|2|||
161023454|NCT04032704|581477253|FG004|Part A|Death|4|||
161023455|NCT04032704|581477254|FG005|Part A|Death|5|||
161023456|NCT04032704|581477255|FG006|Part A|Death|0|||
161023457|NCT04032704|581477256|FG007|Part A|Death|0|||
161023458|NCT04032704|581477257|FG008|Part A|Death|0|||
161023459|NCT04032704|581477258|FG009|Part A|Death|0|||
161023460|NCT04032704|581477259|FG010|Part A|Death|0|||
161023461|NCT04032704|581477260|FG011|Part A|Death|0|||
161023462|NCT04032704|581477261|FG012|Part A|Death|0|||
161023463|NCT04032704|581477262|FG013|Part A|Death|0|||
161023464|NCT04032704|581477263|FG014|Part A|Death|0|||
161023465|NCT04032704|581477264|FG015|Part A|Death|0|||
161023466|NCT04032704|581477265|FG016|Part A|Death|0|||
161023467|NCT04032704|581477266|FG017|Part A|Death|0|||
161023468|NCT04032704|581477249|FG000|Part B|Other|0|||
161023469|NCT04032704|581477250|FG001|Part B|Other|0|||
160587539|NCT01606761|579869960|FG004|Prior to Week 24|Lost to Follow-up|0|||
160587540|NCT01606761|579869956|FG000|Prior to Week 24|Withdrawal by Subject|12|||
160587541|NCT01606761|579869957|FG001|Prior to Week 24|Withdrawal by Subject|10|||
160587542|NCT01606761|579869958|FG002|Prior to Week 24|Withdrawal by Subject|9|||
160587543|NCT01606761|579869959|FG003|Prior to Week 24|Withdrawal by Subject|0|||
160587544|NCT01606761|579869960|FG004|Prior to Week 24|Withdrawal by Subject|0|||
160459998|NCT02720068|579417507|FG006|Overall Study|Progressive Disease|1|||
160459999|NCT02720068|579417508|FG007|Overall Study|Progressive Disease|1|||
160460000|NCT02720068|579417509|FG008|Overall Study|Progressive Disease|0|||
160460001|NCT02720068|579417510|FG009|Overall Study|Progressive Disease|1|||
160587545|NCT01606761|579869956|FG000|Prior to Week 24|Adverse Event|11|||
160587546|NCT01606761|579869957|FG001|Prior to Week 24|Adverse Event|18|||
160460002|NCT02720068|579417511|FG010|Overall Study|Progressive Disease|0|||
160460003|NCT02720068|579417512|FG011|Overall Study|Progressive Disease|4|||
160587547|NCT01606761|579869958|FG002|Prior to Week 24|Adverse Event|22|||
160587548|NCT01606761|579869959|FG003|Prior to Week 24|Adverse Event|0|||
160587549|NCT01606761|579869960|FG004|Prior to Week 24|Adverse Event|0|||
161023470|NCT04032704|581477251|FG002|Part B|Other|0|||
161023471|NCT04032704|581477252|FG003|Part B|Other|0|||
161023472|NCT04032704|581477253|FG004|Part B|Other|0|||
161023473|NCT04032704|581477254|FG005|Part B|Other|0|||
161023474|NCT04032704|581477255|FG006|Part B|Other|0|||
161023475|NCT04032704|581477256|FG007|Part B|Other|1|||
161023476|NCT04032704|581477257|FG008|Part B|Other|2|||
161023477|NCT04032704|581477258|FG009|Part B|Other|1|||
161023478|NCT04032704|581477259|FG010|Part B|Other|1|||
161023479|NCT04032704|581477260|FG011|Part B|Other|1|||
160460004|NCT02720068|579417513|FG012|Overall Study|Progressive Disease|1|||
161023480|NCT04032704|581477261|FG012|Part B|Other|5|||
161023481|NCT04032704|581477262|FG013|Part B|Other|13|||
161023482|NCT04032704|581477263|FG014|Part B|Other|0|||
161023483|NCT04032704|581477264|FG015|Part B|Other|0|||
161023484|NCT04032704|581477265|FG016|Part B|Other|0|||
161023485|NCT04032704|581477266|FG017|Part B|Other|0|||
161023486|NCT04032704|581477249|FG000|Part B|Study termination by Sponsor|0|||
161023487|NCT04032704|581477250|FG001|Part B|Study termination by Sponsor|0|||
161023488|NCT04032704|581477251|FG002|Part B|Study termination by Sponsor|0|||
161023489|NCT04032704|581477252|FG003|Part B|Study termination by Sponsor|0|||
161023490|NCT04032704|581477253|FG004|Part B|Study termination by Sponsor|0|||
161023491|NCT04032704|581477254|FG005|Part B|Study termination by Sponsor|0|||
161023492|NCT04032704|581477255|FG006|Part B|Study termination by Sponsor|0|||
161023493|NCT04032704|581477256|FG007|Part B|Study termination by Sponsor|0|||
161023494|NCT04032704|581477257|FG008|Part B|Study termination by Sponsor|1|||
161023495|NCT04032704|581477258|FG009|Part B|Study termination by Sponsor|0|||
161023496|NCT04032704|581477259|FG010|Part B|Study termination by Sponsor|0|||
161023497|NCT04032704|581477260|FG011|Part B|Study termination by Sponsor|0|||
161023498|NCT04032704|581477261|FG012|Part B|Study termination by Sponsor|0|||
161023499|NCT04032704|581477262|FG013|Part B|Study termination by Sponsor|0|||
161023500|NCT04032704|581477263|FG014|Part B|Study termination by Sponsor|0|||
161023501|NCT04032704|581477264|FG015|Part B|Study termination by Sponsor|0|||
161023502|NCT04032704|581477265|FG016|Part B|Study termination by Sponsor|0|||
161023503|NCT04032704|581477266|FG017|Part B|Study termination by Sponsor|0|||
161023504|NCT04032704|581477249|FG000|Part B|Withdrawal by Subject|0|||
161023505|NCT04032704|581477250|FG001|Part B|Withdrawal by Subject|0|||
161023506|NCT04032704|581477251|FG002|Part B|Withdrawal by Subject|0|||
161023507|NCT04032704|581477252|FG003|Part B|Withdrawal by Subject|0|||
161023508|NCT04032704|581477253|FG004|Part B|Withdrawal by Subject|0|||
161023509|NCT04032704|581477254|FG005|Part B|Withdrawal by Subject|0|||
161023510|NCT04032704|581477255|FG006|Part B|Withdrawal by Subject|3|||
161023511|NCT04032704|581477256|FG007|Part B|Withdrawal by Subject|2|||
161023512|NCT04032704|581477257|FG008|Part B|Withdrawal by Subject|2|||
161023513|NCT04032704|581477258|FG009|Part B|Withdrawal by Subject|1|||
161023514|NCT04032704|581477259|FG010|Part B|Withdrawal by Subject|4|||
161023515|NCT04032704|581477260|FG011|Part B|Withdrawal by Subject|6|||
161023516|NCT04032704|581477261|FG012|Part B|Withdrawal by Subject|2|||
161023517|NCT04032704|581477262|FG013|Part B|Withdrawal by Subject|1|||
161023518|NCT04032704|581477263|FG014|Part B|Withdrawal by Subject|0|||
161023519|NCT04032704|581477264|FG015|Part B|Withdrawal by Subject|1|||
161023520|NCT04032704|581477265|FG016|Part B|Withdrawal by Subject|0|||
161023521|NCT04032704|581477266|FG017|Part B|Withdrawal by Subject|0|||
161023522|NCT04032704|581477249|FG000|Part B|Lost to Follow-up|0|||
161023523|NCT04032704|581477250|FG001|Part B|Lost to Follow-up|0|||
161023524|NCT04032704|581477251|FG002|Part B|Lost to Follow-up|0|||
161023525|NCT04032704|581477252|FG003|Part B|Lost to Follow-up|0|||
161023526|NCT04032704|581477253|FG004|Part B|Lost to Follow-up|0|||
161023527|NCT04032704|581477254|FG005|Part B|Lost to Follow-up|0|||
161023528|NCT04032704|581477255|FG006|Part B|Lost to Follow-up|0|||
161023529|NCT04032704|581477256|FG007|Part B|Lost to Follow-up|0|||
161023530|NCT04032704|581477257|FG008|Part B|Lost to Follow-up|0|||
161023531|NCT04032704|581477258|FG009|Part B|Lost to Follow-up|0|||
161023532|NCT04032704|581477259|FG010|Part B|Lost to Follow-up|0|||
161023533|NCT04032704|581477260|FG011|Part B|Lost to Follow-up|1|||
161023534|NCT04032704|581477261|FG012|Part B|Lost to Follow-up|0|||
161023535|NCT04032704|581477262|FG013|Part B|Lost to Follow-up|0|||
161023536|NCT04032704|581477263|FG014|Part B|Lost to Follow-up|0|||
161023537|NCT04032704|581477264|FG015|Part B|Lost to Follow-up|0|||
161023538|NCT04032704|581477265|FG016|Part B|Lost to Follow-up|0|||
161023539|NCT04032704|581477266|FG017|Part B|Lost to Follow-up|0|||
161023540|NCT04032704|581477249|FG000|Part B|Death|0|||
161023541|NCT04032704|581477250|FG001|Part B|Death|0|||
161023542|NCT04032704|581477251|FG002|Part B|Death|0|||
161023543|NCT04032704|581477252|FG003|Part B|Death|0|||
161023544|NCT04032704|581477253|FG004|Part B|Death|0|||
161023545|NCT04032704|581477254|FG005|Part B|Death|0|||
161023546|NCT04032704|581477255|FG006|Part B|Death|13|||
161023547|NCT04032704|581477256|FG007|Part B|Death|13|||
161023548|NCT04032704|581477257|FG008|Part B|Death|14|||
161023549|NCT04032704|581477258|FG009|Part B|Death|12|||
161023550|NCT04032704|581477259|FG010|Part B|Death|12|||
161023551|NCT04032704|581477260|FG011|Part B|Death|13|||
161023552|NCT04032704|581477261|FG012|Part B|Death|7|||
161023553|NCT04032704|581477262|FG013|Part B|Death|17|||
161023554|NCT04032704|581477263|FG014|Part B|Death|2|||
161023555|NCT04032704|581477264|FG015|Part B|Death|1|||
161023556|NCT04032704|581477265|FG016|Part B|Death|2|||
161023557|NCT04032704|581477266|FG017|Part B|Death|2|||
161023558|NCT05877976|581477267|FG000|Overall Study|Lost to Follow-up|31|||
161023559|NCT04145440|581477268|FG000|Overall Study|Physician Decision|3|||
161023560|NCT04145440|581477269|FG001|Overall Study|Physician Decision|0|||
161023561|NCT04145440|581477268|FG000|Overall Study|Use of prohibited therapy|2|||
161023562|NCT04145440|581477269|FG001|Overall Study|Use of prohibited therapy|3|||
161023563|NCT05808257|581477274|FG000|Overall Study|Lost to Follow-up|8|||
161023564|NCT05808257|581477275|FG001|Overall Study|Lost to Follow-up|8|||
161023565|NCT04907851|581477278|FG000|Overall Study|Consent withdrawn|1|||
161023566|NCT04907851|581477279|FG001|Overall Study|Consent withdrawn|2|||
161023567|NCT04907851|581477280|FG002|Overall Study|Consent withdrawn|0|||
161023568|NCT04907851|581477278|FG000|Overall Study|Death|5|||
161023569|NCT04907851|581477279|FG001|Overall Study|Death|15|||
161023570|NCT04907851|581477280|FG002|Overall Study|Death|10|||
161023571|NCT04248725|581477283|FG000|Post-Treatment|Lost to Follow-up|6|||
161023572|NCT04248725|581477284|FG001|Post-Treatment|Lost to Follow-up|5|||
161023573|NCT04248725|581477283|FG000|6-Month Follow Up|Lost to Follow-up|9|||
161023574|NCT04248725|581477284|FG001|6-Month Follow Up|Lost to Follow-up|8|||
161023575|NCT04436276|581477294|FG000|Overall Study|Adverse Event|0|||
161023576|NCT04436276|581477295|FG001|Overall Study|Adverse Event|0|||
161023577|NCT04436276|581477296|FG002|Overall Study|Adverse Event|0|||
161023578|NCT04436276|581477297|FG003|Overall Study|Adverse Event|0|||
161023579|NCT04436276|581477298|FG004|Overall Study|Adverse Event|0|||
161023580|NCT04436276|581477299|FG005|Overall Study|Adverse Event|0|||
161023581|NCT04436276|581477300|FG006|Overall Study|Adverse Event|0|||
161023582|NCT04436276|581477301|FG007|Overall Study|Adverse Event|0|||
161023583|NCT04436276|581477302|FG008|Overall Study|Adverse Event|0|||
161023584|NCT04436276|581477303|FG009|Overall Study|Adverse Event|0|||
161023585|NCT04436276|581477304|FG010|Overall Study|Adverse Event|0|||
161023586|NCT04436276|581477305|FG011|Overall Study|Adverse Event|0|||
161023587|NCT04436276|581477306|FG012|Overall Study|Adverse Event|0|||
161023588|NCT04436276|581477307|FG013|Overall Study|Adverse Event|0|||
161023589|NCT04436276|581477308|FG014|Overall Study|Adverse Event|0|||
161023590|NCT04436276|581477309|FG015|Overall Study|Adverse Event|0|||
161023591|NCT04436276|581477310|FG016|Overall Study|Adverse Event|1|||
161023592|NCT04436276|581477311|FG017|Overall Study|Adverse Event|0|||
161023593|NCT04436276|581477312|FG018|Overall Study|Adverse Event|0|||
161023594|NCT04436276|581477313|FG019|Overall Study|Adverse Event|0|||
161023595|NCT04436276|581477314|FG020|Overall Study|Adverse Event|0|||
161023596|NCT04436276|581477315|FG021|Overall Study|Adverse Event|0|||
161023597|NCT04436276|581477316|FG022|Overall Study|Adverse Event|0|||
161023598|NCT04436276|581477294|FG000|Overall Study|Death|0|||
161023599|NCT04436276|581477295|FG001|Overall Study|Death|0|||
161023600|NCT04436276|581477296|FG002|Overall Study|Death|0|||
161023601|NCT04436276|581477297|FG003|Overall Study|Death|0|||
161023602|NCT04436276|581477298|FG004|Overall Study|Death|0|||
161023603|NCT04436276|581477299|FG005|Overall Study|Death|0|||
161023604|NCT04436276|581477300|FG006|Overall Study|Death|0|||
161023605|NCT04436276|581477301|FG007|Overall Study|Death|0|||
161023606|NCT04436276|581477302|FG008|Overall Study|Death|0|||
161023607|NCT04436276|581477303|FG009|Overall Study|Death|0|||
161023608|NCT04436276|581477304|FG010|Overall Study|Death|0|||
161023609|NCT04436276|581477305|FG011|Overall Study|Death|0|||
161023610|NCT04436276|581477306|FG012|Overall Study|Death|1|||
161023611|NCT04436276|581477307|FG013|Overall Study|Death|0|||
161023612|NCT04436276|581477308|FG014|Overall Study|Death|1|||
161023613|NCT04436276|581477309|FG015|Overall Study|Death|0|||
161023614|NCT04436276|581477310|FG016|Overall Study|Death|0|||
161023615|NCT04436276|581477311|FG017|Overall Study|Death|0|||
161023616|NCT04436276|581477312|FG018|Overall Study|Death|0|||
161023617|NCT04436276|581477313|FG019|Overall Study|Death|2|||
161023618|NCT04436276|581477314|FG020|Overall Study|Death|0|||
161023619|NCT04436276|581477315|FG021|Overall Study|Death|1|||
161023620|NCT04436276|581477316|FG022|Overall Study|Death|0|||
161023621|NCT04436276|581477294|FG000|Overall Study|Lost to Follow-up|0|||
161023622|NCT04436276|581477295|FG001|Overall Study|Lost to Follow-up|2|||
161023623|NCT04436276|581477296|FG002|Overall Study|Lost to Follow-up|2|||
161023624|NCT04436276|581477297|FG003|Overall Study|Lost to Follow-up|1|||
161023625|NCT04436276|581477298|FG004|Overall Study|Lost to Follow-up|4|||
161023626|NCT04436276|581477299|FG005|Overall Study|Lost to Follow-up|1|||
161023627|NCT04436276|581477300|FG006|Overall Study|Lost to Follow-up|0|||
161023628|NCT04436276|581477301|FG007|Overall Study|Lost to Follow-up|0|||
161023629|NCT04436276|581477302|FG008|Overall Study|Lost to Follow-up|1|||
161023630|NCT04436276|581477303|FG009|Overall Study|Lost to Follow-up|0|||
161023631|NCT04436276|581477304|FG010|Overall Study|Lost to Follow-up|5|||
161023632|NCT04436276|581477305|FG011|Overall Study|Lost to Follow-up|5|||
161023633|NCT04436276|581477306|FG012|Overall Study|Lost to Follow-up|4|||
161023634|NCT04436276|581477307|FG013|Overall Study|Lost to Follow-up|1|||
161023635|NCT04436276|581477308|FG014|Overall Study|Lost to Follow-up|7|||
161023636|NCT04436276|581477309|FG015|Overall Study|Lost to Follow-up|7|||
161023637|NCT04436276|581477310|FG016|Overall Study|Lost to Follow-up|1|||
161023638|NCT04436276|581477311|FG017|Overall Study|Lost to Follow-up|0|||
161023639|NCT04436276|581477312|FG018|Overall Study|Lost to Follow-up|1|||
161023640|NCT04436276|581477313|FG019|Overall Study|Lost to Follow-up|1|||
161023641|NCT04436276|581477314|FG020|Overall Study|Lost to Follow-up|2|||
161023642|NCT04436276|581477315|FG021|Overall Study|Lost to Follow-up|1|||
161023643|NCT04436276|581477316|FG022|Overall Study|Lost to Follow-up|1|||
161023644|NCT04436276|581477294|FG000|Overall Study|Physician Decision|1|||
161023645|NCT04436276|581477295|FG001|Overall Study|Physician Decision|0|||
161023646|NCT04436276|581477296|FG002|Overall Study|Physician Decision|2|||
161023647|NCT04436276|581477297|FG003|Overall Study|Physician Decision|1|||
161023648|NCT04436276|581477298|FG004|Overall Study|Physician Decision|0|||
160460005|NCT02720068|579417514|FG013|Overall Study|Progressive Disease|0|||
161023649|NCT04436276|581477299|FG005|Overall Study|Physician Decision|0|||
161023650|NCT04436276|581477300|FG006|Overall Study|Physician Decision|0|||
161023651|NCT04436276|581477301|FG007|Overall Study|Physician Decision|0|||
161023652|NCT04436276|581477302|FG008|Overall Study|Physician Decision|0|||
161023653|NCT04436276|581477303|FG009|Overall Study|Physician Decision|0|||
161023654|NCT04436276|581477304|FG010|Overall Study|Physician Decision|0|||
161023655|NCT04436276|581477305|FG011|Overall Study|Physician Decision|1|||
161023656|NCT04436276|581477306|FG012|Overall Study|Physician Decision|2|||
160587550|NCT01606761|579869956|FG000|Prior to Week 24|Lack of Efficacy|15|||
160587551|NCT01606761|579869957|FG001|Prior to Week 24|Lack of Efficacy|14|||
160587552|NCT01606761|579869958|FG002|Prior to Week 24|Lack of Efficacy|8|||
160587553|NCT01606761|579869959|FG003|Prior to Week 24|Lack of Efficacy|0|||
160587554|NCT01606761|579869960|FG004|Prior to Week 24|Lack of Efficacy|0|||
160587555|NCT01606761|579869956|FG000|Prior to Week 24|Physician Decision|0|||
160587556|NCT01606761|579869957|FG001|Prior to Week 24|Physician Decision|3|||
160587557|NCT01606761|579869958|FG002|Prior to Week 24|Physician Decision|1|||
160587558|NCT01606761|579869959|FG003|Prior to Week 24|Physician Decision|0|||
160587559|NCT01606761|579869960|FG004|Prior to Week 24|Physician Decision|0|||
160587560|NCT01606761|579869956|FG000|Prior to Week 24|Other|4|||
160587561|NCT01606761|579869957|FG001|Prior to Week 24|Other|7|||
160587562|NCT01606761|579869958|FG002|Prior to Week 24|Other|5|||
160587563|NCT01606761|579869959|FG003|Prior to Week 24|Other|0|||
160587564|NCT01606761|579869960|FG004|Prior to Week 24|Other|0|||
160587565|NCT01606761|579869956|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
160587566|NCT01606761|579869957|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
160587567|NCT01606761|579869958|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
160587568|NCT01606761|579869959|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
160587569|NCT01606761|579869960|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
160587570|NCT01606761|579869956|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
160587571|NCT01606761|579869957|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
160587572|NCT01606761|579869958|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
160587573|NCT01606761|579869959|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
160587574|NCT01606761|579869960|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
160587575|NCT01606761|579869956|FG000|Week 24 to Week 52|Adverse Event|0|||
160587576|NCT01606761|579869957|FG001|Week 24 to Week 52|Adverse Event|11|||
160587577|NCT01606761|579869958|FG002|Week 24 to Week 52|Adverse Event|14|||
160587578|NCT01606761|579869959|FG003|Week 24 to Week 52|Adverse Event|3|||
160587579|NCT01606761|579869960|FG004|Week 24 to Week 52|Adverse Event|15|||
160587580|NCT01606761|579869956|FG000|Week 24 to Week 52|Death|0|||
160587581|NCT01606761|579869957|FG001|Week 24 to Week 52|Death|0|||
160587582|NCT01606761|579869958|FG002|Week 24 to Week 52|Death|2|||
160587583|NCT01606761|579869959|FG003|Week 24 to Week 52|Death|1|||
160587584|NCT01606761|579869960|FG004|Week 24 to Week 52|Death|0|||
161023657|NCT04436276|581477307|FG013|Overall Study|Physician Decision|0|||
161023658|NCT04436276|581477308|FG014|Overall Study|Physician Decision|0|||
161023659|NCT04436276|581477309|FG015|Overall Study|Physician Decision|0|||
161023660|NCT04436276|581477310|FG016|Overall Study|Physician Decision|0|||
161023661|NCT04436276|581477311|FG017|Overall Study|Physician Decision|0|||
161023662|NCT04436276|581477312|FG018|Overall Study|Physician Decision|0|||
161023663|NCT04436276|581477313|FG019|Overall Study|Physician Decision|0|||
161023664|NCT04436276|581477314|FG020|Overall Study|Physician Decision|1|||
161023665|NCT04436276|581477315|FG021|Overall Study|Physician Decision|2|||
161023666|NCT04436276|581477316|FG022|Overall Study|Physician Decision|0|||
161023667|NCT04436276|581477294|FG000|Overall Study|Protocol Violation|0|||
161023668|NCT04436276|581477295|FG001|Overall Study|Protocol Violation|0|||
161023669|NCT04436276|581477296|FG002|Overall Study|Protocol Violation|0|||
161023670|NCT04436276|581477297|FG003|Overall Study|Protocol Violation|0|||
161023671|NCT04436276|581477298|FG004|Overall Study|Protocol Violation|0|||
161023672|NCT04436276|581477299|FG005|Overall Study|Protocol Violation|0|||
161023673|NCT04436276|581477300|FG006|Overall Study|Protocol Violation|0|||
161023674|NCT04436276|581477301|FG007|Overall Study|Protocol Violation|0|||
161023675|NCT04436276|581477302|FG008|Overall Study|Protocol Violation|0|||
161023676|NCT04436276|581477303|FG009|Overall Study|Protocol Violation|0|||
161023677|NCT04436276|581477304|FG010|Overall Study|Protocol Violation|0|||
161023678|NCT04436276|581477305|FG011|Overall Study|Protocol Violation|0|||
161023679|NCT04436276|581477306|FG012|Overall Study|Protocol Violation|0|||
161023680|NCT04436276|581477307|FG013|Overall Study|Protocol Violation|1|||
161023681|NCT04436276|581477308|FG014|Overall Study|Protocol Violation|0|||
160587585|NCT01606761|579869956|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
160587586|NCT01606761|579869957|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
161023682|NCT04436276|581477309|FG015|Overall Study|Protocol Violation|1|||
161023683|NCT04436276|581477310|FG016|Overall Study|Protocol Violation|0|||
160587587|NCT01606761|579869958|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
160587588|NCT01606761|579869959|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
160587589|NCT01606761|579869960|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
160657074|NCT02879643|580124532|FG003|Overall Study|Adverse Event|1|||
160587590|NCT01606761|579869956|FG000|Week 24 to Week 52|Physician Decision|0|||
160587591|NCT01606761|579869957|FG001|Week 24 to Week 52|Physician Decision|1|||
160587592|NCT01606761|579869958|FG002|Week 24 to Week 52|Physician Decision|1|||
160587593|NCT01606761|579869959|FG003|Week 24 to Week 52|Physician Decision|0|||
160587594|NCT01606761|579869960|FG004|Week 24 to Week 52|Physician Decision|0|||
160587595|NCT01606761|579869956|FG000|Week 24 to Week 52|Other|0|||
160587596|NCT01606761|579869957|FG001|Week 24 to Week 52|Other|1|||
160587597|NCT01606761|579869958|FG002|Week 24 to Week 52|Other|5|||
161023684|NCT04436276|581477311|FG017|Overall Study|Protocol Violation|0|||
161023685|NCT04436276|581477312|FG018|Overall Study|Protocol Violation|0|||
161023686|NCT04436276|581477313|FG019|Overall Study|Protocol Violation|0|||
161023687|NCT04436276|581477314|FG020|Overall Study|Protocol Violation|0|||
160587598|NCT01606761|579869959|FG003|Week 24 to Week 52|Other|2|||
160587599|NCT01606761|579869960|FG004|Week 24 to Week 52|Other|2|||
160587600|NCT01606761|579869956|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
160587601|NCT01606761|579869957|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
160587602|NCT01606761|579869958|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
160587603|NCT01606761|579869959|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
160587604|NCT01606761|579869960|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
160587605|NCT01606761|579869956|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
160587606|NCT01606761|579869957|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
160587607|NCT01606761|579869958|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
160587608|NCT01606761|579869959|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
160587609|NCT01606761|579869960|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
160587610|NCT01606761|579869956|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
160587611|NCT01606761|579869957|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
160587612|NCT01606761|579869958|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
160587613|NCT01606761|579869959|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
160587614|NCT01606761|579869960|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
160587615|NCT01606761|579869956|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
160587616|NCT01606761|579869957|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
160587617|NCT01606761|579869958|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
160587618|NCT01606761|579869959|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
160587619|NCT01606761|579869960|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
161023688|NCT04436276|581477315|FG021|Overall Study|Protocol Violation|0|||
161023689|NCT04436276|581477316|FG022|Overall Study|Protocol Violation|0|||
161023690|NCT04436276|581477294|FG000|Overall Study|Withdrawal by Subject|25|||
161023691|NCT04436276|581477295|FG001|Overall Study|Withdrawal by Subject|22|||
161023692|NCT04436276|581477296|FG002|Overall Study|Withdrawal by Subject|24|||
161023693|NCT04436276|581477297|FG003|Overall Study|Withdrawal by Subject|23|||
161023694|NCT04436276|581477298|FG004|Overall Study|Withdrawal by Subject|14|||
161023695|NCT04436276|581477299|FG005|Overall Study|Withdrawal by Subject|0|||
161023696|NCT04436276|581477300|FG006|Overall Study|Withdrawal by Subject|0|||
161023697|NCT04436276|581477301|FG007|Overall Study|Withdrawal by Subject|1|||
161023698|NCT04436276|581477302|FG008|Overall Study|Withdrawal by Subject|0|||
161023699|NCT04436276|581477303|FG009|Overall Study|Withdrawal by Subject|1|||
161023700|NCT04436276|581477304|FG010|Overall Study|Withdrawal by Subject|17|||
161023701|NCT04436276|581477305|FG011|Overall Study|Withdrawal by Subject|7|||
161023702|NCT04436276|581477306|FG012|Overall Study|Withdrawal by Subject|10|||
161023703|NCT04436276|581477307|FG013|Overall Study|Withdrawal by Subject|6|||
161023704|NCT04436276|581477308|FG014|Overall Study|Withdrawal by Subject|20|||
161023705|NCT04436276|581477309|FG015|Overall Study|Withdrawal by Subject|6|||
161023706|NCT04436276|581477310|FG016|Overall Study|Withdrawal by Subject|11|||
161023707|NCT04436276|581477311|FG017|Overall Study|Withdrawal by Subject|4|||
161023708|NCT04436276|581477312|FG018|Overall Study|Withdrawal by Subject|14|||
161023709|NCT04436276|581477313|FG019|Overall Study|Withdrawal by Subject|24|||
161023710|NCT04436276|581477314|FG020|Overall Study|Withdrawal by Subject|24|||
161023711|NCT04436276|581477315|FG021|Overall Study|Withdrawal by Subject|16|||
161023712|NCT04436276|581477316|FG022|Overall Study|Withdrawal by Subject|14|||
161023713|NCT04436276|581477294|FG000|Overall Study|Other|3|||
161023714|NCT04436276|581477295|FG001|Overall Study|Other|2|||
161023715|NCT04436276|581477296|FG002|Overall Study|Other|5|||
161023716|NCT04436276|581477297|FG003|Overall Study|Other|9|||
161023717|NCT04436276|581477298|FG004|Overall Study|Other|23|||
161023718|NCT04436276|581477299|FG005|Overall Study|Other|1|||
161023719|NCT04436276|581477300|FG006|Overall Study|Other|0|||
161023720|NCT04436276|581477301|FG007|Overall Study|Other|0|||
161023721|NCT04436276|581477302|FG008|Overall Study|Other|0|||
161023722|NCT04436276|581477303|FG009|Overall Study|Other|0|||
161023723|NCT04436276|581477304|FG010|Overall Study|Other|3|||
160587620|NCT05086289|579869961|FG000|Overall Study|Adverse Event|4|||
160587621|NCT05086289|579869962|FG001|Overall Study|Adverse Event|2|||
160587622|NCT05086289|579869961|FG000|Overall Study|Lost to Follow-up|2|||
161023724|NCT04436276|581477305|FG011|Overall Study|Other|1|||
161023725|NCT04436276|581477306|FG012|Overall Study|Other|1|||
160587623|NCT05086289|579869962|FG001|Overall Study|Lost to Follow-up|0|||
160587624|NCT05086289|579869961|FG000|Overall Study|Non-compliance with study drug|2|||
160587625|NCT05086289|579869962|FG001|Overall Study|Non-compliance with study drug|1|||
160587626|NCT05086289|579869961|FG000|Overall Study|Physician Decision|2|||
161023726|NCT04436276|581477307|FG013|Overall Study|Other|2|||
161023727|NCT04436276|581477308|FG014|Overall Study|Other|3|||
161023728|NCT04436276|581477309|FG015|Overall Study|Other|0|||
161023729|NCT04436276|581477310|FG016|Overall Study|Other|0|||
161023730|NCT04436276|581477311|FG017|Overall Study|Other|6|||
161023731|NCT04436276|581477312|FG018|Overall Study|Other|1|||
161023732|NCT04436276|581477313|FG019|Overall Study|Other|0|||
161023733|NCT04436276|581477314|FG020|Overall Study|Other|2|||
161023734|NCT04436276|581477315|FG021|Overall Study|Other|2|||
161023735|NCT04436276|581477316|FG022|Overall Study|Other|60|||
160587627|NCT05086289|579869962|FG001|Overall Study|Physician Decision|0|||
160587628|NCT05086289|579869961|FG000|Overall Study|Withdrawal by Subject|5|||
160587629|NCT05086289|579869962|FG001|Overall Study|Withdrawal by Subject|2|||
160587630|NCT00586924|579869963|FG000|Overall Study|Adverse event/serious adverse event|0|||
160587631|NCT00586924|579869964|FG001|Overall Study|Adverse event/serious adverse event|0|||
160587632|NCT00586924|579869965|FG002|Overall Study|Adverse event/serious adverse event|0|||
160587633|NCT00586924|579869966|FG003|Overall Study|Adverse event/serious adverse event|1|||
160587634|NCT00586924|579869967|FG004|Overall Study|Adverse event/serious adverse event|0|||
160587635|NCT00586924|579869968|FG005|Overall Study|Adverse event/serious adverse event|2|||
160587636|NCT00586924|579869963|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
160657075|NCT02879643|580124533|FG004|Overall Study|Adverse Event|0|||
160657076|NCT00182091|580124534|FG000|Overall Study|Withdrawal by Subject|1|||
161023736|NCT03656510|581477318|FG000|Overall Study|Lost to Follow-up|1|||
161023737|NCT03656510|581477319|FG001|Overall Study|Lost to Follow-up|0|||
161023738|NCT03656510|581477320|FG002|Overall Study|Lost to Follow-up|0|||
161023739|NCT03656510|581477321|FG003|Overall Study|Lost to Follow-up|0|||
160657077|NCT00182091|580124535|FG001|Overall Study|Withdrawal by Subject|0|||
161023740|NCT03656510|581477322|FG004|Overall Study|Lost to Follow-up|0|||
161023741|NCT03656510|581477323|FG005|Overall Study|Lost to Follow-up|0|||
161023742|NCT03656510|581477318|FG000|Overall Study|Withdrawal by Subject|1|||
161023743|NCT03656510|581477319|FG001|Overall Study|Withdrawal by Subject|1|||
161023744|NCT03656510|581477320|FG002|Overall Study|Withdrawal by Subject|0|||
160657078|NCT00182091|580124536|FG002|Overall Study|Withdrawal by Subject|0|||
160657079|NCT00182091|580124537|FG003|Overall Study|Withdrawal by Subject|0|||
160657080|NCT01046253|580124538|FG000|Second Intervention|Adverse Event|0|||
160657081|NCT01046253|580124539|FG001|Second Intervention|Adverse Event|1|||
160657082|NCT01046253|580124538|FG000|Second Intervention|Protocol Violation|0|||
160657083|NCT01046253|580124539|FG001|Second Intervention|Protocol Violation|1|||
160657084|NCT02339909|580124540|FG000|Overall Study|Became ineligible after randomisation|89|||
161023745|NCT03656510|581477321|FG003|Overall Study|Withdrawal by Subject|1|||
161023746|NCT03656510|581477322|FG004|Overall Study|Withdrawal by Subject|0|||
161023747|NCT03656510|581477323|FG005|Overall Study|Withdrawal by Subject|0|||
161023748|NCT06457802|581477329|FG000|Overall Study|Early termination of study prior to participant completion|2|||
161023749|NCT06457802|581477330|FG001|Overall Study|Early termination of study prior to participant completion|2|||
161023750|NCT03819153|581477333|FG000|Overall Study|Withdrawal by Subject|20|||
161023751|NCT03819153|581477334|FG001|Overall Study|Withdrawal by Subject|28|||
161023752|NCT03819153|581477333|FG000|Overall Study|Lost to Follow-up|23|||
161023753|NCT03819153|581477334|FG001|Overall Study|Lost to Follow-up|30|||
161023754|NCT03974178|581477335|FG000|Overall Study|Death|0|||
161023755|NCT03974178|581477336|FG001|Overall Study|Death|1|||
161023756|NCT03899259|581477337|FG000|Overall Study|Adverse Event|5|||
161023757|NCT03899259|581477338|FG001|Overall Study|Adverse Event|4|||
161023758|NCT03899259|581477339|FG002|Overall Study|Adverse Event|6|||
161023759|NCT03899259|581477337|FG000|Overall Study|Lack of Efficacy|5|||
161023760|NCT03899259|581477338|FG001|Overall Study|Lack of Efficacy|0|||
161023761|NCT03899259|581477339|FG002|Overall Study|Lack of Efficacy|2|||
161023762|NCT03899259|581477337|FG000|Overall Study|Pregnancy|3|||
161023763|NCT03899259|581477338|FG001|Overall Study|Pregnancy|0|||
161023764|NCT03899259|581477339|FG002|Overall Study|Pregnancy|1|||
161023765|NCT03899259|581477337|FG000|Overall Study|Physician Decision|0|||
161023766|NCT03899259|581477338|FG001|Overall Study|Physician Decision|1|||
161023767|NCT03899259|581477339|FG002|Overall Study|Physician Decision|0|||
161023768|NCT03899259|581477337|FG000|Overall Study|Protocol Deviation|1|||
161023769|NCT03899259|581477338|FG001|Overall Study|Protocol Deviation|1|||
161023770|NCT03899259|581477339|FG002|Overall Study|Protocol Deviation|1|||
161023771|NCT03899259|581477337|FG000|Overall Study|Withdrawal by Subject|8|||
161023772|NCT03899259|581477338|FG001|Overall Study|Withdrawal by Subject|10|||
161023773|NCT03899259|581477339|FG002|Overall Study|Withdrawal by Subject|12|||
161023774|NCT03899259|581477337|FG000|Overall Study|Lost to Follow-up|5|||
161023775|NCT03899259|581477338|FG001|Overall Study|Lost to Follow-up|6|||
161023776|NCT03899259|581477339|FG002|Overall Study|Lost to Follow-up|2|||
161023777|NCT03899259|581477337|FG000|Overall Study|Lack of Adherence|1|||
161023778|NCT03899259|581477338|FG001|Overall Study|Lack of Adherence|0|||
161023779|NCT03899259|581477339|FG002|Overall Study|Lack of Adherence|0|||
161023780|NCT03899259|581477337|FG000|Overall Study|Screen Failure|1|||
161023781|NCT03899259|581477338|FG001|Overall Study|Screen Failure|0|||
161023782|NCT03899259|581477339|FG002|Overall Study|Screen Failure|0|||
161023783|NCT03899259|581477337|FG000|Overall Study|Ongoing Study Participation|127|||
161023784|NCT03899259|581477338|FG001|Overall Study|Ongoing Study Participation|134|||
161023785|NCT03899259|581477339|FG002|Overall Study|Ongoing Study Participation|210|||
161023786|NCT01152450|581477340|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
160587637|NCT00586924|579869964|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
160587638|NCT00586924|579869965|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
161023787|NCT01152450|581477341|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
161023788|NCT01152450|581477342|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
161023789|NCT01152450|581477343|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
160587639|NCT00586924|579869966|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
161023790|NCT01152450|581477344|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
161023791|NCT01152450|581477345|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
161023792|NCT01152450|581477340|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
161023793|NCT01152450|581477341|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
161023794|NCT01152450|581477342|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
161023795|NCT01152450|581477343|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
161023796|NCT01152450|581477344|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
161023797|NCT01152450|581477345|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
161023798|NCT01152450|581477340|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161023799|NCT01152450|581477341|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
161023800|NCT01152450|581477342|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
161023801|NCT01152450|581477343|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161023802|NCT01152450|581477344|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161023803|NCT01152450|581477345|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161023804|NCT01544114|581477350|FG000|Overall Study|Withdrawal by Subject|0|||
161023805|NCT01544114|581477351|FG001|Overall Study|Withdrawal by Subject|0|||
161023806|NCT01544114|581477352|FG002|Overall Study|Withdrawal by Subject|3|||
161023807|NCT01544114|581477350|FG000|Overall Study|Lost to Follow-up|0|||
161023808|NCT01544114|581477351|FG001|Overall Study|Lost to Follow-up|2|||
161023809|NCT01544114|581477352|FG002|Overall Study|Lost to Follow-up|0|||
161023810|NCT01544114|581477350|FG000|Overall Study|Adverse Event|1|||
161023811|NCT01544114|581477351|FG001|Overall Study|Adverse Event|1|||
161023812|NCT01544114|581477352|FG002|Overall Study|Adverse Event|2|||
161023813|NCT01544114|581477350|FG000|Overall Study|Protocol Violation|0|||
161023814|NCT01544114|581477351|FG001|Overall Study|Protocol Violation|1|||
161023815|NCT01544114|581477352|FG002|Overall Study|Protocol Violation|0|||
161023816|NCT04508309|581477358|FG000|Overall Study|Death|0|||
161023817|NCT04508309|581477359|FG001|Overall Study|Death|0|||
161023818|NCT04508309|581477360|FG002|Overall Study|Death|0|||
161023819|NCT04508309|581477361|FG003|Overall Study|Death|0|||
161023820|NCT04508309|581477362|FG004|Overall Study|Death|1|||
161023821|NCT04508309|581477358|FG000|Overall Study|Lost to Follow-up|0|||
161023822|NCT04508309|581477359|FG001|Overall Study|Lost to Follow-up|0|||
161023823|NCT04508309|581477360|FG002|Overall Study|Lost to Follow-up|1|||
161023824|NCT04508309|581477361|FG003|Overall Study|Lost to Follow-up|1|||
161023825|NCT04508309|581477362|FG004|Overall Study|Lost to Follow-up|0|||
161023826|NCT04508309|581477358|FG000|Overall Study|Withdrawal by Subject|0|||
161023827|NCT04508309|581477359|FG001|Overall Study|Withdrawal by Subject|0|||
161023828|NCT04508309|581477360|FG002|Overall Study|Withdrawal by Subject|0|||
161023829|NCT04508309|581477361|FG003|Overall Study|Withdrawal by Subject|0|||
161023830|NCT04508309|581477362|FG004|Overall Study|Withdrawal by Subject|1|||
161023831|NCT03058289|581477363|FG000|Overall Study|Radiographic Deterioration|0|||
161023832|NCT03058289|581477364|FG001|Overall Study|Radiographic Deterioration|3|||
161023833|NCT03058289|581477365|FG002|Overall Study|Radiographic Deterioration|1|||
161023834|NCT03058289|581477366|FG003|Overall Study|Radiographic Deterioration|2|||
161023835|NCT03058289|581477367|FG004|Overall Study|Radiographic Deterioration|6|||
161023836|NCT03058289|581477368|FG005|Overall Study|Radiographic Deterioration|3|||
161023837|NCT03058289|581477369|FG006|Overall Study|Radiographic Deterioration|0|||
161023838|NCT03058289|581477370|FG007|Overall Study|Radiographic Deterioration|4|||
161023839|NCT03058289|581477371|FG008|Overall Study|Radiographic Deterioration|2|||
161023840|NCT03058289|581477363|FG000|Overall Study|Adverse Event|2|||
161023841|NCT03058289|581477364|FG001|Overall Study|Adverse Event|0|||
161023842|NCT03058289|581477365|FG002|Overall Study|Adverse Event|1|||
161023843|NCT03058289|581477366|FG003|Overall Study|Adverse Event|3|||
161023844|NCT03058289|581477367|FG004|Overall Study|Adverse Event|1|||
161023845|NCT03058289|581477368|FG005|Overall Study|Adverse Event|0|||
161023846|NCT03058289|581477369|FG006|Overall Study|Adverse Event|1|||
161023847|NCT03058289|581477370|FG007|Overall Study|Adverse Event|3|||
161023848|NCT03058289|581477371|FG008|Overall Study|Adverse Event|0|||
161023849|NCT03058289|581477363|FG000|Overall Study|Withdrawal by Subject|0|||
161023850|NCT03058289|581477364|FG001|Overall Study|Withdrawal by Subject|0|||
161023851|NCT03058289|581477365|FG002|Overall Study|Withdrawal by Subject|0|||
161023852|NCT03058289|581477366|FG003|Overall Study|Withdrawal by Subject|2|||
161023853|NCT03058289|581477367|FG004|Overall Study|Withdrawal by Subject|0|||
161023854|NCT03058289|581477368|FG005|Overall Study|Withdrawal by Subject|2|||
161023855|NCT03058289|581477369|FG006|Overall Study|Withdrawal by Subject|0|||
161023856|NCT03058289|581477370|FG007|Overall Study|Withdrawal by Subject|4|||
161023857|NCT03058289|581477371|FG008|Overall Study|Withdrawal by Subject|1|||
161023858|NCT03058289|581477363|FG000|Overall Study|Physician Decision|1|||
161023859|NCT03058289|581477364|FG001|Overall Study|Physician Decision|0|||
161023860|NCT03058289|581477365|FG002|Overall Study|Physician Decision|0|||
161023861|NCT03058289|581477366|FG003|Overall Study|Physician Decision|2|||
161023862|NCT03058289|581477367|FG004|Overall Study|Physician Decision|1|||
161023863|NCT03058289|581477368|FG005|Overall Study|Physician Decision|0|||
161023864|NCT03058289|581477369|FG006|Overall Study|Physician Decision|2|||
161023865|NCT03058289|581477370|FG007|Overall Study|Physician Decision|3|||
161023866|NCT03058289|581477371|FG008|Overall Study|Physician Decision|0|||
161023867|NCT03058289|581477363|FG000|Overall Study|Clinical Deterioration|2|||
161023868|NCT03058289|581477364|FG001|Overall Study|Clinical Deterioration|0|||
160969661|NCT02332590|581276917|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
160969662|NCT02332590|581276918|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
160969663|NCT01806584|581276919|FG000|Overall Study|Adverse Event|2|||
160969664|NCT01806584|581276920|FG001|Overall Study|Adverse Event|1|||
160969665|NCT01806584|581276919|FG000|Overall Study|Death|1|||
160969666|NCT01806584|581276920|FG001|Overall Study|Death|0|||
160969667|NCT01806584|581276919|FG000|Overall Study|Lost to Follow-up|0|||
160969668|NCT01806584|581276920|FG001|Overall Study|Lost to Follow-up|2|||
160969669|NCT01806584|581276919|FG000|Overall Study|Study terminated by sponsor|9|||
160969670|NCT01806584|581276920|FG001|Overall Study|Study terminated by sponsor|14|||
160969671|NCT01806584|581276919|FG000|Overall Study|Withdrawal by Subject|1|||
160969672|NCT01806584|581276920|FG001|Overall Study|Withdrawal by Subject|1|||
160969673|NCT01806584|581276919|FG000|Overall Study|Other unspecified|1|||
160969674|NCT01806584|581276920|FG001|Overall Study|Other unspecified|0|||
160969675|NCT00976703|581278767|FG000|Overall Study|Physician Decision|1|||
160969676|NCT00976703|581278768|FG001|Overall Study|Physician Decision|1|||
160969677|NCT00976703|581278767|FG000|Overall Study|ineligible for study|2|||
160969678|NCT00976703|581278768|FG001|Overall Study|ineligible for study|2|||
160969679|NCT00975221|581278771|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
160969680|NCT00975221|581278772|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
160969681|NCT00975221|581278771|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
160969682|NCT00975221|581278772|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
160969683|NCT00975221|581278771|FG000|Titration Phase (Weeks 1-12)|Other|0|||
160969684|NCT00975221|581278772|FG001|Titration Phase (Weeks 1-12)|Other|1|||
160969685|NCT00975221|581278771|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
160969686|NCT00975221|581278772|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
160969687|NCT00975221|581278771|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
160969688|NCT00975221|581278772|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
160969689|NCT00975221|581278771|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
160969690|NCT00975221|581278772|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
160969691|NCT02243631|581278773|FG000|Overall Study|no synovial fluid on second aspirate|0|||
160969692|NCT02243631|581278774|FG001|Overall Study|no synovial fluid on second aspirate|1|||
160969693|NCT01992549|581278777|FG000|Overall Study|Lost to Follow-up|2|||
160969694|NCT01992549|581278777|FG000|Overall Study|Serious Adverse Event|1|||
160969695|NCT01992549|581278777|FG000|Overall Study|Product Switch to Extend Half Life|1|||
160969696|NCT01590771|581278778|FG000|Overall Study|Other Protocol Specified Criteria|5|||
160969697|NCT01590771|581278779|FG001|Overall Study|Other Protocol Specified Criteria|14|||
160969698|NCT01590771|581278778|FG000|Overall Study|Withdrawal by Subject|8|||
160969699|NCT01590771|581278779|FG001|Overall Study|Withdrawal by Subject|15|||
160969700|NCT01590771|581278778|FG000|Overall Study|Protocol Violation|1|||
160969701|NCT01590771|581278779|FG001|Overall Study|Protocol Violation|2|||
160969702|NCT01590771|581278778|FG000|Overall Study|Lost to Follow-up|1|||
160969703|NCT01590771|581278779|FG001|Overall Study|Lost to Follow-up|1|||
160969704|NCT01590771|581278778|FG000|Overall Study|Lack of Efficacy|1|||
160969705|NCT01590771|581278779|FG001|Overall Study|Lack of Efficacy|0|||
160969706|NCT01590771|581278778|FG000|Overall Study|Adverse Event|3|||
160969707|NCT01590771|581278779|FG001|Overall Study|Adverse Event|7|||
160969708|NCT01785628|581278780|FG000|Overall Study|Lost to Follow-up|2|||
160969709|NCT01785628|581278781|FG001|Overall Study|Lost to Follow-up|3|||
160969710|NCT04022889|581278782|FG000|Stage 1: Period 1|Adverse Event|1|||
160969711|NCT04022889|581278783|FG001|Stage 1: Period 1|Adverse Event|0|||
160969712|NCT04022889|581278784|FG002|Stage 1: Period 1|Adverse Event|0|||
160969713|NCT04022889|581278782|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
160969714|NCT04022889|581278783|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
160587640|NCT00586924|579869967|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
160969715|NCT04022889|581278784|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
160969716|NCT04022889|581278782|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
160969717|NCT04022889|581278783|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
161023869|NCT03058289|581477365|FG002|Overall Study|Clinical Deterioration|0|||
160587641|NCT00586924|579869968|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
160587642|NCT00586924|579869963|FG000|Overall Study|Disease progression|0|||
160969718|NCT04022889|581278784|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
160969719|NCT04022889|581278782|FG000|Stage 2|Screen Failure|0|||
160969720|NCT04022889|581278783|FG001|Stage 2|Screen Failure|0|||
160969721|NCT04022889|581278784|FG002|Stage 2|Screen Failure|3|||
161023870|NCT03058289|581477366|FG003|Overall Study|Clinical Deterioration|2|||
160969722|NCT04022889|581278782|FG000|Stage 2|Ineligible for apheresis donation|0|||
160969723|NCT04022889|581278783|FG001|Stage 2|Ineligible for apheresis donation|0|||
160969724|NCT04022889|581278784|FG002|Stage 2|Ineligible for apheresis donation|2|||
160969725|NCT04022889|581278782|FG000|Stage 2|Adverse Event|0|||
160969726|NCT04022889|581278783|FG001|Stage 2|Adverse Event|0|||
160969727|NCT04022889|581278784|FG002|Stage 2|Adverse Event|2|||
160969728|NCT04022889|581278782|FG000|Stage 2|Protocol Violation|0|||
160969729|NCT04022889|581278783|FG001|Stage 2|Protocol Violation|0|||
160969730|NCT04022889|581278784|FG002|Stage 2|Protocol Violation|1|||
160969731|NCT04022889|581278782|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
160969732|NCT04022889|581278783|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
160969733|NCT04022889|581278784|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
160969734|NCT03015116|581278785|FG000|Overall Study|Lost to Follow-up|3|||
160969735|NCT03015116|581278786|FG001|Overall Study|Lost to Follow-up|0|||
160969736|NCT03015116|581278787|FG002|Overall Study|Lost to Follow-up|2|||
160969737|NCT03015116|581278785|FG000|Overall Study|Withdrawal by Subject|3|||
160969738|NCT03015116|581278786|FG001|Overall Study|Withdrawal by Subject|1|||
160969739|NCT03015116|581278787|FG002|Overall Study|Withdrawal by Subject|0|||
160969740|NCT03015116|581278785|FG000|Overall Study|Subject has New Medical Status|1|||
160969741|NCT03015116|581278786|FG001|Overall Study|Subject has New Medical Status|0|||
160969742|NCT03015116|581278787|FG002|Overall Study|Subject has New Medical Status|0|||
160969743|NCT03015116|581278785|FG000|Overall Study|Physician Decision|0|||
160969744|NCT03015116|581278786|FG001|Overall Study|Physician Decision|1|||
160969745|NCT03015116|581278787|FG002|Overall Study|Physician Decision|0|||
160969746|NCT01862991|581278788|FG000|Overall Study|Lost to Follow-up|2|||
160969747|NCT01862991|581278789|FG001|Overall Study|Lost to Follow-up|1|||
160969748|NCT01862991|581278790|FG002|Overall Study|Lost to Follow-up|1|||
160969749|NCT01862991|581278788|FG000|Overall Study|Protocol Violation|1|||
160969750|NCT01862991|581278789|FG001|Overall Study|Protocol Violation|0|||
160969751|NCT01862991|581278790|FG002|Overall Study|Protocol Violation|0|||
160969752|NCT04858802|581278791|FG000|Overall Study|Lost to Follow-up|1|||
160969753|NCT04858802|581278792|FG001|Overall Study|Lost to Follow-up|1|||
160969754|NCT04858802|581278791|FG000|Overall Study|Withdrawal by Subject|1|||
160969755|NCT04858802|581278792|FG001|Overall Study|Withdrawal by Subject|1|||
160969756|NCT00857805|581278793|FG000|Overall Study|Withdrawal by Subject|1|||
160969757|NCT00857805|581278794|FG001|Overall Study|Withdrawal by Subject|1|||
160969758|NCT01289041|581278795|FG000|Overall Study|Adverse Event|24|||
160460006|NCT02720068|579417515|FG014|Overall Study|Progressive Disease|0|||
160460007|NCT02720068|579417516|FG015|Overall Study|Progressive Disease|0|||
160460008|NCT02720068|579417517|FG016|Overall Study|Progressive Disease|0|||
160460009|NCT02720068|579417518|FG017|Overall Study|Progressive Disease|0|||
160969759|NCT01289041|581278795|FG000|Overall Study|Physician Decision|1|||
160969760|NCT01289041|581278795|FG000|Overall Study|Progressive Disease|41|||
160969761|NCT01289041|581278795|FG000|Overall Study|Withdrawal by Subject|3|||
160969762|NCT01289041|581278795|FG000|Overall Study|Death|1|||
160969763|NCT02714868|581278800|FG000|Overall Study|Withdrawal by Subject|3|||
160969764|NCT02714868|581278801|FG001|Overall Study|Withdrawal by Subject|0|||
160969765|NCT02714868|581278800|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
160969766|NCT02714868|581278801|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
160969767|NCT02714868|581278800|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
160969768|NCT02714868|581278801|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
160969769|NCT02013388|581278806|FG000|Overall Study|work emergency|1|||
160969770|NCT02013388|581278807|FG001|Overall Study|work emergency|0|||
160969771|NCT02013388|581278808|FG002|Overall Study|work emergency|0|||
160969772|NCT02013388|581278809|FG003|Overall Study|work emergency|0|||
160969773|NCT02013388|581278810|FG004|Overall Study|work emergency|1|||
160969774|NCT02013388|581278811|FG005|Overall Study|work emergency|0|||
160969775|NCT02013388|581278812|FG006|Overall Study|work emergency|0|||
160969776|NCT02013388|581278813|FG007|Overall Study|work emergency|0|||
160969777|NCT03145766|581278814|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
160969778|NCT03145766|581278815|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
160969779|NCT03145766|581278816|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
160969780|NCT03145766|581278817|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
160969781|NCT03145766|581278818|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
160969782|NCT03145766|581278814|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
160969783|NCT03145766|581278815|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
160969784|NCT03145766|581278816|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
160969785|NCT03145766|581278817|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
160969786|NCT03145766|581278818|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
160969787|NCT03145766|581278814|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
160969788|NCT03145766|581278815|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
160969789|NCT03145766|581278816|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
160969790|NCT03145766|581278817|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
160969791|NCT03145766|581278818|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
160969792|NCT03145766|581278814|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
160969793|NCT03145766|581278815|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
160969794|NCT03145766|581278816|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
160969795|NCT03145766|581278817|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
160969796|NCT03145766|581278818|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
160969797|NCT03145766|581278814|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
160969798|NCT03145766|581278815|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
160969799|NCT03145766|581278816|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
160969800|NCT03145766|581278817|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
160969801|NCT03145766|581278818|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
160969802|NCT03145766|581278814|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
160969803|NCT03145766|581278815|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
160969804|NCT03145766|581278816|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
160969805|NCT03145766|581278817|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
160969806|NCT03145766|581278818|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
160969807|NCT03145766|581278814|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
160969808|NCT03145766|581278815|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
160969809|NCT03145766|581278816|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
160969810|NCT03145766|581278817|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
160969811|NCT03145766|581278818|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
160969812|NCT01932294|581278825|FG000|Overall Study|Death|43|||
160969813|NCT01932294|581278825|FG000|Overall Study|Lost to Follow-up|8|||
160969814|NCT01932294|581278825|FG000|Overall Study|VAD Implantation|20|||
160969815|NCT01932294|581278825|FG000|Overall Study|Heart Transplantation|16|||
160969816|NCT01932294|581278825|FG000|Overall Study|Transferred to other hospitals|12|||
160969817|NCT00409786|581278826|FG000|Overall Study|Withdrawal by Subject|3|||
160587643|NCT00586924|579869964|FG001|Overall Study|Disease progression|0|||
160969818|NCT03075904|581278829|FG000|Overall Study|Physician Decision|3|||
160587644|NCT00586924|579869965|FG002|Overall Study|Disease progression|0|||
160587645|NCT00586924|579869966|FG003|Overall Study|Disease progression|1|||
160587646|NCT00586924|579869967|FG004|Overall Study|Disease progression|1|||
160587647|NCT00586924|579869968|FG005|Overall Study|Disease progression|0|||
160587648|NCT00586924|579869963|FG000|Overall Study|Development of neutralizing antibodies|2|||
160587649|NCT00586924|579869964|FG001|Overall Study|Development of neutralizing antibodies|2|||
160587650|NCT00586924|579869965|FG002|Overall Study|Development of neutralizing antibodies|2|||
160587651|NCT00586924|579869966|FG003|Overall Study|Development of neutralizing antibodies|0|||
160587652|NCT00586924|579869967|FG004|Overall Study|Development of neutralizing antibodies|0|||
160587653|NCT00586924|579869968|FG005|Overall Study|Development of neutralizing antibodies|22|||
160587654|NCT00586924|579869963|FG000|Overall Study|Complete response|0|||
160587655|NCT00586924|579869964|FG001|Overall Study|Complete response|1|||
160587656|NCT00586924|579869965|FG002|Overall Study|Complete response|0|||
160969819|NCT03075904|581278829|FG000|Overall Study|Need for Medication not Permitted|1|||
160969820|NCT00597714|581278830|FG000|Overall Study|Death|56|||
160969821|NCT00597714|581278831|FG001|Overall Study|Death|46|||
160969822|NCT00597714|581278832|FG002|Overall Study|Death|0|||
160587657|NCT00586924|579869966|FG003|Overall Study|Complete response|0|||
160587658|NCT00586924|579869967|FG004|Overall Study|Complete response|2|||
160587659|NCT00586924|579869968|FG005|Overall Study|Complete response|2|||
160969823|NCT00597714|581278830|FG000|Overall Study|Recipient death|0|||
160969824|NCT00597714|581278831|FG001|Overall Study|Recipient death|0|||
160969825|NCT00597714|581278832|FG002|Overall Study|Recipient death|10|||
160969826|NCT02228395|581278833|FG000|First Intervention Period|No longer willing to participate|1|||
160969827|NCT02228395|581278834|FG001|First Intervention Period|No longer willing to participate|0|||
160969828|NCT02228395|581278835|FG002|First Intervention Period|No longer willing to participate|0|||
160969829|NCT02228395|581278833|FG000|First Intervention Period|Unable to comply with study dates|0|||
160969830|NCT02228395|581278834|FG001|First Intervention Period|Unable to comply with study dates|1|||
160969831|NCT02228395|581278835|FG002|First Intervention Period|Unable to comply with study dates|1|||
160969832|NCT02281760|581278838|FG000|Overall Study|Withdrawal by Subject|1|||
160969833|NCT00100932|581278843|FG000|Overall Study|Adverse Event|11|||
160969834|NCT00100932|581278844|FG001|Overall Study|Adverse Event|2|||
160969835|NCT00100932|581278843|FG000|Overall Study|Withdrawal by Subject|6|||
160969836|NCT00100932|581278844|FG001|Overall Study|Withdrawal by Subject|0|||
160587660|NCT00586924|579869963|FG000|Overall Study|Other|1|||
160969837|NCT00100932|581278843|FG000|Overall Study|Progressive Disease|44|||
160460010|NCT02720068|579417501|FG000|Overall Study|Sponsor Decision|0|||
160587661|NCT00586924|579869964|FG001|Overall Study|Other|0|||
160587662|NCT00586924|579869965|FG002|Overall Study|Other|1|||
160587663|NCT00586924|579869966|FG003|Overall Study|Other|1|||
160969838|NCT00100932|581278844|FG001|Overall Study|Progressive Disease|18|||
160969839|NCT00100932|581278843|FG000|Overall Study|Physician Decision|7|||
160969840|NCT00100932|581278844|FG001|Overall Study|Physician Decision|5|||
160969841|NCT00100932|581278843|FG000|Overall Study|Other|5|||
160587664|NCT00586924|579869967|FG004|Overall Study|Other|1|||
160587665|NCT00586924|579869968|FG005|Overall Study|Other|6|||
160587666|NCT01767194|579869971|FG000|Overall Study|Adverse Event|1|||
160587667|NCT01767194|579869972|FG001|Overall Study|Adverse Event|1|||
160587668|NCT01767194|579869971|FG000|Overall Study|Death|0|||
160587669|NCT01767194|579869972|FG001|Overall Study|Death|1|||
160587670|NCT01767194|579869971|FG000|Overall Study|Lack of Efficacy|12|||
160587671|NCT01767194|579869972|FG001|Overall Study|Lack of Efficacy|11|||
160587672|NCT01767194|579869971|FG000|Overall Study|Physician Decision|2|||
160587673|NCT01767194|579869972|FG001|Overall Study|Physician Decision|23|||
160587674|NCT01767194|579869971|FG000|Overall Study|Withdrawal by Subject|0|||
160587675|NCT01767194|579869972|FG001|Overall Study|Withdrawal by Subject|1|||
160587676|NCT01767194|579869971|FG000|Overall Study|Ineligible|1|||
160969842|NCT00100932|581278844|FG001|Overall Study|Other|2|||
160969843|NCT02424591|581278849|FG000|Overall Study|Protocol Violation|2|||
160969844|NCT02424591|581278850|FG001|Overall Study|Protocol Violation|3|||
160969845|NCT00988221|581278853|FG000|Part I|Adverse Event|0|||
160969846|NCT00988221|581278854|FG001|Part I|Adverse Event|1|||
160969847|NCT00988221|581278855|FG002|Part I|Adverse Event|2|||
160969848|NCT00988221|581278856|FG003|Part I|Adverse Event|0|||
160969849|NCT00988221|581278853|FG000|Part I|Insufficient Therapeutic Response|4|||
160969850|NCT00988221|581278854|FG001|Part I|Insufficient Therapeutic Response|6|||
160969851|NCT00988221|581278855|FG002|Part I|Insufficient Therapeutic Response|5|||
160969852|NCT00988221|581278856|FG003|Part I|Insufficient Therapeutic Response|0|||
160969853|NCT00988221|581278853|FG000|Part I|Refused Treatment|0|||
160969854|NCT00988221|581278854|FG001|Part I|Refused Treatment|2|||
160969855|NCT00988221|581278855|FG002|Part I|Refused Treatment|1|||
160969856|NCT00988221|581278856|FG003|Part I|Refused Treatment|0|||
160969857|NCT00988221|581278853|FG000|Part I|Lost to Follow-up|0|||
160969858|NCT00988221|581278854|FG001|Part I|Lost to Follow-up|1|||
160969859|NCT00988221|581278855|FG002|Part I|Lost to Follow-up|0|||
160969860|NCT00988221|581278856|FG003|Part I|Lost to Follow-up|0|||
160969861|NCT00988221|581278853|FG000|Part II|Adverse Event|1|||
160969862|NCT00988221|581278854|FG001|Part II|Adverse Event|0|||
160969863|NCT00988221|581278855|FG002|Part II|Adverse Event|0|||
160969864|NCT00988221|581278856|FG003|Part II|Adverse Event|1|||
160969865|NCT00988221|581278853|FG000|Part II|Withdrawal by Subject|0|||
160969866|NCT00988221|581278854|FG001|Part II|Withdrawal by Subject|0|||
160969867|NCT00988221|581278855|FG002|Part II|Withdrawal by Subject|2|||
160969868|NCT00988221|581278856|FG003|Part II|Withdrawal by Subject|2|||
160969869|NCT00988221|581278853|FG000|Part II|Reason not Specified|0|||
160969870|NCT00988221|581278854|FG001|Part II|Reason not Specified|0|||
160969871|NCT00988221|581278855|FG002|Part II|Reason not Specified|1|||
160969872|NCT00988221|581278856|FG003|Part II|Reason not Specified|0|||
160969873|NCT00988221|581278853|FG000|Part III|Adverse Event|1|||
160969874|NCT00988221|581278854|FG001|Part III|Adverse Event|0|||
160969875|NCT00988221|581278855|FG002|Part III|Adverse Event|1|||
160969876|NCT00988221|581278856|FG003|Part III|Adverse Event|0|||
160969877|NCT00988221|581278853|FG000|Part III|Insufficient Therapeutic Response|0|||
160969878|NCT00988221|581278854|FG001|Part III|Insufficient Therapeutic Response|1|||
160969879|NCT00988221|581278855|FG002|Part III|Insufficient Therapeutic Response|1|||
160969880|NCT00988221|581278856|FG003|Part III|Insufficient Therapeutic Response|0|||
160969881|NCT00988221|581278853|FG000|Part III|Refused Treatment|0|||
160969882|NCT00988221|581278854|FG001|Part III|Refused Treatment|0|||
160969883|NCT00988221|581278855|FG002|Part III|Refused Treatment|1|||
160969884|NCT00988221|581278856|FG003|Part III|Refused Treatment|0|||
160969885|NCT01453348|581278857|FG000|Overall Study|Death|0|||
160969886|NCT01453348|581278858|FG001|Overall Study|Death|0|||
160969887|NCT01453348|581278859|FG002|Overall Study|Death|1|||
160969888|NCT01453348|581278857|FG000|Overall Study|Withdrawal by Subject|0|||
160969889|NCT01453348|581278858|FG001|Overall Study|Withdrawal by Subject|1|||
160969890|NCT01453348|581278859|FG002|Overall Study|Withdrawal by Subject|0|||
160969891|NCT01453348|581278857|FG000|Overall Study|Protocol Violation|1|||
160969892|NCT01453348|581278858|FG001|Overall Study|Protocol Violation|0|||
160969893|NCT01453348|581278859|FG002|Overall Study|Protocol Violation|0|||
160969894|NCT02756832|581278862|FG000|Overall Study|Lost for Observation after Baseline|6|||
160969895|NCT02756832|581278862|FG000|Overall Study|Lost for Observation|13|||
160969896|NCT02756832|581278862|FG000|Overall Study|Patient's Unwillingness|12|||
160969897|NCT02756832|581278862|FG000|Overall Study|Insufficient Efficacy|2|||
160969898|NCT02756832|581278862|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
160460011|NCT02720068|579417502|FG001|Overall Study|Sponsor Decision|0|||
160587677|NCT01767194|579869972|FG001|Overall Study|Ineligible|1|||
160587678|NCT01767194|579869971|FG000|Overall Study|Refusal by patient/parent|2|||
160587679|NCT01767194|579869972|FG001|Overall Study|Refusal by patient/parent|4|||
160969899|NCT02756832|581278862|FG000|Overall Study|Reason not Specified|9|||
160460012|NCT02720068|579417503|FG002|Overall Study|Sponsor Decision|0|||
160460013|NCT02720068|579417504|FG003|Overall Study|Sponsor Decision|0|||
160587680|NCT01767194|579869971|FG000|Overall Study|Criteria not met on time for next cycle|0|||
160969900|NCT02756832|581278862|FG000|Overall Study|Protocol Deviation|10|||
160969901|NCT01498822|581278863|FG000|Overall Study|Protocol Violation|8|||
160969902|NCT01498822|581278864|FG001|Overall Study|Protocol Violation|4|||
160969903|NCT01498822|581278863|FG000|Overall Study|Other Reason|5|||
160969904|NCT01498822|581278864|FG001|Overall Study|Other Reason|2|||
160969905|NCT01498822|581278863|FG000|Overall Study|Lack of Efficacy|7|||
160969906|NCT01498822|581278864|FG001|Overall Study|Lack of Efficacy|2|||
160969907|NCT01498822|581278863|FG000|Overall Study|AE, non-serious non-fatal|8|||
160969908|NCT01498822|581278864|FG001|Overall Study|AE, non-serious non-fatal|17|||
160969909|NCT01498822|581278863|FG000|Overall Study|SAE, non-fatal|2|||
160969910|NCT01498822|581278864|FG001|Overall Study|SAE, non-fatal|2|||
160969911|NCT01498822|581278863|FG000|Overall Study|Adverse Event, serious fatal|1|||
160969912|NCT01498822|581278864|FG001|Overall Study|Adverse Event, serious fatal|1|||
160969913|NCT01498822|581278863|FG000|Overall Study|Withdrawal by Subject|15|||
160969914|NCT01498822|581278864|FG001|Overall Study|Withdrawal by Subject|25|||
160969915|NCT01498822|581278863|FG000|Overall Study|Lost to Follow-up|8|||
160969916|NCT01498822|581278864|FG001|Overall Study|Lost to Follow-up|3|||
160969917|NCT02917265|581278869|FG000|Overall Study|Physician Decision|1|||
160969918|NCT02917265|581278870|FG001|Overall Study|Physician Decision|0|||
160969919|NCT02917265|581278869|FG000|Overall Study|Withdrawal by Subject|1|||
160969920|NCT02917265|581278870|FG001|Overall Study|Withdrawal by Subject|0|||
160969921|NCT00979602|581278883|FG000|Overall Study|Serious Adverse Event|5|||
160969922|NCT00979602|581278884|FG001|Overall Study|Serious Adverse Event|3|||
160969923|NCT00979602|581278883|FG000|Overall Study|Protocol Violation|3|||
160969924|NCT00979602|581278884|FG001|Overall Study|Protocol Violation|0|||
160969925|NCT00979602|581278883|FG000|Overall Study|Withdrawal by Subject|31|||
160969926|NCT00979602|581278884|FG001|Overall Study|Withdrawal by Subject|25|||
160969927|NCT00979602|581278883|FG000|Overall Study|Lost to Follow-up|100|||
160969928|NCT00979602|581278884|FG001|Overall Study|Lost to Follow-up|96|||
160969929|NCT00979602|581278883|FG000|Overall Study|Migrated/moved from study area|3|||
160969930|NCT00979602|581278884|FG001|Overall Study|Migrated/moved from study area|6|||
160969931|NCT00979602|581278883|FG000|Overall Study|Others|3|||
160969932|NCT00979602|581278884|FG001|Overall Study|Others|3|||
160969933|NCT02712398|581278888|FG000|Overall Study|Withdrawal by Subject|6|||
160969934|NCT02712398|581278888|FG000|Overall Study|Lost to Follow-up|6|||
160969935|NCT02712398|581278888|FG000|Overall Study|Sponsor Decision|1|||
160969936|NCT02712398|581278888|FG000|Overall Study|Physician Decision|1|||
160969937|NCT02712398|581278888|FG000|Overall Study|Death|2|||
160969938|NCT02712398|581278888|FG000|Overall Study|Re-operation|21|||
160969939|NCT01719237|581278889|FG000|Overall Study|Physician Decision|0|||
160969940|NCT01719237|581278890|FG001|Overall Study|Physician Decision|1|||
160969941|NCT02002182|581278897|FG000|Overall Study|Withdraw from study|3|||
160969942|NCT02002182|581278898|FG001|Overall Study|Withdraw from study|1|||
160969943|NCT02002182|581278897|FG000|Overall Study|Health Reasons|1|||
160969944|NCT02002182|581278898|FG001|Overall Study|Health Reasons|0|||
160969945|NCT02002182|581278897|FG000|Overall Study|Death|1|||
160969946|NCT02002182|581278898|FG001|Overall Study|Death|0|||
160969947|NCT04772053|581278906|FG000|Overall Study|Physician Decision|2|||
160969948|NCT04772053|581278906|FG000|Overall Study|Withdrawal by Subject|3|||
160969949|NCT04772053|581278906|FG000|Overall Study|Study Terminated by Sponsor|1|||
160969950|NCT04146896|581278911|FG000|Overall Study|Adverse Event|5|||
160969951|NCT04146896|581278912|FG001|Overall Study|Adverse Event|8|||
160969952|NCT04146896|581278911|FG000|Overall Study|Lack of Efficacy|3|||
160969953|NCT04146896|581278912|FG001|Overall Study|Lack of Efficacy|2|||
160969954|NCT04146896|581278911|FG000|Overall Study|Lost to Follow-up|0|||
160969955|NCT04146896|581278912|FG001|Overall Study|Lost to Follow-up|1|||
160969956|NCT04146896|581278911|FG000|Overall Study|Non-compliance|5|||
160969957|NCT04146896|581278912|FG001|Overall Study|Non-compliance|4|||
160969958|NCT04146896|581278911|FG000|Overall Study|Withdrawal by Subject|3|||
160969959|NCT04146896|581278912|FG001|Overall Study|Withdrawal by Subject|5|||
160969960|NCT04146896|581278911|FG000|Overall Study|Randomized in error|1|||
160969961|NCT04146896|581278912|FG001|Overall Study|Randomized in error|2|||
160969962|NCT03107377|581278913|FG000|Overall Study|Adverse Event|3|||
160969963|NCT03107377|581278914|FG001|Overall Study|Adverse Event|3|||
160969964|NCT03107377|581278913|FG000|Overall Study|Protocol Violation|9|||
160969965|NCT03107377|581278914|FG001|Overall Study|Protocol Violation|12|||
160969966|NCT03107377|581278913|FG000|Overall Study|Physician Decision|3|||
160969967|NCT03107377|581278914|FG001|Overall Study|Physician Decision|6|||
160969968|NCT03107377|581278913|FG000|Overall Study|Pregnancy|7|||
160969969|NCT03107377|581278914|FG001|Overall Study|Pregnancy|7|||
160969970|NCT03107377|581278913|FG000|Overall Study|Withdrawal by Subject|16|||
160969971|NCT03107377|581278914|FG001|Overall Study|Withdrawal by Subject|22|||
160969972|NCT03107377|581278913|FG000|Overall Study|Lost to Follow-up|37|||
160969973|NCT03107377|581278914|FG001|Overall Study|Lost to Follow-up|34|||
160969974|NCT03107377|581278913|FG000|Overall Study|Other reason not specified|16|||
160969975|NCT03107377|581278914|FG001|Overall Study|Other reason not specified|15|||
160969976|NCT01597505|581278915|FG000|Overall Study|Physician Decision|5|||
160969977|NCT01597505|581278916|FG001|Overall Study|Physician Decision|0|||
160969978|NCT01597505|581278915|FG000|Overall Study|Adverse Event|19|||
160969979|NCT01597505|581278916|FG001|Overall Study|Adverse Event|7|||
160969980|NCT01597505|581278915|FG000|Overall Study|Lost to Follow-up|4|||
161023871|NCT03058289|581477367|FG004|Overall Study|Clinical Deterioration|1|||
160969981|NCT01597505|581278916|FG001|Overall Study|Lost to Follow-up|2|||
160969982|NCT01597505|581278915|FG000|Overall Study|Withdrawal by Subject|10|||
160969983|NCT01597505|581278916|FG001|Overall Study|Withdrawal by Subject|18|||
160969984|NCT01597505|581278915|FG000|Overall Study|Other|5|||
160969985|NCT01597505|581278916|FG001|Overall Study|Other|6|||
160969986|NCT01597505|581278915|FG000|Overall Study|Missing|1|||
160969987|NCT01597505|581278916|FG001|Overall Study|Missing|0|||
160587681|NCT01767194|579869972|FG001|Overall Study|Criteria not met on time for next cycle|1|||
160587682|NCT00488618|579869974|FG000|Overall Study|Adverse Event|13|||
160587683|NCT00488618|579869975|FG001|Overall Study|Adverse Event|17|||
160969988|NCT02675465|581278918|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
160969989|NCT02675465|581278919|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
160969990|NCT02675465|581278920|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
160969991|NCT02675465|581278921|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
160969992|NCT02675465|581278922|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
160969993|NCT02675465|581278923|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
160969994|NCT02675465|581278918|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
160969995|NCT02675465|581278919|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
160969996|NCT02675465|581278920|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
160969997|NCT02675465|581278921|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
160969998|NCT02675465|581278922|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
160969999|NCT02675465|581278923|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
160970000|NCT02675465|581278918|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
160970001|NCT02675465|581278919|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
160970002|NCT02675465|581278920|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
160970003|NCT02675465|581278921|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
160970004|NCT02675465|581278922|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
160970005|NCT02675465|581278923|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
160970006|NCT02675465|581278918|FG000|Stage 4: Long Term Extension|Death|0|||
160970007|NCT02675465|581278919|FG001|Stage 4: Long Term Extension|Death|0|||
160970008|NCT02675465|581278920|FG002|Stage 4: Long Term Extension|Death|0|||
160970009|NCT02675465|581278921|FG003|Stage 4: Long Term Extension|Death|1|||
160970010|NCT02675465|581278922|FG004|Stage 4: Long Term Extension|Death|0|||
160970011|NCT02675465|581278923|FG005|Stage 4: Long Term Extension|Death|0|||
160970012|NCT00453102|581278924|FG000|Overall Study|Withdrawal by Subject|2|||
160970013|NCT05031078|581278925|FG000|Overall Study|Withdrawal by Subject|0|||
160970014|NCT05031078|581278926|FG001|Overall Study|Withdrawal by Subject|1|||
160970015|NCT05031078|581278927|FG002|Overall Study|Withdrawal by Subject|0|||
160970016|NCT03728972|581278928|FG000|Overall Study|Death|1|||
160970017|NCT03728972|581278929|FG001|Overall Study|Death|0|||
160970018|NCT03728972|581278928|FG000|Overall Study|Lack of Efficacy|1|||
160970019|NCT03728972|581278929|FG001|Overall Study|Lack of Efficacy|0|||
160970020|NCT03728972|581278928|FG000|Overall Study|Physician Decision|3|||
160970021|NCT03728972|581278929|FG001|Overall Study|Physician Decision|0|||
160970022|NCT03728972|581278928|FG000|Overall Study|Disease progression|4|||
160970023|NCT03728972|581278929|FG001|Overall Study|Disease progression|3|||
160970024|NCT01490125|581278934|FG000|Period I|Adverse Event|4|||
160970025|NCT01490125|581278935|FG001|Period I|Adverse Event|1|||
160970026|NCT01490125|581278936|FG002|Period I|Adverse Event|1|||
160970027|NCT01490125|581278937|FG003|Period I|Adverse Event|3|||
160970028|NCT01490125|581278938|FG004|Period I|Adverse Event|2|||
160970029|NCT01490125|581278939|FG005|Period I|Adverse Event|4|||
160970030|NCT01490125|581278934|FG000|Period I|Protocol Violation|1|||
160970031|NCT01490125|581278935|FG001|Period I|Protocol Violation|1|||
160970032|NCT01490125|581278936|FG002|Period I|Protocol Violation|1|||
160970033|NCT01490125|581278937|FG003|Period I|Protocol Violation|1|||
160970034|NCT01490125|581278938|FG004|Period I|Protocol Violation|0|||
160970035|NCT01490125|581278939|FG005|Period I|Protocol Violation|0|||
160970036|NCT01490125|581278934|FG000|Period I|Withdrawal by Subject|1|||
160970037|NCT01490125|581278935|FG001|Period I|Withdrawal by Subject|3|||
160970038|NCT01490125|581278936|FG002|Period I|Withdrawal by Subject|2|||
160970039|NCT01490125|581278937|FG003|Period I|Withdrawal by Subject|1|||
160970040|NCT01490125|581278938|FG004|Period I|Withdrawal by Subject|2|||
160970041|NCT01490125|581278939|FG005|Period I|Withdrawal by Subject|1|||
160970042|NCT01490125|581278934|FG000|Period II|Adverse Event|2|||
160970043|NCT01490125|581278935|FG001|Period II|Adverse Event|3|||
160970044|NCT01490125|581278936|FG002|Period II|Adverse Event|2|||
160970045|NCT01490125|581278937|FG003|Period II|Adverse Event|2|||
160970046|NCT01490125|581278938|FG004|Period II|Adverse Event|4|||
160587684|NCT00488618|579869974|FG000|Overall Study|Insufficient Therapeutic Response|18|||
160970047|NCT01490125|581278939|FG005|Period II|Adverse Event|2|||
160970048|NCT01490125|581278934|FG000|Period II|Protocol Violation|0|||
160970049|NCT01490125|581278935|FG001|Period II|Protocol Violation|0|||
160587685|NCT00488618|579869975|FG001|Overall Study|Insufficient Therapeutic Response|11|||
160970050|NCT01490125|581278936|FG002|Period II|Protocol Violation|1|||
160970051|NCT01490125|581278937|FG003|Period II|Protocol Violation|1|||
160460014|NCT02720068|579417505|FG004|Overall Study|Sponsor Decision|0|||
160970052|NCT01490125|581278938|FG004|Period II|Protocol Violation|0|||
160970053|NCT01490125|581278939|FG005|Period II|Protocol Violation|0|||
160970054|NCT01490125|581278934|FG000|Period II|Lost to Follow-up|0|||
160970055|NCT01490125|581278935|FG001|Period II|Lost to Follow-up|1|||
160970056|NCT01490125|581278936|FG002|Period II|Lost to Follow-up|0|||
160970057|NCT01490125|581278937|FG003|Period II|Lost to Follow-up|0|||
160970058|NCT01490125|581278938|FG004|Period II|Lost to Follow-up|0|||
160970059|NCT01490125|581278939|FG005|Period II|Lost to Follow-up|0|||
160970060|NCT01490125|581278934|FG000|Period II|Withdrawal by Subject|1|||
160970061|NCT01490125|581278935|FG001|Period II|Withdrawal by Subject|0|||
160970062|NCT01490125|581278936|FG002|Period II|Withdrawal by Subject|0|||
160970063|NCT01490125|581278937|FG003|Period II|Withdrawal by Subject|0|||
160970064|NCT01490125|581278938|FG004|Period II|Withdrawal by Subject|0|||
160970065|NCT01490125|581278939|FG005|Period II|Withdrawal by Subject|0|||
160970066|NCT01490125|581278934|FG000|Period III|Adverse Event|3|||
160970067|NCT01490125|581278935|FG001|Period III|Adverse Event|1|||
160970068|NCT01490125|581278936|FG002|Period III|Adverse Event|0|||
160970069|NCT01490125|581278937|FG003|Period III|Adverse Event|1|||
160970070|NCT01490125|581278938|FG004|Period III|Adverse Event|0|||
160970071|NCT01490125|581278939|FG005|Period III|Adverse Event|0|||
160970072|NCT01490125|581278934|FG000|Period III|Death|0|||
160970073|NCT01490125|581278935|FG001|Period III|Death|0|||
160970074|NCT01490125|581278936|FG002|Period III|Death|0|||
160970075|NCT01490125|581278937|FG003|Period III|Death|1|||
160970076|NCT01490125|581278938|FG004|Period III|Death|0|||
160970077|NCT01490125|581278939|FG005|Period III|Death|0|||
160970078|NCT01490125|581278934|FG000|Period III|Lack of Efficacy|0|||
160970079|NCT01490125|581278935|FG001|Period III|Lack of Efficacy|0|||
160970080|NCT01490125|581278936|FG002|Period III|Lack of Efficacy|0|||
160970081|NCT01490125|581278937|FG003|Period III|Lack of Efficacy|0|||
160970082|NCT01490125|581278938|FG004|Period III|Lack of Efficacy|1|||
160970083|NCT01490125|581278939|FG005|Period III|Lack of Efficacy|0|||
160970084|NCT01320943|581278940|FG000|Overall Study|Lost to Follow-up|1|||
160970085|NCT01320943|581278941|FG001|Overall Study|Lost to Follow-up|0|||
160970086|NCT01320943|581278940|FG000|Overall Study|Physician Decision|0|||
160970087|NCT01320943|581278941|FG001|Overall Study|Physician Decision|1|||
160970088|NCT01320943|581278940|FG000|Overall Study|Randomized but not Treated|0|||
160970089|NCT01320943|581278941|FG001|Overall Study|Randomized but not Treated|1|||
160970090|NCT00311155|581281225|FG000|Overall Study|Adverse Event|21|||
160970091|NCT00311155|581281225|FG000|Overall Study|Withdrawal by Subject|17|||
160970092|NCT00311155|581281225|FG000|Overall Study|Did not meet entry criteria|55|||
160970093|NCT00429494|581281228|FG000|Overall Study|Withdrawal by Subject|9|||
160970094|NCT00429494|581281228|FG000|Overall Study|Death|6|||
160970095|NCT03285295|581281243|FG000|Alinity s HBsAg|Protocol Violation|11|||
160970096|NCT03285295|581281244|FG001|Alinity s HBsAg|Protocol Violation|0|||
160970097|NCT03285295|581281245|FG002|Alinity s HBsAg|Protocol Violation|0|||
160970098|NCT03285295|581281246|FG003|Alinity s HBsAg|Protocol Violation|0|||
160970099|NCT03285295|581281247|FG004|Alinity s HBsAg|Protocol Violation|0|||
160970100|NCT03285295|581281243|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
160970101|NCT03285295|581281244|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
160970102|NCT03285295|581281245|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
160970103|NCT03285295|581281246|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
160970104|NCT03285295|581281247|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
160970105|NCT03285295|581281243|FG000|Alinity s HBsAg|No Results Generated|74|||
160970106|NCT03285295|581281244|FG001|Alinity s HBsAg|No Results Generated|6|||
160970107|NCT03285295|581281245|FG002|Alinity s HBsAg|No Results Generated|0|||
160970108|NCT03285295|581281246|FG003|Alinity s HBsAg|No Results Generated|0|||
160970109|NCT03285295|581281247|FG004|Alinity s HBsAg|No Results Generated|0|||
160970110|NCT03285295|581281243|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
160970111|NCT03285295|581281244|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
160970112|NCT03285295|581281245|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
160970113|NCT03285295|581281246|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
160970114|NCT03285295|581281247|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
160970115|NCT03285295|581281243|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
160970116|NCT03285295|581281244|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
160970117|NCT03285295|581281245|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
160970118|NCT03285295|581281246|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
160970119|NCT03285295|581281247|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
160970120|NCT03285295|581281243|FG000|Alinity s HTLV I/II|No Results Generated|70|||
160970121|NCT03285295|581281244|FG001|Alinity s HTLV I/II|No Results Generated|0|||
160970122|NCT03285295|581281245|FG002|Alinity s HTLV I/II|No Results Generated|0|||
160970123|NCT03285295|581281246|FG003|Alinity s HTLV I/II|No Results Generated|0|||
160970124|NCT03285295|581281247|FG004|Alinity s HTLV I/II|No Results Generated|0|||
160970125|NCT03285295|581281243|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
160970126|NCT03285295|581281244|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
160970127|NCT03285295|581281245|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
160970128|NCT03285295|581281246|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
160970129|NCT03285295|581281247|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
160970130|NCT03285295|581281243|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
160970131|NCT03285295|581281244|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
160970132|NCT03285295|581281245|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
160970133|NCT03285295|581281246|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
160970134|NCT03285295|581281247|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
160970135|NCT03285295|581281243|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
160970136|NCT03285295|581281244|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
160970137|NCT03285295|581281245|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
160970138|NCT03285295|581281246|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
160970139|NCT03285295|581281247|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
160970140|NCT03285295|581281243|FG000|Alinity s Anti-HCV|No Results Generated|71|||
160970141|NCT03285295|581281244|FG001|Alinity s Anti-HCV|No Results Generated|0|||
160970142|NCT03285295|581281245|FG002|Alinity s Anti-HCV|No Results Generated|0|||
160970143|NCT03285295|581281246|FG003|Alinity s Anti-HCV|No Results Generated|0|||
160970144|NCT03285295|581281247|FG004|Alinity s Anti-HCV|No Results Generated|0|||
160970145|NCT03285295|581281243|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
160970146|NCT03285295|581281244|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
160970147|NCT03285295|581281245|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
160970148|NCT03285295|581281246|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
160970149|NCT03285295|581281247|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
160970150|NCT03285295|581281243|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
160970151|NCT03285295|581281244|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
160970152|NCT03285295|581281245|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
160970153|NCT03285295|581281246|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
160970154|NCT03285295|581281247|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
160970155|NCT03285295|581281243|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
160970156|NCT03285295|581281244|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
160970157|NCT03285295|581281245|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
160970158|NCT03285295|581281246|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
160970159|NCT03285295|581281247|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
160970160|NCT03285295|581281243|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
160970161|NCT03285295|581281244|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
160970162|NCT03285295|581281245|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
160970163|NCT03285295|581281246|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
160970164|NCT03285295|581281247|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
160970165|NCT03285295|581281243|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
160970166|NCT03285295|581281244|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
160970167|NCT03285295|581281245|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
160970168|NCT03285295|581281246|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
160970169|NCT03285295|581281247|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
160970170|NCT03285295|581281243|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
160970171|NCT03285295|581281244|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
160970172|NCT03285295|581281245|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
160970173|NCT03285295|581281246|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
160970174|NCT03285295|581281247|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
160970175|NCT03285295|581281243|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
160970176|NCT03285295|581281244|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
160970177|NCT03285295|581281245|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
160970178|NCT03285295|581281246|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
160970179|NCT03285295|581281247|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
160970180|NCT03285295|581281243|FG000|Alinity s Anti-HBc|No Results Generated|70|||
160970181|NCT03285295|581281244|FG001|Alinity s Anti-HBc|No Results Generated|0|||
160970182|NCT03285295|581281245|FG002|Alinity s Anti-HBc|No Results Generated|0|||
160970183|NCT03285295|581281246|FG003|Alinity s Anti-HBc|No Results Generated|0|||
160970184|NCT03285295|581281247|FG004|Alinity s Anti-HBc|No Results Generated|0|||
160970185|NCT03285295|581281243|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
160970186|NCT03285295|581281244|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
160970187|NCT03285295|581281245|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
160970188|NCT03285295|581281246|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
160970189|NCT03285295|581281247|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
160970190|NCT03285295|581281243|FG000|Alinity s Chagas|Protocol Violation|76|||
160970191|NCT03285295|581281244|FG001|Alinity s Chagas|Protocol Violation|0|||
160970192|NCT03285295|581281245|FG002|Alinity s Chagas|Protocol Violation|0|||
160970193|NCT03285295|581281246|FG003|Alinity s Chagas|Protocol Violation|0|||
160970194|NCT03285295|581281247|FG004|Alinity s Chagas|Protocol Violation|0|||
160970195|NCT03285295|581281243|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
161023872|NCT03058289|581477368|FG005|Overall Study|Clinical Deterioration|1|||
160587686|NCT00488618|579869974|FG000|Overall Study|Protocol Violation|0|||
160587687|NCT00488618|579869975|FG001|Overall Study|Protocol Violation|2|||
160587688|NCT00488618|579869974|FG000|Overall Study|Withdrawal of Consent|15|||
160587689|NCT00488618|579869975|FG001|Overall Study|Withdrawal of Consent|13|||
160970196|NCT03285295|581281244|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
160970197|NCT03285295|581281245|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
160970198|NCT03285295|581281246|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
160970199|NCT03285295|581281247|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
160970200|NCT03285295|581281243|FG000|Alinity s Chagas|No Results Generated|105|||
160587690|NCT00488618|579869974|FG000|Overall Study|Lost to Follow-up|1|||
160970201|NCT03285295|581281244|FG001|Alinity s Chagas|No Results Generated|0|||
160970202|NCT03285295|581281245|FG002|Alinity s Chagas|No Results Generated|0|||
160970203|NCT03285295|581281246|FG003|Alinity s Chagas|No Results Generated|0|||
160970204|NCT03285295|581281247|FG004|Alinity s Chagas|No Results Generated|0|||
160970205|NCT03285295|581281243|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
160970206|NCT03285295|581281244|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
160970207|NCT03285295|581281245|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
160970208|NCT03285295|581281246|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
160970209|NCT03285295|581281247|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
160970210|NCT02200939|581281251|FG000|Overall Study|Participant withdrew consent|0|||
160970211|NCT02200939|581281252|FG001|Overall Study|Participant withdrew consent|1|||
160970212|NCT02200939|581281251|FG000|Overall Study|Lost to Follow-up|2|||
160970213|NCT02200939|581281252|FG001|Overall Study|Lost to Follow-up|9|||
160970214|NCT02200939|581281251|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
160970215|NCT02200939|581281252|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
160970216|NCT04567693|581281253|FG000|Overall Study|Death|0|||
160970217|NCT04567693|581281254|FG001|Overall Study|Death|0|||
160970218|NCT04567693|581281255|FG002|Overall Study|Death|2|||
160970219|NCT04567693|581281253|FG000|Overall Study|Lost to Follow-up|1|||
160970220|NCT04567693|581281254|FG001|Overall Study|Lost to Follow-up|0|||
160970221|NCT04567693|581281255|FG002|Overall Study|Lost to Follow-up|2|||
160970222|NCT04567693|581281253|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
160970223|NCT04567693|581281254|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
160970224|NCT04567693|581281255|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
160970225|NCT04867785|581281260|FG000|Overall Study|Adverse Event|1|||
160970226|NCT04867785|581281261|FG001|Overall Study|Adverse Event|0|||
160970227|NCT04867785|581281262|FG002|Overall Study|Adverse Event|1|||
160970228|NCT04867785|581281263|FG003|Overall Study|Adverse Event|0|||
160970229|NCT04867785|581281264|FG004|Overall Study|Adverse Event|0|||
160970230|NCT04867785|581281265|FG005|Overall Study|Adverse Event|0|||
160970231|NCT04867785|581281266|FG006|Overall Study|Adverse Event|0|||
160970232|NCT04867785|581281267|FG007|Overall Study|Adverse Event|2|||
160970233|NCT04867785|581281260|FG000|Overall Study|Lost to Follow-up|4|||
160970234|NCT04867785|581281261|FG001|Overall Study|Lost to Follow-up|4|||
160970235|NCT04867785|581281262|FG002|Overall Study|Lost to Follow-up|3|||
160970236|NCT04867785|581281263|FG003|Overall Study|Lost to Follow-up|2|||
160970237|NCT04867785|581281264|FG004|Overall Study|Lost to Follow-up|0|||
160970238|NCT04867785|581281265|FG005|Overall Study|Lost to Follow-up|1|||
160970239|NCT04867785|581281266|FG006|Overall Study|Lost to Follow-up|0|||
160970240|NCT04867785|581281267|FG007|Overall Study|Lost to Follow-up|1|||
160970241|NCT04867785|581281260|FG000|Overall Study|Withdrawal by Subject|6|||
160970242|NCT04867785|581281261|FG001|Overall Study|Withdrawal by Subject|2|||
160970243|NCT04867785|581281262|FG002|Overall Study|Withdrawal by Subject|2|||
160970244|NCT04867785|581281263|FG003|Overall Study|Withdrawal by Subject|1|||
160970245|NCT04867785|581281264|FG004|Overall Study|Withdrawal by Subject|2|||
160970246|NCT04867785|581281265|FG005|Overall Study|Withdrawal by Subject|0|||
160460015|NCT02720068|579417506|FG005|Overall Study|Sponsor Decision|0|||
160460016|NCT02720068|579417507|FG006|Overall Study|Sponsor Decision|0|||
160460017|NCT02720068|579417508|FG007|Overall Study|Sponsor Decision|0|||
160460018|NCT02720068|579417509|FG008|Overall Study|Sponsor Decision|0|||
160460019|NCT02720068|579417510|FG009|Overall Study|Sponsor Decision|0|||
160460020|NCT02720068|579417511|FG010|Overall Study|Sponsor Decision|0|||
160460021|NCT02720068|579417512|FG011|Overall Study|Sponsor Decision|6|||
160460022|NCT02720068|579417513|FG012|Overall Study|Sponsor Decision|3|||
160460023|NCT02720068|579417514|FG013|Overall Study|Sponsor Decision|2|||
160460024|NCT02720068|579417515|FG014|Overall Study|Sponsor Decision|4|||
160460025|NCT02720068|579417516|FG015|Overall Study|Sponsor Decision|4|||
160460026|NCT02720068|579417517|FG016|Overall Study|Sponsor Decision|0|||
160460027|NCT02720068|579417518|FG017|Overall Study|Sponsor Decision|8|||
160460028|NCT02720068|579417501|FG000|Overall Study|Withdrawal by Subject|0|||
160460029|NCT02720068|579417502|FG001|Overall Study|Withdrawal by Subject|0|||
160460030|NCT02720068|579417503|FG002|Overall Study|Withdrawal by Subject|0|||
160460031|NCT02720068|579417504|FG003|Overall Study|Withdrawal by Subject|0|||
160460032|NCT02720068|579417505|FG004|Overall Study|Withdrawal by Subject|0|||
160460033|NCT02720068|579417506|FG005|Overall Study|Withdrawal by Subject|0|||
160460034|NCT02720068|579417507|FG006|Overall Study|Withdrawal by Subject|0|||
160970247|NCT04867785|581281266|FG006|Overall Study|Withdrawal by Subject|2|||
160970248|NCT04867785|581281267|FG007|Overall Study|Withdrawal by Subject|5|||
160970249|NCT04867785|581281260|FG000|Overall Study|Physician Decision|0|||
160970250|NCT04867785|581281261|FG001|Overall Study|Physician Decision|0|||
160970251|NCT04867785|581281262|FG002|Overall Study|Physician Decision|0|||
160460035|NCT02720068|579417508|FG007|Overall Study|Withdrawal by Subject|0|||
160460036|NCT02720068|579417509|FG008|Overall Study|Withdrawal by Subject|0|||
160460037|NCT02720068|579417510|FG009|Overall Study|Withdrawal by Subject|1|||
160460038|NCT02720068|579417511|FG010|Overall Study|Withdrawal by Subject|0|||
160970252|NCT04867785|581281263|FG003|Overall Study|Physician Decision|0|||
160970253|NCT04867785|581281264|FG004|Overall Study|Physician Decision|0|||
160970254|NCT04867785|581281265|FG005|Overall Study|Physician Decision|0|||
160587691|NCT00488618|579869975|FG001|Overall Study|Lost to Follow-up|0|||
160587692|NCT00992446|579869976|FG000|Overall Study|Disease Progression|1|||
160587693|NCT00992446|579869976|FG000|Overall Study|Withdrawal by Subject|2|||
160970255|NCT04867785|581281266|FG006|Overall Study|Physician Decision|0|||
160970256|NCT04867785|581281267|FG007|Overall Study|Physician Decision|1|||
160970257|NCT04867785|581281260|FG000|Overall Study|Inadvertent Enrollment|0|||
160970258|NCT04867785|581281261|FG001|Overall Study|Inadvertent Enrollment|0|||
160970259|NCT04867785|581281262|FG002|Overall Study|Inadvertent Enrollment|0|||
160970260|NCT04867785|581281263|FG003|Overall Study|Inadvertent Enrollment|1|||
160970261|NCT04867785|581281264|FG004|Overall Study|Inadvertent Enrollment|1|||
160970262|NCT04867785|581281265|FG005|Overall Study|Inadvertent Enrollment|0|||
160970263|NCT04867785|581281266|FG006|Overall Study|Inadvertent Enrollment|0|||
160970264|NCT04867785|581281267|FG007|Overall Study|Inadvertent Enrollment|1|||
160970265|NCT04867785|581281260|FG000|Overall Study|Eligibility Criteria Not Met|0|||
160970266|NCT04867785|581281261|FG001|Overall Study|Eligibility Criteria Not Met|0|||
160970267|NCT04867785|581281262|FG002|Overall Study|Eligibility Criteria Not Met|0|||
160970268|NCT04867785|581281263|FG003|Overall Study|Eligibility Criteria Not Met|0|||
160970269|NCT04867785|581281264|FG004|Overall Study|Eligibility Criteria Not Met|0|||
160970270|NCT04867785|581281265|FG005|Overall Study|Eligibility Criteria Not Met|0|||
160970271|NCT04867785|581281266|FG006|Overall Study|Eligibility Criteria Not Met|0|||
160970272|NCT04867785|581281267|FG007|Overall Study|Eligibility Criteria Not Met|1|||
160970273|NCT00553202|581281280|FG000|Overall Study|Death|16|||
160970274|NCT00553202|581281280|FG000|Overall Study|Lost to Follow-up|1|||
160970275|NCT00553202|581281280|FG000|Overall Study|Physician Decision|28|||
160970276|NCT00553202|581281280|FG000|Overall Study|Withdrawal by Subject|1|||
160970277|NCT00553202|581281280|FG000|Overall Study|No donor identified|16|||
160970278|NCT00553202|581281280|FG000|Overall Study|Fails to meet organ function|6|||
160970279|NCT00369681|581281281|FG000|Overall Study|Death|1|||
160970280|NCT03239873|581281284|FG000|Overall Study|Lost to Follow-up|15|||
160970281|NCT03239873|581281285|FG001|Overall Study|Lost to Follow-up|16|||
160970282|NCT03239873|581281284|FG000|Overall Study|Physician Decision|1|||
160970283|NCT03239873|581281285|FG001|Overall Study|Physician Decision|0|||
160970284|NCT03239873|581281284|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
160970285|NCT03239873|581281285|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
160970286|NCT03239873|581281284|FG000|Overall Study|Withdrawal by Subject|2|||
160970287|NCT03239873|581281285|FG001|Overall Study|Withdrawal by Subject|0|||
160970288|NCT03239873|581281284|FG000|Overall Study|Contraindication to study medication|1|||
160970289|NCT03239873|581281285|FG001|Overall Study|Contraindication to study medication|0|||
160970290|NCT03239873|581281284|FG000|Overall Study|Protocol Violation|1|||
160970291|NCT03239873|581281285|FG001|Overall Study|Protocol Violation|0|||
160970292|NCT01250119|581281294|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
160970293|NCT01250119|581281295|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
160970294|NCT01250119|581281294|FG000|Diagnostic Phase|Participants Not Tested|44|||
160970295|NCT01250119|581281295|FG001|Diagnostic Phase|Participants Not Tested|0|||
160970296|NCT01250119|581281294|FG000|Treatment Phase|Progressive Disease|0|||
160970297|NCT01250119|581281295|FG001|Treatment Phase|Progressive Disease|32|||
160970298|NCT01250119|581281294|FG000|Treatment Phase|Death|0|||
160970299|NCT01250119|581281295|FG001|Treatment Phase|Death|2|||
160970300|NCT01250119|581281294|FG000|Treatment Phase|Withdrawal by Subject|0|||
160970301|NCT01250119|581281295|FG001|Treatment Phase|Withdrawal by Subject|1|||
160970302|NCT01250119|581281294|FG000|Treatment Phase|Adverse Event|0|||
160970303|NCT01250119|581281295|FG001|Treatment Phase|Adverse Event|2|||
160970304|NCT01250119|581281294|FG000|Treatment Phase|Unknown reason|0|||
160970305|NCT01250119|581281295|FG001|Treatment Phase|Unknown reason|4|||
160970306|NCT02045433|581281301|FG000|Overall Study|Withdrawal by Subject|1|||
160970307|NCT01559454|581281302|FG000|Overall Study|Lost to Follow-up|3|||
160970308|NCT01559454|581281303|FG001|Overall Study|Lost to Follow-up|2|||
160970309|NCT01559454|581281302|FG000|Overall Study|Withdrawal by Subject|0|||
160970310|NCT01559454|581281303|FG001|Overall Study|Withdrawal by Subject|1|||
160970311|NCT01559454|581281302|FG000|Overall Study|Physician Decision|0|||
160970312|NCT01559454|581281303|FG001|Overall Study|Physician Decision|1|||
160587694|NCT00992446|579869976|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
160587695|NCT00605722|579871449|FG000|Overall Study|Adverse Event|6|||
160970313|NCT01559454|581281302|FG000|Overall Study|Protocol Violation|0|||
160587696|NCT00605722|579871449|FG000|Overall Study|Insufficient therapeutic response|44|||
160970314|NCT01559454|581281303|FG001|Overall Study|Protocol Violation|1|||
160587697|NCT00605722|579871449|FG000|Overall Study|Failure to return|1|||
160970315|NCT01559454|581281302|FG000|Overall Study|Lack of Efficacy|0|||
160970316|NCT01559454|581281303|FG001|Overall Study|Lack of Efficacy|1|||
160970317|NCT00462670|581281308|FG000|Overall Study|Adverse Event|3|||
160970318|NCT00462670|581281309|FG001|Overall Study|Adverse Event|5|||
160970319|NCT00462670|581281308|FG000|Overall Study|Lack of Efficacy|1|||
160970320|NCT00462670|581281309|FG001|Overall Study|Lack of Efficacy|0|||
160970321|NCT00462670|581281308|FG000|Overall Study|Protocol Violation|1|||
160970322|NCT00462670|581281309|FG001|Overall Study|Protocol Violation|0|||
160587698|NCT00333619|579871456|FG000|Overall Study|Death|12|||
160970323|NCT00462670|581281308|FG000|Overall Study|Resolution of signs and symptoms|0|||
160970324|NCT00462670|581281309|FG001|Overall Study|Resolution of signs and symptoms|2|||
160587699|NCT00333619|579871457|FG001|Overall Study|Death|6|||
160587700|NCT00333619|579871456|FG000|Overall Study|Withdrawal by Subject|6|||
160970325|NCT00482274|581281312|FG000|Overall Study|Adverse Event|1|||
160970326|NCT02396537|581281313|FG000|Overall Study|Protocol Violation|0|||
160970327|NCT02396537|581281314|FG001|Overall Study|Protocol Violation|1|||
160970328|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
160970329|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
160970330|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Adverse Event|2|||
160970331|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Adverse Event|5|||
160970332|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
160970333|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
160970334|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
160970335|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
160970336|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Randomized by error|0|||
160970337|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Randomized by error|5|||
160970338|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
160970339|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
160970340|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
160970341|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
160970342|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Change of residence location|0|||
160970343|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Change of residence location|1|||
160970344|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
160970345|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
160970346|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
160970347|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
160970348|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
160970349|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
160970350|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
160970351|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
160970352|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
160970353|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
160970354|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Study site closure|1|||
160970355|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Study site closure|0|||
160970356|NCT00787319|581281317|FG000|Overall Study|Lost to Follow-up|2|||
160970357|NCT00787319|581281317|FG000|Overall Study|Withdrawal by Subject|15|||
160970358|NCT00787319|581281317|FG000|Overall Study|Adverse Event|3|||
160970359|NCT00787319|581281317|FG000|Overall Study|Objective progression or relapse|30|||
160970360|NCT00787319|581281317|FG000|Overall Study|Lack of Efficacy|1|||
160970361|NCT00787319|581281317|FG000|Overall Study|Budget exhausted/exceeded|1|||
160970362|NCT00787319|581281317|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
160970363|NCT00787319|581281317|FG000|Overall Study|No health insurance reimbursement|2|||
160970364|NCT00787319|581281317|FG000|Overall Study|Stabilized disease findings|3|||
160970365|NCT00787319|581281317|FG000|Overall Study|Inactive disease|5|||
160970366|NCT04522180|581281325|FG000|Overall Study|Investigator judgement|3|||
160970367|NCT04522180|581281326|FG001|Overall Study|Investigator judgement|4|||
160970368|NCT04522180|581281325|FG000|Overall Study|Voluntary withdrawal|1|||
160970369|NCT04522180|581281326|FG001|Overall Study|Voluntary withdrawal|0|||
160970370|NCT04522180|581281325|FG000|Overall Study|Pregnancy|0|||
160970371|NCT04522180|581281326|FG001|Overall Study|Pregnancy|1|||
160970372|NCT04522180|581281325|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
160970373|NCT04522180|581281326|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
160970374|NCT04522180|581281325|FG000|Overall Study|Reason not specified|8|||
160970375|NCT04522180|581281326|FG001|Overall Study|Reason not specified|5|||
160970376|NCT05807919|581281327|FG000|Overall Study|Received antibiotics - excluded|0|||
160970377|NCT05807919|581281328|FG001|Overall Study|Received antibiotics - excluded|1|||
160970378|NCT05807919|581281327|FG000|Overall Study|Withdrawal by Subject|0|||
160970379|NCT05807919|581281328|FG001|Overall Study|Withdrawal by Subject|3|||
160970380|NCT05807919|581281327|FG000|Overall Study|Adverse Event|1|||
160970381|NCT05807919|581281328|FG001|Overall Study|Adverse Event|1|||
160970382|NCT00747123|581281329|FG000|Overall Study|Investigator's request|0|||
160970383|NCT00747123|581281330|FG001|Overall Study|Investigator's request|0|||
160970384|NCT00747123|581281331|FG002|Overall Study|Investigator's request|1|||
160970385|NCT00747123|581281332|FG003|Overall Study|Investigator's request|0|||
160970386|NCT00747123|581281329|FG000|Overall Study|Withdrew consent|0|||
160970387|NCT00747123|581281330|FG001|Overall Study|Withdrew consent|1|||
160970388|NCT00747123|581281331|FG002|Overall Study|Withdrew consent|0|||
160970389|NCT00747123|581281332|FG003|Overall Study|Withdrew consent|0|||
160587701|NCT00333619|579871457|FG001|Overall Study|Withdrawal by Subject|1|||
160587702|NCT00333619|579871456|FG000|Overall Study|Lost to Follow-up|3|||
160587703|NCT00333619|579871457|FG001|Overall Study|Lost to Follow-up|3|||
160587704|NCT01120379|579871466|FG000|One Year Timepoint|Withdrawal by Subject|41|||
160587705|NCT01120379|579871466|FG000|One Year Timepoint|Lost to Follow-up|115|||
160587706|NCT01120379|579871466|FG000|One Year Timepoint|Death|108|||
160587707|NCT01120379|579871466|FG000|One Year Timepoint|Physician Decision|9|||
160587708|NCT01120379|579871466|FG000|One Year Timepoint|Any other reason for early termination|5|||
160587709|NCT01120379|579871466|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
160587710|NCT01120379|579871466|FG000|Two Year Timepoint|Lost to Follow-up|87|||
160587711|NCT01120379|579871466|FG000|Two Year Timepoint|Death|123|||
160587712|NCT01120379|579871466|FG000|Two Year Timepoint|Physician Decision|12|||
160970390|NCT00747123|581281329|FG000|Overall Study|Adverse Event|0|||
160970391|NCT00747123|581281330|FG001|Overall Study|Adverse Event|1|||
160970392|NCT00747123|581281331|FG002|Overall Study|Adverse Event|0|||
160970393|NCT00747123|581281332|FG003|Overall Study|Adverse Event|1|||
160970394|NCT02277743|581281343|FG000|Overall Study|Protocol Violation|1|||
160970395|NCT02277743|581281344|FG001|Overall Study|Protocol Violation|1|||
160970396|NCT02277743|581281345|FG002|Overall Study|Protocol Violation|1|||
160970397|NCT02277743|581281343|FG000|Overall Study|Adverse Event|10|||
160970398|NCT02277743|581281344|FG001|Overall Study|Adverse Event|6|||
160970399|NCT02277743|581281345|FG002|Overall Study|Adverse Event|6|||
160970400|NCT02277743|581281343|FG000|Overall Study|Lack of Efficacy|11|||
160970401|NCT02277743|581281344|FG001|Overall Study|Lack of Efficacy|4|||
160970402|NCT02277743|581281345|FG002|Overall Study|Lack of Efficacy|3|||
160970403|NCT02277743|581281343|FG000|Overall Study|Other than specified above|18|||
160970404|NCT02277743|581281344|FG001|Overall Study|Other than specified above|5|||
160970405|NCT02277743|581281345|FG002|Overall Study|Other than specified above|16|||
160970406|NCT01224158|581281346|FG000|Overall Study|Withdrawal by Subject|1|||
160970407|NCT01224158|581281347|FG001|Overall Study|Withdrawal by Subject|0|||
160970408|NCT03976466|581281350|FG000|Overall Study|Lost to Follow-up|1|||
160970409|NCT03976466|581281351|FG001|Overall Study|Lost to Follow-up|3|||
160970410|NCT02055157|581281352|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
160970411|NCT02055157|581281353|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
160970412|NCT02055157|581281354|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
160970413|NCT02055157|581281355|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
160970414|NCT02055157|581281352|FG000|Initial 6 Months|Adverse Event|0|||
160970415|NCT02055157|581281353|FG001|Initial 6 Months|Adverse Event|0|||
160970416|NCT02055157|581281354|FG002|Initial 6 Months|Adverse Event|0|||
160970417|NCT02055157|581281355|FG003|Initial 6 Months|Adverse Event|1|||
160970418|NCT02055157|581281352|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
160587713|NCT01120379|579871466|FG000|Two Year Timepoint|Any other reason for early termination|4|||
160587714|NCT01120379|579871466|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
160587715|NCT01120379|579871466|FG000|Three Year Timepoint|Lost to Follow-up|43|||
160587716|NCT01120379|579871466|FG000|Three Year Timepoint|Death|120|||
160587717|NCT01120379|579871466|FG000|Three Year Timepoint|Physician Decision|9|||
160587718|NCT01120379|579871466|FG000|Three Year Timepoint|Any other reason for early termination|17|||
160587719|NCT01120379|579871466|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
160587720|NCT01120379|579871466|FG000|Four Year Timepoint|Lost to Follow-up|10|||
160587721|NCT01120379|579871466|FG000|Four Year Timepoint|Death|131|||
160587722|NCT01120379|579871466|FG000|Four Year Timepoint|Physician Decision|5|||
160587723|NCT01120379|579871466|FG000|Four Year Timepoint|Any other reason for early termination|217|||
160587724|NCT03162055|579871467|FG000|Overall Study|Adverse Event|6|||
160587725|NCT03162055|579871468|FG001|Overall Study|Adverse Event|5|||
160587726|NCT03162055|579871467|FG000|Overall Study|Death|3|||
160587727|NCT03162055|579871468|FG001|Overall Study|Death|3|||
160587728|NCT03162055|579871467|FG000|Overall Study|Lost to Follow-up|0|||
160587729|NCT03162055|579871468|FG001|Overall Study|Lost to Follow-up|1|||
160587730|NCT03162055|579871467|FG000|Overall Study|Study-specific withdrawal criteria|22|||
160587731|NCT03162055|579871468|FG001|Overall Study|Study-specific withdrawal criteria|14|||
160970419|NCT02055157|581281353|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
160587732|NCT03162055|579871467|FG000|Overall Study|Withdrawal by Subject|17|||
160587733|NCT03162055|579871468|FG001|Overall Study|Withdrawal by Subject|2|||
160587734|NCT03162055|579871467|FG000|Overall Study|Did not receive treatment|2|||
160970420|NCT02055157|581281354|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
160970421|NCT02055157|581281355|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
160970422|NCT02055157|581281352|FG000|18-month Extension|Investigator decision|0|||
160970423|NCT02055157|581281353|FG001|18-month Extension|Investigator decision|1|||
160587735|NCT03162055|579871468|FG001|Overall Study|Did not receive treatment|0|||
160587736|NCT03162055|579871467|FG000|Overall Study|Incorrect randomization|4|||
160970424|NCT02055157|581281354|FG002|18-month Extension|Investigator decision|0|||
160970425|NCT02055157|581281355|FG003|18-month Extension|Investigator decision|0|||
160970426|NCT02055157|581281352|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
160970427|NCT02055157|581281353|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
160587737|NCT03162055|579871468|FG001|Overall Study|Incorrect randomization|3|||
160587738|NCT03162055|579871467|FG000|Overall Study|Other|8|||
160587739|NCT03162055|579871468|FG001|Overall Study|Other|15|||
160970428|NCT02055157|581281354|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
160970429|NCT02055157|581281355|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
160970430|NCT02034708|581281356|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
160970431|NCT02034708|581281357|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
160970432|NCT02034708|581281356|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
160970433|NCT02034708|581281357|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
160970434|NCT02034708|581281356|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
160970435|NCT02034708|581281357|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
160970436|NCT02034708|581281356|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
160970437|NCT02034708|581281357|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
160970438|NCT00733499|581281360|FG000|Pre-operative|Protocol Violation|0|||
160970439|NCT00733499|581281361|FG001|Pre-operative|Protocol Violation|1|||
160970440|NCT00733499|581281360|FG000|3 Months Follow-up|Death|1|||
160970441|NCT00733499|581281361|FG001|3 Months Follow-up|Death|2|||
160970442|NCT00733499|581281360|FG000|6 Months Follow-up|Death|0|||
160970443|NCT00733499|581281361|FG001|6 Months Follow-up|Death|2|||
160970444|NCT00733499|581281360|FG000|6 Months Follow-up|Adverse Event|0|||
160970445|NCT00733499|581281361|FG001|6 Months Follow-up|Adverse Event|1|||
160970446|NCT00733499|581281360|FG000|12 Months Follow-up|Death|2|||
160970447|NCT00733499|581281361|FG001|12 Months Follow-up|Death|1|||
160970448|NCT00733499|581281360|FG000|24 Months Follow-up|Death|0|||
160970449|NCT00733499|581281361|FG001|24 Months Follow-up|Death|1|||
160970450|NCT00733499|581281360|FG000|5 Year Followup|Adverse Event|2|||
160970451|NCT00733499|581281361|FG001|5 Year Followup|Adverse Event|2|||
160970452|NCT00733499|581281360|FG000|5 Year Followup|Non device related AE|0|||
160970453|NCT00733499|581281361|FG001|5 Year Followup|Non device related AE|1|||
160970454|NCT00733499|581281360|FG000|5 Year Followup|Revision of Study Implant|0|||
160970455|NCT00733499|581281361|FG001|5 Year Followup|Revision of Study Implant|1|||
160970456|NCT00733499|581281360|FG000|5 Year Followup|Lost to Follow-up|2|||
160970457|NCT00733499|581281361|FG001|5 Year Followup|Lost to Follow-up|0|||
160970458|NCT00733499|581281360|FG000|5 Year Followup|Death|13|||
160970459|NCT00733499|581281361|FG001|5 Year Followup|Death|19|||
160970460|NCT00733499|581281360|FG000|5 Year Followup|missing, unable to locate|0|||
160970461|NCT00733499|581281361|FG001|5 Year Followup|missing, unable to locate|1|||
160970462|NCT00733499|581281360|FG000|5 Year Followup|Withdrawal by Subject|4|||
160970463|NCT00733499|581281361|FG001|5 Year Followup|Withdrawal by Subject|1|||
160970464|NCT00733499|581281360|FG000|10 Year Followup|Death|9|||
160970465|NCT00733499|581281361|FG001|10 Year Followup|Death|7|||
160970466|NCT00733499|581281360|FG000|10 Year Followup|Adverse Event|3|||
160970467|NCT00733499|581281361|FG001|10 Year Followup|Adverse Event|3|||
160970468|NCT00733499|581281360|FG000|10 Year Followup|Lost to Follow-up|3|||
160970469|NCT00733499|581281361|FG001|10 Year Followup|Lost to Follow-up|2|||
160970470|NCT00733499|581281360|FG000|10 Year Followup|Withdrawal by Subject|5|||
160970471|NCT00733499|581281361|FG001|10 Year Followup|Withdrawal by Subject|5|||
160970472|NCT00733499|581281360|FG000|10 Year Followup|missing, unable to locate|0|||
160970473|NCT00733499|581281361|FG001|10 Year Followup|missing, unable to locate|2|||
160970474|NCT02010632|581281365|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
160970475|NCT02010632|581281366|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
160970476|NCT02404389|581281367|FG000|Overall Study|Adverse Event|1|||
160970477|NCT02404389|581281368|FG001|Overall Study|Adverse Event|0|||
160970478|NCT02404389|581281369|FG002|Overall Study|Adverse Event|1|||
160970479|NCT02404389|581281370|FG003|Overall Study|Adverse Event|0|||
160970480|NCT02404389|581281371|FG004|Overall Study|Adverse Event|2|||
160970481|NCT02404389|581281367|FG000|Overall Study|Subject/guardian decision|1|||
160970482|NCT02404389|581281368|FG001|Overall Study|Subject/guardian decision|0|||
160970483|NCT02404389|581281369|FG002|Overall Study|Subject/guardian decision|0|||
160970484|NCT02404389|581281370|FG003|Overall Study|Subject/guardian decision|1|||
160970485|NCT02404389|581281371|FG004|Overall Study|Subject/guardian decision|1|||
160970486|NCT05076149|581281377|FG000|Overall Study|Adverse Event|3|||
160970487|NCT05076149|581281378|FG001|Overall Study|Adverse Event|9|||
160970488|NCT05076149|581281377|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
160970489|NCT05076149|581281378|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
160970490|NCT05076149|581281377|FG000|Overall Study|Lost to Follow-up|0|||
160970491|NCT05076149|581281378|FG001|Overall Study|Lost to Follow-up|1|||
160970492|NCT05076149|581281377|FG000|Overall Study|Commercial drug is available for participant|0|||
160970493|NCT05076149|581281378|FG001|Overall Study|Commercial drug is available for participant|1|||
160970494|NCT05076149|581281377|FG000|Overall Study|Other non compliance|1|||
160970495|NCT05076149|581281378|FG001|Overall Study|Other non compliance|1|||
160970496|NCT05076149|581281377|FG000|Overall Study|Physician Decision|0|||
160970497|NCT05076149|581281378|FG001|Overall Study|Physician Decision|1|||
160970498|NCT05076149|581281377|FG000|Overall Study|Other|5|||
160970499|NCT05076149|581281378|FG001|Overall Study|Other|4|||
160970500|NCT00782496|581281379|FG000|Overall Study|Lost to Follow-up|14|||
160970501|NCT00782496|581281380|FG001|Overall Study|Lost to Follow-up|15|||
160970502|NCT02087501|581281381|FG000|Overall Study|Death|7|||
160970503|NCT02087501|581281381|FG000|Overall Study|Open repair of aneurysm|1|||
160970504|NCT02087501|581281381|FG000|Overall Study|Lost to Follow-up|2|||
160970505|NCT00094328|581281382|FG000|Overall Study|Lost to Follow-up|1|||
161023873|NCT03058289|581477369|FG006|Overall Study|Clinical Deterioration|0|||
161023874|NCT03058289|581477370|FG007|Overall Study|Clinical Deterioration|3|||
161023875|NCT03058289|581477371|FG008|Overall Study|Clinical Deterioration|2|||
161023876|NCT03058289|581477363|FG000|Overall Study|Lost to Follow-up|0|||
161023877|NCT03058289|581477364|FG001|Overall Study|Lost to Follow-up|0|||
161023878|NCT03058289|581477365|FG002|Overall Study|Lost to Follow-up|0|||
161023879|NCT03058289|581477366|FG003|Overall Study|Lost to Follow-up|0|||
161023880|NCT03058289|581477367|FG004|Overall Study|Lost to Follow-up|1|||
161023881|NCT03058289|581477368|FG005|Overall Study|Lost to Follow-up|0|||
161023882|NCT03058289|581477369|FG006|Overall Study|Lost to Follow-up|0|||
161023883|NCT03058289|581477370|FG007|Overall Study|Lost to Follow-up|0|||
161023884|NCT03058289|581477371|FG008|Overall Study|Lost to Follow-up|0|||
161023885|NCT03058289|581477363|FG000|Overall Study|Refused Further Treatment|0|||
161023886|NCT03058289|581477364|FG001|Overall Study|Refused Further Treatment|0|||
161023887|NCT03058289|581477365|FG002|Overall Study|Refused Further Treatment|1|||
161023888|NCT03058289|581477366|FG003|Overall Study|Refused Further Treatment|0|||
161023889|NCT03058289|581477367|FG004|Overall Study|Refused Further Treatment|1|||
161023890|NCT03058289|581477368|FG005|Overall Study|Refused Further Treatment|0|||
161023891|NCT03058289|581477369|FG006|Overall Study|Refused Further Treatment|0|||
161023892|NCT03058289|581477370|FG007|Overall Study|Refused Further Treatment|0|||
161023893|NCT03058289|581477371|FG008|Overall Study|Refused Further Treatment|0|||
161023894|NCT03058289|581477363|FG000|Overall Study|Rapid Progression of Disease|0|||
161023895|NCT03058289|581477364|FG001|Overall Study|Rapid Progression of Disease|0|||
161023896|NCT03058289|581477365|FG002|Overall Study|Rapid Progression of Disease|0|||
161023897|NCT03058289|581477366|FG003|Overall Study|Rapid Progression of Disease|1|||
161023898|NCT03058289|581477367|FG004|Overall Study|Rapid Progression of Disease|0|||
161023899|NCT03058289|581477368|FG005|Overall Study|Rapid Progression of Disease|0|||
161023900|NCT03058289|581477369|FG006|Overall Study|Rapid Progression of Disease|0|||
160587740|NCT04031404|579871469|FG000|Baseline|Lost to Follow-up|0|||
160587741|NCT04031404|579871470|FG001|Baseline|Lost to Follow-up|1|||
160587742|NCT04031404|579871469|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
160587743|NCT04031404|579871470|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
160587744|NCT04031404|579871469|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
160587745|NCT04031404|579871470|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
160970506|NCT03682705|581281385|FG000|Overall Study|Adverse Event|1|||
160970507|NCT03682705|581281386|FG001|Overall Study|Adverse Event|1|||
160970508|NCT03682705|581281387|FG002|Overall Study|Adverse Event|1|||
160970509|NCT03682705|581281388|FG003|Overall Study|Adverse Event|0|||
160970510|NCT03682705|581281389|FG004|Overall Study|Adverse Event|1|||
160970511|NCT03682705|581281390|FG005|Overall Study|Adverse Event|1|||
160970512|NCT03682705|581281385|FG000|Overall Study|Withdrawal by Subject|1|||
160970513|NCT03682705|581281386|FG001|Overall Study|Withdrawal by Subject|3|||
160970514|NCT03682705|581281387|FG002|Overall Study|Withdrawal by Subject|2|||
160970515|NCT03682705|581281388|FG003|Overall Study|Withdrawal by Subject|4|||
160970516|NCT03682705|581281389|FG004|Overall Study|Withdrawal by Subject|0|||
160970517|NCT03682705|581281390|FG005|Overall Study|Withdrawal by Subject|1|||
160970518|NCT03682705|581281385|FG000|Overall Study|Other, not specified|0|||
160970519|NCT03682705|581281386|FG001|Overall Study|Other, not specified|0|||
160970520|NCT03682705|581281387|FG002|Overall Study|Other, not specified|0|||
160970521|NCT03682705|581281388|FG003|Overall Study|Other, not specified|1|||
160970522|NCT03682705|581281389|FG004|Overall Study|Other, not specified|2|||
160970523|NCT03682705|581281390|FG005|Overall Study|Other, not specified|0|||
160970524|NCT03682705|581281385|FG000|Overall Study|Lost to Follow-up|0|||
160970525|NCT03682705|581281386|FG001|Overall Study|Lost to Follow-up|0|||
160970526|NCT03682705|581281387|FG002|Overall Study|Lost to Follow-up|0|||
160970527|NCT03682705|581281388|FG003|Overall Study|Lost to Follow-up|0|||
160970528|NCT03682705|581281389|FG004|Overall Study|Lost to Follow-up|3|||
160970529|NCT03682705|581281390|FG005|Overall Study|Lost to Follow-up|0|||
160970530|NCT00117156|581281391|FG000|Overall Study|Adverse Event|9|||
160970531|NCT00117156|581281391|FG000|Overall Study|Physician Decision|1|||
160970532|NCT00117156|581281391|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
160970533|NCT01919970|581281392|FG000|Overall Study|Withdrawal by Subject|3|||
160970534|NCT01919970|581281393|FG001|Overall Study|Withdrawal by Subject|0|||
160970535|NCT00990340|581281394|FG000|First 14-day Treatment|Not Compliant|2|||
160970536|NCT00990340|581281395|FG001|First 14-day Treatment|Not Compliant|1|||
160970537|NCT00990340|581281394|FG000|First 14-day Treatment|Lost to Follow-up|2|||
161023901|NCT03058289|581477370|FG007|Overall Study|Rapid Progression of Disease|0|||
161023902|NCT03058289|581477371|FG008|Overall Study|Rapid Progression of Disease|0|||
161023903|NCT05940194|581477372|FG000|Overall Study|Adverse Event|0|||
161023904|NCT05940194|581477373|FG001|Overall Study|Adverse Event|1|||
161023905|NCT05940194|581477374|FG002|Overall Study|Adverse Event|0|||
160970538|NCT00990340|581281395|FG001|First 14-day Treatment|Lost to Follow-up|1|||
160970539|NCT00990340|581281394|FG000|First 14-day Treatment|Protocol Violation|2|||
161023906|NCT05940194|581477372|FG000|Overall Study|Migrated/Moved from the study area|2|||
161023907|NCT05940194|581477373|FG001|Overall Study|Migrated/Moved from the study area|2|||
160587746|NCT04031404|579871469|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
160657085|NCT02339909|580124541|FG001|Overall Study|Became ineligible after randomisation|63|||
160970540|NCT00990340|581281395|FG001|First 14-day Treatment|Protocol Violation|2|||
160970541|NCT04615182|581281396|FG000|Overall Study|Re-transplanted|2|||
160970542|NCT04615182|581281396|FG000|Overall Study|Protocol Violation|6|||
160970543|NCT04615182|581281396|FG000|Overall Study|Death|6|||
160970544|NCT04615182|581281396|FG000|Overall Study|Death and protocol violation|1|||
160970545|NCT01126060|581281397|FG000|Overall Study|Protocol Violation|0|||
160970546|NCT01126060|581281398|FG001|Overall Study|Protocol Violation|2|||
160970547|NCT03565068|581281399|FG000|Overall Study|Protocol Violation|0|||
160970548|NCT03565068|581281400|FG001|Overall Study|Protocol Violation|0|||
160970549|NCT03565068|581281401|FG002|Overall Study|Protocol Violation|0|||
160970550|NCT03565068|581281402|FG003|Overall Study|Protocol Violation|0|||
160970551|NCT03565068|581281403|FG004|Overall Study|Protocol Violation|1|||
160970552|NCT03565068|581281404|FG005|Overall Study|Protocol Violation|0|||
160970553|NCT03565068|581281405|FG006|Overall Study|Protocol Violation|0|||
160970554|NCT03565068|581281406|FG007|Overall Study|Protocol Violation|1|||
160970555|NCT03565068|581281407|FG008|Overall Study|Protocol Violation|0|||
160970556|NCT03565068|581281399|FG000|Overall Study|Sponsor decision|0|||
160970557|NCT03565068|581281400|FG001|Overall Study|Sponsor decision|0|||
160970558|NCT03565068|581281401|FG002|Overall Study|Sponsor decision|0|||
160970559|NCT03565068|581281402|FG003|Overall Study|Sponsor decision|0|||
160970560|NCT03565068|581281403|FG004|Overall Study|Sponsor decision|1|||
160970561|NCT03565068|581281404|FG005|Overall Study|Sponsor decision|1|||
160970562|NCT03565068|581281405|FG006|Overall Study|Sponsor decision|0|||
160970563|NCT03565068|581281406|FG007|Overall Study|Sponsor decision|0|||
160970564|NCT03565068|581281407|FG008|Overall Study|Sponsor decision|0|||
160970565|NCT03565068|581281399|FG000|Overall Study|Withdrawal by Subject|0|||
160970566|NCT03565068|581281400|FG001|Overall Study|Withdrawal by Subject|0|||
160970567|NCT03565068|581281401|FG002|Overall Study|Withdrawal by Subject|1|||
160970568|NCT03565068|581281402|FG003|Overall Study|Withdrawal by Subject|0|||
160970569|NCT03565068|581281403|FG004|Overall Study|Withdrawal by Subject|2|||
160970570|NCT03565068|581281404|FG005|Overall Study|Withdrawal by Subject|0|||
160970571|NCT03565068|581281405|FG006|Overall Study|Withdrawal by Subject|1|||
160970572|NCT03565068|581281406|FG007|Overall Study|Withdrawal by Subject|5|||
160970573|NCT03565068|581281407|FG008|Overall Study|Withdrawal by Subject|1|||
160970574|NCT03565068|581281399|FG000|Overall Study|Physician Decision|0|||
160970575|NCT03565068|581281400|FG001|Overall Study|Physician Decision|0|||
160970576|NCT03565068|581281401|FG002|Overall Study|Physician Decision|0|||
160970577|NCT03565068|581281402|FG003|Overall Study|Physician Decision|0|||
160970578|NCT03565068|581281403|FG004|Overall Study|Physician Decision|0|||
160970579|NCT03565068|581281404|FG005|Overall Study|Physician Decision|0|||
160970580|NCT03565068|581281405|FG006|Overall Study|Physician Decision|0|||
160970581|NCT03565068|581281406|FG007|Overall Study|Physician Decision|1|||
160970582|NCT03565068|581281407|FG008|Overall Study|Physician Decision|0|||
160970583|NCT03565068|581281399|FG000|Overall Study|Lost to Follow-up|0|||
160970584|NCT03565068|581281400|FG001|Overall Study|Lost to Follow-up|0|||
160970585|NCT03565068|581281401|FG002|Overall Study|Lost to Follow-up|0|||
160970586|NCT03565068|581281402|FG003|Overall Study|Lost to Follow-up|0|||
160970587|NCT03565068|581281403|FG004|Overall Study|Lost to Follow-up|0|||
160970588|NCT03565068|581281404|FG005|Overall Study|Lost to Follow-up|0|||
160970589|NCT03565068|581281405|FG006|Overall Study|Lost to Follow-up|0|||
160970590|NCT03565068|581281406|FG007|Overall Study|Lost to Follow-up|1|||
160970591|NCT03565068|581281407|FG008|Overall Study|Lost to Follow-up|0|||
160970592|NCT01654601|581281418|FG000|1st Administration|Withdrawal by Subject|2|||
160970593|NCT01654601|581281419|FG001|1st Administration|Withdrawal by Subject|0|||
160970594|NCT01654601|581281418|FG000|1st Administration|Protocol Violation|0|||
160970595|NCT01654601|581281419|FG001|1st Administration|Protocol Violation|2|||
160970596|NCT01654601|581281418|FG000|2nd Administration|Adverse Event|1|||
160970597|NCT01654601|581281419|FG001|2nd Administration|Adverse Event|0|||
160970598|NCT01654601|581281418|FG000|2nd Administration|Protocol Violation|0|||
160970599|NCT01654601|581281419|FG001|2nd Administration|Protocol Violation|1|||
160970600|NCT02636270|581281420|FG000|Overall Study|Adverse Event|1|||
160970601|NCT02636270|581281421|FG001|Overall Study|Adverse Event|0|||
160970602|NCT02636270|581281422|FG002|Overall Study|Adverse Event|0|||
160970603|NCT02636270|581281420|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
160970604|NCT02636270|581281421|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
160970605|NCT02636270|581281422|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
160970606|NCT03722264|581283519|FG000|Overall Study|Physician Decision|3|||
160970607|NCT00957931|581283520|FG000|Overall Study|Death|4|||
160970608|NCT01486758|581283521|FG000|Overall Study|Lost to Follow-up|0|||
160970609|NCT01486758|581283522|FG001|Overall Study|Lost to Follow-up|1|||
160970610|NCT01062763|581283523|FG000|Overall Study|Adverse Event|3|||
160970611|NCT01062763|581283524|FG001|Overall Study|Adverse Event|4|||
160970612|NCT02494921|581283525|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
160970613|NCT02494921|581283526|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
160970614|NCT02494921|581283527|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
160970615|NCT02494921|581283528|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
160587747|NCT04031404|579871470|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
160587748|NCT04031404|579871469|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
160587749|NCT04031404|579871470|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
160587750|NCT01354353|579871479|FG000|Overall Study|Adverse Event|1|||
160970616|NCT02494921|581283529|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
160970617|NCT02494921|581283525|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
160970618|NCT02494921|581283526|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
160970619|NCT02494921|581283527|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
160970620|NCT02494921|581283528|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
160970621|NCT02494921|581283529|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
160970622|NCT02494921|581283525|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
160970623|NCT02494921|581283526|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
160970624|NCT02494921|581283527|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
160970625|NCT02494921|581283528|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
160970626|NCT02494921|581283529|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
160970627|NCT02392611|581283530|FG000|Overall Study|Adverse Event|0|||
160970628|NCT02392611|581283531|FG001|Overall Study|Adverse Event|0|||
160970629|NCT02392611|581283532|FG002|Overall Study|Adverse Event|0|||
160970630|NCT02392611|581283533|FG003|Overall Study|Adverse Event|1|||
160970631|NCT02392611|581283534|FG004|Overall Study|Adverse Event|0|||
160970632|NCT02392611|581283535|FG005|Overall Study|Adverse Event|0|||
160970633|NCT02392611|581283536|FG006|Overall Study|Adverse Event|0|||
160970634|NCT02392611|581283537|FG007|Overall Study|Adverse Event|0|||
160970635|NCT02392611|581283538|FG008|Overall Study|Adverse Event|0|||
160970636|NCT02392611|581283530|FG000|Overall Study|Progressive disease|0|||
160970637|NCT02392611|581283531|FG001|Overall Study|Progressive disease|0|||
160970638|NCT02392611|581283532|FG002|Overall Study|Progressive disease|0|||
160970639|NCT02392611|581283533|FG003|Overall Study|Progressive disease|2|||
160970640|NCT02392611|581283534|FG004|Overall Study|Progressive disease|1|||
160970641|NCT02392611|581283535|FG005|Overall Study|Progressive disease|0|||
160970642|NCT02392611|581283536|FG006|Overall Study|Progressive disease|0|||
160970643|NCT02392611|581283537|FG007|Overall Study|Progressive disease|0|||
160970644|NCT02392611|581283538|FG008|Overall Study|Progressive disease|0|||
160970645|NCT02392611|581283530|FG000|Overall Study|Death|1|||
160970646|NCT02392611|581283531|FG001|Overall Study|Death|0|||
160970647|NCT02392611|581283532|FG002|Overall Study|Death|0|||
160970648|NCT02392611|581283533|FG003|Overall Study|Death|0|||
160970649|NCT02392611|581283534|FG004|Overall Study|Death|0|||
160970650|NCT02392611|581283535|FG005|Overall Study|Death|1|||
160970651|NCT02392611|581283536|FG006|Overall Study|Death|0|||
160970652|NCT02392611|581283537|FG007|Overall Study|Death|0|||
160970653|NCT02392611|581283538|FG008|Overall Study|Death|0|||
160970654|NCT02392611|581283530|FG000|Overall Study|Withdrawal by Subject|0|||
160970655|NCT02392611|581283531|FG001|Overall Study|Withdrawal by Subject|0|||
160970656|NCT02392611|581283532|FG002|Overall Study|Withdrawal by Subject|0|||
160970657|NCT02392611|581283533|FG003|Overall Study|Withdrawal by Subject|1|||
160970658|NCT02392611|581283534|FG004|Overall Study|Withdrawal by Subject|0|||
160970659|NCT02392611|581283535|FG005|Overall Study|Withdrawal by Subject|0|||
160970660|NCT02392611|581283536|FG006|Overall Study|Withdrawal by Subject|0|||
160970661|NCT02392611|581283537|FG007|Overall Study|Withdrawal by Subject|0|||
160970662|NCT02392611|581283538|FG008|Overall Study|Withdrawal by Subject|0|||
160970663|NCT02392611|581283530|FG000|Overall Study|Lost to Follow-up|0|||
160970664|NCT02392611|581283531|FG001|Overall Study|Lost to Follow-up|0|||
160970665|NCT02392611|581283532|FG002|Overall Study|Lost to Follow-up|0|||
160970666|NCT02392611|581283533|FG003|Overall Study|Lost to Follow-up|0|||
160970667|NCT02392611|581283534|FG004|Overall Study|Lost to Follow-up|0|||
160970668|NCT02392611|581283535|FG005|Overall Study|Lost to Follow-up|0|||
160970669|NCT02392611|581283536|FG006|Overall Study|Lost to Follow-up|1|||
160970670|NCT02392611|581283537|FG007|Overall Study|Lost to Follow-up|0|||
160970671|NCT02392611|581283538|FG008|Overall Study|Lost to Follow-up|0|||
160970672|NCT02392611|581283530|FG000|Overall Study|Enrolled, not treated|0|||
160970673|NCT02392611|581283531|FG001|Overall Study|Enrolled, not treated|0|||
160970674|NCT02392611|581283532|FG002|Overall Study|Enrolled, not treated|0|||
160970675|NCT02392611|581283533|FG003|Overall Study|Enrolled, not treated|2|||
160970676|NCT02392611|581283534|FG004|Overall Study|Enrolled, not treated|0|||
160587751|NCT01354353|579871480|FG001|Overall Study|Adverse Event|0|||
160587752|NCT01354353|579871481|FG002|Overall Study|Adverse Event|0|||
160587753|NCT01354353|579871482|FG003|Overall Study|Adverse Event|4|||
160587754|NCT01354353|579871483|FG004|Overall Study|Adverse Event|0|||
160970677|NCT02392611|581283535|FG005|Overall Study|Enrolled, not treated|0|||
160970678|NCT02392611|581283536|FG006|Overall Study|Enrolled, not treated|0|||
160970679|NCT02392611|581283537|FG007|Overall Study|Enrolled, not treated|0|||
160970680|NCT02392611|581283538|FG008|Overall Study|Enrolled, not treated|0|||
160970681|NCT02991482|581283539|FG000|Overall Study|Disease progression|56|||
160970682|NCT02991482|581283540|FG001|Overall Study|Disease progression|47|||
160970683|NCT02991482|581283539|FG000|Overall Study|Death|4|||
160587755|NCT01354353|579871484|FG005|Overall Study|Adverse Event|5|||
160587756|NCT01354353|579871479|FG000|Overall Study|Entry Criteria Not Met|0|||
160970684|NCT02991482|581283540|FG001|Overall Study|Death|4|||
160970685|NCT02991482|581283539|FG000|Overall Study|Adverse Event|1|||
160970686|NCT02991482|581283540|FG001|Overall Study|Adverse Event|6|||
160970687|NCT02991482|581283539|FG000|Overall Study|Patient decision|1|||
160970688|NCT02991482|581283540|FG001|Overall Study|Patient decision|1|||
160970689|NCT02991482|581283539|FG000|Overall Study|Physician Decision|0|||
160970690|NCT02991482|581283540|FG001|Overall Study|Physician Decision|6|||
160970691|NCT02991482|581283539|FG000|Overall Study|Clinical deterioration|1|||
160970692|NCT02991482|581283540|FG001|Overall Study|Clinical deterioration|0|||
160970693|NCT02991482|581283539|FG000|Overall Study|Patient feeling too unwell|1|||
160970694|NCT02991482|581283540|FG001|Overall Study|Patient feeling too unwell|0|||
160970695|NCT02991482|581283539|FG000|Overall Study|Worsening of performance status|0|||
160970696|NCT02991482|581283540|FG001|Overall Study|Worsening of performance status|1|||
160970697|NCT02991482|581283539|FG000|Overall Study|Death prior to study drug initiation|1|||
160970698|NCT02991482|581283540|FG001|Overall Study|Death prior to study drug initiation|0|||
160970699|NCT02991482|581283539|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
160970700|NCT02991482|581283540|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
160970701|NCT02887989|581283549|FG000|Overall Study|Withdrawal by Subject|8|||
160970702|NCT02887989|581283550|FG001|Overall Study|Withdrawal by Subject|11|||
160970703|NCT02887989|581283549|FG000|Overall Study|Death|1|||
160970704|NCT02887989|581283550|FG001|Overall Study|Death|0|||
160970705|NCT05648357|581283551|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
160970706|NCT00768430|581283552|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
160970707|NCT00768430|581283553|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
160970708|NCT03585296|581283556|FG000|Overall Study|Adverse Event|1|||
160970709|NCT03585296|581283556|FG000|Overall Study|Lost to Follow-up|2|||
160970710|NCT03585296|581283556|FG000|Overall Study|Withdrawal by Subject|2|||
160970711|NCT00041756|581283557|FG000|Overall Study|Adverse Event|4|||
160587757|NCT01354353|579871480|FG001|Overall Study|Entry Criteria Not Met|0|||
160970712|NCT00041756|581283558|FG001|Overall Study|Adverse Event|10|||
160970713|NCT00041756|581283559|FG002|Overall Study|Adverse Event|6|||
160970714|NCT00041756|581283560|FG003|Overall Study|Adverse Event|11|||
160970715|NCT00041756|581283561|FG004|Overall Study|Adverse Event|34|||
160970716|NCT00041756|581283557|FG000|Overall Study|Protocol Violation|1|||
160970717|NCT00041756|581283558|FG001|Overall Study|Protocol Violation|1|||
160970718|NCT00041756|581283559|FG002|Overall Study|Protocol Violation|2|||
160970719|NCT00041756|581283560|FG003|Overall Study|Protocol Violation|2|||
160970720|NCT00041756|581283561|FG004|Overall Study|Protocol Violation|1|||
160970721|NCT00041756|581283557|FG000|Overall Study|Withdrawal by Subject|3|||
160970722|NCT00041756|581283558|FG001|Overall Study|Withdrawal by Subject|3|||
160970723|NCT00041756|581283559|FG002|Overall Study|Withdrawal by Subject|4|||
160970724|NCT00041756|581283560|FG003|Overall Study|Withdrawal by Subject|2|||
160970725|NCT00041756|581283561|FG004|Overall Study|Withdrawal by Subject|3|||
160970726|NCT00041756|581283557|FG000|Overall Study|Lost to Follow-up|0|||
160970727|NCT00041756|581283558|FG001|Overall Study|Lost to Follow-up|1|||
160970728|NCT00041756|581283559|FG002|Overall Study|Lost to Follow-up|0|||
160970729|NCT00041756|581283560|FG003|Overall Study|Lost to Follow-up|1|||
160970730|NCT00041756|581283561|FG004|Overall Study|Lost to Follow-up|0|||
160970731|NCT00041756|581283557|FG000|Overall Study|Unable to meet protocol criteria|0|||
160970732|NCT00041756|581283558|FG001|Overall Study|Unable to meet protocol criteria|0|||
160970733|NCT00041756|581283559|FG002|Overall Study|Unable to meet protocol criteria|1|||
160587758|NCT01354353|579871481|FG002|Overall Study|Entry Criteria Not Met|0|||
160587759|NCT01354353|579871482|FG003|Overall Study|Entry Criteria Not Met|1|||
160587760|NCT01354353|579871483|FG004|Overall Study|Entry Criteria Not Met|1|||
160587761|NCT01354353|579871484|FG005|Overall Study|Entry Criteria Not Met|0|||
160587762|NCT01354353|579871479|FG000|Overall Study|Physician Decision|0|||
160587763|NCT01354353|579871480|FG001|Overall Study|Physician Decision|1|||
160587764|NCT01354353|579871481|FG002|Overall Study|Physician Decision|1|||
160587765|NCT01354353|579871482|FG003|Overall Study|Physician Decision|0|||
160587766|NCT01354353|579871483|FG004|Overall Study|Physician Decision|0|||
160587767|NCT01354353|579871484|FG005|Overall Study|Physician Decision|0|||
160587768|NCT01354353|579871479|FG000|Overall Study|Withdrawal by Subject|2|||
160587769|NCT01354353|579871480|FG001|Overall Study|Withdrawal by Subject|0|||
160587770|NCT01354353|579871481|FG002|Overall Study|Withdrawal by Subject|1|||
160587771|NCT01354353|579871482|FG003|Overall Study|Withdrawal by Subject|0|||
160970734|NCT00041756|581283560|FG003|Overall Study|Unable to meet protocol criteria|0|||
160970735|NCT00041756|581283561|FG004|Overall Study|Unable to meet protocol criteria|1|||
160970736|NCT00041756|581283557|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
160970737|NCT00041756|581283558|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
160970738|NCT00041756|581283559|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
160970739|NCT00041756|581283560|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
160970740|NCT00041756|581283561|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
160970741|NCT02110732|581283562|FG000|Overall Study|Physician Decision|5|||
160970742|NCT02110732|581283563|FG001|Overall Study|Physician Decision|2|||
160970743|NCT02110732|581283562|FG000|Overall Study|Lost to Follow-up|1|||
160970744|NCT02110732|581283563|FG001|Overall Study|Lost to Follow-up|1|||
160970745|NCT04887948|581283567|FG000|Overall Study|Death|1|||
160970746|NCT04887948|581283568|FG001|Overall Study|Death|0|||
160970747|NCT04887948|581283569|FG002|Overall Study|Death|0|||
160970748|NCT04887948|581283567|FG000|Overall Study|Lost to Follow-up|1|||
160970749|NCT04887948|581283568|FG001|Overall Study|Lost to Follow-up|0|||
160970750|NCT04887948|581283569|FG002|Overall Study|Lost to Follow-up|3|||
160970751|NCT04887948|581283567|FG000|Overall Study|Physician Decision|0|||
160587772|NCT01354353|579871483|FG004|Overall Study|Withdrawal by Subject|0|||
160587773|NCT01354353|579871484|FG005|Overall Study|Withdrawal by Subject|1|||
160587774|NCT00831441|579871485|FG000|Randomized|Death|82|||
160970752|NCT04887948|581283568|FG001|Overall Study|Physician Decision|4|||
160970753|NCT04887948|581283569|FG002|Overall Study|Physician Decision|1|||
160970754|NCT04887948|581283567|FG000|Overall Study|Protocol Violation|1|||
160970755|NCT04887948|581283568|FG001|Overall Study|Protocol Violation|1|||
160970756|NCT04887948|581283569|FG002|Overall Study|Protocol Violation|0|||
160970757|NCT04887948|581283567|FG000|Overall Study|Withdrawal by Subject|0|||
160970758|NCT04887948|581283568|FG001|Overall Study|Withdrawal by Subject|6|||
160970759|NCT04887948|581283569|FG002|Overall Study|Withdrawal by Subject|1|||
160970760|NCT04887948|581283567|FG000|Overall Study|No longer met eligibility criteria|1|||
160970761|NCT04887948|581283568|FG001|Overall Study|No longer met eligibility criteria|2|||
160970762|NCT04887948|581283569|FG002|Overall Study|No longer met eligibility criteria|1|||
160970763|NCT04887948|581283567|FG000|Overall Study|Other|2|||
160970764|NCT04887948|581283568|FG001|Overall Study|Other|1|||
160970765|NCT04887948|581283569|FG002|Overall Study|Other|1|||
160970766|NCT02312856|581283570|FG000|Overall Study|Death|1|||
160970767|NCT02312856|581283570|FG000|Overall Study|Lost to Follow-up|3|||
160970768|NCT04415151|581283571|FG000|Overall Study|Death|1|||
160970769|NCT04415151|581283572|FG001|Overall Study|Death|1|||
160970770|NCT04415151|581283571|FG000|Overall Study|Withdrawal by Subject|1|||
160970771|NCT04415151|581283572|FG001|Overall Study|Withdrawal by Subject|0|||
160587775|NCT00831441|579871486|FG001|Randomized|Death|81|||
160587776|NCT00831441|579871485|FG000|Randomized|Adverse Event|248|||
160587777|NCT00831441|579871486|FG001|Randomized|Adverse Event|321|||
160970772|NCT00638235|581283573|FG000|Overall Study|Lost to Follow-up|31|||
160970773|NCT00638235|581283574|FG001|Overall Study|Lost to Follow-up|3|||
160970774|NCT00638235|581283575|FG002|Overall Study|Lost to Follow-up|18|||
160970775|NCT00638235|581283576|FG003|Overall Study|Lost to Follow-up|10|||
160970776|NCT00638235|581283577|FG004|Overall Study|Lost to Follow-up|13|||
160970777|NCT00638235|581283578|FG005|Overall Study|Lost to Follow-up|26|||
160970778|NCT00638235|581283579|FG006|Overall Study|Lost to Follow-up|0|||
160970779|NCT00638235|581283580|FG007|Overall Study|Lost to Follow-up|1|||
160970780|NCT00638235|581283581|FG008|Overall Study|Lost to Follow-up|18|||
160970781|NCT01588990|581283582|FG000|Phase A|Withdrawal by Subject|5|||
160970782|NCT01588990|581283582|FG000|Phase A|Physician Decision|11|||
160970783|NCT01588990|581283582|FG000|Phase A|Other|14|||
160970784|NCT01588990|581283582|FG000|Phase A|Lost to Follow-up|1|||
160970785|NCT01588990|581283582|FG000|Phase A|Death|5|||
160970786|NCT01588990|581283582|FG000|Phase A|Adverse Event|28|||
160970787|NCT01588990|581283582|FG000|Phase A|Still on therapy at end of study|6|||
160970788|NCT01588990|581283582|FG000|Phase B|Adverse Event|2|||
160970789|NCT01588990|581283582|FG000|Phase B|Still on therapy at end of study|5|||
160970790|NCT01588990|581283582|FG000|Phase B|Withdrawal by Subject|3|||
160970791|NCT01588990|581283582|FG000|Phase B|Physician Decision|4|||
160970792|NCT01588990|581283582|FG000|Phase B|Other|2|||
160970793|NCT02367716|581283585|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
160970794|NCT01473381|581283586|FG000|Overall Study|Adverse Event|8|||
160970795|NCT01473381|581283587|FG001|Overall Study|Adverse Event|20|||
160970796|NCT01473381|581283588|FG002|Overall Study|Adverse Event|25|||
160970797|NCT01473381|581283589|FG003|Overall Study|Adverse Event|17|||
160587778|NCT00831441|579871485|FG000|Randomized|Emergency procedure|2|||
160970798|NCT01473381|581283586|FG000|Overall Study|Insufficient Therapeutic Response|10|||
160970799|NCT01473381|581283587|FG001|Overall Study|Insufficient Therapeutic Response|1|||
160970800|NCT01473381|581283588|FG002|Overall Study|Insufficient Therapeutic Response|2|||
160970801|NCT01473381|581283589|FG003|Overall Study|Insufficient Therapeutic Response|3|||
160970802|NCT01473381|581283586|FG000|Overall Study|Protocol Violation|17|||
160970803|NCT01473381|581283587|FG001|Overall Study|Protocol Violation|23|||
160970804|NCT01473381|581283588|FG002|Overall Study|Protocol Violation|19|||
160970805|NCT01473381|581283589|FG003|Overall Study|Protocol Violation|17|||
160970806|NCT01473381|581283586|FG000|Overall Study|Withdrawal of Consent|20|||
160970807|NCT01473381|581283587|FG001|Overall Study|Withdrawal of Consent|21|||
160970808|NCT01473381|581283588|FG002|Overall Study|Withdrawal of Consent|20|||
160970809|NCT01473381|581283589|FG003|Overall Study|Withdrawal of Consent|26|||
160970810|NCT01473381|581283586|FG000|Overall Study|Lost to Follow-up|25|||
160970811|NCT01473381|581283587|FG001|Overall Study|Lost to Follow-up|28|||
160970812|NCT01473381|581283588|FG002|Overall Study|Lost to Follow-up|35|||
160970813|NCT01473381|581283589|FG003|Overall Study|Lost to Follow-up|23|||
160970814|NCT01473381|581283586|FG000|Overall Study|Other Reasons|0|||
160970815|NCT01473381|581283587|FG001|Overall Study|Other Reasons|0|||
160587779|NCT00831441|579871486|FG001|Randomized|Emergency procedure|2|||
160587780|NCT00831441|579871485|FG000|Randomized|Elective procedure|26|||
160970816|NCT01473381|581283588|FG002|Overall Study|Other Reasons|1|||
160587781|NCT00831441|579871486|FG001|Randomized|Elective procedure|25|||
160587782|NCT00831441|579871485|FG000|Randomized|Physician Decision|26|||
160587783|NCT00831441|579871486|FG001|Randomized|Physician Decision|35|||
160587784|NCT00831441|579871485|FG000|Randomized|No longer met criteria|13|||
160587785|NCT00831441|579871486|FG001|Randomized|No longer met criteria|19|||
160587786|NCT00831441|579871485|FG000|Randomized|Withdrawal by Subject|178|||
160587787|NCT00831441|579871486|FG001|Randomized|Withdrawal by Subject|212|||
160587788|NCT00831441|579871485|FG000|Randomized|Lost to Follow-up|26|||
160587789|NCT00831441|579871486|FG001|Randomized|Lost to Follow-up|35|||
160587790|NCT00831441|579871485|FG000|Randomized|Administrative reason by sponsor|2780|||
160657086|NCT02339909|580124542|FG002|Overall Study|Became ineligible after randomisation|71|||
160657087|NCT00860028|580124543|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
160657088|NCT00860028|580124544|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
160657089|NCT03481309|580124545|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
160657090|NCT03481309|580124546|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
160657091|NCT03481309|580124547|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
160657092|NCT03481309|580124548|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
160657093|NCT03481309|580124549|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
160657094|NCT03481309|580124550|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
160657095|NCT03309956|580124551|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
160657096|NCT00419770|580125918|FG000|Overall Study|Withdrawal by Subject|5|||
160657097|NCT00419770|580125919|FG001|Overall Study|Withdrawal by Subject|1|||
160657098|NCT02424188|580125928|FG000|Overall Study|Death|2|||
160657099|NCT02424188|580125929|FG001|Overall Study|Death|2|||
160657100|NCT02424188|580125928|FG000|Overall Study|Lost to Follow-up|1|||
160657101|NCT02424188|580125929|FG001|Overall Study|Lost to Follow-up|3|||
160657102|NCT02424188|580125928|FG000|Overall Study|Incarceration|1|||
160657103|NCT02424188|580125929|FG001|Overall Study|Incarceration|0|||
160657104|NCT01108094|580125935|FG000|Overall Study|Adverse Event|2|||
160657105|NCT01108094|580125936|FG001|Overall Study|Adverse Event|0|||
160657106|NCT01108094|580125937|FG002|Overall Study|Adverse Event|0|||
160657107|NCT01108094|580125938|FG003|Overall Study|Adverse Event|0|||
160657108|NCT01108094|580125935|FG000|Overall Study|Withdrawal by Subject|1|||
160657109|NCT01108094|580125936|FG001|Overall Study|Withdrawal by Subject|0|||
160657110|NCT01108094|580125937|FG002|Overall Study|Withdrawal by Subject|0|||
160970817|NCT01473381|581283589|FG003|Overall Study|Other Reasons|3|||
160970818|NCT00539643|581283590|FG000|Overall Study|Adverse Event|1|||
160970819|NCT00539643|581283591|FG001|Overall Study|Adverse Event|0|||
160970820|NCT00539643|581283590|FG000|Overall Study|Death|2|||
160970821|NCT00539643|581283591|FG001|Overall Study|Death|1|||
160970822|NCT00539643|581283590|FG000|Overall Study|Physician Decision|3|||
160970823|NCT00539643|581283591|FG001|Overall Study|Physician Decision|1|||
160657111|NCT01108094|580125938|FG003|Overall Study|Withdrawal by Subject|0|||
160970824|NCT00539643|581283590|FG000|Overall Study|Withdrawal by Subject|0|||
160970825|NCT00539643|581283591|FG001|Overall Study|Withdrawal by Subject|1|||
160970826|NCT01641926|581283594|FG000|Overall Study|Adverse Event|5|||
160970827|NCT01641926|581283595|FG001|Overall Study|Adverse Event|2|||
160970828|NCT01641926|581283596|FG002|Overall Study|Adverse Event|3|||
160970829|NCT01641926|581283597|FG003|Overall Study|Adverse Event|1|||
160970830|NCT01641926|581283594|FG000|Overall Study|Lost to Follow-up|2|||
160970831|NCT01641926|581283595|FG001|Overall Study|Lost to Follow-up|2|||
160970832|NCT01641926|581283596|FG002|Overall Study|Lost to Follow-up|1|||
160970833|NCT01641926|581283597|FG003|Overall Study|Lost to Follow-up|0|||
160970834|NCT01641926|581283594|FG000|Overall Study|Physician Decision|6|||
160970835|NCT01641926|581283595|FG001|Overall Study|Physician Decision|5|||
160970836|NCT01641926|581283596|FG002|Overall Study|Physician Decision|0|||
160970837|NCT01641926|581283597|FG003|Overall Study|Physician Decision|1|||
160970838|NCT01641926|581283594|FG000|Overall Study|Protocol Violation|1|||
160970839|NCT01641926|581283595|FG001|Overall Study|Protocol Violation|0|||
160970840|NCT01641926|581283596|FG002|Overall Study|Protocol Violation|0|||
160970841|NCT01641926|581283597|FG003|Overall Study|Protocol Violation|1|||
160587791|NCT00831441|579871486|FG001|Randomized|Administrative reason by sponsor|2671|||
160587792|NCT00831441|579871485|FG000|Randomized|poor/non-compliance|30|||
160657112|NCT04510857|580125943|FG000|Overall Study|Withdrawal by Subject|1|||
160657113|NCT04510857|580125944|FG001|Overall Study|Withdrawal by Subject|2|||
160657114|NCT00688064|580125945|FG000|Overall Study|Protocol Violation|0|||
160587793|NCT00831441|579871486|FG001|Randomized|poor/non-compliance|38|||
160657115|NCT00688064|580125946|FG001|Overall Study|Protocol Violation|1|||
160657116|NCT00688064|580125945|FG000|Overall Study|Adverse Event|2|||
160970842|NCT01641926|581283594|FG000|Overall Study|Withdrawal by Subject|13|||
160970843|NCT01641926|581283595|FG001|Overall Study|Withdrawal by Subject|5|||
160970844|NCT01641926|581283596|FG002|Overall Study|Withdrawal by Subject|6|||
160970845|NCT01641926|581283597|FG003|Overall Study|Withdrawal by Subject|1|||
160970846|NCT01641926|581283594|FG000|Overall Study|Not Treated|1|||
160587794|NCT00831441|579871485|FG000|Randomized|non-specified|276|||
160587795|NCT00831441|579871486|FG001|Randomized|non-specified|266|||
160657117|NCT00688064|580125946|FG001|Overall Study|Adverse Event|4|||
160970847|NCT01641926|581283595|FG001|Overall Study|Not Treated|1|||
160970848|NCT01641926|581283596|FG002|Overall Study|Not Treated|1|||
160970849|NCT01641926|581283597|FG003|Overall Study|Not Treated|0|||
160970850|NCT01800201|581283598|FG000|Overall Study|Withdrawal by Subject|2|||
160970851|NCT01800201|581283599|FG001|Overall Study|Withdrawal by Subject|0|||
160970852|NCT01800201|581283598|FG000|Overall Study|patient privacy concerns|1|||
160970853|NCT01800201|581283599|FG001|Overall Study|patient privacy concerns|1|||
160970854|NCT01800201|581283598|FG000|Overall Study|did not want to use device|0|||
160970855|NCT01800201|581283599|FG001|Overall Study|did not want to use device|1|||
160970856|NCT01800201|581283598|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
160970857|NCT01800201|581283599|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
160970858|NCT01480596|581283600|FG000|Overall Study|Adverse Event|3|||
160970859|NCT01480596|581283601|FG001|Overall Study|Adverse Event|0|||
160970860|NCT01480596|581283600|FG000|Overall Study|MG exacerbation or change in medication|2|||
160970861|NCT01480596|581283601|FG001|Overall Study|MG exacerbation or change in medication|2|||
160970862|NCT02904902|581283602|FG000|Overall Study|Withdrawal by Subject|1|||
160970863|NCT05400746|581283607|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
160970864|NCT05400746|581283608|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
160970865|NCT05400746|581283609|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
160970866|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
160970867|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
160970868|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
160587796|NCT00831441|579871485|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
160587797|NCT00831441|579871486|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
160587798|NCT00831441|579871485|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
160587799|NCT00831441|579871486|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
160587800|NCT00831441|579871485|FG000|Follow Up (30 Days)|Death|63|||
160587801|NCT00831441|579871486|FG001|Follow Up (30 Days)|Death|86|||
160587802|NCT00831441|579871485|FG000|Follow Up (30 Days)|non-specified|16|||
160587803|NCT00831441|579871486|FG001|Follow Up (30 Days)|non-specified|26|||
160587804|NCT00831441|579871485|FG000|Follow Up (30 Days)|missing end of study status|0|||
160587805|NCT00831441|579871486|FG001|Follow Up (30 Days)|missing end of study status|1|||
160587806|NCT05674344|579871487|FG000|Overall Study|Screen Fail|21|||
160587807|NCT05674344|579871487|FG000|Overall Study|Incomplete study procedures|3|||
160587808|NCT00111917|579871488|FG000|Overall Study|Withdrawal by Subject|1|||
160587809|NCT00111917|579871489|FG001|Overall Study|Withdrawal by Subject|1|||
160587810|NCT01640925|579871490|FG000|Overall Study|Withdrawal by Subject|1|||
160587811|NCT01640925|579871491|FG001|Overall Study|Withdrawal by Subject|0|||
160587812|NCT01640925|579871490|FG000|Overall Study|Previously enrolled in this trial|13|||
160587813|NCT01640925|579871491|FG001|Overall Study|Previously enrolled in this trial|11|||
160587814|NCT02156492|579871492|FG000|Period 1|No Reason Given|0|||
160587815|NCT02156492|579871493|FG001|Period 1|No Reason Given|1|||
160587816|NCT02156492|579871494|FG002|Period 1|No Reason Given|0|||
160587817|NCT02156492|579871492|FG000|Period 3|Adverse Event|0|||
160587818|NCT02156492|579871493|FG001|Period 3|Adverse Event|1|||
160587819|NCT02156492|579871494|FG002|Period 3|Adverse Event|0|||
160587820|NCT00485589|579871503|FG000|Overall Study|Death|2|||
160587821|NCT00485589|579871504|FG001|Overall Study|Death|2|||
160587822|NCT00485589|579871505|FG002|Overall Study|Death|0|||
160587823|NCT00485589|579871503|FG000|Overall Study|Failure to return|6|||
160587824|NCT00485589|579871504|FG001|Overall Study|Failure to return|5|||
160587825|NCT00485589|579871505|FG002|Overall Study|Failure to return|1|||
160587826|NCT00485589|579871503|FG000|Overall Study|Protocol Violation|1|||
160587827|NCT00485589|579871504|FG001|Overall Study|Protocol Violation|0|||
160587828|NCT00485589|579871505|FG002|Overall Study|Protocol Violation|0|||
160587829|NCT00485589|579871503|FG000|Overall Study|Violation of selection criteria at entry|0|||
160587830|NCT00485589|579871504|FG001|Overall Study|Violation of selection criteria at entry|3|||
160587831|NCT00485589|579871505|FG002|Overall Study|Violation of selection criteria at entry|1|||
160587832|NCT00485589|579871503|FG000|Overall Study|Administrative/Other|1|||
160587833|NCT00485589|579871504|FG001|Overall Study|Administrative/Other|2|||
160970869|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
160970870|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
160460039|NCT02720068|579417512|FG011|Overall Study|Withdrawal by Subject|27|||
160460040|NCT02720068|579417513|FG012|Overall Study|Withdrawal by Subject|2|||
160587834|NCT00485589|579871505|FG002|Overall Study|Administrative/Other|1|||
160587835|NCT00485589|579871503|FG000|Overall Study|Insufficient therapeutic response|10|||
160587836|NCT00485589|579871504|FG001|Overall Study|Insufficient therapeutic response|3|||
160587837|NCT00485589|579871505|FG002|Overall Study|Insufficient therapeutic response|1|||
160587838|NCT00485589|579871503|FG000|Overall Study|Refused treatment/did not cooperate|1|||
160587839|NCT00485589|579871504|FG001|Overall Study|Refused treatment/did not cooperate|0|||
160587840|NCT00485589|579871505|FG002|Overall Study|Refused treatment/did not cooperate|2|||
160970871|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
160970872|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
160460041|NCT02720068|579417514|FG013|Overall Study|Withdrawal by Subject|8|||
160587841|NCT00485589|579871503|FG000|Overall Study|Withdrawal by Subject|3|||
160587842|NCT00485589|579871504|FG001|Overall Study|Withdrawal by Subject|2|||
160587843|NCT00485589|579871505|FG002|Overall Study|Withdrawal by Subject|2|||
160970873|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Physician Decision|4|||
160970874|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Physician Decision|1|||
160970875|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Physician Decision|3|||
160970876|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Physician Decision|0|||
160970877|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Physician Decision|0|||
160970878|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Physician Decision|1|||
160970879|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Physician Decision|0|||
160970880|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Other|0|||
160970881|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Other|1|||
160970882|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Other|0|||
160970883|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Other|0|||
160970884|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Other|0|||
160970885|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Other|0|||
160970886|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Other|0|||
160970887|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970888|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970889|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970890|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970891|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970892|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970893|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
160970894|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
160970895|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
160970896|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
160970897|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
160970898|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
160970899|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
160970900|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
160970901|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Pregnancy|0|||
160970902|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Pregnancy|0|||
160970903|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Pregnancy|1|||
160970904|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Pregnancy|0|||
160970905|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Pregnancy|0|||
160970906|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Pregnancy|0|||
160970907|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Pregnancy|0|||
160970908|NCT05375955|581283610|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970909|NCT05375955|581283611|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970910|NCT05375955|581283612|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
160970911|NCT05375955|581283613|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970912|NCT05375955|581283614|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970913|NCT05375955|581283615|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970914|NCT05375955|581283616|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970915|NCT05375955|581283610|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
160970916|NCT05375955|581283611|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
160970917|NCT05375955|581283612|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
160970918|NCT05375955|581283613|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
160970919|NCT05375955|581283614|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
160970920|NCT05375955|581283615|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
160970921|NCT05375955|581283616|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
160970922|NCT05375955|581283610|FG000|Follow-up (up to 5 Weeks)|Other|0|||
160970923|NCT05375955|581283611|FG001|Follow-up (up to 5 Weeks)|Other|1|||
160970924|NCT05375955|581283612|FG002|Follow-up (up to 5 Weeks)|Other|0|||
160970925|NCT05375955|581283613|FG003|Follow-up (up to 5 Weeks)|Other|0|||
160970926|NCT05375955|581283614|FG004|Follow-up (up to 5 Weeks)|Other|0|||
160970927|NCT05375955|581283615|FG005|Follow-up (up to 5 Weeks)|Other|0|||
160970928|NCT05375955|581283616|FG006|Follow-up (up to 5 Weeks)|Other|0|||
160970929|NCT05375955|581283610|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
160970930|NCT05375955|581283611|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
160970931|NCT05375955|581283612|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
160970932|NCT05375955|581283613|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
160970933|NCT05375955|581283614|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
160970934|NCT05375955|581283615|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
160970935|NCT05375955|581283616|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
160970936|NCT05375955|581283610|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
161023908|NCT05940194|581477374|FG002|Overall Study|Migrated/Moved from the study area|4|||
161023909|NCT03800654|581477376|FG000|Overall Study|Time constraints|3|||
161023910|NCT03800654|581477377|FG001|Overall Study|Time constraints|3|||
160970937|NCT05375955|581283611|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
160970938|NCT05375955|581283612|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
160970939|NCT05375955|581283613|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
160970940|NCT05375955|581283614|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
160970941|NCT05375955|581283615|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
161023911|NCT03800654|581477378|FG002|Overall Study|Time constraints|3|||
160970942|NCT05375955|581283616|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
160970943|NCT03879408|581283626|FG000|Overall Study|Lost to Follow-up|0|||
160970944|NCT03879408|581283627|FG001|Overall Study|Lost to Follow-up|3|||
160970945|NCT03879408|581283628|FG002|Overall Study|Lost to Follow-up|2|||
160970946|NCT03879408|581283629|FG003|Overall Study|Lost to Follow-up|1|||
160970947|NCT03879408|581283630|FG004|Overall Study|Lost to Follow-up|0|||
160970948|NCT03879408|581283626|FG000|Overall Study|Withdrawal by Subject|2|||
160970949|NCT03879408|581283627|FG001|Overall Study|Withdrawal by Subject|1|||
160970950|NCT03879408|581283628|FG002|Overall Study|Withdrawal by Subject|1|||
160970951|NCT03879408|581283629|FG003|Overall Study|Withdrawal by Subject|0|||
160970952|NCT03879408|581283630|FG004|Overall Study|Withdrawal by Subject|1|||
160970953|NCT05458024|581283631|FG000|Overall Study|Withdrawal by Subject|1|||
160970954|NCT05458024|581283632|FG001|Overall Study|Withdrawal by Subject|1|||
160970955|NCT00943306|581283634|FG000|Overall Study|Physician Decision|1|||
160970956|NCT00943306|581283634|FG000|Overall Study|Death|1|||
160970957|NCT00943306|581283634|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
160970958|NCT00733980|581283635|FG000|Overall Study|Adverse Event|5|||
160970959|NCT00733980|581283636|FG001|Overall Study|Adverse Event|2|||
160970960|NCT00733980|581283635|FG000|Overall Study|Lack of Efficacy|0|||
160970961|NCT00733980|581283636|FG001|Overall Study|Lack of Efficacy|1|||
160970962|NCT00733980|581283635|FG000|Overall Study|Protocol Violation|2|||
160970963|NCT00733980|581283636|FG001|Overall Study|Protocol Violation|1|||
160970964|NCT00733980|581283635|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
160970965|NCT00733980|581283636|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
160970966|NCT00733980|581283635|FG000|Overall Study|Lost to Follow-up|6|||
160970967|NCT00733980|581283636|FG001|Overall Study|Lost to Follow-up|11|||
160970968|NCT00733980|581283635|FG000|Overall Study|Physician Decision|2|||
160970969|NCT00733980|581283636|FG001|Overall Study|Physician Decision|3|||
160970970|NCT00733980|581283635|FG000|Overall Study|Withdrawal by Subject|6|||
160970971|NCT00733980|581283636|FG001|Overall Study|Withdrawal by Subject|2|||
160970972|NCT02739347|581283637|FG000|Overall Study|Adverse Event|3|||
160970973|NCT02739347|581283638|FG001|Overall Study|Adverse Event|0|||
160970974|NCT02739347|581283637|FG000|Overall Study|Protocol Violation|0|||
160970975|NCT02739347|581283638|FG001|Overall Study|Protocol Violation|1|||
160970976|NCT02739347|581283637|FG000|Overall Study|Lost to Follow-up|0|||
160970977|NCT02739347|581283638|FG001|Overall Study|Lost to Follow-up|2|||
160970978|NCT01552954|581283639|FG000|Overall Study|Adverse Event|1|||
160970979|NCT01552954|581283640|FG001|Overall Study|Adverse Event|2|||
160970980|NCT01552954|581283639|FG000|Overall Study|Lost to Follow-up|1|||
160970981|NCT01552954|581283640|FG001|Overall Study|Lost to Follow-up|1|||
160970982|NCT01552954|581283639|FG000|Overall Study|Withdrawal by Subject|1|||
160970983|NCT01552954|581283640|FG001|Overall Study|Withdrawal by Subject|1|||
160970984|NCT01552954|581283639|FG000|Overall Study|Protocol Violation|1|||
160970985|NCT01552954|581283640|FG001|Overall Study|Protocol Violation|2|||
160970986|NCT01552954|581283639|FG000|Overall Study|diagnosed DM|1|||
160970987|NCT01552954|581283640|FG001|Overall Study|diagnosed DM|0|||
160970988|NCT01931735|581283641|FG000|Randomized Phase|Lost to Follow-up|2|||
160970989|NCT01931735|581283642|FG001|Randomized Phase|Lost to Follow-up|2|||
160970990|NCT01931735|581283643|FG002|Randomized Phase|Lost to Follow-up|5|||
160970991|NCT01931735|581283644|FG003|Randomized Phase|Lost to Follow-up|0|||
160970992|NCT01931735|581283641|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
160970993|NCT01931735|581283642|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
160970994|NCT01931735|581283643|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
160970995|NCT01931735|581283644|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
160970996|NCT01931735|581283641|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
160587844|NCT00485589|579871503|FG000|Overall Study|Adverse Event|3|||
160587845|NCT00485589|579871504|FG001|Overall Study|Adverse Event|3|||
160587846|NCT00485589|579871505|FG002|Overall Study|Adverse Event|10|||
160970997|NCT01931735|581283642|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
160970998|NCT01931735|581283643|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
160970999|NCT01931735|581283644|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
160971000|NCT02719990|581283645|FG000|Overall Study|Physician Decision|2|||
160971001|NCT02719990|581283645|FG000|Overall Study|Withdrawal by Subject|2|||
160971002|NCT02719990|581283645|FG000|Overall Study|Study Terminated By Sponsor|32|||
160971003|NCT00652938|581283646|FG000|Overall Study|Adverse Event|1|||
160971004|NCT00652938|581283647|FG001|Overall Study|Adverse Event|0|||
160971005|NCT00652938|581283648|FG002|Overall Study|Adverse Event|2|||
160587847|NCT02924688|579871508|FG000|Overall Study|Adverse Event|9|||
160971006|NCT00652938|581283646|FG000|Overall Study|Withdrawal by Subject|0|||
160971007|NCT00652938|581283647|FG001|Overall Study|Withdrawal by Subject|6|||
160971008|NCT00652938|581283648|FG002|Overall Study|Withdrawal by Subject|1|||
160971009|NCT00652938|581283646|FG000|Overall Study|Lost to Follow-up|0|||
160971010|NCT00652938|581283647|FG001|Overall Study|Lost to Follow-up|0|||
160971011|NCT00652938|581283648|FG002|Overall Study|Lost to Follow-up|2|||
160971012|NCT00652938|581283646|FG000|Overall Study|fear of blood sampling|0|||
160971013|NCT00652938|581283647|FG001|Overall Study|fear of blood sampling|1|||
160971014|NCT00652938|581283648|FG002|Overall Study|fear of blood sampling|0|||
160971015|NCT03324880|581283649|FG000|Overall Study|Adverse Event|0|||
160971016|NCT03324880|581283650|FG001|Overall Study|Adverse Event|2|||
160971017|NCT03324880|581283649|FG000|Overall Study|Withdrawal by Subject|2|||
160971018|NCT03324880|581283650|FG001|Overall Study|Withdrawal by Subject|2|||
160971019|NCT03324880|581283649|FG000|Overall Study|Lost to Follow-up|0|||
160971020|NCT03324880|581283650|FG001|Overall Study|Lost to Follow-up|1|||
160971021|NCT03324880|581283649|FG000|Overall Study|Product Recall|0|||
160971022|NCT03324880|581283650|FG001|Overall Study|Product Recall|1|||
160971023|NCT01412801|581283654|FG000|Overall Study|Death|0|||
160971024|NCT01412801|581283655|FG001|Overall Study|Death|1|||
160971025|NCT01412801|581283656|FG002|Overall Study|Death|0|||
160971026|NCT01412801|581283657|FG003|Overall Study|Death|4|||
160971027|NCT01412801|581283658|FG004|Overall Study|Death|2|||
160971028|NCT01412801|581283659|FG005|Overall Study|Death|2|||
160971029|NCT01412801|581283654|FG000|Overall Study|Lost to Follow-up|1|||
160971030|NCT01412801|581283655|FG001|Overall Study|Lost to Follow-up|2|||
160971031|NCT01412801|581283656|FG002|Overall Study|Lost to Follow-up|4|||
160971032|NCT01412801|581283657|FG003|Overall Study|Lost to Follow-up|0|||
160971033|NCT01412801|581283658|FG004|Overall Study|Lost to Follow-up|1|||
160971034|NCT01412801|581283659|FG005|Overall Study|Lost to Follow-up|1|||
160971035|NCT01412801|581283654|FG000|Overall Study|Withdrawal by Subject|3|||
160971036|NCT01412801|581283655|FG001|Overall Study|Withdrawal by Subject|2|||
160971037|NCT01412801|581283656|FG002|Overall Study|Withdrawal by Subject|1|||
160971038|NCT01412801|581283657|FG003|Overall Study|Withdrawal by Subject|0|||
160971039|NCT01412801|581283658|FG004|Overall Study|Withdrawal by Subject|0|||
160971040|NCT01412801|581283659|FG005|Overall Study|Withdrawal by Subject|0|||
160971041|NCT01412801|581283654|FG000|Overall Study|Relocated to another area|0|||
160971042|NCT01412801|581283655|FG001|Overall Study|Relocated to another area|0|||
160971043|NCT01412801|581283656|FG002|Overall Study|Relocated to another area|2|||
160971044|NCT01412801|581283657|FG003|Overall Study|Relocated to another area|0|||
160971045|NCT01412801|581283658|FG004|Overall Study|Relocated to another area|0|||
160971046|NCT01412801|581283659|FG005|Overall Study|Relocated to another area|0|||
160971047|NCT01235403|581283660|FG000|Overall Study|Adverse Event|14|||
160971048|NCT01235403|581283660|FG000|Overall Study|Lost to Follow-up|2|||
160971049|NCT01235403|581283660|FG000|Overall Study|Withdrawal by Subject|4|||
160971050|NCT01235403|581283660|FG000|Overall Study|Lack of Efficacy|2|||
160971051|NCT01235403|581283660|FG000|Overall Study|Other reasons for premature termination|4|||
160971052|NCT01547299|581283661|FG000|Overall Study|Withdrawal by Subject|2|||
160971053|NCT01547299|581283662|FG001|Overall Study|Withdrawal by Subject|2|||
160971054|NCT00717314|581283664|FG000|Overall Study|Adverse Event|3|||
160971055|NCT00717314|581283665|FG001|Overall Study|Adverse Event|2|||
160971056|NCT00717314|581283664|FG000|Overall Study|Protocol Violation|1|||
160971057|NCT00717314|581283665|FG001|Overall Study|Protocol Violation|0|||
160971058|NCT00717314|581283664|FG000|Overall Study|Lost to Follow-up|1|||
160971059|NCT00717314|581283665|FG001|Overall Study|Lost to Follow-up|5|||
160971060|NCT00717314|581283664|FG000|Overall Study|Withdrawal by Subject|1|||
160971061|NCT00717314|581283665|FG001|Overall Study|Withdrawal by Subject|3|||
160971062|NCT05096208|581283666|FG000|Overall Study|Lost to Follow-up|3|||
160971063|NCT05096208|581283667|FG001|Overall Study|Lost to Follow-up|5|||
160971064|NCT05096208|581283668|FG002|Overall Study|Lost to Follow-up|5|||
160971065|NCT05096208|581283669|FG003|Overall Study|Lost to Follow-up|2|||
160971066|NCT05096208|581283666|FG000|Overall Study|Withdrawal by Subject|0|||
160971067|NCT05096208|581283667|FG001|Overall Study|Withdrawal by Subject|1|||
160971068|NCT05096208|581283668|FG002|Overall Study|Withdrawal by Subject|2|||
161023912|NCT03800654|581477376|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
160587848|NCT02924688|579871509|FG001|Overall Study|Adverse Event|3|||
160587849|NCT02924688|579871510|FG002|Overall Study|Adverse Event|2|||
160587850|NCT02924688|579871511|FG003|Overall Study|Adverse Event|2|||
161023913|NCT03800654|581477377|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
161023914|NCT03800654|581477378|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
161023915|NCT03800654|581477376|FG000|Overall Study|Lost to Follow-up|2|||
160460042|NCT02720068|579417515|FG014|Overall Study|Withdrawal by Subject|7|||
160460043|NCT02720068|579417516|FG015|Overall Study|Withdrawal by Subject|0|||
160587851|NCT02924688|579871512|FG004|Overall Study|Adverse Event|3|||
160971069|NCT05096208|581283669|FG003|Overall Study|Withdrawal by Subject|3|||
160971070|NCT05096208|581283666|FG000|Overall Study|No longer met eligibility criteria|1|||
160971071|NCT05096208|581283667|FG001|Overall Study|No longer met eligibility criteria|0|||
160971072|NCT05096208|581283668|FG002|Overall Study|No longer met eligibility criteria|0|||
160971073|NCT05096208|581283669|FG003|Overall Study|No longer met eligibility criteria|0|||
160971074|NCT05096208|581283666|FG000|Overall Study|Other|0|||
160971075|NCT05096208|581283667|FG001|Overall Study|Other|0|||
160971076|NCT05096208|581283668|FG002|Overall Study|Other|1|||
160971077|NCT05096208|581283669|FG003|Overall Study|Other|0|||
160971078|NCT01483937|581283671|FG000|Overall Study|Withdrawal by Subject|4|||
160971079|NCT01483937|581283672|FG001|Overall Study|Withdrawal by Subject|3|||
160971080|NCT02213328|581283673|FG000|Overall Study|Withdrawal by Subject|10|||
160971081|NCT02213328|581283673|FG000|Overall Study|Physician Decision|2|||
160971082|NCT02213328|581283673|FG000|Overall Study|Lost to Follow-up|16|||
160587852|NCT02924688|579871513|FG005|Overall Study|Adverse Event|2|||
160587853|NCT02924688|579871508|FG000|Overall Study|Lack of Efficacy|2|||
160587854|NCT02924688|579871509|FG001|Overall Study|Lack of Efficacy|3|||
160587855|NCT02924688|579871510|FG002|Overall Study|Lack of Efficacy|4|||
160587856|NCT02924688|579871511|FG003|Overall Study|Lack of Efficacy|2|||
160587857|NCT02924688|579871512|FG004|Overall Study|Lack of Efficacy|1|||
160587858|NCT02924688|579871513|FG005|Overall Study|Lack of Efficacy|1|||
160587859|NCT02924688|579871508|FG000|Overall Study|Protocol Violation|3|||
160587860|NCT02924688|579871509|FG001|Overall Study|Protocol Violation|7|||
160587861|NCT02924688|579871510|FG002|Overall Study|Protocol Violation|5|||
160587862|NCT02924688|579871511|FG003|Overall Study|Protocol Violation|6|||
160587863|NCT02924688|579871512|FG004|Overall Study|Protocol Violation|2|||
160587864|NCT02924688|579871513|FG005|Overall Study|Protocol Violation|2|||
160587865|NCT02924688|579871508|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
160587866|NCT02924688|579871509|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
160587867|NCT02924688|579871510|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
160587868|NCT02924688|579871511|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
160587869|NCT02924688|579871512|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
160587870|NCT02924688|579871513|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
160587871|NCT02924688|579871508|FG000|Overall Study|Lost to Follow-up|2|||
160587872|NCT02924688|579871509|FG001|Overall Study|Lost to Follow-up|4|||
160587873|NCT02924688|579871510|FG002|Overall Study|Lost to Follow-up|2|||
160587874|NCT02924688|579871511|FG003|Overall Study|Lost to Follow-up|4|||
160587875|NCT02924688|579871512|FG004|Overall Study|Lost to Follow-up|2|||
160587876|NCT02924688|579871513|FG005|Overall Study|Lost to Follow-up|4|||
160587877|NCT02924688|579871508|FG000|Overall Study|Physician Decision|2|||
160587878|NCT02924688|579871509|FG001|Overall Study|Physician Decision|1|||
160587879|NCT02924688|579871510|FG002|Overall Study|Physician Decision|0|||
160587880|NCT02924688|579871511|FG003|Overall Study|Physician Decision|1|||
160587881|NCT02924688|579871512|FG004|Overall Study|Physician Decision|1|||
160587882|NCT02924688|579871513|FG005|Overall Study|Physician Decision|1|||
160587883|NCT02924688|579871508|FG000|Overall Study|Withdrawal by Subject|14|||
160587884|NCT02924688|579871509|FG001|Overall Study|Withdrawal by Subject|13|||
160587885|NCT02924688|579871510|FG002|Overall Study|Withdrawal by Subject|9|||
160587886|NCT02924688|579871511|FG003|Overall Study|Withdrawal by Subject|12|||
160587887|NCT02924688|579871512|FG004|Overall Study|Withdrawal by Subject|13|||
160587888|NCT02924688|579871513|FG005|Overall Study|Withdrawal by Subject|14|||
160587889|NCT01944969|579871516|FG000|Overall Study|Adverse Event|1|||
160657118|NCT00688064|580125945|FG000|Overall Study|Withdrawal by Subject|7|||
160971083|NCT04043962|581283674|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
160971084|NCT04043962|581283674|FG000|Post-Treatment|Withdrawal by Subject|5|||
160971085|NCT04043962|581283674|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
160971086|NCT01874145|581283675|FG000|Core Period|Non-compliance|1|||
160971087|NCT01874145|581283676|FG001|Core Period|Non-compliance|0|||
160971088|NCT01874145|581283675|FG000|Core Period|Protocol Violation|1|||
160971089|NCT01874145|581283676|FG001|Core Period|Protocol Violation|1|||
160971090|NCT01874145|581283675|FG000|Core Period|Physician Decision|1|||
160971091|NCT01874145|581283676|FG001|Core Period|Physician Decision|1|||
160971092|NCT01874145|581283675|FG000|Core Period|Adverse Event|0|||
160971093|NCT01874145|581283676|FG001|Core Period|Adverse Event|1|||
160971094|NCT01874145|581283675|FG000|Core Period|Withdrawal by Subject|0|||
160971095|NCT01874145|581283676|FG001|Core Period|Withdrawal by Subject|4|||
160971096|NCT01874145|581283675|FG000|Extension Period|Adverse Event|3|||
160971097|NCT01874145|581283676|FG001|Extension Period|Adverse Event|2|||
160971098|NCT01874145|581283675|FG000|Extension Period|Withdrawal by Subject|2|||
160971099|NCT01874145|581283676|FG001|Extension Period|Withdrawal by Subject|1|||
160971100|NCT01874145|581283675|FG000|Extension Period|Lost to Follow-up|1|||
160971101|NCT01874145|581283676|FG001|Extension Period|Lost to Follow-up|1|||
160971102|NCT00402337|581283677|FG000|Overall Study|Adverse Event|0|||
160971103|NCT00402337|581283678|FG001|Overall Study|Adverse Event|2|||
160971104|NCT00402337|581283679|FG002|Overall Study|Adverse Event|2|||
160971105|NCT00402337|581283680|FG003|Overall Study|Adverse Event|3|||
160971106|NCT00402337|581283681|FG004|Overall Study|Adverse Event|2|||
160971107|NCT00402337|581283677|FG000|Overall Study|Noncompliance|0|||
160971108|NCT00402337|581283678|FG001|Overall Study|Noncompliance|0|||
160971109|NCT00402337|581283679|FG002|Overall Study|Noncompliance|0|||
160971110|NCT00402337|581283680|FG003|Overall Study|Noncompliance|0|||
160971111|NCT00402337|581283681|FG004|Overall Study|Noncompliance|2|||
160971112|NCT00402337|581283677|FG000|Overall Study|Withdrawal by Subject|5|||
160460044|NCT02720068|579417517|FG016|Overall Study|Withdrawal by Subject|0|||
160971113|NCT00402337|581283678|FG001|Overall Study|Withdrawal by Subject|3|||
160587890|NCT01944969|579871516|FG000|Overall Study|Lack of Efficacy|1|||
160587891|NCT01944969|579871516|FG000|Overall Study|Non-compliance with IMP|1|||
160587892|NCT01944969|579871516|FG000|Overall Study|Administrative or other reasons|23|||
160587893|NCT00424294|579871519|FG000|Overall Study|Adverse Event|4|||
160587894|NCT00424294|579871520|FG001|Overall Study|Adverse Event|10|||
160587895|NCT00424294|579871519|FG000|Overall Study|Lack of Efficacy|2|||
160971114|NCT00402337|581283679|FG002|Overall Study|Withdrawal by Subject|1|||
161023916|NCT03800654|581477377|FG001|Overall Study|Lost to Follow-up|1|||
161023917|NCT03800654|581477378|FG002|Overall Study|Lost to Follow-up|6|||
161023918|NCT03800654|581477376|FG000|Overall Study|Medical Health Issue|0|||
161023919|NCT03800654|581477377|FG001|Overall Study|Medical Health Issue|0|||
161023920|NCT03800654|581477378|FG002|Overall Study|Medical Health Issue|1|||
161023921|NCT03800654|581477376|FG000|Overall Study|Personal Issues|0|||
161023922|NCT03800654|581477377|FG001|Overall Study|Personal Issues|2|||
161023923|NCT03800654|581477378|FG002|Overall Study|Personal Issues|0|||
161023924|NCT03800654|581477376|FG000|Overall Study|Protocol Violation|0|||
161023925|NCT03800654|581477377|FG001|Overall Study|Protocol Violation|1|||
161023926|NCT03800654|581477378|FG002|Overall Study|Protocol Violation|0|||
160587896|NCT00424294|579871520|FG001|Overall Study|Lack of Efficacy|1|||
160587897|NCT00424294|579871519|FG000|Overall Study|Withdrawal by Subject|1|||
160587898|NCT00424294|579871520|FG001|Overall Study|Withdrawal by Subject|2|||
160587899|NCT00424294|579871519|FG000|Overall Study|Other|0|||
160587900|NCT00424294|579871520|FG001|Overall Study|Other|2|||
160587901|NCT00424294|579871519|FG000|Overall Study|Randomized but not Treated|1|||
160971115|NCT00402337|581283680|FG003|Overall Study|Withdrawal by Subject|6|||
160971116|NCT00402337|581283681|FG004|Overall Study|Withdrawal by Subject|4|||
160971117|NCT00402337|581283677|FG000|Overall Study|Lost to Follow-up|0|||
160971118|NCT00402337|581283678|FG001|Overall Study|Lost to Follow-up|0|||
160971119|NCT00402337|581283679|FG002|Overall Study|Lost to Follow-up|1|||
160971120|NCT00402337|581283680|FG003|Overall Study|Lost to Follow-up|2|||
160971121|NCT00402337|581283681|FG004|Overall Study|Lost to Follow-up|0|||
160971122|NCT00402337|581283677|FG000|Overall Study|Physician Decision|0|||
160971123|NCT00402337|581283678|FG001|Overall Study|Physician Decision|0|||
160971124|NCT00402337|581283679|FG002|Overall Study|Physician Decision|0|||
160971125|NCT00402337|581283680|FG003|Overall Study|Physician Decision|1|||
160971126|NCT00402337|581283681|FG004|Overall Study|Physician Decision|0|||
160971127|NCT00402337|581283677|FG000|Overall Study|Other Reason|0|||
160971128|NCT00402337|581283678|FG001|Overall Study|Other Reason|1|||
160971129|NCT00402337|581283679|FG002|Overall Study|Other Reason|0|||
160971130|NCT00402337|581283680|FG003|Overall Study|Other Reason|0|||
160971131|NCT00402337|581283681|FG004|Overall Study|Other Reason|0|||
160971132|NCT01833143|581283682|FG000|Overall Study|Not Treated|1|||
160971133|NCT00767104|581285490|FG000|Overall Study|Lost to Follow-up|1|||
160971134|NCT00767104|581285491|FG001|Overall Study|Lost to Follow-up|2|||
160971135|NCT00840996|581285492|FG000|Overall Study|Withdrawal by Subject|1|||
160971136|NCT00840996|581285493|FG001|Overall Study|Withdrawal by Subject|0|||
160971137|NCT02762981|581285494|FG000|Overall Study|Adverse Event|2|||
160971138|NCT02762981|581285495|FG001|Overall Study|Adverse Event|3|||
160971139|NCT02762981|581285496|FG002|Overall Study|Adverse Event|1|||
160971140|NCT02762981|581285497|FG003|Overall Study|Adverse Event|1|||
160971141|NCT02762981|581285498|FG004|Overall Study|Adverse Event|3|||
160971142|NCT02762981|581285494|FG000|Overall Study|Physician Decision|0|||
160971143|NCT02762981|581285495|FG001|Overall Study|Physician Decision|1|||
160971144|NCT02762981|581285496|FG002|Overall Study|Physician Decision|0|||
160971145|NCT02762981|581285497|FG003|Overall Study|Physician Decision|0|||
160971146|NCT02762981|581285498|FG004|Overall Study|Physician Decision|1|||
160971147|NCT02762981|581285494|FG000|Overall Study|Disease progression|11|||
160971148|NCT02762981|581285495|FG001|Overall Study|Disease progression|23|||
160971149|NCT02762981|581285496|FG002|Overall Study|Disease progression|4|||
160971150|NCT02762981|581285497|FG003|Overall Study|Disease progression|10|||
160971151|NCT02762981|581285498|FG004|Overall Study|Disease progression|1|||
160971152|NCT02762981|581285494|FG000|Overall Study|Enrolled not treated|1|||
160971153|NCT02762981|581285495|FG001|Overall Study|Enrolled not treated|5|||
160971154|NCT02762981|581285496|FG002|Overall Study|Enrolled not treated|0|||
160971155|NCT02762981|581285497|FG003|Overall Study|Enrolled not treated|2|||
160971156|NCT02762981|581285498|FG004|Overall Study|Enrolled not treated|0|||
160971157|NCT02762981|581285494|FG000|Overall Study|Other|2|||
160971158|NCT02762981|581285495|FG001|Overall Study|Other|3|||
160971159|NCT02762981|581285496|FG002|Overall Study|Other|1|||
160971160|NCT02762981|581285497|FG003|Overall Study|Other|0|||
160971161|NCT02762981|581285498|FG004|Overall Study|Other|0|||
160971162|NCT02762981|581285494|FG000|Overall Study|Missing|1|||
160971163|NCT02762981|581285495|FG001|Overall Study|Missing|0|||
160971164|NCT02762981|581285496|FG002|Overall Study|Missing|0|||
160971165|NCT02762981|581285497|FG003|Overall Study|Missing|0|||
160971166|NCT02762981|581285498|FG004|Overall Study|Missing|0|||
161023927|NCT03459729|581477379|FG000|Overall Study|Physician Decision|2|||
161023928|NCT06182033|581477380|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
160587902|NCT00424294|579871520|FG001|Overall Study|Randomized but not Treated|0|||
160587903|NCT02108951|579871521|FG000|Overall Study|Lost to Follow-up|1|||
160971167|NCT02762981|581285494|FG000|Overall Study|Withdrawal by Subject|0|||
160971168|NCT02762981|581285495|FG001|Overall Study|Withdrawal by Subject|5|||
160971169|NCT02762981|581285496|FG002|Overall Study|Withdrawal by Subject|1|||
160971170|NCT02762981|581285497|FG003|Overall Study|Withdrawal by Subject|3|||
160971171|NCT02762981|581285498|FG004|Overall Study|Withdrawal by Subject|0|||
160971172|NCT02145078|581285499|FG000|Overall Study|Death|1|||
160971173|NCT02145078|581285499|FG000|Overall Study|Reason not given|3|||
160971174|NCT01350141|581285500|FG000|Overall Study|Lost to Follow-up|1|||
160971175|NCT01350141|581285501|FG001|Overall Study|Lost to Follow-up|0|||
160971176|NCT01350141|581285502|FG002|Overall Study|Lost to Follow-up|1|||
160971177|NCT01350141|581285500|FG000|Overall Study|Withdrawal by Subject|1|||
160971178|NCT01350141|581285501|FG001|Overall Study|Withdrawal by Subject|0|||
160971179|NCT01350141|581285502|FG002|Overall Study|Withdrawal by Subject|0|||
160971180|NCT01350141|581285500|FG000|Overall Study|Randomized but not treated|1|||
160971181|NCT01350141|581285501|FG001|Overall Study|Randomized but not treated|0|||
160971182|NCT01350141|581285502|FG002|Overall Study|Randomized but not treated|0|||
160971183|NCT01616771|581285508|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
160971184|NCT04399356|581285513|FG000|Overall Study|Lost to Follow-up|1|||
160971185|NCT04399356|581285514|FG001|Overall Study|Lost to Follow-up|1|||
160971186|NCT04399356|581285513|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
160971187|NCT04399356|581285514|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
160971188|NCT04399356|581285513|FG000|Overall Study|Withdrawal by Subject|1|||
160971189|NCT04399356|581285514|FG001|Overall Study|Withdrawal by Subject|0|||
160971190|NCT04359771|581285515|FG000|Overall Study|Lack of Efficacy|2|||
160971191|NCT04359771|581285516|FG001|Overall Study|Lack of Efficacy|2|||
160971192|NCT04041440|581285518|FG000|Overall Study|Withdrawal by Subject|0|||
160971193|NCT04041440|581285519|FG001|Overall Study|Withdrawal by Subject|1|||
160971194|NCT04041440|581285518|FG000|Overall Study|Lost to Follow-up|0|||
160971195|NCT04041440|581285519|FG001|Overall Study|Lost to Follow-up|1|||
160971196|NCT02306265|581285520|FG000|Overall Study|Withdrawal by Subject|1|||
160971197|NCT02247804|581285525|FG000|Treatment Period 1|Adverse Event|9|||
160971198|NCT02247804|581285526|FG001|Treatment Period 1|Adverse Event|2|||
160971199|NCT02247804|581285527|FG002|Treatment Period 1|Adverse Event|0|||
160971200|NCT02247804|581285525|FG000|Treatment Period 1|Lack of Efficacy|0|||
160971201|NCT02247804|581285526|FG001|Treatment Period 1|Lack of Efficacy|0|||
160971202|NCT02247804|581285527|FG002|Treatment Period 1|Lack of Efficacy|2|||
160971203|NCT02247804|581285525|FG000|Treatment Period 1|Lost to Follow-up|1|||
160971204|NCT02247804|581285526|FG001|Treatment Period 1|Lost to Follow-up|0|||
160971205|NCT02247804|581285527|FG002|Treatment Period 1|Lost to Follow-up|2|||
160971206|NCT02247804|581285525|FG000|Treatment Period 1|Personal Reasons|7|||
160971207|NCT02247804|581285526|FG001|Treatment Period 1|Personal Reasons|1|||
160971208|NCT02247804|581285527|FG002|Treatment Period 1|Personal Reasons|2|||
160971209|NCT02247804|581285525|FG000|Treatment Period 1|Protocol Deviation|0|||
160971210|NCT02247804|581285526|FG001|Treatment Period 1|Protocol Deviation|0|||
160971211|NCT02247804|581285527|FG002|Treatment Period 1|Protocol Deviation|1|||
160971212|NCT02247804|581285525|FG000|Treatment Period 1|Randomized but not Treated|5|||
160971213|NCT02247804|581285526|FG001|Treatment Period 1|Randomized but not Treated|1|||
160971214|NCT02247804|581285527|FG002|Treatment Period 1|Randomized but not Treated|1|||
160971215|NCT02247804|581285525|FG000|Treatment Period 2|Adverse Event|6|||
160971216|NCT02247804|581285526|FG001|Treatment Period 2|Adverse Event|3|||
160971217|NCT02247804|581285527|FG002|Treatment Period 2|Adverse Event|3|||
160971218|NCT02247804|581285525|FG000|Treatment Period 2|Lack of Efficacy|0|||
160971219|NCT02247804|581285526|FG001|Treatment Period 2|Lack of Efficacy|0|||
160971220|NCT02247804|581285527|FG002|Treatment Period 2|Lack of Efficacy|1|||
160587904|NCT02108951|579871521|FG000|Overall Study|Patient's/guardian's decision|1|||
160587905|NCT02108951|579871521|FG000|Overall Study|Study Terminated by Sponsor|14|||
160587906|NCT01098461|579871526|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
160587907|NCT01098461|579871527|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
160587908|NCT01098461|579871528|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
160587909|NCT01098461|579871529|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
160587910|NCT01098461|579871526|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
160971221|NCT02247804|581285525|FG000|Treatment Period 2|Lost to Follow-up|0|||
160971222|NCT02247804|581285526|FG001|Treatment Period 2|Lost to Follow-up|1|||
160971223|NCT02247804|581285527|FG002|Treatment Period 2|Lost to Follow-up|1|||
160971224|NCT02247804|581285525|FG000|Treatment Period 2|Personal Reasons|2|||
160971225|NCT02247804|581285526|FG001|Treatment Period 2|Personal Reasons|1|||
160971226|NCT02247804|581285527|FG002|Treatment Period 2|Personal Reasons|1|||
160971227|NCT02247804|581285525|FG000|Treatment Period 2|Reason not Specified|0|||
161023929|NCT06182033|581477381|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
160657119|NCT00688064|580125946|FG001|Overall Study|Withdrawal by Subject|7|||
160971228|NCT02247804|581285526|FG001|Treatment Period 2|Reason not Specified|0|||
160971229|NCT02247804|581285527|FG002|Treatment Period 2|Reason not Specified|2|||
160971230|NCT02247804|581285525|FG000|Treatment Period 3|Adverse Event|4|||
160971231|NCT02247804|581285526|FG001|Treatment Period 3|Adverse Event|3|||
160971232|NCT02247804|581285527|FG002|Treatment Period 3|Adverse Event|3|||
160971233|NCT02247804|581285525|FG000|Treatment Period 3|Lack of Efficacy|0|||
160971234|NCT02247804|581285526|FG001|Treatment Period 3|Lack of Efficacy|1|||
160971235|NCT02247804|581285527|FG002|Treatment Period 3|Lack of Efficacy|0|||
160971236|NCT02247804|581285525|FG000|Treatment Period 3|Lost to Follow-up|1|||
160971237|NCT02247804|581285526|FG001|Treatment Period 3|Lost to Follow-up|2|||
160971238|NCT02247804|581285527|FG002|Treatment Period 3|Lost to Follow-up|2|||
160657120|NCT00688064|580125945|FG000|Overall Study|Lost to Follow-up|10|||
160587911|NCT01098461|579871527|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
160587912|NCT01098461|579871528|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
160587913|NCT01098461|579871529|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
160587914|NCT01098461|579871526|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
160587915|NCT01098461|579871527|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
160587916|NCT01098461|579871528|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
160587917|NCT01098461|579871529|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
160587918|NCT01098461|579871526|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
160587919|NCT01098461|579871527|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
160587920|NCT01098461|579871528|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
160587921|NCT01098461|579871529|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
160587922|NCT01098461|579871526|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
160587923|NCT01098461|579871527|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
160971239|NCT02247804|581285525|FG000|Treatment Period 3|Personal Reasons|4|||
160971240|NCT02247804|581285526|FG001|Treatment Period 3|Personal Reasons|3|||
160971241|NCT02247804|581285527|FG002|Treatment Period 3|Personal Reasons|2|||
160587924|NCT01098461|579871528|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
160587925|NCT01098461|579871529|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
160971242|NCT02247804|581285525|FG000|Treatment Period 3|Reason not Specified|2|||
160971243|NCT02247804|581285526|FG001|Treatment Period 3|Reason not Specified|1|||
160971244|NCT02247804|581285527|FG002|Treatment Period 3|Reason not Specified|3|||
160971245|NCT01346514|581285530|FG000|Overall Study|Lost to Follow-up|19|||
160971246|NCT01346514|581285531|FG001|Overall Study|Lost to Follow-up|30|||
160971247|NCT01346514|581285530|FG000|Overall Study|Withdrawal by Subject|7|||
160971248|NCT01346514|581285531|FG001|Overall Study|Withdrawal by Subject|3|||
160971249|NCT01346514|581285530|FG000|Overall Study|Death|3|||
160971250|NCT01346514|581285531|FG001|Overall Study|Death|4|||
160971251|NCT00909480|581285532|FG000|Overall Study|Adverse Event|5|||
160971252|NCT00909480|581285533|FG001|Overall Study|Adverse Event|3|||
160971253|NCT00909480|581285532|FG000|Overall Study|Protocol Violation|6|||
160971254|NCT00909480|581285533|FG001|Overall Study|Protocol Violation|8|||
160971255|NCT00909480|581285532|FG000|Overall Study|Withdrawal criteria|9|||
160971256|NCT00909480|581285533|FG001|Overall Study|Withdrawal criteria|11|||
160971257|NCT00909480|581285532|FG000|Overall Study|Unclassified|18|||
160971258|NCT00909480|581285533|FG001|Overall Study|Unclassified|19|||
160971259|NCT03002038|581285537|FG000|Overall Study|Adverse Event|3|||
160971260|NCT03002038|581285538|FG001|Overall Study|Adverse Event|1|||
160971261|NCT03002038|581285537|FG000|Overall Study|Withdrawal by Subject|8|||
160971262|NCT03002038|581285538|FG001|Overall Study|Withdrawal by Subject|4|||
160971263|NCT03002038|581285537|FG000|Overall Study|Immigration to another region|0|||
160971264|NCT03002038|581285538|FG001|Overall Study|Immigration to another region|2|||
160971265|NCT01054573|581285539|FG000|Overall Study|Adverse Event|1|||
160971266|NCT01054573|581285540|FG001|Overall Study|Adverse Event|0|||
160971267|NCT01054573|581285541|FG002|Overall Study|Adverse Event|1|||
160971268|NCT01054573|581285542|FG003|Overall Study|Adverse Event|1|||
160971269|NCT01054573|581285539|FG000|Overall Study|Lost to Follow-up|0|||
160971270|NCT01054573|581285540|FG001|Overall Study|Lost to Follow-up|2|||
160971271|NCT01054573|581285541|FG002|Overall Study|Lost to Follow-up|0|||
160971272|NCT01054573|581285542|FG003|Overall Study|Lost to Follow-up|0|||
160971273|NCT01054573|581285539|FG000|Overall Study|Withdrawal by Subject|0|||
160971274|NCT01054573|581285540|FG001|Overall Study|Withdrawal by Subject|2|||
160971275|NCT01054573|581285541|FG002|Overall Study|Withdrawal by Subject|2|||
160971276|NCT01054573|581285542|FG003|Overall Study|Withdrawal by Subject|1|||
160971277|NCT03812536|581285543|FG000|Overall Study|Protocol Violation|2|||
160971278|NCT03812536|581285544|FG001|Overall Study|Protocol Violation|0|||
160971279|NCT03812536|581285543|FG000|Overall Study|Withdrawal by Subject|1|||
160971280|NCT03812536|581285544|FG001|Overall Study|Withdrawal by Subject|1|||
160971281|NCT00152009|581285545|FG000|Overall Study|Adverse Event|9|||
160971282|NCT00152009|581285546|FG001|Overall Study|Adverse Event|13|||
160971283|NCT00152009|581285547|FG002|Overall Study|Adverse Event|20|||
160971284|NCT00152009|581285548|FG003|Overall Study|Adverse Event|1|||
160971285|NCT00152009|581285545|FG000|Overall Study|Protocol Violation|3|||
160971286|NCT00152009|581285546|FG001|Overall Study|Protocol Violation|0|||
160971287|NCT00152009|581285547|FG002|Overall Study|Protocol Violation|0|||
160971288|NCT00152009|581285548|FG003|Overall Study|Protocol Violation|1|||
160971289|NCT00152009|581285545|FG000|Overall Study|Withdrawal by Subject|2|||
160971290|NCT00152009|581285546|FG001|Overall Study|Withdrawal by Subject|3|||
160971291|NCT00152009|581285547|FG002|Overall Study|Withdrawal by Subject|4|||
160971292|NCT00152009|581285548|FG003|Overall Study|Withdrawal by Subject|9|||
160971293|NCT00152009|581285545|FG000|Overall Study|Lost to Follow-up|2|||
160971294|NCT00152009|581285546|FG001|Overall Study|Lost to Follow-up|4|||
160971295|NCT00152009|581285547|FG002|Overall Study|Lost to Follow-up|3|||
160971296|NCT00152009|581285548|FG003|Overall Study|Lost to Follow-up|3|||
160971297|NCT00152009|581285545|FG000|Overall Study|Lack of Efficacy|8|||
160971298|NCT00152009|581285546|FG001|Overall Study|Lack of Efficacy|6|||
160971299|NCT00152009|581285547|FG002|Overall Study|Lack of Efficacy|7|||
160971300|NCT00152009|581285548|FG003|Overall Study|Lack of Efficacy|15|||
160971301|NCT00152009|581285545|FG000|Overall Study|ECG abnormalities|2|||
160971302|NCT00152009|581285546|FG001|Overall Study|ECG abnormalities|2|||
160971303|NCT00152009|581285547|FG002|Overall Study|ECG abnormalities|2|||
160971304|NCT00152009|581285548|FG003|Overall Study|ECG abnormalities|1|||
160971305|NCT00152009|581285545|FG000|Overall Study|Sponsor's decision|3|||
160971306|NCT00152009|581285546|FG001|Overall Study|Sponsor's decision|3|||
160971307|NCT00152009|581285547|FG002|Overall Study|Sponsor's decision|1|||
160971308|NCT00152009|581285548|FG003|Overall Study|Sponsor's decision|3|||
160971309|NCT01306201|581285549|FG000|Overall Study|Arrhythmia|4|||
160971310|NCT01306201|581285549|FG000|Overall Study|Files could not be processed|3|||
160971311|NCT01306201|581285549|FG000|Overall Study|Files unreadable|3|||
160971312|NCT00393523|581285550|FG000|Overall Study|Lost to Follow-up|0|||
160971313|NCT00393523|581285551|FG001|Overall Study|Lost to Follow-up|0|||
160971314|NCT00393523|581285552|FG002|Overall Study|Lost to Follow-up|0|||
160971315|NCT00393523|581285553|FG003|Overall Study|Lost to Follow-up|2|||
160971316|NCT00393523|581285554|FG004|Overall Study|Lost to Follow-up|1|||
160971317|NCT00393523|581285550|FG000|Overall Study|Protocol Violation|6|||
160971318|NCT00393523|581285551|FG001|Overall Study|Protocol Violation|2|||
160971319|NCT00393523|581285552|FG002|Overall Study|Protocol Violation|0|||
160971320|NCT00393523|581285553|FG003|Overall Study|Protocol Violation|1|||
160971321|NCT00393523|581285554|FG004|Overall Study|Protocol Violation|0|||
160971322|NCT00393523|581285550|FG000|Overall Study|Withdrawal by Subject|6|||
160971323|NCT00393523|581285551|FG001|Overall Study|Withdrawal by Subject|7|||
160971324|NCT00393523|581285552|FG002|Overall Study|Withdrawal by Subject|2|||
160971325|NCT00393523|581285553|FG003|Overall Study|Withdrawal by Subject|3|||
160971326|NCT00393523|581285554|FG004|Overall Study|Withdrawal by Subject|0|||
160971327|NCT00393523|581285550|FG000|Overall Study|Difficulties in specimen collection|0|||
160971328|NCT00393523|581285551|FG001|Overall Study|Difficulties in specimen collection|0|||
160971329|NCT00393523|581285552|FG002|Overall Study|Difficulties in specimen collection|1|||
160971330|NCT00393523|581285553|FG003|Overall Study|Difficulties in specimen collection|0|||
160971331|NCT00393523|581285554|FG004|Overall Study|Difficulties in specimen collection|0|||
160971332|NCT00393523|581285550|FG000|Overall Study|Vaccine supply issue|0|||
160971333|NCT00393523|581285551|FG001|Overall Study|Vaccine supply issue|0|||
160971334|NCT00393523|581285552|FG002|Overall Study|Vaccine supply issue|1|||
160971335|NCT00393523|581285553|FG003|Overall Study|Vaccine supply issue|0|||
160971336|NCT00393523|581285554|FG004|Overall Study|Vaccine supply issue|0|||
160971337|NCT01735396|581285560|FG000|Overall Study|not evaluable|1|||
160971338|NCT00980005|581285563|FG000|Overall Study|Withdrawal by Subject|6|||
160971339|NCT00980005|581285564|FG001|Overall Study|Withdrawal by Subject|17|||
160971340|NCT00980005|581285563|FG000|Overall Study|Lost to Follow-up|37|||
160971341|NCT00980005|581285564|FG001|Overall Study|Lost to Follow-up|43|||
160971342|NCT00980005|581285563|FG000|Overall Study|Other|4|||
160971343|NCT00980005|581285564|FG001|Overall Study|Other|3|||
160971344|NCT00572624|581285565|FG000|Overall Study|Lost to Follow-up|10|||
160971345|NCT00572624|581285566|FG001|Overall Study|Lost to Follow-up|4|||
160971346|NCT00572624|581285565|FG000|Overall Study|Wanted to do a different diet program|1|||
160971347|NCT00572624|581285566|FG001|Overall Study|Wanted to do a different diet program|0|||
160971348|NCT00572624|581285565|FG000|Overall Study|Medication change|1|||
160971349|NCT00572624|581285566|FG001|Overall Study|Medication change|0|||
160971350|NCT00572624|581285565|FG000|Overall Study|Started a new job-- no time for study|1|||
160971351|NCT00572624|581285566|FG001|Overall Study|Started a new job-- no time for study|0|||
160971352|NCT00572624|581285565|FG000|Overall Study|Admitted to being a smoker|1|||
161023930|NCT06182033|581477380|FG000|Overall Study|Target child relocation|1|||
161023931|NCT06182033|581477381|FG001|Overall Study|Target child relocation|1|||
161023932|NCT06182033|581477380|FG000|Overall Study|Withdrawal by Subject|1|||
160587926|NCT01098461|579871526|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
160587927|NCT01098461|579871527|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
160587928|NCT01098461|579871528|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
160587929|NCT01098461|579871529|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
160587930|NCT01098461|579871526|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
161023933|NCT06182033|581477381|FG001|Overall Study|Withdrawal by Subject|0|||
161023934|NCT02626533|581477383|FG000|Overall Study|Protocol Violation|14|||
161023935|NCT02626533|581477383|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
161023936|NCT02626533|581477383|FG000|Overall Study|Withdrawal by Subject|1|||
161023937|NCT05576155|581477386|FG000|Overall Study|Withdrawal by Subject|1|||
161023938|NCT05576155|581477387|FG001|Overall Study|Withdrawal by Subject|1|||
160587931|NCT01098461|579871527|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
160587932|NCT01098461|579871528|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
160971353|NCT00572624|581285566|FG001|Overall Study|Admitted to being a smoker|0|||
160971354|NCT00572624|581285565|FG000|Overall Study|Refused to do the stress test|1|||
160971355|NCT00572624|581285566|FG001|Overall Study|Refused to do the stress test|0|||
160971356|NCT00572624|581285565|FG000|Overall Study|Problem with vascular access|1|||
161023939|NCT04515849|581477388|FG000|Overall Study|Adverse Event|0|||
161023940|NCT04515849|581477389|FG001|Overall Study|Adverse Event|0|||
161023941|NCT04515849|581477390|FG002|Overall Study|Adverse Event|0|||
161023942|NCT04515849|581477391|FG003|Overall Study|Adverse Event|1|||
161023943|NCT04515849|581477392|FG004|Overall Study|Adverse Event|2|||
161023944|NCT04515849|581477388|FG000|Overall Study|Death|2|||
161023945|NCT04515849|581477389|FG001|Overall Study|Death|0|||
161023946|NCT04515849|581477390|FG002|Overall Study|Death|0|||
161023947|NCT04515849|581477391|FG003|Overall Study|Death|0|||
160971357|NCT00572624|581285566|FG001|Overall Study|Problem with vascular access|0|||
160971358|NCT00572624|581285565|FG000|Overall Study|Health issues unrelated to the study|1|||
160971359|NCT00572624|581285566|FG001|Overall Study|Health issues unrelated to the study|0|||
160971360|NCT00098254|581285571|FG000|Overall Study|Adverse Event|2|||
160971361|NCT00098254|581285571|FG000|Overall Study|Death|1|||
160971362|NCT02118337|581285572|FG000|Overall Study|Other|1|||
160971363|NCT02118337|581285573|FG001|Overall Study|Other|0|||
160971364|NCT02118337|581285574|FG002|Overall Study|Other|0|||
160971365|NCT02118337|581285575|FG003|Overall Study|Other|0|||
160971366|NCT02118337|581285576|FG004|Overall Study|Other|2|||
160971367|NCT02118337|581285577|FG005|Overall Study|Other|3|||
160971368|NCT02118337|581285578|FG006|Overall Study|Other|1|||
160971369|NCT02118337|581285579|FG007|Overall Study|Other|28|||
160971370|NCT02118337|581285580|FG008|Overall Study|Other|15|||
160971371|NCT02118337|581285572|FG000|Overall Study|Lost to Follow-up|0|||
160971372|NCT02118337|581285573|FG001|Overall Study|Lost to Follow-up|0|||
160971373|NCT02118337|581285574|FG002|Overall Study|Lost to Follow-up|0|||
160971374|NCT02118337|581285575|FG003|Overall Study|Lost to Follow-up|0|||
160971375|NCT02118337|581285576|FG004|Overall Study|Lost to Follow-up|0|||
160971376|NCT02118337|581285577|FG005|Overall Study|Lost to Follow-up|0|||
160971377|NCT02118337|581285578|FG006|Overall Study|Lost to Follow-up|0|||
160971378|NCT02118337|581285579|FG007|Overall Study|Lost to Follow-up|1|||
160971379|NCT02118337|581285580|FG008|Overall Study|Lost to Follow-up|0|||
160971380|NCT02118337|581285572|FG000|Overall Study|Withdrawal by Subject|1|||
160971381|NCT02118337|581285573|FG001|Overall Study|Withdrawal by Subject|3|||
160971382|NCT02118337|581285574|FG002|Overall Study|Withdrawal by Subject|2|||
160971383|NCT02118337|581285575|FG003|Overall Study|Withdrawal by Subject|1|||
160971384|NCT02118337|581285576|FG004|Overall Study|Withdrawal by Subject|2|||
160971385|NCT02118337|581285577|FG005|Overall Study|Withdrawal by Subject|2|||
160971386|NCT02118337|581285578|FG006|Overall Study|Withdrawal by Subject|1|||
160971387|NCT02118337|581285579|FG007|Overall Study|Withdrawal by Subject|4|||
160971388|NCT02118337|581285580|FG008|Overall Study|Withdrawal by Subject|2|||
160971389|NCT02118337|581285572|FG000|Overall Study|Death|2|||
160971390|NCT02118337|581285573|FG001|Overall Study|Death|2|||
160971391|NCT02118337|581285574|FG002|Overall Study|Death|1|||
160971392|NCT02118337|581285575|FG003|Overall Study|Death|2|||
160971393|NCT02118337|581285576|FG004|Overall Study|Death|5|||
160971394|NCT02118337|581285577|FG005|Overall Study|Death|1|||
160971395|NCT02118337|581285578|FG006|Overall Study|Death|2|||
160971396|NCT02118337|581285579|FG007|Overall Study|Death|9|||
160971397|NCT02118337|581285580|FG008|Overall Study|Death|4|||
160971398|NCT00130793|581285582|FG000|Overall Study|Lost to Follow-up|1|||
160971399|NCT00130793|581285583|FG001|Overall Study|Lost to Follow-up|4|||
160971400|NCT00130793|581285582|FG000|Overall Study|Withdrew consent|2|||
160971401|NCT00130793|581285583|FG001|Overall Study|Withdrew consent|0|||
160971402|NCT00211237|581285584|FG000|Baseline|Withdrew|1|||
160971403|NCT00211237|581285585|FG001|Baseline|Withdrew|3|||
160971404|NCT00211237|581285586|FG002|Baseline|Withdrew|0|||
160971405|NCT00211237|581285584|FG000|Baseline|Refused random assignment|1|||
160971406|NCT00211237|581285585|FG001|Baseline|Refused random assignment|0|||
160971407|NCT00211237|581285586|FG002|Baseline|Refused random assignment|0|||
160971408|NCT00211237|581285584|FG000|1 Month|Death|2|||
160971409|NCT00211237|581285585|FG001|1 Month|Death|1|||
160971410|NCT00211237|581285586|FG002|1 Month|Death|0|||
160971411|NCT00211237|581285584|FG000|1 Month|Lost to Follow-up|0|||
160971412|NCT00211237|581285585|FG001|1 Month|Lost to Follow-up|2|||
160971413|NCT00211237|581285586|FG002|1 Month|Lost to Follow-up|0|||
160971414|NCT00211237|581285584|FG000|1 Month|Withdrew|0|||
160971415|NCT00211237|581285585|FG001|1 Month|Withdrew|4|||
160971416|NCT00211237|581285586|FG002|1 Month|Withdrew|0|||
160971417|NCT00211237|581285584|FG000|1 Month|Additional surgery needed|1|||
160971418|NCT00211237|581285585|FG001|1 Month|Additional surgery needed|0|||
160971419|NCT00211237|581285586|FG002|1 Month|Additional surgery needed|0|||
160971420|NCT00211237|581285584|FG000|1 Month|Non-medical problem|0|||
161023948|NCT04515849|581477392|FG004|Overall Study|Death|0|||
161023949|NCT04515849|581477388|FG000|Overall Study|Other:family emergency|0|||
160460045|NCT02720068|579417518|FG017|Overall Study|Withdrawal by Subject|2|||
160971421|NCT00211237|581285585|FG001|1 Month|Non-medical problem|2|||
160971422|NCT00211237|581285586|FG002|1 Month|Non-medical problem|0|||
160971423|NCT00211237|581285584|FG000|3 Months|Death|7|||
160971424|NCT00211237|581285585|FG001|3 Months|Death|3|||
160971425|NCT00211237|581285586|FG002|3 Months|Death|0|||
160971426|NCT00211237|581285584|FG000|3 Months|Could not comply with protocol|1|||
160971427|NCT00211237|581285585|FG001|3 Months|Could not comply with protocol|0|||
160971428|NCT00211237|581285586|FG002|3 Months|Could not comply with protocol|0|||
160971429|NCT00211237|581285584|FG000|3 Months|Withdrew|0|||
160971430|NCT00211237|581285585|FG001|3 Months|Withdrew|1|||
160971431|NCT00211237|581285586|FG002|3 Months|Withdrew|0|||
160971432|NCT00211237|581285584|FG000|3 Months|Non-medical problem|0|||
160971433|NCT00211237|581285585|FG001|3 Months|Non-medical problem|0|||
160971434|NCT00211237|581285586|FG002|3 Months|Non-medical problem|1|||
160971435|NCT00211237|581285584|FG000|6 Months|Death|6|||
160971436|NCT00211237|581285585|FG001|6 Months|Death|0|||
160971437|NCT00211237|581285586|FG002|6 Months|Death|3|||
160971438|NCT00211237|581285584|FG000|6 Months|Lost to Follow-up|2|||
160971439|NCT00211237|581285585|FG001|6 Months|Lost to Follow-up|0|||
160971440|NCT00211237|581285586|FG002|6 Months|Lost to Follow-up|0|||
160971441|NCT00211237|581285584|FG000|6 Months|Could not comply with protocol|0|||
160971442|NCT00211237|581285585|FG001|6 Months|Could not comply with protocol|2|||
160971443|NCT00211237|581285586|FG002|6 Months|Could not comply with protocol|0|||
160971444|NCT00211237|581285584|FG000|12 Months|Death|8|||
160971445|NCT00211237|581285585|FG001|12 Months|Death|2|||
160971446|NCT00211237|581285586|FG002|12 Months|Death|3|||
160971447|NCT00211237|581285584|FG000|12 Months|Lost to Follow-up|1|||
160971448|NCT00211237|581285585|FG001|12 Months|Lost to Follow-up|0|||
160971449|NCT00211237|581285586|FG002|12 Months|Lost to Follow-up|1|||
160971450|NCT00211237|581285584|FG000|12 Months|Withdrew|0|||
160971451|NCT00211237|581285585|FG001|12 Months|Withdrew|0|||
160971452|NCT00211237|581285586|FG002|12 Months|Withdrew|1|||
160971453|NCT00211237|581285584|FG000|12 Months|unrelated medical problem|0|||
160971454|NCT00211237|581285585|FG001|12 Months|unrelated medical problem|0|||
160971455|NCT00211237|581285586|FG002|12 Months|unrelated medical problem|1|||
160971456|NCT01003639|581285589|FG000|Overall Study|Lost to Follow-up|6|||
160971457|NCT01003639|581285590|FG001|Overall Study|Lost to Follow-up|9|||
160971458|NCT01003639|581285589|FG000|Overall Study|Withdrawal by Subject|9|||
160971459|NCT01003639|581285590|FG001|Overall Study|Withdrawal by Subject|5|||
160971460|NCT01003639|581285589|FG000|Overall Study|Lack of Efficacy|1|||
160971461|NCT01003639|581285590|FG001|Overall Study|Lack of Efficacy|6|||
160971462|NCT01003639|581285589|FG000|Overall Study|Adverse Event|0|||
160971463|NCT01003639|581285590|FG001|Overall Study|Adverse Event|1|||
160971464|NCT01003639|581285589|FG000|Overall Study|Protocol Violation|0|||
160971465|NCT01003639|581285590|FG001|Overall Study|Protocol Violation|1|||
160971466|NCT01003639|581285589|FG000|Overall Study|Physician Decision|1|||
160971467|NCT01003639|581285590|FG001|Overall Study|Physician Decision|0|||
160971468|NCT03724396|581285591|FG000|Overall Study|Lost to Follow-up|1|||
160971469|NCT03724396|581285592|FG001|Overall Study|Lost to Follow-up|1|||
160971470|NCT03724396|581285591|FG000|Overall Study|Withdrawal by Subject|1|||
160971471|NCT03724396|581285592|FG001|Overall Study|Withdrawal by Subject|0|||
160971472|NCT02237508|581285594|FG000|Overall Study|Withdrawal by Subject|0|||
160971473|NCT02237508|581285595|FG001|Overall Study|Withdrawal by Subject|2|||
160971474|NCT02237508|581285596|FG002|Overall Study|Withdrawal by Subject|0|||
160971475|NCT02237508|581285597|FG003|Overall Study|Withdrawal by Subject|1|||
160971476|NCT02237508|581285598|FG004|Overall Study|Withdrawal by Subject|0|||
160971477|NCT02237508|581285599|FG005|Overall Study|Withdrawal by Subject|1|||
160971478|NCT02237508|581285600|FG006|Overall Study|Withdrawal by Subject|1|||
160971479|NCT02237508|581285601|FG007|Overall Study|Withdrawal by Subject|0|||
160971480|NCT02237508|581285602|FG008|Overall Study|Withdrawal by Subject|1|||
160971481|NCT02237508|581285603|FG009|Overall Study|Withdrawal by Subject|0|||
160971482|NCT02237508|581285594|FG000|Overall Study|Physician Decision|0|||
160971483|NCT02237508|581285595|FG001|Overall Study|Physician Decision|1|||
160971484|NCT02237508|581285596|FG002|Overall Study|Physician Decision|0|||
160971485|NCT02237508|581285597|FG003|Overall Study|Physician Decision|0|||
160971486|NCT02237508|581285598|FG004|Overall Study|Physician Decision|0|||
160971487|NCT02237508|581285599|FG005|Overall Study|Physician Decision|0|||
160971488|NCT02237508|581285600|FG006|Overall Study|Physician Decision|0|||
160971489|NCT02237508|581285601|FG007|Overall Study|Physician Decision|0|||
160971490|NCT02237508|581285602|FG008|Overall Study|Physician Decision|0|||
160971491|NCT02237508|581285603|FG009|Overall Study|Physician Decision|0|||
160971492|NCT02237508|581285594|FG000|Overall Study|Protocol Violation|0|||
160971493|NCT02237508|581285595|FG001|Overall Study|Protocol Violation|0|||
160971494|NCT02237508|581285596|FG002|Overall Study|Protocol Violation|1|||
160971495|NCT02237508|581285597|FG003|Overall Study|Protocol Violation|0|||
160971496|NCT02237508|581285598|FG004|Overall Study|Protocol Violation|0|||
160971497|NCT02237508|581285599|FG005|Overall Study|Protocol Violation|0|||
160971498|NCT02237508|581285600|FG006|Overall Study|Protocol Violation|0|||
160971499|NCT02237508|581285601|FG007|Overall Study|Protocol Violation|0|||
160971500|NCT02237508|581285602|FG008|Overall Study|Protocol Violation|0|||
160971501|NCT02237508|581285603|FG009|Overall Study|Protocol Violation|0|||
160971502|NCT01650519|581285604|FG000|Overall Study|Withdrawal by Subject|1|||
160971503|NCT01650519|581285605|FG001|Overall Study|Withdrawal by Subject|0|||
160971504|NCT04000594|581285607|FG000|Overall Study|Withdrawal by Subject|1|||
160971505|NCT04000594|581285608|FG001|Overall Study|Withdrawal by Subject|0|||
160971506|NCT04000594|581285609|FG002|Overall Study|Withdrawal by Subject|0|||
160971507|NCT03489057|581285610|FG000|Overall Study|Lost to Follow-up|16|||
160971508|NCT03489057|581285611|FG001|Overall Study|Lost to Follow-up|16|||
160971509|NCT03489057|581285612|FG002|Overall Study|Lost to Follow-up|14|||
160971510|NCT03489057|581285613|FG003|Overall Study|Lost to Follow-up|14|||
160971511|NCT03489057|581285610|FG000|Overall Study|Withdrawal by Subject|12|||
160971512|NCT03489057|581285611|FG001|Overall Study|Withdrawal by Subject|12|||
160971513|NCT03489057|581285612|FG002|Overall Study|Withdrawal by Subject|8|||
160971514|NCT03489057|581285613|FG003|Overall Study|Withdrawal by Subject|8|||
160971515|NCT03489057|581285610|FG000|Overall Study|Protocol Violation|7|||
160971516|NCT03489057|581285611|FG001|Overall Study|Protocol Violation|7|||
160971517|NCT03489057|581285612|FG002|Overall Study|Protocol Violation|2|||
160971518|NCT03489057|581285613|FG003|Overall Study|Protocol Violation|2|||
160971519|NCT00779779|581285616|FG000|Overall Study|Adverse Event|1|||
160971520|NCT00779779|581285616|FG000|Overall Study|Protocol Violation|14|||
160971521|NCT00779779|581285616|FG000|Overall Study|Withdrawal by Subject|4|||
160971522|NCT00779779|581285616|FG000|Overall Study|Lost to Follow-up|5|||
160971523|NCT01395823|581285617|FG000|Overall Study|Death|4|||
160971524|NCT01395823|581285618|FG001|Overall Study|Death|4|||
160971525|NCT01395823|581285617|FG000|Overall Study|Physician Decision|3|||
160971526|NCT01395823|581285618|FG001|Overall Study|Physician Decision|1|||
160971527|NCT01395823|581285617|FG000|Overall Study|Lost to Follow-up|1|||
160971528|NCT01395823|581285618|FG001|Overall Study|Lost to Follow-up|0|||
160971529|NCT01395823|581285617|FG000|Overall Study|Transplant|1|||
160971530|NCT01395823|581285618|FG001|Overall Study|Transplant|0|||
160971531|NCT01395823|581285617|FG000|Overall Study|GI symptoms|1|||
160971532|NCT01395823|581285618|FG001|Overall Study|GI symptoms|0|||
160971533|NCT01395823|581285617|FG000|Overall Study|Withdrawal by Subject|5|||
160971534|NCT01395823|581285618|FG001|Overall Study|Withdrawal by Subject|4|||
160971535|NCT01778556|581285619|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
160971536|NCT01778556|581285620|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
160971537|NCT01778556|581285619|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160971538|NCT01778556|581285620|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
160971539|NCT01778556|581285619|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
160971540|NCT01778556|581285620|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
160971541|NCT01778556|581285619|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
160971542|NCT01778556|581285620|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
160971543|NCT03300570|581285622|FG000|Overall Study|Adverse Event|0|||
160971544|NCT03300570|581285623|FG001|Overall Study|Adverse Event|1|||
160971545|NCT03300570|581285622|FG000|Overall Study|Withdrawal by Subject|1|||
160971546|NCT03300570|581285623|FG001|Overall Study|Withdrawal by Subject|0|||
160971547|NCT03300570|581285622|FG000|Overall Study|Inadequate bowel prep|1|||
160971548|NCT03300570|581285623|FG001|Overall Study|Inadequate bowel prep|0|||
160971549|NCT00116272|581285624|FG000|Overall Study|Lost to Follow-up|11|||
160971550|NCT00116272|581285625|FG001|Overall Study|Lost to Follow-up|6|||
160971551|NCT00576732|581285626|FG000|DOUBLE BLIND|Adverse Event|0|||
160971552|NCT00576732|581285627|FG001|DOUBLE BLIND|Adverse Event|0|||
160971553|NCT00576732|581285628|FG002|DOUBLE BLIND|Adverse Event|1|||
160971554|NCT00576732|581285629|FG003|DOUBLE BLIND|Adverse Event|0|||
160971555|NCT00576732|581285630|FG004|DOUBLE BLIND|Adverse Event|0|||
160971556|NCT00576732|581285631|FG005|DOUBLE BLIND|Adverse Event|0|||
160971557|NCT00576732|581285626|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
160971558|NCT00576732|581285627|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
160971559|NCT00576732|581285628|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
160971560|NCT00576732|581285629|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
160971561|NCT00576732|581285630|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
160971562|NCT00576732|581285631|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
161023950|NCT04515849|581477389|FG001|Overall Study|Other:family emergency|0|||
161023951|NCT04515849|581477390|FG002|Overall Study|Other:family emergency|0|||
161023952|NCT04515849|581477391|FG003|Overall Study|Other:family emergency|1|||
161023953|NCT04515849|581477392|FG004|Overall Study|Other:family emergency|0|||
161023954|NCT04515849|581477388|FG000|Overall Study|Other:randomised by error|0|||
161023955|NCT04515849|581477389|FG001|Overall Study|Other:randomised by error|1|||
161023956|NCT04515849|581477390|FG002|Overall Study|Other:randomised by error|0|||
161023957|NCT04515849|581477391|FG003|Overall Study|Other:randomised by error|0|||
161023958|NCT04515849|581477392|FG004|Overall Study|Other:randomised by error|0|||
161023959|NCT04515849|581477388|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
161023960|NCT04515849|581477389|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
161023961|NCT04515849|581477390|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
161023962|NCT04515849|581477391|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
161023963|NCT04515849|581477392|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
160971563|NCT00576732|581285626|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
160971564|NCT00576732|581285627|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
160971565|NCT00576732|581285628|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
160971566|NCT00576732|581285629|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
160971567|NCT00576732|581285630|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
160971568|NCT00576732|581285631|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
160971569|NCT00576732|581285626|FG000|DOUBLE BLIND|OTHER|0|||
161023964|NCT04515849|581477388|FG000|Overall Study|Physician Decision|0|||
160971570|NCT00576732|581285627|FG001|DOUBLE BLIND|OTHER|2|||
160971571|NCT00576732|581285628|FG002|DOUBLE BLIND|OTHER|1|||
160971572|NCT00576732|581285629|FG003|DOUBLE BLIND|OTHER|0|||
160971573|NCT00576732|581285630|FG004|DOUBLE BLIND|OTHER|0|||
160971574|NCT00576732|581285631|FG005|DOUBLE BLIND|OTHER|0|||
160971575|NCT00576732|581285626|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
160971576|NCT00576732|581285627|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
160971577|NCT00576732|581285628|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
160971578|NCT00576732|581285629|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
160971579|NCT00576732|581285630|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
160971580|NCT00576732|581285631|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
160971581|NCT00576732|581285626|FG000|DOUBLE BLIND|Protocol Violation|1|||
160971582|NCT00576732|581285627|FG001|DOUBLE BLIND|Protocol Violation|0|||
160971583|NCT00576732|581285628|FG002|DOUBLE BLIND|Protocol Violation|0|||
160971584|NCT00576732|581285629|FG003|DOUBLE BLIND|Protocol Violation|0|||
160971585|NCT00576732|581285630|FG004|DOUBLE BLIND|Protocol Violation|0|||
160971586|NCT00576732|581285631|FG005|DOUBLE BLIND|Protocol Violation|0|||
160971587|NCT00576732|581285626|FG000|OPEN LABEL|Adverse Event|0|||
160971588|NCT00576732|581285627|FG001|OPEN LABEL|Adverse Event|0|||
160971589|NCT00576732|581285628|FG002|OPEN LABEL|Adverse Event|0|||
160971590|NCT00576732|581285629|FG003|OPEN LABEL|Adverse Event|4|||
160971591|NCT00576732|581285630|FG004|OPEN LABEL|Adverse Event|0|||
160971592|NCT00576732|581285631|FG005|OPEN LABEL|Adverse Event|1|||
160971593|NCT00576732|581285626|FG000|OPEN LABEL|Lost to Follow-up|0|||
160971594|NCT00576732|581285627|FG001|OPEN LABEL|Lost to Follow-up|0|||
160971595|NCT00576732|581285628|FG002|OPEN LABEL|Lost to Follow-up|0|||
160971596|NCT00576732|581285629|FG003|OPEN LABEL|Lost to Follow-up|2|||
160971597|NCT00576732|581285630|FG004|OPEN LABEL|Lost to Follow-up|1|||
160971598|NCT00576732|581285631|FG005|OPEN LABEL|Lost to Follow-up|1|||
160971599|NCT00576732|581285626|FG000|OPEN LABEL|Withdrawal by Subject|0|||
160971600|NCT00576732|581285627|FG001|OPEN LABEL|Withdrawal by Subject|0|||
160971601|NCT00576732|581285628|FG002|OPEN LABEL|Withdrawal by Subject|0|||
160971602|NCT00576732|581285629|FG003|OPEN LABEL|Withdrawal by Subject|1|||
160971603|NCT00576732|581285630|FG004|OPEN LABEL|Withdrawal by Subject|0|||
160971604|NCT00576732|581285631|FG005|OPEN LABEL|Withdrawal by Subject|1|||
160971605|NCT00576732|581285626|FG000|OPEN LABEL|OTHER|0|||
160971606|NCT00576732|581285627|FG001|OPEN LABEL|OTHER|0|||
160971607|NCT00576732|581285628|FG002|OPEN LABEL|OTHER|0|||
160971608|NCT00576732|581285629|FG003|OPEN LABEL|OTHER|0|||
160971609|NCT00576732|581285630|FG004|OPEN LABEL|OTHER|0|||
160971610|NCT00576732|581285631|FG005|OPEN LABEL|OTHER|2|||
160971611|NCT00576732|581285626|FG000|OPEN LABEL|Lack of Efficacy|0|||
160971612|NCT00576732|581285627|FG001|OPEN LABEL|Lack of Efficacy|0|||
160971613|NCT00576732|581285628|FG002|OPEN LABEL|Lack of Efficacy|0|||
160971614|NCT00576732|581285629|FG003|OPEN LABEL|Lack of Efficacy|2|||
160971615|NCT00576732|581285630|FG004|OPEN LABEL|Lack of Efficacy|2|||
160971616|NCT00576732|581285631|FG005|OPEN LABEL|Lack of Efficacy|3|||
160971617|NCT00576732|581285626|FG000|OPEN LABEL|Protocol Violation|0|||
160971618|NCT00576732|581285627|FG001|OPEN LABEL|Protocol Violation|0|||
160971619|NCT00576732|581285628|FG002|OPEN LABEL|Protocol Violation|0|||
160971620|NCT00576732|581285629|FG003|OPEN LABEL|Protocol Violation|2|||
160971621|NCT00576732|581285630|FG004|OPEN LABEL|Protocol Violation|1|||
160971622|NCT00576732|581285631|FG005|OPEN LABEL|Protocol Violation|0|||
160971623|NCT03188120|581285633|FG000|Overall Study|Adverse Event|4|||
160971624|NCT03188120|581285633|FG000|Overall Study|Insufficient Effectiveness|8|||
160971625|NCT03188120|581285633|FG000|Overall Study|Improved|12|||
160971626|NCT03188120|581285633|FG000|Overall Study|Lost to Follow-up|7|||
160971627|NCT03188120|581285633|FG000|Overall Study|Other than specified|3|||
160971628|NCT03188120|581285633|FG000|Overall Study|No visit after the first visit|13|||
160971629|NCT02296190|581285634|FG000|Overall Study|Lost to Follow-up|0|||
160971630|NCT02296190|581285635|FG001|Overall Study|Lost to Follow-up|0|||
160971631|NCT02296190|581285636|FG002|Overall Study|Lost to Follow-up|0|||
160971632|NCT02296190|581285637|FG003|Overall Study|Lost to Follow-up|0|||
161023965|NCT04515849|581477389|FG001|Overall Study|Physician Decision|1|||
161023966|NCT04515849|581477390|FG002|Overall Study|Physician Decision|0|||
160971633|NCT02296190|581285638|FG004|Overall Study|Lost to Follow-up|1|||
160971634|NCT02296190|581285639|FG005|Overall Study|Lost to Follow-up|0|||
160971635|NCT02296190|581285634|FG000|Overall Study|Failure to induce PSVT|6|||
160971636|NCT02296190|581285635|FG001|Overall Study|Failure to induce PSVT|10|||
160971637|NCT02296190|581285636|FG002|Overall Study|Failure to induce PSVT|5|||
160587933|NCT01098461|579871529|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
160587934|NCT02662985|579871530|FG000|Treatment Period 1|Adverse Event|0|||
160587935|NCT02662985|579871531|FG001|Treatment Period 1|Adverse Event|2|||
160971638|NCT02296190|581285637|FG003|Overall Study|Failure to induce PSVT|13|||
160971639|NCT02296190|581285638|FG004|Overall Study|Failure to induce PSVT|8|||
160971640|NCT02296190|581285639|FG005|Overall Study|Failure to induce PSVT|0|||
160971641|NCT02296190|581285634|FG000|Overall Study|Physician Decision|1|||
160971642|NCT02296190|581285635|FG001|Overall Study|Physician Decision|1|||
160971643|NCT02296190|581285636|FG002|Overall Study|Physician Decision|0|||
160971644|NCT02296190|581285637|FG003|Overall Study|Physician Decision|1|||
160971645|NCT02296190|581285638|FG004|Overall Study|Physician Decision|2|||
160971646|NCT02296190|581285639|FG005|Overall Study|Physician Decision|0|||
160971647|NCT02296190|581285634|FG000|Overall Study|Withdrawal by Subject|0|||
160971648|NCT02296190|581285635|FG001|Overall Study|Withdrawal by Subject|1|||
160971649|NCT02296190|581285636|FG002|Overall Study|Withdrawal by Subject|0|||
160971650|NCT02296190|581285637|FG003|Overall Study|Withdrawal by Subject|0|||
160971651|NCT02296190|581285638|FG004|Overall Study|Withdrawal by Subject|0|||
160971652|NCT02296190|581285639|FG005|Overall Study|Withdrawal by Subject|0|||
160971653|NCT02296190|581285634|FG000|Overall Study|PSVT < 5 minutes|5|||
160971654|NCT02296190|581285635|FG001|Overall Study|PSVT < 5 minutes|6|||
160971655|NCT02296190|581285636|FG002|Overall Study|PSVT < 5 minutes|6|||
160971656|NCT02296190|581285637|FG003|Overall Study|PSVT < 5 minutes|6|||
160971657|NCT02296190|581285638|FG004|Overall Study|PSVT < 5 minutes|5|||
160971658|NCT02296190|581285639|FG005|Overall Study|PSVT < 5 minutes|0|||
160971659|NCT02296190|581285634|FG000|Overall Study|Patient was given Propofol|0|||
160971660|NCT02296190|581285635|FG001|Overall Study|Patient was given Propofol|1|||
160587936|NCT02662985|579871530|FG000|Treatment Period 1|Protocol Violation|0|||
160587937|NCT02662985|579871531|FG001|Treatment Period 1|Protocol Violation|1|||
160587938|NCT02662985|579871530|FG000|Treatment Period 1|Physician Decision|1|||
160587939|NCT02662985|579871531|FG001|Treatment Period 1|Physician Decision|0|||
160587940|NCT02662985|579871530|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160587941|NCT02662985|579871531|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160587942|NCT02662985|579871530|FG000|Treatment Period 2|Lack of Efficacy|0|||
160587943|NCT02662985|579871531|FG001|Treatment Period 2|Lack of Efficacy|1|||
160587944|NCT02662985|579871530|FG000|Treatment Period 2|Lost to Follow-up|1|||
160587945|NCT02662985|579871531|FG001|Treatment Period 2|Lost to Follow-up|0|||
160587946|NCT02662985|579871530|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
160587947|NCT02662985|579871531|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
160587948|NCT02662985|579871530|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
160587949|NCT02662985|579871531|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
160587950|NCT02662985|579871530|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
160587951|NCT02662985|579871531|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
160587952|NCT02662985|579871530|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
160587953|NCT02662985|579871531|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
160587954|NCT02662985|579871530|FG000|Treatment Period 3 (Extension Period)|Death|0|||
160587955|NCT02662985|579871531|FG001|Treatment Period 3 (Extension Period)|Death|1|||
160587956|NCT05373706|579871532|FG000|Overall Study|Lost to Follow-up|2|||
160587957|NCT05373706|579871533|FG001|Overall Study|Lost to Follow-up|2|||
160587958|NCT01486784|579871534|FG000|Overall Study|Withdrawal by Subject|0|||
160587959|NCT01486784|579871535|FG001|Overall Study|Withdrawal by Subject|0|||
160587960|NCT01486784|579871536|FG002|Overall Study|Withdrawal by Subject|1|||
160587961|NCT01486784|579871537|FG003|Overall Study|Withdrawal by Subject|0|||
160587962|NCT01486784|579871538|FG004|Overall Study|Withdrawal by Subject|1|||
160587963|NCT01486784|579871539|FG005|Overall Study|Withdrawal by Subject|2|||
160587964|NCT01486784|579871534|FG000|Overall Study|Subject did not meet entry criteria|0|||
160587965|NCT01486784|579871535|FG001|Overall Study|Subject did not meet entry criteria|0|||
160587966|NCT01486784|579871536|FG002|Overall Study|Subject did not meet entry criteria|0|||
160587967|NCT01486784|579871537|FG003|Overall Study|Subject did not meet entry criteria|0|||
160587968|NCT01486784|579871538|FG004|Overall Study|Subject did not meet entry criteria|1|||
160587969|NCT01486784|579871539|FG005|Overall Study|Subject did not meet entry criteria|0|||
160587970|NCT01486784|579871534|FG000|Overall Study|Death|0|||
160587971|NCT01486784|579871535|FG001|Overall Study|Death|0|||
160587972|NCT01486784|579871536|FG002|Overall Study|Death|0|||
160587973|NCT01486784|579871537|FG003|Overall Study|Death|0|||
160587974|NCT01486784|579871538|FG004|Overall Study|Death|0|||
160587975|NCT01486784|579871539|FG005|Overall Study|Death|1|||
160587976|NCT03628508|579871545|FG000|Overall Study|Lost to Follow-up|1|||
160587977|NCT01996748|579871546|FG000|Overall Study|Personal reason|1|||
160587978|NCT01996748|579871547|FG001|Overall Study|Personal reason|0|||
160587979|NCT01996748|579871546|FG000|Overall Study|Physician Decision|2|||
160587980|NCT01996748|579871547|FG001|Overall Study|Physician Decision|0|||
160657121|NCT00688064|580125946|FG001|Overall Study|Lost to Follow-up|10|||
160971661|NCT02296190|581285636|FG002|Overall Study|Patient was given Propofol|0|||
160971662|NCT02296190|581285637|FG003|Overall Study|Patient was given Propofol|1|||
160971663|NCT02296190|581285638|FG004|Overall Study|Patient was given Propofol|0|||
160971664|NCT02296190|581285639|FG005|Overall Study|Patient was given Propofol|0|||
160971665|NCT02296190|581285634|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
160971666|NCT02296190|581285635|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
160587981|NCT01996748|579871546|FG000|Overall Study|Adverse Event|1|||
160587982|NCT01996748|579871547|FG001|Overall Study|Adverse Event|4|||
160587983|NCT01996748|579871546|FG000|Overall Study|Withdrawal by Subject|0|||
160587984|NCT01996748|579871547|FG001|Overall Study|Withdrawal by Subject|1|||
160587985|NCT01996748|579871546|FG000|Overall Study|Lost to Follow-up|4|||
160971667|NCT02296190|581285636|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
160971668|NCT02296190|581285637|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
160971669|NCT02296190|581285638|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
160971670|NCT02296190|581285639|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
160971671|NCT02296190|581285634|FG000|Overall Study|Blood pressure <100 after sedation|0|||
160971672|NCT02296190|581285635|FG001|Overall Study|Blood pressure <100 after sedation|0|||
160971673|NCT02296190|581285636|FG002|Overall Study|Blood pressure <100 after sedation|0|||
160971674|NCT02296190|581285637|FG003|Overall Study|Blood pressure <100 after sedation|1|||
160971675|NCT02296190|581285638|FG004|Overall Study|Blood pressure <100 after sedation|0|||
160971676|NCT02296190|581285639|FG005|Overall Study|Blood pressure <100 after sedation|0|||
160971677|NCT02296190|581285634|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
160971678|NCT02296190|581285635|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
160971679|NCT02296190|581285636|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
160971680|NCT02296190|581285637|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
160971681|NCT02296190|581285638|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
160971682|NCT02296190|581285639|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
160971683|NCT02296190|581285634|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
160971684|NCT02296190|581285635|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
160971685|NCT02296190|581285636|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
160971686|NCT02296190|581285637|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
160971687|NCT02296190|581285638|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
160971688|NCT02296190|581285639|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
160971689|NCT02296190|581285634|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
160971690|NCT02296190|581285635|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
160971691|NCT02296190|581285636|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
160971692|NCT02296190|581285637|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
160971693|NCT02296190|581285638|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
160971694|NCT02296190|581285639|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
160971695|NCT02296190|581285634|FG000|Overall Study|Lab result not available in time|1|||
160971696|NCT02296190|581285635|FG001|Overall Study|Lab result not available in time|0|||
160971697|NCT02296190|581285636|FG002|Overall Study|Lab result not available in time|0|||
160971698|NCT02296190|581285637|FG003|Overall Study|Lab result not available in time|0|||
160971699|NCT02296190|581285638|FG004|Overall Study|Lab result not available in time|0|||
160971700|NCT02296190|581285639|FG005|Overall Study|Lab result not available in time|0|||
160971701|NCT00265330|581285640|FG000|Overall Study|Adverse Event|41|||
160971702|NCT00265330|581285640|FG000|Overall Study|Lost to Follow-up|8|||
160971703|NCT00265330|581285640|FG000|Overall Study|Withdrawal by Subject|34|||
160971704|NCT00265330|581285640|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
160971705|NCT00265330|581285640|FG000|Overall Study|Lack of Efficacy|4|||
160971706|NCT00265330|581285640|FG000|Overall Study|Family Scheduling Conflicts|1|||
160971707|NCT00265330|581285640|FG000|Overall Study|Began Taking Formulary Geodon|1|||
160971708|NCT00265330|581285640|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
160971709|NCT00265330|581285640|FG000|Overall Study|Site Closed by Sponsor|1|||
160971710|NCT00265330|581285640|FG000|Overall Study|Principal Investigators Request|1|||
160971711|NCT00265330|581285640|FG000|Overall Study|Withdrew Consent|1|||
160971712|NCT00265330|581285640|FG000|Overall Study|Protocol Violation|1|||
160971713|NCT02178566|581285649|FG000|Overall Study|patient did not complete due to noncompliance|0|||
160971714|NCT02178566|581285650|FG001|Overall Study|patient did not complete due to noncompliance|1|||
160971715|NCT02658630|581285651|FG000|Overall Study|Withdrawal by Subject|4|||
160971716|NCT00682643|581285652|FG000|Overall Study|Adverse Event|12|||
160971717|NCT00682643|581285653|FG001|Overall Study|Adverse Event|23|||
160971718|NCT00682643|581285652|FG000|Overall Study|Lack of Efficacy|2|||
160971719|NCT00682643|581285653|FG001|Overall Study|Lack of Efficacy|0|||
160971720|NCT00682643|581285652|FG000|Overall Study|Protocol Violation|38|||
160971721|NCT00682643|581285653|FG001|Overall Study|Protocol Violation|76|||
160971722|NCT00682643|581285652|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
160971723|NCT00682643|581285653|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
160971724|NCT00682643|581285652|FG000|Overall Study|Lost to Follow-up|1|||
160971725|NCT00682643|581285653|FG001|Overall Study|Lost to Follow-up|6|||
160971726|NCT00682643|581285652|FG000|Overall Study|Physician Decision|2|||
160971727|NCT00682643|581285653|FG001|Overall Study|Physician Decision|6|||
160971728|NCT00682643|581285652|FG000|Overall Study|Withdrawal by Subject|19|||
160971729|NCT00682643|581285653|FG001|Overall Study|Withdrawal by Subject|53|||
160971730|NCT00682643|581285652|FG000|Overall Study|Did Not Receive Study Drug|1|||
160971731|NCT00682643|581285653|FG001|Overall Study|Did Not Receive Study Drug|1|||
160971732|NCT01875185|581285654|FG000|Overall Study|study was terminated|52|||
160971733|NCT01875185|581285655|FG001|Overall Study|study was terminated|48|||
160971734|NCT00085202|581285656|FG000|Overall Study|Still on therapy|2|||
160971735|NCT00085202|581285657|FG001|Overall Study|Still on therapy|0|||
160971736|NCT00085202|581285656|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
160971737|NCT00085202|581285657|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
160971738|NCT00085202|581285656|FG000|Overall Study|Excessive toxicity|6|||
160971739|NCT00085202|581285657|FG001|Overall Study|Excessive toxicity|5|||
160971740|NCT00085202|581285656|FG000|Overall Study|Non-specified|3|||
160971741|NCT00085202|581285657|FG001|Overall Study|Non-specified|5|||
161023967|NCT04515849|581477391|FG003|Overall Study|Physician Decision|0|||
160971742|NCT00085202|581285656|FG000|Overall Study|Withdrawal by Subject|2|||
160971743|NCT00085202|581285657|FG001|Overall Study|Withdrawal by Subject|1|||
160971744|NCT00085202|581285656|FG000|Overall Study|Physician Decision|4|||
160971745|NCT00085202|581285657|FG001|Overall Study|Physician Decision|1|||
160971746|NCT00085202|581285656|FG000|Overall Study|Progressive disease|1|||
160971747|NCT00085202|581285657|FG001|Overall Study|Progressive disease|11|||
160971748|NCT03238300|581285658|FG000|Baseline (Before Intervention)|Physician Decision|0|||
160971749|NCT03238300|581285659|FG001|Baseline (Before Intervention)|Physician Decision|1|||
160971750|NCT03238300|581285658|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
160971751|NCT03238300|581285659|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
160971752|NCT03238300|581285658|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
160971753|NCT03238300|581285659|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
160971754|NCT03238300|581285658|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
160971755|NCT03238300|581285659|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
160971756|NCT00386308|581287539|FG000|Overall Study|Adverse Event|3|||
160971757|NCT00386308|581287540|FG001|Overall Study|Adverse Event|3|||
160971758|NCT00386308|581287539|FG000|Overall Study|Protocol Violation|2|||
160971759|NCT00386308|581287540|FG001|Overall Study|Protocol Violation|5|||
160971760|NCT00386308|581287539|FG000|Overall Study|Lack of Efficacy|0|||
160971761|NCT00386308|581287540|FG001|Overall Study|Lack of Efficacy|2|||
161023968|NCT04515849|581477392|FG004|Overall Study|Physician Decision|0|||
161023969|NCT04515849|581477388|FG000|Overall Study|Withdrawal by Subject|1|||
161023970|NCT04515849|581477389|FG001|Overall Study|Withdrawal by Subject|2|||
161023971|NCT04515849|581477390|FG002|Overall Study|Withdrawal by Subject|1|||
161023972|NCT04515849|581477391|FG003|Overall Study|Withdrawal by Subject|0|||
161023973|NCT04515849|581477392|FG004|Overall Study|Withdrawal by Subject|0|||
161023974|NCT04049643|581477394|FG000|Overall Study|Lack of Efficacy|1|||
160587986|NCT01996748|579871547|FG001|Overall Study|Lost to Follow-up|1|||
160587987|NCT03238235|579871548|FG000|Overall Study|Adverse Event|2|||
160587988|NCT03238235|579871549|FG001|Overall Study|Adverse Event|0|||
160587989|NCT03238235|579871548|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
160587990|NCT03238235|579871549|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
160587991|NCT00243230|579871554|FG000|Double-Blind Period|Adverse Event|0|||
160587992|NCT00243230|579871555|FG001|Double-Blind Period|Adverse Event|2|||
160587993|NCT00243230|579871556|FG002|Double-Blind Period|Adverse Event|2|||
160587994|NCT00243230|579871557|FG003|Double-Blind Period|Adverse Event|0|||
160587995|NCT00243230|579871554|FG000|Double-Blind Period|Withdrawal by Subject|1|||
160587996|NCT00243230|579871555|FG001|Double-Blind Period|Withdrawal by Subject|0|||
160587997|NCT00243230|579871556|FG002|Double-Blind Period|Withdrawal by Subject|0|||
160587998|NCT00243230|579871557|FG003|Double-Blind Period|Withdrawal by Subject|0|||
160587999|NCT00243230|579871554|FG000|Double-Blind Period|Protocol Violation|0|||
160588000|NCT00243230|579871555|FG001|Double-Blind Period|Protocol Violation|0|||
160588001|NCT00243230|579871556|FG002|Double-Blind Period|Protocol Violation|1|||
160588002|NCT00243230|579871557|FG003|Double-Blind Period|Protocol Violation|0|||
160588003|NCT00243230|579871554|FG000|Double-Blind Period|Randomized but Not Treated|0|||
160588004|NCT00243230|579871555|FG001|Double-Blind Period|Randomized but Not Treated|0|||
160588005|NCT00243230|579871556|FG002|Double-Blind Period|Randomized but Not Treated|2|||
160588006|NCT00243230|579871557|FG003|Double-Blind Period|Randomized but Not Treated|0|||
160588007|NCT00243230|579871554|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
160588008|NCT00243230|579871555|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
160588009|NCT00243230|579871556|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
160588010|NCT00243230|579871557|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
160588011|NCT00243230|579871554|FG000|Open Label Period|Adverse Event|0|||
160588012|NCT00243230|579871555|FG001|Open Label Period|Adverse Event|0|||
160588013|NCT00243230|579871556|FG002|Open Label Period|Adverse Event|0|||
160588014|NCT00243230|579871557|FG003|Open Label Period|Adverse Event|2|||
160588015|NCT00243230|579871554|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
160588016|NCT00243230|579871555|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
160588017|NCT00243230|579871556|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
160588018|NCT00243230|579871557|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
160588019|NCT00243230|579871554|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
160588020|NCT00243230|579871555|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
160588021|NCT00243230|579871556|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
160588022|NCT00243230|579871557|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
160588023|NCT00243230|579871554|FG000|Open Label Period|Lost to Follow-up|0|||
160588024|NCT00243230|579871555|FG001|Open Label Period|Lost to Follow-up|0|||
160588025|NCT00243230|579871556|FG002|Open Label Period|Lost to Follow-up|0|||
160971762|NCT00386308|581287539|FG000|Overall Study|Lost to Follow-up|10|||
160971763|NCT00386308|581287540|FG001|Overall Study|Lost to Follow-up|6|||
160971764|NCT00386308|581287539|FG000|Overall Study|Withdrawal by Subject|6|||
160971765|NCT00386308|581287540|FG001|Overall Study|Withdrawal by Subject|2|||
161023975|NCT04049643|581477395|FG001|Overall Study|Lack of Efficacy|1|||
161023976|NCT04049643|581477396|FG002|Overall Study|Lack of Efficacy|0|||
161023977|NCT04049643|581477394|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
161023978|NCT04049643|581477395|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
161023979|NCT04049643|581477396|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
161023980|NCT04081103|581477397|FG000|Overall Study|Adverse Event|1|||
161023981|NCT04081103|581477398|FG001|Overall Study|Adverse Event|1|||
161023982|NCT04081103|581477399|FG002|Overall Study|Adverse Event|1|||
161023983|NCT04081103|581477397|FG000|Overall Study|Physician Decision|0|||
161023984|NCT04081103|581477398|FG001|Overall Study|Physician Decision|0|||
161023985|NCT04081103|581477399|FG002|Overall Study|Physician Decision|1|||
161023986|NCT05623228|581477400|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
160971766|NCT00386308|581287539|FG000|Overall Study|Other Event|8|||
160971767|NCT00386308|581287540|FG001|Overall Study|Other Event|1|||
160971768|NCT03518658|581287541|FG000|Overall Study|Other|51|||
160971769|NCT03518658|581287542|FG001|Overall Study|Other|0|||
160971770|NCT00649389|581287543|FG000|Overall Study|Adverse Event|22|||
160971771|NCT00649389|581287544|FG001|Overall Study|Adverse Event|46|||
160971772|NCT00649389|581287545|FG002|Overall Study|Adverse Event|38|||
160971773|NCT00649389|581287546|FG003|Overall Study|Adverse Event|48|||
160971774|NCT00649389|581287543|FG000|Overall Study|Lost to Follow-up|15|||
160971775|NCT00649389|581287544|FG001|Overall Study|Lost to Follow-up|17|||
160971776|NCT00649389|581287545|FG002|Overall Study|Lost to Follow-up|21|||
160971777|NCT00649389|581287546|FG003|Overall Study|Lost to Follow-up|26|||
160971778|NCT00649389|581287543|FG000|Overall Study|Protocol Violation|11|||
160971779|NCT00649389|581287544|FG001|Overall Study|Protocol Violation|13|||
160971780|NCT00649389|581287545|FG002|Overall Study|Protocol Violation|9|||
160971781|NCT00649389|581287546|FG003|Overall Study|Protocol Violation|8|||
160971782|NCT00649389|581287543|FG000|Overall Study|Withdrawal by Subject|20|||
160971783|NCT00649389|581287544|FG001|Overall Study|Withdrawal by Subject|21|||
160971784|NCT00649389|581287545|FG002|Overall Study|Withdrawal by Subject|19|||
160971785|NCT00649389|581287546|FG003|Overall Study|Withdrawal by Subject|23|||
160971786|NCT00649389|581287543|FG000|Overall Study|Other|3|||
160971787|NCT00649389|581287544|FG001|Overall Study|Other|9|||
160971788|NCT00649389|581287545|FG002|Overall Study|Other|1|||
160971789|NCT00649389|581287546|FG003|Overall Study|Other|6|||
160971790|NCT02746575|581287549|FG000|Overall Study|Surgery cancelled or time chaned|13|||
160971791|NCT02746575|581287549|FG000|Overall Study|Received epidural|10|||
160971792|NCT02746575|581287549|FG000|Overall Study|Withdrawal by Subject|3|||
160971793|NCT02746575|581287549|FG000|Overall Study|Bradycardia/hypotension|9|||
160971794|NCT02746575|581287549|FG000|Overall Study|Study paused|8|||
160971795|NCT02746575|581287549|FG000|Overall Study|put on beta-blocker|3|||
160971796|NCT02746575|581287549|FG000|Overall Study|type of surgery|1|||
160971797|NCT02746575|581287549|FG000|Overall Study|typ of surgery|1|||
160971798|NCT02746575|581287549|FG000|Overall Study|PI unavailable|1|||
160971799|NCT02746575|581287549|FG000|Overall Study|Unknown history of CVA|1|||
160971800|NCT00976482|581287550|FG000|Overall Study|Death|208|||
160971801|NCT00976482|581287550|FG000|Overall Study|Withdrawal by Subject|45|||
160971802|NCT00976482|581287550|FG000|Overall Study|Center terminated|1|||
160971803|NCT00976482|581287550|FG000|Overall Study|Protocol Violation|5|||
160971804|NCT02959671|581287551|FG000|Overall Study|Adverse Event|2|||
160971805|NCT02959671|581287551|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
160971806|NCT00605319|581287557|FG000|Overall Study|Adverse Event|6|||
160971807|NCT00432835|581287560|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
160971808|NCT00432835|581287561|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
160971809|NCT02002884|581287563|FG000|Main Period (MP)|Other|0|||
160971810|NCT02002884|581287564|FG001|Main Period (MP)|Other|3|||
160971811|NCT02002884|581287565|FG002|Main Period (MP)|Other|3|||
160971812|NCT02002884|581287566|FG003|Main Period (MP)|Other|0|||
160971813|NCT02002884|581287563|FG000|Main Period (MP)|Adverse Event|0|||
160971814|NCT02002884|581287564|FG001|Main Period (MP)|Adverse Event|1|||
160971815|NCT02002884|581287565|FG002|Main Period (MP)|Adverse Event|1|||
160971816|NCT02002884|581287566|FG003|Main Period (MP)|Adverse Event|0|||
160971817|NCT02002884|581287563|FG000|Main Period (MP)|Withdrawal by Subject|6|||
160971818|NCT02002884|581287564|FG001|Main Period (MP)|Withdrawal by Subject|2|||
160971819|NCT02002884|581287565|FG002|Main Period (MP)|Withdrawal by Subject|2|||
160971820|NCT02002884|581287566|FG003|Main Period (MP)|Withdrawal by Subject|0|||
160971821|NCT02002884|581287563|FG000|Main Period (MP)|Lost to Follow-up|0|||
161023987|NCT05623228|581477401|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
160588026|NCT00243230|579871557|FG003|Open Label Period|Lost to Follow-up|2|||
160588027|NCT00243230|579871554|FG000|Open Label Period|Withdrawal by Subject|0|||
160588028|NCT00243230|579871555|FG001|Open Label Period|Withdrawal by Subject|0|||
160971822|NCT02002884|581287564|FG001|Main Period (MP)|Lost to Follow-up|0|||
160971823|NCT02002884|581287565|FG002|Main Period (MP)|Lost to Follow-up|2|||
160971824|NCT02002884|581287566|FG003|Main Period (MP)|Lost to Follow-up|0|||
161023988|NCT05623228|581477402|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
160971825|NCT02002884|581287563|FG000|Open-Label Extension Period (OLEX)|Other|0|||
160971826|NCT02002884|581287564|FG001|Open-Label Extension Period (OLEX)|Other|0|||
160971827|NCT02002884|581287565|FG002|Open-Label Extension Period (OLEX)|Other|0|||
160460046|NCT02720068|579417501|FG000|Overall Study|Protocol Violation|0|||
160460047|NCT02720068|579417502|FG001|Overall Study|Protocol Violation|0|||
160460048|NCT02720068|579417503|FG002|Overall Study|Protocol Violation|0|||
160460049|NCT02720068|579417504|FG003|Overall Study|Protocol Violation|0|||
160460050|NCT02720068|579417505|FG004|Overall Study|Protocol Violation|0|||
160460051|NCT02720068|579417506|FG005|Overall Study|Protocol Violation|0|||
160460052|NCT02720068|579417507|FG006|Overall Study|Protocol Violation|0|||
160460053|NCT02720068|579417508|FG007|Overall Study|Protocol Violation|0|||
160460054|NCT02720068|579417509|FG008|Overall Study|Protocol Violation|0|||
160460055|NCT02720068|579417510|FG009|Overall Study|Protocol Violation|0|||
160460056|NCT02720068|579417511|FG010|Overall Study|Protocol Violation|1|||
160460057|NCT02720068|579417512|FG011|Overall Study|Protocol Violation|0|||
160971828|NCT02002884|581287566|FG003|Open-Label Extension Period (OLEX)|Other|24|||
160971829|NCT02002884|581287563|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
160971830|NCT02002884|581287564|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
160971831|NCT02002884|581287565|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
160971832|NCT02002884|581287566|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
160971833|NCT02002884|581287563|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
160971834|NCT02002884|581287564|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
160971835|NCT02002884|581287565|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
160971836|NCT02002884|581287566|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
160971837|NCT02002884|581287563|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
160971838|NCT02002884|581287564|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
160971839|NCT02002884|581287565|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
160971840|NCT02002884|581287566|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
160971841|NCT02002884|581287563|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
160971842|NCT02002884|581287564|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
160971843|NCT02002884|581287565|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
160971844|NCT02002884|581287566|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
160971845|NCT00810082|581287570|FG000|Overall Study|Lost to Follow-up|0|||
160971846|NCT00810082|581287571|FG001|Overall Study|Lost to Follow-up|4|||
160971847|NCT01454830|581287574|FG000|Overall Study|Withdrawal by Subject|4|||
160971848|NCT01454830|581287575|FG001|Overall Study|Withdrawal by Subject|4|||
160971849|NCT01454830|581287574|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
160971850|NCT01454830|581287575|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
160971851|NCT01454830|581287574|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
160971852|NCT01454830|581287575|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
160971853|NCT01454830|581287574|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
160971854|NCT01454830|581287575|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
160971855|NCT01454830|581287574|FG000|Overall Study|Withdrawal - no polysomnography|3|||
160971856|NCT01454830|581287575|FG001|Overall Study|Withdrawal - no polysomnography|2|||
160971857|NCT00584805|581287576|FG000|Overall Study|No longer at risk of exposure|39|||
160971858|NCT00584805|581287576|FG000|Overall Study|Relocation|36|||
160971859|NCT00584805|581287576|FG000|Overall Study|Withdrawal by Subject|18|||
160971860|NCT00584805|581287576|FG000|Overall Study|Non-compliance|1|||
160971861|NCT00584805|581287576|FG000|Overall Study|Lost to follow up|3|||
160971862|NCT00584805|581287576|FG000|Overall Study|Screen failures|2|||
160971863|NCT02341456|581287577|FG000|Overall Study|Disease progression|2|||
160971864|NCT02341456|581287578|FG001|Overall Study|Disease progression|3|||
160971865|NCT02341456|581287579|FG002|Overall Study|Disease progression|1|||
160971866|NCT02341456|581287577|FG000|Overall Study|Death|1|||
160971867|NCT02341456|581287578|FG001|Overall Study|Death|1|||
160971868|NCT02341456|581287579|FG002|Overall Study|Death|1|||
160971869|NCT02341456|581287577|FG000|Overall Study|Withdrawal by Subject|0|||
160971870|NCT02341456|581287578|FG001|Overall Study|Withdrawal by Subject|1|||
160971871|NCT02341456|581287579|FG002|Overall Study|Withdrawal by Subject|1|||
160971872|NCT02341456|581287577|FG000|Overall Study|Moved to local access programme.|0|||
160460058|NCT02720068|579417513|FG012|Overall Study|Protocol Violation|0|||
160460059|NCT02720068|579417514|FG013|Overall Study|Protocol Violation|0|||
160460060|NCT02720068|579417515|FG014|Overall Study|Protocol Violation|1|||
160460061|NCT02720068|579417516|FG015|Overall Study|Protocol Violation|0|||
160460062|NCT02720068|579417517|FG016|Overall Study|Protocol Violation|1|||
160460063|NCT02720068|579417518|FG017|Overall Study|Protocol Violation|0|||
160460064|NCT06408870|579417521|FG000|Washout period|Withdrawal by Subject|1|||
160460065|NCT06408870|579417522|FG001|Washout period|Withdrawal by Subject|0|||
160460066|NCT06408870|579417521|FG000|Washout period|Adverse Event|2|||
160460067|NCT06408870|579417522|FG001|Washout period|Adverse Event|0|||
160588029|NCT00243230|579871556|FG002|Open Label Period|Withdrawal by Subject|0|||
160971873|NCT02341456|581287578|FG001|Overall Study|Moved to local access programme.|1|||
160971874|NCT02341456|581287579|FG002|Overall Study|Moved to local access programme.|1|||
160971875|NCT02341456|581287577|FG000|Overall Study|Physician Decision|1|||
160971876|NCT02341456|581287578|FG001|Overall Study|Physician Decision|0|||
160460068|NCT01773993|579417524|FG000|Overall Study|No Visit After Treatment|35|||
160460069|NCT04664881|579417528|FG000|Overall Study|Withdrawal by Subject|1|||
160460070|NCT04664881|579417529|FG001|Overall Study|Withdrawal by Subject|8|||
160971877|NCT02341456|581287579|FG002|Overall Study|Physician Decision|0|||
160971878|NCT01077362|581287580|FG000|Overall Study|Lack of Efficacy|13|||
160971879|NCT01077362|581287581|FG001|Overall Study|Lack of Efficacy|8|||
160971880|NCT01077362|581287582|FG002|Overall Study|Lack of Efficacy|10|||
160971881|NCT01077362|581287580|FG000|Overall Study|Lost to Follow-up|1|||
160971882|NCT01077362|581287581|FG001|Overall Study|Lost to Follow-up|0|||
160971883|NCT01077362|581287582|FG002|Overall Study|Lost to Follow-up|3|||
160971884|NCT01077362|581287580|FG000|Overall Study|Adverse Event|12|||
160971885|NCT01077362|581287581|FG001|Overall Study|Adverse Event|7|||
160971886|NCT01077362|581287582|FG002|Overall Study|Adverse Event|4|||
160971887|NCT01077362|581287580|FG000|Overall Study|Withdrawal by Subject|5|||
160971888|NCT01077362|581287581|FG001|Overall Study|Withdrawal by Subject|3|||
160971889|NCT01077362|581287582|FG002|Overall Study|Withdrawal by Subject|5|||
160971890|NCT01077362|581287580|FG000|Overall Study|Other|0|||
160971891|NCT01077362|581287581|FG001|Overall Study|Other|1|||
160971892|NCT01077362|581287582|FG002|Overall Study|Other|2|||
160971893|NCT02508532|581287586|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971894|NCT02508532|581287587|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971895|NCT02508532|581287588|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971896|NCT02508532|581287589|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971897|NCT02508532|581287590|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971898|NCT02508532|581287591|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
161023989|NCT05623228|581477403|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161023990|NCT05623228|581477404|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161023991|NCT05623228|581477405|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161023992|NCT05623228|581477406|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161023993|NCT05623228|581477407|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161023994|NCT05623228|581477400|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
160657122|NCT00688064|580125945|FG000|Overall Study|Lack of Efficacy|0|||
160971899|NCT02508532|581287592|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
160971900|NCT02508532|581287593|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971901|NCT02508532|581287594|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971902|NCT02508532|581287586|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971903|NCT02508532|581287587|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971904|NCT02508532|581287588|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971905|NCT02508532|581287589|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971906|NCT02508532|581287590|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971907|NCT02508532|581287591|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971908|NCT02508532|581287592|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971909|NCT02508532|581287593|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
160971910|NCT02508532|581287594|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971911|NCT02508532|581287586|FG000|Part 2 - Treatment|Disease Progression|0|||
160971912|NCT02508532|581287587|FG001|Part 2 - Treatment|Disease Progression|0|||
160971913|NCT02508532|581287588|FG002|Part 2 - Treatment|Disease Progression|0|||
160971914|NCT02508532|581287589|FG003|Part 2 - Treatment|Disease Progression|0|||
160971915|NCT02508532|581287590|FG004|Part 2 - Treatment|Disease Progression|0|||
160971916|NCT02508532|581287591|FG005|Part 2 - Treatment|Disease Progression|0|||
160971917|NCT02508532|581287592|FG006|Part 2 - Treatment|Disease Progression|0|||
160971918|NCT02508532|581287593|FG007|Part 2 - Treatment|Disease Progression|0|||
160971919|NCT02508532|581287594|FG008|Part 2 - Treatment|Disease Progression|118|||
160971920|NCT02508532|581287586|FG000|Part 2 - Treatment|Adverse Event|0|||
160971921|NCT02508532|581287587|FG001|Part 2 - Treatment|Adverse Event|0|||
160971922|NCT02508532|581287588|FG002|Part 2 - Treatment|Adverse Event|0|||
160971923|NCT02508532|581287589|FG003|Part 2 - Treatment|Adverse Event|0|||
160971924|NCT02508532|581287590|FG004|Part 2 - Treatment|Adverse Event|0|||
160971925|NCT02508532|581287591|FG005|Part 2 - Treatment|Adverse Event|0|||
160971926|NCT02508532|581287592|FG006|Part 2 - Treatment|Adverse Event|0|||
160971927|NCT02508532|581287593|FG007|Part 2 - Treatment|Adverse Event|0|||
160971928|NCT02508532|581287594|FG008|Part 2 - Treatment|Adverse Event|49|||
160971929|NCT02508532|581287586|FG000|Part 2 - Treatment|Physician Decision|0|||
160971930|NCT02508532|581287587|FG001|Part 2 - Treatment|Physician Decision|0|||
160971931|NCT02508532|581287588|FG002|Part 2 - Treatment|Physician Decision|0|||
160971932|NCT02508532|581287589|FG003|Part 2 - Treatment|Physician Decision|0|||
160971933|NCT02508532|581287590|FG004|Part 2 - Treatment|Physician Decision|0|||
160971934|NCT02508532|581287591|FG005|Part 2 - Treatment|Physician Decision|0|||
160971935|NCT02508532|581287592|FG006|Part 2 - Treatment|Physician Decision|0|||
160971936|NCT02508532|581287593|FG007|Part 2 - Treatment|Physician Decision|0|||
160971937|NCT02508532|581287594|FG008|Part 2 - Treatment|Physician Decision|12|||
160971938|NCT02508532|581287586|FG000|Part 2 - Treatment|Administrative|0|||
161023995|NCT05623228|581477401|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
160657123|NCT00688064|580125946|FG001|Overall Study|Lack of Efficacy|1|||
160657124|NCT00688064|580125945|FG000|Overall Study|Pregnancy|1|||
160971939|NCT02508532|581287587|FG001|Part 2 - Treatment|Administrative|0|||
160971940|NCT02508532|581287588|FG002|Part 2 - Treatment|Administrative|0|||
160971941|NCT02508532|581287589|FG003|Part 2 - Treatment|Administrative|0|||
160971942|NCT02508532|581287590|FG004|Part 2 - Treatment|Administrative|0|||
160971943|NCT02508532|581287591|FG005|Part 2 - Treatment|Administrative|0|||
160971944|NCT02508532|581287592|FG006|Part 2 - Treatment|Administrative|0|||
160971945|NCT02508532|581287593|FG007|Part 2 - Treatment|Administrative|0|||
160971946|NCT02508532|581287594|FG008|Part 2 - Treatment|Administrative|3|||
160971947|NCT02508532|581287586|FG000|Part 2 - Treatment|Sponsor Decision|0|||
160971948|NCT02508532|581287587|FG001|Part 2 - Treatment|Sponsor Decision|0|||
160971949|NCT02508532|581287588|FG002|Part 2 - Treatment|Sponsor Decision|0|||
160971950|NCT02508532|581287589|FG003|Part 2 - Treatment|Sponsor Decision|0|||
160971951|NCT02508532|581287590|FG004|Part 2 - Treatment|Sponsor Decision|0|||
160971952|NCT02508532|581287591|FG005|Part 2 - Treatment|Sponsor Decision|0|||
160971953|NCT02508532|581287592|FG006|Part 2 - Treatment|Sponsor Decision|0|||
160971954|NCT02508532|581287593|FG007|Part 2 - Treatment|Sponsor Decision|0|||
160971955|NCT02508532|581287594|FG008|Part 2 - Treatment|Sponsor Decision|28|||
160971956|NCT02508532|581287586|FG000|Part 2 - Treatment|Death|0|||
160971957|NCT02508532|581287587|FG001|Part 2 - Treatment|Death|0|||
160971958|NCT02508532|581287588|FG002|Part 2 - Treatment|Death|0|||
160971959|NCT02508532|581287589|FG003|Part 2 - Treatment|Death|0|||
160971960|NCT02508532|581287590|FG004|Part 2 - Treatment|Death|0|||
160971961|NCT02508532|581287591|FG005|Part 2 - Treatment|Death|0|||
160971962|NCT02508532|581287592|FG006|Part 2 - Treatment|Death|0|||
160971963|NCT02508532|581287593|FG007|Part 2 - Treatment|Death|0|||
160971964|NCT02508532|581287594|FG008|Part 2 - Treatment|Death|1|||
160971965|NCT02508532|581287586|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
160971966|NCT02508532|581287587|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
160971967|NCT02508532|581287588|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
160971968|NCT02508532|581287589|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
160971969|NCT02508532|581287590|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
160971970|NCT02508532|581287591|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
160971971|NCT02508532|581287592|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
160971972|NCT02508532|581287593|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
160971973|NCT02508532|581287594|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
160971974|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
160971975|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971976|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971977|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971978|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971979|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971980|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971981|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
160971982|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
160971983|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
160971984|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971985|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
160971986|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971987|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971988|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971989|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971990|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971991|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
160971992|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Death|0|||
160971993|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Death|4|||
160971994|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Death|2|||
160971995|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Death|4|||
160971996|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Death|3|||
160971997|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Death|0|||
160971998|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Death|0|||
160971999|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Death|1|||
160972000|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Death|111|||
160972001|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
160972002|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
160972003|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
160972004|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
160972005|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
160972006|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
160972007|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
160972008|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
160972009|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
160972010|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972011|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972012|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972013|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972014|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972015|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972016|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972017|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972018|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
160972019|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972020|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972021|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
160972022|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972023|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
160972024|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972025|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972026|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972027|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
160972028|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972029|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972030|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972031|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972032|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972033|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972034|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972035|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972036|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
160972037|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
160972038|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
160972039|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
160972040|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
160972041|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
160972042|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
160972043|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
160972044|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
160972045|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
160972046|NCT01111838|581287598|FG000|Overall Study|Patient Ineligible|2|||
160972047|NCT01111838|581287598|FG000|Overall Study|Not Treated|3|||
160972048|NCT01111838|581287598|FG000|Overall Study|Clinical deterioration|1|||
160972049|NCT01111838|581287598|FG000|Overall Study|Other Complicating Disease|1|||
160972050|NCT01287520|581287599|FG000|Overall Study|Adverse Event|2|||
160972051|NCT01287520|581287600|FG001|Overall Study|Adverse Event|2|||
160972052|NCT01287520|581287601|FG002|Overall Study|Adverse Event|2|||
160972053|NCT01287520|581287602|FG003|Overall Study|Adverse Event|1|||
160972054|NCT01287520|581287603|FG004|Overall Study|Adverse Event|1|||
160972055|NCT01287520|581287604|FG005|Overall Study|Adverse Event|2|||
160972056|NCT01287520|581287605|FG006|Overall Study|Adverse Event|0|||
160972057|NCT01287520|581287606|FG007|Overall Study|Adverse Event|2|||
160972058|NCT01287520|581287607|FG008|Overall Study|Adverse Event|0|||
160972059|NCT01287520|581287599|FG000|Overall Study|Physician Decision|1|||
160972060|NCT01287520|581287600|FG001|Overall Study|Physician Decision|1|||
160972061|NCT01287520|581287601|FG002|Overall Study|Physician Decision|2|||
160972062|NCT01287520|581287602|FG003|Overall Study|Physician Decision|0|||
160972063|NCT01287520|581287603|FG004|Overall Study|Physician Decision|1|||
160972064|NCT01287520|581287604|FG005|Overall Study|Physician Decision|1|||
160972065|NCT01287520|581287605|FG006|Overall Study|Physician Decision|0|||
160972066|NCT01287520|581287606|FG007|Overall Study|Physician Decision|1|||
160972067|NCT01287520|581287607|FG008|Overall Study|Physician Decision|0|||
160972068|NCT01287520|581287599|FG000|Overall Study|Progressive disease|0|||
160972069|NCT01287520|581287600|FG001|Overall Study|Progressive disease|4|||
160588030|NCT00243230|579871557|FG003|Open Label Period|Withdrawal by Subject|2|||
160588031|NCT00243230|579871554|FG000|Open Label Period|Protocol Violation|0|||
160588032|NCT00243230|579871555|FG001|Open Label Period|Protocol Violation|0|||
160588033|NCT00243230|579871556|FG002|Open Label Period|Protocol Violation|0|||
160588034|NCT00243230|579871557|FG003|Open Label Period|Protocol Violation|2|||
160588035|NCT00243230|579871554|FG000|Open Label Period|Administrative Reason|0|||
160588036|NCT00243230|579871555|FG001|Open Label Period|Administrative Reason|0|||
160588037|NCT00243230|579871556|FG002|Open Label Period|Administrative Reason|0|||
160657125|NCT00688064|580125946|FG001|Overall Study|Pregnancy|0|||
160972070|NCT01287520|581287601|FG002|Overall Study|Progressive disease|1|||
160657126|NCT00688064|580125945|FG000|Overall Study|Any other reasons|1|||
160657127|NCT00688064|580125946|FG001|Overall Study|Any other reasons|3|||
160972071|NCT01287520|581287602|FG003|Overall Study|Progressive disease|6|||
160972072|NCT01287520|581287603|FG004|Overall Study|Progressive disease|1|||
160972073|NCT01287520|581287604|FG005|Overall Study|Progressive disease|0|||
160972074|NCT01287520|581287605|FG006|Overall Study|Progressive disease|2|||
160972075|NCT01287520|581287606|FG007|Overall Study|Progressive disease|2|||
160460071|NCT04664881|579417528|FG000|Overall Study|Physician Decision|0|||
160588038|NCT00243230|579871557|FG003|Open Label Period|Administrative Reason|63|||
160972076|NCT01287520|581287607|FG008|Overall Study|Progressive disease|4|||
160972077|NCT01287520|581287599|FG000|Overall Study|Withdrawal by Subject|0|||
160972078|NCT01287520|581287600|FG001|Overall Study|Withdrawal by Subject|0|||
160972079|NCT01287520|581287601|FG002|Overall Study|Withdrawal by Subject|0|||
160972080|NCT01287520|581287602|FG003|Overall Study|Withdrawal by Subject|0|||
160972081|NCT01287520|581287603|FG004|Overall Study|Withdrawal by Subject|0|||
160972082|NCT01287520|581287604|FG005|Overall Study|Withdrawal by Subject|1|||
160972083|NCT01287520|581287605|FG006|Overall Study|Withdrawal by Subject|0|||
160972084|NCT01287520|581287606|FG007|Overall Study|Withdrawal by Subject|0|||
160972085|NCT01287520|581287607|FG008|Overall Study|Withdrawal by Subject|1|||
160972086|NCT03587142|581287608|FG000|Overall Study|Lost to Follow-up|5|||
160972087|NCT03587142|581287609|FG001|Overall Study|Lost to Follow-up|3|||
160972088|NCT03587142|581287608|FG000|Overall Study|Did not complete the f4 visit|3|||
160972089|NCT03587142|581287609|FG001|Overall Study|Did not complete the f4 visit|7|||
160972090|NCT03673462|581287610|FG000|Overall Study|Adverse Event|11|||
160972091|NCT03673462|581287611|FG001|Overall Study|Adverse Event|1|||
160972092|NCT03673462|581287610|FG000|Overall Study|Protocol Violation|25|||
160972093|NCT03673462|581287611|FG001|Overall Study|Protocol Violation|11|||
160972094|NCT03673462|581287610|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
160972095|NCT03673462|581287611|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
160972096|NCT03673462|581287610|FG000|Overall Study|Lost to Follow-up|102|||
160972097|NCT03673462|581287611|FG001|Overall Study|Lost to Follow-up|19|||
160972098|NCT02768662|581287612|FG000|Overall Study|Adverse Event|1|||
160972099|NCT02768662|581287612|FG000|Overall Study|Lost to Follow-up|4|||
160972100|NCT02768662|581287612|FG000|Overall Study|Withdrawal by Subject|3|||
160972101|NCT02768662|581287612|FG000|Overall Study|Study terminated by Sponsor|78|||
160972102|NCT04503096|581287620|FG000|Overall Study|Withdrawal by Subject|3|||
160972103|NCT00744328|581287621|FG000|Overall Study|Lost to Follow-up|2|||
160972104|NCT00744328|581287622|FG001|Overall Study|Lost to Follow-up|5|||
160972105|NCT00744328|581287623|FG002|Overall Study|Lost to Follow-up|3|||
160972106|NCT00744328|581287621|FG000|Overall Study|Withdrawal by Subject|5|||
160972107|NCT00744328|581287622|FG001|Overall Study|Withdrawal by Subject|3|||
160972108|NCT00744328|581287623|FG002|Overall Study|Withdrawal by Subject|4|||
160972109|NCT00744328|581287621|FG000|Overall Study|Found ineligible after randomization|0|||
160972110|NCT00744328|581287622|FG001|Overall Study|Found ineligible after randomization|0|||
160972111|NCT00744328|581287623|FG002|Overall Study|Found ineligible after randomization|1|||
160972112|NCT01576367|581287624|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160972113|NCT01576367|581287624|FG000|Overall Study|Moved to commercial use after 6 months|1|||
160972114|NCT02387216|581287625|FG000|Overall Study|Progressive disease|2|||
160972115|NCT02387216|581287626|FG001|Overall Study|Progressive disease|0|||
160972116|NCT02387216|581287625|FG000|Overall Study|Withdrawal by Subject|3|||
160972117|NCT02387216|581287626|FG001|Overall Study|Withdrawal by Subject|5|||
160972118|NCT02387216|581287625|FG000|Overall Study|Physician Decision|2|||
160972119|NCT02387216|581287626|FG001|Overall Study|Physician Decision|0|||
160972120|NCT02387216|581287625|FG000|Overall Study|Sponsor Decision|28|||
160972121|NCT02387216|581287626|FG001|Overall Study|Sponsor Decision|12|||
160972122|NCT02387216|581287625|FG000|Overall Study|Death|60|||
160972123|NCT02387216|581287626|FG001|Overall Study|Death|23|||
160972124|NCT02387216|581287625|FG000|Overall Study|Other|5|||
160972125|NCT02387216|581287626|FG001|Overall Study|Other|4|||
160972126|NCT02387216|581287625|FG000|Overall Study|Lost to Follow-up|0|||
160972127|NCT02387216|581287626|FG001|Overall Study|Lost to Follow-up|3|||
160460072|NCT04664881|579417529|FG001|Overall Study|Physician Decision|5|||
160588039|NCT03011840|579871559|FG000|Overall Study|Not received PIL in post PIL phase|0|||
160588040|NCT03011840|579871560|FG001|Overall Study|Not received PIL in post PIL phase|21|||
160588041|NCT03201198|579871566|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
160588042|NCT03201198|579871567|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
160588043|NCT03201198|579871566|FG000|Overall Study|Withdrawal by Subject|2|||
160588044|NCT03201198|579871567|FG001|Overall Study|Withdrawal by Subject|3|||
160588045|NCT00471445|579871568|FG000|Overall Study|Withdrawal by Subject|1|||
160588046|NCT00471445|579871569|FG001|Overall Study|Withdrawal by Subject|1|||
160588047|NCT00471445|579871568|FG000|Overall Study|Ineligible|1|||
160972128|NCT02091739|581287627|FG000|MP: 16 Weeks|Adverse Event|1|||
160972129|NCT02091739|581287628|FG001|MP: 16 Weeks|Adverse Event|1|||
160972130|NCT02091739|581287629|FG002|MP: 16 Weeks|Adverse Event|1|||
160972131|NCT02091739|581287630|FG003|MP: 16 Weeks|Adverse Event|0|||
160588048|NCT00471445|579871569|FG001|Overall Study|Ineligible|0|||
160588049|NCT00471445|579871568|FG000|Overall Study|Protocol Violation|0|||
160972132|NCT02091739|581287631|FG004|MP: 16 Weeks|Adverse Event|0|||
160588050|NCT00471445|579871569|FG001|Overall Study|Protocol Violation|1|||
160972133|NCT02091739|581287627|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
160972134|NCT02091739|581287628|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
160972135|NCT02091739|581287629|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
161023996|NCT05623228|581477402|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
160972136|NCT02091739|581287630|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
160972137|NCT02091739|581287631|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
160972138|NCT02091739|581287627|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
160972139|NCT02091739|581287628|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
160972140|NCT02091739|581287629|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
160972141|NCT02091739|581287630|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
160972142|NCT02091739|581287631|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
160972143|NCT02091739|581287627|FG000|EP: 48 Weeks|Other|0|||
160972144|NCT02091739|581287628|FG001|EP: 48 Weeks|Other|0|||
160972145|NCT02091739|581287629|FG002|EP: 48 Weeks|Other|0|||
160972146|NCT02091739|581287630|FG003|EP: 48 Weeks|Other|1|||
160972147|NCT02091739|581287631|FG004|EP: 48 Weeks|Other|0|||
160972148|NCT02091739|581287627|FG000|EP: 48 Weeks|Death|0|||
160972149|NCT02091739|581287628|FG001|EP: 48 Weeks|Death|0|||
160972150|NCT02091739|581287629|FG002|EP: 48 Weeks|Death|0|||
160972151|NCT02091739|581287630|FG003|EP: 48 Weeks|Death|3|||
160972152|NCT02091739|581287631|FG004|EP: 48 Weeks|Death|2|||
160972153|NCT02091739|581287627|FG000|EP: 48 Weeks|Adverse Event|0|||
160972154|NCT02091739|581287628|FG001|EP: 48 Weeks|Adverse Event|0|||
160972155|NCT02091739|581287629|FG002|EP: 48 Weeks|Adverse Event|0|||
160972156|NCT02091739|581287630|FG003|EP: 48 Weeks|Adverse Event|2|||
160972157|NCT02091739|581287631|FG004|EP: 48 Weeks|Adverse Event|6|||
160972158|NCT02091739|581287627|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
160972159|NCT02091739|581287628|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
160972160|NCT02091739|581287629|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
160972161|NCT02091739|581287630|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
160972162|NCT02091739|581287631|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
160972163|NCT03528174|581287632|FG000|Overall Study|Adverse Event|1|||
160972164|NCT03528174|581287632|FG000|Overall Study|sensors dislodged|1|||
160972165|NCT04251065|581287633|FG000|Overall Study|Death|2|||
160972166|NCT04251065|581287633|FG000|Overall Study|Lack of Efficacy|3|||
160972167|NCT04251065|581287633|FG000|Overall Study|Death|1|||
160972168|NCT01436201|581287634|FG000|Overall Study|Adverse Event|2|||
160972169|NCT01436201|581287634|FG000|Overall Study|Withdrawal by Subject|1|||
160972170|NCT01436201|581287634|FG000|Overall Study|Protocol Violation|1|||
160972171|NCT00110890|581287635|FG000|Overall Study|Adverse Event|30|||
160972172|NCT00110890|581287636|FG001|Overall Study|Adverse Event|7|||
160972173|NCT00110890|581287635|FG000|Overall Study|Death|16|||
160972174|NCT00110890|581287636|FG001|Overall Study|Death|9|||
160972175|NCT00110890|581287635|FG000|Overall Study|Lost to Follow-up|3|||
160972176|NCT00110890|581287636|FG001|Overall Study|Lost to Follow-up|1|||
160972177|NCT00110890|581287635|FG000|Overall Study|Physician Decision|4|||
160972178|NCT00110890|581287636|FG001|Overall Study|Physician Decision|5|||
160972179|NCT00110890|581287635|FG000|Overall Study|Withdrawal by Subject|17|||
160972180|NCT00110890|581287636|FG001|Overall Study|Withdrawal by Subject|5|||
160460073|NCT04664881|579417528|FG000|Overall Study|Lost to Follow-up|1|||
160460074|NCT04664881|579417529|FG001|Overall Study|Lost to Follow-up|0|||
160460075|NCT04408755|579417555|FG000|Period A (Placebo lead-in)|Other|11|||
160460076|NCT04408755|579417556|FG001|Period A (Placebo lead-in)|Other|0|||
160460077|NCT04408755|579417557|FG002|Period A (Placebo lead-in)|Other|0|||
160460078|NCT04408755|579417558|FG003|Period A (Placebo lead-in)|Other|0|||
160460079|NCT04408755|579417555|FG000|Period B (Randomization Period)|Adverse Event|0|||
160460080|NCT04408755|579417556|FG001|Period B (Randomization Period)|Adverse Event|3|||
160460081|NCT04408755|579417557|FG002|Period B (Randomization Period)|Adverse Event|0|||
160460082|NCT04408755|579417558|FG003|Period B (Randomization Period)|Adverse Event|1|||
160460083|NCT04408755|579417555|FG000|Period B (Randomization Period)|Death|0|||
160460084|NCT04408755|579417556|FG001|Period B (Randomization Period)|Death|0|||
160460085|NCT04408755|579417557|FG002|Period B (Randomization Period)|Death|1|||
160460086|NCT04408755|579417558|FG003|Period B (Randomization Period)|Death|0|||
160460087|NCT04408755|579417555|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
160972181|NCT00110890|581287635|FG000|Overall Study|Protocol Deviation|1|||
160972182|NCT00110890|581287636|FG001|Overall Study|Protocol Deviation|0|||
160972183|NCT00110890|581287635|FG000|Overall Study|Noncompliance|10|||
160460088|NCT04408755|579417556|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
160460089|NCT04408755|579417557|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
160460090|NCT04408755|579417558|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
160972184|NCT00110890|581287636|FG001|Overall Study|Noncompliance|0|||
160972185|NCT00110890|581287635|FG000|Overall Study|Kidney Transplant|16|||
160972186|NCT00110890|581287636|FG001|Overall Study|Kidney Transplant|12|||
160972187|NCT00110890|581287635|FG000|Overall Study|Invest. Product Commercially Available|217|||
160460091|NCT04408755|579417555|FG000|Period B (Randomization Period)|Physician Decision|0|||
160460092|NCT04408755|579417556|FG001|Period B (Randomization Period)|Physician Decision|0|||
160460093|NCT04408755|579417557|FG002|Period B (Randomization Period)|Physician Decision|1|||
160972188|NCT00110890|581287636|FG001|Overall Study|Invest. Product Commercially Available|110|||
160972189|NCT00110890|581287635|FG000|Overall Study|Other|34|||
160972190|NCT00110890|581287636|FG001|Overall Study|Other|23|||
160972191|NCT00110890|581287635|FG000|Overall Study|Ineligibility determined|3|||
160972192|NCT00110890|581287636|FG001|Overall Study|Ineligibility determined|0|||
160972193|NCT00110890|581287635|FG000|Overall Study|Requirement for alternative therapy|0|||
160972194|NCT00110890|581287636|FG001|Overall Study|Requirement for alternative therapy|1|||
160972195|NCT00110890|581287635|FG000|Overall Study|Disease progression|0|||
160972196|NCT00110890|581287636|FG001|Overall Study|Disease progression|1|||
160972197|NCT00110890|581287635|FG000|Overall Study|Parathyroidectomy|0|||
160972198|NCT00110890|581287636|FG001|Overall Study|Parathyroidectomy|1|||
160972199|NCT00110890|581287635|FG000|Overall Study|Did not enter follow-up phase|10|||
160972200|NCT00110890|581287636|FG001|Overall Study|Did not enter follow-up phase|4|||
160972201|NCT01686581|581287637|FG000|Overall Study|Side-effects or Health Problems|15|||
160972202|NCT01686581|581287637|FG000|Overall Study|Lack of Efficacy|90|||
160972203|NCT01686581|581287637|FG000|Overall Study|Participant Concerned about Risks|6|||
160972204|NCT01686581|581287637|FG000|Overall Study|Thinks Injections Too Painful|8|||
160972205|NCT01686581|581287637|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
160972206|NCT01686581|581287637|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
160972207|NCT01686581|581287637|FG000|Overall Study|Thinks it is Inconvenient|17|||
160972208|NCT01686581|581287637|FG000|Overall Study|Other Miscellaneous Reasons|36|||
160972209|NCT01686581|581287637|FG000|Overall Study|Reason Missing|1|||
160972210|NCT01975220|581287638|FG000|Test Period 1|Not treated|0|||
160972211|NCT01975220|581287639|FG001|Test Period 1|Not treated|1|||
160972212|NCT01975220|581287640|FG002|Test Period 1|Not treated|0|||
160972213|NCT01975220|581287641|FG003|Test Period 1|Not treated|0|||
160972214|NCT01975220|581287642|FG004|Test Period 1|Not treated|0|||
160972215|NCT01975220|581287643|FG005|Test Period 1|Not treated|0|||
160972216|NCT00263328|581287646|FG000|Overall Study|Death|0|||
160460094|NCT04408755|579417558|FG003|Period B (Randomization Period)|Physician Decision|0|||
160460095|NCT04408755|579417555|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
160588051|NCT04715230|579871570|FG000|Overall Study|Withdrawal by Subject|1|||
160588052|NCT04715230|579871571|FG001|Overall Study|Withdrawal by Subject|0|||
160588053|NCT04715230|579871572|FG002|Overall Study|Withdrawal by Subject|0|||
160588054|NCT04715230|579871570|FG000|Overall Study|Lost to Follow-up|0|||
160588055|NCT04715230|579871571|FG001|Overall Study|Lost to Follow-up|5|||
160588056|NCT04715230|579871572|FG002|Overall Study|Lost to Follow-up|1|||
160588057|NCT02596711|579871579|FG000|Overall Study|Lost to Follow-up|1|||
160588058|NCT02596711|579871580|FG001|Overall Study|Lost to Follow-up|2|||
160588059|NCT02596711|579871581|FG002|Overall Study|Lost to Follow-up|3|||
160588060|NCT02112994|579871583|FG000|Overall Study|Progressive Disease|0|||
160588061|NCT02112994|579871584|FG001|Overall Study|Progressive Disease|0|||
160588062|NCT02112994|579871585|FG002|Overall Study|Progressive Disease|1|||
160588063|NCT02112994|579871583|FG000|Overall Study|Pregnancy|0|||
160588064|NCT02112994|579871584|FG001|Overall Study|Pregnancy|1|||
160588065|NCT02112994|579871585|FG002|Overall Study|Pregnancy|1|||
160588066|NCT02112994|579871583|FG000|Overall Study|Liver Transplant|0|||
160588067|NCT02112994|579871584|FG001|Overall Study|Liver Transplant|1|||
160588068|NCT02112994|579871585|FG002|Overall Study|Liver Transplant|0|||
160588069|NCT02112994|579871583|FG000|Overall Study|Withdrawal by Subject|0|||
160588070|NCT02112994|579871584|FG001|Overall Study|Withdrawal by Subject|0|||
160588071|NCT02112994|579871585|FG002|Overall Study|Withdrawal by Subject|1|||
160588072|NCT04191577|579871589|FG000|Overall Study|Withdrawal by Subject|2|||
160588073|NCT04191577|579871590|FG001|Overall Study|Withdrawal by Subject|2|||
160588074|NCT04191577|579871591|FG002|Overall Study|Withdrawal by Subject|1|||
160588075|NCT04191577|579871589|FG000|Overall Study|Physician Decision|1|||
160588076|NCT04191577|579871590|FG001|Overall Study|Physician Decision|1|||
160588077|NCT04191577|579871591|FG002|Overall Study|Physician Decision|0|||
160588078|NCT04191577|579871589|FG000|Overall Study|Adverse Event|0|||
160588079|NCT04191577|579871590|FG001|Overall Study|Adverse Event|0|||
160588080|NCT04191577|579871591|FG002|Overall Study|Adverse Event|1|||
160588081|NCT04191577|579871589|FG000|Overall Study|Death|0|||
160588082|NCT04191577|579871590|FG001|Overall Study|Death|0|||
160972217|NCT00263328|581287647|FG001|Overall Study|Death|0|||
160972218|NCT00263328|581287648|FG002|Overall Study|Death|1|||
160972219|NCT00263328|581287646|FG000|Overall Study|Lost to Follow-up|1|||
160972220|NCT00263328|581287647|FG001|Overall Study|Lost to Follow-up|1|||
160972221|NCT00263328|581287648|FG002|Overall Study|Lost to Follow-up|0|||
160972222|NCT00263328|581287646|FG000|Overall Study|Withdrawal by Subject|3|||
160972223|NCT00263328|581287647|FG001|Overall Study|Withdrawal by Subject|0|||
160588083|NCT04191577|579871591|FG002|Overall Study|Death|1|||
160588084|NCT01683071|579871592|FG000|Part 1|Lack of Efficacy|1|||
160588085|NCT01683071|579871593|FG001|Part 1|Lack of Efficacy|0|||
160657128|NCT00728949|580125947|FG000|Overall Study|Adverse Event|8|||
160972224|NCT00263328|581287648|FG002|Overall Study|Withdrawal by Subject|1|||
160972225|NCT00263328|581287646|FG000|Overall Study|Other|3|||
160972226|NCT00263328|581287647|FG001|Overall Study|Other|0|||
160972227|NCT00263328|581287648|FG002|Overall Study|Other|1|||
160972228|NCT00263328|581287646|FG000|Overall Study|Adverse Event|1|||
160972229|NCT00263328|581287647|FG001|Overall Study|Adverse Event|1|||
160588086|NCT01683071|579871594|FG002|Part 1|Lack of Efficacy|0|||
160588087|NCT01683071|579871595|FG003|Part 1|Lack of Efficacy|3|||
160588088|NCT01683071|579871596|FG004|Part 1|Lack of Efficacy|0|||
160588089|NCT01683071|579871597|FG005|Part 1|Lack of Efficacy|0|||
160588090|NCT01683071|579871592|FG000|Part 1|Withdrawal by Subject|1|||
160588091|NCT01683071|579871593|FG001|Part 1|Withdrawal by Subject|2|||
160460096|NCT04408755|579417556|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
160460097|NCT04408755|579417557|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
160460098|NCT04408755|579417558|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
160460099|NCT04408755|579417555|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
160460100|NCT04408755|579417556|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
160460101|NCT04408755|579417557|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
160460102|NCT04408755|579417558|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
160972230|NCT00263328|581287648|FG002|Overall Study|Adverse Event|4|||
160972231|NCT01008475|581287653|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
160972232|NCT01008475|581287654|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
160972233|NCT01008475|581287655|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
160972234|NCT01008475|581287656|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
160972235|NCT01008475|581287657|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
160972236|NCT01008475|581287658|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
160972237|NCT01008475|581287659|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
160972238|NCT01301274|581287660|FG000|Overall Study|Physician Decision|2|||
160972239|NCT01301274|581287661|FG001|Overall Study|Physician Decision|1|||
160972240|NCT00661661|581287662|FG000|Overall Study|Adverse Event|99|||
160972241|NCT00661661|581287663|FG001|Overall Study|Adverse Event|24|||
160972242|NCT00661661|581287662|FG000|Overall Study|Lack of Efficacy|3|||
160972243|NCT00661661|581287663|FG001|Overall Study|Lack of Efficacy|2|||
160972244|NCT00661661|581287662|FG000|Overall Study|Lost to Follow-up|0|||
160972245|NCT00661661|581287663|FG001|Overall Study|Lost to Follow-up|1|||
160972246|NCT00661661|581287662|FG000|Overall Study|Withdrawal by Subject|15|||
160972247|NCT00661661|581287663|FG001|Overall Study|Withdrawal by Subject|5|||
160972248|NCT00661661|581287662|FG000|Overall Study|Other|22|||
160972249|NCT00661661|581287663|FG001|Overall Study|Other|7|||
160972250|NCT00661661|581287662|FG000|Overall Study|Not assigned treatment|1|||
160972251|NCT00661661|581287663|FG001|Overall Study|Not assigned treatment|0|||
160972252|NCT01893827|581287664|FG000|Overall Study|Lost to Follow-up|19|||
160972253|NCT01893827|581287665|FG001|Overall Study|Lost to Follow-up|26|||
160972254|NCT02917941|581287666|FG000|Treatment Period|Adverse Event|11|||
160972255|NCT02917941|581287666|FG000|Treatment Period|Progressive Disease|11|||
160972256|NCT02917941|581287666|FG000|Treatment Period|Reason not Specified|2|||
160972257|NCT02917941|581287666|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
160972258|NCT02917941|581287666|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
160972259|NCT00399763|581287667|FG000|Overall Study|Lost to Follow-up|2|||
160972260|NCT00399763|581287668|FG001|Overall Study|Lost to Follow-up|3|||
160972261|NCT03389477|581287671|FG000|Step 1|Withdrawal by Subject|1|||
160972262|NCT03389477|581287672|FG001|Step 1|Withdrawal by Subject|0|||
160972263|NCT03389477|581287671|FG000|Step 2|Withdrawal by Subject|1|||
160972264|NCT03389477|581287672|FG001|Step 2|Withdrawal by Subject|2|||
160972265|NCT03389477|581287671|FG000|Step 2|Disease progression|1|||
160972266|NCT03389477|581287672|FG001|Step 2|Disease progression|0|||
160972267|NCT03389477|581287671|FG000|Step 2|Death|0|||
160972268|NCT03389477|581287672|FG001|Step 2|Death|1|||
160972269|NCT03389477|581287671|FG000|Step 2|Poor performance status and nutrition|0|||
160972270|NCT03389477|581287672|FG001|Step 2|Poor performance status and nutrition|1|||
160972271|NCT03389477|581287671|FG000|Step 3|Withdrawal after 3 cycles|0|||
160972272|NCT03389477|581287672|FG001|Step 3|Withdrawal after 3 cycles|1|||
160972273|NCT03389477|581287671|FG000|Step 3|Still receiving active treatment|4|||
160972274|NCT03389477|581287672|FG001|Step 3|Still receiving active treatment|0|||
160972275|NCT03389477|581287671|FG000|Step 3|Progressive disease after 2 cycles|1|||
160972276|NCT03389477|581287672|FG001|Step 3|Progressive disease after 2 cycles|0|||
160972277|NCT04512066|581287675|FG000|Double-blind Treatment Period|Adverse Event|6|||
160972278|NCT04512066|581287676|FG001|Double-blind Treatment Period|Adverse Event|4|||
160460103|NCT04408755|579417555|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
160460104|NCT04408755|579417556|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
160460105|NCT04408755|579417557|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
160460106|NCT04408755|579417558|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
160588092|NCT01683071|579871594|FG002|Part 1|Withdrawal by Subject|2|||
160588093|NCT01683071|579871595|FG003|Part 1|Withdrawal by Subject|1|||
160588094|NCT01683071|579871596|FG004|Part 1|Withdrawal by Subject|0|||
160972279|NCT04512066|581287677|FG002|Double-blind Treatment Period|Adverse Event|5|||
160972280|NCT04512066|581287678|FG003|Double-blind Treatment Period|Adverse Event|1|||
160972281|NCT04512066|581287679|FG004|Double-blind Treatment Period|Adverse Event|0|||
160972282|NCT04512066|581287680|FG005|Double-blind Treatment Period|Adverse Event|0|||
160972283|NCT04512066|581287675|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
160972284|NCT04512066|581287676|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
160972285|NCT04512066|581287677|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
160972286|NCT04512066|581287678|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
160588095|NCT01683071|579871597|FG005|Part 1|Withdrawal by Subject|0|||
160972287|NCT04512066|581287679|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
160972288|NCT04512066|581287680|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
160972289|NCT04512066|581287675|FG000|Double-blind Treatment Period|Physician Decision|1|||
160972290|NCT04512066|581287676|FG001|Double-blind Treatment Period|Physician Decision|0|||
160972291|NCT04512066|581287677|FG002|Double-blind Treatment Period|Physician Decision|1|||
160972292|NCT04512066|581287678|FG003|Double-blind Treatment Period|Physician Decision|0|||
160972293|NCT04512066|581287679|FG004|Double-blind Treatment Period|Physician Decision|0|||
160972294|NCT04512066|581287680|FG005|Double-blind Treatment Period|Physician Decision|0|||
160972295|NCT04512066|581287675|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
160972296|NCT04512066|581287676|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
160972297|NCT04512066|581287677|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
160972298|NCT04512066|581287678|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
160972299|NCT04512066|581287679|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
160972300|NCT04512066|581287680|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
160972301|NCT04512066|581287675|FG000|Extension Period|Adverse Event|0|||
160972302|NCT04512066|581287676|FG001|Extension Period|Adverse Event|1|||
160972303|NCT04512066|581287677|FG002|Extension Period|Adverse Event|4|||
160972304|NCT04512066|581287678|FG003|Extension Period|Adverse Event|3|||
160972305|NCT04512066|581287679|FG004|Extension Period|Adverse Event|1|||
160972306|NCT04512066|581287680|FG005|Extension Period|Adverse Event|3|||
160972307|NCT04512066|581287675|FG000|Extension Period|Death|0|||
160972308|NCT04512066|581287676|FG001|Extension Period|Death|0|||
161023997|NCT05623228|581477403|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
161023998|NCT05623228|581477404|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161023999|NCT05623228|581477405|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
160588096|NCT01683071|579871592|FG000|Part 1|Surgery Cancelled|1|||
160588097|NCT01683071|579871593|FG001|Part 1|Surgery Cancelled|0|||
160588098|NCT01683071|579871594|FG002|Part 1|Surgery Cancelled|0|||
160588099|NCT01683071|579871595|FG003|Part 1|Surgery Cancelled|0|||
160588100|NCT01683071|579871596|FG004|Part 1|Surgery Cancelled|0|||
160588101|NCT01683071|579871597|FG005|Part 1|Surgery Cancelled|0|||
160588102|NCT01683071|579871592|FG000|Part 1|Did not receive study drug|1|||
160588103|NCT01683071|579871593|FG001|Part 1|Did not receive study drug|0|||
160588104|NCT01683071|579871594|FG002|Part 1|Did not receive study drug|0|||
160588105|NCT01683071|579871595|FG003|Part 1|Did not receive study drug|1|||
160588106|NCT01683071|579871596|FG004|Part 1|Did not receive study drug|0|||
160588107|NCT01683071|579871597|FG005|Part 1|Did not receive study drug|0|||
160588108|NCT01683071|579871592|FG000|Part 1|Early termination; met exclusion criteria|0|||
160588109|NCT01683071|579871593|FG001|Part 1|Early termination; met exclusion criteria|2|||
160588110|NCT01683071|579871594|FG002|Part 1|Early termination; met exclusion criteria|1|||
160588111|NCT01683071|579871595|FG003|Part 1|Early termination; met exclusion criteria|0|||
160588112|NCT01683071|579871596|FG004|Part 1|Early termination; met exclusion criteria|0|||
160588113|NCT01683071|579871597|FG005|Part 1|Early termination; met exclusion criteria|0|||
160588114|NCT01683071|579871592|FG000|Part 2|Lack of Efficacy|0|||
160588115|NCT01683071|579871593|FG001|Part 2|Lack of Efficacy|0|||
160588116|NCT01683071|579871594|FG002|Part 2|Lack of Efficacy|0|||
160588117|NCT01683071|579871595|FG003|Part 2|Lack of Efficacy|0|||
160588118|NCT01683071|579871596|FG004|Part 2|Lack of Efficacy|3|||
160588119|NCT01683071|579871597|FG005|Part 2|Lack of Efficacy|4|||
160588120|NCT01683071|579871592|FG000|Part 2|Lost to Follow-up|0|||
160588121|NCT01683071|579871593|FG001|Part 2|Lost to Follow-up|0|||
160588122|NCT01683071|579871594|FG002|Part 2|Lost to Follow-up|0|||
160588123|NCT01683071|579871595|FG003|Part 2|Lost to Follow-up|0|||
160588124|NCT01683071|579871596|FG004|Part 2|Lost to Follow-up|2|||
160588125|NCT01683071|579871597|FG005|Part 2|Lost to Follow-up|0|||
160588126|NCT01683071|579871592|FG000|Part 2|Withdrawal by Subject|0|||
160588127|NCT01683071|579871593|FG001|Part 2|Withdrawal by Subject|0|||
160588128|NCT01683071|579871594|FG002|Part 2|Withdrawal by Subject|0|||
160588129|NCT01683071|579871595|FG003|Part 2|Withdrawal by Subject|0|||
160588130|NCT01683071|579871596|FG004|Part 2|Withdrawal by Subject|3|||
160588131|NCT01683071|579871597|FG005|Part 2|Withdrawal by Subject|3|||
160588132|NCT01683071|579871592|FG000|Part 2|Surgery cancelled|0|||
160588133|NCT01683071|579871593|FG001|Part 2|Surgery cancelled|0|||
160588134|NCT01683071|579871594|FG002|Part 2|Surgery cancelled|0|||
160588135|NCT01683071|579871595|FG003|Part 2|Surgery cancelled|0|||
160588136|NCT01683071|579871596|FG004|Part 2|Surgery cancelled|4|||
160588137|NCT01683071|579871597|FG005|Part 2|Surgery cancelled|2|||
160588138|NCT01683071|579871592|FG000|Part 2|Did not receive study drug|0|||
160588139|NCT01683071|579871593|FG001|Part 2|Did not receive study drug|0|||
160588140|NCT01683071|579871594|FG002|Part 2|Did not receive study drug|0|||
160588141|NCT01683071|579871595|FG003|Part 2|Did not receive study drug|0|||
160588142|NCT01683071|579871596|FG004|Part 2|Did not receive study drug|2|||
160972309|NCT04512066|581287677|FG002|Extension Period|Death|0|||
160972310|NCT04512066|581287678|FG003|Extension Period|Death|0|||
160588143|NCT01683071|579871597|FG005|Part 2|Did not receive study drug|1|||
160588144|NCT01683071|579871592|FG000|Part 2|Met exclusion criterion|0|||
160588145|NCT01683071|579871593|FG001|Part 2|Met exclusion criterion|0|||
160972311|NCT04512066|581287679|FG004|Extension Period|Death|0|||
160588146|NCT01683071|579871594|FG002|Part 2|Met exclusion criterion|0|||
160588147|NCT01683071|579871595|FG003|Part 2|Met exclusion criterion|0|||
160972312|NCT04512066|581287680|FG005|Extension Period|Death|1|||
160972313|NCT04512066|581287675|FG000|Extension Period|Lack of Efficacy|0|||
160972314|NCT04512066|581287676|FG001|Extension Period|Lack of Efficacy|4|||
160972315|NCT04512066|581287677|FG002|Extension Period|Lack of Efficacy|4|||
160972316|NCT04512066|581287678|FG003|Extension Period|Lack of Efficacy|1|||
160972317|NCT04512066|581287679|FG004|Extension Period|Lack of Efficacy|3|||
160972318|NCT04512066|581287680|FG005|Extension Period|Lack of Efficacy|3|||
160972319|NCT04512066|581287675|FG000|Extension Period|Lost to Follow-up|0|||
160972320|NCT04512066|581287676|FG001|Extension Period|Lost to Follow-up|1|||
160972321|NCT04512066|581287677|FG002|Extension Period|Lost to Follow-up|5|||
160972322|NCT04512066|581287678|FG003|Extension Period|Lost to Follow-up|2|||
160972323|NCT04512066|581287679|FG004|Extension Period|Lost to Follow-up|3|||
160972324|NCT04512066|581287680|FG005|Extension Period|Lost to Follow-up|2|||
160972325|NCT04512066|581287675|FG000|Extension Period|Non-compliance with study drug|0|||
160972326|NCT04512066|581287676|FG001|Extension Period|Non-compliance with study drug|1|||
160972327|NCT04512066|581287677|FG002|Extension Period|Non-compliance with study drug|0|||
160972328|NCT04512066|581287678|FG003|Extension Period|Non-compliance with study drug|0|||
160972329|NCT04512066|581287679|FG004|Extension Period|Non-compliance with study drug|0|||
160972330|NCT04512066|581287680|FG005|Extension Period|Non-compliance with study drug|1|||
160972331|NCT04512066|581287675|FG000|Extension Period|Other|0|||
160972332|NCT04512066|581287676|FG001|Extension Period|Other|2|||
160972333|NCT04512066|581287677|FG002|Extension Period|Other|0|||
160972334|NCT04512066|581287678|FG003|Extension Period|Other|0|||
160972335|NCT04512066|581287679|FG004|Extension Period|Other|0|||
160972336|NCT04512066|581287680|FG005|Extension Period|Other|0|||
160972337|NCT04512066|581287675|FG000|Extension Period|Physician Decision|0|||
160972338|NCT04512066|581287676|FG001|Extension Period|Physician Decision|2|||
160972339|NCT04512066|581287677|FG002|Extension Period|Physician Decision|0|||
160972340|NCT04512066|581287678|FG003|Extension Period|Physician Decision|1|||
160972341|NCT04512066|581287679|FG004|Extension Period|Physician Decision|1|||
160972342|NCT04512066|581287680|FG005|Extension Period|Physician Decision|0|||
160972343|NCT04512066|581287675|FG000|Extension Period|Withdrawal by Subject|0|||
160972344|NCT04512066|581287676|FG001|Extension Period|Withdrawal by Subject|3|||
160972345|NCT04512066|581287677|FG002|Extension Period|Withdrawal by Subject|7|||
160972346|NCT04512066|581287678|FG003|Extension Period|Withdrawal by Subject|11|||
160972347|NCT04512066|581287679|FG004|Extension Period|Withdrawal by Subject|8|||
160972348|NCT04512066|581287680|FG005|Extension Period|Withdrawal by Subject|4|||
160972349|NCT03403426|581287682|FG000|Overall Study|Death|1|||
160972350|NCT03403426|581287682|FG000|Overall Study|Lost to Follow-up|2|||
160972351|NCT01657266|581287686|FG000|Overall Study|Lost to Follow-up|2|||
160972352|NCT01657266|581287687|FG001|Overall Study|Lost to Follow-up|2|||
160972353|NCT01657266|581287686|FG000|Overall Study|Adverse Event|2|||
160972354|NCT01657266|581287687|FG001|Overall Study|Adverse Event|3|||
160972355|NCT03520400|581287688|FG000|Overall Study|Physician Decision|15|||
160972356|NCT03520400|581287689|FG001|Overall Study|Physician Decision|7|||
160972357|NCT00445679|581287692|FG000|Overall Study|Adverse Event|22|||
160972358|NCT00445679|581287693|FG001|Overall Study|Adverse Event|12|||
160972359|NCT00445679|581287694|FG002|Overall Study|Adverse Event|30|||
160972360|NCT00445679|581287695|FG003|Overall Study|Adverse Event|19|||
160972361|NCT00445679|581287692|FG000|Overall Study|Failed to return|1|||
160972362|NCT00445679|581287693|FG001|Overall Study|Failed to return|3|||
160972363|NCT00445679|581287694|FG002|Overall Study|Failed to return|2|||
160972364|NCT00445679|581287695|FG003|Overall Study|Failed to return|2|||
160972365|NCT00445679|581287692|FG000|Overall Study|Physician Decision|0|||
160972366|NCT00445679|581287693|FG001|Overall Study|Physician Decision|0|||
160972367|NCT00445679|581287694|FG002|Overall Study|Physician Decision|1|||
160972368|NCT00445679|581287695|FG003|Overall Study|Physician Decision|0|||
160972369|NCT00445679|581287692|FG000|Overall Study|Lost to Follow-up|10|||
160972370|NCT00445679|581287693|FG001|Overall Study|Lost to Follow-up|6|||
160972371|NCT00445679|581287694|FG002|Overall Study|Lost to Follow-up|6|||
160972372|NCT00445679|581287695|FG003|Overall Study|Lost to Follow-up|5|||
160972373|NCT00445679|581287692|FG000|Overall Study|Compliance|3|||
160972374|NCT00445679|581287693|FG001|Overall Study|Compliance|2|||
160972375|NCT00445679|581287694|FG002|Overall Study|Compliance|1|||
160972376|NCT00445679|581287695|FG003|Overall Study|Compliance|2|||
160972377|NCT00445679|581287692|FG000|Overall Study|Withdrawal of Informed Consent|0|||
160972378|NCT00445679|581287693|FG001|Overall Study|Withdrawal of Informed Consent|0|||
160972379|NCT00445679|581287694|FG002|Overall Study|Withdrawal of Informed Consent|1|||
160972380|NCT00445679|581287695|FG003|Overall Study|Withdrawal of Informed Consent|0|||
160972381|NCT00445679|581287692|FG000|Overall Study|Protocol Violation|2|||
160972382|NCT00445679|581287693|FG001|Overall Study|Protocol Violation|3|||
160972383|NCT00445679|581287694|FG002|Overall Study|Protocol Violation|3|||
160972384|NCT00445679|581287695|FG003|Overall Study|Protocol Violation|1|||
160972385|NCT00445679|581287692|FG000|Overall Study|Withdrawal by Subject|8|||
160972386|NCT00445679|581287693|FG001|Overall Study|Withdrawal by Subject|14|||
160972387|NCT00445679|581287694|FG002|Overall Study|Withdrawal by Subject|20|||
160972388|NCT00445679|581287695|FG003|Overall Study|Withdrawal by Subject|18|||
160972389|NCT00445679|581287692|FG000|Overall Study|Lack of Efficacy|2|||
160972390|NCT00445679|581287693|FG001|Overall Study|Lack of Efficacy|6|||
160657129|NCT00728949|580125948|FG001|Overall Study|Adverse Event|0|||
160657130|NCT00728949|580125947|FG000|Overall Study|Withdrawal by Subject|2|||
160657131|NCT00728949|580125948|FG001|Overall Study|Withdrawal by Subject|2|||
160657132|NCT00728949|580125947|FG000|Overall Study|Abnormal Lab Results|0|||
160657133|NCT00728949|580125948|FG001|Overall Study|Abnormal Lab Results|2|||
160657134|NCT00728949|580125947|FG000|Overall Study|On treatment at cutoff date|1|||
160657135|NCT00728949|580125948|FG001|Overall Study|On treatment at cutoff date|0|||
160657136|NCT01074554|580125960|FG000|Overall Study|Adverse Event|3|||
160657137|NCT01074554|580125961|FG001|Overall Study|Adverse Event|3|||
160657138|NCT01074554|580125960|FG000|Overall Study|Lost to Follow-up|0|||
160657139|NCT01074554|580125961|FG001|Overall Study|Lost to Follow-up|1|||
160657140|NCT01856309|580125965|FG000|Overall Study|Death|4|||
160657141|NCT01856309|580125966|FG001|Overall Study|Death|6|||
160657142|NCT01856309|580125967|FG002|Overall Study|Death|11|||
160657143|NCT01856309|580125968|FG003|Overall Study|Death|6|||
160657144|NCT01856309|580125965|FG000|Overall Study|Lost to Follow-up|6|||
160657145|NCT01856309|580125966|FG001|Overall Study|Lost to Follow-up|2|||
160657146|NCT01856309|580125967|FG002|Overall Study|Lost to Follow-up|4|||
160657147|NCT01856309|580125968|FG003|Overall Study|Lost to Follow-up|8|||
160657148|NCT01856309|580125965|FG000|Overall Study|Withdrawal by Subject|11|||
160657149|NCT01856309|580125966|FG001|Overall Study|Withdrawal by Subject|13|||
160657150|NCT01856309|580125967|FG002|Overall Study|Withdrawal by Subject|28|||
160657151|NCT01856309|580125968|FG003|Overall Study|Withdrawal by Subject|26|||
160657152|NCT01856309|580125965|FG000|Overall Study|Other|227|||
160657153|NCT01856309|580125966|FG001|Overall Study|Other|225|||
160657154|NCT01856309|580125967|FG002|Overall Study|Other|447|||
160657155|NCT01856309|580125968|FG003|Overall Study|Other|469|||
160657156|NCT01856309|580125965|FG000|Overall Study|Lack of Efficacy|14|||
160657157|NCT01856309|580125966|FG001|Overall Study|Lack of Efficacy|9|||
160657158|NCT01856309|580125967|FG002|Overall Study|Lack of Efficacy|40|||
160657159|NCT01856309|580125968|FG003|Overall Study|Lack of Efficacy|25|||
160657160|NCT01856309|580125965|FG000|Overall Study|Adverse Event|31|||
160657161|NCT01856309|580125966|FG001|Overall Study|Adverse Event|31|||
160657162|NCT01856309|580125967|FG002|Overall Study|Adverse Event|55|||
160657163|NCT01856309|580125968|FG003|Overall Study|Adverse Event|65|||
160657164|NCT01856309|580125965|FG000|Overall Study|Pregnancy|0|||
160657165|NCT01856309|580125966|FG001|Overall Study|Pregnancy|0|||
160657166|NCT01856309|580125967|FG002|Overall Study|Pregnancy|0|||
160657167|NCT01856309|580125968|FG003|Overall Study|Pregnancy|1|||
160657168|NCT01856309|580125965|FG000|Overall Study|Physician Decision|6|||
160657169|NCT01856309|580125966|FG001|Overall Study|Physician Decision|1|||
160657170|NCT01856309|580125967|FG002|Overall Study|Physician Decision|6|||
160657171|NCT01856309|580125968|FG003|Overall Study|Physician Decision|8|||
160657172|NCT01856309|580125965|FG000|Overall Study|Noncompliance With Study Drug|0|||
160657173|NCT01856309|580125966|FG001|Overall Study|Noncompliance With Study Drug|1|||
160657174|NCT01856309|580125967|FG002|Overall Study|Noncompliance With Study Drug|4|||
160657175|NCT01856309|580125968|FG003|Overall Study|Noncompliance With Study Drug|1|||
160972391|NCT00445679|581287694|FG002|Overall Study|Lack of Efficacy|2|||
160972392|NCT00445679|581287695|FG003|Overall Study|Lack of Efficacy|0|||
160972393|NCT00909428|581287699|FG000|Overall Study|Lost to Follow-up|13|||
160972394|NCT00909428|581287700|FG001|Overall Study|Lost to Follow-up|10|||
160972395|NCT00909428|581287701|FG002|Overall Study|Lost to Follow-up|9|||
160972396|NCT03021668|581287702|FG000|Overall Study|Physician Decision|0|||
160657176|NCT00220337|580125971|FG000|Overall Study|Adverse Event|70|||
160657177|NCT00220337|580125971|FG000|Overall Study|Lack of Efficacy|17|||
160657178|NCT00220337|580125971|FG000|Overall Study|Withdrawal by Subject|68|||
160657179|NCT00220337|580125971|FG000|Overall Study|Protocol Violation|2|||
160657180|NCT00220337|580125971|FG000|Overall Study|Lost to Follow-up|5|||
160972397|NCT03021668|581287703|FG001|Overall Study|Physician Decision|1|||
160972398|NCT00116844|581287706|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
160972399|NCT00116844|581287707|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
160972400|NCT00116844|581287706|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
160972401|NCT00116844|581287707|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
161024000|NCT05623228|581477406|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161024001|NCT05623228|581477407|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161024002|NCT05256017|581479571|FG000|Treatment Period|Withdrawal by Subject|1|||
160972402|NCT00116844|581287706|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
161024003|NCT05256017|581479572|FG001|Treatment Period|Withdrawal by Subject|1|||
161024004|NCT05256017|581479571|FG000|Follow-up|Lost to Follow-up|7|||
160657181|NCT00220337|580125971|FG000|Overall Study|Other|12|||
160657182|NCT00220337|580125971|FG000|Overall Study|Unsatisfactory compliance|5|||
160657183|NCT00832377|580125972|FG000|Overall Study|Protocol Violation|1|||
160657184|NCT00944697|580125973|FG000|Overall Study|Withdrawal by Subject|1|||
160657185|NCT00944697|580125974|FG001|Overall Study|Withdrawal by Subject|1|||
160657186|NCT00944697|580125973|FG000|Overall Study|Adverse Event|0|||
160657187|NCT00944697|580125974|FG001|Overall Study|Adverse Event|3|||
160657188|NCT00944697|580125973|FG000|Overall Study|Administrative|1|||
160657189|NCT00944697|580125974|FG001|Overall Study|Administrative|1|||
160657190|NCT01273181|580125975|FG000|Phase I, Dose 1|Study termination|1|||
160972403|NCT00116844|581287707|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
160972404|NCT00116844|581287706|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
160972405|NCT00116844|581287707|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
160972406|NCT00116844|581287706|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
160972407|NCT00116844|581287707|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
160972408|NCT00116844|581287706|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
160972409|NCT00116844|581287707|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
160972410|NCT00116844|581287706|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
160972411|NCT00116844|581287707|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
160972412|NCT00116844|581287706|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
160972413|NCT00116844|581287707|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
160972414|NCT00116844|581287706|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
160972415|NCT00116844|581287707|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
160972416|NCT01933880|581287708|FG000|Overall Study|Withdrawal by Subject|5|||
160972417|NCT01933880|581287709|FG001|Overall Study|Withdrawal by Subject|0|||
160972418|NCT01933880|581287708|FG000|Overall Study|Lack of Efficacy|1|||
160972419|NCT01933880|581287709|FG001|Overall Study|Lack of Efficacy|0|||
160972420|NCT01933880|581287708|FG000|Overall Study|Concomitant medication Interference|0|||
160972421|NCT01933880|581287709|FG001|Overall Study|Concomitant medication Interference|1|||
160972422|NCT01933880|581287708|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
160972423|NCT01933880|581287709|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
160972424|NCT01933880|581287708|FG000|Overall Study|Other|4|||
160972425|NCT01933880|581287709|FG001|Overall Study|Other|0|||
160972426|NCT01933880|581287708|FG000|Overall Study|Protocol Violation|1|||
160972427|NCT01933880|581287709|FG001|Overall Study|Protocol Violation|0|||
160972428|NCT01125722|581287710|FG000|Overall Study|Withdrawal by Subject|2|||
160972429|NCT01125722|581287711|FG001|Overall Study|Withdrawal by Subject|1|||
160972430|NCT01125722|581287710|FG000|Overall Study|Lost to Follow-up|1|||
160972431|NCT01125722|581287711|FG001|Overall Study|Lost to Follow-up|0|||
160972432|NCT03474549|581287712|FG000|Overall Study|Death|31|||
160972433|NCT03474549|581287712|FG000|Overall Study|Lost to Follow-up|4|||
160972434|NCT03474549|581287712|FG000|Overall Study|Withdrawal by Subject|2|||
160972435|NCT00069784|581287713|FG000|Overall Study|Adverse Event|105|||
160972436|NCT00069784|581287714|FG001|Overall Study|Adverse Event|0|||
160972437|NCT00069784|581287713|FG000|Overall Study|Withdrawal by Subject|1090|||
160972438|NCT00069784|581287714|FG001|Overall Study|Withdrawal by Subject|0|||
160972439|NCT00069784|581287713|FG000|Overall Study|Other|17|||
160972440|NCT00069784|581287714|FG001|Overall Study|Other|0|||
160972441|NCT00926003|581287717|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
160972442|NCT00926003|581287718|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
160972443|NCT00926003|581287719|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
160972444|NCT00926003|581287717|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
160972445|NCT00926003|581287718|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
160972446|NCT00926003|581287719|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
160972447|NCT00709059|581287721|FG000|Overall Study|Lost to Follow-up|34|||
160972448|NCT00709059|581287721|FG000|Overall Study|Withdrawal by Subject|19|||
160972449|NCT00709059|581287721|FG000|Overall Study|Physician Decision|7|||
160972450|NCT00709059|581287721|FG000|Overall Study|Disease complication|3|||
160972451|NCT00709059|581287721|FG000|Overall Study|Side effects|20|||
160972452|NCT00709059|581287721|FG000|Overall Study|Serious side effects|11|||
160972453|NCT01786330|581287722|FG000|Overall Study|Withdrawal by Subject|0|||
160972454|NCT01786330|581287723|FG001|Overall Study|Withdrawal by Subject|1|||
160972455|NCT01786330|581287722|FG000|Overall Study|Lost to Follow-up|0|||
160972456|NCT01786330|581287723|FG001|Overall Study|Lost to Follow-up|1|||
160972457|NCT01786330|581287722|FG000|Overall Study|Excluded intraoperatively|0|||
160972458|NCT01786330|581287723|FG001|Overall Study|Excluded intraoperatively|1|||
160972459|NCT01786330|581287722|FG000|Overall Study|Protocol Violation|1|||
160972460|NCT01786330|581287723|FG001|Overall Study|Protocol Violation|0|||
160972461|NCT01167179|581289115|FG000|Overall Study|disease recurrence|4|||
160972462|NCT01167179|581289116|FG001|Overall Study|disease recurrence|4|||
160972463|NCT01167179|581289115|FG000|Overall Study|Death|4|||
160972464|NCT01167179|581289116|FG001|Overall Study|Death|10|||
160972465|NCT01167179|581289115|FG000|Overall Study|Withdrawal by Subject|1|||
160972466|NCT01167179|581289116|FG001|Overall Study|Withdrawal by Subject|2|||
160972467|NCT01167179|581289115|FG000|Overall Study|diverse|6|||
160972468|NCT01167179|581289116|FG001|Overall Study|diverse|5|||
160972469|NCT03017235|581289117|FG000|Overall Study|Withdrawal by Subject|4|||
160972470|NCT03017235|581289118|FG001|Overall Study|Withdrawal by Subject|3|||
160972471|NCT03017235|581289117|FG000|Overall Study|Lost to Follow-up|2|||
160972472|NCT03017235|581289118|FG001|Overall Study|Lost to Follow-up|7|||
160972473|NCT03017235|581289117|FG000|Overall Study|Adverse Event|0|||
160972474|NCT03017235|581289118|FG001|Overall Study|Adverse Event|1|||
160972475|NCT03017235|581289117|FG000|Overall Study|Protocol Violation|2|||
160972476|NCT03017235|581289118|FG001|Overall Study|Protocol Violation|1|||
160972477|NCT03017235|581289117|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
160460107|NCT04408755|579417555|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
160460108|NCT04408755|579417556|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
160460109|NCT04408755|579417557|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
160460110|NCT04408755|579417558|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
160460111|NCT04408755|579417555|FG000|Period B (Randomization Period)|Reason not Specified|0|||
160460112|NCT04408755|579417556|FG001|Period B (Randomization Period)|Reason not Specified|1|||
160460113|NCT04408755|579417557|FG002|Period B (Randomization Period)|Reason not Specified|0|||
160460114|NCT04408755|579417558|FG003|Period B (Randomization Period)|Reason not Specified|2|||
160460115|NCT00308997|579417559|FG000|Overall Study|Subject feigned clinical data|0|||
160460116|NCT00308997|579417560|FG001|Overall Study|Subject feigned clinical data|1|||
160460117|NCT00308997|579417559|FG000|Overall Study|Unable to tolerate intervention|1|||
160460118|NCT00308997|579417560|FG001|Overall Study|Unable to tolerate intervention|0|||
160460119|NCT00412607|579417563|FG000|Overall Study|Withdrawal by Subject|9|||
160460120|NCT00412607|579417563|FG000|Overall Study|Lost to Follow-up|19|||
160460121|NCT00412607|579417563|FG000|Overall Study|Death|61|||
160460122|NCT00412607|579417563|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
160460123|NCT03662022|579417564|FG000|Year 1 2019|prevalent case|83|||
160460124|NCT03662022|579417565|FG001|Year 1 2019|prevalent case|116|||
160460125|NCT03662022|579417566|FG002|Year 1 2019|prevalent case|158|||
160460126|NCT03662022|579417567|FG003|Year 1 2019|prevalent case|99|||
160460127|NCT03662022|579417564|FG000|Year 2 2020|incident case|18|||
160460128|NCT03662022|579417565|FG001|Year 2 2020|incident case|18|||
160460129|NCT03662022|579417566|FG002|Year 2 2020|incident case|16|||
160460130|NCT03662022|579417567|FG003|Year 2 2020|incident case|26|||
160460131|NCT03662022|579417564|FG000|Year 2 2020|other case|18|||
160460132|NCT03662022|579417565|FG001|Year 2 2020|other case|16|||
160460133|NCT03662022|579417566|FG002|Year 2 2020|other case|16|||
160460134|NCT03662022|579417567|FG003|Year 2 2020|other case|24|||
160460135|NCT03662022|579417564|FG000|Year 2 2020|Lost to Follow-up|1633|||
160460136|NCT03662022|579417565|FG001|Year 2 2020|Lost to Follow-up|1183|||
160460137|NCT03662022|579417566|FG002|Year 2 2020|Lost to Follow-up|1381|||
160460138|NCT03662022|579417567|FG003|Year 2 2020|Lost to Follow-up|2858|||
160460139|NCT03662022|579417564|FG000|Year 3 2021|incident case|24|||
160460140|NCT03662022|579417565|FG001|Year 3 2021|incident case|27|||
160588148|NCT01683071|579871596|FG004|Part 2|Met exclusion criterion|1|||
160588149|NCT01683071|579871597|FG005|Part 2|Met exclusion criterion|1|||
160588150|NCT01683071|579871592|FG000|Part 2|Protocol deviation|0|||
160588151|NCT01683071|579871593|FG001|Part 2|Protocol deviation|0|||
160588152|NCT01683071|579871594|FG002|Part 2|Protocol deviation|0|||
161024005|NCT05256017|581479572|FG001|Follow-up|Lost to Follow-up|1|||
161024006|NCT05256017|581479571|FG000|Follow-up|Withdrawal by Subject|1|||
161024007|NCT05256017|581479572|FG001|Follow-up|Withdrawal by Subject|0|||
161024008|NCT05256017|581479571|FG000|Follow-up|Death|0|||
161024009|NCT05256017|581479572|FG001|Follow-up|Death|1|||
161024010|NCT03854227|581479573|FG000|Overall Study|Adverse Event|0|||
161024011|NCT03854227|581479574|FG001|Overall Study|Adverse Event|0|||
161024012|NCT03854227|581479575|FG002|Overall Study|Adverse Event|0|||
161024013|NCT03854227|581479576|FG003|Overall Study|Adverse Event|1|||
161024014|NCT03854227|581479577|FG004|Overall Study|Adverse Event|0|||
161024015|NCT03854227|581479578|FG005|Overall Study|Adverse Event|0|||
161024016|NCT03854227|581479579|FG006|Overall Study|Adverse Event|1|||
161024017|NCT03854227|581479580|FG007|Overall Study|Adverse Event|0|||
161024018|NCT03854227|581479581|FG008|Overall Study|Adverse Event|0|||
161024019|NCT03854227|581479582|FG009|Overall Study|Adverse Event|3|||
160588153|NCT01683071|579871595|FG003|Part 2|Protocol deviation|0|||
160588154|NCT01683071|579871596|FG004|Part 2|Protocol deviation|1|||
160588155|NCT01683071|579871597|FG005|Part 2|Protocol deviation|2|||
160588156|NCT01683071|579871592|FG000|Part 2|Withdrawal by investigator decision|0|||
160588157|NCT01683071|579871593|FG001|Part 2|Withdrawal by investigator decision|0|||
160588158|NCT01683071|579871594|FG002|Part 2|Withdrawal by investigator decision|0|||
160588159|NCT01683071|579871595|FG003|Part 2|Withdrawal by investigator decision|0|||
160588160|NCT01683071|579871596|FG004|Part 2|Withdrawal by investigator decision|1|||
160588161|NCT01683071|579871597|FG005|Part 2|Withdrawal by investigator decision|2|||
161024020|NCT03854227|581479583|FG010|Overall Study|Adverse Event|0|||
160460141|NCT03662022|579417566|FG002|Year 3 2021|incident case|24|||
160588162|NCT01993615|579873075|FG000|Overall Study|Death|1|||
160588163|NCT01993615|579873076|FG001|Overall Study|Death|0|||
160460142|NCT03662022|579417567|FG003|Year 3 2021|incident case|11|||
160460143|NCT03662022|579417564|FG000|Year 3 2021|other case|4|||
160460144|NCT03662022|579417565|FG001|Year 3 2021|other case|15|||
160460145|NCT03662022|579417566|FG002|Year 3 2021|other case|10|||
160460146|NCT03662022|579417567|FG003|Year 3 2021|other case|14|||
161024021|NCT03854227|581479584|FG011|Overall Study|Adverse Event|1|||
160460147|NCT03662022|579417564|FG000|Year 3 2021|Lost to Follow-up|179|||
160460148|NCT03662022|579417565|FG001|Year 3 2021|Lost to Follow-up|244|||
160460149|NCT03662022|579417566|FG002|Year 3 2021|Lost to Follow-up|480|||
160460150|NCT03662022|579417567|FG003|Year 3 2021|Lost to Follow-up|477|||
160588164|NCT03072719|579873080|FG000|Overall Study|Adverse Event|1|||
160588165|NCT03072719|579873081|FG001|Overall Study|Adverse Event|1|||
161024022|NCT03854227|581479573|FG000|Overall Study|Death|0|||
160588166|NCT01104584|579873084|FG000|Overall Study|Study drug never administered|21|||
160588167|NCT01104584|579873084|FG000|Overall Study|Study prematurely discontinued|2|||
160588168|NCT02370498|579873085|FG000|Overall Study|Adverse Event|10|||
160588169|NCT02370498|579873086|FG001|Overall Study|Adverse Event|8|||
160588170|NCT02370498|579873085|FG000|Overall Study|Death|263|||
160588171|NCT02370498|579873086|FG001|Overall Study|Death|265|||
160588172|NCT02370498|579873085|FG000|Overall Study|Protocol Violation|1|||
160588173|NCT02370498|579873086|FG001|Overall Study|Protocol Violation|2|||
160588174|NCT02370498|579873085|FG000|Overall Study|Withdrawal by Subject|7|||
160588175|NCT02370498|579873086|FG001|Overall Study|Withdrawal by Subject|12|||
160588176|NCT02370498|579873085|FG000|Overall Study|Sponsor's decision|15|||
160588177|NCT02370498|579873086|FG001|Overall Study|Sponsor's decision|9|||
160588178|NCT04017442|579873087|FG000|Overall Study|Withdrawal by Subject|0|||
160588179|NCT04017442|579873088|FG001|Overall Study|Withdrawal by Subject|3|||
160588180|NCT04017442|579873087|FG000|Overall Study|Lost to Follow-up|21|||
160588181|NCT04017442|579873088|FG001|Overall Study|Lost to Follow-up|19|||
160588182|NCT03225716|579873092|FG000|Overall Study|Withdrawal by Subject|2|||
160588183|NCT03225716|579873093|FG001|Overall Study|Withdrawal by Subject|2|||
160588184|NCT03225716|579873094|FG002|Overall Study|Withdrawal by Subject|0|||
160588185|NCT03225716|579873092|FG000|Overall Study|Lack of Efficacy|1|||
160588186|NCT03225716|579873093|FG001|Overall Study|Lack of Efficacy|0|||
160588187|NCT03225716|579873094|FG002|Overall Study|Lack of Efficacy|0|||
160588188|NCT03225716|579873092|FG000|Overall Study|Adverse Event|2|||
160588189|NCT03225716|579873093|FG001|Overall Study|Adverse Event|0|||
160588190|NCT03225716|579873094|FG002|Overall Study|Adverse Event|1|||
160588191|NCT03225716|579873092|FG000|Overall Study|Study early termination by Sponsor|0|||
160588192|NCT03225716|579873093|FG001|Overall Study|Study early termination by Sponsor|0|||
160588193|NCT03225716|579873094|FG002|Overall Study|Study early termination by Sponsor|2|||
160588194|NCT00848250|579873095|FG000|Overall Study|surgery was completed without cardiopulm|0|||
160588195|NCT00848250|579873096|FG001|Overall Study|surgery was completed without cardiopulm|1|||
160588196|NCT02226146|579873107|FG000|Overall Study|Received rescue therapy|1|||
160588197|NCT02226146|579873107|FG000|Overall Study|Withdrawal by Subject|2|||
160588198|NCT05464836|579873108|FG000|Overall Study|Progression of Disease|1|||
160588199|NCT05464836|579873108|FG000|Overall Study|Physician Decision|1|||
160588200|NCT01522976|579873109|FG000|Overall Study|Ineligible|4|||
160588201|NCT01522976|579873110|FG001|Overall Study|Ineligible|0|||
160588202|NCT01522976|579873111|FG002|Overall Study|Ineligible|1|||
160588203|NCT01522976|579873109|FG000|Overall Study|Death|7|||
160588204|NCT01522976|579873110|FG001|Overall Study|Death|6|||
160588205|NCT01522976|579873111|FG002|Overall Study|Death|2|||
160588206|NCT01522976|579873109|FG000|Overall Study|Still on treatment|9|||
160588207|NCT01522976|579873110|FG001|Overall Study|Still on treatment|9|||
160588208|NCT01522976|579873111|FG002|Overall Study|Still on treatment|6|||
160588209|NCT01522976|579873109|FG000|Overall Study|Disease progression|28|||
160588210|NCT01522976|579873110|FG001|Overall Study|Disease progression|30|||
160588211|NCT01522976|579873111|FG002|Overall Study|Disease progression|25|||
160588212|NCT01522976|579873109|FG000|Overall Study|Adverse Event|17|||
160588213|NCT01522976|579873110|FG001|Overall Study|Adverse Event|7|||
160588214|NCT01522976|579873111|FG002|Overall Study|Adverse Event|18|||
160588215|NCT01522976|579873109|FG000|Overall Study|Refusal unrelated to adverse event|10|||
160588216|NCT01522976|579873110|FG001|Overall Study|Refusal unrelated to adverse event|13|||
160588217|NCT01522976|579873111|FG002|Overall Study|Refusal unrelated to adverse event|14|||
160588218|NCT01522976|579873109|FG000|Overall Study|Not protocol specified|22|||
160588219|NCT01522976|579873110|FG001|Overall Study|Not protocol specified|27|||
161024023|NCT03854227|581479574|FG001|Overall Study|Death|0|||
161024024|NCT03854227|581479575|FG002|Overall Study|Death|0|||
160588220|NCT01522976|579873111|FG002|Overall Study|Not protocol specified|27|||
160588221|NCT02883049|579873112|FG000|Induction|Adverse Event|52|||
160588222|NCT02883049|579873113|FG001|Induction|Adverse Event|2|||
160588223|NCT02883049|579873114|FG002|Induction|Adverse Event|0|||
160588224|NCT02883049|579873115|FG003|Induction|Adverse Event|0|||
160657191|NCT01273181|580125976|FG001|Phase I, Dose 1|Study termination|0|||
161024025|NCT03854227|581479576|FG003|Overall Study|Death|0|||
161024026|NCT03854227|581479577|FG004|Overall Study|Death|0|||
161024027|NCT03854227|581479578|FG005|Overall Study|Death|1|||
161024028|NCT03854227|581479579|FG006|Overall Study|Death|0|||
160588225|NCT02883049|579873116|FG004|Induction|Adverse Event|0|||
160588226|NCT02883049|579873117|FG005|Induction|Adverse Event|0|||
160588227|NCT02883049|579873118|FG006|Induction|Adverse Event|0|||
160588228|NCT02883049|579873119|FG007|Induction|Adverse Event|0|||
161024029|NCT03854227|581479580|FG007|Overall Study|Death|0|||
160588229|NCT02883049|579873120|FG008|Induction|Adverse Event|0|||
160588230|NCT02883049|579873121|FG009|Induction|Adverse Event|0|||
160588231|NCT02883049|579873122|FG010|Induction|Adverse Event|0|||
160588232|NCT02883049|579873123|FG011|Induction|Adverse Event|0|||
160588233|NCT02883049|579873124|FG012|Induction|Adverse Event|0|||
160588234|NCT02883049|579873125|FG013|Induction|Adverse Event|0|||
160588235|NCT02883049|579873126|FG014|Induction|Adverse Event|0|||
160588236|NCT02883049|579873127|FG015|Induction|Adverse Event|0|||
160588237|NCT02883049|579873112|FG000|Induction|Death|76|||
161024030|NCT03854227|581479581|FG008|Overall Study|Death|0|||
161024031|NCT03854227|581479582|FG009|Overall Study|Death|1|||
161024032|NCT03854227|581479583|FG010|Overall Study|Death|0|||
161024033|NCT03854227|581479584|FG011|Overall Study|Death|1|||
160657192|NCT01273181|580125977|FG002|Phase I, Dose 1|Study termination|0|||
160657193|NCT01273181|580125978|FG003|Phase I, Dose 1|Study termination|0|||
160657194|NCT01273181|580125975|FG000|Phase I, Dose 2|Death during treatment|0|||
160657195|NCT01273181|580125976|FG001|Phase I, Dose 2|Death during treatment|1|||
160657196|NCT01273181|580125977|FG002|Phase I, Dose 2|Death during treatment|0|||
160657197|NCT01273181|580125978|FG003|Phase I, Dose 2|Death during treatment|0|||
160657198|NCT01273181|580125975|FG000|Phase 2, Dose 1|Study termination|0|||
160657199|NCT01273181|580125976|FG001|Phase 2, Dose 1|Study termination|0|||
160657200|NCT01273181|580125977|FG002|Phase 2, Dose 1|Study termination|1|||
160657201|NCT01273181|580125978|FG003|Phase 2, Dose 1|Study termination|0|||
160657202|NCT01273181|580125975|FG000|Phase 2, Dose 2|Death during treatment|0|||
160657203|NCT01273181|580125976|FG001|Phase 2, Dose 2|Death during treatment|0|||
160657204|NCT01273181|580125977|FG002|Phase 2, Dose 2|Death during treatment|0|||
160657205|NCT01273181|580125978|FG003|Phase 2, Dose 2|Death during treatment|1|||
160657206|NCT04276883|580125979|FG000|Overall Study|Withdrawal by Subject|2|||
160657207|NCT04276883|580125980|FG001|Overall Study|Withdrawal by Subject|3|||
160657208|NCT04276883|580125981|FG002|Overall Study|Withdrawal by Subject|6|||
160657209|NCT04276883|580125979|FG000|Overall Study|Lost to Follow-up|1|||
160657210|NCT04276883|580125980|FG001|Overall Study|Lost to Follow-up|3|||
161024034|NCT03854227|581479573|FG000|Overall Study|Physician Decision|0|||
161024035|NCT03854227|581479574|FG001|Overall Study|Physician Decision|0|||
161024036|NCT03854227|581479575|FG002|Overall Study|Physician Decision|0|||
161024037|NCT03854227|581479576|FG003|Overall Study|Physician Decision|0|||
161024038|NCT03854227|581479577|FG004|Overall Study|Physician Decision|0|||
161024039|NCT03854227|581479578|FG005|Overall Study|Physician Decision|1|||
161024040|NCT03854227|581479579|FG006|Overall Study|Physician Decision|0|||
161024041|NCT03854227|581479580|FG007|Overall Study|Physician Decision|0|||
160588238|NCT02883049|579873113|FG001|Induction|Death|8|||
160588239|NCT02883049|579873114|FG002|Induction|Death|0|||
160588240|NCT02883049|579873115|FG003|Induction|Death|0|||
160588241|NCT02883049|579873116|FG004|Induction|Death|0|||
160588242|NCT02883049|579873117|FG005|Induction|Death|0|||
160588243|NCT02883049|579873118|FG006|Induction|Death|0|||
160588244|NCT02883049|579873119|FG007|Induction|Death|0|||
160588245|NCT02883049|579873120|FG008|Induction|Death|0|||
160588246|NCT02883049|579873121|FG009|Induction|Death|0|||
160588247|NCT02883049|579873122|FG010|Induction|Death|0|||
160588248|NCT02883049|579873123|FG011|Induction|Death|0|||
160588249|NCT02883049|579873124|FG012|Induction|Death|0|||
160588250|NCT02883049|579873125|FG013|Induction|Death|0|||
160588251|NCT02883049|579873126|FG014|Induction|Death|0|||
160588252|NCT02883049|579873127|FG015|Induction|Death|0|||
160588253|NCT02883049|579873112|FG000|Induction|Lost to Follow-up|2|||
160588254|NCT02883049|579873113|FG001|Induction|Lost to Follow-up|0|||
160588255|NCT02883049|579873114|FG002|Induction|Lost to Follow-up|0|||
160588256|NCT02883049|579873115|FG003|Induction|Lost to Follow-up|0|||
160588257|NCT02883049|579873116|FG004|Induction|Lost to Follow-up|0|||
160588258|NCT02883049|579873117|FG005|Induction|Lost to Follow-up|0|||
160588259|NCT02883049|579873118|FG006|Induction|Lost to Follow-up|0|||
160588260|NCT02883049|579873119|FG007|Induction|Lost to Follow-up|0|||
160588261|NCT02883049|579873120|FG008|Induction|Lost to Follow-up|0|||
160588262|NCT02883049|579873121|FG009|Induction|Lost to Follow-up|0|||
160588263|NCT02883049|579873122|FG010|Induction|Lost to Follow-up|0|||
160588264|NCT02883049|579873123|FG011|Induction|Lost to Follow-up|0|||
160588265|NCT02883049|579873124|FG012|Induction|Lost to Follow-up|0|||
160588266|NCT02883049|579873125|FG013|Induction|Lost to Follow-up|0|||
160588267|NCT02883049|579873126|FG014|Induction|Lost to Follow-up|0|||
160588268|NCT02883049|579873127|FG015|Induction|Lost to Follow-up|0|||
161024042|NCT03854227|581479581|FG008|Overall Study|Physician Decision|1|||
161024043|NCT03854227|581479582|FG009|Overall Study|Physician Decision|1|||
160588269|NCT02883049|579873112|FG000|Induction|Physician Decision|1407|||
160588270|NCT02883049|579873113|FG001|Induction|Physician Decision|8|||
161024044|NCT03854227|581479583|FG010|Overall Study|Physician Decision|0|||
161024045|NCT03854227|581479584|FG011|Overall Study|Physician Decision|1|||
160657211|NCT04276883|580125981|FG002|Overall Study|Lost to Follow-up|0|||
160657212|NCT04276883|580125979|FG000|Overall Study|Adverse Event|0|||
160657213|NCT04276883|580125980|FG001|Overall Study|Adverse Event|1|||
161024046|NCT03854227|581479573|FG000|Overall Study|Progressive disease|1|||
161024047|NCT03854227|581479574|FG001|Overall Study|Progressive disease|1|||
161024048|NCT03854227|581479575|FG002|Overall Study|Progressive disease|1|||
160588271|NCT02883049|579873114|FG002|Induction|Physician Decision|0|||
160588272|NCT02883049|579873115|FG003|Induction|Physician Decision|0|||
160588273|NCT02883049|579873116|FG004|Induction|Physician Decision|0|||
160588274|NCT02883049|579873117|FG005|Induction|Physician Decision|0|||
160588275|NCT02883049|579873118|FG006|Induction|Physician Decision|0|||
160588276|NCT02883049|579873119|FG007|Induction|Physician Decision|0|||
160588277|NCT02883049|579873120|FG008|Induction|Physician Decision|0|||
160588278|NCT02883049|579873121|FG009|Induction|Physician Decision|0|||
160657214|NCT04276883|580125981|FG002|Overall Study|Adverse Event|0|||
161024049|NCT03854227|581479576|FG003|Overall Study|Progressive disease|2|||
160657215|NCT04276883|580125979|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
160657216|NCT04276883|580125980|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
160657217|NCT04276883|580125981|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
160657218|NCT01876706|580125982|FG000|Overall Study|BPH Intervention|9|||
160657219|NCT01876706|580125982|FG000|Overall Study|Lost to Follow-up|7|||
160657220|NCT01876706|580125982|FG000|Overall Study|Withdrawals|6|||
160657221|NCT01876706|580125982|FG000|Overall Study|Death|3|||
160657222|NCT00604500|580125983|FG000|Overall Study|Adverse Event|2|||
160657223|NCT00604500|580125983|FG000|Overall Study|Protocol Violation|2|||
160657224|NCT00604500|580125983|FG000|Overall Study|Treatment Failure|1|||
160657225|NCT00604500|580125983|FG000|Overall Study|Withdrawal by Subject|4|||
160657226|NCT00604500|580125983|FG000|Overall Study|Administrative|1|||
160657227|NCT00604500|580125983|FG000|Overall Study|Did not meet protocol eligibility|1|||
160657228|NCT02468778|580125989|FG000|Overall Study|Death|2|||
160657229|NCT02468778|580125990|FG001|Overall Study|Death|1|||
160657230|NCT02468778|580125991|FG002|Overall Study|Death|0|||
160657231|NCT02468778|580125989|FG000|Overall Study|Lost to Follow-up|1|||
160657232|NCT02468778|580125990|FG001|Overall Study|Lost to Follow-up|2|||
160657233|NCT02468778|580125991|FG002|Overall Study|Lost to Follow-up|2|||
160657234|NCT02468778|580125989|FG000|Overall Study|Withdrawal by Subject|0|||
160657235|NCT02468778|580125990|FG001|Overall Study|Withdrawal by Subject|1|||
160657236|NCT02468778|580125991|FG002|Overall Study|Withdrawal by Subject|1|||
160657237|NCT02458469|580125995|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
160657238|NCT02458469|580125996|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
160657239|NCT02458469|580125997|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
160657240|NCT02458469|580125998|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
160657241|NCT02458469|580125999|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
160657242|NCT02458469|580126000|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
160657243|NCT02458469|580125995|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
160657244|NCT02458469|580125996|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
160657245|NCT02458469|580125997|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
160657246|NCT02458469|580125998|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
160657247|NCT02458469|580125999|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
160657248|NCT02458469|580126000|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
160657249|NCT02458469|580125995|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
160657250|NCT02458469|580125996|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
160657251|NCT02458469|580125997|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
160657252|NCT02458469|580125998|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
160657253|NCT02458469|580125999|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
160657254|NCT02458469|580126000|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
160657255|NCT00661505|580126002|FG000|Overall Study|Adverse Event|3|||
160657256|NCT00661505|580126002|FG000|Overall Study|Protocol Violation|14|||
160657257|NCT00661505|580126002|FG000|Overall Study|Withdrawal by Subject|8|||
160657258|NCT00661505|580126002|FG000|Overall Study|Lost to Follow-up|3|||
160657259|NCT00661505|580126002|FG000|Overall Study|Other|2|||
160657260|NCT03283709|580126012|FG000|Overall Study|trial terminated|0|||
160657261|NCT03283709|580126013|FG001|Overall Study|trial terminated|1|||
160657262|NCT01347710|580126014|FG000|Overall Study|Withdrawal by Subject|2|||
160657263|NCT01347710|580126014|FG000|Overall Study|Adverse Event|4|||
160657264|NCT01347710|580126014|FG000|Overall Study|Angio or SPECT not completed|18|||
160657265|NCT01347710|580126014|FG000|Overall Study|issue with vitals prior to dosing|1|||
160657266|NCT01347710|580126014|FG000|Overall Study|Lost to Follow-up|1|||
160657267|NCT01347710|580126014|FG000|Overall Study|Physician Decision|2|||
160657268|NCT01347710|580126014|FG000|Overall Study|Other|3|||
160657269|NCT04591626|580126016|FG000|Overall Study|Adverse Event|4|||
160657270|NCT04591626|580126017|FG001|Overall Study|Adverse Event|0|||
160657271|NCT04591626|580126016|FG000|Overall Study|Withdrawal by Subject|5|||
160657272|NCT04591626|580126017|FG001|Overall Study|Withdrawal by Subject|3|||
160972478|NCT03017235|581289118|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
160972479|NCT02254408|581289123|FG000|Overall Study|Randomized But Not Treated|1|||
160972480|NCT02254408|581289124|FG001|Overall Study|Randomized But Not Treated|3|||
160972481|NCT02254408|581289123|FG000|Overall Study|Adverse Event|1|||
160972482|NCT02254408|581289124|FG001|Overall Study|Adverse Event|0|||
160972483|NCT02254408|581289123|FG000|Overall Study|Death|2|||
160972484|NCT02254408|581289124|FG001|Overall Study|Death|3|||
160972485|NCT02254408|581289123|FG000|Overall Study|Investigator's Discretion|0|||
160657273|NCT04591626|580126016|FG000|Overall Study|Physician Decision|0|||
160657274|NCT04591626|580126017|FG001|Overall Study|Physician Decision|1|||
160657275|NCT04591626|580126016|FG000|Overall Study|Death|0|||
160657276|NCT04591626|580126017|FG001|Overall Study|Death|1|||
160657277|NCT04591626|580126016|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160657278|NCT04591626|580126017|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160972486|NCT02254408|581289124|FG001|Overall Study|Investigator's Discretion|1|||
160657279|NCT01004172|580126019|FG000|Overall Study|Progressive Disease in CNS Only|16|||
160657280|NCT01004172|580126019|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
160460151|NCT03662022|579417564|FG000|Year 4 2022|incident case|25|||
160460152|NCT03662022|579417565|FG001|Year 4 2022|incident case|41|||
160460153|NCT03662022|579417566|FG002|Year 4 2022|incident case|28|||
160460154|NCT03662022|579417567|FG003|Year 4 2022|incident case|7|||
160460155|NCT03662022|579417564|FG000|Year 4 2022|other case|8|||
160460156|NCT03662022|579417565|FG001|Year 4 2022|other case|19|||
160460157|NCT03662022|579417566|FG002|Year 4 2022|other case|13|||
160460158|NCT03662022|579417567|FG003|Year 4 2022|other case|7|||
160460159|NCT03662022|579417564|FG000|Year 4 2022|Lost to Follow-up|986|||
160460160|NCT03662022|579417565|FG001|Year 4 2022|Lost to Follow-up|1079|||
160460161|NCT03662022|579417566|FG002|Year 4 2022|Lost to Follow-up|1236|||
160460162|NCT03662022|579417567|FG003|Year 4 2022|Lost to Follow-up|1826|||
160460163|NCT03248479|579417568|FG000|Overall Study|Death|12|||
160460164|NCT03248479|579417569|FG001|Overall Study|Death|44|||
160460165|NCT03248479|579417570|FG002|Overall Study|Death|1|||
160460166|NCT03248479|579417571|FG003|Overall Study|Death|72|||
160460167|NCT03248479|579417572|FG004|Overall Study|Death|17|||
160460168|NCT03248479|579417573|FG005|Overall Study|Death|6|||
160460169|NCT03248479|579417574|FG006|Overall Study|Death|1|||
160460170|NCT03248479|579417575|FG007|Overall Study|Death|14|||
160460171|NCT03248479|579417576|FG008|Overall Study|Death|3|||
160460172|NCT03248479|579417577|FG009|Overall Study|Death|7|||
160460173|NCT03248479|579417578|FG010|Overall Study|Death|3|||
160460174|NCT03248479|579417579|FG011|Overall Study|Death|1|||
160460175|NCT03248479|579417580|FG012|Overall Study|Death|1|||
160460176|NCT03248479|579417568|FG000|Overall Study|Study terminated by sponsor|12|||
160460177|NCT03248479|579417569|FG001|Overall Study|Study terminated by sponsor|15|||
160460178|NCT03248479|579417570|FG002|Overall Study|Study terminated by sponsor|0|||
160972487|NCT02254408|581289123|FG000|Overall Study|Withdrawal by Subject|3|||
160972488|NCT02254408|581289124|FG001|Overall Study|Withdrawal by Subject|3|||
160972489|NCT02254408|581289123|FG000|Overall Study|Lost to Follow-up|1|||
160972490|NCT02254408|581289124|FG001|Overall Study|Lost to Follow-up|0|||
160972491|NCT00917267|581289125|FG000|Overall Study|Adverse Event|15|||
160972492|NCT00917267|581289126|FG001|Overall Study|Adverse Event|36|||
160972493|NCT00917267|581289125|FG000|Overall Study|Physician Decision|2|||
160972494|NCT00917267|581289126|FG001|Overall Study|Physician Decision|4|||
160972495|NCT00917267|581289125|FG000|Overall Study|Protocol Violation|9|||
160972496|NCT00917267|581289126|FG001|Overall Study|Protocol Violation|18|||
160972497|NCT00917267|581289125|FG000|Overall Study|Withdrawal by Subject|5|||
160972498|NCT00917267|581289126|FG001|Overall Study|Withdrawal by Subject|12|||
160972499|NCT00917267|581289125|FG000|Overall Study|Lost to follow up|0|||
160972500|NCT00917267|581289126|FG001|Overall Study|Lost to follow up|2|||
160972501|NCT00917267|581289125|FG000|Overall Study|Entry Criteria Not Met|1|||
160972502|NCT00917267|581289126|FG001|Overall Study|Entry Criteria Not Met|0|||
160972503|NCT00917267|581289125|FG000|Overall Study|Sponsor Decision|5|||
160972504|NCT00917267|581289126|FG001|Overall Study|Sponsor Decision|5|||
161024050|NCT03854227|581479577|FG004|Overall Study|Progressive disease|3|||
161024051|NCT03854227|581479578|FG005|Overall Study|Progressive disease|1|||
161024052|NCT03854227|581479579|FG006|Overall Study|Progressive disease|2|||
161024053|NCT03854227|581479580|FG007|Overall Study|Progressive disease|5|||
161024054|NCT03854227|581479581|FG008|Overall Study|Progressive disease|2|||
161024055|NCT03854227|581479582|FG009|Overall Study|Progressive disease|5|||
161024056|NCT03854227|581479583|FG010|Overall Study|Progressive disease|1|||
161024057|NCT03854227|581479584|FG011|Overall Study|Progressive disease|6|||
161024058|NCT03854227|581479573|FG000|Overall Study|Study terminated by sponsor|0|||
161024059|NCT03854227|581479574|FG001|Overall Study|Study terminated by sponsor|0|||
161024060|NCT03854227|581479575|FG002|Overall Study|Study terminated by sponsor|0|||
161024061|NCT03854227|581479576|FG003|Overall Study|Study terminated by sponsor|0|||
161024062|NCT03854227|581479577|FG004|Overall Study|Study terminated by sponsor|0|||
161024063|NCT03854227|581479578|FG005|Overall Study|Study terminated by sponsor|0|||
161024064|NCT03854227|581479579|FG006|Overall Study|Study terminated by sponsor|0|||
161024065|NCT03854227|581479580|FG007|Overall Study|Study terminated by sponsor|0|||
161024066|NCT03854227|581479581|FG008|Overall Study|Study terminated by sponsor|0|||
161024067|NCT03854227|581479582|FG009|Overall Study|Study terminated by sponsor|1|||
161024068|NCT03854227|581479583|FG010|Overall Study|Study terminated by sponsor|0|||
161024069|NCT03854227|581479584|FG011|Overall Study|Study terminated by sponsor|0|||
161024070|NCT03854227|581479573|FG000|Overall Study|Withdrawal by Subject|0|||
160460179|NCT03248479|579417571|FG003|Overall Study|Study terminated by sponsor|5|||
160460180|NCT03248479|579417572|FG004|Overall Study|Study terminated by sponsor|0|||
160460181|NCT03248479|579417573|FG005|Overall Study|Study terminated by sponsor|0|||
160460182|NCT03248479|579417574|FG006|Overall Study|Study terminated by sponsor|0|||
160588279|NCT02883049|579873122|FG010|Induction|Physician Decision|0|||
160460183|NCT03248479|579417575|FG007|Overall Study|Study terminated by sponsor|1|||
160460184|NCT03248479|579417576|FG008|Overall Study|Study terminated by sponsor|1|||
160460185|NCT03248479|579417577|FG009|Overall Study|Study terminated by sponsor|0|||
160460186|NCT03248479|579417578|FG010|Overall Study|Study terminated by sponsor|5|||
160972505|NCT00917267|581289125|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
161024071|NCT03854227|581479574|FG001|Overall Study|Withdrawal by Subject|0|||
161024072|NCT03854227|581479575|FG002|Overall Study|Withdrawal by Subject|1|||
161024073|NCT03854227|581479576|FG003|Overall Study|Withdrawal by Subject|0|||
160972506|NCT00917267|581289126|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
160972507|NCT01478113|581289129|FG000|Overall Study|Withdrawal by Subject|0|||
160972508|NCT01478113|581289130|FG001|Overall Study|Withdrawal by Subject|1|||
160972509|NCT01478113|581289129|FG000|Overall Study|Physician Decision|1|||
160972510|NCT01478113|581289130|FG001|Overall Study|Physician Decision|0|||
160972511|NCT00289770|581289131|FG000|Year 15|Withdrawal by Subject|1|||
160972512|NCT00423293|581289132|FG000|Overall Study|Ineligible / No protocol treatment|11|||
160972513|NCT02966002|581289139|FG000|Overall Study|Withdrawal by Subject|2|||
160972514|NCT02966002|581289139|FG000|Overall Study|Adverse Event|1|||
160972515|NCT02966002|581289139|FG000|Overall Study|Lost to Follow-up|1|||
160972516|NCT00067990|581289141|FG000|Overall Study|Death|5|||
160972517|NCT00067990|581289142|FG001|Overall Study|Death|7|||
160972518|NCT00067990|581289141|FG000|Overall Study|ESRD, Non IF/TA|1|||
160972519|NCT00067990|581289142|FG001|Overall Study|ESRD, Non IF/TA|3|||
160972520|NCT00067990|581289141|FG000|Overall Study|Withdrawal by Subject|4|||
160972521|NCT00067990|581289142|FG001|Overall Study|Withdrawal by Subject|12|||
160972522|NCT02291432|581289143|FG000|Overall Study|Withdrawal by Subject|2|||
160972523|NCT00519896|581289144|FG000|Overall Study|Protocol Violation|1|||
160972524|NCT00519896|581289144|FG000|Overall Study|Adverse Event|1|||
160972525|NCT03327402|581289145|FG000|Overall Study|Withdrawal by Subject|1|||
160972526|NCT03327402|581289145|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
160972527|NCT03810313|581289146|FG000|Overall Study|Study terminated by sponsor|164|||
160972528|NCT03810313|581289147|FG001|Overall Study|Study terminated by sponsor|159|||
160972529|NCT03810313|581289146|FG000|Overall Study|Subject decision|10|||
160972530|NCT03810313|581289147|FG001|Overall Study|Subject decision|11|||
160588280|NCT02883049|579873123|FG011|Induction|Physician Decision|0|||
160588281|NCT02883049|579873124|FG012|Induction|Physician Decision|0|||
160588282|NCT02883049|579873125|FG013|Induction|Physician Decision|0|||
160588283|NCT02883049|579873126|FG014|Induction|Physician Decision|0|||
160588284|NCT02883049|579873127|FG015|Induction|Physician Decision|0|||
160588285|NCT02883049|579873112|FG000|Induction|Protocol Violation|6|||
160588286|NCT02883049|579873113|FG001|Induction|Protocol Violation|0|||
160588287|NCT02883049|579873114|FG002|Induction|Protocol Violation|0|||
160588288|NCT02883049|579873115|FG003|Induction|Protocol Violation|0|||
160588289|NCT02883049|579873116|FG004|Induction|Protocol Violation|0|||
160588290|NCT02883049|579873117|FG005|Induction|Protocol Violation|0|||
160588291|NCT02883049|579873118|FG006|Induction|Protocol Violation|0|||
160588292|NCT02883049|579873119|FG007|Induction|Protocol Violation|0|||
160588293|NCT02883049|579873120|FG008|Induction|Protocol Violation|0|||
160588294|NCT02883049|579873121|FG009|Induction|Protocol Violation|0|||
160588295|NCT02883049|579873122|FG010|Induction|Protocol Violation|0|||
160588296|NCT02883049|579873123|FG011|Induction|Protocol Violation|0|||
160588297|NCT02883049|579873124|FG012|Induction|Protocol Violation|0|||
160588298|NCT02883049|579873125|FG013|Induction|Protocol Violation|0|||
160588299|NCT02883049|579873126|FG014|Induction|Protocol Violation|0|||
160588300|NCT02883049|579873127|FG015|Induction|Protocol Violation|0|||
160588301|NCT02883049|579873112|FG000|Induction|Withdrawal by Subject|6|||
160588302|NCT02883049|579873113|FG001|Induction|Withdrawal by Subject|0|||
160588303|NCT02883049|579873114|FG002|Induction|Withdrawal by Subject|0|||
160588304|NCT02883049|579873115|FG003|Induction|Withdrawal by Subject|0|||
160588305|NCT02883049|579873116|FG004|Induction|Withdrawal by Subject|0|||
160588306|NCT02883049|579873117|FG005|Induction|Withdrawal by Subject|0|||
160588307|NCT02883049|579873118|FG006|Induction|Withdrawal by Subject|0|||
160588308|NCT02883049|579873119|FG007|Induction|Withdrawal by Subject|0|||
160588309|NCT02883049|579873120|FG008|Induction|Withdrawal by Subject|0|||
160588310|NCT02883049|579873121|FG009|Induction|Withdrawal by Subject|0|||
160588311|NCT02883049|579873122|FG010|Induction|Withdrawal by Subject|0|||
160588312|NCT02883049|579873123|FG011|Induction|Withdrawal by Subject|0|||
160588313|NCT02883049|579873124|FG012|Induction|Withdrawal by Subject|0|||
160588314|NCT02883049|579873125|FG013|Induction|Withdrawal by Subject|0|||
160588315|NCT02883049|579873126|FG014|Induction|Withdrawal by Subject|0|||
160588316|NCT02883049|579873127|FG015|Induction|Withdrawal by Subject|0|||
160588317|NCT02883049|579873112|FG000|Induction|Ineligible|35|||
160588318|NCT02883049|579873113|FG001|Induction|Ineligible|1|||
160588319|NCT02883049|579873114|FG002|Induction|Ineligible|0|||
160588320|NCT02883049|579873115|FG003|Induction|Ineligible|0|||
160588321|NCT02883049|579873116|FG004|Induction|Ineligible|0|||
160588322|NCT02883049|579873117|FG005|Induction|Ineligible|0|||
160588323|NCT02883049|579873118|FG006|Induction|Ineligible|0|||
160588324|NCT02883049|579873119|FG007|Induction|Ineligible|0|||
160588325|NCT02883049|579873120|FG008|Induction|Ineligible|0|||
160588326|NCT02883049|579873121|FG009|Induction|Ineligible|0|||
160588327|NCT02883049|579873122|FG010|Induction|Ineligible|0|||
160972531|NCT03810313|581289146|FG000|Overall Study|Lost to Follow-up|3|||
160588328|NCT02883049|579873123|FG011|Induction|Ineligible|0|||
160588329|NCT02883049|579873124|FG012|Induction|Ineligible|0|||
160588330|NCT02883049|579873125|FG013|Induction|Ineligible|0|||
160588331|NCT02883049|579873126|FG014|Induction|Ineligible|0|||
160588332|NCT02883049|579873127|FG015|Induction|Ineligible|0|||
160972532|NCT03810313|581289147|FG001|Overall Study|Lost to Follow-up|3|||
160972533|NCT03810313|581289146|FG000|Overall Study|Adverse Event|2|||
160657281|NCT01004172|580126019|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
160657282|NCT01004172|580126019|FG000|Overall Study|Adverse Event|1|||
160657283|NCT01004172|580126019|FG000|Overall Study|Physician Decision|1|||
160657284|NCT01004172|580126019|FG000|Overall Study|Symptomatic Deterioration|2|||
160657285|NCT02003183|580126023|FG000|Overall Study|Lost to Follow-up|0|||
161024074|NCT03854227|581479577|FG004|Overall Study|Withdrawal by Subject|0|||
161024075|NCT03854227|581479578|FG005|Overall Study|Withdrawal by Subject|0|||
161024076|NCT03854227|581479579|FG006|Overall Study|Withdrawal by Subject|0|||
160588333|NCT02883049|579873112|FG000|Induction|Refusal of further protocol therapy|466|||
160588334|NCT02883049|579873113|FG001|Induction|Refusal of further protocol therapy|2|||
160588335|NCT02883049|579873114|FG002|Induction|Refusal of further protocol therapy|0|||
160588336|NCT02883049|579873115|FG003|Induction|Refusal of further protocol therapy|0|||
160588337|NCT02883049|579873116|FG004|Induction|Refusal of further protocol therapy|0|||
160588338|NCT02883049|579873117|FG005|Induction|Refusal of further protocol therapy|0|||
160588339|NCT02883049|579873118|FG006|Induction|Refusal of further protocol therapy|0|||
160588340|NCT02883049|579873119|FG007|Induction|Refusal of further protocol therapy|0|||
160588341|NCT02883049|579873120|FG008|Induction|Refusal of further protocol therapy|0|||
160588342|NCT02883049|579873121|FG009|Induction|Refusal of further protocol therapy|0|||
160588343|NCT02883049|579873122|FG010|Induction|Refusal of further protocol therapy|0|||
160588344|NCT02883049|579873123|FG011|Induction|Refusal of further protocol therapy|0|||
160588345|NCT02883049|579873124|FG012|Induction|Refusal of further protocol therapy|0|||
160588346|NCT02883049|579873125|FG013|Induction|Refusal of further protocol therapy|0|||
160588347|NCT02883049|579873126|FG014|Induction|Refusal of further protocol therapy|0|||
160588348|NCT02883049|579873127|FG015|Induction|Refusal of further protocol therapy|0|||
160588349|NCT02883049|579873112|FG000|Induction|Identified as Ph+ patients|279|||
160588350|NCT02883049|579873113|FG001|Induction|Identified as Ph+ patients|1|||
160588351|NCT02883049|579873114|FG002|Induction|Identified as Ph+ patients|0|||
160588352|NCT02883049|579873115|FG003|Induction|Identified as Ph+ patients|0|||
160588353|NCT02883049|579873116|FG004|Induction|Identified as Ph+ patients|0|||
160588354|NCT02883049|579873117|FG005|Induction|Identified as Ph+ patients|0|||
160588355|NCT02883049|579873118|FG006|Induction|Identified as Ph+ patients|0|||
160588356|NCT02883049|579873119|FG007|Induction|Identified as Ph+ patients|0|||
160588357|NCT02883049|579873120|FG008|Induction|Identified as Ph+ patients|0|||
160588358|NCT02883049|579873121|FG009|Induction|Identified as Ph+ patients|0|||
160588359|NCT02883049|579873122|FG010|Induction|Identified as Ph+ patients|0|||
160588360|NCT02883049|579873123|FG011|Induction|Identified as Ph+ patients|0|||
160588361|NCT02883049|579873124|FG012|Induction|Identified as Ph+ patients|0|||
160588362|NCT02883049|579873125|FG013|Induction|Identified as Ph+ patients|0|||
160588363|NCT02883049|579873126|FG014|Induction|Identified as Ph+ patients|0|||
160588364|NCT02883049|579873127|FG015|Induction|Identified as Ph+ patients|0|||
160588365|NCT02883049|579873112|FG000|Induction|M3 Marrow at Day29|8|||
160588366|NCT02883049|579873113|FG001|Induction|M3 Marrow at Day29|1|||
160588367|NCT02883049|579873114|FG002|Induction|M3 Marrow at Day29|0|||
160588368|NCT02883049|579873115|FG003|Induction|M3 Marrow at Day29|0|||
160588369|NCT02883049|579873116|FG004|Induction|M3 Marrow at Day29|0|||
160588370|NCT02883049|579873117|FG005|Induction|M3 Marrow at Day29|0|||
160588371|NCT02883049|579873118|FG006|Induction|M3 Marrow at Day29|0|||
160588372|NCT02883049|579873119|FG007|Induction|M3 Marrow at Day29|0|||
160588373|NCT02883049|579873120|FG008|Induction|M3 Marrow at Day29|0|||
160588374|NCT02883049|579873121|FG009|Induction|M3 Marrow at Day29|0|||
160588375|NCT02883049|579873122|FG010|Induction|M3 Marrow at Day29|0|||
160588376|NCT02883049|579873123|FG011|Induction|M3 Marrow at Day29|0|||
160588377|NCT02883049|579873124|FG012|Induction|M3 Marrow at Day29|0|||
160588378|NCT02883049|579873125|FG013|Induction|M3 Marrow at Day29|0|||
160588379|NCT02883049|579873126|FG014|Induction|M3 Marrow at Day29|0|||
160588380|NCT02883049|579873127|FG015|Induction|M3 Marrow at Day29|0|||
160588381|NCT02883049|579873112|FG000|Induction|Inevaluable|33|||
160588382|NCT02883049|579873113|FG001|Induction|Inevaluable|1|||
160588383|NCT02883049|579873114|FG002|Induction|Inevaluable|0|||
160588384|NCT02883049|579873115|FG003|Induction|Inevaluable|0|||
160588385|NCT02883049|579873116|FG004|Induction|Inevaluable|0|||
160588386|NCT02883049|579873117|FG005|Induction|Inevaluable|0|||
160588387|NCT02883049|579873118|FG006|Induction|Inevaluable|0|||
160588388|NCT02883049|579873119|FG007|Induction|Inevaluable|0|||
160588389|NCT02883049|579873120|FG008|Induction|Inevaluable|0|||
160588390|NCT02883049|579873121|FG009|Induction|Inevaluable|0|||
160588391|NCT02883049|579873122|FG010|Induction|Inevaluable|0|||
160588392|NCT02883049|579873123|FG011|Induction|Inevaluable|0|||
160588393|NCT02883049|579873124|FG012|Induction|Inevaluable|0|||
160657286|NCT02003183|580126024|FG001|Overall Study|Lost to Follow-up|2|||
160657287|NCT00841100|580126029|FG000|Phase 1 (28 Days)|Adverse Event|1|||
160588394|NCT02883049|579873125|FG013|Induction|Inevaluable|0|||
160588395|NCT02883049|579873126|FG014|Induction|Inevaluable|0|||
160588396|NCT02883049|579873127|FG015|Induction|Inevaluable|0|||
160588397|NCT02883049|579873112|FG000|Induction|Identified as VHR at end of Induction|244|||
160588398|NCT02883049|579873113|FG001|Induction|Identified as VHR at end of Induction|0|||
160588399|NCT02883049|579873114|FG002|Induction|Identified as VHR at end of Induction|0|||
161024077|NCT03854227|581479580|FG007|Overall Study|Withdrawal by Subject|0|||
160588400|NCT02883049|579873115|FG003|Induction|Identified as VHR at end of Induction|0|||
160588401|NCT02883049|579873116|FG004|Induction|Identified as VHR at end of Induction|0|||
160588402|NCT02883049|579873117|FG005|Induction|Identified as VHR at end of Induction|0|||
160588403|NCT02883049|579873118|FG006|Induction|Identified as VHR at end of Induction|0|||
160972534|NCT03810313|581289147|FG001|Overall Study|Adverse Event|1|||
160972535|NCT03810313|581289146|FG000|Overall Study|Death|2|||
160972536|NCT03810313|581289147|FG001|Overall Study|Death|1|||
160972537|NCT03810313|581289146|FG000|Overall Study|Physician Decision|0|||
160972538|NCT03810313|581289147|FG001|Overall Study|Physician Decision|1|||
160972539|NCT00301080|581289153|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
160972540|NCT00301080|581289154|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
160972541|NCT00301080|581289155|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
160972542|NCT00301080|581289156|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
160972543|NCT00301080|581289157|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
160972544|NCT02567825|581289160|FG000|Overall Study|No follow-up post-randomization|5|||
160972545|NCT02567825|581289161|FG001|Overall Study|No follow-up post-randomization|1|||
160972546|NCT02567825|581289160|FG000|Overall Study|Follow-up less than 23 months|16|||
160972547|NCT02567825|581289161|FG001|Overall Study|Follow-up less than 23 months|20|||
160972548|NCT03097861|581289166|FG000|Overall Study|Adverse Event|3|||
160972549|NCT03097861|581289167|FG001|Overall Study|Adverse Event|8|||
160972550|NCT03097861|581289168|FG002|Overall Study|Adverse Event|4|||
160972551|NCT03097861|581289166|FG000|Overall Study|Investigator Decision|0|||
160972552|NCT03097861|581289167|FG001|Overall Study|Investigator Decision|1|||
160972553|NCT03097861|581289168|FG002|Overall Study|Investigator Decision|0|||
160972554|NCT03097861|581289166|FG000|Overall Study|Lost to Follow-up|0|||
160972555|NCT03097861|581289167|FG001|Overall Study|Lost to Follow-up|7|||
160972556|NCT03097861|581289168|FG002|Overall Study|Lost to Follow-up|1|||
160972557|NCT03097861|581289166|FG000|Overall Study|Withdrawal by Subject|1|||
160972558|NCT03097861|581289167|FG001|Overall Study|Withdrawal by Subject|5|||
160972559|NCT03097861|581289168|FG002|Overall Study|Withdrawal by Subject|3|||
160972560|NCT03097861|581289166|FG000|Overall Study|Reason not provided|3|||
160972561|NCT03097861|581289167|FG001|Overall Study|Reason not provided|1|||
160972562|NCT03097861|581289168|FG002|Overall Study|Reason not provided|1|||
160972563|NCT05061537|581289172|FG000|Treatment Phase|Progressive disease|0|||
160972564|NCT05061537|581289173|FG001|Treatment Phase|Progressive disease|1|||
160972565|NCT05061537|581289174|FG002|Treatment Phase|Progressive disease|2|||
160972566|NCT05061537|581289175|FG003|Treatment Phase|Progressive disease|0|||
160972567|NCT05061537|581289176|FG004|Treatment Phase|Progressive disease|0|||
160972568|NCT05061537|581289172|FG000|Treatment Phase|Adverse Event|0|||
160972569|NCT05061537|581289173|FG001|Treatment Phase|Adverse Event|0|||
160972570|NCT05061537|581289174|FG002|Treatment Phase|Adverse Event|2|||
160972571|NCT05061537|581289175|FG003|Treatment Phase|Adverse Event|0|||
160972572|NCT05061537|581289176|FG004|Treatment Phase|Adverse Event|0|||
160972573|NCT05061537|581289172|FG000|Treatment Phase|Global deterioration of health status|0|||
160972574|NCT05061537|581289173|FG001|Treatment Phase|Global deterioration of health status|1|||
160972575|NCT05061537|581289174|FG002|Treatment Phase|Global deterioration of health status|0|||
160972576|NCT05061537|581289175|FG003|Treatment Phase|Global deterioration of health status|0|||
160972577|NCT05061537|581289176|FG004|Treatment Phase|Global deterioration of health status|0|||
160972578|NCT05061537|581289172|FG000|Follow up|Other|2|||
160972579|NCT05061537|581289173|FG001|Follow up|Other|0|||
160972580|NCT05061537|581289174|FG002|Follow up|Other|2|||
160972581|NCT05061537|581289175|FG003|Follow up|Other|0|||
160972582|NCT05061537|581289176|FG004|Follow up|Other|0|||
160972583|NCT05061537|581289172|FG000|Follow up|Study terminated by sponsor|0|||
160972584|NCT05061537|581289173|FG001|Follow up|Study terminated by sponsor|0|||
160972585|NCT05061537|581289174|FG002|Follow up|Study terminated by sponsor|2|||
160972586|NCT05061537|581289175|FG003|Follow up|Study terminated by sponsor|0|||
160972587|NCT05061537|581289176|FG004|Follow up|Study terminated by sponsor|0|||
160972588|NCT05061537|581289172|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
160972589|NCT05061537|581289173|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
160972590|NCT05061537|581289174|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
160972591|NCT05061537|581289175|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
160972592|NCT05061537|581289176|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
160972593|NCT05061537|581289172|FG000|Long-term Follow-up|Death|0|||
160972594|NCT05061537|581289173|FG001|Long-term Follow-up|Death|1|||
160972595|NCT05061537|581289174|FG002|Long-term Follow-up|Death|0|||
160972596|NCT05061537|581289175|FG003|Long-term Follow-up|Death|0|||
160972597|NCT05061537|581289176|FG004|Long-term Follow-up|Death|0|||
160972598|NCT03502616|581289177|FG000|Up to Week 16|Withdrawal by Subject|1|||
160972599|NCT03502616|581289178|FG001|Up to Week 16|Withdrawal by Subject|2|||
160972600|NCT03502616|581289177|FG000|Up to Week 16|Lost to Follow-up|0|||
160972601|NCT03502616|581289178|FG001|Up to Week 16|Lost to Follow-up|1|||
160972602|NCT03502616|581289177|FG000|Up to Week 16|Randomized, but not treated|1|||
160972603|NCT03502616|581289178|FG001|Up to Week 16|Randomized, but not treated|0|||
160972604|NCT03502616|581289177|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
160972605|NCT03502616|581289178|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
160972606|NCT03502616|581289177|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
160972607|NCT03502616|581289178|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
160972608|NCT01785563|581289179|FG000|Overall Study|Physician Decision|10|||
160972609|NCT01785563|581289179|FG000|Overall Study|Withdrawal by Subject|1|||
160972610|NCT01785563|581289179|FG000|Overall Study|Protocol Violation|2|||
160972611|NCT01872910|581289181|FG000|Overall Study|Lost to Follow-up|2|||
160972612|NCT01872910|581289182|FG001|Overall Study|Lost to Follow-up|0|||
160972613|NCT01872910|581289183|FG002|Overall Study|Lost to Follow-up|2|||
160972614|NCT01872910|581289184|FG003|Overall Study|Lost to Follow-up|0|||
160972615|NCT01872910|581289185|FG004|Overall Study|Lost to Follow-up|0|||
160972616|NCT01872910|581289186|FG005|Overall Study|Lost to Follow-up|0|||
160972617|NCT01540565|581289192|FG000|Overall Study|Ineligible|2|||
160972618|NCT03469349|581289193|FG000|Overall Study|Withdrawal by Subject|1|||
160972619|NCT03469349|581289194|FG001|Overall Study|Withdrawal by Subject|3|||
160972620|NCT03469349|581289193|FG000|Overall Study|Progressive Disease|0|||
160972621|NCT03469349|581289194|FG001|Overall Study|Progressive Disease|1|||
160972622|NCT03469349|581289193|FG000|Overall Study|Lost to Follow-up|2|||
160972623|NCT03469349|581289194|FG001|Overall Study|Lost to Follow-up|2|||
160972624|NCT03469349|581289193|FG000|Overall Study|Adverse Event|2|||
160972625|NCT03469349|581289194|FG001|Overall Study|Adverse Event|4|||
160972626|NCT01225822|581289211|FG000|Overall Study|Adverse Event|13|||
160972627|NCT01225822|581289212|FG001|Overall Study|Adverse Event|31|||
160972628|NCT01225822|581289213|FG002|Overall Study|Adverse Event|18|||
160972629|NCT01225822|581289214|FG003|Overall Study|Adverse Event|23|||
160972630|NCT01225822|581289215|FG004|Overall Study|Adverse Event|14|||
160972631|NCT01225822|581289211|FG000|Overall Study|Protocol Violation|6|||
160972632|NCT01225822|581289212|FG001|Overall Study|Protocol Violation|8|||
160972633|NCT01225822|581289213|FG002|Overall Study|Protocol Violation|6|||
160972634|NCT01225822|581289214|FG003|Overall Study|Protocol Violation|7|||
160972635|NCT01225822|581289215|FG004|Overall Study|Protocol Violation|4|||
160972636|NCT01225822|581289211|FG000|Overall Study|Lost to Follow-up|0|||
160972637|NCT01225822|581289212|FG001|Overall Study|Lost to Follow-up|0|||
160972638|NCT01225822|581289213|FG002|Overall Study|Lost to Follow-up|0|||
160972639|NCT01225822|581289214|FG003|Overall Study|Lost to Follow-up|1|||
160972640|NCT01225822|581289215|FG004|Overall Study|Lost to Follow-up|0|||
160972641|NCT01225822|581289211|FG000|Overall Study|Withdrawal by Subject|6|||
160972642|NCT01225822|581289212|FG001|Overall Study|Withdrawal by Subject|7|||
160972643|NCT01225822|581289213|FG002|Overall Study|Withdrawal by Subject|7|||
160972644|NCT01225822|581289214|FG003|Overall Study|Withdrawal by Subject|11|||
160972645|NCT01225822|581289215|FG004|Overall Study|Withdrawal by Subject|6|||
160972646|NCT01225822|581289211|FG000|Overall Study|Other|13|||
160972647|NCT01225822|581289212|FG001|Overall Study|Other|10|||
160972648|NCT01225822|581289213|FG002|Overall Study|Other|7|||
160972649|NCT01225822|581289214|FG003|Overall Study|Other|10|||
160972650|NCT01225822|581289215|FG004|Overall Study|Other|7|||
160972651|NCT04078035|581289218|FG000|Session 2|Lost to Follow-up|3|||
160972652|NCT04078035|581289219|FG001|Session 2|Lost to Follow-up|1|||
160972653|NCT04078035|581289218|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
160972654|NCT04078035|581289219|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
160972655|NCT04296890|581289220|FG000|Overall Study|Withdrawal by Subject|1|||
160972656|NCT04296890|581289220|FG000|Overall Study|Death|62|||
160972657|NCT04296890|581289220|FG000|Overall Study|Lost to Follow-up|3|||
160972658|NCT04296890|581289220|FG000|Overall Study|Other than specified|2|||
160972659|NCT02978443|581289222|FG000|Overall Study|Withdrawal by Subject|1|||
160972660|NCT02978443|581289222|FG000|Overall Study|Adverse Event|3|||
161024078|NCT03854227|581479581|FG008|Overall Study|Withdrawal by Subject|0|||
161024079|NCT03854227|581479582|FG009|Overall Study|Withdrawal by Subject|1|||
161024080|NCT03854227|581479583|FG010|Overall Study|Withdrawal by Subject|1|||
161024081|NCT03854227|581479584|FG011|Overall Study|Withdrawal by Subject|0|||
161024082|NCT03854227|581479573|FG000|Overall Study|Disease relapse|0|||
161024083|NCT03854227|581479574|FG001|Overall Study|Disease relapse|0|||
161024084|NCT03854227|581479575|FG002|Overall Study|Disease relapse|0|||
160972661|NCT02978443|581289222|FG000|Overall Study|Disease Progression on study|6|||
161024085|NCT03854227|581479576|FG003|Overall Study|Disease relapse|0|||
161024086|NCT03854227|581479577|FG004|Overall Study|Disease relapse|0|||
161024087|NCT03854227|581479578|FG005|Overall Study|Disease relapse|0|||
161024088|NCT03854227|581479579|FG006|Overall Study|Disease relapse|0|||
161024089|NCT03854227|581479580|FG007|Overall Study|Disease relapse|0|||
161024090|NCT03854227|581479581|FG008|Overall Study|Disease relapse|1|||
161024091|NCT03854227|581479582|FG009|Overall Study|Disease relapse|0|||
161024092|NCT03854227|581479583|FG010|Overall Study|Disease relapse|0|||
161024093|NCT03854227|581479584|FG011|Overall Study|Disease relapse|0|||
161024094|NCT03854227|581479573|FG000|Overall Study|Global deterioration of health status|0|||
161024095|NCT03854227|581479574|FG001|Overall Study|Global deterioration of health status|0|||
161024096|NCT03854227|581479575|FG002|Overall Study|Global deterioration of health status|0|||
160972662|NCT02978443|581289222|FG000|Overall Study|Death|1|||
161024097|NCT03854227|581479576|FG003|Overall Study|Global deterioration of health status|0|||
161024098|NCT03854227|581479577|FG004|Overall Study|Global deterioration of health status|0|||
160972663|NCT02978443|581289222|FG000|Overall Study|Physician Decision|1|||
160972664|NCT02978443|581289222|FG000|Overall Study|Switch to alternative therapy|1|||
160972665|NCT02978443|581289222|FG000|Overall Study|Refused further treatment|1|||
160972666|NCT01279343|581289224|FG000|Overall Study|Did not receive treatment|2|||
160972667|NCT01279343|581289225|FG001|Overall Study|Did not receive treatment|6|||
160972668|NCT03287414|581289226|FG000|Treatment Epoch|Adverse Event|0|||
160972669|NCT03287414|581289227|FG001|Treatment Epoch|Adverse Event|1|||
160972670|NCT03287414|581289226|FG000|Treatment Epoch|Study terminated by sponsor|2|||
160972671|NCT03287414|581289227|FG001|Treatment Epoch|Study terminated by sponsor|2|||
160972672|NCT03287414|581289226|FG000|Treatment Epoch|Subject/Guardian decision|4|||
160972673|NCT03287414|581289227|FG001|Treatment Epoch|Subject/Guardian decision|0|||
160972674|NCT03287414|581289226|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
160972675|NCT03287414|581289227|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
160972676|NCT03287414|581289226|FG000|Treatment Epoch|Withdrawal by Subject|1|||
160972677|NCT03287414|581289227|FG001|Treatment Epoch|Withdrawal by Subject|0|||
160972678|NCT03287414|581289226|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
160972679|NCT03287414|581289227|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
160972680|NCT03287414|581289226|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
160972681|NCT03287414|581289227|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
160972682|NCT02613221|581289230|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
160972683|NCT02613221|581289230|FG000|Overall Study|Adverse Event|2|||
160972684|NCT02613221|581289230|FG000|Overall Study|Voluntary Discontinuation|1|||
160972685|NCT02613221|581289230|FG000|Overall Study|Delayed Treatment|1|||
160972686|NCT02613221|581289230|FG000|Overall Study|Enrolled but Not Treated|1|||
160972687|NCT01353222|581289235|FG000|Overall Study|Death|30|||
160972688|NCT01353222|581289236|FG001|Overall Study|Death|30|||
160972689|NCT01353222|581289235|FG000|Overall Study|Withdrawal by Subject|8|||
160972690|NCT01353222|581289236|FG001|Overall Study|Withdrawal by Subject|5|||
160972691|NCT01353222|581289235|FG000|Overall Study|Study Terminated|31|||
160972692|NCT01353222|581289236|FG001|Overall Study|Study Terminated|37|||
160972693|NCT01353222|581289235|FG000|Overall Study|Site closed research department|1|||
160972694|NCT01353222|581289236|FG001|Overall Study|Site closed research department|0|||
160972695|NCT01119898|581289237|FG000|Overall Study|Adverse Event|4|||
160972696|NCT01119898|581289238|FG001|Overall Study|Adverse Event|5|||
160972697|NCT01119898|581289237|FG000|Overall Study|Withdrawal by Subject|1|||
160972698|NCT01119898|581289238|FG001|Overall Study|Withdrawal by Subject|4|||
160972699|NCT01119898|581289237|FG000|Overall Study|Lack of Efficacy|0|||
160972700|NCT01119898|581289238|FG001|Overall Study|Lack of Efficacy|2|||
160972701|NCT01119898|581289237|FG000|Overall Study|Protocol Violation|1|||
160972702|NCT01119898|581289238|FG001|Overall Study|Protocol Violation|1|||
160972703|NCT01119898|581289237|FG000|Overall Study|Medical procedure|1|||
160972704|NCT01119898|581289238|FG001|Overall Study|Medical procedure|0|||
160972705|NCT01119898|581289237|FG000|Overall Study|Randomized in error did not participate|1|||
160972706|NCT01119898|581289238|FG001|Overall Study|Randomized in error did not participate|0|||
160972707|NCT01807650|581289241|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
160972708|NCT01807650|581289241|FG000|Overall Study|Adverse Event|5|||
160972709|NCT01807650|581289241|FG000|Overall Study|Other|2|||
160972710|NCT02217280|581289242|FG000|Overall Study|Withdrawal by Subject|2|||
160972711|NCT02217280|581289242|FG000|Overall Study|Post-consent sceen fail|2|||
160972712|NCT03573908|581289248|FG000|Treatment Period|Adverse Event|4|||
160972713|NCT03573908|581289249|FG001|Treatment Period|Adverse Event|9|||
160972714|NCT03573908|581289250|FG002|Treatment Period|Adverse Event|0|||
160972715|NCT03573908|581289251|FG003|Treatment Period|Adverse Event|0|||
160972716|NCT03573908|581289252|FG004|Treatment Period|Adverse Event|0|||
160972717|NCT03573908|581289248|FG000|Treatment Period|Protocol Violation|1|||
160972718|NCT03573908|581289249|FG001|Treatment Period|Protocol Violation|0|||
160972719|NCT03573908|581289250|FG002|Treatment Period|Protocol Violation|0|||
160972720|NCT03573908|581289251|FG003|Treatment Period|Protocol Violation|0|||
160972721|NCT03573908|581289252|FG004|Treatment Period|Protocol Violation|0|||
160972722|NCT03573908|581289248|FG000|Treatment Period|Withdrawal by Subject|7|||
160972723|NCT03573908|581289249|FG001|Treatment Period|Withdrawal by Subject|5|||
160972724|NCT03573908|581289250|FG002|Treatment Period|Withdrawal by Subject|0|||
160972725|NCT03573908|581289251|FG003|Treatment Period|Withdrawal by Subject|0|||
160972726|NCT03573908|581289252|FG004|Treatment Period|Withdrawal by Subject|0|||
160972727|NCT03573908|581289248|FG000|Treatment Period|Lost to Follow-up|7|||
160972728|NCT03573908|581289249|FG001|Treatment Period|Lost to Follow-up|6|||
160972729|NCT03573908|581289250|FG002|Treatment Period|Lost to Follow-up|0|||
160972730|NCT03573908|581289251|FG003|Treatment Period|Lost to Follow-up|0|||
160972731|NCT03573908|581289252|FG004|Treatment Period|Lost to Follow-up|0|||
160972732|NCT03573908|581289248|FG000|Treatment Period|Pregnancy|1|||
160972733|NCT03573908|581289249|FG001|Treatment Period|Pregnancy|0|||
160972734|NCT03573908|581289250|FG002|Treatment Period|Pregnancy|0|||
160972735|NCT03573908|581289251|FG003|Treatment Period|Pregnancy|0|||
160588404|NCT02883049|579873119|FG007|Induction|Identified as VHR at end of Induction|0|||
160588405|NCT02883049|579873120|FG008|Induction|Identified as VHR at end of Induction|0|||
160588406|NCT02883049|579873121|FG009|Induction|Identified as VHR at end of Induction|0|||
160588407|NCT02883049|579873122|FG010|Induction|Identified as VHR at end of Induction|0|||
160588408|NCT02883049|579873123|FG011|Induction|Identified as VHR at end of Induction|0|||
160588409|NCT02883049|579873124|FG012|Induction|Identified as VHR at end of Induction|0|||
160588410|NCT02883049|579873125|FG013|Induction|Identified as VHR at end of Induction|0|||
160588411|NCT02883049|579873126|FG014|Induction|Identified as VHR at end of Induction|0|||
160588412|NCT02883049|579873127|FG015|Induction|Identified as VHR at end of Induction|0|||
160588413|NCT02883049|579873112|FG000|Induction|Moved to another non-COG institution|3|||
160588414|NCT02883049|579873113|FG001|Induction|Moved to another non-COG institution|0|||
160588415|NCT02883049|579873114|FG002|Induction|Moved to another non-COG institution|0|||
160588416|NCT02883049|579873115|FG003|Induction|Moved to another non-COG institution|0|||
160588417|NCT02883049|579873116|FG004|Induction|Moved to another non-COG institution|0|||
160588418|NCT02883049|579873117|FG005|Induction|Moved to another non-COG institution|0|||
160588419|NCT02883049|579873118|FG006|Induction|Moved to another non-COG institution|0|||
160588420|NCT02883049|579873119|FG007|Induction|Moved to another non-COG institution|0|||
160588421|NCT02883049|579873120|FG008|Induction|Moved to another non-COG institution|0|||
160588422|NCT02883049|579873121|FG009|Induction|Moved to another non-COG institution|0|||
160588423|NCT02883049|579873122|FG010|Induction|Moved to another non-COG institution|0|||
160588424|NCT02883049|579873123|FG011|Induction|Moved to another non-COG institution|0|||
160588425|NCT02883049|579873124|FG012|Induction|Moved to another non-COG institution|0|||
160588426|NCT02883049|579873125|FG013|Induction|Moved to another non-COG institution|0|||
160588427|NCT02883049|579873126|FG014|Induction|Moved to another non-COG institution|0|||
160588428|NCT02883049|579873127|FG015|Induction|Moved to another non-COG institution|0|||
160588429|NCT02883049|579873112|FG000|Induction|Randomization closed|41|||
160588430|NCT02883049|579873113|FG001|Induction|Randomization closed|0|||
160588431|NCT02883049|579873114|FG002|Induction|Randomization closed|0|||
160588432|NCT02883049|579873115|FG003|Induction|Randomization closed|0|||
160588433|NCT02883049|579873116|FG004|Induction|Randomization closed|0|||
160588434|NCT02883049|579873117|FG005|Induction|Randomization closed|0|||
160588435|NCT02883049|579873118|FG006|Induction|Randomization closed|0|||
160588436|NCT02883049|579873119|FG007|Induction|Randomization closed|0|||
160657288|NCT00841100|580126029|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
160657289|NCT03338972|580126030|FG000|Overall Study|Death|1|||
160657290|NCT03338972|580126031|FG001|Overall Study|Death|1|||
160972736|NCT03573908|581289252|FG004|Treatment Period|Pregnancy|0|||
160972737|NCT03573908|581289248|FG000|Treatment Period|Other, Not Specified|4|||
160972738|NCT03573908|581289249|FG001|Treatment Period|Other, Not Specified|6|||
160972739|NCT03573908|581289250|FG002|Treatment Period|Other, Not Specified|0|||
160972740|NCT03573908|581289251|FG003|Treatment Period|Other, Not Specified|0|||
160972741|NCT03573908|581289252|FG004|Treatment Period|Other, Not Specified|0|||
160972742|NCT03573908|581289248|FG000|Randomized Withdrawal Period|Adverse Event|0|||
160972743|NCT03573908|581289249|FG001|Randomized Withdrawal Period|Adverse Event|0|||
160972744|NCT03573908|581289250|FG002|Randomized Withdrawal Period|Adverse Event|3|||
160972745|NCT03573908|581289251|FG003|Randomized Withdrawal Period|Adverse Event|0|||
160972746|NCT03573908|581289252|FG004|Randomized Withdrawal Period|Adverse Event|0|||
160972747|NCT03573908|581289248|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160972748|NCT03573908|581289249|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160972749|NCT03573908|581289250|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160972750|NCT03573908|581289251|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160972751|NCT03573908|581289252|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
160972752|NCT03573908|581289248|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
160972753|NCT03573908|581289249|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
160972754|NCT03573908|581289250|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
160972755|NCT03573908|581289251|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
160972756|NCT03573908|581289252|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
160972757|NCT03573908|581289248|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
160972758|NCT03573908|581289249|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
160972759|NCT03573908|581289250|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
160972760|NCT03573908|581289251|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
160972761|NCT03573908|581289252|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
160972762|NCT04006925|581289253|FG000|Overall Study|Side effects|2|||
160972763|NCT04006925|581289254|FG001|Overall Study|Side effects|0|||
160972764|NCT02906683|581291016|FG000|Overall Study|Adverse Event|0|||
160972765|NCT02906683|581291017|FG001|Overall Study|Adverse Event|1|||
160972766|NCT02906683|581291018|FG002|Overall Study|Adverse Event|0|||
160972767|NCT02906683|581291016|FG000|Overall Study|Physician Decision|0|||
160972768|NCT02906683|581291017|FG001|Overall Study|Physician Decision|1|||
160972769|NCT02906683|581291018|FG002|Overall Study|Physician Decision|1|||
160972770|NCT02906683|581291016|FG000|Overall Study|Withdrawal by Subject|0|||
160972771|NCT02906683|581291017|FG001|Overall Study|Withdrawal by Subject|2|||
160972772|NCT02906683|581291018|FG002|Overall Study|Withdrawal by Subject|1|||
161024099|NCT03854227|581479578|FG005|Overall Study|Global deterioration of health status|1|||
161024100|NCT03854227|581479579|FG006|Overall Study|Global deterioration of health status|0|||
161024101|NCT03854227|581479580|FG007|Overall Study|Global deterioration of health status|1|||
161024102|NCT03854227|581479581|FG008|Overall Study|Global deterioration of health status|0|||
161024103|NCT03854227|581479582|FG009|Overall Study|Global deterioration of health status|0|||
161024104|NCT03854227|581479583|FG010|Overall Study|Global deterioration of health status|0|||
161024105|NCT03854227|581479584|FG011|Overall Study|Global deterioration of health status|0|||
161024106|NCT03854227|581479573|FG000|Overall Study|Refused further treatment|0|||
161024107|NCT03854227|581479574|FG001|Overall Study|Refused further treatment|0|||
161024108|NCT03854227|581479575|FG002|Overall Study|Refused further treatment|0|||
161024109|NCT03854227|581479576|FG003|Overall Study|Refused further treatment|0|||
161024110|NCT03854227|581479577|FG004|Overall Study|Refused further treatment|0|||
161024111|NCT03854227|581479578|FG005|Overall Study|Refused further treatment|0|||
161024112|NCT03854227|581479579|FG006|Overall Study|Refused further treatment|0|||
161024113|NCT03854227|581479580|FG007|Overall Study|Refused further treatment|0|||
161024114|NCT03854227|581479581|FG008|Overall Study|Refused further treatment|0|||
161024115|NCT03854227|581479582|FG009|Overall Study|Refused further treatment|1|||
161024116|NCT03854227|581479583|FG010|Overall Study|Refused further treatment|0|||
161024117|NCT03854227|581479584|FG011|Overall Study|Refused further treatment|1|||
161024118|NCT03854227|581479573|FG000|Overall Study|Other|0|||
161024119|NCT03854227|581479574|FG001|Overall Study|Other|0|||
161024120|NCT03854227|581479575|FG002|Overall Study|Other|0|||
161024121|NCT03854227|581479576|FG003|Overall Study|Other|0|||
161024122|NCT03854227|581479577|FG004|Overall Study|Other|0|||
161024123|NCT03854227|581479578|FG005|Overall Study|Other|0|||
161024124|NCT03854227|581479579|FG006|Overall Study|Other|0|||
161024125|NCT03854227|581479580|FG007|Overall Study|Other|0|||
161024126|NCT03854227|581479581|FG008|Overall Study|Other|1|||
161024127|NCT03854227|581479582|FG009|Overall Study|Other|1|||
161024128|NCT03854227|581479583|FG010|Overall Study|Other|0|||
161024129|NCT03854227|581479584|FG011|Overall Study|Other|0|||
161024130|NCT01574274|581479585|FG000|Overall Study|Ineligible|0|||
161024131|NCT01574274|581479586|FG001|Overall Study|Ineligible|1|||
161024132|NCT01574274|581479585|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
161024133|NCT01574274|581479586|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
161024134|NCT01574274|581479585|FG000|Overall Study|Ph+ B-ALL|3|||
161024135|NCT01574274|581479586|FG001|Overall Study|Ph+ B-ALL|4|||
161024136|NCT01574274|581479585|FG000|Overall Study|Induction Death|2|||
161024137|NCT01574274|581479586|FG001|Overall Study|Induction Death|0|||
161024138|NCT01574274|581479585|FG000|Overall Study|Induction Failure|4|||
161024139|NCT01574274|581479586|FG001|Overall Study|Induction Failure|1|||
161024140|NCT01574274|581479585|FG000|Overall Study|Adverse Event|16|||
161024141|NCT01574274|581479586|FG001|Overall Study|Adverse Event|13|||
161024142|NCT01574274|581479585|FG000|Overall Study|Remission Death|1|||
161024143|NCT01574274|581479586|FG001|Overall Study|Remission Death|0|||
161024144|NCT01574274|581479585|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
161024145|NCT01574274|581479586|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
161024146|NCT01574274|581479585|FG000|Overall Study|Other, unknown|3|||
161024147|NCT01574274|581479586|FG001|Overall Study|Other, unknown|2|||
161024148|NCT04314713|581479593|FG000|Overall Study|Lost to Follow-up|0|||
161024149|NCT04314713|581479594|FG001|Overall Study|Lost to Follow-up|0|||
161024150|NCT04314713|581479595|FG002|Overall Study|Lost to Follow-up|0|||
161024151|NCT04314713|581479596|FG003|Overall Study|Lost to Follow-up|1|||
161024152|NCT04314713|581479597|FG004|Overall Study|Lost to Follow-up|0|||
161024153|NCT04314713|581479598|FG005|Overall Study|Lost to Follow-up|0|||
161024154|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
161024155|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
161024156|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
161024157|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
161024158|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
161024159|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
161024160|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
161024161|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
161024162|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
161024163|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
161024164|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
161024165|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
161024166|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
161024167|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
161024168|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
161024169|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
161024170|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
161024171|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
161024172|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
161024173|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
160657291|NCT03338972|580126032|FG002|Overall Study|Death|0|||
160657292|NCT03338972|580126033|FG003|Overall Study|Death|0|||
160657293|NCT03338972|580126030|FG000|Overall Study|Withdrawal by Subject|1|||
160657294|NCT03338972|580126031|FG001|Overall Study|Withdrawal by Subject|0|||
160657295|NCT03338972|580126032|FG002|Overall Study|Withdrawal by Subject|0|||
160657296|NCT03338972|580126033|FG003|Overall Study|Withdrawal by Subject|0|||
160657297|NCT01355081|580126034|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
161024174|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161024175|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
161024176|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161024177|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161024178|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161024179|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
161024180|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
161024181|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
161024182|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
161024183|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
160588437|NCT02883049|579873120|FG008|Induction|Randomization closed|0|||
160588438|NCT02883049|579873121|FG009|Induction|Randomization closed|0|||
160588439|NCT02883049|579873122|FG010|Induction|Randomization closed|0|||
160588440|NCT02883049|579873123|FG011|Induction|Randomization closed|0|||
160588441|NCT02883049|579873124|FG012|Induction|Randomization closed|0|||
160588442|NCT02883049|579873125|FG013|Induction|Randomization closed|0|||
160588443|NCT02883049|579873126|FG014|Induction|Randomization closed|0|||
160588444|NCT02883049|579873127|FG015|Induction|Randomization closed|0|||
160588445|NCT02883049|579873112|FG000|Induction|MRD negative|36|||
160588446|NCT02883049|579873113|FG001|Induction|MRD negative|0|||
160588447|NCT02883049|579873114|FG002|Induction|MRD negative|0|||
160588448|NCT02883049|579873115|FG003|Induction|MRD negative|0|||
160588449|NCT02883049|579873116|FG004|Induction|MRD negative|0|||
160588450|NCT02883049|579873117|FG005|Induction|MRD negative|0|||
160588451|NCT02883049|579873118|FG006|Induction|MRD negative|0|||
160588452|NCT02883049|579873119|FG007|Induction|MRD negative|0|||
160588453|NCT02883049|579873120|FG008|Induction|MRD negative|0|||
160588454|NCT02883049|579873121|FG009|Induction|MRD negative|0|||
160588455|NCT02883049|579873122|FG010|Induction|MRD negative|0|||
160588456|NCT02883049|579873123|FG011|Induction|MRD negative|0|||
160588457|NCT02883049|579873124|FG012|Induction|MRD negative|0|||
160588458|NCT02883049|579873125|FG013|Induction|MRD negative|0|||
160588459|NCT02883049|579873126|FG014|Induction|MRD negative|0|||
160588460|NCT02883049|579873127|FG015|Induction|MRD negative|0|||
160588461|NCT02883049|579873112|FG000|Induction|Identified as HR patients|165|||
160588462|NCT02883049|579873113|FG001|Induction|Identified as HR patients|0|||
160588463|NCT02883049|579873114|FG002|Induction|Identified as HR patients|0|||
160588464|NCT02883049|579873115|FG003|Induction|Identified as HR patients|0|||
160588465|NCT02883049|579873116|FG004|Induction|Identified as HR patients|0|||
160588466|NCT02883049|579873117|FG005|Induction|Identified as HR patients|0|||
160588467|NCT02883049|579873118|FG006|Induction|Identified as HR patients|0|||
160588468|NCT02883049|579873119|FG007|Induction|Identified as HR patients|0|||
160588469|NCT02883049|579873120|FG008|Induction|Identified as HR patients|0|||
160588470|NCT02883049|579873121|FG009|Induction|Identified as HR patients|0|||
160588471|NCT02883049|579873122|FG010|Induction|Identified as HR patients|0|||
160588472|NCT02883049|579873123|FG011|Induction|Identified as HR patients|0|||
160588473|NCT02883049|579873124|FG012|Induction|Identified as HR patients|0|||
160588474|NCT02883049|579873125|FG013|Induction|Identified as HR patients|0|||
160588475|NCT02883049|579873126|FG014|Induction|Identified as HR patients|0|||
160588476|NCT02883049|579873127|FG015|Induction|Identified as HR patients|0|||
160588477|NCT02883049|579873112|FG000|Induction|Developed SMN|0|||
160588478|NCT02883049|579873113|FG001|Induction|Developed SMN|1|||
160588479|NCT02883049|579873114|FG002|Induction|Developed SMN|0|||
160588480|NCT02883049|579873115|FG003|Induction|Developed SMN|0|||
160588481|NCT02883049|579873116|FG004|Induction|Developed SMN|0|||
160588482|NCT02883049|579873117|FG005|Induction|Developed SMN|0|||
160588483|NCT02883049|579873118|FG006|Induction|Developed SMN|0|||
160588484|NCT02883049|579873119|FG007|Induction|Developed SMN|0|||
161024184|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
160588485|NCT02883049|579873120|FG008|Induction|Developed SMN|0|||
160588486|NCT02883049|579873121|FG009|Induction|Developed SMN|0|||
160657298|NCT01355081|580126035|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
160588487|NCT02883049|579873122|FG010|Induction|Developed SMN|0|||
160588488|NCT02883049|579873123|FG011|Induction|Developed SMN|0|||
160588489|NCT02883049|579873124|FG012|Induction|Developed SMN|0|||
160588490|NCT02883049|579873125|FG013|Induction|Developed SMN|0|||
160588491|NCT02883049|579873126|FG014|Induction|Developed SMN|0|||
160588492|NCT02883049|579873127|FG015|Induction|Developed SMN|0|||
160588493|NCT02883049|579873112|FG000|Induction|Enrolled onto another COG study|72|||
160588494|NCT02883049|579873113|FG001|Induction|Enrolled onto another COG study|0|||
160588495|NCT02883049|579873114|FG002|Induction|Enrolled onto another COG study|0|||
160588496|NCT02883049|579873115|FG003|Induction|Enrolled onto another COG study|0|||
160657299|NCT01355081|580126036|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
160657300|NCT01355081|580126034|FG000|Overall Study|Major Protocol Deviation|0|||
160657301|NCT01355081|580126035|FG001|Overall Study|Major Protocol Deviation|1|||
161024185|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
160588497|NCT02883049|579873116|FG004|Induction|Enrolled onto another COG study|0|||
160588498|NCT02883049|579873117|FG005|Induction|Enrolled onto another COG study|0|||
160588499|NCT02883049|579873118|FG006|Induction|Enrolled onto another COG study|0|||
160588500|NCT02883049|579873119|FG007|Induction|Enrolled onto another COG study|0|||
160588501|NCT02883049|579873120|FG008|Induction|Enrolled onto another COG study|0|||
160588502|NCT02883049|579873121|FG009|Induction|Enrolled onto another COG study|0|||
160588503|NCT02883049|579873122|FG010|Induction|Enrolled onto another COG study|0|||
160588504|NCT02883049|579873123|FG011|Induction|Enrolled onto another COG study|0|||
160588505|NCT02883049|579873124|FG012|Induction|Enrolled onto another COG study|0|||
160588506|NCT02883049|579873125|FG013|Induction|Enrolled onto another COG study|0|||
160588507|NCT02883049|579873126|FG014|Induction|Enrolled onto another COG study|0|||
160588508|NCT02883049|579873127|FG015|Induction|Enrolled onto another COG study|0|||
160588509|NCT02883049|579873112|FG000|Induction|Incomplete induction data|17|||
160588510|NCT02883049|579873113|FG001|Induction|Incomplete induction data|0|||
160588511|NCT02883049|579873114|FG002|Induction|Incomplete induction data|0|||
160588512|NCT02883049|579873115|FG003|Induction|Incomplete induction data|0|||
160588513|NCT02883049|579873116|FG004|Induction|Incomplete induction data|0|||
160588514|NCT02883049|579873117|FG005|Induction|Incomplete induction data|0|||
160588515|NCT02883049|579873118|FG006|Induction|Incomplete induction data|0|||
160588516|NCT02883049|579873119|FG007|Induction|Incomplete induction data|0|||
160588517|NCT02883049|579873120|FG008|Induction|Incomplete induction data|0|||
160588518|NCT02883049|579873121|FG009|Induction|Incomplete induction data|0|||
160588519|NCT02883049|579873122|FG010|Induction|Incomplete induction data|0|||
160588520|NCT02883049|579873123|FG011|Induction|Incomplete induction data|0|||
160588521|NCT02883049|579873124|FG012|Induction|Incomplete induction data|0|||
160588522|NCT02883049|579873125|FG013|Induction|Incomplete induction data|0|||
160588523|NCT02883049|579873126|FG014|Induction|Incomplete induction data|0|||
160588524|NCT02883049|579873127|FG015|Induction|Incomplete induction data|0|||
160588525|NCT02883049|579873112|FG000|Post Induction|Adverse Event|0|||
160588526|NCT02883049|579873113|FG001|Post Induction|Adverse Event|0|||
160657302|NCT01355081|580126036|FG002|Overall Study|Major Protocol Deviation|0|||
160657303|NCT01355081|580126034|FG000|Overall Study|Lost to Follow-up|0|||
160657304|NCT01355081|580126035|FG001|Overall Study|Lost to Follow-up|0|||
160657305|NCT01355081|580126036|FG002|Overall Study|Lost to Follow-up|1|||
160657306|NCT01355081|580126034|FG000|Overall Study|Withdrawal of Consent|2|||
160657307|NCT01355081|580126035|FG001|Overall Study|Withdrawal of Consent|3|||
160657308|NCT01355081|580126036|FG002|Overall Study|Withdrawal of Consent|3|||
160657309|NCT01355081|580126034|FG000|Overall Study|Lack of Efficacy|2|||
160657310|NCT01355081|580126035|FG001|Overall Study|Lack of Efficacy|1|||
160657311|NCT01355081|580126036|FG002|Overall Study|Lack of Efficacy|1|||
160657312|NCT01355081|580126034|FG000|Overall Study|Non Compliance with Study Medication|0|||
160657313|NCT01355081|580126035|FG001|Overall Study|Non Compliance with Study Medication|1|||
160657314|NCT01355081|580126036|FG002|Overall Study|Non Compliance with Study Medication|0|||
160657315|NCT02719522|580126039|FG000|Overall Study|Implant Failure|4|||
160657316|NCT02719522|580126039|FG000|Overall Study|Death|2|||
160657317|NCT02719522|580126039|FG000|Overall Study|Lost to Follow-up|5|||
160657318|NCT06096168|580126040|FG000|Overall Study|Death|30|||
160657319|NCT06096168|580126040|FG000|Overall Study|Revision|2|||
160657320|NCT01868009|580126041|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
160657321|NCT01868009|580126042|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
160657322|NCT01868009|580126041|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
160657323|NCT01868009|580126042|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
160657324|NCT01868009|580126041|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
160657325|NCT01868009|580126042|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
160657326|NCT04603937|580126043|FG000|Overall Study|Adverse Event|9|||
160657327|NCT04603937|580126044|FG001|Overall Study|Adverse Event|10|||
160657328|NCT04603937|580126043|FG000|Overall Study|Withdrawal by Subject|7|||
160657329|NCT04603937|580126044|FG001|Overall Study|Withdrawal by Subject|6|||
160657330|NCT04603937|580126043|FG000|Overall Study|Lost to Follow-up|5|||
160657331|NCT04603937|580126044|FG001|Overall Study|Lost to Follow-up|6|||
160657332|NCT04603937|580126043|FG000|Overall Study|Physician Decision|0|||
160657333|NCT04603937|580126044|FG001|Overall Study|Physician Decision|1|||
160657334|NCT04603937|580126043|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
160657335|NCT04603937|580126044|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
160657336|NCT00993616|580126045|FG000|Overall Study|No tumor at entry|1|||
160657337|NCT00993616|580126045|FG000|Overall Study|Never treated|1|||
160588527|NCT02883049|579873114|FG002|Post Induction|Adverse Event|0|||
160588528|NCT02883049|579873115|FG003|Post Induction|Adverse Event|7|||
160588529|NCT02883049|579873116|FG004|Post Induction|Adverse Event|8|||
160588530|NCT02883049|579873117|FG005|Post Induction|Adverse Event|3|||
160657338|NCT02585258|580126046|FG000|Overall Study|Adverse Event|28|||
160657339|NCT02585258|580126047|FG001|Overall Study|Adverse Event|29|||
161024186|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
161024187|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
161024188|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
161024189|NCT03852472|581479603|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
161024190|NCT03852472|581479604|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
161024191|NCT03852472|581479605|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
161024192|NCT03852472|581479606|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
161024193|NCT03852472|581479607|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
161024194|NCT03852472|581479603|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
161024195|NCT03852472|581479604|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
161024196|NCT03852472|581479605|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
161024197|NCT03852472|581479606|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
161024198|NCT03852472|581479607|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
161024199|NCT03852472|581479603|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
161024200|NCT03852472|581479604|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
161024201|NCT03852472|581479605|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
161024202|NCT03852472|581479606|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
161024203|NCT03852472|581479607|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
161024204|NCT03852472|581479603|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
161024205|NCT03852472|581479604|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
161024206|NCT03852472|581479605|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
161024207|NCT03852472|581479606|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
161024208|NCT03852472|581479607|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
161024209|NCT03852472|581479603|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
161024210|NCT03852472|581479604|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
161024211|NCT03852472|581479605|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
161024212|NCT03852472|581479606|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
161024213|NCT03852472|581479607|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
161024214|NCT03852472|581479603|FG000|Period 2 - Week 44|Adverse Event|0|||
161024215|NCT03852472|581479604|FG001|Period 2 - Week 44|Adverse Event|3|||
160972773|NCT02906683|581291016|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
160972774|NCT02906683|581291017|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
160972775|NCT02906683|581291018|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
160972776|NCT02906683|581291016|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
160972777|NCT02906683|581291017|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
160972778|NCT02906683|581291018|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
160972779|NCT01158378|581291019|FG000|Overall Study|Death|4|||
160972780|NCT01158378|581291020|FG001|Overall Study|Death|5|||
160972781|NCT01158378|581291019|FG000|Overall Study|Lost to Follow-up|2|||
160972782|NCT01158378|581291020|FG001|Overall Study|Lost to Follow-up|4|||
160972783|NCT01158378|581291019|FG000|Overall Study|Withdrawal by Subject|4|||
160972784|NCT01158378|581291020|FG001|Overall Study|Withdrawal by Subject|0|||
160972785|NCT02769065|581291021|FG000|Overall Study|Voluntary Withdrawal|1|||
160972786|NCT02769065|581291022|FG001|Overall Study|Voluntary Withdrawal|0|||
160972787|NCT02769065|581291023|FG002|Overall Study|Voluntary Withdrawal|0|||
160972788|NCT02769065|581291024|FG003|Overall Study|Voluntary Withdrawal|0|||
160972789|NCT02769065|581291025|FG004|Overall Study|Voluntary Withdrawal|0|||
160972790|NCT02769065|581291026|FG005|Overall Study|Voluntary Withdrawal|0|||
160972791|NCT02769065|581291027|FG006|Overall Study|Voluntary Withdrawal|0|||
160972792|NCT02769065|581291028|FG007|Overall Study|Voluntary Withdrawal|0|||
160972793|NCT02769065|581291029|FG008|Overall Study|Voluntary Withdrawal|0|||
160972794|NCT02769065|581291030|FG009|Overall Study|Voluntary Withdrawal|0|||
160972795|NCT02769065|581291031|FG010|Overall Study|Voluntary Withdrawal|0|||
160972796|NCT02769065|581291032|FG011|Overall Study|Voluntary Withdrawal|0|||
160972797|NCT02769065|581291033|FG012|Overall Study|Voluntary Withdrawal|0|||
160972798|NCT02769065|581291034|FG013|Overall Study|Voluntary Withdrawal|0|||
160972799|NCT02769065|581291035|FG014|Overall Study|Voluntary Withdrawal|0|||
160972800|NCT02769065|581291036|FG015|Overall Study|Voluntary Withdrawal|0|||
160972801|NCT02769065|581291037|FG016|Overall Study|Voluntary Withdrawal|0|||
160972802|NCT02769065|581291038|FG017|Overall Study|Voluntary Withdrawal|0|||
160972803|NCT02769065|581291039|FG018|Overall Study|Voluntary Withdrawal|0|||
160972804|NCT02769065|581291040|FG019|Overall Study|Voluntary Withdrawal|0|||
160588531|NCT02883049|579873118|FG006|Post Induction|Adverse Event|4|||
160588532|NCT02883049|579873119|FG007|Post Induction|Adverse Event|5|||
160972805|NCT02769065|581291041|FG020|Overall Study|Voluntary Withdrawal|0|||
161024216|NCT03852472|581479605|FG002|Period 2 - Week 44|Adverse Event|1|||
161024217|NCT03852472|581479606|FG003|Period 2 - Week 44|Adverse Event|2|||
160588533|NCT02883049|579873120|FG008|Post Induction|Adverse Event|6|||
161024218|NCT03852472|581479607|FG004|Period 2 - Week 44|Adverse Event|2|||
160972806|NCT02769065|581291042|FG021|Overall Study|Voluntary Withdrawal|0|||
160588534|NCT02883049|579873121|FG009|Post Induction|Adverse Event|7|||
160588535|NCT02883049|579873122|FG010|Post Induction|Adverse Event|2|||
160588536|NCT02883049|579873123|FG011|Post Induction|Adverse Event|2|||
160588537|NCT02883049|579873124|FG012|Post Induction|Adverse Event|0|||
160588538|NCT02883049|579873125|FG013|Post Induction|Adverse Event|0|||
160588539|NCT02883049|579873126|FG014|Post Induction|Adverse Event|5|||
161024219|NCT03852472|581479603|FG000|Period 2 - Week 44|COVID-19 Related|0|||
161024220|NCT03852472|581479604|FG001|Period 2 - Week 44|COVID-19 Related|0|||
161024221|NCT03852472|581479605|FG002|Period 2 - Week 44|COVID-19 Related|0|||
161024222|NCT03852472|581479606|FG003|Period 2 - Week 44|COVID-19 Related|1|||
161024223|NCT03852472|581479607|FG004|Period 2 - Week 44|COVID-19 Related|0|||
161024224|NCT03852472|581479603|FG000|Period 2 - Week 44|Reason not stated|0|||
161024225|NCT03852472|581479604|FG001|Period 2 - Week 44|Reason not stated|0|||
161024226|NCT03852472|581479605|FG002|Period 2 - Week 44|Reason not stated|0|||
160972807|NCT02769065|581291043|FG022|Overall Study|Voluntary Withdrawal|0|||
160972808|NCT02769065|581291044|FG023|Overall Study|Voluntary Withdrawal|0|||
160972809|NCT02769065|581291045|FG024|Overall Study|Voluntary Withdrawal|0|||
160972810|NCT02769065|581291046|FG025|Overall Study|Voluntary Withdrawal|0|||
160972811|NCT02769065|581291047|FG026|Overall Study|Voluntary Withdrawal|0|||
160972812|NCT02769065|581291048|FG027|Overall Study|Voluntary Withdrawal|0|||
160972813|NCT02769065|581291049|FG028|Overall Study|Voluntary Withdrawal|0|||
160972814|NCT02769065|581291050|FG029|Overall Study|Voluntary Withdrawal|0|||
160972815|NCT02769065|581291021|FG000|Overall Study|Reason Not Specified|0|||
160972816|NCT02769065|581291022|FG001|Overall Study|Reason Not Specified|0|||
160972817|NCT02769065|581291023|FG002|Overall Study|Reason Not Specified|0|||
160972818|NCT02769065|581291024|FG003|Overall Study|Reason Not Specified|0|||
160972819|NCT02769065|581291025|FG004|Overall Study|Reason Not Specified|0|||
160972820|NCT02769065|581291026|FG005|Overall Study|Reason Not Specified|0|||
160972821|NCT02769065|581291027|FG006|Overall Study|Reason Not Specified|1|||
160972822|NCT02769065|581291028|FG007|Overall Study|Reason Not Specified|0|||
160972823|NCT02769065|581291029|FG008|Overall Study|Reason Not Specified|0|||
160972824|NCT02769065|581291030|FG009|Overall Study|Reason Not Specified|0|||
160972825|NCT02769065|581291031|FG010|Overall Study|Reason Not Specified|0|||
160972826|NCT02769065|581291032|FG011|Overall Study|Reason Not Specified|0|||
160972827|NCT02769065|581291033|FG012|Overall Study|Reason Not Specified|0|||
160972828|NCT02769065|581291034|FG013|Overall Study|Reason Not Specified|0|||
160972829|NCT02769065|581291035|FG014|Overall Study|Reason Not Specified|0|||
160972830|NCT02769065|581291036|FG015|Overall Study|Reason Not Specified|0|||
160972831|NCT02769065|581291037|FG016|Overall Study|Reason Not Specified|0|||
160972832|NCT02769065|581291038|FG017|Overall Study|Reason Not Specified|0|||
160972833|NCT02769065|581291039|FG018|Overall Study|Reason Not Specified|0|||
160972834|NCT02769065|581291040|FG019|Overall Study|Reason Not Specified|0|||
160972835|NCT02769065|581291041|FG020|Overall Study|Reason Not Specified|0|||
160972836|NCT02769065|581291042|FG021|Overall Study|Reason Not Specified|0|||
160972837|NCT02769065|581291043|FG022|Overall Study|Reason Not Specified|0|||
160972838|NCT02769065|581291044|FG023|Overall Study|Reason Not Specified|0|||
160972839|NCT02769065|581291045|FG024|Overall Study|Reason Not Specified|0|||
160972840|NCT02769065|581291046|FG025|Overall Study|Reason Not Specified|0|||
160972841|NCT02769065|581291047|FG026|Overall Study|Reason Not Specified|0|||
160972842|NCT02769065|581291048|FG027|Overall Study|Reason Not Specified|0|||
160972843|NCT02769065|581291049|FG028|Overall Study|Reason Not Specified|0|||
160972844|NCT02769065|581291050|FG029|Overall Study|Reason Not Specified|0|||
160972845|NCT02769065|581291021|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972846|NCT02769065|581291022|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972847|NCT02769065|581291023|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972848|NCT02769065|581291024|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972849|NCT02769065|581291025|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
160588540|NCT02883049|579873127|FG015|Post Induction|Adverse Event|2|||
160588541|NCT02883049|579873112|FG000|Post Induction|Death|0|||
160588542|NCT02883049|579873113|FG001|Post Induction|Death|0|||
160588543|NCT02883049|579873114|FG002|Post Induction|Death|0|||
160588544|NCT02883049|579873115|FG003|Post Induction|Death|9|||
160588545|NCT02883049|579873116|FG004|Post Induction|Death|9|||
160588546|NCT02883049|579873117|FG005|Post Induction|Death|0|||
160588547|NCT02883049|579873118|FG006|Post Induction|Death|1|||
160972850|NCT02769065|581291026|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972851|NCT02769065|581291027|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972852|NCT02769065|581291028|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972853|NCT02769065|581291029|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
160588548|NCT02883049|579873119|FG007|Post Induction|Death|6|||
160588549|NCT02883049|579873120|FG008|Post Induction|Death|5|||
160588550|NCT02883049|579873121|FG009|Post Induction|Death|3|||
160588551|NCT02883049|579873122|FG010|Post Induction|Death|1|||
160588552|NCT02883049|579873123|FG011|Post Induction|Death|0|||
160972854|NCT02769065|581291030|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
161024227|NCT03852472|581479606|FG003|Period 2 - Week 44|Reason not stated|0|||
161024228|NCT03852472|581479607|FG004|Period 2 - Week 44|Reason not stated|1|||
161024229|NCT04880863|581479610|FG000|Overall Study|Adverse Event|1|||
161024230|NCT04880863|581479610|FG000|Overall Study|Patient decision|2|||
161024231|NCT04880863|581479610|FG000|Overall Study|Confirmed Disease Progression|15|||
161024232|NCT04880863|581479610|FG000|Overall Study|Death|3|||
161024233|NCT04880863|581479610|FG000|Overall Study|Physician Decision|4|||
161024234|NCT04880863|581479610|FG000|Overall Study|Unconfirmed Disease Progression|4|||
161024235|NCT04880863|581479610|FG000|Overall Study|Withdrawal by Subject|2|||
161024236|NCT04880863|581479610|FG000|Overall Study|Study discontinuation by the sponsor|4|||
161024237|NCT04880863|581479610|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
161024238|NCT04880863|581479610|FG000|Overall Study|Not received study drug NAP|2|||
161024239|NCT05670587|581479611|FG000|Overall Study|Withdrawal by Subject|3|||
161024240|NCT02305888|581479621|FG000|Overall Study|Lost to Follow-up|0|||
161024241|NCT02305888|581479622|FG001|Overall Study|Lost to Follow-up|0|||
161024242|NCT02305888|581479623|FG002|Overall Study|Lost to Follow-up|1|||
161024243|NCT02305888|581479621|FG000|Overall Study|Adverse Event|0|||
161024244|NCT02305888|581479622|FG001|Overall Study|Adverse Event|1|||
161024245|NCT02305888|581479623|FG002|Overall Study|Adverse Event|0|||
161024246|NCT05139810|581479624|FG000|Overall Study|Voluntary Withdrawal|2|||
161024247|NCT05139810|581479625|FG001|Overall Study|Voluntary Withdrawal|1|||
161024248|NCT05139810|581479626|FG002|Overall Study|Voluntary Withdrawal|0|||
161024249|NCT05139810|581479624|FG000|Overall Study|Pregnancy|1|||
161024250|NCT05139810|581479625|FG001|Overall Study|Pregnancy|0|||
161024251|NCT05139810|581479626|FG002|Overall Study|Pregnancy|0|||
161024252|NCT05139810|581479624|FG000|Overall Study|Roll Over to CS7|19|||
161024253|NCT05139810|581479625|FG001|Overall Study|Roll Over to CS7|44|||
161024254|NCT05139810|581479626|FG002|Overall Study|Roll Over to CS7|20|||
161024255|NCT03240016|581479633|FG000|Overall Study|Adverse Event|9|||
161024256|NCT03240016|581479633|FG000|Overall Study|Withdrawal by Subject|7|||
161024257|NCT03240016|581479633|FG000|Overall Study|Death|1|||
161024258|NCT03240016|581479633|FG000|Overall Study|Physician Decision|2|||
161024259|NCT05200403|581479634|FG000|Overall Study|Withdrawal by Subject|4|||
161024260|NCT05200403|581479635|FG001|Overall Study|Withdrawal by Subject|2|||
161024261|NCT05200403|581479636|FG002|Overall Study|Withdrawal by Subject|6|||
161024262|NCT05546411|581479637|FG000|Overall Study|Progressive Disease|1|||
161024263|NCT05546411|581479638|FG001|Overall Study|Progressive Disease|0|||
161024264|NCT05546411|581479637|FG000|Overall Study|Adverse Event|0|||
161024265|NCT05546411|581479638|FG001|Overall Study|Adverse Event|1|||
161024266|NCT05546411|581479637|FG000|Overall Study|Metastatic disease|1|||
161024267|NCT05546411|581479638|FG001|Overall Study|Metastatic disease|0|||
161024268|NCT04068181|581479646|FG000|Overall Study|Death|17|||
161024269|NCT04068181|581479647|FG001|Overall Study|Death|12|||
161024270|NCT04068181|581479648|FG002|Overall Study|Death|4|||
161024271|NCT04068181|581479649|FG003|Overall Study|Death|7|||
161024272|NCT04068181|581479646|FG000|Overall Study|Lost to Follow-up|1|||
161024273|NCT04068181|581479647|FG001|Overall Study|Lost to Follow-up|0|||
161024274|NCT04068181|581479648|FG002|Overall Study|Lost to Follow-up|0|||
161024275|NCT04068181|581479649|FG003|Overall Study|Lost to Follow-up|0|||
161024276|NCT04068181|581479646|FG000|Overall Study|Withdrawal of consent from study|3|||
161024277|NCT04068181|581479647|FG001|Overall Study|Withdrawal of consent from study|0|||
161024278|NCT04068181|581479648|FG002|Overall Study|Withdrawal of consent from study|0|||
161024279|NCT04068181|581479649|FG003|Overall Study|Withdrawal of consent from study|0|||
161024280|NCT03785964|581479652|FG000|Overall Study|Adverse Event|14|||
161024281|NCT03785964|581479653|FG001|Overall Study|Adverse Event|1|||
161024282|NCT03785964|581479652|FG000|Overall Study|Unqualified Clinical Progression|1|||
161024283|NCT03785964|581479653|FG001|Overall Study|Unqualified Clinical Progression|1|||
161024284|NCT03785964|581479652|FG000|Overall Study|Participant non-compliance|1|||
161024285|NCT03785964|581479653|FG001|Overall Study|Participant non-compliance|1|||
161024286|NCT03785964|581479652|FG000|Overall Study|Not treated|1|||
161024287|NCT03785964|581479653|FG001|Overall Study|Not treated|0|||
161024288|NCT03785964|581479652|FG000|Overall Study|Other reason|5|||
161024289|NCT03785964|581479653|FG001|Overall Study|Other reason|11|||
161024290|NCT03785964|581479652|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
161024291|NCT03785964|581479653|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
161024292|NCT02723591|581479654|FG000|Overall Study|Adverse Event|48|||
161024293|NCT02723591|581479655|FG001|Overall Study|Adverse Event|40|||
161024294|NCT02723591|581479654|FG000|Overall Study|Death|2|||
161024295|NCT02723591|581479655|FG001|Overall Study|Death|2|||
161024296|NCT02723591|581479654|FG000|Overall Study|Lack of Efficacy|4|||
161024297|NCT02723591|581479655|FG001|Overall Study|Lack of Efficacy|3|||
161024298|NCT02723591|581479654|FG000|Overall Study|Lost to Follow-up|1|||
161024299|NCT02723591|581479655|FG001|Overall Study|Lost to Follow-up|7|||
161024300|NCT02723591|581479654|FG000|Overall Study|Protocol Violation|20|||
161024301|NCT02723591|581479655|FG001|Overall Study|Protocol Violation|23|||
161024302|NCT02723591|581479654|FG000|Overall Study|Withdrawal by Subject|4|||
161024303|NCT02723591|581479655|FG001|Overall Study|Withdrawal by Subject|8|||
161024304|NCT02723591|581479654|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
160657340|NCT02585258|580126046|FG000|Overall Study|Death|3|||
160657341|NCT02585258|580126047|FG001|Overall Study|Death|2|||
160657342|NCT02585258|580126046|FG000|Overall Study|Lack of Efficacy|7|||
160657343|NCT02585258|580126047|FG001|Overall Study|Lack of Efficacy|9|||
160657344|NCT02585258|580126046|FG000|Overall Study|includes covid-related access problems|42|||
160657345|NCT02585258|580126047|FG001|Overall Study|includes covid-related access problems|46|||
160657346|NCT02585258|580126046|FG000|Overall Study|Lost to Follow-up|5|||
160657347|NCT02585258|580126047|FG001|Overall Study|Lost to Follow-up|2|||
160657348|NCT05125952|580126048|FG000|Overall Study|Physician Decision|1|||
160657349|NCT03946449|580126049|FG000|Treatment Extension II|Rolled over to another study|0|||
160657350|NCT03946449|580126050|FG001|Treatment Extension II|Rolled over to another study|0|||
160657351|NCT03946449|580126051|FG002|Treatment Extension II|Rolled over to another study|2|||
160657352|NCT03946449|580126049|FG000|Treatment Extension II|Withdrawal by Subject|0|||
160657353|NCT03946449|580126050|FG001|Treatment Extension II|Withdrawal by Subject|0|||
160657354|NCT03946449|580126051|FG002|Treatment Extension II|Withdrawal by Subject|1|||
160657355|NCT02848326|580127502|FG000|Treatment Period|Adverse Event|5|||
160657356|NCT02848326|580127503|FG001|Treatment Period|Adverse Event|4|||
160657357|NCT02848326|580127504|FG002|Treatment Period|Adverse Event|11|||
160657358|NCT02848326|580127505|FG003|Treatment Period|Adverse Event|6|||
160657359|NCT02848326|580127506|FG004|Treatment Period|Adverse Event|5|||
160657360|NCT02848326|580127507|FG005|Treatment Period|Adverse Event|7|||
160972855|NCT02769065|581291031|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
160972856|NCT02769065|581291032|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972857|NCT02769065|581291033|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972858|NCT02769065|581291034|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972859|NCT02769065|581291035|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972860|NCT02769065|581291036|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972861|NCT02769065|581291037|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972862|NCT02769065|581291038|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972863|NCT02769065|581291039|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972864|NCT02769065|581291040|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972865|NCT02769065|581291041|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972866|NCT02769065|581291042|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972867|NCT02769065|581291043|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972868|NCT02769065|581291044|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972869|NCT02769065|581291045|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972870|NCT02769065|581291046|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972871|NCT02769065|581291047|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972872|NCT02769065|581291048|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972873|NCT02769065|581291049|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972874|NCT02769065|581291050|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972875|NCT02531295|581291055|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
160972876|NCT02531295|581291056|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
160972877|NCT02531295|581291057|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
160972878|NCT02531295|581291058|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
160972879|NCT02531295|581291059|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
160972880|NCT02531295|581291060|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
160972881|NCT00453310|581291061|FG000|Overall Study|Progression of Disease|10|||
160972882|NCT01806740|581291062|FG000|Overall Study|Withdrawal by Subject|4|||
160972883|NCT01806740|581291062|FG000|Overall Study|Physician Decision|1|||
160972884|NCT01806740|581291062|FG000|Overall Study|Patient's refusal of treatment|1|||
160972885|NCT04666922|581291063|FG000|Overall Study|Withdrawal by Subject|1|||
160972886|NCT04666922|581291064|FG001|Overall Study|Withdrawal by Subject|0|||
160972887|NCT04666922|581291065|FG002|Overall Study|Withdrawal by Subject|0|||
160972888|NCT04666922|581291066|FG003|Overall Study|Withdrawal by Subject|0|||
160972889|NCT04666922|581291067|FG004|Overall Study|Withdrawal by Subject|0|||
160972890|NCT04666922|581291068|FG005|Overall Study|Withdrawal by Subject|0|||
160972891|NCT04666922|581291069|FG006|Overall Study|Withdrawal by Subject|0|||
160972892|NCT01382940|581291072|FG000|Overall Study|Adverse Event|19|||
160972893|NCT01382940|581291072|FG000|Overall Study|Lost to Follow-up|4|||
160972894|NCT01382940|581291072|FG000|Overall Study|Physician Decision|7|||
160972895|NCT01382940|581291072|FG000|Overall Study|Withdrawal by Subject|23|||
160972896|NCT01382940|581291072|FG000|Overall Study|Protocol Violation|20|||
160972897|NCT02105636|581291073|FG000|Pre-Treatment|Disease Progression|1|||
160972898|NCT02105636|581291074|FG001|Pre-Treatment|Disease Progression|0|||
160972899|NCT02105636|581291073|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
160972900|NCT02105636|581291074|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
160972901|NCT02105636|581291073|FG000|Pre-Treatment|Participant withdrew consent|0|||
160972902|NCT02105636|581291074|FG001|Pre-Treatment|Participant withdrew consent|6|||
160972903|NCT02105636|581291073|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
160972904|NCT02105636|581291074|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
161024305|NCT02723591|581479655|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
161024306|NCT02723591|581479654|FG000|Overall Study|Miscellaneous|5|||
161024307|NCT02723591|581479655|FG001|Overall Study|Miscellaneous|6|||
161024308|NCT05070728|581479656|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
161024309|NCT05070728|581479657|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
161024310|NCT04811040|581479658|FG000|Overall Study|Lost to Follow-up|2|||
161024311|NCT04811040|581479659|FG001|Overall Study|Lost to Follow-up|0|||
160588553|NCT02883049|579873124|FG012|Post Induction|Death|1|||
160588554|NCT02883049|579873125|FG013|Post Induction|Death|1|||
160588555|NCT02883049|579873126|FG014|Post Induction|Death|10|||
160588556|NCT02883049|579873127|FG015|Post Induction|Death|2|||
160588557|NCT02883049|579873112|FG000|Post Induction|Lost to Follow-up|0|||
160588558|NCT02883049|579873113|FG001|Post Induction|Lost to Follow-up|0|||
160588559|NCT02883049|579873114|FG002|Post Induction|Lost to Follow-up|0|||
160588560|NCT02883049|579873115|FG003|Post Induction|Lost to Follow-up|0|||
160588561|NCT02883049|579873116|FG004|Post Induction|Lost to Follow-up|1|||
160588562|NCT02883049|579873117|FG005|Post Induction|Lost to Follow-up|1|||
160588563|NCT02883049|579873118|FG006|Post Induction|Lost to Follow-up|0|||
160588564|NCT02883049|579873119|FG007|Post Induction|Lost to Follow-up|0|||
160588565|NCT02883049|579873120|FG008|Post Induction|Lost to Follow-up|3|||
160588566|NCT02883049|579873121|FG009|Post Induction|Lost to Follow-up|0|||
160588567|NCT02883049|579873122|FG010|Post Induction|Lost to Follow-up|1|||
160588568|NCT02883049|579873123|FG011|Post Induction|Lost to Follow-up|0|||
160588569|NCT02883049|579873124|FG012|Post Induction|Lost to Follow-up|0|||
160588570|NCT02883049|579873125|FG013|Post Induction|Lost to Follow-up|0|||
160588571|NCT02883049|579873126|FG014|Post Induction|Lost to Follow-up|0|||
160588572|NCT02883049|579873127|FG015|Post Induction|Lost to Follow-up|0|||
160588573|NCT02883049|579873112|FG000|Post Induction|Physician Decision|0|||
160588574|NCT02883049|579873113|FG001|Post Induction|Physician Decision|0|||
160588575|NCT02883049|579873114|FG002|Post Induction|Physician Decision|0|||
160588576|NCT02883049|579873115|FG003|Post Induction|Physician Decision|27|||
160588577|NCT02883049|579873116|FG004|Post Induction|Physician Decision|27|||
160588578|NCT02883049|579873117|FG005|Post Induction|Physician Decision|23|||
160588579|NCT02883049|579873118|FG006|Post Induction|Physician Decision|30|||
160588580|NCT02883049|579873119|FG007|Post Induction|Physician Decision|56|||
161024312|NCT04811040|581479660|FG002|Overall Study|Lost to Follow-up|0|||
161024313|NCT04811040|581479661|FG003|Overall Study|Lost to Follow-up|0|||
161024314|NCT04811040|581479658|FG000|Overall Study|Withdrew consent|1|||
161024315|NCT04811040|581479659|FG001|Overall Study|Withdrew consent|1|||
161024316|NCT04811040|581479660|FG002|Overall Study|Withdrew consent|0|||
161024317|NCT04811040|581479661|FG003|Overall Study|Withdrew consent|0|||
161024318|NCT02151981|581479664|FG000|Overall Study|Death|184|||
161024319|NCT02151981|581479665|FG001|Overall Study|Death|88|||
161024320|NCT02151981|581479664|FG000|Overall Study|Lost to Follow-up|7|||
161024321|NCT02151981|581479665|FG001|Overall Study|Lost to Follow-up|1|||
161024322|NCT02151981|581479664|FG000|Overall Study|Withdrawal by Subject|27|||
161024323|NCT02151981|581479665|FG001|Overall Study|Withdrawal by Subject|21|||
161024324|NCT02151981|581479664|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160588581|NCT02883049|579873120|FG008|Post Induction|Physician Decision|85|||
160588582|NCT02883049|579873121|FG009|Post Induction|Physician Decision|12|||
160588583|NCT02883049|579873122|FG010|Post Induction|Physician Decision|5|||
160588584|NCT02883049|579873123|FG011|Post Induction|Physician Decision|14|||
160588585|NCT02883049|579873124|FG012|Post Induction|Physician Decision|1|||
160588586|NCT02883049|579873125|FG013|Post Induction|Physician Decision|11|||
160588587|NCT02883049|579873126|FG014|Post Induction|Physician Decision|19|||
160588588|NCT02883049|579873127|FG015|Post Induction|Physician Decision|5|||
160588589|NCT02883049|579873112|FG000|Post Induction|Protocol Violation|0|||
160588590|NCT02883049|579873113|FG001|Post Induction|Protocol Violation|0|||
160588591|NCT02883049|579873114|FG002|Post Induction|Protocol Violation|0|||
160588592|NCT02883049|579873115|FG003|Post Induction|Protocol Violation|0|||
160588593|NCT02883049|579873116|FG004|Post Induction|Protocol Violation|0|||
160588594|NCT02883049|579873117|FG005|Post Induction|Protocol Violation|0|||
160588595|NCT02883049|579873118|FG006|Post Induction|Protocol Violation|0|||
160588596|NCT02883049|579873119|FG007|Post Induction|Protocol Violation|1|||
160588597|NCT02883049|579873120|FG008|Post Induction|Protocol Violation|0|||
160588598|NCT02883049|579873121|FG009|Post Induction|Protocol Violation|0|||
160588599|NCT02883049|579873122|FG010|Post Induction|Protocol Violation|0|||
160588600|NCT02883049|579873123|FG011|Post Induction|Protocol Violation|0|||
161024325|NCT02151981|581479665|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161024326|NCT02151981|581479664|FG000|Overall Study|Other reasons|1|||
161024327|NCT02151981|581479665|FG001|Overall Study|Other reasons|2|||
161024328|NCT05934942|581479671|FG000|Run-in Period|Not treated|1|||
160588601|NCT02883049|579873124|FG012|Post Induction|Protocol Violation|0|||
160588602|NCT02883049|579873125|FG013|Post Induction|Protocol Violation|0|||
160588603|NCT02883049|579873126|FG014|Post Induction|Protocol Violation|0|||
160588604|NCT02883049|579873127|FG015|Post Induction|Protocol Violation|0|||
160588605|NCT02883049|579873112|FG000|Post Induction|Withdrawal by Subject|0|||
160588606|NCT02883049|579873113|FG001|Post Induction|Withdrawal by Subject|0|||
160588607|NCT02883049|579873114|FG002|Post Induction|Withdrawal by Subject|0|||
160588608|NCT02883049|579873115|FG003|Post Induction|Withdrawal by Subject|5|||
160588609|NCT02883049|579873116|FG004|Post Induction|Withdrawal by Subject|2|||
160588610|NCT02883049|579873117|FG005|Post Induction|Withdrawal by Subject|1|||
160588611|NCT02883049|579873118|FG006|Post Induction|Withdrawal by Subject|0|||
160588612|NCT02883049|579873119|FG007|Post Induction|Withdrawal by Subject|0|||
160588613|NCT02883049|579873120|FG008|Post Induction|Withdrawal by Subject|2|||
160588614|NCT02883049|579873121|FG009|Post Induction|Withdrawal by Subject|0|||
160588615|NCT02883049|579873122|FG010|Post Induction|Withdrawal by Subject|1|||
160588616|NCT02883049|579873123|FG011|Post Induction|Withdrawal by Subject|1|||
160588617|NCT02883049|579873124|FG012|Post Induction|Withdrawal by Subject|0|||
160588618|NCT02883049|579873125|FG013|Post Induction|Withdrawal by Subject|0|||
160588619|NCT02883049|579873126|FG014|Post Induction|Withdrawal by Subject|1|||
160588620|NCT02883049|579873127|FG015|Post Induction|Withdrawal by Subject|0|||
160588621|NCT02883049|579873112|FG000|Post Induction|Ineligible|0|||
160588622|NCT02883049|579873113|FG001|Post Induction|Ineligible|0|||
160588623|NCT02883049|579873114|FG002|Post Induction|Ineligible|2|||
160588624|NCT02883049|579873115|FG003|Post Induction|Ineligible|0|||
160588625|NCT02883049|579873116|FG004|Post Induction|Ineligible|0|||
160588626|NCT02883049|579873117|FG005|Post Induction|Ineligible|0|||
160588627|NCT02883049|579873118|FG006|Post Induction|Ineligible|1|||
160588628|NCT02883049|579873119|FG007|Post Induction|Ineligible|0|||
160588629|NCT02883049|579873120|FG008|Post Induction|Ineligible|0|||
160588630|NCT02883049|579873121|FG009|Post Induction|Ineligible|0|||
160588631|NCT02883049|579873122|FG010|Post Induction|Ineligible|1|||
160588632|NCT02883049|579873123|FG011|Post Induction|Ineligible|0|||
160588633|NCT02883049|579873124|FG012|Post Induction|Ineligible|0|||
160588634|NCT02883049|579873125|FG013|Post Induction|Ineligible|0|||
160588635|NCT02883049|579873126|FG014|Post Induction|Ineligible|0|||
160588636|NCT02883049|579873127|FG015|Post Induction|Ineligible|1|||
160588637|NCT02883049|579873112|FG000|Post Induction|Refusal of further protocol therapy|0|||
160588638|NCT02883049|579873113|FG001|Post Induction|Refusal of further protocol therapy|0|||
160588639|NCT02883049|579873114|FG002|Post Induction|Refusal of further protocol therapy|0|||
160588640|NCT02883049|579873115|FG003|Post Induction|Refusal of further protocol therapy|11|||
160588641|NCT02883049|579873116|FG004|Post Induction|Refusal of further protocol therapy|15|||
160972905|NCT02105636|581291073|FG000|Treatment|Study Drug Toxicity|14|||
160972906|NCT02105636|581291074|FG001|Treatment|Study Drug Toxicity|10|||
160972907|NCT02105636|581291073|FG000|Treatment|Adverse event unrelated to study drug|19|||
160972908|NCT02105636|581291074|FG001|Treatment|Adverse event unrelated to study drug|3|||
160972909|NCT02105636|581291073|FG000|Treatment|Participant request to discontinue study treatment|8|||
160972910|NCT02105636|581291074|FG001|Treatment|Participant request to discontinue study treatment|6|||
160972911|NCT02105636|581291073|FG000|Treatment|Participant withdrew consent|5|||
160972912|NCT02105636|581291074|FG001|Treatment|Participant withdrew consent|1|||
160972913|NCT02105636|581291073|FG000|Treatment|Lost to Follow-up|1|||
160972914|NCT02105636|581291074|FG001|Treatment|Lost to Follow-up|0|||
160972915|NCT02105636|581291073|FG000|Treatment|Maximum Clinical Benefit|1|||
160972916|NCT02105636|581291074|FG001|Treatment|Maximum Clinical Benefit|3|||
160972917|NCT02105636|581291073|FG000|Treatment|Poor/Non-compliance|0|||
160972918|NCT02105636|581291074|FG001|Treatment|Poor/Non-compliance|1|||
160972919|NCT02105636|581291073|FG000|Treatment|Participant no longer meets study criteria|1|||
160972920|NCT02105636|581291074|FG001|Treatment|Participant no longer meets study criteria|0|||
160972921|NCT02105636|581291073|FG000|Treatment|Other reasons|1|||
160972922|NCT02105636|581291074|FG001|Treatment|Other reasons|0|||
160972923|NCT02105636|581291073|FG000|Treatment|Disease Progression|185|||
160972924|NCT02105636|581291074|FG001|Treatment|Disease Progression|87|||
160972925|NCT00720902|581291075|FG000|Overall Study|Withdrawal by Subject|1|||
160972926|NCT00720902|581291076|FG001|Overall Study|Withdrawal by Subject|0|||
160972927|NCT00720902|581291075|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
160972928|NCT00720902|581291076|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
160972929|NCT01993017|581291078|FG000|Overall Study|Death|23|||
160972930|NCT01993017|581291079|FG001|Overall Study|Death|26|||
160972931|NCT01993017|581291080|FG002|Overall Study|Death|18|||
160972932|NCT01993017|581291078|FG000|Overall Study|Could not be contacted|43|||
160972933|NCT01993017|581291079|FG001|Overall Study|Could not be contacted|42|||
160972934|NCT01993017|581291080|FG002|Overall Study|Could not be contacted|38|||
160972935|NCT01993017|581291078|FG000|Overall Study|Dropped out|19|||
160972936|NCT01993017|581291079|FG001|Overall Study|Dropped out|6|||
160972937|NCT01993017|581291080|FG002|Overall Study|Dropped out|11|||
160972938|NCT01993017|581291078|FG000|Overall Study|Other reasons|17|||
160972939|NCT01993017|581291079|FG001|Overall Study|Other reasons|11|||
160972940|NCT01993017|581291080|FG002|Overall Study|Other reasons|7|||
160972941|NCT01993017|581291078|FG000|Overall Study|Ineligible after randomization|4|||
160972942|NCT01993017|581291079|FG001|Overall Study|Ineligible after randomization|5|||
160972943|NCT01993017|581291080|FG002|Overall Study|Ineligible after randomization|5|||
160972944|NCT00003511|581291081|FG000|Overall Study|Not evaluable|4|||
160972945|NCT03638635|581291082|FG000|Initial Hospitalization|Study terminated prematurely|0|||
160972946|NCT03638635|581291083|FG001|Initial Hospitalization|Study terminated prematurely|1|||
160972947|NCT03638635|581291082|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
160972948|NCT03638635|581291083|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
160588642|NCT02883049|579873117|FG005|Post Induction|Refusal of further protocol therapy|9|||
160588643|NCT02883049|579873118|FG006|Post Induction|Refusal of further protocol therapy|13|||
160588644|NCT02883049|579873119|FG007|Post Induction|Refusal of further protocol therapy|5|||
160588645|NCT02883049|579873120|FG008|Post Induction|Refusal of further protocol therapy|21|||
160588646|NCT02883049|579873121|FG009|Post Induction|Refusal of further protocol therapy|7|||
160588647|NCT02883049|579873122|FG010|Post Induction|Refusal of further protocol therapy|0|||
160588648|NCT02883049|579873123|FG011|Post Induction|Refusal of further protocol therapy|7|||
160588649|NCT02883049|579873124|FG012|Post Induction|Refusal of further protocol therapy|3|||
160588650|NCT02883049|579873125|FG013|Post Induction|Refusal of further protocol therapy|0|||
160588651|NCT02883049|579873126|FG014|Post Induction|Refusal of further protocol therapy|4|||
160588652|NCT02883049|579873127|FG015|Post Induction|Refusal of further protocol therapy|1|||
160588653|NCT02883049|579873112|FG000|Post Induction|Inevaluable|0|||
160588654|NCT02883049|579873113|FG001|Post Induction|Inevaluable|0|||
160588655|NCT02883049|579873114|FG002|Post Induction|Inevaluable|0|||
160588656|NCT02883049|579873115|FG003|Post Induction|Inevaluable|1|||
160588657|NCT02883049|579873116|FG004|Post Induction|Inevaluable|1|||
160588658|NCT02883049|579873117|FG005|Post Induction|Inevaluable|2|||
160588659|NCT02883049|579873118|FG006|Post Induction|Inevaluable|7|||
160588660|NCT02883049|579873119|FG007|Post Induction|Inevaluable|6|||
160588661|NCT02883049|579873120|FG008|Post Induction|Inevaluable|4|||
160588662|NCT02883049|579873121|FG009|Post Induction|Inevaluable|4|||
160588663|NCT02883049|579873122|FG010|Post Induction|Inevaluable|1|||
160588664|NCT02883049|579873123|FG011|Post Induction|Inevaluable|1|||
160588665|NCT02883049|579873124|FG012|Post Induction|Inevaluable|2|||
160588666|NCT02883049|579873125|FG013|Post Induction|Inevaluable|0|||
160588667|NCT02883049|579873126|FG014|Post Induction|Inevaluable|0|||
160588668|NCT02883049|579873127|FG015|Post Induction|Inevaluable|1|||
160588669|NCT02883049|579873112|FG000|Post Induction|Moved to another non-COG institution|0|||
160588670|NCT02883049|579873113|FG001|Post Induction|Moved to another non-COG institution|0|||
160588671|NCT02883049|579873114|FG002|Post Induction|Moved to another non-COG institution|0|||
160588672|NCT02883049|579873115|FG003|Post Induction|Moved to another non-COG institution|0|||
160588673|NCT02883049|579873116|FG004|Post Induction|Moved to another non-COG institution|0|||
160588674|NCT02883049|579873117|FG005|Post Induction|Moved to another non-COG institution|0|||
160588675|NCT02883049|579873118|FG006|Post Induction|Moved to another non-COG institution|0|||
160588676|NCT02883049|579873119|FG007|Post Induction|Moved to another non-COG institution|2|||
160588677|NCT02883049|579873120|FG008|Post Induction|Moved to another non-COG institution|2|||
160588678|NCT02883049|579873121|FG009|Post Induction|Moved to another non-COG institution|0|||
160588679|NCT02883049|579873122|FG010|Post Induction|Moved to another non-COG institution|0|||
160588680|NCT02883049|579873123|FG011|Post Induction|Moved to another non-COG institution|1|||
160588681|NCT02883049|579873124|FG012|Post Induction|Moved to another non-COG institution|0|||
161024329|NCT05934942|581479671|FG000|Run-in Period|Withdrawal by Subject|1|||
161024330|NCT05645757|581479686|FG000|Overall Study|Enrolled but treatment not administered|0|||
161024331|NCT05645757|581479687|FG001|Overall Study|Enrolled but treatment not administered|0|||
161024332|NCT05645757|581479688|FG002|Overall Study|Enrolled but treatment not administered|0|||
161024333|NCT05645757|581479689|FG003|Overall Study|Enrolled but treatment not administered|0|||
161024334|NCT05645757|581479690|FG004|Overall Study|Enrolled but treatment not administered|1|||
161024335|NCT05645757|581479691|FG005|Overall Study|Enrolled but treatment not administered|1|||
161024336|NCT05645757|581479692|FG006|Overall Study|Enrolled but treatment not administered|0|||
161024337|NCT05645757|581479693|FG007|Overall Study|Enrolled but treatment not administered|0|||
161024338|NCT04568434|581479698|FG000|Overall Study|Voluntary Withdrawal|0|||
161024339|NCT04568434|581479699|FG001|Overall Study|Voluntary Withdrawal|1|||
161024340|NCT04568434|581479700|FG002|Overall Study|Voluntary Withdrawal|1|||
161024341|NCT04568434|581479698|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
161024342|NCT04568434|581479699|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
161024343|NCT04568434|581479700|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
161024344|NCT04568434|581479698|FG000|Overall Study|Investigator Judgement|1|||
161024345|NCT04568434|581479699|FG001|Overall Study|Investigator Judgement|0|||
161024346|NCT04568434|581479700|FG002|Overall Study|Investigator Judgement|0|||
161024347|NCT05469464|581479701|FG000|Overall Study|Withdrawal by Subject|8|||
161024348|NCT05469464|581479702|FG001|Overall Study|Withdrawal by Subject|7|||
161024349|NCT05469464|581479703|FG002|Overall Study|Withdrawal by Subject|4|||
160588682|NCT02883049|579873125|FG013|Post Induction|Moved to another non-COG institution|0|||
160588683|NCT02883049|579873126|FG014|Post Induction|Moved to another non-COG institution|0|||
160588684|NCT02883049|579873127|FG015|Post Induction|Moved to another non-COG institution|0|||
160588685|NCT02883049|579873112|FG000|Post Induction|Randomization closed|0|||
160588686|NCT02883049|579873113|FG001|Post Induction|Randomization closed|0|||
161024350|NCT05469464|581479704|FG003|Overall Study|Withdrawal by Subject|5|||
161024351|NCT05469464|581479701|FG000|Overall Study|Adverse Event|8|||
161024352|NCT05469464|581479702|FG001|Overall Study|Adverse Event|14|||
161024353|NCT05469464|581479703|FG002|Overall Study|Adverse Event|13|||
161024354|NCT05469464|581479704|FG003|Overall Study|Adverse Event|2|||
160588687|NCT02883049|579873114|FG002|Post Induction|Randomization closed|0|||
160588688|NCT02883049|579873115|FG003|Post Induction|Randomization closed|0|||
160588689|NCT02883049|579873116|FG004|Post Induction|Randomization closed|0|||
160588690|NCT02883049|579873117|FG005|Post Induction|Randomization closed|0|||
160588691|NCT02883049|579873118|FG006|Post Induction|Randomization closed|0|||
160588692|NCT02883049|579873119|FG007|Post Induction|Randomization closed|20|||
160588693|NCT02883049|579873120|FG008|Post Induction|Randomization closed|0|||
160588694|NCT02883049|579873121|FG009|Post Induction|Randomization closed|0|||
160588695|NCT02883049|579873122|FG010|Post Induction|Randomization closed|0|||
160588696|NCT02883049|579873123|FG011|Post Induction|Randomization closed|0|||
160588697|NCT02883049|579873124|FG012|Post Induction|Randomization closed|0|||
160588698|NCT02883049|579873125|FG013|Post Induction|Randomization closed|0|||
160588699|NCT02883049|579873126|FG014|Post Induction|Randomization closed|0|||
160588700|NCT02883049|579873127|FG015|Post Induction|Randomization closed|0|||
160588701|NCT02883049|579873112|FG000|Post Induction|MRD negative|0|||
160588702|NCT02883049|579873113|FG001|Post Induction|MRD negative|0|||
160588703|NCT02883049|579873114|FG002|Post Induction|MRD negative|0|||
160588704|NCT02883049|579873115|FG003|Post Induction|MRD negative|0|||
160588705|NCT02883049|579873116|FG004|Post Induction|MRD negative|0|||
160588706|NCT02883049|579873117|FG005|Post Induction|MRD negative|0|||
160588707|NCT02883049|579873118|FG006|Post Induction|MRD negative|0|||
160588708|NCT02883049|579873119|FG007|Post Induction|MRD negative|11|||
160588709|NCT02883049|579873120|FG008|Post Induction|MRD negative|0|||
160588710|NCT02883049|579873121|FG009|Post Induction|MRD negative|0|||
160588711|NCT02883049|579873122|FG010|Post Induction|MRD negative|0|||
160588712|NCT02883049|579873123|FG011|Post Induction|MRD negative|0|||
160588713|NCT02883049|579873124|FG012|Post Induction|MRD negative|0|||
160588714|NCT02883049|579873125|FG013|Post Induction|MRD negative|0|||
160588715|NCT02883049|579873126|FG014|Post Induction|MRD negative|0|||
160588716|NCT02883049|579873127|FG015|Post Induction|MRD negative|0|||
160588717|NCT02883049|579873112|FG000|Post Induction|Developed SMN|0|||
160588718|NCT02883049|579873113|FG001|Post Induction|Developed SMN|0|||
160588719|NCT02883049|579873114|FG002|Post Induction|Developed SMN|0|||
160588720|NCT02883049|579873115|FG003|Post Induction|Developed SMN|0|||
160588721|NCT02883049|579873116|FG004|Post Induction|Developed SMN|1|||
160588722|NCT02883049|579873117|FG005|Post Induction|Developed SMN|0|||
160588723|NCT02883049|579873118|FG006|Post Induction|Developed SMN|1|||
160588724|NCT02883049|579873119|FG007|Post Induction|Developed SMN|0|||
160588725|NCT02883049|579873120|FG008|Post Induction|Developed SMN|0|||
160588726|NCT02883049|579873121|FG009|Post Induction|Developed SMN|0|||
160588727|NCT02883049|579873122|FG010|Post Induction|Developed SMN|1|||
160588728|NCT02883049|579873123|FG011|Post Induction|Developed SMN|1|||
160588729|NCT02883049|579873124|FG012|Post Induction|Developed SMN|0|||
160588730|NCT02883049|579873125|FG013|Post Induction|Developed SMN|0|||
160588731|NCT02883049|579873126|FG014|Post Induction|Developed SMN|1|||
160588732|NCT02883049|579873127|FG015|Post Induction|Developed SMN|0|||
160588733|NCT02883049|579873112|FG000|Post Induction|Enrolled onto another COG study|0|||
160588734|NCT02883049|579873113|FG001|Post Induction|Enrolled onto another COG study|0|||
160588735|NCT02883049|579873114|FG002|Post Induction|Enrolled onto another COG study|0|||
160588736|NCT02883049|579873115|FG003|Post Induction|Enrolled onto another COG study|1|||
160588737|NCT02883049|579873116|FG004|Post Induction|Enrolled onto another COG study|1|||
160588738|NCT02883049|579873117|FG005|Post Induction|Enrolled onto another COG study|0|||
160657361|NCT02848326|580127502|FG000|Treatment Period|Withdrawal of Consent|20|||
160657362|NCT02848326|580127503|FG001|Treatment Period|Withdrawal of Consent|6|||
160588739|NCT02883049|579873118|FG006|Post Induction|Enrolled onto another COG study|0|||
160588740|NCT02883049|579873119|FG007|Post Induction|Enrolled onto another COG study|4|||
160588741|NCT02883049|579873120|FG008|Post Induction|Enrolled onto another COG study|0|||
160588742|NCT02883049|579873121|FG009|Post Induction|Enrolled onto another COG study|0|||
160588743|NCT02883049|579873122|FG010|Post Induction|Enrolled onto another COG study|0|||
160588744|NCT02883049|579873123|FG011|Post Induction|Enrolled onto another COG study|2|||
160588745|NCT02883049|579873124|FG012|Post Induction|Enrolled onto another COG study|0|||
160588746|NCT02883049|579873125|FG013|Post Induction|Enrolled onto another COG study|1|||
160588747|NCT02883049|579873126|FG014|Post Induction|Enrolled onto another COG study|0|||
160657363|NCT02848326|580127504|FG002|Treatment Period|Withdrawal of Consent|9|||
160657364|NCT02848326|580127505|FG003|Treatment Period|Withdrawal of Consent|6|||
160657365|NCT02848326|580127506|FG004|Treatment Period|Withdrawal of Consent|9|||
160588748|NCT02883049|579873127|FG015|Post Induction|Enrolled onto another COG study|0|||
160588749|NCT02883049|579873112|FG000|Post Induction|Recurrent leukemia|0|||
160588750|NCT02883049|579873113|FG001|Post Induction|Recurrent leukemia|0|||
160588751|NCT02883049|579873114|FG002|Post Induction|Recurrent leukemia|0|||
160588752|NCT02883049|579873115|FG003|Post Induction|Recurrent leukemia|17|||
160588753|NCT02883049|579873116|FG004|Post Induction|Recurrent leukemia|12|||
160588754|NCT02883049|579873117|FG005|Post Induction|Recurrent leukemia|4|||
160588755|NCT02883049|579873118|FG006|Post Induction|Recurrent leukemia|1|||
160588756|NCT02883049|579873119|FG007|Post Induction|Recurrent leukemia|13|||
160588757|NCT02883049|579873120|FG008|Post Induction|Recurrent leukemia|27|||
160588758|NCT02883049|579873121|FG009|Post Induction|Recurrent leukemia|5|||
161024355|NCT05469464|581479701|FG000|Overall Study|Lost to Follow-up|2|||
161024356|NCT05469464|581479702|FG001|Overall Study|Lost to Follow-up|5|||
161024357|NCT05469464|581479703|FG002|Overall Study|Lost to Follow-up|3|||
161024358|NCT05469464|581479704|FG003|Overall Study|Lost to Follow-up|3|||
161024359|NCT05469464|581479701|FG000|Overall Study|Lack of Efficacy|4|||
161024360|NCT05469464|581479702|FG001|Overall Study|Lack of Efficacy|1|||
161024361|NCT05469464|581479703|FG002|Overall Study|Lack of Efficacy|2|||
161024362|NCT05469464|581479704|FG003|Overall Study|Lack of Efficacy|2|||
161024363|NCT05469464|581479701|FG000|Overall Study|Physician Decision|0|||
161024364|NCT05469464|581479702|FG001|Overall Study|Physician Decision|0|||
161024365|NCT05469464|581479703|FG002|Overall Study|Physician Decision|0|||
161024366|NCT05469464|581479704|FG003|Overall Study|Physician Decision|1|||
161024367|NCT03905798|581479705|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
161024368|NCT05374798|581479708|FG000|Overall Study|Lost to Follow-up|2|||
161024369|NCT05374798|581479708|FG000|Overall Study|Withdrawal by Subject|2|||
161024370|NCT05374798|581479708|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
161024371|NCT03463044|581479709|FG000|Overall Study|Lost to Follow-up|0|||
161024372|NCT03463044|581479710|FG001|Overall Study|Lost to Follow-up|0|||
161024373|NCT03463044|581479711|FG002|Overall Study|Lost to Follow-up|0|||
161024374|NCT03463044|581479712|FG003|Overall Study|Lost to Follow-up|0|||
161024375|NCT03463044|581479713|FG004|Overall Study|Lost to Follow-up|0|||
161024376|NCT03463044|581479714|FG005|Overall Study|Lost to Follow-up|0|||
161024377|NCT03463044|581479715|FG006|Overall Study|Lost to Follow-up|0|||
161024378|NCT03463044|581479716|FG007|Overall Study|Lost to Follow-up|1|||
161024379|NCT03463044|581479717|FG008|Overall Study|Lost to Follow-up|0|||
161024380|NCT03334630|581479718|FG000|Overall Study|Withdrawal by Subject|7|||
161024381|NCT03334630|581479719|FG001|Overall Study|Withdrawal by Subject|7|||
161024382|NCT03334630|581479718|FG000|Overall Study|Lost to Follow-up|3|||
161024383|NCT03334630|581479719|FG001|Overall Study|Lost to Follow-up|1|||
161024384|NCT03334630|581479718|FG000|Overall Study|Adverse Event|0|||
161024385|NCT03334630|581479719|FG001|Overall Study|Adverse Event|1|||
161024386|NCT03334630|581479718|FG000|Overall Study|Physician Decision|1|||
161024387|NCT03334630|581479719|FG001|Overall Study|Physician Decision|1|||
161024388|NCT03334630|581479718|FG000|Overall Study|Enrollment closed|2|||
161024389|NCT03334630|581479719|FG001|Overall Study|Enrollment closed|1|||
161024390|NCT03334630|581479718|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
161024391|NCT03334630|581479719|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
161024392|NCT03334630|581479718|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
161024393|NCT03334630|581479719|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
161024394|NCT03759379|581483634|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
161024395|NCT03759379|581483635|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
161024396|NCT03759379|581483634|FG000|Treatment Period|Death|2|||
161024397|NCT03759379|581483635|FG001|Treatment Period|Death|3|||
161024398|NCT03759379|581483634|FG000|Treatment Period|Lost to Follow-up|1|||
161024399|NCT03759379|581483635|FG001|Treatment Period|Lost to Follow-up|0|||
161024400|NCT03759379|581483634|FG000|Treatment Period|Physician Decision|0|||
161024401|NCT03759379|581483635|FG001|Treatment Period|Physician Decision|1|||
161024402|NCT04924608|581483636|FG000|Overall Study|Adverse Event|10|||
161024403|NCT04924608|581483637|FG001|Overall Study|Adverse Event|6|||
161024404|NCT04924608|581483636|FG000|Overall Study|Lost to Follow-up|1|||
161024405|NCT04924608|581483637|FG001|Overall Study|Lost to Follow-up|1|||
161024406|NCT04924608|581483636|FG000|Overall Study|Ongoing at the data cut-off date|54|||
161024407|NCT04924608|581483637|FG001|Overall Study|Ongoing at the data cut-off date|60|||
161024408|NCT04924608|581483636|FG000|Overall Study|Progressive Disease|2|||
161024409|NCT04924608|581483637|FG001|Overall Study|Progressive Disease|0|||
161024410|NCT04924608|581483636|FG000|Overall Study|Withdrawal by Subject|3|||
161024411|NCT04924608|581483637|FG001|Overall Study|Withdrawal by Subject|6|||
160588759|NCT02883049|579873122|FG010|Post Induction|Recurrent leukemia|3|||
160588760|NCT02883049|579873123|FG011|Post Induction|Recurrent leukemia|12|||
160588761|NCT02883049|579873124|FG012|Post Induction|Recurrent leukemia|1|||
160588762|NCT02883049|579873125|FG013|Post Induction|Recurrent leukemia|1|||
160588763|NCT02883049|579873126|FG014|Post Induction|Recurrent leukemia|9|||
160588764|NCT02883049|579873127|FG015|Post Induction|Recurrent leukemia|3|||
160588765|NCT02883049|579873112|FG000|Post Induction|Induction Failure|0|||
161024412|NCT04924608|581483636|FG000|Overall Study|Other reason|1|||
161024413|NCT04924608|581483637|FG001|Overall Study|Other reason|1|||
161024414|NCT05199571|581483638|FG000|Treatment period|Participant decision|3|||
161024415|NCT05199571|581483638|FG000|Treatment period|Physician Decision|1|||
161024416|NCT05199571|581483638|FG000|Post-treatment follow up period|Participant decision|3|||
161024417|NCT02892344|581483639|FG000|Overall Study|Protocol deviation|3|||
161024418|NCT02892344|581483640|FG001|Overall Study|Protocol deviation|4|||
161024419|NCT02892344|581483639|FG000|Overall Study|Adverse Event|1|||
161024420|NCT02892344|581483640|FG001|Overall Study|Adverse Event|8|||
161024421|NCT02892344|581483639|FG000|Overall Study|Lost to Follow-up|0|||
161024422|NCT02892344|581483640|FG001|Overall Study|Lost to Follow-up|1|||
161024423|NCT02892344|581483639|FG000|Overall Study|Non-compliance with study treatment|0|||
160588766|NCT02883049|579873113|FG001|Post Induction|Induction Failure|0|||
161024424|NCT02892344|581483640|FG001|Overall Study|Non-compliance with study treatment|1|||
161024425|NCT02892344|581483639|FG000|Overall Study|Physician Decision|0|||
161024426|NCT02892344|581483640|FG001|Overall Study|Physician Decision|2|||
161024427|NCT02892344|581483639|FG000|Overall Study|Subject/guardian decision|0|||
161024428|NCT02892344|581483640|FG001|Overall Study|Subject/guardian decision|4|||
161024429|NCT02892344|581483639|FG000|Overall Study|Technical problems|0|||
161024430|NCT02892344|581483640|FG001|Overall Study|Technical problems|1|||
161024431|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Adverse Event|5|||
161024432|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Adverse Event|4|||
161024433|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Adverse Event|2|||
161024434|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Adverse Event|3|||
161024435|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Adverse Event|0|||
161024436|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Adverse Event|0|||
161024437|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Adverse Event|0|||
161024438|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|26|||
161024439|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|35|||
161024440|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|31|||
161024441|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|33|||
161024442|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161024443|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161024444|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161024445|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Lost to Follow-up|5|||
161024446|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
161024447|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Lost to Follow-up|6|||
161024448|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
161024449|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
161024450|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
161024451|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
161024452|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
161024453|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
161024454|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161024455|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161024456|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161024457|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161024458|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
160588767|NCT02883049|579873114|FG002|Post Induction|Induction Failure|0|||
160588768|NCT02883049|579873115|FG003|Post Induction|Induction Failure|0|||
160588769|NCT02883049|579873116|FG004|Post Induction|Induction Failure|0|||
160588770|NCT02883049|579873117|FG005|Post Induction|Induction Failure|0|||
160588771|NCT02883049|579873118|FG006|Post Induction|Induction Failure|0|||
160588772|NCT02883049|579873119|FG007|Post Induction|Induction Failure|2|||
160588773|NCT02883049|579873120|FG008|Post Induction|Induction Failure|2|||
160588774|NCT02883049|579873121|FG009|Post Induction|Induction Failure|0|||
160588775|NCT02883049|579873122|FG010|Post Induction|Induction Failure|0|||
160588776|NCT02883049|579873123|FG011|Post Induction|Induction Failure|0|||
160588777|NCT02883049|579873124|FG012|Post Induction|Induction Failure|0|||
160588778|NCT02883049|579873125|FG013|Post Induction|Induction Failure|2|||
160588779|NCT02883049|579873126|FG014|Post Induction|Induction Failure|0|||
160588780|NCT02883049|579873127|FG015|Post Induction|Induction Failure|0|||
160588781|NCT03421964|579873130|FG000|Overall Study|Lost to Follow-up|11|||
160588782|NCT03421964|579873131|FG001|Overall Study|Lost to Follow-up|21|||
160588783|NCT03421964|579873130|FG000|Overall Study|Withdrawal by Subject|9|||
160588784|NCT03421964|579873131|FG001|Overall Study|Withdrawal by Subject|3|||
160588785|NCT03421964|579873130|FG000|Overall Study|Incarcerated|1|||
160588786|NCT03421964|579873131|FG001|Overall Study|Incarcerated|0|||
160588787|NCT03421964|579873130|FG000|Overall Study|Inpt Treatment Facility|1|||
160588788|NCT03421964|579873131|FG001|Overall Study|Inpt Treatment Facility|1|||
160588789|NCT03421964|579873130|FG000|Overall Study|Virtual Platform Issues|1|||
160588790|NCT03421964|579873131|FG001|Overall Study|Virtual Platform Issues|1|||
160588791|NCT02938585|579873132|FG000|Overall Study|Withdrawal by parent or guardian|0|||
160588792|NCT02938585|579873133|FG001|Overall Study|Withdrawal by parent or guardian|1|||
160588793|NCT02938585|579873134|FG002|Overall Study|Withdrawal by parent or guardian|0|||
160588794|NCT02938585|579873135|FG003|Overall Study|Withdrawal by parent or guardian|0|||
160588795|NCT02938585|579873132|FG000|Overall Study|Withdrawal by Subject|0|||
160588796|NCT02938585|579873133|FG001|Overall Study|Withdrawal by Subject|0|||
160588797|NCT02938585|579873134|FG002|Overall Study|Withdrawal by Subject|0|||
160588798|NCT02938585|579873135|FG003|Overall Study|Withdrawal by Subject|5|||
160588799|NCT02106455|579873143|FG000|Overall Study|Case Report Form Uncollected|6|||
160588800|NCT02106455|579873143|FG000|Overall Study|Protocol Deviation|2|||
160588801|NCT03364608|579873144|FG000|Overall Study|Withdrawal by Subject|4|||
161024459|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
161024460|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Randomized But Not Treated|5|||
160588802|NCT03364608|579873144|FG000|Overall Study|Protocol Violation|2|||
160588803|NCT03364608|579873144|FG000|Overall Study|Lost to Follow-up|2|||
160972949|NCT03638635|581291082|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
161024461|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
161024462|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
161024463|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
161024464|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
161024465|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
161024466|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Other Than Specified|11|||
161024467|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Other Than Specified|5|||
161024468|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Other Than Specified|8|||
161024469|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Other Than Specified|7|||
161024470|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Other Than Specified|0|||
161024471|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Other Than Specified|0|||
161024472|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Other Than Specified|0|||
161024473|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Adverse Event|0|||
160972950|NCT03638635|581291083|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
160972951|NCT03980184|581291085|FG000|Overall Study|Dropped out before treatment|2|||
161024474|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Adverse Event|5|||
161024475|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Adverse Event|6|||
161024476|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Adverse Event|14|||
161024477|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Adverse Event|4|||
161024478|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Adverse Event|1|||
160972952|NCT03980184|581291086|FG001|Overall Study|Dropped out before treatment|2|||
160972953|NCT03980184|581291085|FG000|Overall Study|Lost to Follow-up|11|||
161024479|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Adverse Event|3|||
161024480|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Withdrawal by Subject|0|||
161024481|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Withdrawal by Subject|32|||
161024482|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Withdrawal by Subject|29|||
161024483|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Withdrawal by Subject|39|||
161024484|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Withdrawal by Subject|14|||
161024485|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Withdrawal by Subject|15|||
161024486|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Withdrawal by Subject|8|||
161024487|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Protocol Violation|0|||
161024488|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Protocol Violation|1|||
161024489|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Protocol Violation|1|||
161024490|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Protocol Violation|1|||
161024491|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Protocol Violation|0|||
161024492|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Protocol Violation|0|||
161024493|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Protocol Violation|0|||
161024494|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Lost to Follow-up|0|||
161024495|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
161024496|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Lost to Follow-up|19|||
161024497|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
161024498|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Lost to Follow-up|3|||
161024499|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Lost to Follow-up|5|||
161024500|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Lost to Follow-up|4|||
160972954|NCT03980184|581291086|FG001|Overall Study|Lost to Follow-up|13|||
160972955|NCT01129336|581291092|FG000|Overall Study|Protocol Violation|1|||
160972956|NCT01129336|581291093|FG001|Overall Study|Protocol Violation|0|||
160972957|NCT01129336|581291092|FG000|Overall Study|Disease Progression|1|||
160972958|NCT01129336|581291093|FG001|Overall Study|Disease Progression|4|||
160972959|NCT01129336|581291092|FG000|Overall Study|Lost to Follow-up|1|||
160972960|NCT01129336|581291093|FG001|Overall Study|Lost to Follow-up|0|||
160972961|NCT01129336|581291092|FG000|Overall Study|Withdrawal by Subject|7|||
160972962|NCT01129336|581291093|FG001|Overall Study|Withdrawal by Subject|4|||
160972963|NCT01129336|581291092|FG000|Overall Study|Adverse Event|0|||
160972964|NCT01129336|581291093|FG001|Overall Study|Adverse Event|1|||
160972965|NCT01129336|581291092|FG000|Overall Study|Missing Study Completion Status|2|||
160972966|NCT01129336|581291093|FG001|Overall Study|Missing Study Completion Status|3|||
160972967|NCT01129336|581291092|FG000|Overall Study|Death|0|||
160972968|NCT01129336|581291093|FG001|Overall Study|Death|4|||
160972969|NCT00467142|581291096|FG000|Overall Study|Withdrawal by Subject|1|||
160972970|NCT00467142|581291096|FG000|Overall Study|Adverse Event|1|||
160972971|NCT00467142|581291096|FG000|Overall Study|Protocol Violation|1|||
161024501|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
161024502|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
161024503|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
161024504|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
161024505|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
161024506|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
161024507|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
161024508|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024509|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024510|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Randomized But Not Treated|1|||
161024511|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024512|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024513|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024514|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024515|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Other Than Specified|0|||
161024516|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Other Than Specified|12|||
161024517|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Other Than Specified|9|||
161024518|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Other Than Specified|10|||
161024519|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Other Than Specified|4|||
161024520|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Other Than Specified|3|||
161024521|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Other Than Specified|4|||
161024522|NCT03938454|581483648|FG000|Overall Study|Protocol Violation|1|||
161024523|NCT03938454|581483648|FG000|Overall Study|Withdrawal by Subject|2|||
161024524|NCT03938454|581483648|FG000|Overall Study|Lost to Follow-up|3|||
161024525|NCT04441905|581483649|FG000|Overall Study|Lost to Follow-up|1|||
161024526|NCT04441905|581483650|FG001|Overall Study|Lost to Follow-up|0|||
161024527|NCT04441905|581483651|FG002|Overall Study|Lost to Follow-up|0|||
161024528|NCT04441905|581483652|FG003|Overall Study|Lost to Follow-up|0|||
161024529|NCT04441905|581483653|FG004|Overall Study|Lost to Follow-up|0|||
161024530|NCT04441905|581483654|FG005|Overall Study|Lost to Follow-up|0|||
161024531|NCT04441905|581483649|FG000|Overall Study|Enrolled but treatment not administered|0|||
161024532|NCT04441905|581483650|FG001|Overall Study|Enrolled but treatment not administered|1|||
161024533|NCT04441905|581483651|FG002|Overall Study|Enrolled but treatment not administered|0|||
161024534|NCT04441905|581483652|FG003|Overall Study|Enrolled but treatment not administered|0|||
161024535|NCT04441905|581483653|FG004|Overall Study|Enrolled but treatment not administered|0|||
161024536|NCT04441905|581483654|FG005|Overall Study|Enrolled but treatment not administered|0|||
161024537|NCT04441905|581483649|FG000|Overall Study|Became ineligible after enrollment|0|||
161024538|NCT04441905|581483650|FG001|Overall Study|Became ineligible after enrollment|0|||
161024539|NCT04441905|581483651|FG002|Overall Study|Became ineligible after enrollment|0|||
161024540|NCT04441905|581483652|FG003|Overall Study|Became ineligible after enrollment|0|||
161024541|NCT04441905|581483653|FG004|Overall Study|Became ineligible after enrollment|1|||
161024542|NCT04441905|581483654|FG005|Overall Study|Became ineligible after enrollment|0|||
161024543|NCT05415215|581483655|FG000|Neoadjuvant Phase|Adverse Event|0|||
161024544|NCT05415215|581483656|FG001|Neoadjuvant Phase|Adverse Event|8|||
161024545|NCT05415215|581483657|FG002|Neoadjuvant Phase|Adverse Event|0|||
161024546|NCT05415215|581483658|FG003|Neoadjuvant Phase|Adverse Event|0|||
161024547|NCT05415215|581483659|FG004|Neoadjuvant Phase|Adverse Event|0|||
161024548|NCT05415215|581483660|FG005|Neoadjuvant Phase|Adverse Event|0|||
161024549|NCT05415215|581483661|FG006|Neoadjuvant Phase|Adverse Event|0|||
161024550|NCT05415215|581483662|FG007|Neoadjuvant Phase|Adverse Event|0|||
161024551|NCT05415215|581483655|FG000|Neoadjuvant Phase|Death|0|||
161024552|NCT05415215|581483656|FG001|Neoadjuvant Phase|Death|4|||
161024553|NCT05415215|581483657|FG002|Neoadjuvant Phase|Death|0|||
161024554|NCT05415215|581483658|FG003|Neoadjuvant Phase|Death|0|||
161024555|NCT05415215|581483659|FG004|Neoadjuvant Phase|Death|0|||
161024556|NCT05415215|581483660|FG005|Neoadjuvant Phase|Death|0|||
161024557|NCT05415215|581483661|FG006|Neoadjuvant Phase|Death|0|||
161024558|NCT05415215|581483662|FG007|Neoadjuvant Phase|Death|0|||
161024559|NCT05415215|581483655|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
161024560|NCT05415215|581483656|FG001|Neoadjuvant Phase|Withdrawal by Subject|11|||
161024561|NCT05415215|581483657|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
161024562|NCT05415215|581483658|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
161024563|NCT05415215|581483659|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
161024564|NCT05415215|581483660|FG005|Neoadjuvant Phase|Withdrawal by Subject|0|||
161024565|NCT05415215|581483661|FG006|Neoadjuvant Phase|Withdrawal by Subject|0|||
161024566|NCT05415215|581483662|FG007|Neoadjuvant Phase|Withdrawal by Subject|0|||
161024567|NCT05415215|581483655|FG000|Neoadjuvant Phase|Progressive Disease|0|||
161024568|NCT05415215|581483656|FG001|Neoadjuvant Phase|Progressive Disease|2|||
161024569|NCT05415215|581483657|FG002|Neoadjuvant Phase|Progressive Disease|0|||
161024570|NCT05415215|581483658|FG003|Neoadjuvant Phase|Progressive Disease|0|||
161024571|NCT05415215|581483659|FG004|Neoadjuvant Phase|Progressive Disease|0|||
161024572|NCT05415215|581483660|FG005|Neoadjuvant Phase|Progressive Disease|0|||
161024573|NCT05415215|581483661|FG006|Neoadjuvant Phase|Progressive Disease|0|||
161024574|NCT05415215|581483662|FG007|Neoadjuvant Phase|Progressive Disease|0|||
161024575|NCT05415215|581483655|FG000|Neoadjuvant Phase|Reason not Specified|1|||
161024576|NCT05415215|581483656|FG001|Neoadjuvant Phase|Reason not Specified|4|||
161024577|NCT05415215|581483657|FG002|Neoadjuvant Phase|Reason not Specified|0|||
161024578|NCT05415215|581483658|FG003|Neoadjuvant Phase|Reason not Specified|0|||
161024579|NCT05415215|581483659|FG004|Neoadjuvant Phase|Reason not Specified|0|||
161024580|NCT05415215|581483660|FG005|Neoadjuvant Phase|Reason not Specified|0|||
161024581|NCT05415215|581483661|FG006|Neoadjuvant Phase|Reason not Specified|0|||
161024582|NCT05415215|581483662|FG007|Neoadjuvant Phase|Reason not Specified|0|||
161024583|NCT05415215|581483655|FG000|Neoadjuvant Phase|Treatment Intolerance|1|||
160972972|NCT00154310|581291097|FG000|Overall Study|Adverse Event|19|||
161024584|NCT05415215|581483656|FG001|Neoadjuvant Phase|Treatment Intolerance|1|||
161024585|NCT05415215|581483657|FG002|Neoadjuvant Phase|Treatment Intolerance|0|||
161024586|NCT05415215|581483658|FG003|Neoadjuvant Phase|Treatment Intolerance|0|||
161024587|NCT05415215|581483659|FG004|Neoadjuvant Phase|Treatment Intolerance|0|||
161024588|NCT05415215|581483660|FG005|Neoadjuvant Phase|Treatment Intolerance|0|||
161024589|NCT05415215|581483661|FG006|Neoadjuvant Phase|Treatment Intolerance|0|||
161024590|NCT05415215|581483662|FG007|Neoadjuvant Phase|Treatment Intolerance|0|||
161024591|NCT05415215|581483655|FG000|Neoadjuvant Phase|Lost to Follow-up|1|||
161024592|NCT05415215|581483656|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
161024593|NCT05415215|581483657|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
160972973|NCT00154310|581291098|FG001|Overall Study|Adverse Event|9|||
160972974|NCT00154310|581291097|FG000|Overall Study|Lack of Efficacy|5|||
160972975|NCT00154310|581291098|FG001|Overall Study|Lack of Efficacy|4|||
160972976|NCT00154310|581291097|FG000|Overall Study|Protocol Violation|4|||
160972977|NCT00154310|581291098|FG001|Overall Study|Protocol Violation|2|||
160972978|NCT00154310|581291097|FG000|Overall Study|Withdrawal by Subject|9|||
160972979|NCT00154310|581291098|FG001|Overall Study|Withdrawal by Subject|3|||
160972980|NCT00154310|581291097|FG000|Overall Study|Lost to Follow-up|0|||
160972981|NCT00154310|581291098|FG001|Overall Study|Lost to Follow-up|8|||
160972982|NCT00154310|581291097|FG000|Overall Study|Administrative problems|0|||
160972983|NCT00154310|581291098|FG001|Overall Study|Administrative problems|1|||
160972984|NCT00154310|581291097|FG000|Overall Study|Death|0|||
160972985|NCT00154310|581291098|FG001|Overall Study|Death|1|||
160972986|NCT02086162|581291100|FG000|Overall Study|Withdrawal by Subject|4|||
160972987|NCT02086162|581291101|FG001|Overall Study|Withdrawal by Subject|4|||
160972988|NCT02086162|581291100|FG000|Overall Study|moved|1|||
160972989|NCT02086162|581291101|FG001|Overall Study|moved|1|||
160972990|NCT02086162|581291100|FG000|Overall Study|Lost to Follow-up|4|||
160972991|NCT02086162|581291101|FG001|Overall Study|Lost to Follow-up|2|||
160972992|NCT02086162|581291100|FG000|Overall Study|Death|1|||
160972993|NCT02086162|581291101|FG001|Overall Study|Death|0|||
160972994|NCT03447730|581291102|FG000|Overall Study|Adverse Event|0|||
160972995|NCT03447730|581291103|FG001|Overall Study|Adverse Event|2|||
160972996|NCT03447730|581291104|FG002|Overall Study|Adverse Event|0|||
160972997|NCT01248962|581291108|FG000|Overall Study|Withdrawal by Subject|1|||
160972998|NCT01248962|581291109|FG001|Overall Study|Withdrawal by Subject|1|||
160972999|NCT01248962|581291108|FG000|Overall Study|Adverse Event|2|||
160973000|NCT01248962|581291109|FG001|Overall Study|Adverse Event|1|||
160973001|NCT01248962|581291108|FG000|Overall Study|Complete Response after 4 Cycles|1|||
160973002|NCT01248962|581291109|FG001|Overall Study|Complete Response after 4 Cycles|0|||
160973003|NCT01248962|581291108|FG000|Overall Study|Complete Response after 3 Cycles|0|||
160973004|NCT01248962|581291109|FG001|Overall Study|Complete Response after 3 Cycles|1|||
160973005|NCT01248962|581291108|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
160973006|NCT01248962|581291109|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
160973007|NCT01827254|581291111|FG000|Overall Study|Death|10|||
160973008|NCT01827254|581291111|FG000|Overall Study|Case report form not completed|4|||
160973009|NCT01827254|581291111|FG000|Overall Study|Invalidated centre|3|||
160973010|NCT01827254|581291111|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
160973011|NCT01827254|581291111|FG000|Overall Study|Did not complete re-challenge|1|||
160973012|NCT01827254|581291111|FG000|Overall Study|Disease progression|36|||
160973013|NCT01827254|581291111|FG000|Overall Study|Intolerance to treatment|4|||
160973014|NCT01350505|581291112|FG000|Overall Study|Lost to Follow-up|4|||
160973015|NCT01834222|581291113|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
160973016|NCT04702568|581291114|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
160973017|NCT04702568|581291115|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
160973018|NCT04702568|581291114|FG000|Overall Study|Pregnancy|1|||
160973019|NCT04702568|581291115|FG001|Overall Study|Pregnancy|0|||
160973020|NCT04702568|581291114|FG000|Overall Study|Bone marrow transplant|1|||
160973021|NCT04702568|581291115|FG001|Overall Study|Bone marrow transplant|0|||
160973022|NCT04702568|581291114|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
160973023|NCT04702568|581291115|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
160973024|NCT04702568|581291114|FG000|Overall Study|Withdrawal by Subject|0|||
160973025|NCT04702568|581291115|FG001|Overall Study|Withdrawal by Subject|2|||
160973026|NCT00423852|581291118|FG000|Overall Study|Removed pior to the high-dose portion|3|||
160973027|NCT04145037|581291121|FG000|Overall Study|Study terminated|2|||
160973028|NCT04145037|581291122|FG001|Overall Study|Study terminated|0|||
160973029|NCT04145037|581291121|FG000|Overall Study|Withdrawal by Subject|1|||
160973030|NCT04145037|581291122|FG001|Overall Study|Withdrawal by Subject|0|||
160973031|NCT04145037|581291121|FG000|Overall Study|Lost to Follow-up|1|||
160973032|NCT04145037|581291122|FG001|Overall Study|Lost to Follow-up|0|||
160973033|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
160973034|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
160973035|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
161024594|NCT05415215|581483658|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
161024595|NCT05415215|581483659|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
161024596|NCT05415215|581483660|FG005|Neoadjuvant Phase|Lost to Follow-up|0|||
161024597|NCT05415215|581483661|FG006|Neoadjuvant Phase|Lost to Follow-up|0|||
161024598|NCT05415215|581483662|FG007|Neoadjuvant Phase|Lost to Follow-up|0|||
161024599|NCT05415215|581483655|FG000|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161024600|NCT05415215|581483656|FG001|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161024601|NCT05415215|581483657|FG002|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161024602|NCT05415215|581483658|FG003|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
161024603|NCT05415215|581483659|FG004|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
161024604|NCT05415215|581483660|FG005|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161024605|NCT05415215|581483661|FG006|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161024606|NCT05415215|581483662|FG007|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161024607|NCT05415215|581483655|FG000|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161024608|NCT05415215|581483656|FG001|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161024609|NCT05415215|581483657|FG002|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161024610|NCT05415215|581483658|FG003|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
161024611|NCT05415215|581483659|FG004|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
161024612|NCT05415215|581483660|FG005|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161024613|NCT05415215|581483661|FG006|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161024614|NCT05415215|581483662|FG007|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161024615|NCT05415215|581483655|FG000|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161024616|NCT05415215|581483656|FG001|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161024617|NCT05415215|581483657|FG002|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161024618|NCT05415215|581483658|FG003|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161024619|NCT05415215|581483659|FG004|Adjuvant Phase: Cross-over Period|Treatment Intolerance|1|||
161024620|NCT05415215|581483660|FG005|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161024621|NCT05415215|581483661|FG006|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161024622|NCT05415215|581483662|FG007|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161024623|NCT05415215|581483655|FG000|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161024624|NCT05415215|581483656|FG001|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161024625|NCT05415215|581483657|FG002|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161024626|NCT05415215|581483658|FG003|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161024627|NCT05415215|581483659|FG004|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161024628|NCT05415215|581483660|FG005|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161024629|NCT05415215|581483661|FG006|Adjuvant Phase: Continuation Period|Adverse Event|1|||
160588804|NCT03888391|579873147|FG000|Overall Study|Lost to Follow-up|15|||
160588805|NCT02504268|579873150|FG000|Overall Study|Adverse Event|18|||
160588806|NCT02504268|579873151|FG001|Overall Study|Adverse Event|8|||
160588807|NCT02504268|579873152|FG002|Overall Study|Adverse Event|14|||
160588808|NCT02504268|579873153|FG003|Overall Study|Adverse Event|0|||
160588809|NCT02504268|579873154|FG004|Overall Study|Adverse Event|0|||
160588810|NCT02504268|579873155|FG005|Overall Study|Adverse Event|0|||
160588811|NCT02504268|579873156|FG006|Overall Study|Adverse Event|0|||
160588812|NCT02504268|579873157|FG007|Overall Study|Adverse Event|0|||
160588813|NCT02504268|579873158|FG008|Overall Study|Adverse Event|0|||
160588814|NCT02504268|579873150|FG000|Overall Study|Withdrawal of Consent|11|||
160588815|NCT02504268|579873151|FG001|Overall Study|Withdrawal of Consent|10|||
160588816|NCT02504268|579873152|FG002|Overall Study|Withdrawal of Consent|3|||
160588817|NCT02504268|579873153|FG003|Overall Study|Withdrawal of Consent|0|||
160588818|NCT02504268|579873154|FG004|Overall Study|Withdrawal of Consent|0|||
160588819|NCT02504268|579873155|FG005|Overall Study|Withdrawal of Consent|0|||
160588820|NCT02504268|579873156|FG006|Overall Study|Withdrawal of Consent|0|||
160588821|NCT02504268|579873157|FG007|Overall Study|Withdrawal of Consent|0|||
160588822|NCT02504268|579873158|FG008|Overall Study|Withdrawal of Consent|0|||
160588823|NCT02504268|579873150|FG000|Overall Study|Pregnancy|2|||
161024630|NCT05415215|581483662|FG007|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161024631|NCT05415215|581483655|FG000|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161024632|NCT05415215|581483656|FG001|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161024633|NCT05415215|581483657|FG002|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161024634|NCT05415215|581483658|FG003|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161024635|NCT05415215|581483659|FG004|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
160588824|NCT02504268|579873151|FG001|Overall Study|Pregnancy|0|||
160588825|NCT02504268|579873152|FG002|Overall Study|Pregnancy|0|||
160588826|NCT02504268|579873153|FG003|Overall Study|Pregnancy|0|||
160588827|NCT02504268|579873154|FG004|Overall Study|Pregnancy|0|||
160588828|NCT02504268|579873155|FG005|Overall Study|Pregnancy|0|||
160588829|NCT02504268|579873156|FG006|Overall Study|Pregnancy|0|||
160588830|NCT02504268|579873157|FG007|Overall Study|Pregnancy|0|||
160588831|NCT02504268|579873158|FG008|Overall Study|Pregnancy|0|||
161024636|NCT05415215|581483660|FG005|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|1|||
160588832|NCT02504268|579873150|FG000|Overall Study|Lost to Follow-up|3|||
160588833|NCT02504268|579873151|FG001|Overall Study|Lost to Follow-up|6|||
160588834|NCT02504268|579873152|FG002|Overall Study|Lost to Follow-up|4|||
160588835|NCT02504268|579873153|FG003|Overall Study|Lost to Follow-up|0|||
160588836|NCT02504268|579873154|FG004|Overall Study|Lost to Follow-up|0|||
160588837|NCT02504268|579873155|FG005|Overall Study|Lost to Follow-up|0|||
160588838|NCT02504268|579873156|FG006|Overall Study|Lost to Follow-up|0|||
160588839|NCT02504268|579873157|FG007|Overall Study|Lost to Follow-up|0|||
160588840|NCT02504268|579873158|FG008|Overall Study|Lost to Follow-up|0|||
160588841|NCT02504268|579873150|FG000|Overall Study|Death|1|||
160588842|NCT02504268|579873151|FG001|Overall Study|Death|1|||
160588843|NCT02504268|579873152|FG002|Overall Study|Death|0|||
160588844|NCT02504268|579873153|FG003|Overall Study|Death|0|||
160588845|NCT02504268|579873154|FG004|Overall Study|Death|0|||
160588846|NCT02504268|579873155|FG005|Overall Study|Death|0|||
160588847|NCT02504268|579873156|FG006|Overall Study|Death|0|||
160588848|NCT02504268|579873157|FG007|Overall Study|Death|0|||
160588849|NCT02504268|579873158|FG008|Overall Study|Death|0|||
160588850|NCT02504268|579873150|FG000|Overall Study|Subject Request to Discontinue|11|||
160588851|NCT02504268|579873151|FG001|Overall Study|Subject Request to Discontinue|3|||
160588852|NCT02504268|579873152|FG002|Overall Study|Subject Request to Discontinue|6|||
160588853|NCT02504268|579873153|FG003|Overall Study|Subject Request to Discontinue|0|||
160588854|NCT02504268|579873154|FG004|Overall Study|Subject Request to Discontinue|0|||
160588855|NCT02504268|579873155|FG005|Overall Study|Subject Request to Discontinue|0|||
160588856|NCT02504268|579873156|FG006|Overall Study|Subject Request to Discontinue|0|||
160588857|NCT02504268|579873157|FG007|Overall Study|Subject Request to Discontinue|0|||
160588858|NCT02504268|579873158|FG008|Overall Study|Subject Request to Discontinue|0|||
160588859|NCT02504268|579873150|FG000|Overall Study|No Longer Meets Study Criteria|2|||
160588860|NCT02504268|579873151|FG001|Overall Study|No Longer Meets Study Criteria|3|||
160588861|NCT02504268|579873152|FG002|Overall Study|No Longer Meets Study Criteria|0|||
160588862|NCT02504268|579873153|FG003|Overall Study|No Longer Meets Study Criteria|0|||
160588863|NCT02504268|579873154|FG004|Overall Study|No Longer Meets Study Criteria|0|||
160588864|NCT02504268|579873155|FG005|Overall Study|No Longer Meets Study Criteria|0|||
160588865|NCT02504268|579873156|FG006|Overall Study|No Longer Meets Study Criteria|0|||
160588866|NCT02504268|579873157|FG007|Overall Study|No Longer Meets Study Criteria|0|||
160588867|NCT02504268|579873158|FG008|Overall Study|No Longer Meets Study Criteria|0|||
160588868|NCT02504268|579873150|FG000|Overall Study|Lack of Efficacy|11|||
160588869|NCT02504268|579873151|FG001|Overall Study|Lack of Efficacy|35|||
160588870|NCT02504268|579873152|FG002|Overall Study|Lack of Efficacy|9|||
160588871|NCT02504268|579873153|FG003|Overall Study|Lack of Efficacy|0|||
160588872|NCT02504268|579873154|FG004|Overall Study|Lack of Efficacy|0|||
160588873|NCT02504268|579873155|FG005|Overall Study|Lack of Efficacy|0|||
160588874|NCT02504268|579873156|FG006|Overall Study|Lack of Efficacy|0|||
160588875|NCT02504268|579873157|FG007|Overall Study|Lack of Efficacy|0|||
160588876|NCT02504268|579873158|FG008|Overall Study|Lack of Efficacy|0|||
160588877|NCT02504268|579873150|FG000|Overall Study|Poor/Non-Compliance|3|||
160588878|NCT02504268|579873151|FG001|Overall Study|Poor/Non-Compliance|2|||
160588879|NCT02504268|579873152|FG002|Overall Study|Poor/Non-Compliance|3|||
160588880|NCT02504268|579873153|FG003|Overall Study|Poor/Non-Compliance|0|||
160588881|NCT02504268|579873154|FG004|Overall Study|Poor/Non-Compliance|0|||
160588882|NCT02504268|579873155|FG005|Overall Study|Poor/Non-Compliance|0|||
160588883|NCT02504268|579873156|FG006|Overall Study|Poor/Non-Compliance|0|||
160588884|NCT02504268|579873157|FG007|Overall Study|Poor/Non-Compliance|0|||
160588885|NCT02504268|579873158|FG008|Overall Study|Poor/Non-Compliance|0|||
160588886|NCT02504268|579873150|FG000|Overall Study|Not Disclosed|1|||
160588887|NCT02504268|579873151|FG001|Overall Study|Not Disclosed|0|||
160588888|NCT02504268|579873152|FG002|Overall Study|Not Disclosed|2|||
160588889|NCT02504268|579873153|FG003|Overall Study|Not Disclosed|0|||
160588890|NCT02504268|579873154|FG004|Overall Study|Not Disclosed|0|||
160588891|NCT02504268|579873155|FG005|Overall Study|Not Disclosed|0|||
160588892|NCT02504268|579873156|FG006|Overall Study|Not Disclosed|0|||
160588893|NCT02504268|579873157|FG007|Overall Study|Not Disclosed|0|||
160588894|NCT02504268|579873158|FG008|Overall Study|Not Disclosed|0|||
161024637|NCT05415215|581483661|FG006|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161024638|NCT05415215|581483662|FG007|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161024639|NCT05415215|581483655|FG000|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161024640|NCT05415215|581483656|FG001|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
160588895|NCT03025217|579873159|FG000|Overall Study|Pregnancy|1|||
160588896|NCT03025217|579873159|FG000|Overall Study|Lost to Follow-up|1|||
160588897|NCT03025217|579873159|FG000|Overall Study|Not eligible, poor English|2|||
160588898|NCT03654755|579873165|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
160588899|NCT03654755|579873166|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
160588900|NCT03654755|579873167|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
160588901|NCT03654755|579873165|FG000|Overall Study|Withdrawal by Subject|2|||
160588902|NCT03654755|579873166|FG001|Overall Study|Withdrawal by Subject|4|||
160588903|NCT03654755|579873167|FG002|Overall Study|Withdrawal by Subject|8|||
160588904|NCT03654755|579873165|FG000|Overall Study|Lost to Follow-up|1|||
160588905|NCT03654755|579873166|FG001|Overall Study|Lost to Follow-up|3|||
160588906|NCT03654755|579873167|FG002|Overall Study|Lost to Follow-up|7|||
161024641|NCT05415215|581483657|FG002|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161024642|NCT05415215|581483658|FG003|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161024643|NCT05415215|581483659|FG004|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
160588907|NCT03654755|579873165|FG000|Overall Study|Physician Decision|0|||
160588908|NCT03654755|579873166|FG001|Overall Study|Physician Decision|1|||
160588909|NCT03654755|579873167|FG002|Overall Study|Physician Decision|0|||
160588910|NCT03654755|579873165|FG000|Overall Study|Adverse Event|0|||
160588911|NCT03654755|579873166|FG001|Overall Study|Adverse Event|0|||
160588912|NCT03654755|579873167|FG002|Overall Study|Adverse Event|4|||
160588913|NCT03654755|579873165|FG000|Overall Study|Lack of Efficacy|0|||
160588914|NCT03654755|579873166|FG001|Overall Study|Lack of Efficacy|0|||
160588915|NCT03654755|579873167|FG002|Overall Study|Lack of Efficacy|1|||
160588916|NCT00992784|579873169|FG000|Overall Study|Adverse Event|2|||
160588917|NCT00992784|579873170|FG001|Overall Study|Adverse Event|1|||
160588918|NCT00992784|579873171|FG002|Overall Study|Adverse Event|0|||
160588919|NCT00992784|579873169|FG000|Overall Study|Withdrawal by Subject|1|||
160588920|NCT00992784|579873170|FG001|Overall Study|Withdrawal by Subject|1|||
160588921|NCT00992784|579873171|FG002|Overall Study|Withdrawal by Subject|1|||
160588922|NCT00781599|579873172|FG000|Overall Study|Lost to Follow-up|7|||
160588923|NCT00781599|579873173|FG001|Overall Study|Lost to Follow-up|4|||
160588924|NCT01088438|579873174|FG000|Overall Study|Withdrawal by Subject|11|||
160588925|NCT01088438|579873175|FG001|Overall Study|Withdrawal by Subject|6|||
160588926|NCT01088438|579873174|FG000|Overall Study|Lost to Follow-up|18|||
160588927|NCT01088438|579873175|FG001|Overall Study|Lost to Follow-up|30|||
160588928|NCT03337152|579873182|FG000|Overall Study|Physician Decision|1|||
160588929|NCT03337152|579873183|FG001|Overall Study|Physician Decision|0|||
160588930|NCT03337152|579873182|FG000|Overall Study|Lost to Follow-up|1|||
160588931|NCT03337152|579873183|FG001|Overall Study|Lost to Follow-up|3|||
160588932|NCT03337152|579873182|FG000|Overall Study|Adverse Event|3|||
160588933|NCT03337152|579873183|FG001|Overall Study|Adverse Event|1|||
160588934|NCT03337152|579873182|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
160588935|NCT03337152|579873183|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
160588936|NCT00421343|579873184|FG000|Overall Study|Death|1|||
160588937|NCT00421343|579873184|FG000|Overall Study|Withdrawal by Subject|2|||
160588938|NCT00421343|579873184|FG000|Overall Study|Lost to Follow-up|3|||
160588939|NCT01952730|579873187|FG000|Overall Study|FDA shut down core lab used by study|1|||
160588940|NCT00976950|579873192|FG000|Overall Study|Adverse Event|3|||
160588941|NCT00976950|579873192|FG000|Overall Study|Events with no relationship to Aptivus|3|||
160588942|NCT01514188|579873193|FG000|Overall Study|Adverse Event|3|||
160588943|NCT01514188|579873194|FG001|Overall Study|Adverse Event|5|||
160588944|NCT01514188|579873193|FG000|Overall Study|Withdrawal by Subject|2|||
160588945|NCT01514188|579873194|FG001|Overall Study|Withdrawal by Subject|4|||
160588946|NCT01514188|579873193|FG000|Overall Study|Protocol Violation|2|||
160588947|NCT01514188|579873194|FG001|Overall Study|Protocol Violation|4|||
160588948|NCT01514188|579873193|FG000|Overall Study|Physician Decision|0|||
160588949|NCT01514188|579873194|FG001|Overall Study|Physician Decision|2|||
160588950|NCT01514188|579873193|FG000|Overall Study|Disease Progression|13|||
160588951|NCT01514188|579873194|FG001|Overall Study|Disease Progression|14|||
160588952|NCT01514188|579873193|FG000|Overall Study|Death|1|||
160588953|NCT01514188|579873194|FG001|Overall Study|Death|3|||
160588954|NCT01514188|579873193|FG000|Overall Study|Other|2|||
160588955|NCT01514188|579873194|FG001|Overall Study|Other|1|||
160588956|NCT02932332|579873195|FG000|Overall Study|Withdrawal by Subject|1|||
160588957|NCT02932332|579873196|FG001|Overall Study|Withdrawal by Subject|1|||
160588958|NCT02932332|579873197|FG002|Overall Study|Withdrawal by Subject|0|||
160588959|NCT02932332|579873198|FG003|Overall Study|Withdrawal by Subject|1|||
160588960|NCT02932332|579873195|FG000|Overall Study|Chest pain|0|||
160588961|NCT02932332|579873196|FG001|Overall Study|Chest pain|0|||
160588962|NCT02932332|579873197|FG002|Overall Study|Chest pain|0|||
160588963|NCT02932332|579873198|FG003|Overall Study|Chest pain|1|||
160588964|NCT02932332|579873195|FG000|Overall Study|Not Dyspneic cough|1|||
160588965|NCT02932332|579873196|FG001|Overall Study|Not Dyspneic cough|2|||
160588966|NCT02932332|579873197|FG002|Overall Study|Not Dyspneic cough|1|||
160588967|NCT02932332|579873198|FG003|Overall Study|Not Dyspneic cough|0|||
160588968|NCT03442829|579873200|FG000|Overall Study|Scheduling clash|3|||
160588969|NCT03442829|579873201|FG001|Overall Study|Scheduling clash|1|||
160588970|NCT03442829|579873200|FG000|Overall Study|Illness unrelated to study|1|||
160588971|NCT03442829|579873201|FG001|Overall Study|Illness unrelated to study|1|||
160588972|NCT01069523|579873202|FG000|Overall Study|Withdrawal by Subject|4|||
160588973|NCT01069523|579873203|FG001|Overall Study|Withdrawal by Subject|7|||
160588974|NCT02237157|579873208|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
160588975|NCT02237157|579873209|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
160588976|NCT02237157|579873210|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
160588977|NCT02237157|579873211|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
160588978|NCT02237157|579873208|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
161024644|NCT05415215|581483660|FG005|Adjuvant Phase: Continuation Period|Withdrawal by Subject|1|||
160588979|NCT02237157|579873209|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
160973036|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
160973037|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
160973038|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
160973039|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
160973040|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
160973041|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
160973042|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
160973043|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
160973044|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
160973045|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
160973046|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
160973047|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
160973048|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
160973049|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
160973050|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
160973051|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
160973052|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
160973053|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
160973054|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
160973055|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
160973056|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
160973057|NCT02307513|581291123|FG000|Long-term Extension|Physician Decision|1|||
160973058|NCT02307513|581291124|FG001|Long-term Extension|Physician Decision|0|||
160973059|NCT00525265|581291132|FG000|Overall Study|Protocol Violation|1|||
160973060|NCT00525265|581291133|FG001|Overall Study|Protocol Violation|0|||
160973061|NCT01107743|581291134|FG000|Overall Study|Protocol Violation|46|||
160973062|NCT00308737|581291135|FG000|Overall Study|Adverse Event|104|||
160973063|NCT00308737|581291136|FG001|Overall Study|Adverse Event|9|||
160973064|NCT00308737|581291137|FG002|Overall Study|Adverse Event|0|||
160973065|NCT00308737|581291135|FG000|Overall Study|Death|4|||
160973066|NCT00308737|581291136|FG001|Overall Study|Death|3|||
160973067|NCT00308737|581291137|FG002|Overall Study|Death|0|||
160973068|NCT00308737|581291135|FG000|Overall Study|Lost to Follow-up|56|||
160973069|NCT00308737|581291136|FG001|Overall Study|Lost to Follow-up|80|||
160973070|NCT00308737|581291137|FG002|Overall Study|Lost to Follow-up|5|||
160973071|NCT00308737|581291135|FG000|Overall Study|Physician Decision|15|||
160973072|NCT00308737|581291136|FG001|Overall Study|Physician Decision|2|||
160973073|NCT00308737|581291137|FG002|Overall Study|Physician Decision|1|||
160973074|NCT00308737|581291135|FG000|Overall Study|Protocol Violation|34|||
160973075|NCT00308737|581291136|FG001|Overall Study|Protocol Violation|9|||
160973076|NCT00308737|581291137|FG002|Overall Study|Protocol Violation|5|||
160973077|NCT00308737|581291135|FG000|Overall Study|Withdrawal by Subject|218|||
160973078|NCT00308737|581291136|FG001|Overall Study|Withdrawal by Subject|166|||
160973079|NCT00308737|581291137|FG002|Overall Study|Withdrawal by Subject|18|||
160973080|NCT00308737|581291135|FG000|Overall Study|Various|32|||
160973081|NCT00308737|581291136|FG001|Overall Study|Various|20|||
160973082|NCT00308737|581291137|FG002|Overall Study|Various|8|||
160973083|NCT00744263|581291140|FG000|Overall Study|Death|3006|||
160973084|NCT00744263|581291141|FG001|Overall Study|Death|3005|||
160973085|NCT00744263|581291140|FG000|Overall Study|Lost to Follow-up|2038|||
160973086|NCT00744263|581291141|FG001|Overall Study|Lost to Follow-up|2135|||
160973087|NCT00744263|581291140|FG000|Overall Study|Withdrawal by Subject|166|||
160973088|NCT00744263|581291141|FG001|Overall Study|Withdrawal by Subject|150|||
160588980|NCT02237157|579873210|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
160973089|NCT00744263|581291140|FG000|Overall Study|Physician Decision|20|||
160973090|NCT00744263|581291141|FG001|Overall Study|Physician Decision|23|||
160973091|NCT00744263|581291140|FG000|Overall Study|Protocol Violation|3|||
160973092|NCT00744263|581291141|FG001|Overall Study|Protocol Violation|5|||
160973093|NCT00744263|581291140|FG000|Overall Study|Adverse Event|1|||
160973094|NCT00744263|581291141|FG001|Overall Study|Adverse Event|0|||
160973095|NCT00744263|581291140|FG000|Overall Study|Other|2|||
160973096|NCT00744263|581291141|FG001|Overall Study|Other|2|||
160973097|NCT01913639|581291142|FG000|Overall Study|Not Eligible|3|||
160973098|NCT01290822|581291143|FG000|Overall Study|Withdrawal by Subject|1|||
160973099|NCT01290822|581291143|FG000|Overall Study|Physician Decision|10|||
160588981|NCT02237157|579873211|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
160973100|NCT02100722|581291146|FG000|Overall Study|Withdrawal pre-procedure|4|||
160973101|NCT02100722|581291147|FG001|Overall Study|Withdrawal pre-procedure|9|||
160973102|NCT02100722|581291146|FG000|Overall Study|Withdrawal post-procedure|0|||
160973103|NCT02100722|581291147|FG001|Overall Study|Withdrawal post-procedure|3|||
160973104|NCT02100722|581291146|FG000|Overall Study|Lost to Follow-up|2|||
160973105|NCT02100722|581291147|FG001|Overall Study|Lost to Follow-up|2|||
160973106|NCT02100722|581291146|FG000|Overall Study|Continuing on study|751|||
160973107|NCT02100722|581291147|FG001|Overall Study|Continuing on study|729|||
160973108|NCT04986982|581291148|FG000|Overall Study|Withdrawal by Subject|3|||
160588982|NCT04533815|579873216|FG000|Overall Study|Adverse Event|2|||
160588983|NCT04533815|579873216|FG000|Overall Study|Site withdrew|5|||
160588984|NCT00488592|579873217|FG000|Overall Study|Withdrawal by Subject|1|||
160588985|NCT00488592|579873217|FG000|Overall Study|Disease progression|1|||
160588986|NCT00488592|579873217|FG000|Overall Study|Enrolled but not treated|1|||
161024645|NCT05415215|581483661|FG006|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161024646|NCT05415215|581483662|FG007|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161024647|NCT05415215|581483655|FG000|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161024648|NCT05415215|581483656|FG001|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161024649|NCT05415215|581483657|FG002|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161024650|NCT05415215|581483658|FG003|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161024651|NCT05415215|581483659|FG004|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161024652|NCT05415215|581483660|FG005|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
161024653|NCT05415215|581483661|FG006|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
161024654|NCT05415215|581483662|FG007|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161024655|NCT05415215|581483655|FG000|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161024656|NCT05415215|581483656|FG001|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161024657|NCT05415215|581483657|FG002|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161024658|NCT05415215|581483658|FG003|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161024659|NCT05415215|581483659|FG004|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161024660|NCT05415215|581483660|FG005|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161024661|NCT05415215|581483661|FG006|Adjuvant Phase: Continuation Period|Reason not Specified|1|||
161024662|NCT05415215|581483662|FG007|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161024663|NCT05415215|581483655|FG000|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161024664|NCT05415215|581483656|FG001|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161024665|NCT05415215|581483657|FG002|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161024666|NCT05415215|581483658|FG003|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161024667|NCT05415215|581483659|FG004|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161024668|NCT05415215|581483660|FG005|Adjuvant Phase: Continuation Period|Ongoing in Treatment|11|||
161024669|NCT05415215|581483661|FG006|Adjuvant Phase: Continuation Period|Ongoing in Treatment|9|||
161024670|NCT05415215|581483662|FG007|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161024671|NCT05415215|581483655|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161024672|NCT05415215|581483656|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161024673|NCT05415215|581483657|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161024674|NCT05415215|581483658|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161024675|NCT05415215|581483659|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161024676|NCT05415215|581483660|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161024677|NCT05415215|581483661|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161024678|NCT05415215|581483662|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|5|||
161024679|NCT05415215|581483655|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161024680|NCT05415215|581483656|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161024681|NCT05415215|581483657|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161024682|NCT05415215|581483658|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161024683|NCT05415215|581483659|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161024684|NCT05415215|581483660|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161024685|NCT05415215|581483661|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161024686|NCT05415215|581483662|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Death|1|||
161024687|NCT05415215|581483655|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161024688|NCT05415215|581483656|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161024689|NCT05415215|581483657|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161024690|NCT05415215|581483658|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161024691|NCT05415215|581483659|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161024692|NCT05415215|581483660|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161024693|NCT05415215|581483661|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161024694|NCT05415215|581483662|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|2|||
161024695|NCT05415215|581483655|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161024696|NCT05415215|581483656|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161024697|NCT05415215|581483657|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161024698|NCT05415215|581483658|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161024699|NCT05415215|581483659|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161024700|NCT05415215|581483660|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161024701|NCT05415215|581483661|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
160588987|NCT00441103|579873218|FG000|Overall Study|Adverse Event|2|||
160588988|NCT00441103|579873219|FG001|Overall Study|Adverse Event|1|||
161024702|NCT05415215|581483662|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|1|||
161024703|NCT05415215|581483655|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
160588989|NCT00441103|579873218|FG000|Overall Study|Death|1|||
160588990|NCT00441103|579873219|FG001|Overall Study|Death|0|||
160588991|NCT00441103|579873218|FG000|Overall Study|Disease Progression|2|||
160588992|NCT00441103|579873219|FG001|Overall Study|Disease Progression|0|||
160588993|NCT00441103|579873218|FG000|Overall Study|Lost to Follow-up|1|||
160588994|NCT00441103|579873219|FG001|Overall Study|Lost to Follow-up|0|||
160588995|NCT00441103|579873218|FG000|Overall Study|Protocol Violation|1|||
160588996|NCT00441103|579873219|FG001|Overall Study|Protocol Violation|0|||
160588997|NCT00441103|579873218|FG000|Overall Study|Participant unable to use Rebiject II|1|||
160588998|NCT00441103|579873219|FG001|Overall Study|Participant unable to use Rebiject II|0|||
160588999|NCT00441103|579873218|FG000|Overall Study|Participant refused MRI|1|||
160589000|NCT00441103|579873219|FG001|Overall Study|Participant refused MRI|0|||
160589001|NCT00441103|579873218|FG000|Overall Study|Inclusion criteria absent|1|||
160589002|NCT00441103|579873219|FG001|Overall Study|Inclusion criteria absent|0|||
160589003|NCT00441103|579873218|FG000|Overall Study|Non-compliant|0|||
160589004|NCT00441103|579873219|FG001|Overall Study|Non-compliant|1|||
160589005|NCT00441103|579873218|FG000|Overall Study|Participant decided to withdraw|1|||
160589006|NCT00441103|579873219|FG001|Overall Study|Participant decided to withdraw|0|||
160589007|NCT00441103|579873218|FG000|Overall Study|Participant's reason|0|||
160589008|NCT00441103|579873219|FG001|Overall Study|Participant's reason|1|||
160589009|NCT00441103|579873218|FG000|Overall Study|Participant decided to stop|0|||
160589010|NCT00441103|579873219|FG001|Overall Study|Participant decided to stop|1|||
160589011|NCT00515008|579873220|FG000|Overall Study|Lost to Follow-up|1|||
160589012|NCT00515008|579873221|FG001|Overall Study|Lost to Follow-up|0|||
160589013|NCT00515008|579873220|FG000|Overall Study|Declined|0|||
160589014|NCT00515008|579873221|FG001|Overall Study|Declined|3|||
160589015|NCT00515008|579873220|FG000|Overall Study|Left the Boston Area|1|||
160589016|NCT00515008|579873221|FG001|Overall Study|Left the Boston Area|1|||
160589017|NCT00515008|579873220|FG000|Overall Study|Scheduling conflict|1|||
160589018|NCT00515008|579873221|FG001|Overall Study|Scheduling conflict|0|||
160589019|NCT05836818|579873222|FG000|Overall Study|Physician Decision|1|||
160589020|NCT05836818|579873223|FG001|Overall Study|Physician Decision|1|||
160589021|NCT05836818|579873224|FG002|Overall Study|Physician Decision|0|||
160589022|NCT05836818|579873222|FG000|Overall Study|Withdrawal by Subject|0|||
160589023|NCT05836818|579873223|FG001|Overall Study|Withdrawal by Subject|0|||
160589024|NCT05836818|579873224|FG002|Overall Study|Withdrawal by Subject|1|||
160589025|NCT05836818|579873222|FG000|Overall Study|Later found to be previously vaccinated|0|||
160589026|NCT05836818|579873223|FG001|Overall Study|Later found to be previously vaccinated|1|||
160589027|NCT05836818|579873224|FG002|Overall Study|Later found to be previously vaccinated|3|||
160589028|NCT05836818|579873222|FG000|Overall Study|Pregnancy|0|||
160589029|NCT05836818|579873223|FG001|Overall Study|Pregnancy|1|||
160589030|NCT05836818|579873224|FG002|Overall Study|Pregnancy|0|||
160589031|NCT05836818|579873222|FG000|Overall Study|Allergic to vaccines|0|||
160589032|NCT05836818|579873223|FG001|Overall Study|Allergic to vaccines|1|||
160589033|NCT05836818|579873224|FG002|Overall Study|Allergic to vaccines|0|||
160589034|NCT03738566|579873225|FG000|Initial Study Phase|Withdrawal by Subject|1|||
160589035|NCT03738566|579873226|FG001|Initial Study Phase|Withdrawal by Subject|1|||
160589036|NCT03738566|579873227|FG002|Initial Study Phase|Withdrawal by Subject|2|||
160589037|NCT03738566|579873228|FG003|Initial Study Phase|Withdrawal by Subject|0|||
160589038|NCT03738566|579873225|FG000|Initial Study Phase|Death|0|||
160589039|NCT03738566|579873226|FG001|Initial Study Phase|Death|1|||
160589040|NCT03738566|579873227|FG002|Initial Study Phase|Death|0|||
160589041|NCT03738566|579873228|FG003|Initial Study Phase|Death|0|||
160973109|NCT04986982|581291149|FG001|Overall Study|Withdrawal by Subject|1|||
160589042|NCT03738566|579873225|FG000|Initial Study Phase|Treatment failure|5|||
160589043|NCT03738566|579873226|FG001|Initial Study Phase|Treatment failure|0|||
160589044|NCT03738566|579873227|FG002|Initial Study Phase|Treatment failure|0|||
160589045|NCT03738566|579873228|FG003|Initial Study Phase|Treatment failure|0|||
160589046|NCT03738566|579873225|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
160589047|NCT03738566|579873226|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
160589048|NCT03738566|579873227|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
160589049|NCT03738566|579873228|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
160589050|NCT03126539|579873235|FG000|Overall Study|Lost to Follow-up|1|||
160589051|NCT03126539|579873236|FG001|Overall Study|Lost to Follow-up|1|||
160657366|NCT02848326|580127507|FG005|Treatment Period|Withdrawal of Consent|6|||
160589052|NCT03126539|579873237|FG002|Overall Study|Lost to Follow-up|1|||
160589053|NCT03126539|579873238|FG003|Overall Study|Lost to Follow-up|0|||
160589054|NCT03126539|579873239|FG004|Overall Study|Lost to Follow-up|0|||
160589055|NCT01627067|579873240|FG000|Overall Study|Screen Failure|1|||
160589056|NCT00926796|579873241|FG000|Overall Study|Did not receive randomized treatment|4|||
160657367|NCT02848326|580127502|FG000|Treatment Period|Lost to Follow-up|5|||
160657368|NCT02848326|580127503|FG001|Treatment Period|Lost to Follow-up|1|||
160973110|NCT04986982|581291148|FG000|Overall Study|Lack of Efficacy|0|||
160973111|NCT04986982|581291149|FG001|Overall Study|Lack of Efficacy|2|||
160973112|NCT04986982|581291148|FG000|Overall Study|Ineligibility|3|||
161024704|NCT05415215|581483656|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
160973113|NCT04986982|581291149|FG001|Overall Study|Ineligibility|0|||
161024705|NCT05415215|581483657|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
160589057|NCT00926796|579873242|FG001|Overall Study|Did not receive randomized treatment|7|||
160589058|NCT00926796|579873241|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
160589059|NCT00926796|579873242|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
160589060|NCT00926796|579873241|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
160589061|NCT00926796|579873242|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
160589062|NCT00926796|579873241|FG000|Overall Study|Adverse Event|7|||
160589063|NCT00926796|579873242|FG001|Overall Study|Adverse Event|14|||
160589064|NCT00926796|579873241|FG000|Overall Study|Lost to Follow-up|22|||
160589065|NCT00926796|579873242|FG001|Overall Study|Lost to Follow-up|13|||
160589066|NCT00926796|579873241|FG000|Overall Study|Protocol Violation|15|||
160589067|NCT00926796|579873242|FG001|Overall Study|Protocol Violation|11|||
160589068|NCT00926796|579873241|FG000|Overall Study|Withdrawal by Subject|1|||
160589069|NCT00926796|579873242|FG001|Overall Study|Withdrawal by Subject|0|||
160589070|NCT01072539|579873246|FG000|Overall Study|Treated prior to the Site Initiation|1|||
160589071|NCT01072539|579873246|FG000|Overall Study|Protocol Violation|2|||
160589072|NCT00946530|579873247|FG000|Overall Study|Withdrawal by Subject|0|||
160589073|NCT00946530|579873248|FG001|Overall Study|Withdrawal by Subject|3|||
160589074|NCT00946530|579873249|FG002|Overall Study|Withdrawal by Subject|0|||
160589075|NCT00946530|579873250|FG003|Overall Study|Withdrawal by Subject|3|||
160589076|NCT00946530|579873247|FG000|Overall Study|Physician Decision|1|||
160589077|NCT00946530|579873248|FG001|Overall Study|Physician Decision|1|||
160589078|NCT00946530|579873249|FG002|Overall Study|Physician Decision|1|||
160589079|NCT00946530|579873250|FG003|Overall Study|Physician Decision|1|||
160589080|NCT01927744|579874749|FG000|Overall Study|Death|2|||
160589081|NCT01927744|579874750|FG001|Overall Study|Death|9|||
160589082|NCT00369967|579874751|FG000|Overall Study|Lost to Follow-up|23|||
160589083|NCT00369967|579874752|FG001|Overall Study|Lost to Follow-up|12|||
160589084|NCT03073213|579874753|FG000|Multiple Dose Period|Protocol Violation|0|||
160589085|NCT03073213|579874754|FG001|Multiple Dose Period|Protocol Violation|0|||
160589086|NCT03073213|579874755|FG002|Multiple Dose Period|Protocol Violation|1|||
160589087|NCT02064205|579874756|FG000|Overall Study|Withdrawal by Subject|1|||
160589088|NCT02586233|579874758|FG000|Overall Study|Randomized but did not receive treatment|0|||
160589089|NCT02586233|579874759|FG001|Overall Study|Randomized but did not receive treatment|1|||
160589090|NCT02586233|579874760|FG002|Overall Study|Randomized but did not receive treatment|0|||
160589091|NCT02586233|579874761|FG003|Overall Study|Randomized but did not receive treatment|0|||
160589092|NCT02586233|579874762|FG004|Overall Study|Randomized but did not receive treatment|0|||
160589093|NCT02586233|579874763|FG005|Overall Study|Randomized but did not receive treatment|2|||
160589094|NCT02586233|579874764|FG006|Overall Study|Randomized but did not receive treatment|2|||
160589095|NCT02586233|579874758|FG000|Overall Study|Death|0|||
160589096|NCT02586233|579874759|FG001|Overall Study|Death|1|||
160589097|NCT02586233|579874760|FG002|Overall Study|Death|0|||
160589098|NCT02586233|579874761|FG003|Overall Study|Death|0|||
160589099|NCT02586233|579874762|FG004|Overall Study|Death|2|||
160973114|NCT04986982|581291148|FG000|Overall Study|Adverse Event|4|||
160973115|NCT04986982|581291149|FG001|Overall Study|Adverse Event|4|||
160973116|NCT04986982|581291148|FG000|Overall Study|Lost to Follow-up|0|||
160973117|NCT04986982|581291149|FG001|Overall Study|Lost to Follow-up|1|||
160973118|NCT04986982|581291148|FG000|Overall Study|Sponsor's discretion|1|||
160973119|NCT04986982|581291149|FG001|Overall Study|Sponsor's discretion|0|||
160973120|NCT03500640|581291150|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
160973121|NCT03500640|581291151|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
160973122|NCT03500640|581291152|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
160973123|NCT03500640|581291150|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
160973124|NCT03500640|581291151|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
160973125|NCT03500640|581291152|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
160973126|NCT03500640|581291150|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
160973127|NCT03500640|581291151|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
160973128|NCT03500640|581291152|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
160973129|NCT03500640|581291150|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
160973130|NCT03500640|581291151|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
160973131|NCT03500640|581291152|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
160973132|NCT03500640|581291150|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
160973133|NCT03500640|581291151|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
160973134|NCT03500640|581291152|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
160973135|NCT03500640|581291150|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
160973136|NCT03500640|581291151|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
160973137|NCT03500640|581291152|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
160973138|NCT03500640|581291150|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
160973139|NCT03500640|581291151|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
160973140|NCT03500640|581291152|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
160973141|NCT03500640|581291150|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
161024706|NCT05415215|581483658|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161024707|NCT05415215|581483659|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161024708|NCT05415215|581483660|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161024709|NCT05415215|581483661|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161024710|NCT05415215|581483662|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|2|||
161024711|NCT05415215|581483655|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161024712|NCT05415215|581483656|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161024713|NCT05415215|581483657|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161024714|NCT05415215|581483658|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161024715|NCT05415215|581483659|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161024716|NCT05415215|581483660|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161024717|NCT05415215|581483661|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161024718|NCT05415215|581483662|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|4|||
161024719|NCT05415215|581483655|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161024720|NCT05415215|581483656|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161024721|NCT05415215|581483657|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161024722|NCT05415215|581483658|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161024723|NCT05415215|581483659|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161024724|NCT05415215|581483660|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161024725|NCT05415215|581483661|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
160589100|NCT02586233|579874763|FG005|Overall Study|Death|0|||
160589101|NCT02586233|579874764|FG006|Overall Study|Death|0|||
161024726|NCT05415215|581483662|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|25|||
161024727|NCT05415215|581483655|FG000|Follow-up Period|Ongoing in Follow-up|0|||
161024728|NCT05415215|581483656|FG001|Follow-up Period|Ongoing in Follow-up|0|||
161024729|NCT05415215|581483657|FG002|Follow-up Period|Ongoing in Follow-up|0|||
161024730|NCT05415215|581483658|FG003|Follow-up Period|Ongoing in Follow-up|0|||
161024731|NCT05415215|581483659|FG004|Follow-up Period|Ongoing in Follow-up|0|||
161024732|NCT05415215|581483660|FG005|Follow-up Period|Ongoing in Follow-up|44|||
161024733|NCT05415215|581483661|FG006|Follow-up Period|Ongoing in Follow-up|45|||
161024734|NCT05415215|581483662|FG007|Follow-up Period|Ongoing in Follow-up|51|||
161024735|NCT05415215|581483655|FG000|Follow-up Period|Adverse Event|0|||
161024736|NCT05415215|581483656|FG001|Follow-up Period|Adverse Event|0|||
161024737|NCT05415215|581483657|FG002|Follow-up Period|Adverse Event|0|||
161024738|NCT05415215|581483658|FG003|Follow-up Period|Adverse Event|0|||
161024739|NCT05415215|581483659|FG004|Follow-up Period|Adverse Event|0|||
161024740|NCT05415215|581483660|FG005|Follow-up Period|Adverse Event|0|||
161024741|NCT05415215|581483661|FG006|Follow-up Period|Adverse Event|1|||
161024742|NCT05415215|581483662|FG007|Follow-up Period|Adverse Event|0|||
161024743|NCT05415215|581483655|FG000|Follow-up Period|Lost to Follow-up|0|||
161024744|NCT05415215|581483656|FG001|Follow-up Period|Lost to Follow-up|0|||
161024745|NCT05415215|581483657|FG002|Follow-up Period|Lost to Follow-up|0|||
161024746|NCT05415215|581483658|FG003|Follow-up Period|Lost to Follow-up|0|||
161024747|NCT05415215|581483659|FG004|Follow-up Period|Lost to Follow-up|0|||
161024748|NCT05415215|581483660|FG005|Follow-up Period|Lost to Follow-up|1|||
161024749|NCT05415215|581483661|FG006|Follow-up Period|Lost to Follow-up|1|||
161024750|NCT05415215|581483662|FG007|Follow-up Period|Lost to Follow-up|0|||
161024751|NCT05415215|581483655|FG000|Follow-up Period|Withdrawal by Subject|0|||
161024752|NCT05415215|581483656|FG001|Follow-up Period|Withdrawal by Subject|0|||
161024753|NCT05415215|581483657|FG002|Follow-up Period|Withdrawal by Subject|0|||
161024754|NCT05415215|581483658|FG003|Follow-up Period|Withdrawal by Subject|0|||
161024755|NCT05415215|581483659|FG004|Follow-up Period|Withdrawal by Subject|0|||
161024756|NCT05415215|581483660|FG005|Follow-up Period|Withdrawal by Subject|0|||
161024757|NCT05415215|581483661|FG006|Follow-up Period|Withdrawal by Subject|0|||
161024758|NCT05415215|581483662|FG007|Follow-up Period|Withdrawal by Subject|2|||
161024759|NCT03727022|581483663|FG000|Phase A|Lost to Follow-up|2|||
161024760|NCT03727022|581483664|FG001|Phase A|Lost to Follow-up|3|||
161024761|NCT03727022|581483663|FG000|Phase A|Withdrawal by Subject|10|||
161024762|NCT03727022|581483664|FG001|Phase A|Withdrawal by Subject|9|||
161024763|NCT03727022|581483663|FG000|Phase B|Lost to Follow-up|0|||
161024764|NCT03727022|581483664|FG001|Phase B|Lost to Follow-up|1|||
161024765|NCT03727022|581483663|FG000|Phase B|Subject Non-Compliance|1|||
161024766|NCT03727022|581483664|FG001|Phase B|Subject Non-Compliance|0|||
161024767|NCT03727022|581483663|FG000|Phase B|Withdrawal by Subject|3|||
161024768|NCT03727022|581483664|FG001|Phase B|Withdrawal by Subject|3|||
161024769|NCT03727022|581483663|FG000|Phase B|Site Closure|4|||
161024770|NCT03727022|581483664|FG001|Phase B|Site Closure|0|||
161024771|NCT03922802|581483665|FG000|Overall Study|Withdrawal by Subject|4|||
161024772|NCT05550818|581483666|FG000|Overall Study|Protocol Violation|1|||
161024773|NCT05550818|581483667|FG001|Overall Study|Protocol Violation|1|||
161024774|NCT05550818|581483666|FG000|Overall Study|Withdrawal by Subject|2|||
161024775|NCT05550818|581483667|FG001|Overall Study|Withdrawal by Subject|1|||
161024776|NCT04486716|581483668|FG000|Core Phase|Subject decision|6|||
160589102|NCT01205451|579874765|FG000|Overall Study|Lost to Follow-up|1|||
160589103|NCT01205451|579874766|FG001|Overall Study|Lost to Follow-up|1|||
160589104|NCT01205451|579874765|FG000|Overall Study|Withdrawal by Subject|5|||
160589105|NCT01205451|579874766|FG001|Overall Study|Withdrawal by Subject|9|||
160589106|NCT01708941|579874769|FG000|Overall Study|Adverse Event|4|||
160589107|NCT01708941|579874770|FG001|Overall Study|Adverse Event|6|||
160589108|NCT01708941|579874771|FG002|Overall Study|Adverse Event|1|||
160589109|NCT01708941|579874772|FG003|Overall Study|Adverse Event|0|||
160589110|NCT01708941|579874769|FG000|Overall Study|Death|1|||
160589111|NCT01708941|579874770|FG001|Overall Study|Death|1|||
160589112|NCT01708941|579874771|FG002|Overall Study|Death|2|||
160589113|NCT01708941|579874772|FG003|Overall Study|Death|14|||
160589114|NCT01708941|579874769|FG000|Overall Study|Withdrawal by Subject|1|||
160589115|NCT01708941|579874770|FG001|Overall Study|Withdrawal by Subject|0|||
160589116|NCT01708941|579874771|FG002|Overall Study|Withdrawal by Subject|3|||
160589117|NCT01708941|579874772|FG003|Overall Study|Withdrawal by Subject|4|||
160589118|NCT01708941|579874769|FG000|Overall Study|Disease progression|9|||
160589119|NCT01708941|579874770|FG001|Overall Study|Disease progression|10|||
160589120|NCT01708941|579874771|FG002|Overall Study|Disease progression|8|||
160589121|NCT01708941|579874772|FG003|Overall Study|Disease progression|0|||
160589122|NCT01708941|579874769|FG000|Overall Study|Alternative therapy|0|||
160589123|NCT01708941|579874770|FG001|Overall Study|Alternative therapy|0|||
160589124|NCT01708941|579874771|FG002|Overall Study|Alternative therapy|2|||
160589125|NCT01708941|579874772|FG003|Overall Study|Alternative therapy|0|||
160589126|NCT01708941|579874769|FG000|Overall Study|Ineligible and never started treatment|1|||
160589127|NCT01708941|579874770|FG001|Overall Study|Ineligible and never started treatment|0|||
160589128|NCT01708941|579874771|FG002|Overall Study|Ineligible and never started treatment|1|||
160589129|NCT01708941|579874772|FG003|Overall Study|Ineligible and never started treatment|0|||
160589130|NCT01708941|579874769|FG000|Overall Study|Never started treatment|2|||
160589131|NCT01708941|579874770|FG001|Overall Study|Never started treatment|1|||
160589132|NCT01708941|579874771|FG002|Overall Study|Never started treatment|0|||
160589133|NCT01708941|579874772|FG003|Overall Study|Never started treatment|0|||
160589134|NCT01708941|579874769|FG000|Overall Study|Ineligible|0|||
160589135|NCT01708941|579874770|FG001|Overall Study|Ineligible|0|||
160589136|NCT01708941|579874771|FG002|Overall Study|Ineligible|2|||
160589137|NCT01708941|579874772|FG003|Overall Study|Ineligible|0|||
160589138|NCT00229203|579874773|FG000|Overall Study|Progressive disease|18|||
160589139|NCT00229203|579874774|FG001|Overall Study|Progressive disease|9|||
160589140|NCT00229203|579874773|FG000|Overall Study|Toxicity|6|||
160589141|NCT00229203|579874774|FG001|Overall Study|Toxicity|1|||
160589142|NCT00229203|579874773|FG000|Overall Study|Death|4|||
160589143|NCT00229203|579874774|FG001|Overall Study|Death|2|||
160589144|NCT00229203|579874773|FG000|Overall Study|Other|3|||
160589145|NCT00229203|579874774|FG001|Overall Study|Other|3|||
160589146|NCT00229203|579874773|FG000|Overall Study|Withdrawal by Subject|1|||
160589147|NCT00229203|579874774|FG001|Overall Study|Withdrawal by Subject|4|||
160589148|NCT03457103|579874775|FG000|Overall Study|illness/hospitalization|4|||
160589149|NCT03457103|579874776|FG001|Overall Study|illness/hospitalization|2|||
160589150|NCT03457103|579874775|FG000|Overall Study|Lost to Follow-up|2|||
160589151|NCT03457103|579874776|FG001|Overall Study|Lost to Follow-up|1|||
160589152|NCT03457103|579874775|FG000|Overall Study|Withdrawal by Subject|1|||
160589153|NCT03457103|579874776|FG001|Overall Study|Withdrawal by Subject|2|||
160589154|NCT03457103|579874775|FG000|Overall Study|financial/ insurance issues|1|||
160589155|NCT03457103|579874776|FG001|Overall Study|financial/ insurance issues|1|||
160589156|NCT00213980|579874777|FG000|Overall Study|Withdrawal by Subject|3|||
160589157|NCT00213980|579874778|FG001|Overall Study|Withdrawal by Subject|1|||
160589158|NCT00213980|579874777|FG000|Overall Study|Adverse Event|1|||
160589159|NCT00213980|579874778|FG001|Overall Study|Adverse Event|1|||
160589160|NCT00213980|579874777|FG000|Overall Study|Disease progression|0|||
160589161|NCT00213980|579874778|FG001|Overall Study|Disease progression|2|||
160589162|NCT00213980|579874777|FG000|Overall Study|Developed ovarian cancer|1|||
161024777|NCT04486716|581483668|FG000|Core Phase|Adverse Event|5|||
161024778|NCT04486716|581483668|FG000|Core Phase|Lost to Follow-up|1|||
160589163|NCT00213980|579874778|FG001|Overall Study|Developed ovarian cancer|0|||
160589164|NCT00213980|579874777|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
160589165|NCT00213980|579874778|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
160589166|NCT03607838|579874779|FG000|Overall Study|Lack of Efficacy|14|||
160589167|NCT03607838|579874780|FG001|Overall Study|Lack of Efficacy|20|||
160589168|NCT03607838|579874779|FG000|Overall Study|Withdrawal by Subject|13|||
160589169|NCT03607838|579874780|FG001|Overall Study|Withdrawal by Subject|8|||
160589170|NCT03607838|579874779|FG000|Overall Study|Lost to Follow-up|6|||
160589171|NCT03607838|579874780|FG001|Overall Study|Lost to Follow-up|11|||
160589172|NCT03607838|579874779|FG000|Overall Study|Adverse Event|2|||
160589173|NCT03607838|579874780|FG001|Overall Study|Adverse Event|2|||
160589174|NCT03607838|579874779|FG000|Overall Study|Physician Decision|2|||
160589175|NCT03607838|579874780|FG001|Overall Study|Physician Decision|0|||
160589176|NCT03607838|579874779|FG000|Overall Study|Failure to meet randomization criteria|1|||
160589177|NCT03607838|579874780|FG001|Overall Study|Failure to meet randomization criteria|2|||
161024779|NCT04486716|581483668|FG000|Core Phase|Physician Decision|1|||
160589178|NCT03607838|579874779|FG000|Overall Study|Pregnancy|1|||
160589179|NCT03607838|579874780|FG001|Overall Study|Pregnancy|0|||
160589180|NCT03607838|579874779|FG000|Overall Study|Protocol Violation|1|||
160589181|NCT03607838|579874780|FG001|Overall Study|Protocol Violation|0|||
160589182|NCT03607838|579874779|FG000|Overall Study|Due to work|1|||
160589183|NCT03607838|579874780|FG001|Overall Study|Due to work|0|||
160589184|NCT03607838|579874779|FG000|Overall Study|Litigation|0|||
160589185|NCT03607838|579874780|FG001|Overall Study|Litigation|1|||
160589186|NCT03607838|579874779|FG000|Overall Study|Temperature excursion for study drug|0|||
160589187|NCT03607838|579874780|FG001|Overall Study|Temperature excursion for study drug|1|||
160589188|NCT03607838|579874779|FG000|Overall Study|Change of mind|0|||
160589189|NCT03607838|579874780|FG001|Overall Study|Change of mind|1|||
160589190|NCT02411201|579874781|FG000|Overall Study|Adverse Event|2|||
160589191|NCT02411201|579874781|FG000|Overall Study|Withdrawal by Subject|2|||
160589192|NCT02411201|579874781|FG000|Overall Study|Age group completed|2|||
160589193|NCT01260467|579874782|FG000|Overall Study|Withdrawal by Subject|2|||
160589194|NCT00798694|579874783|FG000|Overall Study|Lost to Follow-up|1|||
160589195|NCT00798694|579874784|FG001|Overall Study|Lost to Follow-up|1|||
160589196|NCT00798694|579874783|FG000|Overall Study|Physician Decision|1|||
160589197|NCT00798694|579874784|FG001|Overall Study|Physician Decision|0|||
160589198|NCT01163253|579874790|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
160589199|NCT01163253|579874791|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
160589200|NCT01163253|579874790|FG000|Overall Study|Study Terminated by Sponsor|978|||
160589201|NCT01163253|579874791|FG001|Overall Study|Study Terminated by Sponsor|349|||
160589202|NCT01163253|579874790|FG000|Overall Study|Protocol Violation|43|||
160589203|NCT01163253|579874791|FG001|Overall Study|Protocol Violation|12|||
160589204|NCT01163253|579874790|FG000|Overall Study|Withdrawal by Subject|199|||
160589205|NCT01163253|579874791|FG001|Overall Study|Withdrawal by Subject|50|||
160589206|NCT01163253|579874790|FG000|Overall Study|Medication Error|1|||
160589207|NCT01163253|579874791|FG001|Overall Study|Medication Error|0|||
160589208|NCT01163253|579874790|FG000|Overall Study|Lost to Follow-up|125|||
160589209|NCT01163253|579874791|FG001|Overall Study|Lost to Follow-up|23|||
160589210|NCT01163253|579874790|FG000|Overall Study|Insufficient Clinical Response|423|||
160657369|NCT02848326|580127504|FG002|Treatment Period|Lost to Follow-up|11|||
160657370|NCT02848326|580127505|FG003|Treatment Period|Lost to Follow-up|7|||
160657371|NCT02848326|580127506|FG004|Treatment Period|Lost to Follow-up|2|||
160657372|NCT02848326|580127507|FG005|Treatment Period|Lost to Follow-up|3|||
161024780|NCT04486716|581483668|FG000|Core Phase|Enrolled subjects not treated|9|||
161024781|NCT02797522|581483670|FG000|Overall Study|Study Terminated by Sponsor|0|||
161024782|NCT02797522|581483671|FG001|Overall Study|Study Terminated by Sponsor|0|||
161024783|NCT02797522|581483672|FG002|Overall Study|Study Terminated by Sponsor|0|||
161024784|NCT02797522|581483673|FG003|Overall Study|Study Terminated by Sponsor|0|||
161024785|NCT02797522|581483674|FG004|Overall Study|Study Terminated by Sponsor|0|||
161024786|NCT02797522|581483675|FG005|Overall Study|Study Terminated by Sponsor|0|||
161024787|NCT02797522|581483676|FG006|Overall Study|Study Terminated by Sponsor|0|||
161024788|NCT02797522|581483677|FG007|Overall Study|Study Terminated by Sponsor|4|||
161024789|NCT02797522|581483678|FG008|Overall Study|Study Terminated by Sponsor|2|||
161024790|NCT02797522|581483679|FG009|Overall Study|Study Terminated by Sponsor|4|||
161024791|NCT02797522|581483680|FG010|Overall Study|Study Terminated by Sponsor|1|||
161024792|NCT05888103|581483681|FG000|Overall Study|Participant decision|3|||
161024793|NCT05888103|581483682|FG001|Overall Study|Participant decision|3|||
161024794|NCT04987307|581483683|FG000|Overall Study|Protocol-specified criteria|2|||
161024795|NCT04987307|581483684|FG001|Overall Study|Protocol-specified criteria|0|||
161024796|NCT04987307|581483685|FG002|Overall Study|Protocol-specified criteria|0|||
161024797|NCT04987307|581483686|FG003|Overall Study|Protocol-specified criteria|3|||
161024798|NCT04987307|581483683|FG000|Overall Study|Withdrawal by Subject|34|||
161024799|NCT04987307|581483684|FG001|Overall Study|Withdrawal by Subject|30|||
161024800|NCT04987307|581483685|FG002|Overall Study|Withdrawal by Subject|29|||
161024801|NCT04987307|581483686|FG003|Overall Study|Withdrawal by Subject|35|||
161024802|NCT04987307|581483683|FG000|Overall Study|Decision by sponsor|10|||
160657373|NCT02848326|580127502|FG000|Treatment Period|Pregnancy|0|||
161024803|NCT04987307|581483684|FG001|Overall Study|Decision by sponsor|13|||
161024804|NCT04987307|581483685|FG002|Overall Study|Decision by sponsor|11|||
161024805|NCT04987307|581483686|FG003|Overall Study|Decision by sponsor|9|||
161024806|NCT04987307|581483683|FG000|Overall Study|Lost to Follow-up|1|||
161024807|NCT04987307|581483684|FG001|Overall Study|Lost to Follow-up|0|||
160589211|NCT01163253|579874791|FG001|Overall Study|Insufficient Clinical Response|29|||
160589212|NCT01163253|579874790|FG000|Overall Study|Adverse Event|300|||
160589213|NCT01163253|579874791|FG001|Overall Study|Adverse Event|78|||
160657374|NCT02848326|580127503|FG001|Treatment Period|Pregnancy|0|||
160589214|NCT01163253|579874790|FG000|Overall Study|Death|17|||
160589215|NCT01163253|579874791|FG001|Overall Study|Death|5|||
160589216|NCT01163253|579874790|FG000|Overall Study|Ongoing|13|||
160589217|NCT01163253|579874791|FG001|Overall Study|Ongoing|4|||
160589218|NCT01163253|579874790|FG000|Overall Study|Other Unspecified|170|||
160657375|NCT02848326|580127504|FG002|Treatment Period|Pregnancy|1|||
161024808|NCT04987307|581483685|FG002|Overall Study|Lost to Follow-up|0|||
161024809|NCT04987307|581483686|FG003|Overall Study|Lost to Follow-up|0|||
161024810|NCT04304820|581483687|FG000|Overall Study|Death|1|||
161024811|NCT04304820|581483687|FG000|Overall Study|Lost to Follow-up|1|||
161024812|NCT04304820|581483687|FG000|Overall Study|Pursuing Stem Cell Transplant|4|||
161024813|NCT04304820|581483687|FG000|Overall Study|Pursuing Additional Immunosuppressive therapy|4|||
161024814|NCT04304820|581483687|FG000|Overall Study|Evolution to Myeloid Malignancy|1|||
161024815|NCT03031912|581483688|FG000|Overall Study|Lost to Follow-up|1|||
161024816|NCT03031912|581483689|FG001|Overall Study|Lost to Follow-up|1|||
160589219|NCT01163253|579874791|FG001|Overall Study|Other Unspecified|34|||
160589220|NCT00423735|579874792|FG000|Overall Study|Ineligible / No protocol treatment|8|||
160589221|NCT00423735|579874793|FG001|Overall Study|Ineligible / No protocol treatment|6|||
160589222|NCT00423735|579874794|FG002|Overall Study|Ineligible / No protocol treatment|0|||
160589223|NCT00579501|579874800|FG000|Overall Study|Death|1|||
160589224|NCT00579501|579874800|FG000|Overall Study|End of neoadjuvant therapy|25|||
160589225|NCT00579501|579874800|FG000|Overall Study|toxicity|1|||
160589226|NCT00579501|579874800|FG000|Overall Study|Secondary lesion|1|||
160589227|NCT00579501|579874800|FG000|Overall Study|Radiation therapy before surgery|1|||
160589228|NCT00190983|579874801|FG000|Overall Study|Inevaluable (never treated)|2|||
160589229|NCT02394808|579874802|FG000|Period 1|Unsatisfactory lens fitting|0|||
160589230|NCT02394808|579874803|FG001|Period 1|Unsatisfactory lens fitting|1|||
160589231|NCT02394808|579874802|FG000|Period 2|Lost to Follow-up|1|||
160589232|NCT02394808|579874803|FG001|Period 2|Lost to Follow-up|0|||
160589233|NCT00289185|579874804|FG000|Overall Study|Withdrawal by Subject|4|||
160589234|NCT00289185|579874805|FG001|Overall Study|Withdrawal by Subject|8|||
160589235|NCT00289185|579874804|FG000|Overall Study|Lost to Follow-up|23|||
160589236|NCT00289185|579874805|FG001|Overall Study|Lost to Follow-up|17|||
160589237|NCT00289185|579874804|FG000|Overall Study|Death|1|||
160589238|NCT00289185|579874805|FG001|Overall Study|Death|1|||
160589239|NCT01124448|579874806|FG000|Overall Study|Lost to Follow-up|0|||
160589240|NCT01124448|579874807|FG001|Overall Study|Lost to Follow-up|3|||
160589241|NCT01124448|579874806|FG000|Overall Study|Protocol Violation|2|||
160589242|NCT01124448|579874807|FG001|Overall Study|Protocol Violation|0|||
160589243|NCT03471767|579874808|FG000|Overall Study|Withdrawal by Subject|3|||
160589244|NCT03471767|579874809|FG001|Overall Study|Withdrawal by Subject|1|||
160589245|NCT03471767|579874808|FG000|Overall Study|Adverse Event|1|||
160589246|NCT03471767|579874809|FG001|Overall Study|Adverse Event|0|||
160589247|NCT03471767|579874808|FG000|Overall Study|Lost to Follow-up|1|||
160589248|NCT03471767|579874809|FG001|Overall Study|Lost to Follow-up|0|||
160589249|NCT03471767|579874808|FG000|Overall Study|PI Withdrawal|1|||
160589250|NCT03471767|579874809|FG001|Overall Study|PI Withdrawal|3|||
160589251|NCT00678587|579874810|FG000|Overall Study|Adverse Event|3|||
160589252|NCT00678587|579874811|FG001|Overall Study|Adverse Event|3|||
160589253|NCT00678587|579874810|FG000|Overall Study|Lack of Efficacy|1|||
160589254|NCT00678587|579874811|FG001|Overall Study|Lack of Efficacy|0|||
160589255|NCT00678587|579874810|FG000|Overall Study|Protocol Violation|2|||
160589256|NCT00678587|579874811|FG001|Overall Study|Protocol Violation|1|||
160589257|NCT00678587|579874810|FG000|Overall Study|Study Closed/Terminated|1|||
160589258|NCT00678587|579874811|FG001|Overall Study|Study Closed/Terminated|0|||
160589259|NCT00678587|579874810|FG000|Overall Study|Lost to Follow-up|3|||
160589260|NCT00678587|579874811|FG001|Overall Study|Lost to Follow-up|5|||
160589261|NCT00678587|579874810|FG000|Overall Study|Investigator Discretion|2|||
160589262|NCT00678587|579874811|FG001|Overall Study|Investigator Discretion|6|||
160589263|NCT00678587|579874810|FG000|Overall Study|Withdrew Consent|8|||
160589264|NCT00678587|579874811|FG001|Overall Study|Withdrew Consent|3|||
160589265|NCT01019486|579874814|FG000|Overall Study|Withdrawal by Subject|1|||
160589266|NCT01019486|579874815|FG001|Overall Study|Withdrawal by Subject|1|||
160589267|NCT01019486|579874816|FG002|Overall Study|Withdrawal by Subject|1|||
160589268|NCT01875367|579874817|FG000|Overall Study|Not complete at least 2 questionaries|4|||
160589269|NCT01875367|579874818|FG001|Overall Study|Not complete at least 2 questionaries|2|||
160589270|NCT01875367|579874817|FG000|Overall Study|Not receive study treatment|1|||
160589271|NCT01875367|579874818|FG001|Overall Study|Not receive study treatment|0|||
160589272|NCT02605447|579874819|FG000|Overall Study|Death|66|||
160589273|NCT02605447|579874819|FG000|Overall Study|Physician Decision|1|||
160589274|NCT02605447|579874819|FG000|Overall Study|Lost to Follow-up|24|||
160589275|NCT02605447|579874819|FG000|Overall Study|Withdrawal by Subject|10|||
161024817|NCT03031912|581483690|FG002|Overall Study|Lost to Follow-up|0|||
161024818|NCT03031912|581483691|FG003|Overall Study|Lost to Follow-up|1|||
160589276|NCT02605447|579874819|FG000|Overall Study|Not disclosed|1|||
160589277|NCT02045212|579874820|FG000|Overall Study|Adverse Event|0|||
161024819|NCT03031912|581483692|FG004|Overall Study|Lost to Follow-up|0|||
160589278|NCT02045212|579874821|FG001|Overall Study|Adverse Event|1|||
160589279|NCT02045212|579874820|FG000|Overall Study|Withdrawal by Subject|1|||
160589280|NCT02045212|579874821|FG001|Overall Study|Withdrawal by Subject|0|||
160589281|NCT02045212|579874820|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
160589282|NCT02045212|579874821|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
160589283|NCT02951988|579874822|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
160589284|NCT02951988|579874823|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
160589285|NCT02951988|579874824|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
161024820|NCT03031912|581483693|FG005|Overall Study|Lost to Follow-up|0|||
160589286|NCT02951988|579874825|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
160589287|NCT02951988|579874822|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
160589288|NCT02951988|579874823|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
160589289|NCT02951988|579874824|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
160589290|NCT02951988|579874825|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
160589291|NCT02951988|579874822|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
160589292|NCT02951988|579874823|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
160589293|NCT02951988|579874824|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
160589294|NCT02951988|579874825|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
160589295|NCT02951988|579874822|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
160589296|NCT02951988|579874823|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
160589297|NCT02951988|579874824|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
160589298|NCT02951988|579874825|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
160589299|NCT02951988|579874822|FG000|Open-Label Treatment Period|Protocol Violation|22|||
160589300|NCT02951988|579874823|FG001|Open-Label Treatment Period|Protocol Violation|0|||
160589301|NCT02951988|579874824|FG002|Open-Label Treatment Period|Protocol Violation|0|||
160589302|NCT02951988|579874825|FG003|Open-Label Treatment Period|Protocol Violation|0|||
160589303|NCT02951988|579874822|FG000|Open-Label Treatment Period|Pregnancy|2|||
160589304|NCT02951988|579874823|FG001|Open-Label Treatment Period|Pregnancy|0|||
160589305|NCT02951988|579874824|FG002|Open-Label Treatment Period|Pregnancy|0|||
160589306|NCT02951988|579874825|FG003|Open-Label Treatment Period|Pregnancy|0|||
160589307|NCT02951988|579874822|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
160589308|NCT02951988|579874823|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
160589309|NCT02951988|579874824|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
160589310|NCT02951988|579874825|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
160589311|NCT02951988|579874822|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
160589312|NCT02951988|579874823|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
160589313|NCT02951988|579874824|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
160589314|NCT02951988|579874825|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
160589315|NCT02951988|579874822|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
160589316|NCT02951988|579874823|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
160589317|NCT02951988|579874824|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
160589318|NCT02951988|579874825|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
160589319|NCT02951988|579874822|FG000|Open-Label Treatment Period|Adverse Event|45|||
160589320|NCT02951988|579874823|FG001|Open-Label Treatment Period|Adverse Event|0|||
160589321|NCT02951988|579874824|FG002|Open-Label Treatment Period|Adverse Event|0|||
160589322|NCT02951988|579874825|FG003|Open-Label Treatment Period|Adverse Event|0|||
160589323|NCT02951988|579874822|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
160589324|NCT02951988|579874823|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
160589325|NCT02951988|579874824|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
160589326|NCT02951988|579874825|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
160589327|NCT02951988|579874822|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
160589328|NCT02951988|579874823|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
160589329|NCT02951988|579874824|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
160589330|NCT02951988|579874825|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
160589331|NCT02951988|579874822|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
160589332|NCT02951988|579874823|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
160589333|NCT02951988|579874824|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
160589334|NCT02951988|579874825|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
160589335|NCT02951988|579874822|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
160589336|NCT02951988|579874823|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
160589337|NCT02951988|579874824|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
161024821|NCT03031912|581483694|FG006|Overall Study|Lost to Follow-up|0|||
161024822|NCT03031912|581483695|FG007|Overall Study|Lost to Follow-up|0|||
161024823|NCT03031912|581483696|FG008|Overall Study|Lost to Follow-up|0|||
161024824|NCT03031912|581483697|FG009|Overall Study|Lost to Follow-up|0|||
161024825|NCT03873818|581483698|FG000|Overall Study|Death|9|||
161024826|NCT03873818|581483699|FG001|Overall Study|Death|3|||
161024827|NCT03873818|581483698|FG000|Overall Study|Lost to Follow-up|1|||
161024828|NCT03873818|581483699|FG001|Overall Study|Lost to Follow-up|0|||
161024829|NCT03650400|581483702|FG000|Overall Study|Study terminated by sponsor|0|||
161024830|NCT03650400|581483703|FG001|Overall Study|Study terminated by sponsor|5|||
161024831|NCT04097743|581483704|FG000|Overall Study|Non-compliance of the study instruction.|1|||
160589338|NCT02951988|579874825|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
160589339|NCT02951988|579874822|FG000|Double-Blind Treatment Period|Pregnancy|0|||
160589340|NCT02951988|579874823|FG001|Double-Blind Treatment Period|Pregnancy|1|||
160589341|NCT02951988|579874824|FG002|Double-Blind Treatment Period|Pregnancy|1|||
161024832|NCT04097743|581483705|FG001|Overall Study|Non-compliance of the study instruction.|0|||
161024833|NCT05541861|581483709|FG000|Overall Study|Withdrawal by Subject|0|||
161024834|NCT05541861|581483710|FG001|Overall Study|Withdrawal by Subject|0|||
160589342|NCT02951988|579874825|FG003|Double-Blind Treatment Period|Pregnancy|0|||
160589343|NCT02951988|579874822|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160589344|NCT02951988|579874823|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
160589345|NCT02951988|579874824|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
160589346|NCT02951988|579874825|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
160589347|NCT02951988|579874822|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160589348|NCT02951988|579874823|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
160589349|NCT02951988|579874824|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
160589350|NCT02951988|579874825|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
160589351|NCT02951988|579874822|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160589352|NCT02951988|579874823|FG001|Double-Blind Treatment Period|Adverse Event|8|||
160589353|NCT02951988|579874824|FG002|Double-Blind Treatment Period|Adverse Event|3|||
160589354|NCT02951988|579874825|FG003|Double-Blind Treatment Period|Adverse Event|6|||
160589355|NCT02951988|579874822|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
160589356|NCT02951988|579874823|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
160589357|NCT02951988|579874824|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
160589358|NCT02951988|579874825|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
160589359|NCT00115804|579874828|FG000|Overall Study|Adverse Event|2|||
160589360|NCT00621855|579874829|FG000|Overall Study|Adverse Event|32|||
160589361|NCT00621855|579874830|FG001|Overall Study|Adverse Event|31|||
160589362|NCT00621855|579874831|FG002|Overall Study|Adverse Event|48|||
160589363|NCT00621855|579874832|FG003|Overall Study|Adverse Event|34|||
160589364|NCT00621855|579874833|FG004|Overall Study|Adverse Event|31|||
160589365|NCT00621855|579874829|FG000|Overall Study|Lost to Follow-up|0|||
160589366|NCT00621855|579874830|FG001|Overall Study|Lost to Follow-up|1|||
160589367|NCT00621855|579874831|FG002|Overall Study|Lost to Follow-up|3|||
160589368|NCT00621855|579874832|FG003|Overall Study|Lost to Follow-up|4|||
160589369|NCT00621855|579874833|FG004|Overall Study|Lost to Follow-up|1|||
160589370|NCT00621855|579874829|FG000|Overall Study|Protocol Violation|16|||
160589371|NCT00621855|579874830|FG001|Overall Study|Protocol Violation|8|||
160589372|NCT00621855|579874831|FG002|Overall Study|Protocol Violation|6|||
160589373|NCT00621855|579874832|FG003|Overall Study|Protocol Violation|7|||
160589374|NCT00621855|579874833|FG004|Overall Study|Protocol Violation|8|||
160589375|NCT00621855|579874829|FG000|Overall Study|Withdrawal by Subject|16|||
160589376|NCT00621855|579874830|FG001|Overall Study|Withdrawal by Subject|11|||
160589377|NCT00621855|579874831|FG002|Overall Study|Withdrawal by Subject|13|||
160589378|NCT00621855|579874832|FG003|Overall Study|Withdrawal by Subject|13|||
160589379|NCT00621855|579874833|FG004|Overall Study|Withdrawal by Subject|9|||
160973142|NCT03500640|581291151|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
160973143|NCT03500640|581291152|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
160973144|NCT03500640|581291150|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
160973145|NCT03500640|581291151|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
160973146|NCT03500640|581291152|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
160973147|NCT03500640|581291150|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
160973148|NCT03500640|581291151|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
160973149|NCT03500640|581291152|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
160973150|NCT01535274|581291153|FG000|Overall Study|Determined to be ineligible|0|||
160973151|NCT01535274|581291154|FG001|Overall Study|Determined to be ineligible|1|||
160973152|NCT01535274|581291153|FG000|Overall Study|Misallocated to propofol intervention|0|||
160973153|NCT01535274|581291154|FG001|Overall Study|Misallocated to propofol intervention|1|||
160973154|NCT02954458|581291157|FG000|Overall Study|Adverse Event|0|||
160973155|NCT02954458|581291158|FG001|Overall Study|Adverse Event|0|||
160973156|NCT02954458|581291159|FG002|Overall Study|Adverse Event|0|||
160973157|NCT02954458|581291160|FG003|Overall Study|Adverse Event|1|||
160973158|NCT02954458|581291157|FG000|Overall Study|Withdrawal by Subject|0|||
160973159|NCT02954458|581291158|FG001|Overall Study|Withdrawal by Subject|0|||
160973160|NCT02954458|581291159|FG002|Overall Study|Withdrawal by Subject|0|||
160973161|NCT02954458|581291160|FG003|Overall Study|Withdrawal by Subject|1|||
160973162|NCT02954458|581291157|FG000|Overall Study|Physician Decision|0|||
160973163|NCT02954458|581291158|FG001|Overall Study|Physician Decision|0|||
160973164|NCT02954458|581291159|FG002|Overall Study|Physician Decision|1|||
160973165|NCT02954458|581291160|FG003|Overall Study|Physician Decision|1|||
160973166|NCT02954458|581291157|FG000|Overall Study|Lost to Follow-up|1|||
160973167|NCT02954458|581291158|FG001|Overall Study|Lost to Follow-up|0|||
160973168|NCT02954458|581291159|FG002|Overall Study|Lost to Follow-up|0|||
160973169|NCT02954458|581291160|FG003|Overall Study|Lost to Follow-up|1|||
160589380|NCT00621855|579874829|FG000|Overall Study|Other|9|||
160589381|NCT00621855|579874830|FG001|Overall Study|Other|7|||
160589382|NCT00621855|579874831|FG002|Overall Study|Other|6|||
160589383|NCT00621855|579874832|FG003|Overall Study|Other|5|||
160589384|NCT00621855|579874833|FG004|Overall Study|Other|4|||
160589385|NCT00621855|579874829|FG000|Overall Study|Patients did not receive study drug|3|||
160657376|NCT02848326|580127505|FG003|Treatment Period|Pregnancy|1|||
160973170|NCT02954458|581291157|FG000|Overall Study|Death|0|||
160973171|NCT02954458|581291158|FG001|Overall Study|Death|0|||
160973172|NCT02954458|581291159|FG002|Overall Study|Death|0|||
160589386|NCT00621855|579874830|FG001|Overall Study|Patients did not receive study drug|3|||
160589387|NCT00621855|579874831|FG002|Overall Study|Patients did not receive study drug|5|||
160589388|NCT00621855|579874832|FG003|Overall Study|Patients did not receive study drug|4|||
160589389|NCT00621855|579874833|FG004|Overall Study|Patients did not receive study drug|2|||
160589390|NCT04387136|579874834|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
160589391|NCT04387136|579874835|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
160589392|NCT01029886|579874838|FG000|Overall Study|Adverse Event|12|||
160589393|NCT01029886|579874839|FG001|Overall Study|Adverse Event|25|||
160589394|NCT01029886|579874838|FG000|Overall Study|Lost to Follow-up|1|||
160589395|NCT01029886|579874839|FG001|Overall Study|Lost to Follow-up|0|||
160589396|NCT01029886|579874838|FG000|Overall Study|Physician Decision|2|||
160589397|NCT01029886|579874839|FG001|Overall Study|Physician Decision|6|||
160589398|NCT01029886|579874838|FG000|Overall Study|Protocol Violation|17|||
160589399|NCT01029886|579874839|FG001|Overall Study|Protocol Violation|5|||
160589400|NCT01029886|579874838|FG000|Overall Study|Withdrawal by Subject|8|||
160589401|NCT01029886|579874839|FG001|Overall Study|Withdrawal by Subject|18|||
160589402|NCT01029886|579874838|FG000|Overall Study|Entry Criteria Not Met|13|||
160589403|NCT01029886|579874839|FG001|Overall Study|Entry Criteria Not Met|5|||
160589404|NCT01029886|579874838|FG000|Overall Study|Sponsor Decision|1|||
160589405|NCT01029886|579874839|FG001|Overall Study|Sponsor Decision|0|||
160589406|NCT01029886|579874838|FG000|Overall Study|Loss Glucose Control|7|||
160589407|NCT01029886|579874839|FG001|Overall Study|Loss Glucose Control|1|||
160589408|NCT03294681|579874840|FG000|Overall Study|Withdrawal by Subject|1|||
160589409|NCT00417976|579874841|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
160589410|NCT00417976|579874841|FG000|Overall Study|Treatment -related toxicity|2|||
160589411|NCT04501679|579874842|FG000|Overall Study|Pregnancy|0|||
160589412|NCT04501679|579874843|FG001|Overall Study|Pregnancy|1|||
160657377|NCT02848326|580127506|FG004|Treatment Period|Pregnancy|0|||
160657378|NCT02848326|580127507|FG005|Treatment Period|Pregnancy|1|||
160657379|NCT02848326|580127502|FG000|Treatment Period|Protocol Violation|4|||
160657380|NCT02848326|580127503|FG001|Treatment Period|Protocol Violation|3|||
160657381|NCT02848326|580127504|FG002|Treatment Period|Protocol Violation|4|||
160657382|NCT02848326|580127505|FG003|Treatment Period|Protocol Violation|2|||
161024835|NCT05541861|581483711|FG002|Overall Study|Withdrawal by Subject|0|||
161024836|NCT05541861|581483712|FG003|Overall Study|Withdrawal by Subject|0|||
161024837|NCT05541861|581483713|FG004|Overall Study|Withdrawal by Subject|0|||
161024838|NCT05541861|581483714|FG005|Overall Study|Withdrawal by Subject|0|||
161024839|NCT05541861|581483715|FG006|Overall Study|Withdrawal by Subject|2|||
161024840|NCT05541861|581483716|FG007|Overall Study|Withdrawal by Subject|0|||
161024841|NCT05541861|581483717|FG008|Overall Study|Withdrawal by Subject|0|||
161024842|NCT05541861|581483709|FG000|Overall Study|Randomized but not dosed|0|||
161024843|NCT05541861|581483710|FG001|Overall Study|Randomized but not dosed|1|||
161024844|NCT05541861|581483711|FG002|Overall Study|Randomized but not dosed|1|||
161024845|NCT05541861|581483712|FG003|Overall Study|Randomized but not dosed|0|||
161024846|NCT05541861|581483713|FG004|Overall Study|Randomized but not dosed|0|||
161024847|NCT05541861|581483714|FG005|Overall Study|Randomized but not dosed|0|||
161024848|NCT05541861|581483715|FG006|Overall Study|Randomized but not dosed|1|||
161024849|NCT05541861|581483716|FG007|Overall Study|Randomized but not dosed|0|||
161024850|NCT05541861|581483717|FG008|Overall Study|Randomized but not dosed|1|||
161024851|NCT03474107|581483724|FG000|Overall Study|Adverse Event|42|||
161024852|NCT03474107|581483725|FG001|Overall Study|Adverse Event|46|||
161024853|NCT03474107|581483724|FG000|Overall Study|Death|2|||
161024854|NCT03474107|581483725|FG001|Overall Study|Death|2|||
161024855|NCT03474107|581483724|FG000|Overall Study|Lost to Follow-up|0|||
161024856|NCT03474107|581483725|FG001|Overall Study|Lost to Follow-up|1|||
161024857|NCT03474107|581483724|FG000|Overall Study|Progressive Disease|177|||
161024858|NCT03474107|581483725|FG001|Overall Study|Progressive Disease|180|||
161024859|NCT03474107|581483724|FG000|Overall Study|Protocol Violation|1|||
161024860|NCT03474107|581483725|FG001|Overall Study|Protocol Violation|1|||
161024861|NCT03474107|581483724|FG000|Overall Study|Withdrawal by Subject|15|||
161024862|NCT03474107|581483725|FG001|Overall Study|Withdrawal by Subject|27|||
161024863|NCT03474107|581483724|FG000|Overall Study|Physician Decision|7|||
160589413|NCT04501679|579874842|FG000|Overall Study|Adverse Event|4|||
160589414|NCT04501679|579874843|FG001|Overall Study|Adverse Event|2|||
160657383|NCT02848326|580127506|FG004|Treatment Period|Protocol Violation|3|||
160657384|NCT02848326|580127507|FG005|Treatment Period|Protocol Violation|3|||
160589415|NCT04501679|579874842|FG000|Overall Study|Withdrawal by Subject|2|||
160589416|NCT04501679|579874843|FG001|Overall Study|Withdrawal by Subject|0|||
160589417|NCT04501679|579874842|FG000|Overall Study|Physician Decision|1|||
160589418|NCT04501679|579874843|FG001|Overall Study|Physician Decision|0|||
161024864|NCT03474107|581483725|FG001|Overall Study|Physician Decision|22|||
161024865|NCT03474107|581483724|FG000|Overall Study|Miscellaneous|1|||
161024866|NCT03474107|581483725|FG001|Overall Study|Miscellaneous|6|||
161024867|NCT04452877|581483726|FG000|Overall Study|Adverse Event|5|||
161024868|NCT04452877|581483726|FG000|Overall Study|Lost to Follow-up|1|||
161024869|NCT04452877|581483726|FG000|Overall Study|Physician Decision|4|||
161024870|NCT04452877|581483726|FG000|Overall Study|Progressive Disease|18|||
161024871|NCT04452877|581483726|FG000|Overall Study|Withdrawal by Subject|3|||
160589419|NCT04501679|579874842|FG000|Overall Study|Lost to Follow-up|2|||
160589420|NCT04501679|579874843|FG001|Overall Study|Lost to Follow-up|0|||
160589421|NCT02358369|579874846|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
160589422|NCT02358369|579874847|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
160589423|NCT02358369|579874848|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
160589424|NCT02358369|579874849|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
160589425|NCT02358369|579874850|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
160589426|NCT02358369|579874846|FG000|Treatment Period A/B|Adverse Event|0|||
160589427|NCT02358369|579874847|FG001|Treatment Period A/B|Adverse Event|0|||
160589428|NCT02358369|579874848|FG002|Treatment Period A/B|Adverse Event|1|||
160589429|NCT02358369|579874849|FG003|Treatment Period A/B|Adverse Event|2|||
161024872|NCT05678959|581483727|FG000|Overall Study|Study Terminated by Sponsor|76|||
161024873|NCT05678959|581483728|FG001|Overall Study|Study Terminated by Sponsor|76|||
161024874|NCT05678959|581483727|FG000|Overall Study|Physician Decision|2|||
161024875|NCT05678959|581483728|FG001|Overall Study|Physician Decision|3|||
161024876|NCT05678959|581483727|FG000|Overall Study|Adverse Event|1|||
161024877|NCT05678959|581483728|FG001|Overall Study|Adverse Event|1|||
161024878|NCT05678959|581483727|FG000|Overall Study|Guardian Decision|1|||
161024879|NCT05678959|581483728|FG001|Overall Study|Guardian Decision|0|||
161024880|NCT05678959|581483727|FG000|Overall Study|Protocol Deviation|0|||
161024881|NCT05678959|581483728|FG001|Overall Study|Protocol Deviation|1|||
161024882|NCT05678959|581483727|FG000|Overall Study|Subject Decision|1|||
161024883|NCT05678959|581483728|FG001|Overall Study|Subject Decision|0|||
161024884|NCT05678959|581483727|FG000|Overall Study|Technical Problem|0|||
161024885|NCT05678959|581483728|FG001|Overall Study|Technical Problem|1|||
161024886|NCT02932410|581483729|FG000|Overall Study|Death|7|||
161024887|NCT02932410|581483730|FG001|Overall Study|Death|6|||
161024888|NCT02932410|581483731|FG002|Overall Study|Death|0|||
161024889|NCT02932410|581483732|FG003|Overall Study|Death|0|||
161024890|NCT02932410|581483729|FG000|Overall Study|Lost to Follow-up|1|||
161024891|NCT02932410|581483730|FG001|Overall Study|Lost to Follow-up|2|||
161024892|NCT02932410|581483731|FG002|Overall Study|Lost to Follow-up|0|||
161024893|NCT02932410|581483732|FG003|Overall Study|Lost to Follow-up|0|||
161024894|NCT02932410|581483729|FG000|Overall Study|Parent/Subjects decision|6|||
161024895|NCT02932410|581483730|FG001|Overall Study|Parent/Subjects decision|6|||
161024896|NCT02932410|581483731|FG002|Overall Study|Parent/Subjects decision|1|||
161024897|NCT02932410|581483732|FG003|Overall Study|Parent/Subjects decision|0|||
161024898|NCT02932410|581483729|FG000|Overall Study|Physician Decision|0|||
161024899|NCT02932410|581483730|FG001|Overall Study|Physician Decision|1|||
161024900|NCT02932410|581483731|FG002|Overall Study|Physician Decision|0|||
161024901|NCT02932410|581483732|FG003|Overall Study|Physician Decision|0|||
161024902|NCT05171855|581483735|FG000|Overall Study|Death|1|||
161024903|NCT05171855|581483736|FG001|Overall Study|Death|0|||
161024904|NCT05171855|581483737|FG002|Overall Study|Death|0|||
161024905|NCT05171855|581483735|FG000|Overall Study|Withdrawal by Subject|2|||
161024906|NCT05171855|581483736|FG001|Overall Study|Withdrawal by Subject|0|||
161024907|NCT05171855|581483737|FG002|Overall Study|Withdrawal by Subject|5|||
161024908|NCT05171855|581483735|FG000|Overall Study|Physician Decision|1|||
161024909|NCT05171855|581483736|FG001|Overall Study|Physician Decision|0|||
161024910|NCT05171855|581483737|FG002|Overall Study|Physician Decision|0|||
161024911|NCT05171855|581483735|FG000|Overall Study|Adverse Event|2|||
161024912|NCT05171855|581483736|FG001|Overall Study|Adverse Event|4|||
161024913|NCT05171855|581483737|FG002|Overall Study|Adverse Event|2|||
161024914|NCT05171855|581483735|FG000|Overall Study|Other|0|||
161024915|NCT05171855|581483736|FG001|Overall Study|Other|0|||
161024916|NCT05171855|581483737|FG002|Overall Study|Other|1|||
161024917|NCT05041257|581483738|FG000|Overall Study|Death|37|||
161024918|NCT05041257|581483738|FG000|Overall Study|Lost to Follow-up|3|||
161024919|NCT05041257|581483738|FG000|Overall Study|Sponsor decision|39|||
161024920|NCT02065336|581483739|FG000|Extension Phase|Study Terminated by Sponsor|0|||
161024921|NCT02065336|581483740|FG001|Extension Phase|Study Terminated by Sponsor|0|||
161024922|NCT02065336|581483741|FG002|Extension Phase|Study Terminated by Sponsor|0|||
161024923|NCT02065336|581483742|FG003|Extension Phase|Study Terminated by Sponsor|0|||
160589430|NCT02358369|579874850|FG004|Treatment Period A/B|Adverse Event|0|||
160589431|NCT02358369|579874846|FG000|Treatment Period A/B|Death|0|||
161024924|NCT02065336|581483743|FG004|Extension Phase|Study Terminated by Sponsor|0|||
161024925|NCT02065336|581483744|FG005|Extension Phase|Study Terminated by Sponsor|0|||
161024926|NCT02065336|581483745|FG006|Extension Phase|Study Terminated by Sponsor|0|||
161024927|NCT02065336|581483746|FG007|Extension Phase|Study Terminated by Sponsor|0|||
161024928|NCT02065336|581483747|FG008|Extension Phase|Study Terminated by Sponsor|2|||
161024929|NCT02065336|581483748|FG009|Extension Phase|Study Terminated by Sponsor|8|||
161024930|NCT03226392|581483750|FG000|Overall Study|Protocol Deviation|1|||
161024931|NCT03226392|581483751|FG001|Overall Study|Protocol Deviation|0|||
161024932|NCT03226392|581483750|FG000|Overall Study|Physician Decision|1|||
161024933|NCT03226392|581483751|FG001|Overall Study|Physician Decision|0|||
161024934|NCT03226392|581483750|FG000|Overall Study|Lost to Follow-up|1|||
161024935|NCT03226392|581483751|FG001|Overall Study|Lost to Follow-up|0|||
161024936|NCT03226392|581483750|FG000|Overall Study|Adverse Event|1|||
161024937|NCT03226392|581483751|FG001|Overall Study|Adverse Event|0|||
161024938|NCT03226392|581483750|FG000|Overall Study|Technical Problems|0|||
161024939|NCT03226392|581483751|FG001|Overall Study|Technical Problems|2|||
161024940|NCT03226392|581483750|FG000|Overall Study|Subject/Guardian Decision|7|||
161024941|NCT03226392|581483751|FG001|Overall Study|Subject/Guardian Decision|6|||
161024942|NCT03056755|581483752|FG000|Core Phase|Progressive disease|89|||
161024943|NCT03056755|581483753|FG001|Core Phase|Progressive disease|88|||
161024944|NCT03056755|581483754|FG002|Core Phase|Progressive disease|90|||
161024945|NCT03056755|581483752|FG000|Core Phase|Adverse Event|20|||
161024946|NCT03056755|581483753|FG001|Core Phase|Adverse Event|14|||
161024947|NCT03056755|581483754|FG002|Core Phase|Adverse Event|13|||
161024948|NCT03056755|581483752|FG000|Core Phase|Physician Decision|7|||
161024949|NCT03056755|581483753|FG001|Core Phase|Physician Decision|13|||
161024950|NCT03056755|581483754|FG002|Core Phase|Physician Decision|5|||
161024951|NCT03056755|581483752|FG000|Core Phase|Subject/guardian decision|5|||
161024952|NCT03056755|581483753|FG001|Core Phase|Subject/guardian decision|8|||
161024953|NCT03056755|581483754|FG002|Core Phase|Subject/guardian decision|4|||
161024954|NCT03056755|581483752|FG000|Core Phase|Death|3|||
161024955|NCT03056755|581483753|FG001|Core Phase|Death|2|||
161024956|NCT03056755|581483754|FG002|Core Phase|Death|4|||
161024957|NCT03056755|581483752|FG000|Core Phase|Protocol deviation|1|||
161024958|NCT03056755|581483753|FG001|Core Phase|Protocol deviation|1|||
161024959|NCT03056755|581483754|FG002|Core Phase|Protocol deviation|0|||
161024960|NCT03056755|581483752|FG000|Core Phase|Technical problems|1|||
161024961|NCT03056755|581483753|FG001|Core Phase|Technical problems|0|||
161024962|NCT03056755|581483754|FG002|Core Phase|Technical problems|0|||
161024963|NCT03056755|581483752|FG000|Extension Phase|Physician Decision|1|||
161024964|NCT03056755|581483753|FG001|Extension Phase|Physician Decision|0|||
161024965|NCT03056755|581483754|FG002|Extension Phase|Physician Decision|3|||
161024966|NCT03056755|581483752|FG000|Extension Phase|Adverse Event|0|||
161024967|NCT03056755|581483753|FG001|Extension Phase|Adverse Event|0|||
161024968|NCT03056755|581483754|FG002|Extension Phase|Adverse Event|1|||
161024969|NCT03056755|581483752|FG000|Extension Phase|Subject/guardian decision|0|||
161024970|NCT03056755|581483753|FG001|Extension Phase|Subject/guardian decision|0|||
161024971|NCT03056755|581483754|FG002|Extension Phase|Subject/guardian decision|1|||
161024972|NCT04693715|581483759|FG000|Overall Study|Adverse Events Leading to Death|2|||
161024973|NCT04693715|581483760|FG001|Overall Study|Adverse Events Leading to Death|2|||
161024974|NCT04693715|581483761|FG002|Overall Study|Adverse Events Leading to Death|4|||
161024975|NCT04693715|581483759|FG000|Overall Study|Lost to Follow-up|0|||
161024976|NCT04693715|581483760|FG001|Overall Study|Lost to Follow-up|2|||
161024977|NCT04693715|581483761|FG002|Overall Study|Lost to Follow-up|2|||
161024978|NCT04693715|581483759|FG000|Overall Study|Physician Decision|0|||
161024979|NCT04693715|581483760|FG001|Overall Study|Physician Decision|1|||
161024980|NCT04693715|581483761|FG002|Overall Study|Physician Decision|0|||
161024981|NCT04693715|581483759|FG000|Overall Study|Withdrawal by Legal Authorized Representative|0|||
161024982|NCT04693715|581483760|FG001|Overall Study|Withdrawal by Legal Authorized Representative|1|||
161024983|NCT04693715|581483761|FG002|Overall Study|Withdrawal by Legal Authorized Representative|0|||
161024984|NCT04693715|581483759|FG000|Overall Study|Withdrawal by Subject|0|||
161024985|NCT04693715|581483760|FG001|Overall Study|Withdrawal by Subject|0|||
161024986|NCT04693715|581483761|FG002|Overall Study|Withdrawal by Subject|1|||
161024987|NCT04667949|581483769|FG000|Overall Study|Adverse Event|0|||
161024988|NCT04667949|581483770|FG001|Overall Study|Adverse Event|2|||
161024989|NCT04667949|581483769|FG000|Overall Study|Lost to Follow-up|0|||
161024990|NCT04667949|581483770|FG001|Overall Study|Lost to Follow-up|1|||
160589432|NCT02358369|579874847|FG001|Treatment Period A/B|Death|0|||
160589433|NCT02358369|579874848|FG002|Treatment Period A/B|Death|1|||
160589434|NCT02358369|579874849|FG003|Treatment Period A/B|Death|0|||
160589435|NCT02358369|579874850|FG004|Treatment Period A/B|Death|0|||
160589436|NCT02358369|579874846|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
160589437|NCT02358369|579874847|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
160589438|NCT02358369|579874848|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
160589439|NCT02358369|579874849|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
160589440|NCT02358369|579874850|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
161024991|NCT04667949|581483769|FG000|Overall Study|Physician Decision|0|||
161024992|NCT04667949|581483770|FG001|Overall Study|Physician Decision|2|||
161024993|NCT04667949|581483769|FG000|Overall Study|Subject decision|1|||
161024994|NCT04667949|581483770|FG001|Overall Study|Subject decision|7|||
161024995|NCT04557735|581483771|FG000|Treatment Period (26 Weeks)|Withdrawal by Subject|1|||
161024996|NCT04557735|581483771|FG000|Treatment Period (26 Weeks)|Physician Decision|4|||
161024997|NCT04557735|581483771|FG000|Treatment Period (26 Weeks)|Death|5|||
161024998|NCT04557735|581483771|FG000|Treatment Period (26 Weeks)|Adverse Event|2|||
161024999|NCT04557735|581483771|FG000|Follow-Up Period (26 Weeks)|Physician Decision|1|||
161025000|NCT04557735|581483771|FG000|Follow-Up Period (26 Weeks)|Death|4|||
161025001|NCT03067480|581483772|FG000|Overall Study|Lost to Follow-up|2|||
161025002|NCT03067480|581483773|FG001|Overall Study|Lost to Follow-up|4|||
161025003|NCT03067480|581483772|FG000|Overall Study|started insulin|1|||
161025004|NCT03067480|581483773|FG001|Overall Study|started insulin|1|||
161025005|NCT04504630|581483774|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
161025006|NCT04504630|581483775|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
160589441|NCT02358369|579874846|FG000|Treatment Period C|Adverse Event|0|||
160589442|NCT02358369|579874847|FG001|Treatment Period C|Adverse Event|0|||
160589443|NCT02358369|579874848|FG002|Treatment Period C|Adverse Event|0|||
160589444|NCT02358369|579874849|FG003|Treatment Period C|Adverse Event|0|||
160589445|NCT02358369|579874850|FG004|Treatment Period C|Adverse Event|7|||
160589446|NCT03095521|579874851|FG000|Overall Study|Withdrawal by Subject|0|||
160589447|NCT03095521|579874852|FG001|Overall Study|Withdrawal by Subject|1|||
160589448|NCT03095521|579874851|FG000|Overall Study|Lost to Follow-up|0|||
160589449|NCT03095521|579874852|FG001|Overall Study|Lost to Follow-up|1|||
160589450|NCT01536119|579874855|FG000|Overall Study|Lost to Follow-up|17|||
160589451|NCT01536119|579874856|FG001|Overall Study|Lost to Follow-up|14|||
160589452|NCT03655717|579874857|FG000|Overall Study|Withdrawal by Subject|4|||
160589453|NCT03655717|579874858|FG001|Overall Study|Withdrawal by Subject|8|||
160589454|NCT03655717|579874859|FG002|Overall Study|Withdrawal by Subject|1|||
160589455|NCT03655717|579874860|FG003|Overall Study|Withdrawal by Subject|0|||
160589456|NCT03655717|579874861|FG004|Overall Study|Withdrawal by Subject|0|||
160589457|NCT03655717|579874862|FG005|Overall Study|Withdrawal by Subject|1|||
160589458|NCT03655717|579874863|FG006|Overall Study|Withdrawal by Subject|3|||
160589459|NCT03655717|579874864|FG007|Overall Study|Withdrawal by Subject|1|||
160589460|NCT03655717|579874865|FG008|Overall Study|Withdrawal by Subject|2|||
160589461|NCT03655717|579874866|FG009|Overall Study|Withdrawal by Subject|0|||
160589462|NCT03655717|579874867|FG010|Overall Study|Withdrawal by Subject|0|||
160589463|NCT03655717|579874868|FG011|Overall Study|Withdrawal by Subject|1|||
160589464|NCT03655717|579874869|FG012|Overall Study|Withdrawal by Subject|0|||
160589465|NCT03655717|579874870|FG013|Overall Study|Withdrawal by Subject|3|||
160589466|NCT03655717|579874871|FG014|Overall Study|Withdrawal by Subject|0|||
160589467|NCT03655717|579874872|FG015|Overall Study|Withdrawal by Subject|1|||
160589468|NCT03655717|579874873|FG016|Overall Study|Withdrawal by Subject|0|||
160589469|NCT03655717|579874874|FG017|Overall Study|Withdrawal by Subject|0|||
160589470|NCT03655717|579874875|FG018|Overall Study|Withdrawal by Subject|1|||
160589471|NCT03655717|579874876|FG019|Overall Study|Withdrawal by Subject|0|||
160589472|NCT03655717|579874877|FG020|Overall Study|Withdrawal by Subject|0|||
160589473|NCT03655717|579874878|FG021|Overall Study|Withdrawal by Subject|1|||
160589474|NCT03655717|579874879|FG022|Overall Study|Withdrawal by Subject|2|||
160589475|NCT03655717|579874880|FG023|Overall Study|Withdrawal by Subject|1|||
160589476|NCT03655717|579874881|FG024|Overall Study|Withdrawal by Subject|1|||
160589477|NCT03655717|579874882|FG025|Overall Study|Withdrawal by Subject|0|||
160589478|NCT03655717|579874857|FG000|Overall Study|Physician Decision|3|||
160589479|NCT03655717|579874858|FG001|Overall Study|Physician Decision|3|||
160589480|NCT03655717|579874859|FG002|Overall Study|Physician Decision|0|||
160589481|NCT03655717|579874860|FG003|Overall Study|Physician Decision|0|||
160589482|NCT03655717|579874861|FG004|Overall Study|Physician Decision|0|||
160589483|NCT03655717|579874862|FG005|Overall Study|Physician Decision|0|||
160589484|NCT03655717|579874863|FG006|Overall Study|Physician Decision|0|||
160589485|NCT03655717|579874864|FG007|Overall Study|Physician Decision|0|||
160589486|NCT03655717|579874865|FG008|Overall Study|Physician Decision|0|||
160589487|NCT03655717|579874866|FG009|Overall Study|Physician Decision|1|||
160589488|NCT03655717|579874867|FG010|Overall Study|Physician Decision|0|||
160589489|NCT03655717|579874868|FG011|Overall Study|Physician Decision|0|||
160589490|NCT03655717|579874869|FG012|Overall Study|Physician Decision|0|||
160589491|NCT03655717|579874870|FG013|Overall Study|Physician Decision|0|||
160589492|NCT03655717|579874871|FG014|Overall Study|Physician Decision|0|||
160589493|NCT03655717|579874872|FG015|Overall Study|Physician Decision|0|||
160589494|NCT03655717|579874873|FG016|Overall Study|Physician Decision|0|||
160589495|NCT03655717|579874874|FG017|Overall Study|Physician Decision|0|||
160589496|NCT03655717|579874875|FG018|Overall Study|Physician Decision|0|||
160589497|NCT03655717|579874876|FG019|Overall Study|Physician Decision|1|||
160589498|NCT03655717|579874877|FG020|Overall Study|Physician Decision|0|||
160589499|NCT03655717|579874878|FG021|Overall Study|Physician Decision|0|||
160589500|NCT03655717|579874879|FG022|Overall Study|Physician Decision|0|||
160589501|NCT03655717|579874880|FG023|Overall Study|Physician Decision|1|||
160589502|NCT03655717|579874881|FG024|Overall Study|Physician Decision|0|||
160589503|NCT03655717|579874882|FG025|Overall Study|Physician Decision|0|||
160589504|NCT03655717|579874857|FG000|Overall Study|Lost to Follow-up|3|||
161025007|NCT04504630|581483774|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
160589505|NCT03655717|579874858|FG001|Overall Study|Lost to Follow-up|1|||
160589506|NCT03655717|579874859|FG002|Overall Study|Lost to Follow-up|0|||
161025008|NCT04504630|581483775|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
161025009|NCT05562934|581483776|FG000|Overall Study|Adverse Event|0|||
160589507|NCT03655717|579874860|FG003|Overall Study|Lost to Follow-up|1|||
160589508|NCT03655717|579874861|FG004|Overall Study|Lost to Follow-up|0|||
160589509|NCT03655717|579874862|FG005|Overall Study|Lost to Follow-up|1|||
160589510|NCT03655717|579874863|FG006|Overall Study|Lost to Follow-up|0|||
160589511|NCT03655717|579874864|FG007|Overall Study|Lost to Follow-up|0|||
160589512|NCT03655717|579874865|FG008|Overall Study|Lost to Follow-up|0|||
160589513|NCT03655717|579874866|FG009|Overall Study|Lost to Follow-up|0|||
160589514|NCT03655717|579874867|FG010|Overall Study|Lost to Follow-up|0|||
161025010|NCT05562934|581483777|FG001|Overall Study|Adverse Event|2|||
160589515|NCT03655717|579874868|FG011|Overall Study|Lost to Follow-up|1|||
160589516|NCT03655717|579874869|FG012|Overall Study|Lost to Follow-up|0|||
160589517|NCT03655717|579874870|FG013|Overall Study|Lost to Follow-up|0|||
161025011|NCT05562934|581483778|FG002|Overall Study|Adverse Event|0|||
161025012|NCT05562934|581483779|FG003|Overall Study|Adverse Event|0|||
161025013|NCT05562934|581483780|FG004|Overall Study|Adverse Event|2|||
161025014|NCT05562934|581483776|FG000|Overall Study|Lost to Follow-up|0|||
161025015|NCT05562934|581483777|FG001|Overall Study|Lost to Follow-up|0|||
161025016|NCT05562934|581483778|FG002|Overall Study|Lost to Follow-up|0|||
161025017|NCT05562934|581483779|FG003|Overall Study|Lost to Follow-up|0|||
161025018|NCT05562934|581483780|FG004|Overall Study|Lost to Follow-up|1|||
161025019|NCT05562934|581483776|FG000|Overall Study|Protocol Violation|0|||
161025020|NCT05562934|581483777|FG001|Overall Study|Protocol Violation|0|||
161025021|NCT05562934|581483778|FG002|Overall Study|Protocol Violation|0|||
161025022|NCT05562934|581483779|FG003|Overall Study|Protocol Violation|1|||
161025023|NCT05562934|581483780|FG004|Overall Study|Protocol Violation|1|||
161025024|NCT05562934|581483776|FG000|Overall Study|Withdrawal by Subject|0|||
161025025|NCT05562934|581483777|FG001|Overall Study|Withdrawal by Subject|0|||
161025026|NCT05562934|581483778|FG002|Overall Study|Withdrawal by Subject|1|||
161025027|NCT05562934|581483779|FG003|Overall Study|Withdrawal by Subject|1|||
161025028|NCT05562934|581483780|FG004|Overall Study|Withdrawal by Subject|0|||
161025029|NCT05365217|581483781|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161025030|NCT05365217|581483782|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161025031|NCT04266301|581483783|FG000|Overall Study|Progressive Disease|111|||
161025032|NCT04266301|581483784|FG001|Overall Study|Progressive Disease|92|||
161025033|NCT04266301|581483783|FG000|Overall Study|Adverse Event|41|||
161025034|NCT04266301|581483784|FG001|Overall Study|Adverse Event|43|||
161025035|NCT04266301|581483783|FG000|Overall Study|Death|26|||
161025036|NCT04266301|581483784|FG001|Overall Study|Death|35|||
161025037|NCT04266301|581483783|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
161025038|NCT04266301|581483784|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
161025039|NCT04266301|581483783|FG000|Overall Study|Study Terminated by Sponsor|22|||
161025040|NCT04266301|581483784|FG001|Overall Study|Study Terminated by Sponsor|27|||
161025041|NCT04266301|581483783|FG000|Overall Study|Participant Decision|22|||
161025042|NCT04266301|581483784|FG001|Overall Study|Participant Decision|28|||
161025043|NCT04266301|581483783|FG000|Overall Study|Physician Decision|14|||
161025044|NCT04266301|581483784|FG001|Overall Study|Physician Decision|9|||
161025045|NCT04266301|581483783|FG000|Overall Study|New Therapy for Study Indication|2|||
161025046|NCT04266301|581483784|FG001|Overall Study|New Therapy for Study Indication|4|||
161025047|NCT04266301|581483783|FG000|Overall Study|Protocol Deviation|2|||
161025048|NCT04266301|581483784|FG001|Overall Study|Protocol Deviation|4|||
161025049|NCT04266301|581483783|FG000|Overall Study|Guardian Decision|1|||
160589518|NCT03655717|579874871|FG014|Overall Study|Lost to Follow-up|0|||
160589519|NCT03655717|579874872|FG015|Overall Study|Lost to Follow-up|0|||
160589520|NCT03655717|579874873|FG016|Overall Study|Lost to Follow-up|0|||
160589521|NCT03655717|579874874|FG017|Overall Study|Lost to Follow-up|0|||
160589522|NCT03655717|579874875|FG018|Overall Study|Lost to Follow-up|0|||
160589523|NCT03655717|579874876|FG019|Overall Study|Lost to Follow-up|0|||
160589524|NCT03655717|579874877|FG020|Overall Study|Lost to Follow-up|0|||
160589525|NCT03655717|579874878|FG021|Overall Study|Lost to Follow-up|0|||
160589526|NCT03655717|579874879|FG022|Overall Study|Lost to Follow-up|0|||
160589527|NCT03655717|579874880|FG023|Overall Study|Lost to Follow-up|0|||
161025050|NCT04266301|581483784|FG001|Overall Study|Guardian Decision|0|||
161025051|NCT04266301|581483783|FG000|Overall Study|Lost to Follow-up|1|||
161025052|NCT04266301|581483784|FG001|Overall Study|Lost to Follow-up|0|||
161025053|NCT04266301|581483783|FG000|Overall Study|Participants Not Treated|1|||
161025054|NCT04266301|581483784|FG001|Overall Study|Participants Not Treated|1|||
161025055|NCT03215758|581483785|FG000|Overall Study|Technical Problems|1|||
160589528|NCT03655717|579874881|FG024|Overall Study|Lost to Follow-up|0|||
160589529|NCT03655717|579874882|FG025|Overall Study|Lost to Follow-up|0|||
160589530|NCT01973452|579874883|FG000|Overall Study|Lack of Efficacy|0|||
160589531|NCT01973452|579874884|FG001|Overall Study|Lack of Efficacy|1|||
161025056|NCT03215758|581483786|FG001|Overall Study|Technical Problems|0|||
160589532|NCT01973452|579874883|FG000|Overall Study|Lost to Follow-up|1|||
160589533|NCT01973452|579874884|FG001|Overall Study|Lost to Follow-up|0|||
160589534|NCT01973452|579874883|FG000|Overall Study|Withdrawal by Subject|10|||
160589535|NCT01973452|579874884|FG001|Overall Study|Withdrawal by Subject|9|||
160589536|NCT01973452|579874883|FG000|Overall Study|Ineligible|1|||
160589537|NCT01973452|579874884|FG001|Overall Study|Ineligible|1|||
161025057|NCT03215758|581483785|FG000|Overall Study|Protocol deviation|0|||
161025058|NCT03215758|581483786|FG001|Overall Study|Protocol deviation|1|||
161025059|NCT03215758|581483785|FG000|Overall Study|Physician Decision|0|||
161025060|NCT03215758|581483786|FG001|Overall Study|Physician Decision|1|||
161025061|NCT03215758|581483785|FG000|Overall Study|Death|0|||
161025062|NCT03215758|581483786|FG001|Overall Study|Death|1|||
161025063|NCT03215758|581483785|FG000|Overall Study|Adverse Event|1|||
161025064|NCT03215758|581483786|FG001|Overall Study|Adverse Event|2|||
161025065|NCT03215758|581483785|FG000|Overall Study|Subject/Guardian Decision|3|||
161025066|NCT03215758|581483786|FG001|Overall Study|Subject/Guardian Decision|3|||
160973173|NCT02954458|581291160|FG003|Overall Study|Death|1|||
160973174|NCT02954458|581291157|FG000|Overall Study|Other|0|||
160973175|NCT02954458|581291158|FG001|Overall Study|Other|0|||
160973176|NCT02954458|581291159|FG002|Overall Study|Other|0|||
160973177|NCT02954458|581291160|FG003|Overall Study|Other|7|||
160973178|NCT02690077|581291163|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
160973179|NCT02690077|581291164|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
160973180|NCT02690077|581291163|FG000|Overall Study|Withdrawal by Subject|0|||
160973181|NCT02690077|581291164|FG001|Overall Study|Withdrawal by Subject|5|||
160973182|NCT02690077|581291163|FG000|Overall Study|Excluded by IRB|0|||
160973183|NCT02690077|581291164|FG001|Overall Study|Excluded by IRB|2|||
160973184|NCT01845974|581291165|FG000|Overall Study|screen failure|1|||
160973185|NCT01845974|581291166|FG001|Overall Study|screen failure|0|||
160973186|NCT00612534|581291168|FG000|Overall Study|Adverse Event|0|||
160973187|NCT00612534|581291169|FG001|Overall Study|Adverse Event|4|||
160973188|NCT00612534|581291170|FG002|Overall Study|Adverse Event|2|||
160973189|NCT00612534|581291171|FG003|Overall Study|Adverse Event|1|||
160973190|NCT00612534|581291168|FG000|Overall Study|Lack of Efficacy|13|||
160973191|NCT00612534|581291169|FG001|Overall Study|Lack of Efficacy|12|||
160973192|NCT00612534|581291170|FG002|Overall Study|Lack of Efficacy|5|||
160973193|NCT00612534|581291171|FG003|Overall Study|Lack of Efficacy|16|||
160973194|NCT00612534|581291168|FG000|Overall Study|Other Reason|0|||
160973195|NCT00612534|581291169|FG001|Overall Study|Other Reason|1|||
160973196|NCT00612534|581291170|FG002|Overall Study|Other Reason|0|||
160973197|NCT00612534|581291171|FG003|Overall Study|Other Reason|0|||
160973198|NCT01435655|581291173|FG000|Overall Study|Death|2|||
160973199|NCT01435655|581291173|FG000|Overall Study|Other|1|||
160973200|NCT02839343|581291176|FG000|Overall Study|Withdrawal by Subject|3|||
160973201|NCT02839343|581291177|FG001|Overall Study|Withdrawal by Subject|1|||
160973202|NCT02839343|581291176|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
160973203|NCT02839343|581291177|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
160973204|NCT02839343|581291176|FG000|Overall Study|Adverse Event|1|||
160973205|NCT02839343|581291177|FG001|Overall Study|Adverse Event|0|||
160973206|NCT01852058|581291178|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
160973207|NCT01852058|581291179|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973208|NCT01852058|581291180|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973209|NCT01852058|581291181|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973210|NCT01852058|581291182|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973211|NCT01852058|581291183|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973212|NCT01852058|581291184|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973213|NCT01852058|581291185|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973214|NCT01852058|581291186|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973215|NCT01852058|581291187|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973216|NCT01852058|581291188|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973217|NCT01852058|581291189|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973218|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973219|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973220|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973221|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973222|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
160973223|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973224|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973225|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973226|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973227|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973228|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973229|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973230|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973231|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973232|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973233|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973234|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
160973235|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
160973236|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973237|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973238|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973239|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973240|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973241|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973242|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160589538|NCT01973452|579874883|FG000|Overall Study|Surgery canceled by participant|5|||
160589539|NCT01973452|579874884|FG001|Overall Study|Surgery canceled by participant|3|||
160589540|NCT01927419|579874885|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
160589541|NCT01927419|579874886|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
160589542|NCT01927419|579874885|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
160589543|NCT01927419|579874886|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
160589544|NCT01927419|579874885|FG000|Treatment Period|Disease progression|17|||
160589545|NCT01927419|579874886|FG001|Treatment Period|Disease progression|20|||
160589546|NCT01927419|579874885|FG000|Treatment Period|Study drug toxicity|48|||
160589547|NCT01927419|579874886|FG001|Treatment Period|Study drug toxicity|10|||
160589548|NCT01927419|579874885|FG000|Treatment Period|Death|0|||
160589549|NCT01927419|579874886|FG001|Treatment Period|Death|1|||
160589550|NCT01927419|579874885|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
160589551|NCT01927419|579874886|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
160589552|NCT01927419|579874885|FG000|Treatment Period|Participant request to discontinue|12|||
160589553|NCT01927419|579874886|FG001|Treatment Period|Participant request to discontinue|4|||
160589554|NCT01927419|579874885|FG000|Treatment Period|Withdrawal by Subject|1|||
160589555|NCT01927419|579874886|FG001|Treatment Period|Withdrawal by Subject|1|||
160589556|NCT01927419|579874885|FG000|Treatment Period|Maximum Clinical Benefit|6|||
160589557|NCT01927419|579874886|FG001|Treatment Period|Maximum Clinical Benefit|2|||
160589558|NCT01927419|579874885|FG000|Treatment Period|Other reasons|3|||
160589559|NCT01927419|579874886|FG001|Treatment Period|Other reasons|4|||
160589560|NCT01927419|579874885|FG000|Treatment Period|Not Reported|1|||
160589561|NCT01927419|579874886|FG001|Treatment Period|Not Reported|1|||
160589562|NCT03707158|579874889|FG000|Midtreatment|Lost to Follow-up|16|||
160589563|NCT03707158|579874890|FG001|Midtreatment|Lost to Follow-up|7|||
160589564|NCT03707158|579874889|FG000|Midtreatment|Withdrawal by Subject|28|||
160589565|NCT03707158|579874890|FG001|Midtreatment|Withdrawal by Subject|19|||
160589566|NCT03707158|579874889|FG000|Posttreatment|Lost to Follow-up|0|||
160589567|NCT03707158|579874890|FG001|Posttreatment|Lost to Follow-up|5|||
160589568|NCT03707158|579874889|FG000|Follow-up|Lost to Follow-up|19|||
160589569|NCT03707158|579874890|FG001|Follow-up|Lost to Follow-up|18|||
160589570|NCT03707158|579874889|FG000|Follow-up|Withdrawal by Subject|13|||
160589571|NCT03707158|579874890|FG001|Follow-up|Withdrawal by Subject|6|||
160589572|NCT01454401|579874892|FG000|Overall Study|Death|1|||
160589573|NCT01454401|579874892|FG000|Overall Study|hospitalised|1|||
160589574|NCT01454401|579874892|FG000|Overall Study|osteomyelitis|2|||
160589575|NCT01454401|579874892|FG000|Overall Study|non-adherence|1|||
160589576|NCT01968187|579874895|FG000|Overall Study|Adverse Event|0|||
160589577|NCT01968187|579874896|FG001|Overall Study|Adverse Event|1|||
160589578|NCT01968187|579874895|FG000|Overall Study|Randomized but not treated|1|||
160589579|NCT01968187|579874896|FG001|Overall Study|Randomized but not treated|0|||
160589580|NCT00430521|579874897|FG000|Overall Study|Adverse Event|0|||
160589581|NCT00430521|579874898|FG001|Overall Study|Adverse Event|0|||
160589582|NCT00430521|579874899|FG002|Overall Study|Adverse Event|0|||
160589583|NCT00430521|579874900|FG003|Overall Study|Adverse Event|0|||
160589584|NCT00430521|579874901|FG004|Overall Study|Adverse Event|0|||
160589585|NCT00430521|579874902|FG005|Overall Study|Adverse Event|2|||
160589586|NCT00430521|579874903|FG006|Overall Study|Adverse Event|1|||
160589587|NCT00430521|579874904|FG007|Overall Study|Adverse Event|0|||
160589588|NCT00430521|579874897|FG000|Overall Study|Lost to Follow-up|7|||
160589589|NCT00430521|579874898|FG001|Overall Study|Lost to Follow-up|8|||
160657385|NCT02848326|580127502|FG000|Treatment Period|Non-compliance with Study Drug|4|||
160657386|NCT02848326|580127503|FG001|Treatment Period|Non-compliance with Study Drug|0|||
160657387|NCT02848326|580127504|FG002|Treatment Period|Non-compliance with Study Drug|0|||
160657388|NCT02848326|580127505|FG003|Treatment Period|Non-compliance with Study Drug|1|||
160657389|NCT02848326|580127506|FG004|Treatment Period|Non-compliance with Study Drug|0|||
160589590|NCT00430521|579874899|FG002|Overall Study|Lost to Follow-up|3|||
160589591|NCT00430521|579874900|FG003|Overall Study|Lost to Follow-up|5|||
160589592|NCT00430521|579874901|FG004|Overall Study|Lost to Follow-up|5|||
160589593|NCT00430521|579874902|FG005|Overall Study|Lost to Follow-up|2|||
160589594|NCT00430521|579874903|FG006|Overall Study|Lost to Follow-up|8|||
160589595|NCT00430521|579874904|FG007|Overall Study|Lost to Follow-up|10|||
160589596|NCT00430521|579874897|FG000|Overall Study|Pregnancy|0|||
160589597|NCT00430521|579874898|FG001|Overall Study|Pregnancy|0|||
160589598|NCT00430521|579874899|FG002|Overall Study|Pregnancy|0|||
160589599|NCT00430521|579874900|FG003|Overall Study|Pregnancy|0|||
160589600|NCT00430521|579874901|FG004|Overall Study|Pregnancy|0|||
160589601|NCT00430521|579874902|FG005|Overall Study|Pregnancy|0|||
160589602|NCT00430521|579874903|FG006|Overall Study|Pregnancy|1|||
160589603|NCT00430521|579874904|FG007|Overall Study|Pregnancy|0|||
160589604|NCT00430521|579874897|FG000|Overall Study|Vaccine Expired|0|||
160589605|NCT00430521|579874898|FG001|Overall Study|Vaccine Expired|0|||
160589606|NCT00430521|579874899|FG002|Overall Study|Vaccine Expired|0|||
160589607|NCT00430521|579874900|FG003|Overall Study|Vaccine Expired|0|||
160589608|NCT00430521|579874901|FG004|Overall Study|Vaccine Expired|0|||
160589609|NCT00430521|579874902|FG005|Overall Study|Vaccine Expired|1|||
160589610|NCT00430521|579874903|FG006|Overall Study|Vaccine Expired|0|||
160589611|NCT00430521|579874904|FG007|Overall Study|Vaccine Expired|0|||
160589612|NCT00430521|579874897|FG000|Overall Study|Protocol Violation|1|||
160589613|NCT00430521|579874898|FG001|Overall Study|Protocol Violation|0|||
160589614|NCT00430521|579874899|FG002|Overall Study|Protocol Violation|0|||
160589615|NCT00430521|579874900|FG003|Overall Study|Protocol Violation|0|||
160589616|NCT00430521|579874901|FG004|Overall Study|Protocol Violation|0|||
160589617|NCT00430521|579874902|FG005|Overall Study|Protocol Violation|0|||
160589618|NCT00430521|579874903|FG006|Overall Study|Protocol Violation|0|||
160589619|NCT00430521|579874904|FG007|Overall Study|Protocol Violation|0|||
160589620|NCT00430521|579874897|FG000|Overall Study|Withdrawal by Subject|3|||
160589621|NCT00430521|579874898|FG001|Overall Study|Withdrawal by Subject|1|||
160589622|NCT00430521|579874899|FG002|Overall Study|Withdrawal by Subject|0|||
160589623|NCT00430521|579874900|FG003|Overall Study|Withdrawal by Subject|3|||
160589624|NCT00430521|579874901|FG004|Overall Study|Withdrawal by Subject|0|||
160589625|NCT00430521|579874902|FG005|Overall Study|Withdrawal by Subject|0|||
160589626|NCT00430521|579874903|FG006|Overall Study|Withdrawal by Subject|0|||
160589627|NCT00430521|579874904|FG007|Overall Study|Withdrawal by Subject|2|||
160589628|NCT03675737|579874905|FG000|Overall Study|Death|593|||
160589629|NCT03675737|579874906|FG001|Overall Study|Death|660|||
160589630|NCT03675737|579874905|FG000|Overall Study|Lost to Follow-up|1|||
160589631|NCT03675737|579874906|FG001|Overall Study|Lost to Follow-up|5|||
160589632|NCT03675737|579874905|FG000|Overall Study|Physician Decision|1|||
160589633|NCT03675737|579874906|FG001|Overall Study|Physician Decision|0|||
160589634|NCT03675737|579874905|FG000|Overall Study|Withdrawal by Subject|14|||
160589635|NCT03675737|579874906|FG001|Overall Study|Withdrawal by Subject|12|||
160589636|NCT03675737|579874905|FG000|Overall Study|Ongoing in Study|181|||
160589637|NCT03675737|579874906|FG001|Overall Study|Ongoing in Study|112|||
160589638|NCT03422133|579874907|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
160589639|NCT03422133|579874908|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
160589640|NCT01274338|579876646|FG000|Overall Study|Lack of Efficacy|72|||
160589641|NCT01274338|579876647|FG001|Overall Study|Lack of Efficacy|108|||
160589642|NCT01274338|579876648|FG002|Overall Study|Lack of Efficacy|116|||
160589643|NCT01274338|579876649|FG003|Overall Study|Lack of Efficacy|0|||
160589644|NCT01274338|579876650|FG004|Overall Study|Lack of Efficacy|0|||
160589645|NCT01274338|579876651|FG005|Overall Study|Lack of Efficacy|0|||
160589646|NCT01274338|579876646|FG000|Overall Study|Adverse Event|272|||
160589647|NCT01274338|579876647|FG001|Overall Study|Adverse Event|105|||
160589648|NCT01274338|579876648|FG002|Overall Study|Adverse Event|180|||
160589649|NCT01274338|579876649|FG003|Overall Study|Adverse Event|1|||
160589650|NCT01274338|579876650|FG004|Overall Study|Adverse Event|0|||
160589651|NCT01274338|579876651|FG005|Overall Study|Adverse Event|0|||
160589652|NCT01274338|579876646|FG000|Overall Study|Death|8|||
160589653|NCT01274338|579876647|FG001|Overall Study|Death|1|||
160589654|NCT01274338|579876648|FG002|Overall Study|Death|0|||
160589655|NCT01274338|579876649|FG003|Overall Study|Death|0|||
160589656|NCT01274338|579876650|FG004|Overall Study|Death|0|||
160589657|NCT01274338|579876651|FG005|Overall Study|Death|0|||
160589658|NCT01274338|579876646|FG000|Overall Study|Withdrawal by Subject|27|||
160589659|NCT01274338|579876647|FG001|Overall Study|Withdrawal by Subject|99|||
160589660|NCT01274338|579876648|FG002|Overall Study|Withdrawal by Subject|17|||
160589661|NCT01274338|579876649|FG003|Overall Study|Withdrawal by Subject|0|||
160589662|NCT01274338|579876650|FG004|Overall Study|Withdrawal by Subject|0|||
160589663|NCT01274338|579876651|FG005|Overall Study|Withdrawal by Subject|0|||
160589664|NCT01274338|579876646|FG000|Overall Study|Did not start treatment|8|||
160589665|NCT01274338|579876647|FG001|Overall Study|Did not start treatment|116|||
160589666|NCT01274338|579876648|FG002|Overall Study|Did not start treatment|7|||
160589667|NCT01274338|579876649|FG003|Overall Study|Did not start treatment|0|||
160589668|NCT01274338|579876650|FG004|Overall Study|Did not start treatment|0|||
160589669|NCT01274338|579876651|FG005|Overall Study|Did not start treatment|0|||
160589670|NCT01274338|579876646|FG000|Overall Study|Alternative therapy|0|||
160589671|NCT01274338|579876647|FG001|Overall Study|Alternative therapy|1|||
160589672|NCT01274338|579876648|FG002|Overall Study|Alternative therapy|0|||
160589673|NCT01274338|579876649|FG003|Overall Study|Alternative therapy|0|||
160589674|NCT01274338|579876650|FG004|Overall Study|Alternative therapy|0|||
160589675|NCT01274338|579876651|FG005|Overall Study|Alternative therapy|0|||
160589676|NCT01274338|579876646|FG000|Overall Study|Other complicating diseases|0|||
160589677|NCT01274338|579876647|FG001|Overall Study|Other complicating diseases|3|||
160589678|NCT01274338|579876648|FG002|Overall Study|Other complicating diseases|1|||
161025067|NCT03997383|581483794|FG000|Double-blind Treatment Period|Adverse Event|4|||
161025068|NCT03997383|581483795|FG001|Double-blind Treatment Period|Adverse Event|3|||
160589679|NCT01274338|579876649|FG003|Overall Study|Other complicating diseases|0|||
160589680|NCT01274338|579876650|FG004|Overall Study|Other complicating diseases|0|||
160589681|NCT01274338|579876651|FG005|Overall Study|Other complicating diseases|0|||
160589682|NCT01274338|579876646|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
160589683|NCT01274338|579876647|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
160657390|NCT02848326|580127507|FG005|Treatment Period|Non-compliance with Study Drug|0|||
160657391|NCT02848326|580127502|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
160657392|NCT02848326|580127503|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
160657393|NCT02848326|580127504|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
160657394|NCT02848326|580127505|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
160657395|NCT02848326|580127506|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
160657396|NCT02848326|580127507|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
160657397|NCT02848326|580127502|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
160657398|NCT02848326|580127503|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
160657399|NCT02848326|580127504|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
160657400|NCT02848326|580127505|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
160657401|NCT02848326|580127506|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
160657402|NCT02848326|580127507|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
160657403|NCT04349917|580127525|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
160657404|NCT04349917|580127526|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
160657405|NCT04349917|580127525|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
160657406|NCT04349917|580127526|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
160657407|NCT00441467|580127530|FG000|Overall Study|Adverse Event|6|||
160657408|NCT00441467|580127530|FG000|Overall Study|Withdrawal by Subject|3|||
160657409|NCT00441467|580127530|FG000|Overall Study|Progressive disease|9|||
160657410|NCT01042522|580127532|FG000|Overall Study|Adverse Event|1|||
160657411|NCT01042522|580127533|FG001|Overall Study|Adverse Event|2|||
160657412|NCT01042522|580127532|FG000|Overall Study|Disease Progression|5|||
160657413|NCT01042522|580127533|FG001|Overall Study|Disease Progression|0|||
160657414|NCT01042522|580127532|FG000|Overall Study|Death|1|||
160657415|NCT01042522|580127533|FG001|Overall Study|Death|0|||
160657416|NCT01042522|580127532|FG000|Overall Study|Patient Refused|0|||
160657417|NCT01042522|580127533|FG001|Overall Study|Patient Refused|3|||
160657418|NCT01042522|580127532|FG000|Overall Study|Withdrawal by Subject|1|||
160657419|NCT01042522|580127533|FG001|Overall Study|Withdrawal by Subject|1|||
160657420|NCT00745420|580127535|FG000|Overall Study|Ineligible|1|||
160657421|NCT00088829|580127545|FG000|Overall Study|PI left institution and study was close|22|||
160657422|NCT05818137|580127546|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
160973243|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973244|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973245|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973246|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
160973247|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973248|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973249|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973250|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973251|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973252|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973253|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973254|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973255|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973256|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973257|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973258|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
160973259|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
160973260|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973261|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973262|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973263|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973264|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973265|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973266|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973267|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973268|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973269|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
160973270|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973271|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973272|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973273|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973274|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973275|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973276|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973277|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973278|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973279|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973280|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973281|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973282|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
160973283|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
160973284|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973285|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973286|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973287|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973288|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973289|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973290|NCT01852058|581291178|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973291|NCT01852058|581291179|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973292|NCT01852058|581291180|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973293|NCT01852058|581291181|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973294|NCT01852058|581291182|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973295|NCT01852058|581291183|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973296|NCT01852058|581291184|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973297|NCT01852058|581291185|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
160973298|NCT01852058|581291186|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973299|NCT01852058|581291187|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973300|NCT01852058|581291188|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973301|NCT01852058|581291189|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973302|NCT01852058|581291178|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973303|NCT01852058|581291179|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973304|NCT01852058|581291180|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973305|NCT01852058|581291181|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973306|NCT01852058|581291182|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973307|NCT01852058|581291183|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973308|NCT01852058|581291184|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973309|NCT01852058|581291185|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973310|NCT01852058|581291186|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
160973311|NCT01852058|581291187|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973312|NCT01852058|581291188|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973313|NCT01852058|581291189|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973314|NCT00738101|581291193|FG000|Overall Study|Physician Decision|5|||
160973315|NCT00738101|581291193|FG000|Overall Study|Death|1|||
160973316|NCT00738101|581291193|FG000|Overall Study|Repeat enrollment|1|||
160973317|NCT01396317|581291194|FG000|Overall Study|Adverse Event|1|||
160973318|NCT01396317|581291195|FG001|Overall Study|Adverse Event|0|||
160973319|NCT03661996|581293354|FG000|Overall Study|Adverse Event|0|||
160973320|NCT03661996|581293355|FG001|Overall Study|Adverse Event|0|||
160973321|NCT03661996|581293356|FG002|Overall Study|Adverse Event|1|||
160973322|NCT03661996|581293357|FG003|Overall Study|Adverse Event|1|||
160973323|NCT03661996|581293358|FG004|Overall Study|Adverse Event|0|||
160973324|NCT03661996|581293354|FG000|Overall Study|Lost to Follow-up|5|||
160973325|NCT03661996|581293355|FG001|Overall Study|Lost to Follow-up|1|||
160973326|NCT03661996|581293356|FG002|Overall Study|Lost to Follow-up|2|||
160973327|NCT03661996|581293357|FG003|Overall Study|Lost to Follow-up|2|||
160973328|NCT03661996|581293358|FG004|Overall Study|Lost to Follow-up|6|||
160973329|NCT03661996|581293354|FG000|Overall Study|Physician Decision|1|||
160589684|NCT01274338|579876648|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
160589685|NCT01274338|579876649|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
160589686|NCT01274338|579876650|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
160589687|NCT01274338|579876651|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
160589688|NCT01274338|579876646|FG000|Overall Study|Pregnancy|0|||
160589689|NCT01274338|579876647|FG001|Overall Study|Pregnancy|0|||
160589690|NCT01274338|579876648|FG002|Overall Study|Pregnancy|1|||
160589691|NCT01274338|579876649|FG003|Overall Study|Pregnancy|0|||
160657423|NCT05818137|580127546|FG000|Extension Treatment Period|Ongoing participants|44|||
160589692|NCT01274338|579876650|FG004|Overall Study|Pregnancy|0|||
160589693|NCT01274338|579876651|FG005|Overall Study|Pregnancy|0|||
160589694|NCT01274338|579876646|FG000|Overall Study|Reason not reported|12|||
160657424|NCT01367275|580127547|FG000|Overall Study|Ineligible|1|||
160657425|NCT01367275|580127547|FG000|Overall Study|Disease Progression|2|||
160657426|NCT00048568|580127548|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
160657427|NCT00048568|580127549|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
160589695|NCT01274338|579876647|FG001|Overall Study|Reason not reported|21|||
160589696|NCT01274338|579876648|FG002|Overall Study|Reason not reported|3|||
160589697|NCT01274338|579876649|FG003|Overall Study|Reason not reported|0|||
160589698|NCT01274338|579876650|FG004|Overall Study|Reason not reported|1|||
160589699|NCT01274338|579876651|FG005|Overall Study|Reason not reported|0|||
160589700|NCT03004469|579876652|FG000|Overall Study|Adverse Event|6|||
160589701|NCT03004469|579876653|FG001|Overall Study|Adverse Event|4|||
161025069|NCT03997383|581483794|FG000|Double-blind Treatment Period|Death|4|||
161025070|NCT03997383|581483795|FG001|Double-blind Treatment Period|Death|4|||
161025071|NCT03997383|581483794|FG000|Double-blind Treatment Period|Physician Decision|2|||
161025072|NCT03997383|581483795|FG001|Double-blind Treatment Period|Physician Decision|0|||
161025073|NCT03997383|581483794|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
161025074|NCT03997383|581483795|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
160589702|NCT03004469|579876654|FG002|Overall Study|Adverse Event|6|||
161025075|NCT03997383|581483794|FG000|Open-label Extension Period|Ongoing|148|||
161025076|NCT03997383|581483795|FG001|Open-label Extension Period|Ongoing|151|||
161025077|NCT03997383|581483794|FG000|Open-label Extension Period|Adverse Event|4|||
161025078|NCT03997383|581483795|FG001|Open-label Extension Period|Adverse Event|1|||
161025079|NCT03997383|581483794|FG000|Open-label Extension Period|Death|8|||
161025080|NCT03997383|581483795|FG001|Open-label Extension Period|Death|9|||
161025081|NCT03997383|581483794|FG000|Open-label Extension Period|Physician Decision|1|||
161025082|NCT03997383|581483795|FG001|Open-label Extension Period|Physician Decision|1|||
161025083|NCT03997383|581483794|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
161025084|NCT03997383|581483795|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
161025085|NCT03997383|581483794|FG000|Open-label Extension Period|Reason Not Specified|2|||
161025086|NCT03997383|581483795|FG001|Open-label Extension Period|Reason Not Specified|0|||
161025087|NCT02977988|581483799|FG000|Overall Study|Lost to Follow-up|13|||
161025088|NCT02977988|581483800|FG001|Overall Study|Lost to Follow-up|7|||
161025089|NCT05341115|581483801|FG000|Overall Study|Adverse Event|1|||
161025090|NCT05341115|581483801|FG000|Overall Study|Lost to Follow-up|1|||
161025091|NCT05782816|581483807|FG000|Overall Study|Withdrawal by Subject|1|||
161025092|NCT05782816|581483808|FG001|Overall Study|Withdrawal by Subject|0|||
161025093|NCT04221490|581483809|FG000|At 30 Days Follow-up|Death|7|||
161025094|NCT04221490|581483809|FG000|At 30 Days Follow-up|Physician Decision|1|||
161025095|NCT04221490|581483809|FG000|At 30 Days Follow-up|Missed Visit|4|||
161025096|NCT04221490|581483809|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
161025097|NCT04221490|581483809|FG000|At 6 Months Follow-up|Death|9|||
161025098|NCT04221490|581483809|FG000|At 6 Months Follow-up|Missed Visit|8|||
161025099|NCT04221490|581483809|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
161025100|NCT04221490|581483809|FG000|At 1 Year Follow-up|Death|7|||
161025101|NCT04221490|581483809|FG000|At 1 Year Follow-up|Withdrawal by Subject|2|||
161025102|NCT04221490|581483809|FG000|At 1 Year Follow-up|Missed Visit|9|||
161025103|NCT04221490|581483809|FG000|At 1 Year Follow-up|Exited for Other Reasons|1|||
161025104|NCT05630001|581483810|FG000|Overall Study|Adverse Event|1|||
161025105|NCT05386680|581483811|FG000|Overall Study|Guardian decision|2|||
161025106|NCT03946670|581483812|FG000|Overall Study|Progressive Disease|34|||
161025107|NCT03946670|581483813|FG001|Overall Study|Progressive Disease|27|||
161025108|NCT03946670|581483812|FG000|Overall Study|Adverse Event|7|||
161025109|NCT03946670|581483813|FG001|Overall Study|Adverse Event|10|||
161025110|NCT03946670|581483812|FG000|Overall Study|Physician Decision|6|||
161025111|NCT03946670|581483813|FG001|Overall Study|Physician Decision|5|||
161025112|NCT03946670|581483812|FG000|Overall Study|Death|5|||
161025113|NCT03946670|581483813|FG001|Overall Study|Death|8|||
161025114|NCT03946670|581483812|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
161025115|NCT03946670|581483813|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
161025116|NCT03946670|581483812|FG000|Overall Study|Subject Decision|4|||
161025117|NCT03946670|581483813|FG001|Overall Study|Subject Decision|5|||
161025118|NCT03946670|581483812|FG000|Overall Study|Study Terminated By Sponsor|2|||
161025119|NCT03946670|581483813|FG001|Overall Study|Study Terminated By Sponsor|0|||
161025120|NCT03946670|581483812|FG000|Overall Study|New Therapy For Study Indication|1|||
161025121|NCT03946670|581483813|FG001|Overall Study|New Therapy For Study Indication|0|||
160589703|NCT03004469|579876652|FG000|Overall Study|Lack of Efficacy|1|||
160589704|NCT03004469|579876653|FG001|Overall Study|Lack of Efficacy|0|||
160589705|NCT03004469|579876654|FG002|Overall Study|Lack of Efficacy|1|||
160589706|NCT03004469|579876652|FG000|Overall Study|Lost to Follow-up|23|||
160589707|NCT03004469|579876653|FG001|Overall Study|Lost to Follow-up|14|||
161025122|NCT03946670|581483812|FG000|Overall Study|Not Treated|1|||
161025123|NCT03946670|581483813|FG001|Overall Study|Not Treated|1|||
161025124|NCT06433908|581483814|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|1|||
161025125|NCT06433908|581483815|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
161025126|NCT06433908|581483816|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
161025127|NCT06433908|581483817|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
161025128|NCT06433908|581483814|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161025129|NCT06433908|581483815|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|1|||
161025130|NCT06433908|581483816|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
160589708|NCT03004469|579876654|FG002|Overall Study|Lost to Follow-up|6|||
160589709|NCT03004469|579876652|FG000|Overall Study|Non-Compliance with Study Drug|2|||
160589710|NCT03004469|579876653|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160589711|NCT03004469|579876654|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160589712|NCT03004469|579876652|FG000|Overall Study|Protocol Violation|0|||
160589713|NCT03004469|579876653|FG001|Overall Study|Protocol Violation|0|||
160589714|NCT03004469|579876654|FG002|Overall Study|Protocol Violation|1|||
160589715|NCT03004469|579876652|FG000|Overall Study|Withdrawal by Subject|29|||
161025131|NCT06433908|581483817|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161025132|NCT06433908|581483814|FG000|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161025133|NCT06433908|581483815|FG001|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161025134|NCT06433908|581483816|FG002|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|1|||
161025135|NCT06433908|581483817|FG003|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161025136|NCT04403880|581483818|FG000|Overall Study|Death|1|||
161025137|NCT04403880|581483819|FG001|Overall Study|Death|0|||
161025138|NCT04403880|581483820|FG002|Overall Study|Death|2|||
160657428|NCT00048568|580127550|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
161025139|NCT04403880|581483821|FG003|Overall Study|Death|0|||
161025140|NCT04403880|581483822|FG004|Overall Study|Death|0|||
161025141|NCT04403880|581483823|FG005|Overall Study|Death|0|||
161025142|NCT04403880|581483824|FG006|Overall Study|Death|0|||
161025143|NCT04403880|581483818|FG000|Overall Study|Physician Decision|0|||
161025144|NCT04403880|581483819|FG001|Overall Study|Physician Decision|0|||
161025145|NCT04403880|581483820|FG002|Overall Study|Physician Decision|0|||
161025146|NCT04403880|581483821|FG003|Overall Study|Physician Decision|0|||
161025147|NCT04403880|581483822|FG004|Overall Study|Physician Decision|1|||
161025148|NCT04403880|581483823|FG005|Overall Study|Physician Decision|0|||
161025149|NCT04403880|581483824|FG006|Overall Study|Physician Decision|0|||
161025150|NCT04403880|581483818|FG000|Overall Study|Lost to Follow-up|4|||
161025151|NCT04403880|581483819|FG001|Overall Study|Lost to Follow-up|3|||
161025152|NCT04403880|581483820|FG002|Overall Study|Lost to Follow-up|8|||
161025153|NCT04403880|581483821|FG003|Overall Study|Lost to Follow-up|7|||
161025154|NCT04403880|581483822|FG004|Overall Study|Lost to Follow-up|8|||
161025155|NCT04403880|581483823|FG005|Overall Study|Lost to Follow-up|1|||
161025156|NCT04403880|581483824|FG006|Overall Study|Lost to Follow-up|8|||
161025157|NCT04403880|581483818|FG000|Overall Study|Withdrawal by Subject|8|||
161025158|NCT04403880|581483819|FG001|Overall Study|Withdrawal by Subject|9|||
161025159|NCT04403880|581483820|FG002|Overall Study|Withdrawal by Subject|22|||
161025160|NCT04403880|581483821|FG003|Overall Study|Withdrawal by Subject|16|||
161025161|NCT04403880|581483822|FG004|Overall Study|Withdrawal by Subject|16|||
161025162|NCT04403880|581483823|FG005|Overall Study|Withdrawal by Subject|8|||
161025163|NCT04403880|581483824|FG006|Overall Study|Withdrawal by Subject|11|||
161025164|NCT04403880|581483818|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
161025165|NCT04403880|581483819|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|5|||
161025166|NCT04403880|581483820|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|12|||
161025167|NCT04403880|581483821|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
161025168|NCT04403880|581483822|FG004|Overall Study|Participant Unable to Adhere to Visit Schedule|8|||
161025169|NCT04403880|581483823|FG005|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
161025170|NCT04403880|581483824|FG006|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
161025171|NCT04403880|581483818|FG000|Overall Study|Participant Unable to Comply with Study Procedure|7|||
161025172|NCT04403880|581483819|FG001|Overall Study|Participant Unable to Comply with Study Procedure|1|||
161025173|NCT04403880|581483820|FG002|Overall Study|Participant Unable to Comply with Study Procedure|7|||
161025174|NCT04403880|581483821|FG003|Overall Study|Participant Unable to Comply with Study Procedure|9|||
161025175|NCT04403880|581483822|FG004|Overall Study|Participant Unable to Comply with Study Procedure|8|||
161025176|NCT04403880|581483823|FG005|Overall Study|Participant Unable to Comply with Study Procedure|8|||
161025177|NCT04403880|581483824|FG006|Overall Study|Participant Unable to Comply with Study Procedure|19|||
161025178|NCT04403880|581483818|FG000|Overall Study|Pregnancy|2|||
161025179|NCT04403880|581483819|FG001|Overall Study|Pregnancy|0|||
161025180|NCT04403880|581483820|FG002|Overall Study|Pregnancy|5|||
161025181|NCT04403880|581483821|FG003|Overall Study|Pregnancy|0|||
161025182|NCT04403880|581483822|FG004|Overall Study|Pregnancy|1|||
161025183|NCT04403880|581483823|FG005|Overall Study|Pregnancy|0|||
160589716|NCT03004469|579876653|FG001|Overall Study|Withdrawal by Subject|27|||
160589717|NCT03004469|579876654|FG002|Overall Study|Withdrawal by Subject|10|||
160589718|NCT03004469|579876652|FG000|Overall Study|Other unspecified reason|0|||
160589719|NCT03004469|579876653|FG001|Overall Study|Other unspecified reason|4|||
160589720|NCT03004469|579876654|FG002|Overall Study|Other unspecified reason|1|||
160589721|NCT01397552|579876655|FG000|Overall Study|Adverse Event|1|||
160589722|NCT01397552|579876656|FG001|Overall Study|Adverse Event|0|||
161025184|NCT04403880|581483824|FG006|Overall Study|Pregnancy|1|||
161025185|NCT04403880|581483818|FG000|Overall Study|Sponsor Decision|2|||
161025186|NCT04403880|581483819|FG001|Overall Study|Sponsor Decision|0|||
161025187|NCT04403880|581483820|FG002|Overall Study|Sponsor Decision|14|||
161025188|NCT04403880|581483821|FG003|Overall Study|Sponsor Decision|1|||
161025189|NCT04403880|581483822|FG004|Overall Study|Sponsor Decision|1|||
160589723|NCT01397552|579876655|FG000|Overall Study|Withdrawal by Subject|2|||
160589724|NCT01397552|579876656|FG001|Overall Study|Withdrawal by Subject|1|||
160589725|NCT02287402|579876657|FG000|Treatment Period|Adverse Event|17|||
160589726|NCT02287402|579876657|FG000|Treatment Period|Voluntary Withdrawal|10|||
160589727|NCT02287402|579876657|FG000|Follow-up|Lost to Follow-up|1|||
160589728|NCT02287402|579876657|FG000|Follow-up|Voluntary Withdrawal|2|||
160589729|NCT04247815|579876658|FG000|Overall Study|Adverse Event|1|||
160589730|NCT04247815|579876659|FG001|Overall Study|Adverse Event|0|||
160589731|NCT04247815|579876658|FG000|Overall Study|Withdrawal by Subject|1|||
160589732|NCT04247815|579876659|FG001|Overall Study|Withdrawal by Subject|0|||
160589733|NCT04247815|579876658|FG000|Overall Study|Protocol Violation|0|||
160589734|NCT04247815|579876659|FG001|Overall Study|Protocol Violation|1|||
160589735|NCT03150095|579876660|FG000|Overall Study|Death|0|||
160589736|NCT03150095|579876661|FG001|Overall Study|Death|1|||
160589737|NCT03150095|579876660|FG000|Overall Study|Lost to Follow-up|1|||
160589738|NCT03150095|579876661|FG001|Overall Study|Lost to Follow-up|1|||
160589739|NCT03150095|579876660|FG000|Overall Study|Withdrawal by Subject|4|||
160589740|NCT03150095|579876661|FG001|Overall Study|Withdrawal by Subject|0|||
160589741|NCT03150095|579876660|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
160589742|NCT03150095|579876661|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
160589743|NCT04032171|579876663|FG000|Overall Study|Study Termination|1|||
160589744|NCT04032171|579876664|FG001|Overall Study|Study Termination|0|||
160589745|NCT00089479|579876674|FG000|Overall Study|Death|108|||
160589746|NCT00089479|579876675|FG001|Overall Study|Death|75|||
160589747|NCT00089479|579876674|FG000|Overall Study|Withdrawal by Subject|86|||
160589748|NCT00089479|579876675|FG001|Overall Study|Withdrawal by Subject|107|||
161025190|NCT04403880|581483823|FG005|Overall Study|Sponsor Decision|0|||
161025191|NCT04403880|581483824|FG006|Overall Study|Sponsor Decision|2|||
161025192|NCT04403880|581483818|FG000|Overall Study|Other|18|||
161025193|NCT04403880|581483819|FG001|Overall Study|Other|9|||
161025194|NCT04403880|581483820|FG002|Overall Study|Other|14|||
161025195|NCT04403880|581483821|FG003|Overall Study|Other|10|||
161025196|NCT04403880|581483822|FG004|Overall Study|Other|11|||
161025197|NCT04403880|581483823|FG005|Overall Study|Other|12|||
161025198|NCT04403880|581483824|FG006|Overall Study|Other|15|||
161025199|NCT04652726|581483825|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
161025200|NCT04652726|581483826|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
161025201|NCT04652726|581483827|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
161025202|NCT04652726|581483825|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
161025203|NCT04652726|581483826|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
161025204|NCT04652726|581483827|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
161025205|NCT03780725|581483830|FG000|Overall Study|Progression of disease|3|||
161025206|NCT03780725|581483831|FG001|Overall Study|Progression of disease|4|||
161025207|NCT03780725|581483830|FG000|Overall Study|Adverse Event|0|||
161025208|NCT03780725|581483831|FG001|Overall Study|Adverse Event|1|||
161025209|NCT04138277|581483832|FG000|Pretreatment|Withdrawal by Subject|1|||
161025210|NCT04138277|581483833|FG001|Pretreatment|Withdrawal by Subject|0|||
161025211|NCT04138277|581483832|FG000|Treatment|Adverse Event|6|||
161025212|NCT04138277|581483833|FG001|Treatment|Adverse Event|2|||
160973330|NCT03661996|581293355|FG001|Overall Study|Physician Decision|1|||
160973331|NCT03661996|581293356|FG002|Overall Study|Physician Decision|1|||
160973332|NCT03661996|581293357|FG003|Overall Study|Physician Decision|2|||
160973333|NCT03661996|581293358|FG004|Overall Study|Physician Decision|0|||
160973334|NCT03661996|581293354|FG000|Overall Study|Protocol Violation|0|||
160973335|NCT03661996|581293355|FG001|Overall Study|Protocol Violation|0|||
160973336|NCT03661996|581293356|FG002|Overall Study|Protocol Violation|0|||
160973337|NCT03661996|581293357|FG003|Overall Study|Protocol Violation|0|||
160973338|NCT03661996|581293358|FG004|Overall Study|Protocol Violation|1|||
160973339|NCT03661996|581293354|FG000|Overall Study|Withdrawal by Subject|3|||
160973340|NCT03661996|581293355|FG001|Overall Study|Withdrawal by Subject|5|||
160973341|NCT03661996|581293356|FG002|Overall Study|Withdrawal by Subject|1|||
160973342|NCT03661996|581293357|FG003|Overall Study|Withdrawal by Subject|7|||
160973343|NCT03661996|581293358|FG004|Overall Study|Withdrawal by Subject|7|||
160973344|NCT03661996|581293354|FG000|Overall Study|Sponsors Decision|2|||
160973345|NCT03661996|581293355|FG001|Overall Study|Sponsors Decision|0|||
160973346|NCT03661996|581293356|FG002|Overall Study|Sponsors Decision|0|||
160973347|NCT03661996|581293357|FG003|Overall Study|Sponsors Decision|0|||
160973348|NCT03661996|581293358|FG004|Overall Study|Sponsors Decision|0|||
160973349|NCT03661996|581293354|FG000|Overall Study|Other|1|||
160973350|NCT03661996|581293355|FG001|Overall Study|Other|1|||
160973351|NCT03661996|581293356|FG002|Overall Study|Other|1|||
160973352|NCT03661996|581293357|FG003|Overall Study|Other|1|||
160973353|NCT03661996|581293358|FG004|Overall Study|Other|0|||
160973354|NCT03321513|581293359|FG000|Overall Study|Death|11|||
160973355|NCT03321513|581293360|FG001|Overall Study|Death|5|||
160973356|NCT03321513|581293359|FG000|Overall Study|Withdrawal by Subject|5|||
160973357|NCT03321513|581293360|FG001|Overall Study|Withdrawal by Subject|10|||
161025213|NCT04138277|581483832|FG000|Treatment|Lost to Follow-up|1|||
161025214|NCT04138277|581483833|FG001|Treatment|Lost to Follow-up|0|||
160657429|NCT00048568|580127548|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
160657430|NCT00048568|580127549|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
160657431|NCT00048568|580127550|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
160657432|NCT00048568|580127548|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
160657433|NCT00048568|580127549|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
160657434|NCT00048568|580127550|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
160657435|NCT00048568|580127548|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
160657436|NCT00048568|580127549|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
160657437|NCT00048568|580127550|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
160657438|NCT00048568|580127548|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
160657439|NCT00048568|580127549|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
160657440|NCT00048568|580127550|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
160657441|NCT00048568|580127548|FG000|Double-Blind Period Days 170 to 365|Death|1|||
160657442|NCT00048568|580127549|FG001|Double-Blind Period Days 170 to 365|Death|1|||
160657443|NCT00048568|580127550|FG002|Double-Blind Period Days 170 to 365|Death|0|||
160657444|NCT00048568|580127548|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
160657445|NCT00048568|580127549|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
160657446|NCT00048568|580127550|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
160657447|NCT00048568|580127548|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
160657448|NCT00048568|580127549|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
160657449|NCT00048568|580127550|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
160657450|NCT00048568|580127548|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
160657451|NCT00048568|580127549|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
160657452|NCT00048568|580127550|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
160657453|NCT00048568|580127548|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
160657454|NCT00048568|580127549|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
160657455|NCT00048568|580127550|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
160657456|NCT00048568|580127548|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
160657457|NCT00048568|580127549|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
160657458|NCT00048568|580127550|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
160657459|NCT00048568|580127548|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
160657460|NCT00048568|580127549|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
160657461|NCT00048568|580127550|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
160657462|NCT00048568|580127548|FG000|Open-Label Period|Death|0|||
160657463|NCT00048568|580127549|FG001|Open-Label Period|Death|0|||
160657464|NCT00048568|580127550|FG002|Open-Label Period|Death|13|||
160657465|NCT00048568|580127548|FG000|Open-Label Period|Adverse Event|0|||
160657466|NCT00048568|580127549|FG001|Open-Label Period|Adverse Event|0|||
160657467|NCT00048568|580127550|FG002|Open-Label Period|Adverse Event|49|||
160657468|NCT00048568|580127548|FG000|Open-Label Period|Lack of Efficacy|0|||
160657469|NCT00048568|580127549|FG001|Open-Label Period|Lack of Efficacy|0|||
160657470|NCT00048568|580127550|FG002|Open-Label Period|Lack of Efficacy|32|||
160657471|NCT00048568|580127548|FG000|Open-Label Period|Withdrawal by Subject|0|||
160657472|NCT00048568|580127549|FG001|Open-Label Period|Withdrawal by Subject|0|||
160657473|NCT00048568|580127550|FG002|Open-Label Period|Withdrawal by Subject|26|||
160657474|NCT00048568|580127548|FG000|Open-Label Period|Pregnancy|0|||
160657475|NCT00048568|580127549|FG001|Open-Label Period|Pregnancy|0|||
160657476|NCT00048568|580127550|FG002|Open-Label Period|Pregnancy|5|||
160657477|NCT00048568|580127548|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
160657478|NCT00048568|580127549|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
160657479|NCT00048568|580127550|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
160657480|NCT00048568|580127548|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
160657481|NCT00048568|580127549|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
160657482|NCT00048568|580127550|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
160657483|NCT00048568|580127548|FG000|Open-Label Period|Unknown Reasons|0|||
160657484|NCT00048568|580127549|FG001|Open-Label Period|Unknown Reasons|0|||
160657485|NCT00048568|580127550|FG002|Open-Label Period|Unknown Reasons|25|||
160657486|NCT00048568|580127548|FG000|Open-Label Period|Lost to Follow-up|0|||
160657487|NCT00048568|580127549|FG001|Open-Label Period|Lost to Follow-up|0|||
160657488|NCT00048568|580127550|FG002|Open-Label Period|Lost to Follow-up|7|||
160657489|NCT01717976|580127551|FG000|Overall Study|Protocol Violation|0|||
160657490|NCT01717976|580127552|FG001|Overall Study|Protocol Violation|1|||
160973358|NCT03321513|581293359|FG000|Overall Study|Lost to Follow-up|10|||
160973359|NCT03321513|581293360|FG001|Overall Study|Lost to Follow-up|11|||
160973360|NCT01161472|581293361|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
160973361|NCT01161472|581293362|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
160973362|NCT01161472|581293363|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
160973363|NCT01161472|581293364|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
160973364|NCT02176421|581293384|FG000|Overall Study|Lost to Follow-up|4|||
160973365|NCT02176421|581293384|FG000|Overall Study|Adverse Event|1|||
160973366|NCT04848662|581293385|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
161025215|NCT04138277|581483832|FG000|Treatment|Pregnancy|3|||
161025216|NCT04138277|581483833|FG001|Treatment|Pregnancy|0|||
161025217|NCT04138277|581483832|FG000|Treatment|COVID-19 pandemic|1|||
161025218|NCT04138277|581483833|FG001|Treatment|COVID-19 pandemic|0|||
161025219|NCT04138277|581483832|FG000|Treatment|Withdrawal by Subject|9|||
161025220|NCT04138277|581483833|FG001|Treatment|Withdrawal by Subject|3|||
161025221|NCT04138277|581483832|FG000|Treatment|Sponsor decision|1|||
161025222|NCT04138277|581483833|FG001|Treatment|Sponsor decision|0|||
161025223|NCT04138277|581483832|FG000|Treatment|Physician Decision|1|||
161025224|NCT04138277|581483833|FG001|Treatment|Physician Decision|0|||
161025225|NCT04138277|581483832|FG000|Treatment|Worsening of condition|1|||
161025226|NCT04138277|581483833|FG001|Treatment|Worsening of condition|2|||
161025227|NCT03768414|581483834|FG000|Overall Study|Adverse Event or side effects|72|||
161025228|NCT03768414|581483835|FG001|Overall Study|Adverse Event or side effects|28|||
161025229|NCT03768414|581483834|FG000|Overall Study|Refusal unrelated to adverse event|33|||
161025230|NCT03768414|581483835|FG001|Overall Study|Refusal unrelated to adverse event|33|||
161025231|NCT03768414|581483834|FG000|Overall Study|Progression/relapse|132|||
161025232|NCT03768414|581483835|FG001|Overall Study|Progression/relapse|60|||
161025233|NCT03768414|581483834|FG000|Overall Study|Death|9|||
161025234|NCT03768414|581483835|FG001|Overall Study|Death|6|||
161025235|NCT03768414|581483834|FG000|Overall Study|Other - not protocol specified|45|||
161025236|NCT03768414|581483835|FG001|Overall Study|Other - not protocol specified|18|||
161025237|NCT03768414|581483834|FG000|Overall Study|Reason under review|3|||
161025238|NCT03768414|581483835|FG001|Overall Study|Reason under review|2|||
161025239|NCT05082025|581483836|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
161025240|NCT02442349|581483839|FG000|Overall Study|Death|95|||
161025241|NCT02442349|581483839|FG000|Overall Study|Withdrawal by Subject|27|||
161025242|NCT02442349|581483839|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
161025243|NCT02442349|581483839|FG000|Overall Study|Lost to Follow-up|1|||
161025244|NCT02738008|581483840|FG000|Overall Study|Study Terminated by Sponsor|1|||
161025245|NCT02738008|581483841|FG001|Overall Study|Study Terminated by Sponsor|5|||
161025246|NCT02738008|581483842|FG002|Overall Study|Study Terminated by Sponsor|3|||
161025247|NCT02738008|581483840|FG000|Overall Study|Adverse Event|0|||
161025248|NCT02738008|581483841|FG001|Overall Study|Adverse Event|1|||
161025249|NCT02738008|581483842|FG002|Overall Study|Adverse Event|2|||
161025250|NCT03437278|581483843|FG000|Overall Study|Adverse Event|0|||
161025251|NCT03437278|581483844|FG001|Overall Study|Adverse Event|0|||
161025252|NCT03437278|581483845|FG002|Overall Study|Adverse Event|1|||
161025253|NCT03437278|581483843|FG000|Overall Study|Progressive disease|1|||
161025254|NCT03437278|581483844|FG001|Overall Study|Progressive disease|0|||
161025255|NCT03437278|581483845|FG002|Overall Study|Progressive disease|0|||
161025256|NCT03437278|581483843|FG000|Overall Study|Physician Decision|1|||
161025257|NCT03437278|581483844|FG001|Overall Study|Physician Decision|0|||
161025258|NCT03437278|581483845|FG002|Overall Study|Physician Decision|1|||
161025259|NCT05192382|581483846|FG000|RC Phase (Up to Week 24)|Adverse Event|1|||
161025260|NCT05192382|581483847|FG001|RC Phase (Up to Week 24)|Adverse Event|1|||
161025261|NCT05192382|581483848|FG002|RC Phase (Up to Week 24)|Adverse Event|0|||
161025262|NCT05192382|581483846|FG000|RC Phase (Up to Week 24)|Withdrawal by Subject|1|||
161025263|NCT05192382|581483847|FG001|RC Phase (Up to Week 24)|Withdrawal by Subject|2|||
161025264|NCT05192382|581483848|FG002|RC Phase (Up to Week 24)|Withdrawal by Subject|0|||
161025265|NCT05192382|581483846|FG000|OLE Phase (Up to Week 200)|Discontinued|1|||
161025266|NCT05192382|581483847|FG001|OLE Phase (Up to Week 200)|Discontinued|4|||
161025267|NCT05192382|581483848|FG002|OLE Phase (Up to Week 200)|Discontinued|1|||
161025268|NCT05192382|581483846|FG000|OLE Phase (Up to Week 200)|Ongoing|49|||
161025269|NCT05192382|581483847|FG001|OLE Phase (Up to Week 200)|Ongoing|48|||
161025270|NCT05192382|581483848|FG002|OLE Phase (Up to Week 200)|Ongoing|10|||
161025271|NCT06504862|581483851|FG000|Transition period|Adverse Event|1|||
161025272|NCT06504862|581483852|FG001|Transition period|Adverse Event|0|||
161025273|NCT04328727|581483853|FG000|Overall Study|Guardian Decision|1|||
161025274|NCT04328727|581483853|FG000|Overall Study|Participant decision|4|||
161025275|NCT04328727|581483853|FG000|Overall Study|Death|3|||
161025276|NCT02604199|581483854|FG000|Overall Study|Pregnancy|0|||
161025277|NCT02604199|581483855|FG001|Overall Study|Pregnancy|0|||
161025278|NCT02604199|581483856|FG002|Overall Study|Pregnancy|0|||
161025279|NCT02604199|581483857|FG003|Overall Study|Pregnancy|1|||
161025280|NCT02604199|581483854|FG000|Overall Study|Study terminated by sponsor|0|||
161025281|NCT02604199|581483855|FG001|Overall Study|Study terminated by sponsor|2|||
161025282|NCT02604199|581483856|FG002|Overall Study|Study terminated by sponsor|0|||
161025283|NCT02604199|581483857|FG003|Overall Study|Study terminated by sponsor|2|||
161025284|NCT02604199|581483854|FG000|Overall Study|Withdrawal by Subject|0|||
161025285|NCT02604199|581483855|FG001|Overall Study|Withdrawal by Subject|1|||
161025286|NCT02604199|581483856|FG002|Overall Study|Withdrawal by Subject|0|||
161025287|NCT02604199|581483857|FG003|Overall Study|Withdrawal by Subject|0|||
161025288|NCT02604212|581483858|FG000|Overall Study|Study Terminated by Sponsor|2|||
161025289|NCT02604212|581483859|FG001|Overall Study|Study Terminated by Sponsor|1|||
161025290|NCT02604212|581483860|FG002|Overall Study|Study Terminated by Sponsor|3|||
161025291|NCT02604212|581483861|FG003|Overall Study|Study Terminated by Sponsor|3|||
161025292|NCT02604212|581483858|FG000|Overall Study|Withdrawal by Subject|0|||
161025293|NCT02604212|581483859|FG001|Overall Study|Withdrawal by Subject|0|||
161025294|NCT02604212|581483860|FG002|Overall Study|Withdrawal by Subject|1|||
161025295|NCT02604212|581483861|FG003|Overall Study|Withdrawal by Subject|0|||
161025296|NCT03019406|581483862|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
161025297|NCT03019406|581483863|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
161025298|NCT03019406|581483864|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
161025299|NCT03019406|581483865|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
161025300|NCT02296125|581483869|FG000|Overall Study|Withdrawal by Subject|18|||
161025301|NCT02296125|581483870|FG001|Overall Study|Withdrawal by Subject|8|||
161025302|NCT02296125|581483871|FG002|Overall Study|Withdrawal by Subject|6|||
161025303|NCT02296125|581483872|FG003|Overall Study|Withdrawal by Subject|2|||
161025304|NCT02296125|581483869|FG000|Overall Study|Adverse Event|41|||
161025305|NCT02296125|581483870|FG001|Overall Study|Adverse Event|52|||
161025306|NCT02296125|581483871|FG002|Overall Study|Adverse Event|9|||
161025307|NCT02296125|581483872|FG003|Overall Study|Adverse Event|4|||
161025308|NCT02296125|581483869|FG000|Overall Study|Severe non-compliance to protocol|0|||
161025309|NCT02296125|581483870|FG001|Overall Study|Severe non-compliance to protocol|1|||
161025310|NCT02296125|581483871|FG002|Overall Study|Severe non-compliance to protocol|0|||
161025311|NCT02296125|581483872|FG003|Overall Study|Severe non-compliance to protocol|0|||
161025312|NCT02296125|581483869|FG000|Overall Study|Condition under investigation worsened|153|||
161025313|NCT02296125|581483870|FG001|Overall Study|Condition under investigation worsened|199|||
161025314|NCT02296125|581483871|FG002|Overall Study|Condition under investigation worsened|39|||
161025315|NCT02296125|581483872|FG003|Overall Study|Condition under investigation worsened|56|||
161025316|NCT02296125|581483869|FG000|Overall Study|Any reason not specifically recorded|6|||
161025317|NCT02296125|581483870|FG001|Overall Study|Any reason not specifically recorded|4|||
161025318|NCT02296125|581483871|FG002|Overall Study|Any reason not specifically recorded|2|||
161025319|NCT02296125|581483872|FG003|Overall Study|Any reason not specifically recorded|0|||
161025320|NCT04702776|581483873|FG000|Overall Study|Adverse Event|1|||
161025321|NCT04702776|581483874|FG001|Overall Study|Adverse Event|2|||
161025322|NCT04702776|581483875|FG002|Overall Study|Adverse Event|1|||
161025323|NCT04702776|581483873|FG000|Overall Study|Lost to Follow-up|2|||
161025324|NCT04702776|581483874|FG001|Overall Study|Lost to Follow-up|1|||
161025325|NCT04702776|581483875|FG002|Overall Study|Lost to Follow-up|4|||
161025326|NCT04702776|581483873|FG000|Overall Study|Protocol Violation|2|||
161025327|NCT04702776|581483874|FG001|Overall Study|Protocol Violation|2|||
161025328|NCT04702776|581483875|FG002|Overall Study|Protocol Violation|3|||
161025329|NCT02556736|581483880|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
161025330|NCT02556736|581483881|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
161025331|NCT02556736|581483882|FG002|Open Label Treatment Period|Withdrawal by Subject|1|||
161025332|NCT02556736|581483883|FG003|Open Label Treatment Period|Withdrawal by Subject|1|||
161025333|NCT02556736|581483880|FG000|Open Label Treatment Period|Adverse Event|0|||
161025334|NCT02556736|581483881|FG001|Open Label Treatment Period|Adverse Event|0|||
161025335|NCT02556736|581483882|FG002|Open Label Treatment Period|Adverse Event|0|||
161025336|NCT02556736|581483883|FG003|Open Label Treatment Period|Adverse Event|1|||
161025337|NCT02556736|581483880|FG000|Long-Term Follow-up|Lost to Follow-up|1|||
161025338|NCT02556736|581483881|FG001|Long-Term Follow-up|Lost to Follow-up|0|||
161025339|NCT02556736|581483882|FG002|Long-Term Follow-up|Lost to Follow-up|0|||
161025340|NCT02556736|581483883|FG003|Long-Term Follow-up|Lost to Follow-up|1|||
161025341|NCT04192266|581483891|FG000|Overall Study|Withdrawal by Subject|3|||
161025342|NCT04192266|581483892|FG001|Overall Study|Withdrawal by Subject|2|||
161025343|NCT05358717|581483893|FG000|Overall Study|Adverse Event|0|||
161025344|NCT05358717|581483894|FG001|Overall Study|Adverse Event|1|||
161025345|NCT05358717|581483895|FG002|Overall Study|Adverse Event|1|||
161025346|NCT05358717|581483893|FG000|Overall Study|Death|1|||
161025347|NCT05358717|581483894|FG001|Overall Study|Death|1|||
161025348|NCT05358717|581483895|FG002|Overall Study|Death|0|||
161025349|NCT05358717|581483893|FG000|Overall Study|Withdrawal by Subject|1|||
161025350|NCT05358717|581483894|FG001|Overall Study|Withdrawal by Subject|1|||
161025351|NCT05358717|581483895|FG002|Overall Study|Withdrawal by Subject|2|||
161025352|NCT05358717|581483893|FG000|Overall Study|Study Paused by Sponsor in United States|0|||
161025353|NCT05358717|581483894|FG001|Overall Study|Study Paused by Sponsor in United States|2|||
161025354|NCT05358717|581483895|FG002|Overall Study|Study Paused by Sponsor in United States|0|||
161025355|NCT04870515|581483896|FG000|Overall Study|Lost to Follow-up|0|||
161025356|NCT04870515|581483897|FG001|Overall Study|Lost to Follow-up|2|||
160589749|NCT00089479|579876674|FG000|Overall Study|Lost to Follow-up|137|||
160589750|NCT00089479|579876675|FG001|Overall Study|Lost to Follow-up|107|||
160589751|NCT03943953|579876676|FG000|Trial of ITG 1|Lost to Follow-up|19|||
161025357|NCT04870515|581483896|FG000|Overall Study|Withdrawal by Subject|0|||
161025358|NCT04870515|581483897|FG001|Overall Study|Withdrawal by Subject|1|||
161025359|NCT04870515|581483896|FG000|Overall Study|Withdrawal due to complications with standard of care treatment|2|||
161025360|NCT04870515|581483897|FG001|Overall Study|Withdrawal due to complications with standard of care treatment|0|||
161025361|NCT01302834|581483898|FG000|Overall Study|Protocol Violation|17|||
161025362|NCT01302834|581483899|FG001|Overall Study|Protocol Violation|23|||
161025363|NCT01302834|581483898|FG000|Overall Study|HIV positive|1|||
161025364|NCT01302834|581483899|FG001|Overall Study|HIV positive|3|||
161025365|NCT05528510|581483902|FG000|Overall Study|Death|1|||
161025366|NCT05528510|581483903|FG001|Overall Study|Death|0|||
161025367|NCT05528510|581483904|FG002|Overall Study|Death|0|||
161025368|NCT05528510|581483902|FG000|Overall Study|Lost to Follow-up|1|||
161025369|NCT05528510|581483903|FG001|Overall Study|Lost to Follow-up|0|||
161025370|NCT05528510|581483904|FG002|Overall Study|Lost to Follow-up|0|||
160589752|NCT03943953|579876677|FG001|Trial of ITG 1|Lost to Follow-up|1|||
160589753|NCT03943953|579876676|FG000|Trial of ITG 2|Lost to Follow-up|8|||
160589754|NCT03943953|579876677|FG001|Trial of ITG 2|Lost to Follow-up|0|||
160589755|NCT03943953|579876676|FG000|Trial of ITG 3|Lost to Follow-up|2|||
160589756|NCT03943953|579876677|FG001|Trial of ITG 3|Lost to Follow-up|0|||
160589757|NCT03943953|579876676|FG000|Trial of ITG 4|Lost to Follow-up|2|||
160589758|NCT03943953|579876677|FG001|Trial of ITG 4|Lost to Follow-up|0|||
160589759|NCT01742078|579876680|FG000|Overall Study|Withdrawal by Subject|0|||
160589760|NCT01742078|579876681|FG001|Overall Study|Withdrawal by Subject|0|||
160589761|NCT01742078|579876682|FG002|Overall Study|Withdrawal by Subject|0|||
160589762|NCT01742078|579876683|FG003|Overall Study|Withdrawal by Subject|1|||
160589763|NCT01742078|579876684|FG004|Overall Study|Withdrawal by Subject|0|||
160589764|NCT01742078|579876685|FG005|Overall Study|Withdrawal by Subject|0|||
160589765|NCT01742078|579876686|FG006|Overall Study|Withdrawal by Subject|0|||
160589766|NCT01742078|579876687|FG007|Overall Study|Withdrawal by Subject|0|||
160589767|NCT01742078|579876688|FG008|Overall Study|Withdrawal by Subject|0|||
160589768|NCT05025787|579876689|FG000|Overall Study|Lack of Efficacy|0|||
160589769|NCT05025787|579876690|FG001|Overall Study|Lack of Efficacy|1|||
160589770|NCT05025787|579876689|FG000|Overall Study|Adverse Event|2|||
160589771|NCT05025787|579876690|FG001|Overall Study|Adverse Event|4|||
160589772|NCT05025787|579876689|FG000|Overall Study|Non compliance|0|||
160589773|NCT05025787|579876690|FG001|Overall Study|Non compliance|1|||
160589774|NCT05025787|579876689|FG000|Overall Study|Protocol Violation|3|||
160589775|NCT05025787|579876690|FG001|Overall Study|Protocol Violation|1|||
160589776|NCT05025787|579876689|FG000|Overall Study|Stopping criteria met|1|||
160589777|NCT05025787|579876690|FG001|Overall Study|Stopping criteria met|1|||
160589778|NCT05025787|579876689|FG000|Overall Study|Withdrawal by Subject|3|||
160589779|NCT05025787|579876690|FG001|Overall Study|Withdrawal by Subject|1|||
160589780|NCT03806179|579876691|FG000|Overall Study|Progressive disease|0|||
160589781|NCT03806179|579876692|FG001|Overall Study|Progressive disease|2|||
160589782|NCT05600309|579876693|FG000|Overall Study|Death|41|||
160589783|NCT05600309|579876694|FG001|Overall Study|Death|38|||
160589784|NCT05600309|579876693|FG000|Overall Study|Sponsor Decision|9|||
160589785|NCT05600309|579876694|FG001|Overall Study|Sponsor Decision|6|||
160589786|NCT05822830|579876695|FG000|Overall Study|Adverse Event|6|||
160589787|NCT05822830|579876696|FG001|Overall Study|Adverse Event|6|||
160589788|NCT05822830|579876695|FG000|Overall Study|Assigned Treatment by Mistake|5|||
160589789|NCT05822830|579876696|FG001|Overall Study|Assigned Treatment by Mistake|3|||
160589790|NCT05822830|579876695|FG000|Overall Study|Lost to Follow-up|16|||
160589791|NCT05822830|579876696|FG001|Overall Study|Lost to Follow-up|18|||
160589792|NCT05822830|579876695|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160589793|NCT05822830|579876696|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160589794|NCT05822830|579876695|FG000|Overall Study|Participant was Out of the Country|0|||
160589795|NCT05822830|579876696|FG001|Overall Study|Participant was Out of the Country|1|||
160589796|NCT05822830|579876695|FG000|Overall Study|Pregnancy|1|||
160589797|NCT05822830|579876696|FG001|Overall Study|Pregnancy|2|||
160589798|NCT05822830|579876695|FG000|Overall Study|Withdrawal by Subject|27|||
160589799|NCT05822830|579876696|FG001|Overall Study|Withdrawal by Subject|26|||
160589800|NCT03368664|579876703|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
160589801|NCT03368664|579876703|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
160589802|NCT03368664|579876703|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
160589803|NCT03368664|579876703|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
160589804|NCT02493426|579876704|FG000|Overall Study|Withdrawal by Subject|0|||
160589805|NCT02493426|579876705|FG001|Overall Study|Withdrawal by Subject|1|||
160589806|NCT00807846|579876709|FG000|Overall Study|Adverse Event|5|||
160589807|NCT00807846|579876710|FG001|Overall Study|Adverse Event|0|||
160589808|NCT00807846|579876709|FG000|Overall Study|Lack of Efficacy|2|||
160589809|NCT00807846|579876710|FG001|Overall Study|Lack of Efficacy|0|||
160589810|NCT00807846|579876709|FG000|Overall Study|Protocol Violation|2|||
160589811|NCT00807846|579876710|FG001|Overall Study|Protocol Violation|1|||
160589812|NCT00807846|579876709|FG000|Overall Study|Withdrawal by Subject|2|||
160589813|NCT00807846|579876710|FG001|Overall Study|Withdrawal by Subject|1|||
160589814|NCT00807846|579876709|FG000|Overall Study|Other|1|||
160589815|NCT00807846|579876710|FG001|Overall Study|Other|2|||
160589816|NCT01081873|579876711|FG000|Overall Study|Death|86|||
160589817|NCT01081873|579876711|FG000|Overall Study|Withdrawal by Subject|10|||
160589818|NCT01081873|579876711|FG000|Overall Study|Lost to Follow-up|142|||
160589819|NCT01081873|579876711|FG000|Overall Study|Progression of prostate cancer|13|||
160589820|NCT01081873|579876711|FG000|Overall Study|Other|47|||
161025371|NCT05528510|581483902|FG000|Overall Study|Withdrawal by Subject|4|||
160973367|NCT04848662|581293386|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
160973368|NCT02912468|581293387|FG000|Overall Study|Adverse Event|3|||
160973369|NCT02912468|581293388|FG001|Overall Study|Adverse Event|2|||
160973370|NCT02912468|581293387|FG000|Overall Study|Withdrawal by Subject|6|||
160973371|NCT02912468|581293388|FG001|Overall Study|Withdrawal by Subject|2|||
160973372|NCT02912468|581293387|FG000|Overall Study|Randomized and not treated|0|||
160973373|NCT02912468|581293388|FG001|Overall Study|Randomized and not treated|1|||
160973374|NCT00089895|581293389|FG000|Overall Study|Consent Withdrawn|11|||
160973375|NCT00089895|581293390|FG001|Overall Study|Consent Withdrawn|14|||
160973376|NCT00089895|581293389|FG000|Overall Study|Technical reason|7|||
160973377|NCT00089895|581293390|FG001|Overall Study|Technical reason|2|||
160973378|NCT00089895|581293389|FG000|Overall Study|Surgery|0|||
160973379|NCT00089895|581293390|FG001|Overall Study|Surgery|1|||
160973380|NCT00089895|581293389|FG000|Overall Study|Bleeding|0|||
160973381|NCT00089895|581293390|FG001|Overall Study|Bleeding|2|||
160973382|NCT00089895|581293389|FG000|Overall Study|Physician Decision|3|||
160973383|NCT00089895|581293390|FG001|Overall Study|Physician Decision|7|||
160973384|NCT00089895|581293389|FG000|Overall Study|Exclusion criteria met|6|||
160973385|NCT00089895|581293390|FG001|Overall Study|Exclusion criteria met|6|||
160973386|NCT00089895|581293389|FG000|Overall Study|Not otherwise specified|4|||
160973387|NCT00089895|581293390|FG001|Overall Study|Not otherwise specified|8|||
160973388|NCT00089895|581293389|FG000|Overall Study|Missing|4|||
160973389|NCT00089895|581293390|FG001|Overall Study|Missing|2|||
160973390|NCT05644353|581293391|FG000|Overall Study|Physician Decision|1|||
160973391|NCT05644353|581293392|FG001|Overall Study|Physician Decision|0|||
160973392|NCT05644353|581293393|FG002|Overall Study|Physician Decision|0|||
160973393|NCT05644353|581293394|FG003|Overall Study|Physician Decision|0|||
160973394|NCT05644353|581293395|FG004|Overall Study|Physician Decision|0|||
160973395|NCT05644353|581293396|FG005|Overall Study|Physician Decision|0|||
160973396|NCT05644353|581293391|FG000|Overall Study|Protocol Violation|1|||
160973397|NCT05644353|581293392|FG001|Overall Study|Protocol Violation|0|||
160973398|NCT05644353|581293393|FG002|Overall Study|Protocol Violation|0|||
160973399|NCT05644353|581293394|FG003|Overall Study|Protocol Violation|0|||
160973400|NCT05644353|581293395|FG004|Overall Study|Protocol Violation|0|||
160973401|NCT05644353|581293396|FG005|Overall Study|Protocol Violation|0|||
160973402|NCT05644353|581293391|FG000|Overall Study|Withdrawal by Subject|0|||
160973403|NCT05644353|581293392|FG001|Overall Study|Withdrawal by Subject|2|||
160973404|NCT05644353|581293393|FG002|Overall Study|Withdrawal by Subject|0|||
160973405|NCT05644353|581293394|FG003|Overall Study|Withdrawal by Subject|0|||
160973406|NCT05644353|581293395|FG004|Overall Study|Withdrawal by Subject|1|||
160973407|NCT05644353|581293396|FG005|Overall Study|Withdrawal by Subject|0|||
160973408|NCT05644353|581293391|FG000|Overall Study|Lost to Follow-up|0|||
160973409|NCT05644353|581293392|FG001|Overall Study|Lost to Follow-up|0|||
160973410|NCT05644353|581293393|FG002|Overall Study|Lost to Follow-up|1|||
160973411|NCT05644353|581293394|FG003|Overall Study|Lost to Follow-up|0|||
160973412|NCT05644353|581293395|FG004|Overall Study|Lost to Follow-up|0|||
160973413|NCT05644353|581293396|FG005|Overall Study|Lost to Follow-up|0|||
160973414|NCT02667886|581293397|FG000|Dose Escalation (Part A)|Adverse Event|1|||
160973415|NCT02667886|581293398|FG001|Dose Escalation (Part A)|Adverse Event|3|||
160973416|NCT02667886|581293399|FG002|Dose Escalation (Part A)|Adverse Event|1|||
160973417|NCT02667886|581293400|FG003|Dose Escalation (Part A)|Adverse Event|0|||
160973418|NCT02667886|581293401|FG004|Dose Escalation (Part A)|Adverse Event|0|||
160973419|NCT02667886|581293397|FG000|Dose Escalation (Part A)|Disease Progression|1|||
160973420|NCT02667886|581293398|FG001|Dose Escalation (Part A)|Disease Progression|4|||
160973421|NCT02667886|581293399|FG002|Dose Escalation (Part A)|Disease Progression|3|||
160973422|NCT02667886|581293400|FG003|Dose Escalation (Part A)|Disease Progression|0|||
160973423|NCT02667886|581293401|FG004|Dose Escalation (Part A)|Disease Progression|0|||
160973424|NCT02667886|581293397|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
160973425|NCT02667886|581293398|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
160973426|NCT02667886|581293399|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
160973427|NCT02667886|581293400|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
160973428|NCT02667886|581293401|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
160973429|NCT02667886|581293397|FG000|Dose Expansion (Part B)|Adverse Event|0|||
160973430|NCT02667886|581293398|FG001|Dose Expansion (Part B)|Adverse Event|0|||
160973431|NCT02667886|581293399|FG002|Dose Expansion (Part B)|Adverse Event|0|||
160973432|NCT02667886|581293400|FG003|Dose Expansion (Part B)|Adverse Event|9|||
160973433|NCT02667886|581293401|FG004|Dose Expansion (Part B)|Adverse Event|0|||
160973434|NCT02667886|581293397|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
160973435|NCT02667886|581293398|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
160973436|NCT02667886|581293399|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
160973437|NCT02667886|581293400|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
160973438|NCT02667886|581293401|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
160973439|NCT02667886|581293397|FG000|Dose Expansion (Part B)|Disease Progression|0|||
160973440|NCT02667886|581293398|FG001|Dose Expansion (Part B)|Disease Progression|0|||
160973441|NCT02667886|581293399|FG002|Dose Expansion (Part B)|Disease Progression|0|||
160973442|NCT02667886|581293400|FG003|Dose Expansion (Part B)|Disease Progression|38|||
161025372|NCT05528510|581483903|FG001|Overall Study|Withdrawal by Subject|1|||
161025373|NCT05528510|581483904|FG002|Overall Study|Withdrawal by Subject|3|||
161025374|NCT05528510|581483902|FG000|Overall Study|Other|2|||
161025375|NCT05528510|581483903|FG001|Overall Study|Other|2|||
161025376|NCT05528510|581483904|FG002|Overall Study|Other|1|||
161025377|NCT04837040|581483911|FG000|RC Phase (Up to Week 36)|Withdrawal by Subject|0|||
161025378|NCT04837040|581483912|FG001|RC Phase (Up to Week 36)|Withdrawal by Subject|1|||
161025379|NCT02838420|581483913|FG000|Overall Study|Ongoing in Study|113|||
161025380|NCT02838420|581483914|FG001|Overall Study|Ongoing in Study|45|||
161025381|NCT02838420|581483913|FG000|Overall Study|Lost to Follow-up|1|||
161025382|NCT02838420|581483914|FG001|Overall Study|Lost to Follow-up|0|||
161025383|NCT02838420|581483913|FG000|Overall Study|Withdrawal by Subject|3|||
161025384|NCT02838420|581483914|FG001|Overall Study|Withdrawal by Subject|4|||
161025385|NCT02838420|581483913|FG000|Overall Study|Death|8|||
161025386|NCT02838420|581483914|FG001|Overall Study|Death|13|||
161025387|NCT02961218|581483915|FG000|Overall Study|Lost to Follow-up|0|||
161025388|NCT02961218|581483916|FG001|Overall Study|Lost to Follow-up|2|||
161025389|NCT02961218|581483915|FG000|Overall Study|Physician Decision|0|||
161025390|NCT02961218|581483916|FG001|Overall Study|Physician Decision|2|||
161025391|NCT02961218|581483915|FG000|Overall Study|Subject/Guardian Decision|3|||
161025392|NCT02961218|581483916|FG001|Overall Study|Subject/Guardian Decision|1|||
161025393|NCT01856478|581483917|FG000|Overall Study|Not treated|0|||
161025394|NCT01856478|581483918|FG001|Overall Study|Not treated|8|||
161025395|NCT01856478|581483917|FG000|Overall Study|Progressive disease per RECIST|146|||
161025396|NCT01856478|581483918|FG001|Overall Study|Progressive disease per RECIST|49|||
161025397|NCT01856478|581483917|FG000|Overall Study|Worsening of underlying cancer|6|||
161025398|NCT01856478|581483918|FG001|Overall Study|Worsening of underlying cancer|2|||
161025399|NCT01856478|581483917|FG000|Overall Study|Adverse events|57|||
161025400|NCT01856478|581483918|FG001|Overall Study|Adverse events|30|||
161025401|NCT01856478|581483917|FG000|Overall Study|Non-compliant with protocol|1|||
161025402|NCT01856478|581483918|FG001|Overall Study|Non-compliant with protocol|1|||
161025403|NCT01856478|581483917|FG000|Overall Study|Lost to Follow-up|1|||
161025404|NCT01856478|581483918|FG001|Overall Study|Lost to Follow-up|1|||
161025405|NCT01856478|581483917|FG000|Overall Study|Refused to continue trial medication|13|||
161025406|NCT01856478|581483918|FG001|Overall Study|Refused to continue trial medication|11|||
161025407|NCT01856478|581483917|FG000|Overall Study|Other reason than listed|4|||
161025408|NCT01856478|581483918|FG001|Overall Study|Other reason than listed|10|||
161025409|NCT05032820|581483919|FG000|Overall Study|Lost to Follow-up|1|||
161025410|NCT05032820|581483919|FG000|Overall Study|Withdrawal by Subject|1|||
161025411|NCT04108208|581483920|FG000|Overall Study|Withdrawal by Subject|2|||
161025412|NCT04108208|581483921|FG001|Overall Study|Withdrawal by Subject|6|||
161025413|NCT04108208|581483920|FG000|Overall Study|other-ongoing|20|||
161025414|NCT04108208|581483921|FG001|Overall Study|other-ongoing|40|||
161025415|NCT04108208|581483920|FG000|Overall Study|Death|1|||
161025416|NCT04108208|581483921|FG001|Overall Study|Death|4|||
161025417|NCT04108208|581483920|FG000|Overall Study|Lost to Follow-up|2|||
161025418|NCT04108208|581483921|FG001|Overall Study|Lost to Follow-up|0|||
161025419|NCT04936308|581483922|FG000|Overall Study|Death|0|||
161025420|NCT04936308|581483923|FG001|Overall Study|Death|0|||
160589821|NCT02491073|579876713|FG000|Overall Study|screen failure|1|||
160589822|NCT02491073|579876714|FG001|Overall Study|screen failure|0|||
160589823|NCT01165021|579876715|FG000|Overall Study|Death|1|||
160589824|NCT03977727|579876716|FG000|Second Treatment|Lost to Follow-up|0|||
160589825|NCT03977727|579876717|FG001|Second Treatment|Lost to Follow-up|3|||
160589826|NCT02683525|579876719|FG000|Overall Study|Lost to Follow-up|1|||
160589827|NCT02683525|579876719|FG000|Overall Study|Physician Decision|1|||
160589828|NCT02683525|579876719|FG000|Overall Study|Disease Progression|6|||
160589829|NCT03352414|579876723|FG000|Overall Study|Ineligible by operative criteria|12|||
160589830|NCT03352414|579876724|FG001|Overall Study|Ineligible by operative criteria|10|||
160589831|NCT00516269|579876725|FG000|Overall Study|Adverse Event|2|||
161025421|NCT04936308|581483924|FG002|Overall Study|Death|1|||
161025422|NCT04936308|581483922|FG000|Overall Study|Withdrawal by Subject|6|||
161025423|NCT04936308|581483923|FG001|Overall Study|Withdrawal by Subject|3|||
160589832|NCT00516269|579876726|FG001|Overall Study|Adverse Event|1|||
160589833|NCT00516269|579876725|FG000|Overall Study|Lost to Follow-up|0|||
161025424|NCT04936308|581483924|FG002|Overall Study|Withdrawal by Subject|0|||
161025425|NCT04936308|581483922|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
160589834|NCT00516269|579876726|FG001|Overall Study|Lost to Follow-up|1|||
160589835|NCT00516269|579876725|FG000|Overall Study|Protocol Violation|0|||
161025426|NCT04936308|581483923|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
161025427|NCT04936308|581483924|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
161025428|NCT04936308|581483922|FG000|Overall Study|Completed protocol-required follow-up|1|||
161025429|NCT04936308|581483923|FG001|Overall Study|Completed protocol-required follow-up|2|||
161025430|NCT04936308|581483924|FG002|Overall Study|Completed protocol-required follow-up|2|||
161025431|NCT04936308|581483922|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
161025432|NCT04936308|581483923|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
161025433|NCT04936308|581483924|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
161025434|NCT04936308|581483922|FG000|Overall Study|Other|3|||
161025435|NCT04936308|581483923|FG001|Overall Study|Other|0|||
161025436|NCT04936308|581483924|FG002|Overall Study|Other|2|||
161025437|NCT04770272|581483925|FG000|Overall Study|Death|1|||
161025438|NCT04770272|581483926|FG001|Overall Study|Death|0|||
161025439|NCT04770272|581483925|FG000|Overall Study|Withdrawal by Subject|11|||
161025440|NCT04770272|581483926|FG001|Overall Study|Withdrawal by Subject|12|||
161025441|NCT04770272|581483925|FG000|Overall Study|Protocol Violation|0|||
161025442|NCT04770272|581483926|FG001|Overall Study|Protocol Violation|2|||
161025443|NCT04770272|581483925|FG000|Overall Study|Adverse Event|23|||
161025444|NCT04770272|581483926|FG001|Overall Study|Adverse Event|21|||
161025445|NCT04770272|581483925|FG000|Overall Study|Physician Decision|7|||
161025446|NCT04770272|581483926|FG001|Overall Study|Physician Decision|3|||
161025447|NCT04770272|581483925|FG000|Overall Study|Disease progression|4|||
161025448|NCT04770272|581483926|FG001|Overall Study|Disease progression|8|||
161025449|NCT04770272|581483925|FG000|Overall Study|Switched to other therapy.|0|||
161025450|NCT04770272|581483926|FG001|Overall Study|Switched to other therapy.|2|||
161025451|NCT00602667|581483927|FG000|Overall Study|Still on Therapy|0|||
161025452|NCT00602667|581483928|FG001|Overall Study|Still on Therapy|2|||
161025453|NCT00602667|581483929|FG002|Overall Study|Still on Therapy|2|||
161025454|NCT00602667|581483927|FG000|Overall Study|Death|0|||
161025455|NCT00602667|581483928|FG001|Overall Study|Death|1|||
161025456|NCT00602667|581483929|FG002|Overall Study|Death|1|||
161025457|NCT00602667|581483927|FG000|Overall Study|Family request|3|||
161025458|NCT00602667|581483928|FG001|Overall Study|Family request|25|||
161025459|NCT00602667|581483929|FG002|Overall Study|Family request|6|||
161025460|NCT00602667|581483927|FG000|Overall Study|Excessive toxicity|1|||
161025461|NCT00602667|581483928|FG001|Overall Study|Excessive toxicity|1|||
161025462|NCT00602667|581483929|FG002|Overall Study|Excessive toxicity|0|||
161025463|NCT00602667|581483927|FG000|Overall Study|Second malignancy|0|||
161025464|NCT00602667|581483928|FG001|Overall Study|Second malignancy|1|||
161025465|NCT00602667|581483929|FG002|Overall Study|Second malignancy|0|||
161025466|NCT00602667|581483927|FG000|Overall Study|Physician Decision|2|||
161025467|NCT00602667|581483928|FG001|Overall Study|Physician Decision|3|||
161025468|NCT00602667|581483929|FG002|Overall Study|Physician Decision|8|||
161025469|NCT00602667|581483927|FG000|Overall Study|Progressive disease|13|||
161025470|NCT00602667|581483928|FG001|Overall Study|Progressive disease|48|||
161025471|NCT00602667|581483929|FG002|Overall Study|Progressive disease|45|||
160973443|NCT02667886|581293401|FG004|Dose Expansion (Part B)|Disease Progression|0|||
160973444|NCT02667886|581293397|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
160973445|NCT02667886|581293398|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
160973446|NCT02667886|581293399|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
160973447|NCT02667886|581293400|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
160973448|NCT02667886|581293401|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
160973449|NCT02667886|581293397|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
160973450|NCT02667886|581293398|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
160973451|NCT02667886|581293399|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
160973452|NCT02667886|581293400|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
160973453|NCT02667886|581293401|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
160973454|NCT02667886|581293397|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
160973455|NCT02667886|581293398|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
160973456|NCT02667886|581293399|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
160973457|NCT02667886|581293400|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
160973458|NCT02667886|581293401|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
160973459|NCT01905046|581293402|FG000|Months 13-24|Withdrawal by Subject|10|||
160973460|NCT01905046|581293403|FG001|Months 13-24|Withdrawal by Subject|10|||
160973461|NCT01905046|581293402|FG000|Months 13-24|Adverse Event|3|||
160973462|NCT01905046|581293403|FG001|Months 13-24|Adverse Event|2|||
160973463|NCT01905046|581293402|FG000|Months 13-24|Protocol Violation|3|||
160973464|NCT01905046|581293403|FG001|Months 13-24|Protocol Violation|3|||
160973465|NCT01905046|581293402|FG000|Months 13-24|Physician Decision|1|||
160973466|NCT01905046|581293403|FG001|Months 13-24|Physician Decision|0|||
160973467|NCT05672680|581293404|FG000|Overall Study|Patient Did Not Complete the Form|5|||
160973468|NCT05672680|581293405|FG001|Overall Study|Patient Did Not Complete the Form|4|||
160973469|NCT05672680|581293404|FG000|Overall Study|Procedure Aborted|1|||
160973470|NCT05672680|581293405|FG001|Overall Study|Procedure Aborted|0|||
160973471|NCT03929562|581293406|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
160973472|NCT03929562|581293407|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
160973473|NCT03929562|581293406|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
160973474|NCT03929562|581293407|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
161025472|NCT00602667|581483927|FG000|Overall Study|Progressive disease prior to therapy|0|||
161025473|NCT00602667|581483928|FG001|Overall Study|Progressive disease prior to therapy|0|||
161025474|NCT00602667|581483929|FG002|Overall Study|Progressive disease prior to therapy|1|||
161025475|NCT02363946|581485628|FG000|Overall Study|Lost to Follow-up|0|||
161025476|NCT02363946|581485629|FG001|Overall Study|Lost to Follow-up|0|||
161025477|NCT02363946|581485630|FG002|Overall Study|Lost to Follow-up|0|||
161025478|NCT02363946|581485631|FG003|Overall Study|Lost to Follow-up|0|||
161025479|NCT02363946|581485632|FG004|Overall Study|Lost to Follow-up|0|||
161025480|NCT02363946|581485633|FG005|Overall Study|Lost to Follow-up|0|||
161025481|NCT02363946|581485634|FG006|Overall Study|Lost to Follow-up|0|||
161025482|NCT02363946|581485635|FG007|Overall Study|Lost to Follow-up|1|||
161025483|NCT02363946|581485636|FG008|Overall Study|Lost to Follow-up|0|||
161025484|NCT02363946|581485637|FG009|Overall Study|Lost to Follow-up|0|||
161025485|NCT02363946|581485638|FG010|Overall Study|Lost to Follow-up|0|||
161025486|NCT02363946|581485639|FG011|Overall Study|Lost to Follow-up|0|||
161025487|NCT02363946|581485640|FG012|Overall Study|Lost to Follow-up|0|||
161025488|NCT02975700|581485643|FG000|Overall Study|Adverse Event|1|||
161025489|NCT02975700|581485643|FG000|Overall Study|Progressive disease|3|||
161025490|NCT02975700|581485643|FG000|Overall Study|Failed screening criteria|2|||
161025491|NCT03030261|581485646|FG000|Overall Study|Still receiving continuation therapy|5|||
161025492|NCT04765059|581485647|FG000|Overall Study|Failure to meet randomization criteria|1|||
161025493|NCT04765059|581485648|FG001|Overall Study|Failure to meet randomization criteria|0|||
161025494|NCT04765059|581485647|FG000|Overall Study|Withdrawal by Subject|1|||
161025495|NCT04765059|581485648|FG001|Overall Study|Withdrawal by Subject|4|||
161025496|NCT04765059|581485647|FG000|Overall Study|Lost to Follow-up|1|||
161025497|NCT04765059|581485648|FG001|Overall Study|Lost to Follow-up|1|||
161025498|NCT04765059|581485647|FG000|Overall Study|Death|25|||
161025499|NCT04765059|581485648|FG001|Overall Study|Death|28|||
161025500|NCT04765059|581485647|FG000|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|21|||
161025501|NCT04765059|581485648|FG001|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|16|||
161025502|NCT01615029|581485649|FG000|Overall Study|Adverse Event|1|||
161025503|NCT01615029|581485650|FG001|Overall Study|Adverse Event|0|||
161025504|NCT01615029|581485651|FG002|Overall Study|Adverse Event|3|||
161025505|NCT01615029|581485652|FG003|Overall Study|Adverse Event|0|||
161025506|NCT01615029|581485653|FG004|Overall Study|Adverse Event|4|||
161025507|NCT01615029|581485649|FG000|Overall Study|Progressive disease|1|||
161025508|NCT01615029|581485650|FG001|Overall Study|Progressive disease|1|||
161025509|NCT01615029|581485651|FG002|Overall Study|Progressive disease|1|||
161025510|NCT01615029|581485652|FG003|Overall Study|Progressive disease|1|||
161025511|NCT01615029|581485653|FG004|Overall Study|Progressive disease|10|||
161025512|NCT01615029|581485649|FG000|Overall Study|Physician Decision|0|||
161025513|NCT01615029|581485650|FG001|Overall Study|Physician Decision|0|||
161025514|NCT01615029|581485651|FG002|Overall Study|Physician Decision|0|||
161025515|NCT01615029|581485652|FG003|Overall Study|Physician Decision|0|||
161025516|NCT01615029|581485653|FG004|Overall Study|Physician Decision|2|||
161025517|NCT04300309|581485654|FG000|Overall Study|Lost to Follow-up|1|||
161025518|NCT04300309|581485655|FG001|Overall Study|Lost to Follow-up|0|||
161025519|NCT05213624|581485656|FG000|Overall Study|Adverse Event|0|||
161025520|NCT05213624|581485657|FG001|Overall Study|Adverse Event|3|||
161025521|NCT05213624|581485658|FG002|Overall Study|Adverse Event|0|||
161025522|NCT05213624|581485659|FG003|Overall Study|Adverse Event|0|||
161025523|NCT05213624|581485656|FG000|Overall Study|Protocol deviation|0|||
161025524|NCT05213624|581485657|FG001|Overall Study|Protocol deviation|2|||
161025525|NCT05213624|581485658|FG002|Overall Study|Protocol deviation|0|||
161025526|NCT05213624|581485659|FG003|Overall Study|Protocol deviation|0|||
160589836|NCT00516269|579876726|FG001|Overall Study|Protocol Violation|1|||
160589837|NCT04570657|579876728|FG000|Overall Study|Adverse Event|0|||
160589838|NCT04570657|579876729|FG001|Overall Study|Adverse Event|0|||
160589839|NCT04570657|579876730|FG002|Overall Study|Adverse Event|1|||
160589840|NCT04570657|579876728|FG000|Overall Study|Lost to Follow-up|0|||
160589841|NCT04570657|579876729|FG001|Overall Study|Lost to Follow-up|0|||
160589842|NCT04570657|579876730|FG002|Overall Study|Lost to Follow-up|1|||
160589843|NCT04570657|579876728|FG000|Overall Study|Physician Decision|0|||
161025527|NCT05213624|581485656|FG000|Overall Study|Withdrawal by Subject|0|||
161025528|NCT05213624|581485657|FG001|Overall Study|Withdrawal by Subject|0|||
160589844|NCT04570657|579876729|FG001|Overall Study|Physician Decision|1|||
160589845|NCT04570657|579876730|FG002|Overall Study|Physician Decision|0|||
160589846|NCT04570657|579876728|FG000|Overall Study|Withdrawal by Subject|1|||
160589847|NCT04570657|579876729|FG001|Overall Study|Withdrawal by Subject|2|||
160589848|NCT04570657|579876730|FG002|Overall Study|Withdrawal by Subject|2|||
160589849|NCT01079962|579876731|FG000|Overall Study|Adverse Event|2|||
160589850|NCT01079962|579876732|FG001|Overall Study|Adverse Event|2|||
160589851|NCT01079962|579876731|FG000|Overall Study|Withdrawal by Subject|5|||
160589852|NCT01079962|579876732|FG001|Overall Study|Withdrawal by Subject|7|||
161025529|NCT05213624|581485658|FG002|Overall Study|Withdrawal by Subject|0|||
161025530|NCT05213624|581485659|FG003|Overall Study|Withdrawal by Subject|1|||
160589853|NCT01079962|579876731|FG000|Overall Study|Protocol Violation|2|||
160589854|NCT01079962|579876732|FG001|Overall Study|Protocol Violation|2|||
160589855|NCT01079962|579876731|FG000|Overall Study|No blood pressure (BP) control|3|||
161025531|NCT05213624|581485656|FG000|Overall Study|Not treated|0|||
161025532|NCT05213624|581485657|FG001|Overall Study|Not treated|1|||
161025533|NCT05213624|581485658|FG002|Overall Study|Not treated|2|||
161025534|NCT05213624|581485659|FG003|Overall Study|Not treated|2|||
161025535|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Adverse Event|1|||
161025536|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Adverse Event|4|||
161025537|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
161025538|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
161025539|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
161025540|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
161025541|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
161025542|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Death|0|||
161025543|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Death|2|||
161025544|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Death|0|||
161025545|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Death|0|||
160973475|NCT03929562|581293406|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
161025546|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Death|0|||
160973476|NCT03929562|581293407|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
160973477|NCT02778399|581293415|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
160973478|NCT02778399|581293416|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
160973479|NCT02778399|581293417|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
160973480|NCT02778399|581293418|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
160973481|NCT02778399|581293419|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
160973482|NCT02778399|581293420|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
160973483|NCT02778399|581293415|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
160973484|NCT02778399|581293416|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
160973485|NCT02778399|581293417|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
160973486|NCT02778399|581293418|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
160973487|NCT02778399|581293419|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
160973488|NCT02778399|581293420|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
160973489|NCT02778399|581293415|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
160973490|NCT02778399|581293416|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
160973491|NCT02778399|581293417|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
160973492|NCT02778399|581293418|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
160973493|NCT02778399|581293419|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
160973494|NCT02778399|581293420|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
160973495|NCT02778399|581293415|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
160973496|NCT02778399|581293416|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
160973497|NCT02778399|581293417|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
160973498|NCT02778399|581293418|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
160973499|NCT02778399|581293419|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
160973500|NCT02778399|581293420|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
160973501|NCT02778399|581293415|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
160973502|NCT02778399|581293416|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
160973503|NCT02778399|581293417|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
160973504|NCT02778399|581293418|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
160973505|NCT02778399|581293419|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
160973506|NCT02778399|581293420|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
160973507|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
160973508|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
160973509|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
160973510|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
160973511|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
160973512|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
160973513|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
160973514|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
160973515|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
160973516|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
160973517|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
160973518|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
160973519|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
160973520|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
160973521|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
160973522|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
160973523|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
160973524|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
160973525|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
161025547|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Death|0|||
161025548|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Death|0|||
161025549|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
161025550|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025551|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025552|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025553|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025554|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025555|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025556|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025557|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
161025558|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025559|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025560|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025561|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025562|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025563|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Progressive disease|0|||
161025564|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Progressive disease|1|||
161025565|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Progressive disease|0|||
161025566|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Progressive disease|0|||
161025567|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Progressive disease|0|||
161025568|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Progressive disease|0|||
161025569|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Progressive disease|0|||
161025570|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
161025571|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
161025572|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161025573|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161025574|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161025575|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161025576|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161025577|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Other|1|||
161025578|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Other|0|||
161025579|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Other|0|||
161025580|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Other|0|||
161025581|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Other|0|||
161025582|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Other|0|||
161025583|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Other|0|||
161025584|NCT04585815|581485660|FG000|Sub-study A- Follow-up Phase|Death|0|||
161025585|NCT04585815|581485661|FG001|Sub-study A- Follow-up Phase|Death|1|||
161025586|NCT04585815|581485662|FG002|Sub-study A- Follow-up Phase|Death|0|||
161025587|NCT04585815|581485663|FG003|Sub-study A- Follow-up Phase|Death|0|||
161025588|NCT04585815|581485664|FG004|Sub-study A- Follow-up Phase|Death|0|||
161025589|NCT04585815|581485665|FG005|Sub-study A- Follow-up Phase|Death|0|||
161025590|NCT04585815|581485666|FG006|Sub-study A- Follow-up Phase|Death|0|||
161025591|NCT04585815|581485660|FG000|Sub-study A- Follow-up Phase|Study terminated by sponsor|1|||
161025592|NCT04585815|581485661|FG001|Sub-study A- Follow-up Phase|Study terminated by sponsor|3|||
161025593|NCT04585815|581485662|FG002|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161025594|NCT04585815|581485663|FG003|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161025595|NCT04585815|581485664|FG004|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161025596|NCT04585815|581485665|FG005|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
160589856|NCT01079962|579876732|FG001|Overall Study|No blood pressure (BP) control|0|||
160589857|NCT01079962|579876731|FG000|Overall Study|Inclusion/exclusion criteria|1|||
160589858|NCT01079962|579876732|FG001|Overall Study|Inclusion/exclusion criteria|3|||
160589859|NCT01079962|579876731|FG000|Overall Study|Participant not returning for next visit|1|||
160589860|NCT01079962|579876732|FG001|Overall Study|Participant not returning for next visit|0|||
160589861|NCT01079962|579876731|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
160589862|NCT01079962|579876732|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
160589863|NCT01331239|579876733|FG000|Part II: Core Study|Adverse Event|0|||
160589864|NCT01331239|579876734|FG001|Part II: Core Study|Adverse Event|3|||
160589865|NCT01331239|579876735|FG002|Part II: Core Study|Adverse Event|0|||
160589866|NCT01331239|579876733|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
160589867|NCT01331239|579876734|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
160589868|NCT01331239|579876735|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
160589869|NCT01331239|579876733|FG000|Part II: Core Study|Withdrawal by Subject|0|||
160589870|NCT01331239|579876734|FG001|Part II: Core Study|Withdrawal by Subject|2|||
160589871|NCT01331239|579876735|FG002|Part II: Core Study|Withdrawal by Subject|0|||
160589872|NCT01331239|579876733|FG000|Part II: Core Study|Administrative problems|0|||
160657491|NCT01996033|580127554|FG000|Overall Study|Death|1|||
161025597|NCT04585815|581485666|FG006|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161025598|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
161025599|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
160657492|NCT01996033|580127554|FG000|Overall Study|Physician Decision|1|||
161025600|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
160589873|NCT01331239|579876734|FG001|Part II: Core Study|Administrative problems|1|||
160589874|NCT01331239|579876735|FG002|Part II: Core Study|Administrative problems|0|||
161025601|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
161025602|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
161025603|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
161025604|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
161025605|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Death|0|||
161025606|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Death|0|||
161025607|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Death|0|||
161025608|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Death|1|||
161025609|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Death|0|||
161025610|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Death|0|||
161025611|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Death|0|||
161025612|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
161025613|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
161025614|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
161025615|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
161025616|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
161025617|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Progressive disease|1|||
161025618|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Progressive disease|5|||
161025619|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161025620|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161025621|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161025622|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
161025623|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161025624|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
161025625|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161025626|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025627|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025628|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025629|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
161025630|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025631|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025632|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025633|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
161025634|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
161025635|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
161025636|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
161025637|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
161025638|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Physician Decision|0|||
161025639|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
161025640|NCT04585815|581485660|FG000|Sub-study B- Follow-up Phase|Death|0|||
161025641|NCT04585815|581485661|FG001|Sub-study B- Follow-up Phase|Death|0|||
161025642|NCT04585815|581485662|FG002|Sub-study B- Follow-up Phase|Death|1|||
161025643|NCT04585815|581485663|FG003|Sub-study B- Follow-up Phase|Death|3|||
161025644|NCT04585815|581485664|FG004|Sub-study B- Follow-up Phase|Death|1|||
161025645|NCT04585815|581485665|FG005|Sub-study B- Follow-up Phase|Death|0|||
161025646|NCT04585815|581485666|FG006|Sub-study B- Follow-up Phase|Death|3|||
161025647|NCT04585815|581485660|FG000|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025648|NCT04585815|581485661|FG001|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025649|NCT04585815|581485662|FG002|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025650|NCT04585815|581485663|FG003|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025651|NCT04585815|581485664|FG004|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025652|NCT04585815|581485665|FG005|Sub-study B- Follow-up Phase|Study terminated by sponsor|1|||
161025653|NCT04585815|581485666|FG006|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025654|NCT02441686|581485667|FG000|Induction|Adverse Event|4|||
161025655|NCT02441686|581485667|FG000|Induction|Complicating disease|1|||
161025656|NCT02441686|581485667|FG000|Induction|Physician Decision|1|||
161025657|NCT02441686|581485667|FG000|Induction|Withdrawal by Subject|1|||
160589875|NCT01008995|579876736|FG000|Controlled Period|Adverse Event|1|||
160589876|NCT01008995|579876737|FG001|Controlled Period|Adverse Event|2|||
160589877|NCT01008995|579876738|FG002|Controlled Period|Adverse Event|0|||
160589878|NCT01008995|579876739|FG003|Controlled Period|Adverse Event|0|||
160589879|NCT01008995|579876736|FG000|Controlled Period|Other|2|||
161025658|NCT02441686|581485667|FG000|Induction|Did not receive treatment|1|||
161025659|NCT02441686|581485667|FG000|Maintenance|Remaining on Treatment|23|||
161025660|NCT02441686|581485667|FG000|Maintenance|Physician Decision|1|||
161025661|NCT02441686|581485667|FG000|Maintenance|Adverse Event|3|||
161025662|NCT02441686|581485667|FG000|Maintenance|Progressive Disease|10|||
161025663|NCT02441686|581485667|FG000|Maintenance|Withdrawal by Subject|1|||
161025664|NCT04647526|581485668|FG000|Overall Study|Death|13|||
160589880|NCT01008995|579876737|FG001|Controlled Period|Other|1|||
160589881|NCT01008995|579876738|FG002|Controlled Period|Other|0|||
161025665|NCT04647526|581485669|FG001|Overall Study|Death|76|||
161025666|NCT04647526|581485670|FG002|Overall Study|Death|32|||
161025667|NCT04647526|581485671|FG003|Overall Study|Death|0|||
161025668|NCT04647526|581485668|FG000|Overall Study|Lost to Follow-up|1|||
161025669|NCT04647526|581485669|FG001|Overall Study|Lost to Follow-up|0|||
161025670|NCT04647526|581485670|FG002|Overall Study|Lost to Follow-up|1|||
161025671|NCT04647526|581485671|FG003|Overall Study|Lost to Follow-up|0|||
161025672|NCT04647526|581485668|FG000|Overall Study|Withdrawal by Subject|4|||
161025673|NCT04647526|581485669|FG001|Overall Study|Withdrawal by Subject|15|||
161025674|NCT04647526|581485670|FG002|Overall Study|Withdrawal by Subject|8|||
161025675|NCT04647526|581485671|FG003|Overall Study|Withdrawal by Subject|1|||
161025676|NCT04647526|581485668|FG000|Overall Study|Incorrect enrollment|0|||
161025677|NCT04647526|581485669|FG001|Overall Study|Incorrect enrollment|1|||
161025678|NCT04647526|581485670|FG002|Overall Study|Incorrect enrollment|1|||
161025679|NCT04647526|581485671|FG003|Overall Study|Incorrect enrollment|0|||
161025680|NCT04647526|581485668|FG000|Overall Study|Physician Decision|0|||
161025681|NCT04647526|581485669|FG001|Overall Study|Physician Decision|1|||
161025682|NCT04647526|581485670|FG002|Overall Study|Physician Decision|1|||
161025683|NCT04647526|581485671|FG003|Overall Study|Physician Decision|0|||
161025684|NCT04647526|581485668|FG000|Overall Study|Ongoing|9|||
161025685|NCT04647526|581485669|FG001|Overall Study|Ongoing|183|||
161025686|NCT04647526|581485670|FG002|Overall Study|Ongoing|93|||
161025687|NCT04647526|581485671|FG003|Overall Study|Ongoing|15|||
161025688|NCT01854775|581485672|FG000|Treatment Phase (48 Weeks)|Withdrew consent|1|||
161025689|NCT01854775|581485673|FG001|Treatment Phase (48 Weeks)|Withdrew consent|1|||
161025690|NCT01854775|581485674|FG002|Treatment Phase (48 Weeks)|Withdrew consent|0|||
161025691|NCT01854775|581485672|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
161025692|NCT01854775|581485673|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
161025693|NCT01854775|581485674|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
161025694|NCT01854775|581485672|FG000|Extension Phase|Pregnancy|1|||
161025695|NCT01854775|581485673|FG001|Extension Phase|Pregnancy|0|||
161025696|NCT01854775|581485674|FG002|Extension Phase|Pregnancy|0|||
161025697|NCT01854775|581485672|FG000|Extension Phase|Investigator's Discretion|1|||
161025698|NCT01854775|581485673|FG001|Extension Phase|Investigator's Discretion|0|||
161025699|NCT01854775|581485674|FG002|Extension Phase|Investigator's Discretion|0|||
161025700|NCT01854775|581485672|FG000|Extension Phase|Non-Compliance with study drug|1|||
161025701|NCT01854775|581485673|FG001|Extension Phase|Non-Compliance with study drug|0|||
161025702|NCT01854775|581485674|FG002|Extension Phase|Non-Compliance with study drug|0|||
161025703|NCT01854775|581485672|FG000|Extension Phase|Lost to Follow-up|1|||
161025704|NCT01854775|581485673|FG001|Extension Phase|Lost to Follow-up|0|||
161025705|NCT01854775|581485674|FG002|Extension Phase|Lost to Follow-up|0|||
161025706|NCT01854775|581485672|FG000|Extension Phase|Withdrew consent|0|||
161025707|NCT01854775|581485673|FG001|Extension Phase|Withdrew consent|1|||
160589882|NCT01008995|579876739|FG003|Controlled Period|Other|0|||
160589883|NCT01008995|579876736|FG000|After Controlled Period|Adverse Event|0|||
160589884|NCT01008995|579876737|FG001|After Controlled Period|Adverse Event|0|||
160589885|NCT01008995|579876738|FG002|After Controlled Period|Adverse Event|1|||
160589886|NCT01008995|579876739|FG003|After Controlled Period|Adverse Event|1|||
160589887|NCT01008995|579876736|FG000|After Controlled Period|Other|0|||
160589888|NCT01008995|579876737|FG001|After Controlled Period|Other|0|||
160589889|NCT01008995|579876738|FG002|After Controlled Period|Other|1|||
160589890|NCT01008995|579876739|FG003|After Controlled Period|Other|0|||
160589891|NCT04167306|579876740|FG000|Overall Study|Lost to Follow-up|2|||
160589892|NCT04167306|579876741|FG001|Overall Study|Lost to Follow-up|2|||
160589893|NCT04167306|579876742|FG002|Overall Study|Lost to Follow-up|5|||
160589894|NCT04167306|579876743|FG003|Overall Study|Lost to Follow-up|5|||
160589895|NCT04167306|579876740|FG000|Overall Study|Adverse Event|13|||
160589896|NCT04167306|579876741|FG001|Overall Study|Adverse Event|14|||
160657493|NCT01996033|580127554|FG000|Overall Study|Withdrawal by Subject|4|||
160657494|NCT01996033|580127554|FG000|Overall Study|Lost to Follow-up|3|||
161025708|NCT01854775|581485674|FG002|Extension Phase|Withdrew consent|0|||
161025709|NCT04068311|581485675|FG000|Overall Study|Death|3|||
161025710|NCT04068311|581485676|FG001|Overall Study|Death|3|||
161025711|NCT04068311|581485675|FG000|Overall Study|Lost to Follow-up|24|||
161025712|NCT04068311|581485676|FG001|Overall Study|Lost to Follow-up|68|||
161025713|NCT04068311|581485675|FG000|Overall Study|Withdrawal by Subject|5|||
161025714|NCT04068311|581485676|FG001|Overall Study|Withdrawal by Subject|0|||
161025715|NCT04150029|581485677|FG000|Overall Study|Disease Relapse|0|||
161025716|NCT04150029|581485678|FG001|Overall Study|Disease Relapse|18|||
161025717|NCT04150029|581485677|FG000|Overall Study|Progressive Disease|2|||
161025718|NCT04150029|581485678|FG001|Overall Study|Progressive Disease|16|||
161025719|NCT04150029|581485677|FG000|Overall Study|Adverse Event|1|||
161025720|NCT04150029|581485678|FG001|Overall Study|Adverse Event|11|||
161025721|NCT04150029|581485677|FG000|Overall Study|Physician Decision|0|||
160589897|NCT04167306|579876742|FG002|Overall Study|Adverse Event|5|||
160589898|NCT04167306|579876743|FG003|Overall Study|Adverse Event|4|||
160589899|NCT04167306|579876740|FG000|Overall Study|Withdrawal by Subject|4|||
160589900|NCT04167306|579876741|FG001|Overall Study|Withdrawal by Subject|6|||
161025722|NCT04150029|581485678|FG001|Overall Study|Physician Decision|10|||
160973526|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
160973527|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
160973528|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
160973529|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
160973530|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
160973531|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
160973532|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
160973533|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
160973534|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
160973535|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
160973536|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
160973537|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
160973538|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
160973539|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
160973540|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
160973541|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
160973542|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
160973543|NCT00405639|581293422|FG000|Overall Study|Withdrawal by Subject|1|||
160973544|NCT00405639|581293423|FG001|Overall Study|Withdrawal by Subject|0|||
160973545|NCT00405639|581293422|FG000|Overall Study|Adverse Event|1|||
160973546|NCT00405639|581293423|FG001|Overall Study|Adverse Event|0|||
160973547|NCT00405639|581293422|FG000|Overall Study|Seizure prior to receiving BNP|1|||
160973548|NCT00405639|581293423|FG001|Overall Study|Seizure prior to receiving BNP|0|||
160589901|NCT04167306|579876742|FG002|Overall Study|Withdrawal by Subject|8|||
160589902|NCT04167306|579876743|FG003|Overall Study|Withdrawal by Subject|3|||
160589903|NCT04167306|579876740|FG000|Overall Study|covid|1|||
161025723|NCT04150029|581485677|FG000|Overall Study|Study Terminated by Sponsor|1|||
161025724|NCT04150029|581485678|FG001|Overall Study|Study Terminated by Sponsor|10|||
161025725|NCT04150029|581485677|FG000|Overall Study|Death|0|||
161025726|NCT04150029|581485678|FG001|Overall Study|Death|8|||
161025727|NCT04150029|581485677|FG000|Overall Study|Participant Decision|0|||
161025728|NCT04150029|581485678|FG001|Overall Study|Participant Decision|7|||
161025729|NCT04150029|581485677|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
161025730|NCT04150029|581485678|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
161025731|NCT01602380|581485679|FG000|Overall Study|Death|147|||
161025732|NCT01602380|581485680|FG001|Overall Study|Death|145|||
161025733|NCT01602380|581485679|FG000|Overall Study|Withdrawal by Subject|39|||
161025734|NCT01602380|581485680|FG001|Overall Study|Withdrawal by Subject|41|||
161025735|NCT01602380|581485679|FG000|Overall Study|Lost to Follow-up|15|||
161025736|NCT01602380|581485680|FG001|Overall Study|Lost to Follow-up|12|||
161025737|NCT01602380|581485679|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161025738|NCT01602380|581485680|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
161025739|NCT01602380|581485679|FG000|Overall Study|Other|2|||
161025740|NCT01602380|581485680|FG001|Overall Study|Other|0|||
161025741|NCT05497284|581485681|FG000|Overall Study|Adverse Event|1|||
161025742|NCT05497284|581485682|FG001|Overall Study|Adverse Event|0|||
161025743|NCT05497284|581485681|FG000|Overall Study|Physician Decision|0|||
161025744|NCT05497284|581485682|FG001|Overall Study|Physician Decision|1|||
161025745|NCT05497284|581485681|FG000|Overall Study|Study terminated by sponsor|7|||
161025746|NCT05497284|581485682|FG001|Overall Study|Study terminated by sponsor|4|||
161025747|NCT05497284|581485681|FG000|Overall Study|Subject Decision|0|||
161025748|NCT05497284|581485682|FG001|Overall Study|Subject Decision|1|||
161025749|NCT03816891|581485684|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161025750|NCT03816891|581485685|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161025751|NCT03816891|581485686|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161025752|NCT03816891|581485687|FG003|Double-Blind Period|Withdrawal by Subject|2|||
161025753|NCT03816891|581485688|FG004|Double-Blind Period|Withdrawal by Subject|0|||
161025754|NCT03816891|581485689|FG005|Double-Blind Period|Withdrawal by Subject|0|||
161025755|NCT03816891|581485684|FG000|Double-Blind Period|Adverse Event|0|||
161025756|NCT03816891|581485685|FG001|Double-Blind Period|Adverse Event|0|||
160589904|NCT04167306|579876741|FG001|Overall Study|covid|1|||
160589905|NCT04167306|579876742|FG002|Overall Study|covid|2|||
161025757|NCT03816891|581485686|FG002|Double-Blind Period|Adverse Event|2|||
161025758|NCT03816891|581485687|FG003|Double-Blind Period|Adverse Event|0|||
160973549|NCT02130284|581293432|FG000|Overall Study|Withdrawal by Subject|3|||
161025759|NCT03816891|581485688|FG004|Double-Blind Period|Adverse Event|0|||
161025760|NCT03816891|581485689|FG005|Double-Blind Period|Adverse Event|0|||
160589906|NCT04167306|579876743|FG003|Overall Study|covid|1|||
160589907|NCT04167306|579876740|FG000|Overall Study|concomitant medication|0|||
161025761|NCT03816891|581485684|FG000|Double-Blind Period|Lost to Follow-up|2|||
160589908|NCT04167306|579876741|FG001|Overall Study|concomitant medication|0|||
161025762|NCT03816891|581485685|FG001|Double-Blind Period|Lost to Follow-up|0|||
161025763|NCT03816891|581485686|FG002|Double-Blind Period|Lost to Follow-up|0|||
161025764|NCT03816891|581485687|FG003|Double-Blind Period|Lost to Follow-up|0|||
161025765|NCT03816891|581485688|FG004|Double-Blind Period|Lost to Follow-up|0|||
160589909|NCT04167306|579876742|FG002|Overall Study|concomitant medication|0|||
160589910|NCT04167306|579876743|FG003|Overall Study|concomitant medication|1|||
160589911|NCT04167306|579876740|FG000|Overall Study|Alcohol treatment|0|||
160589912|NCT04167306|579876741|FG001|Overall Study|Alcohol treatment|4|||
160589913|NCT04167306|579876742|FG002|Overall Study|Alcohol treatment|3|||
160589914|NCT04167306|579876743|FG003|Overall Study|Alcohol treatment|2|||
160589915|NCT04167306|579876740|FG000|Overall Study|non-compliance|0|||
160973550|NCT02130284|581293432|FG000|Overall Study|Subject Withdrew Consent|1|||
160973551|NCT02130284|581293432|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
160973552|NCT02130284|581293432|FG000|Overall Study|Subject was screened as backup for study|3|||
160973553|NCT02130284|581293432|FG000|Overall Study|Screen Failure|1|||
160973554|NCT05778526|581293435|FG000|Overall Study|Lost to Follow-up|0|||
160973555|NCT05778526|581293436|FG001|Overall Study|Lost to Follow-up|1|||
160973556|NCT05778526|581293437|FG002|Overall Study|Lost to Follow-up|3|||
160973557|NCT05778526|581293435|FG000|Overall Study|Protocol Violation|0|||
160973558|NCT05778526|581293436|FG001|Overall Study|Protocol Violation|0|||
160973559|NCT05778526|581293437|FG002|Overall Study|Protocol Violation|8|||
160973560|NCT03108157|581293440|FG000|Overall Study|Protocol Violation|15|||
160973561|NCT03108157|581293441|FG001|Overall Study|Protocol Violation|4|||
160973562|NCT02223754|581293442|FG000|Period 1|Adverse Event|1|||
160973563|NCT02223754|581293443|FG001|Period 1|Adverse Event|0|||
160973564|NCT02223754|581293442|FG000|Period 1|Lost to Follow-up|0|||
160973565|NCT02223754|581293443|FG001|Period 1|Lost to Follow-up|1|||
160973566|NCT02223754|581293442|FG000|Period 1|Protocol Violation|2|||
160973567|NCT02223754|581293443|FG001|Period 1|Protocol Violation|4|||
160973568|NCT02223754|581293442|FG000|Period 1|Withdrawal by Subject|0|||
160973569|NCT02223754|581293443|FG001|Period 1|Withdrawal by Subject|4|||
160973570|NCT02223754|581293442|FG000|Period 1|Test Article No Longer Available|1|||
160973571|NCT02223754|581293443|FG001|Period 1|Test Article No Longer Available|5|||
160973572|NCT02223754|581293442|FG000|Period 1|Unsatisfactory Visual Response|0|||
160973573|NCT02223754|581293443|FG001|Period 1|Unsatisfactory Visual Response|1|||
160973574|NCT02223754|581293442|FG000|Period 2|Adverse Event|0|||
160973575|NCT02223754|581293443|FG001|Period 2|Adverse Event|1|||
160973576|NCT02223754|581293442|FG000|Period 2|Protocol Violation|1|||
160973577|NCT02223754|581293443|FG001|Period 2|Protocol Violation|0|||
160973578|NCT02223754|581293442|FG000|Period 2|Lens Discomfort|1|||
160973579|NCT02223754|581293443|FG001|Period 2|Lens Discomfort|1|||
160973580|NCT02223754|581293442|FG000|Period 2|Lost to Follow-up|1|||
160973581|NCT02223754|581293443|FG001|Period 2|Lost to Follow-up|0|||
160973582|NCT02223754|581293442|FG000|Period 2|Test Article No Longer Available|0|||
160973583|NCT02223754|581293443|FG001|Period 2|Test Article No Longer Available|1|||
160973584|NCT04395183|581293445|FG000|Overall Study|Withdrawal by Subject|1|||
160973585|NCT04395183|581293446|FG001|Overall Study|Withdrawal by Subject|0|||
160973586|NCT04395183|581293447|FG002|Overall Study|Withdrawal by Subject|2|||
160973587|NCT04395183|581293448|FG003|Overall Study|Withdrawal by Subject|2|||
160973588|NCT02668016|581293449|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
160973589|NCT02668016|581293449|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
160973590|NCT02668016|581293449|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
160973591|NCT02668016|581293449|FG000|Month 4|Withdrawal due to severe symptoms|1|||
160973592|NCT02668016|581293449|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
160973593|NCT02668016|581293449|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
160973594|NCT02668016|581293449|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
160973595|NCT02668016|581293449|FG000|Month 6|Withdrawal due to severe symptoms|2|||
160973596|NCT02668016|581293449|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
160973597|NCT02668016|581293449|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
160973598|NCT02668016|581293449|FG000|Month 8|Withdrawal due to severe symptoms|1|||
160973599|NCT02668016|581293449|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
160973600|NCT02668016|581293449|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
160973601|NCT02668016|581293449|FG000|Month 10|Withdrawal due to severe symptoms|1|||
160973602|NCT02668016|581293449|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
160973603|NCT01122381|581293454|FG000|Overall Study|study terminated early|0|||
160973604|NCT01122381|581293455|FG001|Overall Study|study terminated early|1|||
160973605|NCT00736489|581293456|FG000|Period 1|Lost to Follow-up|1|||
160973606|NCT00736489|581293457|FG001|Period 1|Lost to Follow-up|0|||
160973607|NCT00736489|581293458|FG002|Period 1|Lost to Follow-up|0|||
160973608|NCT00736489|581293459|FG003|Period 1|Lost to Follow-up|0|||
160973609|NCT00736489|581293460|FG004|Period 1|Lost to Follow-up|0|||
160973610|NCT00736489|581293461|FG005|Period 1|Lost to Follow-up|0|||
160973611|NCT00736489|581293456|FG000|Period 1|Withdrawal by Subject|0|||
160973612|NCT00736489|581293457|FG001|Period 1|Withdrawal by Subject|0|||
160973613|NCT00736489|581293458|FG002|Period 1|Withdrawal by Subject|0|||
160973614|NCT00736489|581293459|FG003|Period 1|Withdrawal by Subject|0|||
160973615|NCT00736489|581293460|FG004|Period 1|Withdrawal by Subject|0|||
160973616|NCT00736489|581293461|FG005|Period 1|Withdrawal by Subject|1|||
160589916|NCT04167306|579876741|FG001|Overall Study|non-compliance|0|||
160589917|NCT04167306|579876742|FG002|Overall Study|non-compliance|1|||
160589918|NCT04167306|579876743|FG003|Overall Study|non-compliance|0|||
160589919|NCT04167306|579876740|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
160589920|NCT04167306|579876741|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
160589921|NCT04167306|579876742|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
160657495|NCT01345019|580127573|FG000|Blinded Treatment Phase|Death|147|||
160973617|NCT02395133|581293462|FG000|Overall Study|Adverse Event|4|||
160973618|NCT02395133|581293463|FG001|Overall Study|Adverse Event|1|||
160973619|NCT02395133|581293464|FG002|Overall Study|Adverse Event|3|||
160973620|NCT02395133|581293465|FG003|Overall Study|Adverse Event|0|||
160973621|NCT02395133|581293462|FG000|Overall Study|Lack of Efficacy|1|||
160973622|NCT02395133|581293463|FG001|Overall Study|Lack of Efficacy|0|||
160973623|NCT02395133|581293464|FG002|Overall Study|Lack of Efficacy|1|||
160973624|NCT02395133|581293465|FG003|Overall Study|Lack of Efficacy|1|||
160973625|NCT02395133|581293462|FG000|Overall Study|Protocol Violation|1|||
160973626|NCT02395133|581293463|FG001|Overall Study|Protocol Violation|1|||
160973627|NCT02395133|581293464|FG002|Overall Study|Protocol Violation|0|||
160973628|NCT02395133|581293465|FG003|Overall Study|Protocol Violation|3|||
160973629|NCT02395133|581293462|FG000|Overall Study|Lost to Follow-up|0|||
160973630|NCT02395133|581293463|FG001|Overall Study|Lost to Follow-up|1|||
160973631|NCT02395133|581293464|FG002|Overall Study|Lost to Follow-up|1|||
160973632|NCT02395133|581293465|FG003|Overall Study|Lost to Follow-up|0|||
160973633|NCT02395133|581293462|FG000|Overall Study|Pregnancy|0|||
160973634|NCT02395133|581293463|FG001|Overall Study|Pregnancy|0|||
160973635|NCT02395133|581293464|FG002|Overall Study|Pregnancy|3|||
160973636|NCT02395133|581293465|FG003|Overall Study|Pregnancy|0|||
160973637|NCT02395133|581293462|FG000|Overall Study|Consent withdrawn with no reason given|1|||
160973638|NCT02395133|581293463|FG001|Overall Study|Consent withdrawn with no reason given|3|||
160973639|NCT02395133|581293464|FG002|Overall Study|Consent withdrawn with no reason given|0|||
160973640|NCT02395133|581293465|FG003|Overall Study|Consent withdrawn with no reason given|2|||
160973641|NCT02395133|581293462|FG000|Overall Study|Consent withdrawn with personal reason|0|||
160973642|NCT02395133|581293463|FG001|Overall Study|Consent withdrawn with personal reason|1|||
160973643|NCT02395133|581293464|FG002|Overall Study|Consent withdrawn with personal reason|0|||
160973644|NCT02395133|581293465|FG003|Overall Study|Consent withdrawn with personal reason|3|||
160973645|NCT02395133|581293462|FG000|Overall Study|Sponsor decision|2|||
160973646|NCT02395133|581293463|FG001|Overall Study|Sponsor decision|0|||
160973647|NCT02395133|581293464|FG002|Overall Study|Sponsor decision|0|||
160973648|NCT02395133|581293465|FG003|Overall Study|Sponsor decision|1|||
160973649|NCT02395133|581293462|FG000|Overall Study|Other than specified above|5|||
160973650|NCT02395133|581293463|FG001|Overall Study|Other than specified above|2|||
160973651|NCT02395133|581293464|FG002|Overall Study|Other than specified above|2|||
160973652|NCT02395133|581293465|FG003|Overall Study|Other than specified above|4|||
160973653|NCT02234063|581293468|FG000|Overall Study|Lost to Follow-up|235|||
160973654|NCT02234063|581293469|FG001|Overall Study|Lost to Follow-up|42|||
160973655|NCT02234063|581293468|FG000|Overall Study|Withdrawal by Subject|20|||
160973656|NCT02234063|581293469|FG001|Overall Study|Withdrawal by Subject|1|||
160973657|NCT00510458|581293470|FG000|Overall Study|5 year not evaluable/missed|21|||
160973658|NCT00510458|581293470|FG000|Overall Study|Death|1|||
160973659|NCT00510458|581293470|FG000|Overall Study|Terminated|14|||
160973660|NCT00510458|581293470|FG000|Overall Study|Lost to Follow-up|6|||
160973661|NCT00510458|581293470|FG000|Overall Study|Withdrawal by Subject|3|||
160973662|NCT00510458|581293470|FG000|Overall Study|Revision|2|||
160973663|NCT02569710|581293471|FG000|Overall Study|Adverse Event|1|||
160973664|NCT02569710|581293472|FG001|Overall Study|Adverse Event|0|||
160973665|NCT02569710|581293473|FG002|Overall Study|Adverse Event|0|||
160973666|NCT02569710|581293474|FG003|Overall Study|Adverse Event|0|||
160973667|NCT02569710|581293475|FG004|Overall Study|Adverse Event|0|||
160973668|NCT02569710|581293476|FG005|Overall Study|Adverse Event|0|||
160973669|NCT02569710|581293477|FG006|Overall Study|Adverse Event|0|||
160973670|NCT02569710|581293478|FG007|Overall Study|Adverse Event|0|||
160973671|NCT02569710|581293479|FG008|Overall Study|Adverse Event|0|||
160973672|NCT02569710|581293480|FG009|Overall Study|Adverse Event|0|||
160973673|NCT02569710|581293471|FG000|Overall Study|Lost to Follow-up|0|||
160973674|NCT02569710|581293472|FG001|Overall Study|Lost to Follow-up|0|||
160973675|NCT02569710|581293473|FG002|Overall Study|Lost to Follow-up|0|||
160973676|NCT02569710|581293474|FG003|Overall Study|Lost to Follow-up|0|||
160973677|NCT02569710|581293475|FG004|Overall Study|Lost to Follow-up|0|||
160973678|NCT02569710|581293476|FG005|Overall Study|Lost to Follow-up|0|||
160973679|NCT02569710|581293477|FG006|Overall Study|Lost to Follow-up|1|||
160973680|NCT02569710|581293478|FG007|Overall Study|Lost to Follow-up|0|||
160973681|NCT02569710|581293479|FG008|Overall Study|Lost to Follow-up|1|||
160973682|NCT02569710|581293480|FG009|Overall Study|Lost to Follow-up|0|||
160973683|NCT02569710|581293471|FG000|Overall Study|Virologic failure|0|||
160973684|NCT02569710|581293472|FG001|Overall Study|Virologic failure|0|||
160973685|NCT02569710|581293473|FG002|Overall Study|Virologic failure|0|||
160973686|NCT02569710|581293474|FG003|Overall Study|Virologic failure|0|||
160973687|NCT02569710|581293475|FG004|Overall Study|Virologic failure|1|||
160973688|NCT02569710|581293476|FG005|Overall Study|Virologic failure|0|||
160973689|NCT02569710|581293477|FG006|Overall Study|Virologic failure|1|||
160973690|NCT02569710|581293478|FG007|Overall Study|Virologic failure|0|||
160973691|NCT02569710|581293479|FG008|Overall Study|Virologic failure|0|||
160973692|NCT02569710|581293480|FG009|Overall Study|Virologic failure|0|||
160973693|NCT02569710|581293471|FG000|Overall Study|Withdrawal by Subject|0|||
160973694|NCT02569710|581293472|FG001|Overall Study|Withdrawal by Subject|0|||
160973695|NCT02569710|581293473|FG002|Overall Study|Withdrawal by Subject|0|||
160973696|NCT02569710|581293474|FG003|Overall Study|Withdrawal by Subject|0|||
160973697|NCT02569710|581293475|FG004|Overall Study|Withdrawal by Subject|0|||
160973698|NCT02569710|581293476|FG005|Overall Study|Withdrawal by Subject|1|||
160973699|NCT02569710|581293477|FG006|Overall Study|Withdrawal by Subject|0|||
160973700|NCT02569710|581293478|FG007|Overall Study|Withdrawal by Subject|0|||
160973701|NCT02569710|581293479|FG008|Overall Study|Withdrawal by Subject|0|||
160973702|NCT02569710|581293480|FG009|Overall Study|Withdrawal by Subject|0|||
160973703|NCT02946918|581293481|FG000|Overall Study|Patient unblinded himself|1|||
160973704|NCT02946918|581293482|FG001|Overall Study|Patient unblinded himself|0|||
160973705|NCT02946918|581293481|FG000|Overall Study|Physician Decision|0|||
160973706|NCT02946918|581293482|FG001|Overall Study|Physician Decision|2|||
160973707|NCT02946918|581293481|FG000|Overall Study|Ran out of study medication|0|||
160973708|NCT02946918|581293482|FG001|Overall Study|Ran out of study medication|1|||
160973709|NCT02669095|581293483|FG000|Overall Study|Adverse Event|1|||
160973710|NCT02669095|581293484|FG001|Overall Study|Adverse Event|0|||
160973711|NCT02669095|581293483|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
160973712|NCT02669095|581293484|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
160973713|NCT02669095|581293483|FG000|Overall Study|Torn Lens|0|||
160973714|NCT02669095|581293484|FG001|Overall Study|Torn Lens|1|||
160973715|NCT02669095|581293483|FG000|Overall Study|Visit 5 assessments not completed|0|||
160973716|NCT02669095|581293484|FG001|Overall Study|Visit 5 assessments not completed|1|||
160973717|NCT01555164|581293490|FG000|Overall Study|Adverse Event|5|||
160973718|NCT01555164|581293491|FG001|Overall Study|Adverse Event|7|||
160973719|NCT01555164|581293490|FG000|Overall Study|Hyperglycemia|0|||
160973720|NCT01555164|581293491|FG001|Overall Study|Hyperglycemia|1|||
160973721|NCT01555164|581293490|FG000|Overall Study|Investigator's Discretion|2|||
160973722|NCT01555164|581293491|FG001|Overall Study|Investigator's Discretion|2|||
160973723|NCT01555164|581293490|FG000|Overall Study|Lost to Follow-up|4|||
160973724|NCT01555164|581293491|FG001|Overall Study|Lost to Follow-up|3|||
160973725|NCT01555164|581293490|FG000|Overall Study|Protocol Violation|9|||
160973726|NCT01555164|581293491|FG001|Overall Study|Protocol Violation|5|||
160973727|NCT01555164|581293490|FG000|Overall Study|Subject Non-compliance|14|||
160973728|NCT01555164|581293491|FG001|Overall Study|Subject Non-compliance|6|||
160973729|NCT01555164|581293490|FG000|Overall Study|Subject Withdrew Consent|6|||
160973730|NCT01555164|581293491|FG001|Overall Study|Subject Withdrew Consent|11|||
160973731|NCT03203694|581293492|FG000|Overall Study|Withdrawal by Subject|2|||
160973732|NCT03203694|581293493|FG001|Overall Study|Withdrawal by Subject|0|||
160973733|NCT03203694|581293494|FG002|Overall Study|Withdrawal by Subject|0|||
160973734|NCT03203694|581293495|FG003|Overall Study|Withdrawal by Subject|0|||
160973735|NCT03203694|581293496|FG004|Overall Study|Withdrawal by Subject|0|||
160973736|NCT03203694|581293497|FG005|Overall Study|Withdrawal by Subject|0|||
160973737|NCT02969525|581293504|FG000|Double-Blind Period|Adverse Event|0|||
160973738|NCT02969525|581293505|FG001|Double-Blind Period|Adverse Event|0|||
160973739|NCT02969525|581293506|FG002|Double-Blind Period|Adverse Event|1|||
160973740|NCT02969525|581293507|FG003|Double-Blind Period|Adverse Event|1|||
160973741|NCT02969525|581293508|FG004|Double-Blind Period|Adverse Event|0|||
160973742|NCT02969525|581293509|FG005|Double-Blind Period|Adverse Event|0|||
160973743|NCT02969525|581293510|FG006|Double-Blind Period|Adverse Event|0|||
160973744|NCT02969525|581293511|FG007|Double-Blind Period|Adverse Event|0|||
160973745|NCT02969525|581293512|FG008|Double-Blind Period|Adverse Event|0|||
160973746|NCT02969525|581293513|FG009|Double-Blind Period|Adverse Event|0|||
160973747|NCT02969525|581293514|FG010|Double-Blind Period|Adverse Event|0|||
160973748|NCT02969525|581293515|FG011|Double-Blind Period|Adverse Event|0|||
160973749|NCT02969525|581293504|FG000|Double-Blind Period|LOW EGFR|0|||
160973750|NCT02969525|581293505|FG001|Double-Blind Period|LOW EGFR|0|||
160973751|NCT02969525|581293506|FG002|Double-Blind Period|LOW EGFR|0|||
160973752|NCT02969525|581293507|FG003|Double-Blind Period|LOW EGFR|1|||
160973753|NCT02969525|581293508|FG004|Double-Blind Period|LOW EGFR|0|||
160973754|NCT02969525|581293509|FG005|Double-Blind Period|LOW EGFR|0|||
160973755|NCT02969525|581293510|FG006|Double-Blind Period|LOW EGFR|0|||
160973756|NCT02969525|581293511|FG007|Double-Blind Period|LOW EGFR|0|||
160973757|NCT02969525|581293512|FG008|Double-Blind Period|LOW EGFR|0|||
160973758|NCT02969525|581293513|FG009|Double-Blind Period|LOW EGFR|0|||
160973759|NCT02969525|581293514|FG010|Double-Blind Period|LOW EGFR|0|||
160973760|NCT02969525|581293515|FG011|Double-Blind Period|LOW EGFR|0|||
160973761|NCT02969525|581293504|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
160973762|NCT02969525|581293505|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973763|NCT02969525|581293506|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973764|NCT02969525|581293507|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
160589922|NCT04167306|579876743|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
160589923|NCT03731364|579876746|FG000|Overall Study|Adverse Event|0|||
160589924|NCT03731364|579876747|FG001|Overall Study|Adverse Event|0|||
160589925|NCT03731364|579876748|FG002|Overall Study|Adverse Event|1|||
160589926|NCT03731364|579876749|FG003|Overall Study|Adverse Event|2|||
160589927|NCT03731364|579876750|FG004|Overall Study|Adverse Event|1|||
160589928|NCT00403559|579876751|FG000|Overall Study|Adverse Event|0|||
160589929|NCT00403559|579876752|FG001|Overall Study|Adverse Event|1|||
160589930|NCT00403559|579876751|FG000|Overall Study|Lost to Follow-up|3|||
160589931|NCT00403559|579876752|FG001|Overall Study|Lost to Follow-up|3|||
160589932|NCT00403559|579876751|FG000|Overall Study|Withdrawal by Subject|1|||
160589933|NCT00403559|579876752|FG001|Overall Study|Withdrawal by Subject|0|||
160589934|NCT00547378|579876753|FG000|Randomized Cohort|Withdrawal by Subject|7|||
160589935|NCT00547378|579876754|FG001|Randomized Cohort|Withdrawal by Subject|5|||
160589936|NCT00547378|579876755|FG002|Randomized Cohort|Withdrawal by Subject|0|||
160589937|NCT00547378|579876753|FG000|Randomized Cohort|Death|0|||
160589938|NCT00547378|579876754|FG001|Randomized Cohort|Death|1|||
160589939|NCT00547378|579876755|FG002|Randomized Cohort|Death|0|||
160589940|NCT00547378|579876753|FG000|Randomized Cohort|Lost to Follow-up|1|||
160589941|NCT00547378|579876754|FG001|Randomized Cohort|Lost to Follow-up|0|||
160589942|NCT00547378|579876755|FG002|Randomized Cohort|Lost to Follow-up|0|||
160589943|NCT00547378|579876753|FG000|Randomized Cohort|Adverse Event|1|||
160589944|NCT00547378|579876754|FG001|Randomized Cohort|Adverse Event|0|||
160589945|NCT00547378|579876755|FG002|Randomized Cohort|Adverse Event|0|||
160589946|NCT00547378|579876753|FG000|Randomized Cohort|Other reasons|2|||
160589947|NCT00547378|579876754|FG001|Randomized Cohort|Other reasons|0|||
160589948|NCT00547378|579876755|FG002|Randomized Cohort|Other reasons|0|||
160973765|NCT02969525|581293508|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973766|NCT02969525|581293509|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973767|NCT02969525|581293510|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973768|NCT02969525|581293511|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973769|NCT02969525|581293512|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973770|NCT02969525|581293513|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973771|NCT02969525|581293514|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973772|NCT02969525|581293515|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973773|NCT02969525|581293504|FG000|Dose-Blind Period|Adverse Event|0|||
160973774|NCT02969525|581293505|FG001|Dose-Blind Period|Adverse Event|0|||
160973775|NCT02969525|581293506|FG002|Dose-Blind Period|Adverse Event|0|||
160973776|NCT02969525|581293507|FG003|Dose-Blind Period|Adverse Event|0|||
160973777|NCT02969525|581293508|FG004|Dose-Blind Period|Adverse Event|0|||
160973778|NCT02969525|581293509|FG005|Dose-Blind Period|Adverse Event|0|||
160973779|NCT02969525|581293510|FG006|Dose-Blind Period|Adverse Event|0|||
160973780|NCT02969525|581293511|FG007|Dose-Blind Period|Adverse Event|0|||
160973781|NCT02969525|581293512|FG008|Dose-Blind Period|Adverse Event|0|||
160973782|NCT02969525|581293513|FG009|Dose-Blind Period|Adverse Event|1|||
160973783|NCT02969525|581293514|FG010|Dose-Blind Period|Adverse Event|1|||
160973784|NCT02969525|581293515|FG011|Dose-Blind Period|Adverse Event|1|||
160973785|NCT02969525|581293504|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
160973786|NCT02969525|581293505|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
160973787|NCT02969525|581293506|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
160973788|NCT02969525|581293507|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
160973789|NCT02969525|581293508|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
160973790|NCT02969525|581293509|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
160973791|NCT02969525|581293510|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
160973792|NCT02969525|581293511|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
160973793|NCT02969525|581293512|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
160973794|NCT02969525|581293513|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
160973795|NCT02969525|581293514|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
160973796|NCT02969525|581293515|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
160973797|NCT02969525|581293504|FG000|Dose-Blind Period|Non-cooperating patient|0|||
160973798|NCT02969525|581293505|FG001|Dose-Blind Period|Non-cooperating patient|0|||
160973799|NCT02969525|581293506|FG002|Dose-Blind Period|Non-cooperating patient|0|||
160973800|NCT02969525|581293507|FG003|Dose-Blind Period|Non-cooperating patient|0|||
160973801|NCT02969525|581293508|FG004|Dose-Blind Period|Non-cooperating patient|0|||
160973802|NCT02969525|581293509|FG005|Dose-Blind Period|Non-cooperating patient|0|||
160973803|NCT02969525|581293510|FG006|Dose-Blind Period|Non-cooperating patient|0|||
160973804|NCT02969525|581293511|FG007|Dose-Blind Period|Non-cooperating patient|0|||
160973805|NCT02969525|581293512|FG008|Dose-Blind Period|Non-cooperating patient|0|||
160973806|NCT02969525|581293513|FG009|Dose-Blind Period|Non-cooperating patient|0|||
160973807|NCT02969525|581293514|FG010|Dose-Blind Period|Non-cooperating patient|0|||
160973808|NCT02969525|581293515|FG011|Dose-Blind Period|Non-cooperating patient|1|||
160973809|NCT02969525|581293504|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973810|NCT02969525|581293505|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973811|NCT02969525|581293506|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973812|NCT02969525|581293507|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161025766|NCT03816891|581485689|FG005|Double-Blind Period|Lost to Follow-up|1|||
161025767|NCT03816891|581485684|FG000|Double-Blind Period|Physician Decision|0|||
161025768|NCT03816891|581485685|FG001|Double-Blind Period|Physician Decision|0|||
161025769|NCT03816891|581485686|FG002|Double-Blind Period|Physician Decision|0|||
161025770|NCT03816891|581485687|FG003|Double-Blind Period|Physician Decision|1|||
161025771|NCT03816891|581485688|FG004|Double-Blind Period|Physician Decision|0|||
161025772|NCT03816891|581485689|FG005|Double-Blind Period|Physician Decision|0|||
161025773|NCT03816891|581485684|FG000|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161025774|NCT03816891|581485685|FG001|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161025775|NCT03816891|581485686|FG002|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161025776|NCT03816891|581485687|FG003|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161025777|NCT03816891|581485688|FG004|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161025778|NCT03816891|581485689|FG005|Double-Blind Period|Coronavirus Disease (COVID-19)|1|||
161025779|NCT03816891|581485684|FG000|Double-Blind Period|Other|1|||
161025780|NCT03816891|581485685|FG001|Double-Blind Period|Other|0|||
161025781|NCT03816891|581485686|FG002|Double-Blind Period|Other|0|||
161025782|NCT03816891|581485687|FG003|Double-Blind Period|Other|0|||
161025783|NCT03816891|581485688|FG004|Double-Blind Period|Other|0|||
161025784|NCT03816891|581485689|FG005|Double-Blind Period|Other|0|||
161025785|NCT03816891|581485684|FG000|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
161025786|NCT03816891|581485685|FG001|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
161025787|NCT03816891|581485686|FG002|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|4|||
161025788|NCT03816891|581485687|FG003|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|3|||
161025789|NCT03816891|581485688|FG004|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|2|||
161025790|NCT03816891|581485689|FG005|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
161025791|NCT03816891|581485684|FG000|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
161025792|NCT03816891|581485685|FG001|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
161025793|NCT03816891|581485686|FG002|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
161025794|NCT03816891|581485687|FG003|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
161025795|NCT03816891|581485688|FG004|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
161025796|NCT03816891|581485689|FG005|Open-Label Period (Phase 2b Only)|Adverse Event|1|||
161025797|NCT03816891|581485684|FG000|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161025798|NCT03816891|581485685|FG001|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161025799|NCT03816891|581485686|FG002|Open-Label Period (Phase 2b Only)|Lack of Efficacy|1|||
161025800|NCT03816891|581485687|FG003|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161025801|NCT03816891|581485688|FG004|Open-Label Period (Phase 2b Only)|Lack of Efficacy|3|||
161025802|NCT03816891|581485689|FG005|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161025803|NCT03816891|581485684|FG000|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161025804|NCT03816891|581485685|FG001|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161025805|NCT03816891|581485686|FG002|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161025806|NCT03816891|581485687|FG003|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161025807|NCT03816891|581485688|FG004|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
161025808|NCT03816891|581485689|FG005|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
161025809|NCT03816891|581485684|FG000|Open-Label Period (Phase 2b Only)|Other|0|||
161025810|NCT03816891|581485685|FG001|Open-Label Period (Phase 2b Only)|Other|0|||
161025811|NCT03816891|581485686|FG002|Open-Label Period (Phase 2b Only)|Other|0|||
161025812|NCT03816891|581485687|FG003|Open-Label Period (Phase 2b Only)|Other|0|||
161025813|NCT03816891|581485688|FG004|Open-Label Period (Phase 2b Only)|Other|0|||
161025814|NCT03816891|581485689|FG005|Open-Label Period (Phase 2b Only)|Other|1|||
161025815|NCT02577029|581485690|FG000|Overall Study|Adverse Event|1|||
160589949|NCT00547378|579876753|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
161025816|NCT02577029|581485691|FG001|Overall Study|Adverse Event|0|||
161025817|NCT02577029|581485692|FG002|Overall Study|Adverse Event|2|||
161025818|NCT02577029|581485693|FG003|Overall Study|Adverse Event|0|||
161025819|NCT02577029|581485694|FG004|Overall Study|Adverse Event|1|||
161025820|NCT02577029|581485695|FG005|Overall Study|Adverse Event|0|||
161025821|NCT02577029|581485696|FG006|Overall Study|Adverse Event|0|||
161025822|NCT02577029|581485697|FG007|Overall Study|Adverse Event|0|||
161025823|NCT02577029|581485690|FG000|Overall Study|Withdrawal by Subject|0|||
161025824|NCT02577029|581485691|FG001|Overall Study|Withdrawal by Subject|0|||
161025825|NCT02577029|581485692|FG002|Overall Study|Withdrawal by Subject|0|||
161025826|NCT02577029|581485693|FG003|Overall Study|Withdrawal by Subject|0|||
161025827|NCT02577029|581485694|FG004|Overall Study|Withdrawal by Subject|0|||
161025828|NCT02577029|581485695|FG005|Overall Study|Withdrawal by Subject|1|||
161025829|NCT02577029|581485696|FG006|Overall Study|Withdrawal by Subject|0|||
161025830|NCT02577029|581485697|FG007|Overall Study|Withdrawal by Subject|0|||
161025831|NCT02577029|581485690|FG000|Overall Study|Sponsor Termination of the Study|9|||
161025832|NCT02577029|581485691|FG001|Overall Study|Sponsor Termination of the Study|2|||
161025833|NCT02577029|581485692|FG002|Overall Study|Sponsor Termination of the Study|5|||
161025834|NCT02577029|581485693|FG003|Overall Study|Sponsor Termination of the Study|12|||
161025835|NCT02577029|581485694|FG004|Overall Study|Sponsor Termination of the Study|10|||
161025836|NCT02577029|581485695|FG005|Overall Study|Sponsor Termination of the Study|12|||
161025837|NCT02577029|581485696|FG006|Overall Study|Sponsor Termination of the Study|12|||
161025838|NCT02577029|581485697|FG007|Overall Study|Sponsor Termination of the Study|12|||
161025839|NCT02068885|581485698|FG000|Overall Study|Withdrew|3|||
161025840|NCT02068885|581485699|FG001|Overall Study|Withdrew|5|||
161025841|NCT02068885|581485700|FG002|Overall Study|Withdrew|8|||
161025842|NCT00124306|581485718|FG000|Overall Study|Adverse Event|7|||
161025843|NCT00124306|581485719|FG001|Overall Study|Adverse Event|2|||
161025844|NCT00124306|581485718|FG000|Overall Study|Lost to Follow-up|10|||
161025845|NCT00124306|581485719|FG001|Overall Study|Lost to Follow-up|6|||
161025846|NCT00124306|581485718|FG000|Overall Study|Lack of Efficacy|3|||
161025847|NCT00124306|581485719|FG001|Overall Study|Lack of Efficacy|6|||
161025848|NCT00124306|581485718|FG000|Overall Study|Personal constraints|0|||
161025849|NCT00124306|581485719|FG001|Overall Study|Personal constraints|2|||
161025850|NCT00124306|581485718|FG000|Overall Study|Use of unacceptable medication|1|||
161025851|NCT00124306|581485719|FG001|Overall Study|Use of unacceptable medication|0|||
161025852|NCT00124306|581485718|FG000|Overall Study|Abnormal lab result|0|||
161025853|NCT00124306|581485719|FG001|Overall Study|Abnormal lab result|1|||
161025854|NCT00124306|581485718|FG000|Overall Study|Other|2|||
161025855|NCT00124306|581485719|FG001|Overall Study|Other|0|||
161025856|NCT03369704|581485723|FG000|Treatment Epoch|technical problems|1|||
161025857|NCT03369704|581485724|FG001|Treatment Epoch|technical problems|0|||
161025858|NCT03369704|581485723|FG000|Treatment Epoch|Protocol Violation|1|||
161025859|NCT03369704|581485724|FG001|Treatment Epoch|Protocol Violation|0|||
161025860|NCT03369704|581485723|FG000|Treatment Epoch|Lost to Follow-up|0|||
161025861|NCT03369704|581485724|FG001|Treatment Epoch|Lost to Follow-up|1|||
161025862|NCT03369704|581485723|FG000|Treatment Epoch|Lack of Efficacy|0|||
161025863|NCT03369704|581485724|FG001|Treatment Epoch|Lack of Efficacy|2|||
161025864|NCT03369704|581485723|FG000|Treatment Epoch|Adverse Event|2|||
161025865|NCT03369704|581485724|FG001|Treatment Epoch|Adverse Event|0|||
161025866|NCT03369704|581485723|FG000|Follow-up Epoch|Lost to Follow-up|1|||
161025867|NCT03369704|581485724|FG001|Follow-up Epoch|Lost to Follow-up|0|||
161025868|NCT04379518|581485726|FG000|Overall Study|Physician Decision|2|||
161025869|NCT04379518|581485727|FG001|Overall Study|Physician Decision|0|||
161025870|NCT04379518|581485728|FG002|Overall Study|Physician Decision|0|||
161025871|NCT04379518|581485729|FG003|Overall Study|Physician Decision|0|||
161025872|NCT04379518|581485730|FG004|Overall Study|Physician Decision|0|||
161025873|NCT04379518|581485726|FG000|Overall Study|Withdrawal by Subject|1|||
161025874|NCT04379518|581485727|FG001|Overall Study|Withdrawal by Subject|0|||
161025875|NCT04379518|581485728|FG002|Overall Study|Withdrawal by Subject|0|||
161025876|NCT04379518|581485729|FG003|Overall Study|Withdrawal by Subject|0|||
161025877|NCT04379518|581485730|FG004|Overall Study|Withdrawal by Subject|0|||
161025878|NCT05666505|581485731|FG000|Overall Study|Withdrawn due to caregiver consent obtained from non-legal guardian|1|||
161025879|NCT03100149|581485732|FG000|Overall Study|Adverse Event|0|||
161025880|NCT03100149|581485733|FG001|Overall Study|Adverse Event|1|||
161025881|NCT03100149|581485734|FG002|Overall Study|Adverse Event|0|||
161025882|NCT03100149|581485732|FG000|Overall Study|Participant Moved out of Country|0|||
161025883|NCT03100149|581485733|FG001|Overall Study|Participant Moved out of Country|0|||
161025884|NCT03100149|581485734|FG002|Overall Study|Participant Moved out of Country|1|||
161025885|NCT03100149|581485732|FG000|Overall Study|Withdrawal by Subject|0|||
161025886|NCT03100149|581485733|FG001|Overall Study|Withdrawal by Subject|3|||
161025887|NCT03100149|581485734|FG002|Overall Study|Withdrawal by Subject|1|||
161025888|NCT03697876|581485735|FG000|Overall Study|Lost to Follow-up|0|||
161025889|NCT03697876|581485736|FG001|Overall Study|Lost to Follow-up|1|||
161025890|NCT03697876|581485735|FG000|Overall Study|Adverse Event|1|||
161025891|NCT03697876|581485736|FG001|Overall Study|Adverse Event|0|||
161025892|NCT04721977|581485737|FG000|Overall Study|Death|15|||
161025893|NCT04721977|581485737|FG000|Overall Study|Ongoing|51|||
161025894|NCT02670525|581485738|FG000|Overall Study|Death|94|||
161025895|NCT02670525|581485739|FG001|Overall Study|Death|14|||
161025896|NCT02670525|581485738|FG000|Overall Study|Lost to Follow-up|4|||
161025897|NCT02670525|581485739|FG001|Overall Study|Lost to Follow-up|1|||
161025898|NCT02670525|581485738|FG000|Overall Study|Subject withdrew consent|1|||
161025899|NCT02670525|581485739|FG001|Overall Study|Subject withdrew consent|0|||
161025900|NCT02670525|581485738|FG000|Overall Study|Unknown, data entry delayed|123|||
161025901|NCT02670525|581485739|FG001|Overall Study|Unknown, data entry delayed|78|||
161025902|NCT04622046|581486197|FG000|Intervention Period|Adverse Event|1|||
161025903|NCT04622046|581486197|FG000|Intervention Period|Withdrawal by Subject|2|||
161025904|NCT04622046|581486197|FG000|Extension Period|Ongoing in the Extension Period|21|||
161025905|NCT05135000|581486198|FG000|Overall Study|Adverse Event|2|||
161025906|NCT05135000|581486199|FG001|Overall Study|Adverse Event|0|||
161025907|NCT05135000|581486198|FG000|Overall Study|Lost to Follow-up|1|||
161025908|NCT05135000|581486199|FG001|Overall Study|Lost to Follow-up|0|||
161025909|NCT05135000|581486198|FG000|Overall Study|Study Terminated by Sponsor|6|||
161025910|NCT05135000|581486199|FG001|Overall Study|Study Terminated by Sponsor|3|||
161025911|NCT03596645|581486202|FG000|Overall Study|Adverse Event|17|||
161025912|NCT03596645|581486203|FG001|Overall Study|Adverse Event|0|||
161025913|NCT03596645|581486202|FG000|Overall Study|Lack of Efficacy|8|||
161025914|NCT03596645|581486203|FG001|Overall Study|Lack of Efficacy|0|||
161025915|NCT03596645|581486202|FG000|Overall Study|Lost to Follow-up|1|||
161025916|NCT03596645|581486203|FG001|Overall Study|Lost to Follow-up|1|||
161025917|NCT03596645|581486202|FG000|Overall Study|Physician Decision|1|||
161025918|NCT03596645|581486203|FG001|Overall Study|Physician Decision|1|||
161025919|NCT03596645|581486202|FG000|Overall Study|Protocol Violation|1|||
161025920|NCT03596645|581486203|FG001|Overall Study|Protocol Violation|0|||
161025921|NCT03596645|581486202|FG000|Overall Study|Initiated Prohibited Medication|1|||
161025922|NCT03596645|581486203|FG001|Overall Study|Initiated Prohibited Medication|0|||
161025923|NCT03596645|581486202|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161025924|NCT03596645|581486203|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161025925|NCT03596645|581486202|FG000|Overall Study|No mucosal healing achieved|1|||
161025926|NCT03596645|581486203|FG001|Overall Study|No mucosal healing achieved|0|||
161025927|NCT03596645|581486202|FG000|Overall Study|Disease progression|1|||
161025928|NCT03596645|581486203|FG001|Overall Study|Disease progression|0|||
161025929|NCT03596645|581486202|FG000|Overall Study|Ongoing|37|||
161025930|NCT03596645|581486203|FG001|Overall Study|Ongoing|12|||
161025931|NCT03596645|581486202|FG000|Overall Study|Randomized but not treated|0|||
161025932|NCT03596645|581486203|FG001|Overall Study|Randomized but not treated|1|||
161025933|NCT04153149|581486204|FG000|Double Blind Period|Death|63|||
161025934|NCT04153149|581486205|FG001|Double Blind Period|Death|49|||
161025935|NCT04153149|581486206|FG002|Double Blind Period|Death|0|||
161025936|NCT04153149|581486207|FG003|Double Blind Period|Death|0|||
161025937|NCT04153149|581486204|FG000|Double Blind Period|Withdrawal by Subject|16|||
161025938|NCT04153149|581486205|FG001|Double Blind Period|Withdrawal by Subject|11|||
161025939|NCT04153149|581486206|FG002|Double Blind Period|Withdrawal by Subject|0|||
161025940|NCT04153149|581486207|FG003|Double Blind Period|Withdrawal by Subject|0|||
161025941|NCT04153149|581486204|FG000|Double Blind Period|Adverse Event|6|||
161025942|NCT04153149|581486205|FG001|Double Blind Period|Adverse Event|2|||
161025943|NCT04153149|581486206|FG002|Double Blind Period|Adverse Event|0|||
161025944|NCT04153149|581486207|FG003|Double Blind Period|Adverse Event|0|||
161025945|NCT04153149|581486204|FG000|Double Blind Period|Lost to Follow-up|2|||
161025946|NCT04153149|581486205|FG001|Double Blind Period|Lost to Follow-up|1|||
161025947|NCT04153149|581486206|FG002|Double Blind Period|Lost to Follow-up|0|||
161025948|NCT04153149|581486207|FG003|Double Blind Period|Lost to Follow-up|0|||
161025949|NCT04153149|581486204|FG000|Double Blind Period|Withdrawal by guardian|0|||
161025950|NCT04153149|581486205|FG001|Double Blind Period|Withdrawal by guardian|2|||
161025951|NCT04153149|581486206|FG002|Double Blind Period|Withdrawal by guardian|0|||
161025952|NCT04153149|581486207|FG003|Double Blind Period|Withdrawal by guardian|0|||
161025953|NCT04153149|581486204|FG000|Double Blind Period|Reason Not Specified|5|||
161025954|NCT04153149|581486205|FG001|Double Blind Period|Reason Not Specified|4|||
161025955|NCT04153149|581486206|FG002|Double Blind Period|Reason Not Specified|0|||
161025956|NCT04153149|581486207|FG003|Double Blind Period|Reason Not Specified|0|||
161025957|NCT04153149|581486204|FG000|Double Blind Period|Physician Decision|2|||
161025958|NCT04153149|581486205|FG001|Double Blind Period|Physician Decision|0|||
161025959|NCT04153149|581486206|FG002|Double Blind Period|Physician Decision|0|||
161025960|NCT04153149|581486207|FG003|Double Blind Period|Physician Decision|0|||
161025961|NCT04153149|581486204|FG000|Open Label Extension Period|Death|0|||
161025962|NCT04153149|581486205|FG001|Open Label Extension Period|Death|0|||
161025963|NCT04153149|581486206|FG002|Open Label Extension Period|Death|7|||
161025964|NCT04153149|581486207|FG003|Open Label Extension Period|Death|3|||
161025965|NCT04153149|581486204|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
161025966|NCT04153149|581486205|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
161025967|NCT04153149|581486206|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
161025968|NCT04153149|581486207|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
161025969|NCT04153149|581486204|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161025970|NCT04153149|581486205|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161025971|NCT04153149|581486206|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161025972|NCT04153149|581486207|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
161025973|NCT04153149|581486204|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
161025974|NCT04153149|581486205|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
161025975|NCT04153149|581486206|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
161025976|NCT04153149|581486207|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
161025977|NCT05321082|581486208|FG000|Overall Study|Other than listed|40|||
160589950|NCT00547378|579876754|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
160589951|NCT00547378|579876755|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
160589952|NCT00547378|579876753|FG000|All Implanted Cohort|Adverse Event|4|||
160589953|NCT00547378|579876754|FG001|All Implanted Cohort|Adverse Event|10|||
161025978|NCT05321082|581486209|FG001|Overall Study|Other than listed|26|||
161025979|NCT05321082|581486210|FG002|Overall Study|Other than listed|27|||
161025980|NCT05321082|581486208|FG000|Overall Study|Lost to Follow-up|0|||
161025981|NCT05321082|581486209|FG001|Overall Study|Lost to Follow-up|1|||
160589954|NCT00547378|579876755|FG002|All Implanted Cohort|Adverse Event|17|||
160589955|NCT00547378|579876753|FG000|All Implanted Cohort|Lost to Follow-up|0|||
161025982|NCT05321082|581486210|FG002|Overall Study|Lost to Follow-up|0|||
161025983|NCT05321082|581486208|FG000|Overall Study|Withdrawal by Subject|30|||
161025984|NCT05321082|581486209|FG001|Overall Study|Withdrawal by Subject|34|||
161025985|NCT05321082|581486210|FG002|Overall Study|Withdrawal by Subject|42|||
161025986|NCT05321082|581486208|FG000|Overall Study|Protocol Violation|0|||
161025987|NCT05321082|581486209|FG001|Overall Study|Protocol Violation|0|||
161025988|NCT05321082|581486210|FG002|Overall Study|Protocol Violation|1|||
161025989|NCT05321082|581486208|FG000|Overall Study|Adverse Event|49|||
161025990|NCT05321082|581486209|FG001|Overall Study|Adverse Event|49|||
161025991|NCT05321082|581486210|FG002|Overall Study|Adverse Event|48|||
161025992|NCT05321082|581486208|FG000|Overall Study|Lack of Efficacy|2|||
161025993|NCT05321082|581486209|FG001|Overall Study|Lack of Efficacy|0|||
161025994|NCT05321082|581486210|FG002|Overall Study|Lack of Efficacy|1|||
161025995|NCT05321082|581486208|FG000|Overall Study|Not treated|1|||
161025996|NCT05321082|581486209|FG001|Overall Study|Not treated|0|||
161025997|NCT05321082|581486210|FG002|Overall Study|Not treated|1|||
161025998|NCT05089656|581486346|FG000|Period 1 - First Intervention (52 weeks)|Physician Decision|1|||
161025999|NCT05089656|581486347|FG001|Period 1 - First Intervention (52 weeks)|Physician Decision|0|||
161026000|NCT05089656|581486346|FG000|Period 1 - First Intervention (52 weeks)|Guardian decision|1|||
161026001|NCT05089656|581486347|FG001|Period 1 - First Intervention (52 weeks)|Guardian decision|0|||
161026002|NCT05089656|581486346|FG000|Period 1 - First Intervention (52 weeks)|Adverse Event|0|||
161026003|NCT05089656|581486347|FG001|Period 1 - First Intervention (52 weeks)|Adverse Event|1|||
161026004|NCT05089656|581486346|FG000|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|6|||
161026005|NCT05089656|581486347|FG001|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|4|||
161026006|NCT02535416|581486351|FG000|Overall Study|Family bereavement overseas|1|||
161026007|NCT02535416|581486352|FG001|Overall Study|Family bereavement overseas|0|||
161026008|NCT02535416|581486353|FG002|Overall Study|Family bereavement overseas|0|||
161026009|NCT02535416|581486354|FG003|Overall Study|Family bereavement overseas|0|||
161026010|NCT02535416|581486355|FG004|Overall Study|Family bereavement overseas|0|||
161026011|NCT02535416|581486356|FG005|Overall Study|Family bereavement overseas|0|||
161026012|NCT02535416|581486357|FG006|Overall Study|Family bereavement overseas|0|||
161026013|NCT02535416|581486358|FG007|Overall Study|Family bereavement overseas|0|||
161026014|NCT02535416|581486359|FG008|Overall Study|Family bereavement overseas|0|||
161026015|NCT07147257|581486360|FG000|Overall Study|Pregnancy|1|||
161026016|NCT07147257|581486361|FG001|Overall Study|Pregnancy|0|||
161026017|NCT07147257|581486360|FG000|Overall Study|Physician Decision|0|||
161026018|NCT07147257|581486361|FG001|Overall Study|Physician Decision|1|||
161026019|NCT07147257|581486360|FG000|Overall Study|Withdrawal by Subject|0|||
161026020|NCT07147257|581486361|FG001|Overall Study|Withdrawal by Subject|1|||
161026021|NCT07147257|581486360|FG000|Overall Study|Drug administration failure|0|||
161026022|NCT07147257|581486361|FG001|Overall Study|Drug administration failure|1|||
161026023|NCT04573881|581486362|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
160657496|NCT01345019|580127574|FG001|Blinded Treatment Phase|Death|137|||
160657497|NCT01345019|580127573|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
160657498|NCT01345019|580127574|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
160657499|NCT01345019|580127573|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
160657500|NCT01345019|580127574|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
160657501|NCT01345019|580127573|FG000|Blinded Treatment Phase|Disease Progression|12|||
160657502|NCT01345019|580127574|FG001|Blinded Treatment Phase|Disease Progression|10|||
160657503|NCT01345019|580127573|FG000|Blinded Treatment Phase|Adverse Event|6|||
160657504|NCT01345019|580127574|FG001|Blinded Treatment Phase|Adverse Event|13|||
160657505|NCT01345019|580127573|FG000|Blinded Treatment Phase|Administrative Decision|10|||
160657506|NCT01345019|580127574|FG001|Blinded Treatment Phase|Administrative Decision|8|||
160657507|NCT01345019|580127573|FG000|Blinded Treatment Phase|Noncompliance|5|||
160657508|NCT01345019|580127574|FG001|Blinded Treatment Phase|Noncompliance|3|||
160657509|NCT01345019|580127573|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
160657510|NCT01345019|580127574|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
160657511|NCT01345019|580127573|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
160657512|NCT01345019|580127574|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
160657513|NCT01345019|580127573|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
160657514|NCT01345019|580127574|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
160657515|NCT01345019|580127573|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
160657516|NCT01345019|580127574|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
160657517|NCT01345019|580127573|FG000|Open Label Treatment Phase|Death|49|||
160657518|NCT01345019|580127574|FG001|Open Label Treatment Phase|Death|48|||
160973813|NCT02969525|581293508|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973814|NCT02969525|581293509|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973815|NCT02969525|581293510|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973816|NCT02969525|581293511|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973817|NCT02969525|581293512|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973818|NCT02969525|581293513|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973819|NCT02969525|581293514|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
160973820|NCT02969525|581293515|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973821|NCT02172625|581293516|FG000|Overall Study|Adverse Event|0|||
160973822|NCT02172625|581293517|FG001|Overall Study|Adverse Event|1|||
160973823|NCT02172625|581293516|FG000|Overall Study|Pregnancy|0|||
160973824|NCT02172625|581293517|FG001|Overall Study|Pregnancy|1|||
160973825|NCT02172625|581293516|FG000|Overall Study|car accident|0|||
160973826|NCT02172625|581293517|FG001|Overall Study|car accident|1|||
160973827|NCT03445065|581293518|FG000|Overall Study|Withdrawal by Subject|3|||
160973828|NCT03445065|581293519|FG001|Overall Study|Withdrawal by Subject|6|||
160973829|NCT03445065|581293520|FG002|Overall Study|Withdrawal by Subject|2|||
160973830|NCT03445065|581293521|FG003|Overall Study|Withdrawal by Subject|2|||
160973831|NCT03445065|581293518|FG000|Overall Study|Other|4|||
160973832|NCT03445065|581293519|FG001|Overall Study|Other|3|||
160973833|NCT03445065|581293520|FG002|Overall Study|Other|3|||
160973834|NCT03445065|581293521|FG003|Overall Study|Other|1|||
160973835|NCT00524030|581293522|FG000|Overall Study|Lack of Efficacy|10|||
160973836|NCT00524030|581293523|FG001|Overall Study|Lack of Efficacy|24|||
160973837|NCT00524030|581293522|FG000|Overall Study|Lost to Follow-up|0|||
160973838|NCT00524030|581293523|FG001|Overall Study|Lost to Follow-up|2|||
160973839|NCT00524030|581293522|FG000|Overall Study|Withdrawal by Subject|3|||
160973840|NCT00524030|581293523|FG001|Overall Study|Withdrawal by Subject|8|||
160973841|NCT00524030|581293522|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
160973842|NCT00524030|581293523|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
160973843|NCT00524030|581293522|FG000|Overall Study|Protocol Violation|0|||
160973844|NCT00524030|581293523|FG001|Overall Study|Protocol Violation|1|||
160973845|NCT00524030|581293522|FG000|Overall Study|Pregnancy|1|||
160973846|NCT00524030|581293523|FG001|Overall Study|Pregnancy|0|||
160973847|NCT00524030|581293522|FG000|Overall Study|Adverse Event|3|||
160973848|NCT00524030|581293523|FG001|Overall Study|Adverse Event|21|||
160973849|NCT00524030|581293522|FG000|Overall Study|Death|0|||
160973850|NCT00524030|581293523|FG001|Overall Study|Death|1|||
160973851|NCT03315130|581293524|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
160973852|NCT03315130|581293525|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
160973853|NCT03315130|581293526|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
160973854|NCT03315130|581293527|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
160973855|NCT03315130|581293524|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
160973856|NCT03315130|581293525|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
160973857|NCT03315130|581293526|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
160973858|NCT03315130|581293527|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
160973859|NCT03315130|581293524|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
160973860|NCT03315130|581293525|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
160973861|NCT03315130|581293526|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
160973862|NCT03315130|581293527|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
160973863|NCT03315130|581293524|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
160973864|NCT03315130|581293525|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
160973865|NCT03315130|581293526|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
160973866|NCT03315130|581293527|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
160973867|NCT03315130|581293524|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
160973868|NCT03315130|581293525|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
160973869|NCT03315130|581293526|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
160973870|NCT03315130|581293527|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
160973871|NCT03315130|581293524|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
160973872|NCT03315130|581293525|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
160973873|NCT03315130|581293526|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
160973874|NCT03315130|581293527|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
160973875|NCT02944656|581293528|FG000|Overall Study|No longer eligible|3|||
160973876|NCT02944656|581293529|FG001|Overall Study|No longer eligible|0|||
160973877|NCT02944656|581293528|FG000|Overall Study|Lost to Follow-up|7|||
160973878|NCT02944656|581293529|FG001|Overall Study|Lost to Follow-up|10|||
160973879|NCT04398537|581293530|FG000|Overall Study|Physician Decision|10|||
160973880|NCT04398537|581293531|FG001|Overall Study|Physician Decision|15|||
160973881|NCT03535337|581293532|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
160973882|NCT03535337|581293533|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
160973883|NCT03535337|581293534|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
160973884|NCT03535337|581293535|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
160973885|NCT03535337|581293536|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
160973886|NCT03535337|581293537|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
160973887|NCT03535337|581293538|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
160973888|NCT03535337|581293539|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
160973889|NCT03535337|581293540|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
160973890|NCT03535337|581293541|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
160973891|NCT05879198|581293542|FG000|Overall Study|Lost to Follow-up|1|||
160973892|NCT01598298|581293543|FG000|Overall Study|Not eligible|5|||
160973893|NCT01598298|581293544|FG001|Overall Study|Not eligible|5|||
160973894|NCT01598298|581293543|FG000|Overall Study|Adverse Event|21|||
160973895|NCT01598298|581293544|FG001|Overall Study|Adverse Event|19|||
160973896|NCT01598298|581293543|FG000|Overall Study|Progression/relapse|0|||
160973897|NCT01598298|581293544|FG001|Overall Study|Progression/relapse|2|||
160973898|NCT01598298|581293543|FG000|Overall Study|Withdrawal by Subject|10|||
160973899|NCT01598298|581293544|FG001|Overall Study|Withdrawal by Subject|15|||
160973900|NCT01598298|581293543|FG000|Overall Study|Other reason (not protocol specified)|4|||
160973901|NCT01598298|581293544|FG001|Overall Study|Other reason (not protocol specified)|0|||
160973902|NCT00663117|581295273|FG000|Overall Study|Lack of Efficacy|1|||
160973903|NCT00663117|581295274|FG001|Overall Study|Lack of Efficacy|0|||
160973904|NCT02781506|581295275|FG000|Overall Study|Adverse Event|5|||
160973905|NCT02593539|581295276|FG000|Overall Study|Adverse Event|1|||
160973906|NCT00437125|581295279|FG000|Overall Study|Adverse Event|12|||
160973907|NCT00437125|581295279|FG000|Overall Study|Death|1|||
160973908|NCT00437125|581295279|FG000|Overall Study|Clinical Relapse|1|||
160973909|NCT00437125|581295279|FG000|Overall Study|Lack of Efficacy|1|||
160973910|NCT00437125|581295279|FG000|Overall Study|Lost to Follow-up|1|||
160973911|NCT00437125|581295279|FG000|Overall Study|Withdrawal by Subject|13|||
160973912|NCT00437125|581295279|FG000|Overall Study|Withdrawal by Caregiver|2|||
160973913|NCT00437125|581295279|FG000|Overall Study|Physician Decision|1|||
160973914|NCT02248961|581295280|FG000|Overall Study|Adverse Event|1|||
160973915|NCT02248961|581295281|FG001|Overall Study|Adverse Event|0|||
160973916|NCT02248961|581295280|FG000|Overall Study|Withdrawal by Subject|1|||
160973917|NCT02248961|581295281|FG001|Overall Study|Withdrawal by Subject|2|||
160973918|NCT02248961|581295280|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
160973919|NCT02248961|581295281|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
160973920|NCT00244374|581295288|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
160973921|NCT00244374|581295289|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
160973922|NCT00244374|581295290|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
160973923|NCT00244374|581295291|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
160973924|NCT00244374|581295292|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
160973925|NCT00244374|581295288|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
160973926|NCT00244374|581295289|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
160973927|NCT00244374|581295290|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
160973928|NCT00244374|581295291|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
160973929|NCT00244374|581295292|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
160973930|NCT00244374|581295288|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
160973931|NCT00244374|581295289|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
160973932|NCT00244374|581295290|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
160973933|NCT00244374|581295291|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
160973934|NCT00244374|581295292|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
160973935|NCT00244374|581295288|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
160973936|NCT00244374|581295289|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
160973937|NCT00244374|581295290|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
160973938|NCT00244374|581295291|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
160973939|NCT00244374|581295292|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
160973940|NCT00244374|581295288|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
160973941|NCT00244374|581295289|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
160973942|NCT00244374|581295290|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
160973943|NCT00244374|581295291|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
160973944|NCT00244374|581295292|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
160973945|NCT00244374|581295288|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
160973946|NCT00244374|581295289|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
160973947|NCT00244374|581295290|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
160973948|NCT00244374|581295291|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
160973949|NCT00244374|581295292|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
160973950|NCT00244374|581295288|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
160973951|NCT00244374|581295289|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
160973952|NCT00244374|581295290|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
160973953|NCT00244374|581295291|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
160973954|NCT00244374|581295292|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
160973955|NCT00244374|581295288|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
160973956|NCT00244374|581295289|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
160973957|NCT00244374|581295290|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
160973958|NCT00244374|581295291|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
160973959|NCT00244374|581295292|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
160973960|NCT00244374|581295288|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
160973961|NCT00244374|581295289|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
160973962|NCT00244374|581295290|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
160973963|NCT00244374|581295291|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
160973964|NCT00244374|581295292|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
160973965|NCT03462706|581295294|FG000|Overall Study|Polyp was pedunculated|1|||
160973966|NCT03462706|581295295|FG001|Overall Study|Polyp was pedunculated|0|||
160973967|NCT03462706|581295296|FG002|Overall Study|Polyp was pedunculated|1|||
160973968|NCT03462706|581295297|FG003|Overall Study|Polyp was pedunculated|0|||
160973969|NCT03462706|581295294|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
160973970|NCT03462706|581295295|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
160973971|NCT03462706|581295296|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
160973972|NCT03462706|581295297|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
160973973|NCT04105972|581295307|FG000|Overall Study|Adverse Event|2|||
160973974|NCT04105972|581295308|FG001|Overall Study|Adverse Event|1|||
160973975|NCT02802319|581295309|FG000|Overall Study|Physician Decision|2|||
160973976|NCT02802319|581295310|FG001|Overall Study|Physician Decision|1|||
160973977|NCT02802319|581295309|FG000|Overall Study|Lost to Follow-up|0|||
160973978|NCT02802319|581295310|FG001|Overall Study|Lost to Follow-up|4|||
160973979|NCT04651114|581295311|FG000|Overall Study|Withdrawal by Subject|8|||
160973980|NCT01923896|581295316|FG000|Overall Study|Adverse Event|1|||
160973981|NCT01923896|581295317|FG001|Overall Study|Adverse Event|0|||
160973982|NCT03545113|581295320|FG000|Overall Study|Surgery Cancelled|1|||
160973983|NCT03545113|581295321|FG001|Overall Study|Surgery Cancelled|0|||
160973984|NCT03545113|581295320|FG000|Overall Study|Death|1|||
160973985|NCT03545113|581295321|FG001|Overall Study|Death|0|||
160973986|NCT03545113|581295320|FG000|Overall Study|Adverse Event|2|||
160973987|NCT03545113|581295321|FG001|Overall Study|Adverse Event|0|||
160973988|NCT03545113|581295320|FG000|Overall Study|Received different surgery|1|||
160973989|NCT03545113|581295321|FG001|Overall Study|Received different surgery|0|||
160973990|NCT00235443|581295322|FG000|Overall Study|Adverse Event|4|||
160973991|NCT00235443|581295323|FG001|Overall Study|Adverse Event|12|||
160973992|NCT00235443|581295324|FG002|Overall Study|Adverse Event|17|||
160973993|NCT00235443|581295325|FG003|Overall Study|Adverse Event|44|||
160973994|NCT00235443|581295326|FG004|Overall Study|Adverse Event|10|||
160973995|NCT00235443|581295327|FG005|Overall Study|Adverse Event|15|||
160589956|NCT00547378|579876754|FG001|All Implanted Cohort|Lost to Follow-up|1|||
160589957|NCT00547378|579876755|FG002|All Implanted Cohort|Lost to Follow-up|14|||
160589958|NCT00547378|579876753|FG000|All Implanted Cohort|Death|3|||
160589959|NCT00547378|579876754|FG001|All Implanted Cohort|Death|1|||
160589960|NCT00547378|579876755|FG002|All Implanted Cohort|Death|4|||
160589961|NCT00547378|579876753|FG000|All Implanted Cohort|Physician Decision|0|||
160589962|NCT00547378|579876754|FG001|All Implanted Cohort|Physician Decision|2|||
160589963|NCT00547378|579876755|FG002|All Implanted Cohort|Physician Decision|6|||
160589964|NCT00547378|579876753|FG000|All Implanted Cohort|Site closure|2|||
160589965|NCT00547378|579876754|FG001|All Implanted Cohort|Site closure|0|||
160589966|NCT00547378|579876755|FG002|All Implanted Cohort|Site closure|1|||
160589967|NCT00547378|579876753|FG000|All Implanted Cohort|Other reasons|1|||
160589968|NCT00547378|579876754|FG001|All Implanted Cohort|Other reasons|0|||
160589969|NCT00547378|579876755|FG002|All Implanted Cohort|Other reasons|1|||
160589970|NCT01982773|579876756|FG000|Overall Study|Withdrawal by Subject|1|||
160657519|NCT01345019|580127573|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
160657520|NCT01345019|580127574|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
160657521|NCT01345019|580127573|FG000|Open Label Treatment Phase|Adverse Event|30|||
160657522|NCT01345019|580127574|FG001|Open Label Treatment Phase|Adverse Event|51|||
160657523|NCT01345019|580127573|FG000|Open Label Treatment Phase|Administrative Decision|30|||
160657524|NCT01345019|580127574|FG001|Open Label Treatment Phase|Administrative Decision|15|||
160657525|NCT01345019|580127573|FG000|Open Label Treatment Phase|Disease Progression|17|||
160657526|NCT01345019|580127574|FG001|Open Label Treatment Phase|Disease Progression|18|||
160657527|NCT01345019|580127573|FG000|Open Label Treatment Phase|Noncompliance|5|||
160657528|NCT01345019|580127574|FG001|Open Label Treatment Phase|Noncompliance|4|||
160657529|NCT01345019|580127573|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
160657530|NCT01345019|580127574|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
160657531|NCT01345019|580127573|FG000|Open Label Treatment Phase|Pregnancy|1|||
160657532|NCT01345019|580127574|FG001|Open Label Treatment Phase|Pregnancy|0|||
160657533|NCT01345019|580127573|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
160657534|NCT01345019|580127574|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
160657535|NCT01345019|580127573|FG000|Open Label Treatment Phase|Protocol Violation|0|||
160657536|NCT01345019|580127574|FG001|Open Label Treatment Phase|Protocol Violation|1|||
160657537|NCT02636907|580127575|FG000|Autoinjector Assessment Period|Adverse Event|2|||
160657538|NCT02636907|580127575|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
160657539|NCT02636907|580127575|FG000|Extension Phase|Adverse Event|2|||
160657540|NCT02636907|580127575|FG000|Extension Phase|Withdrawal by Subject|4|||
160657541|NCT02636907|580127575|FG000|Extension Phase|Physician Decision|1|||
160657542|NCT02636907|580127575|FG000|Extension Phase|Lost to Follow-up|2|||
160657543|NCT02636907|580127575|FG000|Extension Phase|Lack of Efficacy|1|||
160973996|NCT00235443|581295322|FG000|Overall Study|Lack of Efficacy|0|||
160973997|NCT00235443|581295323|FG001|Overall Study|Lack of Efficacy|1|||
160973998|NCT00235443|581295324|FG002|Overall Study|Lack of Efficacy|5|||
160973999|NCT00235443|581295325|FG003|Overall Study|Lack of Efficacy|12|||
160974000|NCT00235443|581295326|FG004|Overall Study|Lack of Efficacy|2|||
160974001|NCT00235443|581295327|FG005|Overall Study|Lack of Efficacy|9|||
160974002|NCT00235443|581295322|FG000|Overall Study|Withdrawal by Subject|3|||
160974003|NCT00235443|581295323|FG001|Overall Study|Withdrawal by Subject|9|||
160974004|NCT00235443|581295324|FG002|Overall Study|Withdrawal by Subject|25|||
160974005|NCT00235443|581295325|FG003|Overall Study|Withdrawal by Subject|24|||
160974006|NCT00235443|581295326|FG004|Overall Study|Withdrawal by Subject|10|||
160974007|NCT00235443|581295327|FG005|Overall Study|Withdrawal by Subject|12|||
160974008|NCT00235443|581295322|FG000|Overall Study|Lost to Follow-up|0|||
160974009|NCT00235443|581295323|FG001|Overall Study|Lost to Follow-up|8|||
160974010|NCT00235443|581295324|FG002|Overall Study|Lost to Follow-up|6|||
160974011|NCT00235443|581295325|FG003|Overall Study|Lost to Follow-up|6|||
160974012|NCT00235443|581295326|FG004|Overall Study|Lost to Follow-up|4|||
160974013|NCT00235443|581295327|FG005|Overall Study|Lost to Follow-up|3|||
160589971|NCT01982773|579876757|FG001|Overall Study|Withdrawal by Subject|3|||
160589972|NCT01982773|579876756|FG000|Overall Study|Lost to Follow-up|7|||
160589973|NCT01982773|579876757|FG001|Overall Study|Lost to Follow-up|1|||
160589974|NCT02720016|579876760|FG000|Overall Study|Separation of couple|6|||
160589975|NCT02720016|579876761|FG001|Overall Study|Separation of couple|8|||
160589976|NCT02720016|579876762|FG002|Overall Study|Separation of couple|2|||
160589977|NCT02720016|579876760|FG000|Overall Study|Withdrawal by Subject|6|||
160589978|NCT02720016|579876761|FG001|Overall Study|Withdrawal by Subject|6|||
160589979|NCT02720016|579876762|FG002|Overall Study|Withdrawal by Subject|4|||
160589980|NCT02720016|579876760|FG000|Overall Study|Scheduling issues|2|||
160589981|NCT02720016|579876761|FG001|Overall Study|Scheduling issues|4|||
160589982|NCT02720016|579876762|FG002|Overall Study|Scheduling issues|7|||
160589983|NCT02720016|579876760|FG000|Overall Study|Childcare|2|||
160589984|NCT02720016|579876761|FG001|Overall Study|Childcare|0|||
160589985|NCT02720016|579876762|FG002|Overall Study|Childcare|2|||
160589986|NCT02720016|579876760|FG000|Overall Study|Withdrawal by PI|2|||
160589987|NCT02720016|579876761|FG001|Overall Study|Withdrawal by PI|2|||
160589988|NCT02720016|579876762|FG002|Overall Study|Withdrawal by PI|0|||
160589989|NCT02720016|579876760|FG000|Overall Study|Moved away|2|||
160589990|NCT02720016|579876761|FG001|Overall Study|Moved away|0|||
160589991|NCT02720016|579876762|FG002|Overall Study|Moved away|0|||
160589992|NCT02720016|579876760|FG000|Overall Study|Not Primary Health Concern|0|||
160974014|NCT00235443|581295322|FG000|Overall Study|Unsatisfactory compliance|0|||
160589993|NCT02720016|579876761|FG001|Overall Study|Not Primary Health Concern|0|||
160589994|NCT02720016|579876762|FG002|Overall Study|Not Primary Health Concern|2|||
160589995|NCT02720016|579876760|FG000|Overall Study|Transportation issues|0|||
160589996|NCT02720016|579876761|FG001|Overall Study|Transportation issues|0|||
160589997|NCT02720016|579876762|FG002|Overall Study|Transportation issues|1|||
160589998|NCT02720016|579876760|FG000|Overall Study|Other|0|||
160589999|NCT02720016|579876761|FG001|Overall Study|Other|0|||
160590000|NCT02720016|579876762|FG002|Overall Study|Other|2|||
160590001|NCT02121756|579876764|FG000|Overall Study|Adverse Event|3|||
160590002|NCT02121756|579876765|FG001|Overall Study|Adverse Event|0|||
160590003|NCT02121756|579876764|FG000|Overall Study|Protocol Violation|1|||
160590004|NCT02121756|579876765|FG001|Overall Study|Protocol Violation|1|||
160657544|NCT03830164|580127580|FG000|Overall Study|Adverse Event|0|||
160974015|NCT00235443|581295323|FG001|Overall Study|Unsatisfactory compliance|2|||
160974016|NCT00235443|581295324|FG002|Overall Study|Unsatisfactory compliance|3|||
160974017|NCT00235443|581295325|FG003|Overall Study|Unsatisfactory compliance|4|||
160974018|NCT00235443|581295326|FG004|Overall Study|Unsatisfactory compliance|1|||
160974019|NCT00235443|581295327|FG005|Overall Study|Unsatisfactory compliance|0|||
160974020|NCT00235443|581295322|FG000|Overall Study|Other reasons for premature termination|1|||
160974021|NCT00235443|581295323|FG001|Overall Study|Other reasons for premature termination|6|||
160974022|NCT00235443|581295324|FG002|Overall Study|Other reasons for premature termination|6|||
160974023|NCT00235443|581295325|FG003|Overall Study|Other reasons for premature termination|7|||
160974024|NCT00235443|581295326|FG004|Overall Study|Other reasons for premature termination|3|||
160974025|NCT00235443|581295327|FG005|Overall Study|Other reasons for premature termination|6|||
160974026|NCT00474929|581295331|FG000|Overall Study|Withdrawal by Subject|0|||
160974027|NCT00474929|581295332|FG001|Overall Study|Withdrawal by Subject|1|||
160974028|NCT00474929|581295333|FG002|Overall Study|Withdrawal by Subject|0|||
160974029|NCT00474929|581295334|FG003|Overall Study|Withdrawal by Subject|0|||
160974030|NCT00474929|581295335|FG004|Overall Study|Withdrawal by Subject|0|||
160974031|NCT00474929|581295331|FG000|Overall Study|Unrelated medical condition|0|||
160974032|NCT00474929|581295332|FG001|Overall Study|Unrelated medical condition|0|||
160974033|NCT00474929|581295333|FG002|Overall Study|Unrelated medical condition|1|||
160974034|NCT00474929|581295334|FG003|Overall Study|Unrelated medical condition|0|||
160974035|NCT00474929|581295335|FG004|Overall Study|Unrelated medical condition|0|||
160974036|NCT00474929|581295331|FG000|Overall Study|Physician Decision|0|||
160974037|NCT00474929|581295332|FG001|Overall Study|Physician Decision|0|||
160974038|NCT00474929|581295333|FG002|Overall Study|Physician Decision|1|||
160974039|NCT00474929|581295334|FG003|Overall Study|Physician Decision|2|||
160974040|NCT00474929|581295335|FG004|Overall Study|Physician Decision|0|||
160974041|NCT03029247|581295338|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
160974042|NCT03029247|581295339|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
160974043|NCT03029247|581295338|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
160974044|NCT03029247|581295339|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
160974045|NCT03029247|581295338|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
160974046|NCT03029247|581295339|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
160974047|NCT03029247|581295338|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
160974048|NCT03029247|581295339|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
160974049|NCT02593305|581295340|FG000|Post 1|Comparison only group. No intervention.|0|||
160974050|NCT02593305|581295341|FG001|Post 1|Comparison only group. No intervention.|0|||
160974051|NCT02593305|581295342|FG002|Post 1|Comparison only group. No intervention.|10|||
160974052|NCT02757521|581295343|FG000|Overall Study|Adverse Event|1|||
160590005|NCT02121756|579876764|FG000|Overall Study|Physician Decision|2|||
160974053|NCT02757521|581295344|FG001|Overall Study|Adverse Event|0|||
160974054|NCT00999661|581295349|FG000|Overall Study|Lost to Follow-up|59|||
160974055|NCT00999661|581295349|FG000|Overall Study|Adverse Event|1|||
160974056|NCT00999661|581295349|FG000|Overall Study|Withdrawal by Subject|1|||
160974057|NCT00999661|581295349|FG000|Overall Study|Not meeting eligibility criteria|9|||
160974058|NCT00312858|581295350|FG000|Overall Study|Adverse Event|0|||
160974059|NCT00312858|581295351|FG001|Overall Study|Adverse Event|1|||
160974060|NCT00312858|581295350|FG000|Overall Study|Lost to Follow-up|25|||
160974061|NCT00312858|581295351|FG001|Overall Study|Lost to Follow-up|42|||
160974062|NCT00312858|581295350|FG000|Overall Study|Protocol Violation|3|||
160974063|NCT00312858|581295351|FG001|Overall Study|Protocol Violation|8|||
160974064|NCT00312858|581295350|FG000|Overall Study|Withdraw by Participant|20|||
160974065|NCT00312858|581295351|FG001|Overall Study|Withdraw by Participant|20|||
160974066|NCT00312858|581295350|FG000|Overall Study|Participant Moved|11|||
160974067|NCT00312858|581295351|FG001|Overall Study|Participant Moved|10|||
160974068|NCT00312858|581295350|FG000|Overall Study|Other|9|||
160974069|NCT00312858|581295351|FG001|Overall Study|Other|12|||
160974070|NCT01622348|581295356|FG000|Overall Study|Withdrawal by Subject|1|||
160974071|NCT01622348|581295357|FG001|Overall Study|Withdrawal by Subject|0|||
160974072|NCT01622348|581295358|FG002|Overall Study|Withdrawal by Subject|1|||
160974073|NCT00422799|581295359|FG000|Overall Study|Withdrawal by Subject|6|||
160974074|NCT00422799|581295359|FG000|Overall Study|Adverse Event|7|||
160974075|NCT01965158|581295360|FG000|Overall Study|Adverse Event|14|||
160974076|NCT01965158|581295361|FG001|Overall Study|Adverse Event|5|||
160974077|NCT01965158|581295360|FG000|Overall Study|Withdrawal by Subject|16|||
160974078|NCT01965158|581295361|FG001|Overall Study|Withdrawal by Subject|24|||
160974079|NCT01965158|581295360|FG000|Overall Study|Lost to Follow-up|7|||
160974080|NCT01965158|581295361|FG001|Overall Study|Lost to Follow-up|5|||
160974081|NCT01965158|581295360|FG000|Overall Study|Protocol Violation|1|||
160974082|NCT01965158|581295361|FG001|Overall Study|Protocol Violation|1|||
160974083|NCT01965158|581295360|FG000|Overall Study|Other - Miscellaneous|3|||
160974084|NCT01965158|581295361|FG001|Overall Study|Other - Miscellaneous|0|||
160974085|NCT04537897|581295362|FG000|Overall Study|Other than listed|0|||
160974086|NCT04537897|581295363|FG001|Overall Study|Other than listed|0|||
160974087|NCT04537897|581295364|FG002|Overall Study|Other than listed|0|||
160974088|NCT04537897|581295365|FG003|Overall Study|Other than listed|0|||
160974089|NCT04537897|581295366|FG004|Overall Study|Other than listed|0|||
160974090|NCT04537897|581295367|FG005|Overall Study|Other than listed|0|||
160974091|NCT04537897|581295368|FG006|Overall Study|Other than listed|1|||
160974092|NCT04537897|581295369|FG007|Overall Study|Other than listed|0|||
160974093|NCT04537897|581295370|FG008|Overall Study|Other than listed|0|||
160974094|NCT04537897|581295362|FG000|Overall Study|Adverse Event|0|||
160974095|NCT04537897|581295363|FG001|Overall Study|Adverse Event|0|||
160974096|NCT04537897|581295364|FG002|Overall Study|Adverse Event|0|||
160974097|NCT04537897|581295365|FG003|Overall Study|Adverse Event|1|||
160974098|NCT04537897|581295366|FG004|Overall Study|Adverse Event|0|||
160974099|NCT04537897|581295367|FG005|Overall Study|Adverse Event|0|||
160974100|NCT04537897|581295368|FG006|Overall Study|Adverse Event|0|||
160974101|NCT04537897|581295369|FG007|Overall Study|Adverse Event|0|||
160974102|NCT04537897|581295370|FG008|Overall Study|Adverse Event|0|||
160974103|NCT04537897|581295362|FG000|Overall Study|Withdrawal by Subject|0|||
160590006|NCT02121756|579876765|FG001|Overall Study|Physician Decision|1|||
160974104|NCT04537897|581295363|FG001|Overall Study|Withdrawal by Subject|1|||
160974105|NCT04537897|581295364|FG002|Overall Study|Withdrawal by Subject|0|||
160657545|NCT03830164|580127581|FG001|Overall Study|Adverse Event|2|||
160657546|NCT03830164|580127582|FG002|Overall Study|Adverse Event|0|||
160590007|NCT05319080|579876766|FG000|Overall Study|Withdrawal by Subject|2|||
160590008|NCT05319080|579876766|FG000|Overall Study|Physician Decision|4|||
160590009|NCT00751114|579876767|FG000|Overall Study|Adverse Event|2|||
160590010|NCT00751114|579876768|FG001|Overall Study|Adverse Event|4|||
160590011|NCT00751114|579876767|FG000|Overall Study|Protocol Violation|8|||
160590012|NCT00751114|579876768|FG001|Overall Study|Protocol Violation|9|||
160590013|NCT00751114|579876767|FG000|Overall Study|Withdrawal by Subject|9|||
160590014|NCT00751114|579876768|FG001|Overall Study|Withdrawal by Subject|4|||
160590015|NCT00751114|579876767|FG000|Overall Study|Lost to Follow-up|4|||
160974106|NCT04537897|581295365|FG003|Overall Study|Withdrawal by Subject|0|||
160974107|NCT04537897|581295366|FG004|Overall Study|Withdrawal by Subject|0|||
160974108|NCT04537897|581295367|FG005|Overall Study|Withdrawal by Subject|0|||
160974109|NCT04537897|581295368|FG006|Overall Study|Withdrawal by Subject|0|||
160974110|NCT04537897|581295369|FG007|Overall Study|Withdrawal by Subject|0|||
160974111|NCT04537897|581295370|FG008|Overall Study|Withdrawal by Subject|0|||
160974112|NCT00197028|581295374|FG000|Overall Study|Adverse Event|2|||
160974113|NCT00197028|581295375|FG001|Overall Study|Adverse Event|2|||
160974114|NCT00197028|581295374|FG000|Overall Study|Protocol Violation|2|||
160974115|NCT00197028|581295375|FG001|Overall Study|Protocol Violation|1|||
160974116|NCT00197028|581295374|FG000|Overall Study|Withdrawal by Subject|8|||
160974117|NCT00197028|581295375|FG001|Overall Study|Withdrawal by Subject|12|||
160974118|NCT00197028|581295374|FG000|Overall Study|Lost to Follow-up|1|||
160974119|NCT00197028|581295375|FG001|Overall Study|Lost to Follow-up|0|||
160974120|NCT00197028|581295374|FG000|Overall Study|Other|3|||
160974121|NCT00197028|581295375|FG001|Overall Study|Other|6|||
160974122|NCT03893825|581295376|FG000|Overall Study|Death|2|||
160974123|NCT03893825|581295377|FG001|Overall Study|Death|1|||
160974124|NCT03893825|581295376|FG000|Overall Study|Adverse Event|0|||
160974125|NCT03893825|581295377|FG001|Overall Study|Adverse Event|2|||
160974126|NCT03893825|581295376|FG000|Overall Study|Withdrawal by Subject|19|||
160974127|NCT03893825|581295377|FG001|Overall Study|Withdrawal by Subject|21|||
160974128|NCT03893825|581295376|FG000|Overall Study|Protocol deviation|1|||
160974129|NCT03893825|581295377|FG001|Overall Study|Protocol deviation|0|||
160974130|NCT03893825|581295376|FG000|Overall Study|Lost to Follow-up|10|||
160974131|NCT03893825|581295377|FG001|Overall Study|Lost to Follow-up|10|||
160974132|NCT03893825|581295376|FG000|Overall Study|Other than specified|7|||
160974133|NCT03893825|581295377|FG001|Overall Study|Other than specified|6|||
160974134|NCT00692406|581295378|FG000|Overall Study|PI dropped, bad data|57|||
160974135|NCT01617005|581295379|FG000|Overall Study|Pregnancy|1|||
160974136|NCT01617005|581295379|FG000|Overall Study|Lack of motivation for treatment|1|||
160974137|NCT01515189|581295380|FG000|Induction|Disease Progression|109|||
160974138|NCT01515189|581295381|FG001|Induction|Disease Progression|155|||
160974139|NCT01515189|581295380|FG000|Induction|Study drug toxicity|86|||
160974140|NCT01515189|581295381|FG001|Induction|Study drug toxicity|36|||
160974141|NCT01515189|581295380|FG000|Induction|Death|24|||
160974142|NCT01515189|581295381|FG001|Induction|Death|17|||
160974143|NCT01515189|581295380|FG000|Induction|Adverse Event|14|||
160974144|NCT01515189|581295381|FG001|Induction|Adverse Event|9|||
160974145|NCT01515189|581295380|FG000|Induction|Withdrawal by Subject|3|||
160974146|NCT01515189|581295381|FG001|Induction|Withdrawal by Subject|9|||
160974147|NCT01515189|581295380|FG000|Induction|No longer meets study criteria|0|||
160974148|NCT01515189|581295381|FG001|Induction|No longer meets study criteria|2|||
160974149|NCT01515189|581295380|FG000|Induction|Lost to Follow-up|1|||
160974150|NCT01515189|581295381|FG001|Induction|Lost to Follow-up|0|||
160974151|NCT01515189|581295380|FG000|Induction|Other|0|||
160974152|NCT01515189|581295381|FG001|Induction|Other|4|||
160974153|NCT01515189|581295380|FG000|First Re-Induction Phase|Disease progression|6|||
160974154|NCT01515189|581295381|FG001|First Re-Induction Phase|Disease progression|14|||
160974155|NCT01515189|581295380|FG000|First Re-Induction Phase|Study drug toxicity|5|||
160974156|NCT01515189|581295381|FG001|First Re-Induction Phase|Study drug toxicity|0|||
160974157|NCT01515189|581295380|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
160974158|NCT01515189|581295381|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
160974159|NCT01515189|581295380|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
160974160|NCT01515189|581295381|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
160974161|NCT01515189|581295380|FG000|First Re-Induction Phase|Other|1|||
160974162|NCT01515189|581295381|FG001|First Re-Induction Phase|Other|0|||
160974163|NCT00284089|581295384|FG000|Multiple Dose Phase|Adverse Event|1|||
160974164|NCT00284089|581295385|FG001|Multiple Dose Phase|Adverse Event|0|||
160974165|NCT00284089|581295386|FG002|Multiple Dose Phase|Adverse Event|1|||
160974166|NCT00284089|581295387|FG003|Multiple Dose Phase|Adverse Event|1|||
160974167|NCT00284089|581295384|FG000|Multiple Dose Phase|Protocol Violation|0|||
160974168|NCT00284089|581295385|FG001|Multiple Dose Phase|Protocol Violation|0|||
160974169|NCT00284089|581295386|FG002|Multiple Dose Phase|Protocol Violation|1|||
160974170|NCT00284089|581295387|FG003|Multiple Dose Phase|Protocol Violation|0|||
160974171|NCT00284089|581295384|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
160974172|NCT00284089|581295385|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
160974173|NCT00284089|581295386|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
160974174|NCT00284089|581295387|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
160974175|NCT00284089|581295384|FG000|Multiple Dose Phase|Death|0|||
160974176|NCT00284089|581295385|FG001|Multiple Dose Phase|Death|0|||
160974177|NCT00284089|581295386|FG002|Multiple Dose Phase|Death|1|||
160974178|NCT00284089|581295387|FG003|Multiple Dose Phase|Death|1|||
160974179|NCT00284089|581295384|FG000|Extension Phase|Adverse Event|0|||
160974180|NCT00284089|581295385|FG001|Extension Phase|Adverse Event|0|||
160974181|NCT00284089|581295386|FG002|Extension Phase|Adverse Event|2|||
160974182|NCT00284089|581295387|FG003|Extension Phase|Adverse Event|2|||
160974183|NCT00284089|581295384|FG000|Extension Phase|condition no longer requires study drug|2|||
160657547|NCT03830164|580127580|FG000|Overall Study|Lack of Efficacy|1|||
160657548|NCT03830164|580127581|FG001|Overall Study|Lack of Efficacy|5|||
160657549|NCT03830164|580127582|FG002|Overall Study|Lack of Efficacy|0|||
160657550|NCT03830164|580127580|FG000|Overall Study|Lost to Follow-up|0|||
160657551|NCT03830164|580127581|FG001|Overall Study|Lost to Follow-up|1|||
160657552|NCT03830164|580127582|FG002|Overall Study|Lost to Follow-up|0|||
160657553|NCT03830164|580127580|FG000|Overall Study|Withdrawal by Subject|1|||
160657554|NCT03830164|580127581|FG001|Overall Study|Withdrawal by Subject|0|||
160657555|NCT03830164|580127582|FG002|Overall Study|Withdrawal by Subject|0|||
160657556|NCT04099888|580127583|FG000|Overall Study|Study terminated by sponsor|9|||
160657557|NCT04099888|580127584|FG001|Overall Study|Study terminated by sponsor|11|||
160657558|NCT04099888|580127583|FG000|Overall Study|Lost to Follow-up|1|||
160657559|NCT04099888|580127584|FG001|Overall Study|Lost to Follow-up|1|||
160657560|NCT04099888|580127583|FG000|Overall Study|Withdrawal by Subject|5|||
160657561|NCT04099888|580127584|FG001|Overall Study|Withdrawal by Subject|6|||
160657562|NCT04099888|580127583|FG000|Overall Study|Death|5|||
160657563|NCT04099888|580127584|FG001|Overall Study|Death|2|||
160657564|NCT04099888|580127583|FG000|Overall Study|Other|1|||
160657565|NCT04099888|580127584|FG001|Overall Study|Other|0|||
160657566|NCT02731157|580127586|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
160657567|NCT00497796|580127590|FG000|Overall Study|Adverse event (not related)|9|||
160657568|NCT00497796|580127591|FG001|Overall Study|Adverse event (not related)|9|||
160657569|NCT00497796|580127590|FG000|Overall Study|Adverse event (related)|5|||
160657570|NCT00497796|580127591|FG001|Overall Study|Adverse event (related)|4|||
160657571|NCT00497796|580127590|FG000|Overall Study|CMV infection or disease treatment|30|||
160657572|NCT00497796|580127591|FG001|Overall Study|CMV infection or disease treatment|4|||
160657573|NCT00497796|580127590|FG000|Overall Study|Consent withdrawn|10|||
160657574|NCT00497796|580127591|FG001|Overall Study|Consent withdrawn|3|||
160657575|NCT00497796|580127590|FG000|Overall Study|Investigator/sponsor discretion|31|||
160657576|NCT00497796|580127591|FG001|Overall Study|Investigator/sponsor discretion|34|||
160657577|NCT00497796|580127590|FG000|Overall Study|Lost to Follow-up|0|||
160657578|NCT00497796|580127591|FG001|Overall Study|Lost to Follow-up|1|||
160657579|NCT00497796|580127590|FG000|Overall Study|Not applicable (randomized not treated)|0|||
160657580|NCT00497796|580127591|FG001|Overall Study|Not applicable (randomized not treated)|4|||
160657581|NCT02732210|580127592|FG000|Overall Study|Site Closed|0|||
160657582|NCT02732210|580127593|FG001|Overall Study|Site Closed|11|||
160657583|NCT02732210|580127592|FG000|Overall Study|Study Ended|13|||
160657584|NCT02732210|580127593|FG001|Overall Study|Study Ended|13|||
160657585|NCT02732210|580127592|FG000|Overall Study|Withdrawal by Subject|28|||
160657586|NCT02732210|580127593|FG001|Overall Study|Withdrawal by Subject|87|||
160657587|NCT02732210|580127592|FG000|Overall Study|Lost to Follow-up|5|||
160657588|NCT02732210|580127593|FG001|Overall Study|Lost to Follow-up|57|||
160657589|NCT02732210|580127592|FG000|Overall Study|Death|4|||
160657590|NCT02732210|580127593|FG001|Overall Study|Death|15|||
160657591|NCT02732210|580127592|FG000|Overall Study|Other|35|||
160657592|NCT02732210|580127593|FG001|Overall Study|Other|103|||
160657593|NCT02732210|580127592|FG000|Overall Study|Missing|0|||
160657594|NCT02732210|580127593|FG001|Overall Study|Missing|8|||
160657595|NCT03561883|580127595|FG000|Overall Study|Adverse Event|10|||
160657596|NCT03561883|580127596|FG001|Overall Study|Adverse Event|13|||
160657597|NCT03561883|580127595|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160657598|NCT03561883|580127596|FG001|Overall Study|Non-Compliance With Study Drug|2|||
160657599|NCT03561883|580127595|FG000|Overall Study|Protocol Violation|2|||
160657600|NCT03561883|580127596|FG001|Overall Study|Protocol Violation|3|||
160657601|NCT03561883|580127595|FG000|Overall Study|Withdrawal by Subject|14|||
160657602|NCT03561883|580127596|FG001|Overall Study|Withdrawal by Subject|6|||
160657603|NCT03561883|580127595|FG000|Overall Study|Lost to Follow-up|2|||
160657604|NCT03561883|580127596|FG001|Overall Study|Lost to Follow-up|6|||
160657605|NCT03561883|580127595|FG000|Overall Study|Study Terminated by Sponsor|12|||
160657606|NCT03561883|580127596|FG001|Overall Study|Study Terminated by Sponsor|11|||
160657607|NCT03561883|580127595|FG000|Overall Study|Physician Decision|1|||
160657608|NCT03561883|580127596|FG001|Overall Study|Physician Decision|0|||
160657609|NCT03561883|580127595|FG000|Overall Study|Randomized by Mistake|1|||
160657610|NCT03561883|580127596|FG001|Overall Study|Randomized by Mistake|0|||
160657611|NCT03561883|580127595|FG000|Overall Study|Other, Not Specified|3|||
160657612|NCT03561883|580127596|FG001|Overall Study|Other, Not Specified|2|||
160657613|NCT02603952|580127606|FG000|Overall Study|Withdrawal by Subject|1|||
160657614|NCT02603952|580127607|FG001|Overall Study|Withdrawal by Subject|0|||
160657615|NCT02603952|580127608|FG002|Overall Study|Withdrawal by Subject|0|||
160657616|NCT02603952|580127609|FG003|Overall Study|Withdrawal by Subject|0|||
160657617|NCT02603952|580127606|FG000|Overall Study|Received oseltamivir by error|0|||
160657618|NCT02603952|580127607|FG001|Overall Study|Received oseltamivir by error|0|||
160590016|NCT00751114|579876768|FG001|Overall Study|Lost to Follow-up|7|||
160590017|NCT00751114|579876767|FG000|Overall Study|Lack of Efficacy|0|||
160590018|NCT00751114|579876768|FG001|Overall Study|Lack of Efficacy|7|||
160590019|NCT00751114|579876767|FG000|Overall Study|Not Treated|13|||
160590020|NCT00751114|579876768|FG001|Overall Study|Not Treated|1|||
160590021|NCT00751114|579876767|FG000|Overall Study|Out of country for 2 months|1|||
160590022|NCT00751114|579876768|FG001|Overall Study|Out of country for 2 months|0|||
160590023|NCT00751114|579876767|FG000|Overall Study|Move to another city|1|||
160590024|NCT00751114|579876768|FG001|Overall Study|Move to another city|0|||
160657619|NCT02603952|580127608|FG002|Overall Study|Received oseltamivir by error|0|||
160657620|NCT02603952|580127609|FG003|Overall Study|Received oseltamivir by error|1|||
160657621|NCT00958243|580127613|FG000|Overall Study|Withdrawal by Subject|0|||
160657622|NCT00958243|580127614|FG001|Overall Study|Withdrawal by Subject|1|||
160657623|NCT00958243|580127615|FG002|Overall Study|Withdrawal by Subject|3|||
160657624|NCT00958243|580127616|FG003|Overall Study|Withdrawal by Subject|1|||
160590025|NCT00448916|579876769|FG000|Overall Study|Adverse Event|2|||
160974184|NCT00284089|581295385|FG001|Extension Phase|condition no longer requires study drug|0|||
160974185|NCT00284089|581295386|FG002|Extension Phase|condition no longer requires study drug|2|||
160974186|NCT00284089|581295387|FG003|Extension Phase|condition no longer requires study drug|7|||
160974187|NCT00284089|581295384|FG000|Extension Phase|Protocol Violation|0|||
160974188|NCT00284089|581295385|FG001|Extension Phase|Protocol Violation|0|||
160974189|NCT00284089|581295386|FG002|Extension Phase|Protocol Violation|1|||
160974190|NCT00284089|581295387|FG003|Extension Phase|Protocol Violation|0|||
160974191|NCT00284089|581295384|FG000|Extension Phase|Withdrawal by Subject|0|||
160974192|NCT00284089|581295385|FG001|Extension Phase|Withdrawal by Subject|0|||
160974193|NCT00284089|581295386|FG002|Extension Phase|Withdrawal by Subject|1|||
160974194|NCT00284089|581295387|FG003|Extension Phase|Withdrawal by Subject|3|||
160974195|NCT02541383|581295388|FG000|Overall Study|Death|50|||
160974196|NCT02541383|581295389|FG001|Overall Study|Death|37|||
160974197|NCT02541383|581295390|FG002|Overall Study|Death|48|||
160974198|NCT02541383|581295391|FG003|Overall Study|Death|41|||
160974199|NCT02541383|581295392|FG004|Overall Study|Death|21|||
160974200|NCT02541383|581295393|FG005|Overall Study|Death|25|||
160974201|NCT02541383|581295388|FG000|Overall Study|Lost to Follow-up|5|||
160974202|NCT02541383|581295389|FG001|Overall Study|Lost to Follow-up|3|||
160974203|NCT02541383|581295390|FG002|Overall Study|Lost to Follow-up|1|||
160974204|NCT02541383|581295391|FG003|Overall Study|Lost to Follow-up|1|||
160974205|NCT02541383|581295392|FG004|Overall Study|Lost to Follow-up|3|||
160974206|NCT02541383|581295393|FG005|Overall Study|Lost to Follow-up|0|||
160974207|NCT02541383|581295388|FG000|Overall Study|Consent withdrawn|5|||
160974208|NCT02541383|581295389|FG001|Overall Study|Consent withdrawn|6|||
160974209|NCT02541383|581295390|FG002|Overall Study|Consent withdrawn|1|||
160974210|NCT02541383|581295391|FG003|Overall Study|Consent withdrawn|1|||
160974211|NCT02541383|581295392|FG004|Overall Study|Consent withdrawn|0|||
160974212|NCT02541383|581295393|FG005|Overall Study|Consent withdrawn|0|||
160974213|NCT02541383|581295388|FG000|Overall Study|Sponsor's decision|1|||
160974214|NCT02541383|581295389|FG001|Overall Study|Sponsor's decision|1|||
160974215|NCT02541383|581295390|FG002|Overall Study|Sponsor's decision|0|||
160974216|NCT02541383|581295391|FG003|Overall Study|Sponsor's decision|0|||
160974217|NCT02541383|581295392|FG004|Overall Study|Sponsor's decision|0|||
160974218|NCT02541383|581295393|FG005|Overall Study|Sponsor's decision|0|||
160974219|NCT05796518|581295394|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
160974220|NCT00594217|581295395|FG000|Overall Study|Withdrawal by Subject|1|||
160974221|NCT00594217|581295396|FG001|Overall Study|Withdrawal by Subject|3|||
160974222|NCT04186403|581295397|FG000|Overall Study|Adverse Event|1|||
160974223|NCT04186403|581295398|FG001|Overall Study|Adverse Event|8|||
160974224|NCT04186403|581295397|FG000|Overall Study|Lost to Follow-up|7|||
160974225|NCT04186403|581295398|FG001|Overall Study|Lost to Follow-up|3|||
160974226|NCT04186403|581295397|FG000|Overall Study|Physician Decision|1|||
160974227|NCT04186403|581295398|FG001|Overall Study|Physician Decision|0|||
160974228|NCT04186403|581295397|FG000|Overall Study|Withdrawal by Subject|7|||
160974229|NCT04186403|581295398|FG001|Overall Study|Withdrawal by Subject|8|||
160974230|NCT04186403|581295397|FG000|Overall Study|Other: Not Related to Covid-19|3|||
160974231|NCT04186403|581295398|FG001|Overall Study|Other: Not Related to Covid-19|0|||
160974232|NCT01407354|581295403|FG000|First Intervention|Withdrawal by Subject|0|||
160974233|NCT01407354|581295404|FG001|First Intervention|Withdrawal by Subject|2|||
160974234|NCT01407354|581295403|FG000|First Intervention|Adverse Event|1|||
160974235|NCT01407354|581295404|FG001|First Intervention|Adverse Event|0|||
160974236|NCT01407354|581295403|FG000|First Intervention|Physician Decision|1|||
160974237|NCT01407354|581295404|FG001|First Intervention|Physician Decision|0|||
160974238|NCT01036022|581295405|FG000|Overall Study|Adverse Event|1|||
160974239|NCT01036022|581295406|FG001|Overall Study|Adverse Event|3|||
160974240|NCT01036022|581295407|FG002|Overall Study|Adverse Event|2|||
160974241|NCT01036022|581295408|FG003|Overall Study|Adverse Event|1|||
160974242|NCT01036022|581295409|FG004|Overall Study|Adverse Event|0|||
160974243|NCT01036022|581295410|FG005|Overall Study|Adverse Event|2|||
160974244|NCT01036022|581295405|FG000|Overall Study|Lack of Efficacy|1|||
160974245|NCT01036022|581295406|FG001|Overall Study|Lack of Efficacy|1|||
160974246|NCT01036022|581295407|FG002|Overall Study|Lack of Efficacy|1|||
160974247|NCT01036022|581295408|FG003|Overall Study|Lack of Efficacy|0|||
160974248|NCT01036022|581295409|FG004|Overall Study|Lack of Efficacy|1|||
160974249|NCT01036022|581295410|FG005|Overall Study|Lack of Efficacy|1|||
160974250|NCT01036022|581295405|FG000|Overall Study|Physician Decision|0|||
160974251|NCT01036022|581295406|FG001|Overall Study|Physician Decision|0|||
160974252|NCT01036022|581295407|FG002|Overall Study|Physician Decision|1|||
160974253|NCT01036022|581295408|FG003|Overall Study|Physician Decision|0|||
160974254|NCT01036022|581295409|FG004|Overall Study|Physician Decision|0|||
160974255|NCT01036022|581295410|FG005|Overall Study|Physician Decision|0|||
160974256|NCT01036022|581295405|FG000|Overall Study|Withdrawal by Subject|0|||
160974257|NCT01036022|581295406|FG001|Overall Study|Withdrawal by Subject|0|||
160974258|NCT01036022|581295407|FG002|Overall Study|Withdrawal by Subject|0|||
160974259|NCT01036022|581295408|FG003|Overall Study|Withdrawal by Subject|1|||
160974260|NCT01036022|581295409|FG004|Overall Study|Withdrawal by Subject|2|||
160974261|NCT01036022|581295410|FG005|Overall Study|Withdrawal by Subject|0|||
160657625|NCT00958243|580127617|FG004|Overall Study|Withdrawal by Subject|1|||
160657626|NCT00958243|580127618|FG005|Overall Study|Withdrawal by Subject|5|||
160657627|NCT00958243|580127613|FG000|Overall Study|Lost to Follow-up|2|||
160657628|NCT00958243|580127614|FG001|Overall Study|Lost to Follow-up|5|||
160657629|NCT00958243|580127615|FG002|Overall Study|Lost to Follow-up|11|||
160657630|NCT00958243|580127616|FG003|Overall Study|Lost to Follow-up|2|||
160657631|NCT00958243|580127617|FG004|Overall Study|Lost to Follow-up|8|||
160657632|NCT00958243|580127618|FG005|Overall Study|Lost to Follow-up|5|||
160657633|NCT04646109|580127619|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
160657634|NCT04646109|580127620|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
160657635|NCT06176768|580127621|FG000|Overall Study|Adverse Event|1|||
160657636|NCT06176768|580127622|FG001|Overall Study|Adverse Event|0|||
160657637|NCT06176768|580127621|FG000|Overall Study|Assigned treatment by mistake|1|||
160657638|NCT06176768|580127622|FG001|Overall Study|Assigned treatment by mistake|0|||
160657639|NCT06176768|580127621|FG000|Overall Study|Lost to Follow-up|0|||
160657640|NCT06176768|580127622|FG001|Overall Study|Lost to Follow-up|3|||
160657641|NCT06176768|580127621|FG000|Overall Study|Physician Decision|1|||
160657642|NCT06176768|580127622|FG001|Overall Study|Physician Decision|0|||
160657643|NCT06176768|580127621|FG000|Overall Study|Protocol deviation|3|||
160657644|NCT06176768|580127622|FG001|Overall Study|Protocol deviation|1|||
160657645|NCT06176768|580127621|FG000|Overall Study|Other|1|||
160657646|NCT06176768|580127622|FG001|Overall Study|Other|0|||
160657647|NCT06176768|580127621|FG000|Overall Study|Withdrawal by Subject|6|||
160657648|NCT06176768|580127622|FG001|Overall Study|Withdrawal by Subject|9|||
160657649|NCT02672553|580127628|FG000|Overall Study|Death|3|||
160657650|NCT02672553|580127629|FG001|Overall Study|Death|5|||
160657651|NCT02672553|580127628|FG000|Overall Study|Valve Explant|1|||
160657652|NCT02672553|580127629|FG001|Overall Study|Valve Explant|0|||
160657653|NCT02672553|580127628|FG000|Overall Study|Conversion to Commercial Valve|3|||
160657654|NCT02672553|580127629|FG001|Overall Study|Conversion to Commercial Valve|0|||
160657655|NCT02672553|580127628|FG000|Overall Study|Withdrawal by Subject|3|||
160657656|NCT02672553|580127629|FG001|Overall Study|Withdrawal by Subject|3|||
160657657|NCT02672553|580127628|FG000|Overall Study|Intraoperative screen failure|2|||
160657658|NCT02672553|580127629|FG001|Overall Study|Intraoperative screen failure|0|||
160657659|NCT01606306|580127630|FG000|Overall Study|Lack of Efficacy|2|||
160657660|NCT01606306|580127631|FG001|Overall Study|Lack of Efficacy|1|||
160657661|NCT01606306|580127632|FG002|Overall Study|Lack of Efficacy|4|||
160657662|NCT01606306|580127633|FG003|Overall Study|Lack of Efficacy|4|||
160657663|NCT01606306|580127634|FG004|Overall Study|Lack of Efficacy|1|||
160657664|NCT01606306|580127635|FG005|Overall Study|Lack of Efficacy|2|||
160657665|NCT01606306|580127630|FG000|Overall Study|Adverse Event|1|||
160657666|NCT01606306|580127631|FG001|Overall Study|Adverse Event|0|||
160657667|NCT01606306|580127632|FG002|Overall Study|Adverse Event|1|||
160657668|NCT01606306|580127633|FG003|Overall Study|Adverse Event|1|||
160974262|NCT04534114|581295412|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
160974263|NCT04534114|581295413|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
160974264|NCT04534114|581295414|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
160974265|NCT04534114|581295415|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
160974266|NCT04534114|581295412|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
160974267|NCT04534114|581295413|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
160974268|NCT04534114|581295414|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
160974269|NCT04534114|581295415|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
160974270|NCT04534114|581295412|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
160974271|NCT04534114|581295413|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
160974272|NCT04534114|581295414|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
160974273|NCT04534114|581295415|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
160974274|NCT04534114|581295412|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
160974275|NCT04534114|581295413|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
160974276|NCT04534114|581295414|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
160974277|NCT04534114|581295415|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
160974278|NCT04534114|581295412|FG000|Main Treatment Period|Physician Decision|0|||
160974279|NCT04534114|581295413|FG001|Main Treatment Period|Physician Decision|0|||
160974280|NCT04534114|581295414|FG002|Main Treatment Period|Physician Decision|0|||
160974281|NCT04534114|581295415|FG003|Main Treatment Period|Physician Decision|1|||
160657669|NCT01606306|580127634|FG004|Overall Study|Adverse Event|2|||
160657670|NCT01606306|580127635|FG005|Overall Study|Adverse Event|0|||
160657671|NCT01606306|580127630|FG000|Overall Study|Lost to Follow-up|7|||
160657672|NCT01606306|580127631|FG001|Overall Study|Lost to Follow-up|4|||
160657673|NCT01606306|580127632|FG002|Overall Study|Lost to Follow-up|5|||
160657674|NCT01606306|580127633|FG003|Overall Study|Lost to Follow-up|4|||
160657675|NCT01606306|580127634|FG004|Overall Study|Lost to Follow-up|3|||
160657676|NCT01606306|580127635|FG005|Overall Study|Lost to Follow-up|5|||
160974282|NCT04534114|581295412|FG000|Main Treatment Period|Death|1|||
160974283|NCT04534114|581295413|FG001|Main Treatment Period|Death|0|||
160974284|NCT04534114|581295414|FG002|Main Treatment Period|Death|0|||
160974285|NCT04534114|581295415|FG003|Main Treatment Period|Death|1|||
160974286|NCT04534114|581295412|FG000|Main Treatment Period|Other reason|1|||
160974287|NCT04534114|581295413|FG001|Main Treatment Period|Other reason|1|||
160974288|NCT04534114|581295414|FG002|Main Treatment Period|Other reason|0|||
160974289|NCT04534114|581295415|FG003|Main Treatment Period|Other reason|0|||
160974290|NCT04534114|581295412|FG000|Main Treatment Period|Participant decision|1|||
160974291|NCT04534114|581295413|FG001|Main Treatment Period|Participant decision|3|||
160974292|NCT04534114|581295414|FG002|Main Treatment Period|Participant decision|3|||
160974293|NCT04534114|581295415|FG003|Main Treatment Period|Participant decision|1|||
160974294|NCT04534114|581295412|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
160974295|NCT04534114|581295413|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
160974296|NCT04534114|581295414|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
160974297|NCT04534114|581295415|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
160974298|NCT04534114|581295412|FG000|Main Treatment Period|Adverse Event|4|||
160974299|NCT04534114|581295413|FG001|Main Treatment Period|Adverse Event|2|||
160974300|NCT04534114|581295414|FG002|Main Treatment Period|Adverse Event|1|||
160974301|NCT04534114|581295415|FG003|Main Treatment Period|Adverse Event|2|||
160974302|NCT04534114|581295412|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
160974303|NCT04534114|581295413|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
160974304|NCT04534114|581295414|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
160974305|NCT04534114|581295415|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
160974306|NCT04534114|581295412|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
160974307|NCT04534114|581295413|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
160974308|NCT04534114|581295414|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
160590026|NCT00448916|579876770|FG001|Overall Study|Adverse Event|2|||
160590027|NCT00448916|579876771|FG002|Overall Study|Adverse Event|3|||
160590028|NCT00448916|579876772|FG003|Overall Study|Adverse Event|2|||
160590029|NCT00448916|579876769|FG000|Overall Study|Lack of Efficacy|1|||
160590030|NCT00448916|579876770|FG001|Overall Study|Lack of Efficacy|0|||
160590031|NCT00448916|579876771|FG002|Overall Study|Lack of Efficacy|2|||
160590032|NCT00448916|579876772|FG003|Overall Study|Lack of Efficacy|1|||
160590033|NCT00448916|579876769|FG000|Overall Study|Withdrawal by Subject|3|||
160590034|NCT00448916|579876770|FG001|Overall Study|Withdrawal by Subject|3|||
160590035|NCT00448916|579876771|FG002|Overall Study|Withdrawal by Subject|1|||
160590036|NCT00448916|579876772|FG003|Overall Study|Withdrawal by Subject|1|||
160590037|NCT00448916|579876769|FG000|Overall Study|Other|1|||
160590038|NCT00448916|579876770|FG001|Overall Study|Other|0|||
160590039|NCT00448916|579876771|FG002|Overall Study|Other|0|||
160590040|NCT00448916|579876772|FG003|Overall Study|Other|0|||
160590041|NCT00448916|579876769|FG000|Overall Study|Lost to Follow-up|0|||
160590042|NCT00448916|579876770|FG001|Overall Study|Lost to Follow-up|1|||
160590043|NCT00448916|579876771|FG002|Overall Study|Lost to Follow-up|0|||
160590044|NCT00448916|579876772|FG003|Overall Study|Lost to Follow-up|1|||
160590045|NCT00448916|579876769|FG000|Overall Study|Protocol Violation|0|||
160590046|NCT00448916|579876770|FG001|Overall Study|Protocol Violation|0|||
160590047|NCT00448916|579876771|FG002|Overall Study|Protocol Violation|0|||
160590048|NCT00448916|579876772|FG003|Overall Study|Protocol Violation|1|||
160590049|NCT01185249|579876773|FG000|Overall Study|Patients discharged or change in status|42|||
160590050|NCT02365584|579876774|FG000|Overall Study|Adverse Event|2|||
160590051|NCT02365584|579876775|FG001|Overall Study|Adverse Event|2|||
160590052|NCT02365584|579876774|FG000|Overall Study|Withdrawal by Subject|1|||
160590053|NCT02365584|579876775|FG001|Overall Study|Withdrawal by Subject|0|||
160590054|NCT02365584|579876774|FG000|Overall Study|Disease Progression|9|||
160590055|NCT02365584|579876775|FG001|Overall Study|Disease Progression|12|||
160590056|NCT03521193|579876777|FG000|Overall Study|Withdrawal by Subject|8|||
160590057|NCT03521193|579876778|FG001|Overall Study|Withdrawal by Subject|0|||
160590058|NCT03521193|579876777|FG000|Overall Study|non compliant to ASA treatment|8|||
160590059|NCT03521193|579876778|FG001|Overall Study|non compliant to ASA treatment|0|||
160590060|NCT00064350|579876779|FG000|Induction Treatment|Disease Progression|5|||
160590061|NCT00064350|579876780|FG001|Induction Treatment|Disease Progression|1|||
160590062|NCT00064350|579876781|FG002|Induction Treatment|Disease Progression|110|||
160590063|NCT00064350|579876779|FG000|Induction Treatment|Adverse Event|0|||
160590064|NCT00064350|579876780|FG001|Induction Treatment|Adverse Event|2|||
160590065|NCT00064350|579876781|FG002|Induction Treatment|Adverse Event|49|||
160590066|NCT00064350|579876779|FG000|Induction Treatment|Death|0|||
160590067|NCT00064350|579876780|FG001|Induction Treatment|Death|0|||
160590068|NCT00064350|579876781|FG002|Induction Treatment|Death|9|||
160590069|NCT00064350|579876779|FG000|Induction Treatment|Withdrawal by Subject|0|||
160590070|NCT00064350|579876780|FG001|Induction Treatment|Withdrawal by Subject|0|||
160590071|NCT00064350|579876781|FG002|Induction Treatment|Withdrawal by Subject|21|||
160590072|NCT00064350|579876779|FG000|Induction Treatment|Ineligible or never started treatment|3|||
160590073|NCT00064350|579876780|FG001|Induction Treatment|Ineligible or never started treatment|6|||
160590074|NCT00064350|579876781|FG002|Induction Treatment|Ineligible or never started treatment|34|||
160590075|NCT00064350|579876779|FG000|Induction Treatment|Other|0|||
160590076|NCT00064350|579876780|FG001|Induction Treatment|Other|0|||
160590077|NCT00064350|579876781|FG002|Induction Treatment|Other|13|||
160590078|NCT00064350|579876779|FG000|Randomization|Adverse Event|8|||
160590079|NCT00064350|579876780|FG001|Randomization|Adverse Event|3|||
160590080|NCT00064350|579876781|FG002|Randomization|Adverse Event|0|||
160590081|NCT00064350|579876779|FG000|Randomization|Death|3|||
160590082|NCT00064350|579876780|FG001|Randomization|Death|0|||
160590083|NCT00064350|579876781|FG002|Randomization|Death|0|||
160590084|NCT00064350|579876779|FG000|Randomization|Withdrawal by Subject|1|||
160590085|NCT00064350|579876780|FG001|Randomization|Withdrawal by Subject|0|||
160590086|NCT00064350|579876781|FG002|Randomization|Withdrawal by Subject|0|||
160590087|NCT00064350|579876779|FG000|Randomization|Ineligible or never started treatment|9|||
160590088|NCT00064350|579876780|FG001|Randomization|Ineligible or never started treatment|15|||
160974309|NCT04534114|581295415|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
160974310|NCT04534114|581295412|FG000|Extension Treatment Period|Other reason|0|||
160974311|NCT04534114|581295413|FG001|Extension Treatment Period|Other reason|1|||
160974312|NCT04534114|581295414|FG002|Extension Treatment Period|Other reason|0|||
160974313|NCT04534114|581295415|FG003|Extension Treatment Period|Other reason|0|||
160974314|NCT04534114|581295412|FG000|Extension Treatment Period|Death|0|||
160974315|NCT04534114|581295413|FG001|Extension Treatment Period|Death|0|||
160974316|NCT04534114|581295414|FG002|Extension Treatment Period|Death|1|||
160974317|NCT04534114|581295415|FG003|Extension Treatment Period|Death|2|||
160974318|NCT04534114|581295412|FG000|Extension Treatment Period|Adverse Event|0|||
160974319|NCT04534114|581295413|FG001|Extension Treatment Period|Adverse Event|1|||
160974320|NCT04534114|581295414|FG002|Extension Treatment Period|Adverse Event|0|||
160974321|NCT04534114|581295415|FG003|Extension Treatment Period|Adverse Event|1|||
160974322|NCT04534114|581295412|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
160974323|NCT04534114|581295413|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
160974324|NCT04534114|581295414|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
160974325|NCT04534114|581295415|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
160974326|NCT02759185|581295416|FG000|Stage 1|Adverse Event|0|||
160974327|NCT02759185|581295417|FG001|Stage 1|Adverse Event|1|||
160974328|NCT02759185|581295418|FG002|Stage 1|Adverse Event|3|||
160974329|NCT02759185|581295419|FG003|Stage 1|Adverse Event|0|||
160974330|NCT02759185|581295420|FG004|Stage 1|Adverse Event|0|||
160974331|NCT02759185|581295421|FG005|Stage 1|Adverse Event|0|||
160974332|NCT02759185|581295422|FG006|Stage 1|Adverse Event|0|||
160974333|NCT02759185|581295416|FG000|Stage 1|Withdrawal by Subject|1|||
160974334|NCT02759185|581295417|FG001|Stage 1|Withdrawal by Subject|0|||
160974335|NCT02759185|581295418|FG002|Stage 1|Withdrawal by Subject|0|||
160974336|NCT02759185|581295419|FG003|Stage 1|Withdrawal by Subject|0|||
160974337|NCT02759185|581295420|FG004|Stage 1|Withdrawal by Subject|0|||
160974338|NCT02759185|581295421|FG005|Stage 1|Withdrawal by Subject|0|||
160974339|NCT02759185|581295422|FG006|Stage 1|Withdrawal by Subject|0|||
160974340|NCT02759185|581295416|FG000|Stage 2|Adverse Event|0|||
160974341|NCT02759185|581295417|FG001|Stage 2|Adverse Event|0|||
160974342|NCT02759185|581295418|FG002|Stage 2|Adverse Event|0|||
160974343|NCT02759185|581295419|FG003|Stage 2|Adverse Event|0|||
160974344|NCT02759185|581295420|FG004|Stage 2|Adverse Event|1|||
160974345|NCT02759185|581295421|FG005|Stage 2|Adverse Event|2|||
160974346|NCT02759185|581295422|FG006|Stage 2|Adverse Event|0|||
160974347|NCT02759185|581295416|FG000|Stage 2|Withdrawal by Subject|0|||
160974348|NCT02759185|581295417|FG001|Stage 2|Withdrawal by Subject|0|||
160974349|NCT02759185|581295418|FG002|Stage 2|Withdrawal by Subject|0|||
160974350|NCT02759185|581295419|FG003|Stage 2|Withdrawal by Subject|0|||
160974351|NCT02759185|581295420|FG004|Stage 2|Withdrawal by Subject|1|||
160974352|NCT02759185|581295421|FG005|Stage 2|Withdrawal by Subject|1|||
160974353|NCT02759185|581295422|FG006|Stage 2|Withdrawal by Subject|1|||
160974354|NCT00962247|581295427|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
160974355|NCT00962247|581295427|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
160974356|NCT00886639|581295439|FG000|Overall Study|acute exacerbation|14|||
160974357|NCT00886639|581295439|FG000|Overall Study|non-compliance|2|||
160974358|NCT01871558|581295440|FG000|Overall Study|Other reason|0|||
160974359|NCT01871558|581295441|FG001|Overall Study|Other reason|1|||
160974360|NCT01871558|581295440|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
160974361|NCT01871558|581295441|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
160974362|NCT01871558|581295440|FG000|Overall Study|Withdrawal by Subject|2|||
160974363|NCT01871558|581295441|FG001|Overall Study|Withdrawal by Subject|0|||
160974364|NCT01709305|581295442|FG000|Phase 1|Clinical Adverse Event|80|||
160974365|NCT01709305|581295443|FG001|Phase 1|Clinical Adverse Event|0|||
160974366|NCT01709305|581295444|FG002|Phase 1|Clinical Adverse Event|0|||
160974367|NCT01709305|581295445|FG003|Phase 1|Clinical Adverse Event|0|||
160974368|NCT01709305|581295446|FG004|Phase 1|Clinical Adverse Event|0|||
160974369|NCT01709305|581295442|FG000|Phase 1|Death|2|||
160974370|NCT01709305|581295443|FG001|Phase 1|Death|0|||
160974371|NCT01709305|581295444|FG002|Phase 1|Death|0|||
160974372|NCT01709305|581295445|FG003|Phase 1|Death|0|||
160974373|NCT01709305|581295446|FG004|Phase 1|Death|0|||
160974374|NCT01709305|581295442|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
160974375|NCT01709305|581295443|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
160974376|NCT01709305|581295444|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
160974377|NCT01709305|581295445|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
160974378|NCT01709305|581295446|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
160974379|NCT01709305|581295442|FG000|Phase 1|Laboratory Adverse Event|16|||
160974380|NCT01709305|581295443|FG001|Phase 1|Laboratory Adverse Event|0|||
160974381|NCT01709305|581295444|FG002|Phase 1|Laboratory Adverse Event|0|||
160974382|NCT01709305|581295445|FG003|Phase 1|Laboratory Adverse Event|0|||
160974383|NCT01709305|581295446|FG004|Phase 1|Laboratory Adverse Event|0|||
160974384|NCT01709305|581295442|FG000|Phase 1|Lost to Follow-up|147|||
160974385|NCT01709305|581295443|FG001|Phase 1|Lost to Follow-up|0|||
160974386|NCT01709305|581295444|FG002|Phase 1|Lost to Follow-up|0|||
160974387|NCT01709305|581295445|FG003|Phase 1|Lost to Follow-up|0|||
160974388|NCT01709305|581295446|FG004|Phase 1|Lost to Follow-up|0|||
160974389|NCT01709305|581295442|FG000|Phase 1|Travel, moving, etc.|30|||
160974390|NCT01709305|581295443|FG001|Phase 1|Travel, moving, etc.|0|||
160974391|NCT01709305|581295444|FG002|Phase 1|Travel, moving, etc.|0|||
160974392|NCT01709305|581295445|FG003|Phase 1|Travel, moving, etc.|0|||
160974393|NCT01709305|581295446|FG004|Phase 1|Travel, moving, etc.|0|||
160974394|NCT01709305|581295442|FG000|Phase 1|Physician Decision|13|||
160974395|NCT01709305|581295443|FG001|Phase 1|Physician Decision|0|||
160974396|NCT01709305|581295444|FG002|Phase 1|Physician Decision|0|||
160974397|NCT01709305|581295445|FG003|Phase 1|Physician Decision|0|||
160974398|NCT01709305|581295446|FG004|Phase 1|Physician Decision|0|||
160974399|NCT01709305|581295442|FG000|Phase 1|Protocol Violation|118|||
160974400|NCT01709305|581295443|FG001|Phase 1|Protocol Violation|0|||
160974401|NCT01709305|581295444|FG002|Phase 1|Protocol Violation|0|||
160974402|NCT01709305|581295445|FG003|Phase 1|Protocol Violation|0|||
160974403|NCT01709305|581295446|FG004|Phase 1|Protocol Violation|0|||
160974404|NCT01709305|581295442|FG000|Phase 1|Withdrawal by Subject|218|||
160974405|NCT01709305|581295443|FG001|Phase 1|Withdrawal by Subject|0|||
160974406|NCT01709305|581295444|FG002|Phase 1|Withdrawal by Subject|0|||
160974407|NCT01709305|581295445|FG003|Phase 1|Withdrawal by Subject|0|||
160974408|NCT01709305|581295446|FG004|Phase 1|Withdrawal by Subject|0|||
160974409|NCT01709305|581295442|FG000|Phase 2|Clinical Adverse Event|0|||
160974410|NCT01709305|581295443|FG001|Phase 2|Clinical Adverse Event|10|||
160974411|NCT01709305|581295444|FG002|Phase 2|Clinical Adverse Event|10|||
160974412|NCT01709305|581295445|FG003|Phase 2|Clinical Adverse Event|6|||
160974413|NCT01709305|581295446|FG004|Phase 2|Clinical Adverse Event|11|||
160974414|NCT01709305|581295442|FG000|Phase 2|Death|0|||
160974415|NCT01709305|581295443|FG001|Phase 2|Death|0|||
160974416|NCT01709305|581295444|FG002|Phase 2|Death|1|||
160974417|NCT01709305|581295445|FG003|Phase 2|Death|0|||
160974418|NCT01709305|581295446|FG004|Phase 2|Death|0|||
160974419|NCT01709305|581295442|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
160974420|NCT01709305|581295443|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
160974421|NCT01709305|581295444|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
160974422|NCT01709305|581295445|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
160657677|NCT01606306|580127630|FG000|Overall Study|Withdrawal by Subject|4|||
160657678|NCT01606306|580127631|FG001|Overall Study|Withdrawal by Subject|3|||
160657679|NCT01606306|580127632|FG002|Overall Study|Withdrawal by Subject|4|||
160657680|NCT01606306|580127633|FG003|Overall Study|Withdrawal by Subject|4|||
160657681|NCT01606306|580127634|FG004|Overall Study|Withdrawal by Subject|5|||
160657682|NCT01606306|580127635|FG005|Overall Study|Withdrawal by Subject|4|||
160657683|NCT01606306|580127630|FG000|Overall Study|Physician Decision|1|||
160657684|NCT01606306|580127631|FG001|Overall Study|Physician Decision|2|||
160657685|NCT01606306|580127632|FG002|Overall Study|Physician Decision|0|||
160657686|NCT01606306|580127633|FG003|Overall Study|Physician Decision|0|||
160657687|NCT01606306|580127634|FG004|Overall Study|Physician Decision|0|||
160657688|NCT01606306|580127635|FG005|Overall Study|Physician Decision|0|||
160657689|NCT00950872|580127636|FG000|Overall Study|Withdrawal by Subject|1|||
160657690|NCT00950872|580127636|FG000|Overall Study|Did not have surgery|2|||
160657691|NCT01759290|580127637|FG000|Overall Study|Subjects withdrawn consent|5|||
160657692|NCT01759290|580127637|FG000|Overall Study|Physician Decision|2|||
160657693|NCT01759290|580127637|FG000|Overall Study|Death|17|||
160657694|NCT01759290|580127637|FG000|Overall Study|Lost to Follow-up|53|||
160657695|NCT01759290|580127637|FG000|Overall Study|Unknown reason|4|||
160657696|NCT01766778|580127648|FG000|Overall Study|Adverse Event|4|||
160657697|NCT01766778|580127649|FG001|Overall Study|Adverse Event|4|||
160657698|NCT01766778|580127648|FG000|Overall Study|Withdrawal by Subject|1|||
160657699|NCT01766778|580127649|FG001|Overall Study|Withdrawal by Subject|0|||
160657700|NCT01054599|580127650|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
160657701|NCT01054599|580127651|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
160657702|NCT01054599|580127650|FG000|Overall Study|Protocol Violation|1|||
160657703|NCT01054599|580127651|FG001|Overall Study|Protocol Violation|0|||
160657704|NCT01054599|580127650|FG000|Overall Study|Spells/seizure-like episodes|1|||
160657705|NCT01054599|580127651|FG001|Overall Study|Spells/seizure-like episodes|1|||
160657706|NCT01054599|580127650|FG000|Overall Study|Timing/scheduling difficulties|1|||
160657707|NCT01054599|580127651|FG001|Overall Study|Timing/scheduling difficulties|1|||
160657708|NCT01054599|580127650|FG000|Overall Study|Visual impairment, WTAR <80|0|||
160657709|NCT01054599|580127651|FG001|Overall Study|Visual impairment, WTAR <80|1|||
160657710|NCT01054599|580127650|FG000|Overall Study|Lost to Follow-up|0|||
160657711|NCT01054599|580127651|FG001|Overall Study|Lost to Follow-up|2|||
160657712|NCT01054599|580127650|FG000|Overall Study|Adverse Event|0|||
160657713|NCT01054599|580127651|FG001|Overall Study|Adverse Event|1|||
160657714|NCT01054599|580127650|FG000|Overall Study|Withdrawal by Subject|0|||
160657715|NCT01054599|580127651|FG001|Overall Study|Withdrawal by Subject|1|||
160657716|NCT01104662|580127652|FG000|Overall Study|Adverse Event|2|||
160657717|NCT01104662|580127653|FG001|Overall Study|Adverse Event|2|||
160657718|NCT01104662|580127654|FG002|Overall Study|Adverse Event|0|||
160590089|NCT00064350|579876781|FG002|Randomization|Ineligible or never started treatment|0|||
160590090|NCT00064350|579876779|FG000|Randomization|Other|5|||
160590091|NCT00064350|579876780|FG001|Randomization|Other|0|||
160590092|NCT00064350|579876781|FG002|Randomization|Other|0|||
160590093|NCT00064350|579876779|FG000|Cross-Over|Adverse Event|0|||
160590094|NCT00064350|579876780|FG001|Cross-Over|Adverse Event|1|||
160590095|NCT00064350|579876781|FG002|Cross-Over|Adverse Event|0|||
160590096|NCT00064350|579876779|FG000|Cross-Over|Death|1|||
160974423|NCT01709305|581295446|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
160974424|NCT01709305|581295442|FG000|Phase 2|Laboratory Adverse Event|0|||
160974425|NCT01709305|581295443|FG001|Phase 2|Laboratory Adverse Event|1|||
160974426|NCT01709305|581295444|FG002|Phase 2|Laboratory Adverse Event|0|||
160974427|NCT01709305|581295445|FG003|Phase 2|Laboratory Adverse Event|1|||
160974428|NCT01709305|581295446|FG004|Phase 2|Laboratory Adverse Event|1|||
160974429|NCT01709305|581295442|FG000|Phase 2|Lost to Follow-up|0|||
160974430|NCT01709305|581295443|FG001|Phase 2|Lost to Follow-up|10|||
160974431|NCT01709305|581295444|FG002|Phase 2|Lost to Follow-up|6|||
160974432|NCT01709305|581295445|FG003|Phase 2|Lost to Follow-up|9|||
160974433|NCT01709305|581295446|FG004|Phase 2|Lost to Follow-up|5|||
160974434|NCT01709305|581295442|FG000|Phase 2|Travel, moving, etc.|0|||
160974435|NCT01709305|581295443|FG001|Phase 2|Travel, moving, etc.|2|||
160974436|NCT01709305|581295444|FG002|Phase 2|Travel, moving, etc.|3|||
160974437|NCT01709305|581295445|FG003|Phase 2|Travel, moving, etc.|3|||
160974438|NCT01709305|581295446|FG004|Phase 2|Travel, moving, etc.|5|||
160974439|NCT01709305|581295442|FG000|Phase 2|Physician Decision|0|||
160974440|NCT01709305|581295443|FG001|Phase 2|Physician Decision|2|||
160974441|NCT01709305|581295444|FG002|Phase 2|Physician Decision|0|||
160974442|NCT01709305|581295445|FG003|Phase 2|Physician Decision|1|||
160974443|NCT01709305|581295446|FG004|Phase 2|Physician Decision|2|||
160974444|NCT01709305|581295442|FG000|Phase 2|Protocol Violation|0|||
160974445|NCT01709305|581295443|FG001|Phase 2|Protocol Violation|19|||
160974446|NCT01709305|581295444|FG002|Phase 2|Protocol Violation|19|||
160974447|NCT01709305|581295445|FG003|Phase 2|Protocol Violation|13|||
160974448|NCT01709305|581295446|FG004|Phase 2|Protocol Violation|9|||
160974449|NCT01709305|581295442|FG000|Phase 2|Withdrawal by Subject|0|||
160974450|NCT01709305|581295443|FG001|Phase 2|Withdrawal by Subject|8|||
160974451|NCT01709305|581295444|FG002|Phase 2|Withdrawal by Subject|6|||
160974452|NCT01709305|581295445|FG003|Phase 2|Withdrawal by Subject|15|||
160974453|NCT01709305|581295446|FG004|Phase 2|Withdrawal by Subject|12|||
160974454|NCT03443713|581295449|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
160974455|NCT03443713|581295450|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
160974456|NCT03443713|581295451|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
160974457|NCT00118898|581295452|FG000|Overall Study|Death|6|||
160974458|NCT00118898|581295453|FG001|Overall Study|Death|11|||
160974459|NCT00118898|581295454|FG002|Overall Study|Death|6|||
160974460|NCT00118898|581295455|FG003|Overall Study|Death|8|||
160974461|NCT00118898|581295452|FG000|Overall Study|Lost to Follow-up|26|||
160974462|NCT00118898|581295453|FG001|Overall Study|Lost to Follow-up|34|||
160974463|NCT00118898|581295454|FG002|Overall Study|Lost to Follow-up|33|||
160974464|NCT00118898|581295455|FG003|Overall Study|Lost to Follow-up|33|||
160974465|NCT00118898|581295452|FG000|Overall Study|Withdrawal by Subject|10|||
160974466|NCT00118898|581295453|FG001|Overall Study|Withdrawal by Subject|5|||
160974467|NCT00118898|581295454|FG002|Overall Study|Withdrawal by Subject|8|||
160974468|NCT00118898|581295455|FG003|Overall Study|Withdrawal by Subject|8|||
160974469|NCT00118898|581295452|FG000|Overall Study|Site Closure|33|||
160974470|NCT00118898|581295453|FG001|Overall Study|Site Closure|31|||
160974471|NCT00118898|581295454|FG002|Overall Study|Site Closure|28|||
160974472|NCT00118898|581295455|FG003|Overall Study|Site Closure|37|||
160974473|NCT00118898|581295452|FG000|Overall Study|Severe debilitation|1|||
160974474|NCT00118898|581295453|FG001|Overall Study|Severe debilitation|4|||
160974475|NCT00118898|581295454|FG002|Overall Study|Severe debilitation|6|||
160974476|NCT00118898|581295455|FG003|Overall Study|Severe debilitation|4|||
160974477|NCT00118898|581295452|FG000|Overall Study|Not compliant with requirements|11|||
160974478|NCT00118898|581295453|FG001|Overall Study|Not compliant with requirements|13|||
160974479|NCT00118898|581295454|FG002|Overall Study|Not compliant with requirements|11|||
160974480|NCT00118898|581295455|FG003|Overall Study|Not compliant with requirements|11|||
160974481|NCT00118898|581295452|FG000|Overall Study|Not able to get to clinic|34|||
160974482|NCT00118898|581295453|FG001|Overall Study|Not able to get to clinic|43|||
160974483|NCT00118898|581295454|FG002|Overall Study|Not able to get to clinic|31|||
160974484|NCT00118898|581295455|FG003|Overall Study|Not able to get to clinic|40|||
160974485|NCT02714205|581295456|FG000|Overall Study|Cannot tolerate medication|1|||
160974486|NCT02714205|581295457|FG001|Overall Study|Cannot tolerate medication|0|||
160974487|NCT02714205|581295456|FG000|Overall Study|Adverse Event|2|||
160974488|NCT02714205|581295457|FG001|Overall Study|Adverse Event|0|||
160974489|NCT02714205|581295456|FG000|Overall Study|Too busy|1|||
160974490|NCT02714205|581295457|FG001|Overall Study|Too busy|0|||
160974491|NCT02714205|581295456|FG000|Overall Study|Incomplete outcome data|0|||
160974492|NCT02714205|581295457|FG001|Overall Study|Incomplete outcome data|1|||
160974493|NCT02073097|581295458|FG000|Overall Study|Adverse Event|0|||
160974494|NCT02073097|581295459|FG001|Overall Study|Adverse Event|0|||
160974495|NCT02073097|581295460|FG002|Overall Study|Adverse Event|0|||
160974496|NCT02073097|581295461|FG003|Overall Study|Adverse Event|0|||
160974497|NCT02073097|581295462|FG004|Overall Study|Adverse Event|0|||
160974498|NCT02073097|581295463|FG005|Overall Study|Adverse Event|0|||
160974499|NCT02073097|581295464|FG006|Overall Study|Adverse Event|0|||
160974500|NCT02073097|581295465|FG007|Overall Study|Adverse Event|2|||
160974501|NCT02073097|581295458|FG000|Overall Study|Withdrawal by Subject|0|||
160974502|NCT02073097|581295459|FG001|Overall Study|Withdrawal by Subject|0|||
160657719|NCT01104662|580127655|FG003|Overall Study|Adverse Event|1|||
160657720|NCT01104662|580127656|FG004|Overall Study|Adverse Event|1|||
160657721|NCT01104662|580127657|FG005|Overall Study|Adverse Event|1|||
160657722|NCT01104662|580127658|FG006|Overall Study|Adverse Event|0|||
160657723|NCT01104662|580127659|FG007|Overall Study|Adverse Event|0|||
160657724|NCT01104662|580127652|FG000|Overall Study|Clinical Failure|1|||
160657725|NCT01104662|580127653|FG001|Overall Study|Clinical Failure|0|||
160657726|NCT01104662|580127654|FG002|Overall Study|Clinical Failure|0|||
160657727|NCT01104662|580127655|FG003|Overall Study|Clinical Failure|0|||
160657728|NCT01104662|580127656|FG004|Overall Study|Clinical Failure|0|||
160657729|NCT01104662|580127657|FG005|Overall Study|Clinical Failure|1|||
160657730|NCT01104662|580127658|FG006|Overall Study|Clinical Failure|0|||
160657731|NCT01104662|580127659|FG007|Overall Study|Clinical Failure|0|||
160657732|NCT01104662|580127652|FG000|Overall Study|Participant left investigator's care|1|||
160657733|NCT01104662|580127653|FG001|Overall Study|Participant left investigator's care|1|||
160657734|NCT01104662|580127654|FG002|Overall Study|Participant left investigator's care|0|||
160657735|NCT01104662|580127655|FG003|Overall Study|Participant left investigator's care|0|||
160657736|NCT01104662|580127656|FG004|Overall Study|Participant left investigator's care|0|||
160657737|NCT01104662|580127657|FG005|Overall Study|Participant left investigator's care|0|||
160657738|NCT01104662|580127658|FG006|Overall Study|Participant left investigator's care|0|||
160657739|NCT01104662|580127659|FG007|Overall Study|Participant left investigator's care|0|||
160657740|NCT01104662|580127652|FG000|Overall Study|Reason not specified|3|||
160657741|NCT01104662|580127653|FG001|Overall Study|Reason not specified|3|||
160657742|NCT01104662|580127654|FG002|Overall Study|Reason not specified|0|||
160657743|NCT01104662|580127655|FG003|Overall Study|Reason not specified|0|||
160657744|NCT01104662|580127656|FG004|Overall Study|Reason not specified|0|||
160657745|NCT01104662|580127657|FG005|Overall Study|Reason not specified|1|||
160974503|NCT02073097|581295460|FG002|Overall Study|Withdrawal by Subject|0|||
160974504|NCT02073097|581295461|FG003|Overall Study|Withdrawal by Subject|0|||
160974505|NCT02073097|581295462|FG004|Overall Study|Withdrawal by Subject|0|||
160974506|NCT02073097|581295463|FG005|Overall Study|Withdrawal by Subject|0|||
160974507|NCT02073097|581295464|FG006|Overall Study|Withdrawal by Subject|0|||
160974508|NCT02073097|581295465|FG007|Overall Study|Withdrawal by Subject|2|||
160974509|NCT02073097|581295458|FG000|Overall Study|Death|0|||
160974510|NCT02073097|581295459|FG001|Overall Study|Death|0|||
160974511|NCT02073097|581295460|FG002|Overall Study|Death|0|||
160974512|NCT02073097|581295461|FG003|Overall Study|Death|0|||
160974513|NCT02073097|581295462|FG004|Overall Study|Death|0|||
160974514|NCT02073097|581295463|FG005|Overall Study|Death|0|||
160974515|NCT02073097|581295464|FG006|Overall Study|Death|0|||
160974516|NCT02073097|581295465|FG007|Overall Study|Death|1|||
160974517|NCT02073097|581295458|FG000|Overall Study|Physician Decision|0|||
160974518|NCT02073097|581295459|FG001|Overall Study|Physician Decision|0|||
160974519|NCT02073097|581295460|FG002|Overall Study|Physician Decision|0|||
160974520|NCT02073097|581295461|FG003|Overall Study|Physician Decision|0|||
160974521|NCT02073097|581295462|FG004|Overall Study|Physician Decision|0|||
160974522|NCT02073097|581295463|FG005|Overall Study|Physician Decision|0|||
160974523|NCT02073097|581295464|FG006|Overall Study|Physician Decision|0|||
160974524|NCT02073097|581295465|FG007|Overall Study|Physician Decision|1|||
160974525|NCT01693692|581295468|FG000|Overall Study|Withdrawal by Subject|12|||
160974526|NCT01693692|581295469|FG001|Overall Study|Withdrawal by Subject|10|||
160974527|NCT01693692|581295470|FG002|Overall Study|Withdrawal by Subject|11|||
160974528|NCT01693692|581295468|FG000|Overall Study|Adverse Event|7|||
160974529|NCT01693692|581295469|FG001|Overall Study|Adverse Event|14|||
160974530|NCT01693692|581295470|FG002|Overall Study|Adverse Event|9|||
160974531|NCT01693692|581295468|FG000|Overall Study|Physician Decision|0|||
160974532|NCT01693692|581295469|FG001|Overall Study|Physician Decision|0|||
160974533|NCT01693692|581295470|FG002|Overall Study|Physician Decision|1|||
160974534|NCT01693692|581295468|FG000|Overall Study|Protocol Violation|5|||
160974535|NCT01693692|581295469|FG001|Overall Study|Protocol Violation|4|||
160974536|NCT01693692|581295470|FG002|Overall Study|Protocol Violation|6|||
160974537|NCT01693692|581295468|FG000|Overall Study|Lost to Follow-up|2|||
160974538|NCT01693692|581295469|FG001|Overall Study|Lost to Follow-up|2|||
160974539|NCT01693692|581295470|FG002|Overall Study|Lost to Follow-up|3|||
160974540|NCT01693692|581295468|FG000|Overall Study|Other|4|||
160974541|NCT01693692|581295469|FG001|Overall Study|Other|4|||
160974542|NCT01693692|581295470|FG002|Overall Study|Other|6|||
160974543|NCT04424290|581297484|FG000|Overall Study|Not treated|0|||
160974544|NCT04424290|581297485|FG001|Overall Study|Not treated|0|||
160974545|NCT04424290|581297486|FG002|Overall Study|Not treated|1|||
160974546|NCT04424290|581297487|FG003|Overall Study|Not treated|0|||
160974547|NCT04424290|581297488|FG004|Overall Study|Not treated|1|||
160974548|NCT04424290|581297484|FG000|Overall Study|Adverse Event|0|||
160974549|NCT04424290|581297485|FG001|Overall Study|Adverse Event|0|||
160974550|NCT04424290|581297486|FG002|Overall Study|Adverse Event|0|||
160974551|NCT04424290|581297487|FG003|Overall Study|Adverse Event|2|||
160974552|NCT04424290|581297488|FG004|Overall Study|Adverse Event|0|||
160974553|NCT04424290|581297484|FG000|Overall Study|Withdrawal by Subject|0|||
160974554|NCT04424290|581297485|FG001|Overall Study|Withdrawal by Subject|0|||
160590097|NCT00064350|579876780|FG001|Cross-Over|Death|3|||
160590098|NCT00064350|579876781|FG002|Cross-Over|Death|0|||
160590099|NCT00064350|579876779|FG000|Cross-Over|Withdrawal by Subject|2|||
160590100|NCT00064350|579876780|FG001|Cross-Over|Withdrawal by Subject|2|||
160590101|NCT00064350|579876781|FG002|Cross-Over|Withdrawal by Subject|0|||
160590102|NCT00064350|579876779|FG000|Cross-Over|Ineligible or never started treatment|3|||
160590103|NCT00064350|579876780|FG001|Cross-Over|Ineligible or never started treatment|6|||
160974555|NCT04424290|581297486|FG002|Overall Study|Withdrawal by Subject|0|||
160974556|NCT04424290|581297487|FG003|Overall Study|Withdrawal by Subject|0|||
160974557|NCT04424290|581297488|FG004|Overall Study|Withdrawal by Subject|1|||
160974558|NCT04424290|581297484|FG000|Overall Study|Other than listed|0|||
160974559|NCT04424290|581297485|FG001|Overall Study|Other than listed|0|||
160974560|NCT04424290|581297486|FG002|Overall Study|Other than listed|0|||
160974561|NCT04424290|581297487|FG003|Overall Study|Other than listed|1|||
160974562|NCT04424290|581297488|FG004|Overall Study|Other than listed|0|||
160974563|NCT02914184|581297492|FG000|Overall Study|Lost to Follow-up|7|||
160974564|NCT02914184|581297493|FG001|Overall Study|Lost to Follow-up|10|||
160974565|NCT02914184|581297494|FG002|Overall Study|Lost to Follow-up|8|||
160974566|NCT02914184|581297495|FG003|Overall Study|Lost to Follow-up|7|||
160974567|NCT02914184|581297492|FG000|Overall Study|Withdrawal by Subject|4|||
160974568|NCT02914184|581297493|FG001|Overall Study|Withdrawal by Subject|2|||
160974569|NCT02914184|581297494|FG002|Overall Study|Withdrawal by Subject|7|||
160974570|NCT02914184|581297495|FG003|Overall Study|Withdrawal by Subject|3|||
160974571|NCT02914184|581297492|FG000|Overall Study|Other|1|||
160974572|NCT02914184|581297493|FG001|Overall Study|Other|0|||
160974573|NCT02914184|581297494|FG002|Overall Study|Other|0|||
160974574|NCT02914184|581297495|FG003|Overall Study|Other|0|||
160974575|NCT02914184|581297492|FG000|Overall Study|Migrated/moved from the study area|2|||
160974576|NCT02914184|581297493|FG001|Overall Study|Migrated/moved from the study area|1|||
160974577|NCT02914184|581297494|FG002|Overall Study|Migrated/moved from the study area|2|||
160974578|NCT02914184|581297495|FG003|Overall Study|Migrated/moved from the study area|1|||
160974579|NCT00798174|581297496|FG000|Overall Study|inability to implant azygos coil|3|||
160974580|NCT00798174|581297497|FG001|Overall Study|inability to implant azygos coil|3|||
160974581|NCT00798174|581297496|FG000|Overall Study|Inability to sedate for DFT testing|1|||
160974582|NCT00798174|581297497|FG001|Overall Study|Inability to sedate for DFT testing|0|||
160590104|NCT00064350|579876781|FG002|Cross-Over|Ineligible or never started treatment|0|||
160590105|NCT00064350|579876779|FG000|Cross-Over|Other|0|||
160590106|NCT00064350|579876780|FG001|Cross-Over|Other|2|||
160590107|NCT00064350|579876781|FG002|Cross-Over|Other|0|||
160974583|NCT01683994|581297499|FG000|Overall Study|Withdrawal by Subject|1|||
160974584|NCT01683994|581297500|FG001|Overall Study|Withdrawal by Subject|0|||
160974585|NCT01683994|581297501|FG002|Overall Study|Withdrawal by Subject|0|||
160974586|NCT01683994|581297502|FG003|Overall Study|Withdrawal by Subject|1|||
160974587|NCT01683994|581297503|FG004|Overall Study|Withdrawal by Subject|0|||
160974588|NCT01683994|581297499|FG000|Overall Study|Intercurrent illness|0|||
160974589|NCT01683994|581297500|FG001|Overall Study|Intercurrent illness|0|||
160974590|NCT01683994|581297501|FG002|Overall Study|Intercurrent illness|0|||
160974591|NCT01683994|581297502|FG003|Overall Study|Intercurrent illness|2|||
160974592|NCT01683994|581297503|FG004|Overall Study|Intercurrent illness|1|||
160974593|NCT02318719|581297509|FG000|Double-blind Phase|Adverse Event|7|||
160974594|NCT02318719|581297510|FG001|Double-blind Phase|Adverse Event|6|||
160974595|NCT02318719|581297511|FG002|Double-blind Phase|Adverse Event|12|||
160590108|NCT00838916|579876782|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
160974596|NCT02318719|581297512|FG003|Double-blind Phase|Adverse Event|4|||
160974597|NCT02318719|581297513|FG004|Double-blind Phase|Adverse Event|0|||
160590109|NCT00838916|579876783|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
160974598|NCT02318719|581297509|FG000|Double-blind Phase|Lack of Efficacy|5|||
160974599|NCT02318719|581297510|FG001|Double-blind Phase|Lack of Efficacy|0|||
160974600|NCT02318719|581297511|FG002|Double-blind Phase|Lack of Efficacy|1|||
160590110|NCT00838916|579876782|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
160590111|NCT00838916|579876783|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
160590112|NCT00838916|579876782|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
160590113|NCT00838916|579876783|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
160590114|NCT00838916|579876782|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
160590115|NCT00838916|579876783|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
160590116|NCT00838916|579876782|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
160590117|NCT00838916|579876783|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
160590118|NCT00838916|579876782|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
160590119|NCT00838916|579876783|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
160590120|NCT00838916|579876782|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
160590121|NCT00838916|579876783|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
160590122|NCT00838916|579876782|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
160590123|NCT00838916|579876783|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
160590124|NCT00838916|579876782|FG000|Treatment Period (156 Weeks)|Missing|3|||
160590125|NCT00838916|579876783|FG001|Treatment Period (156 Weeks)|Missing|1|||
160590126|NCT00838916|579876782|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
160590127|NCT00838916|579876783|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
160590128|NCT00838916|579876782|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
160590129|NCT00838916|579876783|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
160590130|NCT00838916|579876782|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
160590131|NCT00838916|579876783|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
160590132|NCT00838916|579876782|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
160590133|NCT00838916|579876783|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
160590134|NCT00838916|579876782|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
160590135|NCT00838916|579876783|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
160590136|NCT00838916|579876782|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
160590137|NCT00838916|579876783|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
160590138|NCT00838916|579876782|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
160590139|NCT00838916|579876783|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
160590140|NCT00838916|579876782|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
160590141|NCT00838916|579876783|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
160590142|NCT00838916|579876782|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
160590143|NCT00838916|579876783|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
160590144|NCT00838916|579876782|FG000|Follow-up Period (8 Weeks)|Missing|3|||
160590145|NCT00838916|579876783|FG001|Follow-up Period (8 Weeks)|Missing|0|||
160590146|NCT00115765|579876784|FG000|Overall Study|Withdrawal by Subject|22|||
160590147|NCT00115765|579876785|FG001|Overall Study|Withdrawal by Subject|53|||
160590148|NCT00115765|579876786|FG002|Overall Study|Withdrawal by Subject|76|||
160590149|NCT00115765|579876787|FG003|Overall Study|Withdrawal by Subject|15|||
160590150|NCT00115765|579876784|FG000|Overall Study|Physician Decision|4|||
160590151|NCT00115765|579876785|FG001|Overall Study|Physician Decision|15|||
160590152|NCT00115765|579876786|FG002|Overall Study|Physician Decision|18|||
160590153|NCT00115765|579876787|FG003|Overall Study|Physician Decision|13|||
160590154|NCT00115765|579876784|FG000|Overall Study|Lost to Follow-up|3|||
160590155|NCT00115765|579876785|FG001|Overall Study|Lost to Follow-up|20|||
160590156|NCT00115765|579876786|FG002|Overall Study|Lost to Follow-up|18|||
160590157|NCT00115765|579876787|FG003|Overall Study|Lost to Follow-up|1|||
160590158|NCT00115765|579876784|FG000|Overall Study|Other|6|||
160590159|NCT00115765|579876785|FG001|Overall Study|Other|12|||
160590160|NCT00115765|579876786|FG002|Overall Study|Other|9|||
160590161|NCT00115765|579876787|FG003|Overall Study|Other|2|||
160590162|NCT02773238|579876790|FG000|Overall Study|Lack of Efficacy|4|||
160590163|NCT03260205|579876791|FG000|Overall Study|Adverse Event|2|||
160590164|NCT03260205|579876792|FG001|Overall Study|Adverse Event|0|||
160974601|NCT02318719|581297512|FG003|Double-blind Phase|Lack of Efficacy|1|||
160974602|NCT02318719|581297513|FG004|Double-blind Phase|Lack of Efficacy|0|||
160974603|NCT02318719|581297509|FG000|Double-blind Phase|Protocol Violation|0|||
160974604|NCT02318719|581297510|FG001|Double-blind Phase|Protocol Violation|1|||
160974605|NCT02318719|581297511|FG002|Double-blind Phase|Protocol Violation|3|||
160974606|NCT02318719|581297512|FG003|Double-blind Phase|Protocol Violation|0|||
160974607|NCT02318719|581297513|FG004|Double-blind Phase|Protocol Violation|0|||
160974608|NCT02318719|581297509|FG000|Double-blind Phase|Withdrawal by Subject|25|||
160974609|NCT02318719|581297510|FG001|Double-blind Phase|Withdrawal by Subject|7|||
160974610|NCT02318719|581297511|FG002|Double-blind Phase|Withdrawal by Subject|9|||
160974611|NCT02318719|581297512|FG003|Double-blind Phase|Withdrawal by Subject|10|||
160974612|NCT02318719|581297513|FG004|Double-blind Phase|Withdrawal by Subject|0|||
160974613|NCT02318719|581297509|FG000|Double-blind Phase|Other|1|||
160974614|NCT02318719|581297510|FG001|Double-blind Phase|Other|2|||
160974615|NCT02318719|581297511|FG002|Double-blind Phase|Other|0|||
160974616|NCT02318719|581297512|FG003|Double-blind Phase|Other|0|||
160974617|NCT02318719|581297513|FG004|Double-blind Phase|Other|0|||
160974618|NCT02318719|581297509|FG000|Open-label Extension Phase|Adverse Event|0|||
160974619|NCT02318719|581297510|FG001|Open-label Extension Phase|Adverse Event|0|||
160974620|NCT02318719|581297511|FG002|Open-label Extension Phase|Adverse Event|0|||
160974621|NCT02318719|581297512|FG003|Open-label Extension Phase|Adverse Event|0|||
160974622|NCT02318719|581297513|FG004|Open-label Extension Phase|Adverse Event|15|||
160974623|NCT02318719|581297509|FG000|Open-label Extension Phase|Death|0|||
160974624|NCT02318719|581297510|FG001|Open-label Extension Phase|Death|0|||
160974625|NCT02318719|581297511|FG002|Open-label Extension Phase|Death|0|||
160974626|NCT02318719|581297512|FG003|Open-label Extension Phase|Death|0|||
160974627|NCT02318719|581297513|FG004|Open-label Extension Phase|Death|1|||
160974628|NCT02318719|581297509|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
160974629|NCT02318719|581297510|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
160974630|NCT02318719|581297511|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
160974631|NCT02318719|581297512|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
160974632|NCT02318719|581297513|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
160974633|NCT02318719|581297509|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
160974634|NCT02318719|581297510|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
160974635|NCT02318719|581297511|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
160974636|NCT02318719|581297512|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
160974637|NCT02318719|581297513|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
160974638|NCT02318719|581297509|FG000|Open-label Extension Phase|Other|0|||
160974639|NCT02318719|581297510|FG001|Open-label Extension Phase|Other|0|||
160974640|NCT02318719|581297511|FG002|Open-label Extension Phase|Other|0|||
160974641|NCT02318719|581297512|FG003|Open-label Extension Phase|Other|0|||
160974642|NCT02318719|581297513|FG004|Open-label Extension Phase|Other|7|||
160974643|NCT00802659|581297514|FG000|Overall Study|Physician Decision|0|||
160974644|NCT00802659|581297515|FG001|Overall Study|Physician Decision|1|||
160974645|NCT00802659|581297516|FG002|Overall Study|Physician Decision|0|||
160974646|NCT00802659|581297517|FG003|Overall Study|Physician Decision|0|||
160974647|NCT00806624|581297518|FG000|Overall Study|Adverse Event|2|||
160974648|NCT00806624|581297519|FG001|Overall Study|Adverse Event|8|||
160974649|NCT00806624|581297520|FG002|Overall Study|Adverse Event|0|||
160974650|NCT00806624|581297518|FG000|Overall Study|Death|0|||
160974651|NCT00806624|581297519|FG001|Overall Study|Death|1|||
160974652|NCT00806624|581297520|FG002|Overall Study|Death|1|||
160974653|NCT00806624|581297518|FG000|Overall Study|Lost to Follow-up|1|||
160974654|NCT00806624|581297519|FG001|Overall Study|Lost to Follow-up|0|||
160974655|NCT00806624|581297520|FG002|Overall Study|Lost to Follow-up|1|||
160974656|NCT00806624|581297518|FG000|Overall Study|Withdrawal by Subject|6|||
160974657|NCT00806624|581297519|FG001|Overall Study|Withdrawal by Subject|3|||
160974658|NCT00806624|581297520|FG002|Overall Study|Withdrawal by Subject|3|||
160974659|NCT00806624|581297518|FG000|Overall Study|discontinued before start of treatment|0|||
160974660|NCT00806624|581297519|FG001|Overall Study|discontinued before start of treatment|0|||
160974661|NCT00806624|581297520|FG002|Overall Study|discontinued before start of treatment|1|||
160974662|NCT03093428|581297521|FG000|Overall Study|Not eligible for treatment|2|||
160590165|NCT03260205|579876793|FG002|Overall Study|Adverse Event|2|||
160590166|NCT03260205|579876794|FG003|Overall Study|Adverse Event|2|||
160590167|NCT03260205|579876795|FG004|Overall Study|Adverse Event|4|||
160590168|NCT03260205|579876791|FG000|Overall Study|Lost to Follow-up|2|||
160590169|NCT03260205|579876792|FG001|Overall Study|Lost to Follow-up|2|||
160590170|NCT03260205|579876793|FG002|Overall Study|Lost to Follow-up|1|||
160590171|NCT03260205|579876794|FG003|Overall Study|Lost to Follow-up|1|||
160590172|NCT03260205|579876795|FG004|Overall Study|Lost to Follow-up|5|||
160590173|NCT03260205|579876791|FG000|Overall Study|Protocol Violation|0|||
160590174|NCT03260205|579876792|FG001|Overall Study|Protocol Violation|0|||
160590175|NCT03260205|579876793|FG002|Overall Study|Protocol Violation|2|||
160590176|NCT03260205|579876794|FG003|Overall Study|Protocol Violation|0|||
160590177|NCT03260205|579876795|FG004|Overall Study|Protocol Violation|1|||
160590178|NCT03260205|579876791|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
160590179|NCT03260205|579876792|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
160590180|NCT03260205|579876793|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
160590181|NCT03260205|579876794|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
160590182|NCT03260205|579876795|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
160590183|NCT03260205|579876791|FG000|Overall Study|Other: Unspecified|0|||
160590184|NCT03260205|579876792|FG001|Overall Study|Other: Unspecified|0|||
160590185|NCT03260205|579876793|FG002|Overall Study|Other: Unspecified|3|||
160590186|NCT03260205|579876794|FG003|Overall Study|Other: Unspecified|1|||
160590187|NCT03260205|579876795|FG004|Overall Study|Other: Unspecified|1|||
160590188|NCT03260205|579876791|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
160590189|NCT03260205|579876792|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
160590190|NCT03260205|579876793|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
160590191|NCT03260205|579876794|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
160590192|NCT03260205|579876795|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
160590193|NCT05108805|579876799|FG000|Overall Study|T-cell expansion was not successful.|5|||
160590194|NCT01511107|579876800|FG000|Overall Study|Ineligible|3|||
160590195|NCT01511107|579876801|FG001|Overall Study|Ineligible|2|||
160590196|NCT01511107|579876800|FG000|Overall Study|Lost to Follow-up|10|||
160590197|NCT01511107|579876801|FG001|Overall Study|Lost to Follow-up|19|||
160590198|NCT01511107|579876800|FG000|Overall Study|Withdrawal by Subject|9|||
160590199|NCT01511107|579876801|FG001|Overall Study|Withdrawal by Subject|20|||
160590200|NCT05195359|579878578|FG000|Overall Study|Lost to Follow-up|124|||
160590201|NCT05195359|579878579|FG001|Overall Study|Lost to Follow-up|34|||
160590202|NCT01146951|579878580|FG000|Overall Study|Adverse Event|4|||
160590203|NCT01146951|579878581|FG001|Overall Study|Adverse Event|1|||
160590204|NCT01747811|579878582|FG000|Overall Study|Lack of Efficacy|2|||
160590205|NCT01747811|579878583|FG001|Overall Study|Lack of Efficacy|4|||
160590206|NCT02492997|579878584|FG000|Overall Study|Withdrawal by Subject|1|||
160590207|NCT02492997|579878585|FG001|Overall Study|Withdrawal by Subject|0|||
160590208|NCT02492997|579878584|FG000|Overall Study|Gained Weight|1|||
160590209|NCT02492997|579878585|FG001|Overall Study|Gained Weight|0|||
160590210|NCT02492997|579878584|FG000|Overall Study|Lost to Follow-up|0|||
160590211|NCT02492997|579878585|FG001|Overall Study|Lost to Follow-up|1|||
160590212|NCT01089582|579878586|FG000|Overall Study|Death|2|||
160590213|NCT01089582|579878586|FG000|Overall Study|Adverse Event|15|||
160590214|NCT01089582|579878586|FG000|Overall Study|Lost to Follow-up|8|||
160590215|NCT01089582|579878586|FG000|Overall Study|Other|4|||
160590216|NCT01089582|579878586|FG000|Overall Study|Withdrawal by Subject|1|||
160590217|NCT04069156|579878587|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
160590218|NCT04069156|579878588|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
160590219|NCT04069156|579878587|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
160590220|NCT04069156|579878588|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
160590221|NCT04069156|579878587|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
160590222|NCT04069156|579878588|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
160590223|NCT04069156|579878587|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
160590224|NCT04069156|579878588|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
160590225|NCT02130427|579878592|FG000|Overall Study|Imaging results not interpretable|30|||
160590226|NCT02108600|579878593|FG000|Overall Study|Withdrawal by Subject|2|||
160590227|NCT02108600|579878594|FG001|Overall Study|Withdrawal by Subject|0|||
160590228|NCT02108600|579878593|FG000|Overall Study|Lost to Follow-up|1|||
160590229|NCT02108600|579878594|FG001|Overall Study|Lost to Follow-up|1|||
160590230|NCT01295580|579878597|FG000|Overall Study|Protocol Violation|4|||
160590231|NCT01295580|579878598|FG001|Overall Study|Protocol Violation|2|||
160590232|NCT01295580|579878597|FG000|Overall Study|Withdrawal by Subject|1|||
160590233|NCT01295580|579878598|FG001|Overall Study|Withdrawal by Subject|4|||
160590234|NCT01295580|579878597|FG000|Overall Study|Adverse Event|2|||
160590235|NCT01295580|579878598|FG001|Overall Study|Adverse Event|1|||
160590236|NCT01295580|579878597|FG000|Overall Study|Lost to Follow-up|1|||
160590237|NCT01295580|579878598|FG001|Overall Study|Lost to Follow-up|0|||
160590238|NCT01295580|579878597|FG000|Overall Study|Lack of Efficacy|1|||
160590239|NCT01295580|579878598|FG001|Overall Study|Lack of Efficacy|0|||
160590240|NCT01295580|579878597|FG000|Overall Study|Other: inconvenience|1|||
160590241|NCT01295580|579878598|FG001|Overall Study|Other: inconvenience|0|||
160590242|NCT01295580|579878597|FG000|Overall Study|Other: family objection|0|||
160590243|NCT01295580|579878598|FG001|Overall Study|Other: family objection|1|||
160590244|NCT05441592|579878601|FG000|Overall Study|Lost to Follow-up|1|||
160590245|NCT05441592|579878602|FG001|Overall Study|Lost to Follow-up|5|||
160590246|NCT01021852|579878603|FG000|Treatment Period 1|Adverse Event|3|||
160590247|NCT01021852|579878604|FG001|Treatment Period 1|Adverse Event|1|||
160590248|NCT01021852|579878605|FG002|Treatment Period 1|Adverse Event|1|||
160590249|NCT01021852|579878606|FG003|Treatment Period 1|Adverse Event|0|||
160590250|NCT01021852|579878607|FG004|Treatment Period 1|Adverse Event|2|||
160590251|NCT01021852|579878608|FG005|Treatment Period 1|Adverse Event|2|||
160590252|NCT01021852|579878609|FG006|Treatment Period 1|Adverse Event|0|||
160590253|NCT01021852|579878610|FG007|Treatment Period 1|Adverse Event|0|||
160590254|NCT01021852|579878603|FG000|Treatment Period 1|Pregnancy|0|||
160590255|NCT01021852|579878604|FG001|Treatment Period 1|Pregnancy|0|||
160590256|NCT01021852|579878605|FG002|Treatment Period 1|Pregnancy|1|||
160590257|NCT01021852|579878606|FG003|Treatment Period 1|Pregnancy|0|||
160590258|NCT01021852|579878607|FG004|Treatment Period 1|Pregnancy|0|||
160590259|NCT01021852|579878608|FG005|Treatment Period 1|Pregnancy|0|||
160590260|NCT01021852|579878609|FG006|Treatment Period 1|Pregnancy|0|||
160590261|NCT01021852|579878610|FG007|Treatment Period 1|Pregnancy|0|||
160590262|NCT01021852|579878603|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160590263|NCT01021852|579878604|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160590264|NCT01021852|579878605|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160974663|NCT03093428|581297522|FG001|Overall Study|Not eligible for treatment|1|||
160974664|NCT03093428|581297521|FG000|Overall Study|Progression|14|||
160974665|NCT03093428|581297522|FG001|Overall Study|Progression|4|||
160974666|NCT03093428|581297521|FG000|Overall Study|Death|1|||
160974667|NCT03093428|581297522|FG001|Overall Study|Death|0|||
160974668|NCT03093428|581297521|FG000|Overall Study|Adverse Event|1|||
160974669|NCT03093428|581297522|FG001|Overall Study|Adverse Event|0|||
160974670|NCT03093428|581297521|FG000|Overall Study|Withdrawal by Subject|1|||
160974671|NCT03093428|581297522|FG001|Overall Study|Withdrawal by Subject|1|||
160974672|NCT01336634|581297526|FG000|Overall Study|Study closed/terminated|5|||
160974673|NCT01336634|581297527|FG001|Overall Study|Study closed/terminated|6|||
160974674|NCT01336634|581297528|FG002|Overall Study|Study closed/terminated|6|||
160974675|NCT01336634|581297526|FG000|Overall Study|Lost to Follow-up|2|||
160590265|NCT01021852|579878606|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160590266|NCT01021852|579878607|FG004|Treatment Period 1|Withdrawal by Subject|1|||
160590267|NCT01021852|579878608|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160974676|NCT01336634|581297527|FG001|Overall Study|Lost to Follow-up|1|||
160657746|NCT01104662|580127658|FG006|Overall Study|Reason not specified|0|||
160657747|NCT01104662|580127659|FG007|Overall Study|Reason not specified|0|||
160657748|NCT01104662|580127652|FG000|Overall Study|Randomized but not treated|3|||
160657749|NCT01104662|580127653|FG001|Overall Study|Randomized but not treated|4|||
160657750|NCT01104662|580127654|FG002|Overall Study|Randomized but not treated|1|||
160657751|NCT01104662|580127655|FG003|Overall Study|Randomized but not treated|0|||
160657752|NCT01104662|580127656|FG004|Overall Study|Randomized but not treated|0|||
160657753|NCT01104662|580127657|FG005|Overall Study|Randomized but not treated|1|||
160657754|NCT01104662|580127658|FG006|Overall Study|Randomized but not treated|0|||
160657755|NCT01104662|580127659|FG007|Overall Study|Randomized but not treated|0|||
160657756|NCT02937701|580129779|FG000|Day 1 to Week 22|Adverse Event|11|||
160657757|NCT02937701|580129780|FG001|Day 1 to Week 22|Adverse Event|14|||
160657758|NCT02937701|580129781|FG002|Day 1 to Week 22|Adverse Event|0|||
160657759|NCT02937701|580129782|FG003|Day 1 to Week 22|Adverse Event|0|||
160657760|NCT02937701|580129783|FG004|Day 1 to Week 22|Adverse Event|0|||
160657761|NCT02937701|580129779|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
160657762|NCT02937701|580129780|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
160657763|NCT02937701|580129781|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
160657764|NCT02937701|580129782|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
160657765|NCT02937701|580129783|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
160657766|NCT02937701|580129779|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
160657767|NCT02937701|580129780|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
160657768|NCT02937701|580129781|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
160657769|NCT02937701|580129782|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
160657770|NCT02937701|580129783|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
160657771|NCT02937701|580129779|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
160657772|NCT02937701|580129780|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
160657773|NCT02937701|580129781|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
160657774|NCT02937701|580129782|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
160657775|NCT02937701|580129783|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
160657776|NCT02937701|580129779|FG000|Day 1 to Week 22|Death|1|||
160657777|NCT02937701|580129780|FG001|Day 1 to Week 22|Death|1|||
160657778|NCT02937701|580129781|FG002|Day 1 to Week 22|Death|0|||
160657779|NCT02937701|580129782|FG003|Day 1 to Week 22|Death|0|||
160657780|NCT02937701|580129783|FG004|Day 1 to Week 22|Death|0|||
160657781|NCT02937701|580129779|FG000|Day 1 to Week 22|Protocol Violation|1|||
160657782|NCT02937701|580129780|FG001|Day 1 to Week 22|Protocol Violation|1|||
160657783|NCT02937701|580129781|FG002|Day 1 to Week 22|Protocol Violation|0|||
160657784|NCT02937701|580129782|FG003|Day 1 to Week 22|Protocol Violation|0|||
160657785|NCT02937701|580129783|FG004|Day 1 to Week 22|Protocol Violation|0|||
160657786|NCT02937701|580129779|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
160657787|NCT02937701|580129780|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
160657788|NCT02937701|580129781|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
160657789|NCT02937701|580129782|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
160657790|NCT02937701|580129783|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
160657791|NCT02937701|580129779|FG000|Day 1 to Week 22|Physician Decision|2|||
160657792|NCT02937701|580129780|FG001|Day 1 to Week 22|Physician Decision|0|||
160657793|NCT02937701|580129781|FG002|Day 1 to Week 22|Physician Decision|0|||
160657794|NCT02937701|580129782|FG003|Day 1 to Week 22|Physician Decision|0|||
160657795|NCT02937701|580129783|FG004|Day 1 to Week 22|Physician Decision|0|||
160657796|NCT02937701|580129779|FG000|Day 1 to Week 22|Other|1|||
160657797|NCT02937701|580129780|FG001|Day 1 to Week 22|Other|0|||
160657798|NCT02937701|580129781|FG002|Day 1 to Week 22|Other|0|||
160657799|NCT02937701|580129782|FG003|Day 1 to Week 22|Other|0|||
160657800|NCT02937701|580129783|FG004|Day 1 to Week 22|Other|0|||
160657801|NCT02937701|580129779|FG000|Week 22 to Week 50|Adverse Event|0|||
160657802|NCT02937701|580129780|FG001|Week 22 to Week 50|Adverse Event|0|||
160657803|NCT02937701|580129781|FG002|Week 22 to Week 50|Adverse Event|10|||
160657804|NCT02937701|580129782|FG003|Week 22 to Week 50|Adverse Event|3|||
160657805|NCT02937701|580129783|FG004|Week 22 to Week 50|Adverse Event|3|||
160657806|NCT02937701|580129779|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
160657807|NCT02937701|580129780|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
160657808|NCT02937701|580129781|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
160657809|NCT02937701|580129782|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
160657810|NCT02937701|580129783|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
160657811|NCT02937701|580129779|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
160657812|NCT02937701|580129780|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
160657813|NCT02937701|580129781|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
160657814|NCT02937701|580129782|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
160657815|NCT02937701|580129783|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
160657816|NCT02937701|580129779|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
160657817|NCT02937701|580129780|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
160657818|NCT02937701|580129781|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
160657819|NCT02937701|580129782|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
160657820|NCT02937701|580129783|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
160657821|NCT02937701|580129779|FG000|Week 22 to Week 50|Physician Decision|0|||
160657822|NCT02937701|580129780|FG001|Week 22 to Week 50|Physician Decision|0|||
160657823|NCT02937701|580129781|FG002|Week 22 to Week 50|Physician Decision|2|||
160657824|NCT02937701|580129782|FG003|Week 22 to Week 50|Physician Decision|0|||
160657825|NCT02937701|580129783|FG004|Week 22 to Week 50|Physician Decision|1|||
160657826|NCT02937701|580129779|FG000|Week 22 to Week 50|Other|0|||
160657827|NCT02937701|580129780|FG001|Week 22 to Week 50|Other|0|||
160657828|NCT02937701|580129781|FG002|Week 22 to Week 50|Other|0|||
160657829|NCT02937701|580129782|FG003|Week 22 to Week 50|Other|0|||
160657830|NCT02937701|580129783|FG004|Week 22 to Week 50|Other|1|||
160657831|NCT02289963|580129784|FG000|Overall Study|Adverse Event|1|||
160657832|NCT02289963|580129785|FG001|Overall Study|Adverse Event|2|||
160657833|NCT02289963|580129784|FG000|Overall Study|Poor compliance to protocol|1|||
160974677|NCT01336634|581297528|FG002|Overall Study|Lost to Follow-up|1|||
160974678|NCT01336634|581297526|FG000|Overall Study|Physician Decision|1|||
160974679|NCT01336634|581297527|FG001|Overall Study|Physician Decision|1|||
160974680|NCT01336634|581297528|FG002|Overall Study|Physician Decision|0|||
160974681|NCT01336634|581297526|FG000|Overall Study|Withdrawal by Subject|6|||
160974682|NCT01336634|581297527|FG001|Overall Study|Withdrawal by Subject|0|||
160974683|NCT01336634|581297528|FG002|Overall Study|Withdrawal by Subject|2|||
160974684|NCT01973491|581297529|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
160974685|NCT01973491|581297529|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
160974686|NCT01973491|581297529|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
160974687|NCT01863043|581297530|FG000|Overall Study|Death|6|||
160974688|NCT01863043|581297531|FG001|Overall Study|Death|1|||
160974689|NCT01863043|581297530|FG000|Overall Study|Withdrawal by Subject|0|||
160657834|NCT02289963|580129785|FG001|Overall Study|Poor compliance to protocol|0|||
160657835|NCT02289963|580129784|FG000|Overall Study|Withdrawal by Subject|1|||
160590268|NCT01021852|579878609|FG006|Treatment Period 1|Withdrawal by Subject|0|||
160590269|NCT01021852|579878610|FG007|Treatment Period 1|Withdrawal by Subject|1|||
160590270|NCT01021852|579878603|FG000|Treatment Period 1|Not Treated|0|||
160590271|NCT01021852|579878604|FG001|Treatment Period 1|Not Treated|0|||
160590272|NCT01021852|579878605|FG002|Treatment Period 1|Not Treated|0|||
160590273|NCT01021852|579878606|FG003|Treatment Period 1|Not Treated|2|||
160590274|NCT01021852|579878607|FG004|Treatment Period 1|Not Treated|0|||
160590275|NCT01021852|579878608|FG005|Treatment Period 1|Not Treated|0|||
160590276|NCT01021852|579878609|FG006|Treatment Period 1|Not Treated|0|||
160590277|NCT01021852|579878610|FG007|Treatment Period 1|Not Treated|0|||
160590278|NCT01021852|579878603|FG000|Washout Period-Placebo|Adverse Event|0|||
160590279|NCT01021852|579878604|FG001|Washout Period-Placebo|Adverse Event|0|||
160590280|NCT01021852|579878605|FG002|Washout Period-Placebo|Adverse Event|0|||
160590281|NCT01021852|579878606|FG003|Washout Period-Placebo|Adverse Event|1|||
160590282|NCT01021852|579878607|FG004|Washout Period-Placebo|Adverse Event|0|||
160590283|NCT01021852|579878608|FG005|Washout Period-Placebo|Adverse Event|1|||
160590284|NCT01021852|579878609|FG006|Washout Period-Placebo|Adverse Event|0|||
160590285|NCT01021852|579878610|FG007|Washout Period-Placebo|Adverse Event|0|||
160590286|NCT01021852|579878603|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
160590287|NCT01021852|579878604|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
160590288|NCT01021852|579878605|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
160590289|NCT01021852|579878606|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
160590290|NCT01021852|579878607|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
160590291|NCT01021852|579878608|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
160590292|NCT01021852|579878609|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
160590293|NCT01021852|579878610|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
160590294|NCT01021852|579878603|FG000|Washout Period-Placebo|Protocol Violation|0|||
160590295|NCT01021852|579878604|FG001|Washout Period-Placebo|Protocol Violation|0|||
160590296|NCT01021852|579878605|FG002|Washout Period-Placebo|Protocol Violation|0|||
160590297|NCT01021852|579878606|FG003|Washout Period-Placebo|Protocol Violation|0|||
160590298|NCT01021852|579878607|FG004|Washout Period-Placebo|Protocol Violation|0|||
160590299|NCT01021852|579878608|FG005|Washout Period-Placebo|Protocol Violation|0|||
160590300|NCT01021852|579878609|FG006|Washout Period-Placebo|Protocol Violation|1|||
160590301|NCT01021852|579878610|FG007|Washout Period-Placebo|Protocol Violation|0|||
160590302|NCT01021852|579878603|FG000|Washout Period-No Drug|Adverse Event|1|||
160590303|NCT01021852|579878604|FG001|Washout Period-No Drug|Adverse Event|0|||
160590304|NCT01021852|579878605|FG002|Washout Period-No Drug|Adverse Event|0|||
160590305|NCT01021852|579878606|FG003|Washout Period-No Drug|Adverse Event|0|||
160590306|NCT01021852|579878607|FG004|Washout Period-No Drug|Adverse Event|0|||
160590307|NCT01021852|579878608|FG005|Washout Period-No Drug|Adverse Event|1|||
160590308|NCT01021852|579878609|FG006|Washout Period-No Drug|Adverse Event|0|||
160590309|NCT01021852|579878610|FG007|Washout Period-No Drug|Adverse Event|0|||
160590310|NCT01021852|579878603|FG000|Treatment Period 2|Adverse Event|0|||
160590311|NCT01021852|579878604|FG001|Treatment Period 2|Adverse Event|1|||
160590312|NCT01021852|579878605|FG002|Treatment Period 2|Adverse Event|0|||
160590313|NCT01021852|579878606|FG003|Treatment Period 2|Adverse Event|0|||
160657836|NCT02289963|580129785|FG001|Overall Study|Withdrawal by Subject|0|||
160657837|NCT02289963|580129784|FG000|Overall Study|Last injection missed|2|||
160657838|NCT02289963|580129785|FG001|Overall Study|Last injection missed|2|||
160657839|NCT02289963|580129784|FG000|Overall Study|End treatment visit outside visit window|0|||
160657840|NCT02289963|580129785|FG001|Overall Study|End treatment visit outside visit window|4|||
160657841|NCT02289963|580129784|FG000|Overall Study|Other than specified above|0|||
160657842|NCT02289963|580129785|FG001|Overall Study|Other than specified above|2|||
160657843|NCT01507051|580129789|FG000|Overall Study|Withdrawal by Subject|1|||
160590314|NCT01021852|579878607|FG004|Treatment Period 2|Adverse Event|1|||
160590315|NCT01021852|579878608|FG005|Treatment Period 2|Adverse Event|0|||
160590316|NCT01021852|579878609|FG006|Treatment Period 2|Adverse Event|1|||
160590317|NCT01021852|579878610|FG007|Treatment Period 2|Adverse Event|0|||
160590318|NCT01021852|579878603|FG000|Treatment Period 2|Lack of Efficacy|0|||
160590319|NCT01021852|579878604|FG001|Treatment Period 2|Lack of Efficacy|0|||
160657844|NCT01507051|580129790|FG001|Overall Study|Withdrawal by Subject|3|||
160657845|NCT01507051|580129791|FG002|Overall Study|Withdrawal by Subject|1|||
160974690|NCT01863043|581297531|FG001|Overall Study|Withdrawal by Subject|2|||
160974691|NCT01863043|581297530|FG000|Overall Study|Adverse Event|7|||
160974692|NCT01863043|581297531|FG001|Overall Study|Adverse Event|8|||
160974693|NCT01863043|581297530|FG000|Overall Study|exclusion criteria found after enrollment|0|||
160974694|NCT01863043|581297531|FG001|Overall Study|exclusion criteria found after enrollment|1|||
160974695|NCT01987596|581297532|FG000|Overall Study|Physician Decision|1|||
160974696|NCT01987596|581297533|FG001|Overall Study|Physician Decision|0|||
160974697|NCT01987596|581297532|FG000|Overall Study|Progressive Disease; missing all period|0|||
160974698|NCT01987596|581297533|FG001|Overall Study|Progressive Disease; missing all period|1|||
160974699|NCT02632786|581297536|FG000|Overall Study|Adverse Event|2|||
160974700|NCT02632786|581297537|FG001|Overall Study|Adverse Event|1|||
160974701|NCT02632786|581297536|FG000|Overall Study|Death|3|||
160974702|NCT02632786|581297537|FG001|Overall Study|Death|2|||
160974703|NCT02632786|581297536|FG000|Overall Study|Physician Decision|5|||
160974704|NCT02632786|581297537|FG001|Overall Study|Physician Decision|4|||
160974705|NCT02632786|581297536|FG000|Overall Study|Withdrawal by Subject|1|||
160974706|NCT02632786|581297537|FG001|Overall Study|Withdrawal by Subject|0|||
160974707|NCT00854295|581297538|FG000|Overall Study|Death|7|||
160974708|NCT00854295|581297539|FG001|Overall Study|Death|0|||
160974709|NCT00854295|581297540|FG002|Overall Study|Death|1|||
160974710|NCT00854295|581297541|FG003|Overall Study|Death|1|||
160974711|NCT00854295|581297538|FG000|Overall Study|Adverse Event|6|||
160974712|NCT00854295|581297539|FG001|Overall Study|Adverse Event|1|||
160974713|NCT00854295|581297540|FG002|Overall Study|Adverse Event|1|||
160974714|NCT00854295|581297541|FG003|Overall Study|Adverse Event|3|||
160590320|NCT01021852|579878605|FG002|Treatment Period 2|Lack of Efficacy|0|||
160590321|NCT01021852|579878606|FG003|Treatment Period 2|Lack of Efficacy|0|||
160590322|NCT01021852|579878607|FG004|Treatment Period 2|Lack of Efficacy|0|||
160590323|NCT01021852|579878608|FG005|Treatment Period 2|Lack of Efficacy|1|||
160590324|NCT01021852|579878609|FG006|Treatment Period 2|Lack of Efficacy|0|||
160590325|NCT01021852|579878610|FG007|Treatment Period 2|Lack of Efficacy|0|||
160590326|NCT01021852|579878603|FG000|Treatment Period 2|Physician Decision|0|||
160590327|NCT01021852|579878604|FG001|Treatment Period 2|Physician Decision|0|||
160590328|NCT01021852|579878605|FG002|Treatment Period 2|Physician Decision|1|||
160590329|NCT01021852|579878606|FG003|Treatment Period 2|Physician Decision|0|||
160590330|NCT01021852|579878607|FG004|Treatment Period 2|Physician Decision|0|||
160590331|NCT01021852|579878608|FG005|Treatment Period 2|Physician Decision|0|||
160590332|NCT01021852|579878609|FG006|Treatment Period 2|Physician Decision|0|||
160590333|NCT01021852|579878610|FG007|Treatment Period 2|Physician Decision|0|||
160590334|NCT01021852|579878603|FG000|Treatment Period 2|Protocol Violation|0|||
160590335|NCT01021852|579878604|FG001|Treatment Period 2|Protocol Violation|0|||
160590336|NCT01021852|579878605|FG002|Treatment Period 2|Protocol Violation|0|||
160590337|NCT01021852|579878606|FG003|Treatment Period 2|Protocol Violation|0|||
160590338|NCT01021852|579878607|FG004|Treatment Period 2|Protocol Violation|1|||
160590339|NCT01021852|579878608|FG005|Treatment Period 2|Protocol Violation|0|||
160590340|NCT01021852|579878609|FG006|Treatment Period 2|Protocol Violation|1|||
160657846|NCT01507051|580129792|FG003|Overall Study|Withdrawal by Subject|6|||
160657847|NCT01507051|580129789|FG000|Overall Study|Physician Decision|0|||
160657848|NCT01507051|580129790|FG001|Overall Study|Physician Decision|0|||
160657849|NCT01507051|580129791|FG002|Overall Study|Physician Decision|0|||
160657850|NCT01507051|580129792|FG003|Overall Study|Physician Decision|1|||
160657851|NCT01507051|580129789|FG000|Overall Study|Adverse Event|1|||
160657852|NCT01507051|580129790|FG001|Overall Study|Adverse Event|0|||
160657853|NCT01507051|580129791|FG002|Overall Study|Adverse Event|0|||
160657854|NCT01507051|580129792|FG003|Overall Study|Adverse Event|0|||
160657855|NCT01941095|580129793|FG000|Overall Study|Insufficient therapeutic response|13|||
160657856|NCT01941095|580129793|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
160657857|NCT01941095|580129793|FG000|Overall Study|Adverse Event|11|||
160657858|NCT01941095|580129793|FG000|Overall Study|Physician Decision|3|||
160657859|NCT01941095|580129793|FG000|Overall Study|Withdrawal by Subject|17|||
160657860|NCT01941095|580129793|FG000|Overall Study|Lost to Follow-up|10|||
160657861|NCT02532764|580129794|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
160657862|NCT02532764|580129795|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
160657863|NCT02532764|580129796|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
160657864|NCT02532764|580129797|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
160657865|NCT02532764|580129798|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
160657866|NCT02532764|580129799|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
160657867|NCT02532764|580129800|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
160657868|NCT02532764|580129801|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
160657869|NCT02532764|580129802|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
160657870|NCT02532764|580129803|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
160657871|NCT03527745|580129804|FG000|Overall Study|Lost to Follow-up|3|||
160657872|NCT03527745|580129805|FG001|Overall Study|Lost to Follow-up|6|||
160657873|NCT03527745|580129806|FG002|Overall Study|Lost to Follow-up|7|||
160657874|NCT03527745|580129807|FG003|Overall Study|Lost to Follow-up|9|||
160657875|NCT03527745|580129808|FG004|Overall Study|Lost to Follow-up|0|||
160657876|NCT03527745|580129809|FG005|Overall Study|Lost to Follow-up|2|||
160657877|NCT03527745|580129810|FG006|Overall Study|Lost to Follow-up|3|||
160657878|NCT03527745|580129811|FG007|Overall Study|Lost to Follow-up|2|||
160657879|NCT03527745|580129812|FG008|Overall Study|Lost to Follow-up|3|||
160657880|NCT03527745|580129813|FG009|Overall Study|Lost to Follow-up|2|||
160657881|NCT03527745|580129814|FG010|Overall Study|Lost to Follow-up|1|||
160657882|NCT03527745|580129815|FG011|Overall Study|Lost to Follow-up|1|||
160657883|NCT03527745|580129816|FG012|Overall Study|Lost to Follow-up|0|||
160657884|NCT03527745|580129817|FG013|Overall Study|Lost to Follow-up|0|||
160657885|NCT03527745|580129818|FG014|Overall Study|Lost to Follow-up|0|||
160657886|NCT03527745|580129819|FG015|Overall Study|Lost to Follow-up|0|||
160657887|NCT03527745|580129820|FG016|Overall Study|Lost to Follow-up|1|||
160657888|NCT03527745|580129821|FG017|Overall Study|Lost to Follow-up|0|||
160657889|NCT03527745|580129822|FG018|Overall Study|Lost to Follow-up|0|||
160657890|NCT03527745|580129823|FG019|Overall Study|Lost to Follow-up|1|||
160657891|NCT03527745|580129824|FG020|Overall Study|Lost to Follow-up|1|||
160657892|NCT03527745|580129825|FG021|Overall Study|Lost to Follow-up|5|||
160657893|NCT03527745|580129826|FG022|Overall Study|Lost to Follow-up|6|||
160657894|NCT03527745|580129827|FG023|Overall Study|Lost to Follow-up|8|||
160974715|NCT00854295|581297538|FG000|Overall Study|Lost to Follow-up|18|||
160974716|NCT00854295|581297539|FG001|Overall Study|Lost to Follow-up|5|||
160974717|NCT00854295|581297540|FG002|Overall Study|Lost to Follow-up|21|||
160974718|NCT00854295|581297541|FG003|Overall Study|Lost to Follow-up|21|||
160974719|NCT00854295|581297538|FG000|Overall Study|Physician Decision|10|||
160974720|NCT00854295|581297539|FG001|Overall Study|Physician Decision|0|||
160974721|NCT00854295|581297540|FG002|Overall Study|Physician Decision|0|||
160974722|NCT00854295|581297541|FG003|Overall Study|Physician Decision|0|||
160974723|NCT00709592|581297542|FG000|Overall Study|Unable to proceed to transplant|0|||
160974724|NCT00709592|581297543|FG001|Overall Study|Unable to proceed to transplant|1|||
160974725|NCT03154359|581297547|FG000|Overall Study|Adverse Event|1|||
160974726|NCT03154359|581297547|FG000|Overall Study|Lack of Efficacy|2|||
160974727|NCT03154359|581297547|FG000|Overall Study|Lost to Follow-up|3|||
160974728|NCT03154359|581297547|FG000|Overall Study|Physician Decision|3|||
160974729|NCT03154359|581297547|FG000|Overall Study|Protocol Violation|4|||
160974730|NCT03154359|581297547|FG000|Overall Study|Withdrawal by Subject|5|||
160974731|NCT03154359|581297547|FG000|Overall Study|Disruption of study due to COVID-19|4|||
160974732|NCT02440594|581297548|FG000|Overall Study|Lost to Follow-up|34|||
160974733|NCT02440594|581297549|FG001|Overall Study|Lost to Follow-up|33|||
160974734|NCT02440594|581297550|FG002|Overall Study|Lost to Follow-up|54|||
160974735|NCT02440594|581297551|FG003|Overall Study|Lost to Follow-up|47|||
160974736|NCT02440594|581297552|FG004|Overall Study|Lost to Follow-up|5|||
160974737|NCT02440594|581297553|FG005|Overall Study|Lost to Follow-up|4|||
160974738|NCT02440594|581297554|FG006|Overall Study|Lost to Follow-up|28|||
160974739|NCT02440594|581297555|FG007|Overall Study|Lost to Follow-up|48|||
160974740|NCT02440594|581297548|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
160974741|NCT02440594|581297549|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
160974742|NCT02440594|581297550|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
160974743|NCT02440594|581297551|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
160974744|NCT02440594|581297552|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
160974745|NCT02440594|581297553|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
160974746|NCT02440594|581297554|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
160974747|NCT02440594|581297555|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
160590341|NCT01021852|579878610|FG007|Treatment Period 2|Protocol Violation|0|||
160590342|NCT01021852|579878603|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160590343|NCT01021852|579878604|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160590344|NCT01021852|579878605|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160590345|NCT01021852|579878606|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160590346|NCT01021852|579878607|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160590347|NCT01021852|579878608|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160590348|NCT01021852|579878609|FG006|Treatment Period 2|Withdrawal by Subject|1|||
160590349|NCT01021852|579878610|FG007|Treatment Period 2|Withdrawal by Subject|2|||
160590350|NCT01025817|579878611|FG000|Completed Study Medication|Adverse Event|66|||
160590351|NCT01025817|579878612|FG001|Completed Study Medication|Adverse Event|39|||
160590352|NCT01025817|579878611|FG000|Completed Study Medication|Protocol Deviation|9|||
160590353|NCT01025817|579878612|FG001|Completed Study Medication|Protocol Deviation|8|||
160590354|NCT01025817|579878611|FG000|Completed Study Medication|Withdrawal by Subject|8|||
160590355|NCT01025817|579878612|FG001|Completed Study Medication|Withdrawal by Subject|9|||
160590356|NCT01025817|579878611|FG000|Completed Study Medication|Administrative problems|7|||
160590357|NCT01025817|579878612|FG001|Completed Study Medication|Administrative problems|5|||
160590358|NCT01025817|579878611|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
160590359|NCT01025817|579878612|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
160590360|NCT01025817|579878611|FG000|Completed Study Medication|Abnormal test procedure|4|||
160590361|NCT01025817|579878612|FG001|Completed Study Medication|Abnormal test procedure|0|||
160590362|NCT01025817|579878611|FG000|Completed Study Medication|Graft loss|2|||
160590363|NCT01025817|579878612|FG001|Completed Study Medication|Graft loss|5|||
160590364|NCT01025817|579878611|FG000|Completed Study Medication|Death|2|||
160590365|NCT01025817|579878612|FG001|Completed Study Medication|Death|2|||
160590366|NCT01025817|579878611|FG000|Completed Study Medication|Abnormal lab values|0|||
160590367|NCT01025817|579878612|FG001|Completed Study Medication|Abnormal lab values|2|||
160590368|NCT01025817|579878611|FG000|Completed Study Medication|Subject no longer required study drug|0|||
160590369|NCT01025817|579878612|FG001|Completed Study Medication|Subject no longer required study drug|1|||
160590370|NCT01025817|579878611|FG000|Completed Study Medication|Lost to Follow-up|0|||
160590371|NCT01025817|579878612|FG001|Completed Study Medication|Lost to Follow-up|1|||
160590372|NCT01025817|579878611|FG000|Completed Study|Withdrawal by Subject|8|||
160590373|NCT01025817|579878612|FG001|Completed Study|Withdrawal by Subject|16|||
160590374|NCT01025817|579878611|FG000|Completed Study|Death|6|||
160974748|NCT02440594|581297548|FG000|Overall Study|Withdrawal by Subject|81|||
160974749|NCT02440594|581297549|FG001|Overall Study|Withdrawal by Subject|67|||
160590375|NCT01025817|579878612|FG001|Completed Study|Death|5|||
160590376|NCT01025817|579878611|FG000|Completed Study|Missing|2|||
160590377|NCT01025817|579878612|FG001|Completed Study|Missing|0|||
160590378|NCT01025817|579878611|FG000|Completed Study|Lost to Follow-up|0|||
160590379|NCT01025817|579878612|FG001|Completed Study|Lost to Follow-up|1|||
160657895|NCT03527745|580129828|FG024|Overall Study|Lost to Follow-up|1|||
160657896|NCT03527745|580129829|FG025|Overall Study|Lost to Follow-up|3|||
160657897|NCT01475838|580129834|FG000|Randomized Phase|Randomized but Not Treated|0|||
160657898|NCT01475838|580129835|FG001|Randomized Phase|Randomized but Not Treated|5|||
160657899|NCT01475838|580129834|FG000|Randomized Phase|Adverse Event|6|||
160657900|NCT01475838|580129835|FG001|Randomized Phase|Adverse Event|1|||
160657901|NCT01475838|580129834|FG000|Randomized Phase|Pregnancy|0|||
160657902|NCT01475838|580129835|FG001|Randomized Phase|Pregnancy|1|||
160657903|NCT01475838|580129834|FG000|Randomized Phase|Investigators Discretion|1|||
160657904|NCT01475838|580129835|FG001|Randomized Phase|Investigators Discretion|2|||
160657905|NCT01475838|580129834|FG000|Randomized Phase|Withdrew Consent|10|||
160590380|NCT01419665|579878613|FG000|Combination Treatment|Adverse Event|7|||
160590381|NCT01419665|579878614|FG001|Combination Treatment|Adverse Event|10|||
160590382|NCT01419665|579878613|FG000|Combination Treatment|Physician Decision|5|||
160590383|NCT01419665|579878614|FG001|Combination Treatment|Physician Decision|8|||
160590384|NCT01419665|579878613|FG000|Combination Treatment|Protocol Violation|6|||
160590385|NCT01419665|579878614|FG001|Combination Treatment|Protocol Violation|2|||
160590386|NCT01419665|579878613|FG000|Combination Treatment|disease progression|10|||
160590387|NCT01419665|579878614|FG001|Combination Treatment|disease progression|9|||
160590388|NCT01419665|579878613|FG000|Combination Treatment|Death|5|||
160590389|NCT01419665|579878614|FG001|Combination Treatment|Death|7|||
160590390|NCT01419665|579878613|FG000|Combination Treatment|administrative problems|0|||
160590391|NCT01419665|579878614|FG001|Combination Treatment|administrative problems|1|||
160590392|NCT01419665|579878613|FG000|Combination Treatment|Withdrawal by Subject|5|||
160590393|NCT01419665|579878614|FG001|Combination Treatment|Withdrawal by Subject|4|||
160590394|NCT01419665|579878613|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
160590395|NCT01419665|579878614|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
160590396|NCT01419665|579878613|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
160590397|NCT01419665|579878614|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
160590398|NCT01419665|579878613|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
160590399|NCT01419665|579878614|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
160590400|NCT01419665|579878613|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
160590401|NCT01419665|579878614|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
160590402|NCT01419665|579878613|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
160590403|NCT01419665|579878614|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
160590404|NCT01419665|579878613|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
160590405|NCT01419665|579878614|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
160590406|NCT01419665|579878613|FG000|Maintenance Treatment and/or Follow up|Death|1|||
160590407|NCT01419665|579878614|FG001|Maintenance Treatment and/or Follow up|Death|2|||
160590408|NCT01419665|579878613|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
160590409|NCT01419665|579878614|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
160590410|NCT01419665|579878613|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
160590411|NCT01419665|579878614|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
160590412|NCT01419665|579878613|FG000|Open Label Phase|Death|1|||
160590413|NCT01419665|579878614|FG001|Open Label Phase|Death|0|||
160590414|NCT01419665|579878613|FG000|Open Label Phase|disease progression|0|||
160590415|NCT01419665|579878614|FG001|Open Label Phase|disease progression|1|||
160590416|NCT01655823|579878615|FG000|Overall Study|Lost to Follow-up|0|||
160590417|NCT01655823|579878616|FG001|Overall Study|Lost to Follow-up|1|||
160590418|NCT01655823|579878617|FG002|Overall Study|Lost to Follow-up|0|||
160590419|NCT01655823|579878618|FG003|Overall Study|Lost to Follow-up|0|||
160590420|NCT01655823|579878619|FG004|Overall Study|Lost to Follow-up|1|||
160590421|NCT01655823|579878615|FG000|Overall Study|Withdrawal by Subject|0|||
160590422|NCT01655823|579878616|FG001|Overall Study|Withdrawal by Subject|1|||
160590423|NCT01655823|579878617|FG002|Overall Study|Withdrawal by Subject|0|||
160657906|NCT01475838|580129835|FG001|Randomized Phase|Withdrew Consent|14|||
160657907|NCT01475838|580129834|FG000|Randomized Phase|Lost to Follow-up|3|||
160590424|NCT01655823|579878618|FG003|Overall Study|Withdrawal by Subject|1|||
160590425|NCT01655823|579878619|FG004|Overall Study|Withdrawal by Subject|0|||
160460187|NCT03248479|579417579|FG011|Overall Study|Study terminated by sponsor|4|||
160460188|NCT03248479|579417580|FG012|Overall Study|Study terminated by sponsor|0|||
160460189|NCT03248479|579417568|FG000|Overall Study|Consent withdrawn|6|||
160590426|NCT02632110|579878624|FG000|Overall Study|Withdrawal by Subject|1|||
160590427|NCT02632110|579878625|FG001|Overall Study|Withdrawal by Subject|1|||
160590428|NCT02632110|579878626|FG002|Overall Study|Withdrawal by Subject|0|||
160590429|NCT02632110|579878627|FG003|Overall Study|Withdrawal by Subject|0|||
160590430|NCT02632110|579878628|FG004|Overall Study|Withdrawal by Subject|1|||
160590431|NCT02632110|579878629|FG005|Overall Study|Withdrawal by Subject|1|||
160590432|NCT02632110|579878630|FG006|Overall Study|Withdrawal by Subject|3|||
160590433|NCT02632110|579878631|FG007|Overall Study|Withdrawal by Subject|3|||
160590434|NCT02632110|579878632|FG008|Overall Study|Withdrawal by Subject|1|||
160590435|NCT02632110|579878633|FG009|Overall Study|Withdrawal by Subject|1|||
160590436|NCT02998554|579878637|FG000|Overall Study|Adverse Event|8|||
160590437|NCT02998554|579878638|FG001|Overall Study|Adverse Event|3|||
160590438|NCT02998554|579878637|FG000|Overall Study|Protocol deviation|1|||
160590439|NCT02998554|579878638|FG001|Overall Study|Protocol deviation|0|||
160590440|NCT02998554|579878637|FG000|Overall Study|Withdrawal by Subject|2|||
160590441|NCT02998554|579878638|FG001|Overall Study|Withdrawal by Subject|6|||
160590442|NCT02998554|579878637|FG000|Overall Study|Lost to Follow-up|0|||
160590443|NCT02998554|579878638|FG001|Overall Study|Lost to Follow-up|1|||
160590444|NCT02998554|579878637|FG000|Overall Study|Lack of Efficacy|0|||
160590445|NCT02998554|579878638|FG001|Overall Study|Lack of Efficacy|1|||
160590446|NCT02953782|579878639|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
160590447|NCT02953782|579878640|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
160590448|NCT02953782|579878641|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
160590449|NCT02953782|579878642|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
160590450|NCT02953782|579878643|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
160590451|NCT02953782|579878644|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
160974750|NCT02440594|581297550|FG002|Overall Study|Withdrawal by Subject|59|||
160974751|NCT02440594|581297551|FG003|Overall Study|Withdrawal by Subject|38|||
160974752|NCT02440594|581297552|FG004|Overall Study|Withdrawal by Subject|2|||
160974753|NCT02440594|581297553|FG005|Overall Study|Withdrawal by Subject|2|||
160974754|NCT02440594|581297554|FG006|Overall Study|Withdrawal by Subject|7|||
160974755|NCT02440594|581297555|FG007|Overall Study|Withdrawal by Subject|7|||
160974756|NCT02440594|581297548|FG000|Overall Study|Administratively w/drawn|3|||
160974757|NCT02440594|581297549|FG001|Overall Study|Administratively w/drawn|2|||
160974758|NCT02440594|581297550|FG002|Overall Study|Administratively w/drawn|0|||
160974759|NCT02440594|581297551|FG003|Overall Study|Administratively w/drawn|0|||
160974760|NCT02440594|581297552|FG004|Overall Study|Administratively w/drawn|0|||
160974761|NCT02440594|581297553|FG005|Overall Study|Administratively w/drawn|0|||
160974762|NCT02440594|581297554|FG006|Overall Study|Administratively w/drawn|2|||
160974763|NCT02440594|581297555|FG007|Overall Study|Administratively w/drawn|1|||
160974764|NCT04250337|581297556|FG000|Overall Study|Adverse Event|0|||
160974765|NCT04250337|581297557|FG001|Overall Study|Adverse Event|3|||
160974766|NCT04250337|581297556|FG000|Overall Study|Lack of Efficacy|1|||
160974767|NCT04250337|581297557|FG001|Overall Study|Lack of Efficacy|3|||
160974768|NCT04250337|581297556|FG000|Overall Study|Physician Decision|1|||
160974769|NCT04250337|581297557|FG001|Overall Study|Physician Decision|0|||
160974770|NCT04250337|581297556|FG000|Overall Study|Protocol Deviation|2|||
160974771|NCT04250337|581297557|FG001|Overall Study|Protocol Deviation|2|||
160974772|NCT04250337|581297556|FG000|Overall Study|Withdrawal by Subject|4|||
160974773|NCT04250337|581297557|FG001|Overall Study|Withdrawal by Subject|3|||
160974774|NCT00152763|581297558|FG000|Overall Study|Death|4|||
160974775|NCT00152763|581297559|FG001|Overall Study|Death|1|||
160974776|NCT00152763|581297560|FG002|Overall Study|Death|2|||
160974777|NCT00152763|581297561|FG003|Overall Study|Death|1|||
160974778|NCT00152763|581297558|FG000|Overall Study|Lost to Follow-up|6|||
160974779|NCT00152763|581297559|FG001|Overall Study|Lost to Follow-up|4|||
160974780|NCT00152763|581297560|FG002|Overall Study|Lost to Follow-up|2|||
160974781|NCT00152763|581297561|FG003|Overall Study|Lost to Follow-up|13|||
160974782|NCT04668989|581297564|FG000|First Intervention|Covid-19 related self-isolation|0|||
160974783|NCT04668989|581297565|FG001|First Intervention|Covid-19 related self-isolation|1|||
160974784|NCT04668989|581297564|FG000|Second Intervention|Adverse Event|0|||
160974785|NCT04668989|581297565|FG001|Second Intervention|Adverse Event|1|||
160974786|NCT00569803|581297566|FG000|Overall Study|Lost to Follow-up|1|||
160974787|NCT00569803|581297567|FG001|Overall Study|Lost to Follow-up|0|||
160974788|NCT00569803|581297568|FG002|Overall Study|Lost to Follow-up|0|||
160974789|NCT00569803|581297569|FG003|Overall Study|Lost to Follow-up|0|||
160974790|NCT00569803|581297570|FG004|Overall Study|Lost to Follow-up|0|||
160974791|NCT00569803|581297571|FG005|Overall Study|Lost to Follow-up|0|||
160974792|NCT00569803|581297572|FG006|Overall Study|Lost to Follow-up|0|||
160974793|NCT00569803|581297573|FG007|Overall Study|Lost to Follow-up|0|||
160974794|NCT00569803|581297566|FG000|Overall Study|injection syringe leaked during dosing|0|||
160974795|NCT00569803|581297567|FG001|Overall Study|injection syringe leaked during dosing|0|||
160974796|NCT00569803|581297568|FG002|Overall Study|injection syringe leaked during dosing|0|||
160974797|NCT00569803|581297569|FG003|Overall Study|injection syringe leaked during dosing|1|||
160974798|NCT00569803|581297570|FG004|Overall Study|injection syringe leaked during dosing|0|||
160974799|NCT00569803|581297571|FG005|Overall Study|injection syringe leaked during dosing|0|||
160974800|NCT00569803|581297572|FG006|Overall Study|injection syringe leaked during dosing|0|||
160974801|NCT00569803|581297573|FG007|Overall Study|injection syringe leaked during dosing|0|||
160974802|NCT00569803|581297566|FG000|Overall Study|Withdrawal by Subject|0|||
160974803|NCT00569803|581297567|FG001|Overall Study|Withdrawal by Subject|0|||
160974804|NCT00569803|581297568|FG002|Overall Study|Withdrawal by Subject|0|||
160974805|NCT00569803|581297569|FG003|Overall Study|Withdrawal by Subject|0|||
160974806|NCT00569803|581297570|FG004|Overall Study|Withdrawal by Subject|0|||
160974807|NCT00569803|581297571|FG005|Overall Study|Withdrawal by Subject|0|||
160974808|NCT00569803|581297572|FG006|Overall Study|Withdrawal by Subject|0|||
160974809|NCT00569803|581297573|FG007|Overall Study|Withdrawal by Subject|1|||
160974810|NCT01993823|581297574|FG000|Overall Study|Requested by the patient|6|||
160974811|NCT01993823|581297575|FG001|Overall Study|Requested by the patient|11|||
160974812|NCT01993823|581297574|FG000|Overall Study|Protocol Violation|0|||
160974813|NCT01993823|581297575|FG001|Overall Study|Protocol Violation|1|||
160974814|NCT01993823|581297574|FG000|Overall Study|Lost to Follow-up|1|||
160974815|NCT01993823|581297575|FG001|Overall Study|Lost to Follow-up|4|||
160974816|NCT00791921|581297582|FG000|Overall Study|Protocol planed|24|||
160590452|NCT02953782|579878645|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
160590453|NCT02953782|579878646|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
160590454|NCT02953782|579878639|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
160590455|NCT02953782|579878640|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
160590456|NCT02953782|579878641|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
160590457|NCT02953782|579878642|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
160590458|NCT02953782|579878643|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
160590459|NCT02953782|579878644|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
160590460|NCT02953782|579878645|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
160590461|NCT02953782|579878646|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
160590462|NCT02953782|579878639|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
160590463|NCT02953782|579878640|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
160590464|NCT02953782|579878641|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
160590465|NCT02953782|579878642|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
160590466|NCT02953782|579878643|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
160590467|NCT02953782|579878644|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
160590468|NCT02953782|579878645|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
160590469|NCT02953782|579878646|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
160590470|NCT02953782|579878639|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
160590471|NCT02953782|579878640|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
160590472|NCT02953782|579878641|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
160590473|NCT02953782|579878642|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
160590474|NCT02953782|579878643|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
160590475|NCT02953782|579878644|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
160590476|NCT02953782|579878645|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
160590477|NCT02953782|579878646|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
160590478|NCT02953782|579878639|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
160590479|NCT02953782|579878640|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
160590480|NCT02953782|579878641|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
160590481|NCT02953782|579878642|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
160590482|NCT02953782|579878643|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
160590483|NCT02953782|579878644|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
160590484|NCT02953782|579878645|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
160590485|NCT02953782|579878646|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
160590486|NCT02953782|579878639|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
160590487|NCT02953782|579878640|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
160590488|NCT02953782|579878641|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
160590489|NCT02953782|579878642|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
160590490|NCT02953782|579878643|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
160590491|NCT02953782|579878644|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
160590492|NCT02953782|579878645|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
160974817|NCT00791921|581297583|FG001|Overall Study|Protocol planed|88|||
160974818|NCT00791921|581297582|FG000|Overall Study|Withdrawal by Subject|1|||
160974819|NCT00791921|581297583|FG001|Overall Study|Withdrawal by Subject|2|||
160974820|NCT00791921|581297582|FG000|Overall Study|Adverse Event|8|||
160974821|NCT00791921|581297583|FG001|Overall Study|Adverse Event|2|||
160974822|NCT00791921|581297582|FG000|Overall Study|Lack of Efficacy|0|||
160974823|NCT00791921|581297583|FG001|Overall Study|Lack of Efficacy|2|||
160974824|NCT00791921|581297582|FG000|Overall Study|Lack of study drug administration|1|||
160974825|NCT00791921|581297583|FG001|Overall Study|Lack of study drug administration|1|||
160974826|NCT00791921|581297582|FG000|Overall Study|Reason other than those above|0|||
160974827|NCT00791921|581297583|FG001|Overall Study|Reason other than those above|1|||
160974828|NCT01592695|581297587|FG000|Overall Study|Lost to Follow-up|8|||
160974829|NCT01592695|581297588|FG001|Overall Study|Lost to Follow-up|4|||
160974830|NCT00474175|581297589|FG000|Overall Study|Lack of Efficacy|0|||
160974831|NCT00474175|581297590|FG001|Overall Study|Lack of Efficacy|0|||
160974832|NCT00474175|581297591|FG002|Overall Study|Lack of Efficacy|1|||
160974833|NCT00474175|581297589|FG000|Overall Study|Withdrawal by Subject|0|||
160974834|NCT00474175|581297590|FG001|Overall Study|Withdrawal by Subject|1|||
160974835|NCT00474175|581297591|FG002|Overall Study|Withdrawal by Subject|1|||
160974836|NCT00474175|581297589|FG000|Overall Study|Ineligible|1|||
160974837|NCT00474175|581297590|FG001|Overall Study|Ineligible|3|||
160974838|NCT00474175|581297591|FG002|Overall Study|Ineligible|1|||
160974839|NCT00474175|581297589|FG000|Overall Study|Protocol Violation|0|||
160974840|NCT00474175|581297590|FG001|Overall Study|Protocol Violation|2|||
160974841|NCT00474175|581297591|FG002|Overall Study|Protocol Violation|1|||
160974842|NCT00474175|581297589|FG000|Overall Study|Administrative|0|||
160974843|NCT00474175|581297590|FG001|Overall Study|Administrative|1|||
160657908|NCT01475838|580129835|FG001|Randomized Phase|Lost to Follow-up|4|||
160657909|NCT01475838|580129834|FG000|Randomized Phase|Participant Noncompliance|1|||
160657910|NCT01475838|580129835|FG001|Randomized Phase|Participant Noncompliance|5|||
160974844|NCT00474175|581297591|FG002|Overall Study|Administrative|0|||
160974845|NCT01619787|581297592|FG000|Overall Study|Lost to Follow-up|5|||
160974846|NCT03029780|581297596|FG000|Overall Study|Disease Progression|20|||
160974847|NCT03029780|581297597|FG001|Overall Study|Disease Progression|22|||
160974848|NCT03029780|581297596|FG000|Overall Study|Study Drug Toxicity|15|||
160974849|NCT03029780|581297597|FG001|Overall Study|Study Drug Toxicity|11|||
160974850|NCT03029780|581297596|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
160974851|NCT03029780|581297597|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
160974852|NCT03029780|581297596|FG000|Overall Study|Participant request to discontinue study treatment|4|||
160974853|NCT03029780|581297597|FG001|Overall Study|Participant request to discontinue study treatment|1|||
160974854|NCT03029780|581297596|FG000|Overall Study|Maximum clinical benefit|1|||
160974855|NCT03029780|581297597|FG001|Overall Study|Maximum clinical benefit|0|||
160974856|NCT03029780|581297596|FG000|Overall Study|Participant no longer meets study criteria|0|||
160974857|NCT03029780|581297597|FG001|Overall Study|Participant no longer meets study criteria|1|||
160974858|NCT03029780|581297596|FG000|Overall Study|Other reasons|6|||
160974859|NCT03029780|581297597|FG001|Overall Study|Other reasons|6|||
160974860|NCT03029780|581297596|FG000|Overall Study|Not reported|1|||
160974861|NCT03029780|581297597|FG001|Overall Study|Not reported|1|||
160974862|NCT03029780|581297596|FG000|Overall Study|Death|2|||
160974863|NCT03029780|581297597|FG001|Overall Study|Death|6|||
160974864|NCT00178256|581297598|FG000|Overall Study|Adverse Event|2|||
160974865|NCT00178256|581297599|FG001|Overall Study|Adverse Event|0|||
160974866|NCT00178256|581297600|FG002|Overall Study|Adverse Event|0|||
160974867|NCT00178256|581297601|FG003|Overall Study|Adverse Event|0|||
160974868|NCT00178256|581297598|FG000|Overall Study|Death|0|||
160974869|NCT00178256|581297599|FG001|Overall Study|Death|1|||
160974870|NCT00178256|581297600|FG002|Overall Study|Death|0|||
160974871|NCT00178256|581297601|FG003|Overall Study|Death|1|||
160974872|NCT00178256|581297598|FG000|Overall Study|Cancer progression|2|||
160974873|NCT00178256|581297599|FG001|Overall Study|Cancer progression|0|||
160974874|NCT00178256|581297600|FG002|Overall Study|Cancer progression|0|||
160974875|NCT00178256|581297601|FG003|Overall Study|Cancer progression|1|||
160974876|NCT01763788|581297602|FG000|Overall Study|Lost to Follow-up|0|||
160974877|NCT01763788|581297603|FG001|Overall Study|Lost to Follow-up|0|||
160974878|NCT01763788|581297604|FG002|Overall Study|Lost to Follow-up|1|||
160974879|NCT01763788|581297605|FG003|Overall Study|Lost to Follow-up|0|||
160974880|NCT03303469|581297606|FG000|Overall Study|Lost to Follow-up|2|||
160974881|NCT03560258|581297607|FG000|Overall Study|Lost to Follow-up|3|||
160974882|NCT03560258|581297608|FG001|Overall Study|Lost to Follow-up|0|||
160974883|NCT03560258|581297609|FG002|Overall Study|Lost to Follow-up|0|||
160974884|NCT03560258|581297607|FG000|Overall Study|Protocol Violation|0|||
160974885|NCT03560258|581297608|FG001|Overall Study|Protocol Violation|1|||
160974886|NCT03560258|581297609|FG002|Overall Study|Protocol Violation|0|||
160974887|NCT03560258|581297607|FG000|Overall Study|Withdrawal by Subject|0|||
160974888|NCT03560258|581297608|FG001|Overall Study|Withdrawal by Subject|0|||
160974889|NCT03560258|581297609|FG002|Overall Study|Withdrawal by Subject|1|||
160974890|NCT01460160|581297610|FG000|Treatment Phase|Lack of Efficacy|3|||
160974891|NCT01460160|581297610|FG000|Treatment Phase|Study Drug Toxicity|2|||
160974892|NCT01460160|581297610|FG000|Treatment Phase|Adverse Event|8|||
160974893|NCT01460160|581297610|FG000|Treatment Phase|Withdrawal by Subject|4|||
160974894|NCT01460160|581297610|FG000|Treatment Phase|Death|2|||
160974895|NCT01460160|581297610|FG000|Treatment Phase|Other reasons|9|||
160974896|NCT01460160|581297610|FG000|Follow-up Phase|Withdrawal by Subject|4|||
160974897|NCT01460160|581297610|FG000|Follow-up Phase|Death|14|||
160974898|NCT01460160|581297610|FG000|Follow-up Phase|Lost to Follow-up|7|||
160974899|NCT01460160|581297610|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
160974900|NCT01460160|581297610|FG000|Follow-up Phase|Other and not reported reasons|5|||
160974901|NCT04488003|581297613|FG000|Assessed for Eligibility|Screen Failure|24|||
160974902|NCT04488003|581297614|FG001|Assessed for Eligibility|Screen Failure|0|||
160974903|NCT04488003|581297615|FG002|Assessed for Eligibility|Screen Failure|0|||
160974904|NCT04488003|581297613|FG000|Assessed for Eligibility|Adverse Event|1|||
160974905|NCT04488003|581297614|FG001|Assessed for Eligibility|Adverse Event|0|||
160974906|NCT04488003|581297615|FG002|Assessed for Eligibility|Adverse Event|0|||
160974907|NCT04488003|581297613|FG000|Assessed for Eligibility|Death|1|||
160974908|NCT04488003|581297614|FG001|Assessed for Eligibility|Death|0|||
160974909|NCT04488003|581297615|FG002|Assessed for Eligibility|Death|0|||
160974910|NCT04488003|581297613|FG000|Assessed for Eligibility|Physician Decision|1|||
160974911|NCT04488003|581297614|FG001|Assessed for Eligibility|Physician Decision|0|||
160974912|NCT04488003|581297615|FG002|Assessed for Eligibility|Physician Decision|0|||
160974913|NCT04488003|581297613|FG000|Allocated to Treatment|Progressive Disease|51|||
160974914|NCT04488003|581297614|FG001|Allocated to Treatment|Progressive Disease|0|||
160974915|NCT04488003|581297615|FG002|Allocated to Treatment|Progressive Disease|0|||
160657911|NCT01475838|580129834|FG000|Randomized Phase|Protocol Violation|9|||
160657912|NCT01475838|580129835|FG001|Randomized Phase|Protocol Violation|4|||
160657913|NCT01475838|580129834|FG000|Extension Phase|Participant Noncompliance|1|||
160657914|NCT01475838|580129835|FG001|Extension Phase|Participant Noncompliance|0|||
160657915|NCT03831048|580129841|FG000|Overall Study|Protocol Violation|9|||
160657916|NCT03831048|580129842|FG001|Overall Study|Protocol Violation|3|||
160657917|NCT03831048|580129841|FG000|Overall Study|Death|4|||
160657918|NCT03831048|580129842|FG001|Overall Study|Death|9|||
160657919|NCT03831048|580129841|FG000|Overall Study|Re-transplant|0|||
160657920|NCT03831048|580129842|FG001|Overall Study|Re-transplant|2|||
160657921|NCT03831048|580129841|FG000|Overall Study|Protocol violation and death|1|||
160657922|NCT03831048|580129842|FG001|Overall Study|Protocol violation and death|1|||
160657923|NCT00560235|580129843|FG000|Phase 1|Discontinued|8|||
160657924|NCT00560235|580129844|FG001|Phase 1|Discontinued|0|||
160657925|NCT00560235|580129845|FG002|Phase 1|Discontinued|0|||
160657926|NCT00560235|580129843|FG000|Phase 1B|Discontinued|0|||
160657927|NCT00560235|580129844|FG001|Phase 1B|Discontinued|19|||
160657928|NCT00560235|580129845|FG002|Phase 1B|Discontinued|0|||
160657929|NCT00560235|580129843|FG000|Phase 2|Discontinued|0|||
160657930|NCT00560235|580129844|FG001|Phase 2|Discontinued|0|||
160657931|NCT00560235|580129845|FG002|Phase 2|Discontinued|96|||
160657932|NCT00560235|580129843|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
160657933|NCT00560235|580129844|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
160657934|NCT00560235|580129845|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
160657935|NCT04015232|580129847|FG000|Overall Study|Withdrawal by Subject|7|||
160657936|NCT04015232|580129848|FG001|Overall Study|Withdrawal by Subject|4|||
160657937|NCT04015232|580129847|FG000|Overall Study|Protocol Violation|1|||
160657938|NCT04015232|580129848|FG001|Overall Study|Protocol Violation|0|||
160657939|NCT04015232|580129847|FG000|Overall Study|Medical Grounds|3|||
160657940|NCT04015232|580129848|FG001|Overall Study|Medical Grounds|3|||
160657941|NCT00365300|580129853|FG000|Open-label Phase|Adverse Event|4|||
160657942|NCT00365300|580129854|FG001|Open-label Phase|Adverse Event|0|||
160657943|NCT00365300|580129853|FG000|Open-label Phase|Failed to Return|1|||
160657944|NCT00365300|580129854|FG001|Open-label Phase|Failed to Return|0|||
160657945|NCT00365300|580129853|FG000|Open-label Phase|Physician Decision|1|||
160657946|NCT00365300|580129854|FG001|Open-label Phase|Physician Decision|0|||
160657947|NCT00365300|580129853|FG000|Open-label Phase|Noncompliance|9|||
160657948|NCT00365300|580129854|FG001|Open-label Phase|Noncompliance|0|||
160657949|NCT00365300|580129853|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
160657950|NCT00365300|580129854|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
160657951|NCT00365300|580129853|FG000|Open-label Phase|Protocol Violation|1|||
160657952|NCT00365300|580129854|FG001|Open-label Phase|Protocol Violation|0|||
160657953|NCT00365300|580129853|FG000|Open-label Phase|Lack of Efficacy|1|||
160657954|NCT00365300|580129854|FG001|Open-label Phase|Lack of Efficacy|0|||
160657955|NCT00365300|580129853|FG000|Open-label Phase|Patient skipped open label phase|1|||
160657956|NCT00365300|580129854|FG001|Open-label Phase|Patient skipped open label phase|0|||
160657957|NCT00365300|580129853|FG000|Double-blind Phase|Failed to return|1|||
160657958|NCT00365300|580129854|FG001|Double-blind Phase|Failed to return|0|||
160657959|NCT00365300|580129853|FG000|Double-blind Phase|Noncompliance|1|||
160657960|NCT00365300|580129854|FG001|Double-blind Phase|Noncompliance|1|||
160657961|NCT00365300|580129853|FG000|Double-blind Phase|Withdrawal by Subject|0|||
160657962|NCT00365300|580129854|FG001|Double-blind Phase|Withdrawal by Subject|1|||
160657963|NCT00365300|580129853|FG000|Double-blind Phase|Protocol Violation|3|||
160657964|NCT00365300|580129854|FG001|Double-blind Phase|Protocol Violation|1|||
160657965|NCT00365300|580129853|FG000|Double-blind Phase|Lack of Efficacy|6|||
160657966|NCT00365300|580129854|FG001|Double-blind Phase|Lack of Efficacy|6|||
160974916|NCT04488003|581297613|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
160974917|NCT04488003|581297614|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
160974918|NCT04488003|581297615|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
160657967|NCT02143102|580129859|FG000|Overall Study|Lost to Follow-up|11|||
160657968|NCT02143102|580129860|FG001|Overall Study|Lost to Follow-up|0|||
160657969|NCT03164772|580129863|FG000|Overall Study|Death|4|||
160974919|NCT04488003|581297613|FG000|Allocated to Treatment|Adverse Event|6|||
160974920|NCT04488003|581297614|FG001|Allocated to Treatment|Adverse Event|0|||
160460190|NCT03248479|579417569|FG001|Overall Study|Consent withdrawn|3|||
160657970|NCT03164772|580129864|FG001|Overall Study|Death|2|||
160657971|NCT03164772|580129863|FG000|Overall Study|Adverse Event|1|||
160657972|NCT03164772|580129864|FG001|Overall Study|Adverse Event|4|||
160657973|NCT03164772|580129863|FG000|Overall Study|Progressive Disease|11|||
160657974|NCT03164772|580129864|FG001|Overall Study|Progressive Disease|21|||
160657975|NCT03164772|580129863|FG000|Overall Study|Physician Decision|2|||
160657976|NCT03164772|580129864|FG001|Overall Study|Physician Decision|0|||
160657977|NCT03164772|580129863|FG000|Overall Study|Withdrawal by Subject|0|||
160657978|NCT03164772|580129864|FG001|Overall Study|Withdrawal by Subject|4|||
160657979|NCT01029353|580129865|FG000|Overall Study|Lost to Follow-up|4|||
160657980|NCT01029353|580129866|FG001|Overall Study|Lost to Follow-up|5|||
160657981|NCT01029353|580129867|FG002|Overall Study|Lost to Follow-up|5|||
160657982|NCT01029353|580129868|FG003|Overall Study|Lost to Follow-up|4|||
160974921|NCT04488003|581297615|FG002|Allocated to Treatment|Adverse Event|0|||
160974922|NCT04488003|581297613|FG000|Allocated to Treatment|Other|5|||
160974923|NCT04488003|581297614|FG001|Allocated to Treatment|Other|0|||
160974924|NCT04488003|581297615|FG002|Allocated to Treatment|Other|0|||
160974925|NCT04488003|581297613|FG000|Allocated to Treatment|Physician Decision|4|||
160974926|NCT04488003|581297614|FG001|Allocated to Treatment|Physician Decision|0|||
160974927|NCT04488003|581297615|FG002|Allocated to Treatment|Physician Decision|0|||
160974928|NCT04488003|581297613|FG000|Allocated to Treatment|Death|4|||
160974929|NCT04488003|581297614|FG001|Allocated to Treatment|Death|0|||
160974930|NCT04488003|581297615|FG002|Allocated to Treatment|Death|0|||
160974931|NCT01737996|581297619|FG000|Overall Study|Adverse Event|0|||
160974932|NCT01737996|581297620|FG001|Overall Study|Adverse Event|1|||
160974933|NCT01737996|581297621|FG002|Overall Study|Adverse Event|1|||
160974934|NCT01737996|581297619|FG000|Overall Study|Withdrawal by Subject|0|||
160974935|NCT01737996|581297620|FG001|Overall Study|Withdrawal by Subject|0|||
160974936|NCT01737996|581297621|FG002|Overall Study|Withdrawal by Subject|1|||
160974937|NCT01003184|581297624|FG000|Overall Study|Adverse Event|12|||
160974938|NCT01003184|581297625|FG001|Overall Study|Adverse Event|5|||
160974939|NCT01003184|581297624|FG000|Overall Study|Lost to Follow-up|1|||
160974940|NCT01003184|581297625|FG001|Overall Study|Lost to Follow-up|0|||
160974941|NCT01003184|581297624|FG000|Overall Study|Loss of glucose control|1|||
160974942|NCT01003184|581297625|FG001|Overall Study|Loss of glucose control|1|||
160974943|NCT01003184|581297624|FG000|Overall Study|Protocol Violation|3|||
160974944|NCT01003184|581297625|FG001|Overall Study|Protocol Violation|0|||
160974945|NCT01003184|581297624|FG000|Overall Study|Withdrawal by Subject|1|||
160974946|NCT01003184|581297625|FG001|Overall Study|Withdrawal by Subject|6|||
160974947|NCT01003184|581297624|FG000|Overall Study|Physician Decision|1|||
160974948|NCT01003184|581297625|FG001|Overall Study|Physician Decision|0|||
160974949|NCT00557622|581297626|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
160974950|NCT00557622|581297627|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
160974951|NCT00557622|581297626|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
160974952|NCT00557622|581297627|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
160974953|NCT00557622|581297626|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
160974954|NCT00557622|581297627|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
160974955|NCT01468922|581297628|FG000|Overall Study|Screening failure|0|||
160974956|NCT01468922|581297629|FG001|Overall Study|Screening failure|0|||
160974957|NCT01468922|581297630|FG002|Overall Study|Screening failure|0|||
160974958|NCT01468922|581297631|FG003|Overall Study|Screening failure|0|||
160974959|NCT01468922|581297632|FG004|Overall Study|Screening failure|0|||
160974960|NCT01468922|581297633|FG005|Overall Study|Screening failure|0|||
160974961|NCT01468922|581297634|FG006|Overall Study|Screening failure|0|||
160974962|NCT01468922|581297635|FG007|Overall Study|Screening failure|0|||
160974963|NCT01468922|581297636|FG008|Overall Study|Screening failure|1|||
160974964|NCT01468922|581297628|FG000|Overall Study|Per patient choice|1|||
160974965|NCT01468922|581297629|FG001|Overall Study|Per patient choice|0|||
160974966|NCT01468922|581297630|FG002|Overall Study|Per patient choice|0|||
160974967|NCT01468922|581297631|FG003|Overall Study|Per patient choice|0|||
160974968|NCT01468922|581297632|FG004|Overall Study|Per patient choice|0|||
160974969|NCT01468922|581297633|FG005|Overall Study|Per patient choice|0|||
160974970|NCT01468922|581297634|FG006|Overall Study|Per patient choice|0|||
160974971|NCT01468922|581297635|FG007|Overall Study|Per patient choice|0|||
160974972|NCT01468922|581297636|FG008|Overall Study|Per patient choice|0|||
160974973|NCT01468922|581297628|FG000|Overall Study|Switched to alternative treatment|1|||
160974974|NCT01468922|581297629|FG001|Overall Study|Switched to alternative treatment|0|||
160974975|NCT01468922|581297630|FG002|Overall Study|Switched to alternative treatment|0|||
160974976|NCT01468922|581297631|FG003|Overall Study|Switched to alternative treatment|0|||
160974977|NCT01468922|581297632|FG004|Overall Study|Switched to alternative treatment|1|||
160974978|NCT01468922|581297633|FG005|Overall Study|Switched to alternative treatment|0|||
160974979|NCT01468922|581297634|FG006|Overall Study|Switched to alternative treatment|0|||
160974980|NCT01468922|581297635|FG007|Overall Study|Switched to alternative treatment|0|||
160974981|NCT01468922|581297636|FG008|Overall Study|Switched to alternative treatment|0|||
160974982|NCT01468922|581297628|FG000|Overall Study|Enrolled on new protocol|0|||
160974983|NCT01468922|581297629|FG001|Overall Study|Enrolled on new protocol|0|||
160974984|NCT01468922|581297630|FG002|Overall Study|Enrolled on new protocol|0|||
160974985|NCT01468922|581297631|FG003|Overall Study|Enrolled on new protocol|0|||
160590493|NCT02953782|579878646|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
160974986|NCT01468922|581297632|FG004|Overall Study|Enrolled on new protocol|1|||
160974987|NCT01468922|581297633|FG005|Overall Study|Enrolled on new protocol|0|||
160974988|NCT01468922|581297634|FG006|Overall Study|Enrolled on new protocol|0|||
160974989|NCT01468922|581297635|FG007|Overall Study|Enrolled on new protocol|0|||
160974990|NCT01468922|581297636|FG008|Overall Study|Enrolled on new protocol|0|||
160974991|NCT01468922|581297628|FG000|Overall Study|Adverse Event|0|||
160974992|NCT01468922|581297629|FG001|Overall Study|Adverse Event|0|||
160974993|NCT01468922|581297630|FG002|Overall Study|Adverse Event|0|||
160974994|NCT01468922|581297631|FG003|Overall Study|Adverse Event|0|||
160974995|NCT01468922|581297632|FG004|Overall Study|Adverse Event|0|||
160974996|NCT01468922|581297633|FG005|Overall Study|Adverse Event|0|||
160974997|NCT01468922|581297634|FG006|Overall Study|Adverse Event|0|||
160974998|NCT01468922|581297635|FG007|Overall Study|Adverse Event|1|||
160974999|NCT01468922|581297636|FG008|Overall Study|Adverse Event|0|||
160975000|NCT01468922|581297628|FG000|Overall Study|Infection of blood|0|||
160975001|NCT01468922|581297629|FG001|Overall Study|Infection of blood|0|||
160975002|NCT01468922|581297630|FG002|Overall Study|Infection of blood|0|||
160975003|NCT01468922|581297631|FG003|Overall Study|Infection of blood|0|||
160975004|NCT01468922|581297632|FG004|Overall Study|Infection of blood|0|||
160975005|NCT01468922|581297633|FG005|Overall Study|Infection of blood|0|||
160975006|NCT01468922|581297634|FG006|Overall Study|Infection of blood|0|||
160975007|NCT01468922|581297635|FG007|Overall Study|Infection of blood|1|||
160975008|NCT01468922|581297636|FG008|Overall Study|Infection of blood|0|||
160975009|NCT01468922|581297628|FG000|Overall Study|Patient choice - surgery|0|||
160975010|NCT01468922|581297629|FG001|Overall Study|Patient choice - surgery|0|||
160975011|NCT01468922|581297630|FG002|Overall Study|Patient choice - surgery|0|||
160975012|NCT01468922|581297631|FG003|Overall Study|Patient choice - surgery|0|||
160975013|NCT01468922|581297632|FG004|Overall Study|Patient choice - surgery|0|||
160975014|NCT01468922|581297633|FG005|Overall Study|Patient choice - surgery|0|||
160975015|NCT01468922|581297634|FG006|Overall Study|Patient choice - surgery|0|||
160975016|NCT01468922|581297635|FG007|Overall Study|Patient choice - surgery|1|||
160975017|NCT01468922|581297636|FG008|Overall Study|Patient choice - surgery|0|||
160975018|NCT01468922|581297628|FG000|Overall Study|Refused further treatment|0|||
160975019|NCT01468922|581297629|FG001|Overall Study|Refused further treatment|0|||
160975020|NCT01468922|581297630|FG002|Overall Study|Refused further treatment|0|||
160975021|NCT01468922|581297631|FG003|Overall Study|Refused further treatment|0|||
160975022|NCT01468922|581297632|FG004|Overall Study|Refused further treatment|0|||
160975023|NCT01468922|581297633|FG005|Overall Study|Refused further treatment|0|||
160975024|NCT01468922|581297634|FG006|Overall Study|Refused further treatment|0|||
160975025|NCT01468922|581297635|FG007|Overall Study|Refused further treatment|1|||
160975026|NCT01468922|581297636|FG008|Overall Study|Refused further treatment|0|||
160975027|NCT01923389|581297637|FG000|Overall Study|Protocol Violation|1|||
160975028|NCT01923389|581297638|FG001|Overall Study|Protocol Violation|0|||
160975029|NCT03237013|581297641|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
160460191|NCT03248479|579417570|FG002|Overall Study|Consent withdrawn|0|||
160975030|NCT03237013|581297642|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
160975031|NCT03237013|581297643|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
160975032|NCT00007475|581297644|FG000|Overall Study|Withdrawal by Subject|1|||
160975033|NCT00007475|581297645|FG001|Overall Study|Withdrawal by Subject|0|||
160975034|NCT00007475|581297646|FG002|Overall Study|Withdrawal by Subject|0|||
160975035|NCT00007475|581297647|FG003|Overall Study|Withdrawal by Subject|0|||
160975036|NCT00007475|581297644|FG000|Overall Study|Adverse Event|3|||
160975037|NCT00007475|581297645|FG001|Overall Study|Adverse Event|0|||
160975038|NCT00007475|581297646|FG002|Overall Study|Adverse Event|0|||
160975039|NCT00007475|581297647|FG003|Overall Study|Adverse Event|0|||
160975040|NCT01719224|581297648|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
160975041|NCT01719224|581297649|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
160975042|NCT00258440|581297650|FG000|Overall Study|Withdrawal by Subject|0|||
160975043|NCT00258440|581297651|FG001|Overall Study|Withdrawal by Subject|0|||
160975044|NCT00258440|581297652|FG002|Overall Study|Withdrawal by Subject|1|||
160975045|NCT00737061|581297653|FG000|Waiting Period|Lost to Follow-up|6|||
160975046|NCT00737061|581297653|FG000|Waiting Period|Withdrawal by Subject|1|||
160975047|NCT00737061|581297653|FG000|Waiting Period|Bilateral placement failure|34|||
160975048|NCT00737061|581297653|FG000|Waiting Period|Deemed patent following HSG|26|||
160975049|NCT00737061|581297653|FG000|Waiting Period|Alternative contraception failure|3|||
160975050|NCT00737061|581297653|FG000|Waiting Period|Elected surgical tubal ligation|5|||
160975051|NCT00737061|581297653|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
160975052|NCT00737061|581297653|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
160975053|NCT00737061|581297653|FG000|1 Year Wearing Period|Discontinued reilance|3|||
160975054|NCT00737061|581297653|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
160975055|NCT03000673|581297654|FG000|Overall Study|Withdrawal by Subject|1|||
160975056|NCT03000673|581297655|FG001|Overall Study|Withdrawal by Subject|0|||
160975057|NCT03000673|581297656|FG002|Overall Study|Withdrawal by Subject|0|||
160975058|NCT03000673|581297657|FG003|Overall Study|Withdrawal by Subject|0|||
160657983|NCT01029353|580129865|FG000|Overall Study|Consent Withdrawn|2|||
160975059|NCT02597933|581297658|FG000|Overall Study|Withdrawal by Subject|7|||
160975060|NCT02597933|581297659|FG001|Overall Study|Withdrawal by Subject|5|||
160975061|NCT02597933|581297658|FG000|Overall Study|Protocol Violation|2|||
160657984|NCT01029353|580129866|FG001|Overall Study|Consent Withdrawn|0|||
160975062|NCT02597933|581297659|FG001|Overall Study|Protocol Violation|2|||
160975063|NCT02597933|581297658|FG000|Overall Study|Adverse Event|20|||
160975064|NCT02597933|581297659|FG001|Overall Study|Adverse Event|28|||
160975065|NCT02597933|581297658|FG000|Overall Study|Not treated|2|||
160975066|NCT02597933|581297659|FG001|Overall Study|Not treated|2|||
160975067|NCT02597933|581297658|FG000|Overall Study|Other than stated above|7|||
160975068|NCT02597933|581297659|FG001|Overall Study|Other than stated above|14|||
160975069|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
160975070|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
160975071|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
160975072|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
160975073|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
160975074|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
160975075|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
160975076|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
160975077|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
160975078|NCT01336621|581297666|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
160975079|NCT01336621|581297666|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
160975080|NCT01336621|581297666|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
160975081|NCT01336621|581297666|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
160975082|NCT01336621|581297666|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
160975083|NCT02487095|581297667|FG000|Dose Expansion|Unable to scan/restage participant|0|||
160975084|NCT02487095|581297668|FG001|Dose Expansion|Unable to scan/restage participant|0|||
160975085|NCT02487095|581297669|FG002|Dose Expansion|Unable to scan/restage participant|0|||
160975086|NCT02487095|581297670|FG003|Dose Expansion|Unable to scan/restage participant|0|||
160975087|NCT02487095|581297671|FG004|Dose Expansion|Unable to scan/restage participant|1|||
160975088|NCT01672853|581297678|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
160975089|NCT01672853|581297679|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
160975090|NCT01672853|581297680|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
160975091|NCT01672853|581297678|FG000|Overall Study|Pregnancy|0|||
160975092|NCT01672853|581297679|FG001|Overall Study|Pregnancy|1|||
160975093|NCT01672853|581297680|FG002|Overall Study|Pregnancy|0|||
160975094|NCT01672853|581297678|FG000|Overall Study|Investigator's Discretion|1|||
160975095|NCT01672853|581297679|FG001|Overall Study|Investigator's Discretion|0|||
160975096|NCT01672853|581297680|FG002|Overall Study|Investigator's Discretion|0|||
160975097|NCT01672853|581297678|FG000|Overall Study|Withdrew Consent|5|||
160975098|NCT01672853|581297679|FG001|Overall Study|Withdrew Consent|5|||
160975099|NCT01672853|581297680|FG002|Overall Study|Withdrew Consent|5|||
160975100|NCT01672853|581297678|FG000|Overall Study|Adverse Event|4|||
160975101|NCT01672853|581297679|FG001|Overall Study|Adverse Event|6|||
160975102|NCT01672853|581297680|FG002|Overall Study|Adverse Event|8|||
160975103|NCT01672853|581297678|FG000|Overall Study|Lost to Follow-up|0|||
160975104|NCT01672853|581297679|FG001|Overall Study|Lost to Follow-up|1|||
160975105|NCT01672853|581297680|FG002|Overall Study|Lost to Follow-up|0|||
160975106|NCT01672853|581297678|FG000|Overall Study|Randomized but Never Treated|0|||
160975107|NCT01672853|581297679|FG001|Overall Study|Randomized but Never Treated|0|||
160975108|NCT01672853|581297680|FG002|Overall Study|Randomized but Never Treated|1|||
160975109|NCT03813147|581297683|FG000|Overall Study|Lack of Efficacy|4|||
160975110|NCT03813147|581297684|FG001|Overall Study|Lack of Efficacy|4|||
160975111|NCT03813147|581297683|FG000|Overall Study|Physician Decision|2|||
160975112|NCT03813147|581297684|FG001|Overall Study|Physician Decision|1|||
160975113|NCT01811563|581299234|FG000|Overall Study|Lost to Follow-up|5|||
160975114|NCT01811563|581299235|FG001|Overall Study|Lost to Follow-up|2|||
160975115|NCT01811563|581299234|FG000|Overall Study|Incorrect Randomization procedure|0|||
160975116|NCT01811563|581299235|FG001|Overall Study|Incorrect Randomization procedure|1|||
160975117|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
160975118|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
160975119|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
160975120|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
160975121|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
160975122|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
160975123|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Death|0|||
160975124|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Death|1|||
160975125|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Adverse Event|11|||
160975126|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Adverse Event|11|||
160975127|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
160975128|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
160975129|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160460192|NCT03248479|579417571|FG003|Overall Study|Consent withdrawn|9|||
160657985|NCT01029353|580129867|FG002|Overall Study|Consent Withdrawn|0|||
160657986|NCT01029353|580129868|FG003|Overall Study|Consent Withdrawn|0|||
160657987|NCT01029353|580129865|FG000|Overall Study|Primary Outcome Indeterminate|1|||
160657988|NCT01029353|580129866|FG001|Overall Study|Primary Outcome Indeterminate|3|||
160657989|NCT01029353|580129867|FG002|Overall Study|Primary Outcome Indeterminate|2|||
160657990|NCT01029353|580129868|FG003|Overall Study|Primary Outcome Indeterminate|0|||
160657991|NCT04538170|580129871|FG000|Overall Study|Withdrawal by Subject|104|||
160657992|NCT04538170|580129872|FG001|Overall Study|Withdrawal by Subject|210|||
160657993|NCT00324168|580129877|FG000|Overall Study|Lost to Follow-up|19|||
160657994|NCT00324168|580129878|FG001|Overall Study|Lost to Follow-up|18|||
160657995|NCT00324168|580129877|FG000|Overall Study|Death|3|||
160657996|NCT00324168|580129878|FG001|Overall Study|Death|3|||
160657997|NCT00324168|580129877|FG000|Overall Study|Patient did not visit in f/u window|6|||
160657998|NCT00324168|580129878|FG001|Overall Study|Patient did not visit in f/u window|9|||
160657999|NCT01203878|580129879|FG000|Overall Study|Withdrawal by Subject|0|||
160658000|NCT01203878|580129880|FG001|Overall Study|Withdrawal by Subject|0|||
160658001|NCT01203878|580129881|FG002|Overall Study|Withdrawal by Subject|1|||
160658002|NCT01203878|580129879|FG000|Overall Study|Adverse Event|0|||
160658003|NCT01203878|580129880|FG001|Overall Study|Adverse Event|0|||
160460193|NCT03248479|579417572|FG004|Overall Study|Consent withdrawn|1|||
160658004|NCT01203878|580129881|FG002|Overall Study|Adverse Event|2|||
160658005|NCT01682083|580129883|FG000|Overall Study|Lost to Follow-up|11|||
160658006|NCT01682083|580129884|FG001|Overall Study|Lost to Follow-up|18|||
160658007|NCT01682083|580129883|FG000|Overall Study|Withdrawal by Subject|31|||
160658008|NCT01682083|580129884|FG001|Overall Study|Withdrawal by Subject|40|||
160658009|NCT01682083|580129883|FG000|Overall Study|Death|60|||
160590494|NCT02953782|579878639|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
160590495|NCT02953782|579878640|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
160590496|NCT02953782|579878641|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
160590497|NCT02953782|579878642|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
160590498|NCT02953782|579878643|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
160590499|NCT02953782|579878644|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
160590500|NCT02953782|579878645|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
160590501|NCT02953782|579878646|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
160590502|NCT02953782|579878639|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
160590503|NCT02953782|579878640|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
160590504|NCT02953782|579878641|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
160590505|NCT02953782|579878642|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
160590506|NCT02953782|579878643|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
160658010|NCT01682083|580129884|FG001|Overall Study|Death|93|||
160658011|NCT01682083|580129883|FG000|Overall Study|Physician Decision|5|||
160658012|NCT01682083|580129884|FG001|Overall Study|Physician Decision|4|||
160658013|NCT01918397|580129885|FG000|Overall Study|Never started treatment|2|||
160590507|NCT02953782|579878644|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
160590508|NCT02953782|579878645|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
160590509|NCT02953782|579878646|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
160590510|NCT01934192|579878649|FG000|Overall Study|Protocol Violation|0|||
160590511|NCT01934192|579878650|FG001|Overall Study|Protocol Violation|0|||
160590512|NCT01934192|579878651|FG002|Overall Study|Protocol Violation|0|||
160590513|NCT01934192|579878652|FG003|Overall Study|Protocol Violation|1|||
160590514|NCT01934192|579878649|FG000|Overall Study|Other: reached stopping criteria|6|||
160590515|NCT01934192|579878650|FG001|Overall Study|Other: reached stopping criteria|5|||
160590516|NCT01934192|579878651|FG002|Overall Study|Other: reached stopping criteria|1|||
160590517|NCT01934192|579878652|FG003|Overall Study|Other: reached stopping criteria|0|||
160590518|NCT01934192|579878649|FG000|Overall Study|Physician Decision|3|||
160590519|NCT01934192|579878650|FG001|Overall Study|Physician Decision|2|||
160590520|NCT01934192|579878651|FG002|Overall Study|Physician Decision|0|||
160590521|NCT01934192|579878652|FG003|Overall Study|Physician Decision|0|||
160590522|NCT01737840|579878653|FG000|Overall Study|Diagnosed with an other pathology|2|||
160590523|NCT01737840|579878654|FG001|Overall Study|Diagnosed with an other pathology|2|||
160590524|NCT01189435|579878655|FG000|Overall Study|Withdrawal by Subject|1|||
160590525|NCT01189435|579878655|FG000|Overall Study|Physician Decision|1|||
160590526|NCT02357849|579878656|FG000|Overall Study|Withdrawal by Subject|2|||
160590527|NCT02357849|579878657|FG001|Overall Study|Withdrawal by Subject|3|||
160590528|NCT03105700|579878658|FG000|Overall Study|screen fail|3|||
160590529|NCT03105700|579878658|FG000|Overall Study|Lost to Follow-up|4|||
160590530|NCT04105244|579878661|FG000|Overall Study|Withdrawal by Subject|10|||
160590531|NCT04105244|579878662|FG001|Overall Study|Withdrawal by Subject|12|||
160590532|NCT04105244|579878661|FG000|Overall Study|Lost to Follow-up|20|||
160590533|NCT04105244|579878662|FG001|Overall Study|Lost to Follow-up|15|||
160590534|NCT04105244|579878661|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
160590535|NCT04105244|579878662|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
160590536|NCT04105244|579878661|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
160590537|NCT04105244|579878662|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
160590538|NCT01449682|579878663|FG000|Overall Study|Death|0|||
160590539|NCT01449682|579878664|FG001|Overall Study|Death|1|||
160590540|NCT01449682|579878663|FG000|Overall Study|Adverse Event|1|||
160590541|NCT01449682|579878664|FG001|Overall Study|Adverse Event|0|||
160590542|NCT02768194|579878665|FG000|Period 1|Adverse Event|0|||
160590543|NCT02768194|579878666|FG001|Period 1|Adverse Event|0|||
160590544|NCT02768194|579878667|FG002|Period 1|Adverse Event|0|||
160590545|NCT02768194|579878668|FG003|Period 1|Adverse Event|1|||
160590546|NCT02768194|579878669|FG004|Period 1|Adverse Event|0|||
160590547|NCT02768194|579878670|FG005|Period 1|Adverse Event|0|||
160590548|NCT02768194|579878665|FG000|Period 2|Other (Reason not specified)|1|||
160590549|NCT02768194|579878666|FG001|Period 2|Other (Reason not specified)|0|||
160590550|NCT02768194|579878667|FG002|Period 2|Other (Reason not specified)|0|||
160590551|NCT02768194|579878668|FG003|Period 2|Other (Reason not specified)|0|||
160590552|NCT02768194|579878669|FG004|Period 2|Other (Reason not specified)|0|||
160590553|NCT02768194|579878670|FG005|Period 2|Other (Reason not specified)|0|||
160590554|NCT02768194|579878665|FG000|Period 3|Other (Reason not specified)|0|||
160590555|NCT02768194|579878666|FG001|Period 3|Other (Reason not specified)|1|||
160590556|NCT02768194|579878667|FG002|Period 3|Other (Reason not specified)|0|||
160590557|NCT02768194|579878668|FG003|Period 3|Other (Reason not specified)|0|||
160590558|NCT02768194|579878669|FG004|Period 3|Other (Reason not specified)|0|||
160590559|NCT02768194|579878670|FG005|Period 3|Other (Reason not specified)|0|||
160590560|NCT04863014|579878671|FG000|Overall Study|Lost to Follow-up|3|||
160590561|NCT04863014|579878672|FG001|Overall Study|Lost to Follow-up|2|||
160590562|NCT04863014|579878671|FG000|Overall Study|Subject Decision|0|||
160590563|NCT04863014|579878672|FG001|Overall Study|Subject Decision|4|||
160590564|NCT03089216|579878674|FG000|Overall Study|Adverse Event|0|||
160590565|NCT03089216|579878675|FG001|Overall Study|Adverse Event|0|||
160590566|NCT03089216|579878676|FG002|Overall Study|Adverse Event|0|||
160590567|NCT03089216|579878677|FG003|Overall Study|Adverse Event|1|||
160590568|NCT03259490|579878678|FG000|Period 1|Withdrawal by Subject|0|||
160590569|NCT03259490|579878679|FG001|Period 1|Withdrawal by Subject|1|||
160590570|NCT03259490|579878678|FG000|Period 2|Protocol Violation|1|||
160590571|NCT03259490|579878679|FG001|Period 2|Protocol Violation|0|||
160590572|NCT00406783|579878682|FG000|Overall Study|Adverse Event|4|||
160590573|NCT00406783|579878683|FG001|Overall Study|Adverse Event|4|||
160590574|NCT00406783|579878682|FG000|Overall Study|Treatment Failure|2|||
160590575|NCT00406783|579878683|FG001|Overall Study|Treatment Failure|3|||
160590576|NCT00406783|579878682|FG000|Overall Study|Lost to Follow-up|3|||
160590577|NCT00406783|579878683|FG001|Overall Study|Lost to Follow-up|0|||
160590578|NCT00406783|579878682|FG000|Overall Study|Withdrawal by Subject|1|||
160590579|NCT00406783|579878683|FG001|Overall Study|Withdrawal by Subject|4|||
160975130|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
160975131|NCT02936037|581299236|FG000|Open Label Extension|Adverse Event|0|||
160975132|NCT02936037|581299237|FG001|Open Label Extension|Adverse Event|3|||
160975133|NCT02936037|581299236|FG000|Open Label Extension|Other|0|||
160975134|NCT02936037|581299237|FG001|Open Label Extension|Other|3|||
160975135|NCT02936037|581299236|FG000|Open Label Extension|Withdrawal by Subject|0|||
160975136|NCT02936037|581299237|FG001|Open Label Extension|Withdrawal by Subject|4|||
160975137|NCT01267825|581299238|FG000|Overall Study|study terminated. no data collected.|1|||
160975138|NCT01267825|581299239|FG001|Overall Study|study terminated. no data collected.|0|||
160975139|NCT04249336|581299240|FG000|Overall Study|Lost to Follow-up|3|||
160590580|NCT00406783|579878682|FG000|Overall Study|Protocol Violation|4|||
160590581|NCT00406783|579878683|FG001|Overall Study|Protocol Violation|4|||
160590582|NCT00675103|579878684|FG000|Overall Study|Lack of Efficacy|2|||
160590583|NCT00675103|579878684|FG000|Overall Study|Adverse Event|1|||
160590584|NCT01935336|579878685|FG000|Overall Study|Adverse Event|1|||
160590585|NCT01935336|579878686|FG001|Overall Study|Adverse Event|0|||
160590586|NCT01935336|579878687|FG002|Overall Study|Adverse Event|0|||
160590587|NCT01935336|579878688|FG003|Overall Study|Adverse Event|0|||
160590588|NCT01935336|579878685|FG000|Overall Study|Progressive disease|5|||
160590589|NCT01935336|579878686|FG001|Overall Study|Progressive disease|3|||
160590590|NCT01935336|579878687|FG002|Overall Study|Progressive disease|47|||
160658014|NCT01918397|580129886|FG001|Overall Study|Never started treatment|1|||
160975140|NCT04249336|581299241|FG001|Overall Study|Lost to Follow-up|3|||
160975141|NCT04249336|581299242|FG002|Overall Study|Lost to Follow-up|3|||
160975142|NCT04249336|581299243|FG003|Overall Study|Lost to Follow-up|3|||
160975144|NCT01189890|581299248|FG000|Overall Study|Adverse Event|3|||
160975145|NCT01189890|581299249|FG001|Overall Study|Adverse Event|4|||
160975146|NCT01189890|581299248|FG000|Overall Study|Lack of Efficacy|7|||
160975147|NCT01189890|581299249|FG001|Overall Study|Lack of Efficacy|2|||
160975148|NCT01189890|581299248|FG000|Overall Study|Lost to Follow-up|1|||
160975149|NCT01189890|581299249|FG001|Overall Study|Lost to Follow-up|7|||
160975150|NCT01189890|581299248|FG000|Overall Study|Protocol Violation|1|||
160975151|NCT01189890|581299249|FG001|Overall Study|Protocol Violation|5|||
160975152|NCT01189890|581299248|FG000|Overall Study|Withdrawal by Subject|15|||
160975153|NCT01189890|581299249|FG001|Overall Study|Withdrawal by Subject|11|||
160975154|NCT01189890|581299248|FG000|Overall Study|Non Compliance|0|||
160975155|NCT01189890|581299249|FG001|Overall Study|Non Compliance|1|||
160975156|NCT01189890|581299248|FG000|Overall Study|Physician Decision|5|||
160975157|NCT01189890|581299249|FG001|Overall Study|Physician Decision|4|||
160975158|NCT01189890|581299248|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
160975159|NCT01189890|581299249|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
160975160|NCT00077636|581299250|FG000|Overall Study|Refused Treatment|9|||
160975161|NCT00077636|581299251|FG001|Overall Study|Refused Treatment|31|||
160975162|NCT00077636|581299250|FG000|Overall Study|Admin|3|||
160975163|NCT00077636|581299251|FG001|Overall Study|Admin|3|||
160975164|NCT00077636|581299250|FG000|Overall Study|Withdrawal by Subject|2|||
160975165|NCT00077636|581299251|FG001|Overall Study|Withdrawal by Subject|2|||
160975166|NCT00077636|581299250|FG000|Overall Study|Adverse Event|17|||
160975167|NCT00077636|581299251|FG001|Overall Study|Adverse Event|34|||
160975168|NCT00077636|581299250|FG000|Overall Study|Protocol Violation|0|||
160975169|NCT00077636|581299251|FG001|Overall Study|Protocol Violation|2|||
160975170|NCT00077636|581299250|FG000|Overall Study|Lost to Follow-up|10|||
160975171|NCT00077636|581299251|FG001|Overall Study|Lost to Follow-up|18|||
160975172|NCT00077636|581299250|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
160975173|NCT00077636|581299251|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
160975174|NCT00068380|581299252|FG000|Overall Study|Withdrawal by Subject|3|||
160975175|NCT00068380|581299252|FG000|Overall Study|Adverse Event|2|||
160975176|NCT01976364|581299253|FG000|Main Study (36 Months)|Adverse Event|63|||
160975177|NCT01976364|581299254|FG001|Main Study (36 Months)|Adverse Event|0|||
160975178|NCT01976364|581299255|FG002|Main Study (36 Months)|Adverse Event|0|||
160975179|NCT01976364|581299253|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
160975180|NCT01976364|581299254|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
160975181|NCT01976364|581299255|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
160975182|NCT01976364|581299253|FG000|Main Study (36 Months)|Other|13|||
160975183|NCT01976364|581299254|FG001|Main Study (36 Months)|Other|0|||
160975184|NCT01976364|581299255|FG002|Main Study (36 Months)|Other|0|||
160975185|NCT01976364|581299253|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
160975186|NCT01976364|581299254|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
160975187|NCT01976364|581299255|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
160975188|NCT01976364|581299253|FG000|Main Study (36 Months)|Medication error|1|||
160975189|NCT01976364|581299254|FG001|Main Study (36 Months)|Medication error|0|||
160975190|NCT01976364|581299255|FG002|Main Study (36 Months)|Medication error|0|||
160975191|NCT01976364|581299253|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
160975192|NCT01976364|581299254|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
160975193|NCT01976364|581299255|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
160975194|NCT01976364|581299253|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
160975195|NCT01976364|581299254|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
160975196|NCT01976364|581299255|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
160975197|NCT01976364|581299253|FG000|Main Study (36 Months)|Protocol Violation|13|||
160975198|NCT01976364|581299254|FG001|Main Study (36 Months)|Protocol Violation|0|||
160975199|NCT01976364|581299255|FG002|Main Study (36 Months)|Protocol Violation|0|||
160975200|NCT01976364|581299253|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
160975201|NCT01976364|581299254|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
160975202|NCT01976364|581299255|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
160975203|NCT01976364|581299253|FG000|Main Study (36 Months)|Death|5|||
160975204|NCT01976364|581299254|FG001|Main Study (36 Months)|Death|0|||
160975205|NCT01976364|581299255|FG002|Main Study (36 Months)|Death|0|||
160975206|NCT01976364|581299253|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
160975207|NCT01976364|581299254|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
160975208|NCT01976364|581299255|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
160975209|NCT01976364|581299253|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
160975210|NCT01976364|581299254|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
160975211|NCT01976364|581299255|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
160975212|NCT01976364|581299253|FG000|Sub-study (12 Months)|Protocol Violation|0|||
160975213|NCT01976364|581299254|FG001|Sub-study (12 Months)|Protocol Violation|1|||
160590591|NCT01935336|579878688|FG003|Overall Study|Progressive disease|66|||
160590592|NCT01810042|579878691|FG000|Overall Study|Lost to Follow-up|10|||
160590593|NCT01208038|579878694|FG000|Overall Study|Withdrawal by Subject|1|||
160590594|NCT01877382|579878697|FG000|Dose Escalation|Progressive disease|2|||
160590595|NCT01877382|579878698|FG001|Dose Escalation|Progressive disease|0|||
160590596|NCT01877382|579878699|FG002|Dose Escalation|Progressive disease|1|||
160590597|NCT01877382|579878700|FG003|Dose Escalation|Progressive disease|6|||
160590598|NCT01877382|579878701|FG004|Dose Escalation|Progressive disease|1|||
160590599|NCT01877382|579878702|FG005|Dose Escalation|Progressive disease|0|||
160590600|NCT01877382|579878703|FG006|Dose Escalation|Progressive disease|3|||
160590601|NCT01877382|579878704|FG007|Dose Escalation|Progressive disease|10|||
160590602|NCT01877382|579878705|FG008|Dose Escalation|Progressive disease|4|||
160590603|NCT01877382|579878706|FG009|Dose Escalation|Progressive disease|2|||
160590604|NCT01877382|579878707|FG010|Dose Escalation|Progressive disease|3|||
160590605|NCT01877382|579878708|FG011|Dose Escalation|Progressive disease|3|||
160590606|NCT01877382|579878709|FG012|Dose Escalation|Progressive disease|13|||
160590607|NCT01877382|579878710|FG013|Dose Escalation|Progressive disease|1|||
160590608|NCT01877382|579878711|FG014|Dose Escalation|Progressive disease|0|||
160590609|NCT01877382|579878697|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
160590610|NCT01877382|579878698|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590611|NCT01877382|579878699|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590612|NCT01877382|579878700|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
160590613|NCT01877382|579878701|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590614|NCT01877382|579878702|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590615|NCT01877382|579878703|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
160590616|NCT01877382|579878704|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590617|NCT01877382|579878705|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590618|NCT01877382|579878706|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590619|NCT01877382|579878707|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590620|NCT01877382|579878708|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590621|NCT01877382|579878709|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590622|NCT01877382|579878710|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590623|NCT01877382|579878711|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590624|NCT01877382|579878697|FG000|Dose Escalation|Clinical progression|0|||
160590625|NCT01877382|579878698|FG001|Dose Escalation|Clinical progression|1|||
160590626|NCT01877382|579878699|FG002|Dose Escalation|Clinical progression|0|||
160590627|NCT01877382|579878700|FG003|Dose Escalation|Clinical progression|2|||
160590628|NCT01877382|579878701|FG004|Dose Escalation|Clinical progression|0|||
160590629|NCT01877382|579878702|FG005|Dose Escalation|Clinical progression|0|||
160590630|NCT01877382|579878703|FG006|Dose Escalation|Clinical progression|1|||
160590631|NCT01877382|579878704|FG007|Dose Escalation|Clinical progression|0|||
160590632|NCT01877382|579878705|FG008|Dose Escalation|Clinical progression|0|||
160590633|NCT01877382|579878706|FG009|Dose Escalation|Clinical progression|1|||
160590634|NCT01877382|579878707|FG010|Dose Escalation|Clinical progression|0|||
160590635|NCT01877382|579878708|FG011|Dose Escalation|Clinical progression|0|||
160590636|NCT01877382|579878709|FG012|Dose Escalation|Clinical progression|2|||
160590637|NCT01877382|579878710|FG013|Dose Escalation|Clinical progression|1|||
160590638|NCT01877382|579878711|FG014|Dose Escalation|Clinical progression|0|||
160590639|NCT01877382|579878697|FG000|Dose Escalation|Adverse Event|0|||
160590640|NCT01877382|579878698|FG001|Dose Escalation|Adverse Event|0|||
160590641|NCT01877382|579878699|FG002|Dose Escalation|Adverse Event|0|||
160590642|NCT01877382|579878700|FG003|Dose Escalation|Adverse Event|4|||
160590643|NCT01877382|579878701|FG004|Dose Escalation|Adverse Event|1|||
160590644|NCT01877382|579878702|FG005|Dose Escalation|Adverse Event|2|||
160590645|NCT01877382|579878703|FG006|Dose Escalation|Adverse Event|1|||
160590646|NCT01877382|579878704|FG007|Dose Escalation|Adverse Event|2|||
160590647|NCT01877382|579878705|FG008|Dose Escalation|Adverse Event|0|||
160975214|NCT01976364|581299255|FG002|Sub-study (12 Months)|Protocol Violation|1|||
160975215|NCT01976364|581299253|FG000|Sub-study (12 Months)|Adverse Event|0|||
160975216|NCT01976364|581299254|FG001|Sub-study (12 Months)|Adverse Event|4|||
160975217|NCT01976364|581299255|FG002|Sub-study (12 Months)|Adverse Event|3|||
160975218|NCT01190215|581299256|FG000|Up to Month 6|Lost to Follow-up|2|||
160975219|NCT01190215|581299257|FG001|Up to Month 6|Lost to Follow-up|0|||
160975220|NCT02960763|581299258|FG000|Step 1|Withdrawal by Subject|10|||
160975221|NCT02960763|581299259|FG001|Step 1|Withdrawal by Subject|8|||
160975222|NCT02960763|581299260|FG002|Step 1|Withdrawal by Subject|13|||
160975223|NCT02960763|581299261|FG003|Step 1|Withdrawal by Subject|0|||
160975224|NCT02960763|581299262|FG004|Step 1|Withdrawal by Subject|0|||
160975225|NCT02960763|581299258|FG000|Step 1|Lost to Follow-up|7|||
160975226|NCT02960763|581299259|FG001|Step 1|Lost to Follow-up|9|||
160975227|NCT02960763|581299260|FG002|Step 1|Lost to Follow-up|12|||
160975228|NCT02960763|581299261|FG003|Step 1|Lost to Follow-up|0|||
160975229|NCT02960763|581299262|FG004|Step 1|Lost to Follow-up|0|||
160975230|NCT02960763|581299258|FG000|Step 1|Death|1|||
160975231|NCT02960763|581299259|FG001|Step 1|Death|1|||
160975232|NCT02960763|581299260|FG002|Step 1|Death|1|||
160975233|NCT02960763|581299261|FG003|Step 1|Death|0|||
160975234|NCT02960763|581299262|FG004|Step 1|Death|0|||
160975235|NCT02960763|581299258|FG000|Step 1|Investigator discretion|1|||
160975236|NCT02960763|581299259|FG001|Step 1|Investigator discretion|0|||
160975237|NCT02960763|581299260|FG002|Step 1|Investigator discretion|1|||
160975238|NCT02960763|581299261|FG003|Step 1|Investigator discretion|0|||
160975239|NCT02960763|581299262|FG004|Step 1|Investigator discretion|0|||
160975240|NCT02960763|581299258|FG000|Step 1|Other|0|||
160975241|NCT02960763|581299259|FG001|Step 1|Other|0|||
160975242|NCT02960763|581299260|FG002|Step 1|Other|1|||
160975243|NCT02960763|581299261|FG003|Step 1|Other|0|||
160975244|NCT02960763|581299262|FG004|Step 1|Other|0|||
160975245|NCT02960763|581299258|FG000|Step 2|Withdrawal by Subject|0|||
160975246|NCT02960763|581299259|FG001|Step 2|Withdrawal by Subject|0|||
160975247|NCT02960763|581299260|FG002|Step 2|Withdrawal by Subject|0|||
160975248|NCT02960763|581299261|FG003|Step 2|Withdrawal by Subject|7|||
160975249|NCT02960763|581299262|FG004|Step 2|Withdrawal by Subject|3|||
160975250|NCT02960763|581299258|FG000|Step 2|Lost to Follow-up|0|||
160975251|NCT02960763|581299259|FG001|Step 2|Lost to Follow-up|0|||
160975252|NCT02960763|581299260|FG002|Step 2|Lost to Follow-up|0|||
160975253|NCT02960763|581299261|FG003|Step 2|Lost to Follow-up|4|||
160975254|NCT02960763|581299262|FG004|Step 2|Lost to Follow-up|1|||
160975255|NCT02960763|581299258|FG000|Step 2|Investigator discretion|0|||
160975256|NCT02960763|581299259|FG001|Step 2|Investigator discretion|0|||
160975257|NCT02960763|581299260|FG002|Step 2|Investigator discretion|0|||
160975258|NCT02960763|581299261|FG003|Step 2|Investigator discretion|0|||
160975259|NCT02960763|581299262|FG004|Step 2|Investigator discretion|1|||
160975260|NCT05340751|581299263|FG000|Overall Study|Physician Decision|3|||
160975261|NCT01014975|581299276|FG000|Overall Study|Withdrawal by Subject|1|||
160975262|NCT01014975|581299277|FG001|Overall Study|Withdrawal by Subject|0|||
160975263|NCT01014975|581299278|FG002|Overall Study|Withdrawal by Subject|1|||
160975264|NCT01014975|581299276|FG000|Overall Study|Death|3|||
160975265|NCT01014975|581299277|FG001|Overall Study|Death|3|||
160975266|NCT01014975|581299278|FG002|Overall Study|Death|4|||
160975267|NCT01014975|581299276|FG000|Overall Study|Lost to Follow-up|0|||
160975268|NCT01014975|581299277|FG001|Overall Study|Lost to Follow-up|0|||
160975269|NCT01014975|581299278|FG002|Overall Study|Lost to Follow-up|1|||
160975270|NCT00313911|581299282|FG000|Overall Study|Serious adverse event|6|||
160975271|NCT00313911|581299283|FG001|Overall Study|Serious adverse event|1|||
160975272|NCT00313911|581299282|FG000|Overall Study|Adverse Event|2|||
160975273|NCT00313911|581299283|FG001|Overall Study|Adverse Event|3|||
160975274|NCT00313911|581299282|FG000|Overall Study|Protocol Violation|19|||
160975275|NCT00313911|581299283|FG001|Overall Study|Protocol Violation|10|||
160975276|NCT00313911|581299282|FG000|Overall Study|Lost to Follow-up|27|||
160975277|NCT00313911|581299283|FG001|Overall Study|Lost to Follow-up|14|||
160975278|NCT00313911|581299282|FG000|Overall Study|Withdrawal by Subject|39|||
160975279|NCT00313911|581299283|FG001|Overall Study|Withdrawal by Subject|12|||
160975280|NCT00313911|581299282|FG000|Overall Study|Did not meet age criteria|1|||
160975281|NCT00313911|581299283|FG001|Overall Study|Did not meet age criteria|1|||
160975282|NCT00451217|581299284|FG000|Overall Study|Lost to Follow-up|0|||
160975283|NCT00451217|581299285|FG001|Overall Study|Lost to Follow-up|1|||
160975284|NCT00451217|581299286|FG002|Overall Study|Lost to Follow-up|1|||
160975285|NCT00451217|581299287|FG003|Overall Study|Lost to Follow-up|1|||
160975286|NCT00451217|581299284|FG000|Overall Study|Withdrawal by Subject|1|||
160975287|NCT00451217|581299285|FG001|Overall Study|Withdrawal by Subject|0|||
160975288|NCT00451217|581299286|FG002|Overall Study|Withdrawal by Subject|0|||
160975289|NCT00451217|581299287|FG003|Overall Study|Withdrawal by Subject|0|||
160975290|NCT00451217|581299284|FG000|Overall Study|Not Treated|1|||
160590648|NCT01877382|579878706|FG009|Dose Escalation|Adverse Event|0|||
160590649|NCT01877382|579878707|FG010|Dose Escalation|Adverse Event|0|||
160590650|NCT01877382|579878708|FG011|Dose Escalation|Adverse Event|0|||
160590651|NCT01877382|579878709|FG012|Dose Escalation|Adverse Event|1|||
160590652|NCT01877382|579878710|FG013|Dose Escalation|Adverse Event|0|||
160590653|NCT01877382|579878711|FG014|Dose Escalation|Adverse Event|0|||
160590654|NCT01877382|579878697|FG000|Dose Escalation|Withdrawal by Subject|0|||
160590655|NCT01877382|579878698|FG001|Dose Escalation|Withdrawal by Subject|0|||
160590656|NCT01877382|579878699|FG002|Dose Escalation|Withdrawal by Subject|0|||
160590657|NCT01877382|579878700|FG003|Dose Escalation|Withdrawal by Subject|0|||
160590658|NCT01877382|579878701|FG004|Dose Escalation|Withdrawal by Subject|0|||
160590659|NCT01877382|579878702|FG005|Dose Escalation|Withdrawal by Subject|3|||
160590660|NCT01877382|579878703|FG006|Dose Escalation|Withdrawal by Subject|2|||
160590661|NCT01877382|579878704|FG007|Dose Escalation|Withdrawal by Subject|1|||
160590662|NCT01877382|579878705|FG008|Dose Escalation|Withdrawal by Subject|1|||
160590663|NCT01877382|579878706|FG009|Dose Escalation|Withdrawal by Subject|0|||
160590664|NCT01877382|579878707|FG010|Dose Escalation|Withdrawal by Subject|0|||
160590665|NCT01877382|579878708|FG011|Dose Escalation|Withdrawal by Subject|0|||
160590666|NCT01877382|579878709|FG012|Dose Escalation|Withdrawal by Subject|0|||
160590667|NCT01877382|579878710|FG013|Dose Escalation|Withdrawal by Subject|0|||
160590668|NCT01877382|579878711|FG014|Dose Escalation|Withdrawal by Subject|0|||
160590669|NCT01877382|579878697|FG000|Dose Escalation|Protocol Violation|0|||
160590670|NCT01877382|579878698|FG001|Dose Escalation|Protocol Violation|0|||
160590671|NCT01877382|579878699|FG002|Dose Escalation|Protocol Violation|0|||
160590672|NCT01877382|579878700|FG003|Dose Escalation|Protocol Violation|0|||
160590673|NCT01877382|579878701|FG004|Dose Escalation|Protocol Violation|0|||
160590674|NCT01877382|579878702|FG005|Dose Escalation|Protocol Violation|0|||
160590675|NCT01877382|579878703|FG006|Dose Escalation|Protocol Violation|1|||
160590676|NCT01877382|579878704|FG007|Dose Escalation|Protocol Violation|0|||
160590677|NCT01877382|579878705|FG008|Dose Escalation|Protocol Violation|0|||
160590678|NCT01877382|579878706|FG009|Dose Escalation|Protocol Violation|0|||
160590679|NCT01877382|579878707|FG010|Dose Escalation|Protocol Violation|0|||
160590680|NCT01877382|579878708|FG011|Dose Escalation|Protocol Violation|0|||
160590681|NCT01877382|579878709|FG012|Dose Escalation|Protocol Violation|0|||
160590682|NCT01877382|579878710|FG013|Dose Escalation|Protocol Violation|0|||
160590683|NCT01877382|579878711|FG014|Dose Escalation|Protocol Violation|0|||
160590684|NCT01877382|579878697|FG000|Dose Escalation|Study terminated by sponsor|0|||
160590685|NCT01877382|579878698|FG001|Dose Escalation|Study terminated by sponsor|0|||
160590686|NCT01877382|579878699|FG002|Dose Escalation|Study terminated by sponsor|0|||
160590687|NCT01877382|579878700|FG003|Dose Escalation|Study terminated by sponsor|0|||
160590688|NCT01877382|579878701|FG004|Dose Escalation|Study terminated by sponsor|0|||
160590689|NCT01877382|579878702|FG005|Dose Escalation|Study terminated by sponsor|0|||
160590690|NCT01877382|579878703|FG006|Dose Escalation|Study terminated by sponsor|0|||
160590691|NCT01877382|579878704|FG007|Dose Escalation|Study terminated by sponsor|1|||
160590692|NCT01877382|579878705|FG008|Dose Escalation|Study terminated by sponsor|1|||
160590693|NCT01877382|579878706|FG009|Dose Escalation|Study terminated by sponsor|0|||
160590694|NCT01877382|579878707|FG010|Dose Escalation|Study terminated by sponsor|0|||
160590695|NCT01877382|579878708|FG011|Dose Escalation|Study terminated by sponsor|0|||
160590696|NCT01877382|579878709|FG012|Dose Escalation|Study terminated by sponsor|3|||
160590697|NCT01877382|579878710|FG013|Dose Escalation|Study terminated by sponsor|0|||
160590698|NCT01877382|579878711|FG014|Dose Escalation|Study terminated by sponsor|0|||
160590699|NCT01877382|579878697|FG000|Dose Escalation|Death|0|||
160590700|NCT01877382|579878698|FG001|Dose Escalation|Death|0|||
160590701|NCT01877382|579878699|FG002|Dose Escalation|Death|0|||
160590702|NCT01877382|579878700|FG003|Dose Escalation|Death|0|||
160590703|NCT01877382|579878701|FG004|Dose Escalation|Death|0|||
160590704|NCT01877382|579878702|FG005|Dose Escalation|Death|0|||
160590705|NCT01877382|579878703|FG006|Dose Escalation|Death|0|||
160590706|NCT01877382|579878704|FG007|Dose Escalation|Death|1|||
160590707|NCT01877382|579878705|FG008|Dose Escalation|Death|0|||
160590708|NCT01877382|579878706|FG009|Dose Escalation|Death|0|||
160590709|NCT01877382|579878707|FG010|Dose Escalation|Death|0|||
160590710|NCT01877382|579878708|FG011|Dose Escalation|Death|0|||
160590711|NCT01877382|579878709|FG012|Dose Escalation|Death|1|||
160590712|NCT01877382|579878710|FG013|Dose Escalation|Death|1|||
160590713|NCT01877382|579878711|FG014|Dose Escalation|Death|0|||
160590714|NCT01877382|579878697|FG000|Dose Expansion|Progressive disease|0|||
160590715|NCT01877382|579878698|FG001|Dose Expansion|Progressive disease|0|||
160590716|NCT01877382|579878699|FG002|Dose Expansion|Progressive disease|0|||
160590717|NCT01877382|579878700|FG003|Dose Expansion|Progressive disease|0|||
160590718|NCT01877382|579878701|FG004|Dose Expansion|Progressive disease|0|||
160590719|NCT01877382|579878702|FG005|Dose Expansion|Progressive disease|0|||
160590720|NCT01877382|579878703|FG006|Dose Expansion|Progressive disease|0|||
160590721|NCT01877382|579878704|FG007|Dose Expansion|Progressive disease|0|||
160590722|NCT01877382|579878705|FG008|Dose Expansion|Progressive disease|0|||
160590723|NCT01877382|579878706|FG009|Dose Expansion|Progressive disease|0|||
160590724|NCT01877382|579878707|FG010|Dose Expansion|Progressive disease|0|||
160590725|NCT01877382|579878708|FG011|Dose Expansion|Progressive disease|0|||
160590726|NCT01877382|579878709|FG012|Dose Expansion|Progressive disease|0|||
160590727|NCT01877382|579878710|FG013|Dose Expansion|Progressive disease|0|||
160590728|NCT01877382|579878711|FG014|Dose Expansion|Progressive disease|11|||
160590729|NCT01877382|579878697|FG000|Dose Expansion|Clinical progression|0|||
160590730|NCT01877382|579878698|FG001|Dose Expansion|Clinical progression|0|||
160590731|NCT01877382|579878699|FG002|Dose Expansion|Clinical progression|0|||
160590732|NCT01877382|579878700|FG003|Dose Expansion|Clinical progression|0|||
160590733|NCT01877382|579878701|FG004|Dose Expansion|Clinical progression|0|||
160590734|NCT01877382|579878702|FG005|Dose Expansion|Clinical progression|0|||
160590735|NCT01877382|579878703|FG006|Dose Expansion|Clinical progression|0|||
160975291|NCT00451217|581299285|FG001|Overall Study|Not Treated|1|||
160975292|NCT00451217|581299286|FG002|Overall Study|Not Treated|3|||
160975293|NCT00451217|581299287|FG003|Overall Study|Not Treated|4|||
160975294|NCT03066622|581299288|FG000|Overall Study|Lost to Follow-up|24|||
160975295|NCT03066622|581299289|FG001|Overall Study|Lost to Follow-up|25|||
160975296|NCT03066622|581299288|FG000|Overall Study|Withdrawal by Subject|2|||
160975297|NCT03066622|581299289|FG001|Overall Study|Withdrawal by Subject|1|||
160975298|NCT00641719|581299290|FG000|Overall Study|Lack of Efficacy|1|||
160975299|NCT00641719|581299291|FG001|Overall Study|Lack of Efficacy|2|||
160975300|NCT00641719|581299290|FG000|Overall Study|Adverse Event|24|||
160975301|NCT00641719|581299291|FG001|Overall Study|Adverse Event|29|||
160975302|NCT00641719|581299290|FG000|Overall Study|Withdrawal by Subject|4|||
160975303|NCT00641719|581299291|FG001|Overall Study|Withdrawal by Subject|4|||
160975304|NCT00641719|581299290|FG000|Overall Study|Reason Not Specified|1|||
160975305|NCT00641719|581299291|FG001|Overall Study|Reason Not Specified|2|||
160975306|NCT03321006|581299292|FG000|Overall Study|Death|1|||
160975307|NCT03321006|581299293|FG001|Overall Study|Death|0|||
160975308|NCT03321006|581299292|FG000|Overall Study|Lack of Efficacy|1|||
160975309|NCT03321006|581299293|FG001|Overall Study|Lack of Efficacy|0|||
160975310|NCT00885352|581299296|FG000|Overall Study|Adverse Event|2|||
160975311|NCT00885352|581299297|FG001|Overall Study|Adverse Event|3|||
160975312|NCT00885352|581299296|FG000|Overall Study|Lost to Follow-up|2|||
160975313|NCT00885352|581299297|FG001|Overall Study|Lost to Follow-up|2|||
160975314|NCT00885352|581299296|FG000|Overall Study|Physician Decision|0|||
160975315|NCT00885352|581299297|FG001|Overall Study|Physician Decision|3|||
160975316|NCT00885352|581299296|FG000|Overall Study|Protocol Violation|0|||
160975317|NCT00885352|581299297|FG001|Overall Study|Protocol Violation|2|||
160975318|NCT00885352|581299296|FG000|Overall Study|Withdrawal by Subject|1|||
160975319|NCT00885352|581299297|FG001|Overall Study|Withdrawal by Subject|5|||
160590736|NCT01877382|579878704|FG007|Dose Expansion|Clinical progression|0|||
160975320|NCT00885352|581299296|FG000|Overall Study|Contradiction to study medication|0|||
160975321|NCT00885352|581299297|FG001|Overall Study|Contradiction to study medication|2|||
160975322|NCT00885352|581299296|FG000|Overall Study|Excluded medication|2|||
160975323|NCT00885352|581299297|FG001|Overall Study|Excluded medication|2|||
160975324|NCT00885352|581299296|FG000|Overall Study|Lab abnormalities|1|||
160975325|NCT00885352|581299297|FG001|Overall Study|Lab abnormalities|1|||
160975326|NCT02006121|581299298|FG000|Double Blind Phase|Adverse Event|6|||
160975327|NCT02006121|581299299|FG001|Double Blind Phase|Adverse Event|0|||
160975328|NCT02006121|581299298|FG000|Double Blind Phase|Lack of Efficacy|1|||
160975329|NCT02006121|581299299|FG001|Double Blind Phase|Lack of Efficacy|16|||
160975330|NCT02006121|581299298|FG000|Double Blind Phase|Withdrawal by Subject|3|||
160975331|NCT02006121|581299299|FG001|Double Blind Phase|Withdrawal by Subject|4|||
160975332|NCT02006121|581299298|FG000|Double Blind Phase|Non-compliance with study drug|1|||
160975333|NCT02006121|581299299|FG001|Double Blind Phase|Non-compliance with study drug|3|||
160975334|NCT02006121|581299298|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
160975335|NCT02006121|581299299|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
160975336|NCT02006121|581299298|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
160975337|NCT02006121|581299299|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
160975338|NCT02006121|581299298|FG000|Open Label Phase|Adverse Event|15|||
160975339|NCT02006121|581299299|FG001|Open Label Phase|Adverse Event|0|||
160975340|NCT02006121|581299298|FG000|Open Label Phase|Lack of Efficacy|2|||
160975341|NCT02006121|581299299|FG001|Open Label Phase|Lack of Efficacy|0|||
160975342|NCT02006121|581299298|FG000|Open Label Phase|Protocol Violation|2|||
160975343|NCT02006121|581299299|FG001|Open Label Phase|Protocol Violation|0|||
160975344|NCT02006121|581299298|FG000|Open Label Phase|Withdrawal by Subject|3|||
160975345|NCT02006121|581299299|FG001|Open Label Phase|Withdrawal by Subject|0|||
160975346|NCT02006121|581299298|FG000|Open Label Phase|Non-compliance with study drug|3|||
160975347|NCT02006121|581299299|FG001|Open Label Phase|Non-compliance with study drug|0|||
160975348|NCT04498247|581299303|FG000|Overall Study|Lost to Follow-up|0|||
160975349|NCT04498247|581299304|FG001|Overall Study|Lost to Follow-up|0|||
160975350|NCT04498247|581299305|FG002|Overall Study|Lost to Follow-up|0|||
160975351|NCT04498247|581299306|FG003|Overall Study|Lost to Follow-up|1|||
160975352|NCT04498247|581299307|FG004|Overall Study|Lost to Follow-up|0|||
160975353|NCT04498247|581299308|FG005|Overall Study|Lost to Follow-up|0|||
160975354|NCT04498247|581299309|FG006|Overall Study|Lost to Follow-up|0|||
160975355|NCT04498247|581299310|FG007|Overall Study|Lost to Follow-up|0|||
160975356|NCT04498247|581299303|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
160975357|NCT04498247|581299304|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975358|NCT04498247|581299305|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975359|NCT04498247|581299306|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975360|NCT04498247|581299307|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975361|NCT04498247|581299308|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975362|NCT04498247|581299309|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975363|NCT04498247|581299310|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975364|NCT04498247|581299303|FG000|Overall Study|Withdrawal by Subject|0|||
160975365|NCT04498247|581299304|FG001|Overall Study|Withdrawal by Subject|8|||
160975366|NCT04498247|581299305|FG002|Overall Study|Withdrawal by Subject|0|||
160975367|NCT04498247|581299306|FG003|Overall Study|Withdrawal by Subject|7|||
160975368|NCT04498247|581299307|FG004|Overall Study|Withdrawal by Subject|0|||
160975369|NCT04498247|581299308|FG005|Overall Study|Withdrawal by Subject|0|||
160975370|NCT04498247|581299309|FG006|Overall Study|Withdrawal by Subject|1|||
160975371|NCT04498247|581299310|FG007|Overall Study|Withdrawal by Subject|0|||
160975372|NCT04498247|581299303|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
160975373|NCT04498247|581299304|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
160975374|NCT04498247|581299305|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
160975375|NCT04498247|581299306|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
160975376|NCT04498247|581299307|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
160975377|NCT04498247|581299308|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
160975378|NCT04498247|581299309|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
160590737|NCT01877382|579878705|FG008|Dose Expansion|Clinical progression|0|||
160590738|NCT01877382|579878706|FG009|Dose Expansion|Clinical progression|0|||
160590739|NCT01877382|579878707|FG010|Dose Expansion|Clinical progression|0|||
160590740|NCT01877382|579878708|FG011|Dose Expansion|Clinical progression|0|||
160590741|NCT01877382|579878709|FG012|Dose Expansion|Clinical progression|0|||
160590742|NCT01877382|579878710|FG013|Dose Expansion|Clinical progression|0|||
160590743|NCT01877382|579878711|FG014|Dose Expansion|Clinical progression|6|||
160590744|NCT01877382|579878697|FG000|Dose Expansion|Adverse Event|0|||
160590745|NCT01877382|579878698|FG001|Dose Expansion|Adverse Event|0|||
160590746|NCT01877382|579878699|FG002|Dose Expansion|Adverse Event|0|||
160590747|NCT01877382|579878700|FG003|Dose Expansion|Adverse Event|0|||
160590748|NCT01877382|579878701|FG004|Dose Expansion|Adverse Event|0|||
160590749|NCT01877382|579878702|FG005|Dose Expansion|Adverse Event|0|||
160590750|NCT01877382|579878703|FG006|Dose Expansion|Adverse Event|0|||
160590751|NCT01877382|579878704|FG007|Dose Expansion|Adverse Event|0|||
160590752|NCT01877382|579878705|FG008|Dose Expansion|Adverse Event|0|||
160590753|NCT01877382|579878706|FG009|Dose Expansion|Adverse Event|0|||
160590754|NCT01877382|579878707|FG010|Dose Expansion|Adverse Event|0|||
160590755|NCT01877382|579878708|FG011|Dose Expansion|Adverse Event|0|||
160590756|NCT01877382|579878709|FG012|Dose Expansion|Adverse Event|0|||
160590757|NCT01877382|579878710|FG013|Dose Expansion|Adverse Event|0|||
160590758|NCT01877382|579878711|FG014|Dose Expansion|Adverse Event|1|||
160590759|NCT01877382|579878697|FG000|Dose Expansion|Death|0|||
160590760|NCT01877382|579878698|FG001|Dose Expansion|Death|0|||
160590761|NCT01877382|579878699|FG002|Dose Expansion|Death|0|||
160590762|NCT01877382|579878700|FG003|Dose Expansion|Death|0|||
160590763|NCT01877382|579878701|FG004|Dose Expansion|Death|0|||
160590764|NCT01877382|579878702|FG005|Dose Expansion|Death|0|||
160590765|NCT01877382|579878703|FG006|Dose Expansion|Death|0|||
160590766|NCT01877382|579878704|FG007|Dose Expansion|Death|0|||
160590767|NCT01877382|579878705|FG008|Dose Expansion|Death|0|||
160590768|NCT01877382|579878706|FG009|Dose Expansion|Death|0|||
160590769|NCT01877382|579878707|FG010|Dose Expansion|Death|0|||
160590770|NCT01877382|579878708|FG011|Dose Expansion|Death|0|||
160590771|NCT01877382|579878709|FG012|Dose Expansion|Death|0|||
160590772|NCT01877382|579878710|FG013|Dose Expansion|Death|0|||
160590773|NCT01877382|579878711|FG014|Dose Expansion|Death|1|||
160590774|NCT01877382|579878697|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590775|NCT01877382|579878698|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590776|NCT01877382|579878699|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590777|NCT01877382|579878700|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590778|NCT01877382|579878701|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590779|NCT01877382|579878702|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590780|NCT01877382|579878703|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590781|NCT01877382|579878704|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590782|NCT01877382|579878705|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590783|NCT01877382|579878706|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590784|NCT01877382|579878707|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590785|NCT01877382|579878708|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590786|NCT01877382|579878709|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590787|NCT01877382|579878710|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
160590788|NCT01877382|579878711|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
160590789|NCT03423979|579878712|FG000|Overall Study|Death|5|||
160590790|NCT03423979|579878712|FG000|Overall Study|Adverse Event|4|||
160590791|NCT03423979|579878712|FG000|Overall Study|Withdrawal by Subject|3|||
160590792|NCT03423979|579878712|FG000|Overall Study|Lost to Follow-up|16|||
160590793|NCT00808249|579878715|FG000|Overall Study|Adverse Event|4|||
160590794|NCT00808249|579878716|FG001|Overall Study|Adverse Event|7|||
160590795|NCT00808249|579878717|FG002|Overall Study|Adverse Event|10|||
160590796|NCT00808249|579878718|FG003|Overall Study|Adverse Event|6|||
160590797|NCT00808249|579878715|FG000|Overall Study|Lost to Follow-up|2|||
160590798|NCT00808249|579878716|FG001|Overall Study|Lost to Follow-up|3|||
160590799|NCT00808249|579878717|FG002|Overall Study|Lost to Follow-up|3|||
160590800|NCT00808249|579878718|FG003|Overall Study|Lost to Follow-up|5|||
160590801|NCT00808249|579878715|FG000|Overall Study|Withdrawal by Subject|4|||
160590802|NCT00808249|579878716|FG001|Overall Study|Withdrawal by Subject|0|||
160590803|NCT00808249|579878717|FG002|Overall Study|Withdrawal by Subject|2|||
160590804|NCT00808249|579878718|FG003|Overall Study|Withdrawal by Subject|4|||
160590805|NCT00808249|579878715|FG000|Overall Study|Protocol Violation|3|||
160590806|NCT00808249|579878716|FG001|Overall Study|Protocol Violation|3|||
160590807|NCT00808249|579878717|FG002|Overall Study|Protocol Violation|3|||
160658015|NCT01918397|580129887|FG002|Overall Study|Never started treatment|0|||
160658016|NCT01918397|580129888|FG003|Overall Study|Never started treatment|0|||
160590808|NCT00808249|579878718|FG003|Overall Study|Protocol Violation|0|||
160658017|NCT01918397|580129885|FG000|Overall Study|Adverse Event|1|||
160658018|NCT01918397|580129886|FG001|Overall Study|Adverse Event|1|||
160658019|NCT01918397|580129887|FG002|Overall Study|Adverse Event|1|||
160658020|NCT01918397|580129888|FG003|Overall Study|Adverse Event|0|||
160658021|NCT01918397|580129885|FG000|Overall Study|Lack of compliance|2|||
160658022|NCT01918397|580129886|FG001|Overall Study|Lack of compliance|2|||
160658023|NCT01918397|580129887|FG002|Overall Study|Lack of compliance|3|||
160658024|NCT01918397|580129888|FG003|Overall Study|Lack of compliance|0|||
160658025|NCT01918397|580129885|FG000|Overall Study|Pregnancy|0|||
160658026|NCT01918397|580129886|FG001|Overall Study|Pregnancy|1|||
160658027|NCT01918397|580129887|FG002|Overall Study|Pregnancy|0|||
160658028|NCT01918397|580129888|FG003|Overall Study|Pregnancy|0|||
160658029|NCT01918397|580129885|FG000|Overall Study|Rifampin susceptible|0|||
160658030|NCT01918397|580129886|FG001|Overall Study|Rifampin susceptible|0|||
160658031|NCT01918397|580129887|FG002|Overall Study|Rifampin susceptible|0|||
160658032|NCT01918397|580129888|FG003|Overall Study|Rifampin susceptible|2|||
160658033|NCT01918397|580129885|FG000|Overall Study|Treatment failure|0|||
160658034|NCT01918397|580129886|FG001|Overall Study|Treatment failure|0|||
160658035|NCT01918397|580129887|FG002|Overall Study|Treatment failure|0|||
160658036|NCT01918397|580129888|FG003|Overall Study|Treatment failure|1|||
160658037|NCT01918397|580129885|FG000|Overall Study|Withdrawal by Subject|3|||
160658038|NCT01918397|580129886|FG001|Overall Study|Withdrawal by Subject|2|||
160658039|NCT01918397|580129887|FG002|Overall Study|Withdrawal by Subject|1|||
160658040|NCT01918397|580129888|FG003|Overall Study|Withdrawal by Subject|1|||
160658041|NCT01918397|580129885|FG000|Overall Study|XDR at baseline|0|||
160658042|NCT01918397|580129886|FG001|Overall Study|XDR at baseline|0|||
160658043|NCT01918397|580129887|FG002|Overall Study|XDR at baseline|1|||
160658044|NCT01918397|580129888|FG003|Overall Study|XDR at baseline|0|||
160658045|NCT01918397|580129885|FG000|Overall Study|Lost to Follow-up|2|||
160658046|NCT01918397|580129886|FG001|Overall Study|Lost to Follow-up|1|||
160658047|NCT01918397|580129887|FG002|Overall Study|Lost to Follow-up|1|||
160658048|NCT01918397|580129888|FG003|Overall Study|Lost to Follow-up|1|||
160658049|NCT01918397|580129885|FG000|Overall Study|Increased QTc|1|||
160658050|NCT01918397|580129886|FG001|Overall Study|Increased QTc|0|||
160658051|NCT01918397|580129887|FG002|Overall Study|Increased QTc|0|||
160658052|NCT01918397|580129888|FG003|Overall Study|Increased QTc|1|||
160658053|NCT01918397|580129885|FG000|Overall Study|Death|0|||
160975379|NCT04498247|581299310|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
160975380|NCT00669903|581299311|FG000|Overall Study|Adverse Event|0|||
160975381|NCT00669903|581299312|FG001|Overall Study|Adverse Event|1|||
160975382|NCT00669903|581299313|FG002|Overall Study|Adverse Event|3|||
160975383|NCT00669903|581299314|FG003|Overall Study|Adverse Event|1|||
160975384|NCT00669903|581299311|FG000|Overall Study|Withdrawal by Subject|0|||
160975385|NCT00669903|581299312|FG001|Overall Study|Withdrawal by Subject|2|||
160975386|NCT00669903|581299313|FG002|Overall Study|Withdrawal by Subject|2|||
160975387|NCT00669903|581299314|FG003|Overall Study|Withdrawal by Subject|2|||
160975388|NCT00669903|581299311|FG000|Overall Study|Lost to Follow-up|1|||
160975389|NCT00669903|581299312|FG001|Overall Study|Lost to Follow-up|1|||
160975390|NCT00669903|581299313|FG002|Overall Study|Lost to Follow-up|0|||
160975391|NCT00669903|581299314|FG003|Overall Study|Lost to Follow-up|1|||
160975392|NCT00669903|581299311|FG000|Overall Study|Protocol Violation|0|||
160975393|NCT00669903|581299312|FG001|Overall Study|Protocol Violation|1|||
160975394|NCT00669903|581299313|FG002|Overall Study|Protocol Violation|0|||
160975395|NCT00669903|581299314|FG003|Overall Study|Protocol Violation|0|||
160975396|NCT00251927|581299315|FG000|Overall Study|Adverse Event|3|||
160975397|NCT00251927|581299316|FG001|Overall Study|Adverse Event|15|||
160975398|NCT00251927|581299315|FG000|Overall Study|Lack of Efficacy|22|||
160975399|NCT00251927|581299316|FG001|Overall Study|Lack of Efficacy|16|||
160975400|NCT00251927|581299315|FG000|Overall Study|Lost to Follow-up|22|||
160975401|NCT00251927|581299316|FG001|Overall Study|Lost to Follow-up|8|||
160975402|NCT00251927|581299315|FG000|Overall Study|Protocol Violation|1|||
160975403|NCT00251927|581299316|FG001|Overall Study|Protocol Violation|2|||
160975404|NCT00251927|581299315|FG000|Overall Study|Pregnancy|2|||
160975405|NCT00251927|581299316|FG001|Overall Study|Pregnancy|0|||
160975406|NCT00251927|581299315|FG000|Overall Study|Withdrawal by Subject|40|||
160975407|NCT00251927|581299316|FG001|Overall Study|Withdrawal by Subject|25|||
160975408|NCT00251927|581299315|FG000|Overall Study|Study-specific discont. achieved|13|||
160975409|NCT00251927|581299316|FG001|Overall Study|Study-specific discont. achieved|2|||
160975410|NCT00251927|581299315|FG000|Overall Study|Study procedure non-compliance|5|||
160975411|NCT00251927|581299316|FG001|Overall Study|Study procedure non-compliance|6|||
160975412|NCT01678820|581299317|FG000|Overall Study|Study Terminated by Sponsor|45|||
160975413|NCT01678820|581299318|FG001|Overall Study|Study Terminated by Sponsor|43|||
160975414|NCT01678820|581299319|FG002|Overall Study|Study Terminated by Sponsor|43|||
160975415|NCT01678820|581299317|FG000|Overall Study|Withdrawal by Subject|2|||
160975416|NCT01678820|581299318|FG001|Overall Study|Withdrawal by Subject|5|||
160658054|NCT01918397|580129886|FG001|Overall Study|Death|0|||
160658055|NCT01918397|580129887|FG002|Overall Study|Death|1|||
160658056|NCT01918397|580129888|FG003|Overall Study|Death|0|||
160975417|NCT01678820|581299319|FG002|Overall Study|Withdrawal by Subject|2|||
160590809|NCT00808249|579878715|FG000|Overall Study|Lack of Efficacy|1|||
160590810|NCT00808249|579878716|FG001|Overall Study|Lack of Efficacy|1|||
160590811|NCT00808249|579878717|FG002|Overall Study|Lack of Efficacy|0|||
160590812|NCT00808249|579878718|FG003|Overall Study|Lack of Efficacy|0|||
160590813|NCT00808249|579878715|FG000|Overall Study|study specific discontinuation criteria|1|||
160590814|NCT00808249|579878716|FG001|Overall Study|study specific discontinuation criteria|0|||
160590815|NCT00808249|579878717|FG002|Overall Study|study specific discontinuation criteria|1|||
160590816|NCT00808249|579878718|FG003|Overall Study|study specific discontinuation criteria|0|||
160590817|NCT00808249|579878715|FG000|Overall Study|All other reasons|2|||
160590818|NCT00808249|579878716|FG001|Overall Study|All other reasons|1|||
160590819|NCT00808249|579878717|FG002|Overall Study|All other reasons|3|||
160590820|NCT00808249|579878718|FG003|Overall Study|All other reasons|1|||
160590821|NCT04095286|579878721|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
160590822|NCT04095286|579878722|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
160590823|NCT04095286|579878723|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
160590824|NCT04095286|579878724|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
160590825|NCT04095286|579878725|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
160590826|NCT04095286|579878726|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
160590827|NCT04095286|579878721|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
160590828|NCT04095286|579878722|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
160590829|NCT04095286|579878723|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
160590830|NCT04095286|579878724|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
160590831|NCT04095286|579878725|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
160590832|NCT04095286|579878726|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
160590833|NCT04095286|579878721|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
160590834|NCT04095286|579878722|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
160590835|NCT04095286|579878723|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
160590836|NCT04095286|579878724|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
160590837|NCT04095286|579878725|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
160590838|NCT04095286|579878726|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
160590839|NCT04095286|579878721|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
160590840|NCT04095286|579878722|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
160590841|NCT04095286|579878723|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
160590842|NCT04095286|579878724|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
160590843|NCT04095286|579878725|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
160590844|NCT04095286|579878726|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
160590845|NCT04095286|579878721|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
160590846|NCT04095286|579878722|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
160590847|NCT04095286|579878723|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
160590848|NCT04095286|579878724|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
160590849|NCT04095286|579878725|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
160590850|NCT04095286|579878726|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
160590851|NCT00479557|579878727|FG000|Overall Study|Death|0|||
160590852|NCT00479557|579878728|FG001|Overall Study|Death|0|||
160590853|NCT00479557|579878729|FG002|Overall Study|Death|0|||
160590854|NCT00479557|579878730|FG003|Overall Study|Death|0|||
160590855|NCT00479557|579878731|FG004|Overall Study|Death|0|||
160590856|NCT00479557|579878732|FG005|Overall Study|Death|1|||
160590857|NCT00479557|579878733|FG006|Overall Study|Death|0|||
160590858|NCT00479557|579878727|FG000|Overall Study|Lack of Efficacy|1|||
160590859|NCT00479557|579878728|FG001|Overall Study|Lack of Efficacy|0|||
160590860|NCT00479557|579878729|FG002|Overall Study|Lack of Efficacy|0|||
160590861|NCT00479557|579878730|FG003|Overall Study|Lack of Efficacy|0|||
160590862|NCT00479557|579878731|FG004|Overall Study|Lack of Efficacy|0|||
160590863|NCT00479557|579878732|FG005|Overall Study|Lack of Efficacy|0|||
160590864|NCT00479557|579878733|FG006|Overall Study|Lack of Efficacy|0|||
160590865|NCT00479557|579878727|FG000|Overall Study|Lost to Follow-up|0|||
160590866|NCT00479557|579878728|FG001|Overall Study|Lost to Follow-up|2|||
160590867|NCT00479557|579878729|FG002|Overall Study|Lost to Follow-up|0|||
160590868|NCT00479557|579878730|FG003|Overall Study|Lost to Follow-up|2|||
160590869|NCT00479557|579878731|FG004|Overall Study|Lost to Follow-up|0|||
160590870|NCT00479557|579878732|FG005|Overall Study|Lost to Follow-up|0|||
160590871|NCT00479557|579878733|FG006|Overall Study|Lost to Follow-up|0|||
160590872|NCT00479557|579878727|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
160590873|NCT00479557|579878728|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
160590874|NCT00479557|579878729|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
160590875|NCT00479557|579878730|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
160590876|NCT00479557|579878731|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
160590877|NCT00479557|579878732|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
160590878|NCT00479557|579878733|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
160590879|NCT00479557|579878727|FG000|Overall Study|AE not related to Study Drug|1|||
160590880|NCT00479557|579878728|FG001|Overall Study|AE not related to Study Drug|3|||
160590881|NCT00479557|579878729|FG002|Overall Study|AE not related to Study Drug|0|||
160590882|NCT00479557|579878730|FG003|Overall Study|AE not related to Study Drug|0|||
160590883|NCT00479557|579878731|FG004|Overall Study|AE not related to Study Drug|2|||
160590884|NCT00479557|579878732|FG005|Overall Study|AE not related to Study Drug|2|||
160590885|NCT00479557|579878733|FG006|Overall Study|AE not related to Study Drug|1|||
160590886|NCT00479557|579878727|FG000|Overall Study|Caregiver Request|2|||
160590887|NCT00479557|579878728|FG001|Overall Study|Caregiver Request|2|||
160590888|NCT00479557|579878729|FG002|Overall Study|Caregiver Request|2|||
160590889|NCT00479557|579878730|FG003|Overall Study|Caregiver Request|0|||
160590890|NCT00479557|579878731|FG004|Overall Study|Caregiver Request|1|||
160590891|NCT00479557|579878732|FG005|Overall Study|Caregiver Request|2|||
160590892|NCT00479557|579878733|FG006|Overall Study|Caregiver Request|0|||
160590893|NCT00479557|579878727|FG000|Overall Study|Investigator Request|0|||
160590894|NCT00479557|579878728|FG001|Overall Study|Investigator Request|0|||
160590895|NCT00479557|579878729|FG002|Overall Study|Investigator Request|1|||
160590896|NCT00479557|579878730|FG003|Overall Study|Investigator Request|0|||
160590897|NCT00479557|579878731|FG004|Overall Study|Investigator Request|0|||
160590898|NCT00479557|579878732|FG005|Overall Study|Investigator Request|0|||
160590899|NCT00479557|579878733|FG006|Overall Study|Investigator Request|0|||
160590900|NCT00479557|579878727|FG000|Overall Study|Subject Request|3|||
160590901|NCT00479557|579878728|FG001|Overall Study|Subject Request|0|||
160590902|NCT00479557|579878729|FG002|Overall Study|Subject Request|1|||
160590903|NCT00479557|579878730|FG003|Overall Study|Subject Request|1|||
160590904|NCT00479557|579878731|FG004|Overall Study|Subject Request|1|||
160590905|NCT00479557|579878732|FG005|Overall Study|Subject Request|4|||
160590906|NCT00479557|579878733|FG006|Overall Study|Subject Request|1|||
160590907|NCT00479557|579878727|FG000|Overall Study|Other|2|||
160590908|NCT00479557|579878728|FG001|Overall Study|Other|3|||
160590909|NCT00479557|579878729|FG002|Overall Study|Other|1|||
160590910|NCT00479557|579878730|FG003|Overall Study|Other|0|||
160590911|NCT00479557|579878731|FG004|Overall Study|Other|0|||
160590912|NCT00479557|579878732|FG005|Overall Study|Other|3|||
160590913|NCT00479557|579878733|FG006|Overall Study|Other|0|||
160590914|NCT05371912|579878736|FG000|Overall Study|Lost to Follow-up|3|||
160590915|NCT05371912|579878737|FG001|Overall Study|Lost to Follow-up|2|||
160590916|NCT04752189|579878738|FG000|Overall Study|Withdrawal by Subject|0|||
160590917|NCT04752189|579878739|FG001|Overall Study|Withdrawal by Subject|150|||
160590918|NCT04752189|579878738|FG000|Overall Study|Lost to Follow-up|261|||
160590919|NCT04752189|579878739|FG001|Overall Study|Lost to Follow-up|126|||
160590920|NCT00975195|579878740|FG000|Overall Study|Adverse Event|108|||
160590921|NCT00975195|579878741|FG001|Overall Study|Adverse Event|101|||
160590922|NCT00975195|579878740|FG000|Overall Study|Lack of Efficacy|6|||
160590923|NCT00975195|579878741|FG001|Overall Study|Lack of Efficacy|6|||
160590924|NCT00975195|579878740|FG000|Overall Study|Protocol Violation|27|||
160590925|NCT00975195|579878741|FG001|Overall Study|Protocol Violation|23|||
160590926|NCT00975195|579878740|FG000|Overall Study|Lost to Follow-up|9|||
160590927|NCT00975195|579878741|FG001|Overall Study|Lost to Follow-up|7|||
160590928|NCT00975195|579878740|FG000|Overall Study|Withdrawal by Subject|48|||
160590929|NCT00975195|579878741|FG001|Overall Study|Withdrawal by Subject|61|||
160590930|NCT00975195|579878740|FG000|Overall Study|Other reason not defined above|29|||
160590931|NCT00975195|579878741|FG001|Overall Study|Other reason not defined above|33|||
160590932|NCT00975195|579878740|FG000|Overall Study|Not treated|1|||
160590933|NCT00975195|579878741|FG001|Overall Study|Not treated|2|||
160590934|NCT03003403|579878746|FG000|Overall Study|Ineligible|8|||
160590935|NCT03003403|579878747|FG001|Overall Study|Ineligible|7|||
160590936|NCT03003403|579878746|FG000|Overall Study|Withdrawal by Subject|3|||
160590937|NCT03003403|579878747|FG001|Overall Study|Withdrawal by Subject|1|||
160590938|NCT02180724|579880306|FG000|Overall Study|Death|26|||
160590939|NCT02180724|579880307|FG001|Overall Study|Death|1|||
160975418|NCT01678820|581299317|FG000|Overall Study|Protocol Specified Criteria|2|||
160975419|NCT01678820|581299318|FG001|Overall Study|Protocol Specified Criteria|3|||
160975420|NCT01678820|581299319|FG002|Overall Study|Protocol Specified Criteria|1|||
160975421|NCT01678820|581299317|FG000|Overall Study|Adverse Event|2|||
160975422|NCT01678820|581299318|FG001|Overall Study|Adverse Event|2|||
160975423|NCT01678820|581299319|FG002|Overall Study|Adverse Event|2|||
160975424|NCT01678820|581299317|FG000|Overall Study|Lost to Follow-up|7|||
160975425|NCT01678820|581299318|FG001|Overall Study|Lost to Follow-up|2|||
160975426|NCT01678820|581299319|FG002|Overall Study|Lost to Follow-up|2|||
160975427|NCT01678820|581299317|FG000|Overall Study|Non-compliance with study drug|0|||
160975428|NCT01678820|581299318|FG001|Overall Study|Non-compliance with study drug|1|||
160975429|NCT01678820|581299319|FG002|Overall Study|Non-compliance with study drug|0|||
160975430|NCT01678820|581299317|FG000|Overall Study|Physician Decision|0|||
160975431|NCT01678820|581299318|FG001|Overall Study|Physician Decision|0|||
160590940|NCT02180724|579880306|FG000|Overall Study|Lost to Follow-up|3|||
160590941|NCT02180724|579880307|FG001|Overall Study|Lost to Follow-up|1|||
160590942|NCT02180724|579880306|FG000|Overall Study|Withdrawal by Subject|4|||
160590943|NCT02180724|579880307|FG001|Overall Study|Withdrawal by Subject|2|||
160590944|NCT02180724|579880306|FG000|Overall Study|PI Decision|5|||
160590945|NCT02180724|579880307|FG001|Overall Study|PI Decision|2|||
160590946|NCT02180724|579880306|FG000|Overall Study|Study terminated by sponsor|54|||
160590947|NCT02180724|579880307|FG001|Overall Study|Study terminated by sponsor|8|||
160590948|NCT01617655|579880312|FG000|Overall Study|Adverse Event|2|||
160590949|NCT01617655|579880313|FG001|Overall Study|Adverse Event|3|||
160590950|NCT01617655|579880312|FG000|Overall Study|Poor compliance to protocol|1|||
160590951|NCT01617655|579880313|FG001|Overall Study|Poor compliance to protocol|4|||
160590952|NCT01617655|579880312|FG000|Overall Study|Participants moved|0|||
160590953|NCT01617655|579880313|FG001|Overall Study|Participants moved|4|||
160590954|NCT01617655|579880312|FG000|Overall Study|Consent withdrawn by participant|1|||
160590955|NCT01617655|579880313|FG001|Overall Study|Consent withdrawn by participant|1|||
160590956|NCT01617655|579880312|FG000|Overall Study|Last visit outside protocol visit window|1|||
160590957|NCT01617655|579880313|FG001|Overall Study|Last visit outside protocol visit window|10|||
160590958|NCT01617655|579880312|FG000|Overall Study|Site closure|3|||
160590959|NCT01617655|579880313|FG001|Overall Study|Site closure|5|||
160590960|NCT01617655|579880312|FG000|Overall Study|Other than specified above|1|||
160590961|NCT01617655|579880313|FG001|Overall Study|Other than specified above|2|||
160590962|NCT01175213|579880316|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
160590963|NCT01175213|579880317|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
160975432|NCT01678820|581299319|FG002|Overall Study|Physician Decision|1|||
160975433|NCT01678820|581299317|FG000|Overall Study|Protocol Violation|4|||
160975434|NCT01678820|581299318|FG001|Overall Study|Protocol Violation|5|||
160975435|NCT01678820|581299319|FG002|Overall Study|Protocol Violation|4|||
160975436|NCT01678820|581299317|FG000|Overall Study|Not treated with double-blind study drug|0|||
160975437|NCT01678820|581299318|FG001|Overall Study|Not treated with double-blind study drug|2|||
160975438|NCT01678820|581299319|FG002|Overall Study|Not treated with double-blind study drug|2|||
160975439|NCT00245856|581299320|FG000|Period Two|Withdrawal by Subject|0|||
160975440|NCT00245856|581299321|FG001|Period Two|Withdrawal by Subject|1|||
160975441|NCT02765490|581299322|FG000|Overall Study|Lost to Follow-up|1|||
160975442|NCT02765490|581299323|FG001|Overall Study|Lost to Follow-up|1|||
160975443|NCT02765490|581299322|FG000|Overall Study|Other|0|||
160975444|NCT02765490|581299323|FG001|Overall Study|Other|1|||
160975445|NCT02765490|581299322|FG000|Overall Study|Death|0|||
160975446|NCT02765490|581299323|FG001|Overall Study|Death|1|||
160975447|NCT03662997|581299328|FG000|Overall Study|Adverse Event|0|||
160975448|NCT03662997|581299329|FG001|Overall Study|Adverse Event|2|||
160975449|NCT03662997|581299330|FG002|Overall Study|Adverse Event|0|||
160975450|NCT03662997|581299331|FG003|Overall Study|Adverse Event|0|||
160975451|NCT05266963|581299334|FG000|Drug Period A|Withdrawal by Subject|0|||
160975452|NCT05266963|581299335|FG001|Drug Period A|Withdrawal by Subject|1|||
160975453|NCT00152971|581299336|FG000|Overall Study|Adverse Event|12|||
160975454|NCT00152971|581299337|FG001|Overall Study|Adverse Event|10|||
160975455|NCT00152971|581299338|FG002|Overall Study|Adverse Event|9|||
160975456|NCT00152971|581299336|FG000|Overall Study|Protocol Violation|10|||
160975457|NCT00152971|581299337|FG001|Overall Study|Protocol Violation|11|||
160975458|NCT00152971|581299338|FG002|Overall Study|Protocol Violation|8|||
160975459|NCT00152971|581299336|FG000|Overall Study|Lost to Follow-up|17|||
160975460|NCT00152971|581299337|FG001|Overall Study|Lost to Follow-up|14|||
160975461|NCT00152971|581299338|FG002|Overall Study|Lost to Follow-up|13|||
160975462|NCT00152971|581299336|FG000|Overall Study|Withdrawal by Subject|9|||
160975463|NCT00152971|581299337|FG001|Overall Study|Withdrawal by Subject|8|||
160975464|NCT00152971|581299338|FG002|Overall Study|Withdrawal by Subject|14|||
160975465|NCT00152971|581299336|FG000|Overall Study|Other|3|||
160975466|NCT00152971|581299337|FG001|Overall Study|Other|5|||
160975467|NCT00152971|581299338|FG002|Overall Study|Other|5|||
160975468|NCT00152971|581299336|FG000|Treatment|Adverse Event|49|||
160975469|NCT00152971|581299337|FG001|Treatment|Adverse Event|40|||
160975470|NCT00152971|581299338|FG002|Treatment|Adverse Event|54|||
160975471|NCT00152971|581299336|FG000|Treatment|Protocol Violation|8|||
160975472|NCT00152971|581299337|FG001|Treatment|Protocol Violation|6|||
160975473|NCT00152971|581299338|FG002|Treatment|Protocol Violation|10|||
160975474|NCT00152971|581299336|FG000|Treatment|Lost to Follow-up|1|||
160975475|NCT00152971|581299337|FG001|Treatment|Lost to Follow-up|2|||
160975476|NCT00152971|581299338|FG002|Treatment|Lost to Follow-up|1|||
160975477|NCT00152971|581299336|FG000|Treatment|Withdrawal by Subject|4|||
160975478|NCT00152971|581299337|FG001|Treatment|Withdrawal by Subject|4|||
160975479|NCT00152971|581299338|FG002|Treatment|Withdrawal by Subject|5|||
160975480|NCT00152971|581299336|FG000|Treatment|Other|9|||
160975481|NCT00152971|581299337|FG001|Treatment|Other|11|||
160975482|NCT00152971|581299338|FG002|Treatment|Other|10|||
160975483|NCT04091360|581299339|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975484|NCT04091360|581299340|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975485|NCT04091360|581299341|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975486|NCT04091360|581299342|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160590964|NCT01175213|579880316|FG000|IGSC, 10%/rHuPH20|Death|1|||
160590965|NCT01175213|579880317|FG001|IGSC, 10%/rHuPH20|Death|0|||
160590966|NCT01175213|579880316|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
160590967|NCT01175213|579880317|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
160590968|NCT01175213|579880316|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
160590969|NCT01175213|579880317|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
160590970|NCT01175213|579880316|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
160590971|NCT01175213|579880317|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
160590972|NCT01175213|579880316|FG000|Safety Follow-up|Adverse Event|1|||
160590973|NCT01175213|579880317|FG001|Safety Follow-up|Adverse Event|0|||
160590974|NCT01754922|579880322|FG000|Overall Study|Adverse Event|0|||
160590975|NCT01754922|579880323|FG001|Overall Study|Adverse Event|1|||
160590976|NCT00259740|579880327|FG000|Overall Study|Physician Decision|1|||
160590977|NCT00259740|579880328|FG001|Overall Study|Physician Decision|1|||
160590978|NCT00259740|579880327|FG000|Overall Study|Adverse Event|0|||
160590979|NCT00259740|579880328|FG001|Overall Study|Adverse Event|2|||
160590980|NCT00259740|579880327|FG000|Overall Study|Withdrawal by Subject|2|||
160590981|NCT00259740|579880328|FG001|Overall Study|Withdrawal by Subject|6|||
160590982|NCT00259740|579880327|FG000|Overall Study|Death|1|||
160590983|NCT00259740|579880328|FG001|Overall Study|Death|1|||
160590984|NCT00259740|579880327|FG000|Overall Study|Disease progression|19|||
160590985|NCT00259740|579880328|FG001|Overall Study|Disease progression|36|||
160590986|NCT00259740|579880327|FG000|Overall Study|Ongoing|17|||
160590987|NCT00259740|579880328|FG001|Overall Study|Ongoing|3|||
160590988|NCT00259740|579880327|FG000|Overall Study|Other|3|||
160590989|NCT00259740|579880328|FG001|Overall Study|Other|0|||
160590990|NCT00259740|579880327|FG000|Overall Study|Requirement for alternative therapy|0|||
160590991|NCT00259740|579880328|FG001|Overall Study|Requirement for alternative therapy|4|||
160590992|NCT01844830|579880333|FG000|Overall Study|Withdrawal by Subject|1|||
160590993|NCT01844830|579880334|FG001|Overall Study|Withdrawal by Subject|0|||
160590994|NCT04735393|579880337|FG000|Overall Study|Lost to Follow-up|46|||
160590995|NCT04735393|579880338|FG001|Overall Study|Lost to Follow-up|24|||
160590996|NCT04735393|579880337|FG000|Overall Study|Physician Decision|2|||
160590997|NCT04735393|579880338|FG001|Overall Study|Physician Decision|1|||
160590998|NCT04735393|579880337|FG000|Overall Study|Not Detailed|1|||
160590999|NCT04735393|579880338|FG001|Overall Study|Not Detailed|2|||
160591000|NCT04735393|579880337|FG000|Overall Study|Withdrawal by Subject|71|||
160591001|NCT04735393|579880338|FG001|Overall Study|Withdrawal by Subject|28|||
160591002|NCT04735393|579880337|FG000|Overall Study|Adverse Event|56|||
160591003|NCT04735393|579880338|FG001|Overall Study|Adverse Event|7|||
160591004|NCT04735393|579880337|FG000|Overall Study|Protocol Violation|6|||
160591005|NCT04735393|579880338|FG001|Overall Study|Protocol Violation|1|||
160591006|NCT04735393|579880337|FG000|Overall Study|Trial terminated by Sponsor|49|||
160591007|NCT04735393|579880338|FG001|Overall Study|Trial terminated by Sponsor|29|||
160591008|NCT00209170|579880339|FG000|Overall Study|Adverse Event|0|||
160591009|NCT00209170|579880340|FG001|Overall Study|Adverse Event|1|||
160591010|NCT00209170|579880339|FG000|Overall Study|Withdrawal by Subject|2|||
160591011|NCT00209170|579880340|FG001|Overall Study|Withdrawal by Subject|1|||
160591012|NCT00209170|579880339|FG000|Overall Study|Lack of Efficacy|0|||
160591013|NCT00209170|579880340|FG001|Overall Study|Lack of Efficacy|1|||
160591014|NCT04580394|579880345|FG000|First Intervention|Incorrectly Randomized|1|||
160591015|NCT04580394|579880345|FG000|First Intervention|Physician Decision|1|||
160591016|NCT04580394|579880345|FG000|First Intervention|Lost to Follow-up|1|||
160591017|NCT04580394|579880345|FG000|Washout (One Week)|Withdrawal by Subject|1|||
160591018|NCT04580394|579880345|FG000|Washout (One Week)|Adverse Event|1|||
160591019|NCT04580394|579880345|FG000|Washout (One Week)|Withdrawal by Subject|2|||
160591020|NCT04580394|579880345|FG000|Third Intervention|Adverse Event|1|||
160591021|NCT04580394|579880345|FG000|Third Intervention|Withdrawal by Subject|1|||
160591022|NCT04580394|579880345|FG000|Washout (One Week)|Withdrawal by Subject|2|||
160591023|NCT04397718|579880348|FG000|Overall Study|Death|7|||
160591024|NCT04397718|579880349|FG001|Overall Study|Death|11|||
160591025|NCT04397718|579880348|FG000|Overall Study|Lost to Follow-up|0|||
160591026|NCT04397718|579880349|FG001|Overall Study|Lost to Follow-up|4|||
160591027|NCT06087328|579880350|FG000|28-Day Treatment|Lost to Follow-up|7|||
160591028|NCT06087328|579880351|FG001|28-Day Treatment|Lost to Follow-up|3|||
160591029|NCT06087328|579880352|FG002|28-Day Treatment|Lost to Follow-up|4|||
160591030|NCT06087328|579880350|FG000|1-month Follow-up|Lost to Follow-up|0|||
160591031|NCT06087328|579880351|FG001|1-month Follow-up|Lost to Follow-up|1|||
160591032|NCT06087328|579880352|FG002|1-month Follow-up|Lost to Follow-up|1|||
160591033|NCT03201965|579880355|FG000|Overall Study|Death|5|||
160591034|NCT03201965|579880356|FG001|Overall Study|Death|65|||
160591035|NCT03201965|579880357|FG002|Overall Study|Death|47|||
160591036|NCT03201965|579880355|FG000|Overall Study|Lost to Follow-up|0|||
160591037|NCT03201965|579880356|FG001|Overall Study|Lost to Follow-up|6|||
160591038|NCT03201965|579880357|FG002|Overall Study|Lost to Follow-up|0|||
160591039|NCT03201965|579880355|FG000|Overall Study|Withdrawal by Subject|3|||
160591040|NCT03201965|579880356|FG001|Overall Study|Withdrawal by Subject|23|||
160591041|NCT03201965|579880357|FG002|Overall Study|Withdrawal by Subject|8|||
160591042|NCT03201965|579880355|FG000|Overall Study|Sponsor's Decision|20|||
160591043|NCT03201965|579880356|FG001|Overall Study|Sponsor's Decision|99|||
160591044|NCT03201965|579880357|FG002|Overall Study|Sponsor's Decision|140|||
160591045|NCT03589326|579880358|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
160591046|NCT03589326|579880359|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
160591047|NCT03589326|579880358|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
160591048|NCT03589326|579880359|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
160591049|NCT03589326|579880358|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
160591050|NCT03589326|579880359|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
160591051|NCT03589326|579880358|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
160591052|NCT03589326|579880359|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
160591053|NCT03589326|579880358|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
160591054|NCT03589326|579880359|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
160591055|NCT01371981|579880362|FG000|Overall Study|Adverse Event|12|||
160591056|NCT01371981|579880363|FG001|Overall Study|Adverse Event|17|||
160591057|NCT01371981|579880364|FG002|Overall Study|Adverse Event|0|||
160591058|NCT01371981|579880365|FG003|Overall Study|Adverse Event|4|||
160591059|NCT01371981|579880366|FG004|Overall Study|Adverse Event|1|||
160591060|NCT01371981|579880367|FG005|Overall Study|Adverse Event|0|||
160591061|NCT01371981|579880362|FG000|Overall Study|Death|22|||
160591062|NCT01371981|579880363|FG001|Overall Study|Death|16|||
160591063|NCT01371981|579880364|FG002|Overall Study|Death|0|||
160591064|NCT01371981|579880365|FG003|Overall Study|Death|0|||
160591065|NCT01371981|579880366|FG004|Overall Study|Death|2|||
160591066|NCT01371981|579880367|FG005|Overall Study|Death|2|||
160591067|NCT01371981|579880362|FG000|Overall Study|Lack of Efficacy|69|||
160591068|NCT01371981|579880363|FG001|Overall Study|Lack of Efficacy|61|||
160591069|NCT01371981|579880364|FG002|Overall Study|Lack of Efficacy|4|||
160591070|NCT01371981|579880365|FG003|Overall Study|Lack of Efficacy|8|||
160591071|NCT01371981|579880366|FG004|Overall Study|Lack of Efficacy|5|||
160591072|NCT01371981|579880367|FG005|Overall Study|Lack of Efficacy|0|||
160591073|NCT01371981|579880362|FG000|Overall Study|Physician Decision|48|||
160658057|NCT01918397|580129885|FG000|Overall Study|Involved in another investigative trial|0|||
160975487|NCT04091360|581299343|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975488|NCT04091360|581299344|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975489|NCT04091360|581299345|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975490|NCT04091360|581299346|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975491|NCT04091360|581299347|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
160975492|NCT04091360|581299348|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
160975493|NCT04091360|581299339|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975494|NCT04091360|581299340|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975495|NCT04091360|581299341|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975496|NCT04091360|581299342|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975497|NCT04091360|581299343|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975498|NCT04091360|581299344|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975499|NCT04091360|581299345|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
160975500|NCT04091360|581299346|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
160975501|NCT04091360|581299347|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975502|NCT04091360|581299348|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975503|NCT04091360|581299339|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975504|NCT04091360|581299340|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975505|NCT04091360|581299341|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975506|NCT04091360|581299342|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975507|NCT04091360|581299343|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975508|NCT04091360|581299344|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975509|NCT04091360|581299345|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
160975510|NCT04091360|581299346|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975511|NCT04091360|581299347|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975512|NCT04091360|581299348|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
160975513|NCT01320735|581299349|FG000|Overall Study|Adverse Event|3|||
160975514|NCT01320735|581299349|FG000|Overall Study|Withdrawal by Subject|3|||
160975515|NCT01320735|581299349|FG000|Overall Study|Lost to Follow-up|13|||
160975516|NCT01320735|581299349|FG000|Overall Study|Administrative Reason|6|||
160975517|NCT01320735|581299349|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
160975518|NCT01320735|581299349|FG000|Overall Study|Protocol Violation|1|||
160975519|NCT01320735|581299349|FG000|Overall Study|Other|1|||
160975520|NCT01320735|581299349|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
160975521|NCT01320735|581299349|FG000|Overall Study|Investigator Unable to be Contacted|17|||
160975522|NCT04599101|581299350|FG000|Overall Study|Lost to Follow-up|5|||
160975523|NCT04599101|581299351|FG001|Overall Study|Lost to Follow-up|5|||
160975524|NCT05952297|581299352|FG000|Overall Study|Withdrawal by Subject|1|||
160975525|NCT05952297|581299353|FG001|Overall Study|Withdrawal by Subject|0|||
160975526|NCT03556358|581299354|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
160975527|NCT03556358|581299355|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
160975528|NCT03556358|581299354|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
160975529|NCT03556358|581299355|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
160975530|NCT03556358|581299354|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
160591074|NCT01371981|579880363|FG001|Overall Study|Physician Decision|63|||
160591075|NCT01371981|579880364|FG002|Overall Study|Physician Decision|1|||
160591076|NCT01371981|579880365|FG003|Overall Study|Physician Decision|7|||
160975531|NCT03556358|581299355|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
160975532|NCT03556358|581299354|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
160975533|NCT03556358|581299355|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
160975534|NCT03556358|581299354|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
160975535|NCT03556358|581299355|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
160975536|NCT03556358|581299354|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
160975537|NCT03556358|581299355|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
160975538|NCT03556358|581299354|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
160975539|NCT03556358|581299355|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
160975540|NCT05067933|581299362|FG000|Overall Study|Withdrawal by Subject|2|||
160975541|NCT05067933|581299363|FG001|Overall Study|Withdrawal by Subject|0|||
160975542|NCT05067933|581299364|FG002|Overall Study|Withdrawal by Subject|0|||
160975543|NCT05067933|581299365|FG003|Overall Study|Withdrawal by Subject|0|||
160975544|NCT05067933|581299366|FG004|Overall Study|Withdrawal by Subject|0|||
160975545|NCT05067933|581299367|FG005|Overall Study|Withdrawal by Subject|0|||
160975546|NCT05067933|581299362|FG000|Overall Study|Lost to Follow-up|1|||
160975547|NCT05067933|581299363|FG001|Overall Study|Lost to Follow-up|1|||
160975548|NCT05067933|581299364|FG002|Overall Study|Lost to Follow-up|1|||
160975549|NCT05067933|581299365|FG003|Overall Study|Lost to Follow-up|2|||
160975550|NCT05067933|581299366|FG004|Overall Study|Lost to Follow-up|1|||
160975551|NCT05067933|581299367|FG005|Overall Study|Lost to Follow-up|0|||
160975552|NCT05067933|581299362|FG000|Overall Study|Miscellaneous|1|||
160975553|NCT05067933|581299363|FG001|Overall Study|Miscellaneous|0|||
160975554|NCT05067933|581299364|FG002|Overall Study|Miscellaneous|0|||
160975555|NCT05067933|581299365|FG003|Overall Study|Miscellaneous|0|||
160975556|NCT05067933|581299366|FG004|Overall Study|Miscellaneous|0|||
160975557|NCT05067933|581299367|FG005|Overall Study|Miscellaneous|0|||
160975558|NCT05067933|581299362|FG000|Overall Study|Death|0|||
160975559|NCT05067933|581299363|FG001|Overall Study|Death|0|||
160975560|NCT05067933|581299364|FG002|Overall Study|Death|0|||
160975561|NCT05067933|581299365|FG003|Overall Study|Death|1|||
160975562|NCT05067933|581299366|FG004|Overall Study|Death|0|||
160975563|NCT05067933|581299367|FG005|Overall Study|Death|0|||
160975564|NCT01065350|581299368|FG000|Overall Study|Received incorrect drug allocation|0|||
160975565|NCT01065350|581299369|FG001|Overall Study|Received incorrect drug allocation|1|||
160975566|NCT02716038|581299376|FG000|Overall Study|Not evaluable|1|||
160975567|NCT02716038|581299376|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
160975568|NCT02716038|581299376|FG000|Overall Study|Unresectable|3|||
160975569|NCT00550550|581299377|FG000|Overall Study|Adverse Event|13|||
160975570|NCT00550550|581299378|FG001|Overall Study|Adverse Event|5|||
160975571|NCT00550550|581299377|FG000|Overall Study|Treatment Failure|0|||
160975572|NCT00550550|581299378|FG001|Overall Study|Treatment Failure|1|||
160975573|NCT00550550|581299377|FG000|Overall Study|Lost to Follow-up|4|||
160975574|NCT00550550|581299378|FG001|Overall Study|Lost to Follow-up|0|||
160975575|NCT00550550|581299377|FG000|Overall Study|Withdrawal by Subject|10|||
160975576|NCT00550550|581299378|FG001|Overall Study|Withdrawal by Subject|8|||
160975577|NCT00550550|581299377|FG000|Overall Study|Protocol Violation|5|||
160975578|NCT00550550|581299378|FG001|Overall Study|Protocol Violation|14|||
160975579|NCT00550550|581299377|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
160975580|NCT00550550|581299378|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
160975581|NCT00550550|581299377|FG000|Overall Study|Randomized But Not Treated|1|||
160975582|NCT00550550|581299378|FG001|Overall Study|Randomized But Not Treated|0|||
160975583|NCT00118092|581299379|FG000|Overall Study|Withdrawal by Subject|1|||
160975584|NCT00118092|581299379|FG000|Overall Study|Protocol Violation|1|||
160975585|NCT00591864|581299380|FG000|Overall Study|Incomplete Imaging|5|||
160975586|NCT02459093|581299385|FG000|Overall Study|Protocol Violation|6|||
160975587|NCT02459093|581299386|FG001|Overall Study|Protocol Violation|11|||
160975588|NCT02459093|581299385|FG000|Overall Study|Lost to Follow-up|6|||
160975589|NCT02459093|581299386|FG001|Overall Study|Lost to Follow-up|7|||
160975590|NCT01103960|581299389|FG000|Overall Study|Adverse Event|2|||
160975591|NCT01103960|581299390|FG001|Overall Study|Adverse Event|1|||
160975592|NCT01103960|581299389|FG000|Overall Study|Withdrawal by Subject|2|||
160975593|NCT01103960|581299390|FG001|Overall Study|Withdrawal by Subject|1|||
160975594|NCT01103960|581299389|FG000|Overall Study|Other|1|||
160975595|NCT01103960|581299390|FG001|Overall Study|Other|0|||
160975596|NCT02875834|581299391|FG000|Open-label Phase|Withdrawal by Subject|3|||
160975597|NCT02875834|581299392|FG001|Open-label Phase|Withdrawal by Subject|0|||
160975598|NCT02875834|581299393|FG002|Open-label Phase|Withdrawal by Subject|0|||
160975599|NCT02875834|581299394|FG003|Open-label Phase|Withdrawal by Subject|0|||
160975600|NCT02875834|581299391|FG000|Open-label Phase|(Not collected)|4|||
160975601|NCT02875834|581299392|FG001|Open-label Phase|(Not collected)|0|||
160591077|NCT01371981|579880366|FG004|Overall Study|Physician Decision|14|||
160975602|NCT02875834|581299393|FG002|Open-label Phase|(Not collected)|0|||
160591078|NCT01371981|579880367|FG005|Overall Study|Physician Decision|3|||
160591079|NCT01371981|579880362|FG000|Overall Study|Withdrawal by Subject|12|||
160591080|NCT01371981|579880363|FG001|Overall Study|Withdrawal by Subject|19|||
160591081|NCT01371981|579880364|FG002|Overall Study|Withdrawal by Subject|1|||
160591082|NCT01371981|579880365|FG003|Overall Study|Withdrawal by Subject|2|||
160591083|NCT01371981|579880366|FG004|Overall Study|Withdrawal by Subject|10|||
160975603|NCT02875834|581299394|FG003|Open-label Phase|(Not collected)|0|||
160975604|NCT02875834|581299391|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
160975605|NCT02875834|581299392|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
160975606|NCT02875834|581299393|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
160975607|NCT02875834|581299394|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
160975608|NCT02875834|581299391|FG000|Randomized Treatment Phase|Protocol Violation|0|||
160975609|NCT02875834|581299392|FG001|Randomized Treatment Phase|Protocol Violation|2|||
160975610|NCT02875834|581299393|FG002|Randomized Treatment Phase|Protocol Violation|0|||
160975611|NCT02875834|581299394|FG003|Randomized Treatment Phase|Protocol Violation|0|||
160975612|NCT02875834|581299391|FG000|Randomized Treatment Phase|(Not collected)|0|||
160975613|NCT02875834|581299392|FG001|Randomized Treatment Phase|(Not collected)|9|||
160975614|NCT02875834|581299393|FG002|Randomized Treatment Phase|(Not collected)|10|||
160975615|NCT02875834|581299394|FG003|Randomized Treatment Phase|(Not collected)|9|||
160975616|NCT01302938|581299395|FG000|Overall Study|Withdrawal by Subject|1|||
160975617|NCT01302938|581299396|FG001|Overall Study|Withdrawal by Subject|0|||
160591084|NCT01371981|579880367|FG005|Overall Study|Withdrawal by Subject|3|||
160591085|NCT01371981|579880362|FG000|Overall Study|Ineligible|19|||
160591086|NCT01371981|579880363|FG001|Overall Study|Ineligible|13|||
160975618|NCT01302938|581299395|FG000|Overall Study|Adverse Event|1|||
160975619|NCT01302938|581299396|FG001|Overall Study|Adverse Event|0|||
160975620|NCT00539279|581299398|FG000|Treatment|Withdrawal by Subject|10|||
160975621|NCT00539279|581299399|FG001|Treatment|Withdrawal by Subject|8|||
160975622|NCT00539279|581299398|FG000|Treatment|Death|1|||
160975623|NCT00539279|581299399|FG001|Treatment|Death|0|||
160975624|NCT00539279|581299398|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
160975625|NCT00539279|581299399|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
160975626|NCT00539279|581299398|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
160975627|NCT00539279|581299399|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
160975628|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
160975629|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
160975630|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
160975631|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
160975632|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
160975633|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
160975634|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
160975635|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
160975636|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975637|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975638|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975639|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975640|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975641|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975642|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
160975643|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
160975644|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
160975645|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160975646|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160975647|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160975648|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160975649|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
160975650|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
160975651|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
160975652|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
160975653|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
160975654|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
160975655|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
160975656|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160975657|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160658058|NCT01918397|580129886|FG001|Overall Study|Involved in another investigative trial|0|||
160658059|NCT01918397|580129887|FG002|Overall Study|Involved in another investigative trial|0|||
160658060|NCT01918397|580129888|FG003|Overall Study|Involved in another investigative trial|1|||
160658061|NCT00437658|580129897|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
160658062|NCT00437658|580129898|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
160658063|NCT00437658|580129899|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
160658064|NCT00437658|580129897|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
160658065|NCT00437658|580129898|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
160658066|NCT00437658|580129899|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
160658067|NCT00437658|580129897|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
160658068|NCT00437658|580129898|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
160658069|NCT00437658|580129899|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
160658070|NCT00437658|580129897|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
160658071|NCT00437658|580129898|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
160658072|NCT00437658|580129899|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
160658073|NCT00437658|580129897|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
160658074|NCT00437658|580129898|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
160658075|NCT00437658|580129899|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
160658076|NCT00437658|580129897|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
160658077|NCT00437658|580129898|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
160658078|NCT00437658|580129899|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
160658079|NCT00437658|580129897|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
160658080|NCT00437658|580129898|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
160658081|NCT00437658|580129899|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
160658082|NCT00437658|580129897|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
160658083|NCT00437658|580129898|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
160658084|NCT00437658|580129899|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
160658085|NCT00437658|580129897|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
160658086|NCT00437658|580129898|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
160658087|NCT00437658|580129899|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
160658088|NCT00437658|580129897|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
160658089|NCT00437658|580129898|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
160658090|NCT00437658|580129899|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
160658091|NCT00437658|580129897|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
160658092|NCT00437658|580129898|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
160658093|NCT00437658|580129899|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
160658094|NCT00437658|580129897|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
160658095|NCT00437658|580129898|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
160658096|NCT00437658|580129899|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
160658097|NCT03952143|580129900|FG000|Lead-In Period|Adverse Event|2|||
160658098|NCT03952143|580129901|FG001|Lead-In Period|Adverse Event|0|||
160658099|NCT03952143|580129902|FG002|Lead-In Period|Adverse Event|0|||
160658100|NCT03952143|580129900|FG000|Lead-In Period|Lack of Efficacy|2|||
160658101|NCT03952143|580129901|FG001|Lead-In Period|Lack of Efficacy|0|||
160658102|NCT03952143|580129902|FG002|Lead-In Period|Lack of Efficacy|0|||
160658103|NCT03952143|580129900|FG000|Lead-In Period|Physician Decision|5|||
160658104|NCT03952143|580129901|FG001|Lead-In Period|Physician Decision|0|||
160658105|NCT03952143|580129902|FG002|Lead-In Period|Physician Decision|0|||
160591087|NCT01371981|579880364|FG002|Overall Study|Ineligible|0|||
160591088|NCT01371981|579880365|FG003|Overall Study|Ineligible|0|||
160591089|NCT01371981|579880366|FG004|Overall Study|Ineligible|0|||
160591090|NCT01371981|579880367|FG005|Overall Study|Ineligible|4|||
160591091|NCT01371981|579880362|FG000|Overall Study|Did not start treatment|2|||
160591092|NCT01371981|579880363|FG001|Overall Study|Did not start treatment|3|||
160591093|NCT01371981|579880364|FG002|Overall Study|Did not start treatment|0|||
160591094|NCT01371981|579880365|FG003|Overall Study|Did not start treatment|0|||
160591095|NCT01371981|579880366|FG004|Overall Study|Did not start treatment|0|||
160591096|NCT01371981|579880367|FG005|Overall Study|Did not start treatment|2|||
160591097|NCT01153893|579880368|FG000|Overall Study|Adverse Event|1|||
160658106|NCT03952143|580129900|FG000|Lead-In Period|Protocol Violation|5|||
160658107|NCT03952143|580129901|FG001|Lead-In Period|Protocol Violation|0|||
160591098|NCT01153893|579880369|FG001|Overall Study|Adverse Event|0|||
160658108|NCT03952143|580129902|FG002|Lead-In Period|Protocol Violation|0|||
160658109|NCT03952143|580129900|FG000|Lead-In Period|Withdrawal by Subject|19|||
160658110|NCT03952143|580129901|FG001|Lead-In Period|Withdrawal by Subject|0|||
160658111|NCT03952143|580129902|FG002|Lead-In Period|Withdrawal by Subject|0|||
160658112|NCT03952143|580129900|FG000|Treatment Period|Adverse Event|0|||
160658113|NCT03952143|580129901|FG001|Treatment Period|Adverse Event|0|||
160658114|NCT03952143|580129902|FG002|Treatment Period|Adverse Event|1|||
160591099|NCT04799405|579880370|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
160591100|NCT00603980|579880371|FG000|Study Qualification|Protocol Violation|3|||
160460194|NCT03248479|579417573|FG005|Overall Study|Consent withdrawn|0|||
160460195|NCT03248479|579417574|FG006|Overall Study|Consent withdrawn|0|||
160591101|NCT00603980|579880371|FG000|Study Qualification|Inconsistent data reporting|13|||
160591102|NCT00603980|579880371|FG000|Main Study|14th subject completed trial|1|||
160591103|NCT01029002|579880372|FG000|Overall Study|Lost to Follow-up|2|||
160591104|NCT01029002|579880373|FG001|Overall Study|Lost to Follow-up|4|||
160591105|NCT01341652|579880374|FG000|Overall Study|Incorrect Random Assignment|0|||
160591106|NCT01341652|579880375|FG001|Overall Study|Incorrect Random Assignment|1|||
160591107|NCT01341652|579880374|FG000|Overall Study|ineligible; presence metastatic disease|0|||
160591108|NCT01341652|579880375|FG001|Overall Study|ineligible; presence metastatic disease|1|||
160591109|NCT02618928|579880378|FG000|Overall Study|Failure to Return|28|||
160591110|NCT02618928|579880378|FG000|Overall Study|Insufficient Virological Response|1|||
160591111|NCT02618928|579880378|FG000|Overall Study|Withdrawal by Subject|2|||
160591112|NCT02618928|579880378|FG000|Overall Study|Death|3|||
160591113|NCT02618928|579880378|FG000|Overall Study|Other|11|||
160591114|NCT02618928|579880378|FG000|Overall Study|Missing|6|||
160591115|NCT02618928|579880378|FG000|Overall Study|Treatment Never Started|7|||
160591116|NCT00118482|579880379|FG000|Overall Study|Lost to Follow-up|7|||
160591117|NCT00118482|579880380|FG001|Overall Study|Lost to Follow-up|7|||
160591118|NCT00118482|579880379|FG000|Overall Study|Withdrawal by Subject|23|||
160591119|NCT00118482|579880380|FG001|Overall Study|Withdrawal by Subject|22|||
160591120|NCT04633473|579880391|FG000|Overall Study|Withdrawal by Subject|6|||
160591121|NCT01822691|579880392|FG000|Overall Study|Withdrawal by Subject|2|||
160591122|NCT01553916|579880393|FG000|Overall Study|Withdrawal by Subject|2|||
160591123|NCT01553916|579880393|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
160591124|NCT02104804|579880396|FG000|Overall Study|Did not take study medication|0|||
160591125|NCT02104804|579880397|FG001|Overall Study|Did not take study medication|1|||
160591126|NCT02104804|579880396|FG000|Overall Study|Study specific discontinuation criteria|6|||
160591127|NCT02104804|579880397|FG001|Overall Study|Study specific discontinuation criteria|1|||
160591128|NCT02104804|579880396|FG000|Overall Study|Other listed|2|||
160591129|NCT02104804|579880397|FG001|Overall Study|Other listed|1|||
160591130|NCT02104804|579880396|FG000|Overall Study|Protocol Violation|0|||
160591131|NCT02104804|579880397|FG001|Overall Study|Protocol Violation|1|||
160591132|NCT02104804|579880396|FG000|Overall Study|Adverse Event|4|||
160591133|NCT02104804|579880397|FG001|Overall Study|Adverse Event|3|||
160591134|NCT02104804|579880396|FG000|Overall Study|Withdrawal by Subject|4|||
160591135|NCT02104804|579880397|FG001|Overall Study|Withdrawal by Subject|12|||
160591136|NCT00438399|579880398|FG000|Overall Study|Lost to Follow-up|2|||
160591137|NCT00438399|579880399|FG001|Overall Study|Lost to Follow-up|2|||
160591138|NCT00438399|579880400|FG002|Overall Study|Lost to Follow-up|1|||
160591139|NCT00438399|579880401|FG003|Overall Study|Lost to Follow-up|1|||
160591140|NCT00438399|579880402|FG004|Overall Study|Lost to Follow-up|1|||
160591141|NCT00438399|579880403|FG005|Overall Study|Lost to Follow-up|1|||
160591142|NCT00438399|579880398|FG000|Overall Study|Adverse Event|0|||
160591143|NCT00438399|579880399|FG001|Overall Study|Adverse Event|0|||
160591144|NCT00438399|579880400|FG002|Overall Study|Adverse Event|1|||
160591145|NCT00438399|579880401|FG003|Overall Study|Adverse Event|1|||
160591146|NCT00438399|579880402|FG004|Overall Study|Adverse Event|0|||
160591147|NCT00438399|579880403|FG005|Overall Study|Adverse Event|1|||
160591148|NCT00438399|579880398|FG000|Overall Study|Withdrawal by Subject|5|||
160591149|NCT00438399|579880399|FG001|Overall Study|Withdrawal by Subject|6|||
160591150|NCT00438399|579880400|FG002|Overall Study|Withdrawal by Subject|3|||
160591151|NCT00438399|579880401|FG003|Overall Study|Withdrawal by Subject|2|||
160591152|NCT00438399|579880402|FG004|Overall Study|Withdrawal by Subject|2|||
160591153|NCT00438399|579880403|FG005|Overall Study|Withdrawal by Subject|2|||
160591154|NCT00438399|579880398|FG000|Overall Study|Protocol Violation|0|||
160591155|NCT00438399|579880399|FG001|Overall Study|Protocol Violation|0|||
160591156|NCT00438399|579880400|FG002|Overall Study|Protocol Violation|1|||
160591157|NCT00438399|579880401|FG003|Overall Study|Protocol Violation|0|||
160591158|NCT00438399|579880402|FG004|Overall Study|Protocol Violation|0|||
160591159|NCT00438399|579880403|FG005|Overall Study|Protocol Violation|1|||
160591160|NCT00438399|579880398|FG000|Overall Study|Subje stopped study|0|||
160591161|NCT00438399|579880399|FG001|Overall Study|Subje stopped study|0|||
160591162|NCT00438399|579880400|FG002|Overall Study|Subje stopped study|1|||
160591163|NCT00438399|579880401|FG003|Overall Study|Subje stopped study|0|||
160591164|NCT00438399|579880402|FG004|Overall Study|Subje stopped study|0|||
160591165|NCT00438399|579880403|FG005|Overall Study|Subje stopped study|0|||
160591166|NCT00438399|579880398|FG000|Overall Study|Pregnancy|0|||
160591167|NCT00438399|579880399|FG001|Overall Study|Pregnancy|0|||
160591168|NCT00438399|579880400|FG002|Overall Study|Pregnancy|0|||
160591169|NCT00438399|579880401|FG003|Overall Study|Pregnancy|0|||
160591170|NCT00438399|579880402|FG004|Overall Study|Pregnancy|0|||
160591171|NCT00438399|579880403|FG005|Overall Study|Pregnancy|1|||
160591172|NCT00438399|579880398|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
160591173|NCT00438399|579880399|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
160591174|NCT00438399|579880400|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
160591175|NCT00438399|579880401|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
160591176|NCT00438399|579880402|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
160591177|NCT00438399|579880403|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
160591178|NCT01364233|579880404|FG000|Overall Study|Lost to Follow-up|1|||
160591179|NCT00819585|579880406|FG000|Core Study|Adverse Event|2|||
160591180|NCT00819585|579880407|FG001|Core Study|Adverse Event|1|||
160591181|NCT00819585|579880408|FG002|Core Study|Adverse Event|1|||
160591182|NCT00819585|579880409|FG003|Core Study|Adverse Event|4|||
160591183|NCT00819585|579880410|FG004|Core Study|Adverse Event|1|||
160591184|NCT00819585|579880411|FG005|Core Study|Adverse Event|0|||
160591185|NCT00819585|579880412|FG006|Core Study|Adverse Event|2|||
160591186|NCT00819585|579880413|FG007|Core Study|Adverse Event|0|||
160591187|NCT00819585|579880414|FG008|Core Study|Adverse Event|0|||
160591188|NCT00819585|579880415|FG009|Core Study|Adverse Event|0|||
160591189|NCT00819585|579880416|FG010|Core Study|Adverse Event|0|||
160591190|NCT00819585|579880406|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
160591191|NCT00819585|579880407|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
160591192|NCT00819585|579880408|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
160591193|NCT00819585|579880409|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
160591194|NCT00819585|579880410|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
160591195|NCT00819585|579880411|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
160591196|NCT00819585|579880412|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
160591197|NCT00819585|579880413|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
160591198|NCT00819585|579880414|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
160591199|NCT00819585|579880415|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
160591200|NCT00819585|579880416|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
160591201|NCT00819585|579880406|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
160591202|NCT00819585|579880407|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
160591203|NCT00819585|579880408|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
160591204|NCT00819585|579880409|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
160591205|NCT00819585|579880410|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
160591206|NCT00819585|579880411|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
160591207|NCT00819585|579880412|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
160591208|NCT00819585|579880413|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
160591209|NCT00819585|579880414|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
160591210|NCT00819585|579880415|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
160591211|NCT00819585|579880416|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
160591212|NCT00819585|579880406|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
160591213|NCT00819585|579880407|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
160591214|NCT00819585|579880408|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
160591215|NCT00819585|579880409|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
160591216|NCT00819585|579880410|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
160591217|NCT00819585|579880411|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
160591218|NCT00819585|579880412|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
160591219|NCT00819585|579880413|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
160591220|NCT00819585|579880414|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
160591221|NCT00819585|579880415|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
160591222|NCT00819585|579880416|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
160591223|NCT00819585|579880406|FG000|Core Study|Subject Withdrew Consent|0|||
160591224|NCT00819585|579880407|FG001|Core Study|Subject Withdrew Consent|3|||
160591225|NCT00819585|579880408|FG002|Core Study|Subject Withdrew Consent|2|||
160591226|NCT00819585|579880409|FG003|Core Study|Subject Withdrew Consent|1|||
160591227|NCT00819585|579880410|FG004|Core Study|Subject Withdrew Consent|0|||
160591228|NCT00819585|579880411|FG005|Core Study|Subject Withdrew Consent|0|||
160591229|NCT00819585|579880412|FG006|Core Study|Subject Withdrew Consent|3|||
160591230|NCT00819585|579880413|FG007|Core Study|Subject Withdrew Consent|0|||
160591231|NCT00819585|579880414|FG008|Core Study|Subject Withdrew Consent|0|||
160591232|NCT00819585|579880415|FG009|Core Study|Subject Withdrew Consent|0|||
160591233|NCT00819585|579880416|FG010|Core Study|Subject Withdrew Consent|0|||
160591234|NCT00819585|579880406|FG000|Core Study|Lost to Follow-up|2|||
160591235|NCT00819585|579880407|FG001|Core Study|Lost to Follow-up|1|||
160591236|NCT00819585|579880408|FG002|Core Study|Lost to Follow-up|2|||
160591237|NCT00819585|579880409|FG003|Core Study|Lost to Follow-up|0|||
160591238|NCT00819585|579880410|FG004|Core Study|Lost to Follow-up|1|||
160591239|NCT00819585|579880411|FG005|Core Study|Lost to Follow-up|1|||
160591240|NCT00819585|579880412|FG006|Core Study|Lost to Follow-up|1|||
160591241|NCT00819585|579880413|FG007|Core Study|Lost to Follow-up|0|||
160591242|NCT00819585|579880414|FG008|Core Study|Lost to Follow-up|0|||
160591243|NCT00819585|579880415|FG009|Core Study|Lost to Follow-up|0|||
160591244|NCT00819585|579880416|FG010|Core Study|Lost to Follow-up|0|||
160591245|NCT00819585|579880406|FG000|Core Study|Administrative Problems|0|||
160591246|NCT00819585|579880407|FG001|Core Study|Administrative Problems|0|||
160591247|NCT00819585|579880408|FG002|Core Study|Administrative Problems|0|||
160591248|NCT00819585|579880409|FG003|Core Study|Administrative Problems|0|||
160591249|NCT00819585|579880410|FG004|Core Study|Administrative Problems|0|||
160591250|NCT00819585|579880411|FG005|Core Study|Administrative Problems|0|||
160591251|NCT00819585|579880412|FG006|Core Study|Administrative Problems|2|||
160591252|NCT00819585|579880413|FG007|Core Study|Administrative Problems|0|||
160591253|NCT00819585|579880414|FG008|Core Study|Administrative Problems|0|||
160591254|NCT00819585|579880415|FG009|Core Study|Administrative Problems|0|||
160591255|NCT00819585|579880416|FG010|Core Study|Administrative Problems|0|||
160591256|NCT00819585|579880406|FG000|Core Study|Death|0|||
160591257|NCT00819585|579880407|FG001|Core Study|Death|0|||
160591258|NCT00819585|579880408|FG002|Core Study|Death|0|||
160591259|NCT00819585|579880409|FG003|Core Study|Death|0|||
160591260|NCT00819585|579880410|FG004|Core Study|Death|0|||
160591261|NCT00819585|579880411|FG005|Core Study|Death|0|||
160591262|NCT00819585|579880412|FG006|Core Study|Death|1|||
160591263|NCT00819585|579880413|FG007|Core Study|Death|0|||
160591264|NCT00819585|579880414|FG008|Core Study|Death|0|||
160591265|NCT00819585|579880415|FG009|Core Study|Death|0|||
160591266|NCT00819585|579880416|FG010|Core Study|Death|0|||
160591267|NCT00819585|579880406|FG000|Core Study|Protocol Violation|0|||
160591268|NCT00819585|579880407|FG001|Core Study|Protocol Violation|0|||
160591269|NCT00819585|579880408|FG002|Core Study|Protocol Violation|1|||
160591270|NCT00819585|579880409|FG003|Core Study|Protocol Violation|0|||
160591271|NCT00819585|579880410|FG004|Core Study|Protocol Violation|0|||
160591272|NCT00819585|579880411|FG005|Core Study|Protocol Violation|1|||
160591273|NCT00819585|579880412|FG006|Core Study|Protocol Violation|3|||
160591274|NCT00819585|579880413|FG007|Core Study|Protocol Violation|0|||
160591275|NCT00819585|579880414|FG008|Core Study|Protocol Violation|0|||
160591276|NCT00819585|579880415|FG009|Core Study|Protocol Violation|0|||
160591277|NCT00819585|579880416|FG010|Core Study|Protocol Violation|0|||
160591278|NCT00819585|579880406|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
160591279|NCT00819585|579880407|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
160591280|NCT00819585|579880408|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
160591281|NCT00819585|579880409|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
160591282|NCT00819585|579880410|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
160591283|NCT00819585|579880411|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
160591284|NCT00819585|579880412|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
160591285|NCT00819585|579880413|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
160591286|NCT00819585|579880414|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
160591287|NCT00819585|579880415|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
160591288|NCT00819585|579880416|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
160591289|NCT00819585|579880406|FG000|Extension Study|Subject Withdrew Consent|0|||
160591290|NCT00819585|579880407|FG001|Extension Study|Subject Withdrew Consent|0|||
160591291|NCT00819585|579880408|FG002|Extension Study|Subject Withdrew Consent|0|||
160591292|NCT00819585|579880409|FG003|Extension Study|Subject Withdrew Consent|0|||
160591293|NCT00819585|579880410|FG004|Extension Study|Subject Withdrew Consent|0|||
160591294|NCT00819585|579880411|FG005|Extension Study|Subject Withdrew Consent|0|||
160591295|NCT00819585|579880412|FG006|Extension Study|Subject Withdrew Consent|0|||
160591296|NCT00819585|579880413|FG007|Extension Study|Subject Withdrew Consent|0|||
160591297|NCT00819585|579880414|FG008|Extension Study|Subject Withdrew Consent|3|||
160591298|NCT00819585|579880415|FG009|Extension Study|Subject Withdrew Consent|0|||
160591299|NCT00819585|579880416|FG010|Extension Study|Subject Withdrew Consent|1|||
160591300|NCT00819585|579880406|FG000|Extension Study|Lost to Follow-up|0|||
160591301|NCT00819585|579880407|FG001|Extension Study|Lost to Follow-up|0|||
160591302|NCT00819585|579880408|FG002|Extension Study|Lost to Follow-up|0|||
160591303|NCT00819585|579880409|FG003|Extension Study|Lost to Follow-up|0|||
160591304|NCT00819585|579880410|FG004|Extension Study|Lost to Follow-up|0|||
160591305|NCT00819585|579880411|FG005|Extension Study|Lost to Follow-up|0|||
160591306|NCT00819585|579880412|FG006|Extension Study|Lost to Follow-up|0|||
160591307|NCT00819585|579880413|FG007|Extension Study|Lost to Follow-up|0|||
160591308|NCT00819585|579880414|FG008|Extension Study|Lost to Follow-up|2|||
160591309|NCT00819585|579880415|FG009|Extension Study|Lost to Follow-up|1|||
160591310|NCT00819585|579880416|FG010|Extension Study|Lost to Follow-up|1|||
160591311|NCT00819585|579880406|FG000|Extension Study|Death|0|||
160591312|NCT00819585|579880407|FG001|Extension Study|Death|0|||
160591313|NCT00819585|579880408|FG002|Extension Study|Death|0|||
160591314|NCT00819585|579880409|FG003|Extension Study|Death|0|||
160591315|NCT00819585|579880410|FG004|Extension Study|Death|0|||
160591316|NCT00819585|579880411|FG005|Extension Study|Death|0|||
160591317|NCT00819585|579880412|FG006|Extension Study|Death|0|||
160591318|NCT00819585|579880413|FG007|Extension Study|Death|0|||
160591319|NCT00819585|579880414|FG008|Extension Study|Death|2|||
160591320|NCT00819585|579880415|FG009|Extension Study|Death|0|||
160591321|NCT00819585|579880416|FG010|Extension Study|Death|0|||
160591322|NCT03334396|579880417|FG000|Overall Study|Adverse Event|1|||
160591323|NCT03334396|579880418|FG001|Overall Study|Adverse Event|0|||
160591324|NCT03334396|579880419|FG002|Overall Study|Adverse Event|1|||
160591325|NCT03334396|579880420|FG003|Overall Study|Adverse Event|0|||
160591326|NCT03334396|579880421|FG004|Overall Study|Adverse Event|0|||
160591327|NCT03334396|579880422|FG005|Overall Study|Adverse Event|0|||
160591328|NCT03334396|579880423|FG006|Overall Study|Adverse Event|0|||
160591329|NCT03334396|579880424|FG007|Overall Study|Adverse Event|0|||
160591330|NCT03334396|579880417|FG000|Overall Study|Lack of Efficacy|10|||
160591331|NCT03334396|579880418|FG001|Overall Study|Lack of Efficacy|4|||
160591332|NCT03334396|579880419|FG002|Overall Study|Lack of Efficacy|1|||
160591333|NCT03334396|579880420|FG003|Overall Study|Lack of Efficacy|3|||
160591334|NCT03334396|579880421|FG004|Overall Study|Lack of Efficacy|1|||
160591335|NCT03334396|579880422|FG005|Overall Study|Lack of Efficacy|0|||
160591336|NCT03334396|579880423|FG006|Overall Study|Lack of Efficacy|0|||
160591337|NCT03334396|579880424|FG007|Overall Study|Lack of Efficacy|1|||
160591338|NCT03334396|579880417|FG000|Overall Study|Lost to Follow-up|0|||
160591339|NCT03334396|579880418|FG001|Overall Study|Lost to Follow-up|0|||
160591340|NCT03334396|579880419|FG002|Overall Study|Lost to Follow-up|1|||
160591341|NCT03334396|579880420|FG003|Overall Study|Lost to Follow-up|0|||
160591342|NCT03334396|579880421|FG004|Overall Study|Lost to Follow-up|0|||
160591343|NCT03334396|579880422|FG005|Overall Study|Lost to Follow-up|0|||
160591344|NCT03334396|579880423|FG006|Overall Study|Lost to Follow-up|1|||
160591345|NCT03334396|579880424|FG007|Overall Study|Lost to Follow-up|0|||
160591346|NCT03334396|579880417|FG000|Overall Study|Physician Decision|1|||
160591347|NCT03334396|579880418|FG001|Overall Study|Physician Decision|0|||
160591348|NCT03334396|579880419|FG002|Overall Study|Physician Decision|0|||
160591349|NCT03334396|579880420|FG003|Overall Study|Physician Decision|0|||
160591350|NCT03334396|579880421|FG004|Overall Study|Physician Decision|0|||
160591351|NCT03334396|579880422|FG005|Overall Study|Physician Decision|0|||
160591352|NCT03334396|579880423|FG006|Overall Study|Physician Decision|0|||
160591353|NCT03334396|579880424|FG007|Overall Study|Physician Decision|0|||
160975658|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
160591354|NCT03334396|579880417|FG000|Overall Study|Withdrawal by Subject|10|||
160591355|NCT03334396|579880418|FG001|Overall Study|Withdrawal by Subject|5|||
160591356|NCT03334396|579880419|FG002|Overall Study|Withdrawal by Subject|7|||
160591357|NCT03334396|579880420|FG003|Overall Study|Withdrawal by Subject|2|||
160591358|NCT03334396|579880421|FG004|Overall Study|Withdrawal by Subject|2|||
160591359|NCT03334396|579880422|FG005|Overall Study|Withdrawal by Subject|1|||
160591360|NCT03334396|579880423|FG006|Overall Study|Withdrawal by Subject|2|||
160591361|NCT03334396|579880424|FG007|Overall Study|Withdrawal by Subject|0|||
160591362|NCT03334396|579880417|FG000|Overall Study|Pregnancy|0|||
160591363|NCT03334396|579880418|FG001|Overall Study|Pregnancy|1|||
160591364|NCT03334396|579880419|FG002|Overall Study|Pregnancy|0|||
160591365|NCT03334396|579880420|FG003|Overall Study|Pregnancy|0|||
160591366|NCT03334396|579880421|FG004|Overall Study|Pregnancy|0|||
160591367|NCT03334396|579880422|FG005|Overall Study|Pregnancy|0|||
160591368|NCT03334396|579880423|FG006|Overall Study|Pregnancy|0|||
160591369|NCT03334396|579880424|FG007|Overall Study|Pregnancy|0|||
160975659|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160975660|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160975661|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160975662|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160975663|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
160975664|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
160975665|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
160591370|NCT03334396|579880417|FG000|Overall Study|Ineligible|0|||
160591371|NCT03334396|579880418|FG001|Overall Study|Ineligible|1|||
160591372|NCT03334396|579880419|FG002|Overall Study|Ineligible|0|||
160591373|NCT03334396|579880420|FG003|Overall Study|Ineligible|0|||
160591374|NCT03334396|579880421|FG004|Overall Study|Ineligible|0|||
160591375|NCT03334396|579880422|FG005|Overall Study|Ineligible|0|||
160591376|NCT03334396|579880423|FG006|Overall Study|Ineligible|0|||
160591377|NCT03334396|579880424|FG007|Overall Study|Ineligible|0|||
160591378|NCT03334396|579880417|FG000|Overall Study|Started New Job|1|||
160591379|NCT03334396|579880418|FG001|Overall Study|Started New Job|0|||
160591380|NCT03334396|579880419|FG002|Overall Study|Started New Job|0|||
160591381|NCT03334396|579880420|FG003|Overall Study|Started New Job|0|||
160591382|NCT03334396|579880421|FG004|Overall Study|Started New Job|0|||
160591383|NCT03334396|579880422|FG005|Overall Study|Started New Job|0|||
160591384|NCT03334396|579880423|FG006|Overall Study|Started New Job|0|||
160591385|NCT03334396|579880424|FG007|Overall Study|Started New Job|0|||
160591386|NCT02034474|579880425|FG000|Overall Study|Adverse Event|3|||
160591387|NCT02034474|579880426|FG001|Overall Study|Adverse Event|2|||
160591388|NCT02034474|579880425|FG000|Overall Study|Withdrawal by Subject|1|||
160591389|NCT02034474|579880426|FG001|Overall Study|Withdrawal by Subject|2|||
160591390|NCT01391819|579880427|FG000|Overall Study|Withdrawal by Subject|56|||
160591391|NCT01391819|579880427|FG000|Overall Study|Migrated/moved from study area|82|||
160591392|NCT01391819|579880427|FG000|Overall Study|Lost to Follow-up|252|||
160591393|NCT01391819|579880427|FG000|Overall Study|Death|3|||
160591394|NCT01391819|579880427|FG000|Overall Study|Other|9|||
160591395|NCT03488251|579880429|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
160591396|NCT03488251|579880430|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
160591397|NCT03488251|579880431|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
160591398|NCT03488251|579880432|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
160460196|NCT03248479|579417575|FG007|Overall Study|Consent withdrawn|1|||
160460197|NCT03248479|579417576|FG008|Overall Study|Consent withdrawn|0|||
160460198|NCT03248479|579417577|FG009|Overall Study|Consent withdrawn|3|||
160460199|NCT03248479|579417578|FG010|Overall Study|Consent withdrawn|1|||
160460200|NCT03248479|579417579|FG011|Overall Study|Consent withdrawn|0|||
160591399|NCT03488251|579880429|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
160591400|NCT03488251|579880430|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
160591401|NCT03488251|579880431|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
160591402|NCT03488251|579880432|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
160591403|NCT03488251|579880429|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
160591404|NCT03488251|579880430|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
160591405|NCT03488251|579880431|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
160591406|NCT03488251|579880432|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
160591407|NCT03488251|579880429|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
160591408|NCT03488251|579880430|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
160591409|NCT03488251|579880431|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
160591410|NCT03488251|579880432|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
160591411|NCT03488251|579880429|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
160591412|NCT03488251|579880430|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
160591413|NCT03488251|579880431|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
160591414|NCT03488251|579880432|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
160591415|NCT00995670|579880433|FG000|Overall Study|Failed arterial cannulation|1|||
160591416|NCT00995670|579880434|FG001|Overall Study|Failed arterial cannulation|0|||
160591417|NCT00995670|579880435|FG002|Overall Study|Failed arterial cannulation|3|||
160591418|NCT03600714|579880436|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
160591419|NCT00592553|579880438|FG000|Overall Study|Protocol Noncompliance|1|||
160591420|NCT00592553|579880439|FG001|Overall Study|Protocol Noncompliance|0|||
160591421|NCT00592553|579880440|FG002|Overall Study|Protocol Noncompliance|0|||
160591422|NCT03829332|579880441|FG000|Overall Study|Death|225|||
160591423|NCT03829332|579880442|FG001|Overall Study|Death|230|||
160591424|NCT03829332|579880441|FG000|Overall Study|Lost to Follow-up|1|||
160591425|NCT03829332|579880442|FG001|Overall Study|Lost to Follow-up|3|||
160591426|NCT03829332|579880441|FG000|Overall Study|Physician Decision|1|||
160591427|NCT03829332|579880442|FG001|Overall Study|Physician Decision|0|||
160591428|NCT03829332|579880441|FG000|Overall Study|Sponsor Decision|71|||
160591429|NCT03829332|579880442|FG001|Overall Study|Sponsor Decision|72|||
160591430|NCT03829332|579880441|FG000|Overall Study|Withdrawal by Subject|11|||
160591431|NCT03829332|579880442|FG001|Overall Study|Withdrawal by Subject|9|||
160591432|NCT02509494|579880443|FG000|Overall Study|Lost to Follow-up|8|||
160591433|NCT02509494|579880444|FG001|Overall Study|Lost to Follow-up|47|||
160658115|NCT03952143|580129900|FG000|Treatment Period|Lost to Follow-up|0|||
160591434|NCT02509494|579880445|FG002|Overall Study|Lost to Follow-up|19|||
160591435|NCT02509494|579880446|FG003|Overall Study|Lost to Follow-up|6|||
160591436|NCT02509494|579880447|FG004|Overall Study|Lost to Follow-up|3|||
160591437|NCT02509494|579880448|FG005|Overall Study|Lost to Follow-up|3|||
160591438|NCT02509494|579880449|FG006|Overall Study|Lost to Follow-up|1|||
160591439|NCT02509494|579880450|FG007|Overall Study|Lost to Follow-up|3|||
160591440|NCT02509494|579880451|FG008|Overall Study|Lost to Follow-up|1|||
160591441|NCT02509494|579880443|FG000|Overall Study|Physician Decision|2|||
160591442|NCT02509494|579880444|FG001|Overall Study|Physician Decision|1|||
160460201|NCT03248479|579417580|FG012|Overall Study|Consent withdrawn|1|||
160658116|NCT03952143|580129901|FG001|Treatment Period|Lost to Follow-up|2|||
160658117|NCT03952143|580129902|FG002|Treatment Period|Lost to Follow-up|0|||
160658118|NCT03952143|580129900|FG000|Treatment Period|Physician Decision|0|||
160658119|NCT03952143|580129901|FG001|Treatment Period|Physician Decision|0|||
160658120|NCT03952143|580129902|FG002|Treatment Period|Physician Decision|2|||
160658121|NCT03952143|580129900|FG000|Treatment Period|Protocol Violation|0|||
160658122|NCT03952143|580129901|FG001|Treatment Period|Protocol Violation|0|||
160658123|NCT03952143|580129902|FG002|Treatment Period|Protocol Violation|1|||
160658124|NCT03952143|580129900|FG000|Treatment Period|Withdrawal by Subject|0|||
160658125|NCT03952143|580129901|FG001|Treatment Period|Withdrawal by Subject|5|||
160658126|NCT03952143|580129902|FG002|Treatment Period|Withdrawal by Subject|26|||
160658127|NCT03952143|580129900|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
160658128|NCT03952143|580129901|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
160658129|NCT03952143|580129902|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
160658130|NCT03952143|580129900|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
160658131|NCT03952143|580129901|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
160658132|NCT03952143|580129902|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
160658133|NCT02152566|580129903|FG000|Overall Study|Lost to Follow-up|1|||
160658134|NCT02152566|580129903|FG000|Overall Study|Withdrawal by Subject|2|||
160658135|NCT00496964|580129904|FG000|Overall Study|Withdrawal by Subject|0|||
160658136|NCT00496964|580129905|FG001|Overall Study|Withdrawal by Subject|1|||
160658137|NCT01328093|580129906|FG000|Double-Blind Phase|Adverse Event|78|||
160658138|NCT01328093|580129907|FG001|Double-Blind Phase|Adverse Event|15|||
160658139|NCT01328093|580129906|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
160658140|NCT01328093|580129907|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
160658141|NCT01328093|580129906|FG000|Double-Blind Phase|Lost to Follow-up|39|||
160658142|NCT01328093|580129907|FG001|Double-Blind Phase|Lost to Follow-up|14|||
160658143|NCT01328093|580129906|FG000|Double-Blind Phase|Protocol Violation|30|||
160658144|NCT01328093|580129907|FG001|Double-Blind Phase|Protocol Violation|10|||
160658145|NCT01328093|580129906|FG000|Double-Blind Phase|Lack of Efficacy|55|||
160658146|NCT01328093|580129907|FG001|Double-Blind Phase|Lack of Efficacy|13|||
160658147|NCT01328093|580129906|FG000|Double-Blind Phase|Sponsor Decision|17|||
160658148|NCT01328093|580129907|FG001|Double-Blind Phase|Sponsor Decision|3|||
160658149|NCT01328093|580129906|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
160658150|NCT01328093|580129907|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
160658151|NCT01328093|580129906|FG000|Double-Blind Phase|Scheduling conflict|8|||
160658152|NCT01328093|580129907|FG001|Double-Blind Phase|Scheduling conflict|3|||
160658153|NCT01328093|580129906|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
160658154|NCT01328093|580129907|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
160658155|NCT01328093|580129906|FG000|Double-Blind Phase|Death|1|||
160658156|NCT01328093|580129907|FG001|Double-Blind Phase|Death|0|||
160658157|NCT01328093|580129906|FG000|Open-Label Phase|Sponsor Decision|98|||
160658158|NCT01328093|580129907|FG001|Open-Label Phase|Sponsor Decision|34|||
160658159|NCT01328093|580129906|FG000|Open-Label Phase|Protocol Violation|8|||
160658160|NCT01328093|580129907|FG001|Open-Label Phase|Protocol Violation|3|||
160658161|NCT01328093|580129906|FG000|Open-Label Phase|Lost to Follow-up|10|||
160658162|NCT01328093|580129907|FG001|Open-Label Phase|Lost to Follow-up|1|||
160658163|NCT01328093|580129906|FG000|Open-Label Phase|Adverse Event|10|||
160658164|NCT01328093|580129907|FG001|Open-Label Phase|Adverse Event|4|||
160658165|NCT01328093|580129906|FG000|Open-Label Phase|Lack of Efficacy|5|||
160658166|NCT01328093|580129907|FG001|Open-Label Phase|Lack of Efficacy|6|||
160658167|NCT01328093|580129906|FG000|Open-Label Phase|Withdrawal by Subject|4|||
160658168|NCT01328093|580129907|FG001|Open-Label Phase|Withdrawal by Subject|1|||
160658169|NCT01328093|580129906|FG000|Open-Label Phase|Scheduling conflict|2|||
160658170|NCT01328093|580129907|FG001|Open-Label Phase|Scheduling conflict|1|||
160658171|NCT01328093|580129906|FG000|Open-Label Phase|Subject is moving or has moved|2|||
160658172|NCT01328093|580129907|FG001|Open-Label Phase|Subject is moving or has moved|0|||
160658173|NCT01328093|580129906|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
160658174|NCT01328093|580129907|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
160658175|NCT03980483|580129908|FG000|Overall Study|Adverse Event|13|||
160658176|NCT03980483|580129909|FG001|Overall Study|Adverse Event|29|||
160658177|NCT03980483|580129910|FG002|Overall Study|Adverse Event|11|||
160658178|NCT03980483|580129911|FG003|Overall Study|Adverse Event|2|||
160658179|NCT03980483|580129912|FG004|Overall Study|Adverse Event|2|||
160658180|NCT03980483|580129913|FG005|Overall Study|Adverse Event|2|||
160658181|NCT03980483|580129908|FG000|Overall Study|Lack of Efficacy|7|||
160975666|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160658182|NCT03980483|580129909|FG001|Overall Study|Lack of Efficacy|6|||
160658183|NCT03980483|580129910|FG002|Overall Study|Lack of Efficacy|0|||
160658184|NCT03980483|580129911|FG003|Overall Study|Lack of Efficacy|3|||
160975667|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160658185|NCT03980483|580129912|FG004|Overall Study|Lack of Efficacy|1|||
160658186|NCT03980483|580129913|FG005|Overall Study|Lack of Efficacy|1|||
160658187|NCT03980483|580129908|FG000|Overall Study|Lost to Follow-up|2|||
160658188|NCT03980483|580129909|FG001|Overall Study|Lost to Follow-up|4|||
160975668|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160975669|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160975670|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
160975671|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
160975672|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
160975673|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
160975674|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
160975675|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
160975676|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
160975677|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975678|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975679|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975680|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975681|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975682|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975683|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
160975684|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160975685|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160975686|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160975687|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
160975688|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160975689|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
160975690|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
160975691|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160975692|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160975693|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160975694|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
160975695|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
160975696|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
160975697|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
160975698|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
160975699|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
160975700|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
160975701|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
160975702|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
160975703|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
160975704|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
160975705|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160975706|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160975707|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160975708|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
160975709|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
160975710|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
160975711|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
160975712|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
160975713|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
160975714|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
160975715|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
160975716|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
160975717|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
160975718|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
160975719|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
160975720|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
160975721|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
160975722|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
160975723|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
160975724|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
160975725|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
160975726|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
160591443|NCT02509494|579880445|FG002|Overall Study|Physician Decision|0|||
160591444|NCT02509494|579880446|FG003|Overall Study|Physician Decision|0|||
160591445|NCT02509494|579880447|FG004|Overall Study|Physician Decision|0|||
160591446|NCT02509494|579880448|FG005|Overall Study|Physician Decision|0|||
160591447|NCT02509494|579880449|FG006|Overall Study|Physician Decision|0|||
160591448|NCT02509494|579880450|FG007|Overall Study|Physician Decision|0|||
160591449|NCT02509494|579880451|FG008|Overall Study|Physician Decision|0|||
160591450|NCT02509494|579880443|FG000|Overall Study|Withdrawal by Subject|4|||
160591451|NCT02509494|579880444|FG001|Overall Study|Withdrawal by Subject|17|||
160591452|NCT02509494|579880445|FG002|Overall Study|Withdrawal by Subject|7|||
160591453|NCT02509494|579880446|FG003|Overall Study|Withdrawal by Subject|5|||
160591454|NCT02509494|579880447|FG004|Overall Study|Withdrawal by Subject|0|||
160591455|NCT02509494|579880448|FG005|Overall Study|Withdrawal by Subject|6|||
160591456|NCT02509494|579880449|FG006|Overall Study|Withdrawal by Subject|1|||
160591457|NCT02509494|579880450|FG007|Overall Study|Withdrawal by Subject|2|||
160591458|NCT02509494|579880451|FG008|Overall Study|Withdrawal by Subject|1|||
160591459|NCT02509494|579880443|FG000|Overall Study|Death|0|||
160591460|NCT02509494|579880444|FG001|Overall Study|Death|1|||
160591461|NCT02509494|579880445|FG002|Overall Study|Death|0|||
160591462|NCT02509494|579880446|FG003|Overall Study|Death|0|||
160591463|NCT02509494|579880447|FG004|Overall Study|Death|1|||
160591464|NCT02509494|579880448|FG005|Overall Study|Death|0|||
160591465|NCT02509494|579880449|FG006|Overall Study|Death|0|||
160591466|NCT02509494|579880450|FG007|Overall Study|Death|1|||
160591467|NCT02509494|579880451|FG008|Overall Study|Death|0|||
160591468|NCT02509494|579880443|FG000|Overall Study|Other|0|||
160591469|NCT02509494|579880444|FG001|Overall Study|Other|4|||
160591470|NCT02509494|579880445|FG002|Overall Study|Other|5|||
160591471|NCT02509494|579880446|FG003|Overall Study|Other|0|||
160591472|NCT02509494|579880447|FG004|Overall Study|Other|0|||
160591473|NCT02509494|579880448|FG005|Overall Study|Other|0|||
160591474|NCT02509494|579880449|FG006|Overall Study|Other|0|||
160591475|NCT02509494|579880450|FG007|Overall Study|Other|0|||
160460202|NCT03248479|579417568|FG000|Overall Study|Lost to Follow-up|2|||
160591476|NCT02509494|579880451|FG008|Overall Study|Other|0|||
160591477|NCT02509494|579880443|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160591478|NCT02509494|579880444|FG001|Overall Study|Non-Compliance With Study Drug|11|||
160591479|NCT02509494|579880445|FG002|Overall Study|Non-Compliance With Study Drug|7|||
160591480|NCT02509494|579880446|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160591481|NCT02509494|579880447|FG004|Overall Study|Non-Compliance With Study Drug|1|||
160975727|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
160975728|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
160975729|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
160975730|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
160975731|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
160975732|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
160975733|NCT04287868|581299412|FG000|Overall Study|Screening fail|1|||
160975734|NCT04287868|581299413|FG001|Overall Study|Screening fail|0|||
160975735|NCT02961881|581300592|FG000|Overall Study|Adverse Event|1|||
160975736|NCT02961881|581300593|FG001|Overall Study|Adverse Event|2|||
160975737|NCT02961881|581300594|FG002|Overall Study|Adverse Event|2|||
160975738|NCT02961881|581300595|FG003|Overall Study|Adverse Event|0|||
160975739|NCT02961881|581300596|FG004|Overall Study|Adverse Event|1|||
160975740|NCT02961881|581300592|FG000|Overall Study|Participant request|0|||
160975741|NCT02961881|581300593|FG001|Overall Study|Participant request|2|||
160975742|NCT02961881|581300594|FG002|Overall Study|Participant request|0|||
160975743|NCT02961881|581300595|FG003|Overall Study|Participant request|0|||
160975744|NCT02961881|581300596|FG004|Overall Study|Participant request|0|||
160975745|NCT02961881|581300592|FG000|Overall Study|Disease progression|1|||
160975746|NCT02961881|581300593|FG001|Overall Study|Disease progression|0|||
160975747|NCT02961881|581300594|FG002|Overall Study|Disease progression|1|||
160975748|NCT02961881|581300595|FG003|Overall Study|Disease progression|0|||
160975749|NCT02961881|581300596|FG004|Overall Study|Disease progression|0|||
160975750|NCT00636792|581300597|FG000|Overall Study|Adverse Event|16|||
160975751|NCT00636792|581300597|FG000|Overall Study|Physician Decision|7|||
160975752|NCT00636792|581300597|FG000|Overall Study|Progressive Disease|4|||
160975753|NCT00636792|581300597|FG000|Overall Study|Withdrawal by Subject|3|||
160975754|NCT00636792|581300597|FG000|Overall Study|Other|3|||
160975755|NCT01928225|581300598|FG000|Overall Study|Pregnancy|1|||
160975756|NCT01928225|581300599|FG001|Overall Study|Pregnancy|0|||
160975757|NCT01928225|581300598|FG000|Overall Study|basaloid cervical cancer|1|||
160975758|NCT01928225|581300599|FG001|Overall Study|basaloid cervical cancer|0|||
160975759|NCT01928225|581300598|FG000|Overall Study|Lost to Follow-up|1|||
160975760|NCT01928225|581300599|FG001|Overall Study|Lost to Follow-up|3|||
160975761|NCT03101241|581300601|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
160975762|NCT03101241|581300602|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
160975763|NCT03101241|581300601|FG000|Overall Study|Participant withdrew consent|3|||
160658189|NCT03980483|580129910|FG002|Overall Study|Lost to Follow-up|2|||
160975764|NCT03101241|581300602|FG001|Overall Study|Participant withdrew consent|1|||
160975765|NCT03101241|581300601|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
160975766|NCT03101241|581300602|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
160975767|NCT03101241|581300601|FG000|Overall Study|Lost to Follow-up|2|||
160975768|NCT03101241|581300602|FG001|Overall Study|Lost to Follow-up|0|||
160975769|NCT03101241|581300601|FG000|Overall Study|Lack of Efficacy|0|||
160975770|NCT03101241|581300602|FG001|Overall Study|Lack of Efficacy|1|||
160975771|NCT03101241|581300601|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
160975772|NCT03101241|581300602|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
160975773|NCT03283696|581300603|FG000|Overall Study|Physician Decision|5|||
160975774|NCT03283696|581300604|FG001|Overall Study|Physician Decision|6|||
160975775|NCT03283696|581300603|FG000|Overall Study|Withdrawal by Subject|2|||
160975776|NCT03283696|581300604|FG001|Overall Study|Withdrawal by Subject|0|||
160975777|NCT01512745|581300606|FG000|Overall Study|Adverse Event|22|||
160591482|NCT02509494|579880448|FG005|Overall Study|Non-Compliance With Study Drug|2|||
160591483|NCT02509494|579880449|FG006|Overall Study|Non-Compliance With Study Drug|1|||
160591484|NCT02509494|579880450|FG007|Overall Study|Non-Compliance With Study Drug|1|||
160591485|NCT02509494|579880451|FG008|Overall Study|Non-Compliance With Study Drug|0|||
160591486|NCT05084053|579882715|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
160591487|NCT05084053|579882716|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
160591488|NCT05084053|579882717|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
160591489|NCT05084053|579882718|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
160591490|NCT05084053|579882715|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
160591491|NCT05084053|579882716|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
160591492|NCT05084053|579882717|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
160591493|NCT05084053|579882718|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
160591494|NCT05084053|579882715|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
160591495|NCT05084053|579882716|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
160591496|NCT05084053|579882717|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
160591497|NCT05084053|579882718|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
160591498|NCT01255306|579882722|FG000|Overall Study|Physician Decision|1|||
160591499|NCT01255306|579882723|FG001|Overall Study|Physician Decision|1|||
160591500|NCT04092816|579882728|FG000|Overall Study|Lost to Follow-up|1|||
160591501|NCT04092816|579882729|FG001|Overall Study|Lost to Follow-up|2|||
160591502|NCT03363919|579882732|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
160975778|NCT01512745|581300607|FG001|Overall Study|Adverse Event|3|||
160975779|NCT01512745|581300606|FG000|Overall Study|Death|9|||
160975780|NCT01512745|581300607|FG001|Overall Study|Death|13|||
160975781|NCT01512745|581300606|FG000|Overall Study|Withdrawal by Subject|2|||
160975782|NCT01512745|581300607|FG001|Overall Study|Withdrawal by Subject|2|||
160975783|NCT01512745|581300606|FG000|Overall Study|Lost to Follow-up|4|||
160975784|NCT01512745|581300607|FG001|Overall Study|Lost to Follow-up|0|||
160975785|NCT01512745|581300606|FG000|Overall Study|Lack of Efficacy|2|||
160975786|NCT01512745|581300607|FG001|Overall Study|Lack of Efficacy|2|||
160975787|NCT01512745|581300606|FG000|Overall Study|Protocol Violation|1|||
160975788|NCT01512745|581300607|FG001|Overall Study|Protocol Violation|0|||
160975789|NCT02357810|581300608|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
160975790|NCT02357810|581300608|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
160975791|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Adverse Event|5|||
160975792|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
160975793|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
160975794|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
160975795|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Death|1|||
160975796|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Physician Decision|1|||
160975797|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Other|1|||
160975798|NCT02357810|581300608|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
160975799|NCT02357810|581300608|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
160975800|NCT02357810|581300608|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
160975801|NCT02357810|581300608|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
160975802|NCT02357810|581300608|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
160975803|NCT02357810|581300608|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
160975804|NCT00562978|581300609|FG000|Overall Study|Patient had imaging dose only|1|||
160975805|NCT00562978|581300610|FG001|Overall Study|Patient had imaging dose only|11|||
160975806|NCT00675506|581300612|FG000|Overall Study|Lost to Follow-up|1|||
160975807|NCT00675506|581300613|FG001|Overall Study|Lost to Follow-up|5|||
160975808|NCT00675506|581300612|FG000|Overall Study|Lost interest|3|||
160975809|NCT00675506|581300613|FG001|Overall Study|Lost interest|5|||
160975810|NCT00675506|581300612|FG000|Overall Study|Elevated fasting glucose|2|||
160975811|NCT00675506|581300613|FG001|Overall Study|Elevated fasting glucose|1|||
160975812|NCT00675506|581300612|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
160975813|NCT00675506|581300613|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
160975814|NCT00675506|581300612|FG000|Overall Study|Elevated IGF-1|2|||
160975815|NCT00675506|581300613|FG001|Overall Study|Elevated IGF-1|0|||
160975816|NCT00675506|581300612|FG000|Overall Study|Hypersensitivity Reaction|1|||
160975817|NCT00675506|581300613|FG001|Overall Study|Hypersensitivity Reaction|0|||
160975818|NCT00675506|581300612|FG000|Overall Study|Disclosed history of cancer|1|||
160975819|NCT00675506|581300613|FG001|Overall Study|Disclosed history of cancer|0|||
160975820|NCT00675506|581300612|FG000|Overall Study|Declined participation|1|||
160975821|NCT00675506|581300613|FG001|Overall Study|Declined participation|0|||
160975822|NCT00675506|581300612|FG000|Overall Study|Schedule conflict|0|||
160975823|NCT00675506|581300613|FG001|Overall Study|Schedule conflict|1|||
160591503|NCT03363919|579882733|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
160591504|NCT03363919|579882732|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
160591505|NCT03363919|579882733|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
160591506|NCT01975246|579882734|FG000|Overall Study|Adverse Event|2|||
160591507|NCT01975246|579882735|FG001|Overall Study|Adverse Event|1|||
160591508|NCT01975246|579882734|FG000|Overall Study|Lack of Efficacy|1|||
160591509|NCT01975246|579882735|FG001|Overall Study|Lack of Efficacy|0|||
160591510|NCT01975246|579882734|FG000|Overall Study|Protocol Violation|1|||
160591511|NCT01975246|579882735|FG001|Overall Study|Protocol Violation|0|||
160591512|NCT01975246|579882734|FG000|Overall Study|Other than stated|0|||
160591513|NCT01975246|579882735|FG001|Overall Study|Other than stated|1|||
160591514|NCT01646398|579882736|FG000|Overall Study|Withdrawal by Subject|1|||
160591515|NCT01646398|579882737|FG001|Overall Study|Withdrawal by Subject|0|||
160591516|NCT01263093|579882738|FG000|Washout|Physician Decision|1|||
160591517|NCT01263093|579882739|FG001|Washout|Physician Decision|0|||
160591518|NCT01263093|579882738|FG000|Period 2|Adverse Event|1|||
160591519|NCT01263093|579882739|FG001|Period 2|Adverse Event|0|||
160591520|NCT00571519|579882740|FG000|Overall Study|Subject withdrew consent|0|||
160591521|NCT00571519|579882741|FG001|Overall Study|Subject withdrew consent|1|||
160591522|NCT00571519|579882742|FG002|Overall Study|Subject withdrew consent|0|||
160591523|NCT00571519|579882743|FG003|Overall Study|Subject withdrew consent|2|||
160591524|NCT00571519|579882744|FG004|Overall Study|Subject withdrew consent|1|||
160591525|NCT00571519|579882745|FG005|Overall Study|Subject withdrew consent|1|||
160591526|NCT00571519|579882746|FG006|Overall Study|Subject withdrew consent|2|||
160591527|NCT00571519|579882740|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
160591528|NCT00571519|579882741|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
160591529|NCT00571519|579882742|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
160591530|NCT00571519|579882743|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
160591531|NCT00571519|579882744|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
160591532|NCT00571519|579882745|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
160591533|NCT00571519|579882746|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
160591534|NCT00571519|579882740|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
160591535|NCT00571519|579882741|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
160591536|NCT00571519|579882742|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
160591537|NCT00571519|579882743|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
160591538|NCT00571519|579882744|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
160591539|NCT00571519|579882745|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
160591540|NCT00571519|579882746|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
160591541|NCT00571519|579882740|FG000|Overall Study|Termination of study by Sponsor|2|||
160591542|NCT00571519|579882741|FG001|Overall Study|Termination of study by Sponsor|7|||
160591543|NCT00571519|579882742|FG002|Overall Study|Termination of study by Sponsor|10|||
160591544|NCT00571519|579882743|FG003|Overall Study|Termination of study by Sponsor|24|||
160591545|NCT00571519|579882744|FG004|Overall Study|Termination of study by Sponsor|8|||
160591546|NCT00571519|579882745|FG005|Overall Study|Termination of study by Sponsor|9|||
160591547|NCT00571519|579882746|FG006|Overall Study|Termination of study by Sponsor|22|||
160591548|NCT00571519|579882740|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
160591549|NCT00571519|579882741|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
160591550|NCT00571519|579882742|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
160632912|NCT02575807|580036104|FG000|Overall Study|Study terminated by Sponsor|0|||
160591551|NCT00571519|579882743|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
160591552|NCT00571519|579882744|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
160591553|NCT00571519|579882745|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
160591554|NCT00571519|579882746|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
160591555|NCT02701192|579882751|FG000|Overall Study|Protocol Violation|2|||
160591556|NCT02701192|579882751|FG000|Overall Study|Lost to Follow-up|4|||
160591557|NCT02700919|579882753|FG000|Overall Study|Physician Decision|1|||
160591558|NCT02700919|579882754|FG001|Overall Study|Physician Decision|0|||
160591559|NCT02700919|579882755|FG002|Overall Study|Physician Decision|0|||
160591560|NCT02700919|579882753|FG000|Overall Study|Protocol Violation|1|||
160591561|NCT02700919|579882754|FG001|Overall Study|Protocol Violation|0|||
160591562|NCT02700919|579882755|FG002|Overall Study|Protocol Violation|0|||
160591563|NCT02700919|579882753|FG000|Overall Study|Adverse Event|1|||
160591564|NCT02700919|579882754|FG001|Overall Study|Adverse Event|3|||
160658190|NCT03980483|580129911|FG003|Overall Study|Lost to Follow-up|1|||
160658191|NCT03980483|580129912|FG004|Overall Study|Lost to Follow-up|2|||
160658192|NCT03980483|580129913|FG005|Overall Study|Lost to Follow-up|0|||
160591565|NCT02700919|579882755|FG002|Overall Study|Adverse Event|1|||
160975824|NCT06173570|581300614|FG000|Overall Study|Adverse Event|1|||
160975825|NCT06173570|581300615|FG001|Overall Study|Adverse Event|0|||
160975826|NCT06173570|581300616|FG002|Overall Study|Adverse Event|0|||
160975827|NCT06173570|581300617|FG003|Overall Study|Adverse Event|2|||
160975828|NCT06173570|581300618|FG004|Overall Study|Adverse Event|0|||
160975829|NCT06173570|581300614|FG000|Overall Study|Lost to Follow-up|1|||
160975830|NCT06173570|581300615|FG001|Overall Study|Lost to Follow-up|0|||
160975831|NCT06173570|581300616|FG002|Overall Study|Lost to Follow-up|0|||
160975832|NCT06173570|581300617|FG003|Overall Study|Lost to Follow-up|0|||
160591566|NCT02700919|579882753|FG000|Overall Study|Withdrawal by Subject|5|||
160591567|NCT02700919|579882754|FG001|Overall Study|Withdrawal by Subject|8|||
160591568|NCT02700919|579882755|FG002|Overall Study|Withdrawal by Subject|2|||
160591569|NCT02700919|579882753|FG000|Overall Study|Lost to Follow-up|2|||
160591570|NCT02700919|579882754|FG001|Overall Study|Lost to Follow-up|0|||
160591571|NCT02700919|579882755|FG002|Overall Study|Lost to Follow-up|0|||
160591572|NCT02700919|579882753|FG000|Overall Study|Other|2|||
160591573|NCT02700919|579882754|FG001|Overall Study|Other|1|||
160591574|NCT02700919|579882755|FG002|Overall Study|Other|1|||
160591575|NCT00696436|579882756|FG000|Overall Study|Adverse Event|7|||
160591576|NCT00696436|579882757|FG001|Overall Study|Adverse Event|9|||
160591577|NCT00696436|579882758|FG002|Overall Study|Adverse Event|8|||
160591578|NCT00696436|579882759|FG003|Overall Study|Adverse Event|6|||
160591579|NCT00696436|579882760|FG004|Overall Study|Adverse Event|4|||
160591580|NCT00696436|579882756|FG000|Overall Study|Protocol Violation|3|||
160591581|NCT00696436|579882757|FG001|Overall Study|Protocol Violation|2|||
160591582|NCT00696436|579882758|FG002|Overall Study|Protocol Violation|2|||
160591583|NCT00696436|579882759|FG003|Overall Study|Protocol Violation|0|||
160460203|NCT03248479|579417569|FG001|Overall Study|Lost to Follow-up|1|||
160591584|NCT00696436|579882760|FG004|Overall Study|Protocol Violation|1|||
160591585|NCT00696436|579882756|FG000|Overall Study|Lost to Follow-up|1|||
160591586|NCT00696436|579882757|FG001|Overall Study|Lost to Follow-up|6|||
160591587|NCT00696436|579882758|FG002|Overall Study|Lost to Follow-up|2|||
160591588|NCT00696436|579882759|FG003|Overall Study|Lost to Follow-up|4|||
160975833|NCT06173570|581300618|FG004|Overall Study|Lost to Follow-up|2|||
160975834|NCT06173570|581300614|FG000|Overall Study|Protocol Violation|0|||
160975835|NCT06173570|581300615|FG001|Overall Study|Protocol Violation|2|||
160975836|NCT06173570|581300616|FG002|Overall Study|Protocol Violation|0|||
160975837|NCT06173570|581300617|FG003|Overall Study|Protocol Violation|0|||
160975838|NCT06173570|581300618|FG004|Overall Study|Protocol Violation|1|||
160975839|NCT06173570|581300614|FG000|Overall Study|Withdrawal by Subject|0|||
160975840|NCT06173570|581300615|FG001|Overall Study|Withdrawal by Subject|1|||
160975841|NCT06173570|581300616|FG002|Overall Study|Withdrawal by Subject|1|||
160975842|NCT06173570|581300617|FG003|Overall Study|Withdrawal by Subject|1|||
160975843|NCT06173570|581300618|FG004|Overall Study|Withdrawal by Subject|1|||
160975844|NCT06173570|581300614|FG000|Overall Study|Non-compliance with Study Drug|1|||
160975845|NCT06173570|581300615|FG001|Overall Study|Non-compliance with Study Drug|0|||
160975846|NCT06173570|581300616|FG002|Overall Study|Non-compliance with Study Drug|0|||
160975847|NCT06173570|581300617|FG003|Overall Study|Non-compliance with Study Drug|0|||
160975848|NCT06173570|581300618|FG004|Overall Study|Non-compliance with Study Drug|0|||
160975849|NCT06173570|581300614|FG000|Overall Study|Screen Failure|0|||
160975850|NCT06173570|581300615|FG001|Overall Study|Screen Failure|0|||
160975851|NCT06173570|581300616|FG002|Overall Study|Screen Failure|0|||
160975852|NCT06173570|581300617|FG003|Overall Study|Screen Failure|0|||
160975853|NCT06173570|581300618|FG004|Overall Study|Screen Failure|1|||
160975854|NCT06173570|581300614|FG000|Overall Study|Other|2|||
160975855|NCT06173570|581300615|FG001|Overall Study|Other|1|||
160975856|NCT06173570|581300616|FG002|Overall Study|Other|0|||
160975857|NCT06173570|581300617|FG003|Overall Study|Other|2|||
160975858|NCT06173570|581300618|FG004|Overall Study|Other|0|||
160975859|NCT03820323|581300619|FG000|Overall Study|Lost to Follow-up|2|||
160975860|NCT03820323|581300620|FG001|Overall Study|Lost to Follow-up|1|||
160975861|NCT03820323|581300619|FG000|Overall Study|Missed 12-month visit|22|||
160975862|NCT03820323|581300620|FG001|Overall Study|Missed 12-month visit|14|||
160975863|NCT03820323|581300619|FG000|Overall Study|Death|2|||
160975864|NCT03820323|581300620|FG001|Overall Study|Death|1|||
160975865|NCT03820323|581300619|FG000|Overall Study|Transferred out|13|||
160975866|NCT03820323|581300620|FG001|Overall Study|Transferred out|11|||
160975867|NCT03820323|581300619|FG000|Overall Study|Terminated|0|||
160975868|NCT03820323|581300620|FG001|Overall Study|Terminated|3|||
160975869|NCT03820323|581300619|FG000|Overall Study|Withdrawal by Subject|1|||
160975870|NCT03820323|581300620|FG001|Overall Study|Withdrawal by Subject|6|||
160975871|NCT03151395|581300621|FG000|Overall Study|Adverse Event|2|||
160975872|NCT03151395|581300621|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
160975873|NCT03151395|581300621|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
160975874|NCT03151395|581300621|FG000|Overall Study|Unspecified reason|4|||
160975875|NCT00366301|581300622|FG000|Overall Study|Lost to Follow-up|4|||
160975876|NCT00366301|581300623|FG001|Overall Study|Lost to Follow-up|4|||
160975877|NCT00366301|581300624|FG002|Overall Study|Lost to Follow-up|3|||
160975878|NCT00366301|581300625|FG003|Overall Study|Lost to Follow-up|7|||
160975879|NCT00366301|581300622|FG000|Overall Study|Withdrawal by Subject|4|||
160975880|NCT00366301|581300623|FG001|Overall Study|Withdrawal by Subject|2|||
160975881|NCT00366301|581300624|FG002|Overall Study|Withdrawal by Subject|1|||
160975882|NCT00366301|581300625|FG003|Overall Study|Withdrawal by Subject|1|||
160591589|NCT00696436|579882760|FG004|Overall Study|Lost to Follow-up|3|||
160591590|NCT00696436|579882756|FG000|Overall Study|Withdrawal by Subject|4|||
160591591|NCT00696436|579882757|FG001|Overall Study|Withdrawal by Subject|11|||
160591592|NCT00696436|579882758|FG002|Overall Study|Withdrawal by Subject|5|||
160591593|NCT00696436|579882759|FG003|Overall Study|Withdrawal by Subject|7|||
160591594|NCT00696436|579882760|FG004|Overall Study|Withdrawal by Subject|1|||
160591595|NCT00696436|579882756|FG000|Overall Study|Lack of Efficacy|3|||
160591596|NCT00696436|579882757|FG001|Overall Study|Lack of Efficacy|1|||
160591597|NCT00696436|579882758|FG002|Overall Study|Lack of Efficacy|5|||
160591598|NCT00696436|579882759|FG003|Overall Study|Lack of Efficacy|2|||
160591599|NCT00696436|579882760|FG004|Overall Study|Lack of Efficacy|4|||
160591600|NCT00696436|579882756|FG000|Overall Study|Participant Unavailability|2|||
160591601|NCT00696436|579882757|FG001|Overall Study|Participant Unavailability|0|||
160591602|NCT00696436|579882758|FG002|Overall Study|Participant Unavailability|2|||
160591603|NCT00696436|579882759|FG003|Overall Study|Participant Unavailability|1|||
160591604|NCT00696436|579882760|FG004|Overall Study|Participant Unavailability|0|||
160591605|NCT00696436|579882756|FG000|Overall Study|Administrative Error|2|||
160658193|NCT03980483|580129908|FG000|Overall Study|Protocol Violation|4|||
160658194|NCT03980483|580129909|FG001|Overall Study|Protocol Violation|2|||
160658195|NCT03980483|580129910|FG002|Overall Study|Protocol Violation|1|||
160591606|NCT00696436|579882757|FG001|Overall Study|Administrative Error|0|||
160591607|NCT00696436|579882758|FG002|Overall Study|Administrative Error|2|||
160591608|NCT00696436|579882759|FG003|Overall Study|Administrative Error|0|||
160591609|NCT00696436|579882760|FG004|Overall Study|Administrative Error|0|||
160591610|NCT00696436|579882756|FG000|Overall Study|Participant Non-compliance|0|||
160591611|NCT00696436|579882757|FG001|Overall Study|Participant Non-compliance|0|||
160591612|NCT00696436|579882758|FG002|Overall Study|Participant Non-compliance|1|||
160591613|NCT00696436|579882759|FG003|Overall Study|Participant Non-compliance|2|||
160591614|NCT00696436|579882760|FG004|Overall Study|Participant Non-compliance|0|||
160591615|NCT00696436|579882756|FG000|Overall Study|Administrative Decision|1|||
160591616|NCT00696436|579882757|FG001|Overall Study|Administrative Decision|0|||
160591617|NCT00696436|579882758|FG002|Overall Study|Administrative Decision|0|||
160658196|NCT03980483|580129911|FG003|Overall Study|Protocol Violation|1|||
160975883|NCT01348776|581300626|FG000|Overall Study|Lost to Follow-up|3|||
160975884|NCT01372605|581300627|FG000|Overall Study|Death|1|||
160975885|NCT01372605|581300628|FG001|Overall Study|Death|2|||
160975886|NCT01372605|581300627|FG000|Overall Study|Lost to Follow-up|2|||
160975887|NCT01372605|581300628|FG001|Overall Study|Lost to Follow-up|1|||
160975888|NCT01372605|581300627|FG000|Overall Study|Withdrawal by Subject|4|||
160975889|NCT01372605|581300628|FG001|Overall Study|Withdrawal by Subject|7|||
160975890|NCT01372605|581300627|FG000|Overall Study|Moved|3|||
160975891|NCT01372605|581300628|FG001|Overall Study|Moved|0|||
160591618|NCT00696436|579882759|FG003|Overall Study|Administrative Decision|0|||
160591619|NCT00696436|579882760|FG004|Overall Study|Administrative Decision|0|||
160975892|NCT01372605|581300627|FG000|Overall Study|Changed medical home|2|||
160975893|NCT01372605|581300628|FG001|Overall Study|Changed medical home|0|||
160975894|NCT00210119|581300629|FG000|Overall Study|Protocol Violation|1|||
160975895|NCT00210119|581300629|FG000|Overall Study|Withdrawal by Subject|1|||
160975896|NCT00951509|581300630|FG000|Overall Study|Withdrawal by Subject|2|||
160591620|NCT00696436|579882756|FG000|Overall Study|Missing|0|||
160658197|NCT03980483|580129912|FG004|Overall Study|Protocol Violation|0|||
160658198|NCT03980483|580129913|FG005|Overall Study|Protocol Violation|0|||
160658199|NCT03980483|580129908|FG000|Overall Study|Physician Decision|14|||
160658200|NCT03980483|580129909|FG001|Overall Study|Physician Decision|10|||
160658201|NCT03980483|580129910|FG002|Overall Study|Physician Decision|7|||
160658202|NCT03980483|580129911|FG003|Overall Study|Physician Decision|4|||
160658203|NCT03980483|580129912|FG004|Overall Study|Physician Decision|4|||
160658204|NCT03980483|580129913|FG005|Overall Study|Physician Decision|2|||
160658205|NCT03980483|580129908|FG000|Overall Study|Withdrawal by Subject|38|||
160658206|NCT03980483|580129909|FG001|Overall Study|Withdrawal by Subject|21|||
160658207|NCT03980483|580129910|FG002|Overall Study|Withdrawal by Subject|15|||
160658208|NCT03980483|580129911|FG003|Overall Study|Withdrawal by Subject|5|||
160658209|NCT03980483|580129912|FG004|Overall Study|Withdrawal by Subject|3|||
160658210|NCT03980483|580129913|FG005|Overall Study|Withdrawal by Subject|4|||
160658211|NCT03980483|580129908|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
160658212|NCT03980483|580129909|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
160658213|NCT03980483|580129910|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
160658214|NCT03980483|580129911|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
160591621|NCT00696436|579882757|FG001|Overall Study|Missing|1|||
160591622|NCT00696436|579882758|FG002|Overall Study|Missing|1|||
160591623|NCT00696436|579882759|FG003|Overall Study|Missing|0|||
160591624|NCT00696436|579882760|FG004|Overall Study|Missing|0|||
160591625|NCT01517412|579882766|FG000|Overall Study|Adverse Event|10|||
160460204|NCT03248479|579417570|FG002|Overall Study|Lost to Follow-up|0|||
160658215|NCT03980483|580129912|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
160658216|NCT03980483|580129913|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
160658217|NCT03980483|580129908|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
160658218|NCT03980483|580129909|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
160658219|NCT03980483|580129910|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
160658220|NCT03980483|580129911|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
160460205|NCT03248479|579417571|FG003|Overall Study|Lost to Follow-up|0|||
160460206|NCT03248479|579417572|FG004|Overall Study|Lost to Follow-up|0|||
160460207|NCT03248479|579417573|FG005|Overall Study|Lost to Follow-up|0|||
160460208|NCT03248479|579417574|FG006|Overall Study|Lost to Follow-up|0|||
160975897|NCT01830881|581300635|FG000|Overall Study|Changed decision to have an abortion|0|||
160975898|NCT01830881|581300636|FG001|Overall Study|Changed decision to have an abortion|1|||
160975899|NCT03125941|581300637|FG000|Overall Study|did not receive intervention|1|||
160975900|NCT03125941|581300638|FG001|Overall Study|did not receive intervention|2|||
160975901|NCT00734214|581300639|FG000|Overall Study|Withdrawal by Subject|3|||
160975902|NCT00734214|581300640|FG001|Overall Study|Withdrawal by Subject|4|||
160975903|NCT00734214|581300639|FG000|Overall Study|MD withdrawal|1|||
160975904|NCT00734214|581300640|FG001|Overall Study|MD withdrawal|0|||
160975905|NCT00406419|581300647|FG000|Overall Study|Death|3|||
160975906|NCT00406419|581300648|FG001|Overall Study|Death|1|||
160975907|NCT00406419|581300649|FG002|Overall Study|Death|4|||
160975908|NCT00406419|581300647|FG000|Overall Study|Protocol Violation|6|||
160975909|NCT00406419|581300648|FG001|Overall Study|Protocol Violation|2|||
160975910|NCT00406419|581300649|FG002|Overall Study|Protocol Violation|5|||
160975911|NCT00406419|581300647|FG000|Overall Study|Study Terminated by Sponsor|260|||
160975912|NCT00406419|581300648|FG001|Overall Study|Study Terminated by Sponsor|288|||
160975913|NCT00406419|581300649|FG002|Overall Study|Study Terminated by Sponsor|282|||
160975914|NCT00406419|581300647|FG000|Overall Study|Withdrawal by Subject|17|||
160975915|NCT00406419|581300648|FG001|Overall Study|Withdrawal by Subject|24|||
160975916|NCT00406419|581300649|FG002|Overall Study|Withdrawal by Subject|26|||
160975917|NCT00406419|581300647|FG000|Overall Study|Lack of Efficacy|12|||
160975918|NCT00406419|581300648|FG001|Overall Study|Lack of Efficacy|1|||
160975919|NCT00406419|581300649|FG002|Overall Study|Lack of Efficacy|6|||
160975920|NCT00406419|581300647|FG000|Overall Study|Non-Compliance with Study Drug|5|||
160975921|NCT00406419|581300648|FG001|Overall Study|Non-Compliance with Study Drug|6|||
160975922|NCT00406419|581300649|FG002|Overall Study|Non-Compliance with Study Drug|3|||
160975923|NCT00406419|581300647|FG000|Overall Study|Adverse Event|10|||
160975924|NCT00406419|581300648|FG001|Overall Study|Adverse Event|12|||
160658221|NCT03980483|580129912|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
160658222|NCT03980483|580129913|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
160658223|NCT03980483|580129908|FG000|Overall Study|Other|0|||
160975925|NCT00406419|581300649|FG002|Overall Study|Adverse Event|16|||
160975926|NCT00406419|581300647|FG000|Overall Study|Lost to Follow-up|11|||
160975927|NCT00406419|581300648|FG001|Overall Study|Lost to Follow-up|10|||
160975928|NCT00406419|581300649|FG002|Overall Study|Lost to Follow-up|5|||
160460209|NCT03248479|579417575|FG007|Overall Study|Lost to Follow-up|0|||
160460210|NCT03248479|579417576|FG008|Overall Study|Lost to Follow-up|0|||
160460211|NCT03248479|579417577|FG009|Overall Study|Lost to Follow-up|0|||
160460212|NCT03248479|579417578|FG010|Overall Study|Lost to Follow-up|0|||
160460213|NCT03248479|579417579|FG011|Overall Study|Lost to Follow-up|0|||
160460214|NCT03248479|579417580|FG012|Overall Study|Lost to Follow-up|1|||
160460215|NCT03248479|579417568|FG000|Overall Study|Not reported|0|||
160460216|NCT03248479|579417569|FG001|Overall Study|Not reported|0|||
160460217|NCT03248479|579417570|FG002|Overall Study|Not reported|0|||
160460218|NCT03248479|579417571|FG003|Overall Study|Not reported|1|||
160975929|NCT01115491|581300652|FG000|Overall Study|Death|22|||
160975930|NCT01115491|581300652|FG000|Overall Study|Adverse Event|3|||
160975931|NCT01115491|581300652|FG000|Overall Study|Lost to Follow-up|3|||
160975932|NCT01115491|581300652|FG000|Overall Study|Withdrawal by Subject|1|||
160975933|NCT01115491|581300652|FG000|Overall Study|Physician Decision|1|||
160975934|NCT03856996|581300653|FG000|Overall Study|Withdrawal by Subject|1|||
160975935|NCT03856996|581300654|FG001|Overall Study|Withdrawal by Subject|0|||
160975936|NCT03856996|581300653|FG000|Overall Study|Lost to Follow-up|0|||
160975937|NCT03856996|581300654|FG001|Overall Study|Lost to Follow-up|1|||
160975938|NCT03856996|581300653|FG000|Overall Study|Adverse Event|1|||
160975939|NCT03856996|581300654|FG001|Overall Study|Adverse Event|1|||
160975940|NCT03856996|581300653|FG000|Overall Study|Other|1|||
160975941|NCT03856996|581300654|FG001|Overall Study|Other|0|||
160975942|NCT04362137|581300657|FG000|Overall Study|Death|9|||
160975943|NCT04362137|581300658|FG001|Overall Study|Death|3|||
160975944|NCT04362137|581300657|FG000|Overall Study|Patient decision|6|||
160975945|NCT04362137|581300658|FG001|Overall Study|Patient decision|3|||
160975946|NCT04362137|581300657|FG000|Overall Study|Adverse Event|1|||
160975947|NCT04362137|581300658|FG001|Overall Study|Adverse Event|0|||
160975948|NCT04362137|581300657|FG000|Overall Study|Lost to Follow-up|1|||
160975949|NCT04362137|581300658|FG001|Overall Study|Lost to Follow-up|0|||
160975950|NCT04362137|581300657|FG000|Overall Study|Protocol deviation|1|||
160975951|NCT04362137|581300658|FG001|Overall Study|Protocol deviation|0|||
160975952|NCT01821898|581300662|FG000|Overall Study|Withdrawal by Subject|2|||
160975953|NCT01821898|581300663|FG001|Overall Study|Withdrawal by Subject|1|||
160975954|NCT03679767|581300666|FG000|Overall Study|Death|16|||
160975955|NCT03679767|581300667|FG001|Overall Study|Death|11|||
160975956|NCT03679767|581300668|FG002|Overall Study|Death|17|||
160975957|NCT03679767|581300669|FG003|Overall Study|Death|10|||
160975958|NCT03679767|581300666|FG000|Overall Study|Lost to Follow-up|1|||
160975959|NCT03679767|581300667|FG001|Overall Study|Lost to Follow-up|1|||
160975960|NCT03679767|581300668|FG002|Overall Study|Lost to Follow-up|1|||
160975961|NCT03679767|581300669|FG003|Overall Study|Lost to Follow-up|1|||
160975962|NCT03679767|581300666|FG000|Overall Study|Withdrawal by Subject|0|||
160975963|NCT03679767|581300667|FG001|Overall Study|Withdrawal by Subject|0|||
160975964|NCT03679767|581300668|FG002|Overall Study|Withdrawal by Subject|0|||
160975965|NCT03679767|581300669|FG003|Overall Study|Withdrawal by Subject|1|||
160975966|NCT03679767|581300666|FG000|Overall Study|Follow-up Completed|18|||
160975967|NCT03679767|581300667|FG001|Overall Study|Follow-up Completed|11|||
160975968|NCT03679767|581300668|FG002|Overall Study|Follow-up Completed|11|||
160975969|NCT03679767|581300669|FG003|Overall Study|Follow-up Completed|20|||
160975970|NCT03679767|581300666|FG000|Overall Study|Entered Hospice Care|0|||
160975971|NCT03679767|581300667|FG001|Overall Study|Entered Hospice Care|0|||
160975972|NCT03679767|581300668|FG002|Overall Study|Entered Hospice Care|0|||
160975973|NCT03679767|581300669|FG003|Overall Study|Entered Hospice Care|1|||
160460219|NCT03248479|579417572|FG004|Overall Study|Not reported|1|||
160975974|NCT03679767|581300666|FG000|Overall Study|Progressive Disease|0|||
160975975|NCT03679767|581300667|FG001|Overall Study|Progressive Disease|0|||
160975976|NCT03679767|581300668|FG002|Overall Study|Progressive Disease|0|||
160975977|NCT03679767|581300669|FG003|Overall Study|Progressive Disease|1|||
160975978|NCT00180713|581300676|FG000|Overall Study|Withdrawal by Subject|2|||
160975979|NCT00180713|581300677|FG001|Overall Study|Withdrawal by Subject|0|||
160975980|NCT00180713|581300676|FG000|Overall Study|Adverse Event|3|||
160975981|NCT00180713|581300677|FG001|Overall Study|Adverse Event|3|||
160975982|NCT05295732|581300678|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
160975983|NCT05295732|581300679|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
160975984|NCT05295732|581300680|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
160975985|NCT05295732|581300681|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
160975986|NCT05295732|581300682|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
160975987|NCT05295732|581300678|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
160975988|NCT05295732|581300679|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
160975989|NCT05295732|581300680|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
160975990|NCT05295732|581300681|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
160975991|NCT05295732|581300682|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
160975992|NCT03311230|581300685|FG000|Overall Study|Withdrawal by Subject|1|||
160975993|NCT03311230|581300686|FG001|Overall Study|Withdrawal by Subject|4|||
160975994|NCT03311230|581300687|FG002|Overall Study|Withdrawal by Subject|2|||
160975995|NCT03311230|581300688|FG003|Overall Study|Withdrawal by Subject|7|||
160975996|NCT03311230|581300685|FG000|Overall Study|Unrelated injury|0|||
160975997|NCT03311230|581300686|FG001|Overall Study|Unrelated injury|1|||
160975998|NCT03311230|581300687|FG002|Overall Study|Unrelated injury|0|||
160975999|NCT03311230|581300688|FG003|Overall Study|Unrelated injury|0|||
160976000|NCT05200936|581300690|FG000|Overall Study|Withdrawal by Subject|2|||
160976001|NCT05200936|581300691|FG001|Overall Study|Withdrawal by Subject|2|||
160976002|NCT05200936|581300690|FG000|Overall Study|Lost to Follow-up|2|||
160976003|NCT05200936|581300691|FG001|Overall Study|Lost to Follow-up|0|||
160976004|NCT05200936|581300690|FG000|Overall Study|Pregnancy|0|||
160976005|NCT05200936|581300691|FG001|Overall Study|Pregnancy|1|||
160976006|NCT01338012|581300692|FG000|Overall Study|Death|4|||
160976007|NCT01338012|581300692|FG000|Overall Study|Study terminated|4|||
160976008|NCT02089230|581300693|FG000|Overall Study|Death|0|||
160976009|NCT02089230|581300694|FG001|Overall Study|Death|0|||
160976010|NCT02089230|581300695|FG002|Overall Study|Death|2|||
160976011|NCT02089230|581300693|FG000|Overall Study|Seeking Alternative Therapy|0|||
160976012|NCT02089230|581300694|FG001|Overall Study|Seeking Alternative Therapy|0|||
160976013|NCT02089230|581300695|FG002|Overall Study|Seeking Alternative Therapy|4|||
160976014|NCT02791490|581302145|FG000|Overall Study|Lost to Follow-up|1|||
160976015|NCT02791490|581302146|FG001|Overall Study|Lost to Follow-up|2|||
160976016|NCT02791490|581302145|FG000|Overall Study|Withdrawal by Subject|2|||
160976017|NCT02791490|581302146|FG001|Overall Study|Withdrawal by Subject|6|||
160976018|NCT01235975|581302151|FG000|Overall Study|Serious Adverse Event|0|||
160976019|NCT01235975|581302152|FG001|Overall Study|Serious Adverse Event|1|||
160976020|NCT01235975|581302151|FG000|Overall Study|Withdrawal by Subject|8|||
160976021|NCT01235975|581302152|FG001|Overall Study|Withdrawal by Subject|2|||
160976022|NCT01235975|581302151|FG000|Overall Study|Migrated/moved from study area|2|||
160976023|NCT01235975|581302152|FG001|Overall Study|Migrated/moved from study area|1|||
160976024|NCT01235975|581302151|FG000|Overall Study|Lost to Follow-up|7|||
160976025|NCT01235975|581302152|FG001|Overall Study|Lost to Follow-up|3|||
160976026|NCT00919893|581302155|FG000|Overall Study|Protocol Violation|19|||
160976027|NCT00919893|581302156|FG001|Overall Study|Protocol Violation|9|||
160976028|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
160976029|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
160976030|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
160976031|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
160976032|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
160976033|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
160976034|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
160976035|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
160976036|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
160591626|NCT01517412|579882767|FG001|Overall Study|Adverse Event|11|||
160591627|NCT01517412|579882766|FG000|Overall Study|Lack of Efficacy|10|||
160591628|NCT01517412|579882767|FG001|Overall Study|Lack of Efficacy|5|||
160591629|NCT01517412|579882766|FG000|Overall Study|Poor compliance to protocol|8|||
160591630|NCT01517412|579882767|FG001|Overall Study|Poor compliance to protocol|3|||
160591631|NCT01517412|579882766|FG000|Overall Study|Other than specified above|8|||
160976037|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
160976038|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
160976039|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
160976040|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
160976041|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
160976042|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
160976043|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
160591632|NCT01517412|579882767|FG001|Overall Study|Other than specified above|5|||
160591633|NCT01253187|579882768|FG000|Period 2|Withdrawal by Subject|0|||
160976044|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
160976045|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
160976046|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
160658224|NCT03980483|580129909|FG001|Overall Study|Other|1|||
160658225|NCT03980483|580129910|FG002|Overall Study|Other|0|||
160658226|NCT03980483|580129911|FG003|Overall Study|Other|0|||
160658227|NCT03980483|580129912|FG004|Overall Study|Other|0|||
160658228|NCT03980483|580129913|FG005|Overall Study|Other|0|||
160658229|NCT01225146|580129914|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
160658230|NCT01225146|580129915|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
160658231|NCT00623779|580129916|FG000|Overall Study|Adverse Event|1|||
160658232|NCT00623779|580129917|FG001|Overall Study|Adverse Event|3|||
160658233|NCT00623779|580129918|FG002|Overall Study|Adverse Event|0|||
160658234|NCT00623779|580129916|FG000|Overall Study|Criteria from CSR|2|||
160658235|NCT00623779|580129917|FG001|Overall Study|Criteria from CSR|0|||
160658236|NCT00623779|580129918|FG002|Overall Study|Criteria from CSR|1|||
160658237|NCT00686959|580129920|FG000|Overall Study|Participants censored (no death events)|124|||
160658238|NCT00686959|580129921|FG001|Overall Study|Participants censored (no death events)|117|||
160658239|NCT02191891|580129923|FG000|Overall Study|Withdrawal by Subject|0|||
160658240|NCT02191891|580129924|FG001|Overall Study|Withdrawal by Subject|1|||
160658241|NCT02191891|580129925|FG002|Overall Study|Withdrawal by Subject|0|||
160658242|NCT02191891|580129926|FG003|Overall Study|Withdrawal by Subject|0|||
160658243|NCT02191891|580129927|FG004|Overall Study|Withdrawal by Subject|1|||
160658244|NCT02191891|580129923|FG000|Overall Study|Adverse Event|0|||
160658245|NCT02191891|580129924|FG001|Overall Study|Adverse Event|1|||
160976047|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
160976048|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
160976049|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
160976050|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
160976051|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
160976052|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
160976053|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
160976054|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
160976055|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
160976056|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
160976057|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
160976058|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
160976059|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
160976060|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
160976061|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
160976062|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
160976063|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
160976064|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
160976065|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
160976066|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
160658246|NCT02191891|580129925|FG002|Overall Study|Adverse Event|0|||
160658247|NCT02191891|580129926|FG003|Overall Study|Adverse Event|0|||
160658248|NCT02191891|580129927|FG004|Overall Study|Adverse Event|2|||
160976067|NCT00365378|581302163|FG000|Extension|Adverse Event|0|||
160976068|NCT00365378|581302164|FG001|Extension|Adverse Event|0|||
160976069|NCT00365378|581302165|FG002|Extension|Adverse Event|1|||
160658249|NCT02191891|580129923|FG000|Overall Study|Disease Progression|4|||
160591634|NCT01253187|579882769|FG001|Period 2|Withdrawal by Subject|0|||
160976070|NCT00365378|581302163|FG000|Extension|Moved|0|||
160976071|NCT00365378|581302164|FG001|Extension|Moved|0|||
160976072|NCT00365378|581302165|FG002|Extension|Moved|8|||
160976073|NCT00365378|581302163|FG000|Extension|Lost to Follow-up|0|||
160976074|NCT00365378|581302164|FG001|Extension|Lost to Follow-up|0|||
160976075|NCT00365378|581302165|FG002|Extension|Lost to Follow-up|57|||
160976076|NCT00365378|581302163|FG000|Extension|Protocol Violation|0|||
160976077|NCT00365378|581302164|FG001|Extension|Protocol Violation|0|||
160976078|NCT00365378|581302165|FG002|Extension|Protocol Violation|2|||
160976079|NCT00365378|581302163|FG000|Extension|Withdrawal by Subject|0|||
160976080|NCT00365378|581302164|FG001|Extension|Withdrawal by Subject|0|||
160976081|NCT00365378|581302165|FG002|Extension|Withdrawal by Subject|98|||
160976082|NCT00365378|581302163|FG000|Extension|Other|0|||
160976083|NCT00365378|581302164|FG001|Extension|Other|0|||
160976084|NCT00365378|581302165|FG002|Extension|Other|31|||
160976085|NCT04741802|581302166|FG000|Overall Study|Death|1|||
160976086|NCT04741802|581302166|FG000|Overall Study|Lost to Follow-up|11|||
160976087|NCT01381874|581302177|FG000|Overall Study|Lost to Follow-up|1|||
160976088|NCT01381874|581302178|FG001|Overall Study|Lost to Follow-up|1|||
160976089|NCT01381874|581302179|FG002|Overall Study|Lost to Follow-up|0|||
160976090|NCT01381874|581302177|FG000|Overall Study|Withdrawal by Subject|9|||
160976091|NCT01381874|581302178|FG001|Overall Study|Withdrawal by Subject|10|||
160976092|NCT01381874|581302179|FG002|Overall Study|Withdrawal by Subject|9|||
160976093|NCT01381874|581302177|FG000|Overall Study|Other|67|||
160976094|NCT01381874|581302178|FG001|Overall Study|Other|52|||
160976095|NCT01381874|581302179|FG002|Overall Study|Other|67|||
160976096|NCT00452413|581302182|FG000|Overall Study|Progressive Disease|4|||
160976097|NCT00452413|581302183|FG001|Overall Study|Progressive Disease|11|||
160976098|NCT00452413|581302184|FG002|Overall Study|Progressive Disease|30|||
160976099|NCT00452413|581302182|FG000|Overall Study|Withdrawal by Subject|0|||
160976100|NCT00452413|581302183|FG001|Overall Study|Withdrawal by Subject|1|||
160976101|NCT00452413|581302184|FG002|Overall Study|Withdrawal by Subject|4|||
160976102|NCT00452413|581302182|FG000|Overall Study|Adverse Event|0|||
160976103|NCT00452413|581302183|FG001|Overall Study|Adverse Event|0|||
160976104|NCT00452413|581302184|FG002|Overall Study|Adverse Event|5|||
160976105|NCT00452413|581302182|FG000|Overall Study|Physician Decision|0|||
160976106|NCT00452413|581302183|FG001|Overall Study|Physician Decision|0|||
160976107|NCT00452413|581302184|FG002|Overall Study|Physician Decision|4|||
160976108|NCT00452413|581302182|FG000|Overall Study|Death due to study disease|0|||
160976109|NCT00452413|581302183|FG001|Overall Study|Death due to study disease|0|||
160976110|NCT00452413|581302184|FG002|Overall Study|Death due to study disease|2|||
160976111|NCT00452413|581302182|FG000|Overall Study|Death due to adverse event (AE)|0|||
160976112|NCT00452413|581302183|FG001|Overall Study|Death due to adverse event (AE)|0|||
160976113|NCT00452413|581302184|FG002|Overall Study|Death due to adverse event (AE)|1|||
160976114|NCT00452413|581302182|FG000|Overall Study|On treatment|0|||
160976115|NCT00452413|581302183|FG001|Overall Study|On treatment|0|||
160976116|NCT00452413|581302184|FG002|Overall Study|On treatment|3|||
160976117|NCT03119610|581302186|FG000|Overall Study|Adverse Event|1|||
160976118|NCT03119610|581302187|FG001|Overall Study|Adverse Event|0|||
160976119|NCT03119610|581302186|FG000|Overall Study|Lost to Follow-up|0|||
160976120|NCT03119610|581302187|FG001|Overall Study|Lost to Follow-up|1|||
160976121|NCT00114634|581302188|FG000|Overall Study|failure to return forms|3|||
160976122|NCT00684762|581302191|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
160976123|NCT00684762|581302192|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
160976124|NCT02310126|581302204|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
160976125|NCT02310126|581302205|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
160976126|NCT02310126|581302204|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
160976127|NCT02310126|581302205|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
160976128|NCT01539863|581302208|FG000|Overall Study|Lost to Follow-up|5|||
160976129|NCT01539863|581302209|FG001|Overall Study|Lost to Follow-up|4|||
160976130|NCT02693834|581302213|FG000|Baseline Measurement|Withdrawal by Subject|1|||
160976131|NCT02693834|581302214|FG001|Baseline Measurement|Withdrawal by Subject|0|||
160976132|NCT02693834|581302213|FG000|Baseline Measurement|Adverse Event|1|||
160976133|NCT02693834|581302214|FG001|Baseline Measurement|Adverse Event|0|||
160976134|NCT02693834|581302213|FG000|Week 2 Practice|Adverse Event|0|||
160976135|NCT02693834|581302214|FG001|Week 2 Practice|Adverse Event|1|||
160976136|NCT02111213|581302217|FG000|Overall Study|Withdrawal by Subject|3|||
160976137|NCT02111213|581302218|FG001|Overall Study|Withdrawal by Subject|2|||
160976138|NCT02111213|581302217|FG000|Overall Study|Lost to Follow-up|3|||
160976139|NCT02111213|581302218|FG001|Overall Study|Lost to Follow-up|4|||
160976140|NCT02226172|581302223|FG000|Overall Study|Participant refused further follow-up|4|||
160976141|NCT02226172|581302223|FG000|Overall Study|Other|5|||
160976142|NCT02226172|581302223|FG000|Overall Study|Death|1|||
160976143|NCT02226172|581302223|FG000|Overall Study|Study terminated by sponsor|1|||
160976144|NCT02226172|581302223|FG000|Overall Study|Adverse Event|6|||
160976145|NCT00439179|581302227|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
160976146|NCT00439179|581302228|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
160976147|NCT00439179|581302229|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
160658250|NCT02191891|580129924|FG001|Overall Study|Disease Progression|10|||
160658251|NCT02191891|580129925|FG002|Overall Study|Disease Progression|4|||
160658252|NCT02191891|580129926|FG003|Overall Study|Disease Progression|2|||
160658253|NCT02191891|580129927|FG004|Overall Study|Disease Progression|7|||
160658254|NCT01448057|580129928|FG000|Overall Study|Protocol Violation|3|||
160658255|NCT01448057|580129929|FG001|Overall Study|Protocol Violation|2|||
160658256|NCT01448057|580129928|FG000|Overall Study|Lost to Follow-up|3|||
160658257|NCT01448057|580129929|FG001|Overall Study|Lost to Follow-up|0|||
160658258|NCT01448057|580129928|FG000|Overall Study|Adverse Event|0|||
160658259|NCT01448057|580129929|FG001|Overall Study|Adverse Event|2|||
160658260|NCT01448057|580129928|FG000|Overall Study|Withdrawal by Subject|2|||
160658261|NCT01448057|580129929|FG001|Overall Study|Withdrawal by Subject|0|||
160658262|NCT03883906|580129930|FG000|Overall Study|Withdrawal by Subject|2|||
160658263|NCT03883906|580129930|FG000|Overall Study|Physician Decision|5|||
160658264|NCT03912337|580129935|FG000|Overall Study|Withdrawal of Consent From Study|1|||
160658265|NCT03912337|580129936|FG001|Overall Study|Withdrawal of Consent From Study|0|||
160658266|NCT03912337|580129935|FG000|Overall Study|Lost to Follow-up|1|||
160658267|NCT03912337|580129936|FG001|Overall Study|Lost to Follow-up|1|||
160658268|NCT03978624|580129937|FG000|Overall Study|Protocol Violation|1|||
160658269|NCT03978624|580129938|FG001|Overall Study|Protocol Violation|0|||
160658270|NCT02365207|580129944|FG000|Overall Study|Withdrawal by Subject|1|||
160658271|NCT02365207|580129944|FG000|Overall Study|Physician Decision|1|||
160658272|NCT01318499|580129947|FG000|Overall Study|Adverse Event|16|||
160591635|NCT01253187|579882770|FG002|Period 2|Withdrawal by Subject|0|||
160591636|NCT01253187|579882771|FG003|Period 2|Withdrawal by Subject|0|||
160591637|NCT01253187|579882772|FG004|Period 2|Withdrawal by Subject|1|||
160591638|NCT01253187|579882773|FG005|Period 2|Withdrawal by Subject|0|||
160591639|NCT01253187|579882768|FG000|Period 3|Pregnancy|1|||
160591640|NCT01253187|579882769|FG001|Period 3|Pregnancy|0|||
160591641|NCT01253187|579882770|FG002|Period 3|Pregnancy|0|||
160591642|NCT01253187|579882771|FG003|Period 3|Pregnancy|0|||
160591643|NCT01253187|579882772|FG004|Period 3|Pregnancy|0|||
160591644|NCT01253187|579882773|FG005|Period 3|Pregnancy|0|||
160591645|NCT01253187|579882768|FG000|Period 3|difficulty with blood sampling|0|||
160591646|NCT01253187|579882769|FG001|Period 3|difficulty with blood sampling|1|||
160591647|NCT01253187|579882770|FG002|Period 3|difficulty with blood sampling|0|||
160591648|NCT01253187|579882771|FG003|Period 3|difficulty with blood sampling|0|||
160591649|NCT01253187|579882772|FG004|Period 3|difficulty with blood sampling|0|||
160591650|NCT01253187|579882773|FG005|Period 3|difficulty with blood sampling|0|||
160591651|NCT01253187|579882768|FG000|Period 3|non-compliance|0|||
160591652|NCT01253187|579882769|FG001|Period 3|non-compliance|0|||
160591653|NCT01253187|579882770|FG002|Period 3|non-compliance|0|||
160591654|NCT01253187|579882771|FG003|Period 3|non-compliance|0|||
160591655|NCT01253187|579882772|FG004|Period 3|non-compliance|1|||
160591656|NCT01253187|579882773|FG005|Period 3|non-compliance|0|||
160591657|NCT03569449|579882774|FG000|Overall Study|Lost to Follow-up|0|||
160591658|NCT03569449|579882775|FG001|Overall Study|Lost to Follow-up|1|||
160591659|NCT03569449|579882776|FG002|Overall Study|Lost to Follow-up|0|||
160591660|NCT03569449|579882777|FG003|Overall Study|Lost to Follow-up|2|||
160591661|NCT03569449|579882778|FG004|Overall Study|Lost to Follow-up|0|||
160591662|NCT03569449|579882779|FG005|Overall Study|Lost to Follow-up|0|||
160591663|NCT03569449|579882780|FG006|Overall Study|Lost to Follow-up|0|||
160591664|NCT03569449|579882781|FG007|Overall Study|Lost to Follow-up|0|||
160591665|NCT03569449|579882782|FG008|Overall Study|Lost to Follow-up|0|||
160591666|NCT03569449|579882783|FG009|Overall Study|Lost to Follow-up|0|||
160658273|NCT01318499|580129948|FG001|Overall Study|Adverse Event|11|||
160658274|NCT01318499|580129949|FG002|Overall Study|Adverse Event|6|||
160658275|NCT01318499|580129947|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
160591667|NCT03569449|579882784|FG010|Overall Study|Lost to Follow-up|0|||
160591668|NCT03569449|579882785|FG011|Overall Study|Lost to Follow-up|0|||
160658276|NCT01318499|580129948|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
160658277|NCT01318499|580129949|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
160658278|NCT01318499|580129947|FG000|Overall Study|Noncompliance|2|||
160658279|NCT01318499|580129948|FG001|Overall Study|Noncompliance|3|||
160591669|NCT03569449|579882786|FG012|Overall Study|Lost to Follow-up|0|||
160591670|NCT03569449|579882787|FG013|Overall Study|Lost to Follow-up|0|||
160591671|NCT03569449|579882788|FG014|Overall Study|Lost to Follow-up|1|||
160591672|NCT03569449|579882789|FG015|Overall Study|Lost to Follow-up|0|||
160591673|NCT03569449|579882774|FG000|Overall Study|Withdrawal by Subject|0|||
160591674|NCT03569449|579882775|FG001|Overall Study|Withdrawal by Subject|1|||
160591675|NCT03569449|579882776|FG002|Overall Study|Withdrawal by Subject|0|||
160658280|NCT01318499|580129949|FG002|Overall Study|Noncompliance|0|||
160658281|NCT01318499|580129947|FG000|Overall Study|Treatment Failure|19|||
160658282|NCT01318499|580129948|FG001|Overall Study|Treatment Failure|19|||
160658283|NCT01318499|580129949|FG002|Overall Study|Treatment Failure|101|||
160658284|NCT01318499|580129947|FG000|Overall Study|Protocol Violation|2|||
160658285|NCT01318499|580129948|FG001|Overall Study|Protocol Violation|4|||
160976148|NCT00439179|581302230|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
160976149|NCT02761629|581302231|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
160976150|NCT02761629|581302232|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
160976151|NCT02761629|581302231|FG000|Overall Study|Insufficient Therapeutic Response|2|||
160976152|NCT02761629|581302232|FG001|Overall Study|Insufficient Therapeutic Response|7|||
160976153|NCT02761629|581302231|FG000|Overall Study|Failure to Return|2|||
160976154|NCT02761629|581302232|FG001|Overall Study|Failure to Return|4|||
160976155|NCT02761629|581302231|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
160976156|NCT02761629|581302232|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
160976157|NCT02761629|581302231|FG000|Overall Study|Protocol Violation|2|||
160976158|NCT02761629|581302232|FG001|Overall Study|Protocol Violation|2|||
160976159|NCT02761629|581302231|FG000|Overall Study|Withdrawal by Subject|0|||
160976160|NCT02761629|581302232|FG001|Overall Study|Withdrawal by Subject|3|||
160976161|NCT02761629|581302231|FG000|Overall Study|Other|0|||
160976162|NCT02761629|581302232|FG001|Overall Study|Other|2|||
160976163|NCT02761629|581302231|FG000|Overall Study|Lost to Follow-up|4|||
160976164|NCT02761629|581302232|FG001|Overall Study|Lost to Follow-up|1|||
160976165|NCT02761629|581302231|FG000|Overall Study|Randomized But Not Treated|8|||
160976166|NCT02761629|581302232|FG001|Overall Study|Randomized But Not Treated|4|||
160976167|NCT00936221|581302239|FG000|Overall Study|Withdrawal by Subject|1|||
160976168|NCT00936221|581302240|FG001|Overall Study|Withdrawal by Subject|1|||
160976169|NCT01844115|581302243|FG000|Overall Study|Adverse Event|4|||
160976170|NCT01844115|581302244|FG001|Overall Study|Adverse Event|22|||
160976171|NCT01844115|581302243|FG000|Overall Study|Lack of Efficacy|1|||
160976172|NCT01844115|581302244|FG001|Overall Study|Lack of Efficacy|4|||
160976173|NCT01844115|581302243|FG000|Overall Study|Protocol Violation|12|||
160976174|NCT01844115|581302244|FG001|Overall Study|Protocol Violation|10|||
160976175|NCT01844115|581302243|FG000|Overall Study|Withdrawal by Subject|11|||
160976176|NCT01844115|581302244|FG001|Overall Study|Withdrawal by Subject|11|||
160976177|NCT01844115|581302243|FG000|Overall Study|Lost to Follow-up|11|||
160976178|NCT01844115|581302244|FG001|Overall Study|Lost to Follow-up|10|||
160976179|NCT01844115|581302243|FG000|Overall Study|Pregnancy|0|||
160976180|NCT01844115|581302244|FG001|Overall Study|Pregnancy|1|||
160976181|NCT00545363|581302245|FG000|Overall Study|Adverse Event|6|||
160976182|NCT00545363|581302246|FG001|Overall Study|Adverse Event|7|||
160976183|NCT00545363|581302245|FG000|Overall Study|Withdrawal by Subject|6|||
160976184|NCT00545363|581302246|FG001|Overall Study|Withdrawal by Subject|5|||
160976185|NCT00545363|581302245|FG000|Overall Study|Non-compliance|3|||
160976186|NCT00545363|581302246|FG001|Overall Study|Non-compliance|1|||
160976187|NCT00545363|581302245|FG000|Overall Study|Did not meet entry criteria|1|||
160976188|NCT00545363|581302246|FG001|Overall Study|Did not meet entry criteria|1|||
160976189|NCT00545363|581302245|FG000|Overall Study|Lost to Follow-up|2|||
160976190|NCT00545363|581302246|FG001|Overall Study|Lost to Follow-up|0|||
160976191|NCT00545363|581302245|FG000|Overall Study|Other|1|||
160976192|NCT00545363|581302246|FG001|Overall Study|Other|1|||
160976193|NCT02153359|581302247|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
160976194|NCT02153359|581302248|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
160976195|NCT01775930|581302249|FG000|Overall Study|Futility stopping boundary met|1|||
160976196|NCT01208415|581302250|FG000|Overall Study|Death|1|||
160976197|NCT01208415|581302250|FG000|Overall Study|Lost to Follow-up|2|||
160976198|NCT01208415|581302250|FG000|Overall Study|Withdrawal by Subject|3|||
160976199|NCT01208415|581302250|FG000|Overall Study|Device not placed|1|||
160976200|NCT01208415|581302250|FG000|Overall Study|Still be eligible for follow-up|33|||
160976201|NCT02340520|581302251|FG000|Overall Study|Lost to Follow-up|1|||
160976202|NCT02340520|581302251|FG000|Overall Study|Patient did not take drug as specified|1|||
160976203|NCT02340520|581302251|FG000|Overall Study|Withdrawal by Subject|1|||
160976204|NCT01586338|581302253|FG000|Overall Study|Adverse Event|3|||
160976205|NCT01586338|581302253|FG000|Overall Study|Lost to Follow-up|1|||
160976206|NCT01586338|581302253|FG000|Overall Study|Withdrawal by participant|3|||
160976207|NCT01586338|581302253|FG000|Overall Study|Other|1|||
160976208|NCT01868074|581302258|FG000|Overall Study|Lost to Follow-up|3|||
160976209|NCT01868074|581302259|FG001|Overall Study|Lost to Follow-up|2|||
160976210|NCT01868074|581302258|FG000|Overall Study|Withdrawal by Subject|4|||
160976211|NCT01868074|581302259|FG001|Overall Study|Withdrawal by Subject|2|||
160976212|NCT03306043|581302260|FG000|Overall Study|Adverse Event|1|||
160976213|NCT03306043|581302260|FG000|Overall Study|Lost to Follow-up|1|||
160976214|NCT03306043|581302260|FG000|Overall Study|Withdrawal by Subject|2|||
160976215|NCT02494206|581302261|FG000|Overall Study|Adverse Event|1|||
160976216|NCT02494206|581302261|FG000|Overall Study|Disease Progression|1|||
160976217|NCT01013792|581302262|FG000|Overall Study|Study suspended|2|||
160976218|NCT01013792|581302263|FG001|Overall Study|Study suspended|1|||
160976219|NCT01013792|581302262|FG000|Overall Study|Adverse Event|0|||
160460220|NCT03248479|579417573|FG005|Overall Study|Not reported|0|||
160591676|NCT03569449|579882777|FG003|Overall Study|Withdrawal by Subject|0|||
160591677|NCT03569449|579882778|FG004|Overall Study|Withdrawal by Subject|1|||
160591678|NCT03569449|579882779|FG005|Overall Study|Withdrawal by Subject|0|||
160591679|NCT03569449|579882780|FG006|Overall Study|Withdrawal by Subject|0|||
160976220|NCT01013792|581302263|FG001|Overall Study|Adverse Event|3|||
160976221|NCT01013792|581302262|FG000|Overall Study|Lost to Follow-up|0|||
160976222|NCT01013792|581302263|FG001|Overall Study|Lost to Follow-up|1|||
160976223|NCT01234649|581302264|FG000|Overall Study|Withdrawal by Subject|32|||
160976224|NCT01234649|581302265|FG001|Overall Study|Withdrawal by Subject|26|||
160976225|NCT01234649|581302264|FG000|Overall Study|Pregnancy|6|||
160976226|NCT01234649|581302265|FG001|Overall Study|Pregnancy|6|||
160976227|NCT01234649|581302264|FG000|Overall Study|intolerant to side effects|4|||
160976228|NCT01234649|581302265|FG001|Overall Study|intolerant to side effects|3|||
160976229|NCT01234649|581302264|FG000|Overall Study|Allergic reaction|1|||
160976230|NCT01234649|581302265|FG001|Overall Study|Allergic reaction|0|||
160591680|NCT03569449|579882781|FG007|Overall Study|Withdrawal by Subject|0|||
160591681|NCT03569449|579882782|FG008|Overall Study|Withdrawal by Subject|0|||
160591682|NCT03569449|579882783|FG009|Overall Study|Withdrawal by Subject|0|||
160591683|NCT03569449|579882784|FG010|Overall Study|Withdrawal by Subject|0|||
160591684|NCT03569449|579882785|FG011|Overall Study|Withdrawal by Subject|0|||
160591685|NCT03569449|579882786|FG012|Overall Study|Withdrawal by Subject|0|||
160591686|NCT03569449|579882787|FG013|Overall Study|Withdrawal by Subject|0|||
160591687|NCT03569449|579882788|FG014|Overall Study|Withdrawal by Subject|0|||
160591688|NCT03569449|579882789|FG015|Overall Study|Withdrawal by Subject|0|||
160591689|NCT04124692|579882790|FG000|Overall Study|Medical reason|0|||
160591690|NCT04124692|579882791|FG001|Overall Study|Medical reason|1|||
160591691|NCT04124692|579882790|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
160591692|NCT04124692|579882791|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
160591693|NCT04124692|579882790|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
160591694|NCT04124692|579882791|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
160591695|NCT04124692|579882790|FG000|Overall Study|Lost to Follow-up|2|||
160591696|NCT04124692|579882791|FG001|Overall Study|Lost to Follow-up|4|||
160658286|NCT01318499|580129949|FG002|Overall Study|Protocol Violation|2|||
160976231|NCT01234649|581302264|FG000|Overall Study|Lack of Efficacy|0|||
160976232|NCT01234649|581302265|FG001|Overall Study|Lack of Efficacy|3|||
160976233|NCT01461993|581302266|FG000|Overall Study|Withdrawal by Subject|60|||
160591697|NCT04124692|579882790|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
160591698|NCT04124692|579882791|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
160591699|NCT05279898|579882800|FG000|Overall Study|Withdrawal by Subject|1|||
160591700|NCT05279898|579882801|FG001|Overall Study|Withdrawal by Subject|0|||
160591701|NCT05279898|579882800|FG000|Overall Study|Physician Decision|1|||
160591702|NCT05279898|579882801|FG001|Overall Study|Physician Decision|1|||
160591703|NCT05136170|579882802|FG000|Overall Study|Withdrawal by Subject|2|||
160591704|NCT05136170|579882803|FG001|Overall Study|Withdrawal by Subject|2|||
160591705|NCT05136170|579882802|FG000|Overall Study|Can no longer make office visits|1|||
160591706|NCT05136170|579882803|FG001|Overall Study|Can no longer make office visits|0|||
160591707|NCT04393038|579882804|FG000|Overall Study|Adverse Event|11|||
160591708|NCT04393038|579882805|FG001|Overall Study|Adverse Event|2|||
160591709|NCT04393038|579882804|FG000|Overall Study|Protocol Violation|1|||
160591710|NCT04393038|579882805|FG001|Overall Study|Protocol Violation|0|||
160591711|NCT04393038|579882804|FG000|Overall Study|Death|6|||
160591712|NCT04393038|579882805|FG001|Overall Study|Death|4|||
160591713|NCT04393038|579882804|FG000|Overall Study|Withdrawal by Subject|24|||
160591714|NCT04393038|579882805|FG001|Overall Study|Withdrawal by Subject|8|||
160591715|NCT04393038|579882804|FG000|Overall Study|Lost to Follow-up|5|||
160591716|NCT04393038|579882805|FG001|Overall Study|Lost to Follow-up|4|||
160591717|NCT04393038|579882804|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
160632913|NCT02575807|580036105|FG001|Overall Study|Study terminated by Sponsor|1|||
160591718|NCT04393038|579882805|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
160591719|NCT04393038|579882804|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
160591720|NCT04393038|579882805|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
160591721|NCT05168813|579882806|FG000|Part A (Open-label)|Lost to Follow-up|21|||
160591722|NCT05168813|579882807|FG001|Part A (Open-label)|Lost to Follow-up|39|||
160591723|NCT05168813|579882808|FG002|Part A (Open-label)|Lost to Follow-up|8|||
160591724|NCT05168813|579882809|FG003|Part A (Open-label)|Lost to Follow-up|26|||
160591725|NCT05168813|579882810|FG004|Part A (Open-label)|Lost to Follow-up|0|||
160591726|NCT05168813|579882811|FG005|Part A (Open-label)|Lost to Follow-up|0|||
160591727|NCT05168813|579882806|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
160591728|NCT05168813|579882807|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
160591729|NCT05168813|579882808|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
160591730|NCT05168813|579882809|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
160591731|NCT05168813|579882810|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
160591732|NCT05168813|579882811|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
160591733|NCT05168813|579882806|FG000|Part A (Open-label)|Death|23|||
160591734|NCT05168813|579882807|FG001|Part A (Open-label)|Death|28|||
160591735|NCT05168813|579882808|FG002|Part A (Open-label)|Death|1|||
160591736|NCT05168813|579882809|FG003|Part A (Open-label)|Death|9|||
160591737|NCT05168813|579882810|FG004|Part A (Open-label)|Death|0|||
160591738|NCT05168813|579882811|FG005|Part A (Open-label)|Death|0|||
160591739|NCT05168813|579882806|FG000|Part A (Open-label)|Physician Decision|0|||
160591740|NCT05168813|579882807|FG001|Part A (Open-label)|Physician Decision|1|||
160591741|NCT05168813|579882808|FG002|Part A (Open-label)|Physician Decision|0|||
160591742|NCT05168813|579882809|FG003|Part A (Open-label)|Physician Decision|2|||
160591743|NCT05168813|579882810|FG004|Part A (Open-label)|Physician Decision|0|||
160591744|NCT05168813|579882811|FG005|Part A (Open-label)|Physician Decision|0|||
160591745|NCT05168813|579882806|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
160591746|NCT05168813|579882807|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
160591747|NCT05168813|579882808|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
160591748|NCT05168813|579882809|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
160591749|NCT05168813|579882810|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
160591750|NCT05168813|579882811|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
160591751|NCT05168813|579882806|FG000|Part A (Open-label)|Protocol Violation|0|||
160591752|NCT05168813|579882807|FG001|Part A (Open-label)|Protocol Violation|1|||
160591753|NCT05168813|579882808|FG002|Part A (Open-label)|Protocol Violation|0|||
160591754|NCT05168813|579882809|FG003|Part A (Open-label)|Protocol Violation|0|||
160591755|NCT05168813|579882810|FG004|Part A (Open-label)|Protocol Violation|0|||
160591756|NCT05168813|579882811|FG005|Part A (Open-label)|Protocol Violation|0|||
160591757|NCT05168813|579882806|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
160591758|NCT05168813|579882807|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
160591759|NCT05168813|579882808|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
160591760|NCT05168813|579882809|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
160591761|NCT05168813|579882810|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
160591762|NCT05168813|579882811|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
160591763|NCT05168813|579882806|FG000|Part A (Open-label)|Other|0|||
160591764|NCT05168813|579882807|FG001|Part A (Open-label)|Other|1|||
160591765|NCT05168813|579882808|FG002|Part A (Open-label)|Other|0|||
160591766|NCT05168813|579882809|FG003|Part A (Open-label)|Other|0|||
160591767|NCT05168813|579882810|FG004|Part A (Open-label)|Other|0|||
160591768|NCT05168813|579882811|FG005|Part A (Open-label)|Other|0|||
160591769|NCT05168813|579882806|FG000|Part B (Blinded)|Lost to Follow-up|0|||
160591770|NCT05168813|579882807|FG001|Part B (Blinded)|Lost to Follow-up|0|||
160591771|NCT05168813|579882808|FG002|Part B (Blinded)|Lost to Follow-up|0|||
160591772|NCT05168813|579882809|FG003|Part B (Blinded)|Lost to Follow-up|0|||
160591773|NCT05168813|579882810|FG004|Part B (Blinded)|Lost to Follow-up|219|||
160591774|NCT05168813|579882811|FG005|Part B (Blinded)|Lost to Follow-up|88|||
160591775|NCT05168813|579882806|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
160591776|NCT05168813|579882807|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
160591777|NCT05168813|579882808|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
160591778|NCT05168813|579882809|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
160591779|NCT05168813|579882810|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
160591780|NCT05168813|579882811|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
160591781|NCT05168813|579882806|FG000|Part B (Blinded)|Death|0|||
160591782|NCT05168813|579882807|FG001|Part B (Blinded)|Death|0|||
160591783|NCT05168813|579882808|FG002|Part B (Blinded)|Death|0|||
160591784|NCT05168813|579882809|FG003|Part B (Blinded)|Death|0|||
160591785|NCT05168813|579882810|FG004|Part B (Blinded)|Death|63|||
160591786|NCT05168813|579882811|FG005|Part B (Blinded)|Death|19|||
160591787|NCT05168813|579882806|FG000|Part B (Blinded)|Physician Decision|0|||
160591788|NCT05168813|579882807|FG001|Part B (Blinded)|Physician Decision|0|||
160591789|NCT05168813|579882808|FG002|Part B (Blinded)|Physician Decision|0|||
160591790|NCT05168813|579882809|FG003|Part B (Blinded)|Physician Decision|0|||
160591791|NCT05168813|579882810|FG004|Part B (Blinded)|Physician Decision|6|||
160591792|NCT05168813|579882811|FG005|Part B (Blinded)|Physician Decision|1|||
160591793|NCT05168813|579882806|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
160591794|NCT05168813|579882807|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
160591795|NCT05168813|579882808|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
160591796|NCT05168813|579882809|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
160591797|NCT05168813|579882810|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
160591798|NCT05168813|579882811|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
160591799|NCT05168813|579882806|FG000|Part B (Blinded)|Pregnancy|0|||
160591800|NCT05168813|579882807|FG001|Part B (Blinded)|Pregnancy|0|||
160591801|NCT05168813|579882808|FG002|Part B (Blinded)|Pregnancy|0|||
160591802|NCT05168813|579882809|FG003|Part B (Blinded)|Pregnancy|0|||
160591803|NCT05168813|579882810|FG004|Part B (Blinded)|Pregnancy|1|||
160591804|NCT05168813|579882811|FG005|Part B (Blinded)|Pregnancy|0|||
160591805|NCT05168813|579882806|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
160591806|NCT05168813|579882807|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
160591807|NCT05168813|579882808|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
160591808|NCT05168813|579882809|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
160591809|NCT05168813|579882810|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
160591810|NCT05168813|579882811|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
160591811|NCT05168813|579882806|FG000|Part B (Blinded)|Other|0|||
160591812|NCT05168813|579882807|FG001|Part B (Blinded)|Other|0|||
160591813|NCT05168813|579882808|FG002|Part B (Blinded)|Other|0|||
160591814|NCT05168813|579882809|FG003|Part B (Blinded)|Other|0|||
160591815|NCT05168813|579882810|FG004|Part B (Blinded)|Other|41|||
160591816|NCT05168813|579882811|FG005|Part B (Blinded)|Other|27|||
160591817|NCT01207388|579882813|FG000|Overall Study|Death|67|||
160591818|NCT01207388|579882813|FG000|Overall Study|Withdrawal by Subject|1|||
160591819|NCT02680587|579882814|FG000|Overall Study|Withdrawal by Subject|1|||
160591820|NCT02680587|579882815|FG001|Overall Study|Withdrawal by Subject|0|||
160591821|NCT00571688|579882819|FG000|Overall Study|Lost to Follow-up|3|||
160591822|NCT00571688|579882820|FG001|Overall Study|Lost to Follow-up|6|||
160591823|NCT00571688|579882819|FG000|Overall Study|subject did not tolerate Consta|1|||
160460221|NCT03248479|579417574|FG006|Overall Study|Not reported|0|||
160591824|NCT00571688|579882820|FG001|Overall Study|subject did not tolerate Consta|0|||
160591825|NCT00571688|579882819|FG000|Overall Study|subject moved out of the area|1|||
160591826|NCT00571688|579882820|FG001|Overall Study|subject moved out of the area|0|||
160591827|NCT03224104|579882827|FG000|Overall Study|Lack of Efficacy|2|||
160591828|NCT03224104|579882828|FG001|Overall Study|Lack of Efficacy|6|||
160591829|NCT03224104|579882829|FG002|Overall Study|Lack of Efficacy|3|||
160591830|NCT03224104|579882830|FG003|Overall Study|Lack of Efficacy|4|||
160591831|NCT03224104|579882831|FG004|Overall Study|Lack of Efficacy|42|||
160591832|NCT03224104|579882827|FG000|Overall Study|Withdrawal by Subject|0|||
160591833|NCT03224104|579882828|FG001|Overall Study|Withdrawal by Subject|2|||
160591834|NCT03224104|579882829|FG002|Overall Study|Withdrawal by Subject|0|||
160591835|NCT03224104|579882830|FG003|Overall Study|Withdrawal by Subject|1|||
160591836|NCT03224104|579882831|FG004|Overall Study|Withdrawal by Subject|3|||
160591837|NCT03224104|579882827|FG000|Overall Study|Death|0|||
160591838|NCT03224104|579882828|FG001|Overall Study|Death|1|||
160591839|NCT03224104|579882829|FG002|Overall Study|Death|0|||
160591840|NCT03224104|579882830|FG003|Overall Study|Death|0|||
160591841|NCT03224104|579882831|FG004|Overall Study|Death|0|||
160591842|NCT03224104|579882827|FG000|Overall Study|Adverse Event|1|||
160591843|NCT03224104|579882828|FG001|Overall Study|Adverse Event|0|||
160591844|NCT03224104|579882829|FG002|Overall Study|Adverse Event|0|||
160591845|NCT03224104|579882830|FG003|Overall Study|Adverse Event|1|||
160591846|NCT03224104|579882831|FG004|Overall Study|Adverse Event|3|||
160591847|NCT03224104|579882827|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
160591848|NCT03224104|579882828|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
160591849|NCT03224104|579882829|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
160591850|NCT03224104|579882830|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
160591851|NCT03224104|579882831|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
160591852|NCT03224104|579882827|FG000|Overall Study|Treatment ongoing|0|||
160591853|NCT03224104|579882828|FG001|Overall Study|Treatment ongoing|0|||
160591854|NCT03224104|579882829|FG002|Overall Study|Treatment ongoing|0|||
160591855|NCT03224104|579882830|FG003|Overall Study|Treatment ongoing|0|||
160591856|NCT03224104|579882831|FG004|Overall Study|Treatment ongoing|1|||
160591857|NCT01577160|579882832|FG000|Overall Study|Adverse Event|9|||
160591858|NCT01577160|579882832|FG000|Overall Study|Lack of Efficacy|15|||
160591859|NCT01577160|579882832|FG000|Overall Study|Lost to Follow-up|40|||
160591860|NCT01577160|579882832|FG000|Overall Study|Withdrawal by Subject|18|||
160591861|NCT01577160|579882832|FG000|Overall Study|Subject Uncooperative|7|||
160591862|NCT01577160|579882832|FG000|Overall Study|Other|9|||
160591863|NCT01096849|579882837|FG000|Overall Study|Consent Withdrawn|1|||
160591864|NCT01096849|579882838|FG001|Overall Study|Consent Withdrawn|4|||
160591865|NCT01096849|579882839|FG002|Overall Study|Consent Withdrawn|2|||
160591866|NCT01096849|579882837|FG000|Overall Study|Lack of Efficacy|0|||
160591867|NCT01096849|579882838|FG001|Overall Study|Lack of Efficacy|2|||
160591868|NCT01096849|579882839|FG002|Overall Study|Lack of Efficacy|0|||
160591869|NCT01096849|579882837|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
160591870|NCT01096849|579882838|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
160591871|NCT01096849|579882839|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
160591872|NCT01096849|579882837|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
160591873|NCT01096849|579882838|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
160591874|NCT01096849|579882839|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
160591875|NCT01096849|579882837|FG000|Overall Study|Administrative Reasons|0|||
160591876|NCT01096849|579882838|FG001|Overall Study|Administrative Reasons|1|||
160591877|NCT01096849|579882839|FG002|Overall Study|Administrative Reasons|2|||
160591878|NCT01096849|579882837|FG000|Overall Study|Lost to Follow-up|1|||
160591879|NCT01096849|579882838|FG001|Overall Study|Lost to Follow-up|3|||
160591880|NCT01096849|579882839|FG002|Overall Study|Lost to Follow-up|1|||
160591881|NCT04146467|579882841|FG000|Overall Study|Adverse Event|0|||
160591882|NCT04146467|579882842|FG001|Overall Study|Adverse Event|1|||
160591883|NCT04146467|579882841|FG000|Overall Study|Lost to Follow-up|0|||
160591884|NCT04146467|579882842|FG001|Overall Study|Lost to Follow-up|2|||
160591885|NCT02128763|579882844|FG000|Overall Study|Death|1|||
160591886|NCT02128763|579882845|FG001|Overall Study|Death|0|||
160591887|NCT02128763|579882844|FG000|Overall Study|Lost to Follow-up|19|||
160591888|NCT02128763|579882845|FG001|Overall Study|Lost to Follow-up|16|||
160591889|NCT01253421|579882846|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
160591890|NCT01253421|579882847|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
160591891|NCT01253421|579882848|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
160591892|NCT01253421|579882849|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
160591893|NCT01253421|579882850|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
160591894|NCT01253421|579882846|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
160591895|NCT01253421|579882847|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
160591896|NCT01253421|579882848|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
160591897|NCT01253421|579882849|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
160591898|NCT01253421|579882850|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
160591899|NCT01253421|579882846|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
160658287|NCT01318499|580129947|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
160658288|NCT01318499|580129948|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
160658289|NCT01318499|580129949|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
160658290|NCT01318499|580129947|FG000|Overall Study|Other|7|||
160658291|NCT01318499|580129948|FG001|Overall Study|Other|10|||
160658292|NCT01318499|580129949|FG002|Overall Study|Other|22|||
160658293|NCT01395030|580129950|FG000|Overall Study|Did not complete FCH PET/CT|7|||
160658294|NCT00970281|580129951|FG000|Overall Study|Lack of Efficacy|1|||
160658295|NCT00970281|580129952|FG001|Overall Study|Lack of Efficacy|14|||
160658296|NCT00970281|580129951|FG000|Overall Study|Withdrawal by Subject|0|||
160658297|NCT00970281|580129952|FG001|Overall Study|Withdrawal by Subject|1|||
160658298|NCT00970281|580129951|FG000|Overall Study|Physician Decision|1|||
160658299|NCT00970281|580129952|FG001|Overall Study|Physician Decision|1|||
160658300|NCT01478620|580129958|FG000|Overall Study|Lost to Follow-up|6|||
160658301|NCT02888171|580129964|FG000|Overall Study|Lost to Follow-up|2|||
160658302|NCT02888171|580129965|FG001|Overall Study|Lost to Follow-up|1|||
160658303|NCT02888171|580129964|FG000|Overall Study|Withdrawal by Subject|3|||
160658304|NCT02888171|580129965|FG001|Overall Study|Withdrawal by Subject|2|||
160658305|NCT02888171|580129964|FG000|Overall Study|Adverse Event|0|||
160658306|NCT02888171|580129965|FG001|Overall Study|Adverse Event|1|||
160658307|NCT04032977|580131437|FG000|Overall Study|Withdrawal by Subject|6|||
160658308|NCT04032977|580131438|FG001|Overall Study|Withdrawal by Subject|1|||
160658309|NCT04032977|580131437|FG000|Overall Study|Lost to Follow-up|2|||
160658310|NCT04032977|580131438|FG001|Overall Study|Lost to Follow-up|7|||
160658311|NCT04032977|580131437|FG000|Overall Study|Pregnancy|1|||
160658312|NCT04032977|580131438|FG001|Overall Study|Pregnancy|0|||
160658313|NCT01101022|580131439|FG000|Overall Study|Adverse Event|6|||
160658314|NCT01101022|580131440|FG001|Overall Study|Adverse Event|2|||
160658315|NCT01101022|580131439|FG000|Overall Study|Protocol Violation|4|||
160658316|NCT01101022|580131440|FG001|Overall Study|Protocol Violation|3|||
160658317|NCT01101022|580131439|FG000|Overall Study|Withdrawal by Subject|3|||
160658318|NCT01101022|580131440|FG001|Overall Study|Withdrawal by Subject|8|||
160658319|NCT01101022|580131439|FG000|Overall Study|Lost to Follow-up|1|||
160658320|NCT01101022|580131440|FG001|Overall Study|Lost to Follow-up|4|||
160658321|NCT01101022|580131439|FG000|Overall Study|Lack of Efficacy|0|||
160658322|NCT01101022|580131440|FG001|Overall Study|Lack of Efficacy|7|||
160658323|NCT01101022|580131439|FG000|Overall Study|Sponsor decision|1|||
160658324|NCT01101022|580131440|FG001|Overall Study|Sponsor decision|1|||
160658325|NCT01101022|580131439|FG000|Overall Study|Non-compliance|1|||
160658326|NCT01101022|580131440|FG001|Overall Study|Non-compliance|0|||
160658327|NCT01101022|580131439|FG000|Overall Study|Work schedule|1|||
160658328|NCT01101022|580131440|FG001|Overall Study|Work schedule|1|||
160658329|NCT01101022|580131439|FG000|Overall Study|Vacation|0|||
160658330|NCT01101022|580131440|FG001|Overall Study|Vacation|1|||
160658331|NCT01519661|580131441|FG000|Overall Study|Protocol deviation|6|||
160658332|NCT01519661|580131441|FG000|Overall Study|Lost to Follow-up|3|||
160658333|NCT01519661|580131441|FG000|Overall Study|Withdrawal by Subject|17|||
160658334|NCT01519661|580131441|FG000|Overall Study|Lack of Efficacy|6|||
160591900|NCT01253421|579882847|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
160591901|NCT01253421|579882848|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
160591902|NCT01253421|579882849|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
160591903|NCT01253421|579882850|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
160591904|NCT01253421|579882846|FG000|Assessment and Scheduling|Physician Decision|1|||
160591905|NCT01253421|579882847|FG001|Assessment and Scheduling|Physician Decision|0|||
160591906|NCT01253421|579882848|FG002|Assessment and Scheduling|Physician Decision|0|||
160591907|NCT01253421|579882849|FG003|Assessment and Scheduling|Physician Decision|0|||
160591908|NCT01253421|579882850|FG004|Assessment and Scheduling|Physician Decision|0|||
160658335|NCT01519661|580131441|FG000|Overall Study|Adverse Event|29|||
160658336|NCT03075761|580131442|FG000|Overall Study|Lost to Follow-up|1|||
160658337|NCT03075761|580131443|FG001|Overall Study|Lost to Follow-up|6|||
160658338|NCT01139047|580131444|FG000|Overall Study|Withdrawal by Subject|1|||
160658339|NCT00420303|580131449|FG000|Overall Study|Serious Adverse Event|1|||
160591909|NCT01253421|579882846|FG000|Drug+Scanning Visit|Physician Decision|0|||
160591910|NCT01253421|579882847|FG001|Drug+Scanning Visit|Physician Decision|0|||
160591911|NCT01253421|579882848|FG002|Drug+Scanning Visit|Physician Decision|0|||
160591912|NCT01253421|579882849|FG003|Drug+Scanning Visit|Physician Decision|0|||
160591913|NCT01253421|579882850|FG004|Drug+Scanning Visit|Physician Decision|1|||
160658340|NCT00420303|580131450|FG001|Overall Study|Serious Adverse Event|0|||
160658341|NCT00420303|580131449|FG000|Overall Study|Lack of Efficacy|0|||
160658342|NCT00420303|580131450|FG001|Overall Study|Lack of Efficacy|3|||
160658343|NCT00420303|580131449|FG000|Overall Study|Physician Decision|0|||
160658344|NCT00420303|580131450|FG001|Overall Study|Physician Decision|1|||
160658345|NCT05628675|580131451|FG000|Overall Study|Lost to Follow-up|2|||
160658346|NCT05628675|580131451|FG000|Overall Study|Withdrawal by Subject|1|||
160658347|NCT00883090|580131452|FG000|Overall Study|Sponsor's decision|1|||
160658348|NCT00883090|580131452|FG000|Overall Study|Withdrawal by Subject|1|||
160658349|NCT01087970|580131455|FG000|Overall Study|Protocol Violation|2|||
160591914|NCT01608724|579882852|FG000|Overall Study|Withdrawal by Subject|131|||
160591915|NCT01608724|579882852|FG000|Overall Study|Lost to Follow-up|41|||
160591916|NCT01608724|579882852|FG000|Overall Study|Study-specific discontinuation criteria|32|||
160591917|NCT01608724|579882852|FG000|Overall Study|Adverse Event|29|||
160591918|NCT01608724|579882852|FG000|Overall Study|Protocol Violation|6|||
160591919|NCT01608724|579882852|FG000|Overall Study|bood sugar too high, etc.|3|||
160591920|NCT01608724|579882852|FG000|Overall Study|Safety reasons|1|||
160591921|NCT00099359|579882853|FG000|Overall Study|Death|11|||
160591922|NCT00099359|579882854|FG001|Overall Study|Death|15|||
160591923|NCT00099359|579882855|FG002|Overall Study|Death|17|||
160591924|NCT00099359|579882853|FG000|Overall Study|Withdrawal by Subject|19|||
160591925|NCT00099359|579882854|FG001|Overall Study|Withdrawal by Subject|19|||
160591926|NCT00099359|579882855|FG002|Overall Study|Withdrawal by Subject|23|||
160591927|NCT00099359|579882853|FG000|Overall Study|Lost to Follow-up|15|||
160591928|NCT00099359|579882854|FG001|Overall Study|Lost to Follow-up|24|||
160591929|NCT00099359|579882855|FG002|Overall Study|Lost to Follow-up|24|||
160591930|NCT00099359|579882853|FG000|Overall Study|moved out of area|9|||
160591931|NCT00099359|579882854|FG001|Overall Study|moved out of area|7|||
160591932|NCT00099359|579882855|FG002|Overall Study|moved out of area|4|||
160591933|NCT00717366|579882856|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
160591934|NCT00717366|579882857|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
160591935|NCT00717366|579882856|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
160591936|NCT00717366|579882857|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
160591937|NCT00717366|579882856|FG000|Core Study Period (20 Weeks)|Death|0|||
160591938|NCT00717366|579882857|FG001|Core Study Period (20 Weeks)|Death|1|||
160591939|NCT00717366|579882856|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
160591940|NCT00717366|579882857|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
160591941|NCT00717366|579882856|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
160591942|NCT00717366|579882857|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
160591943|NCT00717366|579882856|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
160591944|NCT00717366|579882857|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
160591945|NCT00717366|579882856|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
160591946|NCT00717366|579882857|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
160591947|NCT01778127|579882860|FG000|Overall Study|Lost to Follow-up|5|||
160591948|NCT01778127|579882861|FG001|Overall Study|Lost to Follow-up|1|||
160591949|NCT01778127|579882862|FG002|Overall Study|Lost to Follow-up|2|||
160591950|NCT01778127|579882860|FG000|Overall Study|Withdrawal by Subject|3|||
160591951|NCT01778127|579882861|FG001|Overall Study|Withdrawal by Subject|1|||
160591952|NCT01778127|579882862|FG002|Overall Study|Withdrawal by Subject|4|||
160591953|NCT01348425|579882863|FG000|Overall Study|Imaging was not taken.|1|||
160591954|NCT01348425|579882864|FG001|Overall Study|Imaging was not taken.|1|||
160591955|NCT01968954|579882873|FG000|Overall Study|Adverse Event|6|||
160591956|NCT01968954|579882874|FG001|Overall Study|Adverse Event|3|||
160591957|NCT01968954|579882873|FG000|Overall Study|Death|1|||
160591958|NCT01968954|579882874|FG001|Overall Study|Death|2|||
160591959|NCT01968954|579882873|FG000|Overall Study|Lost to Follow-up|6|||
160591960|NCT01968954|579882874|FG001|Overall Study|Lost to Follow-up|4|||
160591961|NCT01968954|579882873|FG000|Overall Study|Withdrawal by Subject|20|||
160591962|NCT01968954|579882874|FG001|Overall Study|Withdrawal by Subject|23|||
160591963|NCT01968954|579882873|FG000|Overall Study|Other|7|||
160591964|NCT01968954|579882874|FG001|Overall Study|Other|8|||
160591965|NCT01968954|579882873|FG000|Overall Study|Protocol Violation|0|||
160591966|NCT01968954|579882874|FG001|Overall Study|Protocol Violation|1|||
160591967|NCT01968954|579882873|FG000|Overall Study|Did not met inclusion criteria|0|||
160591968|NCT01968954|579882874|FG001|Overall Study|Did not met inclusion criteria|2|||
160591969|NCT00645567|579882876|FG000|Overall Study|Adverse Event|1|||
160591970|NCT00434122|579882881|FG000|Overall Study|Non-compliance with protocol|0|||
160591971|NCT00434122|579882882|FG001|Overall Study|Non-compliance with protocol|1|||
160591972|NCT00434122|579882881|FG000|Overall Study|loss of subject contact|1|||
160591973|NCT00434122|579882882|FG001|Overall Study|loss of subject contact|1|||
160591974|NCT00434122|579882881|FG000|Overall Study|Personal reasons|1|||
160591975|NCT00434122|579882882|FG001|Overall Study|Personal reasons|1|||
160591976|NCT00434122|579882881|FG000|Overall Study|Large follicle size|2|||
160591977|NCT00434122|579882882|FG001|Overall Study|Large follicle size|2|||
160591978|NCT00434122|579882881|FG000|Overall Study|Low follicular response.|1|||
160591979|NCT00434122|579882882|FG001|Overall Study|Low follicular response.|2|||
160591980|NCT00434122|579882881|FG000|Overall Study|Travelling of subject.|1|||
160658350|NCT01991470|580131456|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
160658351|NCT01991470|580131456|FG000|Enlite 1 Period|Adverse Event|1|||
160658352|NCT01991470|580131456|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
160658353|NCT01991470|580131456|FG000|Enlite 3 Period|Lost to Follow-up|1|||
160658354|NCT01991470|580131456|FG000|Enlite 3 Period|Physician Decision|2|||
160658355|NCT01991470|580131456|FG000|Enlite 3 Period|Physician Decision|8|||
160658356|NCT01991470|580131456|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
160658357|NCT02896361|580131457|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
160591981|NCT00434122|579882882|FG001|Overall Study|Travelling of subject.|0|||
160591982|NCT00255086|579882883|FG000|Overall Study|Adverse Event|1|||
160591983|NCT00255086|579882884|FG001|Overall Study|Adverse Event|1|||
160591984|NCT00255086|579882883|FG000|Overall Study|Protocol Violation|1|||
160591985|NCT00255086|579882884|FG001|Overall Study|Protocol Violation|1|||
160591986|NCT01963208|579882886|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
160591987|NCT01963208|579882887|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
160591988|NCT01963208|579882888|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
160591989|NCT01963208|579882889|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
160591990|NCT01963208|579882890|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
160591991|NCT01963208|579882891|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
160591992|NCT01963208|579882886|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
160591993|NCT01963208|579882887|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
160591994|NCT01963208|579882888|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
160591995|NCT01963208|579882889|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
160591996|NCT01963208|579882890|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
160591997|NCT01963208|579882891|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
160591998|NCT01963208|579882886|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
160591999|NCT01963208|579882887|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
160592000|NCT01963208|579882888|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
160592001|NCT01963208|579882889|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
160592002|NCT01963208|579882890|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
160592003|NCT01963208|579882891|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
160592004|NCT01963208|579882886|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
160592005|NCT01963208|579882887|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
160592006|NCT01963208|579882888|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
160658358|NCT02896361|580131458|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
160976234|NCT01461993|581302267|FG001|Overall Study|Withdrawal by Subject|53|||
160592007|NCT01963208|579882889|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
160592008|NCT01963208|579882890|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
160592009|NCT01963208|579882891|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
160592010|NCT01963208|579882886|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
160592011|NCT01963208|579882887|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
160592012|NCT01963208|579882888|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
160592013|NCT01963208|579882889|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
160592014|NCT01963208|579882890|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
160658359|NCT02896361|580131459|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
160976235|NCT01461993|581302268|FG002|Overall Study|Withdrawal by Subject|16|||
160976236|NCT01461993|581302266|FG000|Overall Study|Lost to Follow-up|44|||
160976237|NCT01461993|581302267|FG001|Overall Study|Lost to Follow-up|48|||
160976238|NCT01461993|581302268|FG002|Overall Study|Lost to Follow-up|22|||
160976239|NCT01461993|581302266|FG000|Overall Study|Protocol Violation|10|||
160976240|NCT01461993|581302267|FG001|Overall Study|Protocol Violation|9|||
160976241|NCT01461993|581302268|FG002|Overall Study|Protocol Violation|7|||
160658360|NCT02896361|580131457|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
160658361|NCT02896361|580131458|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
160658362|NCT02896361|580131459|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
160658363|NCT00274937|580131460|FG000|Overall Study|Physician Decision|10|||
160658364|NCT00274937|580131460|FG000|Overall Study|Withdrawal by Subject|6|||
160658365|NCT00274937|580131460|FG000|Overall Study|Progressive Disease|4|||
160658366|NCT02932878|580131464|FG000|Overall Study|Due to Lab Results|2|||
160658367|NCT02932878|580131465|FG001|Overall Study|Due to Lab Results|1|||
160658368|NCT00849901|580131466|FG000|Acute Treatment Phase|Adverse Event|9|||
160658369|NCT00849901|580131467|FG001|Acute Treatment Phase|Adverse Event|1|||
160658370|NCT00849901|580131468|FG002|Acute Treatment Phase|Adverse Event|3|||
160658371|NCT00849901|580131466|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
160658372|NCT00849901|580131467|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
160658373|NCT00849901|580131468|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
160658374|NCT00849901|580131466|FG000|Acute Treatment Phase|Protocol Violation|0|||
160658375|NCT00849901|580131467|FG001|Acute Treatment Phase|Protocol Violation|2|||
160658376|NCT00849901|580131468|FG002|Acute Treatment Phase|Protocol Violation|1|||
160658377|NCT00849901|580131466|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
160658378|NCT00849901|580131467|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
160658379|NCT00849901|580131468|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
160658380|NCT00849901|580131466|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
160658381|NCT00849901|580131467|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
160658382|NCT00849901|580131468|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
160658383|NCT00849901|580131466|FG000|Acute Treatment Phase|Physician Decision|1|||
160658384|NCT00849901|580131467|FG001|Acute Treatment Phase|Physician Decision|1|||
160658385|NCT00849901|580131468|FG002|Acute Treatment Phase|Physician Decision|1|||
160658386|NCT00849901|580131466|FG000|Acute Treatment Phase|Sponsor Decision|1|||
160658387|NCT00849901|580131467|FG001|Acute Treatment Phase|Sponsor Decision|0|||
160658388|NCT00849901|580131468|FG002|Acute Treatment Phase|Sponsor Decision|0|||
160658389|NCT00849901|580131466|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
160658390|NCT00849901|580131467|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
160658391|NCT00849901|580131468|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
160658392|NCT00849901|580131466|FG000|Extension Phase|Adverse Event|2|||
160658393|NCT00849901|580131467|FG001|Extension Phase|Adverse Event|8|||
160658394|NCT00849901|580131468|FG002|Extension Phase|Adverse Event|4|||
160658395|NCT00849901|580131466|FG000|Extension Phase|Lost to Follow-up|3|||
160658396|NCT00849901|580131467|FG001|Extension Phase|Lost to Follow-up|0|||
160658397|NCT00849901|580131468|FG002|Extension Phase|Lost to Follow-up|1|||
160658398|NCT00849901|580131466|FG000|Extension Phase|Protocol Violation|2|||
160658399|NCT00849901|580131467|FG001|Extension Phase|Protocol Violation|2|||
160658400|NCT00849901|580131468|FG002|Extension Phase|Protocol Violation|4|||
160658401|NCT00849901|580131466|FG000|Extension Phase|Withdrawal by Subject|7|||
160976242|NCT01461993|581302266|FG000|Overall Study|Adverse Event|9|||
160976243|NCT01461993|581302267|FG001|Overall Study|Adverse Event|11|||
160976244|NCT01461993|581302268|FG002|Overall Study|Adverse Event|3|||
160976245|NCT01461993|581302266|FG000|Overall Study|No longer met eligibility criteria|13|||
160976246|NCT01461993|581302267|FG001|Overall Study|No longer met eligibility criteria|18|||
160976247|NCT01461993|581302268|FG002|Overall Study|No longer met eligibility criteria|10|||
160976248|NCT01461993|581302266|FG000|Overall Study|Did not meet entrance criteria|2|||
160976249|NCT01461993|581302267|FG001|Overall Study|Did not meet entrance criteria|3|||
160976250|NCT01461993|581302268|FG002|Overall Study|Did not meet entrance criteria|0|||
160976251|NCT01461993|581302266|FG000|Overall Study|Other|13|||
160976252|NCT01461993|581302267|FG001|Overall Study|Other|15|||
160976253|NCT01461993|581302268|FG002|Overall Study|Other|6|||
160976254|NCT01121484|581302270|FG000|Overall Study|Adverse Event|12|||
160976255|NCT01121484|581302271|FG001|Overall Study|Adverse Event|5|||
160976256|NCT01121484|581302270|FG000|Overall Study|Lack of Efficacy|3|||
160976257|NCT01121484|581302271|FG001|Overall Study|Lack of Efficacy|11|||
160976258|NCT01121484|581302270|FG000|Overall Study|Lost to Follow-up|5|||
160976259|NCT01121484|581302271|FG001|Overall Study|Lost to Follow-up|9|||
160976260|NCT01121484|581302270|FG000|Overall Study|Physician Decision|0|||
160976261|NCT01121484|581302271|FG001|Overall Study|Physician Decision|3|||
160976262|NCT01121484|581302270|FG000|Overall Study|Protocol Violation|1|||
160976263|NCT01121484|581302271|FG001|Overall Study|Protocol Violation|0|||
160976264|NCT01121484|581302270|FG000|Overall Study|Withdrawal by Subject|8|||
160976265|NCT01121484|581302271|FG001|Overall Study|Withdrawal by Subject|7|||
160976266|NCT01121484|581302270|FG000|Overall Study|Discontinuation of study by sponsor|0|||
160976267|NCT01121484|581302271|FG001|Overall Study|Discontinuation of study by sponsor|1|||
160976268|NCT01121484|581302270|FG000|Overall Study|Other|3|||
160976269|NCT01121484|581302271|FG001|Overall Study|Other|3|||
160976270|NCT01121484|581302270|FG000|Overall Study|Randomized, not treated|1|||
160976271|NCT01121484|581302271|FG001|Overall Study|Randomized, not treated|4|||
160976272|NCT06390826|581302272|FG000|Overall Study|Never Start Protocol Therapy|1|||
160976273|NCT06390826|581302272|FG000|Overall Study|Adverse Event|1|||
160976274|NCT06390826|581302272|FG000|Overall Study|Disease Progression|8|||
160976275|NCT05229653|581302273|FG000|Overall Study|Lost to Follow-up|1|||
160592015|NCT01963208|579882891|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
160592016|NCT01963208|579882886|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
160592017|NCT01963208|579882887|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
160592018|NCT01963208|579882888|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
160592019|NCT01963208|579882889|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
160592020|NCT01963208|579882890|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
160592021|NCT01963208|579882891|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
160592022|NCT01963208|579882886|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
160592023|NCT01963208|579882887|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
160592024|NCT01963208|579882888|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
160592025|NCT01963208|579882889|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
160592026|NCT01963208|579882890|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
160592027|NCT01963208|579882891|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
160592028|NCT01963208|579882886|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
160592029|NCT01963208|579882887|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
160592030|NCT01963208|579882888|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
160592031|NCT01963208|579882889|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
160592032|NCT01963208|579882890|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
160592033|NCT01963208|579882891|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
160592034|NCT01963208|579882886|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
160592035|NCT01963208|579882887|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
160592036|NCT01963208|579882888|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
160592037|NCT01963208|579882889|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
160592038|NCT01963208|579882890|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
160460222|NCT03248479|579417575|FG007|Overall Study|Not reported|1|||
160460223|NCT03248479|579417576|FG008|Overall Study|Not reported|1|||
160460224|NCT03248479|579417577|FG009|Overall Study|Not reported|0|||
160460225|NCT03248479|579417578|FG010|Overall Study|Not reported|0|||
160460226|NCT03248479|579417579|FG011|Overall Study|Not reported|0|||
160460227|NCT03248479|579417580|FG012|Overall Study|Not reported|0|||
160460228|NCT06065735|579417581|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
160460229|NCT06065735|579417582|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
160460230|NCT06065735|579417583|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
160460231|NCT06065735|579417581|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
160460232|NCT06065735|579417582|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
160460233|NCT06065735|579417583|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
160460234|NCT06065735|579417581|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
160460235|NCT06065735|579417582|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
160592039|NCT01963208|579882891|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
160592040|NCT01963208|579882886|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
160592041|NCT01963208|579882887|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
160592042|NCT01963208|579882888|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
160592043|NCT01963208|579882889|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
160592044|NCT01963208|579882890|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
160592045|NCT01963208|579882891|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
160592046|NCT01963208|579882886|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
160592047|NCT01963208|579882887|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
160592048|NCT01963208|579882888|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
160592049|NCT01963208|579882889|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
160592050|NCT01963208|579882890|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
160592051|NCT01963208|579882891|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
160592052|NCT01963208|579882886|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
160592053|NCT01963208|579882887|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
160592054|NCT01963208|579882888|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
160592055|NCT01963208|579882889|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
160592056|NCT01963208|579882890|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
160976276|NCT05229653|581302274|FG001|Overall Study|Lost to Follow-up|0|||
160976277|NCT03915951|581302275|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
160976278|NCT03915951|581302276|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
160976279|NCT03915951|581302275|FG000|Overall Study|Adverse Event|12|||
160976280|NCT03915951|581302276|FG001|Overall Study|Adverse Event|6|||
160976281|NCT03915951|581302275|FG000|Overall Study|Disease progression (radiological)|17|||
160976282|NCT03915951|581302276|FG001|Overall Study|Disease progression (radiological)|15|||
160976283|NCT03915951|581302275|FG000|Overall Study|Disease progression (clinical)|4|||
160976284|NCT03915951|581302276|FG001|Overall Study|Disease progression (clinical)|1|||
160976285|NCT03915951|581302275|FG000|Overall Study|Patient decision|0|||
160976286|NCT03915951|581302276|FG001|Overall Study|Patient decision|4|||
160976287|NCT03915951|581302275|FG000|Overall Study|Investigator decision|0|||
160976288|NCT03915951|581302276|FG001|Overall Study|Investigator decision|1|||
160976289|NCT03915951|581302275|FG000|Overall Study|Consent withdrawn|1|||
160976290|NCT03915951|581302276|FG001|Overall Study|Consent withdrawn|1|||
160976291|NCT03915951|581302275|FG000|Overall Study|Death|0|||
160976292|NCT03915951|581302276|FG001|Overall Study|Death|3|||
160976293|NCT05408468|581302277|FG000|Overall Study|Lost to Follow-up|3|||
160976294|NCT05408468|581302278|FG001|Overall Study|Lost to Follow-up|1|||
160976295|NCT05408468|581302277|FG000|Overall Study|Physician Decision|1|||
160976296|NCT05408468|581302278|FG001|Overall Study|Physician Decision|0|||
160976297|NCT05408468|581302277|FG000|Overall Study|Overwhelmed by clinical situation|3|||
160976298|NCT05408468|581302278|FG001|Overall Study|Overwhelmed by clinical situation|0|||
160976299|NCT05408468|581302277|FG000|Overall Study|Personal illness precluding participation|1|||
160976300|NCT05408468|581302278|FG001|Overall Study|Personal illness precluding participation|0|||
160976301|NCT05408468|581302277|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
160976302|NCT05408468|581302278|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
160976303|NCT02204579|581302283|FG000|Overall Study|Screen failures|2|||
160976304|NCT01396395|581302284|FG000|Overall Study|Withdrawal by Subject|10|||
160976305|NCT01396395|581302285|FG001|Overall Study|Withdrawal by Subject|12|||
160976306|NCT01396395|581302284|FG000|Overall Study|Protocol Violation|3|||
160976307|NCT01396395|581302285|FG001|Overall Study|Protocol Violation|1|||
160976308|NCT01396395|581302284|FG000|Overall Study|Adverse Event|10|||
160976309|NCT01396395|581302285|FG001|Overall Study|Adverse Event|2|||
160976310|NCT01396395|581302284|FG000|Overall Study|Lost to Follow-up|17|||
160976311|NCT01396395|581302285|FG001|Overall Study|Lost to Follow-up|11|||
160976312|NCT01396395|581302284|FG000|Overall Study|Other|0|||
160976313|NCT01396395|581302285|FG001|Overall Study|Other|1|||
160976314|NCT03691948|581302286|FG000|Overall Study|Lost to Follow-up|1|||
160976315|NCT03691948|581302287|FG001|Overall Study|Lost to Follow-up|3|||
160976316|NCT01370005|581302288|FG000|Overall Study|Not treated|1|||
160976317|NCT01370005|581302289|FG001|Overall Study|Not treated|0|||
160976318|NCT01370005|581302290|FG002|Overall Study|Not treated|0|||
160976319|NCT01370005|581302288|FG000|Overall Study|Adverse Event|5|||
160976320|NCT01370005|581302289|FG001|Overall Study|Adverse Event|5|||
160976321|NCT01370005|581302290|FG002|Overall Study|Adverse Event|6|||
160976322|NCT01370005|581302288|FG000|Overall Study|Lack of Efficacy|1|||
160976323|NCT01370005|581302289|FG001|Overall Study|Lack of Efficacy|0|||
160976324|NCT01370005|581302290|FG002|Overall Study|Lack of Efficacy|0|||
160976325|NCT01370005|581302288|FG000|Overall Study|Non compliant with protocol|0|||
160976326|NCT01370005|581302289|FG001|Overall Study|Non compliant with protocol|1|||
160976327|NCT01370005|581302290|FG002|Overall Study|Non compliant with protocol|2|||
160976328|NCT01370005|581302288|FG000|Overall Study|Lost to Follow-up|1|||
160976329|NCT01370005|581302289|FG001|Overall Study|Lost to Follow-up|1|||
160976330|NCT01370005|581302290|FG002|Overall Study|Lost to Follow-up|1|||
160976331|NCT01370005|581302288|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
160976332|NCT01370005|581302289|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
160976333|NCT01370005|581302290|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
160976334|NCT01370005|581302288|FG000|Overall Study|Other reason not defined above|3|||
160976335|NCT01370005|581302289|FG001|Overall Study|Other reason not defined above|0|||
160976336|NCT01370005|581302290|FG002|Overall Study|Other reason not defined above|2|||
160976337|NCT02009696|581302291|FG000|Overall Study|Withdrawal by Subject|2|||
160976338|NCT02344537|581302293|FG000|Overall Study|Protocol Violation|1|||
160976339|NCT02344537|581302294|FG001|Overall Study|Protocol Violation|1|||
160976340|NCT02344537|581302293|FG000|Overall Study|Subject started another treatment after wk 6|1|||
160976341|NCT02344537|581302294|FG001|Overall Study|Subject started another treatment after wk 6|0|||
160976342|NCT02344537|581302293|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
160976343|NCT02344537|581302294|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
160976344|NCT05490329|581302297|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
160976345|NCT05490329|581302298|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
160976346|NCT05490329|581302297|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
160976347|NCT05490329|581302298|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
160976348|NCT05490329|581302297|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
160976349|NCT05490329|581302298|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
160976350|NCT02120664|581302299|FG000|Overall Study|Withdrawal by Subject|0|||
160976351|NCT02120664|581302300|FG001|Overall Study|Withdrawal by Subject|0|||
160976352|NCT02120664|581302301|FG002|Overall Study|Withdrawal by Subject|0|||
160976353|NCT02120664|581302302|FG003|Overall Study|Withdrawal by Subject|1|||
160976354|NCT02120664|581302303|FG004|Overall Study|Withdrawal by Subject|0|||
160976355|NCT03916744|581302304|FG000|Overall Study|Withdrawal by Subject|0|||
160976356|NCT03916744|581302305|FG001|Overall Study|Withdrawal by Subject|1|||
160976357|NCT03916744|581302306|FG002|Overall Study|Withdrawal by Subject|2|||
160976358|NCT02460263|581302307|FG000|Transition Period|Withdrawal by Subject|1|||
160976359|NCT02460263|581302307|FG000|Transition Period|Death|1|||
160976360|NCT03176238|581302310|FG000|Overall Study|Unacceptable AEs|15|||
160976361|NCT03176238|581302311|FG001|Overall Study|Unacceptable AEs|8|||
160658402|NCT00849901|580131467|FG001|Extension Phase|Withdrawal by Subject|6|||
160658403|NCT00849901|580131468|FG002|Extension Phase|Withdrawal by Subject|3|||
160658404|NCT00849901|580131466|FG000|Extension Phase|Parent or Caregiver Decision|10|||
160976362|NCT03176238|581302310|FG000|Overall Study|Abnormal lab value(s)|2|||
160976363|NCT03176238|581302311|FG001|Overall Study|Abnormal lab value(s)|0|||
160976364|NCT03176238|581302310|FG000|Overall Study|Inter-current illness|0|||
160592057|NCT01963208|579882891|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
160592058|NCT01963208|579882886|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
160592059|NCT01963208|579882887|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
160592060|NCT01963208|579882888|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
160592061|NCT01963208|579882889|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
160592062|NCT01963208|579882890|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
160592063|NCT01963208|579882891|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
160592064|NCT01963208|579882886|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
160592065|NCT01963208|579882887|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
160592066|NCT01963208|579882888|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
160592067|NCT01963208|579882889|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
160592068|NCT01963208|579882890|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
160592069|NCT01963208|579882891|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
160592070|NCT00349752|579882893|FG000|Overall Study|Adverse Event|8|||
160592071|NCT00349752|579882894|FG001|Overall Study|Adverse Event|12|||
160592072|NCT00349752|579882893|FG000|Overall Study|Lack of Efficacy|37|||
160592073|NCT00349752|579882894|FG001|Overall Study|Lack of Efficacy|42|||
160592074|NCT00349752|579882893|FG000|Overall Study|Lost to Follow-up|4|||
160592075|NCT00349752|579882894|FG001|Overall Study|Lost to Follow-up|2|||
160592076|NCT00349752|579882893|FG000|Overall Study|Personal reasons|6|||
160592077|NCT00349752|579882894|FG001|Overall Study|Personal reasons|5|||
160592078|NCT00349752|579882893|FG000|Overall Study|Other: Required exclusionary medication|0|||
160592079|NCT00349752|579882894|FG001|Overall Study|Other: Required exclusionary medication|1|||
160592080|NCT00349752|579882893|FG000|Overall Study|Other: Non compliance|0|||
160592081|NCT00349752|579882894|FG001|Overall Study|Other: Non compliance|1|||
160592082|NCT00349752|579882893|FG000|Overall Study|Other: Patient stopped steroids|0|||
160592083|NCT00349752|579882894|FG001|Overall Study|Other: Patient stopped steroids|1|||
160592084|NCT00349752|579882893|FG000|Overall Study|Other: Patient's steroid use|1|||
160592085|NCT00349752|579882894|FG001|Overall Study|Other: Patient's steroid use|0|||
160592086|NCT00349752|579882893|FG000|Overall Study|Other: Ineligible|1|||
160592087|NCT00349752|579882894|FG001|Overall Study|Other: Ineligible|0|||
160592088|NCT00349752|579882893|FG000|Overall Study|Other: Inadvertently unblinded|1|||
160592089|NCT00349752|579882894|FG001|Overall Study|Other: Inadvertently unblinded|0|||
160592090|NCT00349752|579882893|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
160592091|NCT00349752|579882894|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
160592092|NCT05294211|579882897|FG000|Overall Study|Withdrawal by Subject|3|||
160592093|NCT05294211|579882897|FG000|Overall Study|Physician Decision|2|||
160592094|NCT05294211|579882897|FG000|Overall Study|Progressed to active labor|1|||
160592095|NCT05294211|579882897|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
160592096|NCT05294211|579882897|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
160592097|NCT01842607|579882899|FG000|Overall Study|Adverse Event|11|||
160592098|NCT01842607|579882899|FG000|Overall Study|Lack of Efficacy|19|||
160592099|NCT01842607|579882899|FG000|Overall Study|Protocol Violation|8|||
160592100|NCT01842607|579882899|FG000|Overall Study|Protocol defined stopping criteria|2|||
160592101|NCT01842607|579882899|FG000|Overall Study|Lost to Follow-up|3|||
160592102|NCT01842607|579882899|FG000|Overall Study|Physician Decision|9|||
160592103|NCT01842607|579882899|FG000|Overall Study|Withdrawal by Subject|14|||
160592104|NCT00012012|579882900|FG000|Overall Study|Protocol Violation|1|||
160592105|NCT00012012|579882901|FG001|Overall Study|Protocol Violation|1|||
160592106|NCT00012012|579882900|FG000|Overall Study|Withdrawal by Subject|0|||
160658405|NCT00849901|580131467|FG001|Extension Phase|Parent or Caregiver Decision|4|||
160658406|NCT00849901|580131468|FG002|Extension Phase|Parent or Caregiver Decision|4|||
160658407|NCT00849901|580131466|FG000|Extension Phase|Physician Decision|1|||
160592107|NCT00012012|579882901|FG001|Overall Study|Withdrawal by Subject|2|||
160658408|NCT00849901|580131467|FG001|Extension Phase|Physician Decision|2|||
160592108|NCT02159469|579882902|FG000|Overall Study|Missing Completion status|1|||
160592109|NCT02159469|579882902|FG000|Overall Study|Adverse Event|5|||
160592110|NCT02159469|579882902|FG000|Overall Study|Non-compliance|2|||
160592111|NCT02159469|579882902|FG000|Overall Study|Withdrawal by Subject|9|||
160592112|NCT02159469|579882902|FG000|Overall Study|Lost to Follow-up|1|||
160976365|NCT03176238|581302311|FG001|Overall Study|Inter-current illness|1|||
160976366|NCT03176238|581302310|FG000|Overall Study|Consent withdrawal|14|||
160976367|NCT03176238|581302311|FG001|Overall Study|Consent withdrawal|2|||
160976368|NCT03176238|581302310|FG000|Overall Study|Lost to Follow-up|3|||
160976369|NCT03176238|581302311|FG001|Overall Study|Lost to Follow-up|0|||
160976370|NCT03176238|581302310|FG000|Overall Study|Administrative problems|1|||
160976371|NCT03176238|581302311|FG001|Overall Study|Administrative problems|0|||
160976372|NCT03176238|581302310|FG000|Overall Study|Death|3|||
160976373|NCT03176238|581302311|FG001|Overall Study|Death|0|||
160976374|NCT03176238|581302310|FG000|Overall Study|Disease Progression|133|||
160976375|NCT03176238|581302311|FG001|Overall Study|Disease Progression|22|||
160976376|NCT03176238|581302310|FG000|Overall Study|Tx duration completed per EAP|0|||
160976377|NCT03176238|581302311|FG001|Overall Study|Tx duration completed per EAP|1|||
160976378|NCT03176238|581302310|FG000|Overall Study|Patient is switched to commercial drug|16|||
160976379|NCT03176238|581302311|FG001|Overall Study|Patient is switched to commercial drug|1|||
160976380|NCT03176238|581302310|FG000|Overall Study|Protocol Violation|1|||
160976381|NCT03176238|581302311|FG001|Overall Study|Protocol Violation|0|||
160976382|NCT03176238|581302310|FG000|Overall Study|Changes in the patient's condition|2|||
160976383|NCT03176238|581302311|FG001|Overall Study|Changes in the patient's condition|1|||
160976384|NCT03176238|581302310|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
160976385|NCT03176238|581302311|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
160976386|NCT04524598|581302312|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
160976387|NCT04524598|581302313|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
160976388|NCT04524598|581302314|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
160976389|NCT04524598|581302315|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
160976390|NCT04524598|581302316|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
160976391|NCT04524598|581302312|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
160976392|NCT04524598|581302313|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
160976393|NCT04524598|581302314|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976394|NCT04524598|581302315|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976395|NCT04524598|581302316|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976396|NCT04524598|581302312|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
160976397|NCT04524598|581302313|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
160976398|NCT04524598|581302314|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
160976399|NCT04524598|581302315|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
160976400|NCT04524598|581302316|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
160976401|NCT04524598|581302312|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
160976402|NCT04524598|581302313|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
160976403|NCT04524598|581302314|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
160976404|NCT04524598|581302315|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
160976405|NCT04524598|581302316|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
160976406|NCT04524598|581302312|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976407|NCT04524598|581302313|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976408|NCT04524598|581302314|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
160976409|NCT04524598|581302315|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
160976410|NCT04524598|581302316|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976411|NCT04524598|581302312|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
160976412|NCT04524598|581302313|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
160976413|NCT04524598|581302314|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
160976414|NCT04524598|581302315|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
160976415|NCT04524598|581302316|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
160976416|NCT04524598|581302312|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976417|NCT04524598|581302313|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976418|NCT04524598|581302314|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976419|NCT04524598|581302315|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976420|NCT04524598|581302316|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
160976421|NCT01351025|581302317|FG000|Week 0 - 20|Lost to Follow-up|2|||
160976422|NCT01351025|581302318|FG001|Week 0 - 20|Lost to Follow-up|1|||
160976423|NCT01351025|581302317|FG000|Week 0 - 20|Withdrawal by Subject|1|||
160976424|NCT01351025|581302318|FG001|Week 0 - 20|Withdrawal by Subject|0|||
160976425|NCT01351025|581302317|FG000|Week 24 - 44|Lost to Follow-up|0|||
160976426|NCT01351025|581302318|FG001|Week 24 - 44|Lost to Follow-up|2|||
160976427|NCT01351025|581302317|FG000|Week 24 - 44|Site closed|0|||
160976428|NCT01351025|581302318|FG001|Week 24 - 44|Site closed|1|||
160976429|NCT01351025|581302317|FG000|Week 24 - 44|unable to get to clinic|1|||
160976430|NCT01351025|581302318|FG001|Week 24 - 44|unable to get to clinic|1|||
160976431|NCT01242176|581304566|FG000|Washout Period of 7 Days|Adverse Event|0|||
160976432|NCT01242176|581304567|FG001|Washout Period of 7 Days|Adverse Event|2|||
160592113|NCT02159469|579882902|FG000|Overall Study|Sponsor's request|2|||
160592114|NCT02159469|579882902|FG000|Overall Study|Met Stopping Criteria|3|||
160592115|NCT02159469|579882902|FG000|Overall Study|Other|1|||
160592116|NCT02159469|579882902|FG000|Overall Study|Multiple|29|||
160592117|NCT03629041|579882903|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
160592118|NCT03629041|579882904|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
160592119|NCT03629041|579882905|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
160592120|NCT03629041|579882906|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
160592121|NCT03730194|579882907|FG000|First Stage Treatment|Withdrawal by Subject|1|||
160592122|NCT03730194|579882908|FG001|First Stage Treatment|Withdrawal by Subject|1|||
160592123|NCT03730194|579882909|FG002|First Stage Treatment|Withdrawal by Subject|0|||
160592124|NCT03730194|579882910|FG003|First Stage Treatment|Withdrawal by Subject|0|||
160592125|NCT03730194|579882911|FG004|First Stage Treatment|Withdrawal by Subject|0|||
160592126|NCT03730194|579882912|FG005|First Stage Treatment|Withdrawal by Subject|0|||
160592127|NCT03730194|579882907|FG000|First Stage Treatment|Protocol Violation|3|||
160592128|NCT03730194|579882908|FG001|First Stage Treatment|Protocol Violation|3|||
160592129|NCT03730194|579882909|FG002|First Stage Treatment|Protocol Violation|0|||
160592130|NCT03730194|579882910|FG003|First Stage Treatment|Protocol Violation|0|||
160592131|NCT03730194|579882911|FG004|First Stage Treatment|Protocol Violation|0|||
160592132|NCT03730194|579882912|FG005|First Stage Treatment|Protocol Violation|0|||
160592133|NCT01179347|579885320|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
160592134|NCT01179347|579885321|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
160592135|NCT01179347|579885320|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
160592136|NCT01179347|579885321|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
160592137|NCT01179347|579885320|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
160592138|NCT01179347|579885321|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
160592139|NCT01179347|579885320|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
160592140|NCT01179347|579885321|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
160592141|NCT01179347|579885320|FG000|Double-blind Period (12 Weeks)|Other|2|||
160592142|NCT01179347|579885321|FG001|Double-blind Period (12 Weeks)|Other|4|||
160592143|NCT01179347|579885320|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
160592144|NCT01179347|579885321|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
160592145|NCT01179347|579885320|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
160592146|NCT01179347|579885321|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
160592147|NCT01179347|579885320|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
160592148|NCT01179347|579885321|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
160592149|NCT01179347|579885320|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
160592150|NCT01179347|579885321|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
160592151|NCT01179347|579885320|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
160592152|NCT01179347|579885321|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
160592153|NCT01179347|579885320|FG000|Open-label Period (12 Weeks)|Other|7|||
160592154|NCT01179347|579885321|FG001|Open-label Period (12 Weeks)|Other|4|||
160592155|NCT04095442|579885325|FG000|Overall Study|Lost to Follow-up|0|||
160592156|NCT04095442|579885326|FG001|Overall Study|Lost to Follow-up|1|||
160592157|NCT04095442|579885325|FG000|Overall Study|Screen failure|1|||
160592158|NCT04095442|579885326|FG001|Overall Study|Screen failure|0|||
160592159|NCT01677624|579885327|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
160592160|NCT01337167|579885331|FG000|Infant Series|Adverse Event|1|||
160592161|NCT01337167|579885332|FG001|Infant Series|Adverse Event|1|||
160658409|NCT00849901|580131468|FG002|Extension Phase|Physician Decision|0|||
160658410|NCT00849901|580131466|FG000|Extension Phase|Lack of Efficacy|2|||
160658411|NCT00849901|580131467|FG001|Extension Phase|Lack of Efficacy|4|||
160658412|NCT00849901|580131468|FG002|Extension Phase|Lack of Efficacy|1|||
160658413|NCT00262223|580131469|FG000|Treatment Phase|Withdrawal by Subject|3|||
160658414|NCT00262223|580131470|FG001|Treatment Phase|Withdrawal by Subject|6|||
160658415|NCT00262223|580131469|FG000|Treatment Phase|Adverse Event|1|||
160658416|NCT00262223|580131470|FG001|Treatment Phase|Adverse Event|2|||
160592162|NCT01337167|579885331|FG000|Infant Series|Death|1|||
160592163|NCT01337167|579885332|FG001|Infant Series|Death|1|||
160592164|NCT01337167|579885331|FG000|Infant Series|Lost to Follow-up|13|||
160592165|NCT01337167|579885332|FG001|Infant Series|Lost to Follow-up|7|||
160658417|NCT00262223|580131469|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
160592166|NCT01337167|579885331|FG000|Infant Series|Non-compliance with study drug|2|||
160658418|NCT00262223|580131470|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
160592167|NCT01337167|579885332|FG001|Infant Series|Non-compliance with study drug|1|||
160592168|NCT01337167|579885331|FG000|Infant Series|Physician Decision|3|||
160592169|NCT01337167|579885332|FG001|Infant Series|Physician Decision|1|||
160592170|NCT01337167|579885331|FG000|Infant Series|Protocol Violation|22|||
160592171|NCT01337167|579885332|FG001|Infant Series|Protocol Violation|9|||
160592172|NCT01337167|579885331|FG000|Infant Series|Withdrawal by Subject|15|||
160658419|NCT00262223|580131469|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
160658420|NCT00262223|580131470|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
160976433|NCT01242176|581304566|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
160976434|NCT01242176|581304567|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
160976435|NCT00358215|581304568|FG000|Overall Study|Ineligibility determined|4|||
160976436|NCT00358215|581304569|FG001|Overall Study|Ineligibility determined|3|||
160976437|NCT00358215|581304568|FG000|Overall Study|Adverse Event|83|||
160976438|NCT00358215|581304569|FG001|Overall Study|Adverse Event|65|||
160976439|NCT00358215|581304568|FG000|Overall Study|Withdrawal by Subject|111|||
160976440|NCT00358215|581304569|FG001|Overall Study|Withdrawal by Subject|102|||
160976441|NCT00358215|581304568|FG000|Overall Study|Participant request|65|||
160976442|NCT00358215|581304569|FG001|Overall Study|Participant request|64|||
160976443|NCT00358215|581304568|FG000|Overall Study|Physician Decision|47|||
160976444|NCT00358215|581304569|FG001|Overall Study|Physician Decision|39|||
160976445|NCT00358215|581304568|FG000|Overall Study|Lost to Follow-up|16|||
160976446|NCT00358215|581304569|FG001|Overall Study|Lost to Follow-up|22|||
160976447|NCT00358215|581304568|FG000|Overall Study|Death|265|||
160592173|NCT01337167|579885332|FG001|Infant Series|Withdrawal by Subject|4|||
160592174|NCT01337167|579885331|FG000|Infant Series|Randomized but not vaccinated|5|||
160592175|NCT01337167|579885332|FG001|Infant Series|Randomized but not vaccinated|3|||
160592176|NCT01337167|579885331|FG000|Interim Period|Lost to Follow-up|51|||
160592177|NCT01337167|579885332|FG001|Interim Period|Lost to Follow-up|23|||
160592178|NCT01337167|579885331|FG000|Interim Period|Non-compliance with study drug|1|||
160592179|NCT01337167|579885332|FG001|Interim Period|Non-compliance with study drug|0|||
160592180|NCT01337167|579885331|FG000|Interim Period|Physician Decision|6|||
160592181|NCT01337167|579885332|FG001|Interim Period|Physician Decision|3|||
160592182|NCT01337167|579885331|FG000|Interim Period|Protocol Violation|5|||
160976448|NCT00358215|581304569|FG001|Overall Study|Death|281|||
160976449|NCT00358215|581304568|FG000|Overall Study|Protocol Violation|64|||
160976450|NCT00358215|581304569|FG001|Overall Study|Protocol Violation|59|||
160976451|NCT00358215|581304568|FG000|Overall Study|Pregnancy|1|||
160976452|NCT00358215|581304569|FG001|Overall Study|Pregnancy|0|||
160976453|NCT00358215|581304568|FG000|Overall Study|Other|21|||
160976454|NCT00358215|581304569|FG001|Overall Study|Other|14|||
160976455|NCT00358215|581304568|FG000|Overall Study|Did not receive investigational product|2|||
160976456|NCT00358215|581304569|FG001|Overall Study|Did not receive investigational product|3|||
160976457|NCT00871351|581304570|FG000|Overall Study|Withdrawal by Subject|1|||
160976458|NCT00871351|581304571|FG001|Overall Study|Withdrawal by Subject|0|||
160976459|NCT00871351|581304572|FG002|Overall Study|Withdrawal by Subject|0|||
160976460|NCT00871351|581304570|FG000|Overall Study|Adverse Event|3|||
160976461|NCT00871351|581304571|FG001|Overall Study|Adverse Event|1|||
160976462|NCT00871351|581304572|FG002|Overall Study|Adverse Event|0|||
160976463|NCT00744237|581304573|FG000|Overall Study|Lack of Efficacy|1|||
160976464|NCT00744237|581304574|FG001|Overall Study|Lack of Efficacy|1|||
160976465|NCT00744237|581304575|FG002|Overall Study|Lack of Efficacy|0|||
160976466|NCT00744237|581304573|FG000|Overall Study|Withdrawal by Subject|9|||
160976467|NCT00744237|581304574|FG001|Overall Study|Withdrawal by Subject|5|||
160976468|NCT00744237|581304575|FG002|Overall Study|Withdrawal by Subject|3|||
160976469|NCT00744237|581304573|FG000|Overall Study|Lost to Follow-up|1|||
160976470|NCT00744237|581304574|FG001|Overall Study|Lost to Follow-up|1|||
160976471|NCT00744237|581304575|FG002|Overall Study|Lost to Follow-up|1|||
160976472|NCT00744237|581304573|FG000|Overall Study|Protocol Violation|3|||
160976473|NCT00744237|581304574|FG001|Overall Study|Protocol Violation|4|||
160976474|NCT00744237|581304575|FG002|Overall Study|Protocol Violation|3|||
160976475|NCT00744237|581304573|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
160976476|NCT00744237|581304574|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
160976477|NCT00744237|581304575|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
160976478|NCT00744237|581304573|FG000|Overall Study|Dosing Error|1|||
160976479|NCT00744237|581304574|FG001|Overall Study|Dosing Error|0|||
160976480|NCT00744237|581304575|FG002|Overall Study|Dosing Error|1|||
160976481|NCT00744237|581304573|FG000|Overall Study|Study Drug Error|1|||
160976482|NCT00744237|581304574|FG001|Overall Study|Study Drug Error|0|||
160976483|NCT00744237|581304575|FG002|Overall Study|Study Drug Error|0|||
160976484|NCT00744237|581304573|FG000|Overall Study|Prohibited Concomitant Medication|0|||
160976485|NCT00744237|581304574|FG001|Overall Study|Prohibited Concomitant Medication|0|||
160976486|NCT00744237|581304575|FG002|Overall Study|Prohibited Concomitant Medication|1|||
160976487|NCT00744237|581304573|FG000|Overall Study|Poor Compliance|0|||
160976488|NCT00744237|581304574|FG001|Overall Study|Poor Compliance|2|||
160976489|NCT00744237|581304575|FG002|Overall Study|Poor Compliance|0|||
160976490|NCT00744237|581304573|FG000|Overall Study|Administrative. Site Closed|1|||
160976491|NCT00744237|581304574|FG001|Overall Study|Administrative. Site Closed|1|||
160976492|NCT00744237|581304575|FG002|Overall Study|Administrative. Site Closed|1|||
160976493|NCT00744237|581304573|FG000|Overall Study|Adverse Event|9|||
160976494|NCT00744237|581304574|FG001|Overall Study|Adverse Event|13|||
160976495|NCT00744237|581304575|FG002|Overall Study|Adverse Event|5|||
160976496|NCT02032173|581304578|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
160976497|NCT02291289|581304582|FG000|Induction Treatment|Withdrawal by Subject|0|||
160976498|NCT02291289|581304583|FG001|Induction Treatment|Withdrawal by Subject|0|||
160976499|NCT02291289|581304584|FG002|Induction Treatment|Withdrawal by Subject|0|||
160976500|NCT02291289|581304585|FG003|Induction Treatment|Withdrawal by Subject|24|||
160976501|NCT02291289|581304586|FG004|Induction Treatment|Withdrawal by Subject|0|||
160976502|NCT02291289|581304587|FG005|Induction Treatment|Withdrawal by Subject|0|||
160976503|NCT02291289|581304588|FG006|Induction Treatment|Withdrawal by Subject|0|||
160976504|NCT02291289|581304589|FG007|Induction Treatment|Withdrawal by Subject|0|||
160976505|NCT02291289|581304590|FG008|Induction Treatment|Withdrawal by Subject|0|||
160976506|NCT02291289|581304591|FG009|Induction Treatment|Withdrawal by Subject|18|||
160976507|NCT02291289|581304592|FG010|Induction Treatment|Withdrawal by Subject|0|||
160976508|NCT02291289|581304593|FG011|Induction Treatment|Withdrawal by Subject|0|||
160976509|NCT02291289|581304594|FG012|Induction Treatment|Withdrawal by Subject|0|||
160976510|NCT02291289|581304582|FG000|Induction Treatment|Adverse Event|0|||
160976511|NCT02291289|581304583|FG001|Induction Treatment|Adverse Event|0|||
160976512|NCT02291289|581304584|FG002|Induction Treatment|Adverse Event|0|||
160976513|NCT02291289|581304585|FG003|Induction Treatment|Adverse Event|3|||
160976514|NCT02291289|581304586|FG004|Induction Treatment|Adverse Event|0|||
160592183|NCT01337167|579885332|FG001|Interim Period|Protocol Violation|3|||
160592184|NCT01337167|579885331|FG000|Interim Period|Withdrawal by Subject|18|||
160592185|NCT01337167|579885332|FG001|Interim Period|Withdrawal by Subject|10|||
160592186|NCT01337167|579885331|FG000|Interim Period|Other protocol criterion not met|0|||
160592187|NCT01337167|579885332|FG001|Interim Period|Other protocol criterion not met|1|||
160592188|NCT01337167|579885331|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
160592189|NCT01337167|579885332|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
160592190|NCT01337167|579885331|FG000|Toddler Vaccinations|Protocol Violation|0|||
160592191|NCT01337167|579885332|FG001|Toddler Vaccinations|Protocol Violation|1|||
160592192|NCT01337167|579885331|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
160592193|NCT01337167|579885332|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
160592194|NCT03833817|579885333|FG000|Overall Study|Withdrawal by Subject|3|||
160592195|NCT03833817|579885334|FG001|Overall Study|Withdrawal by Subject|3|||
160592196|NCT03833817|579885333|FG000|Overall Study|Lost to Follow-up|3|||
160592197|NCT03833817|579885334|FG001|Overall Study|Lost to Follow-up|3|||
160592198|NCT00884221|579885335|FG000|Overall Study|Withdrawal by Subject|0|||
160592199|NCT00884221|579885336|FG001|Overall Study|Withdrawal by Subject|3|||
160592200|NCT00884221|579885335|FG000|Overall Study|Adverse Event|6|||
160592201|NCT00884221|579885336|FG001|Overall Study|Adverse Event|3|||
160592202|NCT00884221|579885335|FG000|Overall Study|Protocol Violation|16|||
160592203|NCT00884221|579885336|FG001|Overall Study|Protocol Violation|13|||
160592204|NCT00884221|579885335|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
160592205|NCT00884221|579885336|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
160592206|NCT02126670|579885339|FG000|Overall Study|Withdrawal by Subject|1|||
160592207|NCT02126670|579885340|FG001|Overall Study|Withdrawal by Subject|0|||
160592208|NCT02126670|579885341|FG002|Overall Study|Withdrawal by Subject|0|||
160592209|NCT02126670|579885342|FG003|Overall Study|Withdrawal by Subject|1|||
160592210|NCT01827319|579885345|FG000|Overall Study|Lost to Follow-up|3|||
160592211|NCT02499575|579885347|FG000|Overall Study|Protocol Violation|0|||
160592212|NCT02499575|579885348|FG001|Overall Study|Protocol Violation|1|||
160592213|NCT05458011|579885349|FG000|DB Period (12 Weeks)|Adverse Event|2|||
160592214|NCT05458011|579885350|FG001|DB Period (12 Weeks)|Adverse Event|1|||
160592215|NCT05458011|579885351|FG002|DB Period (12 Weeks)|Adverse Event|1|||
160592216|NCT05458011|579885349|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
160592217|NCT05458011|579885350|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
160592218|NCT05458011|579885351|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
160592219|NCT05458011|579885349|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
160592220|NCT05458011|579885350|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
160592221|NCT05458011|579885351|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
160592222|NCT05458011|579885349|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
160592223|NCT05458011|579885350|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
160592224|NCT05458011|579885351|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
160592225|NCT05458011|579885349|FG000|OL Period (12 Weeks)|Adverse Event|1|||
160592226|NCT05458011|579885350|FG001|OL Period (12 Weeks)|Adverse Event|2|||
160592227|NCT05458011|579885351|FG002|OL Period (12 Weeks)|Adverse Event|1|||
160592228|NCT05458011|579885349|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
160592229|NCT05458011|579885350|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
160592230|NCT05458011|579885351|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
160592231|NCT00574119|579885352|FG000|Overall Study|Adverse Event|1|||
160592232|NCT00574119|579885352|FG000|Overall Study|Protocol Violation|1|||
160592233|NCT00574119|579885352|FG000|Overall Study|Withdrawal by Subject|1|||
160592234|NCT00574119|579885352|FG000|Overall Study|Physician Decision|1|||
160592235|NCT02690207|579885356|FG000|Overall Study|Lost to Follow-up|48|||
160592236|NCT02690207|579885356|FG000|Overall Study|Withdrawal by Subject|46|||
160592237|NCT02690207|579885356|FG000|Overall Study|Protocol Violation|2|||
160658421|NCT00262223|580131469|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
160976515|NCT02291289|581304587|FG005|Induction Treatment|Adverse Event|0|||
160976516|NCT02291289|581304588|FG006|Induction Treatment|Adverse Event|0|||
160976517|NCT02291289|581304589|FG007|Induction Treatment|Adverse Event|0|||
160976518|NCT02291289|581304590|FG008|Induction Treatment|Adverse Event|0|||
160976519|NCT02291289|581304591|FG009|Induction Treatment|Adverse Event|1|||
160976520|NCT02291289|581304592|FG010|Induction Treatment|Adverse Event|0|||
160976521|NCT02291289|581304593|FG011|Induction Treatment|Adverse Event|0|||
160976522|NCT02291289|581304594|FG012|Induction Treatment|Adverse Event|0|||
160976523|NCT02291289|581304582|FG000|Induction Treatment|Death|25|||
160976524|NCT02291289|581304583|FG001|Induction Treatment|Death|0|||
160976525|NCT02291289|581304584|FG002|Induction Treatment|Death|0|||
160976526|NCT02291289|581304585|FG003|Induction Treatment|Death|111|||
160976527|NCT02291289|581304586|FG004|Induction Treatment|Death|0|||
160976528|NCT02291289|581304587|FG005|Induction Treatment|Death|0|||
160976529|NCT02291289|581304588|FG006|Induction Treatment|Death|1|||
160976530|NCT02291289|581304589|FG007|Induction Treatment|Death|0|||
160976531|NCT02291289|581304590|FG008|Induction Treatment|Death|0|||
160976532|NCT02291289|581304591|FG009|Induction Treatment|Death|82|||
160976533|NCT02291289|581304592|FG010|Induction Treatment|Death|0|||
160976534|NCT02291289|581304593|FG011|Induction Treatment|Death|0|||
160976535|NCT02291289|581304594|FG012|Induction Treatment|Death|0|||
160592238|NCT02690207|579885356|FG000|Overall Study|Serious adverse event|110|||
160592239|NCT02690207|579885356|FG000|Overall Study|Non-serious Adverse Event|18|||
160592240|NCT02690207|579885356|FG000|Overall Study|Migrated/moved from study area|5|||
160592241|NCT02690207|579885356|FG000|Overall Study|Suspected HZ Episode|1|||
160976536|NCT02291289|581304582|FG000|Induction Treatment|Lost to Follow-up|1|||
160976537|NCT02291289|581304583|FG001|Induction Treatment|Lost to Follow-up|0|||
160976538|NCT02291289|581304584|FG002|Induction Treatment|Lost to Follow-up|0|||
160976539|NCT02291289|581304585|FG003|Induction Treatment|Lost to Follow-up|12|||
160976540|NCT02291289|581304586|FG004|Induction Treatment|Lost to Follow-up|0|||
160976541|NCT02291289|581304587|FG005|Induction Treatment|Lost to Follow-up|0|||
160976542|NCT02291289|581304588|FG006|Induction Treatment|Lost to Follow-up|0|||
160976543|NCT02291289|581304589|FG007|Induction Treatment|Lost to Follow-up|0|||
160976544|NCT02291289|581304590|FG008|Induction Treatment|Lost to Follow-up|0|||
160976545|NCT02291289|581304591|FG009|Induction Treatment|Lost to Follow-up|9|||
160976546|NCT02291289|581304592|FG010|Induction Treatment|Lost to Follow-up|0|||
160976547|NCT02291289|581304593|FG011|Induction Treatment|Lost to Follow-up|0|||
160976548|NCT02291289|581304594|FG012|Induction Treatment|Lost to Follow-up|0|||
160976549|NCT02291289|581304582|FG000|Induction Treatment|Non-Compliance|0|||
160976550|NCT02291289|581304583|FG001|Induction Treatment|Non-Compliance|0|||
160976551|NCT02291289|581304584|FG002|Induction Treatment|Non-Compliance|0|||
160976552|NCT02291289|581304585|FG003|Induction Treatment|Non-Compliance|1|||
160976553|NCT02291289|581304586|FG004|Induction Treatment|Non-Compliance|0|||
160976554|NCT02291289|581304587|FG005|Induction Treatment|Non-Compliance|0|||
160976555|NCT02291289|581304588|FG006|Induction Treatment|Non-Compliance|0|||
160976556|NCT02291289|581304589|FG007|Induction Treatment|Non-Compliance|0|||
160976557|NCT02291289|581304590|FG008|Induction Treatment|Non-Compliance|0|||
160976558|NCT02291289|581304591|FG009|Induction Treatment|Non-Compliance|1|||
160976559|NCT02291289|581304592|FG010|Induction Treatment|Non-Compliance|0|||
160976560|NCT02291289|581304593|FG011|Induction Treatment|Non-Compliance|0|||
160976561|NCT02291289|581304594|FG012|Induction Treatment|Non-Compliance|0|||
160976562|NCT02291289|581304582|FG000|Induction Treatment|Reason Not Specified|0|||
160976563|NCT02291289|581304583|FG001|Induction Treatment|Reason Not Specified|0|||
160976564|NCT02291289|581304584|FG002|Induction Treatment|Reason Not Specified|0|||
160976565|NCT02291289|581304585|FG003|Induction Treatment|Reason Not Specified|4|||
160976566|NCT02291289|581304586|FG004|Induction Treatment|Reason Not Specified|0|||
160976567|NCT02291289|581304587|FG005|Induction Treatment|Reason Not Specified|0|||
160976568|NCT02291289|581304588|FG006|Induction Treatment|Reason Not Specified|0|||
160976569|NCT02291289|581304589|FG007|Induction Treatment|Reason Not Specified|0|||
160976570|NCT02291289|581304590|FG008|Induction Treatment|Reason Not Specified|0|||
160976571|NCT02291289|581304591|FG009|Induction Treatment|Reason Not Specified|7|||
160976572|NCT02291289|581304592|FG010|Induction Treatment|Reason Not Specified|0|||
160976573|NCT02291289|581304593|FG011|Induction Treatment|Reason Not Specified|0|||
160976574|NCT02291289|581304594|FG012|Induction Treatment|Reason Not Specified|0|||
160976575|NCT02291289|581304582|FG000|Induction Treatment|Physician Decision|0|||
160976576|NCT02291289|581304583|FG001|Induction Treatment|Physician Decision|0|||
160976577|NCT02291289|581304584|FG002|Induction Treatment|Physician Decision|0|||
160976578|NCT02291289|581304585|FG003|Induction Treatment|Physician Decision|3|||
160976579|NCT02291289|581304586|FG004|Induction Treatment|Physician Decision|0|||
160976580|NCT02291289|581304587|FG005|Induction Treatment|Physician Decision|0|||
160976581|NCT02291289|581304588|FG006|Induction Treatment|Physician Decision|0|||
160976582|NCT02291289|581304589|FG007|Induction Treatment|Physician Decision|0|||
160976583|NCT02291289|581304590|FG008|Induction Treatment|Physician Decision|0|||
160976584|NCT02291289|581304591|FG009|Induction Treatment|Physician Decision|1|||
160976585|NCT02291289|581304592|FG010|Induction Treatment|Physician Decision|0|||
160976586|NCT02291289|581304593|FG011|Induction Treatment|Physician Decision|0|||
160976587|NCT02291289|581304594|FG012|Induction Treatment|Physician Decision|0|||
160976588|NCT02291289|581304582|FG000|Induction Treatment|Protocol Violation|0|||
160976589|NCT02291289|581304583|FG001|Induction Treatment|Protocol Violation|0|||
160976590|NCT02291289|581304584|FG002|Induction Treatment|Protocol Violation|0|||
160976591|NCT02291289|581304585|FG003|Induction Treatment|Protocol Violation|3|||
160976592|NCT02291289|581304586|FG004|Induction Treatment|Protocol Violation|0|||
160976593|NCT02291289|581304587|FG005|Induction Treatment|Protocol Violation|0|||
160976594|NCT02291289|581304588|FG006|Induction Treatment|Protocol Violation|0|||
160976595|NCT02291289|581304589|FG007|Induction Treatment|Protocol Violation|0|||
160976596|NCT02291289|581304590|FG008|Induction Treatment|Protocol Violation|0|||
160976597|NCT02291289|581304591|FG009|Induction Treatment|Protocol Violation|2|||
160976598|NCT02291289|581304592|FG010|Induction Treatment|Protocol Violation|0|||
160976599|NCT02291289|581304593|FG011|Induction Treatment|Protocol Violation|0|||
160976600|NCT02291289|581304594|FG012|Induction Treatment|Protocol Violation|0|||
160976601|NCT02291289|581304582|FG000|Induction Treatment|Missing|4|||
160976602|NCT02291289|581304583|FG001|Induction Treatment|Missing|0|||
160976603|NCT02291289|581304584|FG002|Induction Treatment|Missing|0|||
160976604|NCT02291289|581304585|FG003|Induction Treatment|Missing|14|||
160976605|NCT02291289|581304586|FG004|Induction Treatment|Missing|0|||
160976606|NCT02291289|581304587|FG005|Induction Treatment|Missing|0|||
160976607|NCT02291289|581304588|FG006|Induction Treatment|Missing|0|||
160592242|NCT02690207|579885356|FG000|Overall Study|Other reasons for withdrawal|23|||
160592243|NCT04656418|579885357|FG000|Overall Study|Withdrawal by Subject|1|||
160592244|NCT04656418|579885358|FG001|Overall Study|Withdrawal by Subject|3|||
160592245|NCT03287245|579885359|FG000|Overall Study|Study terminated by sponsor|3|||
160592246|NCT03287245|579885360|FG001|Overall Study|Study terminated by sponsor|0|||
160592247|NCT03287245|579885361|FG002|Overall Study|Study terminated by sponsor|3|||
160592248|NCT03287245|579885362|FG003|Overall Study|Study terminated by sponsor|1|||
160592249|NCT03287245|579885359|FG000|Overall Study|Adverse Event|1|||
160592250|NCT03287245|579885360|FG001|Overall Study|Adverse Event|0|||
160592251|NCT03287245|579885361|FG002|Overall Study|Adverse Event|0|||
160592252|NCT03287245|579885362|FG003|Overall Study|Adverse Event|0|||
160592253|NCT03287245|579885359|FG000|Overall Study|Withdrawal by Subject|8|||
160592254|NCT03287245|579885360|FG001|Overall Study|Withdrawal by Subject|3|||
160592255|NCT03287245|579885361|FG002|Overall Study|Withdrawal by Subject|3|||
160592256|NCT03287245|579885362|FG003|Overall Study|Withdrawal by Subject|0|||
160592257|NCT03287245|579885359|FG000|Overall Study|Physician Decision|3|||
160592258|NCT03287245|579885360|FG001|Overall Study|Physician Decision|2|||
160592259|NCT03287245|579885361|FG002|Overall Study|Physician Decision|0|||
160592260|NCT03287245|579885362|FG003|Overall Study|Physician Decision|0|||
160592261|NCT02586077|579885363|FG000|Overall Study|Withdrawal by Subject|1|||
160592262|NCT02586077|579885363|FG000|Overall Study|Physician Decision|4|||
160592263|NCT02586077|579885363|FG000|Overall Study|Lost to Follow-up|3|||
160592264|NCT02862548|579885364|FG000|Randomized Phase (Up to Week 48)|Death|0|||
160592265|NCT02862548|579885365|FG001|Randomized Phase (Up to Week 48)|Death|1|||
160592266|NCT02862548|579885364|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
160592267|NCT02862548|579885365|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
160592268|NCT02862548|579885364|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
160592269|NCT02862548|579885365|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
160592270|NCT02862548|579885364|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
160592271|NCT02862548|579885365|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
160592272|NCT00880763|579885366|FG000|Extension Period (Part 2)|Adverse Event|0|||
160592273|NCT00880763|579885367|FG001|Extension Period (Part 2)|Adverse Event|0|||
160592274|NCT00880763|579885368|FG002|Extension Period (Part 2)|Adverse Event|1|||
160592275|NCT00880763|579885369|FG003|Extension Period (Part 2)|Adverse Event|1|||
160592276|NCT00880763|579885366|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
160592277|NCT00880763|579885367|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
160592278|NCT00880763|579885368|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
160592279|NCT00880763|579885369|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
160592280|NCT00880763|579885366|FG000|Extension Period (Part 2)|Physician Decision|0|||
160592281|NCT00880763|579885367|FG001|Extension Period (Part 2)|Physician Decision|1|||
160592282|NCT00880763|579885368|FG002|Extension Period (Part 2)|Physician Decision|1|||
160592283|NCT00880763|579885369|FG003|Extension Period (Part 2)|Physician Decision|0|||
160592284|NCT00880763|579885366|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
160592285|NCT00880763|579885367|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
160592286|NCT00880763|579885368|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
160592287|NCT00880763|579885369|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
160592288|NCT01245764|579885370|FG000|Study Phase A|Other|3|||
160592289|NCT01245764|579885371|FG001|Study Phase A|Other|2|||
160592290|NCT01245764|579885372|FG002|Study Phase A|Other|3|||
160592291|NCT01245764|579885373|FG003|Study Phase A|Other|1|||
160592292|NCT01245764|579885370|FG000|Study Phase A|Protocol Violation|6|||
160592293|NCT01245764|579885371|FG001|Study Phase A|Protocol Violation|3|||
160592294|NCT01245764|579885372|FG002|Study Phase A|Protocol Violation|2|||
160592295|NCT01245764|579885373|FG003|Study Phase A|Protocol Violation|2|||
160592296|NCT01245764|579885370|FG000|Study Phase A|Lost to Follow-up|0|||
160592297|NCT01245764|579885371|FG001|Study Phase A|Lost to Follow-up|0|||
160592298|NCT01245764|579885372|FG002|Study Phase A|Lost to Follow-up|5|||
160592299|NCT01245764|579885373|FG003|Study Phase A|Lost to Follow-up|0|||
160592300|NCT00003476|579885374|FG000|Overall Study|Not evaluable|1|||
160592301|NCT02475850|579885375|FG000|Overall Study|Death|155|||
160592302|NCT02475850|579885376|FG001|Overall Study|Death|141|||
160592303|NCT02475850|579885375|FG000|Overall Study|Lost to Follow-up|217|||
160592304|NCT02475850|579885376|FG001|Overall Study|Lost to Follow-up|188|||
160592305|NCT02475850|579885375|FG000|Overall Study|Withdrawal by Subject|221|||
160592306|NCT02475850|579885376|FG001|Overall Study|Withdrawal by Subject|155|||
160592307|NCT02667457|579885379|FG000|Overall Study|Withdrawal by Subject|1|||
160592308|NCT02667457|579885380|FG001|Overall Study|Withdrawal by Subject|0|||
160592309|NCT02667457|579885379|FG000|Overall Study|Other Reason|0|||
160592310|NCT02667457|579885380|FG001|Overall Study|Other Reason|2|||
160592311|NCT03097614|579885381|FG000|Overall Study|Adverse Event|3|||
160976608|NCT02291289|581304589|FG007|Induction Treatment|Missing|0|||
160976609|NCT02291289|581304590|FG008|Induction Treatment|Missing|0|||
160976610|NCT02291289|581304591|FG009|Induction Treatment|Missing|54|||
160976611|NCT02291289|581304592|FG010|Induction Treatment|Missing|0|||
160976612|NCT02291289|581304593|FG011|Induction Treatment|Missing|0|||
160592312|NCT03057951|579885387|FG000|Overall Study|Adverse Event|553|||
160592313|NCT03057951|579885388|FG001|Overall Study|Adverse Event|575|||
160592314|NCT03057951|579885387|FG000|Overall Study|Protocol Violation|30|||
160592315|NCT03057951|579885388|FG001|Overall Study|Protocol Violation|24|||
160592316|NCT03057951|579885387|FG000|Overall Study|Lost to Follow-up|6|||
160592317|NCT03057951|579885388|FG001|Overall Study|Lost to Follow-up|16|||
160592318|NCT03057951|579885387|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
160592319|NCT03057951|579885388|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
160592320|NCT03057951|579885387|FG000|Overall Study|Study drug stopped, reason missing|6|||
160592321|NCT03057951|579885388|FG001|Overall Study|Study drug stopped, reason missing|1|||
160592322|NCT03057951|579885387|FG000|Overall Study|Medical advice|6|||
160592323|NCT03057951|579885388|FG001|Overall Study|Medical advice|2|||
160592324|NCT03057951|579885387|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
160592325|NCT03057951|579885388|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
160592326|NCT03057951|579885387|FG000|Overall Study|Investigator decision|2|||
160592327|NCT03057951|579885388|FG001|Overall Study|Investigator decision|0|||
160592328|NCT03057951|579885387|FG000|Overall Study|Patient decision|5|||
160592329|NCT03057951|579885388|FG001|Overall Study|Patient decision|2|||
160592330|NCT03057951|579885387|FG000|Overall Study|Not attending study visits|3|||
160592331|NCT03057951|579885388|FG001|Overall Study|Not attending study visits|0|||
160592332|NCT03057951|579885387|FG000|Overall Study|Patient moved away|3|||
160592333|NCT03057951|579885388|FG001|Overall Study|Patient moved away|4|||
160592334|NCT03057951|579885387|FG000|Overall Study|Other reason than stated above|23|||
160592335|NCT03057951|579885388|FG001|Overall Study|Other reason than stated above|29|||
160592336|NCT03057951|579885387|FG000|Overall Study|Not treated|2|||
160592337|NCT03057951|579885388|FG001|Overall Study|Not treated|1|||
160592338|NCT03434418|579885389|FG000|Overall Study|Disease Progression|11|||
160592339|NCT03434418|579885389|FG000|Overall Study|Adverse Event|2|||
160592340|NCT03434418|579885389|FG000|Overall Study|Physician Decision|1|||
160592341|NCT03434418|579885389|FG000|Overall Study|Decline in Performance Status (PS)|1|||
160976613|NCT02291289|581304594|FG012|Induction Treatment|Missing|0|||
160976614|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160592342|NCT03039738|579885391|FG000|Overall Study|Incomplete data sets|54|||
160976615|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160592343|NCT03039738|579885392|FG001|Overall Study|Incomplete data sets|0|||
160592344|NCT01293006|579885394|FG000|Period 2|Lost to Follow-up|1|||
160592345|NCT01293006|579885395|FG001|Period 2|Lost to Follow-up|0|||
160592346|NCT01293006|579885396|FG002|Period 2|Lost to Follow-up|0|||
160592347|NCT01293006|579885397|FG003|Period 2|Lost to Follow-up|0|||
160592348|NCT01494987|579885398|FG000|Overall Study|Adverse Event|6|||
160592349|NCT01494987|579885399|FG001|Overall Study|Adverse Event|5|||
160592350|NCT01494987|579885398|FG000|Overall Study|Hyperglycemia|6|||
160592351|NCT01494987|579885399|FG001|Overall Study|Hyperglycemia|4|||
160592352|NCT01494987|579885398|FG000|Overall Study|Investigator's Discretion|1|||
160592353|NCT01494987|579885399|FG001|Overall Study|Investigator's Discretion|2|||
160592354|NCT01494987|579885398|FG000|Overall Study|Lost to Follow-up|1|||
160592355|NCT01494987|579885399|FG001|Overall Study|Lost to Follow-up|1|||
160592356|NCT01494987|579885398|FG000|Overall Study|Protocol Violation|3|||
160592357|NCT01494987|579885399|FG001|Overall Study|Protocol Violation|3|||
160592358|NCT01494987|579885398|FG000|Overall Study|Subject Non-Compliance|9|||
160592359|NCT01494987|579885399|FG001|Overall Study|Subject Non-Compliance|10|||
160592360|NCT01494987|579885398|FG000|Overall Study|Subject Withdrew Consent|2|||
160592361|NCT01494987|579885399|FG001|Overall Study|Subject Withdrew Consent|3|||
160592362|NCT00205699|579885407|FG000|Overall Study|Lost to Follow-up|1|||
160592363|NCT00205699|579885408|FG001|Overall Study|Lost to Follow-up|3|||
160592364|NCT00205699|579885409|FG002|Overall Study|Lost to Follow-up|5|||
160658422|NCT00262223|580131470|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
160658423|NCT01866319|580131471|FG000|Overall Study|Adverse Event|12|||
160658424|NCT01866319|580131472|FG001|Overall Study|Adverse Event|5|||
160658425|NCT01866319|580131473|FG002|Overall Study|Adverse Event|9|||
160592365|NCT00205699|579885407|FG000|Overall Study|Adverse Event|1|||
160592366|NCT00205699|579885408|FG001|Overall Study|Adverse Event|0|||
160592367|NCT00205699|579885409|FG002|Overall Study|Adverse Event|0|||
160592368|NCT00205699|579885407|FG000|Overall Study|Withdrawal by Subject|1|||
160592369|NCT00205699|579885408|FG001|Overall Study|Withdrawal by Subject|2|||
160592370|NCT00205699|579885409|FG002|Overall Study|Withdrawal by Subject|1|||
160592371|NCT00205699|579885407|FG000|Overall Study|Lack of Efficacy|0|||
160592372|NCT00205699|579885408|FG001|Overall Study|Lack of Efficacy|1|||
160592373|NCT00205699|579885409|FG002|Overall Study|Lack of Efficacy|0|||
160592374|NCT01885078|579885410|FG000|Treatment Period|Adverse Event|52|||
160592375|NCT01885078|579885411|FG001|Treatment Period|Adverse Event|136|||
160592376|NCT01885078|579885412|FG002|Treatment Period|Adverse Event|30|||
160592377|NCT01885078|579885413|FG003|Treatment Period|Adverse Event|73|||
160592378|NCT01885078|579885414|FG004|Treatment Period|Adverse Event|17|||
160592379|NCT01885078|579885415|FG005|Treatment Period|Adverse Event|72|||
160592380|NCT01885078|579885416|FG006|Treatment Period|Adverse Event|24|||
160592381|NCT01885078|579885417|FG007|Treatment Period|Adverse Event|5|||
160592382|NCT01885078|579885418|FG008|Treatment Period|Adverse Event|0|||
160592383|NCT01885078|579885419|FG009|Treatment Period|Adverse Event|0|||
160592384|NCT01885078|579885410|FG000|Treatment Period|Death|13|||
160592385|NCT01885078|579885411|FG001|Treatment Period|Death|33|||
160592386|NCT01885078|579885412|FG002|Treatment Period|Death|5|||
160592387|NCT01885078|579885413|FG003|Treatment Period|Death|9|||
160592388|NCT01885078|579885414|FG004|Treatment Period|Death|2|||
160592389|NCT01885078|579885415|FG005|Treatment Period|Death|10|||
160592390|NCT01885078|579885416|FG006|Treatment Period|Death|3|||
160592391|NCT01885078|579885417|FG007|Treatment Period|Death|2|||
160592392|NCT01885078|579885418|FG008|Treatment Period|Death|0|||
160592393|NCT01885078|579885419|FG009|Treatment Period|Death|0|||
160592394|NCT01885078|579885410|FG000|Treatment Period|Lack of Efficacy|12|||
160592395|NCT01885078|579885411|FG001|Treatment Period|Lack of Efficacy|33|||
160592396|NCT01885078|579885412|FG002|Treatment Period|Lack of Efficacy|10|||
160592397|NCT01885078|579885413|FG003|Treatment Period|Lack of Efficacy|23|||
160592398|NCT01885078|579885414|FG004|Treatment Period|Lack of Efficacy|24|||
160592399|NCT01885078|579885415|FG005|Treatment Period|Lack of Efficacy|58|||
160592400|NCT01885078|579885416|FG006|Treatment Period|Lack of Efficacy|9|||
160592401|NCT01885078|579885417|FG007|Treatment Period|Lack of Efficacy|5|||
160592402|NCT01885078|579885418|FG008|Treatment Period|Lack of Efficacy|0|||
160592403|NCT01885078|579885419|FG009|Treatment Period|Lack of Efficacy|0|||
160592404|NCT01885078|579885410|FG000|Treatment Period|Lost to Follow-up|16|||
160592405|NCT01885078|579885411|FG001|Treatment Period|Lost to Follow-up|19|||
160592406|NCT01885078|579885412|FG002|Treatment Period|Lost to Follow-up|7|||
160592407|NCT01885078|579885413|FG003|Treatment Period|Lost to Follow-up|9|||
160592408|NCT01885078|579885414|FG004|Treatment Period|Lost to Follow-up|2|||
160592409|NCT01885078|579885415|FG005|Treatment Period|Lost to Follow-up|8|||
160592410|NCT01885078|579885416|FG006|Treatment Period|Lost to Follow-up|2|||
160592411|NCT01885078|579885417|FG007|Treatment Period|Lost to Follow-up|0|||
160592412|NCT01885078|579885418|FG008|Treatment Period|Lost to Follow-up|0|||
160976616|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976617|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976618|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
160976619|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
160976620|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976621|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976622|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976623|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976624|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
160976625|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
160976626|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976627|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Death|0|||
160976628|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Death|29|||
160976629|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Death|16|||
160976630|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Death|0|||
160976631|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Death|188|||
160976632|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Death|107|||
160976633|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Death|0|||
160976634|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Death|1|||
160976635|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Death|1|||
160976636|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Death|0|||
160976637|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Death|46|||
160976638|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Death|19|||
160976639|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Death|0|||
160976640|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Adverse Event|0|||
160976641|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Adverse Event|0|||
160976642|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Adverse Event|0|||
160976643|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Adverse Event|0|||
160976644|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Adverse Event|1|||
160976645|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Adverse Event|1|||
160976646|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Adverse Event|0|||
160976647|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Adverse Event|0|||
160976648|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Adverse Event|0|||
160976649|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Adverse Event|0|||
160976650|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Adverse Event|0|||
160592413|NCT01885078|579885419|FG009|Treatment Period|Lost to Follow-up|0|||
160592414|NCT01885078|579885410|FG000|Treatment Period|Physician Decision|19|||
160592415|NCT01885078|579885411|FG001|Treatment Period|Physician Decision|21|||
160592416|NCT01885078|579885412|FG002|Treatment Period|Physician Decision|5|||
160592417|NCT01885078|579885413|FG003|Treatment Period|Physician Decision|12|||
160592418|NCT01885078|579885414|FG004|Treatment Period|Physician Decision|9|||
160592419|NCT01885078|579885415|FG005|Treatment Period|Physician Decision|24|||
160592420|NCT01885078|579885416|FG006|Treatment Period|Physician Decision|4|||
160592421|NCT01885078|579885417|FG007|Treatment Period|Physician Decision|3|||
160592422|NCT01885078|579885418|FG008|Treatment Period|Physician Decision|0|||
160592423|NCT01885078|579885419|FG009|Treatment Period|Physician Decision|0|||
160592424|NCT01885078|579885410|FG000|Treatment Period|Protocol Violation|3|||
160592425|NCT01885078|579885411|FG001|Treatment Period|Protocol Violation|5|||
160592426|NCT01885078|579885412|FG002|Treatment Period|Protocol Violation|0|||
160592427|NCT01885078|579885413|FG003|Treatment Period|Protocol Violation|3|||
160592428|NCT01885078|579885414|FG004|Treatment Period|Protocol Violation|1|||
160592429|NCT01885078|579885415|FG005|Treatment Period|Protocol Violation|6|||
160592430|NCT01885078|579885416|FG006|Treatment Period|Protocol Violation|0|||
160592431|NCT01885078|579885417|FG007|Treatment Period|Protocol Violation|0|||
160592432|NCT01885078|579885418|FG008|Treatment Period|Protocol Violation|0|||
160592433|NCT01885078|579885419|FG009|Treatment Period|Protocol Violation|0|||
160592434|NCT01885078|579885410|FG000|Treatment Period|Sponsor Decision|245|||
160592435|NCT01885078|579885411|FG001|Treatment Period|Sponsor Decision|648|||
160592436|NCT01885078|579885412|FG002|Treatment Period|Sponsor Decision|49|||
160592437|NCT01885078|579885413|FG003|Treatment Period|Sponsor Decision|90|||
160592438|NCT01885078|579885414|FG004|Treatment Period|Sponsor Decision|20|||
160592439|NCT01885078|579885415|FG005|Treatment Period|Sponsor Decision|38|||
160592440|NCT01885078|579885416|FG006|Treatment Period|Sponsor Decision|162|||
160592441|NCT01885078|579885417|FG007|Treatment Period|Sponsor Decision|3|||
160592442|NCT01885078|579885418|FG008|Treatment Period|Sponsor Decision|0|||
160592443|NCT01885078|579885419|FG009|Treatment Period|Sponsor Decision|0|||
160592444|NCT01885078|579885410|FG000|Treatment Period|Withdrawal by Subject|72|||
160592445|NCT01885078|579885411|FG001|Treatment Period|Withdrawal by Subject|132|||
160592446|NCT01885078|579885412|FG002|Treatment Period|Withdrawal by Subject|25|||
160592447|NCT01885078|579885413|FG003|Treatment Period|Withdrawal by Subject|63|||
160592448|NCT01885078|579885414|FG004|Treatment Period|Withdrawal by Subject|15|||
160592449|NCT01885078|579885415|FG005|Treatment Period|Withdrawal by Subject|34|||
160592450|NCT01885078|579885416|FG006|Treatment Period|Withdrawal by Subject|17|||
160592451|NCT01885078|579885417|FG007|Treatment Period|Withdrawal by Subject|10|||
160592452|NCT01885078|579885418|FG008|Treatment Period|Withdrawal by Subject|0|||
160592453|NCT01885078|579885419|FG009|Treatment Period|Withdrawal by Subject|0|||
160592454|NCT01885078|579885410|FG000|Treatment Period|Other|0|||
160592455|NCT01885078|579885411|FG001|Treatment Period|Other|0|||
160592456|NCT01885078|579885412|FG002|Treatment Period|Other|0|||
160592457|NCT01885078|579885413|FG003|Treatment Period|Other|1|||
160592458|NCT01885078|579885414|FG004|Treatment Period|Other|0|||
160592459|NCT01885078|579885415|FG005|Treatment Period|Other|0|||
160592460|NCT01885078|579885416|FG006|Treatment Period|Other|0|||
160592461|NCT01885078|579885417|FG007|Treatment Period|Other|0|||
160592462|NCT01885078|579885418|FG008|Treatment Period|Other|0|||
160592463|NCT01885078|579885419|FG009|Treatment Period|Other|0|||
160592464|NCT01885078|579885410|FG000|Step-down Period|Sponsor Decision|0|||
160592465|NCT01885078|579885411|FG001|Step-down Period|Sponsor Decision|0|||
160592466|NCT01885078|579885412|FG002|Step-down Period|Sponsor Decision|0|||
160592467|NCT01885078|579885413|FG003|Step-down Period|Sponsor Decision|0|||
160592468|NCT01885078|579885414|FG004|Step-down Period|Sponsor Decision|0|||
160592469|NCT01885078|579885415|FG005|Step-down Period|Sponsor Decision|0|||
160592470|NCT01885078|579885416|FG006|Step-down Period|Sponsor Decision|0|||
160592471|NCT01885078|579885417|FG007|Step-down Period|Sponsor Decision|0|||
160592472|NCT01885078|579885418|FG008|Step-down Period|Sponsor Decision|1|||
160592473|NCT01885078|579885419|FG009|Step-down Period|Sponsor Decision|1|||
160976651|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Adverse Event|0|||
160976652|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Adverse Event|0|||
160592474|NCT01885078|579885410|FG000|Step-down Period|Adverse Event|0|||
160592475|NCT01885078|579885411|FG001|Step-down Period|Adverse Event|0|||
160658426|NCT01866319|580131471|FG000|Overall Study|Clinical progression|3|||
160658427|NCT01866319|580131472|FG001|Overall Study|Clinical progression|2|||
160658428|NCT01866319|580131473|FG002|Overall Study|Clinical progression|2|||
160658429|NCT01866319|580131471|FG000|Overall Study|Death|153|||
160592476|NCT01885078|579885412|FG002|Step-down Period|Adverse Event|0|||
160592477|NCT01885078|579885413|FG003|Step-down Period|Adverse Event|0|||
160592478|NCT01885078|579885414|FG004|Step-down Period|Adverse Event|0|||
160592479|NCT01885078|579885415|FG005|Step-down Period|Adverse Event|0|||
160592480|NCT01885078|579885416|FG006|Step-down Period|Adverse Event|0|||
160592481|NCT01885078|579885417|FG007|Step-down Period|Adverse Event|0|||
160592482|NCT01885078|579885418|FG008|Step-down Period|Adverse Event|29|||
160592483|NCT01885078|579885419|FG009|Step-down Period|Adverse Event|38|||
160592484|NCT01885078|579885410|FG000|Step-down Period|Withdrawal by Subject|0|||
160592485|NCT01885078|579885411|FG001|Step-down Period|Withdrawal by Subject|0|||
160592486|NCT01885078|579885412|FG002|Step-down Period|Withdrawal by Subject|0|||
160592487|NCT01885078|579885413|FG003|Step-down Period|Withdrawal by Subject|0|||
160592488|NCT01885078|579885414|FG004|Step-down Period|Withdrawal by Subject|0|||
160592489|NCT01885078|579885415|FG005|Step-down Period|Withdrawal by Subject|0|||
160592490|NCT01885078|579885416|FG006|Step-down Period|Withdrawal by Subject|0|||
160592491|NCT01885078|579885417|FG007|Step-down Period|Withdrawal by Subject|0|||
160592492|NCT01885078|579885418|FG008|Step-down Period|Withdrawal by Subject|25|||
160592493|NCT01885078|579885419|FG009|Step-down Period|Withdrawal by Subject|15|||
160592494|NCT01885078|579885410|FG000|Step-down Period|Physician Decision|0|||
160592495|NCT01885078|579885411|FG001|Step-down Period|Physician Decision|0|||
160592496|NCT01885078|579885412|FG002|Step-down Period|Physician Decision|0|||
160592497|NCT01885078|579885413|FG003|Step-down Period|Physician Decision|0|||
160592498|NCT01885078|579885414|FG004|Step-down Period|Physician Decision|0|||
160592499|NCT01885078|579885415|FG005|Step-down Period|Physician Decision|0|||
160592500|NCT01885078|579885416|FG006|Step-down Period|Physician Decision|0|||
160592501|NCT01885078|579885417|FG007|Step-down Period|Physician Decision|0|||
160592502|NCT01885078|579885418|FG008|Step-down Period|Physician Decision|7|||
160592503|NCT01885078|579885419|FG009|Step-down Period|Physician Decision|2|||
160592504|NCT01885078|579885410|FG000|Step-down Period|Death|0|||
160592505|NCT01885078|579885411|FG001|Step-down Period|Death|0|||
160592506|NCT01885078|579885412|FG002|Step-down Period|Death|0|||
160592507|NCT01885078|579885413|FG003|Step-down Period|Death|0|||
160592508|NCT01885078|579885414|FG004|Step-down Period|Death|0|||
160592509|NCT01885078|579885415|FG005|Step-down Period|Death|0|||
160592510|NCT01885078|579885416|FG006|Step-down Period|Death|0|||
160592511|NCT01885078|579885417|FG007|Step-down Period|Death|0|||
160592512|NCT01885078|579885418|FG008|Step-down Period|Death|4|||
160592513|NCT01885078|579885419|FG009|Step-down Period|Death|3|||
160592514|NCT01885078|579885410|FG000|Step-down Period|Lost to Follow-up|0|||
160592515|NCT01885078|579885411|FG001|Step-down Period|Lost to Follow-up|0|||
160592516|NCT01885078|579885412|FG002|Step-down Period|Lost to Follow-up|0|||
160592517|NCT01885078|579885413|FG003|Step-down Period|Lost to Follow-up|0|||
160592518|NCT01885078|579885414|FG004|Step-down Period|Lost to Follow-up|0|||
160592519|NCT01885078|579885415|FG005|Step-down Period|Lost to Follow-up|0|||
160592520|NCT01885078|579885416|FG006|Step-down Period|Lost to Follow-up|0|||
160592521|NCT01885078|579885417|FG007|Step-down Period|Lost to Follow-up|0|||
160592522|NCT01885078|579885418|FG008|Step-down Period|Lost to Follow-up|1|||
160592523|NCT01885078|579885419|FG009|Step-down Period|Lost to Follow-up|1|||
160592524|NCT01885078|579885410|FG000|Step-down Period|Lack of Efficacy|0|||
160658430|NCT01866319|580131472|FG001|Overall Study|Death|154|||
160592525|NCT01885078|579885411|FG001|Step-down Period|Lack of Efficacy|0|||
160592526|NCT01885078|579885412|FG002|Step-down Period|Lack of Efficacy|0|||
160592527|NCT01885078|579885413|FG003|Step-down Period|Lack of Efficacy|0|||
160592528|NCT01885078|579885414|FG004|Step-down Period|Lack of Efficacy|0|||
160592529|NCT01885078|579885415|FG005|Step-down Period|Lack of Efficacy|0|||
160592530|NCT01885078|579885416|FG006|Step-down Period|Lack of Efficacy|0|||
160592531|NCT01885078|579885417|FG007|Step-down Period|Lack of Efficacy|0|||
160592532|NCT01885078|579885418|FG008|Step-down Period|Lack of Efficacy|1|||
160592533|NCT01885078|579885419|FG009|Step-down Period|Lack of Efficacy|0|||
160592534|NCT01885078|579885410|FG000|Step-down Period|Protocol Violation|0|||
160592535|NCT01885078|579885411|FG001|Step-down Period|Protocol Violation|0|||
160592536|NCT01885078|579885412|FG002|Step-down Period|Protocol Violation|0|||
160592537|NCT01885078|579885413|FG003|Step-down Period|Protocol Violation|0|||
160592538|NCT01885078|579885414|FG004|Step-down Period|Protocol Violation|0|||
160592539|NCT01885078|579885415|FG005|Step-down Period|Protocol Violation|0|||
160592540|NCT01885078|579885416|FG006|Step-down Period|Protocol Violation|0|||
160658431|NCT01866319|580131473|FG002|Overall Study|Death|147|||
160976653|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976654|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
160976655|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976656|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976657|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
160976658|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
160976659|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976660|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
160976661|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976662|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976663|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
160976664|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
160976665|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976666|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
160976667|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
160976668|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
160976669|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
160976670|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
160976671|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
160976672|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
160976673|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
160976674|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
160976675|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
160976676|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
160976677|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
160976678|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
160976679|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Physician Decision|0|||
160976680|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Physician Decision|2|||
160976681|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Physician Decision|0|||
160976682|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Physician Decision|0|||
160976683|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Physician Decision|3|||
160976684|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Physician Decision|0|||
160976685|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Physician Decision|0|||
160976686|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Physician Decision|0|||
160976687|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Physician Decision|0|||
160976688|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Physician Decision|0|||
160976689|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Physician Decision|1|||
160976690|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Physician Decision|3|||
160976691|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Physician Decision|0|||
160976692|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Not Treated|0|||
160976693|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Not Treated|0|||
160976694|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Not Treated|2|||
160976695|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Not Treated|0|||
160976696|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Not Treated|0|||
160976697|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Not Treated|0|||
160976698|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Not Treated|0|||
160976699|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Not Treated|0|||
160976700|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Not Treated|0|||
160976701|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Not Treated|0|||
160976702|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Not Treated|0|||
160976703|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Not Treated|0|||
160976704|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Not Treated|0|||
160976705|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976706|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
160976707|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976708|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976709|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976710|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976711|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976712|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976713|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976714|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976715|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976716|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976717|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976718|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
160976719|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
160976720|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
160976721|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
160976722|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
160592541|NCT01885078|579885417|FG007|Step-down Period|Protocol Violation|0|||
160592542|NCT01885078|579885418|FG008|Step-down Period|Protocol Violation|1|||
160592543|NCT01885078|579885419|FG009|Step-down Period|Protocol Violation|1|||
160592544|NCT01194869|579885420|FG000|Overall Study|Disease Progression|2|||
160592545|NCT01194869|579885420|FG000|Overall Study|Toxicity|2|||
160592546|NCT06964165|579885424|FG000|Overall Study|Death|4|||
160592547|NCT06964165|579885425|FG001|Overall Study|Death|4|||
160592548|NCT06964165|579885424|FG000|Overall Study|Physician Decision|1|||
160592549|NCT06964165|579885425|FG001|Overall Study|Physician Decision|1|||
160592550|NCT06964165|579885424|FG000|Overall Study|Withdrawal by Subject|0|||
160592551|NCT06964165|579885425|FG001|Overall Study|Withdrawal by Subject|2|||
160592552|NCT06964165|579885424|FG000|Overall Study|Study terminated by sponsor|12|||
160592553|NCT06964165|579885425|FG001|Overall Study|Study terminated by sponsor|10|||
160592554|NCT06964165|579885424|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
160592555|NCT06964165|579885425|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
160592556|NCT06964165|579885424|FG000|Overall Study|Participant removed due to non-compliance|0|||
160592557|NCT06964165|579885425|FG001|Overall Study|Participant removed due to non-compliance|1|||
160592558|NCT01551758|579885426|FG000|Overall Study|Adverse Event|29|||
160592559|NCT01551758|579885427|FG001|Overall Study|Adverse Event|43|||
160592560|NCT01551758|579885426|FG000|Overall Study|Lack of Efficacy|0|||
160592561|NCT01551758|579885427|FG001|Overall Study|Lack of Efficacy|1|||
160592562|NCT01551758|579885426|FG000|Overall Study|Protocol Violation|5|||
160592563|NCT01551758|579885427|FG001|Overall Study|Protocol Violation|6|||
160592564|NCT01551758|579885426|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
160592565|NCT01551758|579885427|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
160592566|NCT01551758|579885426|FG000|Overall Study|Lost to Follow-up|29|||
160592567|NCT01551758|579885427|FG001|Overall Study|Lost to Follow-up|25|||
160592568|NCT01551758|579885426|FG000|Overall Study|Physician Decision|9|||
160592569|NCT01551758|579885427|FG001|Overall Study|Physician Decision|3|||
160592570|NCT01551758|579885426|FG000|Overall Study|Withdrawal by Subject|14|||
160592571|NCT01551758|579885427|FG001|Overall Study|Withdrawal by Subject|17|||
160592572|NCT01586156|579885429|FG000|Overall Study|Pregnancy|0|||
160592573|NCT01586156|579885430|FG001|Overall Study|Pregnancy|1|||
160592574|NCT01586156|579885431|FG002|Overall Study|Pregnancy|0|||
160592575|NCT04465396|579885434|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
160592576|NCT04465396|579885435|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
160592577|NCT04465396|579885436|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
160592578|NCT04465396|579885437|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
160592579|NCT01766817|579885445|FG000|Overall Study|Drug-related adverse event|1|||
160592580|NCT01766817|579885446|FG001|Overall Study|Drug-related adverse event|2|||
160592581|NCT01766817|579885447|FG002|Overall Study|Drug-related adverse event|1|||
160592582|NCT01766817|579885445|FG000|Overall Study|Drug-unrelated adverse event|3|||
160592583|NCT01766817|579885446|FG001|Overall Study|Drug-unrelated adverse event|3|||
160592584|NCT01766817|579885447|FG002|Overall Study|Drug-unrelated adverse event|3|||
160592585|NCT01766817|579885445|FG000|Overall Study|Death|1|||
160592586|NCT01766817|579885446|FG001|Overall Study|Death|1|||
160592587|NCT01766817|579885447|FG002|Overall Study|Death|0|||
160592588|NCT01766817|579885445|FG000|Overall Study|Unable to take study drug|0|||
160592589|NCT01766817|579885446|FG001|Overall Study|Unable to take study drug|1|||
160592590|NCT01766817|579885447|FG002|Overall Study|Unable to take study drug|0|||
160592591|NCT01766817|579885445|FG000|Overall Study|Withdrawal by Subject|2|||
160592592|NCT01766817|579885446|FG001|Overall Study|Withdrawal by Subject|0|||
160592593|NCT01766817|579885447|FG002|Overall Study|Withdrawal by Subject|3|||
160592594|NCT01766817|579885445|FG000|Overall Study|Subject non-compliance|0|||
160592595|NCT01766817|579885446|FG001|Overall Study|Subject non-compliance|1|||
160592596|NCT01766817|579885447|FG002|Overall Study|Subject non-compliance|2|||
160592597|NCT01766817|579885445|FG000|Overall Study|Physician Decision|3|||
160592598|NCT01766817|579885446|FG001|Overall Study|Physician Decision|3|||
160592599|NCT01766817|579885447|FG002|Overall Study|Physician Decision|4|||
160592600|NCT01766817|579885445|FG000|Overall Study|Other|1|||
160592601|NCT01766817|579885446|FG001|Overall Study|Other|0|||
160592602|NCT01766817|579885447|FG002|Overall Study|Other|0|||
160592603|NCT03814590|579885448|FG000|Overall Study|Adverse Event|0|||
160592604|NCT03814590|579885449|FG001|Overall Study|Adverse Event|0|||
160592605|NCT03814590|579885450|FG002|Overall Study|Adverse Event|0|||
160592606|NCT03814590|579885451|FG003|Overall Study|Adverse Event|0|||
160592607|NCT03814590|579885452|FG004|Overall Study|Adverse Event|0|||
160592608|NCT03814590|579885453|FG005|Overall Study|Adverse Event|1|||
160592609|NCT03814590|579885454|FG006|Overall Study|Adverse Event|1|||
160592610|NCT03814590|579885455|FG007|Overall Study|Adverse Event|1|||
160592611|NCT03814590|579885456|FG008|Overall Study|Adverse Event|0|||
160592612|NCT03814590|579885457|FG009|Overall Study|Adverse Event|0|||
160592613|NCT03814590|579885458|FG010|Overall Study|Adverse Event|1|||
160592614|NCT03814590|579885459|FG011|Overall Study|Adverse Event|0|||
160592615|NCT03814590|579885460|FG012|Overall Study|Adverse Event|3|||
160592616|NCT03814590|579885461|FG013|Overall Study|Adverse Event|0|||
160592617|NCT03814590|579885448|FG000|Overall Study|Lost to Follow-up|0|||
160592618|NCT03814590|579885449|FG001|Overall Study|Lost to Follow-up|2|||
160592619|NCT03814590|579885450|FG002|Overall Study|Lost to Follow-up|1|||
160592620|NCT03814590|579885451|FG003|Overall Study|Lost to Follow-up|0|||
160592621|NCT03814590|579885452|FG004|Overall Study|Lost to Follow-up|1|||
160592622|NCT03814590|579885453|FG005|Overall Study|Lost to Follow-up|1|||
160592623|NCT03814590|579885454|FG006|Overall Study|Lost to Follow-up|1|||
160592624|NCT03814590|579885455|FG007|Overall Study|Lost to Follow-up|1|||
160592625|NCT03814590|579885456|FG008|Overall Study|Lost to Follow-up|0|||
160592626|NCT03814590|579885457|FG009|Overall Study|Lost to Follow-up|0|||
160592627|NCT03814590|579885458|FG010|Overall Study|Lost to Follow-up|1|||
160592628|NCT03814590|579885459|FG011|Overall Study|Lost to Follow-up|0|||
160592629|NCT03814590|579885460|FG012|Overall Study|Lost to Follow-up|0|||
160592630|NCT03814590|579885461|FG013|Overall Study|Lost to Follow-up|1|||
160592631|NCT03814590|579885448|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592632|NCT03814590|579885449|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592633|NCT03814590|579885450|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592634|NCT03814590|579885451|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592635|NCT03814590|579885452|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592636|NCT03814590|579885453|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592637|NCT03814590|579885454|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592638|NCT03814590|579885455|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592639|NCT03814590|579885456|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592640|NCT03814590|579885457|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
160592641|NCT03814590|579885458|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592642|NCT03814590|579885459|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592643|NCT03814590|579885460|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592644|NCT03814590|579885461|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
160592645|NCT03814590|579885448|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
160592646|NCT03814590|579885449|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
160592647|NCT03814590|579885450|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
160592648|NCT03814590|579885451|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
160592649|NCT03814590|579885452|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
160592650|NCT03814590|579885453|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
160592651|NCT03814590|579885454|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
160592652|NCT03814590|579885455|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
160592653|NCT03814590|579885456|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
160592654|NCT03814590|579885457|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
160592655|NCT03814590|579885458|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
160592656|NCT03814590|579885459|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
160592657|NCT03814590|579885460|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
160592658|NCT03814590|579885461|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
160592659|NCT03814590|579885448|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592660|NCT03814590|579885449|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592661|NCT03814590|579885450|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592662|NCT03814590|579885451|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592663|NCT03814590|579885452|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592664|NCT03814590|579885453|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592665|NCT03814590|579885454|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592666|NCT03814590|579885455|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160592667|NCT03814590|579885456|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592668|NCT03814590|579885457|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160592669|NCT03814590|579885458|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592670|NCT03814590|579885459|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592671|NCT03814590|579885460|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592672|NCT03814590|579885461|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160592673|NCT03814590|579885448|FG000|Overall Study|UNKNOWN REASON|0|||
160976723|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
160976724|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
160976725|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
160976726|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
160976727|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
160976728|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
160976729|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
160976730|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
160976731|NCT02291289|581304582|FG000|Early Disease Progression|Death|0|||
160976732|NCT02291289|581304583|FG001|Early Disease Progression|Death|0|||
160976733|NCT02291289|581304584|FG002|Early Disease Progression|Death|0|||
160976734|NCT02291289|581304585|FG003|Early Disease Progression|Death|0|||
160976735|NCT02291289|581304586|FG004|Early Disease Progression|Death|0|||
160976736|NCT02291289|581304587|FG005|Early Disease Progression|Death|0|||
160976737|NCT02291289|581304588|FG006|Early Disease Progression|Death|0|||
160976738|NCT02291289|581304589|FG007|Early Disease Progression|Death|0|||
160976739|NCT02291289|581304590|FG008|Early Disease Progression|Death|0|||
160976740|NCT02291289|581304591|FG009|Early Disease Progression|Death|0|||
160976741|NCT02291289|581304592|FG010|Early Disease Progression|Death|0|||
160976742|NCT02291289|581304593|FG011|Early Disease Progression|Death|0|||
160976743|NCT02291289|581304594|FG012|Early Disease Progression|Death|10|||
160976744|NCT02291289|581304582|FG000|Early Disease Progression|Lost to Follow-up|0|||
160976745|NCT02291289|581304583|FG001|Early Disease Progression|Lost to Follow-up|0|||
160976746|NCT02291289|581304584|FG002|Early Disease Progression|Lost to Follow-up|0|||
160976747|NCT02291289|581304585|FG003|Early Disease Progression|Lost to Follow-up|0|||
160976748|NCT02291289|581304586|FG004|Early Disease Progression|Lost to Follow-up|0|||
160976749|NCT02291289|581304587|FG005|Early Disease Progression|Lost to Follow-up|0|||
160976750|NCT02291289|581304588|FG006|Early Disease Progression|Lost to Follow-up|0|||
160976751|NCT02291289|581304589|FG007|Early Disease Progression|Lost to Follow-up|0|||
160976752|NCT02291289|581304590|FG008|Early Disease Progression|Lost to Follow-up|0|||
160976753|NCT02291289|581304591|FG009|Early Disease Progression|Lost to Follow-up|0|||
160976754|NCT02291289|581304592|FG010|Early Disease Progression|Lost to Follow-up|0|||
160976755|NCT02291289|581304593|FG011|Early Disease Progression|Lost to Follow-up|0|||
160976756|NCT02291289|581304594|FG012|Early Disease Progression|Lost to Follow-up|1|||
160976757|NCT01017120|581304598|FG000|Overall Study|Adverse Event|9|||
160976758|NCT01017120|581304599|FG001|Overall Study|Adverse Event|0|||
160976759|NCT01017120|581304598|FG000|Overall Study|Lost to Follow-up|13|||
160976760|NCT01017120|581304599|FG001|Overall Study|Lost to Follow-up|11|||
160976761|NCT01017120|581304598|FG000|Overall Study|Lack of Efficacy|1|||
160976762|NCT01017120|581304599|FG001|Overall Study|Lack of Efficacy|0|||
160976763|NCT01017120|581304598|FG000|Overall Study|Withdrawal by Subject|39|||
160976764|NCT01017120|581304599|FG001|Overall Study|Withdrawal by Subject|21|||
160976765|NCT01017120|581304598|FG000|Overall Study|Pregnancy|1|||
160976766|NCT01017120|581304599|FG001|Overall Study|Pregnancy|1|||
160976767|NCT01017120|581304598|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
160976768|NCT01017120|581304599|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
160976769|NCT01017120|581304598|FG000|Overall Study|Relocated Out of Town|0|||
160976770|NCT01017120|581304599|FG001|Overall Study|Relocated Out of Town|2|||
160976771|NCT01017120|581304598|FG000|Overall Study|Protocol Violation|1|||
160976772|NCT01017120|581304599|FG001|Overall Study|Protocol Violation|0|||
160976773|NCT01017120|581304598|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
160976774|NCT01017120|581304599|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
160976775|NCT04399551|581304600|FG000|Overall Study|Adverse Event|15|||
160976776|NCT04399551|581304600|FG000|Overall Study|Withdrawal by Subject|6|||
160976777|NCT04399551|581304600|FG000|Overall Study|Physician Decision|3|||
160976778|NCT04399551|581304600|FG000|Overall Study|Lost to Follow-up|2|||
160976779|NCT04399551|581304600|FG000|Overall Study|Protocol Deviation|2|||
160976780|NCT01642602|581304604|FG000|Overall Study|Adverse Event|2|||
160976781|NCT01112514|581304605|FG000|Overall Study|Lost to Follow-up|1|||
160976782|NCT01024959|581304606|FG000|Overall Study|ineligible|12|||
160976783|NCT01024959|581304606|FG000|Overall Study|results not evaluable|12|||
160976784|NCT01024959|581304606|FG000|Overall Study|missing results required for analysis|17|||
160976785|NCT01118455|581304607|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
160976786|NCT01118455|581304608|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
160976787|NCT01912781|581304616|FG000|Overall Study|Withdrawal by Subject|2|||
160976788|NCT01912781|581304617|FG001|Overall Study|Withdrawal by Subject|0|||
160976789|NCT03377790|581304620|FG000|Overall Study|Withdrawal by Subject|1|||
160976790|NCT03377790|581304621|FG001|Overall Study|Withdrawal by Subject|0|||
160976791|NCT03377790|581304620|FG000|Overall Study|Adverse Event|1|||
160976792|NCT03377790|581304621|FG001|Overall Study|Adverse Event|0|||
160976793|NCT03377790|581304620|FG000|Overall Study|Lost to Follow-up|0|||
160976794|NCT03377790|581304621|FG001|Overall Study|Lost to Follow-up|2|||
160976795|NCT03377790|581304620|FG000|Overall Study|Randomized but not treated|1|||
160976796|NCT03377790|581304621|FG001|Overall Study|Randomized but not treated|0|||
160592674|NCT03814590|579885449|FG001|Overall Study|UNKNOWN REASON|0|||
160592675|NCT03814590|579885450|FG002|Overall Study|UNKNOWN REASON|0|||
160592676|NCT03814590|579885451|FG003|Overall Study|UNKNOWN REASON|0|||
160592677|NCT03814590|579885452|FG004|Overall Study|UNKNOWN REASON|0|||
160592678|NCT03814590|579885453|FG005|Overall Study|UNKNOWN REASON|0|||
160592679|NCT03814590|579885454|FG006|Overall Study|UNKNOWN REASON|0|||
160592680|NCT03814590|579885455|FG007|Overall Study|UNKNOWN REASON|1|||
160592681|NCT03814590|579885456|FG008|Overall Study|UNKNOWN REASON|0|||
160592682|NCT03814590|579885457|FG009|Overall Study|UNKNOWN REASON|0|||
160592683|NCT03814590|579885458|FG010|Overall Study|UNKNOWN REASON|0|||
160592684|NCT03814590|579885459|FG011|Overall Study|UNKNOWN REASON|0|||
160592685|NCT03814590|579885460|FG012|Overall Study|UNKNOWN REASON|0|||
160592686|NCT03814590|579885461|FG013|Overall Study|UNKNOWN REASON|0|||
160592687|NCT03519516|579885462|FG000|Overall Study|Adverse Event|0|||
160592688|NCT03519516|579885463|FG001|Overall Study|Adverse Event|1|||
160592689|NCT01244191|579885464|FG000|Overall Study|Progressive disease|295|||
160592690|NCT01244191|579885465|FG001|Overall Study|Progressive disease|350|||
160592691|NCT01244191|579885464|FG000|Overall Study|Clinical disease progression|54|||
160592692|NCT01244191|579885465|FG001|Overall Study|Clinical disease progression|36|||
160592693|NCT01244191|579885464|FG000|Overall Study|Adverse Event|65|||
160592694|NCT01244191|579885465|FG001|Overall Study|Adverse Event|48|||
160592695|NCT01244191|579885464|FG000|Overall Study|Death|22|||
160592696|NCT01244191|579885465|FG001|Overall Study|Death|29|||
160592697|NCT01244191|579885464|FG000|Overall Study|Lost to Follow-up|0|||
160592698|NCT01244191|579885465|FG001|Overall Study|Lost to Follow-up|2|||
160592699|NCT01244191|579885464|FG000|Overall Study|Protocol Violation|1|||
160592700|NCT01244191|579885465|FG001|Overall Study|Protocol Violation|2|||
160592701|NCT01244191|579885464|FG000|Overall Study|Withdrawal by Subject|31|||
160592702|NCT01244191|579885465|FG001|Overall Study|Withdrawal by Subject|23|||
160592703|NCT01244191|579885464|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
160592704|NCT01244191|579885465|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
160592705|NCT01752842|579885466|FG000|Overall Study|Adverse Event|3|||
160592706|NCT01752842|579885467|FG001|Overall Study|Adverse Event|0|||
160592707|NCT01752842|579885466|FG000|Overall Study|Withdrawal by Subject|0|||
160592708|NCT01752842|579885467|FG001|Overall Study|Withdrawal by Subject|2|||
160592709|NCT02164513|579885468|FG000|Overall Study|Adverse Event|162|||
160592710|NCT02164513|579885469|FG001|Overall Study|Adverse Event|180|||
160592711|NCT02164513|579885470|FG002|Overall Study|Adverse Event|111|||
160592712|NCT02164513|579885468|FG000|Overall Study|Other: Study Closed or terminated|5|||
160592713|NCT02164513|579885469|FG001|Overall Study|Other: Study Closed or terminated|2|||
160592714|NCT02164513|579885470|FG002|Overall Study|Other: Study Closed or terminated|4|||
160592715|NCT02164513|579885468|FG000|Overall Study|Lost to Follow-up|30|||
160592716|NCT02164513|579885469|FG001|Overall Study|Lost to Follow-up|36|||
160592717|NCT02164513|579885470|FG002|Overall Study|Lost to Follow-up|22|||
160592718|NCT02164513|579885468|FG000|Overall Study|Physician Decision|47|||
160592719|NCT02164513|579885469|FG001|Overall Study|Physician Decision|57|||
160592720|NCT02164513|579885470|FG002|Overall Study|Physician Decision|28|||
160592721|NCT02164513|579885468|FG000|Overall Study|Withdrawal by Subject|192|||
160592722|NCT02164513|579885469|FG001|Overall Study|Withdrawal by Subject|261|||
160592723|NCT02164513|579885470|FG002|Overall Study|Withdrawal by Subject|130|||
160592724|NCT02164513|579885468|FG000|Overall Study|Other: Reason not provided by site|1|||
160592725|NCT02164513|579885469|FG001|Overall Study|Other: Reason not provided by site|0|||
160592726|NCT02164513|579885470|FG002|Overall Study|Other: Reason not provided by site|0|||
160592727|NCT05301322|579885471|FG000|Overall Study|Adverse Event|7|||
160592728|NCT05301322|579885472|FG001|Overall Study|Adverse Event|3|||
160592729|NCT05301322|579885471|FG000|Overall Study|Death|0|||
160592730|NCT05301322|579885472|FG001|Overall Study|Death|1|||
160592731|NCT05301322|579885471|FG000|Overall Study|Lost to Follow-up|2|||
160592732|NCT05301322|579885472|FG001|Overall Study|Lost to Follow-up|1|||
160592733|NCT05301322|579885471|FG000|Overall Study|Protocol Violation|3|||
160592734|NCT05301322|579885472|FG001|Overall Study|Protocol Violation|1|||
160592735|NCT05301322|579885471|FG000|Overall Study|Withdrawal by Subject|3|||
160592736|NCT05301322|579885472|FG001|Overall Study|Withdrawal by Subject|0|||
160592737|NCT05301322|579885471|FG000|Overall Study|Other|4|||
160592738|NCT05301322|579885472|FG001|Overall Study|Other|0|||
160592739|NCT04971785|579885473|FG000|Overall Study|Withdrew Consent|5|||
160592740|NCT04971785|579885474|FG001|Overall Study|Withdrew Consent|5|||
160592741|NCT04971785|579885475|FG002|Overall Study|Withdrew Consent|17|||
160592742|NCT04971785|579885476|FG003|Overall Study|Withdrew Consent|7|||
160658432|NCT01866319|580131471|FG000|Overall Study|Lost to Follow-up|6|||
160976797|NCT03377790|581304620|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
160976798|NCT03377790|581304621|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
160976799|NCT01533714|581304622|FG000|Overall Study|Adverse Event|0|||
160976800|NCT01533714|581304623|FG001|Overall Study|Adverse Event|1|||
160976801|NCT01533714|581304624|FG002|Overall Study|Adverse Event|2|||
160976802|NCT01533714|581304625|FG003|Overall Study|Adverse Event|2|||
160976803|NCT01533714|581304626|FG004|Overall Study|Adverse Event|2|||
160976804|NCT01533714|581304627|FG005|Overall Study|Adverse Event|1|||
160976805|NCT01533714|581304622|FG000|Overall Study|Lack of Efficacy|0|||
160976806|NCT01533714|581304623|FG001|Overall Study|Lack of Efficacy|0|||
160976807|NCT01533714|581304624|FG002|Overall Study|Lack of Efficacy|0|||
160976808|NCT01533714|581304625|FG003|Overall Study|Lack of Efficacy|0|||
160976809|NCT01533714|581304626|FG004|Overall Study|Lack of Efficacy|0|||
160976810|NCT01533714|581304627|FG005|Overall Study|Lack of Efficacy|1|||
160976811|NCT01533714|581304622|FG000|Overall Study|Withdrawal by Subject|0|||
160976812|NCT01533714|581304623|FG001|Overall Study|Withdrawal by Subject|1|||
160976813|NCT01533714|581304624|FG002|Overall Study|Withdrawal by Subject|0|||
160976814|NCT01533714|581304625|FG003|Overall Study|Withdrawal by Subject|1|||
160976815|NCT01533714|581304626|FG004|Overall Study|Withdrawal by Subject|1|||
160976816|NCT01533714|581304627|FG005|Overall Study|Withdrawal by Subject|0|||
160976817|NCT01533714|581304622|FG000|Overall Study|Exclusion criteria|0|||
160976818|NCT01533714|581304623|FG001|Overall Study|Exclusion criteria|1|||
160976819|NCT01533714|581304624|FG002|Overall Study|Exclusion criteria|0|||
160592743|NCT04971785|579885473|FG000|Overall Study|Adverse Event|7|||
160592744|NCT04971785|579885474|FG001|Overall Study|Adverse Event|8|||
160592745|NCT04971785|579885475|FG002|Overall Study|Adverse Event|6|||
160592746|NCT04971785|579885476|FG003|Overall Study|Adverse Event|3|||
160592747|NCT04971785|579885473|FG000|Overall Study|Lost to Follow-up|2|||
160976820|NCT01533714|581304625|FG003|Overall Study|Exclusion criteria|0|||
160976821|NCT01533714|581304626|FG004|Overall Study|Exclusion criteria|0|||
160976822|NCT01533714|581304627|FG005|Overall Study|Exclusion criteria|0|||
160658433|NCT01866319|580131472|FG001|Overall Study|Lost to Follow-up|3|||
160658434|NCT01866319|580131473|FG002|Overall Study|Lost to Follow-up|8|||
160658435|NCT01866319|580131471|FG000|Overall Study|Physician Decision|1|||
160658436|NCT01866319|580131472|FG001|Overall Study|Physician Decision|0|||
160976823|NCT01533714|581304622|FG000|Overall Study|Positive for purified protein derivative|0|||
160976824|NCT01533714|581304623|FG001|Overall Study|Positive for purified protein derivative|0|||
160976825|NCT01533714|581304624|FG002|Overall Study|Positive for purified protein derivative|1|||
160976826|NCT01533714|581304625|FG003|Overall Study|Positive for purified protein derivative|0|||
160976827|NCT01533714|581304626|FG004|Overall Study|Positive for purified protein derivative|1|||
160976828|NCT01533714|581304627|FG005|Overall Study|Positive for purified protein derivative|0|||
160976829|NCT01533714|581304622|FG000|Overall Study|Withdrawal criteria|0|||
160976830|NCT01533714|581304623|FG001|Overall Study|Withdrawal criteria|0|||
160976831|NCT01533714|581304624|FG002|Overall Study|Withdrawal criteria|1|||
160976832|NCT01533714|581304625|FG003|Overall Study|Withdrawal criteria|0|||
160976833|NCT01533714|581304626|FG004|Overall Study|Withdrawal criteria|3|||
160976834|NCT01533714|581304627|FG005|Overall Study|Withdrawal criteria|1|||
160976835|NCT01533714|581304622|FG000|Overall Study|Ineligibility reason|0|||
160976836|NCT01533714|581304623|FG001|Overall Study|Ineligibility reason|0|||
160976837|NCT01533714|581304624|FG002|Overall Study|Ineligibility reason|0|||
160976838|NCT01533714|581304625|FG003|Overall Study|Ineligibility reason|1|||
160976839|NCT01533714|581304626|FG004|Overall Study|Ineligibility reason|0|||
160976840|NCT01533714|581304627|FG005|Overall Study|Ineligibility reason|0|||
160976841|NCT05033743|581304628|FG000|Overall Study|Lost to Follow-up|1|||
160976842|NCT05033743|581304628|FG000|Overall Study|Protocol Violation|2|||
160976843|NCT05033743|581304628|FG000|Overall Study|Withdrawal by Subject|1|||
160976844|NCT02564055|581304629|FG000|Overall Study|Adverse Event|1|||
160976845|NCT02564055|581304630|FG001|Overall Study|Adverse Event|0|||
160976846|NCT02564055|581304631|FG002|Overall Study|Adverse Event|4|||
160976847|NCT02564055|581304632|FG003|Overall Study|Adverse Event|1|||
160976848|NCT02564055|581304633|FG004|Overall Study|Adverse Event|4|||
160976849|NCT02564055|581304634|FG005|Overall Study|Adverse Event|1|||
160976850|NCT02564055|581304629|FG000|Overall Study|Protocol Violation|1|||
160976851|NCT02564055|581304630|FG001|Overall Study|Protocol Violation|0|||
160976852|NCT02564055|581304631|FG002|Overall Study|Protocol Violation|0|||
160976853|NCT02564055|581304632|FG003|Overall Study|Protocol Violation|0|||
160976854|NCT02564055|581304633|FG004|Overall Study|Protocol Violation|0|||
160976855|NCT02564055|581304634|FG005|Overall Study|Protocol Violation|0|||
160976856|NCT02564055|581304629|FG000|Overall Study|Reached stopping criteria|0|||
160976857|NCT02564055|581304630|FG001|Overall Study|Reached stopping criteria|0|||
160976858|NCT02564055|581304631|FG002|Overall Study|Reached stopping criteria|0|||
160976859|NCT02564055|581304632|FG003|Overall Study|Reached stopping criteria|0|||
160976860|NCT02564055|581304633|FG004|Overall Study|Reached stopping criteria|0|||
160976861|NCT02564055|581304634|FG005|Overall Study|Reached stopping criteria|1|||
160976862|NCT02564055|581304629|FG000|Overall Study|Lost to Follow-up|0|||
160976863|NCT02564055|581304630|FG001|Overall Study|Lost to Follow-up|1|||
160976864|NCT02564055|581304631|FG002|Overall Study|Lost to Follow-up|4|||
160976865|NCT02564055|581304632|FG003|Overall Study|Lost to Follow-up|2|||
160976866|NCT02564055|581304633|FG004|Overall Study|Lost to Follow-up|1|||
160976867|NCT02564055|581304634|FG005|Overall Study|Lost to Follow-up|0|||
160976868|NCT02564055|581304629|FG000|Overall Study|Physician Decision|0|||
160976869|NCT02564055|581304630|FG001|Overall Study|Physician Decision|0|||
160976870|NCT02564055|581304631|FG002|Overall Study|Physician Decision|1|||
160976871|NCT02564055|581304632|FG003|Overall Study|Physician Decision|0|||
160976872|NCT02564055|581304633|FG004|Overall Study|Physician Decision|0|||
160976873|NCT02564055|581304634|FG005|Overall Study|Physician Decision|0|||
160976874|NCT02564055|581304629|FG000|Overall Study|Withdrawal by Subject|4|||
160976875|NCT02564055|581304630|FG001|Overall Study|Withdrawal by Subject|4|||
160592748|NCT04971785|579885474|FG001|Overall Study|Lost to Follow-up|1|||
160592749|NCT04971785|579885475|FG002|Overall Study|Lost to Follow-up|6|||
160592750|NCT04971785|579885476|FG003|Overall Study|Lost to Follow-up|7|||
160592751|NCT04971785|579885473|FG000|Overall Study|Protocol Violation|3|||
160976876|NCT02564055|581304631|FG002|Overall Study|Withdrawal by Subject|3|||
160976877|NCT02564055|581304632|FG003|Overall Study|Withdrawal by Subject|3|||
160976878|NCT02564055|581304633|FG004|Overall Study|Withdrawal by Subject|10|||
160976879|NCT02564055|581304634|FG005|Overall Study|Withdrawal by Subject|10|||
160976880|NCT04161807|581304636|FG000|Overall Study|Withdrawal by Subject|2|||
160976881|NCT04161807|581304636|FG000|Overall Study|Performed only 1 treatment|2|||
160976882|NCT00708305|581304643|FG000|Period 1|Protocol Violation|1|||
160976883|NCT00708305|581304644|FG001|Period 1|Protocol Violation|0|||
160976884|NCT00708305|581304645|FG002|Period 1|Protocol Violation|1|||
160976885|NCT00708305|581304646|FG003|Period 1|Protocol Violation|0|||
160976886|NCT00708305|581304643|FG000|Period 1|Other Reason|0|||
160976887|NCT00708305|581304644|FG001|Period 1|Other Reason|0|||
160976888|NCT00708305|581304645|FG002|Period 1|Other Reason|0|||
160976889|NCT00708305|581304646|FG003|Period 1|Other Reason|2|||
160976890|NCT00708305|581304643|FG000|Period 2|Lost to Follow-up|0|||
160976891|NCT00708305|581304644|FG001|Period 2|Lost to Follow-up|1|||
160976892|NCT00708305|581304645|FG002|Period 2|Lost to Follow-up|0|||
160976893|NCT00708305|581304646|FG003|Period 2|Lost to Follow-up|0|||
160976894|NCT00708305|581304643|FG000|Period 2|Protocol Violation|0|||
160976895|NCT00708305|581304644|FG001|Period 2|Protocol Violation|1|||
160976896|NCT00708305|581304645|FG002|Period 2|Protocol Violation|0|||
160976897|NCT00708305|581304646|FG003|Period 2|Protocol Violation|0|||
160976898|NCT00708305|581304643|FG000|Period 2|Other Reason|1|||
160976899|NCT00708305|581304644|FG001|Period 2|Other Reason|0|||
160976900|NCT00708305|581304645|FG002|Period 2|Other Reason|0|||
160976901|NCT00708305|581304646|FG003|Period 2|Other Reason|1|||
160976902|NCT00708305|581304643|FG000|Period 3|Protocol Violation|0|||
160976903|NCT00708305|581304644|FG001|Period 3|Protocol Violation|2|||
160976904|NCT00708305|581304645|FG002|Period 3|Protocol Violation|0|||
160976905|NCT00708305|581304646|FG003|Period 3|Protocol Violation|0|||
160976906|NCT00708305|581304643|FG000|Period 3|Other Reason|1|||
160976907|NCT00708305|581304644|FG001|Period 3|Other Reason|0|||
160976908|NCT00708305|581304645|FG002|Period 3|Other Reason|0|||
160976909|NCT00708305|581304646|FG003|Period 3|Other Reason|0|||
160976910|NCT00192023|581304651|FG000|Period III - Double-Blind|Adverse Event|3|||
160976911|NCT00192023|581304652|FG001|Period III - Double-Blind|Adverse Event|0|||
160976912|NCT00192023|581304651|FG000|Period III - Double-Blind|Physician Decision|2|||
160976913|NCT00192023|581304652|FG001|Period III - Double-Blind|Physician Decision|0|||
160976914|NCT00192023|581304651|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
160976915|NCT00192023|581304652|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
160976916|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
160976917|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
160976918|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
160976919|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
160976920|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
160976921|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
160976922|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
160976923|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
160976924|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
160976925|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
160976926|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
160976927|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
160976928|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
160976929|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
160976930|NCT02572817|581304678|FG000|Overall Study|Death|6|||
160976931|NCT02572817|581304679|FG001|Overall Study|Death|3|||
160976932|NCT02572817|581304678|FG000|Overall Study|Lost to Follow-up|3|||
160976933|NCT02572817|581304679|FG001|Overall Study|Lost to Follow-up|3|||
160976934|NCT00758160|581304684|FG000|Overall Study|No Longer Requires Study Medication|4|||
160976935|NCT00758160|581304684|FG000|Overall Study|Administration Problems|3|||
160976936|NCT00758160|581304684|FG000|Overall Study|Adverse Event|15|||
160976937|NCT00758160|581304684|FG000|Overall Study|Lack of Efficacy|10|||
160976938|NCT00758160|581304684|FG000|Overall Study|Lost to Follow-up|14|||
160976939|NCT00758160|581304684|FG000|Overall Study|Protocol Violation|12|||
160976940|NCT00758160|581304684|FG000|Overall Study|Withdrawal by Subject|8|||
160976941|NCT01108510|581304688|FG000|Overall Study|Randomized but Not Treated|5|||
160976942|NCT01108510|581304689|FG001|Overall Study|Randomized but Not Treated|1|||
160976943|NCT01108510|581304688|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
160976944|NCT01108510|581304689|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
160976945|NCT01108510|581304688|FG000|Overall Study|Adverse Event|26|||
160976946|NCT01108510|581304689|FG001|Overall Study|Adverse Event|19|||
160976947|NCT01108510|581304688|FG000|Overall Study|Lost to Follow-up|20|||
160976948|NCT01108510|581304689|FG001|Overall Study|Lost to Follow-up|17|||
160976949|NCT01108510|581304688|FG000|Overall Study|Withdrew Consent|21|||
160592752|NCT04971785|579885474|FG001|Overall Study|Protocol Violation|1|||
160592753|NCT04971785|579885475|FG002|Overall Study|Protocol Violation|1|||
160592754|NCT04971785|579885476|FG003|Overall Study|Protocol Violation|2|||
160592755|NCT04971785|579885473|FG000|Overall Study|Investigator's Discretion|3|||
160976950|NCT01108510|581304689|FG001|Overall Study|Withdrew Consent|15|||
160976951|NCT01108510|581304688|FG000|Overall Study|Investigator's Discretion|12|||
160976952|NCT01108510|581304689|FG001|Overall Study|Investigator's Discretion|10|||
160976953|NCT01108510|581304688|FG000|Overall Study|Participant Noncompliance|5|||
160976954|NCT01108510|581304689|FG001|Overall Study|Participant Noncompliance|7|||
160976955|NCT01108510|581304688|FG000|Overall Study|Lack of Efficacy|3|||
160976956|NCT01108510|581304689|FG001|Overall Study|Lack of Efficacy|0|||
160976957|NCT01108510|581304688|FG000|Overall Study|Pregnancy|0|||
160976958|NCT01108510|581304689|FG001|Overall Study|Pregnancy|3|||
160976959|NCT01108510|581304688|FG000|Overall Study|Death|1|||
160976960|NCT01108510|581304689|FG001|Overall Study|Death|1|||
160976961|NCT01258660|581304690|FG000|Overall Study|Adverse Event|2|||
160976962|NCT01258660|581304691|FG001|Overall Study|Adverse Event|4|||
160976963|NCT01258660|581304690|FG000|Overall Study|Withdrawal by Subject|3|||
160976964|NCT01258660|581304691|FG001|Overall Study|Withdrawal by Subject|0|||
160976965|NCT01258660|581304690|FG000|Overall Study|due to relocation|2|||
160976966|NCT01258660|581304691|FG001|Overall Study|due to relocation|0|||
160976967|NCT01258660|581304690|FG000|Overall Study|Protocol Violation|0|||
160976968|NCT01258660|581304691|FG001|Overall Study|Protocol Violation|1|||
160976969|NCT01258660|581304690|FG000|Overall Study|Invalid for primary analysis data set|4|||
160976970|NCT01258660|581304691|FG001|Overall Study|Invalid for primary analysis data set|6|||
160976971|NCT00582491|581304692|FG000|Overall Study|Withdrawal by Subject|1|||
160976972|NCT00582491|581304693|FG001|Overall Study|Withdrawal by Subject|0|||
160976973|NCT04192630|581304696|FG000|Overall Study|Discontinued before surgery|2|||
160976974|NCT04192630|581304697|FG001|Overall Study|Discontinued before surgery|0|||
160976975|NCT04192630|581304696|FG000|Overall Study|Discontinued after surgery|5|||
160976976|NCT04192630|581304697|FG001|Overall Study|Discontinued after surgery|3|||
160976977|NCT01193582|581304698|FG000|Vaccination Series|Withdrawal by Subject|11|||
160592756|NCT04971785|579885474|FG001|Overall Study|Investigator's Discretion|1|||
160592757|NCT04971785|579885475|FG002|Overall Study|Investigator's Discretion|1|||
160592758|NCT04971785|579885476|FG003|Overall Study|Investigator's Discretion|0|||
160592759|NCT04971785|579885473|FG000|Overall Study|Randomized but Never Treated|1|||
160592760|NCT04971785|579885474|FG001|Overall Study|Randomized but Never Treated|2|||
160592761|NCT04971785|579885475|FG002|Overall Study|Randomized but Never Treated|0|||
160592762|NCT04971785|579885476|FG003|Overall Study|Randomized but Never Treated|1|||
160592763|NCT04971785|579885473|FG000|Overall Study|Death|0|||
160592764|NCT04971785|579885474|FG001|Overall Study|Death|1|||
160592765|NCT04971785|579885475|FG002|Overall Study|Death|1|||
160592766|NCT04971785|579885476|FG003|Overall Study|Death|0|||
160592767|NCT04971785|579885473|FG000|Overall Study|Site Terminated by Sponsor|1|||
160592768|NCT04971785|579885474|FG001|Overall Study|Site Terminated by Sponsor|1|||
160592769|NCT04971785|579885475|FG002|Overall Study|Site Terminated by Sponsor|0|||
160592770|NCT04971785|579885476|FG003|Overall Study|Site Terminated by Sponsor|0|||
160592771|NCT01283997|579887246|FG000|Overall Study|Physician Decision|8|||
160592772|NCT01283997|579887247|FG001|Overall Study|Physician Decision|10|||
160592773|NCT01283997|579887246|FG000|Overall Study|Withdrawal by Subject|3|||
160976978|NCT01193582|581304699|FG001|Vaccination Series|Withdrawal by Subject|13|||
160976979|NCT01193582|581304700|FG002|Vaccination Series|Withdrawal by Subject|8|||
160976980|NCT01193582|581304701|FG003|Vaccination Series|Withdrawal by Subject|3|||
160976981|NCT01193582|581304698|FG000|12 Month Follow-up|Death|0|||
160592774|NCT01283997|579887247|FG001|Overall Study|Withdrawal by Subject|2|||
160592775|NCT01283997|579887246|FG000|Overall Study|Physically unable to continue|0|||
160592776|NCT01283997|579887247|FG001|Overall Study|Physically unable to continue|1|||
160592777|NCT01283997|579887246|FG000|Overall Study|Progressive disease|1|||
160592778|NCT01283997|579887247|FG001|Overall Study|Progressive disease|0|||
160592779|NCT01283997|579887246|FG000|Overall Study|Other|4|||
160592780|NCT01283997|579887247|FG001|Overall Study|Other|4|||
160592781|NCT02109744|579887248|FG000|Overall Study|Death|1|||
160592782|NCT02109744|579887249|FG001|Overall Study|Death|1|||
160592783|NCT02109744|579887248|FG000|Overall Study|no marrow exam|1|||
160592784|NCT02109744|579887249|FG001|Overall Study|no marrow exam|0|||
160976982|NCT01193582|581304699|FG001|12 Month Follow-up|Death|0|||
160976983|NCT01193582|581304700|FG002|12 Month Follow-up|Death|1|||
160592785|NCT00255034|579887254|FG000|Overall Study|Withdrawal by Subject|15|||
160592786|NCT00255034|579887255|FG001|Overall Study|Withdrawal by Subject|38|||
160592787|NCT00424346|579887256|FG000|Core Study|Adverse Event|5|||
160592788|NCT00424346|579887257|FG001|Core Study|Adverse Event|3|||
160592789|NCT00424346|579887258|FG002|Core Study|Adverse Event|1|||
160592790|NCT00424346|579887259|FG003|Core Study|Adverse Event|1|||
160592791|NCT00424346|579887256|FG000|Core Study|Abnormal Laboratory Values|0|||
160976984|NCT01193582|581304701|FG003|12 Month Follow-up|Death|0|||
160976985|NCT01193582|581304698|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
160976986|NCT01193582|581304699|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
160976987|NCT01193582|581304700|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
160976988|NCT01193582|581304701|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
160976989|NCT00779584|581304702|FG000|Overall Study|Protocol Violation|0|||
160976990|NCT00779584|581304703|FG001|Overall Study|Protocol Violation|0|||
160976991|NCT00779584|581304704|FG002|Overall Study|Protocol Violation|0|||
160976992|NCT00779584|581304705|FG003|Overall Study|Protocol Violation|0|||
160976993|NCT00779584|581304706|FG004|Overall Study|Protocol Violation|0|||
160976994|NCT00779584|581304707|FG005|Overall Study|Protocol Violation|1|||
160976995|NCT00779584|581304708|FG006|Overall Study|Protocol Violation|0|||
160976996|NCT00779584|581304709|FG007|Overall Study|Protocol Violation|0|||
160976997|NCT00779584|581304710|FG008|Overall Study|Protocol Violation|0|||
160976998|NCT00779584|581304702|FG000|Overall Study|Withdrawal by Subject|1|||
160976999|NCT00779584|581304703|FG001|Overall Study|Withdrawal by Subject|1|||
160977000|NCT00779584|581304704|FG002|Overall Study|Withdrawal by Subject|2|||
160977001|NCT00779584|581304705|FG003|Overall Study|Withdrawal by Subject|0|||
160977002|NCT00779584|581304706|FG004|Overall Study|Withdrawal by Subject|0|||
160592792|NCT00424346|579887257|FG001|Core Study|Abnormal Laboratory Values|1|||
160592793|NCT00424346|579887258|FG002|Core Study|Abnormal Laboratory Values|0|||
160977003|NCT00779584|581304707|FG005|Overall Study|Withdrawal by Subject|2|||
160592794|NCT00424346|579887259|FG003|Core Study|Abnormal Laboratory Values|0|||
160592795|NCT00424346|579887256|FG000|Core Study|Lack of Efficacy|1|||
160592796|NCT00424346|579887257|FG001|Core Study|Lack of Efficacy|3|||
160592797|NCT00424346|579887258|FG002|Core Study|Lack of Efficacy|0|||
160592798|NCT00424346|579887259|FG003|Core Study|Lack of Efficacy|4|||
160592799|NCT00424346|579887256|FG000|Core Study|Withdrawal by Subject|1|||
160592800|NCT00424346|579887257|FG001|Core Study|Withdrawal by Subject|0|||
160592801|NCT00424346|579887258|FG002|Core Study|Withdrawal by Subject|0|||
160592802|NCT00424346|579887259|FG003|Core Study|Withdrawal by Subject|2|||
160592803|NCT00424346|579887256|FG000|Core Study|Lost to Follow-up|1|||
160592804|NCT00424346|579887257|FG001|Core Study|Lost to Follow-up|1|||
160592805|NCT00424346|579887258|FG002|Core Study|Lost to Follow-up|0|||
160592806|NCT00424346|579887259|FG003|Core Study|Lost to Follow-up|0|||
160592807|NCT00424346|579887256|FG000|Core Study|Administrative Problems|1|||
160592808|NCT00424346|579887257|FG001|Core Study|Administrative Problems|0|||
160592809|NCT00424346|579887258|FG002|Core Study|Administrative Problems|1|||
160592810|NCT00424346|579887259|FG003|Core Study|Administrative Problems|0|||
160592811|NCT00424346|579887256|FG000|Core Study|Protocol Violation|0|||
160592812|NCT00424346|579887257|FG001|Core Study|Protocol Violation|0|||
160592813|NCT00424346|579887258|FG002|Core Study|Protocol Violation|2|||
160592814|NCT00424346|579887259|FG003|Core Study|Protocol Violation|0|||
160592815|NCT00424346|579887256|FG000|Extension Phase|Adverse Event|0|||
160592816|NCT00424346|579887257|FG001|Extension Phase|Adverse Event|9|||
160592817|NCT00424346|579887258|FG002|Extension Phase|Adverse Event|5|||
160592818|NCT00424346|579887259|FG003|Extension Phase|Adverse Event|4|||
160592819|NCT00424346|579887256|FG000|Extension Phase|Lack of Efficacy|0|||
160592820|NCT00424346|579887257|FG001|Extension Phase|Lack of Efficacy|16|||
160592821|NCT00424346|579887258|FG002|Extension Phase|Lack of Efficacy|14|||
160592822|NCT00424346|579887259|FG003|Extension Phase|Lack of Efficacy|11|||
160592823|NCT00424346|579887256|FG000|Extension Phase|Withdrawal by Subject|0|||
160592824|NCT00424346|579887257|FG001|Extension Phase|Withdrawal by Subject|5|||
160592825|NCT00424346|579887258|FG002|Extension Phase|Withdrawal by Subject|3|||
160592826|NCT00424346|579887259|FG003|Extension Phase|Withdrawal by Subject|4|||
160592827|NCT00424346|579887256|FG000|Extension Phase|Lost to Follow-up|0|||
160592828|NCT00424346|579887257|FG001|Extension Phase|Lost to Follow-up|2|||
160592829|NCT00424346|579887258|FG002|Extension Phase|Lost to Follow-up|0|||
160592830|NCT00424346|579887259|FG003|Extension Phase|Lost to Follow-up|0|||
160592831|NCT00424346|579887256|FG000|Extension Phase|Administrative Problems|0|||
160592832|NCT00424346|579887257|FG001|Extension Phase|Administrative Problems|69|||
160592833|NCT00424346|579887258|FG002|Extension Phase|Administrative Problems|32|||
160592834|NCT00424346|579887259|FG003|Extension Phase|Administrative Problems|35|||
160592835|NCT00424346|579887256|FG000|Extension Phase|Death|0|||
160592836|NCT00424346|579887257|FG001|Extension Phase|Death|0|||
160592837|NCT00424346|579887258|FG002|Extension Phase|Death|0|||
160592838|NCT00424346|579887259|FG003|Extension Phase|Death|1|||
160592839|NCT00424346|579887256|FG000|Extension Phase|Protocol Violation|0|||
160592840|NCT00424346|579887257|FG001|Extension Phase|Protocol Violation|1|||
160592841|NCT00424346|579887258|FG002|Extension Phase|Protocol Violation|1|||
160592842|NCT00424346|579887259|FG003|Extension Phase|Protocol Violation|0|||
160592843|NCT03947255|579887260|FG000|Overall Study|Study Closure by Sponsor|2|||
160592844|NCT03947255|579887261|FG001|Overall Study|Study Closure by Sponsor|2|||
160658437|NCT01866319|580131473|FG002|Overall Study|Physician Decision|1|||
160592845|NCT03947255|579887260|FG000|Overall Study|Withdrawal by Subject|2|||
160592846|NCT03947255|579887261|FG001|Overall Study|Withdrawal by Subject|2|||
160592847|NCT03947255|579887260|FG000|Overall Study|Lost to Follow-up|2|||
160592848|NCT03947255|579887261|FG001|Overall Study|Lost to Follow-up|0|||
160592849|NCT03947255|579887260|FG000|Overall Study|Death|0|||
160592850|NCT03947255|579887261|FG001|Overall Study|Death|2|||
160592851|NCT00781963|579887266|FG000|Overall Study|Death|3|||
160592852|NCT00781963|579887267|FG001|Overall Study|Death|0|||
160592853|NCT00781963|579887266|FG000|Overall Study|Lost to Follow-up|2|||
160592854|NCT00781963|579887267|FG001|Overall Study|Lost to Follow-up|1|||
160592855|NCT00781963|579887266|FG000|Overall Study|Withdrawal by Subject|3|||
160592856|NCT00781963|579887267|FG001|Overall Study|Withdrawal by Subject|1|||
160592857|NCT00781963|579887266|FG000|Overall Study|Refused follow-up|9|||
160592858|NCT00781963|579887267|FG001|Overall Study|Refused follow-up|0|||
160592859|NCT03297216|579887268|FG000|Overall Study|Death|0|||
160592860|NCT03297216|579887269|FG001|Overall Study|Death|1|||
160592861|NCT03297216|579887268|FG000|Overall Study|Miscarriage|0|||
160592862|NCT03297216|579887269|FG001|Overall Study|Miscarriage|2|||
160592863|NCT03297216|579887268|FG000|Overall Study|Lost to Follow-up|3|||
160592864|NCT03297216|579887269|FG001|Overall Study|Lost to Follow-up|2|||
160592865|NCT00912340|579887273|FG000|Overall Study|Adverse Event|2|||
160592866|NCT00912340|579887274|FG001|Overall Study|Adverse Event|4|||
160592867|NCT00912340|579887275|FG002|Overall Study|Adverse Event|0|||
160592868|NCT00912340|579887273|FG000|Overall Study|Protocol revised to remove arm|0|||
160592869|NCT00912340|579887274|FG001|Overall Study|Protocol revised to remove arm|0|||
160592870|NCT00912340|579887275|FG002|Overall Study|Protocol revised to remove arm|4|||
160592871|NCT00953225|579887280|FG000|Overall Study|Withdrawal by Subject|2|||
160592872|NCT00953225|579887281|FG001|Overall Study|Withdrawal by Subject|0|||
160592873|NCT02254551|579887282|FG000|Dose Escalation|Physician Decision|1|||
160592874|NCT02254551|579887282|FG000|Dose Escalation|Dose-limiting toxicity|2|||
160592875|NCT04058158|579887283|FG000|Period 1|Death|1|||
160592876|NCT04058158|579887284|FG001|Period 1|Death|0|||
160592877|NCT04058158|579887283|FG000|Period 1|Adverse Event|1|||
160592878|NCT04058158|579887284|FG001|Period 1|Adverse Event|1|||
160592879|NCT04058158|579887283|FG000|Period 1|Pregnancy|0|||
160592880|NCT04058158|579887284|FG001|Period 1|Pregnancy|1|||
160592881|NCT01634113|579887285|FG000|Overall Study|Not treated|0|||
160592882|NCT01634113|579887286|FG001|Overall Study|Not treated|0|||
160592883|NCT01634113|579887287|FG002|Overall Study|Not treated|1|||
160592884|NCT00520299|579887290|FG000|Overall Study|Withdrawal by Subject|0|||
160592885|NCT00520299|579887291|FG001|Overall Study|Withdrawal by Subject|0|||
160592886|NCT00520299|579887292|FG002|Overall Study|Withdrawal by Subject|2|||
160592887|NCT00520299|579887290|FG000|Overall Study|Progressive disease|0|||
160592888|NCT00520299|579887291|FG001|Overall Study|Progressive disease|3|||
160592889|NCT00520299|579887292|FG002|Overall Study|Progressive disease|4|||
160592890|NCT01352845|579887293|FG000|Overall Study|Lost to Follow-up|313|||
160592891|NCT01352845|579887294|FG001|Overall Study|Lost to Follow-up|92|||
160592892|NCT01352845|579887293|FG000|Overall Study|No Longer Willing to Participate|205|||
160592893|NCT01352845|579887294|FG001|Overall Study|No Longer Willing to Participate|58|||
160592894|NCT01352845|579887293|FG000|Overall Study|Withdrawal by Subject|48|||
160592895|NCT01352845|579887294|FG001|Overall Study|Withdrawal by Subject|16|||
160592896|NCT01352845|579887293|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
160592897|NCT01352845|579887294|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
160592898|NCT01352845|579887293|FG000|Overall Study|Pregnancy|27|||
160592899|NCT01352845|579887294|FG001|Overall Study|Pregnancy|7|||
160592900|NCT01352845|579887293|FG000|Overall Study|Adverse Event|22|||
160592901|NCT01352845|579887294|FG001|Overall Study|Adverse Event|6|||
160658438|NCT01866319|580131471|FG000|Overall Study|Protocol Violation|0|||
160592902|NCT01352845|579887293|FG000|Overall Study|Other|17|||
160592903|NCT01352845|579887294|FG001|Overall Study|Other|7|||
160592904|NCT01352845|579887293|FG000|Overall Study|Protocol Violation|12|||
160592905|NCT01352845|579887294|FG001|Overall Study|Protocol Violation|6|||
160592906|NCT01352845|579887293|FG000|Overall Study|Death|3|||
160592907|NCT01352845|579887294|FG001|Overall Study|Death|0|||
160658439|NCT01866319|580131472|FG001|Overall Study|Protocol Violation|0|||
160592908|NCT02062463|579887295|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
160592909|NCT02062463|579887296|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
160592910|NCT02062463|579887297|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
160592911|NCT02062463|579887298|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
160592912|NCT02062463|579887295|FG000|Stage 2|Adverse Event|0|||
160592913|NCT02062463|579887296|FG001|Stage 2|Adverse Event|0|||
160592914|NCT02062463|579887297|FG002|Stage 2|Adverse Event|12|||
160592915|NCT02062463|579887298|FG003|Stage 2|Adverse Event|20|||
160592916|NCT02062463|579887295|FG000|Stage 2|Lack of Efficacy|0|||
160592917|NCT02062463|579887296|FG001|Stage 2|Lack of Efficacy|0|||
160592918|NCT02062463|579887297|FG002|Stage 2|Lack of Efficacy|3|||
160592919|NCT02062463|579887298|FG003|Stage 2|Lack of Efficacy|4|||
160977004|NCT00779584|581304708|FG006|Overall Study|Withdrawal by Subject|1|||
160977005|NCT00779584|581304709|FG007|Overall Study|Withdrawal by Subject|0|||
160977006|NCT00779584|581304710|FG008|Overall Study|Withdrawal by Subject|0|||
160977007|NCT00779584|581304702|FG000|Overall Study|Lost to Follow-up|0|||
160977008|NCT00779584|581304703|FG001|Overall Study|Lost to Follow-up|0|||
160977009|NCT00779584|581304704|FG002|Overall Study|Lost to Follow-up|0|||
160977010|NCT00779584|581304705|FG003|Overall Study|Lost to Follow-up|0|||
160977011|NCT00779584|581304706|FG004|Overall Study|Lost to Follow-up|1|||
160977012|NCT00779584|581304707|FG005|Overall Study|Lost to Follow-up|0|||
160977013|NCT00779584|581304708|FG006|Overall Study|Lost to Follow-up|0|||
160977014|NCT00779584|581304709|FG007|Overall Study|Lost to Follow-up|0|||
160977015|NCT00779584|581304710|FG008|Overall Study|Lost to Follow-up|0|||
160977016|NCT00779584|581304702|FG000|Overall Study|Progression of Disease|0|||
160977017|NCT00779584|581304703|FG001|Overall Study|Progression of Disease|1|||
160977018|NCT00779584|581304704|FG002|Overall Study|Progression of Disease|2|||
160977019|NCT00779584|581304705|FG003|Overall Study|Progression of Disease|6|||
160977020|NCT00779584|581304706|FG004|Overall Study|Progression of Disease|5|||
160977021|NCT00779584|581304707|FG005|Overall Study|Progression of Disease|1|||
160977022|NCT00779584|581304708|FG006|Overall Study|Progression of Disease|4|||
160977023|NCT00779584|581304709|FG007|Overall Study|Progression of Disease|2|||
160977024|NCT00779584|581304710|FG008|Overall Study|Progression of Disease|1|||
160977025|NCT00779584|581304702|FG000|Overall Study|Adverse Event|1|||
160977026|NCT00779584|581304703|FG001|Overall Study|Adverse Event|0|||
160977027|NCT00779584|581304704|FG002|Overall Study|Adverse Event|2|||
160977028|NCT00779584|581304705|FG003|Overall Study|Adverse Event|0|||
160977029|NCT00779584|581304706|FG004|Overall Study|Adverse Event|0|||
160977030|NCT00779584|581304707|FG005|Overall Study|Adverse Event|0|||
160977031|NCT00779584|581304708|FG006|Overall Study|Adverse Event|2|||
160977032|NCT00779584|581304709|FG007|Overall Study|Adverse Event|1|||
160977033|NCT00779584|581304710|FG008|Overall Study|Adverse Event|1|||
160977034|NCT00779584|581304702|FG000|Overall Study|Symptomatic Deterioration|1|||
160977035|NCT00779584|581304703|FG001|Overall Study|Symptomatic Deterioration|1|||
160977036|NCT00779584|581304704|FG002|Overall Study|Symptomatic Deterioration|1|||
160977037|NCT00779584|581304705|FG003|Overall Study|Symptomatic Deterioration|0|||
160977038|NCT00779584|581304706|FG004|Overall Study|Symptomatic Deterioration|0|||
160977039|NCT00779584|581304707|FG005|Overall Study|Symptomatic Deterioration|1|||
160977040|NCT00779584|581304708|FG006|Overall Study|Symptomatic Deterioration|1|||
160977041|NCT00779584|581304709|FG007|Overall Study|Symptomatic Deterioration|0|||
160977042|NCT00779584|581304710|FG008|Overall Study|Symptomatic Deterioration|0|||
160977043|NCT00779584|581304702|FG000|Overall Study|Ongoing in Study|0|||
160977044|NCT00779584|581304703|FG001|Overall Study|Ongoing in Study|0|||
160977045|NCT00779584|581304704|FG002|Overall Study|Ongoing in Study|0|||
160977046|NCT00779584|581304705|FG003|Overall Study|Ongoing in Study|0|||
160977047|NCT00779584|581304706|FG004|Overall Study|Ongoing in Study|1|||
160977048|NCT00779584|581304707|FG005|Overall Study|Ongoing in Study|1|||
160977049|NCT00779584|581304708|FG006|Overall Study|Ongoing in Study|0|||
160977050|NCT00779584|581304709|FG007|Overall Study|Ongoing in Study|0|||
160977051|NCT00779584|581304710|FG008|Overall Study|Ongoing in Study|0|||
160977052|NCT01544491|581304716|FG000|Overall Study|Withdrawal by Subject|3|||
160592920|NCT02062463|579887295|FG000|Stage 2|Lost to Follow-up|0|||
160977053|NCT01544491|581304717|FG001|Overall Study|Withdrawal by Subject|2|||
160977054|NCT01544491|581304716|FG000|Overall Study|Lost to Follow-up|0|||
160592921|NCT02062463|579887296|FG001|Stage 2|Lost to Follow-up|0|||
160592922|NCT02062463|579887297|FG002|Stage 2|Lost to Follow-up|20|||
160592923|NCT02062463|579887298|FG003|Stage 2|Lost to Follow-up|20|||
160592924|NCT02062463|579887295|FG000|Stage 2|Non-Compliance|0|||
160592925|NCT02062463|579887296|FG001|Stage 2|Non-Compliance|0|||
160592926|NCT02062463|579887297|FG002|Stage 2|Non-Compliance|0|||
160592927|NCT02062463|579887298|FG003|Stage 2|Non-Compliance|1|||
160592928|NCT02062463|579887295|FG000|Stage 2|Other than specified|0|||
160592929|NCT02062463|579887296|FG001|Stage 2|Other than specified|0|||
160592930|NCT02062463|579887297|FG002|Stage 2|Other than specified|3|||
160592931|NCT02062463|579887298|FG003|Stage 2|Other than specified|1|||
160592932|NCT02062463|579887295|FG000|Stage 2|Withdrawal by Subject|0|||
160592933|NCT02062463|579887296|FG001|Stage 2|Withdrawal by Subject|0|||
160592934|NCT02062463|579887297|FG002|Stage 2|Withdrawal by Subject|15|||
160592935|NCT02062463|579887298|FG003|Stage 2|Withdrawal by Subject|10|||
160592936|NCT01956240|579887307|FG000|Overall Study|Lost to Follow-up|6|||
160592937|NCT01956240|579887308|FG001|Overall Study|Lost to Follow-up|20|||
160592938|NCT01956240|579887307|FG000|Overall Study|Adverse Event|17|||
160592939|NCT01956240|579887308|FG001|Overall Study|Adverse Event|4|||
160592940|NCT00600028|579887311|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
160977055|NCT01544491|581304717|FG001|Overall Study|Lost to Follow-up|1|||
160592941|NCT00600028|579887312|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
160977056|NCT01544491|581304716|FG000|Overall Study|administrative problems|2|||
160977057|NCT01544491|581304717|FG001|Overall Study|administrative problems|0|||
160977058|NCT00896454|581304731|FG000|Overall Study|Death|10|||
160977059|NCT00896454|581304731|FG000|Overall Study|Adverse Event|8|||
160977060|NCT00896454|581304731|FG000|Overall Study|Disease Progression|5|||
160977061|NCT00896454|581304731|FG000|Overall Study|Other|4|||
160977062|NCT00896454|581304731|FG000|Overall Study|Requirement for alternative therapy|3|||
160977063|NCT00896454|581304731|FG000|Overall Study|Ongoing in study|2|||
160977064|NCT00896454|581304731|FG000|Overall Study|Withdrawal by Subject|1|||
160977065|NCT00680056|581304735|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
160977066|NCT00680056|581304736|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
160977067|NCT00680056|581304735|FG000|Second Intervention|Protocol Violation|3|||
160977068|NCT00680056|581304736|FG001|Second Intervention|Protocol Violation|1|||
160977069|NCT03688711|581304742|FG000|Overall Study|Withdrawal by Subject|0|||
160977070|NCT03688711|581304743|FG001|Overall Study|Withdrawal by Subject|1|||
160977071|NCT01018563|581304744|FG000|Overall Study|Termination of the study by Sponsor|2|||
160977072|NCT01018563|581304745|FG001|Overall Study|Termination of the study by Sponsor|1|||
160977073|NCT02306122|581304746|FG000|Initial Physician Randomization|Physician Decision|0|||
160977074|NCT02306122|581304747|FG001|Initial Physician Randomization|Physician Decision|0|||
160977075|NCT02306122|581304748|FG002|Initial Physician Randomization|Physician Decision|0|||
160977076|NCT02306122|581304749|FG003|Initial Physician Randomization|Physician Decision|0|||
160977077|NCT02306122|581304750|FG004|Initial Physician Randomization|Physician Decision|0|||
160977078|NCT02306122|581304751|FG005|Initial Physician Randomization|Physician Decision|0|||
160977079|NCT02306122|581304752|FG006|Initial Physician Randomization|Physician Decision|0|||
160977080|NCT02306122|581304753|FG007|Initial Physician Randomization|Physician Decision|0|||
160977081|NCT02306122|581304754|FG008|Initial Physician Randomization|Physician Decision|1|||
160977082|NCT02306122|581304755|FG009|Initial Physician Randomization|Physician Decision|0|||
160977083|NCT02306122|581304756|FG010|Initial Physician Randomization|Physician Decision|0|||
160977084|NCT02322814|581304757|FG000|Overall Study|Death|7|||
160977085|NCT02322814|581304758|FG001|Overall Study|Death|29|||
160977086|NCT02322814|581304759|FG002|Overall Study|Death|32|||
160977087|NCT02322814|581304760|FG003|Overall Study|Death|23|||
160977088|NCT02322814|581304761|FG004|Overall Study|Death|14|||
160977089|NCT02322814|581304757|FG000|Overall Study|Lost to Follow-up|1|||
160977090|NCT02322814|581304758|FG001|Overall Study|Lost to Follow-up|3|||
160977091|NCT02322814|581304759|FG002|Overall Study|Lost to Follow-up|3|||
160977092|NCT02322814|581304760|FG003|Overall Study|Lost to Follow-up|1|||
160977093|NCT02322814|581304761|FG004|Overall Study|Lost to Follow-up|0|||
160977094|NCT02322814|581304757|FG000|Overall Study|Various Reasons|2|||
160592942|NCT00600028|579887311|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
160592943|NCT00600028|579887312|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
160592944|NCT00600028|579887311|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
160592945|NCT00600028|579887312|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
160592946|NCT01830816|579887313|FG000|Overall Study|Progressive Disease|12|||
160592947|NCT01830816|579887314|FG001|Overall Study|Progressive Disease|7|||
160592948|NCT01830816|579887315|FG002|Overall Study|Progressive Disease|7|||
160592949|NCT01830816|579887313|FG000|Overall Study|Adverse Event|3|||
160592950|NCT01830816|579887314|FG001|Overall Study|Adverse Event|4|||
160592951|NCT01830816|579887315|FG002|Overall Study|Adverse Event|0|||
160592952|NCT01830816|579887313|FG000|Overall Study|Study Terminated by Sponsor|1|||
160592953|NCT01830816|579887314|FG001|Overall Study|Study Terminated by Sponsor|1|||
160592954|NCT01830816|579887315|FG002|Overall Study|Study Terminated by Sponsor|0|||
160592955|NCT01830816|579887313|FG000|Overall Study|Withdrawal by Subject|1|||
160592956|NCT01830816|579887314|FG001|Overall Study|Withdrawal by Subject|1|||
160592957|NCT01830816|579887315|FG002|Overall Study|Withdrawal by Subject|0|||
160592958|NCT01830816|579887313|FG000|Overall Study|Lost to Follow-up|0|||
160592959|NCT01830816|579887314|FG001|Overall Study|Lost to Follow-up|1|||
160592960|NCT01830816|579887315|FG002|Overall Study|Lost to Follow-up|0|||
160592961|NCT01830816|579887313|FG000|Overall Study|Symptomatic Deterioration|1|||
160592962|NCT01830816|579887314|FG001|Overall Study|Symptomatic Deterioration|0|||
160592963|NCT01830816|579887315|FG002|Overall Study|Symptomatic Deterioration|0|||
160592964|NCT01830816|579887313|FG000|Overall Study|Reason not Specified|2|||
160592965|NCT01830816|579887314|FG001|Overall Study|Reason not Specified|0|||
160592966|NCT01830816|579887315|FG002|Overall Study|Reason not Specified|0|||
160592967|NCT02716194|579887316|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
160592968|NCT02716194|579887317|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
160592969|NCT02716194|579887318|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
160592970|NCT03587584|579887322|FG000|Overall Study|SOC deviations|4|||
160592971|NCT03587584|579887323|FG001|Overall Study|SOC deviations|6|||
160592972|NCT03587584|579887322|FG000|Overall Study|Incomplete data|0|||
160592973|NCT03587584|579887323|FG001|Overall Study|Incomplete data|3|||
160592974|NCT00830115|579887324|FG000|Overall Study|Adverse Event|2|||
160592975|NCT00830115|579887324|FG000|Overall Study|Improvement/recovery|1|||
160592976|NCT01107405|579887336|FG000|Overall Study|Adverse Event|1|||
160592977|NCT01107405|579887337|FG001|Overall Study|Adverse Event|1|||
160592978|NCT01107405|579887338|FG002|Overall Study|Adverse Event|0|||
160592979|NCT01107405|579887339|FG003|Overall Study|Adverse Event|0|||
160592980|NCT01107405|579887340|FG004|Overall Study|Adverse Event|2|||
160592981|NCT01107405|579887336|FG000|Overall Study|Withdrawal by Subject|1|||
160592982|NCT01107405|579887337|FG001|Overall Study|Withdrawal by Subject|0|||
160592983|NCT01107405|579887338|FG002|Overall Study|Withdrawal by Subject|1|||
160592984|NCT01107405|579887339|FG003|Overall Study|Withdrawal by Subject|2|||
160592985|NCT01107405|579887340|FG004|Overall Study|Withdrawal by Subject|1|||
160592986|NCT01107405|579887336|FG000|Overall Study|Protocol Violation|0|||
160592987|NCT01107405|579887337|FG001|Overall Study|Protocol Violation|0|||
160592988|NCT01107405|579887338|FG002|Overall Study|Protocol Violation|1|||
160592989|NCT01107405|579887339|FG003|Overall Study|Protocol Violation|1|||
160592990|NCT01107405|579887340|FG004|Overall Study|Protocol Violation|0|||
160592991|NCT01895452|579887347|FG000|Overall Study|Adverse Event|1|||
160592992|NCT01895452|579887348|FG001|Overall Study|Adverse Event|4|||
160592993|NCT01895452|579887347|FG000|Overall Study|Lost to Follow-up|1|||
160592994|NCT01895452|579887348|FG001|Overall Study|Lost to Follow-up|5|||
160592995|NCT01895452|579887347|FG000|Overall Study|Pregnancy|0|||
160592996|NCT01895452|579887348|FG001|Overall Study|Pregnancy|1|||
160977095|NCT02322814|581304758|FG001|Overall Study|Various Reasons|0|||
160977096|NCT02322814|581304759|FG002|Overall Study|Various Reasons|1|||
160977097|NCT02322814|581304760|FG003|Overall Study|Various Reasons|1|||
160977098|NCT02322814|581304761|FG004|Overall Study|Various Reasons|0|||
160977099|NCT02322814|581304757|FG000|Overall Study|Progressive Disease|0|||
160977100|NCT02322814|581304758|FG001|Overall Study|Progressive Disease|0|||
160592997|NCT01895452|579887347|FG000|Overall Study|Withdrawal by Subject|2|||
160592998|NCT01895452|579887348|FG001|Overall Study|Withdrawal by Subject|14|||
160592999|NCT01895452|579887347|FG000|Overall Study|Underlying disease|0|||
160593000|NCT01895452|579887348|FG001|Overall Study|Underlying disease|3|||
160593001|NCT01895452|579887347|FG000|Overall Study|Noncompliance with study drug|0|||
160593002|NCT01895452|579887348|FG001|Overall Study|Noncompliance with study drug|1|||
160593003|NCT01653158|579887349|FG000|Overall Study|Death|0|||
160593004|NCT01653158|579887350|FG001|Overall Study|Death|0|||
160593005|NCT01653158|579887351|FG002|Overall Study|Death|0|||
160593006|NCT01653158|579887352|FG003|Overall Study|Death|1|||
160593007|NCT01653158|579887353|FG004|Overall Study|Death|0|||
160593008|NCT01653158|579887354|FG005|Overall Study|Death|0|||
160593009|NCT01653158|579887355|FG006|Overall Study|Death|0|||
160593010|NCT01653158|579887356|FG007|Overall Study|Death|2|||
160593011|NCT01653158|579887349|FG000|Overall Study|Adverse Event|0|||
160593012|NCT01653158|579887350|FG001|Overall Study|Adverse Event|0|||
160593013|NCT01653158|579887351|FG002|Overall Study|Adverse Event|0|||
160593014|NCT01653158|579887352|FG003|Overall Study|Adverse Event|1|||
160593015|NCT01653158|579887353|FG004|Overall Study|Adverse Event|0|||
160593016|NCT01653158|579887354|FG005|Overall Study|Adverse Event|0|||
160658440|NCT01866319|580131473|FG002|Overall Study|Protocol Violation|1|||
160977101|NCT02322814|581304759|FG002|Overall Study|Progressive Disease|0|||
160977102|NCT02322814|581304760|FG003|Overall Study|Progressive Disease|1|||
160977103|NCT02322814|581304761|FG004|Overall Study|Progressive Disease|1|||
160977104|NCT02322814|581304757|FG000|Overall Study|Protocol Violation|1|||
160977105|NCT02322814|581304758|FG001|Overall Study|Protocol Violation|0|||
160593017|NCT01653158|579887355|FG006|Overall Study|Adverse Event|0|||
160593018|NCT01653158|579887356|FG007|Overall Study|Adverse Event|3|||
160593019|NCT01653158|579887349|FG000|Overall Study|Other|0|||
160593020|NCT01653158|579887350|FG001|Overall Study|Other|0|||
160593021|NCT01653158|579887351|FG002|Overall Study|Other|0|||
160593022|NCT01653158|579887352|FG003|Overall Study|Other|0|||
160593023|NCT01653158|579887353|FG004|Overall Study|Other|0|||
160593024|NCT01653158|579887354|FG005|Overall Study|Other|0|||
160593025|NCT01653158|579887355|FG006|Overall Study|Other|0|||
160593026|NCT01653158|579887356|FG007|Overall Study|Other|1|||
160593027|NCT01653158|579887349|FG000|Overall Study|Progressive disease|0|||
160593028|NCT01653158|579887350|FG001|Overall Study|Progressive disease|0|||
160593029|NCT01653158|579887351|FG002|Overall Study|Progressive disease|0|||
160593030|NCT01653158|579887352|FG003|Overall Study|Progressive disease|0|||
160593031|NCT01653158|579887353|FG004|Overall Study|Progressive disease|1|||
160593032|NCT01653158|579887354|FG005|Overall Study|Progressive disease|1|||
160977106|NCT02322814|581304759|FG002|Overall Study|Protocol Violation|0|||
160593033|NCT01653158|579887355|FG006|Overall Study|Progressive disease|2|||
160593034|NCT01653158|579887356|FG007|Overall Study|Progressive disease|9|||
160593035|NCT01653158|579887349|FG000|Overall Study|Withdrawal by Subject|1|||
160593036|NCT01653158|579887350|FG001|Overall Study|Withdrawal by Subject|0|||
160593037|NCT01653158|579887351|FG002|Overall Study|Withdrawal by Subject|0|||
160593038|NCT01653158|579887352|FG003|Overall Study|Withdrawal by Subject|0|||
160593039|NCT01653158|579887353|FG004|Overall Study|Withdrawal by Subject|0|||
160593040|NCT01653158|579887354|FG005|Overall Study|Withdrawal by Subject|0|||
160593041|NCT01653158|579887355|FG006|Overall Study|Withdrawal by Subject|0|||
160593042|NCT01653158|579887356|FG007|Overall Study|Withdrawal by Subject|0|||
160593043|NCT00433446|579887365|FG000|Overall Study|Adverse Event|4|||
160593044|NCT00433446|579887365|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
160593045|NCT00433446|579887365|FG000|Overall Study|Progression|44|||
160593046|NCT00433446|579887365|FG000|Overall Study|Other - Not Protocol specified|3|||
160593047|NCT00433446|579887365|FG000|Overall Study|Ineligible|9|||
160593048|NCT01188538|579887366|FG000|Overall Study|Lost to Follow-up|0|||
160593049|NCT01188538|579887367|FG001|Overall Study|Lost to Follow-up|1|||
160593050|NCT02899377|579887368|FG000|Overall Study|Adverse Event|1|||
160593051|NCT02899377|579887369|FG001|Overall Study|Adverse Event|0|||
160593052|NCT01170702|579887373|FG000|Overall Study|Exclusion criteria met after consent|1|||
160593053|NCT01170702|579887374|FG001|Overall Study|Exclusion criteria met after consent|2|||
160593054|NCT01170702|579887375|FG002|Overall Study|Exclusion criteria met after consent|0|||
160593055|NCT01170702|579887376|FG003|Overall Study|Exclusion criteria met after consent|2|||
160593056|NCT04999969|579887377|FG000|Overall Study|Death|76|||
160593057|NCT04999969|579887377|FG000|Overall Study|Progressive Disease|1|||
160593058|NCT04999969|579887377|FG000|Overall Study|Withdrawal by Subject|8|||
160593059|NCT04321252|579887379|FG000|Overall Study|Withdrawal by Subject|0|||
160593060|NCT04321252|579887380|FG001|Overall Study|Withdrawal by Subject|0|||
160593061|NCT04321252|579887381|FG002|Overall Study|Withdrawal by Subject|0|||
160593062|NCT04321252|579887382|FG003|Overall Study|Withdrawal by Subject|0|||
160593063|NCT04321252|579887383|FG004|Overall Study|Withdrawal by Subject|0|||
160593064|NCT04321252|579887384|FG005|Overall Study|Withdrawal by Subject|1|||
160593065|NCT04321252|579887385|FG006|Overall Study|Withdrawal by Subject|0|||
160593066|NCT04321252|579887386|FG007|Overall Study|Withdrawal by Subject|0|||
160977107|NCT02322814|581304760|FG003|Overall Study|Protocol Violation|0|||
160977108|NCT02322814|581304761|FG004|Overall Study|Protocol Violation|0|||
160977109|NCT02322814|581304757|FG000|Overall Study|Study Terminated by Sponsor|0|||
160977110|NCT02322814|581304758|FG001|Overall Study|Study Terminated by Sponsor|7|||
160977111|NCT02322814|581304759|FG002|Overall Study|Study Terminated by Sponsor|9|||
160977112|NCT02322814|581304760|FG003|Overall Study|Study Terminated by Sponsor|5|||
160977113|NCT02322814|581304761|FG004|Overall Study|Study Terminated by Sponsor|13|||
160977114|NCT02322814|581304757|FG000|Overall Study|Withdrawal by Subject|5|||
160977115|NCT02322814|581304758|FG001|Overall Study|Withdrawal by Subject|4|||
160977116|NCT02322814|581304759|FG002|Overall Study|Withdrawal by Subject|2|||
160977117|NCT02322814|581304760|FG003|Overall Study|Withdrawal by Subject|1|||
160977118|NCT02322814|581304761|FG004|Overall Study|Withdrawal by Subject|3|||
160977119|NCT02998021|581304767|FG000|Overall Study|Withdrawal by Subject|3|||
160977120|NCT02998021|581304768|FG001|Overall Study|Withdrawal by Subject|1|||
160977121|NCT02998021|581304767|FG000|Overall Study|unsafe home|0|||
160977122|NCT02998021|581304768|FG001|Overall Study|unsafe home|1|||
160977123|NCT03342053|581304769|FG000|Overall Study|Adverse Event|2|||
160977124|NCT03342053|581304770|FG001|Overall Study|Adverse Event|0|||
160977125|NCT03342053|581304769|FG000|Overall Study|Withdrawal by Subject|0|||
160977126|NCT03342053|581304770|FG001|Overall Study|Withdrawal by Subject|1|||
160977127|NCT02294474|581304771|FG000|Overall Study|Adverse Event|7|||
160977128|NCT02294474|581304772|FG001|Overall Study|Adverse Event|7|||
160977129|NCT02294474|581304771|FG000|Overall Study|Lack of Efficacy|2|||
160977130|NCT02294474|581304772|FG001|Overall Study|Lack of Efficacy|1|||
160977131|NCT02294474|581304771|FG000|Overall Study|Protocol Violation|4|||
160977132|NCT02294474|581304772|FG001|Overall Study|Protocol Violation|2|||
160977133|NCT02294474|581304771|FG000|Overall Study|Other than specified above|12|||
160977134|NCT02294474|581304772|FG001|Overall Study|Other than specified above|12|||
160977135|NCT02961374|581304773|FG000|Overall Study|Adverse Event|4|||
160977136|NCT00171873|581304776|FG000|Overall Study|Withdrawal by Subject|4|||
160977137|NCT00171873|581304777|FG001|Overall Study|Withdrawal by Subject|2|||
160977138|NCT00171873|581304776|FG000|Overall Study|Adverse Event|5|||
160977139|NCT00171873|581304777|FG001|Overall Study|Adverse Event|0|||
160977140|NCT00171873|581304776|FG000|Overall Study|Switched to Octreotide|0|||
160977141|NCT00171873|581304777|FG001|Overall Study|Switched to Octreotide|1|||
160977142|NCT02041923|581304778|FG000|Overall Study|Lost to Follow-up|26|||
160977143|NCT02041923|581304779|FG001|Overall Study|Lost to Follow-up|30|||
160977144|NCT00309608|581304782|FG000|Overall Study|Adverse Event|1|||
160977145|NCT00309608|581304783|FG001|Overall Study|Adverse Event|5|||
160977146|NCT00309608|581304784|FG002|Overall Study|Adverse Event|3|||
160977147|NCT00309608|581304785|FG003|Overall Study|Adverse Event|2|||
160977148|NCT00309608|581304786|FG004|Overall Study|Adverse Event|3|||
160977149|NCT00309608|581304782|FG000|Overall Study|Protocol Violation|2|||
160977150|NCT00309608|581304783|FG001|Overall Study|Protocol Violation|0|||
160593067|NCT04321252|579887387|FG008|Overall Study|Withdrawal by Subject|0|||
160593068|NCT06245044|579887388|FG000|No MI help|Technical issues|18|||
160593069|NCT00085917|579887392|FG000|Overall Study|Adverse Event|4|||
160593070|NCT00085917|579887393|FG001|Overall Study|Adverse Event|3|||
160593071|NCT01658579|579887394|FG000|Treatment Period A|Other|0|||
160593072|NCT01658579|579887395|FG001|Treatment Period A|Other|0|||
160593073|NCT01658579|579887396|FG002|Treatment Period A|Other|1|||
160593074|NCT01658579|579887397|FG003|Treatment Period A|Other|1|||
160593075|NCT01658579|579887394|FG000|Treatment Period A|Adverse Event|1|||
160593076|NCT01658579|579887395|FG001|Treatment Period A|Adverse Event|0|||
160593077|NCT01658579|579887396|FG002|Treatment Period A|Adverse Event|0|||
160593078|NCT01658579|579887397|FG003|Treatment Period A|Adverse Event|0|||
160593079|NCT01658579|579887394|FG000|Treatment Period B|Other|0|||
160593080|NCT01658579|579887395|FG001|Treatment Period B|Other|0|||
160593081|NCT01658579|579887396|FG002|Treatment Period B|Other|0|||
160593082|NCT01658579|579887397|FG003|Treatment Period B|Other|1|||
160593083|NCT05590767|579887398|FG000|Overall Study|Protocol Violation|1|||
160593084|NCT05590767|579887398|FG000|Overall Study|surgery canceled|1|||
160593085|NCT05590767|579887398|FG000|Overall Study|interscalene brachial block not performed|1|||
160593086|NCT01464788|579887399|FG000|Overall Study|Lost to Follow-up|0|||
160593087|NCT01464788|579887400|FG001|Overall Study|Lost to Follow-up|1|||
160593088|NCT01464788|579887401|FG002|Overall Study|Lost to Follow-up|0|||
160593089|NCT01464788|579887399|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
160593090|NCT01464788|579887400|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
160593091|NCT01464788|579887401|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
160593092|NCT00125190|579887410|FG000|Overall Study|Subject/Parent Decision|7|||
160593093|NCT00125190|579887410|FG000|Overall Study|Non-compliance|2|||
160593094|NCT00125190|579887410|FG000|Overall Study|Adverse Event|1|||
160593095|NCT00125190|579887410|FG000|Overall Study|Other|1|||
160593096|NCT00125190|579887410|FG000|Overall Study|Lost to Follow-up|4|||
160593097|NCT00363246|579887412|FG000|Overall Study|Death|40|||
160593098|NCT00363246|579887412|FG000|Overall Study|Withdrawal by Subject|19|||
160658441|NCT01866319|580131471|FG000|Overall Study|Withdrawal by Subject|32|||
160977151|NCT00309608|581304784|FG002|Overall Study|Protocol Violation|0|||
160977152|NCT00309608|581304785|FG003|Overall Study|Protocol Violation|0|||
160977153|NCT00309608|581304786|FG004|Overall Study|Protocol Violation|0|||
160977154|NCT00309608|581304782|FG000|Overall Study|Lost to Follow-up|0|||
160977155|NCT00309608|581304783|FG001|Overall Study|Lost to Follow-up|0|||
160977156|NCT00309608|581304784|FG002|Overall Study|Lost to Follow-up|2|||
160977157|NCT00309608|581304785|FG003|Overall Study|Lost to Follow-up|0|||
160977158|NCT00309608|581304786|FG004|Overall Study|Lost to Follow-up|1|||
160977159|NCT00309608|581304782|FG000|Overall Study|Withdrawal by Subject|1|||
160977160|NCT00309608|581304783|FG001|Overall Study|Withdrawal by Subject|4|||
160977161|NCT00309608|581304784|FG002|Overall Study|Withdrawal by Subject|2|||
160977162|NCT00309608|581304785|FG003|Overall Study|Withdrawal by Subject|0|||
160977163|NCT00309608|581304786|FG004|Overall Study|Withdrawal by Subject|0|||
160977164|NCT00309608|581304782|FG000|Overall Study|Other incl. Lack of efficacy|10|||
160977165|NCT00309608|581304783|FG001|Overall Study|Other incl. Lack of efficacy|4|||
160977166|NCT00309608|581304784|FG002|Overall Study|Other incl. Lack of efficacy|3|||
160977167|NCT00309608|581304785|FG003|Overall Study|Other incl. Lack of efficacy|4|||
160977168|NCT00309608|581304786|FG004|Overall Study|Other incl. Lack of efficacy|0|||
160977169|NCT00127413|581304787|FG000|Overall Study|Lost to Follow-up|6|||
160977170|NCT00127413|581304788|FG001|Overall Study|Lost to Follow-up|4|||
160977171|NCT00127413|581304789|FG002|Overall Study|Lost to Follow-up|8|||
160977172|NCT00127413|581304790|FG003|Overall Study|Lost to Follow-up|2|||
160977173|NCT03713021|581304793|FG000|Overall Study|Did not have CT sim scan available|6|||
160977174|NCT03713021|581304793|FG000|Overall Study|Not eligible|4|||
160593099|NCT00363246|579887412|FG000|Overall Study|Lost to Follow-up|14|||
160977175|NCT03713021|581304793|FG000|Overall Study|Issues with TraceIT markers|5|||
160977176|NCT01340482|581306405|FG000|Overall Study|Adverse Event|2|||
160977177|NCT01340482|581306406|FG001|Overall Study|Adverse Event|0|||
160977178|NCT01340482|581306407|FG002|Overall Study|Adverse Event|0|||
160977179|NCT01282476|581306408|FG000|Overall Study|Death|11|||
160977180|NCT00592319|581306411|FG000|Overall Study|Lost to Follow-up|0|||
160977181|NCT00592319|581306412|FG001|Overall Study|Lost to Follow-up|3|||
160977182|NCT01087723|581306414|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
160977183|NCT01087723|581306415|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
160977184|NCT01087723|581306414|FG000|Overall Study|Withdrawal by Subject|10|||
160977185|NCT01087723|581306415|FG001|Overall Study|Withdrawal by Subject|13|||
160977186|NCT01087723|581306414|FG000|Overall Study|Physician Decision|2|||
160977187|NCT01087723|581306415|FG001|Overall Study|Physician Decision|0|||
160977188|NCT01087723|581306414|FG000|Overall Study|Lost to Follow-up|1|||
160977189|NCT01087723|581306415|FG001|Overall Study|Lost to Follow-up|4|||
160977190|NCT01087723|581306414|FG000|Overall Study|Reason Not Specified|1|||
160977191|NCT01087723|581306415|FG001|Overall Study|Reason Not Specified|2|||
160977192|NCT01868035|581306416|FG000|Overall Study|Lost to Follow-up|3|||
160977193|NCT01868035|581306416|FG000|Overall Study|Withdrawal by Subject|1|||
160977194|NCT01868035|581306416|FG000|Overall Study|Progressive Disease|2|||
160977195|NCT01868035|581306416|FG000|Overall Study|Non-compliance|1|||
160977196|NCT01757665|581306421|FG000|Overall Study|Still on Study - Visit Completed|240|||
160977197|NCT01757665|581306422|FG001|Overall Study|Still on Study - Visit Completed|30|||
160977198|NCT01757665|581306421|FG000|Overall Study|Still on Study - Visit Pending|398|||
160977199|NCT01757665|581306422|FG001|Overall Study|Still on Study - Visit Pending|40|||
160977200|NCT01757665|581306421|FG000|Overall Study|Still on Study - Missed Visit|14|||
160977201|NCT01757665|581306422|FG001|Overall Study|Still on Study - Missed Visit|1|||
160977202|NCT01757665|581306421|FG000|Overall Study|Death|25|||
160593100|NCT00363246|579887412|FG000|Overall Study|Bad health|6|||
160593101|NCT00363246|579887412|FG000|Overall Study|Stopped using wheelchair|11|||
160977203|NCT01757665|581306422|FG001|Overall Study|Death|8|||
160593102|NCT00363246|579887412|FG000|Overall Study|Subject expressed security concerns|2|||
160593103|NCT00363246|579887412|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
160593104|NCT00264849|579887413|FG000|Overall Study|Adverse Event|7|||
160593105|NCT00264849|579887414|FG001|Overall Study|Adverse Event|2|||
160593106|NCT00264849|579887413|FG000|Overall Study|Withdrawal by Subject|7|||
160593107|NCT00264849|579887414|FG001|Overall Study|Withdrawal by Subject|11|||
160593108|NCT00264849|579887413|FG000|Overall Study|Protocol Violation|5|||
160593109|NCT00264849|579887414|FG001|Overall Study|Protocol Violation|3|||
160593110|NCT00264849|579887413|FG000|Overall Study|Lack of Efficacy|1|||
160593111|NCT00264849|579887414|FG001|Overall Study|Lack of Efficacy|6|||
160593112|NCT00264849|579887413|FG000|Overall Study|Lost to Follow-up|0|||
160593113|NCT00264849|579887414|FG001|Overall Study|Lost to Follow-up|2|||
160593114|NCT00264849|579887413|FG000|Overall Study|Death|0|||
160593115|NCT00264849|579887414|FG001|Overall Study|Death|1|||
160593116|NCT00264849|579887413|FG000|Overall Study|Administrative Problems|2|||
160593117|NCT00264849|579887414|FG001|Overall Study|Administrative Problems|0|||
160593118|NCT00383721|579887418|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
160593119|NCT00383721|579887419|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
160593120|NCT00383721|579887420|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
160593121|NCT00383721|579887421|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
160593122|NCT00383721|579887422|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
160593123|NCT00383721|579887418|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
160593124|NCT00383721|579887419|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
160593125|NCT00383721|579887420|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
160593126|NCT00383721|579887421|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
160593127|NCT00383721|579887422|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
160593128|NCT00383721|579887418|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
160593129|NCT00383721|579887419|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
160593130|NCT00383721|579887420|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
160593131|NCT00383721|579887421|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
160593132|NCT00383721|579887422|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
160593133|NCT00383721|579887418|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
160593134|NCT00383721|579887419|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
160593135|NCT00383721|579887420|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
160593136|NCT00383721|579887421|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
160593137|NCT00383721|579887422|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
160593138|NCT00383721|579887418|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
160593139|NCT00383721|579887419|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
160593140|NCT00383721|579887420|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
160593141|NCT00383721|579887421|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
160593142|NCT00383721|579887422|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
160593143|NCT00383721|579887418|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
160593144|NCT00383721|579887419|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
160593145|NCT00383721|579887420|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
160593146|NCT00383721|579887421|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
160593147|NCT00383721|579887422|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
160593148|NCT00383721|579887418|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
160593149|NCT00383721|579887419|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
160593150|NCT00383721|579887420|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
160593151|NCT00383721|579887421|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
160593152|NCT00383721|579887422|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
160593153|NCT00383721|579887418|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
160593154|NCT00383721|579887419|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
160593155|NCT00383721|579887420|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
160593156|NCT00383721|579887421|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
160593157|NCT00383721|579887422|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
160593158|NCT00383721|579887418|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
160593159|NCT00383721|579887419|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
160593160|NCT00383721|579887420|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
160593161|NCT00383721|579887421|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
160593162|NCT00383721|579887422|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
160593163|NCT00383721|579887418|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
160593164|NCT00383721|579887419|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
160593165|NCT00383721|579887420|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
160593166|NCT00383721|579887421|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
160593167|NCT00383721|579887422|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
160593168|NCT00383721|579887418|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
160593169|NCT00383721|579887419|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
160593170|NCT00383721|579887420|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
160593171|NCT00383721|579887421|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
160593172|NCT00383721|579887422|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
160593173|NCT00383721|579887418|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
160593174|NCT00383721|579887419|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
160593175|NCT00383721|579887420|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
160593176|NCT00383721|579887421|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
160977204|NCT01757665|581306421|FG000|Overall Study|Explant|1|||
160977205|NCT01757665|581306422|FG001|Overall Study|Explant|2|||
160977206|NCT01757665|581306421|FG000|Overall Study|Withdrawal by Subject|10|||
160977207|NCT01757665|581306422|FG001|Overall Study|Withdrawal by Subject|0|||
160977208|NCT01757665|581306421|FG000|Overall Study|Lost to Follow-up|1|||
160977209|NCT01757665|581306422|FG001|Overall Study|Lost to Follow-up|1|||
160977210|NCT01757665|581306421|FG000|Overall Study|Not Implanted with Device|5|||
160977211|NCT01757665|581306422|FG001|Overall Study|Not Implanted with Device|1|||
160977212|NCT00154063|581306425|FG000|Overall Study|Adverse Event|4|||
160977213|NCT00154063|581306426|FG001|Overall Study|Adverse Event|8|||
160977214|NCT00154063|581306425|FG000|Overall Study|Protocol Violation|1|||
160977215|NCT00154063|581306426|FG001|Overall Study|Protocol Violation|1|||
160977216|NCT00154063|581306425|FG000|Overall Study|Investigator or Sponsor Request|0|||
160977217|NCT00154063|581306426|FG001|Overall Study|Investigator or Sponsor Request|1|||
160977218|NCT00154063|581306425|FG000|Overall Study|Withdrawal by Subject|4|||
160977219|NCT00154063|581306426|FG001|Overall Study|Withdrawal by Subject|9|||
160977220|NCT00154063|581306425|FG000|Overall Study|Other|3|||
160977221|NCT00154063|581306426|FG001|Overall Study|Other|3|||
160977222|NCT01912222|581306427|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
160977223|NCT01912222|581306428|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
160977224|NCT01912222|581306429|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
160977225|NCT01912222|581306427|FG000|Part B: Treatment Period|Progressive disease|10|||
160977226|NCT01912222|581306428|FG001|Part B: Treatment Period|Progressive disease|12|||
160977227|NCT01912222|581306429|FG002|Part B: Treatment Period|Progressive disease|15|||
160977228|NCT01912222|581306427|FG000|Part B: Treatment Period|Adverse Event|1|||
160977229|NCT01912222|581306428|FG001|Part B: Treatment Period|Adverse Event|2|||
160977230|NCT01912222|581306429|FG002|Part B: Treatment Period|Adverse Event|3|||
160977231|NCT01912222|581306427|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
160977232|NCT01912222|581306428|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
160977233|NCT01912222|581306429|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
160977234|NCT01804673|581306430|FG000|Overall Study|Adverse Event|4|||
160977235|NCT01804673|581306430|FG000|Overall Study|Withdrawal by Subject|1|||
160977236|NCT01804673|581306430|FG000|Overall Study|Lack of Efficacy|9|||
160977237|NCT01804673|581306430|FG000|Overall Study|Change to Oral Therapy|37|||
160977238|NCT01804673|581306430|FG000|Overall Study|No Further Therapy Required|84|||
160977239|NCT01804673|581306430|FG000|Overall Study|Use of Prohibited Medication|1|||
160977240|NCT01804673|581306430|FG000|Overall Study|Other|4|||
160977241|NCT01857934|581306438|FG000|Overall Study|Relapse or progression|2|||
160977242|NCT01857934|581306438|FG000|Overall Study|Unacceptable toxicity|3|||
160977243|NCT01857934|581306438|FG000|Overall Study|Unwillingness or inability to comply|2|||
160977244|NCT01857934|581306438|FG000|Overall Study|Physician Decision|3|||
160977245|NCT00603265|581306439|FG000|Overall Study|Adverse Event|2|||
160977246|NCT00603265|581306440|FG001|Overall Study|Adverse Event|11|||
160977247|NCT00603265|581306441|FG002|Overall Study|Adverse Event|1|||
160977248|NCT00603265|581306439|FG000|Overall Study|Withdrawal by Subject|1|||
160977249|NCT00603265|581306440|FG001|Overall Study|Withdrawal by Subject|2|||
160977250|NCT00603265|581306441|FG002|Overall Study|Withdrawal by Subject|1|||
160977251|NCT00603265|581306439|FG000|Overall Study|Lack of Efficacy|3|||
160977252|NCT00603265|581306440|FG001|Overall Study|Lack of Efficacy|0|||
160977253|NCT00603265|581306441|FG002|Overall Study|Lack of Efficacy|3|||
160977254|NCT00603265|581306439|FG000|Overall Study|Lost to Follow-up|0|||
160977255|NCT00603265|581306440|FG001|Overall Study|Lost to Follow-up|1|||
160977256|NCT00603265|581306441|FG002|Overall Study|Lost to Follow-up|0|||
160977257|NCT00603265|581306439|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
160977258|NCT00603265|581306440|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
160977259|NCT00603265|581306441|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
160977260|NCT00603265|581306439|FG000|Overall Study|Participant Left Country, No Responses|0|||
160977261|NCT00603265|581306440|FG001|Overall Study|Participant Left Country, No Responses|1|||
160977262|NCT00603265|581306441|FG002|Overall Study|Participant Left Country, No Responses|0|||
160977263|NCT00603265|581306439|FG000|Overall Study|Protocol Violation|1|||
160977264|NCT00603265|581306440|FG001|Overall Study|Protocol Violation|0|||
160977265|NCT00603265|581306441|FG002|Overall Study|Protocol Violation|0|||
160977266|NCT01375959|581306442|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
160977267|NCT01375959|581306443|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
160977268|NCT01375959|581306442|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
160977269|NCT01375959|581306443|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
160977270|NCT01375959|581306442|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
160977271|NCT01375959|581306443|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
160977272|NCT04012814|581306450|FG000|Overall Study|Lost to Follow-up|4|||
160977273|NCT04012814|581306450|FG000|Overall Study|Withdrawal by Subject|2|||
160977274|NCT04012814|581306450|FG000|Overall Study|Protocol Violation|1|||
160977275|NCT04012814|581306450|FG000|Overall Study|Adverse Event|1|||
160977276|NCT04789577|581306451|FG000|Overall Study|Withdrawal by Subject|1|||
160977277|NCT04789577|581306452|FG001|Overall Study|Withdrawal by Subject|1|||
160977278|NCT04789577|581306453|FG002|Overall Study|Withdrawal by Subject|1|||
160977279|NCT04789577|581306454|FG003|Overall Study|Withdrawal by Subject|3|||
160977280|NCT04789577|581306455|FG004|Overall Study|Withdrawal by Subject|1|||
160977281|NCT04789577|581306456|FG005|Overall Study|Withdrawal by Subject|7|||
160977282|NCT04789577|581306457|FG006|Overall Study|Withdrawal by Subject|1|||
160977283|NCT04789577|581306451|FG000|Overall Study|Lost to Follow-up|7|||
160977284|NCT04789577|581306452|FG001|Overall Study|Lost to Follow-up|12|||
160977285|NCT04789577|581306453|FG002|Overall Study|Lost to Follow-up|7|||
160977286|NCT04789577|581306454|FG003|Overall Study|Lost to Follow-up|10|||
160977287|NCT04789577|581306455|FG004|Overall Study|Lost to Follow-up|8|||
160977288|NCT04789577|581306456|FG005|Overall Study|Lost to Follow-up|6|||
160977289|NCT04789577|581306457|FG006|Overall Study|Lost to Follow-up|10|||
160977290|NCT04789577|581306451|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
160977291|NCT04789577|581306452|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
160977292|NCT04789577|581306453|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
160977293|NCT04789577|581306454|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
160977294|NCT04789577|581306455|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
160977295|NCT04789577|581306456|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
160977296|NCT04789577|581306457|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
160977297|NCT04789577|581306451|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
160977298|NCT04789577|581306452|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
160977299|NCT04789577|581306453|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
160977300|NCT04789577|581306454|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
160977301|NCT04789577|581306455|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
160977302|NCT04789577|581306456|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
160977303|NCT04789577|581306457|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
160977304|NCT02441946|581306458|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
160593177|NCT00383721|579887422|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
160593178|NCT00383721|579887418|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
160593179|NCT00383721|579887419|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
160593180|NCT00383721|579887420|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
160593181|NCT00383721|579887421|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
160593182|NCT00383721|579887422|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
160593183|NCT00383721|579887418|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
160593184|NCT00383721|579887419|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
160593185|NCT00383721|579887420|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
160593186|NCT00383721|579887421|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
160593187|NCT00383721|579887422|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
160593188|NCT00383721|579887418|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
160593189|NCT00383721|579887419|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
160593190|NCT00383721|579887420|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
160593191|NCT00383721|579887421|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
160593192|NCT00383721|579887422|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
160593193|NCT00383721|579887418|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
160593194|NCT00383721|579887419|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
160593195|NCT00383721|579887420|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
160593196|NCT00383721|579887421|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
160593197|NCT00383721|579887422|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
160593198|NCT00383721|579887418|FG000|26-Week Treatment Safety Extension|Administrative|1|||
160593199|NCT00383721|579887419|FG001|26-Week Treatment Safety Extension|Administrative|2|||
160593200|NCT00383721|579887420|FG002|26-Week Treatment Safety Extension|Administrative|3|||
160593201|NCT00383721|579887421|FG003|26-Week Treatment Safety Extension|Administrative|1|||
160593202|NCT00383721|579887422|FG004|26-Week Treatment Safety Extension|Administrative|0|||
160593203|NCT05584202|579887424|FG000|Overall Study|Withdrawal of Consent|3|||
160593204|NCT05584202|579887425|FG001|Overall Study|Withdrawal of Consent|2|||
160593205|NCT05584202|579887424|FG000|Overall Study|Lost to Follow-up|2|||
160593206|NCT05584202|579887425|FG001|Overall Study|Lost to Follow-up|1|||
160593207|NCT05584202|579887424|FG000|Overall Study|Death|0|||
160593208|NCT05584202|579887425|FG001|Overall Study|Death|1|||
160593209|NCT00436982|579889002|FG000|Overall Study|Withdrawal by Subject|3|||
160593210|NCT00436982|579889003|FG001|Overall Study|Withdrawal by Subject|1|||
160977305|NCT02441946|581306459|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
160977306|NCT02441946|581306460|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
160977307|NCT02441946|581306458|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
160977308|NCT02441946|581306459|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
160977309|NCT02441946|581306460|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
160977310|NCT02441946|581306458|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
160977311|NCT02441946|581306459|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
160977312|NCT02441946|581306460|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
160977313|NCT02441946|581306458|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
160977314|NCT02441946|581306459|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
160977315|NCT02441946|581306460|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
160977316|NCT02441946|581306458|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
160977317|NCT02441946|581306459|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
160977318|NCT02441946|581306460|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
160593211|NCT00436982|579889002|FG000|Overall Study|Did not receive allocated intervention|0|||
160593212|NCT00436982|579889003|FG001|Overall Study|Did not receive allocated intervention|1|||
160593213|NCT00436982|579889002|FG000|Overall Study|no RSA data|1|||
160593214|NCT00436982|579889003|FG001|Overall Study|no RSA data|2|||
160593215|NCT02215616|579889007|FG000|Overall Study|Sponsor requested to stop study drug|0|||
160593216|NCT02215616|579889008|FG001|Overall Study|Sponsor requested to stop study drug|0|||
160593217|NCT02215616|579889009|FG002|Overall Study|Sponsor requested to stop study drug|1|||
160593218|NCT02215616|579889010|FG003|Overall Study|Sponsor requested to stop study drug|4|||
160593219|NCT02215616|579889007|FG000|Overall Study|Death|1|||
160593220|NCT02215616|579889008|FG001|Overall Study|Death|0|||
160593221|NCT02215616|579889009|FG002|Overall Study|Death|0|||
160593222|NCT02215616|579889010|FG003|Overall Study|Death|0|||
160593223|NCT02215616|579889007|FG000|Overall Study|Adverse Event|7|||
160593224|NCT02215616|579889008|FG001|Overall Study|Adverse Event|4|||
160593225|NCT02215616|579889009|FG002|Overall Study|Adverse Event|9|||
160593226|NCT02215616|579889010|FG003|Overall Study|Adverse Event|2|||
160593227|NCT02215616|579889007|FG000|Overall Study|Withdrawal by Subject|1|||
160593228|NCT02215616|579889008|FG001|Overall Study|Withdrawal by Subject|8|||
160593229|NCT02215616|579889009|FG002|Overall Study|Withdrawal by Subject|2|||
160593230|NCT02215616|579889010|FG003|Overall Study|Withdrawal by Subject|5|||
160593231|NCT02215616|579889007|FG000|Overall Study|Non-compliance|0|||
160593232|NCT02215616|579889008|FG001|Overall Study|Non-compliance|2|||
160593233|NCT02215616|579889009|FG002|Overall Study|Non-compliance|1|||
160977319|NCT02441946|581306458|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
160977320|NCT02441946|581306459|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
160977321|NCT02441946|581306460|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
160977322|NCT02441946|581306458|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
160977323|NCT02441946|581306459|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
160977324|NCT02441946|581306460|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
160977325|NCT02441946|581306458|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
160977326|NCT02441946|581306459|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
160977327|NCT02441946|581306460|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
160977328|NCT02441946|581306458|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
160977329|NCT02441946|581306459|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
160977330|NCT02441946|581306460|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
160977331|NCT02441946|581306458|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
160977332|NCT02441946|581306459|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
160977333|NCT02441946|581306460|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
160977334|NCT02441946|581306458|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
160977335|NCT02441946|581306459|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
160977336|NCT02441946|581306460|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
160977337|NCT04175912|581306467|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
160977338|NCT04175912|581306468|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
160977339|NCT04175912|581306467|FG000|Overall Study|Adverse Event|0|||
160977340|NCT04175912|581306468|FG001|Overall Study|Adverse Event|3|||
160977341|NCT04175912|581306467|FG000|Overall Study|Never started treatment|3|||
160977342|NCT04175912|581306468|FG001|Overall Study|Never started treatment|3|||
160977343|NCT04175912|581306467|FG000|Overall Study|Death|0|||
160977344|NCT04175912|581306468|FG001|Overall Study|Death|1|||
160977345|NCT04654468|581306469|FG000|Overall Study|Death|1|||
160977346|NCT04654468|581306469|FG000|Overall Study|Ongoing in the Study|50|||
160977347|NCT01155661|581306470|FG000|Overall Study|Adverse Event|101|||
160977348|NCT01155661|581306470|FG000|Overall Study|Death|1|||
160977349|NCT01155661|581306470|FG000|Overall Study|Lack of Efficacy|32|||
160977350|NCT01155661|581306470|FG000|Overall Study|Lost to Follow-up|22|||
160977351|NCT01155661|581306470|FG000|Overall Study|Physician Decision|3|||
160977352|NCT01155661|581306470|FG000|Overall Study|Protocol Violation|35|||
160977353|NCT01155661|581306470|FG000|Overall Study|Withdrawal by Subject|73|||
160977354|NCT01155661|581306470|FG000|Overall Study|Sponsor Decision|13|||
160977355|NCT05064735|581306480|FG000|Overall Study|Withdrawal by Subject|7|||
160977356|NCT05064735|581306481|FG001|Overall Study|Withdrawal by Subject|8|||
160977357|NCT05064735|581306480|FG000|Overall Study|Lost to Follow-up|7|||
160977358|NCT05064735|581306481|FG001|Overall Study|Lost to Follow-up|2|||
160977359|NCT05064735|581306480|FG000|Overall Study|Physician Decision|2|||
160977360|NCT05064735|581306481|FG001|Overall Study|Physician Decision|1|||
160977361|NCT05064735|581306480|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
160977362|NCT05064735|581306481|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
160977363|NCT05064735|581306480|FG000|Overall Study|Site Closure|7|||
160977364|NCT05064735|581306481|FG001|Overall Study|Site Closure|2|||
160977365|NCT04844970|581306485|FG000|Overall Study|Adverse Event|0|||
160977366|NCT04844970|581306486|FG001|Overall Study|Adverse Event|1|||
160977367|NCT04844970|581306485|FG000|Overall Study|Withdrawal by Subject|2|||
160977368|NCT04844970|581306486|FG001|Overall Study|Withdrawal by Subject|0|||
160977369|NCT00447954|581306487|FG000|Overall Study|Adverse Event|0|||
160977370|NCT00447954|581306488|FG001|Overall Study|Adverse Event|2|||
160593234|NCT02215616|579889010|FG003|Overall Study|Non-compliance|0|||
160593235|NCT02215616|579889007|FG000|Overall Study|Protocol Violation|0|||
160593236|NCT02215616|579889008|FG001|Overall Study|Protocol Violation|2|||
160593237|NCT02215616|579889009|FG002|Overall Study|Protocol Violation|0|||
160593238|NCT02215616|579889010|FG003|Overall Study|Protocol Violation|0|||
160593239|NCT02215616|579889007|FG000|Overall Study|Lost to Follow-up|1|||
160593240|NCT02215616|579889008|FG001|Overall Study|Lost to Follow-up|1|||
160593241|NCT02215616|579889009|FG002|Overall Study|Lost to Follow-up|0|||
160593242|NCT02215616|579889010|FG003|Overall Study|Lost to Follow-up|1|||
160593243|NCT02215616|579889007|FG000|Overall Study|Other than specified|1|||
160593244|NCT02215616|579889008|FG001|Overall Study|Other than specified|0|||
160593245|NCT02215616|579889009|FG002|Overall Study|Other than specified|1|||
160593246|NCT02215616|579889010|FG003|Overall Study|Other than specified|1|||
160593247|NCT03172481|579889014|FG000|Double-blind|Withdrawal by Subject|1|||
160593248|NCT03172481|579889015|FG001|Double-blind|Withdrawal by Subject|0|||
160593249|NCT00363051|579889016|FG000|Overall Study|Adminstrative problems|1|||
160593250|NCT00363051|579889017|FG001|Overall Study|Adminstrative problems|1|||
160593251|NCT00363051|579889016|FG000|Overall Study|Adverse Event|21|||
160593252|NCT00363051|579889017|FG001|Overall Study|Adverse Event|12|||
160593253|NCT00363051|579889016|FG000|Overall Study|New Cancer Therapy|2|||
160593254|NCT00363051|579889017|FG001|Overall Study|New Cancer Therapy|1|||
160593255|NCT00363051|579889016|FG000|Overall Study|Withdrawal by Subject|11|||
160593256|NCT00363051|579889017|FG001|Overall Study|Withdrawal by Subject|3|||
160593257|NCT00363051|579889016|FG000|Overall Study|Lost to Follow-up|0|||
160593258|NCT00363051|579889017|FG001|Overall Study|Lost to Follow-up|1|||
160593259|NCT00363051|579889016|FG000|Overall Study|Protocol Violation|0|||
160593260|NCT00363051|579889017|FG001|Overall Study|Protocol Violation|2|||
160593261|NCT00363051|579889016|FG000|Overall Study|Death|3|||
160593262|NCT00363051|579889017|FG001|Overall Study|Death|2|||
160593263|NCT02759562|579889018|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
160593264|NCT02759562|579889019|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
160593265|NCT02759562|579889018|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
160593266|NCT02759562|579889019|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
160593267|NCT02293993|579889020|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
160593268|NCT02293993|579889021|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
160593269|NCT02293993|579889022|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
160593270|NCT02293993|579889023|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
160593271|NCT02293993|579889020|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
160593272|NCT02293993|579889021|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
160977371|NCT00447954|581306489|FG002|Overall Study|Adverse Event|0|||
160977372|NCT00447954|581306487|FG000|Overall Study|Withdrawal by Subject|0|||
160977373|NCT00447954|581306488|FG001|Overall Study|Withdrawal by Subject|1|||
160977374|NCT00447954|581306489|FG002|Overall Study|Withdrawal by Subject|1|||
160977375|NCT00447954|581306487|FG000|Overall Study|Lost to Follow-up|0|||
160977376|NCT00447954|581306488|FG001|Overall Study|Lost to Follow-up|1|||
160977377|NCT00447954|581306489|FG002|Overall Study|Lost to Follow-up|0|||
160977378|NCT00447954|581306487|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
160977379|NCT00447954|581306488|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
160977380|NCT00447954|581306489|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
160977381|NCT00856661|581306490|FG000|Overall Study|Death|15|||
160977382|NCT00856661|581306491|FG001|Overall Study|Death|18|||
160977383|NCT00856661|581306490|FG000|Overall Study|Protocol Violation|2|||
160977384|NCT00856661|581306491|FG001|Overall Study|Protocol Violation|1|||
160977385|NCT00856661|581306490|FG000|Overall Study|Withdrawal by Subject|1|||
160977386|NCT00856661|581306491|FG001|Overall Study|Withdrawal by Subject|2|||
160977387|NCT00856661|581306490|FG000|Overall Study|Lost to Follow-up|1|||
160977388|NCT00856661|581306491|FG001|Overall Study|Lost to Follow-up|3|||
160977389|NCT00856661|581306490|FG000|Overall Study|Physician Judgement|8|||
160977390|NCT00856661|581306491|FG001|Overall Study|Physician Judgement|5|||
160977391|NCT03936777|581306492|FG000|Overall Study|Adverse Event|3|||
160977392|NCT03936777|581306492|FG000|Overall Study|Death|3|||
160977393|NCT03936777|581306492|FG000|Overall Study|Lack of Efficacy|24|||
160977394|NCT03936777|581306492|FG000|Overall Study|Lost to Follow-up|3|||
160977395|NCT03936777|581306492|FG000|Overall Study|Physician Decision|1|||
160977396|NCT03936777|581306492|FG000|Overall Study|Withdrawal by Subject|11|||
160977397|NCT03936777|581306492|FG000|Overall Study|Subjected Weaned of ZX008|1|||
160977398|NCT03936777|581306492|FG000|Overall Study|Missing|6|||
160977399|NCT02301156|581306493|FG000|Overall Study|Adverse Event|13|||
160977400|NCT02301156|581306494|FG001|Overall Study|Adverse Event|14|||
160977401|NCT02301156|581306493|FG000|Overall Study|Death|1|||
160977402|NCT02301156|581306494|FG001|Overall Study|Death|5|||
160593273|NCT02293993|579889022|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
160593274|NCT02293993|579889023|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
160977403|NCT02301156|581306493|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
160593275|NCT02293993|579889020|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
160593276|NCT02293993|579889021|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
160593277|NCT02293993|579889022|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
160593278|NCT02293993|579889023|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
160977404|NCT02301156|581306494|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
160977405|NCT02301156|581306493|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
160977406|NCT02301156|581306494|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
160977407|NCT02301156|581306493|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
160977408|NCT02301156|581306494|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
160977409|NCT02301156|581306493|FG000|Overall Study|Reason not Specified|6|||
160977410|NCT02301156|581306494|FG001|Overall Study|Reason not Specified|3|||
160977411|NCT03734991|581306499|FG000|Overall Study|Adverse Event|4|||
160977412|NCT03734991|581306500|FG001|Overall Study|Adverse Event|0|||
160977413|NCT03734991|581306499|FG000|Overall Study|Lost to Follow-up|4|||
160977414|NCT03734991|581306500|FG001|Overall Study|Lost to Follow-up|0|||
160977415|NCT03734991|581306499|FG000|Overall Study|Physician Decision|0|||
160977416|NCT03734991|581306500|FG001|Overall Study|Physician Decision|1|||
160977417|NCT03734991|581306499|FG000|Overall Study|Pregnancy|1|||
160977418|NCT03734991|581306500|FG001|Overall Study|Pregnancy|0|||
160977419|NCT03734991|581306499|FG000|Overall Study|Withdrawal by Subject|6|||
160977420|NCT03734991|581306500|FG001|Overall Study|Withdrawal by Subject|3|||
160977421|NCT03734991|581306499|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
160977422|NCT03734991|581306500|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
160977423|NCT03734991|581306499|FG000|Overall Study|Other|2|||
160977424|NCT03734991|581306500|FG001|Overall Study|Other|2|||
160977425|NCT02638623|581306501|FG000|Overall Study|Surgery timing|5|||
160977426|NCT02638623|581306502|FG001|Overall Study|Surgery timing|6|||
160977427|NCT02638623|581306501|FG000|Overall Study|Not given intervention|2|||
160977428|NCT02638623|581306502|FG001|Overall Study|Not given intervention|0|||
160977429|NCT03797326|581306508|FG000|Overall Study|Lost to Follow-up|1|||
160977430|NCT03797326|581306509|FG001|Overall Study|Lost to Follow-up|0|||
160977431|NCT03797326|581306510|FG002|Overall Study|Lost to Follow-up|0|||
160977432|NCT03797326|581306511|FG003|Overall Study|Lost to Follow-up|1|||
160977433|NCT03797326|581306512|FG004|Overall Study|Lost to Follow-up|0|||
160977434|NCT03797326|581306513|FG005|Overall Study|Lost to Follow-up|0|||
160977435|NCT03797326|581306514|FG006|Overall Study|Lost to Follow-up|0|||
160977436|NCT03797326|581306515|FG007|Overall Study|Lost to Follow-up|0|||
160977437|NCT03797326|581306508|FG000|Overall Study|Withdrawal by Subject|0|||
160977438|NCT03797326|581306509|FG001|Overall Study|Withdrawal by Subject|0|||
160977439|NCT03797326|581306510|FG002|Overall Study|Withdrawal by Subject|1|||
160977440|NCT03797326|581306511|FG003|Overall Study|Withdrawal by Subject|3|||
160977441|NCT03797326|581306512|FG004|Overall Study|Withdrawal by Subject|0|||
160977442|NCT03797326|581306513|FG005|Overall Study|Withdrawal by Subject|2|||
160977443|NCT03797326|581306514|FG006|Overall Study|Withdrawal by Subject|2|||
160977444|NCT03797326|581306515|FG007|Overall Study|Withdrawal by Subject|3|||
160977445|NCT03797326|581306508|FG000|Overall Study|Sponsor Decision|3|||
160977446|NCT03797326|581306509|FG001|Overall Study|Sponsor Decision|3|||
160977447|NCT03797326|581306510|FG002|Overall Study|Sponsor Decision|3|||
160977448|NCT03797326|581306511|FG003|Overall Study|Sponsor Decision|6|||
160977449|NCT03797326|581306512|FG004|Overall Study|Sponsor Decision|0|||
160977450|NCT03797326|581306513|FG005|Overall Study|Sponsor Decision|3|||
160977451|NCT03797326|581306514|FG006|Overall Study|Sponsor Decision|3|||
160977452|NCT03797326|581306515|FG007|Overall Study|Sponsor Decision|2|||
160593279|NCT02293993|579889020|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
160593280|NCT02293993|579889021|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
160593281|NCT02293993|579889022|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
160593282|NCT02293993|579889023|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
160593283|NCT02293993|579889020|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
160593284|NCT02293993|579889021|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
160593285|NCT02293993|579889022|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
160593286|NCT02293993|579889023|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
160593287|NCT01957709|579889024|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
160593288|NCT01061736|579889026|FG000|Overall Study|Dose regimen not selected|0|||
160593289|NCT01061736|579889027|FG001|Overall Study|Dose regimen not selected|0|||
160593290|NCT01061736|579889028|FG002|Overall Study|Dose regimen not selected|0|||
160593291|NCT01061736|579889029|FG003|Overall Study|Dose regimen not selected|0|||
160593292|NCT01061736|579889030|FG004|Overall Study|Dose regimen not selected|0|||
160593293|NCT01061736|579889031|FG005|Overall Study|Dose regimen not selected|0|||
160593294|NCT01061736|579889032|FG006|Overall Study|Dose regimen not selected|79|||
160593295|NCT01061736|579889033|FG007|Overall Study|Dose regimen not selected|0|||
160593296|NCT01061736|579889034|FG008|Overall Study|Dose regimen not selected|0|||
160593297|NCT01061736|579889035|FG009|Overall Study|Dose regimen not selected|0|||
160593298|NCT01061736|579889026|FG000|Overall Study|Adverse Event|13|||
160593299|NCT01061736|579889027|FG001|Overall Study|Adverse Event|1|||
160593300|NCT01061736|579889028|FG002|Overall Study|Adverse Event|3|||
160593301|NCT01061736|579889029|FG003|Overall Study|Adverse Event|2|||
160593302|NCT01061736|579889030|FG004|Overall Study|Adverse Event|4|||
160593303|NCT01061736|579889031|FG005|Overall Study|Adverse Event|1|||
160593304|NCT01061736|579889032|FG006|Overall Study|Adverse Event|4|||
160593305|NCT01061736|579889033|FG007|Overall Study|Adverse Event|63|||
160593306|NCT01061736|579889034|FG008|Overall Study|Adverse Event|67|||
160593307|NCT01061736|579889035|FG009|Overall Study|Adverse Event|34|||
160593308|NCT01061736|579889026|FG000|Overall Study|Lack of Efficacy|0|||
160593309|NCT01061736|579889027|FG001|Overall Study|Lack of Efficacy|2|||
160593310|NCT01061736|579889028|FG002|Overall Study|Lack of Efficacy|1|||
160593311|NCT01061736|579889029|FG003|Overall Study|Lack of Efficacy|1|||
160593312|NCT01061736|579889030|FG004|Overall Study|Lack of Efficacy|1|||
160593313|NCT01061736|579889031|FG005|Overall Study|Lack of Efficacy|2|||
160593314|NCT01061736|579889032|FG006|Overall Study|Lack of Efficacy|1|||
160593315|NCT01061736|579889033|FG007|Overall Study|Lack of Efficacy|9|||
160593316|NCT01061736|579889034|FG008|Overall Study|Lack of Efficacy|9|||
160593317|NCT01061736|579889035|FG009|Overall Study|Lack of Efficacy|10|||
160593318|NCT01061736|579889026|FG000|Overall Study|Poor compliance to protocol|0|||
160593319|NCT01061736|579889027|FG001|Overall Study|Poor compliance to protocol|0|||
160593320|NCT01061736|579889028|FG002|Overall Study|Poor compliance to protocol|0|||
160593321|NCT01061736|579889029|FG003|Overall Study|Poor compliance to protocol|0|||
160593322|NCT01061736|579889030|FG004|Overall Study|Poor compliance to protocol|0|||
160593323|NCT01061736|579889031|FG005|Overall Study|Poor compliance to protocol|0|||
160593324|NCT01061736|579889032|FG006|Overall Study|Poor compliance to protocol|0|||
160593325|NCT01061736|579889033|FG007|Overall Study|Poor compliance to protocol|2|||
160593326|NCT01061736|579889034|FG008|Overall Study|Poor compliance to protocol|5|||
160593327|NCT01061736|579889035|FG009|Overall Study|Poor compliance to protocol|9|||
160593328|NCT01061736|579889026|FG000|Overall Study|Not treated|0|||
160593329|NCT01061736|579889027|FG001|Overall Study|Not treated|0|||
160593330|NCT01061736|579889028|FG002|Overall Study|Not treated|0|||
160593331|NCT01061736|579889029|FG003|Overall Study|Not treated|0|||
160593332|NCT01061736|579889030|FG004|Overall Study|Not treated|1|||
160593333|NCT01061736|579889031|FG005|Overall Study|Not treated|0|||
160593334|NCT01061736|579889032|FG006|Overall Study|Not treated|0|||
160593335|NCT01061736|579889033|FG007|Overall Study|Not treated|2|||
160593336|NCT01061736|579889034|FG008|Overall Study|Not treated|1|||
160593337|NCT01061736|579889035|FG009|Overall Study|Not treated|0|||
160593338|NCT01061736|579889026|FG000|Overall Study|Other than specified above|0|||
160593339|NCT01061736|579889027|FG001|Overall Study|Other than specified above|1|||
160593340|NCT01061736|579889028|FG002|Overall Study|Other than specified above|2|||
160593341|NCT01061736|579889029|FG003|Overall Study|Other than specified above|0|||
160593342|NCT01061736|579889030|FG004|Overall Study|Other than specified above|1|||
160593343|NCT01061736|579889031|FG005|Overall Study|Other than specified above|0|||
160593344|NCT01061736|579889032|FG006|Overall Study|Other than specified above|0|||
160593345|NCT01061736|579889033|FG007|Overall Study|Other than specified above|18|||
160593346|NCT01061736|579889034|FG008|Overall Study|Other than specified above|15|||
160593347|NCT01061736|579889035|FG009|Overall Study|Other than specified above|21|||
160593348|NCT01925612|579889036|FG000|Overall Study|Progressive Disease|1|||
160593349|NCT01925612|579889037|FG001|Overall Study|Progressive Disease|1|||
160593350|NCT01925612|579889038|FG002|Overall Study|Progressive Disease|1|||
160593351|NCT01925612|579889039|FG003|Overall Study|Progressive Disease|0|||
160593352|NCT01925612|579889040|FG004|Overall Study|Progressive Disease|0|||
160593353|NCT01925612|579889036|FG000|Overall Study|Adverse Event|3|||
160593354|NCT01925612|579889037|FG001|Overall Study|Adverse Event|3|||
160593355|NCT01925612|579889038|FG002|Overall Study|Adverse Event|0|||
160593356|NCT01925612|579889039|FG003|Overall Study|Adverse Event|1|||
160593357|NCT01925612|579889040|FG004|Overall Study|Adverse Event|2|||
160593358|NCT00980343|579889042|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
160593359|NCT00980343|579889043|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
160593360|NCT02310906|579889046|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
160593361|NCT02310906|579889047|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
160593362|NCT02310906|579889048|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
160593363|NCT02310906|579889049|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
160593364|NCT02310906|579889046|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
160593365|NCT02310906|579889047|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
160593366|NCT02310906|579889048|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
160593367|NCT02310906|579889049|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
160593368|NCT02310906|579889046|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
160977453|NCT03797326|581306508|FG000|Overall Study|Death|27|||
160977454|NCT03797326|581306509|FG001|Overall Study|Death|28|||
160977455|NCT03797326|581306510|FG002|Overall Study|Death|95|||
160977456|NCT03797326|581306511|FG003|Overall Study|Death|95|||
160977457|NCT03797326|581306512|FG004|Overall Study|Death|30|||
160977458|NCT03797326|581306513|FG005|Overall Study|Death|96|||
160977459|NCT03797326|581306514|FG006|Overall Study|Death|97|||
160977460|NCT03797326|581306515|FG007|Overall Study|Death|98|||
160977461|NCT03797326|581306508|FG000|Overall Study|Enrolled in error|0|||
160977462|NCT03797326|581306509|FG001|Overall Study|Enrolled in error|0|||
160977463|NCT03797326|581306510|FG002|Overall Study|Enrolled in error|3|||
160977464|NCT03797326|581306511|FG003|Overall Study|Enrolled in error|2|||
160977465|NCT03797326|581306512|FG004|Overall Study|Enrolled in error|2|||
160977466|NCT03797326|581306513|FG005|Overall Study|Enrolled in error|1|||
160977467|NCT03797326|581306514|FG006|Overall Study|Enrolled in error|1|||
160977468|NCT03797326|581306515|FG007|Overall Study|Enrolled in error|0|||
160977469|NCT03012061|581306516|FG000|Overall Study|Withdrawal by Subject|1|||
160977470|NCT03012061|581306517|FG001|Overall Study|Withdrawal by Subject|5|||
160977471|NCT03012061|581306518|FG002|Overall Study|Withdrawal by Subject|4|||
160977472|NCT03012061|581306516|FG000|Overall Study|Investigator Site Closed|1|||
160977473|NCT03012061|581306517|FG001|Overall Study|Investigator Site Closed|2|||
160977474|NCT03012061|581306518|FG002|Overall Study|Investigator Site Closed|0|||
160977475|NCT03012061|581306516|FG000|Overall Study|Lost to Follow-up|2|||
160977476|NCT03012061|581306517|FG001|Overall Study|Lost to Follow-up|1|||
160977477|NCT03012061|581306518|FG002|Overall Study|Lost to Follow-up|0|||
160977478|NCT03012061|581306516|FG000|Overall Study|Study closed/ Terminated|0|||
160977479|NCT03012061|581306517|FG001|Overall Study|Study closed/ Terminated|0|||
160977480|NCT03012061|581306518|FG002|Overall Study|Study closed/ Terminated|1|||
160977481|NCT03012061|581306516|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
160977482|NCT03012061|581306517|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
160977483|NCT03012061|581306518|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
160977484|NCT03012061|581306516|FG000|Overall Study|Protocol Violation|0|||
160977485|NCT03012061|581306517|FG001|Overall Study|Protocol Violation|0|||
160593369|NCT02310906|579889047|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
160593370|NCT02310906|579889048|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
160593371|NCT02310906|579889049|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
160593372|NCT02310906|579889046|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
160593373|NCT02310906|579889047|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
160593374|NCT02310906|579889048|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
160593375|NCT02310906|579889049|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
160593376|NCT01231607|579889050|FG000|Overall Study|Adverse Event|0|||
160593377|NCT01231607|579889051|FG001|Overall Study|Adverse Event|8|||
160593378|NCT01231607|579889052|FG002|Overall Study|Adverse Event|4|||
160593379|NCT01231607|579889053|FG003|Overall Study|Adverse Event|4|||
160593380|NCT01231607|579889054|FG004|Overall Study|Adverse Event|5|||
160593381|NCT01231607|579889050|FG000|Overall Study|Lost to Follow-up|13|||
160593382|NCT01231607|579889051|FG001|Overall Study|Lost to Follow-up|11|||
160593383|NCT01231607|579889052|FG002|Overall Study|Lost to Follow-up|10|||
160593384|NCT01231607|579889053|FG003|Overall Study|Lost to Follow-up|10|||
160593385|NCT01231607|579889054|FG004|Overall Study|Lost to Follow-up|4|||
160593386|NCT01231607|579889050|FG000|Overall Study|Physician Decision|4|||
160593387|NCT01231607|579889051|FG001|Overall Study|Physician Decision|4|||
160593388|NCT01231607|579889052|FG002|Overall Study|Physician Decision|3|||
160593389|NCT01231607|579889053|FG003|Overall Study|Physician Decision|5|||
160593390|NCT01231607|579889054|FG004|Overall Study|Physician Decision|4|||
160593391|NCT01231607|579889050|FG000|Overall Study|Protocol Violation|3|||
160593392|NCT01231607|579889051|FG001|Overall Study|Protocol Violation|2|||
160593393|NCT01231607|579889052|FG002|Overall Study|Protocol Violation|0|||
160593394|NCT01231607|579889053|FG003|Overall Study|Protocol Violation|2|||
160593395|NCT01231607|579889054|FG004|Overall Study|Protocol Violation|2|||
160593396|NCT01231607|579889050|FG000|Overall Study|Withdrawal by Subject|9|||
160593397|NCT01231607|579889051|FG001|Overall Study|Withdrawal by Subject|9|||
160593398|NCT01231607|579889052|FG002|Overall Study|Withdrawal by Subject|14|||
160593399|NCT01231607|579889053|FG003|Overall Study|Withdrawal by Subject|17|||
160593400|NCT01231607|579889054|FG004|Overall Study|Withdrawal by Subject|9|||
160593401|NCT01677507|579889057|FG000|Initial Assignment|Adverse Event|0|||
160593402|NCT01677507|579889058|FG001|Initial Assignment|Adverse Event|1|||
160593403|NCT01677507|579889057|FG000|Initial Assignment|Protocol Violation|0|||
160593404|NCT01677507|579889058|FG001|Initial Assignment|Protocol Violation|1|||
160593405|NCT01677507|579889057|FG000|Second Assigment|Withdrawal by Subject|2|||
160593406|NCT01677507|579889058|FG001|Second Assigment|Withdrawal by Subject|2|||
160593407|NCT01677507|579889057|FG000|Second Assigment|Adverse Event|1|||
160593408|NCT01677507|579889058|FG001|Second Assigment|Adverse Event|3|||
160593409|NCT00469209|579889059|FG000|Overall Study|Adverse Event|1|||
160593410|NCT00469209|579889060|FG001|Overall Study|Adverse Event|0|||
160593411|NCT00469209|579889061|FG002|Overall Study|Adverse Event|1|||
160593412|NCT03779334|579889064|FG000|Overall Study|Withdrawal by Subject|3|||
160593413|NCT03779334|579889065|FG001|Overall Study|Withdrawal by Subject|0|||
160593414|NCT03779334|579889066|FG002|Overall Study|Withdrawal by Subject|0|||
160593415|NCT03779334|579889064|FG000|Overall Study|Ongoing in Study|5|||
160593416|NCT03779334|579889065|FG001|Overall Study|Ongoing in Study|13|||
160593417|NCT03779334|579889066|FG002|Overall Study|Ongoing in Study|5|||
160593418|NCT01082367|579889073|FG000|Double-blind Period|Administrative problems|0|||
160593419|NCT01082367|579889074|FG001|Double-blind Period|Administrative problems|1|||
160593420|NCT01082367|579889073|FG000|Double-blind Period|Lack of Efficacy|5|||
160593421|NCT01082367|579889074|FG001|Double-blind Period|Lack of Efficacy|11|||
160593422|NCT01082367|579889073|FG000|Double-blind Period|Adverse Event|0|||
160593423|NCT01082367|579889074|FG001|Double-blind Period|Adverse Event|1|||
160593424|NCT01082367|579889073|FG000|Follow-up (F-U) Period|Administrative problems|1|||
160593425|NCT01082367|579889074|FG001|Follow-up (F-U) Period|Administrative problems|0|||
160593426|NCT01082367|579889073|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
160593427|NCT01082367|579889074|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
160593428|NCT01082367|579889073|FG000|Follow-up (F-U) Period|Adverse Event|0|||
160593429|NCT01082367|579889074|FG001|Follow-up (F-U) Period|Adverse Event|1|||
160593430|NCT00098020|579889077|FG000|Overall Study|Adverse Event|2|||
160593431|NCT00098020|579889077|FG000|Overall Study|Lost to Follow-up|1|||
160593432|NCT00098020|579889077|FG000|Overall Study|elevated liver enzymes|1|||
160593433|NCT00098020|579889077|FG000|Overall Study|Low urine PCR|1|||
160593434|NCT00098020|579889077|FG000|Overall Study|Low epidermal growth factor receptor|1|||
160593435|NCT00865189|579889083|FG000|Overall Study|Other|1|||
160593436|NCT00865189|579889084|FG001|Overall Study|Other|2|||
160593437|NCT00865189|579889083|FG000|Overall Study|Death|4|||
160593438|NCT00865189|579889084|FG001|Overall Study|Death|11|||
160593439|NCT00865189|579889083|FG000|Overall Study|Lost to Follow-up|6|||
160593440|NCT00865189|579889084|FG001|Overall Study|Lost to Follow-up|6|||
160593441|NCT00865189|579889083|FG000|Overall Study|Withdrawal by Subject|1|||
160593442|NCT00865189|579889084|FG001|Overall Study|Withdrawal by Subject|0|||
160593443|NCT00084929|579889086|FG000|Overall Study|ineligible - medical contraindication|1|||
160593444|NCT00084929|579889086|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
160593445|NCT00084929|579889086|FG000|Overall Study|Ineligible - Medical history|6|||
160593446|NCT00084929|579889086|FG000|Overall Study|Withdrawal by Subject|10|||
160593447|NCT00084929|579889086|FG000|Overall Study|Missing/incomplete CTC exam|9|||
160593448|NCT00084929|579889086|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
160593449|NCT01797965|579889087|FG000|Overall Study|Adverse Event|104|||
160593450|NCT01797965|579889088|FG001|Overall Study|Adverse Event|129|||
160593451|NCT01797965|579889089|FG002|Overall Study|Adverse Event|4|||
160593452|NCT01797965|579889090|FG003|Overall Study|Adverse Event|21|||
160593453|NCT01797965|579889087|FG000|Overall Study|Lost to Follow-up|9|||
160593454|NCT01797965|579889088|FG001|Overall Study|Lost to Follow-up|8|||
160593455|NCT01797965|579889089|FG002|Overall Study|Lost to Follow-up|1|||
160593456|NCT01797965|579889090|FG003|Overall Study|Lost to Follow-up|2|||
160593457|NCT01797965|579889087|FG000|Overall Study|Consent withdrawn|130|||
160593458|NCT01797965|579889088|FG001|Overall Study|Consent withdrawn|117|||
160977486|NCT03012061|581306518|FG002|Overall Study|Protocol Violation|2|||
160593459|NCT01797965|579889089|FG002|Overall Study|Consent withdrawn|3|||
160977487|NCT03012061|581306516|FG000|Overall Study|Lack of Efficacy|0|||
160977488|NCT03012061|581306517|FG001|Overall Study|Lack of Efficacy|1|||
160977489|NCT03012061|581306518|FG002|Overall Study|Lack of Efficacy|0|||
160977490|NCT03012061|581306516|FG000|Overall Study|Adverse Event|2|||
160977491|NCT03012061|581306517|FG001|Overall Study|Adverse Event|0|||
160977492|NCT03012061|581306518|FG002|Overall Study|Adverse Event|0|||
160977493|NCT04152343|581306519|FG000|Overall Study|Transplanted|5|||
160977494|NCT04152343|581306519|FG000|Overall Study|Death|20|||
160977495|NCT04152343|581306519|FG000|Overall Study|Lost to Follow-up|3|||
160977496|NCT01164228|581306520|FG000|Overall Study|Progression|24|||
160977497|NCT01164228|581306521|FG001|Overall Study|Progression|25|||
160977498|NCT01164228|581306520|FG000|Overall Study|Adverse Event|13|||
160977499|NCT01164228|581306521|FG001|Overall Study|Adverse Event|7|||
160977500|NCT01164228|581306520|FG000|Overall Study|Death|1|||
160977501|NCT01164228|581306521|FG001|Overall Study|Death|1|||
160977502|NCT01164228|581306520|FG000|Overall Study|Withdrawal by Subject|2|||
160977503|NCT01164228|581306521|FG001|Overall Study|Withdrawal by Subject|0|||
160977504|NCT01164228|581306520|FG000|Overall Study|Physician Decision|1|||
160977505|NCT01164228|581306521|FG001|Overall Study|Physician Decision|2|||
160977506|NCT01164228|581306520|FG000|Overall Study|Symptomatic deterioration|1|||
160977507|NCT01164228|581306521|FG001|Overall Study|Symptomatic deterioration|0|||
160977508|NCT01164228|581306520|FG000|Overall Study|Never started treatment|1|||
160977509|NCT01164228|581306521|FG001|Overall Study|Never started treatment|3|||
160977510|NCT01164228|581306520|FG000|Overall Study|Ineligible|1|||
160977511|NCT01164228|581306521|FG001|Overall Study|Ineligible|0|||
160977512|NCT02090634|581306522|FG000|Overall Study|Lost to Follow-up|0|||
160977513|NCT02090634|581306523|FG001|Overall Study|Lost to Follow-up|1|||
160977514|NCT02090634|581306522|FG000|Overall Study|Death|0|||
160977515|NCT02090634|581306523|FG001|Overall Study|Death|1|||
160977516|NCT02090634|581306522|FG000|Overall Study|Protocol Violation|3|||
160977517|NCT02090634|581306523|FG001|Overall Study|Protocol Violation|1|||
160977518|NCT02090634|581306522|FG000|Overall Study|Adverse Event|2|||
160977519|NCT02090634|581306523|FG001|Overall Study|Adverse Event|0|||
160977520|NCT01965938|581306524|FG000|Overall Study|Withdrawal by Subject|1|||
160977521|NCT01965938|581306525|FG001|Overall Study|Withdrawal by Subject|0|||
160977522|NCT03757234|581306526|FG000|Overall Study|Adverse Event|0|||
160977523|NCT03757234|581306527|FG001|Overall Study|Adverse Event|0|||
160977524|NCT03757234|581306528|FG002|Overall Study|Adverse Event|0|||
160977525|NCT03757234|581306529|FG003|Overall Study|Adverse Event|0|||
160977526|NCT03757234|581306530|FG004|Overall Study|Adverse Event|1|||
160977527|NCT03757234|581306526|FG000|Overall Study|Lost to Follow-up|1|||
160977528|NCT03757234|581306527|FG001|Overall Study|Lost to Follow-up|0|||
160977529|NCT03757234|581306528|FG002|Overall Study|Lost to Follow-up|0|||
160977530|NCT03757234|581306529|FG003|Overall Study|Lost to Follow-up|0|||
160977531|NCT03757234|581306530|FG004|Overall Study|Lost to Follow-up|1|||
160977532|NCT03757234|581306526|FG000|Overall Study|Withdrawal by Subject|1|||
160977533|NCT03757234|581306527|FG001|Overall Study|Withdrawal by Subject|1|||
160977534|NCT03757234|581306528|FG002|Overall Study|Withdrawal by Subject|0|||
160977535|NCT03757234|581306529|FG003|Overall Study|Withdrawal by Subject|1|||
160977536|NCT03757234|581306530|FG004|Overall Study|Withdrawal by Subject|2|||
160977537|NCT03757234|581306526|FG000|Overall Study|Other|1|||
160977538|NCT03757234|581306527|FG001|Overall Study|Other|1|||
160977539|NCT03757234|581306528|FG002|Overall Study|Other|0|||
160977540|NCT03757234|581306529|FG003|Overall Study|Other|0|||
160977541|NCT03757234|581306530|FG004|Overall Study|Other|0|||
160977542|NCT01027364|581307914|FG000|Overall Study|Adverse Event|1|||
160977543|NCT01027364|581307915|FG001|Overall Study|Adverse Event|0|||
160977544|NCT01027364|581307916|FG002|Overall Study|Adverse Event|1|||
160593460|NCT01797965|579889090|FG003|Overall Study|Consent withdrawn|35|||
160593461|NCT01797965|579889087|FG000|Overall Study|Investigator decision|21|||
160593462|NCT01797965|579889088|FG001|Overall Study|Investigator decision|15|||
160593463|NCT01797965|579889089|FG002|Overall Study|Investigator decision|0|||
160593464|NCT01797965|579889090|FG003|Overall Study|Investigator decision|0|||
160593465|NCT01797965|579889087|FG000|Overall Study|Death|2|||
160593466|NCT01797965|579889088|FG001|Overall Study|Death|4|||
160593467|NCT01797965|579889089|FG002|Overall Study|Death|0|||
160593468|NCT01797965|579889090|FG003|Overall Study|Death|0|||
160593469|NCT01797965|579889087|FG000|Overall Study|Disease progression, defined by protocol|3|||
160593470|NCT01797965|579889088|FG001|Overall Study|Disease progression, defined by protocol|1|||
160593471|NCT01797965|579889089|FG002|Overall Study|Disease progression, defined by protocol|0|||
160593472|NCT01797965|579889090|FG003|Overall Study|Disease progression, defined by protocol|0|||
160593473|NCT01797965|579889087|FG000|Overall Study|Reason Not Specified|280|||
160593474|NCT01797965|579889088|FG001|Overall Study|Reason Not Specified|295|||
160593475|NCT01797965|579889089|FG002|Overall Study|Reason Not Specified|0|||
160593476|NCT01797965|579889090|FG003|Overall Study|Reason Not Specified|15|||
160593477|NCT01764256|579889091|FG000|Received All Vaccinations|Adverse Event|1|||
160593478|NCT01764256|579889092|FG001|Received All Vaccinations|Adverse Event|1|||
160593479|NCT01764256|579889093|FG002|Received All Vaccinations|Adverse Event|0|||
160593480|NCT01764256|579889094|FG003|Received All Vaccinations|Adverse Event|0|||
160593481|NCT01764256|579889091|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
160593482|NCT01764256|579889092|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
160593483|NCT01764256|579889093|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
160593484|NCT01764256|579889094|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
160593485|NCT01764256|579889091|FG000|Received All Vaccinations|Lost to Follow-up|1|||
160593486|NCT01764256|579889092|FG001|Received All Vaccinations|Lost to Follow-up|0|||
160593487|NCT01764256|579889093|FG002|Received All Vaccinations|Lost to Follow-up|0|||
160593488|NCT01764256|579889094|FG003|Received All Vaccinations|Lost to Follow-up|0|||
160593489|NCT01764256|579889091|FG000|Completed Study|Lost to Follow-up|0|||
160593490|NCT01764256|579889092|FG001|Completed Study|Lost to Follow-up|0|||
160593491|NCT01764256|579889093|FG002|Completed Study|Lost to Follow-up|0|||
160593492|NCT01764256|579889094|FG003|Completed Study|Lost to Follow-up|1|||
160593493|NCT00634114|579889095|FG000|Overall Study|Adverse Event|6|||
160593494|NCT00634114|579889096|FG001|Overall Study|Adverse Event|8|||
160593495|NCT00634114|579889097|FG002|Overall Study|Adverse Event|3|||
160593496|NCT00634114|579889095|FG000|Overall Study|Withdrawal by Subject|9|||
160593497|NCT00634114|579889096|FG001|Overall Study|Withdrawal by Subject|6|||
160593498|NCT00634114|579889097|FG002|Overall Study|Withdrawal by Subject|11|||
160593499|NCT00634114|579889095|FG000|Overall Study|Lost to Follow-up|0|||
160593500|NCT00634114|579889096|FG001|Overall Study|Lost to Follow-up|0|||
160593501|NCT00634114|579889097|FG002|Overall Study|Lost to Follow-up|1|||
160593502|NCT00634114|579889095|FG000|Overall Study|Protocol Violation|3|||
160593503|NCT00634114|579889096|FG001|Overall Study|Protocol Violation|3|||
160593504|NCT00634114|579889097|FG002|Overall Study|Protocol Violation|1|||
160593505|NCT00634114|579889095|FG000|Overall Study|Pregnancy|1|||
160593506|NCT00634114|579889096|FG001|Overall Study|Pregnancy|0|||
160593507|NCT00634114|579889097|FG002|Overall Study|Pregnancy|0|||
160593508|NCT00634114|579889095|FG000|Overall Study|Incorrect enrolment|0|||
160593509|NCT00634114|579889096|FG001|Overall Study|Incorrect enrolment|1|||
160593510|NCT00634114|579889097|FG002|Overall Study|Incorrect enrolment|0|||
160593511|NCT00634114|579889095|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
160593512|NCT00634114|579889096|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
160593513|NCT00634114|579889097|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
160593514|NCT00634114|579889095|FG000|Overall Study|Difficult to continue|3|||
160593515|NCT00634114|579889096|FG001|Overall Study|Difficult to continue|1|||
160593516|NCT00634114|579889097|FG002|Overall Study|Difficult to continue|1|||
160593517|NCT00634114|579889095|FG000|Overall Study|Other reason|1|||
160593518|NCT00634114|579889096|FG001|Overall Study|Other reason|1|||
160593519|NCT00634114|579889097|FG002|Overall Study|Other reason|1|||
160593520|NCT01599754|579889098|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
160593521|NCT01599754|579889099|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
160593522|NCT01599754|579889098|FG000|Overall Study|Participant noncompliance|4|||
160593523|NCT01599754|579889099|FG001|Overall Study|Participant noncompliance|4|||
160593524|NCT01599754|579889098|FG000|Overall Study|Lost to Follow-up|13|||
160593525|NCT01599754|579889099|FG001|Overall Study|Lost to Follow-up|6|||
160593526|NCT01599754|579889098|FG000|Overall Study|Death|31|||
160593527|NCT01599754|579889099|FG001|Overall Study|Death|33|||
160593528|NCT01599754|579889098|FG000|Overall Study|Adverse Event|3|||
160593529|NCT01599754|579889099|FG001|Overall Study|Adverse Event|2|||
160593530|NCT01599754|579889098|FG000|Overall Study|Investigator decision|1|||
160593531|NCT01599754|579889099|FG001|Overall Study|Investigator decision|3|||
160593532|NCT01599754|579889098|FG000|Overall Study|Withdrawal by Subject|24|||
160593533|NCT01599754|579889099|FG001|Overall Study|Withdrawal by Subject|25|||
160593534|NCT01599754|579889098|FG000|Overall Study|Study terminated by sponsor|282|||
160593535|NCT01599754|579889099|FG001|Overall Study|Study terminated by sponsor|285|||
160593536|NCT03670641|579889104|FG000|Overall Study|Lost to Follow-up|3|||
160593537|NCT00916370|579889110|FG000|Overall Study|Death|3|||
160593538|NCT00916370|579889111|FG001|Overall Study|Death|1|||
160593539|NCT00916370|579889110|FG000|Overall Study|Withdrawal by Subject|2|||
160593540|NCT00916370|579889111|FG001|Overall Study|Withdrawal by Subject|0|||
160593541|NCT00916370|579889110|FG000|Overall Study|Physician Decision|0|||
160593542|NCT00916370|579889111|FG001|Overall Study|Physician Decision|1|||
160593543|NCT03550131|579889112|FG000|Overall Study|Lost to Follow-up|16|||
160593544|NCT03550131|579889113|FG001|Overall Study|Lost to Follow-up|24|||
160593545|NCT03550131|579889112|FG000|Overall Study|Withdrawal by Subject|36|||
160593546|NCT03550131|579889113|FG001|Overall Study|Withdrawal by Subject|28|||
160593547|NCT03550131|579889112|FG000|Overall Study|Illness of dyad member|10|||
160593548|NCT03550131|579889113|FG001|Overall Study|Illness of dyad member|2|||
160593549|NCT03550131|579889112|FG000|Overall Study|Death of person with dementia|4|||
160593550|NCT03550131|579889113|FG001|Overall Study|Death of person with dementia|8|||
160593551|NCT00414960|579889114|FG000|Overall Study|Adverse Event|4|||
160593552|NCT00414960|579889115|FG001|Overall Study|Adverse Event|0|||
160593553|NCT00414960|579889114|FG000|Overall Study|Withdrawal by Subject|3|||
160593554|NCT00414960|579889115|FG001|Overall Study|Withdrawal by Subject|0|||
160593555|NCT00414960|579889114|FG000|Overall Study|Physician Decision|0|||
160593556|NCT00414960|579889115|FG001|Overall Study|Physician Decision|1|||
160593557|NCT01318512|579889116|FG000|Maintenance Period (6 Months)|Death|2|||
160593558|NCT01318512|579889116|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
160593559|NCT02756650|579889119|FG000|Overall Study|Physician Decision|1|||
160593560|NCT02756650|579889119|FG000|Overall Study|Adverse Event|1|||
160593561|NCT04348591|579889125|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
160593562|NCT04348591|579889126|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
160593563|NCT04348591|579889125|FG000|Imaging Session (120 Min)|Physician Decision|0|||
160593564|NCT04348591|579889126|FG001|Imaging Session (120 Min)|Physician Decision|1|||
160658442|NCT01866319|580131472|FG001|Overall Study|Withdrawal by Subject|14|||
160593565|NCT04348591|579889125|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
160593566|NCT04348591|579889126|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
160593567|NCT03722784|579889129|FG000|Overall Study|Withdrawal by Subject|1|||
160593568|NCT03722784|579889130|FG001|Overall Study|Withdrawal by Subject|0|||
160593569|NCT03722784|579889129|FG000|Overall Study|Physician Decision|1|||
160593570|NCT03722784|579889130|FG001|Overall Study|Physician Decision|1|||
160593571|NCT03722784|579889129|FG000|Overall Study|Protocol Violation|0|||
160593572|NCT03722784|579889130|FG001|Overall Study|Protocol Violation|1|||
160593573|NCT00910429|579889133|FG000|Overall Study|Death|18|||
160593574|NCT00910429|579889134|FG001|Overall Study|Death|12|||
160593575|NCT00910429|579889133|FG000|Overall Study|Withdrawal by Subject|3|||
160593576|NCT00910429|579889134|FG001|Overall Study|Withdrawal by Subject|2|||
160593577|NCT00910429|579889133|FG000|Overall Study|Protocol Violation|1|||
160593578|NCT00910429|579889134|FG001|Overall Study|Protocol Violation|0|||
160593579|NCT00910429|579889133|FG000|Overall Study|Lost to Follow-up|2|||
160593580|NCT00910429|579889134|FG001|Overall Study|Lost to Follow-up|1|||
160593581|NCT00910429|579889133|FG000|Overall Study|Adverse Event|10|||
160593582|NCT00910429|579889134|FG001|Overall Study|Adverse Event|5|||
160593583|NCT00910429|579889133|FG000|Overall Study|Drug non-compliance|1|||
160593584|NCT00910429|579889134|FG001|Overall Study|Drug non-compliance|0|||
160593585|NCT00910429|579889133|FG000|Overall Study|Lack of Efficacy|4|||
160593586|NCT00910429|579889134|FG001|Overall Study|Lack of Efficacy|1|||
160593587|NCT01317615|579889135|FG000|Overall Study|Disease progression|25|||
160593588|NCT01317615|579889135|FG000|Overall Study|New cancer therapy|5|||
160593589|NCT01317615|579889135|FG000|Overall Study|Death|6|||
160593590|NCT01317615|579889135|FG000|Overall Study|Withdrawal by Subject|5|||
160593591|NCT01317615|579889135|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160593592|NCT01317615|579889135|FG000|Overall Study|Adverse Event|7|||
160593593|NCT05757427|579889141|FG000|Overall Study|Adverse Event|1|||
160593594|NCT05757427|579889141|FG000|Overall Study|Device deficiency|1|||
160593595|NCT05757427|579889141|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
160593596|NCT05757427|579889141|FG000|Overall Study|MWBI scan of only 1 breast|3|||
160593597|NCT05757427|579889141|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
160593598|NCT00646113|579890362|FG000|Overall Study|Lost to Follow-up|5|||
160593599|NCT00646113|579890362|FG000|Overall Study|Adverse Event|3|||
160593600|NCT00603733|579890365|FG000|Active Phase ITT|Adverse Event|8|||
160593601|NCT00603733|579890366|FG001|Active Phase ITT|Adverse Event|7|||
160593602|NCT00603733|579890365|FG000|Active Phase ITT|Withdrawal by Subject|0|||
160593603|NCT00603733|579890366|FG001|Active Phase ITT|Withdrawal by Subject|3|||
160593604|NCT00603733|579890365|FG000|Active Phase ITT|Lost to Follow-up|0|||
160593605|NCT00603733|579890366|FG001|Active Phase ITT|Lost to Follow-up|1|||
160593606|NCT00603733|579890365|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
160593607|NCT00603733|579890366|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
160593608|NCT00603733|579890365|FG000|Active Phase ITT|Lack of Efficacy|1|||
160593609|NCT00603733|579890366|FG001|Active Phase ITT|Lack of Efficacy|2|||
160593610|NCT00603733|579890365|FG000|Active Phase ITT|Subject moved, site closed|1|||
160593611|NCT00603733|579890366|FG001|Active Phase ITT|Subject moved, site closed|1|||
160593612|NCT00603733|579890365|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
160593613|NCT00603733|579890366|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
160593614|NCT00603733|579890365|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
160593615|NCT00603733|579890366|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
160593616|NCT00603733|579890365|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
160593617|NCT00603733|579890366|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
160977545|NCT01027364|581307917|FG003|Overall Study|Adverse Event|0|||
160593618|NCT00603733|579890365|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
160977546|NCT01027364|581307914|FG000|Overall Study|Lost to Follow-up|1|||
160977547|NCT01027364|581307915|FG001|Overall Study|Lost to Follow-up|0|||
160977548|NCT01027364|581307916|FG002|Overall Study|Lost to Follow-up|0|||
160977549|NCT01027364|581307917|FG003|Overall Study|Lost to Follow-up|0|||
160977550|NCT01027364|581307914|FG000|Overall Study|Protocol Violation|1|||
160977551|NCT01027364|581307915|FG001|Overall Study|Protocol Violation|0|||
160977552|NCT01027364|581307916|FG002|Overall Study|Protocol Violation|0|||
160977553|NCT01027364|581307917|FG003|Overall Study|Protocol Violation|1|||
160977554|NCT01027364|581307914|FG000|Overall Study|Withdrawal by Subject|1|||
160977555|NCT01027364|581307915|FG001|Overall Study|Withdrawal by Subject|2|||
160977556|NCT01027364|581307916|FG002|Overall Study|Withdrawal by Subject|0|||
160977557|NCT01027364|581307917|FG003|Overall Study|Withdrawal by Subject|0|||
160977558|NCT01394250|581307918|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
160977559|NCT01394250|581307919|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
160977560|NCT01394250|581307918|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
160977561|NCT01394250|581307919|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
160977562|NCT00579982|581307924|FG000|Overall Study|Adverse Event|4|||
160977563|NCT00579982|581307924|FG000|Overall Study|Protocol Violation|4|||
160977564|NCT00988351|581307926|FG000|Overall Study|Withdrawal by Subject|8|||
160977565|NCT00988351|581307927|FG001|Overall Study|Withdrawal by Subject|0|||
160977566|NCT00988351|581307926|FG000|Overall Study|Lost to Follow-up|6|||
160977567|NCT00988351|581307927|FG001|Overall Study|Lost to Follow-up|9|||
160977568|NCT00988351|581307926|FG000|Overall Study|not using CPAP|5|||
160593619|NCT00603733|579890366|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
160593620|NCT00603733|579890365|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
160593621|NCT00603733|579890366|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
160593622|NCT00603733|579890365|FG000|Maintenance Phase ITT|Adverse Event|3|||
160593623|NCT00603733|579890366|FG001|Maintenance Phase ITT|Adverse Event|6|||
160593624|NCT00603733|579890365|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
160593625|NCT00603733|579890366|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
160593626|NCT00603733|579890365|FG000|Maintenance Phase ITT|Protocol Violation|1|||
160593627|NCT00603733|579890366|FG001|Maintenance Phase ITT|Protocol Violation|1|||
160658443|NCT01866319|580131473|FG002|Overall Study|Withdrawal by Subject|12|||
160658444|NCT02942264|580131474|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
160977569|NCT00988351|581307927|FG001|Overall Study|not using CPAP|3|||
160977570|NCT02038764|581307928|FG000|Overall Study|Adverse Event|0|||
160977571|NCT02038764|581307929|FG001|Overall Study|Adverse Event|0|||
160977572|NCT02038764|581307930|FG002|Overall Study|Adverse Event|1|||
160977573|NCT02038764|581307931|FG003|Overall Study|Adverse Event|0|||
160977574|NCT02038764|581307932|FG004|Overall Study|Adverse Event|0|||
160977575|NCT02038764|581307928|FG000|Overall Study|Lost to Follow-up|0|||
160977576|NCT02038764|581307929|FG001|Overall Study|Lost to Follow-up|1|||
160977577|NCT02038764|581307930|FG002|Overall Study|Lost to Follow-up|0|||
160977578|NCT02038764|581307931|FG003|Overall Study|Lost to Follow-up|0|||
160977579|NCT02038764|581307932|FG004|Overall Study|Lost to Follow-up|0|||
160977580|NCT02038764|581307928|FG000|Overall Study|Withdrawal by Subject|0|||
160977581|NCT02038764|581307929|FG001|Overall Study|Withdrawal by Subject|0|||
160977582|NCT02038764|581307930|FG002|Overall Study|Withdrawal by Subject|0|||
160977583|NCT02038764|581307931|FG003|Overall Study|Withdrawal by Subject|0|||
160977584|NCT02038764|581307932|FG004|Overall Study|Withdrawal by Subject|1|||
160977585|NCT02038764|581307928|FG000|Overall Study|Other|1|||
160977586|NCT02038764|581307929|FG001|Overall Study|Other|0|||
160977587|NCT02038764|581307930|FG002|Overall Study|Other|1|||
160977588|NCT02038764|581307931|FG003|Overall Study|Other|0|||
160977589|NCT02038764|581307932|FG004|Overall Study|Other|0|||
160977590|NCT03632434|581307941|FG000|Overall Study|Withdrawal by Subject|2|||
160977591|NCT04297241|581307943|FG000|Overall Study|Withdrawal by Subject|1|||
160977592|NCT04297241|581307943|FG000|Overall Study|Adverse Event|1|||
160977593|NCT04297241|581307943|FG000|Overall Study|Physician Decision|3|||
160977594|NCT02141659|581307944|FG000|Overall Study|Major Protocol Deviation|0|||
160977595|NCT02141659|581307945|FG001|Overall Study|Major Protocol Deviation|1|||
160977596|NCT02141659|581307946|FG002|Overall Study|Major Protocol Deviation|0|||
160977597|NCT02141659|581307947|FG003|Overall Study|Major Protocol Deviation|0|||
160977598|NCT02141659|581307948|FG004|Overall Study|Major Protocol Deviation|0|||
160977599|NCT02141659|581307949|FG005|Overall Study|Major Protocol Deviation|0|||
160977600|NCT02141659|581307944|FG000|Overall Study|Lack of Efficacy|0|||
160977601|NCT02141659|581307945|FG001|Overall Study|Lack of Efficacy|0|||
160977602|NCT02141659|581307946|FG002|Overall Study|Lack of Efficacy|0|||
160977603|NCT02141659|581307947|FG003|Overall Study|Lack of Efficacy|0|||
160977604|NCT02141659|581307948|FG004|Overall Study|Lack of Efficacy|0|||
160977605|NCT02141659|581307949|FG005|Overall Study|Lack of Efficacy|1|||
160977606|NCT02141659|581307944|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
160977607|NCT02141659|581307945|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
160977608|NCT02141659|581307946|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
160593628|NCT00603733|579890365|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
160593629|NCT00603733|579890366|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
160593630|NCT00603733|579890365|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
160593631|NCT00603733|579890366|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
160593632|NCT00603733|579890365|FG000|Maintenance Phase ITT|Physician Decision|0|||
160593633|NCT00603733|579890366|FG001|Maintenance Phase ITT|Physician Decision|1|||
160593634|NCT00603733|579890365|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
160593635|NCT00603733|579890366|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
160593636|NCT01093755|579890367|FG000|Overall Study|Withdrawal by Subject|3|||
160593637|NCT01093755|579890368|FG001|Overall Study|Withdrawal by Subject|4|||
160593638|NCT03115112|579890369|FG000|Overall Study|Adverse Event|5|||
160593639|NCT03115112|579890370|FG001|Overall Study|Adverse Event|1|||
160593640|NCT03115112|579890369|FG000|Overall Study|Withdrawal by Subject|4|||
160593641|NCT03115112|579890370|FG001|Overall Study|Withdrawal by Subject|2|||
160593642|NCT03115112|579890369|FG000|Overall Study|Lost to Follow-up|0|||
160593643|NCT03115112|579890370|FG001|Overall Study|Lost to Follow-up|1|||
160593644|NCT03115112|579890369|FG000|Overall Study|Death|1|||
160593645|NCT03115112|579890370|FG001|Overall Study|Death|0|||
160593646|NCT03115112|579890369|FG000|Overall Study|Pregnancy|1|||
160593647|NCT03115112|579890370|FG001|Overall Study|Pregnancy|0|||
160593648|NCT03115112|579890369|FG000|Overall Study|Site closure|1|||
160593649|NCT03115112|579890370|FG001|Overall Study|Site closure|1|||
160593650|NCT01610076|579890371|FG000|Overall Study|Technical issue with video|0|||
160593651|NCT01610076|579890372|FG001|Overall Study|Technical issue with video|1|||
160593652|NCT01610076|579890371|FG000|Overall Study|Lost to Follow-up|3|||
160593653|NCT01610076|579890372|FG001|Overall Study|Lost to Follow-up|4|||
160593654|NCT02168803|579890373|FG000|Overall Study|Lost to Follow-up|1|||
160593655|NCT02168803|579890374|FG001|Overall Study|Lost to Follow-up|0|||
160593656|NCT02168803|579890375|FG002|Overall Study|Lost to Follow-up|1|||
160593657|NCT02168803|579890373|FG000|Overall Study|Withdrawal by Subject|1|||
160593658|NCT02168803|579890374|FG001|Overall Study|Withdrawal by Subject|1|||
160593659|NCT02168803|579890375|FG002|Overall Study|Withdrawal by Subject|2|||
160593660|NCT02168803|579890373|FG000|Overall Study|Physician Decision|0|||
160593661|NCT02168803|579890374|FG001|Overall Study|Physician Decision|1|||
160593662|NCT02168803|579890375|FG002|Overall Study|Physician Decision|0|||
160593663|NCT02168803|579890373|FG000|Overall Study|Adverse Event|0|||
160593664|NCT02168803|579890374|FG001|Overall Study|Adverse Event|1|||
160593665|NCT02168803|579890375|FG002|Overall Study|Adverse Event|1|||
160593666|NCT02168803|579890373|FG000|Overall Study|Death|0|||
160593667|NCT02168803|579890374|FG001|Overall Study|Death|0|||
160593668|NCT02168803|579890375|FG002|Overall Study|Death|1|||
160593669|NCT02168803|579890373|FG000|Overall Study|Sponsor Decision|0|||
160593670|NCT02168803|579890374|FG001|Overall Study|Sponsor Decision|0|||
160593671|NCT02168803|579890375|FG002|Overall Study|Sponsor Decision|1|||
160593672|NCT02513771|579890382|FG000|Overall Study|Lost to Follow-up|1|||
160593673|NCT02513771|579890383|FG001|Overall Study|Lost to Follow-up|1|||
160593674|NCT02513771|579890382|FG000|Overall Study|Not being able to get to clinic|1|||
160593675|NCT02513771|579890383|FG001|Overall Study|Not being able to get to clinic|0|||
160593676|NCT02022033|579890392|FG000|Overall Study|Physician Decision|1|||
160593677|NCT01429077|579890393|FG000|Overall Study|Lost to Follow-up|0|||
160593678|NCT01429077|579890394|FG001|Overall Study|Lost to Follow-up|3|||
160593679|NCT01879319|579890399|FG000|Overall Study|Withdrawal by Subject|1|||
160593680|NCT01879319|579890400|FG001|Overall Study|Withdrawal by Subject|0|||
160593681|NCT01879319|579890399|FG000|Overall Study|Lost to Follow-up|1|||
160593682|NCT01879319|579890400|FG001|Overall Study|Lost to Follow-up|5|||
160593683|NCT01360762|579890401|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
160593684|NCT01360762|579890401|FG000|Main Study Period (12-month Treatment)|Death|5|||
160593685|NCT01360762|579890401|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
160593686|NCT01360762|579890401|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
160593687|NCT01360762|579890401|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
160593688|NCT01360762|579890401|FG000|Whole Study Period|Lost to Follow-up|10|||
160593689|NCT01360762|579890401|FG000|Whole Study Period|Death|7|||
160593690|NCT01360762|579890401|FG000|Whole Study Period|Patient relapsed|18|||
160593691|NCT01360762|579890401|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
160593692|NCT01103778|579890402|FG000|Overall Study|Lost to Follow-up|1|||
160593693|NCT01103778|579890402|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
160593694|NCT01103778|579890402|FG000|Overall Study|Screen failure|1|||
160593695|NCT03084718|579890403|FG000|Overall Study|Withdrawal by Subject|4|||
160593696|NCT03084718|579890404|FG001|Overall Study|Withdrawal by Subject|3|||
160593697|NCT03084718|579890405|FG002|Overall Study|Withdrawal by Subject|4|||
160593698|NCT03084718|579890406|FG003|Overall Study|Withdrawal by Subject|0|||
160593699|NCT03084718|579890407|FG004|Overall Study|Withdrawal by Subject|0|||
160593700|NCT03084718|579890403|FG000|Overall Study|Physician Decision|1|||
160593701|NCT03084718|579890404|FG001|Overall Study|Physician Decision|0|||
160593702|NCT03084718|579890405|FG002|Overall Study|Physician Decision|0|||
160593703|NCT03084718|579890406|FG003|Overall Study|Physician Decision|0|||
160593704|NCT03084718|579890407|FG004|Overall Study|Physician Decision|0|||
160593705|NCT03084718|579890403|FG000|Overall Study|Adverse Event|3|||
160593706|NCT03084718|579890404|FG001|Overall Study|Adverse Event|5|||
160593707|NCT03084718|579890405|FG002|Overall Study|Adverse Event|5|||
160593708|NCT03084718|579890406|FG003|Overall Study|Adverse Event|8|||
160593709|NCT03084718|579890407|FG004|Overall Study|Adverse Event|2|||
160593710|NCT03084718|579890403|FG000|Overall Study|Lack of Efficacy|2|||
160593711|NCT03084718|579890404|FG001|Overall Study|Lack of Efficacy|0|||
160593712|NCT03084718|579890405|FG002|Overall Study|Lack of Efficacy|1|||
160593713|NCT03084718|579890406|FG003|Overall Study|Lack of Efficacy|4|||
160593714|NCT03084718|579890407|FG004|Overall Study|Lack of Efficacy|0|||
160593715|NCT03084718|579890403|FG000|Overall Study|Lost to Follow-up|0|||
160593716|NCT03084718|579890404|FG001|Overall Study|Lost to Follow-up|1|||
160593717|NCT03084718|579890405|FG002|Overall Study|Lost to Follow-up|0|||
160593718|NCT03084718|579890406|FG003|Overall Study|Lost to Follow-up|0|||
160593719|NCT03084718|579890407|FG004|Overall Study|Lost to Follow-up|2|||
160593720|NCT03084718|579890403|FG000|Overall Study|Protocol Violation|0|||
160593721|NCT03084718|579890404|FG001|Overall Study|Protocol Violation|0|||
160593722|NCT03084718|579890405|FG002|Overall Study|Protocol Violation|1|||
160593723|NCT03084718|579890406|FG003|Overall Study|Protocol Violation|0|||
160593724|NCT03084718|579890407|FG004|Overall Study|Protocol Violation|0|||
160593725|NCT03084718|579890403|FG000|Overall Study|Death|0|||
160593726|NCT03084718|579890404|FG001|Overall Study|Death|1|||
160593727|NCT03084718|579890405|FG002|Overall Study|Death|0|||
160593728|NCT03084718|579890406|FG003|Overall Study|Death|0|||
160593729|NCT03084718|579890407|FG004|Overall Study|Death|0|||
160593730|NCT03084718|579890403|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
160593731|NCT03084718|579890404|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
160593732|NCT03084718|579890405|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
160593733|NCT03084718|579890406|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
160593734|NCT03084718|579890407|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
160593735|NCT02806947|579890408|FG000|Overall Study|Withdrawal by Subject|5|||
160593736|NCT02806947|579890409|FG001|Overall Study|Withdrawal by Subject|1|||
160593737|NCT04929613|579890410|FG000|Overall Study|Withdrawal by Subject|12|||
160593738|NCT00664209|579890415|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
160593739|NCT00664209|579890415|FG000|Study Treatment Period|Physician Decision|4|||
160593740|NCT00664209|579890415|FG000|Study Treatment Period|Withdrawal by Subject|2|||
160593741|NCT02767856|579890426|FG000|Overall Study|Lost to Follow-up|9|||
160593742|NCT02767856|579890427|FG001|Overall Study|Lost to Follow-up|1|||
160593743|NCT02767856|579890426|FG000|Overall Study|Withdrawal by Subject|2|||
160593744|NCT02767856|579890427|FG001|Overall Study|Withdrawal by Subject|1|||
160593745|NCT00091026|579890430|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
160593746|NCT00091026|579890431|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
160593747|NCT00091026|579890430|FG000|Overall Study|Patient withdrew and never received trea|0|||
160593748|NCT00091026|579890431|FG001|Overall Study|Patient withdrew and never received trea|2|||
160593749|NCT00091026|579890430|FG000|Overall Study|Unknown-never received treatment|0|||
160593750|NCT00091026|579890431|FG001|Overall Study|Unknown-never received treatment|1|||
160593751|NCT00418379|579890434|FG000|Year 1|Adverse Event|9|||
160593752|NCT00418379|579890435|FG001|Year 1|Adverse Event|15|||
160593753|NCT00418379|579890436|FG002|Year 1|Adverse Event|3|||
160593754|NCT00418379|579890434|FG000|Year 1|Withdrawal by Subject|7|||
160593755|NCT00418379|579890435|FG001|Year 1|Withdrawal by Subject|8|||
160593756|NCT00418379|579890436|FG002|Year 1|Withdrawal by Subject|5|||
160593757|NCT00418379|579890434|FG000|Year 1|Any other reason not above-mentioned|2|||
160593758|NCT00418379|579890435|FG001|Year 1|Any other reason not above-mentioned|5|||
160593759|NCT00418379|579890436|FG002|Year 1|Any other reason not above-mentioned|7|||
160593760|NCT00418379|579890434|FG000|Year 2|Adverse Event|5|||
160593761|NCT00418379|579890435|FG001|Year 2|Adverse Event|2|||
160593762|NCT00418379|579890436|FG002|Year 2|Adverse Event|1|||
160593763|NCT00418379|579890434|FG000|Year 2|Withdrawal by Subject|1|||
160593764|NCT00418379|579890435|FG001|Year 2|Withdrawal by Subject|1|||
160593765|NCT00418379|579890436|FG002|Year 2|Withdrawal by Subject|3|||
160593766|NCT00418379|579890434|FG000|Year 2|Any other reason not above-mentioned|2|||
160593767|NCT00418379|579890435|FG001|Year 2|Any other reason not above-mentioned|1|||
160593768|NCT00418379|579890436|FG002|Year 2|Any other reason not above-mentioned|6|||
160593769|NCT00418379|579890434|FG000|Year 3|Withdrawal by Subject|1|||
160593770|NCT00418379|579890435|FG001|Year 3|Withdrawal by Subject|1|||
160593771|NCT00418379|579890436|FG002|Year 3|Withdrawal by Subject|2|||
160593772|NCT00418379|579890434|FG000|Year 3|Any other reason not above-mentioned|2|||
160593773|NCT00418379|579890435|FG001|Year 3|Any other reason not above-mentioned|1|||
160593774|NCT00418379|579890436|FG002|Year 3|Any other reason not above-mentioned|1|||
160593775|NCT00418379|579890434|FG000|Year 4|Adverse Event|0|||
160593776|NCT00418379|579890435|FG001|Year 4|Adverse Event|1|||
160593777|NCT00418379|579890436|FG002|Year 4|Adverse Event|0|||
160593778|NCT00418379|579890434|FG000|Year 4|Withdrawal by Subject|2|||
160593779|NCT00418379|579890435|FG001|Year 4|Withdrawal by Subject|3|||
160593780|NCT00418379|579890436|FG002|Year 4|Withdrawal by Subject|2|||
160593781|NCT00418379|579890434|FG000|Year 4|Any other reason not above-mentioned|1|||
160593782|NCT00418379|579890435|FG001|Year 4|Any other reason not above-mentioned|1|||
160593783|NCT00418379|579890436|FG002|Year 4|Any other reason not above-mentioned|0|||
160593784|NCT00418379|579890434|FG000|Year 5|Adverse Event|0|||
160593785|NCT00418379|579890435|FG001|Year 5|Adverse Event|1|||
160593786|NCT00418379|579890436|FG002|Year 5|Adverse Event|0|||
160593787|NCT00418379|579890434|FG000|Year 5|Any other reason not above-mentioned|2|||
160593788|NCT00418379|579890435|FG001|Year 5|Any other reason not above-mentioned|4|||
160593789|NCT00418379|579890436|FG002|Year 5|Any other reason not above-mentioned|3|||
160593790|NCT00843843|579890437|FG000|Overall Study|Physician Decision|1|||
160593791|NCT00843843|579890438|FG001|Overall Study|Physician Decision|1|||
160593792|NCT00843843|579890437|FG000|Overall Study|Protocol Violation|1|||
160593793|NCT00843843|579890438|FG001|Overall Study|Protocol Violation|1|||
160593794|NCT00304915|579890439|FG000|Overall Study|Lost to Follow-up|11|||
160593795|NCT00304915|579890440|FG001|Overall Study|Lost to Follow-up|11|||
160593796|NCT00304915|579890439|FG000|Overall Study|Death|4|||
160593797|NCT00304915|579890440|FG001|Overall Study|Death|5|||
160593798|NCT00304915|579890439|FG000|Overall Study|Withdrawal by Subject|3|||
160593799|NCT00304915|579890440|FG001|Overall Study|Withdrawal by Subject|0|||
160593800|NCT00565058|579890441|FG000|Overall Study|Adverse Event|1|||
160593801|NCT00565058|579890442|FG001|Overall Study|Adverse Event|0|||
160593802|NCT02029638|579890443|FG000|Overall Study|Death|0|||
160593803|NCT02029638|579890444|FG001|Overall Study|Death|0|||
160593804|NCT02029638|579890445|FG002|Overall Study|Death|1|||
160593805|NCT02029638|579890443|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
160593806|NCT02029638|579890444|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
160593807|NCT02029638|579890445|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
160593808|NCT05489081|579890447|FG000|Overall Study|student left classroom|0|||
160593809|NCT05489081|579890448|FG001|Overall Study|student left classroom|1|||
160593810|NCT05489081|579890447|FG000|Overall Study|teacher left school|0|||
160593811|NCT05489081|579890448|FG001|Overall Study|teacher left school|2|||
160658445|NCT02942264|580131475|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
160658446|NCT02942264|580131476|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
160593812|NCT00973921|579890451|FG000|Overall Study|IVUS results were not available|9|||
160593813|NCT02670330|579890462|FG000|Overall Study|Protocol Deviation|1|||
160593814|NCT02670330|579890463|FG001|Overall Study|Protocol Deviation|0|||
160593815|NCT02670330|579890462|FG000|Overall Study|Study Terminated By Sponsor|36|||
160593816|NCT02670330|579890463|FG001|Overall Study|Study Terminated By Sponsor|43|||
160593817|NCT02670330|579890462|FG000|Overall Study|Adverse Event|1|||
160593818|NCT02670330|579890463|FG001|Overall Study|Adverse Event|3|||
160593819|NCT02670330|579890462|FG000|Overall Study|Withdrawal by Subject|34|||
160593820|NCT02670330|579890463|FG001|Overall Study|Withdrawal by Subject|29|||
160593821|NCT02670330|579890462|FG000|Overall Study|Lost to Follow-up|3|||
160593822|NCT02670330|579890463|FG001|Overall Study|Lost to Follow-up|2|||
160593823|NCT02553317|579890464|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
160593824|NCT02553317|579890465|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
160593825|NCT02553317|579890464|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
160593826|NCT02553317|579890465|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
160593827|NCT02553317|579890464|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
160593828|NCT02553317|579890465|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
160593829|NCT02553317|579890464|FG000|Overall Treatment Period + Follow-up|Death|1|||
160593830|NCT02553317|579890465|FG001|Overall Treatment Period + Follow-up|Death|3|||
160593831|NCT02553317|579890464|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
160593832|NCT02553317|579890465|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
160593833|NCT02553317|579890464|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
160593834|NCT02553317|579890465|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
160593835|NCT02553317|579890464|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
160593836|NCT02553317|579890465|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
160593837|NCT02553317|579890464|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
160593838|NCT02553317|579890465|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
160593839|NCT02553317|579890464|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
160593840|NCT02553317|579890465|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
160593841|NCT02553317|579890464|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
160593842|NCT02553317|579890465|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
160593843|NCT02120157|579890466|FG000|Overall Study|Death|8|||
160593844|NCT00622869|579890467|FG000|Overall Study|Subject Withdrew Consent|13|||
160593845|NCT00622869|579890468|FG001|Overall Study|Subject Withdrew Consent|17|||
160593846|NCT00622869|579890469|FG002|Overall Study|Subject Withdrew Consent|11|||
160593847|NCT00622869|579890467|FG000|Overall Study|Administrative Problems|11|||
160593848|NCT00622869|579890468|FG001|Overall Study|Administrative Problems|17|||
160593849|NCT00622869|579890469|FG002|Overall Study|Administrative Problems|13|||
160593850|NCT00622869|579890467|FG000|Overall Study|Death|12|||
160593851|NCT00622869|579890468|FG001|Overall Study|Death|15|||
160593852|NCT00622869|579890469|FG002|Overall Study|Death|10|||
160593853|NCT00622869|579890467|FG000|Overall Study|Lost to Follow-up|2|||
160593854|NCT00622869|579890468|FG001|Overall Study|Lost to Follow-up|4|||
160593855|NCT00622869|579890469|FG002|Overall Study|Lost to Follow-up|2|||
160593856|NCT00622869|579890467|FG000|Overall Study|Graft Loss|5|||
160593857|NCT00622869|579890468|FG001|Overall Study|Graft Loss|3|||
160593858|NCT00622869|579890469|FG002|Overall Study|Graft Loss|2|||
160593859|NCT00622869|579890467|FG000|Overall Study|Missing|0|||
160593860|NCT00622869|579890468|FG001|Overall Study|Missing|1|||
160593861|NCT00622869|579890469|FG002|Overall Study|Missing|1|||
160593862|NCT02648724|579890470|FG000|Overall Study|Withdrawal by Subject|0|||
160593863|NCT02648724|579890471|FG001|Overall Study|Withdrawal by Subject|1|||
160593864|NCT02648724|579890472|FG002|Overall Study|Withdrawal by Subject|1|||
160593865|NCT02648724|579890473|FG003|Overall Study|Withdrawal by Subject|0|||
160593866|NCT02648724|579890474|FG004|Overall Study|Withdrawal by Subject|1|||
160593867|NCT02648724|579890475|FG005|Overall Study|Withdrawal by Subject|0|||
160593868|NCT02648724|579890476|FG006|Overall Study|Withdrawal by Subject|0|||
160593869|NCT02648724|579890470|FG000|Overall Study|Progressive disease|2|||
160593870|NCT02648724|579890471|FG001|Overall Study|Progressive disease|2|||
160593871|NCT02648724|579890472|FG002|Overall Study|Progressive disease|2|||
160593872|NCT02648724|579890473|FG003|Overall Study|Progressive disease|3|||
160593873|NCT02648724|579890474|FG004|Overall Study|Progressive disease|22|||
160593874|NCT02648724|579890475|FG005|Overall Study|Progressive disease|7|||
160593875|NCT02648724|579890476|FG006|Overall Study|Progressive disease|8|||
160593876|NCT02648724|579890470|FG000|Overall Study|Other reason (unknown)|1|||
160593877|NCT02648724|579890471|FG001|Overall Study|Other reason (unknown)|0|||
160593878|NCT02648724|579890472|FG002|Overall Study|Other reason (unknown)|0|||
160593879|NCT02648724|579890473|FG003|Overall Study|Other reason (unknown)|0|||
160593880|NCT02648724|579890474|FG004|Overall Study|Other reason (unknown)|0|||
160593881|NCT02648724|579890475|FG005|Overall Study|Other reason (unknown)|0|||
160593882|NCT02648724|579890476|FG006|Overall Study|Other reason (unknown)|0|||
160593883|NCT02648724|579890470|FG000|Overall Study|Protocol Violation|0|||
160593884|NCT02648724|579890471|FG001|Overall Study|Protocol Violation|0|||
160593885|NCT02648724|579890472|FG002|Overall Study|Protocol Violation|0|||
160593886|NCT02648724|579890473|FG003|Overall Study|Protocol Violation|0|||
160593887|NCT02648724|579890474|FG004|Overall Study|Protocol Violation|1|||
160593888|NCT02648724|579890475|FG005|Overall Study|Protocol Violation|0|||
160593889|NCT02648724|579890476|FG006|Overall Study|Protocol Violation|0|||
160593890|NCT02648724|579890470|FG000|Overall Study|Death|0|||
160593891|NCT02648724|579890471|FG001|Overall Study|Death|0|||
160593892|NCT02648724|579890472|FG002|Overall Study|Death|0|||
160593893|NCT02648724|579890473|FG003|Overall Study|Death|0|||
160593894|NCT02648724|579890474|FG004|Overall Study|Death|0|||
160593895|NCT02648724|579890475|FG005|Overall Study|Death|0|||
160593896|NCT02648724|579890476|FG006|Overall Study|Death|3|||
160593897|NCT02648724|579890470|FG000|Overall Study|Physician Decision|0|||
160593898|NCT02648724|579890471|FG001|Overall Study|Physician Decision|0|||
160593899|NCT02648724|579890472|FG002|Overall Study|Physician Decision|0|||
160593900|NCT02648724|579890473|FG003|Overall Study|Physician Decision|0|||
160593901|NCT02648724|579890474|FG004|Overall Study|Physician Decision|1|||
160593902|NCT02648724|579890475|FG005|Overall Study|Physician Decision|0|||
160593903|NCT02648724|579890476|FG006|Overall Study|Physician Decision|1|||
160593904|NCT02648724|579890470|FG000|Overall Study|Transferred to named patient program|0|||
160593905|NCT02648724|579890471|FG001|Overall Study|Transferred to named patient program|0|||
160593906|NCT02648724|579890472|FG002|Overall Study|Transferred to named patient program|0|||
160593907|NCT02648724|579890473|FG003|Overall Study|Transferred to named patient program|0|||
160593908|NCT02648724|579890474|FG004|Overall Study|Transferred to named patient program|0|||
160593909|NCT02648724|579890475|FG005|Overall Study|Transferred to named patient program|1|||
160593910|NCT02648724|579890476|FG006|Overall Study|Transferred to named patient program|0|||
160593911|NCT00302718|579890478|FG000|Overall Study|Participant left the hospital|1|||
160593912|NCT00302718|579890479|FG001|Overall Study|Participant left the hospital|0|||
160593913|NCT00302718|579890480|FG002|Overall Study|Participant left the hospital|0|||
160593914|NCT00302718|579890481|FG003|Overall Study|Participant left the hospital|1|||
160593915|NCT00302718|579890478|FG000|Overall Study|Withdrawal by Subject|0|||
160593916|NCT00302718|579890479|FG001|Overall Study|Withdrawal by Subject|1|||
160593917|NCT00302718|579890480|FG002|Overall Study|Withdrawal by Subject|0|||
160593918|NCT00302718|579890481|FG003|Overall Study|Withdrawal by Subject|0|||
160593919|NCT00302718|579890478|FG000|Overall Study|Participant left primary care setting|0|||
160593920|NCT00302718|579890479|FG001|Overall Study|Participant left primary care setting|0|||
160593921|NCT00302718|579890480|FG002|Overall Study|Participant left primary care setting|2|||
160593922|NCT00302718|579890481|FG003|Overall Study|Participant left primary care setting|1|||
160593923|NCT00738374|579890482|FG000|Induction Treatment Phase|Adverse Event|14|||
160593924|NCT00738374|579890483|FG001|Induction Treatment Phase|Adverse Event|0|||
160593925|NCT00738374|579890484|FG002|Induction Treatment Phase|Adverse Event|0|||
160593926|NCT00738374|579890485|FG003|Induction Treatment Phase|Adverse Event|0|||
160593927|NCT00738374|579890482|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
160593928|NCT00738374|579890483|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
160593929|NCT00738374|579890484|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
160593930|NCT00738374|579890485|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
160593931|NCT00738374|579890482|FG000|Induction Treatment Phase|Physician Decision|2|||
160593932|NCT00738374|579890483|FG001|Induction Treatment Phase|Physician Decision|0|||
160593933|NCT00738374|579890484|FG002|Induction Treatment Phase|Physician Decision|0|||
160593934|NCT00738374|579890485|FG003|Induction Treatment Phase|Physician Decision|0|||
160593935|NCT00738374|579890482|FG000|Induction Treatment Phase|Protocol Violation|2|||
160593936|NCT00738374|579890483|FG001|Induction Treatment Phase|Protocol Violation|0|||
160593937|NCT00738374|579890484|FG002|Induction Treatment Phase|Protocol Violation|0|||
160593938|NCT00738374|579890485|FG003|Induction Treatment Phase|Protocol Violation|0|||
160593939|NCT00738374|579890482|FG000|Induction Treatment Phase|Non-compliance|1|||
160593940|NCT00738374|579890483|FG001|Induction Treatment Phase|Non-compliance|0|||
160593941|NCT00738374|579890484|FG002|Induction Treatment Phase|Non-compliance|0|||
160593942|NCT00738374|579890485|FG003|Induction Treatment Phase|Non-compliance|0|||
160593943|NCT00738374|579890482|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
160593944|NCT00738374|579890483|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
160593945|NCT00738374|579890484|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
160593946|NCT00738374|579890485|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
160593947|NCT00738374|579890482|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
160593948|NCT00738374|579890483|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
160593949|NCT00738374|579890484|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
160593950|NCT00738374|579890485|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
160593951|NCT00738374|579890482|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
160593952|NCT00738374|579890483|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
160593953|NCT00738374|579890484|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
160593954|NCT00738374|579890485|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
160593955|NCT00738374|579890482|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
160593956|NCT00738374|579890483|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
160593957|NCT00738374|579890484|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
160593958|NCT00738374|579890485|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
160593959|NCT00738374|579890482|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
160593960|NCT00738374|579890483|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
160593961|NCT00738374|579890484|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
160593962|NCT00738374|579890485|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
160593963|NCT00738374|579890482|FG000|Maintenance Treatment/Observation Phase|Other|0|||
160593964|NCT00738374|579890483|FG001|Maintenance Treatment/Observation Phase|Other|1|||
160593965|NCT00738374|579890484|FG002|Maintenance Treatment/Observation Phase|Other|0|||
160593966|NCT00738374|579890485|FG003|Maintenance Treatment/Observation Phase|Other|0|||
160593967|NCT00632541|579890486|FG000|Overall Study|Adverse Event|7|||
160593968|NCT02927873|579890487|FG000|Overall Study|Lost to Follow-up|0|||
160593969|NCT02927873|579890488|FG001|Overall Study|Lost to Follow-up|1|||
160593970|NCT02927873|579890489|FG002|Overall Study|Lost to Follow-up|0|||
160593971|NCT02927873|579890490|FG003|Overall Study|Lost to Follow-up|0|||
160593972|NCT02927873|579890491|FG004|Overall Study|Lost to Follow-up|0|||
160593973|NCT02927873|579890492|FG005|Overall Study|Lost to Follow-up|0|||
160593974|NCT02927873|579890487|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160593975|NCT02927873|579890488|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
160593976|NCT02927873|579890489|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160593977|NCT02927873|579890490|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160593978|NCT02927873|579890491|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160593979|NCT02927873|579890492|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160593980|NCT02927873|579890487|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160593981|NCT02927873|579890488|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160593982|NCT02927873|579890489|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160593983|NCT02927873|579890490|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160593984|NCT02927873|579890491|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160593985|NCT02927873|579890492|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160593986|NCT02927873|579890487|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
160593987|NCT02927873|579890488|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
160593988|NCT02927873|579890489|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
160593989|NCT02927873|579890490|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
160593990|NCT02927873|579890491|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
160593991|NCT02927873|579890492|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
160593992|NCT02927873|579890487|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
160593993|NCT02927873|579890488|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
160658447|NCT02942264|580131477|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
160658448|NCT02942264|580131478|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
160658449|NCT02942264|580131479|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
160658450|NCT02942264|580131480|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
160593994|NCT02927873|579890489|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
160593995|NCT02927873|579890490|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
160593996|NCT02927873|579890491|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
160593997|NCT02927873|579890492|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
160593998|NCT02927873|579890487|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
160593999|NCT02927873|579890488|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
160594000|NCT02927873|579890489|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
160594001|NCT02927873|579890490|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
160594002|NCT02927873|579890491|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
160594003|NCT02927873|579890492|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
160594004|NCT00949910|579892356|FG000|Overall Study|Progressive Disease|3750|||
160594005|NCT00949910|579892356|FG000|Overall Study|Symptomatic Deterioration|1088|||
160594006|NCT00949910|579892356|FG000|Overall Study|Lost to Follow-up|100|||
160594007|NCT00949910|579892356|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
160594008|NCT00949910|579892356|FG000|Overall Study|Participant Refusal|390|||
160594009|NCT00949910|579892356|FG000|Overall Study|Death Due to Malignant Disease|456|||
160594010|NCT00949910|579892356|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
160594011|NCT00949910|579892356|FG000|Overall Study|Death Due to Adverse Event|115|||
160594012|NCT00949910|579892356|FG000|Overall Study|Death Due to Toxicity|3|||
160594013|NCT00949910|579892356|FG000|Overall Study|Death from Unknown Cause|5|||
160594014|NCT00949910|579892356|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
160594015|NCT00949910|579892356|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
160594016|NCT00949910|579892356|FG000|Overall Study|Switched to Commercial Treatment|4|||
160594017|NCT00949910|579892356|FG000|Overall Study|Violation of Eligibility|23|||
160594018|NCT00949910|579892356|FG000|Overall Study|Logistical Reasons|13|||
160594019|NCT00949910|579892356|FG000|Overall Study|Non-Compliance|10|||
160594020|NCT00949910|579892356|FG000|Overall Study|Prolonged Dosing Interruption|4|||
160594021|NCT00949910|579892356|FG000|Overall Study|Adverse Event|83|||
160594022|NCT00949910|579892356|FG000|Overall Study|Serious Adverse Event|6|||
160594023|NCT00949910|579892356|FG000|Overall Study|Physician/Participant Decision|7|||
160594024|NCT00949910|579892356|FG000|Overall Study|Other|4|||
160594025|NCT00949910|579892356|FG000|Overall Study|No Data|9|||
160594026|NCT00971425|579892357|FG000|Overall Study|Adverse Event|1|||
160594027|NCT00971425|579892358|FG001|Overall Study|Adverse Event|1|||
160594028|NCT00971425|579892357|FG000|Overall Study|Withdrawal by Subject|0|||
160594029|NCT00971425|579892358|FG001|Overall Study|Withdrawal by Subject|1|||
160594030|NCT00132314|579892359|FG000|Overall Study|Lost to Follow-up|70|||
160594031|NCT00132314|579892360|FG001|Overall Study|Lost to Follow-up|62|||
160594032|NCT00132314|579892359|FG000|Overall Study|Lacked SSN|1|||
160594033|NCT00132314|579892360|FG001|Overall Study|Lacked SSN|3|||
160594034|NCT00132314|579892359|FG000|Overall Study|Refused intervention at baseline|2|||
160594035|NCT00132314|579892360|FG001|Overall Study|Refused intervention at baseline|7|||
160594036|NCT04019795|579892375|FG000|Overall Study|Withdrawal by Subject|1|||
160594037|NCT04019795|579892376|FG001|Overall Study|Withdrawal by Subject|2|||
160594038|NCT04019795|579892377|FG002|Overall Study|Withdrawal by Subject|2|||
160594039|NCT04019795|579892378|FG003|Overall Study|Withdrawal by Subject|1|||
160594040|NCT04019795|579892375|FG000|Overall Study|Lost to Follow-up|0|||
160594041|NCT04019795|579892376|FG001|Overall Study|Lost to Follow-up|1|||
160594042|NCT04019795|579892377|FG002|Overall Study|Lost to Follow-up|1|||
160594043|NCT04019795|579892378|FG003|Overall Study|Lost to Follow-up|2|||
160594044|NCT04019795|579892375|FG000|Overall Study|Treatment non-compliance|3|||
160594045|NCT04019795|579892376|FG001|Overall Study|Treatment non-compliance|1|||
160594046|NCT04019795|579892377|FG002|Overall Study|Treatment non-compliance|2|||
160658451|NCT02942264|580131481|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
160658452|NCT02942264|580131482|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
160658453|NCT02942264|580131474|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
160594047|NCT04019795|579892378|FG003|Overall Study|Treatment non-compliance|0|||
160594048|NCT04019795|579892375|FG000|Overall Study|Physician Decision|0|||
160594049|NCT04019795|579892376|FG001|Overall Study|Physician Decision|0|||
160594050|NCT04019795|579892377|FG002|Overall Study|Physician Decision|1|||
160594051|NCT04019795|579892378|FG003|Overall Study|Physician Decision|0|||
160594052|NCT04019795|579892375|FG000|Overall Study|Adverse Event|1|||
160594053|NCT04019795|579892376|FG001|Overall Study|Adverse Event|0|||
160594054|NCT04019795|579892377|FG002|Overall Study|Adverse Event|0|||
160594055|NCT04019795|579892378|FG003|Overall Study|Adverse Event|0|||
160594056|NCT03625141|579892379|FG000|Overall Study|Adverse Event|0|||
160594057|NCT03625141|579892380|FG001|Overall Study|Adverse Event|2|||
160594058|NCT03625141|579892379|FG000|Overall Study|Study Terminated By Sponsor|1|||
160594059|NCT03625141|579892380|FG001|Overall Study|Study Terminated By Sponsor|13|||
160594060|NCT03625141|579892379|FG000|Overall Study|Withdrawal by Subject|3|||
160594061|NCT03625141|579892380|FG001|Overall Study|Withdrawal by Subject|0|||
160594062|NCT03625141|579892379|FG000|Overall Study|Withdrawal Of Consent|0|||
160594063|NCT03625141|579892380|FG001|Overall Study|Withdrawal Of Consent|1|||
160594064|NCT03625141|579892379|FG000|Overall Study|Death|11|||
160594065|NCT03625141|579892380|FG001|Overall Study|Death|47|||
160594066|NCT03625141|579892379|FG000|Overall Study|Progressive Disease|0|||
160594067|NCT03625141|579892380|FG001|Overall Study|Progressive Disease|2|||
160594068|NCT03250377|579892381|FG000|Overall Study|Adverse Event|2|||
160594069|NCT03250377|579892382|FG001|Overall Study|Adverse Event|4|||
160594070|NCT03250377|579892383|FG002|Overall Study|Adverse Event|0|||
160594071|NCT03250377|579892384|FG003|Overall Study|Adverse Event|4|||
160594072|NCT03250377|579892381|FG000|Overall Study|Lack of Efficacy|5|||
160594073|NCT03250377|579892382|FG001|Overall Study|Lack of Efficacy|14|||
160594074|NCT03250377|579892383|FG002|Overall Study|Lack of Efficacy|1|||
160594075|NCT03250377|579892384|FG003|Overall Study|Lack of Efficacy|3|||
160594076|NCT03250377|579892381|FG000|Overall Study|Protocol Violation|0|||
160594077|NCT03250377|579892382|FG001|Overall Study|Protocol Violation|2|||
160594078|NCT03250377|579892383|FG002|Overall Study|Protocol Violation|0|||
160594079|NCT03250377|579892384|FG003|Overall Study|Protocol Violation|1|||
160594080|NCT03250377|579892381|FG000|Overall Study|Lost to Follow-up|0|||
160594081|NCT03250377|579892382|FG001|Overall Study|Lost to Follow-up|1|||
160594082|NCT03250377|579892383|FG002|Overall Study|Lost to Follow-up|0|||
160594083|NCT03250377|579892384|FG003|Overall Study|Lost to Follow-up|0|||
160594084|NCT03250377|579892381|FG000|Overall Study|Withdrawal by Subject|7|||
160594085|NCT03250377|579892382|FG001|Overall Study|Withdrawal by Subject|7|||
160594086|NCT03250377|579892383|FG002|Overall Study|Withdrawal by Subject|0|||
160594087|NCT03250377|579892384|FG003|Overall Study|Withdrawal by Subject|4|||
160594088|NCT03250377|579892381|FG000|Overall Study|Investigator's Judgment|1|||
160594089|NCT03250377|579892382|FG001|Overall Study|Investigator's Judgment|0|||
160594090|NCT03250377|579892383|FG002|Overall Study|Investigator's Judgment|0|||
160594091|NCT03250377|579892384|FG003|Overall Study|Investigator's Judgment|0|||
160594092|NCT03250377|579892381|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
160594093|NCT03250377|579892382|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
160594094|NCT03250377|579892383|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
160594095|NCT03250377|579892384|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
160594096|NCT03250377|579892381|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
160594097|NCT03250377|579892382|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
160594098|NCT03250377|579892383|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
160594099|NCT03250377|579892384|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
160594100|NCT03250377|579892381|FG000|Overall Study|Epilepsy Surgery|0|||
160594101|NCT03250377|579892382|FG001|Overall Study|Epilepsy Surgery|1|||
160594102|NCT03250377|579892383|FG002|Overall Study|Epilepsy Surgery|2|||
160594103|NCT03250377|579892384|FG003|Overall Study|Epilepsy Surgery|0|||
160594104|NCT03250377|579892381|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
160594105|NCT03250377|579892382|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
160594106|NCT03250377|579892383|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
160594107|NCT03250377|579892384|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
160594108|NCT03250377|579892381|FG000|Overall Study|Request From The Sponsor|0|||
160594109|NCT03250377|579892382|FG001|Overall Study|Request From The Sponsor|1|||
160594110|NCT03250377|579892383|FG002|Overall Study|Request From The Sponsor|0|||
160594111|NCT03250377|579892384|FG003|Overall Study|Request From The Sponsor|0|||
160594112|NCT03250377|579892381|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
160594113|NCT03250377|579892382|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
160594114|NCT03250377|579892383|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
160594115|NCT03250377|579892384|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
160594116|NCT03250377|579892381|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
160594117|NCT03250377|579892382|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
160594118|NCT03250377|579892383|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
160594119|NCT03250377|579892384|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
160658454|NCT02942264|580131475|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
160594120|NCT03250377|579892381|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
160594121|NCT03250377|579892382|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
160594122|NCT03250377|579892383|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
160594123|NCT03250377|579892384|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
160594124|NCT03250377|579892381|FG000|Overall Study|Pregnancy Event|0|||
160594125|NCT03250377|579892382|FG001|Overall Study|Pregnancy Event|1|||
160594126|NCT03250377|579892383|FG002|Overall Study|Pregnancy Event|0|||
160594127|NCT03250377|579892384|FG003|Overall Study|Pregnancy Event|0|||
160594128|NCT03250377|579892381|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
160594129|NCT03250377|579892382|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
160594130|NCT03250377|579892383|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
160594131|NCT03250377|579892384|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
160594132|NCT03250377|579892381|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
160594133|NCT03250377|579892382|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
160594134|NCT03250377|579892383|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
160594135|NCT03250377|579892384|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
160594136|NCT03250377|579892381|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
160594137|NCT03250377|579892382|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
160594138|NCT03250377|579892383|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
160594139|NCT03250377|579892384|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
160594140|NCT03250377|579892381|FG000|Overall Study|Patient requested to change hospital|0|||
160594141|NCT03250377|579892382|FG001|Overall Study|Patient requested to change hospital|0|||
160594142|NCT03250377|579892383|FG002|Overall Study|Patient requested to change hospital|0|||
160594143|NCT03250377|579892384|FG003|Overall Study|Patient requested to change hospital|1|||
160594144|NCT03250377|579892381|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
160594145|NCT03250377|579892382|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
160594146|NCT03250377|579892383|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
160594147|NCT03250377|579892384|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
160594148|NCT01114373|579892385|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
160594149|NCT01114373|579892386|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
160594150|NCT01114373|579892385|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
160594151|NCT01114373|579892386|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
160594152|NCT01114373|579892385|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
160977609|NCT02141659|581307947|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
160977610|NCT02141659|581307948|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
160977611|NCT02141659|581307949|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
160977612|NCT00305864|581307958|FG000|Overall Study|Ineligible / No protocol treatment|0|||
160977613|NCT00305864|581307959|FG001|Overall Study|Ineligible / No protocol treatment|1|||
160977614|NCT00305864|581307960|FG002|Overall Study|Ineligible / No protocol treatment|1|||
160594153|NCT01114373|579892386|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
160594154|NCT01114373|579892385|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
160594155|NCT01114373|579892386|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
160594156|NCT03444870|579892387|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
160977615|NCT00305864|581307961|FG003|Overall Study|Ineligible / No protocol treatment|13|||
160977616|NCT02836613|581307964|FG000|Overall Study|Accidental drowning|1|||
160977617|NCT02836613|581307965|FG001|Overall Study|Accidental drowning|0|||
160977618|NCT02836613|581307964|FG000|Overall Study|Lost to Follow-up|0|||
160594157|NCT03444870|579892388|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
160594158|NCT03444870|579892389|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
160594159|NCT03444870|579892390|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
160594160|NCT03444870|579892391|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
160594161|NCT03444870|579892392|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
160594162|NCT03444870|579892387|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
160594163|NCT03444870|579892388|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
160594164|NCT03444870|579892389|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
160594165|NCT03444870|579892390|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
160594166|NCT03444870|579892391|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
160594167|NCT03444870|579892392|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
160594168|NCT03444870|579892387|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
160594169|NCT03444870|579892388|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
160594170|NCT03444870|579892389|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
160594171|NCT03444870|579892390|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
160594172|NCT03444870|579892391|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
160594173|NCT03444870|579892392|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
160594174|NCT03444870|579892387|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
160594175|NCT03444870|579892388|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
160594176|NCT03444870|579892389|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
160594177|NCT03444870|579892390|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
160594178|NCT03444870|579892391|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
160594179|NCT03444870|579892392|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
160594180|NCT03444870|579892387|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
160594181|NCT03444870|579892388|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
160594182|NCT03444870|579892389|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
160594183|NCT03444870|579892390|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
160594184|NCT03444870|579892391|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
160594185|NCT03444870|579892392|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
160594186|NCT03444870|579892387|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
160594187|NCT03444870|579892388|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
160594188|NCT03444870|579892389|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
160594189|NCT03444870|579892390|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
160594190|NCT03444870|579892391|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
160594191|NCT03444870|579892392|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
160594192|NCT03444870|579892387|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
160594193|NCT03444870|579892388|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
160594194|NCT03444870|579892389|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
160594195|NCT03444870|579892390|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
160594196|NCT03444870|579892391|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
160594197|NCT03444870|579892392|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
160594198|NCT03444870|579892387|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
160594199|NCT03444870|579892388|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
160594200|NCT03444870|579892389|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
160594201|NCT03444870|579892390|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
160594202|NCT03444870|579892391|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
160594203|NCT03444870|579892392|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
160594204|NCT03444870|579892387|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
160594205|NCT03444870|579892388|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
160594206|NCT03444870|579892389|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
160594207|NCT03444870|579892390|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
160594208|NCT03444870|579892391|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
160594209|NCT03444870|579892392|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
160594210|NCT03444870|579892387|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160594211|NCT03444870|579892388|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160594212|NCT03444870|579892389|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160594213|NCT03444870|579892390|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160594214|NCT03444870|579892391|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
160594215|NCT03444870|579892392|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
160594216|NCT03444870|579892387|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
160594217|NCT03444870|579892388|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
160594218|NCT03444870|579892389|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
160594219|NCT03444870|579892390|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
160594220|NCT03444870|579892391|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
160594221|NCT03444870|579892392|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
160594222|NCT03444870|579892387|FG000|Open-Label Extension (OLE) Period|Death|0|||
160594223|NCT03444870|579892388|FG001|Open-Label Extension (OLE) Period|Death|0|||
160594224|NCT03444870|579892389|FG002|Open-Label Extension (OLE) Period|Death|0|||
160594225|NCT03444870|579892390|FG003|Open-Label Extension (OLE) Period|Death|0|||
160594226|NCT03444870|579892391|FG004|Open-Label Extension (OLE) Period|Death|1|||
160594227|NCT03444870|579892392|FG005|Open-Label Extension (OLE) Period|Death|0|||
160594228|NCT02034552|579892393|FG000|Overall Study|Never treated|3|||
160594229|NCT02034552|579892394|FG001|Overall Study|Never treated|2|||
160594230|NCT02034552|579892395|FG002|Overall Study|Never treated|0|||
160594231|NCT02034552|579892393|FG000|Overall Study|Radiological progression|3|||
160594232|NCT02034552|579892394|FG001|Overall Study|Radiological progression|5|||
160594233|NCT02034552|579892395|FG002|Overall Study|Radiological progression|4|||
160594234|NCT02034552|579892393|FG000|Overall Study|AE not assoc. with disease progression|1|||
160594235|NCT02034552|579892394|FG001|Overall Study|AE not assoc. with disease progression|4|||
160594236|NCT02034552|579892395|FG002|Overall Study|AE not assoc. with disease progression|2|||
160594237|NCT02034552|579892393|FG000|Overall Study|AE associated with disease progression|0|||
160594238|NCT02034552|579892394|FG001|Overall Study|AE associated with disease progression|1|||
160594239|NCT02034552|579892395|FG002|Overall Study|AE associated with disease progression|0|||
160594240|NCT02034552|579892393|FG000|Overall Study|Withdrawal by Subject|2|||
160594241|NCT02034552|579892394|FG001|Overall Study|Withdrawal by Subject|1|||
160594242|NCT02034552|579892395|FG002|Overall Study|Withdrawal by Subject|1|||
160594243|NCT02034552|579892393|FG000|Overall Study|Non-compliance with study drug|0|||
160594244|NCT02034552|579892394|FG001|Overall Study|Non-compliance with study drug|0|||
160594245|NCT02034552|579892395|FG002|Overall Study|Non-compliance with study drug|1|||
160594246|NCT02034552|579892393|FG000|Overall Study|Clinical progression|5|||
160594247|NCT02034552|579892394|FG001|Overall Study|Clinical progression|7|||
160594248|NCT02034552|579892395|FG002|Overall Study|Clinical progression|9|||
160594249|NCT03819218|579892398|FG000|Overall Study|Protocol Violation|1|||
160594250|NCT02501902|579892399|FG000|Overall Study|Subject Refused Further Follow-up|0|||
160594251|NCT02501902|579892400|FG001|Overall Study|Subject Refused Further Follow-up|0|||
160594252|NCT02501902|579892401|FG002|Overall Study|Subject Refused Further Follow-up|0|||
160594253|NCT02501902|579892402|FG003|Overall Study|Subject Refused Further Follow-up|0|||
160594254|NCT02501902|579892403|FG004|Overall Study|Subject Refused Further Follow-up|0|||
160594255|NCT02501902|579892404|FG005|Overall Study|Subject Refused Further Follow-up|0|||
160594256|NCT02501902|579892405|FG006|Overall Study|Subject Refused Further Follow-up|0|||
160594257|NCT02501902|579892406|FG007|Overall Study|Subject Refused Further Follow-up|1|||
160594258|NCT02501902|579892399|FG000|Overall Study|Study Terminated by Sponsor|0|||
160594259|NCT02501902|579892400|FG001|Overall Study|Study Terminated by Sponsor|3|||
160594260|NCT02501902|579892401|FG002|Overall Study|Study Terminated by Sponsor|0|||
160594261|NCT02501902|579892402|FG003|Overall Study|Study Terminated by Sponsor|1|||
160594262|NCT02501902|579892403|FG004|Overall Study|Study Terminated by Sponsor|1|||
160594263|NCT02501902|579892404|FG005|Overall Study|Study Terminated by Sponsor|0|||
160594264|NCT02501902|579892405|FG006|Overall Study|Study Terminated by Sponsor|2|||
160594265|NCT02501902|579892406|FG007|Overall Study|Study Terminated by Sponsor|4|||
160594266|NCT02501902|579892399|FG000|Overall Study|Death|3|||
160594267|NCT02501902|579892400|FG001|Overall Study|Death|4|||
160594268|NCT02501902|579892401|FG002|Overall Study|Death|4|||
160594269|NCT02501902|579892402|FG003|Overall Study|Death|10|||
160594270|NCT02501902|579892403|FG004|Overall Study|Death|10|||
160594271|NCT02501902|579892404|FG005|Overall Study|Death|11|||
160594272|NCT02501902|579892405|FG006|Overall Study|Death|7|||
160594273|NCT02501902|579892406|FG007|Overall Study|Death|15|||
160594274|NCT02267278|579892407|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
160594275|NCT02267278|579892407|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
160594276|NCT02267278|579892407|FG000|Overall Study|Developed new cancer diagnoses|2|||
160594277|NCT02267278|579892407|FG000|Overall Study|prescribed prohibited medication|1|||
160594278|NCT04295356|579892408|FG000|Overall Study|Physician Decision|1|||
160594279|NCT04295356|579892409|FG001|Overall Study|Physician Decision|0|||
160594280|NCT04295356|579892408|FG000|Overall Study|Lost to Follow-up|0|||
160594281|NCT04295356|579892409|FG001|Overall Study|Lost to Follow-up|3|||
160594282|NCT04295356|579892408|FG000|Overall Study|Protocol Violation|0|||
160594283|NCT04295356|579892409|FG001|Overall Study|Protocol Violation|1|||
160594284|NCT01280266|579892410|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
160594285|NCT01280266|579892411|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
160594286|NCT01280266|579892410|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
160594287|NCT01280266|579892411|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
160594288|NCT04116073|579892414|FG000|Overall Study|Withdrawal by Subject|2|||
160594289|NCT04116073|579892414|FG000|Overall Study|failed to maintained eligibility|1|||
160594290|NCT01453998|579892418|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
160594291|NCT01453998|579892419|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
160594292|NCT01453998|579892420|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
160594293|NCT01840228|579892427|FG000|Overall Study|Lost to Follow-up|1|||
160594294|NCT01840228|579892428|FG001|Overall Study|Lost to Follow-up|1|||
160594295|NCT03495453|579892429|FG000|Overall Study|Withdrawal by Subject|0|||
160594296|NCT03495453|579892430|FG001|Overall Study|Withdrawal by Subject|1|||
160594297|NCT00712933|579892431|FG000|Overall Study|Adverse Event|69|||
160594298|NCT00712933|579892431|FG000|Overall Study|Lack of Efficacy|6|||
160594299|NCT00712933|579892431|FG000|Overall Study|Lost to Follow-up|22|||
160594300|NCT00712933|579892431|FG000|Overall Study|Non-compliance with study drug|13|||
160594301|NCT00712933|579892431|FG000|Overall Study|Other Pregnancy|37|||
160594302|NCT00712933|579892431|FG000|Overall Study|Sponsor decision|14|||
160594303|NCT00712933|579892431|FG000|Overall Study|Withdrew consent|4|||
160594304|NCT00712933|579892431|FG000|Overall Study|Hip replacement surgery|1|||
160594305|NCT00712933|579892431|FG000|Overall Study|Involved in Clinical research|3|||
160594306|NCT00712933|579892431|FG000|Overall Study|Participant hospitalized|1|||
160977619|NCT02836613|581307965|FG001|Overall Study|Lost to Follow-up|1|||
160977620|NCT02836613|581307964|FG000|Overall Study|Withdrawal by Subject|0|||
160977621|NCT02836613|581307965|FG001|Overall Study|Withdrawal by Subject|2|||
160977622|NCT01464255|581307966|FG000|Overall Study|unresolve corneal staining|0|||
160977623|NCT01464255|581307967|FG001|Overall Study|unresolve corneal staining|1|||
160977624|NCT01799720|581307968|FG000|Overall Study|Withdrawal by Subject|3|||
160977625|NCT01799720|581307969|FG001|Overall Study|Withdrawal by Subject|0|||
160977626|NCT01799720|581307970|FG002|Overall Study|Withdrawal by Subject|0|||
160977627|NCT01799720|581307968|FG000|Overall Study|Protocol Violation|0|||
160977628|NCT01799720|581307969|FG001|Overall Study|Protocol Violation|1|||
160977629|NCT01799720|581307970|FG002|Overall Study|Protocol Violation|0|||
160977630|NCT01799720|581307968|FG000|Overall Study|Pregnancy|0|||
160977631|NCT01799720|581307969|FG001|Overall Study|Pregnancy|0|||
160977632|NCT01799720|581307970|FG002|Overall Study|Pregnancy|1|||
160977633|NCT03169881|581307979|FG000|Overall Study|Incomplete Follow-up|10|||
160977634|NCT03169881|581307980|FG001|Overall Study|Incomplete Follow-up|15|||
160977635|NCT03169881|581307979|FG000|Overall Study|Lost to Follow-up|18|||
160977636|NCT03169881|581307980|FG001|Overall Study|Lost to Follow-up|20|||
160977637|NCT03169881|581307979|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
160977638|NCT03169881|581307980|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
160977639|NCT04908449|581307981|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
160977640|NCT04908449|581307982|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
160977641|NCT04908449|581307981|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
160977642|NCT04908449|581307982|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
160977643|NCT02401308|581307987|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
160977644|NCT02401308|581307988|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
160977645|NCT02736968|581307992|FG000|Overall Study|Lost to Follow-up|0|||
160977646|NCT02736968|581307993|FG001|Overall Study|Lost to Follow-up|0|||
160977647|NCT02736968|581307994|FG002|Overall Study|Lost to Follow-up|0|||
160977648|NCT02736968|581307995|FG003|Overall Study|Lost to Follow-up|0|||
160977649|NCT02736968|581307996|FG004|Overall Study|Lost to Follow-up|0|||
160977650|NCT02736968|581307997|FG005|Overall Study|Lost to Follow-up|0|||
160977651|NCT02736968|581307998|FG006|Overall Study|Lost to Follow-up|5|||
160977652|NCT02736968|581307999|FG007|Overall Study|Lost to Follow-up|2|||
160977653|NCT02736968|581307992|FG000|Overall Study|COVID-19 Pandemic|0|||
160977654|NCT02736968|581307993|FG001|Overall Study|COVID-19 Pandemic|0|||
160977655|NCT02736968|581307994|FG002|Overall Study|COVID-19 Pandemic|0|||
160977656|NCT02736968|581307995|FG003|Overall Study|COVID-19 Pandemic|0|||
160977657|NCT02736968|581307996|FG004|Overall Study|COVID-19 Pandemic|0|||
160977658|NCT02736968|581307997|FG005|Overall Study|COVID-19 Pandemic|0|||
160977659|NCT02736968|581307998|FG006|Overall Study|COVID-19 Pandemic|2|||
160977660|NCT02736968|581307999|FG007|Overall Study|COVID-19 Pandemic|0|||
160977661|NCT02736968|581307992|FG000|Overall Study|Withdrawal by Subject|0|||
160977662|NCT02736968|581307993|FG001|Overall Study|Withdrawal by Subject|0|||
160977663|NCT02736968|581307994|FG002|Overall Study|Withdrawal by Subject|0|||
160977664|NCT02736968|581307995|FG003|Overall Study|Withdrawal by Subject|0|||
160977665|NCT02736968|581307996|FG004|Overall Study|Withdrawal by Subject|0|||
160977666|NCT02736968|581307997|FG005|Overall Study|Withdrawal by Subject|0|||
160977667|NCT02736968|581307998|FG006|Overall Study|Withdrawal by Subject|1|||
160977668|NCT02736968|581307999|FG007|Overall Study|Withdrawal by Subject|0|||
160977669|NCT00147225|581308002|FG000|Overall Study|Withdrawal by Subject|1|||
160977670|NCT00147225|581308003|FG001|Overall Study|Withdrawal by Subject|0|||
160977671|NCT00147225|581308004|FG002|Overall Study|Withdrawal by Subject|1|||
160977672|NCT00147225|581308005|FG003|Overall Study|Withdrawal by Subject|0|||
160977673|NCT00147225|581308006|FG004|Overall Study|Withdrawal by Subject|0|||
160977674|NCT00147225|581308007|FG005|Overall Study|Withdrawal by Subject|1|||
160977675|NCT00147225|581308002|FG000|Overall Study|Adverse Event|0|||
160977676|NCT00147225|581308003|FG001|Overall Study|Adverse Event|0|||
160594307|NCT00712933|579892431|FG000|Overall Study|Participant travelled overseas|2|||
160977677|NCT00147225|581308004|FG002|Overall Study|Adverse Event|1|||
160977678|NCT00147225|581308005|FG003|Overall Study|Adverse Event|1|||
160977679|NCT00147225|581308006|FG004|Overall Study|Adverse Event|0|||
160977680|NCT00147225|581308007|FG005|Overall Study|Adverse Event|0|||
160977681|NCT00147225|581308002|FG000|Overall Study|Screen Failure|0|||
160977682|NCT00147225|581308003|FG001|Overall Study|Screen Failure|0|||
160977683|NCT00147225|581308004|FG002|Overall Study|Screen Failure|0|||
160977684|NCT00147225|581308005|FG003|Overall Study|Screen Failure|0|||
160977685|NCT00147225|581308006|FG004|Overall Study|Screen Failure|1|||
160977686|NCT00147225|581308007|FG005|Overall Study|Screen Failure|0|||
160977687|NCT00147225|581308002|FG000|Overall Study|Chemotherapy Changed|0|||
160594308|NCT00712933|579892431|FG000|Overall Study|Death of patient|1|||
160594309|NCT00712933|579892431|FG000|Overall Study|Other Physician decision|1|||
160594310|NCT00712933|579892431|FG000|Overall Study|Not committed to contraception|1|||
160594311|NCT00712933|579892431|FG000|Overall Study|Participant received medication|1|||
160594312|NCT00712933|579892431|FG000|Overall Study|Physician Decision|36|||
160594313|NCT00712933|579892431|FG000|Overall Study|Protocol Violation|4|||
160977688|NCT00147225|581308003|FG001|Overall Study|Chemotherapy Changed|0|||
160977689|NCT00147225|581308004|FG002|Overall Study|Chemotherapy Changed|0|||
160977690|NCT00147225|581308005|FG003|Overall Study|Chemotherapy Changed|0|||
160977691|NCT00147225|581308006|FG004|Overall Study|Chemotherapy Changed|0|||
160977692|NCT00147225|581308007|FG005|Overall Study|Chemotherapy Changed|1|||
160977693|NCT01032044|581308008|FG000|Overall Study|Protocol Violation|14|||
160977694|NCT01032044|581308009|FG001|Overall Study|Protocol Violation|8|||
160977695|NCT01032044|581308008|FG000|Overall Study|Adverse Event|0|||
160977696|NCT01032044|581308009|FG001|Overall Study|Adverse Event|1|||
160977697|NCT01032044|581308008|FG000|Overall Study|Lost to Follow-up|11|||
160977698|NCT01032044|581308009|FG001|Overall Study|Lost to Follow-up|11|||
160977699|NCT01567865|581308016|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
160977700|NCT01567865|581308017|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
160977701|NCT01567865|581308018|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
160977702|NCT01567865|581308019|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
160977703|NCT01567865|581308016|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
160977704|NCT01567865|581308017|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
160977705|NCT01567865|581308018|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
160977706|NCT01567865|581308019|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
160977707|NCT01051063|581308028|FG000|Overall Study|Death|2|||
160977708|NCT01051063|581308029|FG001|Overall Study|Death|2|||
160977709|NCT01051063|581308028|FG000|Overall Study|Withdrawal by Subject|1|||
160977710|NCT01051063|581308029|FG001|Overall Study|Withdrawal by Subject|1|||
160977711|NCT01051063|581308028|FG000|Overall Study|Termination of the study|5|||
160594314|NCT00712933|579892431|FG000|Overall Study|Withdrawal by Subject|151|||
160594315|NCT01413542|579892433|FG000|Overall Study|Physician Decision|1|||
160594316|NCT01413542|579892434|FG001|Overall Study|Physician Decision|0|||
160594317|NCT01413542|579892435|FG002|Overall Study|Physician Decision|3|||
160594318|NCT01413542|579892436|FG003|Overall Study|Physician Decision|0|||
160594319|NCT01413542|579892433|FG000|Overall Study|Adverse Event|0|||
160594320|NCT01413542|579892434|FG001|Overall Study|Adverse Event|0|||
160594321|NCT01413542|579892435|FG002|Overall Study|Adverse Event|0|||
160594322|NCT01413542|579892436|FG003|Overall Study|Adverse Event|1|||
160594323|NCT03067129|579892437|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
160658455|NCT02942264|580131476|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
160594324|NCT03067129|579892438|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
160594325|NCT03067129|579892439|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
160594326|NCT03067129|579892440|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
160594327|NCT03067129|579892437|FG000|Overall Study|Withdrawal by Subject|0|||
160594328|NCT03067129|579892438|FG001|Overall Study|Withdrawal by Subject|0|||
160594329|NCT03067129|579892439|FG002|Overall Study|Withdrawal by Subject|1|||
160594330|NCT03067129|579892440|FG003|Overall Study|Withdrawal by Subject|2|||
160594331|NCT03067129|579892437|FG000|Overall Study|Lost to Follow-up|5|||
160594332|NCT03067129|579892438|FG001|Overall Study|Lost to Follow-up|5|||
160594333|NCT03067129|579892439|FG002|Overall Study|Lost to Follow-up|4|||
160594334|NCT03067129|579892440|FG003|Overall Study|Lost to Follow-up|3|||
160594335|NCT00065442|579892441|FG000|Overall Study|Lost to Follow-up|1|||
160594336|NCT00065442|579892442|FG001|Overall Study|Lost to Follow-up|1|||
160594337|NCT00065442|579892441|FG000|Overall Study|Death|121|||
160594338|NCT00065442|579892442|FG001|Overall Study|Death|210|||
160594339|NCT00065442|579892441|FG000|Overall Study|Withdrawal by Subject|3|||
160658456|NCT02942264|580131477|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
160594340|NCT00065442|579892442|FG001|Overall Study|Withdrawal by Subject|9|||
160594341|NCT00712322|579892446|FG000|Overall Study|Protocol deviation|0|||
160594342|NCT00712322|579892447|FG001|Overall Study|Protocol deviation|1|||
160594343|NCT00712322|579892448|FG002|Overall Study|Protocol deviation|0|||
160594344|NCT00400712|579892450|FG000|Overall Study|Death|1|||
160594345|NCT00400712|579892451|FG001|Overall Study|Death|0|||
160594346|NCT00400712|579892450|FG000|Overall Study|Withdrawal by Subject|11|||
160594347|NCT00400712|579892451|FG001|Overall Study|Withdrawal by Subject|12|||
160594348|NCT00400712|579892450|FG000|Overall Study|Physician Decision|5|||
160594349|NCT00400712|579892451|FG001|Overall Study|Physician Decision|4|||
160594350|NCT04404010|579892452|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
160658457|NCT02942264|580131478|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
160594351|NCT04404010|579892453|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
160594352|NCT03176277|579892458|FG000|Part A Dose Escalation Study|Adverse Event|1|||
160594353|NCT03176277|579892459|FG001|Part A Dose Escalation Study|Adverse Event|0|||
160594354|NCT03176277|579892460|FG002|Part A Dose Escalation Study|Adverse Event|1|||
160594355|NCT03176277|579892461|FG003|Part A Dose Escalation Study|Adverse Event|0|||
160594356|NCT03176277|579892458|FG000|Part A Dose Escalation Study|Physician Decision|1|||
160594357|NCT03176277|579892459|FG001|Part A Dose Escalation Study|Physician Decision|1|||
160594358|NCT03176277|579892460|FG002|Part A Dose Escalation Study|Physician Decision|2|||
160594359|NCT03176277|579892461|FG003|Part A Dose Escalation Study|Physician Decision|0|||
160594360|NCT03176277|579892458|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
160594361|NCT03176277|579892459|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
160594362|NCT03176277|579892460|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
160594363|NCT03176277|579892461|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
160594364|NCT03176277|579892458|FG000|Part A Dose Escalation Study|Progressive disease|3|||
160594365|NCT03176277|579892459|FG001|Part A Dose Escalation Study|Progressive disease|1|||
160594366|NCT03176277|579892460|FG002|Part A Dose Escalation Study|Progressive disease|3|||
160594367|NCT03176277|579892461|FG003|Part A Dose Escalation Study|Progressive disease|0|||
160594368|NCT02802878|579892462|FG000|Overall Study|Withdrawal by Subject|3|||
160594369|NCT02802878|579892463|FG001|Overall Study|Withdrawal by Subject|3|||
160594370|NCT02802878|579892462|FG000|Overall Study|Protocol Violation|1|||
160594371|NCT02802878|579892463|FG001|Overall Study|Protocol Violation|0|||
160594372|NCT00702052|579892464|FG000|Overall Study|Adverse Event|23|||
160594373|NCT00702052|579892464|FG000|Overall Study|Disease Progression|30|||
160594374|NCT00702052|579892464|FG000|Overall Study|Withdrawal by Subject|5|||
160594375|NCT00101192|579892465|FG000|Overall Study|Ineligible|6|||
160594376|NCT00101192|579892465|FG000|Overall Study|Inevaluable|1|||
160594377|NCT03691610|579892466|FG000|Overall Study|Adverse Event|0|||
160594378|NCT03691610|579892467|FG001|Overall Study|Adverse Event|1|||
160594379|NCT03691610|579892468|FG002|Overall Study|Adverse Event|0|||
160594380|NCT03691610|579892469|FG003|Overall Study|Adverse Event|0|||
160594381|NCT03691610|579892466|FG000|Overall Study|Protocol Deviation|15|||
160594382|NCT03691610|579892467|FG001|Overall Study|Protocol Deviation|8|||
160594383|NCT03691610|579892468|FG002|Overall Study|Protocol Deviation|1|||
160594384|NCT03691610|579892469|FG003|Overall Study|Protocol Deviation|2|||
160594385|NCT03691610|579892466|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
160594386|NCT03691610|579892467|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
160594387|NCT03691610|579892468|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
160594388|NCT03691610|579892469|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
160594389|NCT03691610|579892466|FG000|Overall Study|Lost to Follow-up|20|||
160594390|NCT03691610|579892467|FG001|Overall Study|Lost to Follow-up|11|||
160594391|NCT03691610|579892468|FG002|Overall Study|Lost to Follow-up|5|||
160594392|NCT03691610|579892469|FG003|Overall Study|Lost to Follow-up|2|||
160594393|NCT00242580|579892470|FG000|Overall Study|Adverse Event|3|||
160594394|NCT00242580|579892471|FG001|Overall Study|Adverse Event|0|||
160594395|NCT00242580|579892472|FG002|Overall Study|Adverse Event|2|||
160594396|NCT00242580|579892470|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160594397|NCT00242580|579892471|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
160460236|NCT06065735|579417583|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
160460237|NCT06065735|579417581|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
160460238|NCT06065735|579417582|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
160460239|NCT06065735|579417583|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
160460240|NCT06065735|579417581|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
160460241|NCT06065735|579417582|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
160460242|NCT06065735|579417583|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
160460243|NCT03522298|579417584|FG000|Overall Study|Adverse Event|1|||
160460244|NCT03522298|579417585|FG001|Overall Study|Adverse Event|0|||
160460245|NCT03522298|579417586|FG002|Overall Study|Adverse Event|0|||
160460246|NCT03522298|579417587|FG003|Overall Study|Adverse Event|1|||
160460247|NCT03522298|579417584|FG000|Overall Study|Death|2|||
160460248|NCT03522298|579417585|FG001|Overall Study|Death|4|||
160460249|NCT03522298|579417586|FG002|Overall Study|Death|8|||
160460250|NCT03522298|579417587|FG003|Overall Study|Death|8|||
160460251|NCT03522298|579417584|FG000|Overall Study|Patient decision|0|||
160594398|NCT00242580|579892472|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
160594399|NCT00242580|579892470|FG000|Overall Study|Protocol Violation|0|||
160594400|NCT00242580|579892471|FG001|Overall Study|Protocol Violation|0|||
160594401|NCT00242580|579892472|FG002|Overall Study|Protocol Violation|1|||
160594402|NCT00242580|579892470|FG000|Overall Study|Subject withdrew consent|2|||
160594403|NCT00242580|579892471|FG001|Overall Study|Subject withdrew consent|2|||
160594404|NCT00242580|579892472|FG002|Overall Study|Subject withdrew consent|5|||
160594405|NCT00242580|579892470|FG000|Overall Study|Lost to Follow-up|0|||
160594406|NCT00242580|579892471|FG001|Overall Study|Lost to Follow-up|3|||
160460252|NCT03522298|579417585|FG001|Overall Study|Patient decision|2|||
160460253|NCT03522298|579417586|FG002|Overall Study|Patient decision|2|||
160460254|NCT03522298|579417587|FG003|Overall Study|Patient decision|2|||
160460255|NCT01527188|579417592|FG000|Overall Study|Adverse Event|5|||
160460256|NCT01527188|579417593|FG001|Overall Study|Adverse Event|5|||
160460257|NCT01527188|579417594|FG002|Overall Study|Adverse Event|11|||
160460258|NCT01527188|579417595|FG003|Overall Study|Adverse Event|0|||
160460259|NCT01527188|579417592|FG000|Overall Study|Withdrawal by Subject|3|||
160460260|NCT01527188|579417593|FG001|Overall Study|Withdrawal by Subject|6|||
160460261|NCT01527188|579417594|FG002|Overall Study|Withdrawal by Subject|4|||
160460262|NCT01527188|579417595|FG003|Overall Study|Withdrawal by Subject|4|||
160460263|NCT01527188|579417592|FG000|Overall Study|Any other reason not above-mentioned|6|||
160460264|NCT01527188|579417593|FG001|Overall Study|Any other reason not above-mentioned|7|||
160460265|NCT01527188|579417594|FG002|Overall Study|Any other reason not above-mentioned|8|||
160460266|NCT01527188|579417595|FG003|Overall Study|Any other reason not above-mentioned|8|||
160460267|NCT04626427|579417596|FG000|Overall Study|Death|1|||
160460268|NCT04626427|579417596|FG000|Overall Study|Withdrawal by Subject|1|||
160460269|NCT04626427|579417596|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
160460270|NCT04626427|579417596|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
160460271|NCT01265537|579417597|FG000|Overall Study|Adverse Event|2|||
160460272|NCT01265537|579417598|FG001|Overall Study|Adverse Event|1|||
160460273|NCT01265537|579417597|FG000|Overall Study|Physician Decision|0|||
160460274|NCT01265537|579417598|FG001|Overall Study|Physician Decision|1|||
160460275|NCT03512301|579418596|FG000|Overall Study|Protocol Violation|2|||
160460276|NCT03512301|579418596|FG000|Overall Study|Did Not Qualify|3|||
160460277|NCT03512301|579418596|FG000|Overall Study|Age-ineligible|1|||
160460278|NCT03512301|579418596|FG000|Overall Study|Inadequate fluency with the English language|3|||
160460279|NCT04518943|579418598|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
160460280|NCT04518943|579418599|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
160460281|NCT04518943|579418600|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
160460282|NCT04518943|579418601|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
160460283|NCT04518943|579418602|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
160460284|NCT04518943|579418603|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
160460285|NCT04518943|579418604|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
160460286|NCT04518943|579418605|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
160460287|NCT04518943|579418606|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
160460288|NCT04518943|579418607|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
160460289|NCT04518943|579418608|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
160460290|NCT04518943|579418609|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
160460291|NCT04518943|579418610|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
160460292|NCT04518943|579418611|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
160460293|NCT04518943|579418612|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
160460294|NCT04518943|579418613|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
160460295|NCT04993677|579418620|FG000|Overall Study|Lost to Follow-up|1|||
160460296|NCT04993677|579418621|FG001|Overall Study|Lost to Follow-up|0|||
160460297|NCT04993677|579418622|FG002|Overall Study|Lost to Follow-up|0|||
160460298|NCT04993677|579418623|FG003|Overall Study|Lost to Follow-up|0|||
160460299|NCT04993677|579418620|FG000|Overall Study|Death|11|||
160460300|NCT04993677|579418621|FG001|Overall Study|Death|8|||
160460301|NCT04993677|579418622|FG002|Overall Study|Death|3|||
160460302|NCT04993677|579418623|FG003|Overall Study|Death|1|||
160460303|NCT04993677|579418620|FG000|Overall Study|Subject withdrawal of consent|4|||
160460304|NCT04993677|579418621|FG001|Overall Study|Subject withdrawal of consent|3|||
160460305|NCT04993677|579418622|FG002|Overall Study|Subject withdrawal of consent|0|||
160460306|NCT04993677|579418623|FG003|Overall Study|Subject withdrawal of consent|2|||
160460307|NCT04993677|579418620|FG000|Overall Study|Study termination by sponsor|3|||
160460308|NCT04993677|579418621|FG001|Overall Study|Study termination by sponsor|25|||
160460309|NCT04993677|579418622|FG002|Overall Study|Study termination by sponsor|3|||
160460310|NCT04993677|579418623|FG003|Overall Study|Study termination by sponsor|3|||
160460311|NCT04993677|579418620|FG000|Overall Study|Other|2|||
160460312|NCT04993677|579418621|FG001|Overall Study|Other|3|||
160460313|NCT04993677|579418622|FG002|Overall Study|Other|3|||
160460314|NCT04993677|579418623|FG003|Overall Study|Other|2|||
160460315|NCT04174170|579418624|FG000|Placebo Run-in Period|Not Randomized|38|||
160460316|NCT04174170|579418625|FG001|Placebo Run-in Period|Not Randomized|0|||
160460317|NCT04174170|579418626|FG002|Placebo Run-in Period|Not Randomized|0|||
160460318|NCT04174170|579418627|FG003|Placebo Run-in Period|Not Randomized|0|||
160460319|NCT04174170|579418624|FG000|Double Blind Treatment Period|Adverse Event|0|||
160460320|NCT04174170|579418625|FG001|Double Blind Treatment Period|Adverse Event|9|||
160460321|NCT04174170|579418626|FG002|Double Blind Treatment Period|Adverse Event|9|||
160460322|NCT04174170|579418627|FG003|Double Blind Treatment Period|Adverse Event|8|||
160460323|NCT04174170|579418624|FG000|Double Blind Treatment Period|Death|0|||
160460324|NCT04174170|579418625|FG001|Double Blind Treatment Period|Death|1|||
160460325|NCT04174170|579418626|FG002|Double Blind Treatment Period|Death|0|||
160460326|NCT04174170|579418627|FG003|Double Blind Treatment Period|Death|0|||
160460327|NCT04174170|579418624|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
160460328|NCT04174170|579418625|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
160460329|NCT04174170|579418626|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
160460330|NCT04174170|579418627|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
160460331|NCT04174170|579418624|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
160460332|NCT04174170|579418625|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
160460333|NCT04174170|579418626|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
160460334|NCT04174170|579418627|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
160460335|NCT04174170|579418624|FG000|Double Blind Treatment Period|Physician Decision|0|||
160460336|NCT04174170|579418625|FG001|Double Blind Treatment Period|Physician Decision|1|||
160460337|NCT04174170|579418626|FG002|Double Blind Treatment Period|Physician Decision|0|||
160460338|NCT04174170|579418627|FG003|Double Blind Treatment Period|Physician Decision|1|||
160460339|NCT04174170|579418624|FG000|Double Blind Treatment Period|Pregnancy|0|||
160460340|NCT04174170|579418625|FG001|Double Blind Treatment Period|Pregnancy|1|||
160460341|NCT04174170|579418626|FG002|Double Blind Treatment Period|Pregnancy|0|||
160460342|NCT04174170|579418627|FG003|Double Blind Treatment Period|Pregnancy|1|||
160460343|NCT04174170|579418624|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
160460344|NCT04174170|579418625|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
160460345|NCT04174170|579418626|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
160460346|NCT04174170|579418627|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
160460347|NCT04174170|579418624|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
160460348|NCT04174170|579418625|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
160460349|NCT04174170|579418626|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
160460350|NCT04174170|579418627|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
160460351|NCT04174170|579418624|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
160460352|NCT04174170|579418625|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
160460353|NCT04174170|579418626|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
160460354|NCT04174170|579418627|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
160460355|NCT04772534|579418628|FG000|Overall Study|Physician Decision|1|||
160460356|NCT04772534|579418629|FG001|Overall Study|Physician Decision|0|||
160460357|NCT04772534|579418630|FG002|Overall Study|Physician Decision|0|||
160460358|NCT04772534|579418628|FG000|Overall Study|Withdrawal by Subject|3|||
160460359|NCT04772534|579418629|FG001|Overall Study|Withdrawal by Subject|0|||
160460360|NCT04772534|579418630|FG002|Overall Study|Withdrawal by Subject|1|||
160460361|NCT04194450|579418631|FG000|Overall Study|not eligible|1|||
160460362|NCT04194450|579418632|FG001|Overall Study|not eligible|0|||
160460363|NCT05875701|579418641|FG000|Overall Study|Lost to Follow-up|2|||
160460364|NCT05875701|579418642|FG001|Overall Study|Lost to Follow-up|0|||
160460365|NCT05875701|579418641|FG000|Overall Study|Withdrawal by Subject|1|||
160460366|NCT05875701|579418642|FG001|Overall Study|Withdrawal by Subject|1|||
160460367|NCT02656706|579418644|FG000|Overall Study|Insurance Denial|1|||
160460368|NCT04490356|579418648|FG000|Overall Study|Lost to Follow-up|1|||
160460369|NCT03201939|579418656|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
160460370|NCT03201939|579418657|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
160460371|NCT03884439|579418658|FG000|Overall Study|No informed consent for publication of study results|38|||
160460372|NCT03884439|579418658|FG000|Overall Study|Contract violation/deficiency|7|||
160460373|NCT05129501|579418661|FG000|Overall Study|Lost to Follow-up|54|||
160460374|NCT05129501|579418662|FG001|Overall Study|Lost to Follow-up|41|||
160460375|NCT03142009|579418665|FG000|Overall Study|Lost to Follow-up|45|||
160460376|NCT03142009|579418666|FG001|Overall Study|Lost to Follow-up|30|||
160460377|NCT03982186|579418667|FG000|Overall Study|Lost to Follow-up|0|||
160594407|NCT00242580|579892472|FG002|Overall Study|Lost to Follow-up|0|||
160594408|NCT00242580|579892470|FG000|Overall Study|Death|1|||
160594409|NCT00242580|579892471|FG001|Overall Study|Death|2|||
160594410|NCT00242580|579892472|FG002|Overall Study|Death|1|||
160594411|NCT01232894|579892473|FG000|Overall Study|Lost to Follow-up|0|||
160594412|NCT01232894|579892474|FG001|Overall Study|Lost to Follow-up|1|||
160658458|NCT02942264|580131479|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
160658459|NCT02942264|580131480|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
160658460|NCT02942264|580131481|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
160460378|NCT03982186|579418668|FG001|Overall Study|Lost to Follow-up|1|||
160460379|NCT03982186|579418669|FG002|Overall Study|Lost to Follow-up|2|||
160460380|NCT03982186|579418670|FG003|Overall Study|Lost to Follow-up|1|||
160460381|NCT03982186|579418671|FG004|Overall Study|Lost to Follow-up|1|||
160460382|NCT03982186|579418672|FG005|Overall Study|Lost to Follow-up|0|||
160594413|NCT01232894|579892473|FG000|Overall Study|Death|1|||
160594414|NCT01232894|579892474|FG001|Overall Study|Death|0|||
160594415|NCT01232894|579892473|FG000|Overall Study|Protocol Violation|1|||
160594416|NCT01232894|579892474|FG001|Overall Study|Protocol Violation|1|||
160460383|NCT03982186|579418667|FG000|Overall Study|Physician Decision|0|||
160594417|NCT01232894|579892473|FG000|Overall Study|Withdrawal by Subject|8|||
160658461|NCT02942264|580131482|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
160658462|NCT05150964|580131485|FG000|Overall Study|Lost to Follow-up|2|||
160658463|NCT03657160|580131486|FG000|Overall Study|Adverse Event|5|||
160658464|NCT03657160|580131487|FG001|Overall Study|Adverse Event|6|||
160658465|NCT03657160|580131486|FG000|Overall Study|Protocol Deviation|3|||
160460384|NCT03982186|579418668|FG001|Overall Study|Physician Decision|1|||
160658466|NCT03657160|580131487|FG001|Overall Study|Protocol Deviation|0|||
160658467|NCT03657160|580131486|FG000|Overall Study|Withdrawal by Subject|18|||
160658468|NCT03657160|580131487|FG001|Overall Study|Withdrawal by Subject|16|||
160658469|NCT03657160|580131486|FG000|Overall Study|Site Termination|1|||
160460385|NCT03982186|579418669|FG002|Overall Study|Physician Decision|0|||
160460386|NCT03982186|579418670|FG003|Overall Study|Physician Decision|0|||
160460387|NCT03982186|579418671|FG004|Overall Study|Physician Decision|0|||
160460388|NCT03982186|579418672|FG005|Overall Study|Physician Decision|0|||
160460389|NCT03982186|579418667|FG000|Overall Study|Withdrawal by Subject|3|||
160460390|NCT03982186|579418668|FG001|Overall Study|Withdrawal by Subject|4|||
160460391|NCT03982186|579418669|FG002|Overall Study|Withdrawal by Subject|1|||
160460392|NCT03982186|579418670|FG003|Overall Study|Withdrawal by Subject|7|||
160460393|NCT03982186|579418671|FG004|Overall Study|Withdrawal by Subject|2|||
160460394|NCT03982186|579418672|FG005|Overall Study|Withdrawal by Subject|0|||
160460395|NCT03982186|579418667|FG000|Overall Study|Randomized and not treated|0|||
160460396|NCT03982186|579418668|FG001|Overall Study|Randomized and not treated|0|||
160460397|NCT03982186|579418669|FG002|Overall Study|Randomized and not treated|0|||
160460398|NCT03982186|579418670|FG003|Overall Study|Randomized and not treated|1|||
160594418|NCT01232894|579892474|FG001|Overall Study|Withdrawal by Subject|5|||
160594419|NCT01232894|579892473|FG000|Overall Study|Physician Decision|2|||
160594420|NCT01232894|579892474|FG001|Overall Study|Physician Decision|1|||
160460399|NCT03982186|579418671|FG004|Overall Study|Randomized and not treated|0|||
160460400|NCT03982186|579418672|FG005|Overall Study|Randomized and not treated|0|||
160594421|NCT03970395|579892477|FG000|Overall Study|Withdrawal by Subject|3|||
160594422|NCT03970395|579892478|FG001|Overall Study|Withdrawal by Subject|4|||
160594423|NCT03970395|579892477|FG000|Overall Study|Lost to Follow-up|4|||
160460401|NCT01553149|579418673|FG000|Overall Study|Adverse Event|0|||
160460402|NCT01553149|579418674|FG001|Overall Study|Adverse Event|9|||
160460403|NCT01553149|579418673|FG000|Overall Study|Physician Decision|5|||
160460404|NCT01553149|579418674|FG001|Overall Study|Physician Decision|10|||
160460405|NCT01553149|579418673|FG000|Overall Study|Ineligible|0|||
160460406|NCT01553149|579418674|FG001|Overall Study|Ineligible|1|||
160460407|NCT05267639|579419208|FG000|Overall Study|Withdrawal by Subject|1|||
160460408|NCT05267639|579419209|FG001|Overall Study|Withdrawal by Subject|0|||
160460409|NCT00113360|579419210|FG000|Overall Study|Adverse Event|3|||
160460410|NCT00113360|579419210|FG000|Overall Study|Subject required surgery|1|||
160460411|NCT00113360|579419210|FG000|Overall Study|Did not meet eligibility criteria|3|||
160460412|NCT02231749|579419212|FG000|Overall Study|Disease progression|229|||
160460413|NCT02231749|579419213|FG001|Overall Study|Disease progression|297|||
160460414|NCT02231749|579419212|FG000|Overall Study|Study Drug Toxicity|134|||
160460415|NCT02231749|579419213|FG001|Overall Study|Study Drug Toxicity|63|||
160460416|NCT02231749|579419212|FG000|Overall Study|Death|1|||
160460417|NCT02231749|579419213|FG001|Overall Study|Death|1|||
160460418|NCT02231749|579419212|FG000|Overall Study|AE unrelated to Study drug|32|||
160460419|NCT02231749|579419213|FG001|Overall Study|AE unrelated to Study drug|31|||
160460420|NCT02231749|579419212|FG000|Overall Study|Participant's request to discontinue|10|||
160460421|NCT02231749|579419213|FG001|Overall Study|Participant's request to discontinue|21|||
160460422|NCT02231749|579419212|FG000|Overall Study|Participant withdrew Consent|8|||
160460423|NCT02231749|579419213|FG001|Overall Study|Participant withdrew Consent|15|||
160460424|NCT02231749|579419212|FG000|Overall Study|Lost to Follow-up|1|||
160460425|NCT02231749|579419213|FG001|Overall Study|Lost to Follow-up|2|||
160460426|NCT02231749|579419212|FG000|Overall Study|Maximum Clinical Benefit|5|||
160460427|NCT02231749|579419213|FG001|Overall Study|Maximum Clinical Benefit|8|||
160460428|NCT02231749|579419212|FG000|Overall Study|Poor/Non-Compliance|0|||
160460429|NCT02231749|579419213|FG001|Overall Study|Poor/Non-Compliance|3|||
160460430|NCT02231749|579419212|FG000|Overall Study|Pregnancy|1|||
160460431|NCT02231749|579419213|FG001|Overall Study|Pregnancy|0|||
160460432|NCT02231749|579419212|FG000|Overall Study|other|0|||
160594424|NCT03970395|579892478|FG001|Overall Study|Lost to Follow-up|8|||
160594425|NCT02921919|579892479|FG000|Overall Study|Other|5|||
160594426|NCT02921919|579892480|FG001|Overall Study|Other|6|||
160594427|NCT02921919|579892479|FG000|Overall Study|Lost to Follow-up|0|||
160594428|NCT02921919|579892480|FG001|Overall Study|Lost to Follow-up|1|||
160594429|NCT02921919|579892479|FG000|Overall Study|Withdrawal by Subject|5|||
160594430|NCT02921919|579892480|FG001|Overall Study|Withdrawal by Subject|1|||
160460433|NCT02231749|579419213|FG001|Overall Study|other|8|||
160460434|NCT02231749|579419212|FG000|Overall Study|No longer meets Study Criteria|1|||
160460435|NCT02231749|579419213|FG001|Overall Study|No longer meets Study Criteria|0|||
160594431|NCT02921919|579892479|FG000|Overall Study|Disease Progression|47|||
160594432|NCT02921919|579892480|FG001|Overall Study|Disease Progression|38|||
160594433|NCT02921919|579892479|FG000|Overall Study|Physician Decision|3|||
160594434|NCT02921919|579892480|FG001|Overall Study|Physician Decision|2|||
160594435|NCT02921919|579892479|FG000|Overall Study|Adverse Event|6|||
160594436|NCT02921919|579892480|FG001|Overall Study|Adverse Event|4|||
160594437|NCT03666858|579892481|FG000|Cohort 1|Adverse Event|1|||
160460436|NCT04675034|579419222|FG000|Overall Study|Lost to Follow-up|1|||
160460437|NCT04675034|579419223|FG001|Overall Study|Lost to Follow-up|1|||
160460438|NCT04675034|579419224|FG002|Overall Study|Lost to Follow-up|0|||
160460439|NCT04675034|579419225|FG003|Overall Study|Lost to Follow-up|2|||
160460440|NCT04675034|579419226|FG004|Overall Study|Lost to Follow-up|0|||
160460441|NCT04675034|579419222|FG000|Overall Study|Protocol Violation|1|||
160460442|NCT04675034|579419223|FG001|Overall Study|Protocol Violation|0|||
160460443|NCT04675034|579419224|FG002|Overall Study|Protocol Violation|0|||
160460444|NCT04675034|579419225|FG003|Overall Study|Protocol Violation|1|||
160460445|NCT04675034|579419226|FG004|Overall Study|Protocol Violation|3|||
160460446|NCT04675034|579419222|FG000|Overall Study|Withdrawal by Subject|9|||
160460447|NCT04675034|579419223|FG001|Overall Study|Withdrawal by Subject|3|||
160460448|NCT04675034|579419224|FG002|Overall Study|Withdrawal by Subject|4|||
160460449|NCT04675034|579419225|FG003|Overall Study|Withdrawal by Subject|8|||
160460450|NCT04675034|579419226|FG004|Overall Study|Withdrawal by Subject|6|||
160460451|NCT02532621|579419231|FG000|Overall Study|Death|3|||
160460452|NCT02532621|579419231|FG000|Overall Study|Lost to Follow-up|3|||
160460453|NCT02532621|579419231|FG000|Overall Study|Withdrawal by Subject|6|||
160460454|NCT02532621|579419231|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
160460455|NCT02532621|579419231|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
160460456|NCT04281498|579419236|FG000|Overall Study|Progression of disease|1|||
160460457|NCT04281498|579419236|FG000|Overall Study|Planned SCT|1|||
160460458|NCT04281498|579419236|FG000|Overall Study|Alternative Treatment|1|||
160460459|NCT06059443|579419237|FG000|Overall Study|Withdrawal by Subject|2|||
160460460|NCT06059443|579419238|FG001|Overall Study|Withdrawal by Subject|0|||
160460461|NCT06059443|579419237|FG000|Overall Study|Lost to Follow-up|2|||
160460462|NCT06059443|579419238|FG001|Overall Study|Lost to Follow-up|2|||
160460463|NCT01220531|579419241|FG000|Overall Study|Death|7|||
160460464|NCT01220531|579419241|FG000|Overall Study|Lost to Follow-up|1|||
160460465|NCT03008382|579419243|FG000|Overall Study|Withdrawal by Subject|2|||
160460466|NCT03008382|579419244|FG001|Overall Study|Withdrawal by Subject|5|||
160460467|NCT03008382|579419245|FG002|Overall Study|Withdrawal by Subject|2|||
160594438|NCT03666858|579892482|FG001|Cohort 1|Adverse Event|0|||
160594439|NCT03666858|579892481|FG000|Cohort 2|Adverse Event|0|||
160460468|NCT03008382|579419246|FG003|Overall Study|Withdrawal by Subject|0|||
160460469|NCT03008382|579419243|FG000|Overall Study|Protocol Violation|1|||
160460470|NCT03008382|579419244|FG001|Overall Study|Protocol Violation|0|||
160460471|NCT03008382|579419245|FG002|Overall Study|Protocol Violation|0|||
160460472|NCT03008382|579419246|FG003|Overall Study|Protocol Violation|0|||
160460473|NCT03008382|579419243|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
160460474|NCT03008382|579419244|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
160594440|NCT03666858|579892482|FG001|Cohort 2|Adverse Event|1|||
160594441|NCT03282357|579892483|FG000|Overall Study|Lost to Follow-up|3|||
160460475|NCT03008382|579419245|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
160460476|NCT03008382|579419246|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
160460477|NCT03008382|579419243|FG000|Overall Study|Lost to Follow-up|0|||
160460478|NCT03008382|579419244|FG001|Overall Study|Lost to Follow-up|0|||
160594442|NCT03282357|579892483|FG000|Overall Study|Withdrawal by Subject|4|||
160594443|NCT03282357|579892483|FG000|Overall Study|Adverse Event|1|||
160594444|NCT03282357|579892483|FG000|Overall Study|Other|9|||
160594445|NCT01518244|579892485|FG000|Overall Study|Adverse Event|3|||
160594446|NCT00870818|579892486|FG000|Overall Study|Lost to Follow-up|3|||
160594447|NCT00870818|579892487|FG001|Overall Study|Lost to Follow-up|2|||
160594448|NCT00870818|579892488|FG002|Overall Study|Lost to Follow-up|1|||
160594449|NCT00870818|579892489|FG003|Overall Study|Lost to Follow-up|0|||
160594450|NCT00870818|579892490|FG004|Overall Study|Lost to Follow-up|0|||
160594451|NCT00870818|579892486|FG000|Overall Study|Withdrawal by Subject|0|||
160594452|NCT00870818|579892487|FG001|Overall Study|Withdrawal by Subject|0|||
160460479|NCT03008382|579419245|FG002|Overall Study|Lost to Follow-up|1|||
160460480|NCT03008382|579419246|FG003|Overall Study|Lost to Follow-up|0|||
160460481|NCT03008382|579419243|FG000|Overall Study|Screenfail|0|||
160460482|NCT03008382|579419244|FG001|Overall Study|Screenfail|0|||
160460483|NCT03008382|579419245|FG002|Overall Study|Screenfail|2|||
160460484|NCT03008382|579419246|FG003|Overall Study|Screenfail|0|||
160460485|NCT04732871|579420227|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
160460486|NCT04732871|579420228|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
160460487|NCT04732871|579420229|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
160460488|NCT04732871|579420227|FG000|Overall Study|Lost to Follow-up|7|||
160460489|NCT04732871|579420228|FG001|Overall Study|Lost to Follow-up|4|||
160460490|NCT04732871|579420229|FG002|Overall Study|Lost to Follow-up|3|||
160460491|NCT04732871|579420227|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
160460492|NCT04732871|579420228|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
160460493|NCT04732871|579420229|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
160460494|NCT04732871|579420227|FG000|Overall Study|Migrated / moved from the study area|5|||
160460495|NCT04732871|579420228|FG001|Overall Study|Migrated / moved from the study area|0|||
160460496|NCT04732871|579420229|FG002|Overall Study|Migrated / moved from the study area|0|||
160460497|NCT04732871|579420227|FG000|Overall Study|Other|1|||
160460498|NCT04732871|579420228|FG001|Overall Study|Other|0|||
160460499|NCT04732871|579420229|FG002|Overall Study|Other|1|||
160460500|NCT04732871|579420227|FG000|Overall Study|Ongoing|6|||
160460501|NCT04732871|579420228|FG001|Overall Study|Ongoing|0|||
160460502|NCT04732871|579420229|FG002|Overall Study|Ongoing|1|||
160460503|NCT04732871|579420227|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
160460504|NCT04732871|579420228|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
160460505|NCT04732871|579420229|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
160460506|NCT05180539|579420239|FG000|Overall Study|Lost to Follow-up|27|||
160460507|NCT05180539|579420240|FG001|Overall Study|Lost to Follow-up|30|||
160460508|NCT00968149|579420241|FG000|Overall Study|Adverse Event|5|||
160460509|NCT00968149|579420242|FG001|Overall Study|Adverse Event|1|||
160460510|NCT00968149|579420241|FG000|Overall Study|Lack of Efficacy|0|||
160460511|NCT00968149|579420242|FG001|Overall Study|Lack of Efficacy|4|||
160460512|NCT00968149|579420241|FG000|Overall Study|Lost to Follow-up|0|||
160460513|NCT00968149|579420242|FG001|Overall Study|Lost to Follow-up|1|||
160460514|NCT00968149|579420241|FG000|Overall Study|Protocol Violation|4|||
160460515|NCT00968149|579420242|FG001|Overall Study|Protocol Violation|0|||
160460516|NCT00968149|579420241|FG000|Overall Study|Withdrawal by Subject|2|||
160460517|NCT00968149|579420242|FG001|Overall Study|Withdrawal by Subject|0|||
160460518|NCT02719574|579420243|FG000|Phase 1 (Dose Escalation)|Other|0|||
160460519|NCT02719574|579420244|FG001|Phase 1 (Dose Escalation)|Other|2|||
160460520|NCT02719574|579420245|FG002|Phase 1 (Dose Escalation)|Other|1|||
160460521|NCT02719574|579420246|FG003|Phase 1 (Dose Escalation)|Other|2|||
160460522|NCT02719574|579420247|FG004|Phase 1 (Dose Escalation)|Other|2|||
160460523|NCT02719574|579420248|FG005|Phase 1 (Dose Escalation)|Other|0|||
160460524|NCT02719574|579420249|FG006|Phase 1 (Dose Escalation)|Other|0|||
160460525|NCT02719574|579420250|FG007|Phase 1 (Dose Escalation)|Other|0|||
160658470|NCT03657160|580131487|FG001|Overall Study|Site Termination|0|||
160658471|NCT03657160|580131486|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
160460526|NCT02719574|579420251|FG008|Phase 1 (Dose Escalation)|Other|0|||
160460527|NCT02719574|579420252|FG009|Phase 1 (Dose Escalation)|Other|0|||
160460528|NCT02719574|579420253|FG010|Phase 1 (Dose Escalation)|Other|0|||
160460529|NCT02719574|579420254|FG011|Phase 1 (Dose Escalation)|Other|0|||
160460530|NCT02719574|579420255|FG012|Phase 1 (Dose Escalation)|Other|0|||
160460531|NCT02719574|579420256|FG013|Phase 1 (Dose Escalation)|Other|0|||
160460532|NCT02719574|579420257|FG014|Phase 1 (Dose Escalation)|Other|0|||
160460533|NCT02719574|579420258|FG015|Phase 1 (Dose Escalation)|Other|0|||
160460534|NCT02719574|579420259|FG016|Phase 1 (Dose Escalation)|Other|0|||
160460535|NCT02719574|579420243|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
160460536|NCT02719574|579420244|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
160460537|NCT02719574|579420245|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
160460538|NCT02719574|579420246|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
160658472|NCT03657160|580131487|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
160658473|NCT03657160|580131486|FG000|Overall Study|Death|33|||
160460539|NCT02719574|579420247|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
160460540|NCT02719574|579420248|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
160460541|NCT02719574|579420249|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460542|NCT02719574|579420250|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460543|NCT02719574|579420251|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460544|NCT02719574|579420252|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460545|NCT02719574|579420253|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460546|NCT02719574|579420254|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460547|NCT02719574|579420255|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460548|NCT02719574|579420256|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460549|NCT02719574|579420257|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460550|NCT02719574|579420258|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460551|NCT02719574|579420259|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
160460552|NCT02719574|579420243|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460553|NCT02719574|579420244|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
160460554|NCT02719574|579420245|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
160460555|NCT02719574|579420246|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460556|NCT02719574|579420247|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
160460557|NCT02719574|579420248|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
160460558|NCT02719574|579420249|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460559|NCT02719574|579420250|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460560|NCT02719574|579420251|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460561|NCT02719574|579420252|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460562|NCT02719574|579420253|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460563|NCT02719574|579420254|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460564|NCT02719574|579420255|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460565|NCT02719574|579420256|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460566|NCT02719574|579420257|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460567|NCT02719574|579420258|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460568|NCT02719574|579420259|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160460569|NCT02719574|579420243|FG000|Phase 1 (Dose Escalation)|Death|2|||
160460570|NCT02719574|579420244|FG001|Phase 1 (Dose Escalation)|Death|1|||
160460571|NCT02719574|579420245|FG002|Phase 1 (Dose Escalation)|Death|1|||
160460572|NCT02719574|579420246|FG003|Phase 1 (Dose Escalation)|Death|0|||
160460573|NCT02719574|579420247|FG004|Phase 1 (Dose Escalation)|Death|0|||
160460574|NCT02719574|579420248|FG005|Phase 1 (Dose Escalation)|Death|0|||
160460575|NCT02719574|579420249|FG006|Phase 1 (Dose Escalation)|Death|0|||
160460576|NCT02719574|579420250|FG007|Phase 1 (Dose Escalation)|Death|0|||
160460577|NCT02719574|579420251|FG008|Phase 1 (Dose Escalation)|Death|0|||
160460578|NCT02719574|579420252|FG009|Phase 1 (Dose Escalation)|Death|0|||
160460579|NCT02719574|579420253|FG010|Phase 1 (Dose Escalation)|Death|0|||
160460580|NCT02719574|579420254|FG011|Phase 1 (Dose Escalation)|Death|0|||
160460581|NCT02719574|579420255|FG012|Phase 1 (Dose Escalation)|Death|0|||
160460582|NCT02719574|579420256|FG013|Phase 1 (Dose Escalation)|Death|0|||
160460583|NCT02719574|579420257|FG014|Phase 1 (Dose Escalation)|Death|0|||
160460584|NCT02719574|579420258|FG015|Phase 1 (Dose Escalation)|Death|0|||
160460585|NCT02719574|579420259|FG016|Phase 1 (Dose Escalation)|Death|0|||
160460586|NCT02719574|579420243|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460587|NCT02719574|579420244|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
160460588|NCT02719574|579420245|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460589|NCT02719574|579420246|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460590|NCT02719574|579420247|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
160460591|NCT02719574|579420248|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
160460592|NCT02719574|579420249|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460593|NCT02719574|579420250|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460594|NCT02719574|579420251|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460595|NCT02719574|579420252|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
160594453|NCT00870818|579892488|FG002|Overall Study|Withdrawal by Subject|1|||
160594454|NCT00870818|579892489|FG003|Overall Study|Withdrawal by Subject|2|||
160594455|NCT00870818|579892490|FG004|Overall Study|Withdrawal by Subject|0|||
160594456|NCT00870818|579892486|FG000|Overall Study|Terminated by sponsor|29|||
160594457|NCT00870818|579892487|FG001|Overall Study|Terminated by sponsor|70|||
160594458|NCT00870818|579892488|FG002|Overall Study|Terminated by sponsor|36|||
160594459|NCT00870818|579892489|FG003|Overall Study|Terminated by sponsor|36|||
160594460|NCT00870818|579892490|FG004|Overall Study|Terminated by sponsor|38|||
160594461|NCT00870818|579892486|FG000|Overall Study|Other|0|||
160594462|NCT00870818|579892487|FG001|Overall Study|Other|1|||
160594463|NCT00870818|579892488|FG002|Overall Study|Other|0|||
160594464|NCT00870818|579892489|FG003|Overall Study|Other|0|||
160594465|NCT00870818|579892490|FG004|Overall Study|Other|0|||
160594466|NCT04900038|579892491|FG000|Overall Study|Adverse Event|1|||
160594467|NCT04900038|579892492|FG001|Overall Study|Adverse Event|0|||
160594468|NCT04900038|579892493|FG002|Overall Study|Adverse Event|1|||
160658474|NCT03657160|580131487|FG001|Overall Study|Death|26|||
160594469|NCT04900038|579892494|FG003|Overall Study|Adverse Event|1|||
160658475|NCT03657160|580131486|FG000|Overall Study|Death (COVID-19-Related)|1|||
160594470|NCT04900038|579892491|FG000|Overall Study|Withdrawal by Subject|0|||
160594471|NCT04900038|579892492|FG001|Overall Study|Withdrawal by Subject|1|||
160594472|NCT04900038|579892493|FG002|Overall Study|Withdrawal by Subject|0|||
160658476|NCT03657160|580131487|FG001|Overall Study|Death (COVID-19-Related)|0|||
160460596|NCT02719574|579420253|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460597|NCT02719574|579420254|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460598|NCT02719574|579420255|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460599|NCT02719574|579420256|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460600|NCT02719574|579420257|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460601|NCT02719574|579420258|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460602|NCT02719574|579420259|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
160460603|NCT02719574|579420243|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460604|NCT02719574|579420244|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460605|NCT02719574|579420245|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460606|NCT02719574|579420246|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460607|NCT02719574|579420247|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
160460608|NCT02719574|579420248|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
160460609|NCT02719574|579420249|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460610|NCT02719574|579420250|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460611|NCT02719574|579420251|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460612|NCT02719574|579420252|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460613|NCT02719574|579420253|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460614|NCT02719574|579420254|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460615|NCT02719574|579420255|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460616|NCT02719574|579420256|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460617|NCT02719574|579420257|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460618|NCT02719574|579420258|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460619|NCT02719574|579420259|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
160460620|NCT02719574|579420243|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160594473|NCT04900038|579892494|FG003|Overall Study|Withdrawal by Subject|0|||
160460621|NCT02719574|579420244|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160594474|NCT04900038|579892491|FG000|Overall Study|Study terminated by sponsor|18|||
160594475|NCT04900038|579892492|FG001|Overall Study|Study terminated by sponsor|15|||
160594476|NCT04900038|579892493|FG002|Overall Study|Study terminated by sponsor|17|||
160460622|NCT02719574|579420245|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
160594477|NCT04900038|579892494|FG003|Overall Study|Study terminated by sponsor|14|||
160460623|NCT02719574|579420246|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160460624|NCT02719574|579420247|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160460625|NCT02719574|579420248|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160460626|NCT02719574|579420249|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160460627|NCT02719574|579420250|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160460628|NCT02719574|579420251|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160460629|NCT02719574|579420252|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160658477|NCT03657160|580131486|FG000|Overall Study|Reason Not Specified|5|||
160460630|NCT02719574|579420253|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160658478|NCT03657160|580131487|FG001|Overall Study|Reason Not Specified|5|||
160658479|NCT03657160|580131486|FG000|Overall Study|Other (COVID-19-Related)|0|||
160658480|NCT03657160|580131487|FG001|Overall Study|Other (COVID-19-Related)|1|||
160658481|NCT01062256|580131491|FG000|Overall Study|Adverse Event|1|||
160658482|NCT01062256|580131492|FG001|Overall Study|Adverse Event|0|||
160658483|NCT01062256|580131493|FG002|Overall Study|Adverse Event|0|||
160658484|NCT01062256|580131491|FG000|Overall Study|Withdrawal by Subject|1|||
160594478|NCT04900038|579892491|FG000|Overall Study|Protocol Deviation|1|||
160594479|NCT04900038|579892492|FG001|Overall Study|Protocol Deviation|1|||
160594480|NCT04900038|579892493|FG002|Overall Study|Protocol Deviation|0|||
160594481|NCT04900038|579892494|FG003|Overall Study|Protocol Deviation|0|||
160594482|NCT04900038|579892491|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
160594483|NCT04900038|579892492|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
160594484|NCT04900038|579892493|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
160460631|NCT02719574|579420254|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160594485|NCT04900038|579892494|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
160658485|NCT01062256|580131492|FG001|Overall Study|Withdrawal by Subject|1|||
160658486|NCT01062256|580131493|FG002|Overall Study|Withdrawal by Subject|1|||
160658487|NCT01062256|580131491|FG000|Overall Study|Ineligible|1|||
160658488|NCT01062256|580131492|FG001|Overall Study|Ineligible|4|||
160460632|NCT02719574|579420255|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160460633|NCT02719574|579420256|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160460634|NCT02719574|579420257|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160594486|NCT04900038|579892491|FG000|Overall Study|Lost to Follow-up|0|||
160594487|NCT04900038|579892492|FG001|Overall Study|Lost to Follow-up|0|||
160594488|NCT04900038|579892493|FG002|Overall Study|Lost to Follow-up|0|||
160594489|NCT04900038|579892494|FG003|Overall Study|Lost to Follow-up|1|||
160594490|NCT01740388|579892498|FG000|Overall Study|Withdrawal by Subject|1|||
160594491|NCT01740388|579892499|FG001|Overall Study|Withdrawal by Subject|2|||
160594492|NCT01740388|579892498|FG000|Overall Study|Lost to Follow-up|2|||
160594493|NCT01740388|579892499|FG001|Overall Study|Lost to Follow-up|0|||
160594494|NCT01740388|579892498|FG000|Overall Study|Physician Decision|2|||
160594495|NCT01740388|579892499|FG001|Overall Study|Physician Decision|6|||
160658489|NCT01062256|580131493|FG002|Overall Study|Ineligible|3|||
160594496|NCT01740388|579892498|FG000|Overall Study|Subjects missing data, completed|41|||
160594497|NCT01740388|579892499|FG001|Overall Study|Subjects missing data, completed|36|||
160658490|NCT01062256|580131491|FG000|Overall Study|Administrative|0|||
160460635|NCT02719574|579420258|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160460636|NCT02719574|579420259|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
160658491|NCT01062256|580131492|FG001|Overall Study|Administrative|2|||
160460637|NCT02719574|579420243|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160658492|NCT01062256|580131493|FG002|Overall Study|Administrative|0|||
160658493|NCT03099538|580131495|FG000|Overall Study|Lack of Efficacy|3|||
160460638|NCT02719574|579420244|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460639|NCT02719574|579420245|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460640|NCT02719574|579420246|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460641|NCT02719574|579420247|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460642|NCT02719574|579420248|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460643|NCT02719574|579420249|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
160460644|NCT02719574|579420250|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
160460645|NCT02719574|579420251|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
160460646|NCT02719574|579420252|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460647|NCT02719574|579420253|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160658494|NCT01629381|580131510|FG000|Overall Study|Withdrawal by Subject|2|||
160658495|NCT01629381|580131511|FG001|Overall Study|Withdrawal by Subject|5|||
160460648|NCT02719574|579420254|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460649|NCT02719574|579420255|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160658496|NCT00906347|580131514|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
160658497|NCT00906347|580131515|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
160460650|NCT02719574|579420256|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460651|NCT02719574|579420257|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460652|NCT02719574|579420258|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460653|NCT02719574|579420259|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160460654|NCT02719574|579420243|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460655|NCT02719574|579420244|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460656|NCT02719574|579420245|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460657|NCT02719574|579420246|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460658|NCT02719574|579420247|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460659|NCT02719574|579420248|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460660|NCT02719574|579420249|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
160460661|NCT02719574|579420250|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
160460662|NCT02719574|579420251|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460663|NCT02719574|579420252|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460664|NCT02719574|579420253|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460665|NCT02719574|579420254|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460666|NCT02719574|579420255|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460667|NCT02719574|579420256|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460668|NCT02719574|579420257|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460669|NCT02719574|579420258|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460670|NCT02719574|579420259|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
160460671|NCT02719574|579420243|FG000|Phase 1 (Dose Expansion)|Death|0|||
160460672|NCT02719574|579420244|FG001|Phase 1 (Dose Expansion)|Death|0|||
160460673|NCT02719574|579420245|FG002|Phase 1 (Dose Expansion)|Death|0|||
160460674|NCT02719574|579420246|FG003|Phase 1 (Dose Expansion)|Death|0|||
160460675|NCT02719574|579420247|FG004|Phase 1 (Dose Expansion)|Death|0|||
160460676|NCT02719574|579420248|FG005|Phase 1 (Dose Expansion)|Death|0|||
160460677|NCT02719574|579420249|FG006|Phase 1 (Dose Expansion)|Death|1|||
160460678|NCT02719574|579420250|FG007|Phase 1 (Dose Expansion)|Death|6|||
160460679|NCT02719574|579420251|FG008|Phase 1 (Dose Expansion)|Death|0|||
160460680|NCT02719574|579420252|FG009|Phase 1 (Dose Expansion)|Death|0|||
160460681|NCT02719574|579420253|FG010|Phase 1 (Dose Expansion)|Death|0|||
160460682|NCT02719574|579420254|FG011|Phase 1 (Dose Expansion)|Death|0|||
160460683|NCT02719574|579420255|FG012|Phase 1 (Dose Expansion)|Death|0|||
160460684|NCT02719574|579420256|FG013|Phase 1 (Dose Expansion)|Death|0|||
160460685|NCT02719574|579420257|FG014|Phase 1 (Dose Expansion)|Death|0|||
160460686|NCT02719574|579420258|FG015|Phase 1 (Dose Expansion)|Death|0|||
160460687|NCT02719574|579420259|FG016|Phase 1 (Dose Expansion)|Death|0|||
160460688|NCT02719574|579420243|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460689|NCT02719574|579420244|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460690|NCT02719574|579420245|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460691|NCT02719574|579420246|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460692|NCT02719574|579420247|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460693|NCT02719574|579420248|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460694|NCT02719574|579420249|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
160460695|NCT02719574|579420250|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
160460696|NCT02719574|579420251|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460697|NCT02719574|579420252|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460698|NCT02719574|579420253|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460699|NCT02719574|579420254|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460700|NCT02719574|579420255|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460701|NCT02719574|579420256|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
160658498|NCT00906347|580131514|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
160658499|NCT00906347|580131515|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
160658500|NCT00906347|580131514|FG000|Received Study Drug|Refused study drug|1|||
160658501|NCT00906347|580131515|FG001|Received Study Drug|Refused study drug|0|||
160658502|NCT00906347|580131514|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
160658503|NCT00906347|580131515|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
160658504|NCT00680121|580131525|FG000|Overall Study|Lost to Follow-up|27|||
160658505|NCT00680121|580131526|FG001|Overall Study|Lost to Follow-up|23|||
160658506|NCT02849652|580131527|FG000|Overall Study|Lost to Follow-up|104|||
160460702|NCT02719574|579420257|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460703|NCT02719574|579420258|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460704|NCT02719574|579420259|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
160460705|NCT02719574|579420243|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460706|NCT02719574|579420244|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460707|NCT02719574|579420245|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460708|NCT02719574|579420246|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460709|NCT02719574|579420247|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460710|NCT02719574|579420248|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460711|NCT02719574|579420249|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
160460712|NCT02719574|579420250|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
160460713|NCT02719574|579420251|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460714|NCT02719574|579420252|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460715|NCT02719574|579420253|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460716|NCT02719574|579420254|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460717|NCT02719574|579420255|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460718|NCT02719574|579420256|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460719|NCT02719574|579420257|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460720|NCT02719574|579420258|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460721|NCT02719574|579420259|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
160460722|NCT02719574|579420243|FG000|Phase 1 (Dose Expansion)|Other|0|||
160460723|NCT02719574|579420244|FG001|Phase 1 (Dose Expansion)|Other|0|||
160460724|NCT02719574|579420245|FG002|Phase 1 (Dose Expansion)|Other|0|||
160460725|NCT02719574|579420246|FG003|Phase 1 (Dose Expansion)|Other|0|||
160460726|NCT02719574|579420247|FG004|Phase 1 (Dose Expansion)|Other|0|||
160460727|NCT02719574|579420248|FG005|Phase 1 (Dose Expansion)|Other|0|||
160460728|NCT02719574|579420249|FG006|Phase 1 (Dose Expansion)|Other|1|||
160460729|NCT02719574|579420250|FG007|Phase 1 (Dose Expansion)|Other|7|||
160460730|NCT02719574|579420251|FG008|Phase 1 (Dose Expansion)|Other|0|||
160460731|NCT02719574|579420252|FG009|Phase 1 (Dose Expansion)|Other|0|||
160460732|NCT02719574|579420253|FG010|Phase 1 (Dose Expansion)|Other|0|||
160460733|NCT02719574|579420254|FG011|Phase 1 (Dose Expansion)|Other|0|||
160460734|NCT02719574|579420255|FG012|Phase 1 (Dose Expansion)|Other|0|||
160460735|NCT02719574|579420256|FG013|Phase 1 (Dose Expansion)|Other|0|||
160460736|NCT02719574|579420257|FG014|Phase 1 (Dose Expansion)|Other|0|||
160460737|NCT02719574|579420258|FG015|Phase 1 (Dose Expansion)|Other|0|||
160460738|NCT02719574|579420259|FG016|Phase 1 (Dose Expansion)|Other|0|||
160460739|NCT02719574|579420243|FG000|Phase 2|Protocol Defined Disease Progression|0|||
160460740|NCT02719574|579420244|FG001|Phase 2|Protocol Defined Disease Progression|0|||
160460741|NCT02719574|579420245|FG002|Phase 2|Protocol Defined Disease Progression|0|||
160460742|NCT02719574|579420246|FG003|Phase 2|Protocol Defined Disease Progression|0|||
160460743|NCT02719574|579420247|FG004|Phase 2|Protocol Defined Disease Progression|0|||
160460744|NCT02719574|579420248|FG005|Phase 2|Protocol Defined Disease Progression|0|||
160460745|NCT02719574|579420249|FG006|Phase 2|Protocol Defined Disease Progression|0|||
160460746|NCT02719574|579420250|FG007|Phase 2|Protocol Defined Disease Progression|0|||
160460747|NCT02719574|579420251|FG008|Phase 2|Protocol Defined Disease Progression|0|||
160460748|NCT02719574|579420252|FG009|Phase 2|Protocol Defined Disease Progression|65|||
160460749|NCT02719574|579420253|FG010|Phase 2|Protocol Defined Disease Progression|8|||
160460750|NCT02719574|579420254|FG011|Phase 2|Protocol Defined Disease Progression|2|||
160460751|NCT02719574|579420255|FG012|Phase 2|Protocol Defined Disease Progression|4|||
160460752|NCT02719574|579420256|FG013|Phase 2|Protocol Defined Disease Progression|9|||
160460753|NCT02719574|579420257|FG014|Phase 2|Protocol Defined Disease Progression|11|||
160460754|NCT02719574|579420258|FG015|Phase 2|Protocol Defined Disease Progression|3|||
160460755|NCT02719574|579420259|FG016|Phase 2|Protocol Defined Disease Progression|4|||
160460756|NCT02719574|579420243|FG000|Phase 2|Adverse Event|0|||
160460757|NCT02719574|579420244|FG001|Phase 2|Adverse Event|0|||
160460758|NCT02719574|579420245|FG002|Phase 2|Adverse Event|0|||
160460759|NCT02719574|579420246|FG003|Phase 2|Adverse Event|0|||
160460760|NCT02719574|579420247|FG004|Phase 2|Adverse Event|0|||
160460761|NCT02719574|579420248|FG005|Phase 2|Adverse Event|0|||
160460762|NCT02719574|579420249|FG006|Phase 2|Adverse Event|0|||
160460763|NCT02719574|579420250|FG007|Phase 2|Adverse Event|0|||
160460764|NCT02719574|579420251|FG008|Phase 2|Adverse Event|0|||
160460765|NCT02719574|579420252|FG009|Phase 2|Adverse Event|27|||
160460766|NCT02719574|579420253|FG010|Phase 2|Adverse Event|0|||
160460767|NCT02719574|579420254|FG011|Phase 2|Adverse Event|1|||
160460768|NCT02719574|579420255|FG012|Phase 2|Adverse Event|1|||
160460769|NCT02719574|579420256|FG013|Phase 2|Adverse Event|1|||
160460770|NCT02719574|579420257|FG014|Phase 2|Adverse Event|2|||
160460771|NCT02719574|579420258|FG015|Phase 2|Adverse Event|2|||
160460772|NCT02719574|579420259|FG016|Phase 2|Adverse Event|3|||
160460773|NCT02719574|579420243|FG000|Phase 2|Other|0|||
160460774|NCT02719574|579420244|FG001|Phase 2|Other|0|||
160460775|NCT02719574|579420245|FG002|Phase 2|Other|0|||
160460776|NCT02719574|579420246|FG003|Phase 2|Other|0|||
160460777|NCT02719574|579420247|FG004|Phase 2|Other|0|||
160460778|NCT02719574|579420248|FG005|Phase 2|Other|0|||
160460779|NCT02719574|579420249|FG006|Phase 2|Other|0|||
160460780|NCT02719574|579420250|FG007|Phase 2|Other|0|||
160460781|NCT02719574|579420251|FG008|Phase 2|Other|0|||
160460782|NCT02719574|579420252|FG009|Phase 2|Other|20|||
160460783|NCT02719574|579420253|FG010|Phase 2|Other|7|||
160460784|NCT02719574|579420254|FG011|Phase 2|Other|0|||
160460785|NCT02719574|579420255|FG012|Phase 2|Other|5|||
160460786|NCT02719574|579420256|FG013|Phase 2|Other|7|||
160460787|NCT02719574|579420257|FG014|Phase 2|Other|0|||
160460788|NCT02719574|579420258|FG015|Phase 2|Other|1|||
160460789|NCT02719574|579420259|FG016|Phase 2|Other|4|||
160460790|NCT02719574|579420243|FG000|Phase 2|Transplant|0|||
160460791|NCT02719574|579420244|FG001|Phase 2|Transplant|0|||
160460792|NCT02719574|579420245|FG002|Phase 2|Transplant|0|||
160460793|NCT02719574|579420246|FG003|Phase 2|Transplant|0|||
160460794|NCT02719574|579420247|FG004|Phase 2|Transplant|0|||
160460795|NCT02719574|579420248|FG005|Phase 2|Transplant|0|||
160460796|NCT02719574|579420249|FG006|Phase 2|Transplant|0|||
160460797|NCT02719574|579420250|FG007|Phase 2|Transplant|0|||
160460798|NCT02719574|579420251|FG008|Phase 2|Transplant|0|||
160460799|NCT02719574|579420252|FG009|Phase 2|Transplant|15|||
160460800|NCT02719574|579420253|FG010|Phase 2|Transplant|2|||
160460801|NCT02719574|579420254|FG011|Phase 2|Transplant|0|||
160460802|NCT02719574|579420255|FG012|Phase 2|Transplant|6|||
160460803|NCT02719574|579420256|FG013|Phase 2|Transplant|1|||
160460804|NCT02719574|579420257|FG014|Phase 2|Transplant|1|||
160460805|NCT02719574|579420258|FG015|Phase 2|Transplant|0|||
160460806|NCT02719574|579420259|FG016|Phase 2|Transplant|0|||
160460807|NCT02719574|579420243|FG000|Phase 2|Death|0|||
160460808|NCT02719574|579420244|FG001|Phase 2|Death|0|||
160460809|NCT02719574|579420245|FG002|Phase 2|Death|0|||
160460810|NCT02719574|579420246|FG003|Phase 2|Death|0|||
160460811|NCT02719574|579420247|FG004|Phase 2|Death|0|||
160460812|NCT02719574|579420248|FG005|Phase 2|Death|0|||
160460813|NCT02719574|579420249|FG006|Phase 2|Death|0|||
160460814|NCT02719574|579420250|FG007|Phase 2|Death|0|||
160658507|NCT02849652|580131528|FG001|Overall Study|Lost to Follow-up|35|||
160460815|NCT02719574|579420251|FG008|Phase 2|Death|0|||
160460816|NCT02719574|579420252|FG009|Phase 2|Death|14|||
160460817|NCT02719574|579420253|FG010|Phase 2|Death|0|||
160460818|NCT02719574|579420254|FG011|Phase 2|Death|0|||
160460819|NCT02719574|579420255|FG012|Phase 2|Death|1|||
160460820|NCT02719574|579420256|FG013|Phase 2|Death|1|||
160594498|NCT01641991|579892500|FG000|Overall Study|Physician Decision|0|||
160460821|NCT02719574|579420257|FG014|Phase 2|Death|2|||
160460822|NCT02719574|579420258|FG015|Phase 2|Death|0|||
160460823|NCT02719574|579420259|FG016|Phase 2|Death|0|||
160594499|NCT01641991|579892501|FG001|Overall Study|Physician Decision|1|||
160594500|NCT01641991|579892502|FG002|Overall Study|Physician Decision|7|||
160594501|NCT01641991|579892503|FG003|Overall Study|Physician Decision|5|||
160594502|NCT01641991|579892500|FG000|Overall Study|Withdrawal by Subject|4|||
160594503|NCT01641991|579892501|FG001|Overall Study|Withdrawal by Subject|2|||
160460824|NCT02719574|579420243|FG000|Phase 2|Investigator Decision|0|||
160594504|NCT01641991|579892502|FG002|Overall Study|Withdrawal by Subject|1|||
160594505|NCT01641991|579892503|FG003|Overall Study|Withdrawal by Subject|5|||
160460825|NCT02719574|579420244|FG001|Phase 2|Investigator Decision|0|||
160460826|NCT02719574|579420245|FG002|Phase 2|Investigator Decision|0|||
160460827|NCT02719574|579420246|FG003|Phase 2|Investigator Decision|0|||
160460828|NCT02719574|579420247|FG004|Phase 2|Investigator Decision|0|||
160460829|NCT02719574|579420248|FG005|Phase 2|Investigator Decision|0|||
160460830|NCT02719574|579420249|FG006|Phase 2|Investigator Decision|0|||
160460831|NCT02719574|579420250|FG007|Phase 2|Investigator Decision|0|||
160460832|NCT02719574|579420251|FG008|Phase 2|Investigator Decision|0|||
160460833|NCT02719574|579420252|FG009|Phase 2|Investigator Decision|6|||
160460834|NCT02719574|579420253|FG010|Phase 2|Investigator Decision|1|||
160460835|NCT02719574|579420254|FG011|Phase 2|Investigator Decision|2|||
160460836|NCT02719574|579420255|FG012|Phase 2|Investigator Decision|3|||
160460837|NCT02719574|579420256|FG013|Phase 2|Investigator Decision|1|||
160460838|NCT02719574|579420257|FG014|Phase 2|Investigator Decision|3|||
160460839|NCT02719574|579420258|FG015|Phase 2|Investigator Decision|2|||
160460840|NCT02719574|579420259|FG016|Phase 2|Investigator Decision|0|||
160460841|NCT02719574|579420243|FG000|Phase 2|Withdrawal by Subject|0|||
160460842|NCT02719574|579420244|FG001|Phase 2|Withdrawal by Subject|0|||
160460843|NCT02719574|579420245|FG002|Phase 2|Withdrawal by Subject|0|||
160460844|NCT02719574|579420246|FG003|Phase 2|Withdrawal by Subject|0|||
160460845|NCT02719574|579420247|FG004|Phase 2|Withdrawal by Subject|0|||
160460846|NCT02719574|579420248|FG005|Phase 2|Withdrawal by Subject|0|||
160460847|NCT02719574|579420249|FG006|Phase 2|Withdrawal by Subject|0|||
160460848|NCT02719574|579420250|FG007|Phase 2|Withdrawal by Subject|0|||
160460849|NCT02719574|579420251|FG008|Phase 2|Withdrawal by Subject|0|||
160460850|NCT02719574|579420252|FG009|Phase 2|Withdrawal by Subject|5|||
160460851|NCT02719574|579420253|FG010|Phase 2|Withdrawal by Subject|0|||
160460852|NCT02719574|579420254|FG011|Phase 2|Withdrawal by Subject|0|||
160460853|NCT02719574|579420255|FG012|Phase 2|Withdrawal by Subject|0|||
160460854|NCT02719574|579420256|FG013|Phase 2|Withdrawal by Subject|1|||
160460855|NCT02719574|579420257|FG014|Phase 2|Withdrawal by Subject|1|||
160460856|NCT02719574|579420258|FG015|Phase 2|Withdrawal by Subject|2|||
160460857|NCT02719574|579420259|FG016|Phase 2|Withdrawal by Subject|0|||
160460858|NCT02719574|579420243|FG000|Phase 2|Protocol Violation|0|||
160460859|NCT02719574|579420244|FG001|Phase 2|Protocol Violation|0|||
160460860|NCT02719574|579420245|FG002|Phase 2|Protocol Violation|0|||
160460861|NCT02719574|579420246|FG003|Phase 2|Protocol Violation|0|||
160460862|NCT02719574|579420247|FG004|Phase 2|Protocol Violation|0|||
160460863|NCT02719574|579420248|FG005|Phase 2|Protocol Violation|0|||
160460864|NCT02719574|579420249|FG006|Phase 2|Protocol Violation|0|||
160460865|NCT02719574|579420250|FG007|Phase 2|Protocol Violation|0|||
160460866|NCT02719574|579420251|FG008|Phase 2|Protocol Violation|0|||
160460867|NCT02719574|579420252|FG009|Phase 2|Protocol Violation|1|||
160460868|NCT02719574|579420253|FG010|Phase 2|Protocol Violation|0|||
160460869|NCT02719574|579420254|FG011|Phase 2|Protocol Violation|0|||
160460870|NCT02719574|579420255|FG012|Phase 2|Protocol Violation|0|||
160460871|NCT02719574|579420256|FG013|Phase 2|Protocol Violation|0|||
160460872|NCT02719574|579420257|FG014|Phase 2|Protocol Violation|0|||
160460873|NCT02719574|579420258|FG015|Phase 2|Protocol Violation|0|||
160460874|NCT02719574|579420259|FG016|Phase 2|Protocol Violation|0|||
160460875|NCT01976936|579420272|FG000|Overall Study|Did not receive at least 9 doses|9|||
160460876|NCT01976936|579420273|FG001|Overall Study|Did not receive at least 9 doses|4|||
160460877|NCT02467270|579420274|FG000|Overall Study|Participants Never Treated|0|||
160460878|NCT02467270|579420275|FG001|Overall Study|Participants Never Treated|1|||
160460879|NCT02467270|579420276|FG002|Overall Study|Participants Never Treated|0|||
160460880|NCT02467270|579420274|FG000|Overall Study|Ongoing|50|||
160460881|NCT02467270|579420275|FG001|Overall Study|Ongoing|41|||
160460882|NCT02467270|579420276|FG002|Overall Study|Ongoing|43|||
160460883|NCT02467270|579420274|FG000|Overall Study|Adverse Event|16|||
160460884|NCT02467270|579420275|FG001|Overall Study|Adverse Event|15|||
160460885|NCT02467270|579420276|FG002|Overall Study|Adverse Event|14|||
160460886|NCT02467270|579420274|FG000|Overall Study|Progressive Disease|7|||
160460887|NCT02467270|579420275|FG001|Overall Study|Progressive Disease|7|||
160460888|NCT02467270|579420276|FG002|Overall Study|Progressive Disease|4|||
160460889|NCT02467270|579420274|FG000|Overall Study|Death|2|||
160460890|NCT02467270|579420275|FG001|Overall Study|Death|0|||
160460891|NCT02467270|579420276|FG002|Overall Study|Death|2|||
160460892|NCT02467270|579420274|FG000|Overall Study|Lack of Efficacy|12|||
160460893|NCT02467270|579420275|FG001|Overall Study|Lack of Efficacy|18|||
160460894|NCT02467270|579420276|FG002|Overall Study|Lack of Efficacy|23|||
160460895|NCT02467270|579420274|FG000|Overall Study|Non-compliance With Study Drug|0|||
160460896|NCT02467270|579420275|FG001|Overall Study|Non-compliance With Study Drug|2|||
160460897|NCT02467270|579420276|FG002|Overall Study|Non-compliance With Study Drug|1|||
160460898|NCT02467270|579420274|FG000|Overall Study|Lost to Follow-up|2|||
160460899|NCT02467270|579420275|FG001|Overall Study|Lost to Follow-up|1|||
160460900|NCT02467270|579420276|FG002|Overall Study|Lost to Follow-up|0|||
160460901|NCT02467270|579420274|FG000|Overall Study|Pregnancy|0|||
160460902|NCT02467270|579420275|FG001|Overall Study|Pregnancy|1|||
160460903|NCT02467270|579420276|FG002|Overall Study|Pregnancy|0|||
160460904|NCT02467270|579420274|FG000|Overall Study|Physician Decision|0|||
160460905|NCT02467270|579420275|FG001|Overall Study|Physician Decision|4|||
160460906|NCT02467270|579420276|FG002|Overall Study|Physician Decision|1|||
160658508|NCT02849652|580131529|FG002|Overall Study|Lost to Follow-up|116|||
160460907|NCT02467270|579420274|FG000|Overall Study|Withdrawal by Subject|4|||
160460908|NCT02467270|579420275|FG001|Overall Study|Withdrawal by Subject|3|||
160460909|NCT02467270|579420276|FG002|Overall Study|Withdrawal by Subject|5|||
160460910|NCT02467270|579420274|FG000|Overall Study|Reason not Specified|1|||
160460911|NCT02467270|579420275|FG001|Overall Study|Reason not Specified|2|||
160460912|NCT02467270|579420276|FG002|Overall Study|Reason not Specified|1|||
160460913|NCT00495677|579420277|FG000|Stage 1 (25 Days)|Adverse Event|0|||
160460914|NCT00495677|579420278|FG001|Stage 1 (25 Days)|Adverse Event|0|||
160460915|NCT00495677|579420279|FG002|Stage 1 (25 Days)|Adverse Event|1|||
160460916|NCT00495677|579420280|FG003|Stage 1 (25 Days)|Adverse Event|0|||
160460917|NCT00495677|579420281|FG004|Stage 1 (25 Days)|Adverse Event|0|||
160460918|NCT00495677|579420282|FG005|Stage 1 (25 Days)|Adverse Event|0|||
160460919|NCT00495677|579420283|FG006|Stage 1 (25 Days)|Adverse Event|0|||
160460920|NCT05162586|579420285|FG000|Overall Study|Other|0|||
160460921|NCT05162586|579420286|FG001|Overall Study|Other|0|||
160460922|NCT05162586|579420287|FG002|Overall Study|Other|0|||
160460923|NCT05162586|579420288|FG003|Overall Study|Other|0|||
160460924|NCT05162586|579420289|FG004|Overall Study|Other|1|||
160460925|NCT05162586|579420290|FG005|Overall Study|Other|0|||
160460926|NCT05162586|579420291|FG006|Overall Study|Other|2|||
160460927|NCT05162586|579420292|FG007|Overall Study|Other|2|||
160460928|NCT05162586|579420285|FG000|Overall Study|Lack of Efficacy|0|||
160460929|NCT05162586|579420286|FG001|Overall Study|Lack of Efficacy|0|||
160460930|NCT05162586|579420287|FG002|Overall Study|Lack of Efficacy|0|||
160460931|NCT05162586|579420288|FG003|Overall Study|Lack of Efficacy|0|||
160460932|NCT05162586|579420289|FG004|Overall Study|Lack of Efficacy|1|||
160460933|NCT05162586|579420290|FG005|Overall Study|Lack of Efficacy|0|||
160460934|NCT05162586|579420291|FG006|Overall Study|Lack of Efficacy|0|||
160460935|NCT05162586|579420292|FG007|Overall Study|Lack of Efficacy|1|||
160460936|NCT05162586|579420285|FG000|Overall Study|Lost to Follow-up|0|||
160460937|NCT05162586|579420286|FG001|Overall Study|Lost to Follow-up|0|||
160460938|NCT05162586|579420287|FG002|Overall Study|Lost to Follow-up|0|||
160460939|NCT05162586|579420288|FG003|Overall Study|Lost to Follow-up|0|||
160460940|NCT05162586|579420289|FG004|Overall Study|Lost to Follow-up|2|||
160460941|NCT05162586|579420290|FG005|Overall Study|Lost to Follow-up|0|||
160460942|NCT05162586|579420291|FG006|Overall Study|Lost to Follow-up|0|||
160460943|NCT05162586|579420292|FG007|Overall Study|Lost to Follow-up|2|||
160460944|NCT05162586|579420285|FG000|Overall Study|Non-Compliance|0|||
160460945|NCT05162586|579420286|FG001|Overall Study|Non-Compliance|1|||
160460946|NCT05162586|579420287|FG002|Overall Study|Non-Compliance|0|||
160460947|NCT05162586|579420288|FG003|Overall Study|Non-Compliance|0|||
160460948|NCT05162586|579420289|FG004|Overall Study|Non-Compliance|1|||
160460949|NCT05162586|579420290|FG005|Overall Study|Non-Compliance|0|||
160460950|NCT05162586|579420291|FG006|Overall Study|Non-Compliance|0|||
160460951|NCT05162586|579420292|FG007|Overall Study|Non-Compliance|1|||
160460952|NCT05162586|579420285|FG000|Overall Study|Withdrawal by Subject|2|||
160460953|NCT05162586|579420286|FG001|Overall Study|Withdrawal by Subject|0|||
160460954|NCT05162586|579420287|FG002|Overall Study|Withdrawal by Subject|0|||
160460955|NCT05162586|579420288|FG003|Overall Study|Withdrawal by Subject|0|||
160460956|NCT05162586|579420289|FG004|Overall Study|Withdrawal by Subject|7|||
160594506|NCT01641991|579892500|FG000|Overall Study|Adverse Event|2|||
160460957|NCT05162586|579420290|FG005|Overall Study|Withdrawal by Subject|6|||
160460958|NCT05162586|579420291|FG006|Overall Study|Withdrawal by Subject|2|||
160460959|NCT05162586|579420292|FG007|Overall Study|Withdrawal by Subject|2|||
160460960|NCT05162586|579420285|FG000|Overall Study|Adverse Event|2|||
160460961|NCT05162586|579420286|FG001|Overall Study|Adverse Event|0|||
160460962|NCT05162586|579420287|FG002|Overall Study|Adverse Event|1|||
160460963|NCT05162586|579420288|FG003|Overall Study|Adverse Event|2|||
160460964|NCT05162586|579420289|FG004|Overall Study|Adverse Event|4|||
160460965|NCT05162586|579420290|FG005|Overall Study|Adverse Event|1|||
160594507|NCT01641991|579892501|FG001|Overall Study|Adverse Event|1|||
160460966|NCT05162586|579420291|FG006|Overall Study|Adverse Event|5|||
160460967|NCT05162586|579420292|FG007|Overall Study|Adverse Event|2|||
160460968|NCT00357682|579420295|FG000|Overall Study|Did not receive allocated Treatment|10|||
160594508|NCT01641991|579892502|FG002|Overall Study|Adverse Event|2|||
160594509|NCT01641991|579892503|FG003|Overall Study|Adverse Event|1|||
160460969|NCT00357682|579420296|FG001|Overall Study|Did not receive allocated Treatment|9|||
160460970|NCT00357682|579420297|FG002|Overall Study|Did not receive allocated Treatment|9|||
160460971|NCT00357682|579420298|FG003|Overall Study|Did not receive allocated Treatment|10|||
160460972|NCT00357682|579420295|FG000|Overall Study|Withdrew consent|6|||
160460973|NCT00357682|579420296|FG001|Overall Study|Withdrew consent|6|||
160460974|NCT00357682|579420297|FG002|Overall Study|Withdrew consent|5|||
160460975|NCT00357682|579420298|FG003|Overall Study|Withdrew consent|5|||
160460976|NCT00357682|579420295|FG000|Overall Study|Lost to Follow-up|39|||
160460977|NCT00357682|579420296|FG001|Overall Study|Lost to Follow-up|33|||
160460978|NCT00357682|579420297|FG002|Overall Study|Lost to Follow-up|26|||
160460979|NCT00357682|579420298|FG003|Overall Study|Lost to Follow-up|35|||
160460980|NCT00357682|579420295|FG000|Overall Study|Adverse Event|24|||
160460981|NCT00357682|579420296|FG001|Overall Study|Adverse Event|32|||
160460982|NCT00357682|579420297|FG002|Overall Study|Adverse Event|22|||
160460983|NCT00357682|579420298|FG003|Overall Study|Adverse Event|27|||
160460984|NCT00357682|579420295|FG000|Overall Study|Physician Decision|32|||
160460985|NCT00357682|579420296|FG001|Overall Study|Physician Decision|20|||
160460986|NCT00357682|579420297|FG002|Overall Study|Physician Decision|24|||
160460987|NCT00357682|579420298|FG003|Overall Study|Physician Decision|30|||
160460988|NCT00357682|579420295|FG000|Overall Study|Patient decision|73|||
160460989|NCT00357682|579420296|FG001|Overall Study|Patient decision|80|||
160460990|NCT00357682|579420297|FG002|Overall Study|Patient decision|51|||
160460991|NCT00357682|579420298|FG003|Overall Study|Patient decision|59|||
160460992|NCT00357682|579420295|FG000|Overall Study|Other reason|157|||
160460993|NCT00357682|579420296|FG001|Overall Study|Other reason|130|||
160460994|NCT00357682|579420297|FG002|Overall Study|Other reason|114|||
160460995|NCT00357682|579420298|FG003|Overall Study|Other reason|99|||
160460996|NCT05424718|579420303|FG000|Overall Study|Lost to Follow-up|5|||
160460997|NCT05424718|579420304|FG001|Overall Study|Lost to Follow-up|4|||
160460998|NCT04046549|579420305|FG000|Overall Study|Adverse Event|1|||
160460999|NCT04046549|579420305|FG000|Overall Study|Physician Decision|1|||
160461000|NCT04046549|579420305|FG000|Overall Study|Withdrawal by Subject|3|||
160461001|NCT04046549|579420305|FG000|Overall Study|Other, Not Specified|5|||
160461002|NCT03587805|579420307|FG000|Overall Study|Adverse Event|72|||
160461003|NCT03587805|579420307|FG000|Overall Study|Death|1|||
160461004|NCT03587805|579420307|FG000|Overall Study|Lost to Follow-up|78|||
160461005|NCT03587805|579420307|FG000|Overall Study|Withdrawal by Subject|105|||
160461006|NCT03587805|579420307|FG000|Overall Study|Lack of Efficacy|119|||
160461007|NCT03587805|579420307|FG000|Overall Study|Reason unknown|26|||
160461008|NCT03587805|579420307|FG000|Overall Study|COVID_19 pandemic|4|||
160461009|NCT03587805|579420307|FG000|Overall Study|Various reasons|121|||
160461010|NCT03587805|579420307|FG000|Overall Study|Withdrawal by parent/guardian|3|||
160461011|NCT05771467|579420309|FG000|Overall Study|Lost to Follow-up|6|||
160461012|NCT05771467|579420310|FG001|Overall Study|Lost to Follow-up|3|||
160461013|NCT05866926|579420315|FG000|Overall Study|Death|16|||
160461014|NCT05866926|579420316|FG001|Overall Study|Death|9|||
160594510|NCT01641991|579892500|FG000|Overall Study|Lost to Follow-up|0|||
160594511|NCT01641991|579892501|FG001|Overall Study|Lost to Follow-up|2|||
160594512|NCT01641991|579892502|FG002|Overall Study|Lost to Follow-up|3|||
160594513|NCT01641991|579892503|FG003|Overall Study|Lost to Follow-up|1|||
160594514|NCT01641991|579892500|FG000|Overall Study|Protocol Violation|1|||
160594515|NCT01641991|579892501|FG001|Overall Study|Protocol Violation|1|||
160594516|NCT01641991|579892502|FG002|Overall Study|Protocol Violation|3|||
160594517|NCT01641991|579892503|FG003|Overall Study|Protocol Violation|0|||
160594518|NCT01641991|579892500|FG000|Overall Study|Pregnancy|0|||
160594519|NCT01641991|579892501|FG001|Overall Study|Pregnancy|0|||
160594520|NCT01641991|579892502|FG002|Overall Study|Pregnancy|1|||
160594521|NCT01641991|579892503|FG003|Overall Study|Pregnancy|0|||
160594522|NCT01641991|579892500|FG000|Overall Study|no longer eligible|2|||
160594523|NCT01641991|579892501|FG001|Overall Study|no longer eligible|1|||
160594524|NCT01641991|579892502|FG002|Overall Study|no longer eligible|0|||
160594525|NCT01641991|579892503|FG003|Overall Study|no longer eligible|4|||
160594526|NCT03245723|579892512|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
160594527|NCT03245723|579892513|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
160594528|NCT03245723|579892512|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
160594529|NCT03245723|579892513|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
160594530|NCT03245723|579892512|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
160594531|NCT03245723|579892513|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
160594532|NCT03245723|579892512|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
160461015|NCT05866926|579420315|FG000|Overall Study|Lost to Follow-up|0|||
160461016|NCT05866926|579420316|FG001|Overall Study|Lost to Follow-up|1|||
160461017|NCT05866926|579420315|FG000|Overall Study|Adverse Event|1|||
160461018|NCT05866926|579420316|FG001|Overall Study|Adverse Event|0|||
160461019|NCT05866926|579420315|FG000|Overall Study|Withdrawal by Subject|5|||
160461020|NCT05866926|579420316|FG001|Overall Study|Withdrawal by Subject|1|||
160461021|NCT05866926|579420315|FG000|Overall Study|Disease progression|1|||
160461022|NCT05866926|579420316|FG001|Overall Study|Disease progression|0|||
160461023|NCT05866926|579420315|FG000|Overall Study|other causes|2|||
160594533|NCT03245723|579892513|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
160594534|NCT00077376|579892516|FG000|Overall Study|Adverse Event|8|||
160594535|NCT00077376|579892516|FG000|Overall Study|Withdrawal by Subject|2|||
160594536|NCT00077376|579892516|FG000|Overall Study|Death|1|||
160594537|NCT00077376|579892516|FG000|Overall Study|Physician Decision|1|||
160594538|NCT00077376|579892516|FG000|Overall Study|Alternative therapy|5|||
160594539|NCT00077376|579892516|FG000|Overall Study|Complicating disease|1|||
160594540|NCT00077376|579892516|FG000|Overall Study|Still on treatment|1|||
160594541|NCT00077376|579892516|FG000|Overall Study|Symptomatic deterioration|1|||
160594542|NCT00077376|579892516|FG000|Overall Study|Surgery|1|||
160594543|NCT00077376|579892516|FG000|Overall Study|Insurance ran out|1|||
160594544|NCT03784027|579892517|FG000|Period 1|Withdrawal by Subject|0|||
160594545|NCT03784027|579892518|FG001|Period 1|Withdrawal by Subject|1|||
160594546|NCT06025396|579894186|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
160594547|NCT06025396|579894187|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
160594548|NCT06025396|579894188|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
160594549|NCT06025396|579894189|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
160594550|NCT06025396|579894190|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
160594551|NCT06025396|579894186|FG000|Overall Study|Withdrawal by Subject|0|||
160594552|NCT06025396|579894187|FG001|Overall Study|Withdrawal by Subject|1|||
160594553|NCT06025396|579894188|FG002|Overall Study|Withdrawal by Subject|1|||
160594554|NCT06025396|579894189|FG003|Overall Study|Withdrawal by Subject|0|||
160461024|NCT05866926|579420316|FG001|Overall Study|other causes|1|||
160594555|NCT06025396|579894190|FG004|Overall Study|Withdrawal by Subject|0|||
160594556|NCT01512108|579894191|FG000|Overall Study|Adverse Event|9|||
160594557|NCT01512108|579894192|FG001|Overall Study|Adverse Event|4|||
160594558|NCT01512108|579894191|FG000|Overall Study|Protocol Violation|1|||
160461025|NCT00709956|579420317|FG000|Overall Study|Withdrawal by Subject|1|||
160461026|NCT00709956|579420318|FG001|Overall Study|Withdrawal by Subject|1|||
160461027|NCT00709956|579420317|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
160461028|NCT00709956|579420318|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
160461029|NCT01105091|579420319|FG000|Overall Study|Death|2|||
160461030|NCT01105091|579420320|FG001|Overall Study|Death|0|||
160461031|NCT04940624|579420323|FG000|Overall Study|Adverse Event|4|||
160461032|NCT04940624|579420324|FG001|Overall Study|Adverse Event|11|||
160461033|NCT04940624|579420323|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160461034|NCT04940624|579420324|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
160461035|NCT04940624|579420323|FG000|Overall Study|Physician Decision|1|||
160461036|NCT04940624|579420324|FG001|Overall Study|Physician Decision|0|||
160461037|NCT04940624|579420323|FG000|Overall Study|Lost to Follow-up|1|||
160461038|NCT04940624|579420324|FG001|Overall Study|Lost to Follow-up|0|||
160461039|NCT04940624|579420323|FG000|Overall Study|Reason Not Specified|1|||
160461040|NCT04940624|579420324|FG001|Overall Study|Reason Not Specified|0|||
160461041|NCT04479787|579420325|FG000|Through 6 Months|Withdrawal by Subject|16|||
160461042|NCT04479787|579420326|FG001|Through 6 Months|Withdrawal by Subject|14|||
160461043|NCT04479787|579420325|FG000|Through 6 Months|Unsuccessful Trial|17|||
160461044|NCT04479787|579420326|FG001|Through 6 Months|Unsuccessful Trial|0|||
160461045|NCT04479787|579420325|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
160461046|NCT04479787|579420326|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
160461047|NCT04479787|579420325|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
160461048|NCT04479787|579420326|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
160461049|NCT04479787|579420325|FG000|Through 6 Months|Lost to Follow-up|3|||
160461050|NCT04479787|579420326|FG001|Through 6 Months|Lost to Follow-up|2|||
160461051|NCT04479787|579420325|FG000|Through 6 Months|Death|3|||
160461052|NCT04479787|579420326|FG001|Through 6 Months|Death|0|||
160461053|NCT04479787|579420325|FG000|Through 6 Months|Inclusion/Exclusion|2|||
160461054|NCT04479787|579420326|FG001|Through 6 Months|Inclusion/Exclusion|1|||
160461055|NCT04479787|579420325|FG000|Through 6 Months|Subject Became Pregnant|1|||
160461056|NCT04479787|579420326|FG001|Through 6 Months|Subject Became Pregnant|1|||
160461057|NCT04479787|579420325|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
160461058|NCT04479787|579420326|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
160461059|NCT04479787|579420325|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
160461060|NCT04479787|579420326|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
160461061|NCT04479787|579420325|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
160461062|NCT04479787|579420326|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
160461063|NCT04479787|579420325|FG000|After 6 Months|Withdrawal by Subject|3|||
160461064|NCT04479787|579420326|FG001|After 6 Months|Withdrawal by Subject|13|||
160461065|NCT04479787|579420325|FG000|After 6 Months|Unsuccessful Trial|0|||
160461066|NCT04479787|579420326|FG001|After 6 Months|Unsuccessful Trial|7|||
160461067|NCT04479787|579420325|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
160461068|NCT04479787|579420326|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
160461069|NCT04479787|579420325|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
160461070|NCT04479787|579420326|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
160461071|NCT04479787|579420325|FG000|After 6 Months|Death|2|||
160461072|NCT04479787|579420326|FG001|After 6 Months|Death|0|||
160461073|NCT04479787|579420325|FG000|After 6 Months|Lost to Follow-up|1|||
160461074|NCT04479787|579420326|FG001|After 6 Months|Lost to Follow-up|1|||
160461075|NCT04479787|579420325|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
160461076|NCT04479787|579420326|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
160461077|NCT04479787|579420325|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
160461078|NCT04479787|579420326|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
160461079|NCT04479787|579420325|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
160461080|NCT04479787|579420326|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
160461081|NCT04479787|579420325|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
160461082|NCT04479787|579420326|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
160461083|NCT04039113|579420328|FG000|Overall Study|Withdrawal by Subject|8|||
160461084|NCT04039113|579420329|FG001|Overall Study|Withdrawal by Subject|11|||
160461085|NCT04039113|579420328|FG000|Overall Study|Lost to Follow-up|1|||
160461086|NCT04039113|579420329|FG001|Overall Study|Lost to Follow-up|1|||
160461087|NCT04039113|579420328|FG000|Overall Study|Adverse Event|2|||
160461088|NCT04039113|579420329|FG001|Overall Study|Adverse Event|2|||
160461089|NCT04039113|579420328|FG000|Overall Study|Death|2|||
160461090|NCT04039113|579420329|FG001|Overall Study|Death|4|||
160461091|NCT04039113|579420328|FG000|Overall Study|Site Closure|6|||
160461092|NCT04039113|579420329|FG001|Overall Study|Site Closure|0|||
160461093|NCT04039113|579420328|FG000|Overall Study|Failure to meet randomisation criteria|4|||
160594559|NCT01512108|579894192|FG001|Overall Study|Protocol Violation|2|||
160594560|NCT01512108|579894191|FG000|Overall Study|Withdrawal Criteria|1|||
160461094|NCT04039113|579420329|FG001|Overall Study|Failure to meet randomisation criteria|0|||
160461095|NCT02502266|579420871|FG000|Overall Study|Adverse Event|0|||
160461096|NCT02502266|579420872|FG001|Overall Study|Adverse Event|0|||
160461097|NCT02502266|579420873|FG002|Overall Study|Adverse Event|0|||
160461098|NCT02502266|579420874|FG003|Overall Study|Adverse Event|0|||
160461099|NCT02502266|579420875|FG004|Overall Study|Adverse Event|1|||
160461100|NCT02502266|579420876|FG005|Overall Study|Adverse Event|1|||
160461101|NCT02502266|579420877|FG006|Overall Study|Adverse Event|1|||
160461102|NCT02502266|579420871|FG000|Overall Study|Withdrawal by Subject|30|||
160461103|NCT02502266|579420872|FG001|Overall Study|Withdrawal by Subject|15|||
160461104|NCT02502266|579420873|FG002|Overall Study|Withdrawal by Subject|16|||
160461105|NCT02502266|579420874|FG003|Overall Study|Withdrawal by Subject|0|||
160461106|NCT02502266|579420875|FG004|Overall Study|Withdrawal by Subject|0|||
160461107|NCT02502266|579420876|FG005|Overall Study|Withdrawal by Subject|0|||
160461108|NCT02502266|579420877|FG006|Overall Study|Withdrawal by Subject|0|||
160461109|NCT02502266|579420871|FG000|Overall Study|Still on Treatment|0|||
160461110|NCT02502266|579420872|FG001|Overall Study|Still on Treatment|0|||
160461111|NCT02502266|579420873|FG002|Overall Study|Still on Treatment|1|||
160461112|NCT02502266|579420874|FG003|Overall Study|Still on Treatment|0|||
160461113|NCT02502266|579420875|FG004|Overall Study|Still on Treatment|0|||
160461114|NCT02502266|579420876|FG005|Overall Study|Still on Treatment|0|||
160461115|NCT02502266|579420877|FG006|Overall Study|Still on Treatment|0|||
160461116|NCT02502266|579420871|FG000|Overall Study|Other Reasons|19|||
160461117|NCT02502266|579420872|FG001|Overall Study|Other Reasons|6|||
160461118|NCT02502266|579420873|FG002|Overall Study|Other Reasons|14|||
160594561|NCT01512108|579894192|FG001|Overall Study|Withdrawal Criteria|0|||
160594562|NCT01512108|579894191|FG000|Overall Study|Unclassified|11|||
160594563|NCT01512108|579894192|FG001|Overall Study|Unclassified|3|||
160594564|NCT06422377|579894193|FG000|Overall Study|Study Terminated by Sponsor|1|||
160594565|NCT02017899|579894194|FG000|Overall Study|Withdrawal by Subject|0|||
160461119|NCT02502266|579420874|FG003|Overall Study|Other Reasons|0|||
160461120|NCT02502266|579420875|FG004|Overall Study|Other Reasons|1|||
160461121|NCT02502266|579420876|FG005|Overall Study|Other Reasons|1|||
160461122|NCT02502266|579420877|FG006|Overall Study|Other Reasons|0|||
160461123|NCT02502266|579420871|FG000|Overall Study|Arm 4 Discontinued|0|||
160461124|NCT02502266|579420872|FG001|Overall Study|Arm 4 Discontinued|0|||
160461125|NCT02502266|579420873|FG002|Overall Study|Arm 4 Discontinued|0|||
160461126|NCT02502266|579420874|FG003|Overall Study|Arm 4 Discontinued|52|||
160461127|NCT02502266|579420875|FG004|Overall Study|Arm 4 Discontinued|0|||
160461128|NCT02502266|579420876|FG005|Overall Study|Arm 4 Discontinued|0|||
160461129|NCT02502266|579420877|FG006|Overall Study|Arm 4 Discontinued|0|||
160461130|NCT02502266|579420871|FG000|Overall Study|Never treated|0|||
160461131|NCT02502266|579420872|FG001|Overall Study|Never treated|0|||
160461132|NCT02502266|579420873|FG002|Overall Study|Never treated|0|||
160461133|NCT02502266|579420874|FG003|Overall Study|Never treated|0|||
160461134|NCT02502266|579420875|FG004|Overall Study|Never treated|0|||
160461135|NCT02502266|579420876|FG005|Overall Study|Never treated|1|||
160461136|NCT02502266|579420877|FG006|Overall Study|Never treated|0|||
160461137|NCT02306161|579420879|FG000|Overall Study|Death|1|||
160461138|NCT02306161|579420880|FG001|Overall Study|Death|3|||
160461139|NCT02306161|579420879|FG000|Overall Study|Lack of Efficacy|20|||
160461140|NCT02306161|579420880|FG001|Overall Study|Lack of Efficacy|43|||
160461141|NCT02306161|579420879|FG000|Overall Study|Physician Decision|30|||
160461142|NCT02306161|579420880|FG001|Overall Study|Physician Decision|18|||
160461143|NCT02306161|579420879|FG000|Overall Study|Withdrawal by Subject|4|||
160461144|NCT02306161|579420880|FG001|Overall Study|Withdrawal by Subject|0|||
160461145|NCT02306161|579420879|FG000|Overall Study|Ineligible|9|||
160461146|NCT02306161|579420880|FG001|Overall Study|Ineligible|5|||
160461147|NCT03983382|579420883|FG000|Overall Study|Death|1|||
160461148|NCT03983382|579420883|FG000|Overall Study|Lost to Follow-up|3|||
160461149|NCT03983382|579420883|FG000|Overall Study|Physician Decision|2|||
160461150|NCT03983382|579420883|FG000|Overall Study|Withdrawal by Subject|10|||
160461151|NCT03983382|579420883|FG000|Overall Study|Change in cancer treatment|2|||
160461152|NCT02567435|579420890|FG000|Overall Study|Death|1|||
160461153|NCT02567435|579420891|FG001|Overall Study|Death|1|||
160461154|NCT02567435|579420892|FG002|Overall Study|Death|0|||
160461155|NCT02567435|579420893|FG003|Overall Study|Death|0|||
160461156|NCT02567435|579420890|FG000|Overall Study|Ineligible|1|||
160461157|NCT02567435|579420891|FG001|Overall Study|Ineligible|3|||
160461158|NCT02567435|579420892|FG002|Overall Study|Ineligible|0|||
160461159|NCT02567435|579420893|FG003|Overall Study|Ineligible|0|||
160658509|NCT02849652|580131530|FG003|Overall Study|Lost to Follow-up|22|||
160658510|NCT02849652|580131527|FG000|Overall Study|Withdrawal by Subject|10|||
160658511|NCT02849652|580131528|FG001|Overall Study|Withdrawal by Subject|2|||
160658512|NCT02849652|580131529|FG002|Overall Study|Withdrawal by Subject|8|||
160658513|NCT02849652|580131530|FG003|Overall Study|Withdrawal by Subject|4|||
160658514|NCT02545998|580131531|FG000|Overall Study|Lost to Follow-up|12|||
160658515|NCT02545998|580131532|FG001|Overall Study|Lost to Follow-up|3|||
160658516|NCT02545998|580131531|FG000|Overall Study|Withdrawal by Subject|3|||
160658517|NCT02545998|580131532|FG001|Overall Study|Withdrawal by Subject|2|||
160658518|NCT00472290|580131533|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
160461160|NCT02567435|579420890|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
160461161|NCT02567435|579420891|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
160461162|NCT02567435|579420892|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
160461163|NCT02567435|579420893|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
160461164|NCT02166463|579420894|FG000|Overall Study|Lost to Follow-up|0|||
160461165|NCT02166463|579420895|FG001|Overall Study|Lost to Follow-up|1|||
160461166|NCT02166463|579420894|FG000|Overall Study|Physician Decision|10|||
160461167|NCT02166463|579420895|FG001|Overall Study|Physician Decision|10|||
160461168|NCT02166463|579420894|FG000|Overall Study|Ineligible|11|||
160461169|NCT02166463|579420895|FG001|Overall Study|Ineligible|2|||
160461170|NCT02166463|579420894|FG000|Overall Study|Progressive Disease|9|||
160658519|NCT00472290|580131533|FG000|Overall Study|Protocol Specified Criteria|7|||
160461171|NCT02166463|579420895|FG001|Overall Study|Progressive Disease|6|||
160461172|NCT02166463|579420894|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
160461173|NCT02166463|579420895|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
160658520|NCT00472290|580131533|FG000|Overall Study|Administrative Decision|37|||
160658521|NCT00472290|580131533|FG000|Overall Study|Death|3|||
160658522|NCT00472290|580131533|FG000|Overall Study|Lost to Follow-up|1|||
160461174|NCT02166463|579420894|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
160461175|NCT02166463|579420895|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
160461176|NCT02166463|579420894|FG000|Overall Study|Refusal of further protocol therapy|5|||
160461177|NCT02166463|579420895|FG001|Overall Study|Refusal of further protocol therapy|6|||
160461178|NCT00982644|579420898|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
160461179|NCT00982644|579420899|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
160658523|NCT00472290|580131533|FG000|Overall Study|Lack of Efficacy|1|||
160658524|NCT00472290|580131533|FG000|Overall Study|Disease Progression|4|||
160594566|NCT02017899|579894195|FG001|Overall Study|Withdrawal by Subject|0|||
160594567|NCT02017899|579894196|FG002|Overall Study|Withdrawal by Subject|0|||
160594568|NCT02017899|579894197|FG003|Overall Study|Withdrawal by Subject|1|||
160594569|NCT02017899|579894198|FG004|Overall Study|Withdrawal by Subject|1|||
160594570|NCT02017899|579894199|FG005|Overall Study|Withdrawal by Subject|0|||
160461180|NCT00982644|579420898|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
160461181|NCT00982644|579420899|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
160461182|NCT00982644|579420898|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
160461183|NCT00982644|579420899|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
160461184|NCT00982644|579420898|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
160461185|NCT00982644|579420899|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
160461186|NCT00982644|579420898|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
160461187|NCT00982644|579420899|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
160461188|NCT00982644|579420898|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
160461189|NCT00982644|579420899|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
160461190|NCT00982644|579420898|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
160461191|NCT00982644|579420899|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
160461192|NCT00982644|579420898|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
160461193|NCT00982644|579420899|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
160461194|NCT00982644|579420898|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
160461195|NCT00982644|579420899|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
160461196|NCT00982644|579420898|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
160461197|NCT00982644|579420899|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
160461198|NCT03767335|579420906|FG000|Overall Study|Physician Decision|1|||
160461199|NCT03767335|579420907|FG001|Overall Study|Physician Decision|1|||
160461200|NCT03767335|579420908|FG002|Overall Study|Physician Decision|0|||
160461201|NCT03767335|579420906|FG000|Overall Study|Withdrawal by Subject|0|||
160461202|NCT03767335|579420907|FG001|Overall Study|Withdrawal by Subject|0|||
160461203|NCT03767335|579420908|FG002|Overall Study|Withdrawal by Subject|6|||
160461204|NCT03767335|579420906|FG000|Overall Study|Participant excluded from efficacy population|0|||
160461205|NCT03767335|579420907|FG001|Overall Study|Participant excluded from efficacy population|0|||
160461206|NCT03767335|579420908|FG002|Overall Study|Participant excluded from efficacy population|1|||
160461207|NCT03767335|579420906|FG000|Overall Study|Death|0|||
160461208|NCT03767335|579420907|FG001|Overall Study|Death|0|||
160461209|NCT03767335|579420908|FG002|Overall Study|Death|2|||
160461210|NCT03767335|579420906|FG000|Overall Study|Progressive Disease|2|||
160461211|NCT03767335|579420907|FG001|Overall Study|Progressive Disease|2|||
160461212|NCT03767335|579420908|FG002|Overall Study|Progressive Disease|2|||
160461213|NCT03767335|579420906|FG000|Overall Study|Disease progression needing additional medication|0|||
160461214|NCT03767335|579420907|FG001|Overall Study|Disease progression needing additional medication|0|||
160461215|NCT03767335|579420908|FG002|Overall Study|Disease progression needing additional medication|17|||
160461216|NCT03767335|579420906|FG000|Overall Study|Sponsor decision|0|||
160461217|NCT03767335|579420907|FG001|Overall Study|Sponsor decision|0|||
160461218|NCT03767335|579420908|FG002|Overall Study|Sponsor decision|2|||
160461219|NCT03767335|579420906|FG000|Overall Study|Other Medical Reasons|0|||
160461220|NCT03767335|579420907|FG001|Overall Study|Other Medical Reasons|0|||
160461221|NCT03767335|579420908|FG002|Overall Study|Other Medical Reasons|3|||
160461222|NCT03705390|579420909|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
160461223|NCT03705390|579420909|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
160461224|NCT02989662|579420914|FG000|Overall Study|Lost to Follow-up|0|||
160461225|NCT02989662|579420915|FG001|Overall Study|Lost to Follow-up|0|||
160461226|NCT02989662|579420916|FG002|Overall Study|Lost to Follow-up|0|||
160461227|NCT02989662|579420917|FG003|Overall Study|Lost to Follow-up|2|||
160461228|NCT02989662|579420914|FG000|Overall Study|Physician Decision|3|||
160461229|NCT02989662|579420915|FG001|Overall Study|Physician Decision|0|||
160461230|NCT02989662|579420916|FG002|Overall Study|Physician Decision|0|||
160461231|NCT02989662|579420917|FG003|Overall Study|Physician Decision|0|||
160461232|NCT02989662|579420914|FG000|Overall Study|Withdrawal by Subject|1|||
160461233|NCT02989662|579420915|FG001|Overall Study|Withdrawal by Subject|0|||
160461234|NCT02989662|579420916|FG002|Overall Study|Withdrawal by Subject|0|||
160461235|NCT02989662|579420917|FG003|Overall Study|Withdrawal by Subject|0|||
160461236|NCT02726386|579420918|FG000|Overall Study|Adverse Event|17|||
160461237|NCT02726386|579420919|FG001|Overall Study|Adverse Event|20|||
160461238|NCT02726386|579420918|FG000|Overall Study|Withdrawal by Subject|14|||
160461239|NCT02726386|579420919|FG001|Overall Study|Withdrawal by Subject|28|||
160461240|NCT02726386|579420918|FG000|Overall Study|Other reasons|7|||
160461241|NCT02726386|579420919|FG001|Overall Study|Other reasons|8|||
160461242|NCT00353496|579420932|FG000|Overall Study|Adverse Event|1|||
160461243|NCT00353496|579420933|FG001|Overall Study|Adverse Event|0|||
160461244|NCT00353496|579420932|FG000|Overall Study|Protocol Violation|2|||
160461245|NCT00353496|579420933|FG001|Overall Study|Protocol Violation|2|||
160461246|NCT00353496|579420932|FG000|Overall Study|Withdrawal by Subject|3|||
160461247|NCT00353496|579420933|FG001|Overall Study|Withdrawal by Subject|4|||
160461248|NCT00353496|579420932|FG000|Overall Study|Physician Decision|6|||
160461249|NCT00353496|579420933|FG001|Overall Study|Physician Decision|9|||
160461250|NCT00353496|579420932|FG000|Overall Study|Not otherwise specified|4|||
160461251|NCT00353496|579420933|FG001|Overall Study|Not otherwise specified|2|||
160461252|NCT02180867|579420934|FG000|Overall Study|Adverse Event|3|||
160461253|NCT02180867|579420935|FG001|Overall Study|Adverse Event|4|||
160594571|NCT02843178|579894201|FG000|Overall Study|Lost to Follow-up|8|||
160594572|NCT02843178|579894202|FG001|Overall Study|Lost to Follow-up|8|||
160594573|NCT02843178|579894203|FG002|Overall Study|Lost to Follow-up|6|||
160658525|NCT00472290|580131533|FG000|Overall Study|Withdrawal by Subject|5|||
160461254|NCT02180867|579420936|FG002|Overall Study|Adverse Event|1|||
160461255|NCT02180867|579420937|FG003|Overall Study|Adverse Event|5|||
160461256|NCT02180867|579420938|FG004|Overall Study|Adverse Event|0|||
160461257|NCT02180867|579420939|FG005|Overall Study|Adverse Event|0|||
160461258|NCT02180867|579420940|FG006|Overall Study|Adverse Event|0|||
160461259|NCT02180867|579420934|FG000|Overall Study|Death|0|||
160461260|NCT02180867|579420935|FG001|Overall Study|Death|0|||
160461261|NCT02180867|579420936|FG002|Overall Study|Death|0|||
160461262|NCT02180867|579420937|FG003|Overall Study|Death|0|||
160461263|NCT02180867|579420938|FG004|Overall Study|Death|1|||
160461264|NCT02180867|579420939|FG005|Overall Study|Death|0|||
160461265|NCT02180867|579420940|FG006|Overall Study|Death|0|||
160461266|NCT02180867|579420934|FG000|Overall Study|Lack of Efficacy|0|||
160461267|NCT02180867|579420935|FG001|Overall Study|Lack of Efficacy|2|||
160461268|NCT02180867|579420936|FG002|Overall Study|Lack of Efficacy|0|||
160461269|NCT02180867|579420937|FG003|Overall Study|Lack of Efficacy|1|||
160461270|NCT02180867|579420938|FG004|Overall Study|Lack of Efficacy|6|||
160461271|NCT02180867|579420939|FG005|Overall Study|Lack of Efficacy|0|||
160461272|NCT02180867|579420940|FG006|Overall Study|Lack of Efficacy|1|||
160461273|NCT02180867|579420934|FG000|Overall Study|Physician Decision|1|||
160461274|NCT02180867|579420935|FG001|Overall Study|Physician Decision|3|||
160461275|NCT02180867|579420936|FG002|Overall Study|Physician Decision|1|||
160461276|NCT02180867|579420937|FG003|Overall Study|Physician Decision|10|||
160461277|NCT02180867|579420938|FG004|Overall Study|Physician Decision|9|||
160461278|NCT02180867|579420939|FG005|Overall Study|Physician Decision|3|||
160461279|NCT02180867|579420940|FG006|Overall Study|Physician Decision|4|||
160461280|NCT02180867|579420934|FG000|Overall Study|Withdrawal by Subject|0|||
160461281|NCT02180867|579420935|FG001|Overall Study|Withdrawal by Subject|0|||
160461282|NCT02180867|579420936|FG002|Overall Study|Withdrawal by Subject|0|||
160461283|NCT02180867|579420937|FG003|Overall Study|Withdrawal by Subject|1|||
160461284|NCT02180867|579420938|FG004|Overall Study|Withdrawal by Subject|1|||
160461285|NCT02180867|579420939|FG005|Overall Study|Withdrawal by Subject|0|||
160461286|NCT02180867|579420940|FG006|Overall Study|Withdrawal by Subject|0|||
160461287|NCT02180867|579420934|FG000|Overall Study|Ineligible|1|||
160461288|NCT02180867|579420935|FG001|Overall Study|Ineligible|2|||
160461289|NCT02180867|579420936|FG002|Overall Study|Ineligible|0|||
160461290|NCT02180867|579420937|FG003|Overall Study|Ineligible|3|||
160461291|NCT02180867|579420938|FG004|Overall Study|Ineligible|5|||
160461292|NCT02180867|579420939|FG005|Overall Study|Ineligible|0|||
160461293|NCT02180867|579420940|FG006|Overall Study|Ineligible|0|||
160461294|NCT02180867|579420934|FG000|Overall Study|Repeat Eligibility Studies|0|||
160461295|NCT02180867|579420935|FG001|Overall Study|Repeat Eligibility Studies|0|||
160461296|NCT02180867|579420936|FG002|Overall Study|Repeat Eligibility Studies|0|||
160461297|NCT02180867|579420937|FG003|Overall Study|Repeat Eligibility Studies|0|||
160461298|NCT02180867|579420938|FG004|Overall Study|Repeat Eligibility Studies|1|||
160461299|NCT02180867|579420939|FG005|Overall Study|Repeat Eligibility Studies|0|||
160461300|NCT02180867|579420940|FG006|Overall Study|Repeat Eligibility Studies|0|||
160461301|NCT02180867|579420934|FG000|Overall Study|Refusal of further protocol therapy|1|||
160461302|NCT02180867|579420935|FG001|Overall Study|Refusal of further protocol therapy|0|||
160461303|NCT02180867|579420936|FG002|Overall Study|Refusal of further protocol therapy|2|||
160461304|NCT02180867|579420937|FG003|Overall Study|Refusal of further protocol therapy|6|||
160461305|NCT02180867|579420938|FG004|Overall Study|Refusal of further protocol therapy|4|||
160461306|NCT02180867|579420939|FG005|Overall Study|Refusal of further protocol therapy|0|||
160461307|NCT02180867|579420940|FG006|Overall Study|Refusal of further protocol therapy|0|||
160461308|NCT00945724|579420941|FG000|Overall Study|Withdrawal by Subject|2|||
160461309|NCT00945724|579420941|FG000|Overall Study|Physician Decision|1|||
160461310|NCT00945724|579420941|FG000|Overall Study|Adverse Event|5|||
160461311|NCT00945724|579420941|FG000|Overall Study|Second malignancy|1|||
160461312|NCT00557492|579421556|FG000|Overall Study|Change in health insurance|1|||
160461313|NCT01260896|579421563|FG000|First Intervention|Withdrawn Due to Emesis|2|||
160461314|NCT01260896|579421564|FG001|First Intervention|Withdrawn Due to Emesis|0|||
160461315|NCT05030584|579421570|FG000|Overall Study|Adverse Event|17|||
160461316|NCT05030584|579421571|FG001|Overall Study|Adverse Event|2|||
160461317|NCT05030584|579421570|FG000|Overall Study|Lack of Efficacy|0|||
160461318|NCT05030584|579421571|FG001|Overall Study|Lack of Efficacy|6|||
160461319|NCT05030584|579421570|FG000|Overall Study|Lost to Follow-up|5|||
160461320|NCT05030584|579421571|FG001|Overall Study|Lost to Follow-up|2|||
160461321|NCT05030584|579421570|FG000|Overall Study|Non-Compliance with Study Drug|2|||
160461322|NCT05030584|579421571|FG001|Overall Study|Non-Compliance with Study Drug|3|||
160461323|NCT05030584|579421570|FG000|Overall Study|Other reason|4|||
160461324|NCT05030584|579421571|FG001|Overall Study|Other reason|3|||
160461325|NCT05030584|579421570|FG000|Overall Study|Physician Decision|1|||
160461326|NCT05030584|579421571|FG001|Overall Study|Physician Decision|4|||
160461327|NCT05030584|579421570|FG000|Overall Study|Protocol Violation|0|||
160461328|NCT05030584|579421571|FG001|Overall Study|Protocol Violation|2|||
160461329|NCT05030584|579421570|FG000|Overall Study|Randomized by Mistake|0|||
160461330|NCT05030584|579421571|FG001|Overall Study|Randomized by Mistake|2|||
160461331|NCT05030584|579421570|FG000|Overall Study|Withdrawal by Subject|21|||
160461332|NCT05030584|579421571|FG001|Overall Study|Withdrawal by Subject|28|||
160461333|NCT05030584|579421570|FG000|Overall Study|Technical Problems|0|||
160461334|NCT05030584|579421571|FG001|Overall Study|Technical Problems|1|||
160461335|NCT05030584|579421570|FG000|Overall Study|Completed post-treatment/FU visits|41|||
160461336|NCT05030584|579421571|FG001|Overall Study|Completed post-treatment/FU visits|31|||
160461337|NCT03047213|579421572|FG000|Overall Study|Withdrawal by Subject|2|||
160461338|NCT03047213|579421573|FG001|Overall Study|Withdrawal by Subject|0|||
160461339|NCT03047213|579421572|FG000|Overall Study|Adverse Event|2|||
160461340|NCT03047213|579421573|FG001|Overall Study|Adverse Event|0|||
160461341|NCT06393127|579421575|FG000|Washout period|Withdrawal by Subject|1|||
160461342|NCT06393127|579421576|FG001|Washout period|Withdrawal by Subject|0|||
160461343|NCT06393127|579421575|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
160461344|NCT06393127|579421576|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
160461345|NCT02446600|579421577|FG000|Overall Study|Never treated|20|||
160461346|NCT02446600|579421578|FG001|Overall Study|Never treated|2|||
160461347|NCT02446600|579421579|FG002|Overall Study|Never treated|6|||
160461348|NCT02446600|579421580|FG003|Overall Study|Never treated|0|||
160461349|NCT02446600|579421577|FG000|Overall Study|Withdrawal by Subject|19|||
160461350|NCT02446600|579421578|FG001|Overall Study|Withdrawal by Subject|5|||
160461351|NCT02446600|579421579|FG002|Overall Study|Withdrawal by Subject|17|||
160461352|NCT02446600|579421580|FG003|Overall Study|Withdrawal by Subject|0|||
160461353|NCT02446600|579421577|FG000|Overall Study|Ineligible|1|||
160461354|NCT02446600|579421578|FG001|Overall Study|Ineligible|4|||
160461355|NCT02446600|579421579|FG002|Overall Study|Ineligible|4|||
160461356|NCT02446600|579421580|FG003|Overall Study|Ineligible|1|||
160461357|NCT02446600|579421577|FG000|Overall Study|Duplicate Enrollment|0|||
160461358|NCT02446600|579421578|FG001|Overall Study|Duplicate Enrollment|1|||
160461359|NCT02446600|579421579|FG002|Overall Study|Duplicate Enrollment|0|||
160461360|NCT02446600|579421580|FG003|Overall Study|Duplicate Enrollment|0|||
160461361|NCT00328783|579421581|FG000|Overall Study|Could not tolerate ABC|21|||
160461362|NCT00328783|579421581|FG000|Overall Study|No heart in RT field|4|||
160461363|NCT00328783|579421581|FG000|Overall Study|Withdrawal by Subject|1|||
160461364|NCT03660930|579421582|FG000|Overall Study|Adverse Event|0|||
160461365|NCT03660930|579421583|FG001|Overall Study|Adverse Event|0|||
160461366|NCT03660930|579421584|FG002|Overall Study|Adverse Event|0|||
160461367|NCT03660930|579421585|FG003|Overall Study|Adverse Event|2|||
160461368|NCT03660930|579421586|FG004|Overall Study|Adverse Event|0|||
160461369|NCT03660930|579421587|FG005|Overall Study|Adverse Event|1|||
160461370|NCT03660930|579421588|FG006|Overall Study|Adverse Event|0|||
160461371|NCT03660930|579421589|FG007|Overall Study|Adverse Event|0|||
160461372|NCT03660930|579421582|FG000|Overall Study|Withdrawal by Subject|0|||
160461373|NCT03660930|579421583|FG001|Overall Study|Withdrawal by Subject|0|||
160461374|NCT03660930|579421584|FG002|Overall Study|Withdrawal by Subject|0|||
160461375|NCT03660930|579421585|FG003|Overall Study|Withdrawal by Subject|0|||
160461376|NCT03660930|579421586|FG004|Overall Study|Withdrawal by Subject|0|||
160461377|NCT03660930|579421587|FG005|Overall Study|Withdrawal by Subject|1|||
160461378|NCT03660930|579421588|FG006|Overall Study|Withdrawal by Subject|0|||
160461379|NCT03660930|579421589|FG007|Overall Study|Withdrawal by Subject|0|||
160461380|NCT03725332|579421590|FG000|Overall Study|Adverse Event|5|||
160461381|NCT03725332|579421591|FG001|Overall Study|Adverse Event|10|||
160461382|NCT03725332|579421590|FG000|Overall Study|Death|1|||
160461383|NCT03725332|579421591|FG001|Overall Study|Death|3|||
160461384|NCT03725332|579421590|FG000|Overall Study|Lost to Follow-up|43|||
160461385|NCT03725332|579421591|FG001|Overall Study|Lost to Follow-up|122|||
160461386|NCT03725332|579421590|FG000|Overall Study|Withdrawal by Subject|0|||
160461387|NCT03725332|579421591|FG001|Overall Study|Withdrawal by Subject|1|||
160461388|NCT03725332|579421590|FG000|Overall Study|Duplicate enrollment|0|||
160461389|NCT03725332|579421591|FG001|Overall Study|Duplicate enrollment|1|||
160461390|NCT03725332|579421590|FG000|Overall Study|Did not consent|0|||
160594574|NCT02843178|579894204|FG003|Overall Study|Lost to Follow-up|3|||
160594575|NCT02843178|579894201|FG000|Overall Study|Withdrawal by Subject|0|||
160461391|NCT03725332|579421591|FG001|Overall Study|Did not consent|1|||
160461392|NCT03242915|579421598|FG000|Overall Study|Adverse Event|5|||
160461393|NCT03242915|579421599|FG001|Overall Study|Adverse Event|1|||
160461394|NCT03242915|579421598|FG000|Overall Study|Withdrawal by Subject|0|||
160461395|NCT03242915|579421599|FG001|Overall Study|Withdrawal by Subject|2|||
160461396|NCT03242915|579421598|FG000|Overall Study|Physician Decision|4|||
160461397|NCT03242915|579421599|FG001|Overall Study|Physician Decision|1|||
160461398|NCT02112916|579421602|FG000|Overall Study|Adverse Event|6|||
160461399|NCT02112916|579421603|FG001|Overall Study|Adverse Event|9|||
160461400|NCT02112916|579421604|FG002|Overall Study|Adverse Event|3|||
160461401|NCT02112916|579421605|FG003|Overall Study|Adverse Event|2|||
160461402|NCT02112916|579421602|FG000|Overall Study|Death|9|||
160461403|NCT02112916|579421603|FG001|Overall Study|Death|9|||
160461404|NCT02112916|579421604|FG002|Overall Study|Death|3|||
160461405|NCT02112916|579421605|FG003|Overall Study|Death|4|||
160461406|NCT02112916|579421602|FG000|Overall Study|Lost to Follow-up|1|||
160461407|NCT02112916|579421603|FG001|Overall Study|Lost to Follow-up|0|||
160461408|NCT02112916|579421604|FG002|Overall Study|Lost to Follow-up|0|||
160461409|NCT02112916|579421605|FG003|Overall Study|Lost to Follow-up|0|||
160461410|NCT02112916|579421602|FG000|Overall Study|Physician Decision|94|||
160461411|NCT02112916|579421603|FG001|Overall Study|Physician Decision|72|||
160461412|NCT02112916|579421604|FG002|Overall Study|Physician Decision|24|||
160461413|NCT02112916|579421605|FG003|Overall Study|Physician Decision|15|||
160461414|NCT02112916|579421602|FG000|Overall Study|Withdrawal by Subject|5|||
160461415|NCT02112916|579421603|FG001|Overall Study|Withdrawal by Subject|3|||
160461416|NCT02112916|579421604|FG002|Overall Study|Withdrawal by Subject|1|||
160461417|NCT02112916|579421605|FG003|Overall Study|Withdrawal by Subject|1|||
160461418|NCT02112916|579421602|FG000|Overall Study|Ineligible|4|||
160461419|NCT02112916|579421603|FG001|Overall Study|Ineligible|8|||
160461420|NCT02112916|579421604|FG002|Overall Study|Ineligible|3|||
160461421|NCT02112916|579421605|FG003|Overall Study|Ineligible|8|||
160461422|NCT02112916|579421602|FG000|Overall Study|Inevaluable|6|||
160461423|NCT02112916|579421603|FG001|Overall Study|Inevaluable|4|||
160461424|NCT02112916|579421604|FG002|Overall Study|Inevaluable|5|||
160461425|NCT02112916|579421605|FG003|Overall Study|Inevaluable|5|||
160461426|NCT02112916|579421602|FG000|Overall Study|Refusal of further protocol therapy|19|||
160461427|NCT02112916|579421603|FG001|Overall Study|Refusal of further protocol therapy|16|||
160461428|NCT02112916|579421604|FG002|Overall Study|Refusal of further protocol therapy|1|||
160461429|NCT02112916|579421605|FG003|Overall Study|Refusal of further protocol therapy|7|||
160461430|NCT02112916|579421602|FG000|Overall Study|Development of SMN|1|||
160461431|NCT02112916|579421603|FG001|Overall Study|Development of SMN|0|||
160461432|NCT02112916|579421604|FG002|Overall Study|Development of SMN|0|||
160461433|NCT02112916|579421605|FG003|Overall Study|Development of SMN|1|||
160461434|NCT02112916|579421602|FG000|Overall Study|Relapse/Progression|10|||
160461435|NCT02112916|579421603|FG001|Overall Study|Relapse/Progression|18|||
160461436|NCT02112916|579421604|FG002|Overall Study|Relapse/Progression|15|||
160461437|NCT02112916|579421605|FG003|Overall Study|Relapse/Progression|2|||
160461438|NCT02112916|579421602|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
160461439|NCT02112916|579421603|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
160461440|NCT02112916|579421604|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
160461441|NCT02112916|579421605|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
160461442|NCT02112916|579421602|FG000|Overall Study|Still on Therapy|44|||
160461443|NCT02112916|579421603|FG001|Overall Study|Still on Therapy|47|||
160461444|NCT02112916|579421604|FG002|Overall Study|Still on Therapy|3|||
160461445|NCT02112916|579421605|FG003|Overall Study|Still on Therapy|2|||
160461446|NCT02112916|579421602|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
160658526|NCT00472290|580131533|FG000|Overall Study|Adverse Event|6|||
160658527|NCT00472290|580131533|FG000|Overall Study|Requirement for alternative therapy|7|||
160658528|NCT00777829|580131534|FG000|Overall Study|Withdrawal by Subject|0|||
160461447|NCT02112916|579421603|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
160461448|NCT02112916|579421604|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
160461449|NCT02112916|579421605|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
160461450|NCT02112916|579421602|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
160461451|NCT02112916|579421603|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
160461452|NCT02112916|579421604|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
160461453|NCT02112916|579421605|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
160461454|NCT03333915|579421607|FG000|Overall Study|Lost to Follow-up|0|||
160461455|NCT03333915|579421608|FG001|Overall Study|Lost to Follow-up|0|||
160658529|NCT00777829|580131535|FG001|Overall Study|Withdrawal by Subject|2|||
160461456|NCT03333915|579421609|FG002|Overall Study|Lost to Follow-up|1|||
160461457|NCT03333915|579421610|FG003|Overall Study|Lost to Follow-up|0|||
160461458|NCT03333915|579421611|FG004|Overall Study|Lost to Follow-up|0|||
160461459|NCT03333915|579421607|FG000|Overall Study|Disease Progression|0|||
160461460|NCT03333915|579421608|FG001|Overall Study|Disease Progression|1|||
160461461|NCT03333915|579421609|FG002|Overall Study|Disease Progression|0|||
160461462|NCT03333915|579421610|FG003|Overall Study|Disease Progression|0|||
160461463|NCT03333915|579421611|FG004|Overall Study|Disease Progression|0|||
160461464|NCT03333915|579421607|FG000|Overall Study|Death|0|||
160461465|NCT03333915|579421608|FG001|Overall Study|Death|0|||
160461466|NCT03333915|579421609|FG002|Overall Study|Death|0|||
160461467|NCT03333915|579421610|FG003|Overall Study|Death|37|||
160461468|NCT03333915|579421611|FG004|Overall Study|Death|18|||
160461469|NCT03333915|579421607|FG000|Overall Study|Sponsor's Decision|0|||
160461470|NCT03333915|579421608|FG001|Overall Study|Sponsor's Decision|0|||
160461471|NCT03333915|579421609|FG002|Overall Study|Sponsor's Decision|0|||
160461472|NCT03333915|579421610|FG003|Overall Study|Sponsor's Decision|48|||
160461473|NCT03333915|579421611|FG004|Overall Study|Sponsor's Decision|4|||
160461474|NCT03333915|579421607|FG000|Overall Study|Withdrawal by Subject|0|||
160461475|NCT03333915|579421608|FG001|Overall Study|Withdrawal by Subject|0|||
160461476|NCT03333915|579421609|FG002|Overall Study|Withdrawal by Subject|0|||
160461477|NCT03333915|579421610|FG003|Overall Study|Withdrawal by Subject|5|||
160461478|NCT03333915|579421611|FG004|Overall Study|Withdrawal by Subject|1|||
160461479|NCT02206828|579421625|FG000|Overall Study|Lost to Follow-up|7|||
160461480|NCT05039021|579422139|FG000|Overall Study|Death|1|||
160461481|NCT05039021|579422139|FG000|Overall Study|Lost to Follow-up|3|||
160461482|NCT00994643|579422140|FG000|Overall Study|Withdrawal by Subject|1|||
160461483|NCT02566889|579422141|FG000|Overall Study|Withdrawal by Subject|3|||
160461484|NCT02566889|579422142|FG001|Overall Study|Withdrawal by Subject|1|||
160461485|NCT02566889|579422141|FG000|Overall Study|Adverse Event|4|||
160461486|NCT02566889|579422142|FG001|Overall Study|Adverse Event|2|||
160461487|NCT02566889|579422141|FG000|Overall Study|Other|6|||
160461488|NCT02566889|579422142|FG001|Overall Study|Other|2|||
160461489|NCT03391466|579422144|FG000|Overall Study|Death|84|||
160461490|NCT03391466|579422145|FG001|Overall Study|Death|91|||
160461491|NCT03391466|579422144|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
160461492|NCT03391466|579422145|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
160461493|NCT03391466|579422144|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
160461494|NCT03391466|579422145|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
160461495|NCT03391466|579422144|FG000|Overall Study|Lost to Follow-up|9|||
160461496|NCT03391466|579422145|FG001|Overall Study|Lost to Follow-up|5|||
160461497|NCT03391466|579422144|FG000|Overall Study|Reason Not Specified|2|||
160461498|NCT03391466|579422145|FG001|Overall Study|Reason Not Specified|2|||
160461499|NCT03391466|579422144|FG000|Overall Study|Investigator Decision|0|||
160461500|NCT03391466|579422145|FG001|Overall Study|Investigator Decision|1|||
160461501|NCT03140670|579422146|FG000|Overall Study|Withdrawal by Subject|2|||
160461502|NCT03140670|579422146|FG000|Overall Study|Lost to Follow-up|1|||
160594576|NCT02843178|579894202|FG001|Overall Study|Withdrawal by Subject|0|||
160594577|NCT02843178|579894203|FG002|Overall Study|Withdrawal by Subject|1|||
160594578|NCT02843178|579894204|FG003|Overall Study|Withdrawal by Subject|1|||
160594579|NCT02420795|579894211|FG000|Overall Study|Withdrawal by Subject|1|||
160594580|NCT02420795|579894212|FG001|Overall Study|Withdrawal by Subject|0|||
160594581|NCT02420795|579894213|FG002|Overall Study|Withdrawal by Subject|0|||
160594582|NCT02420795|579894211|FG000|Overall Study|Adverse Event|1|||
160594583|NCT02420795|579894212|FG001|Overall Study|Adverse Event|0|||
160594584|NCT02420795|579894213|FG002|Overall Study|Adverse Event|0|||
160594585|NCT02420795|579894211|FG000|Overall Study|Progressive disease|2|||
160594586|NCT02420795|579894212|FG001|Overall Study|Progressive disease|2|||
160594587|NCT02420795|579894213|FG002|Overall Study|Progressive disease|4|||
160594588|NCT02420795|579894211|FG000|Overall Study|Death|0|||
160594589|NCT02420795|579894212|FG001|Overall Study|Death|0|||
160594590|NCT02420795|579894213|FG002|Overall Study|Death|1|||
160594591|NCT03927911|579894214|FG000|Overall Study|problems with eDiary|0|||
160594592|NCT03927911|579894215|FG001|Overall Study|problems with eDiary|1|||
160461503|NCT03140670|579422146|FG000|Overall Study|Physician Decision|1|||
160594593|NCT03927911|579894216|FG002|Overall Study|problems with eDiary|0|||
160594594|NCT03927911|579894217|FG003|Overall Study|problems with eDiary|1|||
160594595|NCT03927911|579894218|FG004|Overall Study|problems with eDiary|0|||
160594596|NCT03927911|579894219|FG005|Overall Study|problems with eDiary|4|||
160594597|NCT03927911|579894214|FG000|Overall Study|Adverse Event|0|||
160461504|NCT03699163|579422147|FG000|Overall Study|Physician Decision|12|||
160461505|NCT03699163|579422148|FG001|Overall Study|Physician Decision|0|||
160461506|NCT03699163|579422147|FG000|Overall Study|failed QC measures|205|||
160461507|NCT03699163|579422148|FG001|Overall Study|failed QC measures|206|||
160461508|NCT04121546|579422154|FG000|Overall Study|Lost to Follow-up|1|||
160461509|NCT04121546|579422155|FG001|Overall Study|Lost to Follow-up|3|||
160461510|NCT04129164|579422156|FG000|Overall Study|Non-compliance with procedures|0|||
160461511|NCT04129164|579422157|FG001|Overall Study|Non-compliance with procedures|0|||
160461512|NCT04129164|579422158|FG002|Overall Study|Non-compliance with procedures|2|||
160461513|NCT04129164|579422159|FG003|Overall Study|Non-compliance with procedures|0|||
160461514|NCT04129164|579422156|FG000|Overall Study|Adverse Event|0|||
160461515|NCT04129164|579422157|FG001|Overall Study|Adverse Event|0|||
160461516|NCT04129164|579422158|FG002|Overall Study|Adverse Event|2|||
160461517|NCT04129164|579422159|FG003|Overall Study|Adverse Event|0|||
160461518|NCT04129164|579422156|FG000|Overall Study|Pregnancy|0|||
160461519|NCT04129164|579422157|FG001|Overall Study|Pregnancy|0|||
160461520|NCT04129164|579422158|FG002|Overall Study|Pregnancy|0|||
160461521|NCT04129164|579422159|FG003|Overall Study|Pregnancy|1|||
160461522|NCT04129164|579422156|FG000|Overall Study|Withdrawal by Subject|3|||
160461523|NCT04129164|579422157|FG001|Overall Study|Withdrawal by Subject|2|||
160461524|NCT04129164|579422158|FG002|Overall Study|Withdrawal by Subject|4|||
160461525|NCT04129164|579422159|FG003|Overall Study|Withdrawal by Subject|6|||
160461526|NCT04129164|579422156|FG000|Overall Study|Death|0|||
160461527|NCT04129164|579422157|FG001|Overall Study|Death|1|||
160461528|NCT04129164|579422158|FG002|Overall Study|Death|0|||
160461529|NCT04129164|579422159|FG003|Overall Study|Death|0|||
160461530|NCT04129164|579422156|FG000|Overall Study|Lost to Follow-up|0|||
160461531|NCT04129164|579422157|FG001|Overall Study|Lost to Follow-up|1|||
160461532|NCT04129164|579422158|FG002|Overall Study|Lost to Follow-up|0|||
160461533|NCT04129164|579422159|FG003|Overall Study|Lost to Follow-up|0|||
160461534|NCT03653364|579422160|FG000|Overall Study|Withdrawal by Subject|1|||
160461535|NCT03653364|579422160|FG000|Overall Study|Enrolled in Error|1|||
160461536|NCT03653364|579422160|FG000|Overall Study|Death|1|||
160461537|NCT02466971|579422165|FG000|Overall Study|eligible and never treated|14|||
160461538|NCT02466971|579422166|FG001|Overall Study|eligible and never treated|20|||
160461539|NCT02466971|579422165|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
160461540|NCT02466971|579422166|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
160461541|NCT02466971|579422165|FG000|Overall Study|ineligible and treated|1|||
160461542|NCT02466971|579422166|FG001|Overall Study|ineligible and treated|0|||
160461543|NCT02466971|579422165|FG000|Overall Study|ineligible and never treated|0|||
160461544|NCT02466971|579422166|FG001|Overall Study|ineligible and never treated|1|||
160461545|NCT02754596|579422167|FG000|Overall Study|Withdrawal by Subject|3|||
160461546|NCT02754596|579422168|FG001|Overall Study|Withdrawal by Subject|4|||
160461547|NCT02754596|579422169|FG002|Overall Study|Withdrawal by Subject|0|||
160461548|NCT02754596|579422167|FG000|Overall Study|Physician Decision|1|||
160461549|NCT02754596|579422168|FG001|Overall Study|Physician Decision|1|||
160461550|NCT02754596|579422169|FG002|Overall Study|Physician Decision|1|||
160461551|NCT02754596|579422167|FG000|Overall Study|Lost to Follow-up|1|||
160461552|NCT02754596|579422168|FG001|Overall Study|Lost to Follow-up|1|||
160461553|NCT02754596|579422169|FG002|Overall Study|Lost to Follow-up|2|||
160461554|NCT02754596|579422167|FG000|Overall Study|Death|0|||
160461555|NCT02754596|579422168|FG001|Overall Study|Death|2|||
160461556|NCT02754596|579422169|FG002|Overall Study|Death|0|||
160461557|NCT02754596|579422167|FG000|Overall Study|Adverse Event|1|||
160461558|NCT02754596|579422168|FG001|Overall Study|Adverse Event|0|||
160461559|NCT02754596|579422169|FG002|Overall Study|Adverse Event|1|||
160461560|NCT02754596|579422167|FG000|Overall Study|Other|1|||
160461561|NCT02754596|579422168|FG001|Overall Study|Other|0|||
160461562|NCT02754596|579422169|FG002|Overall Study|Other|0|||
160461563|NCT02101853|579422171|FG000|Block 1 Induction|Adverse Event|11|||
160461564|NCT02101853|579422172|FG001|Block 1 Induction|Adverse Event|0|||
160461565|NCT02101853|579422173|FG002|Block 1 Induction|Adverse Event|0|||
160461566|NCT02101853|579422174|FG003|Block 1 Induction|Adverse Event|0|||
160461567|NCT02101853|579422175|FG004|Block 1 Induction|Adverse Event|0|||
160461568|NCT02101853|579422176|FG005|Block 1 Induction|Adverse Event|0|||
160461569|NCT02101853|579422171|FG000|Block 1 Induction|Death|20|||
160461570|NCT02101853|579422172|FG001|Block 1 Induction|Death|0|||
160461571|NCT02101853|579422173|FG002|Block 1 Induction|Death|0|||
160461572|NCT02101853|579422174|FG003|Block 1 Induction|Death|0|||
160461573|NCT02101853|579422175|FG004|Block 1 Induction|Death|0|||
160461574|NCT02101853|579422176|FG005|Block 1 Induction|Death|0|||
160461575|NCT02101853|579422171|FG000|Block 1 Induction|Lack of Efficacy|6|||
160461576|NCT02101853|579422172|FG001|Block 1 Induction|Lack of Efficacy|0|||
160594598|NCT03927911|579894215|FG001|Overall Study|Adverse Event|0|||
160594599|NCT03927911|579894216|FG002|Overall Study|Adverse Event|0|||
160594600|NCT03927911|579894217|FG003|Overall Study|Adverse Event|0|||
160594601|NCT03927911|579894218|FG004|Overall Study|Adverse Event|0|||
160461577|NCT02101853|579422173|FG002|Block 1 Induction|Lack of Efficacy|0|||
160461578|NCT02101853|579422174|FG003|Block 1 Induction|Lack of Efficacy|0|||
160461579|NCT02101853|579422175|FG004|Block 1 Induction|Lack of Efficacy|0|||
160594602|NCT03927911|579894219|FG005|Overall Study|Adverse Event|1|||
160594603|NCT03927911|579894214|FG000|Overall Study|not treated -study terminated by sponsor|0|||
160461580|NCT02101853|579422176|FG005|Block 1 Induction|Lack of Efficacy|0|||
160461581|NCT02101853|579422171|FG000|Block 1 Induction|Physician Decision|61|||
160461582|NCT02101853|579422172|FG001|Block 1 Induction|Physician Decision|0|||
160461583|NCT02101853|579422173|FG002|Block 1 Induction|Physician Decision|0|||
160461584|NCT02101853|579422174|FG003|Block 1 Induction|Physician Decision|0|||
160461585|NCT02101853|579422175|FG004|Block 1 Induction|Physician Decision|0|||
160461586|NCT02101853|579422176|FG005|Block 1 Induction|Physician Decision|0|||
160461587|NCT02101853|579422171|FG000|Block 1 Induction|Protocol Violation|2|||
160461588|NCT02101853|579422172|FG001|Block 1 Induction|Protocol Violation|0|||
160461589|NCT02101853|579422173|FG002|Block 1 Induction|Protocol Violation|0|||
160461590|NCT02101853|579422174|FG003|Block 1 Induction|Protocol Violation|0|||
160461591|NCT02101853|579422175|FG004|Block 1 Induction|Protocol Violation|0|||
160461592|NCT02101853|579422176|FG005|Block 1 Induction|Protocol Violation|0|||
160658530|NCT00745095|580131537|FG000|Overall Study|Declined to participate|1|||
160461593|NCT02101853|579422171|FG000|Block 1 Induction|Withdrawal by Subject|65|||
160461594|NCT02101853|579422172|FG001|Block 1 Induction|Withdrawal by Subject|0|||
160461595|NCT02101853|579422173|FG002|Block 1 Induction|Withdrawal by Subject|0|||
160594604|NCT03927911|579894215|FG001|Overall Study|not treated -study terminated by sponsor|1|||
160594605|NCT03927911|579894216|FG002|Overall Study|not treated -study terminated by sponsor|0|||
160461596|NCT02101853|579422174|FG003|Block 1 Induction|Withdrawal by Subject|0|||
160594606|NCT03927911|579894217|FG003|Overall Study|not treated -study terminated by sponsor|0|||
160461597|NCT02101853|579422175|FG004|Block 1 Induction|Withdrawal by Subject|0|||
160461598|NCT02101853|579422176|FG005|Block 1 Induction|Withdrawal by Subject|0|||
160461599|NCT02101853|579422171|FG000|Block 1 Induction|Ineligible|8|||
160461600|NCT02101853|579422172|FG001|Block 1 Induction|Ineligible|0|||
160461601|NCT02101853|579422173|FG002|Block 1 Induction|Ineligible|0|||
160461602|NCT02101853|579422174|FG003|Block 1 Induction|Ineligible|0|||
160461603|NCT02101853|579422175|FG004|Block 1 Induction|Ineligible|0|||
160461604|NCT02101853|579422176|FG005|Block 1 Induction|Ineligible|0|||
160461605|NCT02101853|579422171|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
160461606|NCT02101853|579422172|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
160461607|NCT02101853|579422173|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
160461608|NCT02101853|579422174|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
160461609|NCT02101853|579422175|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
160461610|NCT02101853|579422176|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
160461611|NCT02101853|579422171|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
160461612|NCT02101853|579422172|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
160461613|NCT02101853|579422173|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
160461614|NCT02101853|579422174|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
160461615|NCT02101853|579422175|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
160461616|NCT02101853|579422176|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
160461617|NCT02101853|579422171|FG000|Post Induction Randomization|Adverse Event|0|||
160461618|NCT02101853|579422172|FG001|Post Induction Randomization|Adverse Event|3|||
160461619|NCT02101853|579422173|FG002|Post Induction Randomization|Adverse Event|8|||
160461620|NCT02101853|579422174|FG003|Post Induction Randomization|Adverse Event|4|||
160461621|NCT02101853|579422175|FG004|Post Induction Randomization|Adverse Event|4|||
160461622|NCT02101853|579422176|FG005|Post Induction Randomization|Adverse Event|0|||
160461623|NCT02101853|579422171|FG000|Post Induction Randomization|Death|0|||
160461624|NCT02101853|579422172|FG001|Post Induction Randomization|Death|9|||
160461625|NCT02101853|579422173|FG002|Post Induction Randomization|Death|2|||
160461626|NCT02101853|579422174|FG003|Post Induction Randomization|Death|2|||
160461627|NCT02101853|579422175|FG004|Post Induction Randomization|Death|0|||
160461628|NCT02101853|579422176|FG005|Post Induction Randomization|Death|0|||
160461629|NCT02101853|579422171|FG000|Post Induction Randomization|Lack of Efficacy|0|||
160461630|NCT02101853|579422172|FG001|Post Induction Randomization|Lack of Efficacy|14|||
160461631|NCT02101853|579422173|FG002|Post Induction Randomization|Lack of Efficacy|23|||
160461632|NCT02101853|579422174|FG003|Post Induction Randomization|Lack of Efficacy|18|||
160461633|NCT02101853|579422175|FG004|Post Induction Randomization|Lack of Efficacy|21|||
160461634|NCT02101853|579422176|FG005|Post Induction Randomization|Lack of Efficacy|0|||
160461635|NCT02101853|579422171|FG000|Post Induction Randomization|Physician Decision|0|||
160461636|NCT02101853|579422172|FG001|Post Induction Randomization|Physician Decision|43|||
160461637|NCT02101853|579422173|FG002|Post Induction Randomization|Physician Decision|23|||
160461638|NCT02101853|579422174|FG003|Post Induction Randomization|Physician Decision|14|||
160461639|NCT02101853|579422175|FG004|Post Induction Randomization|Physician Decision|14|||
160461640|NCT02101853|579422176|FG005|Post Induction Randomization|Physician Decision|0|||
160461641|NCT02101853|579422171|FG000|Post Induction Randomization|Protocol Violation|0|||
160461642|NCT02101853|579422172|FG001|Post Induction Randomization|Protocol Violation|3|||
160461643|NCT02101853|579422173|FG002|Post Induction Randomization|Protocol Violation|0|||
160461644|NCT02101853|579422174|FG003|Post Induction Randomization|Protocol Violation|0|||
160461645|NCT02101853|579422175|FG004|Post Induction Randomization|Protocol Violation|0|||
160461646|NCT02101853|579422176|FG005|Post Induction Randomization|Protocol Violation|0|||
160461647|NCT02101853|579422171|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
160658531|NCT00745095|580131538|FG001|Overall Study|Declined to participate|0|||
160658532|NCT00745095|580131539|FG002|Overall Study|Declined to participate|0|||
160658533|NCT00745095|580131540|FG003|Overall Study|Declined to participate|0|||
160658534|NCT00745095|580131541|FG004|Overall Study|Declined to participate|92|||
160658535|NCT00745095|580131542|FG005|Overall Study|Declined to participate|95|||
160658536|NCT00745095|580131537|FG000|Overall Study|Ineligible due to GFR criteria|0|||
160658537|NCT00745095|580131538|FG001|Overall Study|Ineligible due to GFR criteria|2|||
160658538|NCT00745095|580131539|FG002|Overall Study|Ineligible due to GFR criteria|3|||
160658539|NCT00745095|580131540|FG003|Overall Study|Ineligible due to GFR criteria|3|||
160658540|NCT00745095|580131541|FG004|Overall Study|Ineligible due to GFR criteria|30|||
160658541|NCT00745095|580131542|FG005|Overall Study|Ineligible due to GFR criteria|28|||
160658542|NCT01226797|580131548|FG000|Overall Study|Adverse Event|1|||
160658543|NCT01226797|580131549|FG001|Overall Study|Adverse Event|0|||
160658544|NCT01226797|580131548|FG000|Overall Study|No longer willing to participate|1|||
160658545|NCT01226797|580131549|FG001|Overall Study|No longer willing to participate|0|||
160658546|NCT01226797|580131548|FG000|Overall Study|Protocol Violation|0|||
160461648|NCT02101853|579422172|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
160461649|NCT02101853|579422173|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
160461650|NCT02101853|579422174|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
160461651|NCT02101853|579422175|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
160658547|NCT01226797|580131549|FG001|Overall Study|Protocol Violation|1|||
160658548|NCT00577460|580131550|FG000|Overall Study|Adverse Event|11|||
160658549|NCT00577460|580131551|FG001|Overall Study|Adverse Event|7|||
160658550|NCT00577460|580131552|FG002|Overall Study|Adverse Event|14|||
160658551|NCT00577460|580131550|FG000|Overall Study|Protocol Violation|0|||
160658552|NCT00577460|580131551|FG001|Overall Study|Protocol Violation|1|||
160658553|NCT00577460|580131552|FG002|Overall Study|Protocol Violation|1|||
160658554|NCT00577460|580131550|FG000|Overall Study|Lost to Follow-up|0|||
160658555|NCT00577460|580131551|FG001|Overall Study|Lost to Follow-up|3|||
160658556|NCT00577460|580131552|FG002|Overall Study|Lost to Follow-up|4|||
160658557|NCT00577460|580131550|FG000|Overall Study|Withdrawal by Subject|5|||
160658558|NCT00577460|580131551|FG001|Overall Study|Withdrawal by Subject|5|||
160658559|NCT00577460|580131552|FG002|Overall Study|Withdrawal by Subject|6|||
160461652|NCT02101853|579422176|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
160461653|NCT02101853|579422171|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
160461654|NCT02101853|579422172|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
160461655|NCT02101853|579422173|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
160461656|NCT02101853|579422174|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
160461657|NCT02101853|579422175|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
160461658|NCT02101853|579422176|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
160461659|NCT02101853|579422171|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
160461660|NCT02101853|579422172|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
160461661|NCT02101853|579422173|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
160461662|NCT02101853|579422174|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
160461663|NCT02101853|579422175|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
160461664|NCT02101853|579422176|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
160461665|NCT02101853|579422171|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
160461666|NCT02101853|579422172|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
160461667|NCT02101853|579422173|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
160461668|NCT02101853|579422174|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
160461669|NCT02101853|579422175|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
160461670|NCT02101853|579422176|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
160461671|NCT02101853|579422171|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
160461672|NCT02101853|579422172|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
160461673|NCT02101853|579422173|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
160461674|NCT02101853|579422174|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
160461675|NCT02101853|579422175|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
160461676|NCT02101853|579422176|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
160461677|NCT02101853|579422171|FG000|Blinatumomab Salvage Therapy|Death|0|||
160461678|NCT02101853|579422172|FG001|Blinatumomab Salvage Therapy|Death|0|||
160461679|NCT02101853|579422173|FG002|Blinatumomab Salvage Therapy|Death|0|||
160461680|NCT02101853|579422174|FG003|Blinatumomab Salvage Therapy|Death|0|||
160461681|NCT02101853|579422175|FG004|Blinatumomab Salvage Therapy|Death|0|||
160461682|NCT02101853|579422176|FG005|Blinatumomab Salvage Therapy|Death|2|||
160461683|NCT02101853|579422171|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
160461684|NCT02101853|579422172|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
160461685|NCT02101853|579422173|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
160461686|NCT02101853|579422174|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
160461687|NCT02101853|579422175|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
160461688|NCT02101853|579422176|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
160461689|NCT02101853|579422171|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
160461690|NCT02101853|579422172|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
160461691|NCT02101853|579422173|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
160461692|NCT02101853|579422174|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
160461693|NCT02101853|579422175|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
160461694|NCT02101853|579422176|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
160461695|NCT02101853|579422171|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
160461696|NCT02101853|579422172|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
160461697|NCT02101853|579422173|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
160461698|NCT02101853|579422174|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
160461699|NCT02101853|579422175|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
160658560|NCT00577460|580131550|FG000|Overall Study|Other|0|||
160658561|NCT00577460|580131551|FG001|Overall Study|Other|3|||
160658562|NCT00577460|580131552|FG002|Overall Study|Other|2|||
160658563|NCT00162123|580131553|FG000|Overall Study|Disease progression|27|||
160658564|NCT00162123|580131554|FG001|Overall Study|Disease progression|19|||
160461700|NCT02101853|579422176|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
160461701|NCT05707351|579422180|FG000|Overall Study|Withdrawal by Subject|2|||
160461702|NCT05707351|579422180|FG000|Overall Study|Reason Not Specified|1|||
160461703|NCT04174560|579422184|FG000|Overall Study|Lost to Follow-up|1|||
160461704|NCT04174560|579422185|FG001|Overall Study|Lost to Follow-up|0|||
160461705|NCT04174560|579422186|FG002|Overall Study|Lost to Follow-up|0|||
160461706|NCT04174560|579422187|FG003|Overall Study|Lost to Follow-up|0|||
160461707|NCT04174560|579422184|FG000|Overall Study|Withdrawal by Subject|0|||
160461708|NCT04174560|579422185|FG001|Overall Study|Withdrawal by Subject|0|||
160461709|NCT04174560|579422186|FG002|Overall Study|Withdrawal by Subject|2|||
160461710|NCT04174560|579422187|FG003|Overall Study|Withdrawal by Subject|0|||
160461711|NCT03782116|579422194|FG000|Completed Intervetion|Lost to Follow-up|11|||
160461712|NCT03782116|579422195|FG001|Completed Intervetion|Lost to Follow-up|7|||
160461713|NCT03782116|579422194|FG000|Completed Intervetion|Withdrawal by Subject|6|||
160461714|NCT03782116|579422195|FG001|Completed Intervetion|Withdrawal by Subject|5|||
160461715|NCT03782116|579422194|FG000|Included in Analysis|Protocol Violation|5|||
160461716|NCT03782116|579422195|FG001|Included in Analysis|Protocol Violation|5|||
160658565|NCT00162123|580131555|FG002|Overall Study|Disease progression|10|||
160658566|NCT00162123|580131556|FG003|Overall Study|Disease progression|4|||
160461717|NCT04908514|579422196|FG000|Overall Study|Lost to Follow-up|2|||
160658567|NCT00162123|580131557|FG004|Overall Study|Disease progression|8|||
160461718|NCT04908514|579422196|FG000|Overall Study|Withdrawal by Subject|1|||
160461719|NCT02890355|579422197|FG000|Overall Study|Adverse Event|5|||
160658568|NCT00162123|580131558|FG005|Overall Study|Disease progression|3|||
160594607|NCT03927911|579894218|FG004|Overall Study|not treated -study terminated by sponsor|0|||
160461720|NCT02890355|579422198|FG001|Overall Study|Adverse Event|5|||
160594608|NCT03927911|579894219|FG005|Overall Study|not treated -study terminated by sponsor|0|||
160461721|NCT02890355|579422197|FG000|Overall Study|Refusal unrelated to adverse event|5|||
160461722|NCT02890355|579422198|FG001|Overall Study|Refusal unrelated to adverse event|10|||
160594609|NCT03927911|579894214|FG000|Overall Study|Surgery cancelled|0|||
160594610|NCT03927911|579894215|FG001|Overall Study|Surgery cancelled|0|||
160594611|NCT03927911|579894216|FG002|Overall Study|Surgery cancelled|0|||
160594612|NCT03927911|579894217|FG003|Overall Study|Surgery cancelled|1|||
160594613|NCT03927911|579894218|FG004|Overall Study|Surgery cancelled|0|||
160594614|NCT03927911|579894219|FG005|Overall Study|Surgery cancelled|1|||
160594615|NCT03927911|579894214|FG000|Overall Study|Protocol Violation|0|||
160594616|NCT03927911|579894215|FG001|Overall Study|Protocol Violation|0|||
160594617|NCT03927911|579894216|FG002|Overall Study|Protocol Violation|0|||
160461723|NCT02890355|579422197|FG000|Overall Study|Progression/relapse|46|||
160461724|NCT02890355|579422198|FG001|Overall Study|Progression/relapse|39|||
160461725|NCT02890355|579422197|FG000|Overall Study|Not protocol specified|3|||
160461726|NCT02890355|579422198|FG001|Overall Study|Not protocol specified|4|||
160461727|NCT04129450|579422200|FG000|Overall Study|Lost to Follow-up|20|||
160461728|NCT04129450|579422201|FG001|Overall Study|Lost to Follow-up|10|||
160461729|NCT04129450|579422200|FG000|Overall Study|Withdrawal by Subject|9|||
160461730|NCT04129450|579422201|FG001|Overall Study|Withdrawal by Subject|5|||
160461731|NCT04129450|579422200|FG000|Overall Study|Work Family Obligations|2|||
160658569|NCT00162123|580131559|FG006|Overall Study|Disease progression|1|||
160658570|NCT00162123|580131560|FG007|Overall Study|Disease progression|0|||
160658571|NCT00162123|580131553|FG000|Overall Study|Study drug toxicity|6|||
160658572|NCT00162123|580131554|FG001|Overall Study|Study drug toxicity|1|||
160658573|NCT00162123|580131555|FG002|Overall Study|Study drug toxicity|5|||
160658574|NCT00162123|580131556|FG003|Overall Study|Study drug toxicity|0|||
160658575|NCT00162123|580131557|FG004|Overall Study|Study drug toxicity|4|||
160658576|NCT00162123|580131558|FG005|Overall Study|Study drug toxicity|1|||
160658577|NCT00162123|580131559|FG006|Overall Study|Study drug toxicity|1|||
160658578|NCT00162123|580131560|FG007|Overall Study|Study drug toxicity|0|||
160658579|NCT00162123|580131553|FG000|Overall Study|Death|3|||
160658580|NCT00162123|580131554|FG001|Overall Study|Death|3|||
160658581|NCT00162123|580131555|FG002|Overall Study|Death|1|||
160658582|NCT00162123|580131556|FG003|Overall Study|Death|1|||
160658583|NCT00162123|580131557|FG004|Overall Study|Death|1|||
160658584|NCT00162123|580131558|FG005|Overall Study|Death|1|||
160658585|NCT00162123|580131559|FG006|Overall Study|Death|0|||
160658586|NCT00162123|580131560|FG007|Overall Study|Death|0|||
160658587|NCT00162123|580131553|FG000|Overall Study|Withdrawal by Subject|2|||
160658588|NCT00162123|580131554|FG001|Overall Study|Withdrawal by Subject|0|||
160658589|NCT00162123|580131555|FG002|Overall Study|Withdrawal by Subject|2|||
160658590|NCT00162123|580131556|FG003|Overall Study|Withdrawal by Subject|1|||
160658591|NCT00162123|580131557|FG004|Overall Study|Withdrawal by Subject|1|||
160461732|NCT04129450|579422201|FG001|Overall Study|Work Family Obligations|0|||
160461733|NCT04129450|579422200|FG000|Overall Study|Other|3|||
160461734|NCT04129450|579422201|FG001|Overall Study|Other|0|||
160658592|NCT00162123|580131558|FG005|Overall Study|Withdrawal by Subject|2|||
160461735|NCT00220805|579422907|FG000|Overall Study|Adverse Event|1|||
160461736|NCT00220805|579422908|FG001|Overall Study|Adverse Event|3|||
160461737|NCT00220805|579422907|FG000|Overall Study|Withdrawal by Subject|3|||
160461738|NCT00220805|579422908|FG001|Overall Study|Withdrawal by Subject|0|||
160461739|NCT00220805|579422907|FG000|Overall Study|Lack of Efficacy|1|||
160461740|NCT00220805|579422908|FG001|Overall Study|Lack of Efficacy|0|||
160658593|NCT00162123|580131559|FG006|Overall Study|Withdrawal by Subject|1|||
160461741|NCT00220805|579422907|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
160658594|NCT00162123|580131560|FG007|Overall Study|Withdrawal by Subject|0|||
160658595|NCT00162123|580131553|FG000|Overall Study|Deterioration without progression|2|||
160594618|NCT03927911|579894217|FG003|Overall Study|Protocol Violation|0|||
160594619|NCT03927911|579894218|FG004|Overall Study|Protocol Violation|0|||
160594620|NCT03927911|579894219|FG005|Overall Study|Protocol Violation|1|||
160594621|NCT02658968|579894220|FG000|Received Rituximab|Adverse Event|0|||
160594622|NCT02658968|579894221|FG001|Received Rituximab|Adverse Event|0|||
160594623|NCT02658968|579894222|FG002|Received Rituximab|Adverse Event|0|||
160594624|NCT02658968|579894223|FG003|Received Rituximab|Adverse Event|0|||
160594625|NCT02658968|579894224|FG004|Received Rituximab|Adverse Event|1|||
160594626|NCT02658968|579894220|FG000|Received Rituximab|Progressive disease|0|||
160594627|NCT02658968|579894221|FG001|Received Rituximab|Progressive disease|0|||
160594628|NCT02658968|579894222|FG002|Received Rituximab|Progressive disease|0|||
160594629|NCT02658968|579894223|FG003|Received Rituximab|Progressive disease|0|||
160594630|NCT02658968|579894224|FG004|Received Rituximab|Progressive disease|1|||
160594631|NCT02658968|579894220|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
160594632|NCT02658968|579894221|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
160594633|NCT02658968|579894222|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
160594634|NCT02658968|579894223|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
160594635|NCT02658968|579894224|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
160594636|NCT02658968|579894220|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
160594637|NCT02658968|579894221|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
160594638|NCT02658968|579894222|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
160461742|NCT00220805|579422908|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
160461743|NCT02325466|579422909|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
160461744|NCT02325466|579422910|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
160461745|NCT02325466|579422911|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
160461746|NCT02325466|579422909|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
160461747|NCT02325466|579422910|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
160461748|NCT02325466|579422911|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
160461749|NCT02325466|579422909|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
160461750|NCT02325466|579422910|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
160461751|NCT02325466|579422911|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
160461752|NCT02325466|579422909|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
160461753|NCT02325466|579422910|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
160461754|NCT02325466|579422911|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
160461755|NCT02325466|579422909|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
160461756|NCT02325466|579422910|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
160461757|NCT02325466|579422911|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
160461758|NCT02325466|579422909|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
160461759|NCT02325466|579422910|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
160461760|NCT02325466|579422911|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
160461761|NCT02325466|579422909|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
160461762|NCT02325466|579422910|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
160461763|NCT02325466|579422911|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
160461764|NCT02325466|579422909|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
160461765|NCT02325466|579422910|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
160461766|NCT02325466|579422911|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
160461767|NCT02325466|579422909|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
160461768|NCT02325466|579422910|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
160461769|NCT02325466|579422911|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
160461770|NCT01596972|579422927|FG000|Overall Study|Physician Decision|1|||
160461771|NCT01596972|579422928|FG001|Overall Study|Physician Decision|9|||
160461772|NCT01596972|579422927|FG000|Overall Study|Lost to Follow-up|0|||
160461773|NCT01596972|579422928|FG001|Overall Study|Lost to Follow-up|4|||
160461774|NCT01596972|579422927|FG000|Overall Study|Withdrawal by Subject|0|||
160461775|NCT01596972|579422928|FG001|Overall Study|Withdrawal by Subject|1|||
160461776|NCT01639131|579422929|FG000|Overall Study|Disease Progression|6|||
160461777|NCT03286114|579422933|FG000|Overall Study|Adverse Event|6|||
160461778|NCT03286114|579422933|FG000|Overall Study|Death|3|||
160461779|NCT00943917|579422945|FG000|Stage I|Adverse Event|1|||
160461780|NCT00943917|579422946|FG001|Stage I|Adverse Event|2|||
160461781|NCT00943917|579422947|FG002|Stage I|Adverse Event|2|||
160461782|NCT00943917|579422948|FG003|Stage I|Adverse Event|0|||
160461783|NCT00943917|579422949|FG004|Stage I|Adverse Event|0|||
160461784|NCT00943917|579422950|FG005|Stage I|Adverse Event|0|||
160461785|NCT00943917|579422951|FG006|Stage I|Adverse Event|0|||
160461786|NCT00943917|579422952|FG007|Stage I|Adverse Event|0|||
160461787|NCT00943917|579422953|FG008|Stage I|Adverse Event|0|||
160461788|NCT00943917|579422954|FG009|Stage I|Adverse Event|0|||
160461789|NCT00943917|579422955|FG010|Stage I|Adverse Event|0|||
160461790|NCT00943917|579422956|FG011|Stage I|Adverse Event|0|||
160461791|NCT00943917|579422957|FG012|Stage I|Adverse Event|0|||
160461792|NCT00943917|579422958|FG013|Stage I|Adverse Event|0|||
160461793|NCT00943917|579422959|FG014|Stage I|Adverse Event|0|||
160461794|NCT00943917|579422945|FG000|Stage I|Lost to Follow-up|0|||
160461795|NCT00943917|579422946|FG001|Stage I|Lost to Follow-up|0|||
160461796|NCT00943917|579422947|FG002|Stage I|Lost to Follow-up|1|||
160461797|NCT00943917|579422948|FG003|Stage I|Lost to Follow-up|0|||
160461798|NCT00943917|579422949|FG004|Stage I|Lost to Follow-up|0|||
160461799|NCT00943917|579422950|FG005|Stage I|Lost to Follow-up|0|||
160461800|NCT00943917|579422951|FG006|Stage I|Lost to Follow-up|0|||
160594639|NCT02658968|579894223|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
160461801|NCT00943917|579422952|FG007|Stage I|Lost to Follow-up|0|||
160461802|NCT00943917|579422953|FG008|Stage I|Lost to Follow-up|0|||
160461803|NCT00943917|579422954|FG009|Stage I|Lost to Follow-up|0|||
160594640|NCT02658968|579894224|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
160594641|NCT02658968|579894220|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
160461804|NCT00943917|579422955|FG010|Stage I|Lost to Follow-up|0|||
160461805|NCT00943917|579422956|FG011|Stage I|Lost to Follow-up|0|||
160461806|NCT00943917|579422957|FG012|Stage I|Lost to Follow-up|0|||
160461807|NCT00943917|579422958|FG013|Stage I|Lost to Follow-up|0|||
160461808|NCT00943917|579422959|FG014|Stage I|Lost to Follow-up|0|||
160461809|NCT00943917|579422945|FG000|Stage I|hyperglycemia|0|||
160461810|NCT00943917|579422946|FG001|Stage I|hyperglycemia|0|||
160461811|NCT00943917|579422947|FG002|Stage I|hyperglycemia|1|||
160461812|NCT00943917|579422948|FG003|Stage I|hyperglycemia|0|||
160461813|NCT00943917|579422949|FG004|Stage I|hyperglycemia|0|||
160594642|NCT02658968|579894221|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
160594643|NCT02658968|579894222|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
160594644|NCT02658968|579894223|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
160594645|NCT02658968|579894224|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
160594646|NCT02658968|579894220|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
160594647|NCT02658968|579894221|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
160658596|NCT00162123|580131554|FG001|Overall Study|Deterioration without progression|2|||
160594648|NCT02658968|579894222|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
160594649|NCT02658968|579894223|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
160594650|NCT02658968|579894224|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
160594651|NCT02658968|579894220|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
160594652|NCT02658968|579894221|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
160594653|NCT02658968|579894222|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
160594654|NCT02658968|579894223|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
160594655|NCT02658968|579894224|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
160658597|NCT00162123|580131555|FG002|Overall Study|Deterioration without progression|3|||
160658598|NCT00162123|580131556|FG003|Overall Study|Deterioration without progression|0|||
160658599|NCT00162123|580131557|FG004|Overall Study|Deterioration without progression|1|||
160658600|NCT00162123|580131558|FG005|Overall Study|Deterioration without progression|0|||
160461814|NCT00943917|579422950|FG005|Stage I|hyperglycemia|0|||
160461815|NCT00943917|579422951|FG006|Stage I|hyperglycemia|0|||
160461816|NCT00943917|579422952|FG007|Stage I|hyperglycemia|0|||
160461817|NCT00943917|579422953|FG008|Stage I|hyperglycemia|0|||
160461818|NCT00943917|579422954|FG009|Stage I|hyperglycemia|0|||
160461819|NCT00943917|579422955|FG010|Stage I|hyperglycemia|0|||
160461820|NCT00943917|579422956|FG011|Stage I|hyperglycemia|0|||
160461821|NCT00943917|579422957|FG012|Stage I|hyperglycemia|0|||
160461822|NCT00943917|579422958|FG013|Stage I|hyperglycemia|0|||
160461823|NCT00943917|579422959|FG014|Stage I|hyperglycemia|0|||
160461824|NCT00943917|579422945|FG000|Stage I|A1C elevation|1|||
160461825|NCT00943917|579422946|FG001|Stage I|A1C elevation|0|||
160461826|NCT00943917|579422947|FG002|Stage I|A1C elevation|0|||
160461827|NCT00943917|579422948|FG003|Stage I|A1C elevation|0|||
160461828|NCT00943917|579422949|FG004|Stage I|A1C elevation|0|||
160461829|NCT00943917|579422950|FG005|Stage I|A1C elevation|0|||
160461830|NCT00943917|579422951|FG006|Stage I|A1C elevation|0|||
160461831|NCT00943917|579422952|FG007|Stage I|A1C elevation|0|||
160461832|NCT00943917|579422953|FG008|Stage I|A1C elevation|0|||
160461833|NCT00943917|579422954|FG009|Stage I|A1C elevation|0|||
160461834|NCT00943917|579422955|FG010|Stage I|A1C elevation|0|||
160461835|NCT00943917|579422956|FG011|Stage I|A1C elevation|0|||
160461836|NCT00943917|579422957|FG012|Stage I|A1C elevation|0|||
160461837|NCT00943917|579422958|FG013|Stage I|A1C elevation|0|||
160461838|NCT00943917|579422959|FG014|Stage I|A1C elevation|0|||
160461839|NCT00943917|579422945|FG000|Stage I|Withdrawal by Subject|2|||
160461840|NCT00943917|579422946|FG001|Stage I|Withdrawal by Subject|1|||
160461841|NCT00943917|579422947|FG002|Stage I|Withdrawal by Subject|2|||
160461842|NCT00943917|579422948|FG003|Stage I|Withdrawal by Subject|0|||
160461843|NCT00943917|579422949|FG004|Stage I|Withdrawal by Subject|0|||
160461844|NCT00943917|579422950|FG005|Stage I|Withdrawal by Subject|0|||
160461845|NCT00943917|579422951|FG006|Stage I|Withdrawal by Subject|0|||
160461846|NCT00943917|579422952|FG007|Stage I|Withdrawal by Subject|0|||
160461847|NCT00943917|579422953|FG008|Stage I|Withdrawal by Subject|0|||
160461848|NCT00943917|579422954|FG009|Stage I|Withdrawal by Subject|0|||
160461849|NCT00943917|579422955|FG010|Stage I|Withdrawal by Subject|0|||
160461850|NCT00943917|579422956|FG011|Stage I|Withdrawal by Subject|0|||
160461851|NCT00943917|579422957|FG012|Stage I|Withdrawal by Subject|0|||
160594656|NCT03287869|579894225|FG000|Overall Study|Adverse Event|14|||
160594657|NCT03287869|579894226|FG001|Overall Study|Adverse Event|12|||
160594658|NCT03287869|579894225|FG000|Overall Study|Lack of Efficacy|1|||
160594659|NCT03287869|579894226|FG001|Overall Study|Lack of Efficacy|0|||
160594660|NCT03287869|579894225|FG000|Overall Study|Lost to Follow-up|13|||
160594661|NCT03287869|579894226|FG001|Overall Study|Lost to Follow-up|19|||
160594662|NCT03287869|579894225|FG000|Overall Study|Non-Compliance With Study Drug|5|||
160594663|NCT03287869|579894226|FG001|Overall Study|Non-Compliance With Study Drug|9|||
160594664|NCT03287869|579894225|FG000|Overall Study|Progressive Disease|1|||
160461852|NCT00943917|579422958|FG013|Stage I|Withdrawal by Subject|0|||
160594665|NCT03287869|579894226|FG001|Overall Study|Progressive Disease|0|||
160594666|NCT03287869|579894225|FG000|Overall Study|Protocol Deviation|2|||
160461853|NCT00943917|579422959|FG014|Stage I|Withdrawal by Subject|0|||
160461854|NCT00943917|579422945|FG000|Stage II|Adverse Event|0|||
160461855|NCT00943917|579422946|FG001|Stage II|Adverse Event|0|||
160461856|NCT00943917|579422947|FG002|Stage II|Adverse Event|0|||
160461857|NCT00943917|579422948|FG003|Stage II|Adverse Event|0|||
160461858|NCT00943917|579422949|FG004|Stage II|Adverse Event|0|||
160461859|NCT00943917|579422950|FG005|Stage II|Adverse Event|1|||
160461860|NCT00943917|579422951|FG006|Stage II|Adverse Event|3|||
160594667|NCT03287869|579894226|FG001|Overall Study|Protocol Deviation|1|||
160461861|NCT00943917|579422952|FG007|Stage II|Adverse Event|0|||
160461862|NCT00943917|579422953|FG008|Stage II|Adverse Event|1|||
160461863|NCT00943917|579422954|FG009|Stage II|Adverse Event|0|||
160461864|NCT00943917|579422955|FG010|Stage II|Adverse Event|0|||
160594668|NCT03287869|579894225|FG000|Overall Study|Withdrawal by Subject|36|||
160594669|NCT03287869|579894226|FG001|Overall Study|Withdrawal by Subject|43|||
160594670|NCT03287869|579894225|FG000|Overall Study|Early Closure of the Site|0|||
160594671|NCT03287869|579894226|FG001|Overall Study|Early Closure of the Site|1|||
160594672|NCT03287869|579894225|FG000|Overall Study|Physician Decision|5|||
160594673|NCT03287869|579894226|FG001|Overall Study|Physician Decision|5|||
160594674|NCT03287869|579894225|FG000|Overall Study|Reason not Specified|6|||
160461865|NCT00943917|579422956|FG011|Stage II|Adverse Event|0|||
160461866|NCT00943917|579422957|FG012|Stage II|Adverse Event|0|||
160461867|NCT00943917|579422958|FG013|Stage II|Adverse Event|0|||
160461868|NCT00943917|579422959|FG014|Stage II|Adverse Event|0|||
160461869|NCT00943917|579422945|FG000|Stage II|Withdrawal by Subject|0|||
160461870|NCT00943917|579422946|FG001|Stage II|Withdrawal by Subject|0|||
160461871|NCT00943917|579422947|FG002|Stage II|Withdrawal by Subject|0|||
160461872|NCT00943917|579422948|FG003|Stage II|Withdrawal by Subject|0|||
160461873|NCT00943917|579422949|FG004|Stage II|Withdrawal by Subject|0|||
160461874|NCT00943917|579422950|FG005|Stage II|Withdrawal by Subject|1|||
160461875|NCT00943917|579422951|FG006|Stage II|Withdrawal by Subject|0|||
160461876|NCT00943917|579422952|FG007|Stage II|Withdrawal by Subject|0|||
160461877|NCT00943917|579422953|FG008|Stage II|Withdrawal by Subject|0|||
160461878|NCT00943917|579422954|FG009|Stage II|Withdrawal by Subject|0|||
160461879|NCT00943917|579422955|FG010|Stage II|Withdrawal by Subject|0|||
160461880|NCT00943917|579422956|FG011|Stage II|Withdrawal by Subject|0|||
160461881|NCT00943917|579422957|FG012|Stage II|Withdrawal by Subject|0|||
160461882|NCT00943917|579422958|FG013|Stage II|Withdrawal by Subject|0|||
160461883|NCT00943917|579422959|FG014|Stage II|Withdrawal by Subject|0|||
160461884|NCT00943917|579422945|FG000|Stage II|Pregnancy|0|||
160461885|NCT00943917|579422946|FG001|Stage II|Pregnancy|0|||
160461886|NCT00943917|579422947|FG002|Stage II|Pregnancy|0|||
160461887|NCT00943917|579422948|FG003|Stage II|Pregnancy|0|||
160461888|NCT00943917|579422949|FG004|Stage II|Pregnancy|0|||
160461889|NCT00943917|579422950|FG005|Stage II|Pregnancy|1|||
160461890|NCT00943917|579422951|FG006|Stage II|Pregnancy|0|||
160461891|NCT00943917|579422952|FG007|Stage II|Pregnancy|0|||
160461892|NCT00943917|579422953|FG008|Stage II|Pregnancy|0|||
160461893|NCT00943917|579422954|FG009|Stage II|Pregnancy|0|||
160461894|NCT00943917|579422955|FG010|Stage II|Pregnancy|0|||
160461895|NCT00943917|579422956|FG011|Stage II|Pregnancy|0|||
160461896|NCT00943917|579422957|FG012|Stage II|Pregnancy|0|||
160461897|NCT00943917|579422958|FG013|Stage II|Pregnancy|0|||
160461898|NCT00943917|579422959|FG014|Stage II|Pregnancy|0|||
160461899|NCT00943917|579422945|FG000|Stage II Continuation|Adverse Event|0|||
160461900|NCT00943917|579422946|FG001|Stage II Continuation|Adverse Event|0|||
160461901|NCT00943917|579422947|FG002|Stage II Continuation|Adverse Event|0|||
160461902|NCT00943917|579422948|FG003|Stage II Continuation|Adverse Event|0|||
160461903|NCT00943917|579422949|FG004|Stage II Continuation|Adverse Event|0|||
160461904|NCT00943917|579422950|FG005|Stage II Continuation|Adverse Event|0|||
160461905|NCT00943917|579422951|FG006|Stage II Continuation|Adverse Event|0|||
160461906|NCT00943917|579422952|FG007|Stage II Continuation|Adverse Event|0|||
160461907|NCT00943917|579422953|FG008|Stage II Continuation|Adverse Event|0|||
160461908|NCT00943917|579422954|FG009|Stage II Continuation|Adverse Event|0|||
160461909|NCT00943917|579422955|FG010|Stage II Continuation|Adverse Event|0|||
160461910|NCT00943917|579422956|FG011|Stage II Continuation|Adverse Event|1|||
160461911|NCT00943917|579422957|FG012|Stage II Continuation|Adverse Event|2|||
160461912|NCT00943917|579422958|FG013|Stage II Continuation|Adverse Event|1|||
160461913|NCT00943917|579422959|FG014|Stage II Continuation|Adverse Event|1|||
160461914|NCT00943917|579422945|FG000|Stage II Continuation|Withdrawal by Subject|0|||
160461915|NCT00943917|579422946|FG001|Stage II Continuation|Withdrawal by Subject|0|||
160461916|NCT00943917|579422947|FG002|Stage II Continuation|Withdrawal by Subject|0|||
160461917|NCT00943917|579422948|FG003|Stage II Continuation|Withdrawal by Subject|0|||
160461918|NCT00943917|579422949|FG004|Stage II Continuation|Withdrawal by Subject|0|||
160461919|NCT00943917|579422950|FG005|Stage II Continuation|Withdrawal by Subject|0|||
160594675|NCT03287869|579894226|FG001|Overall Study|Reason not Specified|3|||
160461920|NCT00943917|579422951|FG006|Stage II Continuation|Withdrawal by Subject|0|||
160461921|NCT00943917|579422952|FG007|Stage II Continuation|Withdrawal by Subject|0|||
160461922|NCT00943917|579422953|FG008|Stage II Continuation|Withdrawal by Subject|0|||
160461923|NCT00943917|579422954|FG009|Stage II Continuation|Withdrawal by Subject|0|||
160594676|NCT02528253|579894229|FG000|Overall Study|Adverse Event|3|||
160594677|NCT02528253|579894230|FG001|Overall Study|Adverse Event|4|||
160461924|NCT00943917|579422955|FG010|Stage II Continuation|Withdrawal by Subject|0|||
160461925|NCT00943917|579422956|FG011|Stage II Continuation|Withdrawal by Subject|0|||
160461926|NCT00943917|579422957|FG012|Stage II Continuation|Withdrawal by Subject|0|||
160461927|NCT00943917|579422958|FG013|Stage II Continuation|Withdrawal by Subject|1|||
160461928|NCT00943917|579422959|FG014|Stage II Continuation|Withdrawal by Subject|3|||
160461929|NCT00943917|579422945|FG000|Stage II Continuation|Protocol Violation|0|||
160594678|NCT02528253|579894231|FG002|Overall Study|Adverse Event|4|||
160594679|NCT02528253|579894232|FG003|Overall Study|Adverse Event|8|||
160594680|NCT02528253|579894233|FG004|Overall Study|Adverse Event|18|||
160594681|NCT02528253|579894229|FG000|Overall Study|Death|2|||
160594682|NCT02528253|579894230|FG001|Overall Study|Death|2|||
160594683|NCT02528253|579894231|FG002|Overall Study|Death|1|||
160594684|NCT02528253|579894232|FG003|Overall Study|Death|0|||
160594685|NCT02528253|579894233|FG004|Overall Study|Death|1|||
160594686|NCT02528253|579894229|FG000|Overall Study|Insufficient clinical response|7|||
160594687|NCT02528253|579894230|FG001|Overall Study|Insufficient clinical response|10|||
160594688|NCT02528253|579894231|FG002|Overall Study|Insufficient clinical response|13|||
160594689|NCT02528253|579894232|FG003|Overall Study|Insufficient clinical response|12|||
160594690|NCT02528253|579894233|FG004|Overall Study|Insufficient clinical response|16|||
160594691|NCT02528253|579894229|FG000|Overall Study|Lost to Follow-up|16|||
160594692|NCT02528253|579894230|FG001|Overall Study|Lost to Follow-up|9|||
160594693|NCT02528253|579894231|FG002|Overall Study|Lost to Follow-up|31|||
160594694|NCT02528253|579894232|FG003|Overall Study|Lost to Follow-up|16|||
160594695|NCT02528253|579894233|FG004|Overall Study|Lost to Follow-up|34|||
160594696|NCT02528253|579894229|FG000|Overall Study|Other|21|||
160658601|NCT00162123|580131559|FG006|Overall Study|Deterioration without progression|0|||
160461930|NCT00943917|579422946|FG001|Stage II Continuation|Protocol Violation|0|||
160594697|NCT02528253|579894230|FG001|Overall Study|Other|22|||
160461931|NCT00943917|579422947|FG002|Stage II Continuation|Protocol Violation|0|||
160461932|NCT00943917|579422948|FG003|Stage II Continuation|Protocol Violation|0|||
160461933|NCT00943917|579422949|FG004|Stage II Continuation|Protocol Violation|0|||
160461934|NCT00943917|579422950|FG005|Stage II Continuation|Protocol Violation|0|||
160461935|NCT00943917|579422951|FG006|Stage II Continuation|Protocol Violation|0|||
160461936|NCT00943917|579422952|FG007|Stage II Continuation|Protocol Violation|0|||
160461937|NCT00943917|579422953|FG008|Stage II Continuation|Protocol Violation|0|||
160594698|NCT02528253|579894231|FG002|Overall Study|Other|58|||
160594699|NCT02528253|579894232|FG003|Overall Study|Other|52|||
160594700|NCT02528253|579894233|FG004|Overall Study|Other|76|||
160594701|NCT02528253|579894229|FG000|Overall Study|Withdrawal by Subject|25|||
160461938|NCT00943917|579422954|FG009|Stage II Continuation|Protocol Violation|1|||
160594702|NCT02528253|579894230|FG001|Overall Study|Withdrawal by Subject|20|||
160594703|NCT02528253|579894231|FG002|Overall Study|Withdrawal by Subject|29|||
160461939|NCT00943917|579422955|FG010|Stage II Continuation|Protocol Violation|0|||
160461940|NCT00943917|579422956|FG011|Stage II Continuation|Protocol Violation|1|||
160461941|NCT00943917|579422957|FG012|Stage II Continuation|Protocol Violation|0|||
160461942|NCT00943917|579422958|FG013|Stage II Continuation|Protocol Violation|0|||
160461943|NCT00943917|579422959|FG014|Stage II Continuation|Protocol Violation|0|||
160461944|NCT00943917|579422945|FG000|Stage II Continuation|hypoglycemia|0|||
160658602|NCT00162123|580131560|FG007|Overall Study|Deterioration without progression|0|||
160658603|NCT00162123|580131553|FG000|Overall Study|Adverse Event|1|||
160658604|NCT00162123|580131554|FG001|Overall Study|Adverse Event|2|||
160658605|NCT00162123|580131555|FG002|Overall Study|Adverse Event|0|||
160594704|NCT02528253|579894232|FG003|Overall Study|Withdrawal by Subject|48|||
160594705|NCT02528253|579894233|FG004|Overall Study|Withdrawal by Subject|73|||
160594706|NCT02528253|579894229|FG000|Overall Study|Protocol Violation|1|||
160594707|NCT02528253|579894230|FG001|Overall Study|Protocol Violation|2|||
160594708|NCT02528253|579894231|FG002|Overall Study|Protocol Violation|4|||
160594709|NCT02528253|579894232|FG003|Overall Study|Protocol Violation|0|||
160594710|NCT02528253|579894233|FG004|Overall Study|Protocol Violation|4|||
160594711|NCT02528253|579894229|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
160594712|NCT02528253|579894230|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
160594713|NCT02528253|579894231|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
160594714|NCT02528253|579894232|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
160594715|NCT02528253|579894233|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
160658606|NCT00162123|580131556|FG003|Overall Study|Adverse Event|2|||
160461945|NCT00943917|579422946|FG001|Stage II Continuation|hypoglycemia|0|||
160461946|NCT00943917|579422947|FG002|Stage II Continuation|hypoglycemia|0|||
160461947|NCT00943917|579422948|FG003|Stage II Continuation|hypoglycemia|0|||
160461948|NCT00943917|579422949|FG004|Stage II Continuation|hypoglycemia|0|||
160461949|NCT00943917|579422950|FG005|Stage II Continuation|hypoglycemia|0|||
160461950|NCT00943917|579422951|FG006|Stage II Continuation|hypoglycemia|0|||
160461951|NCT00943917|579422952|FG007|Stage II Continuation|hypoglycemia|0|||
160461952|NCT00943917|579422953|FG008|Stage II Continuation|hypoglycemia|0|||
160461953|NCT00943917|579422954|FG009|Stage II Continuation|hypoglycemia|0|||
160461954|NCT00943917|579422955|FG010|Stage II Continuation|hypoglycemia|0|||
160461955|NCT00943917|579422956|FG011|Stage II Continuation|hypoglycemia|0|||
160461956|NCT00943917|579422957|FG012|Stage II Continuation|hypoglycemia|1|||
160461957|NCT00943917|579422958|FG013|Stage II Continuation|hypoglycemia|0|||
160461958|NCT00943917|579422959|FG014|Stage II Continuation|hypoglycemia|0|||
160461959|NCT00943917|579422945|FG000|Stage II Continuation|A1C elevation|0|||
160461960|NCT00943917|579422946|FG001|Stage II Continuation|A1C elevation|0|||
160461961|NCT00943917|579422947|FG002|Stage II Continuation|A1C elevation|0|||
160461962|NCT00943917|579422948|FG003|Stage II Continuation|A1C elevation|0|||
160461963|NCT00943917|579422949|FG004|Stage II Continuation|A1C elevation|0|||
160461964|NCT00943917|579422950|FG005|Stage II Continuation|A1C elevation|0|||
160461965|NCT00943917|579422951|FG006|Stage II Continuation|A1C elevation|0|||
160461966|NCT00943917|579422952|FG007|Stage II Continuation|A1C elevation|0|||
160461967|NCT00943917|579422953|FG008|Stage II Continuation|A1C elevation|0|||
160461968|NCT00943917|579422954|FG009|Stage II Continuation|A1C elevation|0|||
160461969|NCT00943917|579422955|FG010|Stage II Continuation|A1C elevation|0|||
160461970|NCT00943917|579422956|FG011|Stage II Continuation|A1C elevation|0|||
160461971|NCT00943917|579422957|FG012|Stage II Continuation|A1C elevation|0|||
160461972|NCT00943917|579422958|FG013|Stage II Continuation|A1C elevation|1|||
160461973|NCT00943917|579422959|FG014|Stage II Continuation|A1C elevation|0|||
160461974|NCT01171976|579422960|FG000|Overall Study|Protocol Violation|0|||
160461975|NCT01171976|579422961|FG001|Overall Study|Protocol Violation|0|||
160461976|NCT01171976|579422962|FG002|Overall Study|Protocol Violation|1|||
160461977|NCT01171976|579422960|FG000|Overall Study|Death|2|||
160461978|NCT01171976|579422961|FG001|Overall Study|Death|4|||
160461979|NCT01171976|579422962|FG002|Overall Study|Death|1|||
160461980|NCT01171976|579422960|FG000|Overall Study|Lost to Follow-up|4|||
160461981|NCT01171976|579422961|FG001|Overall Study|Lost to Follow-up|0|||
160461982|NCT01171976|579422962|FG002|Overall Study|Lost to Follow-up|2|||
160461983|NCT01171976|579422960|FG000|Overall Study|Withdrawal by Subject|1|||
160461984|NCT01171976|579422961|FG001|Overall Study|Withdrawal by Subject|5|||
160461985|NCT01171976|579422962|FG002|Overall Study|Withdrawal by Subject|6|||
160461986|NCT01171976|579422960|FG000|Overall Study|Abnormal test result|1|||
160461987|NCT01171976|579422961|FG001|Overall Study|Abnormal test result|0|||
160461988|NCT01171976|579422962|FG002|Overall Study|Abnormal test result|0|||
160461989|NCT01171976|579422960|FG000|Overall Study|Adverse Event|6|||
160461990|NCT01171976|579422961|FG001|Overall Study|Adverse Event|2|||
160461991|NCT01171976|579422962|FG002|Overall Study|Adverse Event|5|||
160461992|NCT00003222|579422965|FG000|Overall Study|Physician Decision|0|||
160461993|NCT00003222|579422966|FG001|Overall Study|Physician Decision|1|||
160461994|NCT01313559|579422973|FG000|Overall Study|Withdrawal by Subject|1|||
160461995|NCT01313559|579422974|FG001|Overall Study|Withdrawal by Subject|2|||
160461996|NCT01313559|579422973|FG000|Overall Study|Disease progression|1|||
160461997|NCT01313559|579422974|FG001|Overall Study|Disease progression|0|||
160461998|NCT01313559|579422973|FG000|Overall Study|Rising PSA|2|||
160461999|NCT01313559|579422974|FG001|Overall Study|Rising PSA|0|||
160462000|NCT03872466|579422975|FG000|Overall Study|Withdrawal by Subject|1|||
160462001|NCT03872466|579422976|FG001|Overall Study|Withdrawal by Subject|0|||
160462002|NCT03872466|579422975|FG000|Overall Study|Physician Decision|2|||
160462003|NCT03872466|579422976|FG001|Overall Study|Physician Decision|0|||
160462004|NCT01778686|579422977|FG000|Overall Study|Adverse Event|0|||
160462005|NCT01778686|579422978|FG001|Overall Study|Adverse Event|0|||
160462006|NCT01778686|579422979|FG002|Overall Study|Adverse Event|1|||
160462007|NCT04012567|579422980|FG000|Overall Study|Lost to Follow-up|0|||
160462008|NCT04012567|579422981|FG001|Overall Study|Lost to Follow-up|1|||
160462009|NCT04012567|579422980|FG000|Overall Study|Withdrawal by Subject|1|||
160462010|NCT04012567|579422981|FG001|Overall Study|Withdrawal by Subject|0|||
160462011|NCT04018495|579422983|FG000|Overall Study|Physician Decision|1|||
160462012|NCT05934292|579422993|FG000|Overall Study|Lost to Follow-up|0|||
160462013|NCT05934292|579422994|FG001|Overall Study|Lost to Follow-up|0|||
160462014|NCT05934292|579422995|FG002|Overall Study|Lost to Follow-up|1|||
160462015|NCT05934292|579422996|FG003|Overall Study|Lost to Follow-up|0|||
160594716|NCT00505752|579894234|FG000|Overall Study|Adverse Event|1|||
160594717|NCT00505752|579894235|FG001|Overall Study|Adverse Event|0|||
160462016|NCT05714059|579422999|FG000|Overall Study|Withdrawal by Subject|2|||
160462017|NCT05714059|579423000|FG001|Overall Study|Withdrawal by Subject|2|||
160462018|NCT05714059|579422999|FG000|Overall Study|Adverse Event|0|||
160462019|NCT05714059|579423000|FG001|Overall Study|Adverse Event|1|||
160462020|NCT05714059|579422999|FG000|Overall Study|Lost to Follow-up|0|||
160462021|NCT05714059|579423000|FG001|Overall Study|Lost to Follow-up|1|||
160462022|NCT05714059|579422999|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
160462023|NCT05714059|579423000|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
160462024|NCT05714059|579422999|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
160462025|NCT05714059|579423000|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
160462026|NCT04899674|579423001|FG000|Test|Adverse Event|1|||
160462027|NCT04974047|579423827|FG000|Overall Study|Sponsor Ended Study|20|||
160462028|NCT04974047|579423828|FG001|Overall Study|Sponsor Ended Study|22|||
160462029|NCT04974047|579423827|FG000|Overall Study|Death|8|||
160462030|NCT04974047|579423828|FG001|Overall Study|Death|17|||
160462031|NCT04974047|579423827|FG000|Overall Study|Lost to Follow-up|2|||
160462032|NCT04974047|579423828|FG001|Overall Study|Lost to Follow-up|0|||
160462033|NCT04974047|579423827|FG000|Overall Study|Withdrawal by Subject|0|||
160462034|NCT04974047|579423828|FG001|Overall Study|Withdrawal by Subject|1|||
160462035|NCT00655499|579423829|FG000|Overall Study|not eligible|4|||
160462036|NCT01964300|579423831|FG000|Overall Study|Ineligible after enrollment|0|||
160462037|NCT01964300|579423832|FG001|Overall Study|Ineligible after enrollment|1|||
160462038|NCT01964300|579423831|FG000|Overall Study|Adverse Event|1|||
160462039|NCT01964300|579423832|FG001|Overall Study|Adverse Event|1|||
160462040|NCT01964300|579423831|FG000|Overall Study|Lack of Efficacy|3|||
160462041|NCT01964300|579423832|FG001|Overall Study|Lack of Efficacy|5|||
160462042|NCT01964300|579423831|FG000|Overall Study|Withdrawal by Subject|0|||
160462043|NCT01964300|579423832|FG001|Overall Study|Withdrawal by Subject|1|||
160462044|NCT01964300|579423831|FG000|Overall Study|To receive alternative therapy|1|||
160462045|NCT01964300|579423832|FG001|Overall Study|To receive alternative therapy|2|||
160462046|NCT01964300|579423831|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
160462047|NCT01964300|579423832|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
160462048|NCT01964300|579423831|FG000|Overall Study|Weight criteria not met|0|||
160462049|NCT01964300|579423832|FG001|Overall Study|Weight criteria not met|1|||
160462050|NCT01637402|579423833|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
160462051|NCT01637402|579423834|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
160462052|NCT01637402|579423833|FG000|Standard Dose Regimen|Adverse Event|1|||
160462053|NCT01637402|579423834|FG001|Standard Dose Regimen|Adverse Event|0|||
160462054|NCT01637402|579423833|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
160462055|NCT01637402|579423834|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
160462056|NCT01637402|579423833|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
160462057|NCT01637402|579423834|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
160462058|NCT01637402|579423833|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
160462059|NCT01637402|579423834|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
160462060|NCT01637402|579423833|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
160462061|NCT01637402|579423834|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
160462062|NCT02285270|579423835|FG000|Overall Study|Lost to Follow-up|1|||
160462063|NCT02285270|579423835|FG000|Overall Study|Physician Decision|3|||
160462064|NCT02285270|579423835|FG000|Overall Study|Determined to be ineligible|1|||
160462065|NCT02111096|579423836|FG000|Overall Study|Adverse Event|4|||
160462066|NCT02111096|579423837|FG001|Overall Study|Adverse Event|1|||
160462067|NCT02111096|579423838|FG002|Overall Study|Adverse Event|2|||
160462068|NCT02111096|579423836|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160462069|NCT02111096|579423837|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160462070|NCT02111096|579423838|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160462071|NCT02111096|579423836|FG000|Overall Study|Lost to Follow Up|1|||
160462072|NCT02111096|579423837|FG001|Overall Study|Lost to Follow Up|1|||
160462073|NCT02111096|579423838|FG002|Overall Study|Lost to Follow Up|1|||
160462074|NCT02111096|579423836|FG000|Overall Study|Physician Decision|0|||
160462075|NCT02111096|579423837|FG001|Overall Study|Physician Decision|1|||
160462076|NCT02111096|579423838|FG002|Overall Study|Physician Decision|0|||
160462077|NCT02111096|579423836|FG000|Overall Study|Protocol Violation|1|||
160462078|NCT02111096|579423837|FG001|Overall Study|Protocol Violation|0|||
160462079|NCT02111096|579423838|FG002|Overall Study|Protocol Violation|1|||
160462080|NCT02111096|579423836|FG000|Overall Study|Terminated by Sponsor|53|||
160462081|NCT02111096|579423837|FG001|Overall Study|Terminated by Sponsor|35|||
160594718|NCT00505752|579894236|FG002|Overall Study|Adverse Event|1|||
160462082|NCT02111096|579423838|FG002|Overall Study|Terminated by Sponsor|54|||
160462083|NCT02111096|579423836|FG000|Overall Study|Withdrawal by Subject|4|||
160462084|NCT02111096|579423837|FG001|Overall Study|Withdrawal by Subject|2|||
160462085|NCT02111096|579423838|FG002|Overall Study|Withdrawal by Subject|8|||
160462086|NCT00439270|579423841|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
160462087|NCT00439270|579423842|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
160462088|NCT00439270|579423843|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
160462089|NCT00439270|579423844|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
160462090|NCT00439270|579423845|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
160462091|NCT00439270|579423841|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
160462092|NCT00439270|579423842|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
160462093|NCT00439270|579423843|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
160462094|NCT00439270|579423844|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
160462095|NCT00439270|579423845|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
160462096|NCT00439270|579423841|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
160594719|NCT00505752|579894237|FG003|Overall Study|Adverse Event|0|||
160594720|NCT00505752|579894234|FG000|Overall Study|Lost to Follow-up|1|||
160594721|NCT00505752|579894235|FG001|Overall Study|Lost to Follow-up|0|||
160594722|NCT00505752|579894236|FG002|Overall Study|Lost to Follow-up|0|||
160594723|NCT00505752|579894237|FG003|Overall Study|Lost to Follow-up|0|||
160594724|NCT00505752|579894234|FG000|Overall Study|Lack of ovarian response|1|||
160594725|NCT00505752|579894235|FG001|Overall Study|Lack of ovarian response|3|||
160594726|NCT00505752|579894236|FG002|Overall Study|Lack of ovarian response|0|||
160462097|NCT00439270|579423842|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
160462098|NCT00439270|579423843|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
160462099|NCT00439270|579423844|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
160462100|NCT00439270|579423845|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
160658607|NCT00162123|580131557|FG004|Overall Study|Adverse Event|1|||
160658608|NCT00162123|580131558|FG005|Overall Study|Adverse Event|0|||
160658609|NCT00162123|580131559|FG006|Overall Study|Adverse Event|0|||
160462101|NCT00439270|579423841|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
160658610|NCT00162123|580131560|FG007|Overall Study|Adverse Event|0|||
160462102|NCT00439270|579423842|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
160462103|NCT00439270|579423843|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
160462104|NCT00439270|579423844|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
160462105|NCT00439270|579423845|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
160462106|NCT00439270|579423841|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
160462107|NCT00439270|579423842|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
160462108|NCT00439270|579423843|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
160462109|NCT00439270|579423844|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
160462110|NCT00439270|579423845|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
160462111|NCT00439270|579423841|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
160462112|NCT00439270|579423842|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
160462113|NCT00439270|579423843|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
160462114|NCT00439270|579423844|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
160462115|NCT00439270|579423845|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
160462116|NCT00439270|579423841|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
160462117|NCT00439270|579423842|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
160462118|NCT00439270|579423843|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
160462119|NCT00439270|579423844|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
160462120|NCT00439270|579423845|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
160462121|NCT00439270|579423841|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
160462122|NCT00439270|579423842|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
160462123|NCT00439270|579423843|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
160462124|NCT00439270|579423844|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
160462125|NCT00439270|579423845|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
160462126|NCT00439270|579423841|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
160462127|NCT00439270|579423842|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
160462128|NCT00439270|579423843|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
160462129|NCT00439270|579423844|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
160462130|NCT00439270|579423845|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
160462131|NCT00439270|579423841|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
160462132|NCT00439270|579423842|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
160462133|NCT00439270|579423843|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
160462134|NCT00439270|579423844|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
160462135|NCT00439270|579423845|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
160462136|NCT01268306|579423846|FG000|Overall Study|Lost to Follow-up|1|||
160462137|NCT04334317|579423847|FG000|Overall Study|Adverse Event|1|||
160462138|NCT04334317|579423848|FG001|Overall Study|Adverse Event|2|||
160462139|NCT04334317|579423849|FG002|Overall Study|Adverse Event|0|||
160462140|NCT04334317|579423850|FG003|Overall Study|Adverse Event|0|||
160594727|NCT00505752|579894237|FG003|Overall Study|Lack of ovarian response|0|||
160594728|NCT00505752|579894234|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
160594729|NCT00505752|579894235|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
160594730|NCT00505752|579894236|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
160594731|NCT00505752|579894237|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
160594732|NCT00505752|579894234|FG000|Overall Study|No oocytes retrieved|0|||
160594733|NCT00505752|579894235|FG001|Overall Study|No oocytes retrieved|2|||
160594734|NCT00505752|579894236|FG002|Overall Study|No oocytes retrieved|0|||
160594735|NCT00505752|579894237|FG003|Overall Study|No oocytes retrieved|1|||
160594736|NCT00505752|579894234|FG000|Overall Study|No Fertilization|1|||
160594737|NCT00505752|579894235|FG001|Overall Study|No Fertilization|1|||
160462141|NCT04334317|579423847|FG000|Overall Study|Protocol Deviation|0|||
160462142|NCT04334317|579423848|FG001|Overall Study|Protocol Deviation|1|||
160462143|NCT04334317|579423849|FG002|Overall Study|Protocol Deviation|0|||
160462144|NCT04334317|579423850|FG003|Overall Study|Protocol Deviation|0|||
160462145|NCT04334317|579423847|FG000|Overall Study|Withdrawal by Subject|2|||
160462146|NCT04334317|579423848|FG001|Overall Study|Withdrawal by Subject|2|||
160462147|NCT04334317|579423849|FG002|Overall Study|Withdrawal by Subject|0|||
160462148|NCT04334317|579423850|FG003|Overall Study|Withdrawal by Subject|0|||
160462149|NCT01074294|579423856|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
160462150|NCT01074294|579423857|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
160462151|NCT01074294|579423858|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
160462152|NCT01074294|579423859|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
160462153|NCT01074294|579423856|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
160462154|NCT01074294|579423857|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
160462155|NCT01074294|579423858|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
160462156|NCT01074294|579423859|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
160462157|NCT01074294|579423856|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
160462158|NCT01074294|579423857|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
160462159|NCT01074294|579423858|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
160462160|NCT01074294|579423859|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
160462161|NCT01074294|579423856|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
160462162|NCT01074294|579423857|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
160462163|NCT01074294|579423858|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
160462164|NCT01074294|579423859|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
160462165|NCT01074294|579423856|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
160462166|NCT01074294|579423857|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
160462167|NCT01074294|579423858|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
160462168|NCT01074294|579423859|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
160462169|NCT01074294|579423856|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
160462170|NCT01074294|579423857|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
160462171|NCT01074294|579423858|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
160462172|NCT01074294|579423859|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
160462173|NCT01074294|579423856|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
160462174|NCT01074294|579423857|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
160462175|NCT01074294|579423858|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
160462176|NCT01074294|579423859|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
160462177|NCT01074294|579423856|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
160462178|NCT01074294|579423857|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
160462179|NCT01074294|579423858|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
160462180|NCT01074294|579423859|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
160462181|NCT01074294|579423856|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
160462182|NCT01074294|579423857|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
160462183|NCT01074294|579423858|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
160462184|NCT01074294|579423859|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
160462185|NCT01074294|579423856|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
160462186|NCT01074294|579423857|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
160594738|NCT00505752|579894236|FG002|Overall Study|No Fertilization|2|||
160594739|NCT00505752|579894237|FG003|Overall Study|No Fertilization|1|||
160594740|NCT00505752|579894234|FG000|Overall Study|All embryos/blastocysts discarded|0|||
160594741|NCT00505752|579894235|FG001|Overall Study|All embryos/blastocysts discarded|0|||
160594742|NCT00505752|579894236|FG002|Overall Study|All embryos/blastocysts discarded|1|||
160462187|NCT01074294|579423858|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
160462188|NCT01074294|579423859|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
160462189|NCT01074294|579423856|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
160462190|NCT01074294|579423857|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
160594743|NCT00505752|579894237|FG003|Overall Study|All embryos/blastocysts discarded|1|||
160594744|NCT00505752|579894234|FG000|Overall Study|Other|1|||
160462191|NCT01074294|579423858|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
160462192|NCT01074294|579423859|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
160462193|NCT01074294|579423856|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
160462194|NCT01074294|579423857|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
160462195|NCT01074294|579423858|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
160462196|NCT01074294|579423859|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
160462197|NCT01074294|579423856|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
160462198|NCT01074294|579423857|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
160462199|NCT01074294|579423858|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
160462200|NCT01074294|579423859|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
160462201|NCT03248492|579423860|FG000|Overall Study|Progressive Disease|24|||
160462202|NCT03248492|579423861|FG001|Overall Study|Progressive Disease|23|||
160462203|NCT03248492|579423862|FG002|Overall Study|Progressive Disease|11|||
160462204|NCT03248492|579423863|FG003|Overall Study|Progressive Disease|66|||
160462205|NCT03248492|579423864|FG004|Overall Study|Progressive Disease|1|||
160462206|NCT03248492|579423860|FG000|Overall Study|Adverse Event|14|||
160462207|NCT03248492|579423861|FG001|Overall Study|Adverse Event|13|||
160462208|NCT03248492|579423862|FG002|Overall Study|Adverse Event|9|||
160462209|NCT03248492|579423863|FG003|Overall Study|Adverse Event|22|||
160462210|NCT03248492|579423864|FG004|Overall Study|Adverse Event|2|||
160462211|NCT03248492|579423860|FG000|Overall Study|Withdrawal by Subject|5|||
160462212|NCT03248492|579423861|FG001|Overall Study|Withdrawal by Subject|4|||
160462213|NCT03248492|579423862|FG002|Overall Study|Withdrawal by Subject|0|||
160462214|NCT03248492|579423863|FG003|Overall Study|Withdrawal by Subject|8|||
160462215|NCT03248492|579423864|FG004|Overall Study|Withdrawal by Subject|1|||
160462216|NCT03248492|579423860|FG000|Overall Study|Physician Decision|1|||
160462217|NCT03248492|579423861|FG001|Overall Study|Physician Decision|1|||
160462218|NCT03248492|579423862|FG002|Overall Study|Physician Decision|1|||
160462219|NCT03248492|579423863|FG003|Overall Study|Physician Decision|7|||
160462220|NCT03248492|579423864|FG004|Overall Study|Physician Decision|0|||
160462221|NCT03248492|579423860|FG000|Overall Study|Death|1|||
160462222|NCT03248492|579423861|FG001|Overall Study|Death|1|||
160462223|NCT03248492|579423862|FG002|Overall Study|Death|0|||
160462224|NCT03248492|579423863|FG003|Overall Study|Death|6|||
160462225|NCT03248492|579423864|FG004|Overall Study|Death|0|||
160462226|NCT03248492|579423860|FG000|Overall Study|Study Terminated by Sponsor|3|||
160462227|NCT03248492|579423861|FG001|Overall Study|Study Terminated by Sponsor|1|||
160462228|NCT03248492|579423862|FG002|Overall Study|Study Terminated by Sponsor|0|||
160462229|NCT03248492|579423863|FG003|Overall Study|Study Terminated by Sponsor|7|||
160462230|NCT03248492|579423864|FG004|Overall Study|Study Terminated by Sponsor|0|||
160462231|NCT03248492|579423860|FG000|Overall Study|Other|2|||
160462232|NCT03248492|579423861|FG001|Overall Study|Other|5|||
160462233|NCT03248492|579423862|FG002|Overall Study|Other|0|||
160462234|NCT03248492|579423863|FG003|Overall Study|Other|14|||
160462235|NCT03248492|579423864|FG004|Overall Study|Other|0|||
160462236|NCT04495621|579423867|FG000|Overall Study|Withdrawal by Subject|0|||
160462237|NCT04495621|579423868|FG001|Overall Study|Withdrawal by Subject|3|||
160462238|NCT04495621|579423867|FG000|Overall Study|Death|7|||
160462239|NCT04495621|579423868|FG001|Overall Study|Death|11|||
160462240|NCT04495621|579423867|FG000|Overall Study|Investigator Decision|0|||
160462241|NCT04495621|579423868|FG001|Overall Study|Investigator Decision|7|||
160462242|NCT04495621|579423867|FG000|Overall Study|Lost to Follow-up|0|||
160462243|NCT04495621|579423868|FG001|Overall Study|Lost to Follow-up|1|||
160462244|NCT03774472|579423871|FG000|Overall Study|Physician Decision|1|||
160462245|NCT03774472|579423872|FG001|Overall Study|Physician Decision|0|||
160462246|NCT03774472|579423873|FG002|Overall Study|Physician Decision|0|||
160462247|NCT03774472|579423871|FG000|Overall Study|Progression prior to 4 weeks|0|||
160462248|NCT03774472|579423872|FG001|Overall Study|Progression prior to 4 weeks|1|||
160462249|NCT03774472|579423873|FG002|Overall Study|Progression prior to 4 weeks|0|||
160594745|NCT00505752|579894235|FG001|Overall Study|Other|2|||
160594746|NCT00505752|579894236|FG002|Overall Study|Other|1|||
160594747|NCT00505752|579894237|FG003|Overall Study|Other|2|||
160594748|NCT01624506|579894238|FG000|Overall Study|Lost to Follow-up|29|||
160594749|NCT01624506|579894239|FG001|Overall Study|Lost to Follow-up|15|||
160594750|NCT01624506|579894238|FG000|Overall Study|Withdrawal by Subject|9|||
160594751|NCT01624506|579894239|FG001|Overall Study|Withdrawal by Subject|2|||
160594752|NCT01624506|579894238|FG000|Overall Study|Death|1|||
160594753|NCT01624506|579894239|FG001|Overall Study|Death|0|||
160658611|NCT00162123|580131553|FG000|Overall Study|Not specified (before treatment)|2|||
160594754|NCT01624506|579894238|FG000|Overall Study|LINX explants|23|||
160594755|NCT01624506|579894239|FG001|Overall Study|LINX explants|0|||
160594756|NCT01624506|579894238|FG000|Overall Study|Adverse Event|3|||
160594757|NCT01624506|579894239|FG001|Overall Study|Adverse Event|0|||
160594758|NCT01149343|579894240|FG000|Overall Study|Withdrawal by Subject|1|||
160594759|NCT01149343|579894241|FG001|Overall Study|Withdrawal by Subject|1|||
160594760|NCT01149343|579894242|FG002|Overall Study|Withdrawal by Subject|1|||
160658612|NCT00162123|580131554|FG001|Overall Study|Not specified (before treatment)|0|||
160594761|NCT01149343|579894243|FG003|Overall Study|Withdrawal by Subject|5|||
160594762|NCT01149343|579894240|FG000|Overall Study|Death|10|||
160594763|NCT01149343|579894241|FG001|Overall Study|Death|13|||
160594764|NCT01149343|579894242|FG002|Overall Study|Death|18|||
160594765|NCT01149343|579894243|FG003|Overall Study|Death|18|||
160594766|NCT01149343|579894240|FG000|Overall Study|Lost to Follow-up|1|||
160594767|NCT01149343|579894241|FG001|Overall Study|Lost to Follow-up|0|||
160594768|NCT01149343|579894242|FG002|Overall Study|Lost to Follow-up|0|||
160594769|NCT01149343|579894243|FG003|Overall Study|Lost to Follow-up|1|||
160658613|NCT00162123|580131555|FG002|Overall Study|Not specified (before treatment)|0|||
160462250|NCT03774472|579423871|FG000|Overall Study|Withdrawal by Subject|0|||
160462251|NCT03774472|579423872|FG001|Overall Study|Withdrawal by Subject|1|||
160658614|NCT00162123|580131556|FG003|Overall Study|Not specified (before treatment)|0|||
160658615|NCT00162123|580131557|FG004|Overall Study|Not specified (before treatment)|12|||
160658616|NCT00162123|580131558|FG005|Overall Study|Not specified (before treatment)|1|||
160658617|NCT00162123|580131559|FG006|Overall Study|Not specified (before treatment)|0|||
160658618|NCT00162123|580131560|FG007|Overall Study|Not specified (before treatment)|0|||
160658619|NCT00162123|580131553|FG000|Overall Study|Not specified (after start of treatment)|0|||
160658620|NCT00162123|580131554|FG001|Overall Study|Not specified (after start of treatment)|0|||
160658621|NCT00162123|580131555|FG002|Overall Study|Not specified (after start of treatment)|0|||
160658622|NCT00162123|580131556|FG003|Overall Study|Not specified (after start of treatment)|0|||
160658623|NCT00162123|580131557|FG004|Overall Study|Not specified (after start of treatment)|3|||
160658624|NCT00162123|580131558|FG005|Overall Study|Not specified (after start of treatment)|0|||
160658625|NCT00162123|580131559|FG006|Overall Study|Not specified (after start of treatment)|0|||
160658626|NCT00162123|580131560|FG007|Overall Study|Not specified (after start of treatment)|0|||
160658627|NCT00162123|580131553|FG000|Overall Study|Physician Decision|1|||
160658628|NCT00162123|580131554|FG001|Overall Study|Physician Decision|2|||
160658629|NCT00162123|580131555|FG002|Overall Study|Physician Decision|0|||
160658630|NCT00162123|580131556|FG003|Overall Study|Physician Decision|0|||
160658631|NCT00162123|580131557|FG004|Overall Study|Physician Decision|0|||
160658632|NCT00162123|580131558|FG005|Overall Study|Physician Decision|1|||
160658633|NCT00162123|580131559|FG006|Overall Study|Physician Decision|1|||
160658634|NCT00162123|580131560|FG007|Overall Study|Physician Decision|0|||
160658635|NCT00162123|580131553|FG000|Overall Study|Tumor assessment only (not treated)|0|||
160658636|NCT00162123|580131554|FG001|Overall Study|Tumor assessment only (not treated)|0|||
160658637|NCT00162123|580131555|FG002|Overall Study|Tumor assessment only (not treated)|0|||
160658638|NCT00162123|580131556|FG003|Overall Study|Tumor assessment only (not treated)|0|||
160658639|NCT00162123|580131557|FG004|Overall Study|Tumor assessment only (not treated)|0|||
160658640|NCT00162123|580131558|FG005|Overall Study|Tumor assessment only (not treated)|0|||
160658641|NCT00162123|580131559|FG006|Overall Study|Tumor assessment only (not treated)|0|||
160658642|NCT00162123|580131560|FG007|Overall Study|Tumor assessment only (not treated)|1|||
160462252|NCT03774472|579423873|FG002|Overall Study|Withdrawal by Subject|0|||
160462253|NCT04059406|579423878|FG000|Overall Study|Early Treatment Termination|5|||
160658643|NCT00162123|580131553|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
160658644|NCT00162123|580131554|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
160658645|NCT00162123|580131555|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
160658646|NCT00162123|580131556|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
160462254|NCT04059406|579423879|FG001|Overall Study|Early Treatment Termination|5|||
160658647|NCT00162123|580131557|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
160658648|NCT00162123|580131558|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
160658649|NCT00162123|580131559|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
160658650|NCT00162123|580131560|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
160658651|NCT02016170|580131561|FG000|Overall Study|Adverse Event|1|||
160658652|NCT02016170|580131562|FG001|Overall Study|Adverse Event|1|||
160658653|NCT02016170|580131563|FG002|Overall Study|Adverse Event|0|||
160658654|NCT02016170|580131561|FG000|Overall Study|Protocol Violation|1|||
160658655|NCT02016170|580131562|FG001|Overall Study|Protocol Violation|0|||
160658656|NCT02016170|580131563|FG002|Overall Study|Protocol Violation|0|||
160658657|NCT05214560|580131568|FG000|Overall Study|Screening Failure|1|||
160658658|NCT05214560|580131568|FG000|Overall Study|Physician Decision|4|||
160658659|NCT05214560|580131568|FG000|Overall Study|Withdrawal by Subject|1|||
160658660|NCT05214560|580131568|FG000|Overall Study|Lost to Follow-up|2|||
160658661|NCT05214560|580131568|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
160658662|NCT05214560|580131568|FG000|Overall Study|Study physician not available for the anesthesia|3|||
160658663|NCT05214560|580131568|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
160658664|NCT05214560|580131568|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
160658665|NCT05214560|580131568|FG000|Overall Study|Surgery not performed|3|||
160658666|NCT00408902|580131572|FG000|Overall Study|Lack of Efficacy|7|||
160658667|NCT00408902|580131572|FG000|Overall Study|Adverse Event|3|||
160658668|NCT00878995|580131573|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
160658669|NCT00878995|580131574|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
160658670|NCT03629249|580131575|FG000|Overall Study|Study terminated by sponsor|197|||
160658671|NCT03629249|580131576|FG001|Overall Study|Study terminated by sponsor|197|||
160658672|NCT03629249|580131577|FG002|Overall Study|Study terminated by sponsor|194|||
160658673|NCT03629249|580131575|FG000|Overall Study|Protocol deviation|0|||
160658674|NCT03629249|580131576|FG001|Overall Study|Protocol deviation|2|||
160658675|NCT03629249|580131577|FG002|Overall Study|Protocol deviation|5|||
160658676|NCT03629249|580131575|FG000|Overall Study|Subject decision|1|||
160658677|NCT03629249|580131576|FG001|Overall Study|Subject decision|1|||
160658678|NCT03629249|580131577|FG002|Overall Study|Subject decision|3|||
160658679|NCT03629249|580131575|FG000|Overall Study|Adverse Event|1|||
160658680|NCT03629249|580131576|FG001|Overall Study|Adverse Event|1|||
160658681|NCT03629249|580131577|FG002|Overall Study|Adverse Event|0|||
160658682|NCT03629249|580131575|FG000|Overall Study|Death|1|||
160658683|NCT03629249|580131576|FG001|Overall Study|Death|0|||
160658684|NCT03629249|580131577|FG002|Overall Study|Death|0|||
160658685|NCT03629249|580131575|FG000|Overall Study|Physician Decision|1|||
160658686|NCT03629249|580131576|FG001|Overall Study|Physician Decision|0|||
160658687|NCT03629249|580131577|FG002|Overall Study|Physician Decision|0|||
160658688|NCT00352690|580131578|FG000|Overall Study|Determined to be ineligible|2|||
160462255|NCT04059406|579423880|FG002|Overall Study|Early Treatment Termination|15|||
160462256|NCT05155306|579423881|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
160594770|NCT01149343|579894240|FG000|Overall Study|Other|8|||
160462257|NCT05155306|579423882|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
160462258|NCT05155306|579423883|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
160462259|NCT05155306|579423884|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
160594771|NCT01149343|579894241|FG001|Overall Study|Other|10|||
160594772|NCT01149343|579894242|FG002|Overall Study|Other|2|||
160462260|NCT05155306|579423881|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
160462261|NCT05155306|579423882|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
160462262|NCT05155306|579423883|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
160462263|NCT05155306|579423884|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
160462264|NCT04158141|579423885|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
160462265|NCT04158141|579423886|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
160462266|NCT04158141|579423887|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
160462267|NCT04158141|579423885|FG000|Step 1: Registration|Adverse Event|1|||
160462268|NCT04158141|579423886|FG001|Step 1: Registration|Adverse Event|0|||
160462269|NCT04158141|579423887|FG002|Step 1: Registration|Adverse Event|0|||
160462270|NCT04158141|579423885|FG000|Step 1: Registration|Withdrawal by Subject|1|||
160462271|NCT04158141|579423886|FG001|Step 1: Registration|Withdrawal by Subject|0|||
160462272|NCT04158141|579423887|FG002|Step 1: Registration|Withdrawal by Subject|0|||
160462273|NCT04158141|579423885|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
160462274|NCT04158141|579423886|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
160462275|NCT04158141|579423887|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
160462276|NCT04121741|579423888|FG000|Overall Study|Protocol Violation|1|||
160462277|NCT04121741|579423889|FG001|Overall Study|Protocol Violation|0|||
160462278|NCT04121741|579423890|FG002|Overall Study|Protocol Violation|0|||
160462279|NCT04121741|579423891|FG003|Overall Study|Protocol Violation|0|||
160462280|NCT04121741|579423892|FG004|Overall Study|Protocol Violation|0|||
160462281|NCT04121741|579423893|FG005|Overall Study|Protocol Violation|0|||
160594773|NCT01149343|579894243|FG003|Overall Study|Other|14|||
160462282|NCT01084863|579423895|FG000|Main Study Treatment Period|Disease progression|11|||
160462283|NCT01084863|579423896|FG001|Main Study Treatment Period|Disease progression|7|||
160594774|NCT01149343|579894240|FG000|Overall Study|Sponsor study termination|0|||
160594775|NCT01149343|579894241|FG001|Overall Study|Sponsor study termination|0|||
160594776|NCT01149343|579894242|FG002|Overall Study|Sponsor study termination|0|||
160594777|NCT01149343|579894243|FG003|Overall Study|Sponsor study termination|2|||
160594778|NCT01149343|579894240|FG000|Overall Study|Recurrence / Progressive disease|0|||
160594779|NCT01149343|579894241|FG001|Overall Study|Recurrence / Progressive disease|0|||
160594780|NCT01149343|579894242|FG002|Overall Study|Recurrence / Progressive disease|1|||
160594781|NCT01149343|579894243|FG003|Overall Study|Recurrence / Progressive disease|0|||
160594782|NCT03472040|579894252|FG000|Overall Study|Physician Decision|0|||
160594783|NCT03472040|579894253|FG001|Overall Study|Physician Decision|3|||
160594784|NCT03472040|579894252|FG000|Overall Study|Withdrawal by Subject|10|||
160594785|NCT03472040|579894253|FG001|Overall Study|Withdrawal by Subject|23|||
160594786|NCT03472040|579894252|FG000|Overall Study|Perceived Lack of Efficacy|29|||
160594787|NCT03472040|579894253|FG001|Overall Study|Perceived Lack of Efficacy|30|||
160594788|NCT03472040|579894252|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
160594789|NCT03472040|579894253|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
160594790|NCT03472040|579894252|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
160594791|NCT03472040|579894253|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
160594792|NCT03472040|579894252|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
160594793|NCT03472040|579894253|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
160594794|NCT03472040|579894252|FG000|Overall Study|Subject Non-compliance|2|||
160594795|NCT03472040|579894253|FG001|Overall Study|Subject Non-compliance|5|||
160594796|NCT03472040|579894252|FG000|Overall Study|Discontinuation due to Rash|0|||
160594797|NCT03472040|579894253|FG001|Overall Study|Discontinuation due to Rash|1|||
160594798|NCT03472040|579894252|FG000|Overall Study|Subsequent Ineligibility|0|||
160594799|NCT03472040|579894253|FG001|Overall Study|Subsequent Ineligibility|2|||
160594800|NCT03472040|579894252|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
160594801|NCT03472040|579894253|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
160594802|NCT00225147|579894254|FG000|Open-label Phase|Lost to Follow-up|0|||
160594803|NCT00225147|579894255|FG001|Open-label Phase|Lost to Follow-up|0|||
160594804|NCT00225147|579894256|FG002|Open-label Phase|Lost to Follow-up|0|||
160594805|NCT00225147|579894257|FG003|Open-label Phase|Lost to Follow-up|4|||
160594806|NCT00225147|579894254|FG000|Open-label Phase|Withdrawal by Subject|0|||
160594807|NCT00225147|579894255|FG001|Open-label Phase|Withdrawal by Subject|0|||
160594808|NCT00225147|579894256|FG002|Open-label Phase|Withdrawal by Subject|0|||
160594809|NCT00225147|579894257|FG003|Open-label Phase|Withdrawal by Subject|6|||
160594810|NCT02197897|579894258|FG000|Overall Study|not eligible|1|||
160594811|NCT00650091|579894260|FG000|Amended Study Design|Withdrawal by Subject|12|||
160594812|NCT00650091|579894261|FG001|Amended Study Design|Withdrawal by Subject|11|||
160594813|NCT00650091|579894262|FG002|Amended Study Design|Withdrawal by Subject|0|||
160658689|NCT00352690|580131579|FG001|Overall Study|Determined to be ineligible|0|||
160658690|NCT03633721|580131582|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
160658691|NCT03633721|580131583|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
160658692|NCT03633721|580131584|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
160658693|NCT03633721|580131585|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
160658694|NCT01475474|580131589|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
160658695|NCT01475474|580131589|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
160658696|NCT02343120|580131590|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
160658697|NCT02343120|580131591|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
160658698|NCT02343120|580131592|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
160658699|NCT02343120|580131593|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
160658700|NCT02343120|580131594|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
160658701|NCT02343120|580131590|FG000|Part 1: Dose Escalation|Death|1|||
160658702|NCT02343120|580131591|FG001|Part 1: Dose Escalation|Death|2|||
160658703|NCT02343120|580131592|FG002|Part 1: Dose Escalation|Death|2|||
160462284|NCT01084863|579423895|FG000|Main Study Treatment Period|Adverse Event|5|||
160462285|NCT01084863|579423896|FG001|Main Study Treatment Period|Adverse Event|3|||
160462286|NCT01084863|579423895|FG000|Main Study Treatment Period|Other Reason|0|||
160658704|NCT02343120|580131593|FG003|Part 1: Dose Escalation|Death|2|||
160462287|NCT01084863|579423896|FG001|Main Study Treatment Period|Other Reason|1|||
160462288|NCT01084863|579423895|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
160462289|NCT01084863|579423896|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
160462290|NCT01084863|579423895|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
160462291|NCT01084863|579423896|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
160462292|NCT01084863|579423895|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
160462293|NCT01084863|579423896|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
160462294|NCT01084863|579423895|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
160462295|NCT01084863|579423896|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
160462296|NCT01084863|579423895|FG000|Treatment Period Beyond Cycle 8|Other|0|||
160462297|NCT01084863|579423896|FG001|Treatment Period Beyond Cycle 8|Other|1|||
160462298|NCT01084863|579423895|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
160462299|NCT01084863|579423896|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
160462300|NCT04505722|579423897|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
160462301|NCT04505722|579423898|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
160462302|NCT04505722|579423899|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
160462303|NCT04505722|579423897|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
160462304|NCT04505722|579423898|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
160462305|NCT04505722|579423899|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
160462306|NCT04505722|579423897|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
160462307|NCT04505722|579423898|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
160462308|NCT04505722|579423899|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
160462309|NCT04505722|579423897|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
160462310|NCT04505722|579423898|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
160462311|NCT04505722|579423899|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
160462312|NCT04505722|579423897|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
160462313|NCT04505722|579423898|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
160462314|NCT04505722|579423899|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
160462315|NCT04505722|579423897|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
160462316|NCT04505722|579423898|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
160462317|NCT04505722|579423899|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
160462318|NCT04505722|579423897|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
160462319|NCT04505722|579423898|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
160462320|NCT04505722|579423899|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
160462321|NCT04505722|579423897|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
160462322|NCT04505722|579423898|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
160462323|NCT04505722|579423899|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
160462324|NCT04505722|579423897|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
160462325|NCT04505722|579423898|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
160462326|NCT04505722|579423899|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
160462327|NCT04505722|579423897|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
160462328|NCT04505722|579423898|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
160462329|NCT04505722|579423899|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
160462330|NCT04505722|579423897|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
160462331|NCT04505722|579423898|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
160594814|NCT00650091|579894260|FG000|Amended Study Design|Physician Decision|5|||
160594815|NCT00650091|579894261|FG001|Amended Study Design|Physician Decision|0|||
160594816|NCT00650091|579894262|FG002|Amended Study Design|Physician Decision|0|||
160594817|NCT00650091|579894260|FG000|Amended Study Design|Adverse Event|1|||
160594818|NCT00650091|579894261|FG001|Amended Study Design|Adverse Event|4|||
160594819|NCT00650091|579894262|FG002|Amended Study Design|Adverse Event|0|||
160594820|NCT00650091|579894260|FG000|Amended Study Design|Lung transplantation|4|||
160594821|NCT00650091|579894261|FG001|Amended Study Design|Lung transplantation|2|||
160594822|NCT00650091|579894262|FG002|Amended Study Design|Lung transplantation|0|||
160594823|NCT00650091|579894260|FG000|Amended Study Design|Other|1|||
160594824|NCT00650091|579894261|FG001|Amended Study Design|Other|3|||
160594825|NCT00650091|579894262|FG002|Amended Study Design|Other|0|||
160594826|NCT04268004|579894278|FG000|Overall Study|Excluded from analyses|0|||
160658705|NCT02343120|580131594|FG004|Part 1: Dose Escalation|Death|1|||
160462332|NCT04505722|579423899|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
160462333|NCT04505722|579423897|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
160462334|NCT04505722|579423898|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
160462335|NCT04505722|579423899|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
160462336|NCT04505722|579423897|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
160594827|NCT04268004|579894279|FG001|Overall Study|Excluded from analyses|1|||
160594828|NCT04724733|579894282|FG000|Overall Study|Lost to Follow-up|1|||
160658706|NCT02343120|580131590|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
160594829|NCT04724733|579894283|FG001|Overall Study|Lost to Follow-up|1|||
160594830|NCT04724733|579894284|FG002|Overall Study|Lost to Follow-up|1|||
160594831|NCT03372603|579894285|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
160658707|NCT02343120|580131591|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
160462337|NCT04505722|579423898|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
160462338|NCT04505722|579423899|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
160462339|NCT04505722|579423897|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
160462340|NCT04505722|579423898|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
160462341|NCT04505722|579423899|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
160462342|NCT04505722|579423897|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
160462343|NCT04505722|579423898|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
160462344|NCT04505722|579423899|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
160462345|NCT04755595|579423900|FG000|Overall Study|Lost to Follow-up|1|||
160462346|NCT00319696|579423901|FG000|Overall Study|Adverse Event|36|||
160462347|NCT00319696|579423901|FG000|Overall Study|withdrawal of consent|14|||
160462348|NCT00319696|579423901|FG000|Overall Study|administrative|7|||
160462349|NCT00319696|579423901|FG000|Overall Study|Lost to Follow-up|3|||
160462350|NCT04305327|579423904|FG000|Overall Study|Study early termination|2|||
160462351|NCT04305327|579423905|FG001|Overall Study|Study early termination|5|||
160462352|NCT04305327|579423906|FG002|Overall Study|Study early termination|2|||
160462353|NCT04305327|579423907|FG003|Overall Study|Study early termination|2|||
160462354|NCT04305327|579423904|FG000|Overall Study|Withdrawal by Subject|0|||
160462355|NCT04305327|579423905|FG001|Overall Study|Withdrawal by Subject|1|||
160462356|NCT04305327|579423906|FG002|Overall Study|Withdrawal by Subject|0|||
160462357|NCT04305327|579423907|FG003|Overall Study|Withdrawal by Subject|0|||
160462358|NCT01288443|579424799|FG000|Overall Study|Adverse Event|0|||
160462359|NCT01288443|579424800|FG001|Overall Study|Adverse Event|0|||
160462360|NCT01288443|579424801|FG002|Overall Study|Adverse Event|1|||
160462361|NCT01288443|579424802|FG003|Overall Study|Adverse Event|1|||
160462362|NCT01288443|579424803|FG004|Overall Study|Adverse Event|3|||
160462363|NCT01288443|579424804|FG005|Overall Study|Adverse Event|1|||
160594832|NCT03372603|579894286|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
160594833|NCT03372603|579894285|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
160594834|NCT03372603|579894286|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
160594835|NCT03341923|579894287|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
160594836|NCT03341923|579894288|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
160594837|NCT03986190|579894289|FG000|Overall Study|Withdrawal by Subject|12|||
160594838|NCT03986190|579894290|FG001|Overall Study|Withdrawal by Subject|0|||
160594839|NCT04511819|579894291|FG000|Overall Study|Non-compliance with study drug|5|||
160462364|NCT01288443|579424799|FG000|Overall Study|Poor compliance to protocol|0|||
160462365|NCT01288443|579424800|FG001|Overall Study|Poor compliance to protocol|0|||
160462366|NCT01288443|579424801|FG002|Overall Study|Poor compliance to protocol|0|||
160462367|NCT01288443|579424802|FG003|Overall Study|Poor compliance to protocol|0|||
160462368|NCT01288443|579424803|FG004|Overall Study|Poor compliance to protocol|0|||
160658708|NCT02343120|580131592|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
160658709|NCT02343120|580131593|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
160658710|NCT02343120|580131594|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
160462369|NCT01288443|579424804|FG005|Overall Study|Poor compliance to protocol|1|||
160462370|NCT01288443|579424799|FG000|Overall Study|Participant Moved|0|||
160462371|NCT01288443|579424800|FG001|Overall Study|Participant Moved|0|||
160462372|NCT01288443|579424801|FG002|Overall Study|Participant Moved|0|||
160462373|NCT01288443|579424802|FG003|Overall Study|Participant Moved|1|||
160462374|NCT01288443|579424803|FG004|Overall Study|Participant Moved|2|||
160462375|NCT01288443|579424804|FG005|Overall Study|Participant Moved|1|||
160462376|NCT01288443|579424799|FG000|Overall Study|Consent withdrawn by Participant|0|||
160462377|NCT01288443|579424800|FG001|Overall Study|Consent withdrawn by Participant|0|||
160462378|NCT01288443|579424801|FG002|Overall Study|Consent withdrawn by Participant|0|||
160462379|NCT01288443|579424802|FG003|Overall Study|Consent withdrawn by Participant|0|||
160462380|NCT01288443|579424803|FG004|Overall Study|Consent withdrawn by Participant|0|||
160462381|NCT01288443|579424804|FG005|Overall Study|Consent withdrawn by Participant|1|||
160462382|NCT01288443|579424799|FG000|Overall Study|Lost to Follow-up|0|||
160462383|NCT01288443|579424800|FG001|Overall Study|Lost to Follow-up|1|||
160462384|NCT01288443|579424801|FG002|Overall Study|Lost to Follow-up|0|||
160462385|NCT01288443|579424802|FG003|Overall Study|Lost to Follow-up|0|||
160462386|NCT01288443|579424803|FG004|Overall Study|Lost to Follow-up|0|||
160462387|NCT01288443|579424804|FG005|Overall Study|Lost to Follow-up|0|||
160462388|NCT01288443|579424799|FG000|Overall Study|Study drug auto-injector administration|0|||
160462389|NCT01288443|579424800|FG001|Overall Study|Study drug auto-injector administration|0|||
160462390|NCT01288443|579424801|FG002|Overall Study|Study drug auto-injector administration|0|||
160462391|NCT01288443|579424802|FG003|Overall Study|Study drug auto-injector administration|0|||
160462392|NCT01288443|579424803|FG004|Overall Study|Study drug auto-injector administration|1|||
160462393|NCT01288443|579424804|FG005|Overall Study|Study drug auto-injector administration|1|||
160462394|NCT01288443|579424799|FG000|Overall Study|Other than above|0|||
160462395|NCT01288443|579424800|FG001|Overall Study|Other than above|0|||
160462396|NCT01288443|579424801|FG002|Overall Study|Other than above|0|||
160462397|NCT01288443|579424802|FG003|Overall Study|Other than above|2|||
160462398|NCT01288443|579424803|FG004|Overall Study|Other than above|1|||
160594840|NCT04511819|579894292|FG001|Overall Study|Non-compliance with study drug|1|||
160594841|NCT04511819|579894291|FG000|Overall Study|Withdrawal by Subject|0|||
160594842|NCT04511819|579894292|FG001|Overall Study|Withdrawal by Subject|3|||
160594843|NCT04511819|579894291|FG000|Overall Study|Adverse Event|0|||
160462399|NCT01288443|579424804|FG005|Overall Study|Other than above|0|||
160462400|NCT02438137|579424809|FG000|Overall Study|Lost to Follow-up|3|||
160462401|NCT02438137|579424810|FG001|Overall Study|Lost to Follow-up|2|||
160594844|NCT04511819|579894292|FG001|Overall Study|Adverse Event|1|||
160462402|NCT02438137|579424809|FG000|Overall Study|Adverse Event|1|||
160462403|NCT02438137|579424810|FG001|Overall Study|Adverse Event|0|||
160462404|NCT02438137|579424809|FG000|Overall Study|Withdrawal by Subject|4|||
160462405|NCT02438137|579424810|FG001|Overall Study|Withdrawal by Subject|3|||
160462406|NCT02438137|579424809|FG000|Overall Study|Physician Decision|0|||
160462407|NCT02438137|579424810|FG001|Overall Study|Physician Decision|1|||
160462408|NCT00945321|579424811|FG000|Period 1|Adverse Event|0|||
160462409|NCT00945321|579424812|FG001|Period 1|Adverse Event|0|||
160462410|NCT00945321|579424813|FG002|Period 1|Adverse Event|0|||
160462411|NCT00945321|579424814|FG003|Period 1|Adverse Event|0|||
160462412|NCT00945321|579424815|FG004|Period 1|Adverse Event|1|||
160462413|NCT00945321|579424816|FG005|Period 1|Adverse Event|0|||
160462414|NCT00945321|579424811|FG000|Period 4|Lost to Follow-up|0|||
160462415|NCT00945321|579424812|FG001|Period 4|Lost to Follow-up|0|||
160462416|NCT00945321|579424813|FG002|Period 4|Lost to Follow-up|0|||
160462417|NCT00945321|579424814|FG003|Period 4|Lost to Follow-up|0|||
160462418|NCT00945321|579424815|FG004|Period 4|Lost to Follow-up|0|||
160462419|NCT00945321|579424816|FG005|Period 4|Lost to Follow-up|1|||
160462420|NCT00692913|579424817|FG000|Overall Study|Adverse Event|8|||
160462421|NCT00692913|579424818|FG001|Overall Study|Adverse Event|4|||
160462422|NCT00692913|579424817|FG000|Overall Study|Lost to Follow-up|3|||
160462423|NCT00692913|579424818|FG001|Overall Study|Lost to Follow-up|5|||
160462424|NCT00692913|579424817|FG000|Overall Study|Physician Decision|2|||
160462425|NCT00692913|579424818|FG001|Overall Study|Physician Decision|0|||
160462426|NCT00692913|579424817|FG000|Overall Study|Protocol Violation|1|||
160462427|NCT00692913|579424818|FG001|Overall Study|Protocol Violation|1|||
160462428|NCT00692913|579424817|FG000|Overall Study|Withdrawal by Subject|15|||
160462429|NCT00692913|579424818|FG001|Overall Study|Withdrawal by Subject|20|||
160462430|NCT02291913|579424819|FG000|Overall Study|Progressive Disease|32|||
160462431|NCT02291913|579424819|FG000|Overall Study|Adverse Event|11|||
160462432|NCT02291913|579424819|FG000|Overall Study|Death|2|||
160462433|NCT02291913|579424819|FG000|Overall Study|Physician Decision|1|||
160462434|NCT02291913|579424819|FG000|Overall Study|Withdrawal by Subject|1|||
160462435|NCT02291913|579424819|FG000|Overall Study|Protocol Violation|1|||
160462436|NCT03621735|579424820|FG000|Overall Study|Withdrawal by Subject|13|||
160462437|NCT03621735|579424821|FG001|Overall Study|Withdrawal by Subject|13|||
160462438|NCT00605306|579424824|FG000|Overall Study|Adverse Event|0|||
160462439|NCT00605306|579424825|FG001|Overall Study|Adverse Event|1|||
160462440|NCT03875313|579424828|FG000|Overall Study|Withdrawal by Subject|1|||
160462441|NCT03875313|579424829|FG001|Overall Study|Withdrawal by Subject|3|||
160462442|NCT03875313|579424830|FG002|Overall Study|Withdrawal by Subject|0|||
160462443|NCT03875313|579424831|FG003|Overall Study|Withdrawal by Subject|0|||
160462444|NCT03875313|579424832|FG004|Overall Study|Withdrawal by Subject|0|||
160462445|NCT03875313|579424828|FG000|Overall Study|Death|0|||
160462446|NCT03875313|579424829|FG001|Overall Study|Death|0|||
160462447|NCT03875313|579424830|FG002|Overall Study|Death|0|||
160462448|NCT03875313|579424831|FG003|Overall Study|Death|0|||
160462449|NCT03875313|579424832|FG004|Overall Study|Death|1|||
160594845|NCT04511819|579894291|FG000|Overall Study|Protocol deviation|1|||
160594846|NCT04511819|579894292|FG001|Overall Study|Protocol deviation|0|||
160594847|NCT00844649|579894298|FG000|Overall Study|Progressive Disease|196|||
160594848|NCT00844649|579894299|FG001|Overall Study|Progressive Disease|245|||
160594849|NCT00844649|579894298|FG000|Overall Study|Adverse Event|128|||
160594850|NCT00844649|579894299|FG001|Overall Study|Adverse Event|73|||
160594851|NCT00844649|579894298|FG000|Overall Study|Physician Decision|25|||
160594852|NCT00844649|579894299|FG001|Overall Study|Physician Decision|18|||
160594853|NCT00844649|579894298|FG000|Overall Study|Protocol Violation|10|||
160594854|NCT00844649|579894299|FG001|Overall Study|Protocol Violation|6|||
160594855|NCT00844649|579894298|FG000|Overall Study|Withdrawal by Subject|28|||
160462450|NCT03875313|579424828|FG000|Overall Study|Lost to Follow-up|0|||
160594856|NCT00844649|579894299|FG001|Overall Study|Withdrawal by Subject|39|||
160462451|NCT03875313|579424829|FG001|Overall Study|Lost to Follow-up|0|||
160462452|NCT03875313|579424830|FG002|Overall Study|Lost to Follow-up|0|||
160462453|NCT03875313|579424831|FG003|Overall Study|Lost to Follow-up|0|||
160462454|NCT03875313|579424832|FG004|Overall Study|Lost to Follow-up|1|||
160462455|NCT03875313|579424828|FG000|Overall Study|Study Termination by Sponsor|0|||
160462456|NCT03875313|579424829|FG001|Overall Study|Study Termination by Sponsor|1|||
160462457|NCT03875313|579424830|FG002|Overall Study|Study Termination by Sponsor|1|||
160462458|NCT03875313|579424831|FG003|Overall Study|Study Termination by Sponsor|0|||
160462459|NCT03875313|579424832|FG004|Overall Study|Study Termination by Sponsor|1|||
160462460|NCT03875313|579424828|FG000|Overall Study|New Anticancer Treatment|0|||
160462461|NCT03875313|579424829|FG001|Overall Study|New Anticancer Treatment|1|||
160462462|NCT03875313|579424830|FG002|Overall Study|New Anticancer Treatment|2|||
160462463|NCT03875313|579424831|FG003|Overall Study|New Anticancer Treatment|1|||
160462464|NCT03875313|579424832|FG004|Overall Study|New Anticancer Treatment|0|||
160462465|NCT03875313|579424828|FG000|Overall Study|Other, Not Specified|2|||
160462466|NCT03875313|579424829|FG001|Overall Study|Other, Not Specified|11|||
160594857|NCT00844649|579894298|FG000|Overall Study|Other|7|||
160594858|NCT00844649|579894299|FG001|Overall Study|Other|10|||
160594859|NCT00844649|579894298|FG000|Overall Study|Withdrew prior to starting treatment|11|||
160594860|NCT00844649|579894299|FG001|Overall Study|Withdrew prior to starting treatment|27|||
160594861|NCT01594333|579894301|FG000|Overall Study|Death|96|||
160594862|NCT01594333|579894302|FG001|Overall Study|Death|83|||
160594863|NCT01594333|579894301|FG000|Overall Study|Lost to Follow-up|5|||
160594864|NCT01594333|579894302|FG001|Overall Study|Lost to Follow-up|5|||
160594865|NCT01594333|579894301|FG000|Overall Study|Withdrawal by Subject|60|||
160594866|NCT01594333|579894302|FG001|Overall Study|Withdrawal by Subject|63|||
160594867|NCT00589979|579894303|FG000|Run-In Period|Adverse Event|5|||
160977712|NCT01051063|581308029|FG001|Overall Study|Termination of the study|0|||
160977713|NCT01051063|581308028|FG000|Overall Study|Moved from the study site area|1|||
160977714|NCT01051063|581308029|FG001|Overall Study|Moved from the study site area|0|||
160977715|NCT01051063|581308028|FG000|Overall Study|Other|1|||
160594868|NCT00589979|579894304|FG001|Run-In Period|Adverse Event|0|||
160594869|NCT00589979|579894305|FG002|Run-In Period|Adverse Event|0|||
160594870|NCT00589979|579894303|FG000|Run-In Period|Protocol Violation|3|||
160594871|NCT00589979|579894304|FG001|Run-In Period|Protocol Violation|0|||
160594872|NCT00589979|579894305|FG002|Run-In Period|Protocol Violation|0|||
160977716|NCT01051063|581308029|FG001|Overall Study|Other|0|||
160977717|NCT01051063|581308028|FG000|Overall Study|Lost to Follow-up|0|||
160977718|NCT01051063|581308029|FG001|Overall Study|Lost to Follow-up|1|||
160977719|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
160977720|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
160977721|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
160977722|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
160977723|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
160977724|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
160977725|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
160977726|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
160977727|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
160977728|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
160977729|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
160977730|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
160977731|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
160977732|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
160977733|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
160977734|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
160977735|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
160977736|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
160977737|NCT02023879|581308032|FG000|Extension Open Label Treatment|Adverse Event|1|||
160977738|NCT02023879|581308033|FG001|Extension Open Label Treatment|Adverse Event|7|||
160977739|NCT02023879|581308034|FG002|Extension Open Label Treatment|Adverse Event|3|||
160977740|NCT02023879|581308032|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
160977741|NCT02023879|581308033|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
160977742|NCT02023879|581308034|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
160462467|NCT03875313|579424830|FG002|Overall Study|Other, Not Specified|3|||
160977743|NCT02023879|581308032|FG000|Extension Open Label Treatment|Participant moved|1|||
160977744|NCT02023879|581308033|FG001|Extension Open Label Treatment|Participant moved|2|||
160977745|NCT02023879|581308034|FG002|Extension Open Label Treatment|Participant moved|0|||
160462468|NCT03875313|579424831|FG003|Overall Study|Other, Not Specified|3|||
160462469|NCT03875313|579424832|FG004|Overall Study|Other, Not Specified|1|||
160977746|NCT02023879|581308032|FG000|Extension Open Label Treatment|Other than specified above|2|||
160594873|NCT00589979|579894303|FG000|Run-In Period|Did not qualify for randomization|54|||
160594874|NCT00589979|579894304|FG001|Run-In Period|Did not qualify for randomization|0|||
160594875|NCT00589979|579894305|FG002|Run-In Period|Did not qualify for randomization|0|||
160594876|NCT00589979|579894303|FG000|Run-In Period|Withdrawal by Subject|10|||
160594877|NCT00589979|579894304|FG001|Run-In Period|Withdrawal by Subject|0|||
160594878|NCT00589979|579894305|FG002|Run-In Period|Withdrawal by Subject|0|||
160594879|NCT00589979|579894303|FG000|Run-In Period|Informed Consent Withdrawn|4|||
160594880|NCT00589979|579894304|FG001|Run-In Period|Informed Consent Withdrawn|0|||
160594881|NCT00589979|579894305|FG002|Run-In Period|Informed Consent Withdrawn|0|||
160594882|NCT00589979|579894303|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
160977747|NCT02023879|581308033|FG001|Extension Open Label Treatment|Other than specified above|7|||
160977748|NCT02023879|581308034|FG002|Extension Open Label Treatment|Other than specified above|2|||
160977749|NCT00874432|581308035|FG000|Overall Study|Withdrawal by Subject|1|||
160977750|NCT00874432|581308036|FG001|Overall Study|Withdrawal by Subject|0|||
160977751|NCT00874432|581308037|FG002|Overall Study|Withdrawal by Subject|0|||
160977752|NCT00874432|581308038|FG003|Overall Study|Withdrawal by Subject|0|||
160977753|NCT00874432|581308035|FG000|Overall Study|Physician Decision|1|||
160977754|NCT00874432|581308036|FG001|Overall Study|Physician Decision|0|||
160977755|NCT00874432|581308037|FG002|Overall Study|Physician Decision|0|||
160462470|NCT01092416|579424833|FG000|Enrollment|Atherectomy device not inserted|3|||
160462471|NCT01092416|579424833|FG000|30-Day Follow-up|Death|2|||
160462472|NCT01092416|579424833|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
160462473|NCT01092416|579424833|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
160462474|NCT01092416|579424833|FG000|12-Month Follow-up|Death|16|||
160462475|NCT01092416|579424833|FG000|12-Month Follow-up|Lost to Follow-up|4|||
160462476|NCT01092416|579424833|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
160462477|NCT01092416|579424833|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
160462478|NCT01092416|579424833|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
160462479|NCT03709706|579424834|FG000|Overall Study|Adverse Event|0|||
160462480|NCT03709706|579424835|FG001|Overall Study|Adverse Event|1|||
160462481|NCT03709706|579424834|FG000|Overall Study|Physician Decision|14|||
160462482|NCT03709706|579424835|FG001|Overall Study|Physician Decision|8|||
160462483|NCT03709706|579424834|FG000|Overall Study|Withdrawal by Subject|2|||
160462484|NCT03709706|579424835|FG001|Overall Study|Withdrawal by Subject|1|||
160462485|NCT03709706|579424834|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
160462486|NCT03709706|579424835|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
160462487|NCT01105975|579424836|FG000|Overall Study|Adverse Event|2|||
160462488|NCT01105975|579424837|FG001|Overall Study|Adverse Event|1|||
160462489|NCT01105975|579424838|FG002|Overall Study|Adverse Event|5|||
160462490|NCT01105975|579424839|FG003|Overall Study|Adverse Event|1|||
160462491|NCT01105975|579424840|FG004|Overall Study|Adverse Event|0|||
160462492|NCT01105975|579424841|FG005|Overall Study|Adverse Event|1|||
160462493|NCT01105975|579424842|FG006|Overall Study|Adverse Event|2|||
160462494|NCT01105975|579424843|FG007|Overall Study|Adverse Event|4|||
160462495|NCT01105975|579424844|FG008|Overall Study|Adverse Event|1|||
160462496|NCT01105975|579424845|FG009|Overall Study|Adverse Event|4|||
160594883|NCT00589979|579894304|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
160462497|NCT01105975|579424836|FG000|Overall Study|Withdrawal by Subject|2|||
160462498|NCT01105975|579424837|FG001|Overall Study|Withdrawal by Subject|2|||
160977756|NCT00874432|581308038|FG003|Overall Study|Physician Decision|0|||
160977757|NCT00874432|581308035|FG000|Overall Study|Other|1|||
160977758|NCT00874432|581308036|FG001|Overall Study|Other|2|||
160977759|NCT00874432|581308037|FG002|Overall Study|Other|8|||
160977760|NCT00874432|581308038|FG003|Overall Study|Other|3|||
160977761|NCT05256381|581308039|FG000|Overall Study|Withdrawal by Subject|4|||
160977762|NCT05256381|581308040|FG001|Overall Study|Withdrawal by Subject|0|||
160977763|NCT05256381|581308041|FG002|Overall Study|Withdrawal by Subject|2|||
160977764|NCT05256381|581308042|FG003|Overall Study|Withdrawal by Subject|2|||
160977765|NCT05256381|581308043|FG004|Overall Study|Withdrawal by Subject|8|||
160977766|NCT05256381|581308044|FG005|Overall Study|Withdrawal by Subject|6|||
160977767|NCT05256381|581308039|FG000|Overall Study|Physician Decision|0|||
160977768|NCT05256381|581308040|FG001|Overall Study|Physician Decision|0|||
160977769|NCT05256381|581308041|FG002|Overall Study|Physician Decision|1|||
160977770|NCT05256381|581308042|FG003|Overall Study|Physician Decision|0|||
160977771|NCT05256381|581308043|FG004|Overall Study|Physician Decision|2|||
160977772|NCT05256381|581308044|FG005|Overall Study|Physician Decision|0|||
160977773|NCT05256381|581308039|FG000|Overall Study|Death|17|||
160977774|NCT05256381|581308040|FG001|Overall Study|Death|3|||
160977775|NCT05256381|581308041|FG002|Overall Study|Death|4|||
160977776|NCT05256381|581308042|FG003|Overall Study|Death|5|||
160977777|NCT05256381|581308043|FG004|Overall Study|Death|24|||
160977778|NCT05256381|581308044|FG005|Overall Study|Death|21|||
160977779|NCT05256381|581308039|FG000|Overall Study|Other, not specified|0|||
160977780|NCT05256381|581308040|FG001|Overall Study|Other, not specified|0|||
160977781|NCT05256381|581308041|FG002|Overall Study|Other, not specified|0|||
160977782|NCT05256381|581308042|FG003|Overall Study|Other, not specified|0|||
160977783|NCT05256381|581308043|FG004|Overall Study|Other, not specified|2|||
160977784|NCT05256381|581308044|FG005|Overall Study|Other, not specified|1|||
160977785|NCT05256381|581308039|FG000|Overall Study|Study terminated by sponsor|18|||
160977786|NCT05256381|581308040|FG001|Overall Study|Study terminated by sponsor|5|||
160977787|NCT05256381|581308041|FG002|Overall Study|Study terminated by sponsor|5|||
160977788|NCT05256381|581308042|FG003|Overall Study|Study terminated by sponsor|5|||
160977789|NCT05256381|581308043|FG004|Overall Study|Study terminated by sponsor|18|||
160977790|NCT05256381|581308044|FG005|Overall Study|Study terminated by sponsor|11|||
160977791|NCT05256381|581308039|FG000|Overall Study|Lost to Follow-up|1|||
160977792|NCT05256381|581308040|FG001|Overall Study|Lost to Follow-up|0|||
160977793|NCT05256381|581308041|FG002|Overall Study|Lost to Follow-up|0|||
160977794|NCT05256381|581308042|FG003|Overall Study|Lost to Follow-up|0|||
160977795|NCT05256381|581308043|FG004|Overall Study|Lost to Follow-up|1|||
160977796|NCT05256381|581308044|FG005|Overall Study|Lost to Follow-up|0|||
160977797|NCT01518946|581308047|FG000|Open-label Phase|Other|4|||
160462499|NCT01105975|579424838|FG002|Overall Study|Withdrawal by Subject|2|||
160462500|NCT01105975|579424839|FG003|Overall Study|Withdrawal by Subject|0|||
160462501|NCT01105975|579424840|FG004|Overall Study|Withdrawal by Subject|4|||
160462502|NCT01105975|579424841|FG005|Overall Study|Withdrawal by Subject|1|||
160462503|NCT01105975|579424842|FG006|Overall Study|Withdrawal by Subject|2|||
160462504|NCT01105975|579424843|FG007|Overall Study|Withdrawal by Subject|1|||
160462505|NCT01105975|579424844|FG008|Overall Study|Withdrawal by Subject|0|||
160462506|NCT01105975|579424845|FG009|Overall Study|Withdrawal by Subject|3|||
160462507|NCT01105975|579424836|FG000|Overall Study|Lost to Follow-up|1|||
160462508|NCT01105975|579424837|FG001|Overall Study|Lost to Follow-up|0|||
160462509|NCT01105975|579424838|FG002|Overall Study|Lost to Follow-up|0|||
160462510|NCT01105975|579424839|FG003|Overall Study|Lost to Follow-up|1|||
160462511|NCT01105975|579424840|FG004|Overall Study|Lost to Follow-up|1|||
160462512|NCT01105975|579424841|FG005|Overall Study|Lost to Follow-up|0|||
160462513|NCT01105975|579424842|FG006|Overall Study|Lost to Follow-up|0|||
160462514|NCT01105975|579424843|FG007|Overall Study|Lost to Follow-up|0|||
160462515|NCT01105975|579424844|FG008|Overall Study|Lost to Follow-up|1|||
160462516|NCT01105975|579424845|FG009|Overall Study|Lost to Follow-up|0|||
160462517|NCT01105975|579424836|FG000|Overall Study|Physician Decision|0|||
160462518|NCT01105975|579424837|FG001|Overall Study|Physician Decision|0|||
160462519|NCT01105975|579424838|FG002|Overall Study|Physician Decision|0|||
160462520|NCT01105975|579424839|FG003|Overall Study|Physician Decision|0|||
160462521|NCT01105975|579424840|FG004|Overall Study|Physician Decision|0|||
160462522|NCT01105975|579424841|FG005|Overall Study|Physician Decision|0|||
160462523|NCT01105975|579424842|FG006|Overall Study|Physician Decision|2|||
160462524|NCT01105975|579424843|FG007|Overall Study|Physician Decision|0|||
160462525|NCT01105975|579424844|FG008|Overall Study|Physician Decision|0|||
160462526|NCT01105975|579424845|FG009|Overall Study|Physician Decision|0|||
160462527|NCT01105975|579424836|FG000|Overall Study|Protocol Violation|0|||
160462528|NCT01105975|579424837|FG001|Overall Study|Protocol Violation|2|||
160462529|NCT01105975|579424838|FG002|Overall Study|Protocol Violation|2|||
160462530|NCT01105975|579424839|FG003|Overall Study|Protocol Violation|0|||
160462531|NCT01105975|579424840|FG004|Overall Study|Protocol Violation|1|||
160462532|NCT01105975|579424841|FG005|Overall Study|Protocol Violation|1|||
160462533|NCT01105975|579424842|FG006|Overall Study|Protocol Violation|1|||
160462534|NCT01105975|579424843|FG007|Overall Study|Protocol Violation|1|||
160462535|NCT01105975|579424844|FG008|Overall Study|Protocol Violation|2|||
160462536|NCT01105975|579424845|FG009|Overall Study|Protocol Violation|2|||
160462537|NCT01105975|579424836|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
160462538|NCT01105975|579424837|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
160462539|NCT01105975|579424838|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
160462540|NCT01105975|579424839|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
160462541|NCT01105975|579424840|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
160462542|NCT01105975|579424841|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
160462543|NCT01105975|579424842|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
160462544|NCT01105975|579424843|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
160462545|NCT01105975|579424844|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
160462546|NCT01105975|579424845|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
160462547|NCT04868617|579424846|FG000|Overall Study|Death|1|||
160462548|NCT04868617|579424847|FG001|Overall Study|Death|0|||
160462549|NCT04868617|579424846|FG000|Overall Study|Adverse Event|1|||
160462550|NCT04868617|579424847|FG001|Overall Study|Adverse Event|0|||
160462551|NCT04868617|579424846|FG000|Overall Study|Withdrawal by Subject|1|||
160462552|NCT04868617|579424847|FG001|Overall Study|Withdrawal by Subject|0|||
160462553|NCT04868617|579424846|FG000|Overall Study|Device deficiency|1|||
160462554|NCT04868617|579424847|FG001|Overall Study|Device deficiency|0|||
160462555|NCT03183050|579424848|FG000|Overall Study|Lost to Follow-up|23|||
160462556|NCT02797132|579424851|FG000|Part A (15 Days)|Adverse Event|1|||
160462557|NCT02797132|579424851|FG000|Part B (24 Weeks)|Adverse Event|3|||
160462558|NCT02502526|579424852|FG000|Overall Study|Lost to Follow-up|2|||
160462559|NCT02502526|579424853|FG001|Overall Study|Lost to Follow-up|2|||
160462560|NCT02502526|579424854|FG002|Overall Study|Lost to Follow-up|3|||
160462561|NCT02502526|579424852|FG000|Overall Study|Withdrawal by Subject|0|||
160462562|NCT02502526|579424853|FG001|Overall Study|Withdrawal by Subject|1|||
160462563|NCT02502526|579424854|FG002|Overall Study|Withdrawal by Subject|1|||
160658711|NCT02343120|580131590|FG000|Part 2: Expansion|Sponsor decision|0|||
160462564|NCT02502526|579424852|FG000|Overall Study|Disqualified due to cataract grading|0|||
160462565|NCT02502526|579424853|FG001|Overall Study|Disqualified due to cataract grading|0|||
160462566|NCT02502526|579424854|FG002|Overall Study|Disqualified due to cataract grading|1|||
160462567|NCT02502526|579424852|FG000|Overall Study|Enrollment suspension|4|||
160462568|NCT02502526|579424853|FG001|Overall Study|Enrollment suspension|1|||
160462569|NCT02502526|579424854|FG002|Overall Study|Enrollment suspension|1|||
160462570|NCT03150862|579424855|FG000|Overall Study|Death|2|||
160462571|NCT03150862|579424856|FG001|Overall Study|Death|7|||
160462572|NCT03150862|579424857|FG002|Overall Study|Death|8|||
160462573|NCT03150862|579424858|FG003|Overall Study|Death|27|||
160462574|NCT03150862|579424859|FG004|Overall Study|Death|4|||
160977798|NCT01518946|581308048|FG001|Open-label Phase|Other|0|||
160977799|NCT01518946|581308049|FG002|Open-label Phase|Other|0|||
160977800|NCT01518946|581308047|FG000|Randomized Phase (First Intervention)|Other|0|||
160977801|NCT01518946|581308048|FG001|Randomized Phase (First Intervention)|Other|1|||
160977802|NCT01518946|581308049|FG002|Randomized Phase (First Intervention)|Other|0|||
160594884|NCT00589979|579894305|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
160594885|NCT00589979|579894303|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
160594886|NCT00589979|579894304|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
160594887|NCT00589979|579894305|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
160462575|NCT03150862|579424860|FG005|Overall Study|Death|8|||
160462576|NCT03150862|579424861|FG006|Overall Study|Death|6|||
160462577|NCT03150862|579424862|FG007|Overall Study|Death|21|||
160462578|NCT03150862|579424855|FG000|Overall Study|Withdrawal by Subject|1|||
160462579|NCT03150862|579424856|FG001|Overall Study|Withdrawal by Subject|1|||
160462580|NCT03150862|579424857|FG002|Overall Study|Withdrawal by Subject|0|||
160594888|NCT00589979|579894303|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
160594889|NCT00589979|579894304|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
160462581|NCT03150862|579424858|FG003|Overall Study|Withdrawal by Subject|3|||
160462582|NCT03150862|579424859|FG004|Overall Study|Withdrawal by Subject|1|||
160462583|NCT03150862|579424860|FG005|Overall Study|Withdrawal by Subject|1|||
160462584|NCT03150862|579424861|FG006|Overall Study|Withdrawal by Subject|1|||
160462585|NCT03150862|579424862|FG007|Overall Study|Withdrawal by Subject|3|||
160462586|NCT03150862|579424855|FG000|Overall Study|Lost to Follow-up|0|||
160462587|NCT03150862|579424856|FG001|Overall Study|Lost to Follow-up|0|||
160462588|NCT03150862|579424857|FG002|Overall Study|Lost to Follow-up|1|||
160462589|NCT03150862|579424858|FG003|Overall Study|Lost to Follow-up|0|||
160462590|NCT03150862|579424859|FG004|Overall Study|Lost to Follow-up|0|||
160462591|NCT03150862|579424860|FG005|Overall Study|Lost to Follow-up|0|||
160462592|NCT03150862|579424861|FG006|Overall Study|Lost to Follow-up|0|||
160462593|NCT03150862|579424862|FG007|Overall Study|Lost to Follow-up|2|||
160462594|NCT03150862|579424855|FG000|Overall Study|Sponsor's decision|0|||
160594890|NCT00589979|579894305|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
160462595|NCT03150862|579424856|FG001|Overall Study|Sponsor's decision|0|||
160462596|NCT03150862|579424857|FG002|Overall Study|Sponsor's decision|0|||
160462597|NCT03150862|579424858|FG003|Overall Study|Sponsor's decision|10|||
160462598|NCT03150862|579424859|FG004|Overall Study|Sponsor's decision|3|||
160462599|NCT03150862|579424860|FG005|Overall Study|Sponsor's decision|0|||
160462600|NCT03150862|579424861|FG006|Overall Study|Sponsor's decision|1|||
160462601|NCT03150862|579424862|FG007|Overall Study|Sponsor's decision|1|||
160594891|NCT00589979|579894303|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
160462602|NCT03150862|579424855|FG000|Overall Study|Change in Methylation status|0|||
160462603|NCT03150862|579424856|FG001|Overall Study|Change in Methylation status|0|||
160594892|NCT00589979|579894304|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
160594893|NCT00589979|579894305|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
160462604|NCT03150862|579424857|FG002|Overall Study|Change in Methylation status|0|||
160462605|NCT03150862|579424858|FG003|Overall Study|Change in Methylation status|0|||
160462606|NCT03150862|579424859|FG004|Overall Study|Change in Methylation status|1|||
160462607|NCT03150862|579424860|FG005|Overall Study|Change in Methylation status|0|||
160462608|NCT03150862|579424861|FG006|Overall Study|Change in Methylation status|0|||
160462609|NCT03150862|579424862|FG007|Overall Study|Change in Methylation status|0|||
160462610|NCT03150862|579424855|FG000|Overall Study|Roll over in to Long Term Extension|0|||
160462611|NCT03150862|579424856|FG001|Overall Study|Roll over in to Long Term Extension|0|||
160462612|NCT03150862|579424857|FG002|Overall Study|Roll over in to Long Term Extension|0|||
160462613|NCT03150862|579424858|FG003|Overall Study|Roll over in to Long Term Extension|0|||
160462614|NCT03150862|579424859|FG004|Overall Study|Roll over in to Long Term Extension|0|||
160462615|NCT03150862|579424860|FG005|Overall Study|Roll over in to Long Term Extension|0|||
160462616|NCT03150862|579424861|FG006|Overall Study|Roll over in to Long Term Extension|0|||
160462617|NCT03150862|579424862|FG007|Overall Study|Roll over in to Long Term Extension|1|||
160462618|NCT03150862|579424855|FG000|Overall Study|Progressive Disease|0|||
160462619|NCT03150862|579424856|FG001|Overall Study|Progressive Disease|0|||
160462620|NCT03150862|579424857|FG002|Overall Study|Progressive Disease|0|||
160462621|NCT03150862|579424858|FG003|Overall Study|Progressive Disease|0|||
160462622|NCT03150862|579424859|FG004|Overall Study|Progressive Disease|0|||
160462623|NCT03150862|579424860|FG005|Overall Study|Progressive Disease|0|||
160462624|NCT03150862|579424861|FG006|Overall Study|Progressive Disease|0|||
160462625|NCT03150862|579424862|FG007|Overall Study|Progressive Disease|2|||
160462626|NCT03473223|579424868|FG000|Overall Study|Lost to Follow-up|1|||
160462627|NCT03473223|579424869|FG001|Overall Study|Lost to Follow-up|1|||
160462628|NCT03473223|579424868|FG000|Overall Study|Withdrawal by Subject|47|||
160462629|NCT03473223|579424869|FG001|Overall Study|Withdrawal by Subject|42|||
160462630|NCT03473223|579424868|FG000|Overall Study|Indirect contact|32|||
160462631|NCT03473223|579424869|FG001|Overall Study|Indirect contact|29|||
160462632|NCT03473223|579424868|FG000|Overall Study|Other (Not specified)|32|||
160462633|NCT03473223|579424869|FG001|Overall Study|Other (Not specified)|20|||
160462634|NCT03777657|579424871|FG000|Overall Study|Death|397|||
160462635|NCT03777657|579424872|FG001|Overall Study|Death|431|||
160462636|NCT03777657|579424871|FG000|Overall Study|Study Closed by Sponsor|77|||
160462637|NCT03777657|579424872|FG001|Overall Study|Study Closed by Sponsor|38|||
160462638|NCT03777657|579424871|FG000|Overall Study|Withdrawal by Subject|20|||
160462639|NCT03777657|579424872|FG001|Overall Study|Withdrawal by Subject|17|||
160462640|NCT03777657|579424871|FG000|Overall Study|Lost to Follow-up|6|||
160462641|NCT03777657|579424872|FG001|Overall Study|Lost to Follow-up|10|||
160462642|NCT02549352|579424875|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
160462643|NCT02549352|579424876|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
160462644|NCT02549352|579424875|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
160462645|NCT02549352|579424876|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
160462646|NCT02549352|579424875|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
160462647|NCT02549352|579424876|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
160462648|NCT02549352|579424875|FG000|12-month Follow-up|Withdrawal by Subject|4|||
160462649|NCT02549352|579424876|FG001|12-month Follow-up|Withdrawal by Subject|5|||
160462650|NCT02549352|579424875|FG000|12-month Follow-up|Lost to Follow-up|3|||
160462651|NCT02549352|579424876|FG001|12-month Follow-up|Lost to Follow-up|2|||
160462652|NCT02549352|579424875|FG000|12-month Follow-up|Death|0|||
160462653|NCT02549352|579424876|FG001|12-month Follow-up|Death|1|||
160462654|NCT02549352|579424875|FG000|12-month Follow-up|Protocol Violation|0|||
160462655|NCT02549352|579424876|FG001|12-month Follow-up|Protocol Violation|1|||
160462656|NCT02549352|579424875|FG000|12-month Follow-up|Other|1|||
160462657|NCT02549352|579424876|FG001|12-month Follow-up|Other|3|||
160462658|NCT05864209|579425453|FG000|Overall Study|Lost to Follow-up|2|||
160462659|NCT05864209|579425454|FG001|Overall Study|Lost to Follow-up|3|||
160594894|NCT00589979|579894303|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
160594895|NCT00589979|579894304|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
160462660|NCT04530487|579425455|FG000|Overall Study|Death|1|||
160462661|NCT04977583|579425456|FG000|Overall Study|Lost to Follow-up|8|||
160462662|NCT04977583|579425457|FG001|Overall Study|Lost to Follow-up|4|||
160462663|NCT04977583|579425458|FG002|Overall Study|Lost to Follow-up|13|||
160462664|NCT04977583|579425456|FG000|Overall Study|Withdrawal by Subject|3|||
160462665|NCT04977583|579425457|FG001|Overall Study|Withdrawal by Subject|2|||
160462666|NCT04977583|579425458|FG002|Overall Study|Withdrawal by Subject|1|||
160462667|NCT00146172|579425463|FG000|Overall Study|Adverse Event|0|||
160462668|NCT00146172|579425464|FG001|Overall Study|Adverse Event|0|||
160462669|NCT00146172|579425465|FG002|Overall Study|Adverse Event|1|||
160462670|NCT00146172|579425466|FG003|Overall Study|Adverse Event|1|||
160462671|NCT00146172|579425467|FG004|Overall Study|Adverse Event|0|||
160462672|NCT00146172|579425468|FG005|Overall Study|Adverse Event|2|||
160462673|NCT00146172|579425469|FG006|Overall Study|Adverse Event|3|||
160462674|NCT00146172|579425470|FG007|Overall Study|Adverse Event|10|||
160462675|NCT00146172|579425463|FG000|Overall Study|Lost to Follow-up|0|||
160462676|NCT00146172|579425464|FG001|Overall Study|Lost to Follow-up|0|||
160462677|NCT00146172|579425465|FG002|Overall Study|Lost to Follow-up|0|||
160462678|NCT00146172|579425466|FG003|Overall Study|Lost to Follow-up|0|||
160462679|NCT00146172|579425467|FG004|Overall Study|Lost to Follow-up|0|||
160462680|NCT00146172|579425468|FG005|Overall Study|Lost to Follow-up|0|||
160462681|NCT00146172|579425469|FG006|Overall Study|Lost to Follow-up|0|||
160462682|NCT00146172|579425470|FG007|Overall Study|Lost to Follow-up|1|||
160462683|NCT00146172|579425463|FG000|Overall Study|Disease Progression|2|||
160462684|NCT00146172|579425464|FG001|Overall Study|Disease Progression|4|||
160462685|NCT00146172|579425465|FG002|Overall Study|Disease Progression|2|||
160462686|NCT00146172|579425466|FG003|Overall Study|Disease Progression|5|||
160462687|NCT00146172|579425467|FG004|Overall Study|Disease Progression|2|||
160462688|NCT00146172|579425468|FG005|Overall Study|Disease Progression|2|||
160462689|NCT00146172|579425469|FG006|Overall Study|Disease Progression|1|||
160462690|NCT00146172|579425470|FG007|Overall Study|Disease Progression|22|||
160462691|NCT00146172|579425463|FG000|Overall Study|Death|0|||
160462692|NCT00146172|579425464|FG001|Overall Study|Death|0|||
160462693|NCT00146172|579425465|FG002|Overall Study|Death|0|||
160462694|NCT00146172|579425466|FG003|Overall Study|Death|0|||
160462695|NCT00146172|579425467|FG004|Overall Study|Death|0|||
160462696|NCT00146172|579425468|FG005|Overall Study|Death|0|||
160462697|NCT00146172|579425469|FG006|Overall Study|Death|1|||
160462698|NCT00146172|579425470|FG007|Overall Study|Death|0|||
160462699|NCT00146172|579425463|FG000|Overall Study|Physician Decision|0|||
160462700|NCT00146172|579425464|FG001|Overall Study|Physician Decision|0|||
160462701|NCT00146172|579425465|FG002|Overall Study|Physician Decision|0|||
160462702|NCT00146172|579425466|FG003|Overall Study|Physician Decision|0|||
160462703|NCT00146172|579425467|FG004|Overall Study|Physician Decision|0|||
160462704|NCT00146172|579425468|FG005|Overall Study|Physician Decision|0|||
160462705|NCT00146172|579425469|FG006|Overall Study|Physician Decision|0|||
160462706|NCT00146172|579425470|FG007|Overall Study|Physician Decision|1|||
160462707|NCT00146172|579425463|FG000|Overall Study|Withdrawal by Subject|0|||
160462708|NCT00146172|579425464|FG001|Overall Study|Withdrawal by Subject|0|||
160462709|NCT00146172|579425465|FG002|Overall Study|Withdrawal by Subject|0|||
160462710|NCT00146172|579425466|FG003|Overall Study|Withdrawal by Subject|0|||
160462711|NCT00146172|579425467|FG004|Overall Study|Withdrawal by Subject|0|||
160462712|NCT00146172|579425468|FG005|Overall Study|Withdrawal by Subject|1|||
160462713|NCT00146172|579425469|FG006|Overall Study|Withdrawal by Subject|1|||
160462714|NCT00146172|579425470|FG007|Overall Study|Withdrawal by Subject|4|||
160462715|NCT00146172|579425463|FG000|Overall Study|Symptomatic Deterioration|1|||
160462716|NCT00146172|579425464|FG001|Overall Study|Symptomatic Deterioration|0|||
160462717|NCT00146172|579425465|FG002|Overall Study|Symptomatic Deterioration|1|||
160462718|NCT00146172|579425466|FG003|Overall Study|Symptomatic Deterioration|0|||
160462719|NCT00146172|579425467|FG004|Overall Study|Symptomatic Deterioration|1|||
160462720|NCT00146172|579425468|FG005|Overall Study|Symptomatic Deterioration|2|||
160462721|NCT00146172|579425469|FG006|Overall Study|Symptomatic Deterioration|0|||
160462722|NCT00146172|579425470|FG007|Overall Study|Symptomatic Deterioration|2|||
160462723|NCT00210106|579425471|FG000|Overall Study|Death|1|||
160462724|NCT00210106|579425471|FG000|Overall Study|Protocol Violation|13|||
160462725|NCT00786864|579425472|FG000|Overall Study|Lost to Follow-up|0|||
160462726|NCT00786864|579425473|FG001|Overall Study|Lost to Follow-up|1|||
160462727|NCT00786864|579425472|FG000|Overall Study|Sustained serious back injury|1|||
160462728|NCT00786864|579425473|FG001|Overall Study|Sustained serious back injury|0|||
160462729|NCT02422615|579425474|FG000|Treatment Period|Progressive disease|314|||
160462730|NCT02422615|579425475|FG001|Treatment Period|Progressive disease|200|||
160462731|NCT02422615|579425474|FG000|Treatment Period|Adverse Event|51|||
160462732|NCT02422615|579425475|FG001|Treatment Period|Adverse Event|9|||
160462733|NCT02422615|579425474|FG000|Treatment Period|Physician Decision|32|||
160462734|NCT02422615|579425475|FG001|Treatment Period|Physician Decision|8|||
160462735|NCT02422615|579425474|FG000|Treatment Period|Subject/guardian decision|38|||
160462736|NCT02422615|579425475|FG001|Treatment Period|Subject/guardian decision|8|||
160462737|NCT02422615|579425474|FG000|Treatment Period|Death|2|||
160462738|NCT02422615|579425475|FG001|Treatment Period|Death|1|||
160462739|NCT02422615|579425474|FG000|Treatment Period|Technical problems|0|||
160462740|NCT02422615|579425475|FG001|Treatment Period|Technical problems|1|||
160462741|NCT02422615|579425474|FG000|Treatment Period|Protocol deviation|1|||
160462742|NCT02422615|579425475|FG001|Treatment Period|Protocol deviation|1|||
160462743|NCT02422615|579425474|FG000|Treatment Period|Study terminated as per protocol|46|||
160462744|NCT02422615|579425475|FG001|Treatment Period|Study terminated as per protocol|14|||
160462745|NCT02422615|579425474|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
160462746|NCT02422615|579425475|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160594896|NCT00589979|579894305|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
160658712|NCT02343120|580131591|FG001|Part 2: Expansion|Sponsor decision|0|||
160658713|NCT02343120|580131592|FG002|Part 2: Expansion|Sponsor decision|0|||
160658714|NCT02343120|580131593|FG003|Part 2: Expansion|Sponsor decision|165|||
160658715|NCT02343120|580131594|FG004|Part 2: Expansion|Sponsor decision|67|||
160462747|NCT02422615|579425474|FG000|Post-treatment Efficacy Follow-up|Death|2|||
160462748|NCT02422615|579425475|FG001|Post-treatment Efficacy Follow-up|Death|1|||
160462749|NCT02422615|579425474|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
160462750|NCT02422615|579425475|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160462751|NCT02422615|579425474|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
160462752|NCT02422615|579425475|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
160462753|NCT02422615|579425474|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
160462754|NCT02422615|579425475|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
160462755|NCT02422615|579425474|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
160462756|NCT02422615|579425475|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
160462757|NCT04876417|579425476|FG000|Overall Study|Lost to Follow-up|5|||
160462758|NCT04876417|579425477|FG001|Overall Study|Lost to Follow-up|8|||
160462759|NCT04876417|579425478|FG002|Overall Study|Lost to Follow-up|0|||
160658716|NCT02343120|580131590|FG000|Part 2: Expansion|Death|0|||
160658717|NCT02343120|580131591|FG001|Part 2: Expansion|Death|0|||
160594897|NCT00589979|579894303|FG000|Double-Blind Treatment Period 2|Other|0|||
160594898|NCT00589979|579894304|FG001|Double-Blind Treatment Period 2|Other|0|||
160594899|NCT00589979|579894305|FG002|Double-Blind Treatment Period 2|Other|1|||
160594900|NCT00589979|579894303|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
160462760|NCT04876417|579425479|FG003|Overall Study|Lost to Follow-up|0|||
160462761|NCT00686595|579425481|FG000|Overall Study|Adverse Event|3|||
160658718|NCT02343120|580131592|FG002|Part 2: Expansion|Death|0|||
160658719|NCT02343120|580131593|FG003|Part 2: Expansion|Death|74|||
160658720|NCT02343120|580131594|FG004|Part 2: Expansion|Death|17|||
160594901|NCT00589979|579894304|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
160594902|NCT00589979|579894305|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
160594903|NCT00589979|579894303|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
160594904|NCT00589979|579894304|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
160594905|NCT00589979|579894305|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
160594906|NCT03428997|579894314|FG000|Overall Study|Sponsor decision.|1|||
160594907|NCT03428997|579894314|FG000|Overall Study|Withdrawal by Subject|3|||
160594908|NCT03428997|579894314|FG000|Overall Study|Lost to Follow-up|4|||
160594909|NCT00510068|579894318|FG000|Double-blind Period|Disease progression|98|||
160462762|NCT00686595|579425481|FG000|Overall Study|Protocol Violation|1|||
160462763|NCT00686595|579425481|FG000|Overall Study|Lost to Follow-up|1|||
160594910|NCT00510068|579894319|FG001|Double-blind Period|Disease progression|169|||
160462764|NCT00686595|579425481|FG000|Overall Study|Lack of Efficacy|1|||
160462765|NCT00686595|579425481|FG000|Overall Study|Poor Compliance|1|||
160462766|NCT02964741|579425482|FG000|Overall Study|Protocol Violation|1|||
160462767|NCT02964741|579425483|FG001|Overall Study|Protocol Violation|0|||
160594911|NCT00510068|579894318|FG000|Double-blind Period|Final primary analysis|52|||
160594912|NCT00510068|579894319|FG001|Double-blind Period|Final primary analysis|18|||
160462768|NCT02964741|579425484|FG002|Overall Study|Protocol Violation|0|||
160462769|NCT02964741|579425482|FG000|Overall Study|Withdrawal by Subject|0|||
160658721|NCT02343120|580131590|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
160658722|NCT02343120|580131591|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
160462770|NCT02964741|579425483|FG001|Overall Study|Withdrawal by Subject|1|||
160462771|NCT02964741|579425484|FG002|Overall Study|Withdrawal by Subject|0|||
160462772|NCT02964741|579425482|FG000|Overall Study|claustrophobia|1|||
160462773|NCT02964741|579425483|FG001|Overall Study|claustrophobia|0|||
160462774|NCT02964741|579425484|FG002|Overall Study|claustrophobia|0|||
160462775|NCT00640159|579425488|FG000|Overall Study|Lost to Follow-up|2|||
160462776|NCT00112359|579425489|FG000|Overall Study|Unrelated adverse event|16|||
160462777|NCT00112359|579425490|FG001|Overall Study|Unrelated adverse event|8|||
160594913|NCT00510068|579894318|FG000|Double-blind Period|Adverse Event|37|||
160462778|NCT00112359|579425489|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
160462779|NCT00112359|579425490|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
160462780|NCT00112359|579425489|FG000|Overall Study|Related adverse event|5|||
160594914|NCT00510068|579894319|FG001|Double-blind Period|Adverse Event|7|||
160594915|NCT00510068|579894318|FG000|Double-blind Period|Withdrawal by Subject|8|||
160594916|NCT00510068|579894319|FG001|Double-blind Period|Withdrawal by Subject|6|||
160594917|NCT00510068|579894318|FG000|Double-blind Period|Death|4|||
160594918|NCT00510068|579894319|FG001|Double-blind Period|Death|3|||
160594919|NCT00510068|579894318|FG000|Double-blind Period|Abnormal test result (s)|1|||
160594920|NCT00510068|579894319|FG001|Double-blind Period|Abnormal test result (s)|0|||
160594921|NCT00510068|579894318|FG000|Double-blind Period|Lost to Follow-up|1|||
160594922|NCT00510068|579894319|FG001|Double-blind Period|Lost to Follow-up|0|||
160594923|NCT00510068|579894318|FG000|Double-blind Period|Protocol Violation|6|||
160594924|NCT00510068|579894319|FG001|Double-blind Period|Protocol Violation|0|||
160462781|NCT00112359|579425490|FG001|Overall Study|Related adverse event|3|||
160594925|NCT00510068|579894318|FG000|Open-label Period|Disease Progression|124|||
160462782|NCT00112359|579425489|FG000|Overall Study|Lost to Follow-up|0|||
160462783|NCT00112359|579425490|FG001|Overall Study|Lost to Follow-up|1|||
160462784|NCT00112359|579425489|FG000|Overall Study|Personal/administrative|1|||
160462785|NCT00112359|579425490|FG001|Overall Study|Personal/administrative|1|||
160594926|NCT00510068|579894319|FG001|Open-label Period|Disease Progression|0|||
160594927|NCT00510068|579894318|FG000|Open-label Period|Adverse Event|46|||
160594928|NCT00510068|579894319|FG001|Open-label Period|Adverse Event|0|||
160594929|NCT00510068|579894318|FG000|Open-label Period|Withdrawal by Subject|21|||
160594930|NCT00510068|579894319|FG001|Open-label Period|Withdrawal by Subject|0|||
160594931|NCT00510068|579894318|FG000|Open-label Period|Administrative problems|17|||
160594932|NCT00510068|579894319|FG001|Open-label Period|Administrative problems|0|||
160594933|NCT00510068|579894318|FG000|Open-label Period|Death|7|||
160594934|NCT00510068|579894319|FG001|Open-label Period|Death|0|||
160462786|NCT00112359|579425489|FG000|Overall Study|Other|3|||
160462787|NCT00112359|579425490|FG001|Overall Study|Other|0|||
160462788|NCT00312208|579425491|FG000|Overall Study|Adverse Event|97|||
160462789|NCT00312208|579425492|FG001|Overall Study|Adverse Event|61|||
160462790|NCT00312208|579425491|FG000|Overall Study|Protocol Violation|5|||
160462791|NCT00312208|579425492|FG001|Overall Study|Protocol Violation|3|||
160594935|NCT00510068|579894318|FG000|Open-label Period|New cancer therapy|7|||
160462792|NCT00312208|579425491|FG000|Overall Study|Death|2|||
160462793|NCT00312208|579425492|FG001|Overall Study|Death|1|||
160594936|NCT00510068|579894319|FG001|Open-label Period|New cancer therapy|0|||
160594937|NCT00510068|579894318|FG000|Open-label Period|Protocol Violation|2|||
160594938|NCT00510068|579894319|FG001|Open-label Period|Protocol Violation|0|||
160594939|NCT00510068|579894318|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
160594940|NCT00510068|579894319|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
160594941|NCT01397448|579894320|FG000|Overall Study|Adverse Event|4|||
160594942|NCT01397448|579894321|FG001|Overall Study|Adverse Event|4|||
160594943|NCT01397448|579894322|FG002|Overall Study|Adverse Event|6|||
160594944|NCT01397448|579894320|FG000|Overall Study|Withdrawal by Subject|4|||
160594945|NCT01397448|579894321|FG001|Overall Study|Withdrawal by Subject|4|||
160594946|NCT01397448|579894322|FG002|Overall Study|Withdrawal by Subject|3|||
160594947|NCT01397448|579894320|FG000|Overall Study|Lack of Efficacy|2|||
160462794|NCT00312208|579425491|FG000|Overall Study|Lack of Efficacy|7|||
160462795|NCT00312208|579425492|FG001|Overall Study|Lack of Efficacy|4|||
160462796|NCT00312208|579425491|FG000|Overall Study|Lost to Follow-up|3|||
160462797|NCT00312208|579425492|FG001|Overall Study|Lost to Follow-up|5|||
160462798|NCT00312208|579425491|FG000|Overall Study|Withdrawal by Subject|53|||
160462799|NCT00312208|579425492|FG001|Overall Study|Withdrawal by Subject|42|||
160462800|NCT00312208|579425491|FG000|Overall Study|Other|5|||
160462801|NCT00312208|579425492|FG001|Overall Study|Other|7|||
160462802|NCT01324310|579425493|FG000|Overall Study|Adverse Event|1|||
160594948|NCT01397448|579894321|FG001|Overall Study|Lack of Efficacy|0|||
160594949|NCT01397448|579894322|FG002|Overall Study|Lack of Efficacy|5|||
160594950|NCT01397448|579894320|FG000|Overall Study|Other|8|||
160594951|NCT01397448|579894321|FG001|Overall Study|Other|7|||
160594952|NCT01397448|579894322|FG002|Overall Study|Other|4|||
160594953|NCT00776555|579894329|FG000|Overall Study|Study terminated|3|||
160594954|NCT00776555|579894330|FG001|Overall Study|Study terminated|0|||
160462803|NCT01324310|579425493|FG000|Overall Study|Disease Progression|1|||
160594955|NCT01354431|579894331|FG000|Pre-Treatment Period|Not reported|1|||
160594956|NCT01354431|579894332|FG001|Pre-Treatment Period|Not reported|0|||
160594957|NCT01354431|579894333|FG002|Pre-Treatment Period|Not reported|0|||
160594958|NCT01354431|579894331|FG000|Treatment Period|Disease Progression|50|||
160594959|NCT01354431|579894332|FG001|Treatment Period|Disease Progression|40|||
160594960|NCT01354431|579894333|FG002|Treatment Period|Disease Progression|44|||
160594961|NCT01354431|579894331|FG000|Treatment Period|Study Drug Toxicity|5|||
160594962|NCT01354431|579894332|FG001|Treatment Period|Study Drug Toxicity|8|||
160594963|NCT01354431|579894333|FG002|Treatment Period|Study Drug Toxicity|4|||
160594964|NCT01354431|579894331|FG000|Treatment Period|Death|0|||
160594965|NCT01354431|579894332|FG001|Treatment Period|Death|1|||
160594966|NCT01354431|579894333|FG002|Treatment Period|Death|0|||
160594967|NCT01354431|579894331|FG000|Treatment Period|AE unrelated to study drug|1|||
160594968|NCT01354431|579894332|FG001|Treatment Period|AE unrelated to study drug|2|||
160594969|NCT01354431|579894333|FG002|Treatment Period|AE unrelated to study drug|5|||
160594970|NCT01354431|579894331|FG000|Treatment Period|Participant request to discontinue|2|||
160594971|NCT01354431|579894332|FG001|Treatment Period|Participant request to discontinue|2|||
160594972|NCT01354431|579894333|FG002|Treatment Period|Participant request to discontinue|1|||
160594973|NCT01354431|579894331|FG000|Treatment Period|Participant withdrew consent|0|||
160594974|NCT01354431|579894332|FG001|Treatment Period|Participant withdrew consent|1|||
160594975|NCT01354431|579894333|FG002|Treatment Period|Participant withdrew consent|0|||
160594976|NCT01354431|579894331|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
160594977|NCT01354431|579894332|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
160462804|NCT01315132|579425494|FG000|Overall Study|not treated due to disease progression|1|||
160462805|NCT03213457|579425500|FG000|Screening Period|Withdrawal by Subject|0|||
160462806|NCT03213457|579425501|FG001|Screening Period|Withdrawal by Subject|1|||
160462807|NCT03213457|579425502|FG002|Screening Period|Withdrawal by Subject|0|||
160594978|NCT01354431|579894333|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
160594979|NCT00536978|579894334|FG000|Overall Study|Not eligible for Adback Infusion|22|||
160594980|NCT00929734|579894335|FG000|Overall Study|Lost to Follow-up|2|||
160594981|NCT00929734|579894336|FG001|Overall Study|Lost to Follow-up|1|||
160594982|NCT00929734|579894335|FG000|Overall Study|Withdrawal by Subject|0|||
160462808|NCT03213457|579425500|FG000|Screening Period|Other|1|||
160462809|NCT03213457|579425501|FG001|Screening Period|Other|0|||
160594983|NCT00929734|579894336|FG001|Overall Study|Withdrawal by Subject|2|||
160594984|NCT00980980|579894337|FG000|Overall Study|Withdrawal by Hospital|0|||
160594985|NCT00980980|579894338|FG001|Overall Study|Withdrawal by Hospital|1|||
160462810|NCT03213457|579425502|FG002|Screening Period|Other|0|||
160462811|NCT03213457|579425500|FG000|Double-Blind Period|Adverse Event|3|||
160462812|NCT03213457|579425501|FG001|Double-Blind Period|Adverse Event|2|||
160462813|NCT03213457|579425502|FG002|Double-Blind Period|Adverse Event|7|||
160462814|NCT03213457|579425500|FG000|Double-Blind Period|Withdrawal by Subject|14|||
160462815|NCT03213457|579425501|FG001|Double-Blind Period|Withdrawal by Subject|2|||
160462816|NCT03213457|579425502|FG002|Double-Blind Period|Withdrawal by Subject|14|||
160462817|NCT03213457|579425500|FG000|Double-Blind Period|Lost to Follow-up|2|||
160462818|NCT03213457|579425501|FG001|Double-Blind Period|Lost to Follow-up|3|||
160462819|NCT03213457|579425502|FG002|Double-Blind Period|Lost to Follow-up|9|||
160462820|NCT03213457|579425500|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
160462821|NCT03213457|579425501|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
160462822|NCT03213457|579425502|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
160462823|NCT03213457|579425500|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
160462824|NCT03213457|579425501|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
160462825|NCT03213457|579425502|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
160462826|NCT03213457|579425500|FG000|Double-Blind Period|Pregnancy|5|||
160462827|NCT03213457|579425501|FG001|Double-Blind Period|Pregnancy|0|||
160462828|NCT03213457|579425502|FG002|Double-Blind Period|Pregnancy|0|||
160462829|NCT03213457|579425500|FG000|Double-Blind Period|Other|10|||
160462830|NCT03213457|579425501|FG001|Double-Blind Period|Other|3|||
160594986|NCT00980980|579894339|FG002|Overall Study|Withdrawal by Hospital|0|||
160594987|NCT00121992|579894340|FG000|Overall Study|Treatment not received|2|||
160594988|NCT00121992|579894341|FG001|Overall Study|Treatment not received|11|||
160462831|NCT03213457|579425502|FG002|Double-Blind Period|Other|17|||
160594989|NCT03076190|579894342|FG000|Overall Study|Lost to Follow-up|9|||
160462832|NCT03213457|579425500|FG000|Open-Label Period|Adverse Event|1|||
160594990|NCT03076190|579894343|FG001|Overall Study|Lost to Follow-up|34|||
160462833|NCT03213457|579425501|FG001|Open-Label Period|Adverse Event|2|||
160658723|NCT02343120|580131592|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
160658724|NCT02343120|580131593|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
160462834|NCT03213457|579425502|FG002|Open-Label Period|Adverse Event|2|||
160462835|NCT03213457|579425500|FG000|Open-Label Period|Withdrawal by Subject|12|||
160462836|NCT03213457|579425501|FG001|Open-Label Period|Withdrawal by Subject|5|||
160462837|NCT03213457|579425502|FG002|Open-Label Period|Withdrawal by Subject|24|||
160462838|NCT03213457|579425500|FG000|Open-Label Period|Lost to Follow-up|1|||
160462839|NCT03213457|579425501|FG001|Open-Label Period|Lost to Follow-up|2|||
160462840|NCT03213457|579425502|FG002|Open-Label Period|Lost to Follow-up|8|||
160462841|NCT03213457|579425500|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
160462842|NCT03213457|579425501|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
160462843|NCT03213457|579425502|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
160462844|NCT03213457|579425500|FG000|Open-Label Period|Non-compliance with study procedures|1|||
160462845|NCT03213457|579425501|FG001|Open-Label Period|Non-compliance with study procedures|1|||
160462846|NCT03213457|579425502|FG002|Open-Label Period|Non-compliance with study procedures|2|||
160462847|NCT03213457|579425500|FG000|Open-Label Period|Exclusionary medications|0|||
160462848|NCT03213457|579425501|FG001|Open-Label Period|Exclusionary medications|0|||
160462849|NCT03213457|579425502|FG002|Open-Label Period|Exclusionary medications|1|||
160462850|NCT03213457|579425500|FG000|Open-Label Period|Other|1|||
160462851|NCT03213457|579425501|FG001|Open-Label Period|Other|1|||
160462852|NCT03213457|579425502|FG002|Open-Label Period|Other|6|||
160462853|NCT03213457|579425500|FG000|Follow-Up Period|Adverse Event|16|||
160462854|NCT03213457|579425501|FG001|Follow-Up Period|Adverse Event|8|||
160462855|NCT03213457|579425502|FG002|Follow-Up Period|Adverse Event|37|||
160462856|NCT03213457|579425500|FG000|Follow-Up Period|Withdrawal by Subject|18|||
160462857|NCT03213457|579425501|FG001|Follow-Up Period|Withdrawal by Subject|11|||
160462858|NCT03213457|579425502|FG002|Follow-Up Period|Withdrawal by Subject|55|||
160462859|NCT03213457|579425500|FG000|Follow-Up Period|Lost to Follow-up|28|||
160462860|NCT03213457|579425501|FG001|Follow-Up Period|Lost to Follow-up|15|||
160462861|NCT03213457|579425502|FG002|Follow-Up Period|Lost to Follow-up|50|||
160462862|NCT03213457|579425500|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
160462863|NCT03213457|579425501|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
160462864|NCT03213457|579425502|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
160462865|NCT03213457|579425500|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
160462866|NCT03213457|579425501|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
160462867|NCT03213457|579425502|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
160462868|NCT03213457|579425500|FG000|Follow-Up Period|Pregnancy|7|||
160462869|NCT03213457|579425501|FG001|Follow-Up Period|Pregnancy|0|||
160462870|NCT03213457|579425502|FG002|Follow-Up Period|Pregnancy|18|||
160462871|NCT03213457|579425500|FG000|Follow-Up Period|Exclusionary medications|1|||
160462872|NCT03213457|579425501|FG001|Follow-Up Period|Exclusionary medications|1|||
160462873|NCT03213457|579425502|FG002|Follow-Up Period|Exclusionary medications|5|||
160462874|NCT03213457|579425500|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
160462875|NCT03213457|579425501|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
160462876|NCT03213457|579425502|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
160462877|NCT03213457|579425500|FG000|Follow-Up Period|Other|14|||
160462878|NCT03213457|579425501|FG001|Follow-Up Period|Other|10|||
160462879|NCT03213457|579425502|FG002|Follow-Up Period|Other|31|||
160462880|NCT05521516|579425507|FG000|Overall Study|Withdrawal by Subject|1|||
160462881|NCT05521516|579425508|FG001|Overall Study|Withdrawal by Subject|1|||
160462882|NCT00747565|579425509|FG000|Overall Study|Withdrawal by Subject|10|||
160462883|NCT00747565|579425510|FG001|Overall Study|Withdrawal by Subject|6|||
160594991|NCT03076190|579894342|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
160594992|NCT03076190|579894343|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
160594993|NCT00393913|579894344|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
160594994|NCT00393913|579894344|FG000|Initial Assessment|Withdrawal by Subject|16|||
160594995|NCT00393913|579894344|FG000|CPAP|Withdrawal by Subject|3|||
160594996|NCT00393913|579894344|FG000|CPAP|Physician Decision|1|||
160594997|NCT00393913|579894344|FG000|CPAP|TEchnical problem with CPAP|3|||
160594998|NCT00594204|579894345|FG000|Overall Study|Adverse Event|15|||
160594999|NCT00594204|579894346|FG001|Overall Study|Adverse Event|3|||
160595000|NCT00594204|579894345|FG000|Overall Study|Lost to Follow-up|9|||
160595001|NCT00594204|579894346|FG001|Overall Study|Lost to Follow-up|5|||
160595002|NCT00594204|579894345|FG000|Overall Study|Withdrawal by Subject|23|||
160462884|NCT00747565|579425509|FG000|Overall Study|Lost to Follow-up|4|||
160462885|NCT00747565|579425510|FG001|Overall Study|Lost to Follow-up|1|||
160462886|NCT01983683|579425515|FG000|Overall Study|Withdrawal by Subject|14|||
160462887|NCT01983683|579425516|FG001|Overall Study|Withdrawal by Subject|18|||
160462888|NCT01983683|579425515|FG000|Overall Study|Death|11|||
160462889|NCT01983683|579425516|FG001|Overall Study|Death|15|||
160462890|NCT01983683|579425515|FG000|Overall Study|Physician Decision|8|||
160462891|NCT01983683|579425516|FG001|Overall Study|Physician Decision|9|||
160462892|NCT01983683|579425515|FG000|Overall Study|Lost to Follow-up|4|||
160595003|NCT00594204|579894346|FG001|Overall Study|Withdrawal by Subject|29|||
160595004|NCT00594204|579894345|FG000|Overall Study|Other|4|||
160462893|NCT01983683|579425516|FG001|Overall Study|Lost to Follow-up|8|||
160595005|NCT00594204|579894346|FG001|Overall Study|Other|3|||
160595006|NCT00594204|579894345|FG000|Overall Study|Lack of Efficacy|3|||
160595007|NCT00594204|579894346|FG001|Overall Study|Lack of Efficacy|4|||
160595008|NCT00594204|579894345|FG000|Overall Study|Randomized but not treated|4|||
160595009|NCT00594204|579894346|FG001|Overall Study|Randomized but not treated|1|||
160595010|NCT01529385|579894347|FG000|Overall Study|Lost to Follow-up|2|||
160595011|NCT01529385|579894348|FG001|Overall Study|Lost to Follow-up|1|||
160595012|NCT02379390|579894351|FG000|Overall Study|Adverse Event|1|||
160595013|NCT02379390|579894352|FG001|Overall Study|Adverse Event|1|||
160462894|NCT01983683|579425515|FG000|Overall Study|Sponsor Decision|1|||
160462895|NCT01983683|579425516|FG001|Overall Study|Sponsor Decision|1|||
160462896|NCT00536120|579426275|FG000|Overall Study|Lost to Follow-up|1|||
160462897|NCT00536120|579426276|FG001|Overall Study|Lost to Follow-up|0|||
160462898|NCT00536120|579426275|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
160462899|NCT00536120|579426276|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
160462900|NCT00536120|579426275|FG000|Overall Study|Non-compliance|1|||
160462901|NCT00536120|579426276|FG001|Overall Study|Non-compliance|0|||
160462902|NCT00536120|579426275|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
160462903|NCT00536120|579426276|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
160462904|NCT00536120|579426275|FG000|Overall Study|Steroid Use|0|||
160462905|NCT00536120|579426276|FG001|Overall Study|Steroid Use|2|||
160462906|NCT00536120|579426275|FG000|Overall Study|Missed Study Visit|0|||
160462907|NCT00536120|579426276|FG001|Overall Study|Missed Study Visit|1|||
160462908|NCT04559698|579426277|FG000|Overall Study|Lost to Follow-up|14|||
160462909|NCT04559698|579426278|FG001|Overall Study|Lost to Follow-up|15|||
160462910|NCT04559698|579426277|FG000|Overall Study|Withdrawal by Subject|0|||
160462911|NCT04559698|579426278|FG001|Overall Study|Withdrawal by Subject|1|||
160462912|NCT03437733|579426279|FG000|Overall Study|Eligibility criteria not met|0|||
160595014|NCT02379390|579894351|FG000|Overall Study|Investigator's decision|1|||
160595015|NCT02379390|579894352|FG001|Overall Study|Investigator's decision|0|||
160595016|NCT02379390|579894351|FG000|Overall Study|Study Termination|0|||
160595017|NCT02379390|579894352|FG001|Overall Study|Study Termination|1|||
160595018|NCT02721251|579894353|FG000|Overall Study|Withdrawal by Subject|8|||
160462913|NCT03437733|579426280|FG001|Overall Study|Eligibility criteria not met|3|||
160462914|NCT01982682|579426284|FG000|Overall Study|Physician Decision|1|||
160462915|NCT02760654|579426285|FG000|Overall Study|Lost to Follow-up|3|||
160462916|NCT02760654|579426286|FG001|Overall Study|Lost to Follow-up|3|||
160462917|NCT02760654|579426285|FG000|Overall Study|Withdrawal by Subject|4|||
160462918|NCT02760654|579426286|FG001|Overall Study|Withdrawal by Subject|3|||
160595019|NCT02721251|579894354|FG001|Overall Study|Withdrawal by Subject|7|||
160462919|NCT03876457|579426291|FG000|Overall Study|Lost to Follow-up|1|||
160462920|NCT03876457|579426292|FG001|Overall Study|Lost to Follow-up|3|||
160595020|NCT02721251|579894355|FG002|Overall Study|Withdrawal by Subject|9|||
160595021|NCT02721251|579894353|FG000|Overall Study|poor adherence|2|||
160595022|NCT02721251|579894354|FG001|Overall Study|poor adherence|2|||
160595023|NCT02721251|579894355|FG002|Overall Study|poor adherence|2|||
160595024|NCT01582971|579894362|FG000|Overall Study|Death|2|||
160595025|NCT01582971|579894363|FG001|Overall Study|Death|1|||
160595026|NCT01582971|579894362|FG000|Overall Study|Lost to Follow-up|18|||
160595027|NCT01582971|579894363|FG001|Overall Study|Lost to Follow-up|21|||
160595028|NCT01582971|579894362|FG000|Overall Study|Withdrawal by Subject|4|||
160595029|NCT01582971|579894363|FG001|Overall Study|Withdrawal by Subject|2|||
160595030|NCT01582971|579894362|FG000|Overall Study|Other|15|||
160595031|NCT01582971|579894363|FG001|Overall Study|Other|13|||
160462921|NCT01184326|579426293|FG000|Overall Study|Adverse Event|1|||
160462922|NCT01184326|579426294|FG001|Overall Study|Adverse Event|2|||
160462923|NCT01184326|579426295|FG002|Overall Study|Adverse Event|0|||
160462924|NCT01184326|579426293|FG000|Overall Study|Death|0|||
160462925|NCT01184326|579426294|FG001|Overall Study|Death|0|||
160462926|NCT01184326|579426295|FG002|Overall Study|Death|1|||
160462927|NCT01184326|579426293|FG000|Overall Study|Withdrawal by Subject|0|||
160462928|NCT01184326|579426294|FG001|Overall Study|Withdrawal by Subject|0|||
160462929|NCT01184326|579426295|FG002|Overall Study|Withdrawal by Subject|1|||
160462930|NCT01184326|579426293|FG000|Overall Study|Physician Decision|1|||
160462931|NCT01184326|579426294|FG001|Overall Study|Physician Decision|1|||
160462932|NCT01184326|579426295|FG002|Overall Study|Physician Decision|0|||
160462933|NCT01184326|579426293|FG000|Overall Study|Disease Progression|1|||
160462934|NCT01184326|579426294|FG001|Overall Study|Disease Progression|3|||
160462935|NCT01184326|579426295|FG002|Overall Study|Disease Progression|12|||
160462936|NCT01036724|579426296|FG000|Overall Study|Adverse Event|1|||
160462937|NCT01036724|579426297|FG001|Overall Study|Adverse Event|2|||
160462938|NCT01036724|579426296|FG000|Overall Study|Lack of Efficacy|1|||
160462939|NCT01036724|579426297|FG001|Overall Study|Lack of Efficacy|1|||
160462940|NCT01036724|579426296|FG000|Overall Study|Protocol Violation|4|||
160462941|NCT01036724|579426297|FG001|Overall Study|Protocol Violation|5|||
160462942|NCT01574716|579426299|FG000|Part 1|Death|3|||
160462943|NCT01574716|579426300|FG001|Part 1|Death|1|||
160462944|NCT01574716|579426301|FG002|Part 1|Death|8|||
160462945|NCT01574716|579426302|FG003|Part 1|Death|0|||
160462946|NCT01574716|579426303|FG004|Part 1|Death|0|||
160462947|NCT01574716|579426299|FG000|Part 1|Discontinuation of study by sponsor|0|||
160462948|NCT01574716|579426300|FG001|Part 1|Discontinuation of study by sponsor|0|||
160462949|NCT01574716|579426301|FG002|Part 1|Discontinuation of study by sponsor|1|||
160462950|NCT01574716|579426302|FG003|Part 1|Discontinuation of study by sponsor|0|||
160462951|NCT01574716|579426303|FG004|Part 1|Discontinuation of study by sponsor|0|||
160462952|NCT01574716|579426299|FG000|Part 1|Withdrawal by Subject|0|||
160462953|NCT01574716|579426300|FG001|Part 1|Withdrawal by Subject|2|||
160462954|NCT01574716|579426301|FG002|Part 1|Withdrawal by Subject|0|||
160462955|NCT01574716|579426302|FG003|Part 1|Withdrawal by Subject|0|||
160462956|NCT01574716|579426303|FG004|Part 1|Withdrawal by Subject|0|||
160462957|NCT01574716|579426299|FG000|Part 1|Lost to Follow-up|0|||
160462958|NCT01574716|579426300|FG001|Part 1|Lost to Follow-up|1|||
160462959|NCT01574716|579426301|FG002|Part 1|Lost to Follow-up|0|||
160462960|NCT01574716|579426302|FG003|Part 1|Lost to Follow-up|0|||
160462961|NCT01574716|579426303|FG004|Part 1|Lost to Follow-up|0|||
160462962|NCT01574716|579426299|FG000|Part 2|Progressive disease|0|||
160462963|NCT01574716|579426300|FG001|Part 2|Progressive disease|0|||
160462964|NCT01574716|579426301|FG002|Part 2|Progressive disease|0|||
160462965|NCT01574716|579426302|FG003|Part 2|Progressive disease|1|||
160462966|NCT01574716|579426303|FG004|Part 2|Progressive disease|0|||
160462967|NCT01574716|579426299|FG000|Part 2|Death|0|||
160462968|NCT01574716|579426300|FG001|Part 2|Death|0|||
160462969|NCT01574716|579426301|FG002|Part 2|Death|0|||
160462970|NCT01574716|579426302|FG003|Part 2|Death|76|||
160462971|NCT01574716|579426303|FG004|Part 2|Death|35|||
160462972|NCT01574716|579426299|FG000|Part 2|Discontinuation of study by sponsor|0|||
160462973|NCT01574716|579426300|FG001|Part 2|Discontinuation of study by sponsor|0|||
160462974|NCT01574716|579426301|FG002|Part 2|Discontinuation of study by sponsor|0|||
160462975|NCT01574716|579426302|FG003|Part 2|Discontinuation of study by sponsor|51|||
160462976|NCT01574716|579426303|FG004|Part 2|Discontinuation of study by sponsor|31|||
160658725|NCT02343120|580131594|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
160462977|NCT01574716|579426299|FG000|Part 2|Withdrawal by Subject|0|||
160595032|NCT05691829|579895973|FG000|Overall Study|Physician Decision|2|||
160462978|NCT01574716|579426300|FG001|Part 2|Withdrawal by Subject|0|||
160462979|NCT01574716|579426301|FG002|Part 2|Withdrawal by Subject|0|||
160462980|NCT01574716|579426302|FG003|Part 2|Withdrawal by Subject|5|||
160462981|NCT01574716|579426303|FG004|Part 2|Withdrawal by Subject|4|||
160462982|NCT01574716|579426299|FG000|Part 2|Brain metastases|0|||
160462983|NCT01574716|579426300|FG001|Part 2|Brain metastases|0|||
160462984|NCT01574716|579426301|FG002|Part 2|Brain metastases|0|||
160462985|NCT01574716|579426302|FG003|Part 2|Brain metastases|1|||
160462986|NCT01574716|579426303|FG004|Part 2|Brain metastases|0|||
160462987|NCT01574716|579426299|FG000|Part 2|Lost to Follow-up|0|||
160462988|NCT01574716|579426300|FG001|Part 2|Lost to Follow-up|0|||
160462989|NCT01574716|579426301|FG002|Part 2|Lost to Follow-up|0|||
160462990|NCT01574716|579426302|FG003|Part 2|Lost to Follow-up|3|||
160462991|NCT01574716|579426303|FG004|Part 2|Lost to Follow-up|0|||
160462992|NCT04017611|579426305|FG000|Overall Study|Withdrawn prior to completion|1|||
160462993|NCT00246805|579426317|FG000|Phase 1|Lost to Follow-up|1|||
160462994|NCT00246805|579426318|FG001|Phase 1|Lost to Follow-up|0|||
160462995|NCT01342367|579426320|FG000|Overall Study|Death|1|||
160462996|NCT01342367|579426321|FG001|Overall Study|Death|0|||
160462997|NCT01342367|579426320|FG000|Overall Study|Withdrawal by Subject|1|||
160462998|NCT01342367|579426321|FG001|Overall Study|Withdrawal by Subject|2|||
160462999|NCT03170882|579426324|FG000|Overall Study|Death|17|||
160595033|NCT05691829|579895973|FG000|Overall Study|Eligibility criteria not met|3|||
160595034|NCT00453180|579895978|FG000|Overall Study|Lost to Follow-up|2|||
160595035|NCT00453180|579895979|FG001|Overall Study|Lost to Follow-up|1|||
160595036|NCT00453180|579895978|FG000|Overall Study|Adverse Event|1|||
160595037|NCT00453180|579895979|FG001|Overall Study|Adverse Event|2|||
160595038|NCT00804843|579895980|FG000|Overall Study|Protocol Violation|1|||
160658726|NCT02343120|580131590|FG000|Part 2: Expansion|Lost to Follow-up|0|||
160463000|NCT03170882|579426325|FG001|Overall Study|Death|29|||
160463001|NCT03170882|579426324|FG000|Overall Study|Lost to Follow-up|0|||
160463002|NCT03170882|579426325|FG001|Overall Study|Lost to Follow-up|1|||
160463003|NCT03170882|579426324|FG000|Overall Study|Withdrawal by Subject|4|||
160595039|NCT00804843|579895981|FG001|Overall Study|Protocol Violation|0|||
160595040|NCT00804843|579895980|FG000|Overall Study|Adverse Event|8|||
160595041|NCT00804843|579895981|FG001|Overall Study|Adverse Event|5|||
160463004|NCT03170882|579426325|FG001|Overall Study|Withdrawal by Subject|7|||
160463005|NCT03170882|579426324|FG000|Overall Study|Reason not Specified|28|||
160463006|NCT03170882|579426325|FG001|Overall Study|Reason not Specified|36|||
160463007|NCT01371994|579426329|FG000|Overall Study|Adverse Event|3|||
160658727|NCT02343120|580131591|FG001|Part 2: Expansion|Lost to Follow-up|0|||
160463008|NCT01371994|579426330|FG001|Overall Study|Adverse Event|6|||
160463009|NCT01371994|579426329|FG000|Overall Study|Lack of Efficacy|3|||
160463010|NCT01371994|579426330|FG001|Overall Study|Lack of Efficacy|0|||
160463011|NCT01371994|579426329|FG000|Overall Study|Withdrawal by Subject|13|||
160463012|NCT01371994|579426330|FG001|Overall Study|Withdrawal by Subject|7|||
160463013|NCT01371994|579426329|FG000|Overall Study|Lost to Follow-up|1|||
160463014|NCT01371994|579426330|FG001|Overall Study|Lost to Follow-up|1|||
160463015|NCT01371994|579426329|FG000|Overall Study|Protocol Violation|24|||
160463016|NCT01371994|579426330|FG001|Overall Study|Protocol Violation|17|||
160463017|NCT01371994|579426329|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
160463018|NCT01371994|579426330|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
160463019|NCT01371994|579426329|FG000|Overall Study|Physician Decision|1|||
160463020|NCT01371994|579426330|FG001|Overall Study|Physician Decision|1|||
160463021|NCT01371994|579426329|FG000|Overall Study|Miscellaneous Reasons|6|||
160463022|NCT01371994|579426330|FG001|Overall Study|Miscellaneous Reasons|4|||
160463023|NCT00087685|579426331|FG000|Overall Study|Adverse Event|5|||
160463024|NCT00087685|579426331|FG000|Overall Study|Non-Compliance|1|||
160463025|NCT00087685|579426331|FG000|Overall Study|Progressive Disease|5|||
160463026|NCT00087685|579426331|FG000|Overall Study|Withdrawal by Subject|3|||
160463027|NCT01830595|579426332|FG000|First Period|Withdrawal by Subject|1|||
160463028|NCT01830595|579426333|FG001|First Period|Withdrawal by Subject|3|||
160463029|NCT01830595|579426332|FG000|Washout|Withdrawal by Subject|2|||
160463030|NCT01830595|579426333|FG001|Washout|Withdrawal by Subject|2|||
160463031|NCT05139992|579426335|FG000|Overall Study|Withdrawal by Subject|12|||
160463032|NCT05139992|579426335|FG000|Overall Study|Lost to Follow-up|6|||
160463033|NCT03275285|579426338|FG000|Overall Study|Ongoing|45|||
160463034|NCT03275285|579426339|FG001|Overall Study|Ongoing|69|||
160463035|NCT00115934|579426340|FG000|Overall Study|Lost to Follow-up|1|||
160463036|NCT00115934|579426341|FG001|Overall Study|Lost to Follow-up|0|||
160463037|NCT00115934|579426340|FG000|Overall Study|Did not receive intervention|3|||
160463038|NCT00115934|579426341|FG001|Overall Study|Did not receive intervention|2|||
160463039|NCT00319020|579426343|FG000|Overall Study|Death|2|||
160463040|NCT00319020|579426344|FG001|Overall Study|Death|2|||
160463041|NCT00319020|579426343|FG000|Overall Study|Withdrawal by Subject|4|||
160463042|NCT00319020|579426344|FG001|Overall Study|Withdrawal by Subject|1|||
160463043|NCT00319020|579426343|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
160463044|NCT00319020|579426344|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
160463045|NCT00319020|579426343|FG000|Overall Study|Administrative reason|0|||
160463046|NCT00319020|579426344|FG001|Overall Study|Administrative reason|5|||
160463047|NCT00319020|579426343|FG000|Overall Study|Disease progression|0|||
160463048|NCT00319020|579426344|FG001|Overall Study|Disease progression|2|||
160463049|NCT00319020|579426343|FG000|Overall Study|Transplant|0|||
160463050|NCT00319020|579426344|FG001|Overall Study|Transplant|1|||
160463051|NCT00319020|579426343|FG000|Overall Study|Treatment failure|0|||
160463052|NCT00319020|579426344|FG001|Overall Study|Treatment failure|1|||
160463053|NCT00319020|579426343|FG000|Overall Study|Adverse Event|0|||
160463054|NCT00319020|579426344|FG001|Overall Study|Adverse Event|1|||
160463055|NCT04980300|579426347|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
160463056|NCT04980300|579426348|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
160463057|NCT04980300|579426347|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
160463058|NCT04980300|579426348|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
160463059|NCT04980300|579426347|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
160463060|NCT04980300|579426348|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
160463061|NCT04980300|579426347|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
160595042|NCT00804843|579895980|FG000|Overall Study|Withdrawal by Subject|1|||
160595043|NCT00804843|579895981|FG001|Overall Study|Withdrawal by Subject|2|||
160595044|NCT03326869|579895987|FG000|Overall Study|Study data has been lost to natural disa|1|||
160595045|NCT03326869|579895988|FG001|Overall Study|Study data has been lost to natural disa|1|||
160463062|NCT04980300|579426348|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
160595046|NCT01002742|579895991|FG000|Overall Study|Determined to be ineligible|0|||
160595047|NCT01002742|579895992|FG001|Overall Study|Determined to be ineligible|1|||
160595048|NCT00562640|579895993|FG000|Overall Study|Death|0|||
160595049|NCT00562640|579895994|FG001|Overall Study|Death|1|||
160595050|NCT00562640|579895995|FG002|Overall Study|Death|1|||
160595051|NCT00562640|579895996|FG003|Overall Study|Death|0|||
160595052|NCT01297309|579895998|FG000|Overall Study|Eligibility failure|2|||
160595053|NCT01297309|579895998|FG000|Overall Study|Screen failure|2|||
160595054|NCT01297309|579895998|FG000|Overall Study|Withdrawal by Subject|5|||
160595055|NCT01297309|579895998|FG000|Overall Study|Adverse Event|1|||
160595056|NCT01297309|579895998|FG000|Overall Study|Investigator Decision|2|||
160595057|NCT01297309|579895998|FG000|Overall Study|Death|1|||
160595058|NCT01297309|579895998|FG000|Overall Study|Participant not entering extensionperiod|1|||
160595059|NCT02670928|579895999|FG000|Overall Study|Adverse Event|3|||
160595060|NCT02670928|579896000|FG001|Overall Study|Adverse Event|1|||
160595061|NCT02670928|579895999|FG000|Overall Study|Withdrawal by Subject|4|||
160595062|NCT02670928|579896000|FG001|Overall Study|Withdrawal by Subject|0|||
160595063|NCT02670928|579895999|FG000|Overall Study|Lost to Follow-up|1|||
160595064|NCT02670928|579896000|FG001|Overall Study|Lost to Follow-up|0|||
160463063|NCT02722434|579427660|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
160463064|NCT02722434|579427661|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
160463065|NCT02722434|579427660|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
160463066|NCT02722434|579427661|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
160463067|NCT04989816|579427662|FG000|Overall Study|Death|77|||
160595065|NCT02670928|579895999|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
160595066|NCT02670928|579896000|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
160595067|NCT02591238|579896001|FG000|Overall Study|Pregnancy|1|||
160595068|NCT02591238|579896002|FG001|Overall Study|Pregnancy|0|||
160463068|NCT04989816|579427662|FG000|Overall Study|Lost to Follow-up|3|||
160463069|NCT01084694|579427664|FG000|Overall Study|Withdrawal by Subject|2|||
160463070|NCT01084694|579427665|FG001|Overall Study|Withdrawal by Subject|1|||
160463071|NCT01084694|579427664|FG000|Overall Study|Death|2|||
160463072|NCT01084694|579427665|FG001|Overall Study|Death|12|||
160463073|NCT01084694|579427664|FG000|Overall Study|eligibility not maintained|2|||
160463074|NCT01084694|579427665|FG001|Overall Study|eligibility not maintained|7|||
160463075|NCT01128595|579427671|FG000|Treatment Period 3|Withdrawal by Subject|0|||
160463076|NCT01128595|579427672|FG001|Treatment Period 3|Withdrawal by Subject|1|||
160463077|NCT01128595|579427673|FG002|Treatment Period 3|Withdrawal by Subject|0|||
160463078|NCT01128595|579427674|FG003|Treatment Period 3|Withdrawal by Subject|0|||
160463079|NCT01750684|579427675|FG000|Overall Study|Death|1|||
160463080|NCT01750684|579427676|FG001|Overall Study|Death|0|||
160463081|NCT01750684|579427675|FG000|Overall Study|Non-compliance with Study Drug|0|||
160463082|NCT01750684|579427676|FG001|Overall Study|Non-compliance with Study Drug|1|||
160463083|NCT01750684|579427675|FG000|Overall Study|Withdrawn by Sponsor|0|||
160463084|NCT01750684|579427676|FG001|Overall Study|Withdrawn by Sponsor|1|||
160463085|NCT01750684|579427675|FG000|Overall Study|Protocol Violation|1|||
160463086|NCT01750684|579427676|FG001|Overall Study|Protocol Violation|0|||
160463087|NCT02185794|579427678|FG000|Overall Study|Enrolled but Never Dosed|1|||
160463088|NCT02185794|579427679|FG001|Overall Study|Enrolled but Never Dosed|6|||
160463089|NCT02185794|579427680|FG002|Overall Study|Enrolled but Never Dosed|3|||
160463090|NCT02185794|579427681|FG003|Overall Study|Enrolled but Never Dosed|1|||
160463091|NCT02185794|579427682|FG004|Overall Study|Enrolled but Never Dosed|1|||
160463092|NCT02185794|579427683|FG005|Overall Study|Enrolled but Never Dosed|0|||
160463093|NCT02185794|579427678|FG000|Overall Study|Investigator's Discretion|1|||
160463094|NCT02185794|579427679|FG001|Overall Study|Investigator's Discretion|0|||
160463095|NCT02185794|579427680|FG002|Overall Study|Investigator's Discretion|1|||
160463096|NCT02185794|579427681|FG003|Overall Study|Investigator's Discretion|2|||
160463097|NCT02185794|579427682|FG004|Overall Study|Investigator's Discretion|2|||
160463098|NCT02185794|579427683|FG005|Overall Study|Investigator's Discretion|15|||
160463099|NCT02185794|579427678|FG000|Overall Study|Withdrew Consent|2|||
160463100|NCT02185794|579427679|FG001|Overall Study|Withdrew Consent|5|||
160463101|NCT02185794|579427680|FG002|Overall Study|Withdrew Consent|10|||
160463102|NCT02185794|579427681|FG003|Overall Study|Withdrew Consent|2|||
160463103|NCT02185794|579427682|FG004|Overall Study|Withdrew Consent|0|||
160463104|NCT02185794|579427683|FG005|Overall Study|Withdrew Consent|0|||
160463105|NCT02185794|579427678|FG000|Overall Study|Lost to Follow-up|1|||
160463106|NCT02185794|579427679|FG001|Overall Study|Lost to Follow-up|2|||
160463107|NCT02185794|579427680|FG002|Overall Study|Lost to Follow-up|2|||
160463108|NCT02185794|579427681|FG003|Overall Study|Lost to Follow-up|3|||
160463109|NCT02185794|579427682|FG004|Overall Study|Lost to Follow-up|0|||
160463110|NCT02185794|579427683|FG005|Overall Study|Lost to Follow-up|1|||
160463111|NCT00336505|579427684|FG000|Overall Study|Adverse Event|10|||
160463112|NCT00336505|579427685|FG001|Overall Study|Adverse Event|9|||
160463113|NCT00336505|579427684|FG000|Overall Study|Lack of Efficacy|8|||
160463114|NCT00336505|579427685|FG001|Overall Study|Lack of Efficacy|4|||
160463115|NCT00336505|579427684|FG000|Overall Study|Lost to Follow-up|7|||
160463116|NCT00336505|579427685|FG001|Overall Study|Lost to Follow-up|4|||
160463117|NCT00336505|579427684|FG000|Overall Study|Withdrawal by Subject|5|||
160463118|NCT00336505|579427685|FG001|Overall Study|Withdrawal by Subject|3|||
160463119|NCT00336505|579427684|FG000|Overall Study|Other|7|||
160463120|NCT00336505|579427685|FG001|Overall Study|Other|7|||
160463121|NCT00366249|579427686|FG000|Overall Study|Adverse Event|53|||
160463122|NCT00366249|579427687|FG001|Overall Study|Adverse Event|28|||
160463123|NCT00366249|579427686|FG000|Overall Study|Death|0|||
160463124|NCT00366249|579427687|FG001|Overall Study|Death|1|||
160463125|NCT00366249|579427686|FG000|Overall Study|Physician Decision|5|||
160463126|NCT00366249|579427687|FG001|Overall Study|Physician Decision|2|||
160463127|NCT00366249|579427686|FG000|Overall Study|Lost to Follow-up|2|||
160463128|NCT00366249|579427687|FG001|Overall Study|Lost to Follow-up|0|||
160463129|NCT00366249|579427686|FG000|Overall Study|Protocol Violation|1|||
160463130|NCT00366249|579427687|FG001|Overall Study|Protocol Violation|2|||
160463131|NCT00366249|579427686|FG000|Overall Study|Withdrawal by Subject|18|||
160463132|NCT00366249|579427687|FG001|Overall Study|Withdrawal by Subject|4|||
160463133|NCT00366249|579427686|FG000|Overall Study|Lack of Efficacy|21|||
160463134|NCT00366249|579427687|FG001|Overall Study|Lack of Efficacy|21|||
160463135|NCT00366249|579427686|FG000|Overall Study|Most due to osteomylitis status|31|||
160463136|NCT00366249|579427687|FG001|Overall Study|Most due to osteomylitis status|20|||
160463137|NCT00777049|579427688|FG000|Overall Study|Withdrawal by Subject|1|||
160463138|NCT00777049|579427689|FG001|Overall Study|Withdrawal by Subject|0|||
160463139|NCT00777049|579427688|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
160463140|NCT00777049|579427689|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
160463141|NCT00609869|579427690|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
160463142|NCT00609869|579427690|FG000|Overall Study|Severe hematologic toxicity|1|||
160463143|NCT00609869|579427690|FG000|Overall Study|Withdrawal by Subject|1|||
160463144|NCT00609869|579427690|FG000|Overall Study|Seizures|1|||
160595069|NCT02591238|579896003|FG002|Overall Study|Pregnancy|0|||
160595070|NCT02591238|579896004|FG003|Overall Study|Pregnancy|0|||
160595071|NCT02591238|579896001|FG000|Overall Study|Withdrawal by Subject|0|||
160595072|NCT02591238|579896002|FG001|Overall Study|Withdrawal by Subject|0|||
160595073|NCT02591238|579896003|FG002|Overall Study|Withdrawal by Subject|0|||
160595074|NCT02591238|579896004|FG003|Overall Study|Withdrawal by Subject|1|||
160595075|NCT02591238|579896001|FG000|Overall Study|influenza|0|||
160595076|NCT02591238|579896002|FG001|Overall Study|influenza|0|||
160595077|NCT02591238|579896003|FG002|Overall Study|influenza|0|||
160595078|NCT02591238|579896004|FG003|Overall Study|influenza|1|||
160595079|NCT02591238|579896001|FG000|Overall Study|personal circumstances|0|||
160595080|NCT02591238|579896002|FG001|Overall Study|personal circumstances|0|||
160595081|NCT02591238|579896003|FG002|Overall Study|personal circumstances|0|||
160658728|NCT02343120|580131592|FG002|Part 2: Expansion|Lost to Follow-up|0|||
160658729|NCT02343120|580131593|FG003|Part 2: Expansion|Lost to Follow-up|5|||
160658730|NCT02343120|580131594|FG004|Part 2: Expansion|Lost to Follow-up|2|||
160658731|NCT02343120|580131590|FG000|Part 2: Expansion|Other|0|||
160658732|NCT02343120|580131591|FG001|Part 2: Expansion|Other|0|||
160658733|NCT02343120|580131592|FG002|Part 2: Expansion|Other|0|||
160658734|NCT02343120|580131593|FG003|Part 2: Expansion|Other|1|||
160658735|NCT02343120|580131594|FG004|Part 2: Expansion|Other|5|||
160658736|NCT02343120|580131590|FG000|Part 2: Expansion|Adverse Event|0|||
160658737|NCT02343120|580131591|FG001|Part 2: Expansion|Adverse Event|0|||
160658738|NCT02343120|580131592|FG002|Part 2: Expansion|Adverse Event|0|||
160658739|NCT02343120|580131593|FG003|Part 2: Expansion|Adverse Event|1|||
160658740|NCT02343120|580131594|FG004|Part 2: Expansion|Adverse Event|1|||
160658741|NCT02534493|580131600|FG000|Overall Study|Lost to Follow-up|1|||
160658742|NCT02534493|580131600|FG000|Overall Study|Withdrawal by Subject|1|||
160658743|NCT02514174|580131602|FG000|Overall Study|Patient refused to continue medication|1|||
160658744|NCT02514174|580131602|FG000|Overall Study|Adverse Event|2|||
160658745|NCT02514174|580131602|FG000|Overall Study|Study closed by sponsor|9|||
160463145|NCT00609869|579427690|FG000|Overall Study|Severe tumor flare reaction|1|||
160463146|NCT00609869|579427690|FG000|Overall Study|Hepatitis B infection|1|||
160463147|NCT00609869|579427690|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
160463148|NCT00609869|579427690|FG000|Overall Study|Mantle cell: not evaluable|4|||
160463149|NCT03478969|579427691|FG000|Overall Study|Withdrawal by Subject|4|||
160463150|NCT03478969|579427692|FG001|Overall Study|Withdrawal by Subject|7|||
160463151|NCT03478969|579427693|FG002|Overall Study|Withdrawal by Subject|6|||
160463152|NCT03478969|579427691|FG000|Overall Study|Adverse Event|2|||
160463153|NCT03478969|579427692|FG001|Overall Study|Adverse Event|0|||
160463154|NCT03478969|579427693|FG002|Overall Study|Adverse Event|1|||
160463155|NCT03478969|579427691|FG000|Overall Study|Pregnancy|1|||
160463156|NCT03478969|579427692|FG001|Overall Study|Pregnancy|0|||
160463157|NCT03478969|579427693|FG002|Overall Study|Pregnancy|0|||
160463158|NCT03478969|579427691|FG000|Overall Study|Personal Reasons|1|||
160463159|NCT03478969|579427692|FG001|Overall Study|Personal Reasons|0|||
160463160|NCT03478969|579427693|FG002|Overall Study|Personal Reasons|1|||
160463161|NCT03478969|579427691|FG000|Overall Study|Covid-19|1|||
160463162|NCT03478969|579427692|FG001|Overall Study|Covid-19|4|||
160463163|NCT03478969|579427693|FG002|Overall Study|Covid-19|3|||
160463164|NCT03478969|579427691|FG000|Overall Study|Multiple Reasons|0|||
160463165|NCT03478969|579427692|FG001|Overall Study|Multiple Reasons|1|||
160463166|NCT03478969|579427693|FG002|Overall Study|Multiple Reasons|1|||
160463167|NCT03478969|579427691|FG000|Overall Study|Eligibility Criteria|0|||
160463168|NCT03478969|579427692|FG001|Overall Study|Eligibility Criteria|0|||
160463169|NCT03478969|579427693|FG002|Overall Study|Eligibility Criteria|5|||
160463170|NCT03478969|579427691|FG000|Overall Study|Lost to Follow-up|0|||
160463171|NCT03478969|579427692|FG001|Overall Study|Lost to Follow-up|0|||
160463172|NCT03478969|579427693|FG002|Overall Study|Lost to Follow-up|1|||
160463173|NCT01185600|579427694|FG000|Overall Study|Adverse Event|1|||
160463174|NCT01185600|579427695|FG001|Overall Study|Adverse Event|1|||
160463175|NCT01185600|579427694|FG000|Overall Study|Death|0|||
160463176|NCT01185600|579427695|FG001|Overall Study|Death|1|||
160463177|NCT01185600|579427694|FG000|Overall Study|Lost to Follow-up|0|||
160463178|NCT01185600|579427695|FG001|Overall Study|Lost to Follow-up|5|||
160463179|NCT01185600|579427694|FG000|Overall Study|Physician Decision|29|||
160463180|NCT01185600|579427695|FG001|Overall Study|Physician Decision|35|||
160463181|NCT01185600|579427694|FG000|Overall Study|Withdrawal by Subject|1|||
160463182|NCT01185600|579427695|FG001|Overall Study|Withdrawal by Subject|1|||
160463183|NCT01185600|579427694|FG000|Overall Study|Hold by DSMB|1|||
160463184|NCT01185600|579427695|FG001|Overall Study|Hold by DSMB|2|||
160463185|NCT05405244|579427696|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
160463186|NCT05405244|579427697|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
160463187|NCT05405244|579427696|FG000|Washout (2 Weeks)|Adverse Event|2|||
160463188|NCT05405244|579427697|FG001|Washout (2 Weeks)|Adverse Event|0|||
160463189|NCT05405244|579427696|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
160463190|NCT05405244|579427697|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
160463191|NCT00739934|579427698|FG000|Voriconazole IV|Adverse Event|6|||
160463192|NCT00739934|579427698|FG000|Voriconazole Oral|Other|3|||
160463193|NCT00754065|579427703|FG000|Overall Study|Never received treatment|12|||
160463194|NCT00754065|579427704|FG001|Overall Study|Never received treatment|2|||
160463195|NCT00754065|579427703|FG000|Overall Study|Adverse Event|19|||
160463196|NCT00754065|579427704|FG001|Overall Study|Adverse Event|25|||
160463197|NCT00754065|579427703|FG000|Overall Study|Lost to Follow-up|7|||
160463198|NCT00754065|579427704|FG001|Overall Study|Lost to Follow-up|11|||
160463199|NCT00754065|579427703|FG000|Overall Study|Protocol Violation|12|||
160463200|NCT00754065|579427704|FG001|Overall Study|Protocol Violation|10|||
160463201|NCT00754065|579427703|FG000|Overall Study|Withdrawal by Subject|4|||
160463202|NCT00754065|579427704|FG001|Overall Study|Withdrawal by Subject|5|||
160463203|NCT00754065|579427703|FG000|Overall Study|Pregnancy|6|||
160463204|NCT00754065|579427704|FG001|Overall Study|Pregnancy|0|||
160463205|NCT00754065|579427703|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
160463206|NCT00754065|579427704|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
160658746|NCT02514174|580131602|FG000|Overall Study|Progressive disease|11|||
160463207|NCT04353492|579427707|FG000|Overall Study|Subject decision|24|||
160463208|NCT04353492|579427707|FG000|Overall Study|Physician Decision|5|||
160463209|NCT04353492|579427707|FG000|Overall Study|Adverse Event|3|||
160463210|NCT04353492|579427707|FG000|Overall Study|Pregnancy|3|||
160463211|NCT04353492|579427707|FG000|Overall Study|Lost to Follow-up|2|||
160463212|NCT04353492|579427707|FG000|Overall Study|Protocol deviation|1|||
160463213|NCT04353492|579427707|FG000|Overall Study|Technical problems|1|||
160463214|NCT04250194|579427708|FG000|Overall Study|Declined to schedule biopsy|6|||
160463215|NCT04250194|579427709|FG001|Overall Study|Declined to schedule biopsy|10|||
160595082|NCT02591238|579896004|FG003|Overall Study|personal circumstances|1|||
160658747|NCT02514174|580131602|FG000|Overall Study|Treatment change|1|||
160463216|NCT04250194|579427708|FG000|Overall Study|Medically Unfit for Biopsy|2|||
160658748|NCT02514174|580131602|FG000|Overall Study|Treated off study with Afatinib.|1|||
160658749|NCT02817841|580133178|FG000|Overall Study|Lost to Follow-up|287|||
160595083|NCT02591238|579896001|FG000|Overall Study|personal circumstances|0|||
160463217|NCT04250194|579427709|FG001|Overall Study|Medically Unfit for Biopsy|1|||
160463218|NCT04250194|579427708|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
160463219|NCT04250194|579427709|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
160595084|NCT02591238|579896002|FG001|Overall Study|personal circumstances|1|||
160595085|NCT02591238|579896003|FG002|Overall Study|personal circumstances|0|||
160595086|NCT02591238|579896004|FG003|Overall Study|personal circumstances|0|||
160595087|NCT00640146|579896006|FG000|Overall Study|Adverse Event|2|||
160595088|NCT00640146|579896007|FG001|Overall Study|Adverse Event|0|||
160595089|NCT00640146|579896006|FG000|Overall Study|Lost to Follow-up|0|||
160595090|NCT00640146|579896007|FG001|Overall Study|Lost to Follow-up|1|||
160595091|NCT00640146|579896006|FG000|Overall Study|Lack of Efficacy|0|||
160595092|NCT00640146|579896007|FG001|Overall Study|Lack of Efficacy|1|||
160595093|NCT00640146|579896006|FG000|Overall Study|Withdrawal by Subject|1|||
160595094|NCT00640146|579896007|FG001|Overall Study|Withdrawal by Subject|1|||
160595095|NCT00640146|579896006|FG000|Overall Study|Randomized but not treated|1|||
160463220|NCT04250194|579427708|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
160463221|NCT04250194|579427709|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
160463222|NCT04250194|579427708|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
160463223|NCT04250194|579427709|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
160463224|NCT01500200|579427712|FG000|Stage 1|Adverse Event|1|||
160463225|NCT01500200|579427713|FG001|Stage 1|Adverse Event|4|||
160463226|NCT01500200|579427714|FG002|Stage 1|Adverse Event|5|||
160463227|NCT01500200|579427715|FG003|Stage 1|Adverse Event|0|||
160463228|NCT01500200|579427716|FG004|Stage 1|Adverse Event|0|||
160463229|NCT01500200|579427717|FG005|Stage 1|Adverse Event|0|||
160463230|NCT01500200|579427712|FG000|Stage 1|Lost to Follow-up|2|||
160463231|NCT01500200|579427713|FG001|Stage 1|Lost to Follow-up|2|||
160463232|NCT01500200|579427714|FG002|Stage 1|Lost to Follow-up|1|||
160463233|NCT01500200|579427715|FG003|Stage 1|Lost to Follow-up|0|||
160463234|NCT01500200|579427716|FG004|Stage 1|Lost to Follow-up|0|||
160463235|NCT01500200|579427717|FG005|Stage 1|Lost to Follow-up|0|||
160463236|NCT01500200|579427712|FG000|Stage 1|Withdrawal by Subject|3|||
160463237|NCT01500200|579427713|FG001|Stage 1|Withdrawal by Subject|0|||
160463238|NCT01500200|579427714|FG002|Stage 1|Withdrawal by Subject|0|||
160463239|NCT01500200|579427715|FG003|Stage 1|Withdrawal by Subject|0|||
160463240|NCT01500200|579427716|FG004|Stage 1|Withdrawal by Subject|0|||
160463241|NCT01500200|579427717|FG005|Stage 1|Withdrawal by Subject|0|||
160463242|NCT01500200|579427712|FG000|Stage 1|Noncompliance with Study Drug|1|||
160463243|NCT01500200|579427713|FG001|Stage 1|Noncompliance with Study Drug|0|||
160463244|NCT01500200|579427714|FG002|Stage 1|Noncompliance with Study Drug|0|||
160463245|NCT01500200|579427715|FG003|Stage 1|Noncompliance with Study Drug|0|||
160463246|NCT01500200|579427716|FG004|Stage 1|Noncompliance with Study Drug|0|||
160463247|NCT01500200|579427717|FG005|Stage 1|Noncompliance with Study Drug|0|||
160463248|NCT01500200|579427712|FG000|Stage 1|Physician Decision|1|||
160463249|NCT01500200|579427713|FG001|Stage 1|Physician Decision|0|||
160463250|NCT01500200|579427714|FG002|Stage 1|Physician Decision|0|||
160463251|NCT01500200|579427715|FG003|Stage 1|Physician Decision|0|||
160463252|NCT01500200|579427716|FG004|Stage 1|Physician Decision|0|||
160463253|NCT01500200|579427717|FG005|Stage 1|Physician Decision|0|||
160463254|NCT01500200|579427712|FG000|Stage 2|Adverse Event|0|||
160463255|NCT01500200|579427713|FG001|Stage 2|Adverse Event|0|||
160463256|NCT01500200|579427714|FG002|Stage 2|Adverse Event|0|||
160463257|NCT01500200|579427715|FG003|Stage 2|Adverse Event|0|||
160463258|NCT01500200|579427716|FG004|Stage 2|Adverse Event|5|||
160463259|NCT01500200|579427717|FG005|Stage 2|Adverse Event|4|||
160463260|NCT01961609|579427718|FG000|Initiation|Missing|3|||
160463261|NCT01961609|579427719|FG001|Initiation|Missing|2|||
160463262|NCT01961609|579427720|FG002|Initiation|Missing|0|||
160463263|NCT01961609|579427721|FG003|Initiation|Missing|0|||
160463264|NCT01961609|579427718|FG000|Initiation|Protocol deviation|1|||
160463265|NCT01961609|579427719|FG001|Initiation|Protocol deviation|0|||
160463266|NCT01961609|579427720|FG002|Initiation|Protocol deviation|0|||
160463267|NCT01961609|579427721|FG003|Initiation|Protocol deviation|0|||
160463268|NCT01961609|579427718|FG000|Initiation|Death|0|||
160463269|NCT01961609|579427719|FG001|Initiation|Death|1|||
160463270|NCT01961609|579427720|FG002|Initiation|Death|0|||
160463271|NCT01961609|579427721|FG003|Initiation|Death|0|||
160463272|NCT01961609|579427718|FG000|Initiation|Administrative problems|1|||
160463273|NCT01961609|579427719|FG001|Initiation|Administrative problems|0|||
160463274|NCT01961609|579427720|FG002|Initiation|Administrative problems|0|||
160463275|NCT01961609|579427721|FG003|Initiation|Administrative problems|0|||
160463276|NCT01961609|579427718|FG000|Initiation|Withdrawal by Subject|1|||
160463277|NCT01961609|579427719|FG001|Initiation|Withdrawal by Subject|2|||
160463278|NCT01961609|579427720|FG002|Initiation|Withdrawal by Subject|0|||
160463279|NCT01961609|579427721|FG003|Initiation|Withdrawal by Subject|0|||
160463280|NCT01961609|579427718|FG000|Initiation|Lack of Efficacy|2|||
160463281|NCT01961609|579427719|FG001|Initiation|Lack of Efficacy|1|||
160463282|NCT01961609|579427720|FG002|Initiation|Lack of Efficacy|0|||
160463283|NCT01961609|579427721|FG003|Initiation|Lack of Efficacy|0|||
160463284|NCT01961609|579427718|FG000|Initiation|Abnormal lab values|0|||
160463285|NCT01961609|579427719|FG001|Initiation|Abnormal lab values|1|||
160463286|NCT01961609|579427720|FG002|Initiation|Abnormal lab values|0|||
160463287|NCT01961609|579427721|FG003|Initiation|Abnormal lab values|0|||
160463288|NCT01961609|579427718|FG000|Initiation|Adverse Event|3|||
160463289|NCT01961609|579427719|FG001|Initiation|Adverse Event|5|||
160463290|NCT01961609|579427720|FG002|Initiation|Adverse Event|0|||
160463291|NCT01961609|579427721|FG003|Initiation|Adverse Event|0|||
160463292|NCT01961609|579427718|FG000|Initiation|Randomized but not treated|1|||
160463293|NCT01961609|579427719|FG001|Initiation|Randomized but not treated|1|||
160463294|NCT01961609|579427720|FG002|Initiation|Randomized but not treated|0|||
160463295|NCT01961609|579427721|FG003|Initiation|Randomized but not treated|0|||
160463296|NCT01961609|579427718|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
160463297|NCT01961609|579427719|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
160463298|NCT01961609|579427720|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
160463299|NCT01961609|579427721|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
160463300|NCT01961609|579427718|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
160463301|NCT01961609|579427719|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
160463302|NCT01961609|579427720|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
160463303|NCT01961609|579427721|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
160463304|NCT01961609|579427718|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
160463305|NCT01961609|579427719|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
160463306|NCT01961609|579427720|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
160463307|NCT01961609|579427721|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
160463308|NCT01961609|579427718|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
160463309|NCT01961609|579427719|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
160463310|NCT01961609|579427720|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
160463311|NCT01961609|579427721|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
160463312|NCT01961609|579427718|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
160463313|NCT01961609|579427719|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
160463314|NCT01961609|579427720|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
160463315|NCT01961609|579427721|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
160463316|NCT01961609|579427718|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
160463317|NCT01961609|579427719|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
160463318|NCT01961609|579427720|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
160463319|NCT01961609|579427721|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
160463320|NCT01961609|579427718|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
160463321|NCT01961609|579427719|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
160463322|NCT01961609|579427720|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
160463323|NCT01961609|579427721|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
160463324|NCT01961609|579427718|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
160463325|NCT01961609|579427719|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
160463326|NCT01961609|579427720|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
160463327|NCT01961609|579427721|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
160463328|NCT01961609|579427718|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
160463329|NCT01961609|579427719|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
160463330|NCT01961609|579427720|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
160463331|NCT01961609|579427721|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
160463332|NCT01961609|579427718|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
160463333|NCT01961609|579427719|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
160463334|NCT01961609|579427720|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
160463335|NCT01961609|579427721|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
160463336|NCT01961609|579427718|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
160463337|NCT01961609|579427719|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
160463338|NCT01961609|579427720|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
160463339|NCT01961609|579427721|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
160463340|NCT01961609|579427718|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
160463341|NCT01961609|579427719|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
160463342|NCT01961609|579427720|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
160463343|NCT01961609|579427721|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
160463344|NCT02167451|579427725|FG000|Overall Study|Withdrawal by Subject|1|||
160463345|NCT00571649|579427726|FG000|Treatment Period|Adverse Event|438|||
160463346|NCT00571649|579427727|FG001|Treatment Period|Adverse Event|385|||
160463347|NCT00571649|579427726|FG000|Treatment Period|Clinical endpoint reached|50|||
160595096|NCT00640146|579896007|FG001|Overall Study|Randomized but not treated|3|||
160595097|NCT02455388|579896008|FG000|Overall Study|Protocol Violation|1|||
160595098|NCT02455388|579896009|FG001|Overall Study|Protocol Violation|0|||
160463348|NCT00571649|579427727|FG001|Treatment Period|Clinical endpoint reached|56|||
160463349|NCT00571649|579427726|FG000|Treatment Period|Withdrawal by Subject|285|||
160463350|NCT00571649|579427727|FG001|Treatment Period|Withdrawal by Subject|255|||
160463351|NCT00571649|579427726|FG000|Treatment Period|Death|76|||
160595099|NCT02455388|579896010|FG002|Overall Study|Protocol Violation|4|||
160463352|NCT00571649|579427727|FG001|Treatment Period|Death|59|||
160463353|NCT00571649|579427726|FG000|Treatment Period|Physician Decision|8|||
160463354|NCT00571649|579427727|FG001|Treatment Period|Physician Decision|9|||
160463355|NCT00571649|579427726|FG000|Treatment Period|Lost to Follow-up|43|||
160463356|NCT00571649|579427727|FG001|Treatment Period|Lost to Follow-up|41|||
160595100|NCT02455388|579896008|FG000|Overall Study|Withdrawal by Subject|0|||
160595101|NCT02455388|579896009|FG001|Overall Study|Withdrawal by Subject|0|||
160463357|NCT00571649|579427726|FG000|Treatment Period|Non-compliant with study medication|88|||
160463358|NCT00571649|579427727|FG001|Treatment Period|Non-compliant with study medication|89|||
160463359|NCT00571649|579427726|FG000|Treatment Period|Patient convenience|11|||
160463360|NCT00571649|579427727|FG001|Treatment Period|Patient convenience|13|||
160463361|NCT00571649|579427726|FG000|Treatment Period|Protocol Violation|90|||
160463362|NCT00571649|579427727|FG001|Treatment Period|Protocol Violation|92|||
160463363|NCT00571649|579427726|FG000|Treatment Period|Technical problems|3|||
160463364|NCT00571649|579427727|FG001|Treatment Period|Technical problems|5|||
160463365|NCT00571649|579427726|FG000|Follow-up Period|Adverse Event|46|||
160463366|NCT00571649|579427727|FG001|Follow-up Period|Adverse Event|40|||
160463367|NCT00571649|579427726|FG000|Follow-up Period|Clinical endpoint reached|5|||
160463368|NCT00571649|579427727|FG001|Follow-up Period|Clinical endpoint reached|2|||
160463369|NCT00571649|579427726|FG000|Follow-up Period|Withdrawal by Subject|119|||
160463370|NCT00571649|579427727|FG001|Follow-up Period|Withdrawal by Subject|115|||
160463371|NCT00571649|579427726|FG000|Follow-up Period|Death|132|||
160463372|NCT00571649|579427727|FG001|Follow-up Period|Death|133|||
160463373|NCT00571649|579427726|FG000|Follow-up Period|Physician Decision|7|||
160463374|NCT00571649|579427727|FG001|Follow-up Period|Physician Decision|13|||
160463375|NCT00571649|579427726|FG000|Follow-up Period|Lost to Follow-up|95|||
160463376|NCT00571649|579427727|FG001|Follow-up Period|Lost to Follow-up|92|||
160463377|NCT00571649|579427726|FG000|Follow-up Period|Patient convenience|136|||
160463378|NCT00571649|579427727|FG001|Follow-up Period|Patient convenience|121|||
160463379|NCT00571649|579427726|FG000|Follow-up Period|Protocol Violation|5|||
160463380|NCT00571649|579427727|FG001|Follow-up Period|Protocol Violation|12|||
160463381|NCT01218659|579427728|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
160463382|NCT01218659|579427729|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
160463383|NCT01218659|579427730|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
160463384|NCT01218659|579427728|FG000|18-Month Randomized Period|Did not receive study drug|0|||
160463385|NCT01218659|579427729|FG001|18-Month Randomized Period|Did not receive study drug|3|||
160463386|NCT01218659|579427730|FG002|18-Month Randomized Period|Did not receive study drug|0|||
160463387|NCT01218659|579427728|FG000|12-Month OLE|Withdrawal by Subject|0|||
160463388|NCT01218659|579427729|FG001|12-Month OLE|Withdrawal by Subject|0|||
160463389|NCT01218659|579427730|FG002|12-Month OLE|Withdrawal by Subject|2|||
160463390|NCT01218659|579427728|FG000|12-Month OLE|Physician Decision|0|||
160463391|NCT01218659|579427729|FG001|12-Month OLE|Physician Decision|0|||
160463392|NCT01218659|579427730|FG002|12-Month OLE|Physician Decision|1|||
160463393|NCT01218659|579427728|FG000|12-Month OLE|Lost to Follow-up|0|||
160463394|NCT01218659|579427729|FG001|12-Month OLE|Lost to Follow-up|0|||
160463395|NCT01218659|579427730|FG002|12-Month OLE|Lost to Follow-up|1|||
160463396|NCT01218659|579427728|FG000|12-Month OLE|Pregnancy|0|||
160463397|NCT01218659|579427729|FG001|12-Month OLE|Pregnancy|0|||
160463398|NCT01218659|579427730|FG002|12-Month OLE|Pregnancy|1|||
160463399|NCT01218659|579427728|FG000|12-Month OLE|Lack of Efficacy|0|||
160463400|NCT01218659|579427729|FG001|12-Month OLE|Lack of Efficacy|0|||
160463401|NCT01218659|579427730|FG002|12-Month OLE|Lack of Efficacy|1|||
160463402|NCT01218659|579427728|FG000|12-Month OLE|Declined to participate in the OLE|0|||
160463403|NCT01218659|579427729|FG001|12-Month OLE|Declined to participate in the OLE|0|||
160463404|NCT01218659|579427730|FG002|12-Month OLE|Declined to participate in the OLE|4|||
160463405|NCT03066609|579427737|FG000|INDUCTION|Pregnancy|0|||
160463406|NCT03066609|579427738|FG001|INDUCTION|Pregnancy|0|||
160595102|NCT02455388|579896010|FG002|Overall Study|Withdrawal by Subject|7|||
160463407|NCT03066609|579427739|FG002|INDUCTION|Pregnancy|1|||
160463408|NCT03066609|579427740|FG003|INDUCTION|Pregnancy|0|||
160463409|NCT03066609|579427737|FG000|INDUCTION|Lack of Efficacy|0|||
160463410|NCT03066609|579427738|FG001|INDUCTION|Lack of Efficacy|0|||
160658750|NCT02817841|580133178|FG000|Overall Study|Withdrawal by Subject|183|||
160658751|NCT02817841|580133178|FG000|Overall Study|Adverse event not related to bleeding|131|||
160463411|NCT03066609|579427739|FG002|INDUCTION|Lack of Efficacy|1|||
160463412|NCT03066609|579427740|FG003|INDUCTION|Lack of Efficacy|0|||
160463413|NCT03066609|579427737|FG000|INDUCTION|Adverse Event|2|||
160463414|NCT03066609|579427738|FG001|INDUCTION|Adverse Event|2|||
160463415|NCT03066609|579427739|FG002|INDUCTION|Adverse Event|0|||
160463416|NCT03066609|579427740|FG003|INDUCTION|Adverse Event|0|||
160463417|NCT03066609|579427737|FG000|MAINTENANCE|Adverse Event|0|||
160463418|NCT03066609|579427738|FG001|MAINTENANCE|Adverse Event|0|||
160463419|NCT03066609|579427739|FG002|MAINTENANCE|Adverse Event|0|||
160463420|NCT03066609|579427740|FG003|MAINTENANCE|Adverse Event|1|||
160463421|NCT03066609|579427737|FG000|MAINTENANCE|Withdrawal by Subject|4|||
160463422|NCT03066609|579427738|FG001|MAINTENANCE|Withdrawal by Subject|2|||
160463423|NCT03066609|579427739|FG002|MAINTENANCE|Withdrawal by Subject|1|||
160463424|NCT03066609|579427740|FG003|MAINTENANCE|Withdrawal by Subject|1|||
160463425|NCT03066609|579427737|FG000|MAINTENANCE|Lost to Follow-up|0|||
160463426|NCT03066609|579427738|FG001|MAINTENANCE|Lost to Follow-up|1|||
160463427|NCT03066609|579427739|FG002|MAINTENANCE|Lost to Follow-up|1|||
160463428|NCT03066609|579427740|FG003|MAINTENANCE|Lost to Follow-up|0|||
160463429|NCT03066609|579427737|FG000|MAINTENANCE|Pregnancy|1|||
160463430|NCT03066609|579427738|FG001|MAINTENANCE|Pregnancy|0|||
160463431|NCT03066609|579427739|FG002|MAINTENANCE|Pregnancy|0|||
160463432|NCT03066609|579427740|FG003|MAINTENANCE|Pregnancy|0|||
160463433|NCT03066609|579427737|FG000|MAINTENANCE|Lack of Efficacy|2|||
160463434|NCT03066609|579427738|FG001|MAINTENANCE|Lack of Efficacy|1|||
160463435|NCT03066609|579427739|FG002|MAINTENANCE|Lack of Efficacy|0|||
160463436|NCT03066609|579427740|FG003|MAINTENANCE|Lack of Efficacy|1|||
160463437|NCT03066609|579427737|FG000|OVERALL STUDY|Adverse Event|2|||
160463438|NCT03066609|579427738|FG001|OVERALL STUDY|Adverse Event|2|||
160463439|NCT03066609|579427739|FG002|OVERALL STUDY|Adverse Event|0|||
160463440|NCT03066609|579427740|FG003|OVERALL STUDY|Adverse Event|1|||
160463441|NCT03066609|579427737|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
160463442|NCT03066609|579427738|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
160463443|NCT03066609|579427739|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
160463444|NCT03066609|579427740|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
160463445|NCT03066609|579427737|FG000|OVERALL STUDY|Lost to Follow-up|1|||
160463446|NCT03066609|579427738|FG001|OVERALL STUDY|Lost to Follow-up|1|||
160463447|NCT03066609|579427739|FG002|OVERALL STUDY|Lost to Follow-up|1|||
160463448|NCT03066609|579427740|FG003|OVERALL STUDY|Lost to Follow-up|1|||
160463449|NCT03066609|579427737|FG000|OVERALL STUDY|Pregnancy|1|||
160463450|NCT03066609|579427738|FG001|OVERALL STUDY|Pregnancy|0|||
160463451|NCT03066609|579427739|FG002|OVERALL STUDY|Pregnancy|1|||
160463452|NCT03066609|579427740|FG003|OVERALL STUDY|Pregnancy|0|||
160463453|NCT03066609|579427737|FG000|OVERALL STUDY|Lack of Efficacy|2|||
160658752|NCT02817841|580133178|FG000|Overall Study|Adverse event related to bleeding|51|||
160463454|NCT03066609|579427738|FG001|OVERALL STUDY|Lack of Efficacy|1|||
160463455|NCT03066609|579427739|FG002|OVERALL STUDY|Lack of Efficacy|1|||
160463456|NCT03066609|579427740|FG003|OVERALL STUDY|Lack of Efficacy|1|||
160463457|NCT03066609|579427737|FG000|OVERALL STUDY|discontinued follow up|0|||
160463458|NCT03066609|579427738|FG001|OVERALL STUDY|discontinued follow up|2|||
160463459|NCT03066609|579427739|FG002|OVERALL STUDY|discontinued follow up|0|||
160463460|NCT03066609|579427740|FG003|OVERALL STUDY|discontinued follow up|0|||
160658753|NCT02817841|580133178|FG000|Overall Study|Pregnancy|32|||
160463461|NCT03355573|579427741|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
160463462|NCT03355573|579427741|FG000|Overall Study|Sponsor's decision|1|||
160463463|NCT03355573|579427741|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
160463464|NCT03355573|579427741|FG000|Overall Study|PI's decision|2|||
160463465|NCT03355573|579427741|FG000|Overall Study|Withdrawal by Subject|23|||
160463466|NCT03355573|579427741|FG000|Overall Study|Lost to Follow-up|4|||
160463467|NCT03355573|579427741|FG000|Overall Study|Lack of Efficacy|2|||
160463468|NCT03355573|579427741|FG000|Overall Study|Adverse Event, non-fatal|17|||
160463469|NCT03355573|579427741|FG000|Overall Study|Adverse Event, serious fatal|2|||
160463470|NCT01566890|579427742|FG000|Overall Study|Adverse Event|1|||
160463471|NCT01566890|579427743|FG001|Overall Study|Adverse Event|0|||
160463472|NCT01566890|579427744|FG002|Overall Study|Adverse Event|0|||
160463473|NCT01566890|579427745|FG003|Overall Study|Adverse Event|0|||
160463474|NCT01566890|579427746|FG004|Overall Study|Adverse Event|0|||
160463475|NCT01566890|579427742|FG000|Overall Study|Withdrawal by Subject|3|||
160463476|NCT01566890|579427743|FG001|Overall Study|Withdrawal by Subject|1|||
160463477|NCT01566890|579427744|FG002|Overall Study|Withdrawal by Subject|1|||
160463478|NCT01566890|579427745|FG003|Overall Study|Withdrawal by Subject|1|||
160463479|NCT01566890|579427746|FG004|Overall Study|Withdrawal by Subject|0|||
160463480|NCT01566890|579427742|FG000|Overall Study|Screen failure|6|||
160463481|NCT01566890|579427743|FG001|Overall Study|Screen failure|0|||
160463482|NCT01566890|579427744|FG002|Overall Study|Screen failure|1|||
160463483|NCT01566890|579427745|FG003|Overall Study|Screen failure|1|||
160463484|NCT01566890|579427746|FG004|Overall Study|Screen failure|0|||
160463485|NCT01566890|579427742|FG000|Overall Study|Incomplete CEU data|1|||
160463486|NCT01566890|579427743|FG001|Overall Study|Incomplete CEU data|3|||
160463487|NCT01566890|579427744|FG002|Overall Study|Incomplete CEU data|5|||
160463488|NCT01566890|579427745|FG003|Overall Study|Incomplete CEU data|8|||
160463489|NCT01566890|579427746|FG004|Overall Study|Incomplete CEU data|0|||
160463490|NCT01566890|579427742|FG000|Overall Study|Lost to Follow-up|0|||
160463491|NCT01566890|579427743|FG001|Overall Study|Lost to Follow-up|0|||
160463492|NCT01566890|579427744|FG002|Overall Study|Lost to Follow-up|4|||
160463493|NCT01566890|579427745|FG003|Overall Study|Lost to Follow-up|4|||
160463494|NCT01566890|579427746|FG004|Overall Study|Lost to Follow-up|0|||
160463495|NCT01566890|579427742|FG000|Overall Study|Other|0|||
160463496|NCT01566890|579427743|FG001|Overall Study|Other|0|||
160463497|NCT01566890|579427744|FG002|Overall Study|Other|0|||
160463498|NCT01566890|579427745|FG003|Overall Study|Other|0|||
160463499|NCT01566890|579427746|FG004|Overall Study|Other|7|||
160463500|NCT02284113|579427749|FG000|Overall Study|Adverse Event|1|||
160463501|NCT02284113|579427750|FG001|Overall Study|Adverse Event|0|||
160463502|NCT02284113|579427749|FG000|Overall Study|non-compliance|0|||
160463503|NCT02284113|579427750|FG001|Overall Study|non-compliance|1|||
160463504|NCT02284113|579427749|FG000|Overall Study|Withdrawal by Subject|0|||
160463505|NCT02284113|579427750|FG001|Overall Study|Withdrawal by Subject|1|||
160463506|NCT02284113|579427749|FG000|Overall Study|not provided|0|||
160463507|NCT02284113|579427750|FG001|Overall Study|not provided|1|||
160463508|NCT02284113|579427749|FG000|Overall Study|surgery cancelled|2|||
160463509|NCT02284113|579427750|FG001|Overall Study|surgery cancelled|0|||
160463510|NCT04191824|579427751|FG000|Overall Study|Death|13|||
160463511|NCT04191824|579427752|FG001|Overall Study|Death|12|||
160463512|NCT04191824|579427751|FG000|Overall Study|Lost to Follow-up|456|||
160595103|NCT00324740|579896011|FG000|Overall Study|Withdrawal by Subject|1|||
160595104|NCT00324740|579896012|FG001|Overall Study|Withdrawal by Subject|0|||
160595105|NCT00324740|579896013|FG002|Overall Study|Withdrawal by Subject|1|||
160595106|NCT01357980|579896018|FG000|Overall Study|Lack of Efficacy|0|||
160595107|NCT01357980|579896019|FG001|Overall Study|Lack of Efficacy|1|||
160463513|NCT04191824|579427752|FG001|Overall Study|Lost to Follow-up|435|||
160463514|NCT04191824|579427751|FG000|Overall Study|Physician Decision|2|||
160463515|NCT04191824|579427752|FG001|Overall Study|Physician Decision|1|||
160463516|NCT04191824|579427751|FG000|Overall Study|Protocol Violation|0|||
160463517|NCT04191824|579427752|FG001|Overall Study|Protocol Violation|2|||
160463518|NCT04191824|579427751|FG000|Overall Study|Withdrawal by Subject|16|||
160463519|NCT04191824|579427752|FG001|Overall Study|Withdrawal by Subject|18|||
160463520|NCT04191824|579427751|FG000|Overall Study|Early site closure|24|||
160463521|NCT04191824|579427752|FG001|Overall Study|Early site closure|22|||
160595108|NCT01357980|579896020|FG002|Overall Study|Lack of Efficacy|0|||
160595109|NCT01357980|579896021|FG003|Overall Study|Lack of Efficacy|0|||
160595110|NCT01357980|579896018|FG000|Overall Study|Consent withdrawn|0|||
160463522|NCT01218009|579427753|FG000|Overall Study|Protocol Violation|2|||
160463523|NCT01218009|579427754|FG001|Overall Study|Protocol Violation|1|||
160463524|NCT01218009|579427753|FG000|Overall Study|Withdrawal by Subject|3|||
160463525|NCT01218009|579427754|FG001|Overall Study|Withdrawal by Subject|1|||
160595111|NCT01357980|579896019|FG001|Overall Study|Consent withdrawn|0|||
160595112|NCT01357980|579896020|FG002|Overall Study|Consent withdrawn|1|||
160595113|NCT01357980|579896021|FG003|Overall Study|Consent withdrawn|0|||
160595114|NCT00094835|579896025|FG000|Overall Study|Physician Decision|1|||
160595115|NCT00094835|579896026|FG001|Overall Study|Physician Decision|0|||
160595116|NCT00094835|579896027|FG002|Overall Study|Physician Decision|0|||
160595117|NCT00094835|579896028|FG003|Overall Study|Physician Decision|0|||
160595118|NCT00094835|579896029|FG004|Overall Study|Physician Decision|0|||
160595119|NCT00094835|579896030|FG005|Overall Study|Physician Decision|1|||
160463526|NCT01218009|579427753|FG000|Overall Study|Sponsor terminated study|161|||
160595120|NCT00094835|579896031|FG006|Overall Study|Physician Decision|0|||
160595121|NCT00094835|579896025|FG000|Overall Study|Withdrawal by Subject|0|||
160595122|NCT00094835|579896026|FG001|Overall Study|Withdrawal by Subject|0|||
160595123|NCT00094835|579896027|FG002|Overall Study|Withdrawal by Subject|0|||
160595124|NCT00094835|579896028|FG003|Overall Study|Withdrawal by Subject|0|||
160595125|NCT00094835|579896029|FG004|Overall Study|Withdrawal by Subject|0|||
160595126|NCT00094835|579896030|FG005|Overall Study|Withdrawal by Subject|0|||
160595127|NCT00094835|579896031|FG006|Overall Study|Withdrawal by Subject|1|||
160595128|NCT00094835|579896025|FG000|Overall Study|Lost to Follow-up|0|||
160595129|NCT00094835|579896026|FG001|Overall Study|Lost to Follow-up|0|||
160595130|NCT00094835|579896027|FG002|Overall Study|Lost to Follow-up|0|||
160595131|NCT00094835|579896028|FG003|Overall Study|Lost to Follow-up|0|||
160595132|NCT00094835|579896029|FG004|Overall Study|Lost to Follow-up|1|||
160595133|NCT00094835|579896030|FG005|Overall Study|Lost to Follow-up|0|||
160463527|NCT01218009|579427754|FG001|Overall Study|Sponsor terminated study|163|||
160463528|NCT02397096|579427755|FG000|Day 1 to Week 24|Adverse Event|7|||
160463529|NCT02397096|579427756|FG001|Day 1 to Week 24|Adverse Event|1|||
160463530|NCT02397096|579427755|FG000|Day 1 to Week 24|Death|1|||
160463531|NCT02397096|579427756|FG001|Day 1 to Week 24|Death|0|||
160463532|NCT02397096|579427755|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
160463533|NCT02397096|579427756|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
160463534|NCT02397096|579427755|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
160463535|NCT02397096|579427756|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
160463536|NCT02397096|579427755|FG000|Day 1 to Week 24|Physician Decision|2|||
160463537|NCT02397096|579427756|FG001|Day 1 to Week 24|Physician Decision|3|||
160463538|NCT02397096|579427755|FG000|Day 1 to Week 24|Protocol Violation|1|||
160463539|NCT02397096|579427756|FG001|Day 1 to Week 24|Protocol Violation|4|||
160463540|NCT02397096|579427755|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
160463541|NCT02397096|579427756|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
160463542|NCT02397096|579427755|FG000|Day 1 to Week 24|Randomized, not treated|3|||
160463543|NCT02397096|579427756|FG001|Day 1 to Week 24|Randomized, not treated|0|||
160463544|NCT02397096|579427755|FG000|Week 24 to Week 48|Adverse Event|6|||
160463545|NCT02397096|579427756|FG001|Week 24 to Week 48|Adverse Event|2|||
160463546|NCT02397096|579427755|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
160463547|NCT02397096|579427756|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
160463548|NCT02397096|579427755|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
160463549|NCT02397096|579427756|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
160463550|NCT02397096|579427755|FG000|Week 24 to Week 48|Physician Decision|2|||
160463551|NCT02397096|579427756|FG001|Week 24 to Week 48|Physician Decision|1|||
160463552|NCT02397096|579427755|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
160463553|NCT02397096|579427756|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
160463554|NCT02397096|579427755|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
160463555|NCT02397096|579427756|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
160463556|NCT02397096|579427755|FG000|Study Extension 1|Adverse Event|7|||
160463557|NCT02397096|579427756|FG001|Study Extension 1|Adverse Event|5|||
160463558|NCT02397096|579427755|FG000|Study Extension 1|Death|1|||
160463559|NCT02397096|579427756|FG001|Study Extension 1|Death|0|||
160463560|NCT02397096|579427755|FG000|Study Extension 1|Lack of Efficacy|2|||
160463561|NCT02397096|579427756|FG001|Study Extension 1|Lack of Efficacy|5|||
160463562|NCT02397096|579427755|FG000|Study Extension 1|Lost to Follow-up|2|||
160463563|NCT02397096|579427756|FG001|Study Extension 1|Lost to Follow-up|3|||
160463564|NCT02397096|579427755|FG000|Study Extension 1|Non-compliance with study drug|3|||
160463565|NCT02397096|579427756|FG001|Study Extension 1|Non-compliance with study drug|0|||
160463566|NCT02397096|579427755|FG000|Study Extension 1|Physician Decision|4|||
160463567|NCT02397096|579427756|FG001|Study Extension 1|Physician Decision|2|||
160463568|NCT02397096|579427755|FG000|Study Extension 1|Pregnancy|1|||
160463569|NCT02397096|579427756|FG001|Study Extension 1|Pregnancy|0|||
160463570|NCT02397096|579427755|FG000|Study Extension 1|Protocol Violation|0|||
160463571|NCT02397096|579427756|FG001|Study Extension 1|Protocol Violation|1|||
160463572|NCT02397096|579427755|FG000|Study Extension 1|Withdrawal by Subject|21|||
160595134|NCT00094835|579896031|FG006|Overall Study|Lost to Follow-up|0|||
160595135|NCT00094835|579896025|FG000|Overall Study|Death|1|||
160595136|NCT00094835|579896026|FG001|Overall Study|Death|0|||
160595137|NCT00094835|579896027|FG002|Overall Study|Death|0|||
160463573|NCT02397096|579427756|FG001|Study Extension 1|Withdrawal by Subject|7|||
160463574|NCT02397096|579427755|FG000|Study Extension 2|Adverse Event|3|||
160463575|NCT02397096|579427756|FG001|Study Extension 2|Adverse Event|3|||
160463576|NCT02397096|579427755|FG000|Study Extension 2|Availability of study medication locally|152|||
160463577|NCT02397096|579427756|FG001|Study Extension 2|Availability of study medication locally|64|||
160463578|NCT02397096|579427755|FG000|Study Extension 2|Death|2|||
160463579|NCT02397096|579427756|FG001|Study Extension 2|Death|0|||
160463580|NCT02397096|579427755|FG000|Study Extension 2|Lack of Efficacy|1|||
160463581|NCT02397096|579427756|FG001|Study Extension 2|Lack of Efficacy|0|||
160463582|NCT02397096|579427755|FG000|Study Extension 2|Lost to Follow-up|2|||
160595138|NCT00094835|579896028|FG003|Overall Study|Death|0|||
160595139|NCT00094835|579896029|FG004|Overall Study|Death|1|||
160595140|NCT00094835|579896030|FG005|Overall Study|Death|0|||
160595141|NCT00094835|579896031|FG006|Overall Study|Death|0|||
160463583|NCT02397096|579427756|FG001|Study Extension 2|Lost to Follow-up|1|||
160595142|NCT00094835|579896025|FG000|Overall Study|Non-compliance|1|||
160463584|NCT02397096|579427755|FG000|Study Extension 2|Non-compliance with study drug|1|||
160463585|NCT02397096|579427756|FG001|Study Extension 2|Non-compliance with study drug|0|||
160463586|NCT02397096|579427755|FG000|Study Extension 2|Physician Decision|2|||
160463587|NCT02397096|579427756|FG001|Study Extension 2|Physician Decision|5|||
160595143|NCT00094835|579896026|FG001|Overall Study|Non-compliance|2|||
160595144|NCT00094835|579896027|FG002|Overall Study|Non-compliance|2|||
160595145|NCT00094835|579896028|FG003|Overall Study|Non-compliance|0|||
160463588|NCT02397096|579427755|FG000|Study Extension 2|Pregnancy|1|||
160463589|NCT02397096|579427756|FG001|Study Extension 2|Pregnancy|0|||
160463590|NCT02397096|579427755|FG000|Study Extension 2|Withdrawal by Subject|10|||
160463591|NCT02397096|579427756|FG001|Study Extension 2|Withdrawal by Subject|3|||
160595146|NCT00094835|579896029|FG004|Overall Study|Non-compliance|2|||
160595147|NCT00094835|579896030|FG005|Overall Study|Non-compliance|2|||
160595148|NCT00094835|579896031|FG006|Overall Study|Non-compliance|1|||
160595149|NCT00094835|579896025|FG000|Overall Study|Other|1|||
160595150|NCT00094835|579896026|FG001|Overall Study|Other|1|||
160595151|NCT00094835|579896027|FG002|Overall Study|Other|1|||
160595152|NCT00094835|579896028|FG003|Overall Study|Other|1|||
160595153|NCT00094835|579896029|FG004|Overall Study|Other|0|||
160595154|NCT00094835|579896030|FG005|Overall Study|Other|0|||
160595155|NCT00094835|579896031|FG006|Overall Study|Other|0|||
160595156|NCT00387348|579896032|FG000|Overall Study|Death|1|||
160595157|NCT00387348|579896033|FG001|Overall Study|Death|1|||
160595158|NCT00387348|579896034|FG002|Overall Study|Death|0|||
160463592|NCT02397096|579427755|FG000|Study Extension 3|Adverse Event|1|||
160463593|NCT02397096|579427756|FG001|Study Extension 3|Adverse Event|0|||
160463594|NCT02397096|579427755|FG000|Study Extension 3|Availability of study medication locally|11|||
160463595|NCT02397096|579427756|FG001|Study Extension 3|Availability of study medication locally|3|||
160463596|NCT02397096|579427755|FG000|Study Extension 3|Lost to Follow-up|1|||
160463597|NCT02397096|579427756|FG001|Study Extension 3|Lost to Follow-up|0|||
160463598|NCT02397096|579427755|FG000|Study Extension 3|Withdrawal by Subject|2|||
160463599|NCT02397096|579427756|FG001|Study Extension 3|Withdrawal by Subject|1|||
160463600|NCT05018143|579427757|FG000|Overall Study|Lost to Follow-up|5|||
160463601|NCT05018143|579427758|FG001|Overall Study|Lost to Follow-up|4|||
160463602|NCT05018143|579427757|FG000|Overall Study|Withdrawal by Subject|0|||
160463603|NCT05018143|579427758|FG001|Overall Study|Withdrawal by Subject|1|||
160463604|NCT06688357|579427759|FG000|Overall Study|Adverse Event|0|||
160463605|NCT06688357|579427760|FG001|Overall Study|Adverse Event|1|||
160463606|NCT05116774|579427761|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
160463607|NCT05116774|579427762|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
160463608|NCT05116774|579427761|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
160463609|NCT05116774|579427762|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
160463610|NCT05116774|579427761|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
160463611|NCT05116774|579427762|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
160463612|NCT05116774|579427761|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
160463613|NCT05116774|579427762|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
160463614|NCT03280030|579427763|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
160463615|NCT03280030|579427764|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
160463616|NCT03280030|579427765|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
160463617|NCT03280030|579427763|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
160463618|NCT03280030|579427764|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
160463619|NCT03280030|579427765|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
160463620|NCT03280030|579427763|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
160463621|NCT03280030|579427764|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
160463622|NCT03280030|579427765|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
160463623|NCT03280030|579427763|FG000|Part 2 - Efficacy|Adverse Event|0|||
160463624|NCT03280030|579427764|FG001|Part 2 - Efficacy|Adverse Event|4|||
160463625|NCT03280030|579427765|FG002|Part 2 - Efficacy|Adverse Event|6|||
160463626|NCT03280030|579427763|FG000|Part 2 - Efficacy|Death|0|||
160595159|NCT00387348|579896032|FG000|Overall Study|Physician Decision|1|||
160595160|NCT00387348|579896033|FG001|Overall Study|Physician Decision|0|||
160595161|NCT00387348|579896034|FG002|Overall Study|Physician Decision|1|||
160595162|NCT00387348|579896032|FG000|Overall Study|Withdrawal by Subject|0|||
160595163|NCT00387348|579896033|FG001|Overall Study|Withdrawal by Subject|2|||
160595164|NCT00387348|579896034|FG002|Overall Study|Withdrawal by Subject|2|||
160595165|NCT00387348|579896032|FG000|Overall Study|Adverse Event|1|||
160463627|NCT03280030|579427764|FG001|Part 2 - Efficacy|Death|3|||
160463628|NCT03280030|579427765|FG002|Part 2 - Efficacy|Death|0|||
160463629|NCT03280030|579427763|FG000|Part 2 - Efficacy|Physician Decision|0|||
160463630|NCT03280030|579427764|FG001|Part 2 - Efficacy|Physician Decision|10|||
160463631|NCT03280030|579427765|FG002|Part 2 - Efficacy|Physician Decision|16|||
160463632|NCT03280030|579427763|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
160463633|NCT03280030|579427764|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
160463634|NCT03280030|579427765|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
160463635|NCT03280030|579427763|FG000|Part 2 - Efficacy|Progressive disease|0|||
160463636|NCT03280030|579427764|FG001|Part 2 - Efficacy|Progressive disease|7|||
160463637|NCT03280030|579427765|FG002|Part 2 - Efficacy|Progressive disease|5|||
160463638|NCT04882917|579427771|FG000|Overall Study|Adverse Event|0|||
160463639|NCT04882917|579427772|FG001|Overall Study|Adverse Event|1|||
160463640|NCT04882917|579427773|FG002|Overall Study|Adverse Event|2|||
160463641|NCT04882917|579427774|FG003|Overall Study|Adverse Event|2|||
160463642|NCT04882917|579427771|FG000|Overall Study|Withdrawal by Subject|1|||
160463643|NCT04882917|579427772|FG001|Overall Study|Withdrawal by Subject|0|||
160463644|NCT04882917|579427773|FG002|Overall Study|Withdrawal by Subject|2|||
160463645|NCT04882917|579427774|FG003|Overall Study|Withdrawal by Subject|1|||
160463646|NCT04882917|579427771|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
160463647|NCT04882917|579427772|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
160595166|NCT00387348|579896033|FG001|Overall Study|Adverse Event|0|||
160463648|NCT04882917|579427773|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
160595167|NCT00387348|579896034|FG002|Overall Study|Adverse Event|1|||
160595168|NCT03628599|579896035|FG000|Overall Study|Adverse Event|0|||
160595169|NCT03628599|579896036|FG001|Overall Study|Adverse Event|1|||
160463649|NCT04882917|579427774|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
160463650|NCT03959423|579427778|FG000|Overall Study|Withdrawal by Subject|2|||
160463651|NCT03959423|579427779|FG001|Overall Study|Withdrawal by Subject|3|||
160463652|NCT03959423|579427778|FG000|Overall Study|Physician Decision|0|||
160463653|NCT03959423|579427779|FG001|Overall Study|Physician Decision|1|||
160463654|NCT03959423|579427778|FG000|Overall Study|Lost to Follow-up|1|||
160463655|NCT03959423|579427779|FG001|Overall Study|Lost to Follow-up|0|||
160463656|NCT03959423|579427778|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
160463657|NCT03959423|579427779|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160463658|NCT01470144|579427784|FG000|Overall Study|Adverse Event|2|||
160463659|NCT01470144|579427784|FG000|Overall Study|Death|1|||
160463660|NCT01470144|579427784|FG000|Overall Study|Lung transplant|6|||
160463661|NCT01470144|579427784|FG000|Overall Study|Patient's and investigator's decision|1|||
160463662|NCT00593840|579427785|FG000|Overall Study|Withdrawal by Subject|1|||
160463663|NCT06056310|579428608|FG000|Overall Study|Other Reasons|2|||
160463664|NCT06056310|579428608|FG000|Overall Study|Sponsor Request|16|||
160463665|NCT04503681|579428611|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
160463666|NCT04503681|579428612|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
160463667|NCT03352713|579428615|FG000|Overall Study|Lost to Follow-up|8|||
160463668|NCT03352713|579428615|FG000|Overall Study|Withdrawn by investigator|5|||
160463669|NCT03352713|579428615|FG000|Overall Study|Completed 0 EMAs|8|||
160463670|NCT03352713|579428615|FG000|Overall Study|Device incompatible/stolen|5|||
160463671|NCT01812759|579428616|FG000|Overall Study|Physician Decision|0|||
160463672|NCT01812759|579428617|FG001|Overall Study|Physician Decision|0|||
160463673|NCT01812759|579428618|FG002|Overall Study|Physician Decision|1|||
160463674|NCT02866942|579428619|FG000|Overall Study|Invalid consent|1|||
160463675|NCT00372775|579428620|FG000|Overall Study|Adverse Event|8|||
160463676|NCT00372775|579428620|FG000|Overall Study|Death|15|||
160463677|NCT00372775|579428620|FG000|Overall Study|Objective progression or relapse|30|||
160463678|NCT00372775|579428620|FG000|Overall Study|Global deterioration of health status|6|||
160463679|NCT00372775|579428620|FG000|Overall Study|Withdrawal by Subject|1|||
160463680|NCT00372775|579428620|FG000|Overall Study|Other|1|||
160463681|NCT00372775|579428620|FG000|Overall Study|Not Treated|2|||
160463682|NCT01561300|579428621|FG000|Run in on Placebo|Adverse Event|1|||
160463683|NCT01561300|579428622|FG001|Run in on Placebo|Adverse Event|0|||
160463684|NCT01436175|579428623|FG000|Overall Study|Adverse Event|111|||
160463685|NCT01436175|579428623|FG000|Overall Study|Protocol Violation|49|||
160463686|NCT01436175|579428623|FG000|Overall Study|Withdrawal by Subject|108|||
160463687|NCT01436175|579428623|FG000|Overall Study|Lost to Follow-up|89|||
160463688|NCT01436175|579428623|FG000|Overall Study|Lack of Efficacy|24|||
160463689|NCT01436175|579428623|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
160463690|NCT01436175|579428623|FG000|Overall Study|Other|826|||
160463691|NCT01952366|579428626|FG000|Overall Study|Death|22|||
160463692|NCT01952366|579428626|FG000|Overall Study|Withdrawal by Subject|9|||
160463693|NCT00623194|579428627|FG000|Overall Study|Lack of Efficacy|1|||
160463694|NCT00623194|579428627|FG000|Overall Study|Protocol Violation|3|||
160463695|NCT00623194|579428627|FG000|Overall Study|Unclassified|1|||
160463696|NCT00857766|579428628|FG000|Overall Study|Adverse Event|13|||
160463697|NCT00857766|579428629|FG001|Overall Study|Adverse Event|12|||
160463698|NCT00857766|579428628|FG000|Overall Study|Protocol Violation|11|||
160463699|NCT00857766|579428629|FG001|Overall Study|Protocol Violation|11|||
160463700|NCT00857766|579428628|FG000|Overall Study|Lost to Follow-up|1|||
160463701|NCT00857766|579428629|FG001|Overall Study|Lost to Follow-up|0|||
160463702|NCT00857766|579428628|FG000|Overall Study|Investigator Discretion|2|||
160463703|NCT00857766|579428629|FG001|Overall Study|Investigator Discretion|3|||
160463704|NCT00857766|579428628|FG000|Overall Study|Participant Withdrew Consent|4|||
160463705|NCT00857766|579428629|FG001|Overall Study|Participant Withdrew Consent|4|||
160595170|NCT02769832|579896045|FG000|Overall Study|Death|30|||
160463706|NCT01988402|579428630|FG000|Overall Study|Adverse Event|1|||
160463707|NCT01988402|579428631|FG001|Overall Study|Adverse Event|2|||
160463708|NCT01988402|579428630|FG000|Overall Study|Withdrawal by Subject|1|||
160595171|NCT00868166|579896049|FG000|Overall Study|Death|58|||
160595172|NCT00868166|579896050|FG001|Overall Study|Death|65|||
160595173|NCT00868166|579896049|FG000|Overall Study|Withdrawal by Subject|33|||
160463709|NCT01988402|579428631|FG001|Overall Study|Withdrawal by Subject|0|||
160463710|NCT01212744|579428632|FG000|Overall Study|Withdrawal by Subject|1|||
160463711|NCT00523419|579428636|FG000|Overall Study|Adverse Event|1|||
160463712|NCT00523419|579428636|FG000|Overall Study|Withdrawal by Subject|1|||
160463713|NCT00523419|579428636|FG000|Overall Study|Physician Decision|2|||
160463714|NCT00523419|579428636|FG000|Overall Study|Progressive Disease|22|||
160463715|NCT00523419|579428636|FG000|Overall Study|Death due to Study Disease|4|||
160463716|NCT00523419|579428636|FG000|Overall Study|Death due to Adverse Event|2|||
160463717|NCT00822120|579428637|FG000|Initial Registration|Adverse Event|1|||
160463718|NCT00822120|579428638|FG001|Initial Registration|Adverse Event|0|||
160463719|NCT00822120|579428639|FG002|Initial Registration|Adverse Event|0|||
160463720|NCT00822120|579428640|FG003|Initial Registration|Adverse Event|0|||
160463721|NCT00822120|579428641|FG004|Initial Registration|Adverse Event|0|||
160463722|NCT00822120|579428642|FG005|Initial Registration|Adverse Event|0|||
160463723|NCT00822120|579428637|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
160463724|NCT00822120|579428638|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
160463725|NCT00822120|579428639|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
160463726|NCT00822120|579428640|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
160463727|NCT00822120|579428641|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
160463728|NCT00822120|579428642|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
160463729|NCT00822120|579428637|FG000|Initial Registration|Reasons not Protocol Specified|2|||
160463730|NCT00822120|579428638|FG001|Initial Registration|Reasons not Protocol Specified|0|||
160463731|NCT00822120|579428639|FG002|Initial Registration|Reasons not Protocol Specified|0|||
160463732|NCT00822120|579428640|FG003|Initial Registration|Reasons not Protocol Specified|0|||
160463733|NCT00822120|579428641|FG004|Initial Registration|Reasons not Protocol Specified|0|||
160463734|NCT00822120|579428642|FG005|Initial Registration|Reasons not Protocol Specified|0|||
160463735|NCT00822120|579428637|FG000|Initial Registration|Ineligible|22|||
160463736|NCT00822120|579428638|FG001|Initial Registration|Ineligible|1|||
160463737|NCT00822120|579428639|FG002|Initial Registration|Ineligible|0|||
160463738|NCT00822120|579428640|FG003|Initial Registration|Ineligible|0|||
160463739|NCT00822120|579428641|FG004|Initial Registration|Ineligible|0|||
160463740|NCT00822120|579428642|FG005|Initial Registration|Ineligible|0|||
160463741|NCT00822120|579428637|FG000|PET-directed Therapy|Adverse Event|0|||
160463742|NCT00822120|579428638|FG001|PET-directed Therapy|Adverse Event|0|||
160463743|NCT00822120|579428639|FG002|PET-directed Therapy|Adverse Event|0|||
160463744|NCT00822120|579428640|FG003|PET-directed Therapy|Adverse Event|1|||
160463745|NCT00822120|579428641|FG004|PET-directed Therapy|Adverse Event|0|||
160463746|NCT00822120|579428642|FG005|PET-directed Therapy|Adverse Event|0|||
160463747|NCT00822120|579428637|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
160463748|NCT00822120|579428638|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
160463749|NCT00822120|579428639|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
160463750|NCT00822120|579428640|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
160463751|NCT00822120|579428641|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
160463752|NCT00822120|579428642|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
160463753|NCT00822120|579428637|FG000|PET-directed Therapy|Death|0|||
160463754|NCT00822120|579428638|FG001|PET-directed Therapy|Death|0|||
160463755|NCT00822120|579428639|FG002|PET-directed Therapy|Death|0|||
160463756|NCT00822120|579428640|FG003|PET-directed Therapy|Death|2|||
160463757|NCT00822120|579428641|FG004|PET-directed Therapy|Death|0|||
160463758|NCT00822120|579428642|FG005|PET-directed Therapy|Death|0|||
160463759|NCT00822120|579428637|FG000|PET-directed Therapy|Protocol Violation|0|||
160463760|NCT00822120|579428638|FG001|PET-directed Therapy|Protocol Violation|0|||
160463761|NCT00822120|579428639|FG002|PET-directed Therapy|Protocol Violation|0|||
160463762|NCT00822120|579428640|FG003|PET-directed Therapy|Protocol Violation|6|||
160463763|NCT00822120|579428641|FG004|PET-directed Therapy|Protocol Violation|0|||
160463764|NCT00822120|579428642|FG005|PET-directed Therapy|Protocol Violation|0|||
160463765|NCT01759862|579428643|FG000|Overall Study|Physician Decision|3|||
160463766|NCT01759862|579428644|FG001|Overall Study|Physician Decision|1|||
160463767|NCT01759862|579428643|FG000|Overall Study|Adverse Event|0|||
160463768|NCT01759862|579428644|FG001|Overall Study|Adverse Event|1|||
160463769|NCT04060212|579428646|FG000|Overall Study|Withdrawal by Subject|7|||
160463770|NCT01499849|579428647|FG000|Overall Study|Adverse Event|28|||
160463771|NCT01499849|579428648|FG001|Overall Study|Adverse Event|32|||
160463772|NCT01499849|579428647|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
160463773|NCT01499849|579428648|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
160463774|NCT01499849|579428647|FG000|Overall Study|Withdrawal by Subject|43|||
160463775|NCT01499849|579428648|FG001|Overall Study|Withdrawal by Subject|43|||
160463776|NCT01499849|579428647|FG000|Overall Study|Death|5|||
160463777|NCT01499849|579428648|FG001|Overall Study|Death|7|||
160463778|NCT01499849|579428647|FG000|Overall Study|Disease Progression|11|||
160463779|NCT01499849|579428648|FG001|Overall Study|Disease Progression|10|||
160463780|NCT01499849|579428647|FG000|Overall Study|Protocol Violation|11|||
160463781|NCT01499849|579428648|FG001|Overall Study|Protocol Violation|11|||
160463782|NCT01499849|579428647|FG000|Overall Study|Physician Decision|20|||
160463783|NCT01499849|579428648|FG001|Overall Study|Physician Decision|19|||
160463784|NCT01499849|579428647|FG000|Overall Study|Lack of Efficacy|3|||
160463785|NCT01499849|579428648|FG001|Overall Study|Lack of Efficacy|4|||
160463786|NCT01499849|579428647|FG000|Overall Study|Lost to Follow-up|6|||
160463787|NCT01499849|579428648|FG001|Overall Study|Lost to Follow-up|3|||
160463788|NCT01499849|579428647|FG000|Overall Study|Other Reasons|27|||
160463789|NCT01499849|579428648|FG001|Overall Study|Other Reasons|30|||
160463790|NCT01437319|579428649|FG000|Phase I|Lost to Follow-up|2|||
160463791|NCT01437319|579428650|FG001|Phase I|Lost to Follow-up|0|||
160463792|NCT01437319|579428651|FG002|Phase I|Lost to Follow-up|0|||
160463793|NCT01437319|579428649|FG000|Phase I|Protocol Violation|1|||
160463794|NCT01437319|579428650|FG001|Phase I|Protocol Violation|0|||
160463795|NCT01437319|579428651|FG002|Phase I|Protocol Violation|0|||
160463796|NCT01437319|579428649|FG000|Phase I|Study related symptoms/complaints|27|||
160463797|NCT01437319|579428650|FG001|Phase I|Study related symptoms/complaints|0|||
160463798|NCT01437319|579428651|FG002|Phase I|Study related symptoms/complaints|0|||
160463799|NCT01437319|579428649|FG000|Phase I|Withdrawal by Subject|25|||
160463800|NCT01437319|579428650|FG001|Phase I|Withdrawal by Subject|0|||
160463801|NCT01437319|579428651|FG002|Phase I|Withdrawal by Subject|0|||
160463802|NCT01437319|579428649|FG000|Phase II|Withdrawal by Subject|0|||
160463803|NCT01437319|579428650|FG001|Phase II|Withdrawal by Subject|8|||
160463804|NCT01437319|579428651|FG002|Phase II|Withdrawal by Subject|16|||
160463805|NCT01437319|579428649|FG000|Phase II|Lost to Follow-up|0|||
160463806|NCT01437319|579428650|FG001|Phase II|Lost to Follow-up|7|||
160463807|NCT01437319|579428651|FG002|Phase II|Lost to Follow-up|2|||
160463808|NCT01437319|579428649|FG000|Phase II|Study related symptoms/complaints|0|||
160463809|NCT01437319|579428650|FG001|Phase II|Study related symptoms/complaints|28|||
160463810|NCT01437319|579428651|FG002|Phase II|Study related symptoms/complaints|19|||
160463811|NCT01437319|579428649|FG000|Phase II|Protocol Violation|0|||
160463812|NCT01437319|579428650|FG001|Phase II|Protocol Violation|1|||
160463813|NCT01437319|579428651|FG002|Phase II|Protocol Violation|0|||
160463814|NCT02646618|579428652|FG000|Overall Study|Lost to Follow-up|10|||
160463815|NCT02646618|579428653|FG001|Overall Study|Lost to Follow-up|14|||
160463816|NCT03885232|579428654|FG000|Overall Study|Lost to Follow-up|74|||
160463817|NCT03885232|579428655|FG001|Overall Study|Lost to Follow-up|32|||
160463818|NCT03885232|579428654|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
160463819|NCT03885232|579428655|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
160463820|NCT00274261|579428656|FG000|Overall Study|Adverse Event|19|||
160463821|NCT00274261|579428657|FG001|Overall Study|Adverse Event|11|||
160463822|NCT00274261|579428656|FG000|Overall Study|Pregnancy|114|||
160463823|NCT00274261|579428657|FG001|Overall Study|Pregnancy|83|||
160463824|NCT00274261|579428656|FG000|Overall Study|Withdrawal by Subject|179|||
160463825|NCT00274261|579428657|FG001|Overall Study|Withdrawal by Subject|126|||
160463826|NCT00274261|579428656|FG000|Overall Study|Protocol Violation|71|||
160463827|NCT00274261|579428657|FG001|Overall Study|Protocol Violation|42|||
160463828|NCT00274261|579428656|FG000|Overall Study|Lost to Follow-up|106|||
160463829|NCT00274261|579428657|FG001|Overall Study|Lost to Follow-up|75|||
160463830|NCT03500549|579428658|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
160463831|NCT03500549|579428659|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
160463832|NCT03500549|579428658|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
160463833|NCT03500549|579428659|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
160463834|NCT02016872|579428662|FG000|Overall Study|Withdrawal by Subject|10|||
160463835|NCT02016872|579428662|FG000|Overall Study|Death Progression|2|||
160463836|NCT02016872|579428662|FG000|Overall Study|No FMISO scan|1|||
160463837|NCT02016872|579428662|FG000|Overall Study|Ineligible|2|||
160463838|NCT05601882|579428663|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
160463839|NCT05601882|579428664|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
160463840|NCT05601882|579428665|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
160658754|NCT02817841|580133178|FG000|Overall Study|Pregnancy wish|17|||
160463841|NCT05601882|579428666|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
160463842|NCT05601882|579428663|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
160463843|NCT05601882|579428664|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
160463844|NCT05601882|579428665|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
160463845|NCT05601882|579428666|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
160463846|NCT05601882|579428663|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
160463847|NCT05601882|579428664|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
160463848|NCT05601882|579428665|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
160463849|NCT05601882|579428666|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
160463850|NCT05601882|579428663|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
160463851|NCT05601882|579428664|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
160463852|NCT05601882|579428665|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
160463853|NCT05601882|579428666|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
160463854|NCT05601882|579428663|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
160463855|NCT05601882|579428664|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
160463856|NCT05601882|579428665|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
160463857|NCT05601882|579428666|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
160463858|NCT05601882|579428663|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
160463859|NCT05601882|579428664|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
160463860|NCT05601882|579428665|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
160463861|NCT05601882|579428666|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
160463862|NCT03222609|579428669|FG000|Overall Study|Withdrew consent|2|||
160463863|NCT03222609|579428670|FG001|Overall Study|Withdrew consent|3|||
160463864|NCT03222609|579428671|FG002|Overall Study|Withdrew consent|4|||
160463865|NCT03222609|579428672|FG003|Overall Study|Withdrew consent|2|||
160463866|NCT03222609|579428669|FG000|Overall Study|Lost to Follow-up|1|||
160463867|NCT03222609|579428670|FG001|Overall Study|Lost to Follow-up|0|||
160463868|NCT03222609|579428671|FG002|Overall Study|Lost to Follow-up|0|||
160463869|NCT03222609|579428672|FG003|Overall Study|Lost to Follow-up|0|||
160463870|NCT03222609|579428669|FG000|Overall Study|Death|16|||
160463871|NCT03222609|579428670|FG001|Overall Study|Death|13|||
160463872|NCT03222609|579428671|FG002|Overall Study|Death|9|||
160463873|NCT03222609|579428672|FG003|Overall Study|Death|6|||
160463874|NCT03222609|579428669|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
160463875|NCT03222609|579428670|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
160463876|NCT03222609|579428671|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
160463877|NCT03222609|579428672|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
160463878|NCT03789110|579428673|FG000|Overall Study|Adverse Event|2|||
160463879|NCT03789110|579428673|FG000|Overall Study|Physician Decision|1|||
160463880|NCT03789110|579428673|FG000|Overall Study|Withdrawal by Subject|2|||
160463881|NCT03789110|579428673|FG000|Overall Study|Lack of Efficacy|22|||
160463882|NCT03789110|579428673|FG000|Overall Study|still on treatment|3|||
160463883|NCT00545545|579428674|FG000|Overall Study|Progressive Neoplastic Disease|1|||
160463884|NCT00545545|579428675|FG001|Overall Study|Progressive Neoplastic Disease|5|||
160463885|NCT00545545|579428676|FG002|Overall Study|Progressive Neoplastic Disease|0|||
160463886|NCT00545545|579428677|FG003|Overall Study|Progressive Neoplastic Disease|4|||
160463887|NCT00545545|579428678|FG004|Overall Study|Progressive Neoplastic Disease|8|||
160463888|NCT00545545|579428679|FG005|Overall Study|Progressive Neoplastic Disease|7|||
160463889|NCT00545545|579428674|FG000|Overall Study|Withdrawal by Subject|0|||
160463890|NCT00545545|579428675|FG001|Overall Study|Withdrawal by Subject|1|||
160463891|NCT00545545|579428676|FG002|Overall Study|Withdrawal by Subject|0|||
160463892|NCT00545545|579428677|FG003|Overall Study|Withdrawal by Subject|0|||
160463893|NCT00545545|579428678|FG004|Overall Study|Withdrawal by Subject|0|||
160463894|NCT00545545|579428679|FG005|Overall Study|Withdrawal by Subject|0|||
160463895|NCT00545545|579428674|FG000|Overall Study|Physician Decision|1|||
160463896|NCT00545545|579428675|FG001|Overall Study|Physician Decision|0|||
160463897|NCT00545545|579428676|FG002|Overall Study|Physician Decision|0|||
160463898|NCT00545545|579428677|FG003|Overall Study|Physician Decision|0|||
160463899|NCT00545545|579428678|FG004|Overall Study|Physician Decision|0|||
160463900|NCT00545545|579428679|FG005|Overall Study|Physician Decision|1|||
160463901|NCT00545545|579428674|FG000|Overall Study|Irinotecan intolerance|1|||
160463902|NCT00545545|579428675|FG001|Overall Study|Irinotecan intolerance|1|||
160463903|NCT00545545|579428676|FG002|Overall Study|Irinotecan intolerance|0|||
160463904|NCT00545545|579428677|FG003|Overall Study|Irinotecan intolerance|0|||
160463905|NCT00545545|579428678|FG004|Overall Study|Irinotecan intolerance|0|||
160463906|NCT00545545|579428679|FG005|Overall Study|Irinotecan intolerance|0|||
160463907|NCT00545545|579428674|FG000|Overall Study|No target lesions to track post surgery|0|||
160463908|NCT00545545|579428675|FG001|Overall Study|No target lesions to track post surgery|0|||
160463909|NCT00545545|579428676|FG002|Overall Study|No target lesions to track post surgery|0|||
160463910|NCT00545545|579428677|FG003|Overall Study|No target lesions to track post surgery|0|||
160463911|NCT00545545|579428678|FG004|Overall Study|No target lesions to track post surgery|1|||
160463912|NCT00545545|579428679|FG005|Overall Study|No target lesions to track post surgery|1|||
160463913|NCT03691493|579428683|FG000|Overall Study|Withdrawal by Subject|1|||
160463914|NCT00227266|579428684|FG000|Overall Study|Withdrawal by Subject|0|||
160463915|NCT00227266|579428685|FG001|Overall Study|Withdrawal by Subject|0|||
160463916|NCT00227266|579428686|FG002|Overall Study|Withdrawal by Subject|1|||
160463917|NCT00227266|579428684|FG000|Overall Study|Protocol Violation|1|||
160463918|NCT00227266|579428685|FG001|Overall Study|Protocol Violation|0|||
160463919|NCT00227266|579428686|FG002|Overall Study|Protocol Violation|1|||
160463920|NCT00227266|579428684|FG000|Overall Study|Excessive weight gain|0|||
160658755|NCT02817841|580133178|FG000|Overall Study|Other reasons|53|||
160658756|NCT02817841|580133178|FG000|Overall Study|Protocol Violation|94|||
160463921|NCT00227266|579428685|FG001|Overall Study|Excessive weight gain|0|||
160463922|NCT00227266|579428686|FG002|Overall Study|Excessive weight gain|2|||
160463923|NCT04926740|579428689|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
160463924|NCT04926740|579428690|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
160463925|NCT04926740|579428689|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
160463926|NCT04926740|579428690|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
160463927|NCT05802173|579430126|FG000|Overall Study|Withdrawal by Subject|2|||
160463928|NCT05802173|579430127|FG001|Overall Study|Withdrawal by Subject|0|||
160463929|NCT05802173|579430128|FG002|Overall Study|Withdrawal by Subject|0|||
160463930|NCT05802173|579430126|FG000|Overall Study|Protocol Violation|1|||
160463931|NCT05802173|579430127|FG001|Overall Study|Protocol Violation|0|||
160463932|NCT05802173|579430128|FG002|Overall Study|Protocol Violation|0|||
160463933|NCT05802173|579430126|FG000|Overall Study|Lost to Follow-up|0|||
160463934|NCT05802173|579430127|FG001|Overall Study|Lost to Follow-up|6|||
160463935|NCT05802173|579430128|FG002|Overall Study|Lost to Follow-up|4|||
160463936|NCT05802173|579430126|FG000|Overall Study|non-compliance|0|||
160463937|NCT05802173|579430127|FG001|Overall Study|non-compliance|1|||
160463938|NCT05802173|579430128|FG002|Overall Study|non-compliance|0|||
160463939|NCT00360269|579430129|FG000|Overall Study|Lost to Follow-up|7|||
160463940|NCT00360269|579430130|FG001|Overall Study|Lost to Follow-up|9|||
160463941|NCT00360269|579430129|FG000|Overall Study|Physician Decision|1|||
160658757|NCT04188106|580133179|FG000|Overall Study|Lost to Follow-up|5|||
160463942|NCT00360269|579430130|FG001|Overall Study|Physician Decision|2|||
160463943|NCT00360269|579430129|FG000|Overall Study|Adverse Event|1|||
160463944|NCT00360269|579430130|FG001|Overall Study|Adverse Event|0|||
160463945|NCT00360269|579430129|FG000|Overall Study|Withdrawal by Subject|1|||
160463946|NCT00360269|579430130|FG001|Overall Study|Withdrawal by Subject|1|||
160463947|NCT03758638|579430133|FG000|Overall Study|Pregnancy|17|||
160463948|NCT03758638|579430134|FG001|Overall Study|Pregnancy|25|||
160463949|NCT03758638|579430133|FG000|Overall Study|Lost to Follow-up|60|||
160463950|NCT03758638|579430134|FG001|Overall Study|Lost to Follow-up|54|||
160463951|NCT03758638|579430133|FG000|Overall Study|Protocol Violation|2|||
160463952|NCT03758638|579430134|FG001|Overall Study|Protocol Violation|0|||
160463953|NCT03758638|579430133|FG000|Overall Study|Withdrawal by Subject|8|||
160463954|NCT03758638|579430134|FG001|Overall Study|Withdrawal by Subject|2|||
160463955|NCT03758638|579430133|FG000|Overall Study|Providers not included in the primary outcome.|183|||
160463956|NCT03758638|579430134|FG001|Overall Study|Providers not included in the primary outcome.|128|||
160463957|NCT04213807|579430136|FG000|Overall Study|Physician Decision|0|||
160463958|NCT04213807|579430137|FG001|Overall Study|Physician Decision|0|||
160463959|NCT04213807|579430138|FG002|Overall Study|Physician Decision|1|||
160463960|NCT03442777|579430139|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
160463961|NCT03442777|579430140|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
160463962|NCT03442777|579430141|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
160463963|NCT00790569|579430142|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
160463964|NCT00790569|579430143|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
160463965|NCT00790569|579430144|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
160463966|NCT00790569|579430142|FG000|End of Treatment (6 Month Interview)|Death|0|||
160463967|NCT00790569|579430143|FG001|End of Treatment (6 Month Interview)|Death|2|||
160463968|NCT00790569|579430144|FG002|End of Treatment (6 Month Interview)|Death|1|||
160463969|NCT00790569|579430142|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
160463970|NCT00790569|579430143|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
160463971|NCT00790569|579430144|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
160463972|NCT00790569|579430142|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
160463973|NCT00790569|579430143|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
160463974|NCT00790569|579430144|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
160463975|NCT00790569|579430142|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
160463976|NCT00790569|579430143|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
160463977|NCT00790569|579430144|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
160463978|NCT00790569|579430142|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
160463979|NCT00790569|579430143|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
160463980|NCT00790569|579430144|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
160463981|NCT01627561|579430145|FG000|Overall Study|Lost to Follow-up|1|||
160463982|NCT01627561|579430146|FG001|Overall Study|Lost to Follow-up|0|||
160463983|NCT01627561|579430145|FG000|Overall Study|Withdrawal by Subject|0|||
160463984|NCT01627561|579430146|FG001|Overall Study|Withdrawal by Subject|1|||
160463985|NCT01627561|579430145|FG000|Overall Study|Migrated/moved from study area|0|||
160463986|NCT01627561|579430146|FG001|Overall Study|Migrated/moved from study area|2|||
160463987|NCT00724126|579430147|FG000|Overall Study|Adverse Event|2|||
160463988|NCT00724126|579430148|FG001|Overall Study|Adverse Event|0|||
160463989|NCT00724126|579430147|FG000|Overall Study|Withdrawal by Subject|8|||
160463990|NCT00724126|579430148|FG001|Overall Study|Withdrawal by Subject|6|||
160463991|NCT00724126|579430147|FG000|Overall Study|Lost to Follow-up|6|||
160463992|NCT00724126|579430148|FG001|Overall Study|Lost to Follow-up|6|||
160463993|NCT00724126|579430147|FG000|Overall Study|Noncompliance|2|||
160463994|NCT00724126|579430148|FG001|Overall Study|Noncompliance|1|||
160463995|NCT00724126|579430147|FG000|Overall Study|Subject randomized although ineligible|1|||
160463996|NCT00724126|579430148|FG001|Overall Study|Subject randomized although ineligible|1|||
160463997|NCT00724126|579430147|FG000|Overall Study|Subject had to leave vicinity of site|0|||
160463998|NCT00724126|579430148|FG001|Overall Study|Subject had to leave vicinity of site|1|||
160463999|NCT03577106|579430152|FG000|Overall Study|Withdrawal by Subject|3|||
160464000|NCT03451422|579430153|FG000|Overall Study|Lost to Follow-up|0|||
160464001|NCT03451422|579430154|FG001|Overall Study|Lost to Follow-up|0|||
160464002|NCT03451422|579430155|FG002|Overall Study|Lost to Follow-up|0|||
160464003|NCT03451422|579430156|FG003|Overall Study|Lost to Follow-up|0|||
160464004|NCT03451422|579430157|FG004|Overall Study|Lost to Follow-up|0|||
160464005|NCT03451422|579430158|FG005|Overall Study|Lost to Follow-up|1|||
160464006|NCT03451422|579430153|FG000|Overall Study|Decision by sponsor|1|||
160658758|NCT04188106|580133179|FG000|Overall Study|Non-Compliance|1|||
160464007|NCT03451422|579430154|FG001|Overall Study|Decision by sponsor|0|||
160464008|NCT03451422|579430155|FG002|Overall Study|Decision by sponsor|1|||
160464009|NCT03451422|579430156|FG003|Overall Study|Decision by sponsor|0|||
160464010|NCT03451422|579430157|FG004|Overall Study|Decision by sponsor|0|||
160464011|NCT03451422|579430158|FG005|Overall Study|Decision by sponsor|0|||
160658759|NCT00705536|580133180|FG000|Start Period 1|Withdrawal by Subject|0|||
160595174|NCT00868166|579896050|FG001|Overall Study|Withdrawal by Subject|25|||
160595175|NCT00868166|579896049|FG000|Overall Study|Protocol Violation|1|||
160595176|NCT00868166|579896050|FG001|Overall Study|Protocol Violation|0|||
160595177|NCT00868166|579896049|FG000|Overall Study|Lost to Follow-up|1|||
160595178|NCT00868166|579896050|FG001|Overall Study|Lost to Follow-up|3|||
160595179|NCT00868166|579896049|FG000|Overall Study|Adverse Event|9|||
160464012|NCT03451422|579430153|FG000|Overall Study|Withdrawal by Subject|0|||
160464013|NCT03451422|579430154|FG001|Overall Study|Withdrawal by Subject|0|||
160464014|NCT03451422|579430155|FG002|Overall Study|Withdrawal by Subject|2|||
160464015|NCT03451422|579430156|FG003|Overall Study|Withdrawal by Subject|3|||
160464016|NCT03451422|579430157|FG004|Overall Study|Withdrawal by Subject|2|||
160464017|NCT03451422|579430158|FG005|Overall Study|Withdrawal by Subject|1|||
160464018|NCT01579318|579430159|FG000|Overall Study|Disease Progression|1|||
160464019|NCT03601715|579430162|FG000|Second Intervention|Lost to Follow-up|1|||
160464020|NCT03601715|579430163|FG001|Second Intervention|Lost to Follow-up|1|||
160464021|NCT03601715|579430164|FG002|Second Intervention|Lost to Follow-up|0|||
160464022|NCT02347332|579430165|FG000|Overall Study|Not treated|5|||
160595180|NCT00868166|579896050|FG001|Overall Study|Adverse Event|10|||
160595181|NCT00868166|579896049|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
160595182|NCT00868166|579896050|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
160595183|NCT00868166|579896049|FG000|Overall Study|Non-compliance with IMP|1|||
160595184|NCT00868166|579896050|FG001|Overall Study|Non-compliance with IMP|1|||
160595185|NCT01204697|579896058|FG000|Overall Study|Death|26|||
160595186|NCT01204697|579896059|FG001|Overall Study|Death|27|||
160595187|NCT01204697|579896058|FG000|Overall Study|Lost to Follow-up|3|||
160595188|NCT01204697|579896059|FG001|Overall Study|Lost to Follow-up|4|||
160595189|NCT01204697|579896058|FG000|Overall Study|Withdrawal by Subject|2|||
160595190|NCT01204697|579896059|FG001|Overall Study|Withdrawal by Subject|4|||
160595191|NCT01204697|579896058|FG000|Overall Study|Randomized, but not treated|0|||
160595192|NCT01204697|579896059|FG001|Overall Study|Randomized, but not treated|1|||
160595193|NCT03939637|579896060|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
160595194|NCT03939637|579896061|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
160595195|NCT03939637|579896060|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
160595196|NCT03939637|579896061|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
160595197|NCT00168064|579896064|FG000|Overall Study|Adverse Event|26|||
160595198|NCT00168064|579896065|FG001|Overall Study|Adverse Event|22|||
160595199|NCT00168064|579896064|FG000|Overall Study|Withdrawal by Subject|3|||
160464023|NCT02347332|579430166|FG001|Overall Study|Not treated|2|||
160595200|NCT00168064|579896065|FG001|Overall Study|Withdrawal by Subject|4|||
160595201|NCT00168064|579896064|FG000|Overall Study|Lack of Efficacy|4|||
160595202|NCT00168064|579896065|FG001|Overall Study|Lack of Efficacy|4|||
160595203|NCT00168064|579896064|FG000|Overall Study|Lost to Follow-up|4|||
160595204|NCT00168064|579896065|FG001|Overall Study|Lost to Follow-up|3|||
160595205|NCT00168064|579896064|FG000|Overall Study|Non-compliance|2|||
160595206|NCT00168064|579896065|FG001|Overall Study|Non-compliance|3|||
160595207|NCT00168064|579896064|FG000|Overall Study|Concurrent Illness|4|||
160595208|NCT00168064|579896065|FG001|Overall Study|Concurrent Illness|3|||
160464024|NCT02347332|579430165|FG000|Overall Study|Progressive disease|141|||
160464025|NCT02347332|579430166|FG001|Overall Study|Progressive disease|159|||
160464026|NCT02347332|579430165|FG000|Overall Study|Adverse Event|50|||
160464027|NCT02347332|579430166|FG001|Overall Study|Adverse Event|41|||
160464028|NCT02347332|579430165|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
160464029|NCT02347332|579430166|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
160464030|NCT02347332|579430165|FG000|Overall Study|Protocol Violation|1|||
160464031|NCT02347332|579430166|FG001|Overall Study|Protocol Violation|1|||
160464032|NCT02347332|579430165|FG000|Overall Study|Lost to Follow-up|2|||
160464033|NCT02347332|579430166|FG001|Overall Study|Lost to Follow-up|1|||
160464034|NCT02347332|579430165|FG000|Overall Study|Physician Decision|4|||
160464035|NCT02347332|579430166|FG001|Overall Study|Physician Decision|3|||
160464036|NCT02347332|579430165|FG000|Overall Study|Withdrawal by Subject|20|||
160464037|NCT02347332|579430166|FG001|Overall Study|Withdrawal by Subject|14|||
160464038|NCT02347332|579430165|FG000|Overall Study|Protocol requirement|1|||
160464039|NCT02347332|579430166|FG001|Overall Study|Protocol requirement|1|||
160464040|NCT02347332|579430165|FG000|Overall Study|Switch Post-Trial program|0|||
160464041|NCT02347332|579430166|FG001|Overall Study|Switch Post-Trial program|1|||
160464042|NCT01478594|579430168|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
160464043|NCT01478594|579430169|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
160464044|NCT01478594|579430168|FG000|Overall Study|Death|45|||
160464045|NCT01478594|579430169|FG001|Overall Study|Death|18|||
160464046|NCT01478594|579430168|FG000|Overall Study|Lost to Follow-up|3|||
160464047|NCT01478594|579430169|FG001|Overall Study|Lost to Follow-up|1|||
160464048|NCT01478594|579430168|FG000|Overall Study|Withdrawal by Subject|9|||
160464049|NCT01478594|579430169|FG001|Overall Study|Withdrawal by Subject|3|||
160464050|NCT01478594|579430168|FG000|Overall Study|Study Closed by Sponsor|8|||
160464051|NCT01478594|579430169|FG001|Overall Study|Study Closed by Sponsor|5|||
160464052|NCT01313884|579430170|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
160464053|NCT01970007|579430171|FG000|Overall Study|Death|5|||
160464054|NCT01970007|579430171|FG000|Overall Study|Withdrawal by Subject|23|||
160595209|NCT00168064|579896064|FG000|Overall Study|Subject's Best interest|2|||
160595210|NCT00168064|579896065|FG001|Overall Study|Subject's Best interest|2|||
160464055|NCT01970007|579430171|FG000|Overall Study|Lost to Follow-up|24|||
160464056|NCT01970007|579430171|FG000|Overall Study|"Other endpoint"|3|||
160464057|NCT04384172|579430173|FG000|Overall Study|Lost to Follow-up|0|||
160464058|NCT04384172|579430174|FG001|Overall Study|Lost to Follow-up|2|||
160464059|NCT04384172|579430173|FG000|Overall Study|Pregnancy|1|||
160464060|NCT04384172|579430174|FG001|Overall Study|Pregnancy|0|||
160464061|NCT04384172|579430173|FG000|Overall Study|Withdrawal by Subject|0|||
160464062|NCT04384172|579430174|FG001|Overall Study|Withdrawal by Subject|1|||
160464063|NCT04860505|579430175|FG000|Overall Study|Lost to Follow-up|2|||
160464064|NCT00811941|579430179|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
160464065|NCT00811941|579430180|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
160464066|NCT00811941|579430179|FG000|All Treated Patients|Adverse Event|2|||
160464067|NCT00811941|579430180|FG001|All Treated Patients|Adverse Event|43|||
160464068|NCT00811941|579430179|FG000|All Treated Patients|Lack of Efficacy|2|||
160464069|NCT00811941|579430180|FG001|All Treated Patients|Lack of Efficacy|3|||
160464070|NCT00811941|579430179|FG000|All Treated Patients|Non-compliance|1|||
160464071|NCT00811941|579430180|FG001|All Treated Patients|Non-compliance|8|||
160464072|NCT00811941|579430179|FG000|All Treated Patients|Protocol Violation|5|||
160595211|NCT00168064|579896064|FG000|Overall Study|Various|4|||
160595212|NCT00168064|579896065|FG001|Overall Study|Various|3|||
160595213|NCT01153841|579896066|FG000|Overall Study|Adverse Event|1|||
160595214|NCT01153841|579896067|FG001|Overall Study|Adverse Event|0|||
160595215|NCT01153841|579896066|FG000|Overall Study|Withdrawal by Subject|1|||
160595216|NCT01153841|579896067|FG001|Overall Study|Withdrawal by Subject|0|||
160464073|NCT00811941|579430180|FG001|All Treated Patients|Protocol Violation|17|||
160464074|NCT00811941|579430179|FG000|All Treated Patients|Withdrawal by Subject|35|||
160464075|NCT00811941|579430180|FG001|All Treated Patients|Withdrawal by Subject|94|||
160464076|NCT00811941|579430179|FG000|All Treated Patients|Lost to Follow-up|3|||
160464077|NCT00811941|579430180|FG001|All Treated Patients|Lost to Follow-up|12|||
160464078|NCT00811941|579430179|FG000|All Treated Patients|Other Reason|4|||
160464079|NCT00811941|579430180|FG001|All Treated Patients|Other Reason|14|||
160464080|NCT00942266|579430188|FG000|Overall Study|Withdrawal by Subject|1|||
160464081|NCT00942266|579430189|FG001|Overall Study|Withdrawal by Subject|0|||
160464082|NCT00942266|579430188|FG000|Overall Study|Adverse Event|2|||
160464083|NCT00942266|579430189|FG001|Overall Study|Adverse Event|1|||
160464084|NCT00942266|579430188|FG000|Overall Study|Disease Progression|38|||
160464085|NCT00942266|579430189|FG001|Overall Study|Disease Progression|11|||
160464086|NCT00942266|579430188|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
160464087|NCT00942266|579430189|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
160464088|NCT00942266|579430188|FG000|Overall Study|Intercurrent illness|0|||
160464089|NCT00942266|579430189|FG001|Overall Study|Intercurrent illness|1|||
160464090|NCT00942266|579430188|FG000|Overall Study|Physician Decision|2|||
160595217|NCT01153841|579896066|FG000|Overall Study|Protocol Violation|2|||
160595218|NCT01153841|579896067|FG001|Overall Study|Protocol Violation|0|||
160658760|NCT00705536|580133181|FG001|Start Period 1|Withdrawal by Subject|0|||
160658761|NCT00705536|580133182|FG002|Start Period 1|Withdrawal by Subject|0|||
160658762|NCT00705536|580133183|FG003|Start Period 1|Withdrawal by Subject|1|||
160658763|NCT01746017|580133186|FG000|Period 1|Withdrawal by Subject|0|||
160658764|NCT01746017|580133187|FG001|Period 1|Withdrawal by Subject|0|||
160464091|NCT00942266|579430189|FG001|Overall Study|Physician Decision|0|||
160464092|NCT00942266|579430188|FG000|Overall Study|medical deterioration (pneumonia)|0|||
160464093|NCT00942266|579430189|FG001|Overall Study|medical deterioration (pneumonia)|1|||
160464094|NCT04035447|579430206|FG000|Treatment Period|Lost to Follow-up|6|||
160464095|NCT04035447|579430207|FG001|Treatment Period|Lost to Follow-up|5|||
160464096|NCT04035447|579430206|FG000|Treatment Period|Physician Decision|0|||
160464097|NCT04035447|579430207|FG001|Treatment Period|Physician Decision|2|||
160464098|NCT03304587|579430211|FG000|Overall Study|Headache after intervention|0|||
160464099|NCT03304587|579430212|FG001|Overall Study|Headache after intervention|1|||
160464100|NCT03304587|579430211|FG000|Overall Study|Withdrawal by Subject|1|||
160464101|NCT03304587|579430212|FG001|Overall Study|Withdrawal by Subject|0|||
160464102|NCT01458366|579430214|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
160464103|NCT01458366|579430215|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
160464104|NCT01458366|579430216|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
160464105|NCT01458366|579430217|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
160464106|NCT01458366|579430218|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
160464107|NCT01458366|579430214|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
160464108|NCT01458366|579430215|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
160464109|NCT01458366|579430216|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
160595219|NCT01153841|579896066|FG000|Overall Study|Lost to Follow-up|2|||
160595220|NCT01153841|579896067|FG001|Overall Study|Lost to Follow-up|0|||
160595221|NCT00830804|579896068|FG000|Overall Study|Lost to Follow-up|4|||
160595222|NCT00830804|579896068|FG000|Overall Study|Death|1|||
160595223|NCT00830804|579896068|FG000|Overall Study|Unable to get to clinic|7|||
160595224|NCT00830804|579896068|FG000|Overall Study|Consent withdrawn|2|||
160595225|NCT00830804|579896068|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
160595226|NCT02180217|579896070|FG000|Overall Study|Adverse Event|3|||
160595227|NCT02180217|579896071|FG001|Overall Study|Adverse Event|2|||
160595228|NCT02180217|579896072|FG002|Overall Study|Adverse Event|22|||
160464110|NCT01458366|579430217|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
160464111|NCT01458366|579430218|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
160464112|NCT00174252|579430219|FG000|Overall Study|Protocol Violation|2|||
160464113|NCT05509816|579430220|FG000|Overall Study|Lost to Follow-up|1|||
160464114|NCT02107261|579430227|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
160464115|NCT02107261|579430228|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
160464116|NCT02107261|579430227|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
160464117|NCT02107261|579430228|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
160464118|NCT04337931|579430230|FG000|Overall Study|Death|4|||
160464119|NCT04337931|579430231|FG001|Overall Study|Death|1|||
160464120|NCT04337931|579430232|FG002|Overall Study|Death|7|||
160464121|NCT04337931|579430230|FG000|Overall Study|Withdrawal by Subject|0|||
160464122|NCT04337931|579430231|FG001|Overall Study|Withdrawal by Subject|1|||
160464123|NCT04337931|579430232|FG002|Overall Study|Withdrawal by Subject|0|||
160464124|NCT04337931|579430230|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
160464125|NCT04337931|579430231|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
160464126|NCT04337931|579430232|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
160464127|NCT04337931|579430230|FG000|Overall Study|Study terminated by sponsor|3|||
160464128|NCT04337931|579430231|FG001|Overall Study|Study terminated by sponsor|6|||
160464129|NCT04337931|579430232|FG002|Overall Study|Study terminated by sponsor|2|||
160464130|NCT04337931|579430230|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
160464131|NCT04337931|579430231|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
160464132|NCT04337931|579430232|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
160464133|NCT04337931|579430230|FG000|Overall Study|Colorectal cancer treatment|1|||
160464134|NCT04337931|579430231|FG001|Overall Study|Colorectal cancer treatment|0|||
160464135|NCT04337931|579430232|FG002|Overall Study|Colorectal cancer treatment|0|||
160464136|NCT04337931|579430230|FG000|Overall Study|Participant decision|0|||
160464137|NCT04337931|579430231|FG001|Overall Study|Participant decision|1|||
160464138|NCT04337931|579430232|FG002|Overall Study|Participant decision|0|||
160464139|NCT01738438|579430234|FG000|Overall Study|Disease Progression|32|||
160464140|NCT01738438|579430234|FG000|Overall Study|Adverse Event|3|||
160464141|NCT02130557|579430236|FG000|Overall Study|Withdrawal by Subject|12|||
160464142|NCT02130557|579430237|FG001|Overall Study|Withdrawal by Subject|12|||
160464143|NCT02130557|579430236|FG000|Overall Study|Investigator Request|0|||
160464144|NCT02130557|579430237|FG001|Overall Study|Investigator Request|2|||
160464145|NCT02130557|579430236|FG000|Overall Study|Deceased|14|||
160464146|NCT02130557|579430237|FG001|Overall Study|Deceased|14|||
160464147|NCT02130557|579430236|FG000|Overall Study|Lost to Follow-up|6|||
160464148|NCT02130557|579430237|FG001|Overall Study|Lost to Follow-up|7|||
160464149|NCT02130557|579430236|FG000|Overall Study|Other|2|||
160464150|NCT02130557|579430237|FG001|Overall Study|Other|1|||
160464151|NCT02130557|579430236|FG000|Overall Study|Missing|2|||
160464152|NCT02130557|579430237|FG001|Overall Study|Missing|1|||
160464153|NCT02928172|579430238|FG000|Overall Study|Device did not record data|1|||
160464154|NCT01532999|579430239|FG000|Overall Study|Lost to Follow-up|14|||
160464155|NCT01532999|579430240|FG001|Overall Study|Lost to Follow-up|8|||
160464156|NCT01532999|579430239|FG000|Overall Study|Physician Decision|1|||
160464157|NCT01532999|579430240|FG001|Overall Study|Physician Decision|2|||
160464158|NCT01532999|579430239|FG000|Overall Study|Withdrawal by Subject|5|||
160464159|NCT01532999|579430240|FG001|Overall Study|Withdrawal by Subject|0|||
160464160|NCT01532999|579430239|FG000|Overall Study|Relocated|2|||
160464161|NCT01532999|579430240|FG001|Overall Study|Relocated|0|||
160464162|NCT01532999|579430239|FG000|Overall Study|should not have been randomized|1|||
160464163|NCT01532999|579430240|FG001|Overall Study|should not have been randomized|0|||
160464164|NCT01532999|579430239|FG000|Overall Study|substantial noncompliance|2|||
160464165|NCT01532999|579430240|FG001|Overall Study|substantial noncompliance|0|||
160464166|NCT01532999|579430239|FG000|Overall Study|no show for week 9 assessments|6|||
160464167|NCT01532999|579430240|FG001|Overall Study|no show for week 9 assessments|4|||
160464168|NCT01532999|579430239|FG000|Overall Study|Adverse Event|0|||
160595229|NCT02180217|579896070|FG000|Overall Study|Death|1|||
160595230|NCT02180217|579896071|FG001|Overall Study|Death|1|||
160595231|NCT02180217|579896072|FG002|Overall Study|Death|0|||
160464169|NCT01532999|579430240|FG001|Overall Study|Adverse Event|1|||
160464170|NCT01532999|579430239|FG000|Overall Study|incarcerated|0|||
160464171|NCT01532999|579430240|FG001|Overall Study|incarcerated|1|||
160464172|NCT01532999|579430239|FG000|Overall Study|New job|0|||
160464173|NCT01532999|579430240|FG001|Overall Study|New job|2|||
160464174|NCT03333109|579430241|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
160464175|NCT03333109|579430242|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
160464176|NCT03333109|579430243|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
160464177|NCT03333109|579430241|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160464178|NCT03333109|579430242|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160464179|NCT03333109|579430243|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
160595232|NCT02180217|579896070|FG000|Overall Study|Withdrawal by Subject|1|||
160595233|NCT02180217|579896071|FG001|Overall Study|Withdrawal by Subject|1|||
160595234|NCT02180217|579896072|FG002|Overall Study|Withdrawal by Subject|4|||
160595235|NCT02180217|579896070|FG000|Overall Study|Subject/Guardian decision|5|||
160595236|NCT02180217|579896071|FG001|Overall Study|Subject/Guardian decision|3|||
160595237|NCT02180217|579896072|FG002|Overall Study|Subject/Guardian decision|6|||
160595238|NCT02180217|579896070|FG000|Overall Study|Physician Decision|1|||
160595239|NCT02180217|579896071|FG001|Overall Study|Physician Decision|1|||
160595240|NCT02180217|579896072|FG002|Overall Study|Physician Decision|6|||
160595241|NCT02180217|579896070|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160595242|NCT02180217|579896071|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160595243|NCT02180217|579896072|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160595244|NCT03483116|579896076|FG000|Overall Study|Adverse Event|0|||
160595245|NCT03483116|579896077|FG001|Overall Study|Adverse Event|1|||
160595246|NCT03483116|579896078|FG002|Overall Study|Adverse Event|0|||
160595247|NCT03483116|579896079|FG003|Overall Study|Adverse Event|1|||
160595248|NCT03483116|579896076|FG000|Overall Study|Protocol Violation|1|||
160464180|NCT03333109|579430241|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
160464181|NCT03333109|579430242|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
160464182|NCT03333109|579430243|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
160464183|NCT03333109|579430241|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
160464184|NCT03333109|579430242|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
160464185|NCT03333109|579430243|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
160464186|NCT03333109|579430241|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
160464187|NCT03333109|579430242|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
160464188|NCT03333109|579430243|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
160464189|NCT03333109|579430241|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
160464190|NCT03333109|579430242|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
160464191|NCT03333109|579430243|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
160464192|NCT03333109|579430241|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
160464193|NCT03333109|579430242|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
160464194|NCT03333109|579430243|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
160464195|NCT03333109|579430241|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
160464196|NCT03333109|579430242|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
160464197|NCT03333109|579430243|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
160464198|NCT00918203|579430246|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
160595249|NCT03483116|579896077|FG001|Overall Study|Protocol Violation|0|||
160595250|NCT03483116|579896078|FG002|Overall Study|Protocol Violation|0|||
160595251|NCT03483116|579896079|FG003|Overall Study|Protocol Violation|7|||
160595252|NCT03483116|579896076|FG000|Overall Study|Lost to Follow-up|9|||
160595253|NCT03483116|579896077|FG001|Overall Study|Lost to Follow-up|4|||
160595254|NCT03483116|579896078|FG002|Overall Study|Lost to Follow-up|9|||
160464199|NCT00918203|579430247|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
160595255|NCT03483116|579896079|FG003|Overall Study|Lost to Follow-up|5|||
160595256|NCT03483116|579896076|FG000|Overall Study|Death|1|||
160595257|NCT03483116|579896077|FG001|Overall Study|Death|0|||
160595258|NCT03483116|579896078|FG002|Overall Study|Death|2|||
160595259|NCT03483116|579896079|FG003|Overall Study|Death|1|||
160595260|NCT03483116|579896076|FG000|Overall Study|Withdrawal by Subject|14|||
160595261|NCT03483116|579896077|FG001|Overall Study|Withdrawal by Subject|16|||
160595262|NCT03483116|579896078|FG002|Overall Study|Withdrawal by Subject|14|||
160595263|NCT03483116|579896079|FG003|Overall Study|Withdrawal by Subject|16|||
160595264|NCT03483116|579896076|FG000|Overall Study|Unknown other reason|3|||
160595265|NCT03483116|579896077|FG001|Overall Study|Unknown other reason|2|||
160595266|NCT03483116|579896078|FG002|Overall Study|Unknown other reason|1|||
160595267|NCT03483116|579896079|FG003|Overall Study|Unknown other reason|1|||
160595268|NCT01181102|579896080|FG000|Overall Study|Adverse Event|28|||
160595269|NCT01181102|579896081|FG001|Overall Study|Adverse Event|26|||
160595270|NCT01181102|579896080|FG000|Overall Study|Lack of Efficacy|3|||
160595271|NCT01181102|579896081|FG001|Overall Study|Lack of Efficacy|1|||
160595272|NCT01181102|579896080|FG000|Overall Study|Lost to Follow-up|2|||
160595273|NCT01181102|579896081|FG001|Overall Study|Lost to Follow-up|0|||
160595274|NCT01181102|579896080|FG000|Overall Study|Physician Decision|3|||
160595275|NCT01181102|579896081|FG001|Overall Study|Physician Decision|1|||
160595276|NCT01181102|579896080|FG000|Overall Study|Protocol Violation|5|||
160595277|NCT01181102|579896081|FG001|Overall Study|Protocol Violation|6|||
160595278|NCT01181102|579896080|FG000|Overall Study|Withdrawal by Subject|10|||
160595279|NCT01181102|579896081|FG001|Overall Study|Withdrawal by Subject|12|||
160595280|NCT00239837|579896088|FG000|Overall Study|Lost to Follow-up|3|||
160595281|NCT00239837|579896089|FG001|Overall Study|Lost to Follow-up|7|||
160595282|NCT01309841|579896090|FG000|Overall Study|Other|0|||
160595283|NCT01309841|579896091|FG001|Overall Study|Other|1|||
160595284|NCT01309841|579896092|FG002|Overall Study|Other|1|||
160595285|NCT01309841|579896090|FG000|Overall Study|Lost to Follow-up|7|||
160595286|NCT01309841|579896091|FG001|Overall Study|Lost to Follow-up|6|||
160595287|NCT01309841|579896092|FG002|Overall Study|Lost to Follow-up|4|||
160595288|NCT01309841|579896090|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
160595289|NCT01309841|579896091|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
160595290|NCT01309841|579896092|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
160595291|NCT01309841|579896090|FG000|Overall Study|Lack of Efficacy|0|||
160595292|NCT01309841|579896091|FG001|Overall Study|Lack of Efficacy|0|||
160595293|NCT01309841|579896092|FG002|Overall Study|Lack of Efficacy|2|||
160595294|NCT01309841|579896090|FG000|Overall Study|Adverse Event|9|||
160595295|NCT01309841|579896091|FG001|Overall Study|Adverse Event|22|||
160595296|NCT01309841|579896092|FG002|Overall Study|Adverse Event|11|||
160595297|NCT01309841|579896090|FG000|Overall Study|Death|1|||
160595298|NCT01309841|579896091|FG001|Overall Study|Death|0|||
160595299|NCT01309841|579896092|FG002|Overall Study|Death|0|||
160595300|NCT01309841|579896090|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
160595301|NCT01309841|579896091|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
160595302|NCT01309841|579896092|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
160595303|NCT01309841|579896090|FG000|Overall Study|Withdrawal by Subject|17|||
160595304|NCT01309841|579896091|FG001|Overall Study|Withdrawal by Subject|6|||
160595305|NCT01309841|579896092|FG002|Overall Study|Withdrawal by Subject|13|||
160595306|NCT01309841|579896090|FG000|Overall Study|Did Not Receive Treatment|2|||
160595307|NCT01309841|579896091|FG001|Overall Study|Did Not Receive Treatment|0|||
160595308|NCT01309841|579896092|FG002|Overall Study|Did Not Receive Treatment|1|||
160595309|NCT01309841|579896090|FG000|Overall Study|Severe non-compliance with protocol|0|||
160595310|NCT01309841|579896091|FG001|Overall Study|Severe non-compliance with protocol|5|||
160595311|NCT01309841|579896092|FG002|Overall Study|Severe non-compliance with protocol|2|||
160595312|NCT01838590|579896093|FG000|Overall Study|Lack of Efficacy|12|||
160595313|NCT01838590|579896094|FG001|Overall Study|Lack of Efficacy|4|||
160595314|NCT01838590|579896093|FG000|Overall Study|Lost to Follow-up|0|||
160595315|NCT01838590|579896094|FG001|Overall Study|Lost to Follow-up|1|||
160595316|NCT04685499|579896095|FG000|Overall Study|Study Terminated Early|1|||
160595317|NCT01996904|579896098|FG000|Overall Study|Lost to Follow-up|38|||
160595318|NCT01996904|579896099|FG001|Overall Study|Lost to Follow-up|27|||
160464200|NCT00918203|579430248|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
160464201|NCT00918203|579430246|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
160464202|NCT00918203|579430247|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
160464203|NCT00918203|579430248|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
160464204|NCT00918203|579430246|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
160464205|NCT00918203|579430247|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
160464206|NCT00918203|579430248|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
160464207|NCT00918203|579430246|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
160464208|NCT00918203|579430247|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
160464209|NCT00918203|579430248|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
160464210|NCT00701701|579430249|FG000|Overall Study|Withdrawal by Subject|0|||
160464211|NCT00701701|579430250|FG001|Overall Study|Withdrawal by Subject|1|||
160464212|NCT00701701|579430249|FG000|Overall Study|Adverse Event|0|||
160464213|NCT00701701|579430250|FG001|Overall Study|Adverse Event|1|||
160464214|NCT03834740|579430251|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
160464215|NCT03834740|579430252|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
160464216|NCT03834740|579430253|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
160464217|NCT01208974|579430254|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
160464218|NCT01208974|579430255|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
160464219|NCT01208974|579430256|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
160464220|NCT01208974|579430257|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
160464221|NCT01208974|579430254|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
160464222|NCT01208974|579430255|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
160464223|NCT01208974|579430256|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
160464224|NCT01208974|579430257|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
160464225|NCT01208974|579430254|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
160464226|NCT01208974|579430255|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
160464227|NCT01208974|579430256|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
160464228|NCT01208974|579430257|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
160464229|NCT02500576|579430258|FG000|Overall Study|Adverse Event|0|||
160464230|NCT02500576|579430259|FG001|Overall Study|Adverse Event|1|||
160464231|NCT02500576|579430258|FG000|Overall Study|Death|2|||
160464232|NCT02500576|579430259|FG001|Overall Study|Death|1|||
160464233|NCT02500576|579430258|FG000|Overall Study|Lack of Efficacy|5|||
160464234|NCT02500576|579430259|FG001|Overall Study|Lack of Efficacy|5|||
160464235|NCT02500576|579430258|FG000|Overall Study|Withdrawal by Subject|1|||
160464236|NCT02500576|579430259|FG001|Overall Study|Withdrawal by Subject|1|||
160464237|NCT02678689|579430260|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
160464238|NCT02678689|579430261|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
160464239|NCT02761187|579430262|FG000|Overall Study|Too ill to Participate|13|||
160464240|NCT02761187|579430263|FG001|Overall Study|Too ill to Participate|8|||
160464241|NCT02761187|579430262|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
160464242|NCT02761187|579430263|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
160464243|NCT02761187|579430262|FG000|Overall Study|Patient withdrew consent|64|||
160464244|NCT02761187|579430263|FG001|Overall Study|Patient withdrew consent|58|||
160464245|NCT02761187|579430262|FG000|Overall Study|Physician discretion|4|||
160464246|NCT02761187|579430263|FG001|Overall Study|Physician discretion|8|||
160464247|NCT02761187|579430262|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
160464248|NCT02761187|579430263|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
160464249|NCT02761187|579430262|FG000|Overall Study|On Hospice|20|||
160464250|NCT02761187|579430263|FG001|Overall Study|On Hospice|26|||
160464251|NCT02761187|579430262|FG000|Overall Study|Deceased|474|||
160464252|NCT02761187|579430263|FG001|Overall Study|Deceased|642|||
160464253|NCT02761187|579430262|FG000|Overall Study|Lost to Follow-up|73|||
160595319|NCT04664855|579896101|FG000|Overall Study|Withdrawal by Subject|0|||
160595320|NCT04664855|579896102|FG001|Overall Study|Withdrawal by Subject|2|||
160595321|NCT01441115|579896103|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
160595322|NCT02475395|579896111|FG000|Overall Study|Protocol Violation|30|||
160595323|NCT02475395|579896112|FG001|Overall Study|Protocol Violation|3|||
160464254|NCT02761187|579430263|FG001|Overall Study|Lost to Follow-up|63|||
160464255|NCT02761187|579430262|FG000|Overall Study|Due to study discontinued at site|100|||
160464256|NCT02761187|579430263|FG001|Overall Study|Due to study discontinued at site|85|||
160595324|NCT01086150|579896113|FG000|Overall Study|Withdrawal by Subject|0|||
160595325|NCT01086150|579896114|FG001|Overall Study|Withdrawal by Subject|4|||
160595326|NCT01086150|579896115|FG002|Overall Study|Withdrawal by Subject|1|||
160464257|NCT02761187|579430262|FG000|Overall Study|Reason not Specified|1484|||
160464258|NCT02761187|579430263|FG001|Overall Study|Reason not Specified|937|||
160464259|NCT05704725|579430265|FG000|Overall Study|Lost to Follow-up|0|||
160464260|NCT05704725|579430266|FG001|Overall Study|Lost to Follow-up|1|||
160595327|NCT01086150|579896113|FG000|Overall Study|Lost to Follow-up|0|||
160595328|NCT01086150|579896114|FG001|Overall Study|Lost to Follow-up|1|||
160595329|NCT01086150|579896115|FG002|Overall Study|Lost to Follow-up|0|||
160595330|NCT01086150|579896113|FG000|Overall Study|Screen Failure|0|||
160595331|NCT01086150|579896114|FG001|Overall Study|Screen Failure|1|||
160464261|NCT05704725|579430265|FG000|Overall Study|Withdrawal by Subject|1|||
160464262|NCT05704725|579430266|FG001|Overall Study|Withdrawal by Subject|0|||
160464263|NCT02798471|579430269|FG000|Overall Study|Adverse Event|7|||
160464264|NCT02798471|579430270|FG001|Overall Study|Adverse Event|2|||
160464265|NCT02798471|579430269|FG000|Overall Study|Physician Decision|3|||
160464266|NCT02798471|579430270|FG001|Overall Study|Physician Decision|7|||
160464267|NCT02798471|579430269|FG000|Overall Study|Death|2|||
160464268|NCT02798471|579430270|FG001|Overall Study|Death|3|||
160464269|NCT02798471|579430269|FG000|Overall Study|Lost to Follow-up|0|||
160464270|NCT02798471|579430270|FG001|Overall Study|Lost to Follow-up|1|||
160464271|NCT02798471|579430269|FG000|Overall Study|Other|5|||
160464272|NCT02798471|579430270|FG001|Overall Study|Other|3|||
160464273|NCT02798471|579430269|FG000|Overall Study|Subject withdrew consent|0|||
160464274|NCT02798471|579430270|FG001|Overall Study|Subject withdrew consent|6|||
160464275|NCT02798471|579430269|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
160464276|NCT02798471|579430270|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
160464277|NCT02798471|579430269|FG000|Overall Study|Randomized, but not treated|0|||
160464278|NCT02798471|579430270|FG001|Overall Study|Randomized, but not treated|2|||
160464279|NCT03459196|579432176|FG000|Overall Study|Subject didn't receive study catheter|2|||
160464280|NCT03367156|579432177|FG000|Overall Study|Lack of interest|3|||
160464281|NCT03367156|579432178|FG001|Overall Study|Lack of interest|1|||
160464282|NCT03367156|579432177|FG000|Overall Study|Death|2|||
160464283|NCT03367156|579432178|FG001|Overall Study|Death|0|||
160464284|NCT03367156|579432177|FG000|Overall Study|Lost to Follow-up|2|||
160464285|NCT03367156|579432178|FG001|Overall Study|Lost to Follow-up|1|||
160464286|NCT03367156|579432177|FG000|Overall Study|Became ineligible|1|||
160464287|NCT03367156|579432178|FG001|Overall Study|Became ineligible|2|||
160464288|NCT03367156|579432177|FG000|Overall Study|Hospitalization|1|||
160464289|NCT03367156|579432178|FG001|Overall Study|Hospitalization|0|||
160464290|NCT03367156|579432177|FG000|Overall Study|Concerned about Treatment|11|||
160464291|NCT03367156|579432178|FG001|Overall Study|Concerned about Treatment|3|||
160464292|NCT03367156|579432177|FG000|Overall Study|Started new treatment|4|||
160464293|NCT03367156|579432178|FG001|Overall Study|Started new treatment|1|||
160595332|NCT01086150|579896115|FG002|Overall Study|Screen Failure|0|||
160595333|NCT01681576|579896116|FG000|Period 1|Adverse Event|1|||
160595334|NCT01681576|579896117|FG001|Period 1|Adverse Event|0|||
160595335|NCT01681576|579896116|FG000|Period 1|Protocol Deviation|1|||
160595336|NCT01681576|579896117|FG001|Period 1|Protocol Deviation|0|||
160595337|NCT01681576|579896116|FG000|Period 2|subject/guardian decision|3|||
160595338|NCT01681576|579896117|FG001|Period 2|subject/guardian decision|1|||
160595339|NCT01681576|579896116|FG000|Period 2|Non-compliance with study treatment|1|||
160595340|NCT01681576|579896117|FG001|Period 2|Non-compliance with study treatment|0|||
160595341|NCT00178464|579896119|FG000|Overall Study|Withdrawal by Subject|1|||
160595342|NCT00178464|579896119|FG000|Overall Study|Physician Decision|1|||
160595343|NCT02260648|579896120|FG000|Overall Study|Adverse Event|3|||
160595344|NCT02260648|579896121|FG001|Overall Study|Adverse Event|0|||
160595345|NCT02260648|579896122|FG002|Overall Study|Adverse Event|1|||
160595346|NCT02260648|579896120|FG000|Overall Study|Withdrawal by Subject|1|||
160595347|NCT02260648|579896121|FG001|Overall Study|Withdrawal by Subject|1|||
160595348|NCT02260648|579896122|FG002|Overall Study|Withdrawal by Subject|0|||
160595349|NCT02260648|579896120|FG000|Overall Study|Protocol Violation|1|||
160595350|NCT02260648|579896121|FG001|Overall Study|Protocol Violation|0|||
160595351|NCT02260648|579896122|FG002|Overall Study|Protocol Violation|0|||
160595352|NCT02260648|579896120|FG000|Overall Study|Discontinue Due to Study Termination|13|||
160595353|NCT02260648|579896121|FG001|Overall Study|Discontinue Due to Study Termination|12|||
160595354|NCT02260648|579896122|FG002|Overall Study|Discontinue Due to Study Termination|7|||
160595355|NCT04093258|579896123|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
160595356|NCT04093258|579896124|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
160595357|NCT01890512|579896125|FG000|Overall Study|Physician Decision|1|||
160595358|NCT01890512|579896125|FG000|Overall Study|Withdrawal by Subject|1|||
160595359|NCT01890512|579896125|FG000|Overall Study|Protocol Violation|1|||
160595360|NCT00805545|579896126|FG000|Overall Study|Protocol Violation|3|||
160595361|NCT00805545|579896127|FG001|Overall Study|Protocol Violation|2|||
160595362|NCT00805545|579896126|FG000|Overall Study|Protocol Violation|3|||
160595363|NCT00805545|579896127|FG001|Overall Study|Protocol Violation|1|||
160595364|NCT03543358|579896128|FG000|Overall Study|Death|1|||
160595365|NCT03543358|579896129|FG001|Overall Study|Death|0|||
160595366|NCT03543358|579896128|FG000|Overall Study|Disease Progression|1|||
160595367|NCT03543358|579896129|FG001|Overall Study|Disease Progression|0|||
160595368|NCT03543358|579896128|FG000|Overall Study|Parent Study Closure|1|||
160595369|NCT03543358|579896129|FG001|Overall Study|Parent Study Closure|0|||
160595370|NCT00986427|579896130|FG000|Overall Study|Lost to Follow-up|2|||
160595371|NCT00986427|579896131|FG001|Overall Study|Lost to Follow-up|0|||
160595372|NCT00986427|579896130|FG000|Overall Study|Lack of Efficacy|1|||
160595373|NCT00986427|579896131|FG001|Overall Study|Lack of Efficacy|0|||
160595374|NCT00986427|579896130|FG000|Overall Study|Withdrawal by Subject|1|||
160595375|NCT00986427|579896131|FG001|Overall Study|Withdrawal by Subject|0|||
160595376|NCT01401465|579896132|FG000|Treatment Period 1|Adverse Event|4|||
160595377|NCT01401465|579896133|FG001|Treatment Period 1|Adverse Event|1|||
160595378|NCT01401465|579896132|FG000|Treatment Period 1|Pregnancy|0|||
160595379|NCT01401465|579896133|FG001|Treatment Period 1|Pregnancy|1|||
160595380|NCT01401465|579896132|FG000|Treatment Period 1|Protocol Violation|5|||
160595381|NCT01401465|579896133|FG001|Treatment Period 1|Protocol Violation|0|||
160595382|NCT01401465|579896132|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160595383|NCT01401465|579896133|FG001|Treatment Period 1|Withdrawal by Subject|4|||
160595384|NCT01401465|579896132|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
160595385|NCT01401465|579896133|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
160595386|NCT01401465|579896132|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
160595387|NCT01401465|579896133|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
160595388|NCT01401465|579896132|FG000|Treatment Period 1|Scheduling Difficulties|1|||
160595389|NCT01401465|579896133|FG001|Treatment Period 1|Scheduling Difficulties|1|||
160595390|NCT01401465|579896132|FG000|Treatment Period 2|Lost to Follow-up|0|||
160595391|NCT01401465|579896133|FG001|Treatment Period 2|Lost to Follow-up|1|||
160595392|NCT01401465|579896132|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160595393|NCT01401465|579896133|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160595394|NCT01115738|579896134|FG000|Overall Study|Death|1|||
160595395|NCT01115738|579896135|FG001|Overall Study|Death|0|||
160595396|NCT01115738|579896136|FG002|Overall Study|Death|0|||
160595397|NCT01115738|579896134|FG000|Overall Study|Lost to Follow-up|0|||
160595398|NCT01115738|579896135|FG001|Overall Study|Lost to Follow-up|0|||
160595399|NCT01115738|579896136|FG002|Overall Study|Lost to Follow-up|1|||
160595400|NCT01115738|579896134|FG000|Overall Study|Physician Decision|18|||
160595401|NCT01115738|579896135|FG001|Overall Study|Physician Decision|15|||
160595402|NCT01115738|579896136|FG002|Overall Study|Physician Decision|17|||
160595403|NCT01115738|579896134|FG000|Overall Study|Withdrawal by Subject|6|||
160595404|NCT01115738|579896135|FG001|Overall Study|Withdrawal by Subject|6|||
160595405|NCT01115738|579896136|FG002|Overall Study|Withdrawal by Subject|9|||
160595406|NCT00764478|579896139|FG000|Overall Study|Adverse Event|1|||
160595407|NCT00764478|579896140|FG001|Overall Study|Adverse Event|1|||
160595408|NCT00764478|579896141|FG002|Overall Study|Adverse Event|1|||
160595409|NCT00764478|579896139|FG000|Overall Study|Withdrawal by Subject|7|||
160595410|NCT00764478|579896140|FG001|Overall Study|Withdrawal by Subject|12|||
160595411|NCT00764478|579896141|FG002|Overall Study|Withdrawal by Subject|1|||
160595412|NCT00764478|579896139|FG000|Overall Study|Lost to Follow-up|7|||
160595413|NCT00764478|579896140|FG001|Overall Study|Lost to Follow-up|8|||
160595414|NCT00764478|579896141|FG002|Overall Study|Lost to Follow-up|5|||
160595415|NCT00764478|579896139|FG000|Overall Study|Protocol Violation|0|||
160595416|NCT00764478|579896140|FG001|Overall Study|Protocol Violation|1|||
160595417|NCT00764478|579896141|FG002|Overall Study|Protocol Violation|1|||
160595418|NCT00575094|579896142|FG000|Overall Study|Adverse Event|2|||
160595419|NCT00575094|579896142|FG000|Overall Study|Withdrawal by Subject|1|||
160595420|NCT00643604|579896146|FG000|Overall Study|Death|1|||
160595421|NCT02702011|579896147|FG000|Overall Study|Withdrawal by Subject|0|||
160595422|NCT02702011|579896148|FG001|Overall Study|Withdrawal by Subject|1|||
160595423|NCT02702011|579896149|FG002|Overall Study|Withdrawal by Subject|0|||
160595424|NCT02702011|579896150|FG003|Overall Study|Withdrawal by Subject|0|||
160595425|NCT02921763|579896152|FG000|Overall Study|Adverse Event|4|||
160595426|NCT02921763|579896152|FG000|Overall Study|Lost to Follow-up|4|||
160595427|NCT02921763|579896152|FG000|Overall Study|Lack of Efficacy|3|||
160595428|NCT02921763|579896152|FG000|Overall Study|Protocol Violation|2|||
160595429|NCT02921763|579896152|FG000|Overall Study|Withdrawal by Subject|2|||
160595430|NCT02921763|579896152|FG000|Overall Study|Physician Decision|1|||
160595431|NCT02921763|579896152|FG000|Overall Study|No data obtained|2|||
160595432|NCT04142216|579896155|FG000|Overall Study|Hospitalization|0|||
160595433|NCT04142216|579896156|FG001|Overall Study|Hospitalization|2|||
160595434|NCT04142216|579896155|FG000|Overall Study|Death|3|||
160595435|NCT04142216|579896156|FG001|Overall Study|Death|1|||
160595436|NCT04142216|579896155|FG000|Overall Study|Referral to another hemodialysis unit|3|||
160595437|NCT04142216|579896156|FG001|Overall Study|Referral to another hemodialysis unit|2|||
160595438|NCT04142216|579896155|FG000|Overall Study|Use of clove|0|||
160595439|NCT04142216|579896156|FG001|Overall Study|Use of clove|1|||
160595440|NCT05263921|579897930|FG000|Overall Study|Other: family emergency.|0|||
160595441|NCT05263921|579897931|FG001|Overall Study|Other: family emergency.|0|||
160595442|NCT05263921|579897932|FG002|Overall Study|Other: family emergency.|1|||
160595443|NCT05263921|579897933|FG003|Overall Study|Other: family emergency.|0|||
160595444|NCT02678312|579897937|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
160595445|NCT02678312|579897938|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
160595446|NCT02678312|579897939|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
160595447|NCT02678312|579897940|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
160595448|NCT02678312|579897941|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
160595449|NCT02678312|579897937|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
160595450|NCT02678312|579897938|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
160595451|NCT02678312|579897939|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
160595452|NCT02678312|579897940|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
160595453|NCT02678312|579897941|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
160595454|NCT02678312|579897937|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
160595455|NCT02678312|579897938|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
160595456|NCT02678312|579897939|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
160595457|NCT02678312|579897940|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
160595458|NCT02678312|579897941|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
160595459|NCT02678312|579897937|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
160595460|NCT02678312|579897938|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
160658765|NCT01746017|580133188|FG002|Period 1|Withdrawal by Subject|0|||
160595461|NCT02678312|579897939|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
160595462|NCT02678312|579897940|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
160595463|NCT02678312|579897941|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
160595464|NCT02678312|579897937|FG000|Part 2 Double Blind Epoch|Death|0|||
160595465|NCT02678312|579897938|FG001|Part 2 Double Blind Epoch|Death|0|||
160595466|NCT02678312|579897939|FG002|Part 2 Double Blind Epoch|Death|0|||
160595467|NCT02678312|579897940|FG003|Part 2 Double Blind Epoch|Death|8|||
160595468|NCT02678312|579897941|FG004|Part 2 Double Blind Epoch|Death|12|||
160595469|NCT02678312|579897937|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
160595470|NCT02678312|579897938|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
160595471|NCT02678312|579897939|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
160595472|NCT02678312|579897940|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
160595473|NCT02678312|579897941|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
160595474|NCT02678312|579897937|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
160595475|NCT02678312|579897938|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
160595476|NCT02678312|579897939|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
160595477|NCT02678312|579897940|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
160595478|NCT02678312|579897941|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
160595479|NCT02678312|579897937|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
160595480|NCT02678312|579897938|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
160595481|NCT02678312|579897939|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
160595482|NCT02678312|579897940|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
160595483|NCT02678312|579897941|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
160595484|NCT00656084|579897942|FG000|Overall Study|Adverse Event|4|||
160595485|NCT00656084|579897942|FG000|Overall Study|Withdrawal by Subject|1|||
160595486|NCT00656084|579897942|FG000|Overall Study|Patient Request|1|||
160595487|NCT00656084|579897942|FG000|Overall Study|Investigator Request|1|||
160595488|NCT00525785|579897948|FG000|Overall Study|Withdrawal by Subject|1|||
160595489|NCT00525785|579897948|FG000|Overall Study|Lack of Efficacy|1|||
160595490|NCT00525785|579897948|FG000|Overall Study|Physician Decision|1|||
160595491|NCT04847141|579897949|FG000|Overall Study|Adverse Event|1|||
160595492|NCT04847141|579897950|FG001|Overall Study|Adverse Event|0|||
160595493|NCT04847141|579897951|FG002|Overall Study|Adverse Event|1|||
160595494|NCT04847141|579897949|FG000|Overall Study|Withdrawal by Subject|2|||
160595495|NCT04847141|579897950|FG001|Overall Study|Withdrawal by Subject|4|||
160595496|NCT04847141|579897951|FG002|Overall Study|Withdrawal by Subject|3|||
160595497|NCT04847141|579897949|FG000|Overall Study|Lost to Follow-up|7|||
160595498|NCT04847141|579897950|FG001|Overall Study|Lost to Follow-up|5|||
160595499|NCT04847141|579897951|FG002|Overall Study|Lost to Follow-up|7|||
160595500|NCT04847141|579897949|FG000|Overall Study|Reason not Specified|0|||
160595501|NCT04847141|579897950|FG001|Overall Study|Reason not Specified|1|||
160595502|NCT04847141|579897951|FG002|Overall Study|Reason not Specified|0|||
160595503|NCT04507776|579897953|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
160595504|NCT01136746|579897956|FG000|Overall Study|Lost to Follow-up|0|||
160595505|NCT01136746|579897957|FG001|Overall Study|Lost to Follow-up|2|||
160595506|NCT01136746|579897956|FG000|Overall Study|Protocol Violation|2|||
160595507|NCT01136746|579897957|FG001|Overall Study|Protocol Violation|1|||
160595508|NCT01136746|579897956|FG000|Overall Study|Death|1|||
160595509|NCT01136746|579897957|FG001|Overall Study|Death|0|||
160595510|NCT00092677|579897963|FG000|Overall Study|Lost to Follow-up|0|||
160595511|NCT00092677|579897964|FG001|Overall Study|Lost to Follow-up|2|||
160595512|NCT00092677|579897963|FG000|Overall Study|Adminstrative|5|||
160595513|NCT00092677|579897964|FG001|Overall Study|Adminstrative|9|||
160595514|NCT04624672|579897965|FG000|Overall Study|Early Study Closure|2|||
160595515|NCT04624672|579897966|FG001|Overall Study|Early Study Closure|1|||
160595516|NCT01188096|579897970|FG000|Overall Study|progression of disease|4|||
160595517|NCT01188096|579897970|FG000|Overall Study|Withdrawal by Subject|2|||
160595518|NCT03783442|579897971|FG000|Overall Study|Death|252|||
160595519|NCT03783442|579897972|FG001|Overall Study|Death|268|||
160595520|NCT03783442|579897971|FG000|Overall Study|Withdrawal by Subject|19|||
160658766|NCT01746017|580133189|FG003|Period 1|Withdrawal by Subject|0|||
160658767|NCT01746017|580133190|FG004|Period 1|Withdrawal by Subject|0|||
160658768|NCT01746017|580133191|FG005|Period 1|Withdrawal by Subject|0|||
160595521|NCT03783442|579897972|FG001|Overall Study|Withdrawal by Subject|21|||
160595522|NCT03783442|579897971|FG000|Overall Study|Lost to Follow-up|7|||
160595523|NCT03783442|579897972|FG001|Overall Study|Lost to Follow-up|6|||
160595524|NCT03783442|579897971|FG000|Overall Study|Sponsor Ended Study|48|||
160595525|NCT03783442|579897972|FG001|Overall Study|Sponsor Ended Study|28|||
160658769|NCT01746017|580133192|FG006|Period 1|Withdrawal by Subject|1|||
160658770|NCT01746017|580133193|FG007|Period 1|Withdrawal by Subject|0|||
160658771|NCT01746017|580133194|FG008|Period 1|Withdrawal by Subject|0|||
160658772|NCT01746017|580133195|FG009|Period 1|Withdrawal by Subject|0|||
160658773|NCT01746017|580133196|FG010|Period 1|Withdrawal by Subject|0|||
160658774|NCT01746017|580133186|FG000|Period 3|Withdrawal by Subject|0|||
160658775|NCT01746017|580133187|FG001|Period 3|Withdrawal by Subject|0|||
160658776|NCT01746017|580133188|FG002|Period 3|Withdrawal by Subject|0|||
160658777|NCT01746017|580133189|FG003|Period 3|Withdrawal by Subject|0|||
160658778|NCT01746017|580133190|FG004|Period 3|Withdrawal by Subject|0|||
160658779|NCT01746017|580133191|FG005|Period 3|Withdrawal by Subject|1|||
160658780|NCT01746017|580133192|FG006|Period 3|Withdrawal by Subject|0|||
160658781|NCT01746017|580133193|FG007|Period 3|Withdrawal by Subject|0|||
160658782|NCT01746017|580133194|FG008|Period 3|Withdrawal by Subject|0|||
160658783|NCT01746017|580133195|FG009|Period 3|Withdrawal by Subject|0|||
160658784|NCT01746017|580133196|FG010|Period 3|Withdrawal by Subject|0|||
160658785|NCT01675622|580133197|FG000|Overall Study|Withdrawal by Subject|2|||
160658786|NCT01675622|580133198|FG001|Overall Study|Withdrawal by Subject|2|||
160658787|NCT01675622|580133197|FG000|Overall Study|Adverse Event|12|||
160658788|NCT01675622|580133198|FG001|Overall Study|Adverse Event|10|||
160658789|NCT01675622|580133197|FG000|Overall Study|Protocol Violation|4|||
160658790|NCT01675622|580133198|FG001|Overall Study|Protocol Violation|1|||
160658791|NCT01675622|580133197|FG000|Overall Study|Lack of Efficacy|2|||
160658792|NCT01675622|580133198|FG001|Overall Study|Lack of Efficacy|4|||
160658793|NCT01675622|580133197|FG000|Overall Study|Lost to Follow-up|1|||
160658794|NCT01675622|580133198|FG001|Overall Study|Lost to Follow-up|3|||
160658795|NCT01675622|580133197|FG000|Overall Study|Other|5|||
160658796|NCT01675622|580133198|FG001|Overall Study|Other|4|||
160658797|NCT00840632|580133200|FG000|First Intervention|Withdrawal by Subject|0|||
160658798|NCT00840632|580133201|FG001|First Intervention|Withdrawal by Subject|1|||
160658799|NCT00840632|580133200|FG000|Washout|Withdrawal by Subject|1|||
160658800|NCT00840632|580133201|FG001|Washout|Withdrawal by Subject|1|||
160658801|NCT05017480|580133202|FG000|Stage 1 Study|Withdrawal by Subject|8|||
160658802|NCT05017480|580133203|FG001|Stage 1 Study|Withdrawal by Subject|6|||
160658803|NCT05017480|580133204|FG002|Stage 1 Study|Withdrawal by Subject|0|||
160658804|NCT05017480|580133205|FG003|Stage 1 Study|Withdrawal by Subject|0|||
160658805|NCT05017480|580133206|FG004|Stage 1 Study|Withdrawal by Subject|0|||
160658806|NCT05017480|580133202|FG000|Stage 1 Study|Adverse Event|1|||
160658807|NCT05017480|580133203|FG001|Stage 1 Study|Adverse Event|1|||
160658808|NCT05017480|580133204|FG002|Stage 1 Study|Adverse Event|0|||
160658809|NCT05017480|580133205|FG003|Stage 1 Study|Adverse Event|0|||
160658810|NCT05017480|580133206|FG004|Stage 1 Study|Adverse Event|0|||
160658811|NCT05017480|580133202|FG000|Stage 1 Study|Poor Compliance|1|||
160658812|NCT05017480|580133203|FG001|Stage 1 Study|Poor Compliance|1|||
160658813|NCT05017480|580133204|FG002|Stage 1 Study|Poor Compliance|0|||
160658814|NCT05017480|580133205|FG003|Stage 1 Study|Poor Compliance|0|||
160658815|NCT05017480|580133206|FG004|Stage 1 Study|Poor Compliance|0|||
160658816|NCT05017480|580133202|FG000|Stage 1 Study|Physician Decision|0|||
160658817|NCT05017480|580133203|FG001|Stage 1 Study|Physician Decision|1|||
160658818|NCT05017480|580133204|FG002|Stage 1 Study|Physician Decision|0|||
160658819|NCT05017480|580133205|FG003|Stage 1 Study|Physician Decision|0|||
160658820|NCT05017480|580133206|FG004|Stage 1 Study|Physician Decision|0|||
160658821|NCT05017480|580133202|FG000|Stage 2 Study|Withdrawal by Subject|0|||
160658822|NCT05017480|580133203|FG001|Stage 2 Study|Withdrawal by Subject|0|||
160658823|NCT05017480|580133204|FG002|Stage 2 Study|Withdrawal by Subject|6|||
160658824|NCT05017480|580133205|FG003|Stage 2 Study|Withdrawal by Subject|9|||
160658825|NCT05017480|580133206|FG004|Stage 2 Study|Withdrawal by Subject|11|||
160658826|NCT05017480|580133202|FG000|Stage 2 Study|Lost to Follow-up|0|||
160658827|NCT05017480|580133203|FG001|Stage 2 Study|Lost to Follow-up|0|||
160658828|NCT05017480|580133204|FG002|Stage 2 Study|Lost to Follow-up|0|||
160658829|NCT05017480|580133205|FG003|Stage 2 Study|Lost to Follow-up|2|||
160658830|NCT05017480|580133206|FG004|Stage 2 Study|Lost to Follow-up|1|||
160658831|NCT05017480|580133202|FG000|Stage 2 Study|Adverse Event|0|||
160658832|NCT05017480|580133203|FG001|Stage 2 Study|Adverse Event|0|||
160658833|NCT05017480|580133204|FG002|Stage 2 Study|Adverse Event|0|||
160658834|NCT05017480|580133205|FG003|Stage 2 Study|Adverse Event|1|||
160658835|NCT05017480|580133206|FG004|Stage 2 Study|Adverse Event|0|||
160658836|NCT05017480|580133202|FG000|Stage 2 Study|COVID-19|0|||
160658837|NCT05017480|580133203|FG001|Stage 2 Study|COVID-19|0|||
160658838|NCT05017480|580133204|FG002|Stage 2 Study|COVID-19|0|||
160658839|NCT05017480|580133205|FG003|Stage 2 Study|COVID-19|1|||
160658840|NCT05017480|580133206|FG004|Stage 2 Study|COVID-19|0|||
160658841|NCT05017480|580133202|FG000|Stage 2 Study|Pregnancy|0|||
160658842|NCT05017480|580133203|FG001|Stage 2 Study|Pregnancy|0|||
160658843|NCT05017480|580133204|FG002|Stage 2 Study|Pregnancy|0|||
160658844|NCT05017480|580133205|FG003|Stage 2 Study|Pregnancy|0|||
160658845|NCT05017480|580133206|FG004|Stage 2 Study|Pregnancy|1|||
160658846|NCT02311361|580133207|FG000|Overall Study|Did not receive treatment|0|||
160658847|NCT02311361|580133208|FG001|Overall Study|Did not receive treatment|1|||
160595526|NCT02016898|579897973|FG000|Overall Study|Death|1|||
160595527|NCT02016898|579897974|FG001|Overall Study|Death|1|||
160595528|NCT02016898|579897973|FG000|Overall Study|Lost to Follow-up|4|||
160595529|NCT02016898|579897974|FG001|Overall Study|Lost to Follow-up|4|||
160595530|NCT01335698|579897981|FG000|Treatment Stage 1|Lack of Efficacy|3|||
160595531|NCT01335698|579897982|FG001|Treatment Stage 1|Lack of Efficacy|1|||
160595532|NCT01335698|579897983|FG002|Treatment Stage 1|Lack of Efficacy|3|||
160595533|NCT01335698|579897984|FG003|Treatment Stage 1|Lack of Efficacy|3|||
160595534|NCT01335698|579897985|FG004|Treatment Stage 1|Lack of Efficacy|1|||
160595535|NCT01335698|579897981|FG000|Treatment Stage 1|Adverse Event|1|||
160595536|NCT01335698|579897982|FG001|Treatment Stage 1|Adverse Event|2|||
160595537|NCT01335698|579897983|FG002|Treatment Stage 1|Adverse Event|2|||
160595538|NCT01335698|579897984|FG003|Treatment Stage 1|Adverse Event|1|||
160595539|NCT01335698|579897985|FG004|Treatment Stage 1|Adverse Event|1|||
160595540|NCT01335698|579897981|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
160595541|NCT01335698|579897982|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
160595542|NCT01335698|579897983|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
160595543|NCT01335698|579897984|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
160595544|NCT01335698|579897985|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
160595545|NCT01335698|579897981|FG000|Treatment Stage 1|Lost to Follow-up|1|||
160595546|NCT01335698|579897982|FG001|Treatment Stage 1|Lost to Follow-up|1|||
160595547|NCT01335698|579897983|FG002|Treatment Stage 1|Lost to Follow-up|0|||
160595548|NCT01335698|579897984|FG003|Treatment Stage 1|Lost to Follow-up|0|||
160595549|NCT01335698|579897985|FG004|Treatment Stage 1|Lost to Follow-up|0|||
160595550|NCT01335698|579897981|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
160595551|NCT01335698|579897982|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
160595552|NCT01335698|579897983|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
160595553|NCT01335698|579897984|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
160595554|NCT01335698|579897985|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
160595555|NCT01335698|579897981|FG000|Treatment Stage 1|No longer meets study criteria|1|||
160595556|NCT01335698|579897982|FG001|Treatment Stage 1|No longer meets study criteria|1|||
160595557|NCT01335698|579897983|FG002|Treatment Stage 1|No longer meets study criteria|0|||
160595558|NCT01335698|579897984|FG003|Treatment Stage 1|No longer meets study criteria|1|||
160595559|NCT01335698|579897985|FG004|Treatment Stage 1|No longer meets study criteria|0|||
160595560|NCT01335698|579897981|FG000|Treatment Stage 1|Other|1|||
160595561|NCT01335698|579897982|FG001|Treatment Stage 1|Other|0|||
160595562|NCT01335698|579897983|FG002|Treatment Stage 1|Other|0|||
160595563|NCT01335698|579897984|FG003|Treatment Stage 1|Other|1|||
160595564|NCT01335698|579897985|FG004|Treatment Stage 1|Other|0|||
160595565|NCT01335698|579897981|FG000|Treatment Stage 2|Lack of Efficacy|2|||
160595566|NCT01335698|579897982|FG001|Treatment Stage 2|Lack of Efficacy|1|||
160595567|NCT01335698|579897983|FG002|Treatment Stage 2|Lack of Efficacy|3|||
160595568|NCT01335698|579897984|FG003|Treatment Stage 2|Lack of Efficacy|1|||
160595569|NCT01335698|579897985|FG004|Treatment Stage 2|Lack of Efficacy|0|||
160595570|NCT01335698|579897981|FG000|Treatment Stage 2|Adverse Event|2|||
160595571|NCT01335698|579897982|FG001|Treatment Stage 2|Adverse Event|0|||
160595572|NCT01335698|579897983|FG002|Treatment Stage 2|Adverse Event|0|||
160595573|NCT01335698|579897984|FG003|Treatment Stage 2|Adverse Event|3|||
160595574|NCT01335698|579897985|FG004|Treatment Stage 2|Adverse Event|0|||
160595575|NCT01335698|579897981|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
160595576|NCT01335698|579897982|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
160595577|NCT01335698|579897983|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
160595578|NCT01335698|579897984|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
160595579|NCT01335698|579897985|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
160595580|NCT01335698|579897981|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
160595581|NCT01335698|579897982|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
160595582|NCT01335698|579897983|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
160595583|NCT01335698|579897984|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
160595584|NCT01335698|579897985|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
160595585|NCT01335698|579897981|FG000|Treatment Stage 2|Lost to Follow-up|1|||
160595586|NCT01335698|579897982|FG001|Treatment Stage 2|Lost to Follow-up|0|||
160595587|NCT01335698|579897983|FG002|Treatment Stage 2|Lost to Follow-up|0|||
160595588|NCT01335698|579897984|FG003|Treatment Stage 2|Lost to Follow-up|0|||
160595589|NCT01335698|579897985|FG004|Treatment Stage 2|Lost to Follow-up|0|||
160595590|NCT01335698|579897981|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
160595591|NCT01335698|579897982|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
160595592|NCT01335698|579897983|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
160595593|NCT01335698|579897984|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
160595594|NCT01335698|579897985|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
160595595|NCT01335698|579897981|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
160595596|NCT01335698|579897982|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
160595597|NCT01335698|579897983|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
160595598|NCT01335698|579897984|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
160595599|NCT01335698|579897985|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
160595600|NCT01335698|579897981|FG000|Treatment Stage 2|Switched to another formulation|1|||
160595601|NCT01335698|579897982|FG001|Treatment Stage 2|Switched to another formulation|1|||
160595602|NCT01335698|579897983|FG002|Treatment Stage 2|Switched to another formulation|0|||
160595603|NCT01335698|579897984|FG003|Treatment Stage 2|Switched to another formulation|0|||
160595604|NCT01335698|579897985|FG004|Treatment Stage 2|Switched to another formulation|0|||
160595605|NCT01162304|579897986|FG000|Overall Study|Beck scale to high|11|||
160595606|NCT00585923|579897987|FG000|Overall Study|Physician decided not to continue|31|||
160595607|NCT00585923|579897988|FG001|Overall Study|Physician decided not to continue|33|||
160595608|NCT02815293|579897989|FG000|Overall Study|Study termination by sponsor|10|||
160464510|NCT03762850|579432187|FG000|Overall Study|Death|0|||
160464511|NCT03762850|579432188|FG001|Overall Study|Death|1|||
160464512|NCT03762850|579432187|FG000|Overall Study|Lost to Follow-up|0|||
160464513|NCT03762850|579432188|FG001|Overall Study|Lost to Follow-up|1|||
160464514|NCT03762850|579432187|FG000|Overall Study|Physician Decision|0|||
160464515|NCT03762850|579432188|FG001|Overall Study|Physician Decision|1|||
160464516|NCT03762850|579432187|FG000|Overall Study|Withdrawal by Subject|4|||
160464517|NCT03762850|579432188|FG001|Overall Study|Withdrawal by Subject|9|||
160464518|NCT00092534|579432191|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
160464519|NCT00092534|579432192|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
160464520|NCT00092534|579432193|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
160464521|NCT00092534|579432194|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
160464522|NCT00092534|579432195|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
160464523|NCT00092534|579432191|FG000|Base Study Vaccination Period|Adverse Event|3|||
160464524|NCT00092534|579432192|FG001|Base Study Vaccination Period|Adverse Event|1|||
160464525|NCT00092534|579432193|FG002|Base Study Vaccination Period|Adverse Event|0|||
160464526|NCT00092534|579432194|FG003|Base Study Vaccination Period|Adverse Event|0|||
160464527|NCT00092534|579432195|FG004|Base Study Vaccination Period|Adverse Event|0|||
160464528|NCT00092534|579432191|FG000|Base Study Vaccination Period|Death|5|||
160464529|NCT00092534|579432192|FG001|Base Study Vaccination Period|Death|4|||
160464530|NCT00092534|579432193|FG002|Base Study Vaccination Period|Death|0|||
160464531|NCT00092534|579432194|FG003|Base Study Vaccination Period|Death|0|||
160464532|NCT00092534|579432195|FG004|Base Study Vaccination Period|Death|0|||
160464533|NCT00092534|579432191|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
160464534|NCT00092534|579432192|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
160464535|NCT00092534|579432193|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
160464536|NCT00092534|579432194|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
160464537|NCT00092534|579432195|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
160464538|NCT00092534|579432191|FG000|Base Study Vaccination Period|Physician Decision|1|||
160464539|NCT00092534|579432192|FG001|Base Study Vaccination Period|Physician Decision|0|||
160464540|NCT00092534|579432193|FG002|Base Study Vaccination Period|Physician Decision|0|||
160464541|NCT00092534|579432194|FG003|Base Study Vaccination Period|Physician Decision|0|||
160464542|NCT00092534|579432195|FG004|Base Study Vaccination Period|Physician Decision|0|||
160464543|NCT00092534|579432191|FG000|Base Study Vaccination Period|Pregnancy|9|||
160464544|NCT00092534|579432192|FG001|Base Study Vaccination Period|Pregnancy|7|||
160464545|NCT00092534|579432193|FG002|Base Study Vaccination Period|Pregnancy|0|||
160464546|NCT00092534|579432194|FG003|Base Study Vaccination Period|Pregnancy|0|||
160464547|NCT00092534|579432195|FG004|Base Study Vaccination Period|Pregnancy|0|||
160464548|NCT00092534|579432191|FG000|Base Study Vaccination Period|Protocol Violation|2|||
160464549|NCT00092534|579432192|FG001|Base Study Vaccination Period|Protocol Violation|1|||
160464550|NCT00092534|579432193|FG002|Base Study Vaccination Period|Protocol Violation|0|||
160464551|NCT00092534|579432194|FG003|Base Study Vaccination Period|Protocol Violation|0|||
160464552|NCT00092534|579432195|FG004|Base Study Vaccination Period|Protocol Violation|0|||
160464553|NCT00092534|579432191|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
160464554|NCT00092534|579432192|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
160464555|NCT00092534|579432193|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
160464556|NCT00092534|579432194|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
160464557|NCT00092534|579432195|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
160464558|NCT00092534|579432191|FG000|Base Study Vaccination Period|Moved|14|||
160464559|NCT00092534|579432192|FG001|Base Study Vaccination Period|Moved|12|||
160464560|NCT00092534|579432193|FG002|Base Study Vaccination Period|Moved|0|||
160464561|NCT00092534|579432194|FG003|Base Study Vaccination Period|Moved|0|||
160464562|NCT00092534|579432195|FG004|Base Study Vaccination Period|Moved|0|||
160464563|NCT00092534|579432191|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
160464564|NCT00092534|579432192|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
160464565|NCT00092534|579432193|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
160464566|NCT00092534|579432194|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
160464567|NCT00092534|579432195|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
160464568|NCT00092534|579432191|FG000|Base Study Vaccination Period|Travel|1|||
160464569|NCT00092534|579432192|FG001|Base Study Vaccination Period|Travel|0|||
160464570|NCT00092534|579432193|FG002|Base Study Vaccination Period|Travel|0|||
160464571|NCT00092534|579432194|FG003|Base Study Vaccination Period|Travel|0|||
160464572|NCT00092534|579432195|FG004|Base Study Vaccination Period|Travel|0|||
160464573|NCT00092534|579432191|FG000|Base Study Vaccination Period|Site Closed|0|||
160464574|NCT00092534|579432192|FG001|Base Study Vaccination Period|Site Closed|1|||
160464575|NCT00092534|579432193|FG002|Base Study Vaccination Period|Site Closed|0|||
160464576|NCT00092534|579432194|FG003|Base Study Vaccination Period|Site Closed|0|||
160464577|NCT00092534|579432195|FG004|Base Study Vaccination Period|Site Closed|0|||
160464578|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Adverse Event|2|||
160464579|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Adverse Event|4|||
160464580|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Adverse Event|0|||
160464581|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Adverse Event|0|||
160464582|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Adverse Event|0|||
160464583|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Death|2|||
160464584|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Death|1|||
160464585|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Death|0|||
160464586|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Death|0|||
160464587|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Death|0|||
160464588|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
160464589|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
160464590|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
160464591|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
160464592|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
160464593|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Pregnancy|6|||
160464594|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Pregnancy|10|||
160464595|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Pregnancy|0|||
160464596|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Pregnancy|0|||
160464597|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Pregnancy|0|||
160464598|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
160464599|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
160464600|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
160464601|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
160464602|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
160464603|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
160464604|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
160464605|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
160464606|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
160464607|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
160464608|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Moved|62|||
160464609|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Moved|58|||
160464610|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Moved|0|||
160464611|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Moved|0|||
160464612|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Moved|0|||
160464613|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Travel|10|||
160464614|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Travel|7|||
160464615|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Travel|0|||
160464616|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Travel|0|||
160464617|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Travel|0|||
160464618|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Site Closed|0|||
160464619|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Site Closed|2|||
160464620|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Site Closed|0|||
160464621|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Site Closed|0|||
160464622|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Site Closed|0|||
160464623|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
160464624|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
160464625|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
160464626|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
160464627|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
160464628|NCT00092534|579432191|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
160464629|NCT00092534|579432192|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
160464630|NCT00092534|579432193|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
160464631|NCT00092534|579432194|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
160464632|NCT00092534|579432195|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
160464633|NCT00092534|579432191|FG000|Base Study EXT|Lost to Follow-up|0|||
160464634|NCT00092534|579432192|FG001|Base Study EXT|Lost to Follow-up|0|||
160595609|NCT02815293|579897990|FG001|Overall Study|Study termination by sponsor|7|||
160464635|NCT00092534|579432193|FG002|Base Study EXT|Lost to Follow-up|41|||
160464636|NCT00092534|579432194|FG003|Base Study EXT|Lost to Follow-up|0|||
160595610|NCT02815293|579897991|FG002|Overall Study|Study termination by sponsor|0|||
160595611|NCT02815293|579897989|FG000|Overall Study|Participants not randomized|0|||
160595612|NCT02815293|579897990|FG001|Overall Study|Participants not randomized|0|||
160595613|NCT02815293|579897991|FG002|Overall Study|Participants not randomized|18|||
160595614|NCT02815293|579897989|FG000|Overall Study|Adverse Event|0|||
160595615|NCT02815293|579897990|FG001|Overall Study|Adverse Event|1|||
160595616|NCT02815293|579897991|FG002|Overall Study|Adverse Event|0|||
160595617|NCT01167582|579897992|FG000|Overall Study|Lost to Follow-up|0|||
160595618|NCT01167582|579897993|FG001|Overall Study|Lost to Follow-up|1|||
160595619|NCT03956225|579897994|FG000|Overall Study|Lack of Efficacy|1|||
160595620|NCT03956225|579897995|FG001|Overall Study|Lack of Efficacy|1|||
160595621|NCT03956225|579897994|FG000|Overall Study|Lost to Follow-up|0|||
160595622|NCT03956225|579897995|FG001|Overall Study|Lost to Follow-up|1|||
160595623|NCT03956225|579897994|FG000|Overall Study|Withdrawal by Subject|2|||
160595624|NCT03956225|579897995|FG001|Overall Study|Withdrawal by Subject|1|||
160595625|NCT03956225|579897994|FG000|Overall Study|Other Reasons|2|||
160595626|NCT03956225|579897995|FG001|Overall Study|Other Reasons|1|||
160595627|NCT00567541|579897996|FG000|Overall Study|Adverse Event|0|||
160595628|NCT00567541|579897997|FG001|Overall Study|Adverse Event|1|||
160595629|NCT02157506|579897998|FG000|Overall Study|Adverse Event|0|||
160464637|NCT00092534|579432195|FG004|Base Study EXT|Lost to Follow-up|0|||
160595630|NCT02157506|579897999|FG001|Overall Study|Adverse Event|1|||
160595631|NCT02157506|579898000|FG002|Overall Study|Adverse Event|0|||
160595632|NCT02157506|579898001|FG003|Overall Study|Adverse Event|0|||
160595633|NCT02157506|579898002|FG004|Overall Study|Adverse Event|0|||
160595634|NCT02157506|579897998|FG000|Overall Study|Lost to Follow-up|0|||
160595635|NCT02157506|579897999|FG001|Overall Study|Lost to Follow-up|0|||
160464638|NCT00092534|579432191|FG000|Base Study EXT|Physician Decision|0|||
160464639|NCT00092534|579432192|FG001|Base Study EXT|Physician Decision|0|||
160464640|NCT00092534|579432193|FG002|Base Study EXT|Physician Decision|1|||
160658848|NCT02311361|580133209|FG002|Overall Study|Did not receive treatment|0|||
160464641|NCT00092534|579432194|FG003|Base Study EXT|Physician Decision|0|||
160464642|NCT00092534|579432195|FG004|Base Study EXT|Physician Decision|0|||
160595636|NCT02157506|579898000|FG002|Overall Study|Lost to Follow-up|1|||
160595637|NCT02157506|579898001|FG003|Overall Study|Lost to Follow-up|0|||
160595638|NCT02157506|579898002|FG004|Overall Study|Lost to Follow-up|0|||
160595639|NCT03448224|579898006|FG000|Overall Study|Provided same answer to every question|1|||
160595640|NCT03448224|579898007|FG001|Overall Study|Provided same answer to every question|0|||
160595641|NCT03103906|579898008|FG000|Overall Study|Adverse Event|2|||
160595642|NCT03103906|579898009|FG001|Overall Study|Adverse Event|3|||
160595643|NCT03103906|579898008|FG000|Overall Study|Other|2|||
160595644|NCT03103906|579898009|FG001|Overall Study|Other|0|||
160595645|NCT03498287|579898013|FG000|Overall Study|Withdrawal by Subject|3|||
160595646|NCT03498287|579898014|FG001|Overall Study|Withdrawal by Subject|0|||
160595647|NCT03498287|579898013|FG000|Overall Study|Protocol Violation|0|||
160595648|NCT03498287|579898014|FG001|Overall Study|Protocol Violation|4|||
160595649|NCT03498287|579898013|FG000|Overall Study|Adverse Event|0|||
160595650|NCT03498287|579898014|FG001|Overall Study|Adverse Event|1|||
160595651|NCT00862121|579898015|FG000|Overall Study|Adverse Event|1|||
160595652|NCT00862121|579898016|FG001|Overall Study|Adverse Event|2|||
160595653|NCT00862121|579898015|FG000|Overall Study|Lack of Efficacy|0|||
160595654|NCT00862121|579898016|FG001|Overall Study|Lack of Efficacy|3|||
160595655|NCT00862121|579898015|FG000|Overall Study|Protocol Violation|0|||
160595656|NCT00862121|579898016|FG001|Overall Study|Protocol Violation|1|||
160595657|NCT00862121|579898015|FG000|Overall Study|Exclusion criterion violation|0|||
160595658|NCT00862121|579898016|FG001|Overall Study|Exclusion criterion violation|1|||
160595659|NCT00862121|579898015|FG000|Overall Study|Incorrect randomisation|0|||
160595660|NCT00862121|579898016|FG001|Overall Study|Incorrect randomisation|1|||
160464643|NCT00092534|579432191|FG000|Base Study EXT|Pregnancy|0|||
160464644|NCT00092534|579432192|FG001|Base Study EXT|Pregnancy|0|||
160464645|NCT00092534|579432193|FG002|Base Study EXT|Pregnancy|12|||
160464646|NCT00092534|579432194|FG003|Base Study EXT|Pregnancy|0|||
160464647|NCT00092534|579432195|FG004|Base Study EXT|Pregnancy|0|||
160464648|NCT00092534|579432191|FG000|Base Study EXT|Withdrawal by Subject|0|||
160464649|NCT00092534|579432192|FG001|Base Study EXT|Withdrawal by Subject|0|||
160464650|NCT00092534|579432193|FG002|Base Study EXT|Withdrawal by Subject|18|||
160464651|NCT00092534|579432194|FG003|Base Study EXT|Withdrawal by Subject|0|||
160464652|NCT00092534|579432195|FG004|Base Study EXT|Withdrawal by Subject|0|||
160464653|NCT00092534|579432191|FG000|Base Study EXT|Participant moved|0|||
160464654|NCT00092534|579432192|FG001|Base Study EXT|Participant moved|0|||
160464655|NCT00092534|579432193|FG002|Base Study EXT|Participant moved|6|||
160464656|NCT00092534|579432194|FG003|Base Study EXT|Participant moved|0|||
160464657|NCT00092534|579432195|FG004|Base Study EXT|Participant moved|0|||
160464658|NCT00092534|579432191|FG000|Base Study EXT|Travel|0|||
160464659|NCT00092534|579432192|FG001|Base Study EXT|Travel|0|||
160464660|NCT00092534|579432193|FG002|Base Study EXT|Travel|2|||
160464661|NCT00092534|579432194|FG003|Base Study EXT|Travel|0|||
160464662|NCT00092534|579432195|FG004|Base Study EXT|Travel|0|||
160464663|NCT00092534|579432191|FG000|Base Study EXT|Site closed|0|||
160464664|NCT00092534|579432192|FG001|Base Study EXT|Site closed|0|||
160464665|NCT00092534|579432193|FG002|Base Study EXT|Site closed|21|||
160464666|NCT00092534|579432194|FG003|Base Study EXT|Site closed|0|||
160464667|NCT00092534|579432195|FG004|Base Study EXT|Site closed|0|||
160464668|NCT00092534|579432191|FG000|Base Study EXT|Study ended|0|||
160464669|NCT00092534|579432192|FG001|Base Study EXT|Study ended|0|||
160464670|NCT00092534|579432193|FG002|Base Study EXT|Study ended|29|||
160464671|NCT00092534|579432194|FG003|Base Study EXT|Study ended|0|||
160464672|NCT00092534|579432195|FG004|Base Study EXT|Study ended|0|||
160464673|NCT00092534|579432191|FG000|Base Study EXT|Protocol Violation|0|||
160464674|NCT00092534|579432192|FG001|Base Study EXT|Protocol Violation|0|||
160464675|NCT00092534|579432193|FG002|Base Study EXT|Protocol Violation|15|||
160464676|NCT00092534|579432194|FG003|Base Study EXT|Protocol Violation|0|||
160464677|NCT00092534|579432195|FG004|Base Study EXT|Protocol Violation|0|||
160464678|NCT00092534|579432191|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
160464679|NCT00092534|579432192|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
160464680|NCT00092534|579432193|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
160464681|NCT00092534|579432194|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
160464682|NCT00092534|579432195|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
160464683|NCT03083366|579432196|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
160464684|NCT03083366|579432197|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
160464685|NCT03083366|579432196|FG000|Enrollment Period|Lack of Efficacy|1|||
160464686|NCT03083366|579432197|FG001|Enrollment Period|Lack of Efficacy|0|||
160464687|NCT03752684|579432204|FG000|Overall Study|Lost to Follow-up|4|||
160464688|NCT00048932|579432207|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
160464689|NCT00048932|579432208|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
160464690|NCT00048932|579432209|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
160464691|NCT00048932|579432207|FG000|Double Blind Period (DB)|Adverse Event|51|||
160464692|NCT00048932|579432208|FG001|Double Blind Period (DB)|Adverse Event|19|||
160464693|NCT00048932|579432209|FG002|Double Blind Period (DB)|Adverse Event|0|||
160464694|NCT00048932|579432207|FG000|Double Blind Period (DB)|Death|5|||
160464695|NCT00048932|579432208|FG001|Double Blind Period (DB)|Death|3|||
160464696|NCT00048932|579432209|FG002|Double Blind Period (DB)|Death|0|||
160464697|NCT00048932|579432207|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
160464698|NCT00048932|579432208|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
160464699|NCT00048932|579432209|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
160464700|NCT00048932|579432207|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
160464701|NCT00048932|579432208|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
160464702|NCT00048932|579432209|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
160464703|NCT00048932|579432207|FG000|Double Blind Period (DB)|Relocation|1|||
160464704|NCT00048932|579432208|FG001|Double Blind Period (DB)|Relocation|0|||
160464705|NCT00048932|579432209|FG002|Double Blind Period (DB)|Relocation|0|||
160595661|NCT02007954|579898019|FG000|Overall Study|Received liver transplant|3|||
160595662|NCT02007954|579898019|FG000|Overall Study|Switch in treatment modality|2|||
160595663|NCT02007954|579898019|FG000|Overall Study|Disease progression and unrelated AE|1|||
160595664|NCT02007954|579898019|FG000|Overall Study|Death|1|||
160595665|NCT01054976|579898022|FG000|Overall Study|Adverse Event|16|||
160595666|NCT01054976|579898022|FG000|Overall Study|Uncooperative participations to study|7|||
160595667|NCT01054976|579898022|FG000|Overall Study|Withdrawal by Subject|4|||
160595668|NCT01054976|579898022|FG000|Overall Study|Other|8|||
160595669|NCT01195363|579898024|FG000|Overall Study|Lost to Follow-up|7|||
160464706|NCT00048932|579432207|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
160464707|NCT00048932|579432208|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
160464708|NCT00048932|579432209|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
160464709|NCT00048932|579432207|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
160464710|NCT00048932|579432208|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
160464711|NCT00048932|579432209|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
160464712|NCT00048932|579432207|FG000|Double Blind Period (DB)|Pregnancy|1|||
160464713|NCT00048932|579432208|FG001|Double Blind Period (DB)|Pregnancy|0|||
160464714|NCT00048932|579432209|FG002|Double Blind Period (DB)|Pregnancy|0|||
160464715|NCT00048932|579432207|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
160464716|NCT00048932|579432208|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
160464717|NCT00048932|579432209|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
160464718|NCT00048932|579432207|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
160464719|NCT00048932|579432208|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
160464720|NCT00048932|579432209|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
160464721|NCT00048932|579432207|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
160464722|NCT00048932|579432208|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
160464723|NCT00048932|579432209|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
160464724|NCT00048932|579432207|FG000|Open Label Period (OL)|Death|0|||
160464725|NCT00048932|579432208|FG001|Open Label Period (OL)|Death|0|||
160464726|NCT00048932|579432209|FG002|Open Label Period (OL)|Death|25|||
160464727|NCT00048932|579432207|FG000|Open Label Period (OL)|Adverse Event|0|||
160464728|NCT00048932|579432208|FG001|Open Label Period (OL)|Adverse Event|0|||
160464729|NCT00048932|579432209|FG002|Open Label Period (OL)|Adverse Event|103|||
160464730|NCT00048932|579432207|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
160464731|NCT00048932|579432208|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
160464732|NCT00048932|579432209|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
160464733|NCT00048932|579432207|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
160464734|NCT00048932|579432208|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
160464735|NCT00048932|579432209|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
160464736|NCT00048932|579432207|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
160464737|NCT00048932|579432208|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
160464738|NCT00048932|579432209|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
160464739|NCT00048932|579432207|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
160464740|NCT00048932|579432208|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
160464741|NCT00048932|579432209|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
160464742|NCT00048932|579432207|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
160464743|NCT00048932|579432208|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
160464744|NCT00048932|579432209|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
160464745|NCT00048932|579432207|FG000|Open Label Period (OL)|Pregnancy|0|||
160464746|NCT00048932|579432208|FG001|Open Label Period (OL)|Pregnancy|0|||
160464747|NCT00048932|579432209|FG002|Open Label Period (OL)|Pregnancy|6|||
160464748|NCT00048932|579432207|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
160464749|NCT00048932|579432208|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
160464750|NCT00048932|579432209|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
160464751|NCT00048932|579432207|FG000|Open Label Period (OL)|Investigator Retiring|0|||
160464752|NCT00048932|579432208|FG001|Open Label Period (OL)|Investigator Retiring|0|||
160464753|NCT00048932|579432209|FG002|Open Label Period (OL)|Investigator Retiring|2|||
160464754|NCT00048932|579432207|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
160464755|NCT00048932|579432208|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
160464756|NCT00048932|579432209|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
160464757|NCT00048932|579432207|FG000|Open Label Period (OL)|Participant Relocated|0|||
160464758|NCT00048932|579432208|FG001|Open Label Period (OL)|Participant Relocated|0|||
160464759|NCT00048932|579432209|FG002|Open Label Period (OL)|Participant Relocated|6|||
160464760|NCT00048932|579432207|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
160464761|NCT00048932|579432208|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
160464762|NCT00048932|579432209|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
160464763|NCT00048932|579432207|FG000|Open Label Period (OL)|Site Closure|0|||
160464764|NCT00048932|579432208|FG001|Open Label Period (OL)|Site Closure|0|||
160464765|NCT00048932|579432209|FG002|Open Label Period (OL)|Site Closure|3|||
160464766|NCT00048932|579432207|FG000|Open Label Period (OL)|Trial Terminated|0|||
160464767|NCT00048932|579432208|FG001|Open Label Period (OL)|Trial Terminated|0|||
160464768|NCT00048932|579432209|FG002|Open Label Period (OL)|Trial Terminated|1|||
160464769|NCT00048932|579432207|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
160464770|NCT00048932|579432208|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
160464771|NCT00048932|579432209|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
160464772|NCT00048932|579432207|FG000|Open Label Period (OL)|Patient Decision|0|||
160464773|NCT00048932|579432208|FG001|Open Label Period (OL)|Patient Decision|0|||
160464774|NCT00048932|579432209|FG002|Open Label Period (OL)|Patient Decision|4|||
160464775|NCT00048932|579432207|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
160464776|NCT00048932|579432208|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
160464777|NCT00048932|579432209|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
160464778|NCT00048932|579432207|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
160464779|NCT00048932|579432208|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
160464780|NCT00048932|579432209|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
160464781|NCT00048932|579432207|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
160595670|NCT01195363|579898025|FG001|Overall Study|Lost to Follow-up|4|||
160595671|NCT01195363|579898024|FG000|Overall Study|Adverse Event|3|||
160595672|NCT01195363|579898025|FG001|Overall Study|Adverse Event|1|||
160595673|NCT01195363|579898024|FG000|Overall Study|Lack of Efficacy|0|||
160595674|NCT01195363|579898025|FG001|Overall Study|Lack of Efficacy|4|||
160595675|NCT01195363|579898024|FG000|Overall Study|incarceration|1|||
160464782|NCT00048932|579432208|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
160464783|NCT00048932|579432209|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
160595676|NCT01195363|579898025|FG001|Overall Study|incarceration|0|||
160464784|NCT00048932|579432207|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
160464785|NCT00048932|579432208|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
160464786|NCT00048932|579432209|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
160464787|NCT00048932|579432207|FG000|Open Label Period (OL)|Investigator Decision|0|||
160464788|NCT00048932|579432208|FG001|Open Label Period (OL)|Investigator Decision|0|||
160464789|NCT00048932|579432209|FG002|Open Label Period (OL)|Investigator Decision|4|||
160464790|NCT00048932|579432207|FG000|Open Label Period (OL)|Site Staff Issues|0|||
160464791|NCT00048932|579432208|FG001|Open Label Period (OL)|Site Staff Issues|0|||
160464792|NCT00048932|579432209|FG002|Open Label Period (OL)|Site Staff Issues|2|||
160464793|NCT00048932|579432207|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
160464794|NCT00048932|579432208|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
160464795|NCT00048932|579432209|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
160464796|NCT00048932|579432207|FG000|Open Label Period (OL)|Participant Surgery|0|||
160464797|NCT00048932|579432208|FG001|Open Label Period (OL)|Participant Surgery|0|||
160464798|NCT00048932|579432209|FG002|Open Label Period (OL)|Participant Surgery|1|||
160464799|NCT03244800|579432210|FG000|Overall Study|Adverse Event|0|||
160464800|NCT03244800|579432211|FG001|Overall Study|Adverse Event|1|||
160464801|NCT03244800|579432212|FG002|Overall Study|Adverse Event|0|||
160464802|NCT03244800|579432213|FG003|Overall Study|Adverse Event|1|||
160464803|NCT03244800|579432210|FG000|Overall Study|Withdrew treatment|0|||
160464804|NCT03244800|579432211|FG001|Overall Study|Withdrew treatment|0|||
160464805|NCT03244800|579432212|FG002|Overall Study|Withdrew treatment|0|||
160464806|NCT03244800|579432213|FG003|Overall Study|Withdrew treatment|1|||
160464807|NCT03418922|579432215|FG000|Overall Study|Withdrawal by Subject|0|||
160464808|NCT03418922|579432216|FG001|Overall Study|Withdrawal by Subject|2|||
160595677|NCT01763866|579898027|FG000|Overall Study|Withdrawal by Subject|2|||
160595678|NCT01763866|579898028|FG001|Overall Study|Withdrawal by Subject|1|||
160595679|NCT01763866|579898029|FG002|Overall Study|Withdrawal by Subject|4|||
160595680|NCT01763866|579898030|FG003|Overall Study|Withdrawal by Subject|0|||
160595681|NCT01763866|579898031|FG004|Overall Study|Withdrawal by Subject|0|||
160595682|NCT01763866|579898032|FG005|Overall Study|Withdrawal by Subject|3|||
160595683|NCT01763866|579898033|FG006|Overall Study|Withdrawal by Subject|4|||
160464809|NCT03418922|579432215|FG000|Overall Study|Adverse Event|2|||
160464810|NCT03418922|579432216|FG001|Overall Study|Adverse Event|2|||
160464811|NCT03418922|579432215|FG000|Overall Study|Death|0|||
160464812|NCT03418922|579432216|FG001|Overall Study|Death|1|||
160464813|NCT03418922|579432215|FG000|Overall Study|Physician Decision|0|||
160464814|NCT03418922|579432216|FG001|Overall Study|Physician Decision|1|||
160595684|NCT01763866|579898034|FG007|Overall Study|Withdrawal by Subject|0|||
160595685|NCT01763866|579898035|FG008|Overall Study|Withdrawal by Subject|1|||
160595686|NCT01763866|579898036|FG009|Overall Study|Withdrawal by Subject|1|||
160595687|NCT01763866|579898037|FG010|Overall Study|Withdrawal by Subject|2|||
160595688|NCT01763866|579898038|FG011|Overall Study|Withdrawal by Subject|2|||
160595689|NCT01763866|579898039|FG012|Overall Study|Withdrawal by Subject|2|||
160595690|NCT01763866|579898040|FG013|Overall Study|Withdrawal by Subject|0|||
160595691|NCT01763866|579898041|FG014|Overall Study|Withdrawal by Subject|6|||
160595692|NCT01763866|579898042|FG015|Overall Study|Withdrawal by Subject|3|||
160595693|NCT01763866|579898043|FG016|Overall Study|Withdrawal by Subject|0|||
160595694|NCT01763866|579898044|FG017|Overall Study|Withdrawal by Subject|1|||
160595695|NCT01763866|579898045|FG018|Overall Study|Withdrawal by Subject|1|||
160464815|NCT01640951|579432217|FG000|Overall Study|Adverse Event|8|||
160464816|NCT01640951|579432218|FG001|Overall Study|Adverse Event|3|||
160464817|NCT01640951|579432219|FG002|Overall Study|Adverse Event|10|||
160464818|NCT01640951|579432220|FG003|Overall Study|Adverse Event|6|||
160464819|NCT01640951|579432221|FG004|Overall Study|Adverse Event|1|||
160464820|NCT01640951|579432222|FG005|Overall Study|Adverse Event|11|||
160464821|NCT01640951|579432223|FG006|Overall Study|Adverse Event|1|||
160464822|NCT01640951|579432224|FG007|Overall Study|Adverse Event|3|||
160464823|NCT01640951|579432217|FG000|Overall Study|Lack of Efficacy|20|||
160464824|NCT01640951|579432218|FG001|Overall Study|Lack of Efficacy|1|||
160464825|NCT01640951|579432219|FG002|Overall Study|Lack of Efficacy|7|||
160464826|NCT01640951|579432220|FG003|Overall Study|Lack of Efficacy|14|||
160464827|NCT01640951|579432221|FG004|Overall Study|Lack of Efficacy|0|||
160464828|NCT01640951|579432222|FG005|Overall Study|Lack of Efficacy|6|||
160464829|NCT01640951|579432223|FG006|Overall Study|Lack of Efficacy|5|||
160464830|NCT01640951|579432224|FG007|Overall Study|Lack of Efficacy|6|||
160464831|NCT01640951|579432217|FG000|Overall Study|Lost to Follow-up|1|||
160464832|NCT01640951|579432218|FG001|Overall Study|Lost to Follow-up|0|||
160464833|NCT01640951|579432219|FG002|Overall Study|Lost to Follow-up|6|||
160464834|NCT01640951|579432220|FG003|Overall Study|Lost to Follow-up|2|||
160464835|NCT01640951|579432221|FG004|Overall Study|Lost to Follow-up|2|||
160464836|NCT01640951|579432222|FG005|Overall Study|Lost to Follow-up|3|||
160464837|NCT01640951|579432223|FG006|Overall Study|Lost to Follow-up|1|||
160464838|NCT01640951|579432224|FG007|Overall Study|Lost to Follow-up|1|||
160464839|NCT01640951|579432217|FG000|Overall Study|Non-compliance with study treatment|0|||
160464840|NCT01640951|579432218|FG001|Overall Study|Non-compliance with study treatment|0|||
160464841|NCT01640951|579432219|FG002|Overall Study|Non-compliance with study treatment|1|||
160464842|NCT01640951|579432220|FG003|Overall Study|Non-compliance with study treatment|1|||
160464843|NCT01640951|579432221|FG004|Overall Study|Non-compliance with study treatment|1|||
160464844|NCT01640951|579432222|FG005|Overall Study|Non-compliance with study treatment|4|||
160464845|NCT01640951|579432223|FG006|Overall Study|Non-compliance with study treatment|1|||
160464846|NCT01640951|579432224|FG007|Overall Study|Non-compliance with study treatment|0|||
160464847|NCT01640951|579432217|FG000|Overall Study|Physician Decision|2|||
160464848|NCT01640951|579432218|FG001|Overall Study|Physician Decision|5|||
160464849|NCT01640951|579432219|FG002|Overall Study|Physician Decision|2|||
160464850|NCT01640951|579432220|FG003|Overall Study|Physician Decision|2|||
160464851|NCT01640951|579432221|FG004|Overall Study|Physician Decision|2|||
160464852|NCT01640951|579432222|FG005|Overall Study|Physician Decision|3|||
160464853|NCT01640951|579432223|FG006|Overall Study|Physician Decision|3|||
160464854|NCT01640951|579432224|FG007|Overall Study|Physician Decision|0|||
160464855|NCT01640951|579432217|FG000|Overall Study|Pregnancy|3|||
160464856|NCT01640951|579432218|FG001|Overall Study|Pregnancy|0|||
160464857|NCT01640951|579432219|FG002|Overall Study|Pregnancy|0|||
160464858|NCT01640951|579432220|FG003|Overall Study|Pregnancy|4|||
160464859|NCT01640951|579432221|FG004|Overall Study|Pregnancy|0|||
160464860|NCT01640951|579432222|FG005|Overall Study|Pregnancy|0|||
160464861|NCT01640951|579432223|FG006|Overall Study|Pregnancy|2|||
160464862|NCT01640951|579432224|FG007|Overall Study|Pregnancy|0|||
160464863|NCT01640951|579432217|FG000|Overall Study|Protocol Deviation|0|||
160464864|NCT01640951|579432218|FG001|Overall Study|Protocol Deviation|1|||
160464865|NCT01640951|579432219|FG002|Overall Study|Protocol Deviation|2|||
160464866|NCT01640951|579432220|FG003|Overall Study|Protocol Deviation|1|||
160464867|NCT01640951|579432221|FG004|Overall Study|Protocol Deviation|0|||
160464868|NCT01640951|579432222|FG005|Overall Study|Protocol Deviation|1|||
160464869|NCT01640951|579432223|FG006|Overall Study|Protocol Deviation|0|||
160464870|NCT01640951|579432224|FG007|Overall Study|Protocol Deviation|0|||
160464871|NCT01640951|579432217|FG000|Overall Study|Subject/Guardian decision|12|||
160464872|NCT01640951|579432218|FG001|Overall Study|Subject/Guardian decision|4|||
160464873|NCT01640951|579432219|FG002|Overall Study|Subject/Guardian decision|13|||
160464874|NCT01640951|579432220|FG003|Overall Study|Subject/Guardian decision|15|||
160464875|NCT01640951|579432221|FG004|Overall Study|Subject/Guardian decision|7|||
160464876|NCT01640951|579432222|FG005|Overall Study|Subject/Guardian decision|19|||
160464877|NCT01640951|579432223|FG006|Overall Study|Subject/Guardian decision|5|||
160464878|NCT01640951|579432224|FG007|Overall Study|Subject/Guardian decision|4|||
160464879|NCT01640951|579432217|FG000|Overall Study|Death|0|||
160464880|NCT01640951|579432218|FG001|Overall Study|Death|1|||
160595696|NCT01763866|579898046|FG019|Overall Study|Withdrawal by Subject|1|||
160595697|NCT01763866|579898047|FG020|Overall Study|Withdrawal by Subject|2|||
160595698|NCT01763866|579898048|FG021|Overall Study|Withdrawal by Subject|1|||
160595699|NCT01763866|579898049|FG022|Overall Study|Withdrawal by Subject|2|||
160464881|NCT01640951|579432219|FG002|Overall Study|Death|1|||
160464882|NCT01640951|579432220|FG003|Overall Study|Death|0|||
160464883|NCT01640951|579432221|FG004|Overall Study|Death|0|||
160464884|NCT01640951|579432222|FG005|Overall Study|Death|0|||
160464885|NCT01640951|579432223|FG006|Overall Study|Death|0|||
160464886|NCT01640951|579432224|FG007|Overall Study|Death|2|||
160464887|NCT00582972|579432225|FG000|Overall Study|Protocol Violation|2|||
160464888|NCT00293397|579432226|FG000|Overall Study|Death|2|||
160464889|NCT03631407|579432227|FG000|Overall Study|Withdrawal by Subject|3|||
160464890|NCT03631407|579432228|FG001|Overall Study|Withdrawal by Subject|2|||
160464891|NCT03631407|579432227|FG000|Overall Study|Sponsor Decision|0|||
160464892|NCT03631407|579432228|FG001|Overall Study|Sponsor Decision|2|||
160464893|NCT03631407|579432227|FG000|Overall Study|Death|16|||
160464894|NCT03631407|579432228|FG001|Overall Study|Death|16|||
160464895|NCT03631407|579432227|FG000|Overall Study|Randomized by mistake without study treatment|1|||
160464896|NCT03631407|579432228|FG001|Overall Study|Randomized by mistake without study treatment|0|||
160464897|NCT03802994|579432230|FG000|Overall Study|Lost to Follow-up|0|||
160464898|NCT03802994|579432231|FG001|Overall Study|Lost to Follow-up|2|||
160464899|NCT03802994|579432232|FG002|Overall Study|Lost to Follow-up|3|||
160464900|NCT03802994|579432233|FG003|Overall Study|Lost to Follow-up|2|||
160464901|NCT03802994|579432234|FG004|Overall Study|Lost to Follow-up|2|||
160464902|NCT00983294|579432235|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
160464903|NCT00983294|579432235|FG000|Colchicine With Azithromycin|Adverse Event|1|||
160464904|NCT00622700|579432236|FG000|Core Treatment Period|Randomized but Not Treated|0|||
160658849|NCT02311361|580133210|FG003|Overall Study|Did not receive treatment|1|||
160658850|NCT00633594|580133213|FG000|Overall Study|Adverse Event|0|||
160658851|NCT00633594|580133214|FG001|Overall Study|Adverse Event|4|||
160658852|NCT00633594|580133215|FG002|Overall Study|Adverse Event|7|||
160464905|NCT00622700|579432237|FG001|Core Treatment Period|Randomized but Not Treated|2|||
160464906|NCT00622700|579432238|FG002|Core Treatment Period|Randomized but Not Treated|2|||
160464907|NCT00622700|579432239|FG003|Core Treatment Period|Randomized but Not Treated|0|||
160464908|NCT00622700|579432240|FG004|Core Treatment Period|Randomized but Not Treated|0|||
160464909|NCT00622700|579432241|FG005|Core Treatment Period|Randomized but Not Treated|0|||
160464910|NCT00622700|579432242|FG006|Core Treatment Period|Randomized but Not Treated|0|||
160464911|NCT00622700|579432236|FG000|Core Treatment Period|Adverse Event|18|||
160464912|NCT00622700|579432237|FG001|Core Treatment Period|Adverse Event|25|||
160464913|NCT00622700|579432238|FG002|Core Treatment Period|Adverse Event|18|||
160464914|NCT00622700|579432239|FG003|Core Treatment Period|Adverse Event|0|||
160464915|NCT00622700|579432240|FG004|Core Treatment Period|Adverse Event|0|||
160464916|NCT00622700|579432241|FG005|Core Treatment Period|Adverse Event|0|||
160464917|NCT00622700|579432242|FG006|Core Treatment Period|Adverse Event|0|||
160464918|NCT00622700|579432236|FG000|Core Treatment Period|Lack of Efficacy|19|||
160464919|NCT00622700|579432237|FG001|Core Treatment Period|Lack of Efficacy|6|||
160464920|NCT00622700|579432238|FG002|Core Treatment Period|Lack of Efficacy|12|||
160464921|NCT00622700|579432239|FG003|Core Treatment Period|Lack of Efficacy|0|||
160464922|NCT00622700|579432240|FG004|Core Treatment Period|Lack of Efficacy|0|||
160464923|NCT00622700|579432241|FG005|Core Treatment Period|Lack of Efficacy|0|||
160464924|NCT00622700|579432242|FG006|Core Treatment Period|Lack of Efficacy|0|||
160464925|NCT00622700|579432236|FG000|Core Treatment Period|Lost to Follow-up|1|||
160658853|NCT00633594|580133213|FG000|Overall Study|Death|0|||
160464926|NCT00622700|579432237|FG001|Core Treatment Period|Lost to Follow-up|1|||
160464927|NCT00622700|579432238|FG002|Core Treatment Period|Lost to Follow-up|1|||
160464928|NCT00622700|579432239|FG003|Core Treatment Period|Lost to Follow-up|0|||
160464929|NCT00622700|579432240|FG004|Core Treatment Period|Lost to Follow-up|0|||
160464930|NCT00622700|579432241|FG005|Core Treatment Period|Lost to Follow-up|0|||
160464931|NCT00622700|579432242|FG006|Core Treatment Period|Lost to Follow-up|0|||
160464932|NCT00622700|579432236|FG000|Core Treatment Period|Death|1|||
160464933|NCT00622700|579432237|FG001|Core Treatment Period|Death|0|||
160464934|NCT00622700|579432238|FG002|Core Treatment Period|Death|0|||
160464935|NCT00622700|579432239|FG003|Core Treatment Period|Death|0|||
160464936|NCT00622700|579432240|FG004|Core Treatment Period|Death|0|||
160464937|NCT00622700|579432241|FG005|Core Treatment Period|Death|0|||
160464938|NCT00622700|579432242|FG006|Core Treatment Period|Death|0|||
160464939|NCT00622700|579432236|FG000|Core Treatment Period|Progressive Disease|3|||
160464940|NCT00622700|579432237|FG001|Core Treatment Period|Progressive Disease|1|||
160464941|NCT00622700|579432238|FG002|Core Treatment Period|Progressive Disease|0|||
160464942|NCT00622700|579432239|FG003|Core Treatment Period|Progressive Disease|0|||
160464943|NCT00622700|579432240|FG004|Core Treatment Period|Progressive Disease|0|||
160464944|NCT00622700|579432241|FG005|Core Treatment Period|Progressive Disease|0|||
160464945|NCT00622700|579432242|FG006|Core Treatment Period|Progressive Disease|0|||
160464946|NCT00622700|579432236|FG000|Core Treatment Period|Withdrawal by Subject|12|||
160464947|NCT00622700|579432237|FG001|Core Treatment Period|Withdrawal by Subject|18|||
160464948|NCT00622700|579432238|FG002|Core Treatment Period|Withdrawal by Subject|15|||
160464949|NCT00622700|579432239|FG003|Core Treatment Period|Withdrawal by Subject|0|||
160464950|NCT00622700|579432240|FG004|Core Treatment Period|Withdrawal by Subject|0|||
160464951|NCT00622700|579432241|FG005|Core Treatment Period|Withdrawal by Subject|0|||
160464952|NCT00622700|579432242|FG006|Core Treatment Period|Withdrawal by Subject|0|||
160464953|NCT00622700|579432236|FG000|Core Treatment Period|Other than specified above|2|||
160464954|NCT00622700|579432237|FG001|Core Treatment Period|Other than specified above|2|||
160464955|NCT00622700|579432238|FG002|Core Treatment Period|Other than specified above|5|||
160464956|NCT00622700|579432239|FG003|Core Treatment Period|Other than specified above|0|||
160464957|NCT00622700|579432240|FG004|Core Treatment Period|Other than specified above|0|||
160464958|NCT00622700|579432241|FG005|Core Treatment Period|Other than specified above|0|||
160464959|NCT00622700|579432242|FG006|Core Treatment Period|Other than specified above|0|||
160595700|NCT01763866|579898050|FG023|Overall Study|Withdrawal by Subject|1|||
160595701|NCT01763866|579898027|FG000|Overall Study|Decision by sponsor|0|||
160595702|NCT01763866|579898028|FG001|Overall Study|Decision by sponsor|0|||
160595703|NCT01763866|579898029|FG002|Overall Study|Decision by sponsor|1|||
160595704|NCT01763866|579898030|FG003|Overall Study|Decision by sponsor|0|||
160595705|NCT01763866|579898031|FG004|Overall Study|Decision by sponsor|2|||
160595706|NCT01763866|579898032|FG005|Overall Study|Decision by sponsor|0|||
160595707|NCT01763866|579898033|FG006|Overall Study|Decision by sponsor|2|||
160595708|NCT01763866|579898034|FG007|Overall Study|Decision by sponsor|0|||
160595709|NCT01763866|579898035|FG008|Overall Study|Decision by sponsor|2|||
160595710|NCT01763866|579898036|FG009|Overall Study|Decision by sponsor|0|||
160595711|NCT01763866|579898037|FG010|Overall Study|Decision by sponsor|6|||
160595712|NCT01763866|579898038|FG011|Overall Study|Decision by sponsor|0|||
160595713|NCT01763866|579898039|FG012|Overall Study|Decision by sponsor|1|||
160595714|NCT01763866|579898040|FG013|Overall Study|Decision by sponsor|0|||
160595715|NCT01763866|579898041|FG014|Overall Study|Decision by sponsor|5|||
160595716|NCT01763866|579898042|FG015|Overall Study|Decision by sponsor|0|||
160595717|NCT01763866|579898043|FG016|Overall Study|Decision by sponsor|0|||
160595718|NCT01763866|579898044|FG017|Overall Study|Decision by sponsor|0|||
160595719|NCT01763866|579898045|FG018|Overall Study|Decision by sponsor|4|||
160595720|NCT01763866|579898046|FG019|Overall Study|Decision by sponsor|0|||
160595721|NCT01763866|579898047|FG020|Overall Study|Decision by sponsor|2|||
160658854|NCT00633594|580133214|FG001|Overall Study|Death|1|||
160658855|NCT00633594|580133215|FG002|Overall Study|Death|2|||
160464960|NCT00622700|579432236|FG000|Extension Treatment Period|Adverse Event|0|||
160464961|NCT00622700|579432237|FG001|Extension Treatment Period|Adverse Event|0|||
160464962|NCT00622700|579432238|FG002|Extension Treatment Period|Adverse Event|0|||
160464963|NCT00622700|579432239|FG003|Extension Treatment Period|Adverse Event|5|||
160464964|NCT00622700|579432240|FG004|Extension Treatment Period|Adverse Event|9|||
160464965|NCT00622700|579432241|FG005|Extension Treatment Period|Adverse Event|6|||
160464966|NCT00622700|579432242|FG006|Extension Treatment Period|Adverse Event|8|||
160464967|NCT00622700|579432236|FG000|Extension Treatment Period|Lack of Efficacy|0|||
160464968|NCT00622700|579432237|FG001|Extension Treatment Period|Lack of Efficacy|0|||
160464969|NCT00622700|579432238|FG002|Extension Treatment Period|Lack of Efficacy|0|||
160464970|NCT00622700|579432239|FG003|Extension Treatment Period|Lack of Efficacy|2|||
160464971|NCT00622700|579432240|FG004|Extension Treatment Period|Lack of Efficacy|8|||
160464972|NCT00622700|579432241|FG005|Extension Treatment Period|Lack of Efficacy|1|||
160464973|NCT00622700|579432242|FG006|Extension Treatment Period|Lack of Efficacy|9|||
160464974|NCT00622700|579432236|FG000|Extension Treatment Period|Protocol Violation|0|||
160464975|NCT00622700|579432237|FG001|Extension Treatment Period|Protocol Violation|0|||
160464976|NCT00622700|579432238|FG002|Extension Treatment Period|Protocol Violation|0|||
160464977|NCT00622700|579432239|FG003|Extension Treatment Period|Protocol Violation|0|||
160464978|NCT00622700|579432240|FG004|Extension Treatment Period|Protocol Violation|0|||
160464979|NCT00622700|579432241|FG005|Extension Treatment Period|Protocol Violation|2|||
160464980|NCT00622700|579432242|FG006|Extension Treatment Period|Protocol Violation|0|||
160464981|NCT00622700|579432236|FG000|Extension Treatment Period|Lost to Follow-up|0|||
160464982|NCT00622700|579432237|FG001|Extension Treatment Period|Lost to Follow-up|0|||
160464983|NCT00622700|579432238|FG002|Extension Treatment Period|Lost to Follow-up|0|||
160464984|NCT00622700|579432239|FG003|Extension Treatment Period|Lost to Follow-up|0|||
160464985|NCT00622700|579432240|FG004|Extension Treatment Period|Lost to Follow-up|1|||
160464986|NCT00622700|579432241|FG005|Extension Treatment Period|Lost to Follow-up|0|||
160464987|NCT00622700|579432242|FG006|Extension Treatment Period|Lost to Follow-up|0|||
160464988|NCT00622700|579432236|FG000|Extension Treatment Period|Progressive Disease|0|||
160464989|NCT00622700|579432237|FG001|Extension Treatment Period|Progressive Disease|0|||
160464990|NCT00622700|579432238|FG002|Extension Treatment Period|Progressive Disease|0|||
160464991|NCT00622700|579432239|FG003|Extension Treatment Period|Progressive Disease|1|||
160464992|NCT00622700|579432240|FG004|Extension Treatment Period|Progressive Disease|2|||
160464993|NCT00622700|579432241|FG005|Extension Treatment Period|Progressive Disease|0|||
160464994|NCT00622700|579432242|FG006|Extension Treatment Period|Progressive Disease|2|||
160464995|NCT00622700|579432236|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
160464996|NCT00622700|579432237|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
160658856|NCT00633594|580133213|FG000|Overall Study|Disease Progression|0|||
160658857|NCT00633594|580133214|FG001|Overall Study|Disease Progression|0|||
160595722|NCT01763866|579898048|FG021|Overall Study|Decision by sponsor|0|||
160595723|NCT01763866|579898049|FG022|Overall Study|Decision by sponsor|1|||
160595724|NCT01763866|579898050|FG023|Overall Study|Decision by sponsor|0|||
160595725|NCT01763866|579898027|FG000|Overall Study|Lost to Follow-up|0|||
160595726|NCT01763866|579898028|FG001|Overall Study|Lost to Follow-up|0|||
160595727|NCT01763866|579898029|FG002|Overall Study|Lost to Follow-up|0|||
160595728|NCT01763866|579898030|FG003|Overall Study|Lost to Follow-up|0|||
160595729|NCT01763866|579898031|FG004|Overall Study|Lost to Follow-up|0|||
160595730|NCT01763866|579898032|FG005|Overall Study|Lost to Follow-up|0|||
160595731|NCT01763866|579898033|FG006|Overall Study|Lost to Follow-up|1|||
160595732|NCT01763866|579898034|FG007|Overall Study|Lost to Follow-up|0|||
160595733|NCT01763866|579898035|FG008|Overall Study|Lost to Follow-up|0|||
160595734|NCT01763866|579898036|FG009|Overall Study|Lost to Follow-up|0|||
160595735|NCT01763866|579898037|FG010|Overall Study|Lost to Follow-up|0|||
160595736|NCT01763866|579898038|FG011|Overall Study|Lost to Follow-up|0|||
160595737|NCT01763866|579898039|FG012|Overall Study|Lost to Follow-up|1|||
160595738|NCT01763866|579898040|FG013|Overall Study|Lost to Follow-up|0|||
160595739|NCT01763866|579898041|FG014|Overall Study|Lost to Follow-up|1|||
160595740|NCT01763866|579898042|FG015|Overall Study|Lost to Follow-up|0|||
160595741|NCT01763866|579898043|FG016|Overall Study|Lost to Follow-up|0|||
160595742|NCT01763866|579898044|FG017|Overall Study|Lost to Follow-up|0|||
160595743|NCT01763866|579898045|FG018|Overall Study|Lost to Follow-up|1|||
160595744|NCT01763866|579898046|FG019|Overall Study|Lost to Follow-up|1|||
160595745|NCT01763866|579898047|FG020|Overall Study|Lost to Follow-up|0|||
160595746|NCT01763866|579898048|FG021|Overall Study|Lost to Follow-up|0|||
160595747|NCT01763866|579898049|FG022|Overall Study|Lost to Follow-up|0|||
160595748|NCT01763866|579898050|FG023|Overall Study|Lost to Follow-up|1|||
160595749|NCT01763866|579898027|FG000|Overall Study|Death|0|||
160595750|NCT01763866|579898028|FG001|Overall Study|Death|0|||
160595751|NCT01763866|579898029|FG002|Overall Study|Death|0|||
160595752|NCT01763866|579898030|FG003|Overall Study|Death|0|||
160595753|NCT01763866|579898031|FG004|Overall Study|Death|0|||
160595754|NCT01763866|579898032|FG005|Overall Study|Death|0|||
160595755|NCT01763866|579898033|FG006|Overall Study|Death|0|||
160595756|NCT01763866|579898034|FG007|Overall Study|Death|0|||
160595757|NCT01763866|579898035|FG008|Overall Study|Death|0|||
160595758|NCT01763866|579898036|FG009|Overall Study|Death|0|||
160595759|NCT01763866|579898037|FG010|Overall Study|Death|0|||
160595760|NCT01763866|579898038|FG011|Overall Study|Death|0|||
160595761|NCT01763866|579898039|FG012|Overall Study|Death|0|||
160595762|NCT01763866|579898040|FG013|Overall Study|Death|0|||
160595763|NCT01763866|579898041|FG014|Overall Study|Death|0|||
160464997|NCT00622700|579432238|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
160595764|NCT01763866|579898042|FG015|Overall Study|Death|0|||
160595765|NCT01763866|579898043|FG016|Overall Study|Death|1|||
160595766|NCT01763866|579898044|FG017|Overall Study|Death|0|||
160595767|NCT01763866|579898045|FG018|Overall Study|Death|0|||
160595768|NCT01763866|579898046|FG019|Overall Study|Death|0|||
160464998|NCT00622700|579432239|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
160464999|NCT00622700|579432240|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
160595769|NCT01763866|579898047|FG020|Overall Study|Death|0|||
160595770|NCT01763866|579898048|FG021|Overall Study|Death|0|||
160595771|NCT01763866|579898049|FG022|Overall Study|Death|0|||
160595772|NCT01763866|579898050|FG023|Overall Study|Death|0|||
160595773|NCT01164865|579898056|FG000|Overall Study|Lost to Follow-up|2|||
160595774|NCT01164865|579898057|FG001|Overall Study|Lost to Follow-up|1|||
160595775|NCT00475540|579898058|FG000|36 Months|Lost to Follow-up|4|||
160595776|NCT00475540|579898059|FG001|36 Months|Lost to Follow-up|4|||
160595777|NCT00475540|579898058|FG000|36 Months|Death|1|||
160595778|NCT00475540|579898059|FG001|36 Months|Death|2|||
160595779|NCT00475540|579898058|FG000|36 Months|Censored due to reoperation|3|||
160595780|NCT00475540|579898059|FG001|36 Months|Censored due to reoperation|0|||
160595781|NCT00377429|579898060|FG000|Overall Study|Withdrawal by Subject|5|||
160595782|NCT00377429|579898060|FG000|Overall Study|Adverse Event|8|||
160595783|NCT00377429|579898060|FG000|Overall Study|Physician Decision|1|||
160595784|NCT00377429|579898060|FG000|Overall Study|Patient non-compliance|1|||
160595785|NCT02394795|579898063|FG000|Overall Study|Adverse Event|92|||
160595786|NCT02394795|579898064|FG001|Overall Study|Adverse Event|70|||
160465000|NCT00622700|579432241|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
160465001|NCT00622700|579432242|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
160465002|NCT00622700|579432236|FG000|Extension Treatment Period|Missing|0|||
160465003|NCT00622700|579432237|FG001|Extension Treatment Period|Missing|0|||
160465004|NCT00622700|579432238|FG002|Extension Treatment Period|Missing|0|||
160465005|NCT00622700|579432239|FG003|Extension Treatment Period|Missing|2|||
160465006|NCT00622700|579432240|FG004|Extension Treatment Period|Missing|3|||
160465007|NCT00622700|579432241|FG005|Extension Treatment Period|Missing|1|||
160465008|NCT00622700|579432242|FG006|Extension Treatment Period|Missing|0|||
160465009|NCT00622700|579432236|FG000|Extension Treatment Period|Other than specified above|0|||
160465010|NCT00622700|579432237|FG001|Extension Treatment Period|Other than specified above|0|||
160465011|NCT00622700|579432238|FG002|Extension Treatment Period|Other than specified above|0|||
160465012|NCT00622700|579432239|FG003|Extension Treatment Period|Other than specified above|0|||
160465013|NCT00622700|579432240|FG004|Extension Treatment Period|Other than specified above|0|||
160465014|NCT00622700|579432241|FG005|Extension Treatment Period|Other than specified above|1|||
160465015|NCT00622700|579432242|FG006|Extension Treatment Period|Other than specified above|1|||
160465016|NCT03611556|579432243|FG000|Overall Study|Death|7|||
160465017|NCT03611556|579432244|FG001|Overall Study|Death|7|||
160465018|NCT03611556|579432245|FG002|Overall Study|Death|3|||
160465019|NCT03611556|579432246|FG003|Overall Study|Death|8|||
160465020|NCT03611556|579432247|FG004|Overall Study|Death|47|||
160465021|NCT03611556|579432248|FG005|Overall Study|Death|32|||
160465022|NCT03611556|579432249|FG006|Overall Study|Death|53|||
160465023|NCT03611556|579432243|FG000|Overall Study|Withdrawal by Subject|0|||
160465024|NCT03611556|579432244|FG001|Overall Study|Withdrawal by Subject|0|||
160465025|NCT03611556|579432245|FG002|Overall Study|Withdrawal by Subject|0|||
160465026|NCT03611556|579432246|FG003|Overall Study|Withdrawal by Subject|0|||
160465027|NCT03611556|579432247|FG004|Overall Study|Withdrawal by Subject|4|||
160465028|NCT03611556|579432248|FG005|Overall Study|Withdrawal by Subject|2|||
160465029|NCT03611556|579432249|FG006|Overall Study|Withdrawal by Subject|4|||
160465030|NCT03611556|579432243|FG000|Overall Study|Sponsor decision|0|||
160465031|NCT03611556|579432244|FG001|Overall Study|Sponsor decision|0|||
160465032|NCT03611556|579432245|FG002|Overall Study|Sponsor decision|0|||
160465033|NCT03611556|579432246|FG003|Overall Study|Sponsor decision|0|||
160465034|NCT03611556|579432247|FG004|Overall Study|Sponsor decision|9|||
160465035|NCT03611556|579432248|FG005|Overall Study|Sponsor decision|4|||
160465036|NCT03611556|579432249|FG006|Overall Study|Sponsor decision|12|||
160595787|NCT02394795|579898063|FG000|Overall Study|Lost to Follow-up|0|||
160595788|NCT02394795|579898064|FG001|Overall Study|Lost to Follow-up|1|||
160595789|NCT02394795|579898063|FG000|Overall Study|Withdrawal by Subject|17|||
160595790|NCT02394795|579898064|FG001|Overall Study|Withdrawal by Subject|26|||
160595791|NCT02394795|579898063|FG000|Overall Study|Lack of Efficacy|181|||
160595792|NCT02394795|579898064|FG001|Overall Study|Lack of Efficacy|211|||
160595793|NCT02394795|579898063|FG000|Overall Study|Death|4|||
160595794|NCT02394795|579898064|FG001|Overall Study|Death|5|||
160595795|NCT02394795|579898063|FG000|Overall Study|Physician Decision|109|||
160595796|NCT02394795|579898064|FG001|Overall Study|Physician Decision|93|||
160595797|NCT02939599|579898066|FG000|Overall Study|Adverse Event|1|||
160595798|NCT02939599|579898067|FG001|Overall Study|Adverse Event|0|||
160658858|NCT00633594|580133215|FG002|Overall Study|Disease Progression|1|||
160658859|NCT02028715|580133217|FG000|Overall Study|Adverse Event|2|||
160658860|NCT02028715|580133218|FG001|Overall Study|Adverse Event|2|||
160658861|NCT02028715|580133217|FG000|Overall Study|Physician Decision|1|||
160658862|NCT02028715|580133218|FG001|Overall Study|Physician Decision|0|||
160465037|NCT03611556|579432243|FG000|Overall Study|Reasons|0|||
160465038|NCT03611556|579432244|FG001|Overall Study|Reasons|0|||
160465039|NCT03611556|579432245|FG002|Overall Study|Reasons|0|||
160658863|NCT02028715|580133217|FG000|Overall Study|Did not complete satisfaction surveys|2|||
160465040|NCT03611556|579432246|FG003|Overall Study|Reasons|0|||
160465041|NCT03611556|579432247|FG004|Overall Study|Reasons|2|||
160465042|NCT03611556|579432248|FG005|Overall Study|Reasons|0|||
160465043|NCT03611556|579432249|FG006|Overall Study|Reasons|1|||
160465044|NCT02844439|579432255|FG000|Overall Study|Withdrawal by Subject|1|||
160465045|NCT02844439|579432255|FG000|Overall Study|Lost to Follow-up|2|||
160465046|NCT02844439|579432255|FG000|Overall Study|Termination by Sponsor|4|||
160465047|NCT02844439|579432255|FG000|Overall Study|Death|28|||
160465048|NCT02844439|579432255|FG000|Overall Study|Other|5|||
160465049|NCT00390884|579432258|FG000|Overall Study|Withdrawal by Subject|2|||
160465050|NCT00390884|579432259|FG001|Overall Study|Withdrawal by Subject|2|||
160465051|NCT00756574|579432260|FG000|Overall Study|Withdrawal by Subject|9|||
160595799|NCT02939599|579898066|FG000|Overall Study|Study Terminated By Sponsor|2|||
160658864|NCT02028715|580133218|FG001|Overall Study|Did not complete satisfaction surveys|2|||
160595800|NCT02939599|579898067|FG001|Overall Study|Study Terminated By Sponsor|2|||
160658865|NCT04455633|580133219|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
160465052|NCT00756574|579432261|FG001|Overall Study|Withdrawal by Subject|7|||
160465053|NCT00756574|579432260|FG000|Overall Study|Lost to Follow-up|4|||
160465054|NCT00756574|579432261|FG001|Overall Study|Lost to Follow-up|4|||
160595801|NCT01669811|579898068|FG000|Overall Study|Investigator decision|0|||
160465055|NCT04622332|579432262|FG000|Overall Study|Withdrawal by Subject|4|||
160465056|NCT04622332|579432263|FG001|Overall Study|Withdrawal by Subject|2|||
160465057|NCT04622332|579432262|FG000|Overall Study|Physician Decision|1|||
160465058|NCT04622332|579432263|FG001|Overall Study|Physician Decision|1|||
160465059|NCT04622332|579432262|FG000|Overall Study|Adverse Event|0|||
160465060|NCT04622332|579432263|FG001|Overall Study|Adverse Event|2|||
160465061|NCT04622332|579432262|FG000|Overall Study|Protocol Violation|0|||
160465062|NCT04622332|579432263|FG001|Overall Study|Protocol Violation|1|||
160465063|NCT05966155|579432264|FG000|Overall Study|Death|1|||
160465064|NCT05966155|579432265|FG001|Overall Study|Death|2|||
160465065|NCT05966155|579432264|FG000|Overall Study|Lost to Follow-up|63|||
160465066|NCT05966155|579432265|FG001|Overall Study|Lost to Follow-up|67|||
160465067|NCT05966155|579432264|FG000|Overall Study|Protocol Violation|1|||
160465068|NCT05966155|579432265|FG001|Overall Study|Protocol Violation|0|||
160465069|NCT05966155|579432264|FG000|Overall Study|Withdrawal by Subject|8|||
160465070|NCT05966155|579432265|FG001|Overall Study|Withdrawal by Subject|9|||
160465071|NCT05966155|579432264|FG000|Overall Study|Enrolled Erroneously|0|||
160465072|NCT05966155|579432265|FG001|Overall Study|Enrolled Erroneously|1|||
160465073|NCT05966155|579432264|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
160465074|NCT05966155|579432265|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
160465075|NCT05036278|579432270|FG000|Overall Study|Withdrawal by Subject|1|||
160465076|NCT05036278|579432270|FG000|Overall Study|Adverse Event|1|||
160465077|NCT04647487|579432273|FG000|Overall Study|Protocol Deviation|0|||
160465078|NCT04647487|579432274|FG001|Overall Study|Protocol Deviation|0|||
160465079|NCT04647487|579432275|FG002|Overall Study|Protocol Deviation|1|||
160465080|NCT04647487|579432273|FG000|Overall Study|Withdrawal by Subject|1|||
160465081|NCT04647487|579432274|FG001|Overall Study|Withdrawal by Subject|0|||
160465082|NCT04647487|579432275|FG002|Overall Study|Withdrawal by Subject|2|||
160465083|NCT02787005|579432276|FG000|Overall Study|Adverse Event|24|||
160465084|NCT02787005|579432277|FG001|Overall Study|Adverse Event|9|||
160465085|NCT02787005|579432278|FG002|Overall Study|Adverse Event|9|||
160465086|NCT02787005|579432279|FG003|Overall Study|Adverse Event|7|||
160465087|NCT02787005|579432280|FG004|Overall Study|Adverse Event|2|||
160465088|NCT02787005|579432276|FG000|Overall Study|Death|100|||
160465089|NCT02787005|579432277|FG001|Overall Study|Death|53|||
160465090|NCT02787005|579432278|FG002|Overall Study|Death|48|||
160465091|NCT02787005|579432279|FG003|Overall Study|Death|69|||
160465092|NCT02787005|579432280|FG004|Overall Study|Death|38|||
160465093|NCT02787005|579432276|FG000|Overall Study|Sponsor Decision|7|||
160465094|NCT02787005|579432277|FG001|Overall Study|Sponsor Decision|4|||
160465095|NCT02787005|579432278|FG002|Overall Study|Sponsor Decision|0|||
160465096|NCT02787005|579432279|FG003|Overall Study|Sponsor Decision|4|||
160465097|NCT02787005|579432280|FG004|Overall Study|Sponsor Decision|5|||
160465098|NCT02787005|579432276|FG000|Overall Study|Withdrawal by Subject|2|||
160465099|NCT02787005|579432277|FG001|Overall Study|Withdrawal by Subject|1|||
160465100|NCT02787005|579432278|FG002|Overall Study|Withdrawal by Subject|1|||
160465101|NCT02787005|579432279|FG003|Overall Study|Withdrawal by Subject|0|||
160465102|NCT02787005|579432280|FG004|Overall Study|Withdrawal by Subject|1|||
160465103|NCT02787005|579432276|FG000|Overall Study|Screen Failure|0|||
160465104|NCT02787005|579432277|FG001|Overall Study|Screen Failure|2|||
160465105|NCT02787005|579432278|FG002|Overall Study|Screen Failure|0|||
160465106|NCT02787005|579432279|FG003|Overall Study|Screen Failure|0|||
160465107|NCT02787005|579432280|FG004|Overall Study|Screen Failure|1|||
160465108|NCT02787005|579432276|FG000|Overall Study|Lost to Follow-up|0|||
160465109|NCT02787005|579432277|FG001|Overall Study|Lost to Follow-up|0|||
160465110|NCT02787005|579432278|FG002|Overall Study|Lost to Follow-up|0|||
160465111|NCT02787005|579432279|FG003|Overall Study|Lost to Follow-up|1|||
160465112|NCT02787005|579432280|FG004|Overall Study|Lost to Follow-up|0|||
160465113|NCT03890289|579432286|FG000|Overall Study|Adverse Event|1|||
160465114|NCT03890289|579432286|FG000|Overall Study|Physician Decision|1|||
160465115|NCT03890289|579432286|FG000|Overall Study|Lack of Efficacy|2|||
160465116|NCT02744066|579432293|FG000|Overall Study|Withdrawal by parent|0|||
160465117|NCT02744066|579432294|FG001|Overall Study|Withdrawal by parent|1|||
160465118|NCT02744066|579432293|FG000|Overall Study|Discharged from NICU prior to completion|0|||
160465119|NCT02744066|579432294|FG001|Overall Study|Discharged from NICU prior to completion|4|||
160465120|NCT02408887|579432295|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
160465121|NCT02408887|579432296|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
160465122|NCT02408887|579432295|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
160465123|NCT02408887|579432296|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
160465124|NCT04066075|579432298|FG000|Overall Study|Lost to Follow-up|3|||
160465125|NCT04066075|579432299|FG001|Overall Study|Lost to Follow-up|3|||
160465126|NCT04066075|579432298|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
160465127|NCT04066075|579432299|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
160465128|NCT04066075|579432298|FG000|Overall Study|Withdrawal by Subject|2|||
160465129|NCT04066075|579432299|FG001|Overall Study|Withdrawal by Subject|2|||
160465130|NCT00309166|579432300|FG000|Overall Study|Adverse event, non-fatal|1|||
160465131|NCT00309166|579432301|FG001|Overall Study|Adverse event, non-fatal|0|||
160465132|NCT00309166|579432300|FG000|Overall Study|Withdrawal by Subject|4|||
160465133|NCT00309166|579432301|FG001|Overall Study|Withdrawal by Subject|3|||
160465134|NCT00589875|579432304|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
160465135|NCT00589875|579432304|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
160465136|NCT03357952|579432311|FG000|Overall Study|Withdrawal by Subject|0|||
160465137|NCT03357952|579432312|FG001|Overall Study|Withdrawal by Subject|1|||
160465138|NCT03357952|579432311|FG000|Overall Study|Sponsor Decision|9|||
160465139|NCT03357952|579432312|FG001|Overall Study|Sponsor Decision|0|||
160465140|NCT01675492|579432313|FG000|Overall Study|study completed early - product approval|42|||
160465141|NCT03593226|579432330|FG000|Overall Study|Disease progression|6|||
160465142|NCT03593226|579432331|FG001|Overall Study|Disease progression|13|||
160465143|NCT03593226|579432332|FG002|Overall Study|Disease progression|5|||
160465144|NCT03593226|579432333|FG003|Overall Study|Disease progression|6|||
160465145|NCT03593226|579432330|FG000|Overall Study|Adverse Event|0|||
160465146|NCT03593226|579432331|FG001|Overall Study|Adverse Event|1|||
160465147|NCT03593226|579432332|FG002|Overall Study|Adverse Event|0|||
160465148|NCT03593226|579432333|FG003|Overall Study|Adverse Event|0|||
160465149|NCT03593226|579432330|FG000|Overall Study|Withdrawal by Subject|0|||
160465150|NCT03593226|579432331|FG001|Overall Study|Withdrawal by Subject|4|||
160465151|NCT03593226|579432332|FG002|Overall Study|Withdrawal by Subject|1|||
160465152|NCT03593226|579432333|FG003|Overall Study|Withdrawal by Subject|0|||
160465153|NCT03593226|579432330|FG000|Overall Study|Physician Decision|0|||
160465154|NCT03593226|579432331|FG001|Overall Study|Physician Decision|1|||
160465155|NCT03593226|579432332|FG002|Overall Study|Physician Decision|0|||
160465156|NCT03593226|579432333|FG003|Overall Study|Physician Decision|0|||
160465157|NCT03593226|579432330|FG000|Overall Study|Clinical disease progression|0|||
160465158|NCT03593226|579432331|FG001|Overall Study|Clinical disease progression|0|||
160465159|NCT03593226|579432332|FG002|Overall Study|Clinical disease progression|1|||
160465160|NCT03593226|579432333|FG003|Overall Study|Clinical disease progression|0|||
160465161|NCT04517435|579432334|FG000|Overall Study|Withdrawal by Subject|0|||
160465162|NCT04517435|579432335|FG001|Overall Study|Withdrawal by Subject|0|||
160465163|NCT04517435|579432336|FG002|Overall Study|Withdrawal by Subject|1|||
160465164|NCT04517435|579432334|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
160465165|NCT04517435|579432335|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
160465166|NCT04517435|579432336|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
160465167|NCT03656718|579432337|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
160465168|NCT03656718|579432338|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
160465169|NCT03656718|579432339|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
160465170|NCT03656718|579432340|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
160465171|NCT03656718|579432341|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
160465172|NCT03656718|579432342|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
160465173|NCT03656718|579432343|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
160465174|NCT03656718|579432337|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
160465175|NCT03656718|579432338|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
160465176|NCT03656718|579432339|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
160465177|NCT03656718|579432340|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
160465178|NCT03656718|579432341|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
160465179|NCT03656718|579432342|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
160465180|NCT03656718|579432343|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
160465181|NCT03656718|579432337|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
160465182|NCT03656718|579432338|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
160465183|NCT03656718|579432339|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
160465184|NCT03656718|579432340|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
160465185|NCT03656718|579432341|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
160465186|NCT03656718|579432342|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
160465187|NCT03656718|579432343|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
160465188|NCT03656718|579432337|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
160465189|NCT03656718|579432338|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
160465190|NCT03656718|579432339|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
160465191|NCT03656718|579432340|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
160465192|NCT03656718|579432341|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
160465193|NCT03656718|579432342|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
160465194|NCT03656718|579432343|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
160465195|NCT03656718|579432337|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
160465196|NCT03656718|579432338|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
160465197|NCT03656718|579432339|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
160465198|NCT03656718|579432340|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
160595802|NCT01669811|579898069|FG001|Overall Study|Investigator decision|1|||
160595803|NCT01669811|579898068|FG000|Overall Study|Withdrawal by Subject|1|||
160595804|NCT01669811|579898069|FG001|Overall Study|Withdrawal by Subject|2|||
160595805|NCT01669811|579898068|FG000|Overall Study|Adverse Event|2|||
160595806|NCT01669811|579898069|FG001|Overall Study|Adverse Event|6|||
160595807|NCT01669811|579898068|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
160595808|NCT01669811|579898069|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
160595809|NCT03288493|579898074|FG000|Overall Study|Withdrawal by Subject|4|||
160595810|NCT03288493|579898075|FG001|Overall Study|Withdrawal by Subject|0|||
160595811|NCT03288493|579898076|FG002|Overall Study|Withdrawal by Subject|0|||
160595812|NCT03288493|579898077|FG003|Overall Study|Withdrawal by Subject|0|||
160595813|NCT03288493|579898078|FG004|Overall Study|Withdrawal by Subject|0|||
160595814|NCT03288493|579898079|FG005|Overall Study|Withdrawal by Subject|2|||
160595815|NCT03288493|579898080|FG006|Overall Study|Withdrawal by Subject|0|||
160658866|NCT04455633|580133220|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
160595816|NCT03288493|579898074|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
160595817|NCT03288493|579898075|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
160465199|NCT03656718|579432341|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
160465200|NCT03656718|579432342|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
160465201|NCT03656718|579432343|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
160465202|NCT03656718|579432337|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
160465203|NCT03656718|579432338|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
160465204|NCT03656718|579432339|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
160465205|NCT03656718|579432340|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
160465206|NCT03656718|579432341|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
160465207|NCT03656718|579432342|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
160658867|NCT04455633|580133221|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
160658868|NCT04455633|580133219|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
160658869|NCT04455633|580133220|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
160658870|NCT04455633|580133221|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
160658871|NCT04455633|580133219|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
160658872|NCT04455633|580133220|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
160658873|NCT04455633|580133221|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
160658874|NCT04455633|580133219|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
160658875|NCT04455633|580133220|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
160658876|NCT04455633|580133221|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
160658877|NCT01648166|580133222|FG000|Overall Study|inadequate toenail samples|53|||
160658878|NCT01648166|580133223|FG001|Overall Study|inadequate toenail samples|100|||
160658879|NCT01492361|580133224|FG000|Overall Study|Withdrawal by Subject|281|||
160658880|NCT01492361|580133225|FG001|Overall Study|Withdrawal by Subject|297|||
160658881|NCT01492361|580133224|FG000|Overall Study|Physician Decision|12|||
160658882|NCT01492361|580133225|FG001|Overall Study|Physician Decision|12|||
160658883|NCT01492361|580133224|FG000|Overall Study|Lost to Follow-up|6|||
160658884|NCT01492361|580133225|FG001|Overall Study|Lost to Follow-up|13|||
160658885|NCT01492361|580133224|FG000|Overall Study|Other than specified above|106|||
160658886|NCT01492361|580133225|FG001|Overall Study|Other than specified above|138|||
160658887|NCT01315249|580133226|FG000|Overall Study|Adverse Event|22|||
160658888|NCT01315249|580133227|FG001|Overall Study|Adverse Event|26|||
160658889|NCT01315249|580133226|FG000|Overall Study|Withdrawal by Subject|11|||
160658890|NCT01315249|580133227|FG001|Overall Study|Withdrawal by Subject|10|||
160658891|NCT01315249|580133226|FG000|Overall Study|Protocol Violation|8|||
160658892|NCT01315249|580133227|FG001|Overall Study|Protocol Violation|5|||
160465208|NCT03656718|579432343|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
160658893|NCT01315249|580133226|FG000|Overall Study|Abnormal test results|1|||
160658894|NCT01315249|580133227|FG001|Overall Study|Abnormal test results|2|||
160658895|NCT01315249|580133226|FG000|Overall Study|Administrative problems|1|||
160658896|NCT01315249|580133227|FG001|Overall Study|Administrative problems|0|||
160658897|NCT01315249|580133226|FG000|Overall Study|inability to use device|1|||
160658898|NCT01315249|580133227|FG001|Overall Study|inability to use device|0|||
160658899|NCT01315249|580133226|FG000|Overall Study|Lack of Efficacy|0|||
160595818|NCT03288493|579898076|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
160595819|NCT03288493|579898077|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
160595820|NCT03288493|579898078|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
160595821|NCT03288493|579898079|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
160595822|NCT03288493|579898080|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
160595823|NCT03288493|579898074|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
160595824|NCT03288493|579898075|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
160595825|NCT03288493|579898076|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
160595826|NCT03288493|579898077|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
160595827|NCT03288493|579898078|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
160595828|NCT03288493|579898079|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
160595829|NCT03288493|579898080|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
160595830|NCT03288493|579898074|FG000|Overall Study|Death|2|||
160595831|NCT03288493|579898075|FG001|Overall Study|Death|0|||
160595832|NCT03288493|579898076|FG002|Overall Study|Death|0|||
160595833|NCT03288493|579898077|FG003|Overall Study|Death|0|||
160595834|NCT03288493|579898078|FG004|Overall Study|Death|0|||
160465209|NCT03656718|579432337|FG000|Treatment Period Part C|Disease progression|0|||
160465210|NCT03656718|579432338|FG001|Treatment Period Part C|Disease progression|0|||
160465211|NCT03656718|579432339|FG002|Treatment Period Part C|Disease progression|0|||
160465212|NCT03656718|579432340|FG003|Treatment Period Part C|Disease progression|0|||
160465213|NCT03656718|579432341|FG004|Treatment Period Part C|Disease progression|12|||
160465214|NCT03656718|579432342|FG005|Treatment Period Part C|Disease progression|0|||
160465215|NCT03656718|579432343|FG006|Treatment Period Part C|Disease progression|0|||
160465216|NCT03656718|579432337|FG000|Treatment Period Part C|Death|0|||
160465217|NCT03656718|579432338|FG001|Treatment Period Part C|Death|0|||
160658900|NCT01315249|580133227|FG001|Overall Study|Lack of Efficacy|1|||
160465218|NCT03656718|579432339|FG002|Treatment Period Part C|Death|0|||
160465219|NCT03656718|579432340|FG003|Treatment Period Part C|Death|0|||
160465220|NCT03656718|579432341|FG004|Treatment Period Part C|Death|1|||
160465221|NCT03656718|579432342|FG005|Treatment Period Part C|Death|0|||
160465222|NCT03656718|579432343|FG006|Treatment Period Part C|Death|0|||
160465223|NCT03656718|579432337|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
160465224|NCT03656718|579432338|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
160465225|NCT03656718|579432339|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
160465226|NCT03656718|579432340|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
160465227|NCT03656718|579432341|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
160465228|NCT03656718|579432342|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
160465229|NCT03656718|579432343|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
160465230|NCT03656718|579432337|FG000|Treatment Period Part C|Other reasons|0|||
160465231|NCT03656718|579432338|FG001|Treatment Period Part C|Other reasons|0|||
160465232|NCT03656718|579432339|FG002|Treatment Period Part C|Other reasons|0|||
160465233|NCT03656718|579432340|FG003|Treatment Period Part C|Other reasons|0|||
160465234|NCT03656718|579432341|FG004|Treatment Period Part C|Other reasons|1|||
160465235|NCT03656718|579432342|FG005|Treatment Period Part C|Other reasons|0|||
160465236|NCT03656718|579432343|FG006|Treatment Period Part C|Other reasons|0|||
160465237|NCT03656718|579432337|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
160465238|NCT03656718|579432338|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
160465239|NCT03656718|579432339|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
160465240|NCT03656718|579432340|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
160465241|NCT03656718|579432341|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
160465242|NCT03656718|579432342|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
160465243|NCT03656718|579432343|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
160465244|NCT06191679|579432344|FG000|Baseline|Lost to Follow-up|1|||
160465245|NCT06191679|579432345|FG001|Baseline|Lost to Follow-up|0|||
160465246|NCT06191679|579432346|FG002|Baseline|Lost to Follow-up|1|||
160465247|NCT06191679|579432347|FG003|Baseline|Lost to Follow-up|0|||
160465248|NCT06191679|579432344|FG000|Allocation to Group|Withdrawal by Subject|0|||
160465249|NCT06191679|579432345|FG001|Allocation to Group|Withdrawal by Subject|1|||
160595835|NCT03288493|579898079|FG005|Overall Study|Death|0|||
160595836|NCT03288493|579898080|FG006|Overall Study|Death|0|||
160595837|NCT03288493|579898074|FG000|Overall Study|other reason not listed above|2|||
160595838|NCT03288493|579898075|FG001|Overall Study|other reason not listed above|0|||
160595839|NCT03288493|579898076|FG002|Overall Study|other reason not listed above|0|||
160595840|NCT03288493|579898077|FG003|Overall Study|other reason not listed above|0|||
160595841|NCT03288493|579898078|FG004|Overall Study|other reason not listed above|0|||
160595842|NCT03288493|579898079|FG005|Overall Study|other reason not listed above|0|||
160595843|NCT03288493|579898080|FG006|Overall Study|other reason not listed above|0|||
160465250|NCT06191679|579432346|FG002|Allocation to Group|Withdrawal by Subject|2|||
160595844|NCT05905601|579899812|FG000|Overall Study|Lost to Follow-up|1|||
160595845|NCT05905601|579899813|FG001|Overall Study|Lost to Follow-up|3|||
160595846|NCT03024255|579899814|FG000|Overall Study|Adverse Event|1|||
160595847|NCT03024255|579899815|FG001|Overall Study|Adverse Event|4|||
160595848|NCT03024255|579899816|FG002|Overall Study|Adverse Event|8|||
160595849|NCT03024255|579899817|FG003|Overall Study|Adverse Event|0|||
160595850|NCT03024255|579899814|FG000|Overall Study|Withdrawal by Subject|3|||
160465251|NCT06191679|579432347|FG003|Allocation to Group|Withdrawal by Subject|0|||
160465252|NCT06191679|579432344|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
160465253|NCT06191679|579432345|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
160465254|NCT06191679|579432346|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
160465255|NCT06191679|579432347|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
160465256|NCT06191679|579432344|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
160465257|NCT06191679|579432345|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
160465258|NCT06191679|579432346|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
160465259|NCT06191679|579432347|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
160465260|NCT06191679|579432344|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
160465261|NCT06191679|579432345|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
160465262|NCT06191679|579432346|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
160465263|NCT06191679|579432347|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
160465264|NCT05827068|579432357|FG000|Overall Study|Lost to Follow-up|1|||
160465265|NCT05827068|579432358|FG001|Overall Study|Lost to Follow-up|4|||
160465266|NCT05827068|579432359|FG002|Overall Study|Lost to Follow-up|1|||
160465267|NCT05827068|579432360|FG003|Overall Study|Lost to Follow-up|1|||
160465268|NCT05827068|579432361|FG004|Overall Study|Lost to Follow-up|2|||
160465269|NCT05827068|579432362|FG005|Overall Study|Lost to Follow-up|4|||
160465270|NCT05827068|579432363|FG006|Overall Study|Lost to Follow-up|1|||
160465271|NCT05827068|579432357|FG000|Overall Study|Withdrawal by Subject|4|||
160465272|NCT05827068|579432358|FG001|Overall Study|Withdrawal by Subject|0|||
160465273|NCT05827068|579432359|FG002|Overall Study|Withdrawal by Subject|1|||
160465274|NCT05827068|579432360|FG003|Overall Study|Withdrawal by Subject|2|||
160465275|NCT05827068|579432361|FG004|Overall Study|Withdrawal by Subject|3|||
160465276|NCT05827068|579432362|FG005|Overall Study|Withdrawal by Subject|0|||
160465277|NCT05827068|579432363|FG006|Overall Study|Withdrawal by Subject|1|||
160465278|NCT05827068|579432357|FG000|Overall Study|Physician Decision|0|||
160465279|NCT05827068|579432358|FG001|Overall Study|Physician Decision|0|||
160465280|NCT05827068|579432359|FG002|Overall Study|Physician Decision|0|||
160465281|NCT05827068|579432360|FG003|Overall Study|Physician Decision|0|||
160465282|NCT05827068|579432361|FG004|Overall Study|Physician Decision|1|||
160465283|NCT05827068|579432362|FG005|Overall Study|Physician Decision|0|||
160465284|NCT05827068|579432363|FG006|Overall Study|Physician Decision|1|||
160465285|NCT05827068|579432357|FG000|Overall Study|Other Than Specified|0|||
160465286|NCT05827068|579432358|FG001|Overall Study|Other Than Specified|1|||
160465287|NCT05827068|579432359|FG002|Overall Study|Other Than Specified|0|||
160465288|NCT05827068|579432360|FG003|Overall Study|Other Than Specified|0|||
160465289|NCT05827068|579432361|FG004|Overall Study|Other Than Specified|0|||
160465290|NCT05827068|579432362|FG005|Overall Study|Other Than Specified|0|||
160465291|NCT05827068|579432363|FG006|Overall Study|Other Than Specified|0|||
160465292|NCT05786612|579432369|FG000|Overall Study|Adverse Event|1|||
160465293|NCT05786612|579432370|FG001|Overall Study|Adverse Event|2|||
160465294|NCT05786612|579432369|FG000|Overall Study|one screening failure|0|||
160465295|NCT05786612|579432370|FG001|Overall Study|one screening failure|2|||
160465296|NCT05630833|579432375|FG000|Overall Study|Adverse Event|3|||
160465297|NCT05630833|579432376|FG001|Overall Study|Adverse Event|0|||
160465298|NCT05630833|579432375|FG000|Overall Study|Lack of Efficacy|0|||
160465299|NCT05630833|579432376|FG001|Overall Study|Lack of Efficacy|1|||
160465300|NCT05630833|579432375|FG000|Overall Study|Lost to Follow-up|1|||
160465301|NCT05630833|579432376|FG001|Overall Study|Lost to Follow-up|0|||
160465302|NCT05630833|579432375|FG000|Overall Study|Withdrawal by Subject|3|||
160465303|NCT05630833|579432376|FG001|Overall Study|Withdrawal by Subject|1|||
160465304|NCT00490139|579432377|FG000|Overall Study|Lost to Follow-up|249|||
160465305|NCT00490139|579432378|FG001|Overall Study|Lost to Follow-up|216|||
160465306|NCT00490139|579432379|FG002|Overall Study|Lost to Follow-up|205|||
160465307|NCT00490139|579432380|FG003|Overall Study|Lost to Follow-up|229|||
160465308|NCT00490139|579432377|FG000|Overall Study|Withdrawal by Subject|333|||
160465309|NCT00490139|579432378|FG001|Overall Study|Withdrawal by Subject|322|||
160465310|NCT00490139|579432379|FG002|Overall Study|Withdrawal by Subject|396|||
160465311|NCT00490139|579432380|FG003|Overall Study|Withdrawal by Subject|295|||
160465312|NCT00490139|579432377|FG000|Overall Study|Patient did not sign ICF 12|169|||
160465313|NCT00490139|579432378|FG001|Overall Study|Patient did not sign ICF 12|176|||
160465314|NCT00490139|579432379|FG002|Overall Study|Patient did not sign ICF 12|139|||
160465315|NCT00490139|579432380|FG003|Overall Study|Patient did not sign ICF 12|167|||
160595851|NCT03024255|579899815|FG001|Overall Study|Withdrawal by Subject|1|||
160465316|NCT00490139|579432377|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
160465317|NCT00490139|579432378|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
160465318|NCT00490139|579432379|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
160465319|NCT00490139|579432380|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
160465320|NCT00490139|579432377|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
160465321|NCT00490139|579432378|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
160465322|NCT00490139|579432379|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
160465323|NCT00490139|579432380|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
160465324|NCT00490139|579432377|FG000|Overall Study|Other reasons as defined per protocol|98|||
160465325|NCT00490139|579432378|FG001|Overall Study|Other reasons as defined per protocol|84|||
160465326|NCT00490139|579432379|FG002|Overall Study|Other reasons as defined per protocol|82|||
160465327|NCT00490139|579432380|FG003|Overall Study|Other reasons as defined per protocol|105|||
160465328|NCT02386098|579433779|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
160465329|NCT02386098|579433780|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
160465330|NCT02386098|579433781|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
160465331|NCT02386098|579433782|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
160465332|NCT02386098|579433783|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
160465333|NCT02386098|579433779|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
160465334|NCT02386098|579433780|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
160465335|NCT02386098|579433781|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
160465336|NCT02386098|579433782|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
160465337|NCT02386098|579433783|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
160465338|NCT02386098|579433779|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
160465339|NCT02386098|579433780|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
160465340|NCT02386098|579433781|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
160465341|NCT02386098|579433782|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
160658901|NCT01315249|580133226|FG000|Overall Study|Lost to Follow-up|0|||
160465342|NCT02386098|579433783|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
160465343|NCT02386098|579433779|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
160465344|NCT02386098|579433780|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
160658902|NCT01315249|580133227|FG001|Overall Study|Lost to Follow-up|2|||
160595852|NCT03024255|579899816|FG002|Overall Study|Withdrawal by Subject|0|||
160595853|NCT03024255|579899817|FG003|Overall Study|Withdrawal by Subject|3|||
160465345|NCT02386098|579433781|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
160595854|NCT03024255|579899814|FG000|Overall Study|Protocol Violation|0|||
160595855|NCT03024255|579899815|FG001|Overall Study|Protocol Violation|0|||
160595856|NCT03024255|579899816|FG002|Overall Study|Protocol Violation|2|||
160595857|NCT03024255|579899817|FG003|Overall Study|Protocol Violation|0|||
160595858|NCT03024255|579899814|FG000|Overall Study|Lost to Follow-up|1|||
160595859|NCT03024255|579899815|FG001|Overall Study|Lost to Follow-up|2|||
160595860|NCT03024255|579899816|FG002|Overall Study|Lost to Follow-up|1|||
160595861|NCT03024255|579899817|FG003|Overall Study|Lost to Follow-up|1|||
160595862|NCT03024255|579899814|FG000|Overall Study|Lack of Efficacy|1|||
160595863|NCT03024255|579899815|FG001|Overall Study|Lack of Efficacy|0|||
160595864|NCT03024255|579899816|FG002|Overall Study|Lack of Efficacy|0|||
160595865|NCT03024255|579899817|FG003|Overall Study|Lack of Efficacy|0|||
160595866|NCT03024255|579899814|FG000|Overall Study|Protocol Noncompliance|1|||
160595867|NCT03024255|579899815|FG001|Overall Study|Protocol Noncompliance|1|||
160595868|NCT03024255|579899816|FG002|Overall Study|Protocol Noncompliance|0|||
160465346|NCT02386098|579433782|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
160465347|NCT02386098|579433783|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
160465348|NCT02386098|579433779|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
160465349|NCT02386098|579433780|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
160465350|NCT02386098|579433781|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
160465351|NCT02386098|579433782|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
160465352|NCT02386098|579433783|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
160465353|NCT02386098|579433779|FG000|Stage 1 (96 Weeks)|Other|1|||
160465354|NCT02386098|579433780|FG001|Stage 1 (96 Weeks)|Other|0|||
160465355|NCT02386098|579433781|FG002|Stage 1 (96 Weeks)|Other|0|||
160465356|NCT02386098|579433782|FG003|Stage 1 (96 Weeks)|Other|0|||
160465357|NCT02386098|579433783|FG004|Stage 1 (96 Weeks)|Other|0|||
160465358|NCT02386098|579433779|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
160465359|NCT02386098|579433780|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
160465360|NCT02386098|579433781|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
160465361|NCT02386098|579433782|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
160465362|NCT02386098|579433783|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
160465363|NCT05250115|579433786|FG000|Overall Study|Premature study end|40|||
160465364|NCT05250115|579433786|FG000|Overall Study|Adverse Event|8|||
160465365|NCT05250115|579433786|FG000|Overall Study|Lost to Follow-up|7|||
160465366|NCT05250115|579433786|FG000|Overall Study|Withdrawal by Subject|6|||
160465367|NCT05250115|579433786|FG000|Overall Study|Withdrawal of informed consent|1|||
160465368|NCT05250115|579433786|FG000|Overall Study|Other|7|||
160465369|NCT00890591|579433795|FG000|Overall Study|Lack of Efficacy|20|||
160465370|NCT00776009|579433800|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
160465371|NCT00776009|579433801|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
160465372|NCT00776009|579433802|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
160465373|NCT00776009|579433803|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
160658903|NCT01315249|580133226|FG000|Overall Study|Death|0|||
160465374|NCT00776009|579433804|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
160465375|NCT00776009|579433805|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
160465376|NCT00776009|579433800|FG000|Period 1: First Intervention|Protocol Violation|0|||
160465377|NCT00776009|579433801|FG001|Period 1: First Intervention|Protocol Violation|1|||
160465378|NCT00776009|579433802|FG002|Period 1: First Intervention|Protocol Violation|0|||
160465379|NCT00776009|579433803|FG003|Period 1: First Intervention|Protocol Violation|0|||
160465380|NCT00776009|579433804|FG004|Period 1: First Intervention|Protocol Violation|1|||
160465381|NCT00776009|579433805|FG005|Period 1: First Intervention|Protocol Violation|0|||
160465382|NCT00776009|579433800|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
160465383|NCT00776009|579433801|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
160465384|NCT00776009|579433802|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
160465385|NCT00776009|579433803|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
160465386|NCT00776009|579433804|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
160465387|NCT00776009|579433805|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
160465388|NCT00776009|579433800|FG000|Period 2: Second Intervention|Protocol Violation|1|||
160465389|NCT00776009|579433801|FG001|Period 2: Second Intervention|Protocol Violation|0|||
160465390|NCT00776009|579433802|FG002|Period 2: Second Intervention|Protocol Violation|1|||
160595869|NCT03024255|579899817|FG003|Overall Study|Protocol Noncompliance|1|||
160595870|NCT01415908|579899818|FG000|Overall Study|Withdrawal by Subject|1|||
160595871|NCT01415908|579899819|FG001|Overall Study|Withdrawal by Subject|0|||
160595872|NCT02685995|579899822|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
160595873|NCT02685995|579899823|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
160595874|NCT02384395|579899825|FG000|Overall Study|Physician Decision|4|||
160595875|NCT02384395|579899825|FG000|Overall Study|Withdrawal by Subject|3|||
160595876|NCT02384395|579899825|FG000|Overall Study|Lost to Follow-up|3|||
160595877|NCT01779648|579899826|FG000|Overall Study|Protocol Violation|1|||
160595878|NCT01779648|579899827|FG001|Overall Study|Protocol Violation|0|||
160595879|NCT01797445|579899828|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
160595880|NCT01797445|579899829|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
160595881|NCT01797445|579899828|FG000|Double-Blind Phase|Adverse Event|3|||
160595882|NCT01797445|579899829|FG001|Double-Blind Phase|Adverse Event|0|||
160595883|NCT01797445|579899828|FG000|Double-Blind Phase|Death|5|||
160595884|NCT01797445|579899829|FG001|Double-Blind Phase|Death|4|||
160595885|NCT01797445|579899828|FG000|Double-Blind Phase|Pregnancy|0|||
160595886|NCT01797445|579899829|FG001|Double-Blind Phase|Pregnancy|1|||
160465391|NCT00776009|579433803|FG003|Period 2: Second Intervention|Protocol Violation|0|||
160595887|NCT01797445|579899828|FG000|Double-Blind Phase|Lack of Efficacy|1|||
160595888|NCT01797445|579899829|FG001|Double-Blind Phase|Lack of Efficacy|2|||
160595889|NCT01797445|579899828|FG000|Double-Blind Phase|Investigator's Discretion|15|||
160465392|NCT00776009|579433804|FG004|Period 2: Second Intervention|Protocol Violation|0|||
160595890|NCT01797445|579899829|FG001|Double-Blind Phase|Investigator's Discretion|17|||
160595891|NCT01797445|579899828|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
160595892|NCT01797445|579899829|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
160595893|NCT01797445|579899828|FG000|Double-Blind Phase|Protocol Violation|0|||
160595894|NCT01797445|579899829|FG001|Double-Blind Phase|Protocol Violation|1|||
160595895|NCT01797445|579899828|FG000|Double-Blind Phase|Withdrew Consent|20|||
160595896|NCT01797445|579899829|FG001|Double-Blind Phase|Withdrew Consent|35|||
160595897|NCT01797445|579899828|FG000|Double-Blind Phase|Lost to Follow-up|34|||
160595898|NCT01797445|579899829|FG001|Double-Blind Phase|Lost to Follow-up|26|||
160595899|NCT01797445|579899828|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
160595900|NCT01797445|579899829|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
160595901|NCT00688545|579899830|FG000|Overall Study|Lost to Follow-up|1|||
160595902|NCT00688545|579899831|FG001|Overall Study|Lost to Follow-up|4|||
160595903|NCT00688545|579899830|FG000|Overall Study|Insurance/cost of drug|0|||
160595904|NCT00688545|579899831|FG001|Overall Study|Insurance/cost of drug|1|||
160595905|NCT00688545|579899830|FG000|Overall Study|Withdrawal by Subject|2|||
160595906|NCT00688545|579899831|FG001|Overall Study|Withdrawal by Subject|3|||
160595907|NCT00688545|579899830|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
160595908|NCT00688545|579899831|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
160595909|NCT01878097|579899832|FG000|Baseline|Surveys not fully completed|2497|||
160595910|NCT01878097|579899833|FG001|Baseline|Surveys not fully completed|1800|||
160595911|NCT01878097|579899832|FG000|Implementation Year 1|Surveys not fully completed|3202|||
160595912|NCT01878097|579899833|FG001|Implementation Year 1|Surveys not fully completed|2549|||
160595913|NCT01878097|579899832|FG000|Implementation Year 2|Surveys not fully completed|3281|||
160595914|NCT01878097|579899833|FG001|Implementation Year 2|Surveys not fully completed|2841|||
160595915|NCT01878097|579899832|FG000|Implementation Year 3|Surveys not fully completed|3494|||
160595916|NCT01878097|579899833|FG001|Implementation Year 3|Surveys not fully completed|2980|||
160595917|NCT01878097|579899832|FG000|Implementation Year 4|Surveys not fully completed|3604|||
160595918|NCT01878097|579899833|FG001|Implementation Year 4|Surveys not fully completed|3007|||
160595919|NCT01595438|579899836|FG000|Overall Study|Lost to Follow-up|20|||
160595920|NCT01595438|579899837|FG001|Overall Study|Lost to Follow-up|20|||
160595921|NCT01595438|579899836|FG000|Overall Study|Withdrawal by Subject|12|||
160595922|NCT01595438|579899837|FG001|Overall Study|Withdrawal by Subject|12|||
160595923|NCT01595438|579899836|FG000|Overall Study|Other Eligibility criteria|11|||
160595924|NCT01595438|579899837|FG001|Overall Study|Other Eligibility criteria|9|||
160595925|NCT00985738|579899839|FG000|Overall Study|Study closed prematurely|8|||
160595926|NCT00985738|579899840|FG001|Overall Study|Study closed prematurely|8|||
160595927|NCT02119026|579899845|FG000|1st-line Treatment|Adverse Event|9|||
160595928|NCT02119026|579899846|FG001|1st-line Treatment|Adverse Event|14|||
160595929|NCT02119026|579899845|FG000|1st-line Treatment|Physician Decision|3|||
160595930|NCT02119026|579899846|FG001|1st-line Treatment|Physician Decision|8|||
160595931|NCT02119026|579899845|FG000|1st-line Treatment|Withdrawal by Subject|4|||
160595932|NCT02119026|579899846|FG001|1st-line Treatment|Withdrawal by Subject|10|||
160595933|NCT02119026|579899845|FG000|1st-line Treatment|Patient condition or compliance|6|||
160595934|NCT02119026|579899846|FG001|1st-line Treatment|Patient condition or compliance|4|||
160595935|NCT02119026|579899845|FG000|1st-line Treatment|Surgery of metastases|2|||
160595936|NCT02119026|579899846|FG001|1st-line Treatment|Surgery of metastases|1|||
160595937|NCT02119026|579899845|FG000|1st-line Treatment|Death|2|||
160595938|NCT02119026|579899846|FG001|1st-line Treatment|Death|1|||
160595939|NCT02119026|579899845|FG000|2nd-line Treatment|Lost to Follow-up|2|||
160595940|NCT02119026|579899846|FG001|2nd-line Treatment|Lost to Follow-up|0|||
160595941|NCT02119026|579899845|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
160595942|NCT02119026|579899846|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
160595943|NCT02119026|579899845|FG000|2nd-line Treatment|Adverse Event|4|||
160595944|NCT02119026|579899846|FG001|2nd-line Treatment|Adverse Event|1|||
160595945|NCT00340834|579899849|FG000|Core Phase of Study|Adverse Event|26|||
160595946|NCT00340834|579899850|FG001|Core Phase of Study|Adverse Event|9|||
160595947|NCT00340834|579899851|FG002|Core Phase of Study|Adverse Event|9|||
160595948|NCT00340834|579899852|FG003|Core Phase of Study|Adverse Event|0|||
160595949|NCT00340834|579899853|FG004|Core Phase of Study|Adverse Event|0|||
160595950|NCT00340834|579899849|FG000|Core Phase of Study|Withdrawal by Subject|11|||
160595951|NCT00340834|579899850|FG001|Core Phase of Study|Withdrawal by Subject|9|||
160595952|NCT00340834|579899851|FG002|Core Phase of Study|Withdrawal by Subject|16|||
160595953|NCT00340834|579899852|FG003|Core Phase of Study|Withdrawal by Subject|0|||
160595954|NCT00340834|579899853|FG004|Core Phase of Study|Withdrawal by Subject|0|||
160595955|NCT00340834|579899849|FG000|Core Phase of Study|Administrative Problems|6|||
160595956|NCT00340834|579899850|FG001|Core Phase of Study|Administrative Problems|2|||
160595957|NCT00340834|579899851|FG002|Core Phase of Study|Administrative Problems|7|||
160595958|NCT00340834|579899852|FG003|Core Phase of Study|Administrative Problems|0|||
160658904|NCT01315249|580133227|FG001|Overall Study|Death|1|||
160595959|NCT00340834|579899853|FG004|Core Phase of Study|Administrative Problems|0|||
160658905|NCT03227445|580133228|FG000|Period 1 (28 Days)|Adverse Event|1|||
160658906|NCT03227445|580133229|FG001|Period 1 (28 Days)|Adverse Event|2|||
160595960|NCT00340834|579899849|FG000|Core Phase of Study|Lack of Efficacy|3|||
160595961|NCT00340834|579899850|FG001|Core Phase of Study|Lack of Efficacy|3|||
160595962|NCT00340834|579899851|FG002|Core Phase of Study|Lack of Efficacy|7|||
160595963|NCT00340834|579899852|FG003|Core Phase of Study|Lack of Efficacy|0|||
160595964|NCT00340834|579899853|FG004|Core Phase of Study|Lack of Efficacy|0|||
160595965|NCT00340834|579899849|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
160595966|NCT00340834|579899850|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
160595967|NCT00340834|579899851|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
160595968|NCT00340834|579899852|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
160595969|NCT00340834|579899853|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
160595970|NCT00340834|579899849|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
160595971|NCT00340834|579899850|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
160595972|NCT00340834|579899851|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
160595973|NCT00340834|579899852|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
160595974|NCT00340834|579899853|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
160595975|NCT00340834|579899849|FG000|Core Phase of Study|Lost to Follow-up|1|||
160595976|NCT00340834|579899850|FG001|Core Phase of Study|Lost to Follow-up|1|||
160595977|NCT00340834|579899851|FG002|Core Phase of Study|Lost to Follow-up|4|||
160595978|NCT00340834|579899852|FG003|Core Phase of Study|Lost to Follow-up|0|||
160595979|NCT00340834|579899853|FG004|Core Phase of Study|Lost to Follow-up|0|||
160595980|NCT00340834|579899849|FG000|Core Phase of Study|Death|2|||
160595981|NCT00340834|579899850|FG001|Core Phase of Study|Death|0|||
160595982|NCT00340834|579899851|FG002|Core Phase of Study|Death|0|||
160595983|NCT00340834|579899852|FG003|Core Phase of Study|Death|0|||
160595984|NCT00340834|579899853|FG004|Core Phase of Study|Death|0|||
160595985|NCT00340834|579899849|FG000|Core Phase of Study|Protocol Violation|0|||
160595986|NCT00340834|579899850|FG001|Core Phase of Study|Protocol Violation|0|||
160595987|NCT00340834|579899851|FG002|Core Phase of Study|Protocol Violation|2|||
160595988|NCT00340834|579899852|FG003|Core Phase of Study|Protocol Violation|0|||
160595989|NCT00340834|579899853|FG004|Core Phase of Study|Protocol Violation|0|||
160595990|NCT00340834|579899849|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
160595991|NCT00340834|579899850|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
160595992|NCT00340834|579899851|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
160595993|NCT00340834|579899852|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
160595994|NCT00340834|579899853|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
160595995|NCT00340834|579899849|FG000|Extension Phase of Study|Subject withdrew consent|26|||
160595996|NCT00340834|579899850|FG001|Extension Phase of Study|Subject withdrew consent|31|||
160595997|NCT00340834|579899851|FG002|Extension Phase of Study|Subject withdrew consent|0|||
160595998|NCT00340834|579899852|FG003|Extension Phase of Study|Subject withdrew consent|12|||
160595999|NCT00340834|579899853|FG004|Extension Phase of Study|Subject withdrew consent|15|||
160596000|NCT00340834|579899849|FG000|Extension Phase of Study|Adverse Event|21|||
160596001|NCT00340834|579899850|FG001|Extension Phase of Study|Adverse Event|22|||
160596002|NCT00340834|579899851|FG002|Extension Phase of Study|Adverse Event|0|||
160596003|NCT00340834|579899852|FG003|Extension Phase of Study|Adverse Event|19|||
160596004|NCT00340834|579899853|FG004|Extension Phase of Study|Adverse Event|7|||
160596005|NCT00340834|579899849|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
160596006|NCT00340834|579899850|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
160596007|NCT00340834|579899851|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
160596008|NCT00340834|579899852|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
160596009|NCT00340834|579899853|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
160596010|NCT00340834|579899849|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
160596011|NCT00340834|579899850|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
160596012|NCT00340834|579899851|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
160596013|NCT00340834|579899852|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
160596014|NCT00340834|579899853|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
160596015|NCT00340834|579899849|FG000|Extension Phase of Study|Lost to Follow-up|1|||
160596016|NCT00340834|579899850|FG001|Extension Phase of Study|Lost to Follow-up|1|||
160596017|NCT00340834|579899851|FG002|Extension Phase of Study|Lost to Follow-up|0|||
160596018|NCT00340834|579899852|FG003|Extension Phase of Study|Lost to Follow-up|2|||
160596019|NCT00340834|579899853|FG004|Extension Phase of Study|Lost to Follow-up|3|||
160596020|NCT00340834|579899849|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
160596021|NCT00340834|579899850|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
160596022|NCT00340834|579899851|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
160596023|NCT00340834|579899852|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
160596024|NCT00340834|579899853|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
160596025|NCT00340834|579899849|FG000|Extension Phase of Study|Administrative problems|3|||
160596026|NCT00340834|579899850|FG001|Extension Phase of Study|Administrative problems|0|||
160596027|NCT00340834|579899851|FG002|Extension Phase of Study|Administrative problems|0|||
160596028|NCT00340834|579899852|FG003|Extension Phase of Study|Administrative problems|1|||
160596029|NCT00340834|579899853|FG004|Extension Phase of Study|Administrative problems|1|||
160596030|NCT00340834|579899849|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
160596031|NCT00340834|579899850|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
160596032|NCT00340834|579899851|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
160596033|NCT00340834|579899852|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
160596034|NCT00340834|579899853|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
160596035|NCT00340834|579899849|FG000|Extension Phase of Study|Protocol Violation|3|||
160596036|NCT00340834|579899850|FG001|Extension Phase of Study|Protocol Violation|0|||
160596037|NCT00340834|579899851|FG002|Extension Phase of Study|Protocol Violation|0|||
160596038|NCT00340834|579899852|FG003|Extension Phase of Study|Protocol Violation|0|||
160596039|NCT00340834|579899853|FG004|Extension Phase of Study|Protocol Violation|0|||
160596040|NCT00340834|579899849|FG000|Extension Phase of Study|Death|0|||
160596041|NCT00340834|579899850|FG001|Extension Phase of Study|Death|0|||
160596042|NCT00340834|579899851|FG002|Extension Phase of Study|Death|0|||
160596043|NCT00340834|579899852|FG003|Extension Phase of Study|Death|0|||
160596044|NCT00340834|579899853|FG004|Extension Phase of Study|Death|1|||
160596045|NCT00291499|579899854|FG000|Overall Study|Adverse Event|3|||
160596046|NCT00291499|579899855|FG001|Overall Study|Adverse Event|8|||
160596047|NCT00291499|579899854|FG000|Overall Study|Change to other therapy|2|||
160596048|NCT00291499|579899855|FG001|Overall Study|Change to other therapy|1|||
160596049|NCT00291499|579899854|FG000|Overall Study|Intercurrent illness|1|||
160596050|NCT00291499|579899855|FG001|Overall Study|Intercurrent illness|0|||
160596051|NCT00291499|579899854|FG000|Overall Study|Protocol Violation|2|||
160596052|NCT00291499|579899855|FG001|Overall Study|Protocol Violation|2|||
160596053|NCT00291499|579899854|FG000|Overall Study|Other reasons|1|||
160596054|NCT00291499|579899855|FG001|Overall Study|Other reasons|4|||
160596055|NCT02786836|579899856|FG000|Overall Study|Death|1|||
160596056|NCT02786836|579899856|FG000|Overall Study|Lack of Efficacy|2|||
160596057|NCT02786836|579899856|FG000|Overall Study|Protocol Violation|3|||
160596058|NCT02786836|579899856|FG000|Overall Study|Withdrawal by Subject|3|||
160596059|NCT02786836|579899856|FG000|Overall Study|Liver Transplantation|2|||
160596060|NCT02786836|579899856|FG000|Overall Study|Device or Pharmacy Issues|3|||
160596061|NCT01143714|579899858|FG000|Overall Study|Adverse Event|4|||
160596062|NCT01143714|579899859|FG001|Overall Study|Adverse Event|2|||
160596063|NCT01143714|579899858|FG000|Overall Study|Withdrawal by Subject|1|||
160596064|NCT01143714|579899859|FG001|Overall Study|Withdrawal by Subject|0|||
160596065|NCT01143714|579899858|FG000|Overall Study|Subject non-compliance|0|||
160596066|NCT01143714|579899859|FG001|Overall Study|Subject non-compliance|1|||
160596067|NCT01143714|579899858|FG000|Overall Study|wound closed = deemed healed|1|||
160596068|NCT01143714|579899859|FG001|Overall Study|wound closed = deemed healed|0|||
160596069|NCT01143714|579899858|FG000|Overall Study|wound size increased|1|||
160596070|NCT01143714|579899859|FG001|Overall Study|wound size increased|0|||
160596071|NCT04190186|579899866|FG000|Overall Study|ILR is no longer functioning|0|||
160596072|NCT04190186|579899867|FG001|Overall Study|ILR is no longer functioning|1|||
160596073|NCT04190186|579899866|FG000|Overall Study|Lost to Follow-up|0|||
160596074|NCT04190186|579899867|FG001|Overall Study|Lost to Follow-up|1|||
160596075|NCT04190186|579899866|FG000|Overall Study|Withdrawal by Subject|2|||
160596076|NCT04190186|579899867|FG001|Overall Study|Withdrawal by Subject|0|||
160596077|NCT04190186|579899866|FG000|Overall Study|Subject choice to explant|1|||
160596078|NCT04190186|579899867|FG001|Overall Study|Subject choice to explant|0|||
160596079|NCT04190186|579899866|FG000|Overall Study|Physician Decision|0|||
160596080|NCT04190186|579899867|FG001|Overall Study|Physician Decision|1|||
160596081|NCT04190186|579899866|FG000|Overall Study|Study was stopped|4|||
160596082|NCT04190186|579899867|FG001|Overall Study|Study was stopped|5|||
160596083|NCT01381718|579899868|FG000|Overall Study|Withdrawal by Subject|2|||
160596084|NCT01381718|579899869|FG001|Overall Study|Withdrawal by Subject|5|||
160658907|NCT03227445|580133230|FG002|Period 1 (28 Days)|Adverse Event|0|||
160596085|NCT01381718|579899868|FG000|Overall Study|Lost to Follow-up|3|||
160596086|NCT01381718|579899869|FG001|Overall Study|Lost to Follow-up|5|||
160596087|NCT01381718|579899868|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
160596088|NCT01381718|579899869|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
160596089|NCT03017846|579899870|FG000|Overall Study|Lost to Follow-up|3|||
160596090|NCT03017846|579899870|FG000|Overall Study|Adverse Event|2|||
160596091|NCT00992186|579899873|FG000|Overall Study|Withdrawal by Subject|2|||
160596092|NCT00992186|579899873|FG000|Overall Study|Protocol Violation|1|||
160596093|NCT00992186|579899873|FG000|Overall Study|Physician Decision|1|||
160596094|NCT00992186|579899873|FG000|Overall Study|Adverse Event|9|||
160596095|NCT00992186|579899873|FG000|Overall Study|Progressive Disease|30|||
160596096|NCT00992186|579899873|FG000|Overall Study|Refusal To Receive Study Agent|3|||
160596097|NCT00171314|579899875|FG000|Overall Study|Adverse Event|44|||
160596098|NCT00171314|579899876|FG001|Overall Study|Adverse Event|41|||
160596099|NCT00171314|579899875|FG000|Overall Study|Lack of Efficacy|19|||
160596100|NCT00171314|579899876|FG001|Overall Study|Lack of Efficacy|14|||
160596101|NCT00171314|579899875|FG000|Overall Study|Withdrawal by Subject|9|||
160596102|NCT00171314|579899876|FG001|Overall Study|Withdrawal by Subject|6|||
160596103|NCT00171314|579899875|FG000|Overall Study|Abnormal Test Procedure Results|9|||
160596104|NCT00171314|579899876|FG001|Overall Study|Abnormal Test Procedure Results|3|||
160596105|NCT00171314|579899875|FG000|Overall Study|Protocol Violation|3|||
160596106|NCT00171314|579899876|FG001|Overall Study|Protocol Violation|7|||
160596107|NCT00171314|579899875|FG000|Overall Study|Administrative Problems|4|||
160596108|NCT00171314|579899876|FG001|Overall Study|Administrative Problems|3|||
160596109|NCT00171314|579899875|FG000|Overall Study|Lost to Follow-up|1|||
160596110|NCT00171314|579899876|FG001|Overall Study|Lost to Follow-up|3|||
160596111|NCT00171314|579899875|FG000|Overall Study|Death|2|||
160596112|NCT00171314|579899876|FG001|Overall Study|Death|1|||
160596113|NCT00318565|579899877|FG000|Overall Study|Excluded per protocol|24|||
160596114|NCT00493467|579899878|FG000|Overall Study|Death|1|||
160596115|NCT01409993|579899879|FG000|Overall Study|Adverse Event|4|||
160596116|NCT01409993|579899880|FG001|Overall Study|Adverse Event|4|||
160596117|NCT01409993|579899881|FG002|Overall Study|Adverse Event|3|||
160596118|NCT01409993|579899882|FG003|Overall Study|Adverse Event|1|||
160596119|NCT01409993|579899879|FG000|Overall Study|Withdrawal by Subject|0|||
160596120|NCT01409993|579899880|FG001|Overall Study|Withdrawal by Subject|0|||
160596121|NCT01409993|579899881|FG002|Overall Study|Withdrawal by Subject|0|||
160596122|NCT01409993|579899882|FG003|Overall Study|Withdrawal by Subject|4|||
160596123|NCT01409993|579899879|FG000|Overall Study|Lost to Follow-up|0|||
160596124|NCT01409993|579899880|FG001|Overall Study|Lost to Follow-up|1|||
160596125|NCT01409993|579899881|FG002|Overall Study|Lost to Follow-up|0|||
160596126|NCT01409993|579899882|FG003|Overall Study|Lost to Follow-up|0|||
160596127|NCT00830960|579899883|FG000|Overall Study|Death|5|||
160596128|NCT00830960|579899884|FG001|Overall Study|Death|4|||
160596129|NCT00830960|579899885|FG002|Overall Study|Death|3|||
160596130|NCT00830960|579899886|FG003|Overall Study|Death|2|||
160596131|NCT00830960|579899887|FG004|Overall Study|Death|6|||
160596132|NCT00830960|579899888|FG005|Overall Study|Death|1|||
160596133|NCT00830960|579899883|FG000|Overall Study|Lost to Follow-up|1|||
160596134|NCT00830960|579899884|FG001|Overall Study|Lost to Follow-up|1|||
160596135|NCT00830960|579899885|FG002|Overall Study|Lost to Follow-up|1|||
160596136|NCT00830960|579899886|FG003|Overall Study|Lost to Follow-up|0|||
160596137|NCT00830960|579899887|FG004|Overall Study|Lost to Follow-up|0|||
160596138|NCT00830960|579899888|FG005|Overall Study|Lost to Follow-up|1|||
160596139|NCT00830960|579899883|FG000|Overall Study|Withdrawal by Subject|19|||
160596140|NCT00830960|579899884|FG001|Overall Study|Withdrawal by Subject|19|||
160596141|NCT00830960|579899885|FG002|Overall Study|Withdrawal by Subject|18|||
160596142|NCT00830960|579899886|FG003|Overall Study|Withdrawal by Subject|23|||
160596143|NCT00830960|579899887|FG004|Overall Study|Withdrawal by Subject|16|||
160596144|NCT00830960|579899888|FG005|Overall Study|Withdrawal by Subject|21|||
160596145|NCT00830960|579899883|FG000|Overall Study|Sponsor Decision|1|||
160596146|NCT00830960|579899884|FG001|Overall Study|Sponsor Decision|2|||
160596147|NCT00830960|579899885|FG002|Overall Study|Sponsor Decision|3|||
160596148|NCT00830960|579899886|FG003|Overall Study|Sponsor Decision|4|||
160596149|NCT00830960|579899887|FG004|Overall Study|Sponsor Decision|5|||
160596150|NCT00830960|579899888|FG005|Overall Study|Sponsor Decision|7|||
160596151|NCT00830960|579899883|FG000|Overall Study|No study drug received|7|||
160596152|NCT00830960|579899884|FG001|Overall Study|No study drug received|2|||
160596153|NCT00830960|579899885|FG002|Overall Study|No study drug received|4|||
160596154|NCT00830960|579899886|FG003|Overall Study|No study drug received|3|||
160596155|NCT00830960|579899887|FG004|Overall Study|No study drug received|5|||
160596156|NCT00830960|579899888|FG005|Overall Study|No study drug received|7|||
160596157|NCT03074149|579899889|FG000|Overall Study|Reason unknown|22|||
160596158|NCT03074149|579899890|FG001|Overall Study|Reason unknown|35|||
160596159|NCT03074149|579899889|FG000|Overall Study|Death|10|||
160596160|NCT03074149|579899890|FG001|Overall Study|Death|45|||
160596161|NCT02855450|579899892|FG000|Overall Study|Adverse Event|1|||
160596162|NCT02855450|579899893|FG001|Overall Study|Adverse Event|0|||
160596163|NCT02855450|579899892|FG000|Overall Study|Lost to Follow-up|4|||
160596164|NCT02855450|579899893|FG001|Overall Study|Lost to Follow-up|0|||
160596165|NCT00225212|579899896|FG000|Overall Study|Disease progression|2|||
160596166|NCT00225212|579899896|FG000|Overall Study|Death|1|||
160596167|NCT00225212|579899896|FG000|Overall Study|Adverse Event|2|||
160596168|NCT00225212|579899896|FG000|Overall Study|Intercurrent illness|1|||
160465393|NCT00776009|579433805|FG005|Period 2: Second Intervention|Protocol Violation|0|||
160465394|NCT00776009|579433800|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
160465395|NCT00776009|579433801|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
160465396|NCT00776009|579433802|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
160465397|NCT00776009|579433803|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
160465398|NCT00776009|579433804|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
160465399|NCT00776009|579433805|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
160465400|NCT01536093|579433808|FG000|Overall Study|Death|1|||
160465401|NCT01536093|579433809|FG001|Overall Study|Death|2|||
160465402|NCT01536093|579433808|FG000|Overall Study|absence of maternal colostrum|2|||
160465403|NCT01536093|579433809|FG001|Overall Study|absence of maternal colostrum|0|||
160465404|NCT01536093|579433808|FG000|Overall Study|Withdrawal by Subject|0|||
160465405|NCT01536093|579433809|FG001|Overall Study|Withdrawal by Subject|1|||
160465406|NCT02275611|579433812|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
160465407|NCT02275611|579433813|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
160465408|NCT02275611|579433814|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
160465409|NCT02275611|579433815|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
160465410|NCT01211184|579433821|FG000|Overall Study|Withdrawal by Subject|0|||
160465411|NCT01211184|579433822|FG001|Overall Study|Withdrawal by Subject|2|||
160465412|NCT01211184|579433823|FG002|Overall Study|Withdrawal by Subject|1|||
160465413|NCT01421667|579433824|FG000|Overall Study|Withdrawal by Subject|0|||
160465414|NCT01421667|579433825|FG001|Overall Study|Withdrawal by Subject|1|||
160465415|NCT01421667|579433826|FG002|Overall Study|Withdrawal by Subject|2|||
160465416|NCT01421667|579433827|FG003|Overall Study|Withdrawal by Subject|1|||
160465417|NCT01421667|579433824|FG000|Overall Study|Lost to Follow-up|0|||
160465418|NCT01421667|579433825|FG001|Overall Study|Lost to Follow-up|1|||
160465419|NCT01421667|579433826|FG002|Overall Study|Lost to Follow-up|0|||
160465420|NCT01421667|579433827|FG003|Overall Study|Lost to Follow-up|0|||
160465421|NCT00503906|579433828|FG000|Overall Study|Withdrawal by Subject|1|||
160465422|NCT05580003|579433829|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465423|NCT05580003|579433830|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465424|NCT05580003|579433831|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465425|NCT05580003|579433832|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465426|NCT05580003|579433833|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465427|NCT05580003|579433834|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465428|NCT05580003|579433835|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
160465429|NCT05580003|579433836|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465430|NCT05580003|579433837|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465431|NCT05580003|579433838|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465432|NCT05580003|579433839|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465433|NCT05580003|579433840|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465434|NCT05580003|579433841|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465435|NCT05580003|579433842|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465436|NCT05580003|579433843|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465437|NCT05580003|579433844|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465438|NCT05580003|579433845|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465439|NCT05580003|579433846|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465440|NCT05580003|579433847|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465441|NCT05580003|579433848|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465442|NCT05580003|579433849|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465443|NCT05580003|579433850|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465444|NCT05580003|579433851|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465445|NCT05580003|579433852|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465446|NCT05580003|579433853|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465447|NCT05580003|579433854|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465448|NCT05580003|579433855|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465449|NCT05580003|579433856|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160465450|NCT05580003|579433829|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465451|NCT05580003|579433830|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465452|NCT05580003|579433831|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465453|NCT05580003|579433832|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465454|NCT05580003|579433833|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465455|NCT05580003|579433834|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
160465456|NCT05580003|579433835|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465457|NCT05580003|579433836|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465458|NCT05580003|579433837|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465459|NCT05580003|579433838|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465460|NCT05580003|579433839|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465461|NCT05580003|579433840|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465462|NCT05580003|579433841|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465463|NCT05580003|579433842|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465464|NCT05580003|579433843|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465465|NCT05580003|579433844|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465466|NCT05580003|579433845|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465467|NCT05580003|579433846|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465468|NCT05580003|579433847|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465469|NCT05580003|579433848|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465470|NCT05580003|579433849|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465471|NCT05580003|579433850|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465472|NCT05580003|579433851|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465473|NCT05580003|579433852|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465474|NCT05580003|579433853|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465475|NCT05580003|579433854|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465476|NCT05580003|579433855|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465477|NCT05580003|579433856|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
160465478|NCT05580003|579433829|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465479|NCT05580003|579433830|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465480|NCT05580003|579433831|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465481|NCT05580003|579433832|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
160465482|NCT05580003|579433833|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465483|NCT05580003|579433834|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465484|NCT05580003|579433835|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465485|NCT05580003|579433836|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465486|NCT05580003|579433837|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465487|NCT05580003|579433838|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465488|NCT05580003|579433839|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465489|NCT05580003|579433840|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465490|NCT05580003|579433841|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465491|NCT05580003|579433842|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465492|NCT05580003|579433843|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160596169|NCT05159362|579899899|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
160596170|NCT05159362|579899900|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
160596171|NCT05159362|579899901|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
160596172|NCT00764946|579899902|FG000|Overall Study|Lack of Efficacy|1|||
160596173|NCT00764946|579899903|FG001|Overall Study|Lack of Efficacy|0|||
160596174|NCT00764946|579899904|FG002|Overall Study|Lack of Efficacy|0|||
160596175|NCT00764946|579899902|FG000|Overall Study|Lost to Follow-up|3|||
160596176|NCT00764946|579899903|FG001|Overall Study|Lost to Follow-up|4|||
160596177|NCT00764946|579899904|FG002|Overall Study|Lost to Follow-up|0|||
160596178|NCT00764946|579899902|FG000|Overall Study|Physician Decision|2|||
160596179|NCT00764946|579899903|FG001|Overall Study|Physician Decision|4|||
160596180|NCT00764946|579899904|FG002|Overall Study|Physician Decision|0|||
160596181|NCT00764946|579899902|FG000|Overall Study|Adverse Event|3|||
160596182|NCT00764946|579899903|FG001|Overall Study|Adverse Event|2|||
160465493|NCT05580003|579433844|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465494|NCT05580003|579433845|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160596183|NCT00764946|579899904|FG002|Overall Study|Adverse Event|1|||
160596184|NCT00764946|579899902|FG000|Overall Study|Withdrawal by Subject|3|||
160596185|NCT00764946|579899903|FG001|Overall Study|Withdrawal by Subject|6|||
160596186|NCT00764946|579899904|FG002|Overall Study|Withdrawal by Subject|2|||
160596187|NCT00764946|579899902|FG000|Overall Study|Never Treated|1|||
160596188|NCT00764946|579899903|FG001|Overall Study|Never Treated|1|||
160596189|NCT00764946|579899904|FG002|Overall Study|Never Treated|1|||
160596190|NCT00878215|579899906|FG000|Overall Study|Determined to be ineligible|0|||
160596191|NCT00878215|579899907|FG001|Overall Study|Determined to be ineligible|10|||
160465495|NCT05580003|579433846|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160596192|NCT00878215|579899908|FG002|Overall Study|Determined to be ineligible|0|||
160596193|NCT00878215|579899909|FG003|Overall Study|Determined to be ineligible|0|||
160658908|NCT03227445|580133231|FG003|Period 1 (28 Days)|Adverse Event|1|||
160658909|NCT03227445|580133228|FG000|Period 1 (28 Days)|Protocol Violation|1|||
160658910|NCT03227445|580133229|FG001|Period 1 (28 Days)|Protocol Violation|0|||
160658911|NCT03227445|580133230|FG002|Period 1 (28 Days)|Protocol Violation|0|||
160658912|NCT03227445|580133231|FG003|Period 1 (28 Days)|Protocol Violation|0|||
160658913|NCT03227445|580133228|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
160658914|NCT03227445|580133229|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
160658915|NCT03227445|580133230|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
160658916|NCT03227445|580133231|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
160658917|NCT03227445|580133228|FG000|Period 2 (28 Days)|Adverse Event|1|||
160658918|NCT03227445|580133229|FG001|Period 2 (28 Days)|Adverse Event|0|||
160658919|NCT03227445|580133230|FG002|Period 2 (28 Days)|Adverse Event|2|||
160658920|NCT03227445|580133231|FG003|Period 2 (28 Days)|Adverse Event|1|||
160658921|NCT03227445|580133228|FG000|Period 2 (28 Days)|Protocol Violation|0|||
160658922|NCT03227445|580133229|FG001|Period 2 (28 Days)|Protocol Violation|0|||
160658923|NCT03227445|580133230|FG002|Period 2 (28 Days)|Protocol Violation|0|||
160658924|NCT03227445|580133231|FG003|Period 2 (28 Days)|Protocol Violation|1|||
160658925|NCT03227445|580133228|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
160658926|NCT03227445|580133229|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
160658927|NCT03227445|580133230|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
160658928|NCT03227445|580133231|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
160658929|NCT00445003|580133236|FG000|Overall Study|Death|1|||
160658930|NCT00445003|580133237|FG001|Overall Study|Death|2|||
160658931|NCT00445003|580133238|FG002|Overall Study|Death|1|||
160658932|NCT00445003|580133236|FG000|Overall Study|Missed Visit|3|||
160658933|NCT00445003|580133237|FG001|Overall Study|Missed Visit|5|||
160658934|NCT00445003|580133238|FG002|Overall Study|Missed Visit|1|||
160658935|NCT00445003|580133236|FG000|Overall Study|Dropped|1|||
160465496|NCT05580003|579433847|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465497|NCT05580003|579433848|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465498|NCT05580003|579433849|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465499|NCT05580003|579433850|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465500|NCT05580003|579433851|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465501|NCT05580003|579433852|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465502|NCT05580003|579433853|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465503|NCT05580003|579433854|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465504|NCT05580003|579433855|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465505|NCT05580003|579433856|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
160465506|NCT05580003|579433829|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465507|NCT05580003|579433830|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
160465508|NCT05580003|579433831|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465509|NCT05580003|579433832|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465510|NCT05580003|579433833|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465511|NCT05580003|579433834|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160596194|NCT00138424|579899910|FG000|Overall Study|Physician Decision|0|||
160596195|NCT00138424|579899911|FG001|Overall Study|Physician Decision|1|||
160465512|NCT05580003|579433835|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465513|NCT05580003|579433836|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465514|NCT05580003|579433837|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465515|NCT05580003|579433838|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465516|NCT05580003|579433839|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465517|NCT05580003|579433840|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465518|NCT05580003|579433841|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465519|NCT05580003|579433842|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160596196|NCT00138424|579899912|FG002|Overall Study|Physician Decision|0|||
160596197|NCT00138424|579899913|FG003|Overall Study|Physician Decision|0|||
160596198|NCT00413062|579899918|FG000|Overall Study|Adverse event/serious adverse event|289|||
160596199|NCT00413062|579899919|FG001|Overall Study|Adverse event/serious adverse event|56|||
160596200|NCT00413062|579899918|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
160465520|NCT05580003|579433843|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465521|NCT05580003|579433844|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160658936|NCT00445003|580133237|FG001|Overall Study|Dropped|3|||
160596201|NCT00413062|579899919|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
160596202|NCT00413062|579899918|FG000|Overall Study|Withdrawal of informed consent|111|||
160596203|NCT00413062|579899919|FG001|Overall Study|Withdrawal of informed consent|36|||
160596204|NCT00413062|579899918|FG000|Overall Study|Pregnancy|15|||
160596205|NCT00413062|579899919|FG001|Overall Study|Pregnancy|5|||
160596206|NCT00413062|579899918|FG000|Overall Study|Pregnancy wish|17|||
160596207|NCT00413062|579899919|FG001|Overall Study|Pregnancy wish|6|||
160596208|NCT00413062|579899918|FG000|Overall Study|Lost to Follow-up|175|||
160596209|NCT00413062|579899919|FG001|Overall Study|Lost to Follow-up|73|||
160596210|NCT00413062|579899918|FG000|Overall Study|Other reason|70|||
160596211|NCT00413062|579899919|FG001|Overall Study|Other reason|34|||
160596212|NCT02176291|579899920|FG000|Overall Study|Death|1|||
160465522|NCT05580003|579433845|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465523|NCT05580003|579433846|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465524|NCT05580003|579433847|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465525|NCT05580003|579433848|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465526|NCT05580003|579433849|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465527|NCT05580003|579433850|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465528|NCT05580003|579433851|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465529|NCT05580003|579433852|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160658937|NCT00445003|580133238|FG002|Overall Study|Dropped|2|||
160465530|NCT05580003|579433853|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160658938|NCT00528606|580133239|FG000|Overall Study|Withdrew consent|4|||
160658939|NCT00528606|580133240|FG001|Overall Study|Withdrew consent|3|||
160465531|NCT05580003|579433854|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465532|NCT05580003|579433855|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465533|NCT05580003|579433856|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
160465534|NCT05580003|579433829|FG000|Part 2 (up to 10 Days)|Other|0|||
160465535|NCT05580003|579433830|FG001|Part 2 (up to 10 Days)|Other|0|||
160465536|NCT05580003|579433831|FG002|Part 2 (up to 10 Days)|Other|0|||
160465537|NCT05580003|579433832|FG003|Part 2 (up to 10 Days)|Other|0|||
160465538|NCT05580003|579433833|FG004|Part 2 (up to 10 Days)|Other|0|||
160465539|NCT05580003|579433834|FG005|Part 2 (up to 10 Days)|Other|0|||
160465540|NCT05580003|579433835|FG006|Part 2 (up to 10 Days)|Other|0|||
160465541|NCT05580003|579433836|FG007|Part 2 (up to 10 Days)|Other|0|||
160465542|NCT05580003|579433837|FG008|Part 2 (up to 10 Days)|Other|0|||
160465543|NCT05580003|579433838|FG009|Part 2 (up to 10 Days)|Other|1|||
160465544|NCT05580003|579433839|FG010|Part 2 (up to 10 Days)|Other|0|||
160658940|NCT00528606|580133239|FG000|Overall Study|Lost to Follow-up|4|||
160658941|NCT00528606|580133240|FG001|Overall Study|Lost to Follow-up|1|||
160658942|NCT00528606|580133239|FG000|Overall Study|Adverse Event|3|||
160465545|NCT05580003|579433840|FG011|Part 2 (up to 10 Days)|Other|0|||
160465546|NCT05580003|579433841|FG012|Part 2 (up to 10 Days)|Other|0|||
160465547|NCT05580003|579433842|FG013|Part 2 (up to 10 Days)|Other|0|||
160465548|NCT05580003|579433843|FG014|Part 2 (up to 10 Days)|Other|0|||
160658943|NCT00528606|580133240|FG001|Overall Study|Adverse Event|0|||
160596213|NCT02176291|579899921|FG001|Overall Study|Death|0|||
160596214|NCT02176291|579899920|FG000|Overall Study|non compliance with protocol|2|||
160596215|NCT02176291|579899921|FG001|Overall Study|non compliance with protocol|0|||
160596216|NCT02176291|579899920|FG000|Overall Study|Withdrawal by Subject|2|||
160596217|NCT02176291|579899921|FG001|Overall Study|Withdrawal by Subject|0|||
160596218|NCT00006604|579899922|FG000|Overall Study|Met study objective - no further FU|1|||
160596219|NCT00006604|579899923|FG001|Overall Study|Met study objective - no further FU|0|||
160596220|NCT00006604|579899924|FG002|Overall Study|Met study objective - no further FU|0|||
160596221|NCT00006604|579899925|FG003|Overall Study|Met study objective - no further FU|0|||
160596222|NCT00006604|579899926|FG004|Overall Study|Met study objective - no further FU|0|||
160596223|NCT00006604|579899927|FG005|Overall Study|Met study objective - no further FU|0|||
160596224|NCT00006604|579899928|FG006|Overall Study|Met study objective - no further FU|0|||
160596225|NCT00006604|579899929|FG007|Overall Study|Met study objective - no further FU|0|||
160596226|NCT00006604|579899930|FG008|Overall Study|Met study objective - no further FU|0|||
160596227|NCT00006604|579899931|FG009|Overall Study|Met study objective - no further FU|0|||
160596228|NCT00006604|579899932|FG010|Overall Study|Met study objective - no further FU|0|||
160596229|NCT00006604|579899933|FG011|Overall Study|Met study objective - no further FU|0|||
160596230|NCT00006604|579899934|FG012|Overall Study|Met study objective - no further FU|0|||
160596231|NCT00006604|579899935|FG013|Overall Study|Met study objective - no further FU|0|||
160596232|NCT00006604|579899936|FG014|Overall Study|Met study objective - no further FU|1|||
160596233|NCT00006604|579899937|FG015|Overall Study|Met study objective - no further FU|1|||
160596234|NCT00006604|579899938|FG016|Overall Study|Met study objective - no further FU|0|||
160596235|NCT00006604|579899922|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
160596236|NCT00006604|579899923|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
160596237|NCT00006604|579899924|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
160596238|NCT00006604|579899925|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
160596239|NCT00006604|579899926|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
160596240|NCT00006604|579899927|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
160596241|NCT00006604|579899928|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
160596242|NCT00006604|579899929|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
160596243|NCT00006604|579899930|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
160596244|NCT00006604|579899931|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
160596245|NCT00006604|579899932|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
160596246|NCT00006604|579899933|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
160596247|NCT00006604|579899934|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
160596248|NCT00006604|579899935|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
160596249|NCT00006604|579899936|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
160596250|NCT00006604|579899937|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
160596251|NCT00006604|579899938|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
160596252|NCT00006604|579899922|FG000|Overall Study|Death|0|||
160596253|NCT00006604|579899923|FG001|Overall Study|Death|0|||
160596254|NCT00006604|579899924|FG002|Overall Study|Death|0|||
160596255|NCT00006604|579899925|FG003|Overall Study|Death|0|||
160596256|NCT00006604|579899926|FG004|Overall Study|Death|0|||
160596257|NCT00006604|579899927|FG005|Overall Study|Death|0|||
160596258|NCT00006604|579899928|FG006|Overall Study|Death|0|||
160596259|NCT00006604|579899929|FG007|Overall Study|Death|0|||
160596260|NCT00006604|579899930|FG008|Overall Study|Death|0|||
160596261|NCT00006604|579899931|FG009|Overall Study|Death|1|||
160596262|NCT00006604|579899932|FG010|Overall Study|Death|1|||
160658944|NCT00528606|580133239|FG000|Overall Study|Other|2|||
160596263|NCT00006604|579899933|FG011|Overall Study|Death|1|||
160596264|NCT00006604|579899934|FG012|Overall Study|Death|0|||
160596265|NCT00006604|579899935|FG013|Overall Study|Death|0|||
160596266|NCT00006604|579899936|FG014|Overall Study|Death|0|||
160465549|NCT05580003|579433844|FG015|Part 2 (up to 10 Days)|Other|0|||
160465550|NCT05580003|579433845|FG016|Part 2 (up to 10 Days)|Other|0|||
160465551|NCT05580003|579433846|FG017|Part 2 (up to 10 Days)|Other|0|||
160465552|NCT05580003|579433847|FG018|Part 2 (up to 10 Days)|Other|0|||
160465553|NCT05580003|579433848|FG019|Part 2 (up to 10 Days)|Other|0|||
160465554|NCT05580003|579433849|FG020|Part 2 (up to 10 Days)|Other|0|||
160465555|NCT05580003|579433850|FG021|Part 2 (up to 10 Days)|Other|0|||
160465556|NCT05580003|579433851|FG022|Part 2 (up to 10 Days)|Other|0|||
160465557|NCT05580003|579433852|FG023|Part 2 (up to 10 Days)|Other|0|||
160465558|NCT05580003|579433853|FG024|Part 2 (up to 10 Days)|Other|0|||
160465559|NCT05580003|579433854|FG025|Part 2 (up to 10 Days)|Other|0|||
160465560|NCT05580003|579433855|FG026|Part 2 (up to 10 Days)|Other|0|||
160465561|NCT05580003|579433856|FG027|Part 2 (up to 10 Days)|Other|0|||
160465562|NCT05580003|579433829|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465563|NCT05580003|579433830|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465564|NCT05580003|579433831|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465565|NCT05580003|579433832|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465566|NCT05580003|579433833|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465567|NCT05580003|579433834|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465568|NCT05580003|579433835|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465569|NCT05580003|579433836|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465570|NCT05580003|579433837|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465571|NCT05580003|579433838|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465572|NCT05580003|579433839|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465573|NCT05580003|579433840|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465574|NCT05580003|579433841|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160596267|NCT00006604|579899937|FG015|Overall Study|Death|0|||
160465575|NCT05580003|579433842|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465576|NCT05580003|579433843|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465577|NCT05580003|579433844|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465578|NCT05580003|579433845|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465579|NCT05580003|579433846|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465580|NCT05580003|579433847|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465581|NCT05580003|579433848|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
160596268|NCT00006604|579899938|FG016|Overall Study|Death|0|||
160596269|NCT00006604|579899922|FG000|Overall Study|Severe debilitation, unable to continue|0|||
160596270|NCT00006604|579899923|FG001|Overall Study|Severe debilitation, unable to continue|0|||
160596271|NCT00006604|579899924|FG002|Overall Study|Severe debilitation, unable to continue|0|||
160596272|NCT00006604|579899925|FG003|Overall Study|Severe debilitation, unable to continue|0|||
160596273|NCT00006604|579899926|FG004|Overall Study|Severe debilitation, unable to continue|0|||
160596274|NCT00006604|579899927|FG005|Overall Study|Severe debilitation, unable to continue|0|||
160596275|NCT00006604|579899928|FG006|Overall Study|Severe debilitation, unable to continue|3|||
160596276|NCT00006604|579899929|FG007|Overall Study|Severe debilitation, unable to continue|0|||
160596277|NCT00006604|579899930|FG008|Overall Study|Severe debilitation, unable to continue|0|||
160596278|NCT00006604|579899931|FG009|Overall Study|Severe debilitation, unable to continue|5|||
160596279|NCT00006604|579899932|FG010|Overall Study|Severe debilitation, unable to continue|0|||
160596280|NCT00006604|579899933|FG011|Overall Study|Severe debilitation, unable to continue|2|||
160596281|NCT00006604|579899934|FG012|Overall Study|Severe debilitation, unable to continue|1|||
160596282|NCT00006604|579899935|FG013|Overall Study|Severe debilitation, unable to continue|0|||
160596283|NCT00006604|579899936|FG014|Overall Study|Severe debilitation, unable to continue|2|||
160596284|NCT00006604|579899937|FG015|Overall Study|Severe debilitation, unable to continue|0|||
160596285|NCT00006604|579899938|FG016|Overall Study|Severe debilitation, unable to continue|0|||
160596286|NCT00006604|579899922|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
160596287|NCT00006604|579899923|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
160596288|NCT00006604|579899924|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
160596289|NCT00006604|579899925|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
160465582|NCT05580003|579433849|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160596290|NCT00006604|579899926|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
160596291|NCT00006604|579899927|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
160596292|NCT00006604|579899928|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
160596293|NCT00006604|579899929|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
160596294|NCT00006604|579899930|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
160596295|NCT00006604|579899931|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
160596296|NCT00006604|579899932|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
160596297|NCT00006604|579899933|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
160596298|NCT00006604|579899934|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
160596299|NCT00006604|579899935|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
160596300|NCT00006604|579899936|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
160596301|NCT00006604|579899937|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
160596302|NCT00006604|579899938|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
160596303|NCT00006604|579899922|FG000|Overall Study|Site closing|0|||
160465583|NCT05580003|579433850|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465584|NCT05580003|579433851|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160596304|NCT00006604|579899923|FG001|Overall Study|Site closing|0|||
160596305|NCT00006604|579899924|FG002|Overall Study|Site closing|1|||
160596306|NCT00006604|579899925|FG003|Overall Study|Site closing|1|||
160596307|NCT00006604|579899926|FG004|Overall Study|Site closing|0|||
160596308|NCT00006604|579899927|FG005|Overall Study|Site closing|0|||
160596309|NCT00006604|579899928|FG006|Overall Study|Site closing|0|||
160596310|NCT00006604|579899929|FG007|Overall Study|Site closing|1|||
160596311|NCT00006604|579899930|FG008|Overall Study|Site closing|0|||
160596312|NCT00006604|579899931|FG009|Overall Study|Site closing|0|||
160596313|NCT00006604|579899932|FG010|Overall Study|Site closing|0|||
160596314|NCT00006604|579899933|FG011|Overall Study|Site closing|1|||
160596315|NCT00006604|579899934|FG012|Overall Study|Site closing|1|||
160596316|NCT00006604|579899935|FG013|Overall Study|Site closing|1|||
160596317|NCT00006604|579899936|FG014|Overall Study|Site closing|0|||
160596318|NCT00006604|579899937|FG015|Overall Study|Site closing|0|||
160596319|NCT00006604|579899938|FG016|Overall Study|Site closing|1|||
160596320|NCT00006604|579899922|FG000|Overall Study|Withdrawal by Subject|1|||
160596321|NCT00006604|579899923|FG001|Overall Study|Withdrawal by Subject|0|||
160465585|NCT05580003|579433852|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160596322|NCT00006604|579899924|FG002|Overall Study|Withdrawal by Subject|2|||
160596323|NCT00006604|579899925|FG003|Overall Study|Withdrawal by Subject|0|||
160596324|NCT00006604|579899926|FG004|Overall Study|Withdrawal by Subject|1|||
160596325|NCT00006604|579899927|FG005|Overall Study|Withdrawal by Subject|2|||
160596326|NCT00006604|579899928|FG006|Overall Study|Withdrawal by Subject|2|||
160596327|NCT00006604|579899929|FG007|Overall Study|Withdrawal by Subject|0|||
160596328|NCT00006604|579899930|FG008|Overall Study|Withdrawal by Subject|1|||
160596329|NCT00006604|579899931|FG009|Overall Study|Withdrawal by Subject|3|||
160465586|NCT05580003|579433853|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465587|NCT05580003|579433854|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465588|NCT05580003|579433855|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465589|NCT05580003|579433856|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
160465590|NCT05580003|579433829|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465591|NCT05580003|579433830|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465592|NCT05580003|579433831|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465593|NCT05580003|579433832|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465594|NCT05580003|579433833|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465595|NCT05580003|579433834|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465596|NCT05580003|579433835|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465597|NCT05580003|579433836|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465598|NCT05580003|579433837|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465599|NCT05580003|579433838|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465600|NCT05580003|579433839|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465601|NCT05580003|579433840|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465602|NCT05580003|579433841|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465603|NCT05580003|579433842|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465604|NCT05580003|579433843|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465605|NCT05580003|579433844|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465606|NCT05580003|579433845|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465607|NCT05580003|579433846|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465608|NCT05580003|579433847|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465609|NCT05580003|579433848|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465610|NCT05580003|579433849|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
160465611|NCT05580003|579433850|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465612|NCT05580003|579433851|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465613|NCT05580003|579433852|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465614|NCT05580003|579433853|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465615|NCT05580003|579433854|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465616|NCT05580003|579433855|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465617|NCT05580003|579433856|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
160465618|NCT05580003|579433829|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465619|NCT05580003|579433830|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465620|NCT05580003|579433831|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465621|NCT05580003|579433832|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465622|NCT05580003|579433833|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465623|NCT05580003|579433834|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465624|NCT05580003|579433835|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465625|NCT05580003|579433836|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465626|NCT05580003|579433837|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465627|NCT05580003|579433838|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465628|NCT05580003|579433839|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465629|NCT05580003|579433840|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465630|NCT05580003|579433841|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465631|NCT05580003|579433842|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465632|NCT05580003|579433843|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465633|NCT05580003|579433844|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465634|NCT05580003|579433845|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465635|NCT05580003|579433846|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465636|NCT05580003|579433847|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160658945|NCT00528606|580133240|FG001|Overall Study|Other|0|||
160465637|NCT05580003|579433848|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465638|NCT05580003|579433849|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160596330|NCT00006604|579899932|FG010|Overall Study|Withdrawal by Subject|2|||
160596331|NCT00006604|579899933|FG011|Overall Study|Withdrawal by Subject|0|||
160596332|NCT00006604|579899934|FG012|Overall Study|Withdrawal by Subject|1|||
160596333|NCT00006604|579899935|FG013|Overall Study|Withdrawal by Subject|2|||
160596334|NCT00006604|579899936|FG014|Overall Study|Withdrawal by Subject|1|||
160658946|NCT02475954|580133241|FG000|Overall Study|Withdrawal by Subject|2|||
160658947|NCT02475954|580133242|FG001|Overall Study|Withdrawal by Subject|2|||
160658948|NCT02475954|580133241|FG000|Overall Study|Lost to Follow-up|11|||
160465639|NCT05580003|579433850|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
160465640|NCT05580003|579433851|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160658949|NCT02475954|580133242|FG001|Overall Study|Lost to Follow-up|9|||
160658950|NCT02475954|580133241|FG000|Overall Study|Death|1|||
160596335|NCT00006604|579899937|FG015|Overall Study|Withdrawal by Subject|0|||
160596336|NCT00006604|579899938|FG016|Overall Study|Withdrawal by Subject|1|||
160596337|NCT00006604|579899922|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
160658951|NCT02475954|580133242|FG001|Overall Study|Death|1|||
160465641|NCT05580003|579433852|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465642|NCT05580003|579433853|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465643|NCT05580003|579433854|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160596338|NCT00006604|579899923|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
160596339|NCT00006604|579899924|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
160596340|NCT00006604|579899925|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
160465644|NCT05580003|579433855|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465645|NCT05580003|579433856|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
160465646|NCT05580003|579433829|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465647|NCT05580003|579433830|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465648|NCT05580003|579433831|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465649|NCT05580003|579433832|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465650|NCT05580003|579433833|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465651|NCT05580003|579433834|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465652|NCT05580003|579433835|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465653|NCT05580003|579433836|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465654|NCT05580003|579433837|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465655|NCT05580003|579433838|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465656|NCT05580003|579433839|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465657|NCT05580003|579433840|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465658|NCT05580003|579433841|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465659|NCT05580003|579433842|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465660|NCT05580003|579433843|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465661|NCT05580003|579433844|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465662|NCT05580003|579433845|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465663|NCT05580003|579433846|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465664|NCT05580003|579433847|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465665|NCT05580003|579433848|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465666|NCT05580003|579433849|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465667|NCT05580003|579433850|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465668|NCT05580003|579433851|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465669|NCT05580003|579433852|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465670|NCT05580003|579433853|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465671|NCT05580003|579433854|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465672|NCT05580003|579433855|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
160465673|NCT05580003|579433856|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
160465674|NCT05580003|579433829|FG000|Part 6 Period 2 (Day 1)|Other|0|||
160465675|NCT05580003|579433830|FG001|Part 6 Period 2 (Day 1)|Other|0|||
160465676|NCT05580003|579433831|FG002|Part 6 Period 2 (Day 1)|Other|0|||
160465677|NCT05580003|579433832|FG003|Part 6 Period 2 (Day 1)|Other|0|||
160465678|NCT05580003|579433833|FG004|Part 6 Period 2 (Day 1)|Other|0|||
160465679|NCT05580003|579433834|FG005|Part 6 Period 2 (Day 1)|Other|0|||
160465680|NCT05580003|579433835|FG006|Part 6 Period 2 (Day 1)|Other|0|||
160465681|NCT05580003|579433836|FG007|Part 6 Period 2 (Day 1)|Other|0|||
160465682|NCT05580003|579433837|FG008|Part 6 Period 2 (Day 1)|Other|0|||
160465683|NCT05580003|579433838|FG009|Part 6 Period 2 (Day 1)|Other|0|||
160465684|NCT05580003|579433839|FG010|Part 6 Period 2 (Day 1)|Other|0|||
160465685|NCT05580003|579433840|FG011|Part 6 Period 2 (Day 1)|Other|0|||
160465686|NCT05580003|579433841|FG012|Part 6 Period 2 (Day 1)|Other|0|||
160465687|NCT05580003|579433842|FG013|Part 6 Period 2 (Day 1)|Other|0|||
160465688|NCT05580003|579433843|FG014|Part 6 Period 2 (Day 1)|Other|0|||
160465689|NCT05580003|579433844|FG015|Part 6 Period 2 (Day 1)|Other|0|||
160465690|NCT05580003|579433845|FG016|Part 6 Period 2 (Day 1)|Other|0|||
160465691|NCT05580003|579433846|FG017|Part 6 Period 2 (Day 1)|Other|0|||
160465692|NCT05580003|579433847|FG018|Part 6 Period 2 (Day 1)|Other|0|||
160465693|NCT05580003|579433848|FG019|Part 6 Period 2 (Day 1)|Other|0|||
160465694|NCT05580003|579433849|FG020|Part 6 Period 2 (Day 1)|Other|0|||
160465695|NCT05580003|579433850|FG021|Part 6 Period 2 (Day 1)|Other|0|||
160465696|NCT05580003|579433851|FG022|Part 6 Period 2 (Day 1)|Other|0|||
160465697|NCT05580003|579433852|FG023|Part 6 Period 2 (Day 1)|Other|0|||
160465698|NCT05580003|579433853|FG024|Part 6 Period 2 (Day 1)|Other|1|||
160465699|NCT05580003|579433854|FG025|Part 6 Period 2 (Day 1)|Other|0|||
160465700|NCT05580003|579433855|FG026|Part 6 Period 2 (Day 1)|Other|0|||
160465701|NCT05580003|579433856|FG027|Part 6 Period 2 (Day 1)|Other|0|||
160465702|NCT03516812|579433857|FG000|Overall Study|Adverse Event|4|||
160465703|NCT03516812|579433857|FG000|Overall Study|Lack of Efficacy|2|||
160465704|NCT04795167|579433858|FG000|Overall Study|Death|1|||
160465705|NCT04795167|579433859|FG001|Overall Study|Death|18|||
160465706|NCT04795167|579433860|FG002|Overall Study|Death|1|||
160465707|NCT04795167|579433858|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
160465708|NCT04795167|579433859|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
160465709|NCT04795167|579433860|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
160465710|NCT01753999|579433861|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
160465711|NCT01753999|579433862|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
160465712|NCT01753999|579433861|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
160465713|NCT01753999|579433862|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
160465714|NCT01753999|579433861|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
160465715|NCT01753999|579433862|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
160465716|NCT01753999|579433861|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
160465717|NCT01753999|579433862|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
160465718|NCT01753999|579433861|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
160465719|NCT01753999|579433862|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
160596341|NCT00006604|579899926|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
160596342|NCT00006604|579899927|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
160465720|NCT01753999|579433861|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
160465721|NCT01753999|579433862|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
160465722|NCT03840902|579433863|FG000|Overall Study|Randomized but not treated|1|||
160465723|NCT03840902|579433864|FG001|Overall Study|Randomized but not treated|1|||
160465724|NCT02392234|579433865|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
160465725|NCT02392234|579433866|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
160465726|NCT02392234|579433867|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
160465727|NCT02392234|579433868|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
160465728|NCT02392234|579433869|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
160465729|NCT02392234|579433870|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
160465730|NCT02392234|579433865|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
160465731|NCT02392234|579433866|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
160465732|NCT02392234|579433867|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
160465733|NCT02392234|579433868|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
160465734|NCT02392234|579433869|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
160465735|NCT02392234|579433870|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
160465736|NCT02392234|579433865|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
160465737|NCT02392234|579433866|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
160465738|NCT02392234|579433867|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
160465739|NCT02392234|579433868|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
160465740|NCT02392234|579433869|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
160465741|NCT02392234|579433870|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
160465742|NCT02392234|579433865|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
160465743|NCT02392234|579433866|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
160465744|NCT02392234|579433867|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
160465745|NCT02392234|579433868|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
160465746|NCT02392234|579433869|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
160465747|NCT02392234|579433870|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
160465748|NCT02392234|579433865|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
160465749|NCT02392234|579433866|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
160465750|NCT02392234|579433867|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
160465751|NCT02392234|579433868|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
160465752|NCT02392234|579433869|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
160465753|NCT02392234|579433870|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
160465754|NCT02392234|579433865|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
160465755|NCT02392234|579433866|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
160465756|NCT02392234|579433867|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
160465757|NCT02392234|579433868|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
160465758|NCT02392234|579433869|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
160465759|NCT02392234|579433870|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
160465760|NCT02392234|579433865|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
160465761|NCT02392234|579433866|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
160465762|NCT02392234|579433867|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
160465763|NCT02392234|579433868|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
160465764|NCT02392234|579433869|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
160465765|NCT02392234|579433870|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
160465766|NCT02392234|579433865|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
160465767|NCT02392234|579433866|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
160465768|NCT02392234|579433867|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
160465769|NCT02392234|579433868|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
160465770|NCT02392234|579433869|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
160465771|NCT02392234|579433870|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
160465772|NCT04436289|579433871|FG000|Overall Study|Death prior to hospital discharge|8|||
160465773|NCT04436289|579433872|FG001|Overall Study|Death prior to hospital discharge|5|||
160465774|NCT04436289|579433873|FG002|Overall Study|Death prior to hospital discharge|0|||
160465775|NCT04436289|579433874|FG003|Overall Study|Death prior to hospital discharge|1|||
160465776|NCT04436289|579433871|FG000|Overall Study|Withdrawal by Subject|0|||
160465777|NCT04436289|579433872|FG001|Overall Study|Withdrawal by Subject|1|||
160465778|NCT04436289|579433873|FG002|Overall Study|Withdrawal by Subject|4|||
160465779|NCT04436289|579433874|FG003|Overall Study|Withdrawal by Subject|0|||
160465780|NCT04436289|579433871|FG000|Overall Study|Extended hospital stay|0|||
160465781|NCT04436289|579433872|FG001|Overall Study|Extended hospital stay|1|||
160465782|NCT04436289|579433873|FG002|Overall Study|Extended hospital stay|0|||
160465783|NCT04436289|579433874|FG003|Overall Study|Extended hospital stay|0|||
160465784|NCT04436289|579433871|FG000|Overall Study|Lost to Follow-up|0|||
160465785|NCT04436289|579433872|FG001|Overall Study|Lost to Follow-up|4|||
160465786|NCT04436289|579433873|FG002|Overall Study|Lost to Follow-up|1|||
160465787|NCT04436289|579433874|FG003|Overall Study|Lost to Follow-up|3|||
160465788|NCT03598907|579433875|FG000|Overall Study|Physician Decision|14|||
160465789|NCT03598907|579433876|FG001|Overall Study|Physician Decision|19|||
160465790|NCT03211247|579433879|FG000|Overall Study|Adverse Event|8|||
160465791|NCT03211247|579433880|FG001|Overall Study|Adverse Event|0|||
160465792|NCT03211247|579433881|FG002|Overall Study|Adverse Event|1|||
160465793|NCT03211247|579433882|FG003|Overall Study|Adverse Event|0|||
160465794|NCT03211247|579433883|FG004|Overall Study|Adverse Event|0|||
160465795|NCT03211247|579433879|FG000|Overall Study|Lost to Follow-up|2|||
160465796|NCT03211247|579433880|FG001|Overall Study|Lost to Follow-up|1|||
160465797|NCT03211247|579433881|FG002|Overall Study|Lost to Follow-up|0|||
160465798|NCT03211247|579433882|FG003|Overall Study|Lost to Follow-up|0|||
160465799|NCT03211247|579433883|FG004|Overall Study|Lost to Follow-up|0|||
160465800|NCT03211247|579433879|FG000|Overall Study|Physician Decision|1|||
160465801|NCT03211247|579433880|FG001|Overall Study|Physician Decision|2|||
160596343|NCT00006604|579899928|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
160596344|NCT00006604|579899929|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
160596345|NCT00006604|579899930|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
160596346|NCT00006604|579899931|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
160596347|NCT00006604|579899932|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
160596348|NCT00006604|579899933|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
160596349|NCT00006604|579899934|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
160596350|NCT00006604|579899935|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
160596351|NCT00006604|579899936|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
160596352|NCT00006604|579899937|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
160596353|NCT00006604|579899938|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
160596354|NCT00006604|579899922|FG000|Overall Study|Lost to Follow-up|0|||
160596355|NCT00006604|579899923|FG001|Overall Study|Lost to Follow-up|0|||
160596356|NCT00006604|579899924|FG002|Overall Study|Lost to Follow-up|0|||
160596357|NCT00006604|579899925|FG003|Overall Study|Lost to Follow-up|0|||
160596358|NCT00006604|579899926|FG004|Overall Study|Lost to Follow-up|0|||
160596359|NCT00006604|579899927|FG005|Overall Study|Lost to Follow-up|0|||
160596360|NCT00006604|579899928|FG006|Overall Study|Lost to Follow-up|0|||
160596361|NCT00006604|579899929|FG007|Overall Study|Lost to Follow-up|1|||
160658952|NCT00880568|580133244|FG000|Overall Study|Disease progression|3|||
160658953|NCT00880568|580133245|FG001|Overall Study|Disease progression|3|||
160596362|NCT00006604|579899930|FG008|Overall Study|Lost to Follow-up|0|||
160658954|NCT00880568|580133246|FG002|Overall Study|Disease progression|3|||
160658955|NCT00880568|580133247|FG003|Overall Study|Disease progression|1|||
160658956|NCT00880568|580133248|FG004|Overall Study|Disease progression|3|||
160658957|NCT00880568|580133249|FG005|Overall Study|Disease progression|3|||
160596363|NCT00006604|579899931|FG009|Overall Study|Lost to Follow-up|2|||
160596364|NCT00006604|579899932|FG010|Overall Study|Lost to Follow-up|0|||
160596365|NCT00006604|579899933|FG011|Overall Study|Lost to Follow-up|0|||
160596366|NCT00006604|579899934|FG012|Overall Study|Lost to Follow-up|0|||
160596367|NCT00006604|579899935|FG013|Overall Study|Lost to Follow-up|0|||
160596368|NCT00006604|579899936|FG014|Overall Study|Lost to Follow-up|0|||
160596369|NCT00006604|579899937|FG015|Overall Study|Lost to Follow-up|1|||
160658958|NCT00880568|580133250|FG006|Overall Study|Disease progression|5|||
160658959|NCT00880568|580133251|FG007|Overall Study|Disease progression|0|||
160658960|NCT00880568|580133252|FG008|Overall Study|Disease progression|3|||
160658961|NCT00880568|580133244|FG000|Overall Study|Adverse Event|0|||
160658962|NCT00880568|580133245|FG001|Overall Study|Adverse Event|0|||
160658963|NCT00880568|580133246|FG002|Overall Study|Adverse Event|0|||
160658964|NCT00880568|580133247|FG003|Overall Study|Adverse Event|0|||
160658965|NCT00880568|580133248|FG004|Overall Study|Adverse Event|0|||
160658966|NCT00880568|580133249|FG005|Overall Study|Adverse Event|0|||
160658967|NCT00880568|580133250|FG006|Overall Study|Adverse Event|1|||
160658968|NCT00880568|580133251|FG007|Overall Study|Adverse Event|1|||
160658969|NCT00880568|580133252|FG008|Overall Study|Adverse Event|0|||
160658970|NCT00880568|580133244|FG000|Overall Study|Withdrawal by Subject|0|||
160658971|NCT00880568|580133245|FG001|Overall Study|Withdrawal by Subject|0|||
160658972|NCT00880568|580133246|FG002|Overall Study|Withdrawal by Subject|0|||
160658973|NCT00880568|580133247|FG003|Overall Study|Withdrawal by Subject|0|||
160658974|NCT00880568|580133248|FG004|Overall Study|Withdrawal by Subject|0|||
160658975|NCT00880568|580133249|FG005|Overall Study|Withdrawal by Subject|0|||
160658976|NCT00880568|580133250|FG006|Overall Study|Withdrawal by Subject|0|||
160658977|NCT00880568|580133251|FG007|Overall Study|Withdrawal by Subject|1|||
160658978|NCT00880568|580133252|FG008|Overall Study|Withdrawal by Subject|0|||
160658979|NCT00620022|580133253|FG000|Treatment Period 1|Adverse Event|4|||
160658980|NCT00620022|580133254|FG001|Treatment Period 1|Adverse Event|6|||
160658981|NCT00620022|580133253|FG000|Treatment Period 1|Subject withdrew consent|1|||
160658982|NCT00620022|580133254|FG001|Treatment Period 1|Subject withdrew consent|0|||
160658983|NCT00620022|580133253|FG000|Treatment Period 2|Adverse Event|2|||
160658984|NCT00620022|580133254|FG001|Treatment Period 2|Adverse Event|2|||
160658985|NCT00760266|580133256|FG000|Overall Study|Adverse Event|13|||
160658986|NCT00760266|580133257|FG001|Overall Study|Adverse Event|7|||
160658987|NCT00760266|580133256|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160658988|NCT00760266|580133257|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160658989|NCT00760266|580133256|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160658990|NCT00760266|580133257|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160658991|NCT00760266|580133256|FG000|Overall Study|Lack of Efficacy|2|||
160465802|NCT03211247|579433881|FG002|Overall Study|Physician Decision|0|||
160465803|NCT03211247|579433882|FG003|Overall Study|Physician Decision|0|||
160465804|NCT03211247|579433883|FG004|Overall Study|Physician Decision|0|||
160465805|NCT03211247|579433879|FG000|Overall Study|Non-compliance with study drug|2|||
160465806|NCT03211247|579433880|FG001|Overall Study|Non-compliance with study drug|0|||
160465807|NCT03211247|579433881|FG002|Overall Study|Non-compliance with study drug|0|||
160465808|NCT03211247|579433882|FG003|Overall Study|Non-compliance with study drug|0|||
160465809|NCT03211247|579433883|FG004|Overall Study|Non-compliance with study drug|0|||
160465810|NCT03211247|579433879|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
160658992|NCT00760266|580133257|FG001|Overall Study|Lack of Efficacy|2|||
160658993|NCT00760266|580133256|FG000|Overall Study|Protocol deviation|2|||
160658994|NCT00760266|580133257|FG001|Overall Study|Protocol deviation|4|||
160658995|NCT00760266|580133256|FG000|Overall Study|Patient withdrew consent|3|||
160658996|NCT00760266|580133257|FG001|Overall Study|Patient withdrew consent|3|||
160658997|NCT00760266|580133256|FG000|Overall Study|Lost to Follow-up|2|||
160465811|NCT03211247|579433880|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
160465812|NCT03211247|579433881|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
160465813|NCT03211247|579433882|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
160465814|NCT03211247|579433883|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
160596370|NCT00006604|579899938|FG016|Overall Study|Lost to Follow-up|3|||
160596371|NCT00006604|579899922|FG000|Overall Study|Other Reason|0|||
160596372|NCT00006604|579899923|FG001|Overall Study|Other Reason|0|||
160596373|NCT00006604|579899924|FG002|Overall Study|Other Reason|0|||
160596374|NCT00006604|579899925|FG003|Overall Study|Other Reason|0|||
160596375|NCT00006604|579899926|FG004|Overall Study|Other Reason|0|||
160596376|NCT00006604|579899927|FG005|Overall Study|Other Reason|1|||
160596377|NCT00006604|579899928|FG006|Overall Study|Other Reason|0|||
160596378|NCT00006604|579899929|FG007|Overall Study|Other Reason|0|||
160596379|NCT00006604|579899930|FG008|Overall Study|Other Reason|0|||
160596380|NCT00006604|579899931|FG009|Overall Study|Other Reason|1|||
160596381|NCT00006604|579899932|FG010|Overall Study|Other Reason|0|||
160596382|NCT00006604|579899933|FG011|Overall Study|Other Reason|0|||
160596383|NCT00006604|579899934|FG012|Overall Study|Other Reason|0|||
160596384|NCT00006604|579899935|FG013|Overall Study|Other Reason|0|||
160596385|NCT00006604|579899936|FG014|Overall Study|Other Reason|0|||
160596386|NCT00006604|579899937|FG015|Overall Study|Other Reason|0|||
160596387|NCT00006604|579899938|FG016|Overall Study|Other Reason|0|||
160596388|NCT02431468|579899939|FG000|Overall Study|Adverse Event|2|||
160596389|NCT02431468|579899940|FG001|Overall Study|Adverse Event|4|||
160596390|NCT02431468|579899941|FG002|Overall Study|Adverse Event|5|||
160596391|NCT02431468|579899939|FG000|Overall Study|Withdrawal by Subject|4|||
160596392|NCT02431468|579899940|FG001|Overall Study|Withdrawal by Subject|12|||
160596393|NCT02431468|579899941|FG002|Overall Study|Withdrawal by Subject|2|||
160596394|NCT02431468|579899939|FG000|Overall Study|noncompliance, investigator termination,|2|||
160596395|NCT02431468|579899940|FG001|Overall Study|noncompliance, investigator termination,|2|||
160596396|NCT02431468|579899941|FG002|Overall Study|noncompliance, investigator termination,|2|||
160596397|NCT01056341|579899942|FG000|Overall Study|Treatment Intolerance|0|||
160596398|NCT01056341|579899943|FG001|Overall Study|Treatment Intolerance|2|||
160596399|NCT01056341|579899944|FG002|Overall Study|Treatment Intolerance|0|||
160596400|NCT01056341|579899945|FG003|Overall Study|Treatment Intolerance|2|||
160596401|NCT01056341|579899946|FG004|Overall Study|Treatment Intolerance|0|||
160596402|NCT01056341|579899942|FG000|Overall Study|Lack of Efficacy|32|||
160596403|NCT01056341|579899943|FG001|Overall Study|Lack of Efficacy|30|||
160596404|NCT01056341|579899944|FG002|Overall Study|Lack of Efficacy|7|||
160596405|NCT01056341|579899945|FG003|Overall Study|Lack of Efficacy|25|||
160596406|NCT01056341|579899946|FG004|Overall Study|Lack of Efficacy|9|||
160596407|NCT01056341|579899942|FG000|Overall Study|Other reasons|4|||
160596408|NCT01056341|579899943|FG001|Overall Study|Other reasons|4|||
160596409|NCT01056341|579899944|FG002|Overall Study|Other reasons|8|||
160596410|NCT01056341|579899945|FG003|Overall Study|Other reasons|9|||
160596411|NCT01056341|579899946|FG004|Overall Study|Other reasons|5|||
160465815|NCT03211247|579433879|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
160465816|NCT03211247|579433880|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
160465817|NCT03211247|579433881|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
160465818|NCT03211247|579433882|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
160465819|NCT03211247|579433883|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
160465820|NCT03211247|579433879|FG000|Overall Study|Protocol Violation|0|||
160465821|NCT03211247|579433880|FG001|Overall Study|Protocol Violation|1|||
160465822|NCT03211247|579433881|FG002|Overall Study|Protocol Violation|0|||
160465823|NCT03211247|579433882|FG003|Overall Study|Protocol Violation|0|||
160465824|NCT03211247|579433883|FG004|Overall Study|Protocol Violation|0|||
160465825|NCT02415127|579433884|FG000|Overall Study|Adverse Event|1|||
160465826|NCT02415127|579433885|FG001|Overall Study|Adverse Event|0|||
160465827|NCT05464732|579433888|FG000|Overall Study|Lost to Follow-up|0|||
160465828|NCT05464732|579433889|FG001|Overall Study|Lost to Follow-up|1|||
160465829|NCT05464732|579433888|FG000|Overall Study|Adverse Event|1|||
160465830|NCT05464732|579433889|FG001|Overall Study|Adverse Event|0|||
160465831|NCT03997474|579433890|FG000|Overall Study|Death|6|||
160465832|NCT03997474|579433891|FG001|Overall Study|Death|2|||
160465833|NCT03997474|579433892|FG002|Overall Study|Death|1|||
160465834|NCT03997474|579433890|FG000|Overall Study|Physician Decision|2|||
160465835|NCT03997474|579433891|FG001|Overall Study|Physician Decision|0|||
160465836|NCT03997474|579433892|FG002|Overall Study|Physician Decision|0|||
160465837|NCT03997474|579433890|FG000|Overall Study|study terminated by sponsor|1|||
160465838|NCT03997474|579433891|FG001|Overall Study|study terminated by sponsor|0|||
160465839|NCT03997474|579433892|FG002|Overall Study|study terminated by sponsor|1|||
160465840|NCT03277989|579433893|FG000|Overall Study|Lost to Follow-up|6|||
160465841|NCT03277989|579433893|FG000|Overall Study|Adverse Event|6|||
160465842|NCT03277989|579433893|FG000|Overall Study|Withdrawal by Subject|3|||
160465843|NCT03277989|579433893|FG000|Overall Study|Didn't Receive Study Device|7|||
160465844|NCT03277989|579433893|FG000|Overall Study|Site Closure|26|||
160465845|NCT03277989|579433893|FG000|Overall Study|Sponsor Closure|107|||
160465846|NCT05349838|579433894|FG000|Overall Study|Virological Failure|1|||
160465847|NCT05349838|579433895|FG001|Overall Study|Virological Failure|2|||
160465848|NCT05349838|579433894|FG000|Overall Study|Withdrawal by Subject|2|||
160465849|NCT05349838|579433895|FG001|Overall Study|Withdrawal by Subject|3|||
160465850|NCT05349838|579433894|FG000|Overall Study|Adverse Event|3|||
160465851|NCT05349838|579433895|FG001|Overall Study|Adverse Event|1|||
160465852|NCT05349838|579433894|FG000|Overall Study|Lost to Follow-up|1|||
160465853|NCT05349838|579433895|FG001|Overall Study|Lost to Follow-up|2|||
160465854|NCT05349838|579433894|FG000|Overall Study|Other reasons|5|||
160465855|NCT05349838|579433895|FG001|Overall Study|Other reasons|1|||
160465856|NCT05071430|579433897|FG000|Overall Study|Adverse Event|1|||
160465857|NCT05071430|579433898|FG001|Overall Study|Adverse Event|2|||
160465858|NCT05071430|579433897|FG000|Overall Study|Lost to Follow-up|4|||
160465859|NCT05071430|579433898|FG001|Overall Study|Lost to Follow-up|4|||
160465860|NCT05071430|579433897|FG000|Overall Study|Protocol Violation|1|||
160465861|NCT05071430|579433898|FG001|Overall Study|Protocol Violation|0|||
160465862|NCT05071430|579433897|FG000|Overall Study|Withdrawal by Subject|3|||
160465863|NCT05071430|579433898|FG001|Overall Study|Withdrawal by Subject|2|||
160465864|NCT05071430|579433897|FG000|Overall Study|Other|1|||
160465865|NCT05071430|579433898|FG001|Overall Study|Other|1|||
160465866|NCT01958021|579433901|FG000|Treatment|Progressive disease|206|||
160465867|NCT01958021|579433902|FG001|Treatment|Progressive disease|265|||
160596412|NCT01361919|579899947|FG000|Overall Study|technical issues|10|||
160596413|NCT01361919|579899948|FG001|Overall Study|technical issues|12|||
160596414|NCT01361919|579899949|FG002|Overall Study|technical issues|10|||
160465868|NCT01958021|579433901|FG000|Treatment|Adverse Event|38|||
160465869|NCT01958021|579433902|FG001|Treatment|Adverse Event|10|||
160465870|NCT01958021|579433901|FG000|Treatment|Subject/guardian decision|29|||
160465871|NCT01958021|579433902|FG001|Treatment|Subject/guardian decision|25|||
160465872|NCT01958021|579433901|FG000|Treatment|Physician Decision|28|||
160465873|NCT01958021|579433902|FG001|Treatment|Physician Decision|21|||
160465874|NCT01958021|579433901|FG000|Treatment|Death|6|||
160465875|NCT01958021|579433902|FG001|Treatment|Death|1|||
160465876|NCT01958021|579433901|FG000|Treatment|Protocol deviation|3|||
160465877|NCT01958021|579433902|FG001|Treatment|Protocol deviation|1|||
160596415|NCT03454412|579899950|FG000|Baseline Assesment|Physician Decision|12|||
160465878|NCT01958021|579433901|FG000|Treatment|Sponsor decision|24|||
160465879|NCT01958021|579433902|FG001|Treatment|Sponsor decision|11|||
160596416|NCT02227108|579899955|FG000|Overall Study|Did not receive treatment|2|||
160465880|NCT01958021|579433901|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
160465881|NCT01958021|579433902|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160465882|NCT01958021|579433901|FG000|Post-treatment Efficacy Follow-up|Death|1|||
160465883|NCT01958021|579433902|FG001|Post-treatment Efficacy Follow-up|Death|0|||
160465884|NCT01958021|579433901|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
160465885|NCT01958021|579433902|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160465886|NCT01958021|579433901|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160465887|NCT01958021|579433902|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
160596417|NCT02227108|579899955|FG000|Overall Study|Other|3|||
160596418|NCT02227108|579899955|FG000|Overall Study|Progressive disease|17|||
160596419|NCT02227108|579899955|FG000|Overall Study|Initiation of alternative therapy|2|||
160658998|NCT00760266|580133257|FG001|Overall Study|Lost to Follow-up|1|||
160465888|NCT01958021|579433901|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
160465889|NCT01958021|579433902|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
160465890|NCT01958021|579433901|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
160465891|NCT01958021|579433902|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
160465892|NCT01958021|579433901|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
160465893|NCT01958021|579433902|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
160465894|NCT05037513|579433904|FG000|Intervention Period|Lost to Follow-up|1|||
160465895|NCT05037513|579433905|FG001|Intervention Period|Lost to Follow-up|2|||
160465896|NCT05037513|579433904|FG000|Follow Up Period|Lost to Follow-up|16|||
160465897|NCT05037513|579433905|FG001|Follow Up Period|Lost to Follow-up|21|||
160465898|NCT05037513|579433904|FG000|Follow Up Period|Death|0|||
160465899|NCT05037513|579433905|FG001|Follow Up Period|Death|1|||
160465900|NCT05037513|579433904|FG000|Follow Up Period|Incarcerated|4|||
160465901|NCT05037513|579433905|FG001|Follow Up Period|Incarcerated|2|||
160465902|NCT03664804|579433907|FG000|Overall Study|Withdrawal by Subject|7|||
160465903|NCT05529992|579433908|FG000|Overall Study|Withdrawal by Subject|1|||
160596420|NCT02227108|579899955|FG000|Overall Study|Investigator discretion|1|||
160596421|NCT02227108|579899955|FG000|Overall Study|Adverse Event|6|||
160596422|NCT02486952|579899956|FG000|Overall Study|Not Started Induction Therapy|3|||
160596423|NCT02486952|579899956|FG000|Overall Study|Adverse Event|1|||
160596424|NCT02486952|579899956|FG000|Overall Study|Death|15|||
160596425|NCT02486952|579899956|FG000|Overall Study|Lack of Efficacy|3|||
160596426|NCT02486952|579899956|FG000|Overall Study|Lost to Follow-up|26|||
160596427|NCT02486952|579899956|FG000|Overall Study|Other|2|||
160596428|NCT03589885|579899957|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
160596429|NCT03589885|579899958|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
160596430|NCT03589885|579899959|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
160596431|NCT03589885|579899960|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
160596432|NCT03589885|579899961|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
160596433|NCT03589885|579899957|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
160596434|NCT03589885|579899958|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
160596435|NCT03589885|579899959|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
160596436|NCT03589885|579899960|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
160596437|NCT03589885|579899961|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
160596438|NCT03589885|579899957|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
160596439|NCT03589885|579899958|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
160596440|NCT03589885|579899959|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
160596441|NCT03589885|579899960|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
160596442|NCT03589885|579899961|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
160596443|NCT03589885|579899957|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
160596444|NCT03589885|579899958|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
160596445|NCT03589885|579899959|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
160596446|NCT03589885|579899960|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
160596447|NCT03589885|579899961|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
160596448|NCT03589885|579899957|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
160596449|NCT03589885|579899958|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
160596450|NCT03589885|579899959|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
160596451|NCT03589885|579899960|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
160596452|NCT03589885|579899961|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
160596453|NCT03589885|579899957|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
160596454|NCT03589885|579899958|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
160596455|NCT03589885|579899959|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
160596456|NCT03589885|579899960|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
160596457|NCT03589885|579899961|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
160596458|NCT03589885|579899957|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
160596459|NCT03589885|579899958|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
160596460|NCT03589885|579899959|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
160596461|NCT03589885|579899960|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
160596462|NCT03589885|579899961|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
160596463|NCT03589885|579899957|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
160596464|NCT03589885|579899958|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
160465904|NCT06140290|579433910|FG000|Period 1|Adverse Event|1|||
160596465|NCT03589885|579899959|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
160596466|NCT03589885|579899960|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
160596467|NCT03589885|579899961|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
160596468|NCT04111107|579899962|FG000|Overall Study|Withdrawal by Subject|6|||
160465905|NCT06140290|579433911|FG001|Period 1|Adverse Event|0|||
160596469|NCT04111107|579899962|FG000|Overall Study|Declining Health|5|||
160465906|NCT06140290|579433910|FG000|Period 2|Assigned but not treated|0|||
160465907|NCT06140290|579433911|FG001|Period 2|Assigned but not treated|1|||
160596470|NCT01928485|579899963|FG000|Overall Study|Physician Decision|0|||
160596471|NCT01928485|579899964|FG001|Overall Study|Physician Decision|1|||
160596472|NCT00946881|579899967|FG000|First Treatment|Withdrawal by Subject|1|||
160596473|NCT00946881|579899967|FG000|First Treatment|Patient relocated to another state|1|||
160596474|NCT00946881|579899967|FG000|Retreatment|Withdrawal by Subject|1|||
160596475|NCT00293423|579899968|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
160596476|NCT00293423|579899969|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
160465908|NCT06140290|579433910|FG000|Period 2|Withdrawal by Subject|0|||
160465909|NCT06140290|579433911|FG001|Period 2|Withdrawal by Subject|1|||
160596477|NCT00293423|579899968|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
160596478|NCT00293423|579899969|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
160596479|NCT00293423|579899968|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
160596480|NCT00293423|579899969|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
160596481|NCT00293423|579899968|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
160596482|NCT00293423|579899969|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
160596483|NCT00293423|579899968|FG000|Surgical Resection|processing error during surgical resection|1|||
160596484|NCT00293423|579899969|FG001|Surgical Resection|processing error during surgical resection|0|||
160596485|NCT00293423|579899968|FG000|Surgical Resection|Withdrawal by Subject|4|||
160596486|NCT00293423|579899969|FG001|Surgical Resection|Withdrawal by Subject|0|||
160596487|NCT00293423|579899968|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
160596488|NCT00293423|579899969|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
160596489|NCT01182337|579899974|FG000|Overall Study|Withdrawal by Subject|3|||
160596490|NCT01182337|579899975|FG001|Overall Study|Withdrawal by Subject|1|||
160596491|NCT01182337|579899974|FG000|Overall Study|Lost to Follow-up|0|||
160596492|NCT01182337|579899975|FG001|Overall Study|Lost to Follow-up|1|||
160596493|NCT01714817|579899976|FG000|Year 1 Period|Lack of Efficacy|11|||
160596494|NCT01714817|579899977|FG001|Year 1 Period|Lack of Efficacy|9|||
160596495|NCT01714817|579899976|FG000|Year 1 Period|Adverse Event|20|||
160596496|NCT01714817|579899977|FG001|Year 1 Period|Adverse Event|17|||
160596497|NCT01714817|579899976|FG000|Year 1 Period|Withdrawal by Subject|6|||
160465910|NCT02036970|579435248|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
160465911|NCT02036970|579435249|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
160658999|NCT00760266|580133256|FG000|Overall Study|Administrative Problems|0|||
160596498|NCT01714817|579899977|FG001|Year 1 Period|Withdrawal by Subject|7|||
160596499|NCT01714817|579899976|FG000|Year 1 Period|Death|1|||
160596500|NCT01714817|579899977|FG001|Year 1 Period|Death|1|||
160596501|NCT01714817|579899976|FG000|Year 1 Period|Lost to Follow-up|0|||
160596502|NCT01714817|579899977|FG001|Year 1 Period|Lost to Follow-up|2|||
160596503|NCT01714817|579899976|FG000|Year 1 Period|Poor / non-compliance|0|||
160596504|NCT01714817|579899977|FG001|Year 1 Period|Poor / non-compliance|1|||
160596505|NCT01714817|579899976|FG000|Year 1 Period|Pregnancy|2|||
160596506|NCT01714817|579899977|FG001|Year 1 Period|Pregnancy|0|||
160596507|NCT01714817|579899976|FG000|Year 1 Period|Participant no longer meets criteria|6|||
160596508|NCT01714817|579899977|FG001|Year 1 Period|Participant no longer meets criteria|2|||
160596509|NCT01714817|579899976|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
160596510|NCT01714817|579899977|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
160596511|NCT01714817|579899976|FG000|Year 1 Period|Change in Concomitant Medication|0|||
160596512|NCT01714817|579899977|FG001|Year 1 Period|Change in Concomitant Medication|1|||
160596513|NCT01714817|579899976|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
160596514|NCT01714817|579899977|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
160596515|NCT01714817|579899976|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
160596516|NCT01714817|579899977|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
160596517|NCT01714817|579899976|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
160596518|NCT01714817|579899977|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
160596519|NCT01714817|579899976|FG000|Year 2 Period|Lack of Efficacy|4|||
160596520|NCT01714817|579899977|FG001|Year 2 Period|Lack of Efficacy|12|||
160596521|NCT01714817|579899976|FG000|Year 2 Period|Adverse Event|7|||
160596522|NCT01714817|579899977|FG001|Year 2 Period|Adverse Event|6|||
160596523|NCT01714817|579899976|FG000|Year 2 Period|Participant request to stop treatment|4|||
160596524|NCT01714817|579899977|FG001|Year 2 Period|Participant request to stop treatment|4|||
160596525|NCT01714817|579899976|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
160596526|NCT01714817|579899977|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
160596527|NCT01714817|579899976|FG000|Year 2 Period|Participant withdrew consent|1|||
160596528|NCT01714817|579899977|FG001|Year 2 Period|Participant withdrew consent|5|||
160596529|NCT01714817|579899976|FG000|Year 2 Period|Participant no longer meets criteria|1|||
160596530|NCT01714817|579899977|FG001|Year 2 Period|Participant no longer meets criteria|4|||
160596531|NCT01714817|579899976|FG000|Year 2 Period|Lost to Follow-up|2|||
160596532|NCT01714817|579899977|FG001|Year 2 Period|Lost to Follow-up|0|||
160465912|NCT02036970|579435250|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
160465913|NCT02036970|579435251|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
160465914|NCT02036970|579435252|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
160465915|NCT02036970|579435253|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
160465916|NCT02036970|579435254|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
160465917|NCT02036970|579435255|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
160465918|NCT02036970|579435256|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
160465919|NCT02036970|579435257|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
160465920|NCT02036970|579435248|FG000|Part 1: Day 1 Through Week 16|Death|0|||
160465921|NCT02036970|579435249|FG001|Part 1: Day 1 Through Week 16|Death|0|||
160465922|NCT02036970|579435250|FG002|Part 1: Day 1 Through Week 16|Death|0|||
160465923|NCT02036970|579435251|FG003|Part 1: Day 1 Through Week 16|Death|0|||
160465924|NCT02036970|579435252|FG004|Part 1: Day 1 Through Week 16|Death|0|||
160465925|NCT02036970|579435253|FG005|Part 1: Day 1 Through Week 16|Death|0|||
160465926|NCT02036970|579435254|FG006|Part 1: Day 1 Through Week 16|Death|0|||
160465927|NCT02036970|579435255|FG007|Part 1: Day 1 Through Week 16|Death|0|||
160465928|NCT02036970|579435256|FG008|Part 1: Day 1 Through Week 16|Death|1|||
160465929|NCT02036970|579435257|FG009|Part 1: Day 1 Through Week 16|Death|0|||
160465930|NCT02036970|579435248|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
160465931|NCT02036970|579435249|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
160465932|NCT02036970|579435250|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
160465933|NCT02036970|579435251|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
160465934|NCT02036970|579435252|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
160465935|NCT02036970|579435253|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
160465936|NCT02036970|579435254|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
160596533|NCT01714817|579899976|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
160596534|NCT01714817|579899977|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
160465937|NCT02036970|579435255|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
160465938|NCT02036970|579435256|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
160465939|NCT02036970|579435257|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
160465940|NCT02036970|579435248|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
160465941|NCT02036970|579435249|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
160596535|NCT01714817|579899976|FG000|Year 2 Period|Pregnancy|1|||
160596536|NCT01714817|579899977|FG001|Year 2 Period|Pregnancy|1|||
160596537|NCT01714817|579899976|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
160596538|NCT01714817|579899977|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
160596539|NCT01714817|579899976|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
160596540|NCT01714817|579899977|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
160596541|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
160596542|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
160596543|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
160596544|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
160596545|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
160596546|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
160596547|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
160596548|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
160596549|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
160596550|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
160596551|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
160596552|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
160596553|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
160596554|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
160596555|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
160596556|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
160596557|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
160596558|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
160596559|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
160596560|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
160596561|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
160596562|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
160596563|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
160596564|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
160596565|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
160596566|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
160596567|NCT01714817|579899976|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
160596568|NCT01714817|579899977|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
160596569|NCT01374217|579899978|FG000|Overall Study|Lack of Efficacy|13|||
160596570|NCT02807363|579899981|FG000|Dosing Period|Adverse Event|0|||
160596571|NCT02807363|579899982|FG001|Dosing Period|Adverse Event|1|||
160596572|NCT02807363|579899983|FG002|Dosing Period|Adverse Event|0|||
160596573|NCT02807363|579899984|FG003|Dosing Period|Adverse Event|0|||
160596574|NCT00010803|579901609|FG000|Overall Study|Withdrawal by Subject|97|||
160596575|NCT00010803|579901610|FG001|Overall Study|Withdrawal by Subject|98|||
160596576|NCT03485222|579901611|FG000|Overall Study|Death|0|||
160596577|NCT03485222|579901612|FG001|Overall Study|Death|1|||
160596578|NCT03485222|579901611|FG000|Overall Study|Lost to Follow-up|2|||
160596579|NCT03485222|579901612|FG001|Overall Study|Lost to Follow-up|1|||
160596580|NCT01373918|579901615|FG000|Overall Study|Physician Decision|0|||
160596581|NCT01373918|579901616|FG001|Overall Study|Physician Decision|1|||
160596582|NCT01457924|579901621|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
160596583|NCT01457924|579901622|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
160596584|NCT01457924|579901623|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
160596585|NCT01457924|579901624|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
160596586|NCT01457924|579901625|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
160596587|NCT01457924|579901621|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
160596588|NCT01457924|579901622|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
160596589|NCT01457924|579901623|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
160596590|NCT01457924|579901624|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
160596591|NCT01457924|579901625|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
160596592|NCT01457924|579901621|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
160596593|NCT01457924|579901622|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
160596594|NCT01457924|579901623|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
160596595|NCT01457924|579901624|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
160596596|NCT01457924|579901625|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
160596597|NCT01457924|579901621|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
160596598|NCT01457924|579901622|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
160596599|NCT01457924|579901623|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
160596600|NCT01457924|579901624|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
160596601|NCT01457924|579901625|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
160596602|NCT01457924|579901621|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
160596603|NCT01457924|579901622|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
160596604|NCT01457924|579901623|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
160596605|NCT01457924|579901624|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
160596606|NCT01457924|579901625|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
160596607|NCT01457924|579901621|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
160596608|NCT01457924|579901622|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
160596609|NCT01457924|579901623|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
160596610|NCT01457924|579901624|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
160596611|NCT01457924|579901625|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
160596612|NCT01457924|579901621|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
160596613|NCT01457924|579901622|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
160596614|NCT01457924|579901623|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
160596615|NCT01457924|579901624|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
160596616|NCT01457924|579901625|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
160596617|NCT01457924|579901621|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
160596618|NCT01457924|579901622|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
160596619|NCT01457924|579901623|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
160596620|NCT01457924|579901624|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
160596621|NCT01457924|579901625|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
160596622|NCT01457924|579901621|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
160596623|NCT01457924|579901622|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
160596624|NCT01457924|579901623|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
160596625|NCT01457924|579901624|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
160596626|NCT01457924|579901625|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
160596627|NCT01457924|579901621|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
160596628|NCT01457924|579901622|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
160596629|NCT01457924|579901623|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
160596630|NCT01457924|579901624|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
160596631|NCT01457924|579901625|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
160596632|NCT01457924|579901621|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
160596633|NCT01457924|579901622|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
160596634|NCT01457924|579901623|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
160596635|NCT01457924|579901624|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
160596636|NCT01457924|579901625|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
160596637|NCT01457924|579901621|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
160596638|NCT01457924|579901622|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
160596639|NCT01457924|579901623|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
160465942|NCT02036970|579435250|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
160465943|NCT02036970|579435251|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
160465944|NCT02036970|579435252|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
160465945|NCT02036970|579435253|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
160465946|NCT02036970|579435254|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
160465947|NCT02036970|579435255|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
160465948|NCT02036970|579435256|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
160596640|NCT01457924|579901624|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
160596641|NCT01457924|579901625|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
160465949|NCT02036970|579435257|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
160596642|NCT01457924|579901621|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
160596643|NCT01457924|579901622|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
160596644|NCT01457924|579901623|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
160596645|NCT01457924|579901624|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
160596646|NCT01457924|579901625|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
160596647|NCT02505542|579901628|FG000|Part A: Open-Label Period|Adverse Event|31|||
160596648|NCT02505542|579901629|FG001|Part A: Open-Label Period|Adverse Event|0|||
160596649|NCT02505542|579901630|FG002|Part A: Open-Label Period|Adverse Event|0|||
160596650|NCT02505542|579901631|FG003|Part A: Open-Label Period|Adverse Event|0|||
160596651|NCT02505542|579901628|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
160596652|NCT02505542|579901629|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
160659000|NCT00760266|580133257|FG001|Overall Study|Administrative Problems|1|||
160659001|NCT01239121|580133258|FG000|Overall Study|Withdrawal by Subject|2|||
160465950|NCT02036970|579435248|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
160465951|NCT02036970|579435249|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
160465952|NCT02036970|579435250|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
160465953|NCT02036970|579435251|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
160465954|NCT02036970|579435252|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
160465955|NCT02036970|579435253|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
160465956|NCT02036970|579435254|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
160465957|NCT02036970|579435255|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
160465958|NCT02036970|579435256|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
160465959|NCT02036970|579435257|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
160465960|NCT02036970|579435248|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
160465961|NCT02036970|579435249|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
160465962|NCT02036970|579435250|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
160465963|NCT02036970|579435251|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
160465964|NCT02036970|579435252|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
160465965|NCT02036970|579435253|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
160465966|NCT02036970|579435254|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
160465967|NCT02036970|579435255|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
160465968|NCT02036970|579435256|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
160465969|NCT02036970|579435257|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
160465970|NCT02036970|579435248|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
160465971|NCT02036970|579435249|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
160465972|NCT02036970|579435250|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
160465973|NCT02036970|579435251|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
160465974|NCT02036970|579435252|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
160465975|NCT02036970|579435253|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
160465976|NCT02036970|579435254|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
160465977|NCT02036970|579435255|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
160465978|NCT02036970|579435256|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
160465979|NCT02036970|579435257|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
160465980|NCT02036970|579435248|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
160465981|NCT02036970|579435249|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
160465982|NCT02036970|579435250|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
160465983|NCT02036970|579435251|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
160465984|NCT02036970|579435252|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
160465985|NCT02036970|579435253|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
160465986|NCT02036970|579435254|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
160465987|NCT02036970|579435255|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
160465988|NCT02036970|579435256|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
160465989|NCT02036970|579435257|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
160465990|NCT02036970|579435248|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
160465991|NCT02036970|579435249|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
160465992|NCT02036970|579435250|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
160465993|NCT02036970|579435251|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
160465994|NCT02036970|579435252|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
160465995|NCT02036970|579435253|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
160465996|NCT02036970|579435254|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
160465997|NCT02036970|579435255|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
160465998|NCT02036970|579435256|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
160465999|NCT02036970|579435257|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
160466000|NCT02702843|579435258|FG000|Overall Study|Insufficient data to analyze|15|||
160466001|NCT02702843|579435259|FG001|Overall Study|Insufficient data to analyze|23|||
160466002|NCT02232737|579435263|FG000|Overall Study|Lost to Follow-up|18|||
160466003|NCT02232737|579435264|FG001|Overall Study|Lost to Follow-up|28|||
160466004|NCT02232737|579435265|FG002|Overall Study|Lost to Follow-up|33|||
160466005|NCT02232737|579435263|FG000|Overall Study|Personal reasons|7|||
160466006|NCT02232737|579435264|FG001|Overall Study|Personal reasons|8|||
160466007|NCT02232737|579435265|FG002|Overall Study|Personal reasons|14|||
160466008|NCT02232737|579435263|FG000|Overall Study|Adverse Event|6|||
160466009|NCT02232737|579435264|FG001|Overall Study|Adverse Event|3|||
160466010|NCT02232737|579435265|FG002|Overall Study|Adverse Event|8|||
160466011|NCT02232737|579435263|FG000|Overall Study|Incarcerated|2|||
160466012|NCT02232737|579435264|FG001|Overall Study|Incarcerated|1|||
160466013|NCT02232737|579435265|FG002|Overall Study|Incarcerated|2|||
160466014|NCT02232737|579435263|FG000|Overall Study|Withdrawal by Subject|0|||
160466015|NCT02232737|579435264|FG001|Overall Study|Withdrawal by Subject|1|||
160466016|NCT02232737|579435265|FG002|Overall Study|Withdrawal by Subject|2|||
160466017|NCT02232737|579435263|FG000|Overall Study|Death|0|||
160466018|NCT02232737|579435264|FG001|Overall Study|Death|1|||
160466019|NCT02232737|579435265|FG002|Overall Study|Death|1|||
160466020|NCT02232737|579435263|FG000|Overall Study|Physician Decision|1|||
160466021|NCT02232737|579435264|FG001|Overall Study|Physician Decision|3|||
160466022|NCT02232737|579435265|FG002|Overall Study|Physician Decision|1|||
160466023|NCT02232737|579435263|FG000|Overall Study|Protocol Violation|1|||
160596653|NCT02505542|579901630|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
160596654|NCT02505542|579901631|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
160596655|NCT02505542|579901628|FG000|Part A: Open-Label Period|Protocol Violation|1|||
160596656|NCT02505542|579901629|FG001|Part A: Open-Label Period|Protocol Violation|0|||
160596657|NCT02505542|579901630|FG002|Part A: Open-Label Period|Protocol Violation|0|||
160596658|NCT02505542|579901631|FG003|Part A: Open-Label Period|Protocol Violation|0|||
160596659|NCT02505542|579901628|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
160596660|NCT02505542|579901629|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
160596661|NCT02505542|579901630|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
160596662|NCT02505542|579901631|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
160596663|NCT02505542|579901628|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
160596664|NCT02505542|579901629|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
160596665|NCT02505542|579901630|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
160596666|NCT02505542|579901631|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
160659002|NCT01239121|580133259|FG001|Overall Study|Withdrawal by Subject|4|||
160466024|NCT02232737|579435264|FG001|Overall Study|Protocol Violation|0|||
160466025|NCT02232737|579435265|FG002|Overall Study|Protocol Violation|1|||
160466026|NCT02232737|579435263|FG000|Overall Study|Reason unknown|1|||
160466027|NCT02232737|579435264|FG001|Overall Study|Reason unknown|0|||
160466028|NCT02232737|579435265|FG002|Overall Study|Reason unknown|0|||
160466029|NCT00065182|579435275|FG000|Overall Study|Adverse Event|24|||
160466030|NCT00065182|579435276|FG001|Overall Study|Adverse Event|17|||
160466031|NCT00065182|579435275|FG000|Overall Study|Lost to Follow-up|0|||
160466032|NCT00065182|579435276|FG001|Overall Study|Lost to Follow-up|4|||
160466033|NCT00065182|579435275|FG000|Overall Study|Protocol Violation|3|||
160466034|NCT00065182|579435276|FG001|Overall Study|Protocol Violation|4|||
160466035|NCT00065182|579435275|FG000|Overall Study|Serious adverse events (SAE)|1|||
160466036|NCT00065182|579435276|FG001|Overall Study|Serious adverse events (SAE)|0|||
160466037|NCT00065182|579435275|FG000|Overall Study|Sponsor Decision|11|||
160466038|NCT00065182|579435276|FG001|Overall Study|Sponsor Decision|7|||
160466039|NCT00065182|579435275|FG000|Overall Study|Withdrawal by Subject|8|||
160466040|NCT00065182|579435276|FG001|Overall Study|Withdrawal by Subject|3|||
160466041|NCT00065182|579435275|FG000|Overall Study|No clinical benefit|1|||
160466042|NCT00065182|579435276|FG001|Overall Study|No clinical benefit|0|||
160466043|NCT00065182|579435275|FG000|Overall Study|Death|0|||
160466044|NCT00065182|579435276|FG001|Overall Study|Death|1|||
160466045|NCT00065182|579435275|FG000|Overall Study|Decline in Status|0|||
160466046|NCT00065182|579435276|FG001|Overall Study|Decline in Status|1|||
160466047|NCT02568215|579435277|FG000|Overall Study|Death|1|||
160466048|NCT02568215|579435278|FG001|Overall Study|Death|2|||
160466049|NCT02568215|579435279|FG002|Overall Study|Death|0|||
160466050|NCT02568215|579435277|FG000|Overall Study|Physician Decision|2|||
160466051|NCT02568215|579435278|FG001|Overall Study|Physician Decision|2|||
160466052|NCT02568215|579435279|FG002|Overall Study|Physician Decision|2|||
160466053|NCT02568215|579435277|FG000|Overall Study|Lost to Follow-up|29|||
160466054|NCT02568215|579435278|FG001|Overall Study|Lost to Follow-up|32|||
160466055|NCT02568215|579435279|FG002|Overall Study|Lost to Follow-up|41|||
160466056|NCT02568215|579435277|FG000|Overall Study|Withdrawal by Subject|21|||
160466057|NCT02568215|579435278|FG001|Overall Study|Withdrawal by Subject|19|||
160466058|NCT02568215|579435279|FG002|Overall Study|Withdrawal by Subject|22|||
160466059|NCT02568215|579435277|FG000|Overall Study|Protocol Violation|1|||
160466060|NCT02568215|579435278|FG001|Overall Study|Protocol Violation|1|||
160466061|NCT02568215|579435279|FG002|Overall Study|Protocol Violation|0|||
160466062|NCT02568215|579435277|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
160466063|NCT02568215|579435278|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
160466064|NCT02568215|579435279|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
160466065|NCT02568215|579435277|FG000|Overall Study|Other|0|||
160466066|NCT02568215|579435278|FG001|Overall Study|Other|1|||
160466067|NCT02568215|579435279|FG002|Overall Study|Other|4|||
160466068|NCT01641900|579435280|FG000|Overall Study|Withdrawal by Subject|2|||
160466069|NCT01641900|579435281|FG001|Overall Study|Withdrawal by Subject|2|||
160466070|NCT02941549|579435282|FG000|Overall Study|Adverse Event|1|||
160466071|NCT02941549|579435283|FG001|Overall Study|Adverse Event|0|||
160466072|NCT02941549|579435284|FG002|Overall Study|Adverse Event|0|||
160466073|NCT02941549|579435282|FG000|Overall Study|Withdrawal by Subject|2|||
160466074|NCT02941549|579435283|FG001|Overall Study|Withdrawal by Subject|1|||
160466075|NCT02941549|579435284|FG002|Overall Study|Withdrawal by Subject|2|||
160466076|NCT00263757|579435285|FG000|Overall Study|Withdrawal by Subject|5|||
160466077|NCT00263757|579435286|FG001|Overall Study|Withdrawal by Subject|4|||
160466078|NCT00263757|579435285|FG000|Overall Study|Screen failure|0|||
160466079|NCT00263757|579435286|FG001|Overall Study|Screen failure|1|||
160466080|NCT00263757|579435285|FG000|Overall Study|Adverse Event|3|||
160466081|NCT00263757|579435286|FG001|Overall Study|Adverse Event|3|||
160466082|NCT00713596|579435287|FG000|Overall Study|Study was terminated|2|||
160466083|NCT00713596|579435288|FG001|Overall Study|Study was terminated|3|||
160596667|NCT02505542|579901628|FG000|Part A: Open-Label Period|New medical history available|1|||
160596668|NCT02505542|579901629|FG001|Part A: Open-Label Period|New medical history available|0|||
160596669|NCT02505542|579901630|FG002|Part A: Open-Label Period|New medical history available|0|||
160466084|NCT00713596|579435289|FG002|Overall Study|Study was terminated|2|||
160466085|NCT04545619|579435290|FG000|Overall Study|due to equipment challenges|1|||
160466086|NCT03712371|579435291|FG000|Overall Study|Lack of Efficacy|0|||
160466087|NCT03712371|579435292|FG001|Overall Study|Lack of Efficacy|0|||
160466088|NCT03712371|579435293|FG002|Overall Study|Lack of Efficacy|0|||
160466089|NCT03712371|579435294|FG003|Overall Study|Lack of Efficacy|1|||
160466090|NCT04949542|579435304|FG000|Overall Study|Lost to Follow-up|4|||
160466091|NCT04949542|579435305|FG001|Overall Study|Lost to Follow-up|1|||
160466092|NCT03021993|579435307|FG000|Overall Study|Withdrawal by Subject|4|||
160466093|NCT03021993|579435307|FG000|Overall Study|Physician Decision|1|||
160466094|NCT03021993|579435307|FG000|Overall Study|enrolled but were not treated|1|||
160466095|NCT03021993|579435307|FG000|Overall Study|Death|3|||
160466096|NCT02101775|579435309|FG000|Overall Study|Adverse Event|4|||
160466097|NCT02101775|579435310|FG001|Overall Study|Adverse Event|0|||
160466098|NCT02101775|579435311|FG002|Overall Study|Adverse Event|0|||
160659003|NCT01239121|580133260|FG002|Overall Study|Withdrawal by Subject|0|||
160596670|NCT02505542|579901631|FG003|Part A: Open-Label Period|New medical history available|0|||
160466099|NCT02101775|579435309|FG000|Overall Study|Admission to Hospital|0|||
160466100|NCT02101775|579435310|FG001|Overall Study|Admission to Hospital|1|||
160466101|NCT02101775|579435311|FG002|Overall Study|Admission to Hospital|0|||
160466102|NCT02029235|579435320|FG000|Overall Study|Non-compliance with study meds or diary|4|||
160466103|NCT02029235|579435321|FG001|Overall Study|Non-compliance with study meds or diary|1|||
160466104|NCT02816398|579435327|FG000|Overall Study|Death|5|||
160466105|NCT02816398|579435327|FG000|Overall Study|Lack of Efficacy|8|||
160466106|NCT02816398|579435327|FG000|Overall Study|Lost to Follow-up|1|||
160466107|NCT01387516|579435328|FG000|Overall Study|Lost to Follow-up|4|||
160466108|NCT01387516|579435329|FG001|Overall Study|Lost to Follow-up|4|||
160466109|NCT01387516|579435330|FG002|Overall Study|Lost to Follow-up|2|||
160466110|NCT01387516|579435331|FG003|Overall Study|Lost to Follow-up|3|||
160466111|NCT01387516|579435328|FG000|Overall Study|Withdrawal by Subject|1|||
160466112|NCT01387516|579435329|FG001|Overall Study|Withdrawal by Subject|1|||
160466113|NCT01387516|579435330|FG002|Overall Study|Withdrawal by Subject|2|||
160466114|NCT01387516|579435331|FG003|Overall Study|Withdrawal by Subject|0|||
160466115|NCT01387516|579435328|FG000|Overall Study|Death|0|||
160466116|NCT01387516|579435329|FG001|Overall Study|Death|0|||
160466117|NCT01387516|579435330|FG002|Overall Study|Death|0|||
160466118|NCT01387516|579435331|FG003|Overall Study|Death|1|||
160466119|NCT03582475|579435332|FG000|Treatment Period|Withdrawal by Subject|0|||
160466120|NCT03582475|579435333|FG001|Treatment Period|Withdrawal by Subject|1|||
160466121|NCT03582475|579435332|FG000|Follow-up Period|Withdrawal by Subject|0|||
160466122|NCT03582475|579435333|FG001|Follow-up Period|Withdrawal by Subject|1|||
160466123|NCT03509909|579435338|FG000|Overall Study|Withdrawal by Subject|16|||
160466124|NCT03509909|579435339|FG001|Overall Study|Withdrawal by Subject|9|||
160466125|NCT03509909|579435338|FG000|Overall Study|Lost to Follow-up|3|||
160466126|NCT03509909|579435339|FG001|Overall Study|Lost to Follow-up|4|||
160466127|NCT03509909|579435338|FG000|Overall Study|Adverse Event|2|||
160466128|NCT03509909|579435339|FG001|Overall Study|Adverse Event|0|||
160466129|NCT01400958|579435341|FG000|Overall Study|Physician Decision|0|||
160466130|NCT01400958|579435342|FG001|Overall Study|Physician Decision|1|||
160466131|NCT01400958|579435341|FG000|Overall Study|Withdrawal by Subject|0|||
160466132|NCT01400958|579435342|FG001|Overall Study|Withdrawal by Subject|1|||
160466133|NCT01400958|579435341|FG000|Overall Study|Adverse Event|1|||
160466134|NCT01400958|579435342|FG001|Overall Study|Adverse Event|0|||
160466135|NCT04801420|579435345|FG000|Overall Study|Other|1|||
160466136|NCT04801420|579435346|FG001|Overall Study|Other|2|||
160466137|NCT04801420|579435347|FG002|Overall Study|Other|1|||
160466138|NCT04801420|579435345|FG000|Overall Study|Lost to Follow-up|7|||
160466139|NCT04801420|579435346|FG001|Overall Study|Lost to Follow-up|9|||
160466140|NCT04801420|579435347|FG002|Overall Study|Lost to Follow-up|10|||
160466141|NCT04801420|579435345|FG000|Overall Study|Moved from study area|0|||
160466142|NCT04801420|579435346|FG001|Overall Study|Moved from study area|1|||
160466143|NCT04801420|579435347|FG002|Overall Study|Moved from study area|1|||
160466144|NCT04801420|579435345|FG000|Overall Study|Withdrawal by Subject|5|||
160466145|NCT04801420|579435346|FG001|Overall Study|Withdrawal by Subject|1|||
160466146|NCT04801420|579435347|FG002|Overall Study|Withdrawal by Subject|4|||
160466147|NCT04801420|579435345|FG000|Overall Study|Individual stopping criteria reached|0|||
160466148|NCT04801420|579435346|FG001|Overall Study|Individual stopping criteria reached|1|||
160466149|NCT04801420|579435347|FG002|Overall Study|Individual stopping criteria reached|0|||
160466150|NCT04801420|579435345|FG000|Overall Study|Ongoing in the study|195|||
160466151|NCT04801420|579435346|FG001|Overall Study|Ongoing in the study|195|||
160466152|NCT04801420|579435347|FG002|Overall Study|Ongoing in the study|192|||
160466153|NCT01855750|579435348|FG000|Overall Study|Death|78|||
160466154|NCT01855750|579435349|FG001|Overall Study|Death|78|||
160466155|NCT01855750|579435348|FG000|Overall Study|Lost to Follow-up|9|||
160466156|NCT01855750|579435349|FG001|Overall Study|Lost to Follow-up|23|||
160466157|NCT01855750|579435348|FG000|Overall Study|Withdrawal by Subject|35|||
160466158|NCT01855750|579435349|FG001|Overall Study|Withdrawal by Subject|28|||
160466159|NCT01855750|579435348|FG000|Overall Study|Sponsor ends the study|297|||
160466160|NCT01855750|579435349|FG001|Overall Study|Sponsor ends the study|290|||
160466161|NCT05379270|579435350|FG000|Overall Study|Withdrawal by Subject|1|||
160466162|NCT05379270|579435351|FG001|Overall Study|Withdrawal by Subject|1|||
160466163|NCT03160885|579435352|FG000|Initial Treatment Period|Not dosed|2|||
160466164|NCT03160885|579435353|FG001|Initial Treatment Period|Not dosed|0|||
160466165|NCT03160885|579435354|FG002|Initial Treatment Period|Not dosed|0|||
160466166|NCT03160885|579435355|FG003|Initial Treatment Period|Not dosed|0|||
160466167|NCT03160885|579435356|FG004|Initial Treatment Period|Not dosed|0|||
160466168|NCT03160885|579435357|FG005|Initial Treatment Period|Not dosed|0|||
160466169|NCT03160885|579435358|FG006|Initial Treatment Period|Not dosed|0|||
160466170|NCT03160885|579435352|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
160466171|NCT03160885|579435353|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
160466172|NCT03160885|579435354|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
160466173|NCT03160885|579435355|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
160466174|NCT03160885|579435356|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
160466175|NCT03160885|579435357|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
160466176|NCT03160885|579435358|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
160466177|NCT03160885|579435352|FG000|Open-label Treatment|Not dosed|0|||
160466178|NCT03160885|579435353|FG001|Open-label Treatment|Not dosed|0|||
160466179|NCT03160885|579435354|FG002|Open-label Treatment|Not dosed|0|||
160466180|NCT03160885|579435355|FG003|Open-label Treatment|Not dosed|0|||
160466181|NCT03160885|579435356|FG004|Open-label Treatment|Not dosed|0|||
160596671|NCT02505542|579901628|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
160596672|NCT02505542|579901629|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
160596673|NCT02505542|579901630|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
160596674|NCT02505542|579901631|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
160596675|NCT02505542|579901628|FG000|Part A: Open-Label Period|Pregnancy|2|||
160596676|NCT02505542|579901629|FG001|Part A: Open-Label Period|Pregnancy|0|||
160596677|NCT02505542|579901630|FG002|Part A: Open-Label Period|Pregnancy|0|||
160659004|NCT04006171|580133263|FG000|Overall Study|Withdrawal by Subject|8|||
160659005|NCT04006171|580133264|FG001|Overall Study|Withdrawal by Subject|7|||
160466182|NCT03160885|579435357|FG005|Open-label Treatment|Not dosed|0|||
160659006|NCT04006171|580133263|FG000|Overall Study|missing serum samples|2|||
160659007|NCT04006171|580133264|FG001|Overall Study|missing serum samples|2|||
160466183|NCT03160885|579435358|FG006|Open-label Treatment|Not dosed|2|||
160466184|NCT03160885|579435352|FG000|Open-label Treatment|Discontinued IMP|0|||
160466185|NCT03160885|579435353|FG001|Open-label Treatment|Discontinued IMP|0|||
160466186|NCT03160885|579435354|FG002|Open-label Treatment|Discontinued IMP|0|||
160466187|NCT03160885|579435355|FG003|Open-label Treatment|Discontinued IMP|0|||
160466188|NCT03160885|579435356|FG004|Open-label Treatment|Discontinued IMP|0|||
160466189|NCT03160885|579435357|FG005|Open-label Treatment|Discontinued IMP|0|||
160466190|NCT03160885|579435358|FG006|Open-label Treatment|Discontinued IMP|131|||
160466191|NCT03160885|579435352|FG000|Open-label Treatment|Completed Week 50|0|||
160466192|NCT03160885|579435353|FG001|Open-label Treatment|Completed Week 50|0|||
160466193|NCT03160885|579435354|FG002|Open-label Treatment|Completed Week 50|0|||
160466194|NCT03160885|579435355|FG003|Open-label Treatment|Completed Week 50|0|||
160466195|NCT03160885|579435356|FG004|Open-label Treatment|Completed Week 50|0|||
160596678|NCT02505542|579901631|FG003|Part A: Open-Label Period|Pregnancy|0|||
160596679|NCT02505542|579901628|FG000|Part A: Open-Label Period|Sponsor directive|1|||
160596680|NCT02505542|579901629|FG001|Part A: Open-Label Period|Sponsor directive|0|||
160596681|NCT02505542|579901630|FG002|Part A: Open-Label Period|Sponsor directive|0|||
160596682|NCT02505542|579901631|FG003|Part A: Open-Label Period|Sponsor directive|0|||
160596683|NCT02505542|579901628|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
160466196|NCT03160885|579435357|FG005|Open-label Treatment|Completed Week 50|0|||
160466197|NCT03160885|579435358|FG006|Open-label Treatment|Completed Week 50|4|||
160466198|NCT03160885|579435352|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
160466199|NCT03160885|579435353|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
160466200|NCT03160885|579435354|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
160466201|NCT03160885|579435355|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
160466202|NCT03160885|579435356|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
160466203|NCT03160885|579435357|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
160466204|NCT03160885|579435358|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
160466205|NCT03160885|579435352|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
160466206|NCT03160885|579435353|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
160466207|NCT03160885|579435354|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
160466208|NCT03160885|579435355|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
160466209|NCT03160885|579435356|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
160466210|NCT03160885|579435357|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
160466211|NCT03160885|579435358|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
160466212|NCT03160885|579435352|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
160466213|NCT03160885|579435353|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
160466214|NCT03160885|579435354|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
160466215|NCT03160885|579435355|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
160466216|NCT03160885|579435356|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
160466217|NCT03160885|579435357|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
160466218|NCT03160885|579435358|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
160466219|NCT03160885|579435352|FG000|Maintenance Treatment Period|Completed Week 50|0|||
160466220|NCT03160885|579435353|FG001|Maintenance Treatment Period|Completed Week 50|0|||
160466221|NCT03160885|579435354|FG002|Maintenance Treatment Period|Completed Week 50|1|||
160466222|NCT03160885|579435355|FG003|Maintenance Treatment Period|Completed Week 50|0|||
160466223|NCT03160885|579435356|FG004|Maintenance Treatment Period|Completed Week 50|0|||
160466224|NCT03160885|579435357|FG005|Maintenance Treatment Period|Completed Week 50|0|||
160466225|NCT03160885|579435358|FG006|Maintenance Treatment Period|Completed Week 50|0|||
160466226|NCT03425682|579435359|FG000|Overall Study|Lost to Follow-up|2|||
160466227|NCT03425682|579435360|FG001|Overall Study|Lost to Follow-up|4|||
160466228|NCT03425682|579435359|FG000|Overall Study|Withdrawal by Subject|0|||
160466229|NCT03425682|579435360|FG001|Overall Study|Withdrawal by Subject|3|||
160466230|NCT03425682|579435359|FG000|Overall Study|Subject did not meet I/E|4|||
160466231|NCT03425682|579435360|FG001|Overall Study|Subject did not meet I/E|10|||
160466232|NCT04153890|579435361|FG000|Overall Study|Lost to Follow-up|9|||
160466233|NCT04153890|579435362|FG001|Overall Study|Lost to Follow-up|0|||
160466234|NCT04153890|579435363|FG002|Overall Study|Lost to Follow-up|9|||
160466235|NCT04153890|579435364|FG003|Overall Study|Lost to Follow-up|0|||
160466236|NCT04153890|579435361|FG000|Overall Study|Death|0|||
160466237|NCT04153890|579435362|FG001|Overall Study|Death|2|||
160466238|NCT04153890|579435363|FG002|Overall Study|Death|0|||
160466239|NCT04153890|579435364|FG003|Overall Study|Death|0|||
160596684|NCT02505542|579901629|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
160596685|NCT02505542|579901630|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
160659008|NCT04006171|580133263|FG000|Overall Study|insufficient sample volume|2|||
160466240|NCT04153890|579435361|FG000|Overall Study|Withdrawal by Subject|0|||
160466241|NCT04153890|579435362|FG001|Overall Study|Withdrawal by Subject|0|||
160466242|NCT04153890|579435363|FG002|Overall Study|Withdrawal by Subject|0|||
160466243|NCT04153890|579435364|FG003|Overall Study|Withdrawal by Subject|2|||
160596686|NCT02505542|579901631|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
160466244|NCT03610581|579435365|FG000|Overall Study|Study terminated by sponsor|2|||
160466245|NCT03610581|579435366|FG001|Overall Study|Study terminated by sponsor|0|||
160466246|NCT03610581|579435365|FG000|Overall Study|Other|0|||
160466247|NCT03610581|579435366|FG001|Overall Study|Other|1|||
160466248|NCT03610581|579435365|FG000|Overall Study|Withdrawal by Subject|1|||
160466249|NCT03610581|579435366|FG001|Overall Study|Withdrawal by Subject|0|||
160466250|NCT02307682|579435371|FG000|Overall Study|Adverse Event|9|||
160466251|NCT02307682|579435372|FG001|Overall Study|Adverse Event|8|||
160466252|NCT02307682|579435373|FG002|Overall Study|Adverse Event|12|||
160466253|NCT02307682|579435371|FG000|Overall Study|Lack of Efficacy|1|||
160466254|NCT02307682|579435372|FG001|Overall Study|Lack of Efficacy|0|||
160466255|NCT02307682|579435373|FG002|Overall Study|Lack of Efficacy|1|||
160466256|NCT02307682|579435371|FG000|Overall Study|Physician Decision|2|||
160466257|NCT02307682|579435372|FG001|Overall Study|Physician Decision|2|||
160596687|NCT02505542|579901628|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
160596688|NCT02505542|579901629|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
160596689|NCT02505542|579901630|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
160596690|NCT02505542|579901631|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
160596691|NCT02505542|579901628|FG000|Part A: Open-Label Period|Non-compliance|1|||
160596692|NCT02505542|579901629|FG001|Part A: Open-Label Period|Non-compliance|0|||
160596693|NCT02505542|579901630|FG002|Part A: Open-Label Period|Non-compliance|0|||
160466258|NCT02307682|579435373|FG002|Overall Study|Physician Decision|8|||
160466259|NCT02307682|579435371|FG000|Overall Study|Progressive Disease|1|||
160466260|NCT02307682|579435372|FG001|Overall Study|Progressive Disease|0|||
160466261|NCT02307682|579435373|FG002|Overall Study|Progressive Disease|0|||
160466262|NCT02307682|579435371|FG000|Overall Study|Withdrawal by Subject|26|||
160466263|NCT02307682|579435372|FG001|Overall Study|Withdrawal by Subject|34|||
160466264|NCT02307682|579435373|FG002|Overall Study|Withdrawal by Subject|23|||
160466265|NCT02307682|579435371|FG000|Overall Study|Death|9|||
160466266|NCT02307682|579435372|FG001|Overall Study|Death|7|||
160466267|NCT02307682|579435373|FG002|Overall Study|Death|12|||
160466268|NCT02307682|579435371|FG000|Overall Study|Lost to Follow-up|1|||
160466269|NCT02307682|579435372|FG001|Overall Study|Lost to Follow-up|5|||
160466270|NCT02307682|579435373|FG002|Overall Study|Lost to Follow-up|6|||
160466271|NCT02307682|579435371|FG000|Overall Study|Protocol Deviation|0|||
160466272|NCT02307682|579435372|FG001|Overall Study|Protocol Deviation|0|||
160466273|NCT02307682|579435373|FG002|Overall Study|Protocol Deviation|2|||
160466274|NCT02307682|579435371|FG000|Overall Study|Other|1|||
160466275|NCT02307682|579435372|FG001|Overall Study|Other|1|||
160466276|NCT02307682|579435373|FG002|Overall Study|Other|0|||
160466277|NCT04306367|579435376|FG000|Overall Study|Progression of Disease|9|||
160466278|NCT04306367|579435376|FG000|Overall Study|Adverse Event|3|||
160466279|NCT04306367|579435376|FG000|Overall Study|Withdrawal by Subject|1|||
160466280|NCT02751528|579435383|FG000|Overall Study|Withdrawal by Subject|1|||
160466281|NCT02751528|579435383|FG000|Overall Study|Adverse Event|1|||
160466282|NCT05485805|579435384|FG000|Overall Study|Withdrawal by Subject|1|||
160466283|NCT05485805|579435385|FG001|Overall Study|Withdrawal by Subject|2|||
160466284|NCT05485805|579435386|FG002|Overall Study|Withdrawal by Subject|2|||
160466285|NCT05485805|579435387|FG003|Overall Study|Withdrawal by Subject|0|||
160466286|NCT05485805|579435388|FG004|Overall Study|Withdrawal by Subject|2|||
160466287|NCT05485805|579435384|FG000|Overall Study|Adverse Event|0|||
160466288|NCT05485805|579435385|FG001|Overall Study|Adverse Event|1|||
160466289|NCT05485805|579435386|FG002|Overall Study|Adverse Event|0|||
160466290|NCT05485805|579435387|FG003|Overall Study|Adverse Event|0|||
160466291|NCT05485805|579435388|FG004|Overall Study|Adverse Event|0|||
160466292|NCT05485805|579435384|FG000|Overall Study|Lost to Follow-up|1|||
160466293|NCT05485805|579435385|FG001|Overall Study|Lost to Follow-up|1|||
160466294|NCT05485805|579435386|FG002|Overall Study|Lost to Follow-up|3|||
160466295|NCT05485805|579435387|FG003|Overall Study|Lost to Follow-up|1|||
160466296|NCT05485805|579435388|FG004|Overall Study|Lost to Follow-up|0|||
160466297|NCT04218357|579435389|FG000|1st Allocation|Withdrawal by Subject|1|||
160466298|NCT04218357|579435390|FG001|1st Allocation|Withdrawal by Subject|0|||
160466299|NCT05029284|579436899|FG000|Overall Study|Lost to Follow-up|1|||
160596694|NCT02505542|579901631|FG003|Part A: Open-Label Period|Non-compliance|0|||
160596695|NCT02505542|579901628|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
160596696|NCT02505542|579901629|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
160659009|NCT04006171|580133264|FG001|Overall Study|insufficient sample volume|3|||
160466300|NCT03002194|579436900|FG000|Overall Study|Lost to Follow-up|6|||
160466301|NCT03002194|579436900|FG000|Overall Study|Adverse Event|1|||
160466302|NCT03002194|579436900|FG000|Overall Study|Lack of Efficacy|1|||
160466303|NCT03002194|579436900|FG000|Overall Study|Withdrawal by Subject|2|||
160466304|NCT02200705|579436901|FG000|Overall Study|Excluded|12|||
160466305|NCT02200705|579436901|FG000|Overall Study|Death|21|||
160596697|NCT02505542|579901630|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
160466306|NCT02200705|579436901|FG000|Overall Study|Withdrawal by Subject|22|||
160466307|NCT02200705|579436901|FG000|Overall Study|Lost to Follow-up|13|||
160596698|NCT02505542|579901631|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
160466308|NCT02200705|579436901|FG000|Overall Study|Physician Decision|5|||
160466309|NCT02200705|579436901|FG000|Overall Study|Adverse Event|2|||
160466310|NCT02633215|579436905|FG000|Overall Study|Lost to Follow-up|2|||
160466311|NCT02633215|579436906|FG001|Overall Study|Lost to Follow-up|3|||
160466312|NCT00754325|579436907|FG000|Initial Treatment|Continuing Active Treatment|4|||
160466313|NCT00754325|579436908|FG001|Initial Treatment|Continuing Active Treatment|5|||
160466314|NCT00754325|579436907|FG000|Initial Treatment|Adverse Event|7|||
160466315|NCT00754325|579436908|FG001|Initial Treatment|Adverse Event|6|||
160466316|NCT00754325|579436907|FG000|Initial Treatment|Withdrawal by Subject|2|||
160466317|NCT00754325|579436908|FG001|Initial Treatment|Withdrawal by Subject|2|||
160466318|NCT00754325|579436907|FG000|Initial Treatment|Physician Decision|2|||
160466319|NCT00754325|579436908|FG001|Initial Treatment|Physician Decision|0|||
160466320|NCT00754325|579436907|FG000|Initial Treatment|Sponsor Request|0|||
160466321|NCT00754325|579436908|FG001|Initial Treatment|Sponsor Request|1|||
160466322|NCT00754325|579436907|FG000|Initial Treatment|Disease Progression|35|||
160466323|NCT00754325|579436908|FG001|Initial Treatment|Disease Progression|35|||
160466324|NCT03738228|579436909|FG000|Overall Study|Never received study treatment|2|||
160466325|NCT03738228|579436910|FG001|Overall Study|Never received study treatment|2|||
160466326|NCT03801148|579436911|FG000|Period 1 (2 Days)|Adverse Event|1|||
160466327|NCT03801148|579436912|FG001|Period 1 (2 Days)|Adverse Event|1|||
160466328|NCT03801148|579436913|FG002|Period 1 (2 Days)|Adverse Event|0|||
160466329|NCT03801148|579436914|FG003|Period 1 (2 Days)|Adverse Event|0|||
160466330|NCT03801148|579436911|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
160466331|NCT03801148|579436912|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
160466332|NCT03801148|579436913|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
160466333|NCT03801148|579436914|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
160466334|NCT03801148|579436911|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160466335|NCT03801148|579436912|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160466336|NCT03801148|579436913|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
160466337|NCT03801148|579436914|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160466338|NCT03801148|579436911|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
160466339|NCT03801148|579436912|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
160466340|NCT03801148|579436913|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
160466341|NCT03801148|579436914|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
160466342|NCT06212752|579436915|FG000|Overall Study|Death|5|||
160466343|NCT06212752|579436916|FG001|Overall Study|Death|3|||
160466344|NCT06212752|579436915|FG000|Overall Study|Participants ongoing|23|||
160466345|NCT06212752|579436916|FG001|Overall Study|Participants ongoing|8|||
160466346|NCT04162210|579436917|FG000|Overall Study|Lost to Follow-up|4|||
160466347|NCT04162210|579436918|FG001|Overall Study|Lost to Follow-up|1|||
160466348|NCT04162210|579436917|FG000|Overall Study|Withdrawal by Subject|17|||
160466349|NCT04162210|579436918|FG001|Overall Study|Withdrawal by Subject|9|||
160466350|NCT04162210|579436917|FG000|Overall Study|Ongoing|113|||
160466351|NCT04162210|579436918|FG001|Overall Study|Ongoing|59|||
160466352|NCT00371345|579436919|FG000|Overall Study|Disease Progression|21|||
160466353|NCT00371345|579436920|FG001|Overall Study|Disease Progression|35|||
160466354|NCT00371345|579436919|FG000|Overall Study|Study Drug Toxicity|1|||
160466355|NCT00371345|579436920|FG001|Overall Study|Study Drug Toxicity|7|||
160466356|NCT00371345|579436919|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
160466357|NCT00371345|579436920|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
160466358|NCT00371345|579436919|FG000|Overall Study|Participant Request|1|||
160466359|NCT00371345|579436920|FG001|Overall Study|Participant Request|1|||
160466360|NCT00371345|579436919|FG000|Overall Study|Participant Withdrew Consent|0|||
160466361|NCT00371345|579436920|FG001|Overall Study|Participant Withdrew Consent|1|||
160466362|NCT00705406|579436921|FG000|Overall Study|Lost to Follow-up|3|||
160466363|NCT00705406|579436922|FG001|Overall Study|Lost to Follow-up|3|||
160466364|NCT00705406|579436921|FG000|Overall Study|Did not receive study drug|1|||
160466365|NCT00705406|579436922|FG001|Overall Study|Did not receive study drug|2|||
160466366|NCT01779700|579436923|FG000|Overall Study|Adverse Event|4|||
160466367|NCT01779700|579436924|FG001|Overall Study|Adverse Event|3|||
160466368|NCT01779700|579436923|FG000|Overall Study|Withdrawal by Subject|0|||
160466369|NCT01779700|579436924|FG001|Overall Study|Withdrawal by Subject|2|||
160466370|NCT00918333|579436927|FG000|Overall Study|Drug not taken per protocol|1|||
160659010|NCT03049488|580133265|FG000|Overall Study|Lost to Follow-up|1|||
160466371|NCT00918333|579436928|FG001|Overall Study|Drug not taken per protocol|0|||
160466372|NCT00918333|579436927|FG000|Overall Study|Inadequate amount of drugs provided|1|||
160466373|NCT00918333|579436928|FG001|Overall Study|Inadequate amount of drugs provided|4|||
160466374|NCT00918333|579436927|FG000|Overall Study|Ineligible|1|||
160466375|NCT00918333|579436928|FG001|Overall Study|Ineligible|0|||
160466376|NCT00918333|579436927|FG000|Overall Study|Withdrawal by Subject|0|||
160466377|NCT00918333|579436928|FG001|Overall Study|Withdrawal by Subject|1|||
160466378|NCT04497415|579436929|FG000|Overall Study|Lost to Follow-up|43|||
160659011|NCT03049488|580133266|FG001|Overall Study|Lost to Follow-up|1|||
160659012|NCT03049488|580133267|FG002|Overall Study|Lost to Follow-up|0|||
160466379|NCT04497415|579436930|FG001|Overall Study|Lost to Follow-up|27|||
160466380|NCT02463448|579436934|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
160659013|NCT03049488|580133268|FG003|Overall Study|Lost to Follow-up|0|||
160466381|NCT02463448|579436934|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
160466382|NCT02463448|579436934|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
160466383|NCT02463448|579436934|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
160466384|NCT00683800|579436935|FG000|Overall Study|Adverse Event|195|||
160466385|NCT00683800|579436936|FG001|Overall Study|Adverse Event|102|||
160466386|NCT00683800|579436935|FG000|Overall Study|Death|0|||
160466387|NCT00683800|579436936|FG001|Overall Study|Death|1|||
160466388|NCT00683800|579436935|FG000|Overall Study|Lost to Follow-up|57|||
160466389|NCT00683800|579436936|FG001|Overall Study|Lost to Follow-up|44|||
160466390|NCT00683800|579436935|FG000|Overall Study|Other|5|||
160466391|NCT00683800|579436936|FG001|Overall Study|Other|2|||
160466392|NCT00683800|579436935|FG000|Overall Study|Protocol Violation|13|||
160466393|NCT00683800|579436936|FG001|Overall Study|Protocol Violation|16|||
160466394|NCT00683800|579436935|FG000|Overall Study|Withdrawal by Subject|66|||
160466395|NCT00683800|579436936|FG001|Overall Study|Withdrawal by Subject|64|||
160466396|NCT00683800|579436935|FG000|Overall Study|Lack of Efficacy|61|||
160466397|NCT00683800|579436936|FG001|Overall Study|Lack of Efficacy|104|||
160466398|NCT00683800|579436935|FG000|Overall Study|Randomized, not treated|35|||
160466399|NCT00683800|579436936|FG001|Overall Study|Randomized, not treated|33|||
160466400|NCT03170648|579436943|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
160466401|NCT03170648|579436943|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
160466402|NCT01588951|579436944|FG000|Overall Study|Ineligible in retrospect|0|||
160466403|NCT01588951|579436945|FG001|Overall Study|Ineligible in retrospect|0|||
160466404|NCT01588951|579436946|FG002|Overall Study|Ineligible in retrospect|1|||
160466405|NCT03683576|579436947|FG000|Overall Study|Withdrawal by Subject|2|||
160466406|NCT03683576|579436948|FG001|Overall Study|Withdrawal by Subject|0|||
160466407|NCT03683576|579436949|FG002|Overall Study|Withdrawal by Subject|8|||
160466408|NCT03683576|579436950|FG003|Overall Study|Withdrawal by Subject|3|||
160466409|NCT03683576|579436947|FG000|Overall Study|Adverse Event|3|||
160466410|NCT03683576|579436948|FG001|Overall Study|Adverse Event|0|||
160466411|NCT03683576|579436949|FG002|Overall Study|Adverse Event|0|||
160466412|NCT03683576|579436950|FG003|Overall Study|Adverse Event|4|||
160466413|NCT03683576|579436947|FG000|Overall Study|Lack of Efficacy|1|||
160466414|NCT03683576|579436948|FG001|Overall Study|Lack of Efficacy|0|||
160466415|NCT03683576|579436949|FG002|Overall Study|Lack of Efficacy|1|||
160466416|NCT03683576|579436950|FG003|Overall Study|Lack of Efficacy|1|||
160466417|NCT03683576|579436947|FG000|Overall Study|Lost to Follow-up|0|||
160466418|NCT03683576|579436948|FG001|Overall Study|Lost to Follow-up|1|||
160466419|NCT03683576|579436949|FG002|Overall Study|Lost to Follow-up|2|||
160466420|NCT03683576|579436950|FG003|Overall Study|Lost to Follow-up|0|||
160466421|NCT03683576|579436947|FG000|Overall Study|Other, Not Specified|0|||
160466422|NCT03683576|579436948|FG001|Overall Study|Other, Not Specified|2|||
160466423|NCT03683576|579436949|FG002|Overall Study|Other, Not Specified|0|||
160466424|NCT03683576|579436950|FG003|Overall Study|Other, Not Specified|0|||
160466425|NCT03683576|579436947|FG000|Overall Study|Protocol Violation|0|||
160466426|NCT03683576|579436948|FG001|Overall Study|Protocol Violation|1|||
160466427|NCT03683576|579436949|FG002|Overall Study|Protocol Violation|1|||
160466428|NCT03683576|579436950|FG003|Overall Study|Protocol Violation|0|||
160466429|NCT02454959|579436951|FG000|Overall Study|Protocol-Specified Criteria|3|||
160466430|NCT02454959|579436951|FG000|Overall Study|Physician Decision|1|||
160466431|NCT02454959|579436951|FG000|Overall Study|Withdrawal by Subject|3|||
160466432|NCT02454959|579436951|FG000|Overall Study|Adverse Event|2|||
160466433|NCT02350634|579436952|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
160466434|NCT02499328|579436962|FG000|Overall Study|Withdrawal by Subject|1|||
160466435|NCT02499328|579436963|FG001|Overall Study|Withdrawal by Subject|1|||
160466436|NCT02499328|579436964|FG002|Overall Study|Withdrawal by Subject|5|||
160466437|NCT02499328|579436965|FG003|Overall Study|Withdrawal by Subject|3|||
160466438|NCT02499328|579436966|FG004|Overall Study|Withdrawal by Subject|5|||
160466439|NCT02499328|579436967|FG005|Overall Study|Withdrawal by Subject|0|||
160466440|NCT02499328|579436968|FG006|Overall Study|Withdrawal by Subject|0|||
160466441|NCT02499328|579436969|FG007|Overall Study|Withdrawal by Subject|0|||
160466442|NCT02499328|579436970|FG008|Overall Study|Withdrawal by Subject|2|||
160466443|NCT02499328|579436971|FG009|Overall Study|Withdrawal by Subject|2|||
160466444|NCT02499328|579436972|FG010|Overall Study|Withdrawal by Subject|0|||
160466445|NCT02499328|579436973|FG011|Overall Study|Withdrawal by Subject|3|||
160596699|NCT02505542|579901628|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
160466446|NCT02499328|579436974|FG012|Overall Study|Withdrawal by Subject|7|||
160466447|NCT02499328|579436975|FG013|Overall Study|Withdrawal by Subject|3|||
160466448|NCT02499328|579436976|FG014|Overall Study|Withdrawal by Subject|1|||
160466449|NCT02499328|579436977|FG015|Overall Study|Withdrawal by Subject|0|||
160466450|NCT02499328|579436978|FG016|Overall Study|Withdrawal by Subject|0|||
160466451|NCT02499328|579436979|FG017|Overall Study|Withdrawal by Subject|3|||
160466452|NCT02499328|579436980|FG018|Overall Study|Withdrawal by Subject|0|||
160466453|NCT02499328|579436962|FG000|Overall Study|Lost to Follow-up|0|||
160466454|NCT02499328|579436963|FG001|Overall Study|Lost to Follow-up|1|||
160466455|NCT02499328|579436964|FG002|Overall Study|Lost to Follow-up|1|||
160466456|NCT02499328|579436965|FG003|Overall Study|Lost to Follow-up|2|||
160466457|NCT02499328|579436966|FG004|Overall Study|Lost to Follow-up|0|||
160466458|NCT02499328|579436967|FG005|Overall Study|Lost to Follow-up|0|||
160466459|NCT02499328|579436968|FG006|Overall Study|Lost to Follow-up|0|||
160466460|NCT02499328|579436969|FG007|Overall Study|Lost to Follow-up|2|||
160466461|NCT02499328|579436970|FG008|Overall Study|Lost to Follow-up|3|||
160466462|NCT02499328|579436971|FG009|Overall Study|Lost to Follow-up|0|||
160466463|NCT02499328|579436972|FG010|Overall Study|Lost to Follow-up|0|||
160466464|NCT02499328|579436973|FG011|Overall Study|Lost to Follow-up|0|||
160466465|NCT02499328|579436974|FG012|Overall Study|Lost to Follow-up|0|||
160466466|NCT02499328|579436975|FG013|Overall Study|Lost to Follow-up|0|||
160466467|NCT02499328|579436976|FG014|Overall Study|Lost to Follow-up|0|||
160466468|NCT02499328|579436977|FG015|Overall Study|Lost to Follow-up|0|||
160466469|NCT02499328|579436978|FG016|Overall Study|Lost to Follow-up|0|||
160466470|NCT02499328|579436979|FG017|Overall Study|Lost to Follow-up|0|||
160466471|NCT02499328|579436980|FG018|Overall Study|Lost to Follow-up|1|||
160466472|NCT02499328|579436962|FG000|Overall Study|Death|0|||
160466473|NCT02499328|579436963|FG001|Overall Study|Death|3|||
160466474|NCT02499328|579436964|FG002|Overall Study|Death|3|||
160466475|NCT02499328|579436965|FG003|Overall Study|Death|2|||
160466476|NCT02499328|579436966|FG004|Overall Study|Death|4|||
160466477|NCT02499328|579436967|FG005|Overall Study|Death|7|||
160466478|NCT02499328|579436968|FG006|Overall Study|Death|3|||
160466479|NCT02499328|579436969|FG007|Overall Study|Death|0|||
160466480|NCT02499328|579436970|FG008|Overall Study|Death|2|||
160466481|NCT02499328|579436971|FG009|Overall Study|Death|6|||
160466482|NCT02499328|579436972|FG010|Overall Study|Death|6|||
160466483|NCT02499328|579436973|FG011|Overall Study|Death|20|||
160466484|NCT02499328|579436974|FG012|Overall Study|Death|9|||
160466485|NCT02499328|579436975|FG013|Overall Study|Death|7|||
160466486|NCT02499328|579436976|FG014|Overall Study|Death|3|||
160466487|NCT02499328|579436977|FG015|Overall Study|Death|1|||
160466488|NCT02499328|579436978|FG016|Overall Study|Death|1|||
160466489|NCT02499328|579436979|FG017|Overall Study|Death|16|||
160466490|NCT02499328|579436980|FG018|Overall Study|Death|5|||
160466491|NCT02499328|579436962|FG000|Overall Study|"Other"|2|||
160466492|NCT02499328|579436963|FG001|Overall Study|"Other"|2|||
160466493|NCT02499328|579436964|FG002|Overall Study|"Other"|1|||
160466494|NCT02499328|579436965|FG003|Overall Study|"Other"|3|||
160466495|NCT02499328|579436966|FG004|Overall Study|"Other"|6|||
160466496|NCT02499328|579436967|FG005|Overall Study|"Other"|2|||
160466497|NCT02499328|579436968|FG006|Overall Study|"Other"|3|||
160466498|NCT02499328|579436969|FG007|Overall Study|"Other"|4|||
160466499|NCT02499328|579436970|FG008|Overall Study|"Other"|6|||
160466500|NCT02499328|579436971|FG009|Overall Study|"Other"|16|||
160466501|NCT02499328|579436972|FG010|Overall Study|"Other"|13|||
160466502|NCT02499328|579436973|FG011|Overall Study|"Other"|31|||
160466503|NCT02499328|579436974|FG012|Overall Study|"Other"|8|||
160466504|NCT02499328|579436975|FG013|Overall Study|"Other"|7|||
160466505|NCT02499328|579436976|FG014|Overall Study|"Other"|6|||
160466506|NCT02499328|579436977|FG015|Overall Study|"Other"|0|||
160466507|NCT02499328|579436978|FG016|Overall Study|"Other"|0|||
160466508|NCT02499328|579436979|FG017|Overall Study|"Other"|34|||
160466509|NCT02499328|579436980|FG018|Overall Study|"Other"|43|||
160466510|NCT02499328|579436962|FG000|Overall Study|Disease Progression|0|||
160466511|NCT02499328|579436963|FG001|Overall Study|Disease Progression|0|||
160466512|NCT02499328|579436964|FG002|Overall Study|Disease Progression|0|||
160466513|NCT02499328|579436965|FG003|Overall Study|Disease Progression|0|||
160466514|NCT02499328|579436966|FG004|Overall Study|Disease Progression|0|||
160466515|NCT02499328|579436967|FG005|Overall Study|Disease Progression|0|||
160466516|NCT02499328|579436968|FG006|Overall Study|Disease Progression|1|||
160596700|NCT02505542|579901629|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
160596701|NCT02505542|579901630|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
160596702|NCT02505542|579901631|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
160466517|NCT02499328|579436969|FG007|Overall Study|Disease Progression|0|||
160466518|NCT02499328|579436970|FG008|Overall Study|Disease Progression|1|||
160466519|NCT02499328|579436971|FG009|Overall Study|Disease Progression|0|||
160466520|NCT02499328|579436972|FG010|Overall Study|Disease Progression|1|||
160466521|NCT02499328|579436973|FG011|Overall Study|Disease Progression|0|||
160466522|NCT02499328|579436974|FG012|Overall Study|Disease Progression|0|||
160466523|NCT02499328|579436975|FG013|Overall Study|Disease Progression|0|||
160466524|NCT02499328|579436976|FG014|Overall Study|Disease Progression|0|||
160466525|NCT02499328|579436977|FG015|Overall Study|Disease Progression|0|||
160466526|NCT02499328|579436978|FG016|Overall Study|Disease Progression|0|||
160466527|NCT02499328|579436979|FG017|Overall Study|Disease Progression|2|||
160466528|NCT02499328|579436980|FG018|Overall Study|Disease Progression|0|||
160466529|NCT02499328|579436962|FG000|Overall Study|Adverse Event|1|||
160466530|NCT02499328|579436963|FG001|Overall Study|Adverse Event|0|||
160466531|NCT02499328|579436964|FG002|Overall Study|Adverse Event|0|||
160466532|NCT02499328|579436965|FG003|Overall Study|Adverse Event|1|||
160466533|NCT02499328|579436966|FG004|Overall Study|Adverse Event|0|||
160466534|NCT02499328|579436967|FG005|Overall Study|Adverse Event|0|||
160466535|NCT02499328|579436968|FG006|Overall Study|Adverse Event|0|||
160466536|NCT02499328|579436969|FG007|Overall Study|Adverse Event|0|||
160466537|NCT02499328|579436970|FG008|Overall Study|Adverse Event|0|||
160466538|NCT02499328|579436971|FG009|Overall Study|Adverse Event|0|||
160466539|NCT02499328|579436972|FG010|Overall Study|Adverse Event|0|||
160466540|NCT02499328|579436973|FG011|Overall Study|Adverse Event|0|||
160466541|NCT02499328|579436974|FG012|Overall Study|Adverse Event|1|||
160466542|NCT02499328|579436975|FG013|Overall Study|Adverse Event|0|||
160466543|NCT02499328|579436976|FG014|Overall Study|Adverse Event|0|||
160466544|NCT02499328|579436977|FG015|Overall Study|Adverse Event|0|||
160466545|NCT02499328|579436978|FG016|Overall Study|Adverse Event|0|||
160466546|NCT02499328|579436979|FG017|Overall Study|Adverse Event|0|||
160466547|NCT02499328|579436980|FG018|Overall Study|Adverse Event|0|||
160466548|NCT03611075|579436981|FG000|Overall Study|Physician Decision|0|||
160466549|NCT03611075|579436982|FG001|Overall Study|Physician Decision|1|||
160466550|NCT03611075|579436983|FG002|Overall Study|Physician Decision|1|||
160466551|NCT03611075|579436984|FG003|Overall Study|Physician Decision|0|||
160466552|NCT03611075|579436985|FG004|Overall Study|Physician Decision|0|||
160466553|NCT03611075|579436986|FG005|Overall Study|Physician Decision|0|||
160466554|NCT03611075|579436987|FG006|Overall Study|Physician Decision|0|||
160466555|NCT03611075|579436988|FG007|Overall Study|Physician Decision|0|||
160466556|NCT03611075|579436989|FG008|Overall Study|Physician Decision|0|||
160466557|NCT03611075|579436981|FG000|Overall Study|Lost to Follow-up|1|||
160466558|NCT03611075|579436982|FG001|Overall Study|Lost to Follow-up|0|||
160466559|NCT03611075|579436983|FG002|Overall Study|Lost to Follow-up|0|||
160466560|NCT03611075|579436984|FG003|Overall Study|Lost to Follow-up|2|||
160466561|NCT03611075|579436985|FG004|Overall Study|Lost to Follow-up|0|||
160466562|NCT03611075|579436986|FG005|Overall Study|Lost to Follow-up|0|||
160466563|NCT03611075|579436987|FG006|Overall Study|Lost to Follow-up|0|||
160466564|NCT03611075|579436988|FG007|Overall Study|Lost to Follow-up|0|||
160466565|NCT03611075|579436989|FG008|Overall Study|Lost to Follow-up|0|||
160466566|NCT03611075|579436981|FG000|Overall Study|Withdrawal by Subject|0|||
160466567|NCT03611075|579436982|FG001|Overall Study|Withdrawal by Subject|1|||
160466568|NCT03611075|579436983|FG002|Overall Study|Withdrawal by Subject|1|||
160466569|NCT03611075|579436984|FG003|Overall Study|Withdrawal by Subject|1|||
160466570|NCT03611075|579436985|FG004|Overall Study|Withdrawal by Subject|0|||
160466571|NCT03611075|579436986|FG005|Overall Study|Withdrawal by Subject|0|||
160466572|NCT03611075|579436987|FG006|Overall Study|Withdrawal by Subject|1|||
160466573|NCT03611075|579436988|FG007|Overall Study|Withdrawal by Subject|0|||
160466574|NCT03611075|579436989|FG008|Overall Study|Withdrawal by Subject|0|||
160466575|NCT03611075|579436981|FG000|Overall Study|Reason unknown|0|||
160466576|NCT03611075|579436982|FG001|Overall Study|Reason unknown|0|||
160466577|NCT03611075|579436983|FG002|Overall Study|Reason unknown|0|||
160466578|NCT03611075|579436984|FG003|Overall Study|Reason unknown|1|||
160466579|NCT03611075|579436985|FG004|Overall Study|Reason unknown|0|||
160466580|NCT03611075|579436986|FG005|Overall Study|Reason unknown|0|||
160466581|NCT03611075|579436987|FG006|Overall Study|Reason unknown|1|||
160466582|NCT03611075|579436988|FG007|Overall Study|Reason unknown|0|||
160466583|NCT03611075|579436989|FG008|Overall Study|Reason unknown|0|||
160466584|NCT03488719|579436990|FG000|Overall Study|Adverse Event|0|||
160466585|NCT03488719|579436991|FG001|Overall Study|Adverse Event|4|||
160466586|NCT03488719|579436992|FG002|Overall Study|Adverse Event|2|||
160466587|NCT03488719|579436990|FG000|Overall Study|Other|0|||
160466588|NCT03488719|579436991|FG001|Overall Study|Other|0|||
160466589|NCT03488719|579436992|FG002|Overall Study|Other|5|||
160466590|NCT03414684|579437000|FG000|First-course Treatment|Complete response|0|||
160466591|NCT03414684|579437001|FG001|First-course Treatment|Complete response|1|||
160466592|NCT03414684|579437000|FG000|First-course Treatment|Intercurrent illness|1|||
160466593|NCT03414684|579437001|FG001|First-course Treatment|Intercurrent illness|0|||
160466594|NCT03414684|579437000|FG000|First-course Treatment|Progressive Disease|31|||
160466595|NCT03414684|579437001|FG001|First-course Treatment|Progressive Disease|32|||
160466596|NCT03414684|579437000|FG000|First-course Treatment|Adverse Event|1|||
160466597|NCT03414684|579437001|FG001|First-course Treatment|Adverse Event|2|||
160466598|NCT03414684|579437000|FG000|First-course Treatment|Physician Decision|0|||
160466599|NCT03414684|579437001|FG001|First-course Treatment|Physician Decision|1|||
160466600|NCT03414684|579437000|FG000|First-course Treatment|Withdrawal by Subject|0|||
160466601|NCT03414684|579437001|FG001|First-course Treatment|Withdrawal by Subject|1|||
160466602|NCT03414684|579437000|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
160466603|NCT03414684|579437001|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
160466604|NCT03414684|579437000|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
160466605|NCT03414684|579437001|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
160466606|NCT03414684|579437000|FG000|First-course Treatment|Still on treatment|3|||
160466607|NCT03414684|579437001|FG001|First-course Treatment|Still on treatment|0|||
160466608|NCT03414684|579437000|FG000|First-course Treatment|Never started protocol therapy|2|||
160466609|NCT03414684|579437001|FG001|First-course Treatment|Never started protocol therapy|1|||
160466610|NCT03414684|579437000|FG000|Crossover Treatment|Progressive disease|0|||
160466611|NCT03414684|579437001|FG001|Crossover Treatment|Progressive disease|12|||
160466612|NCT03414684|579437000|FG000|Crossover Treatment|Adverse Event|0|||
160596703|NCT02505542|579901628|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
160596704|NCT02505542|579901629|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
160596705|NCT02505542|579901630|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
160466613|NCT03414684|579437001|FG001|Crossover Treatment|Adverse Event|3|||
160466614|NCT03414684|579437000|FG000|Crossover Treatment|Physician Decision|0|||
160466615|NCT03414684|579437001|FG001|Crossover Treatment|Physician Decision|1|||
160466616|NCT03414684|579437000|FG000|Crossover Treatment|Still on treatment|0|||
160466617|NCT03414684|579437001|FG001|Crossover Treatment|Still on treatment|2|||
160466618|NCT04038580|579437002|FG000|Washout 1|Death|0|||
160466619|NCT04038580|579437003|FG001|Washout 1|Death|0|||
160466620|NCT04038580|579437004|FG002|Washout 1|Death|0|||
160466621|NCT04038580|579437005|FG003|Washout 1|Death|1|||
160466622|NCT04038580|579437006|FG004|Washout 1|Death|0|||
160466623|NCT04038580|579437007|FG005|Washout 1|Death|0|||
160466624|NCT04038580|579437002|FG000|Washout 1|Withdrawal by Subject|0|||
160466625|NCT04038580|579437003|FG001|Washout 1|Withdrawal by Subject|0|||
160466626|NCT04038580|579437004|FG002|Washout 1|Withdrawal by Subject|0|||
160466627|NCT04038580|579437005|FG003|Washout 1|Withdrawal by Subject|0|||
160466628|NCT04038580|579437006|FG004|Washout 1|Withdrawal by Subject|1|||
160466629|NCT04038580|579437007|FG005|Washout 1|Withdrawal by Subject|0|||
160466630|NCT04038580|579437002|FG000|Wash-out 2|Withdrawal by Subject|1|||
160466631|NCT04038580|579437003|FG001|Wash-out 2|Withdrawal by Subject|0|||
160466632|NCT04038580|579437004|FG002|Wash-out 2|Withdrawal by Subject|0|||
160466633|NCT04038580|579437005|FG003|Wash-out 2|Withdrawal by Subject|2|||
160466634|NCT04038580|579437006|FG004|Wash-out 2|Withdrawal by Subject|0|||
160466635|NCT04038580|579437007|FG005|Wash-out 2|Withdrawal by Subject|1|||
160466636|NCT04038580|579437002|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
160466637|NCT04038580|579437003|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
160466638|NCT04038580|579437004|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
160466639|NCT04038580|579437005|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
160466640|NCT04038580|579437006|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
160466641|NCT04038580|579437007|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
160466642|NCT04038580|579437002|FG000|Wash-out 3|Withdrawal by Subject|1|||
160466643|NCT04038580|579437003|FG001|Wash-out 3|Withdrawal by Subject|0|||
160466644|NCT04038580|579437004|FG002|Wash-out 3|Withdrawal by Subject|2|||
160466645|NCT04038580|579437005|FG003|Wash-out 3|Withdrawal by Subject|0|||
160466646|NCT04038580|579437006|FG004|Wash-out 3|Withdrawal by Subject|0|||
160466647|NCT04038580|579437007|FG005|Wash-out 3|Withdrawal by Subject|0|||
160466648|NCT03477175|579437008|FG000|Overall Study|Unable to travel due to COVID-19|0|||
160466649|NCT03477175|579437009|FG001|Overall Study|Unable to travel due to COVID-19|1|||
160466650|NCT03477175|579437008|FG000|Overall Study|Physician Decision|1|||
160466651|NCT03477175|579437009|FG001|Overall Study|Physician Decision|0|||
160466652|NCT03477175|579437008|FG000|Overall Study|Transitioned to commercial drug|6|||
160466653|NCT03477175|579437009|FG001|Overall Study|Transitioned to commercial drug|6|||
160466654|NCT03477175|579437008|FG000|Overall Study|Lost to Follow-up|1|||
160466655|NCT03477175|579437009|FG001|Overall Study|Lost to Follow-up|1|||
160466656|NCT03477175|579437008|FG000|Overall Study|Withdrawal by Subject|3|||
160466657|NCT03477175|579437009|FG001|Overall Study|Withdrawal by Subject|1|||
160466658|NCT03477175|579437008|FG000|Overall Study|Adverse Event|1|||
160466659|NCT03477175|579437009|FG001|Overall Study|Adverse Event|5|||
160466660|NCT03477175|579437008|FG000|Overall Study|Disease Progression|7|||
160466661|NCT03477175|579437009|FG001|Overall Study|Disease Progression|7|||
160466662|NCT02078648|579437010|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
160466663|NCT02078648|579437011|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
160466664|NCT02078648|579437010|FG000|Overall Study|Adverse Event|0|||
160466665|NCT02078648|579437011|FG001|Overall Study|Adverse Event|1|||
160466666|NCT02078648|579437010|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
160466667|NCT02078648|579437011|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
160466668|NCT02078648|579437010|FG000|Overall Study|Withdrawal by Subject|3|||
160466669|NCT02078648|579437011|FG001|Overall Study|Withdrawal by Subject|1|||
160466670|NCT02078648|579437010|FG000|Overall Study|Investigator Decision|5|||
160466671|NCT02078648|579437011|FG001|Overall Study|Investigator Decision|7|||
160466672|NCT02078648|579437010|FG000|Overall Study|Death|1|||
160466673|NCT02078648|579437011|FG001|Overall Study|Death|1|||
160466674|NCT02078648|579437010|FG000|Overall Study|Undefined|0|||
160466675|NCT02078648|579437011|FG001|Overall Study|Undefined|1|||
160466676|NCT04088227|579437012|FG000|Overall Study|Withdrawal by Subject|1|||
160659014|NCT03049488|580133269|FG004|Overall Study|Lost to Follow-up|0|||
160466677|NCT04088227|579437013|FG001|Overall Study|Withdrawal by Subject|0|||
160466678|NCT04088227|579437012|FG000|Overall Study|Surgery postponed >5weeks|1|||
160466679|NCT04088227|579437013|FG001|Overall Study|Surgery postponed >5weeks|0|||
160466680|NCT04021862|579437014|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
160466681|NCT04021862|579437015|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
160466682|NCT04021862|579437016|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
160466683|NCT04021862|579437017|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
160466684|NCT04021862|579437018|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
160466685|NCT04021862|579437019|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
160466686|NCT04021862|579437014|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
160659015|NCT03049488|580133270|FG005|Overall Study|Lost to Follow-up|0|||
160466687|NCT04021862|579437015|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
160466688|NCT04021862|579437016|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
160466689|NCT04021862|579437017|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
160466690|NCT04021862|579437018|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
160466691|NCT04021862|579437019|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
160466692|NCT04021862|579437014|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
160466693|NCT04021862|579437015|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
160466694|NCT04021862|579437016|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
160466695|NCT04021862|579437017|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
160466696|NCT04021862|579437018|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
160466697|NCT04021862|579437019|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
160466698|NCT04021862|579437014|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
160466699|NCT04021862|579437015|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
160466700|NCT04021862|579437016|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
160466701|NCT04021862|579437017|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
160466702|NCT04021862|579437018|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
160466703|NCT04021862|579437019|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
160466704|NCT04021862|579437014|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
160466705|NCT04021862|579437015|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
160466706|NCT04021862|579437016|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
160466707|NCT04021862|579437017|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
160466708|NCT04021862|579437018|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
160466709|NCT04021862|579437019|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
160466710|NCT03227861|579437020|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
160466711|NCT03227861|579437020|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
160466712|NCT03227861|579437020|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
160466713|NCT03227861|579437020|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
160466714|NCT03227861|579437020|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
160466715|NCT03227861|579437020|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
160466716|NCT03227861|579437020|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
160466717|NCT03227861|579437020|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
160466718|NCT03227861|579437020|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
160596706|NCT02505542|579901631|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
160596707|NCT02505542|579901628|FG000|Part B: Double-Blind Period|Adverse Event|0|||
160596708|NCT02505542|579901629|FG001|Part B: Double-Blind Period|Adverse Event|0|||
160596709|NCT02505542|579901630|FG002|Part B: Double-Blind Period|Adverse Event|1|||
160596710|NCT02505542|579901631|FG003|Part B: Double-Blind Period|Adverse Event|3|||
160596711|NCT02505542|579901628|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
160596712|NCT02505542|579901629|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
160596713|NCT02505542|579901630|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
160596714|NCT02505542|579901631|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
160596715|NCT02505542|579901628|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
160596716|NCT02505542|579901629|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
160596717|NCT02505542|579901630|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
160596718|NCT02505542|579901631|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
160596719|NCT02505542|579901628|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
160596720|NCT02505542|579901629|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
160596721|NCT02505542|579901630|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
160596722|NCT02505542|579901631|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
160596723|NCT02505542|579901628|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
160596724|NCT02505542|579901629|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
160596725|NCT02505542|579901630|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
160596726|NCT02505542|579901631|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
160596727|NCT02505542|579901628|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
160596728|NCT02505542|579901629|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
160596729|NCT02505542|579901630|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
160596730|NCT02505542|579901631|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
160596731|NCT02505542|579901628|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
160596732|NCT02505542|579901629|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
160596733|NCT02505542|579901630|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
160596734|NCT02505542|579901631|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
160596735|NCT02505542|579901628|FG000|Part B: Double-Blind Period|Miscalculation|0|||
160596736|NCT02505542|579901629|FG001|Part B: Double-Blind Period|Miscalculation|1|||
160596737|NCT02505542|579901630|FG002|Part B: Double-Blind Period|Miscalculation|0|||
160596738|NCT02505542|579901631|FG003|Part B: Double-Blind Period|Miscalculation|0|||
160596739|NCT02505542|579901628|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
160596740|NCT02505542|579901629|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
160466719|NCT03227861|579437020|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
160466720|NCT03116464|579437983|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
160466721|NCT00442104|579437986|FG000|Overall Study|Adverse Event|5|||
160466722|NCT00442104|579437986|FG000|Overall Study|Death|2|||
160466723|NCT00442104|579437986|FG000|Overall Study|Lost to Follow-up|3|||
160466724|NCT00442104|579437986|FG000|Overall Study|Withdrawal by Subject|5|||
160466725|NCT00442104|579437986|FG000|Overall Study|Insufficient Clinical Response|10|||
160466726|NCT00442104|579437986|FG000|Overall Study|Other|21|||
160466727|NCT00442104|579437986|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
160466728|NCT00975585|579437991|FG000|Overall Study|Adverse Event|0|||
160466729|NCT00975585|579437992|FG001|Overall Study|Adverse Event|4|||
160466730|NCT00975585|579437991|FG000|Overall Study|Lost to Follow-up|3|||
160466731|NCT00975585|579437992|FG001|Overall Study|Lost to Follow-up|5|||
160466732|NCT00975585|579437991|FG000|Overall Study|Withdrawal by Subject|2|||
160466733|NCT00975585|579437992|FG001|Overall Study|Withdrawal by Subject|1|||
160466734|NCT00975585|579437991|FG000|Overall Study|Lens issue|2|||
160466735|NCT00975585|579437992|FG001|Overall Study|Lens issue|2|||
160466736|NCT00205179|579437993|FG000|Overall Study|Death|0|||
160466737|NCT00205179|579437994|FG001|Overall Study|Death|2|||
160466738|NCT00205179|579437993|FG000|Overall Study|Physician Decision|1|||
160466739|NCT00205179|579437994|FG001|Overall Study|Physician Decision|1|||
160466740|NCT00205179|579437993|FG000|Overall Study|Adverse Event|1|||
160466741|NCT00205179|579437994|FG001|Overall Study|Adverse Event|1|||
160466742|NCT01619059|579437995|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
160466743|NCT01619059|579437996|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
160466744|NCT01619059|579437995|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
160466745|NCT01619059|579437996|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
160466746|NCT01619059|579437995|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
160466747|NCT01619059|579437996|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
160466748|NCT01619059|579437995|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
160466749|NCT01619059|579437996|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
160466750|NCT01619059|579437995|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
160466751|NCT01619059|579437996|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
160466752|NCT01619059|579437995|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
160466753|NCT01619059|579437996|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
160466754|NCT01619059|579437995|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
160466755|NCT01619059|579437996|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
160466756|NCT01619059|579437995|FG000|Long-Term (LT) Treatment Period|Death|1|||
160466757|NCT01619059|579437996|FG001|Long-Term (LT) Treatment Period|Death|0|||
160466758|NCT01619059|579437995|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
160466759|NCT01619059|579437996|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
160466760|NCT01619059|579437995|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
160466761|NCT01619059|579437996|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
160466762|NCT01787032|579437999|FG000|Overall Study|Protocol Violation|0|||
160466763|NCT01787032|579438000|FG001|Overall Study|Protocol Violation|0|||
160466764|NCT01787032|579438001|FG002|Overall Study|Protocol Violation|0|||
160466765|NCT01787032|579438002|FG003|Overall Study|Protocol Violation|0|||
160466766|NCT01787032|579438003|FG004|Overall Study|Protocol Violation|1|||
160466767|NCT01787032|579438004|FG005|Overall Study|Protocol Violation|1|||
160466768|NCT00388726|579438005|FG000|Overall Study|Adverse Event|50|||
160466769|NCT00388726|579438006|FG001|Overall Study|Adverse Event|24|||
160466770|NCT00388726|579438005|FG000|Overall Study|Progressive Disease|336|||
160466771|NCT00388726|579438006|FG001|Overall Study|Progressive Disease|153|||
160466772|NCT00388726|579438005|FG000|Overall Study|Clinical Progression|61|||
160466773|NCT00388726|579438006|FG001|Overall Study|Clinical Progression|36|||
160466774|NCT00388726|579438005|FG000|Overall Study|Withdrawal by Subject|10|||
160466775|NCT00388726|579438006|FG001|Overall Study|Withdrawal by Subject|7|||
160596741|NCT02505542|579901630|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
160596742|NCT02505542|579901631|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
160466776|NCT00388726|579438005|FG000|Overall Study|Administrative|6|||
160466777|NCT00388726|579438006|FG001|Overall Study|Administrative|9|||
160466778|NCT00388726|579438005|FG000|Overall Study|Physician Decision|18|||
160466779|NCT00388726|579438006|FG001|Overall Study|Physician Decision|13|||
160596743|NCT01438307|579901634|FG000|Overall Study|Death|1|||
160596744|NCT01438307|579901635|FG001|Overall Study|Death|1|||
160466780|NCT00388726|579438005|FG000|Overall Study|Death|3|||
160466781|NCT00388726|579438006|FG001|Overall Study|Death|2|||
160466782|NCT02406092|579438007|FG000|Overall Study|Screen failure|10|||
160466783|NCT02406092|579438008|FG001|Overall Study|Screen failure|7|||
160466784|NCT02406092|579438007|FG000|Overall Study|Death|22|||
160596745|NCT02378883|579901636|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
160466785|NCT02406092|579438008|FG001|Overall Study|Death|5|||
160466786|NCT02406092|579438007|FG000|Overall Study|Lost to Follow-up|4|||
160466787|NCT02406092|579438008|FG001|Overall Study|Lost to Follow-up|1|||
160466788|NCT02406092|579438007|FG000|Overall Study|Adverse Event|1|||
160659016|NCT03049488|580133265|FG000|Overall Study|Moved from Area|1|||
160466789|NCT02406092|579438008|FG001|Overall Study|Adverse Event|0|||
160466790|NCT02406092|579438007|FG000|Overall Study|Withdrawal by Subject|1|||
160466791|NCT02406092|579438008|FG001|Overall Study|Withdrawal by Subject|0|||
160466792|NCT03041233|579438009|FG000|Overall Study|Death|5|||
160466793|NCT03041233|579438009|FG000|Overall Study|Physician Decision|1|||
160466794|NCT03041233|579438009|FG000|Overall Study|Lost to Follow-up|16|||
160466795|NCT03041233|579438009|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
160466796|NCT03041233|579438009|FG000|Overall Study|Sponsor Request|1|||
160466797|NCT03041233|579438009|FG000|Overall Study|Duplicate subject|1|||
160466798|NCT03041233|579438009|FG000|Overall Study|Re-ablation|1|||
160466799|NCT00853593|579438013|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
160466800|NCT00853593|579438013|FG000|Overall Study|Model 4396 lead not attempted|29|||
160466801|NCT00853593|579438013|FG000|Overall Study|Implant not attempted|4|||
160466802|NCT03229408|579438014|FG000|Overall Study|Withdrawal by Subject|4|||
160466803|NCT03229408|579438015|FG001|Overall Study|Withdrawal by Subject|1|||
160466804|NCT03229408|579438014|FG000|Overall Study|Adverse Event|2|||
160466805|NCT03229408|579438015|FG001|Overall Study|Adverse Event|0|||
160466806|NCT03229408|579438014|FG000|Overall Study|Pregnancy|0|||
160466807|NCT03229408|579438015|FG001|Overall Study|Pregnancy|1|||
160466808|NCT03229408|579438014|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
160466809|NCT03229408|579438015|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
160466810|NCT03745313|579438020|FG000|At 30 Days Follow-up|Death|2|||
160466811|NCT03745313|579438020|FG000|At 6 Months Follow-up|Death|1|||
160466812|NCT03745313|579438020|FG000|At 6 Months Follow-up|Missed Visit|1|||
160466813|NCT03745313|579438020|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
160466814|NCT03745313|579438020|FG000|At 1 Year Follow-up|Death|2|||
160466815|NCT03745313|579438020|FG000|At 1 Year Follow-up|Missed Visit|2|||
160466816|NCT03745313|579438020|FG000|At 2 Year Follow-up|Missed Visit|1|||
160466817|NCT02052440|579438024|FG000|Overall Study|Withdrawal by Subject|0|||
160466818|NCT02052440|579438025|FG001|Overall Study|Withdrawal by Subject|1|||
160466819|NCT01367236|579438029|FG000|Overall Study|Withdrawal by Subject|3|||
160466820|NCT01367236|579438030|FG001|Overall Study|Withdrawal by Subject|1|||
160466821|NCT02628626|579438035|FG000|Overall Study|Withdrawal by Subject|2|||
160466822|NCT02628626|579438036|FG001|Overall Study|Withdrawal by Subject|2|||
160466823|NCT01593020|579438037|FG000|Overall Study|Adverse Event|1|||
160466824|NCT01593020|579438038|FG001|Overall Study|Adverse Event|1|||
160466825|NCT01593020|579438037|FG000|Overall Study|Death|0|||
160466826|NCT01593020|579438038|FG001|Overall Study|Death|1|||
160466827|NCT01593020|579438037|FG000|Overall Study|Ineligible|1|||
160466828|NCT01593020|579438038|FG001|Overall Study|Ineligible|0|||
160466829|NCT02972359|579438042|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
160466830|NCT02972359|579438042|FG000|Overall Study|Lack of Efficacy|1|||
160466831|NCT02972359|579438042|FG000|Overall Study|Adverse Event|4|||
160466832|NCT02972359|579438042|FG000|Overall Study|Death|1|||
160466833|NCT02972359|579438042|FG000|Overall Study|Withdrawal by Subject|30|||
160466834|NCT02972359|579438042|FG000|Overall Study|Protocol Violation|1|||
160466835|NCT02972359|579438042|FG000|Overall Study|Lost to Follow-up|26|||
160466836|NCT02972359|579438042|FG000|Overall Study|Other reasons|5|||
160466837|NCT02972359|579438042|FG000|Overall Study|Missing|1|||
160466838|NCT05525572|579438043|FG000|Overall Study|Lost to Follow-up|2|||
160466839|NCT05025384|579438050|FG000|Overall Study|Physician Decision|5|||
160466840|NCT05025384|579438051|FG001|Overall Study|Physician Decision|6|||
160466841|NCT05251363|579438052|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
160466842|NCT05251363|579438052|FG000|Overall Study After Implant Period|Death|9|||
160466843|NCT05251363|579438052|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
160466844|NCT05251363|579438052|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
160466845|NCT05251363|579438052|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
160466846|NCT05251363|579438052|FG000|Overall Study After Implant Period|Physician Decision|1|||
160466847|NCT05251363|579438052|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
160466848|NCT00489307|579438053|FG000|Overall Study|Death|1|||
160466849|NCT00489307|579438054|FG001|Overall Study|Death|1|||
160466850|NCT00489307|579438053|FG000|Overall Study|Lost to Follow-up|2|||
160466851|NCT00489307|579438054|FG001|Overall Study|Lost to Follow-up|2|||
160466852|NCT00489307|579438053|FG000|Overall Study|Physician Decision|1|||
160466853|NCT00489307|579438054|FG001|Overall Study|Physician Decision|0|||
160466854|NCT00489307|579438053|FG000|Overall Study|Withdrawal by Subject|2|||
160466855|NCT00489307|579438054|FG001|Overall Study|Withdrawal by Subject|4|||
160466856|NCT00489307|579438053|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
160466857|NCT00489307|579438054|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
160466858|NCT00489307|579438053|FG000|Overall Study|Surgery after assignment|1|||
160466859|NCT00489307|579438054|FG001|Overall Study|Surgery after assignment|0|||
160466860|NCT00489307|579438053|FG000|Overall Study|Did not fill up the forms|2|||
160466861|NCT00489307|579438054|FG001|Overall Study|Did not fill up the forms|1|||
160466862|NCT00489307|579438053|FG000|Overall Study|Patient or family refusal|5|||
160466863|NCT00489307|579438054|FG001|Overall Study|Patient or family refusal|9|||
160466864|NCT03835754|579438055|FG000|Overall Study|Death|4|||
160466865|NCT02517268|579438058|FG000|Overall Study|Withdrawal by Subject|1|||
160466866|NCT02517268|579438059|FG001|Overall Study|Withdrawal by Subject|0|||
160466867|NCT05810285|579438065|FG000|Overall Study|Death|4|||
160466868|NCT05810285|579438066|FG001|Overall Study|Death|21|||
160466869|NCT05810285|579438065|FG000|Overall Study|Adverse Event|18|||
160466870|NCT05810285|579438066|FG001|Overall Study|Adverse Event|16|||
160466871|NCT04484623|579438067|FG000|Overall Study|Lost to Follow-up|0|||
160466872|NCT04484623|579438068|FG001|Overall Study|Lost to Follow-up|1|||
160466873|NCT04484623|579438067|FG000|Overall Study|Protocol Deviation|1|||
160466874|NCT04484623|579438068|FG001|Overall Study|Protocol Deviation|0|||
160466875|NCT04484623|579438067|FG000|Overall Study|Physician Decision|1|||
160466876|NCT04484623|579438068|FG001|Overall Study|Physician Decision|0|||
160466877|NCT04484623|579438067|FG000|Overall Study|Withdrawal by Subject|11|||
160466878|NCT04484623|579438068|FG001|Overall Study|Withdrawal by Subject|8|||
160466879|NCT04484623|579438067|FG000|Overall Study|Ongoing|94|||
160466880|NCT04484623|579438068|FG001|Overall Study|Ongoing|84|||
160466881|NCT05470114|579438069|FG000|Overall Study|Withdrawal by Subject|1|||
160466882|NCT05470114|579438070|FG001|Overall Study|Withdrawal by Subject|0|||
160466883|NCT05470114|579438069|FG000|Overall Study|Lost to Follow-up|1|||
160466884|NCT05470114|579438070|FG001|Overall Study|Lost to Follow-up|0|||
160466885|NCT04649047|579438075|FG000|Overall Study|Withdrawal by Subject|3|||
160466886|NCT05886777|579438076|FG000|Overall Study|Lost to Follow-up|1|||
160466887|NCT05886777|579438077|FG001|Overall Study|Lost to Follow-up|0|||
160466888|NCT05886777|579438078|FG002|Overall Study|Lost to Follow-up|2|||
160466889|NCT05886777|579438079|FG003|Overall Study|Lost to Follow-up|1|||
160466890|NCT05886777|579438080|FG004|Overall Study|Lost to Follow-up|0|||
160466891|NCT05886777|579438081|FG005|Overall Study|Lost to Follow-up|2|||
160466892|NCT05886777|579438082|FG006|Overall Study|Lost to Follow-up|0|||
160466893|NCT05886777|579438076|FG000|Overall Study|Other|0|||
160466894|NCT05886777|579438077|FG001|Overall Study|Other|2|||
160466895|NCT05886777|579438078|FG002|Overall Study|Other|1|||
160466896|NCT05886777|579438079|FG003|Overall Study|Other|0|||
160466897|NCT05886777|579438080|FG004|Overall Study|Other|0|||
160466898|NCT05886777|579438081|FG005|Overall Study|Other|0|||
160466899|NCT05886777|579438082|FG006|Overall Study|Other|0|||
160466900|NCT05886777|579438076|FG000|Overall Study|Withdrawal by Subject|1|||
160466901|NCT05886777|579438077|FG001|Overall Study|Withdrawal by Subject|0|||
160466902|NCT05886777|579438078|FG002|Overall Study|Withdrawal by Subject|1|||
160466903|NCT05886777|579438079|FG003|Overall Study|Withdrawal by Subject|4|||
160466904|NCT05886777|579438080|FG004|Overall Study|Withdrawal by Subject|3|||
160466905|NCT05886777|579438081|FG005|Overall Study|Withdrawal by Subject|1|||
160466906|NCT05886777|579438082|FG006|Overall Study|Withdrawal by Subject|1|||
160466907|NCT05886777|579438076|FG000|Overall Study|Protocol Violation|0|||
160466908|NCT05886777|579438077|FG001|Overall Study|Protocol Violation|0|||
160466909|NCT05886777|579438078|FG002|Overall Study|Protocol Violation|1|||
160466910|NCT05886777|579438079|FG003|Overall Study|Protocol Violation|0|||
160466911|NCT05886777|579438080|FG004|Overall Study|Protocol Violation|0|||
160466912|NCT05886777|579438081|FG005|Overall Study|Protocol Violation|0|||
160466913|NCT05886777|579438082|FG006|Overall Study|Protocol Violation|0|||
160466914|NCT05886777|579438076|FG000|Overall Study|No longer met eligibility criteria|0|||
160466915|NCT05886777|579438077|FG001|Overall Study|No longer met eligibility criteria|1|||
160466916|NCT05886777|579438078|FG002|Overall Study|No longer met eligibility criteria|0|||
160466917|NCT05886777|579438079|FG003|Overall Study|No longer met eligibility criteria|0|||
160466918|NCT05886777|579438080|FG004|Overall Study|No longer met eligibility criteria|0|||
160466919|NCT05886777|579438081|FG005|Overall Study|No longer met eligibility criteria|0|||
160466920|NCT05886777|579438082|FG006|Overall Study|No longer met eligibility criteria|0|||
160466921|NCT03773107|579438083|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
160466922|NCT03773107|579438084|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
160466923|NCT03773107|579438085|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
160466924|NCT03773107|579438086|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
160466925|NCT07204444|579438088|FG000|Overall Study|Medical/Hospitalization|6|||
160596746|NCT02378883|579901636|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
160466926|NCT07204444|579438089|FG001|Overall Study|Medical/Hospitalization|9|||
160466927|NCT07204444|579438090|FG002|Overall Study|Medical/Hospitalization|6|||
160466928|NCT07204444|579438088|FG000|Overall Study|Treatment Provider Issue|1|||
160466929|NCT07204444|579438089|FG001|Overall Study|Treatment Provider Issue|3|||
160466930|NCT07204444|579438090|FG002|Overall Study|Treatment Provider Issue|0|||
160466931|NCT07204444|579438088|FG000|Overall Study|Withdrawal by Subject|11|||
160596747|NCT02378883|579901636|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
160466932|NCT07204444|579438089|FG001|Overall Study|Withdrawal by Subject|5|||
160466933|NCT07204444|579438090|FG002|Overall Study|Withdrawal by Subject|5|||
160596748|NCT02378883|579901636|FG000|30 Day Follow-Up|Physician Decision|2|||
160466934|NCT07204444|579438088|FG000|Overall Study|Death|3|||
160466935|NCT07204444|579438089|FG001|Overall Study|Death|6|||
160466936|NCT07204444|579438090|FG002|Overall Study|Death|1|||
160466937|NCT07204444|579438088|FG000|Overall Study|Unable To Reach|29|||
160596749|NCT02378883|579901636|FG000|30 Day Follow-Up|Missed Visit|2|||
160596750|NCT02378883|579901636|FG000|30 Day Follow-Up|Death|1|||
160596751|NCT02378883|579901636|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
160596752|NCT02378883|579901636|FG000|12 Months Follow-Up|Death|2|||
160596753|NCT01588353|579901637|FG000|Step2|Withdrawal by Subject|0|||
160596754|NCT01588353|579901638|FG001|Step2|Withdrawal by Subject|1|||
160596755|NCT01588353|579901639|FG002|Step2|Withdrawal by Subject|0|||
160596756|NCT01588353|579901637|FG000|Step3|Adverse Event|0|||
160596757|NCT01588353|579901638|FG001|Step3|Adverse Event|0|||
160596758|NCT01588353|579901639|FG002|Step3|Adverse Event|2|||
160596759|NCT01504971|579901643|FG000|Overall Study|Physician Decision|13|||
160596760|NCT00936117|579901646|FG000|Overall Study|Adverse Event|7|||
160466938|NCT07204444|579438089|FG001|Overall Study|Unable To Reach|26|||
160466939|NCT07204444|579438090|FG002|Overall Study|Unable To Reach|17|||
160466940|NCT07204444|579438088|FG000|Overall Study|Protocol Deviation|3|||
160466941|NCT07204444|579438089|FG001|Overall Study|Protocol Deviation|2|||
160466942|NCT07204444|579438090|FG002|Overall Study|Protocol Deviation|0|||
160466943|NCT02972034|579439592|FG000|Overall Study|Death|11|||
160466944|NCT02972034|579439593|FG001|Overall Study|Death|1|||
160466945|NCT02972034|579439594|FG002|Overall Study|Death|3|||
160466946|NCT02972034|579439595|FG003|Overall Study|Death|3|||
160466947|NCT02972034|579439596|FG004|Overall Study|Death|2|||
160466948|NCT02972034|579439597|FG005|Overall Study|Death|2|||
160466949|NCT02972034|579439598|FG006|Overall Study|Death|3|||
160466950|NCT02972034|579439599|FG007|Overall Study|Death|4|||
160466951|NCT02972034|579439600|FG008|Overall Study|Death|8|||
160596761|NCT00936117|579901646|FG000|Overall Study|Unable to continue oral medication|3|||
160466952|NCT02972034|579439601|FG009|Overall Study|Death|11|||
160466953|NCT02972034|579439602|FG010|Overall Study|Death|3|||
160466954|NCT02972034|579439603|FG011|Overall Study|Death|2|||
160466955|NCT02972034|579439604|FG012|Overall Study|Death|11|||
160466956|NCT02972034|579439605|FG013|Overall Study|Death|10|||
160466957|NCT02972034|579439606|FG014|Overall Study|Death|9|||
160466958|NCT02972034|579439592|FG000|Overall Study|Lost to Follow-up|0|||
160466959|NCT02972034|579439593|FG001|Overall Study|Lost to Follow-up|0|||
160466960|NCT02972034|579439594|FG002|Overall Study|Lost to Follow-up|0|||
160596762|NCT04581863|579901647|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
160596763|NCT04581863|579901648|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
160466961|NCT02972034|579439595|FG003|Overall Study|Lost to Follow-up|0|||
160466962|NCT02972034|579439596|FG004|Overall Study|Lost to Follow-up|1|||
160466963|NCT02972034|579439597|FG005|Overall Study|Lost to Follow-up|0|||
160466964|NCT02972034|579439598|FG006|Overall Study|Lost to Follow-up|0|||
160466965|NCT02972034|579439599|FG007|Overall Study|Lost to Follow-up|1|||
160466966|NCT02972034|579439600|FG008|Overall Study|Lost to Follow-up|0|||
160466967|NCT02972034|579439601|FG009|Overall Study|Lost to Follow-up|0|||
160466968|NCT02972034|579439602|FG010|Overall Study|Lost to Follow-up|0|||
160466969|NCT02972034|579439603|FG011|Overall Study|Lost to Follow-up|0|||
160466970|NCT02972034|579439604|FG012|Overall Study|Lost to Follow-up|0|||
160466971|NCT02972034|579439605|FG013|Overall Study|Lost to Follow-up|0|||
160466972|NCT02972034|579439606|FG014|Overall Study|Lost to Follow-up|1|||
160466973|NCT02972034|579439592|FG000|Overall Study|Physician Decision|0|||
160466974|NCT02972034|579439593|FG001|Overall Study|Physician Decision|0|||
160596764|NCT01803711|579901655|FG000|Overall Study|Adverse Event|1|||
160596765|NCT01803711|579901656|FG001|Overall Study|Adverse Event|1|||
160596766|NCT01376245|579901657|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
160596767|NCT01376245|579901658|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
160596768|NCT01376245|579901659|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
160596769|NCT01376245|579901660|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
160596770|NCT01376245|579901661|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
160596771|NCT01376245|579901657|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
160596772|NCT01376245|579901658|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
160596773|NCT01376245|579901659|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
160596774|NCT01376245|579901660|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
160596775|NCT01376245|579901661|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
160596776|NCT01376245|579901657|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
160596777|NCT01376245|579901658|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
160596778|NCT01376245|579901659|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
160596779|NCT01376245|579901660|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
160596780|NCT01376245|579901661|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
160596781|NCT01376245|579901657|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
160596782|NCT01376245|579901658|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
160596783|NCT01376245|579901659|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
160596784|NCT01376245|579901660|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
160596785|NCT01376245|579901661|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
160596786|NCT01376245|579901657|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
160596787|NCT01376245|579901658|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
160596788|NCT01376245|579901659|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
160596789|NCT01376245|579901660|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
160596790|NCT01376245|579901661|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
160596791|NCT01376245|579901657|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
160466975|NCT02972034|579439594|FG002|Overall Study|Physician Decision|0|||
160466976|NCT02972034|579439595|FG003|Overall Study|Physician Decision|0|||
160596792|NCT01376245|579901658|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
160596793|NCT01376245|579901659|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
160659017|NCT03049488|580133266|FG001|Overall Study|Moved from Area|0|||
160466977|NCT02972034|579439596|FG004|Overall Study|Physician Decision|0|||
160466978|NCT02972034|579439597|FG005|Overall Study|Physician Decision|0|||
160466979|NCT02972034|579439598|FG006|Overall Study|Physician Decision|0|||
160466980|NCT02972034|579439599|FG007|Overall Study|Physician Decision|1|||
160466981|NCT02972034|579439600|FG008|Overall Study|Physician Decision|0|||
160596794|NCT01376245|579901660|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
160596795|NCT01376245|579901661|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
160596796|NCT01376245|579901657|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
160596797|NCT01376245|579901658|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
160596798|NCT01376245|579901659|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
160596799|NCT01376245|579901660|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
160596800|NCT01376245|579901661|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
160596801|NCT01376245|579901657|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
160596802|NCT01376245|579901658|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
160596803|NCT01376245|579901659|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
160596804|NCT01376245|579901660|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
160659018|NCT03049488|580133267|FG002|Overall Study|Moved from Area|0|||
160659019|NCT03049488|580133268|FG003|Overall Study|Moved from Area|1|||
160659020|NCT03049488|580133269|FG004|Overall Study|Moved from Area|1|||
160659021|NCT03049488|580133270|FG005|Overall Study|Moved from Area|0|||
160659022|NCT03049488|580133265|FG000|Overall Study|Physician Decision|0|||
160596805|NCT01376245|579901661|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
160659023|NCT03049488|580133266|FG001|Overall Study|Physician Decision|1|||
160659024|NCT03049488|580133267|FG002|Overall Study|Physician Decision|0|||
160659025|NCT03049488|580133268|FG003|Overall Study|Physician Decision|0|||
160596806|NCT01376245|579901657|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
160596807|NCT01376245|579901658|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
160596808|NCT01376245|579901659|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
160596809|NCT01376245|579901660|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
160596810|NCT01376245|579901661|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
160596811|NCT01376245|579901657|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160596812|NCT01376245|579901658|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
160596813|NCT01376245|579901659|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160596814|NCT01376245|579901660|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
160596815|NCT01376245|579901661|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
160596816|NCT01376245|579901657|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
160596817|NCT01376245|579901658|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
160596818|NCT01376245|579901659|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
160596819|NCT01376245|579901660|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
160596820|NCT01376245|579901661|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
160596821|NCT01376245|579901657|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
160596822|NCT01376245|579901658|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
160596823|NCT01376245|579901659|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
160596824|NCT01376245|579901660|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
160596825|NCT01376245|579901661|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
160596826|NCT01357889|579901662|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
160596827|NCT01357889|579901663|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
160596828|NCT01357889|579901662|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
160596829|NCT01357889|579901663|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
160596830|NCT01357889|579901662|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
160596831|NCT01357889|579901663|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
160596832|NCT01357889|579901662|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
160596833|NCT01357889|579901663|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
160596834|NCT01357889|579901662|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
160596835|NCT01357889|579901663|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
160596836|NCT01357889|579901662|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
160596837|NCT01357889|579901663|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
160596838|NCT01357889|579901662|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
160596839|NCT01357889|579901663|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
160596840|NCT01357889|579901662|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
160596841|NCT01357889|579901663|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
160596842|NCT01357889|579901662|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
160596843|NCT01357889|579901663|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
160596844|NCT01357889|579901662|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
160596845|NCT01357889|579901663|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
160596846|NCT01357889|579901662|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
160596847|NCT01357889|579901663|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
160596848|NCT01357889|579901662|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
160596849|NCT01357889|579901663|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
160596850|NCT01357889|579901662|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
160596851|NCT01357889|579901663|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
160596852|NCT01170221|579901664|FG000|Overall Study|Lost to Follow-up|22|||
160596853|NCT01170221|579901665|FG001|Overall Study|Lost to Follow-up|21|||
160596854|NCT01170221|579901664|FG000|Overall Study|Withdrawal by Subject|9|||
160596855|NCT01170221|579901665|FG001|Overall Study|Withdrawal by Subject|7|||
160596856|NCT01170221|579901664|FG000|Overall Study|Subject completed only screening and LFU|1|||
160596857|NCT01170221|579901665|FG001|Overall Study|Subject completed only screening and LFU|0|||
160466982|NCT02972034|579439601|FG009|Overall Study|Physician Decision|0|||
160466983|NCT02972034|579439602|FG010|Overall Study|Physician Decision|1|||
160466984|NCT02972034|579439603|FG011|Overall Study|Physician Decision|0|||
160466985|NCT02972034|579439604|FG012|Overall Study|Physician Decision|0|||
160466986|NCT02972034|579439605|FG013|Overall Study|Physician Decision|0|||
160466987|NCT02972034|579439606|FG014|Overall Study|Physician Decision|0|||
160466988|NCT02972034|579439592|FG000|Overall Study|Sponsor Decision|0|||
160466989|NCT02972034|579439593|FG001|Overall Study|Sponsor Decision|0|||
160466990|NCT02972034|579439594|FG002|Overall Study|Sponsor Decision|0|||
160466991|NCT02972034|579439595|FG003|Overall Study|Sponsor Decision|1|||
160466992|NCT02972034|579439596|FG004|Overall Study|Sponsor Decision|0|||
160466993|NCT02972034|579439597|FG005|Overall Study|Sponsor Decision|0|||
160466994|NCT02972034|579439598|FG006|Overall Study|Sponsor Decision|1|||
160466995|NCT02972034|579439599|FG007|Overall Study|Sponsor Decision|1|||
160466996|NCT02972034|579439600|FG008|Overall Study|Sponsor Decision|1|||
160466997|NCT02972034|579439601|FG009|Overall Study|Sponsor Decision|2|||
160466998|NCT02972034|579439602|FG010|Overall Study|Sponsor Decision|2|||
160466999|NCT02972034|579439603|FG011|Overall Study|Sponsor Decision|0|||
160467000|NCT02972034|579439604|FG012|Overall Study|Sponsor Decision|1|||
160467001|NCT02972034|579439605|FG013|Overall Study|Sponsor Decision|0|||
160467002|NCT02972034|579439606|FG014|Overall Study|Sponsor Decision|1|||
160467003|NCT02972034|579439592|FG000|Overall Study|Withdrawal by Subject|3|||
160467004|NCT02972034|579439593|FG001|Overall Study|Withdrawal by Subject|0|||
160467005|NCT02972034|579439594|FG002|Overall Study|Withdrawal by Subject|0|||
160467006|NCT02972034|579439595|FG003|Overall Study|Withdrawal by Subject|0|||
160467007|NCT02972034|579439596|FG004|Overall Study|Withdrawal by Subject|1|||
160467008|NCT02972034|579439597|FG005|Overall Study|Withdrawal by Subject|1|||
160467009|NCT02972034|579439598|FG006|Overall Study|Withdrawal by Subject|0|||
160467010|NCT02972034|579439599|FG007|Overall Study|Withdrawal by Subject|0|||
160467011|NCT02972034|579439600|FG008|Overall Study|Withdrawal by Subject|1|||
160467012|NCT02972034|579439601|FG009|Overall Study|Withdrawal by Subject|1|||
160467013|NCT02972034|579439602|FG010|Overall Study|Withdrawal by Subject|2|||
160467014|NCT02972034|579439603|FG011|Overall Study|Withdrawal by Subject|1|||
160467015|NCT02972034|579439604|FG012|Overall Study|Withdrawal by Subject|1|||
160467016|NCT02972034|579439605|FG013|Overall Study|Withdrawal by Subject|1|||
160467017|NCT02972034|579439606|FG014|Overall Study|Withdrawal by Subject|0|||
160467018|NCT02972034|579439592|FG000|Overall Study|Screen Failure|0|||
160467019|NCT02972034|579439593|FG001|Overall Study|Screen Failure|0|||
160467020|NCT02972034|579439594|FG002|Overall Study|Screen Failure|0|||
160467021|NCT02972034|579439595|FG003|Overall Study|Screen Failure|0|||
160467022|NCT02972034|579439596|FG004|Overall Study|Screen Failure|0|||
160467023|NCT02972034|579439597|FG005|Overall Study|Screen Failure|0|||
160467024|NCT02972034|579439598|FG006|Overall Study|Screen Failure|0|||
160467025|NCT02972034|579439599|FG007|Overall Study|Screen Failure|0|||
160467026|NCT02972034|579439600|FG008|Overall Study|Screen Failure|0|||
160467027|NCT02972034|579439601|FG009|Overall Study|Screen Failure|0|||
160467028|NCT02972034|579439602|FG010|Overall Study|Screen Failure|0|||
160467029|NCT02972034|579439603|FG011|Overall Study|Screen Failure|0|||
160467030|NCT02972034|579439604|FG012|Overall Study|Screen Failure|1|||
160467031|NCT02972034|579439605|FG013|Overall Study|Screen Failure|0|||
160467032|NCT02972034|579439606|FG014|Overall Study|Screen Failure|0|||
160467033|NCT03861052|579439607|FG000|Overall Study|Adverse Event|1|||
160467034|NCT03861052|579439608|FG001|Overall Study|Adverse Event|1|||
160467035|NCT03861052|579439609|FG002|Overall Study|Adverse Event|2|||
160467036|NCT03861052|579439610|FG003|Overall Study|Adverse Event|4|||
160467037|NCT03861052|579439607|FG000|Overall Study|Lost to Follow-up|0|||
160467038|NCT03861052|579439608|FG001|Overall Study|Lost to Follow-up|0|||
160467039|NCT03861052|579439609|FG002|Overall Study|Lost to Follow-up|0|||
160596858|NCT01170221|579901664|FG000|Overall Study|Randomized but not treated|1|||
160596859|NCT01170221|579901665|FG001|Overall Study|Randomized but not treated|0|||
160596860|NCT02693691|579901666|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
160596861|NCT02693691|579901666|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
160596862|NCT02693691|579901666|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
160596863|NCT02693691|579901666|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
160596864|NCT02693691|579901666|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
160467040|NCT03861052|579439610|FG003|Overall Study|Lost to Follow-up|1|||
160467041|NCT03861052|579439607|FG000|Overall Study|Physician Decision|0|||
160467042|NCT03861052|579439608|FG001|Overall Study|Physician Decision|1|||
160467043|NCT03861052|579439609|FG002|Overall Study|Physician Decision|0|||
160596865|NCT02693691|579901666|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
160467044|NCT03861052|579439610|FG003|Overall Study|Physician Decision|0|||
160467045|NCT03861052|579439607|FG000|Overall Study|Withdrawal by Subject|2|||
160467046|NCT03861052|579439608|FG001|Overall Study|Withdrawal by Subject|5|||
160467047|NCT03861052|579439609|FG002|Overall Study|Withdrawal by Subject|3|||
160467048|NCT03861052|579439610|FG003|Overall Study|Withdrawal by Subject|0|||
160467049|NCT03861052|579439607|FG000|Overall Study|Relocation to other city|1|||
160596866|NCT02693691|579901666|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
160467050|NCT03861052|579439608|FG001|Overall Study|Relocation to other city|0|||
160596867|NCT00416312|579901667|FG000|Overall Study|tumors not visible on imaging|2|||
160596868|NCT00050960|579901668|FG000|Overall Study|Progressive Disease|137|||
160596869|NCT00050960|579901669|FG001|Overall Study|Progressive Disease|93|||
160596870|NCT00050960|579901668|FG000|Overall Study|Stable Disease|19|||
160596871|NCT00050960|579901669|FG001|Overall Study|Stable Disease|48|||
160596872|NCT00050960|579901668|FG000|Overall Study|Partial Response|14|||
160596873|NCT00050960|579901669|FG001|Overall Study|Partial Response|19|||
160596874|NCT00050960|579901668|FG000|Overall Study|Complete Response|0|||
160596875|NCT00050960|579901669|FG001|Overall Study|Complete Response|2|||
160596876|NCT00050960|579901668|FG000|Overall Study|Adverse Event|62|||
160596877|NCT00050960|579901669|FG001|Overall Study|Adverse Event|61|||
160596878|NCT00050960|579901668|FG000|Overall Study|Lost to Follow-up|0|||
160596879|NCT00050960|579901669|FG001|Overall Study|Lost to Follow-up|1|||
160596880|NCT00050960|579901668|FG000|Overall Study|Withdrawal by Subject|23|||
160596881|NCT00050960|579901669|FG001|Overall Study|Withdrawal by Subject|18|||
160596882|NCT00050960|579901668|FG000|Overall Study|Administrative|31|||
160596883|NCT00050960|579901669|FG001|Overall Study|Administrative|46|||
160596884|NCT00050960|579901668|FG000|Overall Study|Non-compliance|3|||
160596885|NCT00050960|579901669|FG001|Overall Study|Non-compliance|1|||
160596886|NCT00050960|579901668|FG000|Overall Study|Death|13|||
160596887|NCT00050960|579901669|FG001|Overall Study|Death|15|||
160596888|NCT02727660|579901670|FG000|Overall Study|Lack of Efficacy|40|||
160596889|NCT02727660|579901671|FG001|Overall Study|Lack of Efficacy|40|||
160659026|NCT03049488|580133269|FG004|Overall Study|Physician Decision|0|||
160659027|NCT03049488|580133270|FG005|Overall Study|Physician Decision|0|||
160659028|NCT03049488|580133265|FG000|Overall Study|Withdrawal by Subject|0|||
160596890|NCT02727660|579901672|FG002|Overall Study|Lack of Efficacy|70|||
160596891|NCT02727660|579901670|FG000|Overall Study|Adverse Event|28|||
160596892|NCT02727660|579901671|FG001|Overall Study|Adverse Event|21|||
160596893|NCT02727660|579901672|FG002|Overall Study|Adverse Event|32|||
160596894|NCT02727660|579901670|FG000|Overall Study|Withdrawal by Subject|26|||
160596895|NCT02727660|579901671|FG001|Overall Study|Withdrawal by Subject|25|||
160596896|NCT02727660|579901672|FG002|Overall Study|Withdrawal by Subject|30|||
160596897|NCT02727660|579901670|FG000|Overall Study|Physician Decision|3|||
160596898|NCT02727660|579901671|FG001|Overall Study|Physician Decision|8|||
160596899|NCT02727660|579901672|FG002|Overall Study|Physician Decision|14|||
160596900|NCT02727660|579901670|FG000|Overall Study|Lost to Follow-up|5|||
160596901|NCT02727660|579901671|FG001|Overall Study|Lost to Follow-up|9|||
160596902|NCT02727660|579901672|FG002|Overall Study|Lost to Follow-up|8|||
160596903|NCT02727660|579901670|FG000|Overall Study|Protocol Violation|7|||
160596904|NCT02727660|579901671|FG001|Overall Study|Protocol Violation|5|||
160596905|NCT02727660|579901672|FG002|Overall Study|Protocol Violation|5|||
160596906|NCT02727660|579901670|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
160596907|NCT02727660|579901671|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
160596908|NCT02727660|579901672|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
160596909|NCT02727660|579901670|FG000|Overall Study|Administrative Reasons|2|||
160596910|NCT02727660|579901671|FG001|Overall Study|Administrative Reasons|3|||
160596911|NCT02727660|579901672|FG002|Overall Study|Administrative Reasons|4|||
160596912|NCT01315847|579901678|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
160596913|NCT01315847|579901679|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
160596914|NCT01315847|579901678|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
160596915|NCT01315847|579901679|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
160596916|NCT02940626|579901680|FG000|Overall Study|Death|40|||
160596917|NCT02940626|579901681|FG001|Overall Study|Death|32|||
160596918|NCT02940626|579901680|FG000|Overall Study|Lost to Follow-up|5|||
160596919|NCT02940626|579901681|FG001|Overall Study|Lost to Follow-up|2|||
160596920|NCT02940626|579901680|FG000|Overall Study|Withdrawal by Subject|1|||
160596921|NCT02940626|579901681|FG001|Overall Study|Withdrawal by Subject|0|||
160596922|NCT02940626|579901680|FG000|Overall Study|Transfer to Hospice Care|1|||
160596923|NCT02940626|579901681|FG001|Overall Study|Transfer to Hospice Care|0|||
160596924|NCT02940626|579901680|FG000|Overall Study|Prohibited Concomitant Medication|0|||
160596925|NCT02940626|579901681|FG001|Overall Study|Prohibited Concomitant Medication|1|||
160596926|NCT01324622|579901682|FG000|Overall Study|Lost to Follow-up|7|||
160596927|NCT01324622|579901683|FG001|Overall Study|Lost to Follow-up|7|||
160596928|NCT01324622|579901682|FG000|Overall Study|Death|1|||
160596929|NCT01324622|579901683|FG001|Overall Study|Death|0|||
160596930|NCT01324622|579901682|FG000|Overall Study|Lack of Efficacy|1|||
160467051|NCT03861052|579439609|FG002|Overall Study|Relocation to other city|0|||
160467052|NCT03861052|579439610|FG003|Overall Study|Relocation to other city|0|||
160467053|NCT03009344|579439611|FG000|Overall Study|Lack of Efficacy|5|||
160467054|NCT03009344|579439611|FG000|Overall Study|Withdrawal by Subject|1|||
160467055|NCT03009344|579439611|FG000|Overall Study|Adverse Event|1|||
160467056|NCT00345046|579439618|FG000|Overall Study|Protocol Violation|1|||
160467057|NCT00345046|579439619|FG001|Overall Study|Protocol Violation|1|||
160467058|NCT00345046|579439620|FG002|Overall Study|Protocol Violation|2|||
160467059|NCT03689946|579439621|FG000|Overall Study|Withdrawal by Subject|3|||
160467060|NCT03689946|579439621|FG000|Overall Study|Lost to Follow-up|3|||
160467061|NCT03689946|579439621|FG000|Overall Study|Data corruption|2|||
160467062|NCT01555138|579439622|FG000|Overall Study|Death|0|||
160467063|NCT01555138|579439623|FG001|Overall Study|Death|1|||
160467064|NCT01555138|579439622|FG000|Overall Study|Lost to Follow-up|1|||
160467065|NCT01555138|579439623|FG001|Overall Study|Lost to Follow-up|0|||
160467066|NCT01555138|579439622|FG000|Overall Study|Abnormal Lab reults|1|||
160467067|NCT01555138|579439623|FG001|Overall Study|Abnormal Lab reults|3|||
160467068|NCT01555138|579439622|FG000|Overall Study|Lack of Efficacy|2|||
160467069|NCT01555138|579439623|FG001|Overall Study|Lack of Efficacy|2|||
160467070|NCT01555138|579439622|FG000|Overall Study|Protocol Violation|5|||
160467071|NCT01555138|579439623|FG001|Overall Study|Protocol Violation|3|||
160467072|NCT01555138|579439622|FG000|Overall Study|Administrative problems|8|||
160467073|NCT01555138|579439623|FG001|Overall Study|Administrative problems|0|||
160467074|NCT01555138|579439622|FG000|Overall Study|Withdrawal by Subject|16|||
160467075|NCT01555138|579439623|FG001|Overall Study|Withdrawal by Subject|15|||
160467076|NCT01555138|579439622|FG000|Overall Study|Adverse Event|14|||
160467077|NCT01555138|579439623|FG001|Overall Study|Adverse Event|14|||
160467078|NCT00512252|579439627|FG000|Overall Study|Lost to Follow-up|0|||
160467079|NCT00512252|579439628|FG001|Overall Study|Lost to Follow-up|0|||
160467080|NCT00512252|579439629|FG002|Overall Study|Lost to Follow-up|1|||
160467081|NCT00512252|579439627|FG000|Overall Study|Protocol Violation|0|||
160467082|NCT00512252|579439628|FG001|Overall Study|Protocol Violation|0|||
160467083|NCT00512252|579439629|FG002|Overall Study|Protocol Violation|1|||
160467084|NCT00512252|579439627|FG000|Overall Study|Death|0|||
160467085|NCT00512252|579439628|FG001|Overall Study|Death|0|||
160467086|NCT00512252|579439629|FG002|Overall Study|Death|1|||
160467087|NCT02357966|579439630|FG000|Overall Study|Death|0|||
160467088|NCT02357966|579439631|FG001|Overall Study|Death|0|||
160596931|NCT01324622|579901683|FG001|Overall Study|Lack of Efficacy|0|||
160596932|NCT02219087|579901684|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
160596933|NCT02219087|579901685|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
160596934|NCT05127421|579901686|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
160596935|NCT05127421|579901687|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
160467089|NCT02357966|579439632|FG002|Overall Study|Death|1|||
160596936|NCT05127421|579901688|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
160467090|NCT02357966|579439633|FG003|Overall Study|Death|0|||
160467091|NCT02357966|579439634|FG004|Overall Study|Death|2|||
160467092|NCT02357966|579439635|FG005|Overall Study|Death|0|||
160467093|NCT02357966|579439630|FG000|Overall Study|Physician Decision|1|||
160467094|NCT02357966|579439631|FG001|Overall Study|Physician Decision|0|||
160467095|NCT02357966|579439632|FG002|Overall Study|Physician Decision|0|||
160467096|NCT02357966|579439633|FG003|Overall Study|Physician Decision|0|||
160467097|NCT02357966|579439634|FG004|Overall Study|Physician Decision|1|||
160467098|NCT02357966|579439635|FG005|Overall Study|Physician Decision|0|||
160467099|NCT04608409|579439639|FG000|Overall Study|Physician Decision|1|||
160467100|NCT04608409|579439640|FG001|Overall Study|Physician Decision|1|||
160467101|NCT04608409|579439641|FG002|Overall Study|Physician Decision|2|||
160467102|NCT00454194|579439642|FG000|Overall Study|Adverse Event|7|||
160467103|NCT00454194|579439643|FG001|Overall Study|Adverse Event|2|||
160467104|NCT00454194|579439642|FG000|Overall Study|Withdrawal by Subject|12|||
160467105|NCT00454194|579439643|FG001|Overall Study|Withdrawal by Subject|8|||
160467106|NCT00454194|579439642|FG000|Overall Study|Other Medical Problems|1|||
160467107|NCT00454194|579439643|FG001|Overall Study|Other Medical Problems|2|||
160467108|NCT00454194|579439642|FG000|Overall Study|Other Unspecified Reason|2|||
160467109|NCT00454194|579439643|FG001|Overall Study|Other Unspecified Reason|2|||
160467110|NCT00229658|579439660|FG000|Overall Study|Administrative|2|||
160467111|NCT00229658|579439661|FG001|Overall Study|Administrative|1|||
160467112|NCT00229658|579439660|FG000|Overall Study|Investigator decision|13|||
160467113|NCT00229658|579439661|FG001|Overall Study|Investigator decision|10|||
160467114|NCT00229658|579439660|FG000|Overall Study|Other|80|||
160467115|NCT00229658|579439661|FG001|Overall Study|Other|60|||
160467116|NCT00229658|579439660|FG000|Overall Study|Lost to Follow-up|82|||
160467117|NCT00229658|579439661|FG001|Overall Study|Lost to Follow-up|55|||
160467118|NCT00229658|579439660|FG000|Overall Study|Serious Adverse Event|2|||
160467119|NCT00229658|579439661|FG001|Overall Study|Serious Adverse Event|2|||
160467120|NCT00229658|579439660|FG000|Overall Study|Withdrawal of consent|46|||
160467121|NCT00229658|579439661|FG001|Overall Study|Withdrawal of consent|39|||
160467122|NCT02157116|579439662|FG000|Overall Study|Withdrawal by Subject|4|||
160467123|NCT02157116|579439662|FG000|Overall Study|Physician Decision|3|||
160467124|NCT02157116|579439662|FG000|Overall Study|Failed Screening|2|||
160467125|NCT01953224|579439663|FG000|Overall Study|Lost to Follow-up|1|||
160467126|NCT01953224|579439664|FG001|Overall Study|Lost to Follow-up|1|||
160467127|NCT01953224|579439663|FG000|Overall Study|Withdrawal by Subject|1|||
160467128|NCT01953224|579439664|FG001|Overall Study|Withdrawal by Subject|2|||
160467129|NCT00463229|579439665|FG000|Overall Study|Lost to Follow-up|5|||
160467130|NCT00463229|579439666|FG001|Overall Study|Lost to Follow-up|7|||
160467131|NCT00463229|579439665|FG000|Overall Study|Death|4|||
160467132|NCT00463229|579439666|FG001|Overall Study|Death|3|||
160467133|NCT01359150|579439673|FG000|Overall Study|Lack of Efficacy|1|||
160467134|NCT01359150|579439674|FG001|Overall Study|Lack of Efficacy|1|||
160467135|NCT01359150|579439673|FG000|Overall Study|Withdrawal by Subject|1|||
160467136|NCT01359150|579439674|FG001|Overall Study|Withdrawal by Subject|1|||
160467137|NCT01359150|579439673|FG000|Overall Study|Adverse Event|4|||
160467138|NCT01359150|579439674|FG001|Overall Study|Adverse Event|3|||
160467139|NCT01359150|579439673|FG000|Overall Study|Other|1|||
160467140|NCT01359150|579439674|FG001|Overall Study|Other|0|||
160467141|NCT01700205|579439675|FG000|Overall Study|Withdrawal by Subject|13|||
160467142|NCT01700205|579439676|FG001|Overall Study|Withdrawal by Subject|13|||
160467143|NCT01700205|579439675|FG000|Overall Study|Protocol Violation|2|||
160467144|NCT01700205|579439676|FG001|Overall Study|Protocol Violation|2|||
160467145|NCT01728324|579439677|FG000|Termination of DBV|Adverse Event|14|||
160467146|NCT01728324|579439678|FG001|Termination of DBV|Adverse Event|13|||
160467147|NCT01728324|579439679|FG002|Termination of DBV|Adverse Event|4|||
160467148|NCT01728324|579439677|FG000|Termination of DBV|Lack of Efficacy|14|||
160467149|NCT01728324|579439678|FG001|Termination of DBV|Lack of Efficacy|12|||
160467150|NCT01728324|579439679|FG002|Termination of DBV|Lack of Efficacy|8|||
160467151|NCT01728324|579439677|FG000|Termination of DBV|Withdrawal by Subject|9|||
160467152|NCT01728324|579439678|FG001|Termination of DBV|Withdrawal by Subject|6|||
160467153|NCT01728324|579439679|FG002|Termination of DBV|Withdrawal by Subject|2|||
160467154|NCT01728324|579439677|FG000|Termination of DBV|Other than stated|1|||
160467155|NCT01728324|579439678|FG001|Termination of DBV|Other than stated|3|||
160596937|NCT05127421|579901689|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
160467156|NCT01728324|579439679|FG002|Termination of DBV|Other than stated|0|||
160467157|NCT01728324|579439677|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
160467158|NCT01728324|579439678|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
160467159|NCT01728324|579439679|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
160467160|NCT01728324|579439677|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
160596938|NCT05127421|579901686|FG000|4-Week Double-Blind Period|Physician Decision|1|||
160467161|NCT01728324|579439678|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
160467162|NCT01728324|579439679|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
160467163|NCT01728324|579439677|FG000|Termination of FDV|Adverse Event|14|||
160467164|NCT01728324|579439678|FG001|Termination of FDV|Adverse Event|13|||
160467165|NCT01728324|579439679|FG002|Termination of FDV|Adverse Event|4|||
160467166|NCT01728324|579439677|FG000|Termination of FDV|Lack of Efficacy|14|||
160596939|NCT05127421|579901687|FG001|4-Week Double-Blind Period|Physician Decision|0|||
160596940|NCT05127421|579901688|FG002|4-Week Double-Blind Period|Physician Decision|0|||
160596941|NCT05127421|579901689|FG003|4-Week Double-Blind Period|Physician Decision|0|||
160467167|NCT01728324|579439678|FG001|Termination of FDV|Lack of Efficacy|12|||
160467168|NCT01728324|579439679|FG002|Termination of FDV|Lack of Efficacy|8|||
160467169|NCT01728324|579439677|FG000|Termination of FDV|Withdrawal by Subject|9|||
160467170|NCT01728324|579439678|FG001|Termination of FDV|Withdrawal by Subject|6|||
160467171|NCT01728324|579439679|FG002|Termination of FDV|Withdrawal by Subject|2|||
160467172|NCT01728324|579439677|FG000|Termination of FDV|Other than stated|1|||
160467173|NCT01728324|579439678|FG001|Termination of FDV|Other than stated|3|||
160467174|NCT01728324|579439679|FG002|Termination of FDV|Other than stated|0|||
160467175|NCT01728324|579439677|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
160467176|NCT01728324|579439678|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
160467177|NCT01728324|579439679|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
160467178|NCT01728324|579439677|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
160467179|NCT01728324|579439678|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
160467180|NCT01728324|579439679|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
160467181|NCT01728324|579439677|FG000|Termination of RBV|Adverse Event|15|||
160467182|NCT01728324|579439678|FG001|Termination of RBV|Adverse Event|16|||
160467183|NCT01728324|579439679|FG002|Termination of RBV|Adverse Event|5|||
160467184|NCT01728324|579439677|FG000|Termination of RBV|Lack of Efficacy|14|||
160467185|NCT01728324|579439678|FG001|Termination of RBV|Lack of Efficacy|11|||
160467186|NCT01728324|579439679|FG002|Termination of RBV|Lack of Efficacy|7|||
160467187|NCT01728324|579439677|FG000|Termination of RBV|Withdrawal by Subject|9|||
160467188|NCT01728324|579439678|FG001|Termination of RBV|Withdrawal by Subject|5|||
160467189|NCT01728324|579439679|FG002|Termination of RBV|Withdrawal by Subject|2|||
160467190|NCT01728324|579439677|FG000|Termination of RBV|Other than stated|1|||
160467191|NCT01728324|579439678|FG001|Termination of RBV|Other than stated|3|||
160467192|NCT01728324|579439679|FG002|Termination of RBV|Other than stated|1|||
160467193|NCT01728324|579439677|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
160467194|NCT01728324|579439678|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
160467195|NCT01728324|579439679|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
160467196|NCT01728324|579439677|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
160467197|NCT01728324|579439678|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
160467198|NCT01728324|579439679|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
160467199|NCT02040870|579439682|FG000|Overall Study|Completed treatment phase|6|||
160467200|NCT02040870|579439682|FG000|Overall Study|Adverse Event|7|||
160467201|NCT02040870|579439682|FG000|Overall Study|Progressive disease|58|||
160467202|NCT02040870|579439682|FG000|Overall Study|Physician Decision|6|||
160467203|NCT02040870|579439682|FG000|Overall Study|Subject/guardian decision|10|||
160467204|NCT02040870|579439682|FG000|Overall Study|Lost to Follow-up|3|||
160467205|NCT02040870|579439682|FG000|Overall Study|Death|13|||
160467206|NCT00641537|579439692|FG000|96-week Period|Adverse Event|0|||
160467207|NCT00641537|579439693|FG001|96-week Period|Adverse Event|1|||
160467208|NCT00641537|579439694|FG002|96-week Period|Adverse Event|3|||
160467209|NCT00641537|579439695|FG003|96-week Period|Adverse Event|0|||
160467210|NCT00641537|579439696|FG004|96-week Period|Adverse Event|2|||
160467211|NCT00641537|579439697|FG005|96-week Period|Adverse Event|0|||
160467212|NCT00641537|579439698|FG006|96-week Period|Adverse Event|0|||
160467213|NCT00641537|579439699|FG007|96-week Period|Adverse Event|0|||
160467214|NCT00641537|579439692|FG000|96-week Period|Lost to Follow-up|3|||
160467215|NCT00641537|579439693|FG001|96-week Period|Lost to Follow-up|1|||
160467216|NCT00641537|579439694|FG002|96-week Period|Lost to Follow-up|2|||
160467217|NCT00641537|579439695|FG003|96-week Period|Lost to Follow-up|2|||
160467218|NCT00641537|579439696|FG004|96-week Period|Lost to Follow-up|4|||
160467219|NCT00641537|579439697|FG005|96-week Period|Lost to Follow-up|0|||
160467220|NCT00641537|579439698|FG006|96-week Period|Lost to Follow-up|1|||
160596942|NCT05127421|579901686|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
160596943|NCT05127421|579901687|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
160596944|NCT05127421|579901688|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
160596945|NCT05127421|579901689|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
160596946|NCT05127421|579901686|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
160467221|NCT00641537|579439699|FG007|96-week Period|Lost to Follow-up|0|||
160467222|NCT00641537|579439692|FG000|96-week Period|Protocol Violation|0|||
160467223|NCT00641537|579439693|FG001|96-week Period|Protocol Violation|1|||
160467224|NCT00641537|579439694|FG002|96-week Period|Protocol Violation|0|||
160467225|NCT00641537|579439695|FG003|96-week Period|Protocol Violation|1|||
160467226|NCT00641537|579439696|FG004|96-week Period|Protocol Violation|0|||
160467227|NCT00641537|579439697|FG005|96-week Period|Protocol Violation|1|||
160467228|NCT00641537|579439698|FG006|96-week Period|Protocol Violation|0|||
160467229|NCT00641537|579439699|FG007|96-week Period|Protocol Violation|0|||
160467230|NCT00641537|579439692|FG000|96-week Period|Death|2|||
160467231|NCT00641537|579439693|FG001|96-week Period|Death|0|||
160467232|NCT00641537|579439694|FG002|96-week Period|Death|1|||
160467233|NCT00641537|579439695|FG003|96-week Period|Death|0|||
160467234|NCT00641537|579439696|FG004|96-week Period|Death|0|||
160467235|NCT00641537|579439697|FG005|96-week Period|Death|0|||
160467236|NCT00641537|579439698|FG006|96-week Period|Death|0|||
160467237|NCT00641537|579439699|FG007|96-week Period|Death|0|||
160596947|NCT05127421|579901687|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
160467238|NCT00641537|579439692|FG000|96-week Period|Other|4|||
160467239|NCT00641537|579439693|FG001|96-week Period|Other|7|||
160467240|NCT00641537|579439694|FG002|96-week Period|Other|14|||
160467241|NCT00641537|579439695|FG003|96-week Period|Other|9|||
160467242|NCT00641537|579439696|FG004|96-week Period|Other|11|||
160467243|NCT00641537|579439697|FG005|96-week Period|Other|6|||
160467244|NCT00641537|579439698|FG006|96-week Period|Other|4|||
160467245|NCT00641537|579439699|FG007|96-week Period|Other|6|||
160467246|NCT00641537|579439692|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
160467247|NCT00641537|579439693|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
160467248|NCT00641537|579439694|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
160467249|NCT00641537|579439695|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
160467250|NCT00641537|579439696|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
160467251|NCT00641537|579439697|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
160467252|NCT00641537|579439698|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
160467253|NCT00641537|579439699|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
160467254|NCT00641537|579439692|FG000|24-Week Supplemental Follow-up Period|Other|0|||
160467255|NCT00641537|579439693|FG001|24-Week Supplemental Follow-up Period|Other|2|||
160467256|NCT00641537|579439694|FG002|24-Week Supplemental Follow-up Period|Other|2|||
160467257|NCT00641537|579439695|FG003|24-Week Supplemental Follow-up Period|Other|1|||
160467258|NCT00641537|579439696|FG004|24-Week Supplemental Follow-up Period|Other|3|||
160467259|NCT00641537|579439697|FG005|24-Week Supplemental Follow-up Period|Other|0|||
160467260|NCT00641537|579439698|FG006|24-Week Supplemental Follow-up Period|Other|1|||
160467261|NCT00641537|579439699|FG007|24-Week Supplemental Follow-up Period|Other|1|||
160467262|NCT01706159|579439702|FG000|Overall Study|Withdrawal Criteria|2|||
160467263|NCT01706159|579439703|FG001|Overall Study|Withdrawal Criteria|1|||
160467264|NCT01706159|579439702|FG000|Overall Study|Unclassified|6|||
160467265|NCT01706159|579439703|FG001|Overall Study|Unclassified|1|||
160467266|NCT02235298|579439704|FG000|Overall Study|Lost to Follow-up|6|||
160467267|NCT02235298|579439705|FG001|Overall Study|Lost to Follow-up|5|||
160467268|NCT02235298|579439704|FG000|Overall Study|Adverse Event|2|||
160467269|NCT02235298|579439705|FG001|Overall Study|Adverse Event|2|||
160467270|NCT02235298|579439704|FG000|Overall Study|Withdrawal by Subject|0|||
160467271|NCT02235298|579439705|FG001|Overall Study|Withdrawal by Subject|1|||
160467272|NCT03371017|579439710|FG000|Overall Study|Physician Decision|0|||
160467273|NCT03371017|579439711|FG001|Overall Study|Physician Decision|1|||
160467274|NCT03371017|579439710|FG000|Overall Study|Reason not Specified|0|||
160467275|NCT03371017|579439711|FG001|Overall Study|Reason not Specified|1|||
160467276|NCT03371017|579439710|FG000|Overall Study|Lost to Follow-up|13|||
160467277|NCT03371017|579439711|FG001|Overall Study|Lost to Follow-up|16|||
160467278|NCT03371017|579439710|FG000|Overall Study|Death|228|||
160467279|NCT03371017|579439711|FG001|Overall Study|Death|215|||
160467280|NCT03371017|579439710|FG000|Overall Study|Withdrawal by Subject|20|||
160467281|NCT03371017|579439711|FG001|Overall Study|Withdrawal by Subject|25|||
160467282|NCT03371017|579439710|FG000|Overall Study|Study Ended by Sponsor|37|||
160467283|NCT03371017|579439711|FG001|Overall Study|Study Ended by Sponsor|38|||
160467284|NCT03371017|579439710|FG000|Overall Study|Protocol Deviation|0|||
160467285|NCT03371017|579439711|FG001|Overall Study|Protocol Deviation|1|||
160467286|NCT04686266|579439712|FG000|Overall Study|Withdrawal by Subject|0|||
160467287|NCT04686266|579439713|FG001|Overall Study|Withdrawal by Subject|1|||
160467288|NCT02401815|579439718|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
160467289|NCT02401815|579439719|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
160467290|NCT02401815|579439720|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
160467291|NCT02401815|579439721|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
160467292|NCT02401815|579439722|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
160467293|NCT02401815|579439723|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
160467294|NCT02401815|579439724|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
160467295|NCT02401815|579439725|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
160467296|NCT02401815|579439726|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
160467297|NCT02401815|579439727|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
160467298|NCT02401815|579439718|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
160467299|NCT02401815|579439719|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
160467300|NCT02401815|579439720|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
160467301|NCT02401815|579439721|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
160467302|NCT02401815|579439722|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
160467303|NCT02401815|579439723|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
160467304|NCT02401815|579439724|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
160467305|NCT02401815|579439725|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
160467306|NCT02401815|579439726|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
160467307|NCT02401815|579439727|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
160467308|NCT02401815|579439718|FG000|Dose Escalation (up to 670 Days)|Death|1|||
160467309|NCT02401815|579439719|FG001|Dose Escalation (up to 670 Days)|Death|2|||
160467310|NCT02401815|579439720|FG002|Dose Escalation (up to 670 Days)|Death|3|||
160467311|NCT02401815|579439721|FG003|Dose Escalation (up to 670 Days)|Death|5|||
160467312|NCT02401815|579439722|FG004|Dose Escalation (up to 670 Days)|Death|4|||
160467313|NCT02401815|579439723|FG005|Dose Escalation (up to 670 Days)|Death|0|||
160467314|NCT02401815|579439724|FG006|Dose Escalation (up to 670 Days)|Death|0|||
160467315|NCT02401815|579439725|FG007|Dose Escalation (up to 670 Days)|Death|0|||
160467316|NCT02401815|579439726|FG008|Dose Escalation (up to 670 Days)|Death|0|||
160467317|NCT02401815|579439727|FG009|Dose Escalation (up to 670 Days)|Death|0|||
160467318|NCT02401815|579439718|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
160467319|NCT02401815|579439719|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
160467320|NCT02401815|579439720|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
160467321|NCT02401815|579439721|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
160467322|NCT02401815|579439722|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
160467323|NCT02401815|579439723|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
160467324|NCT02401815|579439724|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
160467325|NCT02401815|579439725|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
160467326|NCT02401815|579439726|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
160467327|NCT02401815|579439727|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
160467328|NCT02401815|579439718|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
160467329|NCT02401815|579439719|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
160467330|NCT02401815|579439720|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
160467331|NCT02401815|579439721|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
160467332|NCT02401815|579439722|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
160467333|NCT02401815|579439723|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
160467334|NCT02401815|579439724|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
160467335|NCT02401815|579439725|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
160467336|NCT02401815|579439726|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
160467337|NCT02401815|579439727|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
160467338|NCT02401815|579439718|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
160467339|NCT02401815|579439719|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
160467340|NCT02401815|579439720|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
160467341|NCT02401815|579439721|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
160467342|NCT02401815|579439722|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
160467343|NCT02401815|579439723|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
160467344|NCT02401815|579439724|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
160467345|NCT02401815|579439725|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
160467346|NCT02401815|579439726|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
160467347|NCT02401815|579439727|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
160467348|NCT02401815|579439718|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467349|NCT02401815|579439719|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467350|NCT02401815|579439720|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467351|NCT02401815|579439721|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467352|NCT02401815|579439722|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467353|NCT02401815|579439723|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467354|NCT02401815|579439724|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
160467355|NCT02401815|579439725|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467356|NCT02401815|579439726|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467357|NCT02401815|579439727|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467358|NCT02401815|579439718|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
160596948|NCT05127421|579901688|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
160596949|NCT05127421|579901689|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
160467359|NCT02401815|579439719|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
160467360|NCT02401815|579439720|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
160596950|NCT05127421|579901686|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
160596951|NCT05127421|579901687|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
160596952|NCT05127421|579901688|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
160467361|NCT02401815|579439721|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
160467362|NCT02401815|579439722|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
160467363|NCT02401815|579439723|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
160467364|NCT02401815|579439724|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
160467365|NCT02401815|579439725|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
160467366|NCT02401815|579439726|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
160467367|NCT02401815|579439727|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
160467368|NCT02401815|579439718|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
160467369|NCT02401815|579439719|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
160467370|NCT02401815|579439720|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
160467371|NCT02401815|579439721|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
160467372|NCT02401815|579439722|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
160467373|NCT02401815|579439723|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
160467374|NCT02401815|579439724|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
160467375|NCT02401815|579439725|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
160467376|NCT02401815|579439726|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
160467377|NCT02401815|579439727|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
160467378|NCT02401815|579439718|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
160467379|NCT02401815|579439719|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
160467380|NCT02401815|579439720|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
160467381|NCT02401815|579439721|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
160467382|NCT02401815|579439722|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
160467383|NCT02401815|579439723|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
160467384|NCT02401815|579439724|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
160467385|NCT02401815|579439725|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
160467386|NCT02401815|579439726|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
160467387|NCT02401815|579439727|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
160467388|NCT02401815|579439718|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467389|NCT02401815|579439719|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467390|NCT02401815|579439720|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467391|NCT02401815|579439721|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467392|NCT02401815|579439722|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467393|NCT02401815|579439723|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467394|NCT02401815|579439724|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467395|NCT02401815|579439725|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
160467396|NCT02401815|579439726|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
160467397|NCT02401815|579439727|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
160467398|NCT02401815|579439718|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
160467399|NCT02401815|579439719|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
160467400|NCT02401815|579439720|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
160467401|NCT02401815|579439721|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
160467402|NCT02401815|579439722|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
160467403|NCT02401815|579439723|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
160467404|NCT02401815|579439724|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
160467405|NCT02401815|579439725|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
160467406|NCT02401815|579439726|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
160467407|NCT02401815|579439727|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
160467408|NCT02401815|579439718|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
160467409|NCT02401815|579439719|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
160467410|NCT02401815|579439720|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
160659029|NCT03049488|580133266|FG001|Overall Study|Withdrawal by Subject|0|||
160659030|NCT03049488|580133267|FG002|Overall Study|Withdrawal by Subject|0|||
160659031|NCT03049488|580133268|FG003|Overall Study|Withdrawal by Subject|1|||
160659032|NCT03049488|580133269|FG004|Overall Study|Withdrawal by Subject|1|||
160659033|NCT03049488|580133270|FG005|Overall Study|Withdrawal by Subject|0|||
160659034|NCT00440557|580133271|FG000|Overall Study|Withdrawal by Subject|10|||
160659035|NCT00440557|580133272|FG001|Overall Study|Withdrawal by Subject|5|||
160659036|NCT00440557|580133273|FG002|Overall Study|Withdrawal by Subject|11|||
160659037|NCT00440557|580133271|FG000|Overall Study|Lost to Follow-up|1|||
160659038|NCT00440557|580133272|FG001|Overall Study|Lost to Follow-up|2|||
160659039|NCT00440557|580133273|FG002|Overall Study|Lost to Follow-up|6|||
160659040|NCT00440557|580133271|FG000|Overall Study|Adverse Event|3|||
160659041|NCT00440557|580133272|FG001|Overall Study|Adverse Event|3|||
160659042|NCT00440557|580133273|FG002|Overall Study|Adverse Event|5|||
160659043|NCT00440557|580133271|FG000|Overall Study|Death|2|||
160659044|NCT00440557|580133272|FG001|Overall Study|Death|6|||
160659045|NCT00440557|580133273|FG002|Overall Study|Death|3|||
160659046|NCT00440557|580133271|FG000|Overall Study|Began Dialysis|4|||
160659047|NCT00440557|580133272|FG001|Overall Study|Began Dialysis|1|||
160659048|NCT00440557|580133273|FG002|Overall Study|Began Dialysis|4|||
160659049|NCT00440557|580133271|FG000|Overall Study|Principal Investigator decision|0|||
160659050|NCT00440557|580133272|FG001|Overall Study|Principal Investigator decision|3|||
160659051|NCT00440557|580133273|FG002|Overall Study|Principal Investigator decision|1|||
160659052|NCT00440557|580133271|FG000|Overall Study|Patient moved|1|||
160659053|NCT00440557|580133272|FG001|Overall Study|Patient moved|2|||
160659054|NCT00440557|580133273|FG002|Overall Study|Patient moved|1|||
160659055|NCT00440557|580133271|FG000|Overall Study|Principal Investigator's office closed|3|||
160467411|NCT02401815|579439721|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
160467412|NCT02401815|579439722|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
160467413|NCT02401815|579439723|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
160467414|NCT02401815|579439724|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
160467415|NCT02401815|579439725|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
160467416|NCT02401815|579439726|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
160467417|NCT02401815|579439727|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
160467418|NCT02401815|579439718|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
160467419|NCT02401815|579439719|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
160467420|NCT02401815|579439720|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
160467421|NCT02401815|579439721|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
160467422|NCT02401815|579439722|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
160467423|NCT02401815|579439723|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
160467424|NCT02401815|579439724|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
160467425|NCT02401815|579439725|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
160467426|NCT02401815|579439726|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
160467427|NCT02401815|579439727|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
160467428|NCT05613907|579439728|FG000|Overall Study|Lost to Follow-up|5|||
160467429|NCT05613907|579439728|FG000|Overall Study|Death|3|||
160467430|NCT05613907|579439728|FG000|Overall Study|Withdrawal by Subject|2|||
160467431|NCT03789656|579439736|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
160467432|NCT03789656|579439737|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
160467433|NCT03789656|579439738|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
160467434|NCT03789656|579439739|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
160467435|NCT03789656|579439740|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
160467436|NCT03789656|579439736|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
160467437|NCT03789656|579439737|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
160467438|NCT03789656|579439738|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
160467439|NCT03789656|579439739|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
160467440|NCT03789656|579439740|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
160467441|NCT03789656|579439736|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
160467442|NCT03789656|579439737|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
160467443|NCT03789656|579439738|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
160467444|NCT03789656|579439739|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
160467445|NCT03789656|579439740|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
160467446|NCT03789656|579439736|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
160596953|NCT05127421|579901689|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
160596954|NCT05127421|579901686|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
160596955|NCT05127421|579901687|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
160596956|NCT05127421|579901688|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
160596957|NCT05127421|579901689|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
160596958|NCT05127421|579901686|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
160596959|NCT05127421|579901687|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
160596960|NCT05127421|579901688|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
160596961|NCT05127421|579901689|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
160596962|NCT05127421|579901686|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
160596963|NCT05127421|579901687|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
160596964|NCT05127421|579901688|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
160596965|NCT05127421|579901689|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
160596966|NCT00618449|579901690|FG000|Overall Study|Lost to Follow-up|98|||
160596967|NCT00618449|579901691|FG001|Overall Study|Lost to Follow-up|110|||
160596968|NCT04311177|579901692|FG000|Overall Study|Adverse Event|3|||
160596969|NCT04311177|579901693|FG001|Overall Study|Adverse Event|1|||
160596970|NCT04311177|579901692|FG000|Overall Study|Physician Decision|4|||
160596971|NCT04311177|579901693|FG001|Overall Study|Physician Decision|3|||
160596972|NCT04311177|579901692|FG000|Overall Study|Withdrawal by Subject|1|||
160596973|NCT04311177|579901693|FG001|Overall Study|Withdrawal by Subject|0|||
160596974|NCT00574496|579901698|FG000|Overall Study|Withdrawal by Subject|1|||
160596975|NCT01969799|579901699|FG000|Overall Study|Adverse Event|0|||
160596976|NCT01969799|579901700|FG001|Overall Study|Adverse Event|1|||
160596977|NCT01969799|579901699|FG000|Overall Study|Death|16|||
160596978|NCT01969799|579901700|FG001|Overall Study|Death|11|||
160596979|NCT01969799|579901699|FG000|Overall Study|Lost to Follow-up|0|||
160596980|NCT01969799|579901700|FG001|Overall Study|Lost to Follow-up|2|||
160596981|NCT01969799|579901699|FG000|Overall Study|Physician Decision|1|||
160596982|NCT01969799|579901700|FG001|Overall Study|Physician Decision|0|||
160596983|NCT00039741|579901701|FG000|Overall Study|Death|0|||
160596984|NCT00039741|579901702|FG001|Overall Study|Death|1|||
160596985|NCT00039741|579901703|FG002|Overall Study|Death|0|||
160596986|NCT00039741|579901704|FG003|Overall Study|Death|0|||
160596987|NCT00039741|579901701|FG000|Overall Study|Lost to Follow-up|3|||
160596988|NCT00039741|579901702|FG001|Overall Study|Lost to Follow-up|1|||
160596989|NCT00039741|579901703|FG002|Overall Study|Lost to Follow-up|5|||
160596990|NCT00039741|579901704|FG003|Overall Study|Lost to Follow-up|2|||
160596991|NCT00039741|579901701|FG000|Overall Study|Confounding medical condition|1|||
160596992|NCT00039741|579901702|FG001|Overall Study|Confounding medical condition|0|||
160596993|NCT00039741|579901703|FG002|Overall Study|Confounding medical condition|0|||
160596994|NCT00039741|579901704|FG003|Overall Study|Confounding medical condition|0|||
160596995|NCT00039741|579901701|FG000|Overall Study|Not able to get to clinic|5|||
160596996|NCT00039741|579901702|FG001|Overall Study|Not able to get to clinic|2|||
160596997|NCT00039741|579901703|FG002|Overall Study|Not able to get to clinic|0|||
160596998|NCT00039741|579901704|FG003|Overall Study|Not able to get to clinic|3|||
160596999|NCT00039741|579901701|FG000|Overall Study|Moved|3|||
160597000|NCT00039741|579901702|FG001|Overall Study|Moved|2|||
160597001|NCT00039741|579901703|FG002|Overall Study|Moved|3|||
160597002|NCT00039741|579901704|FG003|Overall Study|Moved|6|||
160597003|NCT00039741|579901701|FG000|Overall Study|Non-compliance with protocol|1|||
160597004|NCT00039741|579901702|FG001|Overall Study|Non-compliance with protocol|0|||
160597005|NCT00039741|579901703|FG002|Overall Study|Non-compliance with protocol|1|||
160597006|NCT00039741|579901704|FG003|Overall Study|Non-compliance with protocol|0|||
160597007|NCT00039741|579901701|FG000|Overall Study|Withdrew consent|0|||
160597008|NCT00039741|579901702|FG001|Overall Study|Withdrew consent|5|||
160597009|NCT00039741|579901703|FG002|Overall Study|Withdrew consent|0|||
160597010|NCT00039741|579901704|FG003|Overall Study|Withdrew consent|1|||
160597011|NCT00039741|579901701|FG000|Overall Study|Missed final visit|2|||
160597012|NCT00039741|579901702|FG001|Overall Study|Missed final visit|1|||
160597013|NCT00039741|579901703|FG002|Overall Study|Missed final visit|2|||
160597014|NCT00039741|579901704|FG003|Overall Study|Missed final visit|2|||
160597015|NCT03571256|579901707|FG000|Overall Study|Adverse Event|3|||
160597016|NCT03571256|579901708|FG001|Overall Study|Adverse Event|0|||
160597017|NCT03571256|579901709|FG002|Overall Study|Adverse Event|1|||
160597018|NCT03571256|579901707|FG000|Overall Study|Withdrawal by Subject|3|||
160597019|NCT03571256|579901708|FG001|Overall Study|Withdrawal by Subject|1|||
160597020|NCT03571256|579901709|FG002|Overall Study|Withdrawal by Subject|1|||
160597021|NCT03571256|579901707|FG000|Overall Study|Other than specified|0|||
160597022|NCT03571256|579901708|FG001|Overall Study|Other than specified|1|||
160597023|NCT03571256|579901709|FG002|Overall Study|Other than specified|1|||
160597024|NCT03571256|579901707|FG000|Overall Study|Protocol Violation|0|||
160597025|NCT03571256|579901708|FG001|Overall Study|Protocol Violation|1|||
160597026|NCT03571256|579901709|FG002|Overall Study|Protocol Violation|1|||
160597027|NCT02270684|579901710|FG000|Overall Study|Lost to Follow-up|0|||
160597028|NCT02270684|579901711|FG001|Overall Study|Lost to Follow-up|3|||
160597029|NCT02270684|579901710|FG000|Overall Study|Study terminated|1|||
160597030|NCT02270684|579901711|FG001|Overall Study|Study terminated|0|||
160597031|NCT04169061|579901714|FG000|Overall Study|Adverse Event|2|||
160597032|NCT04169061|579901714|FG000|Overall Study|Death|1|||
160597033|NCT04169061|579901714|FG000|Overall Study|Withdrawal by Subject|1|||
160597034|NCT04169061|579901714|FG000|Overall Study|Protocol Violation|1|||
160597035|NCT02555657|579901715|FG000|Overall Study|Death|274|||
160597036|NCT02555657|579901716|FG001|Overall Study|Death|262|||
160597037|NCT02555657|579901715|FG000|Overall Study|Physician Decision|0|||
160597038|NCT02555657|579901716|FG001|Overall Study|Physician Decision|1|||
160597039|NCT02555657|579901715|FG000|Overall Study|Sponsor Decision|27|||
160597040|NCT02555657|579901716|FG001|Overall Study|Sponsor Decision|15|||
160597041|NCT02555657|579901715|FG000|Overall Study|Withdrawal by Subject|11|||
160597042|NCT02555657|579901716|FG001|Overall Study|Withdrawal by Subject|32|||
160597043|NCT02188719|579901717|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
160597044|NCT02188719|579901718|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
160597045|NCT02188719|579901719|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
160597046|NCT02188719|579901720|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
160597047|NCT00192036|579901724|FG000|Overall Study|Protocol Violation|3|||
160597048|NCT00192036|579901724|FG000|Overall Study|Adverse Event|6|||
160597049|NCT00192036|579901724|FG000|Overall Study|Patient/Physician Perception|1|||
160597050|NCT00192036|579901724|FG000|Overall Study|Objective Tumor Progression|4|||
160597051|NCT00192036|579901724|FG000|Overall Study|Clinical Disease Progression|1|||
160597052|NCT00192036|579901724|FG000|Overall Study|Death|1|||
160597053|NCT00192036|579901724|FG000|Overall Study|Unknown or Not Specified|5|||
160597054|NCT03371732|579901725|FG000|Overall Study|Withdrawal by Subject|9|||
160597055|NCT03371732|579901726|FG001|Overall Study|Withdrawal by Subject|3|||
160597056|NCT03371732|579901725|FG000|Overall Study|Refusal to continue|3|||
160597057|NCT03371732|579901726|FG001|Overall Study|Refusal to continue|4|||
160597058|NCT02133742|579901740|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
160597059|NCT02133742|579901740|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
160597060|NCT02133742|579901740|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
160597061|NCT02133742|579901740|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
160597062|NCT02133742|579901740|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
160597063|NCT03479216|579901741|FG000|Overall Study|Withdrawal by Subject|3|||
160597064|NCT03479216|579901742|FG001|Overall Study|Withdrawal by Subject|2|||
160597065|NCT03479216|579901741|FG000|Overall Study|Physician Decision|2|||
160597066|NCT03479216|579901742|FG001|Overall Study|Physician Decision|3|||
160597067|NCT02031432|579901747|FG000|Overall Study|Protocol Violation|1|||
160597068|NCT02031432|579901747|FG000|Overall Study|Lack of Efficacy|5|||
160597069|NCT02031432|579901747|FG000|Overall Study|Cancer Progression|2|||
160597070|NCT02031432|579901747|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
160597071|NCT02031432|579901747|FG000|Overall Study|Adverse Event|8|||
160597072|NCT02031432|579901747|FG000|Overall Study|Withdrawal by Subject|5|||
160597073|NCT02031432|579901747|FG000|Overall Study|Lost to Follow-up|1|||
160597074|NCT02031432|579901747|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
160597075|NCT02031432|579901747|FG000|Overall Study|Death|10|||
160597076|NCT02148211|579901748|FG000|Overall Study|Lost to Follow-up|352|||
160597077|NCT01617187|579901750|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
160597078|NCT01617187|579901751|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
160597079|NCT01617187|579901752|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
160597080|NCT01617187|579901753|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
160597081|NCT01617187|579901750|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
160597082|NCT01617187|579901751|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
160597083|NCT01617187|579901752|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
160597084|NCT01617187|579901753|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
160597085|NCT01617187|579901750|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
160597086|NCT01617187|579901751|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
160597087|NCT01617187|579901752|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
160467447|NCT03789656|579439737|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
160467448|NCT03789656|579439738|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
160597088|NCT01617187|579901753|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
160597089|NCT01617187|579901750|FG000|Treatment Through Study Completion|Adverse Event|1|||
160597090|NCT01617187|579901751|FG001|Treatment Through Study Completion|Adverse Event|1|||
160597091|NCT01617187|579901752|FG002|Treatment Through Study Completion|Adverse Event|0|||
160597092|NCT01617187|579901753|FG003|Treatment Through Study Completion|Adverse Event|1|||
160597093|NCT01617187|579901750|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
160597094|NCT01617187|579901751|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
160597095|NCT01617187|579901752|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
160597096|NCT01617187|579901753|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
160467449|NCT03789656|579439739|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
160597097|NCT01617187|579901750|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
160597098|NCT01617187|579901751|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
160597099|NCT01617187|579901752|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
160597100|NCT01617187|579901753|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
160597101|NCT01617187|579901750|FG000|Treatment Through Study Completion|Protocol Violation|1|||
160597102|NCT01617187|579901751|FG001|Treatment Through Study Completion|Protocol Violation|0|||
160597103|NCT01617187|579901752|FG002|Treatment Through Study Completion|Protocol Violation|0|||
160597104|NCT01617187|579901753|FG003|Treatment Through Study Completion|Protocol Violation|1|||
160597105|NCT01265420|579901755|FG000|Overall Study|Lost to Follow-up|1|||
160597106|NCT03337139|579901758|FG000|Phase I|Withdrawal by Subject|10|||
160597107|NCT03337139|579901759|FG001|Phase I|Withdrawal by Subject|0|||
160597108|NCT01561560|579901764|FG000|First Two Weeks of Wear|Time/job conflict|0|||
160597109|NCT01561560|579901765|FG001|First Two Weeks of Wear|Time/job conflict|1|||
160597110|NCT01561560|579901764|FG000|First Two Weeks of Wear|Adverse Event|0|||
160597111|NCT01561560|579901765|FG001|First Two Weeks of Wear|Adverse Event|1|||
160597112|NCT01561560|579901764|FG000|Second Two Weeks of Wear|Adverse Event|0|||
160597113|NCT01561560|579901765|FG001|Second Two Weeks of Wear|Adverse Event|1|||
160597114|NCT03862131|579901766|FG000|Overall Study|Lost to Follow-up|1|||
160597115|NCT03862131|579901767|FG001|Overall Study|Lost to Follow-up|0|||
160597116|NCT03862131|579901768|FG002|Overall Study|Lost to Follow-up|1|||
160597117|NCT03862131|579901766|FG000|Overall Study|Determined to be ineligible|0|||
160597118|NCT03862131|579901767|FG001|Overall Study|Determined to be ineligible|0|||
160597119|NCT03862131|579901768|FG002|Overall Study|Determined to be ineligible|5|||
160597120|NCT03862131|579901766|FG000|Overall Study|Death|4|||
160597121|NCT03862131|579901767|FG001|Overall Study|Death|4|||
160597122|NCT03862131|579901768|FG002|Overall Study|Death|0|||
160597123|NCT03862131|579901766|FG000|Overall Study|Withdrawal by Subject|5|||
160597124|NCT03862131|579901767|FG001|Overall Study|Withdrawal by Subject|3|||
160597125|NCT03862131|579901768|FG002|Overall Study|Withdrawal by Subject|0|||
160597126|NCT03862131|579901766|FG000|Overall Study|Physician Decision|0|||
160597127|NCT03862131|579901767|FG001|Overall Study|Physician Decision|1|||
160597128|NCT03862131|579901768|FG002|Overall Study|Physician Decision|0|||
160597129|NCT01871896|579901771|FG000|Overall Study|Lost to Follow-up|1|||
160597130|NCT01824693|579903580|FG000|Overall Study|Death|0|||
160597131|NCT01824693|579903581|FG001|Overall Study|Death|1|||
160597132|NCT01824693|579903582|FG002|Overall Study|Death|0|||
160467450|NCT03789656|579439740|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
160467451|NCT05325294|579439745|FG000|Overall Study|Adverse Event|3|||
160597133|NCT01824693|579903580|FG000|Overall Study|Physician Decision|1|||
160597134|NCT01824693|579903581|FG001|Overall Study|Physician Decision|1|||
160597135|NCT01824693|579903582|FG002|Overall Study|Physician Decision|1|||
160597136|NCT01824693|579903580|FG000|Overall Study|Withdrawal by Subject|0|||
160597137|NCT01824693|579903581|FG001|Overall Study|Withdrawal by Subject|0|||
160597138|NCT01824693|579903582|FG002|Overall Study|Withdrawal by Subject|1|||
160597139|NCT01824693|579903580|FG000|Overall Study|Progressive Disease|0|||
160597140|NCT01824693|579903581|FG001|Overall Study|Progressive Disease|5|||
160597141|NCT01824693|579903582|FG002|Overall Study|Progressive Disease|0|||
160597142|NCT01824693|579903580|FG000|Overall Study|Ineligible|0|||
160597143|NCT01824693|579903581|FG001|Overall Study|Ineligible|0|||
160597144|NCT01824693|579903582|FG002|Overall Study|Ineligible|3|||
160597145|NCT01824693|579903580|FG000|Overall Study|No Transplant Planned|0|||
160597146|NCT01824693|579903581|FG001|Overall Study|No Transplant Planned|0|||
160597147|NCT01824693|579903582|FG002|Overall Study|No Transplant Planned|10|||
160597148|NCT02150213|579903583|FG000|Overall Study|Lost to Follow-up|1|||
160597149|NCT02150213|579903583|FG000|Overall Study|Withdrawal by Subject|1|||
160597150|NCT03488238|579903584|FG000|Overall Study|Equipment malfunction|1|||
160597151|NCT03488238|579903584|FG000|Overall Study|Adverse Event|1|||
160597152|NCT01432457|579903585|FG000|Overall Study|Adverse Event|7|||
160597153|NCT01432457|579903586|FG001|Overall Study|Adverse Event|10|||
160597154|NCT01432457|579903587|FG002|Overall Study|Adverse Event|16|||
160597155|NCT01432457|579903585|FG000|Overall Study|Lack of Efficacy|2|||
160597156|NCT01432457|579903586|FG001|Overall Study|Lack of Efficacy|1|||
160597157|NCT01432457|579903587|FG002|Overall Study|Lack of Efficacy|1|||
160597158|NCT01432457|579903585|FG000|Overall Study|Lost to Follow-up|11|||
160597159|NCT01432457|579903586|FG001|Overall Study|Lost to Follow-up|15|||
160597160|NCT01432457|579903587|FG002|Overall Study|Lost to Follow-up|20|||
160597161|NCT01432457|579903585|FG000|Overall Study|Protocol Violation|3|||
160597162|NCT01432457|579903586|FG001|Overall Study|Protocol Violation|2|||
160597163|NCT01432457|579903587|FG002|Overall Study|Protocol Violation|6|||
160597164|NCT01432457|579903585|FG000|Overall Study|Withdrawal by Subject|6|||
160597165|NCT01432457|579903586|FG001|Overall Study|Withdrawal by Subject|11|||
160597166|NCT01432457|579903587|FG002|Overall Study|Withdrawal by Subject|9|||
160597167|NCT01432457|579903585|FG000|Overall Study|Reasons not defined|2|||
160597168|NCT01432457|579903586|FG001|Overall Study|Reasons not defined|3|||
160597169|NCT01432457|579903587|FG002|Overall Study|Reasons not defined|4|||
160597170|NCT01432457|579903585|FG000|Overall Study|Did not take study drug|6|||
160597171|NCT01432457|579903586|FG001|Overall Study|Did not take study drug|6|||
160597172|NCT01432457|579903587|FG002|Overall Study|Did not take study drug|3|||
160597173|NCT03382262|579903588|FG000|Overall Study|Physician Decision|0|||
160597174|NCT03382262|579903589|FG001|Overall Study|Physician Decision|0|||
160597175|NCT03382262|579903590|FG002|Overall Study|Physician Decision|1|||
160597176|NCT03382262|579903591|FG003|Overall Study|Physician Decision|0|||
160597177|NCT03382262|579903588|FG000|Overall Study|Withdrawal by Subject|0|||
160597178|NCT03382262|579903589|FG001|Overall Study|Withdrawal by Subject|0|||
160597179|NCT03382262|579903590|FG002|Overall Study|Withdrawal by Subject|0|||
160597180|NCT03382262|579903591|FG003|Overall Study|Withdrawal by Subject|1|||
160597181|NCT02966353|579903592|FG000|Overall Study|Withdrawal by Subject|7|||
160597182|NCT02966353|579903592|FG000|Overall Study|Adverse Event|4|||
160597183|NCT02966353|579903592|FG000|Overall Study|Death|4|||
160597184|NCT02966353|579903592|FG000|Overall Study|Physician Decision|3|||
160597185|NCT02966353|579903592|FG000|Overall Study|Progressive disease|2|||
160597186|NCT02966353|579903592|FG000|Overall Study|Protocol deviation|2|||
160597187|NCT01090102|579903593|FG000|First 12 Weeks|Withdrawal by Subject|1|||
160597188|NCT01090102|579903594|FG001|First 12 Weeks|Withdrawal by Subject|1|||
160597189|NCT01090102|579903593|FG000|First 12 Weeks|Adverse Event|2|||
160597190|NCT01090102|579903594|FG001|First 12 Weeks|Adverse Event|0|||
160597191|NCT01090102|579903593|FG000|First 12 Weeks|Death|1|||
160597192|NCT01090102|579903594|FG001|First 12 Weeks|Death|1|||
160597193|NCT01090102|579903593|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
160597194|NCT01090102|579903594|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
160597195|NCT03518034|579903597|FG000|Overall Study|Not Treated|5|||
160597196|NCT03518034|579903598|FG001|Overall Study|Not Treated|1|||
160597197|NCT03518034|579903597|FG000|Overall Study|Withdrawal by Subject|309|||
160597198|NCT03518034|579903598|FG001|Overall Study|Withdrawal by Subject|351|||
160467452|NCT05325294|579439746|FG001|Overall Study|Adverse Event|3|||
160597199|NCT03518034|579903597|FG000|Overall Study|Lost to Follow-up|446|||
160597200|NCT03518034|579903598|FG001|Overall Study|Lost to Follow-up|458|||
160597201|NCT03518034|579903597|FG000|Overall Study|Adverse Event|138|||
160597202|NCT03518034|579903598|FG001|Overall Study|Adverse Event|130|||
160597203|NCT03518034|579903597|FG000|Overall Study|Lack of Efficacy|11|||
160597204|NCT03518034|579903598|FG001|Overall Study|Lack of Efficacy|23|||
160597205|NCT03518034|579903597|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
160597206|NCT03518034|579903598|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
160597207|NCT03518034|579903597|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
160597208|NCT03518034|579903598|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
160597209|NCT03518034|579903597|FG000|Overall Study|Other, Not Specified|84|||
160597210|NCT03518034|579903598|FG001|Overall Study|Other, Not Specified|53|||
160597211|NCT03518034|579903597|FG000|Overall Study|Reason Missing|2|||
160597212|NCT03518034|579903598|FG001|Overall Study|Reason Missing|3|||
160597213|NCT00093470|579903602|FG000|Overall Study|Disease progression|39|||
160597214|NCT00093470|579903603|FG001|Overall Study|Disease progression|0|||
160597215|NCT00093470|579903602|FG000|Overall Study|Adverse Event|15|||
160597216|NCT00093470|579903603|FG001|Overall Study|Adverse Event|0|||
160597217|NCT00093470|579903602|FG000|Overall Study|Death|2|||
160597218|NCT00093470|579903603|FG001|Overall Study|Death|0|||
160597219|NCT00093470|579903602|FG000|Overall Study|Withdrawal by Subject|8|||
160597220|NCT00093470|579903603|FG001|Overall Study|Withdrawal by Subject|0|||
160597221|NCT00093470|579903602|FG000|Overall Study|Alternative therapy|2|||
160597222|NCT00093470|579903603|FG001|Overall Study|Alternative therapy|0|||
160597223|NCT00093470|579903602|FG000|Overall Study|Other complicating disease|3|||
160597224|NCT00093470|579903603|FG001|Overall Study|Other complicating disease|0|||
160597225|NCT00093470|579903602|FG000|Overall Study|Physician Decision|2|||
160659056|NCT00440557|580133272|FG001|Overall Study|Principal Investigator's office closed|6|||
160597226|NCT00093470|579903603|FG001|Overall Study|Physician Decision|0|||
160597227|NCT00093470|579903602|FG000|Overall Study|Never started treatment|1|||
160597228|NCT00093470|579903603|FG001|Overall Study|Never started treatment|0|||
160597229|NCT00093470|579903602|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
160597230|NCT00093470|579903603|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
160597231|NCT01019252|579903609|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
160597232|NCT01019252|579903610|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
160597233|NCT01019252|579903609|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
160597234|NCT01019252|579903610|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
160597235|NCT01019252|579903609|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
160597236|NCT01019252|579903610|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
160597237|NCT01019252|579903609|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
160597238|NCT01019252|579903610|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
160597239|NCT02514772|579903611|FG000|Overall Study|Adverse Event|1|||
160597240|NCT02514772|579903612|FG001|Overall Study|Adverse Event|0|||
160467453|NCT05325294|579439745|FG000|Overall Study|Physician Decision|0|||
160467454|NCT05325294|579439746|FG001|Overall Study|Physician Decision|1|||
160467455|NCT05325294|579439745|FG000|Overall Study|Withdrawal by Subject|0|||
160597241|NCT02514772|579903611|FG000|Overall Study|Death|0|||
160597242|NCT02514772|579903612|FG001|Overall Study|Death|1|||
160597243|NCT02514772|579903611|FG000|Overall Study|Withdrawal by Subject|2|||
160597244|NCT02514772|579903612|FG001|Overall Study|Withdrawal by Subject|1|||
160597245|NCT00877006|579903613|FG000|Treatment Period|Death|2|||
160597246|NCT00877006|579903614|FG001|Treatment Period|Death|1|||
160597247|NCT00877006|579903613|FG000|Treatment Period|Adverse Event|10|||
160659057|NCT00440557|580133273|FG002|Overall Study|Principal Investigator's office closed|4|||
160659058|NCT00440557|580133271|FG000|Overall Study|Patient transferred to nursing home|0|||
160659059|NCT00440557|580133272|FG001|Overall Study|Patient transferred to nursing home|1|||
160659060|NCT00440557|580133273|FG002|Overall Study|Patient transferred to nursing home|0|||
160659061|NCT00440557|580133271|FG000|Overall Study|Patient had surgery|1|||
160659062|NCT00440557|580133272|FG001|Overall Study|Patient had surgery|0|||
160659063|NCT00440557|580133273|FG002|Overall Study|Patient had surgery|0|||
160659064|NCT01939197|580133274|FG000|Overall Study|Withdrawal by Subject|1|||
160659065|NCT01939197|580133275|FG001|Overall Study|Withdrawal by Subject|0|||
160659066|NCT01939197|580133276|FG002|Overall Study|Withdrawal by Subject|0|||
160659067|NCT01939197|580133277|FG003|Overall Study|Withdrawal by Subject|0|||
160659068|NCT01939197|580133278|FG004|Overall Study|Withdrawal by Subject|1|||
160659069|NCT01939197|580133279|FG005|Overall Study|Withdrawal by Subject|0|||
160659070|NCT01939197|580133280|FG006|Overall Study|Withdrawal by Subject|0|||
160659071|NCT01939197|580133274|FG000|Overall Study|Lost to Follow-up|0|||
160659072|NCT01939197|580133275|FG001|Overall Study|Lost to Follow-up|1|||
160659073|NCT01939197|580133276|FG002|Overall Study|Lost to Follow-up|0|||
160659074|NCT01939197|580133277|FG003|Overall Study|Lost to Follow-up|1|||
160659075|NCT01939197|580133278|FG004|Overall Study|Lost to Follow-up|3|||
160659076|NCT01939197|580133279|FG005|Overall Study|Lost to Follow-up|1|||
160659077|NCT01939197|580133280|FG006|Overall Study|Lost to Follow-up|2|||
160659078|NCT04977336|580133281|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
160659079|NCT04977336|580133282|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
160659080|NCT04977336|580133283|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
160659081|NCT04977336|580133284|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
160659082|NCT04977336|580133285|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
160659083|NCT04977336|580133281|FG000|Overall Study|Lost to Follow-up|0|||
160659084|NCT04977336|580133282|FG001|Overall Study|Lost to Follow-up|0|||
160659085|NCT04977336|580133283|FG002|Overall Study|Lost to Follow-up|1|||
160659086|NCT04977336|580133284|FG003|Overall Study|Lost to Follow-up|0|||
160659087|NCT04977336|580133285|FG004|Overall Study|Lost to Follow-up|0|||
160659088|NCT03298451|580133286|FG000|Overall Study|Death|275|||
160659089|NCT03298451|580133287|FG001|Overall Study|Death|260|||
160659090|NCT03298451|580133288|FG002|Overall Study|Death|122|||
160659091|NCT03298451|580133289|FG003|Overall Study|Death|280|||
160659092|NCT03298451|580133286|FG000|Overall Study|Lost to Follow-up|1|||
160659093|NCT03298451|580133287|FG001|Overall Study|Lost to Follow-up|1|||
160659094|NCT03298451|580133288|FG002|Overall Study|Lost to Follow-up|0|||
160659095|NCT03298451|580133289|FG003|Overall Study|Lost to Follow-up|7|||
160659096|NCT03298451|580133286|FG000|Overall Study|Withdrawal by Subject|9|||
160659097|NCT03298451|580133287|FG001|Overall Study|Withdrawal by Subject|7|||
160659098|NCT03298451|580133288|FG002|Overall Study|Withdrawal by Subject|1|||
160659099|NCT03298451|580133289|FG003|Overall Study|Withdrawal by Subject|20|||
160659100|NCT02480764|580133291|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
160659101|NCT02480764|580133292|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
160659102|NCT02480764|580133293|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
160659103|NCT02480764|580133291|FG000|Overall Study|Major Protocol Deviation|1|||
160659104|NCT02480764|580133292|FG001|Overall Study|Major Protocol Deviation|4|||
160659105|NCT02480764|580133293|FG002|Overall Study|Major Protocol Deviation|3|||
160659106|NCT02480764|580133291|FG000|Overall Study|Lost to Follow-up|0|||
160659107|NCT02480764|580133292|FG001|Overall Study|Lost to Follow-up|1|||
160659108|NCT02480764|580133293|FG002|Overall Study|Lost to Follow-up|2|||
160659109|NCT02480764|580133291|FG000|Overall Study|Voluntary Withdrawal|6|||
160659110|NCT02480764|580133292|FG001|Overall Study|Voluntary Withdrawal|5|||
160659111|NCT02480764|580133293|FG002|Overall Study|Voluntary Withdrawal|10|||
160659112|NCT02480764|580133291|FG000|Overall Study|Lack of Efficacy|0|||
160659113|NCT02480764|580133292|FG001|Overall Study|Lack of Efficacy|3|||
160597248|NCT00877006|579903614|FG001|Treatment Period|Adverse Event|3|||
160597249|NCT00877006|579903613|FG000|Treatment Period|Withdrawal by Subject|2|||
160597250|NCT00877006|579903614|FG001|Treatment Period|Withdrawal by Subject|3|||
160659114|NCT02480764|580133293|FG002|Overall Study|Lack of Efficacy|3|||
160659115|NCT02480764|580133291|FG000|Overall Study|Reason not Specified|0|||
160659116|NCT02480764|580133292|FG001|Overall Study|Reason not Specified|1|||
160659117|NCT02480764|580133293|FG002|Overall Study|Reason not Specified|0|||
160659118|NCT01030965|580133296|FG000|Overall Study|Lack of Efficacy|3|||
160597251|NCT00877006|579903613|FG000|Treatment Period|Protocol Violation|1|||
160659119|NCT01030965|580133297|FG001|Overall Study|Lack of Efficacy|2|||
160659120|NCT01030965|580133298|FG002|Overall Study|Lack of Efficacy|0|||
160597252|NCT00877006|579903614|FG001|Treatment Period|Protocol Violation|0|||
160597253|NCT00877006|579903613|FG000|Treatment Period|Lost to Follow-up|0|||
160597254|NCT00877006|579903614|FG001|Treatment Period|Lost to Follow-up|1|||
160597255|NCT00877006|579903613|FG000|Treatment Period|Disease Progression|1|||
160597256|NCT00877006|579903614|FG001|Treatment Period|Disease Progression|2|||
160597257|NCT00877006|579903613|FG000|Treatment Period|Started New Treatment Regimen|2|||
160597258|NCT00877006|579903614|FG001|Treatment Period|Started New Treatment Regimen|5|||
160597259|NCT00877006|579903613|FG000|Treatment Period|Other|4|||
160597260|NCT00877006|579903614|FG001|Treatment Period|Other|4|||
160597261|NCT00877006|579903613|FG000|Treatment Period|Randomized but Not Treated|3|||
160597262|NCT00877006|579903614|FG001|Treatment Period|Randomized but Not Treated|8|||
160597263|NCT00877006|579903613|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
160597264|NCT00877006|579903614|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
160597265|NCT00877006|579903613|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
160597266|NCT00877006|579903614|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
160597267|NCT00877006|579903613|FG000|Long-Term Follow-up Period|Death|26|||
160597268|NCT00877006|579903614|FG001|Long-Term Follow-up Period|Death|18|||
160597269|NCT00877006|579903613|FG000|Long-Term Follow-up Period|Other|7|||
160597270|NCT00877006|579903614|FG001|Long-Term Follow-up Period|Other|9|||
160597271|NCT04671342|579903615|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
160597272|NCT04671342|579903615|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
160597273|NCT04671342|579903615|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
160597274|NCT04671342|579903615|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
160597275|NCT04671342|579903615|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
160597276|NCT04671342|579903615|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
160597277|NCT03583606|579903616|FG000|Overall Study|Lost to Follow-up|0|||
160597278|NCT03583606|579903617|FG001|Overall Study|Lost to Follow-up|1|||
160597279|NCT03583606|579903618|FG002|Overall Study|Lost to Follow-up|0|||
160597280|NCT03583606|579903616|FG000|Overall Study|Ineligible at baseline|1|||
160597281|NCT03583606|579903617|FG001|Overall Study|Ineligible at baseline|0|||
160597282|NCT03583606|579903618|FG002|Overall Study|Ineligible at baseline|0|||
160597283|NCT00817206|579903619|FG000|Overall Study|Adverse Event|10|||
160597284|NCT00817206|579903620|FG001|Overall Study|Adverse Event|3|||
160597285|NCT00817206|579903619|FG000|Overall Study|Protocol Violation|0|||
160597286|NCT00817206|579903620|FG001|Overall Study|Protocol Violation|2|||
160597287|NCT00817206|579903619|FG000|Overall Study|Lost to Follow-up|0|||
160597288|NCT00817206|579903620|FG001|Overall Study|Lost to Follow-up|1|||
160597289|NCT00817206|579903619|FG000|Overall Study|Death|2|||
160597290|NCT00817206|579903620|FG001|Overall Study|Death|0|||
160597291|NCT00817206|579903619|FG000|Overall Study|Withdrawal by Subject|7|||
160597292|NCT00817206|579903620|FG001|Overall Study|Withdrawal by Subject|3|||
160597293|NCT00817206|579903619|FG000|Overall Study|Physician Decision|2|||
160597294|NCT00817206|579903620|FG001|Overall Study|Physician Decision|0|||
160597295|NCT00126581|579903621|FG000|Overall Study|Adverse Event|3|||
160597296|NCT00126581|579903622|FG001|Overall Study|Adverse Event|7|||
160597297|NCT00126581|579903621|FG000|Overall Study|Death|3|||
160597298|NCT00126581|579903622|FG001|Overall Study|Death|2|||
160597299|NCT00126581|579903621|FG000|Overall Study|Withdrawal by Subject|1|||
160597300|NCT00126581|579903622|FG001|Overall Study|Withdrawal by Subject|4|||
160597301|NCT00126581|579903621|FG000|Overall Study|Alternative therapy|3|||
160597302|NCT00126581|579903622|FG001|Overall Study|Alternative therapy|3|||
160597303|NCT00126581|579903621|FG000|Overall Study|Other illness/MD discretion|3|||
160597304|NCT00126581|579903622|FG001|Overall Study|Other illness/MD discretion|4|||
160597305|NCT00793182|579903623|FG000|Overall Study|Adverse Event|0|||
160597306|NCT00793182|579903624|FG001|Overall Study|Adverse Event|1|||
160597307|NCT03728140|579903625|FG000|Overall Study|Abnormal embryo transfer operation|10|||
160597308|NCT03728140|579903626|FG001|Overall Study|Abnormal embryo transfer operation|7|||
160597309|NCT02273037|579903628|FG000|Overall Study|Lost to Follow-up|1|||
160597310|NCT02273037|579903629|FG001|Overall Study|Lost to Follow-up|0|||
160597311|NCT02273037|579903628|FG000|Overall Study|Delivered before monitoring initiated|1|||
160597312|NCT02273037|579903629|FG001|Overall Study|Delivered before monitoring initiated|3|||
160597313|NCT02273037|579903628|FG000|Overall Study|Breech delivery|2|||
160597314|NCT02273037|579903629|FG001|Overall Study|Breech delivery|3|||
160597315|NCT02273037|579903628|FG000|Overall Study|Multiple delivery|2|||
160597316|NCT02273037|579903629|FG001|Overall Study|Multiple delivery|2|||
160597317|NCT02273037|579903628|FG000|Overall Study|Other complication|2|||
160597318|NCT02273037|579903629|FG001|Overall Study|Other complication|0|||
160597319|NCT00851253|579903630|FG000|Overall Study|Disease Progression|1|||
160597320|NCT00851253|579903631|FG001|Overall Study|Disease Progression|0|||
160597321|NCT03657810|579903636|FG000|Overall Study|Adverse Event|0|||
160597322|NCT03657810|579903637|FG001|Overall Study|Adverse Event|1|||
160597323|NCT03657810|579903638|FG002|Overall Study|Adverse Event|0|||
160597324|NCT03657810|579903636|FG000|Overall Study|Lack of Efficacy|4|||
160597325|NCT03657810|579903637|FG001|Overall Study|Lack of Efficacy|1|||
160597326|NCT03657810|579903638|FG002|Overall Study|Lack of Efficacy|3|||
160597327|NCT03657810|579903636|FG000|Overall Study|Protocol Violation|1|||
160597328|NCT03657810|579903637|FG001|Overall Study|Protocol Violation|0|||
160597329|NCT03657810|579903638|FG002|Overall Study|Protocol Violation|0|||
160597330|NCT03657810|579903636|FG000|Overall Study|Lost to Follow-up|0|||
160597331|NCT03657810|579903637|FG001|Overall Study|Lost to Follow-up|1|||
160597332|NCT03657810|579903638|FG002|Overall Study|Lost to Follow-up|0|||
160597333|NCT03657810|579903636|FG000|Overall Study|Not provided|0|||
160597334|NCT03657810|579903637|FG001|Overall Study|Not provided|1|||
160597335|NCT03657810|579903638|FG002|Overall Study|Not provided|0|||
160597336|NCT01527110|579903640|FG000|Overall Study|Adverse Event|1|||
160597337|NCT02007252|579903641|FG000|Overall Study|Administrative problems|3|||
160597338|NCT02007252|579903642|FG001|Overall Study|Administrative problems|7|||
160597339|NCT02007252|579903641|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160597340|NCT02007252|579903642|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160597341|NCT02007252|579903641|FG000|Overall Study|Adverse Event|7|||
160597342|NCT02007252|579903642|FG001|Overall Study|Adverse Event|4|||
160597343|NCT00367341|579903643|FG000|Overall Study|Physician Decision|1|||
160597344|NCT00367341|579903644|FG001|Overall Study|Physician Decision|0|||
160597345|NCT00367341|579903643|FG000|Overall Study|Protocol Violation|1|||
160597346|NCT00367341|579903644|FG001|Overall Study|Protocol Violation|0|||
160597347|NCT03325556|579903645|FG000|Open-label Period|Lack of Response in OL period|70|||
160597348|NCT03325556|579903646|FG001|Open-label Period|Lack of Response in OL period|0|||
160597349|NCT03325556|579903647|FG002|Open-label Period|Lack of Response in OL period|0|||
160597350|NCT03325556|579903645|FG000|Open-label Period|Adverse Event|27|||
160597351|NCT03325556|579903646|FG001|Open-label Period|Adverse Event|0|||
160597352|NCT03325556|579903647|FG002|Open-label Period|Adverse Event|0|||
160597353|NCT03325556|579903645|FG000|Open-label Period|Death|1|||
160597354|NCT03325556|579903646|FG001|Open-label Period|Death|0|||
160597355|NCT03325556|579903647|FG002|Open-label Period|Death|0|||
160597356|NCT03325556|579903645|FG000|Open-label Period|Lost to Follow-up|1|||
160597357|NCT03325556|579903646|FG001|Open-label Period|Lost to Follow-up|0|||
160597358|NCT03325556|579903647|FG002|Open-label Period|Lost to Follow-up|0|||
160597359|NCT03325556|579903645|FG000|Open-label Period|Non-compliance with study drug|5|||
160597360|NCT03325556|579903646|FG001|Open-label Period|Non-compliance with study drug|0|||
160597361|NCT03325556|579903647|FG002|Open-label Period|Non-compliance with study drug|0|||
160597362|NCT03325556|579903645|FG000|Open-label Period|Use of prohibited medication|1|||
160597363|NCT03325556|579903646|FG001|Open-label Period|Use of prohibited medication|0|||
160597364|NCT03325556|579903647|FG002|Open-label Period|Use of prohibited medication|0|||
160597365|NCT03325556|579903645|FG000|Open-label Period|Protocol Violation|4|||
160597366|NCT03325556|579903646|FG001|Open-label Period|Protocol Violation|0|||
160597367|NCT03325556|579903647|FG002|Open-label Period|Protocol Violation|0|||
160597368|NCT03325556|579903645|FG000|Open-label Period|Withdrawal by Subject|17|||
160597369|NCT03325556|579903646|FG001|Open-label Period|Withdrawal by Subject|0|||
160597370|NCT03325556|579903647|FG002|Open-label Period|Withdrawal by Subject|0|||
160597371|NCT03325556|579903645|FG000|Open-label Period|Not otherwise specified|8|||
160597372|NCT03325556|579903646|FG001|Open-label Period|Not otherwise specified|0|||
160597373|NCT03325556|579903647|FG002|Open-label Period|Not otherwise specified|0|||
160597374|NCT03325556|579903645|FG000|Open-label Period|Administrative discont. at study termination|41|||
160597375|NCT03325556|579903646|FG001|Open-label Period|Administrative discont. at study termination|0|||
160597376|NCT03325556|579903647|FG002|Open-label Period|Administrative discont. at study termination|0|||
160597377|NCT03325556|579903645|FG000|Double-blind Period|Relapse|0|||
160597378|NCT03325556|579903646|FG001|Double-blind Period|Relapse|15|||
160597379|NCT03325556|579903647|FG002|Double-blind Period|Relapse|34|||
160597380|NCT03325556|579903645|FG000|Double-blind Period|Adverse Event|0|||
160597381|NCT03325556|579903646|FG001|Double-blind Period|Adverse Event|3|||
160597382|NCT03325556|579903647|FG002|Double-blind Period|Adverse Event|1|||
160597383|NCT03325556|579903645|FG000|Double-blind Period|Noncompliance with study drug|0|||
160597384|NCT03325556|579903646|FG001|Double-blind Period|Noncompliance with study drug|0|||
160597385|NCT03325556|579903647|FG002|Double-blind Period|Noncompliance with study drug|1|||
160597386|NCT03325556|579903645|FG000|Double-blind Period|Use of prohibited medication|0|||
160597387|NCT03325556|579903646|FG001|Double-blind Period|Use of prohibited medication|1|||
160597388|NCT03325556|579903647|FG002|Double-blind Period|Use of prohibited medication|0|||
160597389|NCT03325556|579903645|FG000|Double-blind Period|Physician Decision|0|||
160597390|NCT03325556|579903646|FG001|Double-blind Period|Physician Decision|0|||
160597391|NCT03325556|579903647|FG002|Double-blind Period|Physician Decision|1|||
160597392|NCT03325556|579903645|FG000|Double-blind Period|Withdrawal by Subject|0|||
160597393|NCT03325556|579903646|FG001|Double-blind Period|Withdrawal by Subject|6|||
160597394|NCT03325556|579903647|FG002|Double-blind Period|Withdrawal by Subject|4|||
160597395|NCT03325556|579903645|FG000|Double-blind Period|Not otherwise specified|0|||
160597396|NCT03325556|579903646|FG001|Double-blind Period|Not otherwise specified|1|||
160597397|NCT03325556|579903647|FG002|Double-blind Period|Not otherwise specified|5|||
160597398|NCT03325556|579903645|FG000|Double-blind Period|Administrative discont. at study termination|0|||
160597399|NCT03325556|579903646|FG001|Double-blind Period|Administrative discont. at study termination|35|||
160597400|NCT03325556|579903647|FG002|Double-blind Period|Administrative discont. at study termination|31|||
160597401|NCT01705587|579903648|FG000|Overall Study|Withdrawal by Subject|0|||
160597402|NCT01705587|579903649|FG001|Overall Study|Withdrawal by Subject|1|||
160597403|NCT00762268|579903650|FG000|Overall Study|Withdrawal by Subject|3|||
160597404|NCT00762268|579903651|FG001|Overall Study|Withdrawal by Subject|3|||
160597405|NCT04603391|579903652|FG000|First Intervention (4 Days)|Adverse Event|1|||
160597406|NCT04603391|579903653|FG001|First Intervention (4 Days)|Adverse Event|0|||
160597407|NCT04603391|579903652|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
160597408|NCT04603391|579903653|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
160597409|NCT02759861|579903656|FG000|Overall Study|Death|1|||
160597410|NCT02151682|579903657|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
160597411|NCT02151682|579903658|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
160597412|NCT02151682|579903659|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
160597413|NCT02151682|579903660|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
160597414|NCT02151682|579903661|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
160597415|NCT02151682|579903662|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
160597416|NCT02151682|579903657|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
160597417|NCT02151682|579903658|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
160597418|NCT02151682|579903659|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
160597419|NCT02151682|579903660|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
160597420|NCT02151682|579903661|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
160597421|NCT02151682|579903662|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
160597422|NCT02151682|579903657|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
160597423|NCT02151682|579903658|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
160597424|NCT02151682|579903659|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
160597425|NCT02151682|579903660|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
160597426|NCT02151682|579903661|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
160597427|NCT02151682|579903662|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
160597428|NCT02151682|579903657|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
160597429|NCT02151682|579903658|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
160597430|NCT02151682|579903659|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
160597431|NCT02151682|579903660|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
160597432|NCT02151682|579903661|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
160597433|NCT02151682|579903662|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
160597434|NCT02151682|579903657|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
160597435|NCT02151682|579903658|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
160597436|NCT02151682|579903659|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
160597437|NCT02151682|579903660|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
160597438|NCT02151682|579903661|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
160597439|NCT02151682|579903662|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
160597440|NCT02151682|579903657|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
160597441|NCT02151682|579903658|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
160597442|NCT02151682|579903659|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
160597443|NCT02151682|579903660|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
160597444|NCT02151682|579903661|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
160597445|NCT02151682|579903662|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
160597446|NCT02151682|579903657|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
160597447|NCT02151682|579903658|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
160597448|NCT02151682|579903659|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
160597449|NCT02151682|579903660|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
160597450|NCT02151682|579903661|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
160597451|NCT02151682|579903662|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
160597452|NCT02151682|579903657|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
160597453|NCT02151682|579903658|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
160597454|NCT02151682|579903659|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
160597455|NCT02151682|579903660|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
160597456|NCT02151682|579903661|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
160597457|NCT02151682|579903662|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
160597458|NCT02151682|579903657|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
160597459|NCT02151682|579903658|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
160659121|NCT01030965|580133299|FG003|Overall Study|Lack of Efficacy|3|||
160659122|NCT01030965|580133296|FG000|Overall Study|Protocol Violation|1|||
160597460|NCT02151682|579903659|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
160597461|NCT02151682|579903660|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
160597462|NCT02151682|579903661|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
160597463|NCT02151682|579903662|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
160597464|NCT02151682|579903657|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
160597465|NCT02151682|579903658|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
160597466|NCT02151682|579903659|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
160597467|NCT02151682|579903660|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
160597468|NCT02151682|579903661|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
160597469|NCT02151682|579903662|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
160597470|NCT02151682|579903657|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
160597471|NCT02151682|579903658|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
160597472|NCT02151682|579903659|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
160597473|NCT02151682|579903660|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
160597474|NCT02151682|579903661|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
160659123|NCT01030965|580133297|FG001|Overall Study|Protocol Violation|1|||
160597475|NCT02151682|579903662|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
160659124|NCT01030965|580133298|FG002|Overall Study|Protocol Violation|1|||
160659125|NCT01030965|580133299|FG003|Overall Study|Protocol Violation|1|||
160597476|NCT02151682|579903657|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
160597477|NCT02151682|579903658|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
160597478|NCT02151682|579903659|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
160597479|NCT02151682|579903660|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
160597480|NCT02151682|579903661|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
160597481|NCT02151682|579903662|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
160597482|NCT02151682|579903657|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
160597483|NCT02151682|579903658|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
160597484|NCT02151682|579903659|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
160597485|NCT02151682|579903660|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
160597486|NCT02151682|579903661|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
160597487|NCT02151682|579903662|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
160597488|NCT02151682|579903657|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
160597489|NCT02151682|579903658|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
160597490|NCT02151682|579903659|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
160597491|NCT02151682|579903660|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
160597492|NCT02151682|579903661|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
160597493|NCT02151682|579903662|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
160597494|NCT02151682|579903657|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
160597495|NCT02151682|579903658|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
160597496|NCT02151682|579903659|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
160659126|NCT01030965|580133296|FG000|Overall Study|Adverse Event|0|||
160659127|NCT01030965|580133297|FG001|Overall Study|Adverse Event|1|||
160659128|NCT01030965|580133298|FG002|Overall Study|Adverse Event|2|||
160659129|NCT01030965|580133299|FG003|Overall Study|Adverse Event|1|||
160659130|NCT01030965|580133296|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
160659131|NCT01030965|580133297|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
160659132|NCT01030965|580133298|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
160659133|NCT01030965|580133299|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
160659134|NCT01030965|580133296|FG000|Overall Study|Withdrawal by Subject|0|||
160659135|NCT01030965|580133297|FG001|Overall Study|Withdrawal by Subject|1|||
160659136|NCT01030965|580133298|FG002|Overall Study|Withdrawal by Subject|0|||
160659137|NCT01030965|580133299|FG003|Overall Study|Withdrawal by Subject|2|||
160659138|NCT02097290|580133300|FG000|Overall Study|Death|6|||
160659139|NCT02097290|580133300|FG000|Overall Study|Total Withdrawals|3|||
160659140|NCT02097290|580133300|FG000|Overall Study|Attempt|8|||
160659141|NCT03991494|580133301|FG000|Overall Study|Progressive Disease|4|||
160659142|NCT05277389|580133302|FG000|Overall Study|Lost to Follow-up|1|||
160659143|NCT05277389|580133303|FG001|Overall Study|Lost to Follow-up|4|||
160659144|NCT02079532|580133311|FG000|Overall Study|Adverse Event|7|||
160659145|NCT02079532|580133311|FG000|Overall Study|Additional or changed therapy|2|||
160597497|NCT02151682|579903660|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
160597498|NCT02151682|579903661|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
160597499|NCT02151682|579903662|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
160597500|NCT02151682|579903657|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
160659146|NCT02079532|580133311|FG000|Overall Study|Lack of Efficacy|9|||
160659147|NCT02079532|580133311|FG000|Overall Study|Protocol Violation|3|||
160659148|NCT02079532|580133311|FG000|Overall Study|Withdrawal by Subject|1|||
160659149|NCT02079532|580133311|FG000|Overall Study|Administrative problems|1|||
160659150|NCT02079532|580133311|FG000|Overall Study|Inclusion into ReFIRST|3|||
160597501|NCT02151682|579903658|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
160597502|NCT02151682|579903659|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
160597503|NCT02151682|579903660|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
160597504|NCT02151682|579903661|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
160597505|NCT02151682|579903662|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
160597506|NCT02151682|579903657|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
160597507|NCT02151682|579903658|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
160597508|NCT02151682|579903659|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
160597509|NCT02151682|579903660|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
160597510|NCT02151682|579903661|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
160597511|NCT02151682|579903662|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
160597512|NCT02151682|579903657|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
160597513|NCT02151682|579903658|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
160597514|NCT02151682|579903659|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
160597515|NCT02151682|579903660|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
160597516|NCT02151682|579903661|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
160597517|NCT02151682|579903662|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
160597518|NCT00618995|579903663|FG000|Period 1|Adverse Event|0|||
160597519|NCT00618995|579903664|FG001|Period 1|Adverse Event|0|||
160597520|NCT00618995|579903665|FG002|Period 1|Adverse Event|1|||
160597521|NCT00618995|579903666|FG003|Period 1|Adverse Event|0|||
160597522|NCT00618995|579903663|FG000|Period 1|Protocol Violation|0|||
160597523|NCT00618995|579903664|FG001|Period 1|Protocol Violation|1|||
160597524|NCT00618995|579903665|FG002|Period 1|Protocol Violation|1|||
160597525|NCT00618995|579903666|FG003|Period 1|Protocol Violation|0|||
160597526|NCT00618995|579903663|FG000|Period 2|Protocol Violation|0|||
160659151|NCT02079532|580133311|FG000|Overall Study|Other|3|||
160597527|NCT00618995|579903664|FG001|Period 2|Protocol Violation|0|||
160597528|NCT00618995|579903665|FG002|Period 2|Protocol Violation|1|||
160597529|NCT00618995|579903666|FG003|Period 2|Protocol Violation|0|||
160659152|NCT00591630|580133312|FG000|Overall Study|Death|0|||
160597530|NCT00618995|579903663|FG000|Period 4|Adverse Event|1|||
160597531|NCT00618995|579903664|FG001|Period 4|Adverse Event|0|||
160597532|NCT00618995|579903665|FG002|Period 4|Adverse Event|0|||
160597533|NCT00618995|579903666|FG003|Period 4|Adverse Event|0|||
160597534|NCT01306032|579903667|FG000|First Intervention|Adverse Event|1|||
160597535|NCT01306032|579903668|FG001|First Intervention|Adverse Event|0|||
160597536|NCT01306032|579903669|FG002|First Intervention|Adverse Event|1|||
160597537|NCT01306032|579903670|FG003|First Intervention|Adverse Event|0|||
160597538|NCT01306032|579903671|FG004|First Intervention|Adverse Event|0|||
160597539|NCT01306032|579903672|FG005|First Intervention|Adverse Event|1|||
160597540|NCT01306032|579903667|FG000|First Intervention|Withdrawal by Subject|0|||
160597541|NCT01306032|579903668|FG001|First Intervention|Withdrawal by Subject|2|||
160597542|NCT01306032|579903669|FG002|First Intervention|Withdrawal by Subject|0|||
160597543|NCT01306032|579903670|FG003|First Intervention|Withdrawal by Subject|1|||
160597544|NCT01306032|579903671|FG004|First Intervention|Withdrawal by Subject|0|||
160597545|NCT01306032|579903672|FG005|First Intervention|Withdrawal by Subject|0|||
160597546|NCT01306032|579903667|FG000|First Intervention|Death|0|||
160597547|NCT01306032|579903668|FG001|First Intervention|Death|0|||
160597548|NCT01306032|579903669|FG002|First Intervention|Death|1|||
160597549|NCT01306032|579903670|FG003|First Intervention|Death|0|||
160597550|NCT01306032|579903671|FG004|First Intervention|Death|0|||
160597551|NCT01306032|579903672|FG005|First Intervention|Death|0|||
160597552|NCT01306032|579903667|FG000|First Intervention|Ineligible|0|||
160597553|NCT01306032|579903668|FG001|First Intervention|Ineligible|0|||
160597554|NCT01306032|579903669|FG002|First Intervention|Ineligible|0|||
160597555|NCT01306032|579903670|FG003|First Intervention|Ineligible|0|||
160597556|NCT01306032|579903671|FG004|First Intervention|Ineligible|0|||
160597557|NCT01306032|579903672|FG005|First Intervention|Ineligible|1|||
160597558|NCT01306032|579903667|FG000|First Intervention|Progressive disease|0|||
160597559|NCT01306032|579903668|FG001|First Intervention|Progressive disease|0|||
160597560|NCT01306032|579903669|FG002|First Intervention|Progressive disease|0|||
160597561|NCT01306032|579903670|FG003|First Intervention|Progressive disease|0|||
160597562|NCT01306032|579903671|FG004|First Intervention|Progressive disease|2|||
160597563|NCT01306032|579903672|FG005|First Intervention|Progressive disease|0|||
160597564|NCT01306032|579903667|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
160597565|NCT01306032|579903668|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
160597566|NCT01306032|579903669|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
160597567|NCT01306032|579903670|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
160597568|NCT01306032|579903671|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
160597569|NCT01306032|579903672|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
160597570|NCT01306032|579903667|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
160597571|NCT01306032|579903668|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
160597572|NCT01306032|579903669|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
160597573|NCT01306032|579903670|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
160597574|NCT01306032|579903671|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
160597575|NCT01306032|579903672|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
160597576|NCT01213264|579903673|FG000|Overall Study|Adverse Event|1|||
160597577|NCT01213264|579903674|FG001|Overall Study|Adverse Event|0|||
160597578|NCT01213264|579903675|FG002|Overall Study|Adverse Event|0|||
160597579|NCT01213264|579903673|FG000|Overall Study|Lost to Follow-up|1|||
160597580|NCT01213264|579903674|FG001|Overall Study|Lost to Follow-up|2|||
160597581|NCT01213264|579903675|FG002|Overall Study|Lost to Follow-up|6|||
160597582|NCT00973622|579903676|FG000|Overall Study|did not attend MRI|14|||
160597583|NCT00973622|579903677|FG001|Overall Study|did not attend MRI|3|||
160597584|NCT00973622|579903676|FG000|Overall Study|did not pass MRI screen|6|||
160597585|NCT00973622|579903677|FG001|Overall Study|did not pass MRI screen|0|||
160597586|NCT00973622|579903676|FG000|Overall Study|did not complete rTMS sessions|11|||
160597587|NCT00973622|579903677|FG001|Overall Study|did not complete rTMS sessions|2|||
160597588|NCT00555568|579903678|FG000|Overall Study|Lost to Follow-up|26|||
160597589|NCT00555568|579903679|FG001|Overall Study|Lost to Follow-up|16|||
160597590|NCT00555568|579903680|FG002|Overall Study|Lost to Follow-up|16|||
160597591|NCT06000501|579903681|FG000|Overall Study|Screen failure|3|||
160597592|NCT06000501|579903681|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
160597593|NCT06000501|579903681|FG000|Overall Study|Physician Decision|4|||
160597594|NCT06000501|579903681|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
160597595|NCT06000501|579903681|FG000|Overall Study|Scheduling issues|2|||
160597596|NCT02677220|579903682|FG000|Overall Study|Adverse Event|1|||
160597597|NCT00067470|579903683|FG000|Overall Study|Withdrawal by Subject|0|||
160597598|NCT00067470|579903684|FG001|Overall Study|Withdrawal by Subject|1|||
160597599|NCT00050622|579903685|FG000|Overall Study|Adverse Event|1|||
160597600|NCT01342952|579903686|FG000|Overall Study|Adverse Event|0|||
160597601|NCT01342952|579903687|FG001|Overall Study|Adverse Event|5|||
160597602|NCT01342952|579903688|FG002|Overall Study|Adverse Event|1|||
160597603|NCT01342952|579903689|FG003|Overall Study|Adverse Event|0|||
160597604|NCT01342952|579903686|FG000|Overall Study|Lost to Follow-up|0|||
160597605|NCT01342952|579903687|FG001|Overall Study|Lost to Follow-up|2|||
160597606|NCT01342952|579903688|FG002|Overall Study|Lost to Follow-up|0|||
160597607|NCT01342952|579903689|FG003|Overall Study|Lost to Follow-up|0|||
160597608|NCT01342952|579903686|FG000|Overall Study|Withdrawal by Subject|1|||
160597609|NCT01342952|579903687|FG001|Overall Study|Withdrawal by Subject|1|||
160597610|NCT01342952|579903688|FG002|Overall Study|Withdrawal by Subject|0|||
160597611|NCT01342952|579903689|FG003|Overall Study|Withdrawal by Subject|0|||
160597612|NCT01342952|579903686|FG000|Overall Study|Physician Decision|3|||
160597613|NCT01342952|579903687|FG001|Overall Study|Physician Decision|3|||
160597614|NCT01342952|579903688|FG002|Overall Study|Physician Decision|1|||
160597615|NCT01342952|579903689|FG003|Overall Study|Physician Decision|0|||
160597616|NCT01192204|579903692|FG000|Overall Study|could not keep recall appointments|1|||
160597617|NCT01192204|579903693|FG001|Overall Study|could not keep recall appointments|0|||
160597618|NCT03699631|579903696|FG000|Overall Study|Adverse Event|3|||
160597619|NCT00507416|579903697|FG000|Overall Study|Adverse Event|58|||
160597620|NCT00507416|579903698|FG001|Overall Study|Adverse Event|67|||
160597621|NCT00507416|579903699|FG002|Overall Study|Adverse Event|65|||
160597622|NCT00507416|579903697|FG000|Overall Study|Protocol Violation|1|||
160597623|NCT00507416|579903698|FG001|Overall Study|Protocol Violation|2|||
160597624|NCT00507416|579903699|FG002|Overall Study|Protocol Violation|0|||
160597625|NCT00507416|579903697|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
160597626|NCT00507416|579903698|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
160597627|NCT00507416|579903699|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
160597628|NCT00507416|579903697|FG000|Overall Study|Progressive Disease|20|||
160597629|NCT00507416|579903698|FG001|Overall Study|Progressive Disease|10|||
160597630|NCT00507416|579903699|FG002|Overall Study|Progressive Disease|13|||
160597631|NCT00507416|579903697|FG000|Overall Study|Patient declined further treatment|18|||
160597632|NCT00507416|579903698|FG001|Overall Study|Patient declined further treatment|14|||
160597633|NCT00507416|579903699|FG002|Overall Study|Patient declined further treatment|11|||
160597634|NCT00507416|579903697|FG000|Overall Study|Other|11|||
160597635|NCT00507416|579903698|FG001|Overall Study|Other|16|||
160597636|NCT00507416|579903699|FG002|Overall Study|Other|13|||
160597637|NCT00507416|579903697|FG000|Overall Study|Did not Receive Study Treatment|3|||
160597638|NCT00507416|579903698|FG001|Overall Study|Did not Receive Study Treatment|9|||
160597639|NCT00507416|579903699|FG002|Overall Study|Did not Receive Study Treatment|4|||
160597640|NCT00964158|579903700|FG000|Overall Study|Lost to Follow-up|0|||
160597641|NCT00964158|579903701|FG001|Overall Study|Lost to Follow-up|1|||
160597642|NCT00964158|579903702|FG002|Overall Study|Lost to Follow-up|2|||
160597643|NCT00964158|579903700|FG000|Overall Study|Withdrawal by Subject|0|||
160597644|NCT00964158|579903701|FG001|Overall Study|Withdrawal by Subject|0|||
160597645|NCT00964158|579903702|FG002|Overall Study|Withdrawal by Subject|6|||
160597646|NCT03101514|579903703|FG000|Overall Study|Withdrawal by Subject|4|||
160597647|NCT03101514|579903703|FG000|Overall Study|Protocol Violation|2|||
160597648|NCT03101514|579903703|FG000|Overall Study|patient's information was incomplete|1|||
160597649|NCT02247401|579903708|FG000|Overall Study|Adverse Event|1|||
160597650|NCT02247401|579903709|FG001|Overall Study|Adverse Event|0|||
160597651|NCT02247401|579903710|FG002|Overall Study|Adverse Event|0|||
160597652|NCT02247401|579903708|FG000|Overall Study|Withdrawal by Subject|4|||
160597653|NCT02247401|579903709|FG001|Overall Study|Withdrawal by Subject|1|||
160597654|NCT02247401|579903710|FG002|Overall Study|Withdrawal by Subject|1|||
160597655|NCT02247401|579903708|FG000|Overall Study|Lost to Follow-up|1|||
160597656|NCT02247401|579903709|FG001|Overall Study|Lost to Follow-up|1|||
160597657|NCT02247401|579903710|FG002|Overall Study|Lost to Follow-up|1|||
160597658|NCT03695393|579903715|FG000|Overall Study|Death|3|||
160597659|NCT03695393|579903716|FG001|Overall Study|Death|1|||
160597660|NCT03695393|579903715|FG000|Overall Study|Lost to Follow-up|0|||
160597661|NCT03695393|579903716|FG001|Overall Study|Lost to Follow-up|1|||
160597662|NCT04585451|579903717|FG000|Overall Study|Withdrawal by Subject|26|||
160597663|NCT04585451|579903718|FG001|Overall Study|Withdrawal by Subject|0|||
160597664|NCT01578785|579903719|FG000|Overall Study|Withdrawal by Subject|0|||
160597665|NCT01578785|579903720|FG001|Overall Study|Withdrawal by Subject|1|||
160597666|NCT01578785|579903719|FG000|Overall Study|Study terminated by sponsor|59|||
160597667|NCT01578785|579903720|FG001|Overall Study|Study terminated by sponsor|118|||
160597668|NCT00966693|579903721|FG000|Overall Study|Adverse Event|0|||
160597669|NCT00966693|579903722|FG001|Overall Study|Adverse Event|0|||
160597670|NCT00966693|579903723|FG002|Overall Study|Adverse Event|1|||
160597671|NCT00966693|579903724|FG003|Overall Study|Adverse Event|2|||
160597672|NCT00966693|579903721|FG000|Overall Study|Death|0|||
160597673|NCT00966693|579903722|FG001|Overall Study|Death|0|||
160597674|NCT00966693|579903723|FG002|Overall Study|Death|1|||
160597675|NCT00966693|579903724|FG003|Overall Study|Death|0|||
160597676|NCT00966693|579903721|FG000|Overall Study|Withdrawal by Subject|1|||
160597677|NCT00966693|579903722|FG001|Overall Study|Withdrawal by Subject|0|||
160597678|NCT00966693|579903723|FG002|Overall Study|Withdrawal by Subject|0|||
160597679|NCT00966693|579903724|FG003|Overall Study|Withdrawal by Subject|5|||
160597680|NCT00966693|579903721|FG000|Overall Study|Disease Progression|0|||
160597681|NCT00966693|579903722|FG001|Overall Study|Disease Progression|0|||
160597682|NCT00966693|579903723|FG002|Overall Study|Disease Progression|1|||
160597683|NCT00966693|579903724|FG003|Overall Study|Disease Progression|16|||
160597684|NCT00599027|579903727|FG000|Overall Study|Withdrawal by Subject|1|||
160597685|NCT00599027|579903728|FG001|Overall Study|Withdrawal by Subject|1|||
160597686|NCT00599027|579903727|FG000|Overall Study|Adverse Event|0|||
160597687|NCT00599027|579903728|FG001|Overall Study|Adverse Event|1|||
160597688|NCT00599027|579903727|FG000|Overall Study|Treatment Failure|0|||
160597689|NCT00599027|579903728|FG001|Overall Study|Treatment Failure|1|||
160597690|NCT02581982|579903729|FG000|Overall Study|Lack of Efficacy|12|||
160597691|NCT02581982|579903729|FG000|Overall Study|Adverse Event|3|||
160597692|NCT02581982|579903729|FG000|Overall Study|Physician Decision|1|||
160597693|NCT00405821|579903730|FG000|Overall Study|Death|5|||
160597694|NCT00405821|579903731|FG001|Overall Study|Death|7|||
160597695|NCT00405821|579903730|FG000|Overall Study|Lost to Follow-up|7|||
160597696|NCT00405821|579903731|FG001|Overall Study|Lost to Follow-up|7|||
160659153|NCT00591630|580133313|FG001|Overall Study|Death|0|||
160597697|NCT00405821|579903730|FG000|Overall Study|Protocol Violation|1|||
160597698|NCT00405821|579903731|FG001|Overall Study|Protocol Violation|0|||
160597699|NCT00405821|579903730|FG000|Overall Study|initiated ART|9|||
160597700|NCT00405821|579903731|FG001|Overall Study|initiated ART|8|||
160597701|NCT00476996|579903739|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
160597702|NCT00476996|579903740|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
160597703|NCT00476996|579903741|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
160597704|NCT00476996|579903742|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
160597705|NCT00476996|579903739|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
160597706|NCT00476996|579903740|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
160659154|NCT00591630|580133314|FG002|Overall Study|Death|1|||
160597707|NCT00476996|579903741|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
160597708|NCT00476996|579903742|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
160597709|NCT00476996|579903739|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
160597710|NCT00476996|579903740|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
160597711|NCT00476996|579903741|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
160597712|NCT00476996|579903742|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
160597713|NCT00476996|579903739|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
160597714|NCT00476996|579903740|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
160597715|NCT00476996|579903741|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
160597716|NCT00476996|579903742|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
160597717|NCT00476996|579903739|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
160597718|NCT00476996|579903740|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
160597719|NCT00476996|579903741|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
160597720|NCT00476996|579903742|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
160597721|NCT00476996|579903739|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
160597722|NCT00476996|579903740|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
160597723|NCT00476996|579903741|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
160597724|NCT00476996|579903742|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
160597725|NCT00476996|579903739|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
160597726|NCT00476996|579903740|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
160597727|NCT00476996|579903741|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
160597728|NCT00476996|579903742|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
160597729|NCT00476996|579903739|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
160597730|NCT00476996|579903740|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
160597731|NCT00476996|579903741|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
160597732|NCT00476996|579903742|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
160597733|NCT00476996|579903739|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
160597734|NCT00476996|579903740|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
160597735|NCT00476996|579903741|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
160597736|NCT00476996|579903742|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
160597737|NCT00476996|579903739|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
160597738|NCT00476996|579903740|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
160597739|NCT00476996|579903741|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
160597740|NCT00476996|579903742|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
160597741|NCT00476996|579903739|FG000|OLE Phase (From Week 48)|Death|0|||
160597742|NCT00476996|579903740|FG001|OLE Phase (From Week 48)|Death|0|||
160597743|NCT00476996|579903741|FG002|OLE Phase (From Week 48)|Death|0|||
160597744|NCT00476996|579903742|FG003|OLE Phase (From Week 48)|Death|7|||
160597745|NCT00476996|579903739|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
160597746|NCT00476996|579903740|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
160597747|NCT00476996|579903741|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
160597748|NCT00476996|579903742|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
160597749|NCT00476996|579903739|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
160597750|NCT00476996|579903740|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
160597751|NCT00476996|579903741|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
160597752|NCT00476996|579903742|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
160597753|NCT00476996|579903739|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
160597754|NCT00476996|579903740|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
160597755|NCT00476996|579903741|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
160597756|NCT00476996|579903742|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
160597757|NCT00476996|579903739|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
160597758|NCT00476996|579903740|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
160597759|NCT00476996|579903741|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
160597760|NCT00476996|579903742|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
160597761|NCT02554253|579903753|FG000|Overall Study|ineligible after enrollment|1|||
160597762|NCT02554253|579903754|FG001|Overall Study|ineligible after enrollment|0|||
160597763|NCT02554253|579903753|FG000|Overall Study|converted to transcatheter procedure|0|||
160597764|NCT02554253|579903754|FG001|Overall Study|converted to transcatheter procedure|1|||
160597765|NCT02554253|579903753|FG000|Overall Study|received both drugs|0|||
160597766|NCT02554253|579903754|FG001|Overall Study|received both drugs|1|||
160597767|NCT05406440|579906104|FG000|Overall Study|Lost to Follow-up|0|||
160597768|NCT05406440|579906105|FG001|Overall Study|Lost to Follow-up|0|||
160597769|NCT05406440|579906106|FG002|Overall Study|Lost to Follow-up|0|||
160597770|NCT05406440|579906107|FG003|Overall Study|Lost to Follow-up|0|||
160597771|NCT05406440|579906108|FG004|Overall Study|Lost to Follow-up|2|||
160597772|NCT05406440|579906109|FG005|Overall Study|Lost to Follow-up|0|||
160597773|NCT05406440|579906110|FG006|Overall Study|Lost to Follow-up|0|||
160597774|NCT05406440|579906104|FG000|Overall Study|Physician Decision|0|||
160659155|NCT00591630|580133315|FG003|Overall Study|Death|0|||
160659156|NCT01432171|580133316|FG000|Overall Study|Death|1|||
160597775|NCT05406440|579906105|FG001|Overall Study|Physician Decision|0|||
160597776|NCT05406440|579906106|FG002|Overall Study|Physician Decision|0|||
160597777|NCT05406440|579906107|FG003|Overall Study|Physician Decision|0|||
160597778|NCT05406440|579906108|FG004|Overall Study|Physician Decision|1|||
160597779|NCT05406440|579906109|FG005|Overall Study|Physician Decision|0|||
160597780|NCT05406440|579906110|FG006|Overall Study|Physician Decision|0|||
160597781|NCT05406440|579906104|FG000|Overall Study|Withdrawal by Subject|0|||
160597782|NCT05406440|579906105|FG001|Overall Study|Withdrawal by Subject|0|||
160597783|NCT05406440|579906106|FG002|Overall Study|Withdrawal by Subject|0|||
160597784|NCT05406440|579906107|FG003|Overall Study|Withdrawal by Subject|0|||
160597785|NCT05406440|579906108|FG004|Overall Study|Withdrawal by Subject|0|||
160597786|NCT05406440|579906109|FG005|Overall Study|Withdrawal by Subject|2|||
160597787|NCT05406440|579906110|FG006|Overall Study|Withdrawal by Subject|0|||
160597788|NCT01412151|579906111|FG000|Week 0 - 306 - Treatment Period|Death|1|||
160597789|NCT01412151|579906111|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
160597790|NCT01412151|579906111|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
160597791|NCT01412151|579906111|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
160597792|NCT03127852|579906112|FG000|Overall Study|Withdrawal by Subject|4|||
160597793|NCT03127852|579906113|FG001|Overall Study|Withdrawal by Subject|1|||
160597794|NCT03127852|579906112|FG000|Overall Study|Death|1|||
160597795|NCT03127852|579906113|FG001|Overall Study|Death|1|||
160597796|NCT03621189|579906114|FG000|Overall Study|Withdrawal by Subject|0|||
160597797|NCT03621189|579906115|FG001|Overall Study|Withdrawal by Subject|3|||
160597798|NCT03621189|579906114|FG000|Overall Study|Physician Decision|0|||
160597799|NCT03621189|579906115|FG001|Overall Study|Physician Decision|2|||
160597800|NCT01316939|579906118|FG000|Overall Study|Study closed/terminated|26|||
160597801|NCT01316939|579906119|FG001|Overall Study|Study closed/terminated|25|||
160597802|NCT01316939|579906120|FG002|Overall Study|Study closed/terminated|23|||
160597803|NCT01316939|579906118|FG000|Overall Study|Lack of Efficacy|24|||
160597804|NCT01316939|579906119|FG001|Overall Study|Lack of Efficacy|25|||
160597805|NCT01316939|579906120|FG002|Overall Study|Lack of Efficacy|25|||
160597806|NCT01316939|579906118|FG000|Overall Study|Adverse Event|9|||
160597807|NCT01316939|579906119|FG001|Overall Study|Adverse Event|12|||
160597808|NCT01316939|579906120|FG002|Overall Study|Adverse Event|11|||
160597809|NCT01316939|579906118|FG000|Overall Study|Withdrawal by Subject|1|||
160597810|NCT01316939|579906119|FG001|Overall Study|Withdrawal by Subject|3|||
160597811|NCT01316939|579906120|FG002|Overall Study|Withdrawal by Subject|6|||
160597812|NCT01316939|579906118|FG000|Overall Study|Physician Decision|2|||
160597813|NCT01316939|579906119|FG001|Overall Study|Physician Decision|2|||
160597814|NCT01316939|579906120|FG002|Overall Study|Physician Decision|1|||
160597815|NCT01316939|579906118|FG000|Overall Study|Lost to Follow-up|0|||
160597816|NCT01316939|579906119|FG001|Overall Study|Lost to Follow-up|0|||
160597817|NCT01316939|579906120|FG002|Overall Study|Lost to Follow-up|2|||
160597818|NCT01316939|579906118|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
160597819|NCT01316939|579906119|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
160597820|NCT01316939|579906120|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
160597821|NCT01316939|579906118|FG000|Overall Study|Protocol Violation|0|||
160597822|NCT01316939|579906119|FG001|Overall Study|Protocol Violation|1|||
160597823|NCT01316939|579906120|FG002|Overall Study|Protocol Violation|0|||
160597824|NCT04134728|579906121|FG000|Overall Study|Adverse Event|3|||
160597825|NCT04134728|579906122|FG001|Overall Study|Adverse Event|2|||
160597826|NCT04134728|579906123|FG002|Overall Study|Adverse Event|9|||
160597827|NCT04134728|579906124|FG003|Overall Study|Adverse Event|0|||
160597828|NCT04134728|579906125|FG004|Overall Study|Adverse Event|0|||
160597829|NCT04134728|579906126|FG005|Overall Study|Adverse Event|0|||
160597830|NCT04134728|579906121|FG000|Overall Study|Lack of Efficacy|3|||
160597831|NCT04134728|579906122|FG001|Overall Study|Lack of Efficacy|3|||
160659157|NCT01432171|580133317|FG001|Overall Study|Death|2|||
160597832|NCT04134728|579906123|FG002|Overall Study|Lack of Efficacy|1|||
160597833|NCT04134728|579906124|FG003|Overall Study|Lack of Efficacy|2|||
160597834|NCT04134728|579906125|FG004|Overall Study|Lack of Efficacy|0|||
160597835|NCT04134728|579906126|FG005|Overall Study|Lack of Efficacy|0|||
160597836|NCT04134728|579906121|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
160597837|NCT04134728|579906122|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160597838|NCT04134728|579906123|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
160597839|NCT04134728|579906124|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160597840|NCT04134728|579906125|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160597841|NCT04134728|579906126|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160597842|NCT04134728|579906121|FG000|Overall Study|Protocol Deviation|0|||
160597843|NCT04134728|579906122|FG001|Overall Study|Protocol Deviation|0|||
160597844|NCT04134728|579906123|FG002|Overall Study|Protocol Deviation|1|||
160597845|NCT04134728|579906124|FG003|Overall Study|Protocol Deviation|0|||
160597846|NCT04134728|579906125|FG004|Overall Study|Protocol Deviation|0|||
160597847|NCT04134728|579906126|FG005|Overall Study|Protocol Deviation|0|||
160597848|NCT04134728|579906121|FG000|Overall Study|Informed Consent Withdrawn|3|||
160597849|NCT04134728|579906122|FG001|Overall Study|Informed Consent Withdrawn|6|||
160597850|NCT04134728|579906123|FG002|Overall Study|Informed Consent Withdrawn|8|||
160597851|NCT04134728|579906124|FG003|Overall Study|Informed Consent Withdrawn|1|||
160597852|NCT04134728|579906125|FG004|Overall Study|Informed Consent Withdrawn|1|||
160597853|NCT04134728|579906126|FG005|Overall Study|Informed Consent Withdrawn|0|||
160597854|NCT04134728|579906121|FG000|Overall Study|Physician Decision|2|||
160597855|NCT04134728|579906122|FG001|Overall Study|Physician Decision|0|||
160597856|NCT04134728|579906123|FG002|Overall Study|Physician Decision|0|||
160597857|NCT04134728|579906124|FG003|Overall Study|Physician Decision|0|||
160597858|NCT04134728|579906125|FG004|Overall Study|Physician Decision|0|||
160597859|NCT04134728|579906126|FG005|Overall Study|Physician Decision|0|||
160597860|NCT04134728|579906121|FG000|Overall Study|Lost to Follow-up|1|||
160597861|NCT04134728|579906122|FG001|Overall Study|Lost to Follow-up|2|||
160597862|NCT04134728|579906123|FG002|Overall Study|Lost to Follow-up|1|||
160597863|NCT04134728|579906124|FG003|Overall Study|Lost to Follow-up|0|||
160597864|NCT04134728|579906125|FG004|Overall Study|Lost to Follow-up|0|||
160597865|NCT04134728|579906126|FG005|Overall Study|Lost to Follow-up|1|||
160597866|NCT04134728|579906121|FG000|Overall Study|Investigator Site Closed|0|||
160597867|NCT04134728|579906122|FG001|Overall Study|Investigator Site Closed|1|||
160597868|NCT04134728|579906123|FG002|Overall Study|Investigator Site Closed|1|||
160597869|NCT04134728|579906124|FG003|Overall Study|Investigator Site Closed|0|||
160597870|NCT04134728|579906125|FG004|Overall Study|Investigator Site Closed|0|||
160597871|NCT04134728|579906126|FG005|Overall Study|Investigator Site Closed|0|||
160597872|NCT00233324|579906127|FG000|Main Study|Death|68|||
160597873|NCT00233324|579906128|FG001|Main Study|Death|60|||
160597874|NCT00233324|579906129|FG002|Main Study|Death|62|||
160597875|NCT00233324|579906130|FG003|Main Study|Death|47|||
160597876|NCT00233324|579906127|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
160597877|NCT00233324|579906128|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
160597878|NCT00233324|579906129|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
160597879|NCT00233324|579906130|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
160597880|NCT00233324|579906127|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
160597881|NCT00233324|579906128|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
160597882|NCT00233324|579906129|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
160597883|NCT00233324|579906130|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
160597884|NCT01281189|579906135|FG000|Overall Study|Adverse Event|7|||
160597885|NCT01281189|579906136|FG001|Overall Study|Adverse Event|9|||
160597886|NCT01281189|579906135|FG000|Overall Study|Lost to Follow-up|6|||
160597887|NCT01281189|579906136|FG001|Overall Study|Lost to Follow-up|4|||
160597888|NCT01281189|579906135|FG000|Overall Study|Withdrawal by Subject|21|||
160597889|NCT01281189|579906136|FG001|Overall Study|Withdrawal by Subject|24|||
160597890|NCT01281189|579906135|FG000|Overall Study|Physician Decision|2|||
160597891|NCT01281189|579906136|FG001|Overall Study|Physician Decision|3|||
160597892|NCT01281189|579906135|FG000|Overall Study|Death|103|||
160597893|NCT01281189|579906136|FG001|Overall Study|Death|91|||
160597894|NCT01281189|579906135|FG000|Overall Study|Other|8|||
160597895|NCT01281189|579906136|FG001|Overall Study|Other|12|||
160597896|NCT01175590|579906138|FG000|Overall Study|Lost to Follow-up|1|||
160597897|NCT01175590|579906139|FG001|Overall Study|Lost to Follow-up|0|||
160597898|NCT01175590|579906138|FG000|Overall Study|Withdrawal by Subject|0|||
160597899|NCT01175590|579906139|FG001|Overall Study|Withdrawal by Subject|2|||
160597900|NCT01175590|579906138|FG000|Overall Study|Adverse Event|4|||
160597901|NCT01175590|579906139|FG001|Overall Study|Adverse Event|0|||
160597902|NCT01175590|579906138|FG000|Overall Study|Physician Decision|1|||
160597903|NCT01175590|579906139|FG001|Overall Study|Physician Decision|4|||
160597904|NCT01175590|579906138|FG000|Overall Study|Lack of Efficacy|1|||
160597905|NCT01175590|579906139|FG001|Overall Study|Lack of Efficacy|1|||
160597906|NCT01175590|579906138|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
160597907|NCT01175590|579906139|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
160597908|NCT01175590|579906138|FG000|Overall Study|Treated not as randomized|3|||
160659158|NCT01432171|580133316|FG000|Overall Study|Lost to Follow-up|6|||
160597909|NCT01175590|579906139|FG001|Overall Study|Treated not as randomized|2|||
160597910|NCT01175590|579906138|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
160597911|NCT01175590|579906139|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
160597912|NCT01175590|579906138|FG000|Overall Study|Protocol Violation|0|||
160597913|NCT01175590|579906139|FG001|Overall Study|Protocol Violation|1|||
160659159|NCT01432171|580133317|FG001|Overall Study|Lost to Follow-up|5|||
160597914|NCT02062398|579906142|FG000|Overall Study|Implant removal|1|||
160597915|NCT03351478|579906145|FG000|Overall Study|At the subject's own request|11|||
160659160|NCT01432171|580133316|FG000|Overall Study|Withdrawal by Subject|3|||
160597916|NCT03351478|579906146|FG001|Overall Study|At the subject's own request|12|||
160597917|NCT03351478|579906147|FG002|Overall Study|At the subject's own request|5|||
160597918|NCT03351478|579906145|FG000|Overall Study|Adverse Event|1|||
160597919|NCT03351478|579906146|FG001|Overall Study|Adverse Event|2|||
160597920|NCT03351478|579906147|FG002|Overall Study|Adverse Event|1|||
160597921|NCT03351478|579906145|FG000|Overall Study|Poor compliance to protocol|1|||
160597922|NCT03351478|579906146|FG001|Overall Study|Poor compliance to protocol|0|||
160597923|NCT03351478|579906147|FG002|Overall Study|Poor compliance to protocol|0|||
160597924|NCT03351478|579906145|FG000|Overall Study|Reason not Specified|1|||
160597925|NCT03351478|579906146|FG001|Overall Study|Reason not Specified|3|||
160597926|NCT03351478|579906147|FG002|Overall Study|Reason not Specified|0|||
160597927|NCT03351478|579906145|FG000|Overall Study|Lost to Follow-up|0|||
160597928|NCT03351478|579906146|FG001|Overall Study|Lost to Follow-up|0|||
160597929|NCT03351478|579906147|FG002|Overall Study|Lost to Follow-up|1|||
160597930|NCT03911869|579906150|FG000|Safety Lead-in Phase|Death|7|||
160597931|NCT03911869|579906151|FG001|Safety Lead-in Phase|Death|0|||
160597932|NCT03911869|579906152|FG002|Safety Lead-in Phase|Death|0|||
160597933|NCT03911869|579906150|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
160597934|NCT03911869|579906151|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
160597935|NCT03911869|579906152|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
160597936|NCT03911869|579906150|FG000|Safety Lead-in Phase|Other|1|||
160597937|NCT03911869|579906151|FG001|Safety Lead-in Phase|Other|0|||
160597938|NCT03911869|579906152|FG002|Safety Lead-in Phase|Other|0|||
160597939|NCT03911869|579906150|FG000|Phase 2|Death|0|||
160597940|NCT03911869|579906151|FG001|Phase 2|Death|3|||
160597941|NCT03911869|579906152|FG002|Phase 2|Death|0|||
160597942|NCT00608881|579906153|FG000|Overall Study|Death|22|||
160597943|NCT00608881|579906154|FG001|Overall Study|Death|13|||
160597944|NCT00608881|579906153|FG000|Overall Study|Adverse Event|5|||
160597945|NCT00608881|579906154|FG001|Overall Study|Adverse Event|3|||
160597946|NCT00608881|579906153|FG000|Overall Study|Lost to Follow-up|28|||
160659161|NCT01432171|580133317|FG001|Overall Study|Withdrawal by Subject|1|||
160659162|NCT01432171|580133316|FG000|Overall Study|Noncompliance|2|||
160597947|NCT00608881|579906154|FG001|Overall Study|Lost to Follow-up|14|||
160597948|NCT00608881|579906153|FG000|Overall Study|Withdrawal by Subject|18|||
160597949|NCT00608881|579906154|FG001|Overall Study|Withdrawal by Subject|29|||
160659163|NCT01432171|580133317|FG001|Overall Study|Noncompliance|3|||
160597950|NCT00608881|579906153|FG000|Overall Study|Physician Decision|5|||
160597951|NCT00608881|579906154|FG001|Overall Study|Physician Decision|5|||
160597952|NCT00608881|579906153|FG000|Overall Study|Institutionalized|1|||
160597953|NCT00608881|579906154|FG001|Overall Study|Institutionalized|2|||
160597954|NCT00510484|579906156|FG000|Wash-out Period|Adverse Event|0|||
160597955|NCT00510484|579906157|FG001|Wash-out Period|Adverse Event|1|||
160597956|NCT01590212|579906158|FG000|Overall Study|Withdrawal by Subject|2|||
160597957|NCT01590212|579906159|FG001|Overall Study|Withdrawal by Subject|2|||
160597958|NCT01590212|579906160|FG002|Overall Study|Withdrawal by Subject|2|||
160597959|NCT01590212|579906158|FG000|Overall Study|Lost to Follow-up|1|||
160597960|NCT01590212|579906159|FG001|Overall Study|Lost to Follow-up|2|||
160597961|NCT01590212|579906160|FG002|Overall Study|Lost to Follow-up|3|||
160597962|NCT03004976|579906161|FG000|Overall Study|Lost to Follow-up|7|||
160597963|NCT03004976|579906162|FG001|Overall Study|Lost to Follow-up|5|||
160597964|NCT03004976|579906161|FG000|Overall Study|Physician Decision|1|||
160597965|NCT03004976|579906162|FG001|Overall Study|Physician Decision|0|||
160597966|NCT03004976|579906161|FG000|Overall Study|Withdrawal by Subject|1|||
160597967|NCT03004976|579906162|FG001|Overall Study|Withdrawal by Subject|0|||
160597968|NCT03004976|579906161|FG000|Overall Study|Death|4|||
160597969|NCT03004976|579906162|FG001|Overall Study|Death|1|||
160597970|NCT02533401|579906163|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
160597971|NCT02533401|579906163|FG000|Overall Study|Death|5|||
160597972|NCT02533401|579906163|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
160597973|NCT02533401|579906163|FG000|Overall Study|Lost to Follow-up|1|||
160597974|NCT02533401|579906163|FG000|Overall Study|Violation of Selection Criteria|1|||
160597975|NCT01106391|579906166|FG000|Overall Study|Death|12|||
160597976|NCT01106391|579906166|FG000|Overall Study|Withdrawal by Subject|7|||
160597977|NCT01387074|579906167|FG000|Overall Study|Lost to Follow-up|7|||
160597978|NCT01387074|579906167|FG000|Overall Study|Lack of Efficacy|1|||
160597979|NCT00150345|579906168|FG000|Overall Study|Death|5|||
160597980|NCT00150345|579906169|FG001|Overall Study|Death|2|||
160597981|NCT00150345|579906168|FG000|Overall Study|Adverse Event|8|||
160597982|NCT00150345|579906169|FG001|Overall Study|Adverse Event|6|||
160597983|NCT00150345|579906168|FG000|Overall Study|Lack of Efficacy|5|||
160597984|NCT00150345|579906169|FG001|Overall Study|Lack of Efficacy|4|||
160597985|NCT00150345|579906168|FG000|Overall Study|Withdrawal by Subject|3|||
160597986|NCT00150345|579906169|FG001|Overall Study|Withdrawal by Subject|4|||
160597987|NCT00150345|579906168|FG000|Overall Study|Laboratory abnormality|1|||
160597988|NCT00150345|579906169|FG001|Overall Study|Laboratory abnormality|2|||
160597989|NCT00150345|579906168|FG000|Overall Study|Other|12|||
160597990|NCT00150345|579906169|FG001|Overall Study|Other|14|||
160597991|NCT01392742|579906170|FG000|Overall Study|Premature study termination|42|||
160597992|NCT01392742|579906170|FG000|Overall Study|Failure to return|35|||
160597993|NCT01392742|579906170|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
160597994|NCT01392742|579906170|FG000|Overall Study|Lost to Follow-up|34|||
160597995|NCT01392742|579906170|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
160597996|NCT01392742|579906170|FG000|Overall Study|ITR and Protocol deviation|1|||
160597997|NCT01392742|579906170|FG000|Overall Study|Adverse event/intercurrent illness|17|||
160597998|NCT01392742|579906170|FG000|Overall Study|Protocol Violation|14|||
160597999|NCT01392742|579906170|FG000|Overall Study|Other|3|||
160598000|NCT01392742|579906170|FG000|Overall Study|Missing information|13|||
160598001|NCT01998958|579906171|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598002|NCT01998958|579906172|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
160598003|NCT01998958|579906173|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598004|NCT01998958|579906174|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598005|NCT01998958|579906175|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598006|NCT01998958|579906176|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598007|NCT01998958|579906177|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598008|NCT01998958|579906178|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598009|NCT01998958|579906179|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598010|NCT01998958|579906180|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598011|NCT01998958|579906181|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598012|NCT01998958|579906182|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598013|NCT01998958|579906183|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598014|NCT01998958|579906184|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598015|NCT01998958|579906185|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598016|NCT01998958|579906186|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598017|NCT01998958|579906187|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598018|NCT01998958|579906188|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598019|NCT01998958|579906189|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598020|NCT01998958|579906190|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598021|NCT01998958|579906191|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598022|NCT01998958|579906192|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598023|NCT01998958|579906193|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598024|NCT01998958|579906194|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598025|NCT01998958|579906195|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598026|NCT01998958|579906196|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598027|NCT01998958|579906197|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598028|NCT01998958|579906198|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598029|NCT01998958|579906199|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598030|NCT01998958|579906200|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598031|NCT01998958|579906201|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598032|NCT01998958|579906202|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
160598033|NCT01998958|579906171|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598034|NCT01998958|579906172|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
160598035|NCT01998958|579906173|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598036|NCT01998958|579906174|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598037|NCT01998958|579906175|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598038|NCT01998958|579906176|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598039|NCT01998958|579906177|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598040|NCT01998958|579906178|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598041|NCT01998958|579906179|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598042|NCT01998958|579906180|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598043|NCT01998958|579906181|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598044|NCT01998958|579906182|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598045|NCT01998958|579906183|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598046|NCT01998958|579906184|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598047|NCT01998958|579906185|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598048|NCT01998958|579906186|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598049|NCT01998958|579906187|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598050|NCT01998958|579906188|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598051|NCT01998958|579906189|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598052|NCT01998958|579906190|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598053|NCT01998958|579906191|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598054|NCT01998958|579906192|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598055|NCT01998958|579906193|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598056|NCT01998958|579906194|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598057|NCT01998958|579906195|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598058|NCT01998958|579906196|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598059|NCT01998958|579906197|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598060|NCT01998958|579906198|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598061|NCT01998958|579906199|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598062|NCT01998958|579906200|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598063|NCT01998958|579906201|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598064|NCT01998958|579906202|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
160598065|NCT01998958|579906171|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
160598066|NCT01998958|579906172|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
160598067|NCT01998958|579906173|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
160598068|NCT01998958|579906174|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
160598069|NCT01998958|579906175|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
160598070|NCT01998958|579906176|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
160598071|NCT01998958|579906177|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
160598072|NCT01998958|579906178|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
160598073|NCT01998958|579906179|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
160598074|NCT01998958|579906180|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
160598075|NCT01998958|579906181|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
160598076|NCT01998958|579906182|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
160598077|NCT01998958|579906183|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
160598078|NCT01998958|579906184|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
160598079|NCT01998958|579906185|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
160598080|NCT01998958|579906186|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
160598081|NCT01998958|579906187|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
160598082|NCT01998958|579906188|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
160598083|NCT01998958|579906189|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
160598084|NCT01998958|579906190|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
160598085|NCT01998958|579906191|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
160598086|NCT01998958|579906192|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
160598087|NCT01998958|579906193|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
160598088|NCT01998958|579906194|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
160598089|NCT01998958|579906195|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
160598090|NCT01998958|579906196|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
160598091|NCT01998958|579906197|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
160598092|NCT01998958|579906198|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
160598093|NCT01998958|579906199|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
160598094|NCT01998958|579906200|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
160598095|NCT01998958|579906201|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
160598096|NCT01998958|579906202|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
160598097|NCT01998958|579906171|FG000|Period 1 (Panel A and B)|Other|1|||
160598098|NCT01998958|579906172|FG001|Period 1 (Panel A and B)|Other|0|||
160598099|NCT01998958|579906173|FG002|Period 1 (Panel A and B)|Other|0|||
160598100|NCT01998958|579906174|FG003|Period 1 (Panel A and B)|Other|0|||
160598101|NCT01998958|579906175|FG004|Period 1 (Panel A and B)|Other|0|||
160598102|NCT01998958|579906176|FG005|Period 1 (Panel A and B)|Other|0|||
160598103|NCT01998958|579906177|FG006|Period 1 (Panel A and B)|Other|0|||
160598104|NCT01998958|579906178|FG007|Period 1 (Panel A and B)|Other|0|||
160598105|NCT01998958|579906179|FG008|Period 1 (Panel A and B)|Other|0|||
160598106|NCT01998958|579906180|FG009|Period 1 (Panel A and B)|Other|0|||
160598107|NCT01998958|579906181|FG010|Period 1 (Panel A and B)|Other|0|||
160598108|NCT01998958|579906182|FG011|Period 1 (Panel A and B)|Other|0|||
160598109|NCT01998958|579906183|FG012|Period 1 (Panel A and B)|Other|0|||
160598110|NCT01998958|579906184|FG013|Period 1 (Panel A and B)|Other|0|||
160598111|NCT01998958|579906185|FG014|Period 1 (Panel A and B)|Other|0|||
160598112|NCT01998958|579906186|FG015|Period 1 (Panel A and B)|Other|0|||
160598113|NCT01998958|579906187|FG016|Period 1 (Panel A and B)|Other|0|||
160598114|NCT01998958|579906188|FG017|Period 1 (Panel A and B)|Other|0|||
160598115|NCT01998958|579906189|FG018|Period 1 (Panel A and B)|Other|0|||
160598116|NCT01998958|579906190|FG019|Period 1 (Panel A and B)|Other|0|||
160598117|NCT01998958|579906191|FG020|Period 1 (Panel A and B)|Other|0|||
160598118|NCT01998958|579906192|FG021|Period 1 (Panel A and B)|Other|0|||
160598119|NCT01998958|579906193|FG022|Period 1 (Panel A and B)|Other|0|||
160598120|NCT01998958|579906194|FG023|Period 1 (Panel A and B)|Other|0|||
160598121|NCT01998958|579906195|FG024|Period 1 (Panel A and B)|Other|0|||
160598122|NCT01998958|579906196|FG025|Period 1 (Panel A and B)|Other|0|||
160598123|NCT01998958|579906197|FG026|Period 1 (Panel A and B)|Other|0|||
160598124|NCT01998958|579906198|FG027|Period 1 (Panel A and B)|Other|0|||
160598125|NCT01998958|579906199|FG028|Period 1 (Panel A and B)|Other|0|||
160598126|NCT01998958|579906200|FG029|Period 1 (Panel A and B)|Other|0|||
160598127|NCT01998958|579906201|FG030|Period 1 (Panel A and B)|Other|0|||
160598128|NCT01998958|579906202|FG031|Period 1 (Panel A and B)|Other|0|||
160598129|NCT01998958|579906171|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
160598130|NCT01998958|579906172|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
160598131|NCT01998958|579906173|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
160598132|NCT01998958|579906174|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
160598133|NCT01998958|579906175|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
160598134|NCT01998958|579906176|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
160598135|NCT01998958|579906177|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
160598136|NCT01998958|579906178|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
160598137|NCT01998958|579906179|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
160598138|NCT01998958|579906180|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
160598139|NCT01998958|579906181|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
160598140|NCT01998958|579906182|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
160598141|NCT01998958|579906183|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
160598142|NCT01998958|579906184|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
160598143|NCT01998958|579906185|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
160598144|NCT01998958|579906186|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
160598145|NCT01998958|579906187|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
160598146|NCT01998958|579906188|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
160598147|NCT01998958|579906189|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
160598148|NCT01998958|579906190|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
160598149|NCT01998958|579906191|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
160598150|NCT01998958|579906192|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
160598151|NCT01998958|579906193|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
160598152|NCT01998958|579906194|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
160598153|NCT01998958|579906195|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
160598154|NCT01998958|579906196|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
160598155|NCT01998958|579906197|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
160598156|NCT01998958|579906198|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
160598157|NCT01998958|579906199|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
160598158|NCT01998958|579906200|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
160598159|NCT01998958|579906201|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
160598160|NCT01998958|579906202|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
160598161|NCT01998958|579906171|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598162|NCT01998958|579906172|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598163|NCT01998958|579906173|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598164|NCT01998958|579906174|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598165|NCT01998958|579906175|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598166|NCT01998958|579906176|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598167|NCT01998958|579906177|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598168|NCT01998958|579906178|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598169|NCT01998958|579906179|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598170|NCT01998958|579906180|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598171|NCT01998958|579906181|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598172|NCT01998958|579906182|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598173|NCT01998958|579906183|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598174|NCT01998958|579906184|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598175|NCT01998958|579906185|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
160598176|NCT01998958|579906186|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598177|NCT01998958|579906187|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598178|NCT01998958|579906188|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598179|NCT01998958|579906189|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
160598180|NCT01998958|579906190|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598181|NCT01998958|579906191|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598182|NCT01998958|579906192|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598183|NCT01998958|579906193|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598184|NCT01998958|579906194|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598185|NCT01998958|579906195|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598186|NCT01998958|579906196|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598187|NCT01998958|579906197|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598188|NCT01998958|579906198|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598189|NCT01998958|579906199|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160659164|NCT01432171|580133316|FG000|Overall Study|Insurance denial trial coverage|1|||
160659165|NCT01432171|580133317|FG001|Overall Study|Insurance denial trial coverage|0|||
160598190|NCT01998958|579906200|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598191|NCT01998958|579906201|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598192|NCT01998958|579906202|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
160598193|NCT01998958|579906171|FG000|Open Label Phase (Optional)|Adverse Event|0|||
160598194|NCT01998958|579906172|FG001|Open Label Phase (Optional)|Adverse Event|0|||
160598195|NCT01998958|579906173|FG002|Open Label Phase (Optional)|Adverse Event|0|||
160598196|NCT01998958|579906174|FG003|Open Label Phase (Optional)|Adverse Event|0|||
160598197|NCT01998958|579906175|FG004|Open Label Phase (Optional)|Adverse Event|0|||
160598198|NCT01998958|579906176|FG005|Open Label Phase (Optional)|Adverse Event|0|||
160598199|NCT01998958|579906177|FG006|Open Label Phase (Optional)|Adverse Event|0|||
160598200|NCT01998958|579906178|FG007|Open Label Phase (Optional)|Adverse Event|0|||
160659166|NCT01432171|580133316|FG000|Overall Study|Patient moved to palliative care|1|||
160659167|NCT01432171|580133317|FG001|Overall Study|Patient moved to palliative care|0|||
160659168|NCT01691248|580133318|FG000|Overall Study|Protocol Violation|43|||
160659169|NCT01691248|580133319|FG001|Overall Study|Protocol Violation|27|||
160659170|NCT01691248|580133318|FG000|Overall Study|Adverse Event|24|||
160659171|NCT01691248|580133319|FG001|Overall Study|Adverse Event|22|||
160659172|NCT01691248|580133318|FG000|Overall Study|Withdrawal by Subject|20|||
160659173|NCT01691248|580133319|FG001|Overall Study|Withdrawal by Subject|18|||
160659174|NCT01691248|580133318|FG000|Overall Study|Confirmed CDAD|14|||
160659175|NCT01691248|580133319|FG001|Overall Study|Confirmed CDAD|31|||
160659176|NCT01691248|580133318|FG000|Overall Study|Lost to Follow-up|2|||
160659177|NCT01691248|580133319|FG001|Overall Study|Lost to Follow-up|5|||
160659178|NCT01691248|580133318|FG000|Overall Study|Reason not provided|4|||
160659179|NCT01691248|580133319|FG001|Overall Study|Reason not provided|4|||
160659180|NCT01691248|580133318|FG000|Overall Study|Not Treated|4|||
160659181|NCT01691248|580133319|FG001|Overall Study|Not Treated|7|||
160659182|NCT02863575|580133320|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
160659183|NCT02863575|580133321|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
160659184|NCT02863575|580133322|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
160659185|NCT02863575|580133320|FG000|Overall Study|Withdrawal by Subject|0|||
160659186|NCT02863575|580133321|FG001|Overall Study|Withdrawal by Subject|1|||
160659187|NCT02863575|580133322|FG002|Overall Study|Withdrawal by Subject|1|||
160659188|NCT02863575|580133320|FG000|Overall Study|Adverse Event|0|||
160659189|NCT02863575|580133321|FG001|Overall Study|Adverse Event|1|||
160659190|NCT02863575|580133322|FG002|Overall Study|Adverse Event|0|||
160659191|NCT01248247|580134468|FG000|Overall Study|Adverse Event|2|||
160659192|NCT01248247|580134469|FG001|Overall Study|Adverse Event|4|||
160659193|NCT01248247|580134470|FG002|Overall Study|Adverse Event|4|||
160659194|NCT01248247|580134471|FG003|Overall Study|Adverse Event|2|||
160659195|NCT01248247|580134468|FG000|Overall Study|Death|0|||
160659196|NCT01248247|580134469|FG001|Overall Study|Death|1|||
160659197|NCT01248247|580134470|FG002|Overall Study|Death|4|||
160659198|NCT01248247|580134471|FG003|Overall Study|Death|7|||
160659199|NCT01248247|580134468|FG000|Overall Study|Lost to Follow-up|0|||
160659200|NCT01248247|580134469|FG001|Overall Study|Lost to Follow-up|1|||
160659201|NCT01248247|580134470|FG002|Overall Study|Lost to Follow-up|1|||
160659202|NCT01248247|580134471|FG003|Overall Study|Lost to Follow-up|0|||
160659203|NCT01248247|580134468|FG000|Overall Study|Alternative treatment|0|||
160659204|NCT01248247|580134469|FG001|Overall Study|Alternative treatment|1|||
160659205|NCT01248247|580134470|FG002|Overall Study|Alternative treatment|0|||
160659206|NCT01248247|580134471|FG003|Overall Study|Alternative treatment|0|||
160659207|NCT01248247|580134468|FG000|Overall Study|Other|2|||
160659208|NCT01248247|580134469|FG001|Overall Study|Other|8|||
160659209|NCT01248247|580134470|FG002|Overall Study|Other|8|||
160659210|NCT01248247|580134471|FG003|Overall Study|Other|5|||
160659211|NCT01248247|580134468|FG000|Overall Study|Progression|18|||
160659212|NCT01248247|580134469|FG001|Overall Study|Progression|27|||
160659213|NCT01248247|580134470|FG002|Overall Study|Progression|56|||
160659214|NCT01248247|580134471|FG003|Overall Study|Progression|44|||
160659215|NCT01248247|580134468|FG000|Overall Study|Refuse further treatment|0|||
160659216|NCT01248247|580134469|FG001|Overall Study|Refuse further treatment|0|||
160659217|NCT01248247|580134470|FG002|Overall Study|Refuse further treatment|1|||
160659218|NCT01248247|580134471|FG003|Overall Study|Refuse further treatment|2|||
160598201|NCT01998958|579906179|FG008|Open Label Phase (Optional)|Adverse Event|0|||
160598202|NCT01998958|579906180|FG009|Open Label Phase (Optional)|Adverse Event|0|||
160659219|NCT01248247|580134468|FG000|Overall Study|Complicating disease|0|||
160659220|NCT01248247|580134469|FG001|Overall Study|Complicating disease|0|||
160659221|NCT01248247|580134470|FG002|Overall Study|Complicating disease|1|||
160659222|NCT01248247|580134471|FG003|Overall Study|Complicating disease|1|||
160659223|NCT00549718|580134472|FG000|Overall Study|Insufficient clinical response|20|||
160598203|NCT01998958|579906181|FG010|Open Label Phase (Optional)|Adverse Event|0|||
160598204|NCT01998958|579906182|FG011|Open Label Phase (Optional)|Adverse Event|0|||
160598205|NCT01998958|579906183|FG012|Open Label Phase (Optional)|Adverse Event|0|||
160598206|NCT01998958|579906184|FG013|Open Label Phase (Optional)|Adverse Event|0|||
160598207|NCT01998958|579906185|FG014|Open Label Phase (Optional)|Adverse Event|0|||
160598208|NCT01998958|579906186|FG015|Open Label Phase (Optional)|Adverse Event|0|||
160598209|NCT01998958|579906187|FG016|Open Label Phase (Optional)|Adverse Event|0|||
160598210|NCT01998958|579906188|FG017|Open Label Phase (Optional)|Adverse Event|0|||
160598211|NCT01998958|579906189|FG018|Open Label Phase (Optional)|Adverse Event|0|||
160598212|NCT01998958|579906190|FG019|Open Label Phase (Optional)|Adverse Event|0|||
160598213|NCT01998958|579906191|FG020|Open Label Phase (Optional)|Adverse Event|0|||
160598214|NCT01998958|579906192|FG021|Open Label Phase (Optional)|Adverse Event|0|||
160598215|NCT01998958|579906193|FG022|Open Label Phase (Optional)|Adverse Event|0|||
160467456|NCT05325294|579439746|FG001|Overall Study|Withdrawal by Subject|3|||
160467457|NCT05325294|579439745|FG000|Overall Study|Lost to Follow-up|1|||
160467458|NCT05325294|579439746|FG001|Overall Study|Lost to Follow-up|0|||
160467459|NCT05325294|579439745|FG000|Overall Study|Sponsor Request|0|||
160467460|NCT05325294|579439746|FG001|Overall Study|Sponsor Request|2|||
160467461|NCT02488408|579439747|FG000|Part A|Adverse Event|2|||
160467462|NCT02488408|579439748|FG001|Part A|Adverse Event|0|||
160467463|NCT02488408|579439749|FG002|Part A|Adverse Event|0|||
160467464|NCT02488408|579439750|FG003|Part A|Adverse Event|0|||
160467465|NCT02488408|579439751|FG004|Part A|Adverse Event|0|||
160467466|NCT02488408|579439752|FG005|Part A|Adverse Event|0|||
160467467|NCT02488408|579439753|FG006|Part A|Adverse Event|0|||
160598216|NCT01998958|579906194|FG023|Open Label Phase (Optional)|Adverse Event|1|||
160467468|NCT02488408|579439754|FG007|Part A|Adverse Event|0|||
160467469|NCT02488408|579439755|FG008|Part A|Adverse Event|0|||
160467470|NCT02488408|579439756|FG009|Part A|Adverse Event|0|||
160467471|NCT02488408|579439747|FG000|Part A|Death|1|||
160467472|NCT02488408|579439748|FG001|Part A|Death|5|||
160467473|NCT02488408|579439749|FG002|Part A|Death|0|||
160467474|NCT02488408|579439750|FG003|Part A|Death|0|||
160467475|NCT02488408|579439751|FG004|Part A|Death|3|||
160467476|NCT02488408|579439752|FG005|Part A|Death|0|||
160467477|NCT02488408|579439753|FG006|Part A|Death|0|||
160467478|NCT02488408|579439754|FG007|Part A|Death|0|||
160467479|NCT02488408|579439755|FG008|Part A|Death|0|||
160467480|NCT02488408|579439756|FG009|Part A|Death|0|||
160467481|NCT02488408|579439747|FG000|Part A|Disease Progression|2|||
160467482|NCT02488408|579439748|FG001|Part A|Disease Progression|8|||
160467483|NCT02488408|579439749|FG002|Part A|Disease Progression|2|||
160467484|NCT02488408|579439750|FG003|Part A|Disease Progression|3|||
160467485|NCT02488408|579439751|FG004|Part A|Disease Progression|4|||
160467486|NCT02488408|579439752|FG005|Part A|Disease Progression|0|||
160467487|NCT02488408|579439753|FG006|Part A|Disease Progression|0|||
160467488|NCT02488408|579439754|FG007|Part A|Disease Progression|0|||
160467489|NCT02488408|579439755|FG008|Part A|Disease Progression|0|||
160467490|NCT02488408|579439756|FG009|Part A|Disease Progression|0|||
160467491|NCT02488408|579439747|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
160467492|NCT02488408|579439748|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
160467493|NCT02488408|579439749|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
160467494|NCT02488408|579439750|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
160467495|NCT02488408|579439751|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
160467496|NCT02488408|579439752|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
160467497|NCT02488408|579439753|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
160467498|NCT02488408|579439754|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
160467499|NCT02488408|579439755|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
160467500|NCT02488408|579439756|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
160467501|NCT02488408|579439747|FG000|Part A|Investigator Decision|0|||
160467502|NCT02488408|579439748|FG001|Part A|Investigator Decision|1|||
160467503|NCT02488408|579439749|FG002|Part A|Investigator Decision|1|||
160467504|NCT02488408|579439750|FG003|Part A|Investigator Decision|0|||
160467505|NCT02488408|579439751|FG004|Part A|Investigator Decision|0|||
160467506|NCT02488408|579439752|FG005|Part A|Investigator Decision|0|||
160467507|NCT02488408|579439753|FG006|Part A|Investigator Decision|0|||
160467508|NCT02488408|579439754|FG007|Part A|Investigator Decision|0|||
160467509|NCT02488408|579439755|FG008|Part A|Investigator Decision|0|||
160467510|NCT02488408|579439756|FG009|Part A|Investigator Decision|0|||
160467511|NCT02488408|579439747|FG000|Part A|Withdrawal by Subject|0|||
160467512|NCT02488408|579439748|FG001|Part A|Withdrawal by Subject|0|||
160467513|NCT02488408|579439749|FG002|Part A|Withdrawal by Subject|2|||
160467514|NCT02488408|579439750|FG003|Part A|Withdrawal by Subject|0|||
160467515|NCT02488408|579439751|FG004|Part A|Withdrawal by Subject|0|||
160467516|NCT02488408|579439752|FG005|Part A|Withdrawal by Subject|0|||
160467517|NCT02488408|579439753|FG006|Part A|Withdrawal by Subject|0|||
160467518|NCT02488408|579439754|FG007|Part A|Withdrawal by Subject|0|||
160467519|NCT02488408|579439755|FG008|Part A|Withdrawal by Subject|0|||
160467520|NCT02488408|579439756|FG009|Part A|Withdrawal by Subject|0|||
160467521|NCT02488408|579439747|FG000|Part A|Other|1|||
160467522|NCT02488408|579439748|FG001|Part A|Other|0|||
160467523|NCT02488408|579439749|FG002|Part A|Other|0|||
160467524|NCT02488408|579439750|FG003|Part A|Other|0|||
160467525|NCT02488408|579439751|FG004|Part A|Other|0|||
160467526|NCT02488408|579439752|FG005|Part A|Other|0|||
160467527|NCT02488408|579439753|FG006|Part A|Other|0|||
160467528|NCT02488408|579439754|FG007|Part A|Other|0|||
160467529|NCT02488408|579439755|FG008|Part A|Other|0|||
160467530|NCT02488408|579439756|FG009|Part A|Other|0|||
160467531|NCT02488408|579439747|FG000|Part B|Adverse Event|0|||
160467532|NCT02488408|579439748|FG001|Part B|Adverse Event|0|||
160467533|NCT02488408|579439749|FG002|Part B|Adverse Event|0|||
160467534|NCT02488408|579439750|FG003|Part B|Adverse Event|0|||
160467535|NCT02488408|579439751|FG004|Part B|Adverse Event|0|||
160467536|NCT02488408|579439752|FG005|Part B|Adverse Event|2|||
160467537|NCT02488408|579439753|FG006|Part B|Adverse Event|2|||
160467538|NCT02488408|579439754|FG007|Part B|Adverse Event|7|||
160467539|NCT02488408|579439755|FG008|Part B|Adverse Event|2|||
160467540|NCT02488408|579439756|FG009|Part B|Adverse Event|2|||
160467541|NCT02488408|579439747|FG000|Part B|Death|0|||
160467542|NCT02488408|579439748|FG001|Part B|Death|0|||
160467543|NCT02488408|579439749|FG002|Part B|Death|0|||
160467544|NCT02488408|579439750|FG003|Part B|Death|0|||
160467545|NCT02488408|579439751|FG004|Part B|Death|0|||
160467546|NCT02488408|579439752|FG005|Part B|Death|3|||
160467547|NCT02488408|579439753|FG006|Part B|Death|1|||
160467548|NCT02488408|579439754|FG007|Part B|Death|2|||
160467549|NCT02488408|579439755|FG008|Part B|Death|2|||
160467550|NCT02488408|579439756|FG009|Part B|Death|2|||
160467551|NCT02488408|579439747|FG000|Part B|Death due to Disease Progression|0|||
160467552|NCT02488408|579439748|FG001|Part B|Death due to Disease Progression|0|||
160467553|NCT02488408|579439749|FG002|Part B|Death due to Disease Progression|0|||
160467554|NCT02488408|579439750|FG003|Part B|Death due to Disease Progression|0|||
160467555|NCT02488408|579439751|FG004|Part B|Death due to Disease Progression|0|||
160467556|NCT02488408|579439752|FG005|Part B|Death due to Disease Progression|2|||
160467557|NCT02488408|579439753|FG006|Part B|Death due to Disease Progression|2|||
160467558|NCT02488408|579439754|FG007|Part B|Death due to Disease Progression|1|||
160659224|NCT00549718|580134473|FG001|Overall Study|Insufficient clinical response|7|||
160467559|NCT02488408|579439755|FG008|Part B|Death due to Disease Progression|1|||
160467560|NCT02488408|579439756|FG009|Part B|Death due to Disease Progression|1|||
160467561|NCT02488408|579439747|FG000|Part B|Disease Progression|0|||
160467562|NCT02488408|579439748|FG001|Part B|Disease Progression|0|||
160467563|NCT02488408|579439749|FG002|Part B|Disease Progression|0|||
160467564|NCT02488408|579439750|FG003|Part B|Disease Progression|0|||
160467565|NCT02488408|579439751|FG004|Part B|Disease Progression|0|||
160467566|NCT02488408|579439752|FG005|Part B|Disease Progression|6|||
160467567|NCT02488408|579439753|FG006|Part B|Disease Progression|9|||
160467568|NCT02488408|579439754|FG007|Part B|Disease Progression|7|||
160467569|NCT02488408|579439755|FG008|Part B|Disease Progression|9|||
160467570|NCT02488408|579439756|FG009|Part B|Disease Progression|11|||
160467571|NCT02488408|579439747|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
160467572|NCT02488408|579439748|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
160467573|NCT02488408|579439749|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
160467574|NCT02488408|579439750|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
160467575|NCT02488408|579439751|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
160467576|NCT02488408|579439752|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
160467577|NCT02488408|579439753|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
160467578|NCT02488408|579439754|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
160467579|NCT02488408|579439755|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
160467580|NCT02488408|579439756|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
160467581|NCT02488408|579439747|FG000|Part B|Investigator Decision|0|||
160467582|NCT02488408|579439748|FG001|Part B|Investigator Decision|0|||
160467583|NCT02488408|579439749|FG002|Part B|Investigator Decision|0|||
160467584|NCT02488408|579439750|FG003|Part B|Investigator Decision|0|||
160467585|NCT02488408|579439751|FG004|Part B|Investigator Decision|0|||
160467586|NCT02488408|579439752|FG005|Part B|Investigator Decision|0|||
160467587|NCT02488408|579439753|FG006|Part B|Investigator Decision|1|||
160467588|NCT02488408|579439754|FG007|Part B|Investigator Decision|0|||
160467589|NCT02488408|579439755|FG008|Part B|Investigator Decision|2|||
160467590|NCT02488408|579439756|FG009|Part B|Investigator Decision|1|||
160467591|NCT00719888|579439757|FG000|Overall Study|Death|24|||
160467592|NCT00719888|579439758|FG001|Overall Study|Death|9|||
160467593|NCT00719888|579439757|FG000|Overall Study|Relapse|8|||
160467594|NCT00719888|579439758|FG001|Overall Study|Relapse|3|||
160467595|NCT00719888|579439757|FG000|Overall Study|Physician Decision|1|||
160467596|NCT00719888|579439758|FG001|Overall Study|Physician Decision|0|||
160467597|NCT00719888|579439757|FG000|Overall Study|Withdrawal by Subject|1|||
160467598|NCT00719888|579439758|FG001|Overall Study|Withdrawal by Subject|0|||
160467599|NCT00491894|579439759|FG000|Overall Study|Adverse Event|14|||
160467600|NCT00491894|579439759|FG000|Overall Study|Withdrawal by Subject|5|||
160467601|NCT00491894|579439759|FG000|Overall Study|Death|3|||
160467602|NCT00491894|579439759|FG000|Overall Study|Lost to Follow-up|3|||
160467603|NCT00491894|579439759|FG000|Overall Study|Lack of Efficacy|2|||
160467604|NCT00491894|579439759|FG000|Overall Study|Other-Failed to meet any criteria|2|||
160467605|NCT00491894|579439759|FG000|Overall Study|Physician Decision|2|||
160467606|NCT00491894|579439759|FG000|Overall Study|Protocol Violation|2|||
160467607|NCT00491894|579439759|FG000|Overall Study|Other-Intake of prohibited medication|1|||
160467611|NCT04172675|579440895|FG000|Overall Study|Withdrawal by Subject|7|||
160467612|NCT04172675|579440896|FG001|Overall Study|Withdrawal by Subject|5|||
160467613|NCT04172675|579440897|FG002|Overall Study|Withdrawal by Subject|1|||
160467614|NCT04172675|579440898|FG003|Overall Study|Withdrawal by Subject|4|||
160467615|NCT00378898|579440899|FG000|Overall Study|Withdrawal by Subject|10|||
160467616|NCT00378898|579440900|FG001|Overall Study|Withdrawal by Subject|5|||
160467617|NCT00378898|579440899|FG000|Overall Study|Protocol Violation|1|||
160467618|NCT00378898|579440900|FG001|Overall Study|Protocol Violation|1|||
160467619|NCT00551421|579440901|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
160467620|NCT01278030|579440902|FG000|Overall Study|Withdrawal by Subject|8|||
160467621|NCT01278030|579440903|FG001|Overall Study|Withdrawal by Subject|4|||
160598217|NCT01998958|579906195|FG024|Open Label Phase (Optional)|Adverse Event|0|||
160598218|NCT01998958|579906196|FG025|Open Label Phase (Optional)|Adverse Event|0|||
160598219|NCT01998958|579906197|FG026|Open Label Phase (Optional)|Adverse Event|0|||
160598220|NCT01998958|579906198|FG027|Open Label Phase (Optional)|Adverse Event|0|||
160467622|NCT05815342|579440907|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
160467623|NCT05815342|579440907|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
160467624|NCT05815342|579440907|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
160467625|NCT05815342|579440907|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
160598221|NCT01998958|579906199|FG028|Open Label Phase (Optional)|Adverse Event|0|||
160598222|NCT01998958|579906200|FG029|Open Label Phase (Optional)|Adverse Event|0|||
160598223|NCT01998958|579906201|FG030|Open Label Phase (Optional)|Adverse Event|0|||
160598224|NCT01998958|579906202|FG031|Open Label Phase (Optional)|Adverse Event|0|||
160598225|NCT01998958|579906171|FG000|Open Label Phase (Optional)|Other|0|||
160598226|NCT01998958|579906172|FG001|Open Label Phase (Optional)|Other|0|||
160598227|NCT01998958|579906173|FG002|Open Label Phase (Optional)|Other|0|||
160598228|NCT01998958|579906174|FG003|Open Label Phase (Optional)|Other|0|||
160598229|NCT01998958|579906175|FG004|Open Label Phase (Optional)|Other|0|||
160598230|NCT01998958|579906176|FG005|Open Label Phase (Optional)|Other|0|||
160598231|NCT01998958|579906177|FG006|Open Label Phase (Optional)|Other|0|||
160598232|NCT01998958|579906178|FG007|Open Label Phase (Optional)|Other|0|||
160598233|NCT01998958|579906179|FG008|Open Label Phase (Optional)|Other|0|||
160598234|NCT01998958|579906180|FG009|Open Label Phase (Optional)|Other|0|||
160598235|NCT01998958|579906181|FG010|Open Label Phase (Optional)|Other|0|||
160598236|NCT01998958|579906182|FG011|Open Label Phase (Optional)|Other|0|||
160598237|NCT01998958|579906183|FG012|Open Label Phase (Optional)|Other|0|||
160467626|NCT05815342|579440907|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
160467627|NCT00745875|579440912|FG000|Overall Study|Continuing study treatment|4|||
160467628|NCT00745875|579440913|FG001|Overall Study|Continuing study treatment|4|||
160467629|NCT03220724|579440918|FG000|Overall Study|Lost to Follow-up|2|||
160467630|NCT03220724|579440919|FG001|Overall Study|Lost to Follow-up|2|||
160467631|NCT03220724|579440920|FG002|Overall Study|Lost to Follow-up|0|||
160467632|NCT03220724|579440921|FG003|Overall Study|Lost to Follow-up|3|||
160598238|NCT01998958|579906184|FG013|Open Label Phase (Optional)|Other|0|||
160598239|NCT01998958|579906185|FG014|Open Label Phase (Optional)|Other|0|||
160598240|NCT01998958|579906186|FG015|Open Label Phase (Optional)|Other|0|||
160598241|NCT01998958|579906187|FG016|Open Label Phase (Optional)|Other|0|||
160467633|NCT03220724|579440922|FG004|Overall Study|Lost to Follow-up|1|||
160467634|NCT03220724|579440923|FG005|Overall Study|Lost to Follow-up|0|||
160467635|NCT03220724|579440924|FG006|Overall Study|Lost to Follow-up|2|||
160467636|NCT03220724|579440925|FG007|Overall Study|Lost to Follow-up|1|||
160598242|NCT01998958|579906188|FG017|Open Label Phase (Optional)|Other|0|||
160598243|NCT01998958|579906189|FG018|Open Label Phase (Optional)|Other|0|||
160598244|NCT01998958|579906190|FG019|Open Label Phase (Optional)|Other|0|||
160598245|NCT01998958|579906191|FG020|Open Label Phase (Optional)|Other|0|||
160467637|NCT03220724|579440926|FG008|Overall Study|Lost to Follow-up|0|||
160467638|NCT03220724|579440918|FG000|Overall Study|Withdrawal by Subject|1|||
160467639|NCT03220724|579440919|FG001|Overall Study|Withdrawal by Subject|0|||
160467640|NCT03220724|579440920|FG002|Overall Study|Withdrawal by Subject|1|||
160467641|NCT03220724|579440921|FG003|Overall Study|Withdrawal by Subject|0|||
160467642|NCT03220724|579440922|FG004|Overall Study|Withdrawal by Subject|0|||
160467643|NCT03220724|579440923|FG005|Overall Study|Withdrawal by Subject|0|||
160467644|NCT03220724|579440924|FG006|Overall Study|Withdrawal by Subject|0|||
160467645|NCT03220724|579440925|FG007|Overall Study|Withdrawal by Subject|0|||
160467646|NCT03220724|579440926|FG008|Overall Study|Withdrawal by Subject|0|||
160467647|NCT01613417|579440927|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
160467648|NCT01613417|579440928|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
160467649|NCT02000752|579440931|FG000|Overall Study|Dystocic delivery|19|||
160467650|NCT02000752|579440932|FG001|Overall Study|Dystocic delivery|8|||
160467651|NCT02000752|579440931|FG000|Overall Study|Shift Changes|12|||
160467652|NCT02000752|579440932|FG001|Overall Study|Shift Changes|5|||
160467653|NCT00019604|579440934|FG000|Overall Study|Death|1|||
160467654|NCT00019604|579440934|FG000|Overall Study|Progressive disease|23|||
160467655|NCT00019604|579440934|FG000|Overall Study|Refused treatment|1|||
160467656|NCT00019604|579440934|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
160467657|NCT00019604|579440934|FG000|Overall Study|Going to have liver transplant|1|||
160467658|NCT00019604|579440934|FG000|Overall Study|Move to a different study|1|||
160467659|NCT00019604|579440934|FG000|Overall Study|Non compliant on systemic CH|1|||
160467660|NCT00019604|579440934|FG000|Overall Study|Non compliant|1|||
160467661|NCT00019604|579440934|FG000|Overall Study|Resectable disease|1|||
160467662|NCT00019604|579440934|FG000|Overall Study|Started new chemo regimen|1|||
160467663|NCT00019604|579440934|FG000|Overall Study|Pt going to immunotherapy study|1|||
160467664|NCT00019604|579440934|FG000|Overall Study|Too much disease|1|||
160467665|NCT00019604|579440934|FG000|Overall Study|Unable to evaluate|1|||
160467666|NCT00019604|579440934|FG000|Overall Study|Details for other not available|4|||
160467667|NCT03392194|579440936|FG000|Overall Study|Withdrawal by Subject|1|||
160467668|NCT03392194|579440937|FG001|Overall Study|Withdrawal by Subject|2|||
160467669|NCT03392194|579440936|FG000|Overall Study|Conflicts with personal schedule|1|||
160467670|NCT03392194|579440937|FG001|Overall Study|Conflicts with personal schedule|0|||
160467671|NCT00620854|579440940|FG000|Washout 1|Withdrawal by Subject|0|||
160467672|NCT00620854|579440941|FG001|Washout 1|Withdrawal by Subject|0|||
160467673|NCT00620854|579440942|FG002|Washout 1|Withdrawal by Subject|1|||
160467674|NCT00620854|579440943|FG003|Washout 1|Withdrawal by Subject|1|||
160467675|NCT00620854|579440944|FG004|Washout 1|Withdrawal by Subject|0|||
160467676|NCT00620854|579440945|FG005|Washout 1|Withdrawal by Subject|0|||
160467677|NCT00093496|579440948|FG000|Overall Study|Protocol Violation|1|||
160467678|NCT00093496|579440949|FG001|Overall Study|Protocol Violation|3|||
160467679|NCT00586313|579440950|FG000|Overall Study|Lack of Efficacy|2|||
160467680|NCT03205566|579440955|FG000|Phase 1|Protocol Violation|1|||
160467681|NCT03205566|579440956|FG001|Phase 1|Protocol Violation|1|||
160467682|NCT01170208|579440959|FG000|Overall Study|Withdrawal by Subject|5|||
160467683|NCT01170208|579440960|FG001|Overall Study|Withdrawal by Subject|0|||
160467684|NCT01170208|579440961|FG002|Overall Study|Withdrawal by Subject|1|||
160467685|NCT01170208|579440959|FG000|Overall Study|Protocol Violation|1|||
160467686|NCT01170208|579440960|FG001|Overall Study|Protocol Violation|0|||
160467687|NCT01170208|579440961|FG002|Overall Study|Protocol Violation|1|||
160467688|NCT03113409|579440962|FG000|Overall Study|Withdrawal by Subject|5|||
160467689|NCT03113409|579440963|FG001|Overall Study|Withdrawal by Subject|0|||
160467690|NCT03113409|579440964|FG002|Overall Study|Withdrawal by Subject|0|||
160467691|NCT04971733|579440965|FG000|Overall Study|Adverse Event|1|||
160467692|NCT04971733|579440966|FG001|Overall Study|Adverse Event|1|||
160467693|NCT04971733|579440965|FG000|Overall Study|Subject choice|2|||
160467694|NCT04971733|579440966|FG001|Overall Study|Subject choice|0|||
160467695|NCT04971733|579440965|FG000|Overall Study|Withdrawal by Subject|1|||
160467696|NCT04971733|579440966|FG001|Overall Study|Withdrawal by Subject|0|||
160467697|NCT04971733|579440965|FG000|Overall Study|Other|1|||
160467698|NCT04971733|579440966|FG001|Overall Study|Other|0|||
160467699|NCT01160354|579440967|FG000|Overall Study|Death|0|||
160467700|NCT01160354|579440968|FG001|Overall Study|Death|1|||
160467701|NCT01160354|579440969|FG002|Overall Study|Death|1|||
160467702|NCT00600353|579440973|FG000|Overall Study|history of malignancy within 5 years|1|||
160467703|NCT00600353|579440974|FG001|Overall Study|history of malignancy within 5 years|0|||
160467704|NCT00600353|579440973|FG000|Overall Study|History of prepartive regimen|0|||
160467705|NCT00600353|579440974|FG001|Overall Study|History of prepartive regimen|1|||
160467706|NCT04941482|579440975|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
160467707|NCT04941482|579440976|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
160467708|NCT04200664|579440977|FG000|Overall Study|Withdrawal by Subject|1|||
160467709|NCT04200664|579440978|FG001|Overall Study|Withdrawal by Subject|0|||
160467710|NCT04200664|579440979|FG002|Overall Study|Withdrawal by Subject|0|||
160467711|NCT03362190|579440982|FG000|Overall Study|Adverse Event|0|||
160467712|NCT03362190|579440983|FG001|Overall Study|Adverse Event|0|||
160467713|NCT03362190|579440984|FG002|Overall Study|Adverse Event|0|||
160467714|NCT03362190|579440985|FG003|Overall Study|Adverse Event|1|||
160467715|NCT03362190|579440982|FG000|Overall Study|Withdrawal by Subject|0|||
160659225|NCT00549718|580134474|FG002|Overall Study|Insufficient clinical response|18|||
160659226|NCT00549718|580134475|FG003|Overall Study|Insufficient clinical response|32|||
160659227|NCT00549718|580134472|FG000|Overall Study|Adverse Event|6|||
160467716|NCT03362190|579440983|FG001|Overall Study|Withdrawal by Subject|0|||
160467717|NCT03362190|579440984|FG002|Overall Study|Withdrawal by Subject|0|||
160467718|NCT03362190|579440985|FG003|Overall Study|Withdrawal by Subject|1|||
160467719|NCT00687219|579440986|FG000|Overall Study|Adverse Event|8|||
160467720|NCT00687219|579440986|FG000|Overall Study|Discontinuance criteria met|7|||
160467721|NCT00687219|579440986|FG000|Overall Study|HCV-RNA positive conversion|34|||
160467722|NCT00687219|579440986|FG000|Overall Study|Withdrawal by Subject|1|||
160467723|NCT00687219|579440986|FG000|Overall Study|Lack of Efficacy|1|||
160467724|NCT02063659|579440994|FG000|Double-Blind Treatment Period|Adverse Event|1|||
160467725|NCT02063659|579440995|FG001|Double-Blind Treatment Period|Adverse Event|2|||
160467726|NCT02063659|579440996|FG002|Double-Blind Treatment Period|Adverse Event|0|||
160467727|NCT02063659|579440997|FG003|Double-Blind Treatment Period|Adverse Event|0|||
160467728|NCT02063659|579440994|FG000|Double-Blind Treatment Period|Physician Decision|1|||
160467729|NCT02063659|579440995|FG001|Double-Blind Treatment Period|Physician Decision|0|||
160467730|NCT02063659|579440996|FG002|Double-Blind Treatment Period|Physician Decision|0|||
160467731|NCT02063659|579440997|FG003|Double-Blind Treatment Period|Physician Decision|0|||
160467732|NCT02063659|579440994|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
160467733|NCT02063659|579440995|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
160467734|NCT02063659|579440996|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
160467735|NCT02063659|579440997|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
160467736|NCT02063659|579440994|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
160467737|NCT02063659|579440995|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
160467738|NCT02063659|579440996|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
160467739|NCT02063659|579440997|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
160467740|NCT02063659|579440994|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
160467741|NCT02063659|579440995|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
160467742|NCT02063659|579440996|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
160467743|NCT02063659|579440997|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
160467744|NCT02063659|579440994|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
160467745|NCT02063659|579440995|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
160467746|NCT02063659|579440996|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
160467747|NCT02063659|579440997|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
160467748|NCT02063659|579440994|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
160467749|NCT02063659|579440995|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
160467750|NCT02063659|579440996|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
160467751|NCT02063659|579440997|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
160467752|NCT02063659|579440994|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
160467753|NCT02063659|579440995|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
160467754|NCT02063659|579440996|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
160467755|NCT02063659|579440997|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
160467756|NCT04300023|579441000|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
160467757|NCT04300023|579441001|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
160467758|NCT04057131|579441002|FG000|Overall Study|Protocol Violation|24|||
160467759|NCT02830204|579441003|FG000|Overall Study|Death|9|||
160467760|NCT02830204|579441003|FG000|Overall Study|Withdrawal by Subject|1|||
160467761|NCT00748709|579441008|FG000|Overall Study|Progressive disease|15|||
160467762|NCT00748709|579441008|FG000|Overall Study|Drug reducing Toxity|2|||
160467763|NCT00748709|579441008|FG000|Overall Study|Other Adverse Event|1|||
160467764|NCT00748709|579441008|FG000|Overall Study|Withdrawal by Subject|1|||
160467765|NCT00748709|579441008|FG000|Overall Study|Other Reasons|1|||
160467766|NCT05422339|579442429|FG000|Overall Study|Withdrawal by Subject|17|||
160467767|NCT05422339|579442430|FG001|Overall Study|Withdrawal by Subject|15|||
160467768|NCT03070392|579442437|FG000|Overall Study|Not Treated|7|||
160467769|NCT03070392|579442438|FG001|Overall Study|Not Treated|0|||
160467770|NCT03070392|579442439|FG002|Overall Study|Not Treated|3|||
160467771|NCT03070392|579442440|FG003|Overall Study|Not Treated|12|||
160467772|NCT03070392|579442437|FG000|Overall Study|Death|3|||
160467773|NCT03070392|579442438|FG001|Overall Study|Death|0|||
160467774|NCT03070392|579442439|FG002|Overall Study|Death|0|||
160467775|NCT03070392|579442440|FG003|Overall Study|Death|1|||
160659228|NCT00549718|580134473|FG001|Overall Study|Adverse Event|8|||
160659229|NCT00549718|580134474|FG002|Overall Study|Adverse Event|7|||
160467776|NCT03070392|579442437|FG000|Overall Study|Withdrawal by Subject|7|||
160467777|NCT03070392|579442438|FG001|Overall Study|Withdrawal by Subject|0|||
160467778|NCT03070392|579442439|FG002|Overall Study|Withdrawal by Subject|0|||
160467779|NCT03070392|579442440|FG003|Overall Study|Withdrawal by Subject|3|||
160467780|NCT03070392|579442437|FG000|Overall Study|Physician Decision|1|||
160467781|NCT03070392|579442438|FG001|Overall Study|Physician Decision|0|||
160467782|NCT03070392|579442439|FG002|Overall Study|Physician Decision|0|||
160467783|NCT03070392|579442440|FG003|Overall Study|Physician Decision|2|||
160467784|NCT03070392|579442437|FG000|Overall Study|Progressive Disease|154|||
160467785|NCT03070392|579442438|FG001|Overall Study|Progressive Disease|6|||
160467786|NCT03070392|579442439|FG002|Overall Study|Progressive Disease|2|||
160467787|NCT03070392|579442440|FG003|Overall Study|Progressive Disease|70|||
160467788|NCT03070392|579442437|FG000|Overall Study|Adverse Event|6|||
160467789|NCT03070392|579442438|FG001|Overall Study|Adverse Event|1|||
160467790|NCT03070392|579442439|FG002|Overall Study|Adverse Event|1|||
160467791|NCT03070392|579442440|FG003|Overall Study|Adverse Event|3|||
160467792|NCT03070392|579442437|FG000|Overall Study|Alternate anticancer treatment|1|||
160467793|NCT03070392|579442438|FG001|Overall Study|Alternate anticancer treatment|0|||
160467794|NCT03070392|579442439|FG002|Overall Study|Alternate anticancer treatment|0|||
160467795|NCT03070392|579442440|FG003|Overall Study|Alternate anticancer treatment|1|||
160467796|NCT03070392|579442437|FG000|Overall Study|Ongoing|73|||
160467797|NCT03070392|579442438|FG001|Overall Study|Ongoing|0|||
160467798|NCT03070392|579442439|FG002|Overall Study|Ongoing|0|||
160467799|NCT03070392|579442440|FG003|Overall Study|Ongoing|11|||
160467800|NCT03678688|579442441|FG000|Overall Study|Reason not Specified|0|||
160467801|NCT03678688|579442442|FG001|Overall Study|Reason not Specified|0|||
160467802|NCT03678688|579442443|FG002|Overall Study|Reason not Specified|3|||
160467803|NCT03678688|579442444|FG003|Overall Study|Reason not Specified|0|||
160467804|NCT03678688|579442445|FG004|Overall Study|Reason not Specified|1|||
160467805|NCT03678688|579442446|FG005|Overall Study|Reason not Specified|0|||
160467806|NCT03678688|579442447|FG006|Overall Study|Reason not Specified|0|||
160467807|NCT03678688|579442448|FG007|Overall Study|Reason not Specified|0|||
160467808|NCT03678688|579442449|FG008|Overall Study|Reason not Specified|0|||
160467809|NCT03678688|579442441|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
160467810|NCT03678688|579442442|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
160467811|NCT03678688|579442443|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
160467812|NCT03678688|579442444|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
160467813|NCT03678688|579442445|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
160467814|NCT03678688|579442446|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
160467815|NCT03678688|579442447|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
160467816|NCT03678688|579442448|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
160467817|NCT03678688|579442449|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
160467818|NCT03678688|579442441|FG000|Overall Study|Covid Related Adverse Event|0|||
160467819|NCT03678688|579442442|FG001|Overall Study|Covid Related Adverse Event|0|||
160467820|NCT03678688|579442443|FG002|Overall Study|Covid Related Adverse Event|0|||
160467821|NCT03678688|579442444|FG003|Overall Study|Covid Related Adverse Event|0|||
160467822|NCT03678688|579442445|FG004|Overall Study|Covid Related Adverse Event|0|||
160467823|NCT03678688|579442446|FG005|Overall Study|Covid Related Adverse Event|3|||
160467824|NCT03678688|579442447|FG006|Overall Study|Covid Related Adverse Event|1|||
160467825|NCT03678688|579442448|FG007|Overall Study|Covid Related Adverse Event|1|||
160467826|NCT03678688|579442449|FG008|Overall Study|Covid Related Adverse Event|0|||
160467827|NCT03678688|579442441|FG000|Overall Study|Physician Decision|0|||
160467828|NCT03678688|579442442|FG001|Overall Study|Physician Decision|0|||
160467829|NCT03678688|579442443|FG002|Overall Study|Physician Decision|0|||
160467830|NCT03678688|579442444|FG003|Overall Study|Physician Decision|0|||
160467831|NCT03678688|579442445|FG004|Overall Study|Physician Decision|0|||
160467832|NCT03678688|579442446|FG005|Overall Study|Physician Decision|1|||
160467833|NCT03678688|579442447|FG006|Overall Study|Physician Decision|0|||
160467834|NCT03678688|579442448|FG007|Overall Study|Physician Decision|0|||
160467835|NCT03678688|579442449|FG008|Overall Study|Physician Decision|0|||
160467836|NCT03678688|579442441|FG000|Overall Study|Withdrawal by Subject|0|||
160467837|NCT03678688|579442442|FG001|Overall Study|Withdrawal by Subject|0|||
160467838|NCT03678688|579442443|FG002|Overall Study|Withdrawal by Subject|0|||
160467839|NCT03678688|579442444|FG003|Overall Study|Withdrawal by Subject|0|||
160467840|NCT03678688|579442445|FG004|Overall Study|Withdrawal by Subject|0|||
160467841|NCT03678688|579442446|FG005|Overall Study|Withdrawal by Subject|0|||
160467842|NCT03678688|579442447|FG006|Overall Study|Withdrawal by Subject|2|||
160598246|NCT01998958|579906192|FG021|Open Label Phase (Optional)|Other|0|||
160598247|NCT01998958|579906193|FG022|Open Label Phase (Optional)|Other|5|||
160467843|NCT03678688|579442448|FG007|Overall Study|Withdrawal by Subject|1|||
160467844|NCT03678688|579442449|FG008|Overall Study|Withdrawal by Subject|0|||
160467845|NCT02534233|579442455|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
160467846|NCT03136159|579442456|FG000|Overall Study|chorioamnionitis|2|||
160467847|NCT03136159|579442457|FG001|Overall Study|chorioamnionitis|0|||
160467848|NCT03136159|579442456|FG000|Overall Study|vertical skin incision|1|||
160467849|NCT03136159|579442457|FG001|Overall Study|vertical skin incision|0|||
160467850|NCT03136159|579442456|FG000|Overall Study|additional dressing|1|||
160598248|NCT01998958|579906194|FG023|Open Label Phase (Optional)|Other|1|||
160467851|NCT03136159|579442457|FG001|Overall Study|additional dressing|0|||
160467852|NCT03136159|579442456|FG000|Overall Study|never got dressing placed|1|||
160467853|NCT03136159|579442457|FG001|Overall Study|never got dressing placed|0|||
160598249|NCT01998958|579906195|FG024|Open Label Phase (Optional)|Other|0|||
160467854|NCT03823703|579442458|FG000|Overall Study|Sponsor request|0|||
160467855|NCT03823703|579442459|FG001|Overall Study|Sponsor request|3|||
160467856|NCT03823703|579442460|FG002|Overall Study|Sponsor request|4|||
160467857|NCT03823703|579442458|FG000|Overall Study|Adverse Event|3|||
160467858|NCT03823703|579442459|FG001|Overall Study|Adverse Event|1|||
160467859|NCT03823703|579442460|FG002|Overall Study|Adverse Event|0|||
160467860|NCT03823703|579442458|FG000|Overall Study|Withdrawal by Subject|0|||
160467861|NCT03823703|579442459|FG001|Overall Study|Withdrawal by Subject|1|||
160467862|NCT03823703|579442460|FG002|Overall Study|Withdrawal by Subject|0|||
160467863|NCT00925548|579442461|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
160467864|NCT00925548|579442462|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
160467865|NCT00458783|579442464|FG000|Overall Study|Protocol Violation|1228|||
160467866|NCT00458783|579442465|FG001|Overall Study|Protocol Violation|1220|||
160467867|NCT01737398|579442466|FG000|Overall Study|Adverse event or SAE|16|||
160467868|NCT01737398|579442467|FG001|Overall Study|Adverse event or SAE|1|||
160467869|NCT01737398|579442466|FG000|Overall Study|Stopping rule met|2|||
160467870|NCT01737398|579442467|FG001|Overall Study|Stopping rule met|1|||
160467871|NCT01737398|579442466|FG000|Overall Study|Voluntary withdrawal|2|||
160467872|NCT01737398|579442467|FG001|Overall Study|Voluntary withdrawal|3|||
160467873|NCT01737398|579442466|FG000|Overall Study|Ineligibility|1|||
160467874|NCT01737398|579442467|FG001|Overall Study|Ineligibility|0|||
160467875|NCT01737398|579442466|FG000|Overall Study|Liver transplant|1|||
160467876|NCT01737398|579442467|FG001|Overall Study|Liver transplant|0|||
160467877|NCT01737398|579442466|FG000|Overall Study|Disease progression|2|||
160467878|NCT01737398|579442467|FG001|Overall Study|Disease progression|3|||
160467879|NCT01737398|579442466|FG000|Overall Study|Sponsor's decision|2|||
160467880|NCT01737398|579442467|FG001|Overall Study|Sponsor's decision|0|||
160467881|NCT00089609|579442468|FG000|Overall Study|Withdrawal by Subject|3|||
160467882|NCT00089609|579442469|FG001|Overall Study|Withdrawal by Subject|1|||
160467883|NCT00357994|579442470|FG000|Overall Study|Adverse Event|1|||
160467884|NCT00357994|579442471|FG001|Overall Study|Adverse Event|2|||
160467885|NCT00357994|579442470|FG000|Overall Study|Lack of Efficacy|0|||
160467886|NCT00357994|579442471|FG001|Overall Study|Lack of Efficacy|1|||
160467887|NCT00357994|579442470|FG000|Overall Study|Protocol Violation|1|||
160467888|NCT00357994|579442471|FG001|Overall Study|Protocol Violation|0|||
160467889|NCT01833455|579442472|FG000|Overall Study|Withdrawal by Subject|1|||
160467890|NCT01833455|579442473|FG001|Overall Study|Withdrawal by Subject|0|||
160467891|NCT00047385|579442474|FG000|Overall Study|Death before any screening|2|||
160467892|NCT00047385|579442475|FG001|Overall Study|Death before any screening|5|||
160467893|NCT00047385|579442474|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
160467894|NCT00047385|579442475|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
160467895|NCT00047385|579442474|FG000|Overall Study|Eligible for screening but had no screen|260|||
160467896|NCT00047385|579442475|FG001|Overall Study|Eligible for screening but had no screen|492|||
160467897|NCT03865732|579442476|FG000|Overall Study|Adverse Event|0|||
160467898|NCT03865732|579442477|FG001|Overall Study|Adverse Event|1|||
160467899|NCT02095145|579442480|FG000|Overall Study|Withdrawal by Subject|1|||
160467900|NCT02095145|579442481|FG001|Overall Study|Withdrawal by Subject|0|||
160467901|NCT03184987|579442484|FG000|Overall Study|Withdrawal by Subject|0|||
160467902|NCT03184987|579442485|FG001|Overall Study|Withdrawal by Subject|1|||
160467903|NCT03184987|579442486|FG002|Overall Study|Withdrawal by Subject|2|||
160467904|NCT03184987|579442484|FG000|Overall Study|Physician Decision|0|||
160467905|NCT03184987|579442485|FG001|Overall Study|Physician Decision|0|||
160467906|NCT03184987|579442486|FG002|Overall Study|Physician Decision|1|||
160467907|NCT03184987|579442484|FG000|Overall Study|Adverse Event|1|||
160467908|NCT03184987|579442485|FG001|Overall Study|Adverse Event|0|||
160467909|NCT03184987|579442486|FG002|Overall Study|Adverse Event|1|||
160467910|NCT00853580|579442487|FG000|Overall Study|Lost to Follow-up|3|||
160467911|NCT00853580|579442488|FG001|Overall Study|Lost to Follow-up|5|||
160467912|NCT00853580|579442487|FG000|Overall Study|Protocol Violation|2|||
160467913|NCT00853580|579442488|FG001|Overall Study|Protocol Violation|1|||
160467914|NCT00853580|579442487|FG000|Overall Study|Withdrawal by Subject|2|||
160467915|NCT00853580|579442488|FG001|Overall Study|Withdrawal by Subject|8|||
160467916|NCT00853580|579442487|FG000|Overall Study|Commenced contraindicated therapy|0|||
160467917|NCT00853580|579442488|FG001|Overall Study|Commenced contraindicated therapy|2|||
160467918|NCT01767467|579442489|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
160467919|NCT01767467|579442490|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
160467920|NCT01767467|579442489|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
160467921|NCT01767467|579442490|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
160467922|NCT01767467|579442489|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
160467923|NCT01767467|579442490|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
160467924|NCT01767467|579442489|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
160467925|NCT01767467|579442490|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
160467926|NCT01767467|579442489|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
160467927|NCT01767467|579442490|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
160598250|NCT01998958|579906196|FG025|Open Label Phase (Optional)|Other|0|||
160598251|NCT01998958|579906197|FG026|Open Label Phase (Optional)|Other|0|||
160598252|NCT01998958|579906198|FG027|Open Label Phase (Optional)|Other|0|||
160598253|NCT01998958|579906199|FG028|Open Label Phase (Optional)|Other|0|||
160598254|NCT01998958|579906200|FG029|Open Label Phase (Optional)|Other|0|||
160598255|NCT01998958|579906201|FG030|Open Label Phase (Optional)|Other|0|||
160598256|NCT01998958|579906202|FG031|Open Label Phase (Optional)|Other|0|||
160598257|NCT01998958|579906171|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
160467928|NCT01767467|579442489|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
160467929|NCT01767467|579442490|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
160467930|NCT01767467|579442489|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
160467931|NCT01767467|579442490|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
160467932|NCT01767467|579442489|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
160467933|NCT01767467|579442490|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
160467934|NCT01767467|579442489|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
160467935|NCT01767467|579442490|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
160467936|NCT01767467|579442489|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
160467937|NCT01767467|579442490|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
160467938|NCT01767467|579442489|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
160467939|NCT01767467|579442490|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
160467940|NCT01767467|579442489|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
160467941|NCT01767467|579442490|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
160467942|NCT01767467|579442489|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
160467943|NCT01767467|579442490|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
160467944|NCT01767467|579442489|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
160467945|NCT01767467|579442490|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
160467946|NCT02203799|579442493|FG000|Overall Study|Withdrawal by Subject|3|||
160467947|NCT03335488|579442494|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
160467948|NCT03335488|579442495|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
160467949|NCT03335488|579442494|FG000|Safety Extension Period|Adverse Event|1|||
160467950|NCT03335488|579442495|FG001|Safety Extension Period|Adverse Event|0|||
160467951|NCT03335488|579442494|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
160467952|NCT03335488|579442495|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
160467953|NCT01801007|579442498|FG000|Overall Study|Adverse Event|2|||
160467954|NCT01801007|579442498|FG000|Overall Study|Lost to Follow-up|4|||
160467955|NCT01801007|579442498|FG000|Overall Study|Withdrawal by Subject|5|||
160467956|NCT02743819|579442499|FG000|Overall Study|Lack of Efficacy|5|||
160467957|NCT02743819|579442499|FG000|Overall Study|Death|2|||
160467958|NCT02743819|579442499|FG000|Overall Study|Adverse Event|1|||
160467959|NCT04745676|579442500|FG000|Overall Study|Death|1|||
160467960|NCT04745676|579442501|FG001|Overall Study|Death|0|||
160467961|NCT04745676|579442502|FG002|Overall Study|Death|0|||
160467962|NCT03102034|579442505|FG000|Overall Study|Withdrawal by Subject|1|||
160467963|NCT03102034|579442506|FG001|Overall Study|Withdrawal by Subject|0|||
160467964|NCT00145470|579442507|FG000|Overall Study|Adverse Event|19|||
160467965|NCT00145470|579442508|FG001|Overall Study|Adverse Event|25|||
160467966|NCT00145470|579442507|FG000|Overall Study|Lack of Efficacy|27|||
160467967|NCT00145470|579442508|FG001|Overall Study|Lack of Efficacy|13|||
160467968|NCT00145470|579442507|FG000|Overall Study|Withdrawal by Subject|36|||
160467969|NCT00145470|579442508|FG001|Overall Study|Withdrawal by Subject|34|||
160467970|NCT00145470|579442507|FG000|Overall Study|Lost to Follow-up|21|||
160467971|NCT00145470|579442508|FG001|Overall Study|Lost to Follow-up|17|||
160467972|NCT00145470|579442507|FG000|Overall Study|Reason Not Reported|9|||
160467973|NCT00145470|579442508|FG001|Overall Study|Reason Not Reported|9|||
160467974|NCT00676091|579442510|FG000|Infant Series|Parent or legal guardian request|10|||
160467975|NCT00676091|579442511|FG001|Infant Series|Parent or legal guardian request|8|||
160467976|NCT00676091|579442510|FG000|Infant Series|Protocol Violation|6|||
160467977|NCT00676091|579442511|FG001|Infant Series|Protocol Violation|3|||
160467978|NCT00676091|579442510|FG000|Infant Series|Adverse Event|2|||
160598258|NCT01998958|579906172|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598259|NCT01998958|579906173|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598260|NCT01998958|579906174|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598261|NCT01998958|579906175|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598262|NCT01998958|579906176|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598263|NCT01998958|579906177|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598264|NCT01998958|579906178|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598265|NCT01998958|579906179|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598266|NCT01998958|579906180|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
160467979|NCT00676091|579442511|FG001|Infant Series|Adverse Event|3|||
160467980|NCT00676091|579442510|FG000|Infant Series|Failed to return|1|||
160467981|NCT00676091|579442511|FG001|Infant Series|Failed to return|3|||
160598267|NCT01998958|579906181|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598268|NCT01998958|579906182|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
160467982|NCT00676091|579442510|FG000|Infant Series|Lost to Follow-up|1|||
160467983|NCT00676091|579442511|FG001|Infant Series|Lost to Follow-up|0|||
160467984|NCT00676091|579442510|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
160467985|NCT00676091|579442511|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
160598269|NCT01998958|579906183|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598270|NCT01998958|579906184|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598271|NCT01998958|579906185|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598272|NCT01998958|579906186|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598273|NCT01998958|579906187|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598274|NCT01998958|579906188|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598275|NCT01998958|579906189|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598276|NCT01998958|579906190|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598277|NCT01998958|579906191|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598278|NCT01998958|579906192|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598279|NCT01998958|579906193|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
160598280|NCT01998958|579906194|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598281|NCT01998958|579906195|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598282|NCT01998958|579906196|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598283|NCT01998958|579906197|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598284|NCT01998958|579906198|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598285|NCT01998958|579906199|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598286|NCT01998958|579906200|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598287|NCT01998958|579906201|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598288|NCT01998958|579906202|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
160598289|NCT01998958|579906171|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598290|NCT01998958|579906172|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598291|NCT01998958|579906173|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598292|NCT01998958|579906174|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598293|NCT01998958|579906175|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598294|NCT01998958|579906176|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598295|NCT01998958|579906177|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598296|NCT01998958|579906178|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598297|NCT01998958|579906179|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598298|NCT01998958|579906180|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598299|NCT01998958|579906181|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598300|NCT01998958|579906182|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598301|NCT01998958|579906183|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598302|NCT01998958|579906184|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598303|NCT01998958|579906185|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598304|NCT01998958|579906186|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598305|NCT01998958|579906187|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598306|NCT01998958|579906188|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598307|NCT01998958|579906189|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598308|NCT01998958|579906190|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598309|NCT01998958|579906191|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598310|NCT01998958|579906192|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
160598311|NCT01998958|579906193|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
160598312|NCT01998958|579906194|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598313|NCT01998958|579906195|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598314|NCT01998958|579906196|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598315|NCT01998958|579906197|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598316|NCT01998958|579906198|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598317|NCT01998958|579906199|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598318|NCT01998958|579906200|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598319|NCT01998958|579906201|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598320|NCT01998958|579906202|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
160598321|NCT01998958|579906171|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598322|NCT01998958|579906172|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598323|NCT01998958|579906173|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598324|NCT01998958|579906174|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598325|NCT01998958|579906175|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598326|NCT01998958|579906176|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598327|NCT01998958|579906177|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598328|NCT01998958|579906178|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598329|NCT01998958|579906179|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160659230|NCT00549718|580134475|FG003|Overall Study|Adverse Event|3|||
160659231|NCT00549718|580134472|FG000|Overall Study|Lost to Follow-up|4|||
160598330|NCT01998958|579906180|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160467986|NCT00676091|579442510|FG000|After Infant Series|Adverse Event|0|||
160467987|NCT00676091|579442511|FG001|After Infant Series|Adverse Event|1|||
160467988|NCT00676091|579442510|FG000|After Infant Series|Protocol Violation|0|||
160467989|NCT00676091|579442511|FG001|After Infant Series|Protocol Violation|1|||
160467990|NCT00676091|579442510|FG000|After Infant Series|Failed to return|1|||
160467991|NCT00676091|579442511|FG001|After Infant Series|Failed to return|1|||
160467992|NCT00676091|579442510|FG000|Toddler Dose|Failed to return|2|||
160467993|NCT00676091|579442511|FG001|Toddler Dose|Failed to return|0|||
160467994|NCT00676091|579442510|FG000|Toddler Dose|Parent or legal guardian request|1|||
160467995|NCT00676091|579442511|FG001|Toddler Dose|Parent or legal guardian request|0|||
160467996|NCT00914966|579442517|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
160467997|NCT00914966|579442517|FG000|Step 1: 1500 Units|Physician Decision|1|||
160467998|NCT00914966|579442517|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
160467999|NCT01701401|579442518|FG000|Overall Study|Randomized But Not Treated|3|||
160468000|NCT01701401|579442519|FG001|Overall Study|Randomized But Not Treated|1|||
160468001|NCT01701401|579442520|FG002|Overall Study|Randomized But Not Treated|0|||
160598331|NCT01998958|579906181|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598332|NCT01998958|579906182|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598333|NCT01998958|579906183|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160468002|NCT01701401|579442521|FG003|Overall Study|Randomized But Not Treated|1|||
160468003|NCT01701401|579442518|FG000|Overall Study|Lost to Follow-up|5|||
160468004|NCT01701401|579442519|FG001|Overall Study|Lost to Follow-up|5|||
160468005|NCT01701401|579442520|FG002|Overall Study|Lost to Follow-up|1|||
160468006|NCT01701401|579442521|FG003|Overall Study|Lost to Follow-up|3|||
160468007|NCT01701401|579442518|FG000|Overall Study|Withdrew Consent|0|||
160468008|NCT01701401|579442519|FG001|Overall Study|Withdrew Consent|3|||
160468009|NCT01701401|579442520|FG002|Overall Study|Withdrew Consent|1|||
160468010|NCT01701401|579442521|FG003|Overall Study|Withdrew Consent|2|||
160468011|NCT01701401|579442518|FG000|Overall Study|Lack of Efficacy|1|||
160468012|NCT01701401|579442519|FG001|Overall Study|Lack of Efficacy|0|||
160468013|NCT01701401|579442520|FG002|Overall Study|Lack of Efficacy|2|||
160468014|NCT01701401|579442521|FG003|Overall Study|Lack of Efficacy|0|||
160468015|NCT01701401|579442518|FG000|Overall Study|Adverse Event|1|||
160468016|NCT01701401|579442519|FG001|Overall Study|Adverse Event|0|||
160468017|NCT01701401|579442520|FG002|Overall Study|Adverse Event|0|||
160468018|NCT01701401|579442521|FG003|Overall Study|Adverse Event|0|||
160468019|NCT01701401|579442518|FG000|Overall Study|Protocol Violation|0|||
160468020|NCT01701401|579442519|FG001|Overall Study|Protocol Violation|0|||
160468021|NCT01701401|579442520|FG002|Overall Study|Protocol Violation|1|||
160468022|NCT01701401|579442521|FG003|Overall Study|Protocol Violation|0|||
160468023|NCT00989196|579442522|FG000|Treatment Period|Lost to Follow-up|1|||
160468024|NCT00989196|579442523|FG001|Treatment Period|Lost to Follow-up|0|||
160468025|NCT04762277|579442526|FG000|Overall Study|Withdrawal by Subject|0|||
160468026|NCT04762277|579442527|FG001|Overall Study|Withdrawal by Subject|2|||
160468027|NCT04762277|579442526|FG000|Overall Study|Protocol Violation|0|||
160468028|NCT04762277|579442527|FG001|Overall Study|Protocol Violation|1|||
160468029|NCT04762277|579442526|FG000|Overall Study|Adverse Event|1|||
160468030|NCT04762277|579442527|FG001|Overall Study|Adverse Event|0|||
160468031|NCT04827732|579442528|FG000|Overall Study|Did not start treatment|0|||
160468032|NCT04827732|579442529|FG001|Overall Study|Did not start treatment|1|||
160468033|NCT04827732|579442530|FG002|Overall Study|Did not start treatment|0|||
160468034|NCT04827732|579442531|FG003|Overall Study|Did not start treatment|1|||
160468035|NCT05293717|579442539|FG000|Overall Study|Physician Decision|1|||
160468036|NCT00799409|579444267|FG000|Overall Study|Withdrawal by Subject|1|||
160468037|NCT00799409|579444268|FG001|Overall Study|Withdrawal by Subject|0|||
160468038|NCT00799409|579444269|FG002|Overall Study|Withdrawal by Subject|0|||
160598334|NCT01998958|579906184|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598335|NCT01998958|579906185|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598336|NCT01998958|579906186|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598337|NCT01998958|579906187|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598338|NCT01998958|579906188|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160468039|NCT00799409|579444267|FG000|Overall Study|Lost to Follow-up|1|||
160468040|NCT00799409|579444268|FG001|Overall Study|Lost to Follow-up|0|||
160468041|NCT00799409|579444269|FG002|Overall Study|Lost to Follow-up|0|||
160468042|NCT00799409|579444267|FG000|Overall Study|Optimal Dose Not Achieved|2|||
160468043|NCT00799409|579444268|FG001|Overall Study|Optimal Dose Not Achieved|0|||
160468044|NCT00799409|579444269|FG002|Overall Study|Optimal Dose Not Achieved|0|||
160468045|NCT00799409|579444267|FG000|Overall Study|Failure to follow study protocol)|1|||
160468046|NCT00799409|579444268|FG001|Overall Study|Failure to follow study protocol)|0|||
160468047|NCT00799409|579444269|FG002|Overall Study|Failure to follow study protocol)|0|||
160468048|NCT00799409|579444267|FG000|Overall Study|Did not attend lab school day 1|1|||
160468049|NCT00799409|579444268|FG001|Overall Study|Did not attend lab school day 1|0|||
160468050|NCT00799409|579444269|FG002|Overall Study|Did not attend lab school day 1|0|||
160468051|NCT00799409|579444267|FG000|Overall Study|medication compliance|1|||
160468052|NCT00799409|579444268|FG001|Overall Study|medication compliance|0|||
160468053|NCT00799409|579444269|FG002|Overall Study|medication compliance|0|||
160468054|NCT04323800|579444270|FG000|Overall Study|Withdrawal by Subject|4|||
160468055|NCT04323800|579444271|FG001|Overall Study|Withdrawal by Subject|4|||
160468056|NCT04323800|579444270|FG000|Overall Study|Incomplete transfusion|1|||
160468057|NCT04323800|579444271|FG001|Overall Study|Incomplete transfusion|0|||
160468058|NCT04323800|579444270|FG000|Overall Study|Other|0|||
160468059|NCT04323800|579444271|FG001|Overall Study|Other|1|||
160468060|NCT04323800|579444270|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
160468061|NCT04323800|579444271|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
160468062|NCT01732757|579444272|FG000|Overall Study|Lost to Follow-up|1|||
160468063|NCT01732757|579444273|FG001|Overall Study|Lost to Follow-up|0|||
160468064|NCT01732757|579444274|FG002|Overall Study|Lost to Follow-up|0|||
160468065|NCT00731692|579444275|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
160468066|NCT00731692|579444276|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
160468067|NCT00731692|579444277|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
160468068|NCT00731692|579444275|FG000|Core Study (36 Months)|Physician Decision|1|||
160468069|NCT00731692|579444276|FG001|Core Study (36 Months)|Physician Decision|0|||
160468070|NCT00731692|579444277|FG002|Core Study (36 Months)|Physician Decision|2|||
160468071|NCT00731692|579444275|FG000|Core Study (36 Months)|Death|2|||
160468072|NCT00731692|579444276|FG001|Core Study (36 Months)|Death|1|||
160468073|NCT00731692|579444277|FG002|Core Study (36 Months)|Death|2|||
160468074|NCT00731692|579444275|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
160468075|NCT00731692|579444276|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
160468076|NCT00731692|579444277|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
160598339|NCT01998958|579906189|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598340|NCT01998958|579906190|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598341|NCT01998958|579906191|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598342|NCT01998958|579906192|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
160598343|NCT01998958|579906193|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
160598344|NCT01998958|579906194|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
160598345|NCT01998958|579906195|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598346|NCT01998958|579906196|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598347|NCT01998958|579906197|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598348|NCT01998958|579906198|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598349|NCT01998958|579906199|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598350|NCT01998958|579906200|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598351|NCT01998958|579906201|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598352|NCT01998958|579906202|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
160598353|NCT02432703|579906203|FG000|Overall Study|Adverse Event|1|||
160598354|NCT02432703|579906204|FG001|Overall Study|Adverse Event|4|||
160598355|NCT02432703|579906203|FG000|Overall Study|Lack of Efficacy|1|||
160598356|NCT02432703|579906204|FG001|Overall Study|Lack of Efficacy|0|||
160598357|NCT02432703|579906203|FG000|Overall Study|Lost to Follow-up|5|||
160598358|NCT02432703|579906204|FG001|Overall Study|Lost to Follow-up|3|||
160598359|NCT02432703|579906203|FG000|Overall Study|Withdrawal by Subject|9|||
160598360|NCT02432703|579906204|FG001|Overall Study|Withdrawal by Subject|6|||
160598361|NCT02432703|579906203|FG000|Overall Study|Other|6|||
160598362|NCT02432703|579906204|FG001|Overall Study|Other|5|||
160598363|NCT03892707|579906216|FG000|Overall Study|Screen failure|6|||
160598364|NCT03892707|579906217|FG001|Overall Study|Screen failure|0|||
160598365|NCT03892707|579906216|FG000|Overall Study|Pain resolution|0|||
160598366|NCT03892707|579906217|FG001|Overall Study|Pain resolution|4|||
160598367|NCT03892707|579906216|FG000|Overall Study|Withdrawal by Subject|0|||
160598368|NCT03892707|579906217|FG001|Overall Study|Withdrawal by Subject|1|||
160598369|NCT03892707|579906216|FG000|Overall Study|Other (long business trip)|0|||
160598370|NCT03892707|579906217|FG001|Overall Study|Other (long business trip)|1|||
160598371|NCT05224076|579906220|FG000|Overall Study|Lost to Follow-up|24|||
160598372|NCT01807949|579906222|FG000|Overall Study|Adverse Event|1|||
160598373|NCT01807949|579906223|FG001|Overall Study|Adverse Event|2|||
160598374|NCT01807949|579906224|FG002|Overall Study|Adverse Event|2|||
160598375|NCT01807949|579906222|FG000|Overall Study|Withdrawal by Subject|1|||
160659232|NCT00549718|580134473|FG001|Overall Study|Lost to Follow-up|2|||
160468077|NCT00731692|579444275|FG000|Core Study (36 Months)|Administrative|2|||
160468078|NCT00731692|579444276|FG001|Core Study (36 Months)|Administrative|2|||
160468079|NCT00731692|579444277|FG002|Core Study (36 Months)|Administrative|6|||
160468080|NCT00731692|579444275|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
160468081|NCT00731692|579444276|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
160468082|NCT00731692|579444277|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
160468083|NCT00731692|579444275|FG000|Core Study (36 Months)|Protocol Violation|4|||
160468084|NCT00731692|579444276|FG001|Core Study (36 Months)|Protocol Violation|5|||
160598376|NCT01807949|579906223|FG001|Overall Study|Withdrawal by Subject|2|||
160598377|NCT01807949|579906224|FG002|Overall Study|Withdrawal by Subject|2|||
160598378|NCT01807949|579906222|FG000|Overall Study|Non-Compliance|0|||
160598379|NCT01807949|579906223|FG001|Overall Study|Non-Compliance|0|||
160598380|NCT01807949|579906224|FG002|Overall Study|Non-Compliance|1|||
160598381|NCT01807949|579906222|FG000|Overall Study|Undefined|0|||
160598382|NCT01807949|579906223|FG001|Overall Study|Undefined|1|||
160598383|NCT01807949|579906224|FG002|Overall Study|Undefined|2|||
160598384|NCT01807949|579906222|FG000|Overall Study|Randomized But Not Treated|0|||
160598385|NCT01807949|579906223|FG001|Overall Study|Randomized But Not Treated|2|||
160598386|NCT01807949|579906224|FG002|Overall Study|Randomized But Not Treated|2|||
160598387|NCT04325906|579906227|FG000|Overall Study|Withdrawal by Subject|2|||
160598388|NCT04325906|579906228|FG001|Overall Study|Withdrawal by Subject|0|||
160598389|NCT00881361|579906229|FG000|Overall Study|Terminated prior to surgery|27|||
160598390|NCT00881361|579906230|FG001|Overall Study|Terminated prior to surgery|7|||
160598391|NCT00881361|579906231|FG002|Overall Study|Terminated prior to surgery|0|||
160598392|NCT00881361|579906229|FG000|Overall Study|Ineligible|17|||
160598393|NCT00881361|579906230|FG001|Overall Study|Ineligible|2|||
160598394|NCT00881361|579906231|FG002|Overall Study|Ineligible|2|||
160598395|NCT02141217|579906232|FG000|Overall Study|Adverse Event|1|||
160598396|NCT02141217|579906233|FG001|Overall Study|Adverse Event|2|||
160598397|NCT02141217|579906232|FG000|Overall Study|Protocol Violation|1|||
160598398|NCT02141217|579906233|FG001|Overall Study|Protocol Violation|4|||
160598399|NCT02141217|579906232|FG000|Overall Study|Withdrawal by Subject|6|||
160598400|NCT02141217|579906233|FG001|Overall Study|Withdrawal by Subject|0|||
160598401|NCT02141217|579906232|FG000|Overall Study|Lost to Follow-up|1|||
160598402|NCT02141217|579906233|FG001|Overall Study|Lost to Follow-up|1|||
160598403|NCT02141217|579906232|FG000|Overall Study|Physician Decision|1|||
160598404|NCT02141217|579906233|FG001|Overall Study|Physician Decision|0|||
160598405|NCT02141217|579906232|FG000|Overall Study|Surgical Intervention|1|||
160598406|NCT02141217|579906233|FG001|Overall Study|Surgical Intervention|1|||
160598407|NCT01628393|579906238|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
160598408|NCT01628393|579906239|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
160598409|NCT01628393|579906240|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
160598410|NCT01628393|579906241|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
160598411|NCT01628393|579906242|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
160598412|NCT01628393|579906238|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
160598413|NCT01628393|579906239|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
160598414|NCT01628393|579906240|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
160598415|NCT01628393|579906241|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
160598416|NCT01628393|579906242|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
160598417|NCT01628393|579906238|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
160598418|NCT01628393|579906239|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
160598419|NCT01628393|579906240|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
160598420|NCT01628393|579906241|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
160598421|NCT01628393|579906242|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
160598422|NCT01628393|579906238|FG000|Blinded Active Extension Period|Adverse Event|0|||
160598423|NCT01628393|579906239|FG001|Blinded Active Extension Period|Adverse Event|1|||
160598424|NCT01628393|579906240|FG002|Blinded Active Extension Period|Adverse Event|0|||
160598425|NCT01628393|579906241|FG003|Blinded Active Extension Period|Adverse Event|2|||
160598426|NCT01628393|579906242|FG004|Blinded Active Extension Period|Adverse Event|2|||
160598427|NCT01628393|579906238|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
160598428|NCT01628393|579906239|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
160598429|NCT01628393|579906240|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
160598430|NCT01628393|579906241|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
160598431|NCT01628393|579906242|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
160598432|NCT01628393|579906238|FG000|Blinded Active Extension Period|Physician Decision|0|||
160598433|NCT01628393|579906239|FG001|Blinded Active Extension Period|Physician Decision|3|||
160598434|NCT01628393|579906240|FG002|Blinded Active Extension Period|Physician Decision|0|||
160598435|NCT01628393|579906241|FG003|Blinded Active Extension Period|Physician Decision|1|||
160598436|NCT01628393|579906242|FG004|Blinded Active Extension Period|Physician Decision|0|||
160598437|NCT01628393|579906238|FG000|Blinded Active Extension Period|Protocol Violation|0|||
160598438|NCT01628393|579906239|FG001|Blinded Active Extension Period|Protocol Violation|0|||
160598439|NCT01628393|579906240|FG002|Blinded Active Extension Period|Protocol Violation|2|||
160598440|NCT01628393|579906241|FG003|Blinded Active Extension Period|Protocol Violation|1|||
160598441|NCT01628393|579906242|FG004|Blinded Active Extension Period|Protocol Violation|0|||
160598442|NCT01628393|579906238|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
160598443|NCT01628393|579906239|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
160598444|NCT01628393|579906240|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
160598445|NCT01628393|579906241|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
160598446|NCT01628393|579906242|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
160598447|NCT01665768|579906243|FG000|Overall Study|Adverse Event|3|||
160598448|NCT01665768|579906243|FG000|Overall Study|Lack of Efficacy|19|||
160598449|NCT01665768|579906243|FG000|Overall Study|Withdrawal by Subject|1|||
160598450|NCT01329341|579906244|FG000|Overall Study|Withdrawal by Subject|44|||
160598451|NCT00448760|579906245|FG000|Overall Study|Death|3|||
160598452|NCT00561340|579906246|FG000|Overall Study|refused to drink pediasure|6|||
160598453|NCT00561340|579906247|FG001|Overall Study|refused to drink pediasure|0|||
160598454|NCT02988219|579906253|FG000|Overall Study|Lack of Efficacy|1|||
160598455|NCT02988219|579906254|FG001|Overall Study|Lack of Efficacy|1|||
160598456|NCT02988219|579906253|FG000|Overall Study|Withdrawal by Subject|0|||
160598457|NCT02988219|579906254|FG001|Overall Study|Withdrawal by Subject|2|||
160659233|NCT00549718|580134474|FG002|Overall Study|Lost to Follow-up|0|||
160598458|NCT01522443|579906258|FG000|Overall Study|No longer receiving clinical benefit|36|||
160598459|NCT01522443|579906259|FG001|Overall Study|No longer receiving clinical benefit|28|||
160598460|NCT01522443|579906258|FG000|Overall Study|Adverse Event|10|||
160598461|NCT01522443|579906259|FG001|Overall Study|Adverse Event|15|||
160598462|NCT01522443|579906258|FG000|Overall Study|Withdrawal by Subject|5|||
160598463|NCT01522443|579906259|FG001|Overall Study|Withdrawal by Subject|8|||
160598464|NCT01522443|579906258|FG000|Overall Study|No study treatment given|1|||
160598465|NCT01522443|579906259|FG001|Overall Study|No study treatment given|1|||
160598466|NCT01522443|579906258|FG000|Overall Study|Other|1|||
160598467|NCT01522443|579906259|FG001|Overall Study|Other|3|||
160598468|NCT03260894|579906260|FG000|Overall Study|Death|6|||
160598469|NCT03260894|579906261|FG001|Overall Study|Death|8|||
160598470|NCT03260894|579906260|FG000|Overall Study|Withdrawal by Subject|4|||
160598471|NCT03260894|579906261|FG001|Overall Study|Withdrawal by Subject|11|||
160598472|NCT03260894|579906260|FG000|Overall Study|On-going at clinical cut off date|36|||
160598473|NCT03260894|579906261|FG001|Overall Study|On-going at clinical cut off date|31|||
160598474|NCT01074658|579906262|FG000|Overall Study|No implant attempted|19|||
160598475|NCT00426556|579906263|FG000|Phase I - Core Phase|Disease Progression|0|||
160598476|NCT00426556|579906264|FG001|Phase I - Core Phase|Disease Progression|6|||
160598477|NCT00426556|579906265|FG002|Phase I - Core Phase|Disease Progression|2|||
160598478|NCT00426556|579906266|FG003|Phase I - Core Phase|Disease Progression|0|||
160598479|NCT00426556|579906263|FG000|Phase I - Core Phase|Adverse Event|1|||
160598480|NCT00426556|579906264|FG001|Phase I - Core Phase|Adverse Event|3|||
160598481|NCT00426556|579906265|FG002|Phase I - Core Phase|Adverse Event|1|||
160598482|NCT00426556|579906266|FG003|Phase I - Core Phase|Adverse Event|0|||
160598483|NCT00426556|579906263|FG000|Phase I - Core Phase|Death|0|||
160598484|NCT00426556|579906264|FG001|Phase I - Core Phase|Death|1|||
160598485|NCT00426556|579906265|FG002|Phase I - Core Phase|Death|0|||
160598486|NCT00426556|579906266|FG003|Phase I - Core Phase|Death|0|||
160598487|NCT00426556|579906263|FG000|Phase I - Extension Phase|Adverse Event|0|||
160598488|NCT00426556|579906264|FG001|Phase I - Extension Phase|Adverse Event|1|||
160598489|NCT00426556|579906265|FG002|Phase I - Extension Phase|Adverse Event|1|||
160598490|NCT00426556|579906266|FG003|Phase I - Extension Phase|Adverse Event|0|||
160598491|NCT00426556|579906263|FG000|Phase I - Extension Phase|Disease Progression|5|||
160598492|NCT00426556|579906264|FG001|Phase I - Extension Phase|Disease Progression|5|||
160598493|NCT00426556|579906265|FG002|Phase I - Extension Phase|Disease Progression|6|||
160598494|NCT00426556|579906266|FG003|Phase I - Extension Phase|Disease Progression|0|||
160598495|NCT00426556|579906263|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
160598496|NCT00426556|579906264|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
160598497|NCT00426556|579906265|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
160598498|NCT00426556|579906266|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
160598499|NCT00426556|579906263|FG000|Phase II - Core Phase|Disease Progression|0|||
160598500|NCT00426556|579906264|FG001|Phase II - Core Phase|Disease Progression|0|||
160598501|NCT00426556|579906265|FG002|Phase II - Core Phase|Disease Progression|0|||
160598502|NCT00426556|579906266|FG003|Phase II - Core Phase|Disease Progression|16|||
160598503|NCT00426556|579906263|FG000|Phase II - Core Phase|Adverse Event|0|||
160598504|NCT00426556|579906264|FG001|Phase II - Core Phase|Adverse Event|0|||
160598505|NCT00426556|579906265|FG002|Phase II - Core Phase|Adverse Event|0|||
160598506|NCT00426556|579906266|FG003|Phase II - Core Phase|Adverse Event|8|||
160598507|NCT00426556|579906263|FG000|Phase II - Extension Phase|Disease Progression|0|||
160598508|NCT00426556|579906264|FG001|Phase II - Extension Phase|Disease Progression|0|||
160598509|NCT00426556|579906265|FG002|Phase II - Extension Phase|Disease Progression|0|||
160598510|NCT00426556|579906266|FG003|Phase II - Extension Phase|Disease Progression|21|||
160598511|NCT00426556|579906263|FG000|Phase II - Extension Phase|Adverse Event|0|||
160598512|NCT00426556|579906264|FG001|Phase II - Extension Phase|Adverse Event|0|||
160598513|NCT00426556|579906265|FG002|Phase II - Extension Phase|Adverse Event|0|||
160468085|NCT00731692|579444277|FG002|Core Study (36 Months)|Protocol Violation|8|||
160598514|NCT00426556|579906266|FG003|Phase II - Extension Phase|Adverse Event|2|||
160598515|NCT02146248|579906269|FG000|Overall Study|Withdrawal by Subject|2|||
160659234|NCT00549718|580134475|FG003|Overall Study|Lost to Follow-up|6|||
160468086|NCT00731692|579444275|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
160468087|NCT00731692|579444276|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
160468088|NCT00731692|579444277|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
160468089|NCT00731692|579444275|FG000|Core Study (36 Months)|Adverse Event|25|||
160468090|NCT00731692|579444276|FG001|Core Study (36 Months)|Adverse Event|28|||
160468091|NCT00731692|579444277|FG002|Core Study (36 Months)|Adverse Event|29|||
160468092|NCT00731692|579444275|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
160468093|NCT00731692|579444276|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
160468094|NCT00731692|579444277|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
160468095|NCT00731692|579444275|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
160468096|NCT00731692|579444276|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
160468097|NCT00731692|579444277|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
160468098|NCT00731692|579444275|FG000|Extension Phase|Abnormal test procedure|0|||
160468099|NCT00731692|579444276|FG001|Extension Phase|Abnormal test procedure|0|||
160468100|NCT00731692|579444277|FG002|Extension Phase|Abnormal test procedure|1|||
160468101|NCT00731692|579444275|FG000|Extension Phase|Abnormal lab values|0|||
160468102|NCT00731692|579444276|FG001|Extension Phase|Abnormal lab values|0|||
160468103|NCT00731692|579444277|FG002|Extension Phase|Abnormal lab values|1|||
160468104|NCT00731692|579444275|FG000|Extension Phase|Lost to Follow-up|0|||
160468105|NCT00731692|579444276|FG001|Extension Phase|Lost to Follow-up|1|||
160468106|NCT00731692|579444277|FG002|Extension Phase|Lost to Follow-up|4|||
160468107|NCT00731692|579444275|FG000|Extension Phase|Withdrawal by Subject|4|||
160468108|NCT00731692|579444276|FG001|Extension Phase|Withdrawal by Subject|5|||
160468109|NCT00731692|579444277|FG002|Extension Phase|Withdrawal by Subject|3|||
160468110|NCT00731692|579444275|FG000|Extension Phase|Adverse Event|1|||
160468111|NCT00731692|579444276|FG001|Extension Phase|Adverse Event|1|||
160468112|NCT00731692|579444277|FG002|Extension Phase|Adverse Event|15|||
160468113|NCT02372799|579444278|FG000|Treatment Period|Adverse Event|3|||
160468114|NCT02372799|579444279|FG001|Treatment Period|Adverse Event|10|||
160468115|NCT02372799|579444280|FG002|Treatment Period|Adverse Event|6|||
160468116|NCT02372799|579444278|FG000|Treatment Period|Insufficient therapeutic response|2|||
160468117|NCT02372799|579444279|FG001|Treatment Period|Insufficient therapeutic response|2|||
160468118|NCT02372799|579444280|FG002|Treatment Period|Insufficient therapeutic response|0|||
160468119|NCT02372799|579444278|FG000|Treatment Period|Withdrawal by Subject|10|||
160468120|NCT02372799|579444279|FG001|Treatment Period|Withdrawal by Subject|10|||
160468121|NCT02372799|579444280|FG002|Treatment Period|Withdrawal by Subject|2|||
160468122|NCT02372799|579444278|FG000|Treatment Period|Lost to Follow-up|11|||
160468123|NCT02372799|579444279|FG001|Treatment Period|Lost to Follow-up|5|||
160468124|NCT02372799|579444280|FG002|Treatment Period|Lost to Follow-up|3|||
160468125|NCT02372799|579444278|FG000|Treatment Period|Protocol Violation|3|||
160468126|NCT02372799|579444279|FG001|Treatment Period|Protocol Violation|0|||
160468127|NCT02372799|579444280|FG002|Treatment Period|Protocol Violation|0|||
160468128|NCT02372799|579444278|FG000|Treatment Period|Non-compliance with study drug|4|||
160468129|NCT02372799|579444279|FG001|Treatment Period|Non-compliance with study drug|4|||
160468130|NCT02372799|579444280|FG002|Treatment Period|Non-compliance with study drug|4|||
160468131|NCT02372799|579444278|FG000|Treatment Period|Miscellaneous Reasons|1|||
160468132|NCT02372799|579444279|FG001|Treatment Period|Miscellaneous Reasons|1|||
160468133|NCT02372799|579444280|FG002|Treatment Period|Miscellaneous Reasons|0|||
160468134|NCT02372799|579444278|FG000|Down-taper Period|Lost to Follow-up|1|||
160468135|NCT02372799|579444279|FG001|Down-taper Period|Lost to Follow-up|2|||
160468136|NCT02372799|579444280|FG002|Down-taper Period|Lost to Follow-up|2|||
160468137|NCT00747006|579444281|FG000|Overall Study|Adverse Event|1|||
160468138|NCT00747006|579444282|FG001|Overall Study|Adverse Event|0|||
160468139|NCT00747006|579444283|FG002|Overall Study|Adverse Event|0|||
160468140|NCT00747006|579444281|FG000|Overall Study|Lost to Follow-up|0|||
160468141|NCT00747006|579444282|FG001|Overall Study|Lost to Follow-up|1|||
160468142|NCT00747006|579444283|FG002|Overall Study|Lost to Follow-up|0|||
160468143|NCT00747006|579444281|FG000|Overall Study|Physician Decision|2|||
160598516|NCT00425100|579906270|FG000|Overall Study|Adverse Event|36|||
160598517|NCT00425100|579906270|FG000|Overall Study|Lack of Efficacy|4|||
160598518|NCT00425100|579906270|FG000|Overall Study|Lost to Follow-up|2|||
160598519|NCT00425100|579906270|FG000|Overall Study|Protocol Violation|4|||
160598520|NCT00425100|579906270|FG000|Overall Study|Withdrawal by Subject|7|||
160598521|NCT01769469|579906272|FG000|Overall Study|Consent Withdrawn|5|||
160598522|NCT01769469|579906272|FG000|Overall Study|Moved Out Of Area|3|||
160598523|NCT01769469|579906272|FG000|Overall Study|Lost to Follow-up|17|||
160598524|NCT01769469|579906272|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
160468144|NCT00747006|579444282|FG001|Overall Study|Physician Decision|0|||
160598525|NCT01769469|579906272|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
160468145|NCT00747006|579444283|FG002|Overall Study|Physician Decision|1|||
160468146|NCT02132949|579444288|FG000|Overall Study|Death|7|||
160598526|NCT02713789|579906277|FG000|Overall Study|Lost to Follow-up|0|||
160468147|NCT02132949|579444289|FG001|Overall Study|Death|13|||
160468148|NCT02132949|579444288|FG000|Overall Study|Lost to Follow-up|14|||
160468149|NCT02132949|579444289|FG001|Overall Study|Lost to Follow-up|4|||
160598527|NCT02713789|579906278|FG001|Overall Study|Lost to Follow-up|1|||
160598528|NCT02713789|579906279|FG002|Overall Study|Lost to Follow-up|1|||
160598529|NCT04186663|579906287|FG000|Overall Study|Lost to Follow-up|1|||
160598530|NCT04186663|579906287|FG000|Overall Study|Unable to complete blood draw|3|||
160598531|NCT02559206|579906289|FG000|Overall Study|Adverse Event|0|||
160598532|NCT02559206|579906290|FG001|Overall Study|Adverse Event|4|||
160468150|NCT02132949|579444288|FG000|Overall Study|Withdrawal by Subject|6|||
160468151|NCT02132949|579444289|FG001|Overall Study|Withdrawal by Subject|5|||
160659235|NCT00549718|580134472|FG000|Overall Study|Withdrawal by Subject|9|||
160598533|NCT02559206|579906291|FG002|Overall Study|Adverse Event|1|||
160598534|NCT02559206|579906292|FG003|Overall Study|Adverse Event|5|||
160598535|NCT02559206|579906293|FG004|Overall Study|Adverse Event|3|||
160598536|NCT02559206|579906294|FG005|Overall Study|Adverse Event|0|||
160598537|NCT02559206|579906295|FG006|Overall Study|Adverse Event|1|||
160598538|NCT02559206|579906296|FG007|Overall Study|Adverse Event|0|||
160598539|NCT02559206|579906289|FG000|Overall Study|Protocol Violation|1|||
160598540|NCT02559206|579906290|FG001|Overall Study|Protocol Violation|0|||
160468152|NCT02132949|579444288|FG000|Overall Study|Noncompliance|5|||
160598541|NCT02559206|579906291|FG002|Overall Study|Protocol Violation|1|||
160598542|NCT02559206|579906292|FG003|Overall Study|Protocol Violation|0|||
160598543|NCT02559206|579906293|FG004|Overall Study|Protocol Violation|0|||
160598544|NCT02559206|579906294|FG005|Overall Study|Protocol Violation|2|||
160468153|NCT02132949|579444289|FG001|Overall Study|Noncompliance|1|||
160598545|NCT02559206|579906295|FG006|Overall Study|Protocol Violation|0|||
160598546|NCT02559206|579906296|FG007|Overall Study|Protocol Violation|0|||
160598547|NCT02559206|579906289|FG000|Overall Study|Withdrawal by Subject|3|||
160598548|NCT02559206|579906290|FG001|Overall Study|Withdrawal by Subject|3|||
160598549|NCT02559206|579906291|FG002|Overall Study|Withdrawal by Subject|1|||
160598550|NCT02559206|579906292|FG003|Overall Study|Withdrawal by Subject|3|||
160598551|NCT02559206|579906293|FG004|Overall Study|Withdrawal by Subject|5|||
160598552|NCT02559206|579906294|FG005|Overall Study|Withdrawal by Subject|4|||
160598553|NCT02559206|579906295|FG006|Overall Study|Withdrawal by Subject|1|||
160598554|NCT02559206|579906296|FG007|Overall Study|Withdrawal by Subject|2|||
160598555|NCT02559206|579906289|FG000|Overall Study|Lost to Follow-up|3|||
160598556|NCT02559206|579906290|FG001|Overall Study|Lost to Follow-up|5|||
160598557|NCT02559206|579906291|FG002|Overall Study|Lost to Follow-up|3|||
160598558|NCT02559206|579906292|FG003|Overall Study|Lost to Follow-up|3|||
160598559|NCT02559206|579906293|FG004|Overall Study|Lost to Follow-up|2|||
160598560|NCT02559206|579906294|FG005|Overall Study|Lost to Follow-up|5|||
160598561|NCT02559206|579906295|FG006|Overall Study|Lost to Follow-up|1|||
160598562|NCT02559206|579906296|FG007|Overall Study|Lost to Follow-up|4|||
160598563|NCT02559206|579906289|FG000|Overall Study|Lack of Efficacy|1|||
160598564|NCT02559206|579906290|FG001|Overall Study|Lack of Efficacy|0|||
160598565|NCT02559206|579906291|FG002|Overall Study|Lack of Efficacy|3|||
160598566|NCT02559206|579906292|FG003|Overall Study|Lack of Efficacy|2|||
160598567|NCT02559206|579906293|FG004|Overall Study|Lack of Efficacy|2|||
160598568|NCT02559206|579906294|FG005|Overall Study|Lack of Efficacy|3|||
160598569|NCT02559206|579906295|FG006|Overall Study|Lack of Efficacy|3|||
160598570|NCT02559206|579906296|FG007|Overall Study|Lack of Efficacy|3|||
160598571|NCT02559206|579906289|FG000|Overall Study|Other Not Specified|0|||
160598572|NCT02559206|579906290|FG001|Overall Study|Other Not Specified|0|||
160598573|NCT02559206|579906291|FG002|Overall Study|Other Not Specified|0|||
160598574|NCT02559206|579906292|FG003|Overall Study|Other Not Specified|1|||
160598575|NCT02559206|579906293|FG004|Overall Study|Other Not Specified|0|||
160598576|NCT02559206|579906294|FG005|Overall Study|Other Not Specified|0|||
160598577|NCT02559206|579906295|FG006|Overall Study|Other Not Specified|0|||
160598578|NCT02559206|579906296|FG007|Overall Study|Other Not Specified|0|||
160598579|NCT01375647|579907747|FG000|Overall Study|Lost to Follow-up|3|||
160598580|NCT01375647|579907748|FG001|Overall Study|Lost to Follow-up|3|||
160598581|NCT01375647|579907749|FG002|Overall Study|Lost to Follow-up|7|||
160598582|NCT01375647|579907750|FG003|Overall Study|Lost to Follow-up|10|||
160598583|NCT01375647|579907747|FG000|Overall Study|Death|1|||
160598584|NCT01375647|579907748|FG001|Overall Study|Death|2|||
160598585|NCT01375647|579907749|FG002|Overall Study|Death|1|||
160598586|NCT01375647|579907750|FG003|Overall Study|Death|0|||
160598587|NCT01375647|579907747|FG000|Overall Study|Withdrawal by Subject|17|||
160598588|NCT01375647|579907748|FG001|Overall Study|Withdrawal by Subject|20|||
160598589|NCT01375647|579907749|FG002|Overall Study|Withdrawal by Subject|26|||
160598590|NCT01375647|579907750|FG003|Overall Study|Withdrawal by Subject|14|||
160598591|NCT01375647|579907747|FG000|Overall Study|Physician Decision|1|||
160598592|NCT01375647|579907748|FG001|Overall Study|Physician Decision|0|||
160598593|NCT01375647|579907749|FG002|Overall Study|Physician Decision|0|||
160598594|NCT01375647|579907750|FG003|Overall Study|Physician Decision|0|||
160598595|NCT01770145|579907751|FG000|Baseline|Adverse Event|20|||
160598596|NCT01770145|579907751|FG000|Baseline|Withdrawal by Subject|1|||
160598597|NCT01770145|579907751|FG000|Baseline|Lost to Follow-up|1|||
160598598|NCT01770145|579907751|FG000|Baseline|Unable to define optimal dose|4|||
160598599|NCT01770145|579907751|FG000|Treatment|Adverse Event|3|||
160598600|NCT01770145|579907751|FG000|Treatment|Withdrawal by Subject|1|||
160598601|NCT01102140|579907752|FG000|Overall Study|Lost to Follow-up|1|||
160598602|NCT01102140|579907753|FG001|Overall Study|Lost to Follow-up|0|||
160598603|NCT01102140|579907752|FG000|Overall Study|Investigator terminated study|2|||
160598604|NCT01102140|579907753|FG001|Overall Study|Investigator terminated study|2|||
160598605|NCT03788967|579907756|FG000|Overall Study|Lost to Follow-up|14|||
160598606|NCT03788967|579907757|FG001|Overall Study|Lost to Follow-up|10|||
160598607|NCT03788967|579907756|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
160598608|NCT03788967|579907757|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
160598609|NCT03788967|579907756|FG000|Overall Study|Participant Withdrawal of Consent|13|||
160598610|NCT03788967|579907757|FG001|Overall Study|Participant Withdrawal of Consent|5|||
160598611|NCT03788967|579907756|FG000|Overall Study|Adverse Event|1|||
160598612|NCT03788967|579907757|FG001|Overall Study|Adverse Event|1|||
160598613|NCT03788967|579907756|FG000|Overall Study|COVID-19|1|||
160598614|NCT03788967|579907757|FG001|Overall Study|COVID-19|2|||
160598615|NCT04268303|579907758|FG000|Overall Study|Lost to Follow-up|1|||
160598616|NCT04268303|579907759|FG001|Overall Study|Lost to Follow-up|1|||
160598617|NCT04268303|579907760|FG002|Overall Study|Lost to Follow-up|2|||
160598618|NCT04268303|579907758|FG000|Overall Study|Withdrawal by Subject|0|||
160598619|NCT04268303|579907759|FG001|Overall Study|Withdrawal by Subject|1|||
160598620|NCT04268303|579907760|FG002|Overall Study|Withdrawal by Subject|1|||
160598621|NCT04268303|579907758|FG000|Overall Study|Adverse Event|2|||
160598622|NCT04268303|579907759|FG001|Overall Study|Adverse Event|0|||
160598623|NCT04268303|579907760|FG002|Overall Study|Adverse Event|0|||
160468154|NCT02132949|579444288|FG000|Overall Study|Physician Decision|3|||
160468155|NCT02132949|579444289|FG001|Overall Study|Physician Decision|1|||
160598624|NCT00355134|579907761|FG000|Core Phase|Withdrawal by Subject|35|||
160598625|NCT00355134|579907762|FG001|Core Phase|Withdrawal by Subject|24|||
160598626|NCT00355134|579907763|FG002|Core Phase|Withdrawal by Subject|35|||
160598627|NCT00355134|579907764|FG003|Core Phase|Withdrawal by Subject|0|||
160598628|NCT00355134|579907765|FG004|Core Phase|Withdrawal by Subject|0|||
160598629|NCT00355134|579907761|FG000|Core Phase|Adverse Event|28|||
160598630|NCT00355134|579907762|FG001|Core Phase|Adverse Event|22|||
160598631|NCT00355134|579907763|FG002|Core Phase|Adverse Event|16|||
160659236|NCT00549718|580134473|FG001|Overall Study|Withdrawal by Subject|18|||
160659237|NCT00549718|580134474|FG002|Overall Study|Withdrawal by Subject|12|||
160659238|NCT00549718|580134475|FG003|Overall Study|Withdrawal by Subject|13|||
160659239|NCT00549718|580134472|FG000|Overall Study|Administrative|2|||
160468156|NCT02132949|579444288|FG000|Overall Study|Disease Progression|3|||
160468157|NCT02132949|579444289|FG001|Overall Study|Disease Progression|0|||
160659240|NCT00549718|580134473|FG001|Overall Study|Administrative|2|||
160598632|NCT00355134|579907764|FG003|Core Phase|Adverse Event|0|||
160598633|NCT00355134|579907765|FG004|Core Phase|Adverse Event|0|||
160598634|NCT00355134|579907761|FG000|Core Phase|Lost to Follow-up|17|||
160598635|NCT00355134|579907762|FG001|Core Phase|Lost to Follow-up|13|||
160598636|NCT00355134|579907763|FG002|Core Phase|Lost to Follow-up|21|||
160598637|NCT00355134|579907764|FG003|Core Phase|Lost to Follow-up|0|||
160598638|NCT00355134|579907765|FG004|Core Phase|Lost to Follow-up|0|||
160598639|NCT00355134|579907761|FG000|Core Phase|Abnormal laboratory value(s)|19|||
160598640|NCT00355134|579907762|FG001|Core Phase|Abnormal laboratory value(s)|14|||
160598641|NCT00355134|579907763|FG002|Core Phase|Abnormal laboratory value(s)|2|||
160598642|NCT00355134|579907764|FG003|Core Phase|Abnormal laboratory value(s)|0|||
160598643|NCT00355134|579907765|FG004|Core Phase|Abnormal laboratory value(s)|0|||
160598644|NCT00355134|579907761|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
160598645|NCT00355134|579907762|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
160598646|NCT00355134|579907763|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
160598647|NCT00355134|579907764|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
160598648|NCT00355134|579907765|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
160598649|NCT00355134|579907761|FG000|Core Phase|Administrative problems|5|||
160598650|NCT00355134|579907762|FG001|Core Phase|Administrative problems|3|||
160598651|NCT00355134|579907763|FG002|Core Phase|Administrative problems|5|||
160598652|NCT00355134|579907764|FG003|Core Phase|Administrative problems|0|||
160598653|NCT00355134|579907765|FG004|Core Phase|Administrative problems|0|||
160598654|NCT00355134|579907761|FG000|Core Phase|Protocol Violation|3|||
160598655|NCT00355134|579907762|FG001|Core Phase|Protocol Violation|2|||
160598656|NCT00355134|579907763|FG002|Core Phase|Protocol Violation|2|||
160598657|NCT00355134|579907764|FG003|Core Phase|Protocol Violation|0|||
160598658|NCT00355134|579907765|FG004|Core Phase|Protocol Violation|0|||
160659241|NCT00549718|580134474|FG002|Overall Study|Administrative|2|||
160659242|NCT00549718|580134475|FG003|Overall Study|Administrative|1|||
160598659|NCT00355134|579907761|FG000|Core Phase|Abnormal test procedure result(s)|1|||
160598660|NCT00355134|579907762|FG001|Core Phase|Abnormal test procedure result(s)|2|||
160598661|NCT00355134|579907763|FG002|Core Phase|Abnormal test procedure result(s)|1|||
160598662|NCT00355134|579907764|FG003|Core Phase|Abnormal test procedure result(s)|0|||
160598663|NCT00355134|579907765|FG004|Core Phase|Abnormal test procedure result(s)|0|||
160598664|NCT00355134|579907761|FG000|Core Phase|Condition no longer requires study drug|1|||
160598665|NCT00355134|579907762|FG001|Core Phase|Condition no longer requires study drug|0|||
160598666|NCT00355134|579907763|FG002|Core Phase|Condition no longer requires study drug|1|||
160598667|NCT00355134|579907764|FG003|Core Phase|Condition no longer requires study drug|0|||
160598668|NCT00355134|579907765|FG004|Core Phase|Condition no longer requires study drug|0|||
160598669|NCT00355134|579907761|FG000|Extension Phase|Withdrawal by Subject|7|||
160598670|NCT00355134|579907762|FG001|Extension Phase|Withdrawal by Subject|11|||
160598671|NCT00355134|579907763|FG002|Extension Phase|Withdrawal by Subject|0|||
160598672|NCT00355134|579907764|FG003|Extension Phase|Withdrawal by Subject|7|||
160598673|NCT00355134|579907765|FG004|Extension Phase|Withdrawal by Subject|5|||
160598674|NCT00355134|579907761|FG000|Extension Phase|Adverse Event|13|||
160598675|NCT00355134|579907762|FG001|Extension Phase|Adverse Event|9|||
160598676|NCT00355134|579907763|FG002|Extension Phase|Adverse Event|0|||
160598677|NCT00355134|579907764|FG003|Extension Phase|Adverse Event|3|||
160598678|NCT00355134|579907765|FG004|Extension Phase|Adverse Event|5|||
160598679|NCT00355134|579907761|FG000|Extension Phase|Lost to Follow-up|2|||
160598680|NCT00355134|579907762|FG001|Extension Phase|Lost to Follow-up|6|||
160598681|NCT00355134|579907763|FG002|Extension Phase|Lost to Follow-up|0|||
160598682|NCT00355134|579907764|FG003|Extension Phase|Lost to Follow-up|2|||
160598683|NCT00355134|579907765|FG004|Extension Phase|Lost to Follow-up|4|||
160598684|NCT00355134|579907761|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
160598685|NCT00355134|579907762|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
160598686|NCT00355134|579907763|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
160598687|NCT00355134|579907764|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
160598688|NCT00355134|579907765|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
160598689|NCT00355134|579907761|FG000|Extension Phase|Administrative problems|2|||
160659243|NCT00397488|580134476|FG000|Overall Study|Withdrawal by Subject|3|||
160598690|NCT00355134|579907762|FG001|Extension Phase|Administrative problems|4|||
160598691|NCT00355134|579907763|FG002|Extension Phase|Administrative problems|0|||
160598692|NCT00355134|579907764|FG003|Extension Phase|Administrative problems|1|||
160659244|NCT00397488|580134476|FG000|Overall Study|Adverse Event|3|||
160659245|NCT00397488|580134476|FG000|Overall Study|Death|1|||
160598693|NCT00355134|579907765|FG004|Extension Phase|Administrative problems|1|||
160598694|NCT00355134|579907761|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
160598695|NCT00355134|579907762|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
160598696|NCT00355134|579907763|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
160659246|NCT02424097|580134479|FG000|Overall Study|Lost to Follow-up|1|||
160659247|NCT02424097|580134480|FG001|Overall Study|Lost to Follow-up|2|||
160659248|NCT02880761|580134485|FG000|Overall Study|Death|6|||
160659249|NCT02880761|580134486|FG001|Overall Study|Death|8|||
160598697|NCT00355134|579907764|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
160598698|NCT00355134|579907765|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
160598699|NCT00355134|579907761|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
160598700|NCT00355134|579907762|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
160598701|NCT00355134|579907763|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
160598702|NCT00355134|579907764|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
160598703|NCT00355134|579907765|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
160598704|NCT00355134|579907761|FG000|Extension Phase|Protocol Violation|0|||
160598705|NCT00355134|579907762|FG001|Extension Phase|Protocol Violation|0|||
160598706|NCT00355134|579907763|FG002|Extension Phase|Protocol Violation|0|||
160598707|NCT00355134|579907764|FG003|Extension Phase|Protocol Violation|1|||
160598708|NCT00355134|579907765|FG004|Extension Phase|Protocol Violation|0|||
160598709|NCT02715804|579907771|FG000|Overall Study|Death|222|||
160598710|NCT02715804|579907772|FG001|Overall Study|Death|106|||
160598711|NCT02715804|579907771|FG000|Overall Study|Withdrawal by Subject|5|||
160468158|NCT02132949|579444288|FG000|Overall Study|Adverse Event|2|||
160468159|NCT02132949|579444289|FG001|Overall Study|Adverse Event|1|||
160659250|NCT02880761|580134485|FG000|Overall Study|Withdrawal by Subject|3|||
160468160|NCT02132949|579444288|FG000|Overall Study|Withdrew Prior to Treatment|1|||
160598712|NCT02715804|579907772|FG001|Overall Study|Withdrawal by Subject|4|||
160468161|NCT02132949|579444289|FG001|Overall Study|Withdrew Prior to Treatment|2|||
160468162|NCT02132949|579444288|FG000|Overall Study|Reason Unspecified|0|||
160468163|NCT02132949|579444289|FG001|Overall Study|Reason Unspecified|1|||
160468164|NCT01583166|579444292|FG000|Overall Study|Withdrawal by Subject|4|||
160468165|NCT01583166|579444293|FG001|Overall Study|Withdrawal by Subject|6|||
160468166|NCT04652869|579444296|FG000|Overall Study|Withdrawal by Subject|0|||
160468167|NCT04652869|579444297|FG001|Overall Study|Withdrawal by Subject|2|||
160468168|NCT04652869|579444298|FG002|Overall Study|Withdrawal by Subject|0|||
160468169|NCT01372085|579444299|FG000|Washout Period 2|Physician Decision|0|||
160468170|NCT01372085|579444300|FG001|Washout Period 2|Physician Decision|0|||
160468171|NCT01372085|579444301|FG002|Washout Period 2|Physician Decision|0|||
160468172|NCT01372085|579444302|FG003|Washout Period 2|Physician Decision|0|||
160468173|NCT01372085|579444303|FG004|Washout Period 2|Physician Decision|1|||
160468174|NCT01372085|579444304|FG005|Washout Period 2|Physician Decision|0|||
160468175|NCT01372085|579444305|FG006|Washout Period 2|Physician Decision|0|||
160468176|NCT01372085|579444306|FG007|Washout Period 2|Physician Decision|0|||
160468177|NCT01372085|579444307|FG008|Washout Period 2|Physician Decision|0|||
160468178|NCT01372085|579444308|FG009|Washout Period 2|Physician Decision|0|||
160468179|NCT01372085|579444299|FG000|Washout Period 3|Withdrawal by Subject|0|||
160468180|NCT01372085|579444300|FG001|Washout Period 3|Withdrawal by Subject|0|||
160468181|NCT01372085|579444301|FG002|Washout Period 3|Withdrawal by Subject|0|||
160468182|NCT01372085|579444302|FG003|Washout Period 3|Withdrawal by Subject|0|||
160468183|NCT01372085|579444303|FG004|Washout Period 3|Withdrawal by Subject|0|||
160468184|NCT01372085|579444304|FG005|Washout Period 3|Withdrawal by Subject|2|||
160468185|NCT01372085|579444305|FG006|Washout Period 3|Withdrawal by Subject|0|||
160468186|NCT01372085|579444306|FG007|Washout Period 3|Withdrawal by Subject|0|||
160468187|NCT01372085|579444307|FG008|Washout Period 3|Withdrawal by Subject|0|||
160468188|NCT01372085|579444308|FG009|Washout Period 3|Withdrawal by Subject|0|||
160468189|NCT00562094|579444309|FG000|Overall Study|Lost to Follow-up|62|||
160468190|NCT03345979|579444313|FG000|Overall Study|Withdrawal by Subject|20|||
160468191|NCT03345979|579444314|FG001|Overall Study|Withdrawal by Subject|31|||
160468192|NCT03345979|579444313|FG000|Overall Study|Adverse Event|10|||
160468193|NCT03345979|579444314|FG001|Overall Study|Adverse Event|11|||
160468194|NCT03345979|579444313|FG000|Overall Study|Lost to Follow-up|8|||
160468195|NCT03345979|579444314|FG001|Overall Study|Lost to Follow-up|9|||
160598713|NCT02715804|579907771|FG000|Overall Study|Other than specified|2|||
160598714|NCT02715804|579907772|FG001|Overall Study|Other than specified|3|||
160468196|NCT03345979|579444313|FG000|Overall Study|Lack of Efficacy|4|||
160598715|NCT01625611|579907775|FG000|Overall Study|No adlib drinks Lab 1|3|||
160468197|NCT03345979|579444314|FG001|Overall Study|Lack of Efficacy|2|||
160468198|NCT03345979|579444313|FG000|Overall Study|Protocol Violation|1|||
160468199|NCT03345979|579444314|FG001|Overall Study|Protocol Violation|3|||
160468200|NCT03345979|579444313|FG000|Overall Study|Physician Decision|0|||
160468201|NCT03345979|579444314|FG001|Overall Study|Physician Decision|2|||
160598716|NCT01625611|579907776|FG001|Overall Study|No adlib drinks Lab 1|0|||
160598717|NCT01625611|579907775|FG000|Overall Study|Technical issues with PET|1|||
160598718|NCT01625611|579907776|FG001|Overall Study|Technical issues with PET|0|||
160598719|NCT01625611|579907775|FG000|Overall Study|Unable to complete study procedures|1|||
160598720|NCT01625611|579907776|FG001|Overall Study|Unable to complete study procedures|0|||
160598721|NCT01625611|579907775|FG000|Overall Study|Withdrawal by Subject|3|||
160598722|NCT01625611|579907776|FG001|Overall Study|Withdrawal by Subject|0|||
160598723|NCT00948194|579907777|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
160598724|NCT00948194|579907778|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
160598725|NCT00801892|579907785|FG000|Main Study Period|Withdrawal by Subject|0|||
160598726|NCT00801892|579907786|FG001|Main Study Period|Withdrawal by Subject|1|||
160598727|NCT00801892|579907785|FG000|Sham Crossover Period|Lost to Follow-up|0|||
160598728|NCT00801892|579907786|FG001|Sham Crossover Period|Lost to Follow-up|2|||
160598729|NCT01711541|579907789|FG000|Overall Study|Cancel prior to treatment|0|||
160598730|NCT01711541|579907790|FG001|Overall Study|Cancel prior to treatment|0|||
160598731|NCT01711541|579907791|FG002|Overall Study|Cancel prior to treatment|0|||
160598732|NCT01711541|579907792|FG003|Overall Study|Cancel prior to treatment|1|||
160598733|NCT01711541|579907793|FG004|Overall Study|Cancel prior to treatment|0|||
160598734|NCT01711541|579907789|FG000|Overall Study|Ineligible|0|||
160598735|NCT01711541|579907790|FG001|Overall Study|Ineligible|1|||
160598736|NCT01711541|579907791|FG002|Overall Study|Ineligible|0|||
160598737|NCT01711541|579907792|FG003|Overall Study|Ineligible|0|||
160598738|NCT01711541|579907793|FG004|Overall Study|Ineligible|0|||
160598739|NCT00728936|579907794|FG000|Overall Study|Withdrawal by Subject|0|||
160598740|NCT00728936|579907795|FG001|Overall Study|Withdrawal by Subject|0|||
160598741|NCT00728936|579907796|FG002|Overall Study|Withdrawal by Subject|0|||
160598742|NCT00728936|579907797|FG003|Overall Study|Withdrawal by Subject|0|||
160598743|NCT00728936|579907798|FG004|Overall Study|Withdrawal by Subject|0|||
160598744|NCT00728936|579907799|FG005|Overall Study|Withdrawal by Subject|1|||
160598745|NCT00728936|579907800|FG006|Overall Study|Withdrawal by Subject|0|||
160598746|NCT00438464|579907801|FG000|Overall Study|Terminated Early|14|||
160598747|NCT00438464|579907802|FG001|Overall Study|Terminated Early|5|||
160598748|NCT00438464|579907801|FG000|Overall Study|Incomplete data submission|0|||
160598749|NCT00438464|579907802|FG001|Overall Study|Incomplete data submission|2|||
160598750|NCT03943446|579907803|FG000|Overall Study|Lost to Follow-up|0|||
160598751|NCT03943446|579907804|FG001|Overall Study|Lost to Follow-up|0|||
160598752|NCT03943446|579907805|FG002|Overall Study|Lost to Follow-up|1|||
160598753|NCT03943446|579907803|FG000|Overall Study|Withdrawal by Subject|1|||
160598754|NCT03943446|579907804|FG001|Overall Study|Withdrawal by Subject|1|||
160598755|NCT03943446|579907805|FG002|Overall Study|Withdrawal by Subject|2|||
160598756|NCT03943446|579907803|FG000|Overall Study|Study Terminated by Sponsor|1|||
160598757|NCT03943446|579907804|FG001|Overall Study|Study Terminated by Sponsor|2|||
160598758|NCT03943446|579907805|FG002|Overall Study|Study Terminated by Sponsor|1|||
160598759|NCT03943446|579907803|FG000|Overall Study|Reason not Specified|5|||
160598760|NCT03943446|579907804|FG001|Overall Study|Reason not Specified|1|||
160598761|NCT03943446|579907805|FG002|Overall Study|Reason not Specified|3|||
160598762|NCT02905825|579907813|FG000|Overall Study|Protocol Violation|11|||
160598763|NCT02905825|579907813|FG000|Overall Study|Device Malfunction|1|||
160598764|NCT05355818|579907814|FG000|Overall Study|Adverse Event|1|||
160598765|NCT05355818|579907815|FG001|Overall Study|Adverse Event|1|||
160598766|NCT05355818|579907814|FG000|Overall Study|Lack of Efficacy|2|||
160598767|NCT05355818|579907815|FG001|Overall Study|Lack of Efficacy|1|||
160598768|NCT05355818|579907814|FG000|Overall Study|Lost to Follow-up|0|||
160598769|NCT05355818|579907815|FG001|Overall Study|Lost to Follow-up|1|||
160598770|NCT01601704|579907816|FG000|Overall Study|Randomized but not dispensed study med|1|||
160598771|NCT01601704|579907817|FG001|Overall Study|Randomized but not dispensed study med|4|||
160598772|NCT00527072|579907819|FG000|Overall Study|Adverse Event|13|||
160598773|NCT00527072|579907819|FG000|Overall Study|Lack of Efficacy|11|||
160598774|NCT00527072|579907819|FG000|Overall Study|Lost to Follow-up|3|||
160598775|NCT00527072|579907819|FG000|Overall Study|Protocol Violation|2|||
160598776|NCT00527072|579907819|FG000|Overall Study|Withdrawal by Subject|7|||
160598777|NCT02657434|579907820|FG000|Overall Study|Study Terminated By Sponsor|64|||
160598778|NCT02657434|579907821|FG001|Overall Study|Study Terminated By Sponsor|82|||
160598779|NCT02657434|579907820|FG000|Overall Study|Death|189|||
160598780|NCT02657434|579907821|FG001|Overall Study|Death|190|||
160598781|NCT02657434|579907820|FG000|Overall Study|Lost to Follow-up|2|||
160598782|NCT02657434|579907821|FG001|Overall Study|Lost to Follow-up|2|||
160598783|NCT02657434|579907820|FG000|Overall Study|Randomization by Error|2|||
160598784|NCT02657434|579907821|FG001|Overall Study|Randomization by Error|0|||
160598785|NCT02657434|579907820|FG000|Overall Study|Withdrawal by Subject|28|||
160598786|NCT02657434|579907821|FG001|Overall Study|Withdrawal by Subject|17|||
160598787|NCT02657434|579907820|FG000|Overall Study|Protocol Violation|1|||
160598788|NCT02657434|579907821|FG001|Overall Study|Protocol Violation|0|||
160598789|NCT02657434|579907820|FG000|Overall Study|Physician Decision|0|||
160598790|NCT02657434|579907821|FG001|Overall Study|Physician Decision|1|||
160598791|NCT04897594|579907824|FG000|Overall Study|Lost to Follow-up|0|||
160598792|NCT04897594|579907825|FG001|Overall Study|Lost to Follow-up|1|||
160598793|NCT04897594|579907826|FG002|Overall Study|Lost to Follow-up|1|||
160598794|NCT04897594|579907824|FG000|Overall Study|Sponsor Decision|0|||
160598795|NCT04897594|579907825|FG001|Overall Study|Sponsor Decision|0|||
160598796|NCT04897594|579907826|FG002|Overall Study|Sponsor Decision|1|||
160598797|NCT04897594|579907824|FG000|Overall Study|Withdrawal by Subject|1|||
160598798|NCT04897594|579907825|FG001|Overall Study|Withdrawal by Subject|0|||
160598799|NCT04897594|579907826|FG002|Overall Study|Withdrawal by Subject|1|||
160598800|NCT02147691|579907829|FG000|Overall Study|Withdrawal by Subject|2|||
160598801|NCT02147691|579907830|FG001|Overall Study|Withdrawal by Subject|0|||
160598802|NCT02147691|579907829|FG000|Overall Study|Adverse Event|2|||
160598803|NCT02147691|579907830|FG001|Overall Study|Adverse Event|0|||
160598804|NCT02147691|579907829|FG000|Overall Study|Lost to Follow-up|0|||
160598805|NCT02147691|579907830|FG001|Overall Study|Lost to Follow-up|1|||
160659251|NCT02880761|580134486|FG001|Overall Study|Withdrawal by Subject|6|||
160659252|NCT02880761|580134485|FG000|Overall Study|Protocol Violation|4|||
160598806|NCT02137837|579907831|FG000|Overall Study|Adverse Event|0|||
160659253|NCT02880761|580134486|FG001|Overall Study|Protocol Violation|3|||
160598807|NCT02137837|579907832|FG001|Overall Study|Adverse Event|2|||
160598808|NCT02137837|579907833|FG002|Overall Study|Adverse Event|1|||
160468202|NCT00734578|579444315|FG000|Overall Study|Adverse Event|4|||
160468203|NCT00734578|579444316|FG001|Overall Study|Adverse Event|6|||
160468204|NCT00734578|579444317|FG002|Overall Study|Adverse Event|1|||
160468205|NCT00734578|579444315|FG000|Overall Study|Protocol Violation|8|||
160468206|NCT00734578|579444316|FG001|Overall Study|Protocol Violation|6|||
160468207|NCT00734578|579444317|FG002|Overall Study|Protocol Violation|3|||
160468208|NCT00734578|579444315|FG000|Overall Study|Withdrawal by Subject|7|||
160468209|NCT00734578|579444316|FG001|Overall Study|Withdrawal by Subject|8|||
160468210|NCT00734578|579444317|FG002|Overall Study|Withdrawal by Subject|11|||
160468211|NCT00734578|579444315|FG000|Overall Study|Lost to Follow-up|9|||
160468212|NCT00734578|579444316|FG001|Overall Study|Lost to Follow-up|3|||
160468213|NCT00734578|579444317|FG002|Overall Study|Lost to Follow-up|5|||
160468214|NCT00734578|579444315|FG000|Overall Study|Lack of Efficacy|3|||
160468215|NCT00734578|579444316|FG001|Overall Study|Lack of Efficacy|2|||
160468216|NCT00734578|579444317|FG002|Overall Study|Lack of Efficacy|5|||
160468217|NCT00734578|579444315|FG000|Overall Study|Randomized in error|1|||
160468218|NCT00734578|579444316|FG001|Overall Study|Randomized in error|0|||
160468219|NCT00734578|579444317|FG002|Overall Study|Randomized in error|0|||
160468220|NCT00734578|579444315|FG000|Overall Study|Exclusion criteria|1|||
160468221|NCT00734578|579444316|FG001|Overall Study|Exclusion criteria|0|||
160468222|NCT00734578|579444317|FG002|Overall Study|Exclusion criteria|0|||
160468223|NCT00999596|579444318|FG000|Overall Study|Statistical population not required|101|||
160468224|NCT02085941|579444323|FG000|Overall Study|Lack of Efficacy|1|||
160468225|NCT02085941|579444324|FG001|Overall Study|Lack of Efficacy|0|||
160468226|NCT02085941|579444323|FG000|Overall Study|Death|6|||
160468227|NCT02085941|579444324|FG001|Overall Study|Death|1|||
160468228|NCT02085941|579444323|FG000|Overall Study|Lost to Follow-up|1|||
160468229|NCT02085941|579444324|FG001|Overall Study|Lost to Follow-up|0|||
160468230|NCT02085941|579444323|FG000|Overall Study|Physician Decision|0|||
160468231|NCT02085941|579444324|FG001|Overall Study|Physician Decision|2|||
160468232|NCT01629589|579444327|FG000|Overall Study|Protocol Violation|4|||
160468233|NCT01629589|579444328|FG001|Overall Study|Protocol Violation|2|||
160468234|NCT01629589|579444327|FG000|Overall Study|Lost to Follow-up|2|||
160468235|NCT01629589|579444328|FG001|Overall Study|Lost to Follow-up|1|||
160468236|NCT01629589|579444327|FG000|Overall Study|Withdrawal by Subject|2|||
160468237|NCT01629589|579444328|FG001|Overall Study|Withdrawal by Subject|3|||
160468238|NCT01629589|579444327|FG000|Overall Study|Did not receive study vaccine|0|||
160468239|NCT01629589|579444328|FG001|Overall Study|Did not receive study vaccine|1|||
160468240|NCT02079649|579444329|FG000|Overall Study|Lost to Follow-up|0|||
160468241|NCT02079649|579444330|FG001|Overall Study|Lost to Follow-up|0|||
160468242|NCT02079649|579444331|FG002|Overall Study|Lost to Follow-up|0|||
160468243|NCT02079649|579444332|FG003|Overall Study|Lost to Follow-up|1|||
160468244|NCT02079649|579444329|FG000|Overall Study|Withdrawal by Subject|0|||
160468245|NCT02079649|579444330|FG001|Overall Study|Withdrawal by Subject|0|||
160468246|NCT02079649|579444331|FG002|Overall Study|Withdrawal by Subject|0|||
160468247|NCT02079649|579444332|FG003|Overall Study|Withdrawal by Subject|1|||
160468248|NCT02079649|579444329|FG000|Overall Study|Randomization error (prior to treatment)|1|||
160468249|NCT02079649|579444330|FG001|Overall Study|Randomization error (prior to treatment)|0|||
160468250|NCT02079649|579444331|FG002|Overall Study|Randomization error (prior to treatment)|1|||
160468251|NCT02079649|579444332|FG003|Overall Study|Randomization error (prior to treatment)|0|||
160468252|NCT01932970|579444354|FG000|Overall Study|Withdrawal by Subject|5|||
160468253|NCT01932970|579444354|FG000|Overall Study|Death|1|||
160468254|NCT01932970|579444354|FG000|Overall Study|Lost to Follow-up|2|||
160468255|NCT01932970|579444354|FG000|Overall Study|Protocol Specified Criteria|10|||
160468256|NCT03739866|579444358|FG000|Overall Study|Lost to Follow-up|0|||
160468257|NCT03739866|579444359|FG001|Overall Study|Lost to Follow-up|0|||
160598809|NCT02137837|579907831|FG000|Overall Study|Refusal unrelated to adverse event|2|||
160598810|NCT02137837|579907832|FG001|Overall Study|Refusal unrelated to adverse event|2|||
160598811|NCT02137837|579907833|FG002|Overall Study|Refusal unrelated to adverse event|1|||
160598812|NCT02137837|579907831|FG000|Overall Study|Progression/relapse|9|||
160468258|NCT03739866|579444360|FG002|Overall Study|Lost to Follow-up|0|||
160468259|NCT03739866|579444361|FG003|Overall Study|Lost to Follow-up|1|||
160468260|NCT03739866|579444362|FG004|Overall Study|Lost to Follow-up|0|||
160468261|NCT03739866|579444363|FG005|Overall Study|Lost to Follow-up|0|||
160468262|NCT03739866|579444364|FG006|Overall Study|Lost to Follow-up|0|||
160468263|NCT03739866|579444365|FG007|Overall Study|Lost to Follow-up|0|||
160468264|NCT03739866|579444358|FG000|Overall Study|Enrolled but not treated|0|||
160468265|NCT03739866|579444359|FG001|Overall Study|Enrolled but not treated|0|||
160468266|NCT03739866|579444360|FG002|Overall Study|Enrolled but not treated|1|||
160468267|NCT03739866|579444361|FG003|Overall Study|Enrolled but not treated|0|||
160468268|NCT03739866|579444362|FG004|Overall Study|Enrolled but not treated|1|||
160468269|NCT03739866|579444363|FG005|Overall Study|Enrolled but not treated|0|||
160468270|NCT03739866|579444364|FG006|Overall Study|Enrolled but not treated|0|||
160468271|NCT03739866|579444365|FG007|Overall Study|Enrolled but not treated|0|||
160468272|NCT00836498|579444366|FG000|Overall Study|Adverse Event|1|||
160468273|NCT00836498|579444367|FG001|Overall Study|Adverse Event|0|||
160468274|NCT00836498|579444366|FG000|Overall Study|Lost to Follow-up|1|||
160468275|NCT00836498|579444367|FG001|Overall Study|Lost to Follow-up|0|||
160659254|NCT02880761|580134485|FG000|Overall Study|Lost to Follow-up|3|||
160598813|NCT02137837|579907832|FG001|Overall Study|Progression/relapse|7|||
160598814|NCT02137837|579907833|FG002|Overall Study|Progression/relapse|7|||
160598815|NCT02137837|579907831|FG000|Overall Study|Not protocol specified|2|||
160598816|NCT02137837|579907832|FG001|Overall Study|Not protocol specified|1|||
160598817|NCT02137837|579907833|FG002|Overall Study|Not protocol specified|3|||
160598818|NCT01181141|579907834|FG000|Overall Study|Adverse Event|2|||
160598819|NCT01181141|579907835|FG001|Overall Study|Adverse Event|1|||
160598820|NCT01181141|579907834|FG000|Overall Study|Lack of Efficacy|1|||
160598821|NCT01181141|579907835|FG001|Overall Study|Lack of Efficacy|0|||
160598822|NCT01181141|579907834|FG000|Overall Study|Lost to Follow-up|1|||
160598823|NCT01181141|579907835|FG001|Overall Study|Lost to Follow-up|1|||
160598824|NCT01181141|579907834|FG000|Overall Study|Physician Decision|2|||
160468276|NCT00836498|579444366|FG000|Overall Study|Withdrawal by Subject|2|||
160468277|NCT00836498|579444367|FG001|Overall Study|Withdrawal by Subject|1|||
160468278|NCT01034306|579444368|FG000|Overall Study|Adverse Event|1|||
160468279|NCT01034306|579444369|FG001|Overall Study|Adverse Event|0|||
160468280|NCT01034306|579444368|FG000|Overall Study|Lost to Follow-up|0|||
160598825|NCT01181141|579907835|FG001|Overall Study|Physician Decision|0|||
160598826|NCT01181141|579907834|FG000|Overall Study|Protocol Violation|3|||
160598827|NCT01181141|579907835|FG001|Overall Study|Protocol Violation|1|||
160598828|NCT01181141|579907834|FG000|Overall Study|Withdrawal by Subject|3|||
160598829|NCT01181141|579907835|FG001|Overall Study|Withdrawal by Subject|1|||
160598830|NCT00290589|579907836|FG000|Overall Study|Lost to Follow-up|2|||
160598831|NCT00290589|579907837|FG001|Overall Study|Lost to Follow-up|2|||
160598832|NCT00118911|579907838|FG000|Overall Study|Withdrawal by Subject|2|||
160598833|NCT00118911|579907839|FG001|Overall Study|Withdrawal by Subject|5|||
160598834|NCT03496662|579907840|FG000|Overall Study|Adverse Event|0|||
160598835|NCT03496662|579907841|FG001|Overall Study|Adverse Event|0|||
160598836|NCT03496662|579907842|FG002|Overall Study|Adverse Event|4|||
160598837|NCT03496662|579907840|FG000|Overall Study|Withdrawal by Subject|1|||
160598838|NCT03496662|579907841|FG001|Overall Study|Withdrawal by Subject|0|||
160598839|NCT03496662|579907842|FG002|Overall Study|Withdrawal by Subject|2|||
160598840|NCT03496662|579907840|FG000|Overall Study|Death|0|||
160598841|NCT03496662|579907841|FG001|Overall Study|Death|0|||
160598842|NCT03496662|579907842|FG002|Overall Study|Death|2|||
160598843|NCT03496662|579907840|FG000|Overall Study|Noncompliance|0|||
160598844|NCT03496662|579907841|FG001|Overall Study|Noncompliance|0|||
160598845|NCT03496662|579907842|FG002|Overall Study|Noncompliance|1|||
160598846|NCT01467661|579907843|FG000|Overall Study|Adverse Event|16|||
160598847|NCT01467661|579907843|FG000|Overall Study|Withdrawal by Subject|1|||
160598848|NCT01467661|579907843|FG000|Overall Study|Lack of Efficacy|3|||
160598849|NCT01467661|579907843|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
160598850|NCT00691093|579907844|FG000|Overall Study|Adverse Event|1|||
160598851|NCT00691093|579907844|FG000|Overall Study|Lost to Follow-up|1|||
160598852|NCT00691093|579907844|FG000|Overall Study|Lack of Efficacy|1|||
160598853|NCT00691093|579907844|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
160598854|NCT03814005|579907848|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
160598855|NCT03814005|579907849|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
160598856|NCT03814005|579907850|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
160598857|NCT03814005|579907848|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
160598858|NCT03814005|579907849|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
160598859|NCT03814005|579907850|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
160598860|NCT03814005|579907848|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
160598861|NCT03814005|579907849|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
160598862|NCT03814005|579907850|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
160598863|NCT03814005|579907848|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
160598864|NCT03814005|579907849|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
160598865|NCT03814005|579907850|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
160598866|NCT03814005|579907848|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
160468281|NCT01034306|579444369|FG001|Overall Study|Lost to Follow-up|1|||
160598867|NCT03814005|579907849|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
160598868|NCT03814005|579907850|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
160598869|NCT03814005|579907848|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
160598870|NCT03814005|579907849|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
160598871|NCT03814005|579907850|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
160598872|NCT03395223|579907851|FG000|Overall Study|Lost to Follow-up|3|||
160598873|NCT03395223|579907851|FG000|Overall Study|Other|1|||
160598874|NCT00810810|579907852|FG000|Overall Study|Withdrawal by Subject|0|||
160598875|NCT00810810|579907853|FG001|Overall Study|Withdrawal by Subject|8|||
160598876|NCT00810810|579907854|FG002|Overall Study|Withdrawal by Subject|10|||
160598877|NCT00810810|579907855|FG003|Overall Study|Withdrawal by Subject|8|||
160598878|NCT00810810|579907852|FG000|Overall Study|Physician Decision|0|||
160598879|NCT00810810|579907853|FG001|Overall Study|Physician Decision|3|||
160598880|NCT00810810|579907854|FG002|Overall Study|Physician Decision|1|||
160598881|NCT00810810|579907855|FG003|Overall Study|Physician Decision|5|||
160598882|NCT01896856|579907856|FG000|Overall Study|Transportation issues / Non-compliance|0|||
160598883|NCT01896856|579907857|FG001|Overall Study|Transportation issues / Non-compliance|0|||
160598884|NCT01896856|579907858|FG002|Overall Study|Transportation issues / Non-compliance|1|||
160598885|NCT01896856|579907859|FG003|Overall Study|Transportation issues / Non-compliance|0|||
160598886|NCT01896856|579907860|FG004|Overall Study|Transportation issues / Non-compliance|0|||
160598887|NCT01896856|579907861|FG005|Overall Study|Transportation issues / Non-compliance|0|||
160598888|NCT01156532|579907862|FG000|Overall Study|Family Reasons|1|||
160598889|NCT01156532|579907862|FG000|Overall Study|Lost to Follow-up|1|||
160598890|NCT02563925|579907865|FG000|Overall Study|Withdrawal by Subject|2|||
160598891|NCT00282867|579907869|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
160598892|NCT00282867|579907870|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
160598893|NCT00282867|579907871|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
160598894|NCT01700985|579907872|FG000|Overall Study|Incarcerated|0|||
160598895|NCT01700985|579907873|FG001|Overall Study|Incarcerated|1|||
160598896|NCT00965146|579907874|FG000|Overall Study|Death|7|||
160598897|NCT00965146|579907874|FG000|Overall Study|Lost to Follow-up|22|||
160598898|NCT00965146|579907874|FG000|Overall Study|Withdrawal by Subject|17|||
160598899|NCT00965146|579907874|FG000|Overall Study|Unable to return|1|||
160598900|NCT00965146|579907874|FG000|Overall Study|Unwilling to return|11|||
160598901|NCT00965146|579907874|FG000|Overall Study|Intercurrent illness|1|||
160598902|NCT00965146|579907874|FG000|Overall Study|Revision / Removal of Study Implant|6|||
160598903|NCT00965146|579907874|FG000|Overall Study|Overall Study Termination|145|||
160598904|NCT05067452|579907875|FG000|Overall Study|Lost to Follow-up|0|||
160598905|NCT05067452|579907876|FG001|Overall Study|Lost to Follow-up|4|||
160598906|NCT01148693|579907877|FG000|Overall Study|Attempts for cannulation were failed|13|||
160659255|NCT02880761|580134486|FG001|Overall Study|Lost to Follow-up|4|||
160598907|NCT01148693|579907878|FG001|Overall Study|Attempts for cannulation were failed|10|||
160598908|NCT01135017|579907879|FG000|Overall Study|Adverse Event|3|||
160598909|NCT01135017|579907880|FG001|Overall Study|Adverse Event|8|||
160598910|NCT01135017|579907879|FG000|Overall Study|Other than above|3|||
160598911|NCT01135017|579907880|FG001|Overall Study|Other than above|4|||
160598912|NCT00432562|579907884|FG000|Overall Study|Death|3|||
160598913|NCT00432562|579907885|FG001|Overall Study|Death|0|||
160598914|NCT03970824|579907886|FG000|Overall Study|Withdrawal by Subject|1|||
160598915|NCT03970824|579907887|FG001|Overall Study|Withdrawal by Subject|1|||
160598916|NCT03970824|579907888|FG002|Overall Study|Withdrawal by Subject|3|||
160598917|NCT03970824|579907886|FG000|Overall Study|Lost to Follow-up|0|||
160598918|NCT03970824|579907887|FG001|Overall Study|Lost to Follow-up|2|||
160598919|NCT03970824|579907888|FG002|Overall Study|Lost to Follow-up|1|||
160468282|NCT01034306|579444368|FG000|Overall Study|Withdrawal by Subject|2|||
160468283|NCT01034306|579444369|FG001|Overall Study|Withdrawal by Subject|2|||
160468284|NCT01034306|579444368|FG000|Overall Study|hospitalized and decided to stop|1|||
160468285|NCT01034306|579444369|FG001|Overall Study|hospitalized and decided to stop|0|||
160468286|NCT01034306|579444368|FG000|Overall Study|Noncomplience|1|||
160468287|NCT01034306|579444369|FG001|Overall Study|Noncomplience|0|||
160468288|NCT03057600|579444370|FG000|Overall Study|Adverse Event|0|||
160468289|NCT03057600|579444371|FG001|Overall Study|Adverse Event|0|||
160468290|NCT03057600|579444372|FG002|Overall Study|Adverse Event|4|||
160468291|NCT03057600|579444373|FG003|Overall Study|Adverse Event|0|||
160468292|NCT03057600|579444370|FG000|Overall Study|Radiologic Disease Progression|8|||
160468293|NCT03057600|579444371|FG001|Overall Study|Radiologic Disease Progression|7|||
160468294|NCT03057600|579444372|FG002|Overall Study|Radiologic Disease Progression|13|||
160468295|NCT03057600|579444373|FG003|Overall Study|Radiologic Disease Progression|10|||
160468296|NCT03057600|579444370|FG000|Overall Study|Symptomatic Deterioration|0|||
160468297|NCT03057600|579444371|FG001|Overall Study|Symptomatic Deterioration|1|||
160468298|NCT03057600|579444372|FG002|Overall Study|Symptomatic Deterioration|1|||
160468299|NCT03057600|579444373|FG003|Overall Study|Symptomatic Deterioration|0|||
160468300|NCT03057600|579444370|FG000|Overall Study|Investigator Decision|0|||
160468301|NCT03057600|579444371|FG001|Overall Study|Investigator Decision|0|||
160468302|NCT03057600|579444372|FG002|Overall Study|Investigator Decision|1|||
160468303|NCT03057600|579444373|FG003|Overall Study|Investigator Decision|0|||
160468304|NCT03057600|579444370|FG000|Overall Study|Study Termination by Sponsor|0|||
160468305|NCT03057600|579444371|FG001|Overall Study|Study Termination by Sponsor|0|||
160468306|NCT03057600|579444372|FG002|Overall Study|Study Termination by Sponsor|0|||
160468307|NCT03057600|579444373|FG003|Overall Study|Study Termination by Sponsor|2|||
160468308|NCT03057600|579444370|FG000|Overall Study|Withdrawal by Subject|0|||
160468309|NCT03057600|579444371|FG001|Overall Study|Withdrawal by Subject|1|||
160468310|NCT03057600|579444372|FG002|Overall Study|Withdrawal by Subject|0|||
160468311|NCT03057600|579444373|FG003|Overall Study|Withdrawal by Subject|0|||
160468312|NCT03057600|579444370|FG000|Overall Study|Other, Not Specified|1|||
160468313|NCT03057600|579444371|FG001|Overall Study|Other, Not Specified|1|||
160468314|NCT03057600|579444372|FG002|Overall Study|Other, Not Specified|1|||
160468315|NCT03057600|579444373|FG003|Overall Study|Other, Not Specified|1|||
160468316|NCT02384382|579444378|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
160468317|NCT02384382|579444378|FG000|Overall Study|Death|1|||
160468318|NCT02384382|579444378|FG000|Overall Study|Adverse Event|1|||
160468319|NCT02384382|579444378|FG000|Overall Study|Disease progression|16|||
160468320|NCT01953692|579444379|FG000|Overall Study|Adverse Event|5|||
160468321|NCT01953692|579444380|FG001|Overall Study|Adverse Event|2|||
160468322|NCT01953692|579444381|FG002|Overall Study|Adverse Event|4|||
160468323|NCT01953692|579444382|FG003|Overall Study|Adverse Event|2|||
160468324|NCT01953692|579444383|FG004|Overall Study|Adverse Event|1|||
160468325|NCT01953692|579444384|FG005|Overall Study|Adverse Event|2|||
160468326|NCT01953692|579444385|FG006|Overall Study|Adverse Event|0|||
160468327|NCT01953692|579444386|FG007|Overall Study|Adverse Event|0|||
160468328|NCT01953692|579444387|FG008|Overall Study|Adverse Event|0|||
160468329|NCT01953692|579444379|FG000|Overall Study|Clinical Progression|0|||
160468330|NCT01953692|579444380|FG001|Overall Study|Clinical Progression|15|||
160468331|NCT01953692|579444381|FG002|Overall Study|Clinical Progression|7|||
160598920|NCT03970824|579907886|FG000|Overall Study|Adverse Event|1|||
160468332|NCT01953692|579444382|FG003|Overall Study|Clinical Progression|5|||
160468333|NCT01953692|579444383|FG004|Overall Study|Clinical Progression|0|||
160468334|NCT01953692|579444384|FG005|Overall Study|Clinical Progression|7|||
160598921|NCT03970824|579907887|FG001|Overall Study|Adverse Event|0|||
160598922|NCT03970824|579907888|FG002|Overall Study|Adverse Event|0|||
160598923|NCT00673894|579907898|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
160598924|NCT00673894|579907899|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
160598925|NCT00673894|579907898|FG000|First Intervention 4 Weeks|Adverse Event|1|||
160598926|NCT00673894|579907899|FG001|First Intervention 4 Weeks|Adverse Event|0|||
160598927|NCT03549117|579907904|FG000|Overall Study|Withdrawal by Subject|1|||
160598928|NCT03549117|579907905|FG001|Overall Study|Withdrawal by Subject|0|||
160468335|NCT01953692|579444385|FG006|Overall Study|Clinical Progression|20|||
160598929|NCT03148756|579907906|FG000|Overall Study|Study Terminated|0|||
160598930|NCT03148756|579907907|FG001|Overall Study|Study Terminated|1|||
160468336|NCT01953692|579444386|FG007|Overall Study|Clinical Progression|3|||
160468337|NCT01953692|579444387|FG008|Overall Study|Clinical Progression|3|||
160468338|NCT01953692|579444379|FG000|Overall Study|Death|5|||
160468339|NCT01953692|579444380|FG001|Overall Study|Death|0|||
160468340|NCT01953692|579444381|FG002|Overall Study|Death|2|||
160468341|NCT01953692|579444382|FG003|Overall Study|Death|2|||
160468342|NCT01953692|579444383|FG004|Overall Study|Death|1|||
160598931|NCT01736254|579907909|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
160598932|NCT01736254|579907909|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
160468343|NCT01953692|579444384|FG005|Overall Study|Death|3|||
160468344|NCT01953692|579444385|FG006|Overall Study|Death|6|||
160468345|NCT01953692|579444386|FG007|Overall Study|Death|2|||
160468346|NCT01953692|579444387|FG008|Overall Study|Death|1|||
160468347|NCT01953692|579444379|FG000|Overall Study|Excluded Medication|1|||
160468348|NCT01953692|579444380|FG001|Overall Study|Excluded Medication|0|||
160468349|NCT01953692|579444381|FG002|Overall Study|Excluded Medication|0|||
160468350|NCT01953692|579444382|FG003|Overall Study|Excluded Medication|0|||
160468351|NCT01953692|579444383|FG004|Overall Study|Excluded Medication|0|||
160468352|NCT01953692|579444384|FG005|Overall Study|Excluded Medication|0|||
160468353|NCT01953692|579444385|FG006|Overall Study|Excluded Medication|0|||
160468354|NCT01953692|579444386|FG007|Overall Study|Excluded Medication|0|||
160468355|NCT01953692|579444387|FG008|Overall Study|Excluded Medication|0|||
160468356|NCT01953692|579444379|FG000|Overall Study|Lost to Follow-up|1|||
160468357|NCT01953692|579444380|FG001|Overall Study|Lost to Follow-up|0|||
160468358|NCT01953692|579444381|FG002|Overall Study|Lost to Follow-up|3|||
160468359|NCT01953692|579444382|FG003|Overall Study|Lost to Follow-up|1|||
160468360|NCT01953692|579444383|FG004|Overall Study|Lost to Follow-up|0|||
160468361|NCT01953692|579444384|FG005|Overall Study|Lost to Follow-up|1|||
160468362|NCT01953692|579444385|FG006|Overall Study|Lost to Follow-up|0|||
160468363|NCT01953692|579444386|FG007|Overall Study|Lost to Follow-up|0|||
160468364|NCT01953692|579444387|FG008|Overall Study|Lost to Follow-up|0|||
160468365|NCT01953692|579444379|FG000|Overall Study|Physician Decision|11|||
160468366|NCT01953692|579444380|FG001|Overall Study|Physician Decision|4|||
160468367|NCT01953692|579444381|FG002|Overall Study|Physician Decision|2|||
160468368|NCT01953692|579444382|FG003|Overall Study|Physician Decision|2|||
160468369|NCT01953692|579444383|FG004|Overall Study|Physician Decision|1|||
160468370|NCT01953692|579444384|FG005|Overall Study|Physician Decision|2|||
160468371|NCT01953692|579444385|FG006|Overall Study|Physician Decision|4|||
160468372|NCT01953692|579444386|FG007|Overall Study|Physician Decision|1|||
160468373|NCT01953692|579444387|FG008|Overall Study|Physician Decision|0|||
160468374|NCT01953692|579444379|FG000|Overall Study|Protocol Violation|0|||
160598933|NCT04021706|579910068|FG000|Overall Study|Adverse Event|2|||
160468375|NCT01953692|579444380|FG001|Overall Study|Protocol Violation|2|||
160468376|NCT01953692|579444381|FG002|Overall Study|Protocol Violation|1|||
160468377|NCT01953692|579444382|FG003|Overall Study|Protocol Violation|0|||
160468378|NCT01953692|579444383|FG004|Overall Study|Protocol Violation|0|||
160468379|NCT01953692|579444384|FG005|Overall Study|Protocol Violation|0|||
160468380|NCT01953692|579444385|FG006|Overall Study|Protocol Violation|0|||
160468381|NCT01953692|579444386|FG007|Overall Study|Protocol Violation|1|||
160468382|NCT01953692|579444387|FG008|Overall Study|Protocol Violation|0|||
160468383|NCT01953692|579444379|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
160468384|NCT01953692|579444380|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
160468385|NCT01953692|579444381|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
160468386|NCT01953692|579444382|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
160468387|NCT01953692|579444383|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
160468388|NCT01953692|579444384|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
160468389|NCT01953692|579444385|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
160468390|NCT01953692|579444386|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
160468391|NCT01953692|579444387|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
160468392|NCT01953692|579444379|FG000|Overall Study|Withdrawal by Subject|4|||
160468393|NCT01953692|579444380|FG001|Overall Study|Withdrawal by Subject|2|||
160468394|NCT01953692|579444381|FG002|Overall Study|Withdrawal by Subject|1|||
160468395|NCT01953692|579444382|FG003|Overall Study|Withdrawal by Subject|2|||
160468396|NCT01953692|579444383|FG004|Overall Study|Withdrawal by Subject|0|||
160468397|NCT01953692|579444384|FG005|Overall Study|Withdrawal by Subject|3|||
160468398|NCT01953692|579444385|FG006|Overall Study|Withdrawal by Subject|2|||
160468399|NCT01953692|579444386|FG007|Overall Study|Withdrawal by Subject|1|||
160468400|NCT01953692|579444387|FG008|Overall Study|Withdrawal by Subject|1|||
160468401|NCT01822756|579444392|FG000|Overall Study|Adverse Event|0|||
160468402|NCT01822756|579444393|FG001|Overall Study|Adverse Event|0|||
160468403|NCT01822756|579444394|FG002|Overall Study|Adverse Event|0|||
160468404|NCT01822756|579444395|FG003|Overall Study|Adverse Event|2|||
160468405|NCT01822756|579444396|FG004|Overall Study|Adverse Event|0|||
160468406|NCT01822756|579444392|FG000|Overall Study|Disease progression|11|||
160468407|NCT01822756|579444393|FG001|Overall Study|Disease progression|1|||
160468408|NCT01822756|579444394|FG002|Overall Study|Disease progression|7|||
160468409|NCT01822756|579444395|FG003|Overall Study|Disease progression|2|||
160468410|NCT01822756|579444396|FG004|Overall Study|Disease progression|6|||
160468411|NCT01822756|579444392|FG000|Overall Study|Death|2|||
160468412|NCT01822756|579444393|FG001|Overall Study|Death|2|||
160468413|NCT01822756|579444394|FG002|Overall Study|Death|1|||
160468414|NCT01822756|579444395|FG003|Overall Study|Death|0|||
160468415|NCT01822756|579444396|FG004|Overall Study|Death|0|||
160468416|NCT01822756|579444392|FG000|Overall Study|Lost to Follow-up|1|||
160468417|NCT01822756|579444393|FG001|Overall Study|Lost to Follow-up|0|||
160468418|NCT01822756|579444394|FG002|Overall Study|Lost to Follow-up|1|||
160468419|NCT01822756|579444395|FG003|Overall Study|Lost to Follow-up|0|||
160598934|NCT04021706|579910069|FG001|Overall Study|Adverse Event|0|||
160598935|NCT04021706|579910068|FG000|Overall Study|Withdrawal by Subject|1|||
160598936|NCT04021706|579910069|FG001|Overall Study|Withdrawal by Subject|2|||
160598937|NCT04021706|579910068|FG000|Overall Study|Physician Decision|1|||
160468420|NCT01822756|579444396|FG004|Overall Study|Lost to Follow-up|1|||
160468421|NCT01822756|579444392|FG000|Overall Study|Physician Decision|0|||
160468422|NCT01822756|579444393|FG001|Overall Study|Physician Decision|1|||
160468423|NCT01822756|579444394|FG002|Overall Study|Physician Decision|0|||
160468424|NCT01822756|579444395|FG003|Overall Study|Physician Decision|0|||
160468425|NCT01822756|579444396|FG004|Overall Study|Physician Decision|0|||
160468426|NCT01822756|579444392|FG000|Overall Study|disease progression & patient preference|2|||
160468427|NCT01822756|579444393|FG001|Overall Study|disease progression & patient preference|0|||
160598938|NCT04021706|579910069|FG001|Overall Study|Physician Decision|0|||
160598939|NCT02332798|579910072|FG000|Overall Study|Unwilling to Participate in Study|0|||
160468428|NCT01822756|579444394|FG002|Overall Study|disease progression & patient preference|1|||
160468429|NCT01822756|579444395|FG003|Overall Study|disease progression & patient preference|0|||
160468430|NCT01822756|579444396|FG004|Overall Study|disease progression & patient preference|0|||
160468431|NCT01683409|579444397|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
160598940|NCT02332798|579910073|FG001|Overall Study|Unwilling to Participate in Study|1|||
160468432|NCT01683409|579444398|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
160468433|NCT01683409|579444399|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
160468434|NCT01683409|579444400|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
160468435|NCT01683409|579444401|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
160468436|NCT01683409|579444397|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
160468437|NCT01683409|579444398|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
160468438|NCT01683409|579444399|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
160468439|NCT01683409|579444400|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
160598941|NCT02332798|579910074|FG002|Overall Study|Unwilling to Participate in Study|1|||
160468440|NCT01683409|579444401|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
160468441|NCT01683409|579444397|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
160468442|NCT01683409|579444398|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
160598942|NCT02332798|579910072|FG000|Overall Study|Positive Urine Drug Test|0|||
160468443|NCT01683409|579444399|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
160468444|NCT01683409|579444400|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
160468445|NCT01683409|579444401|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
160468446|NCT01683409|579444397|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
160468447|NCT01683409|579444398|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
160468448|NCT01683409|579444399|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
160468449|NCT01683409|579444400|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
160468450|NCT01683409|579444401|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
160468451|NCT01683409|579444397|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
160468452|NCT01683409|579444398|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
160468453|NCT01683409|579444399|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
160468454|NCT01683409|579444400|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
160468455|NCT01683409|579444401|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
160468456|NCT01683409|579444397|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
160468457|NCT01683409|579444398|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
160468458|NCT01683409|579444399|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
160468459|NCT01683409|579444400|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
160468460|NCT01683409|579444401|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
160468461|NCT01683409|579444397|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
160468462|NCT01683409|579444398|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
160468463|NCT01683409|579444399|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
160468464|NCT01683409|579444400|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
160468465|NCT01683409|579444401|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
160468466|NCT01683409|579444397|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
160468467|NCT01683409|579444398|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
160468468|NCT01683409|579444399|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
160468469|NCT01683409|579444400|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
160468470|NCT01683409|579444401|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
160468471|NCT01683409|579444397|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
160468472|NCT01683409|579444398|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
160468473|NCT01683409|579444399|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
160468474|NCT01683409|579444400|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
160468475|NCT01683409|579444401|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
160468476|NCT01683409|579444397|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
160468477|NCT01683409|579444398|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
160468478|NCT01683409|579444399|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
160468479|NCT01683409|579444400|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
160468480|NCT01683409|579444401|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
160468481|NCT01683409|579444397|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
160468482|NCT01683409|579444398|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
160468483|NCT01683409|579444399|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
160468484|NCT01683409|579444400|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
160468485|NCT01683409|579444401|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
160468486|NCT00553332|579444403|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
160468487|NCT00467272|579444410|FG000|Overall Study|Pneumonia|2|||
160468488|NCT00467272|579444410|FG000|Overall Study|Thrombophlebitis|1|||
160468489|NCT01690624|579444416|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
160468490|NCT01690624|579444417|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
160468491|NCT01690624|579444418|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
160468492|NCT01690624|579444419|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
160468493|NCT01690624|579444416|FG000|Overall Study|Adverse event (other than DLT)|3|||
160468494|NCT01690624|579444417|FG001|Overall Study|Adverse event (other than DLT)|1|||
160468495|NCT01690624|579444418|FG002|Overall Study|Adverse event (other than DLT)|1|||
160468496|NCT01690624|579444419|FG003|Overall Study|Adverse event (other than DLT)|1|||
160598943|NCT02332798|579910073|FG001|Overall Study|Positive Urine Drug Test|1|||
160598944|NCT02332798|579910074|FG002|Overall Study|Positive Urine Drug Test|0|||
160598945|NCT02332798|579910072|FG000|Overall Study|Abnormal Laboratory Findings|1|||
160598946|NCT02332798|579910073|FG001|Overall Study|Abnormal Laboratory Findings|0|||
160598947|NCT02332798|579910074|FG002|Overall Study|Abnormal Laboratory Findings|0|||
160598948|NCT02688153|579910075|FG000|Overall Study|Death|7|||
160598949|NCT02688153|579910076|FG001|Overall Study|Death|5|||
160598950|NCT02688153|579910075|FG000|Overall Study|Withdrawal by Subject|4|||
160598951|NCT02688153|579910076|FG001|Overall Study|Withdrawal by Subject|2|||
160598952|NCT02688153|579910075|FG000|Overall Study|Valve Explant|1|||
160468497|NCT01690624|579444416|FG000|Overall Study|Withdrawal by Subject|0|||
160468498|NCT01690624|579444417|FG001|Overall Study|Withdrawal by Subject|0|||
160468499|NCT01690624|579444418|FG002|Overall Study|Withdrawal by Subject|1|||
160468500|NCT01690624|579444419|FG003|Overall Study|Withdrawal by Subject|0|||
160598953|NCT02688153|579910076|FG001|Overall Study|Valve Explant|0|||
160598954|NCT02688153|579910075|FG000|Overall Study|Conversion to Commercial Valve|3|||
160598955|NCT02688153|579910076|FG001|Overall Study|Conversion to Commercial Valve|0|||
160598956|NCT00595868|579910077|FG000|Overall Study|Lost to Follow-up|45|||
160598957|NCT00595868|579910078|FG001|Overall Study|Lost to Follow-up|50|||
160598958|NCT00107172|579910079|FG000|Overall Study|Withdrawal by Subject|1|||
160598959|NCT00107172|579910080|FG001|Overall Study|Withdrawal by Subject|0|||
160598960|NCT00107172|579910079|FG000|Overall Study|Death|0|||
160598961|NCT00107172|579910080|FG001|Overall Study|Death|2|||
160598962|NCT00107172|579910079|FG000|Overall Study|Other Reason|4|||
160598963|NCT00107172|579910080|FG001|Overall Study|Other Reason|3|||
160598964|NCT00859573|579910081|FG000|Overall Study|Withdrawal by Subject|4|||
160598965|NCT00859573|579910082|FG001|Overall Study|Withdrawal by Subject|1|||
160598966|NCT00859573|579910081|FG000|Overall Study|Physician Decision|1|||
160598967|NCT00859573|579910082|FG001|Overall Study|Physician Decision|1|||
160598968|NCT01135394|579910094|FG000|Screening|Lost to Follow-up|2|||
160468501|NCT01690624|579444416|FG000|Overall Study|Sponsor is ending trial|0|||
160598969|NCT01135394|579910094|FG000|Screening|Withdrawal by Subject|10|||
160598970|NCT01135394|579910094|FG000|Screening|Screening failure|16|||
160598971|NCT01135394|579910094|FG000|Screening|Physician Decision|5|||
160598972|NCT01135394|579910094|FG000|Baseline Assessment|Withdrawal by Subject|9|||
160468502|NCT01690624|579444417|FG001|Overall Study|Sponsor is ending trial|0|||
160468503|NCT01690624|579444418|FG002|Overall Study|Sponsor is ending trial|0|||
160468504|NCT01690624|579444419|FG003|Overall Study|Sponsor is ending trial|1|||
160468505|NCT01690624|579444416|FG000|Overall Study|Physician Decision|0|||
160468506|NCT01690624|579444417|FG001|Overall Study|Physician Decision|0|||
160468507|NCT01690624|579444418|FG002|Overall Study|Physician Decision|0|||
160468508|NCT01690624|579444419|FG003|Overall Study|Physician Decision|1|||
160468509|NCT01690624|579444416|FG000|Overall Study|Withdrawal by Subject|0|||
160468510|NCT01690624|579444417|FG001|Overall Study|Withdrawal by Subject|1|||
160468511|NCT01690624|579444418|FG002|Overall Study|Withdrawal by Subject|0|||
160468512|NCT01690624|579444419|FG003|Overall Study|Withdrawal by Subject|0|||
160468513|NCT01690624|579444416|FG000|Overall Study|Lack of Efficacy|1|||
160468514|NCT01690624|579444417|FG001|Overall Study|Lack of Efficacy|1|||
160468515|NCT01690624|579444418|FG002|Overall Study|Lack of Efficacy|3|||
160468516|NCT01690624|579444419|FG003|Overall Study|Lack of Efficacy|0|||
160468517|NCT04445831|579444420|FG000|Overall Study|Withdrawal by Subject|2|||
160468518|NCT04445831|579444421|FG001|Overall Study|Withdrawal by Subject|1|||
160468519|NCT04445831|579444422|FG002|Overall Study|Withdrawal by Subject|1|||
160468520|NCT04445831|579444423|FG003|Overall Study|Withdrawal by Subject|0|||
160468521|NCT04445831|579444424|FG004|Overall Study|Withdrawal by Subject|0|||
160468522|NCT04445831|579444425|FG005|Overall Study|Withdrawal by Subject|0|||
160468523|NCT04445831|579444426|FG006|Overall Study|Withdrawal by Subject|0|||
160468524|NCT04445831|579444420|FG000|Overall Study|Subject withdrawal by caregiver|0|||
160468525|NCT04445831|579444421|FG001|Overall Study|Subject withdrawal by caregiver|1|||
160468526|NCT04445831|579444422|FG002|Overall Study|Subject withdrawal by caregiver|0|||
160468527|NCT04445831|579444423|FG003|Overall Study|Subject withdrawal by caregiver|0|||
160468528|NCT04445831|579444424|FG004|Overall Study|Subject withdrawal by caregiver|0|||
160468529|NCT04445831|579444425|FG005|Overall Study|Subject withdrawal by caregiver|0|||
160468530|NCT04445831|579444426|FG006|Overall Study|Subject withdrawal by caregiver|0|||
160468531|NCT04701203|579444427|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
160468532|NCT04701203|579444428|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
160468533|NCT04701203|579444429|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
160468534|NCT04701203|579444427|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
160468535|NCT04701203|579444428|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
160468536|NCT04701203|579444429|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
160468537|NCT04701203|579444427|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
160468538|NCT04701203|579444428|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
160468539|NCT04701203|579444429|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
160468540|NCT04701203|579444427|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
160468541|NCT04701203|579444428|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
160468542|NCT04701203|579444429|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
160468543|NCT02434328|579444430|FG000|Overall Study|Adverse Event|9|||
160468544|NCT02434328|579444431|FG001|Overall Study|Adverse Event|4|||
160468545|NCT02434328|579444430|FG000|Overall Study|Lack of Efficacy|0|||
160468546|NCT02434328|579444431|FG001|Overall Study|Lack of Efficacy|2|||
160468547|NCT02434328|579444430|FG000|Overall Study|Physician Decision|0|||
160468548|NCT02434328|579444431|FG001|Overall Study|Physician Decision|1|||
160468549|NCT02434328|579444430|FG000|Overall Study|Withdrawal by Subject|12|||
160468550|NCT02434328|579444431|FG001|Overall Study|Withdrawal by Subject|21|||
160468551|NCT02434328|579444430|FG000|Overall Study|Death|4|||
160468552|NCT02434328|579444431|FG001|Overall Study|Death|7|||
160468553|NCT02434328|579444430|FG000|Overall Study|Lost to Follow-up|1|||
160468554|NCT02434328|579444431|FG001|Overall Study|Lost to Follow-up|6|||
160468555|NCT02434328|579444430|FG000|Overall Study|Other|4|||
160468556|NCT02434328|579444431|FG001|Overall Study|Other|1|||
160468557|NCT01563185|579444432|FG000|Overall Study|Withdrawal by Subject|1|||
160468558|NCT01563185|579444432|FG000|Overall Study|Non-Compliance with study drug|1|||
160468559|NCT04577651|579444433|FG000|Overall Study|Screen Failure|7|||
160468560|NCT04577651|579444433|FG000|Overall Study|Adverse Event|1|||
160468561|NCT04577651|579444433|FG000|Overall Study|Death|1|||
160468562|NCT04577651|579444433|FG000|Overall Study|Physician Decision|1|||
160468563|NCT04577651|579444433|FG000|Overall Study|Withdrawal by Subject|3|||
160468564|NCT03147287|579444434|FG000|Overall Study|Randomized Not Treated|2|||
160468565|NCT03147287|579444435|FG001|Overall Study|Randomized Not Treated|1|||
160468566|NCT03147287|579444436|FG002|Overall Study|Randomized Not Treated|1|||
160468567|NCT03147287|579444434|FG000|Overall Study|Progressive Disease RECIST|31|||
160468568|NCT03147287|579444435|FG001|Overall Study|Progressive Disease RECIST|72|||
160468569|NCT03147287|579444436|FG002|Overall Study|Progressive Disease RECIST|32|||
160468570|NCT03147287|579444434|FG000|Overall Study|Progressive Disease not RECIST|13|||
160468571|NCT03147287|579444435|FG001|Overall Study|Progressive Disease not RECIST|21|||
160468572|NCT03147287|579444436|FG002|Overall Study|Progressive Disease not RECIST|13|||
160468573|NCT03147287|579444434|FG000|Overall Study|Physician Decision|1|||
160468574|NCT03147287|579444435|FG001|Overall Study|Physician Decision|2|||
160468575|NCT03147287|579444436|FG002|Overall Study|Physician Decision|1|||
160468576|NCT03147287|579444434|FG000|Overall Study|Intercurrent illness|0|||
160468577|NCT03147287|579444435|FG001|Overall Study|Intercurrent illness|1|||
160468578|NCT03147287|579444436|FG002|Overall Study|Intercurrent illness|0|||
160468579|NCT03147287|579444434|FG000|Overall Study|Withdrawal by Subject|2|||
160468580|NCT03147287|579444435|FG001|Overall Study|Withdrawal by Subject|3|||
160468581|NCT03147287|579444436|FG002|Overall Study|Withdrawal by Subject|2|||
160468582|NCT03147287|579444434|FG000|Overall Study|Patient Non-Compliance|0|||
160468583|NCT03147287|579444435|FG001|Overall Study|Patient Non-Compliance|2|||
160468584|NCT03147287|579444436|FG002|Overall Study|Patient Non-Compliance|0|||
160468585|NCT03147287|579444434|FG000|Overall Study|Patient moved|0|||
160468586|NCT03147287|579444435|FG001|Overall Study|Patient moved|1|||
160468587|NCT03147287|579444436|FG002|Overall Study|Patient moved|0|||
160468588|NCT03147287|579444434|FG000|Overall Study|Arm A crossover without PD|1|||
160468589|NCT03147287|579444435|FG001|Overall Study|Arm A crossover without PD|0|||
160468590|NCT03147287|579444436|FG002|Overall Study|Arm A crossover without PD|0|||
160468591|NCT03147287|579444434|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
160468592|NCT03147287|579444435|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
160468593|NCT03147287|579444436|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
160468594|NCT02556918|579446025|FG000|Overall Study|Protocol Violation|5|||
160468595|NCT02556918|579446026|FG001|Overall Study|Protocol Violation|6|||
160468596|NCT02556918|579446025|FG000|Overall Study|Withdrawal by Subject|4|||
160468597|NCT02556918|579446026|FG001|Overall Study|Withdrawal by Subject|4|||
160468598|NCT04511702|579446034|FG000|Overall Study|Lost to Follow-up|3|||
160468599|NCT04511702|579446035|FG001|Overall Study|Lost to Follow-up|0|||
160468600|NCT04511702|579446036|FG002|Overall Study|Lost to Follow-up|4|||
160468601|NCT04511702|579446034|FG000|Overall Study|Withdrawal by Subject|17|||
160468602|NCT04511702|579446035|FG001|Overall Study|Withdrawal by Subject|1|||
160468603|NCT04511702|579446036|FG002|Overall Study|Withdrawal by Subject|8|||
160468604|NCT05349721|579446037|FG000|Part A (24 Weeks)|Adverse Event|9|||
160468605|NCT05349721|579446038|FG001|Part A (24 Weeks)|Adverse Event|2|||
160468606|NCT05349721|579446037|FG000|Part A (24 Weeks)|Death|8|||
160468607|NCT05349721|579446038|FG001|Part A (24 Weeks)|Death|3|||
160468608|NCT05349721|579446037|FG000|Part A (24 Weeks)|Disease Progression|1|||
160468609|NCT05349721|579446038|FG001|Part A (24 Weeks)|Disease Progression|1|||
160468610|NCT05349721|579446037|FG000|Part A (24 Weeks)|Screen Failure|2|||
160468611|NCT05349721|579446038|FG001|Part A (24 Weeks)|Screen Failure|0|||
160468612|NCT05349721|579446037|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
160468613|NCT05349721|579446038|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
160468614|NCT05349721|579446037|FG000|Part A (24 Weeks)|Other Than Specified|5|||
160468615|NCT05349721|579446038|FG001|Part A (24 Weeks)|Other Than Specified|1|||
160468616|NCT05349721|579446037|FG000|Part B (28 Weeks)|Adverse Event|3|||
160468617|NCT05349721|579446038|FG001|Part B (28 Weeks)|Adverse Event|0|||
160468618|NCT05349721|579446037|FG000|Part B (28 Weeks)|Death|21|||
160468619|NCT05349721|579446038|FG001|Part B (28 Weeks)|Death|11|||
160468620|NCT05349721|579446037|FG000|Part B (28 Weeks)|Disease Progression|2|||
160468621|NCT05349721|579446038|FG001|Part B (28 Weeks)|Disease Progression|1|||
160468622|NCT05349721|579446037|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
160468623|NCT05349721|579446038|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
160468624|NCT05349721|579446037|FG000|Part B (28 Weeks)|Physician Decision|1|||
160468625|NCT05349721|579446038|FG001|Part B (28 Weeks)|Physician Decision|0|||
160468626|NCT05349721|579446037|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
160468627|NCT05349721|579446038|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
160468628|NCT05349721|579446037|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
160468629|NCT05349721|579446038|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
160598973|NCT01135394|579910094|FG000|Baseline Assessment|Physician Decision|3|||
160598974|NCT01135394|579910094|FG000|Baseline Assessment|Lost to Follow-up|2|||
160598975|NCT01135394|579910094|FG000|Baseline Assessment|Adverse Event|1|||
160468630|NCT05349721|579446037|FG000|Part B (28 Weeks)|Other Than Specified|4|||
160468631|NCT05349721|579446038|FG001|Part B (28 Weeks)|Other Than Specified|2|||
160468632|NCT05349721|579446037|FG000|Part C (108 Weeks)|Death|0|||
160468633|NCT05349721|579446038|FG001|Part C (108 Weeks)|Death|1|||
160468634|NCT05349721|579446037|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
160468635|NCT05349721|579446038|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
160468636|NCT05349721|579446037|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
160598976|NCT01135394|579910094|FG000|Study Treatment|Withdrawal by Subject|1|||
160468637|NCT05349721|579446038|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
160468638|NCT05349721|579446037|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
160598977|NCT01135394|579910094|FG000|Study Treatment|Physician Decision|1|||
160598978|NCT01135394|579910094|FG000|Study Treatment|Adverse Event|2|||
160598979|NCT04432376|579910095|FG000|Double-blind Treatment Period|Adverse Event|2|||
160598980|NCT04432376|579910096|FG001|Double-blind Treatment Period|Adverse Event|6|||
160598981|NCT04432376|579910097|FG002|Double-blind Treatment Period|Adverse Event|0|||
160598982|NCT04432376|579910095|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
160598983|NCT04432376|579910096|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
160598984|NCT04432376|579910097|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
160598985|NCT04432376|579910095|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
160598986|NCT04432376|579910096|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
160598987|NCT04432376|579910097|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160598988|NCT04432376|579910095|FG000|Double-blind Treatment Period|Protocol Violation|0|||
160598989|NCT04432376|579910096|FG001|Double-blind Treatment Period|Protocol Violation|1|||
160598990|NCT04432376|579910097|FG002|Double-blind Treatment Period|Protocol Violation|0|||
160598991|NCT04432376|579910095|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
160598992|NCT04432376|579910096|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
160598993|NCT04432376|579910097|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
160598994|NCT00462488|579910098|FG000|Overall Study|Protocol Violation|1|||
160598995|NCT00462488|579910099|FG001|Overall Study|Protocol Violation|0|||
160598996|NCT00462488|579910098|FG000|Overall Study|Lack of Efficacy|19|||
160598997|NCT00462488|579910099|FG001|Overall Study|Lack of Efficacy|17|||
160598998|NCT01742091|579910104|FG000|Overall Study|Adverse Event|0|||
160598999|NCT01742091|579910105|FG001|Overall Study|Adverse Event|0|||
160599000|NCT01742091|579910106|FG002|Overall Study|Adverse Event|0|||
160599001|NCT01742091|579910107|FG003|Overall Study|Adverse Event|0|||
160599002|NCT01742091|579910108|FG004|Overall Study|Adverse Event|1|||
160599003|NCT01742091|579910109|FG005|Overall Study|Adverse Event|0|||
160599004|NCT01742091|579910104|FG000|Overall Study|Physician Decision|0|||
160599005|NCT01742091|579910105|FG001|Overall Study|Physician Decision|0|||
160599006|NCT01742091|579910106|FG002|Overall Study|Physician Decision|0|||
160599007|NCT01742091|579910107|FG003|Overall Study|Physician Decision|0|||
160599008|NCT01742091|579910108|FG004|Overall Study|Physician Decision|0|||
160599009|NCT01742091|579910109|FG005|Overall Study|Physician Decision|1|||
160599010|NCT01742091|579910104|FG000|Overall Study|Withdrawal by Subject|0|||
160599011|NCT01742091|579910105|FG001|Overall Study|Withdrawal by Subject|0|||
160599012|NCT01742091|579910106|FG002|Overall Study|Withdrawal by Subject|0|||
160599013|NCT01742091|579910107|FG003|Overall Study|Withdrawal by Subject|1|||
160599014|NCT01742091|579910108|FG004|Overall Study|Withdrawal by Subject|0|||
160599015|NCT01742091|579910109|FG005|Overall Study|Withdrawal by Subject|0|||
160599016|NCT01742091|579910104|FG000|Overall Study|Lost to Follow-up|0|||
160599017|NCT01742091|579910105|FG001|Overall Study|Lost to Follow-up|0|||
160599018|NCT01742091|579910106|FG002|Overall Study|Lost to Follow-up|0|||
160599019|NCT01742091|579910107|FG003|Overall Study|Lost to Follow-up|0|||
160599020|NCT01742091|579910108|FG004|Overall Study|Lost to Follow-up|0|||
160599021|NCT01742091|579910109|FG005|Overall Study|Lost to Follow-up|1|||
160599022|NCT05742841|579910110|FG000|Overall Study|Withdrawal by Subject|1|||
160599023|NCT05742841|579910110|FG000|Overall Study|Lost to Follow-up|1|||
160599024|NCT02088541|579910111|FG000|Overall Study|Adverse Event|3|||
160599025|NCT02088541|579910112|FG001|Overall Study|Adverse Event|0|||
160599026|NCT02088541|579910113|FG002|Overall Study|Adverse Event|3|||
160599027|NCT02088541|579910114|FG003|Overall Study|Adverse Event|3|||
160599028|NCT02088541|579910115|FG004|Overall Study|Adverse Event|0|||
160599029|NCT02088541|579910111|FG000|Overall Study|Death|51|||
160599030|NCT02088541|579910112|FG001|Overall Study|Death|21|||
160599031|NCT02088541|579910113|FG002|Overall Study|Death|85|||
160599032|NCT02088541|579910114|FG003|Overall Study|Death|28|||
160599033|NCT02088541|579910115|FG004|Overall Study|Death|38|||
160599034|NCT02088541|579910111|FG000|Overall Study|Lost to Follow-up|2|||
160599035|NCT02088541|579910112|FG001|Overall Study|Lost to Follow-up|0|||
160599036|NCT02088541|579910113|FG002|Overall Study|Lost to Follow-up|1|||
160599037|NCT02088541|579910114|FG003|Overall Study|Lost to Follow-up|0|||
160599038|NCT02088541|579910115|FG004|Overall Study|Lost to Follow-up|0|||
160599039|NCT02088541|579910111|FG000|Overall Study|Physician Decision|2|||
160599040|NCT02088541|579910112|FG001|Overall Study|Physician Decision|1|||
160599041|NCT02088541|579910113|FG002|Overall Study|Physician Decision|2|||
160599042|NCT02088541|579910114|FG003|Overall Study|Physician Decision|0|||
160599043|NCT02088541|579910115|FG004|Overall Study|Physician Decision|2|||
160599044|NCT02088541|579910111|FG000|Overall Study|Disease progression|7|||
160599045|NCT02088541|579910112|FG001|Overall Study|Disease progression|1|||
160599046|NCT02088541|579910113|FG002|Overall Study|Disease progression|2|||
160599047|NCT02088541|579910114|FG003|Overall Study|Disease progression|3|||
160599048|NCT02088541|579910115|FG004|Overall Study|Disease progression|1|||
160599049|NCT02088541|579910111|FG000|Overall Study|Study terminated by sponsor|1|||
160599050|NCT02088541|579910112|FG001|Overall Study|Study terminated by sponsor|1|||
160468639|NCT05349721|579446038|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
160468640|NCT00489554|579446041|FG000|Overall Study|Adverse Event|2|||
160599051|NCT02088541|579910113|FG002|Overall Study|Study terminated by sponsor|12|||
160599052|NCT02088541|579910114|FG003|Overall Study|Study terminated by sponsor|2|||
160599053|NCT02088541|579910115|FG004|Overall Study|Study terminated by sponsor|6|||
160599054|NCT02088541|579910111|FG000|Overall Study|Withdrawal by Subject|3|||
160599055|NCT02088541|579910112|FG001|Overall Study|Withdrawal by Subject|2|||
160599056|NCT02088541|579910113|FG002|Overall Study|Withdrawal by Subject|9|||
160599057|NCT02088541|579910114|FG003|Overall Study|Withdrawal by Subject|7|||
160599058|NCT02088541|579910115|FG004|Overall Study|Withdrawal by Subject|10|||
160599059|NCT02088541|579910111|FG000|Overall Study|Other|2|||
160599060|NCT02088541|579910112|FG001|Overall Study|Other|1|||
160599061|NCT02088541|579910113|FG002|Overall Study|Other|3|||
160599062|NCT02088541|579910114|FG003|Overall Study|Other|1|||
160599063|NCT02088541|579910115|FG004|Overall Study|Other|1|||
160599064|NCT03706040|579910116|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
160599065|NCT03706040|579910117|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
160599066|NCT03706040|579910118|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
160599067|NCT03706040|579910119|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
160599068|NCT03706040|579910120|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
160599069|NCT03706040|579910121|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
160599070|NCT03706040|579910122|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
160599071|NCT03706040|579910116|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
160599072|NCT03706040|579910117|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
160599073|NCT03706040|579910118|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
160599074|NCT03706040|579910119|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
160599075|NCT03706040|579910120|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
160599076|NCT03706040|579910121|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
160599077|NCT03706040|579910122|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
160599078|NCT03706040|579910116|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
160599079|NCT03706040|579910117|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
160599080|NCT03706040|579910118|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
160599081|NCT03706040|579910119|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
160599082|NCT03706040|579910120|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
160599083|NCT03706040|579910121|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
160599084|NCT03706040|579910122|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
160599085|NCT03706040|579910116|FG000|Period A (Week 0 to Week 16)|Other|2|||
160599086|NCT03706040|579910117|FG001|Period A (Week 0 to Week 16)|Other|0|||
160599087|NCT03706040|579910118|FG002|Period A (Week 0 to Week 16)|Other|2|||
160599088|NCT03706040|579910119|FG003|Period A (Week 0 to Week 16)|Other|0|||
160599089|NCT03706040|579910120|FG004|Period A (Week 0 to Week 16)|Other|0|||
160599090|NCT03706040|579910121|FG005|Period A (Week 0 to Week 16)|Other|0|||
160599091|NCT03706040|579910122|FG006|Period A (Week 0 to Week 16)|Other|0|||
160468641|NCT00489554|579446041|FG000|Overall Study|Withdrawal by Subject|1|||
160468642|NCT00489554|579446041|FG000|Overall Study|Lost to Follow-up|1|||
160468643|NCT03960645|579446042|FG000|Overall Study|Protocol Violation|1|||
160468644|NCT03960645|579446043|FG001|Overall Study|Protocol Violation|0|||
160468645|NCT03732807|579446046|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
160468646|NCT03732807|579446047|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
160468647|NCT03732807|579446048|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
160468648|NCT03732807|579446049|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
160468649|NCT03732807|579446050|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
160468650|NCT03732807|579446051|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
160468651|NCT03732807|579446052|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
160468652|NCT03732807|579446046|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
160468653|NCT03732807|579446047|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
160468654|NCT03732807|579446048|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
160599092|NCT03706040|579910116|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
160599093|NCT03706040|579910117|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
160599094|NCT03706040|579910118|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
160468655|NCT03732807|579446049|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
160468656|NCT03732807|579446050|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
160468657|NCT03732807|579446051|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
160599095|NCT03706040|579910119|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
160599096|NCT03706040|579910120|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
160599097|NCT03706040|579910121|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
160599098|NCT03706040|579910122|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
160599099|NCT03706040|579910116|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
160468658|NCT03732807|579446052|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
160468659|NCT03732807|579446046|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
160468660|NCT03732807|579446047|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
160468661|NCT03732807|579446048|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
160599100|NCT03706040|579910117|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
160599101|NCT03706040|579910118|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
160599102|NCT03706040|579910119|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
160599103|NCT03706040|579910120|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
160599104|NCT03706040|579910121|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
160599105|NCT03706040|579910122|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
160599106|NCT03706040|579910116|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
160599107|NCT03706040|579910117|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
160599108|NCT03706040|579910118|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
160599109|NCT03706040|579910119|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
160599110|NCT03706040|579910120|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
160599111|NCT03706040|579910121|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
160599112|NCT03706040|579910122|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
160599113|NCT03706040|579910116|FG000|Period B (Week 16 to Week 52)|Other|0|||
160599114|NCT03706040|579910117|FG001|Period B (Week 16 to Week 52)|Other|0|||
160599115|NCT03706040|579910118|FG002|Period B (Week 16 to Week 52)|Other|0|||
160599116|NCT03706040|579910119|FG003|Period B (Week 16 to Week 52)|Other|4|||
160599117|NCT03706040|579910120|FG004|Period B (Week 16 to Week 52)|Other|5|||
160599118|NCT03706040|579910121|FG005|Period B (Week 16 to Week 52)|Other|23|||
160599119|NCT03706040|579910122|FG006|Period B (Week 16 to Week 52)|Other|17|||
160599120|NCT00439725|579910123|FG000|Treatment Period|Withdrawal by Subject|22|||
160599121|NCT00439725|579910124|FG001|Treatment Period|Withdrawal by Subject|19|||
160599122|NCT00439725|579910123|FG000|Treatment Period|Study terminated by sponsor|156|||
160599123|NCT00439725|579910124|FG001|Treatment Period|Study terminated by sponsor|148|||
160599124|NCT00439725|579910123|FG000|Treatment Period|Site closed by investigator|1|||
160599125|NCT00439725|579910124|FG001|Treatment Period|Site closed by investigator|2|||
160599126|NCT00439725|579910123|FG000|Treatment Period|Adverse Event|39|||
160599127|NCT00439725|579910124|FG001|Treatment Period|Adverse Event|18|||
160599128|NCT00439725|579910123|FG000|Treatment Period|Physician Decision|1|||
160599129|NCT00439725|579910124|FG001|Treatment Period|Physician Decision|1|||
160599130|NCT00439725|579910123|FG000|Treatment Period|Protocol Violation|2|||
160599131|NCT00439725|579910124|FG001|Treatment Period|Protocol Violation|1|||
160599132|NCT00439725|579910123|FG000|Treatment Period|Clinical endpoint reached|6|||
160599133|NCT00439725|579910124|FG001|Treatment Period|Clinical endpoint reached|50|||
160599134|NCT00439725|579910123|FG000|Treatment Period|Technical problems|1|||
160599135|NCT00439725|579910124|FG001|Treatment Period|Technical problems|0|||
160599136|NCT00439725|579910123|FG000|Treatment Period|Lost to Follow-up|1|||
160599137|NCT00439725|579910124|FG001|Treatment Period|Lost to Follow-up|1|||
160599138|NCT00439725|579910123|FG000|Treatment Period|Participant convenience|1|||
160599139|NCT00439725|579910124|FG001|Treatment Period|Participant convenience|0|||
160599140|NCT00439725|579910123|FG000|Treatment Period|Protocol driven decision point|1|||
160599141|NCT00439725|579910124|FG001|Treatment Period|Protocol driven decision point|1|||
160599142|NCT00439725|579910123|FG000|Treatment Period|Death|1|||
160599143|NCT00439725|579910124|FG001|Treatment Period|Death|1|||
160599144|NCT00439725|579910123|FG000|Treatment Period|Participant did not receive treatment|4|||
160599145|NCT00439725|579910124|FG001|Treatment Period|Participant did not receive treatment|4|||
160599146|NCT00439725|579910123|FG000|Observational Period|Withdrawal by Subject|2|||
160599147|NCT00439725|579910124|FG001|Observational Period|Withdrawal by Subject|2|||
160599148|NCT00439725|579910123|FG000|Observational Period|Lost to Follow-up|0|||
160599149|NCT00439725|579910124|FG001|Observational Period|Lost to Follow-up|1|||
160599150|NCT00439725|579910123|FG000|Observational Period|Death|0|||
160599151|NCT00439725|579910124|FG001|Observational Period|Death|2|||
160599152|NCT00439725|579910123|FG000|Observational Period|Study termination by sponsor|1|||
160599153|NCT00439725|579910124|FG001|Observational Period|Study termination by sponsor|1|||
160599154|NCT00439725|579910123|FG000|Observational Period|Clinical endpoint reached|3|||
160599155|NCT00439725|579910124|FG001|Observational Period|Clinical endpoint reached|1|||
160599156|NCT00439725|579910123|FG000|Observational Period|Technical problems|1|||
160599157|NCT00439725|579910124|FG001|Observational Period|Technical problems|0|||
160599158|NCT00439725|579910123|FG000|Observational Period|Participant convenience|1|||
160599159|NCT00439725|579910124|FG001|Observational Period|Participant convenience|0|||
160599160|NCT02848313|579910125|FG000|Overall Study|Adverse Event|1|||
160599161|NCT02848313|579910126|FG001|Overall Study|Adverse Event|2|||
160599162|NCT02848313|579910125|FG000|Overall Study|Lack of Efficacy|0|||
160599163|NCT02848313|579910126|FG001|Overall Study|Lack of Efficacy|1|||
160599164|NCT02848313|579910125|FG000|Overall Study|Withdrawal by Subject|1|||
160599165|NCT02848313|579910126|FG001|Overall Study|Withdrawal by Subject|1|||
160599166|NCT02848313|579910125|FG000|Overall Study|Lost to follow up|1|||
160468662|NCT03732807|579446049|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
160599167|NCT02848313|579910126|FG001|Overall Study|Lost to follow up|0|||
160599168|NCT03510910|579910127|FG000|Overall Study|Incomplete Survey|2|||
160599169|NCT03510910|579910128|FG001|Overall Study|Incomplete Survey|3|||
160599170|NCT01673490|579910129|FG000|Overall Study|Lost to Follow-up|1|||
160599171|NCT01673490|579910129|FG000|Overall Study|Adverse Event|3|||
160599172|NCT01673490|579910129|FG000|Overall Study|Withdrawal by Subject|3|||
160599173|NCT00379236|579910130|FG000|Double-blind|Adverse Event|11|||
160599174|NCT00379236|579910131|FG001|Double-blind|Adverse Event|6|||
160599175|NCT00379236|579910132|FG002|Double-blind|Adverse Event|0|||
160599176|NCT00379236|579910130|FG000|Double-blind|Protocol Violation|3|||
160599177|NCT00379236|579910131|FG001|Double-blind|Protocol Violation|3|||
160599178|NCT00379236|579910132|FG002|Double-blind|Protocol Violation|0|||
160599179|NCT00379236|579910130|FG000|Double-blind|Withdrawal by Subject|12|||
160599180|NCT00379236|579910131|FG001|Double-blind|Withdrawal by Subject|13|||
160599181|NCT00379236|579910132|FG002|Double-blind|Withdrawal by Subject|0|||
160599182|NCT00379236|579910130|FG000|Double-blind|Lost to Follow-up|4|||
160599183|NCT00379236|579910131|FG001|Double-blind|Lost to Follow-up|3|||
160599184|NCT00379236|579910132|FG002|Double-blind|Lost to Follow-up|0|||
160599185|NCT00379236|579910130|FG000|Double-blind|Use of exclusionary medication|1|||
160599186|NCT00379236|579910131|FG001|Double-blind|Use of exclusionary medication|2|||
160599187|NCT00379236|579910132|FG002|Double-blind|Use of exclusionary medication|0|||
160599188|NCT00379236|579910130|FG000|Double-blind|Other|3|||
160599189|NCT00379236|579910131|FG001|Double-blind|Other|7|||
160599190|NCT00379236|579910132|FG002|Double-blind|Other|0|||
160599191|NCT00379236|579910130|FG000|Double-blind|Data could not be retrieved|2|||
160599192|NCT00379236|579910131|FG001|Double-blind|Data could not be retrieved|2|||
160599193|NCT00379236|579910132|FG002|Double-blind|Data could not be retrieved|0|||
160599194|NCT00379236|579910130|FG000|Open-label Extension|Adverse Event|0|||
160599195|NCT00379236|579910131|FG001|Open-label Extension|Adverse Event|0|||
160599196|NCT00379236|579910132|FG002|Open-label Extension|Adverse Event|13|||
160599197|NCT00379236|579910130|FG000|Open-label Extension|Protocol Violation|0|||
160599198|NCT00379236|579910131|FG001|Open-label Extension|Protocol Violation|0|||
160599199|NCT00379236|579910132|FG002|Open-label Extension|Protocol Violation|7|||
160599200|NCT00379236|579910130|FG000|Open-label Extension|Withdrawal by Subject|0|||
160599201|NCT00379236|579910131|FG001|Open-label Extension|Withdrawal by Subject|0|||
160599202|NCT00379236|579910132|FG002|Open-label Extension|Withdrawal by Subject|13|||
160599203|NCT00379236|579910130|FG000|Open-label Extension|Lost to Follow-up|0|||
160599204|NCT00379236|579910131|FG001|Open-label Extension|Lost to Follow-up|0|||
160599205|NCT00379236|579910132|FG002|Open-label Extension|Lost to Follow-up|12|||
160599206|NCT00379236|579910130|FG000|Open-label Extension|Use of exclusionary medication|0|||
160599207|NCT00379236|579910131|FG001|Open-label Extension|Use of exclusionary medication|0|||
160599208|NCT00379236|579910132|FG002|Open-label Extension|Use of exclusionary medication|3|||
160599209|NCT00379236|579910130|FG000|Open-label Extension|Other|0|||
160599210|NCT00379236|579910131|FG001|Open-label Extension|Other|0|||
160599211|NCT00379236|579910132|FG002|Open-label Extension|Other|7|||
160599212|NCT02940860|579910138|FG000|Overall Study|Non-serious AE|1|||
160599213|NCT02940860|579910139|FG001|Overall Study|Non-serious AE|2|||
160599214|NCT02940860|579910138|FG000|Overall Study|Serious AE|7|||
160599215|NCT02940860|579910139|FG001|Overall Study|Serious AE|3|||
160599216|NCT02940860|579910138|FG000|Overall Study|Withdrawal by Subject|19|||
160599217|NCT02940860|579910139|FG001|Overall Study|Withdrawal by Subject|9|||
160599218|NCT02940860|579910138|FG000|Overall Study|Lost to Follow-up|13|||
160599219|NCT02940860|579910139|FG001|Overall Study|Lost to Follow-up|7|||
160599220|NCT02940860|579910138|FG000|Overall Study|Physician Decision|5|||
160599221|NCT02940860|579910139|FG001|Overall Study|Physician Decision|3|||
160599222|NCT02940860|579910138|FG000|Overall Study|Sponsor Decision|0|||
160599223|NCT02940860|579910139|FG001|Overall Study|Sponsor Decision|1|||
160599224|NCT02940860|579910138|FG000|Overall Study|Protocol Violation|0|||
160599225|NCT02940860|579910139|FG001|Overall Study|Protocol Violation|2|||
160599226|NCT02940860|579910138|FG000|Overall Study|Death|3|||
160599227|NCT02940860|579910139|FG001|Overall Study|Death|2|||
160599228|NCT02940860|579910138|FG000|Overall Study|Moved, poor venous access, transport|6|||
160599229|NCT02940860|579910139|FG001|Overall Study|Moved, poor venous access, transport|4|||
160599230|NCT02940860|579910138|FG000|Overall Study|Not treated|2|||
160599231|NCT02940860|579910139|FG001|Overall Study|Not treated|2|||
160599232|NCT04914819|579910140|FG000|Overall Study|Pregnancy|3|||
160599233|NCT04914819|579910141|FG001|Overall Study|Pregnancy|1|||
160599234|NCT04914819|579910140|FG000|Overall Study|Discontinued study|4|||
160599235|NCT04914819|579910141|FG001|Overall Study|Discontinued study|1|||
160599236|NCT04914819|579910140|FG000|Overall Study|Lost to Follow-up|7|||
160599237|NCT04914819|579910141|FG001|Overall Study|Lost to Follow-up|0|||
160599238|NCT00511108|579910143|FG000|Overall Study|Adverse Event|2|||
160599239|NCT00511108|579910144|FG001|Overall Study|Adverse Event|0|||
160599240|NCT00511108|579910145|FG002|Overall Study|Adverse Event|1|||
160599241|NCT00511108|579910146|FG003|Overall Study|Adverse Event|2|||
160599242|NCT00511108|579910143|FG000|Overall Study|Lost to Follow-up|0|||
160599243|NCT00511108|579910144|FG001|Overall Study|Lost to Follow-up|2|||
160599244|NCT00511108|579910145|FG002|Overall Study|Lost to Follow-up|1|||
160599245|NCT00511108|579910146|FG003|Overall Study|Lost to Follow-up|0|||
160599246|NCT00511108|579910143|FG000|Overall Study|Physician Decision|0|||
160599247|NCT00511108|579910144|FG001|Overall Study|Physician Decision|0|||
160599248|NCT00511108|579910145|FG002|Overall Study|Physician Decision|0|||
160599249|NCT00511108|579910146|FG003|Overall Study|Physician Decision|1|||
160599250|NCT00511108|579910143|FG000|Overall Study|Withdrawal by Subject|4|||
160599251|NCT00511108|579910144|FG001|Overall Study|Withdrawal by Subject|0|||
160599252|NCT00511108|579910145|FG002|Overall Study|Withdrawal by Subject|3|||
160599253|NCT00511108|579910146|FG003|Overall Study|Withdrawal by Subject|2|||
160599254|NCT05014542|579910150|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
160599255|NCT05014542|579910151|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
160599256|NCT05014542|579910150|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
160599257|NCT05014542|579910151|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
160599258|NCT05014542|579910150|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
160599259|NCT05014542|579910151|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
160599260|NCT05014542|579910150|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
160599261|NCT05014542|579910151|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
160599262|NCT01021813|579910159|FG000|DB Treatment Phase|Adverse Event|60|||
160599263|NCT01021813|579910160|FG001|DB Treatment Phase|Adverse Event|22|||
160599264|NCT01021813|579910161|FG002|DB Treatment Phase|Adverse Event|0|||
160599265|NCT01021813|579910162|FG003|DB Treatment Phase|Adverse Event|0|||
160599266|NCT01021813|579910163|FG004|DB Treatment Phase|Adverse Event|0|||
160599267|NCT01021813|579910159|FG000|DB Treatment Phase|Lack of Efficacy|44|||
160599268|NCT01021813|579910160|FG001|DB Treatment Phase|Lack of Efficacy|28|||
160599269|NCT01021813|579910161|FG002|DB Treatment Phase|Lack of Efficacy|0|||
160599270|NCT01021813|579910162|FG003|DB Treatment Phase|Lack of Efficacy|0|||
160599271|NCT01021813|579910163|FG004|DB Treatment Phase|Lack of Efficacy|0|||
160599272|NCT01021813|579910159|FG000|DB Treatment Phase|Lost to Follow-up|14|||
160599273|NCT01021813|579910160|FG001|DB Treatment Phase|Lost to Follow-up|12|||
160599274|NCT01021813|579910161|FG002|DB Treatment Phase|Lost to Follow-up|0|||
160599275|NCT01021813|579910162|FG003|DB Treatment Phase|Lost to Follow-up|0|||
160599276|NCT01021813|579910163|FG004|DB Treatment Phase|Lost to Follow-up|0|||
160599277|NCT01021813|579910159|FG000|DB Treatment Phase|Physician Decision|17|||
160599278|NCT01021813|579910160|FG001|DB Treatment Phase|Physician Decision|8|||
160599279|NCT01021813|579910161|FG002|DB Treatment Phase|Physician Decision|0|||
160599280|NCT01021813|579910162|FG003|DB Treatment Phase|Physician Decision|0|||
160599281|NCT01021813|579910163|FG004|DB Treatment Phase|Physician Decision|0|||
160599282|NCT01021813|579910159|FG000|DB Treatment Phase|Pregnancy|1|||
160599283|NCT01021813|579910160|FG001|DB Treatment Phase|Pregnancy|0|||
160599284|NCT01021813|579910161|FG002|DB Treatment Phase|Pregnancy|0|||
160599285|NCT01021813|579910162|FG003|DB Treatment Phase|Pregnancy|0|||
160599286|NCT01021813|579910163|FG004|DB Treatment Phase|Pregnancy|0|||
160599287|NCT01021813|579910159|FG000|DB Treatment Phase|Protocol Violation|4|||
160599288|NCT01021813|579910160|FG001|DB Treatment Phase|Protocol Violation|3|||
160599289|NCT01021813|579910161|FG002|DB Treatment Phase|Protocol Violation|0|||
160599290|NCT01021813|579910162|FG003|DB Treatment Phase|Protocol Violation|0|||
160599291|NCT01021813|579910163|FG004|DB Treatment Phase|Protocol Violation|0|||
160599292|NCT01021813|579910159|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
160599293|NCT01021813|579910160|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
160599294|NCT01021813|579910161|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
160599295|NCT01021813|579910162|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
160599296|NCT01021813|579910163|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
160599297|NCT01021813|579910159|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
160599298|NCT01021813|579910160|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
160599299|NCT01021813|579910161|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
160599300|NCT01021813|579910162|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
160599301|NCT01021813|579910163|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
160599302|NCT01021813|579910159|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
160599303|NCT01021813|579910160|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
160599304|NCT01021813|579910161|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
160599305|NCT01021813|579910162|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
160599306|NCT01021813|579910163|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
160599307|NCT01021813|579910159|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
160599308|NCT01021813|579910160|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
160599309|NCT01021813|579910161|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
160599310|NCT01021813|579910162|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
160599311|NCT01021813|579910163|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
160599312|NCT01021813|579910159|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
160599313|NCT01021813|579910160|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
160599314|NCT01021813|579910161|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
160599315|NCT01021813|579910162|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
160599316|NCT01021813|579910163|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
160468663|NCT03732807|579446050|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
160468664|NCT03732807|579446051|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
160468665|NCT03732807|579446052|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
160468666|NCT03732807|579446046|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
160468667|NCT03732807|579446047|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
160468668|NCT03732807|579446048|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
160468669|NCT03732807|579446049|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
160468670|NCT03732807|579446050|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
160468671|NCT03732807|579446051|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
160468672|NCT03732807|579446052|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
160468673|NCT03732807|579446046|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
160468674|NCT03732807|579446047|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
160468675|NCT03732807|579446048|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
160468676|NCT03732807|579446049|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
160468677|NCT03732807|579446050|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
160468678|NCT03732807|579446051|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
160468679|NCT03732807|579446052|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
160468680|NCT03732807|579446046|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
160468681|NCT03732807|579446047|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
160468682|NCT03732807|579446048|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
160468683|NCT03732807|579446049|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
160468684|NCT03732807|579446050|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
160468685|NCT03732807|579446051|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
160468686|NCT03732807|579446052|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
160468687|NCT03732807|579446046|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
160468688|NCT03732807|579446047|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
160468689|NCT03732807|579446048|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
160468690|NCT03732807|579446049|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
160468691|NCT03732807|579446050|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
160468692|NCT03732807|579446051|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
160468693|NCT03732807|579446052|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
160468694|NCT03732807|579446046|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
160468695|NCT03732807|579446047|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
160468696|NCT03732807|579446048|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
160468697|NCT03732807|579446049|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
160468698|NCT03732807|579446050|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
160468699|NCT03732807|579446051|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
160468700|NCT03732807|579446052|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
160468701|NCT03732807|579446046|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
160468702|NCT03732807|579446047|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
160468703|NCT03732807|579446048|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
160468704|NCT03732807|579446049|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
160468705|NCT03732807|579446050|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
160468706|NCT03732807|579446051|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
160468707|NCT03732807|579446052|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
160468708|NCT03732807|579446046|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
160468709|NCT03732807|579446047|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
160468710|NCT03732807|579446048|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
160468711|NCT03732807|579446049|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
160468712|NCT03732807|579446050|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
160468713|NCT03732807|579446051|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
160468714|NCT03732807|579446052|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
160468715|NCT03732807|579446046|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
160468716|NCT03732807|579446047|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
160468717|NCT03732807|579446048|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
160468718|NCT03732807|579446049|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
160468719|NCT03732807|579446050|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
160468720|NCT03732807|579446051|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
160468721|NCT03732807|579446052|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
160468722|NCT03732807|579446046|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
160599317|NCT01021813|579910159|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
160599318|NCT01021813|579910160|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
160599319|NCT01021813|579910161|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
160599320|NCT01021813|579910162|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
160599321|NCT01021813|579910163|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
160599322|NCT00493974|579910165|FG000|Overall Study|Death|1|||
160599323|NCT00493974|579910166|FG001|Overall Study|Death|2|||
160599324|NCT00493974|579910165|FG000|Overall Study|Withdrawal by Subject|8|||
160599325|NCT00493974|579910166|FG001|Overall Study|Withdrawal by Subject|6|||
160599326|NCT00493974|579910165|FG000|Overall Study|Lost to Follow-up|4|||
160599327|NCT00493974|579910166|FG001|Overall Study|Lost to Follow-up|6|||
160599328|NCT00326417|579910167|FG000|Overall Study|Withdrawal by Subject|0|||
160599329|NCT00326417|579910168|FG001|Overall Study|Withdrawal by Subject|0|||
160599330|NCT00326417|579910169|FG002|Overall Study|Withdrawal by Subject|1|||
160599331|NCT00326417|579910170|FG003|Overall Study|Withdrawal by Subject|0|||
160599332|NCT00326417|579910167|FG000|Overall Study|Arm Closed|7|||
160468723|NCT03732807|579446047|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
160468724|NCT03732807|579446048|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
160468725|NCT03732807|579446049|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
160468726|NCT03732807|579446050|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
160468727|NCT03732807|579446051|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
160468728|NCT03732807|579446052|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
160468729|NCT03732807|579446046|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
160468730|NCT03732807|579446047|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
160468731|NCT03732807|579446048|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
160468732|NCT03732807|579446049|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
160468733|NCT03732807|579446050|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
160468734|NCT03732807|579446051|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
160468735|NCT03732807|579446052|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
160468736|NCT03732807|579446046|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
160468737|NCT03732807|579446047|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
160468738|NCT03732807|579446048|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
160468739|NCT03732807|579446049|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
160468740|NCT03732807|579446050|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
160468741|NCT03732807|579446051|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
160468742|NCT03732807|579446052|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
160468743|NCT03737110|579446055|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
160468744|NCT03737110|579446056|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
160468745|NCT03737110|579446057|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
160468746|NCT03737110|579446058|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
160468747|NCT03737110|579446059|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
160468748|NCT03737110|579446060|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
160468749|NCT03737110|579446055|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
160468750|NCT03737110|579446056|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
160468751|NCT03737110|579446057|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
160468752|NCT03737110|579446058|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
160468753|NCT03737110|579446059|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
160468754|NCT03737110|579446060|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
160468755|NCT03737110|579446055|FG000|Run-in (RI) Period|Adverse Event|4|||
160468756|NCT03737110|579446056|FG001|Run-in (RI) Period|Adverse Event|0|||
160468757|NCT03737110|579446057|FG002|Run-in (RI) Period|Adverse Event|0|||
160468758|NCT03737110|579446058|FG003|Run-in (RI) Period|Adverse Event|0|||
160468759|NCT03737110|579446059|FG004|Run-in (RI) Period|Adverse Event|0|||
160468760|NCT03737110|579446060|FG005|Run-in (RI) Period|Adverse Event|0|||
160468761|NCT03737110|579446055|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
160468762|NCT03737110|579446056|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
160468763|NCT03737110|579446057|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
160468764|NCT03737110|579446058|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
160468765|NCT03737110|579446059|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
160468766|NCT03737110|579446060|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
160468767|NCT03737110|579446055|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
160468768|NCT03737110|579446056|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
160468769|NCT03737110|579446057|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
160468770|NCT03737110|579446058|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
160468771|NCT03737110|579446059|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
160468772|NCT03737110|579446060|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
160468773|NCT03737110|579446055|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
160468774|NCT03737110|579446056|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
160468775|NCT03737110|579446057|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
160599333|NCT00326417|579910168|FG001|Overall Study|Arm Closed|0|||
160599334|NCT00326417|579910169|FG002|Overall Study|Arm Closed|0|||
160599335|NCT00326417|579910170|FG003|Overall Study|Arm Closed|3|||
160599336|NCT00326417|579910167|FG000|Overall Study|Death|7|||
160599337|NCT00326417|579910168|FG001|Overall Study|Death|0|||
160599338|NCT00326417|579910169|FG002|Overall Study|Death|0|||
160599339|NCT00326417|579910170|FG003|Overall Study|Death|0|||
160599340|NCT00844285|579910171|FG000|Overall Study|Other|0|||
160599341|NCT00844285|579910172|FG001|Overall Study|Other|1|||
160599342|NCT00844285|579910173|FG002|Overall Study|Other|0|||
160599343|NCT00844285|579910171|FG000|Overall Study|Other than specified|95|||
160599344|NCT00844285|579910172|FG001|Overall Study|Other than specified|129|||
160599345|NCT00844285|579910173|FG002|Overall Study|Other than specified|12|||
160599346|NCT00844285|579910171|FG000|Overall Study|Site closure|256|||
160599347|NCT00844285|579910172|FG001|Overall Study|Site closure|450|||
160599348|NCT00844285|579910173|FG002|Overall Study|Site closure|50|||
160599349|NCT00844285|579910171|FG000|Overall Study|Follow-up < 8 years|16|||
160599350|NCT00844285|579910172|FG001|Overall Study|Follow-up < 8 years|23|||
160599351|NCT00844285|579910173|FG002|Overall Study|Follow-up < 8 years|4|||
160599352|NCT00844285|579910171|FG000|Overall Study|Protocol Violation|26|||
160599353|NCT00844285|579910172|FG001|Overall Study|Protocol Violation|28|||
160599354|NCT00844285|579910173|FG002|Overall Study|Protocol Violation|54|||
160599355|NCT00844285|579910171|FG000|Overall Study|Death|22|||
160599356|NCT00844285|579910172|FG001|Overall Study|Death|21|||
160599357|NCT00844285|579910173|FG002|Overall Study|Death|8|||
160599358|NCT00844285|579910171|FG000|Overall Study|Withdrew Consent|344|||
160599359|NCT00844285|579910172|FG001|Overall Study|Withdrew Consent|466|||
160599360|NCT00844285|579910173|FG002|Overall Study|Withdrew Consent|70|||
160599361|NCT00844285|579910171|FG000|Overall Study|Lost to Follow-up|330|||
160599362|NCT00844285|579910172|FG001|Overall Study|Lost to Follow-up|486|||
160599363|NCT00844285|579910173|FG002|Overall Study|Lost to Follow-up|74|||
160599364|NCT04682353|579910174|FG000|Overall Study|Lost to Follow-up|0|||
160599365|NCT04682353|579910175|FG001|Overall Study|Lost to Follow-up|1|||
160599366|NCT04682353|579910176|FG002|Overall Study|Lost to Follow-up|0|||
160599367|NCT04682353|579910177|FG003|Overall Study|Lost to Follow-up|1|||
160599368|NCT04682353|579910174|FG000|Overall Study|Personal reasons|0|||
160599369|NCT04682353|579910175|FG001|Overall Study|Personal reasons|1|||
160599370|NCT04682353|579910176|FG002|Overall Study|Personal reasons|0|||
160599371|NCT04682353|579910177|FG003|Overall Study|Personal reasons|0|||
160599372|NCT00862654|579910178|FG000|Overall Study|Lack of Efficacy|1|||
160599373|NCT00862654|579910179|FG001|Overall Study|Lack of Efficacy|0|||
160599374|NCT00862654|579910180|FG002|Overall Study|Lack of Efficacy|1|||
160599375|NCT00862654|579910181|FG003|Overall Study|Lack of Efficacy|0|||
160599376|NCT00862654|579910178|FG000|Overall Study|Lost to Follow-up|1|||
160599377|NCT00862654|579910179|FG001|Overall Study|Lost to Follow-up|2|||
160599378|NCT00862654|579910180|FG002|Overall Study|Lost to Follow-up|1|||
160599379|NCT00862654|579910181|FG003|Overall Study|Lost to Follow-up|3|||
160599380|NCT00862654|579910178|FG000|Overall Study|Adverse Event|0|||
160599381|NCT00862654|579910179|FG001|Overall Study|Adverse Event|1|||
160599382|NCT00862654|579910180|FG002|Overall Study|Adverse Event|1|||
160599383|NCT00862654|579910181|FG003|Overall Study|Adverse Event|0|||
160599384|NCT00862654|579910178|FG000|Overall Study|Pregnancy|1|||
160599385|NCT00862654|579910179|FG001|Overall Study|Pregnancy|1|||
160599386|NCT00862654|579910180|FG002|Overall Study|Pregnancy|0|||
160599387|NCT00862654|579910181|FG003|Overall Study|Pregnancy|0|||
160599388|NCT00862654|579910178|FG000|Overall Study|Withdrawal by Subject|2|||
160599389|NCT00862654|579910179|FG001|Overall Study|Withdrawal by Subject|2|||
160599390|NCT00862654|579910180|FG002|Overall Study|Withdrawal by Subject|2|||
160599391|NCT00862654|579910181|FG003|Overall Study|Withdrawal by Subject|3|||
160599392|NCT00862654|579910178|FG000|Overall Study|Subject mistake|0|||
160599393|NCT00862654|579910179|FG001|Overall Study|Subject mistake|1|||
160599394|NCT00862654|579910180|FG002|Overall Study|Subject mistake|0|||
160599395|NCT00862654|579910181|FG003|Overall Study|Subject mistake|0|||
160599396|NCT00862654|579910178|FG000|Overall Study|Familly constraint|0|||
160599397|NCT00862654|579910179|FG001|Overall Study|Familly constraint|1|||
160599398|NCT00862654|579910180|FG002|Overall Study|Familly constraint|0|||
160599399|NCT00862654|579910181|FG003|Overall Study|Familly constraint|0|||
160599400|NCT00862654|579910178|FG000|Overall Study|Never used study drugs|1|||
160599401|NCT00862654|579910179|FG001|Overall Study|Never used study drugs|0|||
160599402|NCT00862654|579910180|FG002|Overall Study|Never used study drugs|0|||
160599403|NCT00862654|579910181|FG003|Overall Study|Never used study drugs|0|||
160599404|NCT00862654|579910178|FG000|Overall Study|Included after end of inclusions|0|||
160599405|NCT00862654|579910179|FG001|Overall Study|Included after end of inclusions|0|||
160599406|NCT00862654|579910180|FG002|Overall Study|Included after end of inclusions|1|||
160599407|NCT00862654|579910181|FG003|Overall Study|Included after end of inclusions|0|||
160599408|NCT03219567|579910182|FG000|Overall Study|Withdrawal by Subject|0|||
160599409|NCT03219567|579910183|FG001|Overall Study|Withdrawal by Subject|1|||
160468776|NCT03737110|579446058|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
160468777|NCT03737110|579446059|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
160468778|NCT03737110|579446060|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
160468779|NCT03737110|579446055|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
160468780|NCT03737110|579446056|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
160468781|NCT03737110|579446057|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
160468782|NCT03737110|579446058|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
160468783|NCT03737110|579446059|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
160468784|NCT03737110|579446060|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
160468785|NCT03737110|579446055|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
160468786|NCT03737110|579446056|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
160468787|NCT03737110|579446057|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
160468788|NCT03737110|579446058|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
160468789|NCT03737110|579446059|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
160468790|NCT03737110|579446060|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
160468791|NCT00599196|579446065|FG000|Overall Study|Lack of Efficacy|22|||
160468792|NCT00599196|579446065|FG000|Overall Study|Adverse Event|93|||
160468793|NCT00599196|579446065|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
160468794|NCT00599196|579446065|FG000|Overall Study|Subject withdrew consent|43|||
160468795|NCT00599196|579446065|FG000|Overall Study|Study ended per sponsor|197|||
160468796|NCT00599196|579446065|FG000|Overall Study|Lost to Follow-up|17|||
160468797|NCT00599196|579446065|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
160468798|NCT00599196|579446065|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
160468799|NCT00599196|579446065|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
160468800|NCT00599196|579446065|FG000|Overall Study|Other: Pt Moved To Australia|1|||
160468801|NCT00599196|579446065|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
160468802|NCT00599196|579446065|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
160468803|NCT01009645|579446079|FG000|Overall Study|Lost to Follow-up|2|||
160468804|NCT01009645|579446080|FG001|Overall Study|Lost to Follow-up|8|||
160468805|NCT01009645|579446081|FG002|Overall Study|Lost to Follow-up|4|||
160468806|NCT01009645|579446082|FG003|Overall Study|Lost to Follow-up|5|||
160468807|NCT01124045|579446083|FG000|Overall Study|Lost to Follow-up|0|||
160468808|NCT01124045|579446084|FG001|Overall Study|Lost to Follow-up|1|||
160468809|NCT01124045|579446083|FG000|Overall Study|Physician Decision|0|||
160468810|NCT01124045|579446084|FG001|Overall Study|Physician Decision|2|||
160468811|NCT01079806|579446086|FG000|Day 1 to Week 96|Adverse Event|0|||
160468812|NCT01079806|579446087|FG001|Day 1 to Week 96|Adverse Event|3|||
160468813|NCT01079806|579446086|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
160468814|NCT01079806|579446087|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
160468815|NCT01079806|579446086|FG000|Day 1 to Week 96|Pregnancy|0|||
160468816|NCT01079806|579446087|FG001|Day 1 to Week 96|Pregnancy|1|||
160468817|NCT01079806|579446086|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
160468818|NCT01079806|579446087|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
160468819|NCT01079806|579446086|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
160468820|NCT01079806|579446087|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
160468821|NCT01079806|579446086|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
160468822|NCT01079806|579446087|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
160468823|NCT01079806|579446086|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
160468824|NCT01079806|579446087|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
160468825|NCT01079806|579446086|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
160468826|NCT01079806|579446087|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
160468827|NCT01079806|579446086|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
160468828|NCT01079806|579446087|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
160468829|NCT01079806|579446086|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
160468830|NCT01079806|579446087|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
160468831|NCT01530334|579446090|FG000|Overall Study|Adverse Event|3|||
160468832|NCT01530334|579446090|FG000|Overall Study|unknown reason|1|||
160468833|NCT01530334|579446090|FG000|Overall Study|Progressive disease|47|||
160468834|NCT03489369|579446091|FG000|Overall Study|Documented Progressive Disease|3|||
160468835|NCT03489369|579446092|FG001|Overall Study|Documented Progressive Disease|2|||
160468836|NCT03489369|579446093|FG002|Overall Study|Documented Progressive Disease|3|||
160468837|NCT03489369|579446094|FG003|Overall Study|Documented Progressive Disease|6|||
160468838|NCT03489369|579446091|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
160468839|NCT03489369|579446092|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
160468840|NCT03489369|579446093|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
160468841|NCT03489369|579446094|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
160468842|NCT01065779|579446101|FG000|Overall Study|Duplicate Investigation|1|||
160468843|NCT01065779|579446101|FG000|Overall Study|Investigation Before Contract Date|37|||
160468844|NCT01065779|579446101|FG000|Overall Study|Non-enrollment Period Administration|10|||
160599410|NCT01313208|579910184|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
160599411|NCT01313208|579910185|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
160599412|NCT01313208|579910184|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
160599413|NCT01313208|579910185|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
160599414|NCT01313208|579910184|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
160599415|NCT01313208|579910185|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
160599416|NCT01313208|579910184|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
160599417|NCT01313208|579910185|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
160599418|NCT01313208|579910184|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
160599419|NCT01313208|579910185|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
160599420|NCT01313208|579910184|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
160599421|NCT01313208|579910185|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
160599422|NCT01313208|579910184|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
160599423|NCT01313208|579910185|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
160599424|NCT01313208|579910184|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
160599425|NCT01313208|579910185|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
160599426|NCT01313208|579910184|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
160599427|NCT01313208|579910185|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
160599428|NCT00004732|579910190|FG000|Overall Study|Withdrawal by Subject|36|||
160599429|NCT00004732|579910191|FG001|Overall Study|Withdrawal by Subject|64|||
160599430|NCT00004732|579910190|FG000|Overall Study|Lost to Follow-up|33|||
160599431|NCT00004732|579910191|FG001|Overall Study|Lost to Follow-up|47|||
160599432|NCT01688635|579910195|FG000|Washout 1|Withdrawal by Subject|1|||
160599433|NCT01688635|579910196|FG001|Washout 1|Withdrawal by Subject|0|||
160599434|NCT01688635|579910195|FG000|Washout 1|Adverse Event|0|||
160599435|NCT01688635|579910196|FG001|Washout 1|Adverse Event|1|||
160599436|NCT01688635|579910195|FG000|Washout 1|Physician Decision|0|||
160599437|NCT01688635|579910196|FG001|Washout 1|Physician Decision|1|||
160599438|NCT01688635|579910195|FG000|Washout 2|Physician Decision|1|||
160599439|NCT01688635|579910196|FG001|Washout 2|Physician Decision|0|||
160599440|NCT01688635|579910195|FG000|Washout 2|Withdrawal by Subject|1|||
160599441|NCT01688635|579910196|FG001|Washout 2|Withdrawal by Subject|0|||
160599442|NCT01688635|579910195|FG000|Washout 2|Sponsor Decision|1|||
160599443|NCT01688635|579910196|FG001|Washout 2|Sponsor Decision|2|||
160599444|NCT01688635|579910195|FG000|Washout 3|Withdrawal by Subject|1|||
160599445|NCT01688635|579910196|FG001|Washout 3|Withdrawal by Subject|0|||
160599446|NCT02674685|579910197|FG000|Overall Study|Withdrawal by Subject|4|||
160599447|NCT01181778|579910198|FG000|Overall Study|Physician Decision|48|||
160599448|NCT02726113|579910199|FG000|Total Enrollment|Physician Decision|0|||
160599449|NCT02726113|579910200|FG001|Total Enrollment|Physician Decision|1|||
160599450|NCT02726113|579910199|FG000|Total Enrollment|Protocol Violation|1|||
160599451|NCT02726113|579910200|FG001|Total Enrollment|Protocol Violation|0|||
160599452|NCT02726113|579910199|FG000|Total Enrollment|Withdrawal by Subject|2|||
160599453|NCT02726113|579910200|FG001|Total Enrollment|Withdrawal by Subject|1|||
160599454|NCT02726113|579910199|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
160599455|NCT02726113|579910200|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
160599456|NCT02726113|579910199|FG000|Genomic Analysis|Protocol Violation|1|||
160599457|NCT02726113|579910200|FG001|Genomic Analysis|Protocol Violation|0|||
160599458|NCT02726113|579910199|FG000|Genomic Analysis|Withdrawal by Subject|2|||
160599459|NCT02726113|579910200|FG001|Genomic Analysis|Withdrawal by Subject|1|||
160599460|NCT02726113|579910199|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
160599461|NCT02726113|579910200|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
160599462|NCT02661464|579910206|FG000|Overall Study|Lost to Follow-up|28|||
160599463|NCT02661464|579910207|FG001|Overall Study|Lost to Follow-up|0|||
160599464|NCT02661464|579910208|FG002|Overall Study|Lost to Follow-up|0|||
160599465|NCT02661464|579910209|FG003|Overall Study|Lost to Follow-up|0|||
160599466|NCT02661464|579910206|FG000|Overall Study|Withdrawal by Subject|3|||
160599467|NCT02661464|579910207|FG001|Overall Study|Withdrawal by Subject|1|||
160599468|NCT02661464|579910208|FG002|Overall Study|Withdrawal by Subject|0|||
160599469|NCT02661464|579910209|FG003|Overall Study|Withdrawal by Subject|0|||
160599470|NCT02661464|579910206|FG000|Overall Study|Participants terminated prematurely|288|||
160599471|NCT02661464|579910207|FG001|Overall Study|Participants terminated prematurely|52|||
160599472|NCT02661464|579910208|FG002|Overall Study|Participants terminated prematurely|1|||
160659256|NCT02943447|580134487|FG000|Blinded Study Phase|Withdrew Consent|1|||
160659257|NCT02943447|580134488|FG001|Blinded Study Phase|Withdrew Consent|2|||
160599473|NCT02661464|579910209|FG003|Overall Study|Participants terminated prematurely|1|||
160599474|NCT02661464|579910206|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
160599475|NCT02661464|579910207|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
160659258|NCT02943447|580134489|FG002|Blinded Study Phase|Withdrew Consent|1|||
160659259|NCT02943447|580134487|FG000|Blinded Study Phase|Adverse Event|3|||
160599476|NCT02661464|579910208|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
160599477|NCT02661464|579910209|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
160659260|NCT02943447|580134488|FG001|Blinded Study Phase|Adverse Event|0|||
160599478|NCT05567393|579910211|FG000|Overall Study|Voluntary Withdrawal|0|||
160599479|NCT05567393|579910212|FG001|Overall Study|Voluntary Withdrawal|0|||
160599480|NCT05567393|579910213|FG002|Overall Study|Voluntary Withdrawal|0|||
160599481|NCT05567393|579910214|FG003|Overall Study|Voluntary Withdrawal|0|||
160599482|NCT05567393|579910215|FG004|Overall Study|Voluntary Withdrawal|0|||
160599483|NCT05567393|579910216|FG005|Overall Study|Voluntary Withdrawal|0|||
160599484|NCT05567393|579910217|FG006|Overall Study|Voluntary Withdrawal|0|||
160599485|NCT05567393|579910218|FG007|Overall Study|Voluntary Withdrawal|0|||
160599486|NCT05567393|579910219|FG008|Overall Study|Voluntary Withdrawal|0|||
160599487|NCT05567393|579910220|FG009|Overall Study|Voluntary Withdrawal|0|||
160599488|NCT05567393|579910221|FG010|Overall Study|Voluntary Withdrawal|0|||
160599489|NCT05567393|579910222|FG011|Overall Study|Voluntary Withdrawal|0|||
160599490|NCT05567393|579910223|FG012|Overall Study|Voluntary Withdrawal|0|||
160599491|NCT05567393|579910224|FG013|Overall Study|Voluntary Withdrawal|1|||
160599492|NCT05567393|579910225|FG014|Overall Study|Voluntary Withdrawal|0|||
160599493|NCT05567393|579910226|FG015|Overall Study|Voluntary Withdrawal|0|||
160599494|NCT05567393|579910227|FG016|Overall Study|Voluntary Withdrawal|0|||
160599495|NCT05567393|579910228|FG017|Overall Study|Voluntary Withdrawal|0|||
160599496|NCT01924299|579910232|FG000|Period 2|Withdrawal by Subject|1|||
160599497|NCT01924299|579910233|FG001|Period 2|Withdrawal by Subject|0|||
160599498|NCT01924299|579910232|FG000|Period 2|Adverse Event|0|||
160659261|NCT02943447|580134489|FG002|Blinded Study Phase|Adverse Event|0|||
160468845|NCT01065779|579446101|FG000|Overall Study|Not Administered With Study Drug|17|||
160468846|NCT01065779|579446101|FG000|Overall Study|Failed to Follow-up|10|||
160468847|NCT01065779|579446101|FG000|Overall Study|Inclusion Criteria Violation|7|||
160468848|NCT02157948|579446102|FG000|Overall Study|Withdrawal by Subject|4|||
160468849|NCT02157948|579446103|FG001|Overall Study|Withdrawal by Subject|5|||
160468850|NCT02157948|579446102|FG000|Overall Study|Lost to Follow-up|3|||
160468851|NCT02157948|579446103|FG001|Overall Study|Lost to Follow-up|2|||
160468852|NCT02157948|579446102|FG000|Overall Study|Protocol Specified Criteria|2|||
160468853|NCT02157948|579446103|FG001|Overall Study|Protocol Specified Criteria|1|||
160468854|NCT02157948|579446102|FG000|Overall Study|Decision by Sponsor|0|||
160468855|NCT02157948|579446103|FG001|Overall Study|Decision by Sponsor|1|||
160468856|NCT01604824|579446104|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
160468857|NCT01604824|579446105|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
160468858|NCT01604824|579446106|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
160468859|NCT01604824|579446107|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
160468860|NCT01604824|579446108|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
160468861|NCT01604824|579446109|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
160468862|NCT01604824|579446104|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
160468863|NCT01604824|579446105|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
160468864|NCT01604824|579446106|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
160468865|NCT01604824|579446107|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
160468866|NCT01604824|579446108|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
160468867|NCT01604824|579446109|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
160468868|NCT02630966|579446110|FG000|Overall Study|Adverse Event|1|||
160468869|NCT02630966|579446111|FG001|Overall Study|Adverse Event|3|||
160468870|NCT02630966|579446110|FG000|Overall Study|Significant Protocol Deviation|0|||
160468871|NCT02630966|579446111|FG001|Overall Study|Significant Protocol Deviation|2|||
160468872|NCT02630966|579446110|FG000|Overall Study|Voluntary Withdrawal|1|||
160468873|NCT02630966|579446111|FG001|Overall Study|Voluntary Withdrawal|1|||
160468874|NCT02630966|579446110|FG000|Overall Study|Lack of Efficacy|0|||
160468875|NCT02630966|579446111|FG001|Overall Study|Lack of Efficacy|2|||
160468876|NCT00665392|579446112|FG000|Overall Study|not treated|1|||
160468877|NCT00243867|579446118|FG000|Overall Study|Adverse Event|24|||
160468878|NCT00243867|579446119|FG001|Overall Study|Adverse Event|34|||
160468879|NCT00243867|579446118|FG000|Overall Study|Lack of Efficacy|115|||
160599499|NCT01924299|579910233|FG001|Period 2|Adverse Event|1|||
160599500|NCT02177175|579910234|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
160599501|NCT02177175|579910235|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
160659262|NCT02943447|580134487|FG000|Blinded Study Phase|Investigator's discretion|1|||
160468880|NCT00243867|579446119|FG001|Overall Study|Lack of Efficacy|78|||
160599502|NCT04199793|579910236|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
160599503|NCT04199793|579910237|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
160468881|NCT00243867|579446118|FG000|Overall Study|Withdrawal by Subject|11|||
160599504|NCT04199793|579910236|FG000|Overall Study|Withdrawal by Subject|1|||
160599505|NCT04199793|579910237|FG001|Overall Study|Withdrawal by Subject|1|||
160599506|NCT03820726|579910238|FG000|Overall Study|Other than listed|23|||
160599507|NCT03820726|579910238|FG000|Overall Study|Withdrawal by Subject|37|||
160599508|NCT03820726|579910238|FG000|Overall Study|Lost to Follow-up|3|||
160599509|NCT03820726|579910238|FG000|Overall Study|Protocol deviation|1|||
160599510|NCT03820726|579910238|FG000|Overall Study|Adverse Event|146|||
160599511|NCT03820726|579910238|FG000|Overall Study|Not treated|1|||
160468882|NCT00243867|579446119|FG001|Overall Study|Withdrawal by Subject|23|||
160468883|NCT00243867|579446118|FG000|Overall Study|Lost to Follow-up|2|||
160468884|NCT00243867|579446119|FG001|Overall Study|Lost to Follow-up|1|||
160468885|NCT00243867|579446118|FG000|Overall Study|Physician Decision|2|||
160468886|NCT00243867|579446119|FG001|Overall Study|Physician Decision|7|||
160468887|NCT00243867|579446118|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
160468888|NCT00243867|579446119|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
160468889|NCT03389802|579446143|FG000|Overall Study|Lack of Efficacy|3|||
160468890|NCT03389802|579446144|FG001|Overall Study|Lack of Efficacy|3|||
160468891|NCT03389802|579446145|FG002|Overall Study|Lack of Efficacy|13|||
160468892|NCT03389802|579446146|FG003|Overall Study|Lack of Efficacy|6|||
160468893|NCT03389802|579446147|FG004|Overall Study|Lack of Efficacy|1|||
160468894|NCT03389802|579446143|FG000|Overall Study|Adverse Event|0|||
160468895|NCT03389802|579446144|FG001|Overall Study|Adverse Event|0|||
160468896|NCT03389802|579446145|FG002|Overall Study|Adverse Event|1|||
160468897|NCT03389802|579446146|FG003|Overall Study|Adverse Event|0|||
160468898|NCT03389802|579446147|FG004|Overall Study|Adverse Event|4|||
160468899|NCT03389802|579446143|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
160468900|NCT03389802|579446144|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
160468901|NCT03389802|579446145|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
160468902|NCT03389802|579446146|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
160468903|NCT03389802|579446147|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
160468904|NCT02426138|579446148|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
160468905|NCT02426138|579446149|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
160659263|NCT02943447|580134488|FG001|Blinded Study Phase|Investigator's discretion|0|||
160659264|NCT02943447|580134489|FG002|Blinded Study Phase|Investigator's discretion|0|||
160659265|NCT02943447|580134487|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
160659266|NCT02943447|580134488|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
160659267|NCT02943447|580134489|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
160659268|NCT02943447|580134487|FG000|Open-Label Extension Phase|Adverse Event|4|||
160659269|NCT02943447|580134488|FG001|Open-Label Extension Phase|Adverse Event|7|||
160659270|NCT02943447|580134489|FG002|Open-Label Extension Phase|Adverse Event|3|||
160659271|NCT02943447|580134487|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
160659272|NCT02943447|580134488|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
160659273|NCT02943447|580134489|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
160659274|NCT02943447|580134487|FG000|Open-Label Extension Phase|Withdrew consent|1|||
160659275|NCT02943447|580134488|FG001|Open-Label Extension Phase|Withdrew consent|1|||
160659276|NCT02943447|580134489|FG002|Open-Label Extension Phase|Withdrew consent|1|||
160659277|NCT02943447|580134487|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
160659278|NCT02943447|580134488|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
160659279|NCT02943447|580134489|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
160659280|NCT02106156|580134490|FG000|Overall Study|Patient Died|19|||
160659281|NCT02106156|580134491|FG001|Overall Study|Patient Died|0|||
160659282|NCT02106156|580134492|FG002|Overall Study|Patient Died|0|||
160659283|NCT02106156|580134490|FG000|Overall Study|Lack of Tolerability|305|||
160659284|NCT02106156|580134491|FG001|Overall Study|Lack of Tolerability|3|||
160659285|NCT02106156|580134492|FG002|Overall Study|Lack of Tolerability|0|||
160468906|NCT04677738|579446150|FG000|Overall Study|Withdrawal by Subject|4|||
160659286|NCT02106156|580134490|FG000|Overall Study|Lack of Virological Response|1044|||
160468907|NCT04677738|579446151|FG001|Overall Study|Withdrawal by Subject|2|||
160468908|NCT02409680|579446157|FG000|Overall Study|Lost to Follow-up|15|||
160468909|NCT02409680|579446158|FG001|Overall Study|Lost to Follow-up|30|||
160468910|NCT04912856|579446167|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
160468911|NCT04912856|579446168|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
160468912|NCT04912856|579446167|FG000|Overall Study|Not reported in synoptic CSR.|0|||
160468913|NCT04912856|579446168|FG001|Overall Study|Not reported in synoptic CSR.|1|||
160468914|NCT06571695|579447936|FG000|Overall Study|Lost to Follow-up|1|||
160468915|NCT06571695|579447937|FG001|Overall Study|Lost to Follow-up|6|||
160468916|NCT00108355|579447938|FG000|Overall Study|Peritonitis at index paracentesis|1|||
160468917|NCT00108355|579447939|FG001|Overall Study|Peritonitis at index paracentesis|1|||
160468918|NCT00108355|579447938|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
160468919|NCT00108355|579447939|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
160468920|NCT04921358|579447940|FG000|Overall Study|Withdrawal by Subject|6|||
160468921|NCT04921358|579447941|FG001|Overall Study|Withdrawal by Subject|13|||
160468922|NCT04921358|579447940|FG000|Overall Study|Lost to Follow-up|3|||
160468923|NCT04921358|579447941|FG001|Overall Study|Lost to Follow-up|6|||
160599512|NCT00888615|579910242|FG000|Overall Study|No treatment|2|||
160599513|NCT00141037|579910243|FG000|Overall Study|Physician Decision|1|||
160599514|NCT00141037|579910244|FG001|Overall Study|Physician Decision|2|||
160599515|NCT00141037|579910243|FG000|Overall Study|Lost to Follow-up|3|||
160599516|NCT00141037|579910244|FG001|Overall Study|Lost to Follow-up|1|||
160599517|NCT00141037|579910243|FG000|Overall Study|Protocol Violation|0|||
160599518|NCT00141037|579910244|FG001|Overall Study|Protocol Violation|2|||
160599519|NCT00141037|579910243|FG000|Overall Study|Withdrawal by Subject|2|||
160599520|NCT00141037|579910244|FG001|Overall Study|Withdrawal by Subject|1|||
160599521|NCT00141037|579910243|FG000|Overall Study|Other|0|||
160599522|NCT00141037|579910244|FG001|Overall Study|Other|1|||
160599523|NCT00141037|579910243|FG000|Overall Study|Moved from area|1|||
160599524|NCT00141037|579910244|FG001|Overall Study|Moved from area|7|||
160599525|NCT00141037|579910243|FG000|Overall Study|Graft Failure|3|||
160599526|NCT00141037|579910244|FG001|Overall Study|Graft Failure|4|||
160599527|NCT00861380|579910245|FG000|Overall Study|Withdrawal Information not recorded|8427|||
160599528|NCT00861380|579910246|FG001|Overall Study|Withdrawal Information not recorded|9112|||
160599529|NCT00861380|579910247|FG002|Overall Study|Withdrawal Information not recorded|8872|||
160599530|NCT00861380|579910248|FG003|Overall Study|Withdrawal Information not recorded|3689|||
160599531|NCT00861380|579910249|FG004|Overall Study|Withdrawal Information not recorded|1812|||
160599532|NCT00861380|579910250|FG005|Overall Study|Withdrawal Information not recorded|6249|||
160599533|NCT00861380|579910251|FG006|Overall Study|Withdrawal Information not recorded|3020|||
160599534|NCT00628758|579910252|FG000|Overall Study|Adverse Event|2|||
160599535|NCT00628758|579910253|FG001|Overall Study|Adverse Event|3|||
160599536|NCT00628758|579910252|FG000|Overall Study|Withdrawal by Subject|6|||
160599537|NCT00628758|579910253|FG001|Overall Study|Withdrawal by Subject|3|||
160599538|NCT00628758|579910252|FG000|Overall Study|Death|1|||
160599539|NCT00628758|579910253|FG001|Overall Study|Death|0|||
160599540|NCT00628758|579910252|FG000|Overall Study|Protocol Violation|5|||
160599541|NCT00628758|579910253|FG001|Overall Study|Protocol Violation|1|||
160599542|NCT00628758|579910252|FG000|Overall Study|Lost to Follow-up|25|||
160599543|NCT00628758|579910253|FG001|Overall Study|Lost to Follow-up|31|||
160599544|NCT00628758|579910252|FG000|Overall Study|Pregnancy|2|||
160599545|NCT00628758|579910253|FG001|Overall Study|Pregnancy|2|||
160599546|NCT00628758|579910252|FG000|Overall Study|Investigator Moved|3|||
160599547|NCT00628758|579910253|FG001|Overall Study|Investigator Moved|0|||
160599548|NCT00628758|579910252|FG000|Overall Study|Treatment Failure|0|||
160599549|NCT00628758|579910253|FG001|Overall Study|Treatment Failure|2|||
160599550|NCT00637377|579910254|FG000|Overall Study|Adverse Event|2|||
160599551|NCT00637377|579910255|FG001|Overall Study|Adverse Event|6|||
160599552|NCT00637377|579910256|FG002|Overall Study|Adverse Event|8|||
160599553|NCT00637377|579910257|FG003|Overall Study|Adverse Event|9|||
160599554|NCT00637377|579910254|FG000|Overall Study|Death|1|||
160599555|NCT00637377|579910255|FG001|Overall Study|Death|3|||
160599556|NCT00637377|579910256|FG002|Overall Study|Death|2|||
160599557|NCT00637377|579910257|FG003|Overall Study|Death|1|||
160599558|NCT00637377|579910254|FG000|Overall Study|Lack of Efficacy|0|||
160659287|NCT02106156|580134491|FG001|Overall Study|Lack of Virological Response|8|||
160599559|NCT00637377|579910255|FG001|Overall Study|Lack of Efficacy|0|||
160599560|NCT00637377|579910256|FG002|Overall Study|Lack of Efficacy|1|||
160599561|NCT00637377|579910257|FG003|Overall Study|Lack of Efficacy|1|||
160599562|NCT00637377|579910254|FG000|Overall Study|Lost to Follow-up|4|||
160468924|NCT04921358|579447940|FG000|Overall Study|Study Terminated by Sponsor|86|||
160468925|NCT04921358|579447941|FG001|Overall Study|Study Terminated by Sponsor|89|||
160599563|NCT00637377|579910255|FG001|Overall Study|Lost to Follow-up|1|||
160599564|NCT00637377|579910256|FG002|Overall Study|Lost to Follow-up|2|||
160599565|NCT00637377|579910257|FG003|Overall Study|Lost to Follow-up|2|||
160599566|NCT00637377|579910254|FG000|Overall Study|Protocol Violation|2|||
160599567|NCT00637377|579910255|FG001|Overall Study|Protocol Violation|1|||
160599568|NCT00637377|579910256|FG002|Overall Study|Protocol Violation|1|||
160599569|NCT00637377|579910257|FG003|Overall Study|Protocol Violation|0|||
160659288|NCT02106156|580134492|FG002|Overall Study|Lack of Virological Response|0|||
160659289|NCT02106156|580134490|FG000|Overall Study|Concomitant Disease|74|||
160468926|NCT04921358|579447940|FG000|Overall Study|Death|92|||
160468927|NCT04921358|579447941|FG001|Overall Study|Death|82|||
160468928|NCT02278796|579447942|FG000|Overall Study|Death|2|||
160468929|NCT02278796|579447943|FG001|Overall Study|Death|3|||
160468930|NCT04926857|579447944|FG000|Overall Study|Withdrawal by Subject|40|||
160468931|NCT04926857|579447944|FG000|Overall Study|Death|9|||
160468932|NCT04926857|579447944|FG000|Overall Study|Study product no longer in use|44|||
160468933|NCT04926857|579447944|FG000|Overall Study|Inadequate data to address primary objective|16|||
160468934|NCT03214081|579447945|FG000|Overall Study|Case Report Forms Uncollected|9|||
160468935|NCT03214081|579447945|FG000|Overall Study|Protocol Deviation|54|||
160468936|NCT00491400|579447946|FG000|Overall Study|Withdrawal by Subject|5|||
160468937|NCT00491400|579447947|FG001|Overall Study|Withdrawal by Subject|4|||
160468938|NCT00597376|579447948|FG000|Overall Study|Withdrawal by Subject|4|||
160468939|NCT00597376|579447949|FG001|Overall Study|Withdrawal by Subject|3|||
160468940|NCT00597376|579447948|FG000|Overall Study|Adverse Event|4|||
160468941|NCT00597376|579447949|FG001|Overall Study|Adverse Event|1|||
160468942|NCT02698475|579447950|FG000|Main Study Period|Lack of Efficacy|1|||
160468943|NCT02698475|579447950|FG000|Main Study Period|Protocol Violation|2|||
160468944|NCT02698475|579447950|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
160468945|NCT02698475|579447950|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
160468946|NCT02698475|579447950|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
160468947|NCT02698475|579447950|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
160468948|NCT02698475|579447950|FG000|Long-Term Extension Period|Other|1|||
160468949|NCT02310581|579447956|FG000|Overall Study|Adverse Event|1|||
160468950|NCT02310581|579447957|FG001|Overall Study|Adverse Event|1|||
160468951|NCT02310581|579447958|FG002|Overall Study|Adverse Event|1|||
160468952|NCT02310581|579447959|FG003|Overall Study|Adverse Event|0|||
160468953|NCT02310581|579447956|FG000|Overall Study|Withdrawal by Subject|2|||
160468954|NCT02310581|579447957|FG001|Overall Study|Withdrawal by Subject|1|||
160468955|NCT02310581|579447958|FG002|Overall Study|Withdrawal by Subject|0|||
160468956|NCT02310581|579447959|FG003|Overall Study|Withdrawal by Subject|1|||
160468957|NCT04237792|579447960|FG000|Treatment (Day 1)|Adverse Event|1|||
160468958|NCT04237792|579447961|FG001|Treatment (Day 1)|Adverse Event|0|||
160468959|NCT04237792|579447962|FG002|Treatment (Day 1)|Adverse Event|0|||
160468960|NCT04237792|579447963|FG003|Treatment (Day 1)|Adverse Event|0|||
160468961|NCT04237792|579447964|FG004|Treatment (Day 1)|Adverse Event|1|||
160468962|NCT04237792|579447965|FG005|Treatment (Day 1)|Adverse Event|1|||
160599570|NCT00637377|579910254|FG000|Overall Study|Withdrawal by Subject|11|||
160599571|NCT00637377|579910255|FG001|Overall Study|Withdrawal by Subject|15|||
160599572|NCT00637377|579910256|FG002|Overall Study|Withdrawal by Subject|13|||
160599573|NCT00637377|579910257|FG003|Overall Study|Withdrawal by Subject|11|||
160599574|NCT00637377|579910254|FG000|Overall Study|Other (no further information available)|7|||
160599575|NCT00637377|579910255|FG001|Overall Study|Other (no further information available)|6|||
160599576|NCT00637377|579910256|FG002|Overall Study|Other (no further information available)|10|||
160599577|NCT00637377|579910257|FG003|Overall Study|Other (no further information available)|5|||
160599578|NCT01293084|579910258|FG000|Overall Study|Physician Decision|3|||
160599579|NCT01293084|579910258|FG000|Overall Study|Withdrawal by Subject|2|||
160599580|NCT01184846|579910263|FG000|Overall Study|Adverse Event|2|||
160599581|NCT01184846|579910263|FG000|Overall Study|Insufficient response|1|||
160599582|NCT03750240|579912499|FG000|Overall Study|Technical Difficulties|2|||
160599583|NCT00927758|579912500|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
160599584|NCT00927758|579912501|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
160599585|NCT00927758|579912502|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
160599586|NCT00927758|579912503|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
160468963|NCT04237792|579447960|FG000|Treatment (Day 1)|Other|0|||
160468964|NCT04237792|579447961|FG001|Treatment (Day 1)|Other|0|||
160468965|NCT04237792|579447962|FG002|Treatment (Day 1)|Other|1|||
160468966|NCT04237792|579447963|FG003|Treatment (Day 1)|Other|0|||
160599587|NCT00927758|579912504|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
160599588|NCT00927758|579912505|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
160599589|NCT00927758|579912500|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
160599590|NCT00927758|579912501|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
160599591|NCT00927758|579912502|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
160599592|NCT00927758|579912503|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
160599593|NCT00927758|579912504|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
160599594|NCT00927758|579912505|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
160599595|NCT03984812|579912506|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
160599596|NCT03984812|579912507|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
160599597|NCT03984812|579912508|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
160599598|NCT03984812|579912509|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
160599599|NCT03984812|579912510|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
160599600|NCT03984812|579912511|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
160599601|NCT03984812|579912512|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
160599602|NCT03984812|579912513|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
160599603|NCT03984812|579912514|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
160599604|NCT03984812|579912515|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
160599605|NCT03984812|579912516|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
160599606|NCT02431793|579912520|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
160599607|NCT02431793|579912521|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
160599608|NCT02431793|579912522|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
160599609|NCT02431793|579912520|FG000|Overall Study|Withdrawal by Subject|7|||
160659290|NCT02106156|580134491|FG001|Overall Study|Concomitant Disease|2|||
160468967|NCT04237792|579447964|FG004|Treatment (Day 1)|Other|0|||
160468968|NCT04237792|579447965|FG005|Treatment (Day 1)|Other|1|||
160468969|NCT04237792|579447960|FG000|Treatment (Day 1)|Not treated|1|||
160468970|NCT04237792|579447961|FG001|Treatment (Day 1)|Not treated|1|||
160468971|NCT04237792|579447962|FG002|Treatment (Day 1)|Not treated|2|||
160468972|NCT04237792|579447963|FG003|Treatment (Day 1)|Not treated|1|||
160468973|NCT04237792|579447964|FG004|Treatment (Day 1)|Not treated|0|||
160468974|NCT04237792|579447965|FG005|Treatment (Day 1)|Not treated|1|||
160468975|NCT04693637|579447966|FG000|Overall Study|Death|4|||
160468976|NCT04693637|579447966|FG000|Overall Study|Withdrawal by Subject|3|||
160468977|NCT04693637|579447966|FG000|Overall Study|Physician Decision|2|||
160468978|NCT04693637|579447966|FG000|Overall Study|Lost to Follow-up|1|||
160468979|NCT03052517|579447967|FG000|Overall Study|Study Terminated By Sponsor|928|||
160468980|NCT03052517|579447968|FG001|Overall Study|Study Terminated By Sponsor|938|||
160468981|NCT03052517|579447969|FG002|Overall Study|Study Terminated By Sponsor|296|||
160468982|NCT03052517|579447967|FG000|Overall Study|Subject/Guardian Decision|50|||
160468983|NCT03052517|579447968|FG001|Overall Study|Subject/Guardian Decision|45|||
160468984|NCT03052517|579447969|FG002|Overall Study|Subject/Guardian Decision|22|||
160468985|NCT03052517|579447967|FG000|Overall Study|Lack of Efficacy|23|||
160468986|NCT03052517|579447968|FG001|Overall Study|Lack of Efficacy|14|||
160468987|NCT03052517|579447969|FG002|Overall Study|Lack of Efficacy|7|||
160468988|NCT03052517|579447967|FG000|Overall Study|Adverse Event|6|||
160468989|NCT03052517|579447968|FG001|Overall Study|Adverse Event|5|||
160468990|NCT03052517|579447969|FG002|Overall Study|Adverse Event|0|||
160468991|NCT03052517|579447967|FG000|Overall Study|Physician Decision|4|||
160468992|NCT03052517|579447968|FG001|Overall Study|Physician Decision|5|||
160468993|NCT03052517|579447969|FG002|Overall Study|Physician Decision|1|||
160468994|NCT03052517|579447967|FG000|Overall Study|Death|3|||
160468995|NCT03052517|579447968|FG001|Overall Study|Death|0|||
160468996|NCT03052517|579447969|FG002|Overall Study|Death|1|||
160468997|NCT03052517|579447967|FG000|Overall Study|Lost to Follow-up|2|||
160468998|NCT03052517|579447968|FG001|Overall Study|Lost to Follow-up|4|||
160468999|NCT03052517|579447969|FG002|Overall Study|Lost to Follow-up|0|||
160469000|NCT03052517|579447967|FG000|Overall Study|Pregnancy|1|||
160469001|NCT03052517|579447968|FG001|Overall Study|Pregnancy|0|||
160469002|NCT03052517|579447969|FG002|Overall Study|Pregnancy|1|||
160469003|NCT03052517|579447967|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
160469004|NCT03052517|579447968|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
160469005|NCT03052517|579447969|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
160469006|NCT03052517|579447967|FG000|Overall Study|Technical Problems|0|||
160469007|NCT03052517|579447968|FG001|Overall Study|Technical Problems|1|||
160469008|NCT03052517|579447969|FG002|Overall Study|Technical Problems|0|||
160469009|NCT04885998|579447970|FG000|Overall Study|Withdrawal by Subject|0|||
160469010|NCT04885998|579447971|FG001|Overall Study|Withdrawal by Subject|2|||
160469011|NCT04885998|579447972|FG002|Overall Study|Withdrawal by Subject|0|||
160469012|NCT04885998|579447973|FG003|Overall Study|Withdrawal by Subject|3|||
160469013|NCT04885998|579447970|FG000|Overall Study|Lost to Follow-up|1|||
160469014|NCT04885998|579447971|FG001|Overall Study|Lost to Follow-up|1|||
160469015|NCT04885998|579447972|FG002|Overall Study|Lost to Follow-up|0|||
160469016|NCT04885998|579447973|FG003|Overall Study|Lost to Follow-up|0|||
160469017|NCT04885998|579447970|FG000|Overall Study|Death|2|||
160469018|NCT04885998|579447971|FG001|Overall Study|Death|1|||
160469019|NCT04885998|579447972|FG002|Overall Study|Death|2|||
160469020|NCT04885998|579447973|FG003|Overall Study|Death|2|||
160469021|NCT04885998|579447970|FG000|Overall Study|Decision by sponsor|1|||
160469022|NCT04885998|579447971|FG001|Overall Study|Decision by sponsor|1|||
160469023|NCT04885998|579447972|FG002|Overall Study|Decision by sponsor|0|||
160469024|NCT04885998|579447973|FG003|Overall Study|Decision by sponsor|0|||
160469025|NCT05260437|579447974|FG000|Overall Study|Lost to Follow-up|5|||
160599610|NCT02431793|579912521|FG001|Overall Study|Withdrawal by Subject|5|||
160599611|NCT02431793|579912522|FG002|Overall Study|Withdrawal by Subject|5|||
160599612|NCT02431793|579912520|FG000|Overall Study|Lost to Follow-up|101|||
160599613|NCT02431793|579912521|FG001|Overall Study|Lost to Follow-up|122|||
160599614|NCT02431793|579912522|FG002|Overall Study|Lost to Follow-up|104|||
160599615|NCT01563107|579912527|FG000|Overall Study|Physician Decision|0|||
160599616|NCT01563107|579912528|FG001|Overall Study|Physician Decision|1|||
160599617|NCT01563107|579912529|FG002|Overall Study|Physician Decision|1|||
160599618|NCT01563107|579912530|FG003|Overall Study|Physician Decision|3|||
160599619|NCT01563107|579912527|FG000|Overall Study|Withdrawal by Subject|1|||
160599620|NCT01563107|579912528|FG001|Overall Study|Withdrawal by Subject|2|||
160599621|NCT01563107|579912529|FG002|Overall Study|Withdrawal by Subject|1|||
160599622|NCT01563107|579912530|FG003|Overall Study|Withdrawal by Subject|2|||
160599623|NCT02707601|579912531|FG000|Overall Study|Death|0|||
160599624|NCT02707601|579912532|FG001|Overall Study|Death|1|||
160599625|NCT02707601|579912531|FG000|Overall Study|Lack of Efficacy|0|||
160599626|NCT02707601|579912532|FG001|Overall Study|Lack of Efficacy|1|||
160599627|NCT02707601|579912531|FG000|Overall Study|Investigator's Discretion|1|||
160599628|NCT02707601|579912532|FG001|Overall Study|Investigator's Discretion|0|||
160599629|NCT02707601|579912531|FG000|Overall Study|Withdrew Consent|0|||
160599630|NCT02707601|579912532|FG001|Overall Study|Withdrew Consent|1|||
160599631|NCT02707601|579912531|FG000|Overall Study|Lost to Follow-up|1|||
160599632|NCT02707601|579912532|FG001|Overall Study|Lost to Follow-up|1|||
160599633|NCT02707601|579912531|FG000|Overall Study|Participants Randomized but Not Treated|2|||
160599634|NCT02707601|579912532|FG001|Overall Study|Participants Randomized but Not Treated|0|||
160599635|NCT00063986|579912534|FG000|Overall Study|Withdrawal by Subject|1|||
160599636|NCT00063986|579912534|FG000|Overall Study|Ineligible|1|||
160599637|NCT00063986|579912534|FG000|Overall Study|Intra-operatively ineligible|4|||
160599638|NCT00247273|579912535|FG000|Overall Study|Adverse Event|85|||
160599639|NCT00247273|579912536|FG001|Overall Study|Adverse Event|80|||
160599640|NCT00247273|579912535|FG000|Overall Study|Physician Decision|6|||
160599641|NCT00247273|579912536|FG001|Overall Study|Physician Decision|3|||
160599642|NCT00247273|579912535|FG000|Overall Study|Lost to Follow-up|7|||
160599643|NCT00247273|579912536|FG001|Overall Study|Lost to Follow-up|7|||
160599644|NCT00247273|579912535|FG000|Overall Study|Withdrawal by Subject|46|||
160599645|NCT00247273|579912536|FG001|Overall Study|Withdrawal by Subject|47|||
160599646|NCT00247273|579912535|FG000|Overall Study|Did not take any study drug|2|||
160599647|NCT00247273|579912536|FG001|Overall Study|Did not take any study drug|0|||
160599648|NCT01709708|579912537|FG000|Overall Study|Protocol Violation|1|||
160599649|NCT01709708|579912538|FG001|Overall Study|Protocol Violation|2|||
160599650|NCT02001688|579912540|FG000|Overall Study|Withdrawal by Subject|0|||
160599651|NCT02001688|579912541|FG001|Overall Study|Withdrawal by Subject|0|||
160599652|NCT02001688|579912542|FG002|Overall Study|Withdrawal by Subject|1|||
160599653|NCT02001688|579912540|FG000|Overall Study|Adverse Event|0|||
160599654|NCT02001688|579912541|FG001|Overall Study|Adverse Event|1|||
160599655|NCT02001688|579912542|FG002|Overall Study|Adverse Event|0|||
160599656|NCT01675141|579912546|FG000|Overall Study|Lenalidomide outside NIH|3|||
160599657|NCT01675141|579912546|FG000|Overall Study|Withdrawal by Subject|3|||
160599658|NCT01675141|579912546|FG000|Overall Study|Physician Decision|4|||
160599659|NCT01675141|579912546|FG000|Overall Study|No treatment, per protocol|1|||
160599660|NCT00105183|579912550|FG000|Overall Study|Death|19|||
160599661|NCT00105183|579912551|FG001|Overall Study|Death|13|||
160599662|NCT00105183|579912552|FG002|Overall Study|Death|15|||
160599663|NCT00105183|579912550|FG000|Overall Study|Withdrawal by Subject|1|||
160599664|NCT00105183|579912551|FG001|Overall Study|Withdrawal by Subject|1|||
160599665|NCT00105183|579912552|FG002|Overall Study|Withdrawal by Subject|4|||
160599666|NCT00105183|579912550|FG000|Overall Study|Physician Decision|1|||
160599667|NCT00105183|579912551|FG001|Overall Study|Physician Decision|2|||
160599668|NCT00105183|579912552|FG002|Overall Study|Physician Decision|3|||
160599669|NCT00105183|579912550|FG000|Overall Study|Lost to Follow-up|0|||
160599670|NCT00105183|579912551|FG001|Overall Study|Lost to Follow-up|1|||
160599671|NCT00105183|579912552|FG002|Overall Study|Lost to Follow-up|1|||
160599672|NCT00105183|579912550|FG000|Overall Study|Other reason|1|||
160599673|NCT00105183|579912551|FG001|Overall Study|Other reason|2|||
160599674|NCT00105183|579912552|FG002|Overall Study|Other reason|0|||
160599675|NCT00270998|579912556|FG000|3 Month Follow-up|Adverse Event|1|||
160599676|NCT00270998|579912557|FG001|3 Month Follow-up|Adverse Event|0|||
160599677|NCT00270998|579912558|FG002|3 Month Follow-up|Adverse Event|0|||
160599678|NCT00270998|579912556|FG000|3 Month Follow-up|Lack of Efficacy|1|||
160599679|NCT00270998|579912557|FG001|3 Month Follow-up|Lack of Efficacy|2|||
160599680|NCT00270998|579912558|FG002|3 Month Follow-up|Lack of Efficacy|1|||
160599681|NCT00270998|579912556|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
160599682|NCT00270998|579912557|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
160599683|NCT00270998|579912558|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
160599684|NCT00270998|579912556|FG000|3 Month Follow-up|Pessary did not fit|12|||
160599685|NCT00270998|579912557|FG001|3 Month Follow-up|Pessary did not fit|0|||
160599686|NCT00270998|579912558|FG002|3 Month Follow-up|Pessary did not fit|0|||
160599687|NCT00270998|579912556|FG000|3 Month Follow-up|Personal/family health|1|||
160469026|NCT05260437|579447975|FG001|Overall Study|Lost to Follow-up|2|||
160469027|NCT05260437|579447976|FG002|Overall Study|Lost to Follow-up|1|||
160469028|NCT05260437|579447977|FG003|Overall Study|Lost to Follow-up|2|||
160469029|NCT05260437|579447978|FG004|Overall Study|Lost to Follow-up|2|||
160469030|NCT05260437|579447974|FG000|Overall Study|Withdrawal by Subject|3|||
160469031|NCT05260437|579447975|FG001|Overall Study|Withdrawal by Subject|0|||
160469032|NCT05260437|579447976|FG002|Overall Study|Withdrawal by Subject|4|||
160469033|NCT05260437|579447977|FG003|Overall Study|Withdrawal by Subject|5|||
160469034|NCT05260437|579447978|FG004|Overall Study|Withdrawal by Subject|0|||
160469035|NCT05260437|579447974|FG000|Overall Study|Vaccine Not Administered|0|||
160469036|NCT05260437|579447975|FG001|Overall Study|Vaccine Not Administered|1|||
160469037|NCT05260437|579447976|FG002|Overall Study|Vaccine Not Administered|0|||
160469038|NCT05260437|579447977|FG003|Overall Study|Vaccine Not Administered|0|||
160469039|NCT05260437|579447978|FG004|Overall Study|Vaccine Not Administered|0|||
160469040|NCT00910962|579447979|FG000|Overall Study|Adverse Event|5|||
160469041|NCT00910962|579447980|FG001|Overall Study|Adverse Event|20|||
160469042|NCT00910962|579447981|FG002|Overall Study|Adverse Event|17|||
160469043|NCT00910962|579447979|FG000|Overall Study|Protocol Violation|1|||
160469044|NCT00910962|579447980|FG001|Overall Study|Protocol Violation|3|||
160469045|NCT00910962|579447981|FG002|Overall Study|Protocol Violation|3|||
160469046|NCT00910962|579447979|FG000|Overall Study|Lost to Follow-up|0|||
160469047|NCT00910962|579447980|FG001|Overall Study|Lost to Follow-up|3|||
160599688|NCT00270998|579912557|FG001|3 Month Follow-up|Personal/family health|1|||
160599689|NCT00270998|579912558|FG002|3 Month Follow-up|Personal/family health|0|||
160599690|NCT00270998|579912556|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
160599691|NCT00270998|579912557|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
160469048|NCT00910962|579447981|FG002|Overall Study|Lost to Follow-up|1|||
160469049|NCT00910962|579447979|FG000|Overall Study|Physician Decision|0|||
160469050|NCT00910962|579447980|FG001|Overall Study|Physician Decision|6|||
160599692|NCT00270998|579912558|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
160599693|NCT00270998|579912556|FG000|12 Month Follow-up|Lack of Efficacy|5|||
160599694|NCT00270998|579912557|FG001|12 Month Follow-up|Lack of Efficacy|4|||
160599695|NCT00270998|579912558|FG002|12 Month Follow-up|Lack of Efficacy|3|||
160599696|NCT00270998|579912556|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
160599697|NCT00270998|579912557|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
160599698|NCT00270998|579912558|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
160599699|NCT00270998|579912556|FG000|12 Month Follow-up|Pessary did not fit|1|||
160599700|NCT00270998|579912557|FG001|12 Month Follow-up|Pessary did not fit|0|||
160599701|NCT00270998|579912558|FG002|12 Month Follow-up|Pessary did not fit|0|||
160599702|NCT00270998|579912556|FG000|12 Month Follow-up|Personal/family health|0|||
160599703|NCT00270998|579912557|FG001|12 Month Follow-up|Personal/family health|5|||
160599704|NCT00270998|579912558|FG002|12 Month Follow-up|Personal/family health|1|||
160599705|NCT00270998|579912556|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
160469051|NCT00910962|579447981|FG002|Overall Study|Physician Decision|6|||
160469052|NCT00910962|579447979|FG000|Overall Study|Withdrawal by Subject|25|||
160469053|NCT00910962|579447980|FG001|Overall Study|Withdrawal by Subject|32|||
160469054|NCT00910962|579447981|FG002|Overall Study|Withdrawal by Subject|32|||
160469055|NCT00910962|579447979|FG000|Overall Study|Reached defined stopping criteria|12|||
160469056|NCT00910962|579447980|FG001|Overall Study|Reached defined stopping criteria|14|||
160469057|NCT00910962|579447981|FG002|Overall Study|Reached defined stopping criteria|17|||
160469058|NCT00195819|579447982|FG000|Double-Blind|Withdrawal by Subject|1|||
160469059|NCT00195819|579447983|FG001|Double-Blind|Withdrawal by Subject|0|||
160469060|NCT00195819|579447982|FG000|Double-Blind|Moved|1|||
160469061|NCT00195819|579447983|FG001|Double-Blind|Moved|0|||
160469062|NCT00195819|579447982|FG000|Open-label|Adverse Event|0|||
160469063|NCT00195819|579447983|FG001|Open-label|Adverse Event|9|||
160469064|NCT00195819|579447982|FG000|Open-label|Lack of Efficacy|0|||
160469065|NCT00195819|579447983|FG001|Open-label|Lack of Efficacy|2|||
160469066|NCT00195819|579447982|FG000|Open-label|Pregnancy|0|||
160469067|NCT00195819|579447983|FG001|Open-label|Pregnancy|1|||
160469068|NCT00195819|579447982|FG000|Open-label|Protocol Violation|0|||
160469069|NCT00195819|579447983|FG001|Open-label|Protocol Violation|2|||
160469070|NCT00195819|579447982|FG000|Open-label|Moved|0|||
160469071|NCT00195819|579447983|FG001|Open-label|Moved|1|||
160469072|NCT00195819|579447982|FG000|Open-label|Withdrawal by Subject|0|||
160469073|NCT00195819|579447983|FG001|Open-label|Withdrawal by Subject|5|||
160469074|NCT00787176|579447984|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
160469075|NCT00787176|579447985|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
160469076|NCT00787176|579447986|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
160469077|NCT00787176|579447987|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
160469078|NCT03298087|579447992|FG000|Overall Study|Withdrawal by Subject|4|||
160469079|NCT02788981|579447995|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
160469080|NCT02788981|579447996|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
160469081|NCT05553366|579447997|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
160469082|NCT05553366|579447998|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
160469083|NCT05553366|579447999|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
160469084|NCT05553366|579447997|FG000|Overall Study|Lost to Follow-up|3|||
160469085|NCT05553366|579447998|FG001|Overall Study|Lost to Follow-up|3|||
160469086|NCT05553366|579447999|FG002|Overall Study|Lost to Follow-up|3|||
160469087|NCT05553366|579447997|FG000|Overall Study|Other non-compliance|1|||
160469088|NCT05553366|579447998|FG001|Overall Study|Other non-compliance|1|||
160469089|NCT05553366|579447999|FG002|Overall Study|Other non-compliance|0|||
160469090|NCT05553366|579447997|FG000|Overall Study|Randomized but not dosed|0|||
160469091|NCT05553366|579447998|FG001|Overall Study|Randomized but not dosed|0|||
160469092|NCT05553366|579447999|FG002|Overall Study|Randomized but not dosed|2|||
160469093|NCT00249769|579448000|FG000|Overall Study|Withdrawal by Subject|1|||
160469094|NCT00249769|579448001|FG001|Overall Study|Withdrawal by Subject|10|||
160469095|NCT00249769|579448002|FG002|Overall Study|Withdrawal by Subject|6|||
160469096|NCT00249769|579448000|FG000|Overall Study|Migration from Study Area|1|||
160469097|NCT00249769|579448001|FG001|Overall Study|Migration from Study Area|3|||
160599706|NCT00270998|579912557|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
160599707|NCT00270998|579912558|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
160599708|NCT04075396|579912559|FG000|Overall Study|Death|11|||
160599709|NCT04075396|579912560|FG001|Overall Study|Death|9|||
160599710|NCT04075396|579912559|FG000|Overall Study|Withdrawal by Subject|1|||
160599711|NCT04075396|579912560|FG001|Overall Study|Withdrawal by Subject|2|||
160599712|NCT04075396|579912559|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
160599713|NCT04075396|579912560|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
160469098|NCT00249769|579448002|FG002|Overall Study|Migration from Study Area|14|||
160469099|NCT00249769|579448000|FG000|Overall Study|Miscellaneous|0|||
160469100|NCT00249769|579448001|FG001|Overall Study|Miscellaneous|2|||
160469101|NCT00249769|579448002|FG002|Overall Study|Miscellaneous|2|||
160469102|NCT00249769|579448000|FG000|Overall Study|Adverse Event|0|||
160469103|NCT00249769|579448001|FG001|Overall Study|Adverse Event|0|||
160469104|NCT00249769|579448002|FG002|Overall Study|Adverse Event|1|||
160469105|NCT00249769|579448000|FG000|Overall Study|Physician Decision|0|||
160469106|NCT00249769|579448001|FG001|Overall Study|Physician Decision|0|||
160469107|NCT00249769|579448002|FG002|Overall Study|Physician Decision|2|||
160469108|NCT00249769|579448000|FG000|Overall Study|Lost to Follow-up|0|||
160469109|NCT00249769|579448001|FG001|Overall Study|Lost to Follow-up|0|||
160469110|NCT00249769|579448002|FG002|Overall Study|Lost to Follow-up|3|||
160469111|NCT02022657|579448007|FG000|Overall Study|Withdrawal by Subject|2|||
160469112|NCT02022657|579448008|FG001|Overall Study|Withdrawal by Subject|0|||
160469113|NCT02022657|579448009|FG002|Overall Study|Withdrawal by Subject|1|||
160469114|NCT02022657|579448010|FG003|Overall Study|Withdrawal by Subject|0|||
160469115|NCT02022657|579448011|FG004|Overall Study|Withdrawal by Subject|0|||
160469116|NCT02022657|579448012|FG005|Overall Study|Withdrawal by Subject|0|||
160469117|NCT02022657|579448007|FG000|Overall Study|Physician Decision|0|||
160469118|NCT02022657|579448008|FG001|Overall Study|Physician Decision|0|||
160469119|NCT02022657|579448009|FG002|Overall Study|Physician Decision|0|||
160469120|NCT02022657|579448010|FG003|Overall Study|Physician Decision|0|||
160469121|NCT02022657|579448011|FG004|Overall Study|Physician Decision|0|||
160469122|NCT02022657|579448012|FG005|Overall Study|Physician Decision|1|||
160469123|NCT03274076|579448014|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
160469124|NCT03274076|579448015|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
160469125|NCT03274076|579448016|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
160469126|NCT03274076|579448017|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
160469127|NCT03274076|579448014|FG000|24 Weeks Open Label|Adverse Event|0|||
160469128|NCT03274076|579448015|FG001|24 Weeks Open Label|Adverse Event|0|||
160469129|NCT03274076|579448016|FG002|24 Weeks Open Label|Adverse Event|2|||
160469130|NCT03274076|579448017|FG003|24 Weeks Open Label|Adverse Event|0|||
160469131|NCT03274076|579448014|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
160469132|NCT03274076|579448015|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
160469133|NCT03274076|579448016|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
160469134|NCT03274076|579448017|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
160469135|NCT00795184|579448018|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
160469136|NCT00795184|579448019|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
160469137|NCT03781375|579448020|FG000|Double-blind Phase|Adverse Event|0|||
160469138|NCT03781375|579448021|FG001|Double-blind Phase|Adverse Event|1|||
160469139|NCT03781375|579448020|FG000|Double-blind Phase|Lack of Response|6|||
160469140|NCT03781375|579448021|FG001|Double-blind Phase|Lack of Response|2|||
160469141|NCT03781375|579448020|FG000|Double-blind Phase|Other|1|||
160469142|NCT03781375|579448021|FG001|Double-blind Phase|Other|3|||
160469143|NCT03781375|579448020|FG000|Open-label Phase|Protocol Issues|0|||
160469144|NCT03781375|579448021|FG001|Open-label Phase|Protocol Issues|1|||
160469145|NCT03781375|579448020|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
160469146|NCT03781375|579448021|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
160469147|NCT03781375|579448020|FG000|Open-label Phase|Other|2|||
160469148|NCT03781375|579448021|FG001|Open-label Phase|Other|2|||
160599714|NCT04075396|579912559|FG000|Overall Study|Enrolled but not-treated|0|||
160599715|NCT04075396|579912560|FG001|Overall Study|Enrolled but not-treated|1|||
160599716|NCT00968708|579912565|FG000|Overall Study|Adverse Event|169|||
160599717|NCT00968708|579912566|FG001|Overall Study|Adverse Event|150|||
160599718|NCT00968708|579912565|FG000|Overall Study|Major Protocol Deviation|0|||
160469149|NCT01303510|579448023|FG000|Overall Study|Lost to Follow-up|1|||
160469150|NCT01303510|579448024|FG001|Overall Study|Lost to Follow-up|0|||
160469151|NCT00822900|579448028|FG000|Overall Study|Withdrawal by Subject|14|||
160599719|NCT00968708|579912566|FG001|Overall Study|Major Protocol Deviation|1|||
160599720|NCT00968708|579912565|FG000|Overall Study|Lost to Follow-up|19|||
160599721|NCT00968708|579912566|FG001|Overall Study|Lost to Follow-up|11|||
160599722|NCT00968708|579912565|FG000|Overall Study|Voluntary Withdrawal|104|||
160599723|NCT00968708|579912566|FG001|Overall Study|Voluntary Withdrawal|101|||
160599724|NCT00968708|579912565|FG000|Overall Study|Investigator Discretion|0|||
160599725|NCT00968708|579912566|FG001|Overall Study|Investigator Discretion|1|||
160599726|NCT00968708|579912565|FG000|Overall Study|Other|26|||
160599727|NCT00968708|579912566|FG001|Overall Study|Other|34|||
160599728|NCT03407170|579912567|FG000|Overall Study|Adverse Event|1|||
160599729|NCT00636441|579912568|FG000|Overall Study|Adverse Event|0|||
160599730|NCT00636441|579912569|FG001|Overall Study|Adverse Event|1|||
160599731|NCT00636441|579912570|FG002|Overall Study|Adverse Event|1|||
160599732|NCT00636441|579912571|FG003|Overall Study|Adverse Event|0|||
160599733|NCT00636441|579912572|FG004|Overall Study|Adverse Event|0|||
160599734|NCT00636441|579912573|FG005|Overall Study|Adverse Event|1|||
160599735|NCT00636441|579912574|FG006|Overall Study|Adverse Event|0|||
160599736|NCT00636441|579912568|FG000|Overall Study|Late, ineligible|0|||
160599737|NCT00636441|579912569|FG001|Overall Study|Late, ineligible|0|||
160599738|NCT00636441|579912570|FG002|Overall Study|Late, ineligible|0|||
160599739|NCT00636441|579912571|FG003|Overall Study|Late, ineligible|0|||
160599740|NCT00636441|579912572|FG004|Overall Study|Late, ineligible|0|||
160599741|NCT00636441|579912573|FG005|Overall Study|Late, ineligible|0|||
160599742|NCT00636441|579912574|FG006|Overall Study|Late, ineligible|1|||
160599743|NCT00636441|579912568|FG000|Overall Study|Screen Failure|0|||
160599744|NCT00636441|579912569|FG001|Overall Study|Screen Failure|0|||
160599745|NCT00636441|579912570|FG002|Overall Study|Screen Failure|0|||
160599746|NCT00636441|579912571|FG003|Overall Study|Screen Failure|0|||
160599747|NCT00636441|579912572|FG004|Overall Study|Screen Failure|0|||
160599748|NCT00636441|579912573|FG005|Overall Study|Screen Failure|0|||
160599749|NCT00636441|579912574|FG006|Overall Study|Screen Failure|17|||
160599750|NCT00305604|579912575|FG000|Overall Study|Adverse Event|6|||
160599751|NCT00305604|579912576|FG001|Overall Study|Adverse Event|3|||
160599752|NCT00305604|579912575|FG000|Overall Study|Lack of Efficacy|11|||
160599753|NCT00305604|579912576|FG001|Overall Study|Lack of Efficacy|18|||
160599754|NCT00305604|579912575|FG000|Overall Study|Lost to Follow-up|0|||
160599755|NCT00305604|579912576|FG001|Overall Study|Lost to Follow-up|4|||
160599756|NCT00305604|579912575|FG000|Overall Study|Protocol Violation|2|||
160599757|NCT00305604|579912576|FG001|Overall Study|Protocol Violation|1|||
160599758|NCT00305604|579912575|FG000|Overall Study|Withdrawal by Subject|12|||
160599759|NCT00305604|579912576|FG001|Overall Study|Withdrawal by Subject|21|||
160599760|NCT00305604|579912575|FG000|Overall Study|Patient moved|1|||
160469152|NCT00822900|579448029|FG001|Overall Study|Withdrawal by Subject|14|||
160469153|NCT00822900|579448028|FG000|Overall Study|Lost to Follow-up|9|||
160469154|NCT00822900|579448029|FG001|Overall Study|Lost to Follow-up|9|||
160469155|NCT00822900|579448028|FG000|Overall Study|Death|83|||
160469156|NCT00822900|579448029|FG001|Overall Study|Death|69|||
160469157|NCT00822900|579448028|FG000|Overall Study|Became a ward of the state|2|||
160469158|NCT00822900|579448029|FG001|Overall Study|Became a ward of the state|1|||
160469159|NCT01968967|579448030|FG000|Treatment Period|Other|22|||
160469160|NCT01968967|579448031|FG001|Treatment Period|Other|22|||
160469161|NCT01968967|579448032|FG002|Treatment Period|Other|0|||
160469162|NCT01968967|579448033|FG003|Treatment Period|Other|0|||
160599761|NCT00305604|579912576|FG001|Overall Study|Patient moved|0|||
160599762|NCT01248364|579912578|FG000|Overall Study|Adverse Event|0|||
160599763|NCT01248364|579912579|FG001|Overall Study|Adverse Event|1|||
160599764|NCT01248364|579912580|FG002|Overall Study|Adverse Event|0|||
160599765|NCT01248364|579912581|FG003|Overall Study|Adverse Event|0|||
160599766|NCT01767519|579912583|FG000|Overall Study|Other Reasons|4|||
160599767|NCT01767519|579912584|FG001|Overall Study|Other Reasons|4|||
160599768|NCT01767519|579912585|FG002|Overall Study|Other Reasons|2|||
160599769|NCT01767519|579912583|FG000|Overall Study|Protocol Violation|0|||
160599770|NCT01767519|579912584|FG001|Overall Study|Protocol Violation|3|||
160599771|NCT01767519|579912585|FG002|Overall Study|Protocol Violation|0|||
160599772|NCT01767519|579912583|FG000|Overall Study|Personal Reasons|1|||
160599773|NCT01767519|579912584|FG001|Overall Study|Personal Reasons|0|||
160599774|NCT01767519|579912585|FG002|Overall Study|Personal Reasons|0|||
160599775|NCT01767519|579912583|FG000|Overall Study|Lost to Follow-up|3|||
160599776|NCT01767519|579912584|FG001|Overall Study|Lost to Follow-up|1|||
160599777|NCT01767519|579912585|FG002|Overall Study|Lost to Follow-up|2|||
160599778|NCT01767519|579912583|FG000|Overall Study|Lack of Efficacy|1|||
160599779|NCT01767519|579912584|FG001|Overall Study|Lack of Efficacy|0|||
160599780|NCT01767519|579912585|FG002|Overall Study|Lack of Efficacy|0|||
160599781|NCT01767519|579912583|FG000|Overall Study|Adverse Event|5|||
160599782|NCT01767519|579912584|FG001|Overall Study|Adverse Event|5|||
160599783|NCT01767519|579912585|FG002|Overall Study|Adverse Event|1|||
160599784|NCT01117012|579912587|FG000|Overall Study|Adverse Event|0|||
160599785|NCT01117012|579912588|FG001|Overall Study|Adverse Event|1|||
160599786|NCT01117012|579912587|FG000|Overall Study|Death|1|||
160599787|NCT01117012|579912588|FG001|Overall Study|Death|1|||
160599788|NCT01117012|579912587|FG000|Overall Study|Withdrawal by Subject|3|||
160599789|NCT01117012|579912588|FG001|Overall Study|Withdrawal by Subject|0|||
160599790|NCT01117012|579912587|FG000|Overall Study|Undefined|4|||
160599791|NCT01117012|579912588|FG001|Overall Study|Undefined|3|||
160599792|NCT01586806|579912594|FG000|Overall Study|Protocol Violation|0|||
160599793|NCT01586806|579912595|FG001|Overall Study|Protocol Violation|1|||
160599794|NCT01586806|579912596|FG002|Overall Study|Protocol Violation|0|||
160599795|NCT01586806|579912594|FG000|Overall Study|Withdrawal by Subject|1|||
160599796|NCT01586806|579912595|FG001|Overall Study|Withdrawal by Subject|0|||
160599797|NCT01586806|579912596|FG002|Overall Study|Withdrawal by Subject|0|||
160599798|NCT01586806|579912594|FG000|Overall Study|Lost to Follow-up|2|||
160599799|NCT01586806|579912595|FG001|Overall Study|Lost to Follow-up|3|||
160599800|NCT01586806|579912596|FG002|Overall Study|Lost to Follow-up|2|||
160599801|NCT00555906|579912597|FG000|Phase 1|Objective Progression or Relapse|3|||
160599802|NCT00555906|579912598|FG001|Phase 1|Objective Progression or Relapse|5|||
160599803|NCT00555906|579912599|FG002|Phase 1|Objective Progression or Relapse|3|||
160469163|NCT01968967|579448034|FG004|Treatment Period|Other|0|||
160469164|NCT01968967|579448030|FG000|Treatment Period|Withdrawal by Subject|71|||
160469165|NCT01968967|579448031|FG001|Treatment Period|Withdrawal by Subject|61|||
160469166|NCT01968967|579448032|FG002|Treatment Period|Withdrawal by Subject|0|||
160469167|NCT01968967|579448033|FG003|Treatment Period|Withdrawal by Subject|0|||
160469168|NCT01968967|579448034|FG004|Treatment Period|Withdrawal by Subject|0|||
160469169|NCT01968967|579448030|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
160469170|NCT01968967|579448031|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
160599804|NCT00555906|579912600|FG003|Phase 1|Objective Progression or Relapse|1|||
160599805|NCT00555906|579912601|FG004|Phase 1|Objective Progression or Relapse|0|||
160469171|NCT01968967|579448032|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
160469172|NCT01968967|579448033|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
160599806|NCT00555906|579912597|FG000|Phase 1|Global Deterioration of Health Status|0|||
160599807|NCT00555906|579912598|FG001|Phase 1|Global Deterioration of Health Status|1|||
160469173|NCT01968967|579448034|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
160599808|NCT00555906|579912599|FG002|Phase 1|Global Deterioration of Health Status|1|||
160599809|NCT00555906|579912600|FG003|Phase 1|Global Deterioration of Health Status|1|||
160599810|NCT00555906|579912601|FG004|Phase 1|Global Deterioration of Health Status|0|||
160599811|NCT00555906|579912597|FG000|Phase 1|Adverse Event|0|||
160599812|NCT00555906|579912598|FG001|Phase 1|Adverse Event|0|||
160599813|NCT00555906|579912599|FG002|Phase 1|Adverse Event|3|||
160599814|NCT00555906|579912600|FG003|Phase 1|Adverse Event|2|||
160659291|NCT02106156|580134492|FG002|Overall Study|Concomitant Disease|0|||
160599815|NCT00555906|579912601|FG004|Phase 1|Adverse Event|0|||
160599816|NCT00555906|579912597|FG000|Phase 1|Withdrawal by Subject|0|||
160469174|NCT01968967|579448030|FG000|Treatment Period|Lost to Follow-up|26|||
160469175|NCT01968967|579448031|FG001|Treatment Period|Lost to Follow-up|31|||
160469176|NCT01968967|579448032|FG002|Treatment Period|Lost to Follow-up|0|||
160469177|NCT01968967|579448033|FG003|Treatment Period|Lost to Follow-up|0|||
160469178|NCT01968967|579448034|FG004|Treatment Period|Lost to Follow-up|0|||
160469179|NCT01968967|579448030|FG000|Treatment Period|Protocol Violation|1|||
160469180|NCT01968967|579448031|FG001|Treatment Period|Protocol Violation|2|||
160469181|NCT01968967|579448032|FG002|Treatment Period|Protocol Violation|0|||
160469182|NCT01968967|579448033|FG003|Treatment Period|Protocol Violation|0|||
160469183|NCT01968967|579448034|FG004|Treatment Period|Protocol Violation|0|||
160469184|NCT01968967|579448030|FG000|Treatment Period|Adverse Event|9|||
160469185|NCT01968967|579448031|FG001|Treatment Period|Adverse Event|8|||
160469186|NCT01968967|579448032|FG002|Treatment Period|Adverse Event|0|||
160469187|NCT01968967|579448033|FG003|Treatment Period|Adverse Event|0|||
160469188|NCT01968967|579448034|FG004|Treatment Period|Adverse Event|0|||
160469189|NCT01968967|579448030|FG000|Treatment Period|Death|9|||
160469190|NCT01968967|579448031|FG001|Treatment Period|Death|2|||
160469191|NCT01968967|579448032|FG002|Treatment Period|Death|0|||
160469192|NCT01968967|579448033|FG003|Treatment Period|Death|0|||
160469193|NCT01968967|579448034|FG004|Treatment Period|Death|0|||
160469194|NCT01968967|579448030|FG000|Treatment Period|Randomized Not Treated|6|||
160469195|NCT01968967|579448031|FG001|Treatment Period|Randomized Not Treated|5|||
160469196|NCT01968967|579448032|FG002|Treatment Period|Randomized Not Treated|0|||
160469197|NCT01968967|579448033|FG003|Treatment Period|Randomized Not Treated|0|||
160469198|NCT01968967|579448034|FG004|Treatment Period|Randomized Not Treated|0|||
160469199|NCT01968967|579448030|FG000|Extension Period|Withdrew Consent|0|||
160469200|NCT01968967|579448031|FG001|Extension Period|Withdrew Consent|0|||
160469201|NCT01968967|579448032|FG002|Extension Period|Withdrew Consent|2|||
160469202|NCT01968967|579448033|FG003|Extension Period|Withdrew Consent|0|||
160469203|NCT01968967|579448034|FG004|Extension Period|Withdrew Consent|5|||
160469204|NCT00701415|579448041|FG000|Overall Study|Adverse Event|0|||
160469205|NCT00701415|579448042|FG001|Overall Study|Adverse Event|1|||
160469206|NCT00701415|579448041|FG000|Overall Study|Social/family issues and needle phobia|1|||
160469207|NCT00701415|579448042|FG001|Overall Study|Social/family issues and needle phobia|0|||
160469208|NCT02106884|579448043|FG000|Overall Study|Change of diagnosis/exclusion|0|||
160469209|NCT02106884|579448044|FG001|Overall Study|Change of diagnosis/exclusion|1|||
160469210|NCT02022670|579448047|FG000|Overall Study|Adverse Event|1|||
160469211|NCT02022670|579448048|FG001|Overall Study|Adverse Event|0|||
160469212|NCT02022670|579448049|FG002|Overall Study|Adverse Event|1|||
160469213|NCT02113449|579448050|FG000|Overall Study|Adverse Event|4|||
160469214|NCT00109031|579448051|FG000|Overall Study|Adverse Event|0|||
160469215|NCT00109031|579448052|FG001|Overall Study|Adverse Event|0|||
160469216|NCT00109031|579448053|FG002|Overall Study|Adverse Event|1|||
160469217|NCT00109031|579448054|FG003|Overall Study|Adverse Event|0|||
160469218|NCT00109031|579448051|FG000|Overall Study|Withdrawal by Subject|0|||
160469219|NCT00109031|579448052|FG001|Overall Study|Withdrawal by Subject|1|||
160469220|NCT00109031|579448053|FG002|Overall Study|Withdrawal by Subject|0|||
160469221|NCT00109031|579448054|FG003|Overall Study|Withdrawal by Subject|0|||
160469222|NCT00109031|579448051|FG000|Overall Study|Physician Decision|0|||
160469223|NCT00109031|579448052|FG001|Overall Study|Physician Decision|1|||
160469224|NCT00109031|579448053|FG002|Overall Study|Physician Decision|0|||
160469225|NCT00109031|579448054|FG003|Overall Study|Physician Decision|0|||
160469226|NCT00109031|579448051|FG000|Overall Study|Protocol Violation|0|||
160469227|NCT00109031|579448052|FG001|Overall Study|Protocol Violation|0|||
160469228|NCT00109031|579448053|FG002|Overall Study|Protocol Violation|1|||
160469229|NCT00109031|579448054|FG003|Overall Study|Protocol Violation|0|||
160469230|NCT02091752|579448057|FG000|Overall Study|Study terminated by Sponsor|2|||
160469231|NCT02091752|579448057|FG000|Overall Study|Adverse Event|1|||
160469232|NCT02060487|579448058|FG000|Overall Study|Other|1|||
160469233|NCT02060487|579448059|FG001|Overall Study|Other|2|||
160469234|NCT02060487|579448060|FG002|Overall Study|Other|1|||
160469235|NCT02060487|579448058|FG000|Overall Study|Lack of Efficacy|0|||
160469236|NCT02060487|579448059|FG001|Overall Study|Lack of Efficacy|1|||
160469237|NCT02060487|579448060|FG002|Overall Study|Lack of Efficacy|0|||
160659292|NCT02106156|580134490|FG000|Overall Study|Lack of Compliance|211|||
160469238|NCT02060487|579448058|FG000|Overall Study|Withdrawal by Subject|3|||
160469239|NCT02060487|579448059|FG001|Overall Study|Withdrawal by Subject|10|||
160469240|NCT02060487|579448060|FG002|Overall Study|Withdrawal by Subject|4|||
160469241|NCT02060487|579448058|FG000|Overall Study|Study Terminated By Sponsor|87|||
160469242|NCT02060487|579448059|FG001|Overall Study|Study Terminated By Sponsor|89|||
160469243|NCT02060487|579448060|FG002|Overall Study|Study Terminated By Sponsor|100|||
160469244|NCT02060487|579448058|FG000|Overall Study|Randomized in error|1|||
160469245|NCT02060487|579448059|FG001|Overall Study|Randomized in error|0|||
160469246|NCT02060487|579448060|FG002|Overall Study|Randomized in error|0|||
160469247|NCT02060487|579448058|FG000|Overall Study|Protocol Violation|0|||
160469248|NCT02060487|579448059|FG001|Overall Study|Protocol Violation|1|||
160469249|NCT02060487|579448060|FG002|Overall Study|Protocol Violation|1|||
160469250|NCT02060487|579448058|FG000|Overall Study|Lost to Follow-up|3|||
160469251|NCT02060487|579448059|FG001|Overall Study|Lost to Follow-up|0|||
160599817|NCT00555906|579912598|FG001|Phase 1|Withdrawal by Subject|0|||
160599818|NCT00555906|579912599|FG002|Phase 1|Withdrawal by Subject|0|||
160599819|NCT00555906|579912600|FG003|Phase 1|Withdrawal by Subject|1|||
160599820|NCT00555906|579912601|FG004|Phase 1|Withdrawal by Subject|0|||
160599821|NCT00555906|579912597|FG000|Phase 2|Adverse Event|0|||
160599822|NCT00555906|579912598|FG001|Phase 2|Adverse Event|0|||
160599823|NCT00555906|579912599|FG002|Phase 2|Adverse Event|0|||
160599824|NCT00555906|579912600|FG003|Phase 2|Adverse Event|0|||
160599825|NCT00555906|579912601|FG004|Phase 2|Adverse Event|4|||
160599826|NCT00555906|579912597|FG000|Phase 2|Global Deterioration of Health Status|0|||
160599827|NCT00555906|579912598|FG001|Phase 2|Global Deterioration of Health Status|0|||
160599828|NCT00555906|579912599|FG002|Phase 2|Global Deterioration of Health Status|0|||
160599829|NCT00555906|579912600|FG003|Phase 2|Global Deterioration of Health Status|0|||
160599830|NCT00555906|579912601|FG004|Phase 2|Global Deterioration of Health Status|2|||
160599831|NCT00555906|579912597|FG000|Phase 2|Objective Progression or Relapse|0|||
160599832|NCT00555906|579912598|FG001|Phase 2|Objective Progression or Relapse|0|||
160599833|NCT00555906|579912599|FG002|Phase 2|Objective Progression or Relapse|0|||
160659293|NCT02106156|580134491|FG001|Overall Study|Lack of Compliance|7|||
160599834|NCT00555906|579912600|FG003|Phase 2|Objective Progression or Relapse|0|||
160599835|NCT00555906|579912601|FG004|Phase 2|Objective Progression or Relapse|16|||
160599836|NCT00555906|579912597|FG000|Phase 2|Withdrawal by Subject|0|||
160659294|NCT02106156|580134492|FG002|Overall Study|Lack of Compliance|0|||
160469252|NCT02060487|579448060|FG002|Overall Study|Lost to Follow-up|2|||
160469253|NCT02060487|579448058|FG000|Overall Study|Death|34|||
160469254|NCT02060487|579448059|FG001|Overall Study|Death|25|||
160469255|NCT02060487|579448060|FG002|Overall Study|Death|19|||
160469256|NCT02060487|579448058|FG000|Overall Study|Adverse Event|0|||
160469257|NCT02060487|579448059|FG001|Overall Study|Adverse Event|0|||
160469258|NCT02060487|579448060|FG002|Overall Study|Adverse Event|1|||
160469259|NCT03697603|579448065|FG000|Overall Study|Adverse Event|3|||
160469260|NCT03697603|579448066|FG001|Overall Study|Adverse Event|18|||
160469261|NCT03697603|579448067|FG002|Overall Study|Adverse Event|3|||
160469262|NCT03697603|579448065|FG000|Overall Study|Physician Decision|1|||
160469263|NCT03697603|579448066|FG001|Overall Study|Physician Decision|0|||
160469264|NCT03697603|579448067|FG002|Overall Study|Physician Decision|2|||
160469265|NCT03697603|579448065|FG000|Overall Study|Protocol Violation|3|||
160469266|NCT03697603|579448066|FG001|Overall Study|Protocol Violation|8|||
160469267|NCT03697603|579448067|FG002|Overall Study|Protocol Violation|5|||
160469268|NCT03697603|579448065|FG000|Overall Study|Withdrawal by Subject|5|||
160469269|NCT03697603|579448066|FG001|Overall Study|Withdrawal by Subject|1|||
160469270|NCT03697603|579448067|FG002|Overall Study|Withdrawal by Subject|1|||
160469271|NCT03697603|579448065|FG000|Overall Study|Protocol Violation|0|||
160469272|NCT03697603|579448066|FG001|Overall Study|Protocol Violation|0|||
160469273|NCT03697603|579448067|FG002|Overall Study|Protocol Violation|1|||
160469274|NCT04218864|579448068|FG000|Overall Study|Lost to Follow-up|8|||
160469275|NCT04218864|579448069|FG001|Overall Study|Lost to Follow-up|4|||
160469276|NCT04218864|579448068|FG000|Overall Study|Withdrawal by Subject|1|||
160469277|NCT04218864|579448069|FG001|Overall Study|Withdrawal by Subject|3|||
160469278|NCT03683030|579448070|FG000|Overall Study|Enrolled but screen failures|12|||
160469279|NCT03683030|579448071|FG001|Overall Study|Enrolled but screen failures|7|||
160469280|NCT03683030|579448070|FG000|Overall Study|Enrolled but no catheter inserted|11|||
160469281|NCT03683030|579448071|FG001|Overall Study|Enrolled but no catheter inserted|13|||
160469282|NCT03683030|579448070|FG000|Overall Study|Withdrawal by Subject|0|||
160469283|NCT03683030|579448071|FG001|Overall Study|Withdrawal by Subject|2|||
160469284|NCT03683030|579448070|FG000|Overall Study|Early termination by subject|1|||
160469285|NCT03683030|579448071|FG001|Overall Study|Early termination by subject|0|||
160469286|NCT03683030|579448070|FG000|Overall Study|Lost to Follow-up|0|||
160469287|NCT03683030|579448071|FG001|Overall Study|Lost to Follow-up|6|||
160469288|NCT03683030|579448070|FG000|Overall Study|Death|0|||
160469289|NCT03683030|579448071|FG001|Overall Study|Death|2|||
160469290|NCT03683030|579448070|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
160469291|NCT03683030|579448071|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
160599837|NCT00555906|579912598|FG001|Phase 2|Withdrawal by Subject|0|||
160599838|NCT00555906|579912599|FG002|Phase 2|Withdrawal by Subject|0|||
160469292|NCT02222493|579448074|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
160469293|NCT02222493|579448075|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
160469294|NCT02222493|579448074|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
160469295|NCT02222493|579448075|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
160599839|NCT00555906|579912600|FG003|Phase 2|Withdrawal by Subject|0|||
160469296|NCT02222493|579448074|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
160469297|NCT02222493|579448075|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
160469298|NCT02222493|579448074|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
160469299|NCT02222493|579448075|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
160469300|NCT02222493|579448074|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
160469301|NCT02222493|579448075|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
160469302|NCT02222493|579448074|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
160469303|NCT02222493|579448075|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
160469304|NCT02222493|579448074|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
160469305|NCT02222493|579448075|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
160469306|NCT02222493|579448074|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
160469307|NCT02222493|579448075|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
160469308|NCT02222493|579448074|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
160469309|NCT02222493|579448075|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
160469310|NCT02222493|579448074|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
160469311|NCT02222493|579448075|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
160469312|NCT02222493|579448074|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
160469313|NCT02222493|579448075|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
160469314|NCT02222493|579448074|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
160469315|NCT02222493|579448075|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
160469316|NCT02222493|579448074|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
160469317|NCT02222493|579448075|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
160469318|NCT02222493|579448074|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
160469319|NCT02222493|579448075|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
160469320|NCT02222493|579448074|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
160469321|NCT02222493|579448075|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
160469322|NCT02222493|579448074|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
160469323|NCT02222493|579448075|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
160469324|NCT02222493|579448074|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
160469325|NCT02222493|579448075|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
160469326|NCT02222493|579448074|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
160469327|NCT02222493|579448075|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
160469328|NCT02222493|579448074|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
160469329|NCT02222493|579448075|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
160469330|NCT02222493|579448074|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
160469331|NCT02222493|579448075|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
160469332|NCT02222493|579448074|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
160469333|NCT02222493|579448075|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
160469334|NCT02222493|579448074|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
160469335|NCT02222493|579448075|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
160469336|NCT00933270|579448078|FG000|Overall Study|Withdrawal by Subject|26|||
160469337|NCT00933270|579448078|FG000|Overall Study|Insufficient Follow-up|10|||
160469338|NCT00933270|579448078|FG000|Overall Study|Lost to Follow-up|14|||
160469339|NCT00933270|579448078|FG000|Overall Study|Adverse Event|1|||
160469340|NCT00933270|579448078|FG000|Overall Study|Missed Visit|2|||
160469341|NCT00933270|579448078|FG000|Overall Study|Death|24|||
160469342|NCT00933270|579448078|FG000|Overall Study|Moved or would not return|10|||
160469343|NCT02542943|579448079|FG000|Overall Study|Lost to Follow-up|1|||
160469344|NCT02542943|579448080|FG001|Overall Study|Lost to Follow-up|0|||
160469345|NCT02542943|579448081|FG002|Overall Study|Lost to Follow-up|0|||
160469346|NCT02542943|579448079|FG000|Overall Study|Withdrawal by Subject|0|||
160469347|NCT02542943|579448080|FG001|Overall Study|Withdrawal by Subject|1|||
160469348|NCT02542943|579448081|FG002|Overall Study|Withdrawal by Subject|0|||
160469349|NCT05824559|579448084|FG000|Overall Study|Adverse Event|2|||
160469350|NCT05824559|579448084|FG000|Overall Study|Physician Decision|2|||
160469351|NCT05824559|579448084|FG000|Overall Study|Progressive Disease|16|||
160469352|NCT05824559|579448084|FG000|Overall Study|Study Terminated by Sponsor|1|||
160469353|NCT05824559|579448084|FG000|Overall Study|Withdrawal by Subject|2|||
160469354|NCT05366751|579448085|FG000|Overall Study|Adverse Event|25|||
160469355|NCT05366751|579448085|FG000|Overall Study|Physician Decision|3|||
160469356|NCT05366751|579448085|FG000|Overall Study|Lost to Follow-up|2|||
160469357|NCT05366751|579448085|FG000|Overall Study|Withdrawal by Subject|14|||
160469358|NCT05366751|579448085|FG000|Overall Study|Study Terminated by Sponsor|50|||
160469359|NCT05366751|579448085|FG000|Overall Study|Site Terminated by Sponsor|3|||
160469360|NCT00647387|579448088|FG000|Overall Study|Lost to Follow-up|6|||
160469361|NCT00647387|579448088|FG000|Overall Study|Unsuccessful implant|5|||
160469362|NCT00647387|579448088|FG000|Overall Study|Device explanted|3|||
160469363|NCT00647387|579448088|FG000|Overall Study|Other Reason|3|||
160599840|NCT00555906|579912601|FG004|Phase 2|Withdrawal by Subject|2|||
160599841|NCT00555906|579912597|FG000|Phase 2|Other|0|||
160469364|NCT00647387|579448088|FG000|Overall Study|Death|2|||
160469365|NCT00302211|579448089|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
160469366|NCT00302211|579448090|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
160469367|NCT00302211|579448091|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
160469368|NCT00302211|579448092|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
160469369|NCT00302211|579448093|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
160469370|NCT00302211|579448089|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
160469371|NCT00302211|579448090|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
160469372|NCT00302211|579448091|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
160469373|NCT00302211|579448092|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
160469374|NCT00302211|579448093|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
160469375|NCT00302211|579448089|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
160469376|NCT00302211|579448090|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
160469377|NCT00302211|579448091|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
160469378|NCT00302211|579448092|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
160469379|NCT00302211|579448093|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
160469380|NCT00302211|579448089|FG000|Double Blind Period (New Patients)|Disease progression|0|||
160469381|NCT00302211|579448090|FG001|Double Blind Period (New Patients)|Disease progression|1|||
160469382|NCT00302211|579448091|FG002|Double Blind Period (New Patients)|Disease progression|1|||
160469383|NCT00302211|579448092|FG003|Double Blind Period (New Patients)|Disease progression|0|||
160469384|NCT00302211|579448093|FG004|Double Blind Period (New Patients)|Disease progression|0|||
160469385|NCT00302211|579448089|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
160469386|NCT00302211|579448090|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
160469387|NCT00302211|579448091|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
160469388|NCT00302211|579448092|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
160469389|NCT00302211|579448093|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
160469390|NCT00302211|579448089|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
160469391|NCT00302211|579448090|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
160469392|NCT00302211|579448091|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
160469393|NCT00302211|579448092|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
160469394|NCT00302211|579448093|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
160469395|NCT00302211|579448089|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
160469396|NCT00302211|579448090|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
160469397|NCT00302211|579448091|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
160469398|NCT00302211|579448092|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
160469399|NCT00302211|579448093|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
160469400|NCT00302211|579448089|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
160469401|NCT00302211|579448090|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
160469402|NCT00302211|579448091|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
160469403|NCT00302211|579448092|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
160469404|NCT00302211|579448093|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
160469405|NCT00302211|579448089|FG000|Open Label-Patients From Double-Blind|Death|0|||
160469406|NCT00302211|579448090|FG001|Open Label-Patients From Double-Blind|Death|0|||
160469407|NCT00302211|579448091|FG002|Open Label-Patients From Double-Blind|Death|0|||
160469408|NCT00302211|579448092|FG003|Open Label-Patients From Double-Blind|Death|1|||
160469409|NCT00302211|579448093|FG004|Open Label-Patients From Double-Blind|Death|1|||
160469410|NCT00302211|579448089|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
160469411|NCT00302211|579448090|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
160469412|NCT00302211|579448091|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
160469413|NCT00302211|579448092|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
160469414|NCT00302211|579448093|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
160469415|NCT00302211|579448089|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
160469416|NCT00302211|579448090|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
160469417|NCT00302211|579448091|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
160469418|NCT00302211|579448092|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
160469419|NCT00302211|579448093|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
160469420|NCT00302211|579448089|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
160469421|NCT00302211|579448090|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
160469422|NCT00302211|579448091|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
160469423|NCT00302211|579448092|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
160469424|NCT00302211|579448093|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
160469425|NCT03137459|579449850|FG000|2-month Assessment|Withdrawal by Subject|13|||
160469426|NCT03137459|579449851|FG001|2-month Assessment|Withdrawal by Subject|3|||
160469427|NCT03137459|579449850|FG000|2-month Assessment|Unable to reach|42|||
160469428|NCT03137459|579449851|FG001|2-month Assessment|Unable to reach|32|||
160469429|NCT03137459|579449850|FG000|2-month Assessment|Refused assessment|7|||
160469430|NCT03137459|579449851|FG001|2-month Assessment|Refused assessment|5|||
160469431|NCT03137459|579449850|FG000|2-month Assessment|Acutely ill|6|||
160469432|NCT03137459|579449851|FG001|2-month Assessment|Acutely ill|2|||
160469433|NCT03137459|579449850|FG000|4-month Assessment|Death|4|||
160469434|NCT03137459|579449851|FG001|4-month Assessment|Death|2|||
160469435|NCT03137459|579449850|FG000|4-month Assessment|Withdrawal by Subject|4|||
160469436|NCT03137459|579449851|FG001|4-month Assessment|Withdrawal by Subject|2|||
160469437|NCT03137459|579449850|FG000|4-month Assessment|Unable to reach|44|||
160469438|NCT03137459|579449851|FG001|4-month Assessment|Unable to reach|29|||
160469439|NCT03137459|579449850|FG000|4-month Assessment|Refused assessment|24|||
160469440|NCT03137459|579449851|FG001|4-month Assessment|Refused assessment|10|||
160469441|NCT03137459|579449850|FG000|4-month Assessment|Acutely ill|2|||
160469442|NCT03137459|579449851|FG001|4-month Assessment|Acutely ill|3|||
160469443|NCT03137459|579449850|FG000|6-months|Lost to Follow-up|14|||
160469444|NCT03137459|579449851|FG001|6-months|Lost to Follow-up|11|||
160469445|NCT03137459|579449850|FG000|6-months|Death|0|||
160469446|NCT03137459|579449851|FG001|6-months|Death|2|||
160469447|NCT03137459|579449850|FG000|6-months|Refused assessment|6|||
160469448|NCT03137459|579449851|FG001|6-months|Refused assessment|3|||
160469449|NCT03137459|579449850|FG000|6-months|Acutely ill|1|||
160469450|NCT03137459|579449851|FG001|6-months|Acutely ill|1|||
160469451|NCT00985088|579449852|FG000|Overall Study|Serious Adverse Event|1|||
160469452|NCT00985088|579449853|FG001|Overall Study|Serious Adverse Event|1|||
160469453|NCT00985088|579449854|FG002|Overall Study|Serious Adverse Event|0|||
160469454|NCT00985088|579449855|FG003|Overall Study|Serious Adverse Event|0|||
160469455|NCT00985088|579449856|FG004|Overall Study|Serious Adverse Event|0|||
160469456|NCT00985088|579449857|FG005|Overall Study|Serious Adverse Event|0|||
160469457|NCT00985088|579449858|FG006|Overall Study|Serious Adverse Event|0|||
160469458|NCT00985088|579449859|FG007|Overall Study|Serious Adverse Event|1|||
160469459|NCT00985088|579449852|FG000|Overall Study|Adverse Event|0|||
160469460|NCT00985088|579449853|FG001|Overall Study|Adverse Event|0|||
160469461|NCT00985088|579449854|FG002|Overall Study|Adverse Event|1|||
160469462|NCT00985088|579449855|FG003|Overall Study|Adverse Event|0|||
160469463|NCT00985088|579449856|FG004|Overall Study|Adverse Event|0|||
160469464|NCT00985088|579449857|FG005|Overall Study|Adverse Event|0|||
160469465|NCT00985088|579449858|FG006|Overall Study|Adverse Event|0|||
160469466|NCT00985088|579449859|FG007|Overall Study|Adverse Event|0|||
160469467|NCT00985088|579449852|FG000|Overall Study|Withdrawal by Subject|4|||
160599842|NCT00555906|579912598|FG001|Phase 2|Other|0|||
160469468|NCT00985088|579449853|FG001|Overall Study|Withdrawal by Subject|0|||
160469469|NCT00985088|579449854|FG002|Overall Study|Withdrawal by Subject|0|||
160599843|NCT00555906|579912599|FG002|Phase 2|Other|0|||
160599844|NCT00555906|579912600|FG003|Phase 2|Other|0|||
160599845|NCT00555906|579912601|FG004|Phase 2|Other|6|||
160599846|NCT00555906|579912597|FG000|Phase 2|Randomized but not Treated|0|||
160599847|NCT00555906|579912598|FG001|Phase 2|Randomized but not Treated|0|||
160469470|NCT00985088|579449855|FG003|Overall Study|Withdrawal by Subject|1|||
160469471|NCT00985088|579449856|FG004|Overall Study|Withdrawal by Subject|3|||
160469472|NCT00985088|579449857|FG005|Overall Study|Withdrawal by Subject|2|||
160469473|NCT00985088|579449858|FG006|Overall Study|Withdrawal by Subject|1|||
160469474|NCT00985088|579449859|FG007|Overall Study|Withdrawal by Subject|2|||
160469475|NCT00985088|579449852|FG000|Overall Study|Migrated/moved from study area|0|||
160599848|NCT00555906|579912599|FG002|Phase 2|Randomized but not Treated|0|||
160599849|NCT00555906|579912600|FG003|Phase 2|Randomized but not Treated|0|||
160659295|NCT02106156|580134490|FG000|Overall Study|Patients Request|307|||
160599850|NCT00555906|579912601|FG004|Phase 2|Randomized but not Treated|2|||
160599851|NCT02849626|579912602|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
160599852|NCT02849626|579912603|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
160599853|NCT02849626|579912604|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
160599854|NCT02849626|579912605|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
160599855|NCT02849626|579912602|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
160599856|NCT02849626|579912603|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
160599857|NCT02849626|579912604|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
160599858|NCT02849626|579912605|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
160599859|NCT02849626|579912602|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
160599860|NCT02849626|579912603|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
160599861|NCT02849626|579912604|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
160599862|NCT02849626|579912605|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
160599863|NCT02849626|579912602|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
160599864|NCT02849626|579912603|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
160599865|NCT02849626|579912604|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
160599866|NCT02849626|579912605|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
160599867|NCT02849626|579912602|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
160599868|NCT02849626|579912603|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
160599869|NCT02849626|579912604|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
160599870|NCT02849626|579912605|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
160599871|NCT02849626|579912602|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
160599872|NCT02849626|579912603|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
160599873|NCT02849626|579912604|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
160599874|NCT02849626|579912605|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
160599875|NCT02849626|579912602|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
160599876|NCT02849626|579912603|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
160599877|NCT02849626|579912604|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
160599878|NCT02849626|579912605|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
160599879|NCT02849626|579912602|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
160599880|NCT02849626|579912603|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
160599881|NCT02849626|579912604|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
160599882|NCT02849626|579912605|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
160599883|NCT02849626|579912602|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
160599884|NCT02849626|579912603|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
160599885|NCT02849626|579912604|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
160599886|NCT02849626|579912605|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
160599887|NCT02849626|579912602|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
160599888|NCT02849626|579912603|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
160599889|NCT02849626|579912604|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
160599890|NCT02849626|579912605|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
160599891|NCT02849626|579912602|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
160599892|NCT02849626|579912603|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
160599893|NCT02849626|579912604|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
160599894|NCT02849626|579912605|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
160599895|NCT01185704|579912606|FG000|Overall Study|Randomized but not treated|3|||
160599896|NCT01185704|579912607|FG001|Overall Study|Randomized but not treated|3|||
160599897|NCT01185704|579912606|FG000|Overall Study|Lack of ovarian response|5|||
160599898|NCT01185704|579912607|FG001|Overall Study|Lack of ovarian response|1|||
160599899|NCT01185704|579912606|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
160599900|NCT01185704|579912607|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
160599901|NCT01185704|579912606|FG000|Overall Study|Ectopic pregnancy|0|||
160599902|NCT01185704|579912607|FG001|Overall Study|Ectopic pregnancy|1|||
160599903|NCT04046341|579912608|FG000|Overall Study|Lost to Follow-up|2|||
160599904|NCT04046341|579912608|FG000|Overall Study|Withdrawal by Subject|1|||
160599905|NCT02447458|579912609|FG000|Overall Study|Other|0|||
160599906|NCT02447458|579912610|FG001|Overall Study|Other|0|||
160469476|NCT00985088|579449853|FG001|Overall Study|Migrated/moved from study area|0|||
160469477|NCT00985088|579449854|FG002|Overall Study|Migrated/moved from study area|1|||
160469478|NCT00985088|579449855|FG003|Overall Study|Migrated/moved from study area|0|||
160469479|NCT00985088|579449856|FG004|Overall Study|Migrated/moved from study area|0|||
160469480|NCT00985088|579449857|FG005|Overall Study|Migrated/moved from study area|0|||
160469481|NCT00985088|579449858|FG006|Overall Study|Migrated/moved from study area|0|||
160469482|NCT00985088|579449859|FG007|Overall Study|Migrated/moved from study area|1|||
160469483|NCT00985088|579449852|FG000|Overall Study|Lost to Follow-up|6|||
160469484|NCT00985088|579449853|FG001|Overall Study|Lost to Follow-up|1|||
160469485|NCT00985088|579449854|FG002|Overall Study|Lost to Follow-up|2|||
160469486|NCT00985088|579449855|FG003|Overall Study|Lost to Follow-up|6|||
160469487|NCT00985088|579449856|FG004|Overall Study|Lost to Follow-up|6|||
160469488|NCT00985088|579449857|FG005|Overall Study|Lost to Follow-up|5|||
160469489|NCT00985088|579449858|FG006|Overall Study|Lost to Follow-up|3|||
160469490|NCT00985088|579449859|FG007|Overall Study|Lost to Follow-up|2|||
160469491|NCT01970878|579449861|FG000|Overall Study|Withdrawal by Subject|11|||
160469492|NCT01970878|579449862|FG001|Overall Study|Withdrawal by Subject|10|||
160469493|NCT01970878|579449863|FG002|Overall Study|Withdrawal by Subject|14|||
160469494|NCT01970878|579449864|FG003|Overall Study|Withdrawal by Subject|7|||
160469495|NCT01970878|579449861|FG000|Overall Study|Lost to Follow-up|1|||
160469496|NCT01970878|579449862|FG001|Overall Study|Lost to Follow-up|3|||
160469497|NCT01970878|579449863|FG002|Overall Study|Lost to Follow-up|2|||
160469498|NCT01970878|579449864|FG003|Overall Study|Lost to Follow-up|4|||
160469499|NCT01970878|579449861|FG000|Overall Study|Administrative Reasons|1|||
160469500|NCT01970878|579449862|FG001|Overall Study|Administrative Reasons|0|||
160469501|NCT01970878|579449863|FG002|Overall Study|Administrative Reasons|0|||
160469502|NCT01970878|579449864|FG003|Overall Study|Administrative Reasons|4|||
160469503|NCT01970878|579449861|FG000|Overall Study|Lack of Efficacy|2|||
160469504|NCT01970878|579449862|FG001|Overall Study|Lack of Efficacy|1|||
160469505|NCT01970878|579449863|FG002|Overall Study|Lack of Efficacy|2|||
160469506|NCT01970878|579449864|FG003|Overall Study|Lack of Efficacy|0|||
160469507|NCT01970878|579449861|FG000|Overall Study|Adverse Event|12|||
160469508|NCT01970878|579449862|FG001|Overall Study|Adverse Event|7|||
160469509|NCT01970878|579449863|FG002|Overall Study|Adverse Event|4|||
160469510|NCT01970878|579449864|FG003|Overall Study|Adverse Event|3|||
160469511|NCT01970878|579449861|FG000|Overall Study|Protocol Specified Criteria|10|||
160469512|NCT01970878|579449862|FG001|Overall Study|Protocol Specified Criteria|4|||
160469513|NCT01970878|579449863|FG002|Overall Study|Protocol Specified Criteria|3|||
160469514|NCT01970878|579449864|FG003|Overall Study|Protocol Specified Criteria|6|||
160469515|NCT01970878|579449861|FG000|Overall Study|Physician Decision|0|||
160469516|NCT01970878|579449862|FG001|Overall Study|Physician Decision|1|||
160469517|NCT01970878|579449863|FG002|Overall Study|Physician Decision|1|||
160469518|NCT01970878|579449864|FG003|Overall Study|Physician Decision|0|||
160469519|NCT01970878|579449861|FG000|Overall Study|No Completion Status|0|||
160469520|NCT01970878|579449862|FG001|Overall Study|No Completion Status|1|||
160469521|NCT01970878|579449863|FG002|Overall Study|No Completion Status|0|||
160469522|NCT01970878|579449864|FG003|Overall Study|No Completion Status|0|||
160469523|NCT02634307|579449865|FG000|Overall Study|Adverse Event|50|||
160469524|NCT02634307|579449866|FG001|Overall Study|Adverse Event|24|||
160469525|NCT02634307|579449867|FG002|Overall Study|Adverse Event|14|||
160469526|NCT02634307|579449865|FG000|Overall Study|Lost to Follow-up|21|||
160469527|NCT02634307|579449866|FG001|Overall Study|Lost to Follow-up|5|||
160469528|NCT02634307|579449867|FG002|Overall Study|Lost to Follow-up|6|||
160469529|NCT02634307|579449865|FG000|Overall Study|Pregnancy|5|||
160469530|NCT02634307|579449866|FG001|Overall Study|Pregnancy|1|||
160469531|NCT02634307|579449867|FG002|Overall Study|Pregnancy|3|||
160469532|NCT02634307|579449865|FG000|Overall Study|Withdrawal by Subject|38|||
160469533|NCT02634307|579449866|FG001|Overall Study|Withdrawal by Subject|24|||
160469534|NCT02634307|579449867|FG002|Overall Study|Withdrawal by Subject|18|||
160469535|NCT02634307|579449865|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160469536|NCT02634307|579449866|FG001|Overall Study|Non-Compliance with Study Drug|2|||
160469537|NCT02634307|579449867|FG002|Overall Study|Non-Compliance with Study Drug|2|||
160469538|NCT02634307|579449865|FG000|Overall Study|Lack of Efficacy|1|||
160469539|NCT02634307|579449866|FG001|Overall Study|Lack of Efficacy|5|||
160469540|NCT02634307|579449867|FG002|Overall Study|Lack of Efficacy|3|||
160469541|NCT02634307|579449865|FG000|Overall Study|Physician Decision|7|||
160469542|NCT02634307|579449866|FG001|Overall Study|Physician Decision|5|||
160469543|NCT02634307|579449867|FG002|Overall Study|Physician Decision|5|||
160469544|NCT02634307|579449865|FG000|Overall Study|Reason not Specified|3|||
160469545|NCT02634307|579449866|FG001|Overall Study|Reason not Specified|5|||
160469546|NCT02634307|579449867|FG002|Overall Study|Reason not Specified|10|||
160469547|NCT00887224|579449873|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
160469548|NCT00887224|579449874|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
160469549|NCT00887224|579449875|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
160469550|NCT00887224|579449873|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
160469551|NCT00887224|579449874|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
160469552|NCT00887224|579449875|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
160469553|NCT00887224|579449873|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
160469554|NCT00887224|579449874|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
160469555|NCT00887224|579449875|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
160469556|NCT00887224|579449873|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
160469557|NCT00887224|579449874|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
160469558|NCT00887224|579449875|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
160469559|NCT00887224|579449873|FG000|Open-label Response (OLR) Phase|Other|1|||
160469560|NCT00887224|579449874|FG001|Open-label Response (OLR) Phase|Other|0|||
160469561|NCT00887224|579449875|FG002|Open-label Response (OLR) Phase|Other|0|||
160469562|NCT00887224|579449873|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
160469563|NCT00887224|579449874|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
160469564|NCT00887224|579449875|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
160469565|NCT00887224|579449873|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
160469566|NCT00887224|579449874|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
160469567|NCT00887224|579449875|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
160469568|NCT00887224|579449873|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
160469569|NCT00887224|579449874|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
160469570|NCT00887224|579449875|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
160469571|NCT00887224|579449873|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
160469572|NCT00887224|579449874|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
160469573|NCT00887224|579449875|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
160469574|NCT00887224|579449873|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
160469575|NCT00887224|579449874|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
160469576|NCT00887224|579449875|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
160469577|NCT00887224|579449873|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
160469578|NCT00887224|579449874|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
160469579|NCT00887224|579449875|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
160469580|NCT00887224|579449873|FG000|Open-label Stability (OLS) Phase|Other|1|||
160469581|NCT00887224|579449874|FG001|Open-label Stability (OLS) Phase|Other|0|||
160469582|NCT00887224|579449875|FG002|Open-label Stability (OLS) Phase|Other|0|||
160469583|NCT00887224|579449873|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
160469584|NCT00887224|579449874|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
160469585|NCT00887224|579449875|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
160469586|NCT00887224|579449873|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
160469587|NCT00887224|579449874|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
160469588|NCT00887224|579449875|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
160469589|NCT00887224|579449873|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
160469590|NCT00887224|579449874|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
160469591|NCT00887224|579449875|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
160469592|NCT00887224|579449873|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
160469593|NCT00887224|579449874|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
160469594|NCT00887224|579449875|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
160469595|NCT00887224|579449873|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
160469596|NCT00887224|579449874|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
160469597|NCT00887224|579449875|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
160469598|NCT00887224|579449873|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
160469599|NCT00887224|579449874|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
160469600|NCT00887224|579449875|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
160469601|NCT00887224|579449873|FG000|OL Taper Phase / OL Follow Up|Other|30|||
160469602|NCT00887224|579449874|FG001|OL Taper Phase / OL Follow Up|Other|0|||
160469603|NCT00887224|579449875|FG002|OL Taper Phase / OL Follow Up|Other|0|||
160469604|NCT00887224|579449873|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
160469605|NCT00887224|579449874|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
160469606|NCT00887224|579449875|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
160469607|NCT00887224|579449873|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
160469608|NCT00887224|579449874|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
160469609|NCT00887224|579449875|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
160469610|NCT00887224|579449873|FG000|Double-blind (DB) Phase|Adverse Event|0|||
160469611|NCT00887224|579449874|FG001|Double-blind (DB) Phase|Adverse Event|7|||
160469612|NCT00887224|579449875|FG002|Double-blind (DB) Phase|Adverse Event|2|||
160469613|NCT00887224|579449873|FG000|Double-blind (DB) Phase|Failed to return|0|||
160469614|NCT00887224|579449874|FG001|Double-blind (DB) Phase|Failed to return|2|||
160469615|NCT00887224|579449875|FG002|Double-blind (DB) Phase|Failed to return|2|||
160469616|NCT00887224|579449873|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
160469617|NCT00887224|579449874|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
160469618|NCT00887224|579449875|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
160469619|NCT00887224|579449873|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
160469620|NCT00887224|579449874|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
160469621|NCT00887224|579449875|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
160659296|NCT02106156|580134491|FG001|Overall Study|Patients Request|9|||
160469622|NCT00887224|579449873|FG000|Double-blind (DB) Phase|Other|0|||
160469623|NCT00887224|579449874|FG001|Double-blind (DB) Phase|Other|2|||
160469624|NCT00887224|579449875|FG002|Double-blind (DB) Phase|Other|0|||
160469625|NCT00887224|579449873|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
160469626|NCT00887224|579449874|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
160469627|NCT00887224|579449875|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
160469628|NCT00887224|579449873|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
160469629|NCT00887224|579449874|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
160599907|NCT02447458|579912611|FG002|Overall Study|Other|1|||
160469630|NCT00887224|579449875|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
160469631|NCT00887224|579449873|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
160469632|NCT00887224|579449874|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
160469633|NCT00887224|579449875|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
160469634|NCT00887224|579449873|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
160469635|NCT00887224|579449874|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
160469636|NCT00887224|579449875|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
160469637|NCT00887224|579449873|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
160469638|NCT00887224|579449874|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
160469639|NCT00887224|579449875|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
160469640|NCT00887224|579449873|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
160469641|NCT00887224|579449874|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
160469642|NCT00887224|579449875|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
160469643|NCT00887224|579449873|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
160469644|NCT00887224|579449874|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
160469645|NCT00887224|579449875|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
160469646|NCT00887224|579449873|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
160469647|NCT00887224|579449874|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
160469648|NCT00887224|579449875|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
160469649|NCT00887224|579449873|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
160469650|NCT00887224|579449874|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
160469651|NCT00887224|579449875|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
160469652|NCT03883828|579449876|FG000|Overall Study|Did not start radiotherapy|1|||
160469653|NCT03883828|579449877|FG001|Overall Study|Did not start radiotherapy|2|||
160469654|NCT01256359|579449881|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
160469655|NCT01256359|579449882|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
160469656|NCT01256359|579449881|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
160469657|NCT01256359|579449882|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
160469658|NCT02575365|579449885|FG000|Overall Study|Lost to Follow-up|4|||
160469659|NCT00487240|579449889|FG000|Overall Study|Withdrawal by Subject|12|||
160469660|NCT00487240|579449890|FG001|Overall Study|Withdrawal by Subject|6|||
160469661|NCT00487240|579449889|FG000|Overall Study|Lost to Follow-up|7|||
160469662|NCT00487240|579449890|FG001|Overall Study|Lost to Follow-up|6|||
160469663|NCT00487240|579449889|FG000|Overall Study|Adverse Event|0|||
160469664|NCT00487240|579449890|FG001|Overall Study|Adverse Event|4|||
160469665|NCT00487240|579449889|FG000|Overall Study|Protocol Violation|5|||
160469666|NCT00487240|579449890|FG001|Overall Study|Protocol Violation|5|||
160469667|NCT00487240|579449889|FG000|Overall Study|Entry Criteria Not Met|3|||
160469668|NCT00487240|579449890|FG001|Overall Study|Entry Criteria Not Met|4|||
160469669|NCT00487240|579449889|FG000|Overall Study|Sponsor Decision|2|||
160469670|NCT00487240|579449890|FG001|Overall Study|Sponsor Decision|1|||
160599908|NCT02447458|579912612|FG003|Overall Study|Other|0|||
160599909|NCT02447458|579912613|FG004|Overall Study|Other|0|||
160599910|NCT02447458|579912614|FG005|Overall Study|Other|0|||
160599911|NCT03505749|579912615|FG000|Overall Study|Lost to Follow-up|7|||
160599912|NCT03505749|579912616|FG001|Overall Study|Lost to Follow-up|11|||
160599913|NCT03505749|579912615|FG000|Overall Study|Withdrawal by Subject|6|||
160599914|NCT03505749|579912616|FG001|Overall Study|Withdrawal by Subject|0|||
160599915|NCT03505749|579912615|FG000|Overall Study|Discharged from treatment|3|||
160599916|NCT03505749|579912616|FG001|Overall Study|Discharged from treatment|6|||
160599917|NCT01151540|579912617|FG000|Overall Study|Other|2|||
160599918|NCT01151540|579912617|FG000|Overall Study|Adverse event, non-fatal|4|||
160599919|NCT01151540|579912617|FG000|Overall Study|Withdrawal by Subject|7|||
160469671|NCT00487240|579449889|FG000|Overall Study|Physician Decision|2|||
160469672|NCT00487240|579449890|FG001|Overall Study|Physician Decision|0|||
160469673|NCT02736188|579449891|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
160469674|NCT02736188|579449891|FG000|Overall Study|Adverse Event|1|||
160469675|NCT02736188|579449891|FG000|Overall Study|Withdrawal by Subject|1|||
160469676|NCT02736188|579449891|FG000|Overall Study|Other|6|||
160599920|NCT03846219|579912619|FG000|Overall Study|Withdrawal by Subject|3|||
160599921|NCT03846219|579912620|FG001|Overall Study|Withdrawal by Subject|2|||
160599922|NCT03846219|579912621|FG002|Overall Study|Withdrawal by Subject|2|||
160599923|NCT03846219|579912619|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
160469677|NCT01698918|579449892|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
160469678|NCT01698918|579449892|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
160469679|NCT01698918|579449892|FG000|First Line Treatment (Core+Extension)|Death|2|||
160469680|NCT01698918|579449892|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
160469681|NCT01698918|579449892|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
160469682|NCT01698918|579449892|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
160469683|NCT01698918|579449892|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
160469684|NCT01698918|579449892|FG000|Second Line Treatment (Core+Extension)|Death|1|||
160469685|NCT01698918|579449892|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
160469686|NCT01698918|579449892|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
160469687|NCT01428583|579449894|FG000|Overall Study|Adverse Event|75|||
160469688|NCT01428583|579449894|FG000|Overall Study|Withdrawal by Subject|51|||
160469689|NCT01428583|579449894|FG000|Overall Study|Lack of Efficacy|37|||
160469690|NCT01428583|579449894|FG000|Overall Study|Lost to Follow-up|17|||
160469691|NCT01428583|579449894|FG000|Overall Study|Death|1|||
160469692|NCT01428583|579449894|FG000|Overall Study|Pregnancy|1|||
160469693|NCT01428583|579449894|FG000|Overall Study|Protocol Violation|1|||
160469694|NCT01428583|579449894|FG000|Overall Study|Physician Decision|12|||
160469695|NCT01428583|579449894|FG000|Overall Study|Non-compliant|25|||
160469696|NCT01428583|579449894|FG000|Overall Study|Confirmed positive urine drug test|8|||
160469697|NCT01428583|579449894|FG000|Overall Study|Sponsor's request|3|||
160469698|NCT01428583|579449894|FG000|Overall Study|Other|6|||
160469699|NCT00768755|579449897|FG000|Phase 1|Death|6|||
160469700|NCT00768755|579449898|FG001|Phase 1|Death|0|||
160469701|NCT00768755|579449899|FG002|Phase 1|Death|0|||
160469702|NCT00768755|579449900|FG003|Phase 1|Death|0|||
160469703|NCT00768755|579449897|FG000|Phase 1|Other|4|||
160469704|NCT00768755|579449898|FG001|Phase 1|Other|0|||
160469705|NCT00768755|579449899|FG002|Phase 1|Other|0|||
160469706|NCT00768755|579449900|FG003|Phase 1|Other|0|||
160469707|NCT00768755|579449897|FG000|Phase 2|Death|0|||
160469708|NCT00768755|579449898|FG001|Phase 2|Death|37|||
160469709|NCT00768755|579449899|FG002|Phase 2|Death|48|||
160469710|NCT00768755|579449900|FG003|Phase 2|Death|31|||
160469711|NCT00768755|579449897|FG000|Phase 2|Protocol Violation|0|||
160469712|NCT00768755|579449898|FG001|Phase 2|Protocol Violation|2|||
160469713|NCT00768755|579449899|FG002|Phase 2|Protocol Violation|0|||
160469714|NCT00768755|579449900|FG003|Phase 2|Protocol Violation|1|||
160469715|NCT00768755|579449897|FG000|Phase 2|Lost to Follow-up|0|||
160469716|NCT00768755|579449898|FG001|Phase 2|Lost to Follow-up|1|||
160469717|NCT00768755|579449899|FG002|Phase 2|Lost to Follow-up|1|||
160469718|NCT00768755|579449900|FG003|Phase 2|Lost to Follow-up|4|||
160469719|NCT00768755|579449897|FG000|Phase 2|Withdrawal by Subject|0|||
160469720|NCT00768755|579449898|FG001|Phase 2|Withdrawal by Subject|1|||
160469721|NCT00768755|579449899|FG002|Phase 2|Withdrawal by Subject|0|||
160469722|NCT00768755|579449900|FG003|Phase 2|Withdrawal by Subject|1|||
160469723|NCT00768755|579449897|FG000|Phase 2|Other|0|||
160469724|NCT00768755|579449898|FG001|Phase 2|Other|1|||
160469725|NCT00768755|579449899|FG002|Phase 2|Other|2|||
160469726|NCT00768755|579449900|FG003|Phase 2|Other|4|||
160469727|NCT00768755|579449897|FG000|Phase 2|Study Terminated by Sponsor|0|||
160469728|NCT00768755|579449898|FG001|Phase 2|Study Terminated by Sponsor|13|||
160469729|NCT00768755|579449899|FG002|Phase 2|Study Terminated by Sponsor|7|||
160469730|NCT00768755|579449900|FG003|Phase 2|Study Terminated by Sponsor|14|||
160469731|NCT00768755|579449897|FG000|Phase 2|Randomized but not treated|0|||
160469732|NCT00768755|579449898|FG001|Phase 2|Randomized but not treated|0|||
160469733|NCT00768755|579449899|FG002|Phase 2|Randomized but not treated|0|||
160469734|NCT00768755|579449900|FG003|Phase 2|Randomized but not treated|2|||
160469735|NCT00670488|579449901|FG000|Overall Study|Adverse Event|0|||
160469736|NCT00670488|579449902|FG001|Overall Study|Adverse Event|7|||
160469737|NCT00670488|579449903|FG002|Overall Study|Adverse Event|0|||
160469738|NCT00670488|579449904|FG003|Overall Study|Adverse Event|3|||
160469739|NCT00670488|579449905|FG004|Overall Study|Adverse Event|1|||
160659297|NCT02106156|580134492|FG002|Overall Study|Patients Request|0|||
160469740|NCT00670488|579449906|FG005|Overall Study|Adverse Event|1|||
160469741|NCT00670488|579449907|FG006|Overall Study|Adverse Event|5|||
160469742|NCT00670488|579449908|FG007|Overall Study|Adverse Event|1|||
160469743|NCT00670488|579449909|FG008|Overall Study|Adverse Event|0|||
160469744|NCT00670488|579449910|FG009|Overall Study|Adverse Event|1|||
160469745|NCT00670488|579449901|FG000|Overall Study|Physician Decision|1|||
160469746|NCT00670488|579449902|FG001|Overall Study|Physician Decision|9|||
160469747|NCT00670488|579449903|FG002|Overall Study|Physician Decision|0|||
160469748|NCT00670488|579449904|FG003|Overall Study|Physician Decision|1|||
160469749|NCT00670488|579449905|FG004|Overall Study|Physician Decision|0|||
160469750|NCT00670488|579449906|FG005|Overall Study|Physician Decision|0|||
160469751|NCT00670488|579449907|FG006|Overall Study|Physician Decision|0|||
160469752|NCT00670488|579449908|FG007|Overall Study|Physician Decision|0|||
160469753|NCT00670488|579449909|FG008|Overall Study|Physician Decision|0|||
160469754|NCT00670488|579449910|FG009|Overall Study|Physician Decision|0|||
160469755|NCT00670488|579449901|FG000|Overall Study|Progressive Disease|2|||
160469756|NCT00670488|579449902|FG001|Overall Study|Progressive Disease|41|||
160599924|NCT03846219|579912620|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
160659298|NCT02106156|580134490|FG000|Overall Study|Lost to Follow-up|451|||
160599925|NCT03846219|579912621|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
160599926|NCT03846219|579912619|FG000|Overall Study|Physician Decision|0|||
160599927|NCT03846219|579912620|FG001|Overall Study|Physician Decision|0|||
160599928|NCT03846219|579912621|FG002|Overall Study|Physician Decision|2|||
160599929|NCT01392378|579912622|FG000|Infant Series|Adverse Event|0|||
160599930|NCT01392378|579912623|FG001|Infant Series|Adverse Event|0|||
160599931|NCT01392378|579912624|FG002|Infant Series|Adverse Event|0|||
160599932|NCT01392378|579912625|FG003|Infant Series|Adverse Event|1|||
160599933|NCT01392378|579912626|FG004|Infant Series|Adverse Event|0|||
160599934|NCT01392378|579912622|FG000|Infant Series|Lost to Follow-up|0|||
160599935|NCT01392378|579912623|FG001|Infant Series|Lost to Follow-up|0|||
160599936|NCT01392378|579912624|FG002|Infant Series|Lost to Follow-up|0|||
160599937|NCT01392378|579912625|FG003|Infant Series|Lost to Follow-up|1|||
160469757|NCT00670488|579449903|FG002|Overall Study|Progressive Disease|3|||
160599938|NCT01392378|579912626|FG004|Infant Series|Lost to Follow-up|0|||
160599939|NCT01392378|579912622|FG000|Infant Series|Protocol Violation|0|||
160599940|NCT01392378|579912623|FG001|Infant Series|Protocol Violation|1|||
160599941|NCT01392378|579912624|FG002|Infant Series|Protocol Violation|0|||
160599942|NCT01392378|579912625|FG003|Infant Series|Protocol Violation|0|||
160599943|NCT01392378|579912626|FG004|Infant Series|Protocol Violation|0|||
160599944|NCT01392378|579912622|FG000|Infant Series|Withdrawal by Parent|4|||
160469758|NCT00670488|579449904|FG003|Overall Study|Progressive Disease|2|||
160469759|NCT00670488|579449905|FG004|Overall Study|Progressive Disease|2|||
160469760|NCT00670488|579449906|FG005|Overall Study|Progressive Disease|4|||
160469761|NCT00670488|579449907|FG006|Overall Study|Progressive Disease|11|||
160469762|NCT00670488|579449908|FG007|Overall Study|Progressive Disease|2|||
160469763|NCT00670488|579449909|FG008|Overall Study|Progressive Disease|2|||
160469764|NCT00670488|579449910|FG009|Overall Study|Progressive Disease|1|||
160469765|NCT00670488|579449901|FG000|Overall Study|Withdrawal by Subject|0|||
160469766|NCT00670488|579449902|FG001|Overall Study|Withdrawal by Subject|1|||
160469767|NCT00670488|579449903|FG002|Overall Study|Withdrawal by Subject|0|||
160469768|NCT00670488|579449904|FG003|Overall Study|Withdrawal by Subject|1|||
160469769|NCT00670488|579449905|FG004|Overall Study|Withdrawal by Subject|0|||
160469770|NCT00670488|579449906|FG005|Overall Study|Withdrawal by Subject|0|||
160469771|NCT00670488|579449907|FG006|Overall Study|Withdrawal by Subject|1|||
160469772|NCT00670488|579449908|FG007|Overall Study|Withdrawal by Subject|0|||
160469773|NCT00670488|579449909|FG008|Overall Study|Withdrawal by Subject|1|||
160469774|NCT00670488|579449910|FG009|Overall Study|Withdrawal by Subject|0|||
160469775|NCT00878189|579449911|FG000|Overall Study|Death|0|||
160469776|NCT00878189|579449912|FG001|Overall Study|Death|1|||
160469777|NCT00878189|579449913|FG002|Overall Study|Death|0|||
160469778|NCT00878189|579449914|FG003|Overall Study|Death|1|||
160469779|NCT00878189|579449915|FG004|Overall Study|Death|0|||
160469780|NCT00878189|579449916|FG005|Overall Study|Death|0|||
160469781|NCT00878189|579449917|FG006|Overall Study|Death|0|||
160469782|NCT00878189|579449918|FG007|Overall Study|Death|0|||
160469783|NCT00878189|579449919|FG008|Overall Study|Death|1|||
160469784|NCT00878189|579449911|FG000|Overall Study|Participant Refused to Follow-up|0|||
160469785|NCT00878189|579449912|FG001|Overall Study|Participant Refused to Follow-up|0|||
160469786|NCT00878189|579449913|FG002|Overall Study|Participant Refused to Follow-up|0|||
160469787|NCT00878189|579449914|FG003|Overall Study|Participant Refused to Follow-up|0|||
160469788|NCT00878189|579449915|FG004|Overall Study|Participant Refused to Follow-up|0|||
160469789|NCT00878189|579449916|FG005|Overall Study|Participant Refused to Follow-up|4|||
160469790|NCT00878189|579449917|FG006|Overall Study|Participant Refused to Follow-up|0|||
160469791|NCT00878189|579449918|FG007|Overall Study|Participant Refused to Follow-up|0|||
160469792|NCT00878189|579449919|FG008|Overall Study|Participant Refused to Follow-up|0|||
160469793|NCT00878189|579449911|FG000|Overall Study|Other|3|||
160469794|NCT00878189|579449912|FG001|Overall Study|Other|2|||
160469795|NCT00878189|579449913|FG002|Overall Study|Other|4|||
160469796|NCT00878189|579449914|FG003|Overall Study|Other|7|||
160469797|NCT00878189|579449915|FG004|Overall Study|Other|4|||
160469798|NCT00878189|579449916|FG005|Overall Study|Other|18|||
160469799|NCT00878189|579449917|FG006|Overall Study|Other|15|||
160469800|NCT00878189|579449918|FG007|Overall Study|Other|3|||
160469801|NCT00878189|579449919|FG008|Overall Study|Other|4|||
160469802|NCT00878189|579449911|FG000|Overall Study|Lost to Follow-up|0|||
160469803|NCT00878189|579449912|FG001|Overall Study|Lost to Follow-up|0|||
160469804|NCT00878189|579449913|FG002|Overall Study|Lost to Follow-up|0|||
160659299|NCT02106156|580134491|FG001|Overall Study|Lost to Follow-up|8|||
160469805|NCT00878189|579449914|FG003|Overall Study|Lost to Follow-up|0|||
160469806|NCT00878189|579449915|FG004|Overall Study|Lost to Follow-up|0|||
160469807|NCT00878189|579449916|FG005|Overall Study|Lost to Follow-up|1|||
160469808|NCT00878189|579449917|FG006|Overall Study|Lost to Follow-up|1|||
160469809|NCT00878189|579449918|FG007|Overall Study|Lost to Follow-up|0|||
160469810|NCT00878189|579449919|FG008|Overall Study|Lost to Follow-up|0|||
160469811|NCT00878189|579449911|FG000|Overall Study|Objection Progression or Relapse|0|||
160469812|NCT00878189|579449912|FG001|Overall Study|Objection Progression or Relapse|0|||
160469813|NCT00878189|579449913|FG002|Overall Study|Objection Progression or Relapse|0|||
160469814|NCT00878189|579449914|FG003|Overall Study|Objection Progression or Relapse|0|||
160469815|NCT00878189|579449915|FG004|Overall Study|Objection Progression or Relapse|0|||
160469816|NCT00878189|579449916|FG005|Overall Study|Objection Progression or Relapse|0|||
160469817|NCT00878189|579449917|FG006|Overall Study|Objection Progression or Relapse|0|||
160469818|NCT00878189|579449918|FG007|Overall Study|Objection Progression or Relapse|0|||
160469819|NCT00878189|579449919|FG008|Overall Study|Objection Progression or Relapse|3|||
160469820|NCT02708498|579449920|FG000|Overall Study|Death|20|||
160469821|NCT02708498|579449921|FG001|Overall Study|Death|19|||
160469822|NCT02708498|579449922|FG002|Overall Study|Death|0|||
160469823|NCT02708498|579449923|FG003|Overall Study|Death|0|||
160469824|NCT02708498|579449924|FG004|Overall Study|Death|1|||
160469825|NCT02708498|579449925|FG005|Overall Study|Death|0|||
160469826|NCT02708498|579449926|FG006|Overall Study|Death|0|||
160469827|NCT02708498|579449927|FG007|Overall Study|Death|0|||
160469828|NCT02708498|579449920|FG000|Overall Study|Unknown reason, missing data|0|||
160469829|NCT02708498|579449921|FG001|Overall Study|Unknown reason, missing data|0|||
160469830|NCT02708498|579449922|FG002|Overall Study|Unknown reason, missing data|62|||
160469831|NCT02708498|579449923|FG003|Overall Study|Unknown reason, missing data|51|||
160469832|NCT02708498|579449924|FG004|Overall Study|Unknown reason, missing data|195|||
160469833|NCT02708498|579449925|FG005|Overall Study|Unknown reason, missing data|132|||
160469834|NCT02708498|579449926|FG006|Overall Study|Unknown reason, missing data|0|||
160469835|NCT02708498|579449927|FG007|Overall Study|Unknown reason, missing data|0|||
160469836|NCT01858688|579449931|FG000|Overall Study|Withdrawal by Subject|8|||
160469837|NCT01858688|579449931|FG000|Overall Study|Participant began another therapy|3|||
160469838|NCT01858688|579449931|FG000|Overall Study|Physician Decision|2|||
160469839|NCT01858688|579449931|FG000|Overall Study|Progressive Disease|2|||
160469840|NCT01858688|579449931|FG000|Overall Study|Reason not reproted|5|||
160469841|NCT00659373|579449943|FG000|Overall Study|Withdrawal by Subject|3|||
160469842|NCT00659373|579449944|FG001|Overall Study|Withdrawal by Subject|5|||
160469843|NCT00659373|579449943|FG000|Overall Study|Assessment Missed|2|||
160469844|NCT00659373|579449944|FG001|Overall Study|Assessment Missed|2|||
160469845|NCT03042767|579449947|FG000|Overall Study|Lost to Follow-up|1|||
160469846|NCT03042767|579449948|FG001|Overall Study|Lost to Follow-up|2|||
160599945|NCT01392378|579912623|FG001|Infant Series|Withdrawal by Parent|1|||
160599946|NCT01392378|579912624|FG002|Infant Series|Withdrawal by Parent|0|||
160599947|NCT01392378|579912625|FG003|Infant Series|Withdrawal by Parent|0|||
160599948|NCT01392378|579912626|FG004|Infant Series|Withdrawal by Parent|0|||
160599949|NCT01392378|579912622|FG000|After Infant Series|Lost to Follow-up|0|||
160599950|NCT01392378|579912623|FG001|After Infant Series|Lost to Follow-up|0|||
160599951|NCT01392378|579912624|FG002|After Infant Series|Lost to Follow-up|1|||
160599952|NCT01392378|579912625|FG003|After Infant Series|Lost to Follow-up|0|||
160659300|NCT02106156|580134492|FG002|Overall Study|Lost to Follow-up|0|||
160469847|NCT04638816|579449950|FG000|Overall Study|Withdrawal by Subject|0|||
160469848|NCT04638816|579449951|FG001|Overall Study|Withdrawal by Subject|1|||
160469849|NCT04638816|579449950|FG000|Overall Study|Lost to Follow-up|0|||
160599953|NCT01392378|579912626|FG004|After Infant Series|Lost to Follow-up|0|||
160599954|NCT01392378|579912622|FG000|After Infant Series|Withdrawal by Parent|0|||
160469850|NCT04638816|579449951|FG001|Overall Study|Lost to Follow-up|1|||
160469851|NCT01328496|579449954|FG000|Overall Study|Significant Change in Health Status|1|||
160469852|NCT01328496|579449955|FG001|Overall Study|Significant Change in Health Status|0|||
160469853|NCT02208843|579449956|FG000|Overall Study|Clinical symptoms of progression|2|||
160469854|NCT02208843|579449956|FG000|Overall Study|Progression disease according to RECIST|24|||
160469855|NCT02208843|579449956|FG000|Overall Study|Adverse Event|12|||
160469856|NCT02208843|579449956|FG000|Overall Study|Protocol Violation|1|||
160469857|NCT02208843|579449956|FG000|Overall Study|Withdrawal by Subject|1|||
160469858|NCT02208843|579449956|FG000|Overall Study|Switched to commercial afatinib|20|||
160469859|NCT04399837|579449958|FG000|Overall Study|Other than listed|0|||
160469860|NCT04399837|579449959|FG001|Overall Study|Other than listed|2|||
160469861|NCT04399837|579449960|FG002|Overall Study|Other than listed|2|||
160469862|NCT04399837|579449961|FG003|Overall Study|Other than listed|3|||
160469863|NCT04399837|579449958|FG000|Overall Study|Withdrawal by Subject|1|||
160469864|NCT04399837|579449959|FG001|Overall Study|Withdrawal by Subject|2|||
160469865|NCT04399837|579449960|FG002|Overall Study|Withdrawal by Subject|1|||
160469866|NCT04399837|579449961|FG003|Overall Study|Withdrawal by Subject|1|||
160469867|NCT03476798|579449969|FG000|Overall Study|Death|1|||
160469868|NCT03476798|579449969|FG000|Overall Study|Withdrawal by Subject|2|||
160469869|NCT03476798|579449969|FG000|Overall Study|Protocol Violation|2|||
160469870|NCT06269003|579449970|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
160469871|NCT06269003|579449971|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
160469872|NCT06269003|579449972|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
160469873|NCT06269003|579449973|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
160469874|NCT03343704|579449977|FG000|Overall Study|Refused to complete follow up|0|||
160469875|NCT03343704|579449978|FG001|Overall Study|Refused to complete follow up|1|||
160469876|NCT03343704|579449977|FG000|Overall Study|Death|0|||
160469877|NCT03343704|579449978|FG001|Overall Study|Death|1|||
160469878|NCT03343704|579449977|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
160469879|NCT03343704|579449978|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
160469880|NCT04224272|579449979|FG000|Part 1 - Dose Finding|Death|4|||
160469881|NCT04224272|579449979|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
160469882|NCT04224272|579449979|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
160469883|NCT04224272|579449979|FG000|Part 2 - Dose Expansion|Death|10|||
160469884|NCT04224272|579449979|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
160469885|NCT02609048|579449980|FG000|Overall Study|Adverse Event|3|||
160469886|NCT02609048|579449981|FG001|Overall Study|Adverse Event|0|||
160469887|NCT02609048|579449982|FG002|Overall Study|Adverse Event|0|||
160469888|NCT02609048|579449980|FG000|Overall Study|Randomized but never treated|1|||
160469889|NCT02609048|579449981|FG001|Overall Study|Randomized but never treated|1|||
160469890|NCT02609048|579449982|FG002|Overall Study|Randomized but never treated|1|||
160469891|NCT02609048|579449980|FG000|Overall Study|Withdrawal of informed consent|1|||
160469892|NCT02609048|579449981|FG001|Overall Study|Withdrawal of informed consent|0|||
160469893|NCT02609048|579449982|FG002|Overall Study|Withdrawal of informed consent|0|||
160469894|NCT02609048|579449980|FG000|Overall Study|Reason not specified|6|||
160599955|NCT01392378|579912623|FG001|After Infant Series|Withdrawal by Parent|1|||
160599956|NCT01392378|579912624|FG002|After Infant Series|Withdrawal by Parent|1|||
160469895|NCT02609048|579449981|FG001|Overall Study|Reason not specified|9|||
160469896|NCT02609048|579449982|FG002|Overall Study|Reason not specified|9|||
160469897|NCT05432986|579449988|FG000|Overall Study|Withdrawal by Subject|2|||
160599957|NCT01392378|579912625|FG003|After Infant Series|Withdrawal by Parent|0|||
160599958|NCT01392378|579912626|FG004|After Infant Series|Withdrawal by Parent|1|||
160599959|NCT01392378|579912622|FG000|Toddler Dose|Lost to Follow-up|0|||
160599960|NCT01392378|579912623|FG001|Toddler Dose|Lost to Follow-up|0|||
160599961|NCT01392378|579912624|FG002|Toddler Dose|Lost to Follow-up|0|||
160599962|NCT01392378|579912625|FG003|Toddler Dose|Lost to Follow-up|1|||
160599963|NCT01392378|579912626|FG004|Toddler Dose|Lost to Follow-up|0|||
160599964|NCT01392378|579912622|FG000|Toddler Dose|Withdrawal by Parent|0|||
160599965|NCT01392378|579912623|FG001|Toddler Dose|Withdrawal by Parent|1|||
160599966|NCT01392378|579912624|FG002|Toddler Dose|Withdrawal by Parent|0|||
160599967|NCT01392378|579912625|FG003|Toddler Dose|Withdrawal by Parent|1|||
160599968|NCT01392378|579912626|FG004|Toddler Dose|Withdrawal by Parent|1|||
160599969|NCT02322411|579912629|FG000|Overall Study|Lost to Follow-up|4|||
160599970|NCT02322411|579912630|FG001|Overall Study|Lost to Follow-up|7|||
160599971|NCT02322411|579912629|FG000|Overall Study|Withdrawal by Subject|1|||
160599972|NCT02322411|579912630|FG001|Overall Study|Withdrawal by Subject|0|||
160599973|NCT00788697|579912632|FG000|Overall Study|No study drug administered|12|||
160599974|NCT00788697|579912632|FG000|Overall Study|Training Patients|74|||
160599975|NCT00788697|579912632|FG000|Overall Study|no truth standard procedure available|5|||
160599976|NCT00788697|579912632|FG000|Overall Study|Technically inadequate truth standard|1|||
160599977|NCT00788697|579912632|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
160599978|NCT01998880|579912633|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
160599979|NCT01998880|579912634|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
160599980|NCT01998880|579912633|FG000|Overall Study|Disease Progression|1|||
160599981|NCT01998880|579912634|FG001|Overall Study|Disease Progression|8|||
160599982|NCT01998880|579912633|FG000|Overall Study|Withdrew Consent|2|||
160599983|NCT01998880|579912634|FG001|Overall Study|Withdrew Consent|1|||
160599984|NCT01998880|579912633|FG000|Overall Study|Death|3|||
160599985|NCT01998880|579912634|FG001|Overall Study|Death|6|||
160599986|NCT01998880|579912633|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160599987|NCT01998880|579912634|FG001|Overall Study|Insufficient Therapeutic Response|5|||
160599988|NCT01998880|579912633|FG000|Overall Study|Administrative/Other|1|||
160599989|NCT01998880|579912634|FG001|Overall Study|Administrative/Other|1|||
160599990|NCT01998880|579912633|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
160599991|NCT01998880|579912634|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
160599992|NCT01998880|579912633|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
160599993|NCT01998880|579912634|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
160599994|NCT01998880|579912633|FG000|Overall Study|Did Not Receive Treatment|3|||
160599995|NCT01998880|579912634|FG001|Overall Study|Did Not Receive Treatment|2|||
160599996|NCT02248857|579912635|FG000|3 Month|Withdrawal by Subject|9|||
160599997|NCT02248857|579912636|FG001|3 Month|Withdrawal by Subject|3|||
160659301|NCT02106156|580134490|FG000|Overall Study|Unplanned Event|82|||
160469898|NCT05432986|579449988|FG000|Overall Study|incomplete measurement|7|||
160599998|NCT02248857|579912637|FG002|3 Month|Withdrawal by Subject|4|||
160599999|NCT02248857|579912635|FG000|3 Month|Unable to reach for 3 month|35|||
160600000|NCT02248857|579912636|FG001|3 Month|Unable to reach for 3 month|29|||
160600001|NCT02248857|579912637|FG002|3 Month|Unable to reach for 3 month|26|||
160600002|NCT02248857|579912635|FG000|3 Month|Partially completed, unable to finish|2|||
160600003|NCT02248857|579912636|FG001|3 Month|Partially completed, unable to finish|2|||
160600004|NCT02248857|579912637|FG002|3 Month|Partially completed, unable to finish|1|||
160600005|NCT02248857|579912635|FG000|6 Month|Lost to Follow-up|27|||
160600006|NCT02248857|579912636|FG001|6 Month|Lost to Follow-up|26|||
160600007|NCT02248857|579912637|FG002|6 Month|Lost to Follow-up|15|||
160600008|NCT02248857|579912635|FG000|6 Month|Partially completed, unable to finish|0|||
160600009|NCT02248857|579912636|FG001|6 Month|Partially completed, unable to finish|1|||
160600010|NCT02248857|579912637|FG002|6 Month|Partially completed, unable to finish|0|||
160600011|NCT02248857|579912635|FG000|6 Month|Withdrawal by Subject|0|||
160600012|NCT02248857|579912636|FG001|6 Month|Withdrawal by Subject|2|||
160600013|NCT02248857|579912637|FG002|6 Month|Withdrawal by Subject|2|||
160600014|NCT02248857|579912635|FG000|6 Month|Death|1|||
160600015|NCT02248857|579912636|FG001|6 Month|Death|0|||
160600016|NCT02248857|579912637|FG002|6 Month|Death|0|||
160600017|NCT02671461|579912638|FG000|Treatment|Adverse Event|0|||
160600018|NCT02671461|579912639|FG001|Treatment|Adverse Event|0|||
160600019|NCT02671461|579912640|FG002|Treatment|Adverse Event|1|||
160600020|NCT02671461|579912638|FG000|Treatment|Administrative Reason by Sponsor|1|||
160600021|NCT02671461|579912639|FG001|Treatment|Administrative Reason by Sponsor|3|||
160600022|NCT02671461|579912640|FG002|Treatment|Administrative Reason by Sponsor|4|||
160600023|NCT02671461|579912638|FG000|Treatment|Randomized, not treated|1|||
160600024|NCT02671461|579912639|FG001|Treatment|Randomized, not treated|0|||
160600025|NCT02671461|579912640|FG002|Treatment|Randomized, not treated|0|||
160600026|NCT02671461|579912638|FG000|Follow-up|Withdrawal by Subject|1|||
160600027|NCT02671461|579912639|FG001|Follow-up|Withdrawal by Subject|0|||
160600028|NCT02671461|579912640|FG002|Follow-up|Withdrawal by Subject|0|||
160600029|NCT02671461|579912638|FG000|Follow-up|Lost to Follow-up|0|||
160600030|NCT02671461|579912639|FG001|Follow-up|Lost to Follow-up|0|||
160600031|NCT02671461|579912640|FG002|Follow-up|Lost to Follow-up|1|||
160600032|NCT02671461|579912638|FG000|Follow-up|Administrative Reason by Sponsor|0|||
160600033|NCT02671461|579912639|FG001|Follow-up|Administrative Reason by Sponsor|1|||
160600034|NCT02671461|579912640|FG002|Follow-up|Administrative Reason by Sponsor|0|||
160600035|NCT02261883|579912641|FG000|Overall Study|Death|3|||
160600036|NCT02261883|579912642|FG001|Overall Study|Death|2|||
160600037|NCT02261883|579912641|FG000|Overall Study|Physician Decision|1|||
160600038|NCT02261883|579912642|FG001|Overall Study|Physician Decision|0|||
160659302|NCT02106156|580134491|FG001|Overall Study|Unplanned Event|2|||
160600039|NCT02261883|579912641|FG000|Overall Study|Protocol Violation|1|||
160600040|NCT02261883|579912642|FG001|Overall Study|Protocol Violation|0|||
160600041|NCT02261883|579912641|FG000|Overall Study|Withdrawal by Subject|0|||
160600042|NCT02261883|579912642|FG001|Overall Study|Withdrawal by Subject|1|||
160600043|NCT02261883|579912641|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
160600044|NCT02261883|579912642|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
160600045|NCT01412060|579912643|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
160600046|NCT01412060|579912644|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
160469899|NCT04992273|579451077|FG000|Overall Study|Lost to Follow-up|0|||
160469900|NCT04992273|579451078|FG001|Overall Study|Lost to Follow-up|1|||
160469901|NCT01364597|579451079|FG000|Overall Study|Adverse Event|4|||
160469902|NCT01364597|579451080|FG001|Overall Study|Adverse Event|5|||
160469903|NCT01364597|579451081|FG002|Overall Study|Adverse Event|16|||
160469904|NCT01364597|579451082|FG003|Overall Study|Adverse Event|7|||
160469905|NCT01364597|579451079|FG000|Overall Study|Lack of Efficacy|4|||
160469906|NCT01364597|579451080|FG001|Overall Study|Lack of Efficacy|4|||
160469907|NCT01364597|579451081|FG002|Overall Study|Lack of Efficacy|23|||
160469908|NCT01364597|579451082|FG003|Overall Study|Lack of Efficacy|8|||
160469909|NCT01364597|579451079|FG000|Overall Study|Protocol Violation|0|||
160469910|NCT01364597|579451080|FG001|Overall Study|Protocol Violation|0|||
160469911|NCT01364597|579451081|FG002|Overall Study|Protocol Violation|2|||
160469912|NCT01364597|579451082|FG003|Overall Study|Protocol Violation|0|||
160469913|NCT01364597|579451079|FG000|Overall Study|Lost to Follow-up|0|||
160469914|NCT01364597|579451080|FG001|Overall Study|Lost to Follow-up|0|||
160469915|NCT01364597|579451081|FG002|Overall Study|Lost to Follow-up|5|||
160659303|NCT02106156|580134492|FG002|Overall Study|Unplanned Event|0|||
160659304|NCT02106156|580134490|FG000|Overall Study|Change of Laboratory Parameter|10|||
160659305|NCT02106156|580134491|FG001|Overall Study|Change of Laboratory Parameter|0|||
160659306|NCT02106156|580134492|FG002|Overall Study|Change of Laboratory Parameter|0|||
160659307|NCT02106156|580134490|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
160659308|NCT02106156|580134491|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
160659309|NCT02106156|580134492|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
160659310|NCT02106156|580134490|FG000|Overall Study|Relocation/Change of Physician|40|||
160659311|NCT02106156|580134491|FG001|Overall Study|Relocation/Change of Physician|1|||
160659312|NCT02106156|580134492|FG002|Overall Study|Relocation/Change of Physician|0|||
160659313|NCT01136382|580134493|FG000|Overall Study|Other|8|||
160659314|NCT01136382|580134494|FG001|Overall Study|Other|3|||
160659315|NCT01136382|580134493|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
160659316|NCT01136382|580134494|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
160659317|NCT01136382|580134493|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
160659318|NCT01136382|580134494|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
160659319|NCT01136382|580134493|FG000|Overall Study|Withdrawal by Subject|4|||
160659320|NCT01136382|580134494|FG001|Overall Study|Withdrawal by Subject|1|||
160659321|NCT03655106|580134506|FG000|Overall Study|Withdrawal by Subject|3|||
160659322|NCT03655106|580134507|FG001|Overall Study|Withdrawal by Subject|2|||
160659323|NCT03655106|580134506|FG000|Overall Study|Lost to Follow-up|2|||
160659324|NCT03655106|580134507|FG001|Overall Study|Lost to Follow-up|1|||
160659325|NCT03655106|580134506|FG000|Overall Study|Duplicate Enrollment|1|||
160659326|NCT03655106|580134507|FG001|Overall Study|Duplicate Enrollment|1|||
160659327|NCT03655106|580134506|FG000|Overall Study|Protocol Violation|3|||
160659328|NCT03655106|580134507|FG001|Overall Study|Protocol Violation|0|||
160659329|NCT01287013|580134515|FG000|Overall Study|Non-evaluable|3|||
160659330|NCT01287013|580134516|FG001|Overall Study|Non-evaluable|5|||
160659331|NCT01287013|580134517|FG002|Overall Study|Non-evaluable|21|||
160659332|NCT01179048|580134518|FG000|Overall Study|Withdrawn - does not allow contact|4|||
160659333|NCT01179048|580134519|FG001|Overall Study|Withdrawn - does not allow contact|8|||
160659334|NCT01179048|580134518|FG000|Overall Study|Lost to Follow-up|8|||
160659335|NCT01179048|580134519|FG001|Overall Study|Lost to Follow-up|9|||
160469916|NCT01364597|579451082|FG003|Overall Study|Lost to Follow-up|3|||
160469917|NCT01364597|579451079|FG000|Overall Study|Withdrawal by Subject|4|||
160469918|NCT01364597|579451080|FG001|Overall Study|Withdrawal by Subject|1|||
160469919|NCT01364597|579451081|FG002|Overall Study|Withdrawal by Subject|18|||
160469920|NCT01364597|579451082|FG003|Overall Study|Withdrawal by Subject|6|||
160469921|NCT01364597|579451079|FG000|Overall Study|Non compliance|1|||
160469922|NCT01364597|579451080|FG001|Overall Study|Non compliance|0|||
160469923|NCT01364597|579451081|FG002|Overall Study|Non compliance|1|||
160600047|NCT01412060|579912645|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
160600048|NCT01412060|579912643|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
160600049|NCT01412060|579912644|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
160600050|NCT01412060|579912645|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
160600051|NCT01412060|579912643|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
160600052|NCT01412060|579912644|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
160600053|NCT01412060|579912645|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
160600054|NCT01412060|579912643|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
160600055|NCT01412060|579912644|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
160600056|NCT01412060|579912645|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
160600057|NCT01412060|579912643|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
160600058|NCT01412060|579912644|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
160600059|NCT01412060|579912645|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
160600060|NCT01412060|579912643|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
160600061|NCT01412060|579912644|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
160600062|NCT01412060|579912645|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
160600063|NCT01412060|579912643|FG000|Period Between RIP and SP|Adverse Event|4|||
160600064|NCT01412060|579912644|FG001|Period Between RIP and SP|Adverse Event|0|||
160600065|NCT01412060|579912645|FG002|Period Between RIP and SP|Adverse Event|0|||
160600066|NCT01412060|579912643|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
160600067|NCT01412060|579912644|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
160600068|NCT01412060|579912645|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
160469924|NCT01364597|579451082|FG003|Overall Study|Non compliance|0|||
160469925|NCT01364597|579451079|FG000|Overall Study|Lack of compliance|1|||
160469926|NCT01364597|579451080|FG001|Overall Study|Lack of compliance|0|||
160469927|NCT01364597|579451081|FG002|Overall Study|Lack of compliance|0|||
160469928|NCT01364597|579451082|FG003|Overall Study|Lack of compliance|0|||
160469929|NCT01364597|579451079|FG000|Overall Study|End of treatment epilepsy|1|||
160469930|NCT01364597|579451080|FG001|Overall Study|End of treatment epilepsy|0|||
160469931|NCT01364597|579451081|FG002|Overall Study|End of treatment epilepsy|0|||
160469932|NCT01364597|579451082|FG003|Overall Study|End of treatment epilepsy|0|||
160469933|NCT01364597|579451079|FG000|Overall Study|No Seizures|1|||
160469934|NCT01364597|579451080|FG001|Overall Study|No Seizures|0|||
160469935|NCT01364597|579451081|FG002|Overall Study|No Seizures|0|||
160469936|NCT01364597|579451082|FG003|Overall Study|No Seizures|0|||
160469937|NCT01364597|579451079|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
160469938|NCT01364597|579451080|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
160469939|NCT01364597|579451081|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
160469940|NCT01364597|579451082|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
160469941|NCT01364597|579451079|FG000|Overall Study|Cure|1|||
160469942|NCT01364597|579451080|FG001|Overall Study|Cure|0|||
160469943|NCT01364597|579451081|FG002|Overall Study|Cure|0|||
160469944|NCT01364597|579451082|FG003|Overall Study|Cure|0|||
160469945|NCT01364597|579451079|FG000|Overall Study|Patient was moving|0|||
160469946|NCT01364597|579451080|FG001|Overall Study|Patient was moving|1|||
160469947|NCT01364597|579451081|FG002|Overall Study|Patient was moving|0|||
160469948|NCT01364597|579451082|FG003|Overall Study|Patient was moving|0|||
160469949|NCT01364597|579451079|FG000|Overall Study|Seizures resolved|0|||
160469950|NCT01364597|579451080|FG001|Overall Study|Seizures resolved|0|||
160469951|NCT01364597|579451081|FG002|Overall Study|Seizures resolved|1|||
160469952|NCT01364597|579451082|FG003|Overall Study|Seizures resolved|0|||
160469953|NCT01364597|579451079|FG000|Overall Study|Patient became seizure-free after surgery|0|||
160469954|NCT01364597|579451080|FG001|Overall Study|Patient became seizure-free after surgery|0|||
160469955|NCT01364597|579451081|FG002|Overall Study|Patient became seizure-free after surgery|1|||
160469956|NCT01364597|579451082|FG003|Overall Study|Patient became seizure-free after surgery|0|||
160469957|NCT01364597|579451079|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
160469958|NCT01364597|579451080|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
160469959|NCT01364597|579451081|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
160469960|NCT01364597|579451082|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
160469961|NCT01364597|579451079|FG000|Overall Study|Patient cured from Epilepsy|0|||
160469962|NCT01364597|579451080|FG001|Overall Study|Patient cured from Epilepsy|0|||
160469963|NCT01364597|579451081|FG002|Overall Study|Patient cured from Epilepsy|1|||
160469964|NCT01364597|579451082|FG003|Overall Study|Patient cured from Epilepsy|0|||
160469965|NCT01364597|579451079|FG000|Overall Study|Investigator decision|0|||
160469966|NCT01364597|579451080|FG001|Overall Study|Investigator decision|0|||
160469967|NCT01364597|579451081|FG002|Overall Study|Investigator decision|1|||
160469968|NCT01364597|579451082|FG003|Overall Study|Investigator decision|0|||
160469969|NCT01364597|579451079|FG000|Overall Study|Sponsor recommended discontinuation|0|||
160469970|NCT01364597|579451080|FG001|Overall Study|Sponsor recommended discontinuation|0|||
160469971|NCT01364597|579451081|FG002|Overall Study|Sponsor recommended discontinuation|0|||
160469972|NCT01364597|579451082|FG003|Overall Study|Sponsor recommended discontinuation|1|||
160469973|NCT01364597|579451079|FG000|Overall Study|Parents went abroad with the patient|0|||
160469974|NCT01364597|579451080|FG001|Overall Study|Parents went abroad with the patient|0|||
160469975|NCT01364597|579451081|FG002|Overall Study|Parents went abroad with the patient|1|||
160469976|NCT01364597|579451082|FG003|Overall Study|Parents went abroad with the patient|0|||
160469977|NCT01364597|579451079|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
160469978|NCT01364597|579451080|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
160469979|NCT01364597|579451081|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
160469980|NCT01364597|579451082|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
160469981|NCT01364597|579451079|FG000|Overall Study|BRV administration dropout|0|||
160469982|NCT01364597|579451080|FG001|Overall Study|BRV administration dropout|0|||
160469983|NCT01364597|579451081|FG002|Overall Study|BRV administration dropout|1|||
160659336|NCT01179048|580134518|FG000|Overall Study|Alive|127|||
160469984|NCT01364597|579451082|FG003|Overall Study|BRV administration dropout|0|||
160469985|NCT01364597|579451079|FG000|Overall Study|Dropout|0|||
160469986|NCT01364597|579451080|FG001|Overall Study|Dropout|0|||
160469987|NCT01364597|579451081|FG002|Overall Study|Dropout|3|||
160469988|NCT01364597|579451082|FG003|Overall Study|Dropout|1|||
160469989|NCT01364597|579451079|FG000|Overall Study|Unreliable subject|0|||
160469990|NCT01364597|579451080|FG001|Overall Study|Unreliable subject|0|||
160659337|NCT01179048|580134519|FG001|Overall Study|Alive|142|||
160469991|NCT01364597|579451081|FG002|Overall Study|Unreliable subject|0|||
160469992|NCT01364597|579451082|FG003|Overall Study|Unreliable subject|1|||
160469993|NCT01364597|579451079|FG000|Overall Study|Other|0|||
160469994|NCT01364597|579451080|FG001|Overall Study|Other|0|||
160469995|NCT01364597|579451081|FG002|Overall Study|Other|0|||
160469996|NCT01364597|579451082|FG003|Overall Study|Other|1|||
160600069|NCT01412060|579912643|FG000|Period Between RIP and SP|Protocol Violation|2|||
160600070|NCT01412060|579912644|FG001|Period Between RIP and SP|Protocol Violation|0|||
160600071|NCT01412060|579912645|FG002|Period Between RIP and SP|Protocol Violation|0|||
160600072|NCT01412060|579912643|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
160600073|NCT01412060|579912644|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
160600074|NCT01412060|579912645|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
160600075|NCT01412060|579912643|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
160600076|NCT01412060|579912644|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
160600077|NCT01412060|579912645|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
160600078|NCT01412060|579912643|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
160600079|NCT01412060|579912644|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
160600080|NCT01412060|579912645|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
160600081|NCT01412060|579912643|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
160600082|NCT01412060|579912644|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
160600083|NCT01412060|579912645|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
160600084|NCT01412060|579912643|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
160600085|NCT01412060|579912644|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
160600086|NCT01412060|579912645|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
160600087|NCT01412060|579912643|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
160600088|NCT01412060|579912644|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
160600089|NCT01412060|579912645|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
160600090|NCT01412060|579912643|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
160600091|NCT01412060|579912644|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
160600092|NCT01412060|579912645|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
160600093|NCT01412060|579912643|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
160600094|NCT01412060|579912644|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
160600095|NCT01412060|579912645|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
160600096|NCT01412060|579912643|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
160600097|NCT01412060|579912644|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
160600098|NCT01412060|579912645|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
160600099|NCT01412060|579912643|FG000|Period Between SP and DBP|Protocol Violation|2|||
160600100|NCT01412060|579912644|FG001|Period Between SP and DBP|Protocol Violation|0|||
160600101|NCT01412060|579912645|FG002|Period Between SP and DBP|Protocol Violation|0|||
160600102|NCT01412060|579912643|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
160600103|NCT01412060|579912644|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
160600104|NCT01412060|579912645|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
160469997|NCT02962284|579451083|FG000|Overall Study|Death|2|||
160469998|NCT02962284|579451084|FG001|Overall Study|Death|0|||
160469999|NCT02962284|579451083|FG000|Overall Study|Progressive disease|2|||
160470000|NCT02962284|579451084|FG001|Overall Study|Progressive disease|3|||
160470001|NCT02962284|579451083|FG000|Overall Study|Withdrawal by Subject|1|||
160470002|NCT02962284|579451084|FG001|Overall Study|Withdrawal by Subject|0|||
160470003|NCT03493282|579451088|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
160470004|NCT03493282|579451089|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
160470005|NCT03493282|579451090|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
160470006|NCT03493282|579451088|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
160470007|NCT03493282|579451089|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
160470008|NCT03493282|579451090|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
160470009|NCT02637063|579451091|FG000|Overall Study|Lost to Follow-up|3|||
160470010|NCT02637063|579451092|FG001|Overall Study|Lost to Follow-up|2|||
160470011|NCT02637063|579451093|FG002|Overall Study|Lost to Follow-up|3|||
160470012|NCT02637063|579451091|FG000|Overall Study|Withdrawal by Subject|2|||
160470013|NCT02637063|579451092|FG001|Overall Study|Withdrawal by Subject|2|||
160470014|NCT02637063|579451093|FG002|Overall Study|Withdrawal by Subject|3|||
160470015|NCT01380145|579451094|FG000|Overall Study|Progressive disease|4|||
160470016|NCT02038049|579451099|FG000|Overall Study|Lost to Follow-up|1|||
160470017|NCT02038049|579451100|FG001|Overall Study|Lost to Follow-up|0|||
160470018|NCT02660086|579451102|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
160470019|NCT02660086|579451103|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
160470020|NCT02660086|579451102|FG000|Overall Study- 12-month|Left full-time employment|12|||
160470021|NCT02660086|579451103|FG001|Overall Study- 12-month|Left full-time employment|20|||
160470022|NCT02660086|579451102|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
160470023|NCT02660086|579451103|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
160470024|NCT02660086|579451102|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
160470025|NCT02660086|579451103|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
160470026|NCT02660086|579451102|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
160470027|NCT02660086|579451103|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
160470028|NCT02660086|579451102|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
160470029|NCT02660086|579451103|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
160470030|NCT01214200|579451106|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
160470031|NCT01214200|579451106|FG000|Overall Study|Withdrawal by Subject|2|||
160470032|NCT00587171|579451107|FG000|Overall Study|Lost to Follow-up|1|||
160470033|NCT00587171|579451108|FG001|Overall Study|Lost to Follow-up|1|||
160470034|NCT01532648|579451109|FG000|Overall Study|Lost to Follow-up|3|||
160470035|NCT01532648|579451110|FG001|Overall Study|Lost to Follow-up|4|||
160470036|NCT01532648|579451109|FG000|Overall Study|Lack of Efficacy|4|||
160470037|NCT01532648|579451110|FG001|Overall Study|Lack of Efficacy|1|||
160470038|NCT01532648|579451109|FG000|Overall Study|Protocol Violation|1|||
160470039|NCT01532648|579451110|FG001|Overall Study|Protocol Violation|1|||
160470040|NCT01532648|579451109|FG000|Overall Study|Adverse Event|12|||
160470041|NCT01532648|579451110|FG001|Overall Study|Adverse Event|9|||
160470042|NCT01532648|579451109|FG000|Overall Study|Withdrawal by Subject|16|||
160470043|NCT01532648|579451110|FG001|Overall Study|Withdrawal by Subject|2|||
160470044|NCT04938453|579451114|FG000|Washout Period 1|Adverse Event|1|||
160470045|NCT04938453|579451115|FG001|Washout Period 1|Adverse Event|0|||
160470046|NCT04938453|579451114|FG000|Washout Period 1|Physician Decision|0|||
160470047|NCT04938453|579451115|FG001|Washout Period 1|Physician Decision|1|||
160470048|NCT03292406|579451116|FG000|Overall Study|Progressive Disease|6|||
160470049|NCT03292406|579451117|FG001|Overall Study|Progressive Disease|3|||
160470050|NCT03292406|579451118|FG002|Overall Study|Progressive Disease|4|||
160470051|NCT03292406|579451116|FG000|Overall Study|Adverse Event|7|||
160470052|NCT03292406|579451117|FG001|Overall Study|Adverse Event|1|||
160470053|NCT03292406|579451118|FG002|Overall Study|Adverse Event|4|||
160470054|NCT03292406|579451116|FG000|Overall Study|Withdrawal by Subject|0|||
160470055|NCT03292406|579451117|FG001|Overall Study|Withdrawal by Subject|7|||
160470056|NCT03292406|579451118|FG002|Overall Study|Withdrawal by Subject|2|||
160470057|NCT03292406|579451116|FG000|Overall Study|Protocol Violation|0|||
160470058|NCT03292406|579451117|FG001|Overall Study|Protocol Violation|1|||
160470059|NCT03292406|579451118|FG002|Overall Study|Protocol Violation|1|||
160470060|NCT03292406|579451116|FG000|Overall Study|Other|0|||
160470061|NCT03292406|579451117|FG001|Overall Study|Other|1|||
160470062|NCT03292406|579451118|FG002|Overall Study|Other|2|||
160470063|NCT03176407|579451124|FG000|Overall Study|Protocol Violation|1|||
160470064|NCT03176407|579451124|FG000|Overall Study|human failure|1|||
160470065|NCT03176407|579451124|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
160470066|NCT02128269|579451126|FG000|Treatment Period|Adverse Event|1|||
160470067|NCT02128269|579451126|FG000|Treatment Period|Physician Decision|1|||
160470068|NCT01829711|579451127|FG000|Overall Study|Lost to Follow-up|2|||
160470069|NCT01829711|579451127|FG000|Overall Study|Withdrawal by Subject|3|||
160470070|NCT01829711|579451127|FG000|Overall Study|Death|4|||
160470071|NCT01829711|579451127|FG000|Overall Study|Started new therapies|17|||
160470072|NCT01829711|579451127|FG000|Overall Study|Adverse Event|3|||
160600105|NCT01412060|579912643|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
160470073|NCT01829711|579451127|FG000|Overall Study|Due to progression of disease|13|||
160470074|NCT01829711|579451127|FG000|Overall Study|Due to lack of response|1|||
160470075|NCT01480258|579451128|FG000|Infant Series|Protocol Violation|2|||
160470076|NCT01480258|579451129|FG001|Infant Series|Protocol Violation|0|||
160470077|NCT01480258|579451128|FG000|Infant Series|Physician Decision|0|||
160470078|NCT01480258|579451129|FG001|Infant Series|Physician Decision|1|||
160470079|NCT01480258|579451128|FG000|Infant Series|Not Vaccinated|3|||
160470080|NCT01480258|579451129|FG001|Infant Series|Not Vaccinated|0|||
160470081|NCT01480258|579451128|FG000|Infant Series|Adverse Event|1|||
160470082|NCT01480258|579451129|FG001|Infant Series|Adverse Event|1|||
160470083|NCT01480258|579451128|FG000|Infant Series|Withdrawal by Subject|1|||
160470084|NCT01480258|579451129|FG001|Infant Series|Withdrawal by Subject|6|||
160470085|NCT01480258|579451128|FG000|Interim Period|Lost to Follow-up|0|||
160470086|NCT01480258|579451129|FG001|Interim Period|Lost to Follow-up|2|||
160470087|NCT01480258|579451128|FG000|Interim Period|Physician Decision|1|||
160470088|NCT01480258|579451129|FG001|Interim Period|Physician Decision|0|||
160470089|NCT01480258|579451128|FG000|Interim Period|Protocol Violation|0|||
160470090|NCT01480258|579451129|FG001|Interim Period|Protocol Violation|1|||
160470091|NCT01480258|579451128|FG000|Interim Period|Withdrawal by Subject|9|||
160470092|NCT01480258|579451129|FG001|Interim Period|Withdrawal by Subject|6|||
160470093|NCT04248868|579451130|FG000|Overall Study|Death|1|||
160470094|NCT04248868|579451130|FG000|Overall Study|Lost to Follow-up|3|||
160470095|NCT04248868|579451130|FG000|Overall Study|Protocol Violation|2|||
160470096|NCT01543204|579451133|FG000|Overall Study|Non-compliance|1|||
160470097|NCT01543204|579451133|FG000|Overall Study|Adverse Event|1|||
160470098|NCT01543204|579451133|FG000|Overall Study|Withdrawal by Subject|4|||
160470099|NCT01543204|579451133|FG000|Overall Study|Requirement for Alternative Therapy|1|||
160470100|NCT01543204|579451133|FG000|Overall Study|Lost to Follow-up|1|||
160470101|NCT03822832|579451141|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
160470102|NCT03822832|579451142|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
160470103|NCT03822832|579451141|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
160470104|NCT03822832|579451142|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
160470105|NCT03822832|579451141|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
160470106|NCT03822832|579451142|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
160470107|NCT03822832|579451141|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
160470108|NCT03822832|579451142|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
160470109|NCT03822832|579451141|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
160470110|NCT03822832|579451142|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
160470111|NCT03822832|579451141|FG000|Re-allocation|Not re-allocated to open label period|2|||
160470112|NCT03822832|579451142|FG001|Re-allocation|Not re-allocated to open label period|6|||
160470113|NCT03822832|579451141|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
160470114|NCT03822832|579451142|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
160470115|NCT03822832|579451141|FG000|Period 2 - Open Label Period|Adverse Event|0|||
160470116|NCT03822832|579451142|FG001|Period 2 - Open Label Period|Adverse Event|3|||
160600106|NCT01412060|579912644|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
160600107|NCT01412060|579912645|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
160600108|NCT01412060|579912643|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
160632914|NCT02575807|580036106|FG002|Overall Study|Study terminated by Sponsor|7|||
160470117|NCT01668719|579451143|FG000|Phase I|On treatment|1|||
160600109|NCT01412060|579912644|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
160600110|NCT01412060|579912645|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
160659338|NCT00051025|580134520|FG000|Overall Study|Progressive Disease|1|||
160470118|NCT01668719|579451144|FG001|Phase I|On treatment|0|||
160470119|NCT01668719|579451145|FG002|Phase I|On treatment|0|||
160470120|NCT01668719|579451143|FG000|Phase I|Adverse Event|2|||
160470121|NCT01668719|579451144|FG001|Phase I|Adverse Event|0|||
160470122|NCT01668719|579451145|FG002|Phase I|Adverse Event|0|||
160470123|NCT01668719|579451143|FG000|Phase I|Progression/relapse|1|||
160470124|NCT01668719|579451144|FG001|Phase I|Progression/relapse|0|||
160600111|NCT01412060|579912643|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
160600112|NCT01412060|579912644|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
160600113|NCT01412060|579912645|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
160600114|NCT01412060|579912643|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
160600115|NCT01412060|579912644|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
160600116|NCT01412060|579912645|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
160600117|NCT01412060|579912643|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
160600118|NCT01412060|579912644|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
160600119|NCT01412060|579912645|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
160659339|NCT00051025|580134521|FG001|Overall Study|Progressive Disease|1|||
160659340|NCT00051025|580134520|FG000|Overall Study|Adverse Event|1|||
160659341|NCT00051025|580134521|FG001|Overall Study|Adverse Event|1|||
160659342|NCT00051025|580134520|FG000|Overall Study|Withdrawal by Subject|0|||
160659343|NCT00051025|580134521|FG001|Overall Study|Withdrawal by Subject|1|||
160659344|NCT00051025|580134520|FG000|Overall Study|Death|0|||
160659345|NCT00051025|580134521|FG001|Overall Study|Death|1|||
160600120|NCT01412060|579912643|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
160600121|NCT01412060|579912644|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
160600122|NCT01412060|579912645|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
160600123|NCT01412060|579912643|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
160600124|NCT01412060|579912644|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
160600125|NCT01412060|579912645|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
160600126|NCT01412060|579912643|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
160470125|NCT01668719|579451145|FG002|Phase I|Progression/relapse|0|||
160470126|NCT01668719|579451143|FG000|Phase I|not protocol specified|2|||
160470127|NCT01668719|579451144|FG001|Phase I|not protocol specified|0|||
160470128|NCT01668719|579451145|FG002|Phase I|not protocol specified|0|||
160470129|NCT01668719|579451143|FG000|Phase II|On treatment|0|||
160470130|NCT01668719|579451144|FG001|Phase II|On treatment|4|||
160470131|NCT01668719|579451145|FG002|Phase II|On treatment|3|||
160470132|NCT01668719|579451143|FG000|Phase II|Adverse Event|0|||
160470133|NCT01668719|579451144|FG001|Phase II|Adverse Event|18|||
160470134|NCT01668719|579451145|FG002|Phase II|Adverse Event|18|||
160470135|NCT01668719|579451143|FG000|Phase II|Refusal unrelated to adverse event|0|||
160470136|NCT01668719|579451144|FG001|Phase II|Refusal unrelated to adverse event|4|||
160470137|NCT01668719|579451145|FG002|Phase II|Refusal unrelated to adverse event|1|||
160470138|NCT01668719|579451143|FG000|Phase II|Progression/relapse|0|||
160470139|NCT01668719|579451144|FG001|Phase II|Progression/relapse|13|||
160470140|NCT01668719|579451145|FG002|Phase II|Progression/relapse|17|||
160470141|NCT01668719|579451143|FG000|Phase II|Death|0|||
160470142|NCT01668719|579451144|FG001|Phase II|Death|0|||
160470143|NCT01668719|579451145|FG002|Phase II|Death|2|||
160470144|NCT01668719|579451143|FG000|Phase II|not protocol specified|0|||
160470145|NCT01668719|579451144|FG001|Phase II|not protocol specified|13|||
160600127|NCT01412060|579912644|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
160600128|NCT01412060|579912645|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
160600129|NCT01412060|579912643|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
160600130|NCT01412060|579912644|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
160600131|NCT01412060|579912645|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
160600132|NCT02983799|579912651|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
160600133|NCT02983799|579912652|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
160470146|NCT01668719|579451145|FG002|Phase II|not protocol specified|7|||
160470147|NCT01321073|579451146|FG000|Overall Study|Did not attempt implant|4|||
160470148|NCT01321073|579451146|FG000|Overall Study|Death|3|||
160470149|NCT04248803|579451147|FG000|Overall Study|Lost to Follow-up|7|||
160470150|NCT04248803|579451148|FG001|Overall Study|Lost to Follow-up|7|||
160470151|NCT04248803|579451149|FG002|Overall Study|Lost to Follow-up|7|||
160659346|NCT01900730|580134522|FG000|Overall Study|Withdrawal by Subject|1|||
160659347|NCT01900730|580134523|FG001|Overall Study|Withdrawal by Subject|0|||
160659348|NCT01900730|580134522|FG000|Overall Study|Screen Failure|1|||
160470152|NCT04248803|579451150|FG003|Overall Study|Lost to Follow-up|7|||
160470153|NCT04248803|579451151|FG004|Overall Study|Lost to Follow-up|7|||
160470154|NCT04248803|579451152|FG005|Overall Study|Lost to Follow-up|7|||
160470155|NCT05352230|579451153|FG000|First Intervention (3 Months)|study terminated|2|||
160470156|NCT05352230|579451154|FG001|First Intervention (3 Months)|study terminated|2|||
160470157|NCT02686658|579451156|FG000|Overall Study|Adverse Event|0|||
160470158|NCT02686658|579451157|FG001|Overall Study|Adverse Event|0|||
160600134|NCT02983799|579912653|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
160600135|NCT02983799|579912654|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
160600136|NCT02983799|579912655|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
160600137|NCT02983799|579912651|FG000|Overall Study|Death|20|||
160600138|NCT02983799|579912652|FG001|Overall Study|Death|5|||
160600139|NCT02983799|579912653|FG002|Overall Study|Death|23|||
160600140|NCT02983799|579912654|FG003|Overall Study|Death|47|||
160600141|NCT02983799|579912655|FG004|Overall Study|Death|7|||
160600142|NCT02983799|579912651|FG000|Overall Study|Withdrawal by Subject|1|||
160600143|NCT02983799|579912652|FG001|Overall Study|Withdrawal by Subject|0|||
160600144|NCT02983799|579912653|FG002|Overall Study|Withdrawal by Subject|3|||
160600145|NCT02983799|579912654|FG003|Overall Study|Withdrawal by Subject|4|||
160600146|NCT02983799|579912655|FG004|Overall Study|Withdrawal by Subject|1|||
160600147|NCT02983799|579912651|FG000|Overall Study|Protocol Violation|0|||
160600148|NCT02983799|579912652|FG001|Overall Study|Protocol Violation|1|||
160600149|NCT02983799|579912653|FG002|Overall Study|Protocol Violation|0|||
160600150|NCT02983799|579912654|FG003|Overall Study|Protocol Violation|0|||
160600151|NCT02983799|579912655|FG004|Overall Study|Protocol Violation|1|||
160600152|NCT02983799|579912651|FG000|Overall Study|Lost to Follow-up|1|||
160600153|NCT02983799|579912652|FG001|Overall Study|Lost to Follow-up|0|||
160600154|NCT02983799|579912653|FG002|Overall Study|Lost to Follow-up|1|||
160600155|NCT02983799|579912654|FG003|Overall Study|Lost to Follow-up|0|||
160600156|NCT02983799|579912655|FG004|Overall Study|Lost to Follow-up|0|||
160600157|NCT00719862|579912661|FG000|Overall Study|Adverse Event|1|||
160600158|NCT00719862|579912662|FG001|Overall Study|Adverse Event|2|||
160600159|NCT00719862|579912661|FG000|Overall Study|Lack of Efficacy|3|||
160600160|NCT00719862|579912662|FG001|Overall Study|Lack of Efficacy|0|||
160600161|NCT00719862|579912661|FG000|Overall Study|Non-Compliance|1|||
160600162|NCT00719862|579912662|FG001|Overall Study|Non-Compliance|0|||
160600163|NCT00719862|579912661|FG000|Overall Study|Withdrawal by Subject|1|||
160600164|NCT00719862|579912662|FG001|Overall Study|Withdrawal by Subject|0|||
160600165|NCT00719862|579912661|FG000|Overall Study|Lost to Follow-up|0|||
160600166|NCT00719862|579912662|FG001|Overall Study|Lost to Follow-up|1|||
160600167|NCT00719862|579912661|FG000|Overall Study|Other|2|||
160600168|NCT00719862|579912662|FG001|Overall Study|Other|3|||
160600169|NCT01626989|579912663|FG000|Screening Period|Screen Failure|15|||
160600170|NCT01626989|579912664|FG001|Screening Period|Screen Failure|0|||
160600171|NCT01626989|579912665|FG002|Screening Period|Screen Failure|0|||
160600172|NCT01626989|579912663|FG000|Screening Period|Withdrawal by Subject|2|||
160600173|NCT01626989|579912664|FG001|Screening Period|Withdrawal by Subject|0|||
160600174|NCT01626989|579912665|FG002|Screening Period|Withdrawal by Subject|0|||
160600175|NCT02293902|579912674|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
160600176|NCT02293902|579912675|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
160600177|NCT02293902|579912676|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
160600178|NCT02293902|579912677|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
160600179|NCT02293902|579912678|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
160600180|NCT02293902|579912674|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
160600181|NCT02293902|579912675|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
160600182|NCT02293902|579912676|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
160600183|NCT02293902|579912677|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
160600184|NCT02293902|579912678|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
160600185|NCT02293902|579912674|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
160600186|NCT02293902|579912675|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
160600187|NCT02293902|579912676|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
160600188|NCT02293902|579912677|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
160600189|NCT02293902|579912678|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
160600190|NCT02293902|579912674|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
160600191|NCT02293902|579912675|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
160600192|NCT02293902|579912676|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
160600193|NCT02293902|579912677|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
160600194|NCT02293902|579912678|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
160600195|NCT02293902|579912674|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
160600196|NCT02293902|579912675|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
160600197|NCT02293902|579912676|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
160600198|NCT02293902|579912677|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
160600199|NCT02293902|579912678|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
160600200|NCT03366844|579914241|FG000|Overall Study|Physician Decision|1|||
160600201|NCT03366844|579914241|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
160600202|NCT02687711|579914244|FG000|Overall Study|Adverse Event|89|||
160600203|NCT02687711|579914244|FG000|Overall Study|Lack of Efficacy|70|||
160600204|NCT02687711|579914244|FG000|Overall Study|Lost to Follow-up|20|||
160600205|NCT02687711|579914244|FG000|Overall Study|Consent withdrawn|15|||
160600206|NCT02687711|579914244|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
160600207|NCT02687711|579914244|FG000|Overall Study|Too expensive|4|||
160600208|NCT02687711|579914244|FG000|Overall Study|Participant moved abroad|1|||
160600209|NCT02687711|579914244|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
160470159|NCT02686658|579451158|FG002|Overall Study|Adverse Event|1|||
160470160|NCT02686658|579451159|FG003|Overall Study|Adverse Event|1|||
160470161|NCT02686658|579451160|FG004|Overall Study|Adverse Event|2|||
160470162|NCT02686658|579451161|FG005|Overall Study|Adverse Event|1|||
160470163|NCT02686658|579451156|FG000|Overall Study|Investigator decision|0|||
160470164|NCT02686658|579451157|FG001|Overall Study|Investigator decision|0|||
160470165|NCT02686658|579451158|FG002|Overall Study|Investigator decision|0|||
160470166|NCT02686658|579451159|FG003|Overall Study|Investigator decision|1|||
160470167|NCT02686658|579451160|FG004|Overall Study|Investigator decision|2|||
160470168|NCT02686658|579451161|FG005|Overall Study|Investigator decision|1|||
160470169|NCT02686658|579451156|FG000|Overall Study|Sponsor decision|1|||
160470170|NCT02686658|579451157|FG001|Overall Study|Sponsor decision|2|||
160470171|NCT02686658|579451158|FG002|Overall Study|Sponsor decision|1|||
160470172|NCT02686658|579451159|FG003|Overall Study|Sponsor decision|5|||
160470173|NCT02686658|579451160|FG004|Overall Study|Sponsor decision|13|||
160470174|NCT02686658|579451161|FG005|Overall Study|Sponsor decision|2|||
160470175|NCT02686658|579451156|FG000|Overall Study|Lost to Follow-up|0|||
160470176|NCT02686658|579451157|FG001|Overall Study|Lost to Follow-up|0|||
160470177|NCT02686658|579451158|FG002|Overall Study|Lost to Follow-up|2|||
160470178|NCT02686658|579451159|FG003|Overall Study|Lost to Follow-up|0|||
160470179|NCT02686658|579451160|FG004|Overall Study|Lost to Follow-up|0|||
160470180|NCT02686658|579451161|FG005|Overall Study|Lost to Follow-up|1|||
160470181|NCT02686658|579451156|FG000|Overall Study|Death|1|||
160470182|NCT02686658|579451157|FG001|Overall Study|Death|0|||
160470183|NCT02686658|579451158|FG002|Overall Study|Death|0|||
160470184|NCT02686658|579451159|FG003|Overall Study|Death|1|||
160470185|NCT02686658|579451160|FG004|Overall Study|Death|1|||
160470186|NCT02686658|579451161|FG005|Overall Study|Death|1|||
160470187|NCT02686658|579451156|FG000|Overall Study|Withdrawal by Subject|2|||
160470188|NCT02686658|579451157|FG001|Overall Study|Withdrawal by Subject|5|||
160470189|NCT02686658|579451158|FG002|Overall Study|Withdrawal by Subject|4|||
160470190|NCT02686658|579451159|FG003|Overall Study|Withdrawal by Subject|4|||
160470191|NCT02686658|579451160|FG004|Overall Study|Withdrawal by Subject|17|||
160470192|NCT02686658|579451161|FG005|Overall Study|Withdrawal by Subject|8|||
160470193|NCT02686658|579451156|FG000|Overall Study|Placed in hospice care|0|||
160470194|NCT02686658|579451157|FG001|Overall Study|Placed in hospice care|0|||
160470195|NCT02686658|579451158|FG002|Overall Study|Placed in hospice care|1|||
160470196|NCT02686658|579451159|FG003|Overall Study|Placed in hospice care|0|||
160470197|NCT02686658|579451160|FG004|Overall Study|Placed in hospice care|0|||
160470198|NCT02686658|579451161|FG005|Overall Study|Placed in hospice care|0|||
160470199|NCT02686658|579451156|FG000|Overall Study|Participant non-compliance|0|||
160470200|NCT02686658|579451157|FG001|Overall Study|Participant non-compliance|0|||
160470201|NCT02686658|579451158|FG002|Overall Study|Participant non-compliance|0|||
160470202|NCT02686658|579451159|FG003|Overall Study|Participant non-compliance|0|||
160470203|NCT02686658|579451160|FG004|Overall Study|Participant non-compliance|0|||
160470204|NCT02686658|579451161|FG005|Overall Study|Participant non-compliance|1|||
160600210|NCT02687711|579914244|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
160600211|NCT02687711|579914244|FG000|Overall Study|Disliked taste|1|||
160600212|NCT02687711|579914244|FG000|Overall Study|Low mood|1|||
160600213|NCT02687711|579914244|FG000|Overall Study|Side effects|1|||
160470205|NCT02686658|579451156|FG000|Overall Study|Concern over coronavirus disease care|0|||
160470206|NCT02686658|579451157|FG001|Overall Study|Concern over coronavirus disease care|0|||
160470207|NCT02686658|579451158|FG002|Overall Study|Concern over coronavirus disease care|0|||
160470208|NCT02686658|579451159|FG003|Overall Study|Concern over coronavirus disease care|0|||
160470209|NCT02686658|579451160|FG004|Overall Study|Concern over coronavirus disease care|2|||
160659349|NCT01900730|580134523|FG001|Overall Study|Screen Failure|0|||
160659350|NCT02109042|580134524|FG000|Overall Study|Sponsor Decision|15|||
160659351|NCT03203447|580134525|FG000|Overall Study|Withdrawal by Subject|2|||
160659352|NCT03203447|580134526|FG001|Overall Study|Withdrawal by Subject|1|||
160659353|NCT03203447|580134525|FG000|Overall Study|Lost to Follow-up|1|||
160659354|NCT03203447|580134526|FG001|Overall Study|Lost to Follow-up|10|||
160659355|NCT03203447|580134525|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
160659356|NCT03203447|580134526|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
160659357|NCT02189941|580134527|FG000|Overall Study|Non-compliance|0|||
160659358|NCT02189941|580134528|FG001|Overall Study|Non-compliance|0|||
160659359|NCT02189941|580134529|FG002|Overall Study|Non-compliance|1|||
160659360|NCT01471093|580134532|FG000|Overall Study|Adverse Event|1|||
160659361|NCT01471093|580134533|FG001|Overall Study|Adverse Event|0|||
160659362|NCT01471093|580134534|FG002|Overall Study|Adverse Event|0|||
160659363|NCT01471093|580134535|FG003|Overall Study|Adverse Event|0|||
160659364|NCT00358449|580134536|FG000|Overall Study|Adverse Event|1|||
160659365|NCT00358449|580134537|FG001|Overall Study|Adverse Event|0|||
160659366|NCT00358449|580134538|FG002|Overall Study|Adverse Event|1|||
160659367|NCT00358449|580134536|FG000|Overall Study|Lost to Follow-up|1|||
160659368|NCT00358449|580134537|FG001|Overall Study|Lost to Follow-up|0|||
160659369|NCT00358449|580134538|FG002|Overall Study|Lost to Follow-up|0|||
160659370|NCT00358449|580134536|FG000|Overall Study|Withdrawal by Subject|2|||
160659371|NCT00358449|580134537|FG001|Overall Study|Withdrawal by Subject|0|||
160659372|NCT00358449|580134538|FG002|Overall Study|Withdrawal by Subject|0|||
160659373|NCT00358449|580134536|FG000|Overall Study|Lack of Efficacy|0|||
160659374|NCT00358449|580134537|FG001|Overall Study|Lack of Efficacy|1|||
160659375|NCT00358449|580134538|FG002|Overall Study|Lack of Efficacy|0|||
160659376|NCT00358449|580134536|FG000|Overall Study|Steriod Inhaler was Increased|0|||
160659377|NCT00358449|580134537|FG001|Overall Study|Steriod Inhaler was Increased|0|||
160659378|NCT00358449|580134538|FG002|Overall Study|Steriod Inhaler was Increased|1|||
160659379|NCT01804270|580134539|FG000|Overall Study|Withdrawal by Subject|1|||
160659380|NCT01804270|580134540|FG001|Overall Study|Withdrawal by Subject|1|||
160659381|NCT03988803|580134542|FG000|Period 2|Prematurely discontinued from medication|2|||
160659382|NCT03988803|580134542|FG000|Period 2|Adverse Event|1|||
160659383|NCT01434693|580134545|FG000|Overall Study|Adverse Event|1|||
160659384|NCT01434693|580134546|FG001|Overall Study|Adverse Event|0|||
160659385|NCT01434693|580134547|FG002|Overall Study|Adverse Event|0|||
160659386|NCT01434693|580134548|FG003|Overall Study|Adverse Event|0|||
160659387|NCT01434693|580134545|FG000|Overall Study|Withdrawal by Subject|1|||
160659388|NCT01434693|580134546|FG001|Overall Study|Withdrawal by Subject|0|||
160659389|NCT01434693|580134547|FG002|Overall Study|Withdrawal by Subject|1|||
160600214|NCT02687711|579914244|FG000|Overall Study|Change of Hospital|1|||
160600215|NCT02687711|579914244|FG000|Overall Study|Liver Encephalopathy|1|||
160600216|NCT02687711|579914244|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
160600217|NCT02687711|579914244|FG000|Overall Study|Withdrawn due to intake interruption|1|||
160600218|NCT02687711|579914244|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
160600219|NCT02687711|579914244|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
160600220|NCT02687711|579914244|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
160600221|NCT02971007|579914246|FG000|Overall Study|Adverse Event|1|||
160600222|NCT02971007|579914247|FG001|Overall Study|Adverse Event|0|||
160600223|NCT02971007|579914248|FG002|Overall Study|Adverse Event|0|||
160600224|NCT02971007|579914246|FG000|Overall Study|Lost to Follow-up|0|||
160600225|NCT02971007|579914247|FG001|Overall Study|Lost to Follow-up|1|||
160600226|NCT02971007|579914248|FG002|Overall Study|Lost to Follow-up|1|||
160600227|NCT02971007|579914246|FG000|Overall Study|Withdrawal by Subject|0|||
160600228|NCT02971007|579914247|FG001|Overall Study|Withdrawal by Subject|1|||
160600229|NCT02971007|579914248|FG002|Overall Study|Withdrawal by Subject|0|||
160600230|NCT02971007|579914246|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
160600231|NCT02971007|579914247|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
160659390|NCT01434693|580134548|FG003|Overall Study|Withdrawal by Subject|1|||
160659391|NCT01434693|580134545|FG000|Overall Study|Lost to Follow-up|1|||
160659392|NCT01434693|580134546|FG001|Overall Study|Lost to Follow-up|0|||
160659393|NCT01434693|580134547|FG002|Overall Study|Lost to Follow-up|0|||
160659394|NCT01434693|580134548|FG003|Overall Study|Lost to Follow-up|0|||
160659395|NCT02178722|580134550|FG000|Overall Study|Withdrawal by Subject|0|||
160659396|NCT02178722|580134551|FG001|Overall Study|Withdrawal by Subject|0|||
160600232|NCT02971007|579914248|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
160659397|NCT02178722|580134552|FG002|Overall Study|Withdrawal by Subject|0|||
160600233|NCT02971007|579914246|FG000|Overall Study|Patient discontinued study drug|0|||
160600234|NCT02971007|579914247|FG001|Overall Study|Patient discontinued study drug|1|||
160659398|NCT02178722|580134553|FG003|Overall Study|Withdrawal by Subject|2|||
160659399|NCT02178722|580134554|FG004|Overall Study|Withdrawal by Subject|33|||
160659400|NCT02178722|580134550|FG000|Overall Study|Death|2|||
160659401|NCT02178722|580134551|FG001|Overall Study|Death|13|||
160659402|NCT02178722|580134552|FG002|Overall Study|Death|12|||
160470210|NCT02686658|579451161|FG005|Overall Study|Concern over coronavirus disease care|1|||
160470211|NCT02309294|579451164|FG000|Overall Study|Withdrawal by Subject|2|||
160470212|NCT01227421|579451165|FG000|Overall Study|Lost to Follow-up|6|||
160470213|NCT01227421|579451166|FG001|Overall Study|Lost to Follow-up|7|||
160470214|NCT01227421|579451167|FG002|Overall Study|Lost to Follow-up|5|||
160470215|NCT01227421|579451165|FG000|Overall Study|Adverse Event|2|||
160470216|NCT01227421|579451166|FG001|Overall Study|Adverse Event|7|||
160470217|NCT01227421|579451167|FG002|Overall Study|Adverse Event|2|||
160470218|NCT01227421|579451165|FG000|Overall Study|Withdrawal by Subject|1|||
160470219|NCT01227421|579451166|FG001|Overall Study|Withdrawal by Subject|2|||
160470220|NCT01227421|579451167|FG002|Overall Study|Withdrawal by Subject|1|||
160470221|NCT01227421|579451165|FG000|Overall Study|Protocol Violation|1|||
160470222|NCT01227421|579451166|FG001|Overall Study|Protocol Violation|1|||
160470223|NCT01227421|579451167|FG002|Overall Study|Protocol Violation|2|||
160470224|NCT01227421|579451165|FG000|Overall Study|Randomized in error|1|||
160470225|NCT01227421|579451166|FG001|Overall Study|Randomized in error|1|||
160470226|NCT01227421|579451167|FG002|Overall Study|Randomized in error|0|||
160470227|NCT02969356|579451175|FG000|Overall Study|Adverse Event|7|||
160470228|NCT02969356|579451175|FG000|Overall Study|Consent withdrawn|2|||
160470229|NCT02969356|579451175|FG000|Overall Study|Lost to Follow-up|3|||
160470230|NCT02969356|579451175|FG000|Overall Study|Did not need to be reinjected|6|||
160470231|NCT02969356|579451175|FG000|Overall Study|Personal reasons|5|||
160470232|NCT01276509|579453068|FG000|Overall Study|Adverse Event|9|||
160470233|NCT01276509|579453069|FG001|Overall Study|Adverse Event|8|||
160470234|NCT01276509|579453070|FG002|Overall Study|Adverse Event|4|||
160470235|NCT01276509|579453071|FG003|Overall Study|Adverse Event|3|||
160470236|NCT01276509|579453068|FG000|Overall Study|Lack of Efficacy|2|||
160470237|NCT01276509|579453069|FG001|Overall Study|Lack of Efficacy|1|||
160470238|NCT01276509|579453070|FG002|Overall Study|Lack of Efficacy|1|||
160470239|NCT01276509|579453071|FG003|Overall Study|Lack of Efficacy|2|||
160470240|NCT01276509|579453068|FG000|Overall Study|Pregnancy|1|||
160470241|NCT01276509|579453069|FG001|Overall Study|Pregnancy|0|||
160470242|NCT01276509|579453070|FG002|Overall Study|Pregnancy|0|||
160470243|NCT01276509|579453071|FG003|Overall Study|Pregnancy|0|||
160470244|NCT01276509|579453068|FG000|Overall Study|Withdrawal by Subject|1|||
160470245|NCT01276509|579453069|FG001|Overall Study|Withdrawal by Subject|2|||
160470246|NCT01276509|579453070|FG002|Overall Study|Withdrawal by Subject|0|||
160470247|NCT01276509|579453071|FG003|Overall Study|Withdrawal by Subject|0|||
160470248|NCT01276509|579453068|FG000|Overall Study|Other|0|||
160470249|NCT01276509|579453069|FG001|Overall Study|Other|1|||
160470250|NCT01276509|579453070|FG002|Overall Study|Other|0|||
160470251|NCT01276509|579453071|FG003|Overall Study|Other|0|||
160470252|NCT00949117|579453073|FG000|Overall Study|Lack of Efficacy|2|||
160470253|NCT00949117|579453074|FG001|Overall Study|Lack of Efficacy|3|||
160470254|NCT00949117|579453073|FG000|Overall Study|Protocol Violation|1|||
160470255|NCT00949117|579453074|FG001|Overall Study|Protocol Violation|1|||
160470256|NCT00949117|579453073|FG000|Overall Study|Adverse Event|0|||
160470257|NCT00949117|579453074|FG001|Overall Study|Adverse Event|1|||
160470258|NCT03964974|579453075|FG000|Overall Study|Lost to Follow-up|3|||
160600235|NCT02971007|579914248|FG002|Overall Study|Patient discontinued study drug|0|||
160600236|NCT03276572|579914252|FG000|Overall Study|In follow-up|0|||
160470259|NCT03964974|579453076|FG001|Overall Study|Lost to Follow-up|2|||
160470260|NCT03964974|579453075|FG000|Overall Study|Withdrawal by Subject|0|||
160470261|NCT03964974|579453076|FG001|Overall Study|Withdrawal by Subject|3|||
160470262|NCT02014402|579453080|FG000|Overall Study|Adverse Event|1|||
160470263|NCT02014402|579453081|FG001|Overall Study|Adverse Event|0|||
160470264|NCT02014402|579453082|FG002|Overall Study|Adverse Event|0|||
160470265|NCT02014402|579453083|FG003|Overall Study|Adverse Event|0|||
160470266|NCT02014402|579453080|FG000|Overall Study|Withdrawal by Subject|1|||
160470267|NCT02014402|579453081|FG001|Overall Study|Withdrawal by Subject|2|||
160470268|NCT02014402|579453082|FG002|Overall Study|Withdrawal by Subject|2|||
160470269|NCT02014402|579453083|FG003|Overall Study|Withdrawal by Subject|1|||
160470270|NCT02014402|579453080|FG000|Overall Study|Subject did not have transportation|0|||
160470271|NCT02014402|579453081|FG001|Overall Study|Subject did not have transportation|1|||
160470272|NCT02014402|579453082|FG002|Overall Study|Subject did not have transportation|0|||
160600237|NCT03276572|579914253|FG001|Overall Study|In follow-up|0|||
160600238|NCT03276572|579914254|FG002|Overall Study|In follow-up|0|||
160600239|NCT03276572|579914255|FG003|Overall Study|In follow-up|0|||
160600240|NCT03276572|579914256|FG004|Overall Study|In follow-up|0|||
160600241|NCT03276572|579914257|FG005|Overall Study|In follow-up|1|||
160600242|NCT03276572|579914258|FG006|Overall Study|In follow-up|1|||
160600243|NCT03276572|579914252|FG000|Overall Study|Lost to Follow-up|0|||
160600244|NCT03276572|579914253|FG001|Overall Study|Lost to Follow-up|0|||
160600245|NCT03276572|579914254|FG002|Overall Study|Lost to Follow-up|0|||
160470273|NCT02014402|579453083|FG003|Overall Study|Subject did not have transportation|0|||
160470274|NCT02014402|579453080|FG000|Overall Study|Lost to Follow-up|0|||
160470275|NCT02014402|579453081|FG001|Overall Study|Lost to Follow-up|0|||
160470276|NCT02014402|579453082|FG002|Overall Study|Lost to Follow-up|1|||
160470277|NCT02014402|579453083|FG003|Overall Study|Lost to Follow-up|2|||
160470278|NCT00670449|579453084|FG000|Overall Study|Adverse Event|6|||
160470279|NCT00670449|579453085|FG001|Overall Study|Adverse Event|2|||
160470280|NCT00670449|579453086|FG002|Overall Study|Adverse Event|8|||
160470281|NCT00670449|579453087|FG003|Overall Study|Adverse Event|5|||
160470282|NCT00670449|579453084|FG000|Overall Study|Protocol Deviation|1|||
160470283|NCT00670449|579453085|FG001|Overall Study|Protocol Deviation|2|||
160470284|NCT00670449|579453086|FG002|Overall Study|Protocol Deviation|0|||
160470285|NCT00670449|579453087|FG003|Overall Study|Protocol Deviation|1|||
160470286|NCT00670449|579453084|FG000|Overall Study|Administrative Problems|0|||
160470287|NCT00670449|579453085|FG001|Overall Study|Administrative Problems|2|||
160470288|NCT00670449|579453086|FG002|Overall Study|Administrative Problems|0|||
160470289|NCT00670449|579453087|FG003|Overall Study|Administrative Problems|1|||
160470290|NCT00670449|579453084|FG000|Overall Study|Subject Withdrew Consent|0|||
160470291|NCT00670449|579453085|FG001|Overall Study|Subject Withdrew Consent|2|||
160470292|NCT00670449|579453086|FG002|Overall Study|Subject Withdrew Consent|0|||
160470293|NCT00670449|579453087|FG003|Overall Study|Subject Withdrew Consent|1|||
160470294|NCT00670449|579453084|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
160470295|NCT00670449|579453085|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160470296|NCT00670449|579453086|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
160470297|NCT00670449|579453087|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160470298|NCT00670449|579453084|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
160470299|NCT00670449|579453085|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
160470300|NCT00670449|579453086|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
160470301|NCT00670449|579453087|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
160470302|NCT00413283|579453088|FG000|Overall Study|Withdrawal by Subject|1|||
160470303|NCT00413283|579453089|FG001|Overall Study|Withdrawal by Subject|0|||
160470304|NCT00413283|579453090|FG002|Overall Study|Withdrawal by Subject|0|||
160470305|NCT00413283|579453091|FG003|Overall Study|Withdrawal by Subject|1|||
160470306|NCT00413283|579453088|FG000|Overall Study|Death|0|||
160470307|NCT00413283|579453089|FG001|Overall Study|Death|0|||
160470308|NCT00413283|579453090|FG002|Overall Study|Death|1|||
160470309|NCT00413283|579453091|FG003|Overall Study|Death|1|||
160470310|NCT00413283|579453088|FG000|Overall Study|Adverse Event|0|||
160470311|NCT00413283|579453089|FG001|Overall Study|Adverse Event|0|||
160470312|NCT00413283|579453090|FG002|Overall Study|Adverse Event|0|||
160470313|NCT00413283|579453091|FG003|Overall Study|Adverse Event|1|||
160470314|NCT00413283|579453088|FG000|Overall Study|Ineligibility determined|0|||
160470315|NCT00413283|579453089|FG001|Overall Study|Ineligibility determined|0|||
160470316|NCT00413283|579453090|FG002|Overall Study|Ineligibility determined|0|||
160470317|NCT00413283|579453091|FG003|Overall Study|Ineligibility determined|1|||
160470318|NCT00413283|579453088|FG000|Overall Study|Protocol deviation|0|||
160470319|NCT00413283|579453089|FG001|Overall Study|Protocol deviation|1|||
160470320|NCT00413283|579453090|FG002|Overall Study|Protocol deviation|0|||
160470321|NCT00413283|579453091|FG003|Overall Study|Protocol deviation|0|||
160470322|NCT00413283|579453088|FG000|Overall Study|Requirement for alternative therapy|0|||
160470323|NCT00413283|579453089|FG001|Overall Study|Requirement for alternative therapy|2|||
160470324|NCT00413283|579453090|FG002|Overall Study|Requirement for alternative therapy|0|||
160470325|NCT00413283|579453091|FG003|Overall Study|Requirement for alternative therapy|0|||
160470326|NCT00413283|579453088|FG000|Overall Study|Other|0|||
160470327|NCT00413283|579453089|FG001|Overall Study|Other|0|||
160470328|NCT00413283|579453090|FG002|Overall Study|Other|1|||
160470329|NCT00413283|579453091|FG003|Overall Study|Other|0|||
160470330|NCT01377844|579453092|FG000|Overall Study|Withdrawal by Subject|25|||
160470331|NCT01377844|579453093|FG001|Overall Study|Withdrawal by Subject|28|||
160470332|NCT01377844|579453092|FG000|Overall Study|Protocol Violation|2|||
160470333|NCT01377844|579453093|FG001|Overall Study|Protocol Violation|3|||
160470334|NCT01377844|579453092|FG000|Overall Study|Adverse Event|3|||
160470335|NCT01377844|579453093|FG001|Overall Study|Adverse Event|0|||
160470336|NCT01377844|579453092|FG000|Overall Study|Physician Decision|6|||
160470337|NCT01377844|579453093|FG001|Overall Study|Physician Decision|3|||
160470338|NCT01377844|579453092|FG000|Overall Study|Study terminated by Sponsor|0|||
160470339|NCT01377844|579453093|FG001|Overall Study|Study terminated by Sponsor|1|||
160470340|NCT00667017|579453095|FG000|Overall Study|Withdrawal by Subject|1|||
160600246|NCT03276572|579914255|FG003|Overall Study|Lost to Follow-up|0|||
160600247|NCT03276572|579914256|FG004|Overall Study|Lost to Follow-up|0|||
160600248|NCT03276572|579914257|FG005|Overall Study|Lost to Follow-up|0|||
160600249|NCT03276572|579914258|FG006|Overall Study|Lost to Follow-up|1|||
160600250|NCT00607919|579914271|FG000|Acute Phase|Adverse Event|9|||
160600251|NCT00607919|579914272|FG001|Acute Phase|Adverse Event|2|||
160600252|NCT00607919|579914271|FG000|Acute Phase|Entry Criteria Not Met|1|||
160470341|NCT01823224|579453096|FG000|Overall Study|Lost to Follow-up|5|||
160659403|NCT02178722|580134553|FG003|Overall Study|Death|12|||
160659404|NCT02178722|580134554|FG004|Overall Study|Death|205|||
160659405|NCT02178722|580134550|FG000|Overall Study|Lost to Follow-up|0|||
160659406|NCT02178722|580134551|FG001|Overall Study|Lost to Follow-up|0|||
160659407|NCT02178722|580134552|FG002|Overall Study|Lost to Follow-up|0|||
160659408|NCT02178722|580134553|FG003|Overall Study|Lost to Follow-up|2|||
160659409|NCT02178722|580134554|FG004|Overall Study|Lost to Follow-up|11|||
160659410|NCT02178722|580134550|FG000|Overall Study|Study terminated by Sponsor|2|||
160659411|NCT02178722|580134551|FG001|Overall Study|Study terminated by Sponsor|7|||
160470342|NCT01823224|579453097|FG001|Overall Study|Lost to Follow-up|6|||
160470343|NCT01823224|579453096|FG000|Overall Study|didn't qualify|1|||
160470344|NCT01823224|579453097|FG001|Overall Study|didn't qualify|2|||
160470345|NCT01823224|579453096|FG000|Overall Study|pharmacy error|0|||
160470346|NCT01823224|579453097|FG001|Overall Study|pharmacy error|1|||
160470347|NCT01823224|579453096|FG000|Overall Study|missed med dose|0|||
160470348|NCT01823224|579453097|FG001|Overall Study|missed med dose|1|||
160470349|NCT01823224|579453096|FG000|Overall Study|Withdrawal by Subject|0|||
160470350|NCT01823224|579453097|FG001|Overall Study|Withdrawal by Subject|1|||
160470351|NCT02148705|579453098|FG000|Overall Study|Death|2|||
160470352|NCT02148705|579453099|FG001|Overall Study|Death|0|||
160470353|NCT02148705|579453100|FG002|Overall Study|Death|0|||
160470354|NCT02148705|579453098|FG000|Overall Study|Lost to Follow-up|13|||
160470355|NCT02148705|579453099|FG001|Overall Study|Lost to Follow-up|4|||
160470356|NCT02148705|579453100|FG002|Overall Study|Lost to Follow-up|10|||
160470357|NCT02148705|579453098|FG000|Overall Study|Withdrawal by Subject|3|||
160470358|NCT02148705|579453099|FG001|Overall Study|Withdrawal by Subject|0|||
160470359|NCT02148705|579453100|FG002|Overall Study|Withdrawal by Subject|2|||
160470360|NCT02148705|579453098|FG000|Overall Study|Not Treated|0|||
160470361|NCT02148705|579453099|FG001|Overall Study|Not Treated|1|||
160470362|NCT02148705|579453100|FG002|Overall Study|Not Treated|5|||
160470363|NCT01737021|579453101|FG000|Overall Study|Lost to Follow-up|5|||
160470364|NCT01737021|579453102|FG001|Overall Study|Lost to Follow-up|3|||
160470365|NCT01673594|579453103|FG000|Overall Study|Adverse Event|3|||
160470366|NCT01673594|579453104|FG001|Overall Study|Adverse Event|1|||
160470367|NCT01673594|579453103|FG000|Overall Study|Lost to Follow-up|1|||
160470368|NCT01673594|579453104|FG001|Overall Study|Lost to Follow-up|0|||
160470369|NCT01673594|579453103|FG000|Overall Study|Physician Decision|2|||
160470370|NCT01673594|579453104|FG001|Overall Study|Physician Decision|4|||
160470371|NCT01673594|579453103|FG000|Overall Study|Withdrawal by Subject|0|||
160470372|NCT01673594|579453104|FG001|Overall Study|Withdrawal by Subject|1|||
160470373|NCT02824198|579453105|FG000|Overall Study|Non-compliance with the protocol|5|||
160470374|NCT02824198|579453106|FG001|Overall Study|Non-compliance with the protocol|1|||
160470375|NCT02824198|579453105|FG000|Overall Study|Lost to Follow-up|5|||
160470376|NCT02824198|579453106|FG001|Overall Study|Lost to Follow-up|2|||
160470377|NCT02824198|579453105|FG000|Overall Study|Withdrawal by Subject|5|||
160470378|NCT02824198|579453106|FG001|Overall Study|Withdrawal by Subject|0|||
160470379|NCT02605174|579453107|FG000|Overall Study|Adverse Event|0|||
160470380|NCT02605174|579453108|FG001|Overall Study|Adverse Event|0|||
160470381|NCT02605174|579453109|FG002|Overall Study|Adverse Event|1|||
160470382|NCT02605174|579453110|FG003|Overall Study|Adverse Event|0|||
160470383|NCT02605174|579453111|FG004|Overall Study|Adverse Event|4|||
160470384|NCT02605174|579453112|FG005|Overall Study|Adverse Event|0|||
160470385|NCT02605174|579453113|FG006|Overall Study|Adverse Event|0|||
160470386|NCT02605174|579453107|FG000|Overall Study|Lost to Follow-up|20|||
160470387|NCT02605174|579453108|FG001|Overall Study|Lost to Follow-up|7|||
160470388|NCT02605174|579453109|FG002|Overall Study|Lost to Follow-up|27|||
160470389|NCT02605174|579453110|FG003|Overall Study|Lost to Follow-up|10|||
160470390|NCT02605174|579453111|FG004|Overall Study|Lost to Follow-up|20|||
160470391|NCT02605174|579453112|FG005|Overall Study|Lost to Follow-up|10|||
160470392|NCT02605174|579453113|FG006|Overall Study|Lost to Follow-up|29|||
160470393|NCT02605174|579453107|FG000|Overall Study|Protocol Violation|10|||
160470394|NCT02605174|579453108|FG001|Overall Study|Protocol Violation|4|||
160470395|NCT02605174|579453109|FG002|Overall Study|Protocol Violation|14|||
160470396|NCT02605174|579453110|FG003|Overall Study|Protocol Violation|6|||
160470397|NCT02605174|579453111|FG004|Overall Study|Protocol Violation|7|||
160470398|NCT02605174|579453112|FG005|Overall Study|Protocol Violation|7|||
160470399|NCT02605174|579453113|FG006|Overall Study|Protocol Violation|12|||
160470400|NCT02605174|579453107|FG000|Overall Study|Pregnancy|1|||
160470401|NCT02605174|579453108|FG001|Overall Study|Pregnancy|0|||
160470402|NCT02605174|579453109|FG002|Overall Study|Pregnancy|0|||
160470403|NCT02605174|579453110|FG003|Overall Study|Pregnancy|2|||
160600253|NCT00607919|579914272|FG001|Acute Phase|Entry Criteria Not Met|1|||
160600254|NCT00607919|579914271|FG000|Acute Phase|Lack of Efficacy|1|||
160600255|NCT00607919|579914272|FG001|Acute Phase|Lack of Efficacy|2|||
160600256|NCT00607919|579914271|FG000|Acute Phase|Lost to Follow-up|9|||
160600257|NCT00607919|579914272|FG001|Acute Phase|Lost to Follow-up|3|||
160470404|NCT02605174|579453111|FG004|Overall Study|Pregnancy|0|||
160600258|NCT00607919|579914271|FG000|Acute Phase|Parent/Caregiver Decision|6|||
160470405|NCT02605174|579453112|FG005|Overall Study|Pregnancy|0|||
160470406|NCT02605174|579453113|FG006|Overall Study|Pregnancy|0|||
160470407|NCT02605174|579453107|FG000|Overall Study|Withdrawal by Subject|9|||
160470408|NCT02605174|579453108|FG001|Overall Study|Withdrawal by Subject|6|||
160470409|NCT02605174|579453109|FG002|Overall Study|Withdrawal by Subject|14|||
160470410|NCT02605174|579453110|FG003|Overall Study|Withdrawal by Subject|11|||
160470411|NCT02605174|579453111|FG004|Overall Study|Withdrawal by Subject|6|||
160470412|NCT02605174|579453112|FG005|Overall Study|Withdrawal by Subject|4|||
160470413|NCT02605174|579453113|FG006|Overall Study|Withdrawal by Subject|15|||
160470414|NCT02605174|579453107|FG000|Overall Study|Physician Decision|2|||
160470415|NCT02605174|579453108|FG001|Overall Study|Physician Decision|0|||
160470416|NCT02605174|579453109|FG002|Overall Study|Physician Decision|0|||
160470417|NCT02605174|579453110|FG003|Overall Study|Physician Decision|0|||
160470418|NCT02605174|579453111|FG004|Overall Study|Physician Decision|0|||
160470419|NCT02605174|579453112|FG005|Overall Study|Physician Decision|0|||
160470420|NCT02605174|579453113|FG006|Overall Study|Physician Decision|3|||
160470421|NCT02605174|579453107|FG000|Overall Study|Randomization Failure|22|||
160470422|NCT02605174|579453108|FG001|Overall Study|Randomization Failure|6|||
160470423|NCT02605174|579453109|FG002|Overall Study|Randomization Failure|20|||
160470424|NCT02605174|579453110|FG003|Overall Study|Randomization Failure|7|||
160470425|NCT02605174|579453111|FG004|Overall Study|Randomization Failure|16|||
160470426|NCT02605174|579453112|FG005|Overall Study|Randomization Failure|11|||
160470427|NCT02605174|579453113|FG006|Overall Study|Randomization Failure|30|||
160470428|NCT04250636|579453114|FG000|Overall Study|Lost to Follow-up|2|||
160470429|NCT01779050|579453115|FG000|Overall Study|Withdrawal by Subject|1|||
160470430|NCT01779050|579453116|FG001|Overall Study|Withdrawal by Subject|0|||
160470431|NCT01353274|579453117|FG000|Overall Study|No case report form (CRF) collected|28|||
160470432|NCT01128959|579453118|FG000|Lead in Period|Adverse Event|3|||
160470433|NCT01128959|579453118|FG000|Treatment Period|Adverse Event|3|||
160470434|NCT01128959|579453118|FG000|Treatment Period|Withdrawal by Subject|1|||
160470435|NCT01409837|579453121|FG000|Overall Study|Withdrawal by Subject|2|||
160470436|NCT01409837|579453122|FG001|Overall Study|Withdrawal by Subject|1|||
160470437|NCT01409837|579453121|FG000|Overall Study|Lost to Follow-up|1|||
160470438|NCT01409837|579453122|FG001|Overall Study|Lost to Follow-up|0|||
160470439|NCT01409837|579453121|FG000|Overall Study|Physician Decision|0|||
160470440|NCT01409837|579453122|FG001|Overall Study|Physician Decision|1|||
160470441|NCT00022672|579453124|FG000|Main Phase: 24 Months|Adverse Event|6|||
160470442|NCT00022672|579453125|FG001|Main Phase: 24 Months|Adverse Event|0|||
160470443|NCT00022672|579453124|FG000|Main Phase: 24 Months|Death|0|||
160470444|NCT00022672|579453125|FG001|Main Phase: 24 Months|Death|3|||
160470445|NCT00022672|579453124|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
160470446|NCT00022672|579453125|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
160470447|NCT00022672|579453124|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
160470448|NCT00022672|579453125|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
160470449|NCT00022672|579453124|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
160470450|NCT00022672|579453125|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
160470451|NCT00022672|579453124|FG000|Main Phase: 24 Months|Refused Treatment|3|||
160470452|NCT00022672|579453125|FG001|Main Phase: 24 Months|Refused Treatment|4|||
160470453|NCT00022672|579453124|FG000|Main Phase: 24 Months|Failure to Return|1|||
160470454|NCT00022672|579453125|FG001|Main Phase: 24 Months|Failure to Return|1|||
160470455|NCT00022672|579453124|FG000|Main Phase: 24 Months|Other|1|||
160470456|NCT00022672|579453125|FG001|Main Phase: 24 Months|Other|0|||
160470457|NCT00022672|579453124|FG000|Extension Phase|Adverse Event|1|||
160470458|NCT00022672|579453125|FG001|Extension Phase|Adverse Event|3|||
160470459|NCT00022672|579453124|FG000|Extension Phase|Death|0|||
160470460|NCT00022672|579453125|FG001|Extension Phase|Death|1|||
160470461|NCT00022672|579453124|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
160470462|NCT00022672|579453125|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
160470463|NCT00022672|579453124|FG000|Extension Phase|Refused Treatment|0|||
160470464|NCT00022672|579453125|FG001|Extension Phase|Refused Treatment|2|||
160470465|NCT00022672|579453124|FG000|Extension Phase|Other|1|||
160470466|NCT00022672|579453125|FG001|Extension Phase|Other|1|||
160470467|NCT00403494|579453126|FG000|Overall Study|Adverse Event|10|||
160470468|NCT00403494|579453127|FG001|Overall Study|Adverse Event|8|||
160470469|NCT00403494|579453126|FG000|Overall Study|Withdrew Consent|3|||
160470470|NCT00403494|579453127|FG001|Overall Study|Withdrew Consent|2|||
160470471|NCT00403494|579453126|FG000|Overall Study|Inappropriately enrolled|0|||
160470472|NCT00403494|579453127|FG001|Overall Study|Inappropriately enrolled|1|||
160470473|NCT00403494|579453126|FG000|Overall Study|Lost to Follow-up|0|||
160470474|NCT00403494|579453127|FG001|Overall Study|Lost to Follow-up|2|||
160470475|NCT00403494|579453126|FG000|Overall Study|Protocol noncompliance|0|||
160470476|NCT00403494|579453127|FG001|Overall Study|Protocol noncompliance|1|||
160470477|NCT00403494|579453126|FG000|Overall Study|Death|1|||
160470478|NCT00403494|579453127|FG001|Overall Study|Death|0|||
160470479|NCT00403494|579453126|FG000|Overall Study|Sponsor Request|1|||
160470480|NCT00403494|579453127|FG001|Overall Study|Sponsor Request|0|||
160470481|NCT05005247|579453128|FG000|Overall Study|Withdrawal by Subject|0|||
160659412|NCT02178722|580134552|FG002|Overall Study|Study terminated by Sponsor|6|||
160470482|NCT05005247|579453129|FG001|Overall Study|Withdrawal by Subject|1|||
160659413|NCT02178722|580134553|FG003|Overall Study|Study terminated by Sponsor|4|||
160600259|NCT00607919|579914272|FG001|Acute Phase|Parent/Caregiver Decision|4|||
160600260|NCT00607919|579914271|FG000|Acute Phase|Protocol Violation|5|||
160600261|NCT00607919|579914272|FG001|Acute Phase|Protocol Violation|1|||
160600262|NCT00607919|579914271|FG000|Acute Phase|Withdrawal by Subject|3|||
160600263|NCT00607919|579914272|FG001|Acute Phase|Withdrawal by Subject|3|||
160600264|NCT00607919|579914271|FG000|Open-Label Phase|Adverse Event|1|||
160600265|NCT00607919|579914272|FG001|Open-Label Phase|Adverse Event|5|||
160600266|NCT00607919|579914271|FG000|Open-Label Phase|Lost to Follow-up|4|||
160659414|NCT02178722|580134554|FG004|Overall Study|Study terminated by Sponsor|128|||
160659415|NCT02178722|580134550|FG000|Overall Study|Physician Decision|0|||
160659416|NCT02178722|580134551|FG001|Overall Study|Physician Decision|0|||
160659417|NCT02178722|580134552|FG002|Overall Study|Physician Decision|0|||
160659418|NCT02178722|580134553|FG003|Overall Study|Physician Decision|0|||
160659419|NCT02178722|580134554|FG004|Overall Study|Physician Decision|3|||
160659420|NCT02178722|580134550|FG000|Overall Study|Other|0|||
160659421|NCT02178722|580134551|FG001|Overall Study|Other|0|||
160659422|NCT02178722|580134552|FG002|Overall Study|Other|0|||
160659423|NCT02178722|580134553|FG003|Overall Study|Other|0|||
160659424|NCT02178722|580134554|FG004|Overall Study|Other|2|||
160659425|NCT01572948|580134555|FG000|Overall Study|Lost to Follow-up|1|||
160659426|NCT01572948|580134556|FG001|Overall Study|Lost to Follow-up|0|||
160659427|NCT01572948|580134555|FG000|Overall Study|unable to contact|0|||
160659428|NCT01572948|580134556|FG001|Overall Study|unable to contact|1|||
160659429|NCT02107092|580134559|FG000|Overall Study|Miscellaneous|3|||
160659430|NCT02107092|580134559|FG000|Overall Study|Subject compliance|3|||
160659431|NCT02107092|580134559|FG000|Overall Study|Hypo-or hyperkalemia|2|||
160659432|NCT02107092|580134559|FG000|Overall Study|Met ECG withdrawal criteria|3|||
160659433|NCT02107092|580134559|FG000|Overall Study|Physician Decision|3|||
160659434|NCT02107092|580134559|FG000|Overall Study|Lost to Follow-up|2|||
160659435|NCT02107092|580134559|FG000|Overall Study|Withdrawal by Subject|9|||
160659436|NCT02107092|580134559|FG000|Overall Study|Adverse Event|7|||
160659437|NCT02107092|580134559|FG000|Overall Study|Expected progression of CKD|12|||
160659438|NCT00537030|580134560|FG000|Overall Study|Physician Decision|2|||
160659439|NCT00537030|580134560|FG000|Overall Study|Withdrawal by Subject|2|||
160659440|NCT00537030|580134560|FG000|Overall Study|≥ Grade 2 allergy|7|||
160659441|NCT00537030|580134560|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
160659442|NCT00537030|580134560|FG000|Overall Study|Ineligible|2|||
160659443|NCT00537030|580134560|FG000|Overall Study|Inevaluable|2|||
160659444|NCT04213326|580134562|FG000|Overall Study|Consent withdrawn|51|||
160659445|NCT04213326|580134563|FG001|Overall Study|Consent withdrawn|241|||
160659446|NCT04213326|580134562|FG000|Overall Study|Lost to Follow-up|50|||
160659447|NCT04213326|580134563|FG001|Overall Study|Lost to Follow-up|902|||
160659448|NCT04213326|580134562|FG000|Overall Study|Protocol Violation|3|||
160659449|NCT04213326|580134563|FG001|Overall Study|Protocol Violation|25|||
160659450|NCT04213326|580134562|FG000|Overall Study|Participant eligibility changed|106|||
160659451|NCT04213326|580134563|FG001|Overall Study|Participant eligibility changed|19|||
160659452|NCT04213326|580134562|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
160600267|NCT00607919|579914272|FG001|Open-Label Phase|Lost to Follow-up|1|||
160600268|NCT00607919|579914271|FG000|Open-Label Phase|Protocol Violation|2|||
160600269|NCT00607919|579914272|FG001|Open-Label Phase|Protocol Violation|2|||
160600270|NCT00607919|579914271|FG000|Open-Label Phase|Withdrawal by Subject|2|||
160600271|NCT00607919|579914272|FG001|Open-Label Phase|Withdrawal by Subject|2|||
160600272|NCT00607919|579914271|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
160600273|NCT00607919|579914272|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
160600274|NCT02580240|579914273|FG000|Overall Study|Physician Decision|2|||
160600275|NCT02580240|579914274|FG001|Overall Study|Physician Decision|0|||
160600276|NCT02954952|579914277|FG000|Overall Study|Withdrawal by Subject|1|||
160659453|NCT04213326|580134563|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
160659454|NCT04213326|580134562|FG000|Overall Study|Incomplete study visit|0|||
160659455|NCT04213326|580134563|FG001|Overall Study|Incomplete study visit|367|||
160659456|NCT01496183|580134564|FG000|Overall Study|Physician Decision|3|||
160659457|NCT01496183|580134565|FG001|Overall Study|Physician Decision|1|||
160659458|NCT01496183|580134564|FG000|Overall Study|Withdrawal by Subject|0|||
160600277|NCT02954952|579914278|FG001|Overall Study|Withdrawal by Subject|0|||
160600278|NCT02954952|579914279|FG002|Overall Study|Withdrawal by Subject|0|||
160600279|NCT02954952|579914277|FG000|Overall Study|No data collected|0|||
160659459|NCT01496183|580134565|FG001|Overall Study|Withdrawal by Subject|1|||
160659460|NCT00669864|580134570|FG000|Overall Study|Lost to Follow-up|2|||
160659461|NCT00669864|580134570|FG000|Overall Study|Protocol Violation|2|||
160659462|NCT00669864|580134570|FG000|Overall Study|Withdrawal by Subject|3|||
160659463|NCT00669864|580134570|FG000|Overall Study|Other|2|||
160659464|NCT02457832|580134576|FG000|Training|Lost to Follow-up|10|||
160659465|NCT02457832|580134577|FG001|Training|Lost to Follow-up|6|||
160659466|NCT02457832|580134578|FG002|Training|Lost to Follow-up|3|||
160659467|NCT02457832|580134576|FG000|One Month Washout|Lost to Follow-up|0|||
160659468|NCT02457832|580134577|FG001|One Month Washout|Lost to Follow-up|1|||
160659469|NCT02457832|580134578|FG002|One Month Washout|Lost to Follow-up|1|||
160659470|NCT01044732|580134579|FG000|Overall Study|Lost to Follow-up|2|||
160659471|NCT01044732|580134580|FG001|Overall Study|Lost to Follow-up|1|||
160659472|NCT01044732|580134579|FG000|Overall Study|Physician Decision|5|||
160659473|NCT01044732|580134580|FG001|Overall Study|Physician Decision|3|||
160659474|NCT01044732|580134579|FG000|Overall Study|Protocol Violation|11|||
160659475|NCT01044732|580134580|FG001|Overall Study|Protocol Violation|12|||
160600280|NCT02954952|579914278|FG001|Overall Study|No data collected|1|||
160659476|NCT01044732|580134579|FG000|Overall Study|Withdrawal by Subject|0|||
160659477|NCT01044732|580134580|FG001|Overall Study|Withdrawal by Subject|1|||
160659478|NCT01044732|580134579|FG000|Overall Study|Inadequate bowel preparation|11|||
160470483|NCT05005247|579453130|FG002|Overall Study|Withdrawal by Subject|0|||
160470484|NCT03490032|579453133|FG000|Overall Study|family issue (child custody)|1|||
160470485|NCT03490032|579453134|FG001|Overall Study|family issue (child custody)|0|||
160470486|NCT03490032|579453135|FG002|Overall Study|family issue (child custody)|0|||
160470487|NCT00308308|579453136|FG000|Overall Study|Adverse Event|17|||
160470488|NCT00308308|579453137|FG001|Overall Study|Adverse Event|2|||
160470489|NCT00308308|579453136|FG000|Overall Study|Lost to Follow-up|5|||
160470490|NCT00308308|579453137|FG001|Overall Study|Lost to Follow-up|5|||
160470491|NCT00308308|579453136|FG000|Overall Study|Physician Decision|15|||
160470492|NCT00308308|579453137|FG001|Overall Study|Physician Decision|7|||
160470493|NCT00308308|579453136|FG000|Overall Study|Protocol Violation|3|||
160470494|NCT00308308|579453137|FG001|Overall Study|Protocol Violation|14|||
160470495|NCT00308308|579453136|FG000|Overall Study|Withdrawal by Subject|47|||
160470496|NCT00308308|579453137|FG001|Overall Study|Withdrawal by Subject|19|||
160470497|NCT00308308|579453136|FG000|Overall Study|Various|7|||
160470498|NCT00308308|579453137|FG001|Overall Study|Various|5|||
160470499|NCT00308308|579453136|FG000|Overall Study|Randomized but not dosed|8|||
160470500|NCT00308308|579453137|FG001|Overall Study|Randomized but not dosed|16|||
160470501|NCT00308308|579453136|FG000|Overall Study|Other|1|||
160470502|NCT00308308|579453137|FG001|Overall Study|Other|0|||
160470503|NCT01852045|579453140|FG000|Overall Study|Adverse Event|1|||
160470504|NCT01852045|579453141|FG001|Overall Study|Adverse Event|0|||
160470505|NCT01852045|579453142|FG002|Overall Study|Adverse Event|0|||
160470506|NCT01852045|579453140|FG000|Overall Study|Lack of Efficacy|3|||
160600281|NCT02954952|579914279|FG002|Overall Study|No data collected|0|||
160600282|NCT02911519|579914280|FG000|Overall Study|Lost to Follow-up|2|||
160600283|NCT02911519|579914281|FG001|Overall Study|Lost to Follow-up|2|||
160600284|NCT02911519|579914280|FG000|Overall Study|Death|0|||
160600285|NCT02911519|579914281|FG001|Overall Study|Death|2|||
160600286|NCT00724815|579914284|FG000|Overall Study|Randomized, not treated|31|||
160600287|NCT00724815|579914285|FG001|Overall Study|Randomized, not treated|30|||
160470507|NCT01852045|579453141|FG001|Overall Study|Lack of Efficacy|0|||
160470508|NCT01852045|579453142|FG002|Overall Study|Lack of Efficacy|0|||
160470509|NCT01852045|579453140|FG000|Overall Study|Lost to Follow-up|0|||
160470510|NCT01852045|579453141|FG001|Overall Study|Lost to Follow-up|1|||
160600288|NCT00724815|579914284|FG000|Overall Study|Adverse Event|5|||
160659479|NCT01044732|580134580|FG001|Overall Study|Inadequate bowel preparation|17|||
160659480|NCT01044732|580134579|FG000|Overall Study|Inability to reach cecum|5|||
160659481|NCT01044732|580134580|FG001|Overall Study|Inability to reach cecum|2|||
160659482|NCT01044732|580134579|FG000|Overall Study|Technical error or malfunction|15|||
160659483|NCT01044732|580134580|FG001|Overall Study|Technical error or malfunction|14|||
160659484|NCT03069937|580134585|FG000|Overall Study|Second primary malignancy noted|1|||
160659485|NCT03144687|580134586|FG000|Overall Study|Death|0|||
160659486|NCT03144687|580134587|FG001|Overall Study|Death|2|||
160659487|NCT03144687|580134586|FG000|Overall Study|Lost to Follow-up|0|||
160659488|NCT03144687|580134587|FG001|Overall Study|Lost to Follow-up|1|||
160659489|NCT03144687|580134586|FG000|Overall Study|Physician Decision|0|||
160659490|NCT03144687|580134587|FG001|Overall Study|Physician Decision|1|||
160659491|NCT03144687|580134586|FG000|Overall Study|Withdrawal by Subject|1|||
160659492|NCT03144687|580134587|FG001|Overall Study|Withdrawal by Subject|3|||
160659493|NCT03144687|580134586|FG000|Overall Study|Not Reported|2|||
160659494|NCT03144687|580134587|FG001|Overall Study|Not Reported|0|||
160659495|NCT00824265|580134590|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
160659496|NCT00824265|580134591|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
160659497|NCT00824265|580134590|FG000|Treatment Phase|Protocol Violation|1|||
160659498|NCT00824265|580134591|FG001|Treatment Phase|Protocol Violation|0|||
160659499|NCT00824265|580134590|FG000|Treatment Phase|Lost to Follow-up|1|||
160659500|NCT00824265|580134591|FG001|Treatment Phase|Lost to Follow-up|1|||
160659501|NCT00824265|580134590|FG000|Treatment Phase|Physician Decision|6|||
160659502|NCT00824265|580134591|FG001|Treatment Phase|Physician Decision|12|||
160659503|NCT00824265|580134590|FG000|Treatment Phase|Withdrawal by Subject|6|||
160659504|NCT00824265|580134591|FG001|Treatment Phase|Withdrawal by Subject|15|||
160659505|NCT00824265|580134590|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
160659506|NCT00824265|580134591|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
160659507|NCT00824265|580134590|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
160659508|NCT00824265|580134591|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
160659509|NCT01411332|580134592|FG000|Enrollment|Protocol Violation|0|||
160659510|NCT01411332|580134593|FG001|Enrollment|Protocol Violation|1|||
160659511|NCT01411332|580134592|FG000|Enrollment|Withdrawal by Subject|0|||
160659512|NCT01411332|580134593|FG001|Enrollment|Withdrawal by Subject|1|||
160659513|NCT01411332|580134592|FG000|Treatment|Lost to Follow-up|1|||
160659514|NCT01411332|580134593|FG001|Treatment|Lost to Follow-up|0|||
160659515|NCT02170688|580134594|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
160659516|NCT02170688|580134595|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
160659517|NCT02170688|580134596|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
160659518|NCT02170688|580134597|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
160659519|NCT02170688|580134598|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
160659520|NCT02170688|580134594|FG000|Overall Study|Full dose not received|0|||
160659521|NCT02170688|580134595|FG001|Overall Study|Full dose not received|1|||
160659522|NCT02170688|580134596|FG002|Overall Study|Full dose not received|0|||
160659523|NCT02170688|580134597|FG003|Overall Study|Full dose not received|0|||
160659524|NCT02170688|580134598|FG004|Overall Study|Full dose not received|0|||
160659525|NCT02170688|580134594|FG000|Overall Study|Physician Decision|0|||
160659526|NCT02170688|580134595|FG001|Overall Study|Physician Decision|0|||
160659527|NCT02170688|580134596|FG002|Overall Study|Physician Decision|1|||
160659528|NCT02170688|580134597|FG003|Overall Study|Physician Decision|0|||
160659529|NCT02170688|580134598|FG004|Overall Study|Physician Decision|0|||
160659530|NCT02920996|580134601|FG000|Overall Study|Adverse Event|8|||
160659531|NCT02920996|580134602|FG001|Overall Study|Adverse Event|0|||
160659532|NCT02920996|580134601|FG000|Overall Study|Physician Decision|1|||
160659533|NCT02920996|580134602|FG001|Overall Study|Physician Decision|0|||
160659534|NCT02920996|580134601|FG000|Overall Study|Death|1|||
160659535|NCT02920996|580134602|FG001|Overall Study|Death|0|||
160659536|NCT02920996|580134601|FG000|Overall Study|Missing|1|||
160659537|NCT02920996|580134602|FG001|Overall Study|Missing|0|||
160659538|NCT02920996|580134601|FG000|Overall Study|Subject Non-Compliance|1|||
160659539|NCT02920996|580134602|FG001|Overall Study|Subject Non-Compliance|0|||
160659540|NCT01402947|580134603|FG000|First Intervention|Adverse Event|0|||
160659541|NCT01402947|580134604|FG001|First Intervention|Adverse Event|1|||
160659542|NCT01471522|580134608|FG000|Overall Study|Withdrawal by Subject|28|||
160659543|NCT01471522|580134609|FG001|Overall Study|Withdrawal by Subject|22|||
160659544|NCT01471522|580134608|FG000|Overall Study|Lost to Follow-up|36|||
160659545|NCT01471522|580134609|FG001|Overall Study|Lost to Follow-up|26|||
160659546|NCT01706926|580134611|FG000|Overall Study|Lost to Follow-up|0|||
160659547|NCT01706926|580134612|FG001|Overall Study|Lost to Follow-up|0|||
160659548|NCT01706926|580134613|FG002|Overall Study|Lost to Follow-up|1|||
160659549|NCT01706926|580134614|FG003|Overall Study|Lost to Follow-up|0|||
160659550|NCT01706926|580134611|FG000|Overall Study|Withdrawal by Subject|2|||
160659551|NCT01706926|580134612|FG001|Overall Study|Withdrawal by Subject|0|||
160659552|NCT01706926|580134613|FG002|Overall Study|Withdrawal by Subject|1|||
160659553|NCT01706926|580134614|FG003|Overall Study|Withdrawal by Subject|2|||
160659554|NCT01706926|580134611|FG000|Overall Study|Other|4|||
160659555|NCT01706926|580134612|FG001|Overall Study|Other|4|||
160600289|NCT00724815|579914285|FG001|Overall Study|Adverse Event|3|||
160600290|NCT00724815|579914284|FG000|Overall Study|Lost to Follow-up|4|||
160600291|NCT00724815|579914285|FG001|Overall Study|Lost to Follow-up|1|||
160600292|NCT00724815|579914284|FG000|Overall Study|Other Various|3|||
160600293|NCT00724815|579914285|FG001|Overall Study|Other Various|5|||
160600294|NCT00810043|579914286|FG000|Overall Study|Withdrawal by Subject|1|||
160470511|NCT01852045|579453142|FG002|Overall Study|Lost to Follow-up|1|||
160470512|NCT01852045|579453140|FG000|Overall Study|Withdrawal by Subject|1|||
160600295|NCT00810043|579914287|FG001|Overall Study|Withdrawal by Subject|0|||
160600296|NCT00810043|579914288|FG002|Overall Study|Withdrawal by Subject|2|||
160600297|NCT00810043|579914286|FG000|Overall Study|Lost to Follow-up|1|||
160600298|NCT00810043|579914287|FG001|Overall Study|Lost to Follow-up|0|||
160600299|NCT00810043|579914288|FG002|Overall Study|Lost to Follow-up|0|||
160600300|NCT00810043|579914286|FG000|Overall Study|Physician Decision|0|||
160600301|NCT00810043|579914287|FG001|Overall Study|Physician Decision|0|||
160600302|NCT00810043|579914288|FG002|Overall Study|Physician Decision|2|||
160600303|NCT00810043|579914286|FG000|Overall Study|Death|2|||
160600304|NCT00810043|579914287|FG001|Overall Study|Death|0|||
160600305|NCT00810043|579914288|FG002|Overall Study|Death|0|||
160600306|NCT00810043|579914286|FG000|Overall Study|Unrelated medical problem|0|||
160600307|NCT00810043|579914287|FG001|Overall Study|Unrelated medical problem|1|||
160600308|NCT00810043|579914288|FG002|Overall Study|Unrelated medical problem|0|||
160600309|NCT00810043|579914286|FG000|Overall Study|Non-medical problem|0|||
160600310|NCT00810043|579914287|FG001|Overall Study|Non-medical problem|0|||
160600311|NCT00810043|579914288|FG002|Overall Study|Non-medical problem|1|||
160600312|NCT00810043|579914286|FG000|Overall Study|No longer met enrollment criteria|0|||
160600313|NCT00810043|579914287|FG001|Overall Study|No longer met enrollment criteria|0|||
160600314|NCT00810043|579914288|FG002|Overall Study|No longer met enrollment criteria|3|||
160600315|NCT03051217|579914292|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
160600316|NCT03051217|579914293|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160600317|NCT03051217|579914294|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
160600318|NCT03051217|579914295|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160600319|NCT03051217|579914296|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160600320|NCT03051217|579914297|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160600321|NCT03051217|579914298|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160600322|NCT03051217|579914292|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
160600323|NCT03051217|579914293|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
160600324|NCT03051217|579914294|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
160600325|NCT03051217|579914295|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
160600326|NCT03051217|579914296|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
160600327|NCT03051217|579914297|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
160600328|NCT03051217|579914298|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
160600329|NCT03051217|579914292|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
160600330|NCT03051217|579914293|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
160600331|NCT03051217|579914294|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
160600332|NCT03051217|579914295|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160600333|NCT03051217|579914296|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160600334|NCT03051217|579914297|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160600335|NCT03051217|579914298|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160600336|NCT03051217|579914292|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
160600337|NCT03051217|579914293|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
160600338|NCT03051217|579914294|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
160600339|NCT03051217|579914295|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
160600340|NCT03051217|579914296|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
160600341|NCT03051217|579914297|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
160600342|NCT03051217|579914298|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
160600343|NCT03051217|579914292|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
160600344|NCT03051217|579914293|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
160600345|NCT03051217|579914294|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
160600346|NCT03051217|579914295|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
160600347|NCT03051217|579914296|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
160600348|NCT03051217|579914297|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
160600349|NCT03051217|579914298|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
160600350|NCT03051217|579914292|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
160600351|NCT03051217|579914293|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
160600352|NCT03051217|579914294|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
160600353|NCT03051217|579914295|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
160600354|NCT03051217|579914296|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
160600355|NCT03051217|579914297|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
160470513|NCT01852045|579453141|FG001|Overall Study|Withdrawal by Subject|0|||
160600356|NCT03051217|579914298|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
160600357|NCT03051217|579914292|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
160600358|NCT03051217|579914293|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
160600359|NCT03051217|579914294|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
160470514|NCT01852045|579453142|FG002|Overall Study|Withdrawal by Subject|1|||
160470515|NCT01852045|579453140|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160470516|NCT01852045|579453141|FG001|Overall Study|Other Miscellaneous Reasons|3|||
160470517|NCT01852045|579453142|FG002|Overall Study|Other Miscellaneous Reasons|2|||
160470518|NCT01951703|579453143|FG000|First Intervention|Withdrawal by Subject|1|||
160470519|NCT01951703|579453144|FG001|First Intervention|Withdrawal by Subject|0|||
160470520|NCT01951703|579453143|FG000|First Intervention|Subject was not compliant|1|||
160470521|NCT01951703|579453144|FG001|First Intervention|Subject was not compliant|1|||
160470522|NCT01951703|579453143|FG000|First Intervention|Physician Decision|1|||
160470523|NCT01951703|579453144|FG001|First Intervention|Physician Decision|0|||
160470524|NCT01951703|579453143|FG000|Second Intervention|Protocol Violation|0|||
160470525|NCT01951703|579453144|FG001|Second Intervention|Protocol Violation|1|||
160470526|NCT01951703|579453143|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
160470527|NCT01951703|579453144|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
160470528|NCT02827201|579453145|FG000|Overall Study|Death|1|||
160470529|NCT02827201|579453146|FG001|Overall Study|Death|2|||
160470530|NCT02827201|579453145|FG000|Overall Study|Patients not treated|1|||
160470531|NCT02827201|579453146|FG001|Overall Study|Patients not treated|1|||
160470532|NCT01021748|579453147|FG000|Overall Study|Adverse Event|2|||
160470533|NCT01021748|579453148|FG001|Overall Study|Adverse Event|1|||
160470534|NCT01021748|579453149|FG002|Overall Study|Adverse Event|2|||
160470535|NCT01021748|579453150|FG003|Overall Study|Adverse Event|0|||
160470536|NCT01021748|579453151|FG004|Overall Study|Adverse Event|2|||
160470537|NCT01021748|579453152|FG005|Overall Study|Adverse Event|0|||
160470538|NCT01021748|579453153|FG006|Overall Study|Adverse Event|1|||
160470539|NCT01021748|579453154|FG007|Overall Study|Adverse Event|0|||
160470540|NCT01021748|579453155|FG008|Overall Study|Adverse Event|7|||
160470541|NCT01021748|579453147|FG000|Overall Study|Physician Decision|1|||
160470542|NCT01021748|579453148|FG001|Overall Study|Physician Decision|0|||
160470543|NCT01021748|579453149|FG002|Overall Study|Physician Decision|1|||
160470544|NCT01021748|579453150|FG003|Overall Study|Physician Decision|1|||
160470545|NCT01021748|579453151|FG004|Overall Study|Physician Decision|0|||
160470546|NCT01021748|579453152|FG005|Overall Study|Physician Decision|0|||
160470547|NCT01021748|579453153|FG006|Overall Study|Physician Decision|1|||
160470548|NCT01021748|579453154|FG007|Overall Study|Physician Decision|1|||
160470549|NCT01021748|579453155|FG008|Overall Study|Physician Decision|2|||
160470550|NCT01021748|579453147|FG000|Overall Study|Progressive Disease|3|||
160470551|NCT01021748|579453148|FG001|Overall Study|Progressive Disease|3|||
160470552|NCT01021748|579453149|FG002|Overall Study|Progressive Disease|4|||
160470553|NCT01021748|579453150|FG003|Overall Study|Progressive Disease|6|||
160470554|NCT01021748|579453151|FG004|Overall Study|Progressive Disease|7|||
160470555|NCT01021748|579453152|FG005|Overall Study|Progressive Disease|3|||
160470556|NCT01021748|579453153|FG006|Overall Study|Progressive Disease|0|||
160470557|NCT01021748|579453154|FG007|Overall Study|Progressive Disease|5|||
160470558|NCT01021748|579453155|FG008|Overall Study|Progressive Disease|6|||
160470559|NCT01021748|579453147|FG000|Overall Study|Withdrawal by Subject|0|||
160470560|NCT01021748|579453148|FG001|Overall Study|Withdrawal by Subject|0|||
160470561|NCT01021748|579453149|FG002|Overall Study|Withdrawal by Subject|0|||
160470562|NCT01021748|579453150|FG003|Overall Study|Withdrawal by Subject|0|||
160470563|NCT01021748|579453151|FG004|Overall Study|Withdrawal by Subject|0|||
160470564|NCT01021748|579453152|FG005|Overall Study|Withdrawal by Subject|0|||
160470565|NCT01021748|579453153|FG006|Overall Study|Withdrawal by Subject|1|||
160470566|NCT01021748|579453154|FG007|Overall Study|Withdrawal by Subject|0|||
160470567|NCT01021748|579453155|FG008|Overall Study|Withdrawal by Subject|1|||
160470568|NCT01021748|579453147|FG000|Overall Study|Not Treated|0|||
160470569|NCT01021748|579453148|FG001|Overall Study|Not Treated|1|||
160470570|NCT01021748|579453149|FG002|Overall Study|Not Treated|0|||
160470571|NCT01021748|579453150|FG003|Overall Study|Not Treated|0|||
160470572|NCT01021748|579453151|FG004|Overall Study|Not Treated|0|||
160470573|NCT01021748|579453152|FG005|Overall Study|Not Treated|0|||
160470574|NCT01021748|579453153|FG006|Overall Study|Not Treated|0|||
160470575|NCT01021748|579453154|FG007|Overall Study|Not Treated|0|||
160470576|NCT01021748|579453155|FG008|Overall Study|Not Treated|0|||
160470577|NCT01640288|579453158|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
160470578|NCT01640288|579453159|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
160470579|NCT01640288|579453158|FG000|Overall Study|Screen Failure|20|||
160470580|NCT01640288|579453159|FG001|Overall Study|Screen Failure|18|||
160470581|NCT01640288|579453158|FG000|Overall Study|Withdrawn by PI|5|||
160470582|NCT01640288|579453159|FG001|Overall Study|Withdrawn by PI|0|||
160470583|NCT01640288|579453158|FG000|Overall Study|Withdrawal by Subject|1|||
160600360|NCT03051217|579914295|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
160600361|NCT03051217|579914296|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
160600362|NCT03051217|579914297|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
160470584|NCT01640288|579453159|FG001|Overall Study|Withdrawal by Subject|0|||
160470585|NCT01485887|579453160|FG000|Overall Study|Withdrawal by Subject|2|||
160659556|NCT01706926|580134613|FG002|Overall Study|Other|4|||
160470586|NCT01485887|579453160|FG000|Overall Study|Adverse Event|8|||
160470587|NCT01485887|579453160|FG000|Overall Study|Deterioration of primary disease|1|||
160470588|NCT01485887|579453160|FG000|Overall Study|Primary disease markedly improved|1|||
160600363|NCT03051217|579914298|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
160600364|NCT03051217|579914292|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
160600365|NCT03051217|579914293|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
160600366|NCT03051217|579914294|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
160600367|NCT03051217|579914295|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
160600368|NCT03051217|579914296|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
160600369|NCT03051217|579914297|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
160600370|NCT03051217|579914298|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
160600371|NCT05507580|579914299|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160600372|NCT05507580|579914300|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
160600373|NCT05507580|579914301|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
160600374|NCT05507580|579914302|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
160600375|NCT05507580|579914303|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
160600376|NCT05507580|579914304|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
160600377|NCT05507580|579914299|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
160600378|NCT05507580|579914300|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160600379|NCT05507580|579914301|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160600380|NCT05507580|579914302|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160600381|NCT05507580|579914303|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160600382|NCT05507580|579914304|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160600383|NCT05507580|579914299|FG000|Double-Blind Treatment Period|Other, not specified|5|||
160600384|NCT05507580|579914300|FG001|Double-Blind Treatment Period|Other, not specified|4|||
160600385|NCT05507580|579914301|FG002|Double-Blind Treatment Period|Other, not specified|0|||
160600386|NCT05507580|579914302|FG003|Double-Blind Treatment Period|Other, not specified|0|||
160600387|NCT05507580|579914303|FG004|Double-Blind Treatment Period|Other, not specified|0|||
160600388|NCT05507580|579914304|FG005|Double-Blind Treatment Period|Other, not specified|0|||
160600389|NCT05507580|579914299|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
160600390|NCT05507580|579914300|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
160600391|NCT05507580|579914301|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
160600392|NCT05507580|579914302|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
160600393|NCT05507580|579914303|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
160600394|NCT05507580|579914304|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
160470589|NCT02234141|579453161|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
160659557|NCT01706926|580134614|FG003|Overall Study|Other|3|||
160470590|NCT02234141|579453162|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
160470591|NCT02234141|579453163|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
160470592|NCT02234141|579453164|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
160470593|NCT02234141|579453165|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
160470594|NCT02234141|579453166|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
160470595|NCT02234141|579453167|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
160470596|NCT02234141|579453161|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
160470597|NCT02234141|579453162|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
160470598|NCT02234141|579453163|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
160470599|NCT02234141|579453164|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
160470600|NCT02234141|579453165|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
160470601|NCT02234141|579453166|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
160470602|NCT02234141|579453167|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
160470603|NCT02234141|579453161|FG000|Treatment Period (24 Weeks)|Death|1|||
160470604|NCT02234141|579453162|FG001|Treatment Period (24 Weeks)|Death|2|||
160470605|NCT02234141|579453163|FG002|Treatment Period (24 Weeks)|Death|0|||
160470606|NCT02234141|579453164|FG003|Treatment Period (24 Weeks)|Death|1|||
160470607|NCT02234141|579453165|FG004|Treatment Period (24 Weeks)|Death|0|||
160470608|NCT02234141|579453166|FG005|Treatment Period (24 Weeks)|Death|0|||
160470609|NCT02234141|579453167|FG006|Treatment Period (24 Weeks)|Death|0|||
160470610|NCT02234141|579453161|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
160470611|NCT02234141|579453162|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
160470612|NCT02234141|579453163|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
160470613|NCT02234141|579453164|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
160470614|NCT02234141|579453165|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
160470615|NCT02234141|579453166|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
160470616|NCT02234141|579453167|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
160470617|NCT02234141|579453161|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
160470618|NCT02234141|579453162|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
160470619|NCT02234141|579453163|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
160470620|NCT02234141|579453164|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
160470621|NCT02234141|579453165|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
160470622|NCT02234141|579453166|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
160470623|NCT02234141|579453167|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
160470624|NCT02234141|579453161|FG000|Long-Term Treatment Period|Death|0|||
160470625|NCT02234141|579453162|FG001|Long-Term Treatment Period|Death|0|||
160470626|NCT02234141|579453163|FG002|Long-Term Treatment Period|Death|0|||
160470627|NCT02234141|579453164|FG003|Long-Term Treatment Period|Death|0|||
160470628|NCT02234141|579453165|FG004|Long-Term Treatment Period|Death|0|||
160470629|NCT02234141|579453166|FG005|Long-Term Treatment Period|Death|1|||
160470630|NCT02234141|579453167|FG006|Long-Term Treatment Period|Death|0|||
160470631|NCT02234141|579453161|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
160470632|NCT02234141|579453162|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
160470633|NCT02234141|579453163|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
160470634|NCT02234141|579453164|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
160470635|NCT02234141|579453165|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
160470636|NCT02234141|579453166|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
160470637|NCT02234141|579453167|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
160470638|NCT02234141|579453161|FG000|Long-Term Treatment Period|Adverse Event|4|||
160470639|NCT02234141|579453162|FG001|Long-Term Treatment Period|Adverse Event|0|||
160470640|NCT02234141|579453163|FG002|Long-Term Treatment Period|Adverse Event|5|||
160470641|NCT02234141|579453164|FG003|Long-Term Treatment Period|Adverse Event|0|||
160470642|NCT02234141|579453165|FG004|Long-Term Treatment Period|Adverse Event|1|||
160470643|NCT02234141|579453166|FG005|Long-Term Treatment Period|Adverse Event|1|||
160470644|NCT02234141|579453167|FG006|Long-Term Treatment Period|Adverse Event|1|||
160470645|NCT02234141|579453161|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
160470646|NCT02234141|579453162|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
160470647|NCT02234141|579453163|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
160470648|NCT02234141|579453164|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
160470649|NCT02234141|579453165|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
160470650|NCT02234141|579453166|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
160470651|NCT02234141|579453167|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
160470652|NCT02234141|579453161|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
160470653|NCT02234141|579453162|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
160600395|NCT05507580|579914299|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
160600396|NCT05507580|579914300|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
160600397|NCT05507580|579914301|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
160600398|NCT05507580|579914302|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
160470654|NCT02234141|579453163|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
160600399|NCT05507580|579914303|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
160600400|NCT05507580|579914304|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
160659558|NCT01215981|580136093|FG000|Overall Study|Physician Decision|0|||
160659559|NCT01215981|580136094|FG001|Overall Study|Physician Decision|1|||
160659560|NCT01215981|580136093|FG000|Overall Study|Protocol Violation|1|||
160659561|NCT01215981|580136094|FG001|Overall Study|Protocol Violation|0|||
160659562|NCT01215981|580136093|FG000|Overall Study|Withdrawal by Subject|1|||
160659563|NCT01215981|580136094|FG001|Overall Study|Withdrawal by Subject|0|||
160659564|NCT03597256|580136095|FG000|Overall Study|Lost to Follow-up|3|||
160659565|NCT03597256|580136096|FG001|Overall Study|Lost to Follow-up|1|||
160659566|NCT03597256|580136095|FG000|Overall Study|Withdrawal by Subject|0|||
160659567|NCT03597256|580136096|FG001|Overall Study|Withdrawal by Subject|1|||
160659568|NCT03597256|580136095|FG000|Overall Study|Could not return for treatment|0|||
160659569|NCT03597256|580136096|FG001|Overall Study|Could not return for treatment|1|||
160659570|NCT03597256|580136095|FG000|Overall Study|Moved from location|0|||
160659571|NCT03597256|580136096|FG001|Overall Study|Moved from location|1|||
160659572|NCT03597256|580136095|FG000|Overall Study|Not accepted the treatment|0|||
160659573|NCT03597256|580136096|FG001|Overall Study|Not accepted the treatment|1|||
160659574|NCT02653664|580136106|FG000|Post-Treatment|Withdrawal by Subject|6|||
160659575|NCT02653664|580136107|FG001|Post-Treatment|Withdrawal by Subject|5|||
160659576|NCT02653664|580136108|FG002|Post-Treatment|Withdrawal by Subject|7|||
160659577|NCT02653664|580136106|FG000|Post-Treatment|Lost to Follow-up|8|||
160659578|NCT02653664|580136107|FG001|Post-Treatment|Lost to Follow-up|1|||
160659579|NCT02653664|580136108|FG002|Post-Treatment|Lost to Follow-up|7|||
160659580|NCT02653664|580136106|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
160659581|NCT02653664|580136107|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
160659582|NCT02653664|580136108|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
160659583|NCT02653664|580136106|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
160659584|NCT02653664|580136107|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
160659585|NCT02653664|580136108|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
160659586|NCT02653664|580136106|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
160659587|NCT02653664|580136107|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
160659588|NCT02653664|580136108|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
160659589|NCT02653664|580136106|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
160659590|NCT02653664|580136107|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
160659591|NCT02653664|580136108|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
160659592|NCT02653664|580136106|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
160659593|NCT02653664|580136107|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
160659594|NCT02653664|580136108|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
160659595|NCT02653664|580136106|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
160659596|NCT02653664|580136107|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
160659597|NCT02653664|580136108|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
160659598|NCT02653664|580136106|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
160659599|NCT02653664|580136107|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
160659600|NCT02653664|580136108|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
160659601|NCT02653664|580136106|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
160659602|NCT02653664|580136107|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
160659603|NCT02653664|580136108|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
160659604|NCT04657770|580136109|FG000|Overall Study|Withdrawal by Subject|3|||
160659605|NCT04657770|580136109|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
160659606|NCT00485472|580136110|FG000|Overall Study|Adverse Event|8|||
160659607|NCT00485472|580136111|FG001|Overall Study|Adverse Event|5|||
160659608|NCT00485472|580136110|FG000|Overall Study|Lack of Efficacy|5|||
160659609|NCT00485472|580136111|FG001|Overall Study|Lack of Efficacy|4|||
160659610|NCT00485472|580136110|FG000|Overall Study|Withdrawal by Subject|1|||
160659611|NCT00485472|580136111|FG001|Overall Study|Withdrawal by Subject|0|||
160659612|NCT00485472|580136110|FG000|Overall Study|Protocol Violation|0|||
160659613|NCT00485472|580136111|FG001|Overall Study|Protocol Violation|1|||
160659614|NCT00485472|580136110|FG000|Overall Study|Other|2|||
160659615|NCT00485472|580136111|FG001|Overall Study|Other|1|||
160659616|NCT00485472|580136110|FG000|Overall Study|Lost to Follow-up|0|||
160659617|NCT00485472|580136111|FG001|Overall Study|Lost to Follow-up|1|||
160659618|NCT00746798|580136112|FG000|Overall Study|Protocol Violation|0|||
160659619|NCT00746798|580136113|FG001|Overall Study|Protocol Violation|1|||
160659620|NCT00746798|580136114|FG002|Overall Study|Protocol Violation|0|||
160470655|NCT02234141|579453164|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
160470656|NCT02234141|579453165|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
160470657|NCT02234141|579453166|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
160600401|NCT05507580|579914299|FG000|Single-Blind Treatment Period|Other, not specified|0|||
160600402|NCT05507580|579914300|FG001|Single-Blind Treatment Period|Other, not specified|0|||
160470658|NCT02234141|579453167|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
160470659|NCT00895245|579453168|FG000|Overall Study|Lack of Efficacy|6|||
160470660|NCT02095678|579453169|FG000|Overall Study|Withdrawal by Subject|0|||
160470661|NCT02095678|579453170|FG001|Overall Study|Withdrawal by Subject|1|||
160470662|NCT02095678|579453169|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
160470663|NCT02095678|579453170|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
160470664|NCT02095678|579453169|FG000|Overall Study|lesion impacted by previous treatment|1|||
160470665|NCT02095678|579453170|FG001|Overall Study|lesion impacted by previous treatment|1|||
160470666|NCT02095678|579453169|FG000|Overall Study|No Confirmed Diagnosis|0|||
160470667|NCT02095678|579453170|FG001|Overall Study|No Confirmed Diagnosis|3|||
160470668|NCT02095678|579453169|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
160470669|NCT02095678|579453170|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
160470670|NCT02095678|579453169|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
160470671|NCT02095678|579453170|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
160470672|NCT03418545|579453171|FG000|Overall Study|Withdrawal by Participant|2|||
160470673|NCT03418545|579453172|FG001|Overall Study|Withdrawal by Participant|4|||
160470674|NCT03418545|579453171|FG000|Overall Study|Lost to Follow-up|3|||
160470675|NCT03418545|579453172|FG001|Overall Study|Lost to Follow-up|5|||
160470676|NCT03418545|579453171|FG000|Overall Study|Reason Not Specified|0|||
160470677|NCT03418545|579453172|FG001|Overall Study|Reason Not Specified|1|||
160470678|NCT03418545|579453171|FG000|Overall Study|Missing Completion Status|0|||
160470679|NCT03418545|579453172|FG001|Overall Study|Missing Completion Status|1|||
160470680|NCT02706483|579453173|FG000|Overall Study|Adverse Event|97|||
160470681|NCT02706483|579453173|FG000|Overall Study|Death|1|||
160470682|NCT02706483|579453173|FG000|Overall Study|Lack of Efficacy|39|||
160470683|NCT02706483|579453173|FG000|Overall Study|Lost to Follow-up|101|||
160470684|NCT02706483|579453173|FG000|Overall Study|Non-compliance with study drug|15|||
160470685|NCT02706483|579453173|FG000|Overall Study|Physician Decision|6|||
160470686|NCT02706483|579453173|FG000|Overall Study|Pregnancy|6|||
160470687|NCT02706483|579453173|FG000|Overall Study|Protocol Violation|18|||
160470688|NCT02706483|579453173|FG000|Overall Study|Withdrawal by Subject|136|||
160470689|NCT02706483|579453173|FG000|Overall Study|Non-compliance with visits|6|||
160470690|NCT02706483|579453173|FG000|Overall Study|Site closure|4|||
160470691|NCT02706483|579453173|FG000|Overall Study|Subject moved|1|||
160470692|NCT04660799|579453174|FG000|Overall Study|Progressive Disease|1|||
160470693|NCT04660799|579453175|FG001|Overall Study|Progressive Disease|1|||
160470694|NCT04660799|579453174|FG000|Overall Study|Death|2|||
160470695|NCT04660799|579453175|FG001|Overall Study|Death|1|||
160470696|NCT04660799|579453174|FG000|Overall Study|Adverse Event|2|||
160470697|NCT04660799|579453175|FG001|Overall Study|Adverse Event|1|||
160470698|NCT04660799|579453174|FG000|Overall Study|Withdrawal by Subject|2|||
160470699|NCT04660799|579453175|FG001|Overall Study|Withdrawal by Subject|5|||
160470700|NCT03131713|579453176|FG000|Overall Study|Lost to Follow-up|5|||
160470701|NCT03131713|579453177|FG001|Overall Study|Lost to Follow-up|0|||
160470702|NCT01972776|579453180|FG000|Part 1|Withdrawal by Subject|0|||
160470703|NCT01972776|579453181|FG001|Part 1|Withdrawal by Subject|0|||
160470704|NCT01972776|579453182|FG002|Part 1|Withdrawal by Subject|1|||
160470705|NCT01972776|579453183|FG003|Part 1|Withdrawal by Subject|0|||
160470706|NCT01972776|579453184|FG004|Part 1|Withdrawal by Subject|0|||
160470707|NCT01972776|579453185|FG005|Part 1|Withdrawal by Subject|0|||
160470708|NCT01972776|579453180|FG000|Part 1|Adverse Event|0|||
160470709|NCT01972776|579453181|FG001|Part 1|Adverse Event|0|||
160470710|NCT01972776|579453182|FG002|Part 1|Adverse Event|1|||
160470711|NCT01972776|579453183|FG003|Part 1|Adverse Event|1|||
160470712|NCT01972776|579453184|FG004|Part 1|Adverse Event|0|||
160470713|NCT01972776|579453185|FG005|Part 1|Adverse Event|0|||
160470714|NCT01972776|579453180|FG000|Part 2|Adverse Event|0|||
160470715|NCT01972776|579453181|FG001|Part 2|Adverse Event|0|||
160470716|NCT01972776|579453182|FG002|Part 2|Adverse Event|0|||
160470717|NCT01972776|579453183|FG003|Part 2|Adverse Event|0|||
160470718|NCT01972776|579453184|FG004|Part 2|Adverse Event|3|||
160470719|NCT01972776|579453185|FG005|Part 2|Adverse Event|0|||
160470720|NCT01972776|579453180|FG000|Part 2|Administrative problems|0|||
160470721|NCT01972776|579453181|FG001|Part 2|Administrative problems|0|||
160470722|NCT01972776|579453182|FG002|Part 2|Administrative problems|0|||
160470723|NCT01972776|579453183|FG003|Part 2|Administrative problems|0|||
160470724|NCT01972776|579453184|FG004|Part 2|Administrative problems|10|||
160600403|NCT05507580|579914301|FG002|Single-Blind Treatment Period|Other, not specified|2|||
160470725|NCT01972776|579453185|FG005|Part 2|Administrative problems|7|||
160470726|NCT01228734|579453189|FG000|Overall Study|Randomized, but not treated|0|||
160600404|NCT05507580|579914302|FG003|Single-Blind Treatment Period|Other, not specified|7|||
160470727|NCT01228734|579453190|FG001|Overall Study|Randomized, but not treated|4|||
160470728|NCT02382640|579453194|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
160600405|NCT05507580|579914303|FG004|Single-Blind Treatment Period|Other, not specified|3|||
160470729|NCT02382640|579453195|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
160600406|NCT05507580|579914304|FG005|Single-Blind Treatment Period|Other, not specified|5|||
160470730|NCT02382640|579453196|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
160600407|NCT00615914|579914307|FG000|Overall Study|Adverse Event|274|||
160600408|NCT00615914|579914307|FG000|Overall Study|Death|20|||
160600409|NCT00615914|579914307|FG000|Overall Study|Lack of Efficacy|59|||
160600410|NCT00615914|579914307|FG000|Overall Study|Lost to Follow-up|187|||
160600411|NCT00615914|579914307|FG000|Overall Study|Withdrawal by Subject|16|||
160600412|NCT00615914|579914307|FG000|Overall Study|Physician Decision|4|||
160600413|NCT00615914|579914307|FG000|Overall Study|No data was collected.|65|||
160600414|NCT00615914|579914307|FG000|Overall Study|No treatment|2|||
160600415|NCT00615914|579914307|FG000|Overall Study|Irregularly enrolled patients|10|||
160600416|NCT03673956|579914308|FG000|Overall Study|Lost to Follow-up|1|||
160600417|NCT03673956|579914309|FG001|Overall Study|Lost to Follow-up|0|||
160600418|NCT03673956|579914310|FG002|Overall Study|Lost to Follow-up|0|||
160600419|NCT03673956|579914311|FG003|Overall Study|Lost to Follow-up|0|||
160600420|NCT03673956|579914308|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
160600421|NCT03673956|579914309|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
160600422|NCT03673956|579914310|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
160600423|NCT03673956|579914311|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
160600424|NCT03037307|579914314|FG000|Period 1|Did Not Meet Study Criteria|0|||
160600425|NCT03037307|579914315|FG001|Period 1|Did Not Meet Study Criteria|0|||
160600426|NCT03037307|579914316|FG002|Period 1|Did Not Meet Study Criteria|0|||
160600427|NCT03037307|579914317|FG003|Period 1|Did Not Meet Study Criteria|1|||
160600428|NCT03037307|579914318|FG004|Period 1|Did Not Meet Study Criteria|0|||
160600429|NCT03037307|579914319|FG005|Period 1|Did Not Meet Study Criteria|0|||
160600430|NCT01855945|579914320|FG000|Overall Study|Adverse Event|0|||
160600431|NCT01855945|579914321|FG001|Overall Study|Adverse Event|0|||
160600432|NCT01855945|579914322|FG002|Overall Study|Adverse Event|0|||
160600433|NCT01855945|579914323|FG003|Overall Study|Adverse Event|0|||
160600434|NCT01855945|579914324|FG004|Overall Study|Adverse Event|0|||
160600435|NCT01855945|579914325|FG005|Overall Study|Adverse Event|0|||
160600436|NCT01855945|579914326|FG006|Overall Study|Adverse Event|1|||
160600437|NCT01855945|579914327|FG007|Overall Study|Adverse Event|0|||
160600438|NCT01855945|579914328|FG008|Overall Study|Adverse Event|0|||
160600439|NCT01855945|579914329|FG009|Overall Study|Adverse Event|0|||
160600440|NCT01855945|579914330|FG010|Overall Study|Adverse Event|0|||
160600441|NCT01855945|579914331|FG011|Overall Study|Adverse Event|0|||
160600442|NCT01855945|579914320|FG000|Overall Study|Death|0|||
160600443|NCT01855945|579914321|FG001|Overall Study|Death|0|||
160600444|NCT01855945|579914322|FG002|Overall Study|Death|0|||
160600445|NCT01855945|579914323|FG003|Overall Study|Death|0|||
160600446|NCT01855945|579914324|FG004|Overall Study|Death|0|||
160600447|NCT01855945|579914325|FG005|Overall Study|Death|0|||
160600448|NCT01855945|579914326|FG006|Overall Study|Death|2|||
160600449|NCT01855945|579914327|FG007|Overall Study|Death|0|||
160600450|NCT01855945|579914328|FG008|Overall Study|Death|0|||
160600451|NCT01855945|579914329|FG009|Overall Study|Death|0|||
160600452|NCT01855945|579914330|FG010|Overall Study|Death|0|||
160600453|NCT01855945|579914331|FG011|Overall Study|Death|0|||
160659621|NCT00746798|580136115|FG003|Overall Study|Protocol Violation|0|||
160470731|NCT02382640|579453197|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
160600454|NCT01855945|579914320|FG000|Overall Study|Lost to Follow-up|11|||
160600455|NCT01855945|579914321|FG001|Overall Study|Lost to Follow-up|10|||
160659622|NCT00746798|580136112|FG000|Overall Study|Withdrawal by Subject|0|||
160600456|NCT01855945|579914322|FG002|Overall Study|Lost to Follow-up|7|||
160600457|NCT01855945|579914323|FG003|Overall Study|Lost to Follow-up|3|||
160600458|NCT01855945|579914324|FG004|Overall Study|Lost to Follow-up|0|||
160600459|NCT01855945|579914325|FG005|Overall Study|Lost to Follow-up|3|||
160600460|NCT01855945|579914326|FG006|Overall Study|Lost to Follow-up|4|||
160470732|NCT01220999|579453198|FG000|Overall Study|Progressive disease|0|||
160470733|NCT01220999|579453199|FG001|Overall Study|Progressive disease|0|||
160470734|NCT01220999|579453200|FG002|Overall Study|Progressive disease|1|||
160470735|NCT01220999|579453201|FG003|Overall Study|Progressive disease|0|||
160470736|NCT01220999|579453202|FG004|Overall Study|Progressive disease|0|||
160470737|NCT01560429|579453205|FG000|Overall Study|Protocol Violation|3|||
160470738|NCT01560429|579453206|FG001|Overall Study|Protocol Violation|6|||
160470739|NCT02449902|579453207|FG000|Overall Study|Adverse Event|0|||
160470740|NCT02449902|579453208|FG001|Overall Study|Adverse Event|1|||
160470741|NCT02449902|579453207|FG000|Overall Study|Withdrawal by Subject|0|||
160470742|NCT02449902|579453208|FG001|Overall Study|Withdrawal by Subject|1|||
160470743|NCT01365546|579453209|FG000|Overall Study|Withdrawal by Subject|1|||
160470744|NCT01365546|579453209|FG000|Overall Study|Screen failure|9|||
160470745|NCT01365546|579453209|FG000|Overall Study|Study termination|1|||
160470746|NCT03326856|579453210|FG000|Overall Study|Lost to Follow-up|1|||
160470747|NCT03326856|579453211|FG001|Overall Study|Lost to Follow-up|1|||
160470748|NCT03326856|579453212|FG002|Overall Study|Lost to Follow-up|0|||
160470749|NCT03326856|579453213|FG003|Overall Study|Lost to Follow-up|0|||
160470750|NCT03326856|579453214|FG004|Overall Study|Lost to Follow-up|0|||
160470751|NCT03162614|579453215|FG000|Overall Study|Lost to Follow-up|2|||
160470752|NCT03162614|579453216|FG001|Overall Study|Lost to Follow-up|1|||
160470753|NCT03162614|579453217|FG002|Overall Study|Lost to Follow-up|1|||
160470754|NCT03162614|579453218|FG003|Overall Study|Lost to Follow-up|1|||
160470755|NCT03162614|579453219|FG004|Overall Study|Lost to Follow-up|2|||
160470756|NCT03162614|579453220|FG005|Overall Study|Lost to Follow-up|0|||
160470757|NCT03162614|579453215|FG000|Overall Study|Protocol Violation|0|||
160470758|NCT03162614|579453216|FG001|Overall Study|Protocol Violation|1|||
160470759|NCT03162614|579453217|FG002|Overall Study|Protocol Violation|0|||
160470760|NCT03162614|579453218|FG003|Overall Study|Protocol Violation|1|||
160470761|NCT03162614|579453219|FG004|Overall Study|Protocol Violation|0|||
160470762|NCT03162614|579453220|FG005|Overall Study|Protocol Violation|0|||
160470763|NCT03162614|579453215|FG000|Overall Study|Withdrawal by Subject|2|||
160470764|NCT03162614|579453216|FG001|Overall Study|Withdrawal by Subject|1|||
160470765|NCT03162614|579453217|FG002|Overall Study|Withdrawal by Subject|1|||
160470766|NCT03162614|579453218|FG003|Overall Study|Withdrawal by Subject|1|||
160470767|NCT03162614|579453219|FG004|Overall Study|Withdrawal by Subject|0|||
160470768|NCT03162614|579453220|FG005|Overall Study|Withdrawal by Subject|0|||
160600461|NCT01855945|579914327|FG007|Overall Study|Lost to Follow-up|7|||
160600462|NCT01855945|579914328|FG008|Overall Study|Lost to Follow-up|2|||
160600463|NCT01855945|579914329|FG009|Overall Study|Lost to Follow-up|0|||
160600464|NCT01855945|579914330|FG010|Overall Study|Lost to Follow-up|0|||
160600465|NCT01855945|579914331|FG011|Overall Study|Lost to Follow-up|2|||
160600466|NCT01855945|579914320|FG000|Overall Study|Other - Unclassified|1|||
160600467|NCT01855945|579914321|FG001|Overall Study|Other - Unclassified|1|||
160659623|NCT00746798|580136113|FG001|Overall Study|Withdrawal by Subject|1|||
160470769|NCT03162614|579453215|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
160600468|NCT01855945|579914322|FG002|Overall Study|Other - Unclassified|1|||
160600469|NCT01855945|579914323|FG003|Overall Study|Other - Unclassified|0|||
160600470|NCT01855945|579914324|FG004|Overall Study|Other - Unclassified|0|||
160470770|NCT03162614|579453216|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
160470771|NCT03162614|579453217|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
160470772|NCT03162614|579453218|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
160470773|NCT03162614|579453219|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
160600471|NCT01855945|579914325|FG005|Overall Study|Other - Unclassified|0|||
160600472|NCT01855945|579914326|FG006|Overall Study|Other - Unclassified|2|||
160600473|NCT01855945|579914327|FG007|Overall Study|Other - Unclassified|1|||
160470774|NCT03162614|579453220|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
160659624|NCT00746798|580136114|FG002|Overall Study|Withdrawal by Subject|1|||
160470775|NCT03861234|579453221|FG000|Overall Study|Not treated|0|||
160470776|NCT03861234|579453222|FG001|Overall Study|Not treated|0|||
160470777|NCT03861234|579453223|FG002|Overall Study|Not treated|0|||
160470778|NCT03861234|579453224|FG003|Overall Study|Not treated|0|||
160470779|NCT03861234|579453225|FG004|Overall Study|Not treated|0|||
160600474|NCT01855945|579914328|FG008|Overall Study|Other - Unclassified|0|||
160600475|NCT01855945|579914329|FG009|Overall Study|Other - Unclassified|0|||
160470780|NCT03861234|579453226|FG005|Overall Study|Not treated|1|||
160470781|NCT03861234|579453227|FG006|Overall Study|Not treated|0|||
160470782|NCT03861234|579453228|FG007|Overall Study|Not treated|0|||
160470783|NCT03861234|579453221|FG000|Overall Study|Adverse Event|0|||
160470784|NCT03861234|579453222|FG001|Overall Study|Adverse Event|0|||
160470785|NCT03861234|579453223|FG002|Overall Study|Adverse Event|0|||
160470786|NCT03861234|579453224|FG003|Overall Study|Adverse Event|0|||
160470787|NCT03861234|579453225|FG004|Overall Study|Adverse Event|0|||
160470788|NCT03861234|579453226|FG005|Overall Study|Adverse Event|1|||
160470789|NCT03861234|579453227|FG006|Overall Study|Adverse Event|0|||
160470790|NCT03861234|579453228|FG007|Overall Study|Adverse Event|0|||
160470791|NCT03861234|579453221|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
160470792|NCT03861234|579453222|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
160470793|NCT03861234|579453223|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
160470794|NCT03861234|579453224|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
160470795|NCT03861234|579453225|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
160470796|NCT03861234|579453226|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
160470797|NCT03861234|579453227|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
160470798|NCT03861234|579453228|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
160470799|NCT03861234|579453221|FG000|Overall Study|As per sponsor decision|0|||
160470800|NCT03861234|579453222|FG001|Overall Study|As per sponsor decision|0|||
160470801|NCT03861234|579453223|FG002|Overall Study|As per sponsor decision|0|||
160470802|NCT03861234|579453224|FG003|Overall Study|As per sponsor decision|0|||
160470803|NCT03861234|579453225|FG004|Overall Study|As per sponsor decision|0|||
160470804|NCT03861234|579453226|FG005|Overall Study|As per sponsor decision|0|||
160470805|NCT03861234|579453227|FG006|Overall Study|As per sponsor decision|1|||
160470806|NCT03861234|579453228|FG007|Overall Study|As per sponsor decision|0|||
160470807|NCT03861234|579453221|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
160470808|NCT03861234|579453222|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
160470809|NCT03861234|579453223|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
160470810|NCT03861234|579453224|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
160470811|NCT03861234|579453225|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
160470812|NCT03861234|579453226|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
160470813|NCT03861234|579453227|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
160470814|NCT03861234|579453228|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
160470815|NCT00621842|579453229|FG000|Overall Study|Adverse Event|6|||
160470816|NCT00621842|579453229|FG000|Overall Study|Withdrawal by Subject|7|||
160470817|NCT00621842|579453229|FG000|Overall Study|Protocol Violation|4|||
160470818|NCT00621842|579453229|FG000|Overall Study|Lack of Efficacy|2|||
160470819|NCT01074242|579453232|FG000|Overall Study|Case report before date of contract|40|||
160470820|NCT01074242|579453232|FG000|Overall Study|Lost to Follow-up|1|||
160470821|NCT01074242|579453232|FG000|Overall Study|Case report unclear|6|||
160470822|NCT01074242|579453232|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
160470823|NCT01074242|579453232|FG000|Overall Study|Duplicate Case Report Form|5|||
160470824|NCT01957163|579453233|FG000|Overall Study|Adverse Event|5|||
160470825|NCT01957163|579453234|FG001|Overall Study|Adverse Event|2|||
160470826|NCT01957163|579453235|FG002|Overall Study|Adverse Event|4|||
160470827|NCT01957163|579453233|FG000|Overall Study|Lack of Efficacy|5|||
160470828|NCT01957163|579453234|FG001|Overall Study|Lack of Efficacy|4|||
160470829|NCT01957163|579453235|FG002|Overall Study|Lack of Efficacy|9|||
160470830|NCT01957163|579453233|FG000|Overall Study|Protocol Violation|1|||
160470831|NCT01957163|579453234|FG001|Overall Study|Protocol Violation|2|||
160470832|NCT01957163|579453235|FG002|Overall Study|Protocol Violation|0|||
160470833|NCT01957163|579453233|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
160470834|NCT01957163|579453234|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
160470835|NCT01957163|579453235|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
160470836|NCT01957163|579453233|FG000|Overall Study|Lost to Follow-up|0|||
160470837|NCT01957163|579453234|FG001|Overall Study|Lost to Follow-up|1|||
160470838|NCT01957163|579453235|FG002|Overall Study|Lost to Follow-up|0|||
160470839|NCT01957163|579453233|FG000|Overall Study|Withdrawal by Subject|4|||
160470840|NCT01957163|579453234|FG001|Overall Study|Withdrawal by Subject|2|||
160470841|NCT01957163|579453235|FG002|Overall Study|Withdrawal by Subject|4|||
160470842|NCT03539055|579453236|FG000|Overall Study|Death|4|||
160470843|NCT03539055|579453236|FG000|Overall Study|Lost to Follow-up|1|||
160659625|NCT00746798|580136115|FG003|Overall Study|Withdrawal by Subject|0|||
160659626|NCT00746798|580136112|FG000|Overall Study|Death|0|||
160659627|NCT00746798|580136113|FG001|Overall Study|Death|0|||
160659628|NCT00746798|580136114|FG002|Overall Study|Death|2|||
160470844|NCT03539055|579453236|FG000|Overall Study|Withdrawal by Subject|2|||
160470845|NCT03539055|579453236|FG000|Overall Study|Screen Fail|7|||
160470846|NCT03539055|579453236|FG000|Overall Study|Drug Intolerance|2|||
160470847|NCT01638000|579453238|FG000|Overall Study|Randomized but Never Received Drug|7|||
160470848|NCT01638000|579453239|FG001|Overall Study|Randomized but Never Received Drug|10|||
160470849|NCT01638000|579453238|FG000|Overall Study|Adverse Event|14|||
160470850|NCT01638000|579453239|FG001|Overall Study|Adverse Event|16|||
160600476|NCT01855945|579914330|FG010|Overall Study|Other - Unclassified|1|||
160470851|NCT01638000|579453238|FG000|Overall Study|Lack of Efficacy|5|||
160470852|NCT01638000|579453239|FG001|Overall Study|Lack of Efficacy|6|||
160470853|NCT01638000|579453238|FG000|Overall Study|Protocol Violation|11|||
160470854|NCT01638000|579453239|FG001|Overall Study|Protocol Violation|13|||
160470855|NCT01638000|579453238|FG000|Overall Study|Withdrawal by Subject|21|||
160470856|NCT01638000|579453239|FG001|Overall Study|Withdrawal by Subject|24|||
160470857|NCT01638000|579453238|FG000|Overall Study|Miscellaneous|2|||
160470858|NCT01638000|579453239|FG001|Overall Study|Miscellaneous|2|||
160470859|NCT00875706|579453240|FG000|Overall Study|Withdrawal by Subject|1|||
160470860|NCT00875706|579453241|FG001|Overall Study|Withdrawal by Subject|0|||
160470861|NCT00875706|579453242|FG002|Overall Study|Withdrawal by Subject|0|||
160470862|NCT03775213|579453243|FG000|Overall Study|Withdrawal by Subject|51|||
160470863|NCT03775213|579453244|FG001|Overall Study|Withdrawal by Subject|53|||
160470864|NCT03775213|579453243|FG000|Overall Study|Incomplete Survey|7|||
160470865|NCT03775213|579453244|FG001|Overall Study|Incomplete Survey|7|||
160470866|NCT00786188|579453245|FG000|Overall Study|Adverse Event|3|||
160470867|NCT00786188|579453246|FG001|Overall Study|Adverse Event|1|||
160470868|NCT00786188|579453245|FG000|Overall Study|Withdrawal by Subject|2|||
160470869|NCT00786188|579453246|FG001|Overall Study|Withdrawal by Subject|0|||
160470870|NCT00326183|579453247|FG000|Overall Study|Lost to Follow-up|104|||
160470871|NCT00326183|579453248|FG001|Overall Study|Lost to Follow-up|56|||
160470872|NCT00326183|579453247|FG000|Overall Study|Protocol Violation|6|||
160470873|NCT00326183|579453248|FG001|Overall Study|Protocol Violation|3|||
160470874|NCT00326183|579453247|FG000|Overall Study|Withdrawal by Subject|35|||
160470875|NCT00326183|579453248|FG001|Overall Study|Withdrawal by Subject|7|||
160470876|NCT00326183|579453247|FG000|Overall Study|Subject Moved|7|||
160470877|NCT00326183|579453248|FG001|Overall Study|Subject Moved|4|||
160600477|NCT01855945|579914331|FG011|Overall Study|Other - Unclassified|0|||
160470878|NCT00326183|579453247|FG000|Overall Study|Other|47|||
160470879|NCT00326183|579453248|FG001|Overall Study|Other|13|||
160470880|NCT00326183|579453247|FG000|Overall Study|Adverse Event|1|||
160470881|NCT00326183|579453248|FG001|Overall Study|Adverse Event|0|||
160470882|NCT01827839|579453252|FG000|Overall Study|Adverse Event|1|||
160470883|NCT01827839|579453252|FG000|Overall Study|Consent Withdrawal|2|||
160470884|NCT00570505|579453253|FG000|Overall Study|Adverse Event|7|||
160470885|NCT00570505|579453253|FG000|Overall Study|Withdrawal by Subject|7|||
160470886|NCT00570505|579453253|FG000|Overall Study|Lost to Follow-up|23|||
160470887|NCT00570505|579453253|FG000|Overall Study|Other loss to follow-up|4|||
160470888|NCT00614614|579453254|FG000|Primary Vaccination Phase|Adverse Event|6|||
160470889|NCT00614614|579453255|FG001|Primary Vaccination Phase|Adverse Event|0|||
160470890|NCT00614614|579453256|FG002|Primary Vaccination Phase|Adverse Event|0|||
160470891|NCT00614614|579453257|FG003|Primary Vaccination Phase|Adverse Event|0|||
160470892|NCT00614614|579453258|FG004|Primary Vaccination Phase|Adverse Event|0|||
160470893|NCT00614614|579453254|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
160470894|NCT00614614|579453255|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
160470895|NCT00614614|579453256|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
160470896|NCT00614614|579453257|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
160600478|NCT01855945|579914320|FG000|Overall Study|Withdrawal by Subject|4|||
160600479|NCT01855945|579914321|FG001|Overall Study|Withdrawal by Subject|0|||
160600480|NCT01855945|579914322|FG002|Overall Study|Withdrawal by Subject|4|||
160600481|NCT01855945|579914323|FG003|Overall Study|Withdrawal by Subject|1|||
160600482|NCT01855945|579914324|FG004|Overall Study|Withdrawal by Subject|1|||
160600483|NCT01855945|579914325|FG005|Overall Study|Withdrawal by Subject|0|||
160600484|NCT01855945|579914326|FG006|Overall Study|Withdrawal by Subject|1|||
160600485|NCT01855945|579914327|FG007|Overall Study|Withdrawal by Subject|0|||
160600486|NCT01855945|579914328|FG008|Overall Study|Withdrawal by Subject|0|||
160600487|NCT01855945|579914329|FG009|Overall Study|Withdrawal by Subject|2|||
160600488|NCT01855945|579914330|FG010|Overall Study|Withdrawal by Subject|4|||
160600489|NCT01855945|579914331|FG011|Overall Study|Withdrawal by Subject|1|||
160600490|NCT02156804|579914336|FG000|Overall Study|Withdrawal by Subject|1|||
160600491|NCT02443805|579914339|FG000|Overall Study|Adverse Event|100|||
160600492|NCT02443805|579914340|FG001|Overall Study|Adverse Event|18|||
160600493|NCT02443805|579914339|FG000|Overall Study|Withdrawal by Subject|73|||
160600494|NCT02443805|579914340|FG001|Overall Study|Withdrawal by Subject|74|||
160600495|NCT02443805|579914339|FG000|Overall Study|Lost to Follow-up|19|||
160600496|NCT02443805|579914340|FG001|Overall Study|Lost to Follow-up|14|||
160600497|NCT02443805|579914339|FG000|Overall Study|Pregnancy|6|||
160600498|NCT02443805|579914340|FG001|Overall Study|Pregnancy|5|||
160600499|NCT02443805|579914339|FG000|Overall Study|Protocol Violation|2|||
160600500|NCT02443805|579914340|FG001|Overall Study|Protocol Violation|4|||
160600501|NCT02443805|579914339|FG000|Overall Study|Lack of Efficacy|1|||
160600502|NCT02443805|579914340|FG001|Overall Study|Lack of Efficacy|1|||
160600503|NCT02443805|579914339|FG000|Overall Study|Non-compliance with study drug|6|||
160600504|NCT02443805|579914340|FG001|Overall Study|Non-compliance with study drug|4|||
160600505|NCT02443805|579914339|FG000|Overall Study|Withdrawal by parent/guardian|3|||
160600506|NCT02443805|579914340|FG001|Overall Study|Withdrawal by parent/guardian|5|||
160600507|NCT02443805|579914339|FG000|Overall Study|Any other reason not above-mentioned|3|||
160600508|NCT02443805|579914340|FG001|Overall Study|Any other reason not above-mentioned|2|||
160600509|NCT00961116|579914341|FG000|Washout Period of 7 Days|Adverse Event|1|||
160600510|NCT00961116|579914342|FG001|Washout Period of 7 Days|Adverse Event|1|||
160600511|NCT00961116|579914341|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
160600512|NCT00961116|579914342|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
160600513|NCT00961116|579914341|FG000|Washout Period of 7 Days|Protocol Violation|0|||
160600514|NCT00961116|579914342|FG001|Washout Period of 7 Days|Protocol Violation|1|||
160600515|NCT02708966|579914343|FG000|Overall Study|Lost to Follow-up|2|||
160600516|NCT02708966|579914344|FG001|Overall Study|Lost to Follow-up|2|||
160600517|NCT00389441|579914345|FG000|Overall Study|Adverse Event|7|||
160470897|NCT00614614|579453258|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
160470898|NCT00614614|579453254|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
160600518|NCT00389441|579914345|FG000|Overall Study|Death|4|||
160600519|NCT00389441|579914345|FG000|Overall Study|Lost to Follow-up|2|||
160600520|NCT00389441|579914345|FG000|Overall Study|Withdrawal by Subject|4|||
160600521|NCT00389441|579914345|FG000|Overall Study|Physician Decision|1|||
160600522|NCT00389441|579914345|FG000|Overall Study|Protocol Violation|1|||
160600523|NCT00389441|579914345|FG000|Overall Study|Global deterioration of health status|4|||
160600524|NCT00389441|579914345|FG000|Overall Study|Objective progression or relapse|26|||
160470899|NCT00614614|579453255|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
160470900|NCT00614614|579453256|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
160600525|NCT00389441|579914345|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
160600526|NCT00389441|579914345|FG000|Overall Study|Clinical progression|1|||
160600527|NCT01981109|579914346|FG000|Overall Study|Death|36|||
160600528|NCT01981109|579914346|FG000|Overall Study|Withdrawal by Subject|40|||
160600529|NCT01981109|579914346|FG000|Overall Study|Lost to Follow-up|9|||
160600530|NCT01981109|579914346|FG000|Overall Study|No Discontinuation Documentation|37|||
160600531|NCT01981109|579914346|FG000|Overall Study|Study Termination|100|||
160600532|NCT01981109|579914346|FG000|Overall Study|No data available|2|||
160600533|NCT00105560|579914348|FG000|Overall Study|Lost to Follow-up|1|||
160600534|NCT02559713|579914350|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
160600535|NCT02193828|579914353|FG000|Overall Study|Withdrawal by Subject|0|||
160470901|NCT00614614|579453257|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
160470902|NCT00614614|579453258|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
160470903|NCT00614614|579453254|FG000|Primary Vaccination Phase|Protocol Violation|9|||
160470904|NCT00614614|579453255|FG001|Primary Vaccination Phase|Protocol Violation|3|||
160470905|NCT00614614|579453256|FG002|Primary Vaccination Phase|Protocol Violation|0|||
160470906|NCT00614614|579453257|FG003|Primary Vaccination Phase|Protocol Violation|0|||
160470907|NCT00614614|579453258|FG004|Primary Vaccination Phase|Protocol Violation|0|||
160470908|NCT00614614|579453254|FG000|Primary Vaccination Phase|Other|4|||
160470909|NCT00614614|579453255|FG001|Primary Vaccination Phase|Other|0|||
160470910|NCT00614614|579453256|FG002|Primary Vaccination Phase|Other|0|||
160470911|NCT00614614|579453257|FG003|Primary Vaccination Phase|Other|0|||
160470912|NCT00614614|579453258|FG004|Primary Vaccination Phase|Other|0|||
160470913|NCT00614614|579453254|FG000|Booster Vaccination Phase|Adverse Event|0|||
160470914|NCT00614614|579453255|FG001|Booster Vaccination Phase|Adverse Event|0|||
160470915|NCT00614614|579453256|FG002|Booster Vaccination Phase|Adverse Event|1|||
160470916|NCT00614614|579453257|FG003|Booster Vaccination Phase|Adverse Event|1|||
160470917|NCT00614614|579453258|FG004|Booster Vaccination Phase|Adverse Event|0|||
160470918|NCT00614614|579453254|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
160470919|NCT00614614|579453255|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
160470920|NCT00614614|579453256|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
160470921|NCT00614614|579453257|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
160470922|NCT00614614|579453258|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
160470923|NCT00614614|579453254|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
160470924|NCT00614614|579453255|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
160470925|NCT00614614|579453256|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
160470926|NCT00614614|579453257|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
160470927|NCT00614614|579453258|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
160470928|NCT00614614|579453254|FG000|Booster Vaccination Phase|Protocol Violation|0|||
160470929|NCT00614614|579453255|FG001|Booster Vaccination Phase|Protocol Violation|0|||
160470930|NCT00614614|579453256|FG002|Booster Vaccination Phase|Protocol Violation|2|||
160470931|NCT00614614|579453257|FG003|Booster Vaccination Phase|Protocol Violation|3|||
160600536|NCT02193828|579914354|FG001|Overall Study|Withdrawal by Subject|0|||
160600537|NCT02193828|579914355|FG002|Overall Study|Withdrawal by Subject|1|||
160600538|NCT02193828|579914356|FG003|Overall Study|Withdrawal by Subject|1|||
160600539|NCT00871572|579914357|FG000|Overall Study|Adverse Event|0|||
160600540|NCT00871572|579914358|FG001|Overall Study|Adverse Event|2|||
160600541|NCT00871572|579914359|FG002|Overall Study|Adverse Event|0|||
160600542|NCT00871572|579914360|FG003|Overall Study|Adverse Event|3|||
160600543|NCT00871572|579914357|FG000|Overall Study|Investigator Decision|0|||
160600544|NCT00871572|579914358|FG001|Overall Study|Investigator Decision|1|||
160600545|NCT00871572|579914359|FG002|Overall Study|Investigator Decision|0|||
160600546|NCT00871572|579914360|FG003|Overall Study|Investigator Decision|1|||
160600547|NCT00871572|579914357|FG000|Overall Study|Lost to Follow-up|0|||
160600548|NCT00871572|579914358|FG001|Overall Study|Lost to Follow-up|1|||
160600549|NCT00871572|579914359|FG002|Overall Study|Lost to Follow-up|0|||
160659629|NCT00746798|580136115|FG003|Overall Study|Death|0|||
160470932|NCT00614614|579453258|FG004|Booster Vaccination Phase|Protocol Violation|0|||
160470933|NCT00614614|579453254|FG000|Booster Vaccination Phase|Other|0|||
160470934|NCT00614614|579453255|FG001|Booster Vaccination Phase|Other|1|||
160470935|NCT00614614|579453256|FG002|Booster Vaccination Phase|Other|3|||
160470936|NCT00614614|579453257|FG003|Booster Vaccination Phase|Other|2|||
160470937|NCT00614614|579453258|FG004|Booster Vaccination Phase|Other|1|||
160470938|NCT05426109|579453259|FG000|Overall Study|Withdrawal by Subject|0|||
160470939|NCT05426109|579453260|FG001|Overall Study|Withdrawal by Subject|1|||
160600550|NCT00871572|579914360|FG003|Overall Study|Lost to Follow-up|1|||
160600551|NCT00871572|579914357|FG000|Overall Study|Protocol Violation|0|||
160600552|NCT00871572|579914358|FG001|Overall Study|Protocol Violation|0|||
160470940|NCT05212285|579453261|FG000|Overall Study|Lack of Efficacy|12|||
160470941|NCT05212285|579453262|FG001|Overall Study|Lack of Efficacy|8|||
160470942|NCT05212285|579453261|FG000|Overall Study|Withdrawal by Subject|8|||
160470943|NCT05212285|579453262|FG001|Overall Study|Withdrawal by Subject|1|||
160470944|NCT05212285|579453261|FG000|Overall Study|Lost to Follow-up|13|||
160470945|NCT05212285|579453262|FG001|Overall Study|Lost to Follow-up|1|||
160470946|NCT05212285|579453261|FG000|Overall Study|miss data|21|||
160470947|NCT05212285|579453262|FG001|Overall Study|miss data|2|||
160470948|NCT01000805|579453263|FG000|Overall Study|Adverse Event|21|||
160470949|NCT01000805|579453264|FG001|Overall Study|Adverse Event|9|||
160470950|NCT01000805|579453263|FG000|Overall Study|Lack of Efficacy|5|||
160470951|NCT01000805|579453264|FG001|Overall Study|Lack of Efficacy|16|||
160470952|NCT01000805|579453263|FG000|Overall Study|Lost to Follow-up|16|||
160470953|NCT01000805|579453264|FG001|Overall Study|Lost to Follow-up|21|||
160470954|NCT01000805|579453263|FG000|Overall Study|Physician Decision|0|||
160470955|NCT01000805|579453264|FG001|Overall Study|Physician Decision|1|||
160470956|NCT01000805|579453263|FG000|Overall Study|Protocol Violation|12|||
160470957|NCT01000805|579453264|FG001|Overall Study|Protocol Violation|8|||
160470958|NCT01000805|579453263|FG000|Overall Study|Withdrawal by Subject|16|||
160470959|NCT01000805|579453264|FG001|Overall Study|Withdrawal by Subject|6|||
160470960|NCT01000805|579453263|FG000|Overall Study|Sponsor Decision|0|||
160470961|NCT01000805|579453264|FG001|Overall Study|Sponsor Decision|1|||
160470974|NCT02713594|579454496|FG000|Overall Study|Withdrawal by Subject|32|||
160470975|NCT02713594|579454497|FG001|Overall Study|Withdrawal by Subject|22|||
160600553|NCT00871572|579914359|FG002|Overall Study|Protocol Violation|1|||
160600554|NCT00871572|579914360|FG003|Overall Study|Protocol Violation|1|||
160600555|NCT00871572|579914357|FG000|Overall Study|Sponsor Decision|1|||
160600556|NCT00871572|579914358|FG001|Overall Study|Sponsor Decision|0|||
160470976|NCT02713594|579454496|FG000|Overall Study|Lost to Follow-up|358|||
160470977|NCT02713594|579454497|FG001|Overall Study|Lost to Follow-up|374|||
160470978|NCT02771366|579454498|FG000|Period 1|Withdrawal by Subject|0|||
160470979|NCT02771366|579454499|FG001|Period 1|Withdrawal by Subject|2|||
160470980|NCT02771366|579454498|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
160470981|NCT02771366|579454499|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
160470982|NCT01185340|579454502|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
160600557|NCT00871572|579914359|FG002|Overall Study|Sponsor Decision|0|||
160470983|NCT01185340|579454503|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160470984|NCT01185340|579454504|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160470985|NCT01185340|579454505|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160470986|NCT01185340|579454502|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
160470987|NCT01185340|579454503|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160470988|NCT01185340|579454504|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160470989|NCT01185340|579454505|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160470990|NCT01185340|579454502|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
160470991|NCT01185340|579454503|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160470992|NCT01185340|579454504|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160470993|NCT01185340|579454505|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160470994|NCT01185340|579454502|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
160470995|NCT01185340|579454503|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160470996|NCT01185340|579454504|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160470997|NCT01185340|579454505|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160470998|NCT01185340|579454502|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
160470999|NCT01185340|579454503|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160471000|NCT01185340|579454504|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160471001|NCT01185340|579454505|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160471002|NCT01185340|579454502|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
160471003|NCT01185340|579454503|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160471004|NCT01185340|579454504|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160471005|NCT01185340|579454505|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160471006|NCT01185340|579454502|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
160471007|NCT01185340|579454503|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160471008|NCT01185340|579454504|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160471009|NCT01185340|579454505|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160471010|NCT01185340|579454502|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
160471011|NCT01185340|579454503|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
160471012|NCT01185340|579454504|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
160471013|NCT01185340|579454505|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
160471014|NCT01185340|579454502|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
160471015|NCT01185340|579454503|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
160471016|NCT01185340|579454504|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
160471017|NCT01185340|579454505|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
160471018|NCT01185340|579454502|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
160471019|NCT01185340|579454503|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
160471020|NCT01185340|579454504|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
160471021|NCT01185340|579454505|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
160471022|NCT01185340|579454502|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
160471023|NCT01185340|579454503|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
160471024|NCT01185340|579454504|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
160471025|NCT01185340|579454505|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
160471026|NCT01185340|579454502|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
160471027|NCT01185340|579454503|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
160471028|NCT01185340|579454504|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
160471029|NCT01185340|579454505|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
160471030|NCT01185340|579454502|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
160471031|NCT01185340|579454503|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
160471032|NCT01185340|579454504|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
160471033|NCT01185340|579454505|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
160471034|NCT01185340|579454502|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
160471035|NCT01185340|579454503|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
160471036|NCT01185340|579454504|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
160471037|NCT01185340|579454505|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
160471038|NCT00246129|579454508|FG000|Overall Study|Lost to Follow-up|1|||
160471039|NCT00246129|579454509|FG001|Overall Study|Lost to Follow-up|0|||
160471040|NCT00246129|579454508|FG000|Overall Study|Death|2|||
160471041|NCT00246129|579454509|FG001|Overall Study|Death|1|||
160471042|NCT00246129|579454508|FG000|Overall Study|suffered primary non-function|1|||
160471043|NCT00246129|579454509|FG001|Overall Study|suffered primary non-function|0|||
160471044|NCT00246129|579454508|FG000|Overall Study|grafts failed|3|||
160471045|NCT00246129|579454509|FG001|Overall Study|grafts failed|1|||
160471046|NCT03469258|579454510|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
160471047|NCT03403036|579454516|FG000|Overall Study|Lack of Efficacy|5|||
160471048|NCT03648541|579454518|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
160471049|NCT03648541|579454519|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
160471050|NCT03648541|579454518|FG000|Re-induction Period Only|Lack of Efficacy|7|||
160471051|NCT03648541|579454519|FG001|Re-induction Period Only|Lack of Efficacy|0|||
160471052|NCT03648541|579454518|FG000|Maintenance Period Only|Missing|0|||
160471053|NCT03648541|579454519|FG001|Maintenance Period Only|Missing|1|||
160471054|NCT03648541|579454518|FG000|Maintenance Period Only|Other not listed below|0|||
160471055|NCT03648541|579454519|FG001|Maintenance Period Only|Other not listed below|4|||
160471056|NCT03648541|579454518|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
160471057|NCT03648541|579454519|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
160471058|NCT03648541|579454518|FG000|Maintenance Period Only|Protocol Violation|0|||
160471059|NCT03648541|579454519|FG001|Maintenance Period Only|Protocol Violation|1|||
160471060|NCT03648541|579454518|FG000|Maintenance Period Only|Lack of Efficacy|0|||
160471061|NCT03648541|579454519|FG001|Maintenance Period Only|Lack of Efficacy|18|||
160471062|NCT03648541|579454518|FG000|Maintenance Period Only|Adverse Event|0|||
160471063|NCT03648541|579454519|FG001|Maintenance Period Only|Adverse Event|4|||
160471064|NCT03648541|579454518|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
160471065|NCT03648541|579454519|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
160600558|NCT00871572|579914360|FG003|Overall Study|Sponsor Decision|0|||
160600559|NCT00871572|579914357|FG000|Overall Study|Withdrawal by Subject|1|||
160600560|NCT00871572|579914358|FG001|Overall Study|Withdrawal by Subject|2|||
160600561|NCT00871572|579914359|FG002|Overall Study|Withdrawal by Subject|3|||
160600562|NCT00871572|579914360|FG003|Overall Study|Withdrawal by Subject|1|||
160600563|NCT04176445|579914363|FG000|Overall Study|Adverse Event|0|||
160600564|NCT04176445|579914364|FG001|Overall Study|Adverse Event|1|||
160600565|NCT04176445|579914363|FG000|Overall Study|change plans weaning after first intervention|0|||
160600566|NCT04176445|579914364|FG001|Overall Study|change plans weaning after first intervention|1|||
160600567|NCT00187889|579914365|FG000|Overall Study|Withdrawal by Subject|6|||
160600568|NCT00187889|579914366|FG001|Overall Study|Withdrawal by Subject|4|||
160600569|NCT04377672|579914367|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
160600570|NCT03954444|579914368|FG000|Overall Study|Withdrawal by Subject|5|||
160600571|NCT03954444|579914369|FG001|Overall Study|Withdrawal by Subject|5|||
160471066|NCT02392507|579454520|FG000|Induction Regimen|Death|3|||
160471067|NCT02392507|579454520|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
160471068|NCT02392507|579454520|FG000|Induction Regimen|Physician Decision|1|||
160471069|NCT02392507|579454520|FG000|Induction Regimen|Withdrawal by Subject|2|||
160471070|NCT02392507|579454520|FG000|Maintenance Regimen|Death|1|||
160471071|NCT02392507|579454520|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
160471072|NCT00273052|579454521|FG000|Overall Study|Withdrawal by Subject|16|||
160600572|NCT03954444|579914370|FG002|Overall Study|Withdrawal by Subject|5|||
160471073|NCT00273052|579454522|FG001|Overall Study|Withdrawal by Subject|19|||
160471074|NCT00273052|579454521|FG000|Overall Study|Adverse Event|21|||
160471075|NCT00273052|579454522|FG001|Overall Study|Adverse Event|19|||
160471076|NCT00273052|579454521|FG000|Overall Study|Protocol Violation|14|||
160471077|NCT00273052|579454522|FG001|Overall Study|Protocol Violation|18|||
160471078|NCT00273052|579454521|FG000|Overall Study|Lost to Follow-up|7|||
160471079|NCT00273052|579454522|FG001|Overall Study|Lost to Follow-up|25|||
160471080|NCT00273052|579454521|FG000|Overall Study|Lack of Efficacy|6|||
160471081|NCT00273052|579454522|FG001|Overall Study|Lack of Efficacy|4|||
160471082|NCT00273052|579454521|FG000|Overall Study|Non-Compliance|3|||
160471083|NCT00273052|579454522|FG001|Overall Study|Non-Compliance|1|||
160471084|NCT00273052|579454521|FG000|Overall Study|Other|2|||
160471085|NCT00273052|579454522|FG001|Overall Study|Other|0|||
160471086|NCT00273052|579454521|FG000|Overall Study|Worsening serum lipid levels|0|||
160471087|NCT00273052|579454522|FG001|Overall Study|Worsening serum lipid levels|2|||
160471088|NCT00240994|579454523|FG000|Overall Study|Lost to Follow-up|1|||
160471089|NCT00240994|579454523|FG000|Overall Study|Protocol Violation|1|||
160471090|NCT00240994|579454523|FG000|Overall Study|Graft failure|1|||
160471091|NCT02630186|579454525|FG000|Overall Study|Withdrawal by Subject|1|||
160471092|NCT00439218|579454526|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
160471093|NCT03142932|579454529|FG000|Overall Study|Lost to Follow-up|2|||
160471094|NCT03142932|579454530|FG001|Overall Study|Lost to Follow-up|11|||
160471095|NCT00624377|579454533|FG000|Overall Study|Lost to Follow-up|355|||
160471096|NCT00624377|579454533|FG000|Overall Study|Withdrawal by Subject|100|||
160471097|NCT00624377|579454533|FG000|Overall Study|Adverse Event|14|||
160471098|NCT00624377|579454533|FG000|Overall Study|Other|91|||
160471099|NCT00624377|579454533|FG000|Overall Study|Non-evaluable population|84|||
160471100|NCT02037568|579454537|FG000|Overall Study|Withdrawal by Subject|17|||
160471101|NCT02037568|579454538|FG001|Overall Study|Withdrawal by Subject|24|||
160471102|NCT02037568|579454537|FG000|Overall Study|Lost to Follow-up|16|||
160471103|NCT02037568|579454538|FG001|Overall Study|Lost to Follow-up|13|||
160471104|NCT02037568|579454537|FG000|Overall Study|Screen Failure|3|||
160471105|NCT02037568|579454538|FG001|Overall Study|Screen Failure|1|||
160471106|NCT02037568|579454537|FG000|Overall Study|Patient did not receive transplant|0|||
160471107|NCT02037568|579454538|FG001|Overall Study|Patient did not receive transplant|1|||
160471108|NCT00721734|579454539|FG000|Overall Study|Progressive Disease|3|||
160471109|NCT00721734|579454540|FG001|Overall Study|Progressive Disease|10|||
160471110|NCT00721734|579454541|FG002|Overall Study|Progressive Disease|4|||
160471111|NCT00721734|579454542|FG003|Overall Study|Progressive Disease|5|||
160471112|NCT00721734|579454543|FG004|Overall Study|Progressive Disease|2|||
160471113|NCT00721734|579454539|FG000|Overall Study|Adverse Event|3|||
160471114|NCT00721734|579454540|FG001|Overall Study|Adverse Event|1|||
160471115|NCT00721734|579454541|FG002|Overall Study|Adverse Event|4|||
160471116|NCT00721734|579454542|FG003|Overall Study|Adverse Event|0|||
160471117|NCT00721734|579454543|FG004|Overall Study|Adverse Event|3|||
160471118|NCT00721734|579454539|FG000|Overall Study|Withdrawal by Subject|2|||
160471119|NCT00721734|579454540|FG001|Overall Study|Withdrawal by Subject|1|||
160471120|NCT00721734|579454541|FG002|Overall Study|Withdrawal by Subject|0|||
160471121|NCT00721734|579454542|FG003|Overall Study|Withdrawal by Subject|0|||
160471122|NCT00721734|579454543|FG004|Overall Study|Withdrawal by Subject|1|||
160471123|NCT00721734|579454539|FG000|Overall Study|Other|0|||
160471124|NCT00721734|579454540|FG001|Overall Study|Other|0|||
160471125|NCT00721734|579454541|FG002|Overall Study|Other|0|||
160471126|NCT00721734|579454542|FG003|Overall Study|Other|1|||
160471127|NCT00721734|579454543|FG004|Overall Study|Other|0|||
160471128|NCT05169684|579454549|FG000|Overall Study|Adverse Event|1|||
160600573|NCT03954444|579914368|FG000|Overall Study|Adverse Event|1|||
160600574|NCT03954444|579914369|FG001|Overall Study|Adverse Event|3|||
160600575|NCT03954444|579914370|FG002|Overall Study|Adverse Event|2|||
160600576|NCT03954444|579914368|FG000|Overall Study|Protocol Violation|0|||
160600577|NCT03954444|579914369|FG001|Overall Study|Protocol Violation|3|||
160471129|NCT05169684|579454550|FG001|Overall Study|Adverse Event|3|||
160471130|NCT05169684|579454549|FG000|Overall Study|Physician Decision|0|||
160471131|NCT05169684|579454550|FG001|Overall Study|Physician Decision|1|||
160600578|NCT03954444|579914370|FG002|Overall Study|Protocol Violation|5|||
160600579|NCT03954444|579914368|FG000|Overall Study|Use of prohibited therapy|1|||
160600580|NCT03954444|579914369|FG001|Overall Study|Use of prohibited therapy|1|||
160471132|NCT05169684|579454549|FG000|Overall Study|Progressive Disease|1|||
160471133|NCT05169684|579454550|FG001|Overall Study|Progressive Disease|1|||
160471134|NCT05169684|579454549|FG000|Overall Study|Participant request to discontinue treatment|0|||
160471135|NCT05169684|579454550|FG001|Overall Study|Participant request to discontinue treatment|1|||
160471136|NCT05169684|579454549|FG000|Overall Study|Other Reason|0|||
160659630|NCT00746798|580136112|FG000|Overall Study|Participant unable to return for visit|1|||
160471137|NCT05169684|579454550|FG001|Overall Study|Other Reason|1|||
160471138|NCT05484661|579454556|FG000|Overall Study|Withdrawal by Subject|1|||
160471139|NCT05484661|579454557|FG001|Overall Study|Withdrawal by Subject|0|||
160471140|NCT03205488|579454563|FG000|Overall Study|Adverse Event|1|||
160600581|NCT03954444|579914370|FG002|Overall Study|Use of prohibited therapy|2|||
160471141|NCT03205488|579454564|FG001|Overall Study|Adverse Event|2|||
160659631|NCT00746798|580136113|FG001|Overall Study|Participant unable to return for visit|0|||
160659632|NCT00746798|580136114|FG002|Overall Study|Participant unable to return for visit|0|||
160659633|NCT00746798|580136115|FG003|Overall Study|Participant unable to return for visit|0|||
160659634|NCT03247556|580136116|FG000|Overall Study|Adverse Event|1|||
160659635|NCT03247556|580136117|FG001|Overall Study|Adverse Event|4|||
160659636|NCT03247556|580136118|FG002|Overall Study|Adverse Event|5|||
160659637|NCT03247556|580136116|FG000|Overall Study|Lost to Follow-up|5|||
160659638|NCT03247556|580136117|FG001|Overall Study|Lost to Follow-up|5|||
160659639|NCT03247556|580136118|FG002|Overall Study|Lost to Follow-up|4|||
160659640|NCT03247556|580136116|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
160659641|NCT03247556|580136117|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
160659642|NCT03247556|580136118|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
160659643|NCT03247556|580136116|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
160659644|NCT03247556|580136117|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
160659645|NCT03247556|580136118|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
160659646|NCT03247556|580136116|FG000|Overall Study|Protocol Violation|2|||
160659647|NCT03247556|580136117|FG001|Overall Study|Protocol Violation|0|||
160659648|NCT03247556|580136118|FG002|Overall Study|Protocol Violation|1|||
160659649|NCT03247556|580136116|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
160659650|NCT03247556|580136117|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
160659651|NCT03247556|580136118|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
160659652|NCT01367457|580136122|FG000|Overall Study|Death|2|||
160659653|NCT01367457|580136123|FG001|Overall Study|Death|0|||
160659654|NCT01367457|580136124|FG002|Overall Study|Death|0|||
160659655|NCT01367457|580136122|FG000|Overall Study|Investigator's decision|2|||
160659656|NCT01367457|580136123|FG001|Overall Study|Investigator's decision|0|||
160659657|NCT01367457|580136124|FG002|Overall Study|Investigator's decision|0|||
160659658|NCT01367457|580136122|FG000|Overall Study|Clinical decline (CD)|2|||
160659659|NCT01367457|580136123|FG001|Overall Study|Clinical decline (CD)|0|||
160659660|NCT01367457|580136124|FG002|Overall Study|Clinical decline (CD)|0|||
160659661|NCT01367457|580136122|FG000|Overall Study|Progression and death|8|||
160659662|NCT01367457|580136123|FG001|Overall Study|Progression and death|0|||
160659663|NCT01367457|580136124|FG002|Overall Study|Progression and death|0|||
160659664|NCT01367457|580136122|FG000|Overall Study|Toxicity|16|||
160659665|NCT01367457|580136123|FG001|Overall Study|Toxicity|0|||
160659666|NCT01367457|580136124|FG002|Overall Study|Toxicity|0|||
160659667|NCT01367457|580136122|FG000|Overall Study|Progression|137|||
160659668|NCT01367457|580136123|FG001|Overall Study|Progression|0|||
160659669|NCT01367457|580136124|FG002|Overall Study|Progression|0|||
160659670|NCT01367457|580136122|FG000|Overall Study|Patient asks for rest + slow progression|1|||
160659671|NCT01367457|580136123|FG001|Overall Study|Patient asks for rest + slow progression|0|||
160659672|NCT01367457|580136124|FG002|Overall Study|Patient asks for rest + slow progression|0|||
160659673|NCT01367457|580136122|FG000|Overall Study|Investigator's opinion, stable disease|1|||
160659674|NCT01367457|580136123|FG001|Overall Study|Investigator's opinion, stable disease|0|||
160659675|NCT01367457|580136124|FG002|Overall Study|Investigator's opinion, stable disease|0|||
160659676|NCT01367457|580136122|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
160659677|NCT01367457|580136123|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
160659678|NCT01367457|580136124|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
160659679|NCT01367457|580136122|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
160659680|NCT01367457|580136123|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
160600582|NCT03954444|579914368|FG000|Overall Study|Lost to Follow-up|1|||
160600583|NCT03954444|579914369|FG001|Overall Study|Lost to Follow-up|0|||
160600584|NCT03954444|579914370|FG002|Overall Study|Lost to Follow-up|1|||
160600585|NCT03954444|579914368|FG000|Overall Study|Non-compliant with study drug application|2|||
160600586|NCT03954444|579914369|FG001|Overall Study|Non-compliant with study drug application|2|||
160600587|NCT03954444|579914370|FG002|Overall Study|Non-compliant with study drug application|0|||
160600588|NCT03954444|579914368|FG000|Overall Study|Administrative reasons|0|||
160600589|NCT03954444|579914369|FG001|Overall Study|Administrative reasons|0|||
160600590|NCT03954444|579914370|FG002|Overall Study|Administrative reasons|1|||
160600591|NCT03954444|579914368|FG000|Overall Study|Miscellaneous|3|||
160600592|NCT03954444|579914369|FG001|Overall Study|Miscellaneous|2|||
160600593|NCT03954444|579914370|FG002|Overall Study|Miscellaneous|1|||
160600594|NCT00435994|579914372|FG000|Overall Study|Lost to Follow-up|7|||
160600595|NCT00435994|579914373|FG001|Overall Study|Lost to Follow-up|0|||
160600596|NCT00435994|579914374|FG002|Overall Study|Lost to Follow-up|0|||
160600597|NCT05109702|579914376|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
160600598|NCT05109702|579914377|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
160600599|NCT05109702|579914378|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
160600600|NCT05109702|579914376|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
160600601|NCT05109702|579914377|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
160600602|NCT05109702|579914378|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
160471142|NCT03205488|579454565|FG002|Overall Study|Adverse Event|4|||
160471143|NCT03205488|579454563|FG000|Overall Study|Protocol Violation|0|||
160471144|NCT03205488|579454564|FG001|Overall Study|Protocol Violation|0|||
160471145|NCT03205488|579454565|FG002|Overall Study|Protocol Violation|1|||
160471146|NCT03652610|579454566|FG000|Overall Study|Lost to Follow-up|1|||
160471147|NCT03652610|579454567|FG001|Overall Study|Lost to Follow-up|0|||
160471148|NCT03652610|579454566|FG000|Overall Study|Withdrawal by Subject|3|||
160471149|NCT03652610|579454567|FG001|Overall Study|Withdrawal by Subject|5|||
160471150|NCT04748341|579454570|FG000|Overall Study|Lost to Follow-up|1|||
160471151|NCT04748341|579454571|FG001|Overall Study|Lost to Follow-up|1|||
160471152|NCT02334215|579454574|FG000|Overall Study|Death|1|||
160471153|NCT02334215|579454575|FG001|Overall Study|Death|1|||
160471154|NCT02334215|579454576|FG002|Overall Study|Death|0|||
160471155|NCT02334215|579454574|FG000|Overall Study|Lost to Follow-up|1|||
160471156|NCT02334215|579454575|FG001|Overall Study|Lost to Follow-up|0|||
160471157|NCT02334215|579454576|FG002|Overall Study|Lost to Follow-up|4|||
160471158|NCT02334215|579454574|FG000|Overall Study|Withdrawal by Subject|2|||
160471159|NCT02334215|579454575|FG001|Overall Study|Withdrawal by Subject|2|||
160471160|NCT02334215|579454576|FG002|Overall Study|Withdrawal by Subject|1|||
160471161|NCT02334215|579454574|FG000|Overall Study|Not released from incarceration on time|3|||
160471162|NCT02334215|579454575|FG001|Overall Study|Not released from incarceration on time|3|||
160471163|NCT02334215|579454576|FG002|Overall Study|Not released from incarceration on time|3|||
160471164|NCT02334215|579454574|FG000|Overall Study|Incarcerated|0|||
160471165|NCT02334215|579454575|FG001|Overall Study|Incarcerated|0|||
160471166|NCT02334215|579454576|FG002|Overall Study|Incarcerated|7|||
160471167|NCT05615363|579454577|FG000|Overall Study|Adverse Event|0|||
160471168|NCT05615363|579454578|FG001|Overall Study|Adverse Event|4|||
160471169|NCT05615363|579454579|FG002|Overall Study|Adverse Event|4|||
160471170|NCT05615363|579454580|FG003|Overall Study|Adverse Event|3|||
160471171|NCT05615363|579454581|FG004|Overall Study|Adverse Event|1|||
160471172|NCT05615363|579454577|FG000|Overall Study|Physician Decision|2|||
160471173|NCT05615363|579454578|FG001|Overall Study|Physician Decision|0|||
160471174|NCT05615363|579454579|FG002|Overall Study|Physician Decision|4|||
160471175|NCT05615363|579454580|FG003|Overall Study|Physician Decision|1|||
160600603|NCT05109702|579914376|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
160600604|NCT05109702|579914377|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
160600605|NCT05109702|579914378|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
160600606|NCT05109702|579914376|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
160600607|NCT05109702|579914377|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
160600608|NCT05109702|579914378|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
160471176|NCT05615363|579454581|FG004|Overall Study|Physician Decision|3|||
160471177|NCT05615363|579454577|FG000|Overall Study|Protocol Violation|2|||
160471178|NCT05615363|579454578|FG001|Overall Study|Protocol Violation|0|||
160471179|NCT05615363|579454579|FG002|Overall Study|Protocol Violation|0|||
160471180|NCT05615363|579454580|FG003|Overall Study|Protocol Violation|0|||
160471181|NCT05615363|579454581|FG004|Overall Study|Protocol Violation|1|||
160471182|NCT05615363|579454577|FG000|Overall Study|Withdrawal by Subject|0|||
160471183|NCT05615363|579454578|FG001|Overall Study|Withdrawal by Subject|0|||
160471184|NCT05615363|579454579|FG002|Overall Study|Withdrawal by Subject|1|||
160471185|NCT05615363|579454580|FG003|Overall Study|Withdrawal by Subject|0|||
160600609|NCT05109702|579914376|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
160600610|NCT05109702|579914377|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
160471186|NCT05615363|579454581|FG004|Overall Study|Withdrawal by Subject|0|||
160471187|NCT05865392|579454582|FG000|Overall Study|Withdrawal by Subject|4|||
160471188|NCT05865392|579454583|FG001|Overall Study|Withdrawal by Subject|0|||
160471189|NCT05865392|579454582|FG000|Overall Study|Didn't meet inclusion criteria|4|||
160471190|NCT05865392|579454583|FG001|Overall Study|Didn't meet inclusion criteria|0|||
160471191|NCT02159989|579454584|FG000|Overall Study|Adverse Event|1|||
160471192|NCT02159989|579454585|FG001|Overall Study|Adverse Event|0|||
160471193|NCT02159989|579454586|FG002|Overall Study|Adverse Event|0|||
160471194|NCT02159989|579454587|FG003|Overall Study|Adverse Event|0|||
160471195|NCT02159989|579454588|FG004|Overall Study|Adverse Event|1|||
160471196|NCT02159989|579454589|FG005|Overall Study|Adverse Event|0|||
160471197|NCT02159989|579454590|FG006|Overall Study|Adverse Event|1|||
160471198|NCT02159989|579454591|FG007|Overall Study|Adverse Event|2|||
160471199|NCT02159989|579454592|FG008|Overall Study|Adverse Event|0|||
160471200|NCT02159989|579454593|FG009|Overall Study|Adverse Event|2|||
160471201|NCT02159989|579454594|FG010|Overall Study|Adverse Event|1|||
160471202|NCT02159989|579454584|FG000|Overall Study|Death|0|||
160471203|NCT02159989|579454585|FG001|Overall Study|Death|0|||
160471204|NCT02159989|579454586|FG002|Overall Study|Death|0|||
160471205|NCT02159989|579454587|FG003|Overall Study|Death|0|||
160471206|NCT02159989|579454588|FG004|Overall Study|Death|0|||
160471207|NCT02159989|579454589|FG005|Overall Study|Death|0|||
160471208|NCT02159989|579454590|FG006|Overall Study|Death|0|||
160471209|NCT02159989|579454591|FG007|Overall Study|Death|0|||
160471210|NCT02159989|579454592|FG008|Overall Study|Death|0|||
160471211|NCT02159989|579454593|FG009|Overall Study|Death|0|||
160471212|NCT02159989|579454594|FG010|Overall Study|Death|1|||
160471213|NCT02159989|579454584|FG000|Overall Study|Lack of Efficacy|2|||
160471214|NCT02159989|579454585|FG001|Overall Study|Lack of Efficacy|3|||
160471215|NCT02159989|579454586|FG002|Overall Study|Lack of Efficacy|3|||
160471216|NCT02159989|579454587|FG003|Overall Study|Lack of Efficacy|0|||
160471217|NCT02159989|579454588|FG004|Overall Study|Lack of Efficacy|2|||
160471218|NCT02159989|579454589|FG005|Overall Study|Lack of Efficacy|3|||
160471219|NCT02159989|579454590|FG006|Overall Study|Lack of Efficacy|3|||
160471220|NCT02159989|579454591|FG007|Overall Study|Lack of Efficacy|1|||
160471221|NCT02159989|579454592|FG008|Overall Study|Lack of Efficacy|3|||
160471222|NCT02159989|579454593|FG009|Overall Study|Lack of Efficacy|6|||
160471223|NCT02159989|579454594|FG010|Overall Study|Lack of Efficacy|7|||
160471224|NCT02159989|579454584|FG000|Overall Study|Lost to Follow-up|0|||
160471225|NCT02159989|579454585|FG001|Overall Study|Lost to Follow-up|0|||
160471226|NCT02159989|579454586|FG002|Overall Study|Lost to Follow-up|0|||
160471227|NCT02159989|579454587|FG003|Overall Study|Lost to Follow-up|1|||
160471228|NCT02159989|579454588|FG004|Overall Study|Lost to Follow-up|0|||
160471229|NCT02159989|579454589|FG005|Overall Study|Lost to Follow-up|0|||
160471230|NCT02159989|579454590|FG006|Overall Study|Lost to Follow-up|0|||
160471231|NCT02159989|579454591|FG007|Overall Study|Lost to Follow-up|0|||
160471232|NCT02159989|579454592|FG008|Overall Study|Lost to Follow-up|0|||
160471233|NCT02159989|579454593|FG009|Overall Study|Lost to Follow-up|0|||
160471234|NCT02159989|579454594|FG010|Overall Study|Lost to Follow-up|1|||
160471235|NCT02159989|579454584|FG000|Overall Study|Withdrawal by Subject|2|||
160471236|NCT02159989|579454585|FG001|Overall Study|Withdrawal by Subject|0|||
160471237|NCT02159989|579454586|FG002|Overall Study|Withdrawal by Subject|0|||
160471238|NCT02159989|579454587|FG003|Overall Study|Withdrawal by Subject|2|||
160471239|NCT02159989|579454588|FG004|Overall Study|Withdrawal by Subject|1|||
160471240|NCT02159989|579454589|FG005|Overall Study|Withdrawal by Subject|0|||
160471241|NCT02159989|579454590|FG006|Overall Study|Withdrawal by Subject|3|||
160471242|NCT02159989|579454591|FG007|Overall Study|Withdrawal by Subject|1|||
160471243|NCT02159989|579454592|FG008|Overall Study|Withdrawal by Subject|0|||
160471244|NCT02159989|579454593|FG009|Overall Study|Withdrawal by Subject|0|||
160471245|NCT02159989|579454594|FG010|Overall Study|Withdrawal by Subject|0|||
160471246|NCT02159989|579454584|FG000|Overall Study|New treatment|0|||
160471247|NCT02159989|579454585|FG001|Overall Study|New treatment|1|||
160600611|NCT05109702|579914378|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
160600612|NCT03094832|579914379|FG000|Overall Study|Lost to Follow-up|0|||
160600613|NCT03094832|579914380|FG001|Overall Study|Lost to Follow-up|0|||
160600614|NCT03094832|579914381|FG002|Overall Study|Lost to Follow-up|0|||
160600615|NCT03094832|579914382|FG003|Overall Study|Lost to Follow-up|1|||
160471248|NCT02159989|579454586|FG002|Overall Study|New treatment|0|||
160471249|NCT02159989|579454587|FG003|Overall Study|New treatment|0|||
160471250|NCT02159989|579454588|FG004|Overall Study|New treatment|0|||
160471251|NCT02159989|579454589|FG005|Overall Study|New treatment|0|||
160471252|NCT02159989|579454590|FG006|Overall Study|New treatment|0|||
160471253|NCT02159989|579454591|FG007|Overall Study|New treatment|0|||
160471254|NCT02159989|579454592|FG008|Overall Study|New treatment|0|||
160471255|NCT02159989|579454593|FG009|Overall Study|New treatment|0|||
160471256|NCT02159989|579454594|FG010|Overall Study|New treatment|0|||
160471257|NCT02159989|579454584|FG000|Overall Study|Insurance Issues|0|||
160471258|NCT02159989|579454585|FG001|Overall Study|Insurance Issues|0|||
160471259|NCT02159989|579454586|FG002|Overall Study|Insurance Issues|0|||
160600616|NCT03094832|579914383|FG004|Overall Study|Lost to Follow-up|1|||
160600617|NCT03094832|579914379|FG000|Overall Study|Death|1|||
160471260|NCT02159989|579454587|FG003|Overall Study|Insurance Issues|0|||
160471261|NCT02159989|579454588|FG004|Overall Study|Insurance Issues|0|||
160471262|NCT02159989|579454589|FG005|Overall Study|Insurance Issues|0|||
160600618|NCT03094832|579914380|FG001|Overall Study|Death|0|||
160600619|NCT03094832|579914381|FG002|Overall Study|Death|0|||
160600620|NCT03094832|579914382|FG003|Overall Study|Death|0|||
160600621|NCT03094832|579914383|FG004|Overall Study|Death|0|||
160600622|NCT03094832|579914379|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160600623|NCT03094832|579914380|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160600624|NCT03094832|579914381|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160600625|NCT03094832|579914382|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160600626|NCT03094832|579914383|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
160600627|NCT03094832|579914379|FG000|Overall Study|Other|13|||
160600628|NCT03094832|579914380|FG001|Overall Study|Other|20|||
160600629|NCT03094832|579914381|FG002|Overall Study|Other|1|||
160600630|NCT03094832|579914382|FG003|Overall Study|Other|7|||
160600631|NCT03094832|579914383|FG004|Overall Study|Other|1|||
160600632|NCT00903370|579914390|FG000|Overall Study|Death|13|||
160600633|NCT00903370|579914391|FG001|Overall Study|Death|10|||
160600634|NCT00903370|579914390|FG000|Overall Study|Withdrawal by Subject|9|||
160600635|NCT00903370|579914391|FG001|Overall Study|Withdrawal by Subject|6|||
160600636|NCT00903370|579914390|FG000|Overall Study|Lost to Follow-up|6|||
160600637|NCT00903370|579914391|FG001|Overall Study|Lost to Follow-up|8|||
160600638|NCT00367432|579914392|FG000|First Period (16 Weeks)|Adverse Event|6|||
160600639|NCT00367432|579914393|FG001|First Period (16 Weeks)|Adverse Event|0|||
160600640|NCT00367432|579914392|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
160600641|NCT00367432|579914393|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
160600642|NCT00367432|579914392|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
160600643|NCT00367432|579914393|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
160600644|NCT00367432|579914392|FG000|First Period (16 Weeks)|Other Reason|2|||
160600645|NCT00367432|579914393|FG001|First Period (16 Weeks)|Other Reason|0|||
160600646|NCT00367432|579914392|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
160600647|NCT00367432|579914393|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
160600648|NCT00367432|579914392|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
160600649|NCT00367432|579914393|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
160600650|NCT00367432|579914392|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
160600651|NCT00367432|579914393|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
160600652|NCT00367432|579914392|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
160600653|NCT00367432|579914393|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
160600654|NCT00367432|579914392|FG000|Second Period (up to 54 Months)|Other Reason|6|||
160600655|NCT00367432|579914393|FG001|Second Period (up to 54 Months)|Other Reason|2|||
160600656|NCT00014911|579914394|FG000|Overall Study|Adverse Event|1|||
160600657|NCT00014911|579914394|FG000|Overall Study|Lost to Follow-up|1|||
160600658|NCT00014911|579914394|FG000|Overall Study|Withdrawal by Subject|6|||
160600659|NCT00014911|579914394|FG000|Overall Study|Unknown Reasons|2|||
160600660|NCT00014911|579914394|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
160600661|NCT00345540|579914399|FG000|Overall Study|Withdrawal by Subject|1|||
160600662|NCT04179786|579914401|FG000|Overall Study|Withdrawal by Subject|8|||
160600663|NCT01938001|579914402|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
160600664|NCT01938001|579914403|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
160600665|NCT01938001|579914402|FG000|Pre-Treatment|Death|1|||
160600666|NCT01938001|579914403|FG001|Pre-Treatment|Death|0|||
160600667|NCT01938001|579914402|FG000|Treatment|Death|2|||
160600668|NCT01938001|579914403|FG001|Treatment|Death|0|||
160600669|NCT01938001|579914402|FG000|Treatment|Adverse Event|14|||
160600670|NCT01938001|579914403|FG001|Treatment|Adverse Event|8|||
160471263|NCT02159989|579454590|FG006|Overall Study|Insurance Issues|0|||
160471264|NCT02159989|579454591|FG007|Overall Study|Insurance Issues|0|||
160471265|NCT02159989|579454592|FG008|Overall Study|Insurance Issues|0|||
160471266|NCT02159989|579454593|FG009|Overall Study|Insurance Issues|1|||
160471267|NCT02159989|579454594|FG010|Overall Study|Insurance Issues|0|||
160471268|NCT04447027|579454596|FG000|Dose Escalation|Withdrawal by Subject|1|||
160471269|NCT04447027|579454597|FG001|Dose Escalation|Withdrawal by Subject|4|||
160471270|NCT04447027|579454598|FG002|Dose Escalation|Withdrawal by Subject|3|||
160471271|NCT04447027|579454599|FG003|Dose Escalation|Withdrawal by Subject|3|||
160471272|NCT04447027|579454600|FG004|Dose Escalation|Withdrawal by Subject|1|||
160471273|NCT04447027|579454601|FG005|Dose Escalation|Withdrawal by Subject|0|||
160471274|NCT04447027|579454602|FG006|Dose Escalation|Withdrawal by Subject|0|||
160600671|NCT01938001|579914402|FG000|Treatment|Progressive Disease|21|||
160600672|NCT01938001|579914403|FG001|Treatment|Progressive Disease|54|||
160600673|NCT01938001|579914402|FG000|Treatment|Withdrawal by Subject|13|||
160600674|NCT01938001|579914403|FG001|Treatment|Withdrawal by Subject|7|||
160600675|NCT01938001|579914402|FG000|Treatment|Other reasons|2|||
160600676|NCT01938001|579914403|FG001|Treatment|Other reasons|1|||
160600677|NCT03310580|579914404|FG000|Overall Study|Adverse Event|0|||
160600678|NCT03310580|579914405|FG001|Overall Study|Adverse Event|1|||
160600679|NCT03310580|579914406|FG002|Overall Study|Adverse Event|0|||
160600680|NCT01105936|579916414|FG000|Period 1|Adverse Event|0|||
160600681|NCT01105936|579916415|FG001|Period 1|Adverse Event|0|||
160600682|NCT01105936|579916416|FG002|Period 1|Adverse Event|0|||
160471275|NCT04447027|579454603|FG007|Dose Escalation|Withdrawal by Subject|0|||
160600683|NCT01105936|579916417|FG003|Period 1|Adverse Event|1|||
160600684|NCT01105936|579916414|FG000|Period 2|Adverse Event|1|||
160600685|NCT01105936|579916415|FG001|Period 2|Adverse Event|0|||
160600686|NCT01105936|579916416|FG002|Period 2|Adverse Event|0|||
160600687|NCT01105936|579916417|FG003|Period 2|Adverse Event|0|||
160600688|NCT01105936|579916414|FG000|Period 3|Protocol Violation|0|||
160600689|NCT01105936|579916415|FG001|Period 3|Protocol Violation|2|||
160600690|NCT01105936|579916416|FG002|Period 3|Protocol Violation|0|||
160600691|NCT01105936|579916417|FG003|Period 3|Protocol Violation|0|||
160600692|NCT03170258|579916420|FG000|Overall Study|Physician Decision|4|||
160600693|NCT03170258|579916421|FG001|Overall Study|Physician Decision|0|||
160600694|NCT03170258|579916420|FG000|Overall Study|Equipment issues|1|||
160600695|NCT03170258|579916421|FG001|Overall Study|Equipment issues|0|||
160600696|NCT03170258|579916420|FG000|Overall Study|Medication|1|||
160600697|NCT03170258|579916421|FG001|Overall Study|Medication|0|||
160600698|NCT03170258|579916420|FG000|Overall Study|Sleep issues|1|||
160600699|NCT03170258|579916421|FG001|Overall Study|Sleep issues|0|||
160600700|NCT00633893|579916424|FG000|Overall Study|Death|1|||
160600701|NCT00633893|579916425|FG001|Overall Study|Death|3|||
160600702|NCT00633893|579916426|FG002|Overall Study|Death|9|||
160600703|NCT00633893|579916424|FG000|Overall Study|Adverse Event|65|||
160600704|NCT00633893|579916425|FG001|Overall Study|Adverse Event|58|||
160600705|NCT00633893|579916426|FG002|Overall Study|Adverse Event|126|||
160600706|NCT00633893|579916424|FG000|Overall Study|Withdrawal by Subject|7|||
160600707|NCT00633893|579916425|FG001|Overall Study|Withdrawal by Subject|12|||
160600708|NCT00633893|579916426|FG002|Overall Study|Withdrawal by Subject|6|||
160600709|NCT00633893|579916424|FG000|Overall Study|Lost to Follow-up|2|||
160600710|NCT00633893|579916425|FG001|Overall Study|Lost to Follow-up|4|||
160600711|NCT00633893|579916426|FG002|Overall Study|Lost to Follow-up|8|||
160600712|NCT00633893|579916424|FG000|Overall Study|Poor/non-compliance|5|||
160600713|NCT00633893|579916425|FG001|Overall Study|Poor/non-compliance|12|||
160600714|NCT00633893|579916426|FG002|Overall Study|Poor/non-compliance|3|||
160600715|NCT00633893|579916424|FG000|Overall Study|Pregnancy|2|||
160600716|NCT00633893|579916425|FG001|Overall Study|Pregnancy|1|||
160600717|NCT00633893|579916426|FG002|Overall Study|Pregnancy|1|||
160600718|NCT00633893|579916424|FG000|Overall Study|Not meet/no longer meets criteria|4|||
160600719|NCT00633893|579916425|FG001|Overall Study|Not meet/no longer meets criteria|6|||
160600720|NCT00633893|579916426|FG002|Overall Study|Not meet/no longer meets criteria|4|||
160600721|NCT00633893|579916424|FG000|Overall Study|Other|28|||
160600722|NCT00633893|579916425|FG001|Overall Study|Other|33|||
160600723|NCT00633893|579916426|FG002|Overall Study|Other|31|||
160600724|NCT02741310|579916427|FG000|Overall Study|Sponsor Decision|2|||
160600725|NCT02741310|579916428|FG001|Overall Study|Sponsor Decision|2|||
160600726|NCT02044822|579916432|FG000|Overall Study|Study Terminated by Sponsor|77|||
160600727|NCT02044822|579916432|FG000|Overall Study|Investigator's Discretion|10|||
160600728|NCT02044822|579916432|FG000|Overall Study|Withdrew Consent|3|||
160600729|NCT02044822|579916432|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
160600730|NCT02044822|579916432|FG000|Overall Study|Lost to Follow-up|1|||
160600731|NCT02025530|579916435|FG000|Overall Study|No longer met elligibility criteria|5|||
160600732|NCT02025530|579916436|FG001|Overall Study|No longer met elligibility criteria|1|||
160600733|NCT03551626|579916437|FG000|Overall Study|Adverse Event|88|||
160600734|NCT03551626|579916437|FG000|Overall Study|Disease relapse|18|||
160600735|NCT03551626|579916437|FG000|Overall Study|Withdrawal of informed consent|6|||
160600736|NCT03551626|579916437|FG000|Overall Study|Patient decision|5|||
160600737|NCT03551626|579916437|FG000|Overall Study|Physician Decision|4|||
160600738|NCT03551626|579916437|FG000|Overall Study|Lost to Follow-up|3|||
160600739|NCT03551626|579916437|FG000|Overall Study|Pregnancy|1|||
160600740|NCT03551626|579916437|FG000|Overall Study|Protocol deviation|1|||
160600741|NCT03551626|579916437|FG000|Overall Study|Technical problems|1|||
160600742|NCT00653328|579916438|FG000|Overall Study|Withdrawal by Subject|1|||
160600743|NCT00653328|579916438|FG000|Overall Study|Adverse Event|2|||
160600744|NCT00653328|579916438|FG000|Overall Study|Disease progression|10|||
160600745|NCT00653328|579916438|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
160600746|NCT01237223|579916445|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
160600747|NCT01237223|579916446|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
160600748|NCT01237223|579916447|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
160600749|NCT01237223|579916448|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
160600750|NCT01237223|579916449|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
160600751|NCT01237223|579916450|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
160600752|NCT01237223|579916445|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
160600753|NCT01237223|579916446|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
160471276|NCT04447027|579454604|FG008|Dose Escalation|Withdrawal by Subject|0|||
160471277|NCT04447027|579454596|FG000|Dose Escalation|Refused further treatment|0|||
160471278|NCT04447027|579454597|FG001|Dose Escalation|Refused further treatment|1|||
160471279|NCT04447027|579454598|FG002|Dose Escalation|Refused further treatment|1|||
160471280|NCT04447027|579454599|FG003|Dose Escalation|Refused further treatment|0|||
160471281|NCT04447027|579454600|FG004|Dose Escalation|Refused further treatment|0|||
160471282|NCT04447027|579454601|FG005|Dose Escalation|Refused further treatment|0|||
160471283|NCT04447027|579454602|FG006|Dose Escalation|Refused further treatment|0|||
160471284|NCT04447027|579454603|FG007|Dose Escalation|Refused further treatment|0|||
160471285|NCT04447027|579454604|FG008|Dose Escalation|Refused further treatment|0|||
160471286|NCT04447027|579454596|FG000|Dose Expansion|Withdrawal by Subject|0|||
160471287|NCT04447027|579454597|FG001|Dose Expansion|Withdrawal by Subject|0|||
160471288|NCT04447027|579454598|FG002|Dose Expansion|Withdrawal by Subject|0|||
160471289|NCT04447027|579454599|FG003|Dose Expansion|Withdrawal by Subject|0|||
160471290|NCT04447027|579454600|FG004|Dose Expansion|Withdrawal by Subject|0|||
160471291|NCT04447027|579454601|FG005|Dose Expansion|Withdrawal by Subject|2|||
160471292|NCT04447027|579454602|FG006|Dose Expansion|Withdrawal by Subject|0|||
160471293|NCT04447027|579454603|FG007|Dose Expansion|Withdrawal by Subject|2|||
160471294|NCT04447027|579454604|FG008|Dose Expansion|Withdrawal by Subject|0|||
160471295|NCT02485925|579454607|FG000|Overall Study|Withdrawal by Subject|3|||
160471296|NCT02485925|579454607|FG000|Overall Study|Death|1|||
160471297|NCT02485925|579454607|FG000|Overall Study|Lost to Follow-up|11|||
160471298|NCT04937504|579454608|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
160471299|NCT04937504|579454609|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
160471300|NCT04937504|579454608|FG000|9 Months Assessment|Lost to Follow-up|3|||
160471301|NCT04937504|579454609|FG001|9 Months Assessment|Lost to Follow-up|2|||
160471302|NCT03662659|579454610|FG000|Pre-treatment|Participant no longer met study criteria|1|||
160471303|NCT03662659|579454611|FG001|Pre-treatment|Participant no longer met study criteria|1|||
160471304|NCT03662659|579454610|FG000|Pre-treatment|Other reasons|1|||
160471305|NCT03662659|579454611|FG001|Pre-treatment|Other reasons|0|||
160471306|NCT03662659|579454610|FG000|Treatment|Completed Treatment|0|||
160471307|NCT03662659|579454611|FG001|Treatment|Completed Treatment|2|||
160471308|NCT03662659|579454610|FG000|Treatment|Disease Progression|85|||
160471309|NCT03662659|579454611|FG001|Treatment|Disease Progression|97|||
160471310|NCT03662659|579454610|FG000|Treatment|Study Drug Toxicity|19|||
160471311|NCT03662659|579454611|FG001|Treatment|Study Drug Toxicity|9|||
160471312|NCT03662659|579454610|FG000|Treatment|Death|11|||
160471313|NCT03662659|579454611|FG001|Treatment|Death|9|||
160471314|NCT03662659|579454610|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
160471315|NCT03662659|579454611|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
160471316|NCT03662659|579454610|FG000|Treatment|Withdrawal by Subject|1|||
160471317|NCT03662659|579454611|FG001|Treatment|Withdrawal by Subject|1|||
160471318|NCT03662659|579454610|FG000|Treatment|Poor/Non-compliance|1|||
160471319|NCT03662659|579454611|FG001|Treatment|Poor/Non-compliance|0|||
160471320|NCT03662659|579454610|FG000|Treatment|Participant no longer meets study criteria|1|||
160471321|NCT03662659|579454611|FG001|Treatment|Participant no longer meets study criteria|0|||
160471322|NCT03662659|579454610|FG000|Treatment|Other reasons|10|||
160471323|NCT03662659|579454611|FG001|Treatment|Other reasons|8|||
160471324|NCT03662659|579454610|FG000|Treatment|Administrative reasons by sponsor|1|||
160471325|NCT03662659|579454611|FG001|Treatment|Administrative reasons by sponsor|0|||
160471326|NCT03662659|579454610|FG000|Treatment|maximum clinical benefit|0|||
160471327|NCT03662659|579454611|FG001|Treatment|maximum clinical benefit|2|||
160471328|NCT04118894|579454616|FG000|Overall Study|Lost to Follow-up|21|||
160471329|NCT04118894|579454616|FG000|Overall Study|Withdrawal by Subject|10|||
160600754|NCT01237223|579916447|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
160600755|NCT01237223|579916448|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
160471330|NCT04118894|579454616|FG000|Overall Study|Adverse Event|4|||
160471331|NCT04369664|579455957|FG000|Overall Study|Physician Decision|1|||
160471332|NCT04369664|579455958|FG001|Overall Study|Physician Decision|0|||
160471333|NCT04493424|579455959|FG000|Overall Study|Termination of the trial by the sponsor|89|||
160471334|NCT04493424|579455959|FG000|Overall Study|Withdrawal by Subject|9|||
160471335|NCT04493424|579455959|FG000|Overall Study|Lost to Follow-up|2|||
160471336|NCT04493424|579455959|FG000|Overall Study|Lack of Efficacy|3|||
160471337|NCT04493424|579455959|FG000|Overall Study|Adverse Event|5|||
160471338|NCT03769090|579455961|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
160471339|NCT03769090|579455962|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
160471340|NCT03769090|579455963|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
160471341|NCT03769090|579455961|FG000|Overall Study|Withdrawal by Subject|52|||
160600756|NCT01237223|579916449|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
160600757|NCT01237223|579916450|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
160600758|NCT01237223|579916445|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
160600759|NCT01237223|579916446|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
160600760|NCT01237223|579916447|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
160600761|NCT01237223|579916448|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
160600762|NCT01237223|579916449|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
160600763|NCT01237223|579916450|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
160600764|NCT01237223|579916445|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
160600765|NCT01237223|579916446|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
160600766|NCT01237223|579916447|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
160600767|NCT01237223|579916448|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
160600768|NCT01237223|579916449|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
160600769|NCT01237223|579916450|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
160600770|NCT01237223|579916445|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
160600771|NCT01237223|579916446|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
160600772|NCT01237223|579916447|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
160600773|NCT01237223|579916448|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
160600774|NCT01237223|579916449|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
160600775|NCT01237223|579916450|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
160600776|NCT01237223|579916445|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
160600777|NCT01237223|579916446|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
160600778|NCT01237223|579916447|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
160600779|NCT01237223|579916448|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
160600780|NCT01237223|579916449|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
160600781|NCT01237223|579916450|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
160600782|NCT01237223|579916445|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
160600783|NCT01237223|579916446|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
160600784|NCT01237223|579916447|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
160600785|NCT01237223|579916448|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
160600786|NCT01237223|579916449|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
160600787|NCT01237223|579916450|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
160600788|NCT01237223|579916445|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
160600789|NCT01237223|579916446|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
160600790|NCT01237223|579916447|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
160600791|NCT01237223|579916448|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
160600792|NCT01237223|579916449|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
160600793|NCT01237223|579916450|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
160600794|NCT01237223|579916445|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
160600795|NCT01237223|579916446|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
160600796|NCT01237223|579916447|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
160600797|NCT01237223|579916448|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
160600798|NCT01237223|579916449|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
160600799|NCT01237223|579916450|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
160600800|NCT01237223|579916445|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
160600801|NCT01237223|579916446|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
160600802|NCT01237223|579916447|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
160600803|NCT01237223|579916448|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
160600804|NCT01237223|579916449|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
160600805|NCT01237223|579916450|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
160600806|NCT00443846|579916454|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
160659681|NCT01367457|580136124|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
160659682|NCT01367457|580136122|FG000|Overall Study|low grade toxicities + stable disease|1|||
160659683|NCT01367457|580136123|FG001|Overall Study|low grade toxicities + stable disease|0|||
160600807|NCT00443846|579916455|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
160600808|NCT00443846|579916454|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
160600809|NCT00443846|579916455|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
160600810|NCT00443846|579916454|FG000|Overall Study|Adverse Event|0|||
160600811|NCT00443846|579916455|FG001|Overall Study|Adverse Event|1|||
160600812|NCT00443846|579916454|FG000|Overall Study|Personal reason|8|||
160600813|NCT00443846|579916455|FG001|Overall Study|Personal reason|3|||
160659684|NCT01367457|580136124|FG002|Overall Study|low grade toxicities + stable disease|0|||
160471342|NCT03769090|579455962|FG001|Overall Study|Withdrawal by Subject|62|||
160471343|NCT03769090|579455963|FG002|Overall Study|Withdrawal by Subject|74|||
160471344|NCT03769090|579455961|FG000|Overall Study|Death|4|||
160471345|NCT03769090|579455962|FG001|Overall Study|Death|2|||
160471346|NCT03769090|579455963|FG002|Overall Study|Death|2|||
160471347|NCT03769090|579455961|FG000|Overall Study|Adverse Event|7|||
160471348|NCT03769090|579455962|FG001|Overall Study|Adverse Event|7|||
160471349|NCT03769090|579455963|FG002|Overall Study|Adverse Event|8|||
160471350|NCT03769090|579455961|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
160471351|NCT03769090|579455962|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
160471352|NCT03769090|579455963|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
160471353|NCT03769090|579455961|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
160471354|NCT03769090|579455962|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
160471355|NCT03769090|579455963|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
160471356|NCT03769090|579455961|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
160471357|NCT03769090|579455962|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
160471358|NCT03769090|579455963|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
160471359|NCT03769090|579455961|FG000|Overall Study|Protocol Violation|5|||
160471360|NCT03769090|579455962|FG001|Overall Study|Protocol Violation|6|||
160471361|NCT03769090|579455963|FG002|Overall Study|Protocol Violation|8|||
160471362|NCT03769090|579455961|FG000|Overall Study|Pregnancy|1|||
160471363|NCT03769090|579455962|FG001|Overall Study|Pregnancy|0|||
160471364|NCT03769090|579455963|FG002|Overall Study|Pregnancy|3|||
160471365|NCT03769090|579455961|FG000|Overall Study|Lost to Follow-up|19|||
160471366|NCT03769090|579455962|FG001|Overall Study|Lost to Follow-up|25|||
160471367|NCT03769090|579455963|FG002|Overall Study|Lost to Follow-up|21|||
160471368|NCT03769090|579455961|FG000|Overall Study|Condition under investigation worsened|2|||
160471369|NCT03769090|579455962|FG001|Overall Study|Condition under investigation worsened|0|||
160471370|NCT03769090|579455963|FG002|Overall Study|Condition under investigation worsened|1|||
160471371|NCT03769090|579455961|FG000|Overall Study|Lack of Efficacy|1|||
160471372|NCT03769090|579455962|FG001|Overall Study|Lack of Efficacy|2|||
160471373|NCT03769090|579455963|FG002|Overall Study|Lack of Efficacy|2|||
160471374|NCT03769090|579455961|FG000|Overall Study|Other reasons|8|||
160471375|NCT03769090|579455962|FG001|Overall Study|Other reasons|12|||
160471376|NCT03769090|579455963|FG002|Overall Study|Other reasons|15|||
160471377|NCT02830893|579455969|FG000|Overall Study|Relocation to out of the country|1|||
160471378|NCT02830893|579455970|FG001|Overall Study|Relocation to out of the country|0|||
160471379|NCT02830893|579455969|FG000|Overall Study|Lost to Follow-up|0|||
160471380|NCT02830893|579455970|FG001|Overall Study|Lost to Follow-up|2|||
160471381|NCT02830893|579455969|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
160471382|NCT02830893|579455970|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
160471383|NCT01277302|579455971|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
160471384|NCT01277302|579455972|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
160471385|NCT01277302|579455973|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
160471386|NCT01277302|579455971|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
160471387|NCT01277302|579455972|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
160471388|NCT01277302|579455973|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
160471389|NCT01277302|579455971|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
160471390|NCT01277302|579455972|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
160471391|NCT01277302|579455973|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
160471392|NCT01277302|579455971|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
160471393|NCT01277302|579455972|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
160471394|NCT01277302|579455973|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
160471395|NCT01277302|579455971|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
160471396|NCT01277302|579455972|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
160471397|NCT01277302|579455973|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
160471398|NCT01277302|579455971|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
160471399|NCT01277302|579455972|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
160471400|NCT01277302|579455973|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
160471401|NCT01277302|579455971|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
160471402|NCT01277302|579455972|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
160471403|NCT01277302|579455973|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
160471404|NCT01277302|579455971|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
160471405|NCT01277302|579455972|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
160471406|NCT01277302|579455973|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
160600814|NCT00443846|579916454|FG000|Overall Study|Lost to Follow-up|1|||
160600815|NCT00443846|579916455|FG001|Overall Study|Lost to Follow-up|2|||
160600816|NCT00445341|579916459|FG000|Overall Study|refused further treatment|1|||
160600817|NCT00445341|579916459|FG000|Overall Study|taken off treatment too early|1|||
160600818|NCT00641706|579916460|FG000|Overall Study|Adverse Event|2|||
160471407|NCT01277302|579455971|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
160471408|NCT01277302|579455972|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
160471409|NCT01277302|579455973|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
160471410|NCT02710669|579455974|FG000|Overall Study|Physician Decision|2|||
160471411|NCT02710669|579455975|FG001|Overall Study|Physician Decision|1|||
160471412|NCT02710669|579455976|FG002|Overall Study|Physician Decision|0|||
160471413|NCT02710669|579455974|FG000|Overall Study|Institutional delays (including COVID)|2|||
160471414|NCT02710669|579455975|FG001|Overall Study|Institutional delays (including COVID)|2|||
160471415|NCT02710669|579455976|FG002|Overall Study|Institutional delays (including COVID)|0|||
160471416|NCT02710669|579455974|FG000|Overall Study|arrived in afib/aflutter|10|||
160471417|NCT02710669|579455975|FG001|Overall Study|arrived in afib/aflutter|8|||
160471418|NCT02710669|579455976|FG002|Overall Study|arrived in afib/aflutter|2|||
160471419|NCT01567852|579455979|FG000|Overall Study|Withdrawal by Subject|3|||
160471420|NCT01567852|579455980|FG001|Overall Study|Withdrawal by Subject|6|||
160471421|NCT01567852|579455979|FG000|Overall Study|ECT discontinued|1|||
160471422|NCT01567852|579455980|FG001|Overall Study|ECT discontinued|1|||
160471423|NCT03332589|579455981|FG000|Overall Study|Lack of Efficacy|2|||
160471424|NCT03332589|579455982|FG001|Overall Study|Lack of Efficacy|0|||
160471425|NCT03332589|579455983|FG002|Overall Study|Lack of Efficacy|0|||
160471426|NCT03332589|579455981|FG000|Overall Study|Adverse Event|1|||
160471427|NCT03332589|579455982|FG001|Overall Study|Adverse Event|0|||
160471428|NCT03332589|579455983|FG002|Overall Study|Adverse Event|0|||
160471429|NCT03332589|579455981|FG000|Overall Study|Death|1|||
160471430|NCT03332589|579455982|FG001|Overall Study|Death|0|||
160471431|NCT03332589|579455983|FG002|Overall Study|Death|0|||
160471432|NCT01190124|579455985|FG000|Overall Study|Death|3|||
160471433|NCT01190124|579455986|FG001|Overall Study|Death|0|||
160471434|NCT01190124|579455987|FG002|Overall Study|Death|0|||
160471435|NCT01190124|579455985|FG000|Overall Study|Therapeutic Failure|12|||
160471436|NCT01190124|579455986|FG001|Overall Study|Therapeutic Failure|0|||
160471437|NCT01190124|579455987|FG002|Overall Study|Therapeutic Failure|1|||
160471438|NCT01190124|579455985|FG000|Overall Study|Lost to Follow-up|2|||
160471439|NCT01190124|579455986|FG001|Overall Study|Lost to Follow-up|0|||
160471440|NCT01190124|579455987|FG002|Overall Study|Lost to Follow-up|0|||
160471441|NCT03690219|579455988|FG000|Overall Study|no injuries|9|||
160471442|NCT03690219|579455989|FG001|Overall Study|no injuries|20|||
160471443|NCT03690219|579455988|FG000|Overall Study|missing information|7|||
160471444|NCT03690219|579455989|FG001|Overall Study|missing information|7|||
160471445|NCT01523392|579455990|FG000|Treatment Period 1|Withdrawal by Subject|2|||
160471446|NCT01523392|579455991|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160471447|NCT01523392|579455990|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
160471448|NCT01523392|579455991|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
160471449|NCT01523392|579455990|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
160471450|NCT01523392|579455991|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
160471451|NCT04809623|579455992|FG000|Overall Study|Study Terminated by Sponsor|1|||
160471452|NCT04809623|579455993|FG001|Overall Study|Study Terminated by Sponsor|0|||
160471453|NCT00671853|579455995|FG000|Overall Study|Lack of Efficacy|3|||
160471454|NCT00671853|579455996|FG001|Overall Study|Lack of Efficacy|7|||
160471455|NCT00671853|579455995|FG000|Overall Study|Adverse Event|7|||
160471456|NCT00671853|579455996|FG001|Overall Study|Adverse Event|1|||
160471457|NCT00671853|579455995|FG000|Overall Study|Withdrawal by Subject|1|||
160471458|NCT00671853|579455996|FG001|Overall Study|Withdrawal by Subject|5|||
160471459|NCT00671853|579455995|FG000|Overall Study|Lost to Follow-up|8|||
160471460|NCT00671853|579455996|FG001|Overall Study|Lost to Follow-up|8|||
160471461|NCT00671853|579455995|FG000|Overall Study|Physician Decision|0|||
160471462|NCT00671853|579455996|FG001|Overall Study|Physician Decision|2|||
160471463|NCT00671853|579455995|FG000|Overall Study|Non-adherence with study procedures|1|||
160471464|NCT00671853|579455996|FG001|Overall Study|Non-adherence with study procedures|4|||
160600819|NCT00641706|579916461|FG001|Overall Study|Adverse Event|1|||
160600820|NCT00641706|579916460|FG000|Overall Study|Withdrawal by Subject|6|||
160471465|NCT02354417|579455997|FG000|Overall Study|Physician Decision|1|||
160471466|NCT02092285|579455998|FG000|Induction Phase|Adverse Event|7|||
160471467|NCT02092285|579455998|FG000|Induction Phase|Physician Decision|4|||
160471468|NCT02092285|579455998|FG000|Induction Phase|Pregnancy|1|||
160471469|NCT02092285|579455998|FG000|Induction Phase|Relapse/Recurrence|7|||
160471470|NCT02092285|579455998|FG000|Induction Phase|Withdrawal by Subject|2|||
160471471|NCT02092285|579455998|FG000|Induction Phase|Lack of Efficacy|14|||
160471472|NCT02092285|579455998|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
160471473|NCT02092285|579455998|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
160471474|NCT02092285|579455998|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
160471475|NCT02092285|579455998|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
160471476|NCT02092285|579455998|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
160471477|NCT02092285|579455998|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
160471478|NCT02092285|579455998|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
160471479|NCT02092285|579455998|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
160471480|NCT02092285|579455998|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
160471481|NCT00087516|579455999|FG000|Overall Study|Adverse Event|10|||
160600821|NCT00641706|579916461|FG001|Overall Study|Withdrawal by Subject|1|||
160600822|NCT00641706|579916460|FG000|Overall Study|Clinical Decline|1|||
160600823|NCT00641706|579916461|FG001|Overall Study|Clinical Decline|0|||
160600824|NCT00641706|579916460|FG000|Overall Study|Lead Investigator Decision|0|||
160600825|NCT00641706|579916461|FG001|Overall Study|Lead Investigator Decision|1|||
160600826|NCT00109772|579916464|FG000|Double-blind Treatment|Adverse Event|14|||
160600827|NCT00109772|579916465|FG001|Double-blind Treatment|Adverse Event|5|||
160659685|NCT01367457|580136122|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
160659686|NCT01367457|580136123|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
160659687|NCT01367457|580136124|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
160600828|NCT00109772|579916464|FG000|Double-blind Treatment|Lack of Efficacy|1|||
160659688|NCT01367457|580136122|FG000|Overall Study|Withdrawal by Subject|1|||
160659689|NCT01367457|580136123|FG001|Overall Study|Withdrawal by Subject|0|||
160659690|NCT01367457|580136124|FG002|Overall Study|Withdrawal by Subject|0|||
160659691|NCT01367457|580136122|FG000|Overall Study|CD, associated leukaemia|1|||
160600829|NCT00109772|579916465|FG001|Double-blind Treatment|Lack of Efficacy|0|||
160600830|NCT00109772|579916464|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
160600831|NCT00109772|579916465|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
160600832|NCT00109772|579916464|FG000|Double-blind Treatment|Lost to Follow-up|2|||
160600833|NCT00109772|579916465|FG001|Double-blind Treatment|Lost to Follow-up|3|||
160600834|NCT00109772|579916464|FG000|Double-blind Treatment|Protocol Violation|0|||
160600835|NCT00109772|579916465|FG001|Double-blind Treatment|Protocol Violation|1|||
160659692|NCT01367457|580136123|FG001|Overall Study|CD, associated leukaemia|0|||
160600836|NCT00109772|579916464|FG000|Double-blind Treatment|Other|0|||
160600837|NCT00109772|579916465|FG001|Double-blind Treatment|Other|4|||
160600838|NCT00109772|579916464|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
160600839|NCT00109772|579916465|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
160600840|NCT00109772|579916464|FG000|Open-label Extension|Adverse Event|10|||
160600841|NCT00109772|579916465|FG001|Open-label Extension|Adverse Event|19|||
160600842|NCT00109772|579916464|FG000|Open-label Extension|Lack of Efficacy|19|||
160600843|NCT00109772|579916465|FG001|Open-label Extension|Lack of Efficacy|11|||
160600844|NCT00109772|579916464|FG000|Open-label Extension|Withdrawal by Subject|9|||
160600845|NCT00109772|579916465|FG001|Open-label Extension|Withdrawal by Subject|6|||
160600846|NCT00109772|579916464|FG000|Open-label Extension|Lost to Follow-up|1|||
160471482|NCT00087516|579456000|FG001|Overall Study|Adverse Event|10|||
160471483|NCT00087516|579456001|FG002|Overall Study|Adverse Event|3|||
160471484|NCT00087516|579456002|FG003|Overall Study|Adverse Event|6|||
160471485|NCT00087516|579455999|FG000|Overall Study|Lack of Efficacy|82|||
160471486|NCT00087516|579456000|FG001|Overall Study|Lack of Efficacy|80|||
160471487|NCT00087516|579456001|FG002|Overall Study|Lack of Efficacy|39|||
160471488|NCT00087516|579456002|FG003|Overall Study|Lack of Efficacy|29|||
160471489|NCT00087516|579455999|FG000|Overall Study|Lost to Follow-up|8|||
160471490|NCT00087516|579456000|FG001|Overall Study|Lost to Follow-up|6|||
160471491|NCT00087516|579456001|FG002|Overall Study|Lost to Follow-up|5|||
160471492|NCT00087516|579456002|FG003|Overall Study|Lost to Follow-up|5|||
160471493|NCT00087516|579455999|FG000|Overall Study|Protocol Violation|4|||
160471494|NCT00087516|579456000|FG001|Overall Study|Protocol Violation|8|||
160471495|NCT00087516|579456001|FG002|Overall Study|Protocol Violation|3|||
160471496|NCT00087516|579456002|FG003|Overall Study|Protocol Violation|6|||
160471497|NCT00087516|579455999|FG000|Overall Study|Withdrawal by Subject|16|||
160471498|NCT00087516|579456000|FG001|Overall Study|Withdrawal by Subject|27|||
160471499|NCT00087516|579456001|FG002|Overall Study|Withdrawal by Subject|11|||
160471500|NCT00087516|579456002|FG003|Overall Study|Withdrawal by Subject|12|||
160471501|NCT00087516|579455999|FG000|Overall Study|Site terminated|0|||
160471502|NCT00087516|579456000|FG001|Overall Study|Site terminated|2|||
160471503|NCT00087516|579456001|FG002|Overall Study|Site terminated|1|||
160471504|NCT00087516|579456002|FG003|Overall Study|Site terminated|0|||
160471505|NCT00087516|579455999|FG000|Overall Study|Protocol specified discontinuation|35|||
160471506|NCT00087516|579456000|FG001|Overall Study|Protocol specified discontinuation|33|||
160471507|NCT00087516|579456001|FG002|Overall Study|Protocol specified discontinuation|33|||
160471508|NCT00087516|579456002|FG003|Overall Study|Protocol specified discontinuation|26|||
160471509|NCT00087516|579455999|FG000|Overall Study|Patient moved|3|||
160471510|NCT00087516|579456000|FG001|Overall Study|Patient moved|2|||
160471511|NCT00087516|579456001|FG002|Overall Study|Patient moved|1|||
160471512|NCT00087516|579456002|FG003|Overall Study|Patient moved|0|||
160471513|NCT00087516|579455999|FG000|Overall Study|Patient was non-compliant|3|||
160471514|NCT00087516|579456000|FG001|Overall Study|Patient was non-compliant|1|||
160471515|NCT00087516|579456001|FG002|Overall Study|Patient was non-compliant|0|||
160471516|NCT00087516|579456002|FG003|Overall Study|Patient was non-compliant|0|||
160471517|NCT00087516|579455999|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
160471518|NCT00087516|579456000|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
160471519|NCT00087516|579456001|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
160471520|NCT00087516|579456002|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
160471521|NCT00087516|579455999|FG000|Overall Study|Other|0|||
160471522|NCT00087516|579456000|FG001|Overall Study|Other|0|||
160471523|NCT00087516|579456001|FG002|Overall Study|Other|1|||
160471524|NCT00087516|579456002|FG003|Overall Study|Other|0|||
160471525|NCT01719172|579456003|FG000|Overall Study|Lost to Follow-up|1|||
160471526|NCT01719172|579456003|FG000|Overall Study|Death|1|||
160471527|NCT01848483|579456004|FG000|Overall Study|Death|2|||
160471528|NCT01848483|579456005|FG001|Overall Study|Death|1|||
160471529|NCT01848483|579456004|FG000|Overall Study|Lost to Follow-up|6|||
160471530|NCT01848483|579456005|FG001|Overall Study|Lost to Follow-up|8|||
160471531|NCT01848483|579456004|FG000|Overall Study|Withdrawal by Subject|1|||
160471532|NCT01848483|579456005|FG001|Overall Study|Withdrawal by Subject|0|||
160471533|NCT01848483|579456004|FG000|Overall Study|Incarceration|2|||
160471534|NCT01848483|579456005|FG001|Overall Study|Incarceration|2|||
160471535|NCT02236611|579456008|FG000|Overall Study|Adverse Event|10|||
160471536|NCT02236611|579456009|FG001|Overall Study|Adverse Event|16|||
160471537|NCT02236611|579456008|FG000|Overall Study|Lack of Efficacy|4|||
160471538|NCT02236611|579456009|FG001|Overall Study|Lack of Efficacy|7|||
160471539|NCT02236611|579456008|FG000|Overall Study|Lost to Follow-up|0|||
160471540|NCT02236611|579456009|FG001|Overall Study|Lost to Follow-up|2|||
160471541|NCT02236611|579456008|FG000|Overall Study|Protocol deviation|3|||
160471542|NCT02236611|579456009|FG001|Overall Study|Protocol deviation|5|||
160471543|NCT02236611|579456008|FG000|Overall Study|Withdrew consent|9|||
160471544|NCT02236611|579456009|FG001|Overall Study|Withdrew consent|4|||
160471545|NCT03041090|579456010|FG000|Overall Study|technical error|0|||
160471546|NCT03041090|579456011|FG001|Overall Study|technical error|3|||
160471547|NCT02202317|579456012|FG000|Overall Study|Lost to Follow-up|1|||
160471548|NCT02338999|579456013|FG000|First Intervention|Withdrawal by Subject|3|||
160471549|NCT02338999|579456014|FG001|First Intervention|Withdrawal by Subject|1|||
160471550|NCT02338999|579456013|FG000|Washout Period|Withdrawal by Subject|0|||
160471551|NCT02338999|579456014|FG001|Washout Period|Withdrawal by Subject|2|||
160471552|NCT02338999|579456013|FG000|Second Intervention|Withdrawal by Subject|0|||
160471553|NCT02338999|579456014|FG001|Second Intervention|Withdrawal by Subject|2|||
160471554|NCT02701296|579456015|FG000|Overall Study|Incomplete Data|0|||
160471555|NCT02701296|579456016|FG001|Overall Study|Incomplete Data|2|||
160471556|NCT01450007|579456018|FG000|Overall Study|Late exclusion before treatment|2|||
160471557|NCT01450007|579456019|FG001|Overall Study|Late exclusion before treatment|3|||
160471558|NCT01450007|579456020|FG002|Overall Study|Late exclusion before treatment|2|||
160471559|NCT01450007|579456018|FG000|Overall Study|Protocol Violation|0|||
160600847|NCT00109772|579916465|FG001|Open-label Extension|Lost to Follow-up|0|||
160600848|NCT00109772|579916464|FG000|Open-label Extension|Death|0|||
160471560|NCT01450007|579456019|FG001|Overall Study|Protocol Violation|1|||
160471561|NCT01450007|579456020|FG002|Overall Study|Protocol Violation|1|||
160471562|NCT01450007|579456018|FG000|Overall Study|Adverse Event|0|||
160471563|NCT01450007|579456019|FG001|Overall Study|Adverse Event|1|||
160471564|NCT01450007|579456020|FG002|Overall Study|Adverse Event|0|||
160471565|NCT03851094|579456021|FG000|Overall Study|Withdrawal by Subject|0|||
160471566|NCT03851094|579456022|FG001|Overall Study|Withdrawal by Subject|1|||
160471567|NCT03851094|579456021|FG000|Overall Study|Participant lost device|0|||
160471568|NCT03851094|579456022|FG001|Overall Study|Participant lost device|1|||
160471569|NCT03851094|579456021|FG000|Overall Study|Participant returned device|0|||
160471570|NCT03851094|579456022|FG001|Overall Study|Participant returned device|2|||
160471571|NCT00484198|579456023|FG000|Overall Study|Participant Withdrew Consent|12|||
160471572|NCT00484198|579456024|FG001|Overall Study|Participant Withdrew Consent|21|||
160471573|NCT00484198|579456025|FG002|Overall Study|Participant Withdrew Consent|47|||
160471574|NCT00484198|579456026|FG003|Overall Study|Participant Withdrew Consent|59|||
160471575|NCT00484198|579456023|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
160471576|NCT00484198|579456024|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
160471577|NCT00484198|579456025|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
160471578|NCT00484198|579456026|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
160471579|NCT00484198|579456023|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
160471580|NCT00484198|579456024|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
160471581|NCT00484198|579456025|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
160471582|NCT00484198|579456026|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
160471583|NCT00484198|579456023|FG000|Overall Study|Adverse Event|3|||
160471584|NCT00484198|579456024|FG001|Overall Study|Adverse Event|11|||
160471585|NCT00484198|579456025|FG002|Overall Study|Adverse Event|32|||
160471586|NCT00484198|579456026|FG003|Overall Study|Adverse Event|31|||
160471587|NCT00484198|579456023|FG000|Overall Study|Protocol Violation|0|||
160471588|NCT00484198|579456024|FG001|Overall Study|Protocol Violation|5|||
160471589|NCT00484198|579456025|FG002|Overall Study|Protocol Violation|6|||
160471590|NCT00484198|579456026|FG003|Overall Study|Protocol Violation|8|||
160471591|NCT00484198|579456023|FG000|Overall Study|Other|7|||
160471592|NCT00484198|579456024|FG001|Overall Study|Other|10|||
160471593|NCT00484198|579456025|FG002|Overall Study|Other|31|||
160471594|NCT00484198|579456026|FG003|Overall Study|Other|28|||
160471595|NCT01536704|579456027|FG000|Washout Period 1|Withdrawal by Subject|1|||
160471596|NCT01536704|579456028|FG001|Washout Period 1|Withdrawal by Subject|2|||
160471597|NCT01536704|579456029|FG002|Washout Period 1|Withdrawal by Subject|0|||
160471598|NCT01536704|579456030|FG003|Washout Period 1|Withdrawal by Subject|0|||
160471599|NCT01536704|579456027|FG000|Washout Period 2|Adverse Event|1|||
160471600|NCT01536704|579456028|FG001|Washout Period 2|Adverse Event|0|||
160471601|NCT01536704|579456029|FG002|Washout Period 2|Adverse Event|0|||
160471602|NCT01536704|579456030|FG003|Washout Period 2|Adverse Event|0|||
160471603|NCT01536704|579456027|FG000|Washout Period 2|Withdrawal by Subject|0|||
160471604|NCT01536704|579456028|FG001|Washout Period 2|Withdrawal by Subject|0|||
160471605|NCT01536704|579456029|FG002|Washout Period 2|Withdrawal by Subject|0|||
160471606|NCT01536704|579456030|FG003|Washout Period 2|Withdrawal by Subject|1|||
160471607|NCT01536704|579456027|FG000|Period 3|Adverse Event|0|||
160471608|NCT01536704|579456028|FG001|Period 3|Adverse Event|0|||
160471609|NCT01536704|579456029|FG002|Period 3|Adverse Event|0|||
160471610|NCT01536704|579456030|FG003|Period 3|Adverse Event|1|||
160471611|NCT01536704|579456027|FG000|Washout Period 3|Adverse Event|0|||
160471612|NCT01536704|579456028|FG001|Washout Period 3|Adverse Event|0|||
160471613|NCT01536704|579456029|FG002|Washout Period 3|Adverse Event|1|||
160659693|NCT01367457|580136124|FG002|Overall Study|CD, associated leukaemia|0|||
160659694|NCT01367457|580136122|FG000|Overall Study|Uncontrolled pain|1|||
160659695|NCT01367457|580136123|FG001|Overall Study|Uncontrolled pain|0|||
160659696|NCT01367457|580136124|FG002|Overall Study|Uncontrolled pain|0|||
160471614|NCT01536704|579456030|FG003|Washout Period 3|Adverse Event|0|||
160471615|NCT04658784|579456031|FG000|6-month Follow-up|Lost to Follow-up|2|||
160471616|NCT04658784|579456032|FG001|6-month Follow-up|Lost to Follow-up|5|||
160471617|NCT02958553|579456033|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
160471618|NCT02958553|579456033|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
160471619|NCT00704340|579456041|FG000|Overall Study|Lost to Follow-up|2|||
160659697|NCT01367457|580136122|FG000|Overall Study|Overall status worsens to grade 4|1|||
160659698|NCT01367457|580136123|FG001|Overall Study|Overall status worsens to grade 4|0|||
160471620|NCT00704340|579456042|FG001|Overall Study|Lost to Follow-up|1|||
160471621|NCT00704340|579456041|FG000|Overall Study|Death|0|||
160471622|NCT00704340|579456042|FG001|Overall Study|Death|1|||
160471623|NCT00703092|579456046|FG000|Overall Study|Withdrawal by Subject|2|||
160471624|NCT02007070|579456047|FG000|Overall Study|Adverse Event|4|||
160471625|NCT02007070|579456047|FG000|Overall Study|Clinical Progression|4|||
160471626|NCT02007070|579456047|FG000|Overall Study|Death|1|||
160471627|NCT02007070|579456047|FG000|Overall Study|Protocol Violation|2|||
160471628|NCT02007070|579456047|FG000|Overall Study|Physician Decision|1|||
160659699|NCT01367457|580136124|FG002|Overall Study|Overall status worsens to grade 4|0|||
160600849|NCT00109772|579916465|FG001|Open-label Extension|Death|1|||
160600850|NCT00109772|579916464|FG000|Open-label Extension|Protocol Violation|2|||
160600851|NCT00109772|579916465|FG001|Open-label Extension|Protocol Violation|2|||
160600852|NCT00109772|579916464|FG000|Open-label Extension|Other|4|||
160600853|NCT00109772|579916465|FG001|Open-label Extension|Other|10|||
160600854|NCT01989754|579916466|FG000|Overall Study|Withdrawal by Subject|10|||
160600855|NCT01989754|579916467|FG001|Overall Study|Withdrawal by Subject|14|||
160600856|NCT01989754|579916466|FG000|Overall Study|Lost to Follow-up|28|||
160600857|NCT01989754|579916467|FG001|Overall Study|Lost to Follow-up|20|||
160600858|NCT01989754|579916466|FG000|Overall Study|Closed Site|1|||
160600859|NCT01989754|579916467|FG001|Overall Study|Closed Site|1|||
160600860|NCT00391807|579916473|FG000|Overall Study|Did not receive study medication|23|||
160600861|NCT00391807|579916473|FG000|Overall Study|Adverse Event|177|||
160600862|NCT00391807|579916473|FG000|Overall Study|Pregnancy|25|||
160600863|NCT00391807|579916473|FG000|Overall Study|Lost to Follow-up|227|||
160600864|NCT00391807|579916473|FG000|Overall Study|Withdrawal by Subject|147|||
160600865|NCT00391807|579916473|FG000|Overall Study|Protocol Violation|20|||
160600866|NCT00391807|579916473|FG000|Overall Study|Various|96|||
160600867|NCT05441540|579916474|FG000|Overall Study|Withdrawal by Subject|2|||
160600868|NCT00813917|579916475|FG000|Overall Study|Adverse Event|0|||
160600869|NCT00813917|579916476|FG001|Overall Study|Adverse Event|1|||
160600870|NCT00813917|579916475|FG000|Overall Study|Withdrawal by Subject|3|||
160600871|NCT00813917|579916476|FG001|Overall Study|Withdrawal by Subject|4|||
160600872|NCT00813917|579916475|FG000|Overall Study|Lost to Follow-up|3|||
160600873|NCT00813917|579916476|FG001|Overall Study|Lost to Follow-up|1|||
160600874|NCT01359046|579916477|FG000|Overall Study|Did not receive allocated intervention|6|||
160600875|NCT01359046|579916478|FG001|Overall Study|Did not receive allocated intervention|6|||
160600876|NCT01359046|579916477|FG000|Overall Study|Physician Decision|1|||
160600877|NCT01359046|579916478|FG001|Overall Study|Physician Decision|11|||
160600878|NCT01369225|579916483|FG000|Overall Study|Withdrawal by Subject|1|||
160600879|NCT01369225|579916484|FG001|Overall Study|Withdrawal by Subject|0|||
160600880|NCT01369225|579916485|FG002|Overall Study|Withdrawal by Subject|2|||
160600881|NCT01369225|579916486|FG003|Overall Study|Withdrawal by Subject|1|||
160600882|NCT01369225|579916487|FG004|Overall Study|Withdrawal by Subject|0|||
160600883|NCT01369225|579916488|FG005|Overall Study|Withdrawal by Subject|0|||
160600884|NCT01369225|579916483|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
160600885|NCT01369225|579916484|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
160600886|NCT01369225|579916485|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
160600887|NCT01369225|579916486|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
160600888|NCT01369225|579916487|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
160600889|NCT01369225|579916488|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
160600890|NCT01369225|579916483|FG000|Overall Study|Other|1|||
160600891|NCT01369225|579916484|FG001|Overall Study|Other|0|||
160600892|NCT01369225|579916485|FG002|Overall Study|Other|0|||
160600893|NCT01369225|579916486|FG003|Overall Study|Other|0|||
160600894|NCT01369225|579916487|FG004|Overall Study|Other|1|||
160600895|NCT01369225|579916488|FG005|Overall Study|Other|0|||
160600896|NCT01369225|579916483|FG000|Overall Study|Adverse Event|0|||
160600897|NCT01369225|579916484|FG001|Overall Study|Adverse Event|0|||
160600898|NCT01369225|579916485|FG002|Overall Study|Adverse Event|0|||
160600899|NCT01369225|579916486|FG003|Overall Study|Adverse Event|1|||
160600900|NCT01369225|579916487|FG004|Overall Study|Adverse Event|1|||
160600901|NCT01369225|579916488|FG005|Overall Study|Adverse Event|0|||
160600902|NCT04539262|579916490|FG000|Overall Study|Adverse Event|0|||
160600903|NCT04539262|579916491|FG001|Overall Study|Adverse Event|0|||
160600904|NCT04539262|579916492|FG002|Overall Study|Adverse Event|1|||
160600905|NCT04539262|579916493|FG003|Overall Study|Adverse Event|0|||
160600906|NCT04539262|579916494|FG004|Overall Study|Adverse Event|0|||
160600907|NCT04539262|579916495|FG005|Overall Study|Adverse Event|0|||
160600908|NCT04539262|579916496|FG006|Overall Study|Adverse Event|0|||
160659700|NCT01367457|580136122|FG000|Overall Study|Stabilisation + frequent infections|1|||
160659701|NCT01367457|580136123|FG001|Overall Study|Stabilisation + frequent infections|0|||
160471629|NCT02007070|579456047|FG000|Overall Study|Progressive Disease|21|||
160600909|NCT04539262|579916497|FG007|Overall Study|Adverse Event|0|||
160600910|NCT04539262|579916490|FG000|Overall Study|Withdrew Consent|0|||
160600911|NCT04539262|579916491|FG001|Overall Study|Withdrew Consent|0|||
160600912|NCT04539262|579916492|FG002|Overall Study|Withdrew Consent|0|||
160600913|NCT04539262|579916493|FG003|Overall Study|Withdrew Consent|1|||
160600914|NCT04539262|579916494|FG004|Overall Study|Withdrew Consent|0|||
160600915|NCT04539262|579916495|FG005|Overall Study|Withdrew Consent|0|||
160600916|NCT04539262|579916496|FG006|Overall Study|Withdrew Consent|0|||
160600917|NCT04539262|579916497|FG007|Overall Study|Withdrew Consent|0|||
160600918|NCT04539262|579916490|FG000|Overall Study|Randomized, Not treated|0|||
160600919|NCT04539262|579916491|FG001|Overall Study|Randomized, Not treated|1|||
160600920|NCT04539262|579916492|FG002|Overall Study|Randomized, Not treated|0|||
160600921|NCT04539262|579916493|FG003|Overall Study|Randomized, Not treated|0|||
160600922|NCT04539262|579916494|FG004|Overall Study|Randomized, Not treated|0|||
160600923|NCT04539262|579916495|FG005|Overall Study|Randomized, Not treated|0|||
160471630|NCT00403845|579456051|FG000|Treatment Period 1|Subject withdrew consent|1|||
160471631|NCT00403845|579456052|FG001|Treatment Period 1|Subject withdrew consent|0|||
160471632|NCT00403845|579456053|FG002|Treatment Period 1|Subject withdrew consent|0|||
160471633|NCT00403845|579456054|FG003|Treatment Period 1|Subject withdrew consent|0|||
160471634|NCT00403845|579456051|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
160471635|NCT00403845|579456052|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
160471636|NCT00403845|579456053|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
160471637|NCT00403845|579456054|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
160471638|NCT00403845|579456051|FG000|Treatment Period 2|Subject withdrew consent|1|||
160600924|NCT04539262|579916496|FG006|Overall Study|Randomized, Not treated|1|||
160600925|NCT04539262|579916497|FG007|Overall Study|Randomized, Not treated|0|||
160600926|NCT02980692|579916500|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
160600927|NCT02980692|579916501|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
160600928|NCT02980692|579916502|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
160600929|NCT02980692|579916503|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
160600930|NCT02980692|579916504|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
160600931|NCT02980692|579916500|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
160600932|NCT02980692|579916501|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
160600933|NCT02980692|579916502|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
160600934|NCT02980692|579916503|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
160600935|NCT02980692|579916504|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
160600936|NCT02980692|579916500|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
160600937|NCT02980692|579916501|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
160600938|NCT02980692|579916502|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
160600939|NCT02980692|579916503|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
160600940|NCT02980692|579916504|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
160600941|NCT02980692|579916500|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
160600942|NCT02980692|579916501|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
160600943|NCT02980692|579916502|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
160600944|NCT02980692|579916503|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
160471639|NCT00403845|579456052|FG001|Treatment Period 2|Subject withdrew consent|0|||
160471640|NCT00403845|579456053|FG002|Treatment Period 2|Subject withdrew consent|0|||
160600945|NCT02980692|579916504|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
160600946|NCT02980692|579916500|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
160600947|NCT02980692|579916501|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
160600948|NCT02980692|579916502|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
160659702|NCT01367457|580136124|FG002|Overall Study|Stabilisation + frequent infections|0|||
160659703|NCT01367457|580136122|FG000|Overall Study|No clinical benefit|1|||
160659704|NCT01367457|580136123|FG001|Overall Study|No clinical benefit|0|||
160659705|NCT01367457|580136124|FG002|Overall Study|No clinical benefit|0|||
160659706|NCT01367457|580136122|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
160659707|NCT01367457|580136123|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
160659708|NCT01367457|580136124|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
160659709|NCT01367457|580136122|FG000|Overall Study|Overall decline|1|||
160659710|NCT01367457|580136123|FG001|Overall Study|Overall decline|0|||
160659711|NCT01367457|580136124|FG002|Overall Study|Overall decline|0|||
160659712|NCT01367457|580136122|FG000|Overall Study|Rejection of treatment|1|||
160659713|NCT01367457|580136123|FG001|Overall Study|Rejection of treatment|0|||
160659714|NCT01367457|580136124|FG002|Overall Study|Rejection of treatment|0|||
160600949|NCT02980692|579916503|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
160600950|NCT02980692|579916504|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
160600951|NCT02980692|579916500|FG000|Double Blind Placebo Controlled Period|Other|1|||
160600952|NCT02980692|579916501|FG001|Double Blind Placebo Controlled Period|Other|0|||
160600953|NCT02980692|579916502|FG002|Double Blind Placebo Controlled Period|Other|0|||
160600954|NCT02980692|579916503|FG003|Double Blind Placebo Controlled Period|Other|0|||
160600955|NCT02980692|579916504|FG004|Double Blind Placebo Controlled Period|Other|1|||
160600956|NCT02980692|579916500|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
160600957|NCT02980692|579916501|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
160600958|NCT02980692|579916502|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
160600959|NCT02980692|579916503|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
160600960|NCT02980692|579916504|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
160600961|NCT02980692|579916500|FG000|Double-blind Follow-up Period|Adverse Event|0|||
160600962|NCT02980692|579916501|FG001|Double-blind Follow-up Period|Adverse Event|0|||
160600963|NCT02980692|579916502|FG002|Double-blind Follow-up Period|Adverse Event|0|||
160600964|NCT02980692|579916503|FG003|Double-blind Follow-up Period|Adverse Event|1|||
160600965|NCT02980692|579916504|FG004|Double-blind Follow-up Period|Adverse Event|1|||
160600966|NCT02980692|579916500|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
160600967|NCT02980692|579916501|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
160600968|NCT02980692|579916502|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
160600969|NCT02980692|579916503|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
160600970|NCT02980692|579916504|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
160600971|NCT02980692|579916500|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
160600972|NCT02980692|579916501|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
160600973|NCT02980692|579916502|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
160600974|NCT02980692|579916503|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
160600975|NCT02980692|579916504|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
160600976|NCT02980692|579916500|FG000|Double-blind Follow-up Period|Pregnancy|0|||
160600977|NCT02980692|579916501|FG001|Double-blind Follow-up Period|Pregnancy|0|||
160600978|NCT02980692|579916502|FG002|Double-blind Follow-up Period|Pregnancy|1|||
160600979|NCT02980692|579916503|FG003|Double-blind Follow-up Period|Pregnancy|1|||
160600980|NCT02980692|579916504|FG004|Double-blind Follow-up Period|Pregnancy|0|||
160600981|NCT02980692|579916500|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
160600982|NCT02980692|579916501|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
160600983|NCT02980692|579916502|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
160600984|NCT02980692|579916503|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
160600985|NCT02980692|579916504|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
160600986|NCT02980692|579916500|FG000|Double-blind Follow-up Period|Other|0|||
160600987|NCT02980692|579916501|FG001|Double-blind Follow-up Period|Other|0|||
160600988|NCT02980692|579916502|FG002|Double-blind Follow-up Period|Other|1|||
160600989|NCT02980692|579916503|FG003|Double-blind Follow-up Period|Other|1|||
160659715|NCT01367457|580136122|FG000|Overall Study|Lost to Follow-up|1|||
160659716|NCT01367457|580136123|FG001|Overall Study|Lost to Follow-up|0|||
160659717|NCT01367457|580136124|FG002|Overall Study|Lost to Follow-up|0|||
160659718|NCT01367457|580136122|FG000|Overall Study|Death from septic shock|1|||
160659719|NCT01367457|580136123|FG001|Overall Study|Death from septic shock|0|||
160600990|NCT02980692|579916504|FG004|Double-blind Follow-up Period|Other|3|||
160659720|NCT01367457|580136124|FG002|Overall Study|Death from septic shock|0|||
160659721|NCT01367457|580136122|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
160659722|NCT01367457|580136123|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
160659723|NCT01367457|580136124|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
160471641|NCT00403845|579456054|FG003|Treatment Period 2|Subject withdrew consent|0|||
160471642|NCT00403845|579456051|FG000|Treatment Period 3|Subject withdrew consent|0|||
160471643|NCT00403845|579456052|FG001|Treatment Period 3|Subject withdrew consent|0|||
160471644|NCT00403845|579456053|FG002|Treatment Period 3|Subject withdrew consent|0|||
160471645|NCT00403845|579456054|FG003|Treatment Period 3|Subject withdrew consent|1|||
160471646|NCT00403845|579456051|FG000|Treatment Period 3|Adverse Event|0|||
160471647|NCT00403845|579456052|FG001|Treatment Period 3|Adverse Event|0|||
160471648|NCT00403845|579456053|FG002|Treatment Period 3|Adverse Event|0|||
160471649|NCT00403845|579456054|FG003|Treatment Period 3|Adverse Event|1|||
160471650|NCT03316170|579456055|FG000|Overall Study|Death|1|||
160471651|NCT03316170|579456056|FG001|Overall Study|Death|0|||
160471652|NCT03316170|579456055|FG000|Overall Study|Lost to Follow-up|6|||
160471653|NCT03316170|579456056|FG001|Overall Study|Lost to Follow-up|7|||
160471654|NCT01836523|579456057|FG000|Overall Study|Adverse Event|15|||
160471655|NCT01836523|579456058|FG001|Overall Study|Adverse Event|41|||
160471656|NCT01836523|579456059|FG002|Overall Study|Adverse Event|49|||
160471657|NCT01836523|579456060|FG003|Overall Study|Adverse Event|14|||
160471658|NCT01836523|579456057|FG000|Overall Study|Protocol Violation|6|||
160471659|NCT01836523|579456058|FG001|Overall Study|Protocol Violation|3|||
160471660|NCT01836523|579456059|FG002|Overall Study|Protocol Violation|2|||
160471661|NCT01836523|579456060|FG003|Overall Study|Protocol Violation|4|||
160471662|NCT01836523|579456057|FG000|Overall Study|Met Withdrawal Criteria|13|||
160471663|NCT01836523|579456058|FG001|Overall Study|Met Withdrawal Criteria|13|||
160471664|NCT01836523|579456059|FG002|Overall Study|Met Withdrawal Criteria|21|||
160471665|NCT01836523|579456060|FG003|Overall Study|Met Withdrawal Criteria|27|||
160471666|NCT01836523|579456057|FG000|Overall Study|Unclassified|17|||
160471667|NCT01836523|579456058|FG001|Overall Study|Unclassified|28|||
160471668|NCT01836523|579456059|FG002|Overall Study|Unclassified|19|||
160471669|NCT01836523|579456060|FG003|Overall Study|Unclassified|29|||
160471670|NCT02935673|579456061|FG000|Overall Study|Adverse Event|0|||
160471671|NCT02935673|579456062|FG001|Overall Study|Adverse Event|1|||
160471672|NCT02935673|579456063|FG002|Overall Study|Adverse Event|0|||
160471673|NCT02935673|579456061|FG000|Overall Study|Withdrawal by Subject|1|||
160471674|NCT02935673|579456062|FG001|Overall Study|Withdrawal by Subject|2|||
160471675|NCT02935673|579456063|FG002|Overall Study|Withdrawal by Subject|0|||
160471676|NCT00749944|579456064|FG000|Overall Study|Lost to Follow-up|2|||
160471677|NCT00749944|579456065|FG001|Overall Study|Lost to Follow-up|1|||
160471678|NCT00749944|579456064|FG000|Overall Study|Other|1|||
160471679|NCT00749944|579456065|FG001|Overall Study|Other|0|||
160471680|NCT00749944|579456064|FG000|Overall Study|Withdrawal by Subject|2|||
160471681|NCT00749944|579456065|FG001|Overall Study|Withdrawal by Subject|0|||
160471682|NCT00681109|579456066|FG000|Overall Study|Lost to Follow-up|2|||
160471683|NCT00681109|579456067|FG001|Overall Study|Lost to Follow-up|6|||
160471684|NCT00681109|579456068|FG002|Overall Study|Lost to Follow-up|0|||
160471685|NCT03128099|579456069|FG000|Overall Study|High dose task was too long|0|||
160471686|NCT03128099|579456070|FG001|Overall Study|High dose task was too long|4|||
160471687|NCT03128099|579456071|FG002|Overall Study|High dose task was too long|0|||
160471688|NCT03128099|579456069|FG000|Overall Study|Participant got a full time job.|1|||
160471689|NCT03128099|579456070|FG001|Overall Study|Participant got a full time job.|0|||
160471690|NCT03128099|579456071|FG002|Overall Study|Participant got a full time job.|0|||
160471691|NCT03128099|579456069|FG000|Overall Study|Became homeless and lost contact|1|||
160471692|NCT03128099|579456070|FG001|Overall Study|Became homeless and lost contact|0|||
160471693|NCT03128099|579456071|FG002|Overall Study|Became homeless and lost contact|0|||
160471694|NCT03128099|579456069|FG000|Overall Study|Did not complete all the assessments|0|||
160471695|NCT03128099|579456070|FG001|Overall Study|Did not complete all the assessments|0|||
160471696|NCT03128099|579456071|FG002|Overall Study|Did not complete all the assessments|1|||
160471697|NCT00148122|579456072|FG000|Overall Study|Withdrawal by Subject|2|||
160471698|NCT02362789|579456082|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
160471699|NCT02362789|579456083|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
160471700|NCT02362789|579456084|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
160471701|NCT02362789|579456082|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
160471702|NCT02362789|579456083|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
160471703|NCT02362789|579456084|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
160471704|NCT02362789|579456082|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
160471705|NCT02362789|579456083|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
160471706|NCT02362789|579456084|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
160471707|NCT02362789|579456082|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
160471708|NCT02362789|579456083|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
160471709|NCT02362789|579456084|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
160471710|NCT02362789|579456082|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
160471711|NCT02362789|579456083|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
160471712|NCT02362789|579456084|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
160471713|NCT03035942|579456089|FG000|Overall Study|Adverse Event|8|||
160600991|NCT00792701|579916505|FG000|Overall Study|Adverse Event|0|||
160600992|NCT00792701|579916506|FG001|Overall Study|Adverse Event|22|||
160600993|NCT00792701|579916505|FG000|Overall Study|Ineligible|1|||
160600994|NCT00792701|579916506|FG001|Overall Study|Ineligible|3|||
160600995|NCT00792701|579916505|FG000|Overall Study|Withdrawal by Subject|1|||
160659724|NCT01367457|580136122|FG000|Overall Study|Patient's Wish|1|||
160659725|NCT01367457|580136123|FG001|Overall Study|Patient's Wish|0|||
160659726|NCT01367457|580136124|FG002|Overall Study|Patient's Wish|0|||
160659727|NCT01367457|580136122|FG000|Overall Study|Palliative. Overall decline|1|||
160659728|NCT01367457|580136123|FG001|Overall Study|Palliative. Overall decline|0|||
160659729|NCT01367457|580136124|FG002|Overall Study|Palliative. Overall decline|0|||
160659730|NCT01367457|580136122|FG000|Overall Study|Suspected DP/suspected active infection|1|||
160659731|NCT01367457|580136123|FG001|Overall Study|Suspected DP/suspected active infection|0|||
160659732|NCT01367457|580136124|FG002|Overall Study|Suspected DP/suspected active infection|0|||
160659733|NCT03478397|580136125|FG000|Overall Study|Refused to participate|31|||
160659734|NCT03478397|580136126|FG001|Overall Study|Refused to participate|7|||
160659735|NCT04206332|580136127|FG000|Part A|Lost to Follow-up|0|||
160659736|NCT04206332|580136128|FG001|Part A|Lost to Follow-up|1|||
160659737|NCT04206332|580136129|FG002|Part A|Lost to Follow-up|0|||
160659738|NCT04206332|580136130|FG003|Part A|Lost to Follow-up|0|||
160471714|NCT03035942|579456090|FG001|Overall Study|Adverse Event|4|||
160659739|NCT04206332|580136131|FG004|Part A|Lost to Follow-up|0|||
160659740|NCT04206332|580136132|FG005|Part A|Lost to Follow-up|0|||
160659741|NCT04206332|580136133|FG006|Part A|Lost to Follow-up|0|||
160659742|NCT04206332|580136134|FG007|Part A|Lost to Follow-up|0|||
160659743|NCT04206332|580136135|FG008|Part A|Lost to Follow-up|0|||
160659744|NCT04206332|580136136|FG009|Part A|Lost to Follow-up|0|||
160659745|NCT04206332|580136137|FG010|Part A|Lost to Follow-up|0|||
160659746|NCT04206332|580136138|FG011|Part A|Lost to Follow-up|0|||
160659747|NCT04206332|580136139|FG012|Part A|Lost to Follow-up|0|||
160659748|NCT04206332|580136140|FG013|Part A|Lost to Follow-up|0|||
160659749|NCT04206332|580136141|FG014|Part A|Lost to Follow-up|0|||
160659750|NCT04206332|580136142|FG015|Part A|Lost to Follow-up|0|||
160659751|NCT04206332|580136143|FG016|Part A|Lost to Follow-up|0|||
160659752|NCT04206332|580136127|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659753|NCT04206332|580136128|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659754|NCT04206332|580136129|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659755|NCT04206332|580136130|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659756|NCT04206332|580136131|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659757|NCT04206332|580136132|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
160659758|NCT04206332|580136133|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659759|NCT04206332|580136134|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659760|NCT04206332|580136135|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659761|NCT04206332|580136136|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659762|NCT04206332|580136137|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659763|NCT04206332|580136138|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659764|NCT04206332|580136139|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659765|NCT04206332|580136140|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659766|NCT04206332|580136141|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659767|NCT04206332|580136142|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659768|NCT04206332|580136143|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
160659769|NCT04206332|580136127|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659770|NCT04206332|580136128|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659771|NCT04206332|580136129|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659772|NCT04206332|580136130|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659773|NCT04206332|580136131|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160471715|NCT03035942|579456091|FG002|Overall Study|Adverse Event|5|||
160471716|NCT05270460|579456092|FG000|Overall Study|Adverse Event|0|||
160471717|NCT05270460|579456093|FG001|Overall Study|Adverse Event|1|||
160471718|NCT05270460|579456094|FG002|Overall Study|Adverse Event|0|||
160471719|NCT05270460|579456092|FG000|Overall Study|Early Termination|0|||
160471720|NCT05270460|579456093|FG001|Overall Study|Early Termination|1|||
160471721|NCT05270460|579456094|FG002|Overall Study|Early Termination|0|||
160471722|NCT00380250|579456095|FG000|Overall Study|Withdrawal by Subject|39|||
160471723|NCT00380250|579456096|FG001|Overall Study|Withdrawal by Subject|28|||
160471724|NCT00380250|579456095|FG000|Overall Study|Adverse Event|20|||
160471725|NCT00380250|579456096|FG001|Overall Study|Adverse Event|9|||
160659774|NCT04206332|580136132|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659775|NCT04206332|580136133|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160471726|NCT00380250|579456095|FG000|Overall Study|Lack of Efficacy|10|||
160471727|NCT00380250|579456096|FG001|Overall Study|Lack of Efficacy|8|||
160471728|NCT00380250|579456095|FG000|Overall Study|Protocol Violation|15|||
160471729|NCT00380250|579456096|FG001|Overall Study|Protocol Violation|5|||
160471730|NCT00380250|579456095|FG000|Overall Study|Lost to Follow-up|14|||
160471731|NCT00380250|579456096|FG001|Overall Study|Lost to Follow-up|5|||
160471732|NCT00380250|579456095|FG000|Overall Study|Physician Decision|1|||
160471733|NCT00380250|579456096|FG001|Overall Study|Physician Decision|0|||
160471734|NCT01989104|579456097|FG000|Overall Study|Withdrawal by Subject|3|||
160471735|NCT01989104|579456098|FG001|Overall Study|Withdrawal by Subject|0|||
160471736|NCT01989104|579456099|FG002|Overall Study|Withdrawal by Subject|0|||
160600996|NCT00792701|579916506|FG001|Overall Study|Withdrawal by Subject|19|||
160600997|NCT00792701|579916505|FG000|Overall Study|Not protocol specified|17|||
160600998|NCT00792701|579916506|FG001|Overall Study|Not protocol specified|0|||
160600999|NCT04702984|579916509|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
160601000|NCT03862495|579916515|FG000|Overall Study|Lost to Follow-up|37|||
160601001|NCT03862495|579916516|FG001|Overall Study|Lost to Follow-up|35|||
160471737|NCT01989104|579456100|FG003|Overall Study|Withdrawal by Subject|0|||
160471738|NCT01989104|579456101|FG004|Overall Study|Withdrawal by Subject|0|||
160471739|NCT03840200|579458368|FG000|Overall Study|Death|6|||
160471740|NCT03840200|579458369|FG001|Overall Study|Death|3|||
160471741|NCT03840200|579458370|FG002|Overall Study|Death|6|||
160471742|NCT03840200|579458371|FG003|Overall Study|Death|10|||
160471743|NCT03840200|579458368|FG000|Overall Study|Reason Not Specified|2|||
160471744|NCT03840200|579458369|FG001|Overall Study|Reason Not Specified|2|||
160471745|NCT03840200|579458370|FG002|Overall Study|Reason Not Specified|1|||
160471746|NCT03840200|579458371|FG003|Overall Study|Reason Not Specified|15|||
160471747|NCT03840200|579458368|FG000|Overall Study|Physician Decision|0|||
160471748|NCT03840200|579458369|FG001|Overall Study|Physician Decision|0|||
160471749|NCT03840200|579458370|FG002|Overall Study|Physician Decision|0|||
160471750|NCT03840200|579458371|FG003|Overall Study|Physician Decision|2|||
160471751|NCT03840200|579458368|FG000|Overall Study|Progressive Disease|0|||
160471752|NCT03840200|579458369|FG001|Overall Study|Progressive Disease|0|||
160471753|NCT03840200|579458370|FG002|Overall Study|Progressive Disease|0|||
160471754|NCT03840200|579458371|FG003|Overall Study|Progressive Disease|1|||
160471755|NCT03840200|579458368|FG000|Overall Study|Withdrawal by Subject|0|||
160471756|NCT03840200|579458369|FG001|Overall Study|Withdrawal by Subject|1|||
160471757|NCT03840200|579458370|FG002|Overall Study|Withdrawal by Subject|0|||
160471758|NCT03840200|579458371|FG003|Overall Study|Withdrawal by Subject|2|||
160471759|NCT01802333|579458372|FG000|Overall Study|Ineligible|2|||
160471760|NCT01802333|579458373|FG001|Overall Study|Ineligible|6|||
160471761|NCT01802333|579458374|FG002|Overall Study|Ineligible|8|||
160471762|NCT01802333|579458372|FG000|Overall Study|Adverse Event|1|||
160471763|NCT01802333|579458373|FG001|Overall Study|Adverse Event|8|||
160471764|NCT01802333|579458374|FG002|Overall Study|Adverse Event|8|||
160471765|NCT01802333|579458372|FG000|Overall Study|Withdrawal by Subject|6|||
160471766|NCT01802333|579458373|FG001|Overall Study|Withdrawal by Subject|6|||
160471767|NCT01802333|579458374|FG002|Overall Study|Withdrawal by Subject|5|||
160471768|NCT01802333|579458372|FG000|Overall Study|Progression/relapse|1|||
160471769|NCT01802333|579458373|FG001|Overall Study|Progression/relapse|3|||
160471770|NCT01802333|579458374|FG002|Overall Study|Progression/relapse|0|||
160601002|NCT00064077|579916517|FG000|Overall Study|Improper prior treatment|1|||
160601003|NCT00064077|579916518|FG001|Overall Study|Improper prior treatment|0|||
160601004|NCT00064077|579916519|FG002|Overall Study|Improper prior treatment|0|||
160601005|NCT00064077|579916520|FG003|Overall Study|Improper prior treatment|0|||
160601006|NCT00064077|579916517|FG000|Overall Study|Poor risk|2|||
160601007|NCT00064077|579916518|FG001|Overall Study|Poor risk|0|||
160601008|NCT00064077|579916519|FG002|Overall Study|Poor risk|1|||
160601009|NCT00064077|579916520|FG003|Overall Study|Poor risk|1|||
160601010|NCT00064077|579916517|FG000|Overall Study|Pathology|10|||
160601011|NCT00064077|579916518|FG001|Overall Study|Pathology|7|||
160659776|NCT04206332|580136134|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
160601012|NCT00064077|579916519|FG002|Overall Study|Pathology|3|||
160659777|NCT04206332|580136135|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160471771|NCT01802333|579458372|FG000|Overall Study|Death|7|||
160471772|NCT01802333|579458373|FG001|Overall Study|Death|14|||
160471773|NCT01802333|579458374|FG002|Overall Study|Death|13|||
160471774|NCT01802333|579458372|FG000|Overall Study|Other - not protocol specified|32|||
160471775|NCT01802333|579458373|FG001|Overall Study|Other - not protocol specified|22|||
160471776|NCT01802333|579458374|FG002|Overall Study|Other - not protocol specified|24|||
160471777|NCT01802333|579458372|FG000|Overall Study|Did not start treatment|0|||
160471778|NCT01802333|579458373|FG001|Overall Study|Did not start treatment|2|||
160601013|NCT00064077|579916520|FG003|Overall Study|Pathology|4|||
160601014|NCT00064077|579916517|FG000|Overall Study|No surgery|0|||
160471779|NCT01802333|579458374|FG002|Overall Study|Did not start treatment|5|||
160471780|NCT01947491|579458377|FG000|Overall Study|Lost to Follow-up|5|||
160471781|NCT01947491|579458378|FG001|Overall Study|Lost to Follow-up|3|||
160601015|NCT00064077|579916518|FG001|Overall Study|No surgery|0|||
160601016|NCT00064077|579916519|FG002|Overall Study|No surgery|1|||
160601017|NCT00064077|579916520|FG003|Overall Study|No surgery|0|||
160601018|NCT00064077|579916517|FG000|Overall Study|No tumor|0|||
160601019|NCT00064077|579916518|FG001|Overall Study|No tumor|0|||
160601020|NCT00064077|579916519|FG002|Overall Study|No tumor|1|||
160601021|NCT00064077|579916520|FG003|Overall Study|No tumor|0|||
160471782|NCT01947491|579458379|FG002|Overall Study|Lost to Follow-up|1|||
160601022|NCT00064077|579916517|FG000|Overall Study|Other reasons|2|||
160601023|NCT00064077|579916518|FG001|Overall Study|Other reasons|2|||
160471783|NCT01947491|579458380|FG003|Overall Study|Lost to Follow-up|2|||
160471784|NCT01947491|579458377|FG000|Overall Study|Lack of Efficacy|1|||
160471785|NCT01947491|579458378|FG001|Overall Study|Lack of Efficacy|0|||
160471786|NCT01947491|579458379|FG002|Overall Study|Lack of Efficacy|0|||
160471787|NCT01947491|579458380|FG003|Overall Study|Lack of Efficacy|1|||
160471788|NCT01947491|579458377|FG000|Overall Study|Protocol Violation|1|||
160471789|NCT01947491|579458378|FG001|Overall Study|Protocol Violation|0|||
160471790|NCT01947491|579458379|FG002|Overall Study|Protocol Violation|0|||
160471791|NCT01947491|579458380|FG003|Overall Study|Protocol Violation|0|||
160471792|NCT01947491|579458377|FG000|Overall Study|Withdrawal by Subject|1|||
160471793|NCT01947491|579458378|FG001|Overall Study|Withdrawal by Subject|1|||
160471794|NCT01947491|579458379|FG002|Overall Study|Withdrawal by Subject|1|||
160471795|NCT01947491|579458380|FG003|Overall Study|Withdrawal by Subject|0|||
160471796|NCT01947491|579458377|FG000|Overall Study|Worsening of condition|0|||
160471797|NCT01947491|579458378|FG001|Overall Study|Worsening of condition|1|||
160471798|NCT01947491|579458379|FG002|Overall Study|Worsening of condition|0|||
160471799|NCT01947491|579458380|FG003|Overall Study|Worsening of condition|0|||
160471800|NCT01947491|579458377|FG000|Overall Study|Adverse Event|0|||
160471801|NCT01947491|579458378|FG001|Overall Study|Adverse Event|1|||
160471802|NCT01947491|579458379|FG002|Overall Study|Adverse Event|0|||
160471803|NCT01947491|579458380|FG003|Overall Study|Adverse Event|2|||
160471804|NCT02224755|579458382|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
160471805|NCT02224755|579458383|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
160471806|NCT02224755|579458382|FG000|Two Year Follow up Post-implant|Death|103|||
160471807|NCT02224755|579458383|FG001|Two Year Follow up Post-implant|Death|98|||
160471808|NCT02224755|579458382|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
160471809|NCT02224755|579458383|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
160471810|NCT02224755|579458382|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
160471811|NCT02224755|579458383|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
160471812|NCT02224755|579458382|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
160471813|NCT02224755|579458383|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
160471814|NCT02067663|579458384|FG000|Overall Study|Lost to Follow-up|13|||
160471815|NCT02067663|579458385|FG001|Overall Study|Lost to Follow-up|14|||
160471816|NCT04311983|579458386|FG000|Overall Study|Lost to Follow-up|421|||
160471817|NCT04311983|579458387|FG001|Overall Study|Lost to Follow-up|456|||
160471818|NCT04311983|579458386|FG000|Overall Study|Incomplete survey|7|||
160471819|NCT04311983|579458387|FG001|Overall Study|Incomplete survey|9|||
160471820|NCT04311983|579458386|FG000|Overall Study|Death|1|||
160471821|NCT04311983|579458387|FG001|Overall Study|Death|0|||
160471822|NCT00486954|579458391|FG000|Pilot Part|Adverse Event|4|||
160471823|NCT00486954|579458392|FG001|Pilot Part|Adverse Event|0|||
160471824|NCT00486954|579458393|FG002|Pilot Part|Adverse Event|5|||
160471825|NCT00486954|579458394|FG003|Pilot Part|Adverse Event|0|||
160471826|NCT00486954|579458395|FG004|Pilot Part|Adverse Event|0|||
160471827|NCT00486954|579458391|FG000|Pilot Part|Disease Progression|2|||
160471828|NCT00486954|579458392|FG001|Pilot Part|Disease Progression|0|||
160471829|NCT00486954|579458393|FG002|Pilot Part|Disease Progression|1|||
160471830|NCT00486954|579458394|FG003|Pilot Part|Disease Progression|0|||
160471831|NCT00486954|579458395|FG004|Pilot Part|Disease Progression|0|||
160471832|NCT00486954|579458391|FG000|Randomized Part|Lost to Follow-up|0|||
160471833|NCT00486954|579458392|FG001|Randomized Part|Lost to Follow-up|0|||
160471834|NCT00486954|579458393|FG002|Randomized Part|Lost to Follow-up|0|||
160471835|NCT00486954|579458394|FG003|Randomized Part|Lost to Follow-up|0|||
160471836|NCT00486954|579458395|FG004|Randomized Part|Lost to Follow-up|1|||
160471837|NCT00486954|579458391|FG000|Randomized Part|Withdrawal by Subject|0|||
160471838|NCT00486954|579458392|FG001|Randomized Part|Withdrawal by Subject|0|||
160471839|NCT00486954|579458393|FG002|Randomized Part|Withdrawal by Subject|0|||
160471840|NCT00486954|579458394|FG003|Randomized Part|Withdrawal by Subject|1|||
160471841|NCT00486954|579458395|FG004|Randomized Part|Withdrawal by Subject|0|||
160471842|NCT00486954|579458391|FG000|Randomized Part|Sponsor Terminated Study|0|||
160471843|NCT00486954|579458392|FG001|Randomized Part|Sponsor Terminated Study|0|||
160471844|NCT00486954|579458393|FG002|Randomized Part|Sponsor Terminated Study|0|||
160471845|NCT00486954|579458394|FG003|Randomized Part|Sponsor Terminated Study|19|||
160471846|NCT00486954|579458395|FG004|Randomized Part|Sponsor Terminated Study|13|||
160471847|NCT05124210|579458396|FG000|Overall Study|Lost to Follow-up|1|||
160471848|NCT05124210|579458397|FG001|Overall Study|Lost to Follow-up|0|||
160471849|NCT05124210|579458396|FG000|Overall Study|Withdrawal by Subject|1|||
160471850|NCT05124210|579458397|FG001|Overall Study|Withdrawal by Subject|0|||
160471851|NCT00638456|579458400|FG000|Overall Study|Withdrawal by Subject|6|||
160471852|NCT00638456|579458401|FG001|Overall Study|Withdrawal by Subject|2|||
160471853|NCT03236779|579458402|FG000|Overall Study|Lost to Follow-up|13|||
160471854|NCT03236779|579458403|FG001|Overall Study|Lost to Follow-up|21|||
160471855|NCT02169414|579458405|FG000|Overall Study|Withdrawal by Subject|1|||
160471856|NCT02169414|579458406|FG001|Overall Study|Withdrawal by Subject|0|||
160471857|NCT02169414|579458407|FG002|Overall Study|Withdrawal by Subject|0|||
160471858|NCT02169414|579458408|FG003|Overall Study|Withdrawal by Subject|0|||
160471859|NCT02169414|579458405|FG000|Overall Study|Adverse Event|0|||
160601024|NCT00064077|579916519|FG002|Overall Study|Other reasons|1|||
160601025|NCT00064077|579916520|FG003|Overall Study|Other reasons|2|||
160601026|NCT04397796|579916521|FG000|Overall Study|Death|3|||
160601027|NCT04397796|579916522|FG001|Overall Study|Death|1|||
160601028|NCT00802867|579916523|FG000|Overall Study|Lost to Follow-up|6|||
160601029|NCT00802867|579916523|FG000|Overall Study|Protocol Violation|6|||
160601030|NCT00802867|579916523|FG000|Overall Study|Withdrawal by Subject|1|||
160601031|NCT00618813|579916526|FG000|Overall Study|Lack of Efficacy|1|||
160601032|NCT00618813|579916526|FG000|Overall Study|Physician Decision|2|||
160601033|NCT00618813|579916526|FG000|Overall Study|Withdrawal by Subject|1|||
160601034|NCT01809197|579916527|FG000|Overall Study|Lost to Follow-up|4|||
160601035|NCT01809197|579916528|FG001|Overall Study|Lost to Follow-up|2|||
160601036|NCT01809197|579916527|FG000|Overall Study|Adverse Event|2|||
160471860|NCT02169414|579458406|FG001|Overall Study|Adverse Event|1|||
160601037|NCT01809197|579916528|FG001|Overall Study|Adverse Event|3|||
160601038|NCT01809197|579916527|FG000|Overall Study|Failed slit lamp exam|1|||
160601039|NCT01809197|579916528|FG001|Overall Study|Failed slit lamp exam|0|||
160471861|NCT02169414|579458407|FG002|Overall Study|Adverse Event|0|||
160471862|NCT02169414|579458408|FG003|Overall Study|Adverse Event|0|||
160471863|NCT02309515|579458409|FG000|Overall Study|Withdrawal by Subject|0|||
160471864|NCT02309515|579458410|FG001|Overall Study|Withdrawal by Subject|1|||
160471865|NCT04070105|579458411|FG000|Overall Study|Lost to Follow-up|0|||
160471866|NCT04070105|579458412|FG001|Overall Study|Lost to Follow-up|0|||
160471867|NCT04070105|579458413|FG002|Overall Study|Lost to Follow-up|0|||
160471868|NCT04070105|579458414|FG003|Overall Study|Lost to Follow-up|0|||
160471869|NCT04070105|579458415|FG004|Overall Study|Lost to Follow-up|0|||
160471870|NCT04070105|579458416|FG005|Overall Study|Lost to Follow-up|1|||
160471871|NCT02547974|579458417|FG000|Overall Study|Withdrawal by Subject|1|||
160471872|NCT02547974|579458418|FG001|Overall Study|Withdrawal by Subject|0|||
160471873|NCT02547974|579458419|FG002|Overall Study|Withdrawal by Subject|0|||
160471874|NCT02547974|579458420|FG003|Overall Study|Withdrawal by Subject|0|||
160471875|NCT01072149|579458421|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471876|NCT01072149|579458422|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471877|NCT01072149|579458423|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
160471878|NCT01072149|579458424|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471879|NCT01072149|579458425|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471880|NCT01072149|579458426|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471881|NCT01072149|579458427|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471882|NCT01072149|579458428|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471883|NCT01072149|579458429|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471884|NCT01072149|579458430|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471885|NCT01072149|579458431|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471886|NCT01072149|579458432|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471887|NCT01072149|579458433|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471888|NCT01072149|579458434|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471889|NCT01072149|579458435|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471890|NCT01072149|579458436|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471891|NCT01072149|579458437|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471892|NCT01072149|579458438|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160471893|NCT01072149|579458421|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471894|NCT01072149|579458422|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471895|NCT01072149|579458423|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471896|NCT01072149|579458424|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471897|NCT01072149|579458425|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471898|NCT01072149|579458426|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471899|NCT01072149|579458427|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471900|NCT01072149|579458428|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471901|NCT01072149|579458429|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471902|NCT01072149|579458430|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471903|NCT01072149|579458431|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471904|NCT01072149|579458432|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471905|NCT01072149|579458433|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471906|NCT01072149|579458434|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471907|NCT01072149|579458435|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471908|NCT01072149|579458436|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471909|NCT01072149|579458437|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
160471910|NCT01072149|579458438|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
160471911|NCT01072149|579458421|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471912|NCT01072149|579458422|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160659778|NCT04206332|580136136|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659779|NCT04206332|580136137|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
160659780|NCT04206332|580136138|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659781|NCT04206332|580136139|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659782|NCT04206332|580136140|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659783|NCT04206332|580136141|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659784|NCT04206332|580136142|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659785|NCT04206332|580136143|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160677536|NCT01567527|580198881|FG002|Conversion Phase.|Met withdrawal criteria|0|||
160471913|NCT01072149|579458423|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471914|NCT01072149|579458424|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471915|NCT01072149|579458425|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471916|NCT01072149|579458426|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471917|NCT01072149|579458427|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471918|NCT01072149|579458428|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160659786|NCT04206332|580136127|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659787|NCT04206332|580136128|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659788|NCT04206332|580136129|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659789|NCT04206332|580136130|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659790|NCT04206332|580136131|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659791|NCT04206332|580136132|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659792|NCT04206332|580136133|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659793|NCT04206332|580136134|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659794|NCT04206332|580136135|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659795|NCT04206332|580136136|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659796|NCT04206332|580136137|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659797|NCT04206332|580136138|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659798|NCT04206332|580136139|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160471919|NCT01072149|579458429|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471920|NCT01072149|579458430|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471921|NCT01072149|579458431|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
160471922|NCT01072149|579458432|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471923|NCT01072149|579458433|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471924|NCT01072149|579458434|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471925|NCT01072149|579458435|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471926|NCT01072149|579458436|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471927|NCT01072149|579458437|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471928|NCT01072149|579458438|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
160471929|NCT01072149|579458421|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471930|NCT01072149|579458422|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
160471931|NCT01072149|579458423|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471932|NCT01072149|579458424|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471933|NCT01072149|579458425|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471934|NCT01072149|579458426|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471935|NCT01072149|579458427|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471936|NCT01072149|579458428|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471937|NCT01072149|579458429|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471938|NCT01072149|579458430|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471939|NCT01072149|579458431|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471940|NCT01072149|579458432|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471941|NCT01072149|579458433|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471942|NCT01072149|579458434|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471943|NCT01072149|579458435|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471944|NCT01072149|579458436|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471945|NCT01072149|579458437|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471946|NCT01072149|579458438|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
160471947|NCT01072149|579458421|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471948|NCT01072149|579458422|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471949|NCT01072149|579458423|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
160471950|NCT01072149|579458424|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471951|NCT01072149|579458425|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471952|NCT01072149|579458426|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471953|NCT01072149|579458427|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471954|NCT01072149|579458428|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471955|NCT01072149|579458429|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471956|NCT01072149|579458430|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471957|NCT01072149|579458431|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471958|NCT01072149|579458432|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471959|NCT01072149|579458433|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471960|NCT01072149|579458434|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471961|NCT01072149|579458435|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471962|NCT01072149|579458436|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471963|NCT01072149|579458437|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471964|NCT01072149|579458438|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
160471965|NCT01072149|579458421|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471966|NCT01072149|579458422|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471967|NCT01072149|579458423|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471968|NCT01072149|579458424|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471969|NCT01072149|579458425|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471970|NCT01072149|579458426|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471971|NCT01072149|579458427|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471972|NCT01072149|579458428|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
160471973|NCT01072149|579458429|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471974|NCT01072149|579458430|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471975|NCT01072149|579458431|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471976|NCT01072149|579458432|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471977|NCT01072149|579458433|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471978|NCT01072149|579458434|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471979|NCT01072149|579458435|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471980|NCT01072149|579458436|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471981|NCT01072149|579458437|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471982|NCT01072149|579458438|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
160471983|NCT01072149|579458421|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
160471984|NCT01072149|579458422|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
160471985|NCT01072149|579458423|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
160471986|NCT01072149|579458424|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
160471987|NCT01072149|579458425|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
160471988|NCT01072149|579458426|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
160471989|NCT01072149|579458427|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
160471990|NCT01072149|579458428|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
160471991|NCT01072149|579458429|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
160471992|NCT01072149|579458430|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
160471993|NCT01072149|579458431|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
160471994|NCT01072149|579458432|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
160471995|NCT01072149|579458433|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
160471996|NCT01072149|579458434|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
160471997|NCT01072149|579458435|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
160471998|NCT01072149|579458436|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
160471999|NCT01072149|579458437|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
160472000|NCT01072149|579458438|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
160472001|NCT01072149|579458421|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472002|NCT01072149|579458422|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472003|NCT01072149|579458423|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472004|NCT01072149|579458424|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472005|NCT01072149|579458425|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472006|NCT01072149|579458426|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472007|NCT01072149|579458427|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472008|NCT01072149|579458428|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472009|NCT01072149|579458429|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472010|NCT01072149|579458430|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472011|NCT01072149|579458431|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472012|NCT01072149|579458432|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472013|NCT01072149|579458433|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472014|NCT01072149|579458434|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472015|NCT01072149|579458435|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472016|NCT01072149|579458436|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
160472017|NCT01072149|579458437|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472018|NCT01072149|579458438|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
160472019|NCT01072149|579458421|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
160472020|NCT01072149|579458422|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
160472021|NCT01072149|579458423|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
160472022|NCT01072149|579458424|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
160472023|NCT01072149|579458425|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
160472024|NCT01072149|579458426|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
160472025|NCT01072149|579458427|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
160472026|NCT01072149|579458428|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
160472027|NCT01072149|579458429|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
160472028|NCT01072149|579458430|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
160472029|NCT01072149|579458431|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
160472030|NCT01072149|579458432|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
160472031|NCT01072149|579458433|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
160472032|NCT01072149|579458434|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
160472033|NCT01072149|579458435|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
160472034|NCT01072149|579458436|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
160472035|NCT01072149|579458437|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
160472036|NCT01072149|579458438|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
160472037|NCT01072149|579458421|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472038|NCT01072149|579458422|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472039|NCT01072149|579458423|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472040|NCT01072149|579458424|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160601040|NCT01809197|579916527|FG000|Overall Study|Non-Compliance|1|||
160601041|NCT01809197|579916528|FG001|Overall Study|Non-Compliance|1|||
160601042|NCT01809197|579916527|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
160601043|NCT01809197|579916528|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
160601044|NCT01809197|579916527|FG000|Overall Study|Withdrawal by Subject|1|||
160601045|NCT01809197|579916528|FG001|Overall Study|Withdrawal by Subject|1|||
160601046|NCT01809197|579916527|FG000|Overall Study|Product not available|0|||
160601047|NCT01809197|579916528|FG001|Overall Study|Product not available|1|||
160601048|NCT03228394|579916529|FG000|Overall Study|Lost to Follow-up|0|||
160601049|NCT03228394|579916530|FG001|Overall Study|Lost to Follow-up|0|||
160601050|NCT03228394|579916531|FG002|Overall Study|Lost to Follow-up|1|||
160601051|NCT03228394|579916532|FG003|Overall Study|Lost to Follow-up|1|||
160601052|NCT03228394|579916533|FG004|Overall Study|Lost to Follow-up|0|||
160601053|NCT03228394|579916534|FG005|Overall Study|Lost to Follow-up|0|||
160472041|NCT01072149|579458425|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472042|NCT01072149|579458426|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472043|NCT01072149|579458427|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472044|NCT01072149|579458428|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472045|NCT01072149|579458429|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472046|NCT01072149|579458430|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472047|NCT01072149|579458431|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472048|NCT01072149|579458432|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472049|NCT01072149|579458433|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
160472050|NCT01072149|579458434|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472051|NCT01072149|579458435|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472052|NCT01072149|579458436|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472053|NCT01072149|579458437|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472054|NCT01072149|579458438|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
160472055|NCT01072149|579458421|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472056|NCT01072149|579458422|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472057|NCT01072149|579458423|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
160472058|NCT01072149|579458424|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472059|NCT01072149|579458425|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472060|NCT01072149|579458426|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472061|NCT01072149|579458427|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472062|NCT01072149|579458428|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472063|NCT01072149|579458429|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472064|NCT01072149|579458430|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472065|NCT01072149|579458431|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472066|NCT01072149|579458432|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472067|NCT01072149|579458433|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472068|NCT01072149|579458434|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
160472069|NCT01072149|579458435|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472070|NCT01072149|579458436|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472071|NCT01072149|579458437|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472072|NCT01072149|579458438|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
160472073|NCT01768572|579458439|FG000|Overall Study|Adverse Event|7|||
160472074|NCT01768572|579458440|FG001|Overall Study|Adverse Event|8|||
160472075|NCT01768572|579458441|FG002|Overall Study|Adverse Event|4|||
160472076|NCT01768572|579458439|FG000|Overall Study|Lack of Efficacy|1|||
160472077|NCT01768572|579458440|FG001|Overall Study|Lack of Efficacy|3|||
160472078|NCT01768572|579458441|FG002|Overall Study|Lack of Efficacy|1|||
160472079|NCT01768572|579458439|FG000|Overall Study|Other, Not due to an adverse event|1|||
160472080|NCT01768572|579458440|FG001|Overall Study|Other, Not due to an adverse event|1|||
160472081|NCT01768572|579458441|FG002|Overall Study|Other, Not due to an adverse event|1|||
160472082|NCT03265132|579458452|FG000|Overall Study|Adverse Event|0|||
160472083|NCT03265132|579458453|FG001|Overall Study|Adverse Event|1|||
160472084|NCT03265132|579458452|FG000|Overall Study|Lack of Efficacy|0|||
160472085|NCT03265132|579458453|FG001|Overall Study|Lack of Efficacy|2|||
160472086|NCT03265132|579458452|FG000|Overall Study|Progressive disease|0|||
160472087|NCT03265132|579458453|FG001|Overall Study|Progressive disease|2|||
160472088|NCT03265132|579458452|FG000|Overall Study|Withdrawal by Subject|0|||
160472089|NCT03265132|579458453|FG001|Overall Study|Withdrawal by Subject|1|||
160472090|NCT03259568|579458459|FG000|Overall Study|Participant performance was low|3|||
160472091|NCT00089791|579458460|FG000|Overall Study|Physician Decision|6|||
160472092|NCT00089791|579458461|FG001|Overall Study|Physician Decision|3|||
160472093|NCT00089791|579458460|FG000|Overall Study|Adverse Event|81|||
160472094|NCT00089791|579458461|FG001|Overall Study|Adverse Event|93|||
160601054|NCT03228394|579916535|FG006|Overall Study|Lost to Follow-up|2|||
160601055|NCT03228394|579916536|FG007|Overall Study|Lost to Follow-up|0|||
160601056|NCT03228394|579916529|FG000|Overall Study|Withdrawal by Subject|0|||
160601057|NCT03228394|579916530|FG001|Overall Study|Withdrawal by Subject|0|||
160472095|NCT00089791|579458460|FG000|Overall Study|Withdrawal by Subject|403|||
160472096|NCT00089791|579458461|FG001|Overall Study|Withdrawal by Subject|344|||
160472097|NCT00089791|579458460|FG000|Overall Study|Death|78|||
160472098|NCT00089791|579458461|FG001|Overall Study|Death|62|||
160472099|NCT00089791|579458460|FG000|Overall Study|Disease progression|7|||
160472100|NCT00089791|579458461|FG001|Overall Study|Disease progression|3|||
160472101|NCT00089791|579458460|FG000|Overall Study|Ineligibility determined|12|||
160472102|NCT00089791|579458461|FG001|Overall Study|Ineligibility determined|9|||
160472103|NCT00089791|579458460|FG000|Overall Study|Lost to Follow-up|57|||
160472104|NCT00089791|579458461|FG001|Overall Study|Lost to Follow-up|57|||
160472105|NCT00089791|579458460|FG000|Overall Study|Noncompliance|17|||
160472106|NCT00089791|579458461|FG001|Overall Study|Noncompliance|13|||
160472107|NCT00089791|579458460|FG000|Overall Study|Other|20|||
160472108|NCT00089791|579458461|FG001|Overall Study|Other|32|||
160472109|NCT00089791|579458460|FG000|Overall Study|Protocol deviation|12|||
160472110|NCT00089791|579458461|FG001|Overall Study|Protocol deviation|10|||
160472111|NCT00089791|579458460|FG000|Overall Study|Requirement for alternative therapy|7|||
160472112|NCT00089791|579458461|FG001|Overall Study|Requirement for alternative therapy|4|||
160472113|NCT02161458|579458462|FG000|Overall Study|Withdrawal by Subject|0|||
160472114|NCT02161458|579458463|FG001|Overall Study|Withdrawal by Subject|4|||
160472115|NCT02161458|579458464|FG002|Overall Study|Withdrawal by Subject|4|||
160472116|NCT02161458|579458465|FG003|Overall Study|Withdrawal by Subject|0|||
160472117|NCT02161458|579458462|FG000|Overall Study|Lost to Follow-up|0|||
160472118|NCT02161458|579458463|FG001|Overall Study|Lost to Follow-up|2|||
160472119|NCT02161458|579458464|FG002|Overall Study|Lost to Follow-up|1|||
160472120|NCT02161458|579458465|FG003|Overall Study|Lost to Follow-up|0|||
160472121|NCT05074433|579458466|FG000|Overall Study|Adverse Event|0|||
160472122|NCT05074433|579458467|FG001|Overall Study|Adverse Event|2|||
160472123|NCT05074433|579458468|FG002|Overall Study|Adverse Event|0|||
160472124|NCT05074433|579458469|FG003|Overall Study|Adverse Event|1|||
160472125|NCT05074433|579458466|FG000|Overall Study|Sponsor Request|0|||
160472126|NCT05074433|579458467|FG001|Overall Study|Sponsor Request|1|||
160472127|NCT05074433|579458468|FG002|Overall Study|Sponsor Request|1|||
160472128|NCT05074433|579458469|FG003|Overall Study|Sponsor Request|0|||
160472129|NCT05074433|579458466|FG000|Overall Study|Death|1|||
160472130|NCT05074433|579458467|FG001|Overall Study|Death|0|||
160472131|NCT05074433|579458468|FG002|Overall Study|Death|0|||
160472132|NCT05074433|579458469|FG003|Overall Study|Death|0|||
160472133|NCT05074433|579458466|FG000|Overall Study|Lost to Follow-up|0|||
160472134|NCT05074433|579458467|FG001|Overall Study|Lost to Follow-up|0|||
160472135|NCT05074433|579458468|FG002|Overall Study|Lost to Follow-up|2|||
160472136|NCT05074433|579458469|FG003|Overall Study|Lost to Follow-up|0|||
160472137|NCT05074433|579458466|FG000|Overall Study|Subject Decision|8|||
160472138|NCT05074433|579458467|FG001|Overall Study|Subject Decision|6|||
160472139|NCT05074433|579458468|FG002|Overall Study|Subject Decision|4|||
160472140|NCT05074433|579458469|FG003|Overall Study|Subject Decision|5|||
160472141|NCT04397263|579458470|FG000|Overall Study|Withdrawal by Subject|2|||
160472142|NCT02251652|579458471|FG000|Overall Study|Withdrawal by Subject|1|||
160472143|NCT01989689|579458472|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
160472144|NCT01989689|579458473|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
160472145|NCT01989689|579458472|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
160472146|NCT01989689|579458473|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
160472147|NCT04492475|579458474|FG000|Overall Study|Enrolled but not treated|8|||
160472148|NCT04492475|579458475|FG001|Overall Study|Enrolled but not treated|8|||
160472149|NCT04492475|579458474|FG000|Overall Study|Withdrawal by Subject|4|||
160472150|NCT04492475|579458475|FG001|Overall Study|Withdrawal by Subject|0|||
160472151|NCT04492475|579458474|FG000|Overall Study|Became ineligible after enrollment|2|||
160472152|NCT04492475|579458475|FG001|Overall Study|Became ineligible after enrollment|0|||
160472153|NCT02066636|579458476|FG000|Overall Study|Disease progression|51|||
160472154|NCT02066636|579458477|FG001|Overall Study|Disease progression|60|||
160472155|NCT02066636|579458478|FG002|Overall Study|Disease progression|700|||
160472156|NCT02066636|579458476|FG000|Overall Study|Study drug toxicity|13|||
160472157|NCT02066636|579458477|FG001|Overall Study|Study drug toxicity|2|||
160472158|NCT02066636|579458478|FG002|Overall Study|Study drug toxicity|58|||
160472159|NCT02066636|579458476|FG000|Overall Study|Death|4|||
160472160|NCT02066636|579458477|FG001|Overall Study|Death|2|||
160472161|NCT02066636|579458478|FG002|Overall Study|Death|158|||
160472162|NCT02066636|579458476|FG000|Overall Study|Adverse event unrelated to study drug|6|||
160472163|NCT02066636|579458477|FG001|Overall Study|Adverse event unrelated to study drug|4|||
160472164|NCT02066636|579458478|FG002|Overall Study|Adverse event unrelated to study drug|45|||
160472165|NCT02066636|579458476|FG000|Overall Study|Participant request to discontinue treatment|12|||
160472166|NCT02066636|579458477|FG001|Overall Study|Participant request to discontinue treatment|12|||
160472167|NCT02066636|579458478|FG002|Overall Study|Participant request to discontinue treatment|70|||
160472168|NCT02066636|579458476|FG000|Overall Study|Participant withdrew consent|10|||
160472169|NCT02066636|579458477|FG001|Overall Study|Participant withdrew consent|18|||
160472170|NCT02066636|579458478|FG002|Overall Study|Participant withdrew consent|61|||
160472171|NCT02066636|579458476|FG000|Overall Study|Lost to Follow-up|0|||
160601058|NCT03228394|579916531|FG002|Overall Study|Withdrawal by Subject|1|||
160601059|NCT03228394|579916532|FG003|Overall Study|Withdrawal by Subject|0|||
160601060|NCT03228394|579916533|FG004|Overall Study|Withdrawal by Subject|0|||
160601061|NCT03228394|579916534|FG005|Overall Study|Withdrawal by Subject|0|||
160601062|NCT03228394|579916535|FG006|Overall Study|Withdrawal by Subject|1|||
160601063|NCT03228394|579916536|FG007|Overall Study|Withdrawal by Subject|3|||
160601064|NCT03228394|579916529|FG000|Overall Study|Protocol Violation|0|||
160601065|NCT03228394|579916530|FG001|Overall Study|Protocol Violation|0|||
160601066|NCT03228394|579916531|FG002|Overall Study|Protocol Violation|0|||
160601067|NCT03228394|579916532|FG003|Overall Study|Protocol Violation|1|||
160601068|NCT03228394|579916533|FG004|Overall Study|Protocol Violation|0|||
160601069|NCT03228394|579916534|FG005|Overall Study|Protocol Violation|0|||
160601070|NCT03228394|579916535|FG006|Overall Study|Protocol Violation|0|||
160601071|NCT03228394|579916536|FG007|Overall Study|Protocol Violation|0|||
160601072|NCT03228394|579916529|FG000|Overall Study|Physician Decision|0|||
160601073|NCT03228394|579916530|FG001|Overall Study|Physician Decision|0|||
160601074|NCT03228394|579916531|FG002|Overall Study|Physician Decision|0|||
160601075|NCT03228394|579916532|FG003|Overall Study|Physician Decision|0|||
160601076|NCT03228394|579916533|FG004|Overall Study|Physician Decision|0|||
160601077|NCT03228394|579916534|FG005|Overall Study|Physician Decision|0|||
160601078|NCT03228394|579916535|FG006|Overall Study|Physician Decision|1|||
160601079|NCT03228394|579916536|FG007|Overall Study|Physician Decision|0|||
160601080|NCT03228394|579916529|FG000|Overall Study|Noncompliance|0|||
160601081|NCT03228394|579916530|FG001|Overall Study|Noncompliance|0|||
160601082|NCT03228394|579916531|FG002|Overall Study|Noncompliance|0|||
160601083|NCT03228394|579916532|FG003|Overall Study|Noncompliance|0|||
160601084|NCT03228394|579916533|FG004|Overall Study|Noncompliance|0|||
160601085|NCT03228394|579916534|FG005|Overall Study|Noncompliance|0|||
160601086|NCT03228394|579916535|FG006|Overall Study|Noncompliance|1|||
160601087|NCT03228394|579916536|FG007|Overall Study|Noncompliance|0|||
160601088|NCT03000686|579916537|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
160601089|NCT03000686|579916538|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
160601090|NCT03000686|579916539|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
160601091|NCT03000686|579916540|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
160601092|NCT00770224|579916543|FG000|Step 1: Induction|Adverse Event|3|||
160601093|NCT00770224|579916544|FG001|Step 1: Induction|Adverse Event|0|||
160601094|NCT00770224|579916543|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
160601095|NCT00770224|579916544|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
160601096|NCT00770224|579916543|FG000|Step 1: Induction|Other reason not protocol specified|2|||
160601097|NCT00770224|579916544|FG001|Step 1: Induction|Other reason not protocol specified|0|||
160601098|NCT00770224|579916543|FG000|Step 1: Induction|Ineligible|2|||
160601099|NCT00770224|579916544|FG001|Step 1: Induction|Ineligible|0|||
160601100|NCT00770224|579916543|FG000|Step 1: Induction|No protocol treatment given|1|||
160601101|NCT00770224|579916544|FG001|Step 1: Induction|No protocol treatment given|0|||
160601102|NCT00770224|579916543|FG000|Step 2: Maintenance|Adverse Event|0|||
160601103|NCT00770224|579916544|FG001|Step 2: Maintenance|Adverse Event|10|||
160601104|NCT00770224|579916543|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
160601105|NCT00770224|579916544|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
160601106|NCT00770224|579916543|FG000|Step 2: Maintenance|Progression/relapse|0|||
160601107|NCT00770224|579916544|FG001|Step 2: Maintenance|Progression/relapse|1|||
160601108|NCT00770224|579916543|FG000|Step 2: Maintenance|Death|0|||
160601109|NCT00770224|579916544|FG001|Step 2: Maintenance|Death|2|||
160601110|NCT00770224|579916543|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
160601111|NCT00770224|579916544|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
160601112|NCT00770224|579916543|FG000|Step 2: Maintenance|Ineligible|0|||
160601113|NCT00770224|579916544|FG001|Step 2: Maintenance|Ineligible|2|||
160601114|NCT04737759|579916545|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
160601115|NCT04737759|579916546|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
160601116|NCT04737759|579916545|FG000|Overall Study|Death|2|||
160601117|NCT04737759|579916546|FG001|Overall Study|Death|0|||
160601118|NCT04737759|579916545|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
160601119|NCT04737759|579916546|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
160601120|NCT04737759|579916545|FG000|Overall Study|Lost to Follow-up|4|||
160601121|NCT04737759|579916546|FG001|Overall Study|Lost to Follow-up|12|||
160601122|NCT01484561|579916547|FG000|Overall Study|Lack of Efficacy|3|||
160601123|NCT01484561|579916548|FG001|Overall Study|Lack of Efficacy|1|||
160601124|NCT01484561|579916547|FG000|Overall Study|Lost to Follow-up|1|||
160601125|NCT01484561|579916548|FG001|Overall Study|Lost to Follow-up|0|||
160601126|NCT01484561|579916547|FG000|Overall Study|Withdrawal by Subject|3|||
160601127|NCT01484561|579916548|FG001|Overall Study|Withdrawal by Subject|0|||
160601128|NCT01484561|579916547|FG000|Overall Study|Other|1|||
160601129|NCT01484561|579916548|FG001|Overall Study|Other|1|||
160601130|NCT01484561|579916547|FG000|Overall Study|Adverse Event|1|||
160601131|NCT01484561|579916548|FG001|Overall Study|Adverse Event|4|||
160601132|NCT01112982|579916549|FG000|Overall Study|Withdrawal by Subject|1|||
160601133|NCT01112982|579916549|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
160601134|NCT03371251|579916550|FG000|Overall Study|Withdrawal by Subject|1|||
160601135|NCT03371251|579916551|FG001|Overall Study|Withdrawal by Subject|0|||
160601136|NCT03371251|579916552|FG002|Overall Study|Withdrawal by Subject|1|||
160601137|NCT03371251|579916553|FG003|Overall Study|Withdrawal by Subject|0|||
160601138|NCT03371251|579916554|FG004|Overall Study|Withdrawal by Subject|2|||
160601139|NCT03371251|579916555|FG005|Overall Study|Withdrawal by Subject|2|||
160601140|NCT03371251|579916550|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
160601141|NCT03371251|579916551|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
160601142|NCT03371251|579916552|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
160601143|NCT03371251|579916553|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
160601144|NCT03371251|579916554|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
160601145|NCT03371251|579916555|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
160601146|NCT03371251|579916550|FG000|Overall Study|Adverse Event|0|||
160601147|NCT03371251|579916551|FG001|Overall Study|Adverse Event|0|||
160601148|NCT03371251|579916552|FG002|Overall Study|Adverse Event|0|||
160601149|NCT03371251|579916553|FG003|Overall Study|Adverse Event|0|||
160601150|NCT03371251|579916554|FG004|Overall Study|Adverse Event|1|||
160601151|NCT03371251|579916555|FG005|Overall Study|Adverse Event|0|||
160601152|NCT03371251|579916550|FG000|Overall Study|Decision by Sponsor|0|||
160601153|NCT03371251|579916551|FG001|Overall Study|Decision by Sponsor|0|||
160601154|NCT03371251|579916552|FG002|Overall Study|Decision by Sponsor|0|||
160601155|NCT03371251|579916553|FG003|Overall Study|Decision by Sponsor|0|||
160601156|NCT03371251|579916554|FG004|Overall Study|Decision by Sponsor|2|||
160601157|NCT03371251|579916555|FG005|Overall Study|Decision by Sponsor|0|||
160601158|NCT00294684|579916556|FG000|Overall Study|Lost to Follow-up|5|||
160601159|NCT00294684|579916557|FG001|Overall Study|Lost to Follow-up|8|||
160601160|NCT02260388|579916560|FG000|Overall Study|Lost to Follow-up|2|||
160601161|NCT02260388|579916561|FG001|Overall Study|Lost to Follow-up|8|||
160601162|NCT02260388|579916562|FG002|Overall Study|Lost to Follow-up|3|||
160601163|NCT02260388|579916563|FG003|Overall Study|Lost to Follow-up|4|||
160601164|NCT05425719|579916564|FG000|Overall Study|Lost to Follow-up|4|||
160601165|NCT05425719|579916565|FG001|Overall Study|Lost to Follow-up|0|||
160601166|NCT05425719|579916564|FG000|Overall Study|Withdrew consent|1|||
160601167|NCT05425719|579916565|FG001|Overall Study|Withdrew consent|1|||
160472172|NCT02066636|579458477|FG001|Overall Study|Lost to Follow-up|2|||
160472173|NCT02066636|579458478|FG002|Overall Study|Lost to Follow-up|2|||
160472174|NCT02066636|579458476|FG000|Overall Study|Maximum clinical benefit|2|||
160472175|NCT02066636|579458477|FG001|Overall Study|Maximum clinical benefit|2|||
160472176|NCT02066636|579458478|FG002|Overall Study|Maximum clinical benefit|3|||
160472177|NCT02066636|579458476|FG000|Overall Study|Poor/non-compliance|2|||
160472178|NCT02066636|579458477|FG001|Overall Study|Poor/non-compliance|1|||
160472179|NCT02066636|579458478|FG002|Overall Study|Poor/non-compliance|1|||
160472180|NCT02066636|579458476|FG000|Overall Study|Participant no loner meets study criteria|3|||
160472181|NCT02066636|579458477|FG001|Overall Study|Participant no loner meets study criteria|2|||
160472182|NCT02066636|579458478|FG002|Overall Study|Participant no loner meets study criteria|28|||
160472183|NCT02066636|579458476|FG000|Overall Study|Administrative reasons by sponsor|8|||
160472184|NCT02066636|579458477|FG001|Overall Study|Administrative reasons by sponsor|5|||
160472185|NCT02066636|579458478|FG002|Overall Study|Administrative reasons by sponsor|0|||
160472186|NCT02066636|579458476|FG000|Overall Study|Other reasons|16|||
160472187|NCT02066636|579458477|FG001|Overall Study|Other reasons|15|||
160472188|NCT02066636|579458478|FG002|Overall Study|Other reasons|50|||
160472189|NCT00391170|579458485|FG000|Overall Study|Withdrawal by Subject|1|||
160472190|NCT00391170|579458486|FG001|Overall Study|Withdrawal by Subject|0|||
160472191|NCT00391170|579458485|FG000|Overall Study|Adverse Event|3|||
160472192|NCT00391170|579458486|FG001|Overall Study|Adverse Event|2|||
160472193|NCT00391170|579458485|FG000|Overall Study|Physician Decision|2|||
160472194|NCT00391170|579458486|FG001|Overall Study|Physician Decision|2|||
160472195|NCT03567616|579458491|FG000|Overall Study|Disease progression|4|||
160472196|NCT03567616|579458491|FG000|Overall Study|Withdrawal by Subject|1|||
160472197|NCT03567616|579458491|FG000|Overall Study|Physician Decision|1|||
160472198|NCT03567616|579458491|FG000|Overall Study|Death|1|||
160472199|NCT03567616|579458491|FG000|Overall Study|Adverse Event|1|||
160472200|NCT02833948|579458493|FG000|Overall Study|Death|2|||
160472201|NCT02833948|579458494|FG001|Overall Study|Death|3|||
160472202|NCT02833948|579458493|FG000|Overall Study|were not scanned|8|||
160472203|NCT02833948|579458494|FG001|Overall Study|were not scanned|13|||
160472204|NCT02833948|579458493|FG000|Overall Study|scans could not be evaluated|5|||
160472205|NCT02833948|579458494|FG001|Overall Study|scans could not be evaluated|2|||
160472206|NCT00680771|579458497|FG000|Overall Study|Withdrawal by Subject|1|||
160472207|NCT00680771|579458498|FG001|Overall Study|Withdrawal by Subject|0|||
160472208|NCT00680771|579458497|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
160472209|NCT00680771|579458498|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
160472210|NCT00680771|579458497|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
160472211|NCT00680771|579458498|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
160601168|NCT00996593|579916566|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
160601169|NCT00996593|579916566|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
160472212|NCT02691702|579458499|FG000|Overall Study|Adverse Event|1|||
160659799|NCT04206332|580136140|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659800|NCT04206332|580136141|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659801|NCT04206332|580136142|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
160659802|NCT04206332|580136143|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
160659803|NCT04206332|580136127|FG000|Part C|Withdrawal by Subject|0|||
160659804|NCT04206332|580136128|FG001|Part C|Withdrawal by Subject|0|||
160659805|NCT04206332|580136129|FG002|Part C|Withdrawal by Subject|0|||
160659806|NCT04206332|580136130|FG003|Part C|Withdrawal by Subject|0|||
160659807|NCT04206332|580136131|FG004|Part C|Withdrawal by Subject|0|||
160659808|NCT04206332|580136132|FG005|Part C|Withdrawal by Subject|0|||
160659809|NCT04206332|580136133|FG006|Part C|Withdrawal by Subject|0|||
160659810|NCT04206332|580136134|FG007|Part C|Withdrawal by Subject|0|||
160659811|NCT04206332|580136135|FG008|Part C|Withdrawal by Subject|0|||
160659812|NCT04206332|580136136|FG009|Part C|Withdrawal by Subject|0|||
160659813|NCT04206332|580136137|FG010|Part C|Withdrawal by Subject|0|||
160659814|NCT04206332|580136138|FG011|Part C|Withdrawal by Subject|0|||
160659815|NCT04206332|580136139|FG012|Part C|Withdrawal by Subject|0|||
160659816|NCT04206332|580136140|FG013|Part C|Withdrawal by Subject|0|||
160659817|NCT04206332|580136141|FG014|Part C|Withdrawal by Subject|2|||
160659818|NCT04206332|580136142|FG015|Part C|Withdrawal by Subject|0|||
160659819|NCT04206332|580136143|FG016|Part C|Withdrawal by Subject|0|||
160659820|NCT02334722|580136144|FG000|Overall Study|Lost to Follow-up|4|||
160659821|NCT02334722|580136145|FG001|Overall Study|Lost to Follow-up|0|||
160659822|NCT02334722|580136144|FG000|Overall Study|6 week questionnaire not completed|2|||
160659823|NCT02334722|580136145|FG001|Overall Study|6 week questionnaire not completed|0|||
160659824|NCT02334722|580136144|FG000|Overall Study|Unable to obtain medication|1|||
160659825|NCT02334722|580136145|FG001|Overall Study|Unable to obtain medication|1|||
160659826|NCT02334722|580136144|FG000|Overall Study|Withdrawal by Subject|0|||
160659827|NCT02334722|580136145|FG001|Overall Study|Withdrawal by Subject|3|||
160659828|NCT02334722|580136144|FG000|Overall Study|Adverse Event|0|||
160659829|NCT02334722|580136145|FG001|Overall Study|Adverse Event|2|||
160659830|NCT02334722|580136144|FG000|Overall Study|Physician Decision|0|||
160659831|NCT02334722|580136145|FG001|Overall Study|Physician Decision|1|||
160659832|NCT01617668|580136146|FG000|Overall Study|Adverse Event|7|||
160659833|NCT01617668|580136147|FG001|Overall Study|Adverse Event|0|||
160659834|NCT01617668|580136148|FG002|Overall Study|Adverse Event|12|||
160659835|NCT01617668|580136149|FG003|Overall Study|Adverse Event|5|||
160659836|NCT01617668|580136146|FG000|Overall Study|Physician Decision|1|||
160659837|NCT01617668|580136147|FG001|Overall Study|Physician Decision|2|||
160659838|NCT01617668|580136148|FG002|Overall Study|Physician Decision|3|||
160659839|NCT01617668|580136149|FG003|Overall Study|Physician Decision|0|||
160659840|NCT01617668|580136146|FG000|Overall Study|Progressive Disease|4|||
160659841|NCT01617668|580136147|FG001|Overall Study|Progressive Disease|4|||
160659842|NCT01617668|580136148|FG002|Overall Study|Progressive Disease|6|||
160659843|NCT01617668|580136149|FG003|Overall Study|Progressive Disease|9|||
160659844|NCT01617668|580136146|FG000|Overall Study|Subject/guardian decision|1|||
160659845|NCT01617668|580136147|FG001|Overall Study|Subject/guardian decision|3|||
160659846|NCT01617668|580136148|FG002|Overall Study|Subject/guardian decision|2|||
160659847|NCT01617668|580136149|FG003|Overall Study|Subject/guardian decision|1|||
160659848|NCT00925769|580136150|FG000|Overall Study|Major toxicity|1|||
160659849|NCT00925769|580136151|FG001|Overall Study|Major toxicity|0|||
160659850|NCT00925769|580136152|FG002|Overall Study|Major toxicity|1|||
160659851|NCT00925769|580136153|FG003|Overall Study|Major toxicity|1|||
160659852|NCT00925769|580136154|FG004|Overall Study|Major toxicity|0|||
160659853|NCT00925769|580136155|FG005|Overall Study|Major toxicity|0|||
160659854|NCT00925769|580136150|FG000|Overall Study|Disease progression|4|||
160659855|NCT00925769|580136151|FG001|Overall Study|Disease progression|5|||
160659856|NCT00925769|580136152|FG002|Overall Study|Disease progression|3|||
160659857|NCT00925769|580136153|FG003|Overall Study|Disease progression|4|||
160659858|NCT00925769|580136154|FG004|Overall Study|Disease progression|2|||
160659859|NCT00925769|580136155|FG005|Overall Study|Disease progression|3|||
160659860|NCT00925769|580136150|FG000|Overall Study|Death|0|||
160659861|NCT00925769|580136151|FG001|Overall Study|Death|0|||
160659862|NCT00925769|580136152|FG002|Overall Study|Death|1|||
160659863|NCT00925769|580136153|FG003|Overall Study|Death|0|||
160659864|NCT00925769|580136154|FG004|Overall Study|Death|0|||
160659865|NCT00925769|580136155|FG005|Overall Study|Death|0|||
160659866|NCT00925769|580136150|FG000|Overall Study|Physician Decision|1|||
160659867|NCT00925769|580136151|FG001|Overall Study|Physician Decision|0|||
160659868|NCT00925769|580136152|FG002|Overall Study|Physician Decision|0|||
160659869|NCT00925769|580136153|FG003|Overall Study|Physician Decision|0|||
160659870|NCT00925769|580136154|FG004|Overall Study|Physician Decision|0|||
160659871|NCT00925769|580136155|FG005|Overall Study|Physician Decision|0|||
160659872|NCT00925769|580136150|FG000|Overall Study|Missing documentation|0|||
160659873|NCT00925769|580136151|FG001|Overall Study|Missing documentation|1|||
160659874|NCT00925769|580136152|FG002|Overall Study|Missing documentation|0|||
160659875|NCT00925769|580136153|FG003|Overall Study|Missing documentation|0|||
160659876|NCT00925769|580136154|FG004|Overall Study|Missing documentation|0|||
160659877|NCT00925769|580136155|FG005|Overall Study|Missing documentation|0|||
160659878|NCT00925769|580136150|FG000|Overall Study|End of study visit not done|0|||
160659879|NCT00925769|580136151|FG001|Overall Study|End of study visit not done|0|||
160659880|NCT00925769|580136152|FG002|Overall Study|End of study visit not done|1|||
160659881|NCT00925769|580136153|FG003|Overall Study|End of study visit not done|0|||
160659882|NCT00925769|580136154|FG004|Overall Study|End of study visit not done|0|||
160659883|NCT00925769|580136155|FG005|Overall Study|End of study visit not done|0|||
160659884|NCT00925769|580136150|FG000|Overall Study|Participant is unable to swallow drug|0|||
160659885|NCT00925769|580136151|FG001|Overall Study|Participant is unable to swallow drug|0|||
160659886|NCT00925769|580136152|FG002|Overall Study|Participant is unable to swallow drug|0|||
160659887|NCT00925769|580136153|FG003|Overall Study|Participant is unable to swallow drug|1|||
160659888|NCT00925769|580136154|FG004|Overall Study|Participant is unable to swallow drug|0|||
160659889|NCT00925769|580136155|FG005|Overall Study|Participant is unable to swallow drug|0|||
160659890|NCT00925769|580136150|FG000|Overall Study|Adverse Event|0|||
160659891|NCT00925769|580136151|FG001|Overall Study|Adverse Event|0|||
160659892|NCT00925769|580136152|FG002|Overall Study|Adverse Event|0|||
160659893|NCT00925769|580136153|FG003|Overall Study|Adverse Event|0|||
160659894|NCT00925769|580136154|FG004|Overall Study|Adverse Event|1|||
160659895|NCT00925769|580136155|FG005|Overall Study|Adverse Event|0|||
160659896|NCT01666730|580136160|FG000|Overall Study|Adverse Event|16|||
160659897|NCT01666730|580136160|FG000|Overall Study|Death|2|||
160601170|NCT00996593|579916566|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
160601171|NCT00996593|579916566|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
160601172|NCT00996593|579916566|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
160601173|NCT00996593|579916566|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
160601174|NCT00996593|579916566|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
160601175|NCT00996593|579916566|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
160601176|NCT00996593|579916566|FG000|Long-Term Follow-Up|Site Closed|1|||
160601177|NCT01033487|579916567|FG000|Fourth Intervention Period|Adverse Event|0|||
160601178|NCT01033487|579916568|FG001|Fourth Intervention Period|Adverse Event|0|||
160601179|NCT01033487|579916569|FG002|Fourth Intervention Period|Adverse Event|0|||
160601180|NCT01033487|579916570|FG003|Fourth Intervention Period|Adverse Event|0|||
160601181|NCT01033487|579916571|FG004|Fourth Intervention Period|Adverse Event|0|||
160601182|NCT01033487|579916572|FG005|Fourth Intervention Period|Adverse Event|0|||
160601183|NCT01033487|579916573|FG006|Fourth Intervention Period|Adverse Event|0|||
160601184|NCT01033487|579916574|FG007|Fourth Intervention Period|Adverse Event|0|||
160601185|NCT01033487|579916575|FG008|Fourth Intervention Period|Adverse Event|1|||
160601186|NCT01033487|579916576|FG009|Fourth Intervention Period|Adverse Event|0|||
160601187|NCT00889681|579916577|FG000|Overall Study|Not meeting qualification Criteria|2|||
160601188|NCT00889681|579916577|FG000|Overall Study|Insurance disapproval|1|||
160601189|NCT00405652|579916580|FG000|Overall Study|Adverse Event|4|||
160601190|NCT03205982|579916581|FG000|Overall Study|Lost to Follow-up|20|||
160601191|NCT03205982|579916582|FG001|Overall Study|Lost to Follow-up|19|||
160601192|NCT03205982|579916581|FG000|Overall Study|Withdrawal by Subject|4|||
160601193|NCT03205982|579916582|FG001|Overall Study|Withdrawal by Subject|3|||
160601194|NCT03205982|579916581|FG000|Overall Study|Withdrawal by PI|0|||
160601195|NCT03205982|579916582|FG001|Overall Study|Withdrawal by PI|1|||
160601196|NCT00418717|579916583|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
160601197|NCT00418717|579916583|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
160601198|NCT02762708|579916588|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
160601199|NCT02762708|579916589|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
160601200|NCT02762708|579916590|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
160601201|NCT02762708|579916591|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
160601202|NCT01468701|579916592|FG000|Overall Study|Not eligible|91|||
160601203|NCT01468701|579916593|FG001|Overall Study|Not eligible|140|||
160601204|NCT01468701|579916594|FG002|Overall Study|Not eligible|29|||
160601205|NCT01468701|579916595|FG003|Overall Study|Not eligible|12|||
160601206|NCT01468701|579916596|FG004|Overall Study|Not eligible|22|||
160601207|NCT01468701|579916597|FG005|Overall Study|Not eligible|2|||
160601208|NCT01468701|579916598|FG006|Overall Study|Not eligible|39|||
160601209|NCT01468701|579916599|FG007|Overall Study|Not eligible|1|||
160601210|NCT01468701|579916600|FG008|Overall Study|Not eligible|40|||
160601211|NCT01468701|579916601|FG009|Overall Study|Not eligible|126|||
160601212|NCT01468701|579916602|FG010|Overall Study|Not eligible|39|||
160659898|NCT01666730|580136160|FG000|Overall Study|Physician Decision|5|||
160659899|NCT01666730|580136160|FG000|Overall Study|Withdrawal by Subject|9|||
160659900|NCT01666730|580136160|FG000|Overall Study|Disease progression/relapse|18|||
160659901|NCT00912288|580136161|FG000|Overall Study|Death|0|||
160659902|NCT00912288|580136162|FG001|Overall Study|Death|1|||
160659903|NCT00912288|580136161|FG000|Overall Study|Adverse Event|1|||
160659904|NCT00912288|580136162|FG001|Overall Study|Adverse Event|1|||
160659905|NCT00912288|580136161|FG000|Overall Study|Lost to Follow-up|1|||
160659906|NCT00912288|580136162|FG001|Overall Study|Lost to Follow-up|0|||
160659907|NCT00912288|580136161|FG000|Overall Study|Protocol Violation|1|||
160659908|NCT00912288|580136162|FG001|Overall Study|Protocol Violation|0|||
160659909|NCT00912288|580136161|FG000|Overall Study|Withdrawal by Subject|3|||
160659910|NCT00912288|580136162|FG001|Overall Study|Withdrawal by Subject|3|||
160659911|NCT00912288|580136161|FG000|Overall Study|Study terminated by sponsor|34|||
160659912|NCT00912288|580136162|FG001|Overall Study|Study terminated by sponsor|35|||
160659913|NCT00912288|580136161|FG000|Overall Study|Other|1|||
160659914|NCT00912288|580136162|FG001|Overall Study|Other|0|||
160659915|NCT01449630|580136163|FG000|Period 1|Physician Decision|1|||
160659916|NCT01449630|580136164|FG001|Period 1|Physician Decision|0|||
160659917|NCT01449630|580136165|FG002|Period 1|Physician Decision|0|||
160659918|NCT01449630|580136166|FG003|Period 1|Physician Decision|1|||
160659919|NCT01449630|580136167|FG004|Period 1|Physician Decision|0|||
160659920|NCT01449630|580136168|FG005|Period 1|Physician Decision|0|||
160659921|NCT01449630|580136169|FG006|Period 1|Physician Decision|0|||
160659922|NCT01449630|580136170|FG007|Period 1|Physician Decision|0|||
160659923|NCT01449630|580136171|FG008|Period 1|Physician Decision|0|||
160659924|NCT01449630|580136163|FG000|Period 1|Sponsor Decision|0|||
160659925|NCT01449630|580136164|FG001|Period 1|Sponsor Decision|0|||
160659926|NCT01449630|580136165|FG002|Period 1|Sponsor Decision|0|||
160659927|NCT01449630|580136166|FG003|Period 1|Sponsor Decision|0|||
160659928|NCT01449630|580136167|FG004|Period 1|Sponsor Decision|0|||
160659929|NCT01449630|580136168|FG005|Period 1|Sponsor Decision|1|||
160659930|NCT01449630|580136169|FG006|Period 1|Sponsor Decision|0|||
160659931|NCT01449630|580136170|FG007|Period 1|Sponsor Decision|0|||
160659932|NCT01449630|580136171|FG008|Period 1|Sponsor Decision|0|||
160659933|NCT01449630|580136163|FG000|Period 2|Sponsor Decision|0|||
160659934|NCT01449630|580136164|FG001|Period 2|Sponsor Decision|0|||
160659935|NCT01449630|580136165|FG002|Period 2|Sponsor Decision|0|||
160659936|NCT01449630|580136166|FG003|Period 2|Sponsor Decision|0|||
160659937|NCT01449630|580136167|FG004|Period 2|Sponsor Decision|0|||
160659938|NCT01449630|580136168|FG005|Period 2|Sponsor Decision|0|||
160659939|NCT01449630|580136169|FG006|Period 2|Sponsor Decision|1|||
160659940|NCT01449630|580136170|FG007|Period 2|Sponsor Decision|0|||
160659941|NCT01449630|580136171|FG008|Period 2|Sponsor Decision|0|||
160659942|NCT02087904|580136172|FG000|Overall Study|Did Not Receive Study Drug|0|||
160659943|NCT02087904|580136173|FG001|Overall Study|Did Not Receive Study Drug|0|||
160659944|NCT02087904|580136174|FG002|Overall Study|Did Not Receive Study Drug|2|||
160659945|NCT02087904|580136175|FG003|Overall Study|Did Not Receive Study Drug|1|||
160659946|NCT02087904|580136172|FG000|Overall Study|Adverse Event|8|||
160659947|NCT02087904|580136173|FG001|Overall Study|Adverse Event|4|||
160659948|NCT02087904|580136174|FG002|Overall Study|Adverse Event|4|||
160659949|NCT02087904|580136175|FG003|Overall Study|Adverse Event|12|||
160659950|NCT02087904|580136172|FG000|Overall Study|Lack of Efficacy|3|||
160659951|NCT02087904|580136173|FG001|Overall Study|Lack of Efficacy|6|||
160659952|NCT02087904|580136174|FG002|Overall Study|Lack of Efficacy|3|||
160659953|NCT02087904|580136175|FG003|Overall Study|Lack of Efficacy|2|||
160659954|NCT02087904|580136172|FG000|Overall Study|Other|6|||
160659955|NCT02087904|580136173|FG001|Overall Study|Other|2|||
160659956|NCT02087904|580136174|FG002|Overall Study|Other|4|||
160659957|NCT02087904|580136175|FG003|Overall Study|Other|4|||
160659958|NCT02087904|580136172|FG000|Overall Study|Withdrawal by Subject|8|||
160659959|NCT02087904|580136173|FG001|Overall Study|Withdrawal by Subject|3|||
160659960|NCT02087904|580136174|FG002|Overall Study|Withdrawal by Subject|7|||
160659961|NCT02087904|580136175|FG003|Overall Study|Withdrawal by Subject|4|||
160659962|NCT02087904|580136172|FG000|Overall Study|Lost to Follow-up|0|||
160659963|NCT02087904|580136173|FG001|Overall Study|Lost to Follow-up|4|||
160659964|NCT02087904|580136174|FG002|Overall Study|Lost to Follow-up|2|||
160659965|NCT02087904|580136175|FG003|Overall Study|Lost to Follow-up|2|||
160659966|NCT01735630|580136176|FG000|Overall Study|Adverse Event|8|||
160659967|NCT01735630|580136177|FG001|Overall Study|Adverse Event|7|||
160601213|NCT01468701|579916603|FG011|Overall Study|Not eligible|33|||
160601214|NCT01468701|579916604|FG012|Overall Study|Not eligible|1|||
160601215|NCT01468701|579916605|FG013|Overall Study|Not eligible|19|||
160601216|NCT01468701|579916606|FG014|Overall Study|Not eligible|1|||
160601217|NCT01468701|579916607|FG015|Overall Study|Not eligible|32|||
160659968|NCT01735630|580136176|FG000|Overall Study|Lost to Follow-up|1|||
160659969|NCT01735630|580136177|FG001|Overall Study|Lost to Follow-up|0|||
160659970|NCT01735630|580136176|FG000|Overall Study|Physician Decision|0|||
160659971|NCT01735630|580136177|FG001|Overall Study|Physician Decision|1|||
160659972|NCT01735630|580136176|FG000|Overall Study|Sponsor Decision|2|||
160659973|NCT01735630|580136177|FG001|Overall Study|Sponsor Decision|1|||
160659974|NCT01735630|580136176|FG000|Overall Study|Withdrawal by Subject|7|||
160659975|NCT01735630|580136177|FG001|Overall Study|Withdrawal by Subject|9|||
160659976|NCT00891293|580136179|FG000|Overall Study|Adverse Event|2|||
160659977|NCT00891293|580136179|FG000|Overall Study|Protocol Violation|2|||
160659978|NCT00891293|580136179|FG000|Overall Study|Laboratory abnormality|4|||
160659979|NCT00891293|580136179|FG000|Overall Study|Lost to Follow-up|7|||
160659980|NCT00891293|580136179|FG000|Overall Study|Subject withdrew consent|7|||
160659981|NCT00891293|580136179|FG000|Overall Study|Sponsor termination|62|||
160659982|NCT01126736|580136184|FG000|Overall Study|Death|2|||
160659983|NCT01126736|580136185|FG001|Overall Study|Death|2|||
160659984|NCT01126736|580136186|FG002|Overall Study|Death|1|||
160659985|NCT01126736|580136187|FG003|Overall Study|Death|19|||
160659986|NCT01126736|580136188|FG004|Overall Study|Death|19|||
160659987|NCT01126736|580136184|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
160601218|NCT01468701|579916608|FG016|Overall Study|Not eligible|0|||
160601219|NCT01468701|579916592|FG000|Overall Study|Lost to Follow-up|306|||
160601220|NCT01468701|579916593|FG001|Overall Study|Lost to Follow-up|0|||
160601221|NCT01468701|579916594|FG002|Overall Study|Lost to Follow-up|0|||
160601222|NCT01468701|579916595|FG003|Overall Study|Lost to Follow-up|0|||
160601223|NCT01468701|579916596|FG004|Overall Study|Lost to Follow-up|0|||
160601224|NCT01468701|579916597|FG005|Overall Study|Lost to Follow-up|0|||
160659988|NCT01126736|580136185|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
160659989|NCT01126736|580136186|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
160659990|NCT01126736|580136187|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
160659991|NCT01126736|580136188|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
160659992|NCT01126736|580136184|FG000|Overall Study|Lost to Follow-up|0|||
160472213|NCT02691702|579458500|FG001|Overall Study|Adverse Event|0|||
160601225|NCT01468701|579916598|FG006|Overall Study|Lost to Follow-up|0|||
160601226|NCT01468701|579916599|FG007|Overall Study|Lost to Follow-up|0|||
160472214|NCT02691702|579458501|FG002|Overall Study|Adverse Event|0|||
160472215|NCT02691702|579458502|FG003|Overall Study|Adverse Event|0|||
160472216|NCT02691702|579458503|FG004|Overall Study|Adverse Event|0|||
160472217|NCT02691702|579458504|FG005|Overall Study|Adverse Event|0|||
160472218|NCT02691702|579458505|FG006|Overall Study|Adverse Event|0|||
160472219|NCT02691702|579458506|FG007|Overall Study|Adverse Event|0|||
160472220|NCT02691702|579458507|FG008|Overall Study|Adverse Event|1|||
160472221|NCT02691702|579458508|FG009|Overall Study|Adverse Event|0|||
160472222|NCT02691702|579458509|FG010|Overall Study|Adverse Event|1|||
160472223|NCT02691702|579458499|FG000|Overall Study|Lost to Follow-up|0|||
160472224|NCT02691702|579458500|FG001|Overall Study|Lost to Follow-up|0|||
160472225|NCT02691702|579458501|FG002|Overall Study|Lost to Follow-up|1|||
160472226|NCT02691702|579458502|FG003|Overall Study|Lost to Follow-up|0|||
160472227|NCT02691702|579458503|FG004|Overall Study|Lost to Follow-up|0|||
160472228|NCT02691702|579458504|FG005|Overall Study|Lost to Follow-up|2|||
160472229|NCT02691702|579458505|FG006|Overall Study|Lost to Follow-up|0|||
160472230|NCT02691702|579458506|FG007|Overall Study|Lost to Follow-up|0|||
160472231|NCT02691702|579458507|FG008|Overall Study|Lost to Follow-up|0|||
160472232|NCT02691702|579458508|FG009|Overall Study|Lost to Follow-up|0|||
160472233|NCT02691702|579458509|FG010|Overall Study|Lost to Follow-up|1|||
160472234|NCT02691702|579458499|FG000|Overall Study|Withdrawal by Subject|1|||
160472235|NCT02691702|579458500|FG001|Overall Study|Withdrawal by Subject|1|||
160472236|NCT02691702|579458501|FG002|Overall Study|Withdrawal by Subject|0|||
160472237|NCT02691702|579458502|FG003|Overall Study|Withdrawal by Subject|0|||
160472238|NCT02691702|579458503|FG004|Overall Study|Withdrawal by Subject|0|||
160472239|NCT02691702|579458504|FG005|Overall Study|Withdrawal by Subject|1|||
160472240|NCT02691702|579458505|FG006|Overall Study|Withdrawal by Subject|2|||
160472241|NCT02691702|579458506|FG007|Overall Study|Withdrawal by Subject|0|||
160472242|NCT02691702|579458507|FG008|Overall Study|Withdrawal by Subject|0|||
160472243|NCT02691702|579458508|FG009|Overall Study|Withdrawal by Subject|0|||
160472244|NCT02691702|579458509|FG010|Overall Study|Withdrawal by Subject|0|||
160472245|NCT02691702|579458499|FG000|Overall Study|Other|0|||
160472246|NCT02691702|579458500|FG001|Overall Study|Other|0|||
160472247|NCT02691702|579458501|FG002|Overall Study|Other|0|||
160472248|NCT02691702|579458502|FG003|Overall Study|Other|0|||
160472249|NCT02691702|579458503|FG004|Overall Study|Other|0|||
160472250|NCT02691702|579458504|FG005|Overall Study|Other|0|||
160472251|NCT02691702|579458505|FG006|Overall Study|Other|1|||
160472252|NCT02691702|579458506|FG007|Overall Study|Other|0|||
160472253|NCT02691702|579458507|FG008|Overall Study|Other|1|||
160472254|NCT02691702|579458508|FG009|Overall Study|Other|0|||
160472255|NCT02691702|579458509|FG010|Overall Study|Other|0|||
160472256|NCT02691702|579458499|FG000|Overall Study|Protocol Violation|0|||
160472257|NCT02691702|579458500|FG001|Overall Study|Protocol Violation|0|||
160472258|NCT02691702|579458501|FG002|Overall Study|Protocol Violation|0|||
160472259|NCT02691702|579458502|FG003|Overall Study|Protocol Violation|0|||
160472260|NCT02691702|579458503|FG004|Overall Study|Protocol Violation|0|||
160472261|NCT02691702|579458504|FG005|Overall Study|Protocol Violation|0|||
160472262|NCT02691702|579458505|FG006|Overall Study|Protocol Violation|0|||
160472263|NCT02691702|579458506|FG007|Overall Study|Protocol Violation|0|||
160472264|NCT02691702|579458507|FG008|Overall Study|Protocol Violation|0|||
160472265|NCT02691702|579458508|FG009|Overall Study|Protocol Violation|2|||
160472266|NCT02691702|579458509|FG010|Overall Study|Protocol Violation|0|||
160472267|NCT05613088|579458510|FG000|Treatment|Ongoing Study Treatment|9|||
160472268|NCT05613088|579458511|FG001|Treatment|Ongoing Study Treatment|2|||
160472269|NCT05613088|579458510|FG000|Treatment|Adverse Event|3|||
160472270|NCT05613088|579458511|FG001|Treatment|Adverse Event|1|||
160472271|NCT05613088|579458510|FG000|Treatment|Other Reasons|0|||
160472272|NCT05613088|579458511|FG001|Treatment|Other Reasons|1|||
160472273|NCT05613088|579458510|FG000|Treatment|Progressive Disease|58|||
160601227|NCT01468701|579916600|FG008|Overall Study|Lost to Follow-up|215|||
160601228|NCT01468701|579916601|FG009|Overall Study|Lost to Follow-up|309|||
160601229|NCT01468701|579916602|FG010|Overall Study|Lost to Follow-up|224|||
160472274|NCT05613088|579458511|FG001|Treatment|Progressive Disease|26|||
160601230|NCT01468701|579916603|FG011|Overall Study|Lost to Follow-up|212|||
160472275|NCT05613088|579458510|FG000|Treatment|Withdrawal by Subject|0|||
160472276|NCT05613088|579458511|FG001|Treatment|Withdrawal by Subject|4|||
160472277|NCT05163353|579458514|FG000|Overall Study|Adverse Event|1|||
160472278|NCT05163353|579458515|FG001|Overall Study|Adverse Event|0|||
160472279|NCT05163353|579458514|FG000|Overall Study|Withdrawal by Subject|21|||
160472280|NCT05163353|579458515|FG001|Overall Study|Withdrawal by Subject|6|||
160472281|NCT05163353|579458514|FG000|Overall Study|Protocol Violation|0|||
160472282|NCT05163353|579458515|FG001|Overall Study|Protocol Violation|1|||
160472283|NCT05163353|579458514|FG000|Overall Study|Lost to Follow-up|13|||
160472284|NCT05163353|579458515|FG001|Overall Study|Lost to Follow-up|2|||
160472285|NCT06086028|579458517|FG000|Overall Study|Withdrawal by Subject|1|||
160472286|NCT06086028|579458518|FG001|Overall Study|Withdrawal by Subject|1|||
160472287|NCT06086028|579458517|FG000|Overall Study|Lost to Follow-up|2|||
160472288|NCT06086028|579458518|FG001|Overall Study|Lost to Follow-up|3|||
160472289|NCT00824408|579458519|FG000|Run-in Phase|Progressive disease|4|||
160601231|NCT01468701|579916604|FG012|Overall Study|Lost to Follow-up|11|||
160472290|NCT00824408|579458520|FG001|Run-in Phase|Progressive disease|4|||
160472291|NCT00824408|579458521|FG002|Run-in Phase|Progressive disease|0|||
160472292|NCT00824408|579458522|FG003|Run-in Phase|Progressive disease|0|||
160472293|NCT00824408|579458523|FG004|Run-in Phase|Progressive disease|0|||
160472294|NCT00824408|579458519|FG000|Run-in Phase|Adverse Event|1|||
160472295|NCT00824408|579458520|FG001|Run-in Phase|Adverse Event|1|||
160472296|NCT00824408|579458521|FG002|Run-in Phase|Adverse Event|0|||
160472297|NCT00824408|579458522|FG003|Run-in Phase|Adverse Event|0|||
160472298|NCT00824408|579458523|FG004|Run-in Phase|Adverse Event|0|||
160472299|NCT00824408|579458519|FG000|Run-in Phase|Refused to continue medication|1|||
160472300|NCT00824408|579458520|FG001|Run-in Phase|Refused to continue medication|0|||
160472301|NCT00824408|579458521|FG002|Run-in Phase|Refused to continue medication|0|||
160472302|NCT00824408|579458522|FG003|Run-in Phase|Refused to continue medication|0|||
160472303|NCT00824408|579458523|FG004|Run-in Phase|Refused to continue medication|0|||
160472304|NCT00824408|579458519|FG000|Run-in Phase|Other reason not defined above|0|||
160472305|NCT00824408|579458520|FG001|Run-in Phase|Other reason not defined above|1|||
160472306|NCT00824408|579458521|FG002|Run-in Phase|Other reason not defined above|0|||
160472307|NCT00824408|579458522|FG003|Run-in Phase|Other reason not defined above|0|||
160472308|NCT00824408|579458523|FG004|Run-in Phase|Other reason not defined above|0|||
160472309|NCT00824408|579458519|FG000|Randomized Phase|Not treated|0|||
160472310|NCT00824408|579458520|FG001|Randomized Phase|Not treated|0|||
160472311|NCT00824408|579458521|FG002|Randomized Phase|Not treated|1|||
160472312|NCT00824408|579458522|FG003|Randomized Phase|Not treated|1|||
160472313|NCT00824408|579458523|FG004|Randomized Phase|Not treated|1|||
160472314|NCT00824408|579458519|FG000|Randomized Phase|Progressive disease|0|||
160472315|NCT00824408|579458520|FG001|Randomized Phase|Progressive disease|0|||
160472316|NCT00824408|579458521|FG002|Randomized Phase|Progressive disease|25|||
160472317|NCT00824408|579458522|FG003|Randomized Phase|Progressive disease|36|||
160472318|NCT00824408|579458523|FG004|Randomized Phase|Progressive disease|34|||
160472319|NCT00824408|579458519|FG000|Randomized Phase|Adverse Event|0|||
160472320|NCT00824408|579458520|FG001|Randomized Phase|Adverse Event|0|||
160472321|NCT00824408|579458521|FG002|Randomized Phase|Adverse Event|4|||
160472322|NCT00824408|579458522|FG003|Randomized Phase|Adverse Event|5|||
160472323|NCT00824408|579458523|FG004|Randomized Phase|Adverse Event|5|||
160472324|NCT00824408|579458519|FG000|Randomized Phase|Refused to continue medication|0|||
160472325|NCT00824408|579458520|FG001|Randomized Phase|Refused to continue medication|0|||
160472326|NCT00824408|579458521|FG002|Randomized Phase|Refused to continue medication|2|||
160472327|NCT00824408|579458522|FG003|Randomized Phase|Refused to continue medication|2|||
160472328|NCT00824408|579458523|FG004|Randomized Phase|Refused to continue medication|2|||
160472329|NCT00824408|579458519|FG000|Randomized Phase|Other reason not defined above|0|||
160472330|NCT00824408|579458520|FG001|Randomized Phase|Other reason not defined above|0|||
160472331|NCT00824408|579458521|FG002|Randomized Phase|Other reason not defined above|4|||
160472332|NCT00824408|579458522|FG003|Randomized Phase|Other reason not defined above|2|||
160472333|NCT00824408|579458523|FG004|Randomized Phase|Other reason not defined above|4|||
160472334|NCT01263496|579458526|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
160472335|NCT01263496|579458527|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
160472336|NCT01263496|579458528|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
160472337|NCT01263496|579458529|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
160472338|NCT01263496|579458530|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
160472339|NCT01263496|579458531|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
160472340|NCT01263496|579458532|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
160472341|NCT01263496|579458533|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
160601232|NCT01468701|579916605|FG013|Overall Study|Lost to Follow-up|164|||
160601233|NCT01468701|579916606|FG014|Overall Study|Lost to Follow-up|17|||
160601234|NCT01468701|579916607|FG015|Overall Study|Lost to Follow-up|127|||
160472342|NCT01263496|579458534|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
160472343|NCT01263496|579458526|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160472344|NCT01263496|579458527|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160472345|NCT01263496|579458528|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160472346|NCT01263496|579458529|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
160472347|NCT01263496|579458530|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
160472348|NCT01263496|579458531|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160472349|NCT01263496|579458532|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160601235|NCT01468701|579916608|FG016|Overall Study|Lost to Follow-up|1|||
160601236|NCT01468701|579916592|FG000|Overall Study|Withdrawal by Subject|165|||
160601237|NCT01468701|579916593|FG001|Overall Study|Withdrawal by Subject|0|||
160601238|NCT01468701|579916594|FG002|Overall Study|Withdrawal by Subject|0|||
160601239|NCT01468701|579916595|FG003|Overall Study|Withdrawal by Subject|0|||
160601240|NCT01468701|579916596|FG004|Overall Study|Withdrawal by Subject|0|||
160601241|NCT01468701|579916597|FG005|Overall Study|Withdrawal by Subject|0|||
160601242|NCT01468701|579916598|FG006|Overall Study|Withdrawal by Subject|0|||
160601243|NCT01468701|579916599|FG007|Overall Study|Withdrawal by Subject|0|||
160601244|NCT01468701|579916600|FG008|Overall Study|Withdrawal by Subject|83|||
160601245|NCT01468701|579916601|FG009|Overall Study|Withdrawal by Subject|88|||
160601246|NCT01468701|579916602|FG010|Overall Study|Withdrawal by Subject|100|||
160601247|NCT01468701|579916603|FG011|Overall Study|Withdrawal by Subject|114|||
160601248|NCT01468701|579916604|FG012|Overall Study|Withdrawal by Subject|9|||
160601249|NCT01468701|579916605|FG013|Overall Study|Withdrawal by Subject|47|||
160601250|NCT01468701|579916606|FG014|Overall Study|Withdrawal by Subject|6|||
160601251|NCT01468701|579916607|FG015|Overall Study|Withdrawal by Subject|31|||
160601252|NCT01468701|579916608|FG016|Overall Study|Withdrawal by Subject|0|||
160601253|NCT01468701|579916592|FG000|Overall Study|Other reasons than listed|437|||
160601254|NCT01468701|579916593|FG001|Overall Study|Other reasons than listed|0|||
160601255|NCT01468701|579916594|FG002|Overall Study|Other reasons than listed|0|||
160601256|NCT01468701|579916595|FG003|Overall Study|Other reasons than listed|0|||
160601257|NCT01468701|579916596|FG004|Overall Study|Other reasons than listed|0|||
160601258|NCT01468701|579916597|FG005|Overall Study|Other reasons than listed|0|||
160601259|NCT01468701|579916598|FG006|Overall Study|Other reasons than listed|0|||
160601260|NCT01468701|579916599|FG007|Overall Study|Other reasons than listed|0|||
160601261|NCT01468701|579916600|FG008|Overall Study|Other reasons than listed|318|||
160601262|NCT01468701|579916601|FG009|Overall Study|Other reasons than listed|658|||
160601263|NCT01468701|579916602|FG010|Overall Study|Other reasons than listed|433|||
160601264|NCT01468701|579916603|FG011|Overall Study|Other reasons than listed|504|||
160601265|NCT01468701|579916604|FG012|Overall Study|Other reasons than listed|28|||
160601266|NCT01468701|579916605|FG013|Overall Study|Other reasons than listed|239|||
160601267|NCT01468701|579916606|FG014|Overall Study|Other reasons than listed|39|||
160601268|NCT01468701|579916607|FG015|Overall Study|Other reasons than listed|172|||
160601269|NCT01468701|579916608|FG016|Overall Study|Other reasons than listed|0|||
160601270|NCT01468701|579916592|FG000|Overall Study|No end of study case report form|0|||
160601271|NCT01468701|579916593|FG001|Overall Study|No end of study case report form|0|||
160601272|NCT01468701|579916594|FG002|Overall Study|No end of study case report form|0|||
160601273|NCT01468701|579916595|FG003|Overall Study|No end of study case report form|0|||
160601274|NCT01468701|579916596|FG004|Overall Study|No end of study case report form|0|||
160601275|NCT01468701|579916597|FG005|Overall Study|No end of study case report form|0|||
160601276|NCT01468701|579916598|FG006|Overall Study|No end of study case report form|0|||
160601277|NCT01468701|579916599|FG007|Overall Study|No end of study case report form|0|||
160601278|NCT01468701|579916600|FG008|Overall Study|No end of study case report form|4|||
160601279|NCT01468701|579916601|FG009|Overall Study|No end of study case report form|1|||
160601280|NCT01468701|579916602|FG010|Overall Study|No end of study case report form|2|||
160601281|NCT01468701|579916603|FG011|Overall Study|No end of study case report form|3|||
160601282|NCT01468701|579916604|FG012|Overall Study|No end of study case report form|0|||
160601283|NCT01468701|579916605|FG013|Overall Study|No end of study case report form|1|||
160601284|NCT01468701|579916606|FG014|Overall Study|No end of study case report form|0|||
160601285|NCT01468701|579916607|FG015|Overall Study|No end of study case report form|0|||
160601286|NCT01468701|579916608|FG016|Overall Study|No end of study case report form|0|||
160601287|NCT01468701|579916592|FG000|Overall Study|Not being followed up|0|||
160601288|NCT01468701|579916593|FG001|Overall Study|Not being followed up|4963|||
160601289|NCT01468701|579916594|FG002|Overall Study|Not being followed up|1755|||
160601290|NCT01468701|579916595|FG003|Overall Study|Not being followed up|703|||
160601291|NCT01468701|579916596|FG004|Overall Study|Not being followed up|1714|||
160601292|NCT01468701|579916597|FG005|Overall Study|Not being followed up|126|||
160601293|NCT01468701|579916598|FG006|Overall Study|Not being followed up|1170|||
160601294|NCT01468701|579916599|FG007|Overall Study|Not being followed up|4|||
160601295|NCT01468701|579916600|FG008|Overall Study|Not being followed up|0|||
160601296|NCT01468701|579916601|FG009|Overall Study|Not being followed up|0|||
160601297|NCT01468701|579916602|FG010|Overall Study|Not being followed up|0|||
160601298|NCT01468701|579916603|FG011|Overall Study|Not being followed up|0|||
160601299|NCT01468701|579916604|FG012|Overall Study|Not being followed up|0|||
160601300|NCT01468701|579916605|FG013|Overall Study|Not being followed up|0|||
160601301|NCT01468701|579916606|FG014|Overall Study|Not being followed up|0|||
160601302|NCT01468701|579916607|FG015|Overall Study|Not being followed up|0|||
160601303|NCT01468701|579916608|FG016|Overall Study|Not being followed up|0|||
160601304|NCT00970268|579916613|FG000|Overall Study|Withdrawal by Subject|12|||
160601305|NCT00970268|579916614|FG001|Overall Study|Withdrawal by Subject|19|||
160601306|NCT00970268|579916613|FG000|Overall Study|Adverse Event|15|||
160601307|NCT00970268|579916614|FG001|Overall Study|Adverse Event|12|||
160601308|NCT00970268|579916613|FG000|Overall Study|Lack of Efficacy|3|||
160601309|NCT00970268|579916614|FG001|Overall Study|Lack of Efficacy|6|||
160472350|NCT01263496|579458533|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160472351|NCT01263496|579458534|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160472352|NCT01263496|579458526|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
160472353|NCT01263496|579458527|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
160472354|NCT01263496|579458528|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
160472355|NCT01263496|579458529|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
160472356|NCT01263496|579458530|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
160472357|NCT01263496|579458531|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
160472358|NCT01263496|579458532|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
160472359|NCT01263496|579458533|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
160472360|NCT01263496|579458534|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
160472361|NCT01263496|579458526|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160472362|NCT01263496|579458527|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
160472363|NCT01263496|579458528|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160472364|NCT01263496|579458529|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160472365|NCT01263496|579458530|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160472366|NCT01263496|579458531|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160472367|NCT01263496|579458532|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160472368|NCT01263496|579458533|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160472369|NCT01263496|579458534|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
160472370|NCT01263496|579458526|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
160472371|NCT01263496|579458527|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160472372|NCT01263496|579458528|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
160472373|NCT01263496|579458529|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160472374|NCT01263496|579458530|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
160472375|NCT01263496|579458531|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
160472376|NCT01263496|579458532|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
160472377|NCT01263496|579458533|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
160472378|NCT01263496|579458534|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
160472379|NCT01263496|579458526|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
160472380|NCT01263496|579458527|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
160472381|NCT01263496|579458528|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
160472382|NCT01263496|579458529|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
160472383|NCT01263496|579458530|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
160472384|NCT01263496|579458531|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
160472385|NCT01263496|579458532|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
160472386|NCT01263496|579458533|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
160472387|NCT01263496|579458534|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
160472388|NCT01263496|579458526|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
160472389|NCT01263496|579458527|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
160472390|NCT01263496|579458528|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
160472391|NCT01263496|579458529|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
160472392|NCT01263496|579458530|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
160472393|NCT01263496|579458531|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
160472394|NCT01263496|579458532|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
160472395|NCT01263496|579458533|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
160472396|NCT01263496|579458534|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
160472397|NCT01218594|579458535|FG000|Overall Study|Death|1|||
160472398|NCT01218594|579458535|FG000|Overall Study|Withdrawal by Subject|3|||
160601310|NCT00970268|579916613|FG000|Overall Study|Protocol Violation|4|||
160601311|NCT00970268|579916614|FG001|Overall Study|Protocol Violation|7|||
160601312|NCT00970268|579916613|FG000|Overall Study|Other Reason|3|||
160601313|NCT00970268|579916614|FG001|Overall Study|Other Reason|1|||
160601314|NCT00970268|579916613|FG000|Overall Study|COPD Exacerbation|4|||
160601315|NCT00970268|579916614|FG001|Overall Study|COPD Exacerbation|2|||
160601316|NCT00970268|579916613|FG000|Overall Study|Lost to Follow-up|1|||
160601317|NCT00970268|579916614|FG001|Overall Study|Lost to Follow-up|2|||
160601318|NCT00970268|579916613|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
160601319|NCT00970268|579916614|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
160601320|NCT01079195|579916615|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
160601321|NCT01079195|579916615|FG000|Overall Study|No Documentation Available|437|||
160601322|NCT01079195|579916615|FG000|Overall Study|Adverse Event|157|||
160601323|NCT01079195|579916615|FG000|Overall Study|Reason Unknown|39|||
160601324|NCT01079195|579916615|FG000|Overall Study|Withdrawal by Subject|18|||
160601325|NCT01079195|579916615|FG000|Overall Study|Financial Reasons|15|||
160659993|NCT01126736|580136185|FG001|Overall Study|Lost to Follow-up|0|||
160472399|NCT01218594|579458535|FG000|Overall Study|Adverse Event|2|||
160601326|NCT01079195|579916615|FG000|Overall Study|Lack of Effectiveness|12|||
160601327|NCT01079195|579916615|FG000|Overall Study|Physician Decision|4|||
160472400|NCT01218594|579458535|FG000|Overall Study|Physician Decision|6|||
160601328|NCT01079195|579916615|FG000|Overall Study|Improved Status of Participant|4|||
160601329|NCT01079195|579916615|FG000|Overall Study|No Follow-up Documentation Available|4|||
160601330|NCT01079195|579916615|FG000|Overall Study|Non-compliance|2|||
160601331|NCT01999946|579916619|FG000|Overall Study|Participant not released from jail|2|||
160601332|NCT01999946|579916620|FG001|Overall Study|Participant not released from jail|2|||
160601333|NCT01999946|579916621|FG002|Overall Study|Participant not released from jail|0|||
160601334|NCT01999946|579916619|FG000|Overall Study|Not included in primary outcome analysis|0|||
160601335|NCT01999946|579916620|FG001|Overall Study|Not included in primary outcome analysis|0|||
160601336|NCT01999946|579916621|FG002|Overall Study|Not included in primary outcome analysis|79|||
160601337|NCT02947022|579916625|FG000|Overall Study|Study Stopped|1|||
160601338|NCT03906136|579918089|FG000|Overall Study|Adverse Event|1|||
160601339|NCT03906136|579918090|FG001|Overall Study|Adverse Event|0|||
160601340|NCT03906136|579918089|FG000|Overall Study|Lost to Follow-up|7|||
160601341|NCT03906136|579918090|FG001|Overall Study|Lost to Follow-up|4|||
160601342|NCT03906136|579918089|FG000|Overall Study|Physician Decision|1|||
160601343|NCT03906136|579918090|FG001|Overall Study|Physician Decision|0|||
160601344|NCT03906136|579918089|FG000|Overall Study|Withdrawal by Subject|3|||
160601345|NCT03906136|579918090|FG001|Overall Study|Withdrawal by Subject|7|||
160601346|NCT02371980|579918091|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
160601347|NCT02371980|579918092|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
160601348|NCT02371980|579918093|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
160601349|NCT02371980|579918094|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
160601350|NCT02371980|579918095|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
160472401|NCT02203032|579458537|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
160472402|NCT02203032|579458538|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
160472403|NCT02203032|579458539|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
160472404|NCT02203032|579458540|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
160472405|NCT02203032|579458537|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
160472406|NCT02203032|579458538|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
160472407|NCT02203032|579458539|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
160472408|NCT02203032|579458540|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
160472409|NCT02203032|579458537|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
160472410|NCT02203032|579458538|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
160472411|NCT02203032|579458539|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
160472412|NCT02203032|579458540|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
160472413|NCT02203032|579458537|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
160472414|NCT02203032|579458538|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
160472415|NCT02203032|579458539|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
160472416|NCT02203032|579458540|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
160601351|NCT02371980|579918091|FG000|Open-label Period|Significant Protocol Deviation|19|||
160601352|NCT02371980|579918092|FG001|Open-label Period|Significant Protocol Deviation|0|||
160601353|NCT02371980|579918093|FG002|Open-label Period|Significant Protocol Deviation|0|||
160601354|NCT02371980|579918094|FG003|Open-label Period|Significant Protocol Deviation|0|||
160601355|NCT02371980|579918095|FG004|Open-label Period|Significant Protocol Deviation|0|||
160601356|NCT02371980|579918091|FG000|Open-label Period|Noncompliance with Study Drug|10|||
160601357|NCT02371980|579918092|FG001|Open-label Period|Noncompliance with Study Drug|0|||
160601358|NCT02371980|579918093|FG002|Open-label Period|Noncompliance with Study Drug|0|||
160601359|NCT02371980|579918094|FG003|Open-label Period|Noncompliance with Study Drug|0|||
160601360|NCT02371980|579918095|FG004|Open-label Period|Noncompliance with Study Drug|0|||
160601361|NCT02371980|579918091|FG000|Open-label Period|Lost to Follow-up|55|||
160601362|NCT02371980|579918092|FG001|Open-label Period|Lost to Follow-up|0|||
160601363|NCT02371980|579918093|FG002|Open-label Period|Lost to Follow-up|0|||
160601364|NCT02371980|579918094|FG003|Open-label Period|Lost to Follow-up|0|||
160601365|NCT02371980|579918095|FG004|Open-label Period|Lost to Follow-up|0|||
160601366|NCT02371980|579918091|FG000|Open-label Period|Voluntary Withdrawal|91|||
160601367|NCT02371980|579918092|FG001|Open-label Period|Voluntary Withdrawal|0|||
160601368|NCT02371980|579918093|FG002|Open-label Period|Voluntary Withdrawal|0|||
160601369|NCT02371980|579918094|FG003|Open-label Period|Voluntary Withdrawal|0|||
160601370|NCT02371980|579918095|FG004|Open-label Period|Voluntary Withdrawal|0|||
160601371|NCT02371980|579918091|FG000|Open-label Period|Pregnancy|1|||
160601372|NCT02371980|579918092|FG001|Open-label Period|Pregnancy|0|||
160601373|NCT02371980|579918093|FG002|Open-label Period|Pregnancy|0|||
160472417|NCT02203032|579458537|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
160601374|NCT02371980|579918094|FG003|Open-label Period|Pregnancy|0|||
160601375|NCT02371980|579918095|FG004|Open-label Period|Pregnancy|0|||
160601376|NCT02371980|579918091|FG000|Open-label Period|Lack of Efficacy|116|||
160601377|NCT02371980|579918092|FG001|Open-label Period|Lack of Efficacy|0|||
160601378|NCT02371980|579918093|FG002|Open-label Period|Lack of Efficacy|0|||
160601379|NCT02371980|579918094|FG003|Open-label Period|Lack of Efficacy|0|||
160601380|NCT02371980|579918095|FG004|Open-label Period|Lack of Efficacy|0|||
160601381|NCT02371980|579918091|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
160601382|NCT02371980|579918092|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
160601383|NCT02371980|579918093|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
160601384|NCT02371980|579918094|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
160601385|NCT02371980|579918095|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
160601386|NCT02371980|579918091|FG000|Open-label Period|Reason not Specified|9|||
160601387|NCT02371980|579918092|FG001|Open-label Period|Reason not Specified|0|||
160601388|NCT02371980|579918093|FG002|Open-label Period|Reason not Specified|0|||
160601389|NCT02371980|579918094|FG003|Open-label Period|Reason not Specified|0|||
160601390|NCT02371980|579918095|FG004|Open-label Period|Reason not Specified|0|||
160601391|NCT02371980|579918091|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
160601392|NCT02371980|579918092|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
160601393|NCT02371980|579918093|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
160601394|NCT02371980|579918094|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
160601395|NCT02371980|579918095|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
160601396|NCT02371980|579918091|FG000|Double-blind Period|Significant Protocol Deviation|0|||
160601397|NCT02371980|579918092|FG001|Double-blind Period|Significant Protocol Deviation|2|||
160601398|NCT02371980|579918093|FG002|Double-blind Period|Significant Protocol Deviation|7|||
160601399|NCT02371980|579918094|FG003|Double-blind Period|Significant Protocol Deviation|3|||
160601400|NCT02371980|579918095|FG004|Double-blind Period|Significant Protocol Deviation|3|||
160601401|NCT02371980|579918091|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
160601402|NCT02371980|579918092|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
160601403|NCT02371980|579918093|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
160601404|NCT02371980|579918094|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
160601405|NCT02371980|579918095|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
160601406|NCT02371980|579918091|FG000|Double-blind Period|Lost to Follow-up|0|||
160601407|NCT02371980|579918092|FG001|Double-blind Period|Lost to Follow-up|8|||
160601408|NCT02371980|579918093|FG002|Double-blind Period|Lost to Follow-up|8|||
160601409|NCT02371980|579918094|FG003|Double-blind Period|Lost to Follow-up|6|||
160601410|NCT02371980|579918095|FG004|Double-blind Period|Lost to Follow-up|5|||
160601411|NCT02371980|579918091|FG000|Double-blind Period|Voluntary Withdrawal|0|||
160601412|NCT02371980|579918092|FG001|Double-blind Period|Voluntary Withdrawal|12|||
160601413|NCT02371980|579918093|FG002|Double-blind Period|Voluntary Withdrawal|8|||
160601414|NCT02371980|579918094|FG003|Double-blind Period|Voluntary Withdrawal|9|||
160601415|NCT02371980|579918095|FG004|Double-blind Period|Voluntary Withdrawal|11|||
160601416|NCT02371980|579918091|FG000|Double-blind Period|Relapse|0|||
160601417|NCT02371980|579918092|FG001|Double-blind Period|Relapse|50|||
160601418|NCT02371980|579918093|FG002|Double-blind Period|Relapse|25|||
160601419|NCT02371980|579918094|FG003|Double-blind Period|Relapse|25|||
160601420|NCT02371980|579918095|FG004|Double-blind Period|Relapse|26|||
160601421|NCT02371980|579918091|FG000|Double-blind Period|Reason not Specified|0|||
160601422|NCT02371980|579918092|FG001|Double-blind Period|Reason not Specified|3|||
160601423|NCT02371980|579918093|FG002|Double-blind Period|Reason not Specified|3|||
160601424|NCT02371980|579918094|FG003|Double-blind Period|Reason not Specified|2|||
160601425|NCT02371980|579918095|FG004|Double-blind Period|Reason not Specified|1|||
160601426|NCT02371980|579918091|FG000|Double-blind Period|Missing|0|||
160601427|NCT02371980|579918092|FG001|Double-blind Period|Missing|1|||
160601428|NCT02371980|579918093|FG002|Double-blind Period|Missing|0|||
160601429|NCT02371980|579918094|FG003|Double-blind Period|Missing|0|||
160601430|NCT02371980|579918095|FG004|Double-blind Period|Missing|0|||
160601431|NCT02009930|579918107|FG000|Overall Study|withdrawn|5|||
160601432|NCT03907969|579918108|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
160601433|NCT03907969|579918109|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
160601434|NCT03907969|579918110|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
160601435|NCT03907969|579918111|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
160601436|NCT03907969|579918112|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
160601437|NCT03907969|579918113|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
160601438|NCT03907969|579918114|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
160601439|NCT03907969|579918115|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
160601440|NCT03907969|579918116|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
160601441|NCT03907969|579918117|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
160601442|NCT03907969|579918118|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
160601443|NCT03907969|579918108|FG000|Monotherapy Part A|Progressive Disease|0|||
160601444|NCT03907969|579918109|FG001|Monotherapy Part A|Progressive Disease|1|||
160601445|NCT03907969|579918110|FG002|Monotherapy Part A|Progressive Disease|0|||
160601446|NCT03907969|579918111|FG003|Monotherapy Part A|Progressive Disease|0|||
160601447|NCT03907969|579918112|FG004|Monotherapy Part A|Progressive Disease|0|||
160601448|NCT03907969|579918113|FG005|Monotherapy Part A|Progressive Disease|1|||
160601449|NCT03907969|579918114|FG006|Monotherapy Part A|Progressive Disease|2|||
160601450|NCT03907969|579918115|FG007|Monotherapy Part A|Progressive Disease|0|||
160601451|NCT03907969|579918116|FG008|Monotherapy Part A|Progressive Disease|0|||
160601452|NCT03907969|579918117|FG009|Monotherapy Part A|Progressive Disease|0|||
160472418|NCT02203032|579458538|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
160472419|NCT02203032|579458539|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
160472420|NCT02203032|579458540|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
160472421|NCT02203032|579458537|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
160472422|NCT02203032|579458538|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
160472423|NCT02203032|579458539|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
160472424|NCT02203032|579458540|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
160472425|NCT02203032|579458537|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
160472426|NCT02203032|579458538|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
160472427|NCT02203032|579458539|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
160472428|NCT02203032|579458540|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
160472429|NCT02203032|579458537|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
160472430|NCT02203032|579458538|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
160472431|NCT02203032|579458539|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
160472432|NCT02203032|579458540|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
160472433|NCT02203032|579458537|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
160472434|NCT02203032|579458538|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
160472435|NCT02203032|579458539|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
160472436|NCT02203032|579458540|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
160472437|NCT02203032|579458537|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
160472438|NCT02203032|579458538|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
160472439|NCT02203032|579458539|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
160472440|NCT02203032|579458540|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
160472441|NCT02203032|579458537|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
160472442|NCT02203032|579458538|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
160472443|NCT02203032|579458539|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
160472444|NCT02203032|579458540|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
160472445|NCT02203032|579458537|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
160472446|NCT02203032|579458538|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
160472447|NCT02203032|579458539|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
160472448|NCT02203032|579458540|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
160472449|NCT02241785|579458543|FG000|Overall Study|Sponsor Termination|43|||
160472450|NCT02241785|579458543|FG000|Overall Study|Withdrawal by Subject|1|||
160472451|NCT02241785|579458543|FG000|Overall Study|Lost to Follow-up|2|||
160472452|NCT02241785|579458543|FG000|Overall Study|Adverse Event|1|||
160472453|NCT03905642|579458546|FG000|Overall Study|Withdrawal by Subject|3|||
160472454|NCT03905642|579458546|FG000|Overall Study|Pregnancy|1|||
160472455|NCT03905642|579458546|FG000|Overall Study|Adverse Event|1|||
160472456|NCT03905642|579458546|FG000|Overall Study|Lack of Efficacy|1|||
160472457|NCT03905642|579458546|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
160472458|NCT05995977|579458547|FG000|Overall Study|Withdrawal by Subject|1|||
160472459|NCT05995977|579458548|FG001|Overall Study|Withdrawal by Subject|4|||
160472460|NCT05995977|579458547|FG000|Overall Study|Lost to Follow-up|2|||
160472461|NCT05995977|579458548|FG001|Overall Study|Lost to Follow-up|0|||
160472462|NCT04181788|579458549|FG000|TREATMENT|Adverse Event|0|||
160472463|NCT04181788|579458550|FG001|TREATMENT|Adverse Event|2|||
160472464|NCT04181788|579458551|FG002|TREATMENT|Adverse Event|1|||
160472465|NCT04181788|579458552|FG003|TREATMENT|Adverse Event|0|||
160472466|NCT04181788|579458553|FG004|TREATMENT|Adverse Event|1|||
160472467|NCT04181788|579458554|FG005|TREATMENT|Adverse Event|3|||
160472468|NCT04181788|579458549|FG000|TREATMENT|Death|0|||
160472469|NCT04181788|579458550|FG001|TREATMENT|Death|0|||
160472470|NCT04181788|579458551|FG002|TREATMENT|Death|0|||
160472471|NCT04181788|579458552|FG003|TREATMENT|Death|0|||
160601453|NCT03907969|579918118|FG010|Monotherapy Part A|Progressive Disease|0|||
160601454|NCT03907969|579918108|FG000|Monotherapy Part A|Death|0|||
160601455|NCT03907969|579918109|FG001|Monotherapy Part A|Death|0|||
160601456|NCT03907969|579918110|FG002|Monotherapy Part A|Death|1|||
160601457|NCT03907969|579918111|FG003|Monotherapy Part A|Death|1|||
160601458|NCT03907969|579918112|FG004|Monotherapy Part A|Death|0|||
160601459|NCT03907969|579918113|FG005|Monotherapy Part A|Death|1|||
160472472|NCT04181788|579458553|FG004|TREATMENT|Death|8|||
160601460|NCT03907969|579918114|FG006|Monotherapy Part A|Death|0|||
160601461|NCT03907969|579918115|FG007|Monotherapy Part A|Death|0|||
160601462|NCT03907969|579918116|FG008|Monotherapy Part A|Death|0|||
160601463|NCT03907969|579918117|FG009|Monotherapy Part A|Death|0|||
160472473|NCT04181788|579458554|FG005|TREATMENT|Death|8|||
160472474|NCT04181788|579458549|FG000|TREATMENT|Physician Decision|0|||
160472475|NCT04181788|579458550|FG001|TREATMENT|Physician Decision|0|||
160472476|NCT04181788|579458551|FG002|TREATMENT|Physician Decision|0|||
160472477|NCT04181788|579458552|FG003|TREATMENT|Physician Decision|0|||
160472478|NCT04181788|579458553|FG004|TREATMENT|Physician Decision|0|||
160472479|NCT04181788|579458554|FG005|TREATMENT|Physician Decision|1|||
160601464|NCT03907969|579918118|FG010|Monotherapy Part A|Death|0|||
160472480|NCT04181788|579458549|FG000|TREATMENT|Progressive disease|3|||
160601465|NCT03907969|579918108|FG000|Combination Therapy Part A|Adverse Event|0|||
160472481|NCT04181788|579458550|FG001|TREATMENT|Progressive disease|3|||
160472482|NCT04181788|579458551|FG002|TREATMENT|Progressive disease|5|||
160472483|NCT04181788|579458552|FG003|TREATMENT|Progressive disease|7|||
160472484|NCT04181788|579458553|FG004|TREATMENT|Progressive disease|20|||
160472485|NCT04181788|579458554|FG005|TREATMENT|Progressive disease|38|||
160472486|NCT04181788|579458549|FG000|TREATMENT|Global deterioration of health status|0|||
160472487|NCT04181788|579458550|FG001|TREATMENT|Global deterioration of health status|2|||
160472488|NCT04181788|579458551|FG002|TREATMENT|Global deterioration of health status|0|||
160472489|NCT04181788|579458552|FG003|TREATMENT|Global deterioration of health status|0|||
160472490|NCT04181788|579458553|FG004|TREATMENT|Global deterioration of health status|2|||
160472491|NCT04181788|579458554|FG005|TREATMENT|Global deterioration of health status|8|||
160472492|NCT04181788|579458549|FG000|TREATMENT|Withdrawal by Subject|1|||
160472493|NCT04181788|579458550|FG001|TREATMENT|Withdrawal by Subject|2|||
160472494|NCT04181788|579458551|FG002|TREATMENT|Withdrawal by Subject|0|||
160472495|NCT04181788|579458552|FG003|TREATMENT|Withdrawal by Subject|0|||
160472496|NCT04181788|579458553|FG004|TREATMENT|Withdrawal by Subject|3|||
160472497|NCT04181788|579458554|FG005|TREATMENT|Withdrawal by Subject|5|||
160472498|NCT04181788|579458549|FG000|TREATMENT|Other unspecified|0|||
160472499|NCT04181788|579458550|FG001|TREATMENT|Other unspecified|0|||
160472500|NCT04181788|579458551|FG002|TREATMENT|Other unspecified|0|||
160472501|NCT04181788|579458552|FG003|TREATMENT|Other unspecified|0|||
160472502|NCT04181788|579458553|FG004|TREATMENT|Other unspecified|0|||
160472503|NCT04181788|579458554|FG005|TREATMENT|Other unspecified|2|||
160472504|NCT04181788|579458549|FG000|TREATMENT|Ongoing|0|||
160472505|NCT04181788|579458550|FG001|TREATMENT|Ongoing|3|||
160472506|NCT04181788|579458551|FG002|TREATMENT|Ongoing|0|||
160472507|NCT04181788|579458552|FG003|TREATMENT|Ongoing|5|||
160472508|NCT04181788|579458553|FG004|TREATMENT|Ongoing|7|||
160472509|NCT04181788|579458554|FG005|TREATMENT|Ongoing|15|||
160472510|NCT04181788|579458549|FG000|FOLLOW-UP|Death|0|||
160472511|NCT04181788|579458550|FG001|FOLLOW-UP|Death|0|||
160472512|NCT04181788|579458551|FG002|FOLLOW-UP|Death|1|||
160472513|NCT04181788|579458552|FG003|FOLLOW-UP|Death|2|||
160472514|NCT04181788|579458553|FG004|FOLLOW-UP|Death|8|||
160472515|NCT04181788|579458554|FG005|FOLLOW-UP|Death|20|||
160472516|NCT04181788|579458549|FG000|FOLLOW-UP|Lost to Follow-up|0|||
160472517|NCT04181788|579458550|FG001|FOLLOW-UP|Lost to Follow-up|0|||
160472518|NCT04181788|579458551|FG002|FOLLOW-UP|Lost to Follow-up|0|||
160472519|NCT04181788|579458552|FG003|FOLLOW-UP|Lost to Follow-up|0|||
160472520|NCT04181788|579458553|FG004|FOLLOW-UP|Lost to Follow-up|0|||
160472521|NCT04181788|579458554|FG005|FOLLOW-UP|Lost to Follow-up|2|||
160472522|NCT04181788|579458549|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
160472523|NCT04181788|579458550|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
160472524|NCT04181788|579458551|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
160472525|NCT04181788|579458552|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
160472526|NCT04181788|579458553|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
160472527|NCT04181788|579458554|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
160472528|NCT04181788|579458549|FG000|FOLLOW-UP|Other unspecified|0|||
160472529|NCT04181788|579458550|FG001|FOLLOW-UP|Other unspecified|1|||
160472530|NCT04181788|579458551|FG002|FOLLOW-UP|Other unspecified|0|||
160472531|NCT04181788|579458552|FG003|FOLLOW-UP|Other unspecified|0|||
160472532|NCT04181788|579458553|FG004|FOLLOW-UP|Other unspecified|0|||
160472533|NCT04181788|579458554|FG005|FOLLOW-UP|Other unspecified|3|||
160472534|NCT04181788|579458549|FG000|FOLLOW-UP|Ongoing|0|||
160472535|NCT04181788|579458550|FG001|FOLLOW-UP|Ongoing|0|||
160472536|NCT04181788|579458551|FG002|FOLLOW-UP|Ongoing|1|||
160472537|NCT04181788|579458552|FG003|FOLLOW-UP|Ongoing|3|||
160472538|NCT04181788|579458553|FG004|FOLLOW-UP|Ongoing|2|||
160472539|NCT04181788|579458554|FG005|FOLLOW-UP|Ongoing|2|||
160472540|NCT04535414|579458555|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
160472541|NCT04535414|579458556|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
160472542|NCT04535414|579458555|FG000|Overall Study|Cancelled appointment|1|||
160601466|NCT03907969|579918109|FG001|Combination Therapy Part A|Adverse Event|0|||
160472543|NCT04535414|579458556|FG001|Overall Study|Cancelled appointment|0|||
160472544|NCT04535414|579458555|FG000|Overall Study|cancelled - food in stomach|2|||
160601467|NCT03907969|579918110|FG002|Combination Therapy Part A|Adverse Event|0|||
160472545|NCT04535414|579458556|FG001|Overall Study|cancelled - food in stomach|0|||
160472546|NCT04535414|579458555|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
160472547|NCT04535414|579458556|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
160472548|NCT04535414|579458555|FG000|Overall Study|Withdrawal by Subject|0|||
160472549|NCT04535414|579458556|FG001|Overall Study|Withdrawal by Subject|1|||
160472550|NCT02196259|579460014|FG000|Overall Study|Researcher choice|0|||
160472551|NCT02196259|579460015|FG001|Overall Study|Researcher choice|0|||
160472552|NCT02196259|579460016|FG002|Overall Study|Researcher choice|1|||
160472553|NCT02196259|579460014|FG000|Overall Study|Partial data analysis|0|||
160472554|NCT02196259|579460015|FG001|Overall Study|Partial data analysis|3|||
160472555|NCT02196259|579460016|FG002|Overall Study|Partial data analysis|0|||
160472556|NCT01668355|579460018|FG000|Overall Study|Death|3|||
160472557|NCT01668355|579460019|FG001|Overall Study|Death|1|||
160472558|NCT01668355|579460018|FG000|Overall Study|Withdrawal by Subject|6|||
160601468|NCT03907969|579918111|FG003|Combination Therapy Part A|Adverse Event|0|||
160601469|NCT03907969|579918112|FG004|Combination Therapy Part A|Adverse Event|0|||
160601470|NCT03907969|579918113|FG005|Combination Therapy Part A|Adverse Event|0|||
160659994|NCT01126736|580136186|FG002|Overall Study|Lost to Follow-up|0|||
160659995|NCT01126736|580136187|FG003|Overall Study|Lost to Follow-up|1|||
160659996|NCT01126736|580136188|FG004|Overall Study|Lost to Follow-up|1|||
160659997|NCT01126736|580136184|FG000|Overall Study|Administrative reasons|0|||
160659998|NCT01126736|580136185|FG001|Overall Study|Administrative reasons|0|||
160659999|NCT01126736|580136186|FG002|Overall Study|Administrative reasons|0|||
160660000|NCT01126736|580136187|FG003|Overall Study|Administrative reasons|0|||
160660001|NCT01126736|580136188|FG004|Overall Study|Administrative reasons|1|||
160660002|NCT01126736|580136184|FG000|Overall Study|Progressive disease|0|||
160660003|NCT01126736|580136185|FG001|Overall Study|Progressive disease|0|||
160660004|NCT01126736|580136186|FG002|Overall Study|Progressive disease|0|||
160660005|NCT01126736|580136187|FG003|Overall Study|Progressive disease|2|||
160660006|NCT01126736|580136188|FG004|Overall Study|Progressive disease|1|||
160660007|NCT01126736|580136184|FG000|Overall Study|Withdrawal by Subject|0|||
160660008|NCT01126736|580136185|FG001|Overall Study|Withdrawal by Subject|0|||
160660009|NCT01126736|580136186|FG002|Overall Study|Withdrawal by Subject|0|||
160660010|NCT01126736|580136187|FG003|Overall Study|Withdrawal by Subject|1|||
160660011|NCT01126736|580136188|FG004|Overall Study|Withdrawal by Subject|1|||
160660012|NCT01126736|580136184|FG000|Overall Study|Other|2|||
160660013|NCT01126736|580136185|FG001|Overall Study|Other|4|||
160660014|NCT01126736|580136186|FG002|Overall Study|Other|4|||
160660015|NCT01126736|580136187|FG003|Overall Study|Other|16|||
160660016|NCT01126736|580136188|FG004|Overall Study|Other|15|||
160660017|NCT00874237|580136189|FG000|Overall Study|Physician Decision|0|||
160660018|NCT00874237|580136190|FG001|Overall Study|Physician Decision|1|||
160660019|NCT00874237|580136191|FG002|Overall Study|Physician Decision|0|||
160660020|NCT00874237|580136192|FG003|Overall Study|Physician Decision|0|||
160660021|NCT00874237|580136193|FG004|Overall Study|Physician Decision|0|||
160660022|NCT00874237|580136194|FG005|Overall Study|Physician Decision|0|||
160660023|NCT00874237|580136189|FG000|Overall Study|Withdrawal by Subject|0|||
160660024|NCT00874237|580136190|FG001|Overall Study|Withdrawal by Subject|0|||
160660025|NCT00874237|580136191|FG002|Overall Study|Withdrawal by Subject|1|||
160660026|NCT00874237|580136192|FG003|Overall Study|Withdrawal by Subject|0|||
160660027|NCT00874237|580136193|FG004|Overall Study|Withdrawal by Subject|0|||
160660028|NCT00874237|580136194|FG005|Overall Study|Withdrawal by Subject|0|||
160660029|NCT00877032|580136199|FG000|Overall Study|Did not meet entrance criteria|0|||
160660030|NCT00877032|580136200|FG001|Overall Study|Did not meet entrance criteria|0|||
160660031|NCT00877032|580136201|FG002|Overall Study|Did not meet entrance criteria|0|||
160660032|NCT00877032|580136202|FG003|Overall Study|Did not meet entrance criteria|1|||
160660033|NCT00877032|580136203|FG004|Overall Study|Did not meet entrance criteria|0|||
160660034|NCT00877032|580136204|FG005|Overall Study|Did not meet entrance criteria|0|||
160660035|NCT00877032|580136205|FG006|Overall Study|Did not meet entrance criteria|2|||
160660036|NCT00813293|580136206|FG000|Overall Study|Intercurrent illness|1|||
160660037|NCT00813293|580136207|FG001|Overall Study|Intercurrent illness|0|||
160660038|NCT00813293|580136206|FG000|Overall Study|Adverse Event|0|||
160660039|NCT00813293|580136207|FG001|Overall Study|Adverse Event|1|||
160660040|NCT02794974|580136208|FG000|Overall Study|Physician Decision|0|||
160660041|NCT02794974|580136209|FG001|Overall Study|Physician Decision|1|||
160660042|NCT02202850|580136210|FG000|Overall Study|Other|2|||
160660043|NCT02202850|580136211|FG001|Overall Study|Other|2|||
160660044|NCT02202850|580136210|FG000|Overall Study|Enbrel treatment discontinued|15|||
160660045|NCT02202850|580136211|FG001|Overall Study|Enbrel treatment discontinued|3|||
160660046|NCT02202850|580136210|FG000|Overall Study|Lost to Follow-up|7|||
160660047|NCT02202850|580136211|FG001|Overall Study|Lost to Follow-up|1|||
160660048|NCT00615069|580136212|FG000|Overall Study|Death|10|||
160660049|NCT00615069|580136212|FG000|Overall Study|Physician Decision|2|||
160660050|NCT00615069|580136212|FG000|Overall Study|Withdrawal by Subject|4|||
160660051|NCT01173692|580136214|FG000|Overall Study|Adverse Event|1|||
160660052|NCT01173692|580136215|FG001|Overall Study|Adverse Event|2|||
160660053|NCT01173692|580136214|FG000|Overall Study|Withdrawal by Subject|1|||
160660054|NCT01173692|580136215|FG001|Overall Study|Withdrawal by Subject|3|||
160660055|NCT01941030|580136221|FG000|Overall Study|Death|3|||
160660056|NCT01941030|580136222|FG001|Overall Study|Death|2|||
160660057|NCT01941030|580136221|FG000|Overall Study|Lost to Follow-up|6|||
160472559|NCT01668355|579460019|FG001|Overall Study|Withdrawal by Subject|1|||
160472560|NCT00535626|579460020|FG000|Overall Study|Death|15|||
160472561|NCT00535626|579460020|FG000|Overall Study|Lost to Follow-up|29|||
160472562|NCT00535626|579460020|FG000|Overall Study|Withdrawal by Subject|20|||
160472563|NCT00535626|579460020|FG000|Overall Study|Removal/revision of study component|8|||
160472564|NCT00535626|579460020|FG000|Overall Study|Subject terminated|31|||
160472565|NCT00535626|579460020|FG000|Overall Study|Unable to return|2|||
160472566|NCT04633200|579460021|FG000|Overall Study|Lost to Follow-up|3|||
160472567|NCT04633200|579460022|FG001|Overall Study|Lost to Follow-up|5|||
160472568|NCT01808534|579460023|FG000|Overall Study|Disease progression|3|||
160472569|NCT01808534|579460023|FG000|Overall Study|Physician Decision|1|||
160472570|NCT02002689|579460024|FG000|Overall Study|Disease Progression|7|||
160472571|NCT02002689|579460024|FG000|Overall Study|Adverse Event|3|||
160472572|NCT01148017|579460027|FG000|Overall Study|Withdrawal by Subject|31|||
160472573|NCT01148017|579460028|FG001|Overall Study|Withdrawal by Subject|14|||
160472574|NCT01148017|579460029|FG002|Overall Study|Withdrawal by Subject|0|||
160472575|NCT01148017|579460030|FG003|Overall Study|Withdrawal by Subject|0|||
160472576|NCT01148017|579460027|FG000|Overall Study|Lost to Follow-up|23|||
160472577|NCT01148017|579460028|FG001|Overall Study|Lost to Follow-up|10|||
160472578|NCT01148017|579460029|FG002|Overall Study|Lost to Follow-up|0|||
160472579|NCT01148017|579460030|FG003|Overall Study|Lost to Follow-up|0|||
160601471|NCT03907969|579918114|FG006|Combination Therapy Part A|Adverse Event|0|||
160601472|NCT03907969|579918115|FG007|Combination Therapy Part A|Adverse Event|0|||
160601473|NCT03907969|579918116|FG008|Combination Therapy Part A|Adverse Event|0|||
160601474|NCT03907969|579918117|FG009|Combination Therapy Part A|Adverse Event|1|||
160601475|NCT03907969|579918118|FG010|Combination Therapy Part A|Adverse Event|1|||
160601476|NCT03907969|579918108|FG000|Combination Therapy Part A|Progressive disease|0|||
160601477|NCT03907969|579918109|FG001|Combination Therapy Part A|Progressive disease|0|||
160601478|NCT03907969|579918110|FG002|Combination Therapy Part A|Progressive disease|0|||
160601479|NCT03907969|579918111|FG003|Combination Therapy Part A|Progressive disease|0|||
160601480|NCT03907969|579918112|FG004|Combination Therapy Part A|Progressive disease|0|||
160601481|NCT03907969|579918113|FG005|Combination Therapy Part A|Progressive disease|0|||
160601482|NCT03907969|579918114|FG006|Combination Therapy Part A|Progressive disease|0|||
160601483|NCT03907969|579918115|FG007|Combination Therapy Part A|Progressive disease|1|||
160601484|NCT03907969|579918116|FG008|Combination Therapy Part A|Progressive disease|0|||
160601485|NCT03907969|579918117|FG009|Combination Therapy Part A|Progressive disease|2|||
160601486|NCT03907969|579918118|FG010|Combination Therapy Part A|Progressive disease|3|||
160601487|NCT03907969|579918108|FG000|Combination Therapy Part A|Death|0|||
160472580|NCT01148017|579460027|FG000|Overall Study|Inappropriate enrollment|1|||
160601488|NCT03907969|579918109|FG001|Combination Therapy Part A|Death|0|||
160601489|NCT03907969|579918110|FG002|Combination Therapy Part A|Death|0|||
160601490|NCT03907969|579918111|FG003|Combination Therapy Part A|Death|0|||
160472581|NCT01148017|579460028|FG001|Overall Study|Inappropriate enrollment|0|||
160472582|NCT01148017|579460029|FG002|Overall Study|Inappropriate enrollment|0|||
160472583|NCT01148017|579460030|FG003|Overall Study|Inappropriate enrollment|0|||
160472584|NCT01148017|579460027|FG000|Overall Study|Administrative reason|22|||
160472585|NCT01148017|579460028|FG001|Overall Study|Administrative reason|9|||
160472586|NCT01148017|579460029|FG002|Overall Study|Administrative reason|0|||
160472587|NCT01148017|579460030|FG003|Overall Study|Administrative reason|0|||
160472588|NCT01148017|579460027|FG000|Overall Study|Unable to classify|3|||
160472589|NCT01148017|579460028|FG001|Overall Study|Unable to classify|1|||
160472590|NCT01148017|579460029|FG002|Overall Study|Unable to classify|0|||
160472591|NCT01148017|579460030|FG003|Overall Study|Unable to classify|0|||
160472592|NCT01332266|579460031|FG000|Phase 1b|Death|3|||
160472593|NCT01332266|579460032|FG001|Phase 1b|Death|3|||
160472594|NCT01332266|579460033|FG002|Phase 1b|Death|2|||
160472595|NCT01332266|579460034|FG003|Phase 1b|Death|0|||
160472596|NCT01332266|579460035|FG004|Phase 1b|Death|0|||
160472597|NCT01332266|579460031|FG000|Phase 1b|Lost to Follow-up|0|||
160472598|NCT01332266|579460032|FG001|Phase 1b|Lost to Follow-up|1|||
160472599|NCT01332266|579460033|FG002|Phase 1b|Lost to Follow-up|0|||
160472600|NCT01332266|579460034|FG003|Phase 1b|Lost to Follow-up|0|||
160472601|NCT01332266|579460035|FG004|Phase 1b|Lost to Follow-up|0|||
160472602|NCT01332266|579460031|FG000|Phase 1b|Withdrawal by Subject|1|||
160472603|NCT01332266|579460032|FG001|Phase 1b|Withdrawal by Subject|1|||
160472604|NCT01332266|579460033|FG002|Phase 1b|Withdrawal by Subject|1|||
160472605|NCT01332266|579460034|FG003|Phase 1b|Withdrawal by Subject|0|||
160472606|NCT01332266|579460035|FG004|Phase 1b|Withdrawal by Subject|0|||
160472607|NCT01332266|579460031|FG000|Phase 2|Death|0|||
160472608|NCT01332266|579460032|FG001|Phase 2|Death|0|||
160472609|NCT01332266|579460033|FG002|Phase 2|Death|0|||
160472610|NCT01332266|579460034|FG003|Phase 2|Death|33|||
160472611|NCT01332266|579460035|FG004|Phase 2|Death|36|||
160472612|NCT01332266|579460031|FG000|Phase 2|Lost to Follow-up|0|||
160472613|NCT01332266|579460032|FG001|Phase 2|Lost to Follow-up|0|||
160472614|NCT01332266|579460033|FG002|Phase 2|Lost to Follow-up|0|||
160472615|NCT01332266|579460034|FG003|Phase 2|Lost to Follow-up|2|||
160472616|NCT01332266|579460035|FG004|Phase 2|Lost to Follow-up|0|||
160472617|NCT01332266|579460031|FG000|Phase 2|Physician Decision|0|||
160472618|NCT01332266|579460032|FG001|Phase 2|Physician Decision|0|||
160472619|NCT01332266|579460033|FG002|Phase 2|Physician Decision|0|||
160472620|NCT01332266|579460034|FG003|Phase 2|Physician Decision|3|||
160472621|NCT01332266|579460035|FG004|Phase 2|Physician Decision|1|||
160472622|NCT01332266|579460031|FG000|Phase 2|Symptomatic deterioration|0|||
160472623|NCT01332266|579460032|FG001|Phase 2|Symptomatic deterioration|0|||
160472624|NCT01332266|579460033|FG002|Phase 2|Symptomatic deterioration|0|||
160472625|NCT01332266|579460034|FG003|Phase 2|Symptomatic deterioration|0|||
160472626|NCT01332266|579460035|FG004|Phase 2|Symptomatic deterioration|1|||
160472627|NCT01332266|579460031|FG000|Phase 2|Progression Disease|0|||
160472628|NCT01332266|579460032|FG001|Phase 2|Progression Disease|0|||
160472629|NCT01332266|579460033|FG002|Phase 2|Progression Disease|0|||
160472630|NCT01332266|579460034|FG003|Phase 2|Progression Disease|2|||
160472631|NCT01332266|579460035|FG004|Phase 2|Progression Disease|1|||
160472632|NCT01332266|579460031|FG000|Phase 2|Withdrawal by Subject|0|||
160472633|NCT01332266|579460032|FG001|Phase 2|Withdrawal by Subject|0|||
160472634|NCT01332266|579460033|FG002|Phase 2|Withdrawal by Subject|0|||
160472635|NCT01332266|579460034|FG003|Phase 2|Withdrawal by Subject|2|||
160472636|NCT01332266|579460035|FG004|Phase 2|Withdrawal by Subject|2|||
160472637|NCT01686152|579460038|FG000|Overall Study|Withdrawal by Subject|11|||
160472638|NCT01686152|579460039|FG001|Overall Study|Withdrawal by Subject|11|||
160472639|NCT01686152|579460040|FG002|Overall Study|Withdrawal by Subject|3|||
160472640|NCT01686152|579460038|FG000|Overall Study|Drug Code Unblinded|0|||
160660058|NCT01941030|580136222|FG001|Overall Study|Lost to Follow-up|5|||
160660059|NCT01941030|580136221|FG000|Overall Study|Withdrawal by Subject|4|||
160472641|NCT01686152|579460039|FG001|Overall Study|Drug Code Unblinded|1|||
160472642|NCT01686152|579460040|FG002|Overall Study|Drug Code Unblinded|0|||
160660060|NCT01941030|580136222|FG001|Overall Study|Withdrawal by Subject|6|||
160472643|NCT01686152|579460038|FG000|Overall Study|Protocol Violation|6|||
160472644|NCT01686152|579460039|FG001|Overall Study|Protocol Violation|1|||
160472645|NCT01686152|579460040|FG002|Overall Study|Protocol Violation|0|||
160472646|NCT01686152|579460038|FG000|Overall Study|Adverse Event|12|||
160472647|NCT01686152|579460039|FG001|Overall Study|Adverse Event|11|||
160472648|NCT01686152|579460040|FG002|Overall Study|Adverse Event|0|||
160472649|NCT01686152|579460038|FG000|Overall Study|Lack of Efficacy|0|||
160472650|NCT01686152|579460039|FG001|Overall Study|Lack of Efficacy|0|||
160472651|NCT01686152|579460040|FG002|Overall Study|Lack of Efficacy|1|||
160472652|NCT01686152|579460038|FG000|Overall Study|IP Non-compliance|5|||
160472653|NCT01686152|579460039|FG001|Overall Study|IP Non-compliance|5|||
160472654|NCT01686152|579460040|FG002|Overall Study|IP Non-compliance|0|||
160472655|NCT01686152|579460038|FG000|Overall Study|Lost to Follow-up|7|||
160472656|NCT01686152|579460039|FG001|Overall Study|Lost to Follow-up|6|||
160472657|NCT01686152|579460040|FG002|Overall Study|Lost to Follow-up|5|||
160472658|NCT01853384|579460041|FG000|Randomized|Adverse Event|5|||
160472659|NCT01853384|579460042|FG001|Randomized|Adverse Event|3|||
160472660|NCT01853384|579460041|FG000|Randomized|Death|1|||
160472661|NCT01853384|579460042|FG001|Randomized|Death|2|||
160472662|NCT01853384|579460041|FG000|Randomized|Lost to Follow-up|1|||
160472663|NCT01853384|579460042|FG001|Randomized|Lost to Follow-up|1|||
160472664|NCT01853384|579460041|FG000|Randomized|Withdrawal by Subject|5|||
160660061|NCT01479439|580136223|FG000|Overall Study|Adverse Event|1|||
160660062|NCT01479439|580136224|FG001|Overall Study|Adverse Event|0|||
160660063|NCT01479439|580136225|FG002|Overall Study|Adverse Event|0|||
160660064|NCT01479439|580136223|FG000|Overall Study|Lost to Follow-up|0|||
160660065|NCT01479439|580136224|FG001|Overall Study|Lost to Follow-up|1|||
160660066|NCT01479439|580136225|FG002|Overall Study|Lost to Follow-up|0|||
160660067|NCT01479439|580136223|FG000|Overall Study|Protocol Violation|0|||
160660068|NCT01479439|580136224|FG001|Overall Study|Protocol Violation|0|||
160660069|NCT01479439|580136225|FG002|Overall Study|Protocol Violation|2|||
160660070|NCT05067647|580136228|FG000|Overall Study|Lost to Follow-up|1|||
160660071|NCT02781727|580136230|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
160660072|NCT02781727|580136231|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
160660073|NCT02781727|580136230|FG000|Treatment Period|Withdrawal by Subject|1|||
160660074|NCT02781727|580136231|FG001|Treatment Period|Withdrawal by Subject|0|||
160660075|NCT02781727|580136230|FG000|Treatment Period|Lost to Follow-up|0|||
160660076|NCT02781727|580136231|FG001|Treatment Period|Lost to Follow-up|1|||
160660077|NCT01569152|580136235|FG000|Phase IIa, Period 1|Early Escape|5|||
160660078|NCT01569152|580136236|FG001|Phase IIa, Period 1|Early Escape|22|||
160660079|NCT01569152|580136237|FG002|Phase IIa, Period 1|Early Escape|0|||
160660080|NCT01569152|580136235|FG000|Phase IIa, Period 1|Adverse Event|4|||
160660081|NCT01569152|580136236|FG001|Phase IIa, Period 1|Adverse Event|0|||
160660082|NCT01569152|580136237|FG002|Phase IIa, Period 1|Adverse Event|0|||
160660083|NCT01569152|580136235|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
160660084|NCT01569152|580136236|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
160660085|NCT01569152|580136237|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
160660086|NCT01569152|580136235|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
160660087|NCT01569152|580136236|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
160660088|NCT01569152|580136237|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
160660089|NCT01569152|580136235|FG000|Phase IIa, Period 1|Protocol Violation|0|||
160660090|NCT01569152|580136236|FG001|Phase IIa, Period 1|Protocol Violation|1|||
160660091|NCT01569152|580136237|FG002|Phase IIa, Period 1|Protocol Violation|0|||
160660092|NCT01569152|580136235|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
160660093|NCT01569152|580136236|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
160660094|NCT01569152|580136237|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
160660095|NCT01569152|580136235|FG000|Safety Extension, Period 3|Adverse Event|0|||
160660096|NCT01569152|580136236|FG001|Safety Extension, Period 3|Adverse Event|0|||
160660097|NCT01569152|580136237|FG002|Safety Extension, Period 3|Adverse Event|4|||
160660098|NCT01569152|580136235|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
160660099|NCT01569152|580136236|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
160660100|NCT01569152|580136237|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
160660101|NCT01569152|580136235|FG000|Safety Extension, Period 3|Physician Decision|0|||
160660102|NCT01569152|580136236|FG001|Safety Extension, Period 3|Physician Decision|0|||
160660103|NCT01569152|580136237|FG002|Safety Extension, Period 3|Physician Decision|2|||
160660104|NCT01569152|580136235|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
160660105|NCT01569152|580136236|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
160472665|NCT01853384|579460042|FG001|Randomized|Withdrawal by Subject|3|||
160472666|NCT01853384|579460041|FG000|Randomized|Sponsor Decision|47|||
160472667|NCT01853384|579460042|FG001|Randomized|Sponsor Decision|34|||
160472668|NCT01853384|579460041|FG000|Randomized|Other|3|||
160472669|NCT01853384|579460042|FG001|Randomized|Other|3|||
160472670|NCT01853384|579460041|FG000|Completed Follow up Visit 1|Early Termination|13|||
160472671|NCT01853384|579460042|FG001|Completed Follow up Visit 1|Early Termination|9|||
160472672|NCT01853384|579460041|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
160472673|NCT01853384|579460042|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
160472674|NCT01853384|579460041|FG000|Completed Follow up Visit 2|Adverse Event|1|||
160472675|NCT01853384|579460042|FG001|Completed Follow up Visit 2|Adverse Event|0|||
160472676|NCT01853384|579460041|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
160660106|NCT01569152|580136237|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
160660107|NCT00683293|580136242|FG000|Overall Study|Withdrawal by Subject|2|||
160660108|NCT00683293|580136243|FG001|Overall Study|Withdrawal by Subject|3|||
160472677|NCT01853384|579460042|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
160660109|NCT00743197|580136246|FG000|Overall Study|Study terminated due to departure of PI.|1|||
160472678|NCT01853384|579460041|FG000|Completed Follow up Visit 2|Death|1|||
160472679|NCT01853384|579460042|FG001|Completed Follow up Visit 2|Death|0|||
160472680|NCT01853384|579460041|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
160472681|NCT01853384|579460042|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
160472682|NCT01019135|579460043|FG000|Overall Study|Did not receive allocated intervention|12|||
160660110|NCT00743197|580136247|FG001|Overall Study|Study terminated due to departure of PI.|2|||
160472683|NCT01019135|579460044|FG001|Overall Study|Did not receive allocated intervention|6|||
160472684|NCT01019135|579460045|FG002|Overall Study|Did not receive allocated intervention|25|||
160660111|NCT02507375|580136248|FG000|Overall Study|Progressive Disease|4|||
160660112|NCT02507375|580136249|FG001|Overall Study|Progressive Disease|5|||
160660113|NCT02507375|580136248|FG000|Overall Study|Death|0|||
160660114|NCT02507375|580136249|FG001|Overall Study|Death|1|||
160472685|NCT01019135|579460043|FG000|Overall Study|Did not attend CR|8|||
160472686|NCT01019135|579460044|FG001|Overall Study|Did not attend CR|13|||
160472687|NCT01019135|579460045|FG002|Overall Study|Did not attend CR|6|||
160472688|NCT01205126|579460046|FG000|Titration Phase|Adverse Event|5|||
160472689|NCT01205126|579460047|FG001|Titration Phase|Adverse Event|3|||
160472690|NCT01205126|579460046|FG000|Titration Phase|Withdrawal by Subject|5|||
160472691|NCT01205126|579460047|FG001|Titration Phase|Withdrawal by Subject|5|||
160472692|NCT01205126|579460046|FG000|Titration Phase|Lost to Follow-up|2|||
160472693|NCT01205126|579460047|FG001|Titration Phase|Lost to Follow-up|2|||
160472694|NCT01205126|579460046|FG000|Titration Phase|No stable titration dose|1|||
160472695|NCT01205126|579460047|FG001|Titration Phase|No stable titration dose|0|||
160472696|NCT01205126|579460046|FG000|Titration Phase|More than maximum dosage required|2|||
160472697|NCT01205126|579460047|FG001|Titration Phase|More than maximum dosage required|3|||
160472698|NCT01205126|579460046|FG000|Titration Phase|Other|8|||
160472699|NCT01205126|579460047|FG001|Titration Phase|Other|6|||
160472700|NCT01205126|579460046|FG000|Between Titration & Maintenance Phase|Other|0|||
160472701|NCT01205126|579460047|FG001|Between Titration & Maintenance Phase|Other|4|||
160472702|NCT01205126|579460046|FG000|Maintenance Phase|Adverse Event|3|||
160472703|NCT01205126|579460047|FG001|Maintenance Phase|Adverse Event|7|||
160472704|NCT01205126|579460046|FG000|Maintenance Phase|Death|4|||
160472705|NCT01205126|579460047|FG001|Maintenance Phase|Death|4|||
160472706|NCT01205126|579460046|FG000|Maintenance Phase|More than the maximum dosage required|5|||
160472707|NCT01205126|579460047|FG001|Maintenance Phase|More than the maximum dosage required|5|||
160472708|NCT01205126|579460046|FG000|Maintenance Phase|Prohibited drugs used|1|||
160472709|NCT01205126|579460047|FG001|Maintenance Phase|Prohibited drugs used|0|||
160472710|NCT01205126|579460046|FG000|Maintenance Phase|Other|11|||
160472711|NCT01205126|579460047|FG001|Maintenance Phase|Other|8|||
160472712|NCT01205126|579460046|FG000|Maintenance Phase|Lost to Follow-up|5|||
160472713|NCT01205126|579460047|FG001|Maintenance Phase|Lost to Follow-up|5|||
160472714|NCT01205126|579460046|FG000|Maintenance Phase|Withdrawal by Subject|8|||
160472715|NCT01205126|579460047|FG001|Maintenance Phase|Withdrawal by Subject|11|||
160472716|NCT00929526|579460048|FG000|Overall Study|Withdrawal by Subject|1|||
160472717|NCT00929526|579460049|FG001|Overall Study|Withdrawal by Subject|11|||
160472718|NCT00929526|579460048|FG000|Overall Study|Lost to Follow-up|8|||
160472719|NCT00929526|579460049|FG001|Overall Study|Lost to Follow-up|12|||
160472720|NCT00929526|579460048|FG000|Overall Study|Other|8|||
160472721|NCT00929526|579460049|FG001|Overall Study|Other|6|||
160472722|NCT00578344|579460052|FG000|Overall Study|Insurance problems|1|||
160472723|NCT00578344|579460052|FG000|Overall Study|Graft failure|1|||
160472724|NCT03374254|579460055|FG000|Overall Study|Death|5|||
160472725|NCT03374254|579460056|FG001|Overall Study|Death|16|||
160472726|NCT03374254|579460057|FG002|Overall Study|Death|13|||
160472727|NCT03374254|579460058|FG003|Overall Study|Death|11|||
160472728|NCT03374254|579460059|FG004|Overall Study|Death|9|||
160472729|NCT03374254|579460060|FG005|Overall Study|Death|12|||
160472730|NCT03374254|579460061|FG006|Overall Study|Death|11|||
160472731|NCT03374254|579460062|FG007|Overall Study|Death|6|||
160472732|NCT03374254|579460063|FG008|Overall Study|Death|7|||
160472733|NCT03374254|579460055|FG000|Overall Study|Lost to Follow-up|0|||
160472734|NCT03374254|579460056|FG001|Overall Study|Lost to Follow-up|0|||
160472735|NCT03374254|579460057|FG002|Overall Study|Lost to Follow-up|0|||
160472736|NCT03374254|579460058|FG003|Overall Study|Lost to Follow-up|0|||
160472737|NCT03374254|579460059|FG004|Overall Study|Lost to Follow-up|0|||
160472738|NCT03374254|579460060|FG005|Overall Study|Lost to Follow-up|0|||
160472739|NCT03374254|579460061|FG006|Overall Study|Lost to Follow-up|2|||
160472740|NCT03374254|579460062|FG007|Overall Study|Lost to Follow-up|0|||
160472741|NCT03374254|579460063|FG008|Overall Study|Lost to Follow-up|0|||
160472742|NCT03374254|579460055|FG000|Overall Study|Sponsor Decision|1|||
160472743|NCT03374254|579460056|FG001|Overall Study|Sponsor Decision|0|||
160472744|NCT03374254|579460057|FG002|Overall Study|Sponsor Decision|2|||
160472745|NCT03374254|579460058|FG003|Overall Study|Sponsor Decision|3|||
160472746|NCT03374254|579460059|FG004|Overall Study|Sponsor Decision|2|||
160472747|NCT03374254|579460060|FG005|Overall Study|Sponsor Decision|3|||
160472748|NCT03374254|579460061|FG006|Overall Study|Sponsor Decision|3|||
160472749|NCT03374254|579460062|FG007|Overall Study|Sponsor Decision|3|||
160472750|NCT03374254|579460063|FG008|Overall Study|Sponsor Decision|4|||
160472751|NCT03374254|579460055|FG000|Overall Study|Withdrawal by Subject|0|||
160472752|NCT03374254|579460056|FG001|Overall Study|Withdrawal by Subject|0|||
160472753|NCT03374254|579460057|FG002|Overall Study|Withdrawal by Subject|0|||
160472754|NCT03374254|579460058|FG003|Overall Study|Withdrawal by Subject|2|||
160472755|NCT03374254|579460059|FG004|Overall Study|Withdrawal by Subject|0|||
160472756|NCT03374254|579460060|FG005|Overall Study|Withdrawal by Subject|1|||
160472757|NCT03374254|579460061|FG006|Overall Study|Withdrawal by Subject|0|||
160472758|NCT03374254|579460062|FG007|Overall Study|Withdrawal by Subject|0|||
160472759|NCT03374254|579460063|FG008|Overall Study|Withdrawal by Subject|0|||
160472760|NCT00923078|579460070|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
160472761|NCT00923078|579460071|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
160472762|NCT00923078|579460072|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
160472763|NCT00923078|579460070|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
160472764|NCT00923078|579460071|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
160472765|NCT00923078|579460072|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
160472766|NCT02245620|579460076|FG000|Overall Study|Physician Decision|1|||
160472767|NCT02245620|579460077|FG001|Overall Study|Physician Decision|1|||
160472768|NCT04766996|579460080|FG000|Overall Study|Withdrawal by Subject|1|||
160472769|NCT04766996|579460081|FG001|Overall Study|Withdrawal by Subject|0|||
160472770|NCT04766996|579460082|FG002|Overall Study|Withdrawal by Subject|13|||
160472771|NCT01322386|579460083|FG000|Overall Study|Protocol Violation|0|||
160472772|NCT01322386|579460084|FG001|Overall Study|Protocol Violation|1|||
160472773|NCT01322386|579460083|FG000|Overall Study|Physician Decision|0|||
160472774|NCT01322386|579460084|FG001|Overall Study|Physician Decision|1|||
160472775|NCT01102426|579460087|FG000|Overall Study|Randomized but not treated|4|||
160472776|NCT01102426|579460088|FG001|Overall Study|Randomized but not treated|1|||
160472777|NCT01102426|579460087|FG000|Overall Study|Adverse Events (treatment-related)|15|||
160472778|NCT01102426|579460088|FG001|Overall Study|Adverse Events (treatment-related)|8|||
160472779|NCT01102426|579460087|FG000|Overall Study|Physician Decision|9|||
160472780|NCT01102426|579460088|FG001|Overall Study|Physician Decision|6|||
160472781|NCT01102426|579460087|FG000|Overall Study|Progressive Disease|85|||
160472782|NCT01102426|579460088|FG001|Overall Study|Progressive Disease|44|||
160472783|NCT01102426|579460087|FG000|Overall Study|Adverse Events (unrelated to|9|||
160472784|NCT01102426|579460088|FG001|Overall Study|Adverse Events (unrelated to|1|||
160472785|NCT01102426|579460087|FG000|Overall Study|Patient Refusal|24|||
160472786|NCT01102426|579460088|FG001|Overall Study|Patient Refusal|12|||
160472787|NCT01102426|579460087|FG000|Overall Study|Death (due to adverse events|0|||
160472788|NCT01102426|579460088|FG001|Overall Study|Death (due to adverse events|1|||
160472789|NCT01102426|579460087|FG000|Overall Study|Death (non-related to the study|19|||
160472790|NCT01102426|579460088|FG001|Overall Study|Death (non-related to the study|8|||
160472791|NCT00871494|579460092|FG000|Overall Study|Protocol Violation|5|||
160472792|NCT00871494|579460092|FG000|Overall Study|Lack of Efficacy|4|||
160472793|NCT00871494|579460092|FG000|Overall Study|Adverse Event|4|||
160472794|NCT00871494|579460092|FG000|Overall Study|Lost to Follow-up|1|||
160472795|NCT02988713|579460099|FG000|Overall Study|Withdrawal by Subject|1|||
160472796|NCT02988713|579460099|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
160472797|NCT02404441|579460100|FG000|Phase 1 Part|Adverse Event|1|||
160472798|NCT02404441|579460101|FG001|Phase 1 Part|Adverse Event|0|||
160472799|NCT02404441|579460102|FG002|Phase 1 Part|Adverse Event|0|||
160472800|NCT02404441|579460103|FG003|Phase 1 Part|Adverse Event|0|||
160472801|NCT02404441|579460104|FG004|Phase 1 Part|Adverse Event|0|||
160472802|NCT02404441|579460105|FG005|Phase 1 Part|Adverse Event|0|||
160472803|NCT02404441|579460106|FG006|Phase 1 Part|Adverse Event|0|||
160472804|NCT02404441|579460107|FG007|Phase 1 Part|Adverse Event|0|||
160472805|NCT02404441|579460108|FG008|Phase 1 Part|Adverse Event|0|||
160472806|NCT02404441|579460109|FG009|Phase 1 Part|Adverse Event|0|||
160472807|NCT02404441|579460100|FG000|Phase 1 Part|Physician Decision|0|||
160472808|NCT02404441|579460101|FG001|Phase 1 Part|Physician Decision|1|||
160472809|NCT02404441|579460102|FG002|Phase 1 Part|Physician Decision|0|||
160472810|NCT02404441|579460103|FG003|Phase 1 Part|Physician Decision|0|||
160472811|NCT02404441|579460104|FG004|Phase 1 Part|Physician Decision|0|||
160472812|NCT02404441|579460105|FG005|Phase 1 Part|Physician Decision|0|||
160472813|NCT02404441|579460106|FG006|Phase 1 Part|Physician Decision|0|||
160472814|NCT02404441|579460107|FG007|Phase 1 Part|Physician Decision|0|||
160472815|NCT02404441|579460108|FG008|Phase 1 Part|Physician Decision|0|||
160472816|NCT02404441|579460109|FG009|Phase 1 Part|Physician Decision|0|||
160472817|NCT02404441|579460100|FG000|Phase 1 Part|Progressive Disease|14|||
160472818|NCT02404441|579460101|FG001|Phase 1 Part|Progressive Disease|11|||
160472819|NCT02404441|579460102|FG002|Phase 1 Part|Progressive Disease|7|||
160472820|NCT02404441|579460103|FG003|Phase 1 Part|Progressive Disease|6|||
160472821|NCT02404441|579460104|FG004|Phase 1 Part|Progressive Disease|9|||
160472822|NCT02404441|579460105|FG005|Phase 1 Part|Progressive Disease|0|||
160472823|NCT02404441|579460106|FG006|Phase 1 Part|Progressive Disease|0|||
160472824|NCT02404441|579460107|FG007|Phase 1 Part|Progressive Disease|0|||
160472825|NCT02404441|579460108|FG008|Phase 1 Part|Progressive Disease|0|||
160472826|NCT02404441|579460109|FG009|Phase 1 Part|Progressive Disease|0|||
160472827|NCT02404441|579460100|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
160472828|NCT02404441|579460101|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
160660115|NCT02507375|580136248|FG000|Overall Study|Refused treatment|0|||
160660116|NCT02507375|580136249|FG001|Overall Study|Refused treatment|1|||
160472829|NCT02404441|579460102|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
160472830|NCT02404441|579460103|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
160472831|NCT02404441|579460104|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
160472832|NCT02404441|579460105|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
160472833|NCT02404441|579460106|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
160472834|NCT02404441|579460107|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
160472835|NCT02404441|579460108|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
160472836|NCT02404441|579460109|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
160472837|NCT02404441|579460100|FG000|Phase 1 Part|Death|1|||
160472838|NCT02404441|579460101|FG001|Phase 1 Part|Death|1|||
160660117|NCT02507375|580136248|FG000|Overall Study|Adverse Event|0|||
160601491|NCT03907969|579918112|FG004|Combination Therapy Part A|Death|0|||
160601492|NCT03907969|579918113|FG005|Combination Therapy Part A|Death|0|||
160601493|NCT03907969|579918114|FG006|Combination Therapy Part A|Death|0|||
160601494|NCT03907969|579918115|FG007|Combination Therapy Part A|Death|0|||
160601495|NCT03907969|579918116|FG008|Combination Therapy Part A|Death|1|||
160601496|NCT03907969|579918117|FG009|Combination Therapy Part A|Death|0|||
160601497|NCT03907969|579918118|FG010|Combination Therapy Part A|Death|1|||
160601498|NCT03907969|579918108|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
160601499|NCT03907969|579918109|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
160601500|NCT03907969|579918110|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
160601501|NCT03907969|579918111|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
160601502|NCT03907969|579918112|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
160601503|NCT03907969|579918113|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
160601504|NCT03907969|579918114|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
160601505|NCT03907969|579918115|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
160601506|NCT03907969|579918116|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
160601507|NCT03907969|579918117|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
160601508|NCT03907969|579918118|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
160601509|NCT03907969|579918108|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
160601510|NCT03907969|579918109|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
160601511|NCT03907969|579918110|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
160601512|NCT03907969|579918111|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
160601513|NCT03907969|579918112|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
160601514|NCT03907969|579918113|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
160601515|NCT03907969|579918114|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
160601516|NCT03907969|579918115|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
160601517|NCT03907969|579918116|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
160601518|NCT03907969|579918117|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
160601519|NCT03907969|579918118|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
160601520|NCT03907969|579918108|FG000|Combination Therapy Part A|Physician Decision|0|||
160601521|NCT03907969|579918109|FG001|Combination Therapy Part A|Physician Decision|0|||
160601522|NCT03907969|579918110|FG002|Combination Therapy Part A|Physician Decision|0|||
160601523|NCT03907969|579918111|FG003|Combination Therapy Part A|Physician Decision|0|||
160601524|NCT03907969|579918112|FG004|Combination Therapy Part A|Physician Decision|0|||
160601525|NCT03907969|579918113|FG005|Combination Therapy Part A|Physician Decision|0|||
160601526|NCT03907969|579918114|FG006|Combination Therapy Part A|Physician Decision|0|||
160601527|NCT03907969|579918115|FG007|Combination Therapy Part A|Physician Decision|1|||
160601528|NCT03907969|579918116|FG008|Combination Therapy Part A|Physician Decision|0|||
160601529|NCT03907969|579918117|FG009|Combination Therapy Part A|Physician Decision|0|||
160601530|NCT03907969|579918118|FG010|Combination Therapy Part A|Physician Decision|1|||
160601531|NCT00666536|579918119|FG000|Overall Study|Adverse Event|9|||
160601532|NCT00666536|579918120|FG001|Overall Study|Adverse Event|19|||
160601533|NCT00666536|579918119|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160601534|NCT00666536|579918120|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160601535|NCT00666536|579918119|FG000|Overall Study|Protocol deviation(s)|8|||
160601536|NCT00666536|579918120|FG001|Overall Study|Protocol deviation(s)|6|||
160601537|NCT00666536|579918119|FG000|Overall Study|Withdrawal by Subject|10|||
160601538|NCT00666536|579918120|FG001|Overall Study|Withdrawal by Subject|9|||
160601539|NCT00666536|579918119|FG000|Overall Study|Lost to Follow-up|4|||
160601540|NCT00666536|579918120|FG001|Overall Study|Lost to Follow-up|3|||
160601541|NCT02853123|579918124|FG000|Treatment Period 1|Adverse Event|0|||
160601542|NCT02853123|579918125|FG001|Treatment Period 1|Adverse Event|3|||
160601543|NCT02853123|579918124|FG000|Washout Period|Worsening of COPD|0|||
160601544|NCT02853123|579918125|FG001|Washout Period|Worsening of COPD|3|||
160601545|NCT02853123|579918124|FG000|Washout Period|Adverse Event|1|||
160601546|NCT02853123|579918125|FG001|Washout Period|Adverse Event|0|||
160601547|NCT02471586|579918126|FG000|Overall Study|Lost to Follow-up|3|||
160601548|NCT02471586|579918127|FG001|Overall Study|Lost to Follow-up|8|||
160601549|NCT02471586|579918128|FG002|Overall Study|Lost to Follow-up|4|||
160601550|NCT02471586|579918126|FG000|Overall Study|Death|2|||
160601551|NCT02471586|579918127|FG001|Overall Study|Death|2|||
160601552|NCT02471586|579918128|FG002|Overall Study|Death|0|||
160601553|NCT01419015|579918130|FG000|Overall Study|Death|2|||
160601554|NCT04209530|579918131|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
160601555|NCT04209530|579918132|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
160660118|NCT02507375|580136249|FG001|Overall Study|Adverse Event|1|||
160601556|NCT04209530|579918131|FG000|Overall Study|Withdrawal by Subject|0|||
160601557|NCT04209530|579918132|FG001|Overall Study|Withdrawal by Subject|1|||
160601558|NCT04839393|579918133|FG000|Overall Study|Adverse Event|0|||
160601559|NCT04839393|579918134|FG001|Overall Study|Adverse Event|0|||
160601560|NCT04839393|579918135|FG002|Overall Study|Adverse Event|2|||
160601561|NCT04839393|579918133|FG000|Overall Study|Withdrawal by participant|0|||
160472839|NCT02404441|579460102|FG002|Phase 1 Part|Death|1|||
160472840|NCT02404441|579460103|FG003|Phase 1 Part|Death|0|||
160472841|NCT02404441|579460104|FG004|Phase 1 Part|Death|1|||
160472842|NCT02404441|579460105|FG005|Phase 1 Part|Death|0|||
160472843|NCT02404441|579460106|FG006|Phase 1 Part|Death|0|||
160472844|NCT02404441|579460107|FG007|Phase 1 Part|Death|0|||
160472845|NCT02404441|579460108|FG008|Phase 1 Part|Death|0|||
160472846|NCT02404441|579460109|FG009|Phase 1 Part|Death|0|||
160472847|NCT02404441|579460100|FG000|Phase 2 Part|Adverse Event|0|||
160472848|NCT02404441|579460101|FG001|Phase 2 Part|Adverse Event|0|||
160472849|NCT02404441|579460102|FG002|Phase 2 Part|Adverse Event|0|||
160472850|NCT02404441|579460103|FG003|Phase 2 Part|Adverse Event|0|||
160472851|NCT02404441|579460104|FG004|Phase 2 Part|Adverse Event|0|||
160472852|NCT02404441|579460105|FG005|Phase 2 Part|Adverse Event|2|||
160472853|NCT02404441|579460106|FG006|Phase 2 Part|Adverse Event|3|||
160472854|NCT02404441|579460107|FG007|Phase 2 Part|Adverse Event|3|||
160472855|NCT02404441|579460108|FG008|Phase 2 Part|Adverse Event|6|||
160472856|NCT02404441|579460109|FG009|Phase 2 Part|Adverse Event|1|||
160472857|NCT02404441|579460100|FG000|Phase 2 Part|Physician Decision|0|||
160472858|NCT02404441|579460101|FG001|Phase 2 Part|Physician Decision|0|||
160472859|NCT02404441|579460102|FG002|Phase 2 Part|Physician Decision|0|||
160472860|NCT02404441|579460103|FG003|Phase 2 Part|Physician Decision|0|||
160472861|NCT02404441|579460104|FG004|Phase 2 Part|Physician Decision|0|||
160472862|NCT02404441|579460105|FG005|Phase 2 Part|Physician Decision|7|||
160472863|NCT02404441|579460106|FG006|Phase 2 Part|Physician Decision|9|||
160472864|NCT02404441|579460107|FG007|Phase 2 Part|Physician Decision|2|||
160472865|NCT02404441|579460108|FG008|Phase 2 Part|Physician Decision|1|||
160472866|NCT02404441|579460109|FG009|Phase 2 Part|Physician Decision|3|||
160472867|NCT02404441|579460100|FG000|Phase 2 Part|Progressive disease|0|||
160472868|NCT02404441|579460101|FG001|Phase 2 Part|Progressive disease|0|||
160472869|NCT02404441|579460102|FG002|Phase 2 Part|Progressive disease|0|||
160472870|NCT02404441|579460103|FG003|Phase 2 Part|Progressive disease|0|||
160472871|NCT02404441|579460104|FG004|Phase 2 Part|Progressive disease|0|||
160472872|NCT02404441|579460105|FG005|Phase 2 Part|Progressive disease|43|||
160472873|NCT02404441|579460106|FG006|Phase 2 Part|Progressive disease|32|||
160472874|NCT02404441|579460107|FG007|Phase 2 Part|Progressive disease|31|||
160472875|NCT02404441|579460108|FG008|Phase 2 Part|Progressive disease|39|||
160472876|NCT02404441|579460109|FG009|Phase 2 Part|Progressive disease|27|||
160472877|NCT02404441|579460100|FG000|Phase 2 Part|Subject/guardian decision|0|||
160472878|NCT02404441|579460101|FG001|Phase 2 Part|Subject/guardian decision|0|||
160472879|NCT02404441|579460102|FG002|Phase 2 Part|Subject/guardian decision|0|||
160472880|NCT02404441|579460103|FG003|Phase 2 Part|Subject/guardian decision|0|||
160472881|NCT02404441|579460104|FG004|Phase 2 Part|Subject/guardian decision|0|||
160472882|NCT02404441|579460105|FG005|Phase 2 Part|Subject/guardian decision|3|||
160472883|NCT02404441|579460106|FG006|Phase 2 Part|Subject/guardian decision|9|||
160472884|NCT02404441|579460107|FG007|Phase 2 Part|Subject/guardian decision|0|||
160472885|NCT02404441|579460108|FG008|Phase 2 Part|Subject/guardian decision|3|||
160472886|NCT02404441|579460109|FG009|Phase 2 Part|Subject/guardian decision|2|||
160472887|NCT02404441|579460100|FG000|Phase 2 Part|Death|0|||
160472888|NCT02404441|579460101|FG001|Phase 2 Part|Death|0|||
160472889|NCT02404441|579460102|FG002|Phase 2 Part|Death|0|||
160472890|NCT02404441|579460103|FG003|Phase 2 Part|Death|0|||
160472891|NCT02404441|579460104|FG004|Phase 2 Part|Death|0|||
160472892|NCT02404441|579460105|FG005|Phase 2 Part|Death|4|||
160472893|NCT02404441|579460106|FG006|Phase 2 Part|Death|8|||
160472894|NCT02404441|579460107|FG007|Phase 2 Part|Death|4|||
160472895|NCT02404441|579460108|FG008|Phase 2 Part|Death|10|||
160472896|NCT02404441|579460109|FG009|Phase 2 Part|Death|9|||
160472897|NCT00088166|579460110|FG000|Overall Study|Adverse Event|11|||
160472898|NCT00088166|579460111|FG001|Overall Study|Adverse Event|9|||
160472899|NCT00088166|579460110|FG000|Overall Study|Death|3|||
160472900|NCT00088166|579460111|FG001|Overall Study|Death|1|||
160472901|NCT00088166|579460110|FG000|Overall Study|Lost to Follow-up|0|||
160472902|NCT00088166|579460111|FG001|Overall Study|Lost to Follow-up|1|||
160472903|NCT00088166|579460110|FG000|Overall Study|Physician Decision|4|||
160472904|NCT00088166|579460111|FG001|Overall Study|Physician Decision|1|||
160472905|NCT00088166|579460110|FG000|Overall Study|Protocol Violation|1|||
160472906|NCT00088166|579460111|FG001|Overall Study|Protocol Violation|5|||
160472907|NCT00088166|579460110|FG000|Overall Study|Patient deterioration|29|||
160472908|NCT00088166|579460111|FG001|Overall Study|Patient deterioration|39|||
160472909|NCT00088166|579460110|FG000|Overall Study|Withdrawal by Subject|5|||
160472910|NCT00088166|579460111|FG001|Overall Study|Withdrawal by Subject|5|||
160472911|NCT02671266|579460112|FG000|Overall Study|Withdrawal by Subject|1|||
160472912|NCT02671266|579460113|FG001|Overall Study|Withdrawal by Subject|1|||
160472913|NCT00666705|579460116|FG000|Overall Study|Withdrawal by Subject|1|||
160472914|NCT01976507|579460117|FG000|Overall Study|Adverse Event|6|||
160472915|NCT01976507|579460117|FG000|Overall Study|ablation not done, drug not given|1|||
160472916|NCT01029704|579460119|FG000|Overall Study|Adverse Event|0|||
160472917|NCT01029704|579460120|FG001|Overall Study|Adverse Event|0|||
160472918|NCT01029704|579460121|FG002|Overall Study|Adverse Event|0|||
160472919|NCT01029704|579460122|FG003|Overall Study|Adverse Event|0|||
160472920|NCT01029704|579460123|FG004|Overall Study|Adverse Event|0|||
160472921|NCT01029704|579460124|FG005|Overall Study|Adverse Event|0|||
160472922|NCT01029704|579460125|FG006|Overall Study|Adverse Event|1|||
160472923|NCT01029704|579460126|FG007|Overall Study|Adverse Event|1|||
160472924|NCT01029704|579460127|FG008|Overall Study|Adverse Event|0|||
160472925|NCT01029704|579460119|FG000|Overall Study|Withdrawal by Subject|0|||
160472926|NCT01029704|579460120|FG001|Overall Study|Withdrawal by Subject|0|||
160472927|NCT01029704|579460121|FG002|Overall Study|Withdrawal by Subject|0|||
160472928|NCT01029704|579460122|FG003|Overall Study|Withdrawal by Subject|0|||
160472929|NCT01029704|579460123|FG004|Overall Study|Withdrawal by Subject|2|||
160472930|NCT01029704|579460124|FG005|Overall Study|Withdrawal by Subject|1|||
160472931|NCT01029704|579460125|FG006|Overall Study|Withdrawal by Subject|1|||
160472932|NCT01029704|579460126|FG007|Overall Study|Withdrawal by Subject|1|||
160472933|NCT01029704|579460127|FG008|Overall Study|Withdrawal by Subject|0|||
160472934|NCT01029704|579460119|FG000|Overall Study|Lost to Follow-up|0|||
160472935|NCT01029704|579460120|FG001|Overall Study|Lost to Follow-up|0|||
160472936|NCT01029704|579460121|FG002|Overall Study|Lost to Follow-up|0|||
160472937|NCT01029704|579460122|FG003|Overall Study|Lost to Follow-up|0|||
160472938|NCT01029704|579460123|FG004|Overall Study|Lost to Follow-up|0|||
160472939|NCT01029704|579460124|FG005|Overall Study|Lost to Follow-up|0|||
160472940|NCT01029704|579460125|FG006|Overall Study|Lost to Follow-up|1|||
160472941|NCT01029704|579460126|FG007|Overall Study|Lost to Follow-up|1|||
160472942|NCT01029704|579460127|FG008|Overall Study|Lost to Follow-up|1|||
160472943|NCT01029704|579460119|FG000|Overall Study|Lack of Efficacy|0|||
160472944|NCT01029704|579460120|FG001|Overall Study|Lack of Efficacy|0|||
160472945|NCT01029704|579460121|FG002|Overall Study|Lack of Efficacy|0|||
160472946|NCT01029704|579460122|FG003|Overall Study|Lack of Efficacy|0|||
160472947|NCT01029704|579460123|FG004|Overall Study|Lack of Efficacy|2|||
160472948|NCT01029704|579460124|FG005|Overall Study|Lack of Efficacy|3|||
160472949|NCT01029704|579460125|FG006|Overall Study|Lack of Efficacy|1|||
160472950|NCT01029704|579460126|FG007|Overall Study|Lack of Efficacy|2|||
160472951|NCT01029704|579460127|FG008|Overall Study|Lack of Efficacy|0|||
160472952|NCT01029704|579460119|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
160472953|NCT01029704|579460120|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
160472954|NCT01029704|579460121|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
160472955|NCT01029704|579460122|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
160472956|NCT01029704|579460123|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
160472957|NCT01029704|579460124|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
160472958|NCT01029704|579460125|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
160472959|NCT01029704|579460126|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
160472960|NCT01029704|579460127|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
160472961|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
160472962|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
160472963|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
160472964|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
160472965|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Death|0|||
160472966|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Death|0|||
160472967|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Death|1|||
160472968|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Death|0|||
160601562|NCT04839393|579918134|FG001|Overall Study|Withdrawal by participant|0|||
160601563|NCT04839393|579918135|FG002|Overall Study|Withdrawal by participant|1|||
160601564|NCT01510028|579918138|FG000|Overall Study|Lack of Efficacy|1|||
160601565|NCT01510028|579918139|FG001|Overall Study|Lack of Efficacy|0|||
160601566|NCT01510028|579918140|FG002|Overall Study|Lack of Efficacy|0|||
160601567|NCT01510028|579918141|FG003|Overall Study|Lack of Efficacy|0|||
160601568|NCT05091918|579918142|FG000|Overall Study|Adverse Event|1|||
160601569|NCT05091918|579918142|FG000|Overall Study|Withdrawal by Subject|81|||
160601570|NCT01100658|579918144|FG000|Overall Study|Withdrawal by Subject|1|||
160601571|NCT01784211|579918145|FG000|Part A (Days 1-15)|Adverse Event|1|||
160601572|NCT01784211|579918146|FG001|Part A (Days 1-15)|Adverse Event|1|||
160601573|NCT01784211|579918147|FG002|Part A (Days 1-15)|Adverse Event|0|||
160601574|NCT01784211|579918148|FG003|Part A (Days 1-15)|Adverse Event|0|||
160472969|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
160472970|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
160472971|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
160472972|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
160472973|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
160472974|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
160472975|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
160472976|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
160601575|NCT01784211|579918149|FG004|Part A (Days 1-15)|Adverse Event|0|||
160601576|NCT01784211|579918150|FG005|Part A (Days 1-15)|Adverse Event|0|||
160601577|NCT01784211|579918145|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
160601578|NCT01784211|579918146|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
160472977|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
160472978|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
160472979|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
160472980|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
160472981|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
160472982|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
160472983|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
160472984|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
160472985|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
160472986|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
160472987|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
160472988|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
160472989|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Other|2|||
160472990|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Other|0|||
160472991|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Other|0|||
160472992|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Other|0|||
160472993|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
160472994|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
160472995|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
160472996|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
160472997|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
160472998|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
160472999|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
160473000|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
160473001|NCT03845517|579460128|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
160473002|NCT03845517|579460129|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
160473003|NCT03845517|579460130|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
160473004|NCT03845517|579460131|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
160473005|NCT03845517|579460128|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
160473006|NCT03845517|579460129|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
160473007|NCT03845517|579460130|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
160473008|NCT03845517|579460131|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
160473009|NCT03845517|579460128|FG000|Follow-up Period (4 Weeks)|Death|0|||
160473010|NCT03845517|579460129|FG001|Follow-up Period (4 Weeks)|Death|0|||
160473011|NCT03845517|579460130|FG002|Follow-up Period (4 Weeks)|Death|1|||
160473012|NCT03845517|579460131|FG003|Follow-up Period (4 Weeks)|Death|1|||
160473013|NCT03845517|579460128|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
160473014|NCT03845517|579460129|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
160473015|NCT03845517|579460130|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
160473016|NCT03845517|579460131|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
160473017|NCT03845517|579460128|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
160473018|NCT03845517|579460129|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
160473019|NCT03845517|579460130|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
160473020|NCT03845517|579460131|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
160473021|NCT03845517|579460128|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
160473022|NCT03845517|579460129|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
160473023|NCT03845517|579460130|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
160473024|NCT03845517|579460131|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
160473025|NCT03845517|579460128|FG000|Follow-up Period (4 Weeks)|Other|1|||
160473026|NCT03845517|579460129|FG001|Follow-up Period (4 Weeks)|Other|0|||
160473027|NCT03845517|579460130|FG002|Follow-up Period (4 Weeks)|Other|1|||
160473028|NCT03845517|579460131|FG003|Follow-up Period (4 Weeks)|Other|0|||
160473029|NCT03845517|579460128|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
160473030|NCT03845517|579460129|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
160473031|NCT03845517|579460130|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
160473032|NCT03845517|579460131|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
160473033|NCT03845517|579460128|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
160473034|NCT03845517|579460129|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
160473035|NCT03845517|579460130|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
160473036|NCT03845517|579460131|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
160473037|NCT03845517|579460128|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
160473038|NCT03845517|579460129|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
160473039|NCT03845517|579460130|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
160473040|NCT03845517|579460131|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
160473041|NCT01109979|579460132|FG000|Overall Study|Physician Decision|2|||
160473042|NCT01109979|579460133|FG001|Overall Study|Physician Decision|0|||
160473043|NCT01109979|579460132|FG000|Overall Study|Withdrawal by Subject|0|||
160473044|NCT01109979|579460133|FG001|Overall Study|Withdrawal by Subject|1|||
160473045|NCT03136861|579460136|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
160473046|NCT03136861|579460137|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
160473047|NCT03136861|579460138|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
160473048|NCT03136861|579460139|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
160601579|NCT01784211|579918147|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
160601580|NCT01784211|579918148|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
160473049|NCT03136861|579460140|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
160473050|NCT03136861|579460141|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
160473051|NCT03136861|579460142|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
160473052|NCT03136861|579460136|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
160473053|NCT03136861|579460137|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
160473054|NCT03136861|579460138|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
160473055|NCT03136861|579460139|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
160473056|NCT03136861|579460140|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
160473057|NCT03136861|579460141|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
160473058|NCT03136861|579460142|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
160473059|NCT03136861|579460136|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
160473060|NCT03136861|579460137|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
160473061|NCT03136861|579460138|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
160473062|NCT03136861|579460139|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
160473063|NCT03136861|579460140|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
160473064|NCT03136861|579460141|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
160473065|NCT03136861|579460142|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
160473066|NCT03136861|579460136|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
160473067|NCT03136861|579460137|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
160473068|NCT03136861|579460138|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
160473069|NCT03136861|579460139|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
160473070|NCT03136861|579460140|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
160473071|NCT03136861|579460141|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
160473072|NCT03136861|579460142|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
160473073|NCT03136861|579460136|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
160473074|NCT03136861|579460137|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
160473075|NCT03136861|579460138|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
160473076|NCT03136861|579460139|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
160473077|NCT03136861|579460140|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
160473078|NCT03136861|579460141|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
160473079|NCT03136861|579460142|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
160473080|NCT03136861|579460136|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
160473081|NCT03136861|579460137|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
160473082|NCT03136861|579460138|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
160473083|NCT03136861|579460139|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
160473084|NCT03136861|579460140|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
160473085|NCT03136861|579460141|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
160473086|NCT03136861|579460142|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
160473087|NCT03136861|579460136|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
160473088|NCT03136861|579460137|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
160473089|NCT03136861|579460138|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
160473090|NCT03136861|579460139|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
160473091|NCT03136861|579460140|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
160473092|NCT03136861|579460141|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
160473093|NCT03136861|579460142|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
160473094|NCT03136861|579460136|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
160473095|NCT03136861|579460137|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
160473096|NCT03136861|579460138|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
160473097|NCT03136861|579460139|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
160473098|NCT03136861|579460140|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
160473099|NCT03136861|579460141|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
160473100|NCT03136861|579460142|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
160473101|NCT03200574|579460144|FG000|Overall Study|Death|4|||
160473102|NCT03200574|579460144|FG000|Overall Study|Withdrawal by Subject|8|||
160473103|NCT03200574|579460144|FG000|Overall Study|Long-Term need for anticoagulation|1|||
160473104|NCT03200574|579460144|FG000|Overall Study|Relocation|2|||
160473105|NCT03200574|579460144|FG000|Overall Study|Lost to Follow-up|2|||
160473106|NCT00705159|579460148|FG000|Overall Study|Withdrawal by Subject|0|||
160473107|NCT00705159|579460149|FG001|Overall Study|Withdrawal by Subject|1|||
160473108|NCT00705159|579460150|FG002|Overall Study|Withdrawal by Subject|1|||
160473109|NCT00705159|579460151|FG003|Overall Study|Withdrawal by Subject|1|||
160473110|NCT00705159|579460148|FG000|Overall Study|Protocol Violation|0|||
160473111|NCT00705159|579460149|FG001|Overall Study|Protocol Violation|1|||
160473112|NCT00705159|579460150|FG002|Overall Study|Protocol Violation|0|||
160473113|NCT00705159|579460151|FG003|Overall Study|Protocol Violation|0|||
160473114|NCT00705159|579460148|FG000|Overall Study|Adverse Event|0|||
160473115|NCT00705159|579460149|FG001|Overall Study|Adverse Event|0|||
160473116|NCT00705159|579460150|FG002|Overall Study|Adverse Event|1|||
160473117|NCT00705159|579460151|FG003|Overall Study|Adverse Event|0|||
160473118|NCT00705159|579460148|FG000|Overall Study|Lost to Follow-up|0|||
160473119|NCT00705159|579460149|FG001|Overall Study|Lost to Follow-up|0|||
160473120|NCT00705159|579460150|FG002|Overall Study|Lost to Follow-up|3|||
160473121|NCT00705159|579460151|FG003|Overall Study|Lost to Follow-up|2|||
160473122|NCT00705159|579460148|FG000|Overall Study|Screen Failure|0|||
160473123|NCT00705159|579460149|FG001|Overall Study|Screen Failure|0|||
160473124|NCT00705159|579460150|FG002|Overall Study|Screen Failure|0|||
160473125|NCT00705159|579460151|FG003|Overall Study|Screen Failure|1|||
160473126|NCT03026166|579460152|FG000|Overall Study|Death|22|||
160473127|NCT03026166|579460153|FG001|Overall Study|Death|7|||
160473128|NCT03026166|579460152|FG000|Overall Study|Physician Decision|2|||
160473129|NCT03026166|579460153|FG001|Overall Study|Physician Decision|0|||
160473130|NCT03026166|579460152|FG000|Overall Study|Withdrawal by Subject|1|||
160473131|NCT03026166|579460153|FG001|Overall Study|Withdrawal by Subject|2|||
160473132|NCT03026166|579460152|FG000|Overall Study|Lost to Follow-up|1|||
160473133|NCT03026166|579460153|FG001|Overall Study|Lost to Follow-up|0|||
160473134|NCT03026166|579460152|FG000|Overall Study|Study Terminated by Sponsor|3|||
160473135|NCT03026166|579460153|FG001|Overall Study|Study Terminated by Sponsor|3|||
160473136|NCT03026166|579460152|FG000|Overall Study|Other|1|||
160473137|NCT03026166|579460153|FG001|Overall Study|Other|0|||
160473138|NCT01262456|579460154|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
160473139|NCT01262456|579460155|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
160473140|NCT01262456|579460156|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
160473141|NCT01262456|579460154|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
160473142|NCT01262456|579460155|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
160473143|NCT01262456|579460156|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
160473144|NCT01262456|579460154|FG000|3-Month Double-Blind Period|Adverse Event|6|||
160473145|NCT01262456|579460155|FG001|3-Month Double-Blind Period|Adverse Event|4|||
160473146|NCT01262456|579460156|FG002|3-Month Double-Blind Period|Adverse Event|8|||
160473147|NCT01262456|579460154|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
160473148|NCT01262456|579460155|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
160473149|NCT01262456|579460156|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
160473150|NCT01262456|579460154|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
160473151|NCT01262456|579460155|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
160473152|NCT01262456|579460156|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
160473153|NCT01262456|579460154|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
160473154|NCT01262456|579460155|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
160473155|NCT01262456|579460156|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
160473156|NCT01262456|579460154|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
160473157|NCT01262456|579460155|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
160473158|NCT01262456|579460156|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
160473159|NCT01262456|579460154|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
160473160|NCT01262456|579460155|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
160473161|NCT01262456|579460156|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
160473162|NCT01262456|579460154|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
160473163|NCT01262456|579460155|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
160473164|NCT01262456|579460156|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
160473165|NCT03938272|579460157|FG000|Overall Study|Withdrawal by Subject|1|||
160473166|NCT03938272|579460158|FG001|Overall Study|Withdrawal by Subject|0|||
160473167|NCT03938272|579460157|FG000|Overall Study|Physician Decision|0|||
160473168|NCT03938272|579460158|FG001|Overall Study|Physician Decision|2|||
160473169|NCT03938272|579460157|FG000|Overall Study|Study termination by sponsor|10|||
160473170|NCT03938272|579460158|FG001|Overall Study|Study termination by sponsor|8|||
160473171|NCT00266656|579460166|FG000|Overall Study|Death|1|||
160473172|NCT00266656|579460167|FG001|Overall Study|Death|0|||
160601581|NCT01784211|579918149|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
160601582|NCT01784211|579918150|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
160473173|NCT00266656|579460166|FG000|Overall Study|Lost to Follow-up|4|||
160473174|NCT00266656|579460167|FG001|Overall Study|Lost to Follow-up|1|||
160473175|NCT00266656|579460166|FG000|Overall Study|Withdrawal by Subject|4|||
160473176|NCT00266656|579460167|FG001|Overall Study|Withdrawal by Subject|2|||
160473177|NCT00266656|579460166|FG000|Overall Study|Did Not Reach Final Height|4|||
160601583|NCT00239356|579918153|FG000|Overall Study|Lack of Efficacy|1|||
160601584|NCT00239356|579918154|FG001|Overall Study|Lack of Efficacy|0|||
160473178|NCT00266656|579460167|FG001|Overall Study|Did Not Reach Final Height|8|||
160473179|NCT00266656|579460166|FG000|Overall Study|Parent/Caregiver Decision|1|||
160473180|NCT00266656|579460167|FG001|Overall Study|Parent/Caregiver Decision|2|||
160473181|NCT04602728|579460168|FG000|Overall Study|Lost to Follow-up|4|||
160601585|NCT00239356|579918153|FG000|Overall Study|Adverse Event|6|||
160601586|NCT00239356|579918154|FG001|Overall Study|Adverse Event|0|||
160473182|NCT04602728|579460169|FG001|Overall Study|Lost to Follow-up|4|||
160473183|NCT04186247|579460170|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
160473184|NCT04186247|579460171|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
160473185|NCT04186247|579460172|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
160473186|NCT04186247|579460173|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
160473187|NCT04186247|579460174|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
160473188|NCT02784834|579462091|FG000|Overall Study|Lack of Efficacy|1|||
160473189|NCT02143713|579462092|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
160473190|NCT02143713|579462093|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
160473191|NCT02143713|579462094|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
160473192|NCT02143713|579462095|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
160473193|NCT02143713|579462092|FG000|Treatment Period (6 Months)|Adverse Event|7|||
160473194|NCT02143713|579462093|FG001|Treatment Period (6 Months)|Adverse Event|8|||
160473195|NCT02143713|579462094|FG002|Treatment Period (6 Months)|Adverse Event|8|||
160473196|NCT02143713|579462095|FG003|Treatment Period (6 Months)|Adverse Event|9|||
160473197|NCT02143713|579462092|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
160473198|NCT02143713|579462093|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
160473199|NCT02143713|579462094|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
160473200|NCT02143713|579462095|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
160473201|NCT02143713|579462092|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
160473202|NCT02143713|579462093|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
160473203|NCT02143713|579462094|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
160473204|NCT02143713|579462095|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
160473205|NCT02143713|579462092|FG000|Treatment Period (6 Months)|Pregnancy|0|||
160473206|NCT02143713|579462093|FG001|Treatment Period (6 Months)|Pregnancy|2|||
160473207|NCT02143713|579462094|FG002|Treatment Period (6 Months)|Pregnancy|2|||
160473208|NCT02143713|579462095|FG003|Treatment Period (6 Months)|Pregnancy|0|||
160473209|NCT02143713|579462092|FG000|Treatment Period (6 Months)|Non-compliance|1|||
160473210|NCT02143713|579462093|FG001|Treatment Period (6 Months)|Non-compliance|0|||
160473211|NCT02143713|579462094|FG002|Treatment Period (6 Months)|Non-compliance|0|||
160473212|NCT02143713|579462095|FG003|Treatment Period (6 Months)|Non-compliance|3|||
160473213|NCT02143713|579462092|FG000|Treatment Period (6 Months)|Other|3|||
160473214|NCT02143713|579462093|FG001|Treatment Period (6 Months)|Other|0|||
160473215|NCT02143713|579462094|FG002|Treatment Period (6 Months)|Other|3|||
160473216|NCT02143713|579462095|FG003|Treatment Period (6 Months)|Other|2|||
160473217|NCT02143713|579462092|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
160473218|NCT02143713|579462093|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
160473219|NCT02143713|579462094|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
160473220|NCT02143713|579462095|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
160473221|NCT02143713|579462092|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
160473222|NCT02143713|579462093|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
160473223|NCT02143713|579462094|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
160473224|NCT02143713|579462095|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
160473225|NCT02143713|579462092|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
160473226|NCT02143713|579462093|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
160473227|NCT02143713|579462094|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
160473228|NCT02143713|579462095|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
160473229|NCT02143713|579462092|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
160473230|NCT02143713|579462093|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
160473231|NCT02143713|579462094|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
160473232|NCT02143713|579462095|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
160473233|NCT02143713|579462092|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
160473234|NCT02143713|579462093|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
160473235|NCT02143713|579462094|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
160473236|NCT02143713|579462095|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
160473237|NCT02143713|579462092|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
160473238|NCT02143713|579462093|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
160473239|NCT02143713|579462094|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
160473240|NCT02143713|579462095|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
160473241|NCT02143713|579462092|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
160601587|NCT00239356|579918153|FG000|Overall Study|Withdrawal by Subject|15|||
160473242|NCT02143713|579462093|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
160473243|NCT02143713|579462094|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
160473244|NCT02143713|579462095|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
160473245|NCT02143713|579462092|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
160473246|NCT02143713|579462093|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
160473247|NCT02143713|579462094|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
160473248|NCT02143713|579462095|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
160601588|NCT00239356|579918154|FG001|Overall Study|Withdrawal by Subject|6|||
160601589|NCT00239356|579918153|FG000|Overall Study|Lost to Follow-up|3|||
160473249|NCT02143713|579462092|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
160473250|NCT02143713|579462093|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
160473251|NCT02143713|579462094|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
160473252|NCT02143713|579462095|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
160473253|NCT01999335|579462096|FG000|Overall Study|Discontinued before receiving treatment|0|||
160473254|NCT01999335|579462097|FG001|Overall Study|Discontinued before receiving treatment|0|||
160473255|NCT01999335|579462098|FG002|Overall Study|Discontinued before receiving treatment|0|||
160473256|NCT01999335|579462099|FG003|Overall Study|Discontinued before receiving treatment|0|||
160473257|NCT01999335|579462100|FG004|Overall Study|Discontinued before receiving treatment|2|||
160473258|NCT01215253|579462101|FG000|Overall Study|Withdrawal by Subject|57|||
160473259|NCT01215253|579462102|FG001|Overall Study|Withdrawal by Subject|35|||
160473260|NCT01215253|579462101|FG000|Overall Study|Physician Decision|9|||
160473261|NCT01215253|579462102|FG001|Overall Study|Physician Decision|12|||
160473262|NCT01215253|579462101|FG000|Overall Study|Lost to Follow-up|6|||
160473263|NCT01215253|579462102|FG001|Overall Study|Lost to Follow-up|4|||
160473264|NCT01215253|579462101|FG000|Overall Study|Other|14|||
160473265|NCT01215253|579462102|FG001|Overall Study|Other|12|||
160473266|NCT00080119|579462103|FG000|Overall Study|Discontinued because of study closure|0|||
160473267|NCT00080119|579462104|FG001|Overall Study|Discontinued because of study closure|0|||
160473268|NCT00080119|579462105|FG002|Overall Study|Discontinued because of study closure|130|||
160473269|NCT00080119|579462106|FG003|Overall Study|Discontinued because of study closure|141|||
160473270|NCT00080119|579462103|FG000|Overall Study|Unable to get to clinic|24|||
160473271|NCT00080119|579462104|FG001|Overall Study|Unable to get to clinic|24|||
160473272|NCT00080119|579462105|FG002|Overall Study|Unable to get to clinic|7|||
160473273|NCT00080119|579462106|FG003|Overall Study|Unable to get to clinic|1|||
160473274|NCT00080119|579462103|FG000|Overall Study|Consent withdrawn|13|||
160473275|NCT00080119|579462104|FG001|Overall Study|Consent withdrawn|17|||
160473276|NCT00080119|579462105|FG002|Overall Study|Consent withdrawn|4|||
160473277|NCT00080119|579462106|FG003|Overall Study|Consent withdrawn|6|||
160473278|NCT00080119|579462103|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
160473279|NCT00080119|579462104|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
160473280|NCT00080119|579462105|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
160473281|NCT00080119|579462106|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
160473282|NCT00080119|579462103|FG000|Overall Study|Lost to Follow-up|16|||
160473283|NCT00080119|579462104|FG001|Overall Study|Lost to Follow-up|19|||
160473284|NCT00080119|579462105|FG002|Overall Study|Lost to Follow-up|19|||
160473285|NCT00080119|579462106|FG003|Overall Study|Lost to Follow-up|14|||
160473286|NCT01090739|579462111|FG000|Enrollment|Withdrawal by Subject|24|||
160473287|NCT01090739|579462111|FG000|Enrollment|Protocol Violation|14|||
160473288|NCT01090739|579462111|FG000|Enrollment|Lost to Follow-up|5|||
160473289|NCT01090739|579462111|FG000|Enrollment|Physician Decision|5|||
160473290|NCT01090739|579462111|FG000|Enrollment|Sponsor termination of site|4|||
160473291|NCT01090739|579462111|FG000|Enrollment|Study implant limit reached|2|||
160473292|NCT01090739|579462111|FG000|Enrollment|Adverse Event|1|||
160473293|NCT01090739|579462111|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
160473294|NCT01090739|579462111|FG000|12 Month Follow-up|Lost to Follow-up|1|||
160473295|NCT01090739|579462111|FG000|12 Month Follow-up|Physician Decision|1|||
160473296|NCT01090739|579462111|FG000|12 Month Follow-up|Death|1|||
160473297|NCT01090739|579462111|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
160473298|NCT01090739|579462111|FG000|24 Month Follow-up|Lost to Follow-up|1|||
160473299|NCT01090739|579462111|FG000|24 Month Follow-up|Death|1|||
160473300|NCT01090739|579462111|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
160473301|NCT01090739|579462111|FG000|36 Month Follow-up|Visit still pending|17|||
160473302|NCT00441168|579462112|FG000|Treatment Period|Death|3|||
160473303|NCT00441168|579462113|FG001|Treatment Period|Death|0|||
160473304|NCT00441168|579462112|FG000|Treatment Period|Adverse Event|1|||
160473305|NCT00441168|579462113|FG001|Treatment Period|Adverse Event|2|||
160473306|NCT00441168|579462112|FG000|Treatment Period|Progressive Disease|0|||
160473307|NCT00441168|579462113|FG001|Treatment Period|Progressive Disease|2|||
160601590|NCT00239356|579918154|FG001|Overall Study|Lost to Follow-up|0|||
160601591|NCT00239356|579918153|FG000|Overall Study|poor/non-compliance|2|||
160473308|NCT00441168|579462112|FG000|Treatment Period|Protocol Violation|0|||
160473309|NCT00441168|579462113|FG001|Treatment Period|Protocol Violation|1|||
160473310|NCT00441168|579462112|FG000|Treatment Period|Lost to Follow-up|0|||
160473311|NCT00441168|579462113|FG001|Treatment Period|Lost to Follow-up|1|||
160601592|NCT00239356|579918154|FG001|Overall Study|poor/non-compliance|0|||
160601593|NCT00239356|579918153|FG000|Overall Study|Pregnancy|1|||
160601594|NCT00239356|579918154|FG001|Overall Study|Pregnancy|0|||
160473312|NCT00441168|579462112|FG000|Treatment Period|Withdrawal by Subject|3|||
160473313|NCT00441168|579462113|FG001|Treatment Period|Withdrawal by Subject|0|||
160473314|NCT00441168|579462112|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
160473315|NCT00441168|579462113|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
160601595|NCT00239356|579918153|FG000|Overall Study|Administrative reason|0|||
160601596|NCT00239356|579918154|FG001|Overall Study|Administrative reason|1|||
160473316|NCT00441168|579462112|FG000|Treatment Period|refractory disease|1|||
160473317|NCT00441168|579462113|FG001|Treatment Period|refractory disease|0|||
160473318|NCT00441168|579462112|FG000|Follow-up Period|Death|3|||
160473319|NCT00441168|579462113|FG001|Follow-up Period|Death|0|||
160473320|NCT00441168|579462112|FG000|Follow-up Period|Lost to Follow-up|5|||
160473321|NCT00441168|579462113|FG001|Follow-up Period|Lost to Follow-up|6|||
160473322|NCT00441168|579462112|FG000|Follow-up Period|Withdrawal by Subject|3|||
160473323|NCT00441168|579462113|FG001|Follow-up Period|Withdrawal by Subject|0|||
160473324|NCT00441168|579462112|FG000|Follow-up Period|Other|1|||
160473325|NCT00441168|579462113|FG001|Follow-up Period|Other|3|||
160473326|NCT04410445|579462115|FG000|Overall Study|Lost to Follow-up|3|||
160473327|NCT04410445|579462116|FG001|Overall Study|Lost to Follow-up|9|||
160473328|NCT04410445|579462115|FG000|Overall Study|Withdrawal by Subject|27|||
160473329|NCT04410445|579462116|FG001|Overall Study|Withdrawal by Subject|15|||
160473330|NCT01320683|579462117|FG000|Overall Study|Positive antibody response|1|||
160473331|NCT02291861|579462118|FG000|Overall Study|Adverse Event|2|||
160473332|NCT02291861|579462119|FG001|Overall Study|Adverse Event|4|||
160473333|NCT02291861|579462120|FG002|Overall Study|Adverse Event|1|||
160473334|NCT02291861|579462121|FG003|Overall Study|Adverse Event|2|||
160473335|NCT02291861|579462118|FG000|Overall Study|Death|0|||
160473336|NCT02291861|579462119|FG001|Overall Study|Death|0|||
160473337|NCT02291861|579462120|FG002|Overall Study|Death|1|||
160473338|NCT02291861|579462121|FG003|Overall Study|Death|1|||
160473339|NCT02291861|579462118|FG000|Overall Study|Protocol Violation|1|||
160473340|NCT02291861|579462119|FG001|Overall Study|Protocol Violation|0|||
160473341|NCT02291861|579462120|FG002|Overall Study|Protocol Violation|0|||
160473342|NCT02291861|579462121|FG003|Overall Study|Protocol Violation|1|||
160473343|NCT02291861|579462118|FG000|Overall Study|Withdrawal by Subject|1|||
160473344|NCT02291861|579462119|FG001|Overall Study|Withdrawal by Subject|2|||
160473345|NCT02291861|579462120|FG002|Overall Study|Withdrawal by Subject|1|||
160473346|NCT02291861|579462121|FG003|Overall Study|Withdrawal by Subject|4|||
160473347|NCT02291861|579462118|FG000|Overall Study|Noncompliance|1|||
160473348|NCT02291861|579462119|FG001|Overall Study|Noncompliance|1|||
160473349|NCT02291861|579462120|FG002|Overall Study|Noncompliance|2|||
160473350|NCT02291861|579462121|FG003|Overall Study|Noncompliance|1|||
160473351|NCT02291861|579462118|FG000|Overall Study|Lost to Follow-up|2|||
160473352|NCT02291861|579462119|FG001|Overall Study|Lost to Follow-up|1|||
160473353|NCT02291861|579462120|FG002|Overall Study|Lost to Follow-up|4|||
160473354|NCT02291861|579462121|FG003|Overall Study|Lost to Follow-up|0|||
160473355|NCT02291861|579462118|FG000|Overall Study|Other|0|||
160473356|NCT02291861|579462119|FG001|Overall Study|Other|0|||
160473357|NCT02291861|579462120|FG002|Overall Study|Other|0|||
160473358|NCT02291861|579462121|FG003|Overall Study|Other|1|||
160473359|NCT02005484|579462124|FG000|Overall Study|Death|1|||
160473360|NCT02005484|579462124|FG000|Overall Study|Disease progression|1|||
160473361|NCT02005484|579462124|FG000|Overall Study|Changed to a Different Study|1|||
160473362|NCT02005484|579462124|FG000|Overall Study|Sponsor decision|1|||
160473363|NCT03547154|579462129|FG000|Overall Study|Disease Progression/Recurrence|6|||
160473364|NCT03547154|579462130|FG001|Overall Study|Disease Progression/Recurrence|14|||
160473365|NCT03547154|579462129|FG000|Overall Study|Adverse Event|26|||
160473366|NCT03547154|579462130|FG001|Overall Study|Adverse Event|31|||
160473367|NCT03547154|579462129|FG000|Overall Study|Protocol Violation|6|||
160473368|NCT03547154|579462130|FG001|Overall Study|Protocol Violation|1|||
160473369|NCT03547154|579462129|FG000|Overall Study|Physician Decision|4|||
160473370|NCT03547154|579462130|FG001|Overall Study|Physician Decision|3|||
160473371|NCT03547154|579462129|FG000|Overall Study|Insufficient Therapeutic Response|13|||
160473372|NCT03547154|579462130|FG001|Overall Study|Insufficient Therapeutic Response|10|||
160601597|NCT00239356|579918153|FG000|Overall Study|Drug available on market|11|||
160601598|NCT00239356|579918154|FG001|Overall Study|Drug available on market|2|||
160601599|NCT01001572|579918155|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
160601600|NCT01001572|579918156|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
160473373|NCT03547154|579462129|FG000|Overall Study|Withdrawal by Subject|10|||
160473374|NCT03547154|579462130|FG001|Overall Study|Withdrawal by Subject|6|||
160601601|NCT01001572|579918157|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
160473375|NCT03547154|579462129|FG000|Overall Study|Not Selected|0|||
160473376|NCT03547154|579462130|FG001|Overall Study|Not Selected|1|||
160473377|NCT03547154|579462129|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
160473378|NCT03547154|579462130|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
160473379|NCT03390166|579462132|FG000|Overall Study|Death|0|||
160473380|NCT03390166|579462133|FG001|Overall Study|Death|1|||
160473381|NCT03390166|579462132|FG000|Overall Study|Lost to Follow-up|6|||
160473382|NCT03390166|579462133|FG001|Overall Study|Lost to Follow-up|4|||
160473383|NCT03390166|579462132|FG000|Overall Study|Physician Decision|2|||
160473384|NCT03390166|579462133|FG001|Overall Study|Physician Decision|1|||
160473385|NCT03390166|579462132|FG000|Overall Study|Move from study area|3|||
160473386|NCT03390166|579462133|FG001|Overall Study|Move from study area|2|||
160473387|NCT03390166|579462132|FG000|Overall Study|To militarycamp for conscript|1|||
160473388|NCT03390166|579462133|FG001|Overall Study|To militarycamp for conscript|0|||
160473389|NCT03390166|579462132|FG000|Overall Study|To drug therapy course|0|||
160601602|NCT01001572|579918155|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
160601603|NCT01001572|579918156|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
160601604|NCT01001572|579918157|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
160601605|NCT01001572|579918155|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
160601606|NCT01001572|579918156|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
160601607|NCT01001572|579918157|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
160601608|NCT01001572|579918155|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
160601609|NCT01001572|579918156|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
160601610|NCT01001572|579918157|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
160601611|NCT01001572|579918155|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
160601612|NCT01001572|579918156|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
160601613|NCT01001572|579918157|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
160601614|NCT01001572|579918155|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
160601615|NCT01001572|579918156|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
160601616|NCT01001572|579918157|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
160601617|NCT01001572|579918155|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
160601618|NCT01001572|579918156|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
160601619|NCT01001572|579918157|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
160601620|NCT01001572|579918155|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
160601621|NCT01001572|579918156|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
160601622|NCT01001572|579918157|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
160601623|NCT01001572|579918155|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
160601624|NCT01001572|579918156|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
160601625|NCT01001572|579918157|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
160601626|NCT01001572|579918155|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
160601627|NCT01001572|579918156|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
160601628|NCT01001572|579918157|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
160601629|NCT01001572|579918155|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
160601630|NCT01001572|579918156|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
160601631|NCT01001572|579918157|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
160601632|NCT01001572|579918155|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
160601633|NCT01001572|579918156|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
160601634|NCT01001572|579918157|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
160601635|NCT01001572|579918155|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
160601636|NCT01001572|579918156|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
160601637|NCT01001572|579918157|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
160601638|NCT01001572|579918155|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160601639|NCT01001572|579918156|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160601640|NCT01001572|579918157|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
160601641|NCT01094808|579918158|FG000|Overall Study|Withdrawal by Subject|1|||
160601642|NCT01094808|579918159|FG001|Overall Study|Withdrawal by Subject|1|||
160601643|NCT01094808|579918160|FG002|Overall Study|Withdrawal by Subject|0|||
160601644|NCT00369278|579918161|FG000|Overall Study|Adverse Event|14|||
160601645|NCT00369278|579918162|FG001|Overall Study|Adverse Event|11|||
160601646|NCT00369278|579918161|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160601647|NCT00369278|579918162|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
160601648|NCT00369278|579918161|FG000|Overall Study|Protocol Violation|2|||
160601649|NCT00369278|579918162|FG001|Overall Study|Protocol Violation|1|||
160601650|NCT00369278|579918161|FG000|Overall Study|Withdrawal by Subject|2|||
160601651|NCT00369278|579918162|FG001|Overall Study|Withdrawal by Subject|2|||
160601652|NCT00369278|579918161|FG000|Overall Study|Lost to Follow-up|1|||
160601653|NCT00369278|579918162|FG001|Overall Study|Lost to Follow-up|0|||
160601654|NCT00369278|579918161|FG000|Overall Study|Graft loss|1|||
160601655|NCT00369278|579918162|FG001|Overall Study|Graft loss|2|||
160601656|NCT01017549|579918167|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
160601657|NCT01017549|579918167|FG000|One-year Follow-up|Lost to Follow-up|2|||
160601658|NCT01017549|579918167|FG000|One-year Follow-up|Withdrawal by Subject|5|||
160601659|NCT01017549|579918167|FG000|5 Year Follow-up|Lost to Follow-up|9|||
160601660|NCT01017549|579918167|FG000|5 Year Follow-up|Mastectomy|3|||
160473390|NCT03390166|579462133|FG001|Overall Study|To drug therapy course|1|||
160473391|NCT03390166|579462132|FG000|Overall Study|Move to work oversea|0|||
160473392|NCT03390166|579462133|FG001|Overall Study|Move to work oversea|1|||
160473393|NCT00526994|579462148|FG000|Overall Study|Lost to Follow-up|98|||
160473394|NCT00526994|579462149|FG001|Overall Study|Lost to Follow-up|108|||
160473395|NCT00526994|579462150|FG002|Overall Study|Lost to Follow-up|96|||
160601661|NCT03725293|579918174|FG000|Overall Study|Physician Decision|9|||
160601662|NCT03725293|579918175|FG001|Overall Study|Physician Decision|6|||
160601663|NCT03725293|579918174|FG000|Overall Study|alternative vascular access needs|1|||
160601664|NCT03725293|579918175|FG001|Overall Study|alternative vascular access needs|2|||
160473396|NCT00526994|579462148|FG000|Overall Study|Death|4|||
160473397|NCT00526994|579462149|FG001|Overall Study|Death|3|||
160473398|NCT00526994|579462150|FG002|Overall Study|Death|3|||
160473399|NCT00526994|579462148|FG000|Overall Study|Withdrawal by Subject|2|||
160473400|NCT00526994|579462149|FG001|Overall Study|Withdrawal by Subject|7|||
160473401|NCT00526994|579462150|FG002|Overall Study|Withdrawal by Subject|5|||
160473402|NCT00526994|579462148|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
160473403|NCT00526994|579462149|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
160473404|NCT00526994|579462150|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
160473405|NCT04821271|579462156|FG000|Period 1|Withdrawal by Subject|2|||
160473406|NCT04821271|579462157|FG001|Period 1|Withdrawal by Subject|0|||
160473407|NCT02521493|579462159|FG000|Overall Study|Death|3|||
160473408|NCT02521493|579462160|FG001|Overall Study|Death|4|||
160473409|NCT02521493|579462161|FG002|Overall Study|Death|1|||
160473410|NCT02521493|579462159|FG000|Overall Study|Physician Decision|19|||
160473411|NCT02521493|579462160|FG001|Overall Study|Physician Decision|1|||
160473412|NCT02521493|579462161|FG002|Overall Study|Physician Decision|2|||
160473413|NCT02521493|579462159|FG000|Overall Study|Withdrawal by Subject|3|||
160473414|NCT02521493|579462160|FG001|Overall Study|Withdrawal by Subject|0|||
160473415|NCT02521493|579462161|FG002|Overall Study|Withdrawal by Subject|0|||
160473416|NCT02521493|579462159|FG000|Overall Study|Ineligible|0|||
160473417|NCT02521493|579462160|FG001|Overall Study|Ineligible|1|||
160473418|NCT02521493|579462161|FG002|Overall Study|Ineligible|0|||
160473419|NCT02521493|579462159|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
160473420|NCT02521493|579462160|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
160473421|NCT02521493|579462161|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
160473422|NCT02521493|579462159|FG000|Overall Study|No MRD result|0|||
160473423|NCT02521493|579462160|FG001|Overall Study|No MRD result|0|||
160473424|NCT02521493|579462161|FG002|Overall Study|No MRD result|4|||
160473425|NCT01880736|579462162|FG000|Overall Study|Adverse Event|0|||
160473426|NCT01880736|579462163|FG001|Overall Study|Adverse Event|0|||
160473427|NCT01880736|579462164|FG002|Overall Study|Adverse Event|0|||
160473428|NCT01880736|579462165|FG003|Overall Study|Adverse Event|1|||
160473429|NCT01880736|579462162|FG000|Overall Study|Withdrawal Criteria|1|||
160473430|NCT01880736|579462163|FG001|Overall Study|Withdrawal Criteria|2|||
160473431|NCT01880736|579462164|FG002|Overall Study|Withdrawal Criteria|1|||
160601665|NCT03725293|579918174|FG000|Overall Study|venous anatomy screen failures|2|||
160601666|NCT03725293|579918175|FG001|Overall Study|venous anatomy screen failures|1|||
160601667|NCT02143141|579918176|FG000|Overall Study|pain scores at 24 hours not collected|1|||
160601668|NCT02143141|579918177|FG001|Overall Study|pain scores at 24 hours not collected|0|||
160601669|NCT01057862|579918178|FG000|Overall Study|Withdrawal by Subject|1|||
160601670|NCT01057862|579918179|FG001|Overall Study|Withdrawal by Subject|2|||
160601671|NCT03363165|579918180|FG000|3-month Follow-up|Death|0|||
160601672|NCT03363165|579918181|FG001|3-month Follow-up|Death|1|||
160601673|NCT03363165|579918180|FG000|6-month Follow-up|Death|0|||
160601674|NCT03363165|579918181|FG001|6-month Follow-up|Death|1|||
160601675|NCT03363165|579918180|FG000|6-month Follow-up|Withdrawal by Subject|1|||
160601676|NCT03363165|579918181|FG001|6-month Follow-up|Withdrawal by Subject|1|||
160601677|NCT03363165|579918180|FG000|12-month Follow-up|Death|1|||
160601678|NCT03363165|579918181|FG001|12-month Follow-up|Death|1|||
160601679|NCT03363165|579918180|FG000|12-month Follow-up|Withdrawal by Subject|1|||
160601680|NCT03363165|579918181|FG001|12-month Follow-up|Withdrawal by Subject|1|||
160601681|NCT00003838|579918182|FG000|Overall Study|Death|0|||
160601682|NCT00003838|579918183|FG001|Overall Study|Death|12|||
160601683|NCT00003838|579918184|FG002|Overall Study|Death|7|||
160601684|NCT00003838|579918182|FG000|Overall Study|Lost to Follow-up|0|||
160601685|NCT00003838|579918183|FG001|Overall Study|Lost to Follow-up|1|||
160601686|NCT00003838|579918184|FG002|Overall Study|Lost to Follow-up|1|||
160601687|NCT00003838|579918182|FG000|Overall Study|Disease Progression|0|||
160601688|NCT00003838|579918183|FG001|Overall Study|Disease Progression|12|||
160601689|NCT00003838|579918184|FG002|Overall Study|Disease Progression|0|||
160601690|NCT00425113|579918185|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
160601691|NCT00425113|579918186|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
160601692|NCT00425113|579918185|FG000|Overall Study|diagnosis of abdominal TB|0|||
160601693|NCT00425113|579918186|FG001|Overall Study|diagnosis of abdominal TB|1|||
160601694|NCT00425113|579918185|FG000|Overall Study|missing study drug more than 14 days|0|||
160601695|NCT00425113|579918186|FG001|Overall Study|missing study drug more than 14 days|1|||
160601696|NCT00425113|579918185|FG000|Overall Study|Withdrawal by Subject|1|||
160473432|NCT01880736|579462165|FG003|Overall Study|Withdrawal Criteria|5|||
160473433|NCT00428714|579462168|FG000|Overall Study|Progressive Disease|28|||
160473434|NCT00428714|579462169|FG001|Overall Study|Progressive Disease|36|||
160473435|NCT00428714|579462168|FG000|Overall Study|Withdrawal by Subject|0|||
160601697|NCT00425113|579918186|FG001|Overall Study|Withdrawal by Subject|0|||
160601698|NCT02920450|579918187|FG000|Overall Study|Death|1|||
160601699|NCT02920450|579918188|FG001|Overall Study|Death|0|||
160601700|NCT02920450|579918189|FG002|Overall Study|Death|0|||
160601701|NCT02920450|579918190|FG003|Overall Study|Death|0|||
160601702|NCT02920450|579918187|FG000|Overall Study|Withdrawal by Subject|1|||
160473436|NCT00428714|579462169|FG001|Overall Study|Withdrawal by Subject|3|||
160601703|NCT02920450|579918188|FG001|Overall Study|Withdrawal by Subject|0|||
160473437|NCT00428714|579462168|FG000|Overall Study|Adverse Event|0|||
160473438|NCT00428714|579462169|FG001|Overall Study|Adverse Event|2|||
160473439|NCT00428714|579462168|FG000|Overall Study|Physician Decision|1|||
160473440|NCT00428714|579462169|FG001|Overall Study|Physician Decision|1|||
160473441|NCT00428714|579462168|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
160473442|NCT00428714|579462169|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
160473443|NCT00428714|579462168|FG000|Overall Study|Death due to other then PD|1|||
160473444|NCT00428714|579462169|FG001|Overall Study|Death due to other then PD|0|||
160473445|NCT02807857|579462172|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
160473446|NCT02807857|579462172|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
160473447|NCT02807857|579462172|FG000|Follow-Up Set|Withdrawal by Subject|8|||
160473448|NCT02807857|579462172|FG000|Follow-Up Set|Lost to Follow-up|7|||
160473449|NCT02807857|579462172|FG000|Follow-Up Set|Physician Decision|6|||
160473450|NCT02807857|579462172|FG000|Follow-Up Set|Adverse Event|3|||
160473451|NCT02807857|579462172|FG000|Follow-Up Set|Death|27|||
160473452|NCT02807857|579462172|FG000|Follow-Up Set|Relocation|2|||
160473453|NCT00513071|579462174|FG000|Overall Study|Adverse Event|1|||
160473454|NCT00513071|579462174|FG000|Overall Study|Withdrawal by Subject|1|||
160473455|NCT00513071|579462174|FG000|Overall Study|Physician Decision|3|||
160473456|NCT00667732|579462176|FG000|Run -In (8 Weeks)|Adverse Event|4|||
160473457|NCT00667732|579462177|FG001|Run -In (8 Weeks)|Adverse Event|0|||
160473458|NCT00667732|579462178|FG002|Run -In (8 Weeks)|Adverse Event|0|||
160473459|NCT00667732|579462176|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
160473460|NCT00667732|579462177|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
160473461|NCT00667732|579462178|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
160473462|NCT00667732|579462176|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
160473463|NCT00667732|579462177|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
160473464|NCT00667732|579462178|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
160473465|NCT02106325|579462181|FG000|Phase 1|Lost to Follow-up|2|||
160473466|NCT02106325|579462182|FG001|Phase 1|Lost to Follow-up|2|||
160473467|NCT02106325|579462181|FG000|Phase 2|Lost to Follow-up|2|||
160473468|NCT02106325|579462182|FG001|Phase 2|Lost to Follow-up|3|||
160473469|NCT02106325|579462181|FG000|Phase 3|Lost to Follow-up|2|||
160473470|NCT02106325|579462182|FG001|Phase 3|Lost to Follow-up|1|||
160473471|NCT00452114|579462184|FG000|Overall Study|Physician Decision|3|||
160473472|NCT00452114|579462185|FG001|Overall Study|Physician Decision|3|||
160473473|NCT03242863|579462186|FG000|Study Week 1|Withdrawal by Subject|0|||
160473474|NCT03242863|579462187|FG001|Study Week 1|Withdrawal by Subject|1|||
160473475|NCT03242863|579462188|FG002|Study Week 1|Withdrawal by Subject|0|||
160473476|NCT03242863|579462189|FG003|Study Week 1|Withdrawal by Subject|0|||
160473477|NCT03242863|579462190|FG004|Study Week 1|Withdrawal by Subject|3|||
160473478|NCT03242863|579462191|FG005|Study Week 1|Withdrawal by Subject|0|||
160473479|NCT05289037|579462199|FG000|Overall Study|Withdrawal by Subject|7|||
160473480|NCT05289037|579462200|FG001|Overall Study|Withdrawal by Subject|0|||
160473481|NCT05289037|579462201|FG002|Overall Study|Withdrawal by Subject|3|||
160473482|NCT05289037|579462202|FG003|Overall Study|Withdrawal by Subject|3|||
160473483|NCT05289037|579462203|FG004|Overall Study|Withdrawal by Subject|1|||
160473484|NCT05289037|579462204|FG005|Overall Study|Withdrawal by Subject|5|||
160473485|NCT05289037|579462205|FG006|Overall Study|Withdrawal by Subject|2|||
160473486|NCT05289037|579462206|FG007|Overall Study|Withdrawal by Subject|1|||
160473487|NCT05289037|579462207|FG008|Overall Study|Withdrawal by Subject|2|||
160473488|NCT05289037|579462208|FG009|Overall Study|Withdrawal by Subject|2|||
160473489|NCT05289037|579462209|FG010|Overall Study|Withdrawal by Subject|1|||
160473490|NCT05289037|579462210|FG011|Overall Study|Withdrawal by Subject|0|||
160473491|NCT05289037|579462211|FG012|Overall Study|Withdrawal by Subject|1|||
160473492|NCT05289037|579462212|FG013|Overall Study|Withdrawal by Subject|2|||
160473493|NCT05289037|579462213|FG014|Overall Study|Withdrawal by Subject|0|||
160473494|NCT05289037|579462214|FG015|Overall Study|Withdrawal by Subject|3|||
160473495|NCT05289037|579462215|FG016|Overall Study|Withdrawal by Subject|3|||
160473496|NCT05289037|579462199|FG000|Overall Study|Lost to Follow-up|1|||
160473497|NCT05289037|579462200|FG001|Overall Study|Lost to Follow-up|4|||
160473498|NCT05289037|579462201|FG002|Overall Study|Lost to Follow-up|3|||
160473499|NCT05289037|579462202|FG003|Overall Study|Lost to Follow-up|3|||
160473500|NCT05289037|579462203|FG004|Overall Study|Lost to Follow-up|3|||
160473501|NCT05289037|579462204|FG005|Overall Study|Lost to Follow-up|2|||
160473502|NCT05289037|579462205|FG006|Overall Study|Lost to Follow-up|3|||
160473503|NCT05289037|579462206|FG007|Overall Study|Lost to Follow-up|2|||
160473504|NCT05289037|579462207|FG008|Overall Study|Lost to Follow-up|2|||
160473505|NCT05289037|579462208|FG009|Overall Study|Lost to Follow-up|1|||
160601704|NCT02920450|579918189|FG002|Overall Study|Withdrawal by Subject|0|||
160473506|NCT05289037|579462209|FG010|Overall Study|Lost to Follow-up|3|||
160473507|NCT05289037|579462210|FG011|Overall Study|Lost to Follow-up|4|||
160473508|NCT05289037|579462211|FG012|Overall Study|Lost to Follow-up|2|||
160473509|NCT05289037|579462212|FG013|Overall Study|Lost to Follow-up|7|||
160473510|NCT05289037|579462213|FG014|Overall Study|Lost to Follow-up|4|||
160473511|NCT05289037|579462214|FG015|Overall Study|Lost to Follow-up|6|||
160473512|NCT05289037|579462215|FG016|Overall Study|Lost to Follow-up|4|||
160473513|NCT05289037|579462199|FG000|Overall Study|Death|0|||
160473514|NCT05289037|579462200|FG001|Overall Study|Death|0|||
160473515|NCT05289037|579462201|FG002|Overall Study|Death|0|||
160473516|NCT05289037|579462202|FG003|Overall Study|Death|0|||
160473517|NCT05289037|579462203|FG004|Overall Study|Death|0|||
160473518|NCT05289037|579462204|FG005|Overall Study|Death|1|||
160473519|NCT05289037|579462205|FG006|Overall Study|Death|0|||
160473520|NCT05289037|579462206|FG007|Overall Study|Death|0|||
160473521|NCT05289037|579462207|FG008|Overall Study|Death|0|||
160473522|NCT05289037|579462208|FG009|Overall Study|Death|0|||
160473523|NCT05289037|579462209|FG010|Overall Study|Death|0|||
160473524|NCT05289037|579462210|FG011|Overall Study|Death|0|||
160473525|NCT05289037|579462211|FG012|Overall Study|Death|0|||
160473526|NCT05289037|579462212|FG013|Overall Study|Death|0|||
160473527|NCT05289037|579462213|FG014|Overall Study|Death|1|||
160473528|NCT05289037|579462214|FG015|Overall Study|Death|0|||
160473529|NCT05289037|579462215|FG016|Overall Study|Death|0|||
160473530|NCT05289037|579462199|FG000|Overall Study|Did not receive vaccine|0|||
160473531|NCT05289037|579462200|FG001|Overall Study|Did not receive vaccine|3|||
160473532|NCT05289037|579462201|FG002|Overall Study|Did not receive vaccine|0|||
160473533|NCT05289037|579462202|FG003|Overall Study|Did not receive vaccine|0|||
160473534|NCT05289037|579462203|FG004|Overall Study|Did not receive vaccine|1|||
160473535|NCT05289037|579462204|FG005|Overall Study|Did not receive vaccine|1|||
160473536|NCT05289037|579462205|FG006|Overall Study|Did not receive vaccine|1|||
160473537|NCT05289037|579462206|FG007|Overall Study|Did not receive vaccine|0|||
160473538|NCT05289037|579462207|FG008|Overall Study|Did not receive vaccine|0|||
160473539|NCT05289037|579462208|FG009|Overall Study|Did not receive vaccine|0|||
160473540|NCT05289037|579462209|FG010|Overall Study|Did not receive vaccine|0|||
160473541|NCT05289037|579462210|FG011|Overall Study|Did not receive vaccine|0|||
160473542|NCT05289037|579462211|FG012|Overall Study|Did not receive vaccine|0|||
160473543|NCT05289037|579462212|FG013|Overall Study|Did not receive vaccine|0|||
160473544|NCT05289037|579462213|FG014|Overall Study|Did not receive vaccine|1|||
160473545|NCT05289037|579462214|FG015|Overall Study|Did not receive vaccine|0|||
160473546|NCT05289037|579462215|FG016|Overall Study|Did not receive vaccine|0|||
160473547|NCT05289037|579462199|FG000|Overall Study|Unable to make last visit|0|||
160473548|NCT05289037|579462200|FG001|Overall Study|Unable to make last visit|0|||
160473549|NCT05289037|579462201|FG002|Overall Study|Unable to make last visit|1|||
160473550|NCT05289037|579462202|FG003|Overall Study|Unable to make last visit|0|||
160473551|NCT05289037|579462203|FG004|Overall Study|Unable to make last visit|0|||
160473552|NCT05289037|579462204|FG005|Overall Study|Unable to make last visit|0|||
160473553|NCT05289037|579462205|FG006|Overall Study|Unable to make last visit|0|||
160473554|NCT05289037|579462206|FG007|Overall Study|Unable to make last visit|0|||
160473555|NCT05289037|579462207|FG008|Overall Study|Unable to make last visit|0|||
160473556|NCT05289037|579462208|FG009|Overall Study|Unable to make last visit|0|||
160473557|NCT05289037|579462209|FG010|Overall Study|Unable to make last visit|0|||
160473558|NCT05289037|579462210|FG011|Overall Study|Unable to make last visit|0|||
160473559|NCT05289037|579462211|FG012|Overall Study|Unable to make last visit|0|||
160473560|NCT05289037|579462212|FG013|Overall Study|Unable to make last visit|0|||
160473561|NCT05289037|579462213|FG014|Overall Study|Unable to make last visit|0|||
160473562|NCT05289037|579462214|FG015|Overall Study|Unable to make last visit|0|||
160473563|NCT05289037|579462215|FG016|Overall Study|Unable to make last visit|0|||
160473564|NCT05289037|579462199|FG000|Overall Study|Protocol deviation|0|||
160473565|NCT05289037|579462200|FG001|Overall Study|Protocol deviation|0|||
160473566|NCT05289037|579462201|FG002|Overall Study|Protocol deviation|0|||
160473567|NCT05289037|579462202|FG003|Overall Study|Protocol deviation|0|||
160473568|NCT05289037|579462203|FG004|Overall Study|Protocol deviation|0|||
160473569|NCT05289037|579462204|FG005|Overall Study|Protocol deviation|0|||
160473570|NCT05289037|579462205|FG006|Overall Study|Protocol deviation|0|||
160473571|NCT05289037|579462206|FG007|Overall Study|Protocol deviation|0|||
160473572|NCT05289037|579462207|FG008|Overall Study|Protocol deviation|0|||
160473573|NCT05289037|579462208|FG009|Overall Study|Protocol deviation|0|||
160473574|NCT05289037|579462209|FG010|Overall Study|Protocol deviation|0|||
160473575|NCT05289037|579462210|FG011|Overall Study|Protocol deviation|0|||
160473576|NCT05289037|579462211|FG012|Overall Study|Protocol deviation|0|||
160473577|NCT05289037|579462212|FG013|Overall Study|Protocol deviation|0|||
160473578|NCT05289037|579462213|FG014|Overall Study|Protocol deviation|0|||
160473579|NCT05289037|579462214|FG015|Overall Study|Protocol deviation|1|||
160473580|NCT05289037|579462215|FG016|Overall Study|Protocol deviation|0|||
160473581|NCT02831049|579462216|FG000|Overall Study|Lost to Follow-up|0|||
160473582|NCT02831049|579462217|FG001|Overall Study|Lost to Follow-up|0|||
160473583|NCT02831049|579462218|FG002|Overall Study|Lost to Follow-up|1|||
160473584|NCT02831049|579462216|FG000|Overall Study|Withdrawal by Subject|0|||
160601705|NCT02920450|579918190|FG003|Overall Study|Withdrawal by Subject|0|||
160473585|NCT02831049|579462217|FG001|Overall Study|Withdrawal by Subject|1|||
160473586|NCT02831049|579462218|FG002|Overall Study|Withdrawal by Subject|1|||
160473587|NCT02831049|579462216|FG000|Overall Study|Pandemic shutdown|1|||
160473588|NCT02831049|579462217|FG001|Overall Study|Pandemic shutdown|0|||
160473589|NCT02831049|579462218|FG002|Overall Study|Pandemic shutdown|0|||
160473590|NCT04852978|579462220|FG000|Overall Study|Physician Decision|0|||
160473591|NCT04852978|579462221|FG001|Overall Study|Physician Decision|1|||
160473592|NCT04852978|579462222|FG002|Overall Study|Physician Decision|0|||
160473593|NCT04852978|579462223|FG003|Overall Study|Physician Decision|0|||
160473594|NCT04852978|579462224|FG004|Overall Study|Physician Decision|0|||
160473595|NCT04852978|579462225|FG005|Overall Study|Physician Decision|0|||
160473596|NCT04852978|579462226|FG006|Overall Study|Physician Decision|0|||
160473597|NCT04852978|579462227|FG007|Overall Study|Physician Decision|2|||
160473598|NCT04852978|579462228|FG008|Overall Study|Physician Decision|0|||
160473599|NCT04852978|579462220|FG000|Overall Study|Sponsor request|0|||
160473600|NCT04852978|579462221|FG001|Overall Study|Sponsor request|0|||
160473601|NCT04852978|579462222|FG002|Overall Study|Sponsor request|1|||
160473602|NCT04852978|579462223|FG003|Overall Study|Sponsor request|0|||
160473603|NCT04852978|579462224|FG004|Overall Study|Sponsor request|0|||
160473604|NCT04852978|579462225|FG005|Overall Study|Sponsor request|0|||
160473605|NCT04852978|579462226|FG006|Overall Study|Sponsor request|0|||
160473606|NCT04852978|579462227|FG007|Overall Study|Sponsor request|0|||
160473607|NCT04852978|579462228|FG008|Overall Study|Sponsor request|0|||
160473608|NCT04852978|579462220|FG000|Overall Study|Death|0|||
160473609|NCT04852978|579462221|FG001|Overall Study|Death|0|||
160473610|NCT04852978|579462222|FG002|Overall Study|Death|0|||
160473611|NCT04852978|579462223|FG003|Overall Study|Death|0|||
160473612|NCT04852978|579462224|FG004|Overall Study|Death|0|||
160473613|NCT04852978|579462225|FG005|Overall Study|Death|0|||
160473614|NCT04852978|579462226|FG006|Overall Study|Death|1|||
160473615|NCT04852978|579462227|FG007|Overall Study|Death|0|||
160473616|NCT04852978|579462228|FG008|Overall Study|Death|0|||
160473617|NCT04852978|579462220|FG000|Overall Study|Lost to Follow-up|3|||
160473618|NCT04852978|579462221|FG001|Overall Study|Lost to Follow-up|2|||
160473619|NCT04852978|579462222|FG002|Overall Study|Lost to Follow-up|2|||
160473620|NCT04852978|579462223|FG003|Overall Study|Lost to Follow-up|0|||
160473621|NCT04852978|579462224|FG004|Overall Study|Lost to Follow-up|2|||
160473622|NCT04852978|579462225|FG005|Overall Study|Lost to Follow-up|4|||
160473623|NCT04852978|579462226|FG006|Overall Study|Lost to Follow-up|1|||
160473624|NCT04852978|579462227|FG007|Overall Study|Lost to Follow-up|2|||
160473625|NCT04852978|579462228|FG008|Overall Study|Lost to Follow-up|2|||
160473626|NCT04852978|579462220|FG000|Overall Study|Withdrawal by Subject|4|||
160473627|NCT04852978|579462221|FG001|Overall Study|Withdrawal by Subject|2|||
160473628|NCT04852978|579462222|FG002|Overall Study|Withdrawal by Subject|2|||
160473629|NCT04852978|579462223|FG003|Overall Study|Withdrawal by Subject|1|||
160473630|NCT04852978|579462224|FG004|Overall Study|Withdrawal by Subject|5|||
160473631|NCT04852978|579462225|FG005|Overall Study|Withdrawal by Subject|3|||
160473632|NCT04852978|579462226|FG006|Overall Study|Withdrawal by Subject|2|||
160473633|NCT04852978|579462227|FG007|Overall Study|Withdrawal by Subject|2|||
160473634|NCT04852978|579462228|FG008|Overall Study|Withdrawal by Subject|1|||
160473635|NCT03786471|579462229|FG000|Overall Study|Death|254|||
160473636|NCT03786471|579462230|FG001|Overall Study|Death|223|||
160473637|NCT03786471|579462231|FG002|Overall Study|Death|37|||
160473638|NCT03786471|579462229|FG000|Overall Study|Lost to Follow-up|63|||
160473639|NCT03786471|579462230|FG001|Overall Study|Lost to Follow-up|50|||
160473640|NCT03786471|579462231|FG002|Overall Study|Lost to Follow-up|15|||
160473641|NCT03786471|579462229|FG000|Overall Study|Withdrawal by Subject|99|||
160473642|NCT03786471|579462230|FG001|Overall Study|Withdrawal by Subject|81|||
160473643|NCT03786471|579462231|FG002|Overall Study|Withdrawal by Subject|11|||
160473644|NCT03141177|579463550|FG000|Overall Study|Death|62|||
160473645|NCT03141177|579463551|FG001|Overall Study|Death|13|||
160473646|NCT03141177|579463552|FG002|Overall Study|Death|84|||
160473647|NCT03141177|579463550|FG000|Overall Study|Participant withdrew consent|9|||
160473648|NCT03141177|579463551|FG001|Overall Study|Participant withdrew consent|2|||
160473649|NCT03141177|579463552|FG002|Overall Study|Participant withdrew consent|13|||
160473650|NCT03141177|579463550|FG000|Overall Study|Not reported|1|||
160473651|NCT03141177|579463551|FG001|Overall Study|Not reported|0|||
160473652|NCT03141177|579463552|FG002|Overall Study|Not reported|1|||
160473653|NCT03141177|579463550|FG000|Overall Study|Lost to Follow-up|2|||
160473654|NCT03141177|579463551|FG001|Overall Study|Lost to Follow-up|1|||
160473655|NCT03141177|579463552|FG002|Overall Study|Lost to Follow-up|1|||
160601706|NCT00126672|579918195|FG000|Overall Study|Adverse Event|4|||
160601707|NCT00126672|579918195|FG000|Overall Study|Lost to Follow-up|4|||
160473656|NCT03141177|579463550|FG000|Overall Study|Other reasons|4|||
160473657|NCT03141177|579463551|FG001|Overall Study|Other reasons|0|||
160473658|NCT03141177|579463552|FG002|Overall Study|Other reasons|11|||
160473659|NCT03141177|579463550|FG000|Overall Study|Participants did not start treatment period|3|||
160473660|NCT03141177|579463551|FG001|Overall Study|Participants did not start treatment period|0|||
160473661|NCT03141177|579463552|FG002|Overall Study|Participants did not start treatment period|8|||
160473662|NCT05006703|579463553|FG000|Overall Study|Withdrawal by Subject|1|||
160473663|NCT05006703|579463554|FG001|Overall Study|Withdrawal by Subject|0|||
160601708|NCT01001234|579918196|FG000|Overall Study|Withdrawal by Subject|2|||
160473664|NCT05006703|579463553|FG000|Overall Study|Lost to Follow-up|13|||
160473665|NCT05006703|579463554|FG001|Overall Study|Lost to Follow-up|5|||
160473666|NCT00264576|579463559|FG000|Overall Study|Lost to Follow-up|1|||
160473667|NCT00264576|579463560|FG001|Overall Study|Lost to Follow-up|1|||
160473668|NCT02659059|579463561|FG000|Overall Study|Other reasons|6|||
160473669|NCT02659059|579463562|FG001|Overall Study|Other reasons|1|||
160473670|NCT02659059|579463561|FG000|Overall Study|Disease Progression|143|||
160473671|NCT02659059|579463562|FG001|Overall Study|Disease Progression|16|||
160473672|NCT02659059|579463561|FG000|Overall Study|Study Drug toxicity|56|||
160473673|NCT02659059|579463562|FG001|Overall Study|Study Drug toxicity|9|||
160473674|NCT02659059|579463561|FG000|Overall Study|Death|3|||
160473675|NCT02659059|579463562|FG001|Overall Study|Death|1|||
160473676|NCT02659059|579463561|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
160473677|NCT02659059|579463562|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
160473678|NCT02659059|579463561|FG000|Overall Study|Participant request to discontinue study treatment|5|||
160473679|NCT02659059|579463562|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160473680|NCT02659059|579463561|FG000|Overall Study|Participant withdrew consent|6|||
160473681|NCT02659059|579463562|FG001|Overall Study|Participant withdrew consent|1|||
160473682|NCT00092456|579463565|FG000|Overall Study|Adverse Event|0|||
160473683|NCT00092456|579463566|FG001|Overall Study|Adverse Event|0|||
160473684|NCT00092456|579463567|FG002|Overall Study|Adverse Event|1|||
160473685|NCT00092456|579463568|FG003|Overall Study|Adverse Event|1|||
160473686|NCT00092456|579463565|FG000|Overall Study|Lost to Follow-up|2|||
160473687|NCT00092456|579463566|FG001|Overall Study|Lost to Follow-up|2|||
160473688|NCT00092456|579463567|FG002|Overall Study|Lost to Follow-up|1|||
160473689|NCT00092456|579463568|FG003|Overall Study|Lost to Follow-up|2|||
160473690|NCT00092456|579463565|FG000|Overall Study|Protocol Violation|5|||
160473691|NCT00092456|579463566|FG001|Overall Study|Protocol Violation|7|||
160473692|NCT00092456|579463567|FG002|Overall Study|Protocol Violation|8|||
160473693|NCT00092456|579463568|FG003|Overall Study|Protocol Violation|6|||
160473694|NCT00092456|579463565|FG000|Overall Study|Withdrawal by Subject|13|||
160473695|NCT00092456|579463566|FG001|Overall Study|Withdrawal by Subject|5|||
160473696|NCT00092456|579463567|FG002|Overall Study|Withdrawal by Subject|16|||
160473697|NCT00092456|579463568|FG003|Overall Study|Withdrawal by Subject|6|||
160473698|NCT00092456|579463565|FG000|Overall Study|Moved|1|||
160473699|NCT00092456|579463566|FG001|Overall Study|Moved|1|||
160473700|NCT00092456|579463567|FG002|Overall Study|Moved|0|||
160473701|NCT00092456|579463568|FG003|Overall Study|Moved|1|||
160473702|NCT00092456|579463565|FG000|Overall Study|Other|4|||
160473703|NCT00092456|579463566|FG001|Overall Study|Other|2|||
160473704|NCT00092456|579463567|FG002|Overall Study|Other|3|||
160473705|NCT00092456|579463568|FG003|Overall Study|Other|0|||
160473706|NCT00215943|579463569|FG000|Overall Study|Disease Progression|3|||
160473707|NCT00215943|579463570|FG001|Overall Study|Disease Progression|5|||
160473708|NCT00215943|579463569|FG000|Overall Study|Alternate therapy|0|||
160473709|NCT00215943|579463570|FG001|Overall Study|Alternate therapy|1|||
160473710|NCT00215943|579463569|FG000|Overall Study|Adverse Event|3|||
160473711|NCT00215943|579463570|FG001|Overall Study|Adverse Event|6|||
160473712|NCT00215943|579463569|FG000|Overall Study|Other disease|0|||
160473713|NCT00215943|579463570|FG001|Overall Study|Other disease|1|||
160473714|NCT00215943|579463569|FG000|Overall Study|Other complications|3|||
160473715|NCT00215943|579463570|FG001|Overall Study|Other complications|1|||
160473716|NCT00443820|579463571|FG000|Overall Study|Adverse Event|1|||
160473717|NCT00443820|579463572|FG001|Overall Study|Adverse Event|1|||
160473718|NCT00443820|579463573|FG002|Overall Study|Adverse Event|0|||
160473719|NCT00443820|579463574|FG003|Overall Study|Adverse Event|0|||
160473720|NCT00443820|579463571|FG000|Overall Study|Lack of Efficacy|3|||
160473721|NCT00443820|579463572|FG001|Overall Study|Lack of Efficacy|2|||
160473722|NCT00443820|579463573|FG002|Overall Study|Lack of Efficacy|1|||
160473723|NCT00443820|579463574|FG003|Overall Study|Lack of Efficacy|1|||
160473724|NCT00443820|579463571|FG000|Overall Study|Protocol Violation|2|||
160473725|NCT00443820|579463572|FG001|Overall Study|Protocol Violation|1|||
160473726|NCT00443820|579463573|FG002|Overall Study|Protocol Violation|2|||
160473727|NCT00443820|579463574|FG003|Overall Study|Protocol Violation|1|||
160473728|NCT00443820|579463571|FG000|Overall Study|Withdrawal by Subject|6|||
160473729|NCT00443820|579463572|FG001|Overall Study|Withdrawal by Subject|7|||
160473730|NCT00443820|579463573|FG002|Overall Study|Withdrawal by Subject|8|||
160473731|NCT00443820|579463574|FG003|Overall Study|Withdrawal by Subject|9|||
160473732|NCT00443820|579463571|FG000|Overall Study|Lost to Follow-up|9|||
160473733|NCT00443820|579463572|FG001|Overall Study|Lost to Follow-up|8|||
160473734|NCT00443820|579463573|FG002|Overall Study|Lost to Follow-up|6|||
160473735|NCT00443820|579463574|FG003|Overall Study|Lost to Follow-up|5|||
160473736|NCT00443820|579463571|FG000|Overall Study|Administrative problems|0|||
160473737|NCT00443820|579463572|FG001|Overall Study|Administrative problems|0|||
160473738|NCT00443820|579463573|FG002|Overall Study|Administrative problems|0|||
160473739|NCT00443820|579463574|FG003|Overall Study|Administrative problems|1|||
160473740|NCT00443820|579463571|FG000|Overall Study|Death|0|||
160473741|NCT00443820|579463572|FG001|Overall Study|Death|0|||
160473742|NCT00443820|579463573|FG002|Overall Study|Death|1|||
160473743|NCT00443820|579463574|FG003|Overall Study|Death|0|||
160473744|NCT02121808|579463575|FG000|Overall Study|Technical problem|3|||
160473745|NCT03924193|579463576|FG000|Overall Study|Adverse Event|10|||
160473746|NCT03924193|579463577|FG001|Overall Study|Adverse Event|0|||
160473747|NCT03924193|579463578|FG002|Overall Study|Adverse Event|10|||
160473748|NCT03924193|579463576|FG000|Overall Study|Withdrawal by Subject|5|||
160660119|NCT02158936|580136250|FG000|Overall Study|Study closed/ terminated|57|||
160660120|NCT02158936|580136251|FG001|Overall Study|Study closed/ terminated|77|||
160660121|NCT02158936|580136250|FG000|Overall Study|Azacitidine tx discontinued|53|||
160660122|NCT02158936|580136251|FG001|Overall Study|Azacitidine tx discontinued|46|||
160660123|NCT02158936|580136250|FG000|Overall Study|Adverse Event|39|||
160660124|NCT02158936|580136251|FG001|Overall Study|Adverse Event|24|||
160660125|NCT02158936|580136250|FG000|Overall Study|Withdrawal by Subject|15|||
160660126|NCT02158936|580136251|FG001|Overall Study|Withdrawal by Subject|16|||
160660127|NCT02158936|580136250|FG000|Overall Study|Physician Decision|15|||
160660128|NCT02158936|580136251|FG001|Overall Study|Physician Decision|13|||
160660129|NCT02158936|580136250|FG000|Overall Study|Lost to Follow-up|0|||
160660130|NCT02158936|580136251|FG001|Overall Study|Lost to Follow-up|1|||
160660131|NCT00522457|580136252|FG000|Overall Study|Due to disease progression|16|||
160660132|NCT00522457|580136252|FG000|Overall Study|Adverse Event|2|||
160660133|NCT01725529|580137709|FG000|Overall Study|Adverse Event|1|||
160660134|NCT01725529|580137710|FG001|Overall Study|Adverse Event|0|||
160660135|NCT01725529|580137711|FG002|Overall Study|Adverse Event|0|||
160660136|NCT01725529|580137709|FG000|Overall Study|Lost to Follow-up|2|||
160660137|NCT01725529|580137710|FG001|Overall Study|Lost to Follow-up|1|||
160660138|NCT01725529|580137711|FG002|Overall Study|Lost to Follow-up|1|||
160660139|NCT01725529|580137709|FG000|Overall Study|Protocol Violation|0|||
160660140|NCT01725529|580137710|FG001|Overall Study|Protocol Violation|1|||
160660141|NCT01725529|580137711|FG002|Overall Study|Protocol Violation|1|||
160660142|NCT01725529|580137709|FG000|Overall Study|Withdrawal by Subject|12|||
160660143|NCT01725529|580137710|FG001|Overall Study|Withdrawal by Subject|14|||
160660144|NCT01725529|580137711|FG002|Overall Study|Withdrawal by Subject|8|||
160660145|NCT04915755|580137714|FG000|Overall Study|Physician Decision|3|||
160660146|NCT04915755|580137715|FG001|Overall Study|Physician Decision|2|||
160660147|NCT04915755|580137714|FG000|Overall Study|Withdrawal by Subject|1|||
160473749|NCT03924193|579463577|FG001|Overall Study|Withdrawal by Subject|10|||
160473750|NCT03924193|579463578|FG002|Overall Study|Withdrawal by Subject|2|||
160473751|NCT01304940|579463588|FG000|Overall Study|not meet symptom severity requirement|3|||
160473752|NCT01304940|579463589|FG001|Overall Study|not meet symptom severity requirement|0|||
160473753|NCT00278395|579463590|FG000|Overall Study|Adverse Event|2|||
160473754|NCT00278395|579463590|FG000|Overall Study|Nonevaluable|1|||
160473755|NCT03740737|579463591|FG000|Overall Study|Protocol deviation|13|||
160473756|NCT03740737|579463592|FG001|Overall Study|Protocol deviation|0|||
160473757|NCT03740737|579463591|FG000|Overall Study|Adverse Event|2|||
160473758|NCT03740737|579463592|FG001|Overall Study|Adverse Event|0|||
160473759|NCT03740737|579463591|FG000|Overall Study|Lost to Follow-up|1|||
160473760|NCT03740737|579463592|FG001|Overall Study|Lost to Follow-up|0|||
160473761|NCT03740737|579463591|FG000|Overall Study|Randomization failure|1|||
160473762|NCT03740737|579463592|FG001|Overall Study|Randomization failure|0|||
160473763|NCT03740737|579463591|FG000|Overall Study|Participant withdrew consent|1|||
160473764|NCT03740737|579463592|FG001|Overall Study|Participant withdrew consent|0|||
160473765|NCT03740737|579463591|FG000|Overall Study|Participant withdrew from trial|2|||
160473766|NCT03740737|579463592|FG001|Overall Study|Participant withdrew from trial|1|||
160473767|NCT00569166|579463595|FG000|Overall Study|Withdrawal by Subject|7|||
160473768|NCT00569166|579463596|FG001|Overall Study|Withdrawal by Subject|5|||
160473769|NCT00569166|579463597|FG002|Overall Study|Withdrawal by Subject|3|||
160473770|NCT00569166|579463595|FG000|Overall Study|Lost to Follow-up|2|||
160473771|NCT00569166|579463596|FG001|Overall Study|Lost to Follow-up|1|||
160473772|NCT00569166|579463597|FG002|Overall Study|Lost to Follow-up|1|||
160473773|NCT02753075|579463604|FG000|Overall Study|Adverse Event|2|||
160473774|NCT02753075|579463605|FG001|Overall Study|Adverse Event|1|||
160473775|NCT02753075|579463606|FG002|Overall Study|Adverse Event|0|||
160473776|NCT02753075|579463604|FG000|Overall Study|Lost to Follow-up|2|||
160473777|NCT02753075|579463605|FG001|Overall Study|Lost to Follow-up|0|||
160473778|NCT02753075|579463606|FG002|Overall Study|Lost to Follow-up|0|||
160473779|NCT02753075|579463604|FG000|Overall Study|Withdrawal of Consent|1|||
160473780|NCT02753075|579463605|FG001|Overall Study|Withdrawal of Consent|1|||
160473781|NCT02753075|579463606|FG002|Overall Study|Withdrawal of Consent|3|||
160473782|NCT02753075|579463604|FG000|Overall Study|Physician Decision|3|||
160473783|NCT02753075|579463605|FG001|Overall Study|Physician Decision|1|||
160473784|NCT02753075|579463606|FG002|Overall Study|Physician Decision|0|||
160473785|NCT00889863|579463607|FG000|Part I: Open Label|Death|1|||
160473786|NCT00889863|579463608|FG001|Part I: Open Label|Death|0|||
160473787|NCT00889863|579463607|FG000|Part I: Open Label|Adverse Event|4|||
160473788|NCT00889863|579463608|FG001|Part I: Open Label|Adverse Event|0|||
160473789|NCT00889863|579463607|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
160473790|NCT00889863|579463608|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
160473791|NCT00889863|579463607|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
160473792|NCT00889863|579463608|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
160473793|NCT00889863|579463607|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
160473794|NCT00889863|579463608|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
160473795|NCT00889863|579463607|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
160473796|NCT00889863|579463608|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
160473797|NCT00889863|579463607|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
160473798|NCT00889863|579463608|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
160473799|NCT03909100|579463609|FG000|Overall Study|Protocol Deviation|2|||
160473800|NCT03909100|579463609|FG000|Overall Study|Technical Problems|4|||
160473801|NCT03909100|579463609|FG000|Overall Study|Withdrawal by Subject|4|||
160473802|NCT03909100|579463609|FG000|Overall Study|Lost to Follow-up|1|||
160473803|NCT03909100|579463609|FG000|Overall Study|Reason not Specified|4|||
160473804|NCT01794299|579463611|FG000|Overall Study|ATIR manufacturing not possible|1|||
160473805|NCT01794299|579463611|FG000|Overall Study|Death|14|||
160473806|NCT01794299|579463611|FG000|Overall Study|Graft failure|1|||
160473807|NCT01794299|579463611|FG000|Overall Study|ATIR batch rejected|2|||
160473808|NCT01794299|579463611|FG000|Overall Study|Relapse|2|||
160473809|NCT01794299|579463611|FG000|Overall Study|Discontinued from active follow-up|1|||
160473810|NCT01794299|579463611|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
160473811|NCT03006393|579463612|FG000|Overall Study|Withdrawal by Subject|1|||
160473812|NCT03006393|579463613|FG001|Overall Study|Withdrawal by Subject|1|||
160473813|NCT03006393|579463612|FG000|Overall Study|Pregnancy|0|||
160473814|NCT03006393|579463613|FG001|Overall Study|Pregnancy|1|||
160473815|NCT03006393|579463612|FG000|Overall Study|Lost to Follow-up|0|||
160473816|NCT03006393|579463613|FG001|Overall Study|Lost to Follow-up|1|||
160473817|NCT00807599|579463616|FG000|Overall Study|Not treated on protocol study|0|||
160473818|NCT00807599|579463617|FG001|Overall Study|Not treated on protocol study|0|||
160473819|NCT00807599|579463618|FG002|Overall Study|Not treated on protocol study|2|||
160473820|NCT00807599|579463616|FG000|Overall Study|Adverse Event|0|||
160473821|NCT00807599|579463617|FG001|Overall Study|Adverse Event|0|||
160473822|NCT00807599|579463618|FG002|Overall Study|Adverse Event|5|||
160601709|NCT01001234|579918197|FG001|Overall Study|Withdrawal by Subject|0|||
160601710|NCT01001234|579918198|FG002|Overall Study|Withdrawal by Subject|3|||
160473823|NCT00807599|579463616|FG000|Overall Study|Inadequate response to induction|0|||
160473824|NCT00807599|579463617|FG001|Overall Study|Inadequate response to induction|0|||
160473825|NCT00807599|579463618|FG002|Overall Study|Inadequate response to induction|9|||
160473826|NCT00807599|579463616|FG000|Overall Study|Withdrawal by Subject|0|||
160473827|NCT00807599|579463617|FG001|Overall Study|Withdrawal by Subject|0|||
160473828|NCT00807599|579463618|FG002|Overall Study|Withdrawal by Subject|1|||
160473829|NCT03695185|579463619|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
160473830|NCT03695185|579463619|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
160473831|NCT03695185|579463619|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
160473832|NCT03695185|579463619|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
160473833|NCT03695185|579463619|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
160473834|NCT03695185|579463619|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
160473835|NCT01328756|579463623|FG000|Overall Study|Protocol Violation|4|||
160473836|NCT01328756|579463623|FG000|Overall Study|Adverse Event|39|||
160473837|NCT01328756|579463623|FG000|Overall Study|Lack of Efficacy|5|||
160473838|NCT01328756|579463623|FG000|Overall Study|Withdrawal by Subject|41|||
160473839|NCT01328756|579463623|FG000|Overall Study|Lost to Follow-up|5|||
160473840|NCT01328756|579463623|FG000|Overall Study|Other|29|||
160473841|NCT00274287|579463626|FG000|Overall Study|Withdrawal by Subject|1|||
160473842|NCT00274287|579463626|FG000|Overall Study|subject non-compliance|1|||
160473843|NCT04183491|579463630|FG000|Overall Study|Withdrawal by Subject|0|||
160473844|NCT04183491|579463631|FG001|Overall Study|Withdrawal by Subject|0|||
160473845|NCT04183491|579463632|FG002|Overall Study|Withdrawal by Subject|1|||
160473846|NCT04183491|579463633|FG003|Overall Study|Withdrawal by Subject|0|||
160473847|NCT04183491|579463634|FG004|Overall Study|Withdrawal by Subject|0|||
160473848|NCT04183491|579463635|FG005|Overall Study|Withdrawal by Subject|1|||
160473849|NCT04183491|579463636|FG006|Overall Study|Withdrawal by Subject|0|||
160473850|NCT02538094|579463637|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
160473851|NCT02538094|579463638|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
160473852|NCT02538094|579463637|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
160473853|NCT02538094|579463638|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
160473854|NCT03288506|579463639|FG000|Overall Study|Withdrawal by Subject|52|||
160473855|NCT03692871|579463640|FG000|Overall Study|Death|1|||
160473856|NCT03692871|579463641|FG001|Overall Study|Death|1|||
160473857|NCT03692871|579463640|FG000|Overall Study|Lost to Follow-up|24|||
160473858|NCT03692871|579463641|FG001|Overall Study|Lost to Follow-up|9|||
160473859|NCT03692871|579463640|FG000|Overall Study|Physician Decision|22|||
160473860|NCT03692871|579463641|FG001|Overall Study|Physician Decision|7|||
160473861|NCT03692871|579463640|FG000|Overall Study|Protocol Deviation|1|||
160473862|NCT03692871|579463641|FG001|Overall Study|Protocol Deviation|0|||
160473863|NCT03692871|579463640|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
160473864|NCT03692871|579463641|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
160473865|NCT02852824|579463644|FG000|Overall Study|Withdrawal by Subject|1|||
160473866|NCT02852824|579463645|FG001|Overall Study|Withdrawal by Subject|0|||
160473867|NCT02852824|579463646|FG002|Overall Study|Withdrawal by Subject|0|||
160473868|NCT02852824|579463647|FG003|Overall Study|Withdrawal by Subject|0|||
160473869|NCT02852824|579463648|FG004|Overall Study|Withdrawal by Subject|0|||
160473870|NCT02852824|579463649|FG005|Overall Study|Withdrawal by Subject|0|||
160473871|NCT02852824|579463650|FG006|Overall Study|Withdrawal by Subject|0|||
160473872|NCT02852824|579463644|FG000|Overall Study|Adverse Event|0|||
160473873|NCT02852824|579463645|FG001|Overall Study|Adverse Event|0|||
160473874|NCT02852824|579463646|FG002|Overall Study|Adverse Event|0|||
160473875|NCT02852824|579463647|FG003|Overall Study|Adverse Event|0|||
160473876|NCT02852824|579463648|FG004|Overall Study|Adverse Event|2|||
160473877|NCT02852824|579463649|FG005|Overall Study|Adverse Event|0|||
160473878|NCT02852824|579463650|FG006|Overall Study|Adverse Event|0|||
160473879|NCT01316913|579463651|FG000|Overall Study|Adverse Event|17|||
160473880|NCT01316913|579463652|FG001|Overall Study|Adverse Event|20|||
160473881|NCT01316913|579463653|FG002|Overall Study|Adverse Event|15|||
160473882|NCT01316913|579463654|FG003|Overall Study|Adverse Event|11|||
160473883|NCT01316913|579463651|FG000|Overall Study|Lack of Efficacy|22|||
160473884|NCT01316913|579463652|FG001|Overall Study|Lack of Efficacy|12|||
160473885|NCT01316913|579463653|FG002|Overall Study|Lack of Efficacy|9|||
160473886|NCT01316913|579463654|FG003|Overall Study|Lack of Efficacy|13|||
160473887|NCT01316913|579463651|FG000|Overall Study|Protocol Violation|1|||
160473888|NCT01316913|579463652|FG001|Overall Study|Protocol Violation|4|||
160473889|NCT01316913|579463653|FG002|Overall Study|Protocol Violation|4|||
160473890|NCT01316913|579463654|FG003|Overall Study|Protocol Violation|1|||
160473891|NCT01316913|579463651|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
160473892|NCT01316913|579463652|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
160473893|NCT01316913|579463653|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
160473894|NCT01316913|579463654|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
160473895|NCT01316913|579463651|FG000|Overall Study|Lost to Follow-up|0|||
160473896|NCT01316913|579463652|FG001|Overall Study|Lost to Follow-up|1|||
160473897|NCT01316913|579463653|FG002|Overall Study|Lost to Follow-up|0|||
160473898|NCT01316913|579463654|FG003|Overall Study|Lost to Follow-up|2|||
160473899|NCT01316913|579463651|FG000|Overall Study|Withdrawal by Subject|10|||
160473900|NCT01316913|579463652|FG001|Overall Study|Withdrawal by Subject|9|||
160473901|NCT01316913|579463653|FG002|Overall Study|Withdrawal by Subject|10|||
160473902|NCT01316913|579463654|FG003|Overall Study|Withdrawal by Subject|6|||
160473903|NCT01860079|579463655|FG000|Overall Study|Physician Decision|14|||
160473904|NCT01860079|579463656|FG001|Overall Study|Physician Decision|22|||
160473905|NCT02102724|579463657|FG000|Overall Study|Lost to Follow-up|1|||
160473906|NCT02102724|579463658|FG001|Overall Study|Lost to Follow-up|0|||
160601711|NCT01001234|579918199|FG003|Overall Study|Withdrawal by Subject|0|||
160601712|NCT01001234|579918200|FG004|Overall Study|Withdrawal by Subject|0|||
160601713|NCT01001234|579918196|FG000|Overall Study|Protocol Violation|34|||
160601714|NCT01001234|579918197|FG001|Overall Study|Protocol Violation|3|||
160601715|NCT01001234|579918198|FG002|Overall Study|Protocol Violation|19|||
160601716|NCT01001234|579918199|FG003|Overall Study|Protocol Violation|18|||
160601717|NCT01001234|579918200|FG004|Overall Study|Protocol Violation|0|||
160601718|NCT01001234|579918196|FG000|Overall Study|Lost to Follow-up|0|||
160601719|NCT01001234|579918197|FG001|Overall Study|Lost to Follow-up|0|||
160601720|NCT01001234|579918198|FG002|Overall Study|Lost to Follow-up|1|||
160601721|NCT01001234|579918199|FG003|Overall Study|Lost to Follow-up|2|||
160601722|NCT01001234|579918200|FG004|Overall Study|Lost to Follow-up|0|||
160601723|NCT01001234|579918196|FG000|Overall Study|Physician Decision|1|||
160601724|NCT01001234|579918197|FG001|Overall Study|Physician Decision|0|||
160601725|NCT01001234|579918198|FG002|Overall Study|Physician Decision|0|||
160601726|NCT01001234|579918199|FG003|Overall Study|Physician Decision|0|||
160601727|NCT01001234|579918200|FG004|Overall Study|Physician Decision|0|||
160601728|NCT01001234|579918196|FG000|Overall Study|Not Treated: Adverse Event|1|||
160601729|NCT01001234|579918197|FG001|Overall Study|Not Treated: Adverse Event|0|||
160601730|NCT01001234|579918198|FG002|Overall Study|Not Treated: Adverse Event|0|||
160601731|NCT01001234|579918199|FG003|Overall Study|Not Treated: Adverse Event|0|||
160601732|NCT01001234|579918200|FG004|Overall Study|Not Treated: Adverse Event|0|||
160601733|NCT01001234|579918196|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
160601734|NCT01001234|579918197|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
160601735|NCT01001234|579918198|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
160601736|NCT01001234|579918199|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
160601737|NCT01001234|579918200|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
160601738|NCT01001234|579918196|FG000|Overall Study|Not Treated: Protocol Violation|3|||
160601739|NCT01001234|579918197|FG001|Overall Study|Not Treated: Protocol Violation|0|||
160601740|NCT01001234|579918198|FG002|Overall Study|Not Treated: Protocol Violation|0|||
160601741|NCT01001234|579918199|FG003|Overall Study|Not Treated: Protocol Violation|0|||
160601742|NCT01001234|579918200|FG004|Overall Study|Not Treated: Protocol Violation|0|||
160601743|NCT01001234|579918196|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
160601744|NCT01001234|579918197|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
160601745|NCT01001234|579918198|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
160601746|NCT01001234|579918199|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
160601747|NCT01001234|579918200|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
160601748|NCT01001234|579918196|FG000|Overall Study|Not Treated: Pregnancy|3|||
160601749|NCT01001234|579918197|FG001|Overall Study|Not Treated: Pregnancy|0|||
160601750|NCT01001234|579918198|FG002|Overall Study|Not Treated: Pregnancy|0|||
160601751|NCT01001234|579918199|FG003|Overall Study|Not Treated: Pregnancy|0|||
160601752|NCT01001234|579918200|FG004|Overall Study|Not Treated: Pregnancy|0|||
160601753|NCT01001234|579918196|FG000|Overall Study|Not Treated: Physician Decision|37|||
160601754|NCT01001234|579918197|FG001|Overall Study|Not Treated: Physician Decision|4|||
160601755|NCT01001234|579918198|FG002|Overall Study|Not Treated: Physician Decision|0|||
160601756|NCT01001234|579918199|FG003|Overall Study|Not Treated: Physician Decision|0|||
160601757|NCT01001234|579918200|FG004|Overall Study|Not Treated: Physician Decision|0|||
160601758|NCT01001234|579918196|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
160601759|NCT01001234|579918197|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
160601760|NCT01001234|579918198|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
160601761|NCT01001234|579918199|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
160601762|NCT01001234|579918200|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
160601763|NCT01851863|579918202|FG000|Overall Study|Did not receive study medication|2|||
160601764|NCT01851863|579918203|FG001|Overall Study|Did not receive study medication|5|||
160601765|NCT01851863|579918204|FG002|Overall Study|Did not receive study medication|3|||
160601766|NCT01851863|579918205|FG003|Overall Study|Did not receive study medication|0|||
160601767|NCT01851863|579918202|FG000|Overall Study|Lost to Follow-up|3|||
160601768|NCT01851863|579918203|FG001|Overall Study|Lost to Follow-up|4|||
160601769|NCT01851863|579918204|FG002|Overall Study|Lost to Follow-up|2|||
160601770|NCT01851863|579918205|FG003|Overall Study|Lost to Follow-up|3|||
160601771|NCT00753623|579918206|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
160473907|NCT02102724|579463657|FG000|Overall Study|surgery for brain aneurysm|1|||
160473908|NCT02102724|579463658|FG001|Overall Study|surgery for brain aneurysm|1|||
160601772|NCT00753623|579918207|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
160601773|NCT00753623|579918206|FG000|Phase I (14 Days)|Physician Decision|1|||
160601774|NCT00753623|579918207|FG001|Phase I (14 Days)|Physician Decision|2|||
160660148|NCT04915755|580137715|FG001|Overall Study|Withdrawal by Subject|1|||
160660149|NCT04915755|580137714|FG000|Overall Study|Ongoing for PACT|3|||
160473909|NCT02008916|579463659|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
160473910|NCT02008916|579463660|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
160473911|NCT02008916|579463661|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
160473912|NCT02008916|579463659|FG000|Week 16 - 156|Adverse Event|4|||
160473913|NCT02008916|579463660|FG001|Week 16 - 156|Adverse Event|2|||
160473914|NCT02008916|579463661|FG002|Week 16 - 156|Adverse Event|3|||
160473915|NCT02008916|579463659|FG000|Week 16 - 156|Withdrawal by Subject|7|||
160473916|NCT02008916|579463660|FG001|Week 16 - 156|Withdrawal by Subject|3|||
160473917|NCT02008916|579463661|FG002|Week 16 - 156|Withdrawal by Subject|5|||
160473918|NCT02008916|579463659|FG000|Week 16 - 156|No longer requires treatment|0|||
160473919|NCT02008916|579463660|FG001|Week 16 - 156|No longer requires treatment|1|||
160473920|NCT02008916|579463661|FG002|Week 16 - 156|No longer requires treatment|0|||
160473921|NCT02008916|579463659|FG000|Week 16 - 156|Lost to Follow-up|5|||
160473922|NCT02008916|579463660|FG001|Week 16 - 156|Lost to Follow-up|0|||
160473923|NCT02008916|579463661|FG002|Week 16 - 156|Lost to Follow-up|0|||
160473924|NCT02008916|579463659|FG000|Week 16 - 156|Lack of Efficacy|3|||
160473925|NCT02008916|579463660|FG001|Week 16 - 156|Lack of Efficacy|5|||
160473926|NCT02008916|579463661|FG002|Week 16 - 156|Lack of Efficacy|2|||
160473927|NCT02008916|579463659|FG000|Week 16 - 156|Pregnancy|0|||
160473928|NCT02008916|579463660|FG001|Week 16 - 156|Pregnancy|1|||
160473929|NCT02008916|579463661|FG002|Week 16 - 156|Pregnancy|0|||
160473930|NCT02008916|579463659|FG000|Week 16 - 156|Physician Decision|0|||
160473931|NCT02008916|579463660|FG001|Week 16 - 156|Physician Decision|1|||
160473932|NCT02008916|579463661|FG002|Week 16 - 156|Physician Decision|0|||
160473933|NCT03803475|579463662|FG000|Overall Study|Physician Decision|1|||
160473934|NCT02915783|579463670|FG000|Overall Study|Death|21|||
160473935|NCT02915783|579463670|FG000|Overall Study|Lost to Follow-up|1|||
160473936|NCT02915783|579463670|FG000|Overall Study|Withdrawal by Subject|2|||
160473937|NCT02950961|579463671|FG000|Overall Study|Study had to stop due to COVID.|7|||
160473938|NCT01915914|579463672|FG000|Acute Phase|Withdrawal by Subject|4|||
160473939|NCT01915914|579463673|FG001|Acute Phase|Withdrawal by Subject|0|||
160473940|NCT01915914|579463674|FG002|Acute Phase|Withdrawal by Subject|0|||
160473941|NCT01915914|579463675|FG003|Acute Phase|Withdrawal by Subject|0|||
160473942|NCT01915914|579463672|FG000|Acute Phase|Lost to Follow-up|4|||
160473943|NCT01915914|579463673|FG001|Acute Phase|Lost to Follow-up|0|||
160473944|NCT01915914|579463674|FG002|Acute Phase|Lost to Follow-up|0|||
160473945|NCT01915914|579463675|FG003|Acute Phase|Lost to Follow-up|0|||
160473946|NCT01915914|579463672|FG000|Acute Phase|Physician Decision|1|||
160473947|NCT01915914|579463673|FG001|Acute Phase|Physician Decision|0|||
160473948|NCT01915914|579463674|FG002|Acute Phase|Physician Decision|0|||
160473949|NCT01915914|579463675|FG003|Acute Phase|Physician Decision|0|||
160473950|NCT01915914|579463672|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
160473951|NCT01915914|579463673|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
160473952|NCT01915914|579463674|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
160473953|NCT01915914|579463675|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
160473954|NCT01915914|579463672|FG000|Acute Phase|"Not Achieved treatment success"|1|||
160473955|NCT01915914|579463673|FG001|Acute Phase|"Not Achieved treatment success"|0|||
160473956|NCT01915914|579463674|FG002|Acute Phase|"Not Achieved treatment success"|0|||
160473957|NCT01915914|579463675|FG003|Acute Phase|"Not Achieved treatment success"|0|||
160473958|NCT01915914|579463672|FG000|Acute Phase|Missing|1|||
160473959|NCT01915914|579463673|FG001|Acute Phase|Missing|0|||
160473960|NCT01915914|579463674|FG002|Acute Phase|Missing|0|||
160473961|NCT01915914|579463675|FG003|Acute Phase|Missing|0|||
160473962|NCT01915914|579463672|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160473963|NCT01915914|579463673|FG001|Maintenance Phase|Withdrawal by Subject|1|||
160473964|NCT01915914|579463674|FG002|Maintenance Phase|Withdrawal by Subject|1|||
160660150|NCT04915755|580137715|FG001|Overall Study|Ongoing for PACT|2|||
160660151|NCT04915755|580137714|FG000|Overall Study|Other|7|||
160660152|NCT04915755|580137715|FG001|Overall Study|Other|11|||
160473965|NCT01915914|579463675|FG003|Maintenance Phase|Withdrawal by Subject|0|||
160473966|NCT01915914|579463672|FG000|Maintenance Phase|Lost to Follow-up|0|||
160473967|NCT01915914|579463673|FG001|Maintenance Phase|Lost to Follow-up|4|||
160473968|NCT01915914|579463674|FG002|Maintenance Phase|Lost to Follow-up|1|||
160473969|NCT01915914|579463675|FG003|Maintenance Phase|Lost to Follow-up|0|||
160473970|NCT01915914|579463672|FG000|Maintenance Phase|Missing|0|||
160473971|NCT01915914|579463673|FG001|Maintenance Phase|Missing|1|||
160473972|NCT01915914|579463674|FG002|Maintenance Phase|Missing|0|||
160473973|NCT01915914|579463675|FG003|Maintenance Phase|Missing|0|||
160473974|NCT01915914|579463672|FG000|Follow-up Phase|Withdrawal by Subject|0|||
160473975|NCT01915914|579463673|FG001|Follow-up Phase|Withdrawal by Subject|0|||
160473976|NCT01915914|579463674|FG002|Follow-up Phase|Withdrawal by Subject|0|||
160473977|NCT01915914|579463675|FG003|Follow-up Phase|Withdrawal by Subject|1|||
160473978|NCT01915914|579463672|FG000|Follow-up Phase|Physician Decision|0|||
160473979|NCT01915914|579463673|FG001|Follow-up Phase|Physician Decision|0|||
160660153|NCT01710657|580137719|FG000|Overall Study|Lost to Follow-up|2|||
160660154|NCT01710657|580137720|FG001|Overall Study|Lost to Follow-up|0|||
160473980|NCT01915914|579463674|FG002|Follow-up Phase|Physician Decision|0|||
160473981|NCT01915914|579463675|FG003|Follow-up Phase|Physician Decision|1|||
160473982|NCT04197713|579463677|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
160473983|NCT04197713|579463678|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
160473984|NCT05338476|579463688|FG000|Period 2|Adverse Event|0|||
160473985|NCT05338476|579463689|FG001|Period 2|Adverse Event|1|||
160473986|NCT00747149|579465246|FG000|Overall Study|Adverse Event|0|||
160473987|NCT00747149|579465247|FG001|Overall Study|Adverse Event|15|||
160473988|NCT00747149|579465246|FG000|Overall Study|Lost to Follow-up|0|||
160473989|NCT00747149|579465247|FG001|Overall Study|Lost to Follow-up|10|||
160473990|NCT00747149|579465246|FG000|Overall Study|Withdrawal by Subject|0|||
160473991|NCT00747149|579465247|FG001|Overall Study|Withdrawal by Subject|6|||
160473992|NCT00747149|579465246|FG000|Overall Study|Did not receive treatment|0|||
160473993|NCT00747149|579465247|FG001|Overall Study|Did not receive treatment|1|||
160473994|NCT00747149|579465246|FG000|Overall Study|Incorrect enrollment|0|||
160473995|NCT00747149|579465247|FG001|Overall Study|Incorrect enrollment|6|||
160473996|NCT00747149|579465246|FG000|Overall Study|Severe non-compliance to protocol|0|||
160473997|NCT00747149|579465247|FG001|Overall Study|Severe non-compliance to protocol|1|||
160473998|NCT00747149|579465246|FG000|Overall Study|Not reported|1|||
160473999|NCT00747149|579465247|FG001|Overall Study|Not reported|4|||
160474000|NCT05487300|579465252|FG000|Overall Study|Withdrawal by Subject|1|||
160474001|NCT05487300|579465253|FG001|Overall Study|Withdrawal by Subject|0|||
160474002|NCT02507297|579465254|FG000|Overall Study|Withdrawal by Subject|1|||
160474003|NCT02507297|579465255|FG001|Overall Study|Withdrawal by Subject|0|||
160474004|NCT02507297|579465254|FG000|Overall Study|Lost to Follow-up|0|||
160474005|NCT02507297|579465255|FG001|Overall Study|Lost to Follow-up|1|||
160474006|NCT01863368|579465256|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
160474007|NCT01863368|579465257|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
160474008|NCT01863368|579465256|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
160474009|NCT01863368|579465257|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
160474010|NCT01863368|579465256|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
160474011|NCT01863368|579465257|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
160474012|NCT01863368|579465256|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
160474013|NCT01863368|579465257|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
160474014|NCT01863368|579465256|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
160474015|NCT01863368|579465257|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
160474016|NCT01863368|579465256|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
160474017|NCT01863368|579465257|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
160474018|NCT00070707|579465258|FG000|Overall Study|Adverse Event|1|||
160474019|NCT00070707|579465259|FG001|Overall Study|Adverse Event|2|||
160474020|NCT00070707|579465258|FG000|Overall Study|Lack of Efficacy|4|||
160474021|NCT00070707|579465259|FG001|Overall Study|Lack of Efficacy|1|||
160474022|NCT00070707|579465258|FG000|Overall Study|Protocol Violation|8|||
160474023|NCT00070707|579465259|FG001|Overall Study|Protocol Violation|4|||
160474024|NCT00070707|579465258|FG000|Overall Study|Unrelated to Study Medication|1|||
160474025|NCT00070707|579465259|FG001|Overall Study|Unrelated to Study Medication|0|||
160474026|NCT00647699|579465260|FG000|Overall Study|Lost to Follow-up|5|||
160474027|NCT00647699|579465261|FG001|Overall Study|Lost to Follow-up|4|||
160474028|NCT00647699|579465260|FG000|Overall Study|Withdrawal by Subject|3|||
160474029|NCT00647699|579465261|FG001|Overall Study|Withdrawal by Subject|8|||
160474030|NCT02489799|579465262|FG000|Overall Study|Lost to Follow-up|4|||
160474031|NCT02489799|579465263|FG001|Overall Study|Lost to Follow-up|1|||
160474032|NCT02489799|579465262|FG000|Overall Study|Failure to Maintain Eligibility|4|||
160474033|NCT02489799|579465263|FG001|Overall Study|Failure to Maintain Eligibility|6|||
160474034|NCT02489799|579465262|FG000|Overall Study|Withdrawal by Subject|1|||
160474035|NCT02489799|579465263|FG001|Overall Study|Withdrawal by Subject|1|||
160474036|NCT02489799|579465262|FG000|Overall Study|Death|0|||
160474037|NCT02489799|579465263|FG001|Overall Study|Death|1|||
160474038|NCT00515112|579465265|FG000|Overall Study|Death|0|||
160474039|NCT00515112|579465266|FG001|Overall Study|Death|1|||
160601775|NCT00753623|579918206|FG000|Phase I (14 Days)|Adverse Event|0|||
160601776|NCT00753623|579918207|FG001|Phase I (14 Days)|Adverse Event|1|||
160601777|NCT00753623|579918206|FG000|Washout (7 Days)|Physician Decision|1|||
160601778|NCT00753623|579918207|FG001|Washout (7 Days)|Physician Decision|0|||
160601779|NCT00753623|579918206|FG000|Phase II (14 Days)|Physician Decision|0|||
160601780|NCT00753623|579918207|FG001|Phase II (14 Days)|Physician Decision|1|||
160601781|NCT03332303|579918208|FG000|Overall Study|Participant did not dose|1|||
160601782|NCT03332303|579918209|FG001|Overall Study|Participant did not dose|2|||
160601783|NCT03332303|579918210|FG002|Overall Study|Participant did not dose|0|||
160601784|NCT03332303|579918208|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
160474040|NCT00515112|579465265|FG000|Overall Study|The study was terminated|3|||
160474041|NCT00515112|579465266|FG001|Overall Study|The study was terminated|2|||
160474042|NCT01241448|579465267|FG000|Overall Study|Adverse Event|1|||
160660155|NCT01710657|580137721|FG002|Overall Study|Lost to Follow-up|1|||
160474043|NCT01241448|579465268|FG001|Overall Study|Adverse Event|0|||
160632915|NCT02575807|580036107|FG003|Overall Study|Study terminated by Sponsor|0|||
160601785|NCT03332303|579918209|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
160601786|NCT03332303|579918210|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
160601787|NCT03332303|579918208|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
160601788|NCT03332303|579918209|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
160601789|NCT03332303|579918210|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
160601790|NCT03332303|579918208|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
160601791|NCT03332303|579918209|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
160601792|NCT03332303|579918210|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
160601793|NCT03332303|579918208|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
160601794|NCT03332303|579918209|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
160601795|NCT03332303|579918210|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
160601796|NCT03332303|579918208|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
160601797|NCT03332303|579918209|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
160601798|NCT03332303|579918210|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
160601799|NCT03332303|579918208|FG000|Overall Study|Participant had a significant protocol deviation|0|||
160601800|NCT03332303|579918209|FG001|Overall Study|Participant had a significant protocol deviation|1|||
160601801|NCT03332303|579918210|FG002|Overall Study|Participant had a significant protocol deviation|0|||
160601802|NCT01957787|579918211|FG000|Overall Study|Death|18|||
160601803|NCT01957787|579918211|FG000|Overall Study|Lost to Follow-up|3|||
160601804|NCT01957787|579918211|FG000|Overall Study|Withdrawal by Subject|3|||
160601805|NCT01957787|579918211|FG000|Overall Study|Entered Hospice or Similar Program|2|||
160601806|NCT01957787|579918211|FG000|Overall Study|Index Tumor(s) Resected|2|||
160601807|NCT01957787|579918211|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
160601808|NCT01957787|579918211|FG000|Overall Study|Local therapy, not cryoablation|6|||
160601809|NCT02224638|579918215|FG000|Overall Study|Adverse Event|1|||
160601810|NCT02224638|579918216|FG001|Overall Study|Adverse Event|1|||
160601811|NCT01400139|579918222|FG000|HYD Core Study|Adverse Event|210|||
160601812|NCT01400139|579918222|FG000|HYD Core Study|Lack of Efficacy|59|||
160601813|NCT01400139|579918222|FG000|HYD Core Study|Withdrawal by Subject|114|||
160601814|NCT01400139|579918222|FG000|HYD Core Study|Lost to Follow-up|39|||
160601815|NCT01400139|579918222|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
160601816|NCT01400139|579918222|FG000|HYD Core Study|Administrative|56|||
160601817|NCT01400139|579918222|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
160601818|NCT01400139|579918222|FG000|HYD Extension Period|Adverse Event|8|||
160601819|NCT01400139|579918222|FG000|HYD Extension Period|Withdrawal by Subject|5|||
160601820|NCT01400139|579918222|FG000|HYD Extension Period|Administrative|10|||
160601821|NCT00631540|579918223|FG000|Overall Study|Withdrawal by Subject|5|||
160601822|NCT00631540|579918223|FG000|Overall Study|Death|4|||
160601823|NCT00631540|579918223|FG000|Overall Study|Lost to Follow-up|2|||
160601824|NCT00631540|579918223|FG000|Overall Study|Core Lab Data Unavailable|3|||
160601825|NCT00795509|579918224|FG000|Overall Study|Protocol Violation|31|||
160601826|NCT00719953|579918227|FG000|Overall Study|Adverse Event|4|||
160601827|NCT03726333|579918229|FG000|Overall Study|Progressive Disease|0|||
160601828|NCT03726333|579918230|FG001|Overall Study|Progressive Disease|0|||
160601829|NCT03726333|579918231|FG002|Overall Study|Progressive Disease|1|||
160601830|NCT03726333|579918232|FG003|Overall Study|Progressive Disease|0|||
160601831|NCT03726333|579918233|FG004|Overall Study|Progressive Disease|0|||
160601832|NCT01230749|579918234|FG000|Overall Study|Adverse Event|0|||
160601833|NCT01230749|579918235|FG001|Overall Study|Adverse Event|0|||
160601834|NCT01230749|579918236|FG002|Overall Study|Adverse Event|0|||
160601835|NCT01230749|579918237|FG003|Overall Study|Adverse Event|1|||
160601836|NCT01230749|579918234|FG000|Overall Study|Physician Decision|0|||
160601837|NCT01230749|579918235|FG001|Overall Study|Physician Decision|0|||
160601838|NCT01230749|579918236|FG002|Overall Study|Physician Decision|1|||
160601839|NCT01230749|579918237|FG003|Overall Study|Physician Decision|0|||
160601840|NCT01230749|579918234|FG000|Overall Study|Withdrawal by Subject|0|||
160601841|NCT01230749|579918235|FG001|Overall Study|Withdrawal by Subject|1|||
160601842|NCT01230749|579918236|FG002|Overall Study|Withdrawal by Subject|0|||
160601843|NCT01230749|579918237|FG003|Overall Study|Withdrawal by Subject|0|||
160601844|NCT01230749|579918234|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
160601845|NCT01230749|579918235|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
160601846|NCT01230749|579918236|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
160601847|NCT01230749|579918237|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
160601848|NCT01696396|579920104|FG000|Overall Study|Withdrawal by Subject|19|||
160601849|NCT01696396|579920105|FG001|Overall Study|Withdrawal by Subject|5|||
160601850|NCT01696396|579920106|FG002|Overall Study|Withdrawal by Subject|19|||
160601851|NCT01696396|579920107|FG003|Overall Study|Withdrawal by Subject|11|||
160601852|NCT01696396|579920104|FG000|Overall Study|Decision by Sponsor|3|||
160601853|NCT01696396|579920105|FG001|Overall Study|Decision by Sponsor|1|||
160601854|NCT01696396|579920106|FG002|Overall Study|Decision by Sponsor|2|||
160601855|NCT01696396|579920107|FG003|Overall Study|Decision by Sponsor|2|||
160474044|NCT01241448|579465269|FG002|Overall Study|Adverse Event|2|||
160474045|NCT01241448|579465270|FG003|Overall Study|Adverse Event|2|||
160474046|NCT01241448|579465267|FG000|Overall Study|Lost to Follow-up|2|||
160474047|NCT01241448|579465268|FG001|Overall Study|Lost to Follow-up|1|||
160474048|NCT01241448|579465269|FG002|Overall Study|Lost to Follow-up|1|||
160474049|NCT01241448|579465270|FG003|Overall Study|Lost to Follow-up|1|||
160474050|NCT01241448|579465267|FG000|Overall Study|Physician Decision|0|||
160474051|NCT01241448|579465268|FG001|Overall Study|Physician Decision|2|||
160474052|NCT01241448|579465269|FG002|Overall Study|Physician Decision|0|||
160474053|NCT01241448|579465270|FG003|Overall Study|Physician Decision|0|||
160474054|NCT01241448|579465267|FG000|Overall Study|Protocol Violation|10|||
160474055|NCT01241448|579465268|FG001|Overall Study|Protocol Violation|5|||
160474056|NCT01241448|579465269|FG002|Overall Study|Protocol Violation|3|||
160474057|NCT01241448|579465270|FG003|Overall Study|Protocol Violation|6|||
160474058|NCT01241448|579465267|FG000|Overall Study|Sponsor Decision|17|||
160474059|NCT01241448|579465268|FG001|Overall Study|Sponsor Decision|14|||
160474060|NCT01241448|579465269|FG002|Overall Study|Sponsor Decision|12|||
160474061|NCT01241448|579465270|FG003|Overall Study|Sponsor Decision|6|||
160474062|NCT01241448|579465267|FG000|Overall Study|Withdrawal by Subject|4|||
160474063|NCT01241448|579465268|FG001|Overall Study|Withdrawal by Subject|5|||
160474064|NCT01241448|579465269|FG002|Overall Study|Withdrawal by Subject|3|||
160474065|NCT01241448|579465270|FG003|Overall Study|Withdrawal by Subject|6|||
160474066|NCT01241448|579465267|FG000|Overall Study|Excluded due to data integrity issues|3|||
160474067|NCT01241448|579465268|FG001|Overall Study|Excluded due to data integrity issues|2|||
160474068|NCT01241448|579465269|FG002|Overall Study|Excluded due to data integrity issues|2|||
160474069|NCT01241448|579465270|FG003|Overall Study|Excluded due to data integrity issues|2|||
160474070|NCT02065895|579465271|FG000|Overall Study|Protocol Violation|1|||
160474071|NCT02065895|579465272|FG001|Overall Study|Protocol Violation|0|||
160474072|NCT02065895|579465273|FG002|Overall Study|Protocol Violation|0|||
160474073|NCT02065895|579465274|FG003|Overall Study|Protocol Violation|1|||
160474074|NCT02065895|579465275|FG004|Overall Study|Protocol Violation|0|||
160474075|NCT02065895|579465276|FG005|Overall Study|Protocol Violation|0|||
160474076|NCT02065895|579465271|FG000|Overall Study|Scheduling conflicts|0|||
160474077|NCT02065895|579465272|FG001|Overall Study|Scheduling conflicts|1|||
160474078|NCT02065895|579465273|FG002|Overall Study|Scheduling conflicts|0|||
160474079|NCT02065895|579465274|FG003|Overall Study|Scheduling conflicts|0|||
160474080|NCT02065895|579465275|FG004|Overall Study|Scheduling conflicts|0|||
160474081|NCT02065895|579465276|FG005|Overall Study|Scheduling conflicts|0|||
160474082|NCT03340961|579465282|FG000|Overall Study|Adverse Event|1|||
160474083|NCT03340961|579465283|FG001|Overall Study|Adverse Event|3|||
160601856|NCT01696396|579920104|FG000|Overall Study|Lost to Follow-up|9|||
160601857|NCT01696396|579920105|FG001|Overall Study|Lost to Follow-up|1|||
160474084|NCT03340961|579465284|FG002|Overall Study|Adverse Event|2|||
160474085|NCT03340961|579465285|FG003|Overall Study|Adverse Event|4|||
160474086|NCT03340961|579465282|FG000|Overall Study|Lost to Follow-up|0|||
160474087|NCT03340961|579465283|FG001|Overall Study|Lost to Follow-up|1|||
160474088|NCT03340961|579465284|FG002|Overall Study|Lost to Follow-up|0|||
160474089|NCT03340961|579465285|FG003|Overall Study|Lost to Follow-up|1|||
160474090|NCT03340961|579465282|FG000|Overall Study|Withdrawal by Subject|3|||
160474091|NCT03340961|579465283|FG001|Overall Study|Withdrawal by Subject|2|||
160474092|NCT03340961|579465284|FG002|Overall Study|Withdrawal by Subject|4|||
160474093|NCT03340961|579465285|FG003|Overall Study|Withdrawal by Subject|7|||
160474094|NCT03340961|579465282|FG000|Overall Study|Use of prohibited treatment|0|||
160474095|NCT03340961|579465283|FG001|Overall Study|Use of prohibited treatment|3|||
160474096|NCT03340961|579465284|FG002|Overall Study|Use of prohibited treatment|2|||
160474097|NCT03340961|579465285|FG003|Overall Study|Use of prohibited treatment|4|||
160474098|NCT03340961|579465282|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
160474099|NCT03340961|579465283|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
160474100|NCT03340961|579465284|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
160474101|NCT03340961|579465285|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
160474102|NCT03340961|579465282|FG000|Overall Study|Subject developed an exclusion criterion|0|||
160474103|NCT03340961|579465283|FG001|Overall Study|Subject developed an exclusion criterion|1|||
160474104|NCT03340961|579465284|FG002|Overall Study|Subject developed an exclusion criterion|0|||
160474105|NCT03340961|579465285|FG003|Overall Study|Subject developed an exclusion criterion|0|||
160474106|NCT03340961|579465282|FG000|Overall Study|Protocol Violation|1|||
160474107|NCT03340961|579465283|FG001|Overall Study|Protocol Violation|0|||
160474108|NCT03340961|579465284|FG002|Overall Study|Protocol Violation|1|||
160474109|NCT03340961|579465285|FG003|Overall Study|Protocol Violation|0|||
160474110|NCT03340961|579465282|FG000|Overall Study|Adverse Event|1|||
160474111|NCT03340961|579465283|FG001|Overall Study|Adverse Event|1|||
160474112|NCT03340961|579465284|FG002|Overall Study|Adverse Event|0|||
160474113|NCT03340961|579465285|FG003|Overall Study|Adverse Event|0|||
160474114|NCT03340961|579465282|FG000|Overall Study|Lack of Efficacy|0|||
160474115|NCT03340961|579465283|FG001|Overall Study|Lack of Efficacy|0|||
160474116|NCT03340961|579465284|FG002|Overall Study|Lack of Efficacy|0|||
160474117|NCT03340961|579465285|FG003|Overall Study|Lack of Efficacy|1|||
160474118|NCT03137784|579465288|FG000|Overall Study|Adverse Event|1|||
160474119|NCT03137784|579465289|FG001|Overall Study|Adverse Event|1|||
160474120|NCT03137784|579465290|FG002|Overall Study|Adverse Event|0|||
160474121|NCT03137784|579465291|FG003|Overall Study|Adverse Event|0|||
160474122|NCT03137784|579465292|FG004|Overall Study|Adverse Event|0|||
160474123|NCT03137784|579465293|FG005|Overall Study|Adverse Event|0|||
160474124|NCT03137784|579465288|FG000|Overall Study|Subject/guardian decision|1|||
160474125|NCT03137784|579465289|FG001|Overall Study|Subject/guardian decision|0|||
160474126|NCT03137784|579465290|FG002|Overall Study|Subject/guardian decision|0|||
160474127|NCT03137784|579465291|FG003|Overall Study|Subject/guardian decision|0|||
160474128|NCT03137784|579465292|FG004|Overall Study|Subject/guardian decision|0|||
160474129|NCT03137784|579465293|FG005|Overall Study|Subject/guardian decision|0|||
160474130|NCT03137784|579465288|FG000|Overall Study|Non-compliance with study treatment|0|||
160474131|NCT03137784|579465289|FG001|Overall Study|Non-compliance with study treatment|0|||
160474132|NCT03137784|579465290|FG002|Overall Study|Non-compliance with study treatment|0|||
160474133|NCT03137784|579465291|FG003|Overall Study|Non-compliance with study treatment|0|||
160474134|NCT03137784|579465292|FG004|Overall Study|Non-compliance with study treatment|1|||
160474135|NCT03137784|579465293|FG005|Overall Study|Non-compliance with study treatment|0|||
160474136|NCT04803734|579465299|FG000|Overall Study|Withdrawal by Subject|0|||
160474137|NCT04803734|579465300|FG001|Overall Study|Withdrawal by Subject|1|||
160474138|NCT04803734|579465299|FG000|Overall Study|Protocol Violation|0|||
160474139|NCT04803734|579465300|FG001|Overall Study|Protocol Violation|1|||
160474140|NCT02152384|579465308|FG000|Period 1|Withdrawal by Subject|0|||
160474141|NCT02152384|579465309|FG001|Period 1|Withdrawal by Subject|1|||
160474142|NCT02152384|579465308|FG000|Period 1|Adverse Event|1|||
160474143|NCT02152384|579465309|FG001|Period 1|Adverse Event|1|||
160474144|NCT01393600|579465311|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
160474145|NCT01393600|579465312|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
160474146|NCT01393600|579465313|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
160474147|NCT01393600|579465314|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
160474148|NCT01393600|579465311|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
160474149|NCT01393600|579465312|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
160474150|NCT01393600|579465313|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
160474151|NCT01393600|579465314|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
160474152|NCT01393600|579465311|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
160474153|NCT01393600|579465312|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
160474154|NCT01393600|579465313|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
160474155|NCT01393600|579465314|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
160474156|NCT01393600|579465311|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
160474157|NCT01393600|579465312|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
160474158|NCT01393600|579465313|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
160474159|NCT01393600|579465314|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
160474160|NCT01393600|579465311|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
160474161|NCT01393600|579465312|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
160474162|NCT01393600|579465313|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
160474163|NCT01393600|579465314|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
160474164|NCT01393600|579465311|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
160601858|NCT01696396|579920106|FG002|Overall Study|Lost to Follow-up|4|||
160474165|NCT01393600|579465312|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
160474166|NCT01393600|579465313|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
160474167|NCT01393600|579465314|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
160474168|NCT01393600|579465311|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
160474169|NCT01393600|579465312|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
160474170|NCT01393600|579465313|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
160474171|NCT01393600|579465314|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
160474172|NCT00603798|579465315|FG000|Overall Study|Adverse Event|4|||
160474173|NCT00603798|579465316|FG001|Overall Study|Adverse Event|2|||
160474174|NCT00603798|579465317|FG002|Overall Study|Adverse Event|1|||
160474175|NCT00603798|579465315|FG000|Overall Study|Withdrawal by Subject|4|||
160474176|NCT00603798|579465316|FG001|Overall Study|Withdrawal by Subject|3|||
160474177|NCT00603798|579465317|FG002|Overall Study|Withdrawal by Subject|4|||
160474178|NCT00603798|579465315|FG000|Overall Study|Lost to Follow-up|1|||
160474179|NCT00603798|579465316|FG001|Overall Study|Lost to Follow-up|0|||
160474180|NCT00603798|579465317|FG002|Overall Study|Lost to Follow-up|1|||
160474181|NCT00603798|579465315|FG000|Overall Study|Non-compliance with study procedures|0|||
160474182|NCT00603798|579465316|FG001|Overall Study|Non-compliance with study procedures|1|||
160474183|NCT00603798|579465317|FG002|Overall Study|Non-compliance with study procedures|0|||
160474184|NCT00603798|579465315|FG000|Overall Study|Not due to AE|1|||
160474185|NCT00603798|579465316|FG001|Overall Study|Not due to AE|1|||
160474186|NCT00603798|579465317|FG002|Overall Study|Not due to AE|4|||
160474187|NCT02964234|579465323|FG000|Overall Study|Lost to Follow-up|22|||
160474188|NCT02964234|579465324|FG001|Overall Study|Lost to Follow-up|13|||
160474189|NCT01799993|579465325|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
160474190|NCT01799993|579465326|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
160474191|NCT01799993|579465325|FG000|Overall Study|Death|61|||
160474192|NCT01799993|579465326|FG001|Overall Study|Death|45|||
160474193|NCT01799993|579465325|FG000|Overall Study|Withdrawal by Subject|23|||
160474194|NCT01799993|579465326|FG001|Overall Study|Withdrawal by Subject|24|||
160474195|NCT01799993|579465325|FG000|Overall Study|Lost to Follow-up|5|||
160474196|NCT01799993|579465326|FG001|Overall Study|Lost to Follow-up|8|||
160474197|NCT01799993|579465325|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
160474198|NCT01799993|579465326|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
160474199|NCT01799993|579465325|FG000|Overall Study|Protocol driven decision point|0|||
160474200|NCT01799993|579465326|FG001|Overall Study|Protocol driven decision point|3|||
160474201|NCT01799993|579465325|FG000|Overall Study|Protocol Violation|1|||
160474202|NCT01799993|579465326|FG001|Overall Study|Protocol Violation|1|||
160474203|NCT01799993|579465325|FG000|Overall Study|Deterioration of general conditions|2|||
160474204|NCT01799993|579465326|FG001|Overall Study|Deterioration of general conditions|0|||
160474205|NCT01799993|579465325|FG000|Overall Study|Screen failure|0|||
160474206|NCT01799993|579465326|FG001|Overall Study|Screen failure|1|||
160474207|NCT01799993|579465325|FG000|Overall Study|Adverse Event|1|||
160474208|NCT01799993|579465326|FG001|Overall Study|Adverse Event|0|||
160474209|NCT01799993|579465325|FG000|Overall Study|Lack of Efficacy|1|||
160474210|NCT01799993|579465326|FG001|Overall Study|Lack of Efficacy|0|||
160474211|NCT01799993|579465325|FG000|Overall Study|Recovery|0|||
160474212|NCT01799993|579465326|FG001|Overall Study|Recovery|1|||
160474213|NCT01799993|579465325|FG000|Overall Study|Logistical difficulties|1|||
160474214|NCT01799993|579465326|FG001|Overall Study|Logistical difficulties|0|||
160474215|NCT01799993|579465325|FG000|Overall Study|Protocol deviation|1|||
160474216|NCT01799993|579465326|FG001|Overall Study|Protocol deviation|0|||
160474217|NCT01799993|579465325|FG000|Overall Study|Non-compliance with medical device|1|||
160474218|NCT01799993|579465326|FG001|Overall Study|Non-compliance with medical device|0|||
160474219|NCT01799993|579465325|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160474220|NCT01799993|579465326|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160474221|NCT01799993|579465325|FG000|Overall Study|Other|1|||
160474222|NCT01799993|579465326|FG001|Overall Study|Other|0|||
160474223|NCT01799993|579465325|FG000|Overall Study|Subject didn't return for follow-up|0|||
160474224|NCT01799993|579465326|FG001|Overall Study|Subject didn't return for follow-up|1|||
160474225|NCT04361617|579465327|FG000|Overall Study|Withdrawal by Subject|0|||
160474226|NCT04361617|579465328|FG001|Overall Study|Withdrawal by Subject|1|||
160474227|NCT01263223|579465329|FG000|Period 2|Withdrawal by Subject|0|||
160474228|NCT01263223|579465330|FG001|Period 2|Withdrawal by Subject|1|||
160474229|NCT01263223|579465329|FG000|7-day Follow-up|Withdrawal by Subject|0|||
160474230|NCT01263223|579465330|FG001|7-day Follow-up|Withdrawal by Subject|1|||
160601859|NCT01696396|579920107|FG003|Overall Study|Lost to Follow-up|1|||
160474231|NCT01263223|579465329|FG000|7-day Follow-up|Lost to Follow-up|1|||
160474232|NCT01263223|579465330|FG001|7-day Follow-up|Lost to Follow-up|0|||
160474233|NCT02246647|579465331|FG000|Overall Study|Withdrawal by Subject|1|||
160474234|NCT02246647|579465332|FG001|Overall Study|Withdrawal by Subject|1|||
160474235|NCT01113541|579465334|FG000|Overall Study|Withdrawal by Subject|1|||
160474236|NCT01113541|579465334|FG000|Overall Study|Protocol Violation|1|||
160474237|NCT01113541|579465334|FG000|Overall Study|Study Terminated by Sponsor|7|||
160474238|NCT01113541|579465334|FG000|Overall Study|Adverse Event|4|||
160474239|NCT01918033|579465338|FG000|Overall Study|Adverse Event|1|||
160474240|NCT01918033|579465339|FG001|Overall Study|Adverse Event|0|||
160474241|NCT01918033|579465340|FG002|Overall Study|Adverse Event|2|||
160474242|NCT01918033|579465338|FG000|Overall Study|Lost to Follow-up|0|||
160474243|NCT01918033|579465339|FG001|Overall Study|Lost to Follow-up|1|||
160474244|NCT01918033|579465340|FG002|Overall Study|Lost to Follow-up|0|||
160474245|NCT01918033|579465338|FG000|Overall Study|Protocol Violation|2|||
160474246|NCT01918033|579465339|FG001|Overall Study|Protocol Violation|0|||
160474247|NCT01918033|579465340|FG002|Overall Study|Protocol Violation|1|||
160474248|NCT01918033|579465338|FG000|Overall Study|Withdrawal by Subject|2|||
160474249|NCT01918033|579465339|FG001|Overall Study|Withdrawal by Subject|1|||
160474250|NCT01918033|579465340|FG002|Overall Study|Withdrawal by Subject|0|||
160474251|NCT04679675|579465341|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
160474252|NCT04679675|579465342|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
160474253|NCT04679675|579465343|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
160474254|NCT04679675|579465344|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
160474255|NCT04679675|579465341|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
160474256|NCT04679675|579465342|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
160474257|NCT04679675|579465343|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
160474258|NCT04679675|579465344|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
160474259|NCT00687297|579465352|FG000|Randomization|Withdrawal by Subject|2|||
160474260|NCT00687297|579465353|FG001|Randomization|Withdrawal by Subject|0|||
160474261|NCT00687297|579465352|FG000|Randomization|Withdrew before treatment, ineligible|1|||
160474262|NCT00687297|579465353|FG001|Randomization|Withdrew before treatment, ineligible|1|||
160474263|NCT00687297|579465352|FG000|Induction|Withdrawal by Subject|4|||
160474264|NCT00687297|579465353|FG001|Induction|Withdrawal by Subject|4|||
160474265|NCT00687297|579465352|FG000|Induction|Adverse Event|16|||
160474266|NCT00687297|579465353|FG001|Induction|Adverse Event|15|||
160474267|NCT00687297|579465352|FG000|Induction|Death|7|||
160474268|NCT00687297|579465353|FG001|Induction|Death|11|||
160474269|NCT00687297|579465352|FG000|Induction|Lack of Efficacy|17|||
160474270|NCT00687297|579465353|FG001|Induction|Lack of Efficacy|21|||
160474271|NCT00687297|579465352|FG000|Induction|Ineligible|0|||
160474272|NCT00687297|579465353|FG001|Induction|Ineligible|1|||
160474273|NCT00687297|579465352|FG000|Induction|Patient Noncompliance|1|||
160474274|NCT00687297|579465353|FG001|Induction|Patient Noncompliance|0|||
160474275|NCT00687297|579465352|FG000|Induction|Physician Decision|0|||
160474276|NCT00687297|579465353|FG001|Induction|Physician Decision|2|||
160474277|NCT00687297|579465352|FG000|Induction|Other|0|||
160474278|NCT00687297|579465353|FG001|Induction|Other|1|||
160474279|NCT02525744|579465356|FG000|Period 1|Physician Decision|0|||
160474280|NCT02525744|579465357|FG001|Period 1|Physician Decision|0|||
160474281|NCT02525744|579465358|FG002|Period 1|Physician Decision|1|||
160474282|NCT02525744|579465359|FG003|Period 1|Physician Decision|0|||
160474283|NCT02525744|579465356|FG000|Period 3|Adverse Event|0|||
160474284|NCT02525744|579465357|FG001|Period 3|Adverse Event|1|||
160474285|NCT02525744|579465358|FG002|Period 3|Adverse Event|0|||
160474286|NCT02525744|579465359|FG003|Period 3|Adverse Event|0|||
160474287|NCT02525744|579465356|FG000|Period 4|Withdrawal by Subject|1|||
160474288|NCT02525744|579465357|FG001|Period 4|Withdrawal by Subject|0|||
160474289|NCT02525744|579465358|FG002|Period 4|Withdrawal by Subject|0|||
160474290|NCT02525744|579465359|FG003|Period 4|Withdrawal by Subject|0|||
160474291|NCT02525744|579465356|FG000|Period 5|Physician Decision|1|||
160474292|NCT02525744|579465357|FG001|Period 5|Physician Decision|0|||
160474293|NCT02525744|579465358|FG002|Period 5|Physician Decision|0|||
160474294|NCT02525744|579465359|FG003|Period 5|Physician Decision|0|||
160474295|NCT01182285|579465360|FG000|First Intervention Week 1-10|Disease progression|1|||
160474296|NCT01182285|579465361|FG001|First Intervention Week 1-10|Disease progression|0|||
160474297|NCT01182285|579465362|FG002|First Intervention Week 1-10|Disease progression|0|||
160474298|NCT01182285|579465360|FG000|First Intervention Week 1-10|Adverse Event|1|||
160474299|NCT01182285|579465361|FG001|First Intervention Week 1-10|Adverse Event|0|||
160474300|NCT01182285|579465362|FG002|First Intervention Week 1-10|Adverse Event|0|||
160474301|NCT01182285|579465360|FG000|First Intervention Week 1-10|Non-compliance|1|||
160474302|NCT01182285|579465361|FG001|First Intervention Week 1-10|Non-compliance|0|||
160474303|NCT01182285|579465362|FG002|First Intervention Week 1-10|Non-compliance|0|||
160474304|NCT01182285|579465360|FG000|Third Intervention Week 11-52|Disease Progression|0|||
160660156|NCT01710657|580137719|FG000|Overall Study|Protocol Violation|2|||
160660157|NCT01710657|580137720|FG001|Overall Study|Protocol Violation|2|||
160474305|NCT01182285|579465361|FG001|Third Intervention Week 11-52|Disease Progression|0|||
160474306|NCT01182285|579465362|FG002|Third Intervention Week 11-52|Disease Progression|6|||
160474307|NCT01182285|579465360|FG000|Third Intervention Week 11-52|Other|0|||
160474308|NCT01182285|579465361|FG001|Third Intervention Week 11-52|Other|0|||
160474309|NCT01182285|579465362|FG002|Third Intervention Week 11-52|Other|2|||
160474310|NCT00472082|579465363|FG000|Overall Study|Study prematurely terminated|5|||
160474311|NCT02069379|579465364|FG000|Baseline Measurements|Lost to Follow-up|1|||
160660158|NCT01710657|580137721|FG002|Overall Study|Protocol Violation|0|||
160660159|NCT01710657|580137719|FG000|Overall Study|Adverse Event|14|||
160660160|NCT01710657|580137720|FG001|Overall Study|Adverse Event|8|||
160660161|NCT01710657|580137721|FG002|Overall Study|Adverse Event|28|||
160660162|NCT01710657|580137719|FG000|Overall Study|Withdrawal by Subject|0|||
160660163|NCT01710657|580137720|FG001|Overall Study|Withdrawal by Subject|1|||
160660164|NCT01710657|580137721|FG002|Overall Study|Withdrawal by Subject|2|||
160660165|NCT01710657|580137719|FG000|Overall Study|Lack of Efficacy|0|||
160660166|NCT01710657|580137720|FG001|Overall Study|Lack of Efficacy|1|||
160660167|NCT01710657|580137721|FG002|Overall Study|Lack of Efficacy|1|||
160660168|NCT02495857|580137727|FG000|Overall Study|Adverse Event|5|||
160660169|NCT02495857|580137728|FG001|Overall Study|Adverse Event|0|||
160660170|NCT02495857|580137729|FG002|Overall Study|Adverse Event|1|||
160660171|NCT02495857|580137727|FG000|Overall Study|Withdrawal by Subject|9|||
160660172|NCT02495857|580137728|FG001|Overall Study|Withdrawal by Subject|6|||
160601860|NCT01696396|579920104|FG000|Overall Study|Death|0|||
160601861|NCT01696396|579920105|FG001|Overall Study|Death|0|||
160601862|NCT01696396|579920106|FG002|Overall Study|Death|1|||
160601863|NCT01696396|579920107|FG003|Overall Study|Death|0|||
160601864|NCT01280812|579920114|FG000|Overall Study|Withdrawal by Subject|2|||
160601865|NCT01280812|579920115|FG001|Overall Study|Withdrawal by Subject|1|||
160601866|NCT01280812|579920116|FG002|Overall Study|Withdrawal by Subject|0|||
160601867|NCT01280812|579920114|FG000|Overall Study|Lost to Follow-up|1|||
160601868|NCT01280812|579920115|FG001|Overall Study|Lost to Follow-up|1|||
160601869|NCT01280812|579920116|FG002|Overall Study|Lost to Follow-up|1|||
160601870|NCT00959894|579920122|FG000|Overall Study|Lost to Follow-up|10|||
160660173|NCT02495857|580137729|FG002|Overall Study|Withdrawal by Subject|10|||
160660174|NCT02495857|580137727|FG000|Overall Study|Physician Decision|0|||
160660175|NCT02495857|580137728|FG001|Overall Study|Physician Decision|1|||
160660176|NCT02495857|580137729|FG002|Overall Study|Physician Decision|0|||
160660177|NCT02495857|580137727|FG000|Overall Study|Protocol Violation|1|||
160660178|NCT02495857|580137728|FG001|Overall Study|Protocol Violation|1|||
160660179|NCT02495857|580137729|FG002|Overall Study|Protocol Violation|2|||
160660180|NCT02495857|580137727|FG000|Overall Study|Lost to Follow-up|4|||
160660181|NCT02495857|580137728|FG001|Overall Study|Lost to Follow-up|5|||
160660182|NCT02495857|580137729|FG002|Overall Study|Lost to Follow-up|3|||
160660183|NCT02495857|580137727|FG000|Overall Study|Other|3|||
160474312|NCT02069379|579465365|FG001|Baseline Measurements|Lost to Follow-up|0|||
160601871|NCT00959894|579920122|FG000|Overall Study|Adverse Event|3|||
160601872|NCT00959894|579920122|FG000|Overall Study|Withdrawal by Subject|1|||
160601873|NCT00959894|579920122|FG000|Overall Study|Need for contraindicated medication|1|||
160601874|NCT00959894|579920122|FG000|Overall Study|Subject moved out of town|1|||
160601875|NCT00922974|579920123|FG000|Phase II Component|Protocol Violation|2|||
160601876|NCT00922974|579920124|FG001|Phase II Component|Protocol Violation|0|||
160601877|NCT00922974|579920123|FG000|Phase II Component|Not evaluable for treatment review|5|||
160601878|NCT00922974|579920124|FG001|Phase II Component|Not evaluable for treatment review|0|||
160601879|NCT00922974|579920123|FG000|Phase III Component|Protocol Violation|8|||
160601880|NCT00922974|579920124|FG001|Phase III Component|Protocol Violation|6|||
160601881|NCT03682055|579920125|FG000|Overall Study|Lack of Efficacy|1|||
160601882|NCT03682055|579920126|FG001|Overall Study|Lack of Efficacy|2|||
160601883|NCT03682055|579920127|FG002|Overall Study|Lack of Efficacy|1|||
160601884|NCT03682055|579920128|FG003|Overall Study|Lack of Efficacy|2|||
160601885|NCT03682055|579920129|FG004|Overall Study|Lack of Efficacy|1|||
160601886|NCT03682055|579920130|FG005|Overall Study|Lack of Efficacy|3|||
160474313|NCT02069379|579465366|FG002|Baseline Measurements|Lost to Follow-up|0|||
160474314|NCT02069379|579465367|FG003|Baseline Measurements|Lost to Follow-up|0|||
160474315|NCT02069379|579465364|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
160474316|NCT02069379|579465365|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
160474317|NCT02069379|579465366|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
160474318|NCT02069379|579465367|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
160474319|NCT02069379|579465364|FG000|First Treatment Arm|Lost to Follow-up|0|||
160474320|NCT02069379|579465365|FG001|First Treatment Arm|Lost to Follow-up|1|||
160474321|NCT02069379|579465366|FG002|First Treatment Arm|Lost to Follow-up|1|||
160601887|NCT03682055|579920125|FG000|Overall Study|Withdrawal by Subject|0|||
160601888|NCT03682055|579920126|FG001|Overall Study|Withdrawal by Subject|0|||
160601889|NCT03682055|579920127|FG002|Overall Study|Withdrawal by Subject|0|||
160601890|NCT03682055|579920128|FG003|Overall Study|Withdrawal by Subject|0|||
160660184|NCT02495857|580137728|FG001|Overall Study|Other|3|||
160660185|NCT02495857|580137729|FG002|Overall Study|Other|2|||
160601891|NCT03682055|579920129|FG004|Overall Study|Withdrawal by Subject|0|||
160601892|NCT03682055|579920130|FG005|Overall Study|Withdrawal by Subject|1|||
160601893|NCT03682055|579920125|FG000|Overall Study|Termination of Study by Sponsor|0|||
160601894|NCT03682055|579920126|FG001|Overall Study|Termination of Study by Sponsor|0|||
160601895|NCT03682055|579920127|FG002|Overall Study|Termination of Study by Sponsor|0|||
160660186|NCT04407806|580137734|FG000|Overall Study|Withdrawal by Subject|1|||
160660187|NCT04407806|580137735|FG001|Overall Study|Withdrawal by Subject|2|||
160660188|NCT03447262|580137736|FG000|Overall Study|Adverse Event|7|||
160660189|NCT03447262|580137736|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
160601896|NCT03682055|579920128|FG003|Overall Study|Termination of Study by Sponsor|0|||
160601897|NCT03682055|579920129|FG004|Overall Study|Termination of Study by Sponsor|0|||
160601898|NCT03682055|579920130|FG005|Overall Study|Termination of Study by Sponsor|3|||
160601899|NCT00191386|579920131|FG000|Overall Study|Adverse Event|16|||
160601900|NCT00191386|579920131|FG000|Overall Study|Lost to Follow-up|1|||
160601901|NCT00191386|579920131|FG000|Overall Study|Entry Criteria Exclusion|3|||
160601902|NCT00191386|579920131|FG000|Overall Study|Protocol Violation|18|||
160601903|NCT00191386|579920131|FG000|Overall Study|Withdrawal by Subject|96|||
160601904|NCT00191386|579920131|FG000|Overall Study|Physician Decision|11|||
160601905|NCT00191386|579920131|FG000|Overall Study|Lack of Efficacy|15|||
160601906|NCT03077243|579920132|FG000|Overall Study|Death|1|||
160601907|NCT03077243|579920133|FG001|Overall Study|Death|2|||
160601908|NCT03077243|579920134|FG002|Overall Study|Death|0|||
160601909|NCT03077243|579920135|FG003|Overall Study|Death|0|||
160474322|NCT02069379|579465367|FG003|First Treatment Arm|Lost to Follow-up|0|||
160474323|NCT02069379|579465364|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
160474324|NCT02069379|579465365|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
160474325|NCT02069379|579465366|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
160474326|NCT02069379|579465367|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
160474327|NCT02069379|579465364|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
160474328|NCT02069379|579465365|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
160474329|NCT02069379|579465366|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
160474330|NCT02069379|579465367|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
160474331|NCT02069379|579465364|FG000|Second Treatment Arm|Lost to Follow-up|0|||
160474332|NCT02069379|579465365|FG001|Second Treatment Arm|Lost to Follow-up|0|||
160474333|NCT02069379|579465366|FG002|Second Treatment Arm|Lost to Follow-up|1|||
160474334|NCT02069379|579465367|FG003|Second Treatment Arm|Lost to Follow-up|0|||
160474335|NCT04617847|579465370|FG000|Overall Study|Withdrawal by Subject|1|||
160474336|NCT04617847|579465371|FG001|Overall Study|Withdrawal by Subject|0|||
160474337|NCT04617847|579465370|FG000|Overall Study|Adverse Event|0|||
160474338|NCT04617847|579465371|FG001|Overall Study|Adverse Event|2|||
160474339|NCT04617847|579465370|FG000|Overall Study|Death|0|||
160474340|NCT04617847|579465371|FG001|Overall Study|Death|1|||
160474341|NCT04617847|579465370|FG000|Overall Study|Termination of Study by Sponsor|2|||
160474342|NCT04617847|579465371|FG001|Overall Study|Termination of Study by Sponsor|21|||
160474343|NCT01525875|579465372|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
160474344|NCT01525875|579465373|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
160474345|NCT01525875|579465372|FG000|Open-label Period|Lost to Follow-up|0|||
160474346|NCT01525875|579465373|FG001|Open-label Period|Lost to Follow-up|2|||
160474347|NCT00700999|579465374|FG000|Overall Study|Lost to Follow-up|7|||
160474348|NCT00700999|579465375|FG001|Overall Study|Lost to Follow-up|7|||
160474349|NCT00700999|579465374|FG000|Overall Study|Excluded - did not meet study criteria|0|||
160474350|NCT00700999|579465375|FG001|Overall Study|Excluded - did not meet study criteria|1|||
160474351|NCT00700999|579465374|FG000|Overall Study|Withdrawal by Subject|8|||
160474352|NCT00700999|579465375|FG001|Overall Study|Withdrawal by Subject|1|||
160474353|NCT00244751|579465376|FG000|Overall Study|Adverse Event|7|||
160474354|NCT00244751|579465377|FG001|Overall Study|Adverse Event|7|||
160474355|NCT00244751|579465378|FG002|Overall Study|Adverse Event|5|||
160474356|NCT00244751|579465376|FG000|Overall Study|Lost to Follow-up|0|||
160474357|NCT00244751|579465377|FG001|Overall Study|Lost to Follow-up|1|||
160474358|NCT00244751|579465378|FG002|Overall Study|Lost to Follow-up|0|||
160474359|NCT00244751|579465376|FG000|Overall Study|Protocol Violation|1|||
160474360|NCT00244751|579465377|FG001|Overall Study|Protocol Violation|0|||
160474361|NCT00244751|579465378|FG002|Overall Study|Protocol Violation|1|||
160474362|NCT00244751|579465376|FG000|Overall Study|Withdrawal by Subject|7|||
160474363|NCT00244751|579465377|FG001|Overall Study|Withdrawal by Subject|5|||
160474364|NCT00244751|579465378|FG002|Overall Study|Withdrawal by Subject|3|||
160474365|NCT00244751|579465376|FG000|Overall Study|Elevated liver enzymes|1|||
160474366|NCT00244751|579465377|FG001|Overall Study|Elevated liver enzymes|0|||
160474367|NCT00244751|579465378|FG002|Overall Study|Elevated liver enzymes|0|||
160474368|NCT00244751|579465376|FG000|Overall Study|Lack of compliance with protocol|0|||
160474369|NCT00244751|579465377|FG001|Overall Study|Lack of compliance with protocol|1|||
160474370|NCT00244751|579465378|FG002|Overall Study|Lack of compliance with protocol|0|||
160474371|NCT00244751|579465376|FG000|Overall Study|Safety reasons|0|||
160474372|NCT00244751|579465377|FG001|Overall Study|Safety reasons|1|||
160474373|NCT00244751|579465378|FG002|Overall Study|Safety reasons|0|||
160474374|NCT00244751|579465376|FG000|Overall Study|Participant randomized by mistake|0|||
160474375|NCT00244751|579465377|FG001|Overall Study|Participant randomized by mistake|0|||
160474376|NCT00244751|579465378|FG002|Overall Study|Participant randomized by mistake|1|||
160474377|NCT03031782|579465382|FG000|Treatment Period 1|Lack of Efficacy|3|||
160474378|NCT03031782|579465383|FG001|Treatment Period 1|Lack of Efficacy|0|||
160474379|NCT03031782|579465384|FG002|Treatment Period 1|Lack of Efficacy|0|||
160474380|NCT03031782|579465385|FG003|Treatment Period 1|Lack of Efficacy|0|||
160474381|NCT03031782|579465386|FG004|Treatment Period 1|Lack of Efficacy|0|||
160474382|NCT03031782|579465382|FG000|Treatment Period 2|Physician Decision|0|||
160474383|NCT03031782|579465383|FG001|Treatment Period 2|Physician Decision|1|||
160474384|NCT03031782|579465384|FG002|Treatment Period 2|Physician Decision|0|||
160474385|NCT03031782|579465385|FG003|Treatment Period 2|Physician Decision|0|||
160474386|NCT03031782|579465386|FG004|Treatment Period 2|Physician Decision|3|||
160474387|NCT03031782|579465382|FG000|Treatment Period 2|Lack of Efficacy|0|||
160474388|NCT03031782|579465383|FG001|Treatment Period 2|Lack of Efficacy|1|||
160474389|NCT03031782|579465384|FG002|Treatment Period 2|Lack of Efficacy|0|||
160474390|NCT03031782|579465385|FG003|Treatment Period 2|Lack of Efficacy|0|||
160474391|NCT03031782|579465386|FG004|Treatment Period 2|Lack of Efficacy|1|||
160474392|NCT03031782|579465382|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160474393|NCT03031782|579465383|FG001|Treatment Period 2|Withdrawal by Subject|3|||
160474394|NCT03031782|579465384|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160474395|NCT03031782|579465385|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160474396|NCT03031782|579465386|FG004|Treatment Period 2|Withdrawal by Subject|1|||
160474397|NCT03031782|579465382|FG000|Treatment Period 2|Adverse Event|0|||
160474398|NCT03031782|579465383|FG001|Treatment Period 2|Adverse Event|1|||
160474399|NCT03031782|579465384|FG002|Treatment Period 2|Adverse Event|2|||
160474400|NCT03031782|579465385|FG003|Treatment Period 2|Adverse Event|0|||
160474401|NCT03031782|579465386|FG004|Treatment Period 2|Adverse Event|0|||
160474402|NCT03031782|579465382|FG000|Treatment Period 3|Withdrawal by Subject|0|||
160474403|NCT03031782|579465383|FG001|Treatment Period 3|Withdrawal by Subject|0|||
160474404|NCT03031782|579465384|FG002|Treatment Period 3|Withdrawal by Subject|0|||
160474405|NCT03031782|579465385|FG003|Treatment Period 3|Withdrawal by Subject|1|||
160474406|NCT03031782|579465386|FG004|Treatment Period 3|Withdrawal by Subject|0|||
160474407|NCT04867382|579465389|FG000|Overall Study|Did not complete the survey|2|||
160474408|NCT04867382|579465390|FG001|Overall Study|Did not complete the survey|1|||
160474409|NCT05445557|579465391|FG000|Double Blind Part|Lost to Follow-up|1|||
160474410|NCT01323790|579465392|FG000|Overall Study|Other|3|||
160474411|NCT01323790|579465393|FG001|Overall Study|Other|2|||
160474412|NCT01323790|579465394|FG002|Overall Study|Other|1|||
160474413|NCT01323790|579465392|FG000|Overall Study|Lost to Follow-up|11|||
160474414|NCT01323790|579465393|FG001|Overall Study|Lost to Follow-up|9|||
160474415|NCT01323790|579465394|FG002|Overall Study|Lost to Follow-up|9|||
160474416|NCT01323790|579465392|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
160474417|NCT01323790|579465393|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
160474418|NCT01323790|579465394|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
160474419|NCT01323790|579465392|FG000|Overall Study|Lack of Efficacy|3|||
160474420|NCT01323790|579465393|FG001|Overall Study|Lack of Efficacy|0|||
160474421|NCT01323790|579465394|FG002|Overall Study|Lack of Efficacy|3|||
160474422|NCT01323790|579465392|FG000|Overall Study|Adverse Event|11|||
160474423|NCT01323790|579465393|FG001|Overall Study|Adverse Event|24|||
160474424|NCT01323790|579465394|FG002|Overall Study|Adverse Event|12|||
160474425|NCT01323790|579465392|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
160474426|NCT01323790|579465393|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
160474427|NCT01323790|579465394|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
160474428|NCT01323790|579465392|FG000|Overall Study|Withdrawal by Subject|23|||
160474429|NCT01323790|579465393|FG001|Overall Study|Withdrawal by Subject|20|||
160474430|NCT01323790|579465394|FG002|Overall Study|Withdrawal by Subject|13|||
160474431|NCT01323790|579465392|FG000|Overall Study|Did Not Receive Treatment|2|||
160474432|NCT01323790|579465393|FG001|Overall Study|Did Not Receive Treatment|0|||
160474433|NCT01323790|579465394|FG002|Overall Study|Did Not Receive Treatment|1|||
160474434|NCT01323790|579465392|FG000|Overall Study|Severe non-compliance with protocol|2|||
160474435|NCT01323790|579465393|FG001|Overall Study|Severe non-compliance with protocol|2|||
160474436|NCT01323790|579465394|FG002|Overall Study|Severe non-compliance with protocol|2|||
160474437|NCT02432274|579465395|FG000|Overall Study|Death|2|||
160474438|NCT02432274|579465396|FG001|Overall Study|Death|6|||
160474439|NCT02432274|579465397|FG002|Overall Study|Death|7|||
160474440|NCT02432274|579465398|FG003|Overall Study|Death|0|||
160474441|NCT02432274|579465399|FG004|Overall Study|Death|27|||
160474442|NCT02432274|579465400|FG005|Overall Study|Death|7|||
160474443|NCT02432274|579465401|FG006|Overall Study|Death|9|||
160474444|NCT02432274|579465402|FG007|Overall Study|Death|14|||
160474445|NCT02432274|579465395|FG000|Overall Study|Withdrawal of Consent|0|||
160474446|NCT02432274|579465396|FG001|Overall Study|Withdrawal of Consent|0|||
160474447|NCT02432274|579465397|FG002|Overall Study|Withdrawal of Consent|0|||
160474448|NCT02432274|579465398|FG003|Overall Study|Withdrawal of Consent|0|||
160474449|NCT02432274|579465399|FG004|Overall Study|Withdrawal of Consent|2|||
160474450|NCT02432274|579465400|FG005|Overall Study|Withdrawal of Consent|0|||
160474451|NCT02432274|579465401|FG006|Overall Study|Withdrawal of Consent|1|||
160601910|NCT03077243|579920132|FG000|Overall Study|Withdrawal by Subject|1|||
160601911|NCT03077243|579920133|FG001|Overall Study|Withdrawal by Subject|3|||
160601912|NCT03077243|579920134|FG002|Overall Study|Withdrawal by Subject|0|||
160601913|NCT03077243|579920135|FG003|Overall Study|Withdrawal by Subject|0|||
160601914|NCT03077243|579920132|FG000|Overall Study|Physician Decision|1|||
160601915|NCT03077243|579920133|FG001|Overall Study|Physician Decision|0|||
160601916|NCT03077243|579920134|FG002|Overall Study|Physician Decision|0|||
160601917|NCT03077243|579920135|FG003|Overall Study|Physician Decision|0|||
160601918|NCT03077243|579920132|FG000|Overall Study|Research at two study sites terminated early|0|||
160601919|NCT03077243|579920133|FG001|Overall Study|Research at two study sites terminated early|0|||
160474452|NCT02432274|579465402|FG007|Overall Study|Withdrawal of Consent|2|||
160474453|NCT01736475|579465403|FG000|Overall Study|Adverse Event|4|||
160474454|NCT01736475|579465404|FG001|Overall Study|Adverse Event|0|||
160474455|NCT01736475|579465403|FG000|Overall Study|Withdrawal by Subject|2|||
160474456|NCT01736475|579465404|FG001|Overall Study|Withdrawal by Subject|0|||
160474457|NCT01736475|579465403|FG000|Overall Study|Protocol Violation|4|||
160474458|NCT01736475|579465404|FG001|Overall Study|Protocol Violation|0|||
160474459|NCT01736475|579465403|FG000|Overall Study|Other - Screen failure|1|||
160474460|NCT01736475|579465404|FG001|Overall Study|Other - Screen failure|0|||
160474461|NCT01736475|579465403|FG000|Overall Study|Other - Surgical procedure|1|||
160601920|NCT03077243|579920134|FG002|Overall Study|Research at two study sites terminated early|0|||
160601921|NCT03077243|579920135|FG003|Overall Study|Research at two study sites terminated early|69|||
160474462|NCT01736475|579465404|FG001|Overall Study|Other - Surgical procedure|0|||
160474463|NCT02114515|579465406|FG000|Overall Study|Lost to Follow-up|52|||
160474464|NCT02114515|579465407|FG001|Overall Study|Lost to Follow-up|55|||
160474465|NCT02114515|579465406|FG000|Overall Study|Death|12|||
160474466|NCT02114515|579465407|FG001|Overall Study|Death|12|||
160474467|NCT02114515|579465406|FG000|Overall Study|Withdrawal by Subject|4|||
160474468|NCT02114515|579465407|FG001|Overall Study|Withdrawal by Subject|22|||
160474469|NCT02114515|579465406|FG000|Overall Study|Other|65|||
160474470|NCT02114515|579465407|FG001|Overall Study|Other|61|||
160474471|NCT02144285|579465408|FG000|Overall Study|Withdrawal by Subject|0|||
160474472|NCT02144285|579465409|FG001|Overall Study|Withdrawal by Subject|0|||
160474473|NCT02144285|579465410|FG002|Overall Study|Withdrawal by Subject|0|||
160474474|NCT02144285|579465411|FG003|Overall Study|Withdrawal by Subject|0|||
160474475|NCT02144285|579465412|FG004|Overall Study|Withdrawal by Subject|1|||
160474476|NCT02144285|579465413|FG005|Overall Study|Withdrawal by Subject|0|||
160474477|NCT02144285|579465414|FG006|Overall Study|Withdrawal by Subject|0|||
160474478|NCT02144285|579465415|FG007|Overall Study|Withdrawal by Subject|0|||
160474479|NCT02144285|579465416|FG008|Overall Study|Withdrawal by Subject|0|||
160474480|NCT02144285|579465417|FG009|Overall Study|Withdrawal by Subject|0|||
160474481|NCT01529632|579465418|FG000|Overall Study|Administrative problem|2|||
160474482|NCT01529632|579465419|FG001|Overall Study|Administrative problem|1|||
160601922|NCT01544478|579920136|FG000|Overall Study|Adverse Event|1|||
160601923|NCT01544478|579920136|FG000|Overall Study|Death|1|||
160601924|NCT01544478|579920136|FG000|Overall Study|Lost to Follow-up|48|||
160601925|NCT01544478|579920136|FG000|Overall Study|Physician Decision|15|||
160474483|NCT01529632|579465418|FG000|Overall Study|Protocol Violation|0|||
160474484|NCT01529632|579465419|FG001|Overall Study|Protocol Violation|1|||
160474485|NCT01529632|579465418|FG000|Overall Study|Adverse Event|1|||
160474486|NCT01529632|579465419|FG001|Overall Study|Adverse Event|1|||
160474487|NCT05184062|579465421|FG000|Overall Study|Lost to Follow-up|5|||
160474488|NCT05184062|579465422|FG001|Overall Study|Lost to Follow-up|1|||
160474489|NCT05184062|579465421|FG000|Overall Study|Withdrawal by Subject|1|||
160474490|NCT05184062|579465422|FG001|Overall Study|Withdrawal by Subject|0|||
160474491|NCT05522777|579466939|FG000|Overall Study|Lack of Efficacy|1|||
160474492|NCT05522777|579466939|FG000|Overall Study|Withdrawal by Subject|1|||
160474493|NCT04914897|579466942|FG000|Overall Study|Withdrawal by Subject|3|||
160474494|NCT04914897|579466943|FG001|Overall Study|Withdrawal by Subject|1|||
160474495|NCT04914897|579466944|FG002|Overall Study|Withdrawal by Subject|1|||
160474496|NCT04914897|579466945|FG003|Overall Study|Withdrawal by Subject|1|||
160474497|NCT04914897|579466942|FG000|Overall Study|Poor compliance to protocol|0|||
160474498|NCT04914897|579466943|FG001|Overall Study|Poor compliance to protocol|0|||
160474499|NCT04914897|579466944|FG002|Overall Study|Poor compliance to protocol|1|||
160474500|NCT04914897|579466945|FG003|Overall Study|Poor compliance to protocol|0|||
160474501|NCT04914897|579466942|FG000|Overall Study|Progressive disease|5|||
160474502|NCT04914897|579466943|FG001|Overall Study|Progressive disease|14|||
160474503|NCT04914897|579466944|FG002|Overall Study|Progressive disease|30|||
160474504|NCT04914897|579466945|FG003|Overall Study|Progressive disease|21|||
160474505|NCT04914897|579466942|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
160474506|NCT04914897|579466943|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
160474507|NCT04914897|579466944|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
160474508|NCT04914897|579466945|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
160474509|NCT04914897|579466942|FG000|Overall Study|Other|1|||
160474510|NCT04914897|579466943|FG001|Overall Study|Other|0|||
160474511|NCT04914897|579466944|FG002|Overall Study|Other|0|||
160474512|NCT04914897|579466945|FG003|Overall Study|Other|1|||
160474513|NCT04783389|579466955|FG000|Overall Study|Withdrawal by Subject|2|||
160474514|NCT04783389|579466956|FG001|Overall Study|Withdrawal by Subject|0|||
160474515|NCT04783389|579466957|FG002|Overall Study|Withdrawal by Subject|0|||
160474516|NCT04783389|579466955|FG000|Overall Study|Termination of Study by Sponsor|10|||
160474517|NCT04783389|579466956|FG001|Overall Study|Termination of Study by Sponsor|12|||
160474518|NCT04783389|579466957|FG002|Overall Study|Termination of Study by Sponsor|14|||
160601926|NCT01544478|579920136|FG000|Overall Study|Pregnancy|1|||
160474519|NCT02164578|579466959|FG000|Treatment Period|Withdrawal by Subject|3|||
160474520|NCT02164578|579466960|FG001|Treatment Period|Withdrawal by Subject|3|||
160474521|NCT02164578|579466959|FG000|Treatment Period|Adverse Event|13|||
160474522|NCT02164578|579466960|FG001|Treatment Period|Adverse Event|6|||
160474523|NCT02164578|579466959|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
160474524|NCT02164578|579466960|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
160474525|NCT02164578|579466959|FG000|Treatment Period|Protocol Violation|0|||
160474526|NCT02164578|579466960|FG001|Treatment Period|Protocol Violation|2|||
160474527|NCT02164578|579466959|FG000|Extension Period|Withdrawal by Subject|2|||
160474528|NCT02164578|579466960|FG001|Extension Period|Withdrawal by Subject|0|||
160474529|NCT02164578|579466959|FG000|Extension Period|Adverse Event|4|||
160474530|NCT02164578|579466960|FG001|Extension Period|Adverse Event|0|||
160474531|NCT02164578|579466959|FG000|Extension Period|Expiry of study medication|1|||
160601927|NCT01544478|579920136|FG000|Overall Study|Withdrawal by Subject|52|||
160601928|NCT00212758|579920137|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
160474532|NCT02164578|579466960|FG001|Extension Period|Expiry of study medication|0|||
160474533|NCT02164578|579466959|FG000|Extension Period|Protocol Violation|0|||
160474534|NCT02164578|579466960|FG001|Extension Period|Protocol Violation|1|||
160474535|NCT01562275|579466966|FG000|Stage 1|Adverse Event|0|||
160474536|NCT01562275|579466967|FG001|Stage 1|Adverse Event|0|||
160474537|NCT01562275|579466968|FG002|Stage 1|Adverse Event|0|||
160474538|NCT01562275|579466969|FG003|Stage 1|Adverse Event|1|||
160474539|NCT01562275|579466970|FG004|Stage 1|Adverse Event|1|||
160474540|NCT01562275|579466971|FG005|Stage 1|Adverse Event|0|||
160474541|NCT01562275|579466972|FG006|Stage 1|Adverse Event|0|||
160474542|NCT01562275|579466973|FG007|Stage 1|Adverse Event|0|||
160474543|NCT01562275|579466974|FG008|Stage 1|Adverse Event|0|||
160474544|NCT01562275|579466975|FG009|Stage 1|Adverse Event|1|||
160474545|NCT01562275|579466976|FG010|Stage 1|Adverse Event|0|||
160474546|NCT01562275|579466977|FG011|Stage 1|Adverse Event|0|||
160474547|NCT01562275|579466978|FG012|Stage 1|Adverse Event|0|||
160474548|NCT01562275|579466966|FG000|Stage 1|Death|1|||
160474549|NCT01562275|579466967|FG001|Stage 1|Death|0|||
160474550|NCT01562275|579466968|FG002|Stage 1|Death|0|||
160474551|NCT01562275|579466969|FG003|Stage 1|Death|0|||
160474552|NCT01562275|579466970|FG004|Stage 1|Death|0|||
160474553|NCT01562275|579466971|FG005|Stage 1|Death|0|||
160474554|NCT01562275|579466972|FG006|Stage 1|Death|0|||
160474555|NCT01562275|579466973|FG007|Stage 1|Death|0|||
160474556|NCT01562275|579466974|FG008|Stage 1|Death|0|||
160474557|NCT01562275|579466975|FG009|Stage 1|Death|0|||
160474558|NCT01562275|579466976|FG010|Stage 1|Death|0|||
160474559|NCT01562275|579466977|FG011|Stage 1|Death|0|||
160474560|NCT01562275|579466978|FG012|Stage 1|Death|0|||
160474561|NCT01562275|579466966|FG000|Stage 1|Non Compliance|0|||
160474562|NCT01562275|579466967|FG001|Stage 1|Non Compliance|0|||
160474563|NCT01562275|579466968|FG002|Stage 1|Non Compliance|1|||
160474564|NCT01562275|579466969|FG003|Stage 1|Non Compliance|0|||
160474565|NCT01562275|579466970|FG004|Stage 1|Non Compliance|0|||
160474566|NCT01562275|579466971|FG005|Stage 1|Non Compliance|0|||
160474567|NCT01562275|579466972|FG006|Stage 1|Non Compliance|0|||
160474568|NCT01562275|579466973|FG007|Stage 1|Non Compliance|0|||
160474569|NCT01562275|579466974|FG008|Stage 1|Non Compliance|0|||
160474570|NCT01562275|579466975|FG009|Stage 1|Non Compliance|0|||
160474571|NCT01562275|579466976|FG010|Stage 1|Non Compliance|0|||
160474572|NCT01562275|579466977|FG011|Stage 1|Non Compliance|0|||
160474573|NCT01562275|579466978|FG012|Stage 1|Non Compliance|0|||
160474574|NCT01562275|579466966|FG000|Stage 1|Physician Decision|0|||
160474575|NCT01562275|579466967|FG001|Stage 1|Physician Decision|0|||
160474576|NCT01562275|579466968|FG002|Stage 1|Physician Decision|0|||
160474577|NCT01562275|579466969|FG003|Stage 1|Physician Decision|0|||
160474578|NCT01562275|579466970|FG004|Stage 1|Physician Decision|1|||
160474579|NCT01562275|579466971|FG005|Stage 1|Physician Decision|0|||
160474580|NCT01562275|579466972|FG006|Stage 1|Physician Decision|1|||
160474581|NCT01562275|579466973|FG007|Stage 1|Physician Decision|0|||
160474582|NCT01562275|579466974|FG008|Stage 1|Physician Decision|1|||
160474583|NCT01562275|579466975|FG009|Stage 1|Physician Decision|0|||
160474584|NCT01562275|579466976|FG010|Stage 1|Physician Decision|0|||
160474585|NCT01562275|579466977|FG011|Stage 1|Physician Decision|0|||
160474586|NCT01562275|579466978|FG012|Stage 1|Physician Decision|0|||
160474587|NCT01562275|579466966|FG000|Stage 1|Progression of Disease|2|||
160474588|NCT01562275|579466967|FG001|Stage 1|Progression of Disease|6|||
160474589|NCT01562275|579466968|FG002|Stage 1|Progression of Disease|2|||
160474590|NCT01562275|579466969|FG003|Stage 1|Progression of Disease|1|||
160474591|NCT01562275|579466970|FG004|Stage 1|Progression of Disease|2|||
160474592|NCT01562275|579466971|FG005|Stage 1|Progression of Disease|4|||
160474593|NCT01562275|579466972|FG006|Stage 1|Progression of Disease|1|||
160474594|NCT01562275|579466973|FG007|Stage 1|Progression of Disease|7|||
160474595|NCT01562275|579466974|FG008|Stage 1|Progression of Disease|2|||
160474596|NCT01562275|579466975|FG009|Stage 1|Progression of Disease|5|||
160474597|NCT01562275|579466976|FG010|Stage 1|Progression of Disease|3|||
160474598|NCT01562275|579466977|FG011|Stage 1|Progression of Disease|0|||
160474599|NCT01562275|579466978|FG012|Stage 1|Progression of Disease|0|||
160474600|NCT01562275|579466966|FG000|Stage 1|Withdrawal by Subject|0|||
160474601|NCT01562275|579466967|FG001|Stage 1|Withdrawal by Subject|1|||
160474602|NCT01562275|579466968|FG002|Stage 1|Withdrawal by Subject|0|||
160474603|NCT01562275|579466969|FG003|Stage 1|Withdrawal by Subject|2|||
160474604|NCT01562275|579466970|FG004|Stage 1|Withdrawal by Subject|0|||
160474605|NCT01562275|579466971|FG005|Stage 1|Withdrawal by Subject|0|||
160474606|NCT01562275|579466972|FG006|Stage 1|Withdrawal by Subject|1|||
160474607|NCT01562275|579466973|FG007|Stage 1|Withdrawal by Subject|0|||
160474608|NCT01562275|579466974|FG008|Stage 1|Withdrawal by Subject|0|||
160474609|NCT01562275|579466975|FG009|Stage 1|Withdrawal by Subject|1|||
160474610|NCT01562275|579466976|FG010|Stage 1|Withdrawal by Subject|0|||
160474611|NCT01562275|579466977|FG011|Stage 1|Withdrawal by Subject|0|||
160474612|NCT01562275|579466978|FG012|Stage 1|Withdrawal by Subject|0|||
160474613|NCT01562275|579466966|FG000|Stage 2|Death|0|||
160474614|NCT01562275|579466967|FG001|Stage 2|Death|0|||
160474615|NCT01562275|579466968|FG002|Stage 2|Death|0|||
160474616|NCT01562275|579466969|FG003|Stage 2|Death|0|||
160474617|NCT01562275|579466970|FG004|Stage 2|Death|0|||
160474618|NCT01562275|579466971|FG005|Stage 2|Death|0|||
160474619|NCT01562275|579466972|FG006|Stage 2|Death|0|||
160474620|NCT01562275|579466973|FG007|Stage 2|Death|0|||
160474621|NCT01562275|579466974|FG008|Stage 2|Death|0|||
160474622|NCT01562275|579466975|FG009|Stage 2|Death|0|||
160474623|NCT01562275|579466976|FG010|Stage 2|Death|0|||
160474624|NCT01562275|579466977|FG011|Stage 2|Death|2|||
160474625|NCT01562275|579466978|FG012|Stage 2|Death|1|||
160474626|NCT01562275|579466966|FG000|Stage 2|Progression of Disease|0|||
160474627|NCT01562275|579466967|FG001|Stage 2|Progression of Disease|0|||
160474628|NCT01562275|579466968|FG002|Stage 2|Progression of Disease|0|||
160474629|NCT01562275|579466969|FG003|Stage 2|Progression of Disease|0|||
160474630|NCT01562275|579466970|FG004|Stage 2|Progression of Disease|0|||
160474631|NCT01562275|579466971|FG005|Stage 2|Progression of Disease|0|||
160474632|NCT01562275|579466972|FG006|Stage 2|Progression of Disease|0|||
160474633|NCT01562275|579466973|FG007|Stage 2|Progression of Disease|0|||
160474634|NCT01562275|579466974|FG008|Stage 2|Progression of Disease|0|||
160474635|NCT01562275|579466975|FG009|Stage 2|Progression of Disease|0|||
160474636|NCT01562275|579466976|FG010|Stage 2|Progression of Disease|0|||
160474637|NCT01562275|579466977|FG011|Stage 2|Progression of Disease|12|||
160474638|NCT01562275|579466978|FG012|Stage 2|Progression of Disease|4|||
160474639|NCT04909593|579466979|FG000|Overall Study|Withdrawal by Subject|1|||
160474640|NCT01018992|579466980|FG000|Overall Study|Adverse Event|8|||
160474641|NCT01018992|579466981|FG001|Overall Study|Adverse Event|3|||
160474642|NCT01018992|579466980|FG000|Overall Study|Withdrawal by Subject|3|||
160474643|NCT01018992|579466981|FG001|Overall Study|Withdrawal by Subject|8|||
160474644|NCT01018992|579466980|FG000|Overall Study|Protocol Violation|0|||
160474645|NCT01018992|579466981|FG001|Overall Study|Protocol Violation|4|||
160474646|NCT01018992|579466980|FG000|Overall Study|Lost to Follow-up|5|||
160474647|NCT01018992|579466981|FG001|Overall Study|Lost to Follow-up|1|||
160474648|NCT03029585|579466984|FG000|Overall Study|Death|1|||
160474649|NCT03029585|579466985|FG001|Overall Study|Death|1|||
160474650|NCT03029585|579466984|FG000|Overall Study|Withdrawal by Subject|1|||
160474651|NCT03029585|579466985|FG001|Overall Study|Withdrawal by Subject|0|||
160474652|NCT02400749|579466986|FG000|Week 0 -16|Withdrawal by Subject|5|||
160474653|NCT02400749|579466987|FG001|Week 0 -16|Withdrawal by Subject|5|||
160474654|NCT02400749|579466986|FG000|Week 0 -16|Adverse Event|3|||
160474655|NCT02400749|579466987|FG001|Week 0 -16|Adverse Event|1|||
160474656|NCT02400749|579466986|FG000|Week 0 -16|Lost to Follow-up|2|||
160474657|NCT02400749|579466987|FG001|Week 0 -16|Lost to Follow-up|0|||
160474658|NCT02400749|579466986|FG000|Week 0 -16|Protocol Violation|1|||
160474659|NCT02400749|579466987|FG001|Week 0 -16|Protocol Violation|0|||
160474660|NCT02400749|579466986|FG000|Week 17 - 32|Withdrawal by Subject|3|||
160474661|NCT02400749|579466987|FG001|Week 17 - 32|Withdrawal by Subject|2|||
160474662|NCT02400749|579466986|FG000|Week 17 - 32|Adverse Event|2|||
160474663|NCT02400749|579466987|FG001|Week 17 - 32|Adverse Event|1|||
160474664|NCT00307489|579466988|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
160474665|NCT00307489|579466989|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
160474666|NCT00307489|579466988|FG000|Baseline Through Week 48|Physician Decision|1|||
160474667|NCT00307489|579466989|FG001|Baseline Through Week 48|Physician Decision|0|||
160474668|NCT00307489|579466988|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
160474669|NCT00307489|579466989|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
160474670|NCT00307489|579466988|FG000|Week 48 Through Week 168|Adverse Event|1|||
160474671|NCT00307489|579466989|FG001|Week 48 Through Week 168|Adverse Event|0|||
160474672|NCT00307489|579466988|FG000|Week 48 Through Week 168|Physician Decision|1|||
160474673|NCT00307489|579466989|FG001|Week 48 Through Week 168|Physician Decision|0|||
160474674|NCT00307489|579466988|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
160474675|NCT00307489|579466989|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
160474676|NCT00307489|579466988|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
160474677|NCT00307489|579466989|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
160474678|NCT00307489|579466988|FG000|Week 48 Through Week 168|Death|0|||
160474679|NCT00307489|579466989|FG001|Week 48 Through Week 168|Death|1|||
160474680|NCT00307489|579466988|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
160474681|NCT00307489|579466989|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
160474682|NCT00307489|579466988|FG000|Week 48 Through Week 168|Seroconversion|1|||
160474683|NCT00307489|579466989|FG001|Week 48 Through Week 168|Seroconversion|0|||
160474684|NCT04425252|579466990|FG000|Overall Study|Withdrawal by Subject|2|||
160474685|NCT04425252|579466991|FG001|Overall Study|Withdrawal by Subject|1|||
160474686|NCT04425252|579466990|FG000|Overall Study|Lost to Follow-up|1|||
160474687|NCT04425252|579466991|FG001|Overall Study|Lost to Follow-up|0|||
160474688|NCT04425252|579466990|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
160474689|NCT04425252|579466991|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
160474690|NCT01825785|579466992|FG000|Overall Study|Adverse Event|0|||
160474691|NCT01825785|579466993|FG001|Overall Study|Adverse Event|0|||
160474692|NCT01825785|579466994|FG002|Overall Study|Adverse Event|0|||
160474693|NCT01825785|579466995|FG003|Overall Study|Adverse Event|0|||
160474694|NCT01825785|579466996|FG004|Overall Study|Adverse Event|1|||
160474695|NCT01825785|579466997|FG005|Overall Study|Adverse Event|0|||
160474696|NCT01825785|579466998|FG006|Overall Study|Adverse Event|0|||
160474697|NCT01825785|579466992|FG000|Overall Study|Withdrawal by Subject|0|||
160474698|NCT01825785|579466993|FG001|Overall Study|Withdrawal by Subject|0|||
160474699|NCT01825785|579466994|FG002|Overall Study|Withdrawal by Subject|0|||
160474700|NCT01825785|579466995|FG003|Overall Study|Withdrawal by Subject|0|||
160474701|NCT01825785|579466996|FG004|Overall Study|Withdrawal by Subject|1|||
160474702|NCT01825785|579466997|FG005|Overall Study|Withdrawal by Subject|1|||
160474703|NCT01825785|579466998|FG006|Overall Study|Withdrawal by Subject|0|||
160474704|NCT00304278|579467001|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
160474705|NCT00304278|579467001|FG000|Overall Study|PT had medical condition preventing TX|1|||
160474706|NCT00507429|579467004|FG000|Treatment Phase|Disease Progression|12|||
160474707|NCT00507429|579467005|FG001|Treatment Phase|Disease Progression|5|||
160474708|NCT00507429|579467004|FG000|Treatment Phase|Adverse Event|12|||
160474709|NCT00507429|579467005|FG001|Treatment Phase|Adverse Event|5|||
160474710|NCT00507429|579467004|FG000|Treatment Phase|Withdrawal by Subject|3|||
160474711|NCT00507429|579467005|FG001|Treatment Phase|Withdrawal by Subject|3|||
160474712|NCT00507429|579467004|FG000|Treatment Phase|Physician Decision|4|||
160474713|NCT00507429|579467005|FG001|Treatment Phase|Physician Decision|2|||
160474714|NCT00507429|579467004|FG000|Treatment Phase|Other|6|||
160474715|NCT00507429|579467005|FG001|Treatment Phase|Other|3|||
160474716|NCT00507429|579467004|FG000|Maintenance Phase|Progressive Disease|14|||
160474717|NCT00507429|579467005|FG001|Maintenance Phase|Progressive Disease|0|||
160474718|NCT04025762|579467006|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
160474719|NCT04025762|579467007|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
160474720|NCT01286311|579467009|FG000|Overall Study|Physician did not want outreach sent|14|||
160474721|NCT01286311|579467010|FG001|Overall Study|Physician did not want outreach sent|0|||
160474722|NCT01437540|579467011|FG000|Overall Study|Not listed below|7|||
160474723|NCT01437540|579467012|FG001|Overall Study|Not listed below|6|||
160474724|NCT01437540|579467011|FG000|Overall Study|COPD exacerbation|13|||
160474725|NCT01437540|579467012|FG001|Overall Study|COPD exacerbation|3|||
160474726|NCT01437540|579467011|FG000|Overall Study|Lost to Follow-up|3|||
160474727|NCT01437540|579467012|FG001|Overall Study|Lost to Follow-up|5|||
160474728|NCT01437540|579467011|FG000|Overall Study|Lack of Efficacy|23|||
160474729|NCT01437540|579467012|FG001|Overall Study|Lack of Efficacy|11|||
160474730|NCT01437540|579467011|FG000|Overall Study|Protocol Violation|24|||
160474731|NCT01437540|579467012|FG001|Overall Study|Protocol Violation|12|||
160474732|NCT01437540|579467011|FG000|Overall Study|Adverse Event|26|||
160474733|NCT01437540|579467012|FG001|Overall Study|Adverse Event|13|||
160474734|NCT01437540|579467011|FG000|Overall Study|Withdrawal by Subject|31|||
160474735|NCT01437540|579467012|FG001|Overall Study|Withdrawal by Subject|15|||
160474736|NCT01381549|579467013|FG000|Overall Study|Ineligible: No organisms isolated|0|||
160474737|NCT01381549|579467014|FG001|Overall Study|Ineligible: No organisms isolated|0|||
160474738|NCT01381549|579467015|FG002|Overall Study|Ineligible: No organisms isolated|1|||
160474739|NCT02981953|579467016|FG000|Overall Study|Death|9|||
160474740|NCT02981953|579467016|FG000|Overall Study|Withdrawal by Subject|1|||
160474741|NCT02981953|579467016|FG000|Overall Study|Withdrawal to non-compliance|1|||
160474742|NCT00805792|579467021|FG000|Overall Study|Death|3|||
160474743|NCT00805792|579467021|FG000|Overall Study|Lost to Follow-up|2|||
160474744|NCT02165202|579467030|FG000|Oral Phase|Refused further participation|5|||
160474745|NCT02165202|579467031|FG001|Oral Phase|Refused further participation|1|||
160474746|NCT02165202|579467030|FG000|Oral Phase|Study product Related Toxicity|1|||
160474747|NCT02165202|579467031|FG001|Oral Phase|Study product Related Toxicity|0|||
160474748|NCT02165202|579467030|FG000|Oral Phase|Unable to contact Participant|1|||
160474749|NCT02165202|579467031|FG001|Oral Phase|Unable to contact Participant|1|||
160474750|NCT02165202|579467030|FG000|Oral Phase|Clinical reasons|1|||
160601929|NCT00212758|579920138|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
160601930|NCT00212758|579920137|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
160601931|NCT00212758|579920138|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
160601932|NCT02574481|579920139|FG000|Overall Study|Withdrawal by Subject|29|||
160601933|NCT02574481|579920140|FG001|Overall Study|Withdrawal by Subject|15|||
160601934|NCT02574481|579920141|FG002|Overall Study|Withdrawal by Subject|4|||
160601935|NCT02574481|579920142|FG003|Overall Study|Withdrawal by Subject|1|||
160601936|NCT02574481|579920139|FG000|Overall Study|Adverse Event|5|||
160474751|NCT02165202|579467031|FG001|Oral Phase|Clinical reasons|0|||
160474752|NCT02165202|579467030|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
160474753|NCT02165202|579467031|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
160474754|NCT02165202|579467030|FG000|Oral Phase|CMC advised termination|1|||
160474755|NCT02165202|579467031|FG001|Oral Phase|CMC advised termination|0|||
160474756|NCT02165202|579467030|FG000|Oral Phase|Relocated, no follow-up planned|1|||
160474757|NCT02165202|579467031|FG001|Oral Phase|Relocated, no follow-up planned|0|||
160474758|NCT02165202|579467030|FG000|Oral Phase|Abnormal EKG|0|||
160474759|NCT02165202|579467031|FG001|Oral Phase|Abnormal EKG|1|||
160474760|NCT02165202|579467030|FG000|Injection Phase|Abnormal Lab Value|5|||
160474761|NCT02165202|579467031|FG001|Injection Phase|Abnormal Lab Value|1|||
160474762|NCT02165202|579467030|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
160601937|NCT02574481|579920140|FG001|Overall Study|Adverse Event|1|||
160474763|NCT02165202|579467031|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
160474764|NCT02165202|579467030|FG000|Injection Phase|Unable to attend within Visit Window|1|||
160474765|NCT02165202|579467031|FG001|Injection Phase|Unable to attend within Visit Window|0|||
160474766|NCT02165202|579467030|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
160474767|NCT02165202|579467031|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
160474768|NCT02165202|579467030|FG000|Injection Phase|End of Study|2|||
160474769|NCT02165202|579467031|FG001|Injection Phase|End of Study|1|||
160474770|NCT02165202|579467030|FG000|Injection Phase|Study Product related Toxicity|1|||
160474771|NCT02165202|579467031|FG001|Injection Phase|Study Product related Toxicity|0|||
160474772|NCT02165202|579467030|FG000|Injection Phase|No longer interested|0|||
160474773|NCT02165202|579467031|FG001|Injection Phase|No longer interested|1|||
160474774|NCT02165202|579467030|FG000|Injection Phase|Participant unwilling to comply|1|||
160474775|NCT02165202|579467031|FG001|Injection Phase|Participant unwilling to comply|0|||
160474776|NCT04328467|579467037|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
160474777|NCT04328467|579467038|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
160474778|NCT04328467|579467039|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
160474779|NCT00990184|579467040|FG000|Overall Study|Physician Decision|1|||
160474780|NCT01975701|579467041|FG000|Overall Study|Lost to Follow-up|1|||
160474781|NCT01975701|579467041|FG000|Overall Study|Death|23|||
160474782|NCT01975701|579467041|FG000|Overall Study|Physician Decision|1|||
160474783|NCT01655498|579467042|FG000|Overall Study|Unrelated health issue|2|||
160474784|NCT01655498|579467042|FG000|Overall Study|Protocol Violation|2|||
160474785|NCT01655498|579467042|FG000|Overall Study|Withdrawal by Subject|1|||
160474786|NCT02446015|579467045|FG000|Overall Study|Adverse Event|0|||
160474787|NCT02446015|579467046|FG001|Overall Study|Adverse Event|1|||
160474788|NCT02446015|579467045|FG000|Overall Study|Withdrawal by Subject|1|||
160474789|NCT02446015|579467046|FG001|Overall Study|Withdrawal by Subject|0|||
160474790|NCT00988429|579467047|FG000|Overall Study|Adverse Event|9|||
160474791|NCT00988429|579467048|FG001|Overall Study|Adverse Event|21|||
160474792|NCT00988429|579467049|FG002|Overall Study|Adverse Event|45|||
160474793|NCT00988429|579467047|FG000|Overall Study|Lack of Efficacy|0|||
160474794|NCT00988429|579467048|FG001|Overall Study|Lack of Efficacy|0|||
160474795|NCT00988429|579467049|FG002|Overall Study|Lack of Efficacy|1|||
160474796|NCT00988429|579467047|FG000|Overall Study|Non-Compliance with Study Drug|5|||
160474797|NCT00988429|579467048|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160474798|NCT00988429|579467049|FG002|Overall Study|Non-Compliance with Study Drug|3|||
160474799|NCT00988429|579467047|FG000|Overall Study|Physician Decision|1|||
160474800|NCT00988429|579467048|FG001|Overall Study|Physician Decision|0|||
160474801|NCT00988429|579467049|FG002|Overall Study|Physician Decision|3|||
160474802|NCT00988429|579467047|FG000|Overall Study|Pregnancy|2|||
160474803|NCT00988429|579467048|FG001|Overall Study|Pregnancy|1|||
160474804|NCT00988429|579467049|FG002|Overall Study|Pregnancy|0|||
160474805|NCT00988429|579467047|FG000|Overall Study|Protocol Violation|4|||
160474806|NCT00988429|579467048|FG001|Overall Study|Protocol Violation|3|||
160474807|NCT00988429|579467049|FG002|Overall Study|Protocol Violation|3|||
160474808|NCT00988429|579467047|FG000|Overall Study|Withdrawal by Subject|7|||
160474809|NCT00988429|579467048|FG001|Overall Study|Withdrawal by Subject|7|||
160474810|NCT00988429|579467049|FG002|Overall Study|Withdrawal by Subject|12|||
160474811|NCT00988429|579467047|FG000|Overall Study|Administrative Reasons|1|||
160474812|NCT00988429|579467048|FG001|Overall Study|Administrative Reasons|2|||
160474813|NCT00988429|579467049|FG002|Overall Study|Administrative Reasons|1|||
160474814|NCT00988429|579467047|FG000|Overall Study|other reasons|8|||
160474815|NCT00988429|579467048|FG001|Overall Study|other reasons|8|||
160474816|NCT00988429|579467049|FG002|Overall Study|other reasons|1|||
160474817|NCT01714947|579467050|FG000|Part B|Progressive Disease|3|||
160474818|NCT00376259|579467053|FG000|Overall Study|Sponsor request - study termination|21|||
160474819|NCT00376259|579467054|FG001|Overall Study|Sponsor request - study termination|21|||
160601938|NCT02574481|579920141|FG002|Overall Study|Adverse Event|1|||
160601939|NCT02574481|579920142|FG003|Overall Study|Adverse Event|0|||
160601940|NCT02574481|579920139|FG000|Overall Study|Visit Missed|15|||
160601941|NCT02574481|579920140|FG001|Overall Study|Visit Missed|7|||
160601942|NCT02574481|579920141|FG002|Overall Study|Visit Missed|5|||
160474820|NCT00376259|579467053|FG000|Overall Study|Patient request|1|||
160474821|NCT00376259|579467054|FG001|Overall Study|Patient request|0|||
160474822|NCT00267956|579467058|FG000|Controlled Period|Adverse Event|4|||
160474823|NCT00267956|579467059|FG001|Controlled Period|Adverse Event|1|||
160474824|NCT00267956|579467060|FG002|Controlled Period|Adverse Event|0|||
160474825|NCT00267956|579467061|FG003|Controlled Period|Adverse Event|0|||
160474826|NCT00267956|579467058|FG000|Controlled Period|Lack of Efficacy|4|||
160474827|NCT00267956|579467059|FG001|Controlled Period|Lack of Efficacy|2|||
160474828|NCT00267956|579467060|FG002|Controlled Period|Lack of Efficacy|0|||
160474829|NCT00267956|579467061|FG003|Controlled Period|Lack of Efficacy|0|||
160474830|NCT00267956|579467058|FG000|Controlled Period|Lost to Follow-up|2|||
160474831|NCT00267956|579467059|FG001|Controlled Period|Lost to Follow-up|0|||
160474832|NCT00267956|579467060|FG002|Controlled Period|Lost to Follow-up|0|||
160601943|NCT02574481|579920142|FG003|Overall Study|Visit Missed|0|||
160601944|NCT02574481|579920139|FG000|Overall Study|Other|7|||
160474833|NCT00267956|579467061|FG003|Controlled Period|Lost to Follow-up|0|||
160474834|NCT00267956|579467058|FG000|Controlled Period|Withdrew consent|3|||
160474835|NCT00267956|579467059|FG001|Controlled Period|Withdrew consent|1|||
160474836|NCT00267956|579467060|FG002|Controlled Period|Withdrew consent|0|||
160474837|NCT00267956|579467061|FG003|Controlled Period|Withdrew consent|0|||
160474838|NCT00267956|579467058|FG000|After Controlled Period|Adverse Event|0|||
160474839|NCT00267956|579467059|FG001|After Controlled Period|Adverse Event|0|||
160474840|NCT00267956|579467060|FG002|After Controlled Period|Adverse Event|2|||
160474841|NCT00267956|579467061|FG003|After Controlled Period|Adverse Event|1|||
160474842|NCT00267956|579467058|FG000|After Controlled Period|Lack of Efficacy|0|||
160474843|NCT00267956|579467059|FG001|After Controlled Period|Lack of Efficacy|0|||
160474844|NCT00267956|579467060|FG002|After Controlled Period|Lack of Efficacy|1|||
160474845|NCT00267956|579467061|FG003|After Controlled Period|Lack of Efficacy|1|||
160474846|NCT00267956|579467058|FG000|After Controlled Period|Lost to Follow-up|0|||
160474847|NCT00267956|579467059|FG001|After Controlled Period|Lost to Follow-up|0|||
160474848|NCT00267956|579467060|FG002|After Controlled Period|Lost to Follow-up|1|||
160474849|NCT00267956|579467061|FG003|After Controlled Period|Lost to Follow-up|0|||
160474850|NCT00267956|579467058|FG000|After Controlled Period|Withdrew consent|0|||
160474851|NCT00267956|579467059|FG001|After Controlled Period|Withdrew consent|0|||
160474852|NCT00267956|579467060|FG002|After Controlled Period|Withdrew consent|1|||
160474853|NCT00267956|579467061|FG003|After Controlled Period|Withdrew consent|0|||
160474854|NCT01393964|579467063|FG000|Overall Study|Disease Progression|4|||
160474855|NCT01393964|579467064|FG001|Overall Study|Disease Progression|3|||
160474856|NCT01393964|579467065|FG002|Overall Study|Disease Progression|5|||
160474857|NCT01393964|579467063|FG000|Overall Study|Study drug toxicity|1|||
160474858|NCT01393964|579467064|FG001|Overall Study|Study drug toxicity|0|||
160474859|NCT01393964|579467065|FG002|Overall Study|Study drug toxicity|0|||
160474860|NCT01393964|579467063|FG000|Overall Study|Withdrawal by Subject|0|||
160474861|NCT01393964|579467064|FG001|Overall Study|Withdrawal by Subject|0|||
160474862|NCT01393964|579467065|FG002|Overall Study|Withdrawal by Subject|1|||
160474863|NCT01393964|579467063|FG000|Overall Study|Adverse event unrelated to study drug|0|||
160474864|NCT01393964|579467064|FG001|Overall Study|Adverse event unrelated to study drug|3|||
160474865|NCT01393964|579467065|FG002|Overall Study|Adverse event unrelated to study drug|0|||
160474866|NCT01393964|579467063|FG000|Overall Study|Subject request stop study treatment|0|||
160474867|NCT01393964|579467064|FG001|Overall Study|Subject request stop study treatment|1|||
160474868|NCT01393964|579467065|FG002|Overall Study|Subject request stop study treatment|0|||
160474869|NCT01393964|579467063|FG000|Overall Study|Subject decided to move to transplant|1|||
160474870|NCT01393964|579467064|FG001|Overall Study|Subject decided to move to transplant|0|||
160474871|NCT01393964|579467065|FG002|Overall Study|Subject decided to move to transplant|0|||
160474872|NCT01393964|579467063|FG000|Overall Study|Subject switched to commercial supply|1|||
160474873|NCT01393964|579467064|FG001|Overall Study|Subject switched to commercial supply|0|||
160474874|NCT01393964|579467065|FG002|Overall Study|Subject switched to commercial supply|2|||
160601945|NCT02574481|579920140|FG001|Overall Study|Other|2|||
160601946|NCT02574481|579920141|FG002|Overall Study|Other|0|||
160601947|NCT02574481|579920142|FG003|Overall Study|Other|0|||
160601948|NCT02574481|579920139|FG000|Overall Study|Death|48|||
160601949|NCT02574481|579920140|FG001|Overall Study|Death|26|||
160601950|NCT02574481|579920141|FG002|Overall Study|Death|12|||
160601951|NCT02574481|579920142|FG003|Overall Study|Death|4|||
160601952|NCT02574481|579920139|FG000|Overall Study|Physician Decision|5|||
160601953|NCT02574481|579920140|FG001|Overall Study|Physician Decision|2|||
160601954|NCT02574481|579920141|FG002|Overall Study|Physician Decision|0|||
160601955|NCT02574481|579920142|FG003|Overall Study|Physician Decision|0|||
160601956|NCT02574481|579920139|FG000|Overall Study|Lost to Follow-up|5|||
160474875|NCT01393964|579467063|FG000|Overall Study|Subject plateaued in terms of effect|1|||
160474876|NCT01393964|579467064|FG001|Overall Study|Subject plateaued in terms of effect|0|||
160474877|NCT01393964|579467065|FG002|Overall Study|Subject plateaued in terms of effect|0|||
160601957|NCT02574481|579920140|FG001|Overall Study|Lost to Follow-up|1|||
160601958|NCT02574481|579920141|FG002|Overall Study|Lost to Follow-up|3|||
160601959|NCT02574481|579920142|FG003|Overall Study|Lost to Follow-up|0|||
160601960|NCT02038790|579920145|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
160601961|NCT02038790|579920146|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
160474878|NCT01393964|579467063|FG000|Overall Study|Investigator removed subject from study|0|||
160601962|NCT00784459|579920148|FG000|Overall Study|Adverse Event|0|||
160474879|NCT01393964|579467064|FG001|Overall Study|Investigator removed subject from study|1|||
160474880|NCT01393964|579467065|FG002|Overall Study|Investigator removed subject from study|0|||
160474881|NCT01393964|579467063|FG000|Overall Study|Subject converted to roll-over study|0|||
160474882|NCT01393964|579467064|FG001|Overall Study|Subject converted to roll-over study|1|||
160474883|NCT01393964|579467065|FG002|Overall Study|Subject converted to roll-over study|0|||
160474884|NCT01393964|579467063|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
160601963|NCT00784459|579920149|FG001|Overall Study|Adverse Event|2|||
160601964|NCT02431702|579920150|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
160601965|NCT02431702|579920151|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
160601966|NCT02431702|579920152|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
160474885|NCT01393964|579467064|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
160474886|NCT01393964|579467065|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
160474887|NCT02399449|579467066|FG000|Overall Study|Withdrawal by Subject|3|||
160474888|NCT02399449|579467067|FG001|Overall Study|Withdrawal by Subject|9|||
160474889|NCT02399449|579467066|FG000|Overall Study|Physician Decision|0|||
160474890|NCT02399449|579467067|FG001|Overall Study|Physician Decision|1|||
160474891|NCT01020435|579467068|FG000|Overall Study|Lost to Follow-up|0|||
160474892|NCT01020435|579467069|FG001|Overall Study|Lost to Follow-up|1|||
160474893|NCT00346398|579467070|FG000|Overall Study|Lost to Follow-up|3|||
160474894|NCT00346398|579467071|FG001|Overall Study|Lost to Follow-up|0|||
160474895|NCT00346398|579467070|FG000|Overall Study|Withdrawal by Subject|0|||
160474896|NCT00346398|579467071|FG001|Overall Study|Withdrawal by Subject|2|||
160474897|NCT03979040|579467072|FG000|Overall Study|Withdrawal by Subject|24|||
160474898|NCT03979040|579467073|FG001|Overall Study|Withdrawal by Subject|32|||
160474899|NCT03979040|579467072|FG000|Overall Study|randomized but never started treatment|32|||
160474900|NCT03979040|579467073|FG001|Overall Study|randomized but never started treatment|39|||
160474901|NCT03979040|579467072|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
160474902|NCT03979040|579467073|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
160474903|NCT02607956|579467074|FG000|Double-Blinded Phase|Withdrew Consent|17|||
160474904|NCT02607956|579467075|FG001|Double-Blinded Phase|Withdrew Consent|19|||
160474905|NCT02607956|579467076|FG002|Double-Blinded Phase|Withdrew Consent|0|||
160474906|NCT02607956|579467077|FG003|Double-Blinded Phase|Withdrew Consent|0|||
160474907|NCT02607956|579467074|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
160474908|NCT02607956|579467075|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
160474909|NCT02607956|579467076|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
160474910|NCT02607956|579467077|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
160474911|NCT02607956|579467074|FG000|Double-Blinded Phase|Randomized but never treated|7|||
160474912|NCT02607956|579467075|FG001|Double-Blinded Phase|Randomized but never treated|5|||
160474913|NCT02607956|579467076|FG002|Double-Blinded Phase|Randomized but never treated|0|||
160474914|NCT02607956|579467077|FG003|Double-Blinded Phase|Randomized but never treated|0|||
160474915|NCT02607956|579467074|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
160474916|NCT02607956|579467075|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
160474917|NCT02607956|579467076|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
160474918|NCT02607956|579467077|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
160474919|NCT02607956|579467074|FG000|Double-Blinded Phase|Death|4|||
160474920|NCT02607956|579467075|FG001|Double-Blinded Phase|Death|4|||
160474921|NCT02607956|579467076|FG002|Double-Blinded Phase|Death|0|||
160474922|NCT02607956|579467077|FG003|Double-Blinded Phase|Death|0|||
160474923|NCT02607956|579467074|FG000|Double-Blinded Phase|Adverse Event|4|||
160474924|NCT02607956|579467075|FG001|Double-Blinded Phase|Adverse Event|3|||
160474925|NCT02607956|579467076|FG002|Double-Blinded Phase|Adverse Event|0|||
160474926|NCT02607956|579467077|FG003|Double-Blinded Phase|Adverse Event|0|||
160474927|NCT02607956|579467074|FG000|Double-Blinded Phase|Protocol Violation|3|||
160474928|NCT02607956|579467075|FG001|Double-Blinded Phase|Protocol Violation|1|||
160474929|NCT02607956|579467076|FG002|Double-Blinded Phase|Protocol Violation|0|||
160474930|NCT02607956|579467077|FG003|Double-Blinded Phase|Protocol Violation|0|||
160474931|NCT02607956|579467074|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
160474932|NCT02607956|579467075|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
160474933|NCT02607956|579467076|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
160474934|NCT02607956|579467077|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
160474935|NCT02607956|579467074|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
160474936|NCT02607956|579467075|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
160474937|NCT02607956|579467076|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
160474938|NCT02607956|579467077|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
160474939|NCT02607956|579467074|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
160474940|NCT02607956|579467075|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
160474941|NCT02607956|579467076|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
160474942|NCT02607956|579467077|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
160474943|NCT02607956|579467074|FG000|Open-Label Extension Phase|Death|0|||
160474944|NCT02607956|579467075|FG001|Open-Label Extension Phase|Death|0|||
160474945|NCT02607956|579467076|FG002|Open-Label Extension Phase|Death|1|||
160474946|NCT02607956|579467077|FG003|Open-Label Extension Phase|Death|3|||
160474947|NCT02607956|579467074|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
160474948|NCT02607956|579467075|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
160474949|NCT02607956|579467076|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
160474950|NCT02607956|579467077|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
160474951|NCT02607956|579467074|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
160474952|NCT02607956|579467075|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
160474953|NCT02607956|579467076|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
160474954|NCT02607956|579467077|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
160474955|NCT02607956|579467074|FG000|Open-Label Extension Phase|Protocol Violation|0|||
160474956|NCT02607956|579467075|FG001|Open-Label Extension Phase|Protocol Violation|0|||
160474957|NCT02607956|579467076|FG002|Open-Label Extension Phase|Protocol Violation|0|||
160474958|NCT02607956|579467077|FG003|Open-Label Extension Phase|Protocol Violation|2|||
160474959|NCT02607956|579467074|FG000|Open-Label Extension Phase|Pregnancy|0|||
160474960|NCT02607956|579467075|FG001|Open-Label Extension Phase|Pregnancy|0|||
160474961|NCT02607956|579467076|FG002|Open-Label Extension Phase|Pregnancy|0|||
160474962|NCT02607956|579467077|FG003|Open-Label Extension Phase|Pregnancy|1|||
160474963|NCT00824850|579467086|FG000|Overall Study|Withdrawal by Subject|0|||
160474964|NCT00824850|579467087|FG001|Overall Study|Withdrawal by Subject|1|||
160474965|NCT01075152|579467088|FG000|Overall Study|Withdrawal by Subject|1|||
160474966|NCT01075152|579467089|FG001|Overall Study|Withdrawal by Subject|0|||
160474967|NCT01079949|579467092|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
160474968|NCT01079949|579467093|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
160474969|NCT01079949|579467092|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
160474970|NCT01079949|579467093|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
160474971|NCT01079949|579467092|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
160474972|NCT01079949|579467093|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
160474973|NCT01079949|579467092|FG000|Overall Study|Randomized but not treated|1|||
160474974|NCT01079949|579467093|FG001|Overall Study|Randomized but not treated|0|||
160474975|NCT03659136|579467098|FG000|Overall Study|Not treated|2|||
160474976|NCT03659136|579467099|FG001|Overall Study|Not treated|0|||
160474977|NCT03659136|579467098|FG000|Overall Study|Covid-19 related|1|||
160474978|NCT03659136|579467099|FG001|Overall Study|Covid-19 related|1|||
160474979|NCT03659136|579467098|FG000|Overall Study|Withdrawal by Subject|1|||
160474980|NCT03659136|579467099|FG001|Overall Study|Withdrawal by Subject|6|||
160474981|NCT03659136|579467098|FG000|Overall Study|Adverse Event|4|||
160474982|NCT03659136|579467099|FG001|Overall Study|Adverse Event|6|||
160474983|NCT03659136|579467098|FG000|Overall Study|Progressive disease|37|||
160474984|NCT03659136|579467099|FG001|Overall Study|Progressive disease|31|||
160474985|NCT03659136|579467098|FG000|Overall Study|Study closure|2|||
160474986|NCT03659136|579467099|FG001|Overall Study|Study closure|2|||
160474987|NCT03659136|579467098|FG000|Overall Study|Sponsor decision/recommendation|3|||
160474988|NCT03659136|579467099|FG001|Overall Study|Sponsor decision/recommendation|2|||
160474989|NCT03659136|579467098|FG000|Overall Study|Switched to other drug/therapy|2|||
160474990|NCT03659136|579467099|FG001|Overall Study|Switched to other drug/therapy|2|||
160474991|NCT03659136|579467098|FG000|Overall Study|Lack of clinical benefit|0|||
160474992|NCT03659136|579467099|FG001|Overall Study|Lack of clinical benefit|1|||
160474993|NCT00813709|579469021|FG000|Double Blind Period|Adverse Event|4|||
160474994|NCT00813709|579469022|FG001|Double Blind Period|Adverse Event|1|||
160474995|NCT00813709|579469023|FG002|Double Blind Period|Adverse Event|4|||
160474996|NCT00813709|579469024|FG003|Double Blind Period|Adverse Event|0|||
160474997|NCT00813709|579469025|FG004|Double Blind Period|Adverse Event|0|||
160474998|NCT00813709|579469026|FG005|Double Blind Period|Adverse Event|0|||
160474999|NCT00813709|579469021|FG000|Double Blind Period|Lost to Follow-up|3|||
160475000|NCT00813709|579469022|FG001|Double Blind Period|Lost to Follow-up|2|||
160475001|NCT00813709|579469023|FG002|Double Blind Period|Lost to Follow-up|2|||
160475002|NCT00813709|579469024|FG003|Double Blind Period|Lost to Follow-up|0|||
160475003|NCT00813709|579469025|FG004|Double Blind Period|Lost to Follow-up|0|||
160475004|NCT00813709|579469026|FG005|Double Blind Period|Lost to Follow-up|0|||
160475005|NCT00813709|579469021|FG000|Double Blind Period|Switched to open label phase|9|||
160475006|NCT00813709|579469022|FG001|Double Blind Period|Switched to open label phase|26|||
160475007|NCT00813709|579469023|FG002|Double Blind Period|Switched to open label phase|18|||
160475008|NCT00813709|579469024|FG003|Double Blind Period|Switched to open label phase|0|||
160475009|NCT00813709|579469025|FG004|Double Blind Period|Switched to open label phase|0|||
160475010|NCT00813709|579469026|FG005|Double Blind Period|Switched to open label phase|0|||
160475011|NCT00813709|579469021|FG000|Double Blind Period|Randomized but not treated|1|||
160475012|NCT00813709|579469022|FG001|Double Blind Period|Randomized but not treated|3|||
160475013|NCT00813709|579469023|FG002|Double Blind Period|Randomized but not treated|1|||
160475014|NCT00813709|579469024|FG003|Double Blind Period|Randomized but not treated|0|||
160475015|NCT00813709|579469025|FG004|Double Blind Period|Randomized but not treated|0|||
160475016|NCT00813709|579469026|FG005|Double Blind Period|Randomized but not treated|0|||
160475017|NCT00813709|579469021|FG000|Double Blind Period|Other|14|||
160475018|NCT00813709|579469022|FG001|Double Blind Period|Other|9|||
160475019|NCT00813709|579469023|FG002|Double Blind Period|Other|6|||
160475020|NCT00813709|579469024|FG003|Double Blind Period|Other|0|||
160475021|NCT00813709|579469025|FG004|Double Blind Period|Other|0|||
160475022|NCT00813709|579469026|FG005|Double Blind Period|Other|0|||
160475023|NCT00813709|579469021|FG000|Open Label Period|Adverse Event|0|||
160475024|NCT00813709|579469022|FG001|Open Label Period|Adverse Event|0|||
160475025|NCT00813709|579469023|FG002|Open Label Period|Adverse Event|0|||
160475026|NCT00813709|579469024|FG003|Open Label Period|Adverse Event|5|||
160475027|NCT00813709|579469025|FG004|Open Label Period|Adverse Event|4|||
160475028|NCT00813709|579469026|FG005|Open Label Period|Adverse Event|3|||
160475029|NCT00813709|579469021|FG000|Open Label Period|Lack of Efficacy|0|||
160475030|NCT00813709|579469022|FG001|Open Label Period|Lack of Efficacy|0|||
160475031|NCT00813709|579469023|FG002|Open Label Period|Lack of Efficacy|0|||
160475032|NCT00813709|579469024|FG003|Open Label Period|Lack of Efficacy|3|||
160475033|NCT00813709|579469025|FG004|Open Label Period|Lack of Efficacy|1|||
160475034|NCT00813709|579469026|FG005|Open Label Period|Lack of Efficacy|1|||
160475035|NCT00813709|579469021|FG000|Open Label Period|Randomized but not treated|0|||
160475036|NCT00813709|579469022|FG001|Open Label Period|Randomized but not treated|0|||
160475037|NCT00813709|579469023|FG002|Open Label Period|Randomized but not treated|0|||
160475038|NCT00813709|579469024|FG003|Open Label Period|Randomized but not treated|1|||
160475039|NCT00813709|579469025|FG004|Open Label Period|Randomized but not treated|0|||
160475040|NCT00813709|579469026|FG005|Open Label Period|Randomized but not treated|1|||
160475041|NCT00813709|579469021|FG000|Open Label Period|Other|0|||
160475042|NCT00813709|579469022|FG001|Open Label Period|Other|0|||
160475043|NCT00813709|579469023|FG002|Open Label Period|Other|0|||
160475044|NCT00813709|579469024|FG003|Open Label Period|Other|11|||
160475045|NCT00813709|579469025|FG004|Open Label Period|Other|5|||
160475046|NCT00813709|579469026|FG005|Open Label Period|Other|6|||
160475047|NCT01123356|579469027|FG000|Overall Study|Adverse Event|2|||
160475048|NCT01123356|579469027|FG000|Overall Study|Lack of Efficacy|4|||
160475049|NCT01123356|579469027|FG000|Overall Study|Withdrawal by Subject|1|||
160475050|NCT01877720|579469028|FG000|Overall Study|Adverse Event|1|||
160475051|NCT01877720|579469029|FG001|Overall Study|Adverse Event|0|||
160475052|NCT01494467|579469037|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
160475053|NCT01494467|579469038|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
160475054|NCT01494467|579469037|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
160475055|NCT01494467|579469038|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
160475056|NCT01494467|579469037|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
160475057|NCT01494467|579469038|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
160475058|NCT01494467|579469037|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
160475059|NCT01494467|579469038|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
160475060|NCT01494467|579469037|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
160475061|NCT01494467|579469038|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
160475062|NCT01494467|579469037|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
160475063|NCT01494467|579469038|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
160475064|NCT01494467|579469037|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
160475065|NCT01494467|579469038|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
160475066|NCT01494467|579469037|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
160475067|NCT01494467|579469038|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
160475068|NCT01494467|579469037|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
160475069|NCT01494467|579469038|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
160475070|NCT01494467|579469037|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
160475071|NCT01494467|579469038|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
160475072|NCT01494467|579469037|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
160475073|NCT01494467|579469038|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
160475074|NCT01494467|579469037|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
160475075|NCT01494467|579469038|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
160475076|NCT01494467|579469037|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
160475077|NCT01494467|579469038|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
160475078|NCT01494467|579469037|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
160475079|NCT01494467|579469038|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
160475080|NCT02410278|579469041|FG000|Run-in Period|Adverse Event|5|||
160475081|NCT02410278|579469042|FG001|Run-in Period|Adverse Event|0|||
160475082|NCT02410278|579469043|FG002|Run-in Period|Adverse Event|0|||
160475083|NCT02410278|579469041|FG000|Run-in Period|GSRS Threshold Not Met|30|||
160475084|NCT02410278|579469042|FG001|Run-in Period|GSRS Threshold Not Met|0|||
160475085|NCT02410278|579469043|FG002|Run-in Period|GSRS Threshold Not Met|0|||
160475086|NCT02410278|579469041|FG000|Run-in Period|Lost to Follow-up|1|||
160475087|NCT02410278|579469042|FG001|Run-in Period|Lost to Follow-up|0|||
160475088|NCT02410278|579469043|FG002|Run-in Period|Lost to Follow-up|0|||
160475089|NCT02410278|579469041|FG000|Run-in Period|Withdrawal by Subject|1|||
160475090|NCT02410278|579469042|FG001|Run-in Period|Withdrawal by Subject|0|||
160475091|NCT02410278|579469043|FG002|Run-in Period|Withdrawal by Subject|0|||
160475092|NCT02410278|579469041|FG000|Run-in Period|Pregnancy|1|||
160475093|NCT02410278|579469042|FG001|Run-in Period|Pregnancy|0|||
160475094|NCT02410278|579469043|FG002|Run-in Period|Pregnancy|0|||
160475095|NCT02410278|579469041|FG000|Study Treatment Period|Adverse Event|0|||
160475096|NCT02410278|579469042|FG001|Study Treatment Period|Adverse Event|6|||
160475097|NCT02410278|579469043|FG002|Study Treatment Period|Adverse Event|3|||
160475098|NCT02410278|579469041|FG000|Study Treatment Period|Physician Decision|0|||
160475099|NCT02410278|579469042|FG001|Study Treatment Period|Physician Decision|0|||
160475100|NCT02410278|579469043|FG002|Study Treatment Period|Physician Decision|1|||
160475101|NCT02410278|579469041|FG000|Study Treatment Period|Withdrawal by Subject|0|||
160475102|NCT02410278|579469042|FG001|Study Treatment Period|Withdrawal by Subject|1|||
160475103|NCT02410278|579469043|FG002|Study Treatment Period|Withdrawal by Subject|0|||
160475104|NCT02410278|579469041|FG000|Study Treatment Period|Other|0|||
160475105|NCT02410278|579469042|FG001|Study Treatment Period|Other|3|||
160475106|NCT02410278|579469043|FG002|Study Treatment Period|Other|0|||
160475107|NCT02410278|579469041|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
160475108|NCT02410278|579469042|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
160475109|NCT02410278|579469043|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
160475110|NCT02584257|579469044|FG000|Period 1|Withdrawal by Subject|0|||
160475111|NCT02584257|579469045|FG001|Period 1|Withdrawal by Subject|0|||
160475112|NCT02584257|579469046|FG002|Period 1|Withdrawal by Subject|0|||
160475113|NCT02584257|579469047|FG003|Period 1|Withdrawal by Subject|0|||
160475114|NCT02584257|579469048|FG004|Period 1|Withdrawal by Subject|0|||
160475115|NCT02584257|579469049|FG005|Period 1|Withdrawal by Subject|0|||
160475116|NCT02584257|579469050|FG006|Period 1|Withdrawal by Subject|1|||
160475117|NCT02584257|579469051|FG007|Period 1|Withdrawal by Subject|0|||
160475118|NCT02584257|579469052|FG008|Period 1|Withdrawal by Subject|0|||
160475119|NCT02584257|579469044|FG000|Period 2|Physician Decision|1|||
160475120|NCT02584257|579469045|FG001|Period 2|Physician Decision|0|||
160475121|NCT02584257|579469046|FG002|Period 2|Physician Decision|0|||
160475122|NCT02584257|579469047|FG003|Period 2|Physician Decision|0|||
160475123|NCT02584257|579469048|FG004|Period 2|Physician Decision|0|||
160475124|NCT02584257|579469049|FG005|Period 2|Physician Decision|0|||
160475125|NCT02584257|579469050|FG006|Period 2|Physician Decision|0|||
160475126|NCT02584257|579469051|FG007|Period 2|Physician Decision|0|||
160475127|NCT02584257|579469052|FG008|Period 2|Physician Decision|0|||
160475128|NCT02584257|579469044|FG000|Period 2|Adverse Event|0|||
160475129|NCT02584257|579469045|FG001|Period 2|Adverse Event|1|||
160475130|NCT02584257|579469046|FG002|Period 2|Adverse Event|0|||
160475131|NCT02584257|579469047|FG003|Period 2|Adverse Event|0|||
160475132|NCT02584257|579469048|FG004|Period 2|Adverse Event|0|||
160475133|NCT02584257|579469049|FG005|Period 2|Adverse Event|0|||
160475134|NCT02584257|579469050|FG006|Period 2|Adverse Event|0|||
160475135|NCT02584257|579469051|FG007|Period 2|Adverse Event|0|||
160475136|NCT02584257|579469052|FG008|Period 2|Adverse Event|0|||
160475137|NCT01670877|579469053|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
160475138|NCT01670877|579469054|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
160475139|NCT01670877|579469055|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
160475140|NCT01670877|579469056|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
160475141|NCT01670877|579469057|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
160475142|NCT01670877|579469058|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
160475143|NCT01670877|579469053|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
160475144|NCT01670877|579469054|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
160475145|NCT01670877|579469055|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
160475146|NCT01670877|579469056|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
160475147|NCT01670877|579469057|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
160475148|NCT01670877|579469058|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
160475149|NCT01670877|579469053|FG000|Part I and Part 2|Grade 2 vomiting|0|||
160475150|NCT01670877|579469054|FG001|Part I and Part 2|Grade 2 vomiting|0|||
160475151|NCT01670877|579469055|FG002|Part I and Part 2|Grade 2 vomiting|0|||
160475152|NCT01670877|579469056|FG003|Part I and Part 2|Grade 2 vomiting|1|||
160475153|NCT01670877|579469057|FG004|Part I and Part 2|Grade 2 vomiting|0|||
160475154|NCT01670877|579469058|FG005|Part I and Part 2|Grade 2 vomiting|0|||
160475155|NCT01670877|579469053|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
160475156|NCT01670877|579469054|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
160475157|NCT01670877|579469055|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
160475158|NCT01670877|579469056|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
160475159|NCT01670877|579469057|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
160475160|NCT01670877|579469058|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
160475161|NCT01670877|579469053|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
160475162|NCT01670877|579469054|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
160601967|NCT02431702|579920153|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
160601968|NCT02431702|579920154|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
160601969|NCT02431702|579920155|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
160601970|NCT02431702|579920156|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
160601971|NCT02431702|579920150|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
160601972|NCT02431702|579920151|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
160601973|NCT02431702|579920152|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
160475163|NCT01670877|579469055|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
160475164|NCT01670877|579469056|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
160475165|NCT01670877|579469057|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
160475166|NCT01670877|579469058|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
160475167|NCT02309892|579469059|FG000|Overall Study|Physician Decision|1|||
160475168|NCT02309892|579469060|FG001|Overall Study|Physician Decision|0|||
160475169|NCT02309892|579469061|FG002|Overall Study|Physician Decision|0|||
160475170|NCT02309892|579469062|FG003|Overall Study|Physician Decision|0|||
160475171|NCT02309892|579469063|FG004|Overall Study|Physician Decision|0|||
160601974|NCT02431702|579920153|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
160601975|NCT02431702|579920154|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
160601976|NCT02431702|579920155|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
160601977|NCT02431702|579920156|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
160601978|NCT02431702|579920150|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
160601979|NCT02431702|579920151|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
160601980|NCT02431702|579920152|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
160601981|NCT02431702|579920153|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
160601982|NCT02431702|579920154|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
160601983|NCT02431702|579920155|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
160601984|NCT02431702|579920156|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
160601985|NCT02431702|579920150|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
160601986|NCT02431702|579920151|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
160601987|NCT02431702|579920152|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
160601988|NCT02431702|579920153|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
160601989|NCT02431702|579920154|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
160601990|NCT02431702|579920155|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
160601991|NCT02431702|579920156|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
160601992|NCT02431702|579920150|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
160601993|NCT02431702|579920151|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
160601994|NCT02431702|579920152|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
160601995|NCT02431702|579920153|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
160601996|NCT02431702|579920154|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
160601997|NCT02431702|579920155|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
160601998|NCT02431702|579920156|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
160601999|NCT02431702|579920150|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
160602000|NCT02431702|579920151|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
160602001|NCT02431702|579920152|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
160602002|NCT02431702|579920153|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
160602003|NCT02431702|579920154|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
160602004|NCT02431702|579920155|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
160602005|NCT02431702|579920156|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
160602006|NCT02431702|579920150|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
160602007|NCT02431702|579920151|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
160602008|NCT02431702|579920152|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
160602009|NCT02431702|579920153|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
160602010|NCT02431702|579920154|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
160602011|NCT02431702|579920155|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
160602012|NCT02431702|579920156|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
160602013|NCT02431702|579920150|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
160602014|NCT02431702|579920151|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
160602015|NCT02431702|579920152|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
160602016|NCT02431702|579920153|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
160602017|NCT02431702|579920154|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
160602018|NCT02431702|579920155|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
160602019|NCT02431702|579920156|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
160602020|NCT02431702|579920150|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
160602021|NCT02431702|579920151|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
160602022|NCT02431702|579920152|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
160602023|NCT02431702|579920153|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
160602024|NCT02431702|579920154|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
160602025|NCT02431702|579920155|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
160602026|NCT02431702|579920156|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
160602027|NCT02431702|579920150|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
160602028|NCT02431702|579920151|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
160602029|NCT02431702|579920152|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
160602030|NCT02431702|579920153|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
160602031|NCT02431702|579920154|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
160602032|NCT02431702|579920155|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
160602033|NCT02431702|579920156|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
160602034|NCT02431702|579920150|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
160602035|NCT02431702|579920151|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
160602036|NCT02431702|579920152|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
160602037|NCT02431702|579920153|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
160602038|NCT02431702|579920154|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
160602039|NCT02431702|579920155|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
160602040|NCT02431702|579920156|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
160602041|NCT02431702|579920150|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
160602042|NCT02431702|579920151|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
160602043|NCT02431702|579920152|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
160602044|NCT02431702|579920153|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
160602045|NCT02431702|579920154|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
160602046|NCT02431702|579920155|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
160602047|NCT02431702|579920156|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
160602048|NCT02431702|579920150|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
160602049|NCT02431702|579920151|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
160602050|NCT02431702|579920152|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
160602051|NCT02431702|579920153|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
160602052|NCT02431702|579920154|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
160602053|NCT02431702|579920155|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
160602054|NCT02431702|579920156|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
160602055|NCT02431702|579920150|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
160602056|NCT02431702|579920151|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
160602057|NCT02431702|579920152|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
160602058|NCT02431702|579920153|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
160602059|NCT02431702|579920154|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
160602060|NCT02431702|579920155|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
160602061|NCT02431702|579920156|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
160602062|NCT02431702|579920150|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
160602063|NCT02431702|579920151|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
160602064|NCT02431702|579920152|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
160602065|NCT02431702|579920153|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
160602066|NCT02431702|579920154|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
160602067|NCT02431702|579920155|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
160602068|NCT02431702|579920156|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
160602069|NCT02255760|579920171|FG000|Overall Study|Lost to Follow-up|0|||
160602070|NCT02255760|579920172|FG001|Overall Study|Lost to Follow-up|1|||
160602071|NCT02255760|579920173|FG002|Overall Study|Lost to Follow-up|0|||
160602072|NCT02255760|579920174|FG003|Overall Study|Lost to Follow-up|0|||
160602073|NCT02255760|579920175|FG004|Overall Study|Lost to Follow-up|0|||
160602074|NCT01611298|579920182|FG000|Overall Study|Relapsed|2|||
160602075|NCT03238352|579920183|FG000|Overall Study|Lost to Follow-up|0|||
160602076|NCT03238352|579920184|FG001|Overall Study|Lost to Follow-up|2|||
160602077|NCT03238352|579920185|FG002|Overall Study|Lost to Follow-up|1|||
160602078|NCT03238352|579920183|FG000|Overall Study|Withdrawal by Subject|0|||
160602079|NCT03238352|579920184|FG001|Overall Study|Withdrawal by Subject|1|||
160602080|NCT03238352|579920185|FG002|Overall Study|Withdrawal by Subject|0|||
160602081|NCT00928512|579920186|FG000|Overall Study|Adverse Event|4|||
160602082|NCT00928512|579920187|FG001|Overall Study|Adverse Event|3|||
160602083|NCT00928512|579920188|FG002|Overall Study|Adverse Event|2|||
160602084|NCT00928512|579920189|FG003|Overall Study|Adverse Event|8|||
160602085|NCT00928512|579920190|FG004|Overall Study|Adverse Event|6|||
160602086|NCT00928512|579920186|FG000|Overall Study|Lack of Efficacy|2|||
160602087|NCT00928512|579920187|FG001|Overall Study|Lack of Efficacy|0|||
160602088|NCT00928512|579920188|FG002|Overall Study|Lack of Efficacy|4|||
160602089|NCT00928512|579920189|FG003|Overall Study|Lack of Efficacy|7|||
160602090|NCT00928512|579920190|FG004|Overall Study|Lack of Efficacy|3|||
160602091|NCT00928512|579920186|FG000|Overall Study|Protocol Violation|0|||
160602092|NCT00928512|579920187|FG001|Overall Study|Protocol Violation|1|||
160602093|NCT00928512|579920188|FG002|Overall Study|Protocol Violation|0|||
160602094|NCT00928512|579920189|FG003|Overall Study|Protocol Violation|1|||
160602095|NCT00928512|579920190|FG004|Overall Study|Protocol Violation|3|||
160602096|NCT00928512|579920186|FG000|Overall Study|Withdrawal by Subject|3|||
160602097|NCT00928512|579920187|FG001|Overall Study|Withdrawal by Subject|0|||
160602098|NCT00928512|579920188|FG002|Overall Study|Withdrawal by Subject|3|||
160602099|NCT00928512|579920189|FG003|Overall Study|Withdrawal by Subject|4|||
160602100|NCT00928512|579920190|FG004|Overall Study|Withdrawal by Subject|0|||
160602101|NCT00928512|579920186|FG000|Overall Study|Lost to Follow-up|1|||
160602102|NCT00928512|579920187|FG001|Overall Study|Lost to Follow-up|1|||
160602103|NCT00928512|579920188|FG002|Overall Study|Lost to Follow-up|2|||
160602104|NCT00928512|579920189|FG003|Overall Study|Lost to Follow-up|1|||
160602105|NCT00928512|579920190|FG004|Overall Study|Lost to Follow-up|3|||
160602106|NCT00928512|579920186|FG000|Overall Study|Administrative Problems|0|||
160602107|NCT00928512|579920187|FG001|Overall Study|Administrative Problems|1|||
160602108|NCT00928512|579920188|FG002|Overall Study|Administrative Problems|0|||
160602109|NCT00928512|579920189|FG003|Overall Study|Administrative Problems|0|||
160602110|NCT00928512|579920190|FG004|Overall Study|Administrative Problems|0|||
160602111|NCT01963780|579920191|FG000|Overall Study|Death|7|||
160602112|NCT03383614|579920192|FG000|Overall Study|Withdrawal by Subject|0|||
160602113|NCT03383614|579920193|FG001|Overall Study|Withdrawal by Subject|1|||
160602114|NCT03383614|579920194|FG002|Overall Study|Withdrawal by Subject|0|||
160602115|NCT03383614|579920195|FG003|Overall Study|Withdrawal by Subject|0|||
160602116|NCT01296698|579920198|FG000|Overall Study|Adverse Event|1|||
160602117|NCT01296698|579920199|FG001|Overall Study|Adverse Event|0|||
160602118|NCT01296698|579920198|FG000|Overall Study|Death|1|||
160602119|NCT01296698|579920199|FG001|Overall Study|Death|0|||
160602120|NCT01296698|579920198|FG000|Overall Study|Lost to Follow-up|19|||
160602121|NCT01296698|579920199|FG001|Overall Study|Lost to Follow-up|1|||
160602122|NCT01296698|579920198|FG000|Overall Study|Withdrawal by Subject|12|||
160602123|NCT01296698|579920199|FG001|Overall Study|Withdrawal by Subject|0|||
160602124|NCT01296698|579920198|FG000|Overall Study|Difficulty Contacting Subject|2|||
160602125|NCT01296698|579920199|FG001|Overall Study|Difficulty Contacting Subject|0|||
160602126|NCT01296698|579920198|FG000|Overall Study|Study Terminated by Sponsor|209|||
160602127|NCT01296698|579920199|FG001|Overall Study|Study Terminated by Sponsor|12|||
160602128|NCT03495817|579920203|FG000|26 Week Open Label|Adverse Event|3|||
160602129|NCT03495817|579920203|FG000|26 Week Open Label|Withdrawal by Subject|4|||
160602130|NCT03495817|579920203|FG000|26 Week Open Label|Lost to Follow-up|1|||
160602131|NCT03495817|579920203|FG000|26 Week Extension|Lost to Follow-up|2|||
160602132|NCT01686958|579920204|FG000|Overall Study|Withdrawal by Subject|1|||
160602133|NCT04294095|579920211|FG000|Overall Study|Adverse Event|1|||
160602134|NCT04294095|579920212|FG001|Overall Study|Adverse Event|0|||
160602135|NCT00293241|579920215|FG000|Overall Study|Lost to Follow-up|9|||
160602136|NCT00293241|579920216|FG001|Overall Study|Lost to Follow-up|16|||
160602137|NCT00293241|579920215|FG000|Overall Study|Physician Decision|23|||
160602138|NCT00293241|579920216|FG001|Overall Study|Physician Decision|17|||
160602139|NCT00293241|579920215|FG000|Overall Study|Withdrawal by Subject|4|||
160602140|NCT00293241|579920216|FG001|Overall Study|Withdrawal by Subject|8|||
160602141|NCT03803202|579920217|FG000|Overall Study|Other|0|||
160602142|NCT03803202|579920218|FG001|Overall Study|Other|1|||
160602143|NCT03803202|579920219|FG002|Overall Study|Other|0|||
160602144|NCT03803202|579920220|FG003|Overall Study|Other|0|||
160602145|NCT03803202|579920221|FG004|Overall Study|Other|0|||
160602146|NCT03803202|579920222|FG005|Overall Study|Other|0|||
160602147|NCT03803202|579920223|FG006|Overall Study|Other|0|||
160602148|NCT03803202|579920224|FG007|Overall Study|Other|0|||
160602149|NCT03803202|579920225|FG008|Overall Study|Other|0|||
160602150|NCT03803202|579920217|FG000|Overall Study|Death|0|||
160602151|NCT03803202|579920218|FG001|Overall Study|Death|0|||
160602152|NCT03803202|579920219|FG002|Overall Study|Death|0|||
160602153|NCT03803202|579920220|FG003|Overall Study|Death|0|||
160602154|NCT03803202|579920221|FG004|Overall Study|Death|0|||
160602155|NCT03803202|579920222|FG005|Overall Study|Death|1|||
160475172|NCT02309892|579469064|FG005|Overall Study|Physician Decision|0|||
160475173|NCT02309892|579469065|FG006|Overall Study|Physician Decision|0|||
160475174|NCT02309892|579469059|FG000|Overall Study|Adverse Event|1|||
160475175|NCT02309892|579469060|FG001|Overall Study|Adverse Event|0|||
160475176|NCT02309892|579469061|FG002|Overall Study|Adverse Event|1|||
160475177|NCT02309892|579469062|FG003|Overall Study|Adverse Event|0|||
160475178|NCT02309892|579469063|FG004|Overall Study|Adverse Event|0|||
160475179|NCT02309892|579469064|FG005|Overall Study|Adverse Event|0|||
160475180|NCT02309892|579469065|FG006|Overall Study|Adverse Event|0|||
160602156|NCT03803202|579920223|FG006|Overall Study|Death|0|||
160602157|NCT03803202|579920224|FG007|Overall Study|Death|0|||
160602158|NCT03803202|579920225|FG008|Overall Study|Death|0|||
160602159|NCT03803202|579920217|FG000|Overall Study|Withdrawal by Subject|0|||
160602160|NCT03803202|579920218|FG001|Overall Study|Withdrawal by Subject|0|||
160475181|NCT02309892|579469059|FG000|Overall Study|Progressive Disease|0|||
160475182|NCT02309892|579469060|FG001|Overall Study|Progressive Disease|1|||
160602161|NCT03803202|579920219|FG002|Overall Study|Withdrawal by Subject|1|||
160602162|NCT03803202|579920220|FG003|Overall Study|Withdrawal by Subject|0|||
160602163|NCT03803202|579920221|FG004|Overall Study|Withdrawal by Subject|0|||
160475183|NCT02309892|579469061|FG002|Overall Study|Progressive Disease|0|||
160475184|NCT02309892|579469062|FG003|Overall Study|Progressive Disease|0|||
160602164|NCT03803202|579920222|FG005|Overall Study|Withdrawal by Subject|0|||
160602165|NCT03803202|579920223|FG006|Overall Study|Withdrawal by Subject|0|||
160602166|NCT03803202|579920224|FG007|Overall Study|Withdrawal by Subject|1|||
160602167|NCT03803202|579920225|FG008|Overall Study|Withdrawal by Subject|0|||
160602168|NCT03803202|579920217|FG000|Overall Study|Lost to Follow-up|0|||
160602169|NCT03803202|579920218|FG001|Overall Study|Lost to Follow-up|0|||
160602170|NCT03803202|579920219|FG002|Overall Study|Lost to Follow-up|0|||
160475185|NCT02309892|579469063|FG004|Overall Study|Progressive Disease|1|||
160602171|NCT03803202|579920220|FG003|Overall Study|Lost to Follow-up|1|||
160602172|NCT03803202|579920221|FG004|Overall Study|Lost to Follow-up|1|||
160602173|NCT03803202|579920222|FG005|Overall Study|Lost to Follow-up|0|||
160602174|NCT03803202|579920223|FG006|Overall Study|Lost to Follow-up|1|||
160602175|NCT03803202|579920224|FG007|Overall Study|Lost to Follow-up|0|||
160602176|NCT03803202|579920225|FG008|Overall Study|Lost to Follow-up|0|||
160602177|NCT03595384|579920226|FG000|Overall Study|Other time commitments|8|||
160602178|NCT03595384|579920226|FG000|Overall Study|Changes to session time|7|||
160602179|NCT03595384|579920226|FG000|Overall Study|Relocation out of country|1|||
160602180|NCT01125293|579920227|FG000|Overall Study|Disease Progression|1|||
160602181|NCT01125293|579920228|FG001|Overall Study|Disease Progression|3|||
160602182|NCT01125293|579920229|FG002|Overall Study|Disease Progression|4|||
160602183|NCT01125293|579920230|FG003|Overall Study|Disease Progression|3|||
160602184|NCT01125293|579920231|FG004|Overall Study|Disease Progression|5|||
160602185|NCT01125293|579920232|FG005|Overall Study|Disease Progression|12|||
160602186|NCT01125293|579920227|FG000|Overall Study|Adverse Event|1|||
160602187|NCT01125293|579920228|FG001|Overall Study|Adverse Event|0|||
160602188|NCT01125293|579920229|FG002|Overall Study|Adverse Event|0|||
160602189|NCT01125293|579920230|FG003|Overall Study|Adverse Event|0|||
160602190|NCT01125293|579920231|FG004|Overall Study|Adverse Event|2|||
160602191|NCT01125293|579920232|FG005|Overall Study|Adverse Event|8|||
160602192|NCT01125293|579920227|FG000|Overall Study|Symptomatic Deterioration|1|||
160602193|NCT01125293|579920228|FG001|Overall Study|Symptomatic Deterioration|0|||
160602194|NCT01125293|579920229|FG002|Overall Study|Symptomatic Deterioration|0|||
160602195|NCT01125293|579920230|FG003|Overall Study|Symptomatic Deterioration|0|||
160602196|NCT01125293|579920231|FG004|Overall Study|Symptomatic Deterioration|0|||
160602197|NCT01125293|579920232|FG005|Overall Study|Symptomatic Deterioration|0|||
160602198|NCT01125293|579920227|FG000|Overall Study|Death|0|||
160602199|NCT01125293|579920228|FG001|Overall Study|Death|0|||
160602200|NCT01125293|579920229|FG002|Overall Study|Death|0|||
160602201|NCT01125293|579920230|FG003|Overall Study|Death|0|||
160602202|NCT01125293|579920231|FG004|Overall Study|Death|1|||
160602203|NCT01125293|579920232|FG005|Overall Study|Death|0|||
160602204|NCT01125293|579920227|FG000|Overall Study|Withdrawal by Subject|0|||
160602205|NCT01125293|579920228|FG001|Overall Study|Withdrawal by Subject|0|||
160602206|NCT01125293|579920229|FG002|Overall Study|Withdrawal by Subject|0|||
160602207|NCT01125293|579920230|FG003|Overall Study|Withdrawal by Subject|0|||
160602208|NCT01125293|579920231|FG004|Overall Study|Withdrawal by Subject|2|||
160602209|NCT01125293|579920232|FG005|Overall Study|Withdrawal by Subject|1|||
160602210|NCT01125293|579920227|FG000|Overall Study|Physician Decision|0|||
160602211|NCT01125293|579920228|FG001|Overall Study|Physician Decision|0|||
160602212|NCT01125293|579920229|FG002|Overall Study|Physician Decision|0|||
160602213|NCT01125293|579920230|FG003|Overall Study|Physician Decision|0|||
160602214|NCT01125293|579920231|FG004|Overall Study|Physician Decision|0|||
160602215|NCT01125293|579920232|FG005|Overall Study|Physician Decision|2|||
160475186|NCT02309892|579469064|FG005|Overall Study|Progressive Disease|0|||
160475187|NCT02309892|579469065|FG006|Overall Study|Progressive Disease|0|||
160660190|NCT03447262|580137736|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
160475188|NCT02309892|579469059|FG000|Overall Study|Death|0|||
160475189|NCT02309892|579469060|FG001|Overall Study|Death|0|||
160475190|NCT02309892|579469061|FG002|Overall Study|Death|0|||
160475191|NCT02309892|579469062|FG003|Overall Study|Death|0|||
160475192|NCT02309892|579469063|FG004|Overall Study|Death|0|||
160475193|NCT02309892|579469064|FG005|Overall Study|Death|1|||
160475194|NCT02309892|579469065|FG006|Overall Study|Death|0|||
160475195|NCT02721147|579469068|FG000|Overall Study|Lost to Follow-up|2|||
160475196|NCT02721147|579469069|FG001|Overall Study|Lost to Follow-up|0|||
160475197|NCT02721147|579469070|FG002|Overall Study|Lost to Follow-up|0|||
160475198|NCT05376397|579469071|FG000|Overall Study|Lost to Follow-up|1|||
160475199|NCT01722097|579469072|FG000|Overall Study|Patient sheets not returned|6|||
160475200|NCT01722097|579469073|FG001|Overall Study|Patient sheets not returned|5|||
160475201|NCT01535261|579469075|FG000|Overall Study|Physician Decision|8|||
160475202|NCT01535261|579469075|FG000|Overall Study|Protocol Violation|3|||
160475203|NCT01535261|579469075|FG000|Overall Study|Death|5|||
160475204|NCT01535261|579469075|FG000|Overall Study|Lost to Follow-up|8|||
160475205|NCT01535261|579469075|FG000|Overall Study|Withdrawal by Subject|14|||
160475206|NCT01535261|579469075|FG000|Overall Study|Adverse Event|12|||
160475207|NCT01137682|579469078|FG000|Overall Study|Adverse Event-CORE|2|||
160475208|NCT01137682|579469079|FG001|Overall Study|Adverse Event-CORE|4|||
160475209|NCT01137682|579469080|FG002|Overall Study|Adverse Event-CORE|0|||
160475210|NCT01137682|579469078|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
160475211|NCT01137682|579469079|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
160475212|NCT01137682|579469080|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
160475213|NCT01137682|579469078|FG000|Overall Study|Administrative problems-CORE|2|||
160475214|NCT01137682|579469079|FG001|Overall Study|Administrative problems-CORE|1|||
160475215|NCT01137682|579469080|FG002|Overall Study|Administrative problems-CORE|0|||
160475216|NCT01137682|579469078|FG000|Overall Study|Protocol Violation-CORE|0|||
160475217|NCT01137682|579469079|FG001|Overall Study|Protocol Violation-CORE|1|||
160475218|NCT01137682|579469080|FG002|Overall Study|Protocol Violation-CORE|1|||
160475219|NCT01137682|579469078|FG000|Overall Study|Adverse Event-Extension|4|||
160475220|NCT01137682|579469079|FG001|Overall Study|Adverse Event-Extension|8|||
160475221|NCT01137682|579469080|FG002|Overall Study|Adverse Event-Extension|7|||
160475222|NCT01137682|579469078|FG000|Overall Study|Lack of Efficacy-Extension|15|||
160475223|NCT01137682|579469079|FG001|Overall Study|Lack of Efficacy-Extension|9|||
160475224|NCT01137682|579469080|FG002|Overall Study|Lack of Efficacy-Extension|13|||
160475225|NCT01137682|579469078|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
160475226|NCT01137682|579469079|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
160475227|NCT01137682|579469080|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
160475228|NCT01137682|579469078|FG000|Overall Study|Lost to Follow Up-Extension|0|||
160475229|NCT01137682|579469079|FG001|Overall Study|Lost to Follow Up-Extension|1|||
160475230|NCT01137682|579469080|FG002|Overall Study|Lost to Follow Up-Extension|0|||
160475231|NCT01137682|579469078|FG000|Overall Study|Administrative problems-Extension|0|||
160475232|NCT01137682|579469079|FG001|Overall Study|Administrative problems-Extension|2|||
160475233|NCT01137682|579469080|FG002|Overall Study|Administrative problems-Extension|0|||
160475234|NCT01137682|579469078|FG000|Overall Study|Death-Extension|2|||
160475235|NCT01137682|579469079|FG001|Overall Study|Death-Extension|0|||
160475236|NCT01137682|579469080|FG002|Overall Study|Death-Extension|0|||
160475237|NCT01137682|579469078|FG000|Overall Study|Protocol Violation-Extension|2|||
160475238|NCT01137682|579469079|FG001|Overall Study|Protocol Violation-Extension|1|||
160475239|NCT01137682|579469080|FG002|Overall Study|Protocol Violation-Extension|0|||
160475240|NCT01137682|579469078|FG000|Overall Study|Did not enter extension|2|||
160475241|NCT01137682|579469079|FG001|Overall Study|Did not enter extension|3|||
160602216|NCT01270958|579920233|FG000|Overall Study|Lost to Follow-up|2|||
160602217|NCT01270958|579920233|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
160602218|NCT01406652|579920236|FG000|Overall Study|Lost-to-follow-up|3|||
160475242|NCT01137682|579469080|FG002|Overall Study|Did not enter extension|2|||
160475243|NCT01137682|579469078|FG000|Overall Study|Did not receive treatment in extension|0|||
160475244|NCT01137682|579469079|FG001|Overall Study|Did not receive treatment in extension|0|||
160475245|NCT01137682|579469080|FG002|Overall Study|Did not receive treatment in extension|1|||
160475246|NCT02009332|579469081|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
160475247|NCT02009332|579469082|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
160475248|NCT02009332|579469083|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
160475249|NCT02009332|579469084|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
160475250|NCT02009332|579469085|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
160475251|NCT02009332|579469086|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
160475252|NCT02009332|579469081|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
160475253|NCT02009332|579469082|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
160475254|NCT02009332|579469083|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
160475255|NCT02009332|579469084|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
160475256|NCT02009332|579469085|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
160475257|NCT02009332|579469086|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
160475258|NCT02009332|579469081|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
160475259|NCT02009332|579469082|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
160475260|NCT02009332|579469083|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
160475261|NCT02009332|579469084|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
160475262|NCT02009332|579469085|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
160475263|NCT02009332|579469086|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
160475264|NCT01912599|579469087|FG000|Overall Study|Withdrawal by Subject|0|||
160475265|NCT01912599|579469088|FG001|Overall Study|Withdrawal by Subject|1|||
160475266|NCT01280721|579469092|FG000|Overall Study|Adverse Event|4|||
160475267|NCT01280721|579469092|FG000|Overall Study|Physician Decision|3|||
160475268|NCT01280721|579469092|FG000|Overall Study|Withdrawal by Subject|6|||
160475269|NCT01280721|579469092|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
160475270|NCT01280721|579469092|FG000|Overall Study|No tolerability for the lowest dose|2|||
160475271|NCT01180400|579469093|FG000|Overall Study|Withdrawal by Subject|5|||
160475272|NCT01180400|579469094|FG001|Overall Study|Withdrawal by Subject|6|||
160475273|NCT01180400|579469093|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160475274|NCT01180400|579469094|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
160475275|NCT01180400|579469093|FG000|Overall Study|Adverse Event|12|||
160475276|NCT01180400|579469094|FG001|Overall Study|Adverse Event|10|||
160475277|NCT01180400|579469093|FG000|Overall Study|Severe non-compliance to protocol|1|||
160475278|NCT01180400|579469094|FG001|Overall Study|Severe non-compliance to protocol|2|||
160475279|NCT01180400|579469093|FG000|Overall Study|Condition under investigation worsened|2|||
160475280|NCT01180400|579469094|FG001|Overall Study|Condition under investigation worsened|1|||
160475281|NCT01180400|579469093|FG000|Overall Study|Lack of Efficacy|2|||
160475282|NCT01180400|579469094|FG001|Overall Study|Lack of Efficacy|0|||
160475283|NCT01180400|579469093|FG000|Overall Study|Study-specific withdrawal criteria|1|||
160475284|NCT01180400|579469094|FG001|Overall Study|Study-specific withdrawal criteria|2|||
160475285|NCT01180400|579469093|FG000|Overall Study|Lost to Follow-up|2|||
160475286|NCT01180400|579469094|FG001|Overall Study|Lost to Follow-up|3|||
160475287|NCT01180400|579469093|FG000|Overall Study|Other|0|||
160475288|NCT01180400|579469094|FG001|Overall Study|Other|1|||
160475289|NCT00042939|579469096|FG000|Overall Study|Adverse Event|6|||
160475290|NCT00042939|579469097|FG001|Overall Study|Adverse Event|7|||
160475291|NCT00042939|579469096|FG000|Overall Study|Death|3|||
160475292|NCT00042939|579469097|FG001|Overall Study|Death|2|||
160475293|NCT00042939|579469096|FG000|Overall Study|Withdrawal by Subject|3|||
160475294|NCT00042939|579469097|FG001|Overall Study|Withdrawal by Subject|4|||
160475295|NCT00042939|579469096|FG000|Overall Study|Other disease|1|||
160475296|NCT00042939|579469097|FG001|Overall Study|Other disease|0|||
160475297|NCT00042939|579469096|FG000|Overall Study|Ineligible|2|||
160475298|NCT00042939|579469097|FG001|Overall Study|Ineligible|2|||
160475299|NCT00042939|579469096|FG000|Overall Study|Deterioration of health|3|||
160475300|NCT00042939|579469097|FG001|Overall Study|Deterioration of health|4|||
160475301|NCT00042939|579469096|FG000|Overall Study|QOL diminished|1|||
160475302|NCT00042939|579469097|FG001|Overall Study|QOL diminished|0|||
160475303|NCT00042939|579469096|FG000|Overall Study|Rising ca 19-9|1|||
160475304|NCT00042939|579469097|FG001|Overall Study|Rising ca 19-9|0|||
160475305|NCT00042939|579469096|FG000|Overall Study|Patient non-compliance|1|||
160475306|NCT00042939|579469097|FG001|Overall Study|Patient non-compliance|0|||
160475307|NCT00042939|579469096|FG000|Overall Study|Still on treatment|1|||
160475308|NCT00042939|579469097|FG001|Overall Study|Still on treatment|0|||
160475309|NCT00042939|579469096|FG000|Overall Study|Treatment break > 4 weeks|0|||
160475310|NCT00042939|579469097|FG001|Overall Study|Treatment break > 4 weeks|1|||
160475311|NCT00042939|579469096|FG000|Overall Study|Did not start treatment|2|||
160475312|NCT00042939|579469097|FG001|Overall Study|Did not start treatment|1|||
160475313|NCT03349476|579469098|FG000|Overall Study|Physician Decision|3|||
160475314|NCT00795639|579469099|FG000|Overall Study|Death|1|||
160475315|NCT00795639|579469100|FG001|Overall Study|Death|6|||
160475316|NCT00795639|579469099|FG000|Overall Study|Withdrawal by Subject|1|||
160475317|NCT00795639|579469100|FG001|Overall Study|Withdrawal by Subject|3|||
160475318|NCT00795639|579469099|FG000|Overall Study|Pregnancy|1|||
160475319|NCT00795639|579469100|FG001|Overall Study|Pregnancy|0|||
160475320|NCT00795639|579469099|FG000|Overall Study|Adverse Event|5|||
160475321|NCT00795639|579469100|FG001|Overall Study|Adverse Event|2|||
160475322|NCT00795639|579469099|FG000|Overall Study|Other|0|||
160475323|NCT00795639|579469100|FG001|Overall Study|Other|2|||
160475324|NCT00795639|579469099|FG000|Overall Study|Terminated by sponsor|13|||
160475325|NCT00795639|579469100|FG001|Overall Study|Terminated by sponsor|12|||
160475326|NCT00795639|579469099|FG000|Overall Study|Randomized and not treated|0|||
160475327|NCT00795639|579469100|FG001|Overall Study|Randomized and not treated|1|||
160475328|NCT03449979|579469101|FG000|Overall Study|Technical difficulty|0|||
160475329|NCT03449979|579469102|FG001|Overall Study|Technical difficulty|0|||
160475330|NCT03449979|579469103|FG002|Overall Study|Technical difficulty|0|||
160475331|NCT03449979|579469104|FG003|Overall Study|Technical difficulty|1|||
160475332|NCT01762345|579469105|FG000|Overall Study|Adverse Event|5|||
160475333|NCT01762345|579469105|FG000|Overall Study|Protocol Violation|2|||
160475334|NCT02379078|579469106|FG000|Overall Study|Lost to Follow-up|33|||
160475335|NCT02379078|579469107|FG001|Overall Study|Lost to Follow-up|30|||
160475336|NCT02379078|579469106|FG000|Overall Study|Withdrawal by Subject|6|||
160475337|NCT02379078|579469107|FG001|Overall Study|Withdrawal by Subject|5|||
160475338|NCT03481725|579469108|FG000|Overall Study|Withdrawal by Subject|1|||
160475339|NCT03481725|579469109|FG001|Overall Study|Withdrawal by Subject|0|||
160475340|NCT03444155|579469112|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
160475341|NCT03444155|579469113|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
160475342|NCT02877680|579469114|FG000|Overall Study|Lost to Follow-up|1|||
160475343|NCT02877680|579469115|FG001|Overall Study|Lost to Follow-up|1|||
160475344|NCT01133678|579469116|FG000|Overall Study|Death|1|||
160475345|NCT01133678|579469117|FG001|Overall Study|Death|1|||
160475346|NCT02077374|579469128|FG000|Overall Study|Withdrawal by Subject|0|||
160475347|NCT02077374|579469129|FG001|Overall Study|Withdrawal by Subject|1|||
160475348|NCT02077374|579469128|FG000|Overall Study|Protocol Violation|0|||
160475349|NCT02077374|579469129|FG001|Overall Study|Protocol Violation|1|||
160475350|NCT01777932|579469130|FG000|Overall Study|Disease progression|136|||
160475351|NCT01777932|579469130|FG000|Overall Study|Death|3|||
160475352|NCT01777932|579469130|FG000|Overall Study|Adverse Event|34|||
160475353|NCT01777932|579469130|FG000|Overall Study|Lost to Follow-up|3|||
160475354|NCT01777932|579469130|FG000|Overall Study|Investigator decision|10|||
160475355|NCT01777932|579469130|FG000|Overall Study|Reimbursement limit|9|||
160475356|NCT01777932|579469130|FG000|Overall Study|Patient refused further treatment|10|||
160475357|NCT00068107|579469136|FG000|Overall Study|end-stage renal disease|6|||
160475358|NCT00068107|579469136|FG000|Overall Study|Death|2|||
160475359|NCT00068107|579469136|FG000|Overall Study|Withdrawal by Subject|1|||
160475360|NCT01419184|579469137|FG000|Overall Study|Site data not available|3|||
160475361|NCT01419184|579469138|FG001|Overall Study|Site data not available|2|||
160475362|NCT01419184|579469137|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
160475363|NCT01419184|579469138|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
160475364|NCT01419184|579469137|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
160475365|NCT01419184|579469138|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
160475366|NCT01419184|579469137|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
160475367|NCT01419184|579469138|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
160475368|NCT01419184|579469137|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
160475369|NCT01419184|579469138|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
160475370|NCT01419184|579469137|FG000|Overall Study|Participant randomized, not treated|1|||
160475371|NCT01419184|579469138|FG001|Overall Study|Participant randomized, not treated|0|||
160475372|NCT03989232|579469143|FG000|Overall Study|Lost to Follow-up|3|||
160475373|NCT03989232|579469144|FG001|Overall Study|Lost to Follow-up|10|||
160475374|NCT03989232|579469143|FG000|Overall Study|Withdrawal by Subject|6|||
160475375|NCT03989232|579469144|FG001|Overall Study|Withdrawal by Subject|6|||
160475376|NCT03989232|579469143|FG000|Overall Study|Death|1|||
160475377|NCT03989232|579469144|FG001|Overall Study|Death|2|||
160475378|NCT02644122|579469147|FG000|Overall Study|Withdrawal by Subject|1|||
160475379|NCT00424476|579469150|FG000|Overall Study|Withdrawal by Subject|7|||
160475380|NCT00424476|579469151|FG001|Overall Study|Withdrawal by Subject|6|||
160475381|NCT00424476|579469152|FG002|Overall Study|Withdrawal by Subject|3|||
160475382|NCT00424476|579469150|FG000|Overall Study|Adverse Event|19|||
160475383|NCT00424476|579469151|FG001|Overall Study|Adverse Event|16|||
160475384|NCT00424476|579469152|FG002|Overall Study|Adverse Event|15|||
160475385|NCT00424476|579469150|FG000|Overall Study|Lack of Efficacy|16|||
160475386|NCT00424476|579469151|FG001|Overall Study|Lack of Efficacy|12|||
160475387|NCT00424476|579469152|FG002|Overall Study|Lack of Efficacy|12|||
160475388|NCT00424476|579469150|FG000|Overall Study|Lack of Compliance|1|||
160475389|NCT00424476|579469151|FG001|Overall Study|Lack of Compliance|1|||
160475390|NCT00424476|579469152|FG002|Overall Study|Lack of Compliance|1|||
160475391|NCT00424476|579469150|FG000|Overall Study|Lost to Follow-up|4|||
160475392|NCT00424476|579469151|FG001|Overall Study|Lost to Follow-up|6|||
160475393|NCT00424476|579469152|FG002|Overall Study|Lost to Follow-up|3|||
160475394|NCT00424476|579469150|FG000|Overall Study|Protocol Violation|7|||
160475395|NCT00424476|579469151|FG001|Overall Study|Protocol Violation|2|||
160475396|NCT00424476|579469152|FG002|Overall Study|Protocol Violation|3|||
160475397|NCT00424476|579469150|FG000|Overall Study|Physician Decision|3|||
160475398|NCT00424476|579469151|FG001|Overall Study|Physician Decision|2|||
160475399|NCT00424476|579469152|FG002|Overall Study|Physician Decision|3|||
160475400|NCT00424476|579469150|FG000|Overall Study|Other|4|||
160475401|NCT00424476|579469151|FG001|Overall Study|Other|3|||
160475402|NCT00424476|579469152|FG002|Overall Study|Other|9|||
160475403|NCT02514824|579469153|FG000|Overall Study|Withdrawal by Subject|1|||
160475404|NCT02514824|579469154|FG001|Overall Study|Withdrawal by Subject|0|||
160475405|NCT02514824|579469155|FG002|Overall Study|Withdrawal by Subject|0|||
160475406|NCT02514824|579469156|FG003|Overall Study|Withdrawal by Subject|0|||
160475407|NCT02514824|579469153|FG000|Overall Study|Dose-Limiting Toxicity|0|||
160475408|NCT02514824|579469154|FG001|Overall Study|Dose-Limiting Toxicity|1|||
160475409|NCT02514824|579469155|FG002|Overall Study|Dose-Limiting Toxicity|0|||
160475410|NCT02514824|579469156|FG003|Overall Study|Dose-Limiting Toxicity|0|||
160475411|NCT01930188|579469157|FG000|Overall Study|unclassified|4|||
160475412|NCT01930188|579469158|FG001|Overall Study|unclassified|5|||
160475413|NCT01930188|579469159|FG002|Overall Study|unclassified|3|||
160475414|NCT01930188|579469157|FG000|Overall Study|Missing follow-up information|2|||
160475415|NCT01930188|579469158|FG001|Overall Study|Missing follow-up information|2|||
160475416|NCT01930188|579469159|FG002|Overall Study|Missing follow-up information|3|||
160475417|NCT01930188|579469157|FG000|Overall Study|Lost to Follow-up|5|||
160475418|NCT01930188|579469158|FG001|Overall Study|Lost to Follow-up|2|||
160475419|NCT01930188|579469159|FG002|Overall Study|Lost to Follow-up|2|||
160475420|NCT01930188|579469157|FG000|Overall Study|Death|2|||
160475421|NCT01930188|579469158|FG001|Overall Study|Death|1|||
160475422|NCT01930188|579469159|FG002|Overall Study|Death|3|||
160475423|NCT01930188|579469157|FG000|Overall Study|Withdrawal by Subject|9|||
160475424|NCT01930188|579469158|FG001|Overall Study|Withdrawal by Subject|11|||
160475425|NCT01930188|579469159|FG002|Overall Study|Withdrawal by Subject|8|||
160475426|NCT02170207|579469162|FG000|Overall Study|Case report forms unavailable|5|||
160475427|NCT00657709|579469163|FG000|Overall Study|AE or Death|7|||
160475428|NCT00657709|579469164|FG001|Overall Study|AE or Death|7|||
160475429|NCT00657709|579469165|FG002|Overall Study|AE or Death|6|||
160475430|NCT00657709|579469166|FG003|Overall Study|AE or Death|7|||
160475431|NCT00657709|579469167|FG004|Overall Study|AE or Death|1|||
160475432|NCT00657709|579469163|FG000|Overall Study|Withdrawal by Subject|7|||
160475433|NCT00657709|579469164|FG001|Overall Study|Withdrawal by Subject|15|||
160475434|NCT00657709|579469165|FG002|Overall Study|Withdrawal by Subject|15|||
160475435|NCT00657709|579469166|FG003|Overall Study|Withdrawal by Subject|5|||
160475436|NCT00657709|579469167|FG004|Overall Study|Withdrawal by Subject|9|||
160475437|NCT00657709|579469163|FG000|Overall Study|Lost to Follow-up|9|||
160475438|NCT00657709|579469164|FG001|Overall Study|Lost to Follow-up|9|||
160475439|NCT00657709|579469165|FG002|Overall Study|Lost to Follow-up|7|||
160475440|NCT00657709|579469166|FG003|Overall Study|Lost to Follow-up|1|||
160475441|NCT00657709|579469167|FG004|Overall Study|Lost to Follow-up|21|||
160475442|NCT00657709|579469163|FG000|Overall Study|Protocol Violation|0|||
160475443|NCT00657709|579469164|FG001|Overall Study|Protocol Violation|2|||
160475444|NCT00657709|579469165|FG002|Overall Study|Protocol Violation|0|||
160475445|NCT00657709|579469166|FG003|Overall Study|Protocol Violation|1|||
160475446|NCT00657709|579469167|FG004|Overall Study|Protocol Violation|2|||
160475447|NCT03122860|579469168|FG000|Overall Study|Discontinued Before Treatment|1|||
160475448|NCT03122860|579469169|FG001|Overall Study|Discontinued Before Treatment|1|||
160475449|NCT03122860|579469170|FG002|Overall Study|Discontinued Before Treatment|2|||
160475450|NCT03122860|579469171|FG003|Overall Study|Discontinued Before Treatment|0|||
160475451|NCT03122860|579469172|FG004|Overall Study|Discontinued Before Treatment|1|||
160475452|NCT03122860|579469173|FG005|Overall Study|Discontinued Before Treatment|0|||
160475453|NCT03122860|579469168|FG000|Overall Study|Adverse Event|1|||
160475454|NCT03122860|579469169|FG001|Overall Study|Adverse Event|0|||
160475455|NCT03122860|579469170|FG002|Overall Study|Adverse Event|1|||
160475456|NCT03122860|579469171|FG003|Overall Study|Adverse Event|1|||
160475457|NCT03122860|579469172|FG004|Overall Study|Adverse Event|0|||
160475458|NCT03122860|579469173|FG005|Overall Study|Adverse Event|0|||
160475459|NCT03122860|579469168|FG000|Overall Study|Lost to Follow-up|5|||
160475460|NCT03122860|579469169|FG001|Overall Study|Lost to Follow-up|2|||
160475461|NCT03122860|579469170|FG002|Overall Study|Lost to Follow-up|3|||
160475462|NCT03122860|579469171|FG003|Overall Study|Lost to Follow-up|3|||
160475463|NCT03122860|579469172|FG004|Overall Study|Lost to Follow-up|5|||
160475464|NCT03122860|579469173|FG005|Overall Study|Lost to Follow-up|4|||
160475465|NCT03122860|579469168|FG000|Overall Study|Subject Non-Compliance|0|||
160475466|NCT03122860|579469169|FG001|Overall Study|Subject Non-Compliance|0|||
160475467|NCT03122860|579469170|FG002|Overall Study|Subject Non-Compliance|1|||
160475468|NCT03122860|579469171|FG003|Overall Study|Subject Non-Compliance|0|||
160475469|NCT03122860|579469172|FG004|Overall Study|Subject Non-Compliance|0|||
160475470|NCT03122860|579469173|FG005|Overall Study|Subject Non-Compliance|0|||
160475471|NCT03122860|579469168|FG000|Overall Study|Withdrawal by Subject|3|||
160475472|NCT03122860|579469169|FG001|Overall Study|Withdrawal by Subject|2|||
160475473|NCT03122860|579469170|FG002|Overall Study|Withdrawal by Subject|5|||
160475474|NCT03122860|579469171|FG003|Overall Study|Withdrawal by Subject|7|||
160475475|NCT03122860|579469172|FG004|Overall Study|Withdrawal by Subject|9|||
160475476|NCT03122860|579469173|FG005|Overall Study|Withdrawal by Subject|8|||
160475477|NCT01138657|579469174|FG000|Overall Study|Adverse Event|3|||
160475478|NCT01138657|579469175|FG001|Overall Study|Adverse Event|10|||
160475479|NCT01138657|579469174|FG000|Overall Study|Lack of Efficacy|2|||
160475480|NCT01138657|579469175|FG001|Overall Study|Lack of Efficacy|1|||
160475481|NCT01138657|579469174|FG000|Overall Study|Lost to Follow-up|0|||
160475482|NCT01138657|579469175|FG001|Overall Study|Lost to Follow-up|3|||
160475483|NCT01138657|579469174|FG000|Overall Study|Miscellaneous Reasons|3|||
160475484|NCT01138657|579469175|FG001|Overall Study|Miscellaneous Reasons|4|||
160475485|NCT02574286|579469176|FG000|Overall Study|Adverse Event|3|||
160475486|NCT02574286|579469176|FG000|Overall Study|Withdrawal by Subject|2|||
160475487|NCT00090519|579469179|FG000|Overall Study|Adverse Event|5|||
160475488|NCT00090519|579469180|FG001|Overall Study|Adverse Event|4|||
160475489|NCT00090519|579469179|FG000|Overall Study|Death|9|||
160475490|NCT00090519|579469180|FG001|Overall Study|Death|9|||
160475491|NCT00090519|579469179|FG000|Overall Study|Lost to Follow-up|26|||
160475492|NCT00090519|579469180|FG001|Overall Study|Lost to Follow-up|29|||
160475493|NCT00090519|579469179|FG000|Overall Study|Withdrawal by Subject|28|||
160475494|NCT00090519|579469180|FG001|Overall Study|Withdrawal by Subject|29|||
160475495|NCT00090519|579469179|FG000|Overall Study|Physician Decision|2|||
160475496|NCT00090519|579469180|FG001|Overall Study|Physician Decision|3|||
160475497|NCT00090519|579469179|FG000|Overall Study|Sponsor Decision|3|||
160475498|NCT00090519|579469180|FG001|Overall Study|Sponsor Decision|1|||
160475499|NCT00960206|579469181|FG000|Overall Study|Death|7|||
160475500|NCT00960206|579469182|FG001|Overall Study|Death|4|||
160475501|NCT00960206|579469183|FG002|Overall Study|Death|1|||
160475502|NCT00960206|579469181|FG000|Overall Study|Unwilling/Unable to return|1|||
160475503|NCT00960206|579469182|FG001|Overall Study|Unwilling/Unable to return|2|||
160475504|NCT00960206|579469183|FG002|Overall Study|Unwilling/Unable to return|0|||
160475505|NCT00960206|579469181|FG000|Overall Study|Lost to Follow-up|8|||
160475506|NCT00960206|579469182|FG001|Overall Study|Lost to Follow-up|14|||
160475507|NCT00960206|579469183|FG002|Overall Study|Lost to Follow-up|8|||
160475508|NCT00960206|579469181|FG000|Overall Study|Withdrawal by Subject|2|||
160475509|NCT00960206|579469182|FG001|Overall Study|Withdrawal by Subject|4|||
160475510|NCT00960206|579469183|FG002|Overall Study|Withdrawal by Subject|0|||
160475511|NCT00960206|579469181|FG000|Overall Study|Revision of study component|2|||
160475512|NCT00960206|579469182|FG001|Overall Study|Revision of study component|2|||
160475513|NCT00960206|579469183|FG002|Overall Study|Revision of study component|2|||
160475514|NCT00960206|579469181|FG000|Overall Study|Missing 10 year data|20|||
160475515|NCT00960206|579469182|FG001|Overall Study|Missing 10 year data|1|||
160475516|NCT00960206|579469183|FG002|Overall Study|Missing 10 year data|1|||
160475517|NCT02326220|579469188|FG000|Double-blind Treatment Period|Adverse Event|1|||
160475518|NCT02326220|579469189|FG001|Double-blind Treatment Period|Adverse Event|2|||
160475519|NCT02326220|579469190|FG002|Double-blind Treatment Period|Adverse Event|0|||
160475520|NCT02326220|579469188|FG000|Double-blind Treatment Period|Protocol Violation|0|||
160475521|NCT02326220|579469189|FG001|Double-blind Treatment Period|Protocol Violation|1|||
160475522|NCT02326220|579469190|FG002|Double-blind Treatment Period|Protocol Violation|0|||
160475523|NCT02326220|579469188|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
160475524|NCT02326220|579469189|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
160475525|NCT02326220|579469190|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160475526|NCT02326220|579469188|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
160475527|NCT02326220|579469189|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
160475528|NCT02326220|579469190|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
160475529|NCT02326220|579469188|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
160475530|NCT02326220|579469189|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
160475531|NCT02326220|579469190|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
160475532|NCT02699099|579469191|FG000|Overall Study|Adverse Event|1|||
160475533|NCT02699099|579469192|FG001|Overall Study|Adverse Event|0|||
160475534|NCT02699099|579469193|FG002|Overall Study|Adverse Event|2|||
160475535|NCT02699099|579469191|FG000|Overall Study|Lost to Follow-up|0|||
160475536|NCT02699099|579469192|FG001|Overall Study|Lost to Follow-up|1|||
160475537|NCT02699099|579469193|FG002|Overall Study|Lost to Follow-up|0|||
160475538|NCT02699099|579469191|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
160475539|NCT02699099|579469192|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
160475540|NCT02699099|579469193|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
160475541|NCT01240590|579469196|FG000|Phase I|Refused further treatment|0|||
160475542|NCT01240590|579469197|FG001|Phase I|Refused further treatment|0|||
160475543|NCT01240590|579469198|FG002|Phase I|Refused further treatment|3|||
160475544|NCT01240590|579469199|FG003|Phase I|Refused further treatment|0|||
160475545|NCT01240590|579469200|FG004|Phase I|Refused further treatment|0|||
160475546|NCT01240590|579469196|FG000|Phase II|Refused further treatment|0|||
160475547|NCT01240590|579469197|FG001|Phase II|Refused further treatment|0|||
160475548|NCT01240590|579469198|FG002|Phase II|Refused further treatment|0|||
160475549|NCT01240590|579469199|FG003|Phase II|Refused further treatment|2|||
160602219|NCT01406652|579920237|FG001|Overall Study|Lost-to-follow-up|4|||
160602220|NCT01406652|579920236|FG000|Overall Study|Withdrawal by Subject|2|||
160602221|NCT01406652|579920237|FG001|Overall Study|Withdrawal by Subject|2|||
160602222|NCT01406652|579920236|FG000|Overall Study|Insufficient follow-up|5|||
160602223|NCT01406652|579920237|FG001|Overall Study|Insufficient follow-up|4|||
160602224|NCT01406652|579920236|FG000|Overall Study|Infection not sure|10|||
160602225|NCT01406652|579920237|FG001|Overall Study|Infection not sure|10|||
160475550|NCT01240590|579469200|FG004|Phase II|Refused further treatment|1|||
160475551|NCT02659540|579469201|FG000|Overall Study|Adverse Event|3|||
160475552|NCT02659540|579469202|FG001|Overall Study|Adverse Event|2|||
160475553|NCT02659540|579469201|FG000|Overall Study|Death|1|||
160475554|NCT02659540|579469202|FG001|Overall Study|Death|0|||
160475555|NCT02659540|579469201|FG000|Overall Study|Progressive disease|2|||
160475556|NCT02659540|579469202|FG001|Overall Study|Progressive disease|6|||
160475557|NCT02548585|579469203|FG000|Overall Study|Withdrawal by Subject|0|||
160475558|NCT02548585|579469204|FG001|Overall Study|Withdrawal by Subject|0|||
160475559|NCT02548585|579469205|FG002|Overall Study|Withdrawal by Subject|0|||
160475560|NCT02548585|579469206|FG003|Overall Study|Withdrawal by Subject|0|||
160475561|NCT02548585|579469207|FG004|Overall Study|Withdrawal by Subject|0|||
160475562|NCT02548585|579469208|FG005|Overall Study|Withdrawal by Subject|1|||
160475563|NCT02548585|579469209|FG006|Overall Study|Withdrawal by Subject|0|||
160475564|NCT02548585|579469203|FG000|Overall Study|Lost to Follow-up|1|||
160475565|NCT02548585|579469204|FG001|Overall Study|Lost to Follow-up|0|||
160475566|NCT02548585|579469205|FG002|Overall Study|Lost to Follow-up|0|||
160475567|NCT02548585|579469206|FG003|Overall Study|Lost to Follow-up|0|||
160475568|NCT02548585|579469207|FG004|Overall Study|Lost to Follow-up|0|||
160475569|NCT02548585|579469208|FG005|Overall Study|Lost to Follow-up|0|||
160475570|NCT02548585|579469209|FG006|Overall Study|Lost to Follow-up|0|||
160475571|NCT02548585|579469203|FG000|Overall Study|Other|1|||
160475572|NCT02548585|579469204|FG001|Overall Study|Other|0|||
160475573|NCT02548585|579469205|FG002|Overall Study|Other|0|||
160475574|NCT02548585|579469206|FG003|Overall Study|Other|2|||
160475575|NCT02548585|579469207|FG004|Overall Study|Other|3|||
160602226|NCT00659126|579920240|FG000|Overall Study|Adverse Event|2|||
160475576|NCT02548585|579469208|FG005|Overall Study|Other|0|||
160475577|NCT02548585|579469209|FG006|Overall Study|Other|1|||
160475578|NCT02548585|579469203|FG000|Overall Study|Randomized but not treated|0|||
160475579|NCT02548585|579469204|FG001|Overall Study|Randomized but not treated|0|||
160602227|NCT00659126|579920241|FG001|Overall Study|Adverse Event|2|||
160602228|NCT00659126|579920240|FG000|Overall Study|Screen failure|1|||
160602229|NCT00659126|579920241|FG001|Overall Study|Screen failure|1|||
160602230|NCT00659126|579920240|FG000|Overall Study|Technical problems with MRI|0|||
160602231|NCT00659126|579920241|FG001|Overall Study|Technical problems with MRI|1|||
160602232|NCT00260429|579920242|FG000|Overall Study|failure to follow appointments|1|||
160602233|NCT00260429|579920243|FG001|Overall Study|failure to follow appointments|0|||
160602234|NCT00260429|579920242|FG000|Overall Study|scheduled hand surgery|1|||
160602235|NCT00260429|579920243|FG001|Overall Study|scheduled hand surgery|0|||
160602236|NCT02633046|579920247|FG000|Overall Study|Adverse Event|8|||
160602237|NCT02633046|579920247|FG000|Overall Study|Physician Decision|7|||
160602238|NCT02633046|579920247|FG000|Overall Study|Withdrawal by Subject|8|||
160602239|NCT02633046|579920247|FG000|Overall Study|Increased proteinuria|2|||
160602240|NCT02633046|579920247|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
160602241|NCT02633046|579920247|FG000|Overall Study|Mutual decision patient and physician|1|||
160602242|NCT00587301|579920249|FG000|Overall Study|Screen Failure|9|||
160602243|NCT00587301|579920249|FG000|Overall Study|Lost to Follow-up|22|||
160602244|NCT00587301|579920249|FG000|Overall Study|Withdrawal by Subject|7|||
160602245|NCT00587301|579920249|FG000|Overall Study|Protocol Violation|7|||
160602246|NCT00719537|579920251|FG000|Overall Study|Withdrawal by Subject|1|||
160602247|NCT00719537|579920252|FG001|Overall Study|Withdrawal by Subject|0|||
160602248|NCT00719537|579920251|FG000|Overall Study|Lost to Follow-up|0|||
160602249|NCT00719537|579920252|FG001|Overall Study|Lost to Follow-up|1|||
160602250|NCT02460978|579920253|FG000|Overall Study|Adverse Event|17|||
160602251|NCT02460978|579920254|FG001|Overall Study|Adverse Event|11|||
160602252|NCT02460978|579920255|FG002|Overall Study|Adverse Event|11|||
160602253|NCT02460978|579920253|FG000|Overall Study|Withdrawal by Subject|5|||
160602254|NCT02460978|579920254|FG001|Overall Study|Withdrawal by Subject|5|||
160602255|NCT02460978|579920255|FG002|Overall Study|Withdrawal by Subject|14|||
160602256|NCT02460978|579920253|FG000|Overall Study|Lost to Follow-up|2|||
160602257|NCT02460978|579920254|FG001|Overall Study|Lost to Follow-up|3|||
160602258|NCT02460978|579920255|FG002|Overall Study|Lost to Follow-up|1|||
160602259|NCT02460978|579920253|FG000|Overall Study|Protocol Violation|1|||
160602260|NCT02460978|579920254|FG001|Overall Study|Protocol Violation|1|||
160602261|NCT02460978|579920255|FG002|Overall Study|Protocol Violation|1|||
160602262|NCT02460978|579920253|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
160602263|NCT02460978|579920254|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
160602264|NCT02460978|579920255|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
160602265|NCT02460978|579920253|FG000|Overall Study|Pregnancy|0|||
160602266|NCT02460978|579920254|FG001|Overall Study|Pregnancy|0|||
160602267|NCT02460978|579920255|FG002|Overall Study|Pregnancy|2|||
160602268|NCT01142193|579920256|FG000|Overall Study|Adverse Event|12|||
160602269|NCT01142193|579920257|FG001|Overall Study|Adverse Event|4|||
160602270|NCT01142193|579920256|FG000|Overall Study|Lack of Efficacy|2|||
160602271|NCT01142193|579920257|FG001|Overall Study|Lack of Efficacy|1|||
160602272|NCT01142193|579920256|FG000|Overall Study|Physician Decision|1|||
160602273|NCT01142193|579920257|FG001|Overall Study|Physician Decision|1|||
160602274|NCT01142193|579920256|FG000|Overall Study|Withdrawal by Subject|4|||
160602275|NCT01142193|579920257|FG001|Overall Study|Withdrawal by Subject|3|||
160602276|NCT01142193|579920256|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
160602277|NCT01142193|579920257|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
160602278|NCT01142193|579920256|FG000|Overall Study|Other|1|||
160602279|NCT01142193|579920257|FG001|Overall Study|Other|2|||
160602280|NCT00994162|579920258|FG000|Overall Study|Withdrawal by Subject|1|||
160602281|NCT00994162|579920258|FG000|Overall Study|Lost to Follow-up|2|||
160602282|NCT00994162|579920258|FG000|Overall Study|Product Complaint|1|||
160602283|NCT00994162|579920258|FG000|Overall Study|Poor Compliance|5|||
160602284|NCT00994162|579920258|FG000|Overall Study|Lack of Response|3|||
160602285|NCT00994162|579920258|FG000|Overall Study|Discharged from Hospital|4|||
160602286|NCT00994162|579920258|FG000|Overall Study|Death|2|||
160602287|NCT00994162|579920258|FG000|Overall Study|Care Transferred to Another Physician|2|||
160602288|NCT00994162|579920258|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
160602289|NCT00994162|579920258|FG000|Overall Study|Physician Decision|2|||
160602290|NCT00994162|579920258|FG000|Overall Study|Surrounding Wound Erythematous|1|||
160602291|NCT00994162|579920258|FG000|Overall Study|Machine Losing Vaccum|1|||
160602292|NCT00994162|579920258|FG000|Overall Study|Patient Lived Too Far Away|1|||
160602293|NCT00994162|579920258|FG000|Overall Study|Above Knee Amputation|1|||
160602294|NCT00994162|579920258|FG000|Overall Study|Reason Not Reported By Site|1|||
160602295|NCT01225172|579920266|FG000|Overall Study|Subject decision to stop|1|||
160602296|NCT01225172|579920267|FG001|Overall Study|Subject decision to stop|0|||
160602297|NCT01225172|579920266|FG000|Overall Study|Subject request to discontinue treatment|3|||
160602298|NCT01225172|579920267|FG001|Overall Study|Subject request to discontinue treatment|1|||
160602299|NCT01225172|579920266|FG000|Overall Study|Subject no longer meets study criteria|1|||
160602300|NCT01225172|579920267|FG001|Overall Study|Subject no longer meets study criteria|0|||
160602301|NCT01225172|579920266|FG000|Overall Study|Withdrawal by Subject|1|||
160602302|NCT01225172|579920267|FG001|Overall Study|Withdrawal by Subject|0|||
160602303|NCT03136367|579920278|FG000|T1 Consultation|discontinued mistakenly included|2|||
160602304|NCT03136367|579920279|FG001|T1 Consultation|discontinued mistakenly included|6|||
160602305|NCT03136367|579920280|FG002|T1 Consultation|discontinued mistakenly included|1|||
160602306|NCT03136367|579920278|FG000|T1 Consultation|Discontinued other|0|||
160602307|NCT03136367|579920279|FG001|T1 Consultation|Discontinued other|1|||
160602308|NCT03136367|579920280|FG002|T1 Consultation|Discontinued other|0|||
160602309|NCT03136367|579920278|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
160602310|NCT03136367|579920279|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
160602311|NCT03136367|579920280|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
160602312|NCT03136367|579920278|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
160602313|NCT03136367|579920279|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
160602314|NCT03136367|579920280|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
160602315|NCT03136367|579920278|FG000|T2 Post-consultation|Discontinued other|0|||
160602316|NCT03136367|579920279|FG001|T2 Post-consultation|Discontinued other|2|||
160602317|NCT03136367|579920280|FG002|T2 Post-consultation|Discontinued other|6|||
160602318|NCT03136367|579920278|FG000|T2 Post-consultation|Discontinued transferred care|0|||
160602319|NCT03136367|579920279|FG001|T2 Post-consultation|Discontinued transferred care|0|||
160602320|NCT03136367|579920280|FG002|T2 Post-consultation|Discontinued transferred care|3|||
160602321|NCT03136367|579920278|FG000|T2 Post-consultation|Discontinued lost contact|0|||
160602322|NCT03136367|579920279|FG001|T2 Post-consultation|Discontinued lost contact|1|||
160602323|NCT03136367|579920280|FG002|T2 Post-consultation|Discontinued lost contact|0|||
160602324|NCT03136367|579920278|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
160602325|NCT03136367|579920279|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
160602326|NCT03136367|579920280|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
160602327|NCT03136367|579920278|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
160602328|NCT03136367|579920279|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
160602329|NCT03136367|579920280|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
160602330|NCT03136367|579920278|FG000|T3 1 Week After Surgery|other discontinued|2|||
160602331|NCT03136367|579920279|FG001|T3 1 Week After Surgery|other discontinued|4|||
160602332|NCT03136367|579920280|FG002|T3 1 Week After Surgery|other discontinued|3|||
160602333|NCT03136367|579920278|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
160602334|NCT03136367|579920279|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
160602335|NCT03136367|579920280|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
160602336|NCT03136367|579920278|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
160475580|NCT02548585|579469205|FG002|Overall Study|Randomized but not treated|0|||
160475581|NCT02548585|579469206|FG003|Overall Study|Randomized but not treated|0|||
160602337|NCT03136367|579920279|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
160602338|NCT03136367|579920280|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
160602339|NCT03136367|579920278|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
160602340|NCT03136367|579920279|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
160602341|NCT03136367|579920280|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
160602342|NCT03136367|579920278|FG000|T4 12 Weeks After Surgery|Death|0|||
160602343|NCT03136367|579920279|FG001|T4 12 Weeks After Surgery|Death|1|||
160602344|NCT03136367|579920280|FG002|T4 12 Weeks After Surgery|Death|3|||
160602345|NCT03136367|579920278|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
160602346|NCT03136367|579920279|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
160602347|NCT03136367|579920280|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
160602348|NCT03136367|579920278|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
160602349|NCT03136367|579920279|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
160602350|NCT03136367|579920280|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
160602351|NCT03136367|579920278|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
160602352|NCT03136367|579920279|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
160602353|NCT03136367|579920280|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
160602354|NCT03136367|579920278|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
160602355|NCT03136367|579920279|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
160602356|NCT03136367|579920280|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
160602357|NCT03136367|579920278|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
160602358|NCT03136367|579920279|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
160602359|NCT03136367|579920280|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
160602360|NCT03136367|579920278|FG000|T5 1 Year After Surgery|Death|0|||
160602361|NCT03136367|579920279|FG001|T5 1 Year After Surgery|Death|0|||
160602362|NCT03136367|579920280|FG002|T5 1 Year After Surgery|Death|1|||
160602363|NCT03136367|579920278|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
160602364|NCT03136367|579920279|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
160602365|NCT03136367|579920280|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
160602366|NCT03136367|579920278|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
160475582|NCT02548585|579469207|FG004|Overall Study|Randomized but not treated|0|||
160475583|NCT02548585|579469208|FG005|Overall Study|Randomized but not treated|1|||
160475584|NCT02548585|579469209|FG006|Overall Study|Randomized but not treated|0|||
160475585|NCT04820491|579469214|FG000|Overall Study|Withdrawal by Subject|1|||
160475586|NCT04820491|579469215|FG001|Overall Study|Withdrawal by Subject|0|||
160475587|NCT00452452|579469216|FG000|Overall Study|Protocol Violation|0|||
160475588|NCT00452452|579469217|FG001|Overall Study|Protocol Violation|0|||
160475589|NCT00452452|579469218|FG002|Overall Study|Protocol Violation|1|||
160475590|NCT00452452|579469216|FG000|Overall Study|Withdrawal by Subject|1|||
160475591|NCT00452452|579469217|FG001|Overall Study|Withdrawal by Subject|0|||
160475592|NCT00452452|579469218|FG002|Overall Study|Withdrawal by Subject|0|||
160475593|NCT00452452|579469216|FG000|Overall Study|Lost to Follow-up|1|||
160475594|NCT00452452|579469217|FG001|Overall Study|Lost to Follow-up|0|||
160475595|NCT00452452|579469218|FG002|Overall Study|Lost to Follow-up|0|||
160475596|NCT00711555|579471113|FG000|Overall Study|Adverse Event|3|||
160475597|NCT03020914|579471116|FG000|Overall Study|Surgery Cancelled|1|||
160475598|NCT03020914|579471117|FG001|Overall Study|Surgery Cancelled|0|||
160475599|NCT03976102|579471118|FG000|Overall Study|Withdrawal by Subject|4|||
160475600|NCT03976102|579471119|FG001|Overall Study|Withdrawal by Subject|4|||
160475601|NCT03976102|579471118|FG000|Overall Study|Adverse Event|2|||
160475602|NCT03976102|579471119|FG001|Overall Study|Adverse Event|4|||
160475603|NCT03976102|579471118|FG000|Overall Study|Not related to Covid-19|9|||
160475604|NCT03976102|579471119|FG001|Overall Study|Not related to Covid-19|13|||
160475605|NCT03976102|579471118|FG000|Overall Study|Lost to Follow-up|0|||
160475606|NCT03976102|579471119|FG001|Overall Study|Lost to Follow-up|2|||
160475607|NCT03976102|579471118|FG000|Overall Study|Death|3|||
160475608|NCT03976102|579471119|FG001|Overall Study|Death|2|||
160475609|NCT03976102|579471118|FG000|Overall Study|Physician Decision|1|||
160475610|NCT03976102|579471119|FG001|Overall Study|Physician Decision|1|||
160475611|NCT05066230|579471124|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
160475612|NCT05066230|579471125|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
160475613|NCT05066230|579471124|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
160475614|NCT05066230|579471125|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
160475615|NCT05066230|579471124|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
160475616|NCT05066230|579471125|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
160475617|NCT05066230|579471124|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
160475618|NCT05066230|579471125|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
160475619|NCT05066230|579471124|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
160475620|NCT05066230|579471125|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
160475621|NCT05066230|579471124|FG000|After Week 48|Adverse Event|1|||
160475622|NCT05066230|579471125|FG001|After Week 48|Adverse Event|0|||
160475623|NCT05066230|579471124|FG000|After Week 48|Non-compliance with study schedule|1|||
160475624|NCT05066230|579471125|FG001|After Week 48|Non-compliance with study schedule|0|||
160475625|NCT05066230|579471124|FG000|After Week 48|Withdrawal by Subject|0|||
160475626|NCT05066230|579471125|FG001|After Week 48|Withdrawal by Subject|1|||
160475627|NCT05066230|579471124|FG000|After Week 48|Lost to Follow-up|3|||
160475628|NCT05066230|579471125|FG001|After Week 48|Lost to Follow-up|3|||
160475629|NCT05066230|579471124|FG000|After Week 48|Sponsor Request|115|||
160475630|NCT05066230|579471125|FG001|After Week 48|Sponsor Request|111|||
160475631|NCT03072238|579471126|FG000|Overall Study|Withdrawal by Subject|44|||
160475632|NCT03072238|579471127|FG001|Overall Study|Withdrawal by Subject|64|||
160475633|NCT03072238|579471126|FG000|Overall Study|Lost to Follow-up|14|||
160475634|NCT03072238|579471127|FG001|Overall Study|Lost to Follow-up|5|||
160475635|NCT03072238|579471126|FG000|Overall Study|Physician Decision|4|||
160475636|NCT03072238|579471127|FG001|Overall Study|Physician Decision|6|||
160475637|NCT03072238|579471126|FG000|Overall Study|Death|351|||
160475638|NCT03072238|579471127|FG001|Overall Study|Death|318|||
160475639|NCT03072238|579471126|FG000|Overall Study|Progressive Disease|3|||
160475640|NCT03072238|579471127|FG001|Overall Study|Progressive Disease|4|||
160475641|NCT03072238|579471126|FG000|Overall Study|Reason Not Specified|138|||
160475642|NCT03072238|579471127|FG001|Overall Study|Reason Not Specified|150|||
160475643|NCT02889900|579471133|FG000|Overall Study|Adverse Event|11|||
160475644|NCT02889900|579471133|FG000|Overall Study|Condition under investigation worsened|32|||
160475645|NCT02889900|579471133|FG000|Overall Study|Other|5|||
160475646|NCT02889900|579471133|FG000|Overall Study|Withdrawal by Subject|7|||
160475647|NCT02889900|579471133|FG000|Overall Study|Not treated|2|||
160475648|NCT01416285|579471134|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
160475649|NCT01416285|579471135|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
160475650|NCT01248715|579471136|FG000|Overall Study|Not influenza positive|501|||
160475651|NCT01248715|579471137|FG001|Overall Study|Not influenza positive|510|||
160475652|NCT01919489|579471141|FG000|Overall Study|Rejected the need of injections|4|||
160475653|NCT01919489|579471142|FG001|Overall Study|Rejected the need of injections|7|||
160475654|NCT01919489|579471141|FG000|Overall Study|Adverse Event|10|||
160475655|NCT01919489|579471142|FG001|Overall Study|Adverse Event|0|||
160475656|NCT01919489|579471141|FG000|Overall Study|Hospital readmission|2|||
160475657|NCT01919489|579471142|FG001|Overall Study|Hospital readmission|9|||
160475658|NCT01919489|579471141|FG000|Overall Study|Death|2|||
160475659|NCT01919489|579471142|FG001|Overall Study|Death|1|||
160475660|NCT01919489|579471141|FG000|Overall Study|Lost to Follow-up|38|||
160475661|NCT01919489|579471142|FG001|Overall Study|Lost to Follow-up|27|||
160475662|NCT00857311|579471143|FG000|Overall Study|Lost to Follow-up|1|||
160475663|NCT00857311|579471144|FG001|Overall Study|Lost to Follow-up|0|||
160475664|NCT00857311|579471145|FG002|Overall Study|Lost to Follow-up|0|||
160475665|NCT00857311|579471146|FG003|Overall Study|Lost to Follow-up|0|||
160475666|NCT01587703|579471147|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
160475667|NCT01587703|579471148|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475668|NCT01587703|579471149|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475669|NCT01587703|579471150|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475670|NCT01587703|579471151|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475671|NCT01587703|579471152|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475672|NCT01587703|579471153|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475673|NCT01587703|579471154|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475674|NCT01587703|579471155|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475675|NCT01587703|579471156|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475676|NCT01587703|579471157|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475677|NCT01587703|579471158|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475678|NCT01587703|579471159|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475679|NCT01587703|579471160|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475680|NCT01587703|579471161|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475681|NCT01587703|579471162|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475682|NCT01587703|579471163|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475683|NCT01587703|579471164|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475684|NCT01587703|579471165|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
160475685|NCT01587703|579471147|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475686|NCT01587703|579471148|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475687|NCT01587703|579471149|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475688|NCT01587703|579471150|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475689|NCT01587703|579471151|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475690|NCT01587703|579471152|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
160475691|NCT01587703|579471153|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475692|NCT01587703|579471154|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
160475693|NCT01587703|579471155|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475694|NCT01587703|579471156|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475695|NCT01587703|579471157|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475696|NCT01587703|579471158|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475697|NCT01587703|579471159|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475698|NCT01587703|579471160|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475699|NCT01587703|579471161|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475700|NCT01587703|579471162|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475701|NCT01587703|579471163|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475702|NCT01587703|579471164|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475703|NCT01587703|579471165|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
160475704|NCT01587703|579471147|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475705|NCT01587703|579471148|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475706|NCT01587703|579471149|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475707|NCT01587703|579471150|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475708|NCT01587703|579471151|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475709|NCT01587703|579471152|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475710|NCT01587703|579471153|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
160475711|NCT01587703|579471154|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475712|NCT01587703|579471155|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475713|NCT01587703|579471156|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475714|NCT01587703|579471157|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475715|NCT01587703|579471158|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475716|NCT01587703|579471159|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475717|NCT01587703|579471160|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475718|NCT01587703|579471161|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475719|NCT01587703|579471162|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475720|NCT01587703|579471163|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475721|NCT01587703|579471164|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475722|NCT01587703|579471165|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
160475723|NCT01587703|579471147|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
160475724|NCT01587703|579471148|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
160475725|NCT01587703|579471149|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
160475726|NCT01587703|579471150|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
160475727|NCT01587703|579471151|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
160475728|NCT01587703|579471152|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
160475729|NCT01587703|579471153|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
160475730|NCT01587703|579471154|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
160475731|NCT01587703|579471155|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475732|NCT01587703|579471156|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475733|NCT01587703|579471157|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475734|NCT01587703|579471158|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475735|NCT01587703|579471159|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475736|NCT01587703|579471160|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475737|NCT01587703|579471161|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475738|NCT01587703|579471162|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475739|NCT01587703|579471163|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475740|NCT01587703|579471164|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475741|NCT01587703|579471165|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
160475742|NCT01587703|579471147|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475743|NCT01587703|579471148|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475744|NCT01587703|579471149|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475745|NCT01587703|579471150|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475746|NCT01587703|579471151|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475747|NCT01587703|579471152|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475748|NCT01587703|579471153|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475749|NCT01587703|579471154|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475750|NCT01587703|579471155|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
160475751|NCT01587703|579471156|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
160475752|NCT01587703|579471157|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
160475753|NCT01587703|579471158|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475754|NCT01587703|579471159|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475755|NCT01587703|579471160|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475756|NCT01587703|579471161|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475757|NCT01587703|579471162|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475758|NCT01587703|579471163|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160602367|NCT03136367|579920279|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
160602368|NCT03136367|579920280|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
160602369|NCT03136367|579920278|FG000|T5 1 Year After Surgery|study ended before due|31|||
160602370|NCT03136367|579920279|FG001|T5 1 Year After Surgery|study ended before due|103|||
160602371|NCT03136367|579920280|FG002|T5 1 Year After Surgery|study ended before due|110|||
160602372|NCT03136367|579920278|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
160602373|NCT03136367|579920279|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
160602374|NCT03136367|579920280|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
160602375|NCT03175562|579920284|FG000|Overall Study|Adverse Event|1|||
160602376|NCT03175562|579920284|FG000|Overall Study|Lost to Follow-up|3|||
160602377|NCT03175562|579920284|FG000|Overall Study|Withdrawal by Subject|7|||
160602378|NCT03175562|579920284|FG000|Overall Study|Other (Not Specified)|5|||
160602379|NCT02146833|579920285|FG000|Overall Study|Death|10|||
160602380|NCT02146833|579920285|FG000|Overall Study|No longer consented to study treatment|1|||
160602381|NCT00446641|579922393|FG000|Overall Study|Withdrawal by Subject|8|||
160602382|NCT00446641|579922394|FG001|Overall Study|Withdrawal by Subject|3|||
160602383|NCT00446641|579922393|FG000|Overall Study|poor compliance|8|||
160602384|NCT00446641|579922394|FG001|Overall Study|poor compliance|6|||
160602385|NCT00446641|579922393|FG000|Overall Study|Lost to Follow-up|1|||
160602386|NCT00446641|579922394|FG001|Overall Study|Lost to Follow-up|1|||
160602387|NCT01826448|579922396|FG000|Overall Study|Adverse Event|1|||
160602388|NCT01826448|579922397|FG001|Overall Study|Adverse Event|3|||
160602389|NCT01826448|579922396|FG000|Overall Study|Disease progression|2|||
160602390|NCT01826448|579922397|FG001|Overall Study|Disease progression|4|||
160602391|NCT01826448|579922396|FG000|Overall Study|Withdrawal by Subject|1|||
160602392|NCT01826448|579922397|FG001|Overall Study|Withdrawal by Subject|0|||
160602393|NCT01826448|579922396|FG000|Overall Study|Physician Decision|0|||
160602394|NCT01826448|579922397|FG001|Overall Study|Physician Decision|1|||
160602395|NCT01826448|579922396|FG000|Overall Study|2 active cancers|0|||
160602396|NCT01826448|579922397|FG001|Overall Study|2 active cancers|1|||
160602397|NCT00880100|579922400|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
160602398|NCT00880100|579922400|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
160602399|NCT00880100|579922400|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
160602400|NCT04038385|579922401|FG000|Overall Study|Completed baseline assessment only|7|||
160602401|NCT04038385|579922402|FG001|Overall Study|Completed baseline assessment only|4|||
160602402|NCT04038385|579922401|FG000|Overall Study|Moved out of area|4|||
160602403|NCT04038385|579922402|FG001|Overall Study|Moved out of area|2|||
160602404|NCT04038385|579922401|FG000|Overall Study|Discontinued study involvement|6|||
160602405|NCT04038385|579922402|FG001|Overall Study|Discontinued study involvement|1|||
160602406|NCT03424044|579922403|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
160602407|NCT03424044|579922404|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
160602408|NCT03424044|579922405|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
160602409|NCT03424044|579922406|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
160602410|NCT03424044|579922407|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
160602411|NCT03424044|579922408|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
160602412|NCT03424044|579922409|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
160602413|NCT03424044|579922410|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
160602414|NCT03424044|579922411|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
160602415|NCT03424044|579922403|FG000|First Intervention (76 Hours)|Adverse Event|0|||
160602416|NCT03424044|579922404|FG001|First Intervention (76 Hours)|Adverse Event|0|||
160602417|NCT03424044|579922405|FG002|First Intervention (76 Hours)|Adverse Event|0|||
160602418|NCT03424044|579922406|FG003|First Intervention (76 Hours)|Adverse Event|0|||
160602419|NCT03424044|579922407|FG004|First Intervention (76 Hours)|Adverse Event|1|||
160602420|NCT03424044|579922408|FG005|First Intervention (76 Hours)|Adverse Event|0|||
160602421|NCT03424044|579922409|FG006|First Intervention (76 Hours)|Adverse Event|0|||
160602422|NCT03424044|579922410|FG007|First Intervention (76 Hours)|Adverse Event|0|||
160602423|NCT03424044|579922411|FG008|First Intervention (76 Hours)|Adverse Event|0|||
160602424|NCT03424044|579922403|FG000|First Intervention (76 Hours)|device issues|0|||
160602425|NCT03424044|579922404|FG001|First Intervention (76 Hours)|device issues|0|||
160602426|NCT03424044|579922405|FG002|First Intervention (76 Hours)|device issues|0|||
160602427|NCT03424044|579922406|FG003|First Intervention (76 Hours)|device issues|0|||
160602428|NCT03424044|579922407|FG004|First Intervention (76 Hours)|device issues|0|||
160602429|NCT03424044|579922408|FG005|First Intervention (76 Hours)|device issues|0|||
160602430|NCT03424044|579922409|FG006|First Intervention (76 Hours)|device issues|1|||
160602431|NCT03424044|579922410|FG007|First Intervention (76 Hours)|device issues|1|||
160602432|NCT03424044|579922411|FG008|First Intervention (76 Hours)|device issues|1|||
160602433|NCT03424044|579922403|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
160602434|NCT03424044|579922404|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
160602435|NCT03424044|579922405|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
160602436|NCT03424044|579922406|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
160602437|NCT03424044|579922407|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
160602438|NCT03424044|579922408|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
160602439|NCT03424044|579922409|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
160602440|NCT03424044|579922410|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
160602441|NCT03424044|579922411|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
160602442|NCT03424044|579922403|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
160602443|NCT03424044|579922404|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
160602444|NCT03424044|579922405|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
160602445|NCT03424044|579922406|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
160602446|NCT03424044|579922407|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
160602447|NCT03424044|579922408|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
160602448|NCT03424044|579922409|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
160602449|NCT03424044|579922410|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
160602450|NCT03424044|579922411|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
160602451|NCT00402285|579922416|FG000|Overall Study|insufficient RNA quality|7|||
160602452|NCT00402285|579922417|FG001|Overall Study|insufficient RNA quality|6|||
160602453|NCT00402285|579922418|FG002|Overall Study|insufficient RNA quality|2|||
160602454|NCT00405275|579922421|FG000|Overall Study|Death|1|||
160602455|NCT00405275|579922422|FG001|Overall Study|Death|0|||
160602456|NCT00405275|579922421|FG000|Overall Study|Lost to Follow-up|5|||
160602457|NCT00405275|579922422|FG001|Overall Study|Lost to Follow-up|1|||
160602458|NCT00405275|579922421|FG000|Overall Study|Withdrawal by Subject|7|||
160602459|NCT00405275|579922422|FG001|Overall Study|Withdrawal by Subject|9|||
160602460|NCT00405275|579922421|FG000|Overall Study|Unwilling to continue|10|||
160602461|NCT00405275|579922422|FG001|Overall Study|Unwilling to continue|9|||
160602462|NCT00088595|579922423|FG000|Overall Study|Adverse Event|11|||
160602463|NCT00088595|579922423|FG000|Overall Study|Withdrawal by Subject|8|||
160602464|NCT00088595|579922423|FG000|Overall Study|Ongoing (After Core)|7|||
160602465|NCT00088595|579922423|FG000|Overall Study|New Cancer Therapy|2|||
160602466|NCT01308853|579922426|FG000|Overall Study|Adverse Event|1|||
160602467|NCT01308853|579922426|FG000|Overall Study|Lost to Follow-up|2|||
160602468|NCT01308853|579922426|FG000|Overall Study|Insertion of permanent implants|1|||
160602469|NCT01376388|579922429|FG000|Overall Study|Adverse Event|13|||
160602470|NCT01376388|579922429|FG000|Overall Study|Lack of Efficacy|2|||
160602471|NCT01376388|579922429|FG000|Overall Study|Withdrawal by Subject|3|||
160602472|NCT02959970|579922442|FG000|Overall Study|Adverse Event|1|||
160602473|NCT02959970|579922443|FG001|Overall Study|Adverse Event|0|||
160602474|NCT02959970|579922442|FG000|Overall Study|Withdrawal by Subject|0|||
160602475|NCT02959970|579922443|FG001|Overall Study|Withdrawal by Subject|2|||
160602476|NCT02959970|579922442|FG000|Overall Study|Lost to Follow-up|1|||
160602477|NCT02959970|579922443|FG001|Overall Study|Lost to Follow-up|5|||
160602478|NCT01473355|579922448|FG000|Overall Study|Protocol Violation|2|||
160602479|NCT01473355|579922448|FG000|Overall Study|Adverse Event|2|||
160602480|NCT01473355|579922448|FG000|Overall Study|Lost to Follow-up|2|||
160602481|NCT00106249|579922449|FG000|Overall Study|Lost to Follow-up|3|||
160602482|NCT00106249|579922450|FG001|Overall Study|Lost to Follow-up|2|||
160602483|NCT03417505|579922453|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
160602484|NCT03417505|579922454|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
160602485|NCT03235726|579922459|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
160602486|NCT03235726|579922460|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
160602487|NCT03235726|579922461|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
160602488|NCT03235726|579922462|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
160602489|NCT03235726|579922463|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
160602490|NCT03235726|579922464|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
160602491|NCT03235726|579922465|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
160602492|NCT03235726|579922466|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
160602493|NCT03235726|579922467|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
160602494|NCT03235726|579922468|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
160602495|NCT03235726|579922459|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
160602496|NCT03235726|579922460|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
160602497|NCT03235726|579922461|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
160602498|NCT03235726|579922462|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
160602499|NCT03235726|579922463|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
160602500|NCT03235726|579922464|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
160602501|NCT03235726|579922465|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
160602502|NCT03235726|579922466|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
160602503|NCT03235726|579922467|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
160602504|NCT03235726|579922468|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
160602505|NCT01831804|579922469|FG000|Overall Study|Adverse Event|0|||
160602506|NCT01831804|579922470|FG001|Overall Study|Adverse Event|0|||
160602507|NCT01831804|579922471|FG002|Overall Study|Adverse Event|0|||
160602508|NCT01831804|579922472|FG003|Overall Study|Adverse Event|0|||
160602509|NCT01831804|579922473|FG004|Overall Study|Adverse Event|0|||
160602510|NCT01831804|579922474|FG005|Overall Study|Adverse Event|0|||
160602511|NCT01831804|579922475|FG006|Overall Study|Adverse Event|1|||
160602512|NCT01831804|579922476|FG007|Overall Study|Adverse Event|0|||
160602513|NCT01831804|579922477|FG008|Overall Study|Adverse Event|1|||
160602514|NCT01831804|579922469|FG000|Overall Study|Protocol Violation|0|||
160602515|NCT01831804|579922470|FG001|Overall Study|Protocol Violation|0|||
160602516|NCT01831804|579922471|FG002|Overall Study|Protocol Violation|2|||
160602517|NCT01831804|579922472|FG003|Overall Study|Protocol Violation|0|||
160602518|NCT01831804|579922473|FG004|Overall Study|Protocol Violation|0|||
160475759|NCT01587703|579471164|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475760|NCT01587703|579471165|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
160475761|NCT01587703|579471147|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475762|NCT01587703|579471148|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475763|NCT01587703|579471149|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475764|NCT01587703|579471150|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475765|NCT01587703|579471151|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475766|NCT01587703|579471152|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475767|NCT01587703|579471153|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475768|NCT01587703|579471154|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475769|NCT01587703|579471155|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
160475770|NCT01587703|579471156|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475771|NCT01587703|579471157|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
160475772|NCT01587703|579471158|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475773|NCT01587703|579471159|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475774|NCT01587703|579471160|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475775|NCT01587703|579471161|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475776|NCT01587703|579471162|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475777|NCT01587703|579471163|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475778|NCT01587703|579471164|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475779|NCT01587703|579471165|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
160475780|NCT01587703|579471147|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475781|NCT01587703|579471148|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475782|NCT01587703|579471149|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475783|NCT01587703|579471150|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475784|NCT01587703|579471151|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475785|NCT01587703|579471152|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475786|NCT01587703|579471153|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475787|NCT01587703|579471154|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475788|NCT01587703|579471155|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475789|NCT01587703|579471156|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
160475790|NCT01587703|579471157|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
160475791|NCT01587703|579471158|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475792|NCT01587703|579471159|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475793|NCT01587703|579471160|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475794|NCT01587703|579471161|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475795|NCT01587703|579471162|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475796|NCT01587703|579471163|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475797|NCT01587703|579471164|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475798|NCT01587703|579471165|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
160475799|NCT01587703|579471147|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475800|NCT01587703|579471148|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475801|NCT01587703|579471149|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475802|NCT01587703|579471150|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475803|NCT01587703|579471151|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475804|NCT01587703|579471152|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475805|NCT01587703|579471153|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475806|NCT01587703|579471154|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160602519|NCT01831804|579922474|FG005|Overall Study|Protocol Violation|0|||
160602520|NCT01831804|579922475|FG006|Overall Study|Protocol Violation|0|||
160475807|NCT01587703|579471155|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
160475808|NCT01587703|579471156|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475809|NCT01587703|579471157|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475810|NCT01587703|579471158|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475811|NCT01587703|579471159|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475812|NCT01587703|579471160|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475813|NCT01587703|579471161|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475814|NCT01587703|579471162|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475815|NCT01587703|579471163|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475816|NCT01587703|579471164|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475817|NCT01587703|579471165|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
160475818|NCT01587703|579471147|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475819|NCT01587703|579471148|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475820|NCT01587703|579471149|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475821|NCT01587703|579471150|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475822|NCT01587703|579471151|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475823|NCT01587703|579471152|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475824|NCT01587703|579471153|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475825|NCT01587703|579471154|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475826|NCT01587703|579471155|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475827|NCT01587703|579471156|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475828|NCT01587703|579471157|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475829|NCT01587703|579471158|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475830|NCT01587703|579471159|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475831|NCT01587703|579471160|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475832|NCT01587703|579471161|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475833|NCT01587703|579471162|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475834|NCT01587703|579471163|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475835|NCT01587703|579471164|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
160475836|NCT01587703|579471165|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
160475837|NCT01587703|579471147|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475838|NCT01587703|579471148|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475839|NCT01587703|579471149|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475840|NCT01587703|579471150|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475841|NCT01587703|579471151|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475842|NCT01587703|579471152|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475843|NCT01587703|579471153|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475844|NCT01587703|579471154|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475845|NCT01587703|579471155|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475846|NCT01587703|579471156|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475847|NCT01587703|579471157|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475848|NCT01587703|579471158|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475849|NCT01587703|579471159|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475850|NCT01587703|579471160|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475851|NCT01587703|579471161|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475852|NCT01587703|579471162|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475853|NCT01587703|579471163|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
160475854|NCT01587703|579471164|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
160475855|NCT01587703|579471165|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
160475856|NCT01587703|579471147|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475857|NCT01587703|579471148|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475858|NCT01587703|579471149|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475859|NCT01587703|579471150|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475860|NCT01587703|579471151|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475861|NCT01587703|579471152|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475862|NCT01587703|579471153|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475863|NCT01587703|579471154|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475864|NCT01587703|579471155|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475865|NCT01587703|579471156|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160602521|NCT01831804|579922476|FG007|Overall Study|Protocol Violation|0|||
160602522|NCT01831804|579922477|FG008|Overall Study|Protocol Violation|0|||
160602523|NCT01831804|579922469|FG000|Overall Study|Protocol defined stopping criteria|1|||
160602524|NCT01831804|579922470|FG001|Overall Study|Protocol defined stopping criteria|1|||
160602525|NCT01831804|579922471|FG002|Overall Study|Protocol defined stopping criteria|3|||
160660191|NCT03447262|580137736|FG000|Overall Study|Death|2|||
160660192|NCT03447262|580137736|FG000|Overall Study|Study Termination by Sponsor|455|||
160660193|NCT03447262|580137736|FG000|Overall Study|Other|4|||
160660194|NCT02058498|580137742|FG000|Overall Study|Withdrawal by Subject|4|||
160660195|NCT04605094|580137743|FG000|Overall Study|Adverse Event|2|||
160660196|NCT04605094|580137744|FG001|Overall Study|Adverse Event|2|||
160660197|NCT04605094|580137743|FG000|Overall Study|Lost to Follow-up|1|||
160660198|NCT04605094|580137744|FG001|Overall Study|Lost to Follow-up|4|||
160475866|NCT01587703|579471157|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475867|NCT01587703|579471158|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475868|NCT01587703|579471159|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475869|NCT01587703|579471160|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475870|NCT01587703|579471161|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475871|NCT01587703|579471162|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
160475872|NCT01587703|579471163|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475873|NCT01587703|579471164|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475874|NCT01587703|579471165|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
160475875|NCT01587703|579471147|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475876|NCT01587703|579471148|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475877|NCT01587703|579471149|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475878|NCT01587703|579471150|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475879|NCT01587703|579471151|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475880|NCT01587703|579471152|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475881|NCT01587703|579471153|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475882|NCT01587703|579471154|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475883|NCT01587703|579471155|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475884|NCT01587703|579471156|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160602526|NCT01831804|579922472|FG003|Overall Study|Protocol defined stopping criteria|0|||
160602527|NCT01831804|579922473|FG004|Overall Study|Protocol defined stopping criteria|1|||
160602528|NCT01831804|579922474|FG005|Overall Study|Protocol defined stopping criteria|0|||
160602529|NCT01831804|579922475|FG006|Overall Study|Protocol defined stopping criteria|0|||
160602530|NCT01831804|579922476|FG007|Overall Study|Protocol defined stopping criteria|0|||
160602531|NCT01831804|579922477|FG008|Overall Study|Protocol defined stopping criteria|0|||
160602532|NCT01831804|579922469|FG000|Overall Study|Lost to Follow-up|0|||
160602533|NCT01831804|579922470|FG001|Overall Study|Lost to Follow-up|0|||
160602534|NCT01831804|579922471|FG002|Overall Study|Lost to Follow-up|1|||
160602535|NCT01831804|579922472|FG003|Overall Study|Lost to Follow-up|0|||
160602536|NCT01831804|579922473|FG004|Overall Study|Lost to Follow-up|0|||
160602537|NCT01831804|579922474|FG005|Overall Study|Lost to Follow-up|0|||
160602538|NCT01831804|579922475|FG006|Overall Study|Lost to Follow-up|0|||
160602539|NCT01831804|579922476|FG007|Overall Study|Lost to Follow-up|0|||
160602540|NCT01831804|579922477|FG008|Overall Study|Lost to Follow-up|1|||
160602541|NCT01831804|579922469|FG000|Overall Study|Investigator discretion|0|||
160602542|NCT01831804|579922470|FG001|Overall Study|Investigator discretion|0|||
160602543|NCT01831804|579922471|FG002|Overall Study|Investigator discretion|0|||
160602544|NCT01831804|579922472|FG003|Overall Study|Investigator discretion|0|||
160602545|NCT01831804|579922473|FG004|Overall Study|Investigator discretion|1|||
160602546|NCT01831804|579922474|FG005|Overall Study|Investigator discretion|0|||
160602547|NCT01831804|579922475|FG006|Overall Study|Investigator discretion|0|||
160602548|NCT01831804|579922476|FG007|Overall Study|Investigator discretion|1|||
160602549|NCT01831804|579922477|FG008|Overall Study|Investigator discretion|0|||
160602550|NCT01831804|579922469|FG000|Overall Study|Withdrew Consent|0|||
160602551|NCT01831804|579922470|FG001|Overall Study|Withdrew Consent|1|||
160602552|NCT01831804|579922471|FG002|Overall Study|Withdrew Consent|0|||
160602553|NCT01831804|579922472|FG003|Overall Study|Withdrew Consent|0|||
160602554|NCT01831804|579922473|FG004|Overall Study|Withdrew Consent|0|||
160602555|NCT01831804|579922474|FG005|Overall Study|Withdrew Consent|0|||
160602556|NCT01831804|579922475|FG006|Overall Study|Withdrew Consent|0|||
160602557|NCT01831804|579922476|FG007|Overall Study|Withdrew Consent|2|||
160602558|NCT01831804|579922477|FG008|Overall Study|Withdrew Consent|0|||
160602559|NCT01819506|579922478|FG000|Overall Study|Physician Decision|5|||
160602560|NCT01819506|579922479|FG001|Overall Study|Physician Decision|2|||
160660199|NCT04605094|580137743|FG000|Overall Study|Physician Decision|2|||
160660200|NCT04605094|580137744|FG001|Overall Study|Physician Decision|2|||
160475885|NCT01587703|579471157|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160602561|NCT01819506|579922478|FG000|Overall Study|Withdrawal by Subject|3|||
160602562|NCT01819506|579922479|FG001|Overall Study|Withdrawal by Subject|3|||
160602563|NCT00879437|579922482|FG000|Overall Study|Protocol Violation|0|||
160602564|NCT00879437|579922483|FG001|Overall Study|Protocol Violation|1|||
160660201|NCT04605094|580137743|FG000|Overall Study|Study terminated by Sponsor|31|||
160602565|NCT00879437|579922482|FG000|Overall Study|Death|1|||
160660202|NCT04605094|580137744|FG001|Overall Study|Study terminated by Sponsor|33|||
160602566|NCT00879437|579922483|FG001|Overall Study|Death|0|||
160660203|NCT04605094|580137743|FG000|Overall Study|Withdrawal by Subject|22|||
160475886|NCT01587703|579471158|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
160475887|NCT01587703|579471159|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475888|NCT01587703|579471160|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475889|NCT01587703|579471161|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
160475890|NCT01587703|579471162|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475891|NCT01587703|579471163|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475892|NCT01587703|579471164|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475893|NCT01587703|579471165|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
160475894|NCT01587703|579471147|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475895|NCT01587703|579471148|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475896|NCT01587703|579471149|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475897|NCT01587703|579471150|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475898|NCT01587703|579471151|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475899|NCT01587703|579471152|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475900|NCT01587703|579471153|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475901|NCT01587703|579471154|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475902|NCT01587703|579471155|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475903|NCT01587703|579471156|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475904|NCT01587703|579471157|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475905|NCT01587703|579471158|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
160475906|NCT01587703|579471159|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
160475907|NCT01587703|579471160|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
160475908|NCT01587703|579471161|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
160475909|NCT01587703|579471162|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
160475910|NCT01587703|579471163|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
160475911|NCT01587703|579471164|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475912|NCT01587703|579471165|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
160475913|NCT01587703|579471147|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475914|NCT01587703|579471148|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475915|NCT01587703|579471149|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475916|NCT01587703|579471150|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475917|NCT01587703|579471151|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475918|NCT01587703|579471152|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475919|NCT01587703|579471153|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475920|NCT01587703|579471154|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475921|NCT01587703|579471155|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475922|NCT01587703|579471156|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475923|NCT01587703|579471157|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475924|NCT01587703|579471158|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
160475925|NCT01587703|579471159|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
160475926|NCT01587703|579471160|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
160475927|NCT01587703|579471161|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
160475928|NCT01587703|579471162|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
160475929|NCT01587703|579471163|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
160475930|NCT01587703|579471164|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475931|NCT01587703|579471165|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
160475932|NCT01587703|579471147|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475933|NCT01587703|579471148|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475934|NCT01587703|579471149|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475935|NCT01587703|579471150|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475936|NCT01587703|579471151|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475937|NCT01587703|579471152|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475938|NCT01587703|579471153|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475939|NCT01587703|579471154|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475940|NCT01587703|579471155|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475941|NCT01587703|579471156|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475942|NCT01587703|579471157|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475943|NCT01587703|579471158|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
160602567|NCT00268463|579922484|FG000|Overall Study|study terminated due to low accrual|10|||
160602568|NCT00268463|579922485|FG001|Overall Study|study terminated due to low accrual|12|||
160602569|NCT04685538|579922486|FG000|Overall Study|Adverse Event|0|||
160602570|NCT04685538|579922487|FG001|Overall Study|Adverse Event|1|||
160475944|NCT01587703|579471159|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160602571|NCT04685538|579922486|FG000|Overall Study|Lost to Follow-up|0|||
160602572|NCT04685538|579922487|FG001|Overall Study|Lost to Follow-up|2|||
160475945|NCT01587703|579471160|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160602573|NCT00291187|579922488|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
160602574|NCT00291187|579922489|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
160602575|NCT00291187|579922490|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
160660204|NCT04605094|580137744|FG001|Overall Study|Withdrawal by Subject|19|||
160660205|NCT04605094|580137743|FG000|Overall Study|Other|1|||
160660206|NCT04605094|580137744|FG001|Overall Study|Other|1|||
160475946|NCT01587703|579471161|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475947|NCT01587703|579471162|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475948|NCT01587703|579471163|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475949|NCT01587703|579471164|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475950|NCT01587703|579471165|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
160475951|NCT04751929|579471166|FG000|Overall Study|Withdrawal by Subject|2|||
160475952|NCT04751929|579471167|FG001|Overall Study|Withdrawal by Subject|0|||
160475953|NCT04751929|579471168|FG002|Overall Study|Withdrawal by Subject|0|||
160475954|NCT04751929|579471169|FG003|Overall Study|Withdrawal by Subject|0|||
160660207|NCT05327491|580137749|FG000|Periods 1 & 2|Miscellaneous|0|||
160660208|NCT05327491|580137750|FG001|Periods 1 & 2|Miscellaneous|1|||
160660209|NCT05327491|580137751|FG002|Periods 1 & 2|Miscellaneous|0|||
160475955|NCT04751929|579471166|FG000|Overall Study|Rising PSA|0|||
160475956|NCT04751929|579471167|FG001|Overall Study|Rising PSA|1|||
160475957|NCT04751929|579471168|FG002|Overall Study|Rising PSA|0|||
160475958|NCT04751929|579471169|FG003|Overall Study|Rising PSA|0|||
160475959|NCT04751929|579471166|FG000|Overall Study|Adverse Event|1|||
160475960|NCT04751929|579471167|FG001|Overall Study|Adverse Event|2|||
160475961|NCT04751929|579471168|FG002|Overall Study|Adverse Event|0|||
160475962|NCT04751929|579471169|FG003|Overall Study|Adverse Event|0|||
160475963|NCT04751929|579471166|FG000|Overall Study|Progressive Disease|3|||
160475964|NCT04751929|579471167|FG001|Overall Study|Progressive Disease|4|||
160660210|NCT05327491|580137752|FG003|Periods 1 & 2|Miscellaneous|0|||
160660211|NCT05327491|580137749|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
160660212|NCT05327491|580137750|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
160660213|NCT05327491|580137751|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
160660214|NCT05327491|580137752|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
160660215|NCT05612724|580137755|FG000|Overall Study|Lost to Follow-up|4|||
160660216|NCT04000815|580137762|FG000|Overall Study|Lost to Follow-up|9|||
160660217|NCT04000815|580137763|FG001|Overall Study|Lost to Follow-up|2|||
160660218|NCT04000815|580137764|FG002|Overall Study|Lost to Follow-up|3|||
160660219|NCT04000815|580137762|FG000|Overall Study|Withdrawal by Subject|4|||
160660220|NCT04000815|580137763|FG001|Overall Study|Withdrawal by Subject|3|||
160660221|NCT04000815|580137764|FG002|Overall Study|Withdrawal by Subject|2|||
160660222|NCT04000815|580137762|FG000|Overall Study|Right ovarian cyst occured|1|||
160660223|NCT04000815|580137763|FG001|Overall Study|Right ovarian cyst occured|0|||
160660224|NCT04000815|580137764|FG002|Overall Study|Right ovarian cyst occured|0|||
160660225|NCT04000815|580137762|FG000|Overall Study|Hypertension occured on follow up|0|||
160660226|NCT04000815|580137763|FG001|Overall Study|Hypertension occured on follow up|0|||
160660227|NCT04000815|580137764|FG002|Overall Study|Hypertension occured on follow up|2|||
160660228|NCT00239577|580137765|FG000|Primary Phase|Adverse Event|0|||
160660229|NCT00239577|580137766|FG001|Primary Phase|Adverse Event|0|||
160660230|NCT00239577|580137767|FG002|Primary Phase|Adverse Event|1|||
160660231|NCT00239577|580137768|FG003|Primary Phase|Adverse Event|0|||
160660232|NCT00239577|580137765|FG000|Primary Phase|Other|5|||
160660233|NCT00239577|580137766|FG001|Primary Phase|Other|3|||
160660234|NCT00239577|580137767|FG002|Primary Phase|Other|2|||
160660235|NCT00239577|580137768|FG003|Primary Phase|Other|0|||
160660236|NCT02017964|580137769|FG000|Overall Study|Patient deemed ineligible|1|||
160660237|NCT01391793|580137770|FG000|Overall Study|Ineligible|3|||
160475965|NCT04751929|579471168|FG002|Overall Study|Progressive Disease|4|||
160475966|NCT04751929|579471169|FG003|Overall Study|Progressive Disease|0|||
160475967|NCT04751929|579471166|FG000|Overall Study|Death|1|||
160475968|NCT04751929|579471167|FG001|Overall Study|Death|1|||
160475969|NCT04751929|579471168|FG002|Overall Study|Death|0|||
160475970|NCT04751929|579471169|FG003|Overall Study|Death|0|||
160475971|NCT00759681|579471170|FG000|Overall Study|Death|2|||
160475972|NCT00759681|579471171|FG001|Overall Study|Death|5|||
160660238|NCT01391793|580137771|FG001|Overall Study|Ineligible|0|||
160660239|NCT01391793|580137770|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
160660240|NCT01391793|580137771|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
160660241|NCT01391793|580137770|FG000|Overall Study|No DMSA|73|||
160660242|NCT01391793|580137771|FG001|Overall Study|No DMSA|57|||
160660243|NCT00105196|580137772|FG000|Overall Study|Lack of Efficacy|2|||
160660244|NCT00105196|580137773|FG001|Overall Study|Lack of Efficacy|3|||
160660245|NCT00105196|580137772|FG000|Overall Study|Adverse Event|11|||
160660246|NCT00105196|580137773|FG001|Overall Study|Adverse Event|3|||
160475973|NCT00759681|579471170|FG000|Overall Study|Lost to Follow-up|8|||
160475974|NCT00759681|579471171|FG001|Overall Study|Lost to Follow-up|5|||
160475975|NCT00930644|579471172|FG000|Overall Study|Withdrawal by Subject|4|||
160475976|NCT00930644|579471172|FG000|Overall Study|Physician Decision|2|||
160475977|NCT00930644|579471172|FG000|Overall Study|Death|1|||
160475978|NCT00930644|579471172|FG000|Overall Study|Adverse Event|16|||
160475979|NCT00473512|579471175|FG000|Period 1 (Phase 1)|Adverse Event|0|||
160475980|NCT00473512|579471176|FG001|Period 1 (Phase 1)|Adverse Event|0|||
160660247|NCT00105196|580137772|FG000|Overall Study|Withdrawal by Subject|6|||
160602576|NCT00291187|579922491|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
160602577|NCT01040845|579922492|FG000|Overall Study|Withdrawal by Subject|1|||
160602578|NCT01040845|579922493|FG001|Overall Study|Withdrawal by Subject|1|||
160602579|NCT01040845|579922492|FG000|Overall Study|Physician Decision|1|||
160602580|NCT01040845|579922493|FG001|Overall Study|Physician Decision|0|||
160602581|NCT04362813|579922494|FG000|Overall Study|Death|12|||
160602582|NCT04362813|579922495|FG001|Overall Study|Death|16|||
160602583|NCT04362813|579922494|FG000|Overall Study|Withdrawal by Subject|3|||
160602584|NCT04362813|579922495|FG001|Overall Study|Withdrawal by Subject|1|||
160602585|NCT04362813|579922494|FG000|Overall Study|Protocol Violation|0|||
160602586|NCT04362813|579922495|FG001|Overall Study|Protocol Violation|3|||
160602587|NCT04362813|579922494|FG000|Overall Study|Lost to Follow-up|1|||
160602588|NCT04362813|579922495|FG001|Overall Study|Lost to Follow-up|1|||
160602589|NCT04362813|579922494|FG000|Overall Study|Enrolled but did not receive treatment|2|||
160602590|NCT04362813|579922495|FG001|Overall Study|Enrolled but did not receive treatment|4|||
160602591|NCT01732107|579922499|FG000|Overall Study|Adverse Event|2|||
160602592|NCT01732107|579922499|FG000|Overall Study|Disease Progression|8|||
160602593|NCT01732107|579922499|FG000|Overall Study|Physician Decision|1|||
160602594|NCT01732107|579922499|FG000|Overall Study|Withdrawal by Subject|2|||
160602595|NCT02023268|579922500|FG000|Overall Study|Lack of Efficacy|0|||
160602596|NCT02023268|579922501|FG001|Overall Study|Lack of Efficacy|1|||
160602597|NCT02023268|579922500|FG000|Overall Study|Adverse Event|0|||
160602598|NCT02023268|579922501|FG001|Overall Study|Adverse Event|2|||
160602599|NCT02023268|579922500|FG000|Overall Study|Withdrawal by Subject|0|||
160602600|NCT02023268|579922501|FG001|Overall Study|Withdrawal by Subject|1|||
160602601|NCT00615459|579922503|FG000|Period I|Adverse Event|2|||
160602602|NCT00615459|579922504|FG001|Period I|Adverse Event|0|||
160602603|NCT00615459|579922505|FG002|Period I|Adverse Event|1|||
160602604|NCT00615459|579922506|FG003|Period I|Adverse Event|0|||
160602605|NCT00615459|579922503|FG000|Period I|Subject withdrew consent|1|||
160602606|NCT00615459|579922504|FG001|Period I|Subject withdrew consent|0|||
160602607|NCT00615459|579922505|FG002|Period I|Subject withdrew consent|0|||
160602608|NCT00615459|579922506|FG003|Period I|Subject withdrew consent|1|||
160602609|NCT00615459|579922503|FG000|Period I|Abnormal test procedure results|1|||
160602610|NCT00615459|579922504|FG001|Period I|Abnormal test procedure results|1|||
160602611|NCT00615459|579922505|FG002|Period I|Abnormal test procedure results|1|||
160602612|NCT00615459|579922506|FG003|Period I|Abnormal test procedure results|0|||
160602613|NCT00615459|579922503|FG000|Period II|Adverse Event|1|||
160602614|NCT00615459|579922504|FG001|Period II|Adverse Event|0|||
160602615|NCT00615459|579922505|FG002|Period II|Adverse Event|0|||
160602616|NCT00615459|579922506|FG003|Period II|Adverse Event|0|||
160602617|NCT00615459|579922503|FG000|Period II|Lost to Follow-up|0|||
160602618|NCT00615459|579922504|FG001|Period II|Lost to Follow-up|0|||
160602619|NCT00615459|579922505|FG002|Period II|Lost to Follow-up|0|||
160602620|NCT00615459|579922506|FG003|Period II|Lost to Follow-up|1|||
160602621|NCT00615459|579922503|FG000|Period III|Adverse Event|0|||
160602622|NCT00615459|579922504|FG001|Period III|Adverse Event|1|||
160602623|NCT00615459|579922505|FG002|Period III|Adverse Event|0|||
160602624|NCT00615459|579922506|FG003|Period III|Adverse Event|0|||
160602625|NCT00615459|579922503|FG000|Period III|Administrative problems|0|||
160602626|NCT00615459|579922504|FG001|Period III|Administrative problems|1|||
160602627|NCT00615459|579922505|FG002|Period III|Administrative problems|1|||
160602628|NCT00615459|579922506|FG003|Period III|Administrative problems|0|||
160602629|NCT00615459|579922503|FG000|Period III|Unsatisfactory therapeutic effect|0|||
160602630|NCT00615459|579922504|FG001|Period III|Unsatisfactory therapeutic effect|1|||
160602631|NCT00615459|579922505|FG002|Period III|Unsatisfactory therapeutic effect|0|||
160602632|NCT00615459|579922506|FG003|Period III|Unsatisfactory therapeutic effect|0|||
160602633|NCT02017704|579922511|FG000|Overall Study|Withdrawal by Subject|2|||
160602634|NCT02017704|579922512|FG001|Overall Study|Withdrawal by Subject|0|||
160602635|NCT00918346|579922513|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
160602636|NCT00918346|579922514|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
160602637|NCT02076334|579922515|FG000|Overall Study|Protocol Violation|1|||
160602638|NCT02076334|579922516|FG001|Overall Study|Protocol Violation|0|||
160602639|NCT02076334|579922517|FG002|Overall Study|Protocol Violation|0|||
160602640|NCT02076334|579922518|FG003|Overall Study|Protocol Violation|0|||
160602641|NCT02076334|579922515|FG000|Overall Study|Lost to Follow-up|0|||
160602642|NCT02076334|579922516|FG001|Overall Study|Lost to Follow-up|1|||
160602643|NCT02076334|579922517|FG002|Overall Study|Lost to Follow-up|1|||
160602644|NCT02076334|579922518|FG003|Overall Study|Lost to Follow-up|0|||
160602645|NCT02076334|579922515|FG000|Overall Study|muscle soreness|0|||
160602646|NCT02076334|579922516|FG001|Overall Study|muscle soreness|0|||
160475981|NCT00473512|579471177|FG002|Period 1 (Phase 1)|Adverse Event|0|||
160602647|NCT02076334|579922517|FG002|Overall Study|muscle soreness|0|||
160475982|NCT00473512|579471178|FG003|Period 1 (Phase 1)|Adverse Event|5|||
160475983|NCT00473512|579471179|FG004|Period 1 (Phase 1)|Adverse Event|0|||
160475984|NCT00473512|579471175|FG000|Period 1 (Phase 1)|Death|0|||
160475985|NCT00473512|579471176|FG001|Period 1 (Phase 1)|Death|0|||
160602648|NCT02076334|579922518|FG003|Overall Study|muscle soreness|1|||
160602649|NCT03379376|579922519|FG000|Overall Study|Lost to Follow-up|2|||
160602650|NCT03379376|579922519|FG000|Overall Study|Did not wish to complete follow up|1|||
160602651|NCT03379376|579922519|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
160602652|NCT03379376|579922519|FG000|Overall Study|Death|1|||
160602653|NCT02475629|579922520|FG000|Overall Study|Adverse Event|1|||
160602654|NCT02475629|579922520|FG000|Overall Study|Death|4|||
160602655|NCT02475629|579922520|FG000|Overall Study|Physician Decision|1|||
160475986|NCT00473512|579471177|FG002|Period 1 (Phase 1)|Death|0|||
160602656|NCT02475629|579922520|FG000|Overall Study|Withdrawal by Subject|1|||
160602657|NCT02475629|579922520|FG000|Overall Study|Lost to Follow-up|1|||
160602658|NCT02475629|579922520|FG000|Overall Study|Subject non-compliance|1|||
160602659|NCT04153929|579922521|FG000|Overall Study|Other than listed|2|||
160602660|NCT04153929|579922522|FG001|Overall Study|Other than listed|2|||
160602661|NCT04153929|579922523|FG002|Overall Study|Other than listed|0|||
160602662|NCT04153929|579922524|FG003|Overall Study|Other than listed|1|||
160602663|NCT04153929|579922525|FG004|Overall Study|Other than listed|0|||
160602664|NCT04153929|579922526|FG005|Overall Study|Other than listed|2|||
160602665|NCT04153929|579922527|FG006|Overall Study|Other than listed|2|||
160602666|NCT04153929|579922528|FG007|Overall Study|Other than listed|1|||
160602667|NCT04153929|579922521|FG000|Overall Study|Lost to Follow-up|2|||
160602668|NCT04153929|579922522|FG001|Overall Study|Lost to Follow-up|1|||
160602669|NCT04153929|579922523|FG002|Overall Study|Lost to Follow-up|0|||
160602670|NCT04153929|579922524|FG003|Overall Study|Lost to Follow-up|1|||
160602671|NCT04153929|579922525|FG004|Overall Study|Lost to Follow-up|1|||
160602672|NCT04153929|579922526|FG005|Overall Study|Lost to Follow-up|0|||
160602673|NCT04153929|579922527|FG006|Overall Study|Lost to Follow-up|0|||
160602674|NCT04153929|579922528|FG007|Overall Study|Lost to Follow-up|0|||
160602675|NCT04153929|579922521|FG000|Overall Study|Withdrawal by Subject|3|||
160602676|NCT04153929|579922522|FG001|Overall Study|Withdrawal by Subject|1|||
160602677|NCT04153929|579922523|FG002|Overall Study|Withdrawal by Subject|0|||
160602678|NCT04153929|579922524|FG003|Overall Study|Withdrawal by Subject|3|||
160602679|NCT04153929|579922525|FG004|Overall Study|Withdrawal by Subject|1|||
160602680|NCT04153929|579922526|FG005|Overall Study|Withdrawal by Subject|0|||
160602681|NCT04153929|579922527|FG006|Overall Study|Withdrawal by Subject|1|||
160602682|NCT04153929|579922528|FG007|Overall Study|Withdrawal by Subject|0|||
160602683|NCT04153929|579922521|FG000|Overall Study|Protocol Violation|0|||
160602684|NCT04153929|579922522|FG001|Overall Study|Protocol Violation|0|||
160602685|NCT04153929|579922523|FG002|Overall Study|Protocol Violation|0|||
160602686|NCT04153929|579922524|FG003|Overall Study|Protocol Violation|0|||
160602687|NCT04153929|579922525|FG004|Overall Study|Protocol Violation|0|||
160602688|NCT04153929|579922526|FG005|Overall Study|Protocol Violation|0|||
160602689|NCT04153929|579922527|FG006|Overall Study|Protocol Violation|1|||
160602690|NCT04153929|579922528|FG007|Overall Study|Protocol Violation|2|||
160602691|NCT04153929|579922521|FG000|Overall Study|Adverse Event|3|||
160602692|NCT04153929|579922522|FG001|Overall Study|Adverse Event|5|||
160602693|NCT04153929|579922523|FG002|Overall Study|Adverse Event|5|||
160602694|NCT04153929|579922524|FG003|Overall Study|Adverse Event|11|||
160602695|NCT04153929|579922525|FG004|Overall Study|Adverse Event|15|||
160602696|NCT04153929|579922526|FG005|Overall Study|Adverse Event|4|||
160602697|NCT04153929|579922527|FG006|Overall Study|Adverse Event|8|||
160602698|NCT04153929|579922528|FG007|Overall Study|Adverse Event|2|||
160602699|NCT04153929|579922521|FG000|Overall Study|Not treated|1|||
160602700|NCT04153929|579922522|FG001|Overall Study|Not treated|0|||
160602701|NCT04153929|579922523|FG002|Overall Study|Not treated|0|||
160602702|NCT04153929|579922524|FG003|Overall Study|Not treated|0|||
160602703|NCT04153929|579922525|FG004|Overall Study|Not treated|0|||
160602704|NCT04153929|579922526|FG005|Overall Study|Not treated|0|||
160602705|NCT04153929|579922527|FG006|Overall Study|Not treated|1|||
160602706|NCT04153929|579922528|FG007|Overall Study|Not treated|0|||
160602707|NCT04083794|579922529|FG000|Overall Study|Lost to Follow-up|9|||
160602708|NCT01749800|579922530|FG000|Overall Study|not meeting inclusion criteria|3|||
160602709|NCT01749800|579922531|FG001|Overall Study|not meeting inclusion criteria|0|||
160602710|NCT01749800|579922532|FG002|Overall Study|not meeting inclusion criteria|0|||
160602711|NCT01749800|579922530|FG000|Overall Study|Withdrawal by Subject|0|||
160602712|NCT01749800|579922531|FG001|Overall Study|Withdrawal by Subject|1|||
160602713|NCT01749800|579922532|FG002|Overall Study|Withdrawal by Subject|0|||
160602714|NCT02810951|579922537|FG000|Overall Study|Adverse Event|1|||
160602715|NCT03199638|579922538|FG000|Overall Study|inability to drink glutamine during regularly|0|||
160602716|NCT03199638|579922539|FG001|Overall Study|inability to drink glutamine during regularly|2|||
160602717|NCT01575899|579922542|FG000|Overall Study|Lost to Follow-up|3|||
160602718|NCT01575899|579922543|FG001|Overall Study|Lost to Follow-up|4|||
160602719|NCT01575899|579922544|FG002|Overall Study|Lost to Follow-up|2|||
160602720|NCT01575899|579922542|FG000|Overall Study|Protocol Violation|2|||
160602721|NCT01575899|579922543|FG001|Overall Study|Protocol Violation|1|||
160602722|NCT01575899|579922544|FG002|Overall Study|Protocol Violation|0|||
160602723|NCT02807844|579922545|FG000|Overall Study|Physician Decision|0|||
160602724|NCT02807844|579922546|FG001|Overall Study|Physician Decision|0|||
160602725|NCT02807844|579922547|FG002|Overall Study|Physician Decision|0|||
160602726|NCT02807844|579922548|FG003|Overall Study|Physician Decision|0|||
160602727|NCT02807844|579922549|FG004|Overall Study|Physician Decision|0|||
160602728|NCT02807844|579922550|FG005|Overall Study|Physician Decision|0|||
160602729|NCT02807844|579922551|FG006|Overall Study|Physician Decision|3|||
160602730|NCT02807844|579922552|FG007|Overall Study|Physician Decision|0|||
160602731|NCT02807844|579922553|FG008|Overall Study|Physician Decision|1|||
160602732|NCT02807844|579922554|FG009|Overall Study|Physician Decision|2|||
160602733|NCT02807844|579922545|FG000|Overall Study|Death|0|||
160602734|NCT02807844|579922546|FG001|Overall Study|Death|0|||
160602735|NCT02807844|579922547|FG002|Overall Study|Death|2|||
160602736|NCT02807844|579922548|FG003|Overall Study|Death|4|||
160602737|NCT02807844|579922549|FG004|Overall Study|Death|1|||
160602738|NCT02807844|579922550|FG005|Overall Study|Death|2|||
160660248|NCT00105196|580137773|FG001|Overall Study|Withdrawal by Subject|6|||
160660249|NCT00105196|580137772|FG000|Overall Study|Lost to Follow-up|3|||
160660250|NCT00105196|580137773|FG001|Overall Study|Lost to Follow-up|2|||
160660251|NCT00105196|580137772|FG000|Overall Study|Poor/noncompliance|3|||
160660252|NCT00105196|580137773|FG001|Overall Study|Poor/noncompliance|4|||
160660253|NCT00105196|580137772|FG000|Overall Study|Protocol Violation|5|||
160660254|NCT00105196|580137773|FG001|Overall Study|Protocol Violation|2|||
160660255|NCT00105196|580137772|FG000|Overall Study|pending surgery|0|||
160660256|NCT00105196|580137773|FG001|Overall Study|pending surgery|1|||
160660257|NCT00105196|580137772|FG000|Overall Study|marijuana use|0|||
160660258|NCT00105196|580137773|FG001|Overall Study|marijuana use|1|||
160660259|NCT00105196|580137772|FG000|Overall Study|Subject became unblinded|0|||
160660260|NCT00105196|580137773|FG001|Overall Study|Subject became unblinded|1|||
160660261|NCT03340727|580137774|FG000|Overall Study|Death|1|||
160660262|NCT03340727|580137775|FG001|Overall Study|Death|0|||
160660263|NCT03340727|580137774|FG000|Overall Study|Lost to Follow-up|31|||
160660264|NCT03340727|580137775|FG001|Overall Study|Lost to Follow-up|35|||
160660265|NCT03340727|580137774|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
160660266|NCT03340727|580137775|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
160660267|NCT03340727|580137774|FG000|Overall Study|Transferred to another facility|10|||
160660268|NCT03340727|580137775|FG001|Overall Study|Transferred to another facility|7|||
160660269|NCT03340727|580137774|FG000|Overall Study|Withdrawal by Subject|28|||
160602739|NCT02807844|579922551|FG006|Overall Study|Death|1|||
160602740|NCT02807844|579922552|FG007|Overall Study|Death|2|||
160602741|NCT02807844|579922553|FG008|Overall Study|Death|0|||
160602742|NCT02807844|579922554|FG009|Overall Study|Death|1|||
160602743|NCT02807844|579922545|FG000|Overall Study|Withdrawal by Subject|0|||
160602744|NCT02807844|579922546|FG001|Overall Study|Withdrawal by Subject|0|||
160602745|NCT02807844|579922547|FG002|Overall Study|Withdrawal by Subject|2|||
160602746|NCT02807844|579922548|FG003|Overall Study|Withdrawal by Subject|1|||
160602747|NCT02807844|579922549|FG004|Overall Study|Withdrawal by Subject|1|||
160602748|NCT02807844|579922550|FG005|Overall Study|Withdrawal by Subject|0|||
160602749|NCT02807844|579922551|FG006|Overall Study|Withdrawal by Subject|1|||
160602750|NCT02807844|579922552|FG007|Overall Study|Withdrawal by Subject|0|||
160602751|NCT02807844|579922553|FG008|Overall Study|Withdrawal by Subject|0|||
160602752|NCT02807844|579922554|FG009|Overall Study|Withdrawal by Subject|0|||
160602753|NCT02807844|579922545|FG000|Overall Study|Progressive disease|5|||
160602754|NCT02807844|579922546|FG001|Overall Study|Progressive disease|12|||
160602755|NCT02807844|579922547|FG002|Overall Study|Progressive disease|8|||
160602756|NCT02807844|579922548|FG003|Overall Study|Progressive disease|8|||
160602757|NCT02807844|579922549|FG004|Overall Study|Progressive disease|3|||
160602758|NCT02807844|579922550|FG005|Overall Study|Progressive disease|8|||
160602759|NCT02807844|579922551|FG006|Overall Study|Progressive disease|14|||
160602760|NCT02807844|579922552|FG007|Overall Study|Progressive disease|17|||
160602761|NCT02807844|579922553|FG008|Overall Study|Progressive disease|19|||
160602762|NCT02807844|579922554|FG009|Overall Study|Progressive disease|15|||
160602763|NCT02807844|579922545|FG000|Overall Study|Adverse Event|1|||
160602764|NCT02807844|579922546|FG001|Overall Study|Adverse Event|0|||
160602765|NCT02807844|579922547|FG002|Overall Study|Adverse Event|0|||
160602766|NCT02807844|579922548|FG003|Overall Study|Adverse Event|0|||
160602767|NCT02807844|579922549|FG004|Overall Study|Adverse Event|1|||
160602768|NCT02807844|579922550|FG005|Overall Study|Adverse Event|1|||
160602769|NCT02807844|579922551|FG006|Overall Study|Adverse Event|1|||
160602770|NCT02807844|579922552|FG007|Overall Study|Adverse Event|1|||
160602771|NCT02807844|579922553|FG008|Overall Study|Adverse Event|1|||
160602772|NCT02807844|579922554|FG009|Overall Study|Adverse Event|2|||
160602773|NCT03097029|579922555|FG000|Overall Study|Withdrawal by Subject|1|||
160602774|NCT00709124|579922556|FG000|Overall Study|Death|3|||
160602775|NCT00709124|579922557|FG001|Overall Study|Death|1|||
160602776|NCT00709124|579922556|FG000|Overall Study|encephalopathy; can't do assessment|1|||
160602777|NCT00709124|579922557|FG001|Overall Study|encephalopathy; can't do assessment|0|||
160602778|NCT00373490|579922558|FG000|Overall Study|Adverse Event|0|||
160602779|NCT00373490|579922559|FG001|Overall Study|Adverse Event|1|||
160602780|NCT00373490|579922558|FG000|Overall Study|Lack of Efficacy|9|||
160602781|NCT00373490|579922559|FG001|Overall Study|Lack of Efficacy|4|||
160602782|NCT00373490|579922558|FG000|Overall Study|Withdrawal by Subject|0|||
160602783|NCT00373490|579922559|FG001|Overall Study|Withdrawal by Subject|1|||
160602784|NCT00753688|579922566|FG000|Overall Study|Death|102|||
160602785|NCT00753688|579922567|FG001|Overall Study|Death|203|||
160602786|NCT00753688|579922566|FG000|Overall Study|Missing|4|||
160602787|NCT00753688|579922567|FG001|Overall Study|Missing|9|||
160602788|NCT00753688|579922566|FG000|Overall Study|Participant Withdrew Consent|2|||
160602789|NCT00753688|579922567|FG001|Overall Study|Participant Withdrew Consent|2|||
160602790|NCT00753688|579922566|FG000|Overall Study|Ongoing - in Follow-up|15|||
160602791|NCT00753688|579922567|FG001|Overall Study|Ongoing - in Follow-up|31|||
160602792|NCT00753688|579922566|FG000|Overall Study|Adverse Event|0|||
160602793|NCT00753688|579922567|FG001|Overall Study|Adverse Event|1|||
160602794|NCT01250756|579922568|FG000|Infant Series|Withdrawal by Subject|4|||
160602795|NCT01250756|579922569|FG001|Infant Series|Withdrawal by Subject|5|||
160602796|NCT01250756|579922568|FG000|Infant Series|Randomized, Not Vaccinated|2|||
160602797|NCT01250756|579922569|FG001|Infant Series|Randomized, Not Vaccinated|2|||
160602798|NCT01250756|579922568|FG000|Infant Series|Other|22|||
160602799|NCT01250756|579922569|FG001|Infant Series|Other|0|||
160602800|NCT01250756|579922568|FG000|After Infant Series|Adverse Event|5|||
160602801|NCT01250756|579922569|FG001|After Infant Series|Adverse Event|2|||
160602802|NCT01250756|579922568|FG000|After Infant Series|Withdrawal by Subject|4|||
160602803|NCT01250756|579922569|FG001|After Infant Series|Withdrawal by Subject|1|||
160602804|NCT01250756|579922568|FG000|After Infant Series|Other|2|||
160602805|NCT01250756|579922569|FG001|After Infant Series|Other|1|||
160602806|NCT01250756|579922568|FG000|Toddler Dose|Adverse Event|0|||
160602807|NCT01250756|579922569|FG001|Toddler Dose|Adverse Event|1|||
160602808|NCT01250756|579922568|FG000|After Toddler Dose|Adverse Event|0|||
160602809|NCT01250756|579922569|FG001|After Toddler Dose|Adverse Event|1|||
160602810|NCT00108953|579922570|FG000|Follow-up|Death|18|||
160602811|NCT00108953|579922571|FG001|Follow-up|Death|26|||
160602812|NCT00108953|579922570|FG000|Follow-up|Lost to Follow-up|1|||
160602813|NCT00108953|579922571|FG001|Follow-up|Lost to Follow-up|1|||
160602814|NCT00108953|579922570|FG000|Follow-up|Study terminated by sponsor|10|||
160602815|NCT00108953|579922571|FG001|Follow-up|Study terminated by sponsor|6|||
160602816|NCT02999100|579922574|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
160602817|NCT02999100|579922575|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
160660270|NCT03340727|580137775|FG001|Overall Study|Withdrawal by Subject|17|||
160660271|NCT00533273|580137778|FG000|Double-blind|Withdrew consent|0|||
160660272|NCT00533273|580137779|FG001|Double-blind|Withdrew consent|2|||
160660273|NCT00533273|580137778|FG000|Open-label|Withdrawal by Subject|6|||
160660274|NCT00533273|580137779|FG001|Open-label|Withdrawal by Subject|0|||
160660275|NCT01873586|580137781|FG000|Overall Study|Lost to Follow-up|3|||
160660276|NCT00669942|580137782|FG000|Parts 2 and 3|Adverse Event|0|||
160660277|NCT00669942|580137783|FG001|Parts 2 and 3|Adverse Event|0|||
160660278|NCT00669942|580137784|FG002|Parts 2 and 3|Adverse Event|0|||
160660279|NCT00669942|580137785|FG003|Parts 2 and 3|Adverse Event|0|||
160660280|NCT00669942|580137786|FG004|Parts 2 and 3|Adverse Event|0|||
160660281|NCT00669942|580137787|FG005|Parts 2 and 3|Adverse Event|0|||
160660282|NCT00669942|580137788|FG006|Parts 2 and 3|Adverse Event|0|||
160660283|NCT00669942|580137789|FG007|Parts 2 and 3|Adverse Event|2|||
160660284|NCT00669942|580137790|FG008|Parts 2 and 3|Adverse Event|1|||
160660285|NCT00669942|580137791|FG009|Parts 2 and 3|Adverse Event|0|||
160660286|NCT00669942|580137792|FG010|Parts 2 and 3|Adverse Event|0|||
160660287|NCT00669942|580137793|FG011|Parts 2 and 3|Adverse Event|0|||
160660288|NCT00669942|580137782|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
160660289|NCT00669942|580137783|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
160660290|NCT00669942|580137784|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
160660291|NCT00669942|580137785|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
160660292|NCT00669942|580137786|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
160660293|NCT00669942|580137787|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
160660294|NCT00669942|580137788|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
160660295|NCT00669942|580137789|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
160660296|NCT00669942|580137790|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
160660297|NCT00669942|580137791|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
160660298|NCT00669942|580137792|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
160660299|NCT00669942|580137793|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
160660300|NCT00669942|580137782|FG000|Parts 2 and 3|Protocol Violation|0|||
160660301|NCT00669942|580137783|FG001|Parts 2 and 3|Protocol Violation|0|||
160660302|NCT00669942|580137784|FG002|Parts 2 and 3|Protocol Violation|0|||
160660303|NCT00669942|580137785|FG003|Parts 2 and 3|Protocol Violation|0|||
160660304|NCT00669942|580137786|FG004|Parts 2 and 3|Protocol Violation|0|||
160660305|NCT00669942|580137787|FG005|Parts 2 and 3|Protocol Violation|1|||
160660306|NCT00669942|580137788|FG006|Parts 2 and 3|Protocol Violation|0|||
160660307|NCT00669942|580137789|FG007|Parts 2 and 3|Protocol Violation|0|||
160660308|NCT00669942|580137790|FG008|Parts 2 and 3|Protocol Violation|0|||
160660309|NCT00669942|580137791|FG009|Parts 2 and 3|Protocol Violation|0|||
160660310|NCT00669942|580137792|FG010|Parts 2 and 3|Protocol Violation|0|||
160660311|NCT00669942|580137793|FG011|Parts 2 and 3|Protocol Violation|0|||
160660312|NCT03752528|580137794|FG000|Part A|Lost to Follow-up|1|||
160660313|NCT03752528|580137794|FG000|Part A|Protocol Violation|1|||
160660314|NCT03752528|580137794|FG000|Part B|Protocol Violation|1|||
160660315|NCT03752528|580137794|FG000|Part B|Study terminated by sponsor|3|||
160660316|NCT01981720|580137795|FG000|Overall Study|Adverse Event|1|||
160660317|NCT01981720|580137795|FG000|Overall Study|Withdrawal by Subject|3|||
160660318|NCT01981720|580137795|FG000|Overall Study|Pregnancy|1|||
160660319|NCT00282048|580137796|FG000|Overall Study|Lack of Efficacy|30|||
160660320|NCT00282048|580137796|FG000|Overall Study|Adverse Event|22|||
160660321|NCT00282048|580137796|FG000|Overall Study|Withdrawal by Subject|1|||
160660322|NCT00282048|580137796|FG000|Overall Study|Other|8|||
160660323|NCT00282048|580137796|FG000|Overall Study|Ongoing|1|||
160660324|NCT00259012|580137799|FG000|Overall Study|Adverse Event|0|||
160660325|NCT00259012|580137800|FG001|Overall Study|Adverse Event|1|||
160660326|NCT00259012|580137799|FG000|Overall Study|Withdrawal by Subject|1|||
160660327|NCT00259012|580137800|FG001|Overall Study|Withdrawal by Subject|0|||
160660328|NCT00259012|580137799|FG000|Overall Study|Physician Decision|0|||
160660329|NCT00259012|580137800|FG001|Overall Study|Physician Decision|1|||
160660330|NCT00259012|580137799|FG000|Overall Study|Lost to Follow-up|0|||
160660331|NCT00259012|580137800|FG001|Overall Study|Lost to Follow-up|1|||
160660332|NCT00259012|580137799|FG000|Overall Study|Protocol Violation|1|||
160660333|NCT00259012|580137800|FG001|Overall Study|Protocol Violation|1|||
160660334|NCT03522675|580137801|FG000|Overall Study|Screen fail|1|||
160660335|NCT03522675|580137801|FG000|Overall Study|Non-reactive to histamine|1|||
160660336|NCT00707161|580137802|FG000|Overall Study|Physician Decision|6|||
160660337|NCT02674477|580137803|FG000|Overall Study|Protocol Violation|8|||
160660338|NCT02674477|580137804|FG001|Overall Study|Protocol Violation|2|||
160660339|NCT02336165|580137809|FG000|Overall Study|Death|3|||
160660340|NCT02336165|580137810|FG001|Overall Study|Death|0|||
160660341|NCT02336165|580137811|FG002|Overall Study|Death|0|||
160660342|NCT02336165|580137812|FG003|Overall Study|Death|0|||
160660343|NCT02336165|580137813|FG004|Overall Study|Death|1|||
160660344|NCT02336165|580137809|FG000|Overall Study|Physician Decision|2|||
160660345|NCT02336165|580137810|FG001|Overall Study|Physician Decision|2|||
160660346|NCT02336165|580137811|FG002|Overall Study|Physician Decision|1|||
160660347|NCT02336165|580137812|FG003|Overall Study|Physician Decision|1|||
160660348|NCT02336165|580137813|FG004|Overall Study|Physician Decision|0|||
160660349|NCT02336165|580137809|FG000|Overall Study|Withdrawal by Subject|0|||
160475987|NCT00473512|579471178|FG003|Period 1 (Phase 1)|Death|1|||
160475988|NCT00473512|579471179|FG004|Period 1 (Phase 1)|Death|0|||
160475989|NCT00473512|579471175|FG000|Period 1 (Phase 1)|Disease Progression|1|||
160475990|NCT00473512|579471176|FG001|Period 1 (Phase 1)|Disease Progression|1|||
160475991|NCT00473512|579471177|FG002|Period 1 (Phase 1)|Disease Progression|0|||
160475992|NCT00473512|579471178|FG003|Period 1 (Phase 1)|Disease Progression|10|||
160475993|NCT00473512|579471179|FG004|Period 1 (Phase 1)|Disease Progression|1|||
160475994|NCT00473512|579471175|FG000|Period 1 (Phase 1)|Other|0|||
160475995|NCT00473512|579471176|FG001|Period 1 (Phase 1)|Other|0|||
160475996|NCT00473512|579471177|FG002|Period 1 (Phase 1)|Other|0|||
160475997|NCT00473512|579471178|FG003|Period 1 (Phase 1)|Other|1|||
160475998|NCT00473512|579471179|FG004|Period 1 (Phase 1)|Other|0|||
160475999|NCT00473512|579471175|FG000|Period 2 (Phase 2)|Adverse Event|0|||
160476000|NCT00473512|579471176|FG001|Period 2 (Phase 2)|Adverse Event|0|||
160476001|NCT00473512|579471177|FG002|Period 2 (Phase 2)|Adverse Event|0|||
160476002|NCT00473512|579471178|FG003|Period 2 (Phase 2)|Adverse Event|1|||
160476003|NCT00473512|579471179|FG004|Period 2 (Phase 2)|Adverse Event|0|||
160476004|NCT00473512|579471175|FG000|Period 2 (Phase 2)|Death|0|||
160476005|NCT00473512|579471176|FG001|Period 2 (Phase 2)|Death|0|||
160476006|NCT00473512|579471177|FG002|Period 2 (Phase 2)|Death|0|||
160476007|NCT00473512|579471178|FG003|Period 2 (Phase 2)|Death|1|||
160476008|NCT00473512|579471179|FG004|Period 2 (Phase 2)|Death|1|||
160476009|NCT00473512|579471175|FG000|Period 2 (Phase 2)|Disease Progression|0|||
160476010|NCT00473512|579471176|FG001|Period 2 (Phase 2)|Disease Progression|2|||
160476011|NCT00473512|579471177|FG002|Period 2 (Phase 2)|Disease Progression|2|||
160476012|NCT00473512|579471178|FG003|Period 2 (Phase 2)|Disease Progression|17|||
160476013|NCT00473512|579471179|FG004|Period 2 (Phase 2)|Disease Progression|1|||
160476014|NCT00473512|579471175|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
160602818|NCT02999100|579922576|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
160476015|NCT00473512|579471176|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
160476016|NCT00473512|579471177|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
160476017|NCT00473512|579471178|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
160476018|NCT00473512|579471179|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
160476019|NCT00473512|579471175|FG000|Period 2 (Phase 2)|Other|1|||
160476020|NCT00473512|579471176|FG001|Period 2 (Phase 2)|Other|0|||
160476021|NCT00473512|579471177|FG002|Period 2 (Phase 2)|Other|0|||
160476022|NCT00473512|579471178|FG003|Period 2 (Phase 2)|Other|3|||
160476023|NCT00473512|579471179|FG004|Period 2 (Phase 2)|Other|0|||
160476024|NCT01129011|579471182|FG000|Overall Study|Adverse Event|20|||
160476025|NCT01129011|579471183|FG001|Overall Study|Adverse Event|30|||
160476026|NCT01129011|579471182|FG000|Overall Study|Withdrawal by Subject|24|||
160476027|NCT01129011|579471183|FG001|Overall Study|Withdrawal by Subject|8|||
160476028|NCT01129011|579471182|FG000|Overall Study|Lost to Follow-up|6|||
160476029|NCT01129011|579471183|FG001|Overall Study|Lost to Follow-up|7|||
160476030|NCT01129011|579471182|FG000|Overall Study|Duodenal Ulcer|2|||
160476031|NCT01129011|579471183|FG001|Overall Study|Duodenal Ulcer|8|||
160476032|NCT01129011|579471182|FG000|Overall Study|misc|7|||
160476033|NCT01129011|579471183|FG001|Overall Study|misc|4|||
160476034|NCT01012999|579471184|FG000|Overall Study|Protocol Violation|1|||
160476035|NCT01369147|579471185|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
160476036|NCT01369147|579471186|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
160476037|NCT01369147|579471187|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
160602819|NCT02999100|579922577|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
160602820|NCT02999100|579922578|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
160602821|NCT02999100|579922579|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
160602822|NCT02999100|579922574|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
160476038|NCT00417885|579471188|FG000|Overall Study|Adverse Event|1|||
160476039|NCT00417885|579471188|FG000|Overall Study|Objective Progression or Relapse|3|||
160476040|NCT00417885|579471188|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
160476041|NCT01757288|579471192|FG000|Overall Study|Consent withdrawal|0|||
160476042|NCT01757288|579471193|FG001|Overall Study|Consent withdrawal|4|||
160476043|NCT01757288|579471194|FG002|Overall Study|Consent withdrawal|4|||
160602823|NCT02999100|579922575|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
160602824|NCT02999100|579922576|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
160602825|NCT02999100|579922577|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
160602826|NCT02999100|579922578|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
160476044|NCT01757288|579471192|FG000|Overall Study|Patient off study, IRB hold.|0|||
160476045|NCT01757288|579471193|FG001|Overall Study|Patient off study, IRB hold.|0|||
160476046|NCT01757288|579471194|FG002|Overall Study|Patient off study, IRB hold.|1|||
160476047|NCT01757288|579471192|FG000|Overall Study|Patient death prior to starting treatment|0|||
160476048|NCT01757288|579471193|FG001|Overall Study|Patient death prior to starting treatment|0|||
160476049|NCT01757288|579471194|FG002|Overall Study|Patient death prior to starting treatment|1|||
160476050|NCT01757288|579471192|FG000|Overall Study|Wrong medication administered|0|||
160476051|NCT01757288|579471193|FG001|Overall Study|Wrong medication administered|1|||
160476052|NCT01757288|579471194|FG002|Overall Study|Wrong medication administered|0|||
160476053|NCT01757288|579471192|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
160476054|NCT01757288|579471193|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
160476055|NCT01757288|579471194|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
160476056|NCT01757288|579471192|FG000|Overall Study|Not meeting protocol constraints|0|||
160476057|NCT01757288|579471193|FG001|Overall Study|Not meeting protocol constraints|1|||
160476058|NCT01757288|579471194|FG002|Overall Study|Not meeting protocol constraints|1|||
160476059|NCT01757288|579471192|FG000|Overall Study|Multiple missed appointments|0|||
160476060|NCT01757288|579471193|FG001|Overall Study|Multiple missed appointments|1|||
160476061|NCT01757288|579471194|FG002|Overall Study|Multiple missed appointments|0|||
160476062|NCT01757288|579471192|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
160476063|NCT01757288|579471193|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
160476064|NCT01757288|579471194|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
160476065|NCT01757288|579471192|FG000|Overall Study|>2 weeks treatment break|0|||
160476066|NCT01757288|579471193|FG001|Overall Study|>2 weeks treatment break|0|||
160602827|NCT02999100|579922579|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
160602828|NCT02999100|579922574|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
160602829|NCT02999100|579922575|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
160602830|NCT02999100|579922576|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
160602831|NCT02999100|579922577|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
160602832|NCT02999100|579922578|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
160602833|NCT02999100|579922579|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
160602834|NCT02228564|579922580|FG000|Overall Study|Withdrawal by Subject|10|||
160602835|NCT02228564|579922580|FG000|Overall Study|Death|11|||
160602836|NCT02228564|579922580|FG000|Overall Study|Physician Decision|5|||
160602837|NCT02228564|579922580|FG000|Overall Study|Lost to Follow-up|17|||
160602838|NCT02228564|579922580|FG000|Overall Study|Other|6|||
160602839|NCT01455415|579922581|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
160602840|NCT01455415|579922582|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
160602841|NCT01455415|579922581|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
160602842|NCT01455415|579922582|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
160602843|NCT01455415|579922581|FG000|Period 1|Drug Error not Associated to AE|0|||
160602844|NCT01455415|579922582|FG001|Period 1|Drug Error not Associated to AE|1|||
160602845|NCT01455415|579922581|FG000|Period 1|AE Not Related to Study Drug|2|||
160602846|NCT01455415|579922582|FG001|Period 1|AE Not Related to Study Drug|6|||
160602847|NCT01455415|579922581|FG000|Period 1|Withdrawal by Subject|4|||
160602848|NCT01455415|579922582|FG001|Period 1|Withdrawal by Subject|5|||
160602849|NCT01455415|579922581|FG000|Period 1|Unspecified Reason|1|||
160602850|NCT01455415|579922582|FG001|Period 1|Unspecified Reason|1|||
160602851|NCT01455415|579922581|FG000|Period 1|Protocol Violation|0|||
160602852|NCT01455415|579922582|FG001|Period 1|Protocol Violation|2|||
160602853|NCT01455415|579922581|FG000|Washout|AE Related to Study Drug|2|||
160602854|NCT01455415|579922582|FG001|Washout|AE Related to Study Drug|0|||
160602855|NCT01455415|579922581|FG000|Washout|Lost to Follow-up|1|||
160602856|NCT01455415|579922582|FG001|Washout|Lost to Follow-up|0|||
160602857|NCT01455415|579922581|FG000|Washout|Drug Error not Associated to AE|2|||
160602858|NCT01455415|579922582|FG001|Washout|Drug Error not Associated to AE|1|||
160602859|NCT01455415|579922581|FG000|Washout|AE Not Related to Study Drug|2|||
160602860|NCT01455415|579922582|FG001|Washout|AE Not Related to Study Drug|3|||
160602861|NCT01455415|579922581|FG000|Washout|Unspecified Reason|1|||
160602862|NCT01455415|579922582|FG001|Washout|Unspecified Reason|2|||
160602863|NCT01455415|579922581|FG000|Washout|Protocol Violation|0|||
160602864|NCT01455415|579922582|FG001|Washout|Protocol Violation|1|||
160602865|NCT01455415|579922581|FG000|Period 2|AE Related to Study Drug|1|||
160602866|NCT01455415|579922582|FG001|Period 2|AE Related to Study Drug|2|||
160602867|NCT01455415|579922581|FG000|Period 2|Lost to Follow-up|2|||
160602868|NCT01455415|579922582|FG001|Period 2|Lost to Follow-up|1|||
160602869|NCT01455415|579922581|FG000|Period 2|AE Not Related to Study Drug|2|||
160602870|NCT01455415|579922582|FG001|Period 2|AE Not Related to Study Drug|1|||
160602871|NCT01455415|579922581|FG000|Period 2|Lack of Efficacy|2|||
160602872|NCT01455415|579922582|FG001|Period 2|Lack of Efficacy|0|||
160602873|NCT01455415|579922581|FG000|Period 2|Withdrawal by Subject|2|||
160602874|NCT01455415|579922582|FG001|Period 2|Withdrawal by Subject|3|||
160660350|NCT02336165|580137810|FG001|Overall Study|Withdrawal by Subject|0|||
160602875|NCT01455415|579922581|FG000|Period 2|Unspecified Reason|2|||
160602876|NCT01455415|579922582|FG001|Period 2|Unspecified Reason|3|||
160602877|NCT01455415|579922581|FG000|Period 2|Protocol Violation|2|||
160602878|NCT01455415|579922582|FG001|Period 2|Protocol Violation|0|||
160602879|NCT01455415|579922581|FG000|Follow-up|AE Related to Study Drug|0|||
160476067|NCT01757288|579471194|FG002|Overall Study|>2 weeks treatment break|1|||
160476068|NCT02825550|579471196|FG000|Overall Study|Physician Decision|1|||
160476069|NCT04626128|579471199|FG000|Overall Study|Withdrawal by Subject|0|||
160476070|NCT04626128|579471200|FG001|Overall Study|Withdrawal by Subject|1|||
160476071|NCT04626128|579471201|FG002|Overall Study|Withdrawal by Subject|0|||
160476072|NCT04626128|579471202|FG003|Overall Study|Withdrawal by Subject|0|||
160476073|NCT00248794|579471205|FG000|Overall Study|Lost to Follow-up|6|||
160476074|NCT00248794|579471206|FG001|Overall Study|Lost to Follow-up|8|||
160476075|NCT00248794|579471207|FG002|Overall Study|Lost to Follow-up|3|||
160476076|NCT03209492|579471208|FG000|Overall Study|Case Report Forms Uncollected|5|||
160476077|NCT04908488|579471209|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
160476078|NCT04908488|579471210|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
160476079|NCT04908488|579471209|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
160476080|NCT04908488|579471210|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
160476081|NCT01107912|579471213|FG000|Period 1|Adverse Event|0|||
160476082|NCT01107912|579471214|FG001|Period 1|Adverse Event|0|||
160476083|NCT01107912|579471215|FG002|Period 1|Adverse Event|0|||
160476084|NCT01107912|579471216|FG003|Period 1|Adverse Event|0|||
160476085|NCT01107912|579471217|FG004|Period 1|Adverse Event|2|||
160476086|NCT01107912|579471218|FG005|Period 1|Adverse Event|0|||
160476087|NCT01107912|579471213|FG000|Period 1|Physician Decision|0|||
160476088|NCT01107912|579471214|FG001|Period 1|Physician Decision|0|||
160476089|NCT01107912|579471215|FG002|Period 1|Physician Decision|0|||
160476090|NCT01107912|579471216|FG003|Period 1|Physician Decision|0|||
160476091|NCT01107912|579471217|FG004|Period 1|Physician Decision|1|||
160476092|NCT01107912|579471218|FG005|Period 1|Physician Decision|0|||
160476093|NCT01107912|579471213|FG000|Period 1|Withdrawal by Subject|1|||
160476094|NCT01107912|579471214|FG001|Period 1|Withdrawal by Subject|0|||
160476095|NCT01107912|579471215|FG002|Period 1|Withdrawal by Subject|0|||
160476096|NCT01107912|579471216|FG003|Period 1|Withdrawal by Subject|0|||
160476097|NCT01107912|579471217|FG004|Period 1|Withdrawal by Subject|0|||
160476098|NCT01107912|579471218|FG005|Period 1|Withdrawal by Subject|0|||
160476099|NCT01107912|579471213|FG000|Period 2|Physician Decision|0|||
160476100|NCT01107912|579471214|FG001|Period 2|Physician Decision|0|||
160476101|NCT01107912|579471215|FG002|Period 2|Physician Decision|1|||
160476102|NCT01107912|579471216|FG003|Period 2|Physician Decision|0|||
160476103|NCT01107912|579471217|FG004|Period 2|Physician Decision|0|||
160476104|NCT01107912|579471218|FG005|Period 2|Physician Decision|0|||
160476105|NCT01107912|579471213|FG000|Period 3|Adverse Event|0|||
160476106|NCT01107912|579471214|FG001|Period 3|Adverse Event|1|||
160476107|NCT01107912|579471215|FG002|Period 3|Adverse Event|1|||
160476108|NCT01107912|579471216|FG003|Period 3|Adverse Event|0|||
160476109|NCT01107912|579471217|FG004|Period 3|Adverse Event|0|||
160476110|NCT01107912|579471218|FG005|Period 3|Adverse Event|0|||
160476111|NCT01107912|579471213|FG000|Period 3|Withdrawal by Subject|0|||
160476112|NCT01107912|579471214|FG001|Period 3|Withdrawal by Subject|0|||
160476113|NCT01107912|579471215|FG002|Period 3|Withdrawal by Subject|0|||
160476114|NCT01107912|579471216|FG003|Period 3|Withdrawal by Subject|1|||
160476115|NCT01107912|579471217|FG004|Period 3|Withdrawal by Subject|0|||
160476116|NCT01107912|579471218|FG005|Period 3|Withdrawal by Subject|0|||
160476117|NCT01894620|579471219|FG000|Overall Study|Withdrawal by Subject|0|||
160476118|NCT01894620|579471220|FG001|Overall Study|Withdrawal by Subject|1|||
160476119|NCT01124916|579471221|FG000|Overall Study|Lost to Follow-up|3|||
160476120|NCT01124916|579471222|FG001|Overall Study|Lost to Follow-up|2|||
160476121|NCT02206607|579471223|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
160476122|NCT02206607|579471224|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
160476123|NCT02206607|579471225|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
160476124|NCT02206607|579471226|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
160476125|NCT02206607|579471227|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
160476126|NCT02206607|579471223|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
160476127|NCT02206607|579471224|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
160476128|NCT02206607|579471225|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
160476129|NCT02206607|579471226|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
160476130|NCT02206607|579471227|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
160476131|NCT00879710|579471228|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
160476132|NCT00879710|579471229|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
160476133|NCT00879710|579471230|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
160476134|NCT00879710|579471231|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
160476135|NCT00879710|579471228|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
160476136|NCT00879710|579471229|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
160476137|NCT00879710|579471230|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
160476138|NCT00879710|579471231|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
160476139|NCT00761267|579471232|FG000|Overall Study|Death|1|||
160476140|NCT00761267|579471233|FG001|Overall Study|Death|2|||
160476141|NCT00761267|579471234|FG002|Overall Study|Death|5|||
160476142|NCT00761267|579471232|FG000|Overall Study|Lost to Follow-up|0|||
160476143|NCT00761267|579471233|FG001|Overall Study|Lost to Follow-up|0|||
160476144|NCT00761267|579471234|FG002|Overall Study|Lost to Follow-up|1|||
160476145|NCT00761267|579471232|FG000|Overall Study|Randomized but not treated|1|||
160476146|NCT00761267|579471233|FG001|Overall Study|Randomized but not treated|1|||
160476147|NCT00761267|579471234|FG002|Overall Study|Randomized but not treated|0|||
160476148|NCT00761267|579471232|FG000|Overall Study|Withdrawal by Subject|0|||
160476149|NCT00761267|579471233|FG001|Overall Study|Withdrawal by Subject|1|||
160476150|NCT00761267|579471234|FG002|Overall Study|Withdrawal by Subject|0|||
160476151|NCT01864200|579471235|FG000|Overall Study|Lost to Follow-up|1|||
160476152|NCT01864200|579471236|FG001|Overall Study|Lost to Follow-up|3|||
160476153|NCT01864200|579471235|FG000|Overall Study|Protocol Violation|1|||
160476154|NCT01864200|579471236|FG001|Overall Study|Protocol Violation|0|||
160476155|NCT00963924|579471239|FG000|Overall Study|Adverse Event|1|||
160476156|NCT00963924|579471240|FG001|Overall Study|Adverse Event|0|||
160476157|NCT00963924|579471239|FG000|Overall Study|Withdrawal by Subject|0|||
160476158|NCT00963924|579471240|FG001|Overall Study|Withdrawal by Subject|1|||
160476159|NCT00963924|579471239|FG000|Overall Study|Changed antipsychotic|0|||
160476160|NCT00963924|579471240|FG001|Overall Study|Changed antipsychotic|1|||
160476161|NCT00963924|579471239|FG000|Overall Study|Lost to Follow-up|0|||
160476162|NCT00963924|579471240|FG001|Overall Study|Lost to Follow-up|1|||
160476163|NCT00446095|579471241|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
160476164|NCT00446095|579471242|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
160476165|NCT00446095|579471243|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
160476166|NCT00446095|579471244|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
160476167|NCT00446095|579471245|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
160476168|NCT00446095|579471241|FG000|Phase II (8 Weeks)|Adverse Event|0|||
160476169|NCT00446095|579471242|FG001|Phase II (8 Weeks)|Adverse Event|1|||
160476170|NCT00446095|579471243|FG002|Phase II (8 Weeks)|Adverse Event|1|||
160476171|NCT00446095|579471244|FG003|Phase II (8 Weeks)|Adverse Event|0|||
160476172|NCT00446095|579471245|FG004|Phase II (8 Weeks)|Adverse Event|0|||
160476173|NCT00446095|579471241|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
160476174|NCT00446095|579471242|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
160476175|NCT00446095|579471243|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
160476176|NCT00446095|579471244|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
160476177|NCT00446095|579471245|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
160476178|NCT00446095|579471241|FG000|Phase II (8 Weeks)|Physician Decision|1|||
160476179|NCT00446095|579471242|FG001|Phase II (8 Weeks)|Physician Decision|0|||
160476180|NCT00446095|579471243|FG002|Phase II (8 Weeks)|Physician Decision|0|||
160476181|NCT00446095|579471244|FG003|Phase II (8 Weeks)|Physician Decision|0|||
160476182|NCT00446095|579471245|FG004|Phase II (8 Weeks)|Physician Decision|0|||
160476183|NCT00446095|579471241|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
160476184|NCT00446095|579471242|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
160476185|NCT00446095|579471243|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
160476186|NCT00446095|579471244|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
160476187|NCT00446095|579471245|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
160476188|NCT00446095|579471241|FG000|Phase II (8 Weeks)|Ongoing|0|||
160476189|NCT00446095|579471242|FG001|Phase II (8 Weeks)|Ongoing|0|||
160476190|NCT00446095|579471243|FG002|Phase II (8 Weeks)|Ongoing|1|||
160476191|NCT00446095|579471244|FG003|Phase II (8 Weeks)|Ongoing|0|||
160476192|NCT00446095|579471245|FG004|Phase II (8 Weeks)|Ongoing|0|||
160602880|NCT01455415|579922582|FG001|Follow-up|AE Related to Study Drug|1|||
160602881|NCT01455415|579922581|FG000|Follow-up|Lack of Efficacy|0|||
160602882|NCT01455415|579922582|FG001|Follow-up|Lack of Efficacy|1|||
160602883|NCT01455415|579922581|FG000|Follow-up|Withdrawal by Subject|2|||
160476193|NCT00446095|579471241|FG000|Phase I (28 Days)|Adverse Event|0|||
160476194|NCT00446095|579471242|FG001|Phase I (28 Days)|Adverse Event|0|||
160476195|NCT00446095|579471243|FG002|Phase I (28 Days)|Adverse Event|0|||
160476196|NCT00446095|579471244|FG003|Phase I (28 Days)|Adverse Event|1|||
160476197|NCT00446095|579471245|FG004|Phase I (28 Days)|Adverse Event|0|||
160476198|NCT00446095|579471241|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
160476199|NCT00446095|579471242|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
160476200|NCT00446095|579471243|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
160476201|NCT00446095|579471244|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
160476202|NCT00446095|579471245|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
160476203|NCT02159352|579471249|FG000|Overall Study|Adverse Event|3|||
160602884|NCT01455415|579922582|FG001|Follow-up|Withdrawal by Subject|0|||
160476204|NCT02159352|579471250|FG001|Overall Study|Adverse Event|1|||
160476205|NCT02159352|579471249|FG000|Overall Study|Withdrawal by Subject|0|||
160476206|NCT02159352|579471250|FG001|Overall Study|Withdrawal by Subject|1|||
160602885|NCT01455415|579922581|FG000|Follow-up|Unspecified Reason|1|||
160602886|NCT01455415|579922582|FG001|Follow-up|Unspecified Reason|0|||
160602887|NCT01946412|579922583|FG000|Overall Study|Adverse Event|1|||
160602888|NCT01946412|579922583|FG000|Overall Study|Non-Compliance|1|||
160602889|NCT01946412|579922583|FG000|Overall Study|Continued with commercial Kalydeco|2|||
160602890|NCT01946412|579922583|FG000|Overall Study|Difficulty in swallowing|1|||
160602891|NCT01594749|579924250|FG000|Overall Study|Adverse Event|2|||
160602892|NCT01594749|579924251|FG001|Overall Study|Adverse Event|1|||
160602893|NCT01594749|579924250|FG000|Overall Study|Withdrawal by Subject|2|||
160602894|NCT01594749|579924251|FG001|Overall Study|Withdrawal by Subject|2|||
160602895|NCT01594749|579924250|FG000|Overall Study|Protocol Violation|2|||
160602896|NCT01594749|579924251|FG001|Overall Study|Protocol Violation|0|||
160602897|NCT01594749|579924250|FG000|Overall Study|Physician Decision|1|||
160602898|NCT01594749|579924251|FG001|Overall Study|Physician Decision|1|||
160660351|NCT02336165|580137811|FG002|Overall Study|Withdrawal by Subject|1|||
160660352|NCT02336165|580137812|FG003|Overall Study|Withdrawal by Subject|0|||
160660353|NCT02336165|580137813|FG004|Overall Study|Withdrawal by Subject|1|||
160660354|NCT02336165|580137809|FG000|Overall Study|Adverse Event|4|||
160660355|NCT02336165|580137810|FG001|Overall Study|Adverse Event|1|||
160660356|NCT02336165|580137811|FG002|Overall Study|Adverse Event|2|||
160660357|NCT02336165|580137812|FG003|Overall Study|Adverse Event|4|||
160660358|NCT02336165|580137813|FG004|Overall Study|Adverse Event|1|||
160476207|NCT00529529|579471251|FG000|Overall Study|Adverse Event|12|||
160476208|NCT00529529|579471252|FG001|Overall Study|Adverse Event|17|||
160476209|NCT00529529|579471253|FG002|Overall Study|Adverse Event|8|||
160476210|NCT00529529|579471251|FG000|Overall Study|Subject withdrew consent|12|||
160476211|NCT00529529|579471252|FG001|Overall Study|Subject withdrew consent|9|||
160476212|NCT00529529|579471253|FG002|Overall Study|Subject withdrew consent|12|||
160476213|NCT00529529|579471251|FG000|Overall Study|Protocol deviation|8|||
160476214|NCT00529529|579471252|FG001|Overall Study|Protocol deviation|12|||
160476215|NCT00529529|579471253|FG002|Overall Study|Protocol deviation|5|||
160476216|NCT00529529|579471251|FG000|Overall Study|Lost to Follow-up|5|||
160476217|NCT00529529|579471252|FG001|Overall Study|Lost to Follow-up|3|||
160476218|NCT00529529|579471253|FG002|Overall Study|Lost to Follow-up|1|||
160476219|NCT00529529|579471251|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160476220|NCT00529529|579471252|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160476221|NCT00529529|579471253|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
160476222|NCT00529529|579471251|FG000|Overall Study|Death|2|||
160476223|NCT00529529|579471252|FG001|Overall Study|Death|0|||
160476224|NCT00529529|579471253|FG002|Overall Study|Death|0|||
160476225|NCT00529529|579471251|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160602899|NCT01594749|579924250|FG000|Overall Study|Non-compliance with Protocol|0|||
160602900|NCT01594749|579924251|FG001|Overall Study|Non-compliance with Protocol|1|||
160602901|NCT01594749|579924250|FG000|Overall Study|Lost to Follow-up|1|||
160602902|NCT01594749|579924251|FG001|Overall Study|Lost to Follow-up|0|||
160602903|NCT01594749|579924250|FG000|Overall Study|Death|9|||
160476226|NCT00529529|579471252|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160476227|NCT00529529|579471253|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160476228|NCT00529529|579471251|FG000|Overall Study|Administrative problems|1|||
160476229|NCT00529529|579471252|FG001|Overall Study|Administrative problems|0|||
160476230|NCT00529529|579471253|FG002|Overall Study|Administrative problems|3|||
160476231|NCT00337610|579471254|FG000|Overall Study|Adverse Event|2|||
160476232|NCT00337610|579471255|FG001|Overall Study|Adverse Event|2|||
160476233|NCT00337610|579471254|FG000|Overall Study|Death|0|||
160476234|NCT00337610|579471255|FG001|Overall Study|Death|1|||
160476235|NCT00337610|579471254|FG000|Overall Study|Lack of Efficacy|6|||
160476236|NCT00337610|579471255|FG001|Overall Study|Lack of Efficacy|3|||
160602904|NCT01594749|579924251|FG001|Overall Study|Death|3|||
160602905|NCT01594749|579924250|FG000|Overall Study|Not Treated|4|||
160602906|NCT01594749|579924251|FG001|Overall Study|Not Treated|10|||
160602907|NCT01594749|579924250|FG000|Overall Study|Lost Source Documentation|1|||
160602908|NCT01594749|579924251|FG001|Overall Study|Lost Source Documentation|0|||
160602909|NCT02578992|579924253|FG000|Overall Study|equipment not available or malfunction|3|||
160602910|NCT02578992|579924254|FG001|Overall Study|equipment not available or malfunction|3|||
160602911|NCT00086385|579924255|FG000|Overall Study|Death|2|||
160602912|NCT00086385|579924256|FG001|Overall Study|Death|2|||
160602913|NCT00086385|579924257|FG002|Overall Study|Death|1|||
160602914|NCT00086385|579924258|FG003|Overall Study|Death|1|||
160602915|NCT04445688|579924265|FG000|Washout (One Week)|Adverse Event|2|||
160602916|NCT04445688|579924265|FG000|Washout (One Week)|Withdrawal by Subject|1|||
160602917|NCT01975675|579924268|FG000|Overall Study|Death|0|||
160602918|NCT01975675|579924269|FG001|Overall Study|Death|1|||
160602919|NCT01975675|579924270|FG002|Overall Study|Death|0|||
160602920|NCT01975675|579924271|FG003|Overall Study|Death|0|||
160602921|NCT03639987|579924272|FG000|Overall Study|Study terminated by sponsor|26|||
160602922|NCT03639987|579924273|FG001|Overall Study|Study terminated by sponsor|25|||
160602923|NCT03639987|579924272|FG000|Overall Study|Lost to Follow-up|0|||
160602924|NCT03639987|579924273|FG001|Overall Study|Lost to Follow-up|1|||
160602925|NCT00224003|579924274|FG000|Overall Study|Adverse Event|1|||
160602926|NCT00224003|579924274|FG000|Overall Study|Protocol Violation|2|||
160602927|NCT00224003|579924274|FG000|Overall Study|Withdrawal by Subject|1|||
160602928|NCT00224003|579924274|FG000|Overall Study|unk|3|||
160602929|NCT03549429|579924275|FG000|Overall Study|Protocol Violation|5|||
160602930|NCT03549429|579924276|FG001|Overall Study|Protocol Violation|3|||
160476237|NCT00337610|579471254|FG000|Overall Study|Lost to Follow-up|3|||
160476238|NCT00337610|579471255|FG001|Overall Study|Lost to Follow-up|3|||
160476239|NCT00337610|579471254|FG000|Overall Study|Withdrawal by Subject|6|||
160476240|NCT00337610|579471255|FG001|Overall Study|Withdrawal by Subject|5|||
160476241|NCT02279732|579471260|FG000|Overall Study|Death|23|||
160602931|NCT00729326|579924286|FG000|Overall Study|Lost to Follow-up|2|||
160602932|NCT00729326|579924287|FG001|Overall Study|Lost to Follow-up|0|||
160602933|NCT00729326|579924286|FG000|Overall Study|Physician Decision|0|||
160602934|NCT00729326|579924287|FG001|Overall Study|Physician Decision|1|||
160602935|NCT00729326|579924286|FG000|Overall Study|Protocol Violation|3|||
160602936|NCT00729326|579924287|FG001|Overall Study|Protocol Violation|2|||
160476242|NCT02279732|579471261|FG001|Overall Study|Death|20|||
160476243|NCT02279732|579471260|FG000|Overall Study|Disease Progression|13|||
160476244|NCT02279732|579471261|FG001|Overall Study|Disease Progression|3|||
160602937|NCT00729326|579924286|FG000|Overall Study|Subject Decision|4|||
160602938|NCT00729326|579924287|FG001|Overall Study|Subject Decision|4|||
160602939|NCT00729326|579924286|FG000|Overall Study|Sponsor Decision|1|||
160602940|NCT00729326|579924287|FG001|Overall Study|Sponsor Decision|2|||
160476245|NCT02279732|579471260|FG000|Overall Study|Withdrawal by Subject|2|||
160476246|NCT02279732|579471261|FG001|Overall Study|Withdrawal by Subject|7|||
160476247|NCT02279732|579471260|FG000|Overall Study|Adverse Event|1|||
160476248|NCT02279732|579471261|FG001|Overall Study|Adverse Event|2|||
160476249|NCT02279732|579471260|FG000|Overall Study|Administrative Reason By Sponsor|0|||
160476250|NCT02279732|579471261|FG001|Overall Study|Administrative Reason By Sponsor|2|||
160476251|NCT02279732|579471260|FG000|Overall Study|Study Drug Toxicity|2|||
160476252|NCT02279732|579471261|FG001|Overall Study|Study Drug Toxicity|0|||
160476253|NCT02279732|579471260|FG000|Overall Study|Lost to Follow-up|0|||
160602941|NCT01235728|579924288|FG000|Overall Study|Protocol Violation|0|||
160602942|NCT01235728|579924289|FG001|Overall Study|Protocol Violation|0|||
160602943|NCT01235728|579924290|FG002|Overall Study|Protocol Violation|0|||
160476254|NCT02279732|579471261|FG001|Overall Study|Lost to Follow-up|1|||
160602944|NCT01235728|579924291|FG003|Overall Study|Protocol Violation|1|||
160476255|NCT02279732|579471260|FG000|Overall Study|Maximum Clinical Benefit|1|||
160476256|NCT02279732|579471261|FG001|Overall Study|Maximum Clinical Benefit|0|||
160476257|NCT02279732|579471260|FG000|Overall Study|Subject Requested to Discontinue|0|||
160476258|NCT02279732|579471261|FG001|Overall Study|Subject Requested to Discontinue|1|||
160476259|NCT02279732|579471260|FG000|Overall Study|Other|53|||
160476260|NCT02279732|579471261|FG001|Overall Study|Other|67|||
160476261|NCT02279732|579471260|FG000|Overall Study|Other|3|||
160476262|NCT02279732|579471261|FG001|Overall Study|Other|3|||
160476263|NCT02203513|579471265|FG000|Overall Study|Refused further treatment|2|||
160476264|NCT02203513|579471266|FG001|Overall Study|Refused further treatment|0|||
160476265|NCT02203513|579471267|FG002|Overall Study|Refused further treatment|1|||
160476266|NCT02203513|579471268|FG003|Overall Study|Refused further treatment|0|||
160476267|NCT02203513|579471269|FG004|Overall Study|Refused further treatment|0|||
160476268|NCT02203513|579471265|FG000|Overall Study|Switched to alternative treatment|3|||
160476269|NCT02203513|579471266|FG001|Overall Study|Switched to alternative treatment|4|||
160476270|NCT02203513|579471267|FG002|Overall Study|Switched to alternative treatment|0|||
160476271|NCT02203513|579471268|FG003|Overall Study|Switched to alternative treatment|0|||
160476272|NCT02203513|579471269|FG004|Overall Study|Switched to alternative treatment|4|||
160476273|NCT02203513|579471265|FG000|Overall Study|Did not receive investigational product (IP)|0|||
160476274|NCT02203513|579471266|FG001|Overall Study|Did not receive investigational product (IP)|1|||
160476275|NCT02203513|579471267|FG002|Overall Study|Did not receive investigational product (IP)|0|||
160476276|NCT02203513|579471268|FG003|Overall Study|Did not receive investigational product (IP)|0|||
160476277|NCT02203513|579471269|FG004|Overall Study|Did not receive investigational product (IP)|0|||
160476278|NCT02203513|579471265|FG000|Overall Study|Death (unrelated to study therapy)|1|||
160476279|NCT02203513|579471266|FG001|Overall Study|Death (unrelated to study therapy)|3|||
160476280|NCT02203513|579471267|FG002|Overall Study|Death (unrelated to study therapy)|1|||
160476281|NCT02203513|579471268|FG003|Overall Study|Death (unrelated to study therapy)|0|||
160476282|NCT02203513|579471269|FG004|Overall Study|Death (unrelated to study therapy)|2|||
160476283|NCT02203513|579471265|FG000|Overall Study|Lost to Follow-up|0|||
160476284|NCT02203513|579471266|FG001|Overall Study|Lost to Follow-up|0|||
160476285|NCT02203513|579471267|FG002|Overall Study|Lost to Follow-up|1|||
160476286|NCT02203513|579471268|FG003|Overall Study|Lost to Follow-up|1|||
160476287|NCT02203513|579471269|FG004|Overall Study|Lost to Follow-up|0|||
160476288|NCT01441596|579471270|FG000|Overall Study|Other reason not defined below|0|||
160476289|NCT01441596|579471271|FG001|Overall Study|Other reason not defined below|2|||
160476290|NCT01441596|579471272|FG002|Overall Study|Other reason not defined below|1|||
160476291|NCT01441596|579471270|FG000|Overall Study|Withdrawal by Subject|4|||
160476292|NCT01441596|579471271|FG001|Overall Study|Withdrawal by Subject|0|||
160476293|NCT01441596|579471272|FG002|Overall Study|Withdrawal by Subject|2|||
160476294|NCT01441596|579471270|FG000|Overall Study|Not treated|0|||
160476295|NCT01441596|579471271|FG001|Overall Study|Not treated|1|||
160476296|NCT01441596|579471272|FG002|Overall Study|Not treated|1|||
160476297|NCT03055988|579471273|FG000|Period 1|Adverse Event|0|||
160476298|NCT03055988|579471274|FG001|Period 1|Adverse Event|1|||
160476299|NCT03055988|579471273|FG000|Period 1|Lost to Follow-up|1|||
160476300|NCT03055988|579471274|FG001|Period 1|Lost to Follow-up|0|||
160476301|NCT03055988|579471273|FG000|Period 1|Withdrawal by Subject|0|||
160476302|NCT03055988|579471274|FG001|Period 1|Withdrawal by Subject|4|||
160476303|NCT03055988|579471273|FG000|Period 2|Adverse Event|0|||
160476304|NCT03055988|579471274|FG001|Period 2|Adverse Event|1|||
160476305|NCT03055988|579471273|FG000|Period 2|Other than listed|1|||
160476306|NCT03055988|579471274|FG001|Period 2|Other than listed|1|||
160476307|NCT01681511|579471275|FG000|Overall Study|No Treatment Received|1|||
160476308|NCT01681511|579471276|FG001|Overall Study|No Treatment Received|3|||
160476309|NCT01681511|579471275|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
160476310|NCT01681511|579471276|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
160476311|NCT01681511|579471275|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
160476312|NCT01681511|579471276|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
160476313|NCT01681511|579471275|FG000|Overall Study|No Daily Urine Sample Collected|0|||
160476314|NCT01681511|579471276|FG001|Overall Study|No Daily Urine Sample Collected|1|||
160476315|NCT01681511|579471275|FG000|Overall Study|No post-catheter sample collected|11|||
160476316|NCT01681511|579471276|FG001|Overall Study|No post-catheter sample collected|4|||
160476317|NCT01156675|579471277|FG000|Overall Study|Death|5|||
160476318|NCT01156675|579471278|FG001|Overall Study|Death|3|||
160476319|NCT01156675|579471279|FG002|Overall Study|Death|0|||
160476320|NCT01156675|579471277|FG000|Overall Study|No data|29|||
160476321|NCT01156675|579471278|FG001|Overall Study|No data|22|||
160476322|NCT01156675|579471279|FG002|Overall Study|No data|2|||
160476323|NCT00116649|579471293|FG000|Overall Study|Adverse Event|20|||
160476324|NCT00116649|579471293|FG000|Overall Study|Lack of Efficacy|1|||
160476325|NCT00116649|579471293|FG000|Overall Study|Lost to Follow-up|32|||
160476326|NCT00116649|579471293|FG000|Overall Study|Withdrawal by Subject|68|||
160476327|NCT00116649|579471293|FG000|Overall Study|Local Skin Reaction|9|||
160476328|NCT00116649|579471293|FG000|Overall Study|Various Reasons|18|||
160476329|NCT00116649|579471293|FG000|Overall Study|Protocol Specified|7|||
160476330|NCT02161146|579471294|FG000|Overall Study|Adverse Event|1|||
160660359|NCT02336165|580137809|FG000|Overall Study|Progressive disease|23|||
160660360|NCT02336165|580137810|FG001|Overall Study|Progressive disease|22|||
160660361|NCT02336165|580137811|FG002|Overall Study|Progressive disease|27|||
160660362|NCT02336165|580137812|FG003|Overall Study|Progressive disease|24|||
160602945|NCT01235728|579924292|FG004|Overall Study|Protocol Violation|0|||
160602946|NCT01235728|579924293|FG005|Overall Study|Protocol Violation|0|||
160602947|NCT01235728|579924294|FG006|Overall Study|Protocol Violation|0|||
160602948|NCT01235728|579924295|FG007|Overall Study|Protocol Violation|0|||
160602949|NCT01000025|579924296|FG000|Overall Study|Adverse Event|43|||
160602950|NCT01000025|579924297|FG001|Overall Study|Adverse Event|2|||
160602951|NCT01000025|579924296|FG000|Overall Study|Withdrawal by Subject|13|||
160602952|NCT01000025|579924297|FG001|Overall Study|Withdrawal by Subject|8|||
160602953|NCT01000025|579924296|FG000|Overall Study|Death|23|||
160602954|NCT01000025|579924297|FG001|Overall Study|Death|13|||
160602955|NCT01000025|579924296|FG000|Overall Study|Lack of Efficacy|363|||
160602956|NCT01000025|579924297|FG001|Overall Study|Lack of Efficacy|208|||
160602957|NCT01000025|579924296|FG000|Overall Study|Intercurrent Illness|26|||
160602958|NCT01000025|579924297|FG001|Overall Study|Intercurrent Illness|7|||
160602959|NCT04423757|579924298|FG000|Overall Study|Adverse Event|2|||
160602960|NCT04423757|579924299|FG001|Overall Study|Adverse Event|0|||
160602961|NCT04423757|579924298|FG000|Overall Study|Not treated|1|||
160602962|NCT04423757|579924299|FG001|Overall Study|Not treated|1|||
160602963|NCT02738580|579924300|FG000|Overall Study|Adverse Event|1|||
160602964|NCT02738580|579924301|FG001|Overall Study|Adverse Event|0|||
160602965|NCT02738580|579924300|FG000|Overall Study|Lack of Efficacy|3|||
160602966|NCT02738580|579924301|FG001|Overall Study|Lack of Efficacy|2|||
160602967|NCT02738580|579924300|FG000|Overall Study|Withdrawal by Subject|0|||
160602968|NCT02738580|579924301|FG001|Overall Study|Withdrawal by Subject|1|||
160602969|NCT02738580|579924300|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
160602970|NCT02738580|579924301|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
160602971|NCT01202760|579924302|FG000|Overall Study|Entry Criteria Not Met|0|||
160602972|NCT01202760|579924303|FG001|Overall Study|Entry Criteria Not Met|3|||
160602973|NCT01202760|579924304|FG002|Overall Study|Entry Criteria Not Met|1|||
160602974|NCT01202760|579924302|FG000|Overall Study|Adverse Event|11|||
160602975|NCT01202760|579924303|FG001|Overall Study|Adverse Event|9|||
160602976|NCT01202760|579924304|FG002|Overall Study|Adverse Event|10|||
160602977|NCT01202760|579924302|FG000|Overall Study|Death|2|||
160602978|NCT01202760|579924303|FG001|Overall Study|Death|1|||
160602979|NCT01202760|579924304|FG002|Overall Study|Death|0|||
160602980|NCT01202760|579924302|FG000|Overall Study|Lack of Efficacy|6|||
160602981|NCT01202760|579924303|FG001|Overall Study|Lack of Efficacy|8|||
160602982|NCT01202760|579924304|FG002|Overall Study|Lack of Efficacy|7|||
160602983|NCT01202760|579924302|FG000|Overall Study|Lost to Follow-up|0|||
160602984|NCT01202760|579924303|FG001|Overall Study|Lost to Follow-up|2|||
160602985|NCT01202760|579924304|FG002|Overall Study|Lost to Follow-up|1|||
160602986|NCT01202760|579924302|FG000|Overall Study|Parent / Caregiver Decision|0|||
160602987|NCT01202760|579924303|FG001|Overall Study|Parent / Caregiver Decision|1|||
160602988|NCT01202760|579924304|FG002|Overall Study|Parent / Caregiver Decision|0|||
160602989|NCT01202760|579924302|FG000|Overall Study|Withdrawal by Subject|17|||
160602990|NCT01202760|579924303|FG001|Overall Study|Withdrawal by Subject|18|||
160602991|NCT01202760|579924304|FG002|Overall Study|Withdrawal by Subject|14|||
160602992|NCT01202760|579924302|FG000|Overall Study|Physician Decision|0|||
160602993|NCT01202760|579924303|FG001|Overall Study|Physician Decision|1|||
160602994|NCT01202760|579924304|FG002|Overall Study|Physician Decision|0|||
160602995|NCT01202760|579924302|FG000|Overall Study|Protocol Violation|7|||
160602996|NCT01202760|579924303|FG001|Overall Study|Protocol Violation|5|||
160602997|NCT01202760|579924304|FG002|Overall Study|Protocol Violation|2|||
160602998|NCT01202760|579924302|FG000|Overall Study|Sponsor Decision|4|||
160602999|NCT01202760|579924303|FG001|Overall Study|Sponsor Decision|4|||
160603000|NCT01202760|579924304|FG002|Overall Study|Sponsor Decision|0|||
160603001|NCT01654523|579924305|FG000|Overall Study|Withdrawal by Subject|1|||
160603002|NCT04354155|579924306|FG000|Overall Study|Withdrawal by Subject|1|||
160603003|NCT04354155|579924306|FG000|Overall Study|Did not meet criteria for study intervention|1|||
160603004|NCT01015820|579924309|FG000|Overall Study|Suboptimal measurements|1|||
160603005|NCT01015820|579924310|FG001|Overall Study|Suboptimal measurements|0|||
160603006|NCT02925312|579924317|FG000|Overall Study|Lost to Follow-up|25|||
160660363|NCT02336165|580137813|FG004|Overall Study|Progressive disease|19|||
160603007|NCT02925312|579924318|FG001|Overall Study|Lost to Follow-up|0|||
160603008|NCT02925312|579924317|FG000|Overall Study|Adverse Event|2|||
160603009|NCT02925312|579924318|FG001|Overall Study|Adverse Event|0|||
160603010|NCT02142504|579924319|FG000|Overall Study|Protocol Violation|2|||
160603011|NCT02142504|579924320|FG001|Overall Study|Protocol Violation|1|||
160660364|NCT02336165|580137809|FG000|Overall Study|Non-compliance|1|||
160603012|NCT02142504|579924321|FG002|Overall Study|Protocol Violation|2|||
160603013|NCT02142504|579924319|FG000|Overall Study|Adverse Event|2|||
160603014|NCT02142504|579924320|FG001|Overall Study|Adverse Event|3|||
160603015|NCT02142504|579924321|FG002|Overall Study|Adverse Event|4|||
160603016|NCT02142504|579924319|FG000|Overall Study|Lost to Follow-up|12|||
160603017|NCT02142504|579924320|FG001|Overall Study|Lost to Follow-up|19|||
160603018|NCT02142504|579924321|FG002|Overall Study|Lost to Follow-up|17|||
160603019|NCT02142504|579924319|FG000|Overall Study|Withdrawal by Subject|7|||
160603020|NCT02142504|579924320|FG001|Overall Study|Withdrawal by Subject|9|||
160603021|NCT02142504|579924321|FG002|Overall Study|Withdrawal by Subject|11|||
160603022|NCT02142504|579924319|FG000|Overall Study|Pregnancy|4|||
160603023|NCT02142504|579924320|FG001|Overall Study|Pregnancy|4|||
160476331|NCT02161146|579471295|FG001|Overall Study|Adverse Event|1|||
160660365|NCT02336165|580137810|FG001|Overall Study|Non-compliance|0|||
160660366|NCT02336165|580137811|FG002|Overall Study|Non-compliance|0|||
160660367|NCT02336165|580137812|FG003|Overall Study|Non-compliance|1|||
160660368|NCT02336165|580137813|FG004|Overall Study|Non-compliance|0|||
160660369|NCT02336165|580137809|FG000|Overall Study|Other|1|||
160660370|NCT02336165|580137810|FG001|Overall Study|Other|0|||
160660371|NCT02336165|580137811|FG002|Overall Study|Other|0|||
160660372|NCT02336165|580137812|FG003|Overall Study|Other|1|||
160660373|NCT02336165|580137813|FG004|Overall Study|Other|0|||
160660374|NCT00450190|580137814|FG000|Overall Study|Withdrawal by Subject|2|||
160660375|NCT03002077|580137817|FG000|Overall Study|Non-compliance with Study Drug|4|||
160660376|NCT03002077|580137817|FG000|Overall Study|Non-compliance w/Background ADT|1|||
160660377|NCT03002077|580137817|FG000|Overall Study|Study Terminated by Sponsor|257|||
160660378|NCT03002077|580137817|FG000|Overall Study|Site Terminated by Sponsor|5|||
160660379|NCT03002077|580137817|FG000|Overall Study|Miscellaneous Reasons|10|||
160660380|NCT03002077|580137817|FG000|Overall Study|Adverse Event|23|||
160660381|NCT03002077|580137817|FG000|Overall Study|Lack of Efficacy|20|||
160660382|NCT03002077|580137817|FG000|Overall Study|Withdrawal by Subject|72|||
160660383|NCT03002077|580137817|FG000|Overall Study|Lost to Follow-up|21|||
160660384|NCT03002077|580137817|FG000|Overall Study|Pregnancy|4|||
160660385|NCT03002077|580137817|FG000|Overall Study|Protocol Violation|21|||
160660386|NCT00834756|580137820|FG000|First Intervention|Adverse Event|1|||
160660387|NCT00834756|580137821|FG001|First Intervention|Adverse Event|0|||
160660388|NCT00834756|580137820|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
160660389|NCT00834756|580137821|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
160660390|NCT04625114|580137833|FG000|Overall Study|Adverse Event|3|||
160660391|NCT04625114|580137834|FG001|Overall Study|Adverse Event|1|||
160660392|NCT04625114|580137833|FG000|Overall Study|Withdrawal by Subject|2|||
160660393|NCT04625114|580137834|FG001|Overall Study|Withdrawal by Subject|0|||
160660394|NCT00986245|580137835|FG000|First Intervention|Poor compliance|8|||
160660395|NCT00986245|580137836|FG001|First Intervention|Poor compliance|4|||
160660396|NCT00986245|580137835|FG000|First Intervention|Lack of Efficacy|1|||
160660397|NCT00986245|580137836|FG001|First Intervention|Lack of Efficacy|2|||
160660398|NCT00986245|580137835|FG000|First Intervention|Withdrawal by Subject|0|||
160660399|NCT00986245|580137836|FG001|First Intervention|Withdrawal by Subject|1|||
160660400|NCT00986245|580137835|FG000|First Intervention|Protocol Violation|0|||
160660401|NCT00986245|580137836|FG001|First Intervention|Protocol Violation|1|||
160660402|NCT00986245|580137835|FG000|First Intervention|Out of indication|1|||
160660403|NCT00986245|580137836|FG001|First Intervention|Out of indication|0|||
160660404|NCT00986245|580137835|FG000|Second Intervention|Poor compliance|1|||
160660405|NCT00986245|580137836|FG001|Second Intervention|Poor compliance|0|||
160660406|NCT00986245|580137835|FG000|Second Intervention|Lost to Follow-up|1|||
160660407|NCT00986245|580137836|FG001|Second Intervention|Lost to Follow-up|0|||
160660408|NCT00986245|580137835|FG000|Second Intervention|Protocol Violation|0|||
160660409|NCT00986245|580137836|FG001|Second Intervention|Protocol Violation|1|||
160660410|NCT00854308|580137840|FG000|Overall Study|Disease progression|42|||
160660411|NCT00854308|580137841|FG001|Overall Study|Disease progression|50|||
160660412|NCT00854308|580137840|FG000|Overall Study|Adverse Event|8|||
160660413|NCT00854308|580137841|FG001|Overall Study|Adverse Event|3|||
160660414|NCT00854308|580137840|FG000|Overall Study|Death|2|||
160660415|NCT00854308|580137841|FG001|Overall Study|Death|5|||
160660416|NCT00854308|580137840|FG000|Overall Study|Physician Decision|6|||
160660417|NCT00854308|580137841|FG001|Overall Study|Physician Decision|6|||
160660418|NCT00854308|580137840|FG000|Overall Study|Withdrawal by Subject|4|||
160660419|NCT00854308|580137841|FG001|Overall Study|Withdrawal by Subject|2|||
160660420|NCT00854308|580137840|FG000|Overall Study|Sponsor's decision to terminate study|0|||
160660421|NCT00854308|580137841|FG001|Overall Study|Sponsor's decision to terminate study|1|||
160660422|NCT01390844|580137842|FG000|Treatment Phase|Adverse Event|12|||
160660423|NCT01390844|580137843|FG001|Treatment Phase|Adverse Event|2|||
160660424|NCT01390844|580137844|FG002|Treatment Phase|Adverse Event|3|||
160660425|NCT01390844|580137845|FG003|Treatment Phase|Adverse Event|2|||
160660426|NCT01390844|580137842|FG000|Treatment Phase|Treatment Failure|23|||
160660427|NCT01390844|580137843|FG001|Treatment Phase|Treatment Failure|25|||
160660428|NCT01390844|580137844|FG002|Treatment Phase|Treatment Failure|10|||
160660429|NCT01390844|580137845|FG003|Treatment Phase|Treatment Failure|13|||
160660430|NCT01390844|580137842|FG000|Treatment Phase|Non-Medical Reasons|5|||
160660431|NCT01390844|580137843|FG001|Treatment Phase|Non-Medical Reasons|1|||
160660432|NCT01390844|580137844|FG002|Treatment Phase|Non-Medical Reasons|8|||
160660433|NCT01390844|580137845|FG003|Treatment Phase|Non-Medical Reasons|1|||
160660434|NCT01390844|580137842|FG000|Treatment Phase|Non-GCP Compliant|0|||
160660435|NCT01390844|580137843|FG001|Treatment Phase|Non-GCP Compliant|0|||
160660436|NCT01390844|580137844|FG002|Treatment Phase|Non-GCP Compliant|10|||
160476332|NCT02161146|579471296|FG002|Overall Study|Adverse Event|0|||
160660437|NCT01390844|580137845|FG003|Treatment Phase|Non-GCP Compliant|3|||
160660438|NCT01390844|580137842|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
160660439|NCT01390844|580137843|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
160660440|NCT01390844|580137844|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
160660441|NCT01390844|580137845|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
160660442|NCT03048500|580137846|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
160660443|NCT03048500|580137846|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
160660444|NCT03048500|580137846|FG000|Reached 1st Response/Continued Treatment|Death|1|||
160660445|NCT03048500|580137846|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
160603024|NCT02142504|579924321|FG002|Overall Study|Pregnancy|2|||
160603025|NCT02142504|579924319|FG000|Overall Study|Physician Decision|0|||
160603026|NCT02142504|579924320|FG001|Overall Study|Physician Decision|1|||
160603027|NCT02142504|579924321|FG002|Overall Study|Physician Decision|3|||
160603028|NCT02142504|579924319|FG000|Overall Study|Reason Not Specified|4|||
160603029|NCT02142504|579924320|FG001|Overall Study|Reason Not Specified|5|||
160603030|NCT02142504|579924321|FG002|Overall Study|Reason Not Specified|4|||
160603031|NCT01998399|579924322|FG000|Overall Study|Lost to Follow-up|1|||
160603032|NCT01998399|579924323|FG001|Overall Study|Lost to Follow-up|3|||
160603033|NCT01998399|579924322|FG000|Overall Study|Death|4|||
160603034|NCT01998399|579924323|FG001|Overall Study|Death|2|||
160603035|NCT01998399|579924322|FG000|Overall Study|Study stopped before dosing completed|3|||
160603036|NCT01998399|579924323|FG001|Overall Study|Study stopped before dosing completed|3|||
160603037|NCT01998399|579924322|FG000|Overall Study|Withdrawal by Subject|0|||
160603038|NCT01998399|579924323|FG001|Overall Study|Withdrawal by Subject|1|||
160603039|NCT00617591|579924331|FG000|Overall Study|Withdrew consent during Induction|4|||
160603040|NCT00617591|579924331|FG000|Overall Study|Withdrew consent during Maintenance|6|||
160603041|NCT04114539|579924332|FG000|Overall Study|Adverse Event|14|||
160603042|NCT04114539|579924332|FG000|Overall Study|Lost to Follow-up|2|||
160603043|NCT04114539|579924332|FG000|Overall Study|Non-compliance with Protocol|2|||
160603044|NCT04114539|579924332|FG000|Overall Study|Non-compliance with Study Drug|1|||
160603045|NCT04114539|579924332|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
160603046|NCT04114539|579924332|FG000|Overall Study|Withdrew consent|10|||
160603047|NCT04114539|579924332|FG000|Overall Study|Others not specified|5|||
160603048|NCT04114539|579924332|FG000|Overall Study|Investigator Decision|2|||
160603049|NCT00376246|579924333|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
160603050|NCT00376246|579924334|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
160603051|NCT00376246|579924333|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160603052|NCT00376246|579924334|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
160603053|NCT00376246|579924333|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
160603054|NCT00376246|579924334|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
160603055|NCT00351819|579924340|FG000|Overall Study|Lost to Follow-up|4|||
160603056|NCT00351819|579924341|FG001|Overall Study|Lost to Follow-up|4|||
160603057|NCT00351819|579924340|FG000|Overall Study|Withdrawal by Subject|0|||
160603058|NCT00351819|579924341|FG001|Overall Study|Withdrawal by Subject|4|||
160603059|NCT00351819|579924340|FG000|Overall Study|Elevated PSA|1|||
160603060|NCT00351819|579924341|FG001|Overall Study|Elevated PSA|1|||
160603061|NCT00351819|579924340|FG000|Overall Study|Traumatic ankle fracture|1|||
160660446|NCT03048500|580137846|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
160603062|NCT00351819|579924341|FG001|Overall Study|Traumatic ankle fracture|0|||
160603063|NCT00351819|579924340|FG000|Overall Study|Unprofessional behavior|1|||
160603064|NCT00351819|579924341|FG001|Overall Study|Unprofessional behavior|0|||
160603065|NCT00351819|579924340|FG000|Overall Study|Non-compliance|0|||
160603066|NCT00351819|579924341|FG001|Overall Study|Non-compliance|1|||
160603067|NCT00351819|579924340|FG000|Overall Study|Incarcerated|0|||
160603068|NCT00351819|579924341|FG001|Overall Study|Incarcerated|1|||
160603069|NCT00351819|579924340|FG000|Overall Study|Enrolled in another trial|0|||
160603070|NCT00351819|579924341|FG001|Overall Study|Enrolled in another trial|1|||
160603071|NCT00588523|579924344|FG000|Overall Study|Not treated|3|||
160603072|NCT01459068|579924347|FG000|Overall Study|Withdrawal by Subject|8|||
160603073|NCT01459068|579924348|FG001|Overall Study|Withdrawal by Subject|18|||
160603074|NCT01459068|579924347|FG000|Overall Study|Lost to Follow-up|31|||
160603075|NCT01459068|579924348|FG001|Overall Study|Lost to Follow-up|15|||
160603076|NCT01459068|579924347|FG000|Overall Study|Death|0|||
160603077|NCT01459068|579924348|FG001|Overall Study|Death|1|||
160603078|NCT02023112|579924349|FG000|Overall Study|Withdrawal by Subject|2|||
160603079|NCT02023112|579924350|FG001|Overall Study|Withdrawal by Subject|1|||
160603080|NCT02910219|579924351|FG000|Overall Study|Withdrawal by Subject|1|||
160603081|NCT02910219|579924352|FG001|Overall Study|Withdrawal by Subject|1|||
160603082|NCT01425749|579924353|FG000|Overall Study|progression of melanoma|0|||
160603083|NCT01425749|579924354|FG001|Overall Study|progression of melanoma|1|||
160476333|NCT02161146|579471297|FG003|Overall Study|Adverse Event|1|||
160476334|NCT02161146|579471298|FG004|Overall Study|Adverse Event|0|||
160476335|NCT02161146|579471294|FG000|Overall Study|Lost to Follow-up|0|||
160476336|NCT02161146|579471295|FG001|Overall Study|Lost to Follow-up|1|||
160476337|NCT02161146|579471296|FG002|Overall Study|Lost to Follow-up|0|||
160476338|NCT02161146|579471297|FG003|Overall Study|Lost to Follow-up|0|||
160476339|NCT02161146|579471298|FG004|Overall Study|Lost to Follow-up|0|||
160476340|NCT02161146|579471294|FG000|Overall Study|Personal Reasons|0|||
160476341|NCT02161146|579471295|FG001|Overall Study|Personal Reasons|1|||
160476342|NCT02161146|579471296|FG002|Overall Study|Personal Reasons|0|||
160476343|NCT02161146|579471297|FG003|Overall Study|Personal Reasons|2|||
160476344|NCT02161146|579471298|FG004|Overall Study|Personal Reasons|1|||
160476345|NCT02161146|579471294|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160476346|NCT02161146|579471295|FG001|Overall Study|Other Miscellaneous Reasons|1|||
160476347|NCT02161146|579471296|FG002|Overall Study|Other Miscellaneous Reasons|0|||
160476348|NCT02161146|579471297|FG003|Overall Study|Other Miscellaneous Reasons|0|||
160476349|NCT02161146|579471298|FG004|Overall Study|Other Miscellaneous Reasons|0|||
160476350|NCT00845520|579471299|FG000|Overall Study|Death|1|||
160476351|NCT00845520|579471300|FG001|Overall Study|Death|2|||
160476352|NCT00845520|579471301|FG002|Overall Study|Death|0|||
160476353|NCT00845520|579471299|FG000|Overall Study|Lost to Follow-up|1|||
160476354|NCT00845520|579471300|FG001|Overall Study|Lost to Follow-up|0|||
160476355|NCT00845520|579471301|FG002|Overall Study|Lost to Follow-up|0|||
160476356|NCT00845520|579471299|FG000|Overall Study|Adverse Event|0|||
160476357|NCT00845520|579471300|FG001|Overall Study|Adverse Event|0|||
160476358|NCT00845520|579471301|FG002|Overall Study|Adverse Event|1|||
160476359|NCT02613403|579471302|FG000|Overall Study|Lost to Follow-up|0|||
160476360|NCT02613403|579471303|FG001|Overall Study|Lost to Follow-up|1|||
160476361|NCT02613403|579471304|FG002|Overall Study|Lost to Follow-up|0|||
160476362|NCT02613403|579471305|FG003|Overall Study|Lost to Follow-up|0|||
160476363|NCT02613403|579471306|FG004|Overall Study|Lost to Follow-up|0|||
160476364|NCT02613403|579471302|FG000|Overall Study|Withdrawal by Subject|2|||
160476365|NCT02613403|579471303|FG001|Overall Study|Withdrawal by Subject|0|||
160476366|NCT02613403|579471304|FG002|Overall Study|Withdrawal by Subject|0|||
160476367|NCT02613403|579471305|FG003|Overall Study|Withdrawal by Subject|0|||
160476368|NCT02613403|579471306|FG004|Overall Study|Withdrawal by Subject|0|||
160476369|NCT00800176|579471307|FG000|Overall Study|Adverse Event|2|||
160476370|NCT00800176|579471308|FG001|Overall Study|Adverse Event|1|||
160476371|NCT00800176|579471309|FG002|Overall Study|Adverse Event|0|||
160476372|NCT00800176|579471310|FG003|Overall Study|Adverse Event|2|||
160476373|NCT00800176|579471311|FG004|Overall Study|Adverse Event|1|||
160476374|NCT00800176|579471312|FG005|Overall Study|Adverse Event|1|||
160476375|NCT00800176|579471307|FG000|Overall Study|Refused treatment|3|||
160476376|NCT00800176|579471308|FG001|Overall Study|Refused treatment|2|||
160476377|NCT00800176|579471309|FG002|Overall Study|Refused treatment|0|||
160476378|NCT00800176|579471310|FG003|Overall Study|Refused treatment|0|||
160476379|NCT00800176|579471311|FG004|Overall Study|Refused treatment|1|||
160476380|NCT00800176|579471312|FG005|Overall Study|Refused treatment|4|||
160476381|NCT00800176|579471307|FG000|Overall Study|Failure to return|3|||
160476382|NCT00800176|579471308|FG001|Overall Study|Failure to return|3|||
160476383|NCT00800176|579471309|FG002|Overall Study|Failure to return|0|||
160476384|NCT00800176|579471310|FG003|Overall Study|Failure to return|2|||
160476385|NCT00800176|579471311|FG004|Overall Study|Failure to return|0|||
160476386|NCT00800176|579471312|FG005|Overall Study|Failure to return|0|||
160476387|NCT00800176|579471307|FG000|Overall Study|Other|1|||
160476388|NCT00800176|579471308|FG001|Overall Study|Other|0|||
160476389|NCT00800176|579471309|FG002|Overall Study|Other|0|||
160476390|NCT00800176|579471310|FG003|Overall Study|Other|0|||
160476391|NCT00800176|579471311|FG004|Overall Study|Other|2|||
160476392|NCT00800176|579471312|FG005|Overall Study|Other|0|||
160476393|NCT04620733|579473200|FG000|Overall Study|Adverse Event|4|||
160476394|NCT04620733|579473201|FG001|Overall Study|Adverse Event|3|||
160476395|NCT04620733|579473200|FG000|Overall Study|Withdrawal by Subject|2|||
160603084|NCT02096042|579924357|FG000|Overall Study|Disease Progression|1|||
160603085|NCT02096042|579924358|FG001|Overall Study|Disease Progression|0|||
160603086|NCT02096042|579924359|FG002|Overall Study|Disease Progression|0|||
160476396|NCT04620733|579473201|FG001|Overall Study|Withdrawal by Subject|5|||
160476397|NCT04620733|579473200|FG000|Overall Study|Lost to Follow-up|1|||
160476398|NCT04620733|579473201|FG001|Overall Study|Lost to Follow-up|1|||
160476399|NCT04620733|579473200|FG000|Overall Study|Protocol Deviation|1|||
160476400|NCT04620733|579473201|FG001|Overall Study|Protocol Deviation|1|||
160476401|NCT04620733|579473200|FG000|Overall Study|Reason Not Specified|0|||
160476402|NCT04620733|579473201|FG001|Overall Study|Reason Not Specified|1|||
160476403|NCT00451906|579473206|FG000|Overall Study|Adverse Event|515|||
160476404|NCT00451906|579473206|FG000|Overall Study|Lost to Follow-up|31|||
160476405|NCT00451906|579473206|FG000|Overall Study|Withdrawal by Subject|111|||
160476406|NCT00451906|579473206|FG000|Overall Study|Protocol Violation|21|||
160603087|NCT00701441|579924363|FG000|Overall Study|failure in cpap compliance|0|||
160476407|NCT00451906|579473206|FG000|Overall Study|Progressive disease|1328|||
160476408|NCT00451906|579473206|FG000|Overall Study|Termination of the study|108|||
160476409|NCT00451906|579473206|FG000|Overall Study|Other Reasons|121|||
160660447|NCT03048500|580137846|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
160660448|NCT03048500|580137846|FG000|Follow up for 3 Years|Death|12|||
160660449|NCT02079766|580137849|FG000|Overall Study|Physician Decision|1|||
160660450|NCT02079766|580137850|FG001|Overall Study|Physician Decision|0|||
160660451|NCT02079766|580137849|FG000|Overall Study|Withdrawal by Subject|1|||
160660452|NCT02079766|580137850|FG001|Overall Study|Withdrawal by Subject|0|||
160660453|NCT03018249|580137861|FG000|Overall Study|Withdrawal by Subject|2|||
160660454|NCT03018249|580137862|FG001|Overall Study|Withdrawal by Subject|2|||
160660455|NCT03544138|580137863|FG000|Overall Study|Lost to Follow-up|29|||
160660456|NCT00727571|580139530|FG000|Overall Study|Ineligibility determined|1|||
160660457|NCT00727571|580139531|FG001|Overall Study|Ineligibility determined|1|||
160660458|NCT00727571|580139532|FG002|Overall Study|Ineligibility determined|1|||
160660459|NCT00727571|580139533|FG003|Overall Study|Ineligibility determined|0|||
160660460|NCT00727571|580139530|FG000|Overall Study|Death|0|||
160660461|NCT00727571|580139531|FG001|Overall Study|Death|19|||
160660462|NCT00727571|580139532|FG002|Overall Study|Death|5|||
160660463|NCT00727571|580139533|FG003|Overall Study|Death|1|||
160660464|NCT00727571|580139530|FG000|Overall Study|Physician Decision|0|||
160660465|NCT00727571|580139531|FG001|Overall Study|Physician Decision|5|||
160660466|NCT00727571|580139532|FG002|Overall Study|Physician Decision|0|||
160660467|NCT00727571|580139533|FG003|Overall Study|Physician Decision|0|||
160660468|NCT00727571|580139530|FG000|Overall Study|Withdrawal by Subject|0|||
160660469|NCT00727571|580139531|FG001|Overall Study|Withdrawal by Subject|10|||
160660470|NCT00727571|580139532|FG002|Overall Study|Withdrawal by Subject|11|||
160660471|NCT00727571|580139533|FG003|Overall Study|Withdrawal by Subject|0|||
160660472|NCT00727571|580139530|FG000|Overall Study|Subject Non Compliance|0|||
160660473|NCT00727571|580139531|FG001|Overall Study|Subject Non Compliance|6|||
160660474|NCT00727571|580139532|FG002|Overall Study|Subject Non Compliance|0|||
160660475|NCT00727571|580139533|FG003|Overall Study|Subject Non Compliance|4|||
160660476|NCT00727571|580139530|FG000|Overall Study|Dismissed from nursing home|0|||
160660477|NCT00727571|580139531|FG001|Overall Study|Dismissed from nursing home|9|||
160660478|NCT00727571|580139532|FG002|Overall Study|Dismissed from nursing home|5|||
160603088|NCT00701441|579924364|FG001|Overall Study|failure in cpap compliance|4|||
160603089|NCT03034057|579924365|FG000|Overall Study|Withdrawal by Subject|10|||
160603090|NCT03034057|579924365|FG000|Overall Study|Protocol Violation|1|||
160603091|NCT03034057|579924365|FG000|Overall Study|Not defined|2|||
160603092|NCT03034057|579924365|FG000|Overall Study|Lost to Follow-up|19|||
160603093|NCT03034057|579924365|FG000|Overall Study|Adverse Event|22|||
160603094|NCT03034057|579924365|FG000|Overall Study|Medication error without associated AE|1|||
160603095|NCT03339401|579924367|FG000|Overall Study|Death|2|||
160603096|NCT03339401|579924368|FG001|Overall Study|Death|1|||
160603097|NCT03339401|579924367|FG000|Overall Study|Withdrawal by Subject|2|||
160603098|NCT03339401|579924368|FG001|Overall Study|Withdrawal by Subject|0|||
160603099|NCT03339401|579924367|FG000|Overall Study|Study terminated|4|||
160603100|NCT03339401|579924368|FG001|Overall Study|Study terminated|3|||
160603101|NCT03339401|579924367|FG000|Overall Study|Investigator Decision|1|||
160603102|NCT03339401|579924368|FG001|Overall Study|Investigator Decision|0|||
160603103|NCT00718523|579924369|FG000|Overall Study|Withdrawal by Subject|5|||
160603104|NCT00718523|579924370|FG001|Overall Study|Withdrawal by Subject|7|||
160603105|NCT00718523|579924369|FG000|Overall Study|Death|13|||
160603106|NCT00718523|579924370|FG001|Overall Study|Death|17|||
160603107|NCT01313078|579924371|FG000|Overall Study|Death|1|||
160660479|NCT00727571|580139533|FG003|Overall Study|Dismissed from nursing home|0|||
160660480|NCT00727571|580139530|FG000|Overall Study|Hospitalization|0|||
160660481|NCT00727571|580139531|FG001|Overall Study|Hospitalization|1|||
160660482|NCT00727571|580139532|FG002|Overall Study|Hospitalization|0|||
160476410|NCT00451906|579473206|FG000|Overall Study|Did not complete final visit|4|||
160476411|NCT00608959|579473207|FG000|Part 1|Did not meet eligibility criteria|1|||
160476412|NCT01005602|579473208|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
160476413|NCT01005602|579473209|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
160476414|NCT01131325|579473212|FG000|Overall Study|Adverse Event|1|||
160476415|NCT01131325|579473212|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
160476416|NCT03761849|579473213|FG000|Overall Study|transferred to OpenLabelExtension|35|||
160476417|NCT03761849|579473214|FG001|Overall Study|transferred to OpenLabelExtension|34|||
160476418|NCT03761849|579473215|FG002|Overall Study|transferred to OpenLabelExtension|36|||
160476419|NCT03761849|579473216|FG003|Overall Study|transferred to OpenLabelExtension|0|||
160476420|NCT03761849|579473217|FG004|Overall Study|transferred to OpenLabelExtension|0|||
160476421|NCT03761849|579473218|FG005|Overall Study|transferred to OpenLabelExtension|0|||
160476422|NCT03761849|579473213|FG000|Overall Study|Adverse Event|1|||
160476423|NCT03761849|579473214|FG001|Overall Study|Adverse Event|0|||
160476424|NCT03761849|579473215|FG002|Overall Study|Adverse Event|0|||
160476425|NCT03761849|579473216|FG003|Overall Study|Adverse Event|0|||
160476426|NCT03761849|579473217|FG004|Overall Study|Adverse Event|2|||
160476427|NCT03761849|579473218|FG005|Overall Study|Adverse Event|3|||
160603108|NCT01313078|579924371|FG000|Overall Study|Discontinued study drug|1|||
160603109|NCT01313078|579924371|FG000|Overall Study|Withdrawal by Subject|1|||
160476428|NCT03761849|579473213|FG000|Overall Study|Withdrawal by Subject|0|||
160476429|NCT03761849|579473214|FG001|Overall Study|Withdrawal by Subject|0|||
160476430|NCT03761849|579473215|FG002|Overall Study|Withdrawal by Subject|0|||
160476431|NCT03761849|579473216|FG003|Overall Study|Withdrawal by Subject|41|||
160476432|NCT03761849|579473217|FG004|Overall Study|Withdrawal by Subject|43|||
160476433|NCT03761849|579473218|FG005|Overall Study|Withdrawal by Subject|35|||
160476434|NCT03761849|579473213|FG000|Overall Study|Lost to Follow-up|0|||
160476435|NCT03761849|579473214|FG001|Overall Study|Lost to Follow-up|1|||
160476436|NCT03761849|579473215|FG002|Overall Study|Lost to Follow-up|0|||
160476437|NCT03761849|579473216|FG003|Overall Study|Lost to Follow-up|2|||
160476438|NCT03761849|579473217|FG004|Overall Study|Lost to Follow-up|4|||
160476439|NCT03761849|579473218|FG005|Overall Study|Lost to Follow-up|5|||
160476440|NCT03761849|579473213|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
160476441|NCT03761849|579473214|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
160476442|NCT03761849|579473215|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
160476443|NCT03761849|579473216|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
160476444|NCT03761849|579473217|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
160476445|NCT03761849|579473218|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
160476446|NCT03761849|579473213|FG000|Overall Study|Physician Decision|0|||
160476447|NCT03761849|579473214|FG001|Overall Study|Physician Decision|0|||
160476448|NCT03761849|579473215|FG002|Overall Study|Physician Decision|0|||
160476449|NCT03761849|579473216|FG003|Overall Study|Physician Decision|1|||
160476450|NCT03761849|579473217|FG004|Overall Study|Physician Decision|4|||
160476451|NCT03761849|579473218|FG005|Overall Study|Physician Decision|4|||
160476452|NCT03761849|579473213|FG000|Overall Study|Death|0|||
160476453|NCT03761849|579473214|FG001|Overall Study|Death|0|||
160476454|NCT03761849|579473215|FG002|Overall Study|Death|0|||
160476455|NCT03761849|579473216|FG003|Overall Study|Death|1|||
160476456|NCT03761849|579473217|FG004|Overall Study|Death|1|||
160476457|NCT03761849|579473218|FG005|Overall Study|Death|3|||
160476458|NCT03761849|579473213|FG000|Overall Study|Protocol Violation|0|||
160476459|NCT03761849|579473214|FG001|Overall Study|Protocol Violation|0|||
160476460|NCT03761849|579473215|FG002|Overall Study|Protocol Violation|0|||
160476461|NCT03761849|579473216|FG003|Overall Study|Protocol Violation|2|||
160476462|NCT03761849|579473217|FG004|Overall Study|Protocol Violation|2|||
160476463|NCT03761849|579473218|FG005|Overall Study|Protocol Violation|1|||
160476464|NCT03761849|579473213|FG000|Overall Study|Participant could not come to site|0|||
160476465|NCT03761849|579473214|FG001|Overall Study|Participant could not come to site|0|||
160476466|NCT03761849|579473215|FG002|Overall Study|Participant could not come to site|0|||
160476467|NCT03761849|579473216|FG003|Overall Study|Participant could not come to site|0|||
160476468|NCT03761849|579473217|FG004|Overall Study|Participant could not come to site|1|||
160476469|NCT03761849|579473218|FG005|Overall Study|Participant could not come to site|0|||
160476470|NCT03761849|579473213|FG000|Overall Study|SF- safety Finding|0|||
160476471|NCT03761849|579473214|FG001|Overall Study|SF- safety Finding|0|||
160476472|NCT03761849|579473215|FG002|Overall Study|SF- safety Finding|0|||
160476473|NCT03761849|579473216|FG003|Overall Study|SF- safety Finding|0|||
160476474|NCT03761849|579473217|FG004|Overall Study|SF- safety Finding|0|||
160476475|NCT03761849|579473218|FG005|Overall Study|SF- safety Finding|1|||
160476476|NCT03761849|579473213|FG000|Overall Study|Patient did not attend visit|0|||
160476477|NCT03761849|579473214|FG001|Overall Study|Patient did not attend visit|0|||
160476478|NCT03761849|579473215|FG002|Overall Study|Patient did not attend visit|0|||
160476479|NCT03761849|579473216|FG003|Overall Study|Patient did not attend visit|0|||
160476480|NCT03761849|579473217|FG004|Overall Study|Patient did not attend visit|0|||
160476481|NCT03761849|579473218|FG005|Overall Study|Patient did not attend visit|1|||
160476482|NCT03884478|579473219|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
160476483|NCT03884478|579473220|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
160476484|NCT03884478|579473221|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
160476485|NCT03884478|579473219|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
160476486|NCT03884478|579473220|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
160476487|NCT03884478|579473221|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
160476488|NCT03884478|579473219|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
160476489|NCT03884478|579473220|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
160476490|NCT03884478|579473221|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
160476491|NCT03884478|579473219|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
160476492|NCT03884478|579473220|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
160476493|NCT03884478|579473221|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
160476494|NCT01807234|579473222|FG000|Overall Study|Lost to Follow-up|2|||
160476495|NCT01807234|579473223|FG001|Overall Study|Lost to Follow-up|5|||
160603110|NCT00910728|579924372|FG000|Overall Study|Lack of Efficacy|2|||
160603111|NCT00910728|579924373|FG001|Overall Study|Lack of Efficacy|3|||
160603112|NCT00910728|579924374|FG002|Overall Study|Lack of Efficacy|1|||
160603113|NCT00910728|579924375|FG003|Overall Study|Lack of Efficacy|2|||
160603114|NCT00910728|579924376|FG004|Overall Study|Lack of Efficacy|1|||
160603115|NCT00910728|579924377|FG005|Overall Study|Lack of Efficacy|0|||
160603116|NCT00910728|579924378|FG006|Overall Study|Lack of Efficacy|2|||
160476496|NCT01807234|579473224|FG002|Overall Study|Lost to Follow-up|1|||
160476497|NCT01807234|579473225|FG003|Overall Study|Lost to Follow-up|1|||
160603117|NCT00910728|579924379|FG007|Overall Study|Lack of Efficacy|2|||
160476498|NCT01807234|579473226|FG004|Overall Study|Lost to Follow-up|1|||
160476499|NCT01807234|579473227|FG005|Overall Study|Lost to Follow-up|2|||
160476500|NCT01807234|579473222|FG000|Overall Study|Withdrawal by Subject|3|||
160476501|NCT01807234|579473223|FG001|Overall Study|Withdrawal by Subject|1|||
160476502|NCT01807234|579473224|FG002|Overall Study|Withdrawal by Subject|1|||
160476503|NCT01807234|579473225|FG003|Overall Study|Withdrawal by Subject|1|||
160476504|NCT01807234|579473226|FG004|Overall Study|Withdrawal by Subject|2|||
160476505|NCT01807234|579473227|FG005|Overall Study|Withdrawal by Subject|1|||
160476506|NCT01807234|579473222|FG000|Overall Study|Lack of Efficacy|0|||
160476507|NCT01807234|579473223|FG001|Overall Study|Lack of Efficacy|0|||
160476508|NCT01807234|579473224|FG002|Overall Study|Lack of Efficacy|0|||
160476509|NCT01807234|579473225|FG003|Overall Study|Lack of Efficacy|0|||
160476510|NCT01807234|579473226|FG004|Overall Study|Lack of Efficacy|1|||
160476511|NCT01807234|579473227|FG005|Overall Study|Lack of Efficacy|1|||
160476512|NCT01540474|579473228|FG000|Vaccination Period|Lost to Follow-up|0|||
160476513|NCT01540474|579473229|FG001|Vaccination Period|Lost to Follow-up|1|||
160476514|NCT01540474|579473230|FG002|Vaccination Period|Lost to Follow-up|0|||
160476515|NCT01540474|579473231|FG003|Vaccination Period|Lost to Follow-up|0|||
160476516|NCT00828139|579473232|FG000|Overall Study|Adverse Event|8|||
160476517|NCT00828139|579473233|FG001|Overall Study|Adverse Event|1|||
160476518|NCT00828139|579473234|FG002|Overall Study|Adverse Event|10|||
160476519|NCT00828139|579473235|FG003|Overall Study|Adverse Event|5|||
160476520|NCT00828139|579473232|FG000|Overall Study|Death|2|||
160476521|NCT00828139|579473233|FG001|Overall Study|Death|1|||
160476522|NCT00828139|579473234|FG002|Overall Study|Death|0|||
160476523|NCT00828139|579473235|FG003|Overall Study|Death|2|||
160476524|NCT00828139|579473232|FG000|Overall Study|Refusal unrelated to toxicity|3|||
160476525|NCT00828139|579473233|FG001|Overall Study|Refusal unrelated to toxicity|4|||
160476526|NCT00828139|579473234|FG002|Overall Study|Refusal unrelated to toxicity|5|||
160476527|NCT00828139|579473235|FG003|Overall Study|Refusal unrelated to toxicity|3|||
160476528|NCT00828139|579473232|FG000|Overall Study|Disease Progression|24|||
160476529|NCT00828139|579473233|FG001|Overall Study|Disease Progression|33|||
160476530|NCT00828139|579473234|FG002|Overall Study|Disease Progression|35|||
160476531|NCT00828139|579473235|FG003|Overall Study|Disease Progression|39|||
160476532|NCT00828139|579473232|FG000|Overall Study|Other|4|||
160476533|NCT00828139|579473233|FG001|Overall Study|Other|2|||
160476534|NCT00828139|579473234|FG002|Overall Study|Other|5|||
160476535|NCT00828139|579473235|FG003|Overall Study|Other|2|||
160476536|NCT04271254|579473239|FG000|Overall Study|Withdrawal by Subject|3|||
160476537|NCT01345253|579473240|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
160476538|NCT01345253|579473241|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
160476539|NCT01345253|579473240|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
160476540|NCT01345253|579473241|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
160476541|NCT01345253|579473240|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
160476542|NCT01345253|579473241|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
160476543|NCT01345253|579473240|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
160476544|NCT01345253|579473241|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
160476545|NCT01345253|579473240|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
160476546|NCT01345253|579473241|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
160476547|NCT01345253|579473240|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
160476548|NCT01345253|579473241|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
160476549|NCT01345253|579473240|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
160476550|NCT01345253|579473241|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
160476551|NCT01345253|579473240|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
160476552|NCT01345253|579473241|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
160476553|NCT01345253|579473240|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
160476554|NCT01345253|579473241|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
160476555|NCT01345253|579473240|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
160476556|NCT01345253|579473241|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
160476557|NCT01345253|579473240|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
160603118|NCT00910728|579924380|FG008|Overall Study|Lack of Efficacy|2|||
160603119|NCT00910728|579924372|FG000|Overall Study|Withdrawal by Subject|0|||
160603120|NCT00910728|579924373|FG001|Overall Study|Withdrawal by Subject|0|||
160603121|NCT00910728|579924374|FG002|Overall Study|Withdrawal by Subject|0|||
160603122|NCT00910728|579924375|FG003|Overall Study|Withdrawal by Subject|0|||
160603123|NCT00910728|579924376|FG004|Overall Study|Withdrawal by Subject|3|||
160603124|NCT00910728|579924377|FG005|Overall Study|Withdrawal by Subject|1|||
160476558|NCT01345253|579473241|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
160476559|NCT01345253|579473240|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
160476560|NCT01345253|579473241|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
160476561|NCT01345253|579473240|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
160476562|NCT01345253|579473241|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
160476563|NCT01345253|579473240|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
160476564|NCT01345253|579473241|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
160476565|NCT01345253|579473240|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
160476566|NCT01345253|579473241|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
160476567|NCT03693989|579473246|FG000|Overall Study|Protocol Violation|3|||
160476568|NCT03693989|579473247|FG001|Overall Study|Protocol Violation|4|||
160476569|NCT01190436|579473248|FG000|Overall Study|Lost to Follow-up|35|||
160476570|NCT01190436|579473248|FG000|Overall Study|Other|4|||
160476571|NCT03146845|579473249|FG000|Overall Study|Reference ulcer healed|1|||
160476572|NCT03146845|579473250|FG001|Overall Study|Reference ulcer healed|0|||
160476573|NCT03146845|579473249|FG000|Overall Study|Physician Decision|1|||
160476574|NCT03146845|579473250|FG001|Overall Study|Physician Decision|0|||
160476575|NCT03146845|579473249|FG000|Overall Study|Adverse Event|1|||
160476576|NCT03146845|579473250|FG001|Overall Study|Adverse Event|0|||
160476577|NCT03146845|579473249|FG000|Overall Study|Withdrawal by Subject|2|||
160476578|NCT03146845|579473250|FG001|Overall Study|Withdrawal by Subject|0|||
160476579|NCT03146845|579473249|FG000|Overall Study|Noncompliance|0|||
160476580|NCT03146845|579473250|FG001|Overall Study|Noncompliance|1|||
160476581|NCT03146845|579473249|FG000|Overall Study|Protocol Violation|0|||
160476582|NCT03146845|579473250|FG001|Overall Study|Protocol Violation|2|||
160476583|NCT03146845|579473249|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
160476584|NCT03146845|579473250|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
160476585|NCT01052272|579473253|FG000|Overall Study|Death|0|||
160476586|NCT01052272|579473254|FG001|Overall Study|Death|0|||
160476587|NCT01052272|579473255|FG002|Overall Study|Death|1|||
160476588|NCT01052272|579473256|FG003|Overall Study|Death|1|||
160476589|NCT01052272|579473253|FG000|Overall Study|Physician Decision|0|||
160476590|NCT01052272|579473254|FG001|Overall Study|Physician Decision|1|||
160476591|NCT01052272|579473255|FG002|Overall Study|Physician Decision|0|||
160476592|NCT01052272|579473256|FG003|Overall Study|Physician Decision|0|||
160476593|NCT01052272|579473253|FG000|Overall Study|patient refuses follow-up|5|||
160476594|NCT01052272|579473254|FG001|Overall Study|patient refuses follow-up|4|||
160476595|NCT01052272|579473255|FG002|Overall Study|patient refuses follow-up|2|||
160476596|NCT01052272|579473256|FG003|Overall Study|patient refuses follow-up|4|||
160476597|NCT01052272|579473253|FG000|Overall Study|Withdrawal by Subject|0|||
160476598|NCT01052272|579473254|FG001|Overall Study|Withdrawal by Subject|2|||
160476599|NCT01052272|579473255|FG002|Overall Study|Withdrawal by Subject|3|||
160476600|NCT01052272|579473256|FG003|Overall Study|Withdrawal by Subject|2|||
160476601|NCT01052272|579473253|FG000|Overall Study|placed in long-term care|0|||
160476602|NCT01052272|579473254|FG001|Overall Study|placed in long-term care|0|||
160476603|NCT01052272|579473255|FG002|Overall Study|placed in long-term care|1|||
160476604|NCT01052272|579473256|FG003|Overall Study|placed in long-term care|0|||
160476605|NCT01052272|579473253|FG000|Overall Study|decline in health|0|||
160476606|NCT01052272|579473254|FG001|Overall Study|decline in health|0|||
160476607|NCT01052272|579473255|FG002|Overall Study|decline in health|1|||
160476608|NCT01052272|579473256|FG003|Overall Study|decline in health|0|||
160476609|NCT00113529|579473258|FG000|Overall Study|Adverse Event|4|||
160476610|NCT00113529|579473258|FG000|Overall Study|Lack of Efficacy|20|||
160476611|NCT00113529|579473258|FG000|Overall Study|Decision of sponsor|6|||
160476612|NCT00113529|579473258|FG000|Overall Study|Withdrawal by Subject|4|||
160476613|NCT00648895|579473261|FG000|Overall Study|Lack of Efficacy|0|||
160476614|NCT00648895|579473262|FG001|Overall Study|Lack of Efficacy|1|||
160476615|NCT03386344|579473263|FG000|Overall Study|Adverse Event|6|||
160476616|NCT03386344|579473264|FG001|Overall Study|Adverse Event|3|||
160476617|NCT03386344|579473265|FG002|Overall Study|Adverse Event|1|||
160476618|NCT03386344|579473263|FG000|Overall Study|Poor Compliance to Protocol|0|||
160476619|NCT03386344|579473264|FG001|Overall Study|Poor Compliance to Protocol|1|||
160476620|NCT03386344|579473265|FG002|Overall Study|Poor Compliance to Protocol|0|||
160476621|NCT03386344|579473263|FG000|Overall Study|Study Terminated by Sponsor|101|||
160476622|NCT03386344|579473264|FG001|Overall Study|Study Terminated by Sponsor|102|||
160603125|NCT00910728|579924378|FG006|Overall Study|Withdrawal by Subject|2|||
160603126|NCT00910728|579924379|FG007|Overall Study|Withdrawal by Subject|0|||
160603127|NCT00910728|579924380|FG008|Overall Study|Withdrawal by Subject|0|||
160603128|NCT00910728|579924372|FG000|Overall Study|(not specified)|2|||
160476623|NCT03386344|579473265|FG002|Overall Study|Study Terminated by Sponsor|106|||
160476624|NCT03386344|579473263|FG000|Overall Study|Lost to Follow-up|3|||
160603129|NCT00910728|579924373|FG001|Overall Study|(not specified)|0|||
160476625|NCT03386344|579473264|FG001|Overall Study|Lost to Follow-up|2|||
160603130|NCT00910728|579924374|FG002|Overall Study|(not specified)|1|||
160603131|NCT00910728|579924375|FG003|Overall Study|(not specified)|0|||
160603132|NCT00910728|579924376|FG004|Overall Study|(not specified)|1|||
160476626|NCT03386344|579473265|FG002|Overall Study|Lost to Follow-up|1|||
160476627|NCT03386344|579473263|FG000|Overall Study|At the Participant's own Request|7|||
160476628|NCT03386344|579473264|FG001|Overall Study|At the Participant's own Request|7|||
160476629|NCT03386344|579473265|FG002|Overall Study|At the Participant's own Request|8|||
160476630|NCT03386344|579473263|FG000|Overall Study|Reason not Specified|0|||
160476631|NCT03386344|579473264|FG001|Overall Study|Reason not Specified|1|||
160476632|NCT03386344|579473265|FG002|Overall Study|Reason not Specified|0|||
160476633|NCT01077284|579473266|FG000|Overall Study|Adverse Event|2|||
160476634|NCT01077284|579473267|FG001|Overall Study|Adverse Event|0|||
160603133|NCT00910728|579924377|FG005|Overall Study|(not specified)|0|||
160603134|NCT00910728|579924378|FG006|Overall Study|(not specified)|0|||
160603135|NCT00910728|579924379|FG007|Overall Study|(not specified)|0|||
160603136|NCT00910728|579924380|FG008|Overall Study|(not specified)|0|||
160603137|NCT00910728|579924372|FG000|Overall Study|Adverse Event|2|||
160603138|NCT00910728|579924373|FG001|Overall Study|Adverse Event|0|||
160603139|NCT00910728|579924374|FG002|Overall Study|Adverse Event|1|||
160603140|NCT00910728|579924375|FG003|Overall Study|Adverse Event|1|||
160603141|NCT00910728|579924376|FG004|Overall Study|Adverse Event|0|||
160660483|NCT00727571|580139533|FG003|Overall Study|Hospitalization|1|||
160660484|NCT00727571|580139530|FG000|Overall Study|AE not leading to hospitalization|0|||
160660485|NCT00727571|580139531|FG001|Overall Study|AE not leading to hospitalization|0|||
160660486|NCT00727571|580139532|FG002|Overall Study|AE not leading to hospitalization|2|||
160660487|NCT00727571|580139533|FG003|Overall Study|AE not leading to hospitalization|0|||
160660488|NCT00727571|580139530|FG000|Overall Study|Other|0|||
160660489|NCT00727571|580139531|FG001|Overall Study|Other|4|||
160603142|NCT00910728|579924377|FG005|Overall Study|Adverse Event|0|||
160603143|NCT00910728|579924378|FG006|Overall Study|Adverse Event|2|||
160603144|NCT00910728|579924379|FG007|Overall Study|Adverse Event|1|||
160603145|NCT00910728|579924380|FG008|Overall Study|Adverse Event|1|||
160603146|NCT01068717|579924384|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
160603147|NCT01068717|579924385|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
160603148|NCT01068717|579924386|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
160603149|NCT01068717|579924387|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
160603150|NCT01822223|579924388|FG000|Overall Study|Death|0|||
160603151|NCT01822223|579924389|FG001|Overall Study|Death|1|||
160603152|NCT01449955|579924392|FG000|Overall Study|Withdrawal by Subject|1|||
160603153|NCT01449955|579924393|FG001|Overall Study|Withdrawal by Subject|2|||
160603154|NCT03404518|579924398|FG000|Overall Study|Lost to Follow-up|28|||
160603155|NCT03404518|579924399|FG001|Overall Study|Lost to Follow-up|30|||
160603156|NCT03404518|579924398|FG000|Overall Study|Protocol Violation|13|||
160603157|NCT03404518|579924399|FG001|Overall Study|Protocol Violation|6|||
160603158|NCT05041062|579924400|FG000|Overall Study|Adverse Event|2|||
160603159|NCT03693404|579924404|FG000|Overall Study|Withdrawal by Subject|1|||
160603160|NCT03693404|579924405|FG001|Overall Study|Withdrawal by Subject|0|||
160603161|NCT03693404|579924404|FG000|Overall Study|Lost to Follow-up|0|||
160603162|NCT03693404|579924405|FG001|Overall Study|Lost to Follow-up|5|||
160603163|NCT03693404|579924404|FG000|Overall Study|Excluded from Analysis|0|||
160603164|NCT03693404|579924405|FG001|Overall Study|Excluded from Analysis|1|||
160603165|NCT01176240|579924406|FG000|Study 306A|Lack of Efficacy|2|||
160603166|NCT01176240|579924407|FG001|Study 306A|Lack of Efficacy|1|||
160603167|NCT01176240|579924406|FG000|Study 306A|Protocol Violation|0|||
160603168|NCT01176240|579924407|FG001|Study 306A|Protocol Violation|1|||
160603169|NCT01176240|579924406|FG000|Study 306A|Withdrawal by Subject|0|||
160603170|NCT01176240|579924407|FG001|Study 306A|Withdrawal by Subject|1|||
160603171|NCT01176240|579924406|FG000|Study 306A|Stop due to diverse problems|1|||
160603172|NCT01176240|579924407|FG001|Study 306A|Stop due to diverse problems|0|||
160603173|NCT01176240|579924406|FG000|Study 306B|Lack of Efficacy|5|||
160603174|NCT01176240|579924407|FG001|Study 306B|Lack of Efficacy|3|||
160603175|NCT01176240|579924406|FG000|Study 306B|Adverse Event|10|||
160603176|NCT01176240|579924407|FG001|Study 306B|Adverse Event|5|||
160660490|NCT00727571|580139532|FG002|Overall Study|Other|6|||
160603177|NCT01176240|579924406|FG000|Study 306B|Protocol Violation|2|||
160603178|NCT01176240|579924407|FG001|Study 306B|Protocol Violation|3|||
160603179|NCT01176240|579924406|FG000|Study 306B|Withdrawal by Subject|4|||
160603180|NCT01176240|579924407|FG001|Study 306B|Withdrawal by Subject|1|||
160603181|NCT01176240|579924406|FG000|Study 306B|Physician Decision|2|||
160603182|NCT01176240|579924407|FG001|Study 306B|Physician Decision|1|||
160603183|NCT01176240|579924406|FG000|Study 306B|Supine Hypertension|1|||
160603184|NCT01176240|579924407|FG001|Study 306B|Supine Hypertension|2|||
160603185|NCT01176240|579924406|FG000|Study 306B|Lost to Follow-up|0|||
160603186|NCT01176240|579924407|FG001|Study 306B|Lost to Follow-up|1|||
160603187|NCT01176240|579924406|FG000|Study 306B|withdrew prior to dosing|2|||
160603188|NCT01176240|579924407|FG001|Study 306B|withdrew prior to dosing|1|||
160603189|NCT05200455|579924410|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
160603190|NCT00807014|579924411|FG000|Overall Study|Participant Considered Disease Cured|13|||
160603191|NCT00807014|579924412|FG001|Overall Study|Participant Considered Disease Cured|2|||
160603192|NCT00807014|579924411|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
160603193|NCT00807014|579924412|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
160603194|NCT00807014|579924411|FG000|Overall Study|Protocol Violation|2|||
160603195|NCT00807014|579924412|FG001|Overall Study|Protocol Violation|8|||
160603196|NCT00807014|579924411|FG000|Overall Study|Adverse Event|0|||
160603197|NCT00807014|579924412|FG001|Overall Study|Adverse Event|2|||
160603198|NCT00807014|579924411|FG000|Overall Study|Lost to Follow-up|9|||
160603199|NCT00807014|579924412|FG001|Overall Study|Lost to Follow-up|7|||
160603200|NCT00807014|579924411|FG000|Overall Study|Recovery|1|||
160603201|NCT00807014|579924412|FG001|Overall Study|Recovery|0|||
160603202|NCT00807014|579924411|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
160603203|NCT00807014|579924412|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
160603204|NCT00651313|579924413|FG000|Overall Study|Adverse Event|0|||
160603205|NCT00651313|579924414|FG001|Overall Study|Adverse Event|1|||
160603206|NCT00651313|579924413|FG000|Overall Study|Withdrawal by Subject|3|||
160603207|NCT00651313|579924414|FG001|Overall Study|Withdrawal by Subject|1|||
160476635|NCT01077284|579473268|FG002|Overall Study|Adverse Event|1|||
160476636|NCT01077284|579473266|FG000|Overall Study|Lost to Follow-up|1|||
160476637|NCT01077284|579473267|FG001|Overall Study|Lost to Follow-up|2|||
160476638|NCT01077284|579473268|FG002|Overall Study|Lost to Follow-up|0|||
160476639|NCT01077284|579473266|FG000|Overall Study|Withdrawal by Subject|2|||
160476640|NCT01077284|579473267|FG001|Overall Study|Withdrawal by Subject|3|||
160476641|NCT01077284|579473268|FG002|Overall Study|Withdrawal by Subject|1|||
160476642|NCT01077284|579473266|FG000|Overall Study|Other|0|||
160476643|NCT01077284|579473267|FG001|Overall Study|Other|0|||
160476644|NCT01077284|579473268|FG002|Overall Study|Other|1|||
160476645|NCT00841321|579473273|FG000|Overall Study|Lost to Follow-up|1|||
160476646|NCT00841321|579473274|FG001|Overall Study|Lost to Follow-up|1|||
160476647|NCT00841321|579473273|FG000|Overall Study|Adverse Event|0|||
160476648|NCT00841321|579473274|FG001|Overall Study|Adverse Event|2|||
160476649|NCT02632747|579473277|FG000|Wash-out Period|Adverse Event|1|||
160476650|NCT02632747|579473278|FG001|Wash-out Period|Adverse Event|0|||
160476651|NCT04421456|579473279|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
160476652|NCT04421456|579473280|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
160476653|NCT04421456|579473281|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
160476654|NCT04421456|579473279|FG000|Randomized Treatment Period|Adverse Event|0|||
160476655|NCT04421456|579473280|FG001|Randomized Treatment Period|Adverse Event|1|||
160476656|NCT04421456|579473281|FG002|Randomized Treatment Period|Adverse Event|0|||
160476657|NCT04421456|579473279|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
160476658|NCT04421456|579473280|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
160476659|NCT04421456|579473281|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
160476660|NCT04421456|579473279|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
160476661|NCT04421456|579473280|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
160476662|NCT04421456|579473281|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
160476663|NCT04421456|579473279|FG000|Randomized Treatment Period|Participant non-compliance|1|||
160476664|NCT04421456|579473280|FG001|Randomized Treatment Period|Participant non-compliance|1|||
160476665|NCT04421456|579473281|FG002|Randomized Treatment Period|Participant non-compliance|2|||
160476666|NCT04421456|579473279|FG000|Randomized Treatment Period|Other|0|||
160476667|NCT04421456|579473280|FG001|Randomized Treatment Period|Other|1|||
160476668|NCT04421456|579473281|FG002|Randomized Treatment Period|Other|3|||
160476669|NCT03875729|579473286|FG000|Overall Study|Adverse Event|0|||
160476670|NCT03875729|579473287|FG001|Overall Study|Adverse Event|5|||
160476671|NCT03875729|579473286|FG000|Overall Study|Withdrawal by Subject|8|||
160476672|NCT03875729|579473287|FG001|Overall Study|Withdrawal by Subject|11|||
160476673|NCT03875729|579473286|FG000|Overall Study|Pregnancy|0|||
160476674|NCT03875729|579473287|FG001|Overall Study|Pregnancy|1|||
160476675|NCT03875729|579473286|FG000|Overall Study|Lost to Follow-up|0|||
160476676|NCT03875729|579473287|FG001|Overall Study|Lost to Follow-up|5|||
160476677|NCT03875729|579473286|FG000|Overall Study|Personal reasons|2|||
160476678|NCT03875729|579473287|FG001|Overall Study|Personal reasons|0|||
160603208|NCT00651313|579924413|FG000|Overall Study|Lost to Follow-up|1|||
160603209|NCT00651313|579924414|FG001|Overall Study|Lost to Follow-up|1|||
160603210|NCT00651313|579924413|FG000|Overall Study|Adminstrative Discontinuation|2|||
160603211|NCT00651313|579924414|FG001|Overall Study|Adminstrative Discontinuation|3|||
160603212|NCT03700736|579924415|FG000|Overall Study|Pregnancy|1|||
160603213|NCT03700736|579924416|FG001|Overall Study|Pregnancy|1|||
160603214|NCT03700736|579924415|FG000|Overall Study|Withdrawal by Subject|2|||
160476679|NCT00753896|579473288|FG000|Overall Study|Adverse Event|4|||
160476680|NCT00753896|579473288|FG000|Overall Study|Death|1|||
160476681|NCT00753896|579473288|FG000|Overall Study|Lost to Follow-up|2|||
160476682|NCT00753896|579473288|FG000|Overall Study|Protocol Violation|1|||
160476683|NCT00753896|579473288|FG000|Overall Study|Withdrawal by Subject|4|||
160476684|NCT00753896|579473288|FG000|Overall Study|Entry Criteria Not Met|4|||
160476685|NCT01280656|579473289|FG000|Overall Study|Adverse Event|1|||
160476686|NCT01280656|579473290|FG001|Overall Study|Adverse Event|14|||
160476687|NCT01280656|579473291|FG002|Overall Study|Adverse Event|13|||
160476688|NCT01280656|579473289|FG000|Overall Study|Lack of Efficacy|1|||
160476689|NCT01280656|579473290|FG001|Overall Study|Lack of Efficacy|22|||
160476690|NCT01280656|579473291|FG002|Overall Study|Lack of Efficacy|38|||
160476691|NCT01280656|579473289|FG000|Overall Study|Treatment shortening (RGT)|0|||
160476692|NCT01280656|579473290|FG001|Overall Study|Treatment shortening (RGT)|4|||
160476693|NCT01280656|579473291|FG002|Overall Study|Treatment shortening (RGT)|5|||
160476694|NCT01280656|579473289|FG000|Overall Study|Other|1|||
160476695|NCT01280656|579473290|FG001|Overall Study|Other|7|||
160476696|NCT01280656|579473291|FG002|Overall Study|Other|7|||
160476697|NCT00952523|579473292|FG000|Overall Study|Withdrawal by Subject|7|||
160476698|NCT01029925|579473293|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
160476699|NCT01029925|579473293|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
160476700|NCT01029925|579473293|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
160476701|NCT05265247|579473294|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
160476702|NCT05265247|579473295|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
160476703|NCT05265247|579473294|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
160476704|NCT05265247|579473295|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
160476705|NCT05265247|579473294|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
160476706|NCT05265247|579473295|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
160476707|NCT02707952|579473300|FG000|Overall Study|Adverse Event|1|||
160476708|NCT02707952|579473301|FG001|Overall Study|Adverse Event|0|||
160476709|NCT02707952|579473302|FG002|Overall Study|Adverse Event|0|||
160476710|NCT02707952|579473303|FG003|Overall Study|Adverse Event|0|||
160476711|NCT02707952|579473300|FG000|Overall Study|Lost to Follow-up|1|||
160476712|NCT02707952|579473301|FG001|Overall Study|Lost to Follow-up|0|||
160476713|NCT02707952|579473302|FG002|Overall Study|Lost to Follow-up|0|||
160476714|NCT02707952|579473303|FG003|Overall Study|Lost to Follow-up|0|||
160476715|NCT02707952|579473300|FG000|Overall Study|Withdrawal by Subject|0|||
160476716|NCT02707952|579473301|FG001|Overall Study|Withdrawal by Subject|1|||
160476717|NCT02707952|579473302|FG002|Overall Study|Withdrawal by Subject|2|||
160476718|NCT02707952|579473303|FG003|Overall Study|Withdrawal by Subject|0|||
160476719|NCT01287832|579473305|FG000|Overall Study|Adverse Event|1|||
160476720|NCT01287832|579473306|FG001|Overall Study|Adverse Event|0|||
160476721|NCT01287832|579473305|FG000|Overall Study|Death|0|||
160476722|NCT01287832|579473306|FG001|Overall Study|Death|1|||
160476723|NCT03065400|579473309|FG000|Overall Study|Adverse Event|1|||
160476724|NCT03065400|579473309|FG000|Overall Study|Physician Decision|3|||
160476725|NCT03065400|579473309|FG000|Overall Study|Withdrawal by Subject|1|||
160476726|NCT03065400|579473309|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
160476727|NCT03072862|579473310|FG000|Overall Study|Withdrawal by Subject|4|||
160476728|NCT03072862|579473310|FG000|Overall Study|Lost to Follow-up|6|||
160476729|NCT03072862|579473310|FG000|Overall Study|Protocol Violation|4|||
160476730|NCT03072862|579473310|FG000|Overall Study|Physician Decision|2|||
160476731|NCT03072862|579473310|FG000|Overall Study|Death|1|||
160476732|NCT03072862|579473310|FG000|Overall Study|Adverse Event|1|||
160476733|NCT00632736|579473311|FG000|Overall Study|Adverse Event|104|||
160476734|NCT00632736|579473311|FG000|Overall Study|Lost to Follow-up|15|||
160476735|NCT00632736|579473311|FG000|Overall Study|Protocol Violation|14|||
160476736|NCT00632736|579473311|FG000|Overall Study|Withdrawal by Subject|99|||
160476737|NCT00632736|579473311|FG000|Overall Study|Lack of Efficacy|5|||
160476738|NCT00632736|579473311|FG000|Overall Study|Sponsor terminated study|5|||
160476739|NCT00632736|579473311|FG000|Overall Study|Non-compliance|10|||
160476740|NCT00632736|579473311|FG000|Overall Study|Other|16|||
160476741|NCT03015220|579473314|FG000|Overall Study|Withdrawal by Subject|3|||
160476742|NCT03015220|579473315|FG001|Overall Study|Withdrawal by Subject|2|||
160476743|NCT03015220|579473316|FG002|Overall Study|Withdrawal by Subject|2|||
160476744|NCT03015220|579473317|FG003|Overall Study|Withdrawal by Subject|2|||
160603215|NCT03700736|579924416|FG001|Overall Study|Withdrawal by Subject|6|||
160603216|NCT04126031|579924418|FG000|Part A|Withdrawal by Subject|0|||
160603217|NCT04126031|579924419|FG001|Part A|Withdrawal by Subject|0|||
160603218|NCT04126031|579924420|FG002|Part A|Withdrawal by Subject|1|||
160603219|NCT04126031|579924421|FG003|Part A|Withdrawal by Subject|0|||
160476745|NCT03015220|579473314|FG000|Overall Study|Lost to Follow-up|0|||
160476746|NCT03015220|579473315|FG001|Overall Study|Lost to Follow-up|0|||
160603220|NCT04126031|579924422|FG004|Part A|Withdrawal by Subject|0|||
160603221|NCT04126031|579924423|FG005|Part A|Withdrawal by Subject|0|||
160476747|NCT03015220|579473316|FG002|Overall Study|Lost to Follow-up|1|||
160603222|NCT04126031|579924418|FG000|Part A|Other|1|||
160660491|NCT00727571|580139533|FG003|Overall Study|Other|0|||
160476748|NCT03015220|579473317|FG003|Overall Study|Lost to Follow-up|0|||
160476749|NCT01670526|579473318|FG000|Overall Study|Withdrawal by Subject|3|||
160476750|NCT01670526|579473319|FG001|Overall Study|Withdrawal by Subject|1|||
160603223|NCT04126031|579924419|FG001|Part A|Other|0|||
160603224|NCT04126031|579924420|FG002|Part A|Other|0|||
160476751|NCT01670526|579473318|FG000|Overall Study|Lost to Follow-up|9|||
160476752|NCT01670526|579473319|FG001|Overall Study|Lost to Follow-up|5|||
160476753|NCT00392197|579473320|FG000|Overall Study|Adverse Event|4|||
160476754|NCT00392197|579473321|FG001|Overall Study|Adverse Event|12|||
160476755|NCT00392197|579473320|FG000|Overall Study|Lack of Efficacy|3|||
160476756|NCT00392197|579473321|FG001|Overall Study|Lack of Efficacy|4|||
160476757|NCT00392197|579473320|FG000|Overall Study|Lost to Follow-up|0|||
160476758|NCT00392197|579473321|FG001|Overall Study|Lost to Follow-up|1|||
160476759|NCT00392197|579473320|FG000|Overall Study|Physician Decision|3|||
160476760|NCT00392197|579473321|FG001|Overall Study|Physician Decision|2|||
160476761|NCT00392197|579473320|FG000|Overall Study|Protocol Violation|7|||
160476762|NCT00392197|579473321|FG001|Overall Study|Protocol Violation|5|||
160476763|NCT00392197|579473320|FG000|Overall Study|Withdrawal by Subject|4|||
160476764|NCT00392197|579473321|FG001|Overall Study|Withdrawal by Subject|6|||
160476765|NCT01794689|579473322|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
160476766|NCT01794689|579473323|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
160476767|NCT01794689|579473324|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
160476768|NCT01794689|579473325|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
160476769|NCT01794689|579473322|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
160476770|NCT01794689|579473323|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
160476771|NCT01794689|579473324|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
160476772|NCT01794689|579473325|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
160476773|NCT01794689|579473322|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
160476774|NCT01794689|579473323|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
160476775|NCT01794689|579473324|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
160476776|NCT01794689|579473325|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
160476777|NCT01794689|579473322|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
160476778|NCT01794689|579473323|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
160476779|NCT01794689|579473324|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
160476780|NCT01794689|579473325|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
160476781|NCT01528605|579473326|FG000|Overall Study|Lost to Follow-up|1|||
160476782|NCT01528605|579473327|FG001|Overall Study|Lost to Follow-up|0|||
160476783|NCT01528605|579473328|FG002|Overall Study|Lost to Follow-up|1|||
160476784|NCT01528605|579473329|FG003|Overall Study|Lost to Follow-up|1|||
160476785|NCT01528605|579473330|FG004|Overall Study|Lost to Follow-up|0|||
160476786|NCT01528605|579473331|FG005|Overall Study|Lost to Follow-up|0|||
160476787|NCT01528605|579473326|FG000|Overall Study|Death|1|||
160476788|NCT01528605|579473327|FG001|Overall Study|Death|0|||
160476789|NCT01528605|579473328|FG002|Overall Study|Death|0|||
160476790|NCT01528605|579473329|FG003|Overall Study|Death|0|||
160476791|NCT01528605|579473330|FG004|Overall Study|Death|0|||
160476792|NCT01528605|579473331|FG005|Overall Study|Death|0|||
160476793|NCT04447287|579473333|FG000|Period 1: Run-in Period|Adverse Event|3|||
160476794|NCT04447287|579473334|FG001|Period 1: Run-in Period|Adverse Event|0|||
160476795|NCT04447287|579473335|FG002|Period 1: Run-in Period|Adverse Event|0|||
160476796|NCT04447287|579473333|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
160476797|NCT04447287|579473334|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
160476798|NCT04447287|579473335|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
160476799|NCT04447287|579473333|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
160476800|NCT04447287|579473334|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
160476801|NCT04447287|579473335|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
160476802|NCT05700851|579473336|FG000|Overall Study|Received a kidney transplant|1|||
160476803|NCT05700851|579473336|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
160476804|NCT05700851|579473336|FG000|Overall Study|Withdrawal by Subject|1|||
160476805|NCT02978716|579473337|FG000|Overall Study|Death|25|||
160476806|NCT02978716|579473338|FG001|Overall Study|Death|13|||
160476807|NCT02978716|579473339|FG002|Overall Study|Death|20|||
160476808|NCT02978716|579473337|FG000|Overall Study|Lost to Follow-up|0|||
160476809|NCT02978716|579473338|FG001|Overall Study|Lost to Follow-up|0|||
160476810|NCT02978716|579473339|FG002|Overall Study|Lost to Follow-up|1|||
160476811|NCT02978716|579473337|FG000|Overall Study|Withdrawal by Subject|6|||
160476812|NCT02978716|579473338|FG001|Overall Study|Withdrawal by Subject|4|||
160476813|NCT02978716|579473339|FG002|Overall Study|Withdrawal by Subject|5|||
160476814|NCT02978716|579473337|FG000|Overall Study|Sponsor terminated|2|||
160476815|NCT02978716|579473338|FG001|Overall Study|Sponsor terminated|13|||
160476816|NCT02978716|579473339|FG002|Overall Study|Sponsor terminated|9|||
160476817|NCT02978716|579473337|FG000|Overall Study|Other|1|||
160476818|NCT02978716|579473338|FG001|Overall Study|Other|3|||
160476819|NCT02978716|579473339|FG002|Overall Study|Other|0|||
160476820|NCT00866619|579473350|FG000|Overall Study|Adverse Event|112|||
160476821|NCT00866619|579473351|FG001|Overall Study|Adverse Event|106|||
160476822|NCT00866619|579473352|FG002|Overall Study|Adverse Event|47|||
160660492|NCT02724462|580139534|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
160476823|NCT00866619|579473353|FG003|Overall Study|Adverse Event|44|||
160476824|NCT00866619|579473350|FG000|Overall Study|Protocol Violation|2|||
160603225|NCT04126031|579924421|FG003|Part A|Other|0|||
160603226|NCT04126031|579924422|FG004|Part A|Other|0|||
160603227|NCT04126031|579924423|FG005|Part A|Other|0|||
160603228|NCT04126031|579924418|FG000|Part B|Adverse Event|0|||
160603229|NCT04126031|579924419|FG001|Part B|Adverse Event|0|||
160603230|NCT04126031|579924420|FG002|Part B|Adverse Event|0|||
160603231|NCT04126031|579924421|FG003|Part B|Adverse Event|0|||
160603232|NCT04126031|579924422|FG004|Part B|Adverse Event|0|||
160603233|NCT04126031|579924423|FG005|Part B|Adverse Event|2|||
160603234|NCT04126031|579924418|FG000|Part B|Pre-existing hypertransaminasemia|0|||
160603235|NCT04126031|579924419|FG001|Part B|Pre-existing hypertransaminasemia|0|||
160603236|NCT04126031|579924420|FG002|Part B|Pre-existing hypertransaminasemia|0|||
160603237|NCT04126031|579924421|FG003|Part B|Pre-existing hypertransaminasemia|0|||
160603238|NCT04126031|579924422|FG004|Part B|Pre-existing hypertransaminasemia|1|||
160603239|NCT04126031|579924423|FG005|Part B|Pre-existing hypertransaminasemia|0|||
160603240|NCT00131664|579924424|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
160603241|NCT00131664|579924425|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
160603242|NCT00131664|579924426|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
160603243|NCT00131664|579924427|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
160603244|NCT00131664|579924428|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
160603245|NCT00131664|579924429|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
160603246|NCT00131664|579924424|FG000|First Period (First 6 Months)|Death|0|||
160603247|NCT00131664|579924425|FG001|First Period (First 6 Months)|Death|1|||
160603248|NCT00131664|579924426|FG002|First Period (First 6 Months)|Death|0|||
160603249|NCT00131664|579924427|FG003|First Period (First 6 Months)|Death|0|||
160603250|NCT00131664|579924428|FG004|First Period (First 6 Months)|Death|0|||
160603251|NCT00131664|579924429|FG005|First Period (First 6 Months)|Death|0|||
160603252|NCT00131664|579924424|FG000|First Period (First 6 Months)|Protocol Violation|2|||
160603253|NCT00131664|579924425|FG001|First Period (First 6 Months)|Protocol Violation|2|||
160603254|NCT00131664|579924426|FG002|First Period (First 6 Months)|Protocol Violation|1|||
160603255|NCT00131664|579924427|FG003|First Period (First 6 Months)|Protocol Violation|0|||
160603256|NCT00131664|579924428|FG004|First Period (First 6 Months)|Protocol Violation|0|||
160603257|NCT00131664|579924429|FG005|First Period (First 6 Months)|Protocol Violation|0|||
160603258|NCT00131664|579924424|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
160603259|NCT00131664|579924425|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
160603260|NCT00131664|579924426|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
160603261|NCT00131664|579924427|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
160603262|NCT00131664|579924428|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
160603263|NCT00131664|579924429|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
160603264|NCT00131664|579924424|FG000|First Period (First 6 Months)|Adverse Event|9|||
160603265|NCT00131664|579924425|FG001|First Period (First 6 Months)|Adverse Event|4|||
160603266|NCT00131664|579924426|FG002|First Period (First 6 Months)|Adverse Event|5|||
160603267|NCT00131664|579924427|FG003|First Period (First 6 Months)|Adverse Event|0|||
160603268|NCT00131664|579924428|FG004|First Period (First 6 Months)|Adverse Event|0|||
160603269|NCT00131664|579924429|FG005|First Period (First 6 Months)|Adverse Event|0|||
160603270|NCT00131664|579924424|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
160603271|NCT00131664|579924425|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
160603272|NCT00131664|579924426|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
160603273|NCT00131664|579924427|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
160603274|NCT00131664|579924428|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
160603275|NCT00131664|579924429|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
160476825|NCT00866619|579473351|FG001|Overall Study|Protocol Violation|39|||
160603276|NCT00131664|579924424|FG000|First Period (First 6 Months)|Administrative reasons|2|||
160603277|NCT00131664|579924425|FG001|First Period (First 6 Months)|Administrative reasons|0|||
160603278|NCT00131664|579924426|FG002|First Period (First 6 Months)|Administrative reasons|5|||
160603279|NCT00131664|579924427|FG003|First Period (First 6 Months)|Administrative reasons|0|||
160603280|NCT00131664|579924428|FG004|First Period (First 6 Months)|Administrative reasons|0|||
160603281|NCT00131664|579924429|FG005|First Period (First 6 Months)|Administrative reasons|0|||
160603282|NCT00131664|579924424|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
160603283|NCT00131664|579924425|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
160660493|NCT02724462|580139535|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
160476826|NCT00866619|579473352|FG002|Overall Study|Protocol Violation|2|||
160476827|NCT00866619|579473353|FG003|Overall Study|Protocol Violation|17|||
160476828|NCT00866619|579473350|FG000|Overall Study|Withdrawal by Subject|587|||
160476829|NCT00866619|579473351|FG001|Overall Study|Withdrawal by Subject|295|||
160476830|NCT00866619|579473352|FG002|Overall Study|Withdrawal by Subject|272|||
160476831|NCT00866619|579473353|FG003|Overall Study|Withdrawal by Subject|144|||
160476832|NCT00866619|579473350|FG000|Overall Study|Lost to Follow-up|1145|||
160476833|NCT00866619|579473351|FG001|Overall Study|Lost to Follow-up|830|||
160476834|NCT00866619|579473352|FG002|Overall Study|Lost to Follow-up|568|||
160476835|NCT00866619|579473353|FG003|Overall Study|Lost to Follow-up|425|||
160476836|NCT00882050|579473357|FG000|Overall Study|Physician Decision|1|||
160476837|NCT00882050|579473358|FG001|Overall Study|Physician Decision|0|||
160476838|NCT00882050|579473359|FG002|Overall Study|Physician Decision|0|||
160476839|NCT00805441|579473360|FG000|Overall Study|Adverse Event|5|||
160476840|NCT00805441|579473361|FG001|Overall Study|Adverse Event|2|||
160476841|NCT00805441|579473360|FG000|Overall Study|Lack of Efficacy|0|||
160476842|NCT00805441|579473361|FG001|Overall Study|Lack of Efficacy|2|||
160476843|NCT00805441|579473360|FG000|Overall Study|Protocol Violation|4|||
160476844|NCT00805441|579473361|FG001|Overall Study|Protocol Violation|8|||
160476845|NCT00805441|579473360|FG000|Overall Study|Lost to Follow-up|10|||
160476846|NCT00805441|579473361|FG001|Overall Study|Lost to Follow-up|13|||
160476847|NCT00805441|579473360|FG000|Overall Study|Withdrawal by Subject|15|||
160476848|NCT00805441|579473361|FG001|Overall Study|Withdrawal by Subject|9|||
160476849|NCT00805441|579473360|FG000|Overall Study|Physician Decision|0|||
160476850|NCT00805441|579473361|FG001|Overall Study|Physician Decision|1|||
160476851|NCT00805441|579473360|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
160476852|NCT00805441|579473361|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
160476853|NCT02068352|579475032|FG000|Overall Study|Lost to Follow-up|0|||
160476854|NCT02068352|579475033|FG001|Overall Study|Lost to Follow-up|2|||
160476855|NCT02068352|579475034|FG002|Overall Study|Lost to Follow-up|0|||
160476856|NCT02068352|579475032|FG000|Overall Study|Adverse Event|4|||
160476857|NCT02068352|579475033|FG001|Overall Study|Adverse Event|2|||
160476858|NCT02068352|579475034|FG002|Overall Study|Adverse Event|7|||
160476859|NCT02068352|579475032|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
160476860|NCT02068352|579475033|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
160476861|NCT02068352|579475034|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
160476862|NCT02068352|579475032|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
160476863|NCT02068352|579475033|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
160476864|NCT02068352|579475034|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
160476865|NCT02068352|579475032|FG000|Overall Study|Protocol Deviation|0|||
160476866|NCT02068352|579475033|FG001|Overall Study|Protocol Deviation|0|||
160476867|NCT02068352|579475034|FG002|Overall Study|Protocol Deviation|1|||
160476868|NCT01767376|579475038|FG000|Overall Study|Lost to Follow-up|3|||
160476869|NCT01767376|579475039|FG001|Overall Study|Lost to Follow-up|2|||
160476870|NCT01767376|579475040|FG002|Overall Study|Lost to Follow-up|0|||
160476871|NCT01767376|579475038|FG000|Overall Study|Withdrawal by Subject|1|||
160476872|NCT01767376|579475039|FG001|Overall Study|Withdrawal by Subject|1|||
160476873|NCT01767376|579475040|FG002|Overall Study|Withdrawal by Subject|0|||
160476874|NCT03557307|579475041|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
160476875|NCT03557307|579475041|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
160476876|NCT03557307|579475041|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
160476877|NCT03557307|579475041|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
160476878|NCT03557307|579475041|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
160476879|NCT03557307|579475041|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
160476880|NCT03557307|579475041|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
160476881|NCT03557307|579475041|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
160476882|NCT03557307|579475041|FG000|Period 2: Maintenance Phase|Death|3|||
160476883|NCT03557307|579475041|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
160476884|NCT03557307|579475041|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
160476885|NCT03557307|579475041|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
160476886|NCT03557307|579475041|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
160476887|NCT03557307|579475041|FG000|Period 2: Maintenance Phase|other|3|||
160476888|NCT03745651|579475042|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
160476889|NCT03745651|579475043|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
160476890|NCT03745651|579475044|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160476891|NCT03745651|579475045|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160476892|NCT03745651|579475046|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160476893|NCT03745651|579475047|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160476894|NCT03745651|579475048|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160476895|NCT03745651|579475042|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
160476896|NCT03745651|579475043|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
160476897|NCT03745651|579475044|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
160476898|NCT03745651|579475045|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160476899|NCT03745651|579475046|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160476900|NCT03745651|579475047|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160476901|NCT03745651|579475048|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160476902|NCT03745651|579475042|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
160476903|NCT03745651|579475043|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160476904|NCT03745651|579475044|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
160476905|NCT03745651|579475045|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160476906|NCT03745651|579475046|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160476907|NCT03745651|579475047|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160476908|NCT03745651|579475048|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160476909|NCT03745651|579475042|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160476910|NCT03745651|579475043|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
160476911|NCT03745651|579475044|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160476912|NCT03745651|579475045|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160476913|NCT03745651|579475046|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160476914|NCT03745651|579475047|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160476915|NCT03745651|579475048|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160476916|NCT03745651|579475042|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
160476917|NCT03745651|579475043|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
160476918|NCT03745651|579475044|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
160476919|NCT03745651|579475045|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160476920|NCT03745651|579475046|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160476921|NCT03745651|579475047|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160476922|NCT03745651|579475048|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160476923|NCT03745651|579475042|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
160476924|NCT03745651|579475043|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
160476925|NCT03745651|579475044|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
160476926|NCT03745651|579475045|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
160476927|NCT03745651|579475046|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
160476928|NCT03745651|579475047|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
160476929|NCT03745651|579475048|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
160476930|NCT03745651|579475042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160476931|NCT03745651|579475043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160476932|NCT03745651|579475044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160476933|NCT03745651|579475045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160476934|NCT03745651|579475046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160476935|NCT03745651|579475047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
160476936|NCT03745651|579475048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160476937|NCT03745651|579475042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160476938|NCT03745651|579475043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160476939|NCT03745651|579475044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160476940|NCT03745651|579475045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
160476941|NCT03745651|579475046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160476942|NCT03745651|579475047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
160476943|NCT03745651|579475048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
160476944|NCT03745651|579475042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160476945|NCT03745651|579475043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160476946|NCT03745651|579475044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160476947|NCT03745651|579475045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
160476948|NCT03745651|579475046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
160476949|NCT03745651|579475047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
160476950|NCT03745651|579475048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
160476951|NCT03745651|579475042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160476952|NCT03745651|579475043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160476953|NCT03745651|579475044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160476954|NCT03745651|579475045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
160476955|NCT03745651|579475046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160476956|NCT03745651|579475047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
160476957|NCT03745651|579475048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
160476958|NCT03745651|579475042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
160476959|NCT03745651|579475043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
160476960|NCT03745651|579475044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
160476961|NCT03745651|579475045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
160476962|NCT03745651|579475046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
160476963|NCT03745651|579475047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
160476964|NCT03745651|579475048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
160476965|NCT03745651|579475042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160476966|NCT03745651|579475043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160476967|NCT03745651|579475044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160476968|NCT03745651|579475045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160476969|NCT03745651|579475046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160476970|NCT03745651|579475047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
160476971|NCT03745651|579475048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160476972|NCT03745651|579475042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160476973|NCT03745651|579475043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160476974|NCT03745651|579475044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160476975|NCT03745651|579475045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
160476976|NCT03745651|579475046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
160476977|NCT03745651|579475047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
160476978|NCT03745651|579475048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
160476979|NCT03745651|579475042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
160476980|NCT03745651|579475043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
160476981|NCT03745651|579475044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
160476982|NCT03745651|579475045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
160476983|NCT03745651|579475046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
160476984|NCT03745651|579475047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
160476985|NCT03745651|579475048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
160476986|NCT04175834|579475049|FG000|Overall Study|Withdrawal by Subject|1|||
160476987|NCT04175834|579475050|FG001|Overall Study|Withdrawal by Subject|0|||
160476988|NCT01322347|579475051|FG000|Overall Study|Adverse Event|7|||
160476989|NCT01322347|579475052|FG001|Overall Study|Adverse Event|2|||
160476990|NCT01322347|579475051|FG000|Overall Study|Death|5|||
160476991|NCT01322347|579475052|FG001|Overall Study|Death|3|||
160476992|NCT01322347|579475051|FG000|Overall Study|Physician Decision|2|||
160476993|NCT01322347|579475052|FG001|Overall Study|Physician Decision|1|||
160476994|NCT01322347|579475051|FG000|Overall Study|Protocol Violation|5|||
160476995|NCT01322347|579475052|FG001|Overall Study|Protocol Violation|2|||
160476996|NCT01322347|579475051|FG000|Overall Study|Withdrawal by Subject|1|||
160476997|NCT01322347|579475052|FG001|Overall Study|Withdrawal by Subject|4|||
160476998|NCT01322347|579475051|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
160476999|NCT01322347|579475052|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
160477000|NCT01322347|579475051|FG000|Overall Study|blood transfusion|5|||
160477001|NCT01322347|579475052|FG001|Overall Study|blood transfusion|5|||
160477002|NCT01322347|579475051|FG000|Overall Study|sponsor decision|1|||
160477003|NCT01322347|579475052|FG001|Overall Study|sponsor decision|3|||
160477004|NCT01322347|579475051|FG000|Overall Study|ineligible|6|||
160477005|NCT01322347|579475052|FG001|Overall Study|ineligible|3|||
160477006|NCT01322347|579475051|FG000|Overall Study|kidney transplant|3|||
160477007|NCT01322347|579475052|FG001|Overall Study|kidney transplant|1|||
160477008|NCT01322347|579475051|FG000|Overall Study|study drug withheld > 12 wks|0|||
160477009|NCT01322347|579475052|FG001|Overall Study|study drug withheld > 12 wks|1|||
160477010|NCT01322347|579475051|FG000|Overall Study|moved/changed dialysis|2|||
160477011|NCT01322347|579475052|FG001|Overall Study|moved/changed dialysis|4|||
160477012|NCT01193283|579475053|FG000|Overall Study|Death|1|||
160477013|NCT04883541|579475054|FG000|Overall Study|Not attending regular yoga class|16|||
160477014|NCT04883541|579475055|FG001|Overall Study|Not attending regular yoga class|0|||
160477015|NCT04883541|579475054|FG000|Overall Study|Not attending the pregnancy school|0|||
160477016|NCT04883541|579475055|FG001|Overall Study|Not attending the pregnancy school|9|||
160477017|NCT04239911|579475056|FG000|Overall Study|Lost to Follow-up|2|||
160477018|NCT04239911|579475057|FG001|Overall Study|Lost to Follow-up|1|||
160477019|NCT02137785|579475058|FG000|Overall Study|Lost to Follow-up|1|||
160477020|NCT02137785|579475059|FG001|Overall Study|Lost to Follow-up|0|||
160477021|NCT02137785|579475058|FG000|Overall Study|Withdrawal by Subject|1|||
160477022|NCT02137785|579475059|FG001|Overall Study|Withdrawal by Subject|4|||
160477023|NCT02137785|579475058|FG000|Overall Study|subject moved out of state|1|||
160477024|NCT02137785|579475059|FG001|Overall Study|subject moved out of state|0|||
160477025|NCT03345407|579475061|FG000|Overall Study|Withdrawal by Subject|11|||
160603284|NCT00131664|579924426|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
160603285|NCT00131664|579924427|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
160603286|NCT00131664|579924428|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
160603287|NCT00131664|579924429|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
160603288|NCT00131664|579924424|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
160603289|NCT00131664|579924425|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
160603290|NCT00131664|579924426|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
160603291|NCT00131664|579924427|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
160603292|NCT00131664|579924428|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
160477026|NCT03345407|579475062|FG001|Overall Study|Withdrawal by Subject|1|||
160477027|NCT03345407|579475063|FG002|Overall Study|Withdrawal by Subject|5|||
160477028|NCT03345407|579475064|FG003|Overall Study|Withdrawal by Subject|6|||
160477029|NCT03345407|579475065|FG004|Overall Study|Withdrawal by Subject|3|||
160477030|NCT03345407|579475066|FG005|Overall Study|Withdrawal by Subject|6|||
160477031|NCT03345407|579475067|FG006|Overall Study|Withdrawal by Subject|16|||
160477032|NCT03345407|579475061|FG000|Overall Study|Physician Decision|3|||
160477033|NCT03345407|579475062|FG001|Overall Study|Physician Decision|1|||
160477034|NCT03345407|579475063|FG002|Overall Study|Physician Decision|0|||
160477035|NCT03345407|579475064|FG003|Overall Study|Physician Decision|0|||
160477036|NCT03345407|579475065|FG004|Overall Study|Physician Decision|1|||
160477037|NCT03345407|579475066|FG005|Overall Study|Physician Decision|2|||
160477038|NCT03345407|579475067|FG006|Overall Study|Physician Decision|3|||
160477039|NCT03345407|579475061|FG000|Overall Study|Lost to Follow-up|2|||
160477040|NCT03345407|579475062|FG001|Overall Study|Lost to Follow-up|0|||
160477041|NCT03345407|579475063|FG002|Overall Study|Lost to Follow-up|1|||
160477042|NCT03345407|579475064|FG003|Overall Study|Lost to Follow-up|0|||
160477043|NCT03345407|579475065|FG004|Overall Study|Lost to Follow-up|1|||
160477044|NCT03345407|579475066|FG005|Overall Study|Lost to Follow-up|2|||
160477045|NCT03345407|579475067|FG006|Overall Study|Lost to Follow-up|3|||
160477046|NCT03345407|579475061|FG000|Overall Study|Protocol-defined stopping criteria|9|||
160477047|NCT03345407|579475062|FG001|Overall Study|Protocol-defined stopping criteria|0|||
160477048|NCT03345407|579475063|FG002|Overall Study|Protocol-defined stopping criteria|0|||
160477049|NCT03345407|579475064|FG003|Overall Study|Protocol-defined stopping criteria|0|||
160477050|NCT03345407|579475065|FG004|Overall Study|Protocol-defined stopping criteria|2|||
160477051|NCT03345407|579475066|FG005|Overall Study|Protocol-defined stopping criteria|1|||
160477052|NCT03345407|579475067|FG006|Overall Study|Protocol-defined stopping criteria|1|||
160477053|NCT03345407|579475061|FG000|Overall Study|Protocol Violation|2|||
160477054|NCT03345407|579475062|FG001|Overall Study|Protocol Violation|0|||
160477055|NCT03345407|579475063|FG002|Overall Study|Protocol Violation|0|||
160477056|NCT03345407|579475064|FG003|Overall Study|Protocol Violation|0|||
160477057|NCT03345407|579475065|FG004|Overall Study|Protocol Violation|1|||
160477058|NCT03345407|579475066|FG005|Overall Study|Protocol Violation|0|||
160477059|NCT03345407|579475067|FG006|Overall Study|Protocol Violation|3|||
160477060|NCT03345407|579475061|FG000|Overall Study|Lack of Efficacy|1|||
160477061|NCT03345407|579475062|FG001|Overall Study|Lack of Efficacy|1|||
160477062|NCT03345407|579475063|FG002|Overall Study|Lack of Efficacy|1|||
160477063|NCT03345407|579475064|FG003|Overall Study|Lack of Efficacy|1|||
160477064|NCT03345407|579475065|FG004|Overall Study|Lack of Efficacy|1|||
160477065|NCT03345407|579475066|FG005|Overall Study|Lack of Efficacy|0|||
160477066|NCT03345407|579475067|FG006|Overall Study|Lack of Efficacy|3|||
160477067|NCT03345407|579475061|FG000|Overall Study|Adverse Event|4|||
160477068|NCT03345407|579475062|FG001|Overall Study|Adverse Event|0|||
160477069|NCT03345407|579475063|FG002|Overall Study|Adverse Event|5|||
160477070|NCT03345407|579475064|FG003|Overall Study|Adverse Event|4|||
160477071|NCT03345407|579475065|FG004|Overall Study|Adverse Event|6|||
160477072|NCT03345407|579475066|FG005|Overall Study|Adverse Event|5|||
160477073|NCT03345407|579475067|FG006|Overall Study|Adverse Event|16|||
160477074|NCT01584648|579475068|FG000|Overall Study|Death|136|||
160477075|NCT01584648|579475069|FG001|Overall Study|Death|146|||
160477076|NCT01584648|579475068|FG000|Overall Study|Lost to Follow-up|9|||
160477077|NCT01584648|579475069|FG001|Overall Study|Lost to Follow-up|9|||
160477078|NCT01584648|579475068|FG000|Overall Study|Investigator discretion|3|||
160477079|NCT01584648|579475069|FG001|Overall Study|Investigator discretion|2|||
160477080|NCT01584648|579475068|FG000|Overall Study|Withdrew consent|13|||
160477081|NCT01584648|579475069|FG001|Overall Study|Withdrew consent|4|||
160477082|NCT01584648|579475068|FG000|Overall Study|Study closed/terminated|50|||
160477083|NCT01584648|579475069|FG001|Overall Study|Study closed/terminated|23|||
160477084|NCT01584648|579475068|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
160477085|NCT01584648|579475069|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
160477086|NCT02256553|579475072|FG000|Period I|Adverse Event|5|||
160477087|NCT02256553|579475072|FG000|Period I|Protocol Violation|1|||
160477088|NCT02256553|579475072|FG000|Period II|Adverse Event|1|||
160477089|NCT02256553|579475072|FG000|Period II|Subject Moved|1|||
160477090|NCT02256553|579475072|FG000|Period III|Adverse Event|3|||
160477091|NCT01358175|579475075|FG000|Overall Study|Death|1|||
160477092|NCT01358175|579475076|FG001|Overall Study|Death|0|||
160477093|NCT01358175|579475077|FG002|Overall Study|Death|1|||
160477094|NCT01358175|579475075|FG000|Overall Study|Withdrawal by Subject|9|||
160477095|NCT01358175|579475076|FG001|Overall Study|Withdrawal by Subject|5|||
160477096|NCT01358175|579475077|FG002|Overall Study|Withdrawal by Subject|10|||
160477097|NCT01358175|579475075|FG000|Overall Study|Technical issues|0|||
160477098|NCT01358175|579475076|FG001|Overall Study|Technical issues|1|||
160477099|NCT01358175|579475077|FG002|Overall Study|Technical issues|0|||
160477100|NCT01358175|579475075|FG000|Overall Study|Pregnancy|0|||
160477101|NCT01358175|579475076|FG001|Overall Study|Pregnancy|1|||
160477102|NCT01358175|579475077|FG002|Overall Study|Pregnancy|0|||
160477103|NCT01358175|579475075|FG000|Overall Study|Physician Decision|1|||
160477104|NCT01358175|579475076|FG001|Overall Study|Physician Decision|0|||
160477105|NCT01358175|579475077|FG002|Overall Study|Physician Decision|0|||
160477106|NCT01358175|579475075|FG000|Overall Study|Non Compliance with Study Treatment|0|||
160477107|NCT01358175|579475076|FG001|Overall Study|Non Compliance with Study Treatment|1|||
160477108|NCT01358175|579475077|FG002|Overall Study|Non Compliance with Study Treatment|1|||
160477109|NCT01358175|579475075|FG000|Overall Study|Lost to Follow-up|1|||
160477110|NCT01358175|579475076|FG001|Overall Study|Lost to Follow-up|1|||
160477111|NCT01358175|579475077|FG002|Overall Study|Lost to Follow-up|3|||
160477112|NCT01358175|579475075|FG000|Overall Study|Lack of Efficacy|3|||
160477113|NCT01358175|579475076|FG001|Overall Study|Lack of Efficacy|8|||
160477114|NCT01358175|579475077|FG002|Overall Study|Lack of Efficacy|6|||
160477115|NCT01358175|579475075|FG000|Overall Study|Adverse Event|6|||
160477116|NCT01358175|579475076|FG001|Overall Study|Adverse Event|11|||
160477117|NCT01358175|579475077|FG002|Overall Study|Adverse Event|11|||
160477118|NCT00595959|579475078|FG000|Overall Study|Withdrawal by Subject|1|||
160477119|NCT00595959|579475078|FG000|Overall Study|Lost to Follow-up|1|||
160477120|NCT00886834|579475079|FG000|Overall Study|Protocol Violation|0|||
160477121|NCT00886834|579475080|FG001|Overall Study|Protocol Violation|3|||
160477122|NCT04085614|579475081|FG000|Overall Study|Protocol Violation|9|||
160477123|NCT04085614|579475082|FG001|Overall Study|Protocol Violation|6|||
160477124|NCT00476957|579475087|FG000|Overall Study|Lost to Follow-up|176|||
160477125|NCT00476957|579475088|FG001|Overall Study|Lost to Follow-up|193|||
160477126|NCT02516202|579475089|FG000|Overall Study|Withdrawal by Subject|1|||
160477127|NCT02516202|579475090|FG001|Overall Study|Withdrawal by Subject|0|||
160477128|NCT02516202|579475091|FG002|Overall Study|Withdrawal by Subject|1|||
160477129|NCT02516202|579475089|FG000|Overall Study|Lost to Follow-up|1|||
160477130|NCT02516202|579475090|FG001|Overall Study|Lost to Follow-up|1|||
160477131|NCT02516202|579475091|FG002|Overall Study|Lost to Follow-up|1|||
160477132|NCT02516202|579475089|FG000|Overall Study|Stopped Follow-up|0|||
160477133|NCT02516202|579475090|FG001|Overall Study|Stopped Follow-up|0|||
160477134|NCT02516202|579475091|FG002|Overall Study|Stopped Follow-up|1|||
160477135|NCT00409747|579475092|FG000|Overall Study|Withdrawal by Subject|1|||
160477136|NCT01000649|579475093|FG000|Overall Study|Adverse Event|5|||
160477137|NCT01000649|579475094|FG001|Overall Study|Adverse Event|1|||
160477138|NCT01000649|579475095|FG002|Overall Study|Adverse Event|2|||
160477139|NCT01000649|579475096|FG003|Overall Study|Adverse Event|4|||
160477140|NCT01000649|579475093|FG000|Overall Study|Lost to Follow-up|0|||
160477141|NCT01000649|579475094|FG001|Overall Study|Lost to Follow-up|2|||
160477142|NCT01000649|579475095|FG002|Overall Study|Lost to Follow-up|0|||
160477143|NCT01000649|579475096|FG003|Overall Study|Lost to Follow-up|2|||
160477144|NCT01916109|579475099|FG000|Overall Study|Withdrawal by Subject|1|||
160477145|NCT00103857|579475100|FG000|54-Week Base Study|Adverse Event|12|||
160477146|NCT00103857|579475101|FG001|54-Week Base Study|Adverse Event|9|||
160477147|NCT00103857|579475102|FG002|54-Week Base Study|Adverse Event|11|||
160477148|NCT00103857|579475103|FG003|54-Week Base Study|Adverse Event|6|||
160477149|NCT00103857|579475104|FG004|54-Week Base Study|Adverse Event|5|||
160477150|NCT00103857|579475105|FG005|54-Week Base Study|Adverse Event|11|||
160477151|NCT00103857|579475106|FG006|54-Week Base Study|Adverse Event|3|||
160477152|NCT00103857|579475100|FG000|54-Week Base Study|Death|0|||
160477153|NCT00103857|579475101|FG001|54-Week Base Study|Death|0|||
160477154|NCT00103857|579475102|FG002|54-Week Base Study|Death|0|||
160477155|NCT00103857|579475103|FG003|54-Week Base Study|Death|0|||
160477156|NCT00103857|579475104|FG004|54-Week Base Study|Death|1|||
160477157|NCT00103857|579475105|FG005|54-Week Base Study|Death|1|||
160477158|NCT00103857|579475106|FG006|54-Week Base Study|Death|0|||
160477159|NCT00103857|579475100|FG000|54-Week Base Study|Lack of Efficacy|11|||
160477160|NCT00103857|579475101|FG001|54-Week Base Study|Lack of Efficacy|14|||
160477161|NCT00103857|579475102|FG002|54-Week Base Study|Lack of Efficacy|8|||
160477162|NCT00103857|579475103|FG003|54-Week Base Study|Lack of Efficacy|4|||
160477163|NCT00103857|579475104|FG004|54-Week Base Study|Lack of Efficacy|3|||
160477164|NCT00103857|579475105|FG005|54-Week Base Study|Lack of Efficacy|14|||
160477165|NCT00103857|579475106|FG006|54-Week Base Study|Lack of Efficacy|19|||
160477166|NCT00103857|579475100|FG000|54-Week Base Study|Lost to Follow-up|5|||
160477167|NCT00103857|579475101|FG001|54-Week Base Study|Lost to Follow-up|4|||
160477168|NCT00103857|579475102|FG002|54-Week Base Study|Lost to Follow-up|7|||
160477169|NCT00103857|579475103|FG003|54-Week Base Study|Lost to Follow-up|5|||
160477170|NCT00103857|579475104|FG004|54-Week Base Study|Lost to Follow-up|10|||
160477171|NCT00103857|579475105|FG005|54-Week Base Study|Lost to Follow-up|9|||
160477172|NCT00103857|579475106|FG006|54-Week Base Study|Lost to Follow-up|3|||
160477173|NCT00103857|579475100|FG000|54-Week Base Study|Physician Decision|1|||
160477174|NCT00103857|579475101|FG001|54-Week Base Study|Physician Decision|1|||
160477175|NCT00103857|579475102|FG002|54-Week Base Study|Physician Decision|0|||
160477176|NCT00103857|579475103|FG003|54-Week Base Study|Physician Decision|0|||
160477177|NCT00103857|579475104|FG004|54-Week Base Study|Physician Decision|1|||
160477178|NCT00103857|579475105|FG005|54-Week Base Study|Physician Decision|0|||
160477179|NCT00103857|579475106|FG006|54-Week Base Study|Physician Decision|0|||
160477180|NCT00103857|579475100|FG000|54-Week Base Study|Pregnancy|1|||
160477181|NCT00103857|579475101|FG001|54-Week Base Study|Pregnancy|0|||
160477182|NCT00103857|579475102|FG002|54-Week Base Study|Pregnancy|0|||
160477183|NCT00103857|579475103|FG003|54-Week Base Study|Pregnancy|0|||
160477184|NCT00103857|579475104|FG004|54-Week Base Study|Pregnancy|1|||
160603293|NCT00131664|579924429|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
160603294|NCT00131664|579924424|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
160603295|NCT00131664|579924425|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
160603296|NCT00131664|579924426|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
160603297|NCT00131664|579924427|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
160603298|NCT00131664|579924428|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
160603299|NCT00131664|579924429|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
160603300|NCT00131664|579924424|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
160603301|NCT00131664|579924425|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
160603302|NCT00131664|579924426|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
160603303|NCT00131664|579924427|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
160603304|NCT00131664|579924428|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
160603305|NCT00131664|579924429|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
160603306|NCT00131664|579924424|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
160603307|NCT00131664|579924425|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
160603308|NCT00131664|579924426|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
160603309|NCT00131664|579924427|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
160603310|NCT00131664|579924428|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
160603311|NCT00131664|579924429|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
160603312|NCT00131664|579924424|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
160603313|NCT00131664|579924425|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
160603314|NCT00131664|579924426|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
160603315|NCT00131664|579924427|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
160603316|NCT00131664|579924428|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
160603317|NCT00131664|579924429|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
160603318|NCT00323310|579926641|FG000|Overall Study|Withdrawal by Subject|1|||
160603319|NCT00323310|579926641|FG000|Overall Study|a parent refused blood draw|1|||
160603320|NCT00323310|579926641|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
160603321|NCT03565991|579926642|FG000|Overall Study|Other|11|||
160603322|NCT03565991|579926643|FG001|Overall Study|Other|0|||
160603323|NCT03565991|579926642|FG000|Overall Study|Global deterioration of health status|14|||
160603324|NCT03565991|579926643|FG001|Overall Study|Global deterioration of health status|4|||
160603325|NCT03565991|579926642|FG000|Overall Study|Withdrawal by Subject|2|||
160603326|NCT03565991|579926643|FG001|Overall Study|Withdrawal by Subject|6|||
160603327|NCT03565991|579926642|FG000|Overall Study|Progressive disease|121|||
160603328|NCT03565991|579926643|FG001|Overall Study|Progressive disease|29|||
160603329|NCT03565991|579926642|FG000|Overall Study|Death|3|||
160603330|NCT03565991|579926643|FG001|Overall Study|Death|0|||
160603331|NCT03565991|579926642|FG000|Overall Study|Adverse Event|7|||
160603332|NCT03565991|579926643|FG001|Overall Study|Adverse Event|2|||
160603333|NCT02944513|579926644|FG000|Overall Study|Withdrawal by Subject|4|||
160603334|NCT02944513|579926645|FG001|Overall Study|Withdrawal by Subject|1|||
160603335|NCT00937326|579926646|FG000|Overall Study|Adverse Event|0|||
160603336|NCT00937326|579926647|FG001|Overall Study|Adverse Event|3|||
160603337|NCT00937326|579926648|FG002|Overall Study|Adverse Event|1|||
160603338|NCT00937326|579926649|FG003|Overall Study|Adverse Event|1|||
160603339|NCT00937326|579926650|FG004|Overall Study|Adverse Event|2|||
160603340|NCT00937326|579926646|FG000|Overall Study|Death|0|||
160603341|NCT00937326|579926647|FG001|Overall Study|Death|0|||
160603342|NCT00937326|579926648|FG002|Overall Study|Death|1|||
160603343|NCT00937326|579926649|FG003|Overall Study|Death|0|||
160603344|NCT00937326|579926650|FG004|Overall Study|Death|0|||
160603345|NCT00937326|579926646|FG000|Overall Study|Withdrawal by Subject|3|||
160603346|NCT00937326|579926647|FG001|Overall Study|Withdrawal by Subject|4|||
160603347|NCT00937326|579926648|FG002|Overall Study|Withdrawal by Subject|1|||
160603348|NCT00937326|579926649|FG003|Overall Study|Withdrawal by Subject|4|||
160603349|NCT00937326|579926650|FG004|Overall Study|Withdrawal by Subject|3|||
160603350|NCT00937326|579926646|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
160603351|NCT00937326|579926647|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
160603352|NCT00937326|579926648|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
160603353|NCT00937326|579926649|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
160603354|NCT00937326|579926650|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
160603355|NCT00790218|579926651|FG000|Overall Study|Death|1|||
160660494|NCT02724462|580139534|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
160603356|NCT00790218|579926652|FG001|Overall Study|Death|0|||
160603357|NCT00790218|579926653|FG002|Overall Study|Death|0|||
160603358|NCT04402385|579926659|FG000|Overall Study|Withdrawal by Subject|4|||
160477185|NCT00103857|579475105|FG005|54-Week Base Study|Pregnancy|0|||
160477186|NCT00103857|579475106|FG006|54-Week Base Study|Pregnancy|1|||
160477187|NCT00103857|579475100|FG000|54-Week Base Study|Protocol Violation|6|||
160477188|NCT00103857|579475101|FG001|54-Week Base Study|Protocol Violation|4|||
160477189|NCT00103857|579475102|FG002|54-Week Base Study|Protocol Violation|2|||
160477190|NCT00103857|579475103|FG003|54-Week Base Study|Protocol Violation|4|||
160477191|NCT00103857|579475104|FG004|54-Week Base Study|Protocol Violation|0|||
160477192|NCT00103857|579475105|FG005|54-Week Base Study|Protocol Violation|3|||
160477193|NCT00103857|579475106|FG006|54-Week Base Study|Protocol Violation|3|||
160477194|NCT00103857|579475100|FG000|54-Week Base Study|Withdrawal by Subject|17|||
160477195|NCT00103857|579475101|FG001|54-Week Base Study|Withdrawal by Subject|16|||
160477196|NCT00103857|579475102|FG002|54-Week Base Study|Withdrawal by Subject|16|||
160477197|NCT00103857|579475103|FG003|54-Week Base Study|Withdrawal by Subject|15|||
160477198|NCT00103857|579475104|FG004|54-Week Base Study|Withdrawal by Subject|10|||
160477199|NCT00103857|579475105|FG005|54-Week Base Study|Withdrawal by Subject|15|||
160477200|NCT00103857|579475106|FG006|54-Week Base Study|Withdrawal by Subject|4|||
160477201|NCT00103857|579475100|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
160477202|NCT00103857|579475101|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
160477203|NCT00103857|579475102|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
160477204|NCT00103857|579475103|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
160477205|NCT00103857|579475104|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
160477206|NCT00103857|579475105|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
160477207|NCT00103857|579475106|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
160477208|NCT00103857|579475100|FG000|54-Week Base Study|patient moved|0|||
160477209|NCT00103857|579475101|FG001|54-Week Base Study|patient moved|1|||
160477210|NCT00103857|579475102|FG002|54-Week Base Study|patient moved|1|||
160477211|NCT00103857|579475103|FG003|54-Week Base Study|patient moved|2|||
160477212|NCT00103857|579475104|FG004|54-Week Base Study|patient moved|3|||
160477213|NCT00103857|579475105|FG005|54-Week Base Study|patient moved|1|||
160477214|NCT00103857|579475106|FG006|54-Week Base Study|patient moved|0|||
160477215|NCT00103857|579475100|FG000|54-Week Base Study|non-compliance with study procedures|1|||
160477216|NCT00103857|579475101|FG001|54-Week Base Study|non-compliance with study procedures|2|||
160477217|NCT00103857|579475102|FG002|54-Week Base Study|non-compliance with study procedures|0|||
160477218|NCT00103857|579475103|FG003|54-Week Base Study|non-compliance with study procedures|0|||
160477219|NCT00103857|579475104|FG004|54-Week Base Study|non-compliance with study procedures|0|||
160477220|NCT00103857|579475105|FG005|54-Week Base Study|non-compliance with study procedures|2|||
160477221|NCT00103857|579475106|FG006|54-Week Base Study|non-compliance with study procedures|0|||
160477222|NCT00103857|579475100|FG000|54-Week Base Study|patient incarcerated|0|||
160477223|NCT00103857|579475101|FG001|54-Week Base Study|patient incarcerated|0|||
160477224|NCT00103857|579475102|FG002|54-Week Base Study|patient incarcerated|0|||
160477225|NCT00103857|579475103|FG003|54-Week Base Study|patient incarcerated|0|||
160477226|NCT00103857|579475104|FG004|54-Week Base Study|patient incarcerated|1|||
160477227|NCT00103857|579475105|FG005|54-Week Base Study|patient incarcerated|1|||
160477228|NCT00103857|579475106|FG006|54-Week Base Study|patient incarcerated|0|||
160477229|NCT00103857|579475100|FG000|54-Week Base Study|laboratory reporting error|0|||
160477230|NCT00103857|579475101|FG001|54-Week Base Study|laboratory reporting error|0|||
160477231|NCT00103857|579475102|FG002|54-Week Base Study|laboratory reporting error|0|||
160477232|NCT00103857|579475103|FG003|54-Week Base Study|laboratory reporting error|0|||
160477233|NCT00103857|579475104|FG004|54-Week Base Study|laboratory reporting error|1|||
160477234|NCT00103857|579475105|FG005|54-Week Base Study|laboratory reporting error|0|||
160477235|NCT00103857|579475106|FG006|54-Week Base Study|laboratory reporting error|0|||
160477236|NCT00103857|579475100|FG000|54-Week Base Study|site error|0|||
160477237|NCT00103857|579475101|FG001|54-Week Base Study|site error|0|||
160477238|NCT00103857|579475102|FG002|54-Week Base Study|site error|0|||
160477239|NCT00103857|579475103|FG003|54-Week Base Study|site error|0|||
160477240|NCT00103857|579475104|FG004|54-Week Base Study|site error|0|||
160477241|NCT00103857|579475105|FG005|54-Week Base Study|site error|1|||
160477242|NCT00103857|579475106|FG006|54-Week Base Study|site error|0|||
160477243|NCT00103857|579475100|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
160477244|NCT00103857|579475101|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
160477245|NCT00103857|579475102|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
160603359|NCT04402385|579926660|FG001|Overall Study|Withdrawal by Subject|4|||
160603360|NCT04402385|579926659|FG000|Overall Study|Lost to Follow-up|1|||
160603361|NCT04402385|579926660|FG001|Overall Study|Lost to Follow-up|1|||
160603362|NCT04402385|579926659|FG000|Overall Study|Physician Decision|0|||
160477246|NCT00103857|579475103|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
160477247|NCT00103857|579475104|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
160477248|NCT00103857|579475105|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
160477249|NCT00103857|579475106|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
160477250|NCT00103857|579475100|FG000|50-Week Extension Study|Adverse Event|2|||
160477251|NCT00103857|579475101|FG001|50-Week Extension Study|Adverse Event|3|||
160477252|NCT00103857|579475102|FG002|50-Week Extension Study|Adverse Event|2|||
160603363|NCT04402385|579926660|FG001|Overall Study|Physician Decision|1|||
160477253|NCT00103857|579475103|FG003|50-Week Extension Study|Adverse Event|0|||
160477254|NCT00103857|579475104|FG004|50-Week Extension Study|Adverse Event|1|||
160477255|NCT00103857|579475105|FG005|50-Week Extension Study|Adverse Event|1|||
160477256|NCT00103857|579475106|FG006|50-Week Extension Study|Adverse Event|0|||
160477257|NCT00103857|579475100|FG000|50-Week Extension Study|Death|0|||
160477258|NCT00103857|579475101|FG001|50-Week Extension Study|Death|0|||
160477259|NCT00103857|579475102|FG002|50-Week Extension Study|Death|0|||
160477260|NCT00103857|579475103|FG003|50-Week Extension Study|Death|1|||
160477261|NCT00103857|579475104|FG004|50-Week Extension Study|Death|0|||
160477262|NCT00103857|579475105|FG005|50-Week Extension Study|Death|1|||
160477263|NCT00103857|579475106|FG006|50-Week Extension Study|Death|0|||
160477264|NCT00103857|579475100|FG000|50-Week Extension Study|Lack of Efficacy|26|||
160477265|NCT00103857|579475101|FG001|50-Week Extension Study|Lack of Efficacy|15|||
160477266|NCT00103857|579475102|FG002|50-Week Extension Study|Lack of Efficacy|13|||
160477267|NCT00103857|579475103|FG003|50-Week Extension Study|Lack of Efficacy|16|||
160477268|NCT00103857|579475104|FG004|50-Week Extension Study|Lack of Efficacy|8|||
160477269|NCT00103857|579475105|FG005|50-Week Extension Study|Lack of Efficacy|8|||
160477270|NCT00103857|579475106|FG006|50-Week Extension Study|Lack of Efficacy|0|||
160477271|NCT00103857|579475100|FG000|50-Week Extension Study|Lost to Follow-up|4|||
160477272|NCT00103857|579475101|FG001|50-Week Extension Study|Lost to Follow-up|0|||
160477273|NCT00103857|579475102|FG002|50-Week Extension Study|Lost to Follow-up|1|||
160477274|NCT00103857|579475103|FG003|50-Week Extension Study|Lost to Follow-up|4|||
160477275|NCT00103857|579475104|FG004|50-Week Extension Study|Lost to Follow-up|3|||
160477276|NCT00103857|579475105|FG005|50-Week Extension Study|Lost to Follow-up|3|||
160477277|NCT00103857|579475106|FG006|50-Week Extension Study|Lost to Follow-up|0|||
160477278|NCT00103857|579475100|FG000|50-Week Extension Study|Physician Decision|0|||
160477279|NCT00103857|579475101|FG001|50-Week Extension Study|Physician Decision|1|||
160477280|NCT00103857|579475102|FG002|50-Week Extension Study|Physician Decision|1|||
160477281|NCT00103857|579475103|FG003|50-Week Extension Study|Physician Decision|0|||
160603364|NCT00731666|579926661|FG000|Overall Study|Adverse Event|2|||
160603365|NCT00731666|579926661|FG000|Overall Study|Lost to Follow-up|8|||
160603366|NCT00731666|579926661|FG000|Overall Study|Withdrawal by Subject|2|||
160603367|NCT03250624|579926663|FG000|Overall Study|Lack of Efficacy|1|||
160603368|NCT03250624|579926664|FG001|Overall Study|Lack of Efficacy|4|||
160603369|NCT03250624|579926663|FG000|Overall Study|Adverse Event|0|||
160603370|NCT03250624|579926664|FG001|Overall Study|Adverse Event|1|||
160477282|NCT00103857|579475104|FG004|50-Week Extension Study|Physician Decision|0|||
160477283|NCT00103857|579475105|FG005|50-Week Extension Study|Physician Decision|0|||
160477284|NCT00103857|579475106|FG006|50-Week Extension Study|Physician Decision|0|||
160477285|NCT00103857|579475100|FG000|50-Week Extension Study|Pregnancy|0|||
160603371|NCT03250624|579926663|FG000|Overall Study|Other|1|||
160603372|NCT03250624|579926664|FG001|Overall Study|Other|2|||
160603373|NCT00948428|579926665|FG000|Overall Study|Withdrawal by Subject|6|||
160603374|NCT00948428|579926666|FG001|Overall Study|Withdrawal by Subject|12|||
160603375|NCT00948428|579926667|FG002|Overall Study|Withdrawal by Subject|7|||
160477286|NCT00103857|579475101|FG001|50-Week Extension Study|Pregnancy|0|||
160477287|NCT00103857|579475102|FG002|50-Week Extension Study|Pregnancy|1|||
160477288|NCT00103857|579475103|FG003|50-Week Extension Study|Pregnancy|0|||
160477289|NCT00103857|579475104|FG004|50-Week Extension Study|Pregnancy|1|||
160603376|NCT00948428|579926665|FG000|Overall Study|Adverse Event|6|||
160603377|NCT00948428|579926666|FG001|Overall Study|Adverse Event|3|||
160477290|NCT00103857|579475105|FG005|50-Week Extension Study|Pregnancy|0|||
160603378|NCT00948428|579926667|FG002|Overall Study|Adverse Event|0|||
160603379|NCT00948428|579926665|FG000|Overall Study|Lost to Follow-up|2|||
160603380|NCT00948428|579926666|FG001|Overall Study|Lost to Follow-up|1|||
160603381|NCT00948428|579926667|FG002|Overall Study|Lost to Follow-up|1|||
160603382|NCT00948428|579926665|FG000|Overall Study|Death|2|||
160603383|NCT00948428|579926666|FG001|Overall Study|Death|0|||
160603384|NCT00948428|579926667|FG002|Overall Study|Death|0|||
160603385|NCT00948428|579926665|FG000|Overall Study|Intercurrent Illness|1|||
160603386|NCT00948428|579926666|FG001|Overall Study|Intercurrent Illness|0|||
160603387|NCT00948428|579926667|FG002|Overall Study|Intercurrent Illness|0|||
160603388|NCT00948428|579926665|FG000|Overall Study|Non-compliance|1|||
160603389|NCT00948428|579926666|FG001|Overall Study|Non-compliance|2|||
160603390|NCT00948428|579926667|FG002|Overall Study|Non-compliance|0|||
160603391|NCT01843205|579926678|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
160603392|NCT01843205|579926679|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
160603393|NCT00606177|579926680|FG000|Overall Study|Adverse Event|9|||
160603394|NCT00606177|579926681|FG001|Overall Study|Adverse Event|5|||
160603395|NCT00606177|579926680|FG000|Overall Study|Lack of Efficacy|3|||
160603396|NCT00606177|579926681|FG001|Overall Study|Lack of Efficacy|7|||
160603397|NCT00606177|579926680|FG000|Overall Study|Physician Decision|1|||
160603398|NCT00606177|579926681|FG001|Overall Study|Physician Decision|0|||
160603399|NCT00606177|579926680|FG000|Overall Study|Protocol Violation|1|||
160603400|NCT00606177|579926681|FG001|Overall Study|Protocol Violation|4|||
160603401|NCT00606177|579926680|FG000|Overall Study|Withdrawal by Subject|5|||
160603402|NCT00606177|579926681|FG001|Overall Study|Withdrawal by Subject|6|||
160603403|NCT00606177|579926680|FG000|Overall Study|Progression to depressive phase|6|||
160603404|NCT00606177|579926681|FG001|Overall Study|Progression to depressive phase|1|||
160603405|NCT00606177|579926680|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
160603406|NCT00606177|579926681|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
160603407|NCT00606177|579926680|FG000|Overall Study|Change of residence or other commitments|1|||
160603408|NCT00606177|579926681|FG001|Overall Study|Change of residence or other commitments|1|||
160603409|NCT00136357|579926682|FG000|Overall Study|Withdrawal by Subject|3|||
160603410|NCT00136357|579926683|FG001|Overall Study|Withdrawal by Subject|2|||
160603411|NCT01518309|579926688|FG000|Overall Study|Adverse Event|6|||
160603412|NCT01518309|579926688|FG000|Overall Study|Death|6|||
160603413|NCT01518309|579926688|FG000|Overall Study|Lack of Efficacy|7|||
160603414|NCT01518309|579926688|FG000|Overall Study|Withdrawal by Subject|6|||
160603415|NCT01518309|579926688|FG000|Overall Study|Physician Decision|3|||
160603416|NCT01518309|579926688|FG000|Overall Study|Sponsor Decision|2|||
160603417|NCT01518309|579926688|FG000|Overall Study|Not in Predefined Categories|9|||
160603418|NCT02603172|579926689|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
160603419|NCT02603172|579926690|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
160603420|NCT02603172|579926691|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
160603421|NCT02603172|579926692|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
160603422|NCT02603172|579926693|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
160603423|NCT02603172|579926694|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
160603424|NCT02603172|579926695|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
160603425|NCT02603172|579926696|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
160603426|NCT00863317|579926697|FG000|Overall Study|Lost to Follow-up|8|||
160603427|NCT00863317|579926698|FG001|Overall Study|Lost to Follow-up|9|||
160603428|NCT00038142|579926701|FG000|Overall Study|Ineligible|1|||
160603429|NCT00038142|579926702|FG001|Overall Study|Ineligible|0|||
160603430|NCT00038142|579926701|FG000|Overall Study|Progressive Disease|11|||
160477291|NCT00103857|579475106|FG006|50-Week Extension Study|Pregnancy|0|||
160477292|NCT00103857|579475100|FG000|50-Week Extension Study|Protocol Violation|1|||
160477293|NCT00103857|579475101|FG001|50-Week Extension Study|Protocol Violation|1|||
160477294|NCT00103857|579475102|FG002|50-Week Extension Study|Protocol Violation|1|||
160477295|NCT00103857|579475103|FG003|50-Week Extension Study|Protocol Violation|2|||
160477296|NCT00103857|579475104|FG004|50-Week Extension Study|Protocol Violation|0|||
160477297|NCT00103857|579475105|FG005|50-Week Extension Study|Protocol Violation|1|||
160477298|NCT00103857|579475106|FG006|50-Week Extension Study|Protocol Violation|0|||
160477299|NCT00103857|579475100|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
160477300|NCT00103857|579475101|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
160477301|NCT00103857|579475102|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
160477302|NCT00103857|579475103|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
160477303|NCT00103857|579475104|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
160477304|NCT00103857|579475105|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
160477305|NCT00103857|579475106|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
160477306|NCT00103857|579475100|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
160477307|NCT00103857|579475101|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
160477308|NCT00103857|579475102|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
160477309|NCT00103857|579475103|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
160477310|NCT00103857|579475104|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
160477311|NCT00103857|579475105|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
160477312|NCT00103857|579475106|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
160477313|NCT00103857|579475100|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
160477314|NCT00103857|579475101|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
160477315|NCT00103857|579475102|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
160477316|NCT00103857|579475103|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
160477317|NCT00103857|579475104|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
160477318|NCT00103857|579475105|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
160477319|NCT00103857|579475106|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
160477320|NCT00103857|579475100|FG000|50-Week Extension Study|patient moved|0|||
160477321|NCT00103857|579475101|FG001|50-Week Extension Study|patient moved|0|||
160477322|NCT00103857|579475102|FG002|50-Week Extension Study|patient moved|1|||
160477323|NCT00103857|579475103|FG003|50-Week Extension Study|patient moved|2|||
160477324|NCT00103857|579475104|FG004|50-Week Extension Study|patient moved|0|||
160477325|NCT00103857|579475105|FG005|50-Week Extension Study|patient moved|0|||
160477326|NCT00103857|579475106|FG006|50-Week Extension Study|patient moved|0|||
160477327|NCT00103857|579475100|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
160477328|NCT00103857|579475101|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
160477329|NCT00103857|579475102|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
160477330|NCT00103857|579475103|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
160477331|NCT00103857|579475104|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
160477332|NCT00103857|579475105|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
160477333|NCT00103857|579475106|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
160477334|NCT00103857|579475100|FG000|50-Week Extension Study|reason unspecified|0|||
160477335|NCT00103857|579475101|FG001|50-Week Extension Study|reason unspecified|0|||
160477336|NCT00103857|579475102|FG002|50-Week Extension Study|reason unspecified|0|||
160477337|NCT00103857|579475103|FG003|50-Week Extension Study|reason unspecified|0|||
160477338|NCT00103857|579475104|FG004|50-Week Extension Study|reason unspecified|1|||
160477339|NCT00103857|579475105|FG005|50-Week Extension Study|reason unspecified|0|||
160477340|NCT00103857|579475106|FG006|50-Week Extension Study|reason unspecified|0|||
160477341|NCT03347396|579475107|FG000|Part A (26 Weeks)|Adverse Event|1|||
160477342|NCT03347396|579475108|FG001|Part A (26 Weeks)|Adverse Event|0|||
160477343|NCT03347396|579475107|FG000|Part A (26 Weeks)|Death|0|||
160477344|NCT03347396|579475108|FG001|Part A (26 Weeks)|Death|1|||
160477345|NCT03347396|579475107|FG000|Part B (149 Weeks)|Adverse Event|1|||
160477346|NCT03347396|579475108|FG001|Part B (149 Weeks)|Adverse Event|1|||
160477347|NCT03347396|579475107|FG000|Part B (149 Weeks)|Death|1|||
160477348|NCT03347396|579475108|FG001|Part B (149 Weeks)|Death|0|||
160477349|NCT02312258|579475111|FG000|Overall Study|Lost to Follow-up|8|||
160477350|NCT02312258|579475112|FG001|Overall Study|Lost to Follow-up|8|||
160477351|NCT02312258|579475111|FG000|Overall Study|Withdrawal by Patient|49|||
160477352|NCT02312258|579475112|FG001|Overall Study|Withdrawal by Patient|76|||
160477353|NCT02312258|579475111|FG000|Overall Study|Reason not Specified|107|||
160477354|NCT02312258|579475112|FG001|Overall Study|Reason not Specified|159|||
160477355|NCT02312258|579475111|FG000|Overall Study|Missing|2|||
160477356|NCT02312258|579475112|FG001|Overall Study|Missing|1|||
160477357|NCT02312258|579475111|FG000|Overall Study|Death|115|||
160477358|NCT02312258|579475112|FG001|Overall Study|Death|181|||
160477359|NCT01697956|579475113|FG000|Overall Study|Protocol Violation|1|||
160477360|NCT01697956|579475114|FG001|Overall Study|Protocol Violation|1|||
160477361|NCT01970527|579475115|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
160477362|NCT01970527|579475116|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
160477363|NCT01970527|579475115|FG000|Treatment|Disease progression|0|||
160477364|NCT01970527|579475116|FG001|Treatment|Disease progression|1|||
160477365|NCT01970527|579475115|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
160477366|NCT01970527|579475116|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
160477367|NCT01970527|579475115|FG000|Treatment|Death|0|||
160477368|NCT01970527|579475116|FG001|Treatment|Death|1|||
160477369|NCT01970527|579475115|FG000|Follow-up Clinic Visit|Disease progression|1|||
160477370|NCT01970527|579475116|FG001|Follow-up Clinic Visit|Disease progression|1|||
160477371|NCT01970527|579475115|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
160477372|NCT01970527|579475116|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
160477373|NCT01970527|579475115|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
160477374|NCT01970527|579475116|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
160477375|NCT03060525|579475117|FG000|Overall Study|moved out of state|1|||
160477376|NCT03060525|579475118|FG001|Overall Study|moved out of state|1|||
160477377|NCT03060525|579475119|FG002|Overall Study|moved out of state|1|||
160477378|NCT03060525|579475120|FG003|Overall Study|moved out of state|1|||
160477379|NCT03060525|579475117|FG000|Overall Study|unable to meet time commitment required of study|2|||
160477380|NCT03060525|579475118|FG001|Overall Study|unable to meet time commitment required of study|3|||
160477381|NCT03060525|579475119|FG002|Overall Study|unable to meet time commitment required of study|3|||
160477382|NCT03060525|579475120|FG003|Overall Study|unable to meet time commitment required of study|1|||
160477383|NCT03060525|579475117|FG000|Overall Study|no longer interested in doing intervention|0|||
160477384|NCT03060525|579475118|FG001|Overall Study|no longer interested in doing intervention|0|||
160477385|NCT03060525|579475119|FG002|Overall Study|no longer interested in doing intervention|0|||
160477386|NCT03060525|579475120|FG003|Overall Study|no longer interested in doing intervention|1|||
160477387|NCT01964547|579475121|FG000|Overall Study|Adverse Event|8|||
160477388|NCT01964547|579475122|FG001|Overall Study|Adverse Event|2|||
160477389|NCT01964547|579475121|FG000|Overall Study|Withdrawal by Subject|4|||
160477390|NCT01964547|579475122|FG001|Overall Study|Withdrawal by Subject|7|||
160477391|NCT01964547|579475121|FG000|Overall Study|Lost to Follow-up|0|||
160477392|NCT01964547|579475122|FG001|Overall Study|Lost to Follow-up|1|||
160477393|NCT01964547|579475121|FG000|Overall Study|Withdrawal by Investigator|0|||
160477394|NCT01964547|579475122|FG001|Overall Study|Withdrawal by Investigator|1|||
160477395|NCT01115309|579475123|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
160477396|NCT01115309|579475123|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
160477397|NCT01115309|579475123|FG000|Long-term Follow-up|Lost to Follow-up|6|||
160477398|NCT02147093|579475126|FG000|Period 1|Lost to Follow-up|0|||
160477399|NCT02147093|579475127|FG001|Period 1|Lost to Follow-up|1|||
160477400|NCT02147093|579475126|FG000|Period 2|Protocol Violation|2|||
160477401|NCT02147093|579475127|FG001|Period 2|Protocol Violation|0|||
160477402|NCT03246724|579475128|FG000|Overall Study|Withdrawal by Subject|5|||
160477403|NCT03246724|579475129|FG001|Overall Study|Withdrawal by Subject|2|||
160477404|NCT03246724|579475130|FG002|Overall Study|Withdrawal by Subject|4|||
160603431|NCT00038142|579926702|FG001|Overall Study|Progressive Disease|7|||
160477405|NCT03246724|579475131|FG003|Overall Study|Withdrawal by Subject|2|||
160603432|NCT00038142|579926701|FG000|Overall Study|Death|1|||
160660495|NCT02724462|580139535|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
160660496|NCT02724462|580139534|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
160660497|NCT02724462|580139535|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
160660498|NCT02724462|580139534|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
160660499|NCT02724462|580139535|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
160660500|NCT02724462|580139534|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
160660501|NCT02724462|580139535|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
160660502|NCT02724462|580139534|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
160660503|NCT02724462|580139535|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
160660504|NCT00469417|580139536|FG000|Overall Study|Treatment failure all lesions|18|||
160660505|NCT00469417|580139537|FG001|Overall Study|Treatment failure all lesions|11|||
160660506|NCT00469417|580139536|FG000|Overall Study|Consent withdrawn|1|||
160660507|NCT00469417|580139537|FG001|Overall Study|Consent withdrawn|1|||
160660508|NCT00469417|580139536|FG000|Overall Study|Adverse Event|8|||
160660509|NCT00469417|580139537|FG001|Overall Study|Adverse Event|2|||
160660510|NCT00469417|580139536|FG000|Overall Study|Lost to Follow-up|1|||
160660511|NCT00469417|580139537|FG001|Overall Study|Lost to Follow-up|2|||
160660512|NCT00469417|580139536|FG000|Overall Study|Intercurrent disease|0|||
160660513|NCT00469417|580139537|FG001|Overall Study|Intercurrent disease|1|||
160660514|NCT00469417|580139536|FG000|Overall Study|Randomized but not treated|2|||
160660515|NCT00469417|580139537|FG001|Overall Study|Randomized but not treated|0|||
160660516|NCT02188303|580139538|FG000|Overall Study|Adverse Event|0|||
160660517|NCT02188303|580139539|FG001|Overall Study|Adverse Event|0|||
160660518|NCT02188303|580139540|FG002|Overall Study|Adverse Event|0|||
160603433|NCT00038142|579926702|FG001|Overall Study|Death|0|||
160603434|NCT00038142|579926701|FG000|Overall Study|Adverse Event|1|||
160603435|NCT00038142|579926702|FG001|Overall Study|Adverse Event|0|||
160477406|NCT03246724|579475128|FG000|Overall Study|Ineligible on day of surgery|7|||
160477407|NCT03246724|579475129|FG001|Overall Study|Ineligible on day of surgery|2|||
160477408|NCT03246724|579475130|FG002|Overall Study|Ineligible on day of surgery|0|||
160477409|NCT03246724|579475131|FG003|Overall Study|Ineligible on day of surgery|3|||
160477410|NCT03246724|579475128|FG000|Overall Study|Study completed before surgical date|2|||
160477411|NCT03246724|579475129|FG001|Overall Study|Study completed before surgical date|1|||
160477412|NCT03246724|579475130|FG002|Overall Study|Study completed before surgical date|8|||
160477413|NCT03246724|579475131|FG003|Overall Study|Study completed before surgical date|1|||
160477414|NCT03246724|579475128|FG000|Overall Study|Transferred to other arm|0|||
160477415|NCT03246724|579475129|FG001|Overall Study|Transferred to other arm|0|||
160477416|NCT03246724|579475130|FG002|Overall Study|Transferred to other arm|1|||
160477417|NCT03246724|579475131|FG003|Overall Study|Transferred to other arm|0|||
160477418|NCT03246724|579475128|FG000|Overall Study|Unable to obtain medication timely|0|||
160477419|NCT03246724|579475129|FG001|Overall Study|Unable to obtain medication timely|2|||
160477420|NCT03246724|579475130|FG002|Overall Study|Unable to obtain medication timely|2|||
160477421|NCT03246724|579475131|FG003|Overall Study|Unable to obtain medication timely|1|||
160477422|NCT03246724|579475128|FG000|Overall Study|Re-consented to participate|0|||
160477423|NCT03246724|579475129|FG001|Overall Study|Re-consented to participate|0|||
160477424|NCT03246724|579475130|FG002|Overall Study|Re-consented to participate|0|||
160477425|NCT03246724|579475131|FG003|Overall Study|Re-consented to participate|1|||
160477426|NCT00655824|579475132|FG000|Overall Study|Adverse Event|3|||
160477427|NCT00655824|579475132|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
160477428|NCT00655824|579475132|FG000|Overall Study|Protocol Violation|1|||
160477429|NCT00655824|579475132|FG000|Overall Study|Withdrawal by Subject|4|||
160477430|NCT00655824|579475132|FG000|Overall Study|Deterioration of Trial Disease|2|||
160477431|NCT00589628|579475133|FG000|Overall Study|Lost to Follow-up|0|||
160477432|NCT00589628|579475134|FG001|Overall Study|Lost to Follow-up|1|||
160477433|NCT02189759|579475137|FG000|Overall Study|Lost to Follow-up|0|||
160477434|NCT02189759|579475138|FG001|Overall Study|Lost to Follow-up|0|||
160603436|NCT00038142|579926701|FG000|Overall Study|Unknown Reason|8|||
160603437|NCT00038142|579926702|FG001|Overall Study|Unknown Reason|0|||
160603438|NCT00441727|579926703|FG000|Overall Study|Protocol Violation|19|||
160603439|NCT00441727|579926704|FG001|Overall Study|Protocol Violation|28|||
160603440|NCT00441727|579926705|FG002|Overall Study|Protocol Violation|32|||
160603441|NCT00441727|579926703|FG000|Overall Study|Adverse Event|26|||
160603442|NCT00441727|579926704|FG001|Overall Study|Adverse Event|33|||
160603443|NCT00441727|579926705|FG002|Overall Study|Adverse Event|28|||
160603444|NCT00441727|579926703|FG000|Overall Study|Lack of Efficacy|7|||
160603445|NCT00441727|579926704|FG001|Overall Study|Lack of Efficacy|8|||
160603446|NCT00441727|579926705|FG002|Overall Study|Lack of Efficacy|48|||
160603447|NCT00441727|579926703|FG000|Overall Study|Withdrawal by Subject|40|||
160603448|NCT00441727|579926704|FG001|Overall Study|Withdrawal by Subject|34|||
160603449|NCT00441727|579926705|FG002|Overall Study|Withdrawal by Subject|47|||
160603450|NCT00441727|579926703|FG000|Overall Study|Lost to Follow-up|5|||
160603451|NCT00441727|579926704|FG001|Overall Study|Lost to Follow-up|6|||
160603452|NCT00441727|579926705|FG002|Overall Study|Lost to Follow-up|5|||
160603453|NCT00441727|579926703|FG000|Overall Study|Safety Reasons|3|||
160603454|NCT00441727|579926704|FG001|Overall Study|Safety Reasons|1|||
160603455|NCT00441727|579926705|FG002|Overall Study|Safety Reasons|3|||
160603456|NCT00441727|579926703|FG000|Overall Study|Various reason specified|6|||
160603457|NCT00441727|579926704|FG001|Overall Study|Various reason specified|8|||
160603458|NCT00441727|579926705|FG002|Overall Study|Various reason specified|5|||
160603459|NCT02133001|579926710|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
160603460|NCT02133001|579926711|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
160603461|NCT02133001|579926710|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
160603462|NCT02133001|579926711|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
160603463|NCT02133001|579926710|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
160603464|NCT02133001|579926711|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
160603465|NCT02133001|579926710|FG000|Double Blind (Day 1-25)|Other|2|||
160603466|NCT02133001|579926711|FG001|Double Blind (Day 1-25)|Other|2|||
160603467|NCT02133001|579926710|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
160603468|NCT02133001|579926711|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
160603469|NCT02133001|579926710|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
160603470|NCT02133001|579926711|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
160603471|NCT02133001|579926710|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
160603472|NCT02133001|579926711|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
160603473|NCT02133001|579926710|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
160603474|NCT02133001|579926711|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
160603475|NCT04211961|579926712|FG000|Overall Study|Death|0|||
160603476|NCT04211961|579926713|FG001|Overall Study|Death|1|||
160603477|NCT04211961|579926712|FG000|Overall Study|Lost to Follow-up|0|||
160477435|NCT02189759|579475139|FG002|Overall Study|Lost to Follow-up|2|||
160477436|NCT02189759|579475140|FG003|Overall Study|Lost to Follow-up|5|||
160477437|NCT03032198|579475141|FG000|Overall Study|Screen Fail|1|||
160603478|NCT04211961|579926713|FG001|Overall Study|Lost to Follow-up|1|||
160603479|NCT04211961|579926712|FG000|Overall Study|Withdrawal by Subject|0|||
160477438|NCT02470806|579475142|FG000|Overall Study|Lost to Follow-up|1|||
160477439|NCT02470806|579475143|FG001|Overall Study|Lost to Follow-up|1|||
160477440|NCT02470806|579475142|FG000|Overall Study|Adverse Event|5|||
160477441|NCT02470806|579475143|FG001|Overall Study|Adverse Event|2|||
160477442|NCT02470806|579475142|FG000|Overall Study|Protocol Violation|4|||
160477443|NCT02470806|579475143|FG001|Overall Study|Protocol Violation|11|||
160477444|NCT02470806|579475142|FG000|Overall Study|Physician Decision|0|||
160477445|NCT02470806|579475143|FG001|Overall Study|Physician Decision|3|||
160477446|NCT02470806|579475142|FG000|Overall Study|Withdrawal by Subject|3|||
160477447|NCT02470806|579475143|FG001|Overall Study|Withdrawal by Subject|10|||
160477448|NCT02470806|579475142|FG000|Overall Study|Lack of Efficacy|5|||
160477449|NCT02470806|579475143|FG001|Overall Study|Lack of Efficacy|15|||
160477450|NCT02892019|579475148|FG000|Overall Study|randomized but not treated|0|||
160477451|NCT02892019|579475149|FG001|Overall Study|randomized but not treated|1|||
160477452|NCT02892019|579475148|FG000|Overall Study|Withdrawal by Subject|0|||
160477453|NCT02892019|579475149|FG001|Overall Study|Withdrawal by Subject|1|||
160477454|NCT02892019|579475148|FG000|Overall Study|Adverse Event|1|||
160477455|NCT02892019|579475149|FG001|Overall Study|Adverse Event|1|||
160477456|NCT03890484|579475150|FG000|Overall Study|Lost to Follow-up|1|||
160477457|NCT03890484|579475151|FG001|Overall Study|Lost to Follow-up|1|||
160603480|NCT04211961|579926713|FG001|Overall Study|Withdrawal by Subject|1|||
160603481|NCT00420342|579926716|FG000|Overall Study|Lost to Follow-up|1|||
160603482|NCT00420342|579926717|FG001|Overall Study|Lost to Follow-up|0|||
160603483|NCT00420342|579926718|FG002|Overall Study|Lost to Follow-up|1|||
160603484|NCT00420342|579926716|FG000|Overall Study|Withdrawal by Subject|0|||
160603485|NCT00420342|579926717|FG001|Overall Study|Withdrawal by Subject|2|||
160603486|NCT00420342|579926718|FG002|Overall Study|Withdrawal by Subject|0|||
160603487|NCT04072575|579926725|FG000|Overall Study|Physician Decision|1|||
160603488|NCT04072575|579926725|FG000|Overall Study|Adverse Event|7|||
160603489|NCT04072575|579926725|FG000|Overall Study|Withdrawal by Subject|14|||
160603490|NCT04072575|579926725|FG000|Overall Study|Other|2|||
160603491|NCT00114218|579926728|FG000|Overall Study|Wrong Cell Type|2|||
160603492|NCT00114218|579926728|FG000|Overall Study|Wrong Primary|1|||
160603493|NCT00114218|579926728|FG000|Overall Study|Never Treated|1|||
160603494|NCT01505114|579926729|FG000|Overall Study|Withdrawal by Subject|5|||
160603495|NCT01505114|579926730|FG001|Overall Study|Withdrawal by Subject|4|||
160603496|NCT01505114|579926731|FG002|Overall Study|Withdrawal by Subject|4|||
160603497|NCT01505114|579926732|FG003|Overall Study|Withdrawal by Subject|7|||
160603498|NCT01505114|579926729|FG000|Overall Study|Death|1|||
160603499|NCT01505114|579926730|FG001|Overall Study|Death|0|||
160603500|NCT01505114|579926731|FG002|Overall Study|Death|0|||
160603501|NCT01505114|579926732|FG003|Overall Study|Death|1|||
160603502|NCT01505114|579926729|FG000|Overall Study|unable to adhere to visit schedule|3|||
160603503|NCT01505114|579926730|FG001|Overall Study|unable to adhere to visit schedule|2|||
160603504|NCT01505114|579926731|FG002|Overall Study|unable to adhere to visit schedule|3|||
160603505|NCT01505114|579926732|FG003|Overall Study|unable to adhere to visit schedule|3|||
160603506|NCT01505114|579926729|FG000|Overall Study|Lost to Follow-up|11|||
160603507|NCT01505114|579926730|FG001|Overall Study|Lost to Follow-up|5|||
160603508|NCT01505114|579926731|FG002|Overall Study|Lost to Follow-up|8|||
160603509|NCT01505114|579926732|FG003|Overall Study|Lost to Follow-up|7|||
160603510|NCT01505114|579926729|FG000|Overall Study|relocated|4|||
160603511|NCT01505114|579926730|FG001|Overall Study|relocated|2|||
160603512|NCT01505114|579926731|FG002|Overall Study|relocated|2|||
160603513|NCT01505114|579926732|FG003|Overall Study|relocated|3|||
160603514|NCT01505114|579926729|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
160603515|NCT01505114|579926730|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
160603516|NCT01505114|579926731|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
160603517|NCT01505114|579926732|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
160603518|NCT01505114|579926729|FG000|Overall Study|staff safety concerns|0|||
160603519|NCT01505114|579926730|FG001|Overall Study|staff safety concerns|0|||
160603520|NCT01505114|579926731|FG002|Overall Study|staff safety concerns|0|||
160603521|NCT01505114|579926732|FG003|Overall Study|staff safety concerns|1|||
160603522|NCT01505114|579926729|FG000|Overall Study|investigator decision|1|||
160477458|NCT00518206|579475152|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
160477459|NCT00518206|579475153|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
160477460|NCT00518206|579475152|FG000|Overall Study|Withdrawal by Subject|2|||
160477461|NCT00518206|579475153|FG001|Overall Study|Withdrawal by Subject|0|||
160477462|NCT00518206|579475152|FG000|Overall Study|Drug Supply Issue|1|||
160477463|NCT00518206|579475153|FG001|Overall Study|Drug Supply Issue|0|||
160477464|NCT00518206|579475152|FG000|Overall Study|Reason Unknown|1|||
160477465|NCT00518206|579475153|FG001|Overall Study|Reason Unknown|0|||
160477466|NCT00518206|579475152|FG000|Overall Study|Completion Status Unknown|1|||
160477467|NCT00518206|579475153|FG001|Overall Study|Completion Status Unknown|0|||
160603523|NCT01505114|579926730|FG001|Overall Study|investigator decision|0|||
160603524|NCT01505114|579926731|FG002|Overall Study|investigator decision|1|||
160603525|NCT01505114|579926732|FG003|Overall Study|investigator decision|0|||
160603526|NCT01235507|579926734|FG000|Overall Study|Adverse Event|1|||
160603527|NCT01235507|579926734|FG000|Overall Study|Withdrawal by Subject|1|||
160477468|NCT03075878|579475154|FG000|Overall Study|Physician Decision|1|||
160477469|NCT02188459|579475155|FG000|Overall Study|Lost to Follow-up|3|||
160477470|NCT02188459|579475156|FG001|Overall Study|Lost to Follow-up|4|||
160477471|NCT02188459|579475155|FG000|Overall Study|Early Termination|0|||
160477472|NCT02188459|579475156|FG001|Overall Study|Early Termination|3|||
160477473|NCT02612285|579475161|FG000|Overall Study|Withdrawal by Subject|1|||
160477474|NCT02935894|579475162|FG000|Overall Study|Subject dismissed|1|||
160477475|NCT04895085|579475165|FG000|Overall Study|Death|1|||
160477476|NCT04895085|579475165|FG000|Overall Study|Withdrawal by Subject|1|||
160477477|NCT04895085|579475165|FG000|Overall Study|No longer eligible: Moved from area|1|||
160477478|NCT04919499|579475170|FG000|Overall Study|Adverse Event|0|||
160477479|NCT04919499|579475171|FG001|Overall Study|Adverse Event|0|||
160477480|NCT04919499|579475172|FG002|Overall Study|Adverse Event|0|||
160477481|NCT04919499|579475173|FG003|Overall Study|Adverse Event|0|||
160477482|NCT04919499|579475174|FG004|Overall Study|Adverse Event|2|||
160477483|NCT04919499|579475170|FG000|Overall Study|Not treated|0|||
160477484|NCT04919499|579475171|FG001|Overall Study|Not treated|0|||
160477485|NCT04919499|579475172|FG002|Overall Study|Not treated|0|||
160477486|NCT04919499|579475173|FG003|Overall Study|Not treated|1|||
160477487|NCT04919499|579475174|FG004|Overall Study|Not treated|0|||
160477488|NCT00946998|579476723|FG000|Overall Study|Exited prior to first outcome assessment|5|||
160477489|NCT00946998|579476724|FG001|Overall Study|Exited prior to first outcome assessment|3|||
160477490|NCT01945593|579476725|FG000|Overall Study|Adverse Event|0|||
160477491|NCT01945593|579476726|FG001|Overall Study|Adverse Event|0|||
160477492|NCT01945593|579476727|FG002|Overall Study|Adverse Event|0|||
160477493|NCT01945593|579476728|FG003|Overall Study|Adverse Event|5|||
160477494|NCT01945593|579476725|FG000|Overall Study|Physician Decision|0|||
160477495|NCT01945593|579476726|FG001|Overall Study|Physician Decision|0|||
160477496|NCT01945593|579476727|FG002|Overall Study|Physician Decision|1|||
160477497|NCT01945593|579476728|FG003|Overall Study|Physician Decision|1|||
160477498|NCT01945593|579476725|FG000|Overall Study|Withdrawal by Subject|0|||
160477499|NCT01945593|579476726|FG001|Overall Study|Withdrawal by Subject|2|||
160477500|NCT01945593|579476727|FG002|Overall Study|Withdrawal by Subject|0|||
160477501|NCT01945593|579476728|FG003|Overall Study|Withdrawal by Subject|4|||
160477502|NCT01945593|579476725|FG000|Overall Study|Protocol Violation|0|||
160477503|NCT01945593|579476726|FG001|Overall Study|Protocol Violation|2|||
160477504|NCT01945593|579476727|FG002|Overall Study|Protocol Violation|1|||
160477505|NCT01945593|579476728|FG003|Overall Study|Protocol Violation|3|||
160477506|NCT01945593|579476725|FG000|Overall Study|Death|0|||
160477507|NCT01945593|579476726|FG001|Overall Study|Death|0|||
160477508|NCT01945593|579476727|FG002|Overall Study|Death|1|||
160477509|NCT01945593|579476728|FG003|Overall Study|Death|0|||
160477510|NCT01945593|579476725|FG000|Overall Study|Other: Terminated|0|||
160477511|NCT01945593|579476726|FG001|Overall Study|Other: Terminated|0|||
160477512|NCT01945593|579476727|FG002|Overall Study|Other: Terminated|0|||
160477513|NCT01945593|579476728|FG003|Overall Study|Other: Terminated|1|||
160477514|NCT01945593|579476725|FG000|Overall Study|Other: Surgical Procedure|0|||
160477515|NCT01945593|579476726|FG001|Overall Study|Other: Surgical Procedure|2|||
160477516|NCT01945593|579476727|FG002|Overall Study|Other: Surgical Procedure|0|||
160477517|NCT01945593|579476728|FG003|Overall Study|Other: Surgical Procedure|6|||
160477518|NCT01945593|579476725|FG000|Overall Study|Other: Screen Failure|0|||
160477519|NCT01945593|579476726|FG001|Overall Study|Other: Screen Failure|2|||
160477520|NCT01945593|579476727|FG002|Overall Study|Other: Screen Failure|0|||
160477521|NCT01945593|579476728|FG003|Overall Study|Other: Screen Failure|0|||
160477522|NCT00228813|579476729|FG000|Overall Study|Death|4|||
160477523|NCT02213094|579476736|FG000|Overall Study|Adverse Event|1|||
160477524|NCT02213094|579476737|FG001|Overall Study|Adverse Event|0|||
160477525|NCT02163499|579476738|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
160477526|NCT02163499|579476738|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
160603528|NCT01421069|579926737|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
160603529|NCT01421069|579926737|FG000|Parent Study|Failed to return|3|||
160603530|NCT01421069|579926737|FG000|Parent Study|Withdrawal by Subject|1|||
160603531|NCT01421069|579926737|FG000|Parent Study|Lost to Follow-up|2|||
160477527|NCT02163499|579476738|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
160477528|NCT02163499|579476738|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
160477529|NCT02163499|579476738|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
160477530|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
160477531|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
160477532|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
160477533|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
160477534|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
160477535|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
160477536|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
160477537|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
160477538|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
160477539|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Death|8|||
160603532|NCT01421069|579926737|FG000|Parent Study|Lack of Efficacy|1|||
160603533|NCT01421069|579926737|FG000|Overall Period for Extension Study|Other|2|||
160477540|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
160477541|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
160477542|NCT02163499|579476738|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
160477543|NCT00555620|579476742|FG000|Overall Study|Death|0|||
160477544|NCT00555620|579476743|FG001|Overall Study|Death|1|||
160477545|NCT00555620|579476744|FG002|Overall Study|Death|0|||
160477546|NCT00555620|579476745|FG003|Overall Study|Death|0|||
160477547|NCT00555620|579476746|FG004|Overall Study|Death|0|||
160477548|NCT00555620|579476747|FG005|Overall Study|Death|1|||
160477549|NCT00555620|579476742|FG000|Overall Study|Study terminated by sponsor|0|||
160477550|NCT00555620|579476743|FG001|Overall Study|Study terminated by sponsor|0|||
160477551|NCT00555620|579476744|FG002|Overall Study|Study terminated by sponsor|1|||
160477552|NCT00555620|579476745|FG003|Overall Study|Study terminated by sponsor|0|||
160477553|NCT00555620|579476746|FG004|Overall Study|Study terminated by sponsor|0|||
160477554|NCT00555620|579476747|FG005|Overall Study|Study terminated by sponsor|0|||
160477555|NCT00555620|579476742|FG000|Overall Study|Adverse Event|0|||
160477556|NCT00555620|579476743|FG001|Overall Study|Adverse Event|0|||
160477557|NCT00555620|579476744|FG002|Overall Study|Adverse Event|1|||
160477558|NCT00555620|579476745|FG003|Overall Study|Adverse Event|5|||
160477559|NCT00555620|579476746|FG004|Overall Study|Adverse Event|0|||
160477560|NCT00555620|579476747|FG005|Overall Study|Adverse Event|1|||
160477561|NCT00555620|579476742|FG000|Overall Study|Objective progression or relapse|6|||
160477562|NCT00555620|579476743|FG001|Overall Study|Objective progression or relapse|5|||
160477563|NCT00555620|579476744|FG002|Overall Study|Objective progression or relapse|12|||
160477564|NCT00555620|579476745|FG003|Overall Study|Objective progression or relapse|17|||
160477565|NCT00555620|579476746|FG004|Overall Study|Objective progression or relapse|3|||
160477566|NCT00555620|579476747|FG005|Overall Study|Objective progression or relapse|16|||
160477567|NCT00555620|579476742|FG000|Overall Study|Participant refused treatment|0|||
160477568|NCT00555620|579476743|FG001|Overall Study|Participant refused treatment|1|||
160477569|NCT00555620|579476744|FG002|Overall Study|Participant refused treatment|1|||
160477570|NCT00555620|579476745|FG003|Overall Study|Participant refused treatment|0|||
160477571|NCT00555620|579476746|FG004|Overall Study|Participant refused treatment|0|||
160477572|NCT00555620|579476747|FG005|Overall Study|Participant refused treatment|1|||
160477573|NCT00555620|579476742|FG000|Overall Study|Other|0|||
160477574|NCT00555620|579476743|FG001|Overall Study|Other|0|||
160477575|NCT00555620|579476744|FG002|Overall Study|Other|0|||
160477576|NCT00555620|579476745|FG003|Overall Study|Other|1|||
160477577|NCT00555620|579476746|FG004|Overall Study|Other|0|||
160477578|NCT00555620|579476747|FG005|Overall Study|Other|3|||
160477579|NCT00476151|579476748|FG000|Overall Study|Adverse Event|0|||
160477580|NCT00476151|579476749|FG001|Overall Study|Adverse Event|2|||
160477581|NCT00476151|579476748|FG000|Overall Study|Protocol Violation|1|||
160477582|NCT00476151|579476749|FG001|Overall Study|Protocol Violation|3|||
160477583|NCT00476151|579476748|FG000|Overall Study|Withdrawal by Subject|2|||
160477584|NCT00476151|579476749|FG001|Overall Study|Withdrawal by Subject|0|||
160477585|NCT00476151|579476748|FG000|Overall Study|Physician Decision|0|||
160477586|NCT00476151|579476749|FG001|Overall Study|Physician Decision|2|||
160477587|NCT00946088|579476751|FG000|Overall Study|Withdrawal by Subject|0|||
160477588|NCT00946088|579476752|FG001|Overall Study|Withdrawal by Subject|1|||
160477589|NCT03456856|579476756|FG000|Overall Study|Lost to Follow-up|2|||
160477590|NCT03456856|579476756|FG000|Overall Study|Withdrawal by Subject|1|||
160477591|NCT02542696|579476758|FG000|Overall Study|Adverse Event|167|||
160477592|NCT02542696|579476758|FG000|Overall Study|Lack of Efficacy|26|||
160477593|NCT02542696|579476758|FG000|Overall Study|Lost to Follow-up|6|||
160477594|NCT02542696|579476758|FG000|Overall Study|Withdrawal by Subject|104|||
160477595|NCT02542696|579476758|FG000|Overall Study|Protocol Violation|5|||
160477596|NCT02542696|579476758|FG000|Overall Study|Death|8|||
160477597|NCT02542696|579476758|FG000|Overall Study|DECREASED OFF TIME|1|||
160477598|NCT02542696|579476758|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
160477599|NCT02542696|579476758|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
160477600|NCT02542696|579476758|FG000|Overall Study|MEDICAL HISTORY|1|||
160477601|NCT02542696|579476758|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
160477602|NCT02542696|579476758|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
160477603|NCT02542696|579476758|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
160477604|NCT02542696|579476758|FG000|Overall Study|SPONSOR DECISION|3|||
160477605|NCT02542696|579476758|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
160477606|NCT02542696|579476758|FG000|Overall Study|SUBJECT DECISION|2|||
160477607|NCT03262389|579476759|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
160477608|NCT03262389|579476759|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
160477609|NCT03262389|579476759|FG000|Overall Study|opted out of PET/MR|1|||
160477610|NCT00379210|579476761|FG000|Overall Study|Withdrawal by Subject|10|||
160477611|NCT00379210|579476762|FG001|Overall Study|Withdrawal by Subject|7|||
160477612|NCT00821093|579476763|FG000|Overall Study|Adverse Event|20|||
160477613|NCT00821093|579476764|FG001|Overall Study|Adverse Event|12|||
160477614|NCT00821093|579476763|FG000|Overall Study|Withdrawal by Subject|9|||
160477615|NCT00821093|579476764|FG001|Overall Study|Withdrawal by Subject|13|||
160477616|NCT00821093|579476763|FG000|Overall Study|Lost to Follow-up|9|||
160477617|NCT00821093|579476764|FG001|Overall Study|Lost to Follow-up|3|||
160477618|NCT00821093|579476763|FG000|Overall Study|Protocol deviation|3|||
160477619|NCT00821093|579476764|FG001|Overall Study|Protocol deviation|6|||
160477620|NCT00821093|579476763|FG000|Overall Study|Abnormal laboratory value(s)|2|||
160477621|NCT00821093|579476764|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160477622|NCT00821093|579476763|FG000|Overall Study|Lack of Efficacy|2|||
160477623|NCT00821093|579476764|FG001|Overall Study|Lack of Efficacy|2|||
160477624|NCT00821093|579476763|FG000|Overall Study|Death|2|||
160477625|NCT00821093|579476764|FG001|Overall Study|Death|1|||
160477626|NCT00821093|579476763|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160477627|NCT00821093|579476764|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160477628|NCT00821093|579476763|FG000|Overall Study|Administrative problems|1|||
160477629|NCT00821093|579476764|FG001|Overall Study|Administrative problems|2|||
160477630|NCT05104242|579476765|FG000|Overall Study|Withdrawal by Subject|1|||
160477631|NCT05104242|579476766|FG001|Overall Study|Withdrawal by Subject|5|||
160477632|NCT05104242|579476765|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
160477633|NCT05104242|579476766|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
160477634|NCT02469155|579476771|FG000|Overall Study|Adverse Event|6|||
160477635|NCT02469155|579476772|FG001|Overall Study|Adverse Event|0|||
160477636|NCT02469155|579476773|FG002|Overall Study|Adverse Event|1|||
160477637|NCT02469155|579476774|FG003|Overall Study|Adverse Event|10|||
160477638|NCT02469155|579476771|FG000|Overall Study|Lack of Efficacy|13|||
160477639|NCT02469155|579476772|FG001|Overall Study|Lack of Efficacy|10|||
160477640|NCT02469155|579476773|FG002|Overall Study|Lack of Efficacy|10|||
160477641|NCT02469155|579476774|FG003|Overall Study|Lack of Efficacy|8|||
160477642|NCT02469155|579476771|FG000|Overall Study|Death|0|||
160477643|NCT02469155|579476772|FG001|Overall Study|Death|0|||
160477644|NCT02469155|579476773|FG002|Overall Study|Death|0|||
160477645|NCT02469155|579476774|FG003|Overall Study|Death|1|||
160603534|NCT01421069|579926737|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
160603535|NCT01421069|579926737|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
160603536|NCT01421069|579926737|FG000|Overall Period for Extension Study|Pregnancy|1|||
160603537|NCT01421069|579926737|FG000|Overall Period for Extension Study|Adverse Event|1|||
160603538|NCT01421069|579926737|FG000|Overall Period for Extension Study|Protocol Violation|1|||
160603539|NCT01421069|579926737|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
160477646|NCT02469155|579476771|FG000|Overall Study|Lost to Follow-up|5|||
160477647|NCT02469155|579476772|FG001|Overall Study|Lost to Follow-up|2|||
160477648|NCT02469155|579476773|FG002|Overall Study|Lost to Follow-up|7|||
160477649|NCT02469155|579476774|FG003|Overall Study|Lost to Follow-up|2|||
160477650|NCT02469155|579476771|FG000|Overall Study|Physician Decision|0|||
160477651|NCT02469155|579476772|FG001|Overall Study|Physician Decision|0|||
160477652|NCT02469155|579476773|FG002|Overall Study|Physician Decision|1|||
160477653|NCT02469155|579476774|FG003|Overall Study|Physician Decision|0|||
160477654|NCT02469155|579476771|FG000|Overall Study|Withdrawal by Subject|34|||
160477655|NCT02469155|579476772|FG001|Overall Study|Withdrawal by Subject|30|||
160477656|NCT02469155|579476773|FG002|Overall Study|Withdrawal by Subject|20|||
160477657|NCT02469155|579476774|FG003|Overall Study|Withdrawal by Subject|37|||
160477658|NCT02469155|579476771|FG000|Overall Study|Other|3|||
160477659|NCT02469155|579476772|FG001|Overall Study|Other|3|||
160477660|NCT02469155|579476773|FG002|Overall Study|Other|2|||
160477661|NCT02469155|579476774|FG003|Overall Study|Other|10|||
160477662|NCT02469155|579476771|FG000|Overall Study|Protocol Violation|0|||
160477663|NCT02469155|579476772|FG001|Overall Study|Protocol Violation|1|||
160477664|NCT02469155|579476773|FG002|Overall Study|Protocol Violation|0|||
160477665|NCT02469155|579476774|FG003|Overall Study|Protocol Violation|1|||
160477666|NCT02991118|579476775|FG000|Overall Study|Death|3|||
160477667|NCT02991118|579476776|FG001|Overall Study|Death|8|||
160477668|NCT02991118|579476775|FG000|Overall Study|Protocol Violation|0|||
160477669|NCT02991118|579476776|FG001|Overall Study|Protocol Violation|3|||
160477670|NCT02991118|579476775|FG000|Overall Study|Physician Decision|0|||
160477671|NCT02991118|579476776|FG001|Overall Study|Physician Decision|1|||
160477672|NCT02991118|579476775|FG000|Overall Study|Moved out of the country|0|||
160477673|NCT02991118|579476776|FG001|Overall Study|Moved out of the country|1|||
160477674|NCT02991118|579476775|FG000|Overall Study|Adverse Event|2|||
160477675|NCT02991118|579476776|FG001|Overall Study|Adverse Event|2|||
160477676|NCT02991118|579476775|FG000|Overall Study|Withdrawal by Subject|1|||
160477677|NCT02991118|579476776|FG001|Overall Study|Withdrawal by Subject|7|||
160477678|NCT02991118|579476775|FG000|Overall Study|Could not attend study visits|0|||
160477679|NCT02991118|579476776|FG001|Overall Study|Could not attend study visits|1|||
160477680|NCT02991118|579476775|FG000|Overall Study|Lost to Follow-up|1|||
160477681|NCT02991118|579476776|FG001|Overall Study|Lost to Follow-up|9|||
160477682|NCT02764320|579476784|FG000|Overall Study|Withdrawal by Subject|35|||
160603540|NCT01421069|579926737|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
160603541|NCT01421069|579926737|FG000|Active Treatment Period|Other|1|||
160603542|NCT01421069|579926737|FG000|Active Treatment Period|No longer willing to participate in study|8|||
160477683|NCT02764320|579476785|FG001|Overall Study|Withdrawal by Subject|38|||
160477684|NCT02764320|579476784|FG000|Overall Study|Protocol Violation|11|||
160477685|NCT02764320|579476785|FG001|Overall Study|Protocol Violation|6|||
160477686|NCT02764320|579476784|FG000|Overall Study|Adverse Event|2|||
160477687|NCT02764320|579476785|FG001|Overall Study|Adverse Event|0|||
160477688|NCT02764320|579476784|FG000|Overall Study|Health Issues unable to continue|2|||
160477689|NCT02764320|579476785|FG001|Overall Study|Health Issues unable to continue|0|||
160477690|NCT02764320|579476784|FG000|Overall Study|Did not meet inclusion criteria|1|||
160477691|NCT02764320|579476785|FG001|Overall Study|Did not meet inclusion criteria|0|||
160477692|NCT02764320|579476784|FG000|Overall Study|Subject moved|0|||
160477693|NCT02764320|579476785|FG001|Overall Study|Subject moved|2|||
160477694|NCT02764320|579476784|FG000|Overall Study|Overused medication unavailable|0|||
160477695|NCT02764320|579476785|FG001|Overall Study|Overused medication unavailable|1|||
160477696|NCT02764320|579476784|FG000|Overall Study|Seeking care outside site|0|||
160477697|NCT02764320|579476785|FG001|Overall Study|Seeking care outside site|1|||
160477698|NCT02764320|579476784|FG000|Overall Study|Technology barriers|0|||
160477699|NCT02764320|579476785|FG001|Overall Study|Technology barriers|1|||
160477700|NCT04765046|579476786|FG000|Overall Study|Screen Failure|2|||
160477701|NCT04765046|579476786|FG000|Overall Study|Withdrawal by Subject|4|||
160477702|NCT04765046|579476786|FG000|Overall Study|Physician Decision|4|||
160477703|NCT04765046|579476786|FG000|Overall Study|Surgery Cancelled|8|||
160477704|NCT03150589|579476788|FG000|Overall Study|Withdrawal by Subject|16|||
160477705|NCT03150589|579476789|FG001|Overall Study|Withdrawal by Subject|9|||
160477706|NCT03150589|579476788|FG000|Overall Study|Adverse Event|7|||
160477707|NCT03150589|579476789|FG001|Overall Study|Adverse Event|6|||
160477708|NCT03150589|579476788|FG000|Overall Study|Protocol Violation|4|||
160477709|NCT03150589|579476789|FG001|Overall Study|Protocol Violation|3|||
160477710|NCT03150589|579476788|FG000|Overall Study|Lost to Follow-up|3|||
160477711|NCT03150589|579476789|FG001|Overall Study|Lost to Follow-up|3|||
160477712|NCT03150589|579476788|FG000|Overall Study|Death|2|||
160477713|NCT03150589|579476789|FG001|Overall Study|Death|3|||
160477714|NCT03150589|579476788|FG000|Overall Study|IP non-compliance and other reasons|12|||
160477715|NCT03150589|579476789|FG001|Overall Study|IP non-compliance and other reasons|3|||
160477716|NCT01405508|579476790|FG000|Overall Study|AE, non-serious non-fatal|1|||
160477717|NCT01405508|579476791|FG001|Overall Study|AE, non-serious non-fatal|1|||
160477718|NCT01405508|579476792|FG002|Overall Study|AE, non-serious non-fatal|0|||
160477719|NCT01405508|579476793|FG003|Overall Study|AE, non-serious non-fatal|0|||
160477720|NCT03529942|579476794|FG000|Overall Study|Withdrawal by Subject|13|||
160477721|NCT03529942|579476794|FG000|Overall Study|Physician Decision|1|||
160477722|NCT03529942|579476794|FG000|Overall Study|Lost to Follow-up|7|||
160477723|NCT03529942|579476794|FG000|Overall Study|Needle inserted but no drug administered|1|||
160477724|NCT03529942|579476794|FG000|Overall Study|Personal reasons|1|||
160477725|NCT01989156|579476801|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
160477726|NCT01989156|579476802|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
160477727|NCT01989156|579476803|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
160477728|NCT01989156|579476801|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
160477729|NCT01989156|579476802|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
160477730|NCT01989156|579476803|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
160477731|NCT01989156|579476801|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
160477732|NCT01989156|579476802|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
160603543|NCT01421069|579926737|FG000|Active Treatment Period|Insufficient clinical response|1|||
160477733|NCT01989156|579476803|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
160477734|NCT01989156|579476801|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
160477735|NCT01989156|579476802|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
160477736|NCT01989156|579476803|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
160477737|NCT01989156|579476801|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
160603544|NCT01421069|579926737|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
160477738|NCT01989156|579476802|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
160477739|NCT01989156|579476803|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
160477740|NCT01989156|579476801|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
160477741|NCT01989156|579476802|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
160477742|NCT01989156|579476803|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
160477743|NCT01989156|579476801|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
160477744|NCT01989156|579476802|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
160477745|NCT01989156|579476803|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
160477746|NCT01989156|579476801|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
160477747|NCT01989156|579476802|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
160477748|NCT01989156|579476803|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
160477749|NCT03839355|579476804|FG000|Overall Study|Withdrawal by Subject|1|||
160477750|NCT03839355|579476805|FG001|Overall Study|Withdrawal by Subject|0|||
160477751|NCT03541369|579476807|FG000|Overall Study|Death|0|||
160477752|NCT03541369|579476808|FG001|Overall Study|Death|0|||
160477753|NCT03541369|579476809|FG002|Overall Study|Death|0|||
160477754|NCT03541369|579476810|FG003|Overall Study|Death|0|||
160477755|NCT03541369|579476811|FG004|Overall Study|Death|1|||
160477756|NCT03541369|579476812|FG005|Overall Study|Death|1|||
160477757|NCT03541369|579476813|FG006|Overall Study|Death|0|||
160477758|NCT03541369|579476814|FG007|Overall Study|Death|2|||
160477759|NCT03541369|579476815|FG008|Overall Study|Death|1|||
160477760|NCT03541369|579476816|FG009|Overall Study|Death|2|||
160477761|NCT03541369|579476817|FG010|Overall Study|Death|1|||
160477762|NCT03541369|579476818|FG011|Overall Study|Death|0|||
160477763|NCT03541369|579476819|FG012|Overall Study|Death|2|||
160477764|NCT03541369|579476820|FG013|Overall Study|Death|1|||
160477765|NCT03541369|579476821|FG014|Overall Study|Death|1|||
160477766|NCT03541369|579476822|FG015|Overall Study|Death|1|||
160477767|NCT03541369|579476823|FG016|Overall Study|Death|0|||
160477768|NCT03541369|579476824|FG017|Overall Study|Death|1|||
160603545|NCT01421069|579926737|FG000|Active Treatment Period|Pregnancy|1|||
160603546|NCT01421069|579926737|FG000|Active Treatment Period|Adverse Event|1|||
160603547|NCT01421069|579926737|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
160603548|NCT01421069|579926737|FG000|Active Treatment Period|Enrolled in observational period|29|||
160603549|NCT01421069|579926737|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
160477769|NCT03541369|579476807|FG000|Overall Study|Decision by sponsor|0|||
160477770|NCT03541369|579476808|FG001|Overall Study|Decision by sponsor|0|||
160477771|NCT03541369|579476809|FG002|Overall Study|Decision by sponsor|0|||
160477772|NCT03541369|579476810|FG003|Overall Study|Decision by sponsor|1|||
160603550|NCT01421069|579926737|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
160477773|NCT03541369|579476811|FG004|Overall Study|Decision by sponsor|0|||
160477774|NCT03541369|579476812|FG005|Overall Study|Decision by sponsor|2|||
160603551|NCT01421069|579926737|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
160603552|NCT01421069|579926737|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
160660519|NCT02188303|580139541|FG003|Overall Study|Adverse Event|0|||
160477775|NCT03541369|579476813|FG006|Overall Study|Decision by sponsor|0|||
160477776|NCT03541369|579476814|FG007|Overall Study|Decision by sponsor|1|||
160477777|NCT03541369|579476815|FG008|Overall Study|Decision by sponsor|2|||
160477778|NCT03541369|579476816|FG009|Overall Study|Decision by sponsor|0|||
160477779|NCT03541369|579476817|FG010|Overall Study|Decision by sponsor|0|||
160477780|NCT03541369|579476818|FG011|Overall Study|Decision by sponsor|0|||
160477781|NCT03541369|579476819|FG012|Overall Study|Decision by sponsor|2|||
160477782|NCT03541369|579476820|FG013|Overall Study|Decision by sponsor|2|||
160477783|NCT03541369|579476821|FG014|Overall Study|Decision by sponsor|0|||
160477784|NCT03541369|579476822|FG015|Overall Study|Decision by sponsor|1|||
160477785|NCT03541369|579476823|FG016|Overall Study|Decision by sponsor|1|||
160477786|NCT03541369|579476824|FG017|Overall Study|Decision by sponsor|1|||
160477787|NCT03541369|579476807|FG000|Overall Study|Withdrawal by Subject|0|||
160477788|NCT03541369|579476808|FG001|Overall Study|Withdrawal by Subject|0|||
160477789|NCT03541369|579476809|FG002|Overall Study|Withdrawal by Subject|0|||
160477790|NCT03541369|579476810|FG003|Overall Study|Withdrawal by Subject|0|||
160477791|NCT03541369|579476811|FG004|Overall Study|Withdrawal by Subject|0|||
160477792|NCT03541369|579476812|FG005|Overall Study|Withdrawal by Subject|0|||
160477793|NCT03541369|579476813|FG006|Overall Study|Withdrawal by Subject|1|||
160477794|NCT03541369|579476814|FG007|Overall Study|Withdrawal by Subject|0|||
160477795|NCT03541369|579476815|FG008|Overall Study|Withdrawal by Subject|0|||
160477796|NCT03541369|579476816|FG009|Overall Study|Withdrawal by Subject|0|||
160660520|NCT02188303|580139542|FG004|Overall Study|Adverse Event|0|||
160477797|NCT03541369|579476817|FG010|Overall Study|Withdrawal by Subject|0|||
160477798|NCT03541369|579476818|FG011|Overall Study|Withdrawal by Subject|1|||
160477799|NCT03541369|579476819|FG012|Overall Study|Withdrawal by Subject|0|||
160477800|NCT03541369|579476820|FG013|Overall Study|Withdrawal by Subject|0|||
160477801|NCT03541369|579476821|FG014|Overall Study|Withdrawal by Subject|3|||
160477802|NCT03541369|579476822|FG015|Overall Study|Withdrawal by Subject|0|||
160477803|NCT03541369|579476823|FG016|Overall Study|Withdrawal by Subject|4|||
160477804|NCT03541369|579476824|FG017|Overall Study|Withdrawal by Subject|2|||
160477805|NCT03541369|579476807|FG000|Overall Study|Lost to Follow-up|0|||
160477806|NCT03541369|579476808|FG001|Overall Study|Lost to Follow-up|0|||
160477807|NCT03541369|579476809|FG002|Overall Study|Lost to Follow-up|0|||
160477808|NCT03541369|579476810|FG003|Overall Study|Lost to Follow-up|0|||
160477809|NCT03541369|579476811|FG004|Overall Study|Lost to Follow-up|1|||
160477810|NCT03541369|579476812|FG005|Overall Study|Lost to Follow-up|0|||
160477811|NCT03541369|579476813|FG006|Overall Study|Lost to Follow-up|0|||
160477812|NCT03541369|579476814|FG007|Overall Study|Lost to Follow-up|0|||
160477813|NCT03541369|579476815|FG008|Overall Study|Lost to Follow-up|1|||
160477814|NCT03541369|579476816|FG009|Overall Study|Lost to Follow-up|0|||
160477815|NCT03541369|579476817|FG010|Overall Study|Lost to Follow-up|0|||
160477816|NCT03541369|579476818|FG011|Overall Study|Lost to Follow-up|0|||
160477817|NCT03541369|579476819|FG012|Overall Study|Lost to Follow-up|1|||
160477818|NCT03541369|579476820|FG013|Overall Study|Lost to Follow-up|0|||
160477819|NCT03541369|579476821|FG014|Overall Study|Lost to Follow-up|0|||
160477820|NCT03541369|579476822|FG015|Overall Study|Lost to Follow-up|0|||
160477821|NCT03541369|579476823|FG016|Overall Study|Lost to Follow-up|0|||
160477822|NCT03541369|579476824|FG017|Overall Study|Lost to Follow-up|0|||
160477823|NCT01856569|579476825|FG000|Overall Study|Other|1|||
160477824|NCT01856569|579476825|FG000|Overall Study|Changed Site/Structure|1|||
160477825|NCT01856569|579476825|FG000|Overall Study|Lost to Follow-up|3|||
160477826|NCT01856569|579476825|FG000|Overall Study|Did not met inclusion criteria|8|||
160477827|NCT00696241|579476826|FG000|Overall Study|Adverse Event|11|||
160477828|NCT00696241|579476827|FG001|Overall Study|Adverse Event|3|||
160477829|NCT00696241|579476828|FG002|Overall Study|Adverse Event|6|||
160477830|NCT00696241|579476829|FG003|Overall Study|Adverse Event|4|||
160477831|NCT00696241|579476830|FG004|Overall Study|Adverse Event|5|||
160477832|NCT00696241|579476826|FG000|Overall Study|Protocol Violation|1|||
160477833|NCT00696241|579476827|FG001|Overall Study|Protocol Violation|1|||
160477834|NCT00696241|579476828|FG002|Overall Study|Protocol Violation|2|||
160477835|NCT00696241|579476829|FG003|Overall Study|Protocol Violation|0|||
160477836|NCT00696241|579476830|FG004|Overall Study|Protocol Violation|3|||
160477837|NCT00696241|579476826|FG000|Overall Study|Lost to Follow-up|1|||
160477838|NCT00696241|579476827|FG001|Overall Study|Lost to Follow-up|4|||
160477839|NCT00696241|579476828|FG002|Overall Study|Lost to Follow-up|1|||
160477840|NCT00696241|579476829|FG003|Overall Study|Lost to Follow-up|2|||
160477841|NCT00696241|579476830|FG004|Overall Study|Lost to Follow-up|0|||
160477842|NCT00696241|579476826|FG000|Overall Study|Withdrawal by Subject|4|||
160477843|NCT00696241|579476827|FG001|Overall Study|Withdrawal by Subject|8|||
160477844|NCT00696241|579476828|FG002|Overall Study|Withdrawal by Subject|6|||
160477845|NCT00696241|579476829|FG003|Overall Study|Withdrawal by Subject|1|||
160477846|NCT00696241|579476830|FG004|Overall Study|Withdrawal by Subject|0|||
160477847|NCT00696241|579476826|FG000|Overall Study|Lack of Efficacy|1|||
160477848|NCT00696241|579476827|FG001|Overall Study|Lack of Efficacy|5|||
160477849|NCT00696241|579476828|FG002|Overall Study|Lack of Efficacy|4|||
160477850|NCT00696241|579476829|FG003|Overall Study|Lack of Efficacy|5|||
160477851|NCT00696241|579476830|FG004|Overall Study|Lack of Efficacy|3|||
160477852|NCT00696241|579476826|FG000|Overall Study|Other|6|||
160477853|NCT00696241|579476827|FG001|Overall Study|Other|1|||
160477854|NCT00696241|579476828|FG002|Overall Study|Other|5|||
160477855|NCT00696241|579476829|FG003|Overall Study|Other|2|||
160477856|NCT00696241|579476830|FG004|Overall Study|Other|1|||
160477857|NCT04749797|579476832|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
160477858|NCT04749797|579476833|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
160477859|NCT04749797|579476834|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
160477860|NCT02513667|579476835|FG000|Overall Study|Withdrawal by Subject|0|||
160477861|NCT02513667|579476836|FG001|Overall Study|Withdrawal by Subject|1|||
160477862|NCT00871715|579476837|FG000|Overall Study|Withdrawal by Subject|6|||
160477863|NCT00871715|579476838|FG001|Overall Study|Withdrawal by Subject|10|||
160477864|NCT00871715|579476839|FG002|Overall Study|Withdrawal by Subject|15|||
160477865|NCT00871715|579476837|FG000|Overall Study|Physician Decision|6|||
160477866|NCT00871715|579476838|FG001|Overall Study|Physician Decision|0|||
160477867|NCT00871715|579476839|FG002|Overall Study|Physician Decision|2|||
160477868|NCT00871715|579476837|FG000|Overall Study|Lost to Follow-up|3|||
160477869|NCT00871715|579476838|FG001|Overall Study|Lost to Follow-up|6|||
160477870|NCT00871715|579476839|FG002|Overall Study|Lost to Follow-up|9|||
160477871|NCT02291549|579476842|FG000|Overall Study|Lost to Follow-up|1|||
160477872|NCT02291549|579476843|FG001|Overall Study|Lost to Follow-up|0|||
160477873|NCT02291549|579476842|FG000|Overall Study|Withdrawal by Subject|0|||
160477874|NCT02291549|579476843|FG001|Overall Study|Withdrawal by Subject|1|||
160477875|NCT00537914|579476844|FG000|Overall Study|Death|1|||
160477876|NCT00537914|579476844|FG000|Overall Study|Adverse Event|7|||
160477877|NCT00537914|579476844|FG000|Overall Study|Treatment failure|10|||
160477878|NCT00537914|579476844|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
160477879|NCT00537914|579476844|FG000|Overall Study|Lost to Follow-up|19|||
160603553|NCT01421069|579926737|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
160603554|NCT01421069|579926737|FG000|2b. Retreatment Period|Protocol Violation|1|||
160603555|NCT01421069|579926737|FG000|Observational Period|Other|1|||
160603556|NCT01421069|579926737|FG000|Observational Period|No longer willing to participate in study|4|||
160603557|NCT01421069|579926737|FG000|Observational Period|Lost to Follow-up|3|||
160603558|NCT01641081|579926738|FG000|Period 1|Sponsor request (potential unblinding)|0|||
160477880|NCT00537914|579476844|FG000|Overall Study|Withdrawal of informed consent|59|||
160603559|NCT01641081|579926739|FG001|Period 1|Sponsor request (potential unblinding)|0|||
160477881|NCT01147471|579476848|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
160477882|NCT01147471|579476849|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
160603560|NCT01641081|579926740|FG002|Period 1|Sponsor request (potential unblinding)|0|||
160660521|NCT02188303|580139543|FG005|Overall Study|Adverse Event|2|||
160660522|NCT02188303|580139544|FG006|Overall Study|Adverse Event|0|||
160660523|NCT02188303|580139545|FG007|Overall Study|Adverse Event|2|||
160660524|NCT02188303|580139538|FG000|Overall Study|Dose Termination Criteria Met|0|||
160660525|NCT02188303|580139539|FG001|Overall Study|Dose Termination Criteria Met|0|||
160660526|NCT02188303|580139540|FG002|Overall Study|Dose Termination Criteria Met|0|||
160660527|NCT02188303|580139541|FG003|Overall Study|Dose Termination Criteria Met|0|||
160660528|NCT02188303|580139542|FG004|Overall Study|Dose Termination Criteria Met|0|||
160660529|NCT02188303|580139543|FG005|Overall Study|Dose Termination Criteria Met|0|||
160477883|NCT01147471|579476848|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
160603561|NCT01641081|579926741|FG003|Period 1|Sponsor request (potential unblinding)|0|||
160603562|NCT01641081|579926742|FG004|Period 1|Sponsor request (potential unblinding)|0|||
160660530|NCT02188303|580139544|FG006|Overall Study|Dose Termination Criteria Met|2|||
160660531|NCT02188303|580139545|FG007|Overall Study|Dose Termination Criteria Met|4|||
160660532|NCT00096447|580139548|FG000|Overall Study|Never treated|1|||
160603563|NCT01641081|579926743|FG005|Period 1|Sponsor request (potential unblinding)|0|||
160603564|NCT01641081|579926744|FG006|Period 1|Sponsor request (potential unblinding)|1|||
160603565|NCT01641081|579926745|FG007|Period 1|Sponsor request (potential unblinding)|0|||
160603566|NCT01641081|579926746|FG008|Period 1|Sponsor request (potential unblinding)|0|||
160603567|NCT01641081|579926747|FG009|Period 1|Sponsor request (potential unblinding)|0|||
160603568|NCT01641081|579926738|FG000|Period 1|Protocol Violation|0|||
160603569|NCT01641081|579926739|FG001|Period 1|Protocol Violation|0|||
160603570|NCT01641081|579926740|FG002|Period 1|Protocol Violation|0|||
160477884|NCT01147471|579476849|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
160477885|NCT01147471|579476848|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
160477886|NCT01147471|579476849|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
160477887|NCT01147471|579476848|FG000|3 Month Follow Up|Lost to Follow-up|1|||
160477888|NCT01147471|579476849|FG001|3 Month Follow Up|Lost to Follow-up|1|||
160477889|NCT01147471|579476848|FG000|3 Month Follow Up|Physician Decision|0|||
160477890|NCT01147471|579476849|FG001|3 Month Follow Up|Physician Decision|1|||
160477891|NCT01147471|579476848|FG000|6 Month Follow Up|Lost to Follow-up|4|||
160477892|NCT01147471|579476849|FG001|6 Month Follow Up|Lost to Follow-up|2|||
160477893|NCT01229176|579476850|FG000|Overall Study|Withdrawal by Subject|0|||
160477894|NCT01229176|579476851|FG001|Overall Study|Withdrawal by Subject|0|||
160477895|NCT01229176|579476852|FG002|Overall Study|Withdrawal by Subject|0|||
160477896|NCT01229176|579476853|FG003|Overall Study|Withdrawal by Subject|1|||
160477897|NCT01229176|579476854|FG004|Overall Study|Withdrawal by Subject|1|||
160477898|NCT01229176|579476855|FG005|Overall Study|Withdrawal by Subject|1|||
160477899|NCT01229176|579476856|FG006|Overall Study|Withdrawal by Subject|0|||
160477900|NCT01229176|579476857|FG007|Overall Study|Withdrawal by Subject|1|||
160477901|NCT01229176|579476850|FG000|Overall Study|Lost to Follow-up|0|||
160477902|NCT01229176|579476851|FG001|Overall Study|Lost to Follow-up|3|||
160477903|NCT01229176|579476852|FG002|Overall Study|Lost to Follow-up|0|||
160477904|NCT01229176|579476853|FG003|Overall Study|Lost to Follow-up|0|||
160477905|NCT01229176|579476854|FG004|Overall Study|Lost to Follow-up|1|||
160477906|NCT01229176|579476855|FG005|Overall Study|Lost to Follow-up|1|||
160477907|NCT01229176|579476856|FG006|Overall Study|Lost to Follow-up|0|||
160477908|NCT01229176|579476857|FG007|Overall Study|Lost to Follow-up|2|||
160477909|NCT02367794|579476858|FG000|Overall Study|Death|252|||
160477910|NCT02367794|579476859|FG001|Overall Study|Death|245|||
160477911|NCT02367794|579476860|FG002|Overall Study|Death|243|||
160477912|NCT02367794|579476858|FG000|Overall Study|Lost to Follow-up|1|||
160477913|NCT02367794|579476859|FG001|Overall Study|Lost to Follow-up|2|||
160477914|NCT02367794|579476860|FG002|Overall Study|Lost to Follow-up|2|||
160477915|NCT02367794|579476858|FG000|Overall Study|Physician Decision|0|||
160477916|NCT02367794|579476859|FG001|Overall Study|Physician Decision|5|||
160477917|NCT02367794|579476860|FG002|Overall Study|Physician Decision|3|||
160477918|NCT02367794|579476858|FG000|Overall Study|Protocol Violation|1|||
160477919|NCT02367794|579476859|FG001|Overall Study|Protocol Violation|0|||
160477920|NCT02367794|579476860|FG002|Overall Study|Protocol Violation|1|||
160477921|NCT02367794|579476858|FG000|Overall Study|Withdrawal by Subject|25|||
160477922|NCT02367794|579476859|FG001|Overall Study|Withdrawal by Subject|12|||
160477923|NCT02367794|579476860|FG002|Overall Study|Withdrawal by Subject|20|||
160477924|NCT02367794|579476858|FG000|Overall Study|Brain metastasis|1|||
160477925|NCT02367794|579476859|FG001|Overall Study|Brain metastasis|0|||
160477926|NCT02367794|579476860|FG002|Overall Study|Brain metastasis|0|||
160477927|NCT02367794|579476858|FG000|Overall Study|Randomized in error|0|||
160477928|NCT02367794|579476859|FG001|Overall Study|Randomized in error|0|||
160477929|NCT02367794|579476860|FG002|Overall Study|Randomized in error|1|||
160477930|NCT02367794|579476858|FG000|Overall Study|Patient unable to receive carboplatin|0|||
160477931|NCT02367794|579476859|FG001|Overall Study|Patient unable to receive carboplatin|0|||
160477932|NCT02367794|579476860|FG002|Overall Study|Patient unable to receive carboplatin|1|||
160477933|NCT02367794|579476858|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
160477934|NCT02367794|579476859|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
160477935|NCT02367794|579476860|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
160477936|NCT02367794|579476858|FG000|Overall Study|Adverse Event|0|||
160477937|NCT02367794|579476859|FG001|Overall Study|Adverse Event|0|||
160477938|NCT02367794|579476860|FG002|Overall Study|Adverse Event|2|||
160477939|NCT02367794|579476858|FG000|Overall Study|Study Terminated By Sponsor|0|||
160477940|NCT02367794|579476859|FG001|Overall Study|Study Terminated By Sponsor|1|||
160477941|NCT02367794|579476860|FG002|Overall Study|Study Terminated By Sponsor|1|||
160477942|NCT02367794|579476858|FG000|Overall Study|Moved to Roll-Over Study|0|||
160603571|NCT01641081|579926741|FG003|Period 1|Protocol Violation|0|||
160603572|NCT01641081|579926742|FG004|Period 1|Protocol Violation|1|||
160603573|NCT01641081|579926743|FG005|Period 1|Protocol Violation|0|||
160603574|NCT01641081|579926744|FG006|Period 1|Protocol Violation|0|||
160603575|NCT01641081|579926745|FG007|Period 1|Protocol Violation|1|||
160603576|NCT01641081|579926746|FG008|Period 1|Protocol Violation|0|||
160603577|NCT01641081|579926747|FG009|Period 1|Protocol Violation|0|||
160603578|NCT01641081|579926738|FG000|Period 1|Adverse Event|1|||
160603579|NCT01641081|579926739|FG001|Period 1|Adverse Event|0|||
160603580|NCT01641081|579926740|FG002|Period 1|Adverse Event|0|||
160603581|NCT01641081|579926741|FG003|Period 1|Adverse Event|0|||
160603582|NCT01641081|579926742|FG004|Period 1|Adverse Event|0|||
160603583|NCT01641081|579926743|FG005|Period 1|Adverse Event|0|||
160603584|NCT01641081|579926744|FG006|Period 1|Adverse Event|0|||
160603585|NCT01641081|579926745|FG007|Period 1|Adverse Event|2|||
160603586|NCT01641081|579926746|FG008|Period 1|Adverse Event|0|||
160603587|NCT01641081|579926747|FG009|Period 1|Adverse Event|0|||
160603588|NCT01641081|579926738|FG000|Period 2|Adverse Event|0|||
160603589|NCT01641081|579926739|FG001|Period 2|Adverse Event|0|||
160603590|NCT01641081|579926740|FG002|Period 2|Adverse Event|0|||
160603591|NCT01641081|579926741|FG003|Period 2|Adverse Event|0|||
160603592|NCT01641081|579926742|FG004|Period 2|Adverse Event|0|||
160603593|NCT01641081|579926743|FG005|Period 2|Adverse Event|1|||
160603594|NCT01641081|579926744|FG006|Period 2|Adverse Event|0|||
160603595|NCT01641081|579926745|FG007|Period 2|Adverse Event|0|||
160603596|NCT01641081|579926746|FG008|Period 2|Adverse Event|0|||
160603597|NCT01641081|579926747|FG009|Period 2|Adverse Event|0|||
160603598|NCT01641081|579926738|FG000|Period 2|Withdrawal by Subject|0|||
160603599|NCT01641081|579926739|FG001|Period 2|Withdrawal by Subject|0|||
160603600|NCT01641081|579926740|FG002|Period 2|Withdrawal by Subject|0|||
160603601|NCT01641081|579926741|FG003|Period 2|Withdrawal by Subject|1|||
160603602|NCT01641081|579926742|FG004|Period 2|Withdrawal by Subject|0|||
160603603|NCT01641081|579926743|FG005|Period 2|Withdrawal by Subject|0|||
160603604|NCT01641081|579926744|FG006|Period 2|Withdrawal by Subject|2|||
160603605|NCT01641081|579926745|FG007|Period 2|Withdrawal by Subject|0|||
160603606|NCT01641081|579926746|FG008|Period 2|Withdrawal by Subject|0|||
160603607|NCT01641081|579926747|FG009|Period 2|Withdrawal by Subject|0|||
160603608|NCT01641081|579926738|FG000|Period 2|Protocol Violation|1|||
160603609|NCT01641081|579926739|FG001|Period 2|Protocol Violation|0|||
160603610|NCT01641081|579926740|FG002|Period 2|Protocol Violation|0|||
160603611|NCT01641081|579926741|FG003|Period 2|Protocol Violation|0|||
160603612|NCT01641081|579926742|FG004|Period 2|Protocol Violation|0|||
160603613|NCT01641081|579926743|FG005|Period 2|Protocol Violation|0|||
160603614|NCT01641081|579926744|FG006|Period 2|Protocol Violation|0|||
160603615|NCT01641081|579926745|FG007|Period 2|Protocol Violation|0|||
160603616|NCT01641081|579926746|FG008|Period 2|Protocol Violation|0|||
160603617|NCT01641081|579926747|FG009|Period 2|Protocol Violation|0|||
160603618|NCT01641081|579926738|FG000|Period 3|Adverse Event|0|||
160603619|NCT01641081|579926739|FG001|Period 3|Adverse Event|0|||
160603620|NCT01641081|579926740|FG002|Period 3|Adverse Event|1|||
160603621|NCT01641081|579926741|FG003|Period 3|Adverse Event|0|||
160603622|NCT01641081|579926742|FG004|Period 3|Adverse Event|0|||
160603623|NCT01641081|579926743|FG005|Period 3|Adverse Event|0|||
160603624|NCT01641081|579926744|FG006|Period 3|Adverse Event|0|||
160603625|NCT01641081|579926745|FG007|Period 3|Adverse Event|0|||
160603626|NCT01641081|579926746|FG008|Period 3|Adverse Event|0|||
160603627|NCT01641081|579926747|FG009|Period 3|Adverse Event|0|||
160603628|NCT01641081|579926738|FG000|Period 3|Withdrawal by Subject|0|||
160603629|NCT01641081|579926739|FG001|Period 3|Withdrawal by Subject|0|||
160603630|NCT01641081|579926740|FG002|Period 3|Withdrawal by Subject|0|||
160603631|NCT01641081|579926741|FG003|Period 3|Withdrawal by Subject|0|||
160603632|NCT01641081|579926742|FG004|Period 3|Withdrawal by Subject|0|||
160603633|NCT01641081|579926743|FG005|Period 3|Withdrawal by Subject|0|||
160603634|NCT01641081|579926744|FG006|Period 3|Withdrawal by Subject|0|||
160603635|NCT01641081|579926745|FG007|Period 3|Withdrawal by Subject|0|||
160603636|NCT01641081|579926746|FG008|Period 3|Withdrawal by Subject|1|||
160603637|NCT01641081|579926747|FG009|Period 3|Withdrawal by Subject|0|||
160603638|NCT01641081|579926738|FG000|Period 4|Adverse Event|0|||
160603639|NCT01641081|579926739|FG001|Period 4|Adverse Event|1|||
160603640|NCT01641081|579926740|FG002|Period 4|Adverse Event|0|||
160603641|NCT01641081|579926741|FG003|Period 4|Adverse Event|1|||
160603642|NCT01641081|579926742|FG004|Period 4|Adverse Event|0|||
160603643|NCT01641081|579926743|FG005|Period 4|Adverse Event|0|||
160603644|NCT01641081|579926744|FG006|Period 4|Adverse Event|0|||
160603645|NCT01641081|579926745|FG007|Period 4|Adverse Event|0|||
160603646|NCT01641081|579926746|FG008|Period 4|Adverse Event|0|||
160603647|NCT01641081|579926747|FG009|Period 4|Adverse Event|0|||
160603648|NCT01641081|579926738|FG000|Period 5|Adverse Event|0|||
160603649|NCT01641081|579926739|FG001|Period 5|Adverse Event|0|||
160603650|NCT01641081|579926740|FG002|Period 5|Adverse Event|2|||
160603651|NCT01641081|579926741|FG003|Period 5|Adverse Event|0|||
160603652|NCT01641081|579926742|FG004|Period 5|Adverse Event|0|||
160603653|NCT01641081|579926743|FG005|Period 5|Adverse Event|0|||
160603654|NCT01641081|579926744|FG006|Period 5|Adverse Event|0|||
160603655|NCT01641081|579926745|FG007|Period 5|Adverse Event|0|||
160603656|NCT01641081|579926746|FG008|Period 5|Adverse Event|0|||
160603657|NCT01641081|579926747|FG009|Period 5|Adverse Event|0|||
160603658|NCT01095666|579926751|FG000|Overall Study|Lack of Efficacy|0|||
160603659|NCT01095666|579926752|FG001|Overall Study|Lack of Efficacy|0|||
160603660|NCT01095666|579926753|FG002|Overall Study|Lack of Efficacy|1|||
160603661|NCT01095666|579926751|FG000|Overall Study|Adverse Event|2|||
160603662|NCT01095666|579926752|FG001|Overall Study|Adverse Event|1|||
160603663|NCT01095666|579926753|FG002|Overall Study|Adverse Event|3|||
160603664|NCT01095666|579926751|FG000|Overall Study|Lost to Follow-up|2|||
160603665|NCT01095666|579926752|FG001|Overall Study|Lost to Follow-up|2|||
160603666|NCT01095666|579926753|FG002|Overall Study|Lost to Follow-up|0|||
160603667|NCT01095666|579926751|FG000|Overall Study|Withdrawal by Subject|6|||
160603668|NCT01095666|579926752|FG001|Overall Study|Withdrawal by Subject|6|||
160603669|NCT01095666|579926753|FG002|Overall Study|Withdrawal by Subject|1|||
160603670|NCT01095666|579926751|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
160603671|NCT01095666|579926752|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
160603672|NCT01095666|579926753|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
160603673|NCT00166517|579926756|FG000|Overall Study|Lost to Follow-up|1|||
160603674|NCT00166517|579926757|FG001|Overall Study|Lost to Follow-up|0|||
160603675|NCT00166517|579926756|FG000|Overall Study|Protocol Violation|4|||
160660533|NCT01034358|580139549|FG000|Overall Study|Withdrawal by Subject|1|||
160660534|NCT01034358|580139549|FG000|Overall Study|Protocol Violation|1|||
160660535|NCT01838941|580139550|FG000|Overall Study|Adverse Event|1|||
160660536|NCT01838941|580139550|FG000|Overall Study|Withdrawal by Subject|1|||
160660537|NCT00377260|580139558|FG000|Overall Study|Lost to Follow-up|0|||
160660538|NCT00377260|580139559|FG001|Overall Study|Lost to Follow-up|1|||
160660539|NCT00377260|580139558|FG000|Overall Study|Withdrawal by Subject|2|||
160660540|NCT00377260|580139559|FG001|Overall Study|Withdrawal by Subject|4|||
160660541|NCT00829530|580139560|FG000|First Intervention|Adverse Event|0|||
160660542|NCT00829530|580139561|FG001|First Intervention|Adverse Event|1|||
160660543|NCT00829530|580139560|FG000|First Intervention|Intolerance to Venopuncture|0|||
160660544|NCT00829530|580139561|FG001|First Intervention|Intolerance to Venopuncture|1|||
160660545|NCT00829530|580139560|FG000|Second Intervention|Intolerance to Venopuncture|1|||
160660546|NCT00829530|580139561|FG001|Second Intervention|Intolerance to Venopuncture|0|||
160660547|NCT02300103|580139562|FG000|Overall Study|Lack of Efficacy|3|||
160660548|NCT02300103|580139562|FG000|Overall Study|Protocol Violation|1|||
160660549|NCT02300103|580139562|FG000|Overall Study|Withdrew Consent|2|||
160660550|NCT04091971|580139563|FG000|Overall Study|Withdrawal by Subject|1|||
160660551|NCT04091971|580139563|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
160660552|NCT04091971|580139563|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
160660553|NCT01015625|580139564|FG000|Overall Study|Lost to Follow-up|3|||
160660554|NCT01015625|580139565|FG001|Overall Study|Lost to Follow-up|1|||
160660555|NCT01015625|580139564|FG000|Overall Study|Withdrawal by Subject|2|||
160660556|NCT01015625|580139565|FG001|Overall Study|Withdrawal by Subject|3|||
160660557|NCT01015625|580139564|FG000|Overall Study|Physician Decision|2|||
160660558|NCT01015625|580139565|FG001|Overall Study|Physician Decision|0|||
160660559|NCT01015625|580139564|FG000|Overall Study|Death|30|||
160660560|NCT01015625|580139565|FG001|Overall Study|Death|22|||
160660561|NCT00150462|580139568|FG000|Overall Study|Disease Progression or Relapse|3|||
160660562|NCT00150462|580139569|FG001|Overall Study|Disease Progression or Relapse|1|||
160660563|NCT00150462|580139570|FG002|Overall Study|Disease Progression or Relapse|2|||
160660564|NCT00150462|580139571|FG003|Overall Study|Disease Progression or Relapse|1|||
160660565|NCT00150462|580139572|FG004|Overall Study|Disease Progression or Relapse|2|||
160660566|NCT00150462|580139573|FG005|Overall Study|Disease Progression or Relapse|2|||
160660567|NCT00150462|580139574|FG006|Overall Study|Disease Progression or Relapse|3|||
160660568|NCT00150462|580139575|FG007|Overall Study|Disease Progression or Relapse|5|||
160660569|NCT00150462|580139576|FG008|Overall Study|Disease Progression or Relapse|5|||
160660570|NCT00150462|580139577|FG009|Overall Study|Disease Progression or Relapse|3|||
160660571|NCT00150462|580139578|FG010|Overall Study|Disease Progression or Relapse|2|||
160660572|NCT00150462|580139568|FG000|Overall Study|Withdrawal by Subject|0|||
160660573|NCT00150462|580139569|FG001|Overall Study|Withdrawal by Subject|1|||
160660574|NCT00150462|580139570|FG002|Overall Study|Withdrawal by Subject|1|||
160660575|NCT00150462|580139571|FG003|Overall Study|Withdrawal by Subject|0|||
160660576|NCT00150462|580139572|FG004|Overall Study|Withdrawal by Subject|1|||
160660577|NCT00150462|580139573|FG005|Overall Study|Withdrawal by Subject|2|||
160660578|NCT00150462|580139574|FG006|Overall Study|Withdrawal by Subject|0|||
160660579|NCT00150462|580139575|FG007|Overall Study|Withdrawal by Subject|1|||
160660580|NCT00150462|580139576|FG008|Overall Study|Withdrawal by Subject|0|||
160660581|NCT00150462|580139577|FG009|Overall Study|Withdrawal by Subject|1|||
160660582|NCT00150462|580139578|FG010|Overall Study|Withdrawal by Subject|0|||
160660583|NCT00150462|580139568|FG000|Overall Study|Death|0|||
160660584|NCT00150462|580139569|FG001|Overall Study|Death|1|||
160660585|NCT00150462|580139570|FG002|Overall Study|Death|0|||
160660586|NCT00150462|580139571|FG003|Overall Study|Death|0|||
160660587|NCT00150462|580139572|FG004|Overall Study|Death|0|||
160660588|NCT00150462|580139573|FG005|Overall Study|Death|0|||
160660589|NCT00150462|580139574|FG006|Overall Study|Death|0|||
160660590|NCT00150462|580139575|FG007|Overall Study|Death|0|||
160660591|NCT00150462|580139576|FG008|Overall Study|Death|1|||
160660592|NCT00150462|580139577|FG009|Overall Study|Death|0|||
160660593|NCT00150462|580139578|FG010|Overall Study|Death|0|||
160660594|NCT00150462|580139568|FG000|Overall Study|Adverse Event|0|||
160660595|NCT00150462|580139569|FG001|Overall Study|Adverse Event|0|||
160660596|NCT00150462|580139570|FG002|Overall Study|Adverse Event|0|||
160660597|NCT00150462|580139571|FG003|Overall Study|Adverse Event|1|||
160660598|NCT00150462|580139572|FG004|Overall Study|Adverse Event|0|||
160660599|NCT00150462|580139573|FG005|Overall Study|Adverse Event|0|||
160660600|NCT00150462|580139574|FG006|Overall Study|Adverse Event|0|||
160660601|NCT00150462|580139575|FG007|Overall Study|Adverse Event|2|||
160660602|NCT00150462|580139576|FG008|Overall Study|Adverse Event|0|||
160660603|NCT00150462|580139577|FG009|Overall Study|Adverse Event|1|||
160660604|NCT00150462|580139578|FG010|Overall Study|Adverse Event|0|||
160660605|NCT00150462|580139568|FG000|Overall Study|Physician Decision|0|||
160660606|NCT00150462|580139569|FG001|Overall Study|Physician Decision|0|||
160660607|NCT00150462|580139570|FG002|Overall Study|Physician Decision|1|||
160660608|NCT00150462|580139571|FG003|Overall Study|Physician Decision|1|||
160477943|NCT02367794|579476859|FG001|Overall Study|Moved to Roll-Over Study|15|||
160477944|NCT02367794|579476860|FG002|Overall Study|Moved to Roll-Over Study|13|||
160477945|NCT02367794|579476858|FG000|Overall Study|Sponsor Request|60|||
160477946|NCT02367794|579476859|FG001|Overall Study|Sponsor Request|57|||
160477947|NCT02367794|579476860|FG002|Overall Study|Sponsor Request|45|||
160477948|NCT02367794|579476858|FG000|Overall Study|Moved into PTAP Study|0|||
160477949|NCT02367794|579476859|FG001|Overall Study|Moved into PTAP Study|2|||
160477950|NCT02367794|579476860|FG002|Overall Study|Moved into PTAP Study|3|||
160477951|NCT02367794|579476858|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
160477952|NCT02367794|579476859|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
160477953|NCT02367794|579476860|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
160477954|NCT02367794|579476858|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
160477955|NCT02367794|579476859|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
160477956|NCT02367794|579476860|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
160477957|NCT02367794|579476858|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
160477958|NCT02367794|579476859|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
160477959|NCT02367794|579476860|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
160477960|NCT02367794|579476858|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
160477961|NCT02367794|579476859|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
160477962|NCT02367794|579476860|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
160477963|NCT01986348|579476861|FG000|Overall Study|Death|8|||
160477964|NCT01986348|579476862|FG001|Overall Study|Death|22|||
160477965|NCT01986348|579476863|FG002|Overall Study|Death|10|||
160477966|NCT01986348|579476864|FG003|Overall Study|Death|21|||
160603676|NCT00166517|579926757|FG001|Overall Study|Protocol Violation|1|||
160603677|NCT00166517|579926756|FG000|Overall Study|Withdrawal by Subject|0|||
160477967|NCT01986348|579476861|FG000|Overall Study|Lost to Follow-up|0|||
160477968|NCT01986348|579476862|FG001|Overall Study|Lost to Follow-up|0|||
160477969|NCT01986348|579476863|FG002|Overall Study|Lost to Follow-up|0|||
160477970|NCT01986348|579476864|FG003|Overall Study|Lost to Follow-up|2|||
160477971|NCT01986348|579476861|FG000|Overall Study|Physician Decision|0|||
160477972|NCT01986348|579476862|FG001|Overall Study|Physician Decision|0|||
160477973|NCT01986348|579476863|FG002|Overall Study|Physician Decision|0|||
160477974|NCT01986348|579476864|FG003|Overall Study|Physician Decision|1|||
160477975|NCT01986348|579476861|FG000|Overall Study|Progressive Disease|0|||
160477976|NCT01986348|579476862|FG001|Overall Study|Progressive Disease|0|||
160477977|NCT01986348|579476863|FG002|Overall Study|Progressive Disease|2|||
160477978|NCT01986348|579476864|FG003|Overall Study|Progressive Disease|0|||
160477979|NCT01986348|579476861|FG000|Overall Study|Withdrawal by Participant|0|||
160477980|NCT01986348|579476862|FG001|Overall Study|Withdrawal by Participant|1|||
160477981|NCT01986348|579476863|FG002|Overall Study|Withdrawal by Participant|2|||
160477982|NCT01986348|579476864|FG003|Overall Study|Withdrawal by Participant|1|||
160477983|NCT01986348|579476861|FG000|Overall Study|Study Terminated by Sponsor|0|||
160477984|NCT01986348|579476862|FG001|Overall Study|Study Terminated by Sponsor|0|||
160477985|NCT01986348|579476863|FG002|Overall Study|Study Terminated by Sponsor|0|||
160477986|NCT01986348|579476864|FG003|Overall Study|Study Terminated by Sponsor|3|||
160477987|NCT01986348|579476861|FG000|Overall Study|Other-unspecified|0|||
160603678|NCT00166517|579926757|FG001|Overall Study|Withdrawal by Subject|1|||
160603679|NCT03094611|579926761|FG000|Overall Study|Lack of Efficacy|1|||
160603680|NCT03094611|579926761|FG000|Overall Study|Stem Cell Transplant|1|||
160603681|NCT04285853|579926762|FG000|Overall Study|Withdrawal by Subject|1|||
160603682|NCT04285853|579926763|FG001|Overall Study|Withdrawal by Subject|0|||
160477988|NCT01986348|579476862|FG001|Overall Study|Other-unspecified|1|||
160477989|NCT01986348|579476863|FG002|Overall Study|Other-unspecified|0|||
160477990|NCT01986348|579476864|FG003|Overall Study|Other-unspecified|2|||
160603683|NCT04285853|579926762|FG000|Overall Study|Lost to Follow-up|9|||
160477991|NCT02010684|579476865|FG000|Overall Study|Lost to Follow-up|8|||
160477992|NCT02010684|579476866|FG001|Overall Study|Lost to Follow-up|18|||
160477993|NCT02010684|579476865|FG000|Overall Study|Withdrawal by Subject|4|||
160477994|NCT02010684|579476866|FG001|Overall Study|Withdrawal by Subject|5|||
160477995|NCT02942771|579476872|FG000|Overall Study|Adverse Event|1|||
160477996|NCT02942771|579476873|FG001|Overall Study|Adverse Event|0|||
160477997|NCT02942771|579476874|FG002|Overall Study|Adverse Event|0|||
160477998|NCT02942771|579476875|FG003|Overall Study|Adverse Event|0|||
160477999|NCT02942771|579476876|FG004|Overall Study|Adverse Event|2|||
160478000|NCT02942771|579476872|FG000|Overall Study|Lost to Follow-up|1|||
160478001|NCT02942771|579476873|FG001|Overall Study|Lost to Follow-up|0|||
160478002|NCT02942771|579476874|FG002|Overall Study|Lost to Follow-up|0|||
160478003|NCT02942771|579476875|FG003|Overall Study|Lost to Follow-up|0|||
160478004|NCT02942771|579476876|FG004|Overall Study|Lost to Follow-up|0|||
160478005|NCT02942771|579476872|FG000|Overall Study|Withdrawal by Subject|1|||
160478006|NCT02942771|579476873|FG001|Overall Study|Withdrawal by Subject|0|||
160478007|NCT02942771|579476874|FG002|Overall Study|Withdrawal by Subject|0|||
160478008|NCT02942771|579476875|FG003|Overall Study|Withdrawal by Subject|0|||
160478009|NCT02942771|579476876|FG004|Overall Study|Withdrawal by Subject|2|||
160478010|NCT02158806|579476877|FG000|Overall Study|Death|2|||
160478011|NCT02158806|579476878|FG001|Overall Study|Death|0|||
160478012|NCT02158806|579476877|FG000|Overall Study|Withdrawal by Subject|2|||
160478013|NCT02158806|579476878|FG001|Overall Study|Withdrawal by Subject|0|||
160478014|NCT02158806|579476877|FG000|Overall Study|Lost to Follow-up|0|||
160478015|NCT02158806|579476878|FG001|Overall Study|Lost to Follow-up|3|||
160478016|NCT02158806|579476877|FG000|Overall Study|Moved out of area|0|||
160478017|NCT02158806|579476878|FG001|Overall Study|Moved out of area|1|||
160478018|NCT02158806|579476877|FG000|Overall Study|Transferred to palliative care|0|||
160478019|NCT02158806|579476878|FG001|Overall Study|Transferred to palliative care|1|||
160478020|NCT01898299|579476882|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
160478021|NCT01898299|579476883|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
160478022|NCT02340806|579476884|FG000|Overall Study|Protocol Violation|2|||
160603684|NCT04285853|579926763|FG001|Overall Study|Lost to Follow-up|5|||
160603685|NCT01496274|579926764|FG000|Overall Study|Protocol Violation|0|||
160603686|NCT01496274|579926765|FG001|Overall Study|Protocol Violation|1|||
160603687|NCT01496274|579926764|FG000|Overall Study|Adverse Event|1|||
160603688|NCT01496274|579926765|FG001|Overall Study|Adverse Event|1|||
160603689|NCT01496274|579926764|FG000|Overall Study|Withdrawal by Subject|2|||
160603690|NCT01496274|579926765|FG001|Overall Study|Withdrawal by Subject|0|||
160603691|NCT01496274|579926764|FG000|Overall Study|Lost to Follow-up|0|||
160660609|NCT00150462|580139572|FG004|Overall Study|Physician Decision|0|||
160660610|NCT00150462|580139573|FG005|Overall Study|Physician Decision|0|||
160478023|NCT02340806|579476885|FG001|Overall Study|Protocol Violation|0|||
160478024|NCT02340806|579476884|FG000|Overall Study|epidural catheter replaced|2|||
160478025|NCT02340806|579476885|FG001|Overall Study|epidural catheter replaced|1|||
160478026|NCT02340806|579476884|FG000|Overall Study|history of chronic pain medication|1|||
160478027|NCT02340806|579476885|FG001|Overall Study|history of chronic pain medication|0|||
160478028|NCT02340806|579476884|FG000|Overall Study|re-dose < 90 min of CSE|1|||
160478029|NCT02340806|579476885|FG001|Overall Study|re-dose < 90 min of CSE|3|||
160478030|NCT01186809|579476886|FG000|Overall Study|Death|30|||
160603692|NCT01496274|579926765|FG001|Overall Study|Lost to Follow-up|3|||
160603693|NCT00196196|579926771|FG000|Overall Study|Withdrawal by Subject|2|||
160603694|NCT00196196|579926771|FG000|Overall Study|Did not have required condition (hydroce|5|||
160478031|NCT01159600|579476887|FG000|Overall Study|Not treated|0|||
160603695|NCT02679781|579926774|FG000|Overall Study|Lost to Follow-up|1|||
160660611|NCT00150462|580139574|FG006|Overall Study|Physician Decision|0|||
160660612|NCT00150462|580139575|FG007|Overall Study|Physician Decision|0|||
160660613|NCT00150462|580139576|FG008|Overall Study|Physician Decision|0|||
160660614|NCT00150462|580139577|FG009|Overall Study|Physician Decision|0|||
160660615|NCT00150462|580139578|FG010|Overall Study|Physician Decision|0|||
160660616|NCT00150462|580139568|FG000|Overall Study|Other|0|||
160660617|NCT00150462|580139569|FG001|Overall Study|Other|0|||
160478032|NCT01159600|579476888|FG001|Overall Study|Not treated|0|||
160478033|NCT01159600|579476889|FG002|Overall Study|Not treated|1|||
160478034|NCT01159600|579476890|FG003|Overall Study|Not treated|0|||
160478035|NCT01159600|579476891|FG004|Overall Study|Not treated|0|||
160478036|NCT01159600|579476892|FG005|Overall Study|Not treated|1|||
160478037|NCT01159600|579476893|FG006|Overall Study|Not treated|2|||
160478038|NCT01159600|579476894|FG007|Overall Study|Not treated|2|||
160478039|NCT01159600|579476887|FG000|Overall Study|Adverse Event|7|||
160478040|NCT01159600|579476888|FG001|Overall Study|Adverse Event|2|||
160478041|NCT01159600|579476889|FG002|Overall Study|Adverse Event|5|||
160478042|NCT01159600|579476890|FG003|Overall Study|Adverse Event|1|||
160478043|NCT01159600|579476891|FG004|Overall Study|Adverse Event|8|||
160478044|NCT01159600|579476892|FG005|Overall Study|Adverse Event|6|||
160478045|NCT01159600|579476893|FG006|Overall Study|Adverse Event|7|||
160478046|NCT01159600|579476894|FG007|Overall Study|Adverse Event|5|||
160478047|NCT01159600|579476887|FG000|Overall Study|Lack of Efficacy|0|||
160478048|NCT01159600|579476888|FG001|Overall Study|Lack of Efficacy|0|||
160660618|NCT00150462|580139570|FG002|Overall Study|Other|0|||
160660619|NCT00150462|580139571|FG003|Overall Study|Other|0|||
160660620|NCT00150462|580139572|FG004|Overall Study|Other|0|||
160660621|NCT00150462|580139573|FG005|Overall Study|Other|0|||
160478049|NCT01159600|579476889|FG002|Overall Study|Lack of Efficacy|0|||
160478050|NCT01159600|579476890|FG003|Overall Study|Lack of Efficacy|0|||
160478051|NCT01159600|579476891|FG004|Overall Study|Lack of Efficacy|2|||
160660622|NCT00150462|580139574|FG006|Overall Study|Other|0|||
160603696|NCT02679781|579926775|FG001|Overall Study|Lost to Follow-up|2|||
160603697|NCT02679781|579926774|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
160603698|NCT02679781|579926775|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
160603699|NCT04209400|579926776|FG000|Overall Study|Withdrawal by Subject|0|||
160603700|NCT04209400|579926777|FG001|Overall Study|Withdrawal by Subject|1|||
160603701|NCT04968353|579926780|FG000|Overall Study|Non-compliance|1|||
160478052|NCT01159600|579476892|FG005|Overall Study|Lack of Efficacy|0|||
160478053|NCT01159600|579476893|FG006|Overall Study|Lack of Efficacy|0|||
160478054|NCT01159600|579476894|FG007|Overall Study|Lack of Efficacy|1|||
160478055|NCT01159600|579476887|FG000|Overall Study|Non compliant with protocol|2|||
160478056|NCT01159600|579476888|FG001|Overall Study|Non compliant with protocol|1|||
160478057|NCT01159600|579476889|FG002|Overall Study|Non compliant with protocol|0|||
160478058|NCT01159600|579476890|FG003|Overall Study|Non compliant with protocol|0|||
160478059|NCT01159600|579476891|FG004|Overall Study|Non compliant with protocol|2|||
160478060|NCT01159600|579476892|FG005|Overall Study|Non compliant with protocol|0|||
160478061|NCT01159600|579476893|FG006|Overall Study|Non compliant with protocol|2|||
160478062|NCT01159600|579476894|FG007|Overall Study|Non compliant with protocol|0|||
160478063|NCT01159600|579476887|FG000|Overall Study|Lost to Follow-up|2|||
160478064|NCT01159600|579476888|FG001|Overall Study|Lost to Follow-up|3|||
160478065|NCT01159600|579476889|FG002|Overall Study|Lost to Follow-up|4|||
160478066|NCT01159600|579476890|FG003|Overall Study|Lost to Follow-up|3|||
160478067|NCT01159600|579476891|FG004|Overall Study|Lost to Follow-up|3|||
160478068|NCT01159600|579476892|FG005|Overall Study|Lost to Follow-up|0|||
160478069|NCT01159600|579476893|FG006|Overall Study|Lost to Follow-up|3|||
160478070|NCT01159600|579476894|FG007|Overall Study|Lost to Follow-up|2|||
160478071|NCT01159600|579476887|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
160478072|NCT01159600|579476888|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
160478073|NCT01159600|579476889|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
160478074|NCT01159600|579476890|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
160478075|NCT01159600|579476891|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
160478076|NCT01159600|579476892|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
160478077|NCT01159600|579476893|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
160478078|NCT01159600|579476894|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
160478079|NCT01159600|579476887|FG000|Overall Study|Other reason not defined above|3|||
160478080|NCT01159600|579476888|FG001|Overall Study|Other reason not defined above|0|||
160478081|NCT01159600|579476889|FG002|Overall Study|Other reason not defined above|4|||
160478082|NCT01159600|579476890|FG003|Overall Study|Other reason not defined above|2|||
160478083|NCT01159600|579476891|FG004|Overall Study|Other reason not defined above|5|||
160478084|NCT01159600|579476892|FG005|Overall Study|Other reason not defined above|7|||
160478085|NCT01159600|579476893|FG006|Overall Study|Other reason not defined above|3|||
160478086|NCT01159600|579476894|FG007|Overall Study|Other reason not defined above|3|||
160478087|NCT05356130|579478200|FG000|Overall Study|Withdrawal by Subject|0|||
160478088|NCT05356130|579478201|FG001|Overall Study|Withdrawal by Subject|0|||
160478089|NCT05356130|579478202|FG002|Overall Study|Withdrawal by Subject|3|||
160478090|NCT04820023|579478205|FG000|Overall Study|Death|0|||
160478091|NCT04820023|579478206|FG001|Overall Study|Death|0|||
160478092|NCT04820023|579478207|FG002|Overall Study|Death|0|||
160478093|NCT04820023|579478208|FG003|Overall Study|Death|0|||
160478094|NCT04820023|579478209|FG004|Overall Study|Death|0|||
160478095|NCT04820023|579478210|FG005|Overall Study|Death|0|||
160478096|NCT04820023|579478211|FG006|Overall Study|Death|1|||
160478097|NCT04820023|579478212|FG007|Overall Study|Death|0|||
160478098|NCT04820023|579478213|FG008|Overall Study|Death|1|||
160478099|NCT04820023|579478205|FG000|Overall Study|Withdrawal by Subject|1|||
160478100|NCT04820023|579478206|FG001|Overall Study|Withdrawal by Subject|2|||
160478101|NCT04820023|579478207|FG002|Overall Study|Withdrawal by Subject|2|||
160478102|NCT04820023|579478208|FG003|Overall Study|Withdrawal by Subject|1|||
160478103|NCT04820023|579478209|FG004|Overall Study|Withdrawal by Subject|4|||
160478104|NCT04820023|579478210|FG005|Overall Study|Withdrawal by Subject|3|||
160478105|NCT04820023|579478211|FG006|Overall Study|Withdrawal by Subject|3|||
160478106|NCT04820023|579478212|FG007|Overall Study|Withdrawal by Subject|6|||
160478107|NCT04820023|579478213|FG008|Overall Study|Withdrawal by Subject|5|||
160478108|NCT04820023|579478205|FG000|Overall Study|Progressive Disease|3|||
160478109|NCT04820023|579478206|FG001|Overall Study|Progressive Disease|0|||
160478110|NCT04820023|579478207|FG002|Overall Study|Progressive Disease|2|||
160478111|NCT04820023|579478208|FG003|Overall Study|Progressive Disease|2|||
160478112|NCT04820023|579478209|FG004|Overall Study|Progressive Disease|2|||
160478113|NCT04820023|579478210|FG005|Overall Study|Progressive Disease|0|||
160478114|NCT04820023|579478211|FG006|Overall Study|Progressive Disease|1|||
160478115|NCT04820023|579478212|FG007|Overall Study|Progressive Disease|1|||
160478116|NCT04820023|579478213|FG008|Overall Study|Progressive Disease|0|||
160478117|NCT04820023|579478205|FG000|Overall Study|New anti-cancer therapy|0|||
160478118|NCT04820023|579478206|FG001|Overall Study|New anti-cancer therapy|0|||
160478119|NCT04820023|579478207|FG002|Overall Study|New anti-cancer therapy|0|||
160478120|NCT04820023|579478208|FG003|Overall Study|New anti-cancer therapy|0|||
160478121|NCT04820023|579478209|FG004|Overall Study|New anti-cancer therapy|2|||
160478122|NCT04820023|579478210|FG005|Overall Study|New anti-cancer therapy|0|||
160478123|NCT04820023|579478211|FG006|Overall Study|New anti-cancer therapy|0|||
160478124|NCT04820023|579478212|FG007|Overall Study|New anti-cancer therapy|0|||
160478125|NCT04820023|579478213|FG008|Overall Study|New anti-cancer therapy|0|||
160478126|NCT04820023|579478205|FG000|Overall Study|Other|0|||
160478127|NCT04820023|579478206|FG001|Overall Study|Other|1|||
160478128|NCT04820023|579478207|FG002|Overall Study|Other|0|||
160478129|NCT04820023|579478208|FG003|Overall Study|Other|0|||
160478130|NCT04820023|579478209|FG004|Overall Study|Other|0|||
160478131|NCT04820023|579478210|FG005|Overall Study|Other|0|||
160478132|NCT04820023|579478211|FG006|Overall Study|Other|0|||
160478133|NCT04820023|579478212|FG007|Overall Study|Other|2|||
160478134|NCT04820023|579478213|FG008|Overall Study|Other|0|||
160478135|NCT02109172|579478224|FG000|Overall Study|Withdrawal by Subject|1|||
160478136|NCT02109172|579478225|FG001|Overall Study|Withdrawal by Subject|0|||
160478137|NCT02109172|579478226|FG002|Overall Study|Withdrawal by Subject|0|||
160478138|NCT02109172|579478227|FG003|Overall Study|Withdrawal by Subject|1|||
160478139|NCT02109172|579478228|FG004|Overall Study|Withdrawal by Subject|0|||
160478140|NCT02109172|579478229|FG005|Overall Study|Withdrawal by Subject|0|||
160478141|NCT02109172|579478224|FG000|Overall Study|Adverse Event|0|||
160478142|NCT02109172|579478225|FG001|Overall Study|Adverse Event|0|||
160478143|NCT02109172|579478226|FG002|Overall Study|Adverse Event|1|||
160478144|NCT02109172|579478227|FG003|Overall Study|Adverse Event|0|||
160478145|NCT02109172|579478228|FG004|Overall Study|Adverse Event|0|||
160478146|NCT02109172|579478229|FG005|Overall Study|Adverse Event|1|||
160478147|NCT02109172|579478224|FG000|Overall Study|Death|0|||
160478148|NCT02109172|579478225|FG001|Overall Study|Death|0|||
160478149|NCT02109172|579478226|FG002|Overall Study|Death|0|||
160478150|NCT02109172|579478227|FG003|Overall Study|Death|0|||
160478151|NCT02109172|579478228|FG004|Overall Study|Death|1|||
160478152|NCT02109172|579478229|FG005|Overall Study|Death|0|||
160478153|NCT00538629|579478230|FG000|Overall Study|At subject's request|1|||
160478154|NCT00538629|579478230|FG000|Overall Study|Adverse Event|2|||
160478155|NCT00538629|579478230|FG000|Overall Study|Lack of Efficacy|12|||
160478156|NCT00538629|579478230|FG000|Overall Study|Lost to Follow-up|6|||
160478157|NCT00538629|579478230|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
160478158|NCT01922102|579478233|FG000|Overall Study|Withdrawal by Subject|7|||
160478159|NCT01922102|579478234|FG001|Overall Study|Withdrawal by Subject|3|||
160478160|NCT01922102|579478235|FG002|Overall Study|Withdrawal by Subject|7|||
160478161|NCT01922102|579478233|FG000|Overall Study|Physician Decision|0|||
160478162|NCT01922102|579478234|FG001|Overall Study|Physician Decision|2|||
160478163|NCT01922102|579478235|FG002|Overall Study|Physician Decision|1|||
160478164|NCT01922102|579478233|FG000|Overall Study|Adverse Event|1|||
160478165|NCT01922102|579478234|FG001|Overall Study|Adverse Event|2|||
160478166|NCT01922102|579478235|FG002|Overall Study|Adverse Event|0|||
160478167|NCT01922102|579478233|FG000|Overall Study|Lost to Follow-up|1|||
160478168|NCT01922102|579478234|FG001|Overall Study|Lost to Follow-up|0|||
160478169|NCT01922102|579478235|FG002|Overall Study|Lost to Follow-up|0|||
160478170|NCT01922102|579478233|FG000|Overall Study|Administrative problems|0|||
160478171|NCT01922102|579478234|FG001|Overall Study|Administrative problems|2|||
160478172|NCT01922102|579478235|FG002|Overall Study|Administrative problems|0|||
160478173|NCT05203822|579478236|FG000|Overall Study|Adverse Event|1|||
160478174|NCT05203822|579478236|FG000|Overall Study|Withdrawal by Subject|1|||
160478175|NCT01816165|579478243|FG000|Overall Study|Adverse Event|1|||
160478176|NCT01816165|579478244|FG001|Overall Study|Adverse Event|0|||
160478177|NCT01816165|579478245|FG002|Overall Study|Adverse Event|0|||
160478178|NCT01816165|579478246|FG003|Overall Study|Adverse Event|0|||
160478179|NCT00447499|579478247|FG000|Overall Study|Adverse Event|1|||
160478180|NCT00447499|579478247|FG000|Overall Study|Patient Decision|4|||
160478181|NCT00447499|579478247|FG000|Overall Study|Sponsor Decision|1|||
160478182|NCT00447499|579478247|FG000|Overall Study|Physician Decision|1|||
160478183|NCT03360071|579478249|FG000|Overall Study|Lost to Follow-up|1|||
160478184|NCT03360071|579478250|FG001|Overall Study|Lost to Follow-up|0|||
160478185|NCT03184519|579478259|FG000|Overall Study|Lost to Follow-up|6|||
160478186|NCT03184519|579478259|FG000|Overall Study|Physician Decision|21|||
160478187|NCT02823574|579478263|FG000|Randomization|Disease Progression|0|||
160478188|NCT02823574|579478264|FG001|Randomization|Disease Progression|0|||
160478189|NCT02823574|579478265|FG002|Randomization|Disease Progression|1|||
160478190|NCT02823574|579478266|FG003|Randomization|Disease Progression|0|||
160478191|NCT02823574|579478263|FG000|Randomization|AE unrelated to Study Drug|1|||
160478192|NCT02823574|579478264|FG001|Randomization|AE unrelated to Study Drug|0|||
160478193|NCT02823574|579478265|FG002|Randomization|AE unrelated to Study Drug|0|||
160478194|NCT02823574|579478266|FG003|Randomization|AE unrelated to Study Drug|0|||
160478195|NCT02823574|579478263|FG000|Treatment Period|Poor/Non Compliance|1|||
160478196|NCT02823574|579478264|FG001|Treatment Period|Poor/Non Compliance|0|||
160478197|NCT02823574|579478265|FG002|Treatment Period|Poor/Non Compliance|0|||
160478198|NCT02823574|579478266|FG003|Treatment Period|Poor/Non Compliance|1|||
160603702|NCT04968353|579926781|FG001|Overall Study|Non-compliance|0|||
160603703|NCT04968353|579926782|FG002|Overall Study|Non-compliance|2|||
160603704|NCT04968353|579926783|FG003|Overall Study|Non-compliance|0|||
160603705|NCT00318370|579926784|FG000|Period 1|Lack of Efficacy|5|||
160478199|NCT02823574|579478263|FG000|Treatment Period|Maximum Clinical Benefit|8|||
160478200|NCT02823574|579478264|FG001|Treatment Period|Maximum Clinical Benefit|4|||
160478201|NCT02823574|579478265|FG002|Treatment Period|Maximum Clinical Benefit|7|||
160478202|NCT02823574|579478266|FG003|Treatment Period|Maximum Clinical Benefit|1|||
160478203|NCT02823574|579478263|FG000|Treatment Period|Lost to Follow-up|1|||
160478204|NCT02823574|579478264|FG001|Treatment Period|Lost to Follow-up|1|||
160478205|NCT02823574|579478265|FG002|Treatment Period|Lost to Follow-up|0|||
160478206|NCT02823574|579478266|FG003|Treatment Period|Lost to Follow-up|0|||
160478207|NCT02823574|579478263|FG000|Treatment Period|Participant withdrew consent|4|||
160478208|NCT02823574|579478264|FG001|Treatment Period|Participant withdrew consent|0|||
160478209|NCT02823574|579478265|FG002|Treatment Period|Participant withdrew consent|0|||
160478210|NCT02823574|579478266|FG003|Treatment Period|Participant withdrew consent|1|||
160478211|NCT02823574|579478263|FG000|Treatment Period|Participant request to discontinue|5|||
160478212|NCT02823574|579478264|FG001|Treatment Period|Participant request to discontinue|0|||
160478213|NCT02823574|579478265|FG002|Treatment Period|Participant request to discontinue|3|||
160478214|NCT02823574|579478266|FG003|Treatment Period|Participant request to discontinue|2|||
160478215|NCT02823574|579478263|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
160478216|NCT02823574|579478264|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
160478217|NCT02823574|579478265|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
160478218|NCT02823574|579478266|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
160478219|NCT02823574|579478263|FG000|Treatment Period|Study Drug Toxicity|11|||
160478220|NCT02823574|579478264|FG001|Treatment Period|Study Drug Toxicity|2|||
160478221|NCT02823574|579478265|FG002|Treatment Period|Study Drug Toxicity|14|||
160478222|NCT02823574|579478266|FG003|Treatment Period|Study Drug Toxicity|4|||
160478223|NCT02823574|579478263|FG000|Treatment Period|Disease Progression|113|||
160478224|NCT02823574|579478264|FG001|Treatment Period|Disease Progression|64|||
160478225|NCT02823574|579478265|FG002|Treatment Period|Disease Progression|82|||
160478226|NCT02823574|579478266|FG003|Treatment Period|Disease Progression|43|||
160478227|NCT02823574|579478263|FG000|Treatment Period|Other reasons|5|||
160478228|NCT02823574|579478264|FG001|Treatment Period|Other reasons|9|||
160478229|NCT02823574|579478265|FG002|Treatment Period|Other reasons|3|||
160478230|NCT02823574|579478266|FG003|Treatment Period|Other reasons|6|||
160478231|NCT02823574|579478263|FG000|Treatment Period|Participant no longer meets study criteria|0|||
160478232|NCT02823574|579478264|FG001|Treatment Period|Participant no longer meets study criteria|0|||
160478233|NCT02823574|579478265|FG002|Treatment Period|Participant no longer meets study criteria|1|||
160478234|NCT02823574|579478266|FG003|Treatment Period|Participant no longer meets study criteria|0|||
160478235|NCT02823574|579478263|FG000|Treatment Period|Death|0|||
160478236|NCT02823574|579478264|FG001|Treatment Period|Death|0|||
160478237|NCT02823574|579478265|FG002|Treatment Period|Death|3|||
160478238|NCT02823574|579478266|FG003|Treatment Period|Death|1|||
160478239|NCT00590759|579478267|FG000|Overall Study|Death|52|||
160603706|NCT00318370|579926785|FG001|Period 1|Lack of Efficacy|0|||
160603707|NCT00318370|579926786|FG002|Period 1|Lack of Efficacy|0|||
160478240|NCT00590759|579478267|FG000|Overall Study|Lost to Follow-up|28|||
160478241|NCT00096278|579478272|FG000|Overall Study|No follow-up data|15|||
160478242|NCT00096278|579478273|FG001|Overall Study|No follow-up data|18|||
160603708|NCT00318370|579926784|FG000|Period 1|Physician Decision|1|||
160478243|NCT00096278|579478272|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
160478244|NCT00096278|579478273|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
160478245|NCT02865083|579478274|FG000|Overall Study|Early Termination|3|||
160478246|NCT02865083|579478275|FG001|Overall Study|Early Termination|1|||
160603709|NCT00318370|579926785|FG001|Period 1|Physician Decision|0|||
160603710|NCT00318370|579926786|FG002|Period 1|Physician Decision|0|||
160603711|NCT00318370|579926784|FG000|Period 1|Withdrawal by Subject|1|||
160478247|NCT03651271|579478276|FG000|Overall Study|Death|4|||
160478248|NCT03651271|579478277|FG001|Overall Study|Death|37|||
160478249|NCT03651271|579478278|FG002|Overall Study|Death|0|||
160478250|NCT03651271|579478279|FG003|Overall Study|Death|2|||
160478251|NCT03651271|579478280|FG004|Overall Study|Death|6|||
160478252|NCT03651271|579478276|FG000|Overall Study|Lost to Follow-up|1|||
160478253|NCT03651271|579478277|FG001|Overall Study|Lost to Follow-up|5|||
160478254|NCT03651271|579478278|FG002|Overall Study|Lost to Follow-up|0|||
160478255|NCT03651271|579478279|FG003|Overall Study|Lost to Follow-up|1|||
160478256|NCT03651271|579478280|FG004|Overall Study|Lost to Follow-up|0|||
160478257|NCT03651271|579478276|FG000|Overall Study|Physician Decision|0|||
160478258|NCT03651271|579478277|FG001|Overall Study|Physician Decision|2|||
160603712|NCT00318370|579926785|FG001|Period 1|Withdrawal by Subject|0|||
160603713|NCT00318370|579926786|FG002|Period 1|Withdrawal by Subject|0|||
160603714|NCT00318370|579926784|FG000|Period 2|Adverse Event|0|||
160603715|NCT00318370|579926785|FG001|Period 2|Adverse Event|3|||
160603716|NCT00318370|579926786|FG002|Period 2|Adverse Event|0|||
160603717|NCT00318370|579926784|FG000|Period 2|Lack of Efficacy|0|||
160603718|NCT00318370|579926785|FG001|Period 2|Lack of Efficacy|5|||
160603719|NCT00318370|579926786|FG002|Period 2|Lack of Efficacy|0|||
160603720|NCT00318370|579926784|FG000|Period 2|Physician Decision|0|||
160603721|NCT00318370|579926785|FG001|Period 2|Physician Decision|1|||
160603722|NCT00318370|579926786|FG002|Period 2|Physician Decision|0|||
160603723|NCT00318370|579926784|FG000|Period 2|Withdrawal by Subject|0|||
160603724|NCT00318370|579926785|FG001|Period 2|Withdrawal by Subject|1|||
160660623|NCT00150462|580139575|FG007|Overall Study|Other|0|||
160660624|NCT00150462|580139576|FG008|Overall Study|Other|0|||
160660625|NCT00150462|580139577|FG009|Overall Study|Other|1|||
160660626|NCT00150462|580139578|FG010|Overall Study|Other|1|||
160660627|NCT00569374|580139579|FG000|Overall Study|Withdrawal by Subject|4|||
160660628|NCT03107091|580139580|FG000|Overall Study|Physician Decision|1|||
160660629|NCT04466111|580139583|FG000|Prior to Trial Phase|Physician Decision|1|||
160660630|NCT03553823|580139592|FG000|Overall Study|Physician Decision|0|||
160660631|NCT03553823|580139593|FG001|Overall Study|Physician Decision|1|||
160660632|NCT00893464|580139594|FG000|Overall Study|Did not complete therapy/experience PD|0|||
160660633|NCT00893464|580139595|FG001|Overall Study|Did not complete therapy/experience PD|0|||
160660634|NCT00893464|580139596|FG002|Overall Study|Did not complete therapy/experience PD|0|||
160660635|NCT00893464|580139597|FG003|Overall Study|Did not complete therapy/experience PD|0|||
160660636|NCT00893464|580139598|FG004|Overall Study|Did not complete therapy/experience PD|0|||
160660637|NCT00893464|580139599|FG005|Overall Study|Did not complete therapy/experience PD|0|||
160660638|NCT00893464|580139600|FG006|Overall Study|Did not complete therapy/experience PD|2|||
160660639|NCT00893464|580139601|FG007|Overall Study|Did not complete therapy/experience PD|2|||
160478259|NCT03651271|579478278|FG002|Overall Study|Physician Decision|0|||
160478260|NCT03651271|579478279|FG003|Overall Study|Physician Decision|0|||
160478261|NCT03651271|579478280|FG004|Overall Study|Physician Decision|0|||
160478262|NCT03651271|579478276|FG000|Overall Study|Withdrawal by Subject|1|||
160478263|NCT03651271|579478277|FG001|Overall Study|Withdrawal by Subject|15|||
160478264|NCT03651271|579478278|FG002|Overall Study|Withdrawal by Subject|0|||
160603725|NCT00318370|579926786|FG002|Period 2|Withdrawal by Subject|0|||
160603726|NCT00318370|579926784|FG000|Period 2|Other|0|||
160603727|NCT00318370|579926785|FG001|Period 2|Other|1|||
160603728|NCT00318370|579926786|FG002|Period 2|Other|0|||
160603729|NCT00318370|579926784|FG000|Period 3|Adverse Event|0|||
160478265|NCT03651271|579478279|FG003|Overall Study|Withdrawal by Subject|0|||
160478266|NCT03651271|579478280|FG004|Overall Study|Withdrawal by Subject|1|||
160478267|NCT03651271|579478276|FG000|Overall Study|Patient medically unable to continue|0|||
160478268|NCT03651271|579478277|FG001|Overall Study|Patient medically unable to continue|0|||
160478269|NCT03651271|579478278|FG002|Overall Study|Patient medically unable to continue|0|||
160603730|NCT00318370|579926785|FG001|Period 3|Adverse Event|0|||
160603731|NCT00318370|579926786|FG002|Period 3|Adverse Event|1|||
160603732|NCT00318370|579926784|FG000|Period 3|Lack of Efficacy|0|||
160603733|NCT00318370|579926785|FG001|Period 3|Lack of Efficacy|0|||
160603734|NCT00318370|579926786|FG002|Period 3|Lack of Efficacy|24|||
160603735|NCT00318370|579926784|FG000|Period 3|Death|0|||
160603736|NCT00318370|579926785|FG001|Period 3|Death|0|||
160603737|NCT00318370|579926786|FG002|Period 3|Death|1|||
160603738|NCT00318370|579926784|FG000|Period 3|Physician Decision|0|||
160603739|NCT00318370|579926785|FG001|Period 3|Physician Decision|0|||
160603740|NCT00318370|579926786|FG002|Period 3|Physician Decision|1|||
160603741|NCT00318370|579926784|FG000|Period 3|Withdrawal by Subject|0|||
160603742|NCT00318370|579926785|FG001|Period 3|Withdrawal by Subject|0|||
160603743|NCT00318370|579926786|FG002|Period 3|Withdrawal by Subject|3|||
160603744|NCT00318370|579926784|FG000|Period 3|Other|0|||
160603745|NCT00318370|579926785|FG001|Period 3|Other|0|||
160603746|NCT00318370|579926786|FG002|Period 3|Other|3|||
160603747|NCT00892957|579926792|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
160603748|NCT00892957|579926793|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
160603749|NCT00892957|579926792|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
160603750|NCT00892957|579926793|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
160603751|NCT03307629|579926799|FG000|Overall Study|Withdrawal by Subject|0|||
160603752|NCT03307629|579926800|FG001|Overall Study|Withdrawal by Subject|0|||
160603753|NCT03307629|579926801|FG002|Overall Study|Withdrawal by Subject|0|||
160660640|NCT03450070|580139602|FG000|Overall Study|Withdrawal by Subject|8|||
160660641|NCT02910037|580139605|FG000|Overall Study|Withdrawal by Subject|4|||
160478270|NCT03651271|579478279|FG003|Overall Study|Patient medically unable to continue|1|||
160478271|NCT03651271|579478280|FG004|Overall Study|Patient medically unable to continue|0|||
160478272|NCT02959866|579478286|FG000|Overall Study|Withdrawal by Subject|1|||
160478273|NCT00636168|579478287|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
160478274|NCT00636168|579478288|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
160478275|NCT00636168|579478287|FG000|Randomized to Study Drug|Adverse Event|1|||
160478276|NCT00636168|579478288|FG001|Randomized to Study Drug|Adverse Event|0|||
160478277|NCT00636168|579478287|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
160478278|NCT00636168|579478288|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
160478279|NCT00636168|579478287|FG000|Treated With Study Drug|Recurrence of disease|135|||
160478280|NCT00636168|579478288|FG001|Treated With Study Drug|Recurrence of disease|282|||
160478281|NCT00636168|579478287|FG000|Treated With Study Drug|Adverse Event|250|||
160478282|NCT00636168|579478288|FG001|Treated With Study Drug|Adverse Event|22|||
160478283|NCT00636168|579478287|FG000|Treated With Study Drug|Participant withdrew consent|16|||
160478284|NCT00636168|579478288|FG001|Treated With Study Drug|Participant withdrew consent|21|||
160478285|NCT00636168|579478287|FG000|Treated With Study Drug|Poor/non-compliance|1|||
160478286|NCT00636168|579478288|FG001|Treated With Study Drug|Poor/non-compliance|3|||
160478287|NCT00636168|579478287|FG000|Treated With Study Drug|Death|3|||
160478288|NCT00636168|579478288|FG001|Treated With Study Drug|Death|0|||
160478289|NCT00636168|579478287|FG000|Treated With Study Drug|Pregnancy|1|||
160478290|NCT00636168|579478288|FG001|Treated With Study Drug|Pregnancy|0|||
160478291|NCT00636168|579478287|FG000|Treated With Study Drug|No longer meets study criteria|1|||
160478292|NCT00636168|579478288|FG001|Treated With Study Drug|No longer meets study criteria|0|||
160478293|NCT00636168|579478287|FG000|Treated With Study Drug|Other reason|1|||
160478294|NCT00636168|579478288|FG001|Treated With Study Drug|Other reason|3|||
160478295|NCT00636168|579478287|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
160478296|NCT00636168|579478288|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
160478297|NCT00636168|579478287|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
160478298|NCT00636168|579478288|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
160478299|NCT00636168|579478287|FG000|Long Term Follow-Up|Death|8|||
160478300|NCT00636168|579478288|FG001|Long Term Follow-Up|Death|9|||
160478301|NCT01240785|579478291|FG000|Overall Study|Lost to Follow-up|1|||
160478302|NCT01240785|579478292|FG001|Overall Study|Lost to Follow-up|0|||
160478303|NCT01240785|579478291|FG000|Overall Study|Protocol Violation|0|||
160478304|NCT01240785|579478292|FG001|Overall Study|Protocol Violation|3|||
160478305|NCT02006641|579478293|FG000|Overall Study|Withdrawal before treatment|2|||
160478306|NCT02006641|579478294|FG001|Overall Study|Withdrawal before treatment|5|||
160478307|NCT02006641|579478295|FG002|Overall Study|Withdrawal before treatment|3|||
160478308|NCT02006641|579478293|FG000|Overall Study|Adverse Event|15|||
160478309|NCT02006641|579478294|FG001|Overall Study|Adverse Event|11|||
160478310|NCT02006641|579478295|FG002|Overall Study|Adverse Event|15|||
160478311|NCT02006641|579478293|FG000|Overall Study|Protocol Violation|0|||
160478312|NCT02006641|579478294|FG001|Overall Study|Protocol Violation|2|||
160478313|NCT02006641|579478295|FG002|Overall Study|Protocol Violation|2|||
160478314|NCT02006641|579478293|FG000|Overall Study|Lost to Follow-up|0|||
160478315|NCT02006641|579478294|FG001|Overall Study|Lost to Follow-up|1|||
160478316|NCT02006641|579478295|FG002|Overall Study|Lost to Follow-up|0|||
160478317|NCT02006641|579478293|FG000|Overall Study|Withdrawal by Subject|7|||
160478318|NCT02006641|579478294|FG001|Overall Study|Withdrawal by Subject|12|||
160478319|NCT02006641|579478295|FG002|Overall Study|Withdrawal by Subject|11|||
160478320|NCT02006641|579478293|FG000|Overall Study|Other reason: patient didn't show up|1|||
160478321|NCT02006641|579478294|FG001|Overall Study|Other reason: patient didn't show up|0|||
160478322|NCT02006641|579478295|FG002|Overall Study|Other reason: patient didn't show up|0|||
160478323|NCT02006641|579478293|FG000|Overall Study|Other reason:patient didn't want to come|0|||
160478324|NCT02006641|579478294|FG001|Overall Study|Other reason:patient didn't want to come|0|||
160478325|NCT02006641|579478295|FG002|Overall Study|Other reason:patient didn't want to come|1|||
160478326|NCT02006641|579478293|FG000|Overall Study|Other reason: patient has moved|1|||
160603754|NCT03307629|579926802|FG003|Overall Study|Withdrawal by Subject|2|||
160603755|NCT03307629|579926799|FG000|Overall Study|Disease Progression|0|||
160603756|NCT03307629|579926800|FG001|Overall Study|Disease Progression|0|||
160603757|NCT03307629|579926801|FG002|Overall Study|Disease Progression|0|||
160478327|NCT02006641|579478294|FG001|Overall Study|Other reason: patient has moved|0|||
160603758|NCT03307629|579926802|FG003|Overall Study|Disease Progression|3|||
160478328|NCT02006641|579478295|FG002|Overall Study|Other reason: patient has moved|1|||
160478329|NCT02006641|579478293|FG000|Overall Study|Other reason: caregiver in hospital|0|||
160478330|NCT02006641|579478294|FG001|Overall Study|Other reason: caregiver in hospital|1|||
160478331|NCT02006641|579478295|FG002|Overall Study|Other reason: caregiver in hospital|0|||
160478332|NCT02006641|579478293|FG000|Overall Study|Other reason: patient's wife has died|0|||
160478333|NCT02006641|579478294|FG001|Overall Study|Other reason: patient's wife has died|0|||
160603759|NCT03307629|579926799|FG000|Overall Study|Death|0|||
160660642|NCT02910037|580139605|FG000|Overall Study|Lost to Follow-up|6|||
160603760|NCT03307629|579926800|FG001|Overall Study|Death|3|||
160603761|NCT03307629|579926801|FG002|Overall Study|Death|0|||
160603762|NCT03307629|579926802|FG003|Overall Study|Death|1|||
160603763|NCT02853032|579926807|FG000|Overall Study|Adverse Event|4|||
160603764|NCT02853032|579926808|FG001|Overall Study|Adverse Event|0|||
160603765|NCT02853032|579926807|FG000|Overall Study|Withdrawal by Subject|3|||
160603766|NCT02853032|579926808|FG001|Overall Study|Withdrawal by Subject|1|||
160603767|NCT02853032|579926807|FG000|Overall Study|Requested to withdraw from all treatment|2|||
160603768|NCT02853032|579926808|FG001|Overall Study|Requested to withdraw from all treatment|2|||
160603769|NCT04876599|579926809|FG000|Overall Study|Missed|2|||
160603770|NCT04876599|579926810|FG001|Overall Study|Missed|0|||
160603771|NCT04876599|579926809|FG000|Overall Study|Declined|2|||
160603772|NCT04876599|579926810|FG001|Overall Study|Declined|3|||
160603773|NCT00676208|579926817|FG000|Overall Study|Lost to Follow-up|0|||
160603774|NCT00676208|579926818|FG001|Overall Study|Lost to Follow-up|2|||
160603775|NCT00676208|579926817|FG000|Overall Study|Incomplete data|2|||
160603776|NCT00676208|579926818|FG001|Overall Study|Incomplete data|4|||
160603777|NCT00669032|579926819|FG000|Overall Study|Lost to Follow-up|6|||
160603778|NCT00669032|579926820|FG001|Overall Study|Lost to Follow-up|5|||
160603779|NCT00669032|579926819|FG000|Overall Study|Lack of Efficacy|8|||
160603780|NCT00669032|579926820|FG001|Overall Study|Lack of Efficacy|19|||
160603781|NCT00669032|579926819|FG000|Overall Study|Withdrawal by Subject|12|||
160603782|NCT00669032|579926820|FG001|Overall Study|Withdrawal by Subject|13|||
160603783|NCT00669032|579926819|FG000|Overall Study|Adverse Event|12|||
160603784|NCT00669032|579926820|FG001|Overall Study|Adverse Event|16|||
160603785|NCT00669032|579926819|FG000|Overall Study|Physician Decision|1|||
160603786|NCT00669032|579926820|FG001|Overall Study|Physician Decision|1|||
160603787|NCT00669032|579926819|FG000|Overall Study|No fulfilment of the selection criteria|5|||
160478334|NCT02006641|579478295|FG002|Overall Study|Other reason: patient's wife has died|1|||
160478335|NCT02006641|579478293|FG000|Overall Study|Other reason: hospitalisation|0|||
160478336|NCT02006641|579478294|FG001|Overall Study|Other reason: hospitalisation|1|||
160478337|NCT02006641|579478295|FG002|Overall Study|Other reason: hospitalisation|0|||
160478338|NCT02006641|579478293|FG000|Overall Study|Other reason: caregiver impossibility|0|||
160478339|NCT02006641|579478294|FG001|Overall Study|Other reason: caregiver impossibility|0|||
160478340|NCT02006641|579478295|FG002|Overall Study|Other reason: caregiver impossibility|1|||
160478341|NCT02006641|579478293|FG000|Overall Study|Other reason: protocol non-compliance|0|||
160478342|NCT02006641|579478294|FG001|Overall Study|Other reason: protocol non-compliance|0|||
160478343|NCT02006641|579478295|FG002|Overall Study|Other reason: protocol non-compliance|1|||
160478344|NCT00689351|579478307|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
160478345|NCT00689351|579478308|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
160478346|NCT00689351|579478307|FG000|Infant Series of Dosing|Adverse Event|1|||
160478347|NCT00689351|579478308|FG001|Infant Series of Dosing|Adverse Event|0|||
160478348|NCT00689351|579478307|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
160478349|NCT00689351|579478308|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
160478350|NCT00689351|579478307|FG000|After Infant Series|Parent/legal guardian request|1|||
160478351|NCT00689351|579478308|FG001|After Infant Series|Parent/legal guardian request|0|||
160478352|NCT01766206|579478309|FG000|Overall Study|Withdrawal by Subject|22|||
160478353|NCT01766206|579478309|FG000|Overall Study|Lost to Follow-up|10|||
160478354|NCT01766206|579478309|FG000|Overall Study|Inappropriate enrollment|18|||
160478355|NCT01766206|579478309|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
160478356|NCT01662505|579478310|FG000|Overall Study|Progressive disease|6|||
160478357|NCT01662505|579478311|FG001|Overall Study|Progressive disease|1|||
160478358|NCT01662505|579478312|FG002|Overall Study|Progressive disease|5|||
160478359|NCT01662505|579478310|FG000|Overall Study|Refused cont. medication|0|||
160478360|NCT01662505|579478311|FG001|Overall Study|Refused cont. medication|0|||
160478361|NCT01662505|579478312|FG002|Overall Study|Refused cont. medication|1|||
160478362|NCT01662505|579478310|FG000|Overall Study|Not specified above|1|||
160478363|NCT01662505|579478311|FG001|Overall Study|Not specified above|3|||
160478364|NCT01662505|579478312|FG002|Overall Study|Not specified above|2|||
160478365|NCT01313663|579478313|FG000|Overall Study|Study Closed/Terminated|2|||
160478366|NCT01313663|579478314|FG001|Overall Study|Study Closed/Terminated|4|||
160478367|NCT01313663|579478313|FG000|Overall Study|Lost to Follow-up|0|||
160478368|NCT01313663|579478314|FG001|Overall Study|Lost to Follow-up|1|||
160478369|NCT01313663|579478313|FG000|Overall Study|Physician Decision|0|||
160478370|NCT01313663|579478314|FG001|Overall Study|Physician Decision|2|||
160478371|NCT01313663|579478313|FG000|Overall Study|Withdrawal by Subject|2|||
160478372|NCT01313663|579478314|FG001|Overall Study|Withdrawal by Subject|1|||
160478373|NCT01661972|579478317|FG000|Overall Study|Adverse Event|1|||
160478374|NCT01661972|579478318|FG001|Overall Study|Adverse Event|2|||
160603788|NCT00669032|579926820|FG001|Overall Study|No fulfilment of the selection criteria|5|||
160603789|NCT01607073|579926823|FG000|Overall Study|Adverse Event|1|||
160603790|NCT00642018|579926824|FG000|Overall Study|Adverse Event|11|||
160603791|NCT00642018|579926825|FG001|Overall Study|Adverse Event|36|||
160603792|NCT00642018|579926824|FG000|Overall Study|Withdrawal by Subject|4|||
160603793|NCT00642018|579926825|FG001|Overall Study|Withdrawal by Subject|10|||
160603794|NCT00642018|579926824|FG000|Overall Study|Progressive Disease|13|||
160603795|NCT00642018|579926825|FG001|Overall Study|Progressive Disease|18|||
160603796|NCT00642018|579926824|FG000|Overall Study|Physician Decision|0|||
160603797|NCT00642018|579926825|FG001|Overall Study|Physician Decision|10|||
160603798|NCT00642018|579926824|FG000|Overall Study|Protocol Violation|0|||
160478375|NCT01661972|579478317|FG000|Overall Study|Death during Treatment period|1|||
160478376|NCT01661972|579478318|FG001|Overall Study|Death during Treatment period|1|||
160478377|NCT01661972|579478317|FG000|Overall Study|Withdrawal by Subject|0|||
160478378|NCT01661972|579478318|FG001|Overall Study|Withdrawal by Subject|1|||
160478379|NCT02138838|579478322|FG000|Overall Study|Study Closure|7|||
160478380|NCT02138838|579478323|FG001|Overall Study|Study Closure|6|||
160478381|NCT02138838|579478322|FG000|Overall Study|Withdrawal by Subject|1|||
160478382|NCT02138838|579478323|FG001|Overall Study|Withdrawal by Subject|5|||
160478383|NCT01294644|579478325|FG000|Overall Study|Adverse Event|2|||
160478384|NCT01294644|579478326|FG001|Overall Study|Adverse Event|0|||
160478385|NCT01294644|579478327|FG002|Overall Study|Adverse Event|1|||
160478386|NCT01294644|579478325|FG000|Overall Study|Withdrawal by Subject|3|||
160478387|NCT01294644|579478326|FG001|Overall Study|Withdrawal by Subject|7|||
160478388|NCT01294644|579478327|FG002|Overall Study|Withdrawal by Subject|4|||
160478389|NCT01294644|579478325|FG000|Overall Study|Lost to Follow-up|3|||
160478390|NCT01294644|579478326|FG001|Overall Study|Lost to Follow-up|2|||
160478391|NCT01294644|579478327|FG002|Overall Study|Lost to Follow-up|5|||
160478392|NCT01294644|579478325|FG000|Overall Study|Miscellaneous Reason|2|||
160478393|NCT01294644|579478326|FG001|Overall Study|Miscellaneous Reason|1|||
160478394|NCT01294644|579478327|FG002|Overall Study|Miscellaneous Reason|4|||
160478395|NCT00853957|579478328|FG000|Overall Study|Adverse Event|9|||
160478396|NCT00853957|579478329|FG001|Overall Study|Adverse Event|3|||
160478397|NCT00853957|579478328|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160478398|NCT00853957|579478329|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160603799|NCT00642018|579926825|FG001|Overall Study|Protocol Violation|1|||
160603800|NCT00642018|579926824|FG000|Overall Study|Death|0|||
160478399|NCT00853957|579478328|FG000|Overall Study|Subject withdrew consent|4|||
160478400|NCT00853957|579478329|FG001|Overall Study|Subject withdrew consent|5|||
160478401|NCT00853957|579478328|FG000|Overall Study|Lost to Follow-up|1|||
160478402|NCT00853957|579478329|FG001|Overall Study|Lost to Follow-up|6|||
160478403|NCT00853957|579478328|FG000|Overall Study|Protocol deviation|0|||
160478404|NCT00853957|579478329|FG001|Overall Study|Protocol deviation|3|||
160478405|NCT01884571|579478330|FG000|Overall Study|Adverse Event|1|||
160478406|NCT01884571|579478330|FG000|Overall Study|Death|2|||
160478407|NCT01884571|579478330|FG000|Overall Study|Withdrawal by Subject|2|||
160478408|NCT01884571|579478330|FG000|Overall Study|Disease progression|3|||
160478409|NCT00760877|579479826|FG000|Overall Study|Protocol Violation|1|||
160478410|NCT00760877|579479827|FG001|Overall Study|Protocol Violation|0|||
160478411|NCT00760877|579479826|FG000|Overall Study|Non-compliance with protocol treatment|2|||
160478412|NCT00760877|579479827|FG001|Overall Study|Non-compliance with protocol treatment|1|||
160478413|NCT00760877|579479826|FG000|Overall Study|Pregnancy|1|||
160478414|NCT00760877|579479827|FG001|Overall Study|Pregnancy|4|||
160478415|NCT00760877|579479826|FG000|Overall Study|Death|2|||
160478416|NCT00760877|579479827|FG001|Overall Study|Death|1|||
160478417|NCT00760877|579479826|FG000|Overall Study|Withdrawal by Subject|7|||
160478418|NCT00760877|579479827|FG001|Overall Study|Withdrawal by Subject|3|||
160478419|NCT00760877|579479826|FG000|Overall Study|Adverse Event|19|||
160478420|NCT00760877|579479827|FG001|Overall Study|Adverse Event|12|||
160603801|NCT00642018|579926825|FG001|Overall Study|Death|3|||
160603802|NCT00642018|579926824|FG000|Overall Study|Entry Criteria Not Met|0|||
160603803|NCT00642018|579926825|FG001|Overall Study|Entry Criteria Not Met|1|||
160603804|NCT01410799|579926826|FG000|Overall Study|PI decision|13|||
160603805|NCT00617656|579926827|FG000|Overall Study|Inclusion error|4|||
160603806|NCT00617656|579926828|FG001|Overall Study|Inclusion error|4|||
160603807|NCT00617656|579926829|FG002|Overall Study|Inclusion error|0|||
160603808|NCT00617656|579926830|FG003|Overall Study|Inclusion error|0|||
160603809|NCT00617656|579926827|FG000|Overall Study|Missing data|44|||
160603810|NCT00617656|579926828|FG001|Overall Study|Missing data|30|||
160660643|NCT01035060|580139606|FG000|Overall Study|Lost to Follow-up|0|||
160478421|NCT00760877|579479826|FG000|Overall Study|Participant diagnosed with AML|0|||
160478422|NCT00760877|579479827|FG001|Overall Study|Participant diagnosed with AML|1|||
160478423|NCT00760877|579479826|FG000|Overall Study|Participant not eligible to cross-over|0|||
160478424|NCT00760877|579479827|FG001|Overall Study|Participant not eligible to cross-over|1|||
160478425|NCT00760877|579479826|FG000|Overall Study|Physician Decision|1|||
160478426|NCT00760877|579479827|FG001|Overall Study|Physician Decision|2|||
160478427|NCT00760877|579479826|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
160478428|NCT00760877|579479827|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
160478429|NCT00760877|579479826|FG000|Overall Study|Treatment failure|1|||
160478430|NCT00760877|579479827|FG001|Overall Study|Treatment failure|0|||
160478431|NCT04413149|579479830|FG000|Overall Study|Death|10|||
160478432|NCT04413149|579479831|FG001|Overall Study|Death|5|||
160660644|NCT01035060|580139607|FG001|Overall Study|Lost to Follow-up|7|||
160660645|NCT01035060|580139606|FG000|Overall Study|Did not quality after 2nd screening|14|||
160660646|NCT01035060|580139607|FG001|Overall Study|Did not quality after 2nd screening|1|||
160660647|NCT01035060|580139606|FG000|Overall Study|Withdrawal by Subject|8|||
160660648|NCT01035060|580139607|FG001|Overall Study|Withdrawal by Subject|6|||
160660649|NCT01035060|580139606|FG000|Overall Study|Physician Decision|2|||
160603811|NCT00617656|579926829|FG002|Overall Study|Missing data|13|||
160478433|NCT04413149|579479830|FG000|Overall Study|Lung transplantation|1|||
160478434|NCT04413149|579479831|FG001|Overall Study|Lung transplantation|0|||
160478435|NCT02878590|579479832|FG000|Overall Study|Withdrawal by Subject|2|||
160478436|NCT01730118|579479833|FG000|Dose Escalation|Death on study|5|||
160478437|NCT01730118|579479834|FG001|Dose Escalation|Death on study|7|||
160478438|NCT01730118|579479835|FG002|Dose Escalation|Death on study|2|||
160478439|NCT01730118|579479836|FG003|Dose Escalation|Death on study|6|||
160478440|NCT01730118|579479837|FG004|Dose Escalation|Death on study|0|||
160478441|NCT01730118|579479838|FG005|Dose Escalation|Death on study|0|||
160478442|NCT01730118|579479839|FG006|Dose Escalation|Death on study|0|||
160478443|NCT01730118|579479833|FG000|Dose Escalation|Died before treatment|0|||
160478444|NCT01730118|579479834|FG001|Dose Escalation|Died before treatment|0|||
160478445|NCT01730118|579479835|FG002|Dose Escalation|Died before treatment|0|||
160478446|NCT01730118|579479836|FG003|Dose Escalation|Died before treatment|0|||
160478447|NCT01730118|579479837|FG004|Dose Escalation|Died before treatment|0|||
160478448|NCT01730118|579479838|FG005|Dose Escalation|Died before treatment|0|||
160478449|NCT01730118|579479839|FG006|Dose Escalation|Died before treatment|1|||
160478450|NCT01730118|579479833|FG000|Dose Escalation|Chose to start a different treatment|1|||
160478451|NCT01730118|579479834|FG001|Dose Escalation|Chose to start a different treatment|0|||
160478452|NCT01730118|579479835|FG002|Dose Escalation|Chose to start a different treatment|0|||
160478453|NCT01730118|579479836|FG003|Dose Escalation|Chose to start a different treatment|0|||
160478454|NCT01730118|579479837|FG004|Dose Escalation|Chose to start a different treatment|0|||
160478455|NCT01730118|579479838|FG005|Dose Escalation|Chose to start a different treatment|0|||
160478456|NCT01730118|579479839|FG006|Dose Escalation|Chose to start a different treatment|0|||
160478457|NCT01730118|579479833|FG000|Dose Escalation|Withdrawal by Subject|0|||
160478458|NCT01730118|579479834|FG001|Dose Escalation|Withdrawal by Subject|0|||
160478459|NCT01730118|579479835|FG002|Dose Escalation|Withdrawal by Subject|1|||
160478460|NCT01730118|579479836|FG003|Dose Escalation|Withdrawal by Subject|0|||
160478461|NCT01730118|579479837|FG004|Dose Escalation|Withdrawal by Subject|0|||
160478462|NCT01730118|579479838|FG005|Dose Escalation|Withdrawal by Subject|0|||
160478463|NCT01730118|579479839|FG006|Dose Escalation|Withdrawal by Subject|0|||
160478464|NCT01730118|579479833|FG000|Dose Escalation|Disease progression prior to treatment|0|||
160478465|NCT01730118|579479834|FG001|Dose Escalation|Disease progression prior to treatment|0|||
160603812|NCT00617656|579926830|FG003|Overall Study|Missing data|6|||
160603813|NCT00617656|579926827|FG000|Overall Study|Withdrawal by Subject|0|||
160478466|NCT01730118|579479835|FG002|Dose Escalation|Disease progression prior to treatment|0|||
160478467|NCT01730118|579479836|FG003|Dose Escalation|Disease progression prior to treatment|0|||
160478468|NCT01730118|579479837|FG004|Dose Escalation|Disease progression prior to treatment|0|||
160478469|NCT01730118|579479838|FG005|Dose Escalation|Disease progression prior to treatment|0|||
160478470|NCT01730118|579479839|FG006|Dose Escalation|Disease progression prior to treatment|1|||
160478471|NCT01730118|579479833|FG000|Dose Expansion|Death|0|||
160478472|NCT01730118|579479834|FG001|Dose Expansion|Death|0|||
160478473|NCT01730118|579479835|FG002|Dose Expansion|Death|0|||
160478474|NCT01730118|579479836|FG003|Dose Expansion|Death|0|||
160478475|NCT01730118|579479837|FG004|Dose Expansion|Death|1|||
160478476|NCT01730118|579479838|FG005|Dose Expansion|Death|0|||
160478477|NCT01730118|579479839|FG006|Dose Expansion|Death|0|||
160478478|NCT01730118|579479833|FG000|Dose Expansion|Other medical condition|0|||
160478479|NCT01730118|579479834|FG001|Dose Expansion|Other medical condition|0|||
160478480|NCT01730118|579479835|FG002|Dose Expansion|Other medical condition|0|||
160478481|NCT01730118|579479836|FG003|Dose Expansion|Other medical condition|0|||
160478482|NCT01730118|579479837|FG004|Dose Expansion|Other medical condition|1|||
160478483|NCT01730118|579479838|FG005|Dose Expansion|Other medical condition|0|||
160478484|NCT01730118|579479839|FG006|Dose Expansion|Other medical condition|0|||
160478485|NCT01730118|579479833|FG000|Dose Expansion|Withdrawal by Subject|0|||
160478486|NCT01730118|579479834|FG001|Dose Expansion|Withdrawal by Subject|0|||
160478487|NCT01730118|579479835|FG002|Dose Expansion|Withdrawal by Subject|0|||
160478488|NCT01730118|579479836|FG003|Dose Expansion|Withdrawal by Subject|0|||
160478489|NCT01730118|579479837|FG004|Dose Expansion|Withdrawal by Subject|1|||
160478490|NCT01730118|579479838|FG005|Dose Expansion|Withdrawal by Subject|0|||
160478491|NCT01730118|579479839|FG006|Dose Expansion|Withdrawal by Subject|0|||
160478492|NCT01730118|579479833|FG000|Dose Expansion|Disease progression|0|||
160478493|NCT01730118|579479834|FG001|Dose Expansion|Disease progression|0|||
160478494|NCT01730118|579479835|FG002|Dose Expansion|Disease progression|0|||
160478495|NCT01730118|579479836|FG003|Dose Expansion|Disease progression|0|||
160478496|NCT01730118|579479837|FG004|Dose Expansion|Disease progression|0|||
160478497|NCT01730118|579479838|FG005|Dose Expansion|Disease progression|1|||
160478498|NCT01730118|579479839|FG006|Dose Expansion|Disease progression|0|||
160478499|NCT01730118|579479833|FG000|Dose Expansion|Inability to return|0|||
160478500|NCT01730118|579479834|FG001|Dose Expansion|Inability to return|0|||
160478501|NCT01730118|579479835|FG002|Dose Expansion|Inability to return|0|||
160478502|NCT01730118|579479836|FG003|Dose Expansion|Inability to return|0|||
160478503|NCT01730118|579479837|FG004|Dose Expansion|Inability to return|0|||
160478504|NCT01730118|579479838|FG005|Dose Expansion|Inability to return|1|||
160478505|NCT01730118|579479839|FG006|Dose Expansion|Inability to return|0|||
160478506|NCT01730118|579479833|FG000|Dose Expansion|Physician Decision|0|||
160478507|NCT01730118|579479834|FG001|Dose Expansion|Physician Decision|0|||
160478508|NCT01730118|579479835|FG002|Dose Expansion|Physician Decision|0|||
160478509|NCT01730118|579479836|FG003|Dose Expansion|Physician Decision|0|||
160478510|NCT01730118|579479837|FG004|Dose Expansion|Physician Decision|0|||
160478511|NCT01730118|579479838|FG005|Dose Expansion|Physician Decision|1|||
160478512|NCT01730118|579479839|FG006|Dose Expansion|Physician Decision|0|||
160478513|NCT05379400|579479845|FG000|Overall Study|Lost to Follow-up|1|||
160478514|NCT05379400|579479846|FG001|Overall Study|Lost to Follow-up|1|||
160478515|NCT04851587|579479848|FG000|Overall Study|Lost to Follow-up|18|||
160478516|NCT01020487|579479852|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
160478517|NCT01020487|579479853|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
160478518|NCT01020487|579479854|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
160478519|NCT01020487|579479852|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
160478520|NCT01020487|579479853|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
160478521|NCT01020487|579479854|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
160478522|NCT01020487|579479852|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
160478523|NCT01020487|579479853|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
160660650|NCT01035060|580139607|FG001|Overall Study|Physician Decision|0|||
160660651|NCT01720264|580139613|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
160478524|NCT01020487|579479854|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
160478525|NCT01020487|579479852|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
160478526|NCT01020487|579479853|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
160478527|NCT01020487|579479854|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
160478528|NCT01020487|579479852|FG000|Part 2 Open-label Period|Adverse Event|0|||
160478529|NCT01020487|579479853|FG001|Part 2 Open-label Period|Adverse Event|4|||
160478530|NCT01020487|579479854|FG002|Part 2 Open-label Period|Adverse Event|1|||
160478531|NCT04049578|579479855|FG000|Overall Study|Physician Decision|1|||
160478532|NCT05878990|579479856|FG000|Overall Study|Lost to Follow-up|7|||
160478533|NCT05878990|579479856|FG000|Overall Study|Withdrawal by Subject|1|||
160478534|NCT03409276|579479857|FG000|Overall Study|Withdrawal by Subject|0|||
160478535|NCT03409276|579479858|FG001|Overall Study|Withdrawal by Subject|0|||
160478536|NCT03409276|579479859|FG002|Overall Study|Withdrawal by Subject|0|||
160660652|NCT01720264|580139613|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
160478537|NCT03409276|579479860|FG003|Overall Study|Withdrawal by Subject|0|||
160478538|NCT03409276|579479861|FG004|Overall Study|Withdrawal by Subject|1|||
160478539|NCT03409276|579479857|FG000|Overall Study|Lost to Follow-up|0|||
160478540|NCT03409276|579479858|FG001|Overall Study|Lost to Follow-up|0|||
160478541|NCT03409276|579479859|FG002|Overall Study|Lost to Follow-up|0|||
160478542|NCT03409276|579479860|FG003|Overall Study|Lost to Follow-up|2|||
160478543|NCT03409276|579479861|FG004|Overall Study|Lost to Follow-up|2|||
160478544|NCT03605745|579479862|FG000|Overall Study|Study was terminated for business reasons|47|||
160478545|NCT01279447|579479863|FG000|Overall Study|Lost to Follow-up|3|||
160478546|NCT01279447|579479864|FG001|Overall Study|Lost to Follow-up|1|||
160478547|NCT01074229|579479865|FG000|Overall Study|Lost to Follow-up|1|||
160478548|NCT01074229|579479866|FG001|Overall Study|Lost to Follow-up|0|||
160478549|NCT01074229|579479867|FG002|Overall Study|Lost to Follow-up|0|||
160478550|NCT01074229|579479865|FG000|Overall Study|Change to open surgical procedure|1|||
160478551|NCT01074229|579479866|FG001|Overall Study|Change to open surgical procedure|3|||
160478552|NCT01074229|579479867|FG002|Overall Study|Change to open surgical procedure|4|||
160478553|NCT04454125|579479868|FG000|Overall Study|Lost to Follow-up|0|||
160478554|NCT04454125|579479869|FG001|Overall Study|Lost to Follow-up|1|||
160478555|NCT01183013|579479870|FG000|Overall Study|Adverse Event|6|||
160478556|NCT01183013|579479871|FG001|Overall Study|Adverse Event|8|||
160478557|NCT01183013|579479872|FG002|Overall Study|Adverse Event|5|||
160478558|NCT01183013|579479873|FG003|Overall Study|Adverse Event|5|||
160478559|NCT01183013|579479874|FG004|Overall Study|Adverse Event|10|||
160478560|NCT01183013|579479875|FG005|Overall Study|Adverse Event|10|||
160478561|NCT01183013|579479876|FG006|Overall Study|Adverse Event|6|||
160478562|NCT01183013|579479870|FG000|Overall Study|Lack of Efficacy|3|||
160478563|NCT01183013|579479871|FG001|Overall Study|Lack of Efficacy|2|||
160478564|NCT01183013|579479872|FG002|Overall Study|Lack of Efficacy|1|||
160478565|NCT01183013|579479873|FG003|Overall Study|Lack of Efficacy|2|||
160478566|NCT01183013|579479874|FG004|Overall Study|Lack of Efficacy|1|||
160478567|NCT01183013|579479875|FG005|Overall Study|Lack of Efficacy|2|||
160478568|NCT01183013|579479876|FG006|Overall Study|Lack of Efficacy|0|||
160478569|NCT01183013|579479870|FG000|Overall Study|Protocol Violation|5|||
160478570|NCT01183013|579479871|FG001|Overall Study|Protocol Violation|2|||
160478571|NCT01183013|579479872|FG002|Overall Study|Protocol Violation|4|||
160478572|NCT01183013|579479873|FG003|Overall Study|Protocol Violation|0|||
160478573|NCT01183013|579479874|FG004|Overall Study|Protocol Violation|4|||
160478574|NCT01183013|579479875|FG005|Overall Study|Protocol Violation|3|||
160478575|NCT01183013|579479876|FG006|Overall Study|Protocol Violation|3|||
160478576|NCT01183013|579479870|FG000|Overall Study|Lost to Follow-up|7|||
160478577|NCT01183013|579479871|FG001|Overall Study|Lost to Follow-up|3|||
160478578|NCT01183013|579479872|FG002|Overall Study|Lost to Follow-up|4|||
160478579|NCT01183013|579479873|FG003|Overall Study|Lost to Follow-up|3|||
160478580|NCT01183013|579479874|FG004|Overall Study|Lost to Follow-up|2|||
160478581|NCT01183013|579479875|FG005|Overall Study|Lost to Follow-up|6|||
160478582|NCT01183013|579479876|FG006|Overall Study|Lost to Follow-up|5|||
160478583|NCT01183013|579479870|FG000|Overall Study|Withdrawal by Subject|9|||
160478584|NCT01183013|579479871|FG001|Overall Study|Withdrawal by Subject|13|||
160478585|NCT01183013|579479872|FG002|Overall Study|Withdrawal by Subject|10|||
160478586|NCT01183013|579479873|FG003|Overall Study|Withdrawal by Subject|8|||
160478587|NCT01183013|579479874|FG004|Overall Study|Withdrawal by Subject|7|||
160478588|NCT01183013|579479875|FG005|Overall Study|Withdrawal by Subject|9|||
160478589|NCT01183013|579479876|FG006|Overall Study|Withdrawal by Subject|10|||
160478590|NCT01183013|579479870|FG000|Overall Study|Reasons other than stated above|15|||
160478591|NCT01183013|579479871|FG001|Overall Study|Reasons other than stated above|11|||
160478592|NCT01183013|579479872|FG002|Overall Study|Reasons other than stated above|17|||
160478593|NCT01183013|579479873|FG003|Overall Study|Reasons other than stated above|12|||
160478594|NCT01183013|579479874|FG004|Overall Study|Reasons other than stated above|12|||
160478595|NCT01183013|579479875|FG005|Overall Study|Reasons other than stated above|15|||
160478596|NCT01183013|579479876|FG006|Overall Study|Reasons other than stated above|13|||
160478597|NCT02092909|579479877|FG000|Overall Study|Adverse Event|0|||
160478598|NCT02092909|579479878|FG001|Overall Study|Adverse Event|0|||
160478599|NCT02092909|579479879|FG002|Overall Study|Adverse Event|4|||
160478600|NCT02092909|579479880|FG003|Overall Study|Adverse Event|2|||
160478601|NCT02092909|579479877|FG000|Overall Study|Lack of Efficacy|0|||
160478602|NCT02092909|579479878|FG001|Overall Study|Lack of Efficacy|2|||
160478603|NCT02092909|579479879|FG002|Overall Study|Lack of Efficacy|1|||
160478604|NCT02092909|579479880|FG003|Overall Study|Lack of Efficacy|0|||
160478605|NCT02092909|579479877|FG000|Overall Study|Withdrawal by Subject|0|||
160478606|NCT02092909|579479878|FG001|Overall Study|Withdrawal by Subject|0|||
160478607|NCT02092909|579479879|FG002|Overall Study|Withdrawal by Subject|2|||
160478608|NCT02092909|579479880|FG003|Overall Study|Withdrawal by Subject|1|||
160478609|NCT02092909|579479877|FG000|Overall Study|Study terminated by Sponsor|0|||
160478610|NCT02092909|579479878|FG001|Overall Study|Study terminated by Sponsor|0|||
160478611|NCT02092909|579479879|FG002|Overall Study|Study terminated by Sponsor|0|||
160478612|NCT02092909|579479880|FG003|Overall Study|Study terminated by Sponsor|2|||
160478613|NCT02092909|579479877|FG000|Overall Study|Miscellaneous|1|||
160478614|NCT02092909|579479878|FG001|Overall Study|Miscellaneous|1|||
160478615|NCT02092909|579479879|FG002|Overall Study|Miscellaneous|2|||
160478616|NCT02092909|579479880|FG003|Overall Study|Miscellaneous|1|||
160478617|NCT02727998|579479881|FG000|Overall Study|Lost to Follow-up|3|||
160478618|NCT02727998|579479882|FG001|Overall Study|Lost to Follow-up|3|||
160478619|NCT02727998|579479881|FG000|Overall Study|Withdrawal by Subject|0|||
160478620|NCT02727998|579479882|FG001|Overall Study|Withdrawal by Subject|1|||
160478621|NCT02105688|579479883|FG000|Part A: Double-Blind|Adverse Event|1|||
160478622|NCT02105688|579479884|FG001|Part A: Double-Blind|Adverse Event|0|||
160478623|NCT02105688|579479883|FG000|Part A: Double-Blind|Death|0|||
160478624|NCT02105688|579479884|FG001|Part A: Double-Blind|Death|1|||
160478625|NCT02105688|579479883|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
160478626|NCT02105688|579479884|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
160478627|NCT02105688|579479883|FG000|Part A: Double-Blind|Physician Decision|0|||
160478628|NCT02105688|579479884|FG001|Part A: Double-Blind|Physician Decision|1|||
160478629|NCT02105688|579479883|FG000|Part A: Double-Blind|Status Unknown|0|||
160478630|NCT02105688|579479884|FG001|Part A: Double-Blind|Status Unknown|2|||
160478631|NCT02105688|579479883|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
160478632|NCT02105688|579479884|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
160478633|NCT02105688|579479883|FG000|Part B: Observational Follow-up|Death|2|||
160478634|NCT02105688|579479884|FG001|Part B: Observational Follow-up|Death|1|||
160478635|NCT02105688|579479883|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
160478636|NCT02105688|579479884|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
160478637|NCT02105688|579479883|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
160478638|NCT02105688|579479884|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
160478639|NCT02105688|579479883|FG000|Part B: Observational Follow-up|Physician Decision|3|||
160478640|NCT02105688|579479884|FG001|Part B: Observational Follow-up|Physician Decision|1|||
160478641|NCT00901459|579479887|FG000|Overall Study|Withdrawal by Subject|6|||
160478642|NCT00910871|579479899|FG000|Overall Study|Adverse Event|5|||
160478643|NCT00910871|579479899|FG000|Overall Study|Death|12|||
160478644|NCT00910871|579479899|FG000|Overall Study|Lost to Follow-up|8|||
160478645|NCT00910871|579479899|FG000|Overall Study|Protocol Violation|11|||
160478646|NCT00910871|579479899|FG000|Overall Study|Withdrawal by Subject|12|||
160478647|NCT00910871|579479899|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
160478648|NCT00910871|579479899|FG000|Overall Study|Undefined|1|||
160478649|NCT00850993|579479900|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
160478650|NCT00850993|579479901|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
160478651|NCT00850993|579479902|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
160478652|NCT00850993|579479903|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
160478653|NCT04501614|579479910|FG000|Overall Study|Study Terminated by Sponsor|6|||
160478654|NCT04501614|579479911|FG001|Overall Study|Study Terminated by Sponsor|3|||
160478655|NCT04501614|579479910|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
160478656|NCT04501614|579479911|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
160478657|NCT02555397|579479915|FG000|Overall Study|Withdrawal by Subject|1|||
160478658|NCT02555397|579479916|FG001|Overall Study|Withdrawal by Subject|0|||
160478659|NCT02555397|579479917|FG002|Overall Study|Withdrawal by Subject|0|||
160478660|NCT02555397|579479918|FG003|Overall Study|Withdrawal by Subject|0|||
160478661|NCT02555397|579479919|FG004|Overall Study|Withdrawal by Subject|0|||
160478662|NCT04529941|579479922|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
160478663|NCT04529941|579479923|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
160478664|NCT01005914|579479925|FG000|Overall Study|Adverse Event|4|||
160478665|NCT01005914|579479925|FG000|Overall Study|Death|4|||
160478666|NCT01005914|579479925|FG000|Overall Study|Lack of Efficacy|1|||
160478667|NCT01005914|579479925|FG000|Overall Study|Withdrawal by Subject|1|||
160478668|NCT00237809|579479928|FG000|Overall Study|Lost to Follow-up|11|||
160478669|NCT00237809|579479929|FG001|Overall Study|Lost to Follow-up|10|||
160478670|NCT00237809|579479930|FG002|Overall Study|Lost to Follow-up|9|||
160478671|NCT00237809|579479931|FG003|Overall Study|Lost to Follow-up|9|||
160478672|NCT01613599|579479935|FG000|Overall Study|Death|9|||
160478673|NCT01613599|579479935|FG000|Overall Study|Lost to Follow-up|5|||
160478674|NCT01613599|579479935|FG000|Overall Study|Withdrawal by Subject|8|||
160478675|NCT01613599|579479935|FG000|Overall Study|Reason not specified|3|||
160478676|NCT02132195|579479936|FG000|Initial Assignment|Relapsed|14|||
160478677|NCT02132195|579479937|FG001|Initial Assignment|Relapsed|0|||
160478678|NCT02132195|579479938|FG002|Initial Assignment|Relapsed|0|||
160478679|NCT02132195|579479936|FG000|Rescue Therapy|Relapsed|0|||
160478680|NCT02132195|579479937|FG001|Rescue Therapy|Relapsed|0|||
160478681|NCT02132195|579479938|FG002|Rescue Therapy|Relapsed|7|||
160478682|NCT02132195|579479936|FG000|Rescue Therapy|Physician Decision|0|||
160478683|NCT02132195|579479937|FG001|Rescue Therapy|Physician Decision|0|||
160478684|NCT02132195|579479938|FG002|Rescue Therapy|Physician Decision|1|||
160478685|NCT02132195|579479936|FG000|Rescue Therapy|Withdrawal by Subject|0|||
160478686|NCT02132195|579479937|FG001|Rescue Therapy|Withdrawal by Subject|0|||
160478687|NCT02132195|579479938|FG002|Rescue Therapy|Withdrawal by Subject|1|||
160478688|NCT02132195|579479936|FG000|Rescue Therapy|Adverse Event|0|||
160478689|NCT02132195|579479937|FG001|Rescue Therapy|Adverse Event|0|||
160478690|NCT02132195|579479938|FG002|Rescue Therapy|Adverse Event|2|||
160478691|NCT00321555|579479941|FG000|Overall Study|Developed antibodies|1|||
160478692|NCT00321555|579479941|FG000|Overall Study|Switched to alternative treatment|3|||
160478693|NCT00321555|579479941|FG000|Overall Study|Physician Decision|1|||
160478694|NCT00321555|579479941|FG000|Overall Study|Disease progression on study|1|||
160478695|NCT02066389|579479942|FG000|Overall Study|Adverse Event|1|||
160478696|NCT02066389|579479943|FG001|Overall Study|Adverse Event|1|||
160478697|NCT02066389|579479944|FG002|Overall Study|Adverse Event|1|||
160478698|NCT02066389|579479945|FG003|Overall Study|Adverse Event|1|||
160478699|NCT02066389|579479946|FG004|Overall Study|Adverse Event|5|||
160478700|NCT02066389|579479947|FG005|Overall Study|Adverse Event|1|||
160478701|NCT02066389|579479942|FG000|Overall Study|Withdrawal by Subject|4|||
160478702|NCT02066389|579479943|FG001|Overall Study|Withdrawal by Subject|0|||
160478703|NCT02066389|579479944|FG002|Overall Study|Withdrawal by Subject|5|||
160478704|NCT02066389|579479945|FG003|Overall Study|Withdrawal by Subject|1|||
160478705|NCT02066389|579479946|FG004|Overall Study|Withdrawal by Subject|1|||
160478706|NCT02066389|579479947|FG005|Overall Study|Withdrawal by Subject|2|||
160478707|NCT02066389|579479942|FG000|Overall Study|Lost to Follow-up|0|||
160478708|NCT02066389|579479943|FG001|Overall Study|Lost to Follow-up|0|||
160478709|NCT02066389|579479944|FG002|Overall Study|Lost to Follow-up|0|||
160478710|NCT02066389|579479945|FG003|Overall Study|Lost to Follow-up|1|||
160478711|NCT02066389|579479946|FG004|Overall Study|Lost to Follow-up|1|||
160478712|NCT02066389|579479947|FG005|Overall Study|Lost to Follow-up|1|||
160478713|NCT02066389|579479942|FG000|Overall Study|Randomized in Error|0|||
160478714|NCT02066389|579479943|FG001|Overall Study|Randomized in Error|0|||
160478715|NCT02066389|579479944|FG002|Overall Study|Randomized in Error|0|||
160478716|NCT02066389|579479945|FG003|Overall Study|Randomized in Error|0|||
160478717|NCT02066389|579479946|FG004|Overall Study|Randomized in Error|0|||
160478718|NCT02066389|579479947|FG005|Overall Study|Randomized in Error|1|||
160478719|NCT02561195|579479949|FG000|Vaccination 1 to 3|Adverse Event|4|||
160478720|NCT02561195|579479950|FG001|Vaccination 1 to 3|Adverse Event|5|||
160478721|NCT02561195|579479951|FG002|Vaccination 1 to 3|Adverse Event|0|||
160478722|NCT02561195|579479952|FG003|Vaccination 1 to 3|Adverse Event|3|||
160478723|NCT02561195|579479953|FG004|Vaccination 1 to 3|Adverse Event|4|||
160478724|NCT02561195|579479954|FG005|Vaccination 1 to 3|Adverse Event|0|||
160478725|NCT02561195|579479955|FG006|Vaccination 1 to 3|Adverse Event|0|||
160478726|NCT02561195|579479956|FG007|Vaccination 1 to 3|Adverse Event|0|||
160478727|NCT02561195|579479957|FG008|Vaccination 1 to 3|Adverse Event|0|||
160478728|NCT02561195|579479958|FG009|Vaccination 1 to 3|Adverse Event|0|||
160478729|NCT02561195|579479959|FG010|Vaccination 1 to 3|Adverse Event|0|||
160478730|NCT02561195|579479960|FG011|Vaccination 1 to 3|Adverse Event|0|||
160478731|NCT02561195|579479961|FG012|Vaccination 1 to 3|Adverse Event|0|||
160478732|NCT02561195|579479962|FG013|Vaccination 1 to 3|Adverse Event|0|||
160478733|NCT02561195|579479949|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
160478734|NCT02561195|579479950|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
160478735|NCT02561195|579479951|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
160478736|NCT02561195|579479952|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
160478737|NCT02561195|579479953|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
160478738|NCT02561195|579479954|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
160478739|NCT02561195|579479955|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
160478740|NCT02561195|579479956|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
160478741|NCT02561195|579479957|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
160478742|NCT02561195|579479958|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
160478743|NCT02561195|579479959|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
160478744|NCT02561195|579479960|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
160478745|NCT02561195|579479961|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
160478746|NCT02561195|579479962|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
160478747|NCT02561195|579479949|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
160478748|NCT02561195|579479950|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
160478749|NCT02561195|579479951|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
160478750|NCT02561195|579479952|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
160478751|NCT02561195|579479953|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
160478752|NCT02561195|579479954|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
160478753|NCT02561195|579479955|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
160603814|NCT00617656|579926828|FG001|Overall Study|Withdrawal by Subject|2|||
160603815|NCT00617656|579926829|FG002|Overall Study|Withdrawal by Subject|0|||
160603816|NCT00617656|579926830|FG003|Overall Study|Withdrawal by Subject|0|||
160603817|NCT01731990|579928717|FG000|Overall Study|Adverse Event|1|||
160478754|NCT02561195|579479956|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
160478755|NCT02561195|579479957|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
160478756|NCT02561195|579479958|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
160478757|NCT02561195|579479959|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
160478758|NCT02561195|579479960|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
160478759|NCT02561195|579479961|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
160603818|NCT01731990|579928718|FG001|Overall Study|Adverse Event|5|||
160603819|NCT01731990|579928717|FG000|Overall Study|Withdrawal by Subject|1|||
160603820|NCT01731990|579928718|FG001|Overall Study|Withdrawal by Subject|1|||
160478760|NCT02561195|579479962|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
160478761|NCT02561195|579479949|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
160478762|NCT02561195|579479950|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
160478763|NCT02561195|579479951|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
160478764|NCT02561195|579479952|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
160478765|NCT02561195|579479953|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
160478766|NCT02561195|579479954|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
160478767|NCT02561195|579479955|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
160478768|NCT02561195|579479956|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
160478769|NCT02561195|579479957|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
160478770|NCT02561195|579479958|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
160478771|NCT02561195|579479959|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
160478772|NCT02561195|579479960|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
160478773|NCT02561195|579479961|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
160478774|NCT02561195|579479962|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
160478775|NCT02561195|579479949|FG000|Vaccination 1 to 3|Other|7|||
160478776|NCT02561195|579479950|FG001|Vaccination 1 to 3|Other|3|||
160478777|NCT02561195|579479951|FG002|Vaccination 1 to 3|Other|1|||
160478778|NCT02561195|579479952|FG003|Vaccination 1 to 3|Other|7|||
160478779|NCT02561195|579479953|FG004|Vaccination 1 to 3|Other|5|||
160478780|NCT02561195|579479954|FG005|Vaccination 1 to 3|Other|1|||
160478781|NCT02561195|579479955|FG006|Vaccination 1 to 3|Other|0|||
160478782|NCT02561195|579479956|FG007|Vaccination 1 to 3|Other|0|||
160478783|NCT02561195|579479957|FG008|Vaccination 1 to 3|Other|0|||
160478784|NCT02561195|579479958|FG009|Vaccination 1 to 3|Other|0|||
160478785|NCT02561195|579479959|FG010|Vaccination 1 to 3|Other|0|||
160478786|NCT02561195|579479960|FG011|Vaccination 1 to 3|Other|0|||
160478787|NCT02561195|579479961|FG012|Vaccination 1 to 3|Other|0|||
160478788|NCT02561195|579479962|FG013|Vaccination 1 to 3|Other|0|||
160478789|NCT02561195|579479949|FG000|Vaccination 1 to 3|Protocol Violation|1|||
160478790|NCT02561195|579479950|FG001|Vaccination 1 to 3|Protocol Violation|0|||
160478791|NCT02561195|579479951|FG002|Vaccination 1 to 3|Protocol Violation|1|||
160478792|NCT02561195|579479952|FG003|Vaccination 1 to 3|Protocol Violation|2|||
160478793|NCT02561195|579479953|FG004|Vaccination 1 to 3|Protocol Violation|5|||
160478794|NCT02561195|579479954|FG005|Vaccination 1 to 3|Protocol Violation|2|||
160478795|NCT02561195|579479955|FG006|Vaccination 1 to 3|Protocol Violation|0|||
160478796|NCT02561195|579479956|FG007|Vaccination 1 to 3|Protocol Violation|0|||
160478797|NCT02561195|579479957|FG008|Vaccination 1 to 3|Protocol Violation|0|||
160478798|NCT02561195|579479958|FG009|Vaccination 1 to 3|Protocol Violation|0|||
160478799|NCT02561195|579479959|FG010|Vaccination 1 to 3|Protocol Violation|0|||
160478800|NCT02561195|579479960|FG011|Vaccination 1 to 3|Protocol Violation|0|||
160478801|NCT02561195|579479961|FG012|Vaccination 1 to 3|Protocol Violation|0|||
160478802|NCT02561195|579479962|FG013|Vaccination 1 to 3|Protocol Violation|0|||
160478803|NCT02561195|579479949|FG000|Vaccination 1 to 3|Death|2|||
160478804|NCT02561195|579479950|FG001|Vaccination 1 to 3|Death|1|||
160478805|NCT02561195|579479951|FG002|Vaccination 1 to 3|Death|0|||
160478806|NCT02561195|579479952|FG003|Vaccination 1 to 3|Death|2|||
160478807|NCT02561195|579479953|FG004|Vaccination 1 to 3|Death|0|||
160478808|NCT02561195|579479954|FG005|Vaccination 1 to 3|Death|0|||
160478809|NCT02561195|579479955|FG006|Vaccination 1 to 3|Death|0|||
160478810|NCT02561195|579479956|FG007|Vaccination 1 to 3|Death|0|||
160478811|NCT02561195|579479957|FG008|Vaccination 1 to 3|Death|0|||
160478812|NCT02561195|579479958|FG009|Vaccination 1 to 3|Death|0|||
160478813|NCT02561195|579479959|FG010|Vaccination 1 to 3|Death|0|||
160478814|NCT02561195|579479960|FG011|Vaccination 1 to 3|Death|0|||
160478815|NCT02561195|579479961|FG012|Vaccination 1 to 3|Death|0|||
160478816|NCT02561195|579479962|FG013|Vaccination 1 to 3|Death|0|||
160478817|NCT02561195|579479949|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
160478818|NCT02561195|579479950|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
160478819|NCT02561195|579479951|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
160478820|NCT02561195|579479952|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
160478821|NCT02561195|579479953|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
160478822|NCT02561195|579479954|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
160478823|NCT02561195|579479955|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
160478824|NCT02561195|579479956|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
160478825|NCT02561195|579479957|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
160478826|NCT02561195|579479958|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
160478827|NCT02561195|579479959|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
160478828|NCT02561195|579479960|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
160478829|NCT02561195|579479961|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
160603821|NCT01731990|579928717|FG000|Overall Study|Protocol deviation|1|||
160603822|NCT01731990|579928718|FG001|Overall Study|Protocol deviation|2|||
160478830|NCT02561195|579479962|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
160478831|NCT02561195|579479949|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
160478832|NCT02561195|579479950|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
160478833|NCT02561195|579479951|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
160478834|NCT02561195|579479952|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
160478835|NCT02561195|579479953|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
160478836|NCT02561195|579479954|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
160478837|NCT02561195|579479955|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
160478838|NCT02561195|579479956|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
160478839|NCT02561195|579479957|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
160478840|NCT02561195|579479958|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
160478841|NCT02561195|579479959|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
160478842|NCT02561195|579479960|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
160478843|NCT02561195|579479961|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
160478844|NCT02561195|579479962|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
160478845|NCT02561195|579479949|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
160478846|NCT02561195|579479950|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
160478847|NCT02561195|579479951|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
160478848|NCT02561195|579479952|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
160478849|NCT02561195|579479953|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
160478850|NCT02561195|579479954|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
160478851|NCT02561195|579479955|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
160478852|NCT02561195|579479956|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
160478853|NCT02561195|579479957|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
160478854|NCT02561195|579479958|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
160478855|NCT02561195|579479959|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
160478856|NCT02561195|579479960|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
160478857|NCT02561195|579479961|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
160478858|NCT02561195|579479962|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
160478859|NCT02561195|579479949|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478860|NCT02561195|579479950|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478861|NCT02561195|579479951|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478862|NCT02561195|579479952|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478863|NCT02561195|579479953|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478864|NCT02561195|579479954|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478865|NCT02561195|579479955|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478866|NCT02561195|579479956|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478867|NCT02561195|579479957|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478868|NCT02561195|579479958|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478869|NCT02561195|579479959|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478870|NCT02561195|579479960|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478871|NCT02561195|579479961|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
160478872|NCT02561195|579479962|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
160478873|NCT02561195|579479949|FG000|Extension Stage (Vaccination 4)|Death|0|||
160478874|NCT02561195|579479950|FG001|Extension Stage (Vaccination 4)|Death|0|||
160478875|NCT02561195|579479951|FG002|Extension Stage (Vaccination 4)|Death|0|||
160478876|NCT02561195|579479952|FG003|Extension Stage (Vaccination 4)|Death|0|||
160478877|NCT02561195|579479953|FG004|Extension Stage (Vaccination 4)|Death|0|||
160478878|NCT02561195|579479954|FG005|Extension Stage (Vaccination 4)|Death|0|||
160478879|NCT02561195|579479955|FG006|Extension Stage (Vaccination 4)|Death|0|||
160478880|NCT02561195|579479956|FG007|Extension Stage (Vaccination 4)|Death|0|||
160478881|NCT02561195|579479957|FG008|Extension Stage (Vaccination 4)|Death|0|||
160478882|NCT02561195|579479958|FG009|Extension Stage (Vaccination 4)|Death|1|||
160478883|NCT02561195|579479959|FG010|Extension Stage (Vaccination 4)|Death|0|||
160478884|NCT02561195|579479960|FG011|Extension Stage (Vaccination 4)|Death|0|||
160478885|NCT02561195|579479961|FG012|Extension Stage (Vaccination 4)|Death|0|||
160478886|NCT02561195|579479962|FG013|Extension Stage (Vaccination 4)|Death|0|||
160478887|NCT02561195|579479949|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
160478888|NCT02561195|579479950|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
160478889|NCT02561195|579479951|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
160478890|NCT02561195|579479952|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
160478891|NCT02561195|579479953|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
160478892|NCT02561195|579479954|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
160478893|NCT02561195|579479955|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
160478894|NCT02561195|579479956|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
160478895|NCT02561195|579479957|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
160478896|NCT02561195|579479958|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
160478897|NCT02561195|579479959|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
160478898|NCT02561195|579479960|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
160478899|NCT02561195|579479961|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
160478900|NCT02561195|579479962|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
160478901|NCT02561195|579479949|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160478902|NCT02561195|579479950|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160478903|NCT02561195|579479951|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160603823|NCT01731990|579928717|FG000|Overall Study|Death|1|||
160603824|NCT01731990|579928718|FG001|Overall Study|Death|0|||
160478904|NCT02561195|579479952|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160478905|NCT02561195|579479953|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160478906|NCT02561195|579479954|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160478907|NCT02561195|579479955|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160478908|NCT02561195|579479956|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160478909|NCT02561195|579479957|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160478910|NCT02561195|579479958|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160478911|NCT02561195|579479959|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
160478912|NCT02561195|579479960|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
160478913|NCT02561195|579479961|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
160478914|NCT02561195|579479962|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
160478915|NCT02561195|579479949|FG000|Extension Stage (Vaccination 4)|Other|0|||
160478916|NCT02561195|579479950|FG001|Extension Stage (Vaccination 4)|Other|0|||
160478917|NCT02561195|579479951|FG002|Extension Stage (Vaccination 4)|Other|0|||
160478918|NCT02561195|579479952|FG003|Extension Stage (Vaccination 4)|Other|0|||
160478919|NCT02561195|579479953|FG004|Extension Stage (Vaccination 4)|Other|0|||
160478920|NCT02561195|579479954|FG005|Extension Stage (Vaccination 4)|Other|0|||
160478921|NCT02561195|579479955|FG006|Extension Stage (Vaccination 4)|Other|0|||
160478922|NCT02561195|579479956|FG007|Extension Stage (Vaccination 4)|Other|0|||
160478923|NCT02561195|579479957|FG008|Extension Stage (Vaccination 4)|Other|0|||
160478924|NCT02561195|579479958|FG009|Extension Stage (Vaccination 4)|Other|0|||
160478925|NCT02561195|579479959|FG010|Extension Stage (Vaccination 4)|Other|2|||
160478926|NCT02561195|579479960|FG011|Extension Stage (Vaccination 4)|Other|2|||
160478927|NCT02561195|579479961|FG012|Extension Stage (Vaccination 4)|Other|1|||
160478928|NCT02561195|579479962|FG013|Extension Stage (Vaccination 4)|Other|0|||
160478929|NCT02561195|579479949|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
160478930|NCT02561195|579479950|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
160478931|NCT02561195|579479951|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
160478932|NCT02561195|579479952|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
160478933|NCT02561195|579479953|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
160478934|NCT02561195|579479954|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
160478935|NCT02561195|579479955|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
160478936|NCT02561195|579479956|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
160478937|NCT02561195|579479957|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
160478938|NCT02561195|579479958|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
160478939|NCT02561195|579479959|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
160478940|NCT02561195|579479960|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
160478941|NCT02561195|579479961|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
160478942|NCT02561195|579479962|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
160478943|NCT03905512|579479963|FG000|Overall Study|Withdrawal by Subject|9|||
160478944|NCT03905512|579479964|FG001|Overall Study|Withdrawal by Subject|8|||
160478945|NCT03905512|579479963|FG000|Overall Study|Adverse Event|1|||
160478946|NCT03905512|579479964|FG001|Overall Study|Adverse Event|2|||
160478947|NCT03905512|579479963|FG000|Overall Study|Lost to Follow-up|4|||
160478948|NCT03905512|579479964|FG001|Overall Study|Lost to Follow-up|3|||
160478949|NCT03905512|579479963|FG000|Overall Study|Other than Specified|7|||
160478950|NCT03905512|579479964|FG001|Overall Study|Other than Specified|4|||
160478951|NCT00736502|579479971|FG000|Overall Study|Adverse Event|22|||
160478952|NCT00736502|579479971|FG000|Overall Study|Lack of Efficacy|16|||
160478953|NCT00736502|579479971|FG000|Overall Study|Lost to Follow-up|27|||
160478954|NCT03987074|579479973|FG000|Overall Study|Withdrew Consent|1|||
160478955|NCT03987074|579479974|FG001|Overall Study|Withdrew Consent|1|||
160478956|NCT03987074|579479975|FG002|Overall Study|Withdrew Consent|0|||
160478957|NCT03987074|579479976|FG003|Overall Study|Withdrew Consent|2|||
160478958|NCT03987074|579479977|FG004|Overall Study|Withdrew Consent|1|||
160478959|NCT03987074|579479973|FG000|Overall Study|Adverse Event|2|||
160478960|NCT03987074|579479974|FG001|Overall Study|Adverse Event|1|||
160478961|NCT03987074|579479975|FG002|Overall Study|Adverse Event|0|||
160478962|NCT03987074|579479976|FG003|Overall Study|Adverse Event|0|||
160478963|NCT03987074|579479977|FG004|Overall Study|Adverse Event|1|||
160603825|NCT01183104|579928721|FG000|Overall Study|Adverse Event|8|||
160603826|NCT01183104|579928722|FG001|Overall Study|Adverse Event|6|||
160603827|NCT01183104|579928721|FG000|Overall Study|Death|0|||
160603828|NCT01183104|579928722|FG001|Overall Study|Death|1|||
160603829|NCT01183104|579928721|FG000|Overall Study|Lost to Follow-up|14|||
160603830|NCT01183104|579928722|FG001|Overall Study|Lost to Follow-up|7|||
160478964|NCT03987074|579479973|FG000|Overall Study|Lost to Follow-up|0|||
160478965|NCT03987074|579479974|FG001|Overall Study|Lost to Follow-up|0|||
160478966|NCT03987074|579479975|FG002|Overall Study|Lost to Follow-up|1|||
160478967|NCT03987074|579479976|FG003|Overall Study|Lost to Follow-up|1|||
160478968|NCT03987074|579479977|FG004|Overall Study|Lost to Follow-up|0|||
160478969|NCT03987074|579479973|FG000|Overall Study|Investigator's Discretion|0|||
160478970|NCT03987074|579479974|FG001|Overall Study|Investigator's Discretion|0|||
160478971|NCT03987074|579479975|FG002|Overall Study|Investigator's Discretion|0|||
160478972|NCT03987074|579479976|FG003|Overall Study|Investigator's Discretion|1|||
160478973|NCT03987074|579479977|FG004|Overall Study|Investigator's Discretion|0|||
160478974|NCT01307800|579479978|FG000|Overall Study|Adverse Event|9|||
160478975|NCT01307800|579479979|FG001|Overall Study|Adverse Event|8|||
160478976|NCT01307800|579479980|FG002|Overall Study|Adverse Event|10|||
160478977|NCT01307800|579479981|FG003|Overall Study|Adverse Event|14|||
160478978|NCT01307800|579479978|FG000|Overall Study|Entry Criteria Not Met|0|||
160478979|NCT01307800|579479979|FG001|Overall Study|Entry Criteria Not Met|0|||
160478980|NCT01307800|579479980|FG002|Overall Study|Entry Criteria Not Met|0|||
160478981|NCT01307800|579479981|FG003|Overall Study|Entry Criteria Not Met|2|||
160478982|NCT01307800|579479978|FG000|Overall Study|Lost to Follow-up|5|||
160478983|NCT01307800|579479979|FG001|Overall Study|Lost to Follow-up|6|||
160478984|NCT01307800|579479980|FG002|Overall Study|Lost to Follow-up|2|||
160478985|NCT01307800|579479981|FG003|Overall Study|Lost to Follow-up|8|||
160478986|NCT01307800|579479978|FG000|Overall Study|Perceived Lack of Efficacy|24|||
160478987|NCT01307800|579479979|FG001|Overall Study|Perceived Lack of Efficacy|23|||
160478988|NCT01307800|579479980|FG002|Overall Study|Perceived Lack of Efficacy|20|||
160478989|NCT01307800|579479981|FG003|Overall Study|Perceived Lack of Efficacy|33|||
160478990|NCT01307800|579479978|FG000|Overall Study|Protocol Violation|0|||
160478991|NCT01307800|579479979|FG001|Overall Study|Protocol Violation|3|||
160478992|NCT01307800|579479980|FG002|Overall Study|Protocol Violation|4|||
160478993|NCT01307800|579479981|FG003|Overall Study|Protocol Violation|5|||
160478994|NCT01307800|579479978|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
160478995|NCT01307800|579479979|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
160478996|NCT01307800|579479980|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
160478997|NCT01307800|579479981|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
160478998|NCT01307800|579479978|FG000|Overall Study|Sponsor Decision|6|||
160478999|NCT01307800|579479979|FG001|Overall Study|Sponsor Decision|9|||
160479000|NCT01307800|579479980|FG002|Overall Study|Sponsor Decision|12|||
160479001|NCT01307800|579479981|FG003|Overall Study|Sponsor Decision|28|||
160479002|NCT01307800|579479978|FG000|Overall Study|Withdrawal by Subject|10|||
160479003|NCT01307800|579479979|FG001|Overall Study|Withdrawal by Subject|11|||
160479004|NCT01307800|579479980|FG002|Overall Study|Withdrawal by Subject|8|||
160479005|NCT01307800|579479981|FG003|Overall Study|Withdrawal by Subject|15|||
160479006|NCT01307800|579479978|FG000|Overall Study|Participant Moved|0|||
160479007|NCT01307800|579479979|FG001|Overall Study|Participant Moved|2|||
160479008|NCT01307800|579479980|FG002|Overall Study|Participant Moved|1|||
160479009|NCT01307800|579479981|FG003|Overall Study|Participant Moved|3|||
160479010|NCT00508144|579479984|FG000|Overall Study|Not eligible|6|||
160479011|NCT00508144|579479984|FG000|Overall Study|Death|5|||
160479012|NCT01084772|579479988|FG000|Baseline|Withdrawal by Subject|7|||
160479013|NCT01084772|579479989|FG001|Baseline|Withdrawal by Subject|6|||
160479014|NCT01084772|579479988|FG000|3 Months|Death|1|||
160479015|NCT01084772|579479989|FG001|3 Months|Death|0|||
160479016|NCT01084772|579479988|FG000|3 Months|Study Termination|2|||
160479017|NCT01084772|579479989|FG001|3 Months|Study Termination|2|||
160479018|NCT01084772|579479988|FG000|1 Year|Withdrawal by Subject|0|||
160479019|NCT01084772|579479989|FG001|1 Year|Withdrawal by Subject|1|||
160479020|NCT01084772|579479988|FG000|1 Year|Lost to Follow-up|3|||
160479021|NCT01084772|579479989|FG001|1 Year|Lost to Follow-up|0|||
160479022|NCT01084772|579479988|FG000|1 Year|Study Termination|0|||
160479023|NCT01084772|579479989|FG001|1 Year|Study Termination|7|||
160479024|NCT01084772|579479988|FG000|2 Years|Withdrawal by Subject|1|||
160479025|NCT01084772|579479989|FG001|2 Years|Withdrawal by Subject|0|||
160479026|NCT01084772|579479988|FG000|2 Years|Lost to Follow-up|5|||
160479027|NCT01084772|579479989|FG001|2 Years|Lost to Follow-up|2|||
160479028|NCT01084772|579479988|FG000|2 Years|Study Termination|3|||
160479029|NCT01084772|579479989|FG001|2 Years|Study Termination|2|||
160603831|NCT01183104|579928721|FG000|Overall Study|Physician Decision|5|||
160479030|NCT04520256|579479990|FG000|Overall Study|Lost to Follow-up|6|||
160603832|NCT01183104|579928722|FG001|Overall Study|Physician Decision|8|||
160603833|NCT01183104|579928721|FG000|Overall Study|Withdrawal by Subject|6|||
160603834|NCT01183104|579928722|FG001|Overall Study|Withdrawal by Subject|11|||
160603835|NCT01183104|579928721|FG000|Overall Study|Nonparticipation in Extension Study|39|||
160479031|NCT04520256|579479991|FG001|Overall Study|Lost to Follow-up|4|||
160479032|NCT04520256|579479992|FG002|Overall Study|Lost to Follow-up|2|||
160479033|NCT04520256|579479993|FG003|Overall Study|Lost to Follow-up|3|||
160479034|NCT04520256|579479994|FG004|Overall Study|Lost to Follow-up|6|||
160479035|NCT04520256|579479995|FG005|Overall Study|Lost to Follow-up|6|||
160479036|NCT04520256|579479996|FG006|Overall Study|Lost to Follow-up|4|||
160479037|NCT04520256|579479997|FG007|Overall Study|Lost to Follow-up|6|||
160479038|NCT04520256|579479998|FG008|Overall Study|Lost to Follow-up|1|||
160479039|NCT04520256|579479999|FG009|Overall Study|Lost to Follow-up|3|||
160479040|NCT04520256|579480000|FG010|Overall Study|Lost to Follow-up|3|||
160479041|NCT04520256|579480001|FG011|Overall Study|Lost to Follow-up|2|||
160479042|NCT04520256|579480002|FG012|Overall Study|Lost to Follow-up|5|||
160479043|NCT04520256|579480003|FG013|Overall Study|Lost to Follow-up|3|||
160603836|NCT01183104|579928722|FG001|Overall Study|Nonparticipation in Extension Study|50|||
160479044|NCT04520256|579480004|FG014|Overall Study|Lost to Follow-up|3|||
160479045|NCT04520256|579480005|FG015|Overall Study|Lost to Follow-up|6|||
160479046|NCT04520256|579480006|FG016|Overall Study|Lost to Follow-up|6|||
160479047|NCT04520256|579480007|FG017|Overall Study|Lost to Follow-up|4|||
160479048|NCT04520256|579480008|FG018|Overall Study|Lost to Follow-up|3|||
160479049|NCT04520256|579480009|FG019|Overall Study|Lost to Follow-up|3|||
160479050|NCT04520256|579480010|FG020|Overall Study|Lost to Follow-up|7|||
160479051|NCT04520256|579480011|FG021|Overall Study|Lost to Follow-up|3|||
160479052|NCT04520256|579480012|FG022|Overall Study|Lost to Follow-up|3|||
160479053|NCT04520256|579480013|FG023|Overall Study|Lost to Follow-up|8|||
160479054|NCT04520256|579480014|FG024|Overall Study|Lost to Follow-up|5|||
160479055|NCT04520256|579480015|FG025|Overall Study|Lost to Follow-up|4|||
160479056|NCT04520256|579480016|FG026|Overall Study|Lost to Follow-up|3|||
160479057|NCT04520256|579480017|FG027|Overall Study|Lost to Follow-up|4|||
160479058|NCT04520256|579480018|FG028|Overall Study|Lost to Follow-up|3|||
160479059|NCT04520256|579480019|FG029|Overall Study|Lost to Follow-up|4|||
160479060|NCT04520256|579480020|FG030|Overall Study|Lost to Follow-up|4|||
160479061|NCT04520256|579480021|FG031|Overall Study|Lost to Follow-up|4|||
160479062|NCT02880293|579481177|FG000|Overall Study|Inevaluable|5|||
160479063|NCT02101554|579481180|FG000|Overall Study|Protocol Violation|0|||
160479064|NCT02101554|579481181|FG001|Overall Study|Protocol Violation|1|||
160479065|NCT02101554|579481182|FG002|Overall Study|Protocol Violation|0|||
160479066|NCT02101554|579481180|FG000|Overall Study|Insufficient Clinical Response|0|||
160479067|NCT02101554|579481181|FG001|Overall Study|Insufficient Clinical Response|2|||
160479068|NCT02101554|579481182|FG002|Overall Study|Insufficient Clinical Response|0|||
160479069|NCT02101554|579481180|FG000|Overall Study|Adverse Event|2|||
160479070|NCT02101554|579481181|FG001|Overall Study|Adverse Event|1|||
160479071|NCT02101554|579481182|FG002|Overall Study|Adverse Event|1|||
160479072|NCT02101554|579481180|FG000|Overall Study|Lost to Follow-up|0|||
160479073|NCT02101554|579481181|FG001|Overall Study|Lost to Follow-up|1|||
160479074|NCT02101554|579481182|FG002|Overall Study|Lost to Follow-up|0|||
160479075|NCT02101554|579481180|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
160479076|NCT02101554|579481181|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
160479077|NCT02101554|579481182|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
160479078|NCT00668746|579481183|FG000|Overall Study|Lost to Follow-up|2|||
160479079|NCT00668746|579481184|FG001|Overall Study|Lost to Follow-up|1|||
160479080|NCT05361304|579481187|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
160479081|NCT05361304|579481188|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
160479082|NCT05361304|579481187|FG000|Overall Study|COVID-19 Related|1|||
160479083|NCT05361304|579481188|FG001|Overall Study|COVID-19 Related|2|||
160479084|NCT05361304|579481187|FG000|Overall Study|Withdrawal by Subject|1|||
160479085|NCT05361304|579481188|FG001|Overall Study|Withdrawal by Subject|0|||
160479086|NCT03320941|579481189|FG000|Overall Study|subject/guardian decision|0|||
160479087|NCT03320941|579481190|FG001|Overall Study|subject/guardian decision|0|||
160479088|NCT03320941|579481191|FG002|Overall Study|subject/guardian decision|0|||
160479089|NCT03320941|579481192|FG003|Overall Study|subject/guardian decision|1|||
160479090|NCT03320941|579481193|FG004|Overall Study|subject/guardian decision|0|||
160479091|NCT02368691|579481195|FG000|Overall Study|Death|13|||
160479092|NCT02368691|579481195|FG000|Overall Study|Lack of Efficacy|15|||
160479093|NCT02368691|579481195|FG000|Overall Study|Physician Decision|4|||
160479094|NCT01838447|579481196|FG000|Overall Study|Change in surgical plan|1|||
160479095|NCT01838447|579481197|FG001|Overall Study|Change in surgical plan|2|||
160479096|NCT01838447|579481196|FG000|Overall Study|Withdrawal by Subject|1|||
160479097|NCT01838447|579481197|FG001|Overall Study|Withdrawal by Subject|1|||
160479098|NCT01114217|579481198|FG000|Overall Study|Adverse Event|5|||
160479099|NCT01114217|579481199|FG001|Overall Study|Adverse Event|3|||
160479100|NCT01114217|579481198|FG000|Overall Study|Lost to Follow-up|17|||
160479101|NCT01114217|579481199|FG001|Overall Study|Lost to Follow-up|33|||
160479102|NCT01114217|579481198|FG000|Overall Study|Withdrawal by Subject|21|||
160479103|NCT01114217|579481199|FG001|Overall Study|Withdrawal by Subject|28|||
160479104|NCT01114217|579481198|FG000|Overall Study|Other-Clerical Error|3|||
160603837|NCT01183104|579928721|FG000|Overall Study|Did not receive study drug|5|||
160603838|NCT01183104|579928722|FG001|Overall Study|Did not receive study drug|9|||
160479105|NCT01114217|579481199|FG001|Overall Study|Other-Clerical Error|0|||
160479106|NCT01114217|579481198|FG000|Overall Study|Other-Early termination|6|||
160479107|NCT01114217|579481199|FG001|Overall Study|Other-Early termination|10|||
160479108|NCT01114217|579481198|FG000|Overall Study|Other-Procedure|1|||
160479109|NCT01114217|579481199|FG001|Overall Study|Other-Procedure|1|||
160479110|NCT01114217|579481198|FG000|Overall Study|Other-Pregnancy|2|||
160479111|NCT01114217|579481199|FG001|Overall Study|Other-Pregnancy|4|||
160479112|NCT01114217|579481198|FG000|Overall Study|Other-Protocol Violation|1|||
160479113|NCT01114217|579481199|FG001|Overall Study|Other-Protocol Violation|3|||
160479114|NCT01114217|579481198|FG000|Overall Study|Other-Lack of Efficacy|1|||
160479115|NCT01114217|579481199|FG001|Overall Study|Other-Lack of Efficacy|0|||
160479116|NCT01114217|579481198|FG000|Overall Study|Other-Non Compliance|2|||
160479117|NCT01114217|579481199|FG001|Overall Study|Other-Non Compliance|0|||
160603839|NCT05516134|579928723|FG000|Overall Study|Lost to Follow-up|1|||
160479118|NCT01114217|579481198|FG000|Overall Study|Other-Physician Decision|1|||
160479119|NCT01114217|579481199|FG001|Overall Study|Other-Physician Decision|1|||
160479120|NCT01114217|579481198|FG000|Overall Study|Other-Sponsor Decision|10|||
160479121|NCT01114217|579481199|FG001|Overall Study|Other-Sponsor Decision|12|||
160479122|NCT01114217|579481198|FG000|Overall Study|Other-Study Termination|0|||
160479123|NCT01114217|579481199|FG001|Overall Study|Other-Study Termination|1|||
160479124|NCT01114217|579481198|FG000|Overall Study|Other-Study Withdrawn|1|||
160479125|NCT01114217|579481199|FG001|Overall Study|Other-Study Withdrawn|1|||
160479126|NCT01114217|579481198|FG000|Overall Study|Other-Site Stopped Communicating|2|||
160479127|NCT01114217|579481199|FG001|Overall Study|Other-Site Stopped Communicating|0|||
160479128|NCT01114217|579481198|FG000|Overall Study|Other-Lost to Follow-up|1|||
160479129|NCT01114217|579481199|FG001|Overall Study|Other-Lost to Follow-up|0|||
160479130|NCT01114217|579481198|FG000|Overall Study|Other-Withdrawal by Subject|1|||
160479131|NCT01114217|579481199|FG001|Overall Study|Other-Withdrawal by Subject|1|||
160479132|NCT06247488|579481200|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
160479133|NCT06247488|579481201|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
160479134|NCT06247488|579481202|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
160479135|NCT06247488|579481203|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
160479136|NCT06247488|579481204|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
160479137|NCT06247488|579481205|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
160479138|NCT06247488|579481200|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
160479139|NCT06247488|579481201|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
160479140|NCT06247488|579481202|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
160479141|NCT06247488|579481203|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
160479142|NCT06247488|579481204|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
160479143|NCT06247488|579481205|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
160479144|NCT06247488|579481200|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
160479145|NCT06247488|579481201|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
160479146|NCT06247488|579481202|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
160479147|NCT06247488|579481203|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
160479148|NCT06247488|579481204|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
160479149|NCT06247488|579481205|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
160479150|NCT06247488|579481200|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
160479151|NCT06247488|579481201|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
160479152|NCT06247488|579481202|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
160479153|NCT06247488|579481203|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
160479154|NCT06247488|579481204|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
160479155|NCT06247488|579481205|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
160479156|NCT06247488|579481200|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
160479157|NCT06247488|579481201|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
160479158|NCT06247488|579481202|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
160479159|NCT06247488|579481203|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
160479160|NCT06247488|579481204|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
160479161|NCT06247488|579481205|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
160479162|NCT06247488|579481200|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
160479163|NCT06247488|579481201|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
160479164|NCT06247488|579481202|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
160479165|NCT06247488|579481203|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
160479166|NCT06247488|579481204|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
160603840|NCT05516134|579928724|FG001|Overall Study|Lost to Follow-up|0|||
160603841|NCT05516134|579928725|FG002|Overall Study|Lost to Follow-up|0|||
160479167|NCT06247488|579481205|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
160479168|NCT06247488|579481200|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
160603842|NCT01355497|579928734|FG000|Overall Study|Death|19|||
160603843|NCT01355497|579928735|FG001|Overall Study|Death|18|||
160603844|NCT01355497|579928734|FG000|Overall Study|Lost to Follow-up|3|||
160603845|NCT01355497|579928735|FG001|Overall Study|Lost to Follow-up|0|||
160603846|NCT01355497|579928734|FG000|Overall Study|Protocol Violation|0|||
160603847|NCT01355497|579928735|FG001|Overall Study|Protocol Violation|1|||
160603848|NCT01355497|579928734|FG000|Overall Study|other-not provided|9|||
160603849|NCT01355497|579928735|FG001|Overall Study|other-not provided|4|||
160603850|NCT01355497|579928734|FG000|Overall Study|Withdrawal by Subject|12|||
160603851|NCT01355497|579928735|FG001|Overall Study|Withdrawal by Subject|20|||
160603852|NCT01355497|579928734|FG000|Overall Study|noncompliance|1|||
160603853|NCT01355497|579928735|FG001|Overall Study|noncompliance|2|||
160479169|NCT06247488|579481201|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
160479170|NCT06247488|579481202|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
160479171|NCT06247488|579481203|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
160479172|NCT06247488|579481204|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
160603854|NCT01355497|579928734|FG000|Overall Study|progressive disease|11|||
160603855|NCT01355497|579928735|FG001|Overall Study|progressive disease|8|||
160603856|NCT01355497|579928734|FG000|Overall Study|Adverse Event|11|||
160603857|NCT01355497|579928735|FG001|Overall Study|Adverse Event|10|||
160603858|NCT01224106|579928737|FG000|Double-Blind Treatment Phase|Death|3|||
160603859|NCT01224106|579928738|FG001|Double-Blind Treatment Phase|Death|0|||
160479173|NCT06247488|579481205|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
160479174|NCT00584909|579481209|FG000|Overall Study|Adverse Event|4|||
160479175|NCT03436797|579481210|FG000|Main Study|Withdrawal by Subject|2|||
160479176|NCT03436797|579481210|FG000|Main Study|Adverse Event|4|||
160479177|NCT03436797|579481210|FG000|Main Study|Lost to Follow-up|1|||
160479178|NCT03436797|579481210|FG000|Main Study|Death|1|||
160479179|NCT03436797|579481210|FG000|Main Study|Non-Specific|2|||
160479180|NCT03436797|579481210|FG000|Extended Dosing|Patient decision|1|||
160479181|NCT04739306|579481211|FG000|Main Study Period|Adverse Event|6|||
160479182|NCT04739306|579481212|FG001|Main Study Period|Adverse Event|7|||
160479183|NCT04739306|579481211|FG000|Main Study Period|Lost to Follow-up|4|||
160479184|NCT04739306|579481212|FG001|Main Study Period|Lost to Follow-up|6|||
160479185|NCT04739306|579481211|FG000|Main Study Period|Physician Decision|1|||
160479186|NCT04739306|579481212|FG001|Main Study Period|Physician Decision|1|||
160479187|NCT04739306|579481211|FG000|Main Study Period|Withdrawal by Subject|8|||
160479188|NCT04739306|579481212|FG001|Main Study Period|Withdrawal by Subject|6|||
160479189|NCT04739306|579481211|FG000|Main Study Period|Protocol Violation|0|||
160479190|NCT04739306|579481212|FG001|Main Study Period|Protocol Violation|1|||
160479191|NCT04739306|579481211|FG000|Main Study Period|War in Ukraine|1|||
160479192|NCT04739306|579481212|FG001|Main Study Period|War in Ukraine|1|||
160479193|NCT01951105|579481217|FG000|Overall Study|Adverse Event|0|||
160479194|NCT01951105|579481218|FG001|Overall Study|Adverse Event|5|||
160479195|NCT01951105|579481219|FG002|Overall Study|Adverse Event|0|||
160479196|NCT01951105|579481217|FG000|Overall Study|Lost to Follow-up|0|||
160479197|NCT01951105|579481218|FG001|Overall Study|Lost to Follow-up|1|||
160479198|NCT01951105|579481219|FG002|Overall Study|Lost to Follow-up|0|||
160479199|NCT01951105|579481217|FG000|Overall Study|Protocol Violation|1|||
160479200|NCT01951105|579481218|FG001|Overall Study|Protocol Violation|1|||
160479201|NCT01951105|579481219|FG002|Overall Study|Protocol Violation|1|||
160479202|NCT01951105|579481217|FG000|Overall Study|Withdrawal by Subject|0|||
160479203|NCT01951105|579481218|FG001|Overall Study|Withdrawal by Subject|3|||
160479204|NCT01951105|579481219|FG002|Overall Study|Withdrawal by Subject|1|||
160479205|NCT04175392|579481220|FG000|Overall Study|Withdrawal by Subject|3|||
160479206|NCT04175392|579481221|FG001|Overall Study|Withdrawal by Subject|2|||
160479207|NCT01103141|579481222|FG000|Overall Study|Death|0|||
160479208|NCT01103141|579481223|FG001|Overall Study|Death|1|||
160479209|NCT01103141|579481222|FG000|Overall Study|Lost to Follow-up|2|||
160479210|NCT01103141|579481223|FG001|Overall Study|Lost to Follow-up|1|||
160479211|NCT05072795|579481226|FG000|Overall Study|Lost to Follow-up|5|||
160479212|NCT00422162|579481230|FG000|Overall Study|Adverse Event|11|||
160479213|NCT00422162|579481231|FG001|Overall Study|Adverse Event|9|||
160479214|NCT00422162|579481230|FG000|Overall Study|Lack of Efficacy|4|||
160479215|NCT00422162|579481231|FG001|Overall Study|Lack of Efficacy|10|||
160479216|NCT00422162|579481230|FG000|Overall Study|Withdrawal by Subject|7|||
160479217|NCT00422162|579481231|FG001|Overall Study|Withdrawal by Subject|6|||
160479218|NCT00422162|579481230|FG000|Overall Study|Lost to Follow-up|1|||
160479219|NCT00422162|579481231|FG001|Overall Study|Lost to Follow-up|2|||
160479220|NCT00422162|579481230|FG000|Overall Study|Non-Compliant with Protocol|1|||
160479221|NCT00422162|579481231|FG001|Overall Study|Non-Compliant with Protocol|1|||
160479222|NCT00422162|579481230|FG000|Overall Study|Other|0|||
160479223|NCT00422162|579481231|FG001|Overall Study|Other|1|||
160479224|NCT00422162|579481230|FG000|Overall Study|Didn't Receive Treatment|0|||
160479225|NCT00422162|579481231|FG001|Overall Study|Didn't Receive Treatment|1|||
160479226|NCT05274906|579481232|FG000|Overall Study|Withdrawal by Subject|2|||
160479227|NCT05274906|579481233|FG001|Overall Study|Withdrawal by Subject|1|||
160479228|NCT00848198|579481234|FG000|Overall Study|Incomplete Case Report Forms|15|||
160479229|NCT02062827|579481238|FG000|Overall Study|Death|1|||
160479230|NCT02062827|579481239|FG001|Overall Study|Death|0|||
160603860|NCT01224106|579928739|FG002|Double-Blind Treatment Phase|Death|0|||
160603861|NCT01224106|579928740|FG003|Double-Blind Treatment Phase|Death|0|||
160479231|NCT02062827|579481240|FG002|Overall Study|Death|0|||
160603862|NCT01224106|579928741|FG004|Double-Blind Treatment Phase|Death|0|||
160603863|NCT01224106|579928737|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
160603864|NCT01224106|579928738|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
160479232|NCT02062827|579481241|FG003|Overall Study|Death|0|||
160479233|NCT02062827|579481242|FG004|Overall Study|Death|0|||
160479234|NCT02062827|579481243|FG005|Overall Study|Death|0|||
160479235|NCT02062827|579481244|FG006|Overall Study|Death|0|||
160479236|NCT02062827|579481245|FG007|Overall Study|Death|0|||
160479237|NCT02062827|579481238|FG000|Overall Study|Withdrawal by Subject|3|||
160479238|NCT02062827|579481239|FG001|Overall Study|Withdrawal by Subject|1|||
160479239|NCT02062827|579481240|FG002|Overall Study|Withdrawal by Subject|1|||
160479240|NCT02062827|579481241|FG003|Overall Study|Withdrawal by Subject|2|||
160479241|NCT02062827|579481242|FG004|Overall Study|Withdrawal by Subject|6|||
160479242|NCT02062827|579481243|FG005|Overall Study|Withdrawal by Subject|0|||
160479243|NCT02062827|579481244|FG006|Overall Study|Withdrawal by Subject|5|||
160479244|NCT02062827|579481245|FG007|Overall Study|Withdrawal by Subject|0|||
160479245|NCT02062827|579481238|FG000|Overall Study|Screen Fail|0|||
160479246|NCT02062827|579481239|FG001|Overall Study|Screen Fail|0|||
160479247|NCT02062827|579481240|FG002|Overall Study|Screen Fail|0|||
160479248|NCT02062827|579481241|FG003|Overall Study|Screen Fail|0|||
160479249|NCT02062827|579481242|FG004|Overall Study|Screen Fail|0|||
160479250|NCT02062827|579481243|FG005|Overall Study|Screen Fail|0|||
160479251|NCT02062827|579481244|FG006|Overall Study|Screen Fail|0|||
160479252|NCT02062827|579481245|FG007|Overall Study|Screen Fail|8|||
160479253|NCT04930263|579481246|FG000|Overall Study|Withdrawal by Subject|3|||
160479254|NCT04930263|579481247|FG001|Overall Study|Withdrawal by Subject|5|||
160479255|NCT02812706|579481249|FG000|Phase 1|Adverse Event|0|||
160479256|NCT02812706|579481250|FG001|Phase 1|Adverse Event|2|||
160479257|NCT02812706|579481251|FG002|Phase 1|Adverse Event|0|||
160479258|NCT02812706|579481249|FG000|Phase 1|Progressive disease|3|||
160479259|NCT02812706|579481250|FG001|Phase 1|Progressive disease|3|||
160479260|NCT02812706|579481251|FG002|Phase 1|Progressive disease|0|||
160479261|NCT02812706|579481249|FG000|Phase 2|Adverse Event|0|||
160479262|NCT02812706|579481250|FG001|Phase 2|Adverse Event|0|||
160479263|NCT02812706|579481251|FG002|Phase 2|Adverse Event|2|||
160479264|NCT02812706|579481249|FG000|Phase 2|Progressive disease|0|||
160479265|NCT02812706|579481250|FG001|Phase 2|Progressive disease|0|||
160479266|NCT02812706|579481251|FG002|Phase 2|Progressive disease|22|||
160479267|NCT02812706|579481249|FG000|Phase 2|Other-Unspecified|0|||
160479268|NCT02812706|579481250|FG001|Phase 2|Other-Unspecified|0|||
160479269|NCT02812706|579481251|FG002|Phase 2|Other-Unspecified|4|||
160479270|NCT02971683|579481252|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
160479271|NCT02971683|579481253|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
160479272|NCT02971683|579481252|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
160479273|NCT02971683|579481253|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
160479274|NCT02971683|579481252|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
160479275|NCT02971683|579481253|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
160479276|NCT02971683|579481252|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
160479277|NCT02971683|579481253|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
160479278|NCT02971683|579481252|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
160479279|NCT02971683|579481253|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
160479280|NCT02971683|579481252|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
160479281|NCT02971683|579481253|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
160479282|NCT02971683|579481252|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
160479283|NCT02971683|579481253|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
160479284|NCT02971683|579481252|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
160479285|NCT02971683|579481253|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
160479286|NCT02971683|579481252|FG000|Open-Label|Lost to Follow-up|1|||
160479287|NCT02971683|579481253|FG001|Open-Label|Lost to Follow-up|0|||
160479288|NCT02971683|579481252|FG000|Open-Label|Participants withdrew consent|0|||
160603865|NCT01224106|579928739|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
160603866|NCT01224106|579928740|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
160603867|NCT01224106|579928741|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
160603868|NCT01224106|579928737|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
160603869|NCT01224106|579928738|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
160603870|NCT01224106|579928739|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
160603871|NCT01224106|579928740|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
160479289|NCT02971683|579481253|FG001|Open-Label|Participants withdrew consent|2|||
160479290|NCT02971683|579481252|FG000|Open-Label|Participant request to discontinue study treatment|1|||
160479291|NCT02971683|579481253|FG001|Open-Label|Participant request to discontinue study treatment|0|||
160479292|NCT02971683|579481252|FG000|Open-Label|Lack of Efficacy|2|||
160479293|NCT02971683|579481253|FG001|Open-Label|Lack of Efficacy|0|||
160479294|NCT02971683|579481252|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
160479295|NCT02971683|579481253|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
160479296|NCT02971683|579481252|FG000|Long-Term Open Label|Participant withdrew consent|1|||
160479297|NCT02971683|579481253|FG001|Long-Term Open Label|Participant withdrew consent|0|||
160603872|NCT01224106|579928741|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
160479298|NCT02971683|579481252|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
160479299|NCT02971683|579481253|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
160479300|NCT02971683|579481252|FG000|Long-Term Open Label|Adverse Event|1|||
160479301|NCT02971683|579481253|FG001|Long-Term Open Label|Adverse Event|2|||
160479302|NCT02971683|579481252|FG000|Long-Term Open Label|Lack of Efficacy|1|||
160479303|NCT02971683|579481253|FG001|Long-Term Open Label|Lack of Efficacy|1|||
160479304|NCT01699178|579481254|FG000|Overall Study|Adverse Event|1|||
160479305|NCT01699178|579481255|FG001|Overall Study|Adverse Event|5|||
160479306|NCT01699178|579481254|FG000|Overall Study|Lost to Follow-up|1|||
160479307|NCT01699178|579481255|FG001|Overall Study|Lost to Follow-up|6|||
160479308|NCT01699178|579481254|FG000|Overall Study|Non-compliance with Study Drug|3|||
160479309|NCT01699178|579481255|FG001|Overall Study|Non-compliance with Study Drug|1|||
160479310|NCT01699178|579481254|FG000|Overall Study|Physician Decision|1|||
160479311|NCT01699178|579481255|FG001|Overall Study|Physician Decision|0|||
160479312|NCT01699178|579481254|FG000|Overall Study|Withdrawal by Subject|4|||
160479313|NCT01699178|579481255|FG001|Overall Study|Withdrawal by Subject|12|||
160479314|NCT01699178|579481254|FG000|Overall Study|Hematocrit >54%|1|||
160479315|NCT01699178|579481255|FG001|Overall Study|Hematocrit >54%|1|||
160479316|NCT01699178|579481254|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
160479317|NCT01699178|579481255|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
160479318|NCT01699178|579481254|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
160479319|NCT01699178|579481255|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
160479320|NCT01468597|579481259|FG000|Overall Study|Found ineligible|17|||
160479321|NCT01468597|579481259|FG000|Overall Study|concomitant valves|12|||
160479322|NCT01468597|579481259|FG000|Overall Study|off-pump CABG|1|||
160479323|NCT01468597|579481259|FG000|Overall Study|no platelet function data|5|||
160479324|NCT00912964|579481260|FG000|Overall Study|Eligibility criterion not met|1|||
160479325|NCT00912964|579481261|FG001|Overall Study|Eligibility criterion not met|1|||
160479326|NCT00912964|579481262|FG002|Overall Study|Eligibility criterion not met|0|||
160479327|NCT00912964|579481260|FG000|Overall Study|Adverse Event|15|||
160479328|NCT00912964|579481261|FG001|Overall Study|Adverse Event|18|||
160479329|NCT00912964|579481262|FG002|Overall Study|Adverse Event|12|||
160479330|NCT00912964|579481260|FG000|Overall Study|Lack of Efficacy|11|||
160479331|NCT00912964|579481261|FG001|Overall Study|Lack of Efficacy|4|||
160479332|NCT00912964|579481262|FG002|Overall Study|Lack of Efficacy|3|||
160479333|NCT00912964|579481260|FG000|Overall Study|Withdrawal by Subject|20|||
160479334|NCT00912964|579481261|FG001|Overall Study|Withdrawal by Subject|12|||
160479335|NCT00912964|579481262|FG002|Overall Study|Withdrawal by Subject|18|||
160479336|NCT00912964|579481260|FG000|Overall Study|Lost to Follow-up|4|||
160479337|NCT00912964|579481261|FG001|Overall Study|Lost to Follow-up|3|||
160479338|NCT00912964|579481262|FG002|Overall Study|Lost to Follow-up|3|||
160479339|NCT00912964|579481260|FG000|Overall Study|Protocol Violation|5|||
160479340|NCT00912964|579481261|FG001|Overall Study|Protocol Violation|3|||
160479341|NCT00912964|579481262|FG002|Overall Study|Protocol Violation|8|||
160479342|NCT00912964|579481260|FG000|Overall Study|Taking exclusionary medications|7|||
160479343|NCT00912964|579481261|FG001|Overall Study|Taking exclusionary medications|4|||
160479344|NCT00912964|579481262|FG002|Overall Study|Taking exclusionary medications|8|||
160479345|NCT00912964|579481260|FG000|Overall Study|Medical History|1|||
160479346|NCT00912964|579481261|FG001|Overall Study|Medical History|0|||
160479347|NCT00912964|579481262|FG002|Overall Study|Medical History|0|||
160479348|NCT00912964|579481260|FG000|Overall Study|Non-compliance with study procedures|2|||
160479349|NCT00912964|579481261|FG001|Overall Study|Non-compliance with study procedures|0|||
160479350|NCT00912964|579481262|FG002|Overall Study|Non-compliance with study procedures|0|||
160479351|NCT00912964|579481260|FG000|Overall Study|Violation of exclusion criterion|0|||
160479352|NCT00912964|579481261|FG001|Overall Study|Violation of exclusion criterion|0|||
160479353|NCT00912964|579481262|FG002|Overall Study|Violation of exclusion criterion|2|||
160479354|NCT00912964|579481260|FG000|Overall Study|Randomized but never received study drug|0|||
160479355|NCT00912964|579481261|FG001|Overall Study|Randomized but never received study drug|1|||
160479356|NCT00912964|579481262|FG002|Overall Study|Randomized but never received study drug|0|||
160479357|NCT00070317|579481263|FG000|Overall Study|Inevaluable (Never Treated)|1|||
160479358|NCT00070317|579481263|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
160479359|NCT00070317|579481263|FG000|Overall Study|Ineligible required test not done|1|||
160479360|NCT00070317|579481263|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
160479361|NCT00070317|579481263|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
160603873|NCT01224106|579928737|FG000|Double-Blind Treatment Phase|Other|0|||
160603874|NCT01224106|579928738|FG001|Double-Blind Treatment Phase|Other|0|||
160603875|NCT01224106|579928739|FG002|Double-Blind Treatment Phase|Other|1|||
160603876|NCT01224106|579928740|FG003|Double-Blind Treatment Phase|Other|0|||
160603877|NCT01224106|579928741|FG004|Double-Blind Treatment Phase|Other|0|||
160603878|NCT01224106|579928737|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
160479362|NCT01517282|579481268|FG000|Overall Study|Consent withdrawn|0|||
160479363|NCT01517282|579481269|FG001|Overall Study|Consent withdrawn|1|||
160479364|NCT01517282|579481270|FG002|Overall Study|Consent withdrawn|1|||
160479365|NCT01517282|579481271|FG003|Overall Study|Consent withdrawn|1|||
160479366|NCT01517282|579481268|FG000|Overall Study|Physician Decision|1|||
160479367|NCT01517282|579481269|FG001|Overall Study|Physician Decision|0|||
160479368|NCT01517282|579481270|FG002|Overall Study|Physician Decision|0|||
160479369|NCT01517282|579481271|FG003|Overall Study|Physician Decision|0|||
160479370|NCT01199302|579481276|FG000|Overall Study|Adverse Event|1|||
160479371|NCT01199302|579481277|FG001|Overall Study|Adverse Event|1|||
160479372|NCT01199302|579481278|FG002|Overall Study|Adverse Event|2|||
160479373|NCT01199302|579481279|FG003|Overall Study|Adverse Event|0|||
160479374|NCT01199302|579481276|FG000|Overall Study|Withdrawal by Subject|2|||
160479375|NCT01199302|579481277|FG001|Overall Study|Withdrawal by Subject|2|||
160479376|NCT01199302|579481278|FG002|Overall Study|Withdrawal by Subject|3|||
160479377|NCT01199302|579481279|FG003|Overall Study|Withdrawal by Subject|0|||
160603879|NCT01224106|579928738|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
160660653|NCT01720264|580139613|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
160660654|NCT00454909|580139614|FG000|Overall Study|Withdrawal by Subject|1|||
160660655|NCT00454909|580139615|FG001|Overall Study|Withdrawal by Subject|0|||
160660656|NCT00454909|580139616|FG002|Overall Study|Withdrawal by Subject|0|||
160660657|NCT00454909|580139614|FG000|Overall Study|Migrated/moved from study area|0|||
160660658|NCT00454909|580139615|FG001|Overall Study|Migrated/moved from study area|0|||
160660659|NCT00454909|580139616|FG002|Overall Study|Migrated/moved from study area|1|||
160660660|NCT00454909|580139614|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
160660661|NCT00454909|580139615|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
160660662|NCT00454909|580139616|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
160479378|NCT01199302|579481276|FG000|Overall Study|Disease Progression|3|||
160479379|NCT01199302|579481277|FG001|Overall Study|Disease Progression|4|||
160479380|NCT01199302|579481278|FG002|Overall Study|Disease Progression|4|||
160479381|NCT01199302|579481279|FG003|Overall Study|Disease Progression|2|||
160479382|NCT01199302|579481276|FG000|Overall Study|Study Termination|13|||
160479383|NCT01199302|579481277|FG001|Overall Study|Study Termination|8|||
160479384|NCT01199302|579481278|FG002|Overall Study|Study Termination|11|||
160479385|NCT01199302|579481279|FG003|Overall Study|Study Termination|9|||
160479386|NCT01199302|579481276|FG000|Overall Study|Lost to Follow-up|0|||
160479387|NCT01199302|579481277|FG001|Overall Study|Lost to Follow-up|1|||
160479388|NCT01199302|579481278|FG002|Overall Study|Lost to Follow-up|0|||
160603880|NCT01224106|579928739|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
160603881|NCT01224106|579928740|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
160603882|NCT01224106|579928741|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
160603883|NCT01224106|579928737|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
160603884|NCT01224106|579928738|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
160603885|NCT01224106|579928739|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
160603886|NCT01224106|579928740|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
160603887|NCT01224106|579928741|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
160603888|NCT01224106|579928737|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
160603889|NCT01224106|579928738|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160603890|NCT01224106|579928739|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
160603891|NCT01224106|579928740|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160603892|NCT01224106|579928741|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160603893|NCT01224106|579928737|FG000|Open-Label Extension (OLE) Phase|Death|0|||
160603894|NCT01224106|579928738|FG001|Open-Label Extension (OLE) Phase|Death|0|||
160603895|NCT01224106|579928739|FG002|Open-Label Extension (OLE) Phase|Death|0|||
160603896|NCT01224106|579928740|FG003|Open-Label Extension (OLE) Phase|Death|1|||
160603897|NCT01224106|579928741|FG004|Open-Label Extension (OLE) Phase|Death|3|||
160603898|NCT01224106|579928737|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
160603899|NCT01224106|579928738|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
160603900|NCT01224106|579928739|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
160603901|NCT01224106|579928740|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
160603902|NCT01224106|579928741|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
160603903|NCT01224106|579928737|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
160603904|NCT01224106|579928738|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
160603905|NCT01224106|579928739|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
160603906|NCT01224106|579928740|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
160603907|NCT01224106|579928741|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
160603908|NCT01224106|579928737|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
160603909|NCT01224106|579928738|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
160603910|NCT01224106|579928739|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
160603911|NCT01224106|579928740|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
160603912|NCT01224106|579928741|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
160603913|NCT01224106|579928737|FG000|Open-Label Extension (OLE) Phase|Other|0|||
160603914|NCT01224106|579928738|FG001|Open-Label Extension (OLE) Phase|Other|0|||
160603915|NCT01224106|579928739|FG002|Open-Label Extension (OLE) Phase|Other|0|||
160603916|NCT01224106|579928740|FG003|Open-Label Extension (OLE) Phase|Other|5|||
160603917|NCT01224106|579928741|FG004|Open-Label Extension (OLE) Phase|Other|3|||
160603918|NCT00839436|579928742|FG000|Overall Study|Developed exclusionary condition|1|||
160603919|NCT00839436|579928743|FG001|Overall Study|Developed exclusionary condition|0|||
160660663|NCT00454909|580139614|FG000|Overall Study|Others|1|||
160603920|NCT00839436|579928744|FG002|Overall Study|Developed exclusionary condition|0|||
160603921|NCT00839436|579928742|FG000|Overall Study|Withdrawal by Subject|0|||
160603922|NCT00839436|579928743|FG001|Overall Study|Withdrawal by Subject|1|||
160660664|NCT00454909|580139615|FG001|Overall Study|Others|0|||
160479389|NCT01199302|579481279|FG003|Overall Study|Lost to Follow-up|0|||
160479390|NCT01199302|579481276|FG000|Overall Study|Other|1|||
160479391|NCT01199302|579481277|FG001|Overall Study|Other|0|||
160479392|NCT01199302|579481278|FG002|Overall Study|Other|0|||
160479393|NCT01199302|579481279|FG003|Overall Study|Other|0|||
160479394|NCT04433091|579481280|FG000|Overall Study|Lost to Follow-up|1|||
160603923|NCT00839436|579928744|FG002|Overall Study|Withdrawal by Subject|0|||
160603924|NCT00839436|579928742|FG000|Overall Study|Study drug no longer available|0|||
160603925|NCT00839436|579928743|FG001|Overall Study|Study drug no longer available|0|||
160603926|NCT00839436|579928744|FG002|Overall Study|Study drug no longer available|1|||
160603927|NCT01440972|579928745|FG000|Overall Study|Withdrawal by Subject|3|||
160603928|NCT01440972|579928746|FG001|Overall Study|Withdrawal by Subject|2|||
160603929|NCT03933215|579928747|FG000|Overall Study|Other|6|||
160603930|NCT03933215|579928747|FG000|Overall Study|Sponsor decision|5|||
160603931|NCT03933215|579928747|FG000|Overall Study|Protocol Violation|5|||
160603932|NCT03933215|579928747|FG000|Overall Study|Withdrawal by Subject|6|||
160603933|NCT03933215|579928747|FG000|Overall Study|Lost to Follow-up|6|||
160603934|NCT03933215|579928747|FG000|Overall Study|Enrolled but not treated|38|||
160603935|NCT05784129|579928748|FG000|Overall Study|Study terminated by sponsor|2|||
160603936|NCT05784129|579928749|FG001|Overall Study|Study terminated by sponsor|2|||
160603937|NCT00407550|579928750|FG000|Overall Study|Adverse Event|0|||
160603938|NCT00407550|579928751|FG001|Overall Study|Adverse Event|1|||
160479395|NCT04433091|579481281|FG001|Overall Study|Lost to Follow-up|0|||
160479396|NCT04433091|579481280|FG000|Overall Study|Withdrawn .|2|||
160479397|NCT04433091|579481281|FG001|Overall Study|Withdrawn .|4|||
160479398|NCT03070301|579481282|FG000|Overall Study|Progression of disease|16|||
160479399|NCT03070301|579481282|FG000|Overall Study|Physician Decision|3|||
160479400|NCT03070301|579481282|FG000|Overall Study|Withdrawal by Subject|1|||
160479401|NCT03820024|579481283|FG000|Overall Study|Physician Decision|1|||
160479402|NCT03820024|579481284|FG001|Overall Study|Physician Decision|2|||
160479403|NCT00814632|579482418|FG000|Overall Study|Lack of Efficacy|2|||
160479404|NCT03978130|579482423|FG000|Overall Study|Lost to Follow-up|13|||
160479405|NCT03978130|579482424|FG001|Overall Study|Lost to Follow-up|14|||
160479406|NCT03978130|579482423|FG000|Overall Study|Withdrawal by Subject|12|||
160479407|NCT03978130|579482424|FG001|Overall Study|Withdrawal by Subject|2|||
160479408|NCT03978130|579482423|FG000|Overall Study|Adverse Event|2|||
160479409|NCT03978130|579482424|FG001|Overall Study|Adverse Event|1|||
160479410|NCT04198428|579482425|FG000|Overall Study|Withdrawal by Subject|150|||
160479411|NCT04198428|579482426|FG001|Overall Study|Withdrawal by Subject|156|||
160479412|NCT02069366|579482442|FG000|Overall Study|Lost to Follow-up|0|||
160479413|NCT02069366|579482443|FG001|Overall Study|Lost to Follow-up|0|||
160479414|NCT02069366|579482444|FG002|Overall Study|Lost to Follow-up|1|||
160479415|NCT02069366|579482445|FG003|Overall Study|Lost to Follow-up|0|||
160479416|NCT02069366|579482446|FG004|Overall Study|Lost to Follow-up|0|||
160479417|NCT02069366|579482447|FG005|Overall Study|Lost to Follow-up|2|||
160479418|NCT02069366|579482442|FG000|Overall Study|Protocol Violation|0|||
160479419|NCT02069366|579482443|FG001|Overall Study|Protocol Violation|0|||
160479420|NCT02069366|579482444|FG002|Overall Study|Protocol Violation|1|||
160479421|NCT02069366|579482445|FG003|Overall Study|Protocol Violation|0|||
160479422|NCT02069366|579482446|FG004|Overall Study|Protocol Violation|0|||
160479423|NCT02069366|579482447|FG005|Overall Study|Protocol Violation|0|||
160479424|NCT02069366|579482442|FG000|Overall Study|Withdrawal by Subject|1|||
160479425|NCT02069366|579482443|FG001|Overall Study|Withdrawal by Subject|0|||
160479426|NCT02069366|579482444|FG002|Overall Study|Withdrawal by Subject|1|||
160479427|NCT02069366|579482445|FG003|Overall Study|Withdrawal by Subject|2|||
160479428|NCT02069366|579482446|FG004|Overall Study|Withdrawal by Subject|0|||
160479429|NCT02069366|579482447|FG005|Overall Study|Withdrawal by Subject|0|||
160479430|NCT03314233|579482449|FG000|Overall Study|No longer eligible at time of delivery|1|||
160479431|NCT01797705|579482450|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
160479432|NCT01797705|579482450|FG000|Overall Study|Withdrawal by Subject|1|||
160479433|NCT02030847|579482452|FG000|Overall Study|Death|10|||
160479434|NCT02030847|579482452|FG000|Overall Study|Disease Progression|15|||
160479435|NCT02030847|579482452|FG000|Overall Study|New Cancer Therapy|8|||
160479436|NCT02030847|579482452|FG000|Overall Study|Physician Decision|3|||
160479437|NCT02030847|579482452|FG000|Overall Study|Withdrawal by Subject|1|||
160479438|NCT00168805|579482453|FG000|Overall Study|Adverse Event|7|||
160479439|NCT00168805|579482454|FG001|Overall Study|Adverse Event|11|||
160479440|NCT00168805|579482455|FG002|Overall Study|Adverse Event|16|||
160479441|NCT00168805|579482453|FG000|Overall Study|Protocol Violation|12|||
160479442|NCT00168805|579482454|FG001|Overall Study|Protocol Violation|11|||
160479443|NCT00168805|579482455|FG002|Overall Study|Protocol Violation|8|||
160479444|NCT00168805|579482453|FG000|Overall Study|Lost to Follow-up|12|||
160479445|NCT00168805|579482454|FG001|Overall Study|Lost to Follow-up|17|||
160479446|NCT00168805|579482455|FG002|Overall Study|Lost to Follow-up|11|||
160479447|NCT00168805|579482453|FG000|Overall Study|Withdrawal by Subject|16|||
160479448|NCT00168805|579482454|FG001|Overall Study|Withdrawal by Subject|18|||
160479449|NCT00168805|579482455|FG002|Overall Study|Withdrawal by Subject|21|||
160479450|NCT00168805|579482453|FG000|Overall Study|Other|24|||
160479451|NCT00168805|579482454|FG001|Overall Study|Other|21|||
160479452|NCT00168805|579482455|FG002|Overall Study|Other|22|||
160479453|NCT00168805|579482453|FG000|Treatment|Adverse Event|25|||
160479454|NCT00168805|579482454|FG001|Treatment|Adverse Event|26|||
160479455|NCT00168805|579482455|FG002|Treatment|Adverse Event|32|||
160479456|NCT00168805|579482453|FG000|Treatment|Protocol Violation|3|||
160479457|NCT00168805|579482454|FG001|Treatment|Protocol Violation|5|||
160479458|NCT00168805|579482455|FG002|Treatment|Protocol Violation|5|||
160479459|NCT00168805|579482453|FG000|Treatment|Withdrawal by Subject|3|||
160479460|NCT00168805|579482454|FG001|Treatment|Withdrawal by Subject|7|||
160479461|NCT00168805|579482455|FG002|Treatment|Withdrawal by Subject|8|||
160479462|NCT00168805|579482453|FG000|Treatment|Other|18|||
160479463|NCT00168805|579482454|FG001|Treatment|Other|18|||
160479464|NCT00168805|579482455|FG002|Treatment|Other|17|||
160479465|NCT01837719|579482456|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
160479466|NCT01837719|579482456|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
160479467|NCT01703988|579482457|FG000|Overall Study|Investigator Judgment|0|||
160479468|NCT01703988|579482458|FG001|Overall Study|Investigator Judgment|0|||
160479469|NCT01703988|579482459|FG002|Overall Study|Investigator Judgment|0|||
160479470|NCT01703988|579482460|FG003|Overall Study|Investigator Judgment|1|||
160479471|NCT02995733|579482461|FG000|Overall Study|Study site closed|9|||
160479472|NCT02995733|579482462|FG001|Overall Study|Study site closed|10|||
160479473|NCT02995733|579482461|FG000|Overall Study|Death|3|||
160479474|NCT02995733|579482462|FG001|Overall Study|Death|4|||
160603939|NCT00407550|579928750|FG000|Overall Study|Withdrawal by Subject|0|||
160603940|NCT00407550|579928751|FG001|Overall Study|Withdrawal by Subject|2|||
160603941|NCT00407550|579928750|FG000|Overall Study|Death|1|||
160603942|NCT00407550|579928751|FG001|Overall Study|Death|0|||
160603943|NCT00407550|579928750|FG000|Overall Study|Insurance or Other medical condition|2|||
160603944|NCT00407550|579928751|FG001|Overall Study|Insurance or Other medical condition|1|||
160603945|NCT01444898|579928752|FG000|Overall Study|Withdrawal by Subject|1|||
160603946|NCT02580591|579928754|FG000|Overall Study|Adverse Event|0|||
160603947|NCT02580591|579928755|FG001|Overall Study|Adverse Event|1|||
160603948|NCT02580591|579928756|FG002|Overall Study|Adverse Event|2|||
160603949|NCT02580591|579928757|FG003|Overall Study|Adverse Event|5|||
160603950|NCT02580591|579928754|FG000|Overall Study|Protocol Violation|3|||
160603951|NCT02580591|579928755|FG001|Overall Study|Protocol Violation|2|||
160603952|NCT02580591|579928756|FG002|Overall Study|Protocol Violation|1|||
160603953|NCT02580591|579928757|FG003|Overall Study|Protocol Violation|1|||
160603954|NCT02580591|579928754|FG000|Overall Study|Lost to Follow-up|5|||
160603955|NCT02580591|579928755|FG001|Overall Study|Lost to Follow-up|3|||
160603956|NCT02580591|579928756|FG002|Overall Study|Lost to Follow-up|3|||
160603957|NCT02580591|579928757|FG003|Overall Study|Lost to Follow-up|1|||
160603958|NCT02580591|579928754|FG000|Overall Study|Withdrawal by Subject|6|||
160603959|NCT02580591|579928755|FG001|Overall Study|Withdrawal by Subject|1|||
160603960|NCT02580591|579928756|FG002|Overall Study|Withdrawal by Subject|2|||
160603961|NCT02580591|579928757|FG003|Overall Study|Withdrawal by Subject|3|||
160603962|NCT02580591|579928754|FG000|Overall Study|Not treated|1|||
160603963|NCT02580591|579928755|FG001|Overall Study|Not treated|1|||
160603964|NCT02580591|579928756|FG002|Overall Study|Not treated|0|||
160603965|NCT02580591|579928757|FG003|Overall Study|Not treated|0|||
160603966|NCT02580591|579928754|FG000|Overall Study|Other than specified|3|||
160603967|NCT02580591|579928755|FG001|Overall Study|Other than specified|2|||
160603968|NCT02580591|579928756|FG002|Overall Study|Other than specified|5|||
160479475|NCT02995733|579482461|FG000|Overall Study|Withdrawal by Subject|6|||
160479476|NCT02995733|579482462|FG001|Overall Study|Withdrawal by Subject|2|||
160479477|NCT02995733|579482461|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
160479478|NCT02995733|579482462|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
160479479|NCT02995733|579482461|FG000|Overall Study|Lost to Follow-up|48|||
160479480|NCT02995733|579482462|FG001|Overall Study|Lost to Follow-up|37|||
160479481|NCT02995733|579482461|FG000|Overall Study|Other|0|||
160479482|NCT02995733|579482462|FG001|Overall Study|Other|1|||
160479483|NCT03785210|579482465|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
160479484|NCT03785210|579482466|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
160479485|NCT04468633|579482467|FG000|Overall Study|Withdrawal by Subject|4|||
160479486|NCT04468633|579482468|FG001|Overall Study|Withdrawal by Subject|0|||
160479487|NCT00460434|579482469|FG000|Overall Study|Lost to Follow-up|3|||
160479488|NCT00460434|579482470|FG001|Overall Study|Lost to Follow-up|7|||
160479489|NCT01498445|579482471|FG000|Overall Study|Lack of Efficacy|0|||
160479490|NCT01498445|579482472|FG001|Overall Study|Lack of Efficacy|0|||
160479491|NCT01498445|579482473|FG002|Overall Study|Lack of Efficacy|1|||
160479492|NCT01498445|579482474|FG003|Overall Study|Lack of Efficacy|2|||
160479493|NCT01498445|579482475|FG004|Overall Study|Lack of Efficacy|0|||
160479494|NCT01498445|579482476|FG005|Overall Study|Lack of Efficacy|0|||
160479495|NCT01498445|579482471|FG000|Overall Study|Screen Failure|0|||
160479496|NCT01498445|579482472|FG001|Overall Study|Screen Failure|0|||
160479497|NCT01498445|579482473|FG002|Overall Study|Screen Failure|0|||
160479498|NCT01498445|579482474|FG003|Overall Study|Screen Failure|0|||
160479499|NCT01498445|579482475|FG004|Overall Study|Screen Failure|1|||
160479500|NCT01498445|579482476|FG005|Overall Study|Screen Failure|1|||
160603969|NCT02580591|579928757|FG003|Overall Study|Other than specified|2|||
160603970|NCT01599806|579928759|FG000|Overall Study|Lost to Follow-up|20|||
160603971|NCT01599806|579928760|FG001|Overall Study|Lost to Follow-up|20|||
160603972|NCT01599806|579928759|FG000|Overall Study|Withdrawal by Subject|12|||
160603973|NCT01599806|579928760|FG001|Overall Study|Withdrawal by Subject|12|||
160603974|NCT01599806|579928759|FG000|Overall Study|Other Eligibility criteria|11|||
160603975|NCT01599806|579928760|FG001|Overall Study|Other Eligibility criteria|9|||
160603976|NCT03006926|579928761|FG000|Overall Study|Adverse Event|0|||
160603977|NCT03006926|579928762|FG001|Overall Study|Adverse Event|27|||
160603978|NCT03006926|579928761|FG000|Overall Study|Withdrawal by Subject|0|||
160603979|NCT03006926|579928762|FG001|Overall Study|Withdrawal by Subject|1|||
160603980|NCT03006926|579928761|FG000|Overall Study|Radiological Disease Progression|0|||
160603981|NCT03006926|579928762|FG001|Overall Study|Radiological Disease Progression|52|||
160603982|NCT03006926|579928761|FG000|Overall Study|Clinical Disease Progression|0|||
160603983|NCT03006926|579928762|FG001|Overall Study|Clinical Disease Progression|10|||
160603984|NCT03006926|579928761|FG000|Overall Study|Other|0|||
160603985|NCT03006926|579928762|FG001|Overall Study|Other|8|||
160603986|NCT01838213|579928763|FG000|Overall Study|Ineligible|166|||
160603987|NCT01838213|579928764|FG001|Overall Study|Ineligible|191|||
160603988|NCT04882072|579928769|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
160603989|NCT04882072|579928770|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
160603990|NCT04882072|579928769|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
160603991|NCT04882072|579928770|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
160660665|NCT00454909|580139616|FG002|Overall Study|Others|0|||
160479501|NCT02465866|579482477|FG000|Period 3|Withdrawal by Subject|0|||
160479502|NCT02465866|579482478|FG001|Period 3|Withdrawal by Subject|1|||
160479503|NCT02465866|579482479|FG002|Period 3|Withdrawal by Subject|0|||
160479504|NCT02465866|579482480|FG003|Period 3|Withdrawal by Subject|0|||
160479505|NCT02023099|579482481|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
160479506|NCT02023099|579482482|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
160479507|NCT02023099|579482483|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
160603992|NCT04882072|579928769|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
160603993|NCT04882072|579928770|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
160603994|NCT02918318|579928771|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
160603995|NCT02918318|579928772|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
160603996|NCT02918318|579928773|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
160603997|NCT02918318|579928774|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
160479508|NCT02023099|579482481|FG000|Overall Study|Withdrawn Consent|3|||
160479509|NCT02023099|579482482|FG001|Overall Study|Withdrawn Consent|0|||
160479510|NCT02023099|579482483|FG002|Overall Study|Withdrawn Consent|1|||
160479511|NCT02023099|579482481|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
160479512|NCT02023099|579482482|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
160479513|NCT02023099|579482483|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
160479514|NCT00203502|579482484|FG000|Overall Study|Death|1|||
160479515|NCT01469819|579482485|FG000|Overall Study|Withdrawal by Subject|1|||
160660666|NCT02549092|580139617|FG000|Treatment Period|Adverse Event|2|||
160479516|NCT01469819|579482485|FG000|Overall Study|Did not meet inclusionary criteria|2|||
160479517|NCT01469819|579482485|FG000|Overall Study|Could not swallow SmartPill|2|||
160479518|NCT01469819|579482485|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
160479519|NCT00561678|579482486|FG000|Overall Study|Withdrawal by Subject|4|||
160479520|NCT00561678|579482487|FG001|Overall Study|Withdrawal by Subject|3|||
160479521|NCT00561678|579482486|FG000|Overall Study|surgery cancelled|1|||
160479522|NCT00561678|579482487|FG001|Overall Study|surgery cancelled|1|||
160479523|NCT00561678|579482486|FG000|Overall Study|surgery rescheduled to different site|2|||
160479524|NCT00561678|579482487|FG001|Overall Study|surgery rescheduled to different site|2|||
160479525|NCT00561678|579482486|FG000|Overall Study|anesthesia provider refusal|1|||
160479526|NCT00561678|579482487|FG001|Overall Study|anesthesia provider refusal|0|||
160479527|NCT01601821|579482490|FG000|Overall Study|Death|2|||
160479528|NCT01601821|579482491|FG001|Overall Study|Death|5|||
160479529|NCT01601821|579482490|FG000|Overall Study|Protocol Violation|2|||
160479530|NCT01601821|579482491|FG001|Overall Study|Protocol Violation|2|||
160479531|NCT01601821|579482490|FG000|Overall Study|Lost to Follow-up|6|||
160479532|NCT01601821|579482491|FG001|Overall Study|Lost to Follow-up|14|||
160479533|NCT01601821|579482490|FG000|Overall Study|Withdrawal by Subject|1|||
160479534|NCT01601821|579482491|FG001|Overall Study|Withdrawal by Subject|0|||
160479535|NCT01601821|579482490|FG000|Overall Study|Graft Loss|6|||
160479536|NCT01601821|579482491|FG001|Overall Study|Graft Loss|6|||
160479537|NCT01601821|579482490|FG000|Overall Study|Study Events|7|||
160479538|NCT01601821|579482491|FG001|Overall Study|Study Events|1|||
160479539|NCT01601821|579482490|FG000|Overall Study|Other|5|||
160479540|NCT01601821|579482491|FG001|Overall Study|Other|1|||
160479541|NCT03708744|579482494|FG000|Overall Study|Withdrawal by Subject|0|||
160479542|NCT03708744|579482495|FG001|Overall Study|Withdrawal by Subject|0|||
160479543|NCT03708744|579482496|FG002|Overall Study|Withdrawal by Subject|1|||
160479544|NCT03708744|579482497|FG003|Overall Study|Withdrawal by Subject|0|||
160479545|NCT02213458|579482500|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
160479546|NCT02213458|579482501|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
160479547|NCT02213458|579482500|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
160479548|NCT02213458|579482501|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
160479549|NCT02213458|579482500|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
160479550|NCT02213458|579482501|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
160479551|NCT02213458|579482500|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
160479552|NCT02213458|579482501|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
160479553|NCT02213458|579482500|FG000|Overall Study|Refused re-consent|6|||
160479554|NCT02213458|579482501|FG001|Overall Study|Refused re-consent|0|||
160479555|NCT02213458|579482500|FG000|Overall Study|Lost to Follow-up|2|||
160479556|NCT02213458|579482501|FG001|Overall Study|Lost to Follow-up|2|||
160479557|NCT02213458|579482500|FG000|Overall Study|Withdrawal by Subject|26|||
160479558|NCT02213458|579482501|FG001|Overall Study|Withdrawal by Subject|8|||
160479559|NCT01622088|579482502|FG000|Overall Study|Adverse Event|20|||
160479560|NCT01622088|579482502|FG000|Overall Study|Lost to Follow-up|1|||
160479561|NCT01622088|579482502|FG000|Overall Study|Withdrawal by Subject|20|||
160479562|NCT01622088|579482502|FG000|Overall Study|Investigator Decision|1|||
160479563|NCT01622088|579482502|FG000|Overall Study|Death|53|||
160479564|NCT01622088|579482502|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
160479565|NCT04016415|579482506|FG000|Overall Study|Adverse Event|2|||
160479566|NCT04016415|579482507|FG001|Overall Study|Adverse Event|1|||
160479567|NCT04016415|579482506|FG000|Overall Study|Lost to Follow-up|6|||
160479568|NCT04016415|579482507|FG001|Overall Study|Lost to Follow-up|2|||
160479569|NCT04016415|579482506|FG000|Overall Study|Physician Decision|5|||
160660667|NCT02549092|580139618|FG001|Treatment Period|Adverse Event|2|||
160479570|NCT04016415|579482507|FG001|Overall Study|Physician Decision|1|||
160479571|NCT04016415|579482506|FG000|Overall Study|Pregnancy|0|||
160479572|NCT04016415|579482507|FG001|Overall Study|Pregnancy|1|||
160479573|NCT04016415|579482506|FG000|Overall Study|Withdrawal by Subject|24|||
160479574|NCT04016415|579482507|FG001|Overall Study|Withdrawal by Subject|27|||
160479575|NCT04016415|579482506|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
160479576|NCT04016415|579482507|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
160479577|NCT03547167|579482510|FG000|Overall Study|Withdrawal by Subject|34|||
160479578|NCT03547167|579482511|FG001|Overall Study|Withdrawal by Subject|12|||
160479579|NCT03547167|579482510|FG000|Overall Study|Screen Failure|0|||
160479580|NCT03547167|579482511|FG001|Overall Study|Screen Failure|1|||
160603998|NCT02918318|579928775|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
160603999|NCT02918318|579928771|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
160604000|NCT02918318|579928772|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
160604001|NCT02918318|579928773|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
160604002|NCT02918318|579928774|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
160604003|NCT02918318|579928775|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
160604004|NCT02918318|579928771|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
160604005|NCT02918318|579928772|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
160604006|NCT02918318|579928773|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
160604007|NCT02918318|579928774|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
160604008|NCT02918318|579928775|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
160604009|NCT02918318|579928771|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
160604010|NCT02918318|579928772|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
160604011|NCT02918318|579928773|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
160479581|NCT03547167|579482510|FG000|Overall Study|Lost to Follow-up|59|||
160479582|NCT03547167|579482511|FG001|Overall Study|Lost to Follow-up|15|||
160479583|NCT03547167|579482510|FG000|Overall Study|Death|4|||
160479584|NCT03547167|579482511|FG001|Overall Study|Death|2|||
160479585|NCT01885559|579482512|FG000|Overall Study|Lost to Follow-up|15|||
160479586|NCT01885559|579482513|FG001|Overall Study|Lost to Follow-up|16|||
160479587|NCT01885559|579482512|FG000|Overall Study|Less than full participation|9|||
160479588|NCT01885559|579482513|FG001|Overall Study|Less than full participation|19|||
160479589|NCT01885559|579482512|FG000|Overall Study|Protocol Violation|0|||
160479590|NCT01885559|579482513|FG001|Overall Study|Protocol Violation|1|||
160479591|NCT00645411|579482514|FG000|Overall Study|Adverse Event|0|||
160479592|NCT00645411|579482515|FG001|Overall Study|Adverse Event|0|||
160479593|NCT00645411|579482516|FG002|Overall Study|Adverse Event|0|||
160479594|NCT00645411|579482517|FG003|Overall Study|Adverse Event|2|||
160479595|NCT00645411|579482514|FG000|Overall Study|Withdrawal by Subject|2|||
160479596|NCT00645411|579482515|FG001|Overall Study|Withdrawal by Subject|1|||
160479597|NCT00645411|579482516|FG002|Overall Study|Withdrawal by Subject|19|||
160479598|NCT00645411|579482517|FG003|Overall Study|Withdrawal by Subject|21|||
160479599|NCT00645411|579482514|FG000|Overall Study|Lost to Follow-up|10|||
160479600|NCT00645411|579482515|FG001|Overall Study|Lost to Follow-up|5|||
160479601|NCT00645411|579482516|FG002|Overall Study|Lost to Follow-up|124|||
160479602|NCT00645411|579482517|FG003|Overall Study|Lost to Follow-up|75|||
160479603|NCT00645411|579482514|FG000|Overall Study|Protocol Violation|1|||
160479604|NCT00645411|579482515|FG001|Overall Study|Protocol Violation|0|||
160479605|NCT00645411|579482516|FG002|Overall Study|Protocol Violation|1|||
160479606|NCT00645411|579482517|FG003|Overall Study|Protocol Violation|0|||
160479607|NCT00645411|579482514|FG000|Overall Study|Inappropriate enrollment|0|||
160479608|NCT00645411|579482515|FG001|Overall Study|Inappropriate enrollment|0|||
160479609|NCT00645411|579482516|FG002|Overall Study|Inappropriate enrollment|4|||
160479610|NCT00645411|579482517|FG003|Overall Study|Inappropriate enrollment|1|||
160479611|NCT00645411|579482514|FG000|Overall Study|Unable to classify|0|||
160479612|NCT00645411|579482515|FG001|Overall Study|Unable to classify|0|||
160479613|NCT00645411|579482516|FG002|Overall Study|Unable to classify|3|||
160479614|NCT00645411|579482517|FG003|Overall Study|Unable to classify|4|||
160479615|NCT03100370|579482521|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160479616|NCT03100370|579482522|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160479617|NCT03100370|579482523|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160479618|NCT03100370|579482524|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160479619|NCT03100370|579482525|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160479620|NCT03100370|579482526|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160479621|NCT02674399|579482527|FG000|Overall Study|Lost to Follow-up|2|||
160479622|NCT02674399|579482528|FG001|Overall Study|Lost to Follow-up|0|||
160604012|NCT02918318|579928774|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
160604013|NCT02918318|579928775|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
160604014|NCT02918318|579928771|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
160479623|NCT01867307|579482529|FG000|Overall Study|Protocol Violation|2|||
160604015|NCT02918318|579928772|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
160604016|NCT02918318|579928773|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
160604017|NCT02918318|579928774|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
160604018|NCT02918318|579928775|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
160604019|NCT02918318|579928771|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
160479624|NCT01867307|579482530|FG001|Overall Study|Protocol Violation|0|||
160479625|NCT01867307|579482529|FG000|Overall Study|Other Adverse Event|1|||
160479626|NCT01867307|579482530|FG001|Overall Study|Other Adverse Event|3|||
160479627|NCT00091572|579482540|FG000|Overall Study|Lost to Follow-up|1|||
160479628|NCT00091572|579482541|FG001|Overall Study|Lost to Follow-up|1|||
160479629|NCT00091572|579482540|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
160479630|NCT00091572|579482541|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
160479631|NCT00091572|579482540|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
160479632|NCT00091572|579482541|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
160479633|NCT00091572|579482540|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
160479634|NCT00091572|579482541|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
160479635|NCT00091572|579482540|FG000|Overall Study|Other Reason|6|||
160479636|NCT00091572|579482541|FG001|Overall Study|Other Reason|13|||
160479637|NCT00091572|579482540|FG000|Overall Study|Ongoing (still on treatment)|8|||
160479638|NCT00091572|579482541|FG001|Overall Study|Ongoing (still on treatment)|12|||
160479639|NCT00091572|579482540|FG000|Overall Study|Major Protocol Violation|2|||
160479640|NCT00091572|579482541|FG001|Overall Study|Major Protocol Violation|0|||
160479641|NCT00091572|579482540|FG000|Overall Study|Toxicity (Related AE)|53|||
160479642|NCT00091572|579482541|FG001|Overall Study|Toxicity (Related AE)|9|||
160479643|NCT03122548|579482546|FG000|Overall Study|Death|2|||
160479644|NCT03122548|579482546|FG000|Overall Study|Progression - subject went into hospice|1|||
160479645|NCT03122548|579482546|FG000|Overall Study|Study Terminated by Sponsor|2|||
160479646|NCT01634165|579482549|FG000|Period 2|Adverse Event|0|||
160479647|NCT01634165|579482550|FG001|Period 2|Adverse Event|1|||
160479648|NCT01634165|579482551|FG002|Period 2|Adverse Event|0|||
160479649|NCT01634165|579482552|FG003|Period 2|Adverse Event|0|||
160479650|NCT04097535|579482555|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
160479651|NCT00676195|579484186|FG000|Overall Study|Lost to Follow-up|1|||
160479652|NCT00676195|579484186|FG000|Overall Study|Adverse Event|1|||
160479653|NCT00676195|579484186|FG000|Overall Study|Physician Decision|1|||
160479654|NCT03322514|579484187|FG000|Overall Study|Withdrawal by Subject|1|||
160479655|NCT03322514|579484188|FG001|Overall Study|Withdrawal by Subject|1|||
160479656|NCT02514577|579484194|FG000|Overall Study|Lost to Follow-up|6|||
160479657|NCT02514577|579484195|FG001|Overall Study|Lost to Follow-up|6|||
160479658|NCT02514577|579484194|FG000|Overall Study|Protocol Violation|1|||
160479659|NCT02514577|579484195|FG001|Overall Study|Protocol Violation|0|||
160479660|NCT02514577|579484194|FG000|Overall Study|Withdrawal by Subject|6|||
160479661|NCT02514577|579484195|FG001|Overall Study|Withdrawal by Subject|6|||
160479662|NCT02514577|579484194|FG000|Overall Study|Adverse Event|1|||
160479663|NCT02514577|579484195|FG001|Overall Study|Adverse Event|1|||
160479664|NCT00489489|579484196|FG000|Overall Study|Not treated due to protocol violation|0|||
160479665|NCT00489489|579484197|FG001|Overall Study|Not treated due to protocol violation|1|||
160479666|NCT00489489|579484198|FG002|Overall Study|Not treated due to protocol violation|1|||
160479667|NCT00489489|579484196|FG000|Overall Study|Adverse Event|1|||
160479668|NCT00489489|579484197|FG001|Overall Study|Adverse Event|1|||
160479669|NCT00489489|579484198|FG002|Overall Study|Adverse Event|1|||
160479670|NCT00489489|579484196|FG000|Overall Study|Protocol Violation|1|||
160479671|NCT00489489|579484197|FG001|Overall Study|Protocol Violation|0|||
160479672|NCT00489489|579484198|FG002|Overall Study|Protocol Violation|1|||
160479673|NCT00489489|579484196|FG000|Overall Study|Progressive disease|0|||
160479674|NCT00489489|579484197|FG001|Overall Study|Progressive disease|1|||
160479675|NCT00489489|579484198|FG002|Overall Study|Progressive disease|0|||
160479676|NCT00489489|579484196|FG000|Overall Study|Participant did not wish to continue|1|||
160479677|NCT00489489|579484197|FG001|Overall Study|Participant did not wish to continue|1|||
160479678|NCT00489489|579484198|FG002|Overall Study|Participant did not wish to continue|0|||
160479679|NCT00489489|579484196|FG000|Overall Study|Other than above|0|||
160479680|NCT00489489|579484197|FG001|Overall Study|Other than above|1|||
160479681|NCT00489489|579484198|FG002|Overall Study|Other than above|0|||
160479682|NCT02136797|579484199|FG000|Overall Study|Not Treated|8|||
160479683|NCT04523571|579484200|FG000|Received 2 Doses|Withdrawal by Subject|0|||
160479684|NCT04523571|579484201|FG001|Received 2 Doses|Withdrawal by Subject|0|||
160479685|NCT04523571|579484202|FG002|Received 2 Doses|Withdrawal by Subject|0|||
160479686|NCT04523571|579484203|FG003|Received 2 Doses|Withdrawal by Subject|1|||
160479687|NCT04523571|579484204|FG004|Received 2 Doses|Withdrawal by Subject|1|||
160479688|NCT04523571|579484205|FG005|Received 2 Doses|Withdrawal by Subject|0|||
160479689|NCT04523571|579484200|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
160479690|NCT04523571|579484201|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
160604020|NCT02918318|579928772|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
160604021|NCT02918318|579928773|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
160604022|NCT02918318|579928774|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
160604023|NCT02918318|579928775|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
160479691|NCT04523571|579484202|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
160479692|NCT04523571|579484203|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
160479693|NCT04523571|579484204|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
160479694|NCT04523571|579484205|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
160479695|NCT04523571|579484200|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
160479696|NCT04523571|579484201|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
160479697|NCT04523571|579484202|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
160479698|NCT04523571|579484203|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
160479699|NCT04523571|579484204|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
160479700|NCT04523571|579484205|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
160479701|NCT04523571|579484200|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
160479702|NCT04523571|579484201|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
160479703|NCT04523571|579484202|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
160479704|NCT04523571|579484203|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
160479705|NCT04523571|579484204|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
160479706|NCT04523571|579484205|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
160479713|NCT00627523|579484207|FG000|Overall Study|Lack of Efficacy|1|||
160479714|NCT00627523|579484208|FG001|Overall Study|Lack of Efficacy|0|||
160479715|NCT00627523|579484207|FG000|Overall Study|Withdrawal by Subject|0|||
160479716|NCT00627523|579484208|FG001|Overall Study|Withdrawal by Subject|2|||
160479717|NCT00627523|579484207|FG000|Overall Study|Other|1|||
160479718|NCT00627523|579484208|FG001|Overall Study|Other|0|||
160479719|NCT02011568|579484213|FG000|Overall Study|Withdrawal by Subject|8|||
160479720|NCT02011568|579484214|FG001|Overall Study|Withdrawal by Subject|10|||
160479721|NCT02011568|579484213|FG000|Overall Study|Physician Decision|1|||
160479722|NCT02011568|579484214|FG001|Overall Study|Physician Decision|3|||
160479723|NCT01038128|579484215|FG000|Overall Study|Lack of Efficacy|1|||
160479724|NCT01038128|579484215|FG000|Overall Study|Lost to Follow-up|1|||
160479725|NCT01038128|579484215|FG000|Overall Study|Withdrawal by Subject|2|||
160479726|NCT03344458|579484220|FG000|Overall Study|Physician Decision|1|||
160479727|NCT03344458|579484220|FG000|Overall Study|Withdrawal by Subject|16|||
160479728|NCT03344458|579484220|FG000|Overall Study|Other reasons|10|||
160479729|NCT03344458|579484220|FG000|Overall Study|Lost to Follow-up|9|||
160479730|NCT03344458|579484220|FG000|Overall Study|Protocol Violation|3|||
160479731|NCT04203199|579484221|FG000|First Intervention Period|Lost to Follow-up|0|||
160479732|NCT04203199|579484222|FG001|First Intervention Period|Lost to Follow-up|1|||
160479733|NCT04203199|579484221|FG000|Second Intervention Period|Medication change|1|||
160479734|NCT04203199|579484222|FG001|Second Intervention Period|Medication change|0|||
160479735|NCT03960437|579484223|FG000|Overall Study|Removed by PI|4|||
160479736|NCT03960437|579484223|FG000|Overall Study|Lost to Follow-up|2|||
160479737|NCT03960437|579484223|FG000|Overall Study|Withdrawal by Subject|1|||
160479738|NCT03960437|579484223|FG000|Overall Study|Death|2|||
160479739|NCT01838499|579484229|FG000|Overall Study|Protocol Violation|0|||
160479740|NCT01838499|579484230|FG001|Overall Study|Protocol Violation|1|||
160479741|NCT01838499|579484229|FG000|Overall Study|Lost to Follow-up|2|||
160479742|NCT01838499|579484230|FG001|Overall Study|Lost to Follow-up|4|||
160479743|NCT01838499|579484229|FG000|Overall Study|Lack of Efficacy|1|||
160479744|NCT01838499|579484230|FG001|Overall Study|Lack of Efficacy|2|||
160479745|NCT01838499|579484229|FG000|Overall Study|Adverse Event|2|||
160479746|NCT01838499|579484230|FG001|Overall Study|Adverse Event|1|||
160479747|NCT01838499|579484229|FG000|Overall Study|Withdrawal by Subject|19|||
160479748|NCT01838499|579484230|FG001|Overall Study|Withdrawal by Subject|9|||
160479749|NCT03614923|579484231|FG000|Overall Study|Withdrawal by Subject|2|||
160479750|NCT03614923|579484232|FG001|Overall Study|Withdrawal by Subject|1|||
160479751|NCT03614923|579484233|FG002|Overall Study|Withdrawal by Subject|1|||
160479752|NCT03614923|579484231|FG000|Overall Study|Adverse Event|0|||
160604024|NCT02918318|579928771|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
160604025|NCT02918318|579928772|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
160604026|NCT02918318|579928773|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
160604027|NCT02918318|579928774|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
160604028|NCT02918318|579928775|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
160604029|NCT02918318|579928771|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
160604030|NCT02918318|579928772|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
160604031|NCT02918318|579928773|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
160604032|NCT02918318|579928774|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
160479753|NCT03614923|579484232|FG001|Overall Study|Adverse Event|2|||
160479754|NCT03614923|579484233|FG002|Overall Study|Adverse Event|1|||
160479755|NCT03614923|579484231|FG000|Overall Study|Lost to Follow-up|1|||
160479756|NCT03614923|579484232|FG001|Overall Study|Lost to Follow-up|0|||
160479757|NCT03614923|579484233|FG002|Overall Study|Lost to Follow-up|1|||
160479758|NCT03614923|579484231|FG000|Overall Study|Lack of Efficacy|2|||
160479759|NCT03614923|579484232|FG001|Overall Study|Lack of Efficacy|0|||
160479760|NCT03614923|579484233|FG002|Overall Study|Lack of Efficacy|1|||
160479761|NCT03614923|579484231|FG000|Overall Study|Non-compliance|0|||
160479762|NCT03614923|579484232|FG001|Overall Study|Non-compliance|1|||
160479763|NCT03614923|579484233|FG002|Overall Study|Non-compliance|0|||
160479764|NCT03614923|579484231|FG000|Overall Study|Other|0|||
160479765|NCT03614923|579484232|FG001|Overall Study|Other|1|||
160479766|NCT03614923|579484233|FG002|Overall Study|Other|1|||
160479767|NCT01136733|579484234|FG000|Phase 1b|Adverse Event|0|||
160479768|NCT01136733|579484235|FG001|Phase 1b|Adverse Event|3|||
160479769|NCT01136733|579484236|FG002|Phase 1b|Adverse Event|1|||
160479770|NCT01136733|579484237|FG003|Phase 1b|Adverse Event|0|||
160479771|NCT01136733|579484238|FG004|Phase 1b|Adverse Event|0|||
160479772|NCT01136733|579484239|FG005|Phase 1b|Adverse Event|0|||
160479773|NCT01136733|579484240|FG006|Phase 1b|Adverse Event|0|||
160479774|NCT01136733|579484234|FG000|Phase 1b|Participant Choice|0|||
160479775|NCT01136733|579484235|FG001|Phase 1b|Participant Choice|0|||
160479776|NCT01136733|579484236|FG002|Phase 1b|Participant Choice|1|||
160479777|NCT01136733|579484237|FG003|Phase 1b|Participant Choice|0|||
160479778|NCT01136733|579484238|FG004|Phase 1b|Participant Choice|0|||
160479779|NCT01136733|579484239|FG005|Phase 1b|Participant Choice|0|||
160479780|NCT01136733|579484240|FG006|Phase 1b|Participant Choice|0|||
160479781|NCT01136733|579484234|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
160479782|NCT01136733|579484235|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
160479783|NCT01136733|579484236|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
160479784|NCT01136733|579484237|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
160479785|NCT01136733|579484238|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
160479786|NCT01136733|579484239|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
160479787|NCT01136733|579484240|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
160479788|NCT01136733|579484234|FG000|Phase 1b|Clinical Progression|1|||
160479789|NCT01136733|579484235|FG001|Phase 1b|Clinical Progression|1|||
160479790|NCT01136733|579484236|FG002|Phase 1b|Clinical Progression|0|||
160479791|NCT01136733|579484237|FG003|Phase 1b|Clinical Progression|0|||
160479792|NCT01136733|579484238|FG004|Phase 1b|Clinical Progression|0|||
160479793|NCT01136733|579484239|FG005|Phase 1b|Clinical Progression|0|||
160479794|NCT01136733|579484240|FG006|Phase 1b|Clinical Progression|0|||
160479795|NCT01136733|579484234|FG000|Phase 2|Disease Progression|0|||
160479796|NCT01136733|579484235|FG001|Phase 2|Disease Progression|0|||
160479797|NCT01136733|579484236|FG002|Phase 2|Disease Progression|0|||
160479798|NCT01136733|579484237|FG003|Phase 2|Disease Progression|0|||
160479799|NCT01136733|579484238|FG004|Phase 2|Disease Progression|30|||
160479800|NCT01136733|579484239|FG005|Phase 2|Disease Progression|32|||
160479801|NCT01136733|579484240|FG006|Phase 2|Disease Progression|38|||
160479802|NCT01136733|579484234|FG000|Phase 2|Adverse Event|0|||
160479803|NCT01136733|579484235|FG001|Phase 2|Adverse Event|0|||
160479804|NCT01136733|579484236|FG002|Phase 2|Adverse Event|0|||
160479805|NCT01136733|579484237|FG003|Phase 2|Adverse Event|0|||
160479806|NCT01136733|579484238|FG004|Phase 2|Adverse Event|11|||
160479807|NCT01136733|579484239|FG005|Phase 2|Adverse Event|13|||
160479808|NCT01136733|579484240|FG006|Phase 2|Adverse Event|5|||
160479809|NCT01136733|579484234|FG000|Phase 2|Participant Choice|0|||
160479810|NCT01136733|579484235|FG001|Phase 2|Participant Choice|0|||
160479811|NCT01136733|579484236|FG002|Phase 2|Participant Choice|0|||
160479812|NCT01136733|579484237|FG003|Phase 2|Participant Choice|0|||
160479813|NCT01136733|579484238|FG004|Phase 2|Participant Choice|3|||
160479814|NCT01136733|579484239|FG005|Phase 2|Participant Choice|0|||
160479815|NCT01136733|579484240|FG006|Phase 2|Participant Choice|1|||
160479816|NCT01136733|579484234|FG000|Phase 2|Administrative-Withdrew Consent|0|||
160479817|NCT01136733|579484235|FG001|Phase 2|Administrative-Withdrew Consent|0|||
160479818|NCT01136733|579484236|FG002|Phase 2|Administrative-Withdrew Consent|0|||
160479819|NCT01136733|579484237|FG003|Phase 2|Administrative-Withdrew Consent|0|||
160479820|NCT01136733|579484238|FG004|Phase 2|Administrative-Withdrew Consent|1|||
160479821|NCT01136733|579484239|FG005|Phase 2|Administrative-Withdrew Consent|0|||
160479822|NCT01136733|579484240|FG006|Phase 2|Administrative-Withdrew Consent|0|||
160479823|NCT01136733|579484234|FG000|Phase 2|Other|0|||
160479824|NCT01136733|579484235|FG001|Phase 2|Other|0|||
160479825|NCT01136733|579484236|FG002|Phase 2|Other|0|||
160479826|NCT01136733|579484237|FG003|Phase 2|Other|0|||
160479827|NCT01136733|579484238|FG004|Phase 2|Other|6|||
160479828|NCT01136733|579484239|FG005|Phase 2|Other|7|||
160479829|NCT01136733|579484240|FG006|Phase 2|Other|6|||
160479830|NCT01882088|579484242|FG000|Overall Study|Intolerance of esophageal manometry|1|||
160479831|NCT01882088|579484242|FG000|Overall Study|no possibility to place the catheter|1|||
160479832|NCT01882088|579484242|FG000|Overall Study|Protocol Violation|1|||
160479833|NCT01882088|579484242|FG000|Overall Study|inadequate pH-impedance tracings|2|||
160479834|NCT02186015|579484243|FG000|Overall Study|Physician Decision|1|||
160479835|NCT02186015|579484244|FG001|Overall Study|Physician Decision|0|||
160479836|NCT02720198|579484247|FG000|Overall Study|Withdrawal by Subject|0|||
160479837|NCT02720198|579484248|FG001|Overall Study|Withdrawal by Subject|1|||
160479838|NCT02722278|579484253|FG000|Overall Study|Withdrawal by Subject|5|||
160479839|NCT02722278|579484254|FG001|Overall Study|Withdrawal by Subject|3|||
160479840|NCT02722278|579484253|FG000|Overall Study|Adverse Event|4|||
160479841|NCT02722278|579484254|FG001|Overall Study|Adverse Event|1|||
160479842|NCT02722278|579484253|FG000|Overall Study|Lost to Follow-up|2|||
160479843|NCT02722278|579484254|FG001|Overall Study|Lost to Follow-up|0|||
160479844|NCT02722278|579484253|FG000|Overall Study|Protocol Violation|1|||
160479845|NCT02722278|579484254|FG001|Overall Study|Protocol Violation|0|||
160479846|NCT02722278|579484253|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
160479847|NCT02722278|579484254|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
160479848|NCT02722278|579484253|FG000|Overall Study|Subject declined after tx assignment|0|||
160479849|NCT02722278|579484254|FG001|Overall Study|Subject declined after tx assignment|1|||
160479850|NCT02722278|579484253|FG000|Overall Study|Site closure not study related|0|||
160479851|NCT02722278|579484254|FG001|Overall Study|Site closure not study related|1|||
160479852|NCT02592434|579484255|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
160479853|NCT02592434|579484256|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
160479854|NCT02592434|579484257|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
160479855|NCT02592434|579484255|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
160479856|NCT02592434|579484256|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
160479857|NCT02592434|579484257|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
160479858|NCT02592434|579484255|FG000|Open-Label Phase (18 Weeks)|Other|3|||
160479859|NCT02592434|579484256|FG001|Open-Label Phase (18 Weeks)|Other|0|||
160479860|NCT02592434|579484257|FG002|Open-Label Phase (18 Weeks)|Other|0|||
160479861|NCT02592434|579484255|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
160479862|NCT02592434|579484256|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
160479863|NCT02592434|579484257|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
160479864|NCT02592434|579484255|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
160479865|NCT02592434|579484256|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
160479866|NCT02592434|579484257|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
160479867|NCT02592434|579484255|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
160479868|NCT02592434|579484256|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
160479869|NCT02592434|579484257|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
160479870|NCT02592434|579484255|FG000|Double Blind Phase (26 Weeks)|Other|0|||
160479871|NCT02592434|579484256|FG001|Double Blind Phase (26 Weeks)|Other|1|||
160479872|NCT02592434|579484257|FG002|Double Blind Phase (26 Weeks)|Other|0|||
160479873|NCT02592434|579484255|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
160479874|NCT02592434|579484256|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
160479875|NCT02592434|579484257|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
160479876|NCT02592434|579484255|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
160479877|NCT02592434|579484256|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
160479878|NCT02592434|579484257|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
160479879|NCT02592434|579484255|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
160479880|NCT02592434|579484256|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
160479881|NCT02592434|579484257|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
160479882|NCT01403805|579484258|FG000|Overall Study|Withdrawal by Subject|0|||
160479883|NCT01403805|579484259|FG001|Overall Study|Withdrawal by Subject|4|||
160479884|NCT01403805|579484258|FG000|Overall Study|Lost to Follow-up|0|||
160479885|NCT01403805|579484259|FG001|Overall Study|Lost to Follow-up|2|||
160479886|NCT01403805|579484258|FG000|Overall Study|Death|0|||
160479887|NCT01403805|579484259|FG001|Overall Study|Death|1|||
160479888|NCT01695993|579484262|FG000|Overall Study|Lost to Follow-up|2|||
160479889|NCT01695993|579484263|FG001|Overall Study|Lost to Follow-up|1|||
160479890|NCT01695993|579484264|FG002|Overall Study|Lost to Follow-up|3|||
160479891|NCT01695993|579484262|FG000|Overall Study|Withdrawal by Subject|2|||
160479892|NCT01695993|579484263|FG001|Overall Study|Withdrawal by Subject|2|||
160479893|NCT01695993|579484264|FG002|Overall Study|Withdrawal by Subject|2|||
160479894|NCT01695993|579484262|FG000|Overall Study|To ill to continue|1|||
160479895|NCT01695993|579484263|FG001|Overall Study|To ill to continue|2|||
160479896|NCT01695993|579484264|FG002|Overall Study|To ill to continue|0|||
160479897|NCT01695993|579484262|FG000|Overall Study|Changed Medical Facility|0|||
160479898|NCT01695993|579484263|FG001|Overall Study|Changed Medical Facility|0|||
160479899|NCT01695993|579484264|FG002|Overall Study|Changed Medical Facility|1|||
160479900|NCT00472199|579484265|FG000|Overall Study|Adverse Event|19|||
160479901|NCT00472199|579484266|FG001|Overall Study|Adverse Event|23|||
160479902|NCT00472199|579484265|FG000|Overall Study|Lack of Efficacy|4|||
160479903|NCT00472199|579484266|FG001|Overall Study|Lack of Efficacy|25|||
160479904|NCT00472199|579484265|FG000|Overall Study|Lost to Follow-up|2|||
160479905|NCT00472199|579484266|FG001|Overall Study|Lost to Follow-up|4|||
160479906|NCT00472199|579484265|FG000|Overall Study|Protocol Violation|3|||
160479907|NCT00472199|579484266|FG001|Overall Study|Protocol Violation|2|||
160479908|NCT00472199|579484265|FG000|Overall Study|Withdrawal by Subject|6|||
160479909|NCT00472199|579484266|FG001|Overall Study|Withdrawal by Subject|5|||
160479910|NCT00472199|579484265|FG000|Overall Study|personal reason|0|||
160479911|NCT00472199|579484266|FG001|Overall Study|personal reason|1|||
160604033|NCT02918318|579928775|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
160604034|NCT02918318|579928771|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
160604035|NCT02918318|579928772|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
160604036|NCT02918318|579928773|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
160479912|NCT00472199|579484265|FG000|Overall Study|patient was asymptomatic|1|||
160479913|NCT00472199|579484266|FG001|Overall Study|patient was asymptomatic|0|||
160479914|NCT00147745|579484268|FG000|Overall Study|Withdrawal by Subject|1|||
160479915|NCT00147745|579484269|FG001|Overall Study|Withdrawal by Subject|0|||
160479916|NCT00147745|579484270|FG002|Overall Study|Withdrawal by Subject|0|||
160479917|NCT01901302|579484271|FG000|Overall Study|Adverse Event|2|||
160479918|NCT01901302|579484272|FG001|Overall Study|Adverse Event|1|||
160479919|NCT01901302|579484271|FG000|Overall Study|Lack of Efficacy|0|||
160479920|NCT01901302|579484272|FG001|Overall Study|Lack of Efficacy|2|||
160479921|NCT01901302|579484271|FG000|Overall Study|Study Terminated by Sponsor|23|||
160479922|NCT01901302|579484272|FG001|Overall Study|Study Terminated by Sponsor|20|||
160479923|NCT01901302|579484271|FG000|Overall Study|Withdrawal by Subject|2|||
160479924|NCT01901302|579484272|FG001|Overall Study|Withdrawal by Subject|0|||
160479925|NCT00510783|579484274|FG000|Overall Study|Lost to Follow-up|29|||
160479926|NCT00510783|579484275|FG001|Overall Study|Lost to Follow-up|25|||
160479927|NCT00510783|579484274|FG000|Overall Study|Withdrawal by Subject|2|||
160479928|NCT00510783|579484275|FG001|Overall Study|Withdrawal by Subject|3|||
160479929|NCT00510783|579484274|FG000|Overall Study|Protocol Violation|0|||
160479930|NCT00510783|579484275|FG001|Overall Study|Protocol Violation|1|||
160479931|NCT00316121|579484276|FG000|Overall Study|Death|1|||
160479932|NCT00316121|579484277|FG001|Overall Study|Death|0|||
160479933|NCT00316121|579484276|FG000|Overall Study|Lost to Follow-up|14|||
160479934|NCT00316121|579484277|FG001|Overall Study|Lost to Follow-up|8|||
160479935|NCT00316121|579484276|FG000|Overall Study|Withdrawal by Subject|2|||
160479936|NCT00316121|579484277|FG001|Overall Study|Withdrawal by Subject|0|||
160479937|NCT00316121|579484276|FG000|Overall Study|Reason is missing|1|||
160479938|NCT00316121|579484277|FG001|Overall Study|Reason is missing|0|||
160479939|NCT00316121|579484276|FG000|Overall Study|Subject relocated|1|||
160479940|NCT00316121|579484277|FG001|Overall Study|Subject relocated|1|||
160479941|NCT00316121|579484276|FG000|Overall Study|Subject refused to return|1|||
160479942|NCT00316121|579484277|FG001|Overall Study|Subject refused to return|0|||
160479943|NCT00316121|579484276|FG000|Overall Study|Subject no show for visit x 3|1|||
160479944|NCT00316121|579484277|FG001|Overall Study|Subject no show for visit x 3|0|||
160479945|NCT00316121|579484276|FG000|Overall Study|Subject did not have 24 month visit|1|||
160479946|NCT00316121|579484277|FG001|Overall Study|Subject did not have 24 month visit|0|||
160479959|NCT00460577|579484287|FG000|Overall Study|Protocol Violation|2|||
160479960|NCT00460577|579484288|FG001|Overall Study|Protocol Violation|6|||
160479961|NCT04043806|579484289|FG000|Overall Study|Commercial drug is available for participants|13|||
160479962|NCT04043806|579484289|FG000|Overall Study|Physician Decision|2|||
160479963|NCT04043806|579484289|FG000|Overall Study|Other|12|||
160479964|NCT04043806|579484289|FG000|Overall Study|Adverse Event|2|||
160479965|NCT04043806|579484289|FG000|Overall Study|Lost to Follow-up|6|||
160479966|NCT04043806|579484289|FG000|Overall Study|Other non-compliance|2|||
160479967|NCT04043806|579484289|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
160479968|NCT04043806|579484289|FG000|Overall Study|Never Dosed|1|||
160479969|NCT03166215|579484294|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
160479970|NCT03166215|579484295|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
160479971|NCT03166215|579484296|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
160479972|NCT03166215|579484294|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
160479973|NCT03166215|579484295|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
160479974|NCT03166215|579484296|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
160479975|NCT04362176|579484299|FG000|Overall Study|Lost to Follow-up|5|||
160479976|NCT04362176|579484300|FG001|Overall Study|Lost to Follow-up|8|||
160479977|NCT04362176|579484299|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
160479978|NCT04362176|579484300|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
160479979|NCT04985604|579484302|FG000|Overall Study|Death|4|||
160479980|NCT04985604|579484303|FG001|Overall Study|Death|6|||
160479981|NCT04985604|579484302|FG000|Overall Study|Withdrawal by Subject|0|||
160479982|NCT04985604|579484303|FG001|Overall Study|Withdrawal by Subject|1|||
160479983|NCT04598776|579484304|FG000|Overall Study|Protocol Violation|5|||
160479984|NCT04598776|579484304|FG000|Overall Study|Physician Decision|4|||
160479985|NCT02282761|579484305|FG000|Overall Study|Death|0|||
160479986|NCT02282761|579484306|FG001|Overall Study|Death|0|||
160479987|NCT02282761|579484307|FG002|Overall Study|Death|1|||
160479988|NCT02282761|579484305|FG000|Overall Study|Adverse Event|6|||
160479989|NCT02282761|579484306|FG001|Overall Study|Adverse Event|2|||
160479990|NCT02282761|579484307|FG002|Overall Study|Adverse Event|0|||
160479991|NCT02282761|579484305|FG000|Overall Study|Lack of Efficacy|11|||
160604037|NCT02918318|579928774|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
160604038|NCT02918318|579928775|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
160604039|NCT02918318|579928771|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
160604040|NCT02918318|579928772|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
160604041|NCT02918318|579928773|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
160604042|NCT02918318|579928774|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
160479992|NCT02282761|579484306|FG001|Overall Study|Lack of Efficacy|6|||
160479993|NCT02282761|579484307|FG002|Overall Study|Lack of Efficacy|17|||
160479994|NCT02282761|579484305|FG000|Overall Study|Lost to Follow-up|2|||
160479995|NCT02282761|579484306|FG001|Overall Study|Lost to Follow-up|2|||
160479996|NCT02282761|579484307|FG002|Overall Study|Lost to Follow-up|1|||
160479997|NCT02282761|579484305|FG000|Overall Study|Physician Decision|0|||
160479998|NCT02282761|579484306|FG001|Overall Study|Physician Decision|0|||
160479999|NCT02282761|579484307|FG002|Overall Study|Physician Decision|2|||
160480000|NCT02282761|579484305|FG000|Overall Study|Withdrawal by Subject|8|||
160480001|NCT02282761|579484306|FG001|Overall Study|Withdrawal by Subject|10|||
160480002|NCT02282761|579484307|FG002|Overall Study|Withdrawal by Subject|16|||
160480003|NCT02282761|579484305|FG000|Overall Study|Other|3|||
160480004|NCT02282761|579484306|FG001|Overall Study|Other|2|||
160480005|NCT02282761|579484307|FG002|Overall Study|Other|1|||
160480006|NCT00658632|579484308|FG000|Overall Study|Adverse Event|13|||
160480007|NCT00658632|579484309|FG001|Overall Study|Adverse Event|11|||
160480008|NCT00658632|579484308|FG000|Overall Study|Lost to Follow-up|25|||
160480009|NCT00658632|579484309|FG001|Overall Study|Lost to Follow-up|23|||
160480010|NCT00658632|579484308|FG000|Overall Study|Withdrawal by Subject|10|||
160480011|NCT00658632|579484309|FG001|Overall Study|Withdrawal by Subject|7|||
160480012|NCT00658632|579484308|FG000|Overall Study|Lack of Efficacy|0|||
160480013|NCT00658632|579484309|FG001|Overall Study|Lack of Efficacy|1|||
160480014|NCT00658632|579484308|FG000|Overall Study|Withdrawal of consent|8|||
160480015|NCT00658632|579484309|FG001|Overall Study|Withdrawal of consent|14|||
160480016|NCT00658632|579484308|FG000|Overall Study|Pregnancy|1|||
160480017|NCT00658632|579484309|FG001|Overall Study|Pregnancy|1|||
160480018|NCT00658632|579484308|FG000|Overall Study|Other|7|||
160480019|NCT00658632|579484309|FG001|Overall Study|Other|8|||
160480020|NCT06312566|579484310|FG000|Overall Study|Protocol Violation|0|||
160480021|NCT06312566|579484311|FG001|Overall Study|Protocol Violation|1|||
160604043|NCT02918318|579928775|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
160480022|NCT02632045|579484312|FG000|Overall Study|Withdrawal by Subject|1|||
160480023|NCT02632045|579484313|FG001|Overall Study|Withdrawal by Subject|2|||
160480024|NCT04551053|579484314|FG000|Overall Study|Death|10|||
160480025|NCT04551053|579484315|FG001|Overall Study|Death|9|||
160480026|NCT04551053|579484314|FG000|Overall Study|Lost to Follow-up|0|||
160480027|NCT04551053|579484315|FG001|Overall Study|Lost to Follow-up|2|||
160480028|NCT04551053|579484314|FG000|Overall Study|Study Terminated by Sponsor|57|||
160480029|NCT04551053|579484315|FG001|Overall Study|Study Terminated by Sponsor|65|||
160480030|NCT04551053|579484314|FG000|Overall Study|Withdrawal by Subject|12|||
160480031|NCT04551053|579484315|FG001|Overall Study|Withdrawal by Subject|5|||
160480032|NCT04551053|579484314|FG000|Overall Study|Adverse Event|2|||
160480033|NCT04551053|579484315|FG001|Overall Study|Adverse Event|0|||
160480034|NCT04551053|579484314|FG000|Overall Study|Lack of Efficacy|2|||
160480035|NCT04551053|579484315|FG001|Overall Study|Lack of Efficacy|1|||
160480036|NCT04551053|579484314|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
160480037|NCT04551053|579484315|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
160604044|NCT02918318|579928771|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
160604045|NCT02918318|579928772|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
160480038|NCT04551053|579484314|FG000|Overall Study|Splenapendectomi|1|||
160480039|NCT04551053|579484315|FG001|Overall Study|Splenapendectomi|0|||
160480040|NCT04551053|579484314|FG000|Overall Study|Medical Decision|1|||
160480041|NCT04551053|579484315|FG001|Overall Study|Medical Decision|1|||
160480042|NCT03861078|579484316|FG000|Overall Study|COVID-19 shut down|4|||
160480043|NCT03861078|579484316|FG000|Overall Study|Lost to Follow-up|1|||
160480044|NCT03861078|579484316|FG000|Overall Study|Protocol Violation|2|||
160480045|NCT03861078|579484316|FG000|Overall Study|lack of venous access|1|||
160480046|NCT00596960|579484318|FG000|Overall Study|Death|1|||
160480047|NCT00596960|579484319|FG001|Overall Study|Death|2|||
160480048|NCT00596960|579484318|FG000|Overall Study|Lost to Follow-up|6|||
160480049|NCT00596960|579484319|FG001|Overall Study|Lost to Follow-up|5|||
160480050|NCT00596960|579484318|FG000|Overall Study|Withdrawal by Subject|1|||
160480051|NCT00596960|579484319|FG001|Overall Study|Withdrawal by Subject|0|||
160480052|NCT00596960|579484318|FG000|Overall Study|Incarcerated|2|||
160480053|NCT00596960|579484319|FG001|Overall Study|Incarcerated|0|||
160480054|NCT00596960|579484318|FG000|Overall Study|Physician Decision|1|||
160480055|NCT00596960|579484319|FG001|Overall Study|Physician Decision|0|||
160480056|NCT00596960|579484318|FG000|Overall Study|Protocol Violation|0|||
160480057|NCT00596960|579484319|FG001|Overall Study|Protocol Violation|1|||
160480058|NCT00596960|579484318|FG000|Overall Study|No alcohol use data|0|||
160480059|NCT00596960|579484319|FG001|Overall Study|No alcohol use data|1|||
160480060|NCT03503188|579484320|FG000|Overall Study|Non eligible in the sub study|0|||
160480061|NCT03503188|579484321|FG001|Overall Study|Non eligible in the sub study|1|||
160480062|NCT02260154|579484322|FG000|Overall Study|Screening failure|2|||
160480063|NCT03560206|579484323|FG000|Overall Study|Lost to Follow-up|19|||
160480064|NCT03560206|579484324|FG001|Overall Study|Lost to Follow-up|11|||
160480065|NCT03560206|579484323|FG000|Overall Study|Withdrawal by Subject|2|||
160480066|NCT03560206|579484324|FG001|Overall Study|Withdrawal by Subject|4|||
160480067|NCT03560206|579484323|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
160480068|NCT03560206|579484324|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
160480069|NCT03560206|579484323|FG000|Overall Study|Busy schedule|14|||
160480070|NCT03560206|579484324|FG001|Overall Study|Busy schedule|2|||
160480071|NCT03560206|579484323|FG000|Overall Study|patients' new health condition such as cancer|10|||
160480072|NCT03560206|579484324|FG001|Overall Study|patients' new health condition such as cancer|1|||
160480073|NCT00738400|579484325|FG000|Overall Study|Adverse Event|3|||
160480074|NCT00738400|579484326|FG001|Overall Study|Adverse Event|1|||
160480075|NCT00738400|579484325|FG000|Overall Study|Withdrawal by Subject|0|||
160480076|NCT00738400|579484326|FG001|Overall Study|Withdrawal by Subject|1|||
160480077|NCT00738400|579484325|FG000|Overall Study|Lack of Efficacy|0|||
160480078|NCT00738400|579484326|FG001|Overall Study|Lack of Efficacy|1|||
160480079|NCT00738400|579484325|FG000|Overall Study|Lost to Follow-up|0|||
160480080|NCT00738400|579484326|FG001|Overall Study|Lost to Follow-up|3|||
160480081|NCT00738400|579484325|FG000|Overall Study|Protocol Violation|1|||
160480082|NCT00738400|579484326|FG001|Overall Study|Protocol Violation|0|||
160480083|NCT00738400|579484325|FG000|Overall Study|Non-compliant with study medication|0|||
160480084|NCT00738400|579484326|FG001|Overall Study|Non-compliant with study medication|1|||
160480085|NCT02255474|579484327|FG000|Overall Study|Lost to Follow-up|1|||
160480086|NCT02255474|579484328|FG001|Overall Study|Lost to Follow-up|1|||
160480087|NCT02255474|579484329|FG002|Overall Study|Lost to Follow-up|3|||
160480088|NCT02255474|579484327|FG000|Overall Study|Withdrawal by Subject|1|||
160480089|NCT02255474|579484328|FG001|Overall Study|Withdrawal by Subject|1|||
160480090|NCT02255474|579484329|FG002|Overall Study|Withdrawal by Subject|0|||
160480091|NCT02993926|579484330|FG000|Enantone Treatment Phase|Adverse Event|1|||
160480092|NCT02993926|579484331|FG001|Enantone Treatment Phase|Adverse Event|0|||
160480093|NCT02993926|579484332|FG002|Enantone Treatment Phase|Adverse Event|0|||
160480094|NCT02993926|579484330|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
160480095|NCT02993926|579484331|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
160480096|NCT02993926|579484332|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
160480097|NCT02993926|579484330|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
160480098|NCT02993926|579484331|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
160480099|NCT02993926|579484332|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
160480100|NCT02993926|579484330|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
160480101|NCT02993926|579484331|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
160480102|NCT02993926|579484332|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
160480103|NCT04295499|579484334|FG000|Overall Study|moving out of state|1|||
160480104|NCT04295499|579484335|FG001|Overall Study|moving out of state|0|||
160480105|NCT04295499|579484334|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
160480106|NCT04295499|579484335|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
160480107|NCT02332889|579484336|FG000|Overall Study|Physician Decision|1|||
160480108|NCT00308113|579484337|FG000|Overall Study|Protocol closure|0|||
160480109|NCT00308113|579484338|FG001|Overall Study|Protocol closure|0|||
160480110|NCT00308113|579484339|FG002|Overall Study|Protocol closure|0|||
160480111|NCT00308113|579484340|FG003|Overall Study|Protocol closure|1|||
160480112|NCT02135445|579484344|FG000|Overall Study|Lost to Follow-up|1|||
160480113|NCT02135445|579484345|FG001|Overall Study|Lost to Follow-up|0|||
160480114|NCT02135445|579484344|FG000|Overall Study|Withdrawal by Subject|1|||
160480115|NCT02135445|579484345|FG001|Overall Study|Withdrawal by Subject|0|||
160604046|NCT02918318|579928773|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
160480116|NCT00705614|579485842|FG000|Initial Intervention|Adverse Event|40|||
160480117|NCT00705614|579485843|FG001|Initial Intervention|Adverse Event|21|||
160480118|NCT00705614|579485842|FG000|Initial Intervention|Lost to Follow-up|310|||
160480119|NCT00705614|579485843|FG001|Initial Intervention|Lost to Follow-up|191|||
160480120|NCT00705614|579485842|FG000|Initial Intervention|Withdrawal by Subject|114|||
160480121|NCT00705614|579485843|FG001|Initial Intervention|Withdrawal by Subject|71|||
160480122|NCT00705614|579485842|FG000|Initial Intervention|Administrative Reason|51|||
160480123|NCT00705614|579485843|FG001|Initial Intervention|Administrative Reason|38|||
160480124|NCT00705614|579485842|FG000|Initial Intervention|Status completion unknown|3|||
160480125|NCT00705614|579485843|FG001|Initial Intervention|Status completion unknown|0|||
160480126|NCT00705614|579485842|FG000|Switch to Remicade|Adverse Event|0|||
160480127|NCT00705614|579485843|FG001|Switch to Remicade|Adverse Event|5|||
160480128|NCT00705614|579485842|FG000|Switch to Remicade|Lost to Follow-up|0|||
160480129|NCT00705614|579485843|FG001|Switch to Remicade|Lost to Follow-up|23|||
160480130|NCT00705614|579485842|FG000|Switch to Remicade|Withdrawal by Subject|0|||
160480131|NCT00705614|579485843|FG001|Switch to Remicade|Withdrawal by Subject|12|||
160480132|NCT00705614|579485842|FG000|Switch to Remicade|Administrative Reason|0|||
160480133|NCT00705614|579485843|FG001|Switch to Remicade|Administrative Reason|9|||
160480134|NCT02661490|579485844|FG000|Overall Study|Lost to Follow-up|0|||
160480135|NCT02661490|579485845|FG001|Overall Study|Lost to Follow-up|1|||
160480136|NCT02661490|579485846|FG002|Overall Study|Lost to Follow-up|0|||
160480137|NCT02661490|579485847|FG003|Overall Study|Lost to Follow-up|0|||
160480138|NCT02661490|579485848|FG004|Overall Study|Lost to Follow-up|2|||
160480139|NCT02661490|579485844|FG000|Overall Study|Withdrawal by Subject|2|||
160480140|NCT02661490|579485845|FG001|Overall Study|Withdrawal by Subject|0|||
160480141|NCT02661490|579485846|FG002|Overall Study|Withdrawal by Subject|2|||
160480142|NCT02661490|579485847|FG003|Overall Study|Withdrawal by Subject|0|||
160480143|NCT02661490|579485848|FG004|Overall Study|Withdrawal by Subject|0|||
160480144|NCT02661490|579485844|FG000|Overall Study|Death|1|||
160480145|NCT02661490|579485845|FG001|Overall Study|Death|1|||
160480146|NCT02661490|579485846|FG002|Overall Study|Death|0|||
160480147|NCT02661490|579485847|FG003|Overall Study|Death|1|||
160480148|NCT02661490|579485848|FG004|Overall Study|Death|0|||
160480149|NCT02661490|579485844|FG000|Overall Study|Reason not Specified|0|||
160480150|NCT02661490|579485845|FG001|Overall Study|Reason not Specified|0|||
160480151|NCT02661490|579485846|FG002|Overall Study|Reason not Specified|0|||
160480152|NCT02661490|579485847|FG003|Overall Study|Reason not Specified|0|||
160480153|NCT02661490|579485848|FG004|Overall Study|Reason not Specified|1|||
160480154|NCT00961298|579485849|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
160480155|NCT00961298|579485849|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
160480156|NCT00961298|579485849|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
160480157|NCT04385849|579485857|FG000|Overall Study|Lost to Follow-up|1|||
160480158|NCT04385849|579485858|FG001|Overall Study|Lost to Follow-up|0|||
160480159|NCT03602053|579485859|FG000|Overall Study|Withdrawal by Subject|7|||
160480160|NCT03602053|579485860|FG001|Overall Study|Withdrawal by Subject|9|||
160480161|NCT03602053|579485861|FG002|Overall Study|Withdrawal by Subject|7|||
160480162|NCT03602053|579485859|FG000|Overall Study|Lost to Follow-up|5|||
160480163|NCT03602053|579485860|FG001|Overall Study|Lost to Follow-up|6|||
160480164|NCT03602053|579485861|FG002|Overall Study|Lost to Follow-up|0|||
160480165|NCT03602053|579485859|FG000|Overall Study|Protocol Violation|3|||
160480166|NCT03602053|579485860|FG001|Overall Study|Protocol Violation|0|||
160480167|NCT03602053|579485861|FG002|Overall Study|Protocol Violation|4|||
160480168|NCT03602053|579485859|FG000|Overall Study|Physician Decision|1|||
160480169|NCT03602053|579485860|FG001|Overall Study|Physician Decision|0|||
160480170|NCT03602053|579485861|FG002|Overall Study|Physician Decision|0|||
160480171|NCT03602053|579485859|FG000|Overall Study|migration|2|||
160480172|NCT03602053|579485860|FG001|Overall Study|migration|3|||
160480173|NCT03602053|579485861|FG002|Overall Study|migration|0|||
160480174|NCT03602053|579485859|FG000|Overall Study|Other|1|||
160480175|NCT03602053|579485860|FG001|Overall Study|Other|0|||
160480176|NCT03602053|579485861|FG002|Overall Study|Other|0|||
160480177|NCT01234675|579485868|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
160480178|NCT01234675|579485869|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
160480179|NCT01234675|579485868|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
160480180|NCT01234675|579485869|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
160480181|NCT00396409|579485870|FG000|Period 1 - 2007|Adverse Event|0|||
160604047|NCT02918318|579928774|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
160480182|NCT00396409|579485871|FG001|Period 1 - 2007|Adverse Event|1|||
160480183|NCT00396409|579485870|FG000|Period 1 - 2007|Lack of Efficacy|0|||
160480184|NCT00396409|579485871|FG001|Period 1 - 2007|Lack of Efficacy|1|||
160480185|NCT00396409|579485870|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
160480186|NCT00396409|579485871|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
160604048|NCT02918318|579928775|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
160604049|NCT02918318|579928771|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
160480187|NCT00396409|579485870|FG000|Period 1 - 2007|Lost to Follow-up|2|||
160480188|NCT00396409|579485871|FG001|Period 1 - 2007|Lost to Follow-up|3|||
160480189|NCT00396409|579485870|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
160480190|NCT00396409|579485871|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
160480191|NCT00396409|579485870|FG000|Period 2 - 2008|Protocol Violation|1|||
160480192|NCT00396409|579485871|FG001|Period 2 - 2008|Protocol Violation|0|||
160480193|NCT00396409|579485870|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
160480194|NCT00396409|579485871|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
160480195|NCT00396409|579485870|FG000|Period 2 - 2008|Lost to Follow-up|3|||
160480196|NCT00396409|579485871|FG001|Period 2 - 2008|Lost to Follow-up|1|||
160480197|NCT00331799|579485872|FG000|Overall Study|Withdrawal by Subject|2|||
160480198|NCT00331799|579485872|FG000|Overall Study|Sedation|1|||
160480199|NCT02889809|579485873|FG000|Overall Study|Withdrawal by Subject|30|||
160480200|NCT02889809|579485874|FG001|Overall Study|Withdrawal by Subject|21|||
160480201|NCT02889809|579485873|FG000|Overall Study|Lost to Follow-up|1|||
160480202|NCT02889809|579485874|FG001|Overall Study|Lost to Follow-up|1|||
160480203|NCT02889809|579485873|FG000|Overall Study|Site Closed|12|||
160480204|NCT02889809|579485874|FG001|Overall Study|Site Closed|11|||
160480205|NCT03696342|579485875|FG000|Overall Study|Lost to Follow-up|1|||
160480206|NCT03696342|579485876|FG001|Overall Study|Lost to Follow-up|0|||
160480207|NCT02409732|579485877|FG000|Overall Study|Withdrawal by Subject|4|||
160480208|NCT02409732|579485877|FG000|Overall Study|Lost to Follow-up|2|||
160480209|NCT01870999|579485879|FG000|Overall Study|Adverse Event|0|||
160480210|NCT01870999|579485880|FG001|Overall Study|Adverse Event|4|||
160480211|NCT01870999|579485881|FG002|Overall Study|Adverse Event|1|||
160480212|NCT01870999|579485879|FG000|Overall Study|Subject met withdrawal criteria|3|||
160480213|NCT01870999|579485880|FG001|Overall Study|Subject met withdrawal criteria|2|||
160480214|NCT01870999|579485881|FG002|Overall Study|Subject met withdrawal criteria|0|||
160480215|NCT01870999|579485879|FG000|Overall Study|Subject withdrawn by Investigator|1|||
160480216|NCT01870999|579485880|FG001|Overall Study|Subject withdrawn by Investigator|0|||
160480217|NCT01870999|579485881|FG002|Overall Study|Subject withdrawn by Investigator|0|||
160480218|NCT01870999|579485879|FG000|Overall Study|Withdrawal by Subject|0|||
160480219|NCT01870999|579485880|FG001|Overall Study|Withdrawal by Subject|2|||
160480220|NCT01870999|579485881|FG002|Overall Study|Withdrawal by Subject|5|||
160480221|NCT01870999|579485879|FG000|Overall Study|Protocol Violation|0|||
160480222|NCT01870999|579485880|FG001|Overall Study|Protocol Violation|0|||
160480223|NCT01870999|579485881|FG002|Overall Study|Protocol Violation|1|||
160480224|NCT00116584|579485882|FG000|Overall Study|Withdrawal by Subject|1|||
160480225|NCT00116584|579485883|FG001|Overall Study|Withdrawal by Subject|0|||
160480226|NCT00116584|579485882|FG000|Overall Study|Protocol Violation|1|||
160480227|NCT00116584|579485883|FG001|Overall Study|Protocol Violation|1|||
160480228|NCT03034772|579485884|FG000|Overall Study|Adverse Event|0|||
160480229|NCT03034772|579485885|FG001|Overall Study|Adverse Event|1|||
160480230|NCT03034772|579485884|FG000|Overall Study|Withdrawal by Subject|0|||
160480231|NCT03034772|579485885|FG001|Overall Study|Withdrawal by Subject|1|||
160480232|NCT01533181|579485890|FG000|Overall Study|Disease progression pre-active treatment|0|||
160480233|NCT01533181|579485891|FG001|Overall Study|Disease progression pre-active treatment|1|||
160480234|NCT01533181|579485890|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
160480235|NCT01533181|579485891|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
160480236|NCT01757171|579485892|FG000|Overall Study|Adverse Event|5|||
160480237|NCT01757171|579485893|FG001|Overall Study|Adverse Event|1|||
160480238|NCT01757171|579485892|FG000|Overall Study|Disease Progression|1|||
160480239|NCT01757171|579485893|FG001|Overall Study|Disease Progression|0|||
160480240|NCT01757171|579485892|FG000|Overall Study|Hospitalization|1|||
160480241|NCT01757171|579485893|FG001|Overall Study|Hospitalization|0|||
160480242|NCT01757171|579485892|FG000|Overall Study|ECOG decline|1|||
160480243|NCT01757171|579485893|FG001|Overall Study|ECOG decline|0|||
160480244|NCT00105521|579485895|FG000|Overall Study|Other|1|||
160480245|NCT00105521|579485896|FG001|Overall Study|Other|1|||
160480246|NCT00105521|579485897|FG002|Overall Study|Other|2|||
160480247|NCT00105521|579485898|FG003|Overall Study|Other|0|||
160480248|NCT00105521|579485895|FG000|Overall Study|Adverse Event|10|||
160480249|NCT00105521|579485896|FG001|Overall Study|Adverse Event|4|||
160480250|NCT00105521|579485897|FG002|Overall Study|Adverse Event|10|||
160480251|NCT00105521|579485898|FG003|Overall Study|Adverse Event|8|||
160480252|NCT00105521|579485895|FG000|Overall Study|Withdrawal by Subject|1|||
160480253|NCT00105521|579485896|FG001|Overall Study|Withdrawal by Subject|0|||
160480254|NCT00105521|579485897|FG002|Overall Study|Withdrawal by Subject|1|||
160480255|NCT00105521|579485898|FG003|Overall Study|Withdrawal by Subject|4|||
160480256|NCT00105521|579485895|FG000|Overall Study|Lack of Efficacy|0|||
160480257|NCT00105521|579485896|FG001|Overall Study|Lack of Efficacy|0|||
160480258|NCT00105521|579485897|FG002|Overall Study|Lack of Efficacy|0|||
160480259|NCT00105521|579485898|FG003|Overall Study|Lack of Efficacy|1|||
160480260|NCT00105521|579485895|FG000|Overall Study|Protocol Violation|3|||
160480261|NCT00105521|579485896|FG001|Overall Study|Protocol Violation|5|||
160480262|NCT00105521|579485897|FG002|Overall Study|Protocol Violation|4|||
160480263|NCT00105521|579485898|FG003|Overall Study|Protocol Violation|4|||
160480264|NCT00105521|579485895|FG000|Overall Study|Lost to Follow-up|0|||
160480265|NCT00105521|579485896|FG001|Overall Study|Lost to Follow-up|1|||
160480266|NCT00105521|579485897|FG002|Overall Study|Lost to Follow-up|0|||
160480267|NCT00105521|579485898|FG003|Overall Study|Lost to Follow-up|0|||
160480268|NCT00385697|579485902|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
160480269|NCT00385697|579485903|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
160480270|NCT00385697|579485904|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
160480271|NCT00385697|579485905|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
160480272|NCT00385697|579485906|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
160480273|NCT00385697|579485902|FG000|Open-label Segment 1|Lost to Follow-up|1|||
160480274|NCT00385697|579485903|FG001|Open-label Segment 1|Lost to Follow-up|0|||
160480275|NCT00385697|579485904|FG002|Open-label Segment 1|Lost to Follow-up|0|||
160480276|NCT00385697|579485905|FG003|Open-label Segment 1|Lost to Follow-up|0|||
160480277|NCT00385697|579485906|FG004|Open-label Segment 1|Lost to Follow-up|0|||
160480278|NCT00385697|579485902|FG000|Double-blind Segment 2|Adverse Event|0|||
160480279|NCT00385697|579485903|FG001|Double-blind Segment 2|Adverse Event|3|||
160480280|NCT00385697|579485904|FG002|Double-blind Segment 2|Adverse Event|1|||
160480281|NCT00385697|579485905|FG003|Double-blind Segment 2|Adverse Event|0|||
160480282|NCT00385697|579485906|FG004|Double-blind Segment 2|Adverse Event|0|||
160480283|NCT00385697|579485902|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
160480284|NCT00385697|579485903|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
160480285|NCT00385697|579485904|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
160480286|NCT00385697|579485905|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
160480287|NCT00385697|579485906|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
160480288|NCT00385697|579485902|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
160480289|NCT00385697|579485903|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
160480290|NCT00385697|579485904|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
160480291|NCT00385697|579485905|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
160480292|NCT00385697|579485906|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
160480293|NCT00385697|579485902|FG000|Double-blind Segment 2|Other|0|||
160480294|NCT00385697|579485903|FG001|Double-blind Segment 2|Other|2|||
160480295|NCT00385697|579485904|FG002|Double-blind Segment 2|Other|0|||
160480296|NCT00385697|579485905|FG003|Double-blind Segment 2|Other|0|||
160480297|NCT00385697|579485906|FG004|Double-blind Segment 2|Other|0|||
160480298|NCT01721109|579485917|FG000|Overall Study|Lack of Efficacy|1|||
160480299|NCT01721109|579485917|FG000|Overall Study|Non- Compliance with Study Drug|3|||
160480300|NCT01721109|579485917|FG000|Overall Study|Withdrew Consent|1|||
160480301|NCT01721109|579485917|FG000|Overall Study|Lost to Follow-up|2|||
160480302|NCT03045302|579485918|FG000|Overall Study|Pre-treatment adverse event|1|||
160480303|NCT00134056|579485919|FG000|Randomization|Not eligible for assigned treatment|22|||
160480304|NCT00134056|579485920|FG001|Randomization|Not eligible for assigned treatment|20|||
160480305|NCT00134056|579485919|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
160480306|NCT00134056|579485920|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
160480307|NCT00134056|579485919|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
160480308|NCT00134056|579485920|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
160480309|NCT00134056|579485919|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
160480310|NCT00134056|579485920|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
160480311|NCT00134056|579485919|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
160480312|NCT00134056|579485920|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
160480313|NCT00742560|579485922|FG000|Overall Study|Adverse Event|0|||
160480314|NCT00742560|579485923|FG001|Overall Study|Adverse Event|0|||
160480315|NCT00742560|579485924|FG002|Overall Study|Adverse Event|1|||
160480316|NCT00742560|579485925|FG003|Overall Study|Adverse Event|1|||
160480317|NCT00742560|579485926|FG004|Overall Study|Adverse Event|1|||
160480318|NCT00742560|579485922|FG000|Overall Study|Death|0|||
160480319|NCT00742560|579485923|FG001|Overall Study|Death|2|||
160480320|NCT00742560|579485924|FG002|Overall Study|Death|0|||
160480321|NCT00742560|579485925|FG003|Overall Study|Death|2|||
160480322|NCT00742560|579485926|FG004|Overall Study|Death|3|||
160480323|NCT00742560|579485922|FG000|Overall Study|Subject's Decision|1|||
160480324|NCT00742560|579485923|FG001|Overall Study|Subject's Decision|0|||
160480325|NCT00742560|579485924|FG002|Overall Study|Subject's Decision|2|||
160480326|NCT00742560|579485925|FG003|Overall Study|Subject's Decision|3|||
160480327|NCT00742560|579485926|FG004|Overall Study|Subject's Decision|3|||
160480328|NCT00742560|579485922|FG000|Overall Study|Investigator's Decision|0|||
160480329|NCT00742560|579485923|FG001|Overall Study|Investigator's Decision|0|||
160480330|NCT00742560|579485924|FG002|Overall Study|Investigator's Decision|4|||
160480331|NCT00742560|579485925|FG003|Overall Study|Investigator's Decision|1|||
160480332|NCT00742560|579485926|FG004|Overall Study|Investigator's Decision|0|||
160480333|NCT00742560|579485922|FG000|Overall Study|Disease Progression|1|||
160480334|NCT00742560|579485923|FG001|Overall Study|Disease Progression|0|||
160480335|NCT00742560|579485924|FG002|Overall Study|Disease Progression|5|||
160480336|NCT00742560|579485925|FG003|Overall Study|Disease Progression|17|||
160480337|NCT00742560|579485926|FG004|Overall Study|Disease Progression|16|||
160480338|NCT00742560|579485922|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
160480339|NCT00742560|579485923|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
160480340|NCT00742560|579485924|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
160480341|NCT00742560|579485925|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
160480342|NCT00742560|579485926|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
160480343|NCT00742560|579485922|FG000|Overall Study|Other|0|||
160480344|NCT00742560|579485923|FG001|Overall Study|Other|1|||
160480345|NCT00742560|579485924|FG002|Overall Study|Other|8|||
160480346|NCT00742560|579485925|FG003|Overall Study|Other|9|||
160480347|NCT00742560|579485926|FG004|Overall Study|Other|9|||
160480348|NCT00742560|579485922|FG000|Overall Study|MIssing|0|||
160480349|NCT00742560|579485923|FG001|Overall Study|MIssing|0|||
160480350|NCT00742560|579485924|FG002|Overall Study|MIssing|0|||
160480351|NCT00742560|579485925|FG003|Overall Study|MIssing|0|||
160480352|NCT00742560|579485926|FG004|Overall Study|MIssing|1|||
160480353|NCT01536795|579485927|FG000|Overall Study|Lost to Follow-up|0|||
160480354|NCT01536795|579485928|FG001|Overall Study|Lost to Follow-up|2|||
160480355|NCT01536795|579485927|FG000|Overall Study|Lack of Efficacy|1|||
160480356|NCT01536795|579485928|FG001|Overall Study|Lack of Efficacy|0|||
160480357|NCT02267746|579485929|FG000|Overall Study|Adverse Event|0|||
160480358|NCT02267746|579485930|FG001|Overall Study|Adverse Event|2|||
160480359|NCT02267746|579485931|FG002|Overall Study|Adverse Event|1|||
160480360|NCT02267746|579485929|FG000|Overall Study|Protocol Violation|8|||
160480361|NCT02267746|579485930|FG001|Overall Study|Protocol Violation|7|||
160480362|NCT02267746|579485931|FG002|Overall Study|Protocol Violation|3|||
160480363|NCT02267746|579485929|FG000|Overall Study|Lack of Efficacy|11|||
160480364|NCT02267746|579485930|FG001|Overall Study|Lack of Efficacy|11|||
160480365|NCT02267746|579485931|FG002|Overall Study|Lack of Efficacy|15|||
160480366|NCT02267746|579485929|FG000|Overall Study|Protocol Violation|1|||
160480367|NCT02267746|579485930|FG001|Overall Study|Protocol Violation|2|||
160480368|NCT02267746|579485931|FG002|Overall Study|Protocol Violation|1|||
160480369|NCT02267746|579485929|FG000|Overall Study|Miscellaneous|1|||
160480370|NCT02267746|579485930|FG001|Overall Study|Miscellaneous|0|||
160480371|NCT02267746|579485931|FG002|Overall Study|Miscellaneous|1|||
160480372|NCT05008224|579485932|FG000|Overall Study|Death|3|||
160480373|NCT05008224|579485932|FG000|Overall Study|Lost to Follow-up|2|||
160480374|NCT05008224|579485932|FG000|Overall Study|Did Not Continue on Extension Study|39|||
160480375|NCT05008224|579485932|FG000|Overall Study|Transferred to Extension Study|100|||
160480376|NCT05008224|579485932|FG000|Overall Study|Withdrawal by Subject|2|||
160480377|NCT00348283|579485933|FG000|Induction|Adverse Event|0|||
160480378|NCT00348283|579485934|FG001|Induction|Adverse Event|2|||
160480379|NCT00348283|579485933|FG000|Induction|Protocol Violation|0|||
160480380|NCT00348283|579485934|FG001|Induction|Protocol Violation|4|||
160480381|NCT00348283|579485933|FG000|Double Blind|Adverse Event|2|||
160480382|NCT00348283|579485934|FG001|Double Blind|Adverse Event|5|||
160480383|NCT00348283|579485933|FG000|Double Blind|Withdrawal by Subject|1|||
160480384|NCT00348283|579485934|FG001|Double Blind|Withdrawal by Subject|1|||
160480385|NCT00348283|579485933|FG000|Double Blind|Protocol Violation|0|||
160480386|NCT00348283|579485934|FG001|Double Blind|Protocol Violation|1|||
160480387|NCT00348283|579485933|FG000|Double Blind|Lack of Efficacy|2|||
160480388|NCT00348283|579485934|FG001|Double Blind|Lack of Efficacy|2|||
160480389|NCT00348283|579485933|FG000|Double Blind|Pregnancy|0|||
160480390|NCT00348283|579485934|FG001|Double Blind|Pregnancy|1|||
160480391|NCT00348283|579485933|FG000|Open Label|Adverse Event|0|||
160480392|NCT00348283|579485934|FG001|Open Label|Adverse Event|8|||
160480393|NCT00348283|579485933|FG000|Open Label|Withdrawal by Subject|0|||
160480394|NCT00348283|579485934|FG001|Open Label|Withdrawal by Subject|4|||
160480395|NCT00348283|579485933|FG000|Open Label|Lost to Follow-up|0|||
160480396|NCT00348283|579485934|FG001|Open Label|Lost to Follow-up|1|||
160480397|NCT00348283|579485933|FG000|Open Label|Lack of Efficacy|0|||
160480398|NCT00348283|579485934|FG001|Open Label|Lack of Efficacy|13|||
160480399|NCT00348283|579485933|FG000|Open Label|Administrative reasons|0|||
160480400|NCT00348283|579485934|FG001|Open Label|Administrative reasons|5|||
160480401|NCT00348283|579485933|FG000|Open Label|Subject moved to the United States|0|||
160480402|NCT00348283|579485934|FG001|Open Label|Subject moved to the United States|1|||
160480403|NCT00348283|579485933|FG000|Open Label|Pregnancy|0|||
160480404|NCT00348283|579485934|FG001|Open Label|Pregnancy|1|||
160480405|NCT00348283|579485933|FG000|Open Label|Sponsor decision|0|||
160480406|NCT00348283|579485934|FG001|Open Label|Sponsor decision|1|||
160480407|NCT05878522|579485940|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160480408|NCT05878522|579485941|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160480409|NCT05878522|579485942|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160604050|NCT02918318|579928772|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
160604051|NCT02918318|579928773|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
160480410|NCT05878522|579485943|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160480411|NCT05878522|579485944|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160480412|NCT05878522|579485945|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160480413|NCT05878522|579485946|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160480414|NCT05878522|579485947|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160480415|NCT05878522|579485948|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
160480416|NCT05878522|579485949|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160480417|NCT05878522|579485950|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160480418|NCT05878522|579485951|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
160604052|NCT02918318|579928774|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
160480419|NCT05878522|579485940|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
160480420|NCT05878522|579485941|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
160480421|NCT05878522|579485942|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
160480422|NCT05878522|579485943|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
160480423|NCT05878522|579485944|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
160480424|NCT05878522|579485945|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
160480425|NCT05878522|579485946|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
160480426|NCT05878522|579485947|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
160480427|NCT05878522|579485948|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
160480428|NCT05878522|579485949|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
160480429|NCT05878522|579485950|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
160480430|NCT05878522|579485951|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
160480431|NCT05878522|579485940|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
160480432|NCT05878522|579485941|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
160480433|NCT05878522|579485942|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
160480434|NCT05878522|579485943|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
160480435|NCT05878522|579485944|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
160480436|NCT05878522|579485945|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
160480437|NCT05878522|579485946|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
160480438|NCT05878522|579485947|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
160480439|NCT05878522|579485948|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
160480440|NCT05878522|579485949|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
160480441|NCT05878522|579485950|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
160480442|NCT05878522|579485951|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
160480443|NCT05878522|579485940|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480444|NCT05878522|579485941|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480445|NCT05878522|579485942|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480446|NCT05878522|579485943|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480447|NCT05878522|579485944|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
160480448|NCT05878522|579485945|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480449|NCT05878522|579485946|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480450|NCT05878522|579485947|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480451|NCT05878522|579485948|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480452|NCT05878522|579485949|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480453|NCT05878522|579485950|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480454|NCT05878522|579485951|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
160480455|NCT05263492|579485952|FG000|Overall Study|Adverse Event|1|||
160480456|NCT05263492|579485952|FG000|Overall Study|Disease progression during active treatment|3|||
160480457|NCT02058992|579485955|FG000|Overall Study|Lost to Follow-up|4|||
160480458|NCT02058992|579485955|FG000|Overall Study|Protocol Violation|92|||
160480459|NCT02058992|579485955|FG000|Overall Study|CRF Uncollected|20|||
160480460|NCT03747575|579485956|FG000|Overall Study|Withdrawal by Subject|6|||
160480461|NCT03747575|579485957|FG001|Overall Study|Withdrawal by Subject|3|||
160480462|NCT03747575|579485956|FG000|Overall Study|Lost to Follow-up|3|||
160480463|NCT03747575|579485957|FG001|Overall Study|Lost to Follow-up|3|||
160480464|NCT03747575|579485956|FG000|Overall Study|Adverse Event|0|||
160480465|NCT03747575|579485957|FG001|Overall Study|Adverse Event|1|||
160480466|NCT01549951|579485959|FG000|Overall Study|Adverse Event|15|||
160480467|NCT01549951|579485959|FG000|Overall Study|Withdrawal by Subject|2|||
160480468|NCT01549951|579485959|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
160480469|NCT01549951|579485959|FG000|Overall Study|Progressive disease|29|||
160480470|NCT01549951|579485959|FG000|Overall Study|Symptomatic deterioration|1|||
160480471|NCT01549951|579485959|FG000|Overall Study|Other|2|||
160480472|NCT02009865|579485968|FG000|Overall Study|Adverse Event|0|||
160480473|NCT02009865|579485969|FG001|Overall Study|Adverse Event|2|||
160480474|NCT02009865|579485968|FG000|Overall Study|Protocol Violation|0|||
160480475|NCT02009865|579485969|FG001|Overall Study|Protocol Violation|2|||
160480476|NCT02009865|579485968|FG000|Overall Study|Withdrawal by Subject|1|||
160480477|NCT02009865|579485969|FG001|Overall Study|Withdrawal by Subject|1|||
160480478|NCT01760876|579485970|FG000|Overall Study|Non-cardiac death (head injury)|1|||
160480479|NCT01760876|579485970|FG000|Overall Study|Carcinoma of prostate|1|||
160480480|NCT01760876|579485970|FG000|Overall Study|Impaired renal function|1|||
160480481|NCT01760876|579485970|FG000|Overall Study|Major depression|1|||
160480482|NCT01760876|579485970|FG000|Overall Study|Very poor baseline OCT quality|2|||
160480483|NCT03689452|579485974|FG000|Overall Study|Lost to Follow-up|1|||
160480484|NCT03689452|579485975|FG001|Overall Study|Lost to Follow-up|1|||
160480485|NCT00525915|579485976|FG000|Overall Study|Non-Compliance|0|||
160480486|NCT00525915|579485977|FG001|Overall Study|Non-Compliance|1|||
160480487|NCT00525915|579485976|FG000|Overall Study|Disease Progression|5|||
160480488|NCT00525915|579485977|FG001|Overall Study|Disease Progression|6|||
160480489|NCT00525915|579485976|FG000|Overall Study|Withdrawal by Subject|1|||
160480490|NCT00525915|579485977|FG001|Overall Study|Withdrawal by Subject|0|||
160480491|NCT00525915|579485976|FG000|Overall Study|Refused Surgery|1|||
160480492|NCT00525915|579485977|FG001|Overall Study|Refused Surgery|2|||
160480493|NCT00525915|579485976|FG000|Overall Study|Unrelated illness|1|||
160604053|NCT02918318|579928775|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
160604054|NCT00990249|579928776|FG000|Overall Study|Disease Progression|8|||
160604055|NCT00990249|579928776|FG000|Overall Study|Non-Compliance|1|||
160604056|NCT00990249|579928776|FG000|Overall Study|Death|2|||
160604057|NCT00990249|579928776|FG000|Overall Study|Not treated|2|||
160604058|NCT01548417|579928777|FG000|Overall Study|Withdrawal by Subject|0|||
160604059|NCT01548417|579928778|FG001|Overall Study|Withdrawal by Subject|2|||
160604060|NCT04583969|579928781|FG000|Overall Study|Death|31|||
160604061|NCT04583969|579928782|FG001|Overall Study|Death|38|||
160604062|NCT04583969|579928781|FG000|Overall Study|Lost to Follow-up|16|||
160604063|NCT04583969|579928782|FG001|Overall Study|Lost to Follow-up|13|||
160604064|NCT04583969|579928781|FG000|Overall Study|Protocol Violation|1|||
160604065|NCT04583969|579928782|FG001|Overall Study|Protocol Violation|0|||
160604066|NCT04583969|579928781|FG000|Overall Study|Withdrawal by Subject|3|||
160604067|NCT04583969|579928782|FG001|Overall Study|Withdrawal by Subject|3|||
160604068|NCT04583969|579928781|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
160604069|NCT04583969|579928782|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
160604070|NCT04583969|579928781|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
160604071|NCT04583969|579928782|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
160604072|NCT04583969|579928781|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
160604073|NCT04583969|579928782|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
160604074|NCT04583969|579928781|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
160604075|NCT04583969|579928782|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
160604076|NCT04583969|579928781|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
160480494|NCT00525915|579485977|FG001|Overall Study|Unrelated illness|0|||
160480495|NCT00732498|579485978|FG000|Overall Study|Ineligible|1|||
160480496|NCT00732498|579485978|FG000|Overall Study|Adverse Event|2|||
160480497|NCT00732498|579485978|FG000|Overall Study|Physician Decision|3|||
160480498|NCT03394508|579485981|FG000|Overall Study|Protocol Violation|0|||
160480499|NCT03394508|579485982|FG001|Overall Study|Protocol Violation|3|||
160480500|NCT03394508|579485981|FG000|Overall Study|Lost to Follow-up|1|||
160480501|NCT03394508|579485982|FG001|Overall Study|Lost to Follow-up|0|||
160480502|NCT00267865|579485983|FG000|Induction Treatment|Died before completing.|2|||
160480503|NCT00267865|579485983|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
160480504|NCT01755598|579485984|FG000|Overall Study|Other|109|||
160480505|NCT01755598|579485985|FG001|Overall Study|Other|109|||
160480506|NCT01755598|579485984|FG000|Overall Study|Lost to Follow-up|32|||
160480507|NCT01755598|579485985|FG001|Overall Study|Lost to Follow-up|43|||
160480508|NCT01755598|579485984|FG000|Overall Study|Migrated/moved from study area|76|||
160480509|NCT01755598|579485985|FG001|Overall Study|Migrated/moved from study area|65|||
160480510|NCT01755598|579485984|FG000|Overall Study|Withdrawal by Subject|22|||
160480511|NCT01755598|579485985|FG001|Overall Study|Withdrawal by Subject|31|||
160480512|NCT01755598|579485984|FG000|Overall Study|Protocol Violation|7|||
160480513|NCT01755598|579485985|FG001|Overall Study|Protocol Violation|7|||
160480514|NCT01755598|579485984|FG000|Overall Study|Adverse Event|19|||
160480515|NCT01755598|579485985|FG001|Overall Study|Adverse Event|28|||
160480516|NCT03556891|579485986|FG000|Initial Pivotal Study|Adverse Event|4|||
160480517|NCT03556891|579485986|FG000|Initial Pivotal Study|MRI Need|3|||
160480518|NCT03556891|579485986|FG000|Initial Pivotal Study|Device Failure|1|||
160480519|NCT03556891|579485986|FG000|Initial Pivotal Study|Death|1|||
160480520|NCT03556891|579485986|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
160480521|NCT03556891|579485986|FG000|Initial Pivotal Study|Missing at random|1|||
160480522|NCT03556891|579485986|FG000|Initial Pivotal Study|Missing due to COVID|1|||
160480523|NCT03556891|579485986|FG000|Initial Pivotal Study|Protocol Violation|1|||
160480524|NCT00088452|579487983|FG000|Overall Study|Did not receive intervention|1|||
160604077|NCT04583969|579928782|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
160604078|NCT02873208|579928783|FG000|Overall Study|Withdrawal by Subject|36|||
160604079|NCT02873208|579928783|FG000|Overall Study|Lost to Follow-up|22|||
160604080|NCT02873208|579928783|FG000|Overall Study|Adverse Event|15|||
160604081|NCT02873208|579928783|FG000|Overall Study|Non-compliance with study drug|12|||
160604082|NCT02873208|579928783|FG000|Overall Study|Protocol Violation|8|||
160604083|NCT02873208|579928783|FG000|Overall Study|Pregnancy|2|||
160604084|NCT02873208|579928783|FG000|Overall Study|Incarceration|1|||
160604085|NCT02873208|579928783|FG000|Overall Study|Lack of Efficacy|1|||
160604086|NCT02873208|579928783|FG000|Overall Study|Physician Decision|1|||
160480525|NCT00088452|579487984|FG001|Overall Study|Did not receive intervention|0|||
160480526|NCT00088452|579487985|FG002|Overall Study|Did not receive intervention|1|||
160480527|NCT02081196|579487987|FG000|Overall Study|Lost to Follow-up|1|||
160604087|NCT00415584|579928784|FG000|Overall Study|Withdrawal by Subject|1|||
160604088|NCT00563368|579928785|FG000|Overall Study|Lost to Follow-up|14|||
160480528|NCT01232569|579487990|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
160480529|NCT01232569|579487991|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
160480530|NCT01232569|579487992|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160604089|NCT00563368|579928786|FG001|Overall Study|Lost to Follow-up|14|||
160604090|NCT00563368|579928787|FG002|Overall Study|Lost to Follow-up|12|||
160604091|NCT00563368|579928788|FG003|Overall Study|Lost to Follow-up|6|||
160604092|NCT00563368|579928789|FG004|Overall Study|Lost to Follow-up|9|||
160604093|NCT00563368|579928790|FG005|Overall Study|Lost to Follow-up|8|||
160480531|NCT01232569|579487993|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
160480532|NCT01232569|579487990|FG000|Double-blind Treatment Period|Escape|2|||
160480533|NCT01232569|579487991|FG001|Double-blind Treatment Period|Escape|2|||
160480534|NCT01232569|579487992|FG002|Double-blind Treatment Period|Escape|0|||
160480535|NCT01232569|579487993|FG003|Double-blind Treatment Period|Escape|0|||
160480536|NCT01232569|579487990|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
160480537|NCT01232569|579487991|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
160480538|NCT01232569|579487992|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
160480539|NCT01232569|579487993|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
160480540|NCT01232569|579487990|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
160480541|NCT01232569|579487991|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
160480542|NCT01232569|579487992|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
160480543|NCT01232569|579487993|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
160480544|NCT01232569|579487990|FG000|Double-blind Treatment Period|Physician Decision|1|||
160604094|NCT00563368|579928791|FG006|Overall Study|Lost to Follow-up|9|||
160480545|NCT01232569|579487991|FG001|Double-blind Treatment Period|Physician Decision|0|||
160480546|NCT01232569|579487992|FG002|Double-blind Treatment Period|Physician Decision|0|||
160480547|NCT01232569|579487993|FG003|Double-blind Treatment Period|Physician Decision|0|||
160480548|NCT01232569|579487990|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
160480549|NCT01232569|579487991|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
160480550|NCT01232569|579487992|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
160480551|NCT01232569|579487993|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
160480552|NCT01232569|579487990|FG000|Double-blind Treatment Period|Death|2|||
160480553|NCT01232569|579487991|FG001|Double-blind Treatment Period|Death|0|||
160480554|NCT01232569|579487992|FG002|Double-blind Treatment Period|Death|0|||
160480555|NCT01232569|579487993|FG003|Double-blind Treatment Period|Death|0|||
160480556|NCT04044352|579487994|FG000|Overall Study|Lost to Follow-up|9|||
160480557|NCT04044352|579487994|FG000|Overall Study|Withdrawal by Subject|2|||
160480558|NCT02388932|579487998|FG000|Overall Study|Death|1|||
160480559|NCT05335005|579488001|FG000|Overall Study|Lost to Follow-up|1|||
160480560|NCT05927753|579488002|FG000|Overall Study|Withdrawal by Subject|0|||
160480561|NCT05927753|579488003|FG001|Overall Study|Withdrawal by Subject|2|||
160480562|NCT05927753|579488002|FG000|Overall Study|Physician Decision|0|||
160480563|NCT05927753|579488003|FG001|Overall Study|Physician Decision|1|||
160480564|NCT00409006|579488007|FG000|Overall Study|Death|15|||
160480565|NCT00409006|579488008|FG001|Overall Study|Death|6|||
160480566|NCT00409006|579488007|FG000|Overall Study|Lost to Follow-up|1|||
160480567|NCT00409006|579488008|FG001|Overall Study|Lost to Follow-up|2|||
160480568|NCT00409006|579488007|FG000|Overall Study|Withdrawal by Subject|3|||
160480569|NCT00409006|579488008|FG001|Overall Study|Withdrawal by Subject|2|||
160480570|NCT00409006|579488007|FG000|Overall Study|Physician Decision|1|||
160480571|NCT00409006|579488008|FG001|Overall Study|Physician Decision|2|||
160480572|NCT02123797|579488009|FG000|Baseline Intervention|Death|9|||
160480573|NCT02123797|579488010|FG001|Baseline Intervention|Death|16|||
160480574|NCT02123797|579488011|FG002|Baseline Intervention|Death|0|||
160480575|NCT02123797|579488012|FG003|Baseline Intervention|Death|0|||
160480576|NCT02123797|579488013|FG004|Baseline Intervention|Death|0|||
160480577|NCT02123797|579488009|FG000|Baseline Intervention|Withdrawal by Subject|2|||
160480578|NCT02123797|579488010|FG001|Baseline Intervention|Withdrawal by Subject|8|||
160480579|NCT02123797|579488011|FG002|Baseline Intervention|Withdrawal by Subject|0|||
160480580|NCT02123797|579488012|FG003|Baseline Intervention|Withdrawal by Subject|0|||
160480581|NCT02123797|579488013|FG004|Baseline Intervention|Withdrawal by Subject|0|||
160480582|NCT02123797|579488009|FG000|Baseline Intervention|Relocation|2|||
160480583|NCT02123797|579488010|FG001|Baseline Intervention|Relocation|0|||
160480584|NCT02123797|579488011|FG002|Baseline Intervention|Relocation|0|||
160604095|NCT00563368|579928785|FG000|Overall Study|Adverse Event|3|||
160604096|NCT00563368|579928786|FG001|Overall Study|Adverse Event|4|||
160604097|NCT00563368|579928787|FG002|Overall Study|Adverse Event|5|||
160604098|NCT00563368|579928788|FG003|Overall Study|Adverse Event|9|||
160604099|NCT00563368|579928789|FG004|Overall Study|Adverse Event|6|||
160604100|NCT00563368|579928790|FG005|Overall Study|Adverse Event|10|||
160604101|NCT00563368|579928791|FG006|Overall Study|Adverse Event|17|||
160604102|NCT00563368|579928785|FG000|Overall Study|Withdrawal by Subject|11|||
160604103|NCT00563368|579928786|FG001|Overall Study|Withdrawal by Subject|6|||
160480585|NCT02123797|579488012|FG003|Baseline Intervention|Relocation|0|||
160480586|NCT02123797|579488013|FG004|Baseline Intervention|Relocation|0|||
160480587|NCT02123797|579488009|FG000|Baseline Intervention|Out of window for initial survey|6|||
160480588|NCT02123797|579488010|FG001|Baseline Intervention|Out of window for initial survey|13|||
160480589|NCT02123797|579488011|FG002|Baseline Intervention|Out of window for initial survey|0|||
160604104|NCT00563368|579928787|FG002|Overall Study|Withdrawal by Subject|5|||
160480590|NCT02123797|579488012|FG003|Baseline Intervention|Out of window for initial survey|0|||
160480591|NCT02123797|579488013|FG004|Baseline Intervention|Out of window for initial survey|0|||
160480592|NCT02123797|579488009|FG000|Baseline Intervention|Lost to Follow-up|0|||
160480593|NCT02123797|579488010|FG001|Baseline Intervention|Lost to Follow-up|5|||
160480594|NCT02123797|579488011|FG002|Baseline Intervention|Lost to Follow-up|0|||
160480595|NCT02123797|579488012|FG003|Baseline Intervention|Lost to Follow-up|0|||
160480596|NCT02123797|579488013|FG004|Baseline Intervention|Lost to Follow-up|0|||
160480597|NCT02123797|579488009|FG000|Baseline Intervention|Other Disease|3|||
160480598|NCT02123797|579488010|FG001|Baseline Intervention|Other Disease|0|||
160480599|NCT02123797|579488011|FG002|Baseline Intervention|Other Disease|0|||
160480600|NCT02123797|579488012|FG003|Baseline Intervention|Other Disease|0|||
160480601|NCT02123797|579488013|FG004|Baseline Intervention|Other Disease|0|||
160480602|NCT02123797|579488009|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
160604105|NCT00563368|579928788|FG003|Overall Study|Withdrawal by Subject|7|||
160604106|NCT00563368|579928789|FG004|Overall Study|Withdrawal by Subject|8|||
160604107|NCT00563368|579928790|FG005|Overall Study|Withdrawal by Subject|5|||
160604108|NCT00563368|579928791|FG006|Overall Study|Withdrawal by Subject|4|||
160604109|NCT00563368|579928785|FG000|Overall Study|protocol non-compliance|1|||
160604110|NCT00563368|579928786|FG001|Overall Study|protocol non-compliance|1|||
160604111|NCT00563368|579928787|FG002|Overall Study|protocol non-compliance|2|||
160604112|NCT00563368|579928788|FG003|Overall Study|protocol non-compliance|1|||
160660668|NCT02549092|580139617|FG000|Treatment Period|Withdrawal by Subject|1|||
160660669|NCT02549092|580139618|FG001|Treatment Period|Withdrawal by Subject|3|||
160660670|NCT02549092|580139617|FG000|Treatment Period|Lack of Efficacy|0|||
160480603|NCT02123797|579488010|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
160480604|NCT02123797|579488011|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
160480605|NCT02123797|579488012|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
160480606|NCT02123797|579488013|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
160480607|NCT02123797|579488009|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
160480608|NCT02123797|579488010|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
160480609|NCT02123797|579488011|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
160480610|NCT02123797|579488012|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
160480611|NCT02123797|579488013|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
160480612|NCT02123797|579488009|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
160480613|NCT02123797|579488010|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
160480614|NCT02123797|579488011|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
160480615|NCT02123797|579488012|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
160480616|NCT02123797|579488013|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
160480617|NCT02123797|579488009|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
160480618|NCT02123797|579488010|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
160480619|NCT02123797|579488011|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
160480620|NCT02123797|579488012|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
160480621|NCT02123797|579488013|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
160480622|NCT02123797|579488009|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
160480623|NCT02123797|579488010|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
160480624|NCT02123797|579488011|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
160480625|NCT02123797|579488012|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
160480626|NCT02123797|579488013|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
160480627|NCT02123797|579488009|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
160480628|NCT02123797|579488010|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
160480629|NCT02123797|579488011|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
160480630|NCT02123797|579488012|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
160480631|NCT02123797|579488013|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
160480632|NCT02123797|579488009|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
160480633|NCT02123797|579488010|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
160604113|NCT00563368|579928789|FG004|Overall Study|protocol non-compliance|0|||
160604114|NCT00563368|579928790|FG005|Overall Study|protocol non-compliance|1|||
160604115|NCT00563368|579928791|FG006|Overall Study|protocol non-compliance|3|||
160604116|NCT00563368|579928785|FG000|Overall Study|Pregnancy|1|||
160604117|NCT00563368|579928786|FG001|Overall Study|Pregnancy|0|||
160604118|NCT00563368|579928787|FG002|Overall Study|Pregnancy|1|||
160604119|NCT00563368|579928788|FG003|Overall Study|Pregnancy|2|||
160604120|NCT00563368|579928789|FG004|Overall Study|Pregnancy|1|||
160660671|NCT02549092|580139618|FG001|Treatment Period|Lack of Efficacy|2|||
160480634|NCT02123797|579488011|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
160480635|NCT02123797|579488012|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
160480636|NCT02123797|579488013|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
160604121|NCT00563368|579928790|FG005|Overall Study|Pregnancy|2|||
160604122|NCT00563368|579928791|FG006|Overall Study|Pregnancy|0|||
160604123|NCT00563368|579928785|FG000|Overall Study|requirement for restricted medication|0|||
160660672|NCT02549092|580139617|FG000|Extension/Transition Period|Adverse Event|1|||
160604124|NCT00563368|579928786|FG001|Overall Study|requirement for restricted medication|0|||
160604125|NCT00563368|579928787|FG002|Overall Study|requirement for restricted medication|2|||
160604126|NCT00563368|579928788|FG003|Overall Study|requirement for restricted medication|0|||
160604127|NCT00563368|579928789|FG004|Overall Study|requirement for restricted medication|0|||
160604128|NCT00563368|579928790|FG005|Overall Study|requirement for restricted medication|0|||
160480637|NCT02123797|579488009|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
160480638|NCT02123797|579488010|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
160480639|NCT02123797|579488011|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
160480640|NCT02123797|579488012|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
160480641|NCT02123797|579488013|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
160480642|NCT02123797|579488009|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
160480643|NCT02123797|579488010|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
160480644|NCT02123797|579488011|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
160480645|NCT02123797|579488012|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
160480646|NCT02123797|579488013|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
160480647|NCT01375777|579488016|FG000|Overall Study|Withdrawal by Subject|0|||
160480648|NCT01375777|579488017|FG001|Overall Study|Withdrawal by Subject|2|||
160480649|NCT01375777|579488018|FG002|Overall Study|Withdrawal by Subject|1|||
160480650|NCT01375777|579488019|FG003|Overall Study|Withdrawal by Subject|0|||
160480651|NCT01375777|579488020|FG004|Overall Study|Withdrawal by Subject|1|||
160480652|NCT01375777|579488021|FG005|Overall Study|Withdrawal by Subject|1|||
160480653|NCT01375777|579488022|FG006|Overall Study|Withdrawal by Subject|1|||
160480654|NCT01375777|579488023|FG007|Overall Study|Withdrawal by Subject|2|||
160480655|NCT01375777|579488024|FG008|Overall Study|Withdrawal by Subject|1|||
160480656|NCT01375777|579488016|FG000|Overall Study|Lost to Follow-up|1|||
160480657|NCT01375777|579488017|FG001|Overall Study|Lost to Follow-up|0|||
160480658|NCT01375777|579488018|FG002|Overall Study|Lost to Follow-up|0|||
160480659|NCT01375777|579488019|FG003|Overall Study|Lost to Follow-up|0|||
160480660|NCT01375777|579488020|FG004|Overall Study|Lost to Follow-up|0|||
160480661|NCT01375777|579488021|FG005|Overall Study|Lost to Follow-up|0|||
160480662|NCT01375777|579488022|FG006|Overall Study|Lost to Follow-up|1|||
160480663|NCT01375777|579488023|FG007|Overall Study|Lost to Follow-up|0|||
160480664|NCT01375777|579488024|FG008|Overall Study|Lost to Follow-up|0|||
160480665|NCT01375777|579488016|FG000|Overall Study|Other|1|||
160480666|NCT01375777|579488017|FG001|Overall Study|Other|1|||
160480667|NCT01375777|579488018|FG002|Overall Study|Other|0|||
160480668|NCT01375777|579488019|FG003|Overall Study|Other|0|||
160480669|NCT01375777|579488020|FG004|Overall Study|Other|0|||
160480670|NCT01375777|579488021|FG005|Overall Study|Other|0|||
160480671|NCT01375777|579488022|FG006|Overall Study|Other|0|||
160480672|NCT01375777|579488023|FG007|Overall Study|Other|0|||
160480673|NCT01375777|579488024|FG008|Overall Study|Other|1|||
160480674|NCT00355784|579488025|FG000|Overall Study|Withdrawal by Subject|0|||
160480675|NCT00355784|579488026|FG001|Overall Study|Withdrawal by Subject|0|||
160480676|NCT00355784|579488027|FG002|Overall Study|Withdrawal by Subject|2|||
160480677|NCT03672188|579488034|FG000|Overall Study|Withdrawal by Subject|0|||
160480678|NCT03672188|579488035|FG001|Overall Study|Withdrawal by Subject|0|||
160480679|NCT03672188|579488036|FG002|Overall Study|Withdrawal by Subject|0|||
160604129|NCT00563368|579928791|FG006|Overall Study|requirement for restricted medication|0|||
160604130|NCT00563368|579928785|FG000|Overall Study|Other|5|||
160604131|NCT00563368|579928786|FG001|Overall Study|Other|5|||
160604132|NCT00563368|579928787|FG002|Overall Study|Other|3|||
160604133|NCT00563368|579928788|FG003|Overall Study|Other|4|||
160604134|NCT00563368|579928789|FG004|Overall Study|Other|4|||
160604135|NCT00563368|579928790|FG005|Overall Study|Other|4|||
160604136|NCT00563368|579928791|FG006|Overall Study|Other|0|||
160604137|NCT01061567|579928792|FG000|Overall Study|Adverse Event|32|||
160604138|NCT01061567|579928792|FG000|Overall Study|Death|2|||
160604139|NCT01061567|579928792|FG000|Overall Study|Lack of Efficacy|3|||
160604140|NCT01061567|579928792|FG000|Overall Study|Lost to Follow-up|24|||
160604141|NCT01061567|579928792|FG000|Overall Study|Protocol Violation|1|||
160604142|NCT01061567|579928792|FG000|Overall Study|Withdrawal by Subject|11|||
160604143|NCT01061567|579928792|FG000|Overall Study|Other reason than stated above|3|||
160604144|NCT03168555|579928802|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
160604145|NCT03168555|579928802|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
160604146|NCT03168555|579928802|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
160604147|NCT03168555|579928802|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
160604148|NCT02959190|579928803|FG000|Open Label|Adverse Event|5|||
160604149|NCT02959190|579928804|FG001|Open Label|Adverse Event|7|||
160604150|NCT02959190|579928805|FG002|Open Label|Adverse Event|3|||
160604151|NCT02959190|579928806|FG003|Open Label|Adverse Event|4|||
160604152|NCT02959190|579928803|FG000|Open Label|Pregnancy|0|||
160604153|NCT02959190|579928804|FG001|Open Label|Pregnancy|1|||
160604154|NCT02959190|579928805|FG002|Open Label|Pregnancy|0|||
160604155|NCT02959190|579928806|FG003|Open Label|Pregnancy|0|||
160480680|NCT03672188|579488037|FG003|Overall Study|Withdrawal by Subject|3|||
160480681|NCT03672188|579488038|FG004|Overall Study|Withdrawal by Subject|0|||
160480682|NCT03672188|579488039|FG005|Overall Study|Withdrawal by Subject|0|||
160480683|NCT03672188|579488040|FG006|Overall Study|Withdrawal by Subject|0|||
160480684|NCT03672188|579488041|FG007|Overall Study|Withdrawal by Subject|0|||
160480685|NCT03672188|579488042|FG008|Overall Study|Withdrawal by Subject|0|||
160604156|NCT02959190|579928803|FG000|Open Label|Withdrawal by Subject|2|||
160604157|NCT02959190|579928804|FG001|Open Label|Withdrawal by Subject|8|||
160480686|NCT03672188|579488043|FG009|Overall Study|Withdrawal by Subject|0|||
160480687|NCT03672188|579488044|FG010|Overall Study|Withdrawal by Subject|0|||
160480688|NCT03672188|579488045|FG011|Overall Study|Withdrawal by Subject|0|||
160480689|NCT03672188|579488046|FG012|Overall Study|Withdrawal by Subject|0|||
160480690|NCT03672188|579488047|FG013|Overall Study|Withdrawal by Subject|0|||
160604158|NCT02959190|579928805|FG002|Open Label|Withdrawal by Subject|0|||
160604159|NCT02959190|579928806|FG003|Open Label|Withdrawal by Subject|0|||
160604160|NCT02959190|579928803|FG000|Open Label|Physician Decision|0|||
160604161|NCT02959190|579928804|FG001|Open Label|Physician Decision|0|||
160604162|NCT02959190|579928805|FG002|Open Label|Physician Decision|1|||
160604163|NCT02959190|579928806|FG003|Open Label|Physician Decision|0|||
160604164|NCT02959190|579928803|FG000|Open Label|Protocol Violation|0|||
160604165|NCT02959190|579928804|FG001|Open Label|Protocol Violation|0|||
160604166|NCT02959190|579928805|FG002|Open Label|Protocol Violation|0|||
160604167|NCT02959190|579928806|FG003|Open Label|Protocol Violation|2|||
160604168|NCT02959190|579928803|FG000|Post Treatment Follow Up|Adverse Event|1|||
160604169|NCT02959190|579928804|FG001|Post Treatment Follow Up|Adverse Event|1|||
160604170|NCT02959190|579928805|FG002|Post Treatment Follow Up|Adverse Event|0|||
160604171|NCT02959190|579928806|FG003|Post Treatment Follow Up|Adverse Event|0|||
160604172|NCT02959190|579928803|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
160480691|NCT03672188|579488048|FG014|Overall Study|Withdrawal by Subject|0|||
160604173|NCT02959190|579928804|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
160604174|NCT02959190|579928805|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
160604175|NCT02959190|579928806|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
160604176|NCT00841672|579928809|FG000|Overall Study|Adverse Event|7|||
160604177|NCT00841672|579928810|FG001|Overall Study|Adverse Event|16|||
160604178|NCT00841672|579928809|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160604179|NCT00841672|579928810|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160604180|NCT00841672|579928809|FG000|Overall Study|Subject withdrew consent|2|||
160604181|NCT00841672|579928810|FG001|Overall Study|Subject withdrew consent|4|||
160604182|NCT00841672|579928809|FG000|Overall Study|Lost to Follow-up|1|||
160604183|NCT00841672|579928810|FG001|Overall Study|Lost to Follow-up|1|||
160604184|NCT00841672|579928809|FG000|Overall Study|Administrative problems|9|||
160604185|NCT00841672|579928810|FG001|Overall Study|Administrative problems|9|||
160604186|NCT00841672|579928809|FG000|Overall Study|Misrandomized|1|||
160604187|NCT00841672|579928810|FG001|Overall Study|Misrandomized|0|||
160604188|NCT00841672|579928809|FG000|Overall Study|Protocol Deviation|0|||
160604189|NCT00841672|579928810|FG001|Overall Study|Protocol Deviation|1|||
160604190|NCT02758613|579928813|FG000|Treatment|Physician and Sponsor Decision|1|||
160604191|NCT02758613|579928814|FG001|Treatment|Physician and Sponsor Decision|0|||
160604192|NCT02758613|579928815|FG002|Treatment|Physician and Sponsor Decision|0|||
160604193|NCT02758613|579928816|FG003|Treatment|Physician and Sponsor Decision|0|||
160604194|NCT02758613|579928813|FG000|Treatment|Withdrawal by Subject|1|||
160604195|NCT02758613|579928814|FG001|Treatment|Withdrawal by Subject|0|||
160604196|NCT02758613|579928815|FG002|Treatment|Withdrawal by Subject|1|||
160604197|NCT02758613|579928816|FG003|Treatment|Withdrawal by Subject|0|||
160604198|NCT00249795|579928818|FG000|Overall Study|Not treated|16|||
160604199|NCT00249795|579928819|FG001|Overall Study|Not treated|14|||
160604200|NCT00249795|579928818|FG000|Overall Study|Symptomatic hypotension|127|||
160604201|NCT00249795|579928819|FG001|Overall Study|Symptomatic hypotension|64|||
160604202|NCT00249795|579928818|FG000|Overall Study|Other Serious Adverse Event|84|||
160480692|NCT03672188|579488034|FG000|Overall Study|Death|0|||
160604203|NCT00249795|579928819|FG001|Overall Study|Other Serious Adverse Event|93|||
160604204|NCT00249795|579928818|FG000|Overall Study|Qualifying condition not present|26|||
160604205|NCT00249795|579928819|FG001|Overall Study|Qualifying condition not present|29|||
160604206|NCT00249795|579928818|FG000|Overall Study|Withdrawal by Subject|678|||
160604207|NCT00249795|579928819|FG001|Overall Study|Withdrawal by Subject|742|||
160604208|NCT00249795|579928818|FG000|Overall Study|Thromboembolic / outcome event|39|||
160604209|NCT00249795|579928819|FG001|Overall Study|Thromboembolic / outcome event|45|||
160604210|NCT00249795|579928818|FG000|Overall Study|Oral anticoagulant required|2|||
160604211|NCT00249795|579928819|FG001|Overall Study|Oral anticoagulant required|0|||
160480693|NCT03672188|579488035|FG001|Overall Study|Death|0|||
160480694|NCT03672188|579488036|FG002|Overall Study|Death|0|||
160480695|NCT03672188|579488037|FG003|Overall Study|Death|0|||
160480696|NCT03672188|579488038|FG004|Overall Study|Death|0|||
160480697|NCT03672188|579488039|FG005|Overall Study|Death|0|||
160480698|NCT03672188|579488040|FG006|Overall Study|Death|0|||
160480699|NCT03672188|579488041|FG007|Overall Study|Death|0|||
160480700|NCT03672188|579488042|FG008|Overall Study|Death|0|||
160480701|NCT03672188|579488043|FG009|Overall Study|Death|0|||
160480702|NCT03672188|579488044|FG010|Overall Study|Death|0|||
160480703|NCT03672188|579488045|FG011|Overall Study|Death|0|||
160480704|NCT03672188|579488046|FG012|Overall Study|Death|1|||
160480705|NCT03672188|579488047|FG013|Overall Study|Death|0|||
160480706|NCT03672188|579488048|FG014|Overall Study|Death|0|||
160480707|NCT03672188|579488034|FG000|Overall Study|Lost to Follow-up|0|||
160480708|NCT03672188|579488035|FG001|Overall Study|Lost to Follow-up|0|||
160480709|NCT03672188|579488036|FG002|Overall Study|Lost to Follow-up|1|||
160480710|NCT03672188|579488037|FG003|Overall Study|Lost to Follow-up|0|||
160480711|NCT03672188|579488038|FG004|Overall Study|Lost to Follow-up|0|||
160480712|NCT03672188|579488039|FG005|Overall Study|Lost to Follow-up|0|||
160480713|NCT03672188|579488040|FG006|Overall Study|Lost to Follow-up|0|||
160480714|NCT03672188|579488041|FG007|Overall Study|Lost to Follow-up|0|||
160480715|NCT03672188|579488042|FG008|Overall Study|Lost to Follow-up|0|||
160480716|NCT03672188|579488043|FG009|Overall Study|Lost to Follow-up|0|||
160480717|NCT03672188|579488044|FG010|Overall Study|Lost to Follow-up|0|||
160480718|NCT03672188|579488045|FG011|Overall Study|Lost to Follow-up|0|||
160480719|NCT03672188|579488046|FG012|Overall Study|Lost to Follow-up|0|||
160480720|NCT03672188|579488047|FG013|Overall Study|Lost to Follow-up|0|||
160480721|NCT03672188|579488048|FG014|Overall Study|Lost to Follow-up|0|||
160480722|NCT03997409|579488049|FG000|Overall Study|Protocol Violation|1|||
160480723|NCT03997409|579488050|FG001|Overall Study|Protocol Violation|1|||
160480724|NCT03997409|579488051|FG002|Overall Study|Protocol Violation|0|||
160480725|NCT03997409|579488049|FG000|Overall Study|Withdrawal by Subject|3|||
160480726|NCT03997409|579488050|FG001|Overall Study|Withdrawal by Subject|0|||
160480727|NCT03997409|579488051|FG002|Overall Study|Withdrawal by Subject|0|||
160480728|NCT03997409|579488049|FG000|Overall Study|Lost to Follow-up|0|||
160480729|NCT03997409|579488050|FG001|Overall Study|Lost to Follow-up|0|||
160480730|NCT03997409|579488051|FG002|Overall Study|Lost to Follow-up|1|||
160480731|NCT01753323|579488052|FG000|Overall Study|Lack of Efficacy|0|||
160480732|NCT01753323|579488053|FG001|Overall Study|Lack of Efficacy|0|||
160480733|NCT01753323|579488054|FG002|Overall Study|Lack of Efficacy|8|||
160480734|NCT01753323|579488052|FG000|Overall Study|Protocol deviation|1|||
160480735|NCT01753323|579488053|FG001|Overall Study|Protocol deviation|0|||
160480736|NCT01753323|579488054|FG002|Overall Study|Protocol deviation|0|||
160480737|NCT01753323|579488052|FG000|Overall Study|Adverse Event|0|||
160480738|NCT01753323|579488053|FG001|Overall Study|Adverse Event|0|||
160480739|NCT01753323|579488054|FG002|Overall Study|Adverse Event|1|||
160480740|NCT01636258|579488055|FG000|Overall Study|Lost to Follow-up|1|||
160480741|NCT01636258|579488056|FG001|Overall Study|Lost to Follow-up|0|||
160480742|NCT01745380|579488067|FG000|Overall Study|Lost to Follow-up|1|||
160480743|NCT01745380|579488068|FG001|Overall Study|Lost to Follow-up|0|||
160480744|NCT01745380|579488067|FG000|Overall Study|Lack of Efficacy|0|||
160480745|NCT01745380|579488068|FG001|Overall Study|Lack of Efficacy|1|||
160480746|NCT02660034|579488069|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
160480747|NCT02660034|579488070|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
160480748|NCT02660034|579488071|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
160480749|NCT02660034|579488072|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
160480750|NCT02660034|579488073|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
160480751|NCT02660034|579488074|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
160480752|NCT02660034|579488075|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
160480753|NCT02660034|579488076|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
160480754|NCT02660034|579488077|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
160480755|NCT02660034|579488078|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
160480756|NCT02660034|579488079|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
160480757|NCT02660034|579488080|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
160480758|NCT02660034|579488081|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
160480759|NCT02660034|579488082|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
160480760|NCT02660034|579488069|FG000|Overall Study|Progressive Disease (Clinical)|7|||
160480761|NCT02660034|579488070|FG001|Overall Study|Progressive Disease (Clinical)|8|||
160480762|NCT02660034|579488071|FG002|Overall Study|Progressive Disease (Clinical)|3|||
160480763|NCT02660034|579488072|FG003|Overall Study|Progressive Disease (Clinical)|9|||
160480764|NCT02660034|579488073|FG004|Overall Study|Progressive Disease (Clinical)|3|||
160480765|NCT02660034|579488074|FG005|Overall Study|Progressive Disease (Clinical)|0|||
160480766|NCT02660034|579488075|FG006|Overall Study|Progressive Disease (Clinical)|0|||
160480767|NCT02660034|579488076|FG007|Overall Study|Progressive Disease (Clinical)|0|||
160480768|NCT02660034|579488077|FG008|Overall Study|Progressive Disease (Clinical)|0|||
160480769|NCT02660034|579488078|FG009|Overall Study|Progressive Disease (Clinical)|0|||
160480770|NCT02660034|579488079|FG010|Overall Study|Progressive Disease (Clinical)|0|||
160480771|NCT02660034|579488080|FG011|Overall Study|Progressive Disease (Clinical)|0|||
160480772|NCT02660034|579488081|FG012|Overall Study|Progressive Disease (Clinical)|0|||
160480773|NCT02660034|579488082|FG013|Overall Study|Progressive Disease (Clinical)|0|||
160480774|NCT02660034|579488069|FG000|Overall Study|Lost to Follow-up|0|||
160480775|NCT02660034|579488070|FG001|Overall Study|Lost to Follow-up|0|||
160480776|NCT02660034|579488071|FG002|Overall Study|Lost to Follow-up|1|||
160480777|NCT02660034|579488072|FG003|Overall Study|Lost to Follow-up|1|||
160480778|NCT02660034|579488073|FG004|Overall Study|Lost to Follow-up|0|||
160480779|NCT02660034|579488074|FG005|Overall Study|Lost to Follow-up|0|||
160480780|NCT02660034|579488075|FG006|Overall Study|Lost to Follow-up|0|||
160480781|NCT02660034|579488076|FG007|Overall Study|Lost to Follow-up|0|||
160480782|NCT02660034|579488077|FG008|Overall Study|Lost to Follow-up|0|||
160480783|NCT02660034|579488078|FG009|Overall Study|Lost to Follow-up|1|||
160480784|NCT02660034|579488079|FG010|Overall Study|Lost to Follow-up|1|||
160480785|NCT02660034|579488080|FG011|Overall Study|Lost to Follow-up|1|||
160480786|NCT02660034|579488081|FG012|Overall Study|Lost to Follow-up|0|||
160480787|NCT02660034|579488082|FG013|Overall Study|Lost to Follow-up|0|||
160480788|NCT02660034|579488069|FG000|Overall Study|Participant moved into special access scheme|1|||
160480789|NCT02660034|579488070|FG001|Overall Study|Participant moved into special access scheme|2|||
160480790|NCT02660034|579488071|FG002|Overall Study|Participant moved into special access scheme|0|||
160480791|NCT02660034|579488072|FG003|Overall Study|Participant moved into special access scheme|0|||
160480792|NCT02660034|579488073|FG004|Overall Study|Participant moved into special access scheme|0|||
160480793|NCT02660034|579488074|FG005|Overall Study|Participant moved into special access scheme|0|||
160480794|NCT02660034|579488075|FG006|Overall Study|Participant moved into special access scheme|0|||
160480795|NCT02660034|579488076|FG007|Overall Study|Participant moved into special access scheme|0|||
160480796|NCT02660034|579488077|FG008|Overall Study|Participant moved into special access scheme|0|||
160480797|NCT02660034|579488078|FG009|Overall Study|Participant moved into special access scheme|0|||
160480798|NCT02660034|579488079|FG010|Overall Study|Participant moved into special access scheme|0|||
160480799|NCT02660034|579488080|FG011|Overall Study|Participant moved into special access scheme|0|||
160480800|NCT02660034|579488081|FG012|Overall Study|Participant moved into special access scheme|0|||
160480801|NCT02660034|579488082|FG013|Overall Study|Participant moved into special access scheme|0|||
160480802|NCT02660034|579488069|FG000|Overall Study|Adverse Event|1|||
160480803|NCT02660034|579488070|FG001|Overall Study|Adverse Event|0|||
160480804|NCT02660034|579488071|FG002|Overall Study|Adverse Event|0|||
160480805|NCT02660034|579488072|FG003|Overall Study|Adverse Event|0|||
160480806|NCT02660034|579488073|FG004|Overall Study|Adverse Event|0|||
160480807|NCT02660034|579488074|FG005|Overall Study|Adverse Event|0|||
160480808|NCT02660034|579488075|FG006|Overall Study|Adverse Event|0|||
160480809|NCT02660034|579488076|FG007|Overall Study|Adverse Event|0|||
160480810|NCT02660034|579488077|FG008|Overall Study|Adverse Event|0|||
160480811|NCT02660034|579488078|FG009|Overall Study|Adverse Event|0|||
160480812|NCT02660034|579488079|FG010|Overall Study|Adverse Event|0|||
160480813|NCT02660034|579488080|FG011|Overall Study|Adverse Event|0|||
160480814|NCT02660034|579488081|FG012|Overall Study|Adverse Event|0|||
160480815|NCT02660034|579488082|FG013|Overall Study|Adverse Event|0|||
160480816|NCT02660034|579488069|FG000|Overall Study|Sponsor Decision|0|||
160480817|NCT02660034|579488070|FG001|Overall Study|Sponsor Decision|1|||
160480818|NCT02660034|579488071|FG002|Overall Study|Sponsor Decision|2|||
160604212|NCT00249795|579928818|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
160604213|NCT00249795|579928819|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
160604214|NCT00249795|579928818|FG000|Overall Study|Non-compliance|71|||
160604215|NCT00249795|579928819|FG001|Overall Study|Non-compliance|69|||
160604216|NCT00249795|579928818|FG000|Overall Study|Study drug intolerance|3|||
160604217|NCT00249795|579928819|FG001|Overall Study|Study drug intolerance|3|||
160604218|NCT00249795|579928818|FG000|Overall Study|Other adverse events (non-serious)|188|||
160604219|NCT00249795|579928819|FG001|Overall Study|Other adverse events (non-serious)|159|||
160604220|NCT00249795|579928818|FG000|Overall Study|Physician withdrew consent|71|||
160604221|NCT00249795|579928819|FG001|Overall Study|Physician withdrew consent|63|||
160604222|NCT00249795|579928818|FG000|Overall Study|Surgery / procedure|4|||
160604223|NCT00249795|579928819|FG001|Overall Study|Surgery / procedure|5|||
160604224|NCT00249795|579928818|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
160604225|NCT00249795|579928819|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
160604226|NCT00249795|579928818|FG000|Overall Study|Lightheadedness / dizziness|15|||
160480819|NCT02660034|579488072|FG003|Overall Study|Sponsor Decision|2|||
160480820|NCT02660034|579488073|FG004|Overall Study|Sponsor Decision|3|||
160480821|NCT02660034|579488074|FG005|Overall Study|Sponsor Decision|0|||
160480822|NCT02660034|579488075|FG006|Overall Study|Sponsor Decision|0|||
160480823|NCT02660034|579488076|FG007|Overall Study|Sponsor Decision|0|||
160480824|NCT02660034|579488077|FG008|Overall Study|Sponsor Decision|0|||
160480825|NCT02660034|579488078|FG009|Overall Study|Sponsor Decision|0|||
160480826|NCT02660034|579488079|FG010|Overall Study|Sponsor Decision|0|||
160480827|NCT02660034|579488080|FG011|Overall Study|Sponsor Decision|0|||
160480828|NCT02660034|579488081|FG012|Overall Study|Sponsor Decision|0|||
160604227|NCT00249795|579928819|FG001|Overall Study|Lightheadedness / dizziness|11|||
160480829|NCT02660034|579488082|FG013|Overall Study|Sponsor Decision|1|||
160480830|NCT02660034|579488069|FG000|Overall Study|Withdrawal by Subject|0|||
160480831|NCT02660034|579488070|FG001|Overall Study|Withdrawal by Subject|0|||
160480832|NCT02660034|579488071|FG002|Overall Study|Withdrawal by Subject|0|||
160480833|NCT02660034|579488072|FG003|Overall Study|Withdrawal by Subject|0|||
160480834|NCT02660034|579488073|FG004|Overall Study|Withdrawal by Subject|0|||
160480835|NCT02660034|579488074|FG005|Overall Study|Withdrawal by Subject|0|||
160480836|NCT02660034|579488075|FG006|Overall Study|Withdrawal by Subject|1|||
160480837|NCT02660034|579488076|FG007|Overall Study|Withdrawal by Subject|1|||
160480838|NCT02660034|579488077|FG008|Overall Study|Withdrawal by Subject|1|||
160480839|NCT02660034|579488078|FG009|Overall Study|Withdrawal by Subject|0|||
160480840|NCT02660034|579488079|FG010|Overall Study|Withdrawal by Subject|0|||
160480841|NCT02660034|579488080|FG011|Overall Study|Withdrawal by Subject|1|||
160480842|NCT02660034|579488081|FG012|Overall Study|Withdrawal by Subject|2|||
160480843|NCT02660034|579488082|FG013|Overall Study|Withdrawal by Subject|0|||
160480844|NCT02660034|579488069|FG000|Overall Study|Death|0|||
160480845|NCT02660034|579488070|FG001|Overall Study|Death|0|||
160480846|NCT02660034|579488071|FG002|Overall Study|Death|0|||
160480847|NCT02660034|579488072|FG003|Overall Study|Death|0|||
160480848|NCT02660034|579488073|FG004|Overall Study|Death|0|||
160480849|NCT02660034|579488074|FG005|Overall Study|Death|13|||
160480850|NCT02660034|579488075|FG006|Overall Study|Death|14|||
160480851|NCT02660034|579488076|FG007|Overall Study|Death|10|||
160480852|NCT02660034|579488077|FG008|Overall Study|Death|9|||
160480853|NCT02660034|579488078|FG009|Overall Study|Death|21|||
160480854|NCT02660034|579488079|FG010|Overall Study|Death|17|||
160480855|NCT02660034|579488080|FG011|Overall Study|Death|15|||
160480856|NCT02660034|579488081|FG012|Overall Study|Death|18|||
160480857|NCT02660034|579488082|FG013|Overall Study|Death|7|||
160480858|NCT02660034|579488069|FG000|Overall Study|Physician Decision|0|||
160480859|NCT02660034|579488070|FG001|Overall Study|Physician Decision|0|||
160480860|NCT02660034|579488071|FG002|Overall Study|Physician Decision|0|||
160480861|NCT02660034|579488072|FG003|Overall Study|Physician Decision|0|||
160480862|NCT02660034|579488073|FG004|Overall Study|Physician Decision|0|||
160480863|NCT02660034|579488074|FG005|Overall Study|Physician Decision|0|||
160480864|NCT02660034|579488075|FG006|Overall Study|Physician Decision|0|||
160480865|NCT02660034|579488076|FG007|Overall Study|Physician Decision|0|||
160480866|NCT02660034|579488077|FG008|Overall Study|Physician Decision|0|||
160480867|NCT02660034|579488078|FG009|Overall Study|Physician Decision|0|||
160480868|NCT02660034|579488079|FG010|Overall Study|Physician Decision|0|||
160480869|NCT02660034|579488080|FG011|Overall Study|Physician Decision|0|||
160480870|NCT02660034|579488081|FG012|Overall Study|Physician Decision|0|||
160480871|NCT02660034|579488082|FG013|Overall Study|Physician Decision|1|||
160480872|NCT02660034|579488069|FG000|Overall Study|Participants transferred to LTE|0|||
160480873|NCT02660034|579488070|FG001|Overall Study|Participants transferred to LTE|0|||
160480874|NCT02660034|579488071|FG002|Overall Study|Participants transferred to LTE|0|||
160480875|NCT02660034|579488072|FG003|Overall Study|Participants transferred to LTE|0|||
160480876|NCT02660034|579488073|FG004|Overall Study|Participants transferred to LTE|0|||
160480877|NCT02660034|579488074|FG005|Overall Study|Participants transferred to LTE|10|||
160480878|NCT02660034|579488075|FG006|Overall Study|Participants transferred to LTE|8|||
160480879|NCT02660034|579488076|FG007|Overall Study|Participants transferred to LTE|8|||
160480880|NCT02660034|579488077|FG008|Overall Study|Participants transferred to LTE|10|||
160480881|NCT02660034|579488078|FG009|Overall Study|Participants transferred to LTE|1|||
160480882|NCT02660034|579488079|FG010|Overall Study|Participants transferred to LTE|2|||
160480883|NCT02660034|579488080|FG011|Overall Study|Participants transferred to LTE|4|||
160480884|NCT02660034|579488081|FG012|Overall Study|Participants transferred to LTE|1|||
160480885|NCT02660034|579488082|FG013|Overall Study|Participants transferred to LTE|1|||
160480886|NCT04879823|579488090|FG000|Overall Study|Physician Decision|3|||
160480887|NCT04879823|579488091|FG001|Overall Study|Physician Decision|1|||
160480888|NCT04879823|579488090|FG000|Overall Study|Protocol Violation|2|||
160480889|NCT04879823|579488091|FG001|Overall Study|Protocol Violation|3|||
160480890|NCT04879823|579488090|FG000|Overall Study|Lost to Follow-up|43|||
160480891|NCT04879823|579488091|FG001|Overall Study|Lost to Follow-up|35|||
160480892|NCT00730925|579488092|FG000|Overall Study|Progressive Disease|21|||
160480893|NCT00730925|579488092|FG000|Overall Study|Dose reducing Event|2|||
160480894|NCT00730925|579488092|FG000|Overall Study|Other Averse Event|7|||
160480895|NCT00730925|579488092|FG000|Overall Study|Protocol Violation|1|||
160480896|NCT00730925|579488092|FG000|Overall Study|Withdrawal by Subject|1|||
160480897|NCT00730925|579488092|FG000|Overall Study|Switch to combination therapy|8|||
160604228|NCT00249795|579928818|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
160604229|NCT00249795|579928819|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
160480898|NCT00730925|579488092|FG000|Overall Study|Other|1|||
160480899|NCT02137239|579488093|FG000|Overall Study|Discontinued Study Treatment|0|||
160480900|NCT02137239|579488094|FG001|Overall Study|Discontinued Study Treatment|3|||
160480901|NCT02137239|579488093|FG000|Overall Study|Withdrew Consent|1|||
160480902|NCT02137239|579488094|FG001|Overall Study|Withdrew Consent|1|||
160480903|NCT02137239|579488093|FG000|Overall Study|Adverse Event|2|||
160604230|NCT00249795|579928818|FG000|Overall Study|Other contraindicated medication|1|||
160480904|NCT02137239|579488094|FG001|Overall Study|Adverse Event|2|||
160480905|NCT04057937|579488095|FG000|Placebo-controlled Phase|Adverse Event|3|||
160480906|NCT04057937|579488096|FG001|Placebo-controlled Phase|Adverse Event|0|||
160480907|NCT04057937|579488095|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
160480908|NCT04057937|579488096|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
160480909|NCT04057937|579488095|FG000|Active-treatment Phase|Pregnancy|0|||
160480910|NCT04057937|579488096|FG001|Active-treatment Phase|Pregnancy|1|||
160480911|NCT04057937|579488095|FG000|Active-treatment Phase|Physician Decision|0|||
160480912|NCT04057937|579488096|FG001|Active-treatment Phase|Physician Decision|1|||
160480913|NCT02029521|579488097|FG000|Overall Study|Protocol Violation|1|||
160480914|NCT02029521|579488098|FG001|Overall Study|Protocol Violation|0|||
160480915|NCT02029521|579488097|FG000|Overall Study|Withdrawal by Subject|1|||
160480916|NCT02029521|579488098|FG001|Overall Study|Withdrawal by Subject|1|||
160480917|NCT01072396|579488099|FG000|Period One|Adverse Event|1|||
160480918|NCT01072396|579488100|FG001|Period One|Adverse Event|1|||
160480919|NCT01072396|579488099|FG000|Period One|Protocol Violation|2|||
160480920|NCT01072396|579488100|FG001|Period One|Protocol Violation|1|||
160480921|NCT01072396|579488099|FG000|Period One|Withdrawal by Subject|2|||
160480922|NCT01072396|579488100|FG001|Period One|Withdrawal by Subject|0|||
160480923|NCT01072396|579488099|FG000|Washout Period|Missing termination information|0|||
160480924|NCT01072396|579488100|FG001|Washout Period|Missing termination information|1|||
160480925|NCT01072396|579488099|FG000|Period Two|Adverse Event|0|||
160480926|NCT01072396|579488100|FG001|Period Two|Adverse Event|3|||
160480927|NCT01072396|579488099|FG000|Period Two|Lost to Follow-up|1|||
160480928|NCT01072396|579488100|FG001|Period Two|Lost to Follow-up|0|||
160480929|NCT02446912|579488101|FG000|Overall Study|Adverse Event|3|||
160480930|NCT02446912|579488102|FG001|Overall Study|Adverse Event|13|||
160480931|NCT02446912|579488103|FG002|Overall Study|Adverse Event|5|||
160480932|NCT02446912|579488101|FG000|Overall Study|Condition under investigation worsened|0|||
160480933|NCT02446912|579488102|FG001|Overall Study|Condition under investigation worsened|1|||
160480934|NCT02446912|579488103|FG002|Overall Study|Condition under investigation worsened|1|||
160480935|NCT02446912|579488101|FG000|Overall Study|Study-specific withdrawal criteria|1|||
160480936|NCT02446912|579488102|FG001|Overall Study|Study-specific withdrawal criteria|0|||
160480937|NCT02446912|579488103|FG002|Overall Study|Study-specific withdrawal criteria|0|||
160480938|NCT02446912|579488101|FG000|Overall Study|Lack of Efficacy|1|||
160480939|NCT02446912|579488102|FG001|Overall Study|Lack of Efficacy|4|||
160480940|NCT02446912|579488103|FG002|Overall Study|Lack of Efficacy|7|||
160480941|NCT02446912|579488101|FG000|Overall Study|Lost to Follow-up|0|||
160480942|NCT02446912|579488102|FG001|Overall Study|Lost to Follow-up|0|||
160480943|NCT02446912|579488103|FG002|Overall Study|Lost to Follow-up|2|||
160480944|NCT02446912|579488101|FG000|Overall Study|Severe non-compliance to protocol|1|||
160480945|NCT02446912|579488102|FG001|Overall Study|Severe non-compliance to protocol|0|||
160480946|NCT02446912|579488103|FG002|Overall Study|Severe non-compliance to protocol|1|||
160480947|NCT02446912|579488101|FG000|Overall Study|Withdrawal by Subject|10|||
160480948|NCT02446912|579488102|FG001|Overall Study|Withdrawal by Subject|15|||
160480949|NCT02446912|579488103|FG002|Overall Study|Withdrawal by Subject|15|||
160480950|NCT02446912|579488101|FG000|Overall Study|Miscellaneous|2|||
160480951|NCT02446912|579488102|FG001|Overall Study|Miscellaneous|2|||
160480952|NCT02446912|579488103|FG002|Overall Study|Miscellaneous|4|||
160480953|NCT01268488|579488104|FG000|Overall Study|Adverse Event|3|||
160480954|NCT01268488|579488104|FG000|Overall Study|Physician Decision|2|||
160480955|NCT01106586|579488107|FG000|Overall Study|Adverse Event|9|||
160480956|NCT01106586|579488108|FG001|Overall Study|Adverse Event|15|||
160480957|NCT01106586|579488107|FG000|Overall Study|Death|1|||
160480958|NCT01106586|579488108|FG001|Overall Study|Death|3|||
160480959|NCT01106586|579488107|FG000|Overall Study|Pregnancy|2|||
160480960|NCT01106586|579488108|FG001|Overall Study|Pregnancy|2|||
160480961|NCT01106586|579488107|FG000|Overall Study|Lack of Efficacy|1|||
160480962|NCT01106586|579488108|FG001|Overall Study|Lack of Efficacy|0|||
160480963|NCT01106586|579488107|FG000|Overall Study|Investigator's Discretion|5|||
160480964|NCT01106586|579488108|FG001|Overall Study|Investigator's Discretion|8|||
160480965|NCT01106586|579488107|FG000|Overall Study|Withdrew Consent|18|||
160480966|NCT01106586|579488108|FG001|Overall Study|Withdrew Consent|30|||
160480967|NCT01106586|579488107|FG000|Overall Study|Lost to Follow-up|24|||
160480968|NCT01106586|579488108|FG001|Overall Study|Lost to Follow-up|20|||
160480969|NCT01106586|579488107|FG000|Overall Study|Participant Noncompliance|12|||
160480970|NCT01106586|579488108|FG001|Overall Study|Participant Noncompliance|10|||
160480971|NCT01106586|579488107|FG000|Overall Study|Protocol Violation|1|||
160480972|NCT01106586|579488108|FG001|Overall Study|Protocol Violation|0|||
160480973|NCT01106586|579488107|FG000|Overall Study|Participant Transferred to Another Study|212|||
160480974|NCT01106586|579488108|FG001|Overall Study|Participant Transferred to Another Study|197|||
160480975|NCT03906240|579488114|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
160604231|NCT00249795|579928819|FG001|Overall Study|Other contraindicated medication|1|||
160480976|NCT03906240|579488115|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
160480977|NCT03906240|579488114|FG000|Overall Study|Lost to Follow-up|1|||
160480978|NCT03906240|579488115|FG001|Overall Study|Lost to Follow-up|0|||
160660673|NCT02549092|580139618|FG001|Extension/Transition Period|Adverse Event|1|||
160660674|NCT02549092|580139617|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
160660675|NCT02549092|580139618|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
160480979|NCT03906240|579488114|FG000|Overall Study|Withdrawal by Subject|0|||
160480980|NCT03906240|579488115|FG001|Overall Study|Withdrawal by Subject|1|||
160480981|NCT01426217|579488116|FG000|Overall Study|lost sample|8|||
160480982|NCT01426217|579488117|FG001|Overall Study|lost sample|14|||
160480983|NCT05216835|579488118|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
160480984|NCT05216835|579488119|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
160480985|NCT05216835|579488120|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
160480986|NCT05216835|579488121|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
160480987|NCT05216835|579488122|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
160480988|NCT05216835|579488123|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
160480989|NCT05216835|579488124|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
160480990|NCT05216835|579488125|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
160480991|NCT05216835|579488118|FG000|Overall Study|Death|0|||
160480992|NCT05216835|579488119|FG001|Overall Study|Death|0|||
160480993|NCT05216835|579488120|FG002|Overall Study|Death|0|||
160480994|NCT05216835|579488121|FG003|Overall Study|Death|1|||
160480995|NCT05216835|579488122|FG004|Overall Study|Death|1|||
160480996|NCT05216835|579488123|FG005|Overall Study|Death|1|||
160480997|NCT05216835|579488124|FG006|Overall Study|Death|1|||
160480998|NCT05216835|579488125|FG007|Overall Study|Death|1|||
160480999|NCT05216835|579488118|FG000|Overall Study|Physician Decision|0|||
160481000|NCT05216835|579488119|FG001|Overall Study|Physician Decision|0|||
160481001|NCT05216835|579488120|FG002|Overall Study|Physician Decision|0|||
160481002|NCT05216835|579488121|FG003|Overall Study|Physician Decision|0|||
160481003|NCT05216835|579488122|FG004|Overall Study|Physician Decision|0|||
160481004|NCT05216835|579488123|FG005|Overall Study|Physician Decision|1|||
160481005|NCT05216835|579488124|FG006|Overall Study|Physician Decision|1|||
160481006|NCT05216835|579488125|FG007|Overall Study|Physician Decision|0|||
160481007|NCT05216835|579488118|FG000|Overall Study|Study terminated by Sponsor|0|||
160481008|NCT05216835|579488119|FG001|Overall Study|Study terminated by Sponsor|0|||
160481009|NCT05216835|579488120|FG002|Overall Study|Study terminated by Sponsor|0|||
160481010|NCT05216835|579488121|FG003|Overall Study|Study terminated by Sponsor|0|||
160481011|NCT05216835|579488122|FG004|Overall Study|Study terminated by Sponsor|0|||
160481012|NCT05216835|579488123|FG005|Overall Study|Study terminated by Sponsor|0|||
160481013|NCT05216835|579488124|FG006|Overall Study|Study terminated by Sponsor|0|||
160481014|NCT05216835|579488125|FG007|Overall Study|Study terminated by Sponsor|1|||
160481015|NCT05216835|579488118|FG000|Overall Study|Withdrawal by Subject|1|||
160481016|NCT05216835|579488119|FG001|Overall Study|Withdrawal by Subject|0|||
160481017|NCT05216835|579488120|FG002|Overall Study|Withdrawal by Subject|1|||
160481018|NCT05216835|579488121|FG003|Overall Study|Withdrawal by Subject|0|||
160481019|NCT05216835|579488122|FG004|Overall Study|Withdrawal by Subject|1|||
160481020|NCT05216835|579488123|FG005|Overall Study|Withdrawal by Subject|0|||
160481021|NCT05216835|579488124|FG006|Overall Study|Withdrawal by Subject|0|||
160481022|NCT05216835|579488125|FG007|Overall Study|Withdrawal by Subject|1|||
160481023|NCT05216835|579488118|FG000|Overall Study|Other|0|||
160481024|NCT05216835|579488119|FG001|Overall Study|Other|1|||
160481025|NCT05216835|579488120|FG002|Overall Study|Other|0|||
160481026|NCT05216835|579488121|FG003|Overall Study|Other|0|||
160481027|NCT05216835|579488122|FG004|Overall Study|Other|0|||
160481028|NCT05216835|579488123|FG005|Overall Study|Other|0|||
160481029|NCT05216835|579488124|FG006|Overall Study|Other|0|||
160481030|NCT05216835|579488125|FG007|Overall Study|Other|0|||
160481031|NCT01075815|579488126|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
160481032|NCT01075815|579488127|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
160481033|NCT01075815|579488126|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
160481034|NCT01075815|579488127|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
160481035|NCT01075815|579488126|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
160481036|NCT01075815|579488127|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
160481037|NCT00617708|579488128|FG000|Overall Study|Adverse Event|0|||
160481038|NCT00617708|579488129|FG001|Overall Study|Adverse Event|6|||
160481039|NCT00617708|579488130|FG002|Overall Study|Adverse Event|9|||
160481040|NCT00617708|579488128|FG000|Overall Study|Withdrawal by Subject|1|||
160481041|NCT00617708|579488129|FG001|Overall Study|Withdrawal by Subject|1|||
160481042|NCT00617708|579488130|FG002|Overall Study|Withdrawal by Subject|7|||
160481043|NCT00617708|579488128|FG000|Overall Study|Death|0|||
160481044|NCT00617708|579488129|FG001|Overall Study|Death|6|||
160481045|NCT00617708|579488130|FG002|Overall Study|Death|5|||
160481046|NCT00617708|579488128|FG000|Overall Study|Progression/Relapse|7|||
160481047|NCT00617708|579488129|FG001|Overall Study|Progression/Relapse|40|||
160481048|NCT00617708|579488130|FG002|Overall Study|Progression/Relapse|36|||
160481049|NCT00617708|579488128|FG000|Overall Study|Not protocol specified|1|||
160481050|NCT00617708|579488129|FG001|Overall Study|Not protocol specified|4|||
160481051|NCT00617708|579488130|FG002|Overall Study|Not protocol specified|2|||
160481052|NCT00617708|579488128|FG000|Overall Study|Not eligible|1|||
160481053|NCT00617708|579488129|FG001|Overall Study|Not eligible|3|||
160604232|NCT00249795|579928818|FG000|Overall Study|Event related to cardiac condition|17|||
160604233|NCT00249795|579928819|FG001|Overall Study|Event related to cardiac condition|16|||
160604234|NCT00249795|579928818|FG000|Overall Study|Patient not wish to continue after May08|4|||
160604235|NCT00249795|579928819|FG001|Overall Study|Patient not wish to continue after May08|6|||
160604236|NCT00249795|579928818|FG000|Overall Study|Site not agree to continue after May08|1|||
160604237|NCT00249795|579928819|FG001|Overall Study|Site not agree to continue after May08|1|||
160604238|NCT00249795|579928818|FG000|Overall Study|Lost to Follow-up|0|||
160604239|NCT00249795|579928819|FG001|Overall Study|Lost to Follow-up|2|||
160604240|NCT00249795|579928818|FG000|Overall Study|Missing|0|||
160660676|NCT02549092|580139617|FG000|Extension/Transition Period|Other, Not Specified|4|||
160481054|NCT00617708|579488130|FG002|Overall Study|Not eligible|5|||
160481055|NCT02991456|579488131|FG000|Overall Study|Adverse Event|2|||
160481056|NCT02991456|579488132|FG001|Overall Study|Adverse Event|0|||
160481057|NCT02991456|579488131|FG000|Overall Study|Lost to Follow-up|0|||
160481058|NCT02991456|579488132|FG001|Overall Study|Lost to Follow-up|2|||
160481059|NCT02991456|579488131|FG000|Overall Study|Withdrawal by Subject|1|||
160481060|NCT02991456|579488132|FG001|Overall Study|Withdrawal by Subject|0|||
160481061|NCT02924051|579488135|FG000|Overall Study|Withdrawal by Subject|1|||
160481062|NCT02924051|579488136|FG001|Overall Study|Withdrawal by Subject|9|||
160481063|NCT02130401|579488137|FG000|Overall Study|Poor enrollment|6|||
160481064|NCT03953079|579488138|FG000|Core Study|Withdrawal by Subject|1|||
160481065|NCT03953079|579488139|FG001|Core Study|Withdrawal by Subject|2|||
160481066|NCT03953079|579488140|FG002|Core Study|Withdrawal by Subject|1|||
160481067|NCT03953079|579488138|FG000|Core Study|COVID-19|0|||
160481068|NCT03953079|579488139|FG001|Core Study|COVID-19|1|||
160481069|NCT03953079|579488140|FG002|Core Study|COVID-19|0|||
160481070|NCT03953079|579488138|FG000|Core Study|Difficulties leaving the house|0|||
160481071|NCT03953079|579488139|FG001|Core Study|Difficulties leaving the house|1|||
160481072|NCT03953079|579488140|FG002|Core Study|Difficulties leaving the house|0|||
160481073|NCT03953079|579488138|FG000|Extension Study|Withdrawal by Subject|1|||
160481074|NCT03953079|579488139|FG001|Extension Study|Withdrawal by Subject|0|||
160481075|NCT03953079|579488140|FG002|Extension Study|Withdrawal by Subject|0|||
160481076|NCT03953079|579488138|FG000|Extension Study|Received Rescue Treatment|5|||
160481077|NCT03953079|579488139|FG001|Extension Study|Received Rescue Treatment|6|||
160481078|NCT03953079|579488140|FG002|Extension Study|Received Rescue Treatment|5|||
160481079|NCT00936065|579488141|FG000|Overall Study|Adverse Event|1|||
160481080|NCT00936065|579488142|FG001|Overall Study|Adverse Event|0|||
160481081|NCT00936065|579488143|FG002|Overall Study|Adverse Event|1|||
160481082|NCT00936065|579488141|FG000|Overall Study|Lack of Efficacy|1|||
160481083|NCT00936065|579488142|FG001|Overall Study|Lack of Efficacy|0|||
160481084|NCT00936065|579488143|FG002|Overall Study|Lack of Efficacy|1|||
160481085|NCT00936065|579488141|FG000|Overall Study|Lost to Follow-up|1|||
160481086|NCT00936065|579488142|FG001|Overall Study|Lost to Follow-up|0|||
160481087|NCT00936065|579488143|FG002|Overall Study|Lost to Follow-up|0|||
160481088|NCT00936065|579488141|FG000|Overall Study|Protocol Violation|1|||
160481089|NCT00936065|579488142|FG001|Overall Study|Protocol Violation|2|||
160481090|NCT00936065|579488143|FG002|Overall Study|Protocol Violation|1|||
160481091|NCT00936065|579488141|FG000|Overall Study|Withdrawal by Subject|0|||
160481092|NCT00936065|579488142|FG001|Overall Study|Withdrawal by Subject|2|||
160481093|NCT00936065|579488143|FG002|Overall Study|Withdrawal by Subject|4|||
160481094|NCT02819141|579488149|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
160481095|NCT02819141|579488150|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
160481096|NCT01002547|579489600|FG000|Overall Study|Withdrawal by Subject|4|||
160481097|NCT01002547|579489601|FG001|Overall Study|Withdrawal by Subject|0|||
160481098|NCT01002547|579489602|FG002|Overall Study|Withdrawal by Subject|5|||
160481099|NCT01002547|579489600|FG000|Overall Study|Lost to Follow-up|2|||
160481100|NCT01002547|579489601|FG001|Overall Study|Lost to Follow-up|1|||
160481101|NCT01002547|579489602|FG002|Overall Study|Lost to Follow-up|1|||
160481102|NCT01002547|579489600|FG000|Overall Study|Physician Decision|1|||
160481103|NCT01002547|579489601|FG001|Overall Study|Physician Decision|0|||
160481104|NCT01002547|579489602|FG002|Overall Study|Physician Decision|0|||
160481105|NCT01002547|579489600|FG000|Overall Study|Death|0|||
160481106|NCT01002547|579489601|FG001|Overall Study|Death|2|||
160481107|NCT01002547|579489602|FG002|Overall Study|Death|2|||
160481108|NCT01002547|579489600|FG000|Overall Study|Adverse Event|1|||
160481109|NCT01002547|579489601|FG001|Overall Study|Adverse Event|0|||
160481110|NCT01002547|579489602|FG002|Overall Study|Adverse Event|0|||
160481111|NCT01184859|579489610|FG000|Period 1: Single Dose|Insufficient urine production|0|||
160481112|NCT01184859|579489611|FG001|Period 1: Single Dose|Insufficient urine production|1|||
160481113|NCT01184859|579489612|FG002|Period 1: Single Dose|Insufficient urine production|0|||
160481114|NCT01184859|579489613|FG003|Period 1: Single Dose|Insufficient urine production|0|||
160481115|NCT01184859|579489614|FG004|Period 1: Single Dose|Insufficient urine production|0|||
160481116|NCT01184859|579489610|FG000|Period 1: Single Dose|Protocol Violation|0|||
160481117|NCT01184859|579489611|FG001|Period 1: Single Dose|Protocol Violation|1|||
160481118|NCT01184859|579489612|FG002|Period 1: Single Dose|Protocol Violation|0|||
160481119|NCT01184859|579489613|FG003|Period 1: Single Dose|Protocol Violation|0|||
160481120|NCT01184859|579489614|FG004|Period 1: Single Dose|Protocol Violation|0|||
160481121|NCT01184859|579489610|FG000|Period 1: Single Dose|Adverse Event|0|||
160481122|NCT01184859|579489611|FG001|Period 1: Single Dose|Adverse Event|0|||
160481123|NCT01184859|579489612|FG002|Period 1: Single Dose|Adverse Event|0|||
160481124|NCT01184859|579489613|FG003|Period 1: Single Dose|Adverse Event|0|||
160481125|NCT01184859|579489614|FG004|Period 1: Single Dose|Adverse Event|1|||
160481126|NCT01184859|579489610|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
160481127|NCT01184859|579489611|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
160481128|NCT01184859|579489612|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
160481129|NCT01184859|579489613|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
160604241|NCT00249795|579928819|FG001|Overall Study|Missing|1|||
160481130|NCT01184859|579489614|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
160481131|NCT01184859|579489610|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
160481132|NCT01184859|579489611|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
160481133|NCT01184859|579489612|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
160481134|NCT01184859|579489613|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
160481135|NCT01184859|579489614|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
160481136|NCT00958711|579489624|FG000|Overall Study|Withdrawal by Subject|0|||
160481137|NCT00958711|579489625|FG001|Overall Study|Withdrawal by Subject|4|||
160481138|NCT00958711|579489624|FG000|Overall Study|Physician Decision|5|||
160481139|NCT00958711|579489625|FG001|Overall Study|Physician Decision|7|||
160481140|NCT00958711|579489624|FG000|Overall Study|Lost to Follow-up|4|||
160481141|NCT00958711|579489625|FG001|Overall Study|Lost to Follow-up|1|||
160481142|NCT00958711|579489624|FG000|Overall Study|Other|2|||
160481143|NCT00958711|579489625|FG001|Overall Study|Other|5|||
160481144|NCT00958711|579489624|FG000|Overall Study|Death|1|||
160481145|NCT00958711|579489625|FG001|Overall Study|Death|2|||
160481146|NCT00958711|579489624|FG000|Overall Study|Adverse Event|1|||
160481147|NCT00958711|579489625|FG001|Overall Study|Adverse Event|2|||
160481148|NCT03722485|579489626|FG000|Overall Study|Withdrawal by Subject|1|||
160481149|NCT03722485|579489627|FG001|Overall Study|Withdrawal by Subject|0|||
160481150|NCT03722485|579489626|FG000|Overall Study|Adverse Event|0|||
160481151|NCT03722485|579489627|FG001|Overall Study|Adverse Event|2|||
160481152|NCT03722485|579489626|FG000|Overall Study|subject discharged prior to study completion|1|||
160481153|NCT03722485|579489627|FG001|Overall Study|subject discharged prior to study completion|5|||
160481154|NCT03722485|579489626|FG000|Overall Study|eligibility criteria not met|2|||
160481155|NCT03722485|579489627|FG001|Overall Study|eligibility criteria not met|0|||
160481156|NCT02151643|579489630|FG000|Overall Study|Adverse Event|2|||
160481157|NCT02151643|579489631|FG001|Overall Study|Adverse Event|0|||
160481158|NCT02151643|579489632|FG002|Overall Study|Adverse Event|1|||
160481159|NCT02151643|579489633|FG003|Overall Study|Adverse Event|4|||
160481160|NCT02151643|579489634|FG004|Overall Study|Adverse Event|0|||
160481161|NCT02151643|579489630|FG000|Overall Study|Withdrawal by Subject|0|||
160481162|NCT02151643|579489631|FG001|Overall Study|Withdrawal by Subject|1|||
160481163|NCT02151643|579489632|FG002|Overall Study|Withdrawal by Subject|1|||
160481164|NCT02151643|579489633|FG003|Overall Study|Withdrawal by Subject|1|||
160481165|NCT02151643|579489634|FG004|Overall Study|Withdrawal by Subject|1|||
160481166|NCT02151643|579489630|FG000|Overall Study|Hyperphosphataemia|1|||
160481167|NCT02151643|579489631|FG001|Overall Study|Hyperphosphataemia|0|||
160481168|NCT02151643|579489632|FG002|Overall Study|Hyperphosphataemia|0|||
160481169|NCT02151643|579489633|FG003|Overall Study|Hyperphosphataemia|0|||
160481170|NCT02151643|579489634|FG004|Overall Study|Hyperphosphataemia|1|||
160481171|NCT02151643|579489630|FG000|Overall Study|High Ferritin levels|3|||
160481172|NCT02151643|579489631|FG001|Overall Study|High Ferritin levels|3|||
160481173|NCT02151643|579489632|FG002|Overall Study|High Ferritin levels|2|||
160481174|NCT02151643|579489633|FG003|Overall Study|High Ferritin levels|2|||
160481175|NCT02151643|579489634|FG004|Overall Study|High Ferritin levels|1|||
160481176|NCT03087851|579489635|FG000|Overall Study|Withdraw on medical grounds|0|||
160481177|NCT03087851|579489636|FG001|Overall Study|Withdraw on medical grounds|1|||
160481178|NCT03087851|579489637|FG002|Overall Study|Withdraw on medical grounds|2|||
160481179|NCT00644332|579489638|FG000|Overall Study|Adverse Event|11|||
160481180|NCT00644332|579489638|FG000|Overall Study|Withdrawal by Subject|6|||
160481181|NCT00644332|579489638|FG000|Overall Study|Completion Status Unknown|2|||
160481182|NCT00644332|579489638|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
160481183|NCT00644332|579489638|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
160481184|NCT03694210|579489639|FG000|Overall Study|Death|1|||
160481185|NCT03694210|579489639|FG000|Overall Study|Screen Failure|7|||
160481186|NCT03050372|579489640|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
160481187|NCT03050372|579489641|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
160481188|NCT03050372|579489640|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
160481189|NCT03050372|579489641|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
160481190|NCT00443755|579489646|FG000|Overall Study|Withdrawal by Subject|2|||
160481191|NCT00443755|579489647|FG001|Overall Study|Withdrawal by Subject|1|||
160481192|NCT02775214|579489648|FG000|Overall Study|Withdrawal by Subject|2|||
160481193|NCT02775214|579489649|FG001|Overall Study|Withdrawal by Subject|0|||
160481194|NCT02706834|579489650|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160481195|NCT02706834|579489651|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
160481196|NCT02706834|579489652|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
160481197|NCT02706834|579489653|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
160481198|NCT02706834|579489654|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
160481199|NCT02706834|579489655|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
160481200|NCT02706834|579489656|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
160481201|NCT02706834|579489657|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
160481202|NCT02706834|579489658|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
160481203|NCT02706834|579489659|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
160481204|NCT02706834|579489660|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
160604242|NCT01203787|579928824|FG000|Overall Study|Death|12|||
160481205|NCT02706834|579489650|FG000|Overall Study|Lost to Follow-up|0|||
160481206|NCT02706834|579489651|FG001|Overall Study|Lost to Follow-up|0|||
160481207|NCT02706834|579489652|FG002|Overall Study|Lost to Follow-up|1|||
160481208|NCT02706834|579489653|FG003|Overall Study|Lost to Follow-up|0|||
160481209|NCT02706834|579489654|FG004|Overall Study|Lost to Follow-up|0|||
160481210|NCT02706834|579489655|FG005|Overall Study|Lost to Follow-up|0|||
160481211|NCT02706834|579489656|FG006|Overall Study|Lost to Follow-up|0|||
160481212|NCT02706834|579489657|FG007|Overall Study|Lost to Follow-up|0|||
160481213|NCT02706834|579489658|FG008|Overall Study|Lost to Follow-up|0|||
160481214|NCT02706834|579489659|FG009|Overall Study|Lost to Follow-up|0|||
160481215|NCT02706834|579489660|FG010|Overall Study|Lost to Follow-up|0|||
160481216|NCT02706834|579489650|FG000|Overall Study|Voluntary Withdrawal|1|||
160481217|NCT02706834|579489651|FG001|Overall Study|Voluntary Withdrawal|0|||
160481218|NCT02706834|579489652|FG002|Overall Study|Voluntary Withdrawal|0|||
160481219|NCT02706834|579489653|FG003|Overall Study|Voluntary Withdrawal|0|||
160481220|NCT02706834|579489654|FG004|Overall Study|Voluntary Withdrawal|0|||
160481221|NCT02706834|579489655|FG005|Overall Study|Voluntary Withdrawal|0|||
160481222|NCT02706834|579489656|FG006|Overall Study|Voluntary Withdrawal|0|||
160481223|NCT02706834|579489657|FG007|Overall Study|Voluntary Withdrawal|0|||
160481224|NCT02706834|579489658|FG008|Overall Study|Voluntary Withdrawal|0|||
160481225|NCT02706834|579489659|FG009|Overall Study|Voluntary Withdrawal|1|||
160481226|NCT02706834|579489660|FG010|Overall Study|Voluntary Withdrawal|0|||
160481227|NCT02706834|579489650|FG000|Overall Study|Other Reason Not Specified|1|||
160481228|NCT02706834|579489651|FG001|Overall Study|Other Reason Not Specified|0|||
160481229|NCT02706834|579489652|FG002|Overall Study|Other Reason Not Specified|0|||
160481230|NCT02706834|579489653|FG003|Overall Study|Other Reason Not Specified|0|||
160481231|NCT02706834|579489654|FG004|Overall Study|Other Reason Not Specified|1|||
160481232|NCT02706834|579489655|FG005|Overall Study|Other Reason Not Specified|0|||
160481233|NCT02706834|579489656|FG006|Overall Study|Other Reason Not Specified|0|||
160481234|NCT02706834|579489657|FG007|Overall Study|Other Reason Not Specified|0|||
160481235|NCT02706834|579489658|FG008|Overall Study|Other Reason Not Specified|0|||
160481236|NCT02706834|579489659|FG009|Overall Study|Other Reason Not Specified|0|||
160481237|NCT02706834|579489660|FG010|Overall Study|Other Reason Not Specified|0|||
160481238|NCT00678899|579489661|FG000|Overall Study|Adverse Event|1|||
160481239|NCT01107353|579489667|FG000|Overall Study|Positive Drug Screen|1|||
160481240|NCT01107353|579489668|FG001|Overall Study|Positive Drug Screen|0|||
160481241|NCT02798861|579489671|FG000|Overall Study|Lost to Follow-up|22|||
160481242|NCT02798861|579489671|FG000|Overall Study|Withdrawal by Subject|1|||
160481243|NCT03647709|579489697|FG000|Overall Study|Lost to Follow-up|5|||
160481244|NCT03647709|579489697|FG000|Overall Study|Physician Decision|6|||
160481245|NCT03647709|579489697|FG000|Overall Study|Withdrawal by Subject|3|||
160481246|NCT05287178|579489698|FG000|Overall Study|Lost to Follow-up|2|||
160481247|NCT01920178|579489699|FG000|Overall Study|Lost to Follow-up|2|||
160481248|NCT01920178|579489700|FG001|Overall Study|Lost to Follow-up|1|||
160481249|NCT03023878|579489701|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
160481250|NCT03023878|579489701|FG000|Pre-Study Run-In Period|Death|1|||
160481251|NCT03023878|579489701|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
160481252|NCT03023878|579489701|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
160481253|NCT03023878|579489701|FG000|Treatment Period|Disease Progression|1|||
160481254|NCT03023878|579489701|FG000|Treatment Period|Withdrawal by Subject|1|||
160481255|NCT03023878|579489701|FG000|Treatment Period|Adverse Event|1|||
160481256|NCT03023878|579489701|FG000|Long Term Follow-Up Period|Death|2|||
160481257|NCT01812837|579489702|FG000|Overall Study|Lost to Follow-up|1|||
160481258|NCT01812837|579489703|FG001|Overall Study|Lost to Follow-up|1|||
160481259|NCT01812837|579489704|FG002|Overall Study|Lost to Follow-up|0|||
160481260|NCT01812837|579489702|FG000|Overall Study|Protocol Violation|1|||
160481261|NCT01812837|579489703|FG001|Overall Study|Protocol Violation|0|||
160481262|NCT01812837|579489704|FG002|Overall Study|Protocol Violation|0|||
160481263|NCT00288353|579489709|FG000|Overall Study|Lack of Efficacy|2|||
160481264|NCT00288353|579489710|FG001|Overall Study|Lack of Efficacy|2|||
160604243|NCT01203787|579928825|FG001|Overall Study|Death|10|||
160481265|NCT00288353|579489709|FG000|Overall Study|Withdrawal by Subject|5|||
160481266|NCT00288353|579489710|FG001|Overall Study|Withdrawal by Subject|5|||
160481267|NCT05234632|579489711|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
160481268|NCT05234632|579489712|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
160481269|NCT05234632|579489711|FG000|Overall Study|Withdrawal by Subject|2|||
160481270|NCT05234632|579489712|FG001|Overall Study|Withdrawal by Subject|0|||
160481271|NCT05234632|579489711|FG000|Overall Study|Adverse Event|0|||
160481272|NCT05234632|579489712|FG001|Overall Study|Adverse Event|4|||
160481273|NCT05234632|579489711|FG000|Overall Study|Physician Decision|1|||
160481274|NCT05234632|579489712|FG001|Overall Study|Physician Decision|1|||
160481275|NCT05234632|579489711|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
160481276|NCT05234632|579489712|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
160481277|NCT05234632|579489711|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
160481278|NCT05234632|579489712|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
160604244|NCT01203787|579928824|FG000|Overall Study|Withdrawal by Subject|6|||
160604245|NCT01203787|579928825|FG001|Overall Study|Withdrawal by Subject|2|||
160481279|NCT04799587|579489713|FG000|Overall Study|Withdrawal by Subject|0|||
160481280|NCT04799587|579489714|FG001|Overall Study|Withdrawal by Subject|1|||
160481281|NCT00728884|579489715|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
160481282|NCT00728884|579489715|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
160481283|NCT02849509|579489717|FG000|Overall Study|Worsening of disease under study|1|||
160481284|NCT02849509|579489718|FG001|Overall Study|Worsening of disease under study|1|||
160481285|NCT02849509|579489719|FG002|Overall Study|Worsening of disease under study|1|||
160481286|NCT02849509|579489717|FG000|Overall Study|Worsening of other pre-existing disease|0|||
160481287|NCT02849509|579489718|FG001|Overall Study|Worsening of other pre-existing disease|1|||
160481288|NCT02849509|579489719|FG002|Overall Study|Worsening of other pre-existing disease|2|||
160481289|NCT02849509|579489717|FG000|Overall Study|Other adverse event|36|||
160481290|NCT02849509|579489718|FG001|Overall Study|Other adverse event|41|||
160481291|NCT02849509|579489719|FG002|Overall Study|Other adverse event|8|||
160481292|NCT02849509|579489717|FG000|Overall Study|Withdrawal by Subject|6|||
160481293|NCT02849509|579489718|FG001|Overall Study|Withdrawal by Subject|17|||
160481294|NCT02849509|579489719|FG002|Overall Study|Withdrawal by Subject|12|||
160481295|NCT02849509|579489717|FG000|Overall Study|Lost to Follow-up|27|||
160481296|NCT02849509|579489718|FG001|Overall Study|Lost to Follow-up|67|||
160481297|NCT02849509|579489719|FG002|Overall Study|Lost to Follow-up|36|||
160481298|NCT02849509|579489717|FG000|Overall Study|Other, reason not specified|14|||
160481299|NCT02849509|579489718|FG001|Overall Study|Other, reason not specified|29|||
160481300|NCT02849509|579489719|FG002|Overall Study|Other, reason not specified|25|||
160481301|NCT02849509|579489717|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
160481302|NCT02849509|579489718|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
160481303|NCT02849509|579489719|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
160481304|NCT02374476|579489728|FG000|VT Induced Ablation|Screening Failures|36|||
160481305|NCT02374476|579489729|FG001|VT Induced Ablation|Screening Failures|0|||
160481306|NCT02374476|579489730|FG002|VT Induced Ablation|Screening Failures|0|||
160481307|NCT02374476|579489728|FG000|Arm Assignment|Withdrawal by Subject|0|||
160481308|NCT02374476|579489729|FG001|Arm Assignment|Withdrawal by Subject|0|||
160481309|NCT02374476|579489730|FG002|Arm Assignment|Withdrawal by Subject|1|||
160481310|NCT05431543|579489735|FG000|Overall Study|Medical History|1|||
160481311|NCT05431543|579489736|FG001|Overall Study|Medical History|0|||
160481312|NCT05431543|579489737|FG002|Overall Study|Medical History|0|||
160481313|NCT02784535|579489738|FG000|Overall Study|Adverse Event|1|||
160481314|NCT02784535|579489739|FG001|Overall Study|Adverse Event|0|||
160481315|NCT02784535|579489738|FG000|Overall Study|Withdrawal by Subject|0|||
160481316|NCT02784535|579489739|FG001|Overall Study|Withdrawal by Subject|1|||
160481317|NCT02784535|579489738|FG000|Overall Study|Physician Decision|0|||
160481318|NCT02784535|579489739|FG001|Overall Study|Physician Decision|1|||
160481319|NCT00914732|579489743|FG000|Overall Study|Lost to Follow-up|6|||
160481320|NCT00914732|579489744|FG001|Overall Study|Lost to Follow-up|7|||
160481321|NCT00914732|579489745|FG002|Overall Study|Lost to Follow-up|9|||
160481322|NCT00914732|579489743|FG000|Overall Study|Withdrawal by Subject|3|||
160481323|NCT00914732|579489744|FG001|Overall Study|Withdrawal by Subject|0|||
160481324|NCT00914732|579489745|FG002|Overall Study|Withdrawal by Subject|2|||
160481325|NCT00914732|579489743|FG000|Overall Study|Adverse Event|1|||
160481326|NCT00914732|579489744|FG001|Overall Study|Adverse Event|0|||
160481327|NCT00914732|579489745|FG002|Overall Study|Adverse Event|0|||
160481328|NCT05615870|579489746|FG000|Overall Study|Lost to Follow-up|10|||
160481329|NCT05615870|579489747|FG001|Overall Study|Lost to Follow-up|13|||
160481330|NCT05615870|579489746|FG000|Overall Study|Physician Decision|2|||
160481331|NCT05615870|579489747|FG001|Overall Study|Physician Decision|0|||
160481332|NCT05615870|579489746|FG000|Overall Study|Withdrawal by Subject|0|||
160481333|NCT05615870|579489747|FG001|Overall Study|Withdrawal by Subject|2|||
160481334|NCT05615870|579489746|FG000|Overall Study|Protocol Violation|0|||
160481335|NCT05615870|579489747|FG001|Overall Study|Protocol Violation|3|||
160481336|NCT05615870|579489746|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
160481337|NCT05615870|579489747|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
160481338|NCT05615870|579489746|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
160481339|NCT05615870|579489747|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
160481340|NCT05615870|579489746|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
160481341|NCT05615870|579489747|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
160481342|NCT00145496|579489750|FG000|Overall Study|Adverse Event|42|||
160481343|NCT00145496|579489751|FG001|Overall Study|Adverse Event|30|||
160481344|NCT00145496|579489750|FG000|Overall Study|Lack of Efficacy|12|||
160481345|NCT00145496|579489751|FG001|Overall Study|Lack of Efficacy|7|||
160481346|NCT00145496|579489750|FG000|Overall Study|Withdrawal by Subject|32|||
160481347|NCT00145496|579489751|FG001|Overall Study|Withdrawal by Subject|26|||
160481348|NCT00145496|579489750|FG000|Overall Study|Lost to Follow-up|12|||
160481349|NCT00145496|579489751|FG001|Overall Study|Lost to Follow-up|5|||
160481350|NCT00145496|579489750|FG000|Overall Study|Other|25|||
160481351|NCT00145496|579489751|FG001|Overall Study|Other|13|||
160481352|NCT01334606|579489754|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
160481353|NCT00990314|579489755|FG000|Overall Study|Death|2|||
160481354|NCT00990314|579489755|FG000|Overall Study|Adverse Event|2|||
160481355|NCT00990314|579489755|FG000|Overall Study|Withdrawal by Subject|3|||
160481356|NCT00990314|579489755|FG000|Overall Study|Non-Compliance|1|||
160481357|NCT00990314|579489755|FG000|Overall Study|Physician Decision|3|||
160481358|NCT00990314|579489755|FG000|Overall Study|Lack of Efficacy|1|||
160481359|NCT02676778|579489756|FG000|Overall Study|Disease Progression|7|||
160481360|NCT02676778|579489757|FG001|Overall Study|Disease Progression|3|||
160481361|NCT02676778|579489758|FG002|Overall Study|Disease Progression|1|||
160481362|NCT02676778|579489756|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
160481363|NCT02676778|579489757|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
160481364|NCT02676778|579489758|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
160481365|NCT02676778|579489756|FG000|Overall Study|Withdrawal by Subject|3|||
160481366|NCT02676778|579489757|FG001|Overall Study|Withdrawal by Subject|2|||
160481367|NCT02676778|579489758|FG002|Overall Study|Withdrawal by Subject|0|||
160481368|NCT02676778|579489756|FG000|Overall Study|Other|4|||
160481369|NCT02676778|579489757|FG001|Overall Study|Other|3|||
160481370|NCT02676778|579489758|FG002|Overall Study|Other|0|||
160481371|NCT02676778|579489756|FG000|Overall Study|Adverse Event|2|||
160481372|NCT02676778|579489757|FG001|Overall Study|Adverse Event|3|||
160481373|NCT02676778|579489758|FG002|Overall Study|Adverse Event|0|||
160481374|NCT03686176|579489763|FG000|Overall Study|Procedure cancelled|1|||
160481375|NCT03686176|579489764|FG001|Overall Study|Procedure cancelled|0|||
160481376|NCT03686176|579489765|FG002|Overall Study|Procedure cancelled|0|||
160481377|NCT03686176|579489763|FG000|Overall Study|VR Malfunction|1|||
160481378|NCT03686176|579489764|FG001|Overall Study|VR Malfunction|0|||
160481379|NCT03686176|579489765|FG002|Overall Study|VR Malfunction|0|||
160604246|NCT01203787|579928824|FG000|Overall Study|Lost to Follow-up|2|||
160604247|NCT01203787|579928825|FG001|Overall Study|Lost to Follow-up|0|||
160604248|NCT01203787|579928824|FG000|Overall Study|Adverse Event|11|||
160604249|NCT01203787|579928825|FG001|Overall Study|Adverse Event|15|||
160604250|NCT03032510|579928826|FG000|Overall Study|Adverse Event|5|||
160604251|NCT03032510|579928827|FG001|Overall Study|Adverse Event|2|||
160604252|NCT03032510|579928826|FG000|Overall Study|Lost to Follow-up|8|||
160604253|NCT03032510|579928827|FG001|Overall Study|Lost to Follow-up|7|||
160604254|NCT03032510|579928826|FG000|Overall Study|Withdrawal by Subject|8|||
160604255|NCT03032510|579928827|FG001|Overall Study|Withdrawal by Subject|7|||
160604256|NCT03032510|579928826|FG000|Overall Study|Subject noncompliance|4|||
160604257|NCT03032510|579928827|FG001|Overall Study|Subject noncompliance|2|||
160604258|NCT03032510|579928826|FG000|Overall Study|Physician Decision|2|||
160604259|NCT03032510|579928827|FG001|Overall Study|Physician Decision|0|||
160604260|NCT01601470|579928828|FG000|Period 2 - LCZ696|Physician Decision|1|||
160604261|NCT00431496|579928831|FG000|Overall Study|Adverse Event|3|||
160604262|NCT00431496|579928831|FG000|Overall Study|Lost to Follow-up|1|||
160604263|NCT00431496|579928831|FG000|Overall Study|Withdrawal by Subject|2|||
160604264|NCT00431496|579928831|FG000|Overall Study|Protocol-specified criteria|5|||
160604265|NCT04018612|579928832|FG000|Overall Study|Withdrawal by Subject|1|||
160604266|NCT04018612|579928833|FG001|Overall Study|Withdrawal by Subject|0|||
160604267|NCT04018612|579928834|FG002|Overall Study|Withdrawal by Subject|1|||
160604268|NCT02343952|579928835|FG000|Study Treatment|Disease Progression|23|||
160604269|NCT02343952|579928835|FG000|Study Treatment|Death|3|||
160604270|NCT02343952|579928835|FG000|Study Treatment|Adverse Event|19|||
160604271|NCT02343952|579928835|FG000|Study Treatment|Withdrawal by Subject|7|||
160604272|NCT02343952|579928835|FG000|Study Treatment|other complicating Diseases|1|||
160604273|NCT02343952|579928835|FG000|Follow up|Withdrawal by Subject|3|||
160604274|NCT02343952|579928835|FG000|Follow up|Death|33|||
160604275|NCT02343952|579928835|FG000|Follow up|Patient does not meet eligibility for study.|1|||
160604276|NCT02343952|579928835|FG000|Follow up|Research department closed by the practice.|5|||
160604277|NCT02343952|579928835|FG000|Follow up|Patient went home to Russia|1|||
160604278|NCT02343952|579928835|FG000|Follow up|Disease Progression|1|||
160604279|NCT02343952|579928835|FG000|Follow up|study terminated|1|||
160604280|NCT00361218|579928836|FG000|Overall Study|Lost to Follow-up|11|||
160481380|NCT00925288|579491593|FG000|Overall Study|Lost to Follow-up|9|||
160481381|NCT00925288|579491594|FG001|Overall Study|Lost to Follow-up|7|||
160481382|NCT00434577|579491595|FG000|Months 0-3|Serious Adverse Event|0|||
160481383|NCT00434577|579491596|FG001|Months 0-3|Serious Adverse Event|0|||
160481384|NCT00434577|579491597|FG002|Months 0-3|Serious Adverse Event|1|||
160481385|NCT00434577|579491598|FG003|Months 0-3|Serious Adverse Event|0|||
160481386|NCT00434577|579491599|FG004|Months 0-3|Serious Adverse Event|0|||
160481387|NCT00434577|579491595|FG000|Months 0-3|Adverse Event|0|||
160604281|NCT00361218|579928836|FG000|Overall Study|Personal Reasons|7|||
160604282|NCT00361218|579928836|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
160604283|NCT02671760|579928837|FG000|Overall Study|Lost to Follow-up|0|||
160604284|NCT02671760|579928838|FG001|Overall Study|Lost to Follow-up|1|||
160604285|NCT02671760|579928839|FG002|Overall Study|Lost to Follow-up|0|||
160481388|NCT00434577|579491596|FG001|Months 0-3|Adverse Event|1|||
160481389|NCT00434577|579491597|FG002|Months 0-3|Adverse Event|1|||
160481390|NCT00434577|579491598|FG003|Months 0-3|Adverse Event|0|||
160481391|NCT00434577|579491599|FG004|Months 0-3|Adverse Event|0|||
160481392|NCT00434577|579491595|FG000|Months 0-3|Lost to Follow-up|0|||
160481393|NCT00434577|579491596|FG001|Months 0-3|Lost to Follow-up|0|||
160481394|NCT00434577|579491597|FG002|Months 0-3|Lost to Follow-up|0|||
160481395|NCT00434577|579491598|FG003|Months 0-3|Lost to Follow-up|0|||
160481396|NCT00434577|579491599|FG004|Months 0-3|Lost to Follow-up|2|||
160481397|NCT00434577|579491595|FG000|Months 0-3|Protocol Violation|1|||
160481398|NCT00434577|579491596|FG001|Months 0-3|Protocol Violation|0|||
160481399|NCT00434577|579491597|FG002|Months 0-3|Protocol Violation|1|||
160481400|NCT00434577|579491598|FG003|Months 0-3|Protocol Violation|0|||
160481401|NCT00434577|579491599|FG004|Months 0-3|Protocol Violation|0|||
160481402|NCT00434577|579491595|FG000|Months 0-3|Withdrawal by Subject|2|||
160481403|NCT00434577|579491596|FG001|Months 0-3|Withdrawal by Subject|1|||
160481404|NCT00434577|579491597|FG002|Months 0-3|Withdrawal by Subject|1|||
160481405|NCT00434577|579491598|FG003|Months 0-3|Withdrawal by Subject|1|||
160481406|NCT00434577|579491599|FG004|Months 0-3|Withdrawal by Subject|1|||
160481407|NCT02176356|579491603|FG000|Overall Study|Screen Failure|14|||
160481408|NCT02176356|579491603|FG000|Overall Study|Lost to Follow-up|4|||
160481409|NCT02176356|579491603|FG000|Overall Study|Personal Reasons|3|||
160481410|NCT02176356|579491603|FG000|Overall Study|Other Miscellaneous Reasons|2|||
160481411|NCT00381888|579491604|FG000|Overall Study|Death|1|||
160481412|NCT00381888|579491604|FG000|Overall Study|Withdrawal by Subject|1|||
160481413|NCT00381888|579491604|FG000|Overall Study|Physician Decision|1|||
160481414|NCT00381888|579491604|FG000|Overall Study|Protocol Violation|9|||
160481415|NCT00381888|579491604|FG000|Overall Study|Had laparoscopic surgery|2|||
160481416|NCT00381888|579491604|FG000|Overall Study|Surgery was cancelled|2|||
160481417|NCT00381888|579491604|FG000|Overall Study|Adverse Event|1|||
160481418|NCT01537120|579491608|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
160481419|NCT01537120|579491608|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
160481420|NCT02543294|579491610|FG000|Overall Study|Lost to Follow-up|3|||
160481421|NCT02543294|579491610|FG000|Overall Study|Physician Decision|2|||
160481422|NCT02543294|579491610|FG000|Overall Study|Withdrawal by Subject|7|||
160481423|NCT02475733|579491611|FG000|Overall Study|Withdrawal by Subject|1|||
160481424|NCT02475733|579491612|FG001|Overall Study|Withdrawal by Subject|0|||
160481425|NCT02475733|579491611|FG000|Overall Study|Physician Decision|1|||
160481426|NCT02475733|579491612|FG001|Overall Study|Physician Decision|0|||
160481427|NCT02131155|579491613|FG000|Overall Study|Adverse Event|1|||
160481428|NCT02131155|579491614|FG001|Overall Study|Adverse Event|0|||
160481429|NCT02131155|579491613|FG000|Overall Study|Treatment completed|1|||
160481430|NCT02131155|579491614|FG001|Overall Study|Treatment completed|0|||
160481431|NCT02131155|579491613|FG000|Overall Study|Primary tumour recurrence|2|||
160481432|NCT02131155|579491614|FG001|Overall Study|Primary tumour recurrence|1|||
160481433|NCT02131155|579491613|FG000|Overall Study|Refused to continue study medication|1|||
160481434|NCT02131155|579491614|FG001|Overall Study|Refused to continue study medication|0|||
160481435|NCT02131155|579491613|FG000|Overall Study|Study early termination|20|||
160481436|NCT02131155|579491614|FG001|Overall Study|Study early termination|10|||
160481437|NCT01887418|579491615|FG000|Overall Study|Travelling difficulties|0|||
160481438|NCT01887418|579491616|FG001|Overall Study|Travelling difficulties|0|||
160481439|NCT01887418|579491617|FG002|Overall Study|Travelling difficulties|1|||
160481440|NCT01014013|579491618|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
160481441|NCT01014013|579491619|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
160481442|NCT01014013|579491618|FG000|Overall Study|Clinical adverse experience|4|||
160481443|NCT01014013|579491619|FG001|Overall Study|Clinical adverse experience|2|||
160481444|NCT01014013|579491618|FG000|Overall Study|Laboratory adverse experience|1|||
160481445|NCT01014013|579491619|FG001|Overall Study|Laboratory adverse experience|1|||
160481446|NCT01014013|579491618|FG000|Overall Study|Protocol Violation|1|||
160481447|NCT01014013|579491619|FG001|Overall Study|Protocol Violation|3|||
160481448|NCT01014013|579491618|FG000|Overall Study|Withdrawal by Subject|7|||
160481449|NCT01014013|579491619|FG001|Overall Study|Withdrawal by Subject|4|||
160481450|NCT01014013|579491618|FG000|Overall Study|Clinical/microbiologic failure|1|||
160481451|NCT01014013|579491619|FG001|Overall Study|Clinical/microbiologic failure|2|||
160481452|NCT01014013|579491618|FG000|Overall Study|Pathogen culture = no growth|26|||
160481453|NCT01014013|579491619|FG001|Overall Study|Pathogen culture = no growth|34|||
160481454|NCT01014013|579491618|FG000|Overall Study|Negative urine culture|2|||
160481455|NCT01014013|579491619|FG001|Overall Study|Negative urine culture|0|||
160481456|NCT01014013|579491618|FG000|Overall Study|Pathogen resistant|7|||
160481457|NCT01014013|579491619|FG001|Overall Study|Pathogen resistant|4|||
160481458|NCT01014013|579491618|FG000|Overall Study|Physician Decision|0|||
160481459|NCT01014013|579491619|FG001|Overall Study|Physician Decision|1|||
160481460|NCT01014013|579491618|FG000|Overall Study|Another antibiotic therapy required|0|||
160481461|NCT01014013|579491619|FG001|Overall Study|Another antibiotic therapy required|1|||
160481462|NCT01014013|579491618|FG000|Overall Study|Appendectomy|1|||
160481463|NCT01014013|579491619|FG001|Overall Study|Appendectomy|0|||
160481464|NCT01014013|579491618|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
160481465|NCT01014013|579491619|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
160481466|NCT00442559|579491626|FG000|Overall Study|Lost to Follow-up|32|||
160481467|NCT00442559|579491627|FG001|Overall Study|Lost to Follow-up|34|||
160481468|NCT00442559|579491626|FG000|Overall Study|Protocol Violation|1|||
160481469|NCT00442559|579491627|FG001|Overall Study|Protocol Violation|1|||
160481470|NCT00442559|579491626|FG000|Overall Study|Withdrawal by Subject|1|||
160481471|NCT00442559|579491627|FG001|Overall Study|Withdrawal by Subject|0|||
160481472|NCT02305797|579491628|FG000|Overall Study|Adverse Event|11|||
160481473|NCT02305797|579491629|FG001|Overall Study|Adverse Event|2|||
160481474|NCT02305797|579491628|FG000|Overall Study|Withdrawal by Subject|9|||
160481475|NCT02305797|579491629|FG001|Overall Study|Withdrawal by Subject|10|||
160481476|NCT02305797|579491628|FG000|Overall Study|Lack of Efficacy|6|||
160481477|NCT02305797|579491629|FG001|Overall Study|Lack of Efficacy|0|||
160481478|NCT02305797|579491628|FG000|Overall Study|Lost to Follow-up|5|||
160481479|NCT02305797|579491629|FG001|Overall Study|Lost to Follow-up|11|||
160481480|NCT02305797|579491628|FG000|Overall Study|Pregnancy|0|||
160481481|NCT02305797|579491629|FG001|Overall Study|Pregnancy|2|||
160481482|NCT02305797|579491628|FG000|Overall Study|Noncompliance|14|||
160481483|NCT02305797|579491629|FG001|Overall Study|Noncompliance|12|||
160481484|NCT02305797|579491628|FG000|Overall Study|Reason not collected|0|||
160481485|NCT02305797|579491629|FG001|Overall Study|Reason not collected|1|||
160481486|NCT03508830|579491630|FG000|Overall Study|Withdrawal by Subject|3|||
160604286|NCT02079519|579928849|FG000|Overall Study|Disease Progression|9|||
160604287|NCT02079519|579928849|FG000|Overall Study|Adverse Event|1|||
160604288|NCT01802515|579928850|FG000|Overall Study|Withdrawal by Subject|3|||
160660677|NCT02549092|580139618|FG001|Extension/Transition Period|Other, Not Specified|2|||
160660678|NCT00910663|580139621|FG000|Period 1|Withdrawal by Subject|0|||
160660679|NCT00910663|580139622|FG001|Period 1|Withdrawal by Subject|1|||
160660680|NCT01772537|580139626|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
160660681|NCT01772537|580139627|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
160660682|NCT01772537|580139628|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
160660683|NCT01536574|580139629|FG000|Overall Study|Adverse Event|4|||
160660684|NCT01536574|580139630|FG001|Overall Study|Adverse Event|5|||
160660685|NCT01536574|580139629|FG000|Overall Study|Withdrawal by Subject|1|||
160660686|NCT01536574|580139630|FG001|Overall Study|Withdrawal by Subject|2|||
160660687|NCT01536574|580139629|FG000|Overall Study|Lack of Efficacy|1|||
160660688|NCT01536574|580139630|FG001|Overall Study|Lack of Efficacy|0|||
160604289|NCT01802515|579928851|FG001|Overall Study|Withdrawal by Subject|0|||
160660689|NCT01376167|580139631|FG000|Overall Study|Lost to Follow-up|2|||
160660690|NCT01376167|580139632|FG001|Overall Study|Lost to Follow-up|4|||
160660691|NCT01376167|580139633|FG002|Overall Study|Lost to Follow-up|2|||
160660692|NCT01376167|580139631|FG000|Overall Study|Physician Decision|1|||
160604290|NCT01802515|579928852|FG002|Overall Study|Withdrawal by Subject|0|||
160604291|NCT02566109|579928853|FG000|Overall Study|Withdrawal by Subject|1|||
160604292|NCT01041404|579928856|FG000|Overall Study|Adverse Event|45|||
160604293|NCT01041404|579928857|FG001|Overall Study|Adverse Event|35|||
160604294|NCT01041404|579928856|FG000|Overall Study|Lack of Efficacy|200|||
160604295|NCT01041404|579928857|FG001|Overall Study|Lack of Efficacy|210|||
160604296|NCT01041404|579928856|FG000|Overall Study|Violation of Selection Criteria|0|||
160604297|NCT01041404|579928857|FG001|Overall Study|Violation of Selection Criteria|1|||
160604298|NCT01041404|579928856|FG000|Overall Study|Protocol Violation|4|||
160604299|NCT01041404|579928857|FG001|Overall Study|Protocol Violation|0|||
160604300|NCT01041404|579928856|FG000|Overall Study|Withdrawal by Subject|29|||
160604301|NCT01041404|579928857|FG001|Overall Study|Withdrawal by Subject|23|||
160604302|NCT01041404|579928856|FG000|Overall Study|Failure to Return|1|||
160604303|NCT01041404|579928857|FG001|Overall Study|Failure to Return|2|||
160604304|NCT01041404|579928856|FG000|Overall Study|Other|11|||
160604305|NCT01041404|579928857|FG001|Overall Study|Other|23|||
160604306|NCT01750840|579928858|FG000|Overall Study|Lost to Follow-up|4|||
160604307|NCT01570309|579928859|FG000|Overall Study|Withdrawal by Subject|3|||
160604308|NCT01570309|579928860|FG001|Overall Study|Withdrawal by Subject|3|||
160604309|NCT02091921|579928861|FG000|Overall Study|Adverse Event|3|||
160660693|NCT01376167|580139632|FG001|Overall Study|Physician Decision|1|||
160660694|NCT01376167|580139633|FG002|Overall Study|Physician Decision|0|||
160481487|NCT03508830|579491631|FG001|Overall Study|Withdrawal by Subject|4|||
160604310|NCT02483078|579928862|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
160604311|NCT02483078|579928863|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
160660695|NCT01376167|580139631|FG000|Overall Study|Withdrawal by Subject|1|||
160660696|NCT01376167|580139632|FG001|Overall Study|Withdrawal by Subject|5|||
160481488|NCT03508830|579491630|FG000|Overall Study|Physician Decision|2|||
160604312|NCT02483078|579928862|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
160660697|NCT01376167|580139633|FG002|Overall Study|Withdrawal by Subject|4|||
160660698|NCT02193165|580139636|FG000|4 Week Product Use|Lost to Follow-up|1|||
160481489|NCT03508830|579491631|FG001|Overall Study|Physician Decision|2|||
160481490|NCT03575572|579491632|FG000|Overall Study|Withdrawal by Subject|2|||
160481491|NCT03575572|579491632|FG000|Overall Study|Physician Decision|2|||
160481492|NCT04908800|579491633|FG000|Overall Study|Adverse Event|0|||
160604313|NCT02483078|579928863|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
160660699|NCT02193165|580139637|FG001|4 Week Product Use|Lost to Follow-up|1|||
160481493|NCT04908800|579491634|FG001|Overall Study|Adverse Event|0|||
160481494|NCT04908800|579491635|FG002|Overall Study|Adverse Event|0|||
160481495|NCT04908800|579491636|FG003|Overall Study|Adverse Event|0|||
160481496|NCT04908800|579491637|FG004|Overall Study|Adverse Event|0|||
160481497|NCT04908800|579491638|FG005|Overall Study|Adverse Event|0|||
160481498|NCT04908800|579491639|FG006|Overall Study|Adverse Event|0|||
160481499|NCT04908800|579491640|FG007|Overall Study|Adverse Event|0|||
160481500|NCT04908800|579491641|FG008|Overall Study|Adverse Event|0|||
160481501|NCT04908800|579491642|FG009|Overall Study|Adverse Event|0|||
160481502|NCT04908800|579491643|FG010|Overall Study|Adverse Event|1|||
160481503|NCT04908800|579491644|FG011|Overall Study|Adverse Event|0|||
160481504|NCT04908800|579491645|FG012|Overall Study|Adverse Event|0|||
160481505|NCT03751280|579491646|FG000|Overall Study|Adverse Event|0|||
160481506|NCT03751280|579491647|FG001|Overall Study|Adverse Event|1|||
160481507|NCT03751280|579491646|FG000|Overall Study|Lost to Follow-up|3|||
160481508|NCT03751280|579491647|FG001|Overall Study|Lost to Follow-up|5|||
160481509|NCT03751280|579491646|FG000|Overall Study|Physician Decision|0|||
160481510|NCT03751280|579491647|FG001|Overall Study|Physician Decision|2|||
160481511|NCT03751280|579491646|FG000|Overall Study|Protocol Violation|0|||
160481512|NCT03751280|579491647|FG001|Overall Study|Protocol Violation|2|||
160481513|NCT03751280|579491646|FG000|Overall Study|Withdrawal by Subject|5|||
160481514|NCT03751280|579491647|FG001|Overall Study|Withdrawal by Subject|2|||
160481515|NCT00296504|579491649|FG000|Interim Analysis|Withdrawal by Subject|8|||
160481516|NCT00296504|579491650|FG001|Interim Analysis|Withdrawal by Subject|0|||
160481517|NCT00296504|579491651|FG002|Interim Analysis|Withdrawal by Subject|12|||
160481518|NCT00296504|579491652|FG003|Interim Analysis|Withdrawal by Subject|0|||
160481519|NCT00296504|579491653|FG004|Interim Analysis|Withdrawal by Subject|5|||
160481520|NCT00296504|579491654|FG005|Interim Analysis|Withdrawal by Subject|5|||
160481521|NCT00296504|579491655|FG006|Interim Analysis|Withdrawal by Subject|9|||
160481522|NCT00296504|579491656|FG007|Interim Analysis|Withdrawal by Subject|3|||
160481523|NCT00296504|579491657|FG008|Interim Analysis|Withdrawal by Subject|0|||
160481524|NCT00296504|579491649|FG000|Interim Analysis|Lost to Follow-up|13|||
160481525|NCT00296504|579491650|FG001|Interim Analysis|Lost to Follow-up|3|||
160481526|NCT00296504|579491651|FG002|Interim Analysis|Lost to Follow-up|26|||
160481527|NCT00296504|579491652|FG003|Interim Analysis|Lost to Follow-up|8|||
160481528|NCT00296504|579491653|FG004|Interim Analysis|Lost to Follow-up|14|||
160481529|NCT00296504|579491654|FG005|Interim Analysis|Lost to Follow-up|4|||
160481530|NCT00296504|579491655|FG006|Interim Analysis|Lost to Follow-up|11|||
160481531|NCT00296504|579491656|FG007|Interim Analysis|Lost to Follow-up|4|||
160481532|NCT00296504|579491657|FG008|Interim Analysis|Lost to Follow-up|0|||
160481533|NCT00296504|579491649|FG000|Interim Analysis|Clinical Progression|1|||
160481534|NCT00296504|579491650|FG001|Interim Analysis|Clinical Progression|0|||
160481535|NCT00296504|579491651|FG002|Interim Analysis|Clinical Progression|1|||
160481536|NCT00296504|579491652|FG003|Interim Analysis|Clinical Progression|1|||
160481537|NCT00296504|579491653|FG004|Interim Analysis|Clinical Progression|0|||
160481538|NCT00296504|579491654|FG005|Interim Analysis|Clinical Progression|2|||
160481539|NCT00296504|579491655|FG006|Interim Analysis|Clinical Progression|1|||
160481540|NCT00296504|579491656|FG007|Interim Analysis|Clinical Progression|2|||
160481541|NCT00296504|579491657|FG008|Interim Analysis|Clinical Progression|0|||
160481542|NCT00296504|579491649|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
160481543|NCT00296504|579491650|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
160481544|NCT00296504|579491651|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
160481545|NCT00296504|579491652|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
160481546|NCT00296504|579491653|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
160481547|NCT00296504|579491654|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
160481548|NCT00296504|579491655|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
160481549|NCT00296504|579491656|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
160481550|NCT00296504|579491657|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
160481551|NCT00296504|579491649|FG000|Interim Analysis|Adverse Event|0|||
160481552|NCT00296504|579491650|FG001|Interim Analysis|Adverse Event|0|||
160481553|NCT00296504|579491651|FG002|Interim Analysis|Adverse Event|13|||
160481554|NCT00296504|579491652|FG003|Interim Analysis|Adverse Event|4|||
160604314|NCT02483078|579928862|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
160604315|NCT02483078|579928863|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
160481555|NCT00296504|579491653|FG004|Interim Analysis|Adverse Event|6|||
160481556|NCT00296504|579491654|FG005|Interim Analysis|Adverse Event|3|||
160481557|NCT00296504|579491655|FG006|Interim Analysis|Adverse Event|4|||
160481558|NCT00296504|579491656|FG007|Interim Analysis|Adverse Event|5|||
160481559|NCT00296504|579491657|FG008|Interim Analysis|Adverse Event|0|||
160481560|NCT00296504|579491649|FG000|Interim Analysis|Protocol Violation|0|||
160481561|NCT00296504|579491650|FG001|Interim Analysis|Protocol Violation|0|||
160481562|NCT00296504|579491651|FG002|Interim Analysis|Protocol Violation|2|||
160481563|NCT00296504|579491652|FG003|Interim Analysis|Protocol Violation|0|||
160481564|NCT00296504|579491653|FG004|Interim Analysis|Protocol Violation|1|||
160481565|NCT00296504|579491654|FG005|Interim Analysis|Protocol Violation|0|||
160481566|NCT00296504|579491655|FG006|Interim Analysis|Protocol Violation|0|||
160481567|NCT00296504|579491656|FG007|Interim Analysis|Protocol Violation|1|||
160481568|NCT00296504|579491657|FG008|Interim Analysis|Protocol Violation|0|||
160481569|NCT00296504|579491649|FG000|Interim Analysis|Insufficient CD4 Response|0|||
160481570|NCT00296504|579491650|FG001|Interim Analysis|Insufficient CD4 Response|0|||
160481571|NCT00296504|579491651|FG002|Interim Analysis|Insufficient CD4 Response|0|||
160481572|NCT00296504|579491652|FG003|Interim Analysis|Insufficient CD4 Response|0|||
160481573|NCT00296504|579491653|FG004|Interim Analysis|Insufficient CD4 Response|1|||
160481574|NCT00296504|579491654|FG005|Interim Analysis|Insufficient CD4 Response|1|||
160481575|NCT00296504|579491655|FG006|Interim Analysis|Insufficient CD4 Response|0|||
160481576|NCT00296504|579491656|FG007|Interim Analysis|Insufficient CD4 Response|0|||
160481577|NCT00296504|579491657|FG008|Interim Analysis|Insufficient CD4 Response|0|||
160481578|NCT00296504|579491649|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
160481579|NCT00296504|579491650|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
160481580|NCT00296504|579491651|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
160481581|NCT00296504|579491652|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
160481582|NCT00296504|579491653|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
160481583|NCT00296504|579491654|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
160481584|NCT00296504|579491655|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
160481585|NCT00296504|579491656|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
160481586|NCT00296504|579491657|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
160481587|NCT00296504|579491649|FG000|Interim Analysis|Pregnancy|4|||
160481588|NCT00296504|579491650|FG001|Interim Analysis|Pregnancy|1|||
160481589|NCT00296504|579491651|FG002|Interim Analysis|Pregnancy|4|||
160481590|NCT00296504|579491652|FG003|Interim Analysis|Pregnancy|2|||
160481591|NCT00296504|579491653|FG004|Interim Analysis|Pregnancy|0|||
160481592|NCT00296504|579491654|FG005|Interim Analysis|Pregnancy|1|||
160481593|NCT00296504|579491655|FG006|Interim Analysis|Pregnancy|1|||
160481594|NCT00296504|579491656|FG007|Interim Analysis|Pregnancy|1|||
160481595|NCT00296504|579491657|FG008|Interim Analysis|Pregnancy|0|||
160481596|NCT00296504|579491649|FG000|Interim Analysis|Death|1|||
160481597|NCT00296504|579491650|FG001|Interim Analysis|Death|0|||
160481598|NCT00296504|579491651|FG002|Interim Analysis|Death|3|||
160481599|NCT00296504|579491652|FG003|Interim Analysis|Death|0|||
160481600|NCT00296504|579491653|FG004|Interim Analysis|Death|0|||
160481601|NCT00296504|579491654|FG005|Interim Analysis|Death|0|||
160481602|NCT00296504|579491655|FG006|Interim Analysis|Death|0|||
160481603|NCT00296504|579491656|FG007|Interim Analysis|Death|0|||
160481604|NCT00296504|579491657|FG008|Interim Analysis|Death|0|||
160481605|NCT00296504|579491649|FG000|Interim Analysis|Participant Non-compliant|0|||
160481606|NCT00296504|579491650|FG001|Interim Analysis|Participant Non-compliant|1|||
160481607|NCT00296504|579491651|FG002|Interim Analysis|Participant Non-compliant|2|||
160481608|NCT00296504|579491652|FG003|Interim Analysis|Participant Non-compliant|1|||
160481609|NCT00296504|579491653|FG004|Interim Analysis|Participant Non-compliant|1|||
160481610|NCT00296504|579491654|FG005|Interim Analysis|Participant Non-compliant|3|||
160481611|NCT00296504|579491655|FG006|Interim Analysis|Participant Non-compliant|6|||
160481612|NCT00296504|579491656|FG007|Interim Analysis|Participant Non-compliant|2|||
160481613|NCT00296504|579491657|FG008|Interim Analysis|Participant Non-compliant|0|||
160481614|NCT00296504|579491649|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
160481615|NCT00296504|579491650|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
160481616|NCT00296504|579491651|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
160481617|NCT00296504|579491652|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
160481618|NCT00296504|579491653|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
160481619|NCT00296504|579491654|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
160481620|NCT00296504|579491655|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
160481621|NCT00296504|579491656|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
160481622|NCT00296504|579491657|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
160481623|NCT00296504|579491649|FG000|Interim Analysis|To Simplify Treatment|0|||
160481624|NCT00296504|579491650|FG001|Interim Analysis|To Simplify Treatment|0|||
160660700|NCT02193165|580139638|FG002|4 Week Product Use|Lost to Follow-up|1|||
160660701|NCT02193165|580139636|FG000|6 Week Product Use|Lost to Follow-up|0|||
160660702|NCT02193165|580139637|FG001|6 Week Product Use|Lost to Follow-up|1|||
160481625|NCT00296504|579491651|FG002|Interim Analysis|To Simplify Treatment|1|||
160481626|NCT00296504|579491652|FG003|Interim Analysis|To Simplify Treatment|0|||
160481627|NCT00296504|579491653|FG004|Interim Analysis|To Simplify Treatment|0|||
160660703|NCT02193165|580139638|FG002|6 Week Product Use|Lost to Follow-up|0|||
160660704|NCT00610363|580139643|FG000|Overall Study|Non-compliance with protocol|0|||
160660705|NCT00610363|580139644|FG001|Overall Study|Non-compliance with protocol|1|||
160660706|NCT00610363|580139643|FG000|Overall Study|Adverse Event|3|||
160660707|NCT00610363|580139644|FG001|Overall Study|Adverse Event|1|||
160660708|NCT00610363|580139643|FG000|Overall Study|Lack of Efficacy|2|||
160660709|NCT00610363|580139644|FG001|Overall Study|Lack of Efficacy|0|||
160660710|NCT00610363|580139643|FG000|Overall Study|Lost to Follow-up|4|||
160481628|NCT00296504|579491654|FG005|Interim Analysis|To Simplify Treatment|0|||
160481629|NCT00296504|579491655|FG006|Interim Analysis|To Simplify Treatment|2|||
160481630|NCT00296504|579491656|FG007|Interim Analysis|To Simplify Treatment|0|||
160481631|NCT00296504|579491657|FG008|Interim Analysis|To Simplify Treatment|0|||
160481632|NCT00296504|579491649|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
160481633|NCT00296504|579491650|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
160481634|NCT00296504|579491651|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
160481635|NCT00296504|579491652|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
160481636|NCT00296504|579491653|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
160481637|NCT00296504|579491654|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
160481638|NCT00296504|579491655|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
160481639|NCT00296504|579491656|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
160481640|NCT00296504|579491657|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
160481641|NCT00296504|579491649|FG000|Interim Analysis|Participant Moved|1|||
160481642|NCT00296504|579491650|FG001|Interim Analysis|Participant Moved|0|||
160481643|NCT00296504|579491651|FG002|Interim Analysis|Participant Moved|1|||
160481644|NCT00296504|579491652|FG003|Interim Analysis|Participant Moved|0|||
160481645|NCT00296504|579491653|FG004|Interim Analysis|Participant Moved|0|||
160481646|NCT00296504|579491654|FG005|Interim Analysis|Participant Moved|1|||
160481647|NCT00296504|579491655|FG006|Interim Analysis|Participant Moved|1|||
160481648|NCT00296504|579491656|FG007|Interim Analysis|Participant Moved|0|||
160481649|NCT00296504|579491657|FG008|Interim Analysis|Participant Moved|0|||
160481650|NCT00296504|579491649|FG000|Interim Analysis|Participant Was Incarcerated|2|||
160481651|NCT00296504|579491650|FG001|Interim Analysis|Participant Was Incarcerated|0|||
160481652|NCT00296504|579491651|FG002|Interim Analysis|Participant Was Incarcerated|1|||
160481653|NCT00296504|579491652|FG003|Interim Analysis|Participant Was Incarcerated|0|||
160481654|NCT00296504|579491653|FG004|Interim Analysis|Participant Was Incarcerated|0|||
160481655|NCT00296504|579491654|FG005|Interim Analysis|Participant Was Incarcerated|0|||
160481656|NCT00296504|579491655|FG006|Interim Analysis|Participant Was Incarcerated|0|||
160481657|NCT00296504|579491656|FG007|Interim Analysis|Participant Was Incarcerated|0|||
160481658|NCT00296504|579491657|FG008|Interim Analysis|Participant Was Incarcerated|0|||
160481659|NCT00296504|579491649|FG000|Interim Analysis|Resistance to FPV|0|||
160481660|NCT00296504|579491650|FG001|Interim Analysis|Resistance to FPV|0|||
160481661|NCT00296504|579491651|FG002|Interim Analysis|Resistance to FPV|1|||
160481662|NCT00296504|579491652|FG003|Interim Analysis|Resistance to FPV|0|||
160481663|NCT00296504|579491653|FG004|Interim Analysis|Resistance to FPV|0|||
160481664|NCT00296504|579491654|FG005|Interim Analysis|Resistance to FPV|0|||
160481665|NCT00296504|579491655|FG006|Interim Analysis|Resistance to FPV|0|||
160481666|NCT00296504|579491656|FG007|Interim Analysis|Resistance to FPV|0|||
160481667|NCT00296504|579491657|FG008|Interim Analysis|Resistance to FPV|0|||
160481668|NCT00296504|579491649|FG000|Interim Analysis|Physician Decision|0|||
160481669|NCT00296504|579491650|FG001|Interim Analysis|Physician Decision|0|||
160481670|NCT00296504|579491651|FG002|Interim Analysis|Physician Decision|1|||
160481671|NCT00296504|579491652|FG003|Interim Analysis|Physician Decision|0|||
160481672|NCT00296504|579491653|FG004|Interim Analysis|Physician Decision|0|||
160660711|NCT00610363|580139644|FG001|Overall Study|Lost to Follow-up|0|||
160481673|NCT00296504|579491654|FG005|Interim Analysis|Physician Decision|0|||
160481674|NCT00296504|579491655|FG006|Interim Analysis|Physician Decision|0|||
160481675|NCT00296504|579491656|FG007|Interim Analysis|Physician Decision|0|||
160481676|NCT00296504|579491657|FG008|Interim Analysis|Physician Decision|0|||
160481677|NCT00296504|579491649|FG000|Interim Analysis|Principle Investigator Discretion|2|||
160481678|NCT00296504|579491650|FG001|Interim Analysis|Principle Investigator Discretion|0|||
160481679|NCT00296504|579491651|FG002|Interim Analysis|Principle Investigator Discretion|1|||
160481680|NCT00296504|579491652|FG003|Interim Analysis|Principle Investigator Discretion|1|||
160481681|NCT00296504|579491653|FG004|Interim Analysis|Principle Investigator Discretion|0|||
160481682|NCT00296504|579491654|FG005|Interim Analysis|Principle Investigator Discretion|0|||
160481683|NCT00296504|579491655|FG006|Interim Analysis|Principle Investigator Discretion|0|||
160660712|NCT00610363|580139643|FG000|Overall Study|Withdrawal by Subject|1|||
160660713|NCT00610363|580139644|FG001|Overall Study|Withdrawal by Subject|0|||
160660714|NCT00610363|580139643|FG000|Overall Study|Other than specified above|1|||
160660715|NCT00610363|580139644|FG001|Overall Study|Other than specified above|1|||
160660716|NCT03361228|580139654|FG000|Overall Study|Other|1|||
160604316|NCT02483078|579928862|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
160604317|NCT02483078|579928863|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
160604318|NCT02483078|579928862|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
160604319|NCT02483078|579928863|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
160604320|NCT02483078|579928862|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
160604321|NCT02483078|579928863|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
160604322|NCT03627494|579928864|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
160481684|NCT00296504|579491656|FG007|Interim Analysis|Principle Investigator Discretion|0|||
160481685|NCT00296504|579491657|FG008|Interim Analysis|Principle Investigator Discretion|0|||
160481686|NCT00296504|579491649|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
160481687|NCT00296504|579491650|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
160481688|NCT00296504|579491651|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
160481689|NCT00296504|579491652|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
160481690|NCT00296504|579491653|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
160481691|NCT00296504|579491654|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
160481692|NCT00296504|579491655|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
160481693|NCT00296504|579491656|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
160481694|NCT00296504|579491657|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
160481695|NCT00296504|579491649|FG000|Interim Analysis|Non-adherence|2|||
160481696|NCT00296504|579491650|FG001|Interim Analysis|Non-adherence|0|||
160481697|NCT00296504|579491651|FG002|Interim Analysis|Non-adherence|0|||
160481698|NCT00296504|579491652|FG003|Interim Analysis|Non-adherence|0|||
160481699|NCT00296504|579491653|FG004|Interim Analysis|Non-adherence|1|||
160481700|NCT00296504|579491654|FG005|Interim Analysis|Non-adherence|0|||
160481701|NCT00296504|579491655|FG006|Interim Analysis|Non-adherence|0|||
160481702|NCT00296504|579491656|FG007|Interim Analysis|Non-adherence|1|||
160481703|NCT00296504|579491657|FG008|Interim Analysis|Non-adherence|0|||
160481704|NCT00296504|579491649|FG000|Interim Analysis|Site Closing|1|||
160481705|NCT00296504|579491650|FG001|Interim Analysis|Site Closing|0|||
160481706|NCT00296504|579491651|FG002|Interim Analysis|Site Closing|0|||
160481707|NCT00296504|579491652|FG003|Interim Analysis|Site Closing|0|||
160481708|NCT00296504|579491653|FG004|Interim Analysis|Site Closing|0|||
160481709|NCT00296504|579491654|FG005|Interim Analysis|Site Closing|1|||
160481710|NCT00296504|579491655|FG006|Interim Analysis|Site Closing|2|||
160481711|NCT00296504|579491656|FG007|Interim Analysis|Site Closing|0|||
160481712|NCT00296504|579491657|FG008|Interim Analysis|Site Closing|0|||
160481713|NCT00296504|579491649|FG000|Interim Analysis|Lack of Personnel at Site|1|||
160481714|NCT00296504|579491650|FG001|Interim Analysis|Lack of Personnel at Site|0|||
160481715|NCT00296504|579491651|FG002|Interim Analysis|Lack of Personnel at Site|0|||
160481716|NCT00296504|579491652|FG003|Interim Analysis|Lack of Personnel at Site|0|||
160481717|NCT00296504|579491653|FG004|Interim Analysis|Lack of Personnel at Site|0|||
160481718|NCT00296504|579491654|FG005|Interim Analysis|Lack of Personnel at Site|0|||
160481719|NCT00296504|579491655|FG006|Interim Analysis|Lack of Personnel at Site|0|||
160481720|NCT00296504|579491656|FG007|Interim Analysis|Lack of Personnel at Site|0|||
160481721|NCT00296504|579491657|FG008|Interim Analysis|Lack of Personnel at Site|0|||
160481722|NCT00296504|579491649|FG000|Interim Analysis|Missed Schedule Date|1|||
160481723|NCT00296504|579491650|FG001|Interim Analysis|Missed Schedule Date|0|||
160481724|NCT00296504|579491651|FG002|Interim Analysis|Missed Schedule Date|0|||
160481725|NCT00296504|579491652|FG003|Interim Analysis|Missed Schedule Date|0|||
160481726|NCT00296504|579491653|FG004|Interim Analysis|Missed Schedule Date|0|||
160481727|NCT00296504|579491654|FG005|Interim Analysis|Missed Schedule Date|0|||
160481728|NCT00296504|579491655|FG006|Interim Analysis|Missed Schedule Date|0|||
160481729|NCT00296504|579491656|FG007|Interim Analysis|Missed Schedule Date|0|||
160481730|NCT00296504|579491657|FG008|Interim Analysis|Missed Schedule Date|0|||
160481731|NCT00296504|579491649|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
160481732|NCT00296504|579491650|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
160481733|NCT00296504|579491651|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
160481734|NCT00296504|579491652|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
160481735|NCT00296504|579491653|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
160481736|NCT00296504|579491654|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
160481737|NCT00296504|579491655|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
160481738|NCT00296504|579491656|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
160481739|NCT00296504|579491657|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
160481740|NCT00296504|579491649|FG000|Interim Analysis|Participant Stopped|0|||
160660717|NCT03361228|580139655|FG001|Overall Study|Other|1|||
160481741|NCT00296504|579491650|FG001|Interim Analysis|Participant Stopped|0|||
160481742|NCT00296504|579491651|FG002|Interim Analysis|Participant Stopped|0|||
160481743|NCT00296504|579491652|FG003|Interim Analysis|Participant Stopped|0|||
160481744|NCT00296504|579491653|FG004|Interim Analysis|Participant Stopped|1|||
160481745|NCT00296504|579491654|FG005|Interim Analysis|Participant Stopped|0|||
160481746|NCT00296504|579491655|FG006|Interim Analysis|Participant Stopped|0|||
160481747|NCT00296504|579491656|FG007|Interim Analysis|Participant Stopped|0|||
160481748|NCT00296504|579491657|FG008|Interim Analysis|Participant Stopped|0|||
160481749|NCT00296504|579491649|FG000|Interim Analysis|Physician and Participant Decision|0|||
160481750|NCT00296504|579491650|FG001|Interim Analysis|Physician and Participant Decision|0|||
160481751|NCT00296504|579491651|FG002|Interim Analysis|Physician and Participant Decision|0|||
160481752|NCT00296504|579491652|FG003|Interim Analysis|Physician and Participant Decision|0|||
160481753|NCT00296504|579491653|FG004|Interim Analysis|Physician and Participant Decision|0|||
160481754|NCT00296504|579491654|FG005|Interim Analysis|Physician and Participant Decision|1|||
160481755|NCT00296504|579491655|FG006|Interim Analysis|Physician and Participant Decision|0|||
160604323|NCT03627494|579928865|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
160604324|NCT03627494|579928866|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
160604325|NCT03627494|579928867|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
160604326|NCT03627494|579928868|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
160604327|NCT03627494|579928869|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
160604328|NCT03627494|579928870|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
160660718|NCT03361228|580139654|FG000|Overall Study|Death|3|||
160604329|NCT03627494|579928871|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
160604330|NCT03627494|579928872|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
160481756|NCT00296504|579491656|FG007|Interim Analysis|Physician and Participant Decision|0|||
160481757|NCT00296504|579491657|FG008|Interim Analysis|Physician and Participant Decision|0|||
160481758|NCT00296504|579491649|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
160481759|NCT00296504|579491650|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
160481760|NCT00296504|579491651|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
160481761|NCT00296504|579491652|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
160481762|NCT00296504|579491653|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
160481763|NCT00296504|579491654|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
160481764|NCT00296504|579491655|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
160481765|NCT00296504|579491656|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
160481766|NCT00296504|579491657|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
160481767|NCT00296504|579491649|FG000|Interim Analysis|Study Ended|0|||
160481768|NCT00296504|579491650|FG001|Interim Analysis|Study Ended|0|||
160481769|NCT00296504|579491651|FG002|Interim Analysis|Study Ended|0|||
160481770|NCT00296504|579491652|FG003|Interim Analysis|Study Ended|0|||
160481771|NCT00296504|579491653|FG004|Interim Analysis|Study Ended|0|||
160481772|NCT00296504|579491654|FG005|Interim Analysis|Study Ended|0|||
160481773|NCT00296504|579491655|FG006|Interim Analysis|Study Ended|1|||
160481774|NCT00296504|579491656|FG007|Interim Analysis|Study Ended|0|||
160481775|NCT00296504|579491657|FG008|Interim Analysis|Study Ended|0|||
160481776|NCT00296504|579491649|FG000|Interim Analysis|Participant Needed Interferon|0|||
160481777|NCT00296504|579491650|FG001|Interim Analysis|Participant Needed Interferon|0|||
160481778|NCT00296504|579491651|FG002|Interim Analysis|Participant Needed Interferon|0|||
160481779|NCT00296504|579491652|FG003|Interim Analysis|Participant Needed Interferon|0|||
160481780|NCT00296504|579491653|FG004|Interim Analysis|Participant Needed Interferon|0|||
160481781|NCT00296504|579491654|FG005|Interim Analysis|Participant Needed Interferon|0|||
160481782|NCT00296504|579491655|FG006|Interim Analysis|Participant Needed Interferon|0|||
160481783|NCT00296504|579491656|FG007|Interim Analysis|Participant Needed Interferon|1|||
160481784|NCT00296504|579491657|FG008|Interim Analysis|Participant Needed Interferon|0|||
160481785|NCT00296504|579491649|FG000|Interim Analysis|Ongoing|32|||
160481786|NCT00296504|579491650|FG001|Interim Analysis|Ongoing|12|||
160481787|NCT00296504|579491651|FG002|Interim Analysis|Ongoing|16|||
160481788|NCT00296504|579491652|FG003|Interim Analysis|Ongoing|22|||
160481789|NCT00296504|579491653|FG004|Interim Analysis|Ongoing|0|||
160481790|NCT00296504|579491654|FG005|Interim Analysis|Ongoing|0|||
160481791|NCT00296504|579491655|FG006|Interim Analysis|Ongoing|30|||
160481792|NCT00296504|579491656|FG007|Interim Analysis|Ongoing|1|||
160481793|NCT00296504|579491657|FG008|Interim Analysis|Ongoing|0|||
160481794|NCT00296504|579491649|FG000|Final Analysis|Withdrawal by Subject|0|||
160481795|NCT00296504|579491650|FG001|Final Analysis|Withdrawal by Subject|0|||
160481796|NCT00296504|579491651|FG002|Final Analysis|Withdrawal by Subject|0|||
160481797|NCT00296504|579491652|FG003|Final Analysis|Withdrawal by Subject|0|||
160481798|NCT00296504|579491653|FG004|Final Analysis|Withdrawal by Subject|0|||
160481799|NCT00296504|579491654|FG005|Final Analysis|Withdrawal by Subject|0|||
160481800|NCT00296504|579491655|FG006|Final Analysis|Withdrawal by Subject|0|||
160481801|NCT00296504|579491656|FG007|Final Analysis|Withdrawal by Subject|0|||
160481802|NCT00296504|579491657|FG008|Final Analysis|Withdrawal by Subject|1|||
160481803|NCT00296504|579491649|FG000|Final Analysis|Lost to Follow-up|0|||
160481804|NCT00296504|579491650|FG001|Final Analysis|Lost to Follow-up|0|||
160481805|NCT00296504|579491651|FG002|Final Analysis|Lost to Follow-up|0|||
160481806|NCT00296504|579491652|FG003|Final Analysis|Lost to Follow-up|0|||
160481807|NCT00296504|579491653|FG004|Final Analysis|Lost to Follow-up|0|||
160481808|NCT00296504|579491654|FG005|Final Analysis|Lost to Follow-up|0|||
160481809|NCT00296504|579491655|FG006|Final Analysis|Lost to Follow-up|0|||
160481810|NCT00296504|579491656|FG007|Final Analysis|Lost to Follow-up|0|||
160481811|NCT00296504|579491657|FG008|Final Analysis|Lost to Follow-up|5|||
160481812|NCT00296504|579491649|FG000|Final Analysis|Insufficient Viral Load Response|0|||
160481813|NCT00296504|579491650|FG001|Final Analysis|Insufficient Viral Load Response|0|||
160481814|NCT00296504|579491651|FG002|Final Analysis|Insufficient Viral Load Response|0|||
160481815|NCT00296504|579491652|FG003|Final Analysis|Insufficient Viral Load Response|0|||
160481816|NCT00296504|579491653|FG004|Final Analysis|Insufficient Viral Load Response|0|||
160660719|NCT03361228|580139655|FG001|Overall Study|Death|0|||
160481817|NCT00296504|579491654|FG005|Final Analysis|Insufficient Viral Load Response|0|||
160481818|NCT00296504|579491655|FG006|Final Analysis|Insufficient Viral Load Response|0|||
160481819|NCT00296504|579491656|FG007|Final Analysis|Insufficient Viral Load Response|0|||
160660720|NCT01722877|580139657|FG000|Overall Study|Death|1|||
160481820|NCT00296504|579491657|FG008|Final Analysis|Insufficient Viral Load Response|6|||
160481821|NCT00296504|579491649|FG000|Final Analysis|Adverse Event|0|||
160481822|NCT00296504|579491650|FG001|Final Analysis|Adverse Event|0|||
160481823|NCT00296504|579491651|FG002|Final Analysis|Adverse Event|0|||
160481824|NCT00296504|579491652|FG003|Final Analysis|Adverse Event|0|||
160481825|NCT00296504|579491653|FG004|Final Analysis|Adverse Event|0|||
160481826|NCT00296504|579491654|FG005|Final Analysis|Adverse Event|0|||
160481827|NCT00296504|579491655|FG006|Final Analysis|Adverse Event|0|||
160481828|NCT00296504|579491656|FG007|Final Analysis|Adverse Event|0|||
160660721|NCT01722877|580139657|FG000|Overall Study|Lost to Follow-up|1|||
160660722|NCT03693430|580139658|FG000|Overall Study|Lost to Follow-up|3|||
160660723|NCT03693430|580139659|FG001|Overall Study|Lost to Follow-up|14|||
160660724|NCT03693430|580139658|FG000|Overall Study|Death|1|||
160660725|NCT03693430|580139659|FG001|Overall Study|Death|0|||
160660726|NCT03693430|580139658|FG000|Overall Study|Withdrawal by Subject|0|||
160660727|NCT03693430|580139659|FG001|Overall Study|Withdrawal by Subject|4|||
160660728|NCT02373098|580139660|FG000|Overall Study|Lost to Follow-up|1|||
160660729|NCT02373098|580139661|FG001|Overall Study|Lost to Follow-up|0|||
160660730|NCT02373098|580139660|FG000|Overall Study|Protocol Violation|3|||
160660731|NCT02373098|580139661|FG001|Overall Study|Protocol Violation|0|||
160660732|NCT02373098|580139660|FG000|Overall Study|Withdrawal by Subject|5|||
160660733|NCT02373098|580139661|FG001|Overall Study|Withdrawal by Subject|0|||
160660734|NCT02373098|580139660|FG000|Overall Study|Adverse Event|3|||
160660735|NCT02373098|580139661|FG001|Overall Study|Adverse Event|0|||
160660736|NCT03929393|580139662|FG000|Overall Study|Death|1|||
160481829|NCT00296504|579491657|FG008|Final Analysis|Adverse Event|2|||
160660737|NCT03929393|580139663|FG001|Overall Study|Death|0|||
160660738|NCT03929393|580139662|FG000|Overall Study|Time Commitment|2|||
160481830|NCT00296504|579491649|FG000|Final Analysis|Pregnancy|0|||
160481831|NCT00296504|579491650|FG001|Final Analysis|Pregnancy|0|||
160481832|NCT00296504|579491651|FG002|Final Analysis|Pregnancy|0|||
160481833|NCT00296504|579491652|FG003|Final Analysis|Pregnancy|0|||
160481834|NCT00296504|579491653|FG004|Final Analysis|Pregnancy|0|||
160481835|NCT00296504|579491654|FG005|Final Analysis|Pregnancy|0|||
160481836|NCT00296504|579491655|FG006|Final Analysis|Pregnancy|0|||
160481837|NCT00296504|579491656|FG007|Final Analysis|Pregnancy|0|||
160481838|NCT00296504|579491657|FG008|Final Analysis|Pregnancy|4|||
160481839|NCT00296504|579491649|FG000|Final Analysis|Tuberculosis|0|||
160481840|NCT00296504|579491650|FG001|Final Analysis|Tuberculosis|0|||
160481841|NCT00296504|579491651|FG002|Final Analysis|Tuberculosis|0|||
160481842|NCT00296504|579491652|FG003|Final Analysis|Tuberculosis|0|||
160481843|NCT00296504|579491653|FG004|Final Analysis|Tuberculosis|0|||
160481844|NCT00296504|579491654|FG005|Final Analysis|Tuberculosis|0|||
160481845|NCT00296504|579491655|FG006|Final Analysis|Tuberculosis|0|||
160481846|NCT00296504|579491656|FG007|Final Analysis|Tuberculosis|0|||
160481847|NCT00296504|579491657|FG008|Final Analysis|Tuberculosis|1|||
160481848|NCT00296504|579491649|FG000|Final Analysis|Participant Moved to Another Country|0|||
160481849|NCT00296504|579491650|FG001|Final Analysis|Participant Moved to Another Country|0|||
160481850|NCT00296504|579491651|FG002|Final Analysis|Participant Moved to Another Country|0|||
160481851|NCT00296504|579491652|FG003|Final Analysis|Participant Moved to Another Country|0|||
160481852|NCT00296504|579491653|FG004|Final Analysis|Participant Moved to Another Country|0|||
160481853|NCT00296504|579491654|FG005|Final Analysis|Participant Moved to Another Country|0|||
160481854|NCT00296504|579491655|FG006|Final Analysis|Participant Moved to Another Country|0|||
160481855|NCT00296504|579491656|FG007|Final Analysis|Participant Moved to Another Country|0|||
160481856|NCT00296504|579491657|FG008|Final Analysis|Participant Moved to Another Country|1|||
160481857|NCT00296504|579491649|FG000|Final Analysis|Poor Adherence|0|||
160481858|NCT00296504|579491650|FG001|Final Analysis|Poor Adherence|0|||
160481859|NCT00296504|579491651|FG002|Final Analysis|Poor Adherence|0|||
160481860|NCT00296504|579491652|FG003|Final Analysis|Poor Adherence|0|||
160481861|NCT00296504|579491653|FG004|Final Analysis|Poor Adherence|0|||
160481862|NCT00296504|579491654|FG005|Final Analysis|Poor Adherence|0|||
160481863|NCT00296504|579491655|FG006|Final Analysis|Poor Adherence|0|||
160481864|NCT00296504|579491656|FG007|Final Analysis|Poor Adherence|0|||
160481865|NCT00296504|579491657|FG008|Final Analysis|Poor Adherence|1|||
160481866|NCT01323309|579491663|FG000|Overall Study|Death|9|||
160481867|NCT01323309|579491664|FG001|Overall Study|Death|15|||
160481868|NCT01323309|579491665|FG002|Overall Study|Death|5|||
160481869|NCT01323309|579491663|FG000|Overall Study|Lost to Follow-up|11|||
160481870|NCT01323309|579491664|FG001|Overall Study|Lost to Follow-up|14|||
160481871|NCT01323309|579491665|FG002|Overall Study|Lost to Follow-up|24|||
160481872|NCT01323309|579491663|FG000|Overall Study|Withdrawal by Subject|14|||
160481873|NCT01323309|579491664|FG001|Overall Study|Withdrawal by Subject|14|||
160481874|NCT01323309|579491665|FG002|Overall Study|Withdrawal by Subject|18|||
160481875|NCT01323309|579491663|FG000|Overall Study|Disease progression|5|||
160481876|NCT01323309|579491664|FG001|Overall Study|Disease progression|11|||
160481877|NCT01323309|579491665|FG002|Overall Study|Disease progression|4|||
160481878|NCT02162771|579491666|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
160481879|NCT02162771|579491667|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
160481880|NCT02162771|579491666|FG000|Core Study Period (Part 2)|Adverse Event|4|||
160481881|NCT02162771|579491667|FG001|Core Study Period (Part 2)|Adverse Event|1|||
160481882|NCT02162771|579491666|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
160481883|NCT02162771|579491667|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
160481884|NCT02162771|579491666|FG000|Core Study Period (Part 2)|Physician Decision|0|||
160481885|NCT02162771|579491667|FG001|Core Study Period (Part 2)|Physician Decision|2|||
160481886|NCT02162771|579491666|FG000|Core Study Period (Part 2)|Death|1|||
160604331|NCT03627494|579928873|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
160604332|NCT03627494|579928874|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
160604333|NCT03627494|579928875|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
160604334|NCT03627494|579928864|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
160481887|NCT02162771|579491667|FG001|Core Study Period (Part 2)|Death|0|||
160481888|NCT02162771|579491666|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
160481889|NCT02162771|579491667|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
160481890|NCT02162771|579491666|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
160481891|NCT02162771|579491667|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
160481892|NCT02162771|579491666|FG000|Maintenance Study Period (Part 2)|Death|2|||
160481893|NCT02162771|579491667|FG001|Maintenance Study Period (Part 2)|Death|1|||
160481894|NCT02162771|579491666|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
160481895|NCT02162771|579491667|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
160481896|NCT02162771|579491666|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
160481897|NCT02162771|579491667|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
160481898|NCT02162771|579491666|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
160481899|NCT02162771|579491667|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
160604335|NCT03627494|579928865|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
160604336|NCT03627494|579928866|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
160604337|NCT03627494|579928867|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
160604338|NCT03627494|579928868|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
160604339|NCT03627494|579928869|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
160604340|NCT03627494|579928870|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
160604341|NCT03627494|579928871|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
160604342|NCT03627494|579928872|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
160604343|NCT03627494|579928873|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
160604344|NCT03627494|579928874|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
160604345|NCT03627494|579928875|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
160604346|NCT03627494|579928864|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
160604347|NCT03627494|579928865|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
160604348|NCT03627494|579928866|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
160604349|NCT03627494|579928867|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
160604350|NCT03627494|579928868|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
160604351|NCT03627494|579928869|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
160604352|NCT03627494|579928870|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
160604353|NCT03627494|579928871|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
160604354|NCT03627494|579928872|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
160660739|NCT03929393|580139663|FG001|Overall Study|Time Commitment|5|||
160660740|NCT03929393|580139662|FG000|Overall Study|Motor Vehicle Accident|0|||
160660741|NCT03929393|580139663|FG001|Overall Study|Motor Vehicle Accident|1|||
160660742|NCT03929393|580139662|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
160660743|NCT03929393|580139663|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
160660744|NCT03929393|580139662|FG000|Overall Study|Other|1|||
160660745|NCT03929393|580139663|FG001|Overall Study|Other|3|||
160660746|NCT00694551|580139674|FG000|Overall Study|Disease Progression|1|||
160660747|NCT00694551|580139675|FG001|Overall Study|Disease Progression|0|||
160660748|NCT00694551|580139676|FG002|Overall Study|Disease Progression|1|||
160660749|NCT01937390|580139677|FG000|Overall Study|Death|2|||
160660750|NCT01937390|580139677|FG000|Overall Study|Lost to Follow-up|7|||
160660751|NCT01937390|580139677|FG000|Overall Study|Withdrawal by Subject|5|||
160660752|NCT01937390|580139677|FG000|Overall Study|Fail to return|21|||
160660753|NCT00154102|580139678|FG000|Overall Study|investigational study phase ongoing|7|||
160660754|NCT00154102|580139679|FG001|Overall Study|investigational study phase ongoing|2|||
160660755|NCT00463606|580139680|FG000|Overall Study|Adverse Event|21|||
160660756|NCT00463606|580139681|FG001|Overall Study|Adverse Event|18|||
160660757|NCT00463606|580139682|FG002|Overall Study|Adverse Event|11|||
160660758|NCT00463606|580139680|FG000|Overall Study|Withdrawal by Subject|11|||
160660759|NCT00463606|580139681|FG001|Overall Study|Withdrawal by Subject|11|||
160660760|NCT00463606|580139682|FG002|Overall Study|Withdrawal by Subject|5|||
160660761|NCT00463606|580139680|FG000|Overall Study|Lost to Follow-up|2|||
160660762|NCT00463606|580139681|FG001|Overall Study|Lost to Follow-up|2|||
160660763|NCT00463606|580139682|FG002|Overall Study|Lost to Follow-up|3|||
160660764|NCT00463606|580139680|FG000|Overall Study|Subject noncompliance|1|||
160660765|NCT00463606|580139681|FG001|Overall Study|Subject noncompliance|1|||
160660766|NCT00463606|580139682|FG002|Overall Study|Subject noncompliance|0|||
160660767|NCT00463606|580139680|FG000|Overall Study|Subject moved out of town|1|||
160660768|NCT00463606|580139681|FG001|Overall Study|Subject moved out of town|0|||
160660769|NCT00463606|580139682|FG002|Overall Study|Subject moved out of town|0|||
160660770|NCT00463606|580139680|FG000|Overall Study|Physician Decision|0|||
160660771|NCT00463606|580139681|FG001|Overall Study|Physician Decision|1|||
160660772|NCT00463606|580139682|FG002|Overall Study|Physician Decision|0|||
160660773|NCT00463606|580139680|FG000|Overall Study|Sponsor request|0|||
160660774|NCT00463606|580139681|FG001|Overall Study|Sponsor request|1|||
160660775|NCT00463606|580139682|FG002|Overall Study|Sponsor request|0|||
160660776|NCT00463606|580139680|FG000|Overall Study|Exclusion criteria violation|2|||
160660777|NCT00463606|580139681|FG001|Overall Study|Exclusion criteria violation|0|||
160660778|NCT00463606|580139682|FG002|Overall Study|Exclusion criteria violation|0|||
160660779|NCT00463606|580139680|FG000|Overall Study|Coordinator error|1|||
160660780|NCT00463606|580139681|FG001|Overall Study|Coordinator error|0|||
160660781|NCT00463606|580139682|FG002|Overall Study|Coordinator error|0|||
160660782|NCT00463606|580139680|FG000|Overall Study|Patient randomized in error|1|||
160660783|NCT00463606|580139681|FG001|Overall Study|Patient randomized in error|0|||
160660784|NCT00463606|580139682|FG002|Overall Study|Patient randomized in error|0|||
160660785|NCT00463606|580139680|FG000|Overall Study|Participation in another ABT-335 trial|1|||
160660786|NCT00463606|580139681|FG001|Overall Study|Participation in another ABT-335 trial|0|||
160660787|NCT00463606|580139682|FG002|Overall Study|Participation in another ABT-335 trial|0|||
160660788|NCT00463606|580139680|FG000|Overall Study|Protocol Violation|0|||
160660789|NCT00463606|580139681|FG001|Overall Study|Protocol Violation|0|||
160660790|NCT00463606|580139682|FG002|Overall Study|Protocol Violation|1|||
160660791|NCT02682602|580139684|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
160660792|NCT02682602|580139685|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
160660793|NCT02682602|580139684|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
160660794|NCT02682602|580139685|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
160660795|NCT03567174|580139686|FG000|Overall Study|Death|24|||
160660796|NCT03567174|580139687|FG001|Overall Study|Death|31|||
160660797|NCT03567174|580139686|FG000|Overall Study|Lost to Follow-up|165|||
160660798|NCT03567174|580139687|FG001|Overall Study|Lost to Follow-up|174|||
160660799|NCT03497897|580141661|FG000|Overall Study|Adverse Event|1|||
160660800|NCT03497897|580141662|FG001|Overall Study|Adverse Event|1|||
160660801|NCT03497897|580141663|FG002|Overall Study|Adverse Event|1|||
160660802|NCT03497897|580141661|FG000|Overall Study|Lost to Follow-up|2|||
160660803|NCT03497897|580141662|FG001|Overall Study|Lost to Follow-up|0|||
160660804|NCT03497897|580141663|FG002|Overall Study|Lost to Follow-up|2|||
160660805|NCT03497897|580141661|FG000|Overall Study|Physician Decision|1|||
160660806|NCT03497897|580141662|FG001|Overall Study|Physician Decision|0|||
160660807|NCT03497897|580141663|FG002|Overall Study|Physician Decision|0|||
160660808|NCT03497897|580141661|FG000|Overall Study|Subject/Guardian Decision|2|||
160660809|NCT03497897|580141662|FG001|Overall Study|Subject/Guardian Decision|1|||
160660810|NCT03497897|580141663|FG002|Overall Study|Subject/Guardian Decision|3|||
160660811|NCT00667862|580141664|FG000|Overall Study|Adverse Event|9|||
160660812|NCT00667862|580141664|FG000|Overall Study|Death|1|||
160660813|NCT00667862|580141664|FG000|Overall Study|Disease Progression|22|||
160660814|NCT00667862|580141664|FG000|Overall Study|Withdrawal by Subject|3|||
160660815|NCT00667095|580141666|FG000|Overall Study|Withdrawal by Subject|0|||
160481900|NCT01078571|579491671|FG000|Overall Study|Adverse Event|36|||
160481901|NCT01078571|579491671|FG000|Overall Study|Lack of effectiveness|36|||
160481902|NCT01078571|579491671|FG000|Overall Study|Reason not reported|21|||
160481903|NCT01078571|579491671|FG000|Overall Study|Withdrawal by Subject|12|||
160481904|NCT01078571|579491671|FG000|Overall Study|Lost to Follow-up|8|||
160481905|NCT01078571|579491671|FG000|Overall Study|Protocol Violation|2|||
160481906|NCT01047306|579491675|FG000|Overall Study|Withdrawal by Subject|2|||
160481907|NCT01047306|579491676|FG001|Overall Study|Withdrawal by Subject|0|||
160481908|NCT01047306|579491675|FG000|Overall Study|Lost to Follow-up|1|||
160481909|NCT01047306|579491676|FG001|Overall Study|Lost to Follow-up|0|||
160481910|NCT01878253|579491677|FG000|Overall Study|Death|1|||
160481911|NCT01878253|579491677|FG000|Overall Study|SIdus System Removal|3|||
160481912|NCT01878253|579491677|FG000|Overall Study|Withdrawal by Subject|1|||
160481913|NCT01878253|579491677|FG000|Overall Study|Lost to Follow-up|2|||
160481914|NCT01878253|579491677|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
160481915|NCT00449033|579491684|FG000|Treatment Period|Adverse Event|117|||
160481916|NCT00449033|579491685|FG001|Treatment Period|Adverse Event|83|||
160481917|NCT00449033|579491684|FG000|Treatment Period|Death|21|||
160481918|NCT00449033|579491685|FG001|Treatment Period|Death|12|||
160481919|NCT00449033|579491684|FG000|Treatment Period|Lost to Follow-up|0|||
160481920|NCT00449033|579491685|FG001|Treatment Period|Lost to Follow-up|2|||
160481921|NCT00449033|579491684|FG000|Treatment Period|Physician Decision|4|||
160481922|NCT00449033|579491685|FG001|Treatment Period|Physician Decision|5|||
160481923|NCT00449033|579491684|FG000|Treatment Period|Protocol Violation|8|||
160481924|NCT00449033|579491685|FG001|Treatment Period|Protocol Violation|7|||
160604355|NCT03627494|579928873|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
160604356|NCT03627494|579928874|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
160604357|NCT03627494|579928875|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
160604358|NCT00509028|579930738|FG000|Overall Study|Adverse Event|2|||
160604359|NCT00509028|579930739|FG001|Overall Study|Adverse Event|0|||
160604360|NCT00509028|579930738|FG000|Overall Study|Withdrawal by Subject|4|||
160604361|NCT00509028|579930739|FG001|Overall Study|Withdrawal by Subject|3|||
160604362|NCT00509028|579930738|FG000|Overall Study|Lost to Follow-up|0|||
160604363|NCT00509028|579930739|FG001|Overall Study|Lost to Follow-up|1|||
160604364|NCT00509028|579930738|FG000|Overall Study|Protocol Violation|4|||
160604365|NCT00509028|579930739|FG001|Overall Study|Protocol Violation|2|||
160604366|NCT00509028|579930738|FG000|Overall Study|Non-compliance|2|||
160604367|NCT00509028|579930739|FG001|Overall Study|Non-compliance|1|||
160604368|NCT01495689|579930741|FG000|Overall Study|Death|0|||
160604369|NCT01495689|579930742|FG001|Overall Study|Death|1|||
160604370|NCT01495689|579930741|FG000|Overall Study|Withdrawal by Subject|3|||
160604371|NCT01495689|579930742|FG001|Overall Study|Withdrawal by Subject|0|||
160604372|NCT01495689|579930741|FG000|Overall Study|Lost to Follow-up|7|||
160604373|NCT01495689|579930742|FG001|Overall Study|Lost to Follow-up|6|||
160604374|NCT00254163|579930743|FG000|Overall Study|Adverse Event|29|||
160604375|NCT00254163|579930744|FG001|Overall Study|Adverse Event|26|||
160604376|NCT00254163|579930743|FG000|Overall Study|Patient request/withdrew consent|6|||
160604377|NCT00254163|579930744|FG001|Overall Study|Patient request/withdrew consent|4|||
160604378|NCT00254163|579930743|FG000|Overall Study|Investigator request|1|||
160604379|NCT00254163|579930744|FG001|Overall Study|Investigator request|3|||
160604380|NCT00254163|579930743|FG000|Overall Study|Failed entry|1|||
160604381|NCT00254163|579930744|FG001|Overall Study|Failed entry|3|||
160604382|NCT00254163|579930743|FG000|Overall Study|Progressive disease|0|||
160604383|NCT00254163|579930744|FG001|Overall Study|Progressive disease|1|||
160604384|NCT00254163|579930743|FG000|Overall Study|Death|0|||
160604385|NCT00254163|579930744|FG001|Overall Study|Death|1|||
160604386|NCT00254163|579930743|FG000|Overall Study|Other|8|||
160604387|NCT00254163|579930744|FG001|Overall Study|Other|8|||
160604388|NCT01119963|579930745|FG000|Overall Study|Lost to Follow-up|1|||
160481925|NCT00449033|579491684|FG000|Treatment Period|Disease Progression|231|||
160660816|NCT00667095|580141667|FG001|Overall Study|Withdrawal by Subject|1|||
160481926|NCT00449033|579491685|FG001|Treatment Period|Disease Progression|288|||
160481927|NCT00449033|579491684|FG000|Treatment Period|Consent Withdrawn|36|||
160481928|NCT00449033|579491685|FG001|Treatment Period|Consent Withdrawn|20|||
160481929|NCT00449033|579491684|FG000|Treatment Period|Amended Protocol Criteria|22|||
160481930|NCT00449033|579491685|FG001|Treatment Period|Amended Protocol Criteria|18|||
160481931|NCT00449033|579491684|FG000|Treatment Period|Non-compliance|7|||
160481932|NCT00449033|579491685|FG001|Treatment Period|Non-compliance|8|||
160481933|NCT00449033|579491684|FG000|Treatment Period|Second Malignancy|0|||
160604389|NCT01119963|579930746|FG001|Overall Study|Lost to Follow-up|1|||
160604390|NCT02579863|579930747|FG000|Overall Study|Final Disposition Unknown|2|||
160604391|NCT02579863|579930748|FG001|Overall Study|Final Disposition Unknown|1|||
160604392|NCT02579863|579930747|FG000|Overall Study|Adverse Event|18|||
160604393|NCT02579863|579930748|FG001|Overall Study|Adverse Event|11|||
160604394|NCT02579863|579930747|FG000|Overall Study|Death|31|||
160604395|NCT02579863|579930748|FG001|Overall Study|Death|29|||
160604396|NCT02579863|579930747|FG000|Overall Study|Lost to Follow-up|2|||
160604397|NCT02579863|579930748|FG001|Overall Study|Lost to Follow-up|1|||
160604398|NCT02579863|579930747|FG000|Overall Study|Physician Decision|1|||
160481934|NCT00449033|579491685|FG001|Treatment Period|Second Malignancy|1|||
160481935|NCT00449033|579491684|FG000|Treatment Period|Reason Missing|0|||
160481936|NCT00449033|579491685|FG001|Treatment Period|Reason Missing|4|||
160481937|NCT00449033|579491684|FG000|Treatment Period|Treatment Ongoing|6|||
160481938|NCT00449033|579491685|FG001|Treatment Period|Treatment Ongoing|4|||
160481939|NCT00449033|579491684|FG000|Follow-up Period|Death|299|||
160481940|NCT00449033|579491685|FG001|Follow-up Period|Death|311|||
160481941|NCT00449033|579491684|FG000|Follow-up Period|Lost to Follow-up|6|||
160481942|NCT00449033|579491685|FG001|Follow-up Period|Lost to Follow-up|10|||
160481943|NCT00449033|579491684|FG000|Follow-up Period|Reason Missing|120|||
160481944|NCT00449033|579491685|FG001|Follow-up Period|Reason Missing|113|||
160481945|NCT04393779|579491686|FG000|Overall Study|Death|1|||
160481946|NCT04393779|579491686|FG000|Overall Study|Device reintervention or explant|4|||
160481947|NCT03802513|579491687|FG000|Overall Study|Lost to Follow-up|1|||
160481948|NCT01648699|579491691|FG000|Overall Study|Death|1|||
160481949|NCT01648699|579491691|FG000|Overall Study|Lost to Follow-up|2|||
160481950|NCT01648699|579491691|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
160481951|NCT04803214|579491692|FG000|Overall Study|Adverse Event|1|||
160481952|NCT04803214|579491693|FG001|Overall Study|Adverse Event|0|||
160481953|NCT04803214|579491692|FG000|Overall Study|Withdrawal by Subject|1|||
160481954|NCT04803214|579491693|FG001|Overall Study|Withdrawal by Subject|2|||
160481955|NCT04803214|579491692|FG000|Overall Study|Lost to Follow-up|2|||
160481956|NCT04803214|579491693|FG001|Overall Study|Lost to Follow-up|4|||
160481957|NCT04803214|579491692|FG000|Overall Study|Physician Decision|1|||
160481958|NCT04803214|579491693|FG001|Overall Study|Physician Decision|1|||
160481959|NCT04803214|579491692|FG000|Overall Study|Missed 12 month visit|0|||
160481960|NCT04803214|579491693|FG001|Overall Study|Missed 12 month visit|3|||
160481961|NCT03219216|579491694|FG000|Overall Study|Lost to Follow-up|0|||
160481962|NCT03219216|579491695|FG001|Overall Study|Lost to Follow-up|1|||
160481963|NCT03005106|579491699|FG000|Overall Study|Lost to Follow-up|16|||
160481964|NCT03005106|579491699|FG000|Overall Study|Adverse Event|1|||
160481965|NCT03005106|579491699|FG000|Overall Study|Physician Decision|1|||
160481966|NCT03005106|579491699|FG000|Overall Study|Death|2|||
160481967|NCT01855399|579491700|FG000|6 Month|Lost to Follow-up|12|||
160481968|NCT01855399|579491701|FG001|6 Month|Lost to Follow-up|9|||
160481969|NCT01855399|579491700|FG000|6 Month|Withdrawal by Subject|8|||
160481970|NCT01855399|579491701|FG001|6 Month|Withdrawal by Subject|6|||
160481971|NCT01855399|579491700|FG000|12 Month|Lost to Follow-up|7|||
160481972|NCT01855399|579491701|FG001|12 Month|Lost to Follow-up|11|||
160481973|NCT00321672|579491702|FG000|Overall Study|Withdrawal by Subject|5|||
160481974|NCT00321672|579491703|FG001|Overall Study|Withdrawal by Subject|1|||
160481975|NCT00321672|579491704|FG002|Overall Study|Withdrawal by Subject|2|||
160481976|NCT00321672|579491705|FG003|Overall Study|Withdrawal by Subject|0|||
160481977|NCT00321672|579491702|FG000|Overall Study|Noncompliance|1|||
160481978|NCT00321672|579491703|FG001|Overall Study|Noncompliance|2|||
160481979|NCT00321672|579491704|FG002|Overall Study|Noncompliance|1|||
160481980|NCT00321672|579491705|FG003|Overall Study|Noncompliance|0|||
160481981|NCT00321672|579491702|FG000|Overall Study|Adverse Event|1|||
160481982|NCT00321672|579491703|FG001|Overall Study|Adverse Event|1|||
160481983|NCT00321672|579491704|FG002|Overall Study|Adverse Event|0|||
160481984|NCT00321672|579491705|FG003|Overall Study|Adverse Event|0|||
160481985|NCT00321672|579491702|FG000|Overall Study|Lack of Efficacy|1|||
160481986|NCT00321672|579491703|FG001|Overall Study|Lack of Efficacy|1|||
160481987|NCT00321672|579491704|FG002|Overall Study|Lack of Efficacy|0|||
160481988|NCT00321672|579491705|FG003|Overall Study|Lack of Efficacy|0|||
160481989|NCT00321672|579491702|FG000|Overall Study|Lost to Follow-up|2|||
160481990|NCT00321672|579491703|FG001|Overall Study|Lost to Follow-up|0|||
160481991|NCT00321672|579491704|FG002|Overall Study|Lost to Follow-up|4|||
160481992|NCT00321672|579491705|FG003|Overall Study|Lost to Follow-up|2|||
160481993|NCT00321672|579491702|FG000|Overall Study|Death|1|||
160481994|NCT00321672|579491703|FG001|Overall Study|Death|0|||
160481995|NCT00321672|579491704|FG002|Overall Study|Death|0|||
160481996|NCT00321672|579491705|FG003|Overall Study|Death|0|||
160481997|NCT00321672|579491702|FG000|Overall Study|Too far to travel for visits|1|||
160481998|NCT00321672|579491703|FG001|Overall Study|Too far to travel for visits|0|||
160481999|NCT00321672|579491704|FG002|Overall Study|Too far to travel for visits|0|||
160482000|NCT00321672|579491705|FG003|Overall Study|Too far to travel for visits|0|||
160482001|NCT00321672|579491702|FG000|Overall Study|Incarcerated|0|||
160482002|NCT00321672|579491703|FG001|Overall Study|Incarcerated|0|||
160482003|NCT00321672|579491704|FG002|Overall Study|Incarcerated|2|||
160482004|NCT00321672|579491705|FG003|Overall Study|Incarcerated|0|||
160482005|NCT00321672|579491702|FG000|Overall Study|Moved out of state|0|||
160482006|NCT00321672|579491703|FG001|Overall Study|Moved out of state|1|||
160482007|NCT00321672|579491704|FG002|Overall Study|Moved out of state|1|||
160482008|NCT00321672|579491705|FG003|Overall Study|Moved out of state|0|||
160482009|NCT00321672|579491702|FG000|Overall Study|Protocol Violation|0|||
160482010|NCT00321672|579491703|FG001|Overall Study|Protocol Violation|0|||
160482011|NCT00321672|579491704|FG002|Overall Study|Protocol Violation|1|||
160482012|NCT00321672|579491705|FG003|Overall Study|Protocol Violation|0|||
160482013|NCT00321672|579491702|FG000|Overall Study|Diagnosis of testicular cancer|0|||
160604399|NCT02579863|579930748|FG001|Overall Study|Physician Decision|2|||
160604400|NCT02579863|579930747|FG000|Overall Study|Screen Failure|0|||
160604401|NCT02579863|579930748|FG001|Overall Study|Screen Failure|2|||
160482014|NCT00321672|579491703|FG001|Overall Study|Diagnosis of testicular cancer|1|||
160482015|NCT00321672|579491704|FG002|Overall Study|Diagnosis of testicular cancer|0|||
160482016|NCT00321672|579491705|FG003|Overall Study|Diagnosis of testicular cancer|0|||
160482017|NCT00321672|579491702|FG000|Overall Study|Extensive travel required for new job|0|||
160482018|NCT00321672|579491703|FG001|Overall Study|Extensive travel required for new job|1|||
160482019|NCT00321672|579491704|FG002|Overall Study|Extensive travel required for new job|0|||
160482020|NCT00321672|579491705|FG003|Overall Study|Extensive travel required for new job|0|||
160604402|NCT02579863|579930747|FG000|Overall Study|Study Terminated at Selected Sites|82|||
160604403|NCT02579863|579930748|FG001|Overall Study|Study Terminated at Selected Sites|88|||
160604404|NCT02579863|579930747|FG000|Overall Study|Withdrawal by Subject|20|||
160604405|NCT02579863|579930748|FG001|Overall Study|Withdrawal by Subject|20|||
160604406|NCT00809614|579930753|FG000|Overall Study|Lack of Efficacy|2|||
160604407|NCT00809614|579930754|FG001|Overall Study|Lack of Efficacy|3|||
160604408|NCT00809614|579930753|FG000|Overall Study|Withdrawal by Subject|1|||
160604409|NCT00809614|579930754|FG001|Overall Study|Withdrawal by Subject|1|||
160604410|NCT00446797|579930755|FG000|Overall Study|Lack of Efficacy|0|||
160604411|NCT00446797|579930756|FG001|Overall Study|Lack of Efficacy|2|||
160604412|NCT00446797|579930755|FG000|Overall Study|Lost to Follow-up|5|||
160604413|NCT00446797|579930756|FG001|Overall Study|Lost to Follow-up|3|||
160604414|NCT00446797|579930755|FG000|Overall Study|Withdrawal by Subject|2|||
160482021|NCT00512902|579491706|FG000|Overall Study|Adverse Event|7|||
160482022|NCT00512902|579491706|FG000|Overall Study|Lost to Follow-up|1|||
160482023|NCT03019289|579491707|FG000|Overall Study|Adverse Event|1|||
160482024|NCT03019289|579491708|FG001|Overall Study|Adverse Event|0|||
160482025|NCT03019289|579491709|FG002|Overall Study|Adverse Event|0|||
160482026|NCT03019289|579491710|FG003|Overall Study|Adverse Event|0|||
160482027|NCT03019289|579491711|FG004|Overall Study|Adverse Event|0|||
160482028|NCT03019289|579491712|FG005|Overall Study|Adverse Event|0|||
160482029|NCT03019289|579491713|FG006|Overall Study|Adverse Event|0|||
160482030|NCT03019289|579491714|FG007|Overall Study|Adverse Event|0|||
160482031|NCT03019289|579491715|FG008|Overall Study|Adverse Event|1|||
160482032|NCT03019289|579491707|FG000|Overall Study|Other|1|||
160482033|NCT03019289|579491708|FG001|Overall Study|Other|0|||
160482034|NCT03019289|579491709|FG002|Overall Study|Other|0|||
160482035|NCT03019289|579491710|FG003|Overall Study|Other|0|||
160482036|NCT03019289|579491711|FG004|Overall Study|Other|0|||
160482037|NCT03019289|579491712|FG005|Overall Study|Other|0|||
160482038|NCT03019289|579491713|FG006|Overall Study|Other|0|||
160482039|NCT03019289|579491714|FG007|Overall Study|Other|0|||
160482040|NCT03019289|579491715|FG008|Overall Study|Other|0|||
160482041|NCT02389894|579491716|FG000|Overall Study|Death|4|||
160482042|NCT02389894|579491717|FG001|Overall Study|Death|5|||
160482043|NCT02389894|579491718|FG002|Overall Study|Death|3|||
160482044|NCT02389894|579491716|FG000|Overall Study|Withdrawal by Subject|2|||
160482045|NCT02389894|579491717|FG001|Overall Study|Withdrawal by Subject|4|||
160482046|NCT02389894|579491718|FG002|Overall Study|Withdrawal by Subject|5|||
160482047|NCT02389894|579491716|FG000|Overall Study|Lost to Follow-up|2|||
160482048|NCT02389894|579491717|FG001|Overall Study|Lost to Follow-up|1|||
160482049|NCT02389894|579491718|FG002|Overall Study|Lost to Follow-up|1|||
160482050|NCT01429285|579491721|FG000|Overall Study|Protocol Violation|9|||
160482051|NCT01429285|579491722|FG001|Overall Study|Protocol Violation|4|||
160482052|NCT01429285|579491721|FG000|Overall Study|Missing Data|5|||
160482053|NCT01429285|579491722|FG001|Overall Study|Missing Data|3|||
160482054|NCT01429285|579491721|FG000|Overall Study|Erroneously Enrolled Twice|8|||
160482055|NCT01429285|579491722|FG001|Overall Study|Erroneously Enrolled Twice|2|||
160604415|NCT00446797|579930756|FG001|Overall Study|Withdrawal by Subject|2|||
160482056|NCT02312245|579491723|FG000|Overall Study|Death|0|||
160604416|NCT00446797|579930755|FG000|Overall Study|Protocol Violation|1|||
160604417|NCT00446797|579930756|FG001|Overall Study|Protocol Violation|3|||
160604418|NCT00446797|579930755|FG000|Overall Study|subject entered at another site|0|||
160604419|NCT00446797|579930756|FG001|Overall Study|subject entered at another site|1|||
160604420|NCT00446797|579930755|FG000|Overall Study|did not meet entrance criteria|0|||
160482057|NCT02312245|579491724|FG001|Overall Study|Death|0|||
160482058|NCT02312245|579491725|FG002|Overall Study|Death|0|||
160482059|NCT02312245|579491726|FG003|Overall Study|Death|1|||
160482060|NCT02312245|579491723|FG000|Overall Study|Withdrawal by Subject|1|||
160482061|NCT02312245|579491724|FG001|Overall Study|Withdrawal by Subject|1|||
160482062|NCT02312245|579491725|FG002|Overall Study|Withdrawal by Subject|0|||
160482063|NCT02312245|579491726|FG003|Overall Study|Withdrawal by Subject|2|||
160482064|NCT02312245|579491723|FG000|Overall Study|Alternative Therapy|1|||
160604421|NCT00446797|579930756|FG001|Overall Study|did not meet entrance criteria|1|||
160604422|NCT00364832|579930757|FG000|Core Period|Early Withdrawals|2|||
160604423|NCT00364832|579930758|FG001|Core Period|Early Withdrawals|2|||
160660817|NCT01520909|580141668|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
160482065|NCT02312245|579491724|FG001|Overall Study|Alternative Therapy|0|||
160660818|NCT01520909|580141669|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
160482066|NCT02312245|579491725|FG002|Overall Study|Alternative Therapy|0|||
160482067|NCT02312245|579491726|FG003|Overall Study|Alternative Therapy|0|||
160482068|NCT02312245|579491723|FG000|Overall Study|Progression|0|||
160482069|NCT02312245|579491724|FG001|Overall Study|Progression|0|||
160482070|NCT02312245|579491725|FG002|Overall Study|Progression|0|||
160482071|NCT02312245|579491726|FG003|Overall Study|Progression|5|||
160482072|NCT02312245|579491723|FG000|Overall Study|Patient went to hospice|0|||
160482073|NCT02312245|579491724|FG001|Overall Study|Patient went to hospice|0|||
160482074|NCT02312245|579491725|FG002|Overall Study|Patient went to hospice|0|||
160482075|NCT02312245|579491726|FG003|Overall Study|Patient went to hospice|1|||
160482076|NCT02312245|579491723|FG000|Overall Study|Ineligible|1|||
160482077|NCT02312245|579491724|FG001|Overall Study|Ineligible|0|||
160482078|NCT02312245|579491725|FG002|Overall Study|Ineligible|0|||
160482079|NCT02312245|579491726|FG003|Overall Study|Ineligible|0|||
160482080|NCT01288729|579491735|FG000|Overall Study|Withdrawal by Subject|1|||
160482081|NCT01288729|579491736|FG001|Overall Study|Withdrawal by Subject|0|||
160482082|NCT03214198|579491737|FG000|Overall Study|Case Report Forms Uncollected|18|||
160482083|NCT03214198|579491737|FG000|Overall Study|Protocol Deviation|18|||
160482084|NCT02255435|579493411|FG000|Overall Study|Patient's Limited Time Availability|0|||
160482085|NCT02255435|579493412|FG001|Overall Study|Patient's Limited Time Availability|0|||
160482086|NCT02255435|579493413|FG002|Overall Study|Patient's Limited Time Availability|0|||
160482087|NCT02255435|579493414|FG003|Overall Study|Patient's Limited Time Availability|0|||
160482088|NCT02255435|579493415|FG004|Overall Study|Patient's Limited Time Availability|0|||
160482089|NCT02255435|579493416|FG005|Overall Study|Patient's Limited Time Availability|0|||
160482090|NCT02255435|579493417|FG006|Overall Study|Patient's Limited Time Availability|0|||
160482091|NCT02255435|579493418|FG007|Overall Study|Patient's Limited Time Availability|1|||
160482092|NCT02255435|579493419|FG008|Overall Study|Patient's Limited Time Availability|0|||
160482093|NCT02255435|579493420|FG009|Overall Study|Patient's Limited Time Availability|0|||
160482094|NCT02255435|579493411|FG000|Overall Study|Withdrawal by Subject|0|||
160482095|NCT02255435|579493412|FG001|Overall Study|Withdrawal by Subject|0|||
160482096|NCT02255435|579493413|FG002|Overall Study|Withdrawal by Subject|0|||
160482097|NCT02255435|579493414|FG003|Overall Study|Withdrawal by Subject|0|||
160482098|NCT02255435|579493415|FG004|Overall Study|Withdrawal by Subject|0|||
160482099|NCT02255435|579493416|FG005|Overall Study|Withdrawal by Subject|0|||
160482100|NCT02255435|579493417|FG006|Overall Study|Withdrawal by Subject|0|||
160482101|NCT02255435|579493418|FG007|Overall Study|Withdrawal by Subject|0|||
160482102|NCT02255435|579493419|FG008|Overall Study|Withdrawal by Subject|1|||
160482103|NCT02255435|579493420|FG009|Overall Study|Withdrawal by Subject|4|||
160482104|NCT02255435|579493411|FG000|Overall Study|Administrative reasons|0|||
160482105|NCT02255435|579493412|FG001|Overall Study|Administrative reasons|0|||
160482106|NCT02255435|579493413|FG002|Overall Study|Administrative reasons|0|||
160482107|NCT02255435|579493414|FG003|Overall Study|Administrative reasons|0|||
160482108|NCT02255435|579493415|FG004|Overall Study|Administrative reasons|0|||
160482109|NCT02255435|579493416|FG005|Overall Study|Administrative reasons|0|||
160482110|NCT02255435|579493417|FG006|Overall Study|Administrative reasons|0|||
160482111|NCT02255435|579493418|FG007|Overall Study|Administrative reasons|0|||
160482112|NCT02255435|579493419|FG008|Overall Study|Administrative reasons|0|||
160482113|NCT02255435|579493420|FG009|Overall Study|Administrative reasons|2|||
160482114|NCT03596905|579493421|FG000|Overall Study|Protocol Violation|0|||
160482115|NCT03596905|579493422|FG001|Overall Study|Protocol Violation|0|||
160482116|NCT03596905|579493423|FG002|Overall Study|Protocol Violation|0|||
160482117|NCT03596905|579493424|FG003|Overall Study|Protocol Violation|0|||
160482118|NCT03596905|579493425|FG004|Overall Study|Protocol Violation|1|||
160482119|NCT03596905|579493426|FG005|Overall Study|Protocol Violation|0|||
160482120|NCT03596905|579493427|FG006|Overall Study|Protocol Violation|0|||
160482121|NCT03596905|579493421|FG000|Overall Study|Withdrawal by Subject|0|||
160482122|NCT03596905|579493422|FG001|Overall Study|Withdrawal by Subject|2|||
160482123|NCT03596905|579493423|FG002|Overall Study|Withdrawal by Subject|1|||
160482124|NCT03596905|579493424|FG003|Overall Study|Withdrawal by Subject|0|||
160482125|NCT03596905|579493425|FG004|Overall Study|Withdrawal by Subject|2|||
160604424|NCT00364832|579930759|FG002|Core Period|Early Withdrawals|1|||
160604425|NCT00364832|579930760|FG003|Core Period|Early Withdrawals|1|||
160604426|NCT00364832|579930761|FG004|Core Period|Early Withdrawals|0|||
160604427|NCT00364832|579930762|FG005|Core Period|Early Withdrawals|0|||
160482126|NCT03596905|579493426|FG005|Overall Study|Withdrawal by Subject|0|||
160482127|NCT03596905|579493427|FG006|Overall Study|Withdrawal by Subject|0|||
160482128|NCT03596905|579493421|FG000|Overall Study|Participant moved and was unable to complete study|0|||
160482129|NCT03596905|579493422|FG001|Overall Study|Participant moved and was unable to complete study|1|||
160482130|NCT03596905|579493423|FG002|Overall Study|Participant moved and was unable to complete study|0|||
160482131|NCT03596905|579493424|FG003|Overall Study|Participant moved and was unable to complete study|0|||
160482132|NCT03596905|579493425|FG004|Overall Study|Participant moved and was unable to complete study|0|||
160482133|NCT03596905|579493426|FG005|Overall Study|Participant moved and was unable to complete study|0|||
160482134|NCT03596905|579493427|FG006|Overall Study|Participant moved and was unable to complete study|0|||
160482135|NCT03596905|579493421|FG000|Overall Study|Adverse Event|0|||
160482136|NCT03596905|579493422|FG001|Overall Study|Adverse Event|0|||
160482137|NCT03596905|579493423|FG002|Overall Study|Adverse Event|0|||
160482138|NCT03596905|579493424|FG003|Overall Study|Adverse Event|0|||
160604428|NCT00364832|579930763|FG006|Core Period|Early Withdrawals|4|||
160482139|NCT03596905|579493425|FG004|Overall Study|Adverse Event|0|||
160482140|NCT03596905|579493426|FG005|Overall Study|Adverse Event|0|||
160482141|NCT03596905|579493427|FG006|Overall Study|Adverse Event|1|||
160482142|NCT03596905|579493421|FG000|Overall Study|Non-Compliance with eDiary|1|||
160482143|NCT03596905|579493422|FG001|Overall Study|Non-Compliance with eDiary|0|||
160482144|NCT03596905|579493423|FG002|Overall Study|Non-Compliance with eDiary|0|||
160482145|NCT03596905|579493424|FG003|Overall Study|Non-Compliance with eDiary|0|||
160482146|NCT03596905|579493425|FG004|Overall Study|Non-Compliance with eDiary|1|||
160482147|NCT03596905|579493426|FG005|Overall Study|Non-Compliance with eDiary|0|||
160482148|NCT03596905|579493427|FG006|Overall Study|Non-Compliance with eDiary|2|||
160482149|NCT03596905|579493421|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160482150|NCT03596905|579493422|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160482151|NCT03596905|579493423|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160482152|NCT03596905|579493424|FG003|Overall Study|Non-Compliance with Study Drug|0|||
160482153|NCT03596905|579493425|FG004|Overall Study|Non-Compliance with Study Drug|1|||
160482154|NCT03596905|579493426|FG005|Overall Study|Non-Compliance with Study Drug|0|||
160482155|NCT03596905|579493427|FG006|Overall Study|Non-Compliance with Study Drug|0|||
160482156|NCT03596905|579493421|FG000|Overall Study|Lost to Follow-up|0|||
160482157|NCT03596905|579493422|FG001|Overall Study|Lost to Follow-up|0|||
160482158|NCT03596905|579493423|FG002|Overall Study|Lost to Follow-up|0|||
160482159|NCT03596905|579493424|FG003|Overall Study|Lost to Follow-up|0|||
160482160|NCT03596905|579493425|FG004|Overall Study|Lost to Follow-up|0|||
160482161|NCT03596905|579493426|FG005|Overall Study|Lost to Follow-up|1|||
160482162|NCT03596905|579493427|FG006|Overall Study|Lost to Follow-up|0|||
160482163|NCT04307134|579493428|FG000|Overall Study|Lost to Follow-up|2|||
160482164|NCT04307134|579493428|FG000|Overall Study|Withdrawal by Subject|3|||
160482165|NCT04307134|579493428|FG000|Overall Study|Other|3|||
160482166|NCT04307134|579493428|FG000|Overall Study|Death|21|||
160482167|NCT04307134|579493428|FG000|Overall Study|Enrolled but not Treated|1|||
160482168|NCT01809691|579493429|FG000|Overall Study|Currently on Treatment|192|||
160482169|NCT01809691|579493430|FG001|Overall Study|Currently on Treatment|100|||
160482170|NCT01809691|579493429|FG000|Overall Study|No Protocol Treatment|10|||
160482171|NCT01809691|579493430|FG001|Overall Study|No Protocol Treatment|11|||
160482172|NCT01809691|579493429|FG000|Overall Study|Adverse Event|80|||
160482173|NCT01809691|579493430|FG001|Overall Study|Adverse Event|21|||
160482174|NCT01809691|579493429|FG000|Overall Study|Disease Progression|226|||
160482175|NCT01809691|579493430|FG001|Overall Study|Disease Progression|372|||
160482176|NCT01809691|579493429|FG000|Overall Study|Death|26|||
160482177|NCT01809691|579493430|FG001|Overall Study|Death|13|||
160482178|NCT01809691|579493429|FG000|Overall Study|Participant Refusal|70|||
160482179|NCT01809691|579493430|FG001|Overall Study|Participant Refusal|72|||
160482180|NCT01809691|579493429|FG000|Overall Study|Other, Not Specified|34|||
160482181|NCT01809691|579493430|FG001|Overall Study|Other, Not Specified|52|||
160482182|NCT00907517|579493431|FG000|Overall Study|Progressive Disease|3|||
160482183|NCT00907517|579493432|FG001|Overall Study|Progressive Disease|3|||
160482184|NCT00907517|579493433|FG002|Overall Study|Progressive Disease|4|||
160482185|NCT00907517|579493434|FG003|Overall Study|Progressive Disease|4|||
160482186|NCT00907517|579493435|FG004|Overall Study|Progressive Disease|4|||
160482187|NCT00907517|579493431|FG000|Overall Study|Symptomatic Deterioration|0|||
160482188|NCT00907517|579493432|FG001|Overall Study|Symptomatic Deterioration|0|||
160482189|NCT00907517|579493433|FG002|Overall Study|Symptomatic Deterioration|0|||
160482190|NCT00907517|579493434|FG003|Overall Study|Symptomatic Deterioration|0|||
160482191|NCT00907517|579493435|FG004|Overall Study|Symptomatic Deterioration|1|||
160482192|NCT01732627|579493436|FG000|Overall Study|Withdrawal by Subject|1|||
160482193|NCT01732627|579493437|FG001|Overall Study|Withdrawal by Subject|0|||
160482194|NCT03541200|579493441|FG000|Overall Study|Adverse Event|19|||
160482195|NCT03541200|579493441|FG000|Overall Study|Death|1|||
160482196|NCT03541200|579493441|FG000|Overall Study|Lost to Follow-up|10|||
160482197|NCT03541200|579493441|FG000|Overall Study|Physician Decision|1|||
160482198|NCT03541200|579493441|FG000|Overall Study|Protocol Violation|51|||
160482199|NCT03541200|579493441|FG000|Overall Study|Withdrawal by Subject|23|||
160482200|NCT03541200|579493441|FG000|Overall Study|other|8|||
160482201|NCT02522299|579493442|FG000|Overall Study|Adverse Event|2|||
160482202|NCT02522299|579493443|FG001|Overall Study|Adverse Event|0|||
160482203|NCT02522299|579493442|FG000|Overall Study|Physician Decision|0|||
160482204|NCT02522299|579493443|FG001|Overall Study|Physician Decision|1|||
160482205|NCT02522299|579493442|FG000|Overall Study|Withdrawal by Subject|2|||
160482206|NCT02522299|579493443|FG001|Overall Study|Withdrawal by Subject|0|||
160482207|NCT02097056|579493446|FG000|Overall Study|Protocol Violation|2|||
160482208|NCT02097056|579493446|FG000|Overall Study|Withdrawal by Subject|15|||
160482209|NCT02097056|579493446|FG000|Overall Study|Lost to Follow-up|2|||
160482210|NCT02097056|579493446|FG000|Overall Study|Adverse Event|37|||
160482211|NCT02097056|579493446|FG000|Overall Study|Other|2|||
160482212|NCT01446042|579493447|FG000|Overall Study|Withdrawal by Subject|12|||
160482213|NCT01446042|579493448|FG001|Overall Study|Withdrawal by Subject|2|||
160660819|NCT01520909|580141670|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
160482214|NCT01446042|579493449|FG002|Overall Study|Withdrawal by Subject|4|||
160482215|NCT01446042|579493447|FG000|Overall Study|Adverse Event|1|||
160482216|NCT01446042|579493448|FG001|Overall Study|Adverse Event|0|||
160482217|NCT01446042|579493449|FG002|Overall Study|Adverse Event|4|||
160482218|NCT01446042|579493447|FG000|Overall Study|Lost to Follow-up|5|||
160482219|NCT01446042|579493448|FG001|Overall Study|Lost to Follow-up|0|||
160482220|NCT01446042|579493449|FG002|Overall Study|Lost to Follow-up|0|||
160482221|NCT01446042|579493447|FG000|Overall Study|Other reasons|2|||
160482222|NCT01446042|579493448|FG001|Overall Study|Other reasons|1|||
160482223|NCT01446042|579493449|FG002|Overall Study|Other reasons|1|||
160482224|NCT05714345|579493456|FG000|Overall Study|Death|1|||
160482225|NCT05714345|579493457|FG001|Overall Study|Death|1|||
160482226|NCT01257698|579493466|FG000|Overall Study|Protocol Violation|4|||
160482227|NCT01257698|579493467|FG001|Overall Study|Protocol Violation|0|||
160482228|NCT00274846|579493473|FG000|Overall Study|Did not receive adequate NK cells|1|||
160482229|NCT01190228|579493474|FG000|Overall Study|Protocol Violation|4|||
160482230|NCT01190228|579493475|FG001|Overall Study|Protocol Violation|0|||
160482231|NCT01190228|579493476|FG002|Overall Study|Protocol Violation|0|||
160482232|NCT01190228|579493474|FG000|Overall Study|Withdrawal by Subject|1|||
160482233|NCT01190228|579493475|FG001|Overall Study|Withdrawal by Subject|0|||
160482234|NCT01190228|579493476|FG002|Overall Study|Withdrawal by Subject|0|||
160482235|NCT01395914|579493482|FG000|Overall Study|Unrelated to study drug AE|6|||
160482236|NCT01395914|579493483|FG001|Overall Study|Unrelated to study drug AE|1|||
160482237|NCT01395914|579493482|FG000|Overall Study|Death|23|||
160482238|NCT01395914|579493483|FG001|Overall Study|Death|17|||
160482239|NCT01395914|579493482|FG000|Overall Study|Other|9|||
160482240|NCT01395914|579493483|FG001|Overall Study|Other|3|||
160482241|NCT01395914|579493482|FG000|Overall Study|Withdrawal by patient|27|||
160482242|NCT01395914|579493483|FG001|Overall Study|Withdrawal by patient|14|||
160482243|NCT01395914|579493482|FG000|Overall Study|Study drug-related AE|1|||
160482244|NCT01395914|579493483|FG001|Overall Study|Study drug-related AE|0|||
160482245|NCT01395914|579493482|FG000|Overall Study|Lost to Follow-up|6|||
160482246|NCT01395914|579493483|FG001|Overall Study|Lost to Follow-up|2|||
160482247|NCT04601857|579493484|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
160482248|NCT04601857|579493485|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
160482249|NCT04601857|579493484|FG000|Overall Study|Disease Progression|2|||
160482250|NCT04601857|579493485|FG001|Overall Study|Disease Progression|4|||
160482251|NCT04601857|579493484|FG000|Overall Study|Clinical Disease Progression|2|||
160482252|NCT04601857|579493485|FG001|Overall Study|Clinical Disease Progression|1|||
160482253|NCT04601857|579493484|FG000|Overall Study|Radiological Progression|4|||
160482254|NCT04601857|579493485|FG001|Overall Study|Radiological Progression|11|||
160482255|NCT04601857|579493484|FG000|Overall Study|Death|1|||
160482256|NCT04601857|579493485|FG001|Overall Study|Death|0|||
160482257|NCT04601857|579493484|FG000|Overall Study|Reason Not Specified|0|||
160482258|NCT04601857|579493485|FG001|Overall Study|Reason Not Specified|1|||
160482259|NCT04601857|579493484|FG000|Overall Study|At the Participant's Request|0|||
160482260|NCT04601857|579493485|FG001|Overall Study|At the Participant's Request|1|||
160482261|NCT00980954|579493486|FG000|Overall Study|Protocol Violation|9|||
160482262|NCT00980954|579493487|FG001|Overall Study|Protocol Violation|15|||
160482263|NCT04115319|579493488|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
160482264|NCT04115319|579493489|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
160482265|NCT04115319|579493488|FG000|Overall Study|Withdrawal by participant|17|||
160482266|NCT04115319|579493489|FG001|Overall Study|Withdrawal by participant|9|||
160482267|NCT04115319|579493488|FG000|Overall Study|Geopolitical Conflict Related|2|||
160482268|NCT04115319|579493489|FG001|Overall Study|Geopolitical Conflict Related|1|||
160482269|NCT04115319|579493488|FG000|Overall Study|COVID-19 Related|1|||
160482270|NCT04115319|579493489|FG001|Overall Study|COVID-19 Related|0|||
160482271|NCT04115319|579493488|FG000|Overall Study|Adverse Event|48|||
160482272|NCT04115319|579493489|FG001|Overall Study|Adverse Event|21|||
160482273|NCT04115319|579493488|FG000|Overall Study|Noncompliance with Study Drug|5|||
160482274|NCT04115319|579493489|FG001|Overall Study|Noncompliance with Study Drug|1|||
160482275|NCT04115319|579493488|FG000|Overall Study|Lack of Efficacy|6|||
160482276|NCT04115319|579493489|FG001|Overall Study|Lack of Efficacy|2|||
160482277|NCT04115319|579493488|FG000|Overall Study|Lost to Follow-up|6|||
160482278|NCT04115319|579493489|FG001|Overall Study|Lost to Follow-up|7|||
160482279|NCT04115319|579493488|FG000|Overall Study|Protocol Deviation|5|||
160482280|NCT04115319|579493489|FG001|Overall Study|Protocol Deviation|1|||
160482281|NCT04115319|579493488|FG000|Overall Study|Participant relocated|5|||
160482282|NCT04115319|579493489|FG001|Overall Study|Participant relocated|2|||
160482283|NCT04115319|579493488|FG000|Overall Study|Personal Reasons|0|||
160482284|NCT04115319|579493489|FG001|Overall Study|Personal Reasons|1|||
160482285|NCT04115319|579493488|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
160482286|NCT04115319|579493489|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
160482287|NCT02256488|579493495|FG000|Overall Study|Lost to Follow-up|6|||
160482288|NCT02256488|579493496|FG001|Overall Study|Lost to Follow-up|6|||
160482289|NCT02256488|579493497|FG002|Overall Study|Lost to Follow-up|9|||
160482290|NCT02256488|579493498|FG003|Overall Study|Lost to Follow-up|3|||
160482291|NCT02256488|579493495|FG000|Overall Study|OTHER|1|||
160482292|NCT02256488|579493496|FG001|Overall Study|OTHER|0|||
160482293|NCT02256488|579493497|FG002|Overall Study|OTHER|1|||
160482294|NCT02256488|579493498|FG003|Overall Study|OTHER|1|||
160482295|NCT02256488|579493495|FG000|Overall Study|Withdrawal by Subject|1|||
160482296|NCT02256488|579493496|FG001|Overall Study|Withdrawal by Subject|0|||
160482297|NCT02256488|579493497|FG002|Overall Study|Withdrawal by Subject|0|||
160482298|NCT02256488|579493498|FG003|Overall Study|Withdrawal by Subject|2|||
160482299|NCT04930445|579493499|FG000|Overall Study|Adverse Event|7|||
160482300|NCT04930445|579493499|FG000|Overall Study|Lost to Follow-up|1|||
160482301|NCT04930445|579493499|FG000|Overall Study|Physician Decision|1|||
160482302|NCT04930445|579493499|FG000|Overall Study|Lack of Efficacy|1|||
160482303|NCT04930445|579493499|FG000|Overall Study|Study Terminated by Sponsor|245|||
160482304|NCT04930445|579493499|FG000|Overall Study|Screen Failure|8|||
160482305|NCT04930445|579493499|FG000|Overall Study|Other|2|||
160482306|NCT00975130|579493500|FG000|Study Part 1|Adverse Event|150|||
160482307|NCT00975130|579493501|FG001|Study Part 1|Adverse Event|0|||
160482308|NCT00975130|579493502|FG002|Study Part 1|Adverse Event|0|||
160482309|NCT00975130|579493500|FG000|Study Part 1|Lost to Follow-up|19|||
160604429|NCT00364832|579930764|FG007|Core Period|Early Withdrawals|1|||
160482310|NCT00975130|579493501|FG001|Study Part 1|Lost to Follow-up|0|||
160482311|NCT00975130|579493502|FG002|Study Part 1|Lost to Follow-up|0|||
160482312|NCT00975130|579493500|FG000|Study Part 1|Withdrawal by Subject|61|||
160482313|NCT00975130|579493501|FG001|Study Part 1|Withdrawal by Subject|0|||
160482314|NCT00975130|579493502|FG002|Study Part 1|Withdrawal by Subject|0|||
160482315|NCT00975130|579493500|FG000|Study Part 1|Protocol Violation|13|||
160482316|NCT00975130|579493501|FG001|Study Part 1|Protocol Violation|0|||
160482317|NCT00975130|579493502|FG002|Study Part 1|Protocol Violation|0|||
160482318|NCT00975130|579493500|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
160482319|NCT00975130|579493501|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
160482320|NCT00975130|579493502|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
160482321|NCT00975130|579493500|FG000|Study Part 1|Administrative|4|||
160482322|NCT00975130|579493501|FG001|Study Part 1|Administrative|0|||
160482323|NCT00975130|579493502|FG002|Study Part 1|Administrative|0|||
160482324|NCT00975130|579493500|FG000|Study Part 1|Withdrew Consent|24|||
160482325|NCT00975130|579493501|FG001|Study Part 1|Withdrew Consent|0|||
160482326|NCT00975130|579493502|FG002|Study Part 1|Withdrew Consent|0|||
160482327|NCT00975130|579493500|FG000|Study Part 2|Adverse Event|0|||
160482328|NCT00975130|579493501|FG001|Study Part 2|Adverse Event|14|||
160482329|NCT00975130|579493502|FG002|Study Part 2|Adverse Event|7|||
160482330|NCT00975130|579493500|FG000|Study Part 2|Lost to Follow-up|0|||
160482331|NCT00975130|579493501|FG001|Study Part 2|Lost to Follow-up|0|||
160482332|NCT00975130|579493502|FG002|Study Part 2|Lost to Follow-up|1|||
160482333|NCT00975130|579493500|FG000|Study Part 2|Withdrawal by Subject|0|||
160482334|NCT00975130|579493501|FG001|Study Part 2|Withdrawal by Subject|13|||
160482335|NCT00975130|579493502|FG002|Study Part 2|Withdrawal by Subject|5|||
160482336|NCT00975130|579493500|FG000|Study Part 2|Withdrew Consent|0|||
160482337|NCT00975130|579493501|FG001|Study Part 2|Withdrew Consent|6|||
160482338|NCT00975130|579493502|FG002|Study Part 2|Withdrew Consent|2|||
160482339|NCT00975130|579493500|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
160482340|NCT00975130|579493501|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
160482341|NCT00975130|579493502|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
160482342|NCT00975130|579493500|FG000|Study Part 2|Administrative|0|||
160482343|NCT00975130|579493501|FG001|Study Part 2|Administrative|1|||
160482344|NCT00975130|579493502|FG002|Study Part 2|Administrative|0|||
160482345|NCT00975130|579493500|FG000|Study Part 2|Protocol Violation|0|||
160482346|NCT00975130|579493501|FG001|Study Part 2|Protocol Violation|0|||
160482347|NCT00975130|579493502|FG002|Study Part 2|Protocol Violation|1|||
160482348|NCT01261793|579493503|FG000|Overall Study|Lack of Efficacy|44|||
160482349|NCT01261793|579493504|FG001|Overall Study|Lack of Efficacy|37|||
160482350|NCT01261793|579493505|FG002|Overall Study|Lack of Efficacy|32|||
160482351|NCT01261793|579493503|FG000|Overall Study|Protocol Violation|3|||
160482352|NCT01261793|579493504|FG001|Overall Study|Protocol Violation|5|||
160482353|NCT01261793|579493505|FG002|Overall Study|Protocol Violation|6|||
160482354|NCT01261793|579493503|FG000|Overall Study|Lost to Follow-up|10|||
160482355|NCT01261793|579493504|FG001|Overall Study|Lost to Follow-up|3|||
160482356|NCT01261793|579493505|FG002|Overall Study|Lost to Follow-up|7|||
160482357|NCT01261793|579493503|FG000|Overall Study|Withdrawal by Subject|12|||
160482358|NCT01261793|579493504|FG001|Overall Study|Withdrawal by Subject|14|||
160482359|NCT01261793|579493505|FG002|Overall Study|Withdrawal by Subject|14|||
160482360|NCT01261793|579493503|FG000|Overall Study|Death|3|||
160482361|NCT01261793|579493504|FG001|Overall Study|Death|1|||
160482362|NCT01261793|579493505|FG002|Overall Study|Death|0|||
160482363|NCT01261793|579493503|FG000|Overall Study|Adverse Event|9|||
160482364|NCT01261793|579493504|FG001|Overall Study|Adverse Event|24|||
160482365|NCT01261793|579493505|FG002|Overall Study|Adverse Event|19|||
160482366|NCT01261793|579493503|FG000|Overall Study|Patient non-availability|1|||
160482367|NCT01261793|579493504|FG001|Overall Study|Patient non-availability|1|||
160482368|NCT01261793|579493505|FG002|Overall Study|Patient non-availability|1|||
160482369|NCT01261793|579493503|FG000|Overall Study|Suspected pregnancy|1|||
160482370|NCT01261793|579493504|FG001|Overall Study|Suspected pregnancy|1|||
160482371|NCT01261793|579493505|FG002|Overall Study|Suspected pregnancy|0|||
160482372|NCT01261793|579493503|FG000|Overall Study|Patient non-compliance|1|||
160482373|NCT01261793|579493504|FG001|Overall Study|Patient non-compliance|0|||
160482374|NCT01261793|579493505|FG002|Overall Study|Patient non-compliance|1|||
160604430|NCT00364832|579930765|FG008|Core Period|Early Withdrawals|0|||
160604431|NCT00364832|579930766|FG009|Core Period|Early Withdrawals|0|||
160604432|NCT00364832|579930767|FG010|Core Period|Early Withdrawals|0|||
160604433|NCT00364832|579930768|FG011|Core Period|Early Withdrawals|0|||
160604434|NCT00364832|579930757|FG000|Extension Year 1|Early Withdrawals|0|||
160604435|NCT00364832|579930758|FG001|Extension Year 1|Early Withdrawals|0|||
160604436|NCT00364832|579930759|FG002|Extension Year 1|Early Withdrawals|0|||
160604437|NCT00364832|579930760|FG003|Extension Year 1|Early Withdrawals|0|||
160604438|NCT00364832|579930761|FG004|Extension Year 1|Early Withdrawals|0|||
160604439|NCT00364832|579930762|FG005|Extension Year 1|Early Withdrawals|0|||
160604440|NCT00364832|579930763|FG006|Extension Year 1|Early Withdrawals|0|||
160604441|NCT00364832|579930764|FG007|Extension Year 1|Early Withdrawals|0|||
160604442|NCT00364832|579930765|FG008|Extension Year 1|Early Withdrawals|0|||
160604443|NCT00364832|579930766|FG009|Extension Year 1|Early Withdrawals|4|||
160604444|NCT00364832|579930767|FG010|Extension Year 1|Early Withdrawals|2|||
160604445|NCT00364832|579930768|FG011|Extension Year 1|Early Withdrawals|10|||
160604446|NCT00364832|579930757|FG000|Extension Year 2|Early Withdrawals|0|||
160604447|NCT00364832|579930758|FG001|Extension Year 2|Early Withdrawals|0|||
160604448|NCT00364832|579930759|FG002|Extension Year 2|Early Withdrawals|0|||
160604449|NCT00364832|579930760|FG003|Extension Year 2|Early Withdrawals|0|||
160604450|NCT00364832|579930761|FG004|Extension Year 2|Early Withdrawals|0|||
160482375|NCT01261793|579493503|FG000|Overall Study|Patient pregnant|1|||
160482376|NCT01261793|579493504|FG001|Overall Study|Patient pregnant|0|||
160482377|NCT01261793|579493505|FG002|Overall Study|Patient pregnant|0|||
160482378|NCT01261793|579493503|FG000|Overall Study|Outside the study area|0|||
160482379|NCT01261793|579493504|FG001|Overall Study|Outside the study area|2|||
160604451|NCT00364832|579930762|FG005|Extension Year 2|Early Withdrawals|0|||
160604452|NCT00364832|579930763|FG006|Extension Year 2|Early Withdrawals|0|||
160482380|NCT01261793|579493505|FG002|Overall Study|Outside the study area|1|||
160482381|NCT01261793|579493503|FG000|Overall Study|Lack of efficacy & patient not available|0|||
160660820|NCT01520909|580141668|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
160482382|NCT01261793|579493504|FG001|Overall Study|Lack of efficacy & patient not available|1|||
160482383|NCT01261793|579493505|FG002|Overall Study|Lack of efficacy & patient not available|0|||
160482384|NCT01261793|579493503|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
160482385|NCT01261793|579493504|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
160482386|NCT01261793|579493505|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
160482387|NCT01261793|579493503|FG000|Overall Study|Randomization error|0|||
160482388|NCT01261793|579493504|FG001|Overall Study|Randomization error|1|||
160482389|NCT01261793|579493505|FG002|Overall Study|Randomization error|0|||
160482390|NCT01261793|579493503|FG000|Overall Study|Patient unable to start IV line|0|||
160482391|NCT01261793|579493504|FG001|Overall Study|Patient unable to start IV line|0|||
160482392|NCT01261793|579493505|FG002|Overall Study|Patient unable to start IV line|1|||
160482393|NCT03562117|579493506|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
160482394|NCT03562117|579493507|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
160482395|NCT03562117|579493508|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
160482396|NCT03928821|579493509|FG000|Overall Study|Death|0|||
160482397|NCT03928821|579493510|FG001|Overall Study|Death|1|||
160482398|NCT03928821|579493511|FG002|Overall Study|Death|0|||
160482399|NCT03928821|579493512|FG003|Overall Study|Death|0|||
160482400|NCT03928821|579493509|FG000|Overall Study|Lost to Follow-up|0|||
160482401|NCT03928821|579493510|FG001|Overall Study|Lost to Follow-up|2|||
160482402|NCT03928821|579493511|FG002|Overall Study|Lost to Follow-up|3|||
160482403|NCT03928821|579493512|FG003|Overall Study|Lost to Follow-up|0|||
160482404|NCT03928821|579493509|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
160482405|NCT03928821|579493510|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
160482406|NCT03928821|579493511|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
160482407|NCT03928821|579493512|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
160482408|NCT03520036|579493513|FG000|Overall Study|Adverse Event|1|||
160482409|NCT03520036|579493514|FG001|Overall Study|Adverse Event|2|||
160482410|NCT03520036|579493515|FG002|Overall Study|Adverse Event|0|||
160482411|NCT03520036|579493513|FG000|Overall Study|Protocol Violation|1|||
160482412|NCT03520036|579493514|FG001|Overall Study|Protocol Violation|0|||
160482413|NCT03520036|579493515|FG002|Overall Study|Protocol Violation|0|||
160482414|NCT03520036|579493513|FG000|Overall Study|Withdrawal by Subject|0|||
160482415|NCT03520036|579493514|FG001|Overall Study|Withdrawal by Subject|1|||
160482416|NCT03520036|579493515|FG002|Overall Study|Withdrawal by Subject|4|||
160482417|NCT03520036|579493513|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
160482418|NCT03520036|579493514|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
160482419|NCT03520036|579493515|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
160482420|NCT04743999|579493516|FG000|3-month Questionnaire|Death|1|||
160482421|NCT04743999|579493516|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
160482422|NCT04743999|579493516|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
160482423|NCT04743999|579493516|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
160482424|NCT01721759|579493517|FG000|Treatment Period|Disease Progression|85|||
160482425|NCT01721759|579493517|FG000|Treatment Period|Study drug toxicity|14|||
160482426|NCT01721759|579493517|FG000|Treatment Period|Death|1|||
160482427|NCT01721759|579493517|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
160482428|NCT01721759|579493517|FG000|Treatment Period|Participant request to withdraw|3|||
160482429|NCT01721759|579493517|FG000|Treatment Period|Other Reasons|3|||
160482430|NCT01721759|579493517|FG000|End of Study Period|Participant Withdrew Consent|5|||
160482431|NCT01721759|579493517|FG000|End of Study Period|Death|101|||
160482432|NCT01721759|579493517|FG000|End of Study Period|Lost to Follow-up|1|||
160482433|NCT01721759|579493517|FG000|End of Study Period|Other Reasons|10|||
160482434|NCT01123200|579493518|FG000|Overall Study|Withdrawal by Subject|1|||
160482435|NCT02577315|579493521|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
160482436|NCT02577315|579493522|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
160482437|NCT01636778|579493523|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
160482438|NCT01636778|579493524|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
160482439|NCT01636778|579493525|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
160482440|NCT01636778|579493523|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
160482441|NCT01636778|579493524|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
160482442|NCT01636778|579493525|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
160482443|NCT01636778|579493523|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
160482444|NCT01636778|579493524|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
160482445|NCT01636778|579493525|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
160482446|NCT01636778|579493523|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
160482447|NCT01636778|579493524|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
160482448|NCT01636778|579493525|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
160482449|NCT01636778|579493523|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
160482450|NCT01636778|579493524|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
160482451|NCT01636778|579493525|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
160482452|NCT01636778|579493523|FG000|Follow-up Period After Part 2|Other|0|||
160482453|NCT01636778|579493524|FG001|Follow-up Period After Part 2|Other|0|||
160482454|NCT01636778|579493525|FG002|Follow-up Period After Part 2|Other|1|||
160604453|NCT00364832|579930764|FG007|Extension Year 2|Early Withdrawals|0|||
160604454|NCT00364832|579930765|FG008|Extension Year 2|Early Withdrawals|0|||
160604455|NCT00364832|579930766|FG009|Extension Year 2|Early Withdrawals|5|||
160604456|NCT00364832|579930767|FG010|Extension Year 2|Early Withdrawals|5|||
160604457|NCT00364832|579930768|FG011|Extension Year 2|Early Withdrawals|3|||
160604458|NCT03210220|579930769|FG000|Overall Study|Physician Decision|1|||
160604459|NCT03210220|579930770|FG001|Overall Study|Physician Decision|0|||
160604460|NCT01366534|579930786|FG000|Overall Study|Lost to Follow-up|1|||
160604461|NCT01366534|579930787|FG001|Overall Study|Lost to Follow-up|0|||
160604462|NCT01366534|579930788|FG002|Overall Study|Lost to Follow-up|0|||
160604463|NCT01366534|579930786|FG000|Overall Study|Migrated|1|||
160604464|NCT01366534|579930787|FG001|Overall Study|Migrated|1|||
160604465|NCT01366534|579930788|FG002|Overall Study|Migrated|0|||
160604466|NCT01366534|579930786|FG000|Overall Study|Declined challenged|0|||
160604467|NCT01366534|579930787|FG001|Overall Study|Declined challenged|1|||
160604468|NCT01366534|579930788|FG002|Overall Study|Declined challenged|0|||
160604469|NCT02640755|579930789|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
160604470|NCT02640755|579930790|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
160604471|NCT02640755|579930789|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
160604472|NCT02640755|579930790|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
160482455|NCT01636778|579493523|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
160482456|NCT01636778|579493524|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
160482457|NCT01636778|579493525|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
160482458|NCT01636778|579493523|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
160482459|NCT01636778|579493524|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
160482460|NCT01636778|579493525|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
160482461|NCT03530345|579493529|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
160482462|NCT03530345|579493530|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
160482463|NCT03530345|579493529|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
160482464|NCT03530345|579493530|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
160482465|NCT03530345|579493529|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
160482466|NCT03530345|579493530|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
160482467|NCT03530345|579493529|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
160482468|NCT03530345|579493530|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
160482469|NCT00170950|579493531|FG000|Overall Study|Death|236|||
160482470|NCT00170950|579493532|FG001|Overall Study|Death|274|||
160482471|NCT00170950|579493531|FG000|Overall Study|Withdrawal by Subject|496|||
160482472|NCT00170950|579493532|FG001|Overall Study|Withdrawal by Subject|498|||
160482473|NCT00170950|579493531|FG000|Overall Study|Lost to Follow-up|134|||
160482474|NCT00170950|579493532|FG001|Overall Study|Lost to Follow-up|115|||
160482475|NCT00170950|579493531|FG000|Overall Study|Missing|2|||
160482476|NCT00170950|579493532|FG001|Overall Study|Missing|1|||
160482477|NCT00170950|579493531|FG000|Overall Study|Termination Data Not Recorded|17|||
160482478|NCT00170950|579493532|FG001|Overall Study|Termination Data Not Recorded|22|||
160482479|NCT00748098|579493533|FG000|First Treatment Intervention Period|Adverse Event|1|||
160482480|NCT00748098|579493534|FG001|First Treatment Intervention Period|Adverse Event|1|||
160482481|NCT00748098|579493533|FG000|First Treatment Intervention Period|Protocol Violation|1|||
160482482|NCT00748098|579493534|FG001|First Treatment Intervention Period|Protocol Violation|0|||
160482483|NCT00748098|579493533|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
160482484|NCT00748098|579493534|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
160482485|NCT00748098|579493533|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
160482486|NCT00748098|579493534|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
160482487|NCT00748098|579493533|FG000|First Taper Period|Protocol Violation|1|||
160482488|NCT00748098|579493534|FG001|First Taper Period|Protocol Violation|0|||
160482489|NCT00748098|579493533|FG000|First Taper Period|Withdrawal by Subject|2|||
160482490|NCT00748098|579493534|FG001|First Taper Period|Withdrawal by Subject|0|||
160482491|NCT00748098|579493533|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
160482492|NCT00748098|579493534|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
160604473|NCT02640755|579930789|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
160604474|NCT02640755|579930790|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
160604475|NCT01192100|579930797|FG000|Overall Study|Withdrawal by Subject|0|||
160604476|NCT01192100|579930798|FG001|Overall Study|Withdrawal by Subject|0|||
160604477|NCT01192100|579930799|FG002|Overall Study|Withdrawal by Subject|0|||
160604478|NCT01192100|579930800|FG003|Overall Study|Withdrawal by Subject|0|||
160604479|NCT01192100|579930801|FG004|Overall Study|Withdrawal by Subject|1|||
160604480|NCT01192100|579930802|FG005|Overall Study|Withdrawal by Subject|0|||
160604481|NCT01192100|579930797|FG000|Overall Study|Protocol Violation|0|||
160660821|NCT01520909|580141669|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
160604482|NCT01192100|579930798|FG001|Overall Study|Protocol Violation|0|||
160604483|NCT01192100|579930799|FG002|Overall Study|Protocol Violation|0|||
160660822|NCT01520909|580141670|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
160482493|NCT00748098|579493533|FG000|1-Week Washout Period|Adverse Event|0|||
160482494|NCT00748098|579493534|FG001|1-Week Washout Period|Adverse Event|1|||
160482495|NCT00748098|579493533|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
160482496|NCT00748098|579493534|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
160482497|NCT00748098|579493533|FG000|Second Treatment Intervention Period|Adverse Event|4|||
160482498|NCT00748098|579493534|FG001|Second Treatment Intervention Period|Adverse Event|1|||
160482499|NCT00748098|579493533|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
160482500|NCT00748098|579493534|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
160482501|NCT00748098|579493533|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
160482502|NCT00748098|579493534|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
160482503|NCT02442622|579493537|FG000|Overall Study|Withdrawal by Subject|3|||
160482504|NCT02442622|579493538|FG001|Overall Study|Withdrawal by Subject|1|||
160482505|NCT02938520|579493539|FG000|Overall Study|On-going at the time of analysis|258|||
160482506|NCT02938520|579493540|FG001|Overall Study|On-going at the time of analysis|261|||
160482507|NCT02938520|579493539|FG000|Overall Study|Physician Decision|2|||
160482508|NCT02938520|579493540|FG001|Overall Study|Physician Decision|5|||
160482509|NCT02938520|579493539|FG000|Overall Study|Lost to Follow-up|2|||
160482510|NCT02938520|579493540|FG001|Overall Study|Lost to Follow-up|2|||
160482511|NCT02938520|579493539|FG000|Overall Study|Withdrawal by Subject|7|||
160482512|NCT02938520|579493540|FG001|Overall Study|Withdrawal by Subject|7|||
160482513|NCT02938520|579493539|FG000|Overall Study|Protocol Violation|0|||
160482514|NCT02938520|579493540|FG001|Overall Study|Protocol Violation|1|||
160482515|NCT02938520|579493539|FG000|Overall Study|Lack of Efficacy|5|||
160482516|NCT02938520|579493540|FG001|Overall Study|Lack of Efficacy|3|||
160482517|NCT02938520|579493539|FG000|Overall Study|Adverse Event|9|||
160482518|NCT02938520|579493540|FG001|Overall Study|Adverse Event|4|||
160482519|NCT04448561|579493544|FG000|Overall Study|Noncompliance|1|||
160482520|NCT04448561|579493545|FG001|Overall Study|Noncompliance|0|||
160482521|NCT00635570|579494574|FG000|Overall Study|Lost to Follow-up|8|||
160482522|NCT00635570|579494575|FG001|Overall Study|Lost to Follow-up|8|||
160482523|NCT00635570|579494574|FG000|Overall Study|Withdrawal by Subject|1|||
160482524|NCT00635570|579494575|FG001|Overall Study|Withdrawal by Subject|1|||
160482525|NCT00635570|579494574|FG000|Overall Study|Adverse Event|2|||
160482526|NCT00635570|579494575|FG001|Overall Study|Adverse Event|0|||
160482527|NCT00635570|579494574|FG000|Overall Study|Physician Decision|1|||
160482528|NCT00635570|579494575|FG001|Overall Study|Physician Decision|0|||
160482529|NCT00635570|579494574|FG000|Overall Study|Did not complete survey|2|||
160482530|NCT00635570|579494575|FG001|Overall Study|Did not complete survey|1|||
160482531|NCT00635570|579494574|FG000|Overall Study|Early termination(No sexual activity)|1|||
160482532|NCT00635570|579494575|FG001|Overall Study|Early termination(No sexual activity)|1|||
160482533|NCT04816708|579494577|FG000|Overall Study|Lost to Follow-up|10|||
160482534|NCT04816708|579494578|FG001|Overall Study|Lost to Follow-up|4|||
160482535|NCT00197106|579494579|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
160482536|NCT00197106|579494580|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
160482537|NCT00197106|579494581|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
160482538|NCT00197106|579494579|FG000|Overall Treatment Period|Lack of Efficacy|0|||
160482539|NCT00197106|579494580|FG001|Overall Treatment Period|Lack of Efficacy|1|||
160482540|NCT00197106|579494581|FG002|Overall Treatment Period|Lack of Efficacy|0|||
160482541|NCT00197106|579494579|FG000|Overall Treatment Period|Lost to Follow-up|0|||
160482542|NCT00197106|579494580|FG001|Overall Treatment Period|Lost to Follow-up|0|||
160482543|NCT00197106|579494581|FG002|Overall Treatment Period|Lost to Follow-up|2|||
160482544|NCT00197106|579494579|FG000|Overall Treatment Period|Protocol Violation|0|||
160482545|NCT00197106|579494580|FG001|Overall Treatment Period|Protocol Violation|0|||
160482546|NCT00197106|579494581|FG002|Overall Treatment Period|Protocol Violation|2|||
160482547|NCT00197106|579494579|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
160482548|NCT00197106|579494580|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
160482549|NCT00197106|579494581|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
160482550|NCT02531126|579494582|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
160482551|NCT02531126|579494583|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
160482552|NCT02531126|579494584|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
160482553|NCT02531126|579494585|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
160482554|NCT02531126|579494582|FG000|Overall Study|Adverse Event|16|||
160482555|NCT02531126|579494583|FG001|Overall Study|Adverse Event|13|||
160482556|NCT02531126|579494584|FG002|Overall Study|Adverse Event|27|||
160482557|NCT02531126|579494585|FG003|Overall Study|Adverse Event|4|||
160482558|NCT02531126|579494582|FG000|Overall Study|Lack of Efficacy|50|||
160482559|NCT02531126|579494583|FG001|Overall Study|Lack of Efficacy|32|||
160482560|NCT02531126|579494584|FG002|Overall Study|Lack of Efficacy|121|||
160604484|NCT01192100|579930800|FG003|Overall Study|Protocol Violation|1|||
160604485|NCT01192100|579930801|FG004|Overall Study|Protocol Violation|0|||
160604486|NCT01192100|579930802|FG005|Overall Study|Protocol Violation|0|||
160604487|NCT02057068|579930803|FG000|Overall Study|Withdrawal by Subject|2|||
160604488|NCT02057068|579930804|FG001|Overall Study|Withdrawal by Subject|2|||
160604489|NCT02057068|579930803|FG000|Overall Study|Caregiver (CG) Health|0|||
160482561|NCT02531126|579494585|FG003|Overall Study|Lack of Efficacy|0|||
160482562|NCT02531126|579494582|FG000|Overall Study|Withdrawal by Subject|38|||
160482563|NCT02531126|579494583|FG001|Overall Study|Withdrawal by Subject|31|||
160482564|NCT02531126|579494584|FG002|Overall Study|Withdrawal by Subject|96|||
160482565|NCT02531126|579494585|FG003|Overall Study|Withdrawal by Subject|6|||
160482566|NCT02531126|579494582|FG000|Overall Study|Pregnancy|2|||
160482567|NCT02531126|579494583|FG001|Overall Study|Pregnancy|3|||
160604490|NCT02057068|579930804|FG001|Overall Study|Caregiver (CG) Health|2|||
160604491|NCT02057068|579930803|FG000|Overall Study|Carepartner (CP) Health|4|||
160604492|NCT02057068|579930804|FG001|Overall Study|Carepartner (CP) Health|2|||
160604493|NCT02057068|579930803|FG000|Overall Study|Lost to Follow-up|2|||
160604494|NCT02057068|579930804|FG001|Overall Study|Lost to Follow-up|2|||
160604495|NCT00865046|579930806|FG000|Overall Study|Lost to Follow-up|1|||
160604496|NCT00865046|579930807|FG001|Overall Study|Lost to Follow-up|4|||
160604497|NCT00865046|579930808|FG002|Overall Study|Lost to Follow-up|0|||
160604498|NCT00865046|579930806|FG000|Overall Study|Death|0|||
160604499|NCT00865046|579930807|FG001|Overall Study|Death|1|||
160604500|NCT00865046|579930808|FG002|Overall Study|Death|1|||
160604501|NCT00865046|579930806|FG000|Overall Study|Withdrawal by Subject|5|||
160604502|NCT00865046|579930807|FG001|Overall Study|Withdrawal by Subject|0|||
160604503|NCT00865046|579930808|FG002|Overall Study|Withdrawal by Subject|0|||
160604504|NCT01098032|579930814|FG000|Overall Study|Withdrawal by Subject|1|||
160604505|NCT01098032|579930815|FG001|Overall Study|Withdrawal by Subject|1|||
160604506|NCT01587274|579930816|FG000|Overall Study|Lost to Follow-up|4|||
160604507|NCT01587274|579930817|FG001|Overall Study|Lost to Follow-up|5|||
160604508|NCT01587274|579930818|FG002|Overall Study|Lost to Follow-up|3|||
160604509|NCT02709109|579930832|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
160604510|NCT02709109|579930833|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
160604511|NCT02709109|579930834|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
160604512|NCT02709109|579930835|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
160604513|NCT02709109|579930832|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
160604514|NCT02709109|579930833|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
160604515|NCT02709109|579930834|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
160604516|NCT02709109|579930835|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
160604517|NCT02709109|579930832|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
160604518|NCT02709109|579930833|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
160604519|NCT02709109|579930834|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
160604520|NCT02709109|579930835|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
160660823|NCT01520909|580141668|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
160660824|NCT01520909|580141669|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
160660825|NCT01520909|580141670|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
160482568|NCT02531126|579494584|FG002|Overall Study|Pregnancy|2|||
160482569|NCT02531126|579494585|FG003|Overall Study|Pregnancy|0|||
160482570|NCT02531126|579494582|FG000|Overall Study|Switched to commercial drug|2|||
160482571|NCT02531126|579494583|FG001|Overall Study|Switched to commercial drug|4|||
160482572|NCT02531126|579494584|FG002|Overall Study|Switched to commercial drug|4|||
160482573|NCT02531126|579494585|FG003|Overall Study|Switched to commercial drug|0|||
160482574|NCT02531126|579494582|FG000|Overall Study|Other reasons|23|||
160482575|NCT02531126|579494583|FG001|Overall Study|Other reasons|29|||
160482576|NCT02531126|579494584|FG002|Overall Study|Other reasons|27|||
160482577|NCT02531126|579494585|FG003|Overall Study|Other reasons|15|||
160482578|NCT02531126|579494582|FG000|Overall Study|Physician Decision|6|||
160482579|NCT02531126|579494583|FG001|Overall Study|Physician Decision|6|||
160482580|NCT02531126|579494584|FG002|Overall Study|Physician Decision|28|||
160482581|NCT02531126|579494585|FG003|Overall Study|Physician Decision|0|||
160482582|NCT02531126|579494582|FG000|Overall Study|Non-compliance with investigational drug|1|||
160482583|NCT02531126|579494583|FG001|Overall Study|Non-compliance with investigational drug|0|||
160482584|NCT02531126|579494584|FG002|Overall Study|Non-compliance with investigational drug|0|||
160482585|NCT02531126|579494585|FG003|Overall Study|Non-compliance with investigational drug|0|||
160482586|NCT00762723|579494586|FG000|Overall Study|Study Terminated slow enrollement|5|||
160482587|NCT00762723|579494587|FG001|Overall Study|Study Terminated slow enrollement|5|||
160482588|NCT00762723|579494588|FG002|Overall Study|Study Terminated slow enrollement|3|||
160482589|NCT00382408|579494589|FG000|Overall Study|Did not meet protocol requirement|3|||
160604521|NCT02709109|579930832|FG000|Washout Period (28 Days)|Other|2|||
160604522|NCT02709109|579930833|FG001|Washout Period (28 Days)|Other|2|||
160604523|NCT02709109|579930834|FG002|Washout Period (28 Days)|Other|3|||
160660826|NCT01520909|580141668|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
160482590|NCT00382408|579494590|FG001|Overall Study|Did not meet protocol requirement|3|||
160482591|NCT00382408|579494589|FG000|Overall Study|Protocol Violation|2|||
160482592|NCT00382408|579494590|FG001|Overall Study|Protocol Violation|2|||
160604524|NCT02709109|579930835|FG003|Washout Period (28 Days)|Other|0|||
160604525|NCT02709109|579930832|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
160604526|NCT02709109|579930833|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
160604527|NCT02709109|579930834|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
160604528|NCT02709109|579930835|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
160482593|NCT00382408|579494589|FG000|Overall Study|Physician Decision|1|||
160482594|NCT00382408|579494590|FG001|Overall Study|Physician Decision|0|||
160482595|NCT00382408|579494589|FG000|Overall Study|Withdrawal by Subject|17|||
160482596|NCT00382408|579494590|FG001|Overall Study|Withdrawal by Subject|6|||
160482597|NCT00382408|579494589|FG000|Overall Study|Pregnancy|2|||
160482598|NCT00382408|579494590|FG001|Overall Study|Pregnancy|0|||
160482599|NCT00382408|579494589|FG000|Overall Study|Lost to Follow-up|19|||
160482600|NCT00382408|579494590|FG001|Overall Study|Lost to Follow-up|8|||
160482601|NCT00382408|579494589|FG000|Overall Study|Other|100|||
160482602|NCT00382408|579494590|FG001|Overall Study|Other|35|||
160482603|NCT03085433|579494591|FG000|Overall Study|Withdrawal by Subject|2|||
160482604|NCT03085433|579494592|FG001|Overall Study|Withdrawal by Subject|4|||
160482605|NCT03085433|579494591|FG000|Overall Study|Physician Decision|33|||
160482606|NCT03085433|579494592|FG001|Overall Study|Physician Decision|50|||
160482607|NCT03809039|579494593|FG000|Part 1|Withdrawal by Subject|1|||
160482608|NCT03809039|579494594|FG001|Part 1|Withdrawal by Subject|0|||
160482609|NCT03809039|579494595|FG002|Part 1|Withdrawal by Subject|0|||
160482610|NCT03809039|579494596|FG003|Part 1|Withdrawal by Subject|1|||
160482611|NCT03809039|579494597|FG004|Part 1|Withdrawal by Subject|0|||
160482612|NCT03809039|579494598|FG005|Part 1|Withdrawal by Subject|0|||
160482613|NCT03809039|579494599|FG006|Part 1|Withdrawal by Subject|0|||
160482614|NCT03809039|579494600|FG007|Part 1|Withdrawal by Subject|0|||
160482615|NCT03809039|579494601|FG008|Part 1|Withdrawal by Subject|0|||
160482616|NCT03809039|579494593|FG000|Part 3|Withdrawn by study termination|0|||
160482617|NCT03809039|579494594|FG001|Part 3|Withdrawn by study termination|0|||
160482618|NCT03809039|579494595|FG002|Part 3|Withdrawn by study termination|0|||
160482619|NCT03809039|579494596|FG003|Part 3|Withdrawn by study termination|0|||
160482620|NCT03809039|579494597|FG004|Part 3|Withdrawn by study termination|0|||
160482621|NCT03809039|579494598|FG005|Part 3|Withdrawn by study termination|0|||
160482622|NCT03809039|579494599|FG006|Part 3|Withdrawn by study termination|0|||
160482623|NCT03809039|579494600|FG007|Part 3|Withdrawn by study termination|2|||
160482624|NCT03809039|579494601|FG008|Part 3|Withdrawn by study termination|6|||
160482625|NCT05271552|579494602|FG000|Overall Study|Adverse Event|4|||
160482626|NCT05271552|579494603|FG001|Overall Study|Adverse Event|6|||
160482627|NCT05271552|579494604|FG002|Overall Study|Adverse Event|3|||
160482628|NCT05271552|579494602|FG000|Overall Study|Death|1|||
160482629|NCT05271552|579494603|FG001|Overall Study|Death|1|||
160482630|NCT05271552|579494604|FG002|Overall Study|Death|1|||
160482631|NCT05271552|579494602|FG000|Overall Study|Lost to Follow-up|1|||
160482632|NCT05271552|579494603|FG001|Overall Study|Lost to Follow-up|5|||
160482633|NCT05271552|579494604|FG002|Overall Study|Lost to Follow-up|4|||
160482634|NCT05271552|579494602|FG000|Overall Study|Withdrawal by Subject|0|||
160482635|NCT05271552|579494603|FG001|Overall Study|Withdrawal by Subject|4|||
160482636|NCT05271552|579494604|FG002|Overall Study|Withdrawal by Subject|7|||
160482637|NCT05271552|579494602|FG000|Overall Study|Other medical reason.|1|||
160482638|NCT05271552|579494603|FG001|Overall Study|Other medical reason.|2|||
160482639|NCT05271552|579494604|FG002|Overall Study|Other medical reason.|0|||
160482640|NCT05271552|579494602|FG000|Overall Study|Other|3|||
160482641|NCT05271552|579494603|FG001|Overall Study|Other|3|||
160482642|NCT05271552|579494604|FG002|Overall Study|Other|6|||
160482643|NCT03840993|579494605|FG000|Overall Study|Adverse Event|1|||
160482644|NCT03840993|579494606|FG001|Overall Study|Adverse Event|0|||
160482645|NCT03840993|579494605|FG000|Overall Study|Lost to Follow-up|4|||
160482646|NCT03840993|579494606|FG001|Overall Study|Lost to Follow-up|0|||
160482647|NCT03840993|579494605|FG000|Overall Study|Physician Decision|0|||
160482648|NCT03840993|579494606|FG001|Overall Study|Physician Decision|1|||
160604529|NCT02709109|579930832|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
160604530|NCT02709109|579930833|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
160604531|NCT02709109|579930834|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
160604532|NCT02709109|579930835|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
160604533|NCT02709109|579930832|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
160482649|NCT03840993|579494605|FG000|Overall Study|Pregnancy|0|||
160482650|NCT03840993|579494606|FG001|Overall Study|Pregnancy|1|||
160482651|NCT03840993|579494605|FG000|Overall Study|Withdrawal by Subject|1|||
160482652|NCT03840993|579494606|FG001|Overall Study|Withdrawal by Subject|3|||
160482653|NCT03840993|579494605|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
160604534|NCT02709109|579930833|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
160482654|NCT03840993|579494606|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
160482655|NCT01572493|579494607|FG000|Overall Study|Physician Decision|1|||
160482656|NCT01572493|579494608|FG001|Overall Study|Physician Decision|0|||
160604535|NCT02709109|579930834|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
160482657|NCT01572493|579494609|FG002|Overall Study|Physician Decision|0|||
160482658|NCT01572493|579494610|FG003|Overall Study|Physician Decision|0|||
160482659|NCT01572493|579494611|FG004|Overall Study|Physician Decision|0|||
160482660|NCT01572493|579494612|FG005|Overall Study|Physician Decision|0|||
160482661|NCT01572493|579494613|FG006|Overall Study|Physician Decision|0|||
160482662|NCT01572493|579494614|FG007|Overall Study|Physician Decision|0|||
160482663|NCT01572493|579494615|FG008|Overall Study|Physician Decision|0|||
160482664|NCT01572493|579494607|FG000|Overall Study|Switched to alternative treatment|0|||
160482665|NCT01572493|579494608|FG001|Overall Study|Switched to alternative treatment|1|||
160482666|NCT01572493|579494609|FG002|Overall Study|Switched to alternative treatment|2|||
160482667|NCT01572493|579494610|FG003|Overall Study|Switched to alternative treatment|1|||
160482668|NCT01572493|579494611|FG004|Overall Study|Switched to alternative treatment|2|||
160482669|NCT01572493|579494612|FG005|Overall Study|Switched to alternative treatment|0|||
160482670|NCT01572493|579494613|FG006|Overall Study|Switched to alternative treatment|2|||
160482671|NCT01572493|579494614|FG007|Overall Study|Switched to alternative treatment|0|||
160482672|NCT01572493|579494615|FG008|Overall Study|Switched to alternative treatment|2|||
160482673|NCT01572493|579494607|FG000|Overall Study|Death|0|||
160482674|NCT01572493|579494608|FG001|Overall Study|Death|0|||
160482675|NCT01572493|579494609|FG002|Overall Study|Death|0|||
160482676|NCT01572493|579494610|FG003|Overall Study|Death|1|||
160482677|NCT01572493|579494611|FG004|Overall Study|Death|0|||
160482678|NCT01572493|579494612|FG005|Overall Study|Death|1|||
160482679|NCT01572493|579494613|FG006|Overall Study|Death|0|||
160482680|NCT01572493|579494614|FG007|Overall Study|Death|0|||
160482681|NCT01572493|579494615|FG008|Overall Study|Death|0|||
160482682|NCT01572493|579494607|FG000|Overall Study|Adverse Event|0|||
160482683|NCT01572493|579494608|FG001|Overall Study|Adverse Event|0|||
160482684|NCT01572493|579494609|FG002|Overall Study|Adverse Event|0|||
160482685|NCT01572493|579494610|FG003|Overall Study|Adverse Event|0|||
160482686|NCT01572493|579494611|FG004|Overall Study|Adverse Event|0|||
160482687|NCT01572493|579494612|FG005|Overall Study|Adverse Event|0|||
160482688|NCT01572493|579494613|FG006|Overall Study|Adverse Event|1|||
160482689|NCT01572493|579494614|FG007|Overall Study|Adverse Event|0|||
160482690|NCT01572493|579494615|FG008|Overall Study|Adverse Event|0|||
160482691|NCT01284634|579494619|FG000|Overall Study|Adverse Event|1|||
160482692|NCT01284634|579494620|FG001|Overall Study|Adverse Event|0|||
160482693|NCT01284634|579494621|FG002|Overall Study|Adverse Event|2|||
160482694|NCT01284634|579494622|FG003|Overall Study|Adverse Event|1|||
160482695|NCT02236598|579494623|FG000|Overall Study|Adverse Event|0|||
160482696|NCT02236598|579494624|FG001|Overall Study|Adverse Event|1|||
160482697|NCT02236598|579494623|FG000|Overall Study|Withdrawal by Subject|0|||
160482698|NCT02236598|579494624|FG001|Overall Study|Withdrawal by Subject|1|||
160482699|NCT04203160|579494636|FG000|Overall Study|Alternative Therapy|3|||
160482700|NCT04203160|579494637|FG001|Overall Study|Alternative Therapy|0|||
160482701|NCT04203160|579494638|FG002|Overall Study|Alternative Therapy|1|||
160482702|NCT04203160|579494639|FG003|Overall Study|Alternative Therapy|0|||
160482703|NCT04203160|579494640|FG004|Overall Study|Alternative Therapy|0|||
160482704|NCT04203160|579494641|FG005|Overall Study|Alternative Therapy|2|||
160482705|NCT04203160|579494636|FG000|Overall Study|Withdrawal by Subject|4|||
160482706|NCT04203160|579494637|FG001|Overall Study|Withdrawal by Subject|5|||
160482707|NCT04203160|579494638|FG002|Overall Study|Withdrawal by Subject|0|||
160482708|NCT04203160|579494639|FG003|Overall Study|Withdrawal by Subject|0|||
160482709|NCT04203160|579494640|FG004|Overall Study|Withdrawal by Subject|0|||
160482710|NCT04203160|579494641|FG005|Overall Study|Withdrawal by Subject|4|||
160482711|NCT04203160|579494636|FG000|Overall Study|Adverse Event|7|||
160482712|NCT04203160|579494637|FG001|Overall Study|Adverse Event|5|||
160482713|NCT04203160|579494638|FG002|Overall Study|Adverse Event|0|||
160482714|NCT04203160|579494639|FG003|Overall Study|Adverse Event|0|||
160482715|NCT04203160|579494640|FG004|Overall Study|Adverse Event|0|||
160482716|NCT04203160|579494641|FG005|Overall Study|Adverse Event|0|||
160482717|NCT04203160|579494636|FG000|Overall Study|Sponsor Termination|1|||
160482718|NCT04203160|579494637|FG001|Overall Study|Sponsor Termination|0|||
160482719|NCT04203160|579494638|FG002|Overall Study|Sponsor Termination|0|||
160482720|NCT04203160|579494639|FG003|Overall Study|Sponsor Termination|0|||
160482721|NCT04203160|579494640|FG004|Overall Study|Sponsor Termination|0|||
160482722|NCT04203160|579494641|FG005|Overall Study|Sponsor Termination|0|||
160482723|NCT04203160|579494636|FG000|Overall Study|Physician Decision|3|||
160482724|NCT04203160|579494637|FG001|Overall Study|Physician Decision|2|||
160604536|NCT02709109|579930835|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
160482725|NCT04203160|579494638|FG002|Overall Study|Physician Decision|0|||
160482726|NCT04203160|579494639|FG003|Overall Study|Physician Decision|0|||
160482727|NCT04203160|579494640|FG004|Overall Study|Physician Decision|0|||
160482728|NCT04203160|579494641|FG005|Overall Study|Physician Decision|0|||
160482729|NCT03048058|579494647|FG000|Overall Study|Lost to Follow-up|4|||
160482730|NCT03048058|579494648|FG001|Overall Study|Lost to Follow-up|0|||
160482731|NCT03048058|579494647|FG000|Overall Study|Withdrawal by Subject|0|||
160482732|NCT03048058|579494648|FG001|Overall Study|Withdrawal by Subject|4|||
160482733|NCT03305458|579494649|FG000|Overall Study|Withdrawal by Subject|50|||
160482734|NCT03305458|579494650|FG001|Overall Study|Withdrawal by Subject|46|||
160482735|NCT03305458|579494651|FG002|Overall Study|Withdrawal by Subject|93|||
160482736|NCT03305458|579494649|FG000|Overall Study|Lost to Follow-up|85|||
160482737|NCT03305458|579494650|FG001|Overall Study|Lost to Follow-up|85|||
160482738|NCT03305458|579494651|FG002|Overall Study|Lost to Follow-up|35|||
160482739|NCT02332824|579494652|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
160482740|NCT02332824|579494653|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
160604537|NCT02709109|579930832|FG000|Treatment Period 2 (28 Days)|Other|0|||
160482741|NCT02332824|579494654|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
160482742|NCT02332824|579494655|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
160482743|NCT02332824|579494656|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
160482744|NCT02332824|579494657|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
160482745|NCT02332824|579494652|FG000|Overall Study|Voluntary Withdrawal|1|||
160482746|NCT02332824|579494653|FG001|Overall Study|Voluntary Withdrawal|0|||
160482747|NCT02332824|579494654|FG002|Overall Study|Voluntary Withdrawal|0|||
160482748|NCT02332824|579494655|FG003|Overall Study|Voluntary Withdrawal|0|||
160482749|NCT02332824|579494656|FG004|Overall Study|Voluntary Withdrawal|0|||
160482750|NCT02332824|579494657|FG005|Overall Study|Voluntary Withdrawal|0|||
160482751|NCT02332824|579494652|FG000|Overall Study|Inconvenient schedule|1|||
160482752|NCT02332824|579494653|FG001|Overall Study|Inconvenient schedule|1|||
160482753|NCT02332824|579494654|FG002|Overall Study|Inconvenient schedule|0|||
160482754|NCT02332824|579494655|FG003|Overall Study|Inconvenient schedule|0|||
160482755|NCT02332824|579494656|FG004|Overall Study|Inconvenient schedule|0|||
160482756|NCT02332824|579494657|FG005|Overall Study|Inconvenient schedule|0|||
160482757|NCT02332824|579494652|FG000|Overall Study|Transfer|0|||
160482758|NCT02332824|579494653|FG001|Overall Study|Transfer|0|||
160482759|NCT02332824|579494654|FG002|Overall Study|Transfer|1|||
160482760|NCT02332824|579494655|FG003|Overall Study|Transfer|1|||
160482761|NCT02332824|579494656|FG004|Overall Study|Transfer|0|||
160482762|NCT02332824|579494657|FG005|Overall Study|Transfer|0|||
160482763|NCT03926117|579494658|FG000|Overall Study|Unclassified|1|||
160482764|NCT03926117|579494659|FG001|Overall Study|Unclassified|4|||
160482765|NCT03926117|579494660|FG002|Overall Study|Unclassified|1|||
160482766|NCT03926117|579494661|FG003|Overall Study|Unclassified|4|||
160482767|NCT03926117|579494658|FG000|Overall Study|Withdrawal by Subject|3|||
160482768|NCT03926117|579494659|FG001|Overall Study|Withdrawal by Subject|0|||
160482769|NCT03926117|579494660|FG002|Overall Study|Withdrawal by Subject|1|||
160482770|NCT03926117|579494661|FG003|Overall Study|Withdrawal by Subject|1|||
160482771|NCT03926117|579494658|FG000|Overall Study|Lost to Follow-up|0|||
160482772|NCT03926117|579494659|FG001|Overall Study|Lost to Follow-up|2|||
160482773|NCT03926117|579494660|FG002|Overall Study|Lost to Follow-up|1|||
160482774|NCT03926117|579494661|FG003|Overall Study|Lost to Follow-up|0|||
160482775|NCT03926117|579494658|FG000|Overall Study|Adverse Event|1|||
160482776|NCT03926117|579494659|FG001|Overall Study|Adverse Event|2|||
160482777|NCT03926117|579494660|FG002|Overall Study|Adverse Event|3|||
160482778|NCT03926117|579494661|FG003|Overall Study|Adverse Event|1|||
160482779|NCT03926117|579494658|FG000|Overall Study|Randomized but not treated|1|||
160482780|NCT03926117|579494659|FG001|Overall Study|Randomized but not treated|1|||
160482781|NCT03926117|579494660|FG002|Overall Study|Randomized but not treated|0|||
160482782|NCT03926117|579494661|FG003|Overall Study|Randomized but not treated|1|||
160482783|NCT03138499|579494662|FG000|Overall Study|Lost to Follow-up|1|||
160482784|NCT03138499|579494663|FG001|Overall Study|Lost to Follow-up|0|||
160482785|NCT03138499|579494662|FG000|Overall Study|Participants withdrew consent|1|||
160482786|NCT03138499|579494663|FG001|Overall Study|Participants withdrew consent|0|||
160482787|NCT03138499|579494662|FG000|Overall Study|Participant discontinued study before treatment|0|||
160482788|NCT03138499|579494663|FG001|Overall Study|Participant discontinued study before treatment|1|||
160482789|NCT03138499|579494662|FG000|Overall Study|Disease Progression|2|||
160482790|NCT03138499|579494663|FG001|Overall Study|Disease Progression|6|||
160482791|NCT03138499|579494662|FG000|Overall Study|Study drug toxicity|2|||
160482792|NCT03138499|579494663|FG001|Overall Study|Study drug toxicity|2|||
160482793|NCT03138499|579494662|FG000|Overall Study|Participant request to discontinue study treatment|1|||
160482794|NCT03138499|579494663|FG001|Overall Study|Participant request to discontinue study treatment|1|||
160482795|NCT03138499|579494662|FG000|Overall Study|Other reasons|2|||
160482796|NCT03138499|579494663|FG001|Overall Study|Other reasons|0|||
160482797|NCT05379023|579494664|FG000|Overall Study|Lost to Follow-up|1|||
160482798|NCT05379023|579494665|FG001|Overall Study|Lost to Follow-up|0|||
160482799|NCT05379023|579494666|FG002|Overall Study|Lost to Follow-up|0|||
160604538|NCT02709109|579930833|FG001|Treatment Period 2 (28 Days)|Other|0|||
160482800|NCT05379023|579494664|FG000|Overall Study|Withdrawal by Subject|2|||
160482801|NCT05379023|579494665|FG001|Overall Study|Withdrawal by Subject|0|||
160482802|NCT05379023|579494666|FG002|Overall Study|Withdrawal by Subject|0|||
160482803|NCT05147662|579494667|FG000|Overall Study|Withdrawal by parent/guardian|3|||
160482804|NCT05147662|579494667|FG000|Overall Study|Assigned to treatment but never treated|1|||
160482805|NCT00508274|579495723|FG000|Overall Study|Adverse Event|5|||
160482806|NCT00508274|579495723|FG000|Overall Study|Death|7|||
160604539|NCT02709109|579930834|FG002|Treatment Period 2 (28 Days)|Other|1|||
160482807|NCT00508274|579495723|FG000|Overall Study|Disease progression|32|||
160482808|NCT00508274|579495723|FG000|Overall Study|Withdrawal by Subject|1|||
160482809|NCT00508274|579495723|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
160482810|NCT00508274|579495723|FG000|Overall Study|Missing|3|||
160482811|NCT04050722|579495724|FG000|Overall Study|Withdrawal by Subject|1|||
160482812|NCT04050722|579495725|FG001|Overall Study|Withdrawal by Subject|0|||
160482813|NCT00377312|579495729|FG000|Overall Study|Adverse Event|1|||
160482814|NCT00377312|579495730|FG001|Overall Study|Adverse Event|1|||
160604540|NCT02709109|579930835|FG003|Treatment Period 2 (28 Days)|Other|0|||
160482815|NCT03451292|579495733|FG000|Overall Study|Death|44|||
160482816|NCT03451292|579495734|FG001|Overall Study|Death|59|||
160482817|NCT03451292|579495733|FG000|Overall Study|Withdrawal by Subject|18|||
160482818|NCT03451292|579495734|FG001|Overall Study|Withdrawal by Subject|13|||
160482819|NCT03451292|579495733|FG000|Overall Study|Transplantation|18|||
160482820|NCT03451292|579495734|FG001|Overall Study|Transplantation|12|||
160482821|NCT03451292|579495733|FG000|Overall Study|Lost to Follow-up|4|||
160482822|NCT03451292|579495734|FG001|Overall Study|Lost to Follow-up|12|||
160482823|NCT03451292|579495733|FG000|Overall Study|Physician Decision|4|||
160482824|NCT03451292|579495734|FG001|Overall Study|Physician Decision|3|||
160482825|NCT03451292|579495733|FG000|Overall Study|Adverse Event|3|||
160482826|NCT03451292|579495734|FG001|Overall Study|Adverse Event|3|||
160482827|NCT03451292|579495733|FG000|Overall Study|Non-compliance with Study Drug|2|||
160482828|NCT03451292|579495734|FG001|Overall Study|Non-compliance with Study Drug|0|||
160482829|NCT00609245|579495742|FG000|Overall Study|Adverse Event|1|||
160482830|NCT01090076|579495743|FG000|Overall Study|Death|1|||
160482831|NCT01090076|579495744|FG001|Overall Study|Death|1|||
160482832|NCT01090076|579495743|FG000|Overall Study|Withdrawal by Subject|0|||
160482833|NCT01090076|579495744|FG001|Overall Study|Withdrawal by Subject|1|||
160482834|NCT02176018|579495745|FG000|Overall Study|Adverse Event|0|||
160482835|NCT02176018|579495746|FG001|Overall Study|Adverse Event|2|||
160482836|NCT02176018|579495745|FG000|Overall Study|Lost to Follow-up|3|||
160482837|NCT02176018|579495746|FG001|Overall Study|Lost to Follow-up|1|||
160482838|NCT02176018|579495745|FG000|Overall Study|Protocol Violation|1|||
160482839|NCT02176018|579495746|FG001|Overall Study|Protocol Violation|1|||
160482840|NCT02176018|579495745|FG000|Overall Study|Withdrawal by Subject|1|||
160482841|NCT02176018|579495746|FG001|Overall Study|Withdrawal by Subject|2|||
160482842|NCT03022045|579495748|FG000|Overall Study|Adverse Event|0|||
160482843|NCT03022045|579495749|FG001|Overall Study|Adverse Event|1|||
160482844|NCT03022045|579495748|FG000|Overall Study|Withdrawal by Subject|1|||
160482845|NCT03022045|579495749|FG001|Overall Study|Withdrawal by Subject|1|||
160482846|NCT02973477|579495750|FG000|First Intervention|Lost to Follow-up|0|||
160482847|NCT02973477|579495751|FG001|First Intervention|Lost to Follow-up|2|||
160482848|NCT02973477|579495750|FG000|Washout|Withdrawal by Subject|1|||
160482849|NCT02973477|579495751|FG001|Washout|Withdrawal by Subject|0|||
160482850|NCT02973477|579495750|FG000|Second Intervention|Lost to Follow-up|1|||
160482851|NCT02973477|579495751|FG001|Second Intervention|Lost to Follow-up|0|||
160482852|NCT02402465|579495753|FG000|Overall Study|Withdrawal by Subject|0|||
160482853|NCT02402465|579495754|FG001|Overall Study|Withdrawal by Subject|0|||
160482854|NCT02402465|579495755|FG002|Overall Study|Withdrawal by Subject|0|||
160482855|NCT02402465|579495756|FG003|Overall Study|Withdrawal by Subject|0|||
160482856|NCT02402465|579495757|FG004|Overall Study|Withdrawal by Subject|0|||
160482857|NCT02402465|579495758|FG005|Overall Study|Withdrawal by Subject|1|||
160482858|NCT02402465|579495753|FG000|Overall Study|Lost to Follow-up|0|||
160482859|NCT02402465|579495754|FG001|Overall Study|Lost to Follow-up|1|||
160482860|NCT02402465|579495755|FG002|Overall Study|Lost to Follow-up|0|||
160482861|NCT02402465|579495756|FG003|Overall Study|Lost to Follow-up|0|||
160482862|NCT02402465|579495757|FG004|Overall Study|Lost to Follow-up|1|||
160482863|NCT02402465|579495758|FG005|Overall Study|Lost to Follow-up|0|||
160482864|NCT03807700|579495759|FG000|Overall Study|Withdrawal by Subject|2|||
160482865|NCT03807700|579495760|FG001|Overall Study|Withdrawal by Subject|1|||
160482866|NCT01059526|579495761|FG000|Overall Study|Patient enrolled but not treated|20|||
160604541|NCT02565615|579930836|FG000|Overall Study|Death|0|||
160604542|NCT02565615|579930837|FG001|Overall Study|Death|1|||
160604543|NCT02565615|579930838|FG002|Overall Study|Death|0|||
160604544|NCT02565615|579930839|FG003|Overall Study|Death|0|||
160604545|NCT02565615|579930840|FG004|Overall Study|Death|4|||
160604546|NCT02565615|579930836|FG000|Overall Study|Not willing to participate in study|2|||
160604547|NCT02565615|579930837|FG001|Overall Study|Not willing to participate in study|21|||
160482867|NCT01059526|579495762|FG001|Overall Study|Patient enrolled but not treated|17|||
160482868|NCT01059526|579495761|FG000|Overall Study|Adverse Event|2|||
160482869|NCT01059526|579495762|FG001|Overall Study|Adverse Event|2|||
160482870|NCT01059526|579495761|FG000|Overall Study|Protocol Violation|0|||
160482871|NCT01059526|579495762|FG001|Overall Study|Protocol Violation|1|||
160482872|NCT01059526|579495761|FG000|Overall Study|Withdrawal by Subject|3|||
160482873|NCT01059526|579495762|FG001|Overall Study|Withdrawal by Subject|1|||
160604548|NCT02565615|579930838|FG002|Overall Study|Not willing to participate in study|0|||
160604549|NCT02565615|579930839|FG003|Overall Study|Not willing to participate in study|1|||
160604550|NCT02565615|579930840|FG004|Overall Study|Not willing to participate in study|169|||
160482874|NCT01059526|579495761|FG000|Overall Study|Lost to Follow-up|4|||
160482875|NCT01059526|579495762|FG001|Overall Study|Lost to Follow-up|1|||
160482876|NCT01059526|579495761|FG000|Overall Study|Patient found to be dermatographic|1|||
160482877|NCT01059526|579495762|FG001|Overall Study|Patient found to be dermatographic|0|||
160482878|NCT01732588|579495763|FG000|First Intervention (7 Days)|Adverse Event|0|||
160482879|NCT01732588|579495764|FG001|First Intervention (7 Days)|Adverse Event|1|||
160482880|NCT01732588|579495765|FG002|First Intervention (7 Days)|Adverse Event|0|||
160482881|NCT02720081|579495766|FG000|Overall Study|Adverse Event|0|||
160604551|NCT02565615|579930836|FG000|Overall Study|Lost to Follow-up|0|||
160604552|NCT02565615|579930837|FG001|Overall Study|Lost to Follow-up|4|||
160604553|NCT02565615|579930838|FG002|Overall Study|Lost to Follow-up|0|||
160604554|NCT02565615|579930839|FG003|Overall Study|Lost to Follow-up|1|||
160604555|NCT02565615|579930840|FG004|Overall Study|Lost to Follow-up|765|||
160604556|NCT02565615|579930836|FG000|Overall Study|Not meeting eligibility criteria|0|||
160604557|NCT02565615|579930837|FG001|Overall Study|Not meeting eligibility criteria|7|||
160604558|NCT02565615|579930838|FG002|Overall Study|Not meeting eligibility criteria|0|||
160604559|NCT02565615|579930839|FG003|Overall Study|Not meeting eligibility criteria|0|||
160604560|NCT02565615|579930840|FG004|Overall Study|Not meeting eligibility criteria|25|||
160604561|NCT02565615|579930836|FG000|Overall Study|Reason not defined|0|||
160604562|NCT02565615|579930837|FG001|Overall Study|Reason not defined|2|||
160604563|NCT02565615|579930838|FG002|Overall Study|Reason not defined|0|||
160604564|NCT02565615|579930839|FG003|Overall Study|Reason not defined|1|||
160604565|NCT02565615|579930840|FG004|Overall Study|Reason not defined|62|||
160604566|NCT02565615|579930836|FG000|Overall Study|Adverse Event|1|||
160604567|NCT02565615|579930837|FG001|Overall Study|Adverse Event|1|||
160604568|NCT02565615|579930838|FG002|Overall Study|Adverse Event|0|||
160604569|NCT02565615|579930839|FG003|Overall Study|Adverse Event|0|||
160604570|NCT02565615|579930840|FG004|Overall Study|Adverse Event|9|||
160604571|NCT02565615|579930836|FG000|Overall Study|Untreated|0|||
160604572|NCT02565615|579930837|FG001|Overall Study|Untreated|0|||
160604573|NCT02565615|579930838|FG002|Overall Study|Untreated|0|||
160604574|NCT02565615|579930839|FG003|Overall Study|Untreated|0|||
160604575|NCT02565615|579930840|FG004|Overall Study|Untreated|567|||
160604576|NCT05563714|579930843|FG000|Overall Study|Death|2|||
160604577|NCT05563714|579930844|FG001|Overall Study|Death|2|||
160604578|NCT05563714|579930845|FG002|Overall Study|Death|0|||
160604579|NCT05563714|579930846|FG003|Overall Study|Death|0|||
160604580|NCT05563714|579930843|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
160604581|NCT05563714|579930844|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
160604582|NCT05563714|579930845|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
160604583|NCT05563714|579930846|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
160604584|NCT05563714|579930843|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
160604585|NCT05563714|579930844|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
160604586|NCT05563714|579930845|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
160604587|NCT05563714|579930846|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
160604588|NCT05563714|579930843|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
160604589|NCT05563714|579930844|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
160604590|NCT05563714|579930845|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
160604591|NCT05563714|579930846|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
160660827|NCT01520909|580141669|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
160482882|NCT02720081|579495767|FG001|Overall Study|Adverse Event|3|||
160482883|NCT02720081|579495766|FG000|Overall Study|Protocol Violation|4|||
160482884|NCT02720081|579495767|FG001|Overall Study|Protocol Violation|1|||
160482885|NCT00428441|579495770|FG000|Overall Study|Lost to Follow-up|1|||
160482886|NCT03132753|579495771|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
160482887|NCT03132753|579495772|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
160482888|NCT03132753|579495771|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
160482889|NCT03132753|579495772|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
160482890|NCT00084747|579495773|FG000|Overall Study|Relapsed|8|||
160482891|NCT00084747|579495773|FG000|Overall Study|Death|3|||
160482892|NCT00084747|579495773|FG000|Overall Study|Withdrawal by Subject|2|||
160482893|NCT00679549|579495775|FG000|Overall Study|dropout|2|||
160482894|NCT00679549|579495776|FG001|Overall Study|dropout|4|||
160482895|NCT00679549|579495775|FG000|Overall Study|missing outcome echocardiograms|4|||
160482896|NCT00679549|579495776|FG001|Overall Study|missing outcome echocardiograms|5|||
160482897|NCT00125853|579495777|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
160482898|NCT00125853|579495778|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
160482899|NCT02744898|579495781|FG000|Overall Study|Progressive Disease|2|||
160604592|NCT05563714|579930843|FG000|Overall Study|Lost to Follow-up|22|||
160482900|NCT02744898|579495781|FG000|Overall Study|Physician Decision|1|||
160482901|NCT02744898|579495781|FG000|Overall Study|Toxicity|1|||
160482902|NCT00157209|579495782|FG000|Overall Study|Ongoing at data cut-off|10|||
160604593|NCT05563714|579930844|FG001|Overall Study|Lost to Follow-up|19|||
160604594|NCT05563714|579930845|FG002|Overall Study|Lost to Follow-up|0|||
160604595|NCT05563714|579930846|FG003|Overall Study|Lost to Follow-up|0|||
160604596|NCT01815580|579930849|FG000|Overall Study|Lost to Follow-up|4|||
160604597|NCT01815580|579930850|FG001|Overall Study|Lost to Follow-up|7|||
160604598|NCT01815580|579930849|FG000|Overall Study|Withdrawal by Subject|3|||
160604599|NCT01815580|579930850|FG001|Overall Study|Withdrawal by Subject|4|||
160482903|NCT00157209|579495783|FG001|Overall Study|Ongoing at data cut-off|0|||
160482904|NCT04474691|579495784|FG000|Overall Study|Withdrawal by Subject|9|||
160482905|NCT01348763|579495785|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
160482906|NCT01348763|579495785|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
160482907|NCT02268526|579495786|FG000|Overall Study|Adverse Event|0|||
160482908|NCT02268526|579495787|FG001|Overall Study|Adverse Event|2|||
160482909|NCT02268526|579495788|FG002|Overall Study|Adverse Event|1|||
160482910|NCT02268526|579495786|FG000|Overall Study|Death|1|||
160482911|NCT02268526|579495787|FG001|Overall Study|Death|11|||
160482912|NCT02268526|579495788|FG002|Overall Study|Death|0|||
160482913|NCT02268526|579495786|FG000|Overall Study|protocol deviation|0|||
160482914|NCT02268526|579495787|FG001|Overall Study|protocol deviation|1|||
160482915|NCT02268526|579495788|FG002|Overall Study|protocol deviation|0|||
160482916|NCT02268526|579495786|FG000|Overall Study|Physician Decision|0|||
160482917|NCT02268526|579495787|FG001|Overall Study|Physician Decision|0|||
160482918|NCT02268526|579495788|FG002|Overall Study|Physician Decision|1|||
160482919|NCT02268526|579495786|FG000|Overall Study|Subject/guardian decision|0|||
160482920|NCT02268526|579495787|FG001|Overall Study|Subject/guardian decision|7|||
160482921|NCT02268526|579495788|FG002|Overall Study|Subject/guardian decision|3|||
160482922|NCT00498797|579495789|FG000|Overall Study|Withdrawal by Subject|4|||
160482923|NCT00498797|579495790|FG001|Overall Study|Withdrawal by Subject|2|||
160482924|NCT00498797|579495789|FG000|Overall Study|Adverse Event|12|||
160482925|NCT00498797|579495790|FG001|Overall Study|Adverse Event|5|||
160482926|NCT00498797|579495789|FG000|Overall Study|Condition under investigation worsened|19|||
160482927|NCT00498797|579495790|FG001|Overall Study|Condition under investigation worsened|21|||
160482928|NCT00498797|579495789|FG000|Overall Study|Other|3|||
160482929|NCT00498797|579495790|FG001|Overall Study|Other|1|||
160482930|NCT00448344|579495800|FG000|Overall Study|Lost to Follow-up|20|||
160482931|NCT00448344|579495801|FG001|Overall Study|Lost to Follow-up|22|||
160482932|NCT00448344|579495800|FG000|Overall Study|Withdrawal by Subject|6|||
160482933|NCT00448344|579495801|FG001|Overall Study|Withdrawal by Subject|8|||
160482934|NCT00448344|579495800|FG000|Overall Study|Death|3|||
160482935|NCT00448344|579495801|FG001|Overall Study|Death|4|||
160482936|NCT00448344|579495800|FG000|Overall Study|Physician Decision|1|||
160482937|NCT00448344|579495801|FG001|Overall Study|Physician Decision|2|||
160482938|NCT01052714|579495807|FG000|Overall Study|Adverse Event|6|||
160482939|NCT01052714|579495808|FG001|Overall Study|Adverse Event|3|||
160482940|NCT01052714|579495809|FG002|Overall Study|Adverse Event|0|||
160482941|NCT01052714|579495807|FG000|Overall Study|Death|1|||
160482942|NCT01052714|579495808|FG001|Overall Study|Death|2|||
160482943|NCT01052714|579495809|FG002|Overall Study|Death|0|||
160482944|NCT01052714|579495807|FG000|Overall Study|Lost to Follow-up|2|||
160482945|NCT01052714|579495808|FG001|Overall Study|Lost to Follow-up|3|||
160482946|NCT01052714|579495809|FG002|Overall Study|Lost to Follow-up|0|||
160482947|NCT01052714|579495807|FG000|Overall Study|Physician Decision|9|||
160482948|NCT01052714|579495808|FG001|Overall Study|Physician Decision|9|||
160482949|NCT01052714|579495809|FG002|Overall Study|Physician Decision|1|||
160482950|NCT01052714|579495807|FG000|Overall Study|Withdrawal by Subject|7|||
160482951|NCT01052714|579495808|FG001|Overall Study|Withdrawal by Subject|12|||
160482952|NCT01052714|579495809|FG002|Overall Study|Withdrawal by Subject|1|||
160482953|NCT00417989|579495813|FG000|Overall Study|Withdrawal by Subject|13|||
160482954|NCT00417989|579495814|FG001|Overall Study|Withdrawal by Subject|13|||
160482955|NCT00417989|579495813|FG000|Overall Study|Lost to Follow-up|1|||
160482956|NCT00417989|579495814|FG001|Overall Study|Lost to Follow-up|6|||
160482957|NCT00417989|579495813|FG000|Overall Study|Protocol Violation|1|||
160482958|NCT00417989|579495814|FG001|Overall Study|Protocol Violation|0|||
160482959|NCT00417989|579495813|FG000|Overall Study|Death|0|||
160482960|NCT00417989|579495814|FG001|Overall Study|Death|1|||
160482961|NCT00417989|579495813|FG000|Overall Study|Physician Decision|5|||
160482962|NCT00417989|579495814|FG001|Overall Study|Physician Decision|2|||
160482963|NCT00990821|579495815|FG000|Overall Study|Withdrawal by Subject|0|||
160482964|NCT00990821|579495816|FG001|Overall Study|Withdrawal by Subject|2|||
160604600|NCT01815580|579930849|FG000|Overall Study|Excluded from analysis|5|||
160604601|NCT01815580|579930850|FG001|Overall Study|Excluded from analysis|4|||
160604602|NCT02120352|579930855|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
160604603|NCT02120352|579930856|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
160482965|NCT00990821|579495817|FG002|Overall Study|Withdrawal by Subject|0|||
160482966|NCT00990821|579495818|FG003|Overall Study|Withdrawal by Subject|0|||
160482967|NCT00990821|579495819|FG004|Overall Study|Withdrawal by Subject|3|||
160482968|NCT00990821|579495820|FG005|Overall Study|Withdrawal by Subject|3|||
160482969|NCT00990821|579495821|FG006|Overall Study|Withdrawal by Subject|1|||
160604604|NCT02120352|579930857|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
160604605|NCT02120352|579930858|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
160604606|NCT02120352|579930859|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
160482970|NCT00990821|579495822|FG007|Overall Study|Withdrawal by Subject|0|||
160482971|NCT00990821|579495823|FG008|Overall Study|Withdrawal by Subject|0|||
160482972|NCT00990821|579495824|FG009|Overall Study|Withdrawal by Subject|1|||
160482973|NCT00990821|579495825|FG010|Overall Study|Withdrawal by Subject|3|||
160604607|NCT02120352|579930860|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
160604608|NCT02120352|579930861|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
160604609|NCT02120352|579930855|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
160604610|NCT02120352|579930856|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
160604611|NCT02120352|579930857|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
160604612|NCT02120352|579930858|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
160604613|NCT02120352|579930859|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
160604614|NCT02120352|579930860|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
160604615|NCT02120352|579930861|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
160604616|NCT02120352|579930855|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
160604617|NCT02120352|579930856|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
160604618|NCT02120352|579930857|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
160604619|NCT02120352|579930858|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
160604620|NCT02120352|579930859|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
160604621|NCT02120352|579930860|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
160604622|NCT02120352|579930861|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
160604623|NCT02120352|579930855|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
160604624|NCT02120352|579930856|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
160604625|NCT02120352|579930857|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
160604626|NCT02120352|579930858|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
160604627|NCT02120352|579930859|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
160604628|NCT02120352|579930860|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
160604629|NCT02120352|579930861|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
160604630|NCT02120352|579930855|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
160604631|NCT02120352|579930856|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
160604632|NCT02120352|579930857|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
160604633|NCT02120352|579930858|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
160604634|NCT02120352|579930859|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
160482974|NCT00990821|579495826|FG011|Overall Study|Withdrawal by Subject|5|||
160482975|NCT00990821|579495827|FG012|Overall Study|Withdrawal by Subject|2|||
160482976|NCT00990821|579495828|FG013|Overall Study|Withdrawal by Subject|1|||
160482977|NCT04150250|579495829|FG000|Overall Study|Lost to Follow-up|0|||
160482978|NCT04150250|579495830|FG001|Overall Study|Lost to Follow-up|2|||
160482979|NCT04212299|579495837|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
160482980|NCT02951052|579495838|FG000|Overall Study|Adverse Event|13|||
160482981|NCT02951052|579495839|FG001|Overall Study|Adverse Event|5|||
160482982|NCT02951052|579495838|FG000|Overall Study|Withdrawal by Subject|1|||
160482983|NCT02951052|579495839|FG001|Overall Study|Withdrawal by Subject|5|||
160482984|NCT02951052|579495838|FG000|Overall Study|Physician Decision|2|||
160482985|NCT02951052|579495839|FG001|Overall Study|Physician Decision|0|||
160482986|NCT02951052|579495838|FG000|Overall Study|Lost to Follow-up|1|||
160482987|NCT02951052|579495839|FG001|Overall Study|Lost to Follow-up|1|||
160482988|NCT02951052|579495838|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
160482989|NCT02951052|579495839|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
160482990|NCT02951052|579495838|FG000|Overall Study|Protocol Violation|5|||
160482991|NCT02951052|579495839|FG001|Overall Study|Protocol Violation|3|||
160482992|NCT02951052|579495838|FG000|Overall Study|Lack of Efficacy|3|||
160482993|NCT02951052|579495839|FG001|Overall Study|Lack of Efficacy|4|||
160482994|NCT02951052|579495838|FG000|Overall Study|Ongoing|1|||
160482995|NCT02951052|579495839|FG001|Overall Study|Ongoing|0|||
160482996|NCT03602859|579495840|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
160482997|NCT03602859|579495841|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
160482998|NCT03602859|579495842|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
160482999|NCT03602859|579495843|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
160483000|NCT03602859|579495840|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
160483001|NCT03602859|579495841|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
160483002|NCT03602859|579495842|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
160483003|NCT03602859|579495843|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
160483004|NCT03602859|579495840|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
160483005|NCT03602859|579495841|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
160483006|NCT03602859|579495842|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
160483007|NCT03602859|579495843|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
160483008|NCT03602859|579495840|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
160483009|NCT03602859|579495841|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
160483010|NCT03602859|579495842|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
160483011|NCT03602859|579495843|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
160483012|NCT03602859|579495840|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
160483013|NCT03602859|579495841|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
160483014|NCT03602859|579495842|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
160483015|NCT03602859|579495843|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
160483016|NCT03602859|579495840|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
160483017|NCT03602859|579495841|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
160483018|NCT03602859|579495842|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
160483019|NCT03602859|579495843|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
160483020|NCT03602859|579495840|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
160483021|NCT03602859|579495841|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
160483022|NCT03602859|579495842|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
160483023|NCT03602859|579495843|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
160483024|NCT03602859|579495840|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
160483025|NCT03602859|579495841|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
160483026|NCT03602859|579495842|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
160483027|NCT03602859|579495843|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
160483028|NCT03602859|579495840|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
160483029|NCT03602859|579495841|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
160483030|NCT03602859|579495842|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
160483031|NCT03602859|579495843|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
160483032|NCT03602859|579495840|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
160483033|NCT03602859|579495841|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
160483034|NCT03602859|579495842|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
160483035|NCT03602859|579495843|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
160483036|NCT03602859|579495840|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
160483037|NCT03602859|579495841|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
160604635|NCT02120352|579930860|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
160604636|NCT02120352|579930861|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
160604637|NCT02120352|579930855|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
160604638|NCT02120352|579930856|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
160604639|NCT02120352|579930857|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
160483038|NCT03602859|579495842|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
160483039|NCT03602859|579495843|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
160483040|NCT03602859|579495840|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
160660828|NCT01520909|580141670|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
160660829|NCT01435265|580141672|FG000|Overall Study|Lost to Follow-up|0|||
160483041|NCT03602859|579495841|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
160483042|NCT03602859|579495842|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
160483043|NCT03602859|579495843|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
160483044|NCT03602859|579495840|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
160483045|NCT03602859|579495841|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
160483046|NCT03602859|579495842|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
160483047|NCT03602859|579495843|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
160483048|NCT03602859|579495840|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
160483049|NCT03602859|579495841|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
160483050|NCT03602859|579495842|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
160660830|NCT01435265|580141673|FG001|Overall Study|Lost to Follow-up|1|||
160660831|NCT02422264|580141674|FG000|Overall Study|Serious Adverse Event|1|||
160660832|NCT02422264|580141675|FG001|Overall Study|Serious Adverse Event|0|||
160483051|NCT03602859|579495843|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
160604640|NCT02120352|579930858|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
160604641|NCT02120352|579930859|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
160604642|NCT02120352|579930860|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
160604643|NCT02120352|579930861|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
160604644|NCT02120352|579930855|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
160604645|NCT02120352|579930856|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
160604646|NCT02120352|579930857|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
160604647|NCT02120352|579930858|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
160604648|NCT02120352|579930859|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
160604649|NCT02120352|579930860|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
160604650|NCT02120352|579930861|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
160604651|NCT02120352|579930855|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
160604652|NCT02120352|579930856|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
160604653|NCT02120352|579930857|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
160604654|NCT02120352|579930858|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
160604655|NCT02120352|579930859|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
160604656|NCT02120352|579930860|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
160604657|NCT02120352|579930861|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
160604658|NCT02120352|579930855|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
160604659|NCT02120352|579930856|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
160604660|NCT02120352|579930857|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
160604661|NCT02120352|579930858|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
160604662|NCT02120352|579930859|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
160604663|NCT02120352|579930860|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
160604664|NCT02120352|579930861|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
160604665|NCT02120352|579930855|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
160604666|NCT02120352|579930856|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
160604667|NCT02120352|579930857|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
160604668|NCT02120352|579930858|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
160604669|NCT02120352|579930859|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
160604670|NCT02120352|579930860|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
160604671|NCT02120352|579930861|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
160483052|NCT03602859|579495840|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
160483053|NCT03602859|579495841|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
160483054|NCT03602859|579495842|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
160483055|NCT03602859|579495843|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
160483056|NCT03602859|579495840|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
160483057|NCT03602859|579495841|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
160483058|NCT03602859|579495842|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
160483059|NCT03602859|579495843|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
160483060|NCT03602859|579495840|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
160483061|NCT03602859|579495841|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
160483062|NCT03602859|579495842|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
160483063|NCT03602859|579495843|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
160483064|NCT03602859|579495840|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
160483065|NCT03602859|579495841|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
160483066|NCT03602859|579495842|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
160483067|NCT03602859|579495843|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
160483068|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
160483069|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
160483070|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
160483071|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
160483072|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
160483073|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
160483074|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
160483075|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
160483076|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
160483077|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
160483078|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
160483079|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
160483080|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
160483081|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
160483082|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
160483083|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
160483084|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
160604672|NCT02120352|579930855|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
160604673|NCT02120352|579930856|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
160604674|NCT02120352|579930857|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
160604675|NCT02120352|579930858|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
160604676|NCT02120352|579930859|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
160604677|NCT02120352|579930860|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
160604678|NCT02120352|579930861|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
160604679|NCT02120352|579930855|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
160604680|NCT02120352|579930856|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
160604681|NCT02120352|579930857|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
160604682|NCT02120352|579930858|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
160604683|NCT02120352|579930859|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
160604684|NCT02120352|579930860|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
160604685|NCT02120352|579930861|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
160604686|NCT02120352|579930855|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
160604687|NCT02120352|579930856|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
160604688|NCT02120352|579930857|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
160604689|NCT02120352|579930858|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
160604690|NCT02120352|579930859|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
160604691|NCT02120352|579930860|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
160604692|NCT02120352|579930861|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
160604693|NCT02120352|579930855|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
160604694|NCT02120352|579930856|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
160604695|NCT02120352|579930857|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
160604696|NCT02120352|579930858|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
160604697|NCT02120352|579930859|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
160604698|NCT02120352|579930860|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
160604699|NCT02120352|579930861|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
160604700|NCT02120352|579930855|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
160604701|NCT02120352|579930856|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
160660833|NCT02422264|580141674|FG000|Overall Study|Withdrawal by Subject|1|||
160660834|NCT02422264|580141675|FG001|Overall Study|Withdrawal by Subject|2|||
160660835|NCT02422264|580141674|FG000|Overall Study|Migrated/moved from study area|3|||
160660836|NCT02422264|580141675|FG001|Overall Study|Migrated/moved from study area|1|||
160660837|NCT02422264|580141674|FG000|Overall Study|Subject vaccinated outside of the study|0|||
160660838|NCT02422264|580141675|FG001|Overall Study|Subject vaccinated outside of the study|1|||
160660839|NCT03021018|580141679|FG000|Overall Study|Adverse Event|1|||
160660840|NCT03021018|580141680|FG001|Overall Study|Adverse Event|0|||
160660841|NCT03021018|580141681|FG002|Overall Study|Adverse Event|0|||
160660842|NCT03021018|580141679|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
160660843|NCT03021018|580141680|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
160660844|NCT03021018|580141681|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
160660845|NCT00856388|580141690|FG000|Overall Study|Other|1|||
160660846|NCT05038293|580141691|FG000|Overall Study|device was not operating properly for one subject.|1|||
160660847|NCT05038293|580141692|FG001|Overall Study|device was not operating properly for one subject.|0|||
160660848|NCT05038293|580141691|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
160660849|NCT05038293|580141692|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
160660850|NCT01171989|580141694|FG000|Overall Study|Lost to Follow-up|0|||
160660851|NCT01171989|580141695|FG001|Overall Study|Lost to Follow-up|0|||
160660852|NCT01171989|580141696|FG002|Overall Study|Lost to Follow-up|1|||
160660853|NCT01247701|580141698|FG000|Overall Study|Death|2|||
160660854|NCT01247701|580141698|FG000|Overall Study|Relapsed|8|||
160660855|NCT04166630|580141699|FG000|Overall Study|Withdrawal by Subject|0|||
160660856|NCT04166630|580141700|FG001|Overall Study|Withdrawal by Subject|1|||
160660857|NCT02822235|580141701|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
160483085|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
160483086|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
160483087|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
160483088|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
160483089|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
160483090|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
160483091|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
160483092|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
160483093|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
160483094|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
160483095|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
160483096|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
160483097|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
160483098|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
160483099|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
160483100|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
160483101|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
160483102|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
160483103|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
160483104|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
160483105|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
160483106|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
160483107|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
160483108|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
160483109|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
160483110|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
160483111|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
160483112|NCT03602859|579495840|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
160483113|NCT03602859|579495841|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
160483114|NCT03602859|579495842|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
160483115|NCT03602859|579495843|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
160483116|NCT01904019|579497396|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
160483117|NCT01904019|579497396|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
160483118|NCT01904019|579497396|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
160483119|NCT01904019|579497396|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
160483120|NCT01904019|579497396|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
160660858|NCT02822235|580141702|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
160660859|NCT02822235|580141701|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
160660860|NCT02822235|580141702|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
160483121|NCT01904019|579497396|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
160483122|NCT01816685|579497399|FG000|Overall Study|Lost to Follow-up|7|||
160483123|NCT01816685|579497400|FG001|Overall Study|Lost to Follow-up|9|||
160483124|NCT01816685|579497399|FG000|Overall Study|Surgery Cancelled|3|||
160483125|NCT01816685|579497400|FG001|Overall Study|Surgery Cancelled|2|||
160483126|NCT01157351|579497401|FG000|Overall Study|Adverse Event|5|||
160483127|NCT01157351|579497402|FG001|Overall Study|Adverse Event|4|||
160483128|NCT01157351|579497401|FG000|Overall Study|Death|1|||
160483129|NCT01157351|579497402|FG001|Overall Study|Death|0|||
160483130|NCT01157351|579497401|FG000|Overall Study|Lost to Follow-up|53|||
160483131|NCT01157351|579497402|FG001|Overall Study|Lost to Follow-up|55|||
160483132|NCT01157351|579497401|FG000|Overall Study|Withdrawal by Subject|37|||
160483133|NCT01157351|579497402|FG001|Overall Study|Withdrawal by Subject|27|||
160483134|NCT01157351|579497401|FG000|Overall Study|Physician Decision|5|||
160483135|NCT01157351|579497402|FG001|Overall Study|Physician Decision|4|||
160483136|NCT01157351|579497401|FG000|Overall Study|Protocol Violation|0|||
160483137|NCT01157351|579497402|FG001|Overall Study|Protocol Violation|1|||
160483138|NCT01157351|579497401|FG000|Overall Study|Other|32|||
160483139|NCT01157351|579497402|FG001|Overall Study|Other|36|||
160483140|NCT01157351|579497401|FG000|Overall Study|Noncompliance with Study Drug|0|||
160483141|NCT01157351|579497402|FG001|Overall Study|Noncompliance with Study Drug|3|||
160483142|NCT01157351|579497401|FG000|Overall Study|Randomized but not Treated|4|||
160483143|NCT01157351|579497402|FG001|Overall Study|Randomized but not Treated|2|||
160483144|NCT01589523|579497403|FG000|Overall Study|Withdrawal by Subject|1|||
160483145|NCT00506922|579497404|FG000|Overall Study|Physician Decision|0|||
160483146|NCT00506922|579497405|FG001|Overall Study|Physician Decision|0|||
160483147|NCT00506922|579497406|FG002|Overall Study|Physician Decision|0|||
160483148|NCT00506922|579497407|FG003|Overall Study|Physician Decision|2|||
160483149|NCT00506922|579497408|FG004|Overall Study|Physician Decision|0|||
160483150|NCT00506922|579497404|FG000|Overall Study|Withdrawal by Subject|0|||
160483151|NCT00506922|579497405|FG001|Overall Study|Withdrawal by Subject|0|||
160483152|NCT00506922|579497406|FG002|Overall Study|Withdrawal by Subject|0|||
160483153|NCT00506922|579497407|FG003|Overall Study|Withdrawal by Subject|0|||
160483154|NCT00506922|579497408|FG004|Overall Study|Withdrawal by Subject|1|||
160483155|NCT00332488|579497409|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
160483156|NCT00332488|579497410|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
160483157|NCT00332488|579497411|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
160483158|NCT00332488|579497409|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
160483159|NCT00332488|579497410|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
160483160|NCT00332488|579497411|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
160483161|NCT00332488|579497409|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
160483162|NCT00332488|579497410|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
160483163|NCT00332488|579497411|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
160483164|NCT00332488|579497409|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
160483165|NCT00332488|579497410|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
160483166|NCT00332488|579497411|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
160483167|NCT00332488|579497409|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
160483168|NCT00332488|579497410|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
160483169|NCT00332488|579497411|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
160483170|NCT00332488|579497409|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
160483171|NCT00332488|579497410|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
160483172|NCT00332488|579497411|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
160483173|NCT00332488|579497409|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
160483174|NCT00332488|579497410|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
160483175|NCT00332488|579497411|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
160483176|NCT00332488|579497409|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
160483177|NCT00332488|579497410|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
160483178|NCT00332488|579497411|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
160483179|NCT00332488|579497409|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
160483180|NCT00332488|579497410|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
160483181|NCT00332488|579497411|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
160483182|NCT00332488|579497409|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
160483183|NCT00332488|579497410|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
160483184|NCT00332488|579497411|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
160483185|NCT00332488|579497409|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
160483186|NCT00332488|579497410|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
160483187|NCT00332488|579497411|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
160604702|NCT02120352|579930857|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
160604703|NCT02120352|579930858|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
160604704|NCT02120352|579930859|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
160483188|NCT00332488|579497409|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
160483189|NCT00332488|579497410|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
160483190|NCT00332488|579497411|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
160604705|NCT02120352|579930860|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
160483191|NCT03721978|579497412|FG000|Overall Study|Withdrawal by Subject|6|||
160483192|NCT03721978|579497413|FG001|Overall Study|Withdrawal by Subject|1|||
160483193|NCT03721978|579497412|FG000|Overall Study|Adverse Event|1|||
160483194|NCT03721978|579497413|FG001|Overall Study|Adverse Event|1|||
160604706|NCT02120352|579930861|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
160604707|NCT02120352|579930855|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
160604708|NCT02120352|579930856|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
160604709|NCT02120352|579930857|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
160604710|NCT02120352|579930858|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
160604711|NCT02120352|579930859|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
160604712|NCT02120352|579930860|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
160604713|NCT02120352|579930861|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
160604714|NCT02120352|579930855|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
160604715|NCT02120352|579930856|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
160604716|NCT02120352|579930857|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
160604717|NCT02120352|579930858|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
160604718|NCT02120352|579930859|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
160604719|NCT02120352|579930860|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
160604720|NCT02120352|579930861|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
160604721|NCT02120352|579930855|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
160604722|NCT02120352|579930856|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
160604723|NCT02120352|579930857|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
160604724|NCT02120352|579930858|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
160604725|NCT02120352|579930859|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
160604726|NCT02120352|579930860|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
160604727|NCT02120352|579930861|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
160483195|NCT03721978|579497412|FG000|Overall Study|Progressive Disease|1|||
160483196|NCT03721978|579497413|FG001|Overall Study|Progressive Disease|0|||
160483197|NCT03721978|579497412|FG000|Overall Study|Lost to Follow-up|5|||
160483198|NCT03721978|579497413|FG001|Overall Study|Lost to Follow-up|1|||
160483199|NCT03721978|579497412|FG000|Overall Study|Reason not Specified|0|||
160483200|NCT03721978|579497413|FG001|Overall Study|Reason not Specified|2|||
160483201|NCT05244226|579497414|FG000|Overall Study|Adverse Event|1|||
160483202|NCT05244226|579497415|FG001|Overall Study|Adverse Event|0|||
160483203|NCT05244226|579497416|FG002|Overall Study|Adverse Event|0|||
160483204|NCT05244226|579497414|FG000|Overall Study|Lost to Follow-up|0|||
160483205|NCT05244226|579497415|FG001|Overall Study|Lost to Follow-up|0|||
160483206|NCT05244226|579497416|FG002|Overall Study|Lost to Follow-up|1|||
160483207|NCT05244226|579497414|FG000|Overall Study|Protocol Violation|0|||
160483208|NCT05244226|579497415|FG001|Overall Study|Protocol Violation|2|||
160483209|NCT05244226|579497416|FG002|Overall Study|Protocol Violation|2|||
160483210|NCT02675998|579497422|FG000|8-Week Treatment Period|Adverse Event|6|||
160483211|NCT02675998|579497423|FG001|8-Week Treatment Period|Adverse Event|5|||
160483212|NCT02675998|579497424|FG002|8-Week Treatment Period|Adverse Event|6|||
160483213|NCT02675998|579497425|FG003|8-Week Treatment Period|Adverse Event|0|||
160483214|NCT02675998|579497422|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
160483215|NCT02675998|579497423|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
160483216|NCT02675998|579497424|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
160483217|NCT02675998|579497425|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
160483218|NCT02675998|579497422|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
160483219|NCT02675998|579497423|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
160483220|NCT02675998|579497424|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
160483221|NCT02675998|579497425|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
160483222|NCT02675998|579497422|FG000|8-Week Treatment Period|Physician Decision|1|||
160483223|NCT02675998|579497423|FG001|8-Week Treatment Period|Physician Decision|0|||
160483224|NCT02675998|579497424|FG002|8-Week Treatment Period|Physician Decision|2|||
160483225|NCT02675998|579497425|FG003|8-Week Treatment Period|Physician Decision|0|||
160483226|NCT02675998|579497422|FG000|8-Week Treatment Period|GI side Effects|1|||
160604728|NCT02120352|579930855|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
160604729|NCT02120352|579930856|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
160604730|NCT02120352|579930857|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
160604731|NCT02120352|579930858|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
160604732|NCT02120352|579930859|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
160604733|NCT02120352|579930860|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
160604734|NCT02120352|579930861|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
160604735|NCT02120352|579930855|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
160483227|NCT02675998|579497423|FG001|8-Week Treatment Period|GI side Effects|4|||
160483228|NCT02675998|579497424|FG002|8-Week Treatment Period|GI side Effects|2|||
160483229|NCT02675998|579497425|FG003|8-Week Treatment Period|GI side Effects|0|||
160483230|NCT02675998|579497422|FG000|8-Week Treatment Period|Protocol Violation|1|||
160483231|NCT02675998|579497423|FG001|8-Week Treatment Period|Protocol Violation|1|||
160483232|NCT02675998|579497424|FG002|8-Week Treatment Period|Protocol Violation|1|||
160483233|NCT02675998|579497425|FG003|8-Week Treatment Period|Protocol Violation|0|||
160483234|NCT02675998|579497422|FG000|8-Week Treatment Period|Other|3|||
160483235|NCT02675998|579497423|FG001|8-Week Treatment Period|Other|1|||
160483236|NCT02675998|579497424|FG002|8-Week Treatment Period|Other|2|||
160483237|NCT02675998|579497425|FG003|8-Week Treatment Period|Other|0|||
160483238|NCT02675998|579497422|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
160483239|NCT02675998|579497423|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
160483240|NCT02675998|579497424|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
160483241|NCT02675998|579497425|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
160483242|NCT02675998|579497422|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
160483243|NCT02675998|579497423|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
160483244|NCT02675998|579497424|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
160483245|NCT02675998|579497425|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
160483246|NCT02675998|579497422|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
160483247|NCT02675998|579497423|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
160483248|NCT02675998|579497424|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
160483249|NCT02675998|579497425|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
160483250|NCT02675998|579497422|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
160483251|NCT02675998|579497423|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
160483252|NCT02675998|579497424|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
160483253|NCT02675998|579497425|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
160483254|NCT02675998|579497422|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
160483255|NCT02675998|579497423|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
160483256|NCT02675998|579497424|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
160483257|NCT02675998|579497425|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
160483258|NCT02561078|579497434|FG000|Overall Study|Adverse Event|5|||
160483259|NCT02561078|579497435|FG001|Overall Study|Adverse Event|2|||
160483260|NCT02561078|579497434|FG000|Overall Study|Death|2|||
160483261|NCT02561078|579497435|FG001|Overall Study|Death|1|||
160483262|NCT02561078|579497434|FG000|Overall Study|Lost to Follow-up|2|||
160483263|NCT02561078|579497435|FG001|Overall Study|Lost to Follow-up|6|||
160483264|NCT02561078|579497434|FG000|Overall Study|Non-Compliance with Study Drug|6|||
160483265|NCT02561078|579497435|FG001|Overall Study|Non-Compliance with Study Drug|3|||
160483266|NCT02561078|579497434|FG000|Overall Study|Physician Decision|2|||
160483267|NCT02561078|579497435|FG001|Overall Study|Physician Decision|3|||
160604736|NCT02120352|579930856|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
160604737|NCT02120352|579930857|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
160604738|NCT02120352|579930858|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
160604739|NCT02120352|579930859|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
160604740|NCT02120352|579930860|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
160604741|NCT02120352|579930861|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
160604742|NCT02120352|579930855|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
160604743|NCT02120352|579930856|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
160604744|NCT02120352|579930857|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
160604745|NCT02120352|579930858|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
160604746|NCT02120352|579930859|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
160604747|NCT02120352|579930860|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
160604748|NCT02120352|579930861|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
160604749|NCT02120352|579930855|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
160604750|NCT02120352|579930856|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
160604751|NCT02120352|579930857|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
160604752|NCT02120352|579930858|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
160604753|NCT02120352|579930859|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
160483268|NCT02561078|579497434|FG000|Overall Study|Withdrawal by Subject|13|||
160483269|NCT02561078|579497435|FG001|Overall Study|Withdrawal by Subject|10|||
160483270|NCT00598871|579497436|FG000|Overall Study|Adverse Event|0|||
160483271|NCT00598871|579497437|FG001|Overall Study|Adverse Event|1|||
160483272|NCT01194271|579497438|FG000|Overall Study|Withdrawal by Subject|1|||
160483273|NCT01194271|579497438|FG000|Overall Study|Ineligible, Screen Failure|1|||
160483274|NCT01194271|579497438|FG000|Overall Study|Death|1|||
160483275|NCT00443898|579497439|FG000|Overall Study|Adverse Event|0|||
160483276|NCT00443898|579497440|FG001|Overall Study|Adverse Event|0|||
160483277|NCT00443898|579497441|FG002|Overall Study|Adverse Event|1|||
160483278|NCT00443898|579497442|FG003|Overall Study|Adverse Event|1|||
160604754|NCT02120352|579930860|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
160604755|NCT02120352|579930861|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
160604756|NCT00842361|579930863|FG000|Overall Study|Protocol Violation|1|||
160483279|NCT00443898|579497439|FG000|Overall Study|Lack of Efficacy|2|||
160604757|NCT00842361|579930864|FG001|Overall Study|Protocol Violation|0|||
160483280|NCT00443898|579497440|FG001|Overall Study|Lack of Efficacy|3|||
160483281|NCT00443898|579497441|FG002|Overall Study|Lack of Efficacy|3|||
160483282|NCT00443898|579497442|FG003|Overall Study|Lack of Efficacy|1|||
160483283|NCT00443898|579497439|FG000|Overall Study|Protocol Violation|1|||
160483284|NCT00443898|579497440|FG001|Overall Study|Protocol Violation|1|||
160483285|NCT00443898|579497441|FG002|Overall Study|Protocol Violation|1|||
160483286|NCT00443898|579497442|FG003|Overall Study|Protocol Violation|0|||
160483287|NCT00443898|579497439|FG000|Overall Study|Withdrawal by Subject|11|||
160483288|NCT00443898|579497440|FG001|Overall Study|Withdrawal by Subject|10|||
160483289|NCT00443898|579497441|FG002|Overall Study|Withdrawal by Subject|10|||
160483290|NCT00443898|579497442|FG003|Overall Study|Withdrawal by Subject|6|||
160483291|NCT00443898|579497439|FG000|Overall Study|Lost to Follow-up|10|||
160483292|NCT00443898|579497440|FG001|Overall Study|Lost to Follow-up|10|||
160483293|NCT00443898|579497441|FG002|Overall Study|Lost to Follow-up|14|||
160483294|NCT00443898|579497442|FG003|Overall Study|Lost to Follow-up|10|||
160483295|NCT00443898|579497439|FG000|Overall Study|Death|0|||
160483296|NCT00443898|579497440|FG001|Overall Study|Death|1|||
160483297|NCT00443898|579497441|FG002|Overall Study|Death|0|||
160483298|NCT00443898|579497442|FG003|Overall Study|Death|0|||
160483299|NCT00043186|579497443|FG000|Overall Study|Physician Decision|0|||
160483300|NCT00043186|579497444|FG001|Overall Study|Physician Decision|0|||
160483301|NCT00043186|579497445|FG002|Overall Study|Physician Decision|3|||
160483302|NCT00043186|579497446|FG003|Overall Study|Physician Decision|0|||
160483303|NCT00043186|579497447|FG004|Overall Study|Physician Decision|1|||
160483304|NCT00043186|579497448|FG005|Overall Study|Physician Decision|0|||
160483305|NCT00043186|579497449|FG006|Overall Study|Physician Decision|0|||
160483306|NCT00043186|579497450|FG007|Overall Study|Physician Decision|1|||
160483307|NCT00043186|579497451|FG008|Overall Study|Physician Decision|1|||
160483308|NCT00043186|579497443|FG000|Overall Study|Adverse Event|2|||
160483309|NCT00043186|579497444|FG001|Overall Study|Adverse Event|2|||
160483310|NCT00043186|579497445|FG002|Overall Study|Adverse Event|2|||
160483311|NCT00043186|579497446|FG003|Overall Study|Adverse Event|3|||
160483312|NCT00043186|579497447|FG004|Overall Study|Adverse Event|2|||
160483313|NCT00043186|579497448|FG005|Overall Study|Adverse Event|1|||
160483314|NCT00043186|579497449|FG006|Overall Study|Adverse Event|2|||
160483315|NCT00043186|579497450|FG007|Overall Study|Adverse Event|1|||
160483316|NCT00043186|579497451|FG008|Overall Study|Adverse Event|3|||
160483317|NCT00043186|579497443|FG000|Overall Study|Withdrawal by Subject|11|||
160483318|NCT00043186|579497444|FG001|Overall Study|Withdrawal by Subject|8|||
160483319|NCT00043186|579497445|FG002|Overall Study|Withdrawal by Subject|11|||
160483320|NCT00043186|579497446|FG003|Overall Study|Withdrawal by Subject|13|||
160483321|NCT00043186|579497447|FG004|Overall Study|Withdrawal by Subject|14|||
160483322|NCT00043186|579497448|FG005|Overall Study|Withdrawal by Subject|6|||
160483323|NCT00043186|579497449|FG006|Overall Study|Withdrawal by Subject|12|||
160483324|NCT00043186|579497450|FG007|Overall Study|Withdrawal by Subject|9|||
160483325|NCT00043186|579497451|FG008|Overall Study|Withdrawal by Subject|10|||
160483326|NCT00043186|579497443|FG000|Overall Study|Death|0|||
160483327|NCT00043186|579497444|FG001|Overall Study|Death|0|||
160483328|NCT00043186|579497445|FG002|Overall Study|Death|1|||
160483329|NCT00043186|579497446|FG003|Overall Study|Death|0|||
160483330|NCT00043186|579497447|FG004|Overall Study|Death|0|||
160483331|NCT00043186|579497448|FG005|Overall Study|Death|0|||
160604758|NCT00842361|579930863|FG000|Overall Study|Unclassified|0|||
160483332|NCT00043186|579497449|FG006|Overall Study|Death|2|||
160483333|NCT00043186|579497450|FG007|Overall Study|Death|0|||
160483334|NCT00043186|579497451|FG008|Overall Study|Death|0|||
160483335|NCT00043186|579497443|FG000|Overall Study|Disease progression|1|||
160483336|NCT00043186|579497444|FG001|Overall Study|Disease progression|0|||
160483337|NCT00043186|579497445|FG002|Overall Study|Disease progression|0|||
160483338|NCT00043186|579497446|FG003|Overall Study|Disease progression|3|||
160483339|NCT00043186|579497447|FG004|Overall Study|Disease progression|0|||
160604759|NCT00842361|579930864|FG001|Overall Study|Unclassified|2|||
160483340|NCT00043186|579497448|FG005|Overall Study|Disease progression|0|||
160483341|NCT00043186|579497449|FG006|Overall Study|Disease progression|0|||
160483342|NCT00043186|579497450|FG007|Overall Study|Disease progression|4|||
160483343|NCT00043186|579497451|FG008|Overall Study|Disease progression|0|||
160483344|NCT00043186|579497443|FG000|Overall Study|Ineligibility determined|0|||
160483345|NCT00043186|579497444|FG001|Overall Study|Ineligibility determined|0|||
160483346|NCT00043186|579497445|FG002|Overall Study|Ineligibility determined|0|||
160483347|NCT00043186|579497446|FG003|Overall Study|Ineligibility determined|0|||
160483348|NCT00043186|579497447|FG004|Overall Study|Ineligibility determined|0|||
160483349|NCT00043186|579497448|FG005|Overall Study|Ineligibility determined|0|||
160483350|NCT00043186|579497449|FG006|Overall Study|Ineligibility determined|0|||
160483351|NCT00043186|579497450|FG007|Overall Study|Ineligibility determined|0|||
160483352|NCT00043186|579497451|FG008|Overall Study|Ineligibility determined|1|||
160483353|NCT00043186|579497443|FG000|Overall Study|Lost to Follow-up|3|||
160483354|NCT00043186|579497444|FG001|Overall Study|Lost to Follow-up|5|||
160483355|NCT00043186|579497445|FG002|Overall Study|Lost to Follow-up|1|||
160483356|NCT00043186|579497446|FG003|Overall Study|Lost to Follow-up|1|||
160483357|NCT00043186|579497447|FG004|Overall Study|Lost to Follow-up|1|||
160483358|NCT00043186|579497448|FG005|Overall Study|Lost to Follow-up|1|||
160483359|NCT00043186|579497449|FG006|Overall Study|Lost to Follow-up|1|||
160483360|NCT00043186|579497450|FG007|Overall Study|Lost to Follow-up|1|||
160483361|NCT00043186|579497451|FG008|Overall Study|Lost to Follow-up|2|||
160483362|NCT00043186|579497443|FG000|Overall Study|Noncompliance|0|||
160483363|NCT00043186|579497444|FG001|Overall Study|Noncompliance|0|||
160483364|NCT00043186|579497445|FG002|Overall Study|Noncompliance|1|||
160483365|NCT00043186|579497446|FG003|Overall Study|Noncompliance|1|||
160483366|NCT00043186|579497447|FG004|Overall Study|Noncompliance|0|||
160483367|NCT00043186|579497448|FG005|Overall Study|Noncompliance|0|||
160483368|NCT00043186|579497449|FG006|Overall Study|Noncompliance|0|||
160483369|NCT00043186|579497450|FG007|Overall Study|Noncompliance|0|||
160483370|NCT00043186|579497451|FG008|Overall Study|Noncompliance|0|||
160483371|NCT00043186|579497443|FG000|Overall Study|Other|0|||
160483372|NCT00043186|579497444|FG001|Overall Study|Other|0|||
160483373|NCT00043186|579497445|FG002|Overall Study|Other|1|||
160483374|NCT00043186|579497446|FG003|Overall Study|Other|1|||
160483375|NCT00043186|579497447|FG004|Overall Study|Other|0|||
160483376|NCT00043186|579497448|FG005|Overall Study|Other|0|||
160483377|NCT00043186|579497449|FG006|Overall Study|Other|0|||
160483378|NCT00043186|579497450|FG007|Overall Study|Other|0|||
160483379|NCT00043186|579497451|FG008|Overall Study|Other|0|||
160483380|NCT00111839|579497462|FG000|Overall Study|Disease Progression|30|||
160483381|NCT00111839|579497463|FG001|Overall Study|Disease Progression|33|||
160483382|NCT00111839|579497464|FG002|Overall Study|Disease Progression|33|||
160483383|NCT00111839|579497462|FG000|Overall Study|Adverse Event|5|||
160483384|NCT00111839|579497463|FG001|Overall Study|Adverse Event|3|||
160483385|NCT00111839|579497464|FG002|Overall Study|Adverse Event|1|||
160483386|NCT00111839|579497462|FG000|Overall Study|Protocol Violation|2|||
160483387|NCT00111839|579497463|FG001|Overall Study|Protocol Violation|4|||
160483388|NCT00111839|579497464|FG002|Overall Study|Protocol Violation|2|||
160483389|NCT00111839|579497462|FG000|Overall Study|Death|1|||
160483390|NCT00111839|579497463|FG001|Overall Study|Death|1|||
160483391|NCT00111839|579497464|FG002|Overall Study|Death|6|||
160483392|NCT00111839|579497462|FG000|Overall Study|Withdrawal by Subject|2|||
160483393|NCT00111839|579497463|FG001|Overall Study|Withdrawal by Subject|2|||
160483394|NCT00111839|579497464|FG002|Overall Study|Withdrawal by Subject|2|||
160483395|NCT00111839|579497462|FG000|Overall Study|Lost to Follow-up|1|||
160483396|NCT00111839|579497463|FG001|Overall Study|Lost to Follow-up|0|||
160483397|NCT00111839|579497464|FG002|Overall Study|Lost to Follow-up|0|||
160483398|NCT00111839|579497462|FG000|Overall Study|Logistical Constraint|1|||
160483399|NCT00111839|579497463|FG001|Overall Study|Logistical Constraint|0|||
160483400|NCT00111839|579497464|FG002|Overall Study|Logistical Constraint|0|||
160483401|NCT00111839|579497462|FG000|Overall Study|Other|6|||
160483402|NCT00111839|579497463|FG001|Overall Study|Other|3|||
160483403|NCT00111839|579497464|FG002|Overall Study|Other|3|||
160483404|NCT00111839|579497462|FG000|Overall Study|Randomized but Not Treated|0|||
160483405|NCT00111839|579497463|FG001|Overall Study|Randomized but Not Treated|0|||
160483406|NCT00111839|579497464|FG002|Overall Study|Randomized but Not Treated|2|||
160483407|NCT03924947|579497465|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
160483408|NCT03924947|579497466|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
160483409|NCT03924947|579497467|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
160483410|NCT03924947|579497468|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
160483411|NCT03924947|579497469|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
160483412|NCT03924947|579497470|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
160483413|NCT01145417|579497471|FG000|Overall Study|Death|1|||
160483414|NCT01145417|579497472|FG001|Overall Study|Death|0|||
160483415|NCT01145417|579497471|FG000|Overall Study|Lost to Follow-up|2|||
160483416|NCT01145417|579497472|FG001|Overall Study|Lost to Follow-up|1|||
160483417|NCT01145417|579497471|FG000|Overall Study|Withdrawal by Subject|1|||
160483418|NCT01145417|579497472|FG001|Overall Study|Withdrawal by Subject|2|||
160483419|NCT01145417|579497471|FG000|Overall Study|Pregnancy|1|||
160483420|NCT01145417|579497472|FG001|Overall Study|Pregnancy|0|||
160483421|NCT01145417|579497471|FG000|Overall Study|Adverse Event|0|||
160483422|NCT01145417|579497472|FG001|Overall Study|Adverse Event|1|||
160483423|NCT01145417|579497471|FG000|Overall Study|Study terminated by sponsor|35|||
160604760|NCT02186561|579930865|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
160604761|NCT02186561|579930865|FG000|Enrollment|Enrollment Cap Reached|5|||
160604762|NCT02186561|579930865|FG000|Enrollment|Insurance Denial|2|||
160604763|NCT02186561|579930865|FG000|Enrollment|Withdrawal by Subject|2|||
160604764|NCT02186561|579930865|FG000|Enrollment|Investigator Withdrew Consent|1|||
160483424|NCT01145417|579497472|FG001|Overall Study|Study terminated by sponsor|43|||
160483425|NCT01145417|579497471|FG000|Overall Study|Other|1|||
160483426|NCT01145417|579497472|FG001|Overall Study|Other|0|||
160483427|NCT02469077|579497473|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
160483428|NCT02469077|579497474|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
160483429|NCT02469077|579497473|FG000|Post Randomization/Intervention Period|Relocated|1|||
160483430|NCT02469077|579497474|FG001|Post Randomization/Intervention Period|Relocated|1|||
160483431|NCT02469077|579497473|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
160483432|NCT02469077|579497474|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
160483433|NCT02469077|579497473|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
160483434|NCT02469077|579497474|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
160483435|NCT00191984|579497476|FG000|Overall Study|Disease Progression|21|||
160483436|NCT00191984|579497476|FG000|Overall Study|Adverse Event|4|||
160483437|NCT00191984|579497476|FG000|Overall Study|Death|2|||
160483438|NCT00191984|579497476|FG000|Overall Study|Entry Criteria Exclusion|1|||
160483439|NCT00191984|579497476|FG000|Overall Study|Withdrawal by Subject|7|||
160483440|NCT00191984|579497476|FG000|Overall Study|Physician Decision|4|||
160483441|NCT03303521|579497477|FG000|Overall Study|Withdrawal by Subject|2|||
160483442|NCT03303521|579497478|FG001|Overall Study|Withdrawal by Subject|0|||
160483443|NCT03303521|579497477|FG000|Overall Study|Death|1|||
160483444|NCT03303521|579497478|FG001|Overall Study|Death|0|||
160483445|NCT03303521|579497477|FG000|Overall Study|Kidney transplantation|0|||
160483446|NCT03303521|579497478|FG001|Overall Study|Kidney transplantation|1|||
160483447|NCT03303521|579497477|FG000|Overall Study|Investigational product discontinuation|0|||
160483448|NCT03303521|579497478|FG001|Overall Study|Investigational product discontinuation|1|||
160483449|NCT03303521|579497477|FG000|Overall Study|Transferred to non-study dialysis center|1|||
160483450|NCT03303521|579497478|FG001|Overall Study|Transferred to non-study dialysis center|0|||
160483451|NCT03303521|579497477|FG000|Overall Study|Non-comliance to study protocol|0|||
160483452|NCT03303521|579497478|FG001|Overall Study|Non-comliance to study protocol|1|||
160483453|NCT03303521|579497477|FG000|Overall Study|Adverse Event|1|||
160483454|NCT03303521|579497478|FG001|Overall Study|Adverse Event|0|||
160483455|NCT01654289|579497479|FG000|Overall Study|Withdrawal by Subject|10|||
160483456|NCT01654289|579497480|FG001|Overall Study|Withdrawal by Subject|8|||
160483457|NCT01654289|579497481|FG002|Overall Study|Withdrawal by Subject|5|||
160483458|NCT01654289|579497479|FG000|Overall Study|Withdrew from intervention only|17|||
160483459|NCT01654289|579497480|FG001|Overall Study|Withdrew from intervention only|20|||
160483460|NCT01654289|579497481|FG002|Overall Study|Withdrew from intervention only|0|||
160483461|NCT00005908|579497482|FG000|Overall Study|Withdrawal by Subject|1|||
160483462|NCT00005908|579497483|FG001|Overall Study|Withdrawal by Subject|0|||
160483463|NCT04748445|579497486|FG000|Overall Study|No longer met eligibility criteria|12|||
160483464|NCT04748445|579497486|FG000|Overall Study|Other|36|||
160483465|NCT04748445|579497486|FG000|Overall Study|Withdrawal by Subject|553|||
160483466|NCT04748445|579497486|FG000|Overall Study|Lost to Follow-up|30|||
160483467|NCT04736602|579497491|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
160483468|NCT04736602|579497491|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
160483469|NCT00938041|579497494|FG000|Overall Study|Lost to Follow-up|6|||
160483470|NCT00938041|579497494|FG000|Overall Study|Received Alternative Therapy|1|||
160483471|NCT00938041|579497494|FG000|Overall Study|Progressive Disease|5|||
160483472|NCT00938041|579497494|FG000|Overall Study|Death|12|||
160483473|NCT00938041|579497494|FG000|Overall Study|Adrenal Insufficiency|3|||
160483474|NCT02504502|579497495|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
160483475|NCT02504502|579497496|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
160483476|NCT02504502|579497495|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
160483477|NCT02504502|579497496|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
160483478|NCT03042559|579497497|FG000|Overall Study|drop out|1|||
160483479|NCT03042559|579497498|FG001|Overall Study|drop out|1|||
160483480|NCT01536535|579497503|FG000|Overall Study|Withdrawal by Subject|10|||
160483481|NCT01536535|579497504|FG001|Overall Study|Withdrawal by Subject|5|||
160483482|NCT01536535|579497503|FG000|Overall Study|Lost to Follow-up|4|||
160483483|NCT01536535|579497504|FG001|Overall Study|Lost to Follow-up|6|||
160483484|NCT01536535|579497503|FG000|Overall Study|Physician Decision|1|||
160483485|NCT01536535|579497504|FG001|Overall Study|Physician Decision|1|||
160483486|NCT01536535|579497503|FG000|Overall Study|Participant moved|0|||
160483487|NCT01536535|579497504|FG001|Overall Study|Participant moved|1|||
160483488|NCT00404547|579497505|FG000|Overall Study|Adverse Event|39|||
160483489|NCT00404547|579497506|FG001|Overall Study|Adverse Event|6|||
160483490|NCT00404547|579497505|FG000|Overall Study|Withdrawal by Subject|19|||
160483491|NCT00404547|579497506|FG001|Overall Study|Withdrawal by Subject|2|||
160483492|NCT00404547|579497505|FG000|Overall Study|Protocol Violation|0|||
160483493|NCT00404547|579497506|FG001|Overall Study|Protocol Violation|1|||
160483494|NCT00404547|579497505|FG000|Overall Study|Lost to Follow-up|20|||
160483495|NCT00404547|579497506|FG001|Overall Study|Lost to Follow-up|9|||
160483496|NCT00404547|579497505|FG000|Overall Study|Lack of compliance|5|||
160483497|NCT00404547|579497506|FG001|Overall Study|Lack of compliance|1|||
160483498|NCT00404547|579497505|FG000|Overall Study|Other|4|||
160483499|NCT00404547|579497506|FG001|Overall Study|Other|0|||
160483500|NCT00404547|579497505|FG000|Overall Study|Reason not stated|3|||
160483501|NCT00404547|579497506|FG001|Overall Study|Reason not stated|6|||
160483502|NCT01485991|579497507|FG000|Overall Study|Adverse Event|0|||
160483503|NCT01485991|579497508|FG001|Overall Study|Adverse Event|4|||
160483504|NCT01485991|579497507|FG000|Overall Study|Lost to Follow-up|13|||
160483505|NCT01485991|579497508|FG001|Overall Study|Lost to Follow-up|10|||
160483506|NCT01485991|579497507|FG000|Overall Study|Withdrawal by Subject|13|||
160483507|NCT01485991|579497508|FG001|Overall Study|Withdrawal by Subject|20|||
160483508|NCT01485991|579497507|FG000|Overall Study|randomized but not treated|6|||
160483509|NCT01485991|579497508|FG001|Overall Study|randomized but not treated|2|||
160483510|NCT01475370|579497509|FG000|Overall Study|Exacerbation of primary disease|2|||
160483511|NCT01475370|579497510|FG001|Overall Study|Exacerbation of primary disease|2|||
160483512|NCT01475370|579497511|FG002|Overall Study|Exacerbation of primary disease|2|||
160483513|NCT01475370|579497509|FG000|Overall Study|Study drug administration difficult|0|||
160483514|NCT01475370|579497510|FG001|Overall Study|Study drug administration difficult|1|||
160483515|NCT01475370|579497511|FG002|Overall Study|Study drug administration difficult|1|||
160483516|NCT01475370|579497509|FG000|Overall Study|Other than specified|1|||
160483517|NCT01475370|579497510|FG001|Overall Study|Other than specified|0|||
160483518|NCT01475370|579497511|FG002|Overall Study|Other than specified|0|||
160483519|NCT04372186|579497512|FG000|Overall Study|Death|24|||
160483520|NCT04372186|579497513|FG001|Overall Study|Death|11|||
160483521|NCT04372186|579497512|FG000|Overall Study|Transferred to a different facility for care|0|||
160483522|NCT04372186|579497513|FG001|Overall Study|Transferred to a different facility for care|2|||
160483523|NCT04736472|579497514|FG000|Overall Study|Lost to Follow-up|1|||
160483524|NCT04736472|579497515|FG001|Overall Study|Lost to Follow-up|0|||
160483525|NCT04736472|579497516|FG002|Overall Study|Lost to Follow-up|0|||
160483526|NCT04736472|579497514|FG000|Overall Study|Withdrawal by Subject|2|||
160483527|NCT04736472|579497515|FG001|Overall Study|Withdrawal by Subject|0|||
160483528|NCT04736472|579497516|FG002|Overall Study|Withdrawal by Subject|0|||
160483529|NCT04736472|579497514|FG000|Overall Study|Protocol Violation|48|||
160483530|NCT04736472|579497515|FG001|Overall Study|Protocol Violation|0|||
160483531|NCT04736472|579497516|FG002|Overall Study|Protocol Violation|6|||
160483532|NCT00577096|579497519|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
160483533|NCT00577096|579497520|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
160483534|NCT00577096|579497519|FG000|Short Term Participation|Withdrawal by Subject|3|||
160483535|NCT00577096|579497520|FG001|Short Term Participation|Withdrawal by Subject|5|||
160483536|NCT00577096|579497519|FG000|Short Term Participation|Death|1|||
160483537|NCT00577096|579497520|FG001|Short Term Participation|Death|1|||
160483538|NCT00832650|579497521|FG000|Overall Study|Randomized but not treated|0|||
160483539|NCT00832650|579497522|FG001|Overall Study|Randomized but not treated|0|||
160483540|NCT00832650|579497523|FG002|Overall Study|Randomized but not treated|1|||
160483541|NCT00440037|579497525|FG000|Overall Study|Withdrawal by Subject|6|||
160483542|NCT00440037|579497525|FG000|Overall Study|Administrative decision|3|||
160483543|NCT03740919|579497528|FG000|Lead-in Period|Lost to Follow-up|1|||
160483544|NCT03740919|579497529|FG001|Lead-in Period|Lost to Follow-up|0|||
160483545|NCT03740919|579497530|FG002|Lead-in Period|Lost to Follow-up|0|||
160483546|NCT03740919|579497531|FG003|Lead-in Period|Lost to Follow-up|0|||
160483547|NCT03740919|579497528|FG000|Lead-in Period|Physician Decision|2|||
160483548|NCT03740919|579497529|FG001|Lead-in Period|Physician Decision|0|||
160483549|NCT03740919|579497530|FG002|Lead-in Period|Physician Decision|0|||
160483550|NCT03740919|579497531|FG003|Lead-in Period|Physician Decision|0|||
160483551|NCT03740919|579497528|FG000|Lead-in Period|Protocol Violation|1|||
160483552|NCT03740919|579497529|FG001|Lead-in Period|Protocol Violation|0|||
160483553|NCT03740919|579497530|FG002|Lead-in Period|Protocol Violation|0|||
160483554|NCT03740919|579497531|FG003|Lead-in Period|Protocol Violation|0|||
160483555|NCT03740919|579497528|FG000|Lead-in Period|Withdrawal by Subject|10|||
160483556|NCT03740919|579497529|FG001|Lead-in Period|Withdrawal by Subject|0|||
160483557|NCT03740919|579497530|FG002|Lead-in Period|Withdrawal by Subject|0|||
160483558|NCT03740919|579497531|FG003|Lead-in Period|Withdrawal by Subject|0|||
160483559|NCT03740919|579497528|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
160604765|NCT02186561|579930865|FG000|30-Day Post Index Procedure Visit|Death|1|||
160604766|NCT02186561|579930865|FG000|1- Year Post Index Procedure Visit|Death|1|||
160604767|NCT02186561|579930865|FG000|1- Year Post Index Procedure Visit|Missed|1|||
160604768|NCT01072448|579930868|FG000|Overall Study|Adverse Event|9|||
160604769|NCT01072448|579930869|FG001|Overall Study|Adverse Event|10|||
160604770|NCT01072448|579930868|FG000|Overall Study|Subject withdrew consent|4|||
160604771|NCT01072448|579930869|FG001|Overall Study|Subject withdrew consent|9|||
160483560|NCT03740919|579497529|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
160483561|NCT03740919|579497530|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
160483562|NCT03740919|579497531|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
160604772|NCT01072448|579930868|FG000|Overall Study|Protocol deviation|3|||
160604773|NCT01072448|579930869|FG001|Overall Study|Protocol deviation|4|||
160604774|NCT01072448|579930868|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160483563|NCT03740919|579497528|FG000|Lead-in Period|Study Task Too Burdensome|1|||
160483564|NCT03740919|579497529|FG001|Lead-in Period|Study Task Too Burdensome|0|||
160604775|NCT01072448|579930869|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160604776|NCT01072448|579930868|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160604777|NCT01072448|579930869|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160604778|NCT01072448|579930868|FG000|Overall Study|Lost to Follow-up|1|||
160660861|NCT02822235|580141701|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
160604779|NCT01072448|579930869|FG001|Overall Study|Lost to Follow-up|1|||
160604780|NCT01072448|579930868|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160604781|NCT01072448|579930869|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160483565|NCT03740919|579497530|FG002|Lead-in Period|Study Task Too Burdensome|0|||
160483566|NCT03740919|579497531|FG003|Lead-in Period|Study Task Too Burdensome|0|||
160483567|NCT03740919|579497528|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
160483568|NCT03740919|579497529|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
160483569|NCT03740919|579497530|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
160483570|NCT03740919|579497531|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
160483571|NCT03740919|579497528|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
160483572|NCT03740919|579497529|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
160483573|NCT03740919|579497530|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
160483574|NCT03740919|579497531|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
160483575|NCT03740919|579497528|FG000|Treatment Period|Adverse Event|0|||
160483576|NCT03740919|579497529|FG001|Treatment Period|Adverse Event|0|||
160483577|NCT03740919|579497530|FG002|Treatment Period|Adverse Event|2|||
160483578|NCT03740919|579497531|FG003|Treatment Period|Adverse Event|0|||
160483579|NCT03740919|579497528|FG000|Treatment Period|Protocol Violation|0|||
160483580|NCT03740919|579497529|FG001|Treatment Period|Protocol Violation|1|||
160483581|NCT03740919|579497530|FG002|Treatment Period|Protocol Violation|0|||
160483582|NCT03740919|579497531|FG003|Treatment Period|Protocol Violation|0|||
160483583|NCT03740919|579497528|FG000|Treatment Period|Withdrawal by Subject|0|||
160483584|NCT03740919|579497529|FG001|Treatment Period|Withdrawal by Subject|7|||
160483585|NCT03740919|579497530|FG002|Treatment Period|Withdrawal by Subject|6|||
160483586|NCT03740919|579497531|FG003|Treatment Period|Withdrawal by Subject|2|||
160483587|NCT03740919|579497528|FG000|Treatment Period|Terminated by Sponsor|0|||
160483588|NCT03740919|579497529|FG001|Treatment Period|Terminated by Sponsor|1|||
160483589|NCT03740919|579497530|FG002|Treatment Period|Terminated by Sponsor|0|||
160483590|NCT03740919|579497531|FG003|Treatment Period|Terminated by Sponsor|0|||
160483591|NCT03740919|579497528|FG000|Treatment Period|Issue with Insulin Pump|0|||
160483592|NCT03740919|579497529|FG001|Treatment Period|Issue with Insulin Pump|1|||
160483593|NCT03740919|579497530|FG002|Treatment Period|Issue with Insulin Pump|0|||
160483594|NCT03740919|579497531|FG003|Treatment Period|Issue with Insulin Pump|0|||
160483595|NCT03740919|579497528|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
160483596|NCT03740919|579497529|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
160483597|NCT03740919|579497530|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
160483598|NCT03740919|579497531|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
160483599|NCT03740919|579497528|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
160483600|NCT03740919|579497529|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
160483601|NCT03740919|579497530|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
160483602|NCT03740919|579497531|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
160483603|NCT03740919|579497528|FG000|Treatment Period|Not Completing Diary|0|||
160483604|NCT03740919|579497529|FG001|Treatment Period|Not Completing Diary|0|||
160483605|NCT03740919|579497530|FG002|Treatment Period|Not Completing Diary|1|||
160483606|NCT03740919|579497531|FG003|Treatment Period|Not Completing Diary|0|||
160483607|NCT03740919|579497528|FG000|Treatment Period|Insulin Painful to Participant|0|||
160483608|NCT03740919|579497529|FG001|Treatment Period|Insulin Painful to Participant|0|||
160483609|NCT03740919|579497530|FG002|Treatment Period|Insulin Painful to Participant|1|||
160483610|NCT03740919|579497531|FG003|Treatment Period|Insulin Painful to Participant|0|||
160483611|NCT01911819|579497534|FG000|Overall Study|Adverse Event|0|||
160483612|NCT01911819|579497535|FG001|Overall Study|Adverse Event|1|||
160483613|NCT01911819|579497536|FG002|Overall Study|Adverse Event|0|||
160483614|NCT01911819|579497534|FG000|Overall Study|Withdrawal by Subject|1|||
160483615|NCT01911819|579497535|FG001|Overall Study|Withdrawal by Subject|1|||
160483616|NCT01911819|579497536|FG002|Overall Study|Withdrawal by Subject|0|||
160483617|NCT04374253|579497541|FG000|Overall Study|Adverse Event|0|||
160483618|NCT04374253|579497542|FG001|Overall Study|Adverse Event|26|||
160483619|NCT04374253|579497543|FG002|Overall Study|Adverse Event|2|||
160483620|NCT04374253|579497544|FG003|Overall Study|Adverse Event|12|||
160483621|NCT04374253|579497541|FG000|Overall Study|Study terminated by sponsor|13|||
160483622|NCT04374253|579497542|FG001|Overall Study|Study terminated by sponsor|593|||
160483623|NCT04374253|579497543|FG002|Overall Study|Study terminated by sponsor|21|||
160483624|NCT04374253|579497544|FG003|Overall Study|Study terminated by sponsor|567|||
160483625|NCT04374253|579497541|FG000|Overall Study|Withdrawal by Subject|0|||
160483626|NCT04374253|579497542|FG001|Overall Study|Withdrawal by Subject|55|||
160483627|NCT04374253|579497543|FG002|Overall Study|Withdrawal by Subject|3|||
160483628|NCT04374253|579497544|FG003|Overall Study|Withdrawal by Subject|40|||
160483629|NCT04374253|579497541|FG000|Overall Study|Physician Decision|1|||
160483630|NCT04374253|579497542|FG001|Overall Study|Physician Decision|10|||
160483631|NCT04374253|579497543|FG002|Overall Study|Physician Decision|1|||
160483632|NCT04374253|579497544|FG003|Overall Study|Physician Decision|10|||
160483633|NCT04374253|579497541|FG000|Overall Study|Protocol Violation|0|||
160483634|NCT04374253|579497542|FG001|Overall Study|Protocol Violation|0|||
160483635|NCT04374253|579497543|FG002|Overall Study|Protocol Violation|0|||
160483636|NCT04374253|579497544|FG003|Overall Study|Protocol Violation|2|||
160483637|NCT04374253|579497541|FG000|Overall Study|Death|0|||
160483638|NCT04374253|579497542|FG001|Overall Study|Death|3|||
160483639|NCT04374253|579497543|FG002|Overall Study|Death|1|||
160483640|NCT04374253|579497544|FG003|Overall Study|Death|1|||
160483641|NCT04374253|579497541|FG000|Overall Study|Lack of Efficacy|0|||
160483642|NCT04374253|579497542|FG001|Overall Study|Lack of Efficacy|0|||
160483643|NCT04374253|579497543|FG002|Overall Study|Lack of Efficacy|0|||
160483644|NCT04374253|579497544|FG003|Overall Study|Lack of Efficacy|1|||
160483645|NCT04374253|579497541|FG000|Overall Study|Lost to Follow-up|1|||
160483646|NCT04374253|579497542|FG001|Overall Study|Lost to Follow-up|1|||
160483647|NCT04374253|579497543|FG002|Overall Study|Lost to Follow-up|0|||
160483648|NCT04374253|579497544|FG003|Overall Study|Lost to Follow-up|2|||
160483649|NCT04374253|579497541|FG000|Overall Study|Reason Not Specified|0|||
160483650|NCT04374253|579497542|FG001|Overall Study|Reason Not Specified|8|||
160483651|NCT04374253|579497543|FG002|Overall Study|Reason Not Specified|0|||
160483652|NCT04374253|579497544|FG003|Overall Study|Reason Not Specified|8|||
160483653|NCT04382053|579497547|FG000|Overall Study|Death|6|||
160483654|NCT04382053|579497548|FG001|Overall Study|Death|8|||
160483655|NCT04382053|579497547|FG000|Overall Study|Lost to Follow-up|0|||
160483656|NCT04382053|579497548|FG001|Overall Study|Lost to Follow-up|2|||
160483657|NCT04382053|579497547|FG000|Overall Study|Protocol Deviation|1|||
160483658|NCT04382053|579497548|FG001|Overall Study|Protocol Deviation|2|||
160483659|NCT04382053|579497547|FG000|Overall Study|Withdrawal by Subject|2|||
160483660|NCT04382053|579497548|FG001|Overall Study|Withdrawal by Subject|1|||
160483661|NCT01945086|579497551|FG000|Overall Study|Withdrawal by Subject|1|||
160483662|NCT01945086|579497552|FG001|Overall Study|Withdrawal by Subject|0|||
160483663|NCT01945086|579497553|FG002|Overall Study|Withdrawal by Subject|1|||
160483664|NCT01945086|579497551|FG000|Overall Study|Adverse Event|0|||
160483665|NCT01945086|579497552|FG001|Overall Study|Adverse Event|0|||
160483666|NCT01945086|579497553|FG002|Overall Study|Adverse Event|1|||
160483667|NCT02093897|579499083|FG000|Overall Study|Physician Decision|1|||
160483668|NCT02093897|579499083|FG000|Overall Study|Planned age group closure - no's reached|17|||
160483669|NCT02093897|579499083|FG000|Overall Study|Adverse event, non-fatal|1|||
160483670|NCT02972242|579499084|FG000|Overall Study|Withdrawal by Subject|1|||
160483671|NCT02972242|579499085|FG001|Overall Study|Withdrawal by Subject|0|||
160483672|NCT04572997|579499086|FG000|Overall Study|Adverse Event|1|||
160483673|NCT03098797|579499087|FG000|Part 2 Open Label Extension|Adverse Event|2|||
160483674|NCT03098797|579499088|FG001|Part 2 Open Label Extension|Adverse Event|0|||
160483675|NCT02956278|579499089|FG000|Overall Study|Withdrawal by Subject|6|||
160483676|NCT02956278|579499090|FG001|Overall Study|Withdrawal by Subject|2|||
160483677|NCT02956278|579499091|FG002|Overall Study|Withdrawal by Subject|0|||
160483678|NCT01967719|579499092|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
160483679|NCT01967719|579499093|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
160483680|NCT01967719|579499094|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
160483681|NCT01967719|579499095|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
160483682|NCT01967719|579499092|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
160483683|NCT01967719|579499093|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
160483684|NCT01967719|579499094|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
160483685|NCT01967719|579499095|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
160483686|NCT02329223|579499096|FG000|Overall Study|Withdrawal by Subject|1|||
160483687|NCT02329223|579499097|FG001|Overall Study|Withdrawal by Subject|2|||
160483688|NCT02329223|579499098|FG002|Overall Study|Withdrawal by Subject|5|||
160483689|NCT02329223|579499096|FG000|Overall Study|Physician Decision|0|||
160483690|NCT02329223|579499097|FG001|Overall Study|Physician Decision|0|||
160483691|NCT02329223|579499098|FG002|Overall Study|Physician Decision|1|||
160483692|NCT02329223|579499096|FG000|Overall Study|Adverse Event|0|||
160604782|NCT01072448|579930868|FG000|Overall Study|Death|0|||
160604783|NCT01072448|579930869|FG001|Overall Study|Death|2|||
160604784|NCT01814826|579930872|FG000|Overall Study|Other|3|||
160604785|NCT01814826|579930873|FG001|Overall Study|Other|5|||
160604786|NCT01814826|579930874|FG002|Overall Study|Other|0|||
160604787|NCT01814826|579930872|FG000|Overall Study|Death|29|||
160604788|NCT01814826|579930873|FG001|Overall Study|Death|24|||
160604789|NCT01814826|579930874|FG002|Overall Study|Death|3|||
160604790|NCT02917629|579930875|FG000|Overall Study|Withdrawal by Subject|0|||
160483693|NCT02329223|579499097|FG001|Overall Study|Adverse Event|1|||
160483694|NCT02329223|579499098|FG002|Overall Study|Adverse Event|0|||
160483695|NCT00651937|579499100|FG000|Overall Study|Withdrawal by Subject|4|||
160483696|NCT00651937|579499101|FG001|Overall Study|Withdrawal by Subject|1|||
160483697|NCT00509821|579499102|FG000|Study Period 1 (Induction)|Death|0|||
160483698|NCT00509821|579499103|FG001|Study Period 1 (Induction)|Death|1|||
160483699|NCT00509821|579499102|FG000|Study Period 1 (Induction)|Adverse Event|0|||
160483700|NCT00509821|579499103|FG001|Study Period 1 (Induction)|Adverse Event|2|||
160483701|NCT00509821|579499102|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
160483702|NCT00509821|579499103|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
160483703|NCT00552513|579499108|FG000|Overall Study|Lost to Follow-up|5|||
160483704|NCT00552513|579499109|FG001|Overall Study|Lost to Follow-up|1|||
160483705|NCT02720185|579499110|FG000|Overall Study|Lost to Follow-up|1|||
160483706|NCT00792259|579499111|FG000|Overall Study|Poor Quality Scans|1|||
160483707|NCT00792259|579499112|FG001|Overall Study|Poor Quality Scans|0|||
160604791|NCT02917629|579930876|FG001|Overall Study|Withdrawal by Subject|1|||
160604792|NCT03271307|579930877|FG000|Overall Study|Lost to Follow-up|0|||
160604793|NCT03271307|579930878|FG001|Overall Study|Lost to Follow-up|0|||
160604794|NCT03271307|579930879|FG002|Overall Study|Lost to Follow-up|0|||
160604795|NCT03271307|579930880|FG003|Overall Study|Lost to Follow-up|28|||
160604796|NCT03271307|579930881|FG004|Overall Study|Lost to Follow-up|91|||
160604797|NCT01042938|579930882|FG000|Overall Study|Withdrawal by Subject|1|||
160604798|NCT01042938|579930883|FG001|Overall Study|Withdrawal by Subject|1|||
160604799|NCT01042938|579930882|FG000|Overall Study|Protocol Violation|1|||
160604800|NCT01042938|579930883|FG001|Overall Study|Protocol Violation|1|||
160604801|NCT01042938|579930882|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
160604802|NCT01042938|579930883|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
160604803|NCT03136484|579930884|FG000|Overall Study|Withdrawal by Subject|19|||
160604804|NCT03136484|579930885|FG001|Overall Study|Withdrawal by Subject|14|||
160604805|NCT03136484|579930884|FG000|Overall Study|Lost to Follow-up|7|||
160604806|NCT03136484|579930885|FG001|Overall Study|Lost to Follow-up|8|||
160604807|NCT03136484|579930884|FG000|Overall Study|Death|1|||
160604808|NCT03136484|579930885|FG001|Overall Study|Death|0|||
160604809|NCT03997760|579930886|FG000|Overall Study|Protocol Deviation|0|||
160604810|NCT03997760|579930887|FG001|Overall Study|Protocol Deviation|1|||
160604811|NCT03997760|579930888|FG002|Overall Study|Protocol Deviation|0|||
160604812|NCT03997760|579930889|FG003|Overall Study|Protocol Deviation|0|||
160604813|NCT00856986|579930890|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
160604814|NCT00856986|579930891|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
160604815|NCT00856986|579930892|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
160604816|NCT00856986|579930893|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
160604817|NCT00856986|579930894|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
160604818|NCT00856986|579930890|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
160604819|NCT00856986|579930891|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
160604820|NCT00856986|579930892|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
160604821|NCT00856986|579930893|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
160604822|NCT00856986|579930894|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
160604823|NCT00856986|579930890|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
160604824|NCT00856986|579930891|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
160604825|NCT00856986|579930892|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
160604826|NCT00856986|579930893|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
160604827|NCT00856986|579930894|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
160604828|NCT00856986|579930890|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
160604829|NCT00856986|579930891|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
160604830|NCT00856986|579930892|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
160604831|NCT00856986|579930893|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
160604832|NCT00856986|579930894|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
160604833|NCT00856986|579930890|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
160604834|NCT00856986|579930891|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
160604835|NCT00856986|579930892|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
160604836|NCT00856986|579930893|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
160604837|NCT00856986|579930894|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
160604838|NCT00856986|579930890|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
160604839|NCT00856986|579930891|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
160604840|NCT00856986|579930892|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
160604841|NCT00856986|579930893|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
160604842|NCT00856986|579930894|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
160604843|NCT00856986|579930890|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
160604844|NCT00856986|579930891|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
160604845|NCT00856986|579930892|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
160604846|NCT00856986|579930893|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
160604847|NCT00856986|579930894|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
160604848|NCT00856986|579930890|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
160604849|NCT00856986|579930891|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
160604850|NCT00856986|579930892|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
160604851|NCT00856986|579930893|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
160604852|NCT00856986|579930894|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
160604853|NCT00856986|579930890|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
160604854|NCT00856986|579930891|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
160660862|NCT02822235|580141702|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
160660863|NCT02822235|580141701|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
160604855|NCT00856986|579930892|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
160604856|NCT00856986|579930893|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
160604857|NCT00856986|579930894|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
160604858|NCT00856986|579930890|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
160604859|NCT00856986|579930891|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
160604860|NCT00856986|579930892|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
160604861|NCT00856986|579930893|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
160604862|NCT00856986|579930894|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
160604863|NCT00856986|579930890|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
160604864|NCT00856986|579930891|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
160604865|NCT00856986|579930892|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
160604866|NCT00856986|579930893|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
160604867|NCT00856986|579930894|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
160604868|NCT00856986|579930890|FG000|Main Period, Weeks 0-26|Unclassified|7|||
160604869|NCT00856986|579930891|FG001|Main Period, Weeks 0-26|Unclassified|6|||
160604870|NCT00856986|579930892|FG002|Main Period, Weeks 0-26|Unclassified|7|||
160604871|NCT00856986|579930893|FG003|Main Period, Weeks 0-26|Unclassified|0|||
160604872|NCT00856986|579930894|FG004|Main Period, Weeks 0-26|Unclassified|0|||
160604873|NCT00856986|579930890|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
160604874|NCT00856986|579930891|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
160604875|NCT00856986|579930892|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
160604876|NCT00856986|579930893|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
160604877|NCT00856986|579930894|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
160604878|NCT00856986|579930890|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
160604879|NCT00856986|579930891|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
160604880|NCT00856986|579930892|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
160604881|NCT00856986|579930893|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
160604882|NCT00856986|579930894|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
160604883|NCT00856986|579930890|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
160604884|NCT00856986|579930891|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
160604885|NCT00856986|579930892|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
160604886|NCT00856986|579930893|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
160604887|NCT00856986|579930894|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
160604888|NCT00856986|579930890|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
160604889|NCT00856986|579930891|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
160604890|NCT00856986|579930892|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
160604891|NCT00856986|579930893|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
160604892|NCT00856986|579930894|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
160604893|NCT00856986|579930890|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
160604894|NCT00856986|579930891|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
160604895|NCT00856986|579930892|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
160604896|NCT00856986|579930893|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
160604897|NCT00856986|579930894|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
160604898|NCT00856986|579930890|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
160604899|NCT00856986|579930891|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
160604900|NCT00856986|579930892|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
160604901|NCT00856986|579930893|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
160604902|NCT00856986|579930894|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
160604903|NCT02999191|579930896|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
160604904|NCT02999191|579930897|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
160604905|NCT02999191|579930898|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
160604906|NCT01432756|579932181|FG000|Overall Study|Lost to Follow-up|1|||
160604907|NCT01432756|579932182|FG001|Overall Study|Lost to Follow-up|0|||
160604908|NCT01432756|579932183|FG002|Overall Study|Lost to Follow-up|2|||
160604909|NCT01432756|579932184|FG003|Overall Study|Lost to Follow-up|1|||
160604910|NCT02177786|579932185|FG000|Overall Study|Withdrew Consent|2|||
160604911|NCT02177786|579932186|FG001|Overall Study|Withdrew Consent|6|||
160604912|NCT02177786|579932187|FG002|Overall Study|Withdrew Consent|9|||
160660864|NCT02822235|580141702|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
160660865|NCT02822235|580141701|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
160660866|NCT02822235|580141702|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
160660867|NCT02822235|580141701|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
160660868|NCT02822235|580141702|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
160660869|NCT01038856|580141705|FG000|Overall Study|Adverse Event|2|||
160660870|NCT04638153|580141706|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160660871|NCT04638153|580141707|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160660872|NCT04638153|580141708|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160660873|NCT04638153|580141706|FG000|Overall Study|Study terminated by sponsor|4|||
160660874|NCT04638153|580141707|FG001|Overall Study|Study terminated by sponsor|2|||
160660875|NCT04638153|580141708|FG002|Overall Study|Study terminated by sponsor|14|||
160660876|NCT01440283|580141709|FG000|Overall Study|Death|3|||
160483708|NCT00792259|579499113|FG002|Overall Study|Poor Quality Scans|0|||
160604913|NCT02177786|579932188|FG003|Overall Study|Withdrew Consent|5|||
160604914|NCT02177786|579932185|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
160604915|NCT02177786|579932186|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
160604916|NCT02177786|579932187|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
160604917|NCT02177786|579932188|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
160604918|NCT02177786|579932185|FG000|Overall Study|Adverse Event|1|||
160604919|NCT02177786|579932186|FG001|Overall Study|Adverse Event|1|||
160660877|NCT01440283|580141709|FG000|Overall Study|Withdrawal by Subject|4|||
160604920|NCT02177786|579932187|FG002|Overall Study|Adverse Event|2|||
160604921|NCT02177786|579932188|FG003|Overall Study|Adverse Event|3|||
160604922|NCT02177786|579932185|FG000|Overall Study|Death|1|||
160604923|NCT02177786|579932186|FG001|Overall Study|Death|1|||
160604924|NCT02177786|579932187|FG002|Overall Study|Death|1|||
160604925|NCT02177786|579932188|FG003|Overall Study|Death|1|||
160604926|NCT02177786|579932185|FG000|Overall Study|Lost to Follow-up|0|||
160604927|NCT02177786|579932186|FG001|Overall Study|Lost to Follow-up|0|||
160604928|NCT02177786|579932187|FG002|Overall Study|Lost to Follow-up|2|||
160604929|NCT02177786|579932188|FG003|Overall Study|Lost to Follow-up|2|||
160604930|NCT02177786|579932185|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160604931|NCT02177786|579932186|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160604932|NCT02177786|579932187|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160604933|NCT02177786|579932188|FG003|Overall Study|Non-Compliance with Study Drug|1|||
160604934|NCT02177786|579932185|FG000|Overall Study|Protocol Violation|0|||
160604935|NCT02177786|579932186|FG001|Overall Study|Protocol Violation|0|||
160604936|NCT02177786|579932187|FG002|Overall Study|Protocol Violation|2|||
160604937|NCT02177786|579932188|FG003|Overall Study|Protocol Violation|0|||
160604938|NCT02177786|579932185|FG000|Overall Study|Progressive Disease|0|||
160604939|NCT02177786|579932186|FG001|Overall Study|Progressive Disease|1|||
160604940|NCT02177786|579932187|FG002|Overall Study|Progressive Disease|0|||
160604941|NCT02177786|579932188|FG003|Overall Study|Progressive Disease|0|||
160604942|NCT02177786|579932185|FG000|Overall Study|Missing study completion status|0|||
160604943|NCT02177786|579932186|FG001|Overall Study|Missing study completion status|1|||
160604944|NCT02177786|579932187|FG002|Overall Study|Missing study completion status|0|||
160604945|NCT02177786|579932188|FG003|Overall Study|Missing study completion status|0|||
160604946|NCT01305941|579932189|FG000|Overall Study|Adverse Event|6|||
160604947|NCT01305941|579932189|FG000|Overall Study|Clinical decline|2|||
160604948|NCT01305941|579932189|FG000|Overall Study|Withdrawal by Subject|1|||
160604949|NCT01305941|579932189|FG000|Overall Study|Death|1|||
160604950|NCT01957215|579932190|FG000|Overall Study|Adverse Event|2|||
160604951|NCT01957215|579932191|FG001|Overall Study|Adverse Event|2|||
160604952|NCT01957215|579932190|FG000|Overall Study|Lost to Follow-up|3|||
160604953|NCT01957215|579932191|FG001|Overall Study|Lost to Follow-up|3|||
160604954|NCT01957215|579932190|FG000|Overall Study|Protocol Violation|1|||
160604955|NCT01957215|579932191|FG001|Overall Study|Protocol Violation|2|||
160604956|NCT01957215|579932190|FG000|Overall Study|Withdrawal by Subject|7|||
160604957|NCT01957215|579932191|FG001|Overall Study|Withdrawal by Subject|5|||
160604958|NCT03597503|579932195|FG000|Overall Study|Withdrawal by Subject|0|||
160604959|NCT03597503|579932196|FG001|Overall Study|Withdrawal by Subject|2|||
160604960|NCT03597503|579932195|FG000|Overall Study|Lost to Follow-up|1|||
160604961|NCT03597503|579932196|FG001|Overall Study|Lost to Follow-up|2|||
160604962|NCT03597503|579932195|FG000|Overall Study|Protocol Violation|1|||
160604963|NCT03597503|579932196|FG001|Overall Study|Protocol Violation|0|||
160604964|NCT02667236|579932199|FG000|Overall Study|Adverse Event|1|||
160604965|NCT02667236|579932200|FG001|Overall Study|Adverse Event|1|||
160604966|NCT02667236|579932199|FG000|Overall Study|Withdrawal by Subject|2|||
160604967|NCT02667236|579932200|FG001|Overall Study|Withdrawal by Subject|0|||
160483709|NCT00371462|579499114|FG000|Overall Study|Withdrawal by Subject|1|||
160483710|NCT00371462|579499115|FG001|Overall Study|Withdrawal by Subject|0|||
160483711|NCT00371462|579499114|FG000|Overall Study|Other|7|||
160483712|NCT00371462|579499115|FG001|Overall Study|Other|8|||
160483713|NCT02507687|579499118|FG000|Overall Study|Adverse Event|3|||
160483714|NCT02507687|579499119|FG001|Overall Study|Adverse Event|2|||
160483715|NCT02507687|579499120|FG002|Overall Study|Adverse Event|2|||
160483716|NCT02507687|579499121|FG003|Overall Study|Adverse Event|2|||
160483717|NCT02507687|579499118|FG000|Overall Study|Withdrawal by Subject|1|||
160604968|NCT00634751|579932205|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
160604969|NCT00634751|579932206|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
160604970|NCT00634751|579932207|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
160604971|NCT00634751|579932208|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
160604972|NCT00634751|579932205|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
160604973|NCT00634751|579932206|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
160604974|NCT00634751|579932207|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
160604975|NCT00634751|579932208|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
160604976|NCT00634751|579932205|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
160604977|NCT00634751|579932206|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
160604978|NCT00634751|579932207|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
160604979|NCT00634751|579932208|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
160604980|NCT00608894|579932209|FG000|Overall Study|Withdrawal by Subject|0|||
160604981|NCT00608894|579932210|FG001|Overall Study|Withdrawal by Subject|2|||
160483718|NCT02507687|579499119|FG001|Overall Study|Withdrawal by Subject|4|||
160483719|NCT02507687|579499120|FG002|Overall Study|Withdrawal by Subject|6|||
160483720|NCT02507687|579499121|FG003|Overall Study|Withdrawal by Subject|6|||
160483721|NCT02507687|579499118|FG000|Overall Study|Protocol Violation|1|||
160483722|NCT02507687|579499119|FG001|Overall Study|Protocol Violation|0|||
160604982|NCT03654560|579932217|FG000|Overall Study|Death|3|||
160604983|NCT03654560|579932218|FG001|Overall Study|Death|1|||
160604984|NCT03654560|579932217|FG000|Overall Study|Lost to Follow-up|1|||
160604985|NCT03654560|579932218|FG001|Overall Study|Lost to Follow-up|0|||
160604986|NCT00209092|579932219|FG000|Overall Study|Progression of disease|7|||
160604987|NCT00209092|579932220|FG001|Overall Study|Progression of disease|1|||
160604988|NCT00209092|579932219|FG000|Overall Study|Adverse Event|0|||
160604989|NCT00209092|579932220|FG001|Overall Study|Adverse Event|1|||
160604990|NCT00209092|579932219|FG000|Overall Study|Withdrawal by Subject|1|||
160604991|NCT00209092|579932220|FG001|Overall Study|Withdrawal by Subject|0|||
160604992|NCT00693420|579932221|FG000|Overall Study|Adverse Event|4|||
160604993|NCT00693420|579932222|FG001|Overall Study|Adverse Event|4|||
160604994|NCT00693420|579932221|FG000|Overall Study|Lost to Follow-up|0|||
160604995|NCT00693420|579932222|FG001|Overall Study|Lost to Follow-up|3|||
160604996|NCT00693420|579932221|FG000|Overall Study|Withdrawal by Subject|1|||
160604997|NCT00693420|579932222|FG001|Overall Study|Withdrawal by Subject|0|||
160604998|NCT00693420|579932221|FG000|Overall Study|Protocol Violation|0|||
160604999|NCT00693420|579932222|FG001|Overall Study|Protocol Violation|2|||
160605000|NCT00693420|579932221|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
160605001|NCT00693420|579932222|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
160605002|NCT00693420|579932221|FG000|Overall Study|Personal Reasons|1|||
160605003|NCT00693420|579932222|FG001|Overall Study|Personal Reasons|4|||
160605004|NCT01235338|579932223|FG000|Overall Study|Adverse Event|3|||
160605005|NCT01235338|579932224|FG001|Overall Study|Adverse Event|2|||
160605006|NCT01235338|579932223|FG000|Overall Study|Protocol Violation|1|||
160605007|NCT01235338|579932224|FG001|Overall Study|Protocol Violation|1|||
160605008|NCT01235338|579932223|FG000|Overall Study|Withdrawal by Subject|5|||
160605009|NCT01235338|579932224|FG001|Overall Study|Withdrawal by Subject|0|||
160605010|NCT01235338|579932223|FG000|Overall Study|Exclusion criteria violations|1|||
160605011|NCT01235338|579932224|FG001|Overall Study|Exclusion criteria violations|1|||
160605012|NCT01235338|579932223|FG000|Overall Study|Positive drug screen|0|||
160605013|NCT01235338|579932224|FG001|Overall Study|Positive drug screen|1|||
160605014|NCT01235338|579932223|FG000|Overall Study|Prohibited meds|1|||
160605015|NCT01235338|579932224|FG001|Overall Study|Prohibited meds|0|||
160605016|NCT05283499|579932226|FG000|Overall Study|Did not receive intervention|1|||
160605017|NCT05283499|579932227|FG001|Overall Study|Did not receive intervention|2|||
160605018|NCT02828644|579932228|FG000|Overall Study|Lost to Follow-up|23|||
160605019|NCT02828644|579932229|FG001|Overall Study|Lost to Follow-up|22|||
160605020|NCT02408484|579932230|FG000|Overall Study|Withdrawal by Subject|3|||
160605021|NCT02408484|579932230|FG000|Overall Study|Not treated during study period|1|||
160605022|NCT02996110|579932231|FG000|Pre-Treatment|Other Reasons|0|||
160605023|NCT02996110|579932232|FG001|Pre-Treatment|Other Reasons|1|||
160605024|NCT02996110|579932233|FG002|Pre-Treatment|Other Reasons|0|||
160605025|NCT02996110|579932234|FG003|Pre-Treatment|Other Reasons|0|||
160605026|NCT02996110|579932235|FG004|Pre-Treatment|Other Reasons|1|||
160605027|NCT02996110|579932231|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
160605028|NCT02996110|579932232|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
160605029|NCT02996110|579932233|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
160605030|NCT02996110|579932234|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
160605031|NCT02996110|579932235|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
160605032|NCT02996110|579932231|FG000|Track 1|Disease Progression|15|||
160605033|NCT02996110|579932232|FG001|Track 1|Disease Progression|17|||
160605034|NCT02996110|579932233|FG002|Track 1|Disease Progression|0|||
160605035|NCT02996110|579932234|FG003|Track 1|Disease Progression|0|||
160605036|NCT02996110|579932235|FG004|Track 1|Disease Progression|0|||
160605037|NCT02996110|579932231|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
160605038|NCT02996110|579932232|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
160605039|NCT02996110|579932233|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
160605040|NCT02996110|579932234|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
160605041|NCT02996110|579932235|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
160605042|NCT02996110|579932231|FG000|Track 1|Study Drug Toxicity|5|||
160605043|NCT02996110|579932232|FG001|Track 1|Study Drug Toxicity|3|||
160605044|NCT02996110|579932233|FG002|Track 1|Study Drug Toxicity|0|||
160605045|NCT02996110|579932234|FG003|Track 1|Study Drug Toxicity|0|||
160605046|NCT02996110|579932235|FG004|Track 1|Study Drug Toxicity|0|||
160605047|NCT02996110|579932231|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
160605048|NCT02996110|579932232|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
160605049|NCT02996110|579932233|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
160660878|NCT01440283|580141709|FG000|Overall Study|Physician Decision|3|||
160605050|NCT02996110|579932234|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
160605051|NCT02996110|579932235|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
160605052|NCT02996110|579932231|FG000|Track 1|Administrative Reason by Sponsor|0|||
160605053|NCT02996110|579932232|FG001|Track 1|Administrative Reason by Sponsor|1|||
160605054|NCT02996110|579932233|FG002|Track 1|Administrative Reason by Sponsor|0|||
160605055|NCT02996110|579932234|FG003|Track 1|Administrative Reason by Sponsor|0|||
160605056|NCT02996110|579932235|FG004|Track 1|Administrative Reason by Sponsor|0|||
160483723|NCT02507687|579499120|FG002|Overall Study|Protocol Violation|2|||
160483724|NCT02507687|579499121|FG003|Overall Study|Protocol Violation|0|||
160483725|NCT02507687|579499118|FG000|Overall Study|Lost to Follow-up|0|||
160483726|NCT02507687|579499119|FG001|Overall Study|Lost to Follow-up|0|||
160483727|NCT02507687|579499120|FG002|Overall Study|Lost to Follow-up|2|||
160483728|NCT02507687|579499121|FG003|Overall Study|Lost to Follow-up|1|||
160483729|NCT02507687|579499118|FG000|Overall Study|Screen Failure|0|||
160483730|NCT02507687|579499119|FG001|Overall Study|Screen Failure|0|||
160483731|NCT02507687|579499120|FG002|Overall Study|Screen Failure|1|||
160483732|NCT02507687|579499121|FG003|Overall Study|Screen Failure|0|||
160483733|NCT02507687|579499118|FG000|Overall Study|Other, Not Specified|0|||
160483734|NCT02507687|579499119|FG001|Overall Study|Other, Not Specified|0|||
160483735|NCT02507687|579499120|FG002|Overall Study|Other, Not Specified|2|||
160483736|NCT02507687|579499121|FG003|Overall Study|Other, Not Specified|4|||
160483737|NCT00275301|579499122|FG000|Overall Study|Adverse Event|5|||
160483738|NCT04357964|579499123|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
160483739|NCT04357964|579499124|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
160483740|NCT04357964|579499123|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
160483741|NCT04357964|579499124|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
160483742|NCT04357964|579499123|FG000|Overall Study|Adipose sample was insufficient quality|0|||
160483743|NCT04357964|579499124|FG001|Overall Study|Adipose sample was insufficient quality|1|||
160483744|NCT00848393|579499127|FG000|Overall Study|Protocol Violation|0|||
160483745|NCT00848393|579499128|FG001|Overall Study|Protocol Violation|0|||
160483746|NCT00848393|579499129|FG002|Overall Study|Protocol Violation|1|||
160483747|NCT00848393|579499127|FG000|Overall Study|surgical complications unrelated to stud|0|||
160483748|NCT00848393|579499128|FG001|Overall Study|surgical complications unrelated to stud|0|||
160483749|NCT00848393|579499129|FG002|Overall Study|surgical complications unrelated to stud|2|||
160483750|NCT00349622|579499136|FG000|Overall Study|Death|168|||
160483751|NCT00349622|579499137|FG001|Overall Study|Death|86|||
160483752|NCT00349622|579499136|FG000|Overall Study|Lost to Follow-up|5|||
160483753|NCT00349622|579499137|FG001|Overall Study|Lost to Follow-up|1|||
160483754|NCT00349622|579499136|FG000|Overall Study|Withdrawal by Subject|5|||
160483755|NCT00349622|579499137|FG001|Overall Study|Withdrawal by Subject|9|||
160483756|NCT03296566|579499138|FG000|Overall Study|Lost to Follow-up|19|||
160483757|NCT03296566|579499139|FG001|Overall Study|Lost to Follow-up|46|||
160483758|NCT03296566|579499138|FG000|Overall Study|Withdrawal by Subject|0|||
160483759|NCT03296566|579499139|FG001|Overall Study|Withdrawal by Subject|3|||
160483760|NCT01503515|579499143|FG000|Overall Study|Adverse Event|4|||
160483761|NCT01503515|579499144|FG001|Overall Study|Adverse Event|5|||
160483762|NCT01503515|579499143|FG000|Overall Study|Death|0|||
160483763|NCT01503515|579499144|FG001|Overall Study|Death|1|||
160483764|NCT01503515|579499143|FG000|Overall Study|Physician Decision|14|||
160483765|NCT01503515|579499144|FG001|Overall Study|Physician Decision|23|||
160483766|NCT01503515|579499143|FG000|Overall Study|Withdrawal by Subject|0|||
160483767|NCT01503515|579499144|FG001|Overall Study|Withdrawal by Subject|1|||
160483768|NCT01503515|579499143|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
160483769|NCT01503515|579499144|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
160483770|NCT01503515|579499143|FG000|Overall Study|Ineligible|1|||
160483771|NCT01503515|579499144|FG001|Overall Study|Ineligible|1|||
160483772|NCT00550771|579499145|FG000|Overall Study|Adverse Event|11|||
160483773|NCT00550771|579499146|FG001|Overall Study|Adverse Event|3|||
160483774|NCT00550771|579499145|FG000|Overall Study|Discontinued for study-related reasons|0|||
160483775|NCT00550771|579499146|FG001|Overall Study|Discontinued for study-related reasons|1|||
160483776|NCT00550771|579499145|FG000|Overall Study|Physician Decision|2|||
160483777|NCT00550771|579499146|FG001|Overall Study|Physician Decision|0|||
160483778|NCT00550771|579499145|FG000|Overall Study|Withdrawal by Subject|0|||
160483779|NCT00550771|579499146|FG001|Overall Study|Withdrawal by Subject|1|||
160483780|NCT00550771|579499145|FG000|Overall Study|Protocol Violation|4|||
160483781|NCT00550771|579499146|FG001|Overall Study|Protocol Violation|5|||
160483782|NCT00726388|579499149|FG000|Overall Study|Withdrawal by Subject|5|||
160483783|NCT00726388|579499149|FG000|Overall Study|Adverse Event|3|||
160483784|NCT00726388|579499149|FG000|Overall Study|Lost to Follow-up|10|||
160483785|NCT00726388|579499149|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
160483786|NCT00726388|579499149|FG000|Overall Study|Other|5|||
160483787|NCT00726388|579499149|FG000|Overall Study|Enrolled, Not Treated|79|||
160483788|NCT00520403|579499150|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
160483789|NCT00520403|579499150|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
160483790|NCT00520403|579499150|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
160483791|NCT00520403|579499150|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
160483792|NCT00520403|579499150|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
160483793|NCT00520403|579499150|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
160483794|NCT00520403|579499150|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
160483795|NCT00520403|579499150|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
160483796|NCT01797562|579499151|FG000|Overall Study|Protocol Violation|5|||
160605057|NCT02996110|579932231|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
160605058|NCT02996110|579932232|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
160605059|NCT02996110|579932233|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
160605060|NCT02996110|579932234|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
160605061|NCT02996110|579932235|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
160605062|NCT02996110|579932231|FG000|Track 2|Disease Progression|33|||
160605063|NCT02996110|579932232|FG001|Track 2|Disease Progression|26|||
160605064|NCT02996110|579932233|FG002|Track 2|Disease Progression|19|||
160605065|NCT02996110|579932234|FG003|Track 2|Disease Progression|16|||
160605066|NCT02996110|579932235|FG004|Track 2|Disease Progression|15|||
160605067|NCT02996110|579932231|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
160605068|NCT02996110|579932232|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
160605069|NCT02996110|579932233|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
160605070|NCT02996110|579932234|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
160605071|NCT02996110|579932235|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
160605072|NCT02996110|579932231|FG000|Track 2|Death|0|||
160605073|NCT02996110|579932232|FG001|Track 2|Death|0|||
160605074|NCT02996110|579932233|FG002|Track 2|Death|1|||
160605075|NCT02996110|579932234|FG003|Track 2|Death|0|||
160605076|NCT02996110|579932235|FG004|Track 2|Death|1|||
160605077|NCT02996110|579932231|FG000|Track 2|Study Drug Toxicity|4|||
160605078|NCT02996110|579932232|FG001|Track 2|Study Drug Toxicity|1|||
160605079|NCT02996110|579932233|FG002|Track 2|Study Drug Toxicity|4|||
160605080|NCT02996110|579932234|FG003|Track 2|Study Drug Toxicity|1|||
160605081|NCT02996110|579932235|FG004|Track 2|Study Drug Toxicity|0|||
160605082|NCT02996110|579932231|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
160605083|NCT02996110|579932232|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
160605084|NCT02996110|579932233|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
160605085|NCT02996110|579932234|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
160605086|NCT02996110|579932235|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
160605087|NCT02996110|579932231|FG000|Track 2|Participant Withdrew Consent|1|||
160605088|NCT02996110|579932232|FG001|Track 2|Participant Withdrew Consent|2|||
160605089|NCT02996110|579932233|FG002|Track 2|Participant Withdrew Consent|3|||
160605090|NCT02996110|579932234|FG003|Track 2|Participant Withdrew Consent|1|||
160605091|NCT02996110|579932235|FG004|Track 2|Participant Withdrew Consent|1|||
160605092|NCT02996110|579932231|FG000|Track 2|Other Reasons|0|||
160605093|NCT02996110|579932232|FG001|Track 2|Other Reasons|0|||
160605094|NCT02996110|579932233|FG002|Track 2|Other Reasons|1|||
160605095|NCT02996110|579932234|FG003|Track 2|Other Reasons|0|||
160605096|NCT02996110|579932235|FG004|Track 2|Other Reasons|1|||
160605097|NCT02436915|579932236|FG000|Overall Study|Withdrawal by Subject|0|||
160605098|NCT02436915|579932237|FG001|Overall Study|Withdrawal by Subject|1|||
160605099|NCT01117181|579932239|FG000|Overall Study|Lost to Follow-up|1|||
160605100|NCT01117181|579932240|FG001|Overall Study|Lost to Follow-up|0|||
160605101|NCT01117181|579932239|FG000|Overall Study|Withdrawal by Subject|0|||
160660879|NCT01196052|580141710|FG000|Overall Study|Adverse Event|9|||
160605102|NCT01117181|579932240|FG001|Overall Study|Withdrawal by Subject|2|||
160605103|NCT03805971|579932246|FG000|Overall Study|Withdrawal by Subject|1|||
160605104|NCT03805971|579932246|FG000|Overall Study|Protocol Violation|2|||
160605105|NCT00517413|579932251|FG000|Overall Study|Adverse Event|7|||
160605106|NCT00517413|579932251|FG000|Overall Study|Death|13|||
160605107|NCT00517413|579932251|FG000|Overall Study|Protocol Violation|15|||
160605108|NCT00517413|579932251|FG000|Overall Study|Withdrawal by Subject|2|||
160605109|NCT00517413|579932251|FG000|Overall Study|Failure to return|1|||
160605110|NCT00517413|579932251|FG000|Overall Study|Other-Reasons|23|||
160605111|NCT03938636|579932252|FG000|Overall Study|Protocol Violation|0|||
160605112|NCT03938636|579932253|FG001|Overall Study|Protocol Violation|1|||
160605113|NCT03938636|579932254|FG002|Overall Study|Protocol Violation|1|||
160605114|NCT03938636|579932252|FG000|Overall Study|Subject withdrew due to death in family|0|||
160605115|NCT03938636|579932253|FG001|Overall Study|Subject withdrew due to death in family|1|||
160605116|NCT03938636|579932254|FG002|Overall Study|Subject withdrew due to death in family|0|||
160605117|NCT03938636|579932252|FG000|Overall Study|Missed visit|0|||
160605118|NCT03938636|579932253|FG001|Overall Study|Missed visit|1|||
160605119|NCT03938636|579932254|FG002|Overall Study|Missed visit|0|||
160605120|NCT03938636|579932252|FG000|Overall Study|Adverse Event|0|||
160605121|NCT03938636|579932253|FG001|Overall Study|Adverse Event|0|||
160483797|NCT01441583|579499152|FG000|Overall Study|Withdrawal by Subject|1|||
160483798|NCT01441583|579499153|FG001|Overall Study|Withdrawal by Subject|1|||
160483799|NCT01441583|579499154|FG002|Overall Study|Withdrawal by Subject|1|||
160483800|NCT01441583|579499152|FG000|Overall Study|Death|1|||
160483801|NCT01441583|579499153|FG001|Overall Study|Death|0|||
160483802|NCT01441583|579499154|FG002|Overall Study|Death|4|||
160483803|NCT01441583|579499152|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
160483804|NCT01441583|579499153|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
160483805|NCT01441583|579499154|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
160483806|NCT00744796|579499155|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
160483807|NCT05372913|579499159|FG000|Overall Study|Withdrawal by Subject|0|||
160483808|NCT05372913|579499160|FG001|Overall Study|Withdrawal by Subject|2|||
160483809|NCT05372913|579499159|FG000|Overall Study|Protocol Violation|2|||
160483810|NCT05372913|579499160|FG001|Overall Study|Protocol Violation|2|||
160483811|NCT05372913|579499159|FG000|Overall Study|Adverse Event|0|||
160483812|NCT05372913|579499160|FG001|Overall Study|Adverse Event|1|||
160483813|NCT03275402|579499161|FG000|Overall Study|Death|17|||
160483814|NCT03275402|579499161|FG000|Overall Study|Study terminated by sponsor|21|||
160483815|NCT03275402|579499161|FG000|Overall Study|Withdrawal by Subject|1|||
160483816|NCT05135156|579499162|FG000|Overall Study|Lost to Follow-up|0|||
160483817|NCT05135156|579499163|FG001|Overall Study|Lost to Follow-up|0|||
160483818|NCT05135156|579499164|FG002|Overall Study|Lost to Follow-up|2|||
160483819|NCT02253147|579499168|FG000|Overall Study|Protocol Violation|30|||
160483820|NCT02253147|579499168|FG000|Overall Study|Did not consent to study extension|9|||
160483821|NCT02253147|579499168|FG000|Overall Study|Conditional re-treatment at W52|5|||
160483822|NCT02253147|579499168|FG000|Overall Study|Lost to Follow-up|2|||
160483823|NCT02253147|579499168|FG000|Overall Study|Withdrawal by Subject|1|||
160483824|NCT02986659|579499169|FG000|First Intervention Period|Adverse Event|3|||
160483825|NCT02986659|579499170|FG001|First Intervention Period|Adverse Event|1|||
160483826|NCT02986659|579499169|FG000|First Intervention Period|Lost to Follow-up|1|||
160483827|NCT02986659|579499170|FG001|First Intervention Period|Lost to Follow-up|0|||
160483828|NCT02986659|579499169|FG000|First Intervention Period|Withdrawal by Subject|0|||
160483829|NCT02986659|579499170|FG001|First Intervention Period|Withdrawal by Subject|1|||
160483830|NCT02986659|579499169|FG000|Second Intervention Period|Adverse Event|0|||
160483831|NCT02986659|579499170|FG001|Second Intervention Period|Adverse Event|6|||
160483832|NCT05012397|579499172|FG000|Overall Study|Death|10|||
160483833|NCT05012397|579499172|FG000|Overall Study|Physician Decision|9|||
160483834|NCT05012397|579499172|FG000|Overall Study|Withdrawal by Subject|5|||
160483835|NCT05012397|579499172|FG000|Overall Study|Lost to Follow-up|2|||
160483836|NCT03334747|579499173|FG000|Treatment Phase|Technical problems|0|||
160483837|NCT03334747|579499174|FG001|Treatment Phase|Technical problems|0|||
160483838|NCT03334747|579499175|FG002|Treatment Phase|Technical problems|0|||
160483839|NCT03334747|579499176|FG003|Treatment Phase|Technical problems|0|||
160483840|NCT03334747|579499177|FG004|Treatment Phase|Technical problems|1|||
160483841|NCT03334747|579499178|FG005|Treatment Phase|Technical problems|0|||
160483842|NCT03334747|579499179|FG006|Treatment Phase|Technical problems|0|||
160483843|NCT03334747|579499180|FG007|Treatment Phase|Technical problems|0|||
160483844|NCT03334747|579499181|FG008|Treatment Phase|Technical problems|0|||
160483845|NCT03334747|579499173|FG000|Treatment Phase|Subject/guardian decision|1|||
160483846|NCT03334747|579499174|FG001|Treatment Phase|Subject/guardian decision|0|||
160483847|NCT03334747|579499175|FG002|Treatment Phase|Subject/guardian decision|0|||
160483848|NCT03334747|579499176|FG003|Treatment Phase|Subject/guardian decision|0|||
160483849|NCT03334747|579499177|FG004|Treatment Phase|Subject/guardian decision|0|||
160483850|NCT03334747|579499178|FG005|Treatment Phase|Subject/guardian decision|1|||
160483851|NCT03334747|579499179|FG006|Treatment Phase|Subject/guardian decision|0|||
160483852|NCT03334747|579499180|FG007|Treatment Phase|Subject/guardian decision|0|||
160483853|NCT03334747|579499181|FG008|Treatment Phase|Subject/guardian decision|0|||
160483854|NCT03334747|579499173|FG000|Follow-Up Phase|Subject/guardian decision|0|||
160483855|NCT03334747|579499174|FG001|Follow-Up Phase|Subject/guardian decision|0|||
160605122|NCT03938636|579932254|FG002|Overall Study|Adverse Event|1|||
160605123|NCT03938636|579932252|FG000|Overall Study|Lost to Follow-up|0|||
160605124|NCT03938636|579932253|FG001|Overall Study|Lost to Follow-up|0|||
160605125|NCT03938636|579932254|FG002|Overall Study|Lost to Follow-up|1|||
160605126|NCT02939976|579932262|FG000|Overall Study|Lost to Follow-up|7|||
160483856|NCT03334747|579499175|FG002|Follow-Up Phase|Subject/guardian decision|0|||
160483857|NCT03334747|579499176|FG003|Follow-Up Phase|Subject/guardian decision|0|||
160483858|NCT03334747|579499177|FG004|Follow-Up Phase|Subject/guardian decision|0|||
160483859|NCT03334747|579499178|FG005|Follow-Up Phase|Subject/guardian decision|0|||
160605127|NCT02939976|579932263|FG001|Overall Study|Lost to Follow-up|1|||
160605128|NCT02939976|579932264|FG002|Overall Study|Lost to Follow-up|1|||
160605129|NCT02939976|579932265|FG003|Overall Study|Lost to Follow-up|2|||
160605130|NCT02939976|579932262|FG000|Overall Study|Withdrawal by Subject|4|||
160483860|NCT03334747|579499179|FG006|Follow-Up Phase|Subject/guardian decision|1|||
160483861|NCT03334747|579499180|FG007|Follow-Up Phase|Subject/guardian decision|0|||
160483862|NCT03334747|579499181|FG008|Follow-Up Phase|Subject/guardian decision|1|||
160483863|NCT01379521|579499183|FG000|Overall Study -Treatment Period|Adverse Event|3|||
160605131|NCT02939976|579932263|FG001|Overall Study|Withdrawal by Subject|0|||
160605132|NCT02939976|579932264|FG002|Overall Study|Withdrawal by Subject|2|||
160605133|NCT02939976|579932265|FG003|Overall Study|Withdrawal by Subject|4|||
160605134|NCT02939976|579932262|FG000|Overall Study|Due to early study closure|4|||
160605135|NCT02939976|579932263|FG001|Overall Study|Due to early study closure|3|||
160605136|NCT02939976|579932264|FG002|Overall Study|Due to early study closure|2|||
160605137|NCT02939976|579932265|FG003|Overall Study|Due to early study closure|3|||
160605138|NCT04080752|579932266|FG000|Overall Study|Adverse Event|2|||
160605139|NCT04080752|579932267|FG001|Overall Study|Adverse Event|3|||
160605140|NCT04080752|579932266|FG000|Overall Study|Lack of Efficacy|1|||
160605141|NCT04080752|579932267|FG001|Overall Study|Lack of Efficacy|0|||
160605142|NCT04080752|579932266|FG000|Overall Study|Lost to Follow-up|1|||
160605143|NCT04080752|579932267|FG001|Overall Study|Lost to Follow-up|0|||
160605144|NCT04080752|579932266|FG000|Overall Study|Pregnancy|0|||
160605145|NCT04080752|579932267|FG001|Overall Study|Pregnancy|1|||
160605146|NCT04080752|579932266|FG000|Overall Study|Withdrawal by Subject|7|||
160605147|NCT04080752|579932267|FG001|Overall Study|Withdrawal by Subject|0|||
160605148|NCT04080752|579932266|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160605149|NCT04080752|579932267|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160605150|NCT04080752|579932266|FG000|Overall Study|Other|2|||
160605151|NCT04080752|579932267|FG001|Overall Study|Other|1|||
160605152|NCT01585168|579932268|FG000|Overall Study|Lost to Follow-up|3|||
160605153|NCT01585168|579932269|FG001|Overall Study|Lost to Follow-up|1|||
160605154|NCT01585168|579932270|FG002|Overall Study|Lost to Follow-up|1|||
160605155|NCT01585168|579932271|FG003|Overall Study|Lost to Follow-up|1|||
160605156|NCT01194414|579932272|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
160605157|NCT01194414|579932273|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
160605158|NCT01194414|579932274|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
160605159|NCT01194414|579932275|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
160605160|NCT01194414|579932272|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
160605161|NCT01194414|579932273|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
160605162|NCT01194414|579932274|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
160605163|NCT01194414|579932275|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
160605164|NCT01194414|579932272|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
160605165|NCT01194414|579932273|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
160605166|NCT01194414|579932274|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
160605167|NCT01194414|579932275|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
160605168|NCT01194414|579932272|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
160605169|NCT01194414|579932273|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
160605170|NCT01194414|579932274|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
160605171|NCT01194414|579932275|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
160605172|NCT01194414|579932272|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
160605173|NCT01194414|579932273|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
160605174|NCT01194414|579932274|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
160605175|NCT01194414|579932275|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
160605176|NCT01194414|579932272|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
160605177|NCT01194414|579932273|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
160605178|NCT01194414|579932274|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
160605179|NCT01194414|579932275|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
160483864|NCT01379521|579499184|FG001|Overall Study -Treatment Period|Adverse Event|0|||
160483865|NCT01379521|579499183|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
160483866|NCT01379521|579499184|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
160605180|NCT01194414|579932272|FG000|24 Weeks Double Blind Period|Other|0|||
160605181|NCT01194414|579932273|FG001|24 Weeks Double Blind Period|Other|1|||
160605182|NCT01194414|579932274|FG002|24 Weeks Double Blind Period|Other|0|||
160605183|NCT01194414|579932275|FG003|24 Weeks Double Blind Period|Other|0|||
160605184|NCT01194414|579932272|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
160605185|NCT01194414|579932273|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
160605186|NCT01194414|579932274|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
160605187|NCT01194414|579932275|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
160605188|NCT01194414|579932272|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
160605189|NCT01194414|579932273|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
160605190|NCT01194414|579932274|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
160605191|NCT01194414|579932275|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
160605192|NCT01194414|579932272|FG000|24 Weeks Double Blind Period|Death|0|||
160605193|NCT01194414|579932273|FG001|24 Weeks Double Blind Period|Death|1|||
160605194|NCT01194414|579932274|FG002|24 Weeks Double Blind Period|Death|0|||
160605195|NCT01194414|579932275|FG003|24 Weeks Double Blind Period|Death|0|||
160605196|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
160605197|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
160660880|NCT01196052|580141710|FG000|Overall Study|Lost to Follow-up|1|||
160605198|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
160605199|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
160605200|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
160605201|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
160605202|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
160605203|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
160605204|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
160605205|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
160605206|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
160605207|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
160605208|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
160605209|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
160605210|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
160605211|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
160605212|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
160605213|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
160605214|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
160605215|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
160605216|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
160605217|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
160605218|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
160605219|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
160605220|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Other|2|||
160605221|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Other|1|||
160605222|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Other|0|||
160605223|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Other|0|||
160605224|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
160605225|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
160605226|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
160605227|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
160605228|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
160605229|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
160605230|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
160605231|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
160605232|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
160605233|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
160605234|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
160605235|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
160605236|NCT01194414|579932272|FG000|72 Weeks Open Label Extension|Death|1|||
160605237|NCT01194414|579932273|FG001|72 Weeks Open Label Extension|Death|2|||
160605238|NCT01194414|579932274|FG002|72 Weeks Open Label Extension|Death|0|||
160605239|NCT01194414|579932275|FG003|72 Weeks Open Label Extension|Death|2|||
160605240|NCT02977507|579932276|FG000|Overall Study|Protocol Deviation|1|||
160605241|NCT02977507|579932277|FG001|Overall Study|Protocol Deviation|0|||
160605242|NCT02977507|579932276|FG000|Overall Study|Lost to Follow-up|1|||
160605243|NCT02977507|579932277|FG001|Overall Study|Lost to Follow-up|0|||
160605244|NCT00329784|579932278|FG000|Overall Study|Lost to Follow-up|0|||
160605245|NCT00329784|579932279|FG001|Overall Study|Lost to Follow-up|1|||
160605246|NCT00329784|579932280|FG002|Overall Study|Lost to Follow-up|0|||
160605247|NCT00329784|579932281|FG003|Overall Study|Lost to Follow-up|0|||
160605248|NCT00329784|579932278|FG000|Overall Study|Withdrawal by Subject|4|||
160605249|NCT00329784|579932279|FG001|Overall Study|Withdrawal by Subject|2|||
160605250|NCT00329784|579932280|FG002|Overall Study|Withdrawal by Subject|0|||
160605251|NCT00329784|579932281|FG003|Overall Study|Withdrawal by Subject|0|||
160605252|NCT00329784|579932278|FG000|Overall Study|Other|1|||
160605253|NCT00329784|579932279|FG001|Overall Study|Other|2|||
160605254|NCT00329784|579932280|FG002|Overall Study|Other|0|||
160605255|NCT00329784|579932281|FG003|Overall Study|Other|0|||
160605256|NCT00654420|579932282|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
160605257|NCT00654420|579932283|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
160605258|NCT00654420|579932284|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
160660881|NCT01196052|580141710|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
160605259|NCT00654420|579932285|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
160605260|NCT00654420|579932282|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
160605261|NCT00654420|579932283|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
160605262|NCT00654420|579932284|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
160605263|NCT00654420|579932285|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
160605264|NCT00654420|579932282|FG000|Phase II|Adverse Event|0|||
160605265|NCT00654420|579932283|FG001|Phase II|Adverse Event|0|||
160605266|NCT00654420|579932284|FG002|Phase II|Adverse Event|3|||
160605267|NCT00654420|579932285|FG003|Phase II|Adverse Event|3|||
160605268|NCT00654420|579932282|FG000|Phase II|Lost to Follow-up|0|||
160605269|NCT00654420|579932283|FG001|Phase II|Lost to Follow-up|0|||
160605270|NCT00654420|579932284|FG002|Phase II|Lost to Follow-up|0|||
160605271|NCT00654420|579932285|FG003|Phase II|Lost to Follow-up|1|||
160605272|NCT00654420|579932282|FG000|Phase II|Physician Decision|0|||
160605273|NCT00654420|579932283|FG001|Phase II|Physician Decision|0|||
160605274|NCT00654420|579932284|FG002|Phase II|Physician Decision|0|||
160605275|NCT00654420|579932285|FG003|Phase II|Physician Decision|4|||
160605276|NCT00654420|579932282|FG000|Phase II|Progressive Disease|0|||
160605277|NCT00654420|579932283|FG001|Phase II|Progressive Disease|0|||
160605278|NCT00654420|579932284|FG002|Phase II|Progressive Disease|29|||
160605279|NCT00654420|579932285|FG003|Phase II|Progressive Disease|29|||
160605280|NCT00654420|579932282|FG000|Phase II|Withdrawal by Subject|0|||
160605281|NCT00654420|579932283|FG001|Phase II|Withdrawal by Subject|0|||
160605282|NCT00654420|579932284|FG002|Phase II|Withdrawal by Subject|4|||
160605283|NCT00654420|579932285|FG003|Phase II|Withdrawal by Subject|1|||
160605284|NCT00654420|579932282|FG000|Phase II|Missing Disposition Record|0|||
160605285|NCT00654420|579932283|FG001|Phase II|Missing Disposition Record|0|||
160605286|NCT00654420|579932284|FG002|Phase II|Missing Disposition Record|1|||
160605287|NCT00654420|579932285|FG003|Phase II|Missing Disposition Record|0|||
160605288|NCT00610207|579932290|FG000|Overall Study|Lost to Follow-up|3|||
160605289|NCT00741260|579932294|FG000|Overall Study|Disease Progression|3|||
160605290|NCT00741260|579932295|FG001|Overall Study|Disease Progression|5|||
160605291|NCT00741260|579932296|FG002|Overall Study|Disease Progression|3|||
160605292|NCT00741260|579932297|FG003|Overall Study|Disease Progression|3|||
160605293|NCT00741260|579932298|FG004|Overall Study|Disease Progression|5|||
160605294|NCT00741260|579932299|FG005|Overall Study|Disease Progression|37|||
160605295|NCT00741260|579932300|FG006|Overall Study|Disease Progression|4|||
160605296|NCT00741260|579932294|FG000|Overall Study|Death|0|||
160605297|NCT00741260|579932295|FG001|Overall Study|Death|1|||
160605298|NCT00741260|579932296|FG002|Overall Study|Death|0|||
160605299|NCT00741260|579932297|FG003|Overall Study|Death|1|||
160605300|NCT00741260|579932298|FG004|Overall Study|Death|2|||
160605301|NCT00741260|579932299|FG005|Overall Study|Death|2|||
160605302|NCT00741260|579932300|FG006|Overall Study|Death|1|||
160605303|NCT00741260|579932294|FG000|Overall Study|Withdrawal by Subject|0|||
160660882|NCT01196052|580141710|FG000|Overall Study|Reason not Specified|5|||
160660883|NCT01196052|580141710|FG000|Overall Study|Withdrawal by Subject|6|||
160660884|NCT03603314|580141711|FG000|Overall Study|Lost to Follow-up|0|||
160660885|NCT03603314|580141712|FG001|Overall Study|Lost to Follow-up|3|||
160660886|NCT03603314|580141713|FG002|Overall Study|Lost to Follow-up|0|||
160660887|NCT03603314|580141711|FG000|Overall Study|Protocol Violation|0|||
160660888|NCT03603314|580141712|FG001|Overall Study|Protocol Violation|1|||
160660889|NCT03603314|580141713|FG002|Overall Study|Protocol Violation|0|||
160660890|NCT03603314|580141711|FG000|Overall Study|Adverse Event|2|||
160660891|NCT03603314|580141712|FG001|Overall Study|Adverse Event|0|||
160660892|NCT03603314|580141713|FG002|Overall Study|Adverse Event|0|||
160660893|NCT03603314|580141711|FG000|Overall Study|Physician Decision|1|||
160660894|NCT03603314|580141712|FG001|Overall Study|Physician Decision|1|||
160660895|NCT03603314|580141713|FG002|Overall Study|Physician Decision|0|||
160660896|NCT03603314|580141711|FG000|Overall Study|Withdrawal by Subject|4|||
160660897|NCT03603314|580141712|FG001|Overall Study|Withdrawal by Subject|5|||
160660898|NCT03603314|580141713|FG002|Overall Study|Withdrawal by Subject|3|||
160660899|NCT03603314|580141711|FG000|Overall Study|Other|0|||
160660900|NCT03603314|580141712|FG001|Overall Study|Other|1|||
160660901|NCT03603314|580141713|FG002|Overall Study|Other|0|||
160660902|NCT01389102|580141714|FG000|Overall Study|Adverse Event|1|||
160660903|NCT01389102|580141715|FG001|Overall Study|Adverse Event|3|||
160660904|NCT01389102|580141716|FG002|Overall Study|Adverse Event|2|||
160660905|NCT01389102|580141717|FG003|Overall Study|Adverse Event|2|||
160660906|NCT01389102|580141718|FG004|Overall Study|Adverse Event|2|||
160660907|NCT01389102|580141719|FG005|Overall Study|Adverse Event|2|||
160660908|NCT01389102|580141714|FG000|Overall Study|Hurricane Katrina|4|||
160660909|NCT01389102|580141715|FG001|Overall Study|Hurricane Katrina|2|||
160660910|NCT01389102|580141716|FG002|Overall Study|Hurricane Katrina|3|||
160660911|NCT01389102|580141717|FG003|Overall Study|Hurricane Katrina|0|||
160660912|NCT01389102|580141718|FG004|Overall Study|Hurricane Katrina|3|||
160660913|NCT01389102|580141719|FG005|Overall Study|Hurricane Katrina|1|||
160660914|NCT01389102|580141714|FG000|Overall Study|Lost to Follow-up|4|||
160660915|NCT01389102|580141715|FG001|Overall Study|Lost to Follow-up|1|||
160660916|NCT01389102|580141716|FG002|Overall Study|Lost to Follow-up|1|||
160660917|NCT01389102|580141717|FG003|Overall Study|Lost to Follow-up|2|||
160605304|NCT00741260|579932295|FG001|Overall Study|Withdrawal by Subject|0|||
160605305|NCT00741260|579932296|FG002|Overall Study|Withdrawal by Subject|0|||
160605306|NCT00741260|579932297|FG003|Overall Study|Withdrawal by Subject|0|||
160660918|NCT01389102|580141718|FG004|Overall Study|Lost to Follow-up|4|||
160660919|NCT01389102|580141719|FG005|Overall Study|Lost to Follow-up|1|||
160660920|NCT01389102|580141714|FG000|Overall Study|Protocol Violation|0|||
160660921|NCT01389102|580141715|FG001|Overall Study|Protocol Violation|0|||
160660922|NCT01389102|580141716|FG002|Overall Study|Protocol Violation|3|||
160660923|NCT01389102|580141717|FG003|Overall Study|Protocol Violation|0|||
160605307|NCT00741260|579932298|FG004|Overall Study|Withdrawal by Subject|1|||
160605308|NCT00741260|579932299|FG005|Overall Study|Withdrawal by Subject|3|||
160605309|NCT00741260|579932300|FG006|Overall Study|Withdrawal by Subject|1|||
160605310|NCT00741260|579932294|FG000|Overall Study|Physician Decision|1|||
160605311|NCT00741260|579932295|FG001|Overall Study|Physician Decision|1|||
160605312|NCT00741260|579932296|FG002|Overall Study|Physician Decision|0|||
160605313|NCT00741260|579932297|FG003|Overall Study|Physician Decision|0|||
160605314|NCT00741260|579932298|FG004|Overall Study|Physician Decision|0|||
160605315|NCT00741260|579932299|FG005|Overall Study|Physician Decision|0|||
160605316|NCT00741260|579932300|FG006|Overall Study|Physician Decision|0|||
160605317|NCT00741260|579932294|FG000|Overall Study|Other|2|||
160605318|NCT00741260|579932295|FG001|Overall Study|Other|1|||
160605319|NCT00741260|579932296|FG002|Overall Study|Other|1|||
160605320|NCT00741260|579932297|FG003|Overall Study|Other|2|||
160605321|NCT00741260|579932298|FG004|Overall Study|Other|1|||
160605322|NCT00741260|579932299|FG005|Overall Study|Other|3|||
160605323|NCT00741260|579932300|FG006|Overall Study|Other|1|||
160605324|NCT01928082|579932304|FG000|Overall Study|Study terminated.|1|||
160605325|NCT02427100|579932308|FG000|Overall Study|Lost to Follow-up|0|||
160605326|NCT02427100|579932309|FG001|Overall Study|Lost to Follow-up|2|||
160605327|NCT01906476|579932310|FG000|Overall Study|Lost to Follow-up|17|||
160605328|NCT01906476|579932311|FG001|Overall Study|Lost to Follow-up|16|||
160605329|NCT01993667|579932315|FG000|Overall Study|Insufficient data to analyze|16|||
160605330|NCT01993667|579932316|FG001|Overall Study|Insufficient data to analyze|16|||
160605331|NCT01993667|579932315|FG000|Overall Study|Insufficient altitude reached|3|||
160605332|NCT01993667|579932316|FG001|Overall Study|Insufficient altitude reached|1|||
160605333|NCT01993667|579932315|FG000|Overall Study|Lost to Follow-up|2|||
160605334|NCT01993667|579932316|FG001|Overall Study|Lost to Follow-up|2|||
160605335|NCT01931150|579932317|FG000|Overall Study|Withdrawal by Subject|1|||
160605336|NCT01931150|579932318|FG001|Overall Study|Withdrawal by Subject|2|||
160605337|NCT00845845|579932321|FG000|Overall Study|Lost to Follow-up|0|||
160605338|NCT00845845|579932322|FG001|Overall Study|Lost to Follow-up|4|||
160605339|NCT01685203|579932323|FG000|Overall Study|Lost to Follow-up|3|||
160605340|NCT01685203|579932324|FG001|Overall Study|Lost to Follow-up|3|||
160605341|NCT01685203|579932325|FG002|Overall Study|Lost to Follow-up|0|||
160605342|NCT01685203|579932326|FG003|Overall Study|Lost to Follow-up|1|||
160605343|NCT01685203|579932327|FG004|Overall Study|Lost to Follow-up|0|||
160605344|NCT01685203|579932328|FG005|Overall Study|Lost to Follow-up|0|||
160605345|NCT01685203|579932329|FG006|Overall Study|Lost to Follow-up|0|||
160605346|NCT01685203|579932323|FG000|Overall Study|Adverse Event|0|||
160605347|NCT01685203|579932324|FG001|Overall Study|Adverse Event|0|||
160605348|NCT01685203|579932325|FG002|Overall Study|Adverse Event|0|||
160605349|NCT01685203|579932326|FG003|Overall Study|Adverse Event|0|||
160605350|NCT01685203|579932327|FG004|Overall Study|Adverse Event|0|||
160605351|NCT01685203|579932328|FG005|Overall Study|Adverse Event|2|||
160605352|NCT01685203|579932329|FG006|Overall Study|Adverse Event|0|||
160605353|NCT01685203|579932323|FG000|Overall Study|Adverse event and withdrew consent|1|||
160605354|NCT01685203|579932324|FG001|Overall Study|Adverse event and withdrew consent|0|||
160605355|NCT01685203|579932325|FG002|Overall Study|Adverse event and withdrew consent|0|||
160605356|NCT01685203|579932326|FG003|Overall Study|Adverse event and withdrew consent|0|||
160605357|NCT01685203|579932327|FG004|Overall Study|Adverse event and withdrew consent|0|||
160605358|NCT01685203|579932328|FG005|Overall Study|Adverse event and withdrew consent|0|||
160605359|NCT01685203|579932329|FG006|Overall Study|Adverse event and withdrew consent|0|||
160605360|NCT01685203|579932323|FG000|Overall Study|Patient's decision|0|||
160605361|NCT01685203|579932324|FG001|Overall Study|Patient's decision|0|||
160605362|NCT01685203|579932325|FG002|Overall Study|Patient's decision|0|||
160605363|NCT01685203|579932326|FG003|Overall Study|Patient's decision|0|||
160605364|NCT01685203|579932327|FG004|Overall Study|Patient's decision|0|||
160605365|NCT01685203|579932328|FG005|Overall Study|Patient's decision|1|||
160605366|NCT01685203|579932329|FG006|Overall Study|Patient's decision|0|||
160605367|NCT00479167|579932330|FG000|Overall Study|Withdrawal by Subject|1|||
160605368|NCT04095793|579932331|FG000|Overall Study|Adverse Event|3|||
160605369|NCT04095793|579932331|FG000|Overall Study|Study Terminated by Sponsor|103|||
160605370|NCT04095793|579932331|FG000|Overall Study|Withdrawal by Subject|4|||
160605371|NCT03619837|579932332|FG000|Screening|received organs from HCV-negative donors|47|||
160605372|NCT03619837|579932332|FG000|Screening|died on the wait-list|2|||
160605373|NCT03619837|579932332|FG000|Screening|remained on the wait list|40|||
160605374|NCT03619837|579932332|FG000|Screening|didn't meet eligibility criteria|3|||
160605375|NCT03619837|579932332|FG000|Screening|withdrew consent|2|||
160605376|NCT03619837|579932332|FG000|Screening|never listed for HCV-viremic donor|1|||
160605377|NCT03619837|579932332|FG000|Screening|developed exclusion criteria|2|||
160605378|NCT03619837|579932332|FG000|Screening|excluded by the investigator due to non-compliance|1|||
160605379|NCT01602549|579932333|FG000|Overall Study|Protocol Violation|0|||
160605380|NCT01602549|579932334|FG001|Overall Study|Protocol Violation|1|||
160605381|NCT01602549|579932333|FG000|Overall Study|Withdrawal by Subject|1|||
160605382|NCT01602549|579932334|FG001|Overall Study|Withdrawal by Subject|0|||
160605383|NCT03695471|579934519|FG000|Overall Study|Cancellation|1|||
160605384|NCT02859558|579934520|FG000|Step 1|Not Eligible|0|||
160605385|NCT02859558|579934521|FG001|Step 1|Not Eligible|0|||
160605386|NCT02859558|579934522|FG002|Step 1|Not Eligible|0|||
160605387|NCT02859558|579934523|FG003|Step 1|Not Eligible|0|||
160605388|NCT02859558|579934524|FG004|Step 1|Not Eligible|3|||
160605389|NCT02859558|579934520|FG000|Step 1|Lost to Follow-up|1|||
160605390|NCT02859558|579934521|FG001|Step 1|Lost to Follow-up|3|||
160605391|NCT02859558|579934522|FG002|Step 1|Lost to Follow-up|3|||
160605392|NCT02859558|579934523|FG003|Step 1|Lost to Follow-up|0|||
160605393|NCT02859558|579934524|FG004|Step 1|Lost to Follow-up|0|||
160605394|NCT02859558|579934520|FG000|Step 1|Did Not Return to Clinic|2|||
160605395|NCT02859558|579934521|FG001|Step 1|Did Not Return to Clinic|3|||
160605396|NCT02859558|579934522|FG002|Step 1|Did Not Return to Clinic|4|||
160605397|NCT02859558|579934523|FG003|Step 1|Did Not Return to Clinic|0|||
160605398|NCT02859558|579934524|FG004|Step 1|Did Not Return to Clinic|0|||
160605399|NCT02859558|579934520|FG000|Step 1|Moved|0|||
160605400|NCT02859558|579934521|FG001|Step 1|Moved|1|||
160605401|NCT02859558|579934522|FG002|Step 1|Moved|1|||
160605402|NCT02859558|579934523|FG003|Step 1|Moved|0|||
160605403|NCT02859558|579934524|FG004|Step 1|Moved|0|||
160605404|NCT02859558|579934520|FG000|Step 1|Withdrawal By Participant|1|||
160605405|NCT02859558|579934521|FG001|Step 1|Withdrawal By Participant|2|||
160605406|NCT02859558|579934522|FG002|Step 1|Withdrawal By Participant|1|||
160605407|NCT02859558|579934523|FG003|Step 1|Withdrawal By Participant|0|||
160605408|NCT02859558|579934524|FG004|Step 1|Withdrawal By Participant|0|||
160605409|NCT02859558|579934520|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
160605410|NCT02859558|579934521|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
160605411|NCT02859558|579934522|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
160605412|NCT02859558|579934523|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
160605413|NCT02859558|579934524|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
160605414|NCT02859558|579934520|FG000|Step 1|Incarceration|0|||
160605415|NCT02859558|579934521|FG001|Step 1|Incarceration|1|||
160605416|NCT02859558|579934522|FG002|Step 1|Incarceration|0|||
160605417|NCT02859558|579934523|FG003|Step 1|Incarceration|0|||
160605418|NCT02859558|579934524|FG004|Step 1|Incarceration|0|||
160605419|NCT02859558|579934520|FG000|Step 1|Non-Adherence to Study Drug|2|||
160605420|NCT02859558|579934521|FG001|Step 1|Non-Adherence to Study Drug|0|||
160605421|NCT02859558|579934522|FG002|Step 1|Non-Adherence to Study Drug|1|||
160605422|NCT02859558|579934523|FG003|Step 1|Non-Adherence to Study Drug|0|||
160605423|NCT02859558|579934524|FG004|Step 1|Non-Adherence to Study Drug|0|||
160605424|NCT02859558|579934520|FG000|Step 1|Non-Adherence to Study Requirements|3|||
160605425|NCT02859558|579934521|FG001|Step 1|Non-Adherence to Study Requirements|1|||
160605426|NCT02859558|579934522|FG002|Step 1|Non-Adherence to Study Requirements|0|||
160605427|NCT02859558|579934523|FG003|Step 1|Non-Adherence to Study Requirements|0|||
160605428|NCT02859558|579934524|FG004|Step 1|Non-Adherence to Study Requirements|0|||
160605429|NCT02859558|579934520|FG000|Step 1|Virologic Failure|2|||
160605430|NCT02859558|579934521|FG001|Step 1|Virologic Failure|1|||
160605431|NCT02859558|579934522|FG002|Step 1|Virologic Failure|1|||
160605432|NCT02859558|579934523|FG003|Step 1|Virologic Failure|0|||
160605433|NCT02859558|579934524|FG004|Step 1|Virologic Failure|0|||
160605434|NCT02859558|579934520|FG000|Step 2|Lost to Follow-up|3|||
160605435|NCT02859558|579934521|FG001|Step 2|Lost to Follow-up|3|||
160605436|NCT02859558|579934522|FG002|Step 2|Lost to Follow-up|1|||
160605437|NCT02859558|579934523|FG003|Step 2|Lost to Follow-up|0|||
160605438|NCT02859558|579934524|FG004|Step 2|Lost to Follow-up|0|||
160605439|NCT02859558|579934520|FG000|Step 2|Withdrawal by Subject|0|||
160605440|NCT02859558|579934521|FG001|Step 2|Withdrawal by Subject|1|||
160605441|NCT02859558|579934522|FG002|Step 2|Withdrawal by Subject|1|||
160605442|NCT02859558|579934523|FG003|Step 2|Withdrawal by Subject|0|||
160605443|NCT02859558|579934524|FG004|Step 2|Withdrawal by Subject|0|||
160483867|NCT01379521|579499183|FG000|Overall Study -Treatment Period|Disease Progression|23|||
160483868|NCT01379521|579499184|FG001|Overall Study -Treatment Period|Disease Progression|22|||
160483869|NCT01379521|579499183|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
160483870|NCT01379521|579499184|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
160605444|NCT02859558|579934520|FG000|Step 2|Unexpected Closure of Site|0|||
160605445|NCT02859558|579934521|FG001|Step 2|Unexpected Closure of Site|1|||
160605446|NCT02859558|579934522|FG002|Step 2|Unexpected Closure of Site|1|||
160605447|NCT02859558|579934523|FG003|Step 2|Unexpected Closure of Site|0|||
160605448|NCT02859558|579934524|FG004|Step 2|Unexpected Closure of Site|0|||
160605449|NCT02859558|579934520|FG000|Step 2|Death|1|||
160605450|NCT02859558|579934521|FG001|Step 2|Death|0|||
160605451|NCT02859558|579934522|FG002|Step 2|Death|0|||
160605452|NCT02859558|579934523|FG003|Step 2|Death|0|||
160605453|NCT02859558|579934524|FG004|Step 2|Death|0|||
160605454|NCT02859558|579934520|FG000|Step 2|Incarceration|0|||
160605455|NCT02859558|579934521|FG001|Step 2|Incarceration|0|||
160605456|NCT02859558|579934522|FG002|Step 2|Incarceration|1|||
160605457|NCT02859558|579934523|FG003|Step 2|Incarceration|0|||
160605458|NCT02859558|579934524|FG004|Step 2|Incarceration|0|||
160605459|NCT04507360|579934525|FG000|Week 1|Lost to Follow-up|0|||
160605460|NCT04507360|579934526|FG001|Week 1|Lost to Follow-up|0|||
160605461|NCT04507360|579934527|FG002|Week 1|Lost to Follow-up|0|||
160605462|NCT04507360|579934528|FG003|Week 1|Lost to Follow-up|0|||
160605463|NCT04507360|579934529|FG004|Week 1|Lost to Follow-up|0|||
160483871|NCT01379521|579499183|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
160483872|NCT01379521|579499184|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
160483873|NCT01379521|579499183|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
160483874|NCT01379521|579499184|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
160483875|NCT01379521|579499183|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
160483876|NCT01379521|579499184|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
160483877|NCT01379521|579499183|FG000|Overall Study -Treatment Period|Death|2|||
160483878|NCT01379521|579499184|FG001|Overall Study -Treatment Period|Death|1|||
160483879|NCT01379521|579499183|FG000|Post-Treatment Evaluations|Disease Progression|22|||
160483880|NCT01379521|579499184|FG001|Post-Treatment Evaluations|Disease Progression|20|||
160483881|NCT01379521|579499183|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
160483882|NCT01379521|579499184|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
160483883|NCT01379521|579499183|FG000|Post-Treatment Evaluations|Death|1|||
160483884|NCT01379521|579499184|FG001|Post-Treatment Evaluations|Death|0|||
160483885|NCT02538471|579499187|FG000|Overall Study|Progression of disease|2|||
160483886|NCT00475735|579499188|FG000|Treatment Period 1|Adverse Event|2|||
160483887|NCT00475735|579499189|FG001|Treatment Period 1|Adverse Event|0|||
160483888|NCT00475735|579499190|FG002|Treatment Period 1|Adverse Event|0|||
160483889|NCT00475735|579499191|FG003|Treatment Period 1|Adverse Event|0|||
160483890|NCT00475735|579499192|FG004|Treatment Period 1|Adverse Event|0|||
160483891|NCT00475735|579499193|FG005|Treatment Period 1|Adverse Event|0|||
160483892|NCT00475735|579499188|FG000|Treatment Period 1|Lack of Efficacy|1|||
160483893|NCT00475735|579499189|FG001|Treatment Period 1|Lack of Efficacy|0|||
160483894|NCT00475735|579499190|FG002|Treatment Period 1|Lack of Efficacy|0|||
160483895|NCT00475735|579499191|FG003|Treatment Period 1|Lack of Efficacy|0|||
160483896|NCT00475735|579499192|FG004|Treatment Period 1|Lack of Efficacy|0|||
160483897|NCT00475735|579499193|FG005|Treatment Period 1|Lack of Efficacy|0|||
160483898|NCT00475735|579499188|FG000|Treatment Period 1|Lost to Follow-up|0|||
160483899|NCT00475735|579499189|FG001|Treatment Period 1|Lost to Follow-up|0|||
160483900|NCT00475735|579499190|FG002|Treatment Period 1|Lost to Follow-up|0|||
160483901|NCT00475735|579499191|FG003|Treatment Period 1|Lost to Follow-up|0|||
160483902|NCT00475735|579499192|FG004|Treatment Period 1|Lost to Follow-up|0|||
160483903|NCT00475735|579499193|FG005|Treatment Period 1|Lost to Follow-up|1|||
160483904|NCT00475735|579499188|FG000|Treatment Period 1|Protocol Violation|0|||
160483905|NCT00475735|579499189|FG001|Treatment Period 1|Protocol Violation|0|||
160483906|NCT00475735|579499190|FG002|Treatment Period 1|Protocol Violation|0|||
160483907|NCT00475735|579499191|FG003|Treatment Period 1|Protocol Violation|1|||
160483908|NCT00475735|579499192|FG004|Treatment Period 1|Protocol Violation|0|||
160483909|NCT00475735|579499193|FG005|Treatment Period 1|Protocol Violation|0|||
160483910|NCT00475735|579499188|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160483911|NCT00475735|579499189|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160483912|NCT00475735|579499190|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160483913|NCT00475735|579499191|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160483914|NCT00475735|579499192|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160483915|NCT00475735|579499193|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160483916|NCT00475735|579499188|FG000|Treatment Period 1|DC due to AE but continuing|0|||
160483917|NCT00475735|579499189|FG001|Treatment Period 1|DC due to AE but continuing|0|||
160483918|NCT00475735|579499190|FG002|Treatment Period 1|DC due to AE but continuing|0|||
160483919|NCT00475735|579499191|FG003|Treatment Period 1|DC due to AE but continuing|1|||
160483920|NCT00475735|579499192|FG004|Treatment Period 1|DC due to AE but continuing|2|||
160483921|NCT00475735|579499193|FG005|Treatment Period 1|DC due to AE but continuing|2|||
160605464|NCT04507360|579934530|FG005|Week 1|Lost to Follow-up|0|||
160605465|NCT04507360|579934531|FG006|Week 1|Lost to Follow-up|0|||
160605466|NCT04507360|579934532|FG007|Week 1|Lost to Follow-up|0|||
160605467|NCT04507360|579934533|FG008|Week 1|Lost to Follow-up|72|||
160483922|NCT00475735|579499188|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
160483923|NCT00475735|579499189|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
160483924|NCT00475735|579499190|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
160483925|NCT00475735|579499191|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
160605468|NCT04507360|579934534|FG009|Week 1|Lost to Follow-up|22|||
160605469|NCT04507360|579934535|FG010|Week 1|Lost to Follow-up|10|||
160605470|NCT04507360|579934525|FG000|Week 2|Lost to Follow-up|0|||
160605471|NCT04507360|579934526|FG001|Week 2|Lost to Follow-up|0|||
160605472|NCT04507360|579934527|FG002|Week 2|Lost to Follow-up|0|||
160605473|NCT04507360|579934528|FG003|Week 2|Lost to Follow-up|0|||
160605474|NCT04507360|579934529|FG004|Week 2|Lost to Follow-up|0|||
160605475|NCT04507360|579934530|FG005|Week 2|Lost to Follow-up|0|||
160605476|NCT04507360|579934531|FG006|Week 2|Lost to Follow-up|0|||
160605477|NCT04507360|579934532|FG007|Week 2|Lost to Follow-up|0|||
160605478|NCT04507360|579934533|FG008|Week 2|Lost to Follow-up|121|||
160605479|NCT04507360|579934534|FG009|Week 2|Lost to Follow-up|85|||
160605480|NCT04507360|579934535|FG010|Week 2|Lost to Follow-up|82|||
160605481|NCT04507360|579934525|FG000|Week 3|Lost to Follow-up|0|||
160605482|NCT04507360|579934526|FG001|Week 3|Lost to Follow-up|0|||
160605483|NCT04507360|579934527|FG002|Week 3|Lost to Follow-up|0|||
160605484|NCT04507360|579934528|FG003|Week 3|Lost to Follow-up|0|||
160605485|NCT04507360|579934529|FG004|Week 3|Lost to Follow-up|0|||
160605486|NCT04507360|579934530|FG005|Week 3|Lost to Follow-up|0|||
160605487|NCT04507360|579934531|FG006|Week 3|Lost to Follow-up|0|||
160605488|NCT04507360|579934532|FG007|Week 3|Lost to Follow-up|0|||
160605489|NCT04507360|579934533|FG008|Week 3|Lost to Follow-up|123|||
160605490|NCT04507360|579934534|FG009|Week 3|Lost to Follow-up|92|||
160605491|NCT04507360|579934535|FG010|Week 3|Lost to Follow-up|84|||
160605492|NCT04507360|579934525|FG000|Week 4|Lost to Follow-up|0|||
160605493|NCT04507360|579934526|FG001|Week 4|Lost to Follow-up|0|||
160605494|NCT04507360|579934527|FG002|Week 4|Lost to Follow-up|0|||
160605495|NCT04507360|579934528|FG003|Week 4|Lost to Follow-up|0|||
160605496|NCT04507360|579934529|FG004|Week 4|Lost to Follow-up|0|||
160605497|NCT04507360|579934530|FG005|Week 4|Lost to Follow-up|0|||
160605498|NCT04507360|579934531|FG006|Week 4|Lost to Follow-up|0|||
160605499|NCT04507360|579934532|FG007|Week 4|Lost to Follow-up|0|||
160605500|NCT04507360|579934533|FG008|Week 4|Lost to Follow-up|131|||
160605501|NCT04507360|579934534|FG009|Week 4|Lost to Follow-up|115|||
160605502|NCT04507360|579934535|FG010|Week 4|Lost to Follow-up|102|||
160605503|NCT04507360|579934525|FG000|Week 5|Lost to Follow-up|0|||
160605504|NCT04507360|579934526|FG001|Week 5|Lost to Follow-up|0|||
160605505|NCT04507360|579934527|FG002|Week 5|Lost to Follow-up|0|||
160605506|NCT04507360|579934528|FG003|Week 5|Lost to Follow-up|0|||
160605507|NCT04507360|579934529|FG004|Week 5|Lost to Follow-up|0|||
160605508|NCT04507360|579934530|FG005|Week 5|Lost to Follow-up|0|||
160605509|NCT04507360|579934531|FG006|Week 5|Lost to Follow-up|0|||
160605510|NCT04507360|579934532|FG007|Week 5|Lost to Follow-up|0|||
160605511|NCT04507360|579934533|FG008|Week 5|Lost to Follow-up|103|||
160605512|NCT04507360|579934534|FG009|Week 5|Lost to Follow-up|135|||
160605513|NCT04507360|579934535|FG010|Week 5|Lost to Follow-up|143|||
160605514|NCT04507360|579934525|FG000|Week 8|Lost to Follow-up|0|||
160605515|NCT04507360|579934526|FG001|Week 8|Lost to Follow-up|0|||
160605516|NCT04507360|579934527|FG002|Week 8|Lost to Follow-up|0|||
160605517|NCT04507360|579934528|FG003|Week 8|Lost to Follow-up|0|||
160605518|NCT04507360|579934529|FG004|Week 8|Lost to Follow-up|0|||
160605519|NCT04507360|579934530|FG005|Week 8|Lost to Follow-up|0|||
160605520|NCT04507360|579934531|FG006|Week 8|Lost to Follow-up|0|||
160605521|NCT04507360|579934532|FG007|Week 8|Lost to Follow-up|0|||
160605522|NCT04507360|579934533|FG008|Week 8|Lost to Follow-up|139|||
160605523|NCT04507360|579934534|FG009|Week 8|Lost to Follow-up|145|||
160605524|NCT04507360|579934535|FG010|Week 8|Lost to Follow-up|152|||
160605525|NCT00400946|579934536|FG000|Overall Study|Ineligible|0|||
160605526|NCT00400946|579934537|FG001|Overall Study|Ineligible|0|||
160605527|NCT00400946|579934538|FG002|Overall Study|Ineligible|0|||
160605528|NCT00400946|579934539|FG003|Overall Study|Ineligible|5|||
160605529|NCT00400946|579934540|FG004|Overall Study|Ineligible|1|||
160605530|NCT00400946|579934536|FG000|Overall Study|Induction Failure|0|||
160605531|NCT00400946|579934537|FG001|Overall Study|Induction Failure|0|||
160605532|NCT00400946|579934538|FG002|Overall Study|Induction Failure|0|||
160605533|NCT00400946|579934539|FG003|Overall Study|Induction Failure|11|||
160605534|NCT00400946|579934540|FG004|Overall Study|Induction Failure|8|||
160605535|NCT00400946|579934536|FG000|Overall Study|Induction Death|0|||
160605536|NCT00400946|579934537|FG001|Overall Study|Induction Death|0|||
160605537|NCT00400946|579934538|FG002|Overall Study|Induction Death|0|||
160605538|NCT00400946|579934539|FG003|Overall Study|Induction Death|13|||
160605539|NCT00400946|579934540|FG004|Overall Study|Induction Death|3|||
160605540|NCT00400946|579934536|FG000|Overall Study|Lost to Follow-up|1|||
160605541|NCT00400946|579934537|FG001|Overall Study|Lost to Follow-up|1|||
160605542|NCT00400946|579934538|FG002|Overall Study|Lost to Follow-up|0|||
160605543|NCT00400946|579934539|FG003|Overall Study|Lost to Follow-up|0|||
160605544|NCT00400946|579934540|FG004|Overall Study|Lost to Follow-up|1|||
160605545|NCT00400946|579934536|FG000|Overall Study|Remission Death|1|||
160605546|NCT00400946|579934537|FG001|Overall Study|Remission Death|1|||
160605547|NCT00400946|579934538|FG002|Overall Study|Remission Death|0|||
160605548|NCT00400946|579934539|FG003|Overall Study|Remission Death|0|||
160605549|NCT00400946|579934540|FG004|Overall Study|Remission Death|1|||
160605550|NCT00400946|579934536|FG000|Overall Study|Relapse|9|||
160605551|NCT00400946|579934537|FG001|Overall Study|Relapse|2|||
160605552|NCT00400946|579934538|FG002|Overall Study|Relapse|1|||
160605553|NCT00400946|579934539|FG003|Overall Study|Relapse|1|||
160605554|NCT00400946|579934540|FG004|Overall Study|Relapse|5|||
160605555|NCT00400946|579934536|FG000|Overall Study|Transplant in CR1|0|||
160605556|NCT00400946|579934537|FG001|Overall Study|Transplant in CR1|0|||
160605557|NCT00400946|579934538|FG002|Overall Study|Transplant in CR1|0|||
160605558|NCT00400946|579934539|FG003|Overall Study|Transplant in CR1|10|||
160605559|NCT00400946|579934540|FG004|Overall Study|Transplant in CR1|1|||
160605560|NCT00400946|579934536|FG000|Overall Study|Withdrawal by Subject|2|||
160605561|NCT00400946|579934537|FG001|Overall Study|Withdrawal by Subject|5|||
160605562|NCT00400946|579934538|FG002|Overall Study|Withdrawal by Subject|1|||
160605563|NCT00400946|579934539|FG003|Overall Study|Withdrawal by Subject|5|||
160605564|NCT00400946|579934540|FG004|Overall Study|Withdrawal by Subject|8|||
160605565|NCT00400946|579934536|FG000|Overall Study|Clinical|1|||
160605566|NCT00400946|579934537|FG001|Overall Study|Clinical|2|||
160605567|NCT00400946|579934538|FG002|Overall Study|Clinical|0|||
160605568|NCT00400946|579934539|FG003|Overall Study|Clinical|2|||
160605569|NCT00400946|579934540|FG004|Overall Study|Clinical|9|||
160605570|NCT00400946|579934536|FG000|Overall Study|Other|0|||
160605571|NCT00400946|579934537|FG001|Overall Study|Other|0|||
160605572|NCT00400946|579934538|FG002|Overall Study|Other|0|||
160605573|NCT00400946|579934539|FG003|Overall Study|Other|0|||
160605574|NCT00400946|579934540|FG004|Overall Study|Other|1|||
160605575|NCT02712008|579934543|FG000|Baseline (Day 1) up to Week 12|Death|3|||
160605576|NCT02712008|579934544|FG001|Baseline (Day 1) up to Week 12|Death|0|||
160605577|NCT02712008|579934545|FG002|Baseline (Day 1) up to Week 12|Death|0|||
160605578|NCT02712008|579934546|FG003|Baseline (Day 1) up to Week 12|Death|0|||
160605579|NCT02712008|579934547|FG004|Baseline (Day 1) up to Week 12|Death|0|||
160605580|NCT02712008|579934548|FG005|Baseline (Day 1) up to Week 12|Death|0|||
160605581|NCT02712008|579934549|FG006|Baseline (Day 1) up to Week 12|Death|0|||
160605582|NCT02712008|579934550|FG007|Baseline (Day 1) up to Week 12|Death|0|||
160605583|NCT02712008|579934543|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160605584|NCT02712008|579934544|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
160605585|NCT02712008|579934545|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
160605586|NCT02712008|579934546|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160605587|NCT02712008|579934547|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160605588|NCT02712008|579934548|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160605589|NCT02712008|579934549|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160605590|NCT02712008|579934550|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160605591|NCT02712008|579934543|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
160605592|NCT02712008|579934544|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160605593|NCT02712008|579934545|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
160605594|NCT02712008|579934546|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160605595|NCT02712008|579934547|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160605596|NCT02712008|579934548|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160605597|NCT02712008|579934549|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160605598|NCT02712008|579934550|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160605599|NCT02712008|579934543|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
160605600|NCT02712008|579934544|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
160605601|NCT02712008|579934545|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
160605602|NCT02712008|579934546|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
160605603|NCT02712008|579934547|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
160605604|NCT02712008|579934548|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
160605605|NCT02712008|579934549|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
160605606|NCT02712008|579934550|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
160605607|NCT02712008|579934543|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
160605608|NCT02712008|579934544|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
160605609|NCT02712008|579934545|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
160605610|NCT02712008|579934546|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
160605611|NCT02712008|579934547|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
160605612|NCT02712008|579934548|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
160605613|NCT02712008|579934549|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
160605614|NCT02712008|579934550|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
160605615|NCT02712008|579934543|FG000|From Week 12 up to Week 36|Adverse Event|0|||
160605616|NCT02712008|579934544|FG001|From Week 12 up to Week 36|Adverse Event|0|||
160605617|NCT02712008|579934545|FG002|From Week 12 up to Week 36|Adverse Event|0|||
160605618|NCT02712008|579934546|FG003|From Week 12 up to Week 36|Adverse Event|0|||
160605619|NCT02712008|579934547|FG004|From Week 12 up to Week 36|Adverse Event|1|||
160605620|NCT02712008|579934548|FG005|From Week 12 up to Week 36|Adverse Event|0|||
160605621|NCT02712008|579934549|FG006|From Week 12 up to Week 36|Adverse Event|0|||
160605622|NCT02712008|579934550|FG007|From Week 12 up to Week 36|Adverse Event|2|||
160605623|NCT02712008|579934543|FG000|From Week 12 up to Week 36|Death|1|||
160605624|NCT02712008|579934544|FG001|From Week 12 up to Week 36|Death|0|||
160605625|NCT02712008|579934545|FG002|From Week 12 up to Week 36|Death|0|||
160605626|NCT02712008|579934546|FG003|From Week 12 up to Week 36|Death|0|||
160605627|NCT02712008|579934547|FG004|From Week 12 up to Week 36|Death|0|||
160605628|NCT02712008|579934548|FG005|From Week 12 up to Week 36|Death|0|||
160605629|NCT02712008|579934549|FG006|From Week 12 up to Week 36|Death|1|||
160605630|NCT02712008|579934550|FG007|From Week 12 up to Week 36|Death|0|||
160605631|NCT02712008|579934543|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
160605632|NCT02712008|579934544|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
160605633|NCT02712008|579934545|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
160605634|NCT02712008|579934546|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
160605635|NCT02712008|579934547|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
160605636|NCT02712008|579934548|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
160605637|NCT02712008|579934549|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
160605638|NCT02712008|579934550|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
160605639|NCT02712008|579934543|FG000|From Week 12 up to Week 36|Physician Decision|0|||
160605640|NCT02712008|579934544|FG001|From Week 12 up to Week 36|Physician Decision|0|||
160605641|NCT02712008|579934545|FG002|From Week 12 up to Week 36|Physician Decision|0|||
160605642|NCT02712008|579934546|FG003|From Week 12 up to Week 36|Physician Decision|1|||
160605643|NCT02712008|579934547|FG004|From Week 12 up to Week 36|Physician Decision|1|||
160605644|NCT02712008|579934548|FG005|From Week 12 up to Week 36|Physician Decision|0|||
160605645|NCT02712008|579934549|FG006|From Week 12 up to Week 36|Physician Decision|0|||
160605646|NCT02712008|579934550|FG007|From Week 12 up to Week 36|Physician Decision|0|||
160605647|NCT02712008|579934543|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
160605648|NCT02712008|579934544|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
160605649|NCT02712008|579934545|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
160605650|NCT02712008|579934546|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
160605651|NCT02712008|579934547|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
160605652|NCT02712008|579934548|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
160605653|NCT02712008|579934549|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
160605654|NCT02712008|579934550|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
160605655|NCT04483544|579934552|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
160605656|NCT04483544|579934552|FG000|Post-Treatment|Admitted to hospice|2|||
160483926|NCT00475735|579499192|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
160605657|NCT04483544|579934552|FG000|Post-Treatment|Study terminated|3|||
160605658|NCT01131078|579934553|FG000|Overall Study|Adverse Event|22|||
160605659|NCT01131078|579934554|FG001|Overall Study|Adverse Event|12|||
160605660|NCT01131078|579934555|FG002|Overall Study|Adverse Event|17|||
160605661|NCT01131078|579934553|FG000|Overall Study|Progressive Disease|58|||
160605662|NCT01131078|579934554|FG001|Overall Study|Progressive Disease|77|||
160605663|NCT01131078|579934555|FG002|Overall Study|Progressive Disease|71|||
160605664|NCT01131078|579934553|FG000|Overall Study|Protocol Violation|1|||
160605665|NCT01131078|579934554|FG001|Overall Study|Protocol Violation|0|||
160605666|NCT01131078|579934555|FG002|Overall Study|Protocol Violation|0|||
160605667|NCT01131078|579934553|FG000|Overall Study|Lost to Follow-up|1|||
160605668|NCT01131078|579934554|FG001|Overall Study|Lost to Follow-up|1|||
160605669|NCT01131078|579934555|FG002|Overall Study|Lost to Follow-up|1|||
160605670|NCT01131078|579934553|FG000|Overall Study|Withdrawal by Subject|2|||
160605671|NCT01131078|579934554|FG001|Overall Study|Withdrawal by Subject|4|||
160605672|NCT01131078|579934555|FG002|Overall Study|Withdrawal by Subject|3|||
160605673|NCT01131078|579934553|FG000|Overall Study|Non-compliance|3|||
160605674|NCT01131078|579934554|FG001|Overall Study|Non-compliance|0|||
160605675|NCT01131078|579934555|FG002|Overall Study|Non-compliance|0|||
160605676|NCT01131078|579934553|FG000|Overall Study|Physician Decision|10|||
160605677|NCT01131078|579934554|FG001|Overall Study|Physician Decision|6|||
160605678|NCT01131078|579934555|FG002|Overall Study|Physician Decision|8|||
160605679|NCT01131078|579934553|FG000|Overall Study|Death|4|||
160605680|NCT01131078|579934554|FG001|Overall Study|Death|0|||
160605681|NCT01131078|579934555|FG002|Overall Study|Death|2|||
160605682|NCT01131078|579934553|FG000|Overall Study|Other|0|||
160605683|NCT01131078|579934554|FG001|Overall Study|Other|1|||
160605684|NCT01131078|579934555|FG002|Overall Study|Other|0|||
160605685|NCT00736385|579934556|FG000|Overall Study|Withdrawal by Subject|2|||
160605686|NCT00736385|579934557|FG001|Overall Study|Withdrawal by Subject|2|||
160605687|NCT00736385|579934556|FG000|Overall Study|Adverse Event|0|||
160605688|NCT00736385|579934557|FG001|Overall Study|Adverse Event|1|||
160605689|NCT00098865|579934558|FG000|Overall Study|Progressive Disease|6|||
160605690|NCT00098865|579934558|FG000|Overall Study|Adverse Event|2|||
160605691|NCT00098865|579934558|FG000|Overall Study|Alternative Therapy|1|||
160605692|NCT03267511|579934559|FG000|Overall Study|Lost to Follow-up|0|||
160605693|NCT03267511|579934560|FG001|Overall Study|Lost to Follow-up|0|||
160605694|NCT03267511|579934561|FG002|Overall Study|Lost to Follow-up|0|||
160605695|NCT03267511|579934562|FG003|Overall Study|Lost to Follow-up|1|||
160605696|NCT00364351|579934563|FG000|Overall Study|Adverse Event|90|||
160605697|NCT00364351|579934564|FG001|Overall Study|Adverse Event|44|||
160605698|NCT00364351|579934563|FG000|Overall Study|Condition under investigation worsened|469|||
160605699|NCT00364351|579934564|FG001|Overall Study|Condition under investigation worsened|497|||
160605700|NCT00364351|579934563|FG000|Overall Study|Prohibited concomitant medication|0|||
160605701|NCT00364351|579934564|FG001|Overall Study|Prohibited concomitant medication|2|||
160605702|NCT00364351|579934563|FG000|Overall Study|Lost to Follow-up|1|||
160605703|NCT00364351|579934564|FG001|Overall Study|Lost to Follow-up|1|||
160605704|NCT00364351|579934563|FG000|Overall Study|Withdrawal by Subject|30|||
160605705|NCT00364351|579934564|FG001|Overall Study|Withdrawal by Subject|29|||
160605706|NCT00364351|579934563|FG000|Overall Study|Incorrect enrollment|1|||
160605707|NCT00364351|579934564|FG001|Overall Study|Incorrect enrollment|1|||
160605708|NCT00364351|579934563|FG000|Overall Study|Sponsor decision|1|||
160605709|NCT00364351|579934564|FG001|Overall Study|Sponsor decision|0|||
160605710|NCT00364351|579934563|FG000|Overall Study|Poor treatment compliance|0|||
160605711|NCT00364351|579934564|FG001|Overall Study|Poor treatment compliance|3|||
160605712|NCT00364351|579934563|FG000|Overall Study|Investigator error|0|||
160605713|NCT00364351|579934564|FG001|Overall Study|Investigator error|2|||
160605714|NCT00364351|579934563|FG000|Overall Study|Patient could not travel to site|0|||
160605715|NCT00364351|579934564|FG001|Overall Study|Patient could not travel to site|1|||
160605716|NCT00364351|579934563|FG000|Overall Study|Randomised treatment not started|0|||
160605717|NCT00364351|579934564|FG001|Overall Study|Randomised treatment not started|3|||
160605718|NCT02043509|579934566|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
160605719|NCT02043509|579934567|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
160605720|NCT02043509|579934566|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
160605721|NCT02043509|579934567|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
160605722|NCT02043509|579934566|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
160605723|NCT02043509|579934567|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
160605724|NCT02043509|579934566|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
160605725|NCT02043509|579934567|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
160605726|NCT00608244|579934573|FG000|Overall Study|Adverse Event|1|||
160605727|NCT00608244|579934573|FG000|Overall Study|Low trough levels|1|||
160605728|NCT00430027|579934574|FG000|Overall Study|Study terminated|8|||
160605729|NCT01977040|579934579|FG000|Overall Study|Vasa previa not confirmed|2|||
160605730|NCT01685060|579934580|FG000|Overall Study|Rollover patients|16|||
160605731|NCT01685060|579934580|FG000|Overall Study|Adverse Event|12|||
160605732|NCT01685060|579934580|FG000|Overall Study|Progressive disease|69|||
160605733|NCT01685060|579934580|FG000|Overall Study|Physician Decision|14|||
160605734|NCT01685060|579934580|FG000|Overall Study|Subject/guardian decision|20|||
160605735|NCT01685060|579934580|FG000|Overall Study|Lost to Follow-up|1|||
160605736|NCT01685060|579934580|FG000|Overall Study|Death|8|||
160605737|NCT00688623|579934583|FG000|Overall Study|Adverse Event|22|||
160605738|NCT00688623|579934583|FG000|Overall Study|abnormal lab value|1|||
160605739|NCT00688623|579934583|FG000|Overall Study|Withdrawal by Subject|4|||
160605740|NCT00688623|579934583|FG000|Overall Study|Death|3|||
160605741|NCT00688623|579934583|FG000|Overall Study|disease progression|23|||
160605742|NCT00688623|579934583|FG000|Overall Study|Protocol Violation|2|||
160605743|NCT02443155|579934584|FG000|Overall Study|Adverse Event|3|||
160605744|NCT02443155|579934585|FG001|Overall Study|Adverse Event|4|||
160605745|NCT02443155|579934586|FG002|Overall Study|Adverse Event|1|||
160605746|NCT02443155|579934587|FG003|Overall Study|Adverse Event|2|||
160605747|NCT02443155|579934584|FG000|Overall Study|Unclassified|0|||
160605748|NCT02443155|579934585|FG001|Overall Study|Unclassified|0|||
160605749|NCT02443155|579934586|FG002|Overall Study|Unclassified|2|||
160605750|NCT02443155|579934587|FG003|Overall Study|Unclassified|1|||
160605751|NCT02443155|579934584|FG000|Overall Study|Withdrawal by Subject|4|||
160605752|NCT02443155|579934585|FG001|Overall Study|Withdrawal by Subject|7|||
160605753|NCT02443155|579934586|FG002|Overall Study|Withdrawal by Subject|3|||
160605754|NCT02443155|579934587|FG003|Overall Study|Withdrawal by Subject|9|||
160605755|NCT02443155|579934584|FG000|Overall Study|Pregnancy|3|||
160605756|NCT02443155|579934585|FG001|Overall Study|Pregnancy|1|||
160605757|NCT02443155|579934586|FG002|Overall Study|Pregnancy|1|||
160605758|NCT02443155|579934587|FG003|Overall Study|Pregnancy|2|||
160605759|NCT02443155|579934584|FG000|Overall Study|Lost to Follow-up|1|||
160605760|NCT02443155|579934585|FG001|Overall Study|Lost to Follow-up|2|||
160605761|NCT02443155|579934586|FG002|Overall Study|Lost to Follow-up|0|||
160605762|NCT02443155|579934587|FG003|Overall Study|Lost to Follow-up|1|||
160605763|NCT02443155|579934584|FG000|Overall Study|Protocol Violation|1|||
160605764|NCT02443155|579934585|FG001|Overall Study|Protocol Violation|0|||
160605765|NCT02443155|579934586|FG002|Overall Study|Protocol Violation|1|||
160605766|NCT02443155|579934587|FG003|Overall Study|Protocol Violation|1|||
160605767|NCT02443155|579934584|FG000|Overall Study|Death|0|||
160605768|NCT02443155|579934585|FG001|Overall Study|Death|0|||
160605769|NCT02443155|579934586|FG002|Overall Study|Death|1|||
160605770|NCT02443155|579934587|FG003|Overall Study|Death|0|||
160605771|NCT02000219|579934588|FG000|14-Week Study Period|Physician Decision|1|||
160605772|NCT02000219|579934588|FG000|14-Week Study Period|Adverse Event|1|||
160605773|NCT02000219|579934588|FG000|14-Week Study Period|Underwent transplantation|1|||
160605774|NCT02000219|579934588|FG000|Continuation Period|Withdrawal by Subject|1|||
160605775|NCT02000219|579934588|FG000|Continuation Period|Had liver transplant|2|||
160605776|NCT02000219|579934588|FG000|Continuation Period|Non-compliance with study drug|2|||
160605777|NCT02809118|579934590|FG000|Overall Study|Withdrawal by Subject|0|||
160605778|NCT02809118|579934591|FG001|Overall Study|Withdrawal by Subject|1|||
160605779|NCT02809118|579934592|FG002|Overall Study|Withdrawal by Subject|1|||
160605780|NCT06048809|579934595|FG000|Overall Study|Adverse Event|2|||
160605781|NCT06048809|579934596|FG001|Overall Study|Adverse Event|0|||
160605782|NCT06048809|579934595|FG000|Overall Study|Withdrawal by Subject|1|||
160605783|NCT06048809|579934596|FG001|Overall Study|Withdrawal by Subject|1|||
160605784|NCT00524043|579934598|FG000|Overall Study|Lack of Efficacy|15|||
160605785|NCT00524043|579934599|FG001|Overall Study|Lack of Efficacy|13|||
160605786|NCT00524043|579934600|FG002|Overall Study|Lack of Efficacy|14|||
160605787|NCT00524043|579934598|FG000|Overall Study|Withdrawal by Subject|5|||
160605788|NCT00524043|579934599|FG001|Overall Study|Withdrawal by Subject|7|||
160605789|NCT00524043|579934600|FG002|Overall Study|Withdrawal by Subject|7|||
160605790|NCT00524043|579934598|FG000|Overall Study|Adverse Event|5|||
160605791|NCT00524043|579934599|FG001|Overall Study|Adverse Event|2|||
160605792|NCT00524043|579934600|FG002|Overall Study|Adverse Event|7|||
160605793|NCT00524043|579934598|FG000|Overall Study|Lost to Follow-up|3|||
160605794|NCT00524043|579934599|FG001|Overall Study|Lost to Follow-up|5|||
160605795|NCT00524043|579934600|FG002|Overall Study|Lost to Follow-up|3|||
160605796|NCT00524043|579934598|FG000|Overall Study|Various (eg, incarceration)|2|||
160605797|NCT00524043|579934599|FG001|Overall Study|Various (eg, incarceration)|1|||
160605798|NCT00524043|579934600|FG002|Overall Study|Various (eg, incarceration)|0|||
160605799|NCT00216086|579934601|FG000|Overall Study|Protocol Violation|1|||
160605800|NCT00216086|579934601|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
160605801|NCT00216086|579934601|FG000|Overall Study|Social Reasons|2|||
160605802|NCT01080625|579934608|FG000|Overall Study|Physician Decision|0|||
160605803|NCT01080625|579934609|FG001|Overall Study|Physician Decision|2|||
160605804|NCT01080625|579934610|FG002|Overall Study|Physician Decision|1|||
160605805|NCT03135262|579934614|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
160605806|NCT03135262|579934615|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
160605807|NCT03135262|579934616|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
160605808|NCT03135262|579934617|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
160605809|NCT03135262|579934618|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
160605810|NCT03135262|579934614|FG000|Overall Study|Progression of disease|0|||
160605811|NCT03135262|579934615|FG001|Overall Study|Progression of disease|0|||
160605812|NCT03135262|579934616|FG002|Overall Study|Progression of disease|0|||
160605813|NCT03135262|579934617|FG003|Overall Study|Progression of disease|1|||
160605814|NCT03135262|579934618|FG004|Overall Study|Progression of disease|0|||
160605815|NCT03135262|579934614|FG000|Overall Study|Death|6|||
160605816|NCT03135262|579934615|FG001|Overall Study|Death|2|||
160605817|NCT03135262|579934616|FG002|Overall Study|Death|2|||
160605818|NCT03135262|579934617|FG003|Overall Study|Death|2|||
160605819|NCT03135262|579934618|FG004|Overall Study|Death|0|||
160605820|NCT03135262|579934614|FG000|Overall Study|Withdrawal by Subject|0|||
160605821|NCT03135262|579934615|FG001|Overall Study|Withdrawal by Subject|0|||
160605822|NCT03135262|579934616|FG002|Overall Study|Withdrawal by Subject|1|||
160605823|NCT03135262|579934617|FG003|Overall Study|Withdrawal by Subject|0|||
160605824|NCT03135262|579934618|FG004|Overall Study|Withdrawal by Subject|1|||
160605825|NCT03135262|579934614|FG000|Overall Study|Study terminated by sponsor|2|||
160605826|NCT03135262|579934615|FG001|Overall Study|Study terminated by sponsor|4|||
160605827|NCT03135262|579934616|FG002|Overall Study|Study terminated by sponsor|4|||
160605828|NCT03135262|579934617|FG003|Overall Study|Study terminated by sponsor|3|||
160605829|NCT03135262|579934618|FG004|Overall Study|Study terminated by sponsor|0|||
160605830|NCT02728206|579934619|FG000|Overall Study|Death|1|||
160605831|NCT00282568|579934620|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
160605832|NCT00282568|579934620|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
160605833|NCT00282568|579934620|FG000|Extended Treatment Period|Adverse Event|17|||
160605834|NCT00282568|579934620|FG000|Extended Treatment Period|Non-compliance|4|||
160605835|NCT00282568|579934620|FG000|Extended Treatment Period|Physician Decision|1|||
160605836|NCT00282568|579934620|FG000|Extended Treatment Period|Lost to Follow-up|2|||
160605837|NCT01408732|579934621|FG000|Overall Study|Withdrawal by Subject|2|||
160605838|NCT01408732|579934622|FG001|Overall Study|Withdrawal by Subject|2|||
160605839|NCT02417064|579934623|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
160605840|NCT02417064|579934624|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
160605841|NCT02417064|579934625|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
160605842|NCT02417064|579934623|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
160605843|NCT02417064|579934624|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
160605844|NCT02417064|579934625|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
160605845|NCT02417064|579934623|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
160605846|NCT02417064|579934624|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
160605847|NCT02417064|579934625|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
160605848|NCT02417064|579934623|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
160605849|NCT02417064|579934624|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
160605850|NCT02417064|579934625|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
160605851|NCT02417064|579934623|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
160605852|NCT02417064|579934624|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
160605853|NCT02417064|579934625|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
160605854|NCT02417064|579934623|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
160605855|NCT02417064|579934624|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
160605856|NCT02417064|579934625|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
160605857|NCT02417064|579934623|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
160605858|NCT02417064|579934624|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
160605859|NCT02417064|579934625|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
160605860|NCT02417064|579934623|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
160605861|NCT02417064|579934624|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
160605862|NCT02417064|579934625|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
160605863|NCT02417064|579934623|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
160605864|NCT02417064|579934624|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
160605865|NCT02417064|579934625|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
160605866|NCT02417064|579934623|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
160605867|NCT02417064|579934624|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
160605868|NCT02417064|579934625|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
160605869|NCT02417064|579934623|FG000|Follow-up Phase (24 Weeks)|Other|2|||
160605870|NCT02417064|579934624|FG001|Follow-up Phase (24 Weeks)|Other|2|||
160605871|NCT02417064|579934625|FG002|Follow-up Phase (24 Weeks)|Other|3|||
160605872|NCT03185819|579934626|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
160605873|NCT03185819|579934627|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
160605874|NCT03185819|579934628|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
160605875|NCT03185819|579934629|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
160605876|NCT03185819|579934626|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
160605877|NCT03185819|579934627|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
160605878|NCT03185819|579934628|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
160605879|NCT03185819|579934629|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
160605880|NCT03185819|579934626|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
160605881|NCT03185819|579934627|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
160605882|NCT03185819|579934628|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
160605883|NCT03185819|579934629|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
160605884|NCT03185819|579934626|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
160605885|NCT03185819|579934627|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
160605886|NCT03185819|579934628|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
160605887|NCT03185819|579934629|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
160605888|NCT03185819|579934626|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
160605889|NCT03185819|579934627|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
160605890|NCT03185819|579934628|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
160605891|NCT03185819|579934629|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
160605892|NCT03185819|579934626|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
160605893|NCT03185819|579934627|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
160605894|NCT03185819|579934628|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
160605895|NCT03185819|579934629|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
160605896|NCT03185819|579934626|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
160605897|NCT03185819|579934627|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
160605898|NCT03185819|579934628|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
160605899|NCT03185819|579934629|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
160605900|NCT03185819|579934626|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
160605901|NCT03185819|579934627|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
160605902|NCT03185819|579934628|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
160605903|NCT03185819|579934629|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
160605904|NCT03185819|579934626|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
160605905|NCT03185819|579934627|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
160660924|NCT01389102|580141718|FG004|Overall Study|Protocol Violation|1|||
160660925|NCT01389102|580141719|FG005|Overall Study|Protocol Violation|1|||
160660926|NCT01389102|580141714|FG000|Overall Study|Withdrawal by Subject|7|||
160660927|NCT01389102|580141715|FG001|Overall Study|Withdrawal by Subject|4|||
160660928|NCT01389102|580141716|FG002|Overall Study|Withdrawal by Subject|9|||
160660929|NCT01389102|580141717|FG003|Overall Study|Withdrawal by Subject|2|||
160660930|NCT01389102|580141718|FG004|Overall Study|Withdrawal by Subject|3|||
160660931|NCT01389102|580141719|FG005|Overall Study|Withdrawal by Subject|3|||
160660932|NCT01389102|580141714|FG000|Overall Study|Subject Traveling Out of Country|0|||
160660933|NCT01389102|580141715|FG001|Overall Study|Subject Traveling Out of Country|0|||
160660934|NCT01389102|580141716|FG002|Overall Study|Subject Traveling Out of Country|0|||
160660935|NCT01389102|580141717|FG003|Overall Study|Subject Traveling Out of Country|1|||
160660936|NCT01389102|580141718|FG004|Overall Study|Subject Traveling Out of Country|0|||
160660937|NCT01389102|580141719|FG005|Overall Study|Subject Traveling Out of Country|0|||
160660938|NCT01389102|580141714|FG000|Overall Study|Subject Moved|2|||
160660939|NCT01389102|580141715|FG001|Overall Study|Subject Moved|0|||
160660940|NCT01389102|580141716|FG002|Overall Study|Subject Moved|1|||
160660941|NCT01389102|580141717|FG003|Overall Study|Subject Moved|0|||
160660942|NCT01389102|580141718|FG004|Overall Study|Subject Moved|0|||
160660943|NCT01389102|580141719|FG005|Overall Study|Subject Moved|0|||
160660944|NCT01389102|580141714|FG000|Overall Study|Unavailable due to husband's illness|0|||
160660945|NCT01389102|580141715|FG001|Overall Study|Unavailable due to husband's illness|1|||
160660946|NCT01389102|580141716|FG002|Overall Study|Unavailable due to husband's illness|0|||
160660947|NCT01389102|580141717|FG003|Overall Study|Unavailable due to husband's illness|0|||
160660948|NCT01389102|580141718|FG004|Overall Study|Unavailable due to husband's illness|0|||
160660949|NCT01389102|580141719|FG005|Overall Study|Unavailable due to husband's illness|0|||
160660950|NCT01389102|580141714|FG000|Overall Study|Investigator Judgement|0|||
160660951|NCT01389102|580141715|FG001|Overall Study|Investigator Judgement|1|||
160660952|NCT01389102|580141716|FG002|Overall Study|Investigator Judgement|0|||
160660953|NCT01389102|580141717|FG003|Overall Study|Investigator Judgement|0|||
160660954|NCT01389102|580141718|FG004|Overall Study|Investigator Judgement|0|||
160660955|NCT01389102|580141719|FG005|Overall Study|Investigator Judgement|0|||
160660956|NCT00050778|580141720|FG000|Overall Study|Adverse Event|13|||
160660957|NCT00050778|580141721|FG001|Overall Study|Adverse Event|3|||
160660958|NCT00050778|580141722|FG002|Overall Study|Adverse Event|2|||
160660959|NCT00050778|580141720|FG000|Overall Study|Death|0|||
160660960|NCT00050778|580141721|FG001|Overall Study|Death|1|||
160660961|NCT00050778|580141722|FG002|Overall Study|Death|1|||
160660962|NCT00050778|580141720|FG000|Overall Study|Lack of Efficacy|16|||
160660963|NCT00050778|580141721|FG001|Overall Study|Lack of Efficacy|2|||
160660964|NCT00050778|580141722|FG002|Overall Study|Lack of Efficacy|2|||
160660965|NCT00050778|580141720|FG000|Overall Study|Lost to Follow-up|0|||
160660966|NCT00050778|580141721|FG001|Overall Study|Lost to Follow-up|2|||
160660967|NCT00050778|580141722|FG002|Overall Study|Lost to Follow-up|4|||
160660968|NCT00050778|580141720|FG000|Overall Study|Physician Decision|3|||
160660969|NCT00050778|580141721|FG001|Overall Study|Physician Decision|0|||
160660970|NCT00050778|580141722|FG002|Overall Study|Physician Decision|2|||
160605906|NCT03185819|579934628|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
160605907|NCT03185819|579934629|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
160605908|NCT03185819|579934626|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
160605909|NCT03185819|579934627|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
160605910|NCT03185819|579934628|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
160605911|NCT03185819|579934629|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
160660971|NCT00050778|580141720|FG000|Overall Study|Protocol Violation|2|||
160660972|NCT00050778|580141721|FG001|Overall Study|Protocol Violation|0|||
160660973|NCT00050778|580141722|FG002|Overall Study|Protocol Violation|1|||
160660974|NCT00050778|580141720|FG000|Overall Study|Withdrawal by Subject|6|||
160660975|NCT00050778|580141721|FG001|Overall Study|Withdrawal by Subject|8|||
160660976|NCT00050778|580141722|FG002|Overall Study|Withdrawal by Subject|4|||
160660977|NCT00050778|580141720|FG000|Overall Study|Randomized but not treated|4|||
160660978|NCT00050778|580141721|FG001|Overall Study|Randomized but not treated|5|||
160660979|NCT00050778|580141722|FG002|Overall Study|Randomized but not treated|2|||
160660980|NCT00050778|580141720|FG000|Overall Study|Familial and personal reasons|1|||
160660981|NCT00050778|580141721|FG001|Overall Study|Familial and personal reasons|0|||
160660982|NCT00050778|580141722|FG002|Overall Study|Familial and personal reasons|0|||
160660983|NCT00064753|580141723|FG000|Overall Study|Death|251|||
160660984|NCT00064753|580141724|FG001|Overall Study|Death|242|||
160660985|NCT00064753|580141723|FG000|Overall Study|Withdrawal by Subject|198|||
160660986|NCT00064753|580141724|FG001|Overall Study|Withdrawal by Subject|171|||
160660987|NCT00064753|580141723|FG000|Overall Study|Lost to Follow-up|225|||
160660988|NCT00064753|580141724|FG001|Overall Study|Lost to Follow-up|235|||
160660989|NCT02193880|580141727|FG000|Overall Study|patients did not collect enough HPC|3|||
160660990|NCT01661686|580141731|FG000|Overall Study|Lost to Follow-up|2|||
160660991|NCT01661686|580141732|FG001|Overall Study|Lost to Follow-up|1|||
160660992|NCT01661686|580141731|FG000|Overall Study|did not receive allocated intervention|0|||
160660993|NCT01661686|580141732|FG001|Overall Study|did not receive allocated intervention|1|||
160660994|NCT04869787|580141733|FG000|Screening|Physician Decision|1|||
160660995|NCT04869787|580141733|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
160660996|NCT02914600|580141734|FG000|Overall Study|Adverse Event|298|||
160660997|NCT02914600|580141735|FG001|Overall Study|Adverse Event|35|||
160660998|NCT02914600|580141736|FG002|Overall Study|Adverse Event|25|||
160660999|NCT02914600|580141734|FG000|Overall Study|Sponsors decision|287|||
160661000|NCT02914600|580141735|FG001|Overall Study|Sponsors decision|41|||
160661001|NCT02914600|580141736|FG002|Overall Study|Sponsors decision|12|||
160661002|NCT02914600|580141734|FG000|Overall Study|Withdrawal by Subject|158|||
160605912|NCT03185819|579934626|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
160605913|NCT03185819|579934627|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
160605914|NCT03185819|579934628|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
160605915|NCT03185819|579934629|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
160605916|NCT03185819|579934626|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
160605917|NCT03185819|579934627|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
160605918|NCT03185819|579934628|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
160605919|NCT03185819|579934629|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
160605920|NCT03185819|579934626|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
160605921|NCT03185819|579934627|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
160605922|NCT03185819|579934628|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
160605923|NCT03185819|579934629|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
160605924|NCT01782885|579934632|FG000|Overall Study|Lost to Follow-up|4|||
160605925|NCT01782885|579934633|FG001|Overall Study|Lost to Follow-up|6|||
160605926|NCT03447821|579934634|FG000|Overall Study|Withdrawal by Subject|1|||
160605927|NCT03447821|579934635|FG001|Overall Study|Withdrawal by Subject|1|||
160605928|NCT03447821|579934636|FG002|Overall Study|Withdrawal by Subject|0|||
160605929|NCT03447821|579934634|FG000|Overall Study|Lost to Follow-up|0|||
160605930|NCT03447821|579934635|FG001|Overall Study|Lost to Follow-up|0|||
160605931|NCT03447821|579934636|FG002|Overall Study|Lost to Follow-up|1|||
160605932|NCT03236506|579934639|FG000|Overall Study|Death|1|||
160605933|NCT03236506|579934640|FG001|Overall Study|Death|1|||
160605934|NCT03236506|579934641|FG002|Overall Study|Death|1|||
160605935|NCT03236506|579934639|FG000|Overall Study|Withdrawal by Subject|3|||
160605936|NCT03236506|579934640|FG001|Overall Study|Withdrawal by Subject|3|||
160605937|NCT03236506|579934641|FG002|Overall Study|Withdrawal by Subject|4|||
160605938|NCT03236506|579934639|FG000|Overall Study|Did not initiate treatment|2|||
160605939|NCT03236506|579934640|FG001|Overall Study|Did not initiate treatment|1|||
160605940|NCT03236506|579934641|FG002|Overall Study|Did not initiate treatment|2|||
160605941|NCT00422669|579934650|FG000|Overall Study|The study was terminated early.|98|||
160605942|NCT00422669|579934651|FG001|Overall Study|The study was terminated early.|100|||
160605943|NCT00422669|579934652|FG002|Overall Study|The study was terminated early.|7|||
160605944|NCT01610206|579934656|FG000|Overall Study|Adverse Event|10|||
160605945|NCT01610206|579934657|FG001|Overall Study|Adverse Event|30|||
160605946|NCT00924729|579934658|FG000|Overall Study|insufficient volume for analysis|1|||
160661003|NCT02914600|580141735|FG001|Overall Study|Withdrawal by Subject|20|||
160605947|NCT00924729|579934659|FG001|Overall Study|insufficient volume for analysis|0|||
160605948|NCT00924729|579934658|FG000|Overall Study|Protocol Violation|1|||
160605949|NCT00924729|579934659|FG001|Overall Study|Protocol Violation|0|||
160605950|NCT01929707|579934660|FG000|Intervention Period 1|Lost to Follow-up|0|||
160483927|NCT00475735|579499193|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
160483928|NCT00475735|579499188|FG000|Treatment Washout|Lost to Follow-up|0|||
160605951|NCT01929707|579934661|FG001|Intervention Period 1|Lost to Follow-up|0|||
160605952|NCT01929707|579934662|FG002|Intervention Period 1|Lost to Follow-up|0|||
160605953|NCT01929707|579934663|FG003|Intervention Period 1|Lost to Follow-up|1|||
160605954|NCT01929707|579934664|FG004|Intervention Period 1|Lost to Follow-up|0|||
160605955|NCT01929707|579934665|FG005|Intervention Period 1|Lost to Follow-up|0|||
160605956|NCT01929707|579934666|FG006|Intervention Period 1|Lost to Follow-up|0|||
160605957|NCT01929707|579934667|FG007|Intervention Period 1|Lost to Follow-up|0|||
160605958|NCT01929707|579934660|FG000|Intervention Period 1|Withdrawal by Subject|0|||
160605959|NCT01929707|579934661|FG001|Intervention Period 1|Withdrawal by Subject|0|||
160605960|NCT01929707|579934662|FG002|Intervention Period 1|Withdrawal by Subject|0|||
160605961|NCT01929707|579934663|FG003|Intervention Period 1|Withdrawal by Subject|2|||
160605962|NCT01929707|579934664|FG004|Intervention Period 1|Withdrawal by Subject|0|||
160605963|NCT01929707|579934665|FG005|Intervention Period 1|Withdrawal by Subject|0|||
160605964|NCT01929707|579934666|FG006|Intervention Period 1|Withdrawal by Subject|0|||
160605965|NCT01929707|579934667|FG007|Intervention Period 1|Withdrawal by Subject|0|||
160605966|NCT01929707|579934660|FG000|Intervention Period 2|Withdrawal by Subject|0|||
160605967|NCT01929707|579934661|FG001|Intervention Period 2|Withdrawal by Subject|0|||
160605968|NCT01929707|579934662|FG002|Intervention Period 2|Withdrawal by Subject|0|||
160605969|NCT01929707|579934663|FG003|Intervention Period 2|Withdrawal by Subject|0|||
160605970|NCT01929707|579934664|FG004|Intervention Period 2|Withdrawal by Subject|0|||
160605971|NCT01929707|579934665|FG005|Intervention Period 2|Withdrawal by Subject|2|||
160605972|NCT01929707|579934666|FG006|Intervention Period 2|Withdrawal by Subject|0|||
160605973|NCT01929707|579934667|FG007|Intervention Period 2|Withdrawal by Subject|0|||
160605974|NCT00023712|579934668|FG000|Overall Study|Not platinum sensitive|1|||
160605975|NCT00023712|579934669|FG001|Overall Study|Not platinum sensitive|0|||
160605976|NCT00023712|579934668|FG000|Overall Study|Never treated|1|||
160605977|NCT00023712|579934669|FG001|Overall Study|Never treated|1|||
160605978|NCT00437203|579934670|FG000|Overall Study|Death|0|||
160605979|NCT00437203|579934671|FG001|Overall Study|Death|0|||
160605980|NCT00437203|579934672|FG002|Overall Study|Death|1|||
160605981|NCT00437203|579934673|FG003|Overall Study|Death|0|||
160605982|NCT00437203|579934674|FG004|Overall Study|Death|0|||
160605983|NCT00437203|579934675|FG005|Overall Study|Death|0|||
160605984|NCT00437203|579934676|FG006|Overall Study|Death|0|||
160605985|NCT00437203|579934677|FG007|Overall Study|Death|1|||
160605986|NCT00437203|579934678|FG008|Overall Study|Death|0|||
160605987|NCT00437203|579934679|FG009|Overall Study|Death|1|||
160605988|NCT00437203|579934670|FG000|Overall Study|Adverse Event|1|||
160605989|NCT00437203|579934671|FG001|Overall Study|Adverse Event|1|||
160605990|NCT00437203|579934672|FG002|Overall Study|Adverse Event|0|||
160605991|NCT00437203|579934673|FG003|Overall Study|Adverse Event|0|||
160605992|NCT00437203|579934674|FG004|Overall Study|Adverse Event|0|||
160605993|NCT00437203|579934675|FG005|Overall Study|Adverse Event|0|||
160605994|NCT00437203|579934676|FG006|Overall Study|Adverse Event|0|||
160605995|NCT00437203|579934677|FG007|Overall Study|Adverse Event|1|||
160605996|NCT00437203|579934678|FG008|Overall Study|Adverse Event|0|||
160605997|NCT00437203|579934679|FG009|Overall Study|Adverse Event|1|||
160605998|NCT00437203|579934670|FG000|Overall Study|Study terminated by sponsor|0|||
160605999|NCT00437203|579934671|FG001|Overall Study|Study terminated by sponsor|0|||
160606000|NCT00437203|579934672|FG002|Overall Study|Study terminated by sponsor|0|||
160606001|NCT00437203|579934673|FG003|Overall Study|Study terminated by sponsor|0|||
160606002|NCT00437203|579934674|FG004|Overall Study|Study terminated by sponsor|0|||
160606003|NCT00437203|579934675|FG005|Overall Study|Study terminated by sponsor|0|||
160606004|NCT00437203|579934676|FG006|Overall Study|Study terminated by sponsor|0|||
160606005|NCT00437203|579934677|FG007|Overall Study|Study terminated by sponsor|0|||
160606006|NCT00437203|579934678|FG008|Overall Study|Study terminated by sponsor|1|||
160606007|NCT00437203|579934679|FG009|Overall Study|Study terminated by sponsor|0|||
160606008|NCT00437203|579934670|FG000|Overall Study|Objective progression or relapse|5|||
160606009|NCT00437203|579934671|FG001|Overall Study|Objective progression or relapse|6|||
160606010|NCT00437203|579934672|FG002|Overall Study|Objective progression or relapse|2|||
160606011|NCT00437203|579934673|FG003|Overall Study|Objective progression or relapse|3|||
160606012|NCT00437203|579934674|FG004|Overall Study|Objective progression or relapse|3|||
160606013|NCT00437203|579934675|FG005|Overall Study|Objective progression or relapse|3|||
160606014|NCT00437203|579934676|FG006|Overall Study|Objective progression or relapse|6|||
160606015|NCT00437203|579934677|FG007|Overall Study|Objective progression or relapse|1|||
160661004|NCT02914600|580141736|FG002|Overall Study|Withdrawal by Subject|18|||
160661005|NCT02914600|580141734|FG000|Overall Study|Investigators discretion|169|||
160606016|NCT00437203|579934678|FG008|Overall Study|Objective progression or relapse|2|||
160606017|NCT00437203|579934679|FG009|Overall Study|Objective progression or relapse|2|||
160606018|NCT00437203|579934670|FG000|Overall Study|Other|0|||
160606019|NCT00437203|579934671|FG001|Overall Study|Other|1|||
160606020|NCT00437203|579934672|FG002|Overall Study|Other|0|||
160606021|NCT00437203|579934673|FG003|Overall Study|Other|0|||
160606022|NCT00437203|579934674|FG004|Overall Study|Other|0|||
160606023|NCT00437203|579934675|FG005|Overall Study|Other|0|||
160606024|NCT00437203|579934676|FG006|Overall Study|Other|1|||
160606025|NCT00437203|579934677|FG007|Overall Study|Other|0|||
160606026|NCT00437203|579934678|FG008|Overall Study|Other|0|||
160606027|NCT00437203|579934679|FG009|Overall Study|Other|0|||
160606028|NCT02896192|579934689|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
160606029|NCT02896192|579934689|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
160606030|NCT02896192|579934689|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
160606031|NCT01997281|579934690|FG000|Overall Study|Withdrawal by Subject|1|||
160606032|NCT01997281|579934691|FG001|Overall Study|Withdrawal by Subject|0|||
160606033|NCT02384993|579934695|FG000|Overall Study|Adverse Event|0|||
160606034|NCT02384993|579934696|FG001|Overall Study|Adverse Event|1|||
160606035|NCT01576406|579934697|FG000|Overall Study|Lost to Follow-up|1|||
160606036|NCT01576406|579934698|FG001|Overall Study|Lost to Follow-up|2|||
160606037|NCT01576406|579934699|FG002|Overall Study|Lost to Follow-up|0|||
160606038|NCT01576406|579934700|FG003|Overall Study|Lost to Follow-up|0|||
160606039|NCT01576406|579934701|FG004|Overall Study|Lost to Follow-up|0|||
160606040|NCT01576406|579934702|FG005|Overall Study|Lost to Follow-up|0|||
160606041|NCT01576406|579934697|FG000|Overall Study|Death|3|||
160606042|NCT01576406|579934698|FG001|Overall Study|Death|4|||
160606043|NCT01576406|579934699|FG002|Overall Study|Death|8|||
160606044|NCT01576406|579934700|FG003|Overall Study|Death|5|||
160606045|NCT01576406|579934701|FG004|Overall Study|Death|7|||
160606046|NCT01576406|579934702|FG005|Overall Study|Death|9|||
160606047|NCT01576406|579934697|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
160606048|NCT01576406|579934698|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
160606049|NCT01576406|579934699|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
160606050|NCT01576406|579934700|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
160606051|NCT01576406|579934701|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
160606052|NCT01576406|579934702|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
160606053|NCT01576406|579934697|FG000|Overall Study|Withdrawal the consent|2|||
160606054|NCT01576406|579934698|FG001|Overall Study|Withdrawal the consent|2|||
160606055|NCT01576406|579934699|FG002|Overall Study|Withdrawal the consent|5|||
160606056|NCT01576406|579934700|FG003|Overall Study|Withdrawal the consent|1|||
160606057|NCT01576406|579934701|FG004|Overall Study|Withdrawal the consent|1|||
160606058|NCT01576406|579934702|FG005|Overall Study|Withdrawal the consent|3|||
160606059|NCT01576406|579934697|FG000|Overall Study|Other|0|||
160606060|NCT01576406|579934698|FG001|Overall Study|Other|0|||
160606061|NCT01576406|579934699|FG002|Overall Study|Other|2|||
160606062|NCT01576406|579934700|FG003|Overall Study|Other|2|||
160606063|NCT01576406|579934701|FG004|Overall Study|Other|0|||
160606064|NCT01576406|579934702|FG005|Overall Study|Other|0|||
160606065|NCT01627782|579934703|FG000|Overall Study|Adverse Event|1|||
160606066|NCT01627782|579934704|FG001|Overall Study|Adverse Event|2|||
160606067|NCT01627782|579934705|FG002|Overall Study|Adverse Event|0|||
160606068|NCT01627782|579934706|FG003|Overall Study|Adverse Event|1|||
160606069|NCT01627782|579934703|FG000|Overall Study|Lack of Efficacy|11|||
160606070|NCT01627782|579934704|FG001|Overall Study|Lack of Efficacy|1|||
160606071|NCT01627782|579934705|FG002|Overall Study|Lack of Efficacy|15|||
160606072|NCT01627782|579934706|FG003|Overall Study|Lack of Efficacy|2|||
160606073|NCT01627782|579934703|FG000|Overall Study|Protocol Violation|1|||
160606074|NCT01627782|579934704|FG001|Overall Study|Protocol Violation|0|||
160606075|NCT01627782|579934705|FG002|Overall Study|Protocol Violation|0|||
160606076|NCT01627782|579934706|FG003|Overall Study|Protocol Violation|0|||
160606077|NCT01627782|579934703|FG000|Overall Study|Withdrawal by Subject|2|||
160606078|NCT01627782|579934704|FG001|Overall Study|Withdrawal by Subject|1|||
160606079|NCT01627782|579934705|FG002|Overall Study|Withdrawal by Subject|0|||
160606080|NCT01627782|579934706|FG003|Overall Study|Withdrawal by Subject|0|||
160606081|NCT01627782|579934703|FG000|Overall Study|Other|0|||
160606082|NCT01627782|579934704|FG001|Overall Study|Other|2|||
160606083|NCT01627782|579934705|FG002|Overall Study|Other|0|||
160606084|NCT01627782|579934706|FG003|Overall Study|Other|3|||
160606085|NCT01627782|579934703|FG000|Overall Study|Randomized But Not Treated|1|||
160606086|NCT01627782|579934704|FG001|Overall Study|Randomized But Not Treated|0|||
160606087|NCT01627782|579934705|FG002|Overall Study|Randomized But Not Treated|0|||
160661006|NCT02914600|580141735|FG001|Overall Study|Investigators discretion|14|||
160661007|NCT02914600|580141736|FG002|Overall Study|Investigators discretion|13|||
160606088|NCT01627782|579934706|FG003|Overall Study|Randomized But Not Treated|0|||
160606089|NCT00981682|579934710|FG000|Overall Study|Adverse Event|48|||
160606090|NCT00981682|579934710|FG000|Overall Study|Withdrawal by Subject|52|||
160606091|NCT00981682|579934710|FG000|Overall Study|Lost to Follow-up|14|||
160606092|NCT00981682|579934710|FG000|Overall Study|Lack of Efficacy|13|||
160606093|NCT00981682|579934710|FG000|Overall Study|Protocol Violation|6|||
160606094|NCT00981682|579934710|FG000|Overall Study|administrative|9|||
160632859|NCT05013749|580036090|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
160632860|NCT05013749|580036091|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
160632861|NCT05013749|580036090|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
160632862|NCT05013749|580036091|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
160632863|NCT01393626|580036094|FG000|Overall Study|Adverse Event|2|||
160632864|NCT01393626|580036095|FG001|Overall Study|Adverse Event|1|||
160632865|NCT01393626|580036096|FG002|Overall Study|Adverse Event|5|||
160606095|NCT01199198|579937269|FG000|Overall Study|Adverse Event|3|||
160606096|NCT01199198|579937270|FG001|Overall Study|Adverse Event|0|||
160606097|NCT01199198|579937269|FG000|Overall Study|Lost to Follow-up|1|||
160606098|NCT01199198|579937270|FG001|Overall Study|Lost to Follow-up|5|||
160606099|NCT01199198|579937269|FG000|Overall Study|Withdrawal by Subject|1|||
160606100|NCT01199198|579937270|FG001|Overall Study|Withdrawal by Subject|2|||
160606101|NCT01199198|579937269|FG000|Overall Study|ICU Transfer|1|||
160606102|NCT01199198|579937270|FG001|Overall Study|ICU Transfer|2|||
160606103|NCT01199198|579937269|FG000|Overall Study|Hospice-care transfer|1|||
160606104|NCT01199198|579937270|FG001|Overall Study|Hospice-care transfer|2|||
160606105|NCT04315298|579937271|FG000|Overall Study|Withdrawal by Subject|0|||
160606106|NCT04315298|579937272|FG001|Overall Study|Withdrawal by Subject|0|||
160606107|NCT04315298|579937273|FG002|Overall Study|Withdrawal by Subject|0|||
160606108|NCT04315298|579937274|FG003|Overall Study|Withdrawal by Subject|2|||
160606109|NCT04315298|579937275|FG004|Overall Study|Withdrawal by Subject|2|||
160606110|NCT04315298|579937276|FG005|Overall Study|Withdrawal by Subject|2|||
160606111|NCT04315298|579937277|FG006|Overall Study|Withdrawal by Subject|0|||
160606112|NCT04315298|579937278|FG007|Overall Study|Withdrawal by Subject|1|||
160606113|NCT04315298|579937279|FG008|Overall Study|Withdrawal by Subject|1|||
160606114|NCT04315298|579937280|FG009|Overall Study|Withdrawal by Subject|1|||
160606115|NCT04315298|579937281|FG010|Overall Study|Withdrawal by Subject|0|||
160606116|NCT04315298|579937282|FG011|Overall Study|Withdrawal by Subject|0|||
160606117|NCT04315298|579937283|FG012|Overall Study|Withdrawal by Subject|0|||
160606118|NCT04315298|579937284|FG013|Overall Study|Withdrawal by Subject|0|||
160606119|NCT04315298|579937285|FG014|Overall Study|Withdrawal by Subject|0|||
160606120|NCT04315298|579937286|FG015|Overall Study|Withdrawal by Subject|0|||
160606121|NCT04315298|579937287|FG016|Overall Study|Withdrawal by Subject|0|||
160606122|NCT04315298|579937288|FG017|Overall Study|Withdrawal by Subject|0|||
160606123|NCT04315298|579937289|FG018|Overall Study|Withdrawal by Subject|0|||
160606124|NCT04315298|579937271|FG000|Overall Study|Physician Decision|0|||
160606125|NCT04315298|579937272|FG001|Overall Study|Physician Decision|0|||
160606126|NCT04315298|579937273|FG002|Overall Study|Physician Decision|0|||
160606127|NCT04315298|579937274|FG003|Overall Study|Physician Decision|0|||
160606128|NCT04315298|579937275|FG004|Overall Study|Physician Decision|1|||
160606129|NCT04315298|579937276|FG005|Overall Study|Physician Decision|0|||
160606130|NCT04315298|579937277|FG006|Overall Study|Physician Decision|0|||
160606131|NCT04315298|579937278|FG007|Overall Study|Physician Decision|0|||
160606132|NCT04315298|579937279|FG008|Overall Study|Physician Decision|0|||
160606133|NCT04315298|579937280|FG009|Overall Study|Physician Decision|0|||
160606134|NCT04315298|579937281|FG010|Overall Study|Physician Decision|0|||
160606135|NCT04315298|579937282|FG011|Overall Study|Physician Decision|0|||
160606136|NCT04315298|579937283|FG012|Overall Study|Physician Decision|0|||
160606137|NCT04315298|579937284|FG013|Overall Study|Physician Decision|0|||
160606138|NCT04315298|579937285|FG014|Overall Study|Physician Decision|0|||
160606139|NCT04315298|579937286|FG015|Overall Study|Physician Decision|0|||
160606140|NCT04315298|579937287|FG016|Overall Study|Physician Decision|0|||
160606141|NCT04315298|579937288|FG017|Overall Study|Physician Decision|0|||
160606142|NCT04315298|579937289|FG018|Overall Study|Physician Decision|0|||
160606143|NCT04315298|579937271|FG000|Overall Study|Lost to Follow-up|5|||
160606144|NCT04315298|579937272|FG001|Overall Study|Lost to Follow-up|10|||
160606145|NCT04315298|579937273|FG002|Overall Study|Lost to Follow-up|6|||
160606146|NCT04315298|579937274|FG003|Overall Study|Lost to Follow-up|8|||
160606147|NCT04315298|579937275|FG004|Overall Study|Lost to Follow-up|12|||
160606148|NCT04315298|579937276|FG005|Overall Study|Lost to Follow-up|13|||
160606149|NCT04315298|579937277|FG006|Overall Study|Lost to Follow-up|9|||
160606150|NCT04315298|579937278|FG007|Overall Study|Lost to Follow-up|16|||
160606151|NCT04315298|579937279|FG008|Overall Study|Lost to Follow-up|14|||
160606152|NCT04315298|579937280|FG009|Overall Study|Lost to Follow-up|0|||
160661008|NCT02914600|580141734|FG000|Overall Study|Lost to Follow-up|10|||
160661009|NCT02914600|580141735|FG001|Overall Study|Lost to Follow-up|4|||
160661010|NCT02914600|580141736|FG002|Overall Study|Lost to Follow-up|0|||
160606153|NCT04315298|579937281|FG010|Overall Study|Lost to Follow-up|2|||
160606154|NCT04315298|579937282|FG011|Overall Study|Lost to Follow-up|1|||
160606155|NCT04315298|579937283|FG012|Overall Study|Lost to Follow-up|0|||
160606156|NCT04315298|579937284|FG013|Overall Study|Lost to Follow-up|0|||
160606157|NCT04315298|579937285|FG014|Overall Study|Lost to Follow-up|0|||
160606158|NCT04315298|579937286|FG015|Overall Study|Lost to Follow-up|2|||
160606159|NCT04315298|579937287|FG016|Overall Study|Lost to Follow-up|0|||
160606160|NCT04315298|579937288|FG017|Overall Study|Lost to Follow-up|0|||
160606161|NCT04315298|579937289|FG018|Overall Study|Lost to Follow-up|0|||
160606162|NCT04315298|579937271|FG000|Overall Study|Death|24|||
160606163|NCT04315298|579937272|FG001|Overall Study|Death|60|||
160606164|NCT04315298|579937273|FG002|Overall Study|Death|49|||
160606165|NCT04315298|579937274|FG003|Overall Study|Death|59|||
160606166|NCT04315298|579937275|FG004|Overall Study|Death|70|||
160606167|NCT04315298|579937276|FG005|Overall Study|Death|114|||
160606168|NCT04315298|579937277|FG006|Overall Study|Death|9|||
160661011|NCT02914600|580141734|FG000|Overall Study|Pregnancy|8|||
160661012|NCT02914600|580141735|FG001|Overall Study|Pregnancy|0|||
160661013|NCT02914600|580141736|FG002|Overall Study|Pregnancy|0|||
160661014|NCT02914600|580141734|FG000|Overall Study|Protocol Violation|5|||
160606169|NCT04315298|579937278|FG007|Overall Study|Death|12|||
160606170|NCT04315298|579937279|FG008|Overall Study|Death|21|||
160606171|NCT04315298|579937280|FG009|Overall Study|Death|16|||
160606172|NCT04315298|579937281|FG010|Overall Study|Death|40|||
160606173|NCT04315298|579937282|FG011|Overall Study|Death|40|||
160606174|NCT04315298|579937283|FG012|Overall Study|Death|3|||
160606175|NCT04315298|579937284|FG013|Overall Study|Death|4|||
160606176|NCT04315298|579937285|FG014|Overall Study|Death|6|||
160606177|NCT04315298|579937286|FG015|Overall Study|Death|4|||
160606178|NCT04315298|579937287|FG016|Overall Study|Death|3|||
160606179|NCT04315298|579937288|FG017|Overall Study|Death|1|||
160606180|NCT04315298|579937289|FG018|Overall Study|Death|0|||
160606181|NCT03050307|579937291|FG000|Overall Study|Adverse Event|4|||
160606182|NCT03050307|579937292|FG001|Overall Study|Adverse Event|2|||
160606183|NCT03050307|579937291|FG000|Overall Study|Significant Protocol Deviation|0|||
160606184|NCT03050307|579937292|FG001|Overall Study|Significant Protocol Deviation|1|||
160606185|NCT03050307|579937291|FG000|Overall Study|Lost to Follow-up|0|||
160606186|NCT03050307|579937292|FG001|Overall Study|Lost to Follow-up|1|||
160606187|NCT03050307|579937291|FG000|Overall Study|Voluntary Withdrawal|3|||
160606188|NCT03050307|579937292|FG001|Overall Study|Voluntary Withdrawal|4|||
160606189|NCT03050307|579937291|FG000|Overall Study|Reason not Specified|1|||
160606190|NCT03050307|579937292|FG001|Overall Study|Reason not Specified|1|||
160606191|NCT00653068|579937293|FG000|Overall Study|Death|9|||
160606192|NCT00653068|579937293|FG000|Overall Study|Lack of Efficacy|34|||
160606193|NCT00653068|579937293|FG000|Overall Study|Physician Decision|4|||
160606194|NCT00653068|579937293|FG000|Overall Study|Withdrawal by Subject|1|||
160606195|NCT00653068|579937293|FG000|Overall Study|Ineligible|2|||
160606196|NCT03950440|579937294|FG000|Overall Study|Death|8|||
160606197|NCT03950440|579937295|FG001|Overall Study|Death|2|||
160606198|NCT03950440|579937296|FG002|Overall Study|Death|1|||
160606199|NCT02892734|579937297|FG000|Treatment on Study|Progressive Disease|2|||
160606200|NCT02892734|579937297|FG000|Follow up for 2 Years|Death|2|||
160606201|NCT02892734|579937297|FG000|Follow up for 2 Years|Study closed early|1|||
160606202|NCT00439309|579937298|FG000|Follow-Up|Death|1|||
160606203|NCT00439309|579937299|FG001|Follow-Up|Death|0|||
160606204|NCT00439309|579937298|FG000|Follow-Up|Lost to Follow-up|2|||
160606205|NCT00439309|579937299|FG001|Follow-Up|Lost to Follow-up|0|||
160606206|NCT00439309|579937298|FG000|Follow-Up|Withdrawal by Subject|0|||
160606207|NCT00439309|579937299|FG001|Follow-Up|Withdrawal by Subject|1|||
160606208|NCT00439309|579937298|FG000|Follow-Up|Late response by subject|0|||
160606209|NCT00439309|579937299|FG001|Follow-Up|Late response by subject|1|||
160606210|NCT00464620|579937300|FG000|Overall Study|Physician Decision|1|||
160606211|NCT00464620|579937301|FG001|Overall Study|Physician Decision|0|||
160606212|NCT00464620|579937302|FG002|Overall Study|Physician Decision|0|||
160606213|NCT00464620|579937300|FG000|Overall Study|Withdrawal by Subject|1|||
160606214|NCT00464620|579937301|FG001|Overall Study|Withdrawal by Subject|0|||
160606215|NCT00464620|579937302|FG002|Overall Study|Withdrawal by Subject|3|||
160606216|NCT00464620|579937300|FG000|Overall Study|Ineligible sarcoma subtype|0|||
160606217|NCT00464620|579937301|FG001|Overall Study|Ineligible sarcoma subtype|2|||
160606218|NCT00464620|579937302|FG002|Overall Study|Ineligible sarcoma subtype|2|||
160606219|NCT00464620|579937300|FG000|Overall Study|Use of prohibited concomitant medication|0|||
160606220|NCT00464620|579937301|FG001|Overall Study|Use of prohibited concomitant medication|0|||
160606221|NCT00464620|579937302|FG002|Overall Study|Use of prohibited concomitant medication|2|||
160606222|NCT01998906|579937303|FG000|Overall Study|Participants ongoing in follow-up|77|||
160606223|NCT01998906|579937304|FG001|Overall Study|Participants ongoing in follow-up|60|||
160606224|NCT01998906|579937305|FG002|Overall Study|Participants ongoing in follow-up|58|||
160606225|NCT01998906|579937303|FG000|Overall Study|Death|21|||
160606226|NCT01998906|579937304|FG001|Overall Study|Death|30|||
160661015|NCT02914600|580141735|FG001|Overall Study|Protocol Violation|3|||
160606227|NCT01998906|579937305|FG002|Overall Study|Death|17|||
160606228|NCT01998906|579937303|FG000|Overall Study|Lack of Efficacy|10|||
160606229|NCT01998906|579937304|FG001|Overall Study|Lack of Efficacy|9|||
160606230|NCT01998906|579937305|FG002|Overall Study|Lack of Efficacy|8|||
160606231|NCT01998906|579937303|FG000|Overall Study|Failure to return|0|||
160606232|NCT01998906|579937304|FG001|Overall Study|Failure to return|2|||
160606233|NCT01998906|579937305|FG002|Overall Study|Failure to return|4|||
160606234|NCT01998906|579937303|FG000|Overall Study|Violation of Selection Criteria|0|||
160606235|NCT01998906|579937304|FG001|Overall Study|Violation of Selection Criteria|0|||
160606236|NCT01998906|579937305|FG002|Overall Study|Violation of Selection Criteria|1|||
160606237|NCT01998906|579937303|FG000|Overall Study|Withdrawal by Subject|1|||
160606238|NCT01998906|579937304|FG001|Overall Study|Withdrawal by Subject|4|||
160606239|NCT01998906|579937305|FG002|Overall Study|Withdrawal by Subject|3|||
160606240|NCT01998906|579937303|FG000|Overall Study|Administrative/Other|2|||
160606241|NCT01998906|579937304|FG001|Overall Study|Administrative/Other|1|||
160606242|NCT01998906|579937305|FG002|Overall Study|Administrative/Other|3|||
160606243|NCT01998906|579937303|FG000|Overall Study|Other|3|||
160483929|NCT00475735|579499189|FG001|Treatment Washout|Lost to Follow-up|1|||
160483930|NCT00475735|579499190|FG002|Treatment Washout|Lost to Follow-up|0|||
160483931|NCT00475735|579499191|FG003|Treatment Washout|Lost to Follow-up|0|||
160661016|NCT02914600|580141736|FG002|Overall Study|Protocol Violation|0|||
160483932|NCT00475735|579499192|FG004|Treatment Washout|Lost to Follow-up|0|||
160483933|NCT00475735|579499193|FG005|Treatment Washout|Lost to Follow-up|0|||
160483934|NCT00475735|579499188|FG000|Treatment Washout|Protocol Violation|0|||
160661017|NCT02914600|580141734|FG000|Overall Study|Non-compliance with study drug|6|||
160661018|NCT02914600|580141735|FG001|Overall Study|Non-compliance with study drug|1|||
160606244|NCT01998906|579937304|FG001|Overall Study|Other|8|||
160606245|NCT01998906|579937305|FG002|Overall Study|Other|4|||
160606246|NCT01572844|579937306|FG000|Overall Study|Physician Decision|1|||
160606247|NCT01572844|579937307|FG001|Overall Study|Physician Decision|1|||
160606248|NCT02158728|579937318|FG000|Overall Study|no procedure according to CIP done|3|||
160606249|NCT02158728|579937318|FG000|Overall Study|no qualified dataset|24|||
160606250|NCT02658149|579937331|FG000|Overall Study|Physician Decision|1|||
160606251|NCT02658149|579937332|FG001|Overall Study|Physician Decision|0|||
160606252|NCT01680991|579937335|FG000|Overall Study|Adverse Event|1|||
160606253|NCT01680991|579937336|FG001|Overall Study|Adverse Event|0|||
160606254|NCT01680991|579937337|FG002|Overall Study|Adverse Event|0|||
160606255|NCT01680991|579937335|FG000|Overall Study|Death|1|||
160606256|NCT01680991|579937336|FG001|Overall Study|Death|0|||
160606257|NCT01680991|579937337|FG002|Overall Study|Death|1|||
160606258|NCT01680991|579937335|FG000|Overall Study|Protocol Violation|0|||
160606259|NCT01680991|579937336|FG001|Overall Study|Protocol Violation|1|||
160606260|NCT01680991|579937337|FG002|Overall Study|Protocol Violation|0|||
160606261|NCT01680991|579937335|FG000|Overall Study|Withdrawal by Subject|5|||
160606262|NCT01680991|579937336|FG001|Overall Study|Withdrawal by Subject|1|||
160606263|NCT01680991|579937337|FG002|Overall Study|Withdrawal by Subject|0|||
160606264|NCT01680991|579937335|FG000|Overall Study|Progressive disease (PD)|0|||
160606265|NCT01680991|579937336|FG001|Overall Study|Progressive disease (PD)|10|||
160606266|NCT01680991|579937337|FG002|Overall Study|Progressive disease (PD)|0|||
160606267|NCT01680991|579937335|FG000|Overall Study|Physician Decision|0|||
160606268|NCT01680991|579937336|FG001|Overall Study|Physician Decision|7|||
160606269|NCT01680991|579937337|FG002|Overall Study|Physician Decision|2|||
160606270|NCT01680991|579937335|FG000|Overall Study|Bad physical condition|0|||
160606271|NCT01680991|579937336|FG001|Overall Study|Bad physical condition|0|||
160606272|NCT01680991|579937337|FG002|Overall Study|Bad physical condition|1|||
160606273|NCT01680991|579937335|FG000|Overall Study|PD confirmed in other hospital|1|||
160606274|NCT01680991|579937336|FG001|Overall Study|PD confirmed in other hospital|0|||
160606275|NCT01680991|579937337|FG002|Overall Study|PD confirmed in other hospital|0|||
160606276|NCT04097028|579937338|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
160606277|NCT04097028|579937338|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
160606278|NCT04097028|579937338|FG000|Overall Study|Disease Progression prior to Surgery|2|||
160606279|NCT04097028|579937338|FG000|Overall Study|Adverse Event prior to Surgery|1|||
160606280|NCT01156363|579937339|FG000|Overall Study|Adverse Event|6|||
160606281|NCT01156363|579937339|FG000|Overall Study|Insufficient Therapeutic Response|5|||
160606282|NCT01156363|579937339|FG000|Overall Study|Failure to Return|1|||
160606283|NCT01156363|579937339|FG000|Overall Study|Refused Treatment|4|||
160606284|NCT01156363|579937339|FG000|Overall Study|Other|6|||
160606285|NCT03745989|579937341|FG000|Overall Study|Death|3|||
160606286|NCT03745989|579937342|FG001|Overall Study|Death|7|||
160606287|NCT03745989|579937343|FG002|Overall Study|Death|4|||
160606288|NCT03745989|579937341|FG000|Overall Study|Lost to Follow-up|0|||
160606289|NCT03745989|579937342|FG001|Overall Study|Lost to Follow-up|2|||
160606290|NCT03745989|579937343|FG002|Overall Study|Lost to Follow-up|0|||
160606291|NCT03745989|579937341|FG000|Overall Study|Sponsor Decision|0|||
160606292|NCT03745989|579937342|FG001|Overall Study|Sponsor Decision|2|||
160606293|NCT03745989|579937343|FG002|Overall Study|Sponsor Decision|8|||
160606294|NCT03745989|579937341|FG000|Overall Study|Withdrawal by Subject|0|||
160606295|NCT03745989|579937342|FG001|Overall Study|Withdrawal by Subject|1|||
160606296|NCT03745989|579937343|FG002|Overall Study|Withdrawal by Subject|3|||
160606297|NCT00735072|579937349|FG000|Overall Study|interrupted study med during ARV change|1|||
160606298|NCT00735072|579937350|FG001|Overall Study|interrupted study med during ARV change|0|||
160606299|NCT00735072|579937349|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
160606300|NCT00735072|579937350|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
160606301|NCT00911144|579937351|FG000|Overall Study|Withdrawal by Subject|16|||
160606302|NCT00911144|579937352|FG001|Overall Study|Withdrawal by Subject|5|||
160606303|NCT01291511|579937353|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
160606304|NCT01291511|579937354|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
160606305|NCT01291511|579937353|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
160606306|NCT01291511|579937354|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
160606307|NCT01291511|579937353|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
160606308|NCT01291511|579937354|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
160606309|NCT01291511|579937353|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
160606310|NCT01291511|579937354|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
160606311|NCT01291511|579937353|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
160606312|NCT01291511|579937354|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
160606313|NCT01291511|579937353|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
160606314|NCT01291511|579937354|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
160606315|NCT01291511|579937353|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
160606316|NCT01291511|579937354|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
160606317|NCT01291511|579937353|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
160606318|NCT01291511|579937354|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
160606319|NCT01291511|579937353|FG000|Cross-Titration and Stabilization Phase|Death|1|||
160606320|NCT01291511|579937354|FG001|Cross-Titration and Stabilization Phase|Death|0|||
160606321|NCT01291511|579937353|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
160606322|NCT01291511|579937354|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
160606323|NCT01291511|579937353|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
160606324|NCT01291511|579937354|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
160661019|NCT02914600|580141736|FG002|Overall Study|Non-compliance with study drug|0|||
160483935|NCT00475735|579499189|FG001|Treatment Washout|Protocol Violation|1|||
160483936|NCT00475735|579499190|FG002|Treatment Washout|Protocol Violation|0|||
160483937|NCT00475735|579499191|FG003|Treatment Washout|Protocol Violation|0|||
160661020|NCT02914600|580141734|FG000|Overall Study|Death|3|||
160661021|NCT02914600|580141735|FG001|Overall Study|Death|1|||
160661022|NCT02914600|580141736|FG002|Overall Study|Death|1|||
160661023|NCT02914600|580141734|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
160661024|NCT02914600|580141735|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
160661025|NCT02914600|580141736|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
160661026|NCT02914600|580141734|FG000|Overall Study|Enrolled but not treated|1|||
160661027|NCT02914600|580141735|FG001|Overall Study|Enrolled but not treated|0|||
160661028|NCT02914600|580141736|FG002|Overall Study|Enrolled but not treated|0|||
160661029|NCT02996682|580141737|FG000|Overall Study|Death|0|||
160661030|NCT02996682|580141738|FG001|Overall Study|Death|3|||
160661031|NCT02457520|580141739|FG000|Active Treatment Phase|Adverse Event|10|||
160483938|NCT00475735|579499192|FG004|Treatment Washout|Protocol Violation|0|||
160483939|NCT00475735|579499193|FG005|Treatment Washout|Protocol Violation|0|||
160483940|NCT00475735|579499188|FG000|Treatment Period 2|Adverse Event|0|||
160483941|NCT00475735|579499189|FG001|Treatment Period 2|Adverse Event|1|||
160483942|NCT00475735|579499190|FG002|Treatment Period 2|Adverse Event|0|||
160483943|NCT00475735|579499191|FG003|Treatment Period 2|Adverse Event|2|||
160483944|NCT00475735|579499192|FG004|Treatment Period 2|Adverse Event|0|||
160483945|NCT00475735|579499193|FG005|Treatment Period 2|Adverse Event|0|||
160483946|NCT00475735|579499188|FG000|Treatment Period 2|Lack of Efficacy|0|||
160483947|NCT00475735|579499189|FG001|Treatment Period 2|Lack of Efficacy|0|||
160483948|NCT00475735|579499190|FG002|Treatment Period 2|Lack of Efficacy|0|||
160483949|NCT00475735|579499191|FG003|Treatment Period 2|Lack of Efficacy|0|||
160483950|NCT00475735|579499192|FG004|Treatment Period 2|Lack of Efficacy|0|||
160483951|NCT00475735|579499193|FG005|Treatment Period 2|Lack of Efficacy|1|||
160483952|NCT00475735|579499188|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160483953|NCT00475735|579499189|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160483954|NCT00475735|579499190|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160483955|NCT00475735|579499191|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160483956|NCT00475735|579499192|FG004|Treatment Period 2|Withdrawal by Subject|1|||
160483957|NCT00475735|579499193|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160483958|NCT02350127|579499194|FG000|4-Month Assessment|Withdrawal by Subject|10|||
160483959|NCT02350127|579499195|FG001|4-Month Assessment|Withdrawal by Subject|9|||
160483960|NCT02350127|579499194|FG000|4-Month Assessment|Death|1|||
160483961|NCT02350127|579499195|FG001|4-Month Assessment|Death|0|||
160483962|NCT02350127|579499194|FG000|8-Month Assessment|Death|1|||
160483963|NCT02350127|579499195|FG001|8-Month Assessment|Death|1|||
160483964|NCT02350127|579499194|FG000|8-Month Assessment|Withdrawal by Subject|5|||
160483965|NCT02350127|579499195|FG001|8-Month Assessment|Withdrawal by Subject|8|||
160483966|NCT00050167|579499197|FG000|Overall Study|not eligible not invasive|1|||
160483967|NCT00050167|579499198|FG001|Overall Study|not eligible not invasive|1|||
160483968|NCT01363297|579499199|FG000|Overall Study|Other|0|||
160483969|NCT01363297|579499200|FG001|Overall Study|Other|0|||
160483970|NCT01363297|579499201|FG002|Overall Study|Other|0|||
160483971|NCT01363297|579499202|FG003|Overall Study|Other|0|||
160483972|NCT01363297|579499203|FG004|Overall Study|Other|1|||
160483973|NCT01363297|579499199|FG000|Overall Study|Death|3|||
160483974|NCT01363297|579499200|FG001|Overall Study|Death|6|||
160483975|NCT01363297|579499201|FG002|Overall Study|Death|6|||
160483976|NCT01363297|579499202|FG003|Overall Study|Death|10|||
160483977|NCT01363297|579499203|FG004|Overall Study|Death|30|||
160483978|NCT02038803|579499207|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
160483979|NCT02038803|579499207|FG000|Overall Study|Lost to Follow-up|1|||
160483980|NCT04754594|579499208|FG000|Blinded Period|Withdrawal by Subject|4|||
160483981|NCT04754594|579499209|FG001|Blinded Period|Withdrawal by Subject|9|||
160483982|NCT04754594|579499210|FG002|Blinded Period|Withdrawal by Subject|0|||
160483983|NCT04754594|579499211|FG003|Blinded Period|Withdrawal by Subject|0|||
160483984|NCT04754594|579499208|FG000|Blinded Period|Protocol Violation|2|||
160661032|NCT02457520|580141739|FG000|Active Treatment Phase|Lost to Follow-up|8|||
160661033|NCT02457520|580141739|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
160483985|NCT04754594|579499209|FG001|Blinded Period|Protocol Violation|2|||
160483986|NCT04754594|579499210|FG002|Blinded Period|Protocol Violation|0|||
160483987|NCT04754594|579499211|FG003|Blinded Period|Protocol Violation|0|||
160483988|NCT04754594|579499208|FG000|Blinded Period|Lost to Follow-up|1|||
160483989|NCT04754594|579499209|FG001|Blinded Period|Lost to Follow-up|1|||
160483990|NCT04754594|579499210|FG002|Blinded Period|Lost to Follow-up|0|||
160483991|NCT04754594|579499211|FG003|Blinded Period|Lost to Follow-up|0|||
160661034|NCT02457520|580141739|FG000|Active Treatment Phase|other|4|||
160483992|NCT04754594|579499208|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
160483993|NCT04754594|579499209|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
160483994|NCT04754594|579499210|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
160483995|NCT04754594|579499211|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
160483996|NCT04754594|579499208|FG000|Unblinded Period|Withdrawal by Subject|6|||
160483997|NCT04754594|579499209|FG001|Unblinded Period|Withdrawal by Subject|8|||
160483998|NCT04754594|579499210|FG002|Unblinded Period|Withdrawal by Subject|0|||
160483999|NCT04754594|579499211|FG003|Unblinded Period|Withdrawal by Subject|0|||
160484000|NCT04754594|579499208|FG000|Unblinded Period|Lost to Follow-up|5|||
160484001|NCT04754594|579499209|FG001|Unblinded Period|Lost to Follow-up|3|||
160484002|NCT04754594|579499210|FG002|Unblinded Period|Lost to Follow-up|0|||
160484003|NCT04754594|579499211|FG003|Unblinded Period|Lost to Follow-up|0|||
160484004|NCT04754594|579499208|FG000|Unblinded Period|Protocol Violation|2|||
160484005|NCT04754594|579499209|FG001|Unblinded Period|Protocol Violation|4|||
160484006|NCT04754594|579499210|FG002|Unblinded Period|Protocol Violation|0|||
160484007|NCT04754594|579499211|FG003|Unblinded Period|Protocol Violation|0|||
160484008|NCT04754594|579499208|FG000|Unblinded Period|Other|3|||
160484009|NCT04754594|579499209|FG001|Unblinded Period|Other|0|||
160484010|NCT04754594|579499210|FG002|Unblinded Period|Other|0|||
160484011|NCT04754594|579499211|FG003|Unblinded Period|Other|0|||
160484012|NCT04754594|579499208|FG000|Infant Participants|Withdrawal by Subject|0|||
160484013|NCT04754594|579499209|FG001|Infant Participants|Withdrawal by Subject|0|||
160484014|NCT04754594|579499210|FG002|Infant Participants|Withdrawal by Subject|9|||
160484015|NCT04754594|579499211|FG003|Infant Participants|Withdrawal by Subject|17|||
160484016|NCT04754594|579499208|FG000|Infant Participants|Lost to Follow-up|0|||
160484017|NCT04754594|579499209|FG001|Infant Participants|Lost to Follow-up|0|||
160484018|NCT04754594|579499210|FG002|Infant Participants|Lost to Follow-up|4|||
160484019|NCT04754594|579499211|FG003|Infant Participants|Lost to Follow-up|10|||
160484020|NCT04754594|579499208|FG000|Infant Participants|Death|0|||
160484021|NCT04754594|579499209|FG001|Infant Participants|Death|0|||
160484022|NCT04754594|579499210|FG002|Infant Participants|Death|1|||
160484023|NCT04754594|579499211|FG003|Infant Participants|Death|1|||
160484024|NCT04754594|579499208|FG000|Infant Participants|Other|0|||
160484025|NCT04754594|579499209|FG001|Infant Participants|Other|0|||
160484026|NCT04754594|579499210|FG002|Infant Participants|Other|1|||
160484027|NCT04754594|579499211|FG003|Infant Participants|Other|1|||
160484028|NCT01247922|579499212|FG000|Overall Study|Disease progression|4|||
160484029|NCT01876823|579499213|FG000|Overall Study|Withdrawal by Subject|5|||
160484030|NCT01876823|579499213|FG000|Overall Study|Physician Decision|2|||
160484031|NCT01876823|579499213|FG000|Overall Study|Patients moved|2|||
160484032|NCT00794573|579499218|FG000|Overall Study|Death|3|||
160484033|NCT00794573|579499219|FG001|Overall Study|Death|0|||
160484034|NCT00794573|579499218|FG000|Overall Study|Withdrawal by Subject|9|||
160484035|NCT00794573|579499219|FG001|Overall Study|Withdrawal by Subject|12|||
160484036|NCT00794573|579499218|FG000|Overall Study|Lost to Follow-up|26|||
160484037|NCT00794573|579499219|FG001|Overall Study|Lost to Follow-up|33|||
160484038|NCT00905255|579499220|FG000|Overall Study|Adverse Event|7|||
160484039|NCT00905255|579499221|FG001|Overall Study|Adverse Event|5|||
160484040|NCT00905255|579499220|FG000|Overall Study|Withdrawal by Subject|5|||
160484041|NCT00905255|579499221|FG001|Overall Study|Withdrawal by Subject|4|||
160484042|NCT00905255|579499220|FG000|Overall Study|Familial and Personal Reasons|1|||
160484043|NCT00905255|579499221|FG001|Overall Study|Familial and Personal Reasons|0|||
160484044|NCT02418819|579499222|FG000|Overall Study|Adverse Event|0|||
160484045|NCT02418819|579499223|FG001|Overall Study|Adverse Event|0|||
160484046|NCT02418819|579499224|FG002|Overall Study|Adverse Event|1|||
160484047|NCT02418819|579499225|FG003|Overall Study|Adverse Event|0|||
160484048|NCT02418819|579499222|FG000|Overall Study|Lost to Follow-up|1|||
160484049|NCT02418819|579499223|FG001|Overall Study|Lost to Follow-up|0|||
160484050|NCT02418819|579499224|FG002|Overall Study|Lost to Follow-up|0|||
160484051|NCT02418819|579499225|FG003|Overall Study|Lost to Follow-up|0|||
160484052|NCT02418819|579499222|FG000|Overall Study|No longer meets eligibility criteria|0|||
160484053|NCT02418819|579499223|FG001|Overall Study|No longer meets eligibility criteria|0|||
160484054|NCT02418819|579499224|FG002|Overall Study|No longer meets eligibility criteria|1|||
160606325|NCT01291511|579937353|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
160606326|NCT01291511|579937354|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
160484055|NCT02418819|579499225|FG003|Overall Study|No longer meets eligibility criteria|0|||
160484056|NCT02418819|579499222|FG000|Overall Study|No longer willing to participate|0|||
160484057|NCT02418819|579499223|FG001|Overall Study|No longer willing to participate|0|||
160484058|NCT02418819|579499224|FG002|Overall Study|No longer willing to participate|2|||
160484059|NCT02418819|579499225|FG003|Overall Study|No longer willing to participate|1|||
160484060|NCT01332318|579499226|FG000|Overall Study|Adverse Event|0|||
160484061|NCT01332318|579499227|FG001|Overall Study|Adverse Event|3|||
160484062|NCT01332318|579499228|FG002|Overall Study|Adverse Event|0|||
160484063|NCT01332318|579499229|FG003|Overall Study|Adverse Event|0|||
160484064|NCT01332318|579499226|FG000|Overall Study|Withdrawal by Subject|1|||
160484065|NCT01332318|579499227|FG001|Overall Study|Withdrawal by Subject|1|||
160484066|NCT01332318|579499228|FG002|Overall Study|Withdrawal by Subject|0|||
160484067|NCT01332318|579499229|FG003|Overall Study|Withdrawal by Subject|1|||
160484068|NCT01332318|579499226|FG000|Overall Study|Protocol Violation|1|||
160484069|NCT01332318|579499227|FG001|Overall Study|Protocol Violation|0|||
160484070|NCT01332318|579499228|FG002|Overall Study|Protocol Violation|1|||
160484071|NCT01332318|579499229|FG003|Overall Study|Protocol Violation|1|||
160484072|NCT02040532|579499230|FG000|Overall Study|Lost to Follow-up|1|||
160484073|NCT02040532|579499230|FG000|Overall Study|Physician Decision|4|||
160484074|NCT02040532|579499230|FG000|Overall Study|Adverse Event|4|||
160484075|NCT02040532|579499230|FG000|Overall Study|Withdrawal by Subject|3|||
160484076|NCT01207453|579499231|FG000|First Intervention|Adverse Event|2|||
160484077|NCT01207453|579499232|FG001|First Intervention|Adverse Event|1|||
160484078|NCT01207453|579499231|FG000|Washout|Adverse Event|1|||
160484079|NCT01207453|579499232|FG001|Washout|Adverse Event|0|||
160484080|NCT01207453|579499231|FG000|Washout|Lost to Follow-up|1|||
160484081|NCT01207453|579499232|FG001|Washout|Lost to Follow-up|0|||
160484082|NCT01207453|579499231|FG000|2nd Intervention|Adverse Event|1|||
160484083|NCT01207453|579499232|FG001|2nd Intervention|Adverse Event|2|||
160484084|NCT01207453|579499231|FG000|2nd Intervention|Lost to Follow-up|1|||
160484085|NCT01207453|579499232|FG001|2nd Intervention|Lost to Follow-up|0|||
160484086|NCT01399905|579499233|FG000|Overall Study|Withdrawal by Subject|1|||
160484087|NCT01399905|579499234|FG001|Overall Study|Withdrawal by Subject|1|||
160484088|NCT01786551|579499238|FG000|Overall Study|Participant withdrew consent|2|||
160484089|NCT01524887|579499239|FG000|Overall Study|Withdrawal by Subject|6|||
160484090|NCT01524887|579499240|FG001|Overall Study|Withdrawal by Subject|2|||
160484091|NCT01524887|579499241|FG002|Overall Study|Withdrawal by Subject|3|||
160484092|NCT01524887|579499239|FG000|Overall Study|Adverse Event|5|||
160484093|NCT01524887|579499240|FG001|Overall Study|Adverse Event|1|||
160484094|NCT01524887|579499241|FG002|Overall Study|Adverse Event|1|||
160484095|NCT01524887|579499239|FG000|Overall Study|Protocol Violation|0|||
160484096|NCT01524887|579499240|FG001|Overall Study|Protocol Violation|0|||
160484097|NCT01524887|579499241|FG002|Overall Study|Protocol Violation|1|||
160484098|NCT01524887|579499239|FG000|Overall Study|Study termination|73|||
160484099|NCT01524887|579499240|FG001|Overall Study|Study termination|87|||
160484100|NCT01524887|579499241|FG002|Overall Study|Study termination|79|||
160484101|NCT01524887|579499239|FG000|Overall Study|Withdrawal by Caregiver|0|||
160484102|NCT01524887|579499240|FG001|Overall Study|Withdrawal by Caregiver|0|||
160484103|NCT01524887|579499241|FG002|Overall Study|Withdrawal by Caregiver|2|||
160484104|NCT01524887|579499239|FG000|Overall Study|Use of prohibited medication|1|||
160484105|NCT01524887|579499240|FG001|Overall Study|Use of prohibited medication|0|||
160484106|NCT01524887|579499241|FG002|Overall Study|Use of prohibited medication|0|||
160484107|NCT01808144|579499244|FG000|Overall Study|Death|1|||
160484108|NCT01808144|579499245|FG001|Overall Study|Death|0|||
160484109|NCT01808144|579499244|FG000|Overall Study|Withdrawal by Subject|16|||
160484110|NCT01808144|579499245|FG001|Overall Study|Withdrawal by Subject|23|||
160484111|NCT01808144|579499244|FG000|Overall Study|Lost to Follow-up|6|||
160484112|NCT01808144|579499245|FG001|Overall Study|Lost to Follow-up|3|||
160484113|NCT01808144|579499244|FG000|Overall Study|Protocol Violation|6|||
160484114|NCT01808144|579499245|FG001|Overall Study|Protocol Violation|6|||
160484115|NCT01808144|579499244|FG000|Overall Study|Gout flare|0|||
160484116|NCT01808144|579499245|FG001|Overall Study|Gout flare|1|||
160484117|NCT01808144|579499244|FG000|Overall Study|Adverse Event|11|||
160484118|NCT01808144|579499245|FG001|Overall Study|Adverse Event|15|||
160484119|NCT00733226|579500856|FG000|Overall Study|Withdrawal by Subject|1|||
160484120|NCT00733226|579500857|FG001|Overall Study|Withdrawal by Subject|0|||
160484121|NCT00733226|579500856|FG000|Overall Study|Lost to Follow-up|2|||
160484122|NCT00733226|579500857|FG001|Overall Study|Lost to Follow-up|0|||
160484123|NCT00733226|579500856|FG000|Overall Study|moved to another place|2|||
160484124|NCT00733226|579500857|FG001|Overall Study|moved to another place|0|||
160484125|NCT03511378|579500858|FG000|Overall Study|Withdrawal by Subject|2|||
160484126|NCT03511378|579500859|FG001|Overall Study|Withdrawal by Subject|2|||
160484127|NCT03511378|579500858|FG000|Overall Study|Patient not coming or schedule visit|1|||
160484128|NCT03511378|579500859|FG001|Overall Study|Patient not coming or schedule visit|0|||
160484129|NCT01350102|579500862|FG000|Overall Study|Adverse Event|0|||
160606327|NCT01291511|579937353|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
160606328|NCT01291511|579937354|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
160484130|NCT01350102|579500863|FG001|Overall Study|Adverse Event|0|||
160484131|NCT01350102|579500864|FG002|Overall Study|Adverse Event|1|||
160484132|NCT01350102|579500865|FG003|Overall Study|Adverse Event|0|||
160484133|NCT03022578|579500869|FG000|Overall Study|Adverse Event|1|||
160484134|NCT03022578|579500869|FG000|Overall Study|Lack of Efficacy|2|||
160484135|NCT03022578|579500869|FG000|Overall Study|Withdrawal by Subject|1|||
160484136|NCT03681353|579500870|FG000|Overall Study|Lost to Follow-up|2|||
160484137|NCT03681353|579500870|FG000|Overall Study|Withdrawal by Subject|3|||
160484138|NCT03681353|579500870|FG000|Overall Study|withdrawn by PI|2|||
160484139|NCT00805285|579500877|FG000|Overall Study|Lack of Efficacy|1|||
160484140|NCT00917462|579500878|FG000|Overall Study|Clinical Deterioration|1|||
160484141|NCT03341312|579500882|FG000|Period 1|Withdrawal by Subject|0|||
160484142|NCT03341312|579500883|FG001|Period 1|Withdrawal by Subject|1|||
160484143|NCT03341312|579500884|FG002|Period 1|Withdrawal by Subject|0|||
160484144|NCT03341312|579500885|FG003|Period 1|Withdrawal by Subject|0|||
160484145|NCT00839306|579500886|FG000|Overall Study|Adverse Event|3|||
160484146|NCT00839306|579500887|FG001|Overall Study|Adverse Event|5|||
160484147|NCT00839306|579500886|FG000|Overall Study|Lost to Follow-up|6|||
160484148|NCT00839306|579500887|FG001|Overall Study|Lost to Follow-up|9|||
160484149|NCT00839306|579500886|FG000|Overall Study|Withdrawal by Subject|5|||
160484150|NCT00839306|579500887|FG001|Overall Study|Withdrawal by Subject|7|||
160484151|NCT00839306|579500886|FG000|Overall Study|Lack of Efficacy|5|||
160484152|NCT00839306|579500887|FG001|Overall Study|Lack of Efficacy|4|||
160484153|NCT00839306|579500886|FG000|Overall Study|Other|6|||
160484154|NCT00839306|579500887|FG001|Overall Study|Other|18|||
160484155|NCT01812707|579500888|FG000|Overall Study|Adverse Event|0|||
160484156|NCT01812707|579500889|FG001|Overall Study|Adverse Event|0|||
160484157|NCT01812707|579500890|FG002|Overall Study|Adverse Event|0|||
160484158|NCT01812707|579500891|FG003|Overall Study|Adverse Event|2|||
160484159|NCT01812707|579500888|FG000|Overall Study|Poor compliance to protocol|1|||
160484160|NCT01812707|579500889|FG001|Overall Study|Poor compliance to protocol|0|||
160484161|NCT01812707|579500890|FG002|Overall Study|Poor compliance to protocol|0|||
160484162|NCT01812707|579500891|FG003|Overall Study|Poor compliance to protocol|0|||
160484163|NCT01812707|579500888|FG000|Overall Study|Consent withdrawn by participant|1|||
160484164|NCT01812707|579500889|FG001|Overall Study|Consent withdrawn by participant|0|||
160484165|NCT01812707|579500890|FG002|Overall Study|Consent withdrawn by participant|0|||
160484166|NCT01812707|579500891|FG003|Overall Study|Consent withdrawn by participant|0|||
160484167|NCT05060237|579500893|FG000|Overall Study|Withdrawal by Subject|4|||
160484168|NCT05060237|579500893|FG000|Overall Study|Screening failure|8|||
160484169|NCT01066897|579500894|FG000|Overall Study|Withdrawal by Subject|1|||
160484170|NCT01066897|579500895|FG001|Overall Study|Withdrawal by Subject|0|||
160484171|NCT01066897|579500894|FG000|Overall Study|stopped study after developing the flu.|1|||
160484172|NCT01066897|579500895|FG001|Overall Study|stopped study after developing the flu.|0|||
160484173|NCT01697592|579500898|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
160484174|NCT01697592|579500899|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
160484175|NCT01697592|579500900|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
160484176|NCT01697592|579500901|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
160484177|NCT01697592|579500902|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
160632866|NCT01393626|580036097|FG003|Overall Study|Adverse Event|0|||
160484178|NCT01697592|579500903|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
160484179|NCT01697592|579500904|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
160484180|NCT01697592|579500905|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
160484181|NCT01697592|579500906|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
160484182|NCT01697592|579500907|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
160484183|NCT01697592|579500898|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160484184|NCT01697592|579500899|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160484185|NCT01697592|579500900|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160484186|NCT01697592|579500901|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160484187|NCT01697592|579500902|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160484188|NCT01697592|579500903|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
160484189|NCT01697592|579500904|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160484190|NCT01697592|579500905|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160484191|NCT01697592|579500906|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160484192|NCT01697592|579500907|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160484193|NCT01697592|579500898|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
160484194|NCT01697592|579500899|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160484195|NCT01697592|579500900|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160484196|NCT01697592|579500901|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160484197|NCT01697592|579500902|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160484198|NCT01697592|579500903|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160484199|NCT01697592|579500904|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160484200|NCT01697592|579500905|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160484201|NCT01697592|579500906|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160484202|NCT01697592|579500907|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160484203|NCT01697592|579500898|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
160484204|NCT01697592|579500899|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
160484205|NCT01697592|579500900|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
160484206|NCT01697592|579500901|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
160484207|NCT01697592|579500902|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
160484208|NCT01697592|579500903|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
160484209|NCT01697592|579500904|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
160484210|NCT01697592|579500905|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
160484211|NCT01697592|579500906|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
160484212|NCT01697592|579500907|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
160484213|NCT01697592|579500898|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
160484214|NCT01697592|579500899|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
160484215|NCT01697592|579500900|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
160484216|NCT01697592|579500901|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
160484217|NCT01697592|579500902|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
160484218|NCT01697592|579500903|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
160484219|NCT01697592|579500904|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
160484220|NCT01697592|579500905|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
160484221|NCT01697592|579500906|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
160484222|NCT01697592|579500907|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
160484223|NCT01697592|579500898|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
160484224|NCT01697592|579500899|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
160484225|NCT01697592|579500900|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
160484226|NCT01697592|579500901|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
160484227|NCT01697592|579500902|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
160484228|NCT01697592|579500903|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
160484229|NCT01697592|579500904|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
160484230|NCT01697592|579500905|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
160484231|NCT01697592|579500906|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
160484232|NCT01697592|579500907|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
160484233|NCT01697592|579500898|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
160484234|NCT01697592|579500899|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
160484235|NCT01697592|579500900|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
160484236|NCT01697592|579500901|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
160484237|NCT01697592|579500902|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
160484238|NCT01697592|579500903|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
160484239|NCT01697592|579500904|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
160484240|NCT01697592|579500905|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
160484241|NCT01697592|579500906|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
160484242|NCT01697592|579500907|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
160484243|NCT01697592|579500898|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
160484244|NCT01697592|579500899|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
160484245|NCT01697592|579500900|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
160484246|NCT01697592|579500901|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
160484247|NCT01697592|579500902|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
160606329|NCT01291511|579937353|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
160606330|NCT01291511|579937354|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
160484248|NCT01697592|579500903|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
160484249|NCT01697592|579500904|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
160484250|NCT01697592|579500905|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
160484251|NCT01697592|579500906|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
160484252|NCT01697592|579500907|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
160484253|NCT02396758|579500908|FG000|Overall Study|Withdrawal by Subject|2|||
160484254|NCT02396758|579500909|FG001|Overall Study|Withdrawal by Subject|0|||
160484255|NCT02396758|579500910|FG002|Overall Study|Withdrawal by Subject|0|||
160484256|NCT02396758|579500911|FG003|Overall Study|Withdrawal by Subject|1|||
160484257|NCT02396758|579500908|FG000|Overall Study|Lost to Follow-up|8|||
160484258|NCT02396758|579500909|FG001|Overall Study|Lost to Follow-up|5|||
160484259|NCT02396758|579500910|FG002|Overall Study|Lost to Follow-up|3|||
160484260|NCT02396758|579500911|FG003|Overall Study|Lost to Follow-up|3|||
160484261|NCT02396758|579500908|FG000|Overall Study|Death|1|||
160484262|NCT02396758|579500909|FG001|Overall Study|Death|1|||
160484263|NCT02396758|579500910|FG002|Overall Study|Death|0|||
160484264|NCT02396758|579500911|FG003|Overall Study|Death|1|||
160484265|NCT02396758|579500908|FG000|Overall Study|Randomized but not treated|1|||
160484266|NCT02396758|579500909|FG001|Overall Study|Randomized but not treated|0|||
160484267|NCT02396758|579500910|FG002|Overall Study|Randomized but not treated|1|||
160484268|NCT02396758|579500911|FG003|Overall Study|Randomized but not treated|0|||
160484269|NCT01631825|579500912|FG000|Overall Study|Adverse Event|42|||
160484270|NCT01631825|579500912|FG000|Overall Study|Lack of Efficacy|7|||
160484271|NCT01631825|579500912|FG000|Overall Study|Withdrawal by Subject|9|||
160484272|NCT01631825|579500912|FG000|Overall Study|Protocol Violation|4|||
160484273|NCT01631825|579500912|FG000|Overall Study|Discontinuation criteria|1|||
160484274|NCT01631825|579500912|FG000|Overall Study|Physician Decision|2|||
160484275|NCT02110225|579500913|FG000|Overall Study|Lost to Follow-up|0|||
160484276|NCT02110225|579500914|FG001|Overall Study|Lost to Follow-up|1|||
160484277|NCT02110225|579500915|FG002|Overall Study|Lost to Follow-up|0|||
160484278|NCT00265096|579500916|FG000|Overall Study|Adverse Event|14|||
160484279|NCT00265096|579500917|FG001|Overall Study|Adverse Event|18|||
160484280|NCT00265096|579500918|FG002|Overall Study|Adverse Event|18|||
160484281|NCT00265096|579500916|FG000|Overall Study|Lost to Follow-up|2|||
160484282|NCT00265096|579500917|FG001|Overall Study|Lost to Follow-up|5|||
160484283|NCT00265096|579500918|FG002|Overall Study|Lost to Follow-up|3|||
160484284|NCT00265096|579500916|FG000|Overall Study|Death|0|||
160484285|NCT00265096|579500917|FG001|Overall Study|Death|1|||
160484286|NCT00265096|579500918|FG002|Overall Study|Death|2|||
160484287|NCT00265096|579500916|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
160484288|NCT00265096|579500917|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
160484289|NCT00265096|579500918|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
160484290|NCT00265096|579500916|FG000|Overall Study|Other|11|||
160484291|NCT00265096|579500917|FG001|Overall Study|Other|19|||
160484292|NCT00265096|579500918|FG002|Overall Study|Other|10|||
160484293|NCT01116440|579500919|FG000|Treatment|Withdrawal by Subject|2|||
160484294|NCT01116440|579500920|FG001|Treatment|Withdrawal by Subject|2|||
160484295|NCT01116440|579500919|FG000|Treatment|Lost to Follow-up|1|||
160484296|NCT01116440|579500920|FG001|Treatment|Lost to Follow-up|1|||
160484297|NCT01116440|579500919|FG000|Treatment|Protocol Violation|0|||
160484298|NCT01116440|579500920|FG001|Treatment|Protocol Violation|2|||
160484299|NCT01116440|579500919|FG000|Treatment|Lack of Efficacy|0|||
160484300|NCT01116440|579500920|FG001|Treatment|Lack of Efficacy|1|||
160484301|NCT01116440|579500919|FG000|Treatment|Adverse Event|0|||
160484302|NCT01116440|579500920|FG001|Treatment|Adverse Event|1|||
160484303|NCT01116440|579500919|FG000|Withdrawal|Withdrawal by Subject|0|||
160484304|NCT01116440|579500920|FG001|Withdrawal|Withdrawal by Subject|1|||
160484305|NCT01116440|579500919|FG000|Withdrawal|Lost to Follow-up|0|||
160484306|NCT01116440|579500920|FG001|Withdrawal|Lost to Follow-up|1|||
160484307|NCT01116440|579500919|FG000|Follow-up|Lost to Follow-up|0|||
160484308|NCT01116440|579500920|FG001|Follow-up|Lost to Follow-up|1|||
160484309|NCT01116440|579500919|FG000|Follow-up|Withdrawal by Subject|0|||
160484310|NCT01116440|579500920|FG001|Follow-up|Withdrawal by Subject|1|||
160484311|NCT00774306|579500921|FG000|Overall Study|Adverse Event|3|||
160484312|NCT00774306|579500922|FG001|Overall Study|Adverse Event|0|||
160484313|NCT00774306|579500923|FG002|Overall Study|Adverse Event|0|||
160484314|NCT00774306|579500924|FG003|Overall Study|Adverse Event|0|||
160484315|NCT00774306|579500921|FG000|Overall Study|Protocol Violation|2|||
160484316|NCT00774306|579500922|FG001|Overall Study|Protocol Violation|0|||
160484317|NCT00774306|579500923|FG002|Overall Study|Protocol Violation|3|||
160484318|NCT00774306|579500924|FG003|Overall Study|Protocol Violation|0|||
160484319|NCT00774306|579500921|FG000|Overall Study|Withdrawal by Subject|6|||
160484320|NCT00774306|579500922|FG001|Overall Study|Withdrawal by Subject|1|||
160484321|NCT00774306|579500923|FG002|Overall Study|Withdrawal by Subject|1|||
160484322|NCT00774306|579500924|FG003|Overall Study|Withdrawal by Subject|0|||
160484323|NCT00774306|579500921|FG000|Overall Study|Lost to Follow-up|6|||
160484324|NCT00774306|579500922|FG001|Overall Study|Lost to Follow-up|0|||
160484325|NCT00774306|579500923|FG002|Overall Study|Lost to Follow-up|4|||
160484326|NCT00774306|579500924|FG003|Overall Study|Lost to Follow-up|5|||
160484327|NCT00774306|579500921|FG000|Overall Study|Death|1|||
160484328|NCT00774306|579500922|FG001|Overall Study|Death|1|||
160484329|NCT00774306|579500923|FG002|Overall Study|Death|0|||
160484330|NCT00774306|579500924|FG003|Overall Study|Death|0|||
160484331|NCT03568708|579500930|FG000|Overall Study|Withdrawal by Subject|1|||
160484332|NCT03568708|579500931|FG001|Overall Study|Withdrawal by Subject|1|||
160484333|NCT03568708|579500930|FG000|Overall Study|Lost to Follow-up|0|||
160484334|NCT03568708|579500931|FG001|Overall Study|Lost to Follow-up|1|||
160484335|NCT01126879|579500932|FG000|Overall Study|Progressive Disease|3|||
160661035|NCT02457520|580141739|FG000|Active Treatment Phase|Physician Decision|1|||
160661036|NCT02457520|580141739|FG000|Active Treatment Phase|Protocol Violation|1|||
160484336|NCT01126879|579500933|FG001|Overall Study|Progressive Disease|1|||
160484337|NCT01126879|579500932|FG000|Overall Study|Withdrawal by Subject|1|||
160484338|NCT01126879|579500933|FG001|Overall Study|Withdrawal by Subject|0|||
160484339|NCT01126879|579500932|FG000|Overall Study|Adverse Event|0|||
160484340|NCT01126879|579500933|FG001|Overall Study|Adverse Event|1|||
160484341|NCT01126879|579500932|FG000|Overall Study|Physician Decision|1|||
160484342|NCT01126879|579500933|FG001|Overall Study|Physician Decision|0|||
160484343|NCT00666835|579500934|FG000|Overall Study|Withdrawal by Subject|5|||
160484344|NCT00666835|579500935|FG001|Overall Study|Withdrawal by Subject|2|||
160484345|NCT00666835|579500934|FG000|Overall Study|Lack of Efficacy|0|||
160484346|NCT00666835|579500935|FG001|Overall Study|Lack of Efficacy|1|||
160484347|NCT00666835|579500934|FG000|Overall Study|Incl./excl. not fulfilled|7|||
160484348|NCT00666835|579500935|FG001|Overall Study|Incl./excl. not fulfilled|2|||
160484349|NCT00666835|579500934|FG000|Overall Study|Adverse Event|7|||
160661037|NCT02457520|580141739|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
160661038|NCT02457520|580141739|FG000|Post-treatment Period|Other: Retreatment Required|7|||
160661039|NCT02457520|580141739|FG000|Post-treatment Period|Lost to Follow-up|23|||
160484350|NCT00666835|579500935|FG001|Overall Study|Adverse Event|6|||
160484351|NCT00666835|579500934|FG000|Overall Study|Protocol Violation|2|||
160484352|NCT00666835|579500935|FG001|Overall Study|Protocol Violation|0|||
160484353|NCT00666835|579500934|FG000|Overall Study|Death|15|||
160484354|NCT00666835|579500935|FG001|Overall Study|Death|4|||
160484355|NCT00666835|579500934|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
160484356|NCT00666835|579500935|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
160484357|NCT00666835|579500934|FG000|Overall Study|Hemoglobulin concentration|4|||
160484358|NCT00666835|579500935|FG001|Overall Study|Hemoglobulin concentration|3|||
160484359|NCT00666835|579500934|FG000|Overall Study|Planned operation|2|||
160484360|NCT00666835|579500935|FG001|Overall Study|Planned operation|0|||
160484361|NCT00666835|579500934|FG000|Overall Study|Physician Decision|1|||
160484362|NCT00666835|579500935|FG001|Overall Study|Physician Decision|2|||
160484363|NCT00511147|579500938|FG000|Overall Study|Withdrawal by Subject|1|||
160484364|NCT00511147|579500938|FG000|Overall Study|Disease progression|5|||
160484365|NCT00511147|579500938|FG000|Overall Study|Required platelet transfusion|1|||
160484366|NCT00899379|579500939|FG000|Overall Study|Adverse Event|2|||
160484367|NCT00899379|579500940|FG001|Overall Study|Adverse Event|2|||
160484368|NCT00899379|579500941|FG002|Overall Study|Adverse Event|1|||
160484369|NCT00899379|579500942|FG003|Overall Study|Adverse Event|1|||
160484370|NCT00899379|579500943|FG004|Overall Study|Adverse Event|2|||
160484371|NCT00899379|579500939|FG000|Overall Study|Lack of Efficacy|0|||
160484372|NCT00899379|579500940|FG001|Overall Study|Lack of Efficacy|4|||
160484373|NCT00899379|579500941|FG002|Overall Study|Lack of Efficacy|3|||
160484374|NCT00899379|579500942|FG003|Overall Study|Lack of Efficacy|0|||
160484375|NCT00899379|579500943|FG004|Overall Study|Lack of Efficacy|1|||
160484376|NCT00899379|579500939|FG000|Overall Study|Lost to Follow-up|9|||
160484377|NCT00899379|579500940|FG001|Overall Study|Lost to Follow-up|3|||
160484378|NCT00899379|579500941|FG002|Overall Study|Lost to Follow-up|0|||
160484379|NCT00899379|579500942|FG003|Overall Study|Lost to Follow-up|6|||
160484380|NCT00899379|579500943|FG004|Overall Study|Lost to Follow-up|2|||
160484381|NCT00899379|579500939|FG000|Overall Study|Protocol Violation|0|||
160484382|NCT00899379|579500940|FG001|Overall Study|Protocol Violation|0|||
160484383|NCT00899379|579500941|FG002|Overall Study|Protocol Violation|1|||
160484384|NCT00899379|579500942|FG003|Overall Study|Protocol Violation|1|||
160484385|NCT00899379|579500943|FG004|Overall Study|Protocol Violation|0|||
160484386|NCT00899379|579500939|FG000|Overall Study|Withdrawal by Subject|2|||
160484387|NCT00899379|579500940|FG001|Overall Study|Withdrawal by Subject|4|||
160484388|NCT00899379|579500941|FG002|Overall Study|Withdrawal by Subject|2|||
160484389|NCT00899379|579500942|FG003|Overall Study|Withdrawal by Subject|3|||
160484390|NCT00899379|579500943|FG004|Overall Study|Withdrawal by Subject|6|||
160484391|NCT00899379|579500939|FG000|Overall Study|Pregnancy|0|||
160484392|NCT00899379|579500940|FG001|Overall Study|Pregnancy|0|||
160484393|NCT00899379|579500941|FG002|Overall Study|Pregnancy|1|||
160484394|NCT00899379|579500942|FG003|Overall Study|Pregnancy|0|||
160484395|NCT00899379|579500943|FG004|Overall Study|Pregnancy|1|||
160484396|NCT00899379|579500939|FG000|Overall Study|Patient Uncooperative|0|||
160484397|NCT00899379|579500940|FG001|Overall Study|Patient Uncooperative|1|||
160484398|NCT00899379|579500941|FG002|Overall Study|Patient Uncooperative|0|||
160484399|NCT00899379|579500942|FG003|Overall Study|Patient Uncooperative|1|||
160484400|NCT00899379|579500943|FG004|Overall Study|Patient Uncooperative|2|||
160484401|NCT00899379|579500939|FG000|Overall Study|Abnormal Baseline ECG|0|||
160484402|NCT00899379|579500940|FG001|Overall Study|Abnormal Baseline ECG|0|||
160484403|NCT00899379|579500941|FG002|Overall Study|Abnormal Baseline ECG|0|||
160484404|NCT00899379|579500942|FG003|Overall Study|Abnormal Baseline ECG|1|||
160484405|NCT00899379|579500943|FG004|Overall Study|Abnormal Baseline ECG|0|||
160484406|NCT00899379|579500939|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
160484407|NCT00899379|579500940|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
160484408|NCT00899379|579500941|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
160484409|NCT00899379|579500942|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
160484410|NCT00899379|579500943|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
160484411|NCT00899379|579500939|FG000|Overall Study|Not Completed/Entered Extn|5|||
160484412|NCT00899379|579500940|FG001|Overall Study|Not Completed/Entered Extn|1|||
160484413|NCT00899379|579500941|FG002|Overall Study|Not Completed/Entered Extn|6|||
160484414|NCT00899379|579500942|FG003|Overall Study|Not Completed/Entered Extn|4|||
160484415|NCT00899379|579500943|FG004|Overall Study|Not Completed/Entered Extn|3|||
160484416|NCT00899379|579500939|FG000|Overall Study|Study Terminated|3|||
160484417|NCT00899379|579500940|FG001|Overall Study|Study Terminated|0|||
160484418|NCT00899379|579500941|FG002|Overall Study|Study Terminated|3|||
160484419|NCT00899379|579500942|FG003|Overall Study|Study Terminated|3|||
160484420|NCT00899379|579500943|FG004|Overall Study|Study Terminated|1|||
160484421|NCT00899379|579500939|FG000|Overall Study|Lost to Follow-up|3|||
160484422|NCT00899379|579500940|FG001|Overall Study|Lost to Follow-up|1|||
160484423|NCT00899379|579500941|FG002|Overall Study|Lost to Follow-up|0|||
160606331|NCT01291511|579937353|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
160484424|NCT00899379|579500942|FG003|Overall Study|Lost to Follow-up|2|||
160484425|NCT00899379|579500943|FG004|Overall Study|Lost to Follow-up|5|||
160484426|NCT00899379|579500939|FG000|Overall Study|Withdrawal by Subject|4|||
160484427|NCT00899379|579500940|FG001|Overall Study|Withdrawal by Subject|7|||
160606332|NCT01291511|579937354|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
160484428|NCT00899379|579500941|FG002|Overall Study|Withdrawal by Subject|4|||
160484429|NCT00899379|579500942|FG003|Overall Study|Withdrawal by Subject|7|||
160484430|NCT00899379|579500943|FG004|Overall Study|Withdrawal by Subject|2|||
160484431|NCT00899379|579500939|FG000|Overall Study|Pregnancy|1|||
160484432|NCT00899379|579500940|FG001|Overall Study|Pregnancy|0|||
160484433|NCT00899379|579500941|FG002|Overall Study|Pregnancy|0|||
160484434|NCT00899379|579500942|FG003|Overall Study|Pregnancy|0|||
160484435|NCT00899379|579500943|FG004|Overall Study|Pregnancy|0|||
160484436|NCT00899379|579500939|FG000|Overall Study|Patient Uncooperative|0|||
160484437|NCT00899379|579500940|FG001|Overall Study|Patient Uncooperative|0|||
160484438|NCT00899379|579500941|FG002|Overall Study|Patient Uncooperative|0|||
160484439|NCT00899379|579500942|FG003|Overall Study|Patient Uncooperative|1|||
160484440|NCT00899379|579500943|FG004|Overall Study|Patient Uncooperative|0|||
160484441|NCT00899379|579500939|FG000|Overall Study|Abnormal Prestudy Labs|0|||
160484442|NCT00899379|579500940|FG001|Overall Study|Abnormal Prestudy Labs|0|||
160484443|NCT00899379|579500941|FG002|Overall Study|Abnormal Prestudy Labs|0|||
160484444|NCT00899379|579500942|FG003|Overall Study|Abnormal Prestudy Labs|0|||
160484445|NCT00899379|579500943|FG004|Overall Study|Abnormal Prestudy Labs|2|||
160484446|NCT00899379|579500939|FG000|Overall Study|Abnormal Baseline ECG|0|||
160484447|NCT00899379|579500940|FG001|Overall Study|Abnormal Baseline ECG|0|||
160484448|NCT00899379|579500941|FG002|Overall Study|Abnormal Baseline ECG|1|||
160484449|NCT00899379|579500942|FG003|Overall Study|Abnormal Baseline ECG|1|||
160484450|NCT00899379|579500943|FG004|Overall Study|Abnormal Baseline ECG|0|||
160484451|NCT00899379|579500939|FG000|Overall Study|No Attack Pretreatment|3|||
160484452|NCT00899379|579500940|FG001|Overall Study|No Attack Pretreatment|5|||
160484453|NCT00899379|579500941|FG002|Overall Study|No Attack Pretreatment|5|||
160484454|NCT00899379|579500942|FG003|Overall Study|No Attack Pretreatment|6|||
160484455|NCT00899379|579500943|FG004|Overall Study|No Attack Pretreatment|4|||
160484456|NCT00899379|579500939|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
160484457|NCT00899379|579500940|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
160484458|NCT00899379|579500941|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
160484459|NCT00899379|579500942|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
160484460|NCT00899379|579500943|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
160484461|NCT00899379|579500939|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
160484462|NCT00899379|579500940|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
160484463|NCT00899379|579500941|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
160484464|NCT00899379|579500942|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
160484465|NCT00899379|579500943|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
160484466|NCT00809783|579500946|FG000|Overall Study|Death|1|||
160484467|NCT00809783|579500947|FG001|Overall Study|Death|0|||
160484468|NCT00809783|579500948|FG002|Overall Study|Death|0|||
160484469|NCT00809783|579500946|FG000|Overall Study|Adverse Event|34|||
160484470|NCT00809783|579500947|FG001|Overall Study|Adverse Event|52|||
160484471|NCT00809783|579500948|FG002|Overall Study|Adverse Event|71|||
160484472|NCT00809783|579500946|FG000|Overall Study|Lack of Efficacy|39|||
160484473|NCT00809783|579500947|FG001|Overall Study|Lack of Efficacy|52|||
160484474|NCT00809783|579500948|FG002|Overall Study|Lack of Efficacy|63|||
160484475|NCT00809783|579500946|FG000|Overall Study|Lost to Follow-up|0|||
160484476|NCT00809783|579500947|FG001|Overall Study|Lost to Follow-up|3|||
160484477|NCT00809783|579500948|FG002|Overall Study|Lost to Follow-up|4|||
160484478|NCT00809783|579500946|FG000|Overall Study|Withdrawal by Subject|47|||
160484479|NCT00809783|579500947|FG001|Overall Study|Withdrawal by Subject|72|||
160484480|NCT00809783|579500948|FG002|Overall Study|Withdrawal by Subject|64|||
160484481|NCT00809783|579500946|FG000|Overall Study|Protocol Violation|2|||
160484482|NCT00809783|579500947|FG001|Overall Study|Protocol Violation|6|||
160484483|NCT00809783|579500948|FG002|Overall Study|Protocol Violation|5|||
160484484|NCT00809783|579500946|FG000|Overall Study|Randomized, but not treated|3|||
160484485|NCT00809783|579500947|FG001|Overall Study|Randomized, but not treated|0|||
160484486|NCT00809783|579500948|FG002|Overall Study|Randomized, but not treated|2|||
160484487|NCT00809783|579500946|FG000|Overall Study|Study Terminated by Sponsor|378|||
160484488|NCT00809783|579500947|FG001|Overall Study|Study Terminated by Sponsor|626|||
160484489|NCT00809783|579500948|FG002|Overall Study|Study Terminated by Sponsor|565|||
160484490|NCT00809783|579500946|FG000|Overall Study|Other|21|||
160484491|NCT00809783|579500947|FG001|Overall Study|Other|21|||
160484492|NCT00809783|579500948|FG002|Overall Study|Other|16|||
160484493|NCT00126555|579500949|FG000|Overall Study|Withdrawal by Subject|1|||
160484494|NCT00126555|579500949|FG000|Overall Study|Adverse Event|2|||
160661040|NCT02457520|580141739|FG000|Post-treatment Period|Other|3|||
160661041|NCT02457520|580141739|FG000|Post-treatment Period|Physician Decision|1|||
160661042|NCT02457520|580141739|FG000|Post-treatment Period|Withdrawal by Subject|14|||
160661043|NCT02511782|580141742|FG000|Overall Study|Withdrawal by Subject|1|||
160484495|NCT00126555|579500949|FG000|Overall Study|Progressive Disease|3|||
160484496|NCT01780545|579500956|FG000|Overall Study|Withdrawal by Subject|3|||
160484497|NCT01780545|579500957|FG001|Overall Study|Withdrawal by Subject|1|||
160484498|NCT01780545|579500956|FG000|Overall Study|Lost to Follow-up|1|||
160484499|NCT01780545|579500957|FG001|Overall Study|Lost to Follow-up|1|||
160484500|NCT03441789|579500958|FG000|Overall Study|Withdrawal by Subject|1|||
160484501|NCT03441789|579500959|FG001|Overall Study|Withdrawal by Subject|1|||
160484502|NCT03441789|579500958|FG000|Overall Study|Adverse Event|0|||
160484503|NCT03441789|579500959|FG001|Overall Study|Adverse Event|1|||
160484504|NCT03441789|579500958|FG000|Overall Study|Protocol Violation|0|||
160484505|NCT03441789|579500959|FG001|Overall Study|Protocol Violation|1|||
160484506|NCT03441789|579500958|FG000|Overall Study|Lost to Follow-up|0|||
160484507|NCT03441789|579500959|FG001|Overall Study|Lost to Follow-up|1|||
160484508|NCT02581189|579500964|FG000|Overall Study|Failure to return|36|||
160484509|NCT02581189|579500964|FG000|Overall Study|Withdrew consent|5|||
160484510|NCT02581189|579500964|FG000|Overall Study|Death|3|||
160484511|NCT02581189|579500964|FG000|Overall Study|Insufficient virological response|2|||
160484512|NCT02581189|579500964|FG000|Overall Study|Other, not specified|7|||
160484513|NCT01514864|579500969|FG000|Overall Study|Disease progression|7|||
160484514|NCT01514864|579500970|FG001|Overall Study|Disease progression|5|||
160484515|NCT01514864|579500969|FG000|Overall Study|Study drug toxicity|2|||
160484516|NCT01514864|579500970|FG001|Overall Study|Study drug toxicity|0|||
160484517|NCT02254681|579500978|FG000|Overall Study|Lack of Efficacy|6|||
160484518|NCT00396097|579500979|FG000|Overall Study|Withdrawal by Subject|17|||
160484519|NCT00396097|579500980|FG001|Overall Study|Withdrawal by Subject|17|||
160484520|NCT00396097|579500979|FG000|Overall Study|Lost to Follow-up|4|||
160484521|NCT00396097|579500980|FG001|Overall Study|Lost to Follow-up|9|||
160484522|NCT00396097|579500979|FG000|Overall Study|Other|3|||
160484523|NCT00396097|579500980|FG001|Overall Study|Other|5|||
160484524|NCT00396097|579500979|FG000|Overall Study|Protocol Violation|0|||
160484525|NCT00396097|579500980|FG001|Overall Study|Protocol Violation|6|||
160484526|NCT00396097|579500979|FG000|Overall Study|Adverse Event|1|||
160484527|NCT00396097|579500980|FG001|Overall Study|Adverse Event|5|||
160484528|NCT00396097|579500979|FG000|Overall Study|Insufficient Clinical Response|1|||
160484529|NCT00396097|579500980|FG001|Overall Study|Insufficient Clinical Response|4|||
160484530|NCT03461211|579500981|FG000|Overall Study|Adverse Event|1|||
160484531|NCT03461211|579500982|FG001|Overall Study|Adverse Event|1|||
160484532|NCT03461211|579500981|FG000|Overall Study|Lack of Efficacy|0|||
160606333|NCT01291511|579937353|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
160606334|NCT01291511|579937354|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
160484533|NCT03461211|579500982|FG001|Overall Study|Lack of Efficacy|1|||
160484534|NCT02316847|579500984|FG000|Overall Study|Adverse Event|0|||
160484535|NCT02316847|579500985|FG001|Overall Study|Adverse Event|3|||
160484536|NCT02316847|579500984|FG000|Overall Study|Lost to Follow-up|0|||
160484537|NCT02316847|579500985|FG001|Overall Study|Lost to Follow-up|2|||
160484538|NCT02316847|579500984|FG000|Overall Study|Physician Decision|0|||
160484539|NCT02316847|579500985|FG001|Overall Study|Physician Decision|1|||
160484540|NCT02316847|579500984|FG000|Overall Study|Pregnancy|0|||
160484541|NCT02316847|579500985|FG001|Overall Study|Pregnancy|1|||
160484542|NCT02316847|579500984|FG000|Overall Study|Withdrawal by Subject|2|||
160484543|NCT02316847|579500985|FG001|Overall Study|Withdrawal by Subject|9|||
160484544|NCT02316847|579500984|FG000|Overall Study|Noncompliance with study drug|0|||
160484545|NCT02316847|579500985|FG001|Overall Study|Noncompliance with study drug|3|||
160484546|NCT02316847|579500984|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
160484547|NCT02316847|579500985|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
160484548|NCT01370018|579500986|FG000|Overall Study|Did not meet criteria for analysis|1|||
160484549|NCT02204319|579500987|FG000|Overall Study|Pregnancy|1|||
160484550|NCT02204319|579500987|FG000|Overall Study|Withdrawal by Subject|2|||
160484551|NCT03746483|579500988|FG000|Overall Study|Adverse Event|0|||
160484552|NCT03746483|579500989|FG001|Overall Study|Adverse Event|1|||
160484553|NCT03746483|579500988|FG000|Overall Study|Lack of Efficacy|3|||
160484554|NCT03746483|579500989|FG001|Overall Study|Lack of Efficacy|2|||
160484555|NCT03746483|579500988|FG000|Overall Study|Lost to Follow-up|1|||
160484556|NCT03746483|579500989|FG001|Overall Study|Lost to Follow-up|0|||
160484557|NCT03746483|579500988|FG000|Overall Study|Protocol Violation|2|||
160484558|NCT03746483|579500989|FG001|Overall Study|Protocol Violation|0|||
160484559|NCT02116582|579500990|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
160484560|NCT02116582|579500990|FG000|Overall Study|Adverse Event|22|||
160484561|NCT02116582|579500990|FG000|Overall Study|Death|9|||
160484562|NCT02116582|579500990|FG000|Overall Study|Progressive Disease|148|||
160484563|NCT02116582|579500990|FG000|Overall Study|Protocol Violation|3|||
160484564|NCT02116582|579500990|FG000|Overall Study|Withdrawal by Subject|8|||
160484565|NCT02116582|579500990|FG000|Overall Study|Other: Miscellaneous|11|||
160484566|NCT02116582|579500990|FG000|Overall Study|Lost to Follow-up|1|||
160484567|NCT02116582|579500990|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
160484568|NCT03356145|579500991|FG000|Overall Study|Withdrawal by Subject|2|||
160484569|NCT03356145|579500992|FG001|Overall Study|Withdrawal by Subject|1|||
160484570|NCT03356145|579500991|FG000|Overall Study|Did not meet inclusion criteria|1|||
160484571|NCT03356145|579500992|FG001|Overall Study|Did not meet inclusion criteria|0|||
160484572|NCT00985621|579500995|FG000|Overall Study|Adverse Event|2|||
160484573|NCT00985621|579500996|FG001|Overall Study|Adverse Event|3|||
160484574|NCT00985621|579500997|FG002|Overall Study|Adverse Event|4|||
160484575|NCT00985621|579500998|FG003|Overall Study|Adverse Event|16|||
160484576|NCT00985621|579500995|FG000|Overall Study|Lack of Efficacy|10|||
160484577|NCT00985621|579500996|FG001|Overall Study|Lack of Efficacy|6|||
160484578|NCT00985621|579500997|FG002|Overall Study|Lack of Efficacy|5|||
160484579|NCT00985621|579500998|FG003|Overall Study|Lack of Efficacy|12|||
160484580|NCT00985621|579500995|FG000|Overall Study|Lost to Follow-up|2|||
160484581|NCT00985621|579500996|FG001|Overall Study|Lost to Follow-up|3|||
160484582|NCT00985621|579500997|FG002|Overall Study|Lost to Follow-up|4|||
160606335|NCT01291511|579937353|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
160606336|NCT01291511|579937354|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
160606337|NCT01291511|579937353|FG000|Double-blind Relapse Prevention Phase|Death|1|||
160606338|NCT01291511|579937354|FG001|Double-blind Relapse Prevention Phase|Death|0|||
160606339|NCT00047008|579937356|FG000|Overall Study|Withdrawn consent|2|||
160606340|NCT00047008|579937357|FG001|Overall Study|Withdrawn consent|3|||
160606341|NCT00047008|579937356|FG000|Overall Study|Ineligible|9|||
160606342|NCT00047008|579937357|FG001|Overall Study|Ineligible|8|||
160606343|NCT00429572|579937358|FG000|Overall Study|Disease progression|1|||
160606344|NCT02773368|579937361|FG000|Overall Study|Lost to Follow-up|4|||
160606345|NCT02773368|579937362|FG001|Overall Study|Lost to Follow-up|1|||
160606346|NCT02773368|579937361|FG000|Overall Study|Withdrawal by Subject|5|||
160606347|NCT02773368|579937362|FG001|Overall Study|Withdrawal by Subject|1|||
160606348|NCT02773368|579937361|FG000|Overall Study|Unclassified|1|||
160606349|NCT02773368|579937362|FG001|Overall Study|Unclassified|1|||
160606350|NCT02773368|579937361|FG000|Overall Study|Missing|0|||
160606351|NCT02773368|579937362|FG001|Overall Study|Missing|1|||
160606352|NCT01929018|579937363|FG000|Overall Study|Lost to Follow-up|1|||
160606353|NCT01929018|579937364|FG001|Overall Study|Lost to Follow-up|0|||
160606354|NCT01929018|579937363|FG000|Overall Study|Hospitalization|0|||
160606355|NCT01929018|579937364|FG001|Overall Study|Hospitalization|1|||
160606356|NCT01047436|579937366|FG000|Overall Study|Protocol Violation|1|||
160606357|NCT01047436|579937367|FG001|Overall Study|Protocol Violation|0|||
160606358|NCT02635867|579937370|FG000|Overall Study|Lost to Follow-up|4|||
160606359|NCT02635867|579937371|FG001|Overall Study|Lost to Follow-up|3|||
160606360|NCT02635867|579937372|FG002|Overall Study|Lost to Follow-up|3|||
160484583|NCT00985621|579500998|FG003|Overall Study|Lost to Follow-up|4|||
160484584|NCT00985621|579500995|FG000|Overall Study|Study Terminated by Sponsor|89|||
160484585|NCT00985621|579500996|FG001|Overall Study|Study Terminated by Sponsor|108|||
160484586|NCT00985621|579500997|FG002|Overall Study|Study Terminated by Sponsor|99|||
160484587|NCT00985621|579500998|FG003|Overall Study|Study Terminated by Sponsor|92|||
160484588|NCT00985621|579500995|FG000|Overall Study|Protocol Violation|1|||
160484589|NCT00985621|579500996|FG001|Overall Study|Protocol Violation|1|||
160484590|NCT00985621|579500997|FG002|Overall Study|Protocol Violation|1|||
160484591|NCT00985621|579500998|FG003|Overall Study|Protocol Violation|0|||
160484592|NCT00985621|579500995|FG000|Overall Study|Withdrawal by Subject|8|||
160484593|NCT00985621|579500996|FG001|Overall Study|Withdrawal by Subject|10|||
160484594|NCT00985621|579500997|FG002|Overall Study|Withdrawal by Subject|8|||
160484595|NCT00985621|579500998|FG003|Overall Study|Withdrawal by Subject|12|||
160484596|NCT00985621|579500995|FG000|Overall Study|Other|1|||
160484597|NCT00985621|579500996|FG001|Overall Study|Other|0|||
160484598|NCT00985621|579500997|FG002|Overall Study|Other|0|||
160606361|NCT02635867|579937373|FG003|Overall Study|Lost to Follow-up|4|||
160484599|NCT00985621|579500998|FG003|Overall Study|Other|0|||
160484600|NCT00985621|579500995|FG000|Overall Study|Randomized but not Treated|1|||
160484601|NCT00985621|579500996|FG001|Overall Study|Randomized but not Treated|0|||
160484602|NCT00985621|579500997|FG002|Overall Study|Randomized but not Treated|2|||
160484603|NCT00985621|579500998|FG003|Overall Study|Randomized but not Treated|1|||
160484604|NCT01774929|579501002|FG000|Overall Study|Adverse Event|3|||
160484605|NCT00714688|579501011|FG000|Overall Study|Lack of Efficacy|14|||
160484606|NCT00714688|579501012|FG001|Overall Study|Lack of Efficacy|1|||
160484607|NCT00714688|579501013|FG002|Overall Study|Lack of Efficacy|4|||
160484608|NCT00714688|579501011|FG000|Overall Study|Withdrawal by Subject|4|||
160484609|NCT00714688|579501012|FG001|Overall Study|Withdrawal by Subject|3|||
160484610|NCT00714688|579501013|FG002|Overall Study|Withdrawal by Subject|3|||
160484611|NCT00714688|579501011|FG000|Overall Study|Lost to Follow-up|5|||
160484612|NCT00714688|579501012|FG001|Overall Study|Lost to Follow-up|2|||
160484613|NCT00714688|579501013|FG002|Overall Study|Lost to Follow-up|0|||
160484614|NCT00714688|579501011|FG000|Overall Study|Adverse Event|2|||
160484615|NCT00714688|579501012|FG001|Overall Study|Adverse Event|15|||
160484616|NCT00714688|579501013|FG002|Overall Study|Adverse Event|19|||
160484617|NCT00714688|579501011|FG000|Overall Study|Subject Non-compliant|3|||
160484618|NCT00714688|579501012|FG001|Overall Study|Subject Non-compliant|5|||
160484619|NCT00714688|579501013|FG002|Overall Study|Subject Non-compliant|5|||
160484620|NCT00714688|579501011|FG000|Overall Study|Ineligible to Continue the Study|0|||
160484621|NCT00714688|579501012|FG001|Overall Study|Ineligible to Continue the Study|1|||
160484622|NCT00714688|579501013|FG002|Overall Study|Ineligible to Continue the Study|1|||
160484623|NCT00714688|579501011|FG000|Overall Study|Sponsor's Decision|0|||
160484624|NCT00714688|579501012|FG001|Overall Study|Sponsor's Decision|2|||
160484625|NCT00714688|579501013|FG002|Overall Study|Sponsor's Decision|0|||
160484626|NCT00714688|579501011|FG000|Overall Study|Other|1|||
160484627|NCT00714688|579501012|FG001|Overall Study|Other|6|||
160484628|NCT00714688|579501013|FG002|Overall Study|Other|5|||
160484629|NCT00500539|579501014|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
160484630|NCT00500539|579501014|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
160484631|NCT00500539|579501014|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
160484632|NCT00500539|579501014|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
160484633|NCT00500539|579501014|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
160484634|NCT00500539|579501014|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
160484635|NCT00500539|579501014|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
160484636|NCT00500539|579501014|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
160484637|NCT00500539|579501014|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
160484638|NCT00500539|579501014|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
160484639|NCT00500539|579501014|FG000|Follow-up Period (16 Weeks)|Death|1|||
160484640|NCT00500539|579501014|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
160484641|NCT00500539|579501014|FG000|Follow-up Period (16 Weeks)|Missing|3|||
160484642|NCT04853394|579501015|FG000|Follow-up Interviews|Lost to Follow-up|22|||
160484643|NCT04853394|579501016|FG001|Follow-up Interviews|Lost to Follow-up|15|||
160484644|NCT03993054|579501019|FG000|Overall Study|PI Decision|1|||
160484645|NCT00383500|579501020|FG000|Overall Study|Withdrawal by Subject|8|||
160484646|NCT00383500|579501021|FG001|Overall Study|Withdrawal by Subject|3|||
160484647|NCT00383500|579501022|FG002|Overall Study|Withdrawal by Subject|0|||
160484648|NCT00383500|579501020|FG000|Overall Study|Lost to Follow-up|0|||
160484649|NCT00383500|579501021|FG001|Overall Study|Lost to Follow-up|0|||
160484650|NCT00383500|579501022|FG002|Overall Study|Lost to Follow-up|2|||
160606362|NCT02635867|579937374|FG004|Overall Study|Lost to Follow-up|1|||
160606363|NCT02565576|579937377|FG000|Overall Study|abnormal lab value|2|||
160606364|NCT02565576|579937378|FG001|Overall Study|abnormal lab value|0|||
160606365|NCT02565576|579937377|FG000|Overall Study|subject / guardian decision|1|||
160606366|NCT02565576|579937378|FG001|Overall Study|subject / guardian decision|3|||
160606367|NCT02565576|579937377|FG000|Overall Study|Lost to Follow-up|1|||
160484651|NCT00961896|579502750|FG000|Overall Study|Abnormal laboratory value|0|||
160484652|NCT00961896|579502751|FG001|Overall Study|Abnormal laboratory value|0|||
160484653|NCT00961896|579502752|FG002|Overall Study|Abnormal laboratory value|1|||
160484654|NCT01983462|579502753|FG000|Overall Study|Adverse Event|1|||
160484655|NCT01983462|579502754|FG001|Overall Study|Adverse Event|0|||
160484656|NCT01983462|579502755|FG002|Overall Study|Adverse Event|0|||
160484657|NCT00755716|579502756|FG000|Overall Study|Adverse Event|1|||
160484658|NCT00755716|579502757|FG001|Overall Study|Adverse Event|4|||
160484659|NCT00755716|579502758|FG002|Overall Study|Adverse Event|1|||
160484660|NCT00755716|579502756|FG000|Overall Study|Lack of Efficacy|2|||
160484661|NCT00755716|579502757|FG001|Overall Study|Lack of Efficacy|0|||
160484662|NCT00755716|579502758|FG002|Overall Study|Lack of Efficacy|0|||
160484663|NCT00755716|579502756|FG000|Overall Study|Lost to Follow-up|5|||
160484664|NCT00755716|579502757|FG001|Overall Study|Lost to Follow-up|3|||
160484665|NCT00755716|579502758|FG002|Overall Study|Lost to Follow-up|1|||
160484666|NCT00755716|579502756|FG000|Overall Study|work schedule issues|0|||
160484667|NCT00755716|579502757|FG001|Overall Study|work schedule issues|1|||
160484668|NCT00755716|579502758|FG002|Overall Study|work schedule issues|1|||
160606368|NCT02565576|579937378|FG001|Overall Study|Lost to Follow-up|0|||
160484669|NCT02229396|579502760|FG000|Overall Study|Adverse Event|6|||
160484670|NCT02229396|579502761|FG001|Overall Study|Adverse Event|12|||
160484671|NCT02229396|579502762|FG002|Overall Study|Adverse Event|12|||
160484672|NCT02229396|579502760|FG000|Overall Study|Death|2|||
160484673|NCT02229396|579502761|FG001|Overall Study|Death|3|||
160484674|NCT02229396|579502762|FG002|Overall Study|Death|1|||
160484675|NCT02229396|579502760|FG000|Overall Study|Lost to Follow-up|14|||
160484676|NCT02229396|579502761|FG001|Overall Study|Lost to Follow-up|14|||
160484677|NCT02229396|579502762|FG002|Overall Study|Lost to Follow-up|21|||
160484678|NCT02229396|579502760|FG000|Overall Study|Protocol Violation|2|||
160484679|NCT02229396|579502761|FG001|Overall Study|Protocol Violation|1|||
160484680|NCT02229396|579502762|FG002|Overall Study|Protocol Violation|0|||
160484681|NCT02229396|579502760|FG000|Overall Study|Patient Incorrectly Randomized|0|||
160484682|NCT02229396|579502761|FG001|Overall Study|Patient Incorrectly Randomized|0|||
160484683|NCT02229396|579502762|FG002|Overall Study|Patient Incorrectly Randomized|1|||
160484684|NCT02229396|579502760|FG000|Overall Study|Other|10|||
160484685|NCT02229396|579502761|FG001|Overall Study|Other|18|||
160484686|NCT02229396|579502762|FG002|Overall Study|Other|15|||
160484687|NCT02229396|579502760|FG000|Overall Study|Withdrawal by Subject|42|||
160484688|NCT02229396|579502761|FG001|Overall Study|Withdrawal by Subject|28|||
160484689|NCT02229396|579502762|FG002|Overall Study|Withdrawal by Subject|41|||
160484690|NCT02229396|579502760|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
160484691|NCT02229396|579502761|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
160484692|NCT02229396|579502762|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
160484693|NCT02229396|579502760|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
160484694|NCT02229396|579502761|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
160484695|NCT02229396|579502762|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
160484696|NCT02679079|579502763|FG000|Overall Study|Adverse Event|2|||
160484697|NCT02679079|579502764|FG001|Overall Study|Adverse Event|0|||
160484698|NCT02679079|579502765|FG002|Overall Study|Adverse Event|2|||
160484699|NCT02679079|579502763|FG000|Overall Study|Protocol Violation|0|||
160484700|NCT02679079|579502764|FG001|Overall Study|Protocol Violation|1|||
160484701|NCT02679079|579502765|FG002|Overall Study|Protocol Violation|0|||
160484702|NCT02679079|579502763|FG000|Overall Study|Withdrawal by Subject|2|||
160484703|NCT02679079|579502764|FG001|Overall Study|Withdrawal by Subject|1|||
160484704|NCT02679079|579502765|FG002|Overall Study|Withdrawal by Subject|0|||
160484705|NCT02005029|579502766|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
160484706|NCT02005029|579502767|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
160484707|NCT02621047|579502768|FG000|Overall Study|Adverse Event|0|||
160484708|NCT02621047|579502769|FG001|Overall Study|Adverse Event|0|||
160484709|NCT02621047|579502770|FG002|Overall Study|Adverse Event|1|||
160484710|NCT01525641|579502773|FG000|Overall Study|Case report form not collected|25|||
160484711|NCT01525641|579502773|FG000|Overall Study|No visit since the first visit|16|||
160484712|NCT01525641|579502773|FG000|Overall Study|Adverse Event|73|||
160484713|NCT01525641|579502773|FG000|Overall Study|Lack of Efficacy|24|||
160484714|NCT01525641|579502773|FG000|Overall Study|Improvement|5|||
160484715|NCT01525641|579502773|FG000|Overall Study|Lost to follow-up (relocation)|1|||
160484716|NCT01525641|579502773|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
160484717|NCT01525641|579502773|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
160484718|NCT01525641|579502773|FG000|Overall Study|Other than stated above|7|||
160484719|NCT03772041|579502774|FG000|Overall Study|Adverse Event|8|||
160484720|NCT03772041|579502775|FG001|Overall Study|Adverse Event|3|||
160484721|NCT03772041|579502774|FG000|Overall Study|Withdrawal by Subject|0|||
160484722|NCT03772041|579502775|FG001|Overall Study|Withdrawal by Subject|2|||
160484723|NCT03772041|579502774|FG000|Overall Study|Protocol Violation|4|||
160484724|NCT03772041|579502775|FG001|Overall Study|Protocol Violation|2|||
160484725|NCT03772041|579502774|FG000|Overall Study|Physician Decision|2|||
160484726|NCT03772041|579502775|FG001|Overall Study|Physician Decision|3|||
160484727|NCT03371485|579502776|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
160484728|NCT03371485|579502776|FG000|2-year Follow-up|Death|5|||
160484729|NCT02853305|579502777|FG000|Overall Study|Death|287|||
160484730|NCT02853305|579502778|FG001|Overall Study|Death|249|||
160484731|NCT02853305|579502779|FG002|Overall Study|Death|300|||
160484732|NCT02853305|579502777|FG000|Overall Study|Withdrawal by Subject|2|||
160484733|NCT02853305|579502778|FG001|Overall Study|Withdrawal by Subject|8|||
160484734|NCT02853305|579502779|FG002|Overall Study|Withdrawal by Subject|3|||
160606369|NCT02565576|579937377|FG000|Overall Study|Death|0|||
160484735|NCT02853305|579502777|FG000|Overall Study|Transferred to Extension Study|46|||
160484736|NCT02853305|579502778|FG001|Overall Study|Transferred to Extension Study|30|||
160606370|NCT02565576|579937378|FG001|Overall Study|Death|2|||
160484737|NCT02853305|579502779|FG002|Overall Study|Transferred to Extension Study|25|||
160484738|NCT02853305|579502777|FG000|Overall Study|Did Not Continue on Extension Study|16|||
160484739|NCT02853305|579502778|FG001|Overall Study|Did Not Continue on Extension Study|20|||
160484740|NCT02853305|579502779|FG002|Overall Study|Did Not Continue on Extension Study|24|||
160484741|NCT01836198|579502780|FG000|Part A, Period 2|Protocol Violation|0|||
160484742|NCT01836198|579502781|FG001|Part A, Period 2|Protocol Violation|1|||
160484743|NCT01836198|579502782|FG002|Part A, Period 2|Protocol Violation|0|||
160484744|NCT00588341|579502787|FG000|Overall Study|Withdrawal by Subject|3|||
160484745|NCT00588341|579502787|FG000|Overall Study|Not treated due to metastatic disease|1|||
160484746|NCT00588341|579502787|FG000|Overall Study|Patient ineligible|1|||
160484747|NCT02642159|579502788|FG000|Overall Study|Randomized but not treated|1|||
160484748|NCT02642159|579502789|FG001|Overall Study|Randomized but not treated|0|||
160484749|NCT02642159|579502788|FG000|Overall Study|Adverse Event|10|||
160484750|NCT02642159|579502789|FG001|Overall Study|Adverse Event|4|||
160484751|NCT02642159|579502788|FG000|Overall Study|Withdrawal by Subject|9|||
160484752|NCT02642159|579502789|FG001|Overall Study|Withdrawal by Subject|1|||
160484753|NCT02642159|579502788|FG000|Overall Study|Poor compliance to study protocol|1|||
160484754|NCT02642159|579502789|FG001|Overall Study|Poor compliance to study protocol|0|||
160484755|NCT02642159|579502788|FG000|Overall Study|Other than specified above|10|||
160484756|NCT02642159|579502789|FG001|Overall Study|Other than specified above|3|||
160484757|NCT01924806|579502792|FG000|Overall Study|Physician Decision|2|||
160484758|NCT01924806|579502793|FG001|Overall Study|Physician Decision|1|||
160484759|NCT01954771|579502794|FG000|Overall Study|Missing HbA1c of end-point|1|||
160484760|NCT01954771|579502795|FG001|Overall Study|Missing HbA1c of end-point|1|||
160484761|NCT01954771|579502796|FG002|Overall Study|Missing HbA1c of end-point|0|||
160484762|NCT01954771|579502794|FG000|Overall Study|Missing CGMS of end-point|1|||
160484763|NCT01954771|579502795|FG001|Overall Study|Missing CGMS of end-point|1|||
160484764|NCT01954771|579502796|FG002|Overall Study|Missing CGMS of end-point|0|||
160484765|NCT01954771|579502794|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
160484766|NCT01954771|579502795|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
160484767|NCT01954771|579502796|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
160484768|NCT03635775|579502800|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
160484769|NCT03635775|579502801|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
160484770|NCT03635775|579502802|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
160484771|NCT03635775|579502803|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
160484772|NCT01026103|579502804|FG000|Overall Study|Physician Decision|1|||
160484773|NCT01026103|579502804|FG000|Overall Study|did not receive study device bc of error|1|||
160484774|NCT02498418|579502806|FG000|Overall Study|Lack of Efficacy|0|||
160484775|NCT02498418|579502807|FG001|Overall Study|Lack of Efficacy|0|||
160484776|NCT02498418|579502808|FG002|Overall Study|Lack of Efficacy|1|||
160484777|NCT02498418|579502806|FG000|Overall Study|Withdrawal by Subject|2|||
160484778|NCT02498418|579502807|FG001|Overall Study|Withdrawal by Subject|0|||
160484779|NCT02498418|579502808|FG002|Overall Study|Withdrawal by Subject|3|||
160484780|NCT02498418|579502806|FG000|Overall Study|Lost to Follow-up|0|||
160484781|NCT02498418|579502807|FG001|Overall Study|Lost to Follow-up|1|||
160484782|NCT02498418|579502808|FG002|Overall Study|Lost to Follow-up|1|||
160484783|NCT02498418|579502806|FG000|Overall Study|Participant taken prohibited medication|0|||
160484784|NCT02498418|579502807|FG001|Overall Study|Participant taken prohibited medication|1|||
160484785|NCT02498418|579502808|FG002|Overall Study|Participant taken prohibited medication|1|||
160484786|NCT00762502|579502809|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
160484787|NCT00762502|579502810|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
160484788|NCT00762502|579502811|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
160484789|NCT00762502|579502809|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
160484790|NCT00762502|579502810|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
160661044|NCT02511782|580141743|FG001|Overall Study|Withdrawal by Subject|0|||
160661045|NCT02511782|580141744|FG002|Overall Study|Withdrawal by Subject|0|||
160661046|NCT00579670|580141745|FG000|Overall Study|Death|1|||
160661047|NCT00579670|580141746|FG001|Overall Study|Death|0|||
160661048|NCT00579670|580141747|FG002|Overall Study|Death|0|||
160661049|NCT00579670|580141748|FG003|Overall Study|Death|0|||
160661050|NCT00579670|580141749|FG004|Overall Study|Death|0|||
160484791|NCT00762502|579502811|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
160484792|NCT00762502|579502809|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
160484793|NCT00762502|579502810|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
160484794|NCT00762502|579502811|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
160484795|NCT01187407|579502815|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
160484796|NCT01187407|579502816|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160484797|NCT01187407|579502817|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160484798|NCT01187407|579502818|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160484799|NCT01187407|579502819|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160484800|NCT01187407|579502815|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
160484801|NCT01187407|579502816|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160484802|NCT01187407|579502817|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160484803|NCT01187407|579502818|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160484804|NCT01187407|579502819|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160484805|NCT01187407|579502815|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
160484806|NCT01187407|579502816|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160484807|NCT01187407|579502817|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160661051|NCT00579670|580141745|FG000|Overall Study|Adverse Event|1|||
160484808|NCT01187407|579502818|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160484809|NCT01187407|579502819|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160484810|NCT01187407|579502815|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
160484811|NCT01187407|579502816|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160484812|NCT01187407|579502817|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160484813|NCT01187407|579502818|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160484814|NCT01187407|579502819|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160484815|NCT01187407|579502815|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
160484816|NCT01187407|579502816|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160484817|NCT01187407|579502817|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160484818|NCT01187407|579502818|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160484819|NCT01187407|579502819|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160484820|NCT01187407|579502815|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
160484821|NCT01187407|579502816|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160484822|NCT01187407|579502817|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160484823|NCT01187407|579502818|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160484824|NCT01187407|579502819|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160484825|NCT01187407|579502815|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
160484826|NCT01187407|579502816|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160484827|NCT01187407|579502817|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160484828|NCT01187407|579502818|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160484829|NCT01187407|579502819|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160484830|NCT01187407|579502815|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
160484831|NCT01187407|579502816|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
160484832|NCT01187407|579502817|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
160484833|NCT01187407|579502818|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
160484834|NCT01187407|579502819|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
160484835|NCT01187407|579502815|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
160484836|NCT01187407|579502816|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
160484837|NCT01187407|579502817|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
160484838|NCT01187407|579502818|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
160484839|NCT01187407|579502819|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
160484840|NCT01187407|579502815|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
160484841|NCT01187407|579502816|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
160484842|NCT01187407|579502817|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
160484843|NCT01187407|579502818|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
160484844|NCT01187407|579502819|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
160484845|NCT01187407|579502815|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
160484846|NCT01187407|579502816|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
160484847|NCT01187407|579502817|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
160484848|NCT01187407|579502818|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
160484849|NCT01187407|579502819|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
160484850|NCT01187407|579502815|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
160484851|NCT01187407|579502816|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
160484852|NCT01187407|579502817|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
160484853|NCT01187407|579502818|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
160484854|NCT01187407|579502819|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
160484855|NCT01187407|579502815|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
160484856|NCT01187407|579502816|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
160484857|NCT01187407|579502817|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
160484858|NCT01187407|579502818|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
160484859|NCT01187407|579502819|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
160484860|NCT01187407|579502815|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
160484861|NCT01187407|579502816|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
160484862|NCT01187407|579502817|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
160484863|NCT01187407|579502818|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
160484864|NCT01187407|579502819|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
160484865|NCT02382406|579502822|FG000|Study Treatment|Disease Progression|8|||
160484866|NCT02382406|579502823|FG001|Study Treatment|Disease Progression|0|||
160484867|NCT02382406|579502824|FG002|Study Treatment|Disease Progression|20|||
160484868|NCT02382406|579502822|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
160484869|NCT02382406|579502823|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
160484870|NCT02382406|579502824|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
160484871|NCT02382406|579502822|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
160484872|NCT02382406|579502823|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
160484873|NCT02382406|579502824|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
160484874|NCT02382406|579502822|FG000|Study Treatment|symptomatic deterioration|1|||
160484875|NCT02382406|579502823|FG001|Study Treatment|symptomatic deterioration|0|||
160484876|NCT02382406|579502824|FG002|Study Treatment|symptomatic deterioration|1|||
160484877|NCT02382406|579502822|FG000|Study Treatment|Death|0|||
160484878|NCT02382406|579502823|FG001|Study Treatment|Death|0|||
160484879|NCT02382406|579502824|FG002|Study Treatment|Death|2|||
160484880|NCT02382406|579502822|FG000|Follow up|Death|11|||
160484881|NCT02382406|579502823|FG001|Follow up|Death|0|||
160484882|NCT02382406|579502824|FG002|Follow up|Death|19|||
160484883|NCT02382406|579502822|FG000|Follow up|Symptomatic deterioration|1|||
160484884|NCT02382406|579502823|FG001|Follow up|Symptomatic deterioration|0|||
160484885|NCT02382406|579502824|FG002|Follow up|Symptomatic deterioration|1|||
160484886|NCT02382406|579502822|FG000|Follow up|Patient Refused Follow-up|1|||
160484887|NCT02382406|579502823|FG001|Follow up|Patient Refused Follow-up|0|||
160484888|NCT02382406|579502824|FG002|Follow up|Patient Refused Follow-up|0|||
160484889|NCT02382406|579502822|FG000|Follow up|Study Terminated|1|||
160484890|NCT02382406|579502823|FG001|Follow up|Study Terminated|0|||
160484891|NCT02382406|579502824|FG002|Follow up|Study Terminated|8|||
160484892|NCT02382406|579502822|FG000|Follow up|Withdrawal by Subject|0|||
160484893|NCT02382406|579502823|FG001|Follow up|Withdrawal by Subject|0|||
160484894|NCT02382406|579502824|FG002|Follow up|Withdrawal by Subject|2|||
160484895|NCT01713998|579502825|FG000|Overall Study|Lost to Follow-up|2|||
160484896|NCT01713998|579502826|FG001|Overall Study|Lost to Follow-up|0|||
160484897|NCT01713998|579502827|FG002|Overall Study|Lost to Follow-up|2|||
160484898|NCT01713998|579502825|FG000|Overall Study|Withdrawal by Subject|1|||
160484899|NCT01713998|579502826|FG001|Overall Study|Withdrawal by Subject|0|||
160484900|NCT01713998|579502827|FG002|Overall Study|Withdrawal by Subject|0|||
160484901|NCT02588027|579502851|FG000|Overall Study|Withdrawal by Subject|1|||
160484902|NCT02588027|579502852|FG001|Overall Study|Withdrawal by Subject|3|||
160484903|NCT02588027|579502851|FG000|Overall Study|Protocol Violation|4|||
160484904|NCT02588027|579502852|FG001|Overall Study|Protocol Violation|1|||
160484905|NCT00853021|579502856|FG000|Overall Study|Adverse Event|2|||
160484906|NCT00853021|579502856|FG000|Overall Study|Withdrawal by Subject|2|||
160484907|NCT00853021|579502856|FG000|Overall Study|Death|1|||
160484908|NCT02864147|579502857|FG000|Overall Study|Withdrawal by Subject|3|||
160484909|NCT02864147|579502858|FG001|Overall Study|Withdrawal by Subject|2|||
160484910|NCT02864147|579502859|FG002|Overall Study|Withdrawal by Subject|1|||
160484911|NCT02864147|579502857|FG000|Overall Study|Lost to Follow-up|0|||
160484912|NCT02864147|579502858|FG001|Overall Study|Lost to Follow-up|4|||
160484913|NCT02864147|579502859|FG002|Overall Study|Lost to Follow-up|0|||
160484914|NCT02864147|579502857|FG000|Overall Study|Adverse Event|0|||
160484915|NCT02864147|579502858|FG001|Overall Study|Adverse Event|1|||
160484916|NCT02864147|579502859|FG002|Overall Study|Adverse Event|0|||
160484917|NCT02864147|579502857|FG000|Overall Study|Pregnancy|4|||
160484918|NCT02864147|579502858|FG001|Overall Study|Pregnancy|0|||
160484919|NCT02864147|579502859|FG002|Overall Study|Pregnancy|0|||
160484920|NCT02864147|579502857|FG000|Overall Study|Physician Decision|0|||
160484921|NCT02864147|579502858|FG001|Overall Study|Physician Decision|0|||
160484922|NCT02864147|579502859|FG002|Overall Study|Physician Decision|1|||
160484923|NCT02864147|579502857|FG000|Overall Study|Opted for excisional procedures|0|||
160484924|NCT02864147|579502858|FG001|Overall Study|Opted for excisional procedures|0|||
160484925|NCT02864147|579502859|FG002|Overall Study|Opted for excisional procedures|3|||
160484926|NCT02269917|579502860|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
160484927|NCT02269917|579502861|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
160484928|NCT02269917|579502862|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
160484929|NCT02269917|579502860|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
160484930|NCT02269917|579502861|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
160484931|NCT02269917|579502862|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
160484932|NCT02269917|579502860|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
160484933|NCT02269917|579502861|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
160484934|NCT02269917|579502862|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
160484935|NCT02269917|579502860|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
160484936|NCT02269917|579502861|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
160484937|NCT02269917|579502862|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
160484938|NCT02269917|579502860|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
160484939|NCT02269917|579502861|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
160484940|NCT02269917|579502862|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
160484941|NCT02269917|579502860|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
160484942|NCT02269917|579502861|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
160484943|NCT02269917|579502862|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
160484944|NCT02269917|579502860|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
160484945|NCT02269917|579502861|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
160484946|NCT02269917|579502862|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
160484947|NCT02269917|579502860|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
160484948|NCT02269917|579502861|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
160484949|NCT02269917|579502862|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
160484950|NCT02269917|579502860|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
160484951|NCT02269917|579502861|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
160484952|NCT02269917|579502862|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
160484953|NCT02269917|579502860|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
160484954|NCT02269917|579502861|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
160484955|NCT02269917|579502862|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
160484956|NCT02269917|579502860|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
160484957|NCT02269917|579502861|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
160484958|NCT02269917|579502862|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
160484959|NCT02269917|579502860|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
160484960|NCT02269917|579502861|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
160484961|NCT02269917|579502862|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
160484962|NCT02269917|579502860|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
160484963|NCT02269917|579502861|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
160484964|NCT02269917|579502862|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
160484965|NCT02269917|579502860|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
160484966|NCT02269917|579502861|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
160484967|NCT02269917|579502862|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
160484968|NCT02269917|579502860|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
160484969|NCT02269917|579502861|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
160484970|NCT02269917|579502862|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
160484971|NCT02269917|579502860|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
160484972|NCT02269917|579502861|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
160484973|NCT02269917|579502862|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
160484974|NCT01770509|579502863|FG000|Overall Study|Injury|0|||
160484975|NCT01770509|579502864|FG001|Overall Study|Injury|1|||
160484976|NCT01770509|579502863|FG000|Overall Study|Lost to Follow-up|1|||
160484977|NCT01770509|579502864|FG001|Overall Study|Lost to Follow-up|2|||
160484978|NCT02865135|579502868|FG000|Overall Study|Death|0|||
160484979|NCT02865135|579502869|FG001|Overall Study|Death|1|||
160484980|NCT02865135|579502870|FG002|Overall Study|Death|0|||
160484981|NCT02865135|579502868|FG000|Overall Study|Progression|6|||
160484982|NCT02865135|579502869|FG001|Overall Study|Progression|2|||
160484983|NCT02865135|579502870|FG002|Overall Study|Progression|2|||
160484984|NCT04394624|579502871|FG000|Overall Study|Adverse Event|6|||
160484985|NCT04394624|579502872|FG001|Overall Study|Adverse Event|0|||
160484986|NCT04394624|579502871|FG000|Overall Study|Progressive disease|24|||
160484987|NCT04394624|579502872|FG001|Overall Study|Progressive disease|0|||
160484988|NCT04394624|579502871|FG000|Overall Study|Not related to COVID-19|1|||
160484989|NCT04394624|579502872|FG001|Overall Study|Not related to COVID-19|0|||
160484990|NCT00676663|579502873|FG000|Overall Study|Death|43|||
160484991|NCT00676663|579502874|FG001|Overall Study|Death|27|||
160484992|NCT00676663|579502873|FG000|Overall Study|Withdrew Consent|1|||
160484993|NCT00676663|579502874|FG001|Overall Study|Withdrew Consent|8|||
160484994|NCT00676663|579502873|FG000|Overall Study|Lost to Follow-up|1|||
160484995|NCT00676663|579502874|FG001|Overall Study|Lost to Follow-up|3|||
160484996|NCT01123642|579502878|FG000|Overall Study|Lost to Follow-up|23|||
160484997|NCT01123642|579502878|FG000|Overall Study|Withdrawal by Subject|9|||
160484998|NCT01123642|579502878|FG000|Overall Study|ineligible at baseline assessment|36|||
160484999|NCT04853238|579502879|FG000|Overall Study|Death|4|||
160485000|NCT04853238|579502880|FG001|Overall Study|Death|0|||
160485001|NCT04853238|579502881|FG002|Overall Study|Death|2|||
160485002|NCT04853238|579502879|FG000|Overall Study|Lost to Follow-up|16|||
160485003|NCT04853238|579502880|FG001|Overall Study|Lost to Follow-up|2|||
160485004|NCT04853238|579502881|FG002|Overall Study|Lost to Follow-up|37|||
160485005|NCT04853238|579502879|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
160485006|NCT04853238|579502880|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
160485007|NCT04853238|579502881|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
160485008|NCT04853238|579502879|FG000|Overall Study|Withdrawal by Subject|6|||
160485009|NCT04853238|579502880|FG001|Overall Study|Withdrawal by Subject|0|||
160485010|NCT04853238|579502881|FG002|Overall Study|Withdrawal by Subject|21|||
160485011|NCT04853238|579502879|FG000|Overall Study|Physician Decision|0|||
160485012|NCT04853238|579502880|FG001|Overall Study|Physician Decision|0|||
160485013|NCT04853238|579502881|FG002|Overall Study|Physician Decision|2|||
160485014|NCT04853238|579502879|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
160485015|NCT04853238|579502880|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
160485016|NCT04853238|579502881|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
160485017|NCT00957996|579504744|FG000|Overall Study|Death|4|||
160485018|NCT00957996|579504745|FG001|Overall Study|Death|10|||
160485019|NCT00957996|579504744|FG000|Overall Study|Lost to Follow-up|4|||
160485020|NCT00957996|579504745|FG001|Overall Study|Lost to Follow-up|7|||
160606371|NCT02565576|579937377|FG000|Overall Study|Adverse Event|1|||
160661052|NCT00579670|580141746|FG001|Overall Study|Adverse Event|0|||
160661053|NCT00579670|580141747|FG002|Overall Study|Adverse Event|1|||
160661054|NCT00579670|580141748|FG003|Overall Study|Adverse Event|2|||
160661055|NCT00579670|580141749|FG004|Overall Study|Adverse Event|0|||
160485021|NCT00957996|579504744|FG000|Overall Study|Withdrawal by Subject|9|||
160485022|NCT00957996|579504745|FG001|Overall Study|Withdrawal by Subject|2|||
160485023|NCT00957996|579504744|FG000|Overall Study|Adverse Event|2|||
160485024|NCT00957996|579504745|FG001|Overall Study|Adverse Event|1|||
160485025|NCT00957996|579504744|FG000|Overall Study|Physician Decision|1|||
160485026|NCT00957996|579504745|FG001|Overall Study|Physician Decision|1|||
160485027|NCT00957996|579504744|FG000|Overall Study|Influenza-related complication|0|||
160485028|NCT00957996|579504745|FG001|Overall Study|Influenza-related complication|1|||
160485029|NCT00957996|579504744|FG000|Overall Study|Missing|1|||
160485030|NCT00957996|579504745|FG001|Overall Study|Missing|0|||
160485031|NCT00957996|579504744|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
160485032|NCT00957996|579504745|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
160485033|NCT00381797|579504753|FG000|Overall Study|Withdrawal by Subject|1|||
160485034|NCT00381797|579504754|FG001|Overall Study|Withdrawal by Subject|1|||
160485035|NCT00381797|579504755|FG002|Overall Study|Withdrawal by Subject|0|||
160485036|NCT00381797|579504756|FG003|Overall Study|Withdrawal by Subject|0|||
160485037|NCT00381797|579504757|FG004|Overall Study|Withdrawal by Subject|2|||
160485038|NCT00381797|579504753|FG000|Overall Study|Ineligible|0|||
160485039|NCT00381797|579504754|FG001|Overall Study|Ineligible|0|||
160485040|NCT00381797|579504755|FG002|Overall Study|Ineligible|0|||
160485041|NCT00381797|579504756|FG003|Overall Study|Ineligible|1|||
160485042|NCT00381797|579504757|FG004|Overall Study|Ineligible|0|||
160485043|NCT00684203|579504758|FG000|Overall Study|Adverse Event|6|||
160485044|NCT00684203|579504759|FG001|Overall Study|Adverse Event|4|||
160485045|NCT00684203|579504760|FG002|Overall Study|Adverse Event|8|||
160485046|NCT00684203|579504761|FG003|Overall Study|Adverse Event|0|||
160485047|NCT00684203|579504762|FG004|Overall Study|Adverse Event|0|||
160485048|NCT00684203|579504763|FG005|Overall Study|Adverse Event|0|||
160485049|NCT00684203|579504758|FG000|Overall Study|Protocol-defined clinical event|3|||
160485050|NCT00684203|579504759|FG001|Overall Study|Protocol-defined clinical event|1|||
160485051|NCT00684203|579504760|FG002|Overall Study|Protocol-defined clinical event|0|||
160485052|NCT00684203|579504761|FG003|Overall Study|Protocol-defined clinical event|0|||
160485053|NCT00684203|579504762|FG004|Overall Study|Protocol-defined clinical event|0|||
160485054|NCT00684203|579504763|FG005|Overall Study|Protocol-defined clinical event|0|||
160485055|NCT00684203|579504758|FG000|Overall Study|Withdrawal by Subject|0|||
160485056|NCT00684203|579504759|FG001|Overall Study|Withdrawal by Subject|2|||
160485057|NCT00684203|579504760|FG002|Overall Study|Withdrawal by Subject|1|||
160485058|NCT00684203|579504761|FG003|Overall Study|Withdrawal by Subject|0|||
160485059|NCT00684203|579504762|FG004|Overall Study|Withdrawal by Subject|0|||
160485060|NCT00684203|579504763|FG005|Overall Study|Withdrawal by Subject|0|||
160485061|NCT00684203|579504758|FG000|Overall Study|Did not meet protocol eligibility|0|||
160485062|NCT00684203|579504759|FG001|Overall Study|Did not meet protocol eligibility|1|||
160485063|NCT00684203|579504760|FG002|Overall Study|Did not meet protocol eligibility|0|||
160485064|NCT00684203|579504761|FG003|Overall Study|Did not meet protocol eligibility|0|||
160485065|NCT00684203|579504762|FG004|Overall Study|Did not meet protocol eligibility|0|||
160485066|NCT00684203|579504763|FG005|Overall Study|Did not meet protocol eligibility|0|||
160485067|NCT01902381|579504766|FG000|Overall Study|Withdrawal by Subject|1|||
160485068|NCT02762500|579504769|FG000|Overall Study|Lack of Efficacy|1|||
160485069|NCT02762500|579504770|FG001|Overall Study|Lack of Efficacy|0|||
160485070|NCT02762500|579504769|FG000|Overall Study|Withdrawal by Subject|1|||
160485071|NCT02762500|579504770|FG001|Overall Study|Withdrawal by Subject|1|||
160485072|NCT02762500|579504769|FG000|Overall Study|Adverse Event|0|||
160485073|NCT02762500|579504770|FG001|Overall Study|Adverse Event|2|||
160485074|NCT00730847|579504771|FG000|Overall Study|Adverse Event|1|||
160485075|NCT00730847|579504771|FG000|Overall Study|Protocol Violation|2|||
160485076|NCT00730847|579504771|FG000|Overall Study|Withdrawal by Subject|16|||
160485077|NCT00730847|579504771|FG000|Overall Study|Lost to Follow-up|67|||
160485078|NCT00730847|579504771|FG000|Overall Study|Unknown completion status|21|||
160485079|NCT00730847|579504771|FG000|Overall Study|Other|24|||
160485080|NCT00280683|579504772|FG000|Overall Study|Withdrawal by Subject|1|||
160485081|NCT00280683|579504773|FG001|Overall Study|Withdrawal by Subject|2|||
160485082|NCT00280683|579504772|FG000|Overall Study|Adverse Event|1|||
160606372|NCT02565576|579937378|FG001|Overall Study|Adverse Event|0|||
160606373|NCT01266070|579937379|FG000|Overall Study|Adverse Event|3|||
160606374|NCT01266070|579937379|FG000|Overall Study|Protocol Violation|1|||
160606375|NCT00939341|579937380|FG000|Overall Study|Adverse Event|15|||
160606376|NCT00939341|579937380|FG000|Overall Study|Pregnancy|1|||
160485083|NCT00280683|579504773|FG001|Overall Study|Adverse Event|1|||
160485084|NCT01243411|579504774|FG000|Overall Study|Withdrawal by Subject|18|||
160606377|NCT00939341|579937380|FG000|Overall Study|Lost to Follow-up|23|||
160485085|NCT01243411|579504774|FG000|Overall Study|Lost to Follow-up|10|||
160485086|NCT01243411|579504774|FG000|Overall Study|Adverse Event|5|||
160485087|NCT01243411|579504774|FG000|Overall Study|Other|8|||
160485088|NCT03193216|579504778|FG000|Overall Study|Lost to Follow-up|1|||
160485089|NCT03193216|579504779|FG001|Overall Study|Lost to Follow-up|0|||
160485090|NCT03193216|579504778|FG000|Overall Study|Withdrawal by Subject|5|||
160485091|NCT03193216|579504779|FG001|Overall Study|Withdrawal by Subject|0|||
160485092|NCT03193216|579504778|FG000|Overall Study|Physician Decision|4|||
160485093|NCT03193216|579504779|FG001|Overall Study|Physician Decision|0|||
160485094|NCT02490878|579504780|FG000|Overall Study|deemed ineligible|0|||
160485095|NCT02490878|579504781|FG001|Overall Study|deemed ineligible|1|||
160606378|NCT00939341|579937380|FG000|Overall Study|Withdrawal by Subject|13|||
160485096|NCT02490878|579504780|FG000|Overall Study|progression prior to treatment|0|||
160485097|NCT02490878|579504781|FG001|Overall Study|progression prior to treatment|1|||
160485098|NCT02490878|579504780|FG000|Overall Study|only submitted baseline QOL|0|||
160485099|NCT02490878|579504781|FG001|Overall Study|only submitted baseline QOL|1|||
160485100|NCT00317603|579504784|FG000|Overall Study|Progressive Disease|3|||
160485101|NCT00523549|579504785|FG000|Overall Study|Adverse Event|6|||
160485102|NCT00523549|579504786|FG001|Overall Study|Adverse Event|3|||
160485103|NCT00523549|579504785|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160485104|NCT00523549|579504786|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160485105|NCT00523549|579504785|FG000|Overall Study|Protocol Deviation|3|||
160485106|NCT00523549|579504786|FG001|Overall Study|Protocol Deviation|1|||
160485107|NCT00523549|579504785|FG000|Overall Study|Patient withdrew consent|7|||
160485108|NCT00523549|579504786|FG001|Overall Study|Patient withdrew consent|6|||
160485109|NCT00523549|579504785|FG000|Overall Study|Lost to Follow-up|3|||
160485110|NCT00523549|579504786|FG001|Overall Study|Lost to Follow-up|5|||
160485111|NCT00843115|579504787|FG000|Overall Study|Death|4|||
160485112|NCT00843115|579504787|FG000|Overall Study|Adverse Event|30|||
160485113|NCT00843115|579504787|FG000|Overall Study|Lost to Follow-up|4|||
160485114|NCT00843115|579504787|FG000|Overall Study|Withdrawal by Subject|17|||
160485115|NCT00843115|579504787|FG000|Overall Study|Family wanted meds stopped|1|||
160485116|NCT00843115|579504787|FG000|Overall Study|Family does not want continuation|1|||
160485117|NCT00843115|579504787|FG000|Overall Study|Patient forgot to take meds|1|||
160485118|NCT00843115|579504787|FG000|Overall Study|Does not meet entrance criteria|1|||
160485119|NCT00843115|579504787|FG000|Overall Study|Physician Decision|1|||
160485120|NCT00843115|579504787|FG000|Overall Study|Family discontinued meds|1|||
160485121|NCT00843115|579504787|FG000|Overall Study|patient took for 2 days then stopped|1|||
160485122|NCT00843115|579504787|FG000|Overall Study|patient never took the medication|1|||
160485123|NCT00843115|579504787|FG000|Overall Study|hospitalized due to deterioration|1|||
160485124|NCT00843115|579504787|FG000|Overall Study|week 12 not done|1|||
160485125|NCT00843115|579504787|FG000|Overall Study|Syndrome De Glissement|1|||
160485126|NCT01264887|579504794|FG000|Overall Study|Adverse Event|5|||
160485127|NCT01264887|579504794|FG000|Overall Study|Death|7|||
160485128|NCT01264887|579504794|FG000|Overall Study|Lack of Efficacy|5|||
160485129|NCT01264887|579504794|FG000|Overall Study|Physician Decision|4|||
160485130|NCT01264887|579504794|FG000|Overall Study|Withdrawal by Subject|6|||
160485131|NCT01264887|579504794|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
160485132|NCT01264887|579504794|FG000|Overall Study|Other|2|||
160485133|NCT02959177|579504795|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
160485134|NCT02959177|579504796|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
160485135|NCT02959177|579504797|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
160661056|NCT00579670|580141745|FG000|Overall Study|Lack of Efficacy|0|||
160661057|NCT00579670|580141746|FG001|Overall Study|Lack of Efficacy|0|||
160661058|NCT00579670|580141747|FG002|Overall Study|Lack of Efficacy|1|||
160661059|NCT00579670|580141748|FG003|Overall Study|Lack of Efficacy|14|||
160485136|NCT02959177|579504795|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
160485137|NCT02959177|579504796|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
160485138|NCT02959177|579504797|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
160485139|NCT02959177|579504795|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
160485140|NCT02959177|579504796|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
160485141|NCT02959177|579504797|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
160485142|NCT02959177|579504795|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
160485143|NCT02959177|579504796|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
160485144|NCT02959177|579504797|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
160485145|NCT02959177|579504795|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
160485146|NCT02959177|579504796|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
160485147|NCT02959177|579504797|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
160485148|NCT02959177|579504795|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
160485149|NCT02959177|579504796|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
160485150|NCT02959177|579504797|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
160485151|NCT02959177|579504795|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
160485152|NCT02959177|579504796|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
160485153|NCT02959177|579504797|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
160485154|NCT00677092|579504804|FG000|Overall Study|Adverse Event|1|||
160485155|NCT00677092|579504804|FG000|Overall Study|Lost to Follow-up|1|||
160485156|NCT00677092|579504804|FG000|Overall Study|Withdrawal by Subject|3|||
160485157|NCT00677092|579504804|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
160485158|NCT02381652|579504809|FG000|Overall Study|Withdrawal by Subject|0|||
160485159|NCT02381652|579504810|FG001|Overall Study|Withdrawal by Subject|0|||
160485160|NCT02381652|579504811|FG002|Overall Study|Withdrawal by Subject|1|||
160485161|NCT03544229|579504812|FG000|Overall Study|Adverse Event|1|||
160485162|NCT03544229|579504813|FG001|Overall Study|Adverse Event|0|||
160485163|NCT03544229|579504814|FG002|Overall Study|Adverse Event|1|||
160485164|NCT03544229|579504815|FG003|Overall Study|Adverse Event|0|||
160485165|NCT03544229|579504812|FG000|Overall Study|Protocol Deviation|0|||
160485166|NCT03544229|579504813|FG001|Overall Study|Protocol Deviation|0|||
160485167|NCT03544229|579504814|FG002|Overall Study|Protocol Deviation|1|||
160485168|NCT03544229|579504815|FG003|Overall Study|Protocol Deviation|0|||
160485169|NCT03544229|579504812|FG000|Overall Study|Lost to Follow-up|3|||
160485170|NCT03544229|579504813|FG001|Overall Study|Lost to Follow-up|0|||
160485171|NCT03544229|579504814|FG002|Overall Study|Lost to Follow-up|0|||
160485172|NCT03544229|579504815|FG003|Overall Study|Lost to Follow-up|2|||
160485173|NCT03544229|579504812|FG000|Overall Study|Voluntary Withdrawal|2|||
160485174|NCT03544229|579504813|FG001|Overall Study|Voluntary Withdrawal|1|||
160485175|NCT03544229|579504814|FG002|Overall Study|Voluntary Withdrawal|3|||
160485176|NCT03544229|579504815|FG003|Overall Study|Voluntary Withdrawal|0|||
160485177|NCT03544229|579504812|FG000|Overall Study|Lack of Efficacy|0|||
160485178|NCT03544229|579504813|FG001|Overall Study|Lack of Efficacy|1|||
160485179|NCT03544229|579504814|FG002|Overall Study|Lack of Efficacy|0|||
160485180|NCT03544229|579504815|FG003|Overall Study|Lack of Efficacy|0|||
160485181|NCT04772313|579504816|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
160485182|NCT04772313|579504816|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
160485183|NCT03187353|579504817|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
160485184|NCT03187353|579504818|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
160485185|NCT03187353|579504817|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
160485186|NCT03187353|579504818|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
160485187|NCT03187353|579504817|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
160485188|NCT03187353|579504818|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
160485189|NCT03187353|579504817|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
160485190|NCT03187353|579504818|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
160485191|NCT03187353|579504817|FG000|Washout (2 Weeks)|Adverse Event|2|||
160485192|NCT03187353|579504818|FG001|Washout (2 Weeks)|Adverse Event|0|||
160485193|NCT03187353|579504817|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
160485194|NCT03187353|579504818|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
160485195|NCT02215954|579504819|FG000|Overall Study|Adverse Event|0|||
160485196|NCT02215954|579504820|FG001|Overall Study|Adverse Event|0|||
160485197|NCT02215954|579504821|FG002|Overall Study|Adverse Event|1|||
160485198|NCT02215954|579504819|FG000|Overall Study|Withdrawal by Subject|0|||
160485199|NCT02215954|579504820|FG001|Overall Study|Withdrawal by Subject|0|||
160485200|NCT02215954|579504821|FG002|Overall Study|Withdrawal by Subject|2|||
160485201|NCT02215954|579504819|FG000|Overall Study|Not exposed|1|||
160485202|NCT02215954|579504820|FG001|Overall Study|Not exposed|1|||
160485203|NCT02215954|579504821|FG002|Overall Study|Not exposed|3|||
160485204|NCT02460562|579504823|FG000|Overall Study|Lost to Follow-up|15|||
160485205|NCT02460562|579504824|FG001|Overall Study|Lost to Follow-up|16|||
160485206|NCT01061775|579504825|FG000|Overall Study|Physician Decision|2|||
160485207|NCT01061775|579504825|FG000|Overall Study|Lost to Follow-up|1|||
160485208|NCT00784277|579504826|FG000|IR Treatment|Adverse Event|4|||
160485209|NCT00784277|579504827|FG001|IR Treatment|Adverse Event|8|||
160485210|NCT00784277|579504828|FG002|IR Treatment|Adverse Event|19|||
160485211|NCT00784277|579504829|FG003|IR Treatment|Adverse Event|35|||
160485212|NCT00784277|579504830|FG004|IR Treatment|Adverse Event|0|||
160485213|NCT00784277|579504831|FG005|IR Treatment|Adverse Event|0|||
160485214|NCT00784277|579504832|FG006|IR Treatment|Adverse Event|0|||
160485215|NCT00784277|579504826|FG000|IR Treatment|Lack of Efficacy|4|||
160485216|NCT00784277|579504827|FG001|IR Treatment|Lack of Efficacy|4|||
160485217|NCT00784277|579504828|FG002|IR Treatment|Lack of Efficacy|1|||
160485218|NCT00784277|579504829|FG003|IR Treatment|Lack of Efficacy|0|||
160485219|NCT00784277|579504830|FG004|IR Treatment|Lack of Efficacy|0|||
160485220|NCT00784277|579504831|FG005|IR Treatment|Lack of Efficacy|0|||
160485221|NCT00784277|579504832|FG006|IR Treatment|Lack of Efficacy|0|||
160485222|NCT00784277|579504826|FG000|IR Treatment|Lost to Follow-up|1|||
160485223|NCT00784277|579504827|FG001|IR Treatment|Lost to Follow-up|0|||
160485224|NCT00784277|579504828|FG002|IR Treatment|Lost to Follow-up|1|||
160485225|NCT00784277|579504829|FG003|IR Treatment|Lost to Follow-up|0|||
160485226|NCT00784277|579504830|FG004|IR Treatment|Lost to Follow-up|0|||
160485227|NCT00784277|579504831|FG005|IR Treatment|Lost to Follow-up|0|||
160485228|NCT00784277|579504832|FG006|IR Treatment|Lost to Follow-up|0|||
160485229|NCT00784277|579504826|FG000|IR Treatment|Withdrawal by Subject|5|||
160485230|NCT00784277|579504827|FG001|IR Treatment|Withdrawal by Subject|1|||
160485231|NCT00784277|579504828|FG002|IR Treatment|Withdrawal by Subject|4|||
160485232|NCT00784277|579504829|FG003|IR Treatment|Withdrawal by Subject|6|||
160485233|NCT00784277|579504830|FG004|IR Treatment|Withdrawal by Subject|0|||
160485234|NCT00784277|579504831|FG005|IR Treatment|Withdrawal by Subject|0|||
160485235|NCT00784277|579504832|FG006|IR Treatment|Withdrawal by Subject|0|||
160485236|NCT00784277|579504826|FG000|IR Treatment|Resolution Of Pain|0|||
160485237|NCT00784277|579504827|FG001|IR Treatment|Resolution Of Pain|1|||
160485238|NCT00784277|579504828|FG002|IR Treatment|Resolution Of Pain|0|||
160485239|NCT00784277|579504829|FG003|IR Treatment|Resolution Of Pain|0|||
160485240|NCT00784277|579504830|FG004|IR Treatment|Resolution Of Pain|0|||
160485241|NCT00784277|579504831|FG005|IR Treatment|Resolution Of Pain|0|||
160485242|NCT00784277|579504832|FG006|IR Treatment|Resolution Of Pain|0|||
160485243|NCT00784277|579504826|FG000|IR Treatment|Other|2|||
160485244|NCT00784277|579504827|FG001|IR Treatment|Other|3|||
160485245|NCT00784277|579504828|FG002|IR Treatment|Other|3|||
160485246|NCT00784277|579504829|FG003|IR Treatment|Other|2|||
160485247|NCT00784277|579504830|FG004|IR Treatment|Other|0|||
160485248|NCT00784277|579504831|FG005|IR Treatment|Other|0|||
160485249|NCT00784277|579504832|FG006|IR Treatment|Other|0|||
160485250|NCT00784277|579504826|FG000|ER Treatment|Adverse Event|0|||
160485251|NCT00784277|579504827|FG001|ER Treatment|Adverse Event|0|||
160485252|NCT00784277|579504828|FG002|ER Treatment|Adverse Event|0|||
160485253|NCT00784277|579504829|FG003|ER Treatment|Adverse Event|0|||
160485254|NCT00784277|579504830|FG004|ER Treatment|Adverse Event|1|||
160485255|NCT00784277|579504831|FG005|ER Treatment|Adverse Event|7|||
160485256|NCT00784277|579504832|FG006|ER Treatment|Adverse Event|7|||
160485257|NCT00784277|579504826|FG000|ER Treatment|Lack of Efficacy|0|||
160485258|NCT00784277|579504827|FG001|ER Treatment|Lack of Efficacy|0|||
160485259|NCT00784277|579504828|FG002|ER Treatment|Lack of Efficacy|0|||
160485260|NCT00784277|579504829|FG003|ER Treatment|Lack of Efficacy|0|||
160485261|NCT00784277|579504830|FG004|ER Treatment|Lack of Efficacy|3|||
160485262|NCT00784277|579504831|FG005|ER Treatment|Lack of Efficacy|4|||
160485263|NCT00784277|579504832|FG006|ER Treatment|Lack of Efficacy|0|||
160485264|NCT00784277|579504826|FG000|ER Treatment|Lost to Follow-up|0|||
160485265|NCT00784277|579504827|FG001|ER Treatment|Lost to Follow-up|0|||
160485266|NCT00784277|579504828|FG002|ER Treatment|Lost to Follow-up|0|||
160485267|NCT00784277|579504829|FG003|ER Treatment|Lost to Follow-up|0|||
160485268|NCT00784277|579504830|FG004|ER Treatment|Lost to Follow-up|0|||
160485269|NCT00784277|579504831|FG005|ER Treatment|Lost to Follow-up|2|||
160485270|NCT00784277|579504832|FG006|ER Treatment|Lost to Follow-up|0|||
160485271|NCT00784277|579504826|FG000|ER Treatment|Withdrawal by Subject|0|||
160485272|NCT00784277|579504827|FG001|ER Treatment|Withdrawal by Subject|0|||
160485273|NCT00784277|579504828|FG002|ER Treatment|Withdrawal by Subject|0|||
160485274|NCT00784277|579504829|FG003|ER Treatment|Withdrawal by Subject|0|||
160485275|NCT00784277|579504830|FG004|ER Treatment|Withdrawal by Subject|2|||
160485276|NCT00784277|579504831|FG005|ER Treatment|Withdrawal by Subject|5|||
160485277|NCT00784277|579504832|FG006|ER Treatment|Withdrawal by Subject|3|||
160485278|NCT00784277|579504826|FG000|ER Treatment|Study Medication Non-Compliant|0|||
160485279|NCT00784277|579504827|FG001|ER Treatment|Study Medication Non-Compliant|0|||
160485280|NCT00784277|579504828|FG002|ER Treatment|Study Medication Non-Compliant|0|||
160485281|NCT00784277|579504829|FG003|ER Treatment|Study Medication Non-Compliant|0|||
160485282|NCT00784277|579504830|FG004|ER Treatment|Study Medication Non-Compliant|2|||
160485283|NCT00784277|579504831|FG005|ER Treatment|Study Medication Non-Compliant|3|||
160485284|NCT00784277|579504832|FG006|ER Treatment|Study Medication Non-Compliant|3|||
160485285|NCT00784277|579504826|FG000|ER Treatment|Other|0|||
160485286|NCT00784277|579504827|FG001|ER Treatment|Other|0|||
160485287|NCT00784277|579504828|FG002|ER Treatment|Other|0|||
160485288|NCT00784277|579504829|FG003|ER Treatment|Other|0|||
160485289|NCT00784277|579504830|FG004|ER Treatment|Other|1|||
160485290|NCT00784277|579504831|FG005|ER Treatment|Other|3|||
160485291|NCT00784277|579504832|FG006|ER Treatment|Other|2|||
160485292|NCT01093222|579504833|FG000|Overall Study|Ineligible|6|||
160485293|NCT01093222|579504833|FG000|Overall Study|Adverse Event|7|||
160485294|NCT01093222|579504833|FG000|Overall Study|Progression/relapse|24|||
160485295|NCT01093222|579504833|FG000|Overall Study|Death|2|||
160485296|NCT01093222|579504833|FG000|Overall Study|Not protocol specified|1|||
160485297|NCT04194541|579504834|FG000|Day 1 Through 13|Lost to Follow-up|3|||
160485298|NCT04194541|579504834|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
160485299|NCT04194541|579504834|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
160485300|NCT02567227|579504837|FG000|9 Weeks|Adverse Event|5|||
160485301|NCT02567227|579504838|FG001|9 Weeks|Adverse Event|5|||
160485302|NCT02567227|579504837|FG000|9 Weeks|Withdrawal by Subject|18|||
160485303|NCT02567227|579504838|FG001|9 Weeks|Withdrawal by Subject|8|||
160485304|NCT02567227|579504837|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
160485305|NCT02567227|579504838|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
160485306|NCT02567227|579504837|FG000|6 Month|Death|2|||
160485307|NCT02567227|579504838|FG001|6 Month|Death|0|||
160485308|NCT02567227|579504837|FG000|6 Month|Lost to Follow-up|43|||
160485309|NCT02567227|579504838|FG001|6 Month|Lost to Follow-up|40|||
160485310|NCT02567227|579504837|FG000|12 Months|Lost to Follow-up|31|||
160485311|NCT02567227|579504838|FG001|12 Months|Lost to Follow-up|32|||
160485312|NCT02567227|579504837|FG000|12 Months|Death|0|||
160485313|NCT02567227|579504838|FG001|12 Months|Death|2|||
160485314|NCT00187135|579504839|FG000|Visit One|Withdrawal by Subject|1|||
160485315|NCT00187135|579504840|FG001|Visit One|Withdrawal by Subject|0|||
160485316|NCT00187135|579504841|FG002|Visit One|Withdrawal by Subject|0|||
160485317|NCT00187135|579504842|FG003|Visit One|Withdrawal by Subject|0|||
160485318|NCT00187135|579504843|FG004|Visit One|Withdrawal by Subject|0|||
160485319|NCT00187135|579504844|FG005|Visit One|Withdrawal by Subject|1|||
160485320|NCT00187135|579504839|FG000|Visit One|Physician Decision|3|||
160485321|NCT00187135|579504840|FG001|Visit One|Physician Decision|1|||
160485322|NCT00187135|579504841|FG002|Visit One|Physician Decision|0|||
160485323|NCT00187135|579504842|FG003|Visit One|Physician Decision|0|||
160485324|NCT00187135|579504843|FG004|Visit One|Physician Decision|0|||
160485325|NCT00187135|579504844|FG005|Visit One|Physician Decision|1|||
160485326|NCT00187135|579504839|FG000|Visit Two|Death|0|||
160485327|NCT00187135|579504840|FG001|Visit Two|Death|0|||
160485328|NCT00187135|579504841|FG002|Visit Two|Death|0|||
160485329|NCT00187135|579504842|FG003|Visit Two|Death|1|||
160485330|NCT00187135|579504843|FG004|Visit Two|Death|0|||
160485331|NCT00187135|579504844|FG005|Visit Two|Death|1|||
160485332|NCT00187135|579504839|FG000|Visit Two|Physician Decision|1|||
160485333|NCT00187135|579504840|FG001|Visit Two|Physician Decision|0|||
160485334|NCT00187135|579504841|FG002|Visit Two|Physician Decision|0|||
160485335|NCT00187135|579504842|FG003|Visit Two|Physician Decision|0|||
160485336|NCT00187135|579504843|FG004|Visit Two|Physician Decision|0|||
160485337|NCT00187135|579504844|FG005|Visit Two|Physician Decision|0|||
160485338|NCT00187135|579504839|FG000|Visit Two|Withdrawal by Subject|1|||
160485339|NCT00187135|579504840|FG001|Visit Two|Withdrawal by Subject|1|||
160485340|NCT00187135|579504841|FG002|Visit Two|Withdrawal by Subject|1|||
160485341|NCT00187135|579504842|FG003|Visit Two|Withdrawal by Subject|0|||
160485342|NCT00187135|579504843|FG004|Visit Two|Withdrawal by Subject|1|||
160485343|NCT00187135|579504844|FG005|Visit Two|Withdrawal by Subject|1|||
160485344|NCT00187135|579504839|FG000|Visit Two|Study Discontinued|3|||
160485345|NCT00187135|579504840|FG001|Visit Two|Study Discontinued|2|||
160485346|NCT00187135|579504841|FG002|Visit Two|Study Discontinued|1|||
160485347|NCT00187135|579504842|FG003|Visit Two|Study Discontinued|7|||
160485348|NCT00187135|579504843|FG004|Visit Two|Study Discontinued|5|||
160485349|NCT00187135|579504844|FG005|Visit Two|Study Discontinued|6|||
160485350|NCT00187135|579504839|FG000|Visit Three|Death|0|||
160485351|NCT00187135|579504840|FG001|Visit Three|Death|0|||
160485352|NCT00187135|579504841|FG002|Visit Three|Death|1|||
160485353|NCT00187135|579504842|FG003|Visit Three|Death|0|||
160606379|NCT00939341|579937380|FG000|Overall Study|Protocol Violation|6|||
160606380|NCT00939341|579937380|FG000|Overall Study|Incorrect enrolment|8|||
160606381|NCT00764322|579937382|FG000|Overall Study|Withdrawal by Subject|11|||
160606382|NCT00764322|579937382|FG000|Overall Study|No CYP2D6 genotyping|9|||
160606383|NCT00796003|579937383|FG000|Overall Study|Disease Progression|2|||
160606384|NCT00796003|579937384|FG001|Overall Study|Disease Progression|13|||
160606385|NCT00796003|579937383|FG000|Overall Study|Adverse Event|1|||
160606386|NCT00796003|579937384|FG001|Overall Study|Adverse Event|7|||
160606387|NCT00796003|579937383|FG000|Overall Study|Specified organ function not met|0|||
160606388|NCT00796003|579937384|FG001|Overall Study|Specified organ function not met|1|||
160485354|NCT00187135|579504843|FG004|Visit Three|Death|1|||
160485355|NCT00187135|579504844|FG005|Visit Three|Death|0|||
160485356|NCT00187135|579504839|FG000|Visit Three|Withdrawal by Subject|0|||
160485357|NCT00187135|579504840|FG001|Visit Three|Withdrawal by Subject|1|||
160485358|NCT00187135|579504841|FG002|Visit Three|Withdrawal by Subject|1|||
160485359|NCT00187135|579504842|FG003|Visit Three|Withdrawal by Subject|2|||
160485360|NCT00187135|579504843|FG004|Visit Three|Withdrawal by Subject|0|||
160485361|NCT00187135|579504844|FG005|Visit Three|Withdrawal by Subject|0|||
160485362|NCT00187135|579504839|FG000|Visit Three|Study Discontinued|7|||
160485363|NCT00187135|579504840|FG001|Visit Three|Study Discontinued|6|||
160485364|NCT00187135|579504841|FG002|Visit Three|Study Discontinued|7|||
160485365|NCT00187135|579504842|FG003|Visit Three|Study Discontinued|7|||
160485366|NCT00187135|579504843|FG004|Visit Three|Study Discontinued|7|||
160485367|NCT00187135|579504844|FG005|Visit Three|Study Discontinued|6|||
160485368|NCT01675050|579504848|FG000|Period One Treatment|Withdrawal by Subject|1|||
160485369|NCT01675050|579504849|FG001|Period One Treatment|Withdrawal by Subject|0|||
160485370|NCT00745121|579504850|FG000|Overall Study|Death|3|||
160485371|NCT00745121|579504851|FG001|Overall Study|Death|0|||
160485372|NCT00745121|579504850|FG000|Overall Study|Adverse Event|1|||
160606389|NCT00796003|579937383|FG000|Overall Study|Physician Decision|0|||
160485373|NCT00745121|579504851|FG001|Overall Study|Adverse Event|0|||
160485374|NCT00745121|579504850|FG000|Overall Study|Lost to Follow-up|1|||
160485375|NCT00745121|579504851|FG001|Overall Study|Lost to Follow-up|0|||
160485376|NCT00745121|579504850|FG000|Overall Study|Withdrawal by Subject|4|||
160485377|NCT00745121|579504851|FG001|Overall Study|Withdrawal by Subject|2|||
160485378|NCT03280108|579504855|FG000|Overall Study|Lost to Follow-up|2|||
160485379|NCT03280108|579504856|FG001|Overall Study|Lost to Follow-up|0|||
160485380|NCT02996097|579504857|FG000|Overall Study|Lost to Follow-up|11|||
160485381|NCT02996097|579504858|FG001|Overall Study|Lost to Follow-up|11|||
160485382|NCT01820637|579504859|FG000|Overall Study|Death|2|||
160485383|NCT01820637|579504859|FG000|Overall Study|Withdrawal by Subject|1|||
160485384|NCT00264498|579504860|FG000|Randomized Treatment|Death|0|||
160485385|NCT00264498|579504861|FG001|Randomized Treatment|Death|3|||
160485386|NCT00264498|579504860|FG000|Randomized Treatment|Withdrawal by Subject|0|||
160485387|NCT00264498|579504861|FG001|Randomized Treatment|Withdrawal by Subject|1|||
160485388|NCT00264498|579504860|FG000|Randomized Treatment|Objective disease Progression|13|||
160485389|NCT00264498|579504861|FG001|Randomized Treatment|Objective disease Progression|14|||
160485390|NCT00264498|579504860|FG000|Randomized Treatment|Physician Decision|1|||
160485391|NCT00264498|579504861|FG001|Randomized Treatment|Physician Decision|0|||
160485392|NCT00264498|579504860|FG000|Randomized Treatment|Incorrectly randomized|1|||
160485393|NCT00264498|579504861|FG001|Randomized Treatment|Incorrectly randomized|0|||
160485394|NCT00264498|579504860|FG000|Randomized Treatment|Study Closure|1|||
160485395|NCT00264498|579504861|FG001|Randomized Treatment|Study Closure|0|||
160485396|NCT00264498|579504860|FG000|Randomized Treatment|Protocol Violation|1|||
160485397|NCT00264498|579504861|FG001|Randomized Treatment|Protocol Violation|0|||
160485398|NCT00264498|579504860|FG000|Crossover Treatment|Death|1|||
160485399|NCT00264498|579504861|FG001|Crossover Treatment|Death|3|||
160485400|NCT00264498|579504860|FG000|Crossover Treatment|Objective disease progression|4|||
160485401|NCT00264498|579504861|FG001|Crossover Treatment|Objective disease progression|5|||
160485402|NCT00264498|579504860|FG000|Crossover Treatment|Study closure|0|||
160485403|NCT00264498|579504861|FG001|Crossover Treatment|Study closure|1|||
160485404|NCT00264498|579504860|FG000|Crossover Treatment|Withdrawal by Subject|1|||
160485405|NCT00264498|579504861|FG001|Crossover Treatment|Withdrawal by Subject|0|||
160485406|NCT03794609|579504862|FG000|Overall Study|Other|10|||
160485407|NCT03794609|579504862|FG000|Overall Study|Withdrawal by Subject|66|||
160485408|NCT03794609|579504862|FG000|Overall Study|The child is enrolled in an interventional study|70|||
160485409|NCT03794609|579504862|FG000|Overall Study|Inclusion/exclusion criteria|8|||
160485410|NCT03794609|579504862|FG000|Overall Study|At sponsor's request|151|||
160485411|NCT03794609|579504862|FG000|Overall Study|Physician Decision|1|||
160485412|NCT03794609|579504862|FG000|Overall Study|Lost to Follow-up|5|||
160485413|NCT03638258|579504863|FG000|Overall Study|Adverse Event|1|||
160485414|NCT03638258|579504864|FG001|Overall Study|Adverse Event|0|||
160485415|NCT03638258|579504865|FG002|Overall Study|Adverse Event|2|||
160485416|NCT03638258|579504863|FG000|Overall Study|Lost to Follow-up|2|||
160485417|NCT03638258|579504864|FG001|Overall Study|Lost to Follow-up|4|||
160485418|NCT03638258|579504865|FG002|Overall Study|Lost to Follow-up|5|||
160485419|NCT03638258|579504863|FG000|Overall Study|Pregnancy|0|||
160485420|NCT03638258|579504864|FG001|Overall Study|Pregnancy|0|||
160485421|NCT03638258|579504865|FG002|Overall Study|Pregnancy|1|||
160485422|NCT03638258|579504863|FG000|Overall Study|Protocol Violation|0|||
160485423|NCT03638258|579504864|FG001|Overall Study|Protocol Violation|0|||
160485424|NCT03638258|579504865|FG002|Overall Study|Protocol Violation|1|||
160485425|NCT03638258|579504863|FG000|Overall Study|Withdrawal by Subject|4|||
160485426|NCT03638258|579504864|FG001|Overall Study|Withdrawal by Subject|5|||
160485427|NCT03638258|579504865|FG002|Overall Study|Withdrawal by Subject|12|||
160485428|NCT03638258|579504863|FG000|Overall Study|Lack of Efficacy|0|||
160485429|NCT03638258|579504864|FG001|Overall Study|Lack of Efficacy|0|||
160485430|NCT03638258|579504865|FG002|Overall Study|Lack of Efficacy|2|||
160485431|NCT04543942|579504866|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
160485432|NCT04543942|579504867|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
160485433|NCT04543942|579504866|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
160485434|NCT04543942|579504867|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
160485435|NCT02205476|579504868|FG000|Overall Study|Study termination by Sponsor|7|||
160485436|NCT02205476|579504869|FG001|Overall Study|Study termination by Sponsor|3|||
160606390|NCT00796003|579937384|FG001|Overall Study|Physician Decision|4|||
160606391|NCT00796003|579937383|FG000|Overall Study|Withdrawal by Subject|0|||
160485437|NCT00139659|579504876|FG000|Overall Study|Adverse Event|12|||
160485438|NCT00139659|579504877|FG001|Overall Study|Adverse Event|1|||
160485439|NCT00139659|579504876|FG000|Overall Study|Lack of Efficacy|1|||
160485440|NCT00139659|579504877|FG001|Overall Study|Lack of Efficacy|1|||
160485441|NCT00139659|579504876|FG000|Overall Study|Lost to Follow-up|7|||
160485442|NCT00139659|579504877|FG001|Overall Study|Lost to Follow-up|3|||
160485443|NCT00139659|579504876|FG000|Overall Study|Reason not Specified|6|||
160485444|NCT00139659|579504877|FG001|Overall Study|Reason not Specified|3|||
160606392|NCT00796003|579937384|FG001|Overall Study|Withdrawal by Subject|1|||
160485445|NCT00139659|579504876|FG000|Overall Study|Withdrawal by Subject|14|||
160485446|NCT00139659|579504877|FG001|Overall Study|Withdrawal by Subject|10|||
160485447|NCT02625922|579504883|FG000|Overall Study|Non-availability of IMP|1|||
160485448|NCT02625922|579504884|FG001|Overall Study|Non-availability of IMP|1|||
160485449|NCT02625922|579504883|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
160485450|NCT02625922|579504884|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
160485451|NCT00640042|579504885|FG000|Enrollment|Did not receive study drug|83|||
160485452|NCT02359552|579504886|FG000|Overall Study|Lost to Follow-up|3|||
160485453|NCT02359552|579504887|FG001|Overall Study|Lost to Follow-up|4|||
160485454|NCT02391116|579504900|FG000|Treatment|Withdrawal by Subject|1|||
160485455|NCT02391116|579504900|FG000|Treatment|Protocol Violation|1|||
160485456|NCT02391116|579504900|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
160485457|NCT02391116|579504900|FG000|Treatment|AE with Clinical PD|3|||
160485458|NCT02391116|579504900|FG000|Safety Follow-up|Adverse Event|1|||
160485459|NCT02391116|579504900|FG000|Safety Follow-up|Withdrawal by Subject|4|||
160485460|NCT02391116|579504900|FG000|Safety Follow-up|Switching to Other Therapy|4|||
160485461|NCT02391116|579504900|FG000|Safety Follow-up|No Follow Up|1|||
160485462|NCT02391116|579504900|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
160485463|NCT02391116|579504900|FG000|Active Follow-up|Withdrawal by Subject|1|||
160485464|NCT02391116|579504900|FG000|Active Follow-up|Switching to Other Therapy|2|||
160485465|NCT02391116|579504900|FG000|Survival Follow-up|Withdrawal by Subject|3|||
160485466|NCT02391116|579504900|FG000|Survival Follow-up|Switching to Other Therapy|1|||
160485467|NCT01747629|579504902|FG000|Overall Study|Adverse Event|1|||
160485468|NCT01747629|579504903|FG001|Overall Study|Adverse Event|2|||
160485469|NCT01747629|579504902|FG000|Overall Study|Withdrawal by Subject|2|||
160485470|NCT01747629|579504903|FG001|Overall Study|Withdrawal by Subject|2|||
160485471|NCT01747629|579504902|FG000|Overall Study|Noncompliance|1|||
160485472|NCT01747629|579504903|FG001|Overall Study|Noncompliance|1|||
160485473|NCT01747629|579504902|FG000|Overall Study|Inclusion criteria not met|1|||
160485474|NCT01747629|579504903|FG001|Overall Study|Inclusion criteria not met|0|||
160485475|NCT01747629|579504902|FG000|Overall Study|Not treated|1|||
160485476|NCT01747629|579504903|FG001|Overall Study|Not treated|0|||
160485477|NCT01747629|579504902|FG000|Overall Study|Other|2|||
160485478|NCT01747629|579504903|FG001|Overall Study|Other|1|||
160485479|NCT00607789|579504904|FG000|Overall Study|Adverse Event|3|||
160485480|NCT00607789|579504905|FG001|Overall Study|Adverse Event|0|||
160485481|NCT00607789|579504904|FG000|Overall Study|Lack of Efficacy|0|||
160485482|NCT00607789|579504905|FG001|Overall Study|Lack of Efficacy|1|||
160485483|NCT00607789|579504904|FG000|Overall Study|Inadequate adherence|3|||
160485484|NCT00607789|579504905|FG001|Overall Study|Inadequate adherence|0|||
160485485|NCT00607789|579504904|FG000|Overall Study|Lost to Follow-up|0|||
160485486|NCT00607789|579504905|FG001|Overall Study|Lost to Follow-up|5|||
160485487|NCT00607789|579504904|FG000|Overall Study|Withdrawal by Subject|1|||
160485488|NCT00607789|579504905|FG001|Overall Study|Withdrawal by Subject|0|||
160485489|NCT01313299|579504906|FG000|Overall Study|Adverse Event|3|||
160485490|NCT01313299|579504907|FG001|Overall Study|Adverse Event|1|||
160485491|NCT01313299|579504908|FG002|Overall Study|Adverse Event|1|||
160485492|NCT01313299|579504906|FG000|Overall Study|Lost to Follow-up|1|||
160485493|NCT01313299|579504907|FG001|Overall Study|Lost to Follow-up|0|||
160485494|NCT01313299|579504908|FG002|Overall Study|Lost to Follow-up|0|||
160485495|NCT01313299|579504906|FG000|Overall Study|Protocol Violation|2|||
160485496|NCT01313299|579504907|FG001|Overall Study|Protocol Violation|0|||
160485497|NCT01313299|579504908|FG002|Overall Study|Protocol Violation|0|||
160485498|NCT01313299|579504906|FG000|Overall Study|Withdrawal by Subject|1|||
160485499|NCT01313299|579504907|FG001|Overall Study|Withdrawal by Subject|0|||
160485500|NCT01313299|579504908|FG002|Overall Study|Withdrawal by Subject|2|||
160485501|NCT01313299|579504906|FG000|Overall Study|Family reason and moved out of state|0|||
160485502|NCT01313299|579504907|FG001|Overall Study|Family reason and moved out of state|2|||
160485503|NCT01313299|579504908|FG002|Overall Study|Family reason and moved out of state|0|||
160485504|NCT01313299|579504906|FG000|Overall Study|Lack of subject compliance|0|||
160661060|NCT00579670|580141749|FG004|Overall Study|Lack of Efficacy|0|||
160485505|NCT01313299|579504907|FG001|Overall Study|Lack of subject compliance|0|||
160485506|NCT01313299|579504908|FG002|Overall Study|Lack of subject compliance|1|||
160485507|NCT02506881|579504909|FG000|First Intervention (Day 1)|Protocol Violation|0|||
160485508|NCT02506881|579504910|FG001|First Intervention (Day 1)|Protocol Violation|0|||
160485509|NCT02506881|579504911|FG002|First Intervention (Day 1)|Protocol Violation|1|||
160485510|NCT02506881|579504912|FG003|First Intervention (Day 1)|Protocol Violation|0|||
160485511|NCT02506881|579504909|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
160485512|NCT02506881|579504910|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
160485513|NCT02506881|579504911|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
160485514|NCT02506881|579504912|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
160485515|NCT02506881|579504909|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
160485516|NCT02506881|579504910|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
160661061|NCT00579670|580141745|FG000|Overall Study|Lost to Follow-up|0|||
160485517|NCT02506881|579504911|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
160485518|NCT02506881|579504912|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
160661062|NCT00579670|580141746|FG001|Overall Study|Lost to Follow-up|1|||
160485519|NCT01919398|579504913|FG000|Overall Study|Progressive Disease|0|||
160485520|NCT01919398|579504914|FG001|Overall Study|Progressive Disease|0|||
160485521|NCT01919398|579504915|FG002|Overall Study|Progressive Disease|4|||
160485522|NCT02391545|579504917|FG000|Overall Study|Death|0|||
160485523|NCT02391545|579504918|FG001|Overall Study|Death|2|||
160485524|NCT02391545|579504917|FG000|Overall Study|Lost to Follow-up|0|||
160485525|NCT02391545|579504918|FG001|Overall Study|Lost to Follow-up|1|||
160485526|NCT02391545|579504917|FG000|Overall Study|Termination of study by sponsor|20|||
160485527|NCT02391545|579504918|FG001|Overall Study|Termination of study by sponsor|20|||
160485528|NCT02391545|579504917|FG000|Overall Study|Withdrawal by Subject|0|||
160485529|NCT02391545|579504918|FG001|Overall Study|Withdrawal by Subject|1|||
160485530|NCT02391545|579504917|FG000|Overall Study|Other Reasons|6|||
160485531|NCT02391545|579504918|FG001|Overall Study|Other Reasons|4|||
160485532|NCT02016690|579504919|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
160485533|NCT02016690|579504919|FG000|Overall Study|Excluded from SAS: Duplication|2|||
160485534|NCT02016690|579504919|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
160485535|NCT02016690|579504919|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
160485536|NCT02016690|579504919|FG000|Overall Study|Did not meet inclusion criteria|13|||
160485537|NCT02016690|579504919|FG000|Overall Study|Hospitalized for RSV at study start|3|||
160485538|NCT01222078|579504920|FG000|Overall Study|Early termination of the study|1|||
160485539|NCT04089332|579504921|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
160485540|NCT04089332|579504921|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
160485541|NCT04089332|579504921|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
160485542|NCT00603278|579504925|FG000|Overall Study|Lack of Efficacy|35|||
160485543|NCT00603278|579504926|FG001|Overall Study|Lack of Efficacy|10|||
160485544|NCT00603278|579504927|FG002|Overall Study|Lack of Efficacy|11|||
160485545|NCT00603278|579504928|FG003|Overall Study|Lack of Efficacy|8|||
160485546|NCT00603278|579504929|FG004|Overall Study|Lack of Efficacy|7|||
160485547|NCT00603278|579504930|FG005|Overall Study|Lack of Efficacy|14|||
160485548|NCT00603278|579504925|FG000|Overall Study|Adverse Event|0|||
160485549|NCT00603278|579504926|FG001|Overall Study|Adverse Event|3|||
160485550|NCT00603278|579504927|FG002|Overall Study|Adverse Event|1|||
160485551|NCT00603278|579504928|FG003|Overall Study|Adverse Event|0|||
160485552|NCT00603278|579504929|FG004|Overall Study|Adverse Event|2|||
160485553|NCT00603278|579504930|FG005|Overall Study|Adverse Event|1|||
160485554|NCT00603278|579504925|FG000|Overall Study|Withdrawal by Subject|2|||
160485555|NCT00603278|579504926|FG001|Overall Study|Withdrawal by Subject|3|||
160485556|NCT00603278|579504927|FG002|Overall Study|Withdrawal by Subject|1|||
160485557|NCT00603278|579504928|FG003|Overall Study|Withdrawal by Subject|2|||
160485558|NCT00603278|579504929|FG004|Overall Study|Withdrawal by Subject|1|||
160485559|NCT00603278|579504930|FG005|Overall Study|Withdrawal by Subject|2|||
160485560|NCT00603278|579504925|FG000|Overall Study|Protocol Violation|3|||
160485561|NCT00603278|579504926|FG001|Overall Study|Protocol Violation|0|||
160485562|NCT00603278|579504927|FG002|Overall Study|Protocol Violation|1|||
160485563|NCT00603278|579504928|FG003|Overall Study|Protocol Violation|1|||
160485564|NCT00603278|579504929|FG004|Overall Study|Protocol Violation|0|||
160485565|NCT00603278|579504930|FG005|Overall Study|Protocol Violation|1|||
160485566|NCT00603278|579504925|FG000|Overall Study|Physician Decision|0|||
160485567|NCT00603278|579504926|FG001|Overall Study|Physician Decision|1|||
160485568|NCT00603278|579504927|FG002|Overall Study|Physician Decision|0|||
160485569|NCT00603278|579504928|FG003|Overall Study|Physician Decision|0|||
160485570|NCT00603278|579504929|FG004|Overall Study|Physician Decision|2|||
160485571|NCT00603278|579504930|FG005|Overall Study|Physician Decision|1|||
160485572|NCT00603278|579504925|FG000|Overall Study|Lost to Follow-up|1|||
160485573|NCT00603278|579504926|FG001|Overall Study|Lost to Follow-up|0|||
160485574|NCT00603278|579504927|FG002|Overall Study|Lost to Follow-up|0|||
160485575|NCT00603278|579504928|FG003|Overall Study|Lost to Follow-up|0|||
160485576|NCT00603278|579504929|FG004|Overall Study|Lost to Follow-up|1|||
160485577|NCT00603278|579504930|FG005|Overall Study|Lost to Follow-up|0|||
160485578|NCT01772147|579506706|FG000|Overall Study|Adverse Event|13|||
160485579|NCT01772147|579506707|FG001|Overall Study|Adverse Event|10|||
160485580|NCT01772147|579506708|FG002|Overall Study|Adverse Event|6|||
160485581|NCT01772147|579506706|FG000|Overall Study|Withdrew Consent|7|||
160485582|NCT01772147|579506707|FG001|Overall Study|Withdrew Consent|8|||
160606393|NCT00796003|579937383|FG000|Overall Study|Other|0|||
160606394|NCT00796003|579937384|FG001|Overall Study|Other|1|||
160485583|NCT01772147|579506708|FG002|Overall Study|Withdrew Consent|4|||
160606395|NCT00796003|579937383|FG000|Overall Study|Participants Not treated|0|||
160485584|NCT01772147|579506706|FG000|Overall Study|Lost to Follow-up|1|||
160485585|NCT01772147|579506707|FG001|Overall Study|Lost to Follow-up|0|||
160485586|NCT01772147|579506708|FG002|Overall Study|Lost to Follow-up|1|||
160485587|NCT01772147|579506706|FG000|Overall Study|Protocol Deviation|2|||
160485588|NCT01772147|579506707|FG001|Overall Study|Protocol Deviation|1|||
160606396|NCT00796003|579937384|FG001|Overall Study|Participants Not treated|2|||
160606397|NCT01131130|579937386|FG000|Period 1 - Baseline|Pregnancy|1|||
160485589|NCT01772147|579506708|FG002|Overall Study|Protocol Deviation|1|||
160485590|NCT01772147|579506706|FG000|Overall Study|Lack of Efficacy|8|||
160485591|NCT01772147|579506707|FG001|Overall Study|Lack of Efficacy|6|||
160661063|NCT00579670|580141747|FG002|Overall Study|Lost to Follow-up|0|||
160485592|NCT01772147|579506708|FG002|Overall Study|Lack of Efficacy|6|||
160485593|NCT00796614|579506716|FG000|Overall Study|Adverse Event|1|||
160485594|NCT00796614|579506717|FG001|Overall Study|Adverse Event|2|||
160485595|NCT00796614|579506718|FG002|Overall Study|Adverse Event|0|||
160485596|NCT00796614|579506719|FG003|Overall Study|Adverse Event|0|||
160485597|NCT00796614|579506716|FG000|Overall Study|Protocol Violation|0|||
160485598|NCT00796614|579506717|FG001|Overall Study|Protocol Violation|0|||
160485599|NCT00796614|579506718|FG002|Overall Study|Protocol Violation|2|||
160485600|NCT00796614|579506719|FG003|Overall Study|Protocol Violation|0|||
160485601|NCT00796614|579506716|FG000|Overall Study|Lost to Follow-up|2|||
160485602|NCT00796614|579506717|FG001|Overall Study|Lost to Follow-up|2|||
160606398|NCT01131130|579937386|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
160485603|NCT00796614|579506718|FG002|Overall Study|Lost to Follow-up|1|||
160485604|NCT00796614|579506719|FG003|Overall Study|Lost to Follow-up|0|||
160485605|NCT00796614|579506716|FG000|Overall Study|Withdrawal by Subject|1|||
160485606|NCT00796614|579506717|FG001|Overall Study|Withdrawal by Subject|0|||
160485607|NCT00796614|579506718|FG002|Overall Study|Withdrawal by Subject|0|||
160485608|NCT00796614|579506719|FG003|Overall Study|Withdrawal by Subject|1|||
160485609|NCT00796614|579506716|FG000|Overall Study|Other than stated|1|||
160485610|NCT00796614|579506717|FG001|Overall Study|Other than stated|0|||
160485611|NCT00796614|579506718|FG002|Overall Study|Other than stated|0|||
160485612|NCT00796614|579506719|FG003|Overall Study|Other than stated|0|||
160485613|NCT00740597|579506720|FG000|Overall Study|insurance would not cover treatment|1|||
160485614|NCT00488319|579506731|FG000|Overall Study|Adverse Event|1|||
160485615|NCT00488319|579506732|FG001|Overall Study|Adverse Event|2|||
160485616|NCT00488319|579506733|FG002|Overall Study|Adverse Event|23|||
160485617|NCT00488319|579506731|FG000|Overall Study|Lack of Efficacy|6|||
160485618|NCT00488319|579506732|FG001|Overall Study|Lack of Efficacy|12|||
160485619|NCT00488319|579506733|FG002|Overall Study|Lack of Efficacy|27|||
160485620|NCT00488319|579506731|FG000|Overall Study|Lost to Follow-up|3|||
160485621|NCT00488319|579506732|FG001|Overall Study|Lost to Follow-up|5|||
160485622|NCT00488319|579506733|FG002|Overall Study|Lost to Follow-up|16|||
160485623|NCT00488319|579506731|FG000|Overall Study|Withdrawal by Subject|5|||
160485624|NCT00488319|579506732|FG001|Overall Study|Withdrawal by Subject|20|||
160485625|NCT00488319|579506733|FG002|Overall Study|Withdrawal by Subject|44|||
160485626|NCT00488319|579506731|FG000|Overall Study|Other reasons for withdrawal|0|||
160485627|NCT00488319|579506732|FG001|Overall Study|Other reasons for withdrawal|4|||
160485628|NCT00488319|579506733|FG002|Overall Study|Other reasons for withdrawal|12|||
160485629|NCT02499835|579506744|FG000|Overall Study|Withdrawal by Subject|1|||
160485630|NCT02499835|579506745|FG001|Overall Study|Withdrawal by Subject|0|||
160485631|NCT02499835|579506746|FG002|Overall Study|Withdrawal by Subject|0|||
160485632|NCT02499835|579506747|FG003|Overall Study|Withdrawal by Subject|1|||
160485633|NCT02499835|579506744|FG000|Overall Study|Physician Decision|0|||
160485634|NCT02499835|579506745|FG001|Overall Study|Physician Decision|3|||
160485635|NCT02499835|579506746|FG002|Overall Study|Physician Decision|18|||
160485636|NCT02499835|579506747|FG003|Overall Study|Physician Decision|7|||
160485637|NCT02499835|579506744|FG000|Overall Study|Adverse Event|0|||
160485638|NCT02499835|579506745|FG001|Overall Study|Adverse Event|0|||
160485639|NCT02499835|579506746|FG002|Overall Study|Adverse Event|0|||
160485640|NCT02499835|579506747|FG003|Overall Study|Adverse Event|1|||
160485641|NCT02499835|579506744|FG000|Overall Study|Disease progression|2|||
160485642|NCT02499835|579506745|FG001|Overall Study|Disease progression|1|||
160485643|NCT02499835|579506746|FG002|Overall Study|Disease progression|0|||
160485644|NCT02499835|579506747|FG003|Overall Study|Disease progression|7|||
160485645|NCT03319719|579506755|FG000|Overall Study|Lost to Follow-up|1|||
160485646|NCT00922441|579506756|FG000|Overall Study|Protocol Violation|0|||
160485647|NCT00922441|579506757|FG001|Overall Study|Protocol Violation|0|||
160485648|NCT00922441|579506758|FG002|Overall Study|Protocol Violation|2|||
160485649|NCT00922441|579506756|FG000|Overall Study|Withdrawal by Subject|0|||
160485650|NCT00922441|579506757|FG001|Overall Study|Withdrawal by Subject|0|||
160485651|NCT00922441|579506758|FG002|Overall Study|Withdrawal by Subject|1|||
160485652|NCT00468858|579506760|FG000|Overall Study|Adverse Event|0|||
160485653|NCT00468858|579506761|FG001|Overall Study|Adverse Event|1|||
160485654|NCT00468858|579506762|FG002|Overall Study|Adverse Event|0|||
160485655|NCT00468858|579506760|FG000|Overall Study|Withdrawal by Subject|7|||
160485656|NCT00468858|579506761|FG001|Overall Study|Withdrawal by Subject|4|||
160485657|NCT00468858|579506762|FG002|Overall Study|Withdrawal by Subject|5|||
160485658|NCT00468858|579506760|FG000|Overall Study|Relocation|1|||
160485659|NCT00468858|579506761|FG001|Overall Study|Relocation|3|||
160485660|NCT00468858|579506762|FG002|Overall Study|Relocation|3|||
160485661|NCT00468858|579506760|FG000|Overall Study|Lost to Follow-up|1|||
160485662|NCT00468858|579506761|FG001|Overall Study|Lost to Follow-up|2|||
160485663|NCT00468858|579506762|FG002|Overall Study|Lost to Follow-up|5|||
160485664|NCT00468858|579506760|FG000|Overall Study|Other|0|||
160485665|NCT00468858|579506761|FG001|Overall Study|Other|0|||
160485666|NCT00468858|579506762|FG002|Overall Study|Other|1|||
160485667|NCT03214250|579506765|FG000|Overall Study|Death|5|||
160485668|NCT03214250|579506766|FG001|Overall Study|Death|5|||
160485669|NCT03214250|579506767|FG002|Overall Study|Death|7|||
160485670|NCT03214250|579506768|FG003|Overall Study|Death|4|||
160485671|NCT03214250|579506769|FG004|Overall Study|Death|23|||
160485672|NCT03214250|579506770|FG005|Overall Study|Death|23|||
160485673|NCT03214250|579506771|FG006|Overall Study|Death|24|||
160485674|NCT03214250|579506765|FG000|Overall Study|Lost to Follow-up|0|||
160485675|NCT03214250|579506766|FG001|Overall Study|Lost to Follow-up|0|||
160485676|NCT03214250|579506767|FG002|Overall Study|Lost to Follow-up|0|||
160485677|NCT03214250|579506768|FG003|Overall Study|Lost to Follow-up|1|||
160485678|NCT03214250|579506769|FG004|Overall Study|Lost to Follow-up|1|||
160485679|NCT03214250|579506770|FG005|Overall Study|Lost to Follow-up|2|||
160485680|NCT03214250|579506771|FG006|Overall Study|Lost to Follow-up|0|||
160485681|NCT03214250|579506765|FG000|Overall Study|Other|0|||
160485682|NCT03214250|579506766|FG001|Overall Study|Other|0|||
160485683|NCT03214250|579506767|FG002|Overall Study|Other|0|||
160485684|NCT03214250|579506768|FG003|Overall Study|Other|0|||
160485685|NCT03214250|579506769|FG004|Overall Study|Other|1|||
160485686|NCT03214250|579506770|FG005|Overall Study|Other|1|||
160485687|NCT03214250|579506771|FG006|Overall Study|Other|2|||
160485688|NCT03214250|579506765|FG000|Overall Study|Remains on Study|2|||
160485689|NCT03214250|579506766|FG001|Overall Study|Remains on Study|2|||
160485690|NCT03214250|579506767|FG002|Overall Study|Remains on Study|0|||
160485691|NCT03214250|579506768|FG003|Overall Study|Remains on Study|1|||
160485692|NCT03214250|579506769|FG004|Overall Study|Remains on Study|7|||
160485693|NCT03214250|579506770|FG005|Overall Study|Remains on Study|5|||
160485694|NCT03214250|579506771|FG006|Overall Study|Remains on Study|3|||
160485695|NCT03214250|579506765|FG000|Overall Study|Withdrawal by Subject|0|||
160485696|NCT03214250|579506766|FG001|Overall Study|Withdrawal by Subject|0|||
160485697|NCT03214250|579506767|FG002|Overall Study|Withdrawal by Subject|1|||
160485698|NCT03214250|579506768|FG003|Overall Study|Withdrawal by Subject|2|||
160485699|NCT03214250|579506769|FG004|Overall Study|Withdrawal by Subject|5|||
160485700|NCT03214250|579506770|FG005|Overall Study|Withdrawal by Subject|0|||
160485701|NCT03214250|579506771|FG006|Overall Study|Withdrawal by Subject|2|||
160485702|NCT00439647|579506777|FG000|Overall Study|Withdrawal by Subject|25|||
160485703|NCT00439647|579506778|FG001|Overall Study|Withdrawal by Subject|22|||
160485704|NCT00439647|579506777|FG000|Overall Study|Death|15|||
160485705|NCT00439647|579506778|FG001|Overall Study|Death|18|||
160485706|NCT00439647|579506777|FG000|Overall Study|Adverse Event|11|||
160485707|NCT00439647|579506778|FG001|Overall Study|Adverse Event|11|||
160485708|NCT00439647|579506777|FG000|Overall Study|Lost to Follow-up|4|||
160485709|NCT00439647|579506778|FG001|Overall Study|Lost to Follow-up|12|||
160485710|NCT00439647|579506777|FG000|Overall Study|Protocol Violation|3|||
160485711|NCT00439647|579506778|FG001|Overall Study|Protocol Violation|4|||
160485712|NCT00439647|579506777|FG000|Overall Study|Lack of Efficacy|0|||
160485713|NCT00439647|579506778|FG001|Overall Study|Lack of Efficacy|4|||
160485714|NCT02171130|579506782|FG000|Overall Study|Death|1|||
160485715|NCT02171130|579506782|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
160485716|NCT02171130|579506782|FG000|Overall Study|Discontinued; Site Termination|5|||
160485717|NCT02171130|579506782|FG000|Overall Study|Withdrawal by Subject|3|||
160485718|NCT02171130|579506782|FG000|Overall Study|Physician Decision|1|||
160485719|NCT02171130|579506782|FG000|Overall Study|Lost to Follow-up|1|||
160485720|NCT02171130|579506782|FG000|Overall Study|Met Exclusion Criteria|1|||
160485721|NCT00591409|579506783|FG000|Overall Study|Not Treated|0|||
160485722|NCT00591409|579506784|FG001|Overall Study|Not Treated|0|||
160485723|NCT00591409|579506785|FG002|Overall Study|Not Treated|0|||
160485724|NCT00591409|579506786|FG003|Overall Study|Not Treated|0|||
160485725|NCT00591409|579506787|FG004|Overall Study|Not Treated|1|||
160485726|NCT00591409|579506788|FG005|Overall Study|Not Treated|0|||
160485727|NCT00591409|579506789|FG006|Overall Study|Not Treated|0|||
160485728|NCT00591409|579506790|FG007|Overall Study|Not Treated|0|||
160485729|NCT00591409|579506791|FG008|Overall Study|Not Treated|0|||
160485730|NCT00591409|579506792|FG009|Overall Study|Not Treated|1|||
160485731|NCT02109107|579506795|FG000|Overall Study|Lost to Follow-up|2|||
160485732|NCT00495612|579506797|FG000|Overall Study|Lost to Follow-up|1|||
160485733|NCT00495612|579506798|FG001|Overall Study|Lost to Follow-up|0|||
160485734|NCT00495612|579506797|FG000|Overall Study|Subject's Decision to Withdraw|3|||
160485735|NCT00495612|579506798|FG001|Overall Study|Subject's Decision to Withdraw|0|||
160485736|NCT06016127|579506801|FG000|Overall Study|Withdrawal by Subject|4|||
160485737|NCT06016127|579506802|FG001|Overall Study|Withdrawal by Subject|3|||
160485738|NCT03340766|579506807|FG000|Overall Study|Withdrawal by Subject|2|||
160485739|NCT03340766|579506808|FG001|Overall Study|Withdrawal by Subject|1|||
160485740|NCT03340766|579506809|FG002|Overall Study|Withdrawal by Subject|3|||
160485741|NCT03340766|579506807|FG000|Overall Study|Lost to Follow-up|0|||
160485742|NCT03340766|579506808|FG001|Overall Study|Lost to Follow-up|0|||
160485743|NCT03340766|579506809|FG002|Overall Study|Lost to Follow-up|1|||
160606399|NCT02437162|579937387|FG000|Overall Study|Protocol Violation|0|||
160606400|NCT02437162|579937388|FG001|Overall Study|Protocol Violation|1|||
160606401|NCT02437162|579937389|FG002|Overall Study|Protocol Violation|0|||
160606402|NCT02437162|579937387|FG000|Overall Study|Randomized but not treated|0|||
160606403|NCT02437162|579937388|FG001|Overall Study|Randomized but not treated|0|||
160485744|NCT03340766|579506807|FG000|Overall Study|Death|6|||
160485745|NCT03340766|579506808|FG001|Overall Study|Death|7|||
160485746|NCT03340766|579506809|FG002|Overall Study|Death|4|||
160485747|NCT00240097|579506810|FG000|Part I|Adverse Event|1|||
160485748|NCT00240097|579506810|FG000|Part I|Death|1|||
160485749|NCT00240097|579506810|FG000|Part I|histology|1|||
160606404|NCT02437162|579937389|FG002|Overall Study|Randomized but not treated|1|||
160485750|NCT00240097|579506810|FG000|Part I|unevaluable|1|||
160485751|NCT00240097|579506810|FG000|Part II|did not continue from Part I|23|||
160485752|NCT02383927|579506811|FG000|Overall Study|Disease Progression|8|||
160485753|NCT02383927|579506812|FG001|Overall Study|Disease Progression|8|||
160485754|NCT02383927|579506813|FG002|Overall Study|Disease Progression|15|||
160485755|NCT02383927|579506814|FG003|Overall Study|Disease Progression|4|||
160485756|NCT02383927|579506811|FG000|Overall Study|Physician Decision|0|||
160485757|NCT02383927|579506812|FG001|Overall Study|Physician Decision|0|||
160485758|NCT02383927|579506813|FG002|Overall Study|Physician Decision|2|||
160485759|NCT02383927|579506814|FG003|Overall Study|Physician Decision|0|||
160485760|NCT02383927|579506811|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
160485761|NCT02383927|579506812|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
160485762|NCT02383927|579506813|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
160485763|NCT02383927|579506814|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
160485764|NCT02383927|579506811|FG000|Overall Study|Adverse Event|4|||
160485765|NCT02383927|579506812|FG001|Overall Study|Adverse Event|1|||
160485766|NCT02383927|579506813|FG002|Overall Study|Adverse Event|3|||
160485767|NCT02383927|579506814|FG003|Overall Study|Adverse Event|5|||
160485768|NCT02383927|579506811|FG000|Overall Study|Miscellaneous|1|||
160485769|NCT02383927|579506812|FG001|Overall Study|Miscellaneous|0|||
160485770|NCT02383927|579506813|FG002|Overall Study|Miscellaneous|0|||
160485771|NCT02383927|579506814|FG003|Overall Study|Miscellaneous|1|||
160485772|NCT02383927|579506811|FG000|Overall Study|Withdrawal by Subject|0|||
160485773|NCT02383927|579506812|FG001|Overall Study|Withdrawal by Subject|1|||
160485774|NCT02383927|579506813|FG002|Overall Study|Withdrawal by Subject|4|||
160485775|NCT02383927|579506814|FG003|Overall Study|Withdrawal by Subject|0|||
160485776|NCT00734851|579506815|FG000|Overall Study|Withdrawal by Subject|2|||
160485777|NCT00734851|579506815|FG000|Overall Study|Lost to Follow-up|1|||
160485778|NCT00734851|579506815|FG000|Overall Study|Physician Decision|18|||
160485779|NCT00981578|579506819|FG000|Overall Study|Death|1|||
160485780|NCT00981578|579506819|FG000|Overall Study|Withdrawal by Subject|2|||
160485781|NCT01294358|579506824|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
160485782|NCT01294358|579506825|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
160485783|NCT01294358|579506826|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
160485784|NCT01294358|579506827|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
160485785|NCT01294358|579506828|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
160485786|NCT01294358|579506824|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
160485787|NCT01294358|579506825|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
160485788|NCT01294358|579506826|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
160485789|NCT01294358|579506827|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
160485790|NCT01294358|579506828|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
160485791|NCT01294358|579506824|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
160485792|NCT01294358|579506825|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
160485793|NCT01294358|579506826|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
160485794|NCT01294358|579506827|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
160485795|NCT01294358|579506828|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
160485796|NCT01294358|579506824|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
160485797|NCT01294358|579506825|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
160485798|NCT01294358|579506826|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
160485799|NCT01294358|579506827|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
160485800|NCT01294358|579506828|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
160485801|NCT03613454|579506829|FG000|Overall Study|Protocol Violation|1|||
160485802|NCT03613454|579506830|FG001|Overall Study|Protocol Violation|0|||
160485803|NCT03613454|579506829|FG000|Overall Study|Protocol Violation|0|||
160606405|NCT02437162|579937387|FG000|Overall Study|Study discontinued by Sponsor|93|||
160606406|NCT02437162|579937388|FG001|Overall Study|Study discontinued by Sponsor|98|||
160606407|NCT02437162|579937389|FG002|Overall Study|Study discontinued by Sponsor|97|||
160606408|NCT02437162|579937387|FG000|Overall Study|Withdrawal by Subject|13|||
160606409|NCT02437162|579937388|FG001|Overall Study|Withdrawal by Subject|7|||
160485804|NCT03613454|579506830|FG001|Overall Study|Protocol Violation|1|||
160485805|NCT02963922|579506831|FG000|Overall Study|Adverse Event|15|||
160485806|NCT02963922|579506832|FG001|Overall Study|Adverse Event|6|||
160485807|NCT02963922|579506831|FG000|Overall Study|Protocol deviation|6|||
160606410|NCT02437162|579937389|FG002|Overall Study|Withdrawal by Subject|9|||
160485808|NCT02963922|579506832|FG001|Overall Study|Protocol deviation|6|||
160485809|NCT02963922|579506831|FG000|Overall Study|Lack of Efficacy|1|||
160485810|NCT02963922|579506832|FG001|Overall Study|Lack of Efficacy|1|||
160485811|NCT02963922|579506831|FG000|Overall Study|Lost to Follow-up|2|||
160485812|NCT02963922|579506832|FG001|Overall Study|Lost to Follow-up|3|||
160485813|NCT02963922|579506831|FG000|Overall Study|Other|8|||
160485814|NCT02963922|579506832|FG001|Overall Study|Other|14|||
160485815|NCT00655668|579506841|FG000|Overall Study|Adverse Event|6|||
160485816|NCT00655668|579506841|FG000|Overall Study|Death|5|||
160485817|NCT00655668|579506841|FG000|Overall Study|Disease Progression|27|||
160485818|NCT00655668|579506841|FG000|Overall Study|Study Terminated|9|||
160485819|NCT00655668|579506841|FG000|Overall Study|Other|1|||
160485820|NCT00655668|579506841|FG000|Overall Study|New Lymphoma Treatment Started|4|||
160485821|NCT00655668|579506841|FG000|Overall Study|Withdrawal by Subject|2|||
160485822|NCT00257556|579506842|FG000|Overall Study|Adverse Event|1|||
160485823|NCT00257556|579506843|FG001|Overall Study|Adverse Event|4|||
160485824|NCT00257556|579506842|FG000|Overall Study|Physician Decision|6|||
160485825|NCT00257556|579506843|FG001|Overall Study|Physician Decision|0|||
160485826|NCT00257556|579506842|FG000|Overall Study|Did not meet hCG criterion|3|||
160485827|NCT00257556|579506843|FG001|Overall Study|Did not meet hCG criterion|0|||
160485828|NCT00257556|579506842|FG000|Overall Study|other reason|4|||
160485829|NCT00257556|579506843|FG001|Overall Study|other reason|6|||
160485830|NCT01780584|579506846|FG000|Overall Study|Death|1|||
160485831|NCT01780584|579506847|FG001|Overall Study|Death|0|||
160485832|NCT01780584|579506848|FG002|Overall Study|Death|1|||
160485833|NCT01780584|579506846|FG000|Overall Study|Adverse Event|0|||
160485834|NCT01780584|579506847|FG001|Overall Study|Adverse Event|1|||
160485835|NCT01780584|579506848|FG002|Overall Study|Adverse Event|0|||
160485836|NCT01780584|579506846|FG000|Overall Study|Protocol Violation|0|||
160485837|NCT01780584|579506847|FG001|Overall Study|Protocol Violation|0|||
160485838|NCT01780584|579506848|FG002|Overall Study|Protocol Violation|1|||
160485839|NCT00141271|579506853|FG000|Overall Study|Adverse Event|31|||
160485840|NCT00141271|579506854|FG001|Overall Study|Adverse Event|19|||
160485841|NCT00141271|579506855|FG002|Overall Study|Adverse Event|17|||
160485842|NCT00141271|579506853|FG000|Overall Study|Laboratory Abnormality|2|||
160485843|NCT00141271|579506854|FG001|Overall Study|Laboratory Abnormality|1|||
160485844|NCT00141271|579506855|FG002|Overall Study|Laboratory Abnormality|1|||
160485845|NCT00141271|579506853|FG000|Overall Study|Lack of Efficacy|7|||
160485846|NCT00141271|579506854|FG001|Overall Study|Lack of Efficacy|7|||
160485847|NCT00141271|579506855|FG002|Overall Study|Lack of Efficacy|3|||
160485848|NCT00141271|579506853|FG000|Overall Study|Lost to Follow-up|15|||
160485849|NCT00141271|579506854|FG001|Overall Study|Lost to Follow-up|15|||
160485850|NCT00141271|579506855|FG002|Overall Study|Lost to Follow-up|21|||
160485851|NCT00141271|579506853|FG000|Overall Study|Withdrawal by Subject|14|||
160485852|NCT00141271|579506854|FG001|Overall Study|Withdrawal by Subject|9|||
160485853|NCT00141271|579506855|FG002|Overall Study|Withdrawal by Subject|10|||
160485854|NCT00141271|579506853|FG000|Overall Study|Other|11|||
160485855|NCT00141271|579506854|FG001|Overall Study|Other|12|||
160485856|NCT00141271|579506855|FG002|Overall Study|Other|5|||
160485857|NCT01544153|579506856|FG000|Overall Study|Under 18|0|||
160485858|NCT01544153|579506857|FG001|Overall Study|Under 18|1|||
160485859|NCT01544153|579506858|FG002|Overall Study|Under 18|0|||
160606411|NCT02437162|579937387|FG000|Overall Study|Adverse Event|0|||
160606412|NCT02437162|579937388|FG001|Overall Study|Adverse Event|1|||
160606413|NCT02437162|579937389|FG002|Overall Study|Adverse Event|0|||
160606414|NCT02437162|579937387|FG000|Overall Study|Lost to Follow-up|1|||
160606415|NCT02437162|579937388|FG001|Overall Study|Lost to Follow-up|0|||
160606416|NCT02437162|579937389|FG002|Overall Study|Lost to Follow-up|1|||
160606417|NCT02437162|579937387|FG000|Overall Study|Death|0|||
160606418|NCT02437162|579937388|FG001|Overall Study|Death|1|||
160606419|NCT02437162|579937389|FG002|Overall Study|Death|0|||
160606420|NCT02437162|579937387|FG000|Overall Study|Other|0|||
160606421|NCT02437162|579937388|FG001|Overall Study|Other|0|||
160485860|NCT01544153|579506859|FG003|Overall Study|Under 18|0|||
160485861|NCT01544153|579506856|FG000|Overall Study|Non-smoker|0|||
160485862|NCT01544153|579506857|FG001|Overall Study|Non-smoker|0|||
160485863|NCT01544153|579506858|FG002|Overall Study|Non-smoker|1|||
160485864|NCT01544153|579506859|FG003|Overall Study|Non-smoker|0|||
160485865|NCT00390806|579506860|FG000|Overall Study|Lost to Follow-up|7|||
160485866|NCT00390806|579506861|FG001|Overall Study|Lost to Follow-up|6|||
160485867|NCT00390806|579506860|FG000|Overall Study|Protocol Violation|2|||
160485868|NCT00390806|579506861|FG001|Overall Study|Protocol Violation|2|||
160485869|NCT00390806|579506860|FG000|Overall Study|Withdrawal by Subject|12|||
160485870|NCT00390806|579506861|FG001|Overall Study|Withdrawal by Subject|15|||
160485871|NCT00390806|579506860|FG000|Overall Study|Investigator Decision|4|||
160485872|NCT00390806|579506861|FG001|Overall Study|Investigator Decision|6|||
160485873|NCT00390806|579506860|FG000|Overall Study|Death|1|||
160485874|NCT00390806|579506861|FG001|Overall Study|Death|0|||
160485875|NCT00390806|579506860|FG000|Overall Study|Physician Decision|0|||
160606422|NCT02437162|579937389|FG002|Overall Study|Other|1|||
160606423|NCT04338321|579937390|FG000|Overall Study|Adverse Event|4|||
160606424|NCT04338321|579937391|FG001|Overall Study|Adverse Event|10|||
160485876|NCT00390806|579506861|FG001|Overall Study|Physician Decision|1|||
160485877|NCT00390806|579506860|FG000|Overall Study|Ongoing|4|||
160485878|NCT00390806|579506861|FG001|Overall Study|Ongoing|2|||
160485879|NCT00884793|579506864|FG000|Overall Study|Withdrawal by Subject|1|||
160485880|NCT03169530|579506865|FG000|Overall Study|Study ended by NIH|15|||
160485881|NCT03169530|579506866|FG001|Overall Study|Study ended by NIH|17|||
160485882|NCT04783519|579506867|FG000|Overall Study|Withdrawal by Subject|2|||
160485883|NCT04783519|579506868|FG001|Overall Study|Withdrawal by Subject|7|||
160485884|NCT04783519|579506869|FG002|Overall Study|Withdrawal by Subject|3|||
160485885|NCT04783519|579506867|FG000|Overall Study|Lost to Follow-up|9|||
160485886|NCT04783519|579506868|FG001|Overall Study|Lost to Follow-up|7|||
160485887|NCT04783519|579506869|FG002|Overall Study|Lost to Follow-up|6|||
160485888|NCT01032200|579506870|FG000|Overall Study|Death|1|||
160485889|NCT01032200|579506871|FG001|Overall Study|Death|1|||
160485890|NCT01032200|579506870|FG000|Overall Study|Withdrawal by Subject|1|||
160485891|NCT01032200|579506871|FG001|Overall Study|Withdrawal by Subject|3|||
160485892|NCT01032200|579506870|FG000|Overall Study|Toxicity|0|||
160485893|NCT01032200|579506871|FG001|Overall Study|Toxicity|2|||
160485894|NCT01032200|579506870|FG000|Overall Study|Progression|1|||
160485895|NCT01032200|579506871|FG001|Overall Study|Progression|0|||
160485896|NCT01032200|579506870|FG000|Overall Study|Multiple|1|||
160485897|NCT01032200|579506871|FG001|Overall Study|Multiple|1|||
160485898|NCT00727259|579506875|FG000|Overall Study|Not all questionnaires completed|1055|||
160485899|NCT01021683|579506876|FG000|Overall Study|Lack of Efficacy|12|||
160485900|NCT01021683|579506876|FG000|Overall Study|Recovery of neutrophil count|51|||
160485901|NCT01021683|579506876|FG000|Overall Study|Other|8|||
160485902|NCT01374971|579506877|FG000|Overall Study|Withdrawal by Subject|1|||
160485903|NCT02273180|579506878|FG000|Overall Study|Adverse Event|2|||
160485904|NCT02273180|579506879|FG001|Overall Study|Adverse Event|2|||
160485905|NCT02273180|579506878|FG000|Overall Study|Lack of Efficacy|1|||
160485906|NCT02273180|579506879|FG001|Overall Study|Lack of Efficacy|0|||
160485907|NCT02273180|579506878|FG000|Overall Study|Protocol Violation|1|||
160485908|NCT02273180|579506879|FG001|Overall Study|Protocol Violation|7|||
160485909|NCT02273180|579506878|FG000|Overall Study|Randomized but not treated|1|||
160485910|NCT02273180|579506879|FG001|Overall Study|Randomized but not treated|0|||
160485911|NCT02273180|579506878|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
160485912|NCT02273180|579506879|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
160485913|NCT02273180|579506878|FG000|Overall Study|Other than specified above|21|||
160485914|NCT02273180|579506879|FG001|Overall Study|Other than specified above|10|||
160485915|NCT04531813|579506880|FG000|Overall Study|Protocol Violation|1|||
160485916|NCT04531813|579506880|FG000|Overall Study|Withdrawal by Subject|1|||
160485917|NCT00746785|579508567|FG000|Overall Study|Lost to Follow-up|29|||
160485918|NCT00746785|579508568|FG001|Overall Study|Lost to Follow-up|25|||
160485919|NCT00746785|579508569|FG002|Overall Study|Lost to Follow-up|27|||
160485920|NCT01231464|579508570|FG000|Overall Study|Adverse Event|0|||
160485921|NCT01231464|579508571|FG001|Overall Study|Adverse Event|1|||
160485922|NCT01231464|579508570|FG000|Overall Study|Protocol Violation|1|||
160485923|NCT01231464|579508571|FG001|Overall Study|Protocol Violation|2|||
160485924|NCT01231464|579508570|FG000|Overall Study|Lost to Follow-up|1|||
160485925|NCT01231464|579508571|FG001|Overall Study|Lost to Follow-up|2|||
160485926|NCT01231464|579508570|FG000|Overall Study|Withdrawal by Subject|3|||
160485927|NCT01231464|579508571|FG001|Overall Study|Withdrawal by Subject|2|||
160485928|NCT00837096|579508575|FG000|Overall Study|Physician Decision|1|||
160485929|NCT00837096|579508576|FG001|Overall Study|Physician Decision|1|||
160485930|NCT00837096|579508575|FG000|Overall Study|Not reported|9|||
160485931|NCT00837096|579508576|FG001|Overall Study|Not reported|8|||
160485932|NCT00983905|579508577|FG000|Theophylline Alone|Adverse Event|1|||
160485933|NCT00983905|579508577|FG000|Colchicine Alone|Adverse Event|2|||
160485934|NCT01169636|579508578|FG000|Overall Study|Adverse Event|0|||
160485935|NCT01169636|579508579|FG001|Overall Study|Adverse Event|0|||
160485936|NCT01169636|579508580|FG002|Overall Study|Adverse Event|1|||
160606425|NCT04338321|579937390|FG000|Overall Study|Death|1|||
160606426|NCT04338321|579937391|FG001|Overall Study|Death|1|||
160606427|NCT04338321|579937390|FG000|Overall Study|Lost to Follow-up|4|||
160606428|NCT04338321|579937391|FG001|Overall Study|Lost to Follow-up|9|||
160606429|NCT04338321|579937390|FG000|Overall Study|Withdrawal by Subject|45|||
160606430|NCT04338321|579937391|FG001|Overall Study|Withdrawal by Subject|69|||
160485937|NCT01169636|579508581|FG003|Overall Study|Adverse Event|1|||
160485938|NCT01169636|579508582|FG004|Overall Study|Adverse Event|0|||
160485939|NCT01169636|579508578|FG000|Overall Study|Screen failure|0|||
160485940|NCT01169636|579508579|FG001|Overall Study|Screen failure|0|||
160485941|NCT01169636|579508580|FG002|Overall Study|Screen failure|2|||
160485942|NCT01169636|579508581|FG003|Overall Study|Screen failure|0|||
160485943|NCT01169636|579508582|FG004|Overall Study|Screen failure|0|||
160485944|NCT01169636|579508578|FG000|Overall Study|Withdrawal by Subject|0|||
160485945|NCT01169636|579508579|FG001|Overall Study|Withdrawal by Subject|0|||
160485946|NCT01169636|579508580|FG002|Overall Study|Withdrawal by Subject|0|||
160485947|NCT01169636|579508581|FG003|Overall Study|Withdrawal by Subject|0|||
160606431|NCT04338321|579937390|FG000|Overall Study|Physician Decision|5|||
160606432|NCT04338321|579937391|FG001|Overall Study|Physician Decision|9|||
160485948|NCT01169636|579508582|FG004|Overall Study|Withdrawal by Subject|3|||
160485949|NCT00494026|579508583|FG000|Overall Study|Sponsor Decision|4|||
160485950|NCT00352053|579508587|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
160485951|NCT00352053|579508588|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
160485952|NCT00352053|579508587|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
160485953|NCT00352053|579508588|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
160485954|NCT00352053|579508587|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
160485955|NCT00352053|579508588|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
160485956|NCT00352053|579508587|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
160485957|NCT00352053|579508588|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
160485958|NCT00352053|579508587|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
160485959|NCT00352053|579508588|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
160485960|NCT00352053|579508587|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
160485961|NCT00352053|579508588|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
160485962|NCT00352053|579508587|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
160485963|NCT00352053|579508588|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
160485964|NCT00352053|579508587|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
160485965|NCT00352053|579508588|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
160485966|NCT00352053|579508587|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
160485967|NCT00352053|579508588|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
160485968|NCT00352053|579508587|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
160485969|NCT00352053|579508588|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
160485970|NCT00352053|579508587|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
160485971|NCT00352053|579508588|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
160485972|NCT00352053|579508587|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
160485973|NCT00352053|579508588|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
160485974|NCT00352053|579508587|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
160485975|NCT00352053|579508588|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
160485976|NCT00632931|579508594|FG000|Part 1, Period 1|Protocol Violation|1|||
160485977|NCT00632931|579508595|FG001|Part 1, Period 1|Protocol Violation|0|||
160485978|NCT00632931|579508596|FG002|Part 1, Period 1|Protocol Violation|0|||
160485979|NCT00632931|579508594|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
160485980|NCT00632931|579508595|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
160485981|NCT00632931|579508596|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
160485982|NCT00632931|579508594|FG000|Part 2|Adverse Event|0|||
160485983|NCT00632931|579508595|FG001|Part 2|Adverse Event|0|||
160485984|NCT00632931|579508596|FG002|Part 2|Adverse Event|3|||
160485985|NCT00632931|579508594|FG000|Part 2|Death|0|||
160485986|NCT00632931|579508595|FG001|Part 2|Death|0|||
160485987|NCT00632931|579508596|FG002|Part 2|Death|1|||
160485988|NCT00632931|579508594|FG000|Part 2|Lack of Efficacy|0|||
160485989|NCT00632931|579508595|FG001|Part 2|Lack of Efficacy|0|||
160485990|NCT00632931|579508596|FG002|Part 2|Lack of Efficacy|17|||
160485991|NCT00632931|579508594|FG000|Part 2|Withdrawal by Subject|0|||
160485992|NCT00632931|579508595|FG001|Part 2|Withdrawal by Subject|0|||
160485993|NCT00632931|579508596|FG002|Part 2|Withdrawal by Subject|3|||
160485994|NCT00833898|579508597|FG000|Overall Study|Withdrawal by Subject|33|||
160485995|NCT00833898|579508598|FG001|Overall Study|Withdrawal by Subject|27|||
160485996|NCT00833898|579508597|FG000|Overall Study|Lost to Follow-up|7|||
160485997|NCT00833898|579508598|FG001|Overall Study|Lost to Follow-up|7|||
160485998|NCT00833898|579508597|FG000|Overall Study|Patient did not receive transplant|0|||
160485999|NCT00833898|579508598|FG001|Overall Study|Patient did not receive transplant|2|||
160486000|NCT03226353|579508603|FG000|Overall Study|Withdrawal by Subject|1|||
160486001|NCT03226353|579508603|FG000|Overall Study|Screen Failure|5|||
160486002|NCT00498433|579508604|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
160486003|NCT00498433|579508605|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
160486004|NCT00498433|579508606|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
160486005|NCT00498433|579508604|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
160486006|NCT00498433|579508605|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
160486007|NCT00498433|579508606|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
160486008|NCT00498433|579508604|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
160486009|NCT00498433|579508605|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
160606433|NCT04338321|579937390|FG000|Overall Study|Other|3|||
160606434|NCT04338321|579937391|FG001|Overall Study|Other|10|||
160486010|NCT00498433|579508606|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
160486011|NCT00498433|579508604|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
160486012|NCT00498433|579508605|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
160486013|NCT00498433|579508606|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
160486014|NCT01885936|579508617|FG000|Overall Study|Withdrawal by Subject|1|||
160486015|NCT01885936|579508618|FG001|Overall Study|Withdrawal by Subject|0|||
160486016|NCT00797511|579508619|FG000|Overall Study|Withdrawal by Subject|1|||
160486017|NCT00427778|579508620|FG000|First Intervention (4 Weeks)|no longer interested|1|||
160486018|NCT00427778|579508621|FG001|First Intervention (4 Weeks)|no longer interested|0|||
160486019|NCT00427778|579508620|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
160486020|NCT00427778|579508621|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
160486021|NCT00427778|579508620|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
160486022|NCT00427778|579508621|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
160486023|NCT00427778|579508620|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
160486024|NCT00427778|579508621|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
160486025|NCT02845375|579508622|FG000|Overall Study|upper airway obstruction|1|||
160486026|NCT02845375|579508623|FG001|Overall Study|upper airway obstruction|2|||
160486027|NCT02845375|579508624|FG002|Overall Study|upper airway obstruction|1|||
160486028|NCT00225277|579508627|FG000|Overall Study|Adverse Event|30|||
160486029|NCT00225277|579508628|FG001|Overall Study|Adverse Event|34|||
160486030|NCT00225277|579508627|FG000|Overall Study|Lack of Efficacy|4|||
160486031|NCT00225277|579508628|FG001|Overall Study|Lack of Efficacy|1|||
160486032|NCT00225277|579508627|FG000|Overall Study|Lost to Follow-up|4|||
160486033|NCT00225277|579508628|FG001|Overall Study|Lost to Follow-up|6|||
160486034|NCT00225277|579508627|FG000|Overall Study|Physician Decision|6|||
160486035|NCT00225277|579508628|FG001|Overall Study|Physician Decision|8|||
160486036|NCT00225277|579508627|FG000|Overall Study|Protocol Violation|6|||
160486037|NCT00225277|579508628|FG001|Overall Study|Protocol Violation|3|||
160486038|NCT00225277|579508627|FG000|Overall Study|Withdrawal by Subject|40|||
160486039|NCT00225277|579508628|FG001|Overall Study|Withdrawal by Subject|34|||
160486040|NCT00225277|579508627|FG000|Overall Study|Other|7|||
160486041|NCT00225277|579508628|FG001|Overall Study|Other|9|||
160486042|NCT01340300|579508631|FG000|Overall Study|Lost to Follow-up|3|||
160486043|NCT01340300|579508632|FG001|Overall Study|Lost to Follow-up|0|||
160486044|NCT01340300|579508633|FG002|Overall Study|Lost to Follow-up|5|||
160486045|NCT01340300|579508634|FG003|Overall Study|Lost to Follow-up|10|||
160661064|NCT00579670|580141748|FG003|Overall Study|Lost to Follow-up|4|||
160661065|NCT00579670|580141749|FG004|Overall Study|Lost to Follow-up|0|||
160661066|NCT00579670|580141745|FG000|Overall Study|Other|0|||
160661067|NCT00579670|580141746|FG001|Overall Study|Other|0|||
160661068|NCT00579670|580141747|FG002|Overall Study|Other|1|||
160661069|NCT00579670|580141748|FG003|Overall Study|Other|2|||
160661070|NCT00579670|580141749|FG004|Overall Study|Other|0|||
160661071|NCT00579670|580141745|FG000|Overall Study|Withdrawal by Subject|0|||
160486046|NCT01340300|579508631|FG000|Overall Study|Withdrawal by Subject|5|||
160661072|NCT00579670|580141746|FG001|Overall Study|Withdrawal by Subject|0|||
160661073|NCT00579670|580141747|FG002|Overall Study|Withdrawal by Subject|1|||
160661074|NCT00579670|580141748|FG003|Overall Study|Withdrawal by Subject|0|||
160486047|NCT01340300|579508632|FG001|Overall Study|Withdrawal by Subject|6|||
160486048|NCT01340300|579508633|FG002|Overall Study|Withdrawal by Subject|6|||
160486049|NCT01340300|579508634|FG003|Overall Study|Withdrawal by Subject|3|||
160486050|NCT01340300|579508631|FG000|Overall Study|Adverse Event|1|||
160486051|NCT01340300|579508632|FG001|Overall Study|Adverse Event|0|||
160486052|NCT01340300|579508633|FG002|Overall Study|Adverse Event|4|||
160486053|NCT01340300|579508634|FG003|Overall Study|Adverse Event|0|||
160486054|NCT01340300|579508631|FG000|Overall Study|Physician Decision|0|||
160486055|NCT01340300|579508632|FG001|Overall Study|Physician Decision|1|||
160486056|NCT01340300|579508633|FG002|Overall Study|Physician Decision|0|||
160486057|NCT01340300|579508634|FG003|Overall Study|Physician Decision|0|||
160486058|NCT01340300|579508631|FG000|Overall Study|Unrelated sickness|0|||
160486059|NCT01340300|579508632|FG001|Overall Study|Unrelated sickness|2|||
160486060|NCT01340300|579508633|FG002|Overall Study|Unrelated sickness|0|||
160486061|NCT01340300|579508634|FG003|Overall Study|Unrelated sickness|1|||
160486062|NCT01951261|579508635|FG000|Overall Study|Death|1|||
160486063|NCT01951261|579508636|FG001|Overall Study|Death|0|||
160486064|NCT01951261|579508635|FG000|Overall Study|Lost to Follow-up|4|||
160486065|NCT01951261|579508636|FG001|Overall Study|Lost to Follow-up|3|||
160486066|NCT01951261|579508635|FG000|Overall Study|Protocol Violation|4|||
160486067|NCT01951261|579508636|FG001|Overall Study|Protocol Violation|3|||
160486068|NCT03927222|579508640|FG000|Overall Study|Progression|3|||
160486069|NCT03927222|579508640|FG000|Overall Study|CMV testing results inconclusive|1|||
160486070|NCT03927222|579508640|FG000|Overall Study|Unable to generate enough vaccines|1|||
160486071|NCT03927222|579508640|FG000|Overall Study|Early study termination|1|||
160486072|NCT00818519|579508653|FG000|Overall Study|Adverse Event|2|||
160486073|NCT00818519|579508654|FG001|Overall Study|Adverse Event|2|||
160486074|NCT00818519|579508653|FG000|Overall Study|Lost to Follow-up|4|||
160486075|NCT00818519|579508654|FG001|Overall Study|Lost to Follow-up|6|||
160486076|NCT00818519|579508653|FG000|Overall Study|Protocol Violation|2|||
160486077|NCT00818519|579508654|FG001|Overall Study|Protocol Violation|1|||
160486078|NCT00818519|579508653|FG000|Overall Study|Pregnancy|0|||
160486079|NCT00818519|579508654|FG001|Overall Study|Pregnancy|1|||
160486080|NCT00818519|579508653|FG000|Overall Study|Withdrawal by Subject|4|||
160486081|NCT00818519|579508654|FG001|Overall Study|Withdrawal by Subject|9|||
160486082|NCT00818519|579508653|FG000|Overall Study|participant recovered completely|1|||
160486083|NCT00818519|579508654|FG001|Overall Study|participant recovered completely|0|||
160486084|NCT00818519|579508653|FG000|Overall Study|participant will leave for long tme|1|||
160486085|NCT00818519|579508654|FG001|Overall Study|participant will leave for long tme|0|||
160486086|NCT01180790|579508656|FG000|Overall Study|Adverse Event|1|||
160486087|NCT01180790|579508657|FG001|Overall Study|Adverse Event|1|||
160486088|NCT01180790|579508658|FG002|Overall Study|Adverse Event|2|||
160486089|NCT01180790|579508659|FG003|Overall Study|Adverse Event|0|||
160486090|NCT01180790|579508660|FG004|Overall Study|Adverse Event|1|||
160486091|NCT01180790|579508661|FG005|Overall Study|Adverse Event|3|||
160486092|NCT01180790|579508662|FG006|Overall Study|Adverse Event|0|||
160486093|NCT01180790|579508656|FG000|Overall Study|Withdrawal by Subject|3|||
160486094|NCT01180790|579508657|FG001|Overall Study|Withdrawal by Subject|0|||
160486095|NCT01180790|579508658|FG002|Overall Study|Withdrawal by Subject|5|||
160486096|NCT01180790|579508659|FG003|Overall Study|Withdrawal by Subject|0|||
160486097|NCT01180790|579508660|FG004|Overall Study|Withdrawal by Subject|2|||
160486098|NCT01180790|579508661|FG005|Overall Study|Withdrawal by Subject|1|||
160486099|NCT01180790|579508662|FG006|Overall Study|Withdrawal by Subject|0|||
160486100|NCT01180790|579508656|FG000|Overall Study|Lost to Follow-up|3|||
160486101|NCT01180790|579508657|FG001|Overall Study|Lost to Follow-up|1|||
160486102|NCT01180790|579508658|FG002|Overall Study|Lost to Follow-up|0|||
160486103|NCT01180790|579508659|FG003|Overall Study|Lost to Follow-up|2|||
160486104|NCT01180790|579508660|FG004|Overall Study|Lost to Follow-up|1|||
160486105|NCT01180790|579508661|FG005|Overall Study|Lost to Follow-up|0|||
160486106|NCT01180790|579508662|FG006|Overall Study|Lost to Follow-up|1|||
160486107|NCT01180790|579508656|FG000|Overall Study|Physician Decision|1|||
160486108|NCT01180790|579508657|FG001|Overall Study|Physician Decision|0|||
160486109|NCT01180790|579508658|FG002|Overall Study|Physician Decision|0|||
160486110|NCT01180790|579508659|FG003|Overall Study|Physician Decision|1|||
160486111|NCT01180790|579508660|FG004|Overall Study|Physician Decision|0|||
160486112|NCT01180790|579508661|FG005|Overall Study|Physician Decision|0|||
160486113|NCT01180790|579508662|FG006|Overall Study|Physician Decision|0|||
160486114|NCT01180790|579508656|FG000|Overall Study|Lack of Efficacy|1|||
160486115|NCT01180790|579508657|FG001|Overall Study|Lack of Efficacy|2|||
160486116|NCT01180790|579508658|FG002|Overall Study|Lack of Efficacy|5|||
160486117|NCT01180790|579508659|FG003|Overall Study|Lack of Efficacy|6|||
160486118|NCT01180790|579508660|FG004|Overall Study|Lack of Efficacy|1|||
160486119|NCT01180790|579508661|FG005|Overall Study|Lack of Efficacy|3|||
160486120|NCT01180790|579508662|FG006|Overall Study|Lack of Efficacy|0|||
160486121|NCT01180790|579508656|FG000|Overall Study|compliance|0|||
160486122|NCT01180790|579508657|FG001|Overall Study|compliance|1|||
160486123|NCT01180790|579508658|FG002|Overall Study|compliance|0|||
160486124|NCT01180790|579508659|FG003|Overall Study|compliance|0|||
160486125|NCT01180790|579508660|FG004|Overall Study|compliance|0|||
160486126|NCT01180790|579508661|FG005|Overall Study|compliance|0|||
160486127|NCT01180790|579508662|FG006|Overall Study|compliance|0|||
160486128|NCT01180790|579508656|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
160486129|NCT01180790|579508657|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
160486130|NCT01180790|579508658|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
160486131|NCT01180790|579508659|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
160486132|NCT01180790|579508660|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
160486133|NCT01180790|579508661|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
160486134|NCT01180790|579508662|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
160486135|NCT02335242|579508663|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
160486136|NCT02335242|579508664|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
160486137|NCT02335242|579508663|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
160486138|NCT02335242|579508664|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
160486139|NCT02335242|579508663|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
160486140|NCT02335242|579508664|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
160486141|NCT04167085|579508665|FG000|Baseline|Withdrawal by Subject|2|||
160486142|NCT04167085|579508666|FG001|Baseline|Withdrawal by Subject|1|||
160486143|NCT04167085|579508665|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
160486144|NCT04167085|579508666|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
160486145|NCT03840148|579508667|FG000|Study Drug Disposition|Adverse Event|13|||
160486146|NCT03840148|579508668|FG001|Study Drug Disposition|Adverse Event|2|||
160486147|NCT03840148|579508667|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
160486148|NCT03840148|579508668|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
160486149|NCT03840148|579508667|FG000|Study Drug Disposition|Lack of Efficacy|3|||
160486150|NCT03840148|579508668|FG001|Study Drug Disposition|Lack of Efficacy|0|||
160486151|NCT03840148|579508667|FG000|Study Drug Disposition|Physician Decision|2|||
160486152|NCT03840148|579508668|FG001|Study Drug Disposition|Physician Decision|0|||
160486153|NCT03840148|579508667|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
160486154|NCT03840148|579508668|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
160486155|NCT03840148|579508667|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
160486156|NCT03840148|579508668|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
160486157|NCT03840148|579508667|FG000|Study Completion Disposition|Physician Decision|2|||
160486158|NCT03840148|579508668|FG001|Study Completion Disposition|Physician Decision|0|||
160486159|NCT03840148|579508667|FG000|Study Completion Disposition|Covid-19 related|2|||
160486160|NCT03840148|579508668|FG001|Study Completion Disposition|Covid-19 related|0|||
160486161|NCT03840148|579508667|FG000|Study Completion Disposition|Lost to Follow-up|1|||
160486162|NCT03840148|579508668|FG001|Study Completion Disposition|Lost to Follow-up|1|||
160486163|NCT03840148|579508667|FG000|Study Completion Disposition|Death|1|||
160486164|NCT03840148|579508668|FG001|Study Completion Disposition|Death|0|||
160486165|NCT03840148|579508667|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
160486166|NCT03840148|579508668|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
160486167|NCT03615404|579508669|FG000|Overall Study|Death|1|||
160486168|NCT03615404|579508669|FG000|Overall Study|vaccine did not pass quality assurance|1|||
160486169|NCT03873038|579508670|FG000|Part 2|Withdrawal by Subject|0|||
160486170|NCT03873038|579508671|FG001|Part 2|Withdrawal by Subject|0|||
160486171|NCT03873038|579508672|FG002|Part 2|Withdrawal by Subject|0|||
160486172|NCT03873038|579508673|FG003|Part 2|Withdrawal by Subject|0|||
160486173|NCT03873038|579508674|FG004|Part 2|Withdrawal by Subject|0|||
160486174|NCT03873038|579508675|FG005|Part 2|Withdrawal by Subject|1|||
160486175|NCT03873038|579508670|FG000|Part 2|Unknon|0|||
160486176|NCT03873038|579508671|FG001|Part 2|Unknon|0|||
160486177|NCT03873038|579508672|FG002|Part 2|Unknon|0|||
160486178|NCT03873038|579508673|FG003|Part 2|Unknon|0|||
160486179|NCT03873038|579508674|FG004|Part 2|Unknon|1|||
160486180|NCT03873038|579508675|FG005|Part 2|Unknon|0|||
160486181|NCT04222088|579508677|FG000|Overall Study|Lost to Follow-up|5|||
160486182|NCT04222088|579508678|FG001|Overall Study|Lost to Follow-up|1|||
160486183|NCT04222088|579508677|FG000|Overall Study|Withdrawal by Subject|4|||
160486184|NCT04222088|579508678|FG001|Overall Study|Withdrawal by Subject|0|||
160486185|NCT00595764|579508679|FG000|Overall Study|Protocol Violation|24|||
160486186|NCT00595764|579508680|FG001|Overall Study|Protocol Violation|19|||
160486187|NCT00595764|579508679|FG000|Overall Study|Missed Medication >1 week|10|||
160486188|NCT00595764|579508680|FG001|Overall Study|Missed Medication >1 week|17|||
160486189|NCT00595764|579508679|FG000|Overall Study|Missed 3 PM visits|1|||
160606435|NCT03321526|579937392|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
160606436|NCT03321526|579937393|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
160606437|NCT03321526|579937392|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
160606438|NCT03321526|579937393|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
160606439|NCT03321526|579937392|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
160606440|NCT03321526|579937393|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
160606441|NCT03321526|579937392|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
160606442|NCT03321526|579937393|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
160486190|NCT00595764|579508680|FG001|Overall Study|Missed 3 PM visits|7|||
160486191|NCT00595764|579508679|FG000|Overall Study|Withdrawal by Subject|4|||
160486192|NCT00595764|579508680|FG001|Overall Study|Withdrawal by Subject|0|||
160486193|NCT03849300|579508681|FG000|Overall Study|move out to different area|1|||
160486194|NCT03849300|579508682|FG001|Overall Study|move out to different area|3|||
160486195|NCT03849300|579508683|FG002|Overall Study|move out to different area|1|||
160486196|NCT03849300|579508684|FG003|Overall Study|move out to different area|4|||
160486197|NCT03849300|579508681|FG000|Overall Study|scheduling/transportation conflict|4|||
160486198|NCT03849300|579508682|FG001|Overall Study|scheduling/transportation conflict|4|||
160486199|NCT03849300|579508683|FG002|Overall Study|scheduling/transportation conflict|3|||
160486200|NCT03849300|579508684|FG003|Overall Study|scheduling/transportation conflict|2|||
160486201|NCT04839289|579508685|FG000|Overall Study|Withdrawal by Subject|1|||
160486202|NCT04839289|579508686|FG001|Overall Study|Withdrawal by Subject|0|||
160486203|NCT00464737|579508688|FG000|Overall Study|Adverse Event|12|||
160486204|NCT00464737|579508689|FG001|Overall Study|Adverse Event|17|||
160486205|NCT00464737|579508690|FG002|Overall Study|Adverse Event|33|||
160486206|NCT00464737|579508688|FG000|Overall Study|Lack of Efficacy|7|||
160486207|NCT00464737|579508689|FG001|Overall Study|Lack of Efficacy|7|||
160486208|NCT00464737|579508690|FG002|Overall Study|Lack of Efficacy|4|||
160486209|NCT00464737|579508688|FG000|Overall Study|Withdrawal by Subject|5|||
160486210|NCT00464737|579508689|FG001|Overall Study|Withdrawal by Subject|3|||
160486211|NCT00464737|579508690|FG002|Overall Study|Withdrawal by Subject|5|||
160486212|NCT00464737|579508688|FG000|Overall Study|Protocol Violation|1|||
160486213|NCT00464737|579508689|FG001|Overall Study|Protocol Violation|1|||
160486214|NCT00464737|579508690|FG002|Overall Study|Protocol Violation|5|||
160486215|NCT00464737|579508688|FG000|Overall Study|Non-compliance|0|||
160486216|NCT00464737|579508689|FG001|Overall Study|Non-compliance|1|||
160486217|NCT00464737|579508690|FG002|Overall Study|Non-compliance|1|||
160486218|NCT00464737|579508688|FG000|Overall Study|Lost to Follow-up|5|||
160486219|NCT00464737|579508689|FG001|Overall Study|Lost to Follow-up|2|||
160486220|NCT00464737|579508690|FG002|Overall Study|Lost to Follow-up|5|||
160486221|NCT00464737|579508688|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
160486222|NCT00464737|579508689|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
160486223|NCT00464737|579508690|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
160486224|NCT00464737|579508688|FG000|Overall Study|Other: Subject left town; family illness|1|||
160486225|NCT00464737|579508689|FG001|Overall Study|Other: Subject left town; family illness|0|||
160486226|NCT00464737|579508690|FG002|Overall Study|Other: Subject left town; family illness|0|||
160486227|NCT00464737|579508688|FG000|Overall Study|Other: Study demands too great|0|||
160486228|NCT00464737|579508689|FG001|Overall Study|Other: Study demands too great|1|||
160486229|NCT00464737|579508690|FG002|Overall Study|Other: Study demands too great|0|||
160486230|NCT00464737|579508688|FG000|Overall Study|Other: Personal family reasons|0|||
160486231|NCT00464737|579508689|FG001|Overall Study|Other: Personal family reasons|0|||
160486232|NCT00464737|579508690|FG002|Overall Study|Other: Personal family reasons|1|||
160486233|NCT00464737|579508688|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
160486234|NCT00464737|579508689|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
160486235|NCT00464737|579508690|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
160486236|NCT00580047|579508693|FG000|Overall Study|Lost to Follow-up|1|||
160486237|NCT00580047|579508694|FG001|Overall Study|Lost to Follow-up|1|||
160486238|NCT00580047|579508695|FG002|Overall Study|Lost to Follow-up|0|||
160486239|NCT00580047|579508693|FG000|Overall Study|Withdrawal by Subject|1|||
160486240|NCT00580047|579508694|FG001|Overall Study|Withdrawal by Subject|1|||
160486241|NCT00580047|579508695|FG002|Overall Study|Withdrawal by Subject|2|||
160486242|NCT00580047|579508693|FG000|Overall Study|Withdrawal by Subject|1|||
160486243|NCT00580047|579508694|FG001|Overall Study|Withdrawal by Subject|0|||
160486244|NCT00580047|579508695|FG002|Overall Study|Withdrawal by Subject|0|||
160486245|NCT02820298|579508698|FG000|Overall Study|Withdrawal by Subject|0|||
160486246|NCT02820298|579508699|FG001|Overall Study|Withdrawal by Subject|1|||
160486247|NCT02820298|579508698|FG000|Overall Study|Physician Decision|1|||
160486248|NCT02820298|579508699|FG001|Overall Study|Physician Decision|0|||
160486249|NCT02820298|579508698|FG000|Overall Study|Protocol Violation|0|||
160486250|NCT02820298|579508699|FG001|Overall Study|Protocol Violation|1|||
160486251|NCT03406507|579508709|FG000|Extension Period|Lack of Efficacy|0|||
160486252|NCT03406507|579508710|FG001|Extension Period|Lack of Efficacy|1|||
160486253|NCT04341584|579508711|FG000|Overall Study|Withdrew consent|0|||
160486254|NCT04341584|579508712|FG001|Overall Study|Withdrew consent|2|||
160486255|NCT04341584|579508713|FG002|Overall Study|Withdrew consent|2|||
160486256|NCT04341584|579508714|FG003|Overall Study|Withdrew consent|1|||
160486257|NCT04130061|579508715|FG000|Overall Study|OR team forgot to request membrane|1|||
160486258|NCT04130061|579508716|FG001|Overall Study|OR team forgot to request membrane|0|||
160486259|NCT03449134|579510446|FG000|52-Week Treatment Period|Death|2|||
160486260|NCT03449134|579510447|FG001|52-Week Treatment Period|Death|1|||
160486261|NCT03449134|579510448|FG002|52-Week Treatment Period|Death|0|||
160486262|NCT03449134|579510446|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
160486263|NCT03449134|579510447|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
160486264|NCT03449134|579510448|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
160486265|NCT03449134|579510446|FG000|52-Week Treatment Period|Physician Decision|2|||
160661075|NCT00579670|580141749|FG004|Overall Study|Withdrawal by Subject|0|||
160661076|NCT00112463|580141750|FG000|Overall Study|Physician Decision|1|||
160486266|NCT03449134|579510447|FG001|52-Week Treatment Period|Physician Decision|3|||
160486267|NCT03449134|579510448|FG002|52-Week Treatment Period|Physician Decision|3|||
160486268|NCT03449134|579510446|FG000|52-Week Treatment Period|Screen Failure|1|||
160486269|NCT03449134|579510447|FG001|52-Week Treatment Period|Screen Failure|0|||
160486270|NCT03449134|579510448|FG002|52-Week Treatment Period|Screen Failure|1|||
160486271|NCT03449134|579510446|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
160486272|NCT03449134|579510447|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
160486273|NCT03449134|579510448|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
160486274|NCT03449134|579510446|FG000|52-Week Treatment Period|Site Closure|1|||
160486275|NCT03449134|579510447|FG001|52-Week Treatment Period|Site Closure|0|||
160486276|NCT03449134|579510448|FG002|52-Week Treatment Period|Site Closure|0|||
160486277|NCT01821729|579510449|FG000|Overall Study|Withdrawal by Subject|1|||
160486278|NCT01644188|579510453|FG000|Overall Study|Adverse Event|44|||
160486279|NCT01644188|579510454|FG001|Overall Study|Adverse Event|20|||
160486280|NCT01644188|579510453|FG000|Overall Study|Poor compliance to protocol|26|||
160486281|NCT01644188|579510454|FG001|Overall Study|Poor compliance to protocol|14|||
160486282|NCT01644188|579510453|FG000|Overall Study|Physician Decision|1|||
160486283|NCT01644188|579510454|FG001|Overall Study|Physician Decision|3|||
160486284|NCT01644188|579510453|FG000|Overall Study|Participant moved|7|||
160486285|NCT01644188|579510454|FG001|Overall Study|Participant moved|2|||
160486286|NCT01644188|579510453|FG000|Overall Study|Related to auto-injector administration|2|||
160486287|NCT01644188|579510454|FG001|Overall Study|Related to auto-injector administration|2|||
160486288|NCT01644188|579510453|FG000|Overall Study|Consent withdrawn by participant|14|||
160486289|NCT01644188|579510454|FG001|Overall Study|Consent withdrawn by participant|7|||
160486290|NCT01644188|579510453|FG000|Overall Study|Selection criteria finally not met|2|||
160486291|NCT01644188|579510454|FG001|Overall Study|Selection criteria finally not met|0|||
160486292|NCT01644188|579510453|FG000|Overall Study|Lost to Follow-up|1|||
160486293|NCT01644188|579510454|FG001|Overall Study|Lost to Follow-up|0|||
160486294|NCT01644188|579510453|FG000|Overall Study|Death|4|||
160486295|NCT01644188|579510454|FG001|Overall Study|Death|3|||
160486296|NCT01644188|579510453|FG000|Overall Study|Last visit outside protocol visit window|14|||
160486297|NCT01644188|579510454|FG001|Overall Study|Last visit outside protocol visit window|16|||
160486298|NCT01644188|579510453|FG000|Overall Study|Site closure|1|||
160486299|NCT01644188|579510454|FG001|Overall Study|Site closure|1|||
160486300|NCT01644188|579510453|FG000|Overall Study|Other than specified above|6|||
160486301|NCT01644188|579510454|FG001|Overall Study|Other than specified above|7|||
160486302|NCT01845649|579510460|FG000|Overall Study|Adverse Event|7|||
160486303|NCT01845649|579510461|FG001|Overall Study|Adverse Event|10|||
160486304|NCT01845649|579510460|FG000|Overall Study|Lack of Efficacy|1|||
160486305|NCT01845649|579510461|FG001|Overall Study|Lack of Efficacy|1|||
160486306|NCT01845649|579510460|FG000|Overall Study|Lost to Follow-up|2|||
160486307|NCT01845649|579510461|FG001|Overall Study|Lost to Follow-up|2|||
160486308|NCT01845649|579510460|FG000|Overall Study|Withdrew Consent|12|||
160486309|NCT01845649|579510461|FG001|Overall Study|Withdrew Consent|4|||
160486310|NCT01845649|579510460|FG000|Overall Study|Protocol Deviation|7|||
160486311|NCT01845649|579510461|FG001|Overall Study|Protocol Deviation|4|||
160486312|NCT01845649|579510460|FG000|Overall Study|Reason not Specified|2|||
160486313|NCT01845649|579510461|FG001|Overall Study|Reason not Specified|1|||
160486314|NCT00719212|579510464|FG000|Overall Study|Death|41|||
160486315|NCT00719212|579510464|FG000|Overall Study|Lost to Follow-up|2|||
160486316|NCT00719212|579510464|FG000|Overall Study|Withdrawal by Subject|1|||
160486317|NCT00966979|579510468|FG000|Overall Study|Death|1|||
160486318|NCT00966979|579510468|FG000|Overall Study|Lost to Follow-up|6|||
160486319|NCT00966979|579510468|FG000|Overall Study|Withdrawal by Subject|14|||
160486320|NCT00966979|579510468|FG000|Overall Study|Adverse Event|5|||
160486321|NCT00966979|579510468|FG000|Overall Study|Sponsor terminated early|49|||
160486322|NCT00966979|579510468|FG000|Overall Study|Censored because surgery not done|2|||
160486323|NCT00966979|579510468|FG000|Overall Study|Censored because study device was not implanted|14|||
160486324|NCT00966979|579510468|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
160486325|NCT03713281|579510469|FG000|Overall Study|Lens handling difficuluties|2|||
160486326|NCT03713281|579510469|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
160486327|NCT01990313|579510471|FG000|Overall Study|Lost to Follow-up|1|||
160486328|NCT02412111|579510472|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
160486329|NCT02412111|579510473|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
160486330|NCT02412111|579510474|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
160486331|NCT02412111|579510472|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
160486332|NCT02412111|579510473|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
160486333|NCT02412111|579510474|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
160486334|NCT02412111|579510472|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
160486335|NCT02412111|579510473|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
160486336|NCT02412111|579510474|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
160486337|NCT02412111|579510472|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
160486338|NCT02412111|579510473|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
160486339|NCT02412111|579510474|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
160486340|NCT02412111|579510472|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
160486341|NCT02412111|579510473|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
160486342|NCT02412111|579510474|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
160486343|NCT02412111|579510472|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
160486344|NCT02412111|579510473|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
160486345|NCT02412111|579510474|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
160486346|NCT02412111|579510472|FG000|Active Comparator Period (8 Weeks)|Other|0|||
160486347|NCT02412111|579510473|FG001|Active Comparator Period (8 Weeks)|Other|0|||
160486348|NCT02412111|579510474|FG002|Active Comparator Period (8 Weeks)|Other|2|||
160486349|NCT00721214|579510476|FG000|Overall Study|Chose another center for transplant|1|||
160486350|NCT00721214|579510476|FG000|Overall Study|Death|3|||
160486351|NCT02396953|579510477|FG000|Overall Study|Withdrawal by Subject|0|||
160486352|NCT02396953|579510478|FG001|Overall Study|Withdrawal by Subject|0|||
160486353|NCT02396953|579510479|FG002|Overall Study|Withdrawal by Subject|1|||
160486354|NCT02396953|579510477|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
160486355|NCT02396953|579510478|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
160486356|NCT02396953|579510479|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
160486357|NCT02396953|579510477|FG000|Overall Study|Personal Reasons|1|||
160486358|NCT02396953|579510478|FG001|Overall Study|Personal Reasons|1|||
160486359|NCT02396953|579510479|FG002|Overall Study|Personal Reasons|0|||
160486360|NCT02624869|579510480|FG000|Overall Study|Lost to Follow-up|0|||
160486361|NCT02624869|579510481|FG001|Overall Study|Lost to Follow-up|0|||
160486362|NCT02624869|579510482|FG002|Overall Study|Lost to Follow-up|1|||
160486363|NCT02624869|579510480|FG000|Overall Study|Withdrawal by Subject|1|||
160486364|NCT02624869|579510481|FG001|Overall Study|Withdrawal by Subject|3|||
160486365|NCT02624869|579510482|FG002|Overall Study|Withdrawal by Subject|1|||
160486366|NCT00510198|579510483|FG000|Overall Study|Withdrawal by Subject|5|||
160486367|NCT00510198|579510484|FG001|Overall Study|Withdrawal by Subject|4|||
160486368|NCT00329550|579510486|FG000|Overall Study|Adverse Event|3|||
160486369|NCT00329550|579510487|FG001|Overall Study|Adverse Event|4|||
160486370|NCT00329550|579510488|FG002|Overall Study|Adverse Event|2|||
160486371|NCT00329550|579510486|FG000|Overall Study|Withdrawal of Consent|1|||
160486372|NCT00329550|579510487|FG001|Overall Study|Withdrawal of Consent|0|||
160486373|NCT00329550|579510488|FG002|Overall Study|Withdrawal of Consent|1|||
160486374|NCT00329550|579510486|FG000|Overall Study|Due to Relocation|0|||
160486375|NCT00329550|579510487|FG001|Overall Study|Due to Relocation|0|||
160486376|NCT00329550|579510488|FG002|Overall Study|Due to Relocation|1|||
160486377|NCT02994784|579510489|FG000|6 Months Follow-up|Lost to Follow-up|3|||
160486378|NCT02466243|579510490|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
160486379|NCT02466243|579510491|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
160486380|NCT02466243|579510490|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
160486381|NCT02466243|579510491|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
160486382|NCT02466243|579510490|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
160486383|NCT02466243|579510491|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
160486384|NCT02466243|579510490|FG000|Part B Open-label Treatment Period|Missing|2|||
160486385|NCT02466243|579510491|FG001|Part B Open-label Treatment Period|Missing|2|||
160486386|NCT01649557|579510492|FG000|Overall Study|Lost to Follow-up|5|||
160486387|NCT01649557|579510493|FG001|Overall Study|Lost to Follow-up|0|||
160486388|NCT01649557|579510494|FG002|Overall Study|Lost to Follow-up|3|||
160486389|NCT01649557|579510492|FG000|Overall Study|Adverse Event|7|||
160486390|NCT01649557|579510493|FG001|Overall Study|Adverse Event|5|||
160486391|NCT01649557|579510494|FG002|Overall Study|Adverse Event|1|||
160486392|NCT01649557|579510492|FG000|Overall Study|Met withdrawal criteria|4|||
160486393|NCT01649557|579510493|FG001|Overall Study|Met withdrawal criteria|0|||
160486394|NCT01649557|579510494|FG002|Overall Study|Met withdrawal criteria|0|||
160486395|NCT01649557|579510492|FG000|Overall Study|Physician Decision|8|||
160486396|NCT01649557|579510493|FG001|Overall Study|Physician Decision|2|||
160486397|NCT01649557|579510494|FG002|Overall Study|Physician Decision|1|||
160486398|NCT01649557|579510492|FG000|Overall Study|Withdrawal by Subject|15|||
160486399|NCT01649557|579510493|FG001|Overall Study|Withdrawal by Subject|5|||
160486400|NCT01649557|579510494|FG002|Overall Study|Withdrawal by Subject|4|||
160486401|NCT01649557|579510492|FG000|Overall Study|Protocol deviation|0|||
160486402|NCT01649557|579510493|FG001|Overall Study|Protocol deviation|2|||
160606443|NCT03321526|579937392|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
160606444|NCT03321526|579937393|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
160486403|NCT01649557|579510494|FG002|Overall Study|Protocol deviation|0|||
160486404|NCT01649557|579510492|FG000|Overall Study|Lack of Efficacy|5|||
160606445|NCT03321526|579937392|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
160486405|NCT01649557|579510493|FG001|Overall Study|Lack of Efficacy|0|||
160486406|NCT01649557|579510494|FG002|Overall Study|Lack of Efficacy|0|||
160486407|NCT01011049|579510495|FG000|Overall Study|Protocol Violation|0|||
160486408|NCT01011049|579510496|FG001|Overall Study|Protocol Violation|0|||
160486409|NCT01011049|579510497|FG002|Overall Study|Protocol Violation|2|||
160486410|NCT01011049|579510498|FG003|Overall Study|Protocol Violation|0|||
160486411|NCT01011049|579510495|FG000|Overall Study|Lost to Follow-up|1|||
160486412|NCT01011049|579510496|FG001|Overall Study|Lost to Follow-up|2|||
160486413|NCT01011049|579510497|FG002|Overall Study|Lost to Follow-up|1|||
160486414|NCT01011049|579510498|FG003|Overall Study|Lost to Follow-up|0|||
160486415|NCT01011049|579510495|FG000|Overall Study|Withdrawal by Subject|0|||
160486416|NCT01011049|579510496|FG001|Overall Study|Withdrawal by Subject|0|||
160486417|NCT01011049|579510497|FG002|Overall Study|Withdrawal by Subject|1|||
160486418|NCT01011049|579510498|FG003|Overall Study|Withdrawal by Subject|0|||
160486419|NCT02815735|579510499|FG000|First Intervention (4 Weeks)|Discomfort|1|||
160486420|NCT02815735|579510500|FG001|First Intervention (4 Weeks)|Discomfort|0|||
160486421|NCT02815735|579510499|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
160486422|NCT02815735|579510500|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
160486423|NCT02815735|579510499|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
160486424|NCT02815735|579510500|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
160486425|NCT02815735|579510499|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
160486426|NCT02815735|579510500|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
160486427|NCT02435381|579510501|FG000|Overall Study|Lost to Follow-up|2|||
160486428|NCT02435381|579510502|FG001|Overall Study|Lost to Follow-up|1|||
160486429|NCT04150341|579510505|FG000|Overall Study|Physician Decision|0|||
160486430|NCT04150341|579510506|FG001|Overall Study|Physician Decision|0|||
160606446|NCT03321526|579937393|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
160606447|NCT03321526|579937392|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
160606448|NCT03321526|579937393|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
160606449|NCT03321526|579937392|FG000|Follow-up Phase (2 Weeks)|Other|24|||
160606450|NCT03321526|579937393|FG001|Follow-up Phase (2 Weeks)|Other|24|||
160606451|NCT03097133|579937394|FG000|Overall Study|Lost to Follow-up|3|||
160606452|NCT03097133|579937395|FG001|Overall Study|Lost to Follow-up|2|||
160606453|NCT03097133|579937394|FG000|Overall Study|Withdrawal by Subject|2|||
160606454|NCT03097133|579937395|FG001|Overall Study|Withdrawal by Subject|5|||
160606455|NCT03097133|579937394|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
160606456|NCT03097133|579937395|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
160486431|NCT04150341|579510507|FG002|Overall Study|Physician Decision|1|||
160486432|NCT04150341|579510508|FG003|Overall Study|Physician Decision|0|||
160486433|NCT04150341|579510509|FG004|Overall Study|Physician Decision|0|||
160486434|NCT04150341|579510510|FG005|Overall Study|Physician Decision|0|||
160606457|NCT03097133|579937394|FG000|Overall Study|Other|3|||
160606458|NCT03097133|579937395|FG001|Overall Study|Other|2|||
160661077|NCT00112463|580141750|FG000|Overall Study|Progression|30|||
160661078|NCT00112463|580141750|FG000|Overall Study|Second Primary|1|||
160661079|NCT00112463|580141750|FG000|Overall Study|Toxicity|3|||
160661080|NCT00112463|580141750|FG000|Overall Study|Withdrawal by Subject|2|||
160661081|NCT00112463|580141750|FG000|Overall Study|Never started treatment|2|||
160661082|NCT00678639|580141751|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
160661083|NCT00678639|580141752|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
160661084|NCT01546545|580141754|FG000|Overall Study|Withdrawal by Subject|1|||
160661085|NCT01214850|580141755|FG000|Overall Study|Withdrawal by Subject|38|||
160661086|NCT01214850|580141756|FG001|Overall Study|Withdrawal by Subject|31|||
160661087|NCT01214850|580141757|FG002|Overall Study|Withdrawal by Subject|28|||
160661088|NCT01214850|580141755|FG000|Overall Study|Lost to Follow-up|124|||
160661089|NCT01214850|580141756|FG001|Overall Study|Lost to Follow-up|98|||
160661090|NCT01214850|580141757|FG002|Overall Study|Lost to Follow-up|123|||
160661091|NCT01214850|580141755|FG000|Overall Study|Protocol Violation|5|||
160661092|NCT01214850|580141756|FG001|Overall Study|Protocol Violation|5|||
160606459|NCT03097133|579937394|FG000|Overall Study|Adverse Event|1|||
160606460|NCT03097133|579937395|FG001|Overall Study|Adverse Event|0|||
160606461|NCT00732641|579937396|FG000|Overall Study|Relapse or Progressive Disease|65|||
160606462|NCT00732641|579937397|FG001|Overall Study|Relapse or Progressive Disease|101|||
160606463|NCT00732641|579937396|FG000|Overall Study|Serious Adverse Events|12|||
160606464|NCT00732641|579937397|FG001|Overall Study|Serious Adverse Events|3|||
160606465|NCT00732641|579937396|FG000|Overall Study|Physician Decision|6|||
160606466|NCT00732641|579937397|FG001|Overall Study|Physician Decision|0|||
160606467|NCT00732641|579937396|FG000|Overall Study|Withdrawal by Subject|4|||
160606468|NCT00732641|579937397|FG001|Overall Study|Withdrawal by Subject|2|||
160606469|NCT00732641|579937396|FG000|Overall Study|Unable to Complete|1|||
160606470|NCT00732641|579937397|FG001|Overall Study|Unable to Complete|1|||
160606471|NCT00732641|579937396|FG000|Overall Study|Other|18|||
160606472|NCT00732641|579937397|FG001|Overall Study|Other|5|||
160606473|NCT02910089|579937398|FG000|Overall Study|Lost insurance eligibility|22|||
160606474|NCT02910089|579937399|FG001|Overall Study|Lost insurance eligibility|16|||
160606475|NCT00732238|579937400|FG000|Overall Study|Bacteremia|4|||
160606476|NCT00732238|579937401|FG001|Overall Study|Bacteremia|1|||
160606477|NCT00732238|579937400|FG000|Overall Study|Asymptomatic bacteriuria|1|||
160606478|NCT00732238|579937401|FG001|Overall Study|Asymptomatic bacteriuria|0|||
160606479|NCT02280096|579937402|FG000|Overall Study|Pregnancy|1|||
160606480|NCT02280096|579937403|FG001|Overall Study|Pregnancy|0|||
160606481|NCT02280096|579937402|FG000|Overall Study|Functional neurological disorder|1|||
160606482|NCT02280096|579937403|FG001|Overall Study|Functional neurological disorder|0|||
160606483|NCT02280096|579937402|FG000|Overall Study|Lack of attachment|0|||
160606484|NCT02280096|579937403|FG001|Overall Study|Lack of attachment|1|||
160606485|NCT00246376|579937406|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
160606486|NCT00246376|579937407|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
160606487|NCT00246376|579937408|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
160606488|NCT00246376|579937409|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
160606489|NCT00246376|579937410|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
160606490|NCT00246376|579937406|FG000|Overall Study|Adverse Event|2|||
160606491|NCT00246376|579937407|FG001|Overall Study|Adverse Event|3|||
160606492|NCT00246376|579937408|FG002|Overall Study|Adverse Event|1|||
160606493|NCT00246376|579937409|FG003|Overall Study|Adverse Event|3|||
160606494|NCT00246376|579937410|FG004|Overall Study|Adverse Event|1|||
160606495|NCT00246376|579937406|FG000|Overall Study|Lost to Follow-up|2|||
160606496|NCT00246376|579937407|FG001|Overall Study|Lost to Follow-up|11|||
160606497|NCT00246376|579937408|FG002|Overall Study|Lost to Follow-up|11|||
160606498|NCT00246376|579937409|FG003|Overall Study|Lost to Follow-up|16|||
160606499|NCT00246376|579937410|FG004|Overall Study|Lost to Follow-up|13|||
160606500|NCT03434041|579937415|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
160606501|NCT03434041|579937416|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
160606502|NCT03434041|579937415|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
160606503|NCT03434041|579937416|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
160606504|NCT03434041|579937415|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
160606505|NCT03434041|579937416|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
160606506|NCT03434041|579937415|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
160606507|NCT03434041|579937416|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
160606508|NCT03434041|579937415|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
160661093|NCT01214850|580141757|FG002|Overall Study|Protocol Violation|6|||
160606509|NCT03434041|579937416|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
160606510|NCT03434041|579937415|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
160606511|NCT03434041|579937416|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
160606512|NCT03434041|579937415|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
160606513|NCT03434041|579937416|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
160661094|NCT01214850|580141755|FG000|Overall Study|Adverse event or death|11|||
160661095|NCT01214850|580141756|FG001|Overall Study|Adverse event or death|8|||
160661096|NCT01214850|580141757|FG002|Overall Study|Adverse event or death|3|||
160606514|NCT03434041|579937415|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
160606515|NCT03434041|579937416|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
160606516|NCT03434041|579937415|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
160606517|NCT03434041|579937416|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
160606518|NCT03434041|579937415|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
160606519|NCT03434041|579937416|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
160606520|NCT03434041|579937415|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
160606521|NCT03434041|579937416|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
160606522|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
160606523|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
160606524|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
160606525|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
160606526|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
160606527|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
160606528|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
160606529|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
160606530|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
160606531|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
160606532|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
160606533|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
160606534|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
160606535|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
160606536|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
160606537|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
160606538|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
160606539|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
160606540|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
160606541|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
160606542|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
160606543|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
160606544|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
160606545|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
160606546|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
160606547|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
160606548|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
160606549|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
160606550|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
160606551|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
160606552|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
160606553|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
160606554|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
160606555|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
160606556|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
160606557|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
160606558|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
160606559|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
160606560|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
160606561|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
160606562|NCT03605836|579937417|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
160606563|NCT03605836|579937418|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
160606564|NCT03605836|579937419|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
160606565|NCT03605836|579937420|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
160606566|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
160606567|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
160606568|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
160606569|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
160606570|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
160606571|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
160606572|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
160486435|NCT04150341|579510505|FG000|Overall Study|Adverse Event|0|||
160486436|NCT04150341|579510506|FG001|Overall Study|Adverse Event|0|||
160486437|NCT04150341|579510507|FG002|Overall Study|Adverse Event|0|||
160486438|NCT04150341|579510508|FG003|Overall Study|Adverse Event|0|||
160486439|NCT04150341|579510509|FG004|Overall Study|Adverse Event|1|||
160486440|NCT04150341|579510510|FG005|Overall Study|Adverse Event|0|||
160486441|NCT00875615|579510511|FG000|Overall Study|Withdrawal by Subject|1|||
160486442|NCT00405912|579510512|FG000|Overall Study|Withdrawal by Subject|12|||
160486443|NCT00405912|579510513|FG001|Overall Study|Withdrawal by Subject|11|||
160486444|NCT00405912|579510514|FG002|Overall Study|Withdrawal by Subject|12|||
160486445|NCT00405912|579510512|FG000|Overall Study|Lost to Follow-up|4|||
160486446|NCT00405912|579510513|FG001|Overall Study|Lost to Follow-up|8|||
160486447|NCT00405912|579510514|FG002|Overall Study|Lost to Follow-up|4|||
160486448|NCT03730662|579510516|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
160486449|NCT03730662|579510517|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
160486450|NCT03730662|579510518|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
160486451|NCT03730662|579510519|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
160486452|NCT03730662|579510516|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
160486453|NCT03730662|579510517|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
160486454|NCT03730662|579510518|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
160486455|NCT03730662|579510519|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
160486456|NCT03730662|579510516|FG000|Treatment Period (52 Weeks)|Death|6|||
160486457|NCT03730662|579510517|FG001|Treatment Period (52 Weeks)|Death|2|||
160486458|NCT03730662|579510518|FG002|Treatment Period (52 Weeks)|Death|2|||
160486459|NCT03730662|579510519|FG003|Treatment Period (52 Weeks)|Death|9|||
160486460|NCT03730662|579510516|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
160486461|NCT03730662|579510517|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
160486462|NCT03730662|579510518|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
160486463|NCT03730662|579510519|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
160606573|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
160606574|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
160606575|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
160606576|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
160606577|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
160606578|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
160606579|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
160606580|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
160606581|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
160606582|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
160606583|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
160606584|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
160606585|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
160606586|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
160606587|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
160606588|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
160606589|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
160606590|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
160606591|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
160606592|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
160606593|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
160606594|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
160606595|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
160606596|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
160606597|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
160606598|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
160606599|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
160606600|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
160606601|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
160606602|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
160606603|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
160606604|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
160606605|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
160606606|NCT03605836|579937417|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
160606607|NCT03605836|579937418|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
160606608|NCT03605836|579937419|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
160606609|NCT03605836|579937420|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
160606610|NCT00621244|579937421|FG000|Overall Study|Withdrawal by Subject|7|||
160486464|NCT03730662|579510516|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
160606611|NCT00621244|579937422|FG001|Overall Study|Withdrawal by Subject|3|||
160606612|NCT00621244|579937423|FG002|Overall Study|Withdrawal by Subject|3|||
160606613|NCT00621244|579937424|FG003|Overall Study|Withdrawal by Subject|3|||
160606614|NCT00621244|579937421|FG000|Overall Study|Disease progression|44|||
160606615|NCT00621244|579937422|FG001|Overall Study|Disease progression|20|||
160606616|NCT00621244|579937423|FG002|Overall Study|Disease progression|20|||
160606617|NCT00621244|579937424|FG003|Overall Study|Disease progression|15|||
160606618|NCT00621244|579937421|FG000|Overall Study|Death|3|||
160606619|NCT00621244|579937422|FG001|Overall Study|Death|3|||
160606620|NCT00621244|579937423|FG002|Overall Study|Death|1|||
160606621|NCT00621244|579937424|FG003|Overall Study|Death|1|||
160606622|NCT00621244|579937421|FG000|Overall Study|Adverse Event|27|||
160606623|NCT00621244|579937422|FG001|Overall Study|Adverse Event|7|||
160606624|NCT00621244|579937423|FG002|Overall Study|Adverse Event|9|||
160606625|NCT00621244|579937424|FG003|Overall Study|Adverse Event|2|||
160606626|NCT00621244|579937421|FG000|Overall Study|Administrative problems|5|||
160606627|NCT00621244|579937422|FG001|Overall Study|Administrative problems|1|||
160606628|NCT00621244|579937423|FG002|Overall Study|Administrative problems|0|||
160606629|NCT00621244|579937424|FG003|Overall Study|Administrative problems|2|||
160606630|NCT01594411|579937425|FG000|Overall Study|Lost to Follow-up|2|||
160606631|NCT01975376|579937426|FG000|Overall Study|Adverse Event|5|||
160661097|NCT01214850|580141755|FG000|Overall Study|Inappropriate enrollment|2|||
160661098|NCT01214850|580141756|FG001|Overall Study|Inappropriate enrollment|1|||
160661099|NCT01214850|580141757|FG002|Overall Study|Inappropriate enrollment|0|||
160661100|NCT01214850|580141755|FG000|Overall Study|Administrative reason|1|||
160661101|NCT01214850|580141756|FG001|Overall Study|Administrative reason|0|||
160661102|NCT01214850|580141757|FG002|Overall Study|Administrative reason|0|||
160661103|NCT01214850|580141755|FG000|Overall Study|Unable to classify|2|||
160661104|NCT01214850|580141756|FG001|Overall Study|Unable to classify|1|||
160661105|NCT01214850|580141757|FG002|Overall Study|Unable to classify|1|||
160486465|NCT03730662|579510517|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
160486466|NCT03730662|579510518|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
160486467|NCT03730662|579510519|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
160486468|NCT03730662|579510516|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
160486469|NCT03730662|579510517|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
160486470|NCT03730662|579510518|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
160606632|NCT01975376|579937427|FG001|Overall Study|Adverse Event|5|||
160606633|NCT01975376|579937426|FG000|Overall Study|Death|65|||
160606634|NCT01975376|579937427|FG001|Overall Study|Death|72|||
160606635|NCT01975376|579937426|FG000|Overall Study|Lost to Follow-up|70|||
160606636|NCT01975376|579937427|FG001|Overall Study|Lost to Follow-up|66|||
160606637|NCT01975376|579937426|FG000|Overall Study|Withdrew consent|68|||
160606638|NCT01975376|579937427|FG001|Overall Study|Withdrew consent|62|||
160486471|NCT03730662|579510519|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
160486472|NCT03730662|579510516|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
160486473|NCT03730662|579510517|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
160486474|NCT03730662|579510518|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
160486475|NCT03730662|579510519|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
160486476|NCT03730662|579510516|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
160486477|NCT03730662|579510517|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
160486478|NCT03730662|579510518|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
160486479|NCT03730662|579510519|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
160486480|NCT03730662|579510516|FG000|Variable Treatment Period|Adverse Event|1|||
160486481|NCT03730662|579510517|FG001|Variable Treatment Period|Adverse Event|2|||
160486482|NCT03730662|579510518|FG002|Variable Treatment Period|Adverse Event|0|||
160486483|NCT03730662|579510519|FG003|Variable Treatment Period|Adverse Event|7|||
160486484|NCT03730662|579510516|FG000|Variable Treatment Period|Death|9|||
160486485|NCT03730662|579510517|FG001|Variable Treatment Period|Death|0|||
160486486|NCT03730662|579510518|FG002|Variable Treatment Period|Death|6|||
160486487|NCT03730662|579510519|FG003|Variable Treatment Period|Death|26|||
160486488|NCT03730662|579510516|FG000|Variable Treatment Period|Lost to Follow-up|2|||
160486489|NCT03730662|579510517|FG001|Variable Treatment Period|Lost to Follow-up|1|||
160486490|NCT03730662|579510518|FG002|Variable Treatment Period|Lost to Follow-up|4|||
160486491|NCT03730662|579510519|FG003|Variable Treatment Period|Lost to Follow-up|11|||
160486492|NCT03730662|579510516|FG000|Variable Treatment Period|Personal Reason|0|||
160486493|NCT03730662|579510517|FG001|Variable Treatment Period|Personal Reason|2|||
160486494|NCT03730662|579510518|FG002|Variable Treatment Period|Personal Reason|1|||
160486495|NCT03730662|579510519|FG003|Variable Treatment Period|Personal Reason|6|||
160486496|NCT03730662|579510516|FG000|Variable Treatment Period|Physician Decision|0|||
160486497|NCT03730662|579510517|FG001|Variable Treatment Period|Physician Decision|0|||
160486498|NCT03730662|579510518|FG002|Variable Treatment Period|Physician Decision|0|||
160486499|NCT03730662|579510519|FG003|Variable Treatment Period|Physician Decision|3|||
160486500|NCT03730662|579510516|FG000|Variable Treatment Period|Protocol Violation|0|||
160486501|NCT03730662|579510517|FG001|Variable Treatment Period|Protocol Violation|1|||
160486502|NCT03730662|579510518|FG002|Variable Treatment Period|Protocol Violation|1|||
160486503|NCT03730662|579510519|FG003|Variable Treatment Period|Protocol Violation|1|||
160486504|NCT03730662|579510516|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
160486505|NCT03730662|579510517|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
160486506|NCT03730662|579510518|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
160486507|NCT03730662|579510519|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
160486508|NCT02895360|579510528|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
160486509|NCT02895360|579510529|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
160486510|NCT02895360|579510530|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
160486511|NCT02895360|579510531|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
160486512|NCT02895360|579510532|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
160486513|NCT02895360|579510533|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
160486514|NCT02895360|579510528|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
160486515|NCT02895360|579510529|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
160486516|NCT02895360|579510530|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
160486517|NCT02895360|579510531|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
160486518|NCT02895360|579510532|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
160486519|NCT02895360|579510533|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
160486520|NCT02895360|579510528|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
160486521|NCT02895360|579510529|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
160486522|NCT02895360|579510530|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
160486523|NCT02895360|579510531|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
160486524|NCT02895360|579510532|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
160486525|NCT02895360|579510533|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
160486526|NCT02895360|579510528|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
160486527|NCT02895360|579510529|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
160486528|NCT02895360|579510530|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
160486529|NCT02895360|579510531|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
160486530|NCT02895360|579510532|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
160486531|NCT02895360|579510533|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
160486532|NCT02895360|579510528|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
160486533|NCT02895360|579510529|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
160486534|NCT02895360|579510530|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
160486535|NCT02895360|579510531|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
160486536|NCT02895360|579510532|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
160486537|NCT02895360|579510533|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
160486538|NCT02895360|579510528|FG000|Phase 2a|Adverse Event|0|||
160486539|NCT02895360|579510529|FG001|Phase 2a|Adverse Event|0|||
160486540|NCT02895360|579510530|FG002|Phase 2a|Adverse Event|0|||
160486541|NCT02895360|579510531|FG003|Phase 2a|Adverse Event|0|||
160661106|NCT00585689|580141762|FG000|Overall Study|Received different ABI-007 schedule|3|||
160486542|NCT02895360|579510532|FG004|Phase 2a|Adverse Event|0|||
160486543|NCT02895360|579510533|FG005|Phase 2a|Adverse Event|1|||
160486544|NCT02895360|579510528|FG000|Phase 2a|Progressive disease|0|||
160486545|NCT02895360|579510529|FG001|Phase 2a|Progressive disease|0|||
160486546|NCT02895360|579510530|FG002|Phase 2a|Progressive disease|0|||
160486547|NCT02895360|579510531|FG003|Phase 2a|Progressive disease|0|||
160486548|NCT02895360|579510532|FG004|Phase 2a|Progressive disease|11|||
160486549|NCT02895360|579510533|FG005|Phase 2a|Progressive disease|11|||
160486550|NCT00307164|579510536|FG000|Overall Study|Death|1|||
160486551|NCT00307164|579510537|FG001|Overall Study|Death|0|||
160486552|NCT00307164|579510536|FG000|Overall Study|Severe debilitation, unable to continue|1|||
160486553|NCT00307164|579510537|FG001|Overall Study|Severe debilitation, unable to continue|0|||
160486554|NCT00307164|579510536|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
160486555|NCT00307164|579510537|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
160486556|NCT00307164|579510536|FG000|Overall Study|Withdrawal by Subject|1|||
160486557|NCT00307164|579510537|FG001|Overall Study|Withdrawal by Subject|8|||
160486558|NCT00307164|579510536|FG000|Overall Study|Not compliant with requirements|4|||
160486559|NCT00307164|579510537|FG001|Overall Study|Not compliant with requirements|4|||
160486560|NCT00307164|579510536|FG000|Overall Study|Lost to Follow-up|6|||
160486561|NCT00307164|579510537|FG001|Overall Study|Lost to Follow-up|1|||
160486562|NCT03712449|579510538|FG000|Overall Study|Withdraw Consent|0|||
160486563|NCT03712449|579510539|FG001|Overall Study|Withdraw Consent|1|||
160486564|NCT00666198|579510540|FG000|Overall Study|Protocol Violation|10|||
160486565|NCT00666198|579510540|FG000|Overall Study|No Visit After First Day of Treatment|13|||
160486566|NCT00666198|579510540|FG000|Overall Study|Safety Not Assessable|6|||
160486567|NCT00666198|579510540|FG000|Overall Study|No Drug Administration|4|||
160486568|NCT03972137|579510543|FG000|Overall Study|Lost to Follow-up|2|||
160486569|NCT03972137|579510543|FG000|Overall Study|Withdrawal by Subject|4|||
160486570|NCT03220776|579510544|FG000|Overall Study|Claustrophobia|0|||
160486571|NCT03220776|579510545|FG001|Overall Study|Claustrophobia|1|||
160486572|NCT03220776|579510546|FG002|Overall Study|Claustrophobia|1|||
160486573|NCT03220776|579510547|FG003|Overall Study|Claustrophobia|0|||
160486574|NCT03220776|579510548|FG004|Overall Study|Claustrophobia|1|||
160486575|NCT03220776|579510549|FG005|Overall Study|Claustrophobia|0|||
160486576|NCT03220776|579510544|FG000|Overall Study|MRI Equipment Failure|1|||
160486577|NCT03220776|579510545|FG001|Overall Study|MRI Equipment Failure|0|||
160486578|NCT03220776|579510546|FG002|Overall Study|MRI Equipment Failure|0|||
160486579|NCT03220776|579510547|FG003|Overall Study|MRI Equipment Failure|0|||
160486580|NCT03220776|579510548|FG004|Overall Study|MRI Equipment Failure|0|||
160486581|NCT03220776|579510549|FG005|Overall Study|MRI Equipment Failure|0|||
160486582|NCT03220776|579510544|FG000|Overall Study|Inclimate Weather|0|||
160486583|NCT03220776|579510545|FG001|Overall Study|Inclimate Weather|0|||
160486584|NCT03220776|579510546|FG002|Overall Study|Inclimate Weather|0|||
160486585|NCT03220776|579510547|FG003|Overall Study|Inclimate Weather|0|||
160486586|NCT03220776|579510548|FG004|Overall Study|Inclimate Weather|0|||
160486587|NCT03220776|579510549|FG005|Overall Study|Inclimate Weather|1|||
160486588|NCT03220776|579510544|FG000|Overall Study|Physician Decision|0|||
160486589|NCT03220776|579510545|FG001|Overall Study|Physician Decision|0|||
160486590|NCT03220776|579510546|FG002|Overall Study|Physician Decision|0|||
160486591|NCT03220776|579510547|FG003|Overall Study|Physician Decision|1|||
160486592|NCT03220776|579510548|FG004|Overall Study|Physician Decision|0|||
160486593|NCT03220776|579510549|FG005|Overall Study|Physician Decision|0|||
160486594|NCT03220776|579510544|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
160486595|NCT03220776|579510545|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
160486596|NCT03220776|579510546|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
160486597|NCT03220776|579510547|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
160486598|NCT03220776|579510548|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
160486599|NCT03220776|579510549|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
160486600|NCT03220776|579510544|FG000|Overall Study|Protocol Violation|0|||
160486601|NCT03220776|579510545|FG001|Overall Study|Protocol Violation|0|||
160486602|NCT03220776|579510546|FG002|Overall Study|Protocol Violation|0|||
160486603|NCT03220776|579510547|FG003|Overall Study|Protocol Violation|2|||
160486604|NCT03220776|579510548|FG004|Overall Study|Protocol Violation|0|||
160486605|NCT03220776|579510549|FG005|Overall Study|Protocol Violation|1|||
160486606|NCT03220776|579510544|FG000|Overall Study|Withdrawal by Subject|1|||
160486607|NCT03220776|579510545|FG001|Overall Study|Withdrawal by Subject|0|||
160486608|NCT03220776|579510546|FG002|Overall Study|Withdrawal by Subject|0|||
160486609|NCT03220776|579510547|FG003|Overall Study|Withdrawal by Subject|0|||
160486610|NCT03220776|579510548|FG004|Overall Study|Withdrawal by Subject|0|||
160486611|NCT03220776|579510549|FG005|Overall Study|Withdrawal by Subject|0|||
160486612|NCT03168425|579510550|FG000|Overall Study|Lost to Follow-up|5|||
160486613|NCT03168425|579510551|FG001|Overall Study|Lost to Follow-up|8|||
160661107|NCT00585689|580141762|FG000|Overall Study|Adverse Event|1|||
160486614|NCT03168425|579510550|FG000|Overall Study|unable to confirm post op opioids|2|||
160486615|NCT03168425|579510551|FG001|Overall Study|unable to confirm post op opioids|3|||
160486616|NCT03029234|579510554|FG000|Overall Study|Sponsor Decision|1|||
160486617|NCT03029234|579510554|FG000|Overall Study|Withdrawal by Subject|5|||
160486618|NCT03029234|579510554|FG000|Overall Study|Death|91|||
160486619|NCT03029234|579510554|FG000|Overall Study|Lost to Follow-up|2|||
160486620|NCT04491006|579510555|FG000|Overall Study|Adverse Event|0|||
160486621|NCT04491006|579510556|FG001|Overall Study|Adverse Event|3|||
160486622|NCT04491006|579510557|FG002|Overall Study|Adverse Event|5|||
160486623|NCT04491006|579510555|FG000|Overall Study|Withdrawal by Subject|1|||
160486624|NCT04491006|579510556|FG001|Overall Study|Withdrawal by Subject|0|||
160486625|NCT04491006|579510557|FG002|Overall Study|Withdrawal by Subject|2|||
160486626|NCT01960114|579510558|FG000|Overall Study|Adverse Event|1|||
160486627|NCT01960114|579510559|FG001|Overall Study|Adverse Event|0|||
160486628|NCT01960114|579510558|FG000|Overall Study|Could not swallow study medication|0|||
160486629|NCT01960114|579510559|FG001|Overall Study|Could not swallow study medication|1|||
160486630|NCT01177137|579510560|FG000|Overall Study|Withdrawal by Subject|10|||
160486631|NCT01177137|579510561|FG001|Overall Study|Withdrawal by Subject|10|||
160486632|NCT01177137|579510562|FG002|Overall Study|Withdrawal by Subject|2|||
160486633|NCT03723915|579510563|FG000|Screening|Failed to meet screening requirements.|2|||
160486634|NCT03723915|579510563|FG000|On Treatment|Failed to meet treatment requirements|2|||
160486635|NCT02201771|579510564|FG000|Overall Study|Death|3|||
160486636|NCT02201771|579510565|FG001|Overall Study|Death|2|||
160486637|NCT02201771|579510566|FG002|Overall Study|Death|0|||
160486638|NCT02201771|579510564|FG000|Overall Study|Protocol Violation|10|||
160486639|NCT02201771|579510565|FG001|Overall Study|Protocol Violation|8|||
160486640|NCT02201771|579510566|FG002|Overall Study|Protocol Violation|10|||
160486641|NCT03569475|579510567|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
160486642|NCT03569475|579510568|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
160486643|NCT03569475|579510569|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
160486644|NCT03569475|579510567|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
160486645|NCT03569475|579510568|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
160486646|NCT03569475|579510569|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
160486647|NCT03569475|579510567|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
160486648|NCT03569475|579510568|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
160486649|NCT03569475|579510569|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
160486650|NCT03569475|579510567|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
160486651|NCT03569475|579510568|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
160486652|NCT03569475|579510569|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
160486653|NCT03569475|579510567|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
160486654|NCT03569475|579510568|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
160486655|NCT03569475|579510569|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
160486656|NCT03569475|579510567|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
160486657|NCT03569475|579510568|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
160486658|NCT03569475|579510569|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
160486659|NCT03569475|579510567|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
160486660|NCT03569475|579510568|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
160486661|NCT03569475|579510569|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
160661108|NCT00585689|580141762|FG000|Overall Study|Patient Declined Surgery|1|||
160661109|NCT00585689|580141762|FG000|Overall Study|Patient had unresectable disease|1|||
160661110|NCT00585689|580141762|FG000|Overall Study|Death|1|||
160661111|NCT02930005|580141764|FG000|Overall Study|Lost to Follow-up|1|||
160486662|NCT03569475|579510567|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
160486663|NCT03569475|579510568|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
160486664|NCT03569475|579510569|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
160486665|NCT03569475|579510567|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
160486666|NCT03569475|579510568|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
160486667|NCT03569475|579510569|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
160486668|NCT01287416|579510571|FG000|Pre-post Training|Withdrawal by Subject|17|||
160486669|NCT01287416|579510572|FG001|Pre-post Training|Withdrawal by Subject|24|||
160486670|NCT01287416|579510571|FG000|Pre-post Training|Lost to Follow-up|5|||
160486671|NCT01287416|579510572|FG001|Pre-post Training|Lost to Follow-up|1|||
160486672|NCT01287416|579510571|FG000|6 Month Follow-up|Lost to Follow-up|3|||
160486673|NCT01287416|579510572|FG001|6 Month Follow-up|Lost to Follow-up|2|||
160486674|NCT00645099|579510574|FG000|Overall Study|Lack of Efficacy|15|||
160486675|NCT00645099|579510575|FG001|Overall Study|Lack of Efficacy|6|||
160486676|NCT00645099|579510574|FG000|Overall Study|Withdrawal by Subject|30|||
160486677|NCT00645099|579510575|FG001|Overall Study|Withdrawal by Subject|22|||
160486678|NCT00645099|579510574|FG000|Overall Study|Lost to Follow-up|6|||
160486679|NCT00645099|579510575|FG001|Overall Study|Lost to Follow-up|4|||
160486680|NCT00645099|579510574|FG000|Overall Study|Adverse Event|11|||
160486681|NCT00645099|579510575|FG001|Overall Study|Adverse Event|5|||
160486682|NCT00645099|579510574|FG000|Overall Study|Other|9|||
160486683|NCT00645099|579510575|FG001|Overall Study|Other|5|||
160661112|NCT02930005|580141765|FG001|Overall Study|Lost to Follow-up|5|||
160661113|NCT00870870|580141766|FG000|Overall Study|Withdrawal by Subject|0|||
160661114|NCT00870870|580141767|FG001|Overall Study|Withdrawal by Subject|1|||
160661115|NCT00870870|580141768|FG002|Overall Study|Withdrawal by Subject|1|||
160661116|NCT00870870|580141769|FG003|Overall Study|Withdrawal by Subject|3|||
160661117|NCT00870870|580141766|FG000|Overall Study|Adverse Event|0|||
160661118|NCT00870870|580141767|FG001|Overall Study|Adverse Event|0|||
160661119|NCT00870870|580141768|FG002|Overall Study|Adverse Event|2|||
160661120|NCT00870870|580141769|FG003|Overall Study|Adverse Event|2|||
160661121|NCT03639311|580141773|FG000|Maintenance Phase|Lost to Follow-up|1|||
160661122|NCT03639311|580141774|FG001|Maintenance Phase|Lost to Follow-up|0|||
160661123|NCT03639311|580141775|FG002|Maintenance Phase|Lost to Follow-up|0|||
160661124|NCT03639311|580141773|FG000|Maintenance Phase|Adverse Event|1|||
160661125|NCT03639311|580141774|FG001|Maintenance Phase|Adverse Event|0|||
160661126|NCT03639311|580141775|FG002|Maintenance Phase|Adverse Event|0|||
160661127|NCT03639311|580141773|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
160486684|NCT01201915|579510576|FG000|Overall Study|Adverse Event|2|||
160606639|NCT01975376|579937426|FG000|Overall Study|Other|2|||
160606640|NCT01975376|579937427|FG001|Overall Study|Other|4|||
160606641|NCT01975376|579937426|FG000|Overall Study|Randomized, Not Treated|16|||
160606642|NCT01975376|579937427|FG001|Overall Study|Randomized, Not Treated|8|||
160606643|NCT01451398|579937428|FG000|Overall Study|Adverse Event|7|||
160606644|NCT01451398|579937429|FG001|Overall Study|Adverse Event|9|||
160606645|NCT01451398|579937428|FG000|Overall Study|Protocol Violation|1|||
160606646|NCT01451398|579937429|FG001|Overall Study|Protocol Violation|2|||
160606647|NCT01451398|579937428|FG000|Overall Study|Physician Decision|1|||
160606648|NCT01451398|579937429|FG001|Overall Study|Physician Decision|1|||
160606649|NCT01451398|579937428|FG000|Overall Study|Withdrawal by Subject|10|||
160606650|NCT01451398|579937429|FG001|Overall Study|Withdrawal by Subject|14|||
160606651|NCT01451398|579937428|FG000|Overall Study|Lost to Follow-up|6|||
160606652|NCT01451398|579937429|FG001|Overall Study|Lost to Follow-up|4|||
160606653|NCT01451398|579937428|FG000|Overall Study|Non-compliance with study drug|1|||
160606654|NCT01451398|579937429|FG001|Overall Study|Non-compliance with study drug|3|||
160606655|NCT01451398|579937428|FG000|Overall Study|Non-compliance with protocol|1|||
160661128|NCT03639311|580141774|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
160661129|NCT03639311|580141775|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
160661130|NCT03639311|580141773|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
160661131|NCT03639311|580141774|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
160661132|NCT03639311|580141775|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
160661133|NCT03639311|580141773|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
160661134|NCT03639311|580141774|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
160661135|NCT03639311|580141775|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
160486685|NCT01201915|579510577|FG001|Overall Study|Adverse Event|1|||
160661136|NCT03639311|580141773|FG000|Maintenance Phase|Lack of Efficacy|1|||
160661137|NCT03639311|580141774|FG001|Maintenance Phase|Lack of Efficacy|0|||
160661138|NCT03639311|580141775|FG002|Maintenance Phase|Lack of Efficacy|0|||
160661139|NCT00822926|580141776|FG000|Second Injection Visit|Lost to Follow-up|1|||
160661140|NCT00822926|580141777|FG001|Second Injection Visit|Lost to Follow-up|0|||
160486686|NCT01201915|579510578|FG002|Overall Study|Adverse Event|1|||
160486687|NCT01201915|579510576|FG000|Overall Study|Lost to Follow-up|0|||
160486688|NCT01201915|579510577|FG001|Overall Study|Lost to Follow-up|4|||
160606656|NCT01451398|579937429|FG001|Overall Study|Non-compliance with protocol|1|||
160606657|NCT01451398|579937428|FG000|Overall Study|Moved out of country|0|||
160606658|NCT01451398|579937429|FG001|Overall Study|Moved out of country|1|||
160606659|NCT01451398|579937428|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
160606660|NCT01451398|579937429|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
160606661|NCT01451398|579937428|FG000|Overall Study|Lack of Efficacy|0|||
160606662|NCT01451398|579937429|FG001|Overall Study|Lack of Efficacy|1|||
160606663|NCT01614795|579937430|FG000|Overall Study|Adverse Event|0|||
160606664|NCT01614795|579937431|FG001|Overall Study|Adverse Event|0|||
160606665|NCT01614795|579937432|FG002|Overall Study|Adverse Event|1|||
160606666|NCT01614795|579937433|FG003|Overall Study|Adverse Event|1|||
160606667|NCT01614795|579937430|FG000|Overall Study|Lack of Efficacy|10|||
160606668|NCT01614795|579937431|FG001|Overall Study|Lack of Efficacy|10|||
160606669|NCT01614795|579937432|FG002|Overall Study|Lack of Efficacy|9|||
160606670|NCT01614795|579937433|FG003|Overall Study|Lack of Efficacy|8|||
160606671|NCT01614795|579937430|FG000|Overall Study|Physician Decision|1|||
160606672|NCT01614795|579937431|FG001|Overall Study|Physician Decision|0|||
160606673|NCT01614795|579937432|FG002|Overall Study|Physician Decision|1|||
160606674|NCT01614795|579937433|FG003|Overall Study|Physician Decision|1|||
160606675|NCT01614795|579937430|FG000|Overall Study|Withdrawal by Subject|0|||
160606676|NCT01614795|579937431|FG001|Overall Study|Withdrawal by Subject|1|||
160606677|NCT01614795|579937432|FG002|Overall Study|Withdrawal by Subject|0|||
160606678|NCT01614795|579937433|FG003|Overall Study|Withdrawal by Subject|2|||
160606679|NCT01614795|579937430|FG000|Overall Study|Ineligible|0|||
160606680|NCT01614795|579937431|FG001|Overall Study|Ineligible|1|||
160606681|NCT01614795|579937432|FG002|Overall Study|Ineligible|0|||
160661141|NCT00822926|580141776|FG000|Second Injection Visit|Withdrawal by Subject|0|||
160661142|NCT00822926|580141777|FG001|Second Injection Visit|Withdrawal by Subject|1|||
160661143|NCT00855738|580141780|FG000|Overall Study|Lost to Follow-up|2|||
160661144|NCT00855738|580141780|FG000|Overall Study|Adverse Event|1|||
160661145|NCT00855738|580141780|FG000|Overall Study|Subject Defaulted|1|||
160661146|NCT00855738|580141780|FG000|Overall Study|Death|1|||
160661147|NCT00304083|580141784|FG000|Overall Study|Withdrawal by Subject|4|||
160661148|NCT00304083|580141785|FG001|Overall Study|Withdrawal by Subject|2|||
160661149|NCT00304083|580141784|FG000|Overall Study|Physician Decision|8|||
160661150|NCT00304083|580141785|FG001|Overall Study|Physician Decision|3|||
160661151|NCT00304083|580141784|FG000|Overall Study|Disease Progression|5|||
160661152|NCT00304083|580141785|FG001|Overall Study|Disease Progression|1|||
160661153|NCT00304083|580141784|FG000|Overall Study|Other|5|||
160661154|NCT00304083|580141785|FG001|Overall Study|Other|2|||
160661155|NCT03966365|580141786|FG000|Overall Study|Protocol Violation|1|||
160661156|NCT03966365|580141787|FG001|Overall Study|Protocol Violation|0|||
160661157|NCT01378975|580141788|FG000|Overall Study|Death|77|||
160661158|NCT01378975|580141789|FG001|Overall Study|Death|46|||
160661159|NCT01378975|580141788|FG000|Overall Study|Investigator Request|1|||
160661160|NCT01378975|580141789|FG001|Overall Study|Investigator Request|0|||
160661161|NCT01378975|580141788|FG000|Overall Study|Lost to Follow-up|4|||
160661162|NCT01378975|580141789|FG001|Overall Study|Lost to Follow-up|1|||
160661163|NCT01378975|580141788|FG000|Overall Study|Withdrew Consent|4|||
160661164|NCT01378975|580141789|FG001|Overall Study|Withdrew Consent|3|||
160661165|NCT02216071|580141806|FG000|Overall Study|Withdrawal by Subject|7|||
160661166|NCT02216071|580141807|FG001|Overall Study|Withdrawal by Subject|2|||
160661167|NCT02216071|580141806|FG000|Overall Study|Lost to Follow-up|3|||
160661168|NCT02216071|580141807|FG001|Overall Study|Lost to Follow-up|3|||
160661169|NCT02216071|580141806|FG000|Overall Study|Protocol Violation|3|||
160661170|NCT02216071|580141807|FG001|Overall Study|Protocol Violation|5|||
160661171|NCT02216071|580141806|FG000|Overall Study|Other|2|||
160661172|NCT02216071|580141807|FG001|Overall Study|Other|2|||
160661173|NCT01706536|580141808|FG000|Overall Study|Withdrawal by Subject|1|||
160661174|NCT01706536|580141809|FG001|Overall Study|Withdrawal by Subject|0|||
160661175|NCT01706536|580141810|FG002|Overall Study|Withdrawal by Subject|1|||
160661176|NCT01706536|580141811|FG003|Overall Study|Withdrawal by Subject|0|||
160661177|NCT01706536|580141812|FG004|Overall Study|Withdrawal by Subject|0|||
160661178|NCT01706536|580141808|FG000|Overall Study|Adverse Event|2|||
160661179|NCT01706536|580141809|FG001|Overall Study|Adverse Event|3|||
160661180|NCT01706536|580141810|FG002|Overall Study|Adverse Event|4|||
160661181|NCT01706536|580141811|FG003|Overall Study|Adverse Event|3|||
160606682|NCT01614795|579937433|FG003|Overall Study|Ineligible|0|||
160606683|NCT00701103|579937434|FG000|Overall Study|Adverse Event|0|||
160606684|NCT00701103|579937435|FG001|Overall Study|Adverse Event|0|||
160606685|NCT00701103|579937436|FG002|Overall Study|Adverse Event|1|||
160606686|NCT00701103|579937437|FG003|Overall Study|Adverse Event|1|||
160606687|NCT00701103|579937438|FG004|Overall Study|Adverse Event|0|||
160606688|NCT00701103|579937439|FG005|Overall Study|Adverse Event|1|||
160606689|NCT00701103|579937440|FG006|Overall Study|Adverse Event|1|||
160606690|NCT00701103|579937441|FG007|Overall Study|Adverse Event|0|||
160606691|NCT00701103|579937442|FG008|Overall Study|Adverse Event|0|||
160606692|NCT00701103|579937443|FG009|Overall Study|Adverse Event|2|||
160661182|NCT01706536|580141812|FG004|Overall Study|Adverse Event|2|||
160661183|NCT01706536|580141808|FG000|Overall Study|Lack of Efficacy|1|||
160661184|NCT01706536|580141809|FG001|Overall Study|Lack of Efficacy|0|||
160606693|NCT00701103|579937444|FG010|Overall Study|Adverse Event|0|||
160606694|NCT00701103|579937434|FG000|Overall Study|Progressive Disease|5|||
160606695|NCT00701103|579937435|FG001|Overall Study|Progressive Disease|2|||
160606696|NCT00701103|579937436|FG002|Overall Study|Progressive Disease|6|||
160606697|NCT00701103|579937437|FG003|Overall Study|Progressive Disease|5|||
160606698|NCT00701103|579937438|FG004|Overall Study|Progressive Disease|6|||
160606699|NCT00701103|579937439|FG005|Overall Study|Progressive Disease|5|||
160606700|NCT00701103|579937440|FG006|Overall Study|Progressive Disease|7|||
160606701|NCT00701103|579937441|FG007|Overall Study|Progressive Disease|7|||
160606702|NCT00701103|579937442|FG008|Overall Study|Progressive Disease|8|||
160606703|NCT00701103|579937443|FG009|Overall Study|Progressive Disease|8|||
160606704|NCT00701103|579937444|FG010|Overall Study|Progressive Disease|11|||
160606705|NCT00701103|579937434|FG000|Overall Study|Withdrawal by Subject|0|||
160606706|NCT00701103|579937435|FG001|Overall Study|Withdrawal by Subject|1|||
160606707|NCT00701103|579937436|FG002|Overall Study|Withdrawal by Subject|1|||
160606708|NCT00701103|579937437|FG003|Overall Study|Withdrawal by Subject|0|||
160606709|NCT00701103|579937438|FG004|Overall Study|Withdrawal by Subject|0|||
160606710|NCT00701103|579937439|FG005|Overall Study|Withdrawal by Subject|0|||
160606711|NCT00701103|579937440|FG006|Overall Study|Withdrawal by Subject|0|||
160606712|NCT00701103|579937441|FG007|Overall Study|Withdrawal by Subject|0|||
160606713|NCT00701103|579937442|FG008|Overall Study|Withdrawal by Subject|0|||
160606714|NCT00701103|579937443|FG009|Overall Study|Withdrawal by Subject|0|||
160606715|NCT00701103|579937444|FG010|Overall Study|Withdrawal by Subject|0|||
160606716|NCT00701103|579937434|FG000|Overall Study|Other|0|||
160606717|NCT00701103|579937435|FG001|Overall Study|Other|0|||
160606718|NCT00701103|579937436|FG002|Overall Study|Other|0|||
160606719|NCT00701103|579937437|FG003|Overall Study|Other|0|||
160606720|NCT00701103|579937438|FG004|Overall Study|Other|0|||
160606721|NCT00701103|579937439|FG005|Overall Study|Other|0|||
160606722|NCT00701103|579937440|FG006|Overall Study|Other|0|||
160606723|NCT00701103|579937441|FG007|Overall Study|Other|0|||
160606724|NCT00701103|579937442|FG008|Overall Study|Other|1|||
160606725|NCT00701103|579937443|FG009|Overall Study|Other|1|||
160606726|NCT00701103|579937444|FG010|Overall Study|Other|0|||
160606727|NCT01915095|579937445|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
160606728|NCT01915095|579937446|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
160606729|NCT01915095|579937447|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
160606730|NCT01915095|579937448|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
160606731|NCT01915095|579937449|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
160606732|NCT02067533|579937450|FG000|Overall Study|Lost to Follow-up|4|||
160606733|NCT02067533|579937451|FG001|Overall Study|Lost to Follow-up|2|||
160606734|NCT00565812|579937452|FG000|Overall Study|Death|2|||
160606735|NCT00565812|579937453|FG001|Overall Study|Death|1|||
160606736|NCT00565812|579937454|FG002|Overall Study|Death|3|||
160606737|NCT00565812|579937452|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
160606738|NCT00565812|579937453|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
160606739|NCT00565812|579937454|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
160606740|NCT00565812|579937452|FG000|Overall Study|Lost to Follow-up|10|||
160606741|NCT00565812|579937453|FG001|Overall Study|Lost to Follow-up|8|||
160606742|NCT00565812|579937454|FG002|Overall Study|Lost to Follow-up|8|||
160606743|NCT00565812|579937452|FG000|Overall Study|Withdrawal by Subject|58|||
160606744|NCT00565812|579937453|FG001|Overall Study|Withdrawal by Subject|47|||
160606745|NCT00565812|579937454|FG002|Overall Study|Withdrawal by Subject|48|||
160606746|NCT00565812|579937452|FG000|Overall Study|Work Schedule|5|||
160606747|NCT00565812|579937453|FG001|Overall Study|Work Schedule|3|||
160606748|NCT00565812|579937454|FG002|Overall Study|Work Schedule|1|||
160606749|NCT00565812|579937452|FG000|Overall Study|Protocol Violation|2|||
160606750|NCT00565812|579937453|FG001|Overall Study|Protocol Violation|6|||
160606751|NCT00565812|579937454|FG002|Overall Study|Protocol Violation|4|||
160606752|NCT00565812|579937452|FG000|Overall Study|Adverse Event|41|||
160606753|NCT00565812|579937453|FG001|Overall Study|Adverse Event|54|||
160606754|NCT00565812|579937454|FG002|Overall Study|Adverse Event|40|||
160606755|NCT00565812|579937452|FG000|Overall Study|Jury Duty|1|||
160606756|NCT00565812|579937453|FG001|Overall Study|Jury Duty|0|||
160606757|NCT00565812|579937454|FG002|Overall Study|Jury Duty|0|||
160606758|NCT00565812|579937452|FG000|Overall Study|Relocated Out of Area|5|||
160606759|NCT00565812|579937453|FG001|Overall Study|Relocated Out of Area|8|||
160606760|NCT00565812|579937454|FG002|Overall Study|Relocated Out of Area|9|||
160606761|NCT00565812|579937452|FG000|Overall Study|Sponsor Decision|1|||
160606762|NCT00565812|579937453|FG001|Overall Study|Sponsor Decision|5|||
160606763|NCT00565812|579937454|FG002|Overall Study|Sponsor Decision|1|||
160606764|NCT00565812|579937452|FG000|Overall Study|Domestic Reasons|7|||
160606765|NCT00565812|579937453|FG001|Overall Study|Domestic Reasons|1|||
160606766|NCT00565812|579937454|FG002|Overall Study|Domestic Reasons|3|||
160606767|NCT00565812|579937452|FG000|Overall Study|Research Site Closure|6|||
160606768|NCT00565812|579937453|FG001|Overall Study|Research Site Closure|1|||
160606769|NCT00565812|579937454|FG002|Overall Study|Research Site Closure|8|||
160606770|NCT00565812|579937452|FG000|Overall Study|Surgical Intervention|0|||
160606771|NCT00565812|579937453|FG001|Overall Study|Surgical Intervention|1|||
160606772|NCT00565812|579937454|FG002|Overall Study|Surgical Intervention|2|||
160606773|NCT00565812|579937452|FG000|Overall Study|Low Compliance|1|||
160606774|NCT00565812|579937453|FG001|Overall Study|Low Compliance|0|||
160606775|NCT00565812|579937454|FG002|Overall Study|Low Compliance|1|||
160606776|NCT00565812|579937452|FG000|Overall Study|Follow-up Visit Not Completed|2|||
160606777|NCT00565812|579937453|FG001|Overall Study|Follow-up Visit Not Completed|0|||
160606778|NCT00565812|579937454|FG002|Overall Study|Follow-up Visit Not Completed|1|||
160606779|NCT00565812|579937452|FG000|Overall Study|Physician Decision|2|||
160606780|NCT00565812|579937453|FG001|Overall Study|Physician Decision|0|||
160606781|NCT00565812|579937454|FG002|Overall Study|Physician Decision|0|||
160606782|NCT00368472|579937459|FG000|Overall Study|Adverse Event|22|||
160606783|NCT00368472|579937459|FG000|Overall Study|Medication non-compliance|4|||
160606784|NCT00368472|579937459|FG000|Overall Study|Protocol Violation|2|||
160606785|NCT00368472|579937459|FG000|Overall Study|Request of Investigator or Sponsor|3|||
160606786|NCT00368472|579937459|FG000|Overall Study|Withdrawal by Subject|40|||
160606787|NCT00368472|579937459|FG000|Overall Study|Diary non-compliance|1|||
160606788|NCT00368472|579937459|FG000|Overall Study|Other|32|||
160606789|NCT00368472|579937459|FG000|Overall Study|Missing Final Disposition Date|1|||
160606790|NCT02650895|579937461|FG000|Overall Study|Withdrawal by Subject|0|||
160606791|NCT02650895|579937462|FG001|Overall Study|Withdrawal by Subject|1|||
160606792|NCT02650895|579937463|FG002|Overall Study|Withdrawal by Subject|0|||
160606793|NCT02650895|579937464|FG003|Overall Study|Withdrawal by Subject|0|||
160606794|NCT02650895|579937465|FG004|Overall Study|Withdrawal by Subject|0|||
160606795|NCT02650895|579937466|FG005|Overall Study|Withdrawal by Subject|0|||
160606796|NCT03209362|579937467|FG000|Overall Study|Adverse Event|0|||
160606797|NCT03209362|579937468|FG001|Overall Study|Adverse Event|1|||
160606798|NCT03209362|579937467|FG000|Overall Study|Lost to Follow-up|0|||
160606799|NCT03209362|579937468|FG001|Overall Study|Lost to Follow-up|1|||
160606800|NCT03209362|579937467|FG000|Overall Study|Withdrawal by Subject|2|||
160606801|NCT03209362|579937468|FG001|Overall Study|Withdrawal by Subject|0|||
160606802|NCT03209362|579937467|FG000|Overall Study|Other|0|||
160606803|NCT03209362|579937468|FG001|Overall Study|Other|1|||
160606804|NCT00643448|579937473|FG000|Overall Study|Lack of Efficacy|2|||
160606805|NCT00643448|579937474|FG001|Overall Study|Lack of Efficacy|0|||
160606806|NCT00643448|579937475|FG002|Overall Study|Lack of Efficacy|4|||
160606807|NCT00643448|579937473|FG000|Overall Study|Adverse Event|2|||
160606808|NCT00643448|579937474|FG001|Overall Study|Adverse Event|2|||
160606809|NCT00643448|579937475|FG002|Overall Study|Adverse Event|2|||
160606810|NCT00643448|579937473|FG000|Overall Study|QTcF>550 ms|0|||
160606811|NCT00643448|579937474|FG001|Overall Study|QTcF>550 ms|3|||
160606812|NCT00643448|579937475|FG002|Overall Study|QTcF>550 ms|0|||
160606813|NCT01004159|579939331|FG000|Overall Study|Adverse Event|2|||
160606814|NCT01004159|579939331|FG000|Overall Study|Disease Progression|18|||
160606815|NCT02204410|579939332|FG000|Overall Study|Lost to Follow-up|5|||
160606816|NCT02204410|579939332|FG000|Overall Study|Physician Decision|2|||
160606817|NCT02204410|579939332|FG000|Overall Study|Protocol Violation|1|||
160606818|NCT02204410|579939332|FG000|Overall Study|Withdrawal by Subject|3|||
160606819|NCT01536418|579939344|FG000|Overall Study|Protocol Violation|2|||
160606820|NCT01536418|579939345|FG001|Overall Study|Protocol Violation|3|||
160606821|NCT01536418|579939344|FG000|Overall Study|Physician Decision|1|||
160606822|NCT01536418|579939345|FG001|Overall Study|Physician Decision|3|||
160606823|NCT01536418|579939344|FG000|Overall Study|Study closed/terminated|41|||
160606824|NCT01536418|579939345|FG001|Overall Study|Study closed/terminated|37|||
160606825|NCT01536418|579939344|FG000|Overall Study|Lack of Efficacy|10|||
160606826|NCT01536418|579939345|FG001|Overall Study|Lack of Efficacy|16|||
160606827|NCT01536418|579939344|FG000|Overall Study|Adverse Event|9|||
160606828|NCT01536418|579939345|FG001|Overall Study|Adverse Event|4|||
160606829|NCT01536418|579939344|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
160606830|NCT01536418|579939345|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
160606831|NCT01536418|579939344|FG000|Overall Study|Withdrawal by Subject|5|||
160606832|NCT01536418|579939345|FG001|Overall Study|Withdrawal by Subject|3|||
160606833|NCT00711412|579939350|FG000|Induction Treatment|Death|2|||
160606834|NCT00711412|579939350|FG000|Induction Treatment|Adverse Event|1|||
160606835|NCT00711412|579939350|FG000|Induction Treatment|Other|1|||
160606836|NCT00711412|579939350|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
160606837|NCT00711412|579939350|FG000|Evaluated for Combination Treatment|Death|1|||
160606838|NCT00711412|579939350|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
160606839|NCT00711412|579939350|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
160606840|NCT00711412|579939350|FG000|Combination Treatment|Progressive Disease|1|||
160606841|NCT00711412|579939350|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
160606842|NCT00711412|579939350|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
160606843|NCT00711412|579939350|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
160606844|NCT00711412|579939350|FG000|Evaluation for Response and Surgery|Death|1|||
160486689|NCT01201915|579510578|FG002|Overall Study|Lost to Follow-up|0|||
160486690|NCT01201915|579510576|FG000|Overall Study|Physician Decision|3|||
160486691|NCT01201915|579510577|FG001|Overall Study|Physician Decision|0|||
160486692|NCT01201915|579510578|FG002|Overall Study|Physician Decision|0|||
160486693|NCT01201915|579510576|FG000|Overall Study|Subject Decision|3|||
160486694|NCT01201915|579510577|FG001|Overall Study|Subject Decision|3|||
160486695|NCT01201915|579510578|FG002|Overall Study|Subject Decision|5|||
160486696|NCT01201915|579510576|FG000|Overall Study|Target Lesion Progression|0|||
160486697|NCT01201915|579510577|FG001|Overall Study|Target Lesion Progression|3|||
160486698|NCT01201915|579510578|FG002|Overall Study|Target Lesion Progression|0|||
160486699|NCT02154516|579510579|FG000|Overall Study|Withdrawal by Subject|0|||
160486700|NCT02154516|579510580|FG001|Overall Study|Withdrawal by Subject|1|||
160486701|NCT02154516|579510579|FG000|Overall Study|Lost to Follow-up|1|||
160486702|NCT02154516|579510580|FG001|Overall Study|Lost to Follow-up|0|||
160486703|NCT02154516|579510579|FG000|Overall Study|Removal/revision of device|1|||
160486704|NCT02154516|579510580|FG001|Overall Study|Removal/revision of device|0|||
160486705|NCT02154516|579510579|FG000|Overall Study|Death|2|||
160486706|NCT02154516|579510580|FG001|Overall Study|Death|1|||
160486707|NCT00663923|579510581|FG000|Overall Study|Lost to Follow-up|2|||
160486708|NCT02316171|579510586|FG000|Overall Study|difficulties with urinary catheter|1|||
160486709|NCT02316171|579510587|FG001|Overall Study|difficulties with urinary catheter|0|||
160486710|NCT02316171|579510588|FG002|Overall Study|difficulties with urinary catheter|0|||
160486711|NCT02316171|579510589|FG003|Overall Study|difficulties with urinary catheter|0|||
160486712|NCT01804140|579510590|FG000|Overall Study|No sampling or biopsy procedures done|114|||
160486713|NCT02785900|579510591|FG000|Overall Study|Study Termination by Sponsor|64|||
160486714|NCT02785900|579510592|FG001|Overall Study|Study Termination by Sponsor|81|||
160486715|NCT02785900|579510591|FG000|Overall Study|Death|46|||
160486716|NCT02785900|579510592|FG001|Overall Study|Death|32|||
160486717|NCT02785900|579510591|FG000|Overall Study|Withdrawal by Subject|4|||
160486718|NCT02785900|579510592|FG001|Overall Study|Withdrawal by Subject|8|||
160486719|NCT02785900|579510591|FG000|Overall Study|Physician Decision|3|||
160486720|NCT02785900|579510592|FG001|Overall Study|Physician Decision|2|||
160486721|NCT00547300|579510593|FG000|Overall Study|Study was Administratively Terminated|25|||
160486722|NCT00547300|579510594|FG001|Overall Study|Study was Administratively Terminated|24|||
160486723|NCT00547300|579510593|FG000|Overall Study|Did not Meet Entry Criteria|0|||
160486724|NCT00547300|579510594|FG001|Overall Study|Did not Meet Entry Criteria|2|||
160486725|NCT04435522|579510597|FG000|Overall Study|Withdrawal by Subject|2|||
160486726|NCT00092521|579512309|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
160486727|NCT00092521|579512310|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
160486728|NCT00092521|579512311|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
160486729|NCT00092521|579512312|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
160486730|NCT00092521|579512309|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
160486731|NCT00092521|579512310|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
160486732|NCT00092521|579512311|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
160486733|NCT00092521|579512312|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
160486734|NCT00092521|579512309|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
160486735|NCT00092521|579512310|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
160486736|NCT00092521|579512311|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
160486737|NCT00092521|579512312|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
160486738|NCT00092521|579512309|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
160486739|NCT00092521|579512310|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
160486740|NCT00092521|579512311|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
160486741|NCT00092521|579512312|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
160486742|NCT00092521|579512309|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
160486743|NCT00092521|579512310|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
160486744|NCT00092521|579512311|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
160486745|NCT00092521|579512312|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
160486746|NCT00092521|579512309|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
160486747|NCT00092521|579512310|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
160486748|NCT00092521|579512311|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
160606845|NCT00711412|579939350|FG000|Survival Follow up Until Death|Other|12|||
160606846|NCT02234050|579939355|FG000|Overall Study|Lack of Efficacy|38|||
160606847|NCT02234050|579939356|FG001|Overall Study|Lack of Efficacy|22|||
160606848|NCT02234050|579939355|FG000|Overall Study|Adverse Event|13|||
160486749|NCT00092521|579512312|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
160486750|NCT00092521|579512309|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
160486751|NCT00092521|579512310|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
160486752|NCT00092521|579512311|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
160486753|NCT00092521|579512312|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
160486754|NCT00092521|579512309|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
160606849|NCT02234050|579939356|FG001|Overall Study|Adverse Event|1|||
160606850|NCT02234050|579939355|FG000|Overall Study|Withdrawal by Subject|4|||
160606851|NCT02234050|579939356|FG001|Overall Study|Withdrawal by Subject|2|||
160606852|NCT02234050|579939355|FG000|Overall Study|Sponsor's decision|6|||
160606853|NCT02234050|579939356|FG001|Overall Study|Sponsor's decision|0|||
160606854|NCT02473289|579939357|FG000|Overall Study|Adverse Event|2|||
160606855|NCT02473289|579939358|FG001|Overall Study|Adverse Event|3|||
160606856|NCT02473289|579939357|FG000|Overall Study|Lost to Follow-up|1|||
160606857|NCT02473289|579939358|FG001|Overall Study|Lost to Follow-up|1|||
160606858|NCT02473289|579939357|FG000|Overall Study|Protocol Violation|0|||
160606859|NCT02473289|579939358|FG001|Overall Study|Protocol Violation|1|||
160606860|NCT02473289|579939357|FG000|Overall Study|Withdrawal of consent|6|||
160606861|NCT02473289|579939358|FG001|Overall Study|Withdrawal of consent|7|||
160606862|NCT02473289|579939357|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
160606863|NCT02473289|579939358|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
160606864|NCT02473289|579939357|FG000|Overall Study|Other|2|||
160606865|NCT02473289|579939358|FG001|Overall Study|Other|0|||
160606866|NCT02244619|579939359|FG000|Overall Study|Did not receive study intervention|8|||
160606867|NCT02244619|579939360|FG001|Overall Study|Did not receive study intervention|21|||
160606868|NCT03285490|579939361|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
160606869|NCT03285490|579939362|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
160606870|NCT03285490|579939361|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
160606871|NCT03285490|579939362|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
160606872|NCT00068822|579939363|FG000|First Randomized Intervention|Lost to Follow-up|1|||
160606873|NCT00068822|579939364|FG001|First Randomized Intervention|Lost to Follow-up|2|||
160606874|NCT00424099|579939365|FG000|Overall Study|Adverse Event|0|||
160606875|NCT00424099|579939366|FG001|Overall Study|Adverse Event|1|||
160606876|NCT00424099|579939367|FG002|Overall Study|Adverse Event|1|||
160606877|NCT00424099|579939368|FG003|Overall Study|Adverse Event|0|||
160606878|NCT00424099|579939365|FG000|Overall Study|Death|0|||
160606879|NCT00424099|579939366|FG001|Overall Study|Death|1|||
160606880|NCT00424099|579939367|FG002|Overall Study|Death|0|||
160606881|NCT00424099|579939368|FG003|Overall Study|Death|0|||
160606882|NCT00424099|579939365|FG000|Overall Study|Illness|2|||
160606883|NCT00424099|579939366|FG001|Overall Study|Illness|0|||
160606884|NCT00424099|579939367|FG002|Overall Study|Illness|1|||
160606885|NCT00424099|579939368|FG003|Overall Study|Illness|4|||
160606886|NCT00424099|579939365|FG000|Overall Study|Lost to Follow-up|0|||
160606887|NCT00424099|579939366|FG001|Overall Study|Lost to Follow-up|0|||
160606888|NCT00424099|579939367|FG002|Overall Study|Lost to Follow-up|3|||
160606889|NCT00424099|579939368|FG003|Overall Study|Lost to Follow-up|0|||
160606890|NCT00424099|579939365|FG000|Overall Study|Hospitalized|1|||
160606891|NCT00424099|579939366|FG001|Overall Study|Hospitalized|2|||
160606892|NCT00424099|579939367|FG002|Overall Study|Hospitalized|1|||
160606893|NCT00424099|579939368|FG003|Overall Study|Hospitalized|3|||
160606894|NCT00424099|579939365|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
160606895|NCT00424099|579939366|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
160606896|NCT00424099|579939367|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
160606897|NCT00424099|579939368|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
160606898|NCT00424099|579939365|FG000|Overall Study|Withdrawal by Subject|1|||
160606899|NCT00424099|579939366|FG001|Overall Study|Withdrawal by Subject|9|||
160606900|NCT00424099|579939367|FG002|Overall Study|Withdrawal by Subject|4|||
160606901|NCT00424099|579939368|FG003|Overall Study|Withdrawal by Subject|6|||
160606902|NCT00424099|579939365|FG000|Overall Study|Physician Decision|0|||
160606903|NCT00424099|579939366|FG001|Overall Study|Physician Decision|0|||
160606904|NCT00424099|579939367|FG002|Overall Study|Physician Decision|1|||
160606905|NCT00424099|579939368|FG003|Overall Study|Physician Decision|0|||
160606906|NCT00424099|579939365|FG000|Overall Study|Missing|0|||
160606907|NCT00424099|579939366|FG001|Overall Study|Missing|0|||
160606908|NCT00424099|579939367|FG002|Overall Study|Missing|1|||
160606909|NCT00424099|579939368|FG003|Overall Study|Missing|0|||
160606910|NCT03689972|579939369|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
160606911|NCT03689972|579939370|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
160606912|NCT03689972|579939371|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
160606913|NCT03689972|579939372|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
160606914|NCT03689972|579939373|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
160606915|NCT03689972|579939369|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
160606916|NCT03689972|579939370|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
160606917|NCT03689972|579939371|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
160606918|NCT03689972|579939372|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
160606919|NCT03689972|579939373|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
160606920|NCT03689972|579939369|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
160606921|NCT03689972|579939370|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
160606922|NCT03689972|579939371|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
160606923|NCT03689972|579939372|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
160606924|NCT03689972|579939373|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
160606925|NCT03689972|579939369|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
160661185|NCT01706536|580141810|FG002|Overall Study|Lack of Efficacy|0|||
160486755|NCT00092521|579512310|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
160486756|NCT00092521|579512311|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
160486757|NCT00092521|579512312|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
160486758|NCT00092521|579512309|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
160486759|NCT00092521|579512310|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
160486760|NCT00092521|579512311|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
160486761|NCT00092521|579512312|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
160486762|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
160486763|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
160486764|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
160486765|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
160486766|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
160486767|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
160486768|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
160486769|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
160486770|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
160486771|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
160486772|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
160486773|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
160486774|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Death|2|||
160486775|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Death|0|||
160486776|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Death|1|||
160486777|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Death|0|||
160486778|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
160486779|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
160486780|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
160486781|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
160486782|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
160486783|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
160486784|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
160486785|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
160486786|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
160486787|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
160486788|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
160486789|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
160486790|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Moved|32|||
160486791|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Moved|2|||
160486792|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Moved|28|||
160486793|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Moved|0|||
160486794|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
160486795|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
160486796|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
160486797|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
160486798|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Travel|2|||
160486799|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Travel|0|||
160486800|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Travel|0|||
160486801|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Travel|0|||
160486802|NCT00092521|579512309|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
160486803|NCT00092521|579512310|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
160486804|NCT00092521|579512311|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
160486805|NCT00092521|579512312|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
160486806|NCT00092521|579512309|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
160486807|NCT00092521|579512310|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
160486808|NCT00092521|579512311|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
160486809|NCT00092521|579512312|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
160486810|NCT00092521|579512309|FG000|Extension Study (Group 4)|Adverse Event|0|||
160486811|NCT00092521|579512310|FG001|Extension Study (Group 4)|Adverse Event|0|||
160486812|NCT00092521|579512311|FG002|Extension Study (Group 4)|Adverse Event|0|||
160486813|NCT00092521|579512312|FG003|Extension Study (Group 4)|Adverse Event|2|||
160486814|NCT00092521|579512309|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
160486815|NCT00092521|579512310|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
160486816|NCT00092521|579512311|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
160606926|NCT03689972|579939370|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
160606927|NCT03689972|579939371|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
160606928|NCT03689972|579939372|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
160606929|NCT03689972|579939373|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
160606930|NCT03689972|579939369|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
160486817|NCT00092521|579512312|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
160486818|NCT00092521|579512309|FG000|Extension Study (Group 4)|Pregnancy|0|||
160486819|NCT00092521|579512310|FG001|Extension Study (Group 4)|Pregnancy|0|||
160661186|NCT01706536|580141811|FG003|Overall Study|Lack of Efficacy|1|||
160661187|NCT01706536|580141812|FG004|Overall Study|Lack of Efficacy|0|||
160661188|NCT01706536|580141808|FG000|Overall Study|non compliance|0|||
160661189|NCT01706536|580141809|FG001|Overall Study|non compliance|1|||
160661190|NCT01706536|580141810|FG002|Overall Study|non compliance|0|||
160661191|NCT01706536|580141811|FG003|Overall Study|non compliance|0|||
160661192|NCT01706536|580141812|FG004|Overall Study|non compliance|0|||
160661193|NCT03262012|580141813|FG000|Overall Study|Withdrawal by Subject|15|||
160661194|NCT03262012|580141814|FG001|Overall Study|Withdrawal by Subject|13|||
160661195|NCT03262012|580141815|FG002|Overall Study|Withdrawal by Subject|8|||
160661196|NCT03262012|580141816|FG003|Overall Study|Withdrawal by Subject|7|||
160661197|NCT03262012|580141813|FG000|Overall Study|Adverse Event|10|||
160661198|NCT03262012|580141814|FG001|Overall Study|Adverse Event|12|||
160661199|NCT03262012|580141815|FG002|Overall Study|Adverse Event|4|||
160661200|NCT03262012|580141816|FG003|Overall Study|Adverse Event|6|||
160661201|NCT03262012|580141813|FG000|Overall Study|Physician Decision|2|||
160661202|NCT03262012|580141814|FG001|Overall Study|Physician Decision|5|||
160661203|NCT03262012|580141815|FG002|Overall Study|Physician Decision|1|||
160661204|NCT03262012|580141816|FG003|Overall Study|Physician Decision|0|||
160661205|NCT03262012|580141813|FG000|Overall Study|Lack of Efficacy|0|||
160661206|NCT03262012|580141814|FG001|Overall Study|Lack of Efficacy|5|||
160606931|NCT03689972|579939370|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
160606932|NCT03689972|579939371|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
160606933|NCT03689972|579939372|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
160606934|NCT03689972|579939373|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
160606935|NCT03689972|579939369|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
160606936|NCT03689972|579939370|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
160606937|NCT03689972|579939371|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
160606938|NCT03689972|579939372|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
160606939|NCT03689972|579939373|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
160606940|NCT03689972|579939369|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
160606941|NCT03689972|579939370|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
160606942|NCT03689972|579939371|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
160606943|NCT03689972|579939372|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
160606944|NCT03689972|579939373|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
160661207|NCT03262012|580141815|FG002|Overall Study|Lack of Efficacy|1|||
160661208|NCT03262012|580141816|FG003|Overall Study|Lack of Efficacy|2|||
160661209|NCT03262012|580141813|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
160661210|NCT03262012|580141814|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
160661211|NCT03262012|580141815|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
160661212|NCT03262012|580141816|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
160661213|NCT04753437|580141819|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160606945|NCT03689972|579939369|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
160606946|NCT03689972|579939370|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
160606947|NCT03689972|579939371|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
160606948|NCT03689972|579939372|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
160606949|NCT03689972|579939373|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
160606950|NCT03689972|579939369|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
160606951|NCT03689972|579939370|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
160606952|NCT03689972|579939371|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
160606953|NCT03689972|579939372|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
160606954|NCT03689972|579939373|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
160606955|NCT03689972|579939369|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
160606956|NCT03689972|579939370|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
160606957|NCT03689972|579939371|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
160606958|NCT03689972|579939372|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
160606959|NCT03689972|579939373|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
160606960|NCT03689972|579939369|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
160606961|NCT03689972|579939370|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
160606962|NCT03689972|579939371|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
160606963|NCT03689972|579939372|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
160606964|NCT03689972|579939373|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
160606965|NCT03689972|579939369|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
160606966|NCT03689972|579939370|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
160606967|NCT03689972|579939371|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
160606968|NCT03689972|579939372|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
160606969|NCT03689972|579939373|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
160606970|NCT03689972|579939369|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
160606971|NCT03689972|579939370|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
160606972|NCT03689972|579939371|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
160606973|NCT03689972|579939372|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
160606974|NCT03689972|579939373|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
160606975|NCT03689972|579939369|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
160606976|NCT03689972|579939370|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
160606977|NCT03689972|579939371|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
160606978|NCT03689972|579939372|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
160606979|NCT03689972|579939373|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
160606980|NCT03689972|579939369|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
160606981|NCT03689972|579939370|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
160606982|NCT03689972|579939371|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
160606983|NCT03689972|579939372|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
160606984|NCT03689972|579939373|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
160606985|NCT03689972|579939369|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
160606986|NCT03689972|579939370|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
160606987|NCT03689972|579939371|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
160606988|NCT03689972|579939372|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
160606989|NCT03689972|579939373|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
160606990|NCT03689972|579939369|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
160606991|NCT03689972|579939370|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
160606992|NCT03689972|579939371|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
160606993|NCT03689972|579939372|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
160606994|NCT03689972|579939373|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
160606995|NCT03689972|579939369|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
160606996|NCT03689972|579939370|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
160606997|NCT03689972|579939371|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
160606998|NCT03689972|579939372|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
160606999|NCT03689972|579939373|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
160607000|NCT03689972|579939369|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
160607001|NCT03689972|579939370|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
160486820|NCT00092521|579512311|FG002|Extension Study (Group 4)|Pregnancy|0|||
160486821|NCT00092521|579512312|FG003|Extension Study (Group 4)|Pregnancy|4|||
160607002|NCT03689972|579939371|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
160607003|NCT03689972|579939372|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
160607004|NCT03689972|579939373|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
160607005|NCT03981744|579939378|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
160607006|NCT03981744|579939379|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
160607007|NCT03981744|579939380|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
160607008|NCT03981744|579939381|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
160607009|NCT03981744|579939378|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
160607010|NCT03981744|579939379|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
160607011|NCT03981744|579939380|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
160607012|NCT03981744|579939381|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
160607013|NCT03981744|579939378|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
160607014|NCT03981744|579939379|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
160607015|NCT03981744|579939380|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
160607016|NCT03981744|579939381|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
160607017|NCT01989572|579939384|FG000|Overall Study|Lack of Efficacy|35|||
160607018|NCT01989572|579939385|FG001|Overall Study|Lack of Efficacy|48|||
160607019|NCT01989572|579939386|FG002|Overall Study|Lack of Efficacy|48|||
160607020|NCT01989572|579939387|FG003|Overall Study|Lack of Efficacy|43|||
160607021|NCT01989572|579939388|FG004|Overall Study|Lack of Efficacy|71|||
160607022|NCT01989572|579939389|FG005|Overall Study|Lack of Efficacy|79|||
160607023|NCT01989572|579939384|FG000|Overall Study|Adverse Event|2|||
160607024|NCT01989572|579939385|FG001|Overall Study|Adverse Event|1|||
160607025|NCT01989572|579939386|FG002|Overall Study|Adverse Event|3|||
160607026|NCT01989572|579939387|FG003|Overall Study|Adverse Event|0|||
160607027|NCT01989572|579939388|FG004|Overall Study|Adverse Event|3|||
160607028|NCT01989572|579939389|FG005|Overall Study|Adverse Event|0|||
160607029|NCT01989572|579939384|FG000|Overall Study|Death|0|||
160607030|NCT01989572|579939385|FG001|Overall Study|Death|0|||
160607031|NCT01989572|579939386|FG002|Overall Study|Death|0|||
160607032|NCT01989572|579939387|FG003|Overall Study|Death|0|||
160607033|NCT01989572|579939388|FG004|Overall Study|Death|1|||
160607034|NCT01989572|579939389|FG005|Overall Study|Death|0|||
160607035|NCT01989572|579939384|FG000|Overall Study|Withdrawal by Subject|4|||
160607036|NCT01989572|579939385|FG001|Overall Study|Withdrawal by Subject|1|||
160607037|NCT01989572|579939386|FG002|Overall Study|Withdrawal by Subject|5|||
160607038|NCT01989572|579939387|FG003|Overall Study|Withdrawal by Subject|1|||
160607039|NCT01989572|579939388|FG004|Overall Study|Withdrawal by Subject|12|||
160607040|NCT01989572|579939389|FG005|Overall Study|Withdrawal by Subject|4|||
160607041|NCT01989572|579939384|FG000|Overall Study|complicating disease|1|||
160607042|NCT01989572|579939385|FG001|Overall Study|complicating disease|1|||
160607043|NCT01989572|579939386|FG002|Overall Study|complicating disease|2|||
160607044|NCT01989572|579939387|FG003|Overall Study|complicating disease|0|||
160607045|NCT01989572|579939388|FG004|Overall Study|complicating disease|1|||
160607046|NCT01989572|579939389|FG005|Overall Study|complicating disease|0|||
160607047|NCT01989572|579939384|FG000|Overall Study|error|2|||
160607048|NCT01989572|579939385|FG001|Overall Study|error|1|||
160607049|NCT01989572|579939386|FG002|Overall Study|error|1|||
160607050|NCT01989572|579939387|FG003|Overall Study|error|1|||
160607051|NCT01989572|579939388|FG004|Overall Study|error|1|||
160607052|NCT01989572|579939389|FG005|Overall Study|error|1|||
160607053|NCT01989572|579939384|FG000|Overall Study|maximum dose reached|0|||
160607054|NCT01989572|579939385|FG001|Overall Study|maximum dose reached|1|||
160607055|NCT01989572|579939386|FG002|Overall Study|maximum dose reached|0|||
160607056|NCT01989572|579939387|FG003|Overall Study|maximum dose reached|0|||
160607057|NCT01989572|579939388|FG004|Overall Study|maximum dose reached|1|||
160607058|NCT01989572|579939389|FG005|Overall Study|maximum dose reached|0|||
160607059|NCT01989572|579939384|FG000|Overall Study|unknown/not specify|3|||
160607060|NCT01989572|579939385|FG001|Overall Study|unknown/not specify|4|||
160607061|NCT01989572|579939386|FG002|Overall Study|unknown/not specify|1|||
160607062|NCT01989572|579939387|FG003|Overall Study|unknown/not specify|3|||
160607063|NCT01989572|579939388|FG004|Overall Study|unknown/not specify|3|||
160607064|NCT01989572|579939389|FG005|Overall Study|unknown/not specify|5|||
160607065|NCT01989572|579939384|FG000|Overall Study|not start protocol therapy|5|||
160607066|NCT01989572|579939385|FG001|Overall Study|not start protocol therapy|1|||
160607067|NCT01989572|579939386|FG002|Overall Study|not start protocol therapy|2|||
160607068|NCT01989572|579939387|FG003|Overall Study|not start protocol therapy|3|||
160661214|NCT04753437|580141820|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
160661215|NCT04753437|580141819|FG000|Overall Study|Liver Function Test Abnormalities|2|||
160607069|NCT01989572|579939388|FG004|Overall Study|not start protocol therapy|4|||
160607070|NCT01989572|579939389|FG005|Overall Study|not start protocol therapy|18|||
160607071|NCT01989572|579939384|FG000|Overall Study|alternative therapy|3|||
160607072|NCT01989572|579939385|FG001|Overall Study|alternative therapy|0|||
160607073|NCT01989572|579939386|FG002|Overall Study|alternative therapy|0|||
160607074|NCT01989572|579939387|FG003|Overall Study|alternative therapy|0|||
160607075|NCT01989572|579939388|FG004|Overall Study|alternative therapy|1|||
160607076|NCT01989572|579939389|FG005|Overall Study|alternative therapy|3|||
160607077|NCT01872897|579939396|FG000|Overall Study|Withdrawal by Subject|1|||
160607078|NCT01872897|579939397|FG001|Overall Study|Withdrawal by Subject|0|||
160607079|NCT04159701|579939398|FG000|Period 1: Treatment Period|Pregnancy|1|||
160607080|NCT04159701|579939399|FG001|Period 1: Treatment Period|Pregnancy|0|||
160607081|NCT04159701|579939398|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
160607082|NCT04159701|579939399|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
160607083|NCT04159701|579939398|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
160607084|NCT04159701|579939399|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
160607085|NCT04159701|579939398|FG000|Washout Period|site terminated by sponsor|0|||
160607086|NCT04159701|579939399|FG001|Washout Period|site terminated by sponsor|1|||
160607087|NCT04159701|579939398|FG000|Washout Period|study terminated by sponsor|10|||
160607088|NCT04159701|579939399|FG001|Washout Period|study terminated by sponsor|3|||
160607089|NCT04159701|579939398|FG000|Washout Period|Withdrawal by Subject|1|||
160607090|NCT04159701|579939399|FG001|Washout Period|Withdrawal by Subject|0|||
160607091|NCT04159701|579939398|FG000|Washout Period|Inadvertent Enrollment|1|||
160607092|NCT04159701|579939399|FG001|Washout Period|Inadvertent Enrollment|0|||
160607093|NCT04159701|579939398|FG000|Washout Period|Miscellaneous|1|||
160607094|NCT04159701|579939399|FG001|Washout Period|Miscellaneous|0|||
160607095|NCT04159701|579939398|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
160607096|NCT04159701|579939399|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
160607097|NCT04159701|579939398|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
160607098|NCT04159701|579939399|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
160607099|NCT04159701|579939398|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
160607100|NCT04159701|579939399|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
160607101|NCT04159701|579939398|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
160607102|NCT04159701|579939399|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
160607103|NCT04159701|579939398|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
160607104|NCT04159701|579939399|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
160607105|NCT00633360|579939403|FG000|Overall Study|Lost to Follow-up|1|||
160607106|NCT00633360|579939404|FG001|Overall Study|Lost to Follow-up|1|||
160607107|NCT00633360|579939403|FG000|Overall Study|Adverse Event|3|||
160607108|NCT00633360|579939404|FG001|Overall Study|Adverse Event|1|||
160607109|NCT00633360|579939403|FG000|Overall Study|Protocol Violation|0|||
160607110|NCT00633360|579939404|FG001|Overall Study|Protocol Violation|1|||
160607111|NCT02348840|579939410|FG000|Overall Study|Withdrawal by Subject|2|||
160607112|NCT02348840|579939411|FG001|Overall Study|Withdrawal by Subject|1|||
160486822|NCT00092521|579512309|FG000|Extension Study (Group 4)|Protocol Violation|0|||
160486823|NCT00092521|579512310|FG001|Extension Study (Group 4)|Protocol Violation|0|||
160486824|NCT00092521|579512311|FG002|Extension Study (Group 4)|Protocol Violation|0|||
160486825|NCT00092521|579512312|FG003|Extension Study (Group 4)|Protocol Violation|2|||
160486826|NCT00092521|579512309|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
160486827|NCT00092521|579512310|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
160486828|NCT00092521|579512311|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
160486829|NCT00092521|579512312|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
160486830|NCT00092521|579512309|FG000|Extension Study (Group 4)|Moved|0|||
160486831|NCT00092521|579512310|FG001|Extension Study (Group 4)|Moved|0|||
160486832|NCT00092521|579512311|FG002|Extension Study (Group 4)|Moved|0|||
160486833|NCT00092521|579512312|FG003|Extension Study (Group 4)|Moved|16|||
160486834|NCT00092521|579512309|FG000|Extension Study (Group 4)|Site Terminated|0|||
160486835|NCT00092521|579512310|FG001|Extension Study (Group 4)|Site Terminated|0|||
160486836|NCT00092521|579512311|FG002|Extension Study (Group 4)|Site Terminated|0|||
160486837|NCT00092521|579512312|FG003|Extension Study (Group 4)|Site Terminated|4|||
160486838|NCT00092521|579512309|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
160486839|NCT00092521|579512310|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
160486840|NCT00092521|579512311|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
160486841|NCT00092521|579512312|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
160486842|NCT01878383|579512313|FG000|Overall Study|Lost to Follow-up|0|||
160486843|NCT01878383|579512314|FG001|Overall Study|Lost to Follow-up|1499|||
160486844|NCT03464383|579512315|FG000|Overall Study|Lost to Follow-up|1|||
160607113|NCT02348840|579939412|FG002|Overall Study|Withdrawal by Subject|0|||
160607114|NCT02348840|579939413|FG003|Overall Study|Withdrawal by Subject|0|||
160607115|NCT01690988|579939414|FG000|Overall Study|Withdrawal by Subject|2|||
160607116|NCT01690988|579939415|FG001|Overall Study|Withdrawal by Subject|2|||
160607117|NCT01690988|579939416|FG002|Overall Study|Withdrawal by Subject|3|||
160607118|NCT01690988|579939414|FG000|Overall Study|Physician Decision|0|||
160486845|NCT03464383|579512316|FG001|Overall Study|Lost to Follow-up|0|||
160486846|NCT03464383|579512317|FG002|Overall Study|Lost to Follow-up|0|||
160486847|NCT03464383|579512315|FG000|Overall Study|Withdrawal by Subject|0|||
160607119|NCT01690988|579939415|FG001|Overall Study|Physician Decision|0|||
160607120|NCT01690988|579939416|FG002|Overall Study|Physician Decision|1|||
160607121|NCT01690988|579939414|FG000|Overall Study|Operation Cancelled|1|||
160607122|NCT01690988|579939415|FG001|Overall Study|Operation Cancelled|1|||
160486848|NCT03464383|579512316|FG001|Overall Study|Withdrawal by Subject|1|||
160607123|NCT01690988|579939416|FG002|Overall Study|Operation Cancelled|0|||
160607124|NCT01690988|579939414|FG000|Overall Study|Determined ineligible|1|||
160607125|NCT01690988|579939415|FG001|Overall Study|Determined ineligible|0|||
160486849|NCT03464383|579512317|FG002|Overall Study|Withdrawal by Subject|0|||
160486850|NCT00560313|579512318|FG000|Overall Study|Adverse Events or Death|2|||
160486851|NCT00560313|579512318|FG000|Overall Study|Withdrawal by Subject|2|||
160486852|NCT00560313|579512318|FG000|Overall Study|Lost to Follow-up|1|||
160486853|NCT00560313|579512318|FG000|Overall Study|Protocol Violation|1|||
160486854|NCT00605566|579512319|FG000|Overall Study|Adverse Event|1|||
160486855|NCT00605566|579512319|FG000|Overall Study|Clinical deterioration|1|||
160486856|NCT00605566|579512319|FG000|Overall Study|Poor compliance in run-in period|1|||
160486857|NCT03475056|579512320|FG000|Overall Study|Lost to Follow-up|0|||
160486858|NCT03475056|579512321|FG001|Overall Study|Lost to Follow-up|1|||
160486859|NCT03475056|579512320|FG000|Overall Study|Moved from Area|0|||
160486860|NCT03475056|579512321|FG001|Overall Study|Moved from Area|2|||
160486861|NCT00113269|579512324|FG000|Overall Study|Not transplanted, donor issues|4|||
160486862|NCT00113269|579512325|FG001|Overall Study|Not transplanted, donor issues|0|||
160486863|NCT00113269|579512326|FG002|Overall Study|Not transplanted, donor issues|2|||
160486864|NCT00113269|579512327|FG003|Overall Study|Not transplanted, donor issues|2|||
160486865|NCT00113269|579512324|FG000|Overall Study|Not transplanted, recipient issues|2|||
160486866|NCT00113269|579512325|FG001|Overall Study|Not transplanted, recipient issues|1|||
160486867|NCT00113269|579512326|FG002|Overall Study|Not transplanted, recipient issues|7|||
160486868|NCT00113269|579512327|FG003|Overall Study|Not transplanted, recipient issues|4|||
160486869|NCT00113269|579512324|FG000|Overall Study|Early graft loss, technical|0|||
160486870|NCT00113269|579512325|FG001|Overall Study|Early graft loss, technical|0|||
160486871|NCT00113269|579512326|FG002|Overall Study|Early graft loss, technical|2|||
160486872|NCT00113269|579512327|FG003|Overall Study|Early graft loss, technical|0|||
160486873|NCT00113269|579512324|FG000|Overall Study|Death in operating room|0|||
160486874|NCT00113269|579512325|FG001|Overall Study|Death in operating room|0|||
160486875|NCT00113269|579512326|FG002|Overall Study|Death in operating room|0|||
160486876|NCT00113269|579512327|FG003|Overall Study|Death in operating room|1|||
160486877|NCT00113269|579512324|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
160486878|NCT00113269|579512325|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
160486879|NCT00113269|579512326|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
160486880|NCT00113269|579512327|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
160486881|NCT00113269|579512324|FG000|Overall Study|Adverse Event|2|||
160486882|NCT00113269|579512325|FG001|Overall Study|Adverse Event|7|||
160486883|NCT00113269|579512326|FG002|Overall Study|Adverse Event|11|||
160486884|NCT00113269|579512327|FG003|Overall Study|Adverse Event|7|||
160486885|NCT00113269|579512324|FG000|Overall Study|Withdrawal by Subject|4|||
160486886|NCT00113269|579512325|FG001|Overall Study|Withdrawal by Subject|3|||
160486887|NCT00113269|579512326|FG002|Overall Study|Withdrawal by Subject|4|||
160486888|NCT00113269|579512327|FG003|Overall Study|Withdrawal by Subject|2|||
160486889|NCT00113269|579512324|FG000|Overall Study|Graft loss|6|||
160486890|NCT00113269|579512325|FG001|Overall Study|Graft loss|6|||
160486891|NCT00113269|579512326|FG002|Overall Study|Graft loss|4|||
160486892|NCT00113269|579512327|FG003|Overall Study|Graft loss|9|||
160486893|NCT00113269|579512324|FG000|Overall Study|Protocol Violation|1|||
160486894|NCT00113269|579512325|FG001|Overall Study|Protocol Violation|0|||
160486895|NCT00113269|579512326|FG002|Overall Study|Protocol Violation|4|||
160486896|NCT00113269|579512327|FG003|Overall Study|Protocol Violation|2|||
160486897|NCT00113269|579512324|FG000|Overall Study|Lost to Follow-up|2|||
160486898|NCT00113269|579512325|FG001|Overall Study|Lost to Follow-up|3|||
160486899|NCT00113269|579512326|FG002|Overall Study|Lost to Follow-up|6|||
160486900|NCT00113269|579512327|FG003|Overall Study|Lost to Follow-up|3|||
160486901|NCT00113269|579512324|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
160486902|NCT00113269|579512325|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
160486903|NCT00113269|579512326|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
160486904|NCT00113269|579512327|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
160486905|NCT00113269|579512324|FG000|Overall Study|Discontinued due to rejection|0|||
160486906|NCT00113269|579512325|FG001|Overall Study|Discontinued due to rejection|0|||
160486907|NCT00113269|579512326|FG002|Overall Study|Discontinued due to rejection|1|||
160486908|NCT00113269|579512327|FG003|Overall Study|Discontinued due to rejection|0|||
160486909|NCT00113269|579512324|FG000|Overall Study|Moved|0|||
160486910|NCT00113269|579512325|FG001|Overall Study|Moved|1|||
160486911|NCT00113269|579512326|FG002|Overall Study|Moved|0|||
160486912|NCT00113269|579512327|FG003|Overall Study|Moved|3|||
160486913|NCT00113269|579512324|FG000|Overall Study|Received pancreas transplant|0|||
160486914|NCT00113269|579512325|FG001|Overall Study|Received pancreas transplant|0|||
160486915|NCT00113269|579512326|FG002|Overall Study|Received pancreas transplant|0|||
160486916|NCT00113269|579512327|FG003|Overall Study|Received pancreas transplant|2|||
160607126|NCT01690988|579939416|FG002|Overall Study|Determined ineligible|0|||
160486917|NCT00113269|579512324|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
160486918|NCT00113269|579512325|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
160486919|NCT00113269|579512326|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
160486920|NCT00113269|579512327|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
160607127|NCT01690988|579939414|FG000|Overall Study|Death|1|||
160607128|NCT01690988|579939415|FG001|Overall Study|Death|1|||
160486921|NCT00113269|579512324|FG000|Overall Study|Did not meet eligibility criteria|1|||
160486922|NCT00113269|579512325|FG001|Overall Study|Did not meet eligibility criteria|0|||
160486923|NCT00113269|579512326|FG002|Overall Study|Did not meet eligibility criteria|0|||
160486924|NCT00113269|579512327|FG003|Overall Study|Did not meet eligibility criteria|1|||
160486925|NCT00113269|579512324|FG000|Overall Study|Unable to return for follow up|2|||
160486926|NCT00113269|579512325|FG001|Overall Study|Unable to return for follow up|1|||
160486927|NCT00113269|579512326|FG002|Overall Study|Unable to return for follow up|0|||
160486928|NCT00113269|579512327|FG003|Overall Study|Unable to return for follow up|0|||
160486929|NCT03864341|579512334|FG000|Overall Study|Withdrawal by Subject|1|||
160486930|NCT01066936|579512335|FG000|Overall Study|Death|2|||
160486931|NCT01066936|579512335|FG000|Overall Study|Device revised/removed|1|||
160486932|NCT01066936|579512335|FG000|Overall Study|Lost to Follow-up|3|||
160486933|NCT01066936|579512335|FG000|Overall Study|Withdrawal by Subject|4|||
160486934|NCT01904136|579512336|FG000|Overall Study|Physician Decision|0|||
160486935|NCT01904136|579512337|FG001|Overall Study|Physician Decision|0|||
160486936|NCT01904136|579512338|FG002|Overall Study|Physician Decision|0|||
160486937|NCT01904136|579512339|FG003|Overall Study|Physician Decision|0|||
160486938|NCT01904136|579512340|FG004|Overall Study|Physician Decision|0|||
160486939|NCT01904136|579512341|FG005|Overall Study|Physician Decision|1|||
160486940|NCT01904136|579512342|FG006|Overall Study|Physician Decision|0|||
160486941|NCT01904136|579512343|FG007|Overall Study|Physician Decision|0|||
160486942|NCT01904136|579512344|FG008|Overall Study|Physician Decision|0|||
160486943|NCT01960348|579512349|FG000|Overall Study|Adverse event, not serious|2|||
160486944|NCT01960348|579512350|FG001|Overall Study|Adverse event, not serious|2|||
160486945|NCT01960348|579512349|FG000|Overall Study|Adverse event, serious fatal|6|||
160607129|NCT01690988|579939416|FG002|Overall Study|Death|1|||
160607130|NCT01690988|579939414|FG000|Overall Study|Sedated|1|||
160607131|NCT01690988|579939415|FG001|Overall Study|Sedated|1|||
160607132|NCT01690988|579939416|FG002|Overall Study|Sedated|2|||
160607133|NCT00312728|579939417|FG000|Overall Study|Progressive disease|53|||
160607134|NCT00312728|579939417|FG000|Overall Study|Adverse Event|32|||
160607135|NCT00312728|579939417|FG000|Overall Study|Withdrawal by Subject|10|||
160607136|NCT00312728|579939417|FG000|Overall Study|Required non-protocol cancer treatment|2|||
160486946|NCT01960348|579512350|FG001|Overall Study|Adverse event, serious fatal|5|||
160486947|NCT01960348|579512349|FG000|Overall Study|Adverse event, serious non-fatal|0|||
160607137|NCT00312728|579939417|FG000|Overall Study|Protocol Violation|2|||
160607138|NCT00312728|579939417|FG000|Overall Study|Other|10|||
160607139|NCT00312728|579939417|FG000|Overall Study|Other|1|||
160607140|NCT03696576|579939418|FG000|Overall Study|Soreness of throat after therapy|1|||
160486948|NCT01960348|579512350|FG001|Overall Study|Adverse event, serious non-fatal|3|||
160486949|NCT01960348|579512349|FG000|Overall Study|Withdrawal by Subject|1|||
160486950|NCT01960348|579512350|FG001|Overall Study|Withdrawal by Subject|11|||
160486951|NCT01960348|579512349|FG000|Overall Study|Physician Decision|0|||
160486952|NCT01960348|579512350|FG001|Overall Study|Physician Decision|1|||
160486953|NCT01960348|579512349|FG000|Overall Study|Protocol Violation|1|||
160486954|NCT01960348|579512350|FG001|Overall Study|Protocol Violation|0|||
160607141|NCT03696576|579939419|FG001|Overall Study|Soreness of throat after therapy|1|||
160607142|NCT03696576|579939418|FG000|Overall Study|Lost to Follow-up|2|||
160607143|NCT03696576|579939419|FG001|Overall Study|Lost to Follow-up|4|||
160607144|NCT00744991|579939420|FG000|Overall Study|Progressive Disease|11|||
160607145|NCT00744991|579939420|FG000|Overall Study|Withdrawal by Subject|8|||
160607146|NCT00744991|579939420|FG000|Overall Study|Physician Decision|3|||
160607147|NCT00744991|579939420|FG000|Overall Study|Adverse Event|2|||
160607148|NCT00744991|579939420|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
160607149|NCT01662986|579939421|FG000|Overall Study|Adverse Event|5|||
160607150|NCT01662986|579939422|FG001|Overall Study|Adverse Event|4|||
160607151|NCT01662986|579939421|FG000|Overall Study|Protocol Violation|2|||
160607152|NCT01662986|579939422|FG001|Overall Study|Protocol Violation|3|||
160607153|NCT01662986|579939421|FG000|Overall Study|Lost to Follow-up|5|||
160607154|NCT01662986|579939422|FG001|Overall Study|Lost to Follow-up|4|||
160607155|NCT01662986|579939421|FG000|Overall Study|Withdrawal by Subject|2|||
160607156|NCT01662986|579939422|FG001|Overall Study|Withdrawal by Subject|2|||
160607157|NCT01662986|579939421|FG000|Overall Study|Not Treated|1|||
160607158|NCT01662986|579939422|FG001|Overall Study|Not Treated|0|||
160607159|NCT01662986|579939421|FG000|Overall Study|Other than stated above|3|||
160607160|NCT01662986|579939422|FG001|Overall Study|Other than stated above|0|||
160607161|NCT01819194|579939430|FG000|Overall Study|Loss of study articles|2|||
160607162|NCT00045630|579939431|FG000|Overall Study|Adverse Event|1|||
160607163|NCT00045630|579939431|FG000|Overall Study|Refusal unrelated to adverse event|1|||
160607164|NCT00045630|579939431|FG000|Overall Study|Progression/relapse|1|||
160607165|NCT00045630|579939431|FG000|Overall Study|Death|1|||
160607166|NCT00045630|579939431|FG000|Overall Study|Ineligible|2|||
160607167|NCT04449276|579939432|FG000|Overall Study|Adverse Event|1|||
160607168|NCT04449276|579939433|FG001|Overall Study|Adverse Event|2|||
160607169|NCT04449276|579939434|FG002|Overall Study|Adverse Event|0|||
160607170|NCT04449276|579939435|FG003|Overall Study|Adverse Event|0|||
160607171|NCT04449276|579939436|FG004|Overall Study|Adverse Event|2|||
160607172|NCT04449276|579939437|FG005|Overall Study|Adverse Event|0|||
160607173|NCT04449276|579939438|FG006|Overall Study|Adverse Event|0|||
160607174|NCT04449276|579939439|FG007|Overall Study|Adverse Event|1|||
160607175|NCT04449276|579939432|FG000|Overall Study|Withdrawal by Subject|2|||
160607176|NCT04449276|579939433|FG001|Overall Study|Withdrawal by Subject|0|||
160607177|NCT04449276|579939434|FG002|Overall Study|Withdrawal by Subject|0|||
160607178|NCT04449276|579939435|FG003|Overall Study|Withdrawal by Subject|1|||
160607179|NCT04449276|579939436|FG004|Overall Study|Withdrawal by Subject|0|||
160607180|NCT04449276|579939437|FG005|Overall Study|Withdrawal by Subject|0|||
160607181|NCT04449276|579939438|FG006|Overall Study|Withdrawal by Subject|0|||
160607182|NCT04449276|579939439|FG007|Overall Study|Withdrawal by Subject|0|||
160607183|NCT04449276|579939432|FG000|Overall Study|Other|0|||
160607184|NCT04449276|579939433|FG001|Overall Study|Other|2|||
160607185|NCT04449276|579939434|FG002|Overall Study|Other|3|||
160607186|NCT04449276|579939435|FG003|Overall Study|Other|2|||
160607187|NCT04449276|579939436|FG004|Overall Study|Other|0|||
160607188|NCT04449276|579939437|FG005|Overall Study|Other|0|||
160607189|NCT04449276|579939438|FG006|Overall Study|Other|0|||
160486955|NCT00853372|579512351|FG000|Overall Study|Death|30|||
160486956|NCT00853372|579512352|FG001|Overall Study|Death|26|||
160486957|NCT00853372|579512351|FG000|Overall Study|Lost to Follow-up|1|||
160486958|NCT00853372|579512352|FG001|Overall Study|Lost to Follow-up|2|||
160486959|NCT00853372|579512351|FG000|Overall Study|Full Consent Withdrawn|1|||
160486960|NCT00853372|579512352|FG001|Overall Study|Full Consent Withdrawn|1|||
160486961|NCT01580995|579512353|FG000|Overall Study|Lost to Follow-up|2|||
160486962|NCT01580995|579512354|FG001|Overall Study|Lost to Follow-up|2|||
160607190|NCT04449276|579939439|FG007|Overall Study|Other|1|||
160607191|NCT00179517|579939441|FG000|Overall Study|Withdrawal by Subject|2|||
160607192|NCT00179517|579939442|FG001|Overall Study|Withdrawal by Subject|1|||
160607193|NCT01448707|579939446|FG000|Overall Study|Adverse Event|3|||
160486963|NCT02517528|579512356|FG000|Overall Study|Withdrawal by Subject|1|||
160486964|NCT02202109|579512358|FG000|Overall Study|Lost to Follow-up|88|||
160607194|NCT01448707|579939447|FG001|Overall Study|Adverse Event|1|||
160607195|NCT01448707|579939446|FG000|Overall Study|Lost to Follow-up|2|||
160607196|NCT01448707|579939447|FG001|Overall Study|Lost to Follow-up|6|||
160607197|NCT01448707|579939446|FG000|Overall Study|Withdrawal by Subject|6|||
160607198|NCT01448707|579939447|FG001|Overall Study|Withdrawal by Subject|7|||
160607199|NCT01448707|579939446|FG000|Overall Study|Other|7|||
160607200|NCT01448707|579939447|FG001|Overall Study|Other|4|||
160607201|NCT00383708|579939453|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
160607202|NCT00383708|579939453|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
160486965|NCT02202109|579512359|FG001|Overall Study|Lost to Follow-up|87|||
160486966|NCT02202109|579512358|FG000|Overall Study|Withdrawal by Subject|2|||
160486967|NCT02202109|579512359|FG001|Overall Study|Withdrawal by Subject|0|||
160486968|NCT01268098|579512362|FG000|Overall Study|Adverse Event|1|||
160486969|NCT01268098|579512363|FG001|Overall Study|Adverse Event|0|||
160486970|NCT04156399|579512370|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
160486971|NCT04156399|579512370|FG000|Overall Study|study suspension due to COVID pandemic|3|||
160486972|NCT01093599|579512373|FG000|Overall Study|Lost to Follow-up|32|||
160486973|NCT01093599|579512374|FG001|Overall Study|Lost to Follow-up|46|||
160486974|NCT01703845|579512375|FG000|Overall Study|Adverse Event|1|||
160486975|NCT01703845|579512376|FG001|Overall Study|Adverse Event|0|||
160486976|NCT01703845|579512375|FG000|Overall Study|Protocol Violation|1|||
160486977|NCT01703845|579512376|FG001|Overall Study|Protocol Violation|0|||
160486978|NCT01703845|579512375|FG000|Overall Study|other than stated above|1|||
160486979|NCT01703845|579512376|FG001|Overall Study|other than stated above|0|||
160486980|NCT03418493|579512377|FG000|Overall Study|Adverse Event|1|||
160486981|NCT03418493|579512378|FG001|Overall Study|Adverse Event|0|||
160486982|NCT03418493|579512379|FG002|Overall Study|Adverse Event|0|||
160486983|NCT03418493|579512380|FG003|Overall Study|Adverse Event|0|||
160486984|NCT03418493|579512381|FG004|Overall Study|Adverse Event|0|||
160486985|NCT03418493|579512382|FG005|Overall Study|Adverse Event|0|||
160486986|NCT03418493|579512383|FG006|Overall Study|Adverse Event|0|||
160486987|NCT03418493|579512384|FG007|Overall Study|Adverse Event|0|||
160486988|NCT03418493|579512385|FG008|Overall Study|Adverse Event|0|||
160486989|NCT03418493|579512386|FG009|Overall Study|Adverse Event|0|||
160486990|NCT03418493|579512387|FG010|Overall Study|Adverse Event|0|||
160486991|NCT03418493|579512377|FG000|Overall Study|Protocol Violation|0|||
160486992|NCT03418493|579512378|FG001|Overall Study|Protocol Violation|0|||
160486993|NCT03418493|579512379|FG002|Overall Study|Protocol Violation|0|||
160486994|NCT03418493|579512380|FG003|Overall Study|Protocol Violation|0|||
160486995|NCT03418493|579512381|FG004|Overall Study|Protocol Violation|0|||
160486996|NCT03418493|579512382|FG005|Overall Study|Protocol Violation|0|||
160486997|NCT03418493|579512383|FG006|Overall Study|Protocol Violation|0|||
160486998|NCT03418493|579512384|FG007|Overall Study|Protocol Violation|0|||
160486999|NCT03418493|579512385|FG008|Overall Study|Protocol Violation|0|||
160487000|NCT03418493|579512386|FG009|Overall Study|Protocol Violation|1|||
160487001|NCT03418493|579512387|FG010|Overall Study|Protocol Violation|0|||
160487002|NCT00526097|579512389|FG000|Overall Study|Adverse Event|6|||
160487003|NCT00526097|579512390|FG001|Overall Study|Adverse Event|44|||
160487004|NCT00526097|579512389|FG000|Overall Study|Protocol Violation|4|||
160487005|NCT00526097|579512390|FG001|Overall Study|Protocol Violation|10|||
160487006|NCT00526097|579512389|FG000|Overall Study|Withdrawal by Subject|3|||
160487007|NCT00526097|579512390|FG001|Overall Study|Withdrawal by Subject|1|||
160487008|NCT00526097|579512389|FG000|Overall Study|Other|2|||
160487009|NCT00526097|579512390|FG001|Overall Study|Other|1|||
160487010|NCT04140266|579512391|FG000|Overall Study|Physician Decision|2|||
160487011|NCT04140266|579512392|FG001|Overall Study|Physician Decision|0|||
160487012|NCT04140266|579512391|FG000|Overall Study|Withdrawal by Subject|4|||
160487013|NCT04140266|579512392|FG001|Overall Study|Withdrawal by Subject|2|||
160487014|NCT00943618|579512393|FG000|Overall Study|Lost to Follow-up|38|||
160487015|NCT00943618|579512394|FG001|Overall Study|Lost to Follow-up|48|||
160487016|NCT00943618|579512395|FG002|Overall Study|Lost to Follow-up|20|||
160487017|NCT00943618|579512393|FG000|Overall Study|Discontinued Medication|17|||
160487018|NCT00943618|579512394|FG001|Overall Study|Discontinued Medication|29|||
160487019|NCT00943618|579512395|FG002|Overall Study|Discontinued Medication|11|||
160487020|NCT01309243|579512400|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
160487021|NCT01309243|579512401|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
160487022|NCT01309243|579512400|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
160487023|NCT01309243|579512401|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
160487024|NCT01309243|579512400|FG000|Randomized Phase Through Week 96|Death|0|||
160487025|NCT01309243|579512401|FG001|Randomized Phase Through Week 96|Death|1|||
160487026|NCT01309243|579512400|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
160487027|NCT01309243|579512401|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
160487028|NCT01309243|579512400|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
160487029|NCT01309243|579512401|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
160487030|NCT01309243|579512400|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
160487031|NCT01309243|579512401|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
160487032|NCT01309243|579512400|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
160487033|NCT01309243|579512401|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
160487034|NCT01309243|579512400|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
160487035|NCT01309243|579512401|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
160487036|NCT01309243|579512400|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
160487037|NCT01309243|579512401|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
160487038|NCT01309243|579512400|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
160487039|NCT01309243|579512401|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
160487040|NCT01309243|579512400|FG000|Extension Phase|Lost to Follow-up|6|||
160607203|NCT00383708|579939453|FG000|Run-in Period|Protocol Violation|4|||
160607204|NCT00383708|579939453|FG000|Run-in Period|Adverse Event|2|||
160607205|NCT00383708|579939453|FG000|Run-in Period|Claustrophobia|1|||
160607206|NCT00383708|579939453|FG000|Co-administration Period|Adverse Event|5|||
160607207|NCT02033850|579939454|FG000|Overall Study|Death|1|||
160607208|NCT02033850|579939455|FG001|Overall Study|Death|0|||
160607209|NCT02033850|579939454|FG000|Overall Study|unrelated medical reason|1|||
160607210|NCT02033850|579939455|FG001|Overall Study|unrelated medical reason|1|||
160607211|NCT02820038|579939456|FG000|Overall Study|Lost to Follow-up|7|||
160607212|NCT02820038|579939457|FG001|Overall Study|Lost to Follow-up|11|||
160607213|NCT02820038|579939458|FG002|Overall Study|Lost to Follow-up|2|||
160607214|NCT02820038|579939459|FG003|Overall Study|Lost to Follow-up|9|||
160607215|NCT02820038|579939456|FG000|Overall Study|Withdrawal by Subject|3|||
160607216|NCT02820038|579939457|FG001|Overall Study|Withdrawal by Subject|14|||
160607217|NCT02820038|579939458|FG002|Overall Study|Withdrawal by Subject|3|||
160607218|NCT02820038|579939459|FG003|Overall Study|Withdrawal by Subject|13|||
160607219|NCT00560794|579939461|FG000|Overall Study|Adverse Event|2|||
160607220|NCT00560794|579939461|FG000|Overall Study|Patient was not Compliant|1|||
160607221|NCT00560794|579939461|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
160607222|NCT00560794|579939461|FG000|Overall Study|Hematological Relapse|1|||
160607223|NCT00560794|579939461|FG000|Overall Study|Received Bone Marrow Transplant|6|||
160607224|NCT04857892|579939462|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
160607225|NCT04857892|579939463|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
160607226|NCT04857892|579939464|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
160607227|NCT04857892|579939465|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
160607228|NCT04857892|579939466|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
160607229|NCT04857892|579939462|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
160607230|NCT04857892|579939463|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
160661216|NCT04753437|580141820|FG001|Overall Study|Liver Function Test Abnormalities|4|||
160661217|NCT00385684|580141823|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
160661218|NCT00385684|580141824|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
160661219|NCT00385684|580141823|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
160661220|NCT00385684|580141824|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
160661221|NCT00385684|580141823|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
160661222|NCT00385684|580141824|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
160661223|NCT02140060|580141825|FG000|Overall Study|Adverse Event|0|||
160661224|NCT02140060|580141826|FG001|Overall Study|Adverse Event|0|||
160661225|NCT02140060|580141827|FG002|Overall Study|Adverse Event|0|||
160661226|NCT02140060|580141828|FG003|Overall Study|Adverse Event|1|||
160661227|NCT02140060|580141829|FG004|Overall Study|Adverse Event|1|||
160661228|NCT02140060|580141830|FG005|Overall Study|Adverse Event|1|||
160661229|NCT02140060|580141825|FG000|Overall Study|Lack of Efficacy|0|||
160661230|NCT02140060|580141826|FG001|Overall Study|Lack of Efficacy|0|||
160661231|NCT02140060|580141827|FG002|Overall Study|Lack of Efficacy|0|||
160661232|NCT02140060|580141828|FG003|Overall Study|Lack of Efficacy|1|||
160661233|NCT02140060|580141829|FG004|Overall Study|Lack of Efficacy|0|||
160661234|NCT02140060|580141830|FG005|Overall Study|Lack of Efficacy|0|||
160661235|NCT01066143|580144031|FG000|Overall Study|ineligible for the study|8|||
160661236|NCT05376319|580144032|FG000|Overall Study|Funding termination|2|||
160661237|NCT05376319|580144033|FG001|Overall Study|Funding termination|4|||
160661238|NCT01340495|580144034|FG000|Overall Study|Withdrawal by Subject|1|||
160661239|NCT00723528|580144035|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
160661240|NCT00723528|580144036|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
160661241|NCT00723528|580144037|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
160661242|NCT00723528|580144038|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
160661243|NCT00723528|580144039|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
160661244|NCT00723528|580144040|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
160661245|NCT00723528|580144041|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
160661246|NCT00723528|580144035|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
160661247|NCT00723528|580144036|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
160487041|NCT01309243|579512401|FG001|Extension Phase|Lost to Follow-up|0|||
160607231|NCT04857892|579939464|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
160661248|NCT00723528|580144037|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
160661249|NCT00723528|580144038|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
160661250|NCT00723528|580144039|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
160661251|NCT00723528|580144040|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
160661252|NCT00723528|580144041|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
160661253|NCT00723528|580144035|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
160661254|NCT00723528|580144036|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
160607232|NCT04857892|579939465|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
160607233|NCT04857892|579939466|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
160607234|NCT04857892|579939462|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
160607235|NCT04857892|579939463|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
160607236|NCT04857892|579939464|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
160607237|NCT04857892|579939465|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
160607238|NCT04857892|579939466|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
160607239|NCT01922739|579939467|FG000|Titration/Adjustment Period|Adverse Event|3|||
160607240|NCT01922739|579939467|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
160607241|NCT01922739|579939467|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
160607242|NCT01922739|579939467|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
160607243|NCT01922739|579939467|FG000|Open-label Treatment Period|Adverse Event|6|||
160607244|NCT01922739|579939467|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
160607245|NCT01922739|579939467|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
160607246|NCT01922739|579939467|FG000|Open-label Treatment Period|Protocol Violation|5|||
160607247|NCT01922739|579939467|FG000|Open-label Treatment Period|Pregnancy|1|||
160607248|NCT01922739|579939467|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
160607249|NCT01922739|579939467|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
160607250|NCT01922739|579939467|FG000|Open-label Treatment Period|Physician Decision|1|||
160607251|NCT01922739|579939467|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
160607252|NCT05104749|579939468|FG000|Overall Study|Lost to Follow-up|2|||
160607253|NCT05104749|579939469|FG001|Overall Study|Lost to Follow-up|3|||
160607254|NCT02963766|579939470|FG000|Double-Blind Period|Adverse Event|1|||
160607255|NCT02963766|579939471|FG001|Double-Blind Period|Adverse Event|0|||
160607256|NCT02963766|579939472|FG002|Double-Blind Period|Adverse Event|1|||
160607257|NCT02963766|579939470|FG000|Double-Blind Period|Physician Decision|1|||
160607258|NCT02963766|579939471|FG001|Double-Blind Period|Physician Decision|0|||
160607259|NCT02963766|579939472|FG002|Double-Blind Period|Physician Decision|0|||
160607260|NCT02963766|579939470|FG000|Double-Blind Period|Withdrawal by Subject|1|||
160607261|NCT02963766|579939471|FG001|Double-Blind Period|Withdrawal by Subject|1|||
160607262|NCT02963766|579939472|FG002|Double-Blind Period|Withdrawal by Subject|0|||
160607263|NCT02963766|579939470|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
160607264|NCT02963766|579939471|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
160607265|NCT02963766|579939472|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
160607266|NCT02963766|579939470|FG000|Double-Blind Period|Protocol Violation|1|||
160607267|NCT02963766|579939471|FG001|Double-Blind Period|Protocol Violation|0|||
160607268|NCT02963766|579939472|FG002|Double-Blind Period|Protocol Violation|0|||
160607269|NCT02963766|579939470|FG000|Double-Blind Period|Lost to Follow-up|0|||
160607270|NCT02963766|579939471|FG001|Double-Blind Period|Lost to Follow-up|1|||
160607271|NCT02963766|579939472|FG002|Double-Blind Period|Lost to Follow-up|0|||
160607272|NCT02963766|579939470|FG000|Open Label Extension (OLE)|Physician Decision|1|||
160607273|NCT02963766|579939471|FG001|Open Label Extension (OLE)|Physician Decision|2|||
160607274|NCT02963766|579939472|FG002|Open Label Extension (OLE)|Physician Decision|2|||
160607275|NCT02963766|579939470|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
160607276|NCT02963766|579939471|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
160487042|NCT01402063|579512404|FG000|Overall Study|Withdrawal by Subject|3|||
160487043|NCT01402063|579512405|FG001|Overall Study|Withdrawal by Subject|3|||
160487044|NCT05153499|579512406|FG000|Overall Study|Withdrawal by Subject|1|||
160487045|NCT05153499|579512407|FG001|Overall Study|Withdrawal by Subject|0|||
160487046|NCT05153499|579512406|FG000|Overall Study|Clinical Hold|1|||
160487047|NCT05153499|579512407|FG001|Overall Study|Clinical Hold|0|||
160487048|NCT05153499|579512406|FG000|Overall Study|Study Termination|6|||
160487049|NCT05153499|579512407|FG001|Overall Study|Study Termination|5|||
160487050|NCT05109117|579512408|FG000|Overall Study|Lost to Follow-up|1|||
160487051|NCT05109117|579512408|FG000|Overall Study|Discontinued for non-compliance|1|||
160487052|NCT02166047|579512410|FG000|Overall Study|Withdrawal by Participant|0|||
160487053|NCT02166047|579512411|FG001|Overall Study|Withdrawal by Participant|1|||
160487054|NCT02166047|579512412|FG002|Overall Study|Withdrawal by Participant|2|||
160487055|NCT02166047|579512413|FG003|Overall Study|Withdrawal by Participant|0|||
160487056|NCT02166047|579512414|FG004|Overall Study|Withdrawal by Participant|0|||
160487057|NCT02166047|579512415|FG005|Overall Study|Withdrawal by Participant|0|||
160487058|NCT02166047|579512416|FG006|Overall Study|Withdrawal by Participant|1|||
160487059|NCT02166047|579512417|FG007|Overall Study|Withdrawal by Participant|0|||
160607277|NCT02963766|579939472|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
160607278|NCT00901394|579939473|FG000|Overall Study|Physician Decision|1|||
160607279|NCT00901394|579939474|FG001|Overall Study|Physician Decision|1|||
160607280|NCT00901394|579939475|FG002|Overall Study|Physician Decision|2|||
160607281|NCT04964557|579939479|FG000|Overall Study|Withdrawal by Subject|3|||
160607282|NCT04964557|579939480|FG001|Overall Study|Withdrawal by Subject|2|||
160607283|NCT04964557|579939479|FG000|Overall Study|Lost to Follow-up|1|||
160607284|NCT04964557|579939480|FG001|Overall Study|Lost to Follow-up|2|||
160607285|NCT04964557|579939479|FG000|Overall Study|Physician Decision|2|||
160487060|NCT02166047|579512418|FG008|Overall Study|Withdrawal by Participant|0|||
160487061|NCT02166047|579512419|FG009|Overall Study|Withdrawal by Participant|0|||
160487062|NCT02166047|579512420|FG010|Overall Study|Withdrawal by Participant|0|||
160607286|NCT04964557|579939480|FG001|Overall Study|Physician Decision|0|||
160607287|NCT04964557|579939479|FG000|Overall Study|Death|3|||
160607288|NCT04964557|579939480|FG001|Overall Study|Death|0|||
160607289|NCT04964557|579939479|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
160607290|NCT04964557|579939480|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
160607291|NCT00251589|579939482|FG000|Overall Study|Adverse Event|5|||
160607292|NCT00251589|579939483|FG001|Overall Study|Adverse Event|1|||
160607293|NCT00251589|579939484|FG002|Overall Study|Adverse Event|2|||
160607294|NCT00251589|579939485|FG003|Overall Study|Adverse Event|1|||
160607295|NCT00251589|579939482|FG000|Overall Study|Withdrawal by Subject|1|||
160607296|NCT00251589|579939483|FG001|Overall Study|Withdrawal by Subject|1|||
160607297|NCT00251589|579939484|FG002|Overall Study|Withdrawal by Subject|0|||
160607298|NCT00251589|579939485|FG003|Overall Study|Withdrawal by Subject|0|||
160607299|NCT00251589|579939482|FG000|Overall Study|Discontinued due to progressive disease|9|||
160607300|NCT00251589|579939483|FG001|Overall Study|Discontinued due to progressive disease|1|||
160607301|NCT00251589|579939484|FG002|Overall Study|Discontinued due to progressive disease|0|||
160607302|NCT00251589|579939485|FG003|Overall Study|Discontinued due to progressive disease|1|||
160607303|NCT02358863|579941369|FG000|Overall Study|Physician Decision|3|||
160607304|NCT05426460|579941378|FG000|Overall Study|Protocol Violation|1|||
160607305|NCT05426460|579941379|FG001|Overall Study|Protocol Violation|1|||
160607306|NCT05426460|579941380|FG002|Overall Study|Protocol Violation|1|||
160607307|NCT05426460|579941381|FG003|Overall Study|Protocol Violation|0|||
160607308|NCT01405027|579941384|FG000|Overall Study|Withdrawn consent|3|||
160607309|NCT01405027|579941385|FG001|Overall Study|Withdrawn consent|0|||
160607310|NCT01405027|579941384|FG000|Overall Study|Lost to Follow-up|16|||
160607311|NCT01405027|579941385|FG001|Overall Study|Lost to Follow-up|24|||
160607312|NCT01405027|579941384|FG000|Overall Study|Investigator judgement|0|||
160607313|NCT01405027|579941385|FG001|Overall Study|Investigator judgement|2|||
160607314|NCT01405027|579941384|FG000|Overall Study|Death|1|||
160607315|NCT01405027|579941385|FG001|Overall Study|Death|0|||
160607316|NCT01405027|579941384|FG000|Overall Study|Other or Unknown|12|||
160607317|NCT01405027|579941385|FG001|Overall Study|Other or Unknown|25|||
160607318|NCT02498392|579941388|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
160607319|NCT02498392|579941389|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
160607320|NCT02498392|579941388|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
160607321|NCT02498392|579941389|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
160607322|NCT02498392|579941388|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
160607323|NCT02498392|579941389|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
160607324|NCT02498392|579941388|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
160607325|NCT02498392|579941389|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
160607326|NCT02498392|579941388|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
160607327|NCT02498392|579941389|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
160607328|NCT02498392|579941388|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
160607329|NCT02498392|579941389|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
160607330|NCT06073054|579941390|FG000|Overall Study|Withdrawal by Subject|2|||
160607331|NCT00981292|579941393|FG000|Day 1|Protocol Violation|1|||
160607332|NCT00981292|579941394|FG001|Day 1|Protocol Violation|0|||
160607333|NCT00981292|579941395|FG002|Day 1|Protocol Violation|0|||
160607334|NCT00981292|579941396|FG003|Day 1|Protocol Violation|0|||
160607335|NCT00981292|579941397|FG004|Day 1|Protocol Violation|0|||
160607336|NCT00981292|579941398|FG005|Day 1|Protocol Violation|2|||
160607337|NCT00981292|579941393|FG000|Day 2|Protocol Violation|2|||
160607338|NCT00981292|579941394|FG001|Day 2|Protocol Violation|0|||
160607339|NCT00981292|579941395|FG002|Day 2|Protocol Violation|0|||
160607340|NCT00981292|579941396|FG003|Day 2|Protocol Violation|0|||
160607341|NCT00981292|579941397|FG004|Day 2|Protocol Violation|0|||
160607342|NCT00981292|579941398|FG005|Day 2|Protocol Violation|0|||
160607343|NCT00981292|579941393|FG000|Day 3|Protocol Violation|0|||
160607344|NCT00981292|579941394|FG001|Day 3|Protocol Violation|0|||
160607345|NCT00981292|579941395|FG002|Day 3|Protocol Violation|0|||
160607346|NCT00981292|579941396|FG003|Day 3|Protocol Violation|0|||
160607347|NCT00981292|579941397|FG004|Day 3|Protocol Violation|0|||
160607348|NCT00981292|579941398|FG005|Day 3|Protocol Violation|1|||
160607349|NCT02782104|579941401|FG000|Overall Study|Other|215|||
160607350|NCT02782104|579941401|FG000|Overall Study|Induction Day 28 Non Responder|9|||
160607351|NCT02782104|579941401|FG000|Overall Study|Non-Compliance with Study Drug|2|||
160607352|NCT02782104|579941401|FG000|Overall Study|Death|8|||
160607353|NCT02782104|579941401|FG000|Overall Study|Pregnancy|6|||
160607354|NCT02782104|579941401|FG000|Overall Study|Withdrawal by Subject|63|||
160607355|NCT02782104|579941401|FG000|Overall Study|Protocol Violation|7|||
160607356|NCT02782104|579941401|FG000|Overall Study|Lack of Efficacy|61|||
160607357|NCT02782104|579941401|FG000|Overall Study|Lost to Follow-up|23|||
160607358|NCT02782104|579941401|FG000|Overall Study|Adverse Event|74|||
160607359|NCT02438787|579941402|FG000|Overall Study|Adverse Event|1|||
160607360|NCT02438787|579941403|FG001|Overall Study|Adverse Event|0|||
160607361|NCT02438787|579941404|FG002|Overall Study|Adverse Event|2|||
160607362|NCT02438787|579941402|FG000|Overall Study|Lack of Efficacy|1|||
160607363|NCT02438787|579941403|FG001|Overall Study|Lack of Efficacy|2|||
160607364|NCT02438787|579941404|FG002|Overall Study|Lack of Efficacy|0|||
160607365|NCT02438787|579941402|FG000|Overall Study|Lost to Follow-up|0|||
160607366|NCT02438787|579941403|FG001|Overall Study|Lost to Follow-up|1|||
160607367|NCT02438787|579941404|FG002|Overall Study|Lost to Follow-up|0|||
160607368|NCT02438787|579941402|FG000|Overall Study|Protocol Violation|0|||
160607369|NCT02438787|579941403|FG001|Overall Study|Protocol Violation|0|||
160607370|NCT02438787|579941404|FG002|Overall Study|Protocol Violation|1|||
160607371|NCT02438787|579941402|FG000|Overall Study|Withdrawal by Subject|15|||
160607372|NCT02438787|579941403|FG001|Overall Study|Withdrawal by Subject|7|||
160607373|NCT02438787|579941404|FG002|Overall Study|Withdrawal by Subject|10|||
160607374|NCT02438787|579941402|FG000|Overall Study|Study discontinued by sponsor|64|||
160607375|NCT02438787|579941403|FG001|Overall Study|Study discontinued by sponsor|72|||
160607376|NCT02438787|579941404|FG002|Overall Study|Study discontinued by sponsor|69|||
160607377|NCT02438787|579941402|FG000|Overall Study|Other|0|||
160607378|NCT02438787|579941403|FG001|Overall Study|Other|1|||
160607379|NCT02438787|579941404|FG002|Overall Study|Other|0|||
160607380|NCT02438787|579941402|FG000|Overall Study|Site terminated by sponsor|0|||
160607381|NCT02438787|579941403|FG001|Overall Study|Site terminated by sponsor|0|||
160607382|NCT02438787|579941404|FG002|Overall Study|Site terminated by sponsor|1|||
160607383|NCT03412565|579941405|FG000|Overall Study|Lost to Follow-up|0|||
160607384|NCT03412565|579941406|FG001|Overall Study|Lost to Follow-up|0|||
160607385|NCT03412565|579941407|FG002|Overall Study|Lost to Follow-up|1|||
160607386|NCT03412565|579941408|FG003|Overall Study|Lost to Follow-up|0|||
160607387|NCT03412565|579941405|FG000|Overall Study|Physician Decision|0|||
160607388|NCT03412565|579941406|FG001|Overall Study|Physician Decision|0|||
160607389|NCT03412565|579941407|FG002|Overall Study|Physician Decision|0|||
160607390|NCT03412565|579941408|FG003|Overall Study|Physician Decision|1|||
160607391|NCT03412565|579941405|FG000|Overall Study|Withdrawal by Subject|0|||
160607392|NCT03412565|579941406|FG001|Overall Study|Withdrawal by Subject|4|||
160607393|NCT03412565|579941407|FG002|Overall Study|Withdrawal by Subject|5|||
160607394|NCT03412565|579941408|FG003|Overall Study|Withdrawal by Subject|5|||
160607395|NCT03412565|579941405|FG000|Overall Study|Death|1|||
160607396|NCT03412565|579941406|FG001|Overall Study|Death|3|||
160607397|NCT03412565|579941407|FG002|Overall Study|Death|4|||
160607398|NCT03412565|579941408|FG003|Overall Study|Death|5|||
160607399|NCT03412565|579941405|FG000|Overall Study|Data collection ended|0|||
160607400|NCT03412565|579941406|FG001|Overall Study|Data collection ended|41|||
160607401|NCT03412565|579941407|FG002|Overall Study|Data collection ended|41|||
160607402|NCT03412565|579941408|FG003|Overall Study|Data collection ended|40|||
160607403|NCT01849562|579941418|FG000|Overall Study|Lost to Follow-up|1|||
160607404|NCT01849562|579941419|FG001|Overall Study|Lost to Follow-up|0|||
160607405|NCT01849562|579941420|FG002|Overall Study|Lost to Follow-up|0|||
160607406|NCT01849562|579941418|FG000|Overall Study|Non-compliance with Study Drug|1|||
160607407|NCT01849562|579941419|FG001|Overall Study|Non-compliance with Study Drug|0|||
160607408|NCT01849562|579941420|FG002|Overall Study|Non-compliance with Study Drug|0|||
160607409|NCT00481988|579941423|FG000|Overall Study|Withdrawal by Subject|1|||
160607410|NCT00481988|579941424|FG001|Overall Study|Withdrawal by Subject|1|||
160487063|NCT02166047|579512421|FG011|Overall Study|Withdrawal by Participant|0|||
160487064|NCT02166047|579512410|FG000|Overall Study|Adverse Event|0|||
160607411|NCT02252588|579941427|FG000|Overall Study|Withdrawal by Subject|4|||
160607412|NCT02252588|579941428|FG001|Overall Study|Withdrawal by Subject|0|||
160607413|NCT00693693|579941429|FG000|Overall Study|Lost to Follow-up|1|||
160607414|NCT00693693|579941430|FG001|Overall Study|Lost to Follow-up|1|||
160607415|NCT00693693|579941431|FG002|Overall Study|Lost to Follow-up|2|||
160607416|NCT04599972|579941436|FG000|Overall Study|Withdrawal by Subject|6|||
160607417|NCT04599972|579941437|FG001|Overall Study|Withdrawal by Subject|1|||
160607418|NCT04599972|579941436|FG000|Overall Study|Adverse Event|1|||
160607419|NCT04599972|579941437|FG001|Overall Study|Adverse Event|1|||
160607420|NCT04599972|579941436|FG000|Overall Study|Lost to Follow-up|1|||
160607421|NCT04599972|579941437|FG001|Overall Study|Lost to Follow-up|6|||
160607422|NCT04599972|579941436|FG000|Overall Study|Protocol Violation|1|||
160607423|NCT04599972|579941437|FG001|Overall Study|Protocol Violation|0|||
160607424|NCT04599972|579941436|FG000|Overall Study|Other reason|1|||
160661255|NCT00723528|580144037|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
160607425|NCT04599972|579941437|FG001|Overall Study|Other reason|0|||
160607426|NCT00638690|579941440|FG000|Overall Study|Death|655|||
160607427|NCT00638690|579941441|FG001|Overall Study|Death|335|||
160607428|NCT00638690|579941440|FG000|Overall Study|Withdrawal by Subject|22|||
160607429|NCT00638690|579941441|FG001|Overall Study|Withdrawal by Subject|5|||
160607430|NCT00638690|579941440|FG000|Overall Study|Lost to Follow-up|4|||
160607431|NCT00638690|579941441|FG001|Overall Study|Lost to Follow-up|2|||
160607432|NCT01025232|579941447|FG000|Overall Study|Study drug no longer available|3|||
160607433|NCT01025232|579941448|FG001|Overall Study|Study drug no longer available|6|||
160607434|NCT00373880|579941449|FG000|Overall Study|Physician Decision|3|||
160607435|NCT00373880|579941449|FG000|Overall Study|Arrested|1|||
160607436|NCT00373880|579941449|FG000|Overall Study|Protocol Violation|14|||
160607437|NCT03748420|579941450|FG000|Overall Study|No 12 month medication adherence data available|0|||
160607438|NCT03748420|579941451|FG001|Overall Study|No 12 month medication adherence data available|1|||
160607439|NCT03748420|579941450|FG000|Overall Study|Death|24|||
160607440|NCT03748420|579941451|FG001|Overall Study|Death|28|||
160607441|NCT03748420|579941450|FG000|Overall Study|Lost to Follow-up|231|||
160607442|NCT03748420|579941451|FG001|Overall Study|Lost to Follow-up|230|||
160607443|NCT01347073|579941453|FG000|Overall Study|Adverse Event|1|||
160607444|NCT01347073|579941453|FG000|Overall Study|Liver Transplant|1|||
160607445|NCT03152110|579941464|FG000|Overall Study|Withdrawal by Subject|3|||
160607446|NCT00552344|579941476|FG000|Overall Study|Lack of Efficacy|55|||
160607447|NCT00552344|579941476|FG000|Overall Study|Loss of efficacy|75|||
160607448|NCT00552344|579941476|FG000|Overall Study|Lost to Follow-up|8|||
160607449|NCT00552344|579941476|FG000|Overall Study|Withdrawal by Subject|48|||
160607450|NCT00552344|579941476|FG000|Overall Study|SAE, non-fatal|6|||
160607451|NCT00552344|579941476|FG000|Overall Study|AE, non-serious non-fatal|38|||
160607452|NCT00552344|579941476|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
160607453|NCT00552344|579941476|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
160607454|NCT00552344|579941476|FG000|Overall Study|Other Reason|22|||
160607455|NCT01634100|579941477|FG000|Overall Study|Withdrawal by Subject|1|||
160607456|NCT01634100|579941478|FG001|Overall Study|Withdrawal by Subject|0|||
160607457|NCT01634100|579941479|FG002|Overall Study|Withdrawal by Subject|1|||
160607458|NCT01634100|579941480|FG003|Overall Study|Withdrawal by Subject|0|||
160607459|NCT01634100|579941481|FG004|Overall Study|Withdrawal by Subject|0|||
160607460|NCT01634100|579941482|FG005|Overall Study|Withdrawal by Subject|0|||
160607461|NCT00338806|579941483|FG000|Acute Phase|Withdrawal by Subject|0|||
160607462|NCT00338806|579941484|FG001|Acute Phase|Withdrawal by Subject|1|||
160607463|NCT00338806|579941483|FG000|Follow-up|Lost to Follow-up|1|||
160607464|NCT00338806|579941484|FG001|Follow-up|Lost to Follow-up|3|||
160607465|NCT03215667|579941488|FG000|Overall Study|Physician Decision|4|||
160607466|NCT00614991|579941489|FG000|Overall Study|Adverse Event|3|||
160607467|NCT00614991|579941490|FG001|Overall Study|Adverse Event|3|||
160607468|NCT00614991|579941491|FG002|Overall Study|Adverse Event|0|||
160607469|NCT00614991|579941492|FG003|Overall Study|Adverse Event|0|||
160607470|NCT00614991|579941493|FG004|Overall Study|Adverse Event|1|||
160607471|NCT00614991|579941494|FG005|Overall Study|Adverse Event|0|||
160607472|NCT00044213|579941502|FG000|Overall Study|Withdrawal by Subject|50|||
160607473|NCT00044213|579941503|FG001|Overall Study|Withdrawal by Subject|65|||
160607474|NCT00044213|579941504|FG002|Overall Study|Withdrawal by Subject|91|||
160607475|NCT00044213|579941505|FG003|Overall Study|Withdrawal by Subject|83|||
160607476|NCT00044213|579941502|FG000|Overall Study|Death|42|||
160607477|NCT00044213|579941503|FG001|Overall Study|Death|42|||
160607478|NCT00044213|579941504|FG002|Overall Study|Death|42|||
160607479|NCT00044213|579941505|FG003|Overall Study|Death|49|||
160607480|NCT00044213|579941502|FG000|Overall Study|Lost to Follow-up|8|||
160607481|NCT00044213|579941503|FG001|Overall Study|Lost to Follow-up|5|||
160607482|NCT00044213|579941504|FG002|Overall Study|Lost to Follow-up|5|||
160607483|NCT00044213|579941505|FG003|Overall Study|Lost to Follow-up|4|||
160607484|NCT00422240|579941506|FG000|Overall Study|Lack of Efficacy|1|||
160607485|NCT00422240|579941507|FG001|Overall Study|Lack of Efficacy|2|||
160607486|NCT00422240|579941508|FG002|Overall Study|Lack of Efficacy|0|||
160607487|NCT00422240|579941509|FG003|Overall Study|Lack of Efficacy|1|||
160607488|NCT00422240|579941506|FG000|Overall Study|Adverse Event|11|||
160607489|NCT00422240|579941507|FG001|Overall Study|Adverse Event|4|||
160607490|NCT00422240|579941508|FG002|Overall Study|Adverse Event|5|||
160607491|NCT00422240|579941509|FG003|Overall Study|Adverse Event|2|||
160607492|NCT00422240|579941506|FG000|Overall Study|Subject request|21|||
160607493|NCT00422240|579941507|FG001|Overall Study|Subject request|17|||
160607494|NCT00422240|579941508|FG002|Overall Study|Subject request|18|||
160607495|NCT00422240|579941509|FG003|Overall Study|Subject request|30|||
160607496|NCT00422240|579941506|FG000|Overall Study|Protocol Violation|0|||
160607497|NCT00422240|579941507|FG001|Overall Study|Protocol Violation|1|||
160607498|NCT00422240|579941508|FG002|Overall Study|Protocol Violation|0|||
160607499|NCT00422240|579941509|FG003|Overall Study|Protocol Violation|1|||
160607500|NCT00422240|579941506|FG000|Overall Study|Lost to Follow-up|31|||
160607501|NCT00422240|579941507|FG001|Overall Study|Lost to Follow-up|32|||
160607502|NCT00422240|579941508|FG002|Overall Study|Lost to Follow-up|19|||
160607503|NCT00422240|579941509|FG003|Overall Study|Lost to Follow-up|34|||
160607504|NCT00422240|579941506|FG000|Overall Study|Other|1|||
160607505|NCT00422240|579941507|FG001|Overall Study|Other|0|||
160607506|NCT00422240|579941508|FG002|Overall Study|Other|0|||
160607507|NCT00422240|579941509|FG003|Overall Study|Other|1|||
160607508|NCT00422240|579941506|FG000|Overall Study|Pregnancy|3|||
160607509|NCT00422240|579941507|FG001|Overall Study|Pregnancy|1|||
160607510|NCT00422240|579941508|FG002|Overall Study|Pregnancy|1|||
160607511|NCT00422240|579941509|FG003|Overall Study|Pregnancy|2|||
160607512|NCT01927068|579941510|FG000|Overall Study|Death|37|||
160607513|NCT01927068|579941511|FG001|Overall Study|Death|3|||
160607514|NCT01927068|579941510|FG000|Overall Study|Withdrawal by Subject|50|||
160607515|NCT01927068|579941511|FG001|Overall Study|Withdrawal by Subject|3|||
160607516|NCT01927068|579941510|FG000|Overall Study|Lost to Follow-up|10|||
160607517|NCT01927068|579941511|FG001|Overall Study|Lost to Follow-up|2|||
160607518|NCT01927068|579941510|FG000|Overall Study|Physician Decision|9|||
160607519|NCT01927068|579941511|FG001|Overall Study|Physician Decision|0|||
160607520|NCT01927068|579941510|FG000|Overall Study|Missed last follow-up visit|2|||
160607521|NCT01927068|579941511|FG001|Overall Study|Missed last follow-up visit|0|||
160607522|NCT00880607|579941515|FG000|Overall Study|Physician Decision|2|||
160607523|NCT00880607|579941516|FG001|Overall Study|Physician Decision|2|||
160607524|NCT00880607|579941515|FG000|Overall Study|Protocol Violation|2|||
160607525|NCT00880607|579941516|FG001|Overall Study|Protocol Violation|1|||
160607526|NCT00880607|579941515|FG000|Overall Study|surgery did not extend past L1 level|3|||
160607527|NCT00880607|579941516|FG001|Overall Study|surgery did not extend past L1 level|0|||
160607528|NCT01624467|579941517|FG000|Overall Study|Withdrawal by Subject|2|||
160607529|NCT01624467|579941517|FG000|Overall Study|Lost to Follow-up|1|||
160607530|NCT01624467|579941517|FG000|Overall Study|Adverse Event|7|||
160607531|NCT01624467|579941517|FG000|Overall Study|Progressive Disease|19|||
160607532|NCT01624467|579941517|FG000|Overall Study|Per Sponsor Requirement|1|||
160607533|NCT01624467|579941517|FG000|Overall Study|Subject Withdrew from Treatment|1|||
160607534|NCT03964493|579941518|FG000|Overall Study|Withdrawal by Subject|4|||
160607535|NCT03964493|579941519|FG001|Overall Study|Withdrawal by Subject|1|||
160607536|NCT03964493|579941518|FG000|Overall Study|Lost to Follow-up|13|||
160607537|NCT03964493|579941519|FG001|Overall Study|Lost to Follow-up|4|||
160607538|NCT02224274|579941523|FG000|Overall Study|Death|1|||
160607539|NCT02224274|579941524|FG001|Overall Study|Death|0|||
160607540|NCT00887068|579941525|FG000|Overall Study|Withdrawal by Subject|2|||
160607541|NCT00887068|579941526|FG001|Overall Study|Withdrawal by Subject|0|||
160607542|NCT00887068|579941525|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
160607543|NCT00887068|579941526|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
160607544|NCT00499460|579941527|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
160607545|NCT00499460|579941528|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
160607546|NCT00499460|579941527|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
160607547|NCT00499460|579941528|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
160607548|NCT00499460|579941527|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
160607549|NCT00499460|579941528|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
160607550|NCT03073200|579941537|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160607551|NCT03073200|579941538|FG001|Double Blind Treatment Period|Protocol Violation|0|||
160607552|NCT03073200|579941539|FG002|Double Blind Treatment Period|Protocol Violation|0|||
160607553|NCT03073200|579941540|FG003|Double Blind Treatment Period|Protocol Violation|0|||
160607554|NCT03073200|579941541|FG004|Double Blind Treatment Period|Protocol Violation|0|||
160607555|NCT03073200|579941542|FG005|Double Blind Treatment Period|Protocol Violation|0|||
160607556|NCT03073200|579941543|FG006|Double Blind Treatment Period|Protocol Violation|0|||
160607557|NCT03073200|579941544|FG007|Double Blind Treatment Period|Protocol Violation|0|||
160607558|NCT03073200|579941545|FG008|Double Blind Treatment Period|Protocol Violation|0|||
160607559|NCT03073200|579941546|FG009|Double Blind Treatment Period|Protocol Violation|0|||
160607560|NCT03073200|579941547|FG010|Double Blind Treatment Period|Protocol Violation|0|||
160607561|NCT03073200|579941548|FG011|Double Blind Treatment Period|Protocol Violation|0|||
160607562|NCT03073200|579941549|FG012|Double Blind Treatment Period|Protocol Violation|0|||
160607563|NCT03073200|579941550|FG013|Double Blind Treatment Period|Protocol Violation|0|||
160607564|NCT03073200|579941551|FG014|Double Blind Treatment Period|Protocol Violation|0|||
160607565|NCT03073200|579941537|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607566|NCT03073200|579941538|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
160607567|NCT03073200|579941539|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607568|NCT03073200|579941540|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607569|NCT03073200|579941541|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607570|NCT03073200|579941542|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607571|NCT03073200|579941543|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607572|NCT03073200|579941544|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607573|NCT03073200|579941545|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607574|NCT03073200|579941546|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607575|NCT03073200|579941547|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607576|NCT03073200|579941548|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607577|NCT03073200|579941549|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607578|NCT03073200|579941550|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160661256|NCT00723528|580144038|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
160661257|NCT00723528|580144039|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
160607579|NCT03073200|579941551|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
160607580|NCT03073200|579941537|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
160607581|NCT03073200|579941538|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607582|NCT03073200|579941539|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
160487065|NCT02166047|579512411|FG001|Overall Study|Adverse Event|0|||
160487066|NCT02166047|579512412|FG002|Overall Study|Adverse Event|0|||
160487067|NCT02166047|579512413|FG003|Overall Study|Adverse Event|0|||
160487068|NCT02166047|579512414|FG004|Overall Study|Adverse Event|1|||
160487069|NCT02166047|579512415|FG005|Overall Study|Adverse Event|0|||
160487070|NCT02166047|579512416|FG006|Overall Study|Adverse Event|1|||
160487071|NCT02166047|579512417|FG007|Overall Study|Adverse Event|0|||
160487072|NCT02166047|579512418|FG008|Overall Study|Adverse Event|0|||
160487073|NCT02166047|579512419|FG009|Overall Study|Adverse Event|0|||
160487074|NCT02166047|579512420|FG010|Overall Study|Adverse Event|2|||
160487075|NCT02166047|579512421|FG011|Overall Study|Adverse Event|0|||
160487076|NCT00451555|579512427|FG000|Overall Study|Protocol Violation|2|||
160487077|NCT00451555|579512428|FG001|Overall Study|Protocol Violation|2|||
160487078|NCT00451555|579512427|FG000|Overall Study|Adverse Event|3|||
160487079|NCT00451555|579512428|FG001|Overall Study|Adverse Event|1|||
160487080|NCT00451555|579512427|FG000|Overall Study|Withdrawal by Subject|6|||
160487081|NCT00451555|579512428|FG001|Overall Study|Withdrawal by Subject|0|||
160487082|NCT00451555|579512427|FG000|Overall Study|Physician Decision|2|||
160487083|NCT00451555|579512428|FG001|Overall Study|Physician Decision|1|||
160487084|NCT00297778|579512439|FG000|Overall Study|Adverse Event|16|||
160487085|NCT00297778|579512440|FG001|Overall Study|Adverse Event|10|||
160487086|NCT00297778|579512439|FG000|Overall Study|Withdrawal by Subject|1|||
160487087|NCT00297778|579512440|FG001|Overall Study|Withdrawal by Subject|5|||
160487088|NCT00297778|579512439|FG000|Overall Study|Lack of Efficacy|2|||
160487089|NCT00297778|579512440|FG001|Overall Study|Lack of Efficacy|1|||
160487090|NCT00297778|579512439|FG000|Overall Study|Non-compliant with trial protocol|0|||
160487091|NCT00297778|579512440|FG001|Overall Study|Non-compliant with trial protocol|3|||
160487092|NCT00297778|579512439|FG000|Overall Study|Other|0|||
160487093|NCT00297778|579512440|FG001|Overall Study|Other|1|||
160487094|NCT00583115|579512441|FG000|Overall Study|Death|1|||
160487095|NCT00839332|579512443|FG000|Phase 1|Disease Progression|38|||
160487096|NCT00839332|579512444|FG001|Phase 1|Disease Progression|0|||
160487097|NCT00839332|579512445|FG002|Phase 1|Disease Progression|0|||
160487098|NCT00839332|579512443|FG000|Phase 1|Adverse Event|6|||
160487099|NCT00839332|579512444|FG001|Phase 1|Adverse Event|0|||
160487100|NCT00839332|579512445|FG002|Phase 1|Adverse Event|0|||
160487101|NCT00839332|579512443|FG000|Phase 1|Withdrawal by Subject|4|||
160487102|NCT00839332|579512444|FG001|Phase 1|Withdrawal by Subject|0|||
160487103|NCT00839332|579512445|FG002|Phase 1|Withdrawal by Subject|0|||
160487104|NCT00839332|579512443|FG000|Phase 1|Physician Decision|2|||
160487105|NCT00839332|579512444|FG001|Phase 1|Physician Decision|0|||
160487106|NCT00839332|579512445|FG002|Phase 1|Physician Decision|0|||
160487107|NCT00839332|579512443|FG000|Phase 2|Protocol Violation|0|||
160487108|NCT00839332|579512444|FG001|Phase 2|Protocol Violation|1|||
160487109|NCT00839332|579512445|FG002|Phase 2|Protocol Violation|0|||
160487110|NCT00839332|579512443|FG000|Phase 2|Disease Progression|0|||
160487111|NCT00839332|579512444|FG001|Phase 2|Disease Progression|46|||
160487112|NCT00839332|579512445|FG002|Phase 2|Disease Progression|21|||
160487113|NCT00839332|579512443|FG000|Phase 2|Adverse Event|0|||
160487114|NCT00839332|579512444|FG001|Phase 2|Adverse Event|8|||
160487115|NCT00839332|579512445|FG002|Phase 2|Adverse Event|6|||
160487116|NCT00839332|579512443|FG000|Phase 2|Death|0|||
160487117|NCT00839332|579512444|FG001|Phase 2|Death|4|||
160487118|NCT00839332|579512445|FG002|Phase 2|Death|2|||
160487119|NCT00839332|579512443|FG000|Phase 2|Withdrawal by Subject|0|||
160487120|NCT00839332|579512444|FG001|Phase 2|Withdrawal by Subject|5|||
160487121|NCT00839332|579512445|FG002|Phase 2|Withdrawal by Subject|8|||
160487122|NCT00839332|579512443|FG000|Phase 2|Physician Decision|0|||
160487123|NCT00839332|579512444|FG001|Phase 2|Physician Decision|4|||
160487124|NCT00839332|579512445|FG002|Phase 2|Physician Decision|1|||
160487125|NCT00839332|579512443|FG000|Phase 2|Lost to Follow-up|0|||
160487126|NCT00839332|579512444|FG001|Phase 2|Lost to Follow-up|0|||
160487127|NCT00839332|579512445|FG002|Phase 2|Lost to Follow-up|1|||
160487128|NCT01200485|579512446|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
160487129|NCT01200485|579512447|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
160487130|NCT01200485|579512448|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
160487131|NCT01200485|579512446|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
160487132|NCT01200485|579512447|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
160487133|NCT01200485|579512448|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
160487134|NCT02630706|579512451|FG000|Overall Study|Adverse Event|2|||
160487135|NCT02630706|579512452|FG001|Overall Study|Adverse Event|1|||
160487136|NCT02630706|579512453|FG002|Overall Study|Adverse Event|1|||
160487137|NCT02630706|579512451|FG000|Overall Study|Lost to Follow-up|0|||
160487138|NCT02630706|579512452|FG001|Overall Study|Lost to Follow-up|1|||
160487139|NCT02630706|579512453|FG002|Overall Study|Lost to Follow-up|2|||
160487140|NCT02630706|579512451|FG000|Overall Study|Physician Decision|1|||
160487141|NCT02630706|579512452|FG001|Overall Study|Physician Decision|1|||
160487142|NCT02630706|579512453|FG002|Overall Study|Physician Decision|0|||
160487143|NCT02630706|579512451|FG000|Overall Study|Pregnancy|0|||
160487144|NCT02630706|579512452|FG001|Overall Study|Pregnancy|1|||
160487145|NCT02630706|579512453|FG002|Overall Study|Pregnancy|0|||
160607583|NCT03073200|579941540|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607584|NCT03073200|579941541|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607585|NCT03073200|579941542|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607586|NCT03073200|579941543|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607587|NCT03073200|579941544|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607588|NCT03073200|579941545|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607589|NCT03073200|579941546|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607590|NCT03073200|579941547|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607591|NCT03073200|579941548|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607592|NCT03073200|579941549|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607593|NCT03073200|579941550|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607594|NCT03073200|579941551|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
160607595|NCT03073200|579941537|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607596|NCT03073200|579941538|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607597|NCT03073200|579941539|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607598|NCT03073200|579941540|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
160607599|NCT03073200|579941541|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
160607600|NCT03073200|579941542|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607601|NCT03073200|579941543|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607602|NCT03073200|579941544|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607603|NCT03073200|579941545|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607604|NCT03073200|579941546|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607605|NCT03073200|579941547|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607606|NCT03073200|579941548|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607607|NCT03073200|579941549|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607608|NCT03073200|579941550|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607609|NCT03073200|579941551|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
160607610|NCT03073200|579941537|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
160607611|NCT03073200|579941538|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
160607612|NCT03073200|579941539|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
160607613|NCT03073200|579941540|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
160607614|NCT03073200|579941541|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
160607615|NCT03073200|579941542|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
160607616|NCT03073200|579941543|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
160607617|NCT03073200|579941544|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
160607618|NCT03073200|579941545|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
160607619|NCT03073200|579941546|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
160607620|NCT03073200|579941547|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
160607621|NCT03073200|579941548|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
160607622|NCT03073200|579941549|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
160607623|NCT03073200|579941550|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
160607624|NCT03073200|579941551|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
160607625|NCT03073200|579941537|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607626|NCT03073200|579941538|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607627|NCT03073200|579941539|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607628|NCT03073200|579941540|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607629|NCT03073200|579941541|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
160607630|NCT03073200|579941542|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607631|NCT03073200|579941543|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607632|NCT03073200|579941544|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607633|NCT03073200|579941545|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607634|NCT03073200|579941546|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607635|NCT03073200|579941547|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607636|NCT03073200|579941548|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607637|NCT03073200|579941549|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607638|NCT03073200|579941550|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607639|NCT03073200|579941551|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
160607640|NCT03073200|579941537|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607641|NCT03073200|579941538|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607642|NCT03073200|579941539|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607643|NCT03073200|579941540|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
160607644|NCT03073200|579941541|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
160607645|NCT03073200|579941542|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607646|NCT03073200|579941543|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607647|NCT03073200|579941544|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607648|NCT03073200|579941545|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607649|NCT03073200|579941546|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607650|NCT03073200|579941547|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607651|NCT03073200|579941548|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607652|NCT03073200|579941549|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607653|NCT03073200|579941550|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607654|NCT03073200|579941551|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
160607655|NCT03073200|579941537|FG000|Extension Period|Lost to Follow-up|0|||
160607656|NCT03073200|579941538|FG001|Extension Period|Lost to Follow-up|0|||
160607657|NCT03073200|579941539|FG002|Extension Period|Lost to Follow-up|0|||
160607658|NCT03073200|579941540|FG003|Extension Period|Lost to Follow-up|0|||
160607659|NCT03073200|579941541|FG004|Extension Period|Lost to Follow-up|0|||
160607660|NCT03073200|579941542|FG005|Extension Period|Lost to Follow-up|0|||
160607661|NCT03073200|579941543|FG006|Extension Period|Lost to Follow-up|1|||
160607662|NCT03073200|579941544|FG007|Extension Period|Lost to Follow-up|1|||
160607663|NCT03073200|579941545|FG008|Extension Period|Lost to Follow-up|0|||
160607664|NCT03073200|579941546|FG009|Extension Period|Lost to Follow-up|0|||
160607665|NCT03073200|579941547|FG010|Extension Period|Lost to Follow-up|0|||
160607666|NCT03073200|579941548|FG011|Extension Period|Lost to Follow-up|0|||
160607667|NCT03073200|579941549|FG012|Extension Period|Lost to Follow-up|0|||
160607668|NCT03073200|579941550|FG013|Extension Period|Lost to Follow-up|0|||
160607669|NCT03073200|579941551|FG014|Extension Period|Lost to Follow-up|0|||
160607670|NCT03073200|579941537|FG000|Extension Period|Sponsor Decision|0|||
160607671|NCT03073200|579941538|FG001|Extension Period|Sponsor Decision|0|||
160607672|NCT03073200|579941539|FG002|Extension Period|Sponsor Decision|0|||
160607673|NCT03073200|579941540|FG003|Extension Period|Sponsor Decision|0|||
160607674|NCT03073200|579941541|FG004|Extension Period|Sponsor Decision|0|||
160607675|NCT03073200|579941542|FG005|Extension Period|Sponsor Decision|0|||
160607676|NCT03073200|579941543|FG006|Extension Period|Sponsor Decision|0|||
160607677|NCT03073200|579941544|FG007|Extension Period|Sponsor Decision|0|||
160607678|NCT03073200|579941545|FG008|Extension Period|Sponsor Decision|1|||
160607679|NCT03073200|579941546|FG009|Extension Period|Sponsor Decision|0|||
160607680|NCT03073200|579941547|FG010|Extension Period|Sponsor Decision|0|||
160607681|NCT03073200|579941548|FG011|Extension Period|Sponsor Decision|0|||
160607682|NCT03073200|579941549|FG012|Extension Period|Sponsor Decision|0|||
160607683|NCT03073200|579941550|FG013|Extension Period|Sponsor Decision|0|||
160607684|NCT03073200|579941551|FG014|Extension Period|Sponsor Decision|0|||
160607685|NCT03073200|579941537|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
160607686|NCT03073200|579941538|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
160607687|NCT03073200|579941539|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
160607688|NCT03073200|579941540|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
160607689|NCT03073200|579941541|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
160607690|NCT03073200|579941542|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
160607691|NCT03073200|579941543|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
160607692|NCT03073200|579941544|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
160607693|NCT03073200|579941545|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
160607694|NCT03073200|579941546|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
160607695|NCT03073200|579941547|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
160607696|NCT03073200|579941548|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
160607697|NCT03073200|579941549|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
160607698|NCT03073200|579941550|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
160607699|NCT03073200|579941551|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
160487146|NCT02630706|579512451|FG000|Overall Study|Withdrawal by Subject|4|||
160607700|NCT03073200|579941537|FG000|Extension Period|Withdrawal by Subject|0|||
160607701|NCT03073200|579941538|FG001|Extension Period|Withdrawal by Subject|0|||
160607702|NCT03073200|579941539|FG002|Extension Period|Withdrawal by Subject|0|||
160607703|NCT03073200|579941540|FG003|Extension Period|Withdrawal by Subject|0|||
160607704|NCT03073200|579941541|FG004|Extension Period|Withdrawal by Subject|0|||
160487147|NCT02630706|579512452|FG001|Overall Study|Withdrawal by Subject|5|||
160487148|NCT02630706|579512453|FG002|Overall Study|Withdrawal by Subject|7|||
160487149|NCT01678898|579512455|FG000|PB-102-F01|Adverse Event|0|||
160487150|NCT01678898|579512456|FG001|PB-102-F01|Adverse Event|1|||
160487151|NCT01678898|579512457|FG002|PB-102-F01|Adverse Event|0|||
160487152|NCT01678898|579512455|FG000|PB-102-F01|Physician Decision|0|||
160487153|NCT01678898|579512456|FG001|PB-102-F01|Physician Decision|1|||
160487154|NCT01678898|579512457|FG002|PB-102-F01|Physician Decision|0|||
160487155|NCT02515097|579512466|FG000|Overall Study|Lost to Follow-up|4|||
160487156|NCT02515097|579512467|FG001|Overall Study|Lost to Follow-up|2|||
160487157|NCT02515097|579512466|FG000|Overall Study|Withdrawal by Subject|1|||
160487158|NCT02515097|579512467|FG001|Overall Study|Withdrawal by Subject|3|||
160487159|NCT02515097|579512466|FG000|Overall Study|Adverse Event|2|||
160487160|NCT02515097|579512467|FG001|Overall Study|Adverse Event|1|||
160487161|NCT01894256|579512470|FG000|Part A|Adverse Event|0|||
160487162|NCT01894256|579512471|FG001|Part A|Adverse Event|1|||
160487163|NCT01894256|579512472|FG002|Part A|Adverse Event|0|||
160487164|NCT01894256|579512470|FG000|Part B|Death|0|||
160487165|NCT01894256|579512471|FG001|Part B|Death|1|||
160487166|NCT01894256|579512472|FG002|Part B|Death|1|||
160487167|NCT01894256|579512470|FG000|Part B|Withdrawal by Subject|0|||
160607705|NCT03073200|579941542|FG005|Extension Period|Withdrawal by Subject|0|||
160607706|NCT03073200|579941543|FG006|Extension Period|Withdrawal by Subject|1|||
160607707|NCT03073200|579941544|FG007|Extension Period|Withdrawal by Subject|2|||
160607708|NCT03073200|579941545|FG008|Extension Period|Withdrawal by Subject|0|||
160607709|NCT03073200|579941546|FG009|Extension Period|Withdrawal by Subject|0|||
160607710|NCT03073200|579941547|FG010|Extension Period|Withdrawal by Subject|0|||
160607711|NCT03073200|579941548|FG011|Extension Period|Withdrawal by Subject|0|||
160607712|NCT03073200|579941549|FG012|Extension Period|Withdrawal by Subject|0|||
160607713|NCT03073200|579941550|FG013|Extension Period|Withdrawal by Subject|0|||
160607714|NCT03073200|579941551|FG014|Extension Period|Withdrawal by Subject|0|||
160607715|NCT03073200|579941537|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607716|NCT03073200|579941538|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607717|NCT03073200|579941539|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607718|NCT03073200|579941540|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607719|NCT03073200|579941541|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607720|NCT03073200|579941542|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607721|NCT03073200|579941543|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607722|NCT03073200|579941544|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607723|NCT03073200|579941545|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607724|NCT03073200|579941546|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607725|NCT03073200|579941547|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607726|NCT03073200|579941548|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
160607727|NCT03073200|579941549|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607728|NCT03073200|579941550|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607729|NCT03073200|579941551|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
160607730|NCT03073200|579941537|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607731|NCT03073200|579941538|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607732|NCT03073200|579941539|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607733|NCT03073200|579941540|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607734|NCT03073200|579941541|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607735|NCT03073200|579941542|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607736|NCT03073200|579941543|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607737|NCT03073200|579941544|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607738|NCT03073200|579941545|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607739|NCT03073200|579941546|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607740|NCT03073200|579941547|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607741|NCT03073200|579941548|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
160607742|NCT03073200|579941549|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607743|NCT03073200|579941550|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607744|NCT03073200|579941551|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
160607745|NCT03073200|579941537|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160661258|NCT00723528|580144040|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
160487168|NCT01894256|579512471|FG001|Part B|Withdrawal by Subject|1|||
160487169|NCT01894256|579512472|FG002|Part B|Withdrawal by Subject|0|||
160487170|NCT01894256|579512470|FG000|Part B|Lack of Efficacy|15|||
160487171|NCT01894256|579512471|FG001|Part B|Lack of Efficacy|12|||
160487172|NCT01894256|579512472|FG002|Part B|Lack of Efficacy|13|||
160487173|NCT02965599|579512473|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
160487174|NCT02965599|579512474|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
160487175|NCT00230971|579512475|FG000|Randomization|No study drug administered|3|||
160487176|NCT00230971|579512476|FG001|Randomization|No study drug administered|3|||
160487177|NCT00230971|579512475|FG000|Baseline Participants|Lost to Follow-up|5|||
160607746|NCT03073200|579941538|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607747|NCT03073200|579941539|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607748|NCT03073200|579941540|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607749|NCT03073200|579941541|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607750|NCT03073200|579941542|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607751|NCT03073200|579941543|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607752|NCT03073200|579941544|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607753|NCT03073200|579941545|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607754|NCT03073200|579941546|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607755|NCT03073200|579941547|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
160607756|NCT03073200|579941548|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
160607757|NCT03073200|579941549|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607758|NCT03073200|579941550|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607759|NCT03073200|579941551|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160607760|NCT03073200|579941537|FG000|Randomized Withdrawal Period|Adverse Event|0|||
160607761|NCT03073200|579941538|FG001|Randomized Withdrawal Period|Adverse Event|0|||
160607762|NCT03073200|579941539|FG002|Randomized Withdrawal Period|Adverse Event|0|||
160661259|NCT00723528|580144041|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
160487178|NCT00230971|579512476|FG001|Baseline Participants|Lost to Follow-up|12|||
160487179|NCT00230971|579512475|FG000|Baseline Participants|Death|6|||
160487180|NCT00230971|579512476|FG001|Baseline Participants|Death|5|||
160487181|NCT00230971|579512475|FG000|Baseline Participants|Withdrawal by Subject|7|||
160487182|NCT00230971|579512476|FG001|Baseline Participants|Withdrawal by Subject|1|||
160487183|NCT00230971|579512475|FG000|Baseline Participants|Adverse Event|1|||
160487184|NCT00230971|579512476|FG001|Baseline Participants|Adverse Event|0|||
160487185|NCT00230971|579512475|FG000|Baseline Participants|No bacteria observed|1|||
160487186|NCT00230971|579512476|FG001|Baseline Participants|No bacteria observed|0|||
160487187|NCT00230971|579512475|FG000|Baseline Participants|Failure to return|1|||
160487188|NCT00230971|579512476|FG001|Baseline Participants|Failure to return|1|||
160487189|NCT00230971|579512475|FG000|Baseline Participants|Reintervention|1|||
160487190|NCT00230971|579512476|FG001|Baseline Participants|Reintervention|0|||
160487191|NCT02799745|579512478|FG000|Overall Study|Participant moved out of state|1|||
160487192|NCT02799745|579512479|FG001|Overall Study|Participant moved out of state|0|||
160487193|NCT02799745|579512478|FG000|Overall Study|Discontinued due to planned surgery|1|||
160487194|NCT02799745|579512479|FG001|Overall Study|Discontinued due to planned surgery|0|||
160487195|NCT02799745|579512478|FG000|Overall Study|Withdrawal by Subject|16|||
160487196|NCT02799745|579512479|FG001|Overall Study|Withdrawal by Subject|25|||
160487197|NCT02799745|579512478|FG000|Overall Study|Protocol Deviation|4|||
160487198|NCT02799745|579512479|FG001|Overall Study|Protocol Deviation|5|||
160487199|NCT02799745|579512478|FG000|Overall Study|Progressive Disease|28|||
160487200|NCT02799745|579512479|FG001|Overall Study|Progressive Disease|38|||
160487201|NCT02799745|579512478|FG000|Overall Study|Lost to Follow-up|3|||
160487202|NCT02799745|579512479|FG001|Overall Study|Lost to Follow-up|2|||
160487203|NCT02799745|579512478|FG000|Overall Study|Death|3|||
160487204|NCT02799745|579512479|FG001|Overall Study|Death|0|||
160487205|NCT02799745|579512478|FG000|Overall Study|Adverse Event|0|||
160487206|NCT02799745|579512479|FG001|Overall Study|Adverse Event|1|||
160487207|NCT01929876|579514129|FG000|Period 2|Non-Compliance|1|||
160487208|NCT01222533|579514131|FG000|Overall Study|Adverse Event|5|||
160487209|NCT01222533|579514131|FG000|Overall Study|Withdrawal by Subject|5|||
160487210|NCT01222533|579514131|FG000|Overall Study|Other|4|||
160487211|NCT03834623|579514132|FG000|Overall Study|Progression|0|||
160487212|NCT03834623|579514133|FG001|Overall Study|Progression|1|||
160487213|NCT01947517|579514134|FG000|Overall Study|Withdrawal by Subject|1|||
160487214|NCT01947517|579514135|FG001|Overall Study|Withdrawal by Subject|1|||
160487215|NCT00460564|579514136|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
160487216|NCT00460564|579514137|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
160487217|NCT00460564|579514138|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160487218|NCT00460564|579514139|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160487219|NCT00460564|579514140|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160607763|NCT03073200|579941540|FG003|Randomized Withdrawal Period|Adverse Event|0|||
160607764|NCT03073200|579941541|FG004|Randomized Withdrawal Period|Adverse Event|0|||
160607765|NCT03073200|579941542|FG005|Randomized Withdrawal Period|Adverse Event|0|||
160607766|NCT03073200|579941543|FG006|Randomized Withdrawal Period|Adverse Event|0|||
160607767|NCT03073200|579941544|FG007|Randomized Withdrawal Period|Adverse Event|0|||
160607768|NCT03073200|579941545|FG008|Randomized Withdrawal Period|Adverse Event|0|||
160607769|NCT03073200|579941546|FG009|Randomized Withdrawal Period|Adverse Event|0|||
160607770|NCT03073200|579941547|FG010|Randomized Withdrawal Period|Adverse Event|1|||
160607771|NCT03073200|579941548|FG011|Randomized Withdrawal Period|Adverse Event|0|||
160607772|NCT03073200|579941549|FG012|Randomized Withdrawal Period|Adverse Event|0|||
160607773|NCT03073200|579941550|FG013|Randomized Withdrawal Period|Adverse Event|0|||
160607774|NCT03073200|579941551|FG014|Randomized Withdrawal Period|Adverse Event|0|||
160607775|NCT03073200|579941537|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607776|NCT03073200|579941538|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607777|NCT03073200|579941539|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607778|NCT03073200|579941540|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607779|NCT03073200|579941541|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607780|NCT03073200|579941542|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607781|NCT03073200|579941543|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607782|NCT03073200|579941544|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607783|NCT03073200|579941545|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607784|NCT03073200|579941546|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607785|NCT03073200|579941547|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607786|NCT03073200|579941548|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607787|NCT03073200|579941549|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607788|NCT03073200|579941550|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
160607789|NCT03073200|579941551|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
160607790|NCT03073200|579941537|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607791|NCT03073200|579941538|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607792|NCT03073200|579941539|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607793|NCT03073200|579941540|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607794|NCT03073200|579941541|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607795|NCT03073200|579941542|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607796|NCT03073200|579941543|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607797|NCT03073200|579941544|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607798|NCT03073200|579941545|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607799|NCT03073200|579941546|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607800|NCT03073200|579941547|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607801|NCT03073200|579941548|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607802|NCT03073200|579941549|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607803|NCT03073200|579941550|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
160607804|NCT03073200|579941551|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160607805|NCT03073200|579941537|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607806|NCT03073200|579941538|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607807|NCT03073200|579941539|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607808|NCT03073200|579941540|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607809|NCT03073200|579941541|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607810|NCT03073200|579941542|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607811|NCT03073200|579941543|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607812|NCT03073200|579941544|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607813|NCT03073200|579941545|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607814|NCT03073200|579941546|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607815|NCT03073200|579941547|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607816|NCT03073200|579941548|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607817|NCT03073200|579941549|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607818|NCT03073200|579941550|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
160607819|NCT03073200|579941551|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
160607820|NCT03073200|579941537|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607821|NCT03073200|579941538|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607822|NCT03073200|579941539|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607823|NCT03073200|579941540|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607824|NCT03073200|579941541|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607825|NCT03073200|579941542|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607826|NCT03073200|579941543|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607827|NCT03073200|579941544|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607828|NCT03073200|579941545|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607829|NCT03073200|579941546|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607830|NCT03073200|579941547|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607831|NCT03073200|579941548|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607832|NCT03073200|579941549|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607833|NCT03073200|579941550|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
160607834|NCT03073200|579941551|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160607835|NCT03073200|579941537|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607836|NCT03073200|579941538|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607837|NCT03073200|579941539|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607838|NCT03073200|579941540|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607839|NCT03073200|579941541|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607840|NCT03073200|579941542|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607841|NCT03073200|579941543|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607842|NCT03073200|579941544|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607843|NCT03073200|579941545|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607844|NCT03073200|579941546|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607845|NCT03073200|579941547|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607846|NCT03073200|579941548|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607847|NCT03073200|579941549|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607848|NCT03073200|579941550|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
160607849|NCT03073200|579941551|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
160607850|NCT03073200|579941537|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607851|NCT03073200|579941538|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607852|NCT03073200|579941539|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607853|NCT03073200|579941540|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607854|NCT03073200|579941541|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607855|NCT03073200|579941542|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607856|NCT03073200|579941543|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607857|NCT03073200|579941544|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607858|NCT03073200|579941545|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607859|NCT03073200|579941546|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607860|NCT03073200|579941547|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607861|NCT03073200|579941548|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607862|NCT03073200|579941549|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607863|NCT03073200|579941550|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
160607864|NCT03073200|579941551|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
160607865|NCT03073200|579941537|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607866|NCT03073200|579941538|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607867|NCT03073200|579941539|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607868|NCT03073200|579941540|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607869|NCT03073200|579941541|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607870|NCT03073200|579941542|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607871|NCT03073200|579941543|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607872|NCT03073200|579941544|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607873|NCT03073200|579941545|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607874|NCT03073200|579941546|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607875|NCT03073200|579941547|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607876|NCT03073200|579941548|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607877|NCT03073200|579941549|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607878|NCT03073200|579941550|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
160607879|NCT03073200|579941551|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160607880|NCT03073200|579941537|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607881|NCT03073200|579941538|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607882|NCT03073200|579941539|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607883|NCT03073200|579941540|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607884|NCT03073200|579941541|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607885|NCT03073200|579941542|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607886|NCT03073200|579941543|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607887|NCT03073200|579941544|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607888|NCT03073200|579941545|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607889|NCT03073200|579941546|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607890|NCT03073200|579941547|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607891|NCT03073200|579941548|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607892|NCT03073200|579941549|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607893|NCT03073200|579941550|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
160607894|NCT03073200|579941551|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
160607895|NCT01474889|579941552|FG000|Overall Study|Physician Decision|1|||
160607896|NCT01474889|579941553|FG001|Overall Study|Physician Decision|0|||
160607897|NCT01474889|579941554|FG002|Overall Study|Physician Decision|0|||
160607898|NCT01474889|579941552|FG000|Overall Study|Did not meet inclusion|1|||
160607899|NCT01474889|579941553|FG001|Overall Study|Did not meet inclusion|0|||
160607900|NCT01474889|579941554|FG002|Overall Study|Did not meet inclusion|0|||
160607901|NCT01474889|579941552|FG000|Overall Study|Withdrawal by Subject|0|||
160607902|NCT01474889|579941553|FG001|Overall Study|Withdrawal by Subject|1|||
160607903|NCT01474889|579941554|FG002|Overall Study|Withdrawal by Subject|0|||
160607904|NCT02290340|579941556|FG000|Overall Study|Lost to Follow-up|0|||
160607905|NCT02290340|579941557|FG001|Overall Study|Lost to Follow-up|0|||
160607906|NCT02290340|579941558|FG002|Overall Study|Lost to Follow-up|0|||
160607907|NCT02290340|579941559|FG003|Overall Study|Lost to Follow-up|1|||
160607908|NCT02290340|579941556|FG000|Overall Study|Withdrawal by Subject|1|||
160607909|NCT02290340|579941557|FG001|Overall Study|Withdrawal by Subject|0|||
160607910|NCT02290340|579941558|FG002|Overall Study|Withdrawal by Subject|0|||
160607911|NCT02290340|579941559|FG003|Overall Study|Withdrawal by Subject|0|||
160607912|NCT02290340|579941556|FG000|Overall Study|Other|1|||
160607913|NCT02290340|579941557|FG001|Overall Study|Other|0|||
160607914|NCT02290340|579941558|FG002|Overall Study|Other|0|||
160607915|NCT02290340|579941559|FG003|Overall Study|Other|1|||
160607916|NCT02493868|579941560|FG000|Induction Phase: DE Participants|Adverse Event|22|||
160607917|NCT02493868|579941561|FG001|Induction Phase: DE Participants|Adverse Event|0|||
160607918|NCT02493868|579941560|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
160607919|NCT02493868|579941561|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
160607920|NCT02493868|579941560|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
160607921|NCT02493868|579941561|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
160607922|NCT02493868|579941560|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
160607923|NCT02493868|579941561|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
160607924|NCT02493868|579941560|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
160607925|NCT02493868|579941561|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
160607926|NCT02493868|579941560|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
160607927|NCT02493868|579941561|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
160607928|NCT02493868|579941560|FG000|Induction Phase: DE Participants|Other|8|||
160607929|NCT02493868|579941561|FG001|Induction Phase: DE Participants|Other|0|||
160607930|NCT02493868|579941560|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
160607931|NCT02493868|579941561|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
160607932|NCT02493868|579941560|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
160607933|NCT02493868|579941561|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
160607934|NCT02493868|579941560|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
160607935|NCT02493868|579941561|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
160607936|NCT02493868|579941560|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
160607937|NCT02493868|579941561|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
160607938|NCT02493868|579941560|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
160607939|NCT02493868|579941561|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
160607940|NCT02493868|579941560|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
160607941|NCT02493868|579941561|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
160607942|NCT02493868|579941560|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
160607943|NCT02493868|579941561|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
160607944|NCT02493868|579941560|FG000|Optimization Phase: DE+TE Participants|Other|10|||
160607945|NCT02493868|579941561|FG001|Optimization Phase: DE+TE Participants|Other|2|||
160607946|NCT02493868|579941560|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
160607947|NCT02493868|579941561|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
160607948|NCT02493868|579941560|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
160607949|NCT02493868|579941561|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
160607950|NCT02493868|579941560|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
160607951|NCT02493868|579941561|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
160607952|NCT02493868|579941560|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
160607953|NCT02493868|579941561|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
160607954|NCT02493868|579941560|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
160607955|NCT02493868|579941561|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
160607956|NCT02493868|579941560|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
160607957|NCT02493868|579941561|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
160607958|NCT02493868|579941560|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
160661260|NCT00723528|580144035|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
160661261|NCT00723528|580144036|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
160607959|NCT02493868|579941561|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
160607960|NCT02493868|579941560|FG000|Follow-up Phase|Lost to Follow-up|1|||
160607961|NCT02493868|579941561|FG001|Follow-up Phase|Lost to Follow-up|0|||
160661262|NCT00723528|580144037|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
160661263|NCT00723528|580144038|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
160661264|NCT00723528|580144039|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
160607962|NCT02493868|579941560|FG000|Follow-up Phase|Withdrawal by Subject|3|||
160607963|NCT02493868|579941561|FG001|Follow-up Phase|Withdrawal by Subject|0|||
160607964|NCT02493868|579941560|FG000|Follow-up Phase|Investigator Decision|5|||
160607965|NCT02493868|579941561|FG001|Follow-up Phase|Investigator Decision|1|||
160607966|NCT02493868|579941560|FG000|Follow-up Phase|Other|2|||
160607967|NCT02493868|579941561|FG001|Follow-up Phase|Other|1|||
160607968|NCT02407236|579941562|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
160607969|NCT02407236|579941563|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
160607970|NCT02407236|579941564|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
160607971|NCT02407236|579941565|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
160607972|NCT02407236|579941566|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
160607973|NCT02407236|579941567|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
160607974|NCT02407236|579941568|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
160607975|NCT02407236|579941569|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
160607976|NCT02407236|579941570|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
160607977|NCT02407236|579941571|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
160607978|NCT02407236|579941572|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
160607979|NCT02407236|579941573|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
160607980|NCT02407236|579941574|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
160607981|NCT02407236|579941562|FG000|Induction Study (8 Weeks)|Death|0|||
160607982|NCT02407236|579941563|FG001|Induction Study (8 Weeks)|Death|0|||
160607983|NCT02407236|579941564|FG002|Induction Study (8 Weeks)|Death|1|||
160607984|NCT02407236|579941565|FG003|Induction Study (8 Weeks)|Death|0|||
160607985|NCT02407236|579941566|FG004|Induction Study (8 Weeks)|Death|0|||
160607986|NCT02407236|579941567|FG005|Induction Study (8 Weeks)|Death|0|||
160607987|NCT02407236|579941568|FG006|Induction Study (8 Weeks)|Death|0|||
160607988|NCT02407236|579941569|FG007|Induction Study (8 Weeks)|Death|0|||
160607989|NCT02407236|579941570|FG008|Induction Study (8 Weeks)|Death|0|||
160607990|NCT02407236|579941571|FG009|Induction Study (8 Weeks)|Death|0|||
160607991|NCT02407236|579941572|FG010|Induction Study (8 Weeks)|Death|0|||
160607992|NCT02407236|579941573|FG011|Induction Study (8 Weeks)|Death|0|||
160607993|NCT02407236|579941574|FG012|Induction Study (8 Weeks)|Death|0|||
160607994|NCT02407236|579941562|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
160607995|NCT02407236|579941563|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
160607996|NCT02407236|579941564|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
160607997|NCT02407236|579941565|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
160607998|NCT02407236|579941566|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
160607999|NCT02407236|579941567|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
160608000|NCT02407236|579941568|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
160608001|NCT02407236|579941569|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
160608002|NCT02407236|579941570|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
160608003|NCT02407236|579941571|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
160608004|NCT02407236|579941572|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
160608005|NCT02407236|579941573|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
160608006|NCT02407236|579941574|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
160608007|NCT02407236|579941562|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608008|NCT02407236|579941563|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608009|NCT02407236|579941564|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
160608010|NCT02407236|579941565|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608011|NCT02407236|579941566|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608012|NCT02407236|579941567|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608013|NCT02407236|579941568|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608014|NCT02407236|579941569|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608015|NCT02407236|579941570|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608016|NCT02407236|579941571|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608017|NCT02407236|579941572|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608018|NCT02407236|579941573|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608019|NCT02407236|579941574|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
160608020|NCT02407236|579941562|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
160608021|NCT02407236|579941563|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
160608022|NCT02407236|579941564|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
160608023|NCT02407236|579941565|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
160608024|NCT02407236|579941566|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
160608025|NCT02407236|579941567|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
160608026|NCT02407236|579941568|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
160608027|NCT02407236|579941569|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
160608028|NCT02407236|579941570|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
160608029|NCT02407236|579941571|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
160608030|NCT02407236|579941572|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
160608031|NCT02407236|579941573|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
160608032|NCT02407236|579941574|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
160608033|NCT02407236|579941562|FG000|Induction Study (8 Weeks)|Other|2|||
160608034|NCT02407236|579941563|FG001|Induction Study (8 Weeks)|Other|1|||
160608035|NCT02407236|579941564|FG002|Induction Study (8 Weeks)|Other|5|||
160487220|NCT00460564|579514141|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160487221|NCT00460564|579514142|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160487222|NCT00460564|579514143|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160487223|NCT00460564|579514136|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
160487224|NCT00460564|579514137|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160487225|NCT00460564|579514138|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160487226|NCT00460564|579514139|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160487227|NCT00460564|579514140|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160487228|NCT00460564|579514141|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160487229|NCT00460564|579514142|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160487230|NCT00460564|579514143|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160487231|NCT00460564|579514136|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
160487232|NCT00460564|579514137|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
160487233|NCT00460564|579514138|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
160487234|NCT00460564|579514139|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
160487235|NCT00460564|579514140|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
160487236|NCT00460564|579514141|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
160487237|NCT00460564|579514142|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
160487238|NCT00460564|579514143|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
160487239|NCT00460564|579514136|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
160487240|NCT00460564|579514137|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
160487241|NCT00460564|579514138|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
160487242|NCT00460564|579514139|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
160487243|NCT00460564|579514140|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
160487244|NCT00460564|579514141|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
160487245|NCT00460564|579514142|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
160487246|NCT00460564|579514143|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
160487247|NCT00460564|579514136|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
160487248|NCT00460564|579514137|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
160487249|NCT00460564|579514138|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
160487250|NCT00460564|579514139|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
160487251|NCT00460564|579514140|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
160487252|NCT00460564|579514141|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
160487253|NCT00460564|579514142|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
160487254|NCT00460564|579514143|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
160487255|NCT03226106|579514149|FG000|Overall Study|Withdrawal by Subject|2|||
160487256|NCT03226106|579514150|FG001|Overall Study|Withdrawal by Subject|0|||
160487257|NCT03226106|579514149|FG000|Overall Study|Adverse Event|1|||
160487258|NCT03226106|579514150|FG001|Overall Study|Adverse Event|0|||
160487259|NCT03226106|579514149|FG000|Overall Study|Lost to Follow-up|2|||
160487260|NCT03226106|579514150|FG001|Overall Study|Lost to Follow-up|0|||
160487261|NCT04349644|579514151|FG000|Allocation/Pretest|Lost to pretest|0|||
160487262|NCT04349644|579514152|FG001|Allocation/Pretest|Lost to pretest|3|||
160487263|NCT04349644|579514151|FG000|Posttest|Lost to posttest|0|||
160487264|NCT04349644|579514152|FG001|Posttest|Lost to posttest|8|||
160487265|NCT04349644|579514151|FG000|Posttest|Discontinued intervention|6|||
160487266|NCT04349644|579514152|FG001|Posttest|Discontinued intervention|0|||
160487267|NCT04349644|579514151|FG000|Follow-up|Lost to Follow-up|0|||
160487268|NCT04349644|579514152|FG001|Follow-up|Lost to Follow-up|2|||
160487269|NCT01084239|579514153|FG000|28-Day Follow-up|Lost to Follow-up|4|||
160487270|NCT01084239|579514154|FG001|28-Day Follow-up|Lost to Follow-up|9|||
160487271|NCT05006417|579514155|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
160487272|NCT00863798|579514156|FG000|Overall Study|Adverse Event|5|||
160487273|NCT00863798|579514157|FG001|Overall Study|Adverse Event|2|||
160487274|NCT00863798|579514158|FG002|Overall Study|Adverse Event|4|||
160487275|NCT00863798|579514156|FG000|Overall Study|Participant failed to return|2|||
160487276|NCT00863798|579514157|FG001|Overall Study|Participant failed to return|1|||
160487277|NCT00863798|579514158|FG002|Overall Study|Participant failed to return|0|||
160487278|NCT00863798|579514156|FG000|Overall Study|Investigator request|1|||
160487279|NCT00863798|579514157|FG001|Overall Study|Investigator request|2|||
160487280|NCT00863798|579514158|FG002|Overall Study|Investigator request|1|||
160487281|NCT00863798|579514156|FG000|Overall Study|Lack of Efficacy|4|||
160487282|NCT00863798|579514157|FG001|Overall Study|Lack of Efficacy|3|||
160487283|NCT00863798|579514158|FG002|Overall Study|Lack of Efficacy|6|||
160487284|NCT00863798|579514156|FG000|Overall Study|Lost to Follow-up|6|||
160487285|NCT00863798|579514157|FG001|Overall Study|Lost to Follow-up|9|||
160487286|NCT00863798|579514158|FG002|Overall Study|Lost to Follow-up|5|||
160487287|NCT00863798|579514156|FG000|Overall Study|Other|2|||
160487288|NCT00863798|579514157|FG001|Overall Study|Other|3|||
160487289|NCT00863798|579514158|FG002|Overall Study|Other|1|||
160487290|NCT00863798|579514156|FG000|Overall Study|Protocol Violation|0|||
160487291|NCT00863798|579514157|FG001|Overall Study|Protocol Violation|1|||
160487292|NCT00863798|579514158|FG002|Overall Study|Protocol Violation|1|||
160487293|NCT00863798|579514156|FG000|Overall Study|Withdrawal by Subject|8|||
160487294|NCT00863798|579514157|FG001|Overall Study|Withdrawal by Subject|7|||
160608036|NCT02407236|579941565|FG003|Induction Study (8 Weeks)|Other|0|||
160608037|NCT02407236|579941566|FG004|Induction Study (8 Weeks)|Other|0|||
160608038|NCT02407236|579941567|FG005|Induction Study (8 Weeks)|Other|0|||
160608039|NCT02407236|579941568|FG006|Induction Study (8 Weeks)|Other|0|||
160608040|NCT02407236|579941569|FG007|Induction Study (8 Weeks)|Other|0|||
160608041|NCT02407236|579941570|FG008|Induction Study (8 Weeks)|Other|0|||
160608042|NCT02407236|579941571|FG009|Induction Study (8 Weeks)|Other|0|||
160608043|NCT02407236|579941572|FG010|Induction Study (8 Weeks)|Other|0|||
160608044|NCT02407236|579941573|FG011|Induction Study (8 Weeks)|Other|0|||
160608045|NCT02407236|579941574|FG012|Induction Study (8 Weeks)|Other|0|||
160608046|NCT02407236|579941562|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
160608047|NCT02407236|579941563|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
160608048|NCT02407236|579941564|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
160608049|NCT02407236|579941565|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
160608050|NCT02407236|579941566|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
160608051|NCT02407236|579941567|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
160608052|NCT02407236|579941568|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
160608053|NCT02407236|579941569|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
160608054|NCT02407236|579941570|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
160608055|NCT02407236|579941571|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
160608056|NCT02407236|579941572|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
160608057|NCT02407236|579941573|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
160608058|NCT02407236|579941574|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
160608059|NCT02407236|579941562|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
160608060|NCT02407236|579941563|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
160608061|NCT02407236|579941564|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
160608062|NCT02407236|579941565|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
160608063|NCT02407236|579941566|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
160608064|NCT02407236|579941567|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
160608065|NCT02407236|579941568|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
160608066|NCT02407236|579941569|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
160608067|NCT02407236|579941570|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
160487295|NCT00863798|579514158|FG002|Overall Study|Withdrawal by Subject|4|||
160487296|NCT00863798|579514156|FG000|Overall Study|Randomized not treated|4|||
160608068|NCT02407236|579941571|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
160608069|NCT02407236|579941572|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
160608070|NCT02407236|579941573|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
160608071|NCT02407236|579941574|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
160608072|NCT02407236|579941562|FG000|Maintenance Study (44 Weeks)|Other|0|||
160608073|NCT02407236|579941563|FG001|Maintenance Study (44 Weeks)|Other|0|||
160608074|NCT02407236|579941564|FG002|Maintenance Study (44 Weeks)|Other|0|||
160608075|NCT02407236|579941565|FG003|Maintenance Study (44 Weeks)|Other|5|||
160608076|NCT02407236|579941566|FG004|Maintenance Study (44 Weeks)|Other|7|||
160608077|NCT02407236|579941567|FG005|Maintenance Study (44 Weeks)|Other|8|||
160608078|NCT02407236|579941568|FG006|Maintenance Study (44 Weeks)|Other|4|||
160608079|NCT02407236|579941569|FG007|Maintenance Study (44 Weeks)|Other|6|||
160608080|NCT02407236|579941570|FG008|Maintenance Study (44 Weeks)|Other|0|||
160608081|NCT02407236|579941571|FG009|Maintenance Study (44 Weeks)|Other|0|||
160608082|NCT02407236|579941572|FG010|Maintenance Study (44 Weeks)|Other|0|||
160608083|NCT02407236|579941573|FG011|Maintenance Study (44 Weeks)|Other|0|||
160608084|NCT02407236|579941574|FG012|Maintenance Study (44 Weeks)|Other|0|||
160608085|NCT02407236|579941562|FG000|Maintenance Study (44 Weeks)|Death|0|||
160608086|NCT02407236|579941563|FG001|Maintenance Study (44 Weeks)|Death|0|||
160608087|NCT02407236|579941564|FG002|Maintenance Study (44 Weeks)|Death|0|||
160608088|NCT02407236|579941565|FG003|Maintenance Study (44 Weeks)|Death|0|||
160487297|NCT00863798|579514157|FG001|Overall Study|Randomized not treated|2|||
160487298|NCT00863798|579514158|FG002|Overall Study|Randomized not treated|3|||
160608089|NCT02407236|579941566|FG004|Maintenance Study (44 Weeks)|Death|0|||
160608090|NCT02407236|579941567|FG005|Maintenance Study (44 Weeks)|Death|0|||
160608091|NCT02407236|579941568|FG006|Maintenance Study (44 Weeks)|Death|0|||
160661265|NCT00723528|580144040|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
160661266|NCT00723528|580144041|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
160608092|NCT02407236|579941569|FG007|Maintenance Study (44 Weeks)|Death|1|||
160608093|NCT02407236|579941570|FG008|Maintenance Study (44 Weeks)|Death|0|||
160608094|NCT02407236|579941571|FG009|Maintenance Study (44 Weeks)|Death|0|||
160608095|NCT02407236|579941572|FG010|Maintenance Study (44 Weeks)|Death|0|||
160608096|NCT02407236|579941573|FG011|Maintenance Study (44 Weeks)|Death|0|||
160608097|NCT02407236|579941574|FG012|Maintenance Study (44 Weeks)|Death|0|||
160608098|NCT02407236|579941562|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
160608099|NCT02407236|579941563|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
160608100|NCT02407236|579941564|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
160608101|NCT02407236|579941565|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
160608102|NCT02407236|579941566|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
160608103|NCT02407236|579941567|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
160608104|NCT02407236|579941568|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
160608105|NCT02407236|579941569|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
160608106|NCT02407236|579941570|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
160608107|NCT02407236|579941571|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
160608108|NCT02407236|579941572|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
160608109|NCT02407236|579941573|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
160608110|NCT02407236|579941574|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
160608111|NCT02407236|579941562|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608112|NCT02407236|579941563|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608113|NCT02407236|579941564|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608114|NCT02407236|579941565|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608115|NCT02407236|579941566|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608116|NCT02407236|579941567|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608117|NCT02407236|579941568|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608118|NCT02407236|579941569|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608119|NCT02407236|579941570|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608120|NCT02407236|579941571|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608121|NCT02407236|579941572|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
160608122|NCT02407236|579941573|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608123|NCT02407236|579941574|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
160608124|NCT02407236|579941562|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
160608125|NCT02407236|579941563|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
160608126|NCT02407236|579941564|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
160608127|NCT02407236|579941565|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
160608128|NCT02407236|579941566|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
160608129|NCT02407236|579941567|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
160608130|NCT02407236|579941568|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
160608131|NCT02407236|579941569|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
160608132|NCT02407236|579941570|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
160608133|NCT02407236|579941571|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
160608134|NCT02407236|579941572|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
160608135|NCT02407236|579941573|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
160608136|NCT02407236|579941574|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
160608137|NCT02407236|579941562|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
160608138|NCT02407236|579941563|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
160608139|NCT02407236|579941564|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
160608140|NCT02407236|579941565|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
160608141|NCT02407236|579941566|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
160608142|NCT02407236|579941567|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
160608143|NCT02407236|579941568|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
160608144|NCT02407236|579941569|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
160608145|NCT02407236|579941570|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
160608146|NCT02407236|579941571|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
160608147|NCT02407236|579941572|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
160608148|NCT02407236|579941573|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
160608149|NCT02407236|579941574|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
160608150|NCT03039569|579941577|FG000|Overall Study|Lost to Follow-up|5|||
160608151|NCT03039569|579941578|FG001|Overall Study|Lost to Follow-up|4|||
160608152|NCT01167153|579941579|FG000|Overall Study|Non-effective therapy|1|||
160608153|NCT01167153|579941580|FG001|Overall Study|Non-effective therapy|4|||
160608154|NCT01167153|579941579|FG000|Overall Study|AE including clinical laboratory AE|2|||
160608155|NCT01167153|579941580|FG001|Overall Study|AE including clinical laboratory AE|8|||
160608156|NCT01167153|579941579|FG000|Overall Study|Hypotension|1|||
160608157|NCT01167153|579941580|FG001|Overall Study|Hypotension|0|||
160608158|NCT01167153|579941579|FG000|Overall Study|Lost to Follow-up|7|||
160608159|NCT01167153|579941580|FG001|Overall Study|Lost to Follow-up|9|||
160608160|NCT01167153|579941579|FG000|Overall Study|Non-compliance to concomitant medication|0|||
160608161|NCT01167153|579941580|FG001|Overall Study|Non-compliance to concomitant medication|2|||
160608162|NCT01167153|579941579|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
160608163|NCT01167153|579941580|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
160608164|NCT01167153|579941579|FG000|Overall Study|Withdrawal consent|1|||
160608165|NCT01167153|579941580|FG001|Overall Study|Withdrawal consent|1|||
160608166|NCT01167153|579941579|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
160608167|NCT01167153|579941580|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
160608168|NCT04888507|579943439|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
160608169|NCT00636155|579943440|FG000|Overall Study|Adverse Event|8|||
160608170|NCT00636155|579943440|FG000|Overall Study|Lack of Efficacy|1|||
160608171|NCT00636155|579943440|FG000|Overall Study|Withdrawal by Subject|3|||
160608172|NCT00636155|579943440|FG000|Overall Study|Stem cell transplant|1|||
160608173|NCT00636155|579943440|FG000|Overall Study|Physician Decision|5|||
160608174|NCT00766142|579943441|FG000|Overall Study|Protocol Violation|4|||
160608175|NCT05643170|579943442|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
160608176|NCT05643170|579943442|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
160608177|NCT02632344|579943453|FG000|Overall Study|Adverse Event|3|||
160608178|NCT02632344|579943453|FG000|Overall Study|Lack of Efficacy|3|||
160608179|NCT02632344|579943453|FG000|Overall Study|Withdrawal by Subject|2|||
160608180|NCT00777257|579943454|FG000|Overall Study|Adverse Event|3|||
160608181|NCT00777257|579943455|FG001|Overall Study|Adverse Event|1|||
160608182|NCT00777257|579943456|FG002|Overall Study|Adverse Event|0|||
160608183|NCT00777257|579943454|FG000|Overall Study|Lost to Follow-up|3|||
160608184|NCT00777257|579943455|FG001|Overall Study|Lost to Follow-up|3|||
160608185|NCT00777257|579943456|FG002|Overall Study|Lost to Follow-up|2|||
160608186|NCT00777257|579943454|FG000|Overall Study|Protocol Violation|2|||
160608187|NCT00777257|579943455|FG001|Overall Study|Protocol Violation|2|||
160608188|NCT00777257|579943456|FG002|Overall Study|Protocol Violation|2|||
160608189|NCT00777257|579943454|FG000|Overall Study|Withdrawal by Subject|3|||
160608190|NCT00777257|579943455|FG001|Overall Study|Withdrawal by Subject|6|||
160608191|NCT00777257|579943456|FG002|Overall Study|Withdrawal by Subject|5|||
160608192|NCT01431521|579943457|FG000|Overall Study|Withdrawal by Subject|0|||
160608193|NCT01431521|579943458|FG001|Overall Study|Withdrawal by Subject|0|||
160608194|NCT01431521|579943459|FG002|Overall Study|Withdrawal by Subject|1|||
160608195|NCT01431521|579943460|FG003|Overall Study|Withdrawal by Subject|0|||
160608196|NCT04984876|579943461|FG000|Overall Study|Subject decision|2|||
160608197|NCT04984876|579943462|FG001|Overall Study|Subject decision|10|||
160608198|NCT04984876|579943463|FG002|Overall Study|Subject decision|3|||
160608199|NCT04984876|579943464|FG003|Overall Study|Subject decision|3|||
160608200|NCT04984876|579943465|FG004|Overall Study|Subject decision|3|||
160608201|NCT04984876|579943466|FG005|Overall Study|Subject decision|0|||
160608202|NCT04984876|579943461|FG000|Overall Study|Guardian decision|0|||
160608203|NCT04984876|579943462|FG001|Overall Study|Guardian decision|1|||
160608204|NCT04984876|579943463|FG002|Overall Study|Guardian decision|0|||
160608205|NCT04984876|579943464|FG003|Overall Study|Guardian decision|2|||
160608206|NCT04984876|579943465|FG004|Overall Study|Guardian decision|0|||
160608207|NCT04984876|579943466|FG005|Overall Study|Guardian decision|1|||
160608208|NCT04984876|579943461|FG000|Overall Study|Lost to Follow-up|0|||
160608209|NCT04984876|579943462|FG001|Overall Study|Lost to Follow-up|0|||
160608210|NCT04984876|579943463|FG002|Overall Study|Lost to Follow-up|1|||
160608211|NCT04984876|579943464|FG003|Overall Study|Lost to Follow-up|1|||
160608212|NCT04984876|579943465|FG004|Overall Study|Lost to Follow-up|0|||
160608213|NCT04984876|579943466|FG005|Overall Study|Lost to Follow-up|0|||
160608214|NCT04984876|579943461|FG000|Overall Study|Physician Decision|1|||
160608215|NCT04984876|579943462|FG001|Overall Study|Physician Decision|0|||
160608216|NCT04984876|579943463|FG002|Overall Study|Physician Decision|0|||
160608217|NCT04984876|579943464|FG003|Overall Study|Physician Decision|1|||
160608218|NCT04984876|579943465|FG004|Overall Study|Physician Decision|0|||
160608219|NCT04984876|579943466|FG005|Overall Study|Physician Decision|0|||
160608220|NCT04984876|579943461|FG000|Overall Study|Adverse Event|0|||
160608221|NCT04984876|579943462|FG001|Overall Study|Adverse Event|0|||
160608222|NCT04984876|579943463|FG002|Overall Study|Adverse Event|1|||
160608223|NCT04984876|579943464|FG003|Overall Study|Adverse Event|0|||
160608224|NCT04984876|579943465|FG004|Overall Study|Adverse Event|0|||
160608225|NCT04984876|579943466|FG005|Overall Study|Adverse Event|0|||
160608226|NCT02000622|579943467|FG000|Overall Study|Withdrawal by Subject|5|||
160608227|NCT02000622|579943468|FG001|Overall Study|Withdrawal by Subject|7|||
160608228|NCT02000622|579943467|FG000|Overall Study|Lost to Follow-up|4|||
160608229|NCT02000622|579943468|FG001|Overall Study|Lost to Follow-up|0|||
160608230|NCT02000622|579943467|FG000|Overall Study|Death|159|||
160608231|NCT02000622|579943468|FG001|Overall Study|Death|73|||
160608232|NCT02000622|579943467|FG000|Overall Study|Withdrawn due to site closure|1|||
160608233|NCT02000622|579943468|FG001|Overall Study|Withdrawn due to site closure|0|||
160608234|NCT01462045|579943469|FG000|Overall Study|Family matter|0|||
160608235|NCT01462045|579943470|FG001|Overall Study|Family matter|1|||
160608236|NCT01462045|579943471|FG002|Overall Study|Family matter|0|||
160608237|NCT01938391|579943474|FG000|6 Month Follow up|Withdrawal by Subject|1|||
160608238|NCT01938391|579943474|FG000|12 Month Follow up|Physician Decision|1|||
160608239|NCT01938391|579943474|FG000|12 Month Follow up|Withdrawal by Subject|1|||
160608240|NCT01077193|579943475|FG000|Overall Study|Lost to Follow-up|1|||
160608241|NCT01077193|579943475|FG000|Overall Study|Withdrawal by Subject|2|||
160608242|NCT01077193|579943475|FG000|Overall Study|Lack of Efficacy|1|||
160608243|NCT01077193|579943475|FG000|Overall Study|Study Terminated by Sponsor|40|||
160608244|NCT04924114|579943479|FG000|Overall Study|Withdrawal by Subject|0|||
160608245|NCT04924114|579943480|FG001|Overall Study|Withdrawal by Subject|2|||
160608246|NCT04924114|579943481|FG002|Overall Study|Withdrawal by Subject|2|||
160608247|NCT04924114|579943482|FG003|Overall Study|Withdrawal by Subject|0|||
160608248|NCT04924114|579943483|FG004|Overall Study|Withdrawal by Subject|2|||
160608249|NCT04960202|579943484|FG000|Overall Study|Other|5|||
160608250|NCT04960202|579943485|FG001|Overall Study|Other|0|||
160608251|NCT04960202|579943484|FG000|Overall Study|Withdrawal by Subject|37|||
160608252|NCT04960202|579943485|FG001|Overall Study|Withdrawal by Subject|43|||
160608253|NCT04960202|579943484|FG000|Overall Study|Lost to Follow-up|20|||
160608254|NCT04960202|579943485|FG001|Overall Study|Lost to Follow-up|16|||
160608255|NCT04960202|579943484|FG000|Overall Study|Death|0|||
160608256|NCT04960202|579943485|FG001|Overall Study|Death|15|||
160608257|NCT03671148|579943486|FG000|Overall Study|Adverse Event|3|||
160608258|NCT03671148|579943487|FG001|Overall Study|Adverse Event|2|||
160608259|NCT03671148|579943486|FG000|Overall Study|Withdrawal by Subject|8|||
160608260|NCT03671148|579943487|FG001|Overall Study|Withdrawal by Subject|2|||
160608261|NCT03671148|579943486|FG000|Overall Study|Lost to Follow-up|1|||
160608262|NCT03671148|579943487|FG001|Overall Study|Lost to Follow-up|2|||
160608263|NCT03671148|579943486|FG000|Overall Study|Lack of Efficacy|7|||
160608264|NCT03671148|579943487|FG001|Overall Study|Lack of Efficacy|2|||
160608265|NCT03671148|579943486|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
160608266|NCT03671148|579943487|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
160608267|NCT03671148|579943486|FG000|Overall Study|Other|1|||
160608268|NCT03671148|579943487|FG001|Overall Study|Other|0|||
160608269|NCT03671148|579943486|FG000|Overall Study|Incomplete Randomization Visit|1|||
160608270|NCT03671148|579943487|FG001|Overall Study|Incomplete Randomization Visit|0|||
160608271|NCT00673816|579943490|FG000|Overall Study|Adverse Event|1|||
160608272|NCT00673816|579943490|FG000|Overall Study|Withdrawal by Subject|1|||
160608273|NCT01804842|579943495|FG000|Overall Study|Adverse Event|1|||
160608274|NCT01804842|579943496|FG001|Overall Study|Adverse Event|1|||
160608275|NCT01804842|579943497|FG002|Overall Study|Adverse Event|0|||
160608276|NCT01804842|579943495|FG000|Overall Study|Lost to Follow-up|1|||
160608277|NCT01804842|579943496|FG001|Overall Study|Lost to Follow-up|0|||
160608278|NCT01804842|579943497|FG002|Overall Study|Lost to Follow-up|0|||
160608279|NCT01804842|579943495|FG000|Overall Study|Non-Compliance|1|||
160608280|NCT01804842|579943496|FG001|Overall Study|Non-Compliance|1|||
160608281|NCT01804842|579943497|FG002|Overall Study|Non-Compliance|0|||
160608282|NCT01804842|579943495|FG000|Overall Study|Personal Reason|0|||
160608283|NCT01804842|579943496|FG001|Overall Study|Personal Reason|0|||
160608284|NCT01804842|579943497|FG002|Overall Study|Personal Reason|1|||
160608285|NCT03774875|579943500|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
160608286|NCT03774875|579943501|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
160608287|NCT03774875|579943500|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
160608288|NCT03774875|579943501|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
160608289|NCT03774875|579943500|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
160608290|NCT03774875|579943501|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
160608291|NCT03774875|579943500|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
160608292|NCT03774875|579943501|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
160608293|NCT03774875|579943500|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
160608294|NCT03774875|579943501|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
160608295|NCT03774875|579943500|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
160608296|NCT03774875|579943501|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
160608297|NCT03774875|579943500|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
160608298|NCT03774875|579943501|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
160608299|NCT03774875|579943500|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
160608300|NCT03774875|579943501|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
160608301|NCT03774875|579943500|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
160608302|NCT03774875|579943501|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
160608303|NCT03774875|579943500|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
160608304|NCT03774875|579943501|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
160608305|NCT03774875|579943500|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
160608306|NCT03774875|579943501|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
160608307|NCT03774875|579943500|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
160608308|NCT03774875|579943501|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
160608309|NCT03774875|579943500|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
160608310|NCT03774875|579943501|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
160608311|NCT02352090|579943502|FG000|Overall Study|general malaise|1|||
160608312|NCT02352090|579943503|FG001|Overall Study|general malaise|0|||
160608313|NCT02352090|579943504|FG002|Overall Study|general malaise|0|||
160608314|NCT02352090|579943502|FG000|Overall Study|non-specified mild side-effects|0|||
160608315|NCT02352090|579943503|FG001|Overall Study|non-specified mild side-effects|0|||
160608316|NCT02352090|579943504|FG002|Overall Study|non-specified mild side-effects|2|||
160608317|NCT03687827|579943505|FG000|Treatment Period 1|Death|0|||
160608318|NCT03687827|579943506|FG001|Treatment Period 1|Death|1|||
160608319|NCT03687827|579943505|FG000|Treatment Period 1|Lost to Follow-up|2|||
160608320|NCT03687827|579943506|FG001|Treatment Period 1|Lost to Follow-up|2|||
160608321|NCT03687827|579943505|FG000|Treatment Period 1|Physician Decision|5|||
160608322|NCT03687827|579943506|FG001|Treatment Period 1|Physician Decision|2|||
160608323|NCT03687827|579943505|FG000|Treatment Period 1|Withdrawal by Subject|7|||
160608324|NCT03687827|579943506|FG001|Treatment Period 1|Withdrawal by Subject|3|||
160608325|NCT03687827|579943505|FG000|Treatment Period 2|Physician Decision|4|||
160608326|NCT03687827|579943506|FG001|Treatment Period 2|Physician Decision|1|||
160608327|NCT03687827|579943505|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160608328|NCT03687827|579943506|FG001|Treatment Period 2|Withdrawal by Subject|2|||
160608329|NCT00413777|579943508|FG000|Fixed-dose Period|Lost to Follow-up|1|||
160608330|NCT00413777|579943509|FG001|Fixed-dose Period|Lost to Follow-up|1|||
160608331|NCT00413777|579943508|FG000|Fixed-dose Period|Adverse Event|2|||
160608332|NCT00413777|579943509|FG001|Fixed-dose Period|Adverse Event|1|||
160608333|NCT00413777|579943508|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
160608334|NCT00413777|579943509|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
160608335|NCT00413777|579943508|FG000|Fixed-dose Period|Withdrew Consent|0|||
160608336|NCT00413777|579943509|FG001|Fixed-dose Period|Withdrew Consent|1|||
160608337|NCT01678313|579943512|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
160608338|NCT01678313|579943513|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
160608339|NCT01678313|579943512|FG000|Completed the 3-month Therapy|Physician Decision|3|||
160608340|NCT01678313|579943513|FG001|Completed the 3-month Therapy|Physician Decision|4|||
160608341|NCT01678313|579943512|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
160608342|NCT01678313|579943513|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
160608343|NCT01678313|579943512|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
160608344|NCT01678313|579943513|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
160608345|NCT03377452|579943514|FG000|Overall Study|Refused assessment|0|||
160608346|NCT03377452|579943515|FG001|Overall Study|Refused assessment|2|||
160608347|NCT03377452|579943514|FG000|Overall Study|Lost to Follow-up|5|||
160608348|NCT03377452|579943515|FG001|Overall Study|Lost to Follow-up|4|||
160608349|NCT05179057|579943516|FG000|Overall Study|Adverse Event|3|||
160608350|NCT05179057|579943517|FG001|Overall Study|Adverse Event|2|||
160608351|NCT05179057|579943516|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
160608352|NCT05179057|579943517|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
160608353|NCT05179057|579943516|FG000|Overall Study|Study terminated|13|||
160608354|NCT05179057|579943517|FG001|Overall Study|Study terminated|7|||
160608355|NCT05179057|579943516|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
160608356|NCT05179057|579943517|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
160608357|NCT05179057|579943516|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
160608358|NCT05179057|579943517|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
160608359|NCT03345342|579943518|FG000|Open-Label Phase|Adverse Event|30|||
160608360|NCT03345342|579943519|FG001|Open-Label Phase|Adverse Event|0|||
160608361|NCT03345342|579943520|FG002|Open-Label Phase|Adverse Event|0|||
160608362|NCT03345342|579943521|FG003|Open-Label Phase|Adverse Event|0|||
160608363|NCT03345342|579943522|FG004|Open-Label Phase|Adverse Event|0|||
160608364|NCT03345342|579943518|FG000|Open-Label Phase|Death|1|||
160608365|NCT03345342|579943519|FG001|Open-Label Phase|Death|0|||
160608366|NCT03345342|579943520|FG002|Open-Label Phase|Death|0|||
160608367|NCT03345342|579943521|FG003|Open-Label Phase|Death|0|||
160608368|NCT03345342|579943522|FG004|Open-Label Phase|Death|0|||
160608369|NCT03345342|579943518|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
160608370|NCT03345342|579943519|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
160608371|NCT03345342|579943520|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
160608372|NCT03345342|579943521|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
160608373|NCT03345342|579943522|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
160608374|NCT03345342|579943518|FG000|Open-Label Phase|Lack of Efficacy|6|||
160608375|NCT03345342|579943519|FG001|Open-Label Phase|Lack of Efficacy|0|||
160608376|NCT03345342|579943520|FG002|Open-Label Phase|Lack of Efficacy|0|||
160608377|NCT03345342|579943521|FG003|Open-Label Phase|Lack of Efficacy|0|||
160608378|NCT03345342|579943522|FG004|Open-Label Phase|Lack of Efficacy|0|||
160608379|NCT03345342|579943518|FG000|Open-Label Phase|Lost to Follow-up|9|||
160608380|NCT03345342|579943519|FG001|Open-Label Phase|Lost to Follow-up|0|||
160608381|NCT03345342|579943520|FG002|Open-Label Phase|Lost to Follow-up|0|||
160608382|NCT03345342|579943521|FG003|Open-Label Phase|Lost to Follow-up|0|||
160608383|NCT03345342|579943522|FG004|Open-Label Phase|Lost to Follow-up|0|||
160608384|NCT03345342|579943518|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
160487299|NCT04238520|579514159|FG000|Overall Study|Withdrawal by Subject|1|||
160487300|NCT04238520|579514160|FG001|Overall Study|Withdrawal by Subject|1|||
160608385|NCT03345342|579943519|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
160608386|NCT03345342|579943520|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
160608387|NCT03345342|579943521|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
160608388|NCT03345342|579943522|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
160608389|NCT03345342|579943518|FG000|Open-Label Phase|Physician Decision|4|||
160608390|NCT03345342|579943519|FG001|Open-Label Phase|Physician Decision|0|||
160608391|NCT03345342|579943520|FG002|Open-Label Phase|Physician Decision|0|||
160608392|NCT03345342|579943521|FG003|Open-Label Phase|Physician Decision|0|||
160487301|NCT04238520|579514159|FG000|Overall Study|Lost to Follow-up|1|||
160487302|NCT04238520|579514160|FG001|Overall Study|Lost to Follow-up|2|||
160487303|NCT04238520|579514159|FG000|Overall Study|Death|0|||
160487304|NCT04238520|579514160|FG001|Overall Study|Death|2|||
160487305|NCT04238520|579514159|FG000|Overall Study|Unsafe home environment for research staff|0|||
160487306|NCT04238520|579514160|FG001|Overall Study|Unsafe home environment for research staff|1|||
160487307|NCT01470599|579514161|FG000|Overall Study|Did not meet entrance criteria|1|||
160487308|NCT01470599|579514162|FG001|Overall Study|Did not meet entrance criteria|0|||
160487309|NCT01470599|579514161|FG000|Overall Study|Lost to Follow-up|2|||
160487310|NCT01470599|579514162|FG001|Overall Study|Lost to Follow-up|1|||
160487311|NCT01470599|579514161|FG000|Overall Study|Withdrawal by Subject|3|||
160487312|NCT01470599|579514162|FG001|Overall Study|Withdrawal by Subject|4|||
160487313|NCT01470599|579514161|FG000|Overall Study|Other|1|||
160487314|NCT01470599|579514162|FG001|Overall Study|Other|0|||
160487315|NCT01470599|579514161|FG000|Overall Study|Protocol Violation|3|||
160487316|NCT01470599|579514162|FG001|Overall Study|Protocol Violation|1|||
160487317|NCT01470599|579514161|FG000|Overall Study|Adverse event related to study drug|2|||
160487318|NCT01470599|579514162|FG001|Overall Study|Adverse event related to study drug|5|||
160487319|NCT01470599|579514161|FG000|Overall Study|Insufficient clinical response|6|||
160487320|NCT01470599|579514162|FG001|Overall Study|Insufficient clinical response|27|||
160487321|NCT01470599|579514161|FG000|Overall Study|Adverse event not related to study drug|1|||
160487322|NCT01470599|579514162|FG001|Overall Study|Adverse event not related to study drug|5|||
160487323|NCT00195442|579514163|FG000|Overall Study|Less than expected therapeutic effect|38|||
160487324|NCT00195442|579514163|FG000|Overall Study|Lost to Follow-up|27|||
160487325|NCT00195442|579514163|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
160487326|NCT00195442|579514163|FG000|Overall Study|Intermittent product shortage|21|||
160487327|NCT00195442|579514163|FG000|Overall Study|Death|7|||
160487328|NCT00195442|579514163|FG000|Overall Study|No reason specified|4|||
160487329|NCT00195442|579514163|FG000|Overall Study|Poor cooperation|2|||
160487330|NCT00195442|579514163|FG000|Overall Study|Other|14|||
160487331|NCT01917006|579514164|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
160487332|NCT01917006|579514165|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
160487333|NCT01917006|579514166|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
160487334|NCT01917006|579514167|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
160487335|NCT01917006|579514168|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
160487336|NCT01917006|579514169|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
160487337|NCT01917006|579514170|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
160487338|NCT01917006|579514171|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
160487339|NCT01917006|579514164|FG000|Randomized-treatment Period|Personal Reasons|0|||
160487340|NCT01917006|579514165|FG001|Randomized-treatment Period|Personal Reasons|0|||
160487341|NCT01917006|579514166|FG002|Randomized-treatment Period|Personal Reasons|0|||
160487342|NCT01917006|579514167|FG003|Randomized-treatment Period|Personal Reasons|0|||
160487343|NCT01917006|579514168|FG004|Randomized-treatment Period|Personal Reasons|0|||
160487344|NCT01917006|579514169|FG005|Randomized-treatment Period|Personal Reasons|1|||
160487345|NCT01917006|579514170|FG006|Randomized-treatment Period|Personal Reasons|0|||
160487346|NCT01917006|579514171|FG007|Randomized-treatment Period|Personal Reasons|0|||
160487347|NCT01917006|579514164|FG000|Randomized-treatment Period|Protocol Violation|1|||
160487348|NCT01917006|579514165|FG001|Randomized-treatment Period|Protocol Violation|0|||
160487349|NCT01917006|579514166|FG002|Randomized-treatment Period|Protocol Violation|0|||
160487350|NCT01917006|579514167|FG003|Randomized-treatment Period|Protocol Violation|0|||
160487351|NCT01917006|579514168|FG004|Randomized-treatment Period|Protocol Violation|0|||
160487352|NCT01917006|579514169|FG005|Randomized-treatment Period|Protocol Violation|0|||
160608393|NCT03345342|579943522|FG004|Open-Label Phase|Physician Decision|0|||
160608394|NCT03345342|579943518|FG000|Open-Label Phase|Protocol Violation|8|||
160608395|NCT03345342|579943519|FG001|Open-Label Phase|Protocol Violation|0|||
160608396|NCT03345342|579943520|FG002|Open-Label Phase|Protocol Violation|0|||
160608397|NCT03345342|579943521|FG003|Open-Label Phase|Protocol Violation|0|||
160608398|NCT03345342|579943522|FG004|Open-Label Phase|Protocol Violation|0|||
160608399|NCT03345342|579943518|FG000|Open-Label Phase|Withdrawal by Subject|57|||
160608400|NCT03345342|579943519|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160608401|NCT03345342|579943520|FG002|Open-Label Phase|Withdrawal by Subject|0|||
160608402|NCT03345342|579943521|FG003|Open-Label Phase|Withdrawal by Subject|0|||
160608403|NCT03345342|579943522|FG004|Open-Label Phase|Withdrawal by Subject|0|||
160608404|NCT03345342|579943518|FG000|Open-Label Phase|Other|15|||
160608405|NCT03345342|579943519|FG001|Open-Label Phase|Other|0|||
160608406|NCT03345342|579943520|FG002|Open-Label Phase|Other|0|||
160608407|NCT03345342|579943521|FG003|Open-Label Phase|Other|0|||
160608408|NCT03345342|579943522|FG004|Open-Label Phase|Other|0|||
160608409|NCT03345342|579943518|FG000|Double-Blind Phase|Adverse Event|0|||
160608410|NCT03345342|579943519|FG001|Double-Blind Phase|Adverse Event|1|||
160608411|NCT03345342|579943520|FG002|Double-Blind Phase|Adverse Event|6|||
160608412|NCT03345342|579943521|FG003|Double-Blind Phase|Adverse Event|0|||
160608413|NCT03345342|579943522|FG004|Double-Blind Phase|Adverse Event|0|||
160608414|NCT03345342|579943518|FG000|Double-Blind Phase|Death|0|||
160608415|NCT03345342|579943519|FG001|Double-Blind Phase|Death|2|||
160608416|NCT03345342|579943520|FG002|Double-Blind Phase|Death|1|||
160608417|NCT03345342|579943521|FG003|Double-Blind Phase|Death|0|||
160608418|NCT03345342|579943522|FG004|Double-Blind Phase|Death|0|||
160608419|NCT03345342|579943518|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
160608420|NCT03345342|579943519|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
160608421|NCT03345342|579943520|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
160608422|NCT03345342|579943521|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
160608423|NCT03345342|579943522|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
160608424|NCT03345342|579943518|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160608425|NCT03345342|579943519|FG001|Double-Blind Phase|Lost to Follow-up|1|||
160608426|NCT03345342|579943520|FG002|Double-Blind Phase|Lost to Follow-up|7|||
160608427|NCT03345342|579943521|FG003|Double-Blind Phase|Lost to Follow-up|0|||
160608428|NCT03345342|579943522|FG004|Double-Blind Phase|Lost to Follow-up|0|||
160608429|NCT03345342|579943518|FG000|Double-Blind Phase|Physician Decision|0|||
160608430|NCT03345342|579943519|FG001|Double-Blind Phase|Physician Decision|1|||
160608431|NCT03345342|579943520|FG002|Double-Blind Phase|Physician Decision|4|||
160608432|NCT03345342|579943521|FG003|Double-Blind Phase|Physician Decision|0|||
160608433|NCT03345342|579943522|FG004|Double-Blind Phase|Physician Decision|0|||
160608434|NCT03345342|579943518|FG000|Double-Blind Phase|Protocol Violation|0|||
160608435|NCT03345342|579943519|FG001|Double-Blind Phase|Protocol Violation|0|||
160608436|NCT03345342|579943520|FG002|Double-Blind Phase|Protocol Violation|1|||
160608437|NCT03345342|579943521|FG003|Double-Blind Phase|Protocol Violation|0|||
160608438|NCT03345342|579943522|FG004|Double-Blind Phase|Protocol Violation|0|||
160608439|NCT03345342|579943518|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
160608440|NCT03345342|579943519|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
160608441|NCT03345342|579943520|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
160608442|NCT03345342|579943521|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160608443|NCT03345342|579943522|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
160608444|NCT03345342|579943518|FG000|Double-Blind Phase|Other|0|||
160608445|NCT03345342|579943519|FG001|Double-Blind Phase|Other|1|||
160608446|NCT03345342|579943520|FG002|Double-Blind Phase|Other|3|||
160608447|NCT03345342|579943521|FG003|Double-Blind Phase|Other|0|||
160608448|NCT03345342|579943522|FG004|Double-Blind Phase|Other|0|||
160608449|NCT03345342|579943518|FG000|Follow-Up Phase|Adverse Event|0|||
160608450|NCT03345342|579943519|FG001|Follow-Up Phase|Adverse Event|0|||
160608451|NCT03345342|579943520|FG002|Follow-Up Phase|Adverse Event|0|||
160608452|NCT03345342|579943521|FG003|Follow-Up Phase|Adverse Event|0|||
160608453|NCT03345342|579943522|FG004|Follow-Up Phase|Adverse Event|4|||
160608454|NCT03345342|579943518|FG000|Follow-Up Phase|Lost to Follow-up|0|||
160608455|NCT03345342|579943519|FG001|Follow-Up Phase|Lost to Follow-up|0|||
160608456|NCT03345342|579943520|FG002|Follow-Up Phase|Lost to Follow-up|0|||
160608457|NCT03345342|579943521|FG003|Follow-Up Phase|Lost to Follow-up|0|||
160608458|NCT03345342|579943522|FG004|Follow-Up Phase|Lost to Follow-up|6|||
160608459|NCT03345342|579943518|FG000|Follow-Up Phase|Physician Decision|0|||
160608460|NCT03345342|579943519|FG001|Follow-Up Phase|Physician Decision|0|||
160608461|NCT03345342|579943520|FG002|Follow-Up Phase|Physician Decision|0|||
160608462|NCT03345342|579943521|FG003|Follow-Up Phase|Physician Decision|0|||
160608463|NCT03345342|579943522|FG004|Follow-Up Phase|Physician Decision|5|||
160608464|NCT03345342|579943518|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
160608465|NCT03345342|579943519|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
160608466|NCT03345342|579943520|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
160608467|NCT03345342|579943521|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
160608468|NCT03345342|579943522|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
160608469|NCT03345342|579943518|FG000|Follow-Up Phase|Other|0|||
160608470|NCT03345342|579943519|FG001|Follow-Up Phase|Other|0|||
160608471|NCT03345342|579943520|FG002|Follow-Up Phase|Other|0|||
160661267|NCT00723528|580144035|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
160608472|NCT03345342|579943521|FG003|Follow-Up Phase|Other|3|||
160608473|NCT03345342|579943522|FG004|Follow-Up Phase|Other|1|||
160608474|NCT03464136|579943523|FG000|Overall Study|Lost to Follow-up|5|||
160608475|NCT03464136|579943524|FG001|Overall Study|Lost to Follow-up|8|||
160608476|NCT03464136|579943523|FG000|Overall Study|Withdrawal by Subject|16|||
160608477|NCT03464136|579943524|FG001|Overall Study|Withdrawal by Subject|13|||
160608478|NCT03464136|579943523|FG000|Overall Study|Death|1|||
160608479|NCT03464136|579943524|FG001|Overall Study|Death|0|||
160608480|NCT03464136|579943523|FG000|Overall Study|Other|8|||
160608481|NCT03464136|579943524|FG001|Overall Study|Other|4|||
160608482|NCT03375203|579943525|FG000|Overall Study|Protocol Violation|0|||
160608483|NCT03375203|579943526|FG001|Overall Study|Protocol Violation|0|||
160608484|NCT03375203|579943527|FG002|Overall Study|Protocol Violation|1|||
160487353|NCT01917006|579514170|FG006|Randomized-treatment Period|Protocol Violation|0|||
160487354|NCT01917006|579514171|FG007|Randomized-treatment Period|Protocol Violation|0|||
160487355|NCT01917006|579514164|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
160487356|NCT01917006|579514165|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
160487357|NCT01917006|579514166|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
160487358|NCT01917006|579514167|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
160487359|NCT01917006|579514168|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
160487360|NCT01917006|579514169|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
160487361|NCT01917006|579514170|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
160487362|NCT01917006|579514171|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
160487363|NCT01917006|579514164|FG000|Open-label Period|Adverse Event|0|||
160487364|NCT01917006|579514165|FG001|Open-label Period|Adverse Event|0|||
160487365|NCT01917006|579514166|FG002|Open-label Period|Adverse Event|0|||
160487366|NCT01917006|579514167|FG003|Open-label Period|Adverse Event|0|||
160487367|NCT01917006|579514168|FG004|Open-label Period|Adverse Event|0|||
160487368|NCT01917006|579514169|FG005|Open-label Period|Adverse Event|0|||
160487369|NCT01917006|579514170|FG006|Open-label Period|Adverse Event|0|||
160487370|NCT01917006|579514171|FG007|Open-label Period|Adverse Event|1|||
160487371|NCT01917006|579514164|FG000|Open-label Period|Lost to Follow-up|0|||
160487372|NCT01917006|579514165|FG001|Open-label Period|Lost to Follow-up|0|||
160487373|NCT01917006|579514166|FG002|Open-label Period|Lost to Follow-up|0|||
160487374|NCT01917006|579514167|FG003|Open-label Period|Lost to Follow-up|0|||
160487375|NCT01917006|579514168|FG004|Open-label Period|Lost to Follow-up|0|||
160487376|NCT01917006|579514169|FG005|Open-label Period|Lost to Follow-up|0|||
160487377|NCT01917006|579514170|FG006|Open-label Period|Lost to Follow-up|0|||
160487378|NCT01917006|579514171|FG007|Open-label Period|Lost to Follow-up|1|||
160487379|NCT02158247|579514177|FG000|Overall Study|Invisible vocal cords|5|||
160487380|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
160487381|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
160487382|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
160487383|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
160487384|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
160487385|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
160487386|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
160487387|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
160487388|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
160487389|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
160487390|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
160487391|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
160487392|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
160487393|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
160487394|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
160487395|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
160487396|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
160487397|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
160487398|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
160487399|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
160487400|NCT02637856|579514184|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
160487401|NCT02637856|579514185|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
160487402|NCT02637856|579514184|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
160487403|NCT02637856|579514185|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
160487404|NCT02637856|579514184|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
160487405|NCT02637856|579514185|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
160487406|NCT02509312|579514186|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
160487407|NCT02509312|579514187|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
160487408|NCT02509312|579514186|FG000|Overall Study|Obstetrician refusal|0|||
160608485|NCT03375203|579943528|FG003|Overall Study|Protocol Violation|0|||
160608486|NCT03375203|579943529|FG004|Overall Study|Protocol Violation|0|||
160608487|NCT03375203|579943525|FG000|Overall Study|Adverse Event|2|||
160608488|NCT03375203|579943526|FG001|Overall Study|Adverse Event|3|||
160608489|NCT03375203|579943527|FG002|Overall Study|Adverse Event|0|||
160608490|NCT03375203|579943528|FG003|Overall Study|Adverse Event|2|||
160608491|NCT03375203|579943529|FG004|Overall Study|Adverse Event|2|||
160608492|NCT03375203|579943525|FG000|Overall Study|Withdrawal by Subject|3|||
160608493|NCT03375203|579943526|FG001|Overall Study|Withdrawal by Subject|0|||
160608494|NCT03375203|579943527|FG002|Overall Study|Withdrawal by Subject|1|||
160608495|NCT03375203|579943528|FG003|Overall Study|Withdrawal by Subject|0|||
160608496|NCT03375203|579943529|FG004|Overall Study|Withdrawal by Subject|2|||
160608497|NCT03375203|579943525|FG000|Overall Study|Non-compliance with study drug|1|||
160608498|NCT03375203|579943526|FG001|Overall Study|Non-compliance with study drug|0|||
160608499|NCT03375203|579943527|FG002|Overall Study|Non-compliance with study drug|0|||
160608500|NCT03375203|579943528|FG003|Overall Study|Non-compliance with study drug|0|||
160608501|NCT03375203|579943529|FG004|Overall Study|Non-compliance with study drug|0|||
160608502|NCT03375203|579943525|FG000|Overall Study|Randomized, not treated.|0|||
160608503|NCT03375203|579943526|FG001|Overall Study|Randomized, not treated.|1|||
160608504|NCT03375203|579943527|FG002|Overall Study|Randomized, not treated.|0|||
160608505|NCT03375203|579943528|FG003|Overall Study|Randomized, not treated.|0|||
160608506|NCT03375203|579943529|FG004|Overall Study|Randomized, not treated.|0|||
160608507|NCT03107793|579943530|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
160608508|NCT03107793|579943531|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
160608509|NCT03107793|579943532|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
160608510|NCT03107793|579943533|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
160608511|NCT03107793|579943534|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
160608512|NCT03107793|579943530|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
160608513|NCT03107793|579943531|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
160608514|NCT03107793|579943532|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
160608515|NCT03107793|579943533|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
160608516|NCT03107793|579943534|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
160608517|NCT03107793|579943530|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
160608518|NCT03107793|579943531|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
160608519|NCT03107793|579943532|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
160608520|NCT03107793|579943533|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
160608521|NCT03107793|579943534|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
160608522|NCT03107793|579943530|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
160608523|NCT03107793|579943531|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160608524|NCT03107793|579943532|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160608525|NCT03107793|579943533|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160608526|NCT03107793|579943534|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160608527|NCT03107793|579943530|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160608528|NCT03107793|579943531|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
160608529|NCT03107793|579943532|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
160608530|NCT03107793|579943533|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160608531|NCT03107793|579943534|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160608532|NCT03107793|579943530|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
160608533|NCT03107793|579943531|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
160608534|NCT03107793|579943532|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
160608535|NCT03107793|579943533|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
160608536|NCT03107793|579943534|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
160608537|NCT03107793|579943530|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
160608538|NCT03107793|579943531|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
160608539|NCT03107793|579943532|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
160608540|NCT03107793|579943533|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
160608541|NCT03107793|579943534|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
160608542|NCT03107793|579943530|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160608543|NCT03107793|579943531|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
160608544|NCT03107793|579943532|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
160677537|NCT01567527|580198882|FG003|Conversion Phase.|Met withdrawal criteria|0|||
160661268|NCT00723528|580144036|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
160661269|NCT00723528|580144037|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
160661270|NCT00723528|580144038|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
160661271|NCT00723528|580144039|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
160661272|NCT00723528|580144040|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
160661273|NCT00723528|580144041|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
160661274|NCT00723528|580144035|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
160608545|NCT03107793|579943533|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160608546|NCT03107793|579943534|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160608547|NCT03107793|579943530|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
160608548|NCT03107793|579943531|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
160608549|NCT03107793|579943532|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
160608550|NCT03107793|579943533|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
160608551|NCT03107793|579943534|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
160608552|NCT03107793|579943530|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
160608553|NCT03107793|579943531|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
160608554|NCT03107793|579943532|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
160608555|NCT03107793|579943533|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
160608556|NCT03107793|579943534|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
160608557|NCT03107793|579943530|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160608558|NCT03107793|579943531|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
160608559|NCT03107793|579943532|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160608560|NCT03107793|579943533|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160608561|NCT03107793|579943534|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160608562|NCT03107793|579943530|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
160608563|NCT03107793|579943531|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
160608564|NCT03107793|579943532|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
160608565|NCT03107793|579943533|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
160608566|NCT03107793|579943534|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
160608567|NCT03107793|579943530|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
160608568|NCT03107793|579943531|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
160608569|NCT03107793|579943532|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
160608570|NCT03107793|579943533|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
160608571|NCT03107793|579943534|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
160608572|NCT03107793|579943530|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
160608573|NCT03107793|579943531|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
160608574|NCT03107793|579943532|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
160608575|NCT03107793|579943533|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
160608576|NCT03107793|579943534|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
160608577|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
160608578|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
160608579|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
160608580|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
160608581|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
160608582|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
160608583|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
160608584|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
160608585|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
160608586|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
160608587|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
160608588|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
160608589|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
160608590|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
160608591|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
160608592|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Death|0|||
160608593|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Death|0|||
160608594|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Death|0|||
160608595|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Death|0|||
160608596|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Death|1|||
160608597|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
160608598|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
160608599|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
160608600|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
160608601|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
160608602|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
160608603|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
160608604|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
160608605|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
160608606|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
160608607|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
160608608|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
160608609|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
160487409|NCT02509312|579514187|FG001|Overall Study|Obstetrician refusal|1|||
160487410|NCT02509312|579514186|FG000|Overall Study|Patient elected for TOLAC|1|||
160487411|NCT02509312|579514187|FG001|Overall Study|Patient elected for TOLAC|0|||
160487412|NCT02509312|579514186|FG000|Overall Study|Cesarean deemed stat|1|||
160487413|NCT02509312|579514187|FG001|Overall Study|Cesarean deemed stat|0|||
160487414|NCT02509312|579514186|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
160487415|NCT02509312|579514187|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
160487416|NCT00702650|579514188|FG000|Overall Study|Withdrawal by Subject|9|||
160487417|NCT00702650|579514188|FG000|Overall Study|Non-Compliance of Study Drug|3|||
160487418|NCT00702650|579514188|FG000|Overall Study|Lost to Follow-up|2|||
160487419|NCT00702650|579514188|FG000|Overall Study|Non-Compliance with Site Directives|1|||
160487420|NCT00702650|579514188|FG000|Overall Study|Sponsor Request|1|||
160487421|NCT00702650|579514188|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
160487422|NCT00702650|579514188|FG000|Overall Study|Adverse Event|3|||
160487423|NCT00943722|579514190|FG000|Base Study|Adverse Event|0|||
160487424|NCT00943722|579514191|FG001|Base Study|Adverse Event|0|||
160487425|NCT00943722|579514192|FG002|Base Study|Adverse Event|0|||
160487426|NCT00943722|579514193|FG003|Base Study|Adverse Event|1|||
160487427|NCT00943722|579514194|FG004|Base Study|Adverse Event|0|||
160487428|NCT00943722|579514195|FG005|Base Study|Adverse Event|0|||
160487429|NCT00943722|579514196|FG006|Base Study|Adverse Event|0|||
160487430|NCT00943722|579514190|FG000|Base Study|Lost to Follow-up|12|||
160487431|NCT00943722|579514191|FG001|Base Study|Lost to Follow-up|8|||
160487432|NCT00943722|579514192|FG002|Base Study|Lost to Follow-up|10|||
160487433|NCT00943722|579514193|FG003|Base Study|Lost to Follow-up|8|||
160487434|NCT00943722|579514194|FG004|Base Study|Lost to Follow-up|11|||
160487435|NCT00943722|579514195|FG005|Base Study|Lost to Follow-up|0|||
160487436|NCT00943722|579514196|FG006|Base Study|Lost to Follow-up|0|||
160487437|NCT00943722|579514190|FG000|Base Study|Physician Decision|1|||
160487438|NCT00943722|579514191|FG001|Base Study|Physician Decision|0|||
160487439|NCT00943722|579514192|FG002|Base Study|Physician Decision|0|||
160487440|NCT00943722|579514193|FG003|Base Study|Physician Decision|0|||
160487441|NCT00943722|579514194|FG004|Base Study|Physician Decision|1|||
160487442|NCT00943722|579514195|FG005|Base Study|Physician Decision|0|||
160487443|NCT00943722|579514196|FG006|Base Study|Physician Decision|0|||
160487444|NCT00943722|579514190|FG000|Base Study|Pregnancy|0|||
160487445|NCT00943722|579514191|FG001|Base Study|Pregnancy|0|||
160487446|NCT00943722|579514192|FG002|Base Study|Pregnancy|1|||
160487447|NCT00943722|579514193|FG003|Base Study|Pregnancy|0|||
160487448|NCT00943722|579514194|FG004|Base Study|Pregnancy|2|||
160487449|NCT00943722|579514195|FG005|Base Study|Pregnancy|0|||
160487450|NCT00943722|579514196|FG006|Base Study|Pregnancy|0|||
160487451|NCT00943722|579514190|FG000|Base Study|Protocol Violation|0|||
160487452|NCT00943722|579514191|FG001|Base Study|Protocol Violation|1|||
160487453|NCT00943722|579514192|FG002|Base Study|Protocol Violation|0|||
160487454|NCT00943722|579514193|FG003|Base Study|Protocol Violation|0|||
160487455|NCT00943722|579514194|FG004|Base Study|Protocol Violation|2|||
160487456|NCT00943722|579514195|FG005|Base Study|Protocol Violation|0|||
160487457|NCT00943722|579514196|FG006|Base Study|Protocol Violation|0|||
160487458|NCT00943722|579514190|FG000|Base Study|Withdrawal by Subject|12|||
160487459|NCT00943722|579514191|FG001|Base Study|Withdrawal by Subject|13|||
160487460|NCT00943722|579514192|FG002|Base Study|Withdrawal by Subject|2|||
160487461|NCT00943722|579514193|FG003|Base Study|Withdrawal by Subject|13|||
160487462|NCT00943722|579514194|FG004|Base Study|Withdrawal by Subject|8|||
160487463|NCT00943722|579514195|FG005|Base Study|Withdrawal by Subject|0|||
160487464|NCT00943722|579514196|FG006|Base Study|Withdrawal by Subject|0|||
160487465|NCT00943722|579514190|FG000|Base Study|Month 12 visit not completed|0|||
160487466|NCT00943722|579514191|FG001|Base Study|Month 12 visit not completed|0|||
160487467|NCT00943722|579514192|FG002|Base Study|Month 12 visit not completed|0|||
160487468|NCT00943722|579514193|FG003|Base Study|Month 12 visit not completed|0|||
160487469|NCT00943722|579514194|FG004|Base Study|Month 12 visit not completed|2|||
160487470|NCT00943722|579514195|FG005|Base Study|Month 12 visit not completed|0|||
160487471|NCT00943722|579514196|FG006|Base Study|Month 12 visit not completed|0|||
160487472|NCT00943722|579514190|FG000|First Extension Study: EXT 1|Adverse Event|0|||
160487473|NCT00943722|579514191|FG001|First Extension Study: EXT 1|Adverse Event|0|||
160487474|NCT00943722|579514192|FG002|First Extension Study: EXT 1|Adverse Event|0|||
160487475|NCT00943722|579514193|FG003|First Extension Study: EXT 1|Adverse Event|0|||
160487476|NCT00943722|579514194|FG004|First Extension Study: EXT 1|Adverse Event|0|||
160487477|NCT00943722|579514195|FG005|First Extension Study: EXT 1|Adverse Event|1|||
160487478|NCT00943722|579514196|FG006|First Extension Study: EXT 1|Adverse Event|0|||
160487479|NCT00943722|579514190|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
160487480|NCT00943722|579514191|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
160487481|NCT00943722|579514192|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
160487482|NCT00943722|579514193|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
160487483|NCT00943722|579514194|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
160487484|NCT00943722|579514195|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
160487485|NCT00943722|579514196|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
160487486|NCT00943722|579514190|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
160608610|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
160608611|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
160608612|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
160608613|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
160608614|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
160608615|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
160608616|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
160608617|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
160608618|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
160608619|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
160608620|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
160608621|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
160608622|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Other|0|||
160608623|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Other|0|||
160608624|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Other|0|||
160608625|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Other|1|||
160608626|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Other|3|||
160608627|NCT03107793|579943530|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
160608628|NCT03107793|579943531|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
160608629|NCT03107793|579943532|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
160608630|NCT03107793|579943533|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
160608631|NCT03107793|579943534|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
160608632|NCT03277105|579943535|FG000|Overall Study|Death|129|||
160608633|NCT03277105|579943536|FG001|Overall Study|Death|124|||
160608634|NCT03277105|579943535|FG000|Overall Study|Lost to Follow-up|2|||
160608635|NCT03277105|579943536|FG001|Overall Study|Lost to Follow-up|4|||
160608636|NCT03277105|579943535|FG000|Overall Study|Withdrawal by Subject|10|||
160608637|NCT03277105|579943536|FG001|Overall Study|Withdrawal by Subject|10|||
160608638|NCT03277105|579943535|FG000|Overall Study|Other|118|||
160608639|NCT03277105|579943536|FG001|Overall Study|Other|125|||
160608640|NCT05180721|579943540|FG000|Overall Study|Lost to Follow-up|4|||
160608641|NCT02040857|579943544|FG000|Overall Study|Adverse Event|14|||
160608642|NCT02040857|579943544|FG000|Overall Study|Physician Decision|5|||
160608643|NCT02040857|579943544|FG000|Overall Study|Withdrawal by Subject|31|||
160608644|NCT02040857|579943544|FG000|Overall Study|patient non-compliance|3|||
160608645|NCT02040857|579943544|FG000|Overall Study|Lost to Follow-up|2|||
160608646|NCT02040857|579943544|FG000|Overall Study|recurrence|4|||
160608647|NCT02040857|579943544|FG000|Overall Study|ineligible|1|||
160608648|NCT03146403|579943545|FG000|Overall Study|Withdrawal by Subject|0|||
160608649|NCT03146403|579943546|FG001|Overall Study|Withdrawal by Subject|3|||
160608650|NCT03146403|579943545|FG000|Overall Study|Lost to Follow-up|2|||
160608651|NCT03146403|579943546|FG001|Overall Study|Lost to Follow-up|0|||
160608652|NCT01024920|579943547|FG000|Overall Study|Progressive disease|47|||
160608653|NCT01024920|579943548|FG001|Overall Study|Progressive disease|25|||
160608654|NCT01024920|579943547|FG000|Overall Study|Adverse Event|8|||
160608655|NCT01024920|579943548|FG001|Overall Study|Adverse Event|4|||
160608656|NCT01024920|579943547|FG000|Overall Study|Lost to Follow-up|0|||
160608657|NCT01024920|579943548|FG001|Overall Study|Lost to Follow-up|1|||
160608658|NCT01024920|579943547|FG000|Overall Study|Patient refusal to continue|4|||
160608659|NCT01024920|579943548|FG001|Overall Study|Patient refusal to continue|0|||
160608660|NCT01024920|579943547|FG000|Overall Study|Other than listed|5|||
160608661|NCT01024920|579943548|FG001|Overall Study|Other than listed|1|||
160608662|NCT01024920|579943547|FG000|Overall Study|Not treated|3|||
160608663|NCT01024920|579943548|FG001|Overall Study|Not treated|0|||
160608664|NCT01024920|579943547|FG000|Overall Study|Protocol Violation|0|||
160608665|NCT01024920|579943548|FG001|Overall Study|Protocol Violation|1|||
160608666|NCT02182999|579943550|FG000|Overall Study|Adverse Event|4|||
160608667|NCT02182999|579943551|FG001|Overall Study|Adverse Event|3|||
160608668|NCT02182999|579943550|FG000|Overall Study|Physician Decision|1|||
160608669|NCT02182999|579943551|FG001|Overall Study|Physician Decision|0|||
160608670|NCT02736929|579943552|FG000|Main Study|Lost to Follow-up|7|||
160608671|NCT02736929|579943553|FG001|Main Study|Lost to Follow-up|1|||
160608672|NCT02736929|579943554|FG002|Main Study|Lost to Follow-up|0|||
160608673|NCT02736929|579943552|FG000|Main Study|Withdrawal by Subject|1|||
160608674|NCT02736929|579943553|FG001|Main Study|Withdrawal by Subject|1|||
160608675|NCT02736929|579943554|FG002|Main Study|Withdrawal by Subject|0|||
160608676|NCT02736929|579943552|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
160608677|NCT02736929|579943553|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
160487487|NCT00943722|579514191|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
160608678|NCT02736929|579943554|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
160487488|NCT00943722|579514192|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
160608679|NCT02972593|579943555|FG000|Overall Study|Lost to Follow-up|19|||
160487489|NCT00943722|579514193|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
160487490|NCT00943722|579514194|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
160487491|NCT00943722|579514195|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
160487492|NCT00943722|579514196|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
160487493|NCT00943722|579514190|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
160487494|NCT00943722|579514191|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
160487495|NCT00943722|579514192|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
160487496|NCT00943722|579514193|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
160487497|NCT00943722|579514194|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
160487498|NCT00943722|579514195|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
160487499|NCT00943722|579514196|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
160487500|NCT00943722|579514190|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
160487501|NCT00943722|579514191|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
160487502|NCT00943722|579514192|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
160487503|NCT00943722|579514193|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
160487504|NCT00943722|579514194|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
160487505|NCT00943722|579514195|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
160487506|NCT00943722|579514196|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
160487507|NCT00943722|579514190|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
160487508|NCT00943722|579514191|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
160487509|NCT00943722|579514192|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
160487510|NCT00943722|579514193|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
160487511|NCT00943722|579514194|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
160487512|NCT00943722|579514195|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
160487513|NCT00943722|579514196|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
160487514|NCT00943722|579514190|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
160487515|NCT00943722|579514191|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
160487516|NCT00943722|579514192|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
160487517|NCT00943722|579514193|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
160487518|NCT00943722|579514194|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
160487519|NCT00943722|579514195|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
160487520|NCT00943722|579514196|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
160487521|NCT00943722|579514190|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
160487522|NCT00943722|579514191|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
160487523|NCT00943722|579514192|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
160487524|NCT00943722|579514193|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
160487525|NCT00943722|579514194|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
160487526|NCT00943722|579514195|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
160487527|NCT00943722|579514196|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
160487528|NCT00943722|579514190|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
160487529|NCT00943722|579514191|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
160487530|NCT00943722|579514192|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
160487531|NCT00943722|579514193|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
160487532|NCT00943722|579514194|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
160487533|NCT00943722|579514195|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
160487534|NCT00943722|579514196|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
160487535|NCT01772823|579514197|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
160487536|NCT01772823|579514198|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
160487537|NCT01772823|579514197|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
160487538|NCT01772823|579514198|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
160487539|NCT01772823|579514197|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
160487540|NCT01772823|579514198|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
160487541|NCT01772823|579514197|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
160487542|NCT01772823|579514198|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
160487543|NCT01772823|579514197|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
160487544|NCT01772823|579514198|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
160487545|NCT01772823|579514197|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
160487546|NCT01772823|579514198|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
160487547|NCT01772823|579514197|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
160487548|NCT01772823|579514198|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
160487549|NCT01772823|579514197|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
160608680|NCT02972593|579943556|FG001|Overall Study|Lost to Follow-up|15|||
160608681|NCT02972593|579943555|FG000|Overall Study|Protocol Violation|1|||
160608682|NCT02972593|579943556|FG001|Overall Study|Protocol Violation|0|||
160608683|NCT00285649|579943557|FG000|Overall Study|Lost to Follow-up|6|||
160608684|NCT00285649|579943558|FG001|Overall Study|Lost to Follow-up|4|||
160608685|NCT00285649|579943559|FG002|Overall Study|Lost to Follow-up|4|||
160608686|NCT00285649|579943557|FG000|Overall Study|Withdrawal by Subject|3|||
160487550|NCT01772823|579514198|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
160608687|NCT00285649|579943558|FG001|Overall Study|Withdrawal by Subject|2|||
160608688|NCT00285649|579943559|FG002|Overall Study|Withdrawal by Subject|2|||
160608689|NCT01855425|579943564|FG000|Overall Study|Physician Decision|20|||
160608690|NCT02203916|579943572|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
160608691|NCT02203916|579943573|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
160608692|NCT02203916|579943574|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
160608693|NCT02203916|579943572|FG000|Overall Study|Major Protocol Deviation|1|||
160608694|NCT02203916|579943573|FG001|Overall Study|Major Protocol Deviation|1|||
160608695|NCT02203916|579943574|FG002|Overall Study|Major Protocol Deviation|0|||
160608696|NCT02203916|579943572|FG000|Overall Study|Lost to Follow-up|0|||
160608697|NCT02203916|579943573|FG001|Overall Study|Lost to Follow-up|1|||
160608698|NCT02203916|579943574|FG002|Overall Study|Lost to Follow-up|0|||
160608699|NCT02203916|579943572|FG000|Overall Study|Voluntary Withdrawal|3|||
160608700|NCT02203916|579943573|FG001|Overall Study|Voluntary Withdrawal|3|||
160608701|NCT02203916|579943574|FG002|Overall Study|Voluntary Withdrawal|8|||
160608702|NCT02203916|579943572|FG000|Overall Study|Lack of Efficacy|3|||
160608703|NCT02203916|579943573|FG001|Overall Study|Lack of Efficacy|0|||
160608704|NCT02203916|579943574|FG002|Overall Study|Lack of Efficacy|0|||
160608705|NCT02203916|579943572|FG000|Overall Study|Reason Not Specified|0|||
160608706|NCT02203916|579943573|FG001|Overall Study|Reason Not Specified|2|||
160608707|NCT02203916|579943574|FG002|Overall Study|Reason Not Specified|1|||
160608708|NCT02865928|579943575|FG000|Overall Study|Withdrawal by Subject|1|||
160608709|NCT02865928|579943576|FG001|Overall Study|Withdrawal by Subject|0|||
160608710|NCT02865928|579943575|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
160608711|NCT02865928|579943576|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
160608712|NCT02865928|579943575|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
160608713|NCT02865928|579943576|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
160608714|NCT04247828|579943582|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
160608715|NCT03077711|579943583|FG000|Overall Study|Lost to Follow-up|2|||
160608716|NCT03077711|579943584|FG001|Overall Study|Lost to Follow-up|2|||
160608717|NCT03077711|579943583|FG000|Overall Study|noncompliant taking medication|2|||
160608718|NCT03077711|579943584|FG001|Overall Study|noncompliant taking medication|0|||
160608719|NCT01437267|579943587|FG000|Overall Study|Withdrawal by Subject|0|||
160608720|NCT01437267|579943588|FG001|Overall Study|Withdrawal by Subject|0|||
160608721|NCT01437267|579943589|FG002|Overall Study|Withdrawal by Subject|0|||
160608722|NCT01437267|579943590|FG003|Overall Study|Withdrawal by Subject|1|||
160608723|NCT01437267|579943591|FG004|Overall Study|Withdrawal by Subject|0|||
160608724|NCT01437267|579943592|FG005|Overall Study|Withdrawal by Subject|0|||
160608725|NCT01437267|579943587|FG000|Overall Study|Protocol Violation|0|||
160608726|NCT01437267|579943588|FG001|Overall Study|Protocol Violation|1|||
160608727|NCT01437267|579943589|FG002|Overall Study|Protocol Violation|0|||
160608728|NCT01437267|579943590|FG003|Overall Study|Protocol Violation|0|||
160608729|NCT01437267|579943591|FG004|Overall Study|Protocol Violation|0|||
160608730|NCT01437267|579943592|FG005|Overall Study|Protocol Violation|0|||
160608731|NCT03934203|579943593|FG000|Overall Study|Adverse Event|0|||
160608732|NCT03934203|579943594|FG001|Overall Study|Adverse Event|0|||
160608733|NCT03934203|579943595|FG002|Overall Study|Adverse Event|1|||
160608734|NCT03934203|579943596|FG003|Overall Study|Adverse Event|0|||
160608735|NCT03934203|579943597|FG004|Overall Study|Adverse Event|1|||
160608736|NCT03934203|579943598|FG005|Overall Study|Adverse Event|0|||
160608737|NCT03934203|579943599|FG006|Overall Study|Adverse Event|2|||
160608738|NCT03934203|579943600|FG007|Overall Study|Adverse Event|0|||
160608739|NCT03934203|579943601|FG008|Overall Study|Adverse Event|0|||
160608740|NCT03934203|579943602|FG009|Overall Study|Adverse Event|0|||
160608741|NCT03934203|579943603|FG010|Overall Study|Adverse Event|0|||
160608742|NCT03934203|579943604|FG011|Overall Study|Adverse Event|0|||
160608743|NCT03934203|579943605|FG012|Overall Study|Adverse Event|0|||
160608744|NCT03934203|579943606|FG013|Overall Study|Adverse Event|1|||
160608745|NCT03934203|579943607|FG014|Overall Study|Adverse Event|0|||
160608746|NCT00333970|579943608|FG000|Overall Study|Withdrawal by Subject|13|||
160608747|NCT00333970|579943609|FG001|Overall Study|Withdrawal by Subject|7|||
160608748|NCT00441480|579943610|FG000|Overall Study|Protocol Violation|1|||
160661275|NCT00723528|580144036|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
160608749|NCT00441480|579943611|FG001|Overall Study|Protocol Violation|1|||
160608750|NCT00441480|579943610|FG000|Overall Study|Withdrawal by Subject|2|||
160608751|NCT00441480|579943611|FG001|Overall Study|Withdrawal by Subject|3|||
160608752|NCT00899678|579943612|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
160608753|NCT00899678|579943613|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
160608754|NCT00899678|579943614|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
160608755|NCT00899678|579943612|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
160608756|NCT00899678|579943613|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
160608757|NCT00899678|579943614|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
160608758|NCT00899678|579943612|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
160608759|NCT00899678|579943613|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
160487551|NCT01772823|579514197|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
160487552|NCT01772823|579514198|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
160487553|NCT01772823|579514197|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
160487554|NCT01772823|579514198|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
160487555|NCT01772823|579514197|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
160487556|NCT01772823|579514198|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
160487557|NCT01772823|579514197|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
160487558|NCT01772823|579514198|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
160487559|NCT01772823|579514197|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
160487560|NCT01772823|579514198|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
160487561|NCT01772823|579514197|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
160487562|NCT01772823|579514198|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
160487563|NCT01772823|579514197|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
160487564|NCT01772823|579514198|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
160487565|NCT01772823|579514197|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
160487566|NCT01772823|579514198|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
160487567|NCT01004185|579514199|FG000|Overall Study|Adverse Event|1|||
160487568|NCT01004185|579514200|FG001|Overall Study|Adverse Event|1|||
160487569|NCT01004185|579514199|FG000|Overall Study|Lost to Follow-up|0|||
160487570|NCT01004185|579514200|FG001|Overall Study|Lost to Follow-up|1|||
160487571|NCT01004185|579514199|FG000|Overall Study|Lack of Efficacy|2|||
160487572|NCT01004185|579514200|FG001|Overall Study|Lack of Efficacy|1|||
160487573|NCT01004185|579514199|FG000|Overall Study|Sponsor Terminated Study|4|||
160487574|NCT01004185|579514200|FG001|Overall Study|Sponsor Terminated Study|5|||
160487575|NCT01004185|579514199|FG000|Overall Study|Withdrawal by Subject|2|||
160487576|NCT01004185|579514200|FG001|Overall Study|Withdrawal by Subject|1|||
160487577|NCT01388478|579514205|FG000|Overall Study|Adverse Event|4|||
160487578|NCT01388478|579514205|FG000|Overall Study|Withdrawal by Subject|1|||
160487579|NCT01990664|579514206|FG000|Overall Study|Lost to Follow-up|2|||
160487580|NCT01990664|579514207|FG001|Overall Study|Lost to Follow-up|6|||
160487581|NCT01990664|579514206|FG000|Overall Study|Withdrawal by Subject|2|||
160487582|NCT01990664|579514207|FG001|Overall Study|Withdrawal by Subject|3|||
160487583|NCT01990664|579514206|FG000|Overall Study|Protocol Violation|1|||
160487584|NCT01990664|579514207|FG001|Overall Study|Protocol Violation|0|||
160487585|NCT01990664|579514206|FG000|Overall Study|Lens Discomfort|1|||
160487586|NCT01990664|579514207|FG001|Overall Study|Lens Discomfort|1|||
160487587|NCT01990664|579514206|FG000|Overall Study|Lens Handling Difficulties|1|||
160487588|NCT01990664|579514207|FG001|Overall Study|Lens Handling Difficulties|0|||
160487589|NCT01990664|579514206|FG000|Overall Study|Unsatisfactory Visual Response|0|||
160487590|NCT01990664|579514207|FG001|Overall Study|Unsatisfactory Visual Response|1|||
160487591|NCT01037413|579514208|FG000|Part A: Skin Testing|Adverse Event|1|||
160487592|NCT01037413|579514209|FG001|Part A: Skin Testing|Adverse Event|0|||
160487593|NCT01037413|579514208|FG000|Part A: Skin Testing|Protocol Violation|1|||
160487594|NCT01037413|579514209|FG001|Part A: Skin Testing|Protocol Violation|0|||
160487595|NCT01037413|579514208|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
160487596|NCT01037413|579514209|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
160487597|NCT01037413|579514208|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
160487598|NCT01037413|579514209|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
160487599|NCT00619983|579514210|FG000|Test Drug Alone|Withdrawal by Subject|1|||
160487600|NCT00619983|579514211|FG001|Test Drug Alone|Withdrawal by Subject|0|||
160487601|NCT00619983|579514212|FG002|Test Drug Alone|Withdrawal by Subject|0|||
160487602|NCT00619983|579514213|FG003|Test Drug Alone|Withdrawal by Subject|1|||
160487603|NCT00619983|579514210|FG000|Test Drug Alone|Failure of daily diary device|1|||
160487604|NCT00619983|579514211|FG001|Test Drug Alone|Failure of daily diary device|1|||
160487605|NCT00619983|579514212|FG002|Test Drug Alone|Failure of daily diary device|2|||
160487606|NCT00619983|579514213|FG003|Test Drug Alone|Failure of daily diary device|2|||
160487607|NCT02560389|579514219|FG000|Overall Study|Lost to Follow-up|1|||
160487608|NCT02560389|579514220|FG001|Overall Study|Lost to Follow-up|2|||
160487609|NCT02560389|579514221|FG002|Overall Study|Lost to Follow-up|2|||
160487610|NCT02560389|579514219|FG000|Overall Study|Tested positive for illicit substance|0|||
160487611|NCT02560389|579514220|FG001|Overall Study|Tested positive for illicit substance|1|||
160608760|NCT00899678|579943614|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
160608761|NCT00899678|579943612|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
160608762|NCT00899678|579943613|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
160608763|NCT00899678|579943614|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
160608764|NCT00899678|579943612|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
160487612|NCT02560389|579514221|FG002|Overall Study|Tested positive for illicit substance|0|||
160487613|NCT02716298|579514222|FG000|First Intervention (1 Month)|Lens discomfort|1|||
160608765|NCT00899678|579943613|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
160608766|NCT00899678|579943614|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
160608767|NCT00899678|579943612|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
160608768|NCT00899678|579943613|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
160608769|NCT00899678|579943614|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
160608770|NCT00899678|579943612|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
160608771|NCT00899678|579943613|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
160608772|NCT00899678|579943614|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
160608773|NCT00899678|579943612|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
160608774|NCT00899678|579943613|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
160608775|NCT00899678|579943614|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
160608776|NCT00899678|579943612|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
160608777|NCT00899678|579943613|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
160608778|NCT00899678|579943614|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
160608779|NCT02092324|579943615|FG000|Overall Study|Adverse Event|1|||
160608780|NCT02092324|579943615|FG000|Overall Study|Lack of Efficacy|6|||
160608781|NCT02092324|579943615|FG000|Overall Study|Proceed to Transplant|3|||
160608782|NCT02092324|579943615|FG000|Overall Study|Physician Decision|7|||
160608783|NCT02092324|579943615|FG000|Overall Study|Misdiagnosis|2|||
160608784|NCT02710422|579945746|FG000|Overall Study|Termination of study|9|||
160608785|NCT02710422|579945747|FG001|Overall Study|Termination of study|9|||
160608786|NCT01370499|579945748|FG000|Overall Study|Adverse Event|38|||
160608787|NCT01370499|579945749|FG001|Overall Study|Adverse Event|12|||
160608788|NCT01370499|579945748|FG000|Overall Study|Lack of Efficacy|4|||
160608789|NCT01370499|579945749|FG001|Overall Study|Lack of Efficacy|2|||
160608790|NCT01370499|579945748|FG000|Overall Study|Lost to Follow-up|2|||
160608791|NCT01370499|579945749|FG001|Overall Study|Lost to Follow-up|1|||
160608792|NCT01370499|579945748|FG000|Overall Study|Physician Decision|3|||
160608793|NCT01370499|579945749|FG001|Overall Study|Physician Decision|3|||
160608794|NCT01370499|579945748|FG000|Overall Study|Protocol Violation|5|||
160608795|NCT01370499|579945749|FG001|Overall Study|Protocol Violation|4|||
160608796|NCT01370499|579945748|FG000|Overall Study|Withdrawal by Subject|18|||
160608797|NCT01370499|579945749|FG001|Overall Study|Withdrawal by Subject|7|||
160608798|NCT01370499|579945748|FG000|Overall Study|Sponsor Decision|41|||
160608799|NCT01370499|579945749|FG001|Overall Study|Sponsor Decision|15|||
160608800|NCT03558828|579945750|FG000|Overall Study|Lost to Follow-up|4|||
160608801|NCT03558828|579945751|FG001|Overall Study|Lost to Follow-up|3|||
160608802|NCT03558828|579945752|FG002|Overall Study|Lost to Follow-up|3|||
160608803|NCT03558828|579945753|FG003|Overall Study|Lost to Follow-up|5|||
160608804|NCT03558828|579945754|FG004|Overall Study|Lost to Follow-up|2|||
160608805|NCT03558828|579945755|FG005|Overall Study|Lost to Follow-up|3|||
160608806|NCT03558828|579945750|FG000|Overall Study|dropped before the intervention|1|||
160608807|NCT03558828|579945751|FG001|Overall Study|dropped before the intervention|1|||
160608808|NCT03558828|579945752|FG002|Overall Study|dropped before the intervention|0|||
160608809|NCT03558828|579945753|FG003|Overall Study|dropped before the intervention|0|||
160608810|NCT03558828|579945754|FG004|Overall Study|dropped before the intervention|0|||
160608811|NCT03558828|579945755|FG005|Overall Study|dropped before the intervention|0|||
160608812|NCT00976963|579945756|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
160608813|NCT00976963|579945757|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
160608814|NCT00976963|579945756|FG000|Overall Study|administrative error|1|||
160608815|NCT00976963|579945757|FG001|Overall Study|administrative error|0|||
160608816|NCT00976963|579945756|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
160608817|NCT00976963|579945757|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
160608818|NCT00608842|579945758|FG000|Overall Study|Participant's Request|0|||
160608819|NCT00608842|579945759|FG001|Overall Study|Participant's Request|1|||
160608820|NCT00608842|579945760|FG002|Overall Study|Participant's Request|2|||
160608821|NCT00608842|579945761|FG003|Overall Study|Participant's Request|1|||
160608822|NCT00608842|579945758|FG000|Overall Study|Lost to Follow-up|1|||
160608823|NCT00608842|579945759|FG001|Overall Study|Lost to Follow-up|0|||
160608824|NCT00608842|579945760|FG002|Overall Study|Lost to Follow-up|0|||
160608825|NCT00608842|579945761|FG003|Overall Study|Lost to Follow-up|0|||
160608826|NCT03039790|579945762|FG000|Overall Study|Lost to Follow-up|2|||
160608827|NCT03039790|579945763|FG001|Overall Study|Lost to Follow-up|0|||
160608828|NCT03039790|579945764|FG002|Overall Study|Lost to Follow-up|1|||
160608829|NCT03039790|579945765|FG003|Overall Study|Lost to Follow-up|1|||
160608830|NCT03039790|579945766|FG004|Overall Study|Lost to Follow-up|0|||
160608831|NCT03039790|579945767|FG005|Overall Study|Lost to Follow-up|1|||
160608832|NCT03039790|579945768|FG006|Overall Study|Lost to Follow-up|1|||
160608833|NCT03039790|579945769|FG007|Overall Study|Lost to Follow-up|1|||
160608834|NCT03039790|579945770|FG008|Overall Study|Lost to Follow-up|0|||
160608835|NCT03039790|579945771|FG009|Overall Study|Lost to Follow-up|1|||
160608836|NCT03039790|579945772|FG010|Overall Study|Lost to Follow-up|1|||
160608837|NCT03039790|579945773|FG011|Overall Study|Lost to Follow-up|0|||
160608838|NCT03039790|579945774|FG012|Overall Study|Lost to Follow-up|1|||
160608839|NCT03039790|579945775|FG013|Overall Study|Lost to Follow-up|0|||
160608840|NCT03039790|579945776|FG014|Overall Study|Lost to Follow-up|3|||
160608841|NCT03039790|579945777|FG015|Overall Study|Lost to Follow-up|1|||
160608842|NCT03039790|579945778|FG016|Overall Study|Lost to Follow-up|2|||
160487614|NCT02716298|579514223|FG001|First Intervention (1 Month)|Lens discomfort|1|||
160487615|NCT00713206|579514226|FG000|Overall Study|Lost to Follow-up|4|||
160487616|NCT00713206|579514227|FG001|Overall Study|Lost to Follow-up|4|||
160608843|NCT03039790|579945779|FG017|Overall Study|Lost to Follow-up|2|||
160608844|NCT03039790|579945780|FG018|Overall Study|Lost to Follow-up|1|||
160608845|NCT03039790|579945781|FG019|Overall Study|Lost to Follow-up|3|||
160608846|NCT03039790|579945762|FG000|Overall Study|Withdrawal of Consent|1|||
160608847|NCT03039790|579945763|FG001|Overall Study|Withdrawal of Consent|0|||
160608848|NCT03039790|579945764|FG002|Overall Study|Withdrawal of Consent|0|||
160608849|NCT03039790|579945765|FG003|Overall Study|Withdrawal of Consent|1|||
160608850|NCT03039790|579945766|FG004|Overall Study|Withdrawal of Consent|0|||
160608851|NCT03039790|579945767|FG005|Overall Study|Withdrawal of Consent|0|||
160608852|NCT03039790|579945768|FG006|Overall Study|Withdrawal of Consent|0|||
160608853|NCT03039790|579945769|FG007|Overall Study|Withdrawal of Consent|0|||
160608854|NCT03039790|579945770|FG008|Overall Study|Withdrawal of Consent|0|||
160608855|NCT03039790|579945771|FG009|Overall Study|Withdrawal of Consent|1|||
160608856|NCT03039790|579945772|FG010|Overall Study|Withdrawal of Consent|0|||
160608857|NCT03039790|579945773|FG011|Overall Study|Withdrawal of Consent|0|||
160608858|NCT03039790|579945774|FG012|Overall Study|Withdrawal of Consent|2|||
160608859|NCT03039790|579945775|FG013|Overall Study|Withdrawal of Consent|0|||
160608860|NCT03039790|579945776|FG014|Overall Study|Withdrawal of Consent|1|||
160608861|NCT03039790|579945777|FG015|Overall Study|Withdrawal of Consent|5|||
160608862|NCT03039790|579945778|FG016|Overall Study|Withdrawal of Consent|3|||
160608863|NCT03039790|579945779|FG017|Overall Study|Withdrawal of Consent|0|||
160608864|NCT03039790|579945780|FG018|Overall Study|Withdrawal of Consent|2|||
160608865|NCT03039790|579945781|FG019|Overall Study|Withdrawal of Consent|5|||
160608866|NCT03039790|579945762|FG000|Overall Study|Death|0|||
160608867|NCT03039790|579945763|FG001|Overall Study|Death|0|||
160608868|NCT03039790|579945764|FG002|Overall Study|Death|0|||
160608869|NCT03039790|579945765|FG003|Overall Study|Death|0|||
160608870|NCT03039790|579945766|FG004|Overall Study|Death|0|||
160608871|NCT03039790|579945767|FG005|Overall Study|Death|0|||
160608872|NCT03039790|579945768|FG006|Overall Study|Death|0|||
160608873|NCT03039790|579945769|FG007|Overall Study|Death|0|||
160608874|NCT03039790|579945770|FG008|Overall Study|Death|0|||
160608875|NCT03039790|579945771|FG009|Overall Study|Death|0|||
160608876|NCT03039790|579945772|FG010|Overall Study|Death|0|||
160608877|NCT03039790|579945773|FG011|Overall Study|Death|0|||
160608878|NCT03039790|579945774|FG012|Overall Study|Death|0|||
160608879|NCT03039790|579945775|FG013|Overall Study|Death|0|||
160608880|NCT03039790|579945776|FG014|Overall Study|Death|0|||
160608881|NCT03039790|579945777|FG015|Overall Study|Death|1|||
160608882|NCT03039790|579945778|FG016|Overall Study|Death|3|||
160608883|NCT03039790|579945779|FG017|Overall Study|Death|0|||
160608884|NCT03039790|579945780|FG018|Overall Study|Death|2|||
160608885|NCT03039790|579945781|FG019|Overall Study|Death|0|||
160487617|NCT00713206|579514226|FG000|Overall Study|Death|1|||
160487618|NCT00713206|579514227|FG001|Overall Study|Death|0|||
160487619|NCT04081389|579514234|FG000|Overall Study|Withdrawal by Subject|0|||
160487620|NCT04081389|579514235|FG001|Overall Study|Withdrawal by Subject|0|||
160487621|NCT04081389|579514236|FG002|Overall Study|Withdrawal by Subject|1|||
160487622|NCT04081389|579514237|FG003|Overall Study|Withdrawal by Subject|0|||
160487623|NCT01114672|579514238|FG000|Overall Study|Death|0|||
160487624|NCT01114672|579514239|FG001|Overall Study|Death|1|||
160487625|NCT01114672|579514238|FG000|Overall Study|Withdrawal by Subject|2|||
160487626|NCT01114672|579514239|FG001|Overall Study|Withdrawal by Subject|1|||
160487627|NCT01114672|579514238|FG000|Overall Study|Lost to Follow-up|1|||
160487628|NCT01114672|579514239|FG001|Overall Study|Lost to Follow-up|0|||
160487629|NCT01114672|579514238|FG000|Overall Study|transplanted|1|||
160487630|NCT01114672|579514239|FG001|Overall Study|transplanted|0|||
160487631|NCT00827775|579514240|FG000|Overall Study|Withdrawal by Subject|0|||
160487632|NCT00827775|579514241|FG001|Overall Study|Withdrawal by Subject|5|||
160487633|NCT02212301|579514242|FG000|Period 1|Lost to Follow-up|0|||
160487634|NCT02212301|579514243|FG001|Period 1|Lost to Follow-up|1|||
160487635|NCT00866918|579514246|FG000|Overall Study|Death|1|||
160487636|NCT00866918|579514247|FG001|Overall Study|Death|5|||
160608886|NCT03039790|579945762|FG000|Overall Study|Reason, not Specified|1|||
160608887|NCT03039790|579945763|FG001|Overall Study|Reason, not Specified|0|||
160608888|NCT03039790|579945764|FG002|Overall Study|Reason, not Specified|0|||
160608889|NCT03039790|579945765|FG003|Overall Study|Reason, not Specified|0|||
160608890|NCT03039790|579945766|FG004|Overall Study|Reason, not Specified|0|||
160608891|NCT03039790|579945767|FG005|Overall Study|Reason, not Specified|0|||
160608892|NCT03039790|579945768|FG006|Overall Study|Reason, not Specified|0|||
160608893|NCT03039790|579945769|FG007|Overall Study|Reason, not Specified|0|||
160487637|NCT00866918|579514246|FG000|Overall Study|Lack of Efficacy|1|||
160487638|NCT00866918|579514247|FG001|Overall Study|Lack of Efficacy|1|||
160487639|NCT00866918|579514246|FG000|Overall Study|Physician Decision|10|||
160487640|NCT00866918|579514247|FG001|Overall Study|Physician Decision|2|||
160608894|NCT03039790|579945770|FG008|Overall Study|Reason, not Specified|0|||
160608895|NCT03039790|579945771|FG009|Overall Study|Reason, not Specified|0|||
160487641|NCT00866918|579514246|FG000|Overall Study|Ineligible|2|||
160487642|NCT00866918|579514247|FG001|Overall Study|Ineligible|4|||
160487643|NCT00866918|579514246|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
160487644|NCT00866918|579514247|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
160487645|NCT00866918|579514246|FG000|Overall Study|Secondary malignancy|1|||
160487646|NCT00866918|579514247|FG001|Overall Study|Secondary malignancy|0|||
160487647|NCT00527514|579514248|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
160487648|NCT00527514|579514248|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
160487649|NCT00527514|579514248|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
160487650|NCT00527514|579514248|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
160487651|NCT00527514|579514248|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
160487652|NCT00527514|579514248|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
160487653|NCT00527514|579514248|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
160487654|NCT03041701|579514249|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
160487655|NCT03041701|579514250|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
160487656|NCT03041701|579514251|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
160487657|NCT03041701|579514249|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
160487658|NCT03041701|579514250|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
160487659|NCT03041701|579514251|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
160487660|NCT00802438|579514255|FG000|Overall Study|Screen Failure|20|||
160487661|NCT00802438|579514255|FG000|Overall Study|Withdrawal by Subject|7|||
160487662|NCT00802438|579514255|FG000|Overall Study|Physician Decision|1|||
160487663|NCT04016805|579514257|FG000|Overall Study|Sponsor's Discretion|30|||
160487664|NCT04016805|579514258|FG001|Overall Study|Sponsor's Discretion|6|||
160487665|NCT04016805|579514259|FG002|Overall Study|Sponsor's Discretion|5|||
160487666|NCT00740870|579514260|FG000|Overall Study|Not Catheterized|4|||
160487667|NCT00740870|579514260|FG000|Overall Study|Further testing contraindicated implant|17|||
160487668|NCT02132117|579514262|FG000|Overall Study|Adverse Event|6|||
160487669|NCT02132117|579514263|FG001|Overall Study|Adverse Event|1|||
160487670|NCT02132117|579514262|FG000|Overall Study|Lost to Follow-up|2|||
160487671|NCT02132117|579514263|FG001|Overall Study|Lost to Follow-up|2|||
160487672|NCT02132117|579514262|FG000|Overall Study|Personal Reasons|1|||
160487673|NCT02132117|579514263|FG001|Overall Study|Personal Reasons|2|||
160487674|NCT02132117|579514262|FG000|Overall Study|Other Miscellaneous Reasons|2|||
160487675|NCT02132117|579514263|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160487676|NCT03078751|579514264|FG000|Overall Study|Adverse Event|4|||
160487677|NCT03078751|579514265|FG001|Overall Study|Adverse Event|0|||
160487678|NCT03078751|579514264|FG000|Overall Study|Physician Decision|1|||
160487679|NCT03078751|579514265|FG001|Overall Study|Physician Decision|0|||
160487680|NCT03078751|579514264|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
160487681|NCT03078751|579514265|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
160487682|NCT03078751|579514264|FG000|Overall Study|Subject/guardian decision|8|||
160487683|NCT03078751|579514265|FG001|Overall Study|Subject/guardian decision|1|||
160487684|NCT03078751|579514264|FG000|Overall Study|Untreated|0|||
160487685|NCT03078751|579514265|FG001|Overall Study|Untreated|4|||
160487686|NCT04414397|579514266|FG000|Control Period|Withdrawal by Subject|2|||
160487687|NCT04414397|579514267|FG001|Control Period|Withdrawal by Subject|2|||
160487688|NCT04414397|579514266|FG000|Control Period|Lost to Follow-up|0|||
160487689|NCT04414397|579514267|FG001|Control Period|Lost to Follow-up|4|||
160487690|NCT04414397|579514266|FG000|Control Period|Protocol deviation|0|||
160487691|NCT04414397|579514267|FG001|Control Period|Protocol deviation|1|||
160487692|NCT04414397|579514266|FG000|Post-Control Period|Withdrawal by Subject|3|||
160608896|NCT03039790|579945772|FG010|Overall Study|Reason, not Specified|0|||
160608897|NCT03039790|579945773|FG011|Overall Study|Reason, not Specified|0|||
160608898|NCT03039790|579945774|FG012|Overall Study|Reason, not Specified|0|||
160608899|NCT03039790|579945775|FG013|Overall Study|Reason, not Specified|0|||
160608900|NCT03039790|579945776|FG014|Overall Study|Reason, not Specified|0|||
160608901|NCT03039790|579945777|FG015|Overall Study|Reason, not Specified|0|||
160608902|NCT03039790|579945778|FG016|Overall Study|Reason, not Specified|2|||
160608903|NCT03039790|579945779|FG017|Overall Study|Reason, not Specified|0|||
160608904|NCT03039790|579945780|FG018|Overall Study|Reason, not Specified|1|||
160608905|NCT03039790|579945781|FG019|Overall Study|Reason, not Specified|0|||
160608906|NCT01600105|579945787|FG000|Total Participants|Withdrawal by Subject|1|||
160608907|NCT01600105|579945788|FG001|Total Participants|Withdrawal by Subject|0|||
160661276|NCT00723528|580144037|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
160487693|NCT04414397|579514267|FG001|Post-Control Period|Withdrawal by Subject|6|||
160487694|NCT04414397|579514266|FG000|Post-Control Period|Lost to Follow-up|4|||
160487695|NCT04414397|579514267|FG001|Post-Control Period|Lost to Follow-up|9|||
160487696|NCT04414397|579514266|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
160487697|NCT04414397|579514267|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
160487698|NCT04414397|579514266|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
160487699|NCT04414397|579514267|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
160487700|NCT02551692|579514269|FG000|Overall Study|Lost to Follow-up|0|||
160608908|NCT01600105|579945787|FG000|Total Participants|No images in PACS|10|||
160608909|NCT01600105|579945788|FG001|Total Participants|No images in PACS|0|||
160608910|NCT01600105|579945787|FG000|Total Participants|Insufficient image quality|30|||
160608911|NCT01600105|579945788|FG001|Total Participants|Insufficient image quality|10|||
160608912|NCT01600105|579945787|FG000|Sub Study I|Insufficient image quality|0|||
160608913|NCT01600105|579945788|FG001|Sub Study I|Insufficient image quality|10|||
160608914|NCT01600105|579945787|FG000|Sub Study II|Withdrawal by Subject|1|||
160487701|NCT02551692|579514270|FG001|Overall Study|Lost to Follow-up|1|||
160487702|NCT02551692|579514271|FG002|Overall Study|Lost to Follow-up|4|||
160608915|NCT01600105|579945788|FG001|Sub Study II|Withdrawal by Subject|0|||
160608916|NCT01600105|579945787|FG000|Sub Study II|No images in PACS|1|||
160608917|NCT01600105|579945788|FG001|Sub Study II|No images in PACS|0|||
160487703|NCT02551692|579514269|FG000|Overall Study|Withdrawal by Subject|1|||
160608918|NCT01600105|579945787|FG000|Sub Study II|Insufficient image quality|3|||
160608919|NCT01600105|579945788|FG001|Sub Study II|Insufficient image quality|0|||
160608920|NCT01600105|579945787|FG000|Sub Study III|Insufficient image quality|5|||
160608921|NCT01600105|579945788|FG001|Sub Study III|Insufficient image quality|0|||
160608922|NCT01600105|579945787|FG000|Sub Study V|Poor Image Quality|2|||
160608923|NCT01600105|579945788|FG001|Sub Study V|Poor Image Quality|0|||
160608924|NCT01263444|579945789|FG000|Overall Study|Adverse Event|8|||
160608925|NCT01263444|579945789|FG000|Overall Study|Withdrawal by Subject|1|||
160608926|NCT01263444|579945789|FG000|Overall Study|Protocol Violation|1|||
160608927|NCT01764022|579945790|FG000|Overall Study|Death|3|||
160608928|NCT01764022|579945791|FG001|Overall Study|Death|5|||
160608929|NCT01764022|579945790|FG000|Overall Study|Withdrawal by Subject|2|||
160608930|NCT01764022|579945791|FG001|Overall Study|Withdrawal by Subject|6|||
160608931|NCT01764022|579945790|FG000|Overall Study|Lack of Efficacy|0|||
160608932|NCT01764022|579945791|FG001|Overall Study|Lack of Efficacy|1|||
160608933|NCT01764022|579945790|FG000|Overall Study|Physician Decision|0|||
160608934|NCT01764022|579945791|FG001|Overall Study|Physician Decision|2|||
160608935|NCT01764022|579945790|FG000|Overall Study|Lost to Follow-up|2|||
160608936|NCT01764022|579945791|FG001|Overall Study|Lost to Follow-up|0|||
160608937|NCT01764022|579945790|FG000|Overall Study|Protocol Violation|1|||
160608938|NCT01764022|579945791|FG001|Overall Study|Protocol Violation|0|||
160608939|NCT01899768|579945793|FG000|Part A|Adverse Event|2|||
160608940|NCT01899768|579945793|FG000|Part A|Withdrawal by Subject|1|||
160608941|NCT01899768|579945793|FG000|Part B|Adverse Event|1|||
160608942|NCT01899768|579945793|FG000|Part B|Withdrawal by Subject|1|||
160608943|NCT04043416|579945794|FG000|Washout|Change in health condition|0|||
160608944|NCT04043416|579945795|FG001|Washout|Change in health condition|1|||
160608945|NCT00414973|579945796|FG000|Overall Study|Withdrawal by Subject|14|||
160608946|NCT00414973|579945797|FG001|Overall Study|Withdrawal by Subject|4|||
160608947|NCT00414973|579945798|FG002|Overall Study|Withdrawal by Subject|1|||
160608948|NCT00414973|579945799|FG003|Overall Study|Withdrawal by Subject|0|||
160608949|NCT00414973|579945796|FG000|Overall Study|Adverse Event|10|||
160608950|NCT00414973|579945797|FG001|Overall Study|Adverse Event|0|||
160608951|NCT00414973|579945798|FG002|Overall Study|Adverse Event|1|||
160608952|NCT00414973|579945799|FG003|Overall Study|Adverse Event|0|||
160608953|NCT00414973|579945796|FG000|Overall Study|Protocol Violation|3|||
160608954|NCT00414973|579945797|FG001|Overall Study|Protocol Violation|4|||
160608955|NCT00414973|579945798|FG002|Overall Study|Protocol Violation|0|||
160608956|NCT00414973|579945799|FG003|Overall Study|Protocol Violation|0|||
160608957|NCT00414973|579945796|FG000|Overall Study|Lost to Follow-up|0|||
160608958|NCT00414973|579945797|FG001|Overall Study|Lost to Follow-up|2|||
160608959|NCT00414973|579945798|FG002|Overall Study|Lost to Follow-up|0|||
160608960|NCT00414973|579945799|FG003|Overall Study|Lost to Follow-up|0|||
160608961|NCT00414973|579945796|FG000|Overall Study|Sponsor Decision|1|||
160608962|NCT00414973|579945797|FG001|Overall Study|Sponsor Decision|0|||
160608963|NCT00414973|579945798|FG002|Overall Study|Sponsor Decision|0|||
160608964|NCT00414973|579945799|FG003|Overall Study|Sponsor Decision|0|||
160608965|NCT00414973|579945796|FG000|Overall Study|Death|0|||
160608966|NCT00414973|579945797|FG001|Overall Study|Death|0|||
160608967|NCT00414973|579945798|FG002|Overall Study|Death|1|||
160608968|NCT00414973|579945799|FG003|Overall Study|Death|0|||
160608969|NCT01466062|579945800|FG000|Overall Study|Adverse Event|1|||
160608970|NCT01466062|579945800|FG000|Overall Study|Withdrawal by Subject|1|||
160608971|NCT01925014|579945801|FG000|Overall Study|Inappropriate enrollment|4|||
160608972|NCT01925014|579945802|FG001|Overall Study|Inappropriate enrollment|6|||
160608973|NCT01925014|579945801|FG000|Overall Study|Withdrawal by Subject|5|||
160608974|NCT01925014|579945802|FG001|Overall Study|Withdrawal by Subject|13|||
160608975|NCT01196091|579945806|FG000|Overall Study|Adverse Event|22|||
160608976|NCT01196091|579945807|FG001|Overall Study|Adverse Event|27|||
160608977|NCT01196091|579945808|FG002|Overall Study|Adverse Event|26|||
160608978|NCT01196091|579945806|FG000|Overall Study|Death|3|||
160608979|NCT01196091|579945807|FG001|Overall Study|Death|2|||
160608980|NCT01196091|579945808|FG002|Overall Study|Death|2|||
160608981|NCT01196091|579945806|FG000|Overall Study|Entry Criteria Not Met|11|||
160608982|NCT01196091|579945807|FG001|Overall Study|Entry Criteria Not Met|11|||
160608983|NCT01196091|579945808|FG002|Overall Study|Entry Criteria Not Met|10|||
160608984|NCT01196091|579945806|FG000|Overall Study|Lack of Efficacy|15|||
160608985|NCT01196091|579945807|FG001|Overall Study|Lack of Efficacy|12|||
160608986|NCT01196091|579945808|FG002|Overall Study|Lack of Efficacy|17|||
160608987|NCT01196091|579945806|FG000|Overall Study|Lost to Follow-up|5|||
160608988|NCT01196091|579945807|FG001|Overall Study|Lost to Follow-up|5|||
160608989|NCT01196091|579945808|FG002|Overall Study|Lost to Follow-up|6|||
160608990|NCT01196091|579945806|FG000|Overall Study|Parent/Caregiver Decision|0|||
160608991|NCT01196091|579945807|FG001|Overall Study|Parent/Caregiver Decision|0|||
160608992|NCT01196091|579945808|FG002|Overall Study|Parent/Caregiver Decision|1|||
160608993|NCT01196091|579945806|FG000|Overall Study|Withdrawal by Subject|16|||
160608994|NCT01196091|579945807|FG001|Overall Study|Withdrawal by Subject|19|||
160608995|NCT01196091|579945808|FG002|Overall Study|Withdrawal by Subject|22|||
160608996|NCT01196091|579945806|FG000|Overall Study|Physician Decision|3|||
160608997|NCT01196091|579945807|FG001|Overall Study|Physician Decision|3|||
160608998|NCT01196091|579945808|FG002|Overall Study|Physician Decision|4|||
160608999|NCT01196091|579945806|FG000|Overall Study|Protocol Violation|1|||
160609000|NCT01196091|579945807|FG001|Overall Study|Protocol Violation|3|||
160609001|NCT01196091|579945808|FG002|Overall Study|Protocol Violation|3|||
160609002|NCT01196091|579945806|FG000|Overall Study|Sponsor Decision|6|||
160609003|NCT01196091|579945807|FG001|Overall Study|Sponsor Decision|5|||
160609004|NCT01196091|579945808|FG002|Overall Study|Sponsor Decision|4|||
160609005|NCT01196091|579945806|FG000|Overall Study|Excluded Site|5|||
160609006|NCT01196091|579945807|FG001|Overall Study|Excluded Site|11|||
160609007|NCT01196091|579945808|FG002|Overall Study|Excluded Site|8|||
160609008|NCT01196091|579945806|FG000|Overall Study|Randomized, No Study Drug Received|1|||
160609009|NCT01196091|579945807|FG001|Overall Study|Randomized, No Study Drug Received|0|||
160609010|NCT01196091|579945808|FG002|Overall Study|Randomized, No Study Drug Received|1|||
160609011|NCT00471276|579945809|FG000|Overall Study|Death|2|||
160487704|NCT02551692|579514270|FG001|Overall Study|Withdrawal by Subject|0|||
160609012|NCT00471276|579945809|FG000|Overall Study|Adverse Event|16|||
160609013|NCT00471276|579945809|FG000|Overall Study|Protocol Violation|1|||
160609014|NCT00471276|579945809|FG000|Overall Study|Objective progression or relapse|54|||
160487705|NCT02551692|579514271|FG002|Overall Study|Withdrawal by Subject|1|||
160487706|NCT03030599|579514272|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
160487707|NCT03030599|579514273|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
160487708|NCT03030599|579514274|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
160487709|NCT03030599|579514272|FG000|Open Label Treatment and Titration|Other|1|||
160487710|NCT03030599|579514273|FG001|Open Label Treatment and Titration|Other|0|||
160487711|NCT03030599|579514274|FG002|Open Label Treatment and Titration|Other|0|||
160487712|NCT03030599|579514272|FG000|Open Label Treatment and Titration|Physician Decision|3|||
160487713|NCT03030599|579514273|FG001|Open Label Treatment and Titration|Physician Decision|0|||
160487714|NCT03030599|579514274|FG002|Open Label Treatment and Titration|Physician Decision|0|||
160487715|NCT03030599|579514272|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
160487716|NCT03030599|579514273|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
160487717|NCT03030599|579514274|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
160487718|NCT03030599|579514272|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
160487719|NCT03030599|579514273|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
160487720|NCT03030599|579514274|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
160609015|NCT00471276|579945809|FG000|Overall Study|Global deterioration of health status|1|||
160609016|NCT00471276|579945809|FG000|Overall Study|Other|3|||
160609017|NCT00471276|579945809|FG000|Overall Study|Refused treatment|6|||
160609018|NCT01487863|579945813|FG000|Overall Study|Death|19|||
160609019|NCT01487863|579945814|FG001|Overall Study|Death|19|||
160609020|NCT02324049|579945815|FG000|Part C|Study terminated|11|||
160609021|NCT02159365|579945816|FG000|Overall Study|Disease Progression|23|||
160609022|NCT02159365|579945816|FG000|Overall Study|Other reasons|11|||
160609023|NCT02159365|579945816|FG000|Overall Study|Administrative reason by Sponsor|9|||
160609024|NCT02159365|579945816|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
160609025|NCT02159365|579945816|FG000|Overall Study|Study drug toxicity|7|||
160609026|NCT02159365|579945816|FG000|Overall Study|Maximum clinical benefit|3|||
160609027|NCT02159365|579945816|FG000|Overall Study|Subject request to discontinue treatment|3|||
160609028|NCT02159365|579945816|FG000|Overall Study|Subject withdrew consent|3|||
160609029|NCT02159365|579945816|FG000|Overall Study|Death|1|||
160609030|NCT02159365|579945816|FG000|Overall Study|Lost to Follow-up|1|||
160609031|NCT04051944|579945817|FG000|Overall Study|Study ending|1|||
160609032|NCT04051944|579945818|FG001|Overall Study|Study ending|1|||
160609033|NCT04051944|579945817|FG000|Overall Study|Early study termination by participant|1|||
160609034|NCT04051944|579945818|FG001|Overall Study|Early study termination by participant|0|||
160609035|NCT04051944|579945817|FG000|Overall Study|Withdrawal by Subject|2|||
160609036|NCT04051944|579945818|FG001|Overall Study|Withdrawal by Subject|2|||
160609037|NCT04051944|579945817|FG000|Overall Study|Lack of Efficacy|3|||
160609038|NCT04051944|579945818|FG001|Overall Study|Lack of Efficacy|0|||
160609039|NCT04051944|579945817|FG000|Overall Study|Adverse event, non- fatal|1|||
160609040|NCT04051944|579945818|FG001|Overall Study|Adverse event, non- fatal|1|||
160487721|NCT03030599|579514272|FG000|Open Label Treatment and Titration|Adverse Event|18|||
160487722|NCT03030599|579514273|FG001|Open Label Treatment and Titration|Adverse Event|0|||
160487723|NCT03030599|579514274|FG002|Open Label Treatment and Titration|Adverse Event|0|||
160487724|NCT03030599|579514272|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
160487725|NCT03030599|579514273|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
160487726|NCT03030599|579514274|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
160487727|NCT03030599|579514272|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
160487728|NCT03030599|579514273|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
160487729|NCT03030599|579514274|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
160487730|NCT03030599|579514272|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
160487731|NCT03030599|579514273|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
160487732|NCT03030599|579514274|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
160487733|NCT03030599|579514272|FG000|Stable Dose|Protocol deviation|3|||
160487734|NCT03030599|579514273|FG001|Stable Dose|Protocol deviation|0|||
160487735|NCT03030599|579514274|FG002|Stable Dose|Protocol deviation|0|||
160487736|NCT03030599|579514272|FG000|Stable Dose|Adverse Event|1|||
160609041|NCT03083470|579945819|FG000|Overall Study|Lost to Follow-up|0|||
160609042|NCT03083470|579945820|FG001|Overall Study|Lost to Follow-up|0|||
160661277|NCT00723528|580144038|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
160661278|NCT00723528|580144039|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
160609043|NCT03083470|579945821|FG002|Overall Study|Lost to Follow-up|0|||
160661279|NCT00723528|580144040|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
160661280|NCT00723528|580144041|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
160661281|NCT00723528|580144035|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
160487737|NCT03030599|579514273|FG001|Stable Dose|Adverse Event|0|||
160487738|NCT03030599|579514274|FG002|Stable Dose|Adverse Event|0|||
160487739|NCT03030599|579514272|FG000|Stable Dose|Lost to Follow-up|1|||
160609044|NCT03083470|579945822|FG003|Overall Study|Lost to Follow-up|0|||
160609045|NCT03083470|579945823|FG004|Overall Study|Lost to Follow-up|1|||
160609046|NCT03083470|579945819|FG000|Overall Study|Withdrawal by Subject|0|||
160609047|NCT03083470|579945820|FG001|Overall Study|Withdrawal by Subject|0|||
160609048|NCT03083470|579945821|FG002|Overall Study|Withdrawal by Subject|0|||
160609049|NCT03083470|579945822|FG003|Overall Study|Withdrawal by Subject|0|||
160609050|NCT03083470|579945823|FG004|Overall Study|Withdrawal by Subject|1|||
160609051|NCT01512693|579945824|FG000|Overall Study|Withdrawal by Subject|0|||
160609052|NCT01512693|579945825|FG001|Overall Study|Withdrawal by Subject|1|||
160609053|NCT00981747|579945837|FG000|Losartan|Withdrawal by Subject|1|||
160609054|NCT00981747|579945837|FG000|Losartan|Death|1|||
160609055|NCT00981747|579945837|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
160609056|NCT00033371|579945843|FG000|Overall Study|Adverse Event|1|||
160609057|NCT00033371|579945844|FG001|Overall Study|Adverse Event|5|||
160609058|NCT00033371|579945843|FG000|Overall Study|Lost to Follow-up|2|||
160609059|NCT00033371|579945844|FG001|Overall Study|Lost to Follow-up|1|||
160609060|NCT00033371|579945843|FG000|Overall Study|Withdrawal by Subject|3|||
160609061|NCT00033371|579945844|FG001|Overall Study|Withdrawal by Subject|3|||
160609062|NCT00033371|579945843|FG000|Overall Study|Disease Progression|0|||
160609063|NCT00033371|579945844|FG001|Overall Study|Disease Progression|1|||
160609064|NCT02699125|579945845|FG000|Placebo|Lost to Follow-up|2|||
160609065|NCT02699125|579945846|FG001|Placebo|Lost to Follow-up|0|||
160609066|NCT02699125|579945845|FG000|Placebo|Protocol Violation|1|||
160609067|NCT02699125|579945846|FG001|Placebo|Protocol Violation|0|||
160609068|NCT02699125|579945845|FG000|Placebo|Withdrawal by Subject|0|||
160609069|NCT02699125|579945846|FG001|Placebo|Withdrawal by Subject|4|||
160609070|NCT02699125|579945845|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
160609071|NCT02699125|579945846|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
160609072|NCT01390038|579945849|FG000|Overall Study|Death|1|||
160609073|NCT01390038|579945849|FG000|Overall Study|Lost to Follow-up|1|||
160609074|NCT01390038|579945849|FG000|Overall Study|Withdrawal by Subject|4|||
160609075|NCT01390038|579945849|FG000|Overall Study|Simpliciti System Removal|2|||
160609076|NCT03799627|579945854|FG000|Overall Study|Adverse Event|1|||
160609077|NCT03799627|579945855|FG001|Overall Study|Adverse Event|2|||
160609078|NCT03799627|579945856|FG002|Overall Study|Adverse Event|0|||
160609079|NCT03799627|579945857|FG003|Overall Study|Adverse Event|0|||
160609080|NCT03799627|579945858|FG004|Overall Study|Adverse Event|2|||
160609081|NCT03799627|579945859|FG005|Overall Study|Adverse Event|5|||
160609082|NCT03799627|579945860|FG006|Overall Study|Adverse Event|0|||
160609083|NCT03799627|579945861|FG007|Overall Study|Adverse Event|2|||
160609084|NCT03799627|579945862|FG008|Overall Study|Adverse Event|0|||
160609085|NCT03799627|579945854|FG000|Overall Study|Physician Decision|2|||
160609086|NCT03799627|579945855|FG001|Overall Study|Physician Decision|2|||
160609087|NCT03799627|579945856|FG002|Overall Study|Physician Decision|0|||
160609088|NCT03799627|579945857|FG003|Overall Study|Physician Decision|0|||
160609089|NCT03799627|579945858|FG004|Overall Study|Physician Decision|2|||
160609090|NCT03799627|579945859|FG005|Overall Study|Physician Decision|2|||
160609091|NCT03799627|579945860|FG006|Overall Study|Physician Decision|0|||
160609092|NCT03799627|579945861|FG007|Overall Study|Physician Decision|0|||
160609093|NCT03799627|579945862|FG008|Overall Study|Physician Decision|0|||
160609094|NCT03799627|579945854|FG000|Overall Study|Withdrawal by Subject|1|||
160609095|NCT03799627|579945855|FG001|Overall Study|Withdrawal by Subject|1|||
160609096|NCT03799627|579945856|FG002|Overall Study|Withdrawal by Subject|0|||
160609097|NCT03799627|579945857|FG003|Overall Study|Withdrawal by Subject|2|||
160609098|NCT03799627|579945858|FG004|Overall Study|Withdrawal by Subject|0|||
160609099|NCT03799627|579945859|FG005|Overall Study|Withdrawal by Subject|3|||
160609100|NCT03799627|579945860|FG006|Overall Study|Withdrawal by Subject|0|||
160609101|NCT03799627|579945861|FG007|Overall Study|Withdrawal by Subject|0|||
160609102|NCT03799627|579945862|FG008|Overall Study|Withdrawal by Subject|0|||
160609103|NCT03799627|579945854|FG000|Overall Study|Lack of Efficacy|0|||
160609104|NCT03799627|579945855|FG001|Overall Study|Lack of Efficacy|0|||
160609105|NCT03799627|579945856|FG002|Overall Study|Lack of Efficacy|0|||
160661282|NCT00723528|580144036|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
160661283|NCT00723528|580144037|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
160661284|NCT00723528|580144038|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
160661285|NCT00723528|580144039|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
160661286|NCT00723528|580144040|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
160487740|NCT03030599|579514273|FG001|Stable Dose|Lost to Follow-up|0|||
160609106|NCT03799627|579945857|FG003|Overall Study|Lack of Efficacy|1|||
160609107|NCT03799627|579945858|FG004|Overall Study|Lack of Efficacy|0|||
160609108|NCT03799627|579945859|FG005|Overall Study|Lack of Efficacy|0|||
160609109|NCT03799627|579945860|FG006|Overall Study|Lack of Efficacy|0|||
160609110|NCT03799627|579945861|FG007|Overall Study|Lack of Efficacy|0|||
160609111|NCT03799627|579945862|FG008|Overall Study|Lack of Efficacy|0|||
160609112|NCT03799627|579945854|FG000|Overall Study|Lost to Follow-up|0|||
160609113|NCT03799627|579945855|FG001|Overall Study|Lost to Follow-up|0|||
160609114|NCT03799627|579945856|FG002|Overall Study|Lost to Follow-up|0|||
160609115|NCT03799627|579945857|FG003|Overall Study|Lost to Follow-up|0|||
160609116|NCT03799627|579945858|FG004|Overall Study|Lost to Follow-up|0|||
160609117|NCT03799627|579945859|FG005|Overall Study|Lost to Follow-up|0|||
160609118|NCT03799627|579945860|FG006|Overall Study|Lost to Follow-up|1|||
160609119|NCT03799627|579945861|FG007|Overall Study|Lost to Follow-up|0|||
160609120|NCT03799627|579945862|FG008|Overall Study|Lost to Follow-up|1|||
160609121|NCT03799627|579945854|FG000|Overall Study|Death|0|||
160609122|NCT03799627|579945855|FG001|Overall Study|Death|0|||
160609123|NCT03799627|579945856|FG002|Overall Study|Death|0|||
160609124|NCT03799627|579945857|FG003|Overall Study|Death|1|||
160609125|NCT03799627|579945858|FG004|Overall Study|Death|0|||
160609126|NCT03799627|579945859|FG005|Overall Study|Death|0|||
160609127|NCT03799627|579945860|FG006|Overall Study|Death|0|||
160609128|NCT03799627|579945861|FG007|Overall Study|Death|0|||
160609129|NCT03799627|579945862|FG008|Overall Study|Death|0|||
160609130|NCT03799627|579945854|FG000|Overall Study|Study Drug Put on Hold|1|||
160609131|NCT03799627|579945855|FG001|Overall Study|Study Drug Put on Hold|0|||
160609132|NCT03799627|579945856|FG002|Overall Study|Study Drug Put on Hold|0|||
160609133|NCT03799627|579945857|FG003|Overall Study|Study Drug Put on Hold|0|||
160609134|NCT03799627|579945858|FG004|Overall Study|Study Drug Put on Hold|0|||
160609135|NCT03799627|579945859|FG005|Overall Study|Study Drug Put on Hold|0|||
160609136|NCT03799627|579945860|FG006|Overall Study|Study Drug Put on Hold|0|||
160609137|NCT03799627|579945861|FG007|Overall Study|Study Drug Put on Hold|0|||
160609138|NCT03799627|579945862|FG008|Overall Study|Study Drug Put on Hold|0|||
160609139|NCT03799627|579945854|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
160609140|NCT03799627|579945855|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
160609141|NCT03799627|579945856|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
160609142|NCT03799627|579945857|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
160609143|NCT03799627|579945858|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
160609144|NCT03799627|579945859|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
160609145|NCT03799627|579945860|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
160609146|NCT03799627|579945861|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
160609147|NCT03799627|579945862|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
160609148|NCT03799627|579945854|FG000|Overall Study|Kidney Transplantation|1|||
160609149|NCT03799627|579945855|FG001|Overall Study|Kidney Transplantation|0|||
160609150|NCT03799627|579945856|FG002|Overall Study|Kidney Transplantation|0|||
160609151|NCT03799627|579945857|FG003|Overall Study|Kidney Transplantation|1|||
160609152|NCT03799627|579945858|FG004|Overall Study|Kidney Transplantation|1|||
160609153|NCT03799627|579945859|FG005|Overall Study|Kidney Transplantation|0|||
160609154|NCT03799627|579945860|FG006|Overall Study|Kidney Transplantation|0|||
160609155|NCT03799627|579945861|FG007|Overall Study|Kidney Transplantation|0|||
160609156|NCT03799627|579945862|FG008|Overall Study|Kidney Transplantation|0|||
160609157|NCT03799627|579945854|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
160609158|NCT03799627|579945855|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
160609159|NCT03799627|579945856|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
160609160|NCT03799627|579945857|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
160609161|NCT03799627|579945858|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
160609162|NCT03799627|579945859|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
160609163|NCT03799627|579945860|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
160609164|NCT03799627|579945861|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
160609165|NCT03799627|579945862|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
160609166|NCT03799627|579945854|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
160609167|NCT03799627|579945855|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
160609168|NCT03799627|579945856|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
160609169|NCT03799627|579945857|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
160609170|NCT03799627|579945858|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
160609171|NCT03799627|579945859|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
160609172|NCT03799627|579945860|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
160609173|NCT03799627|579945861|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
160609174|NCT03799627|579945862|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
160609175|NCT03799627|579945854|FG000|Overall Study|Met Exclusion Criteria|0|||
160609176|NCT03799627|579945855|FG001|Overall Study|Met Exclusion Criteria|0|||
160609177|NCT03799627|579945856|FG002|Overall Study|Met Exclusion Criteria|0|||
160609178|NCT03799627|579945857|FG003|Overall Study|Met Exclusion Criteria|1|||
160609179|NCT03799627|579945858|FG004|Overall Study|Met Exclusion Criteria|0|||
160609180|NCT03799627|579945859|FG005|Overall Study|Met Exclusion Criteria|0|||
160661287|NCT00723528|580144041|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
160661288|NCT00723528|580144035|FG000|Period 2: After Controlled Period|Other|0|||
160609181|NCT03799627|579945860|FG006|Overall Study|Met Exclusion Criteria|0|||
160609182|NCT03799627|579945861|FG007|Overall Study|Met Exclusion Criteria|0|||
160609183|NCT03799627|579945862|FG008|Overall Study|Met Exclusion Criteria|0|||
160609184|NCT03799627|579945854|FG000|Overall Study|Investigational Product Noncompliance|0|||
160609185|NCT03799627|579945855|FG001|Overall Study|Investigational Product Noncompliance|0|||
160609186|NCT03799627|579945856|FG002|Overall Study|Investigational Product Noncompliance|0|||
160609187|NCT03799627|579945857|FG003|Overall Study|Investigational Product Noncompliance|1|||
160609188|NCT03799627|579945858|FG004|Overall Study|Investigational Product Noncompliance|0|||
160609189|NCT03799627|579945859|FG005|Overall Study|Investigational Product Noncompliance|0|||
160609190|NCT03799627|579945860|FG006|Overall Study|Investigational Product Noncompliance|0|||
160609191|NCT03799627|579945861|FG007|Overall Study|Investigational Product Noncompliance|0|||
160609192|NCT03799627|579945862|FG008|Overall Study|Investigational Product Noncompliance|0|||
160609193|NCT03799627|579945854|FG000|Overall Study|Participant Relocation|0|||
160609194|NCT03799627|579945855|FG001|Overall Study|Participant Relocation|0|||
160609195|NCT03799627|579945856|FG002|Overall Study|Participant Relocation|0|||
160609196|NCT03799627|579945857|FG003|Overall Study|Participant Relocation|1|||
160609197|NCT03799627|579945858|FG004|Overall Study|Participant Relocation|0|||
160609198|NCT03799627|579945859|FG005|Overall Study|Participant Relocation|1|||
160609199|NCT03799627|579945860|FG006|Overall Study|Participant Relocation|0|||
160609200|NCT03799627|579945861|FG007|Overall Study|Participant Relocation|0|||
160609201|NCT03799627|579945862|FG008|Overall Study|Participant Relocation|0|||
160609202|NCT03799627|579945854|FG000|Overall Study|Eurofin Issue|0|||
160609203|NCT03799627|579945855|FG001|Overall Study|Eurofin Issue|0|||
160609204|NCT03799627|579945856|FG002|Overall Study|Eurofin Issue|0|||
160609205|NCT03799627|579945857|FG003|Overall Study|Eurofin Issue|0|||
160609206|NCT03799627|579945858|FG004|Overall Study|Eurofin Issue|1|||
160609207|NCT03799627|579945859|FG005|Overall Study|Eurofin Issue|0|||
160609208|NCT03799627|579945860|FG006|Overall Study|Eurofin Issue|0|||
160609209|NCT03799627|579945861|FG007|Overall Study|Eurofin Issue|0|||
160609210|NCT03799627|579945862|FG008|Overall Study|Eurofin Issue|0|||
160609211|NCT03799627|579945854|FG000|Overall Study|Noncompliance with Site Instructions|0|||
160609212|NCT03799627|579945855|FG001|Overall Study|Noncompliance with Site Instructions|0|||
160609213|NCT03799627|579945856|FG002|Overall Study|Noncompliance with Site Instructions|0|||
160609214|NCT03799627|579945857|FG003|Overall Study|Noncompliance with Site Instructions|0|||
160609215|NCT03799627|579945858|FG004|Overall Study|Noncompliance with Site Instructions|1|||
160609216|NCT03799627|579945859|FG005|Overall Study|Noncompliance with Site Instructions|0|||
160609217|NCT03799627|579945860|FG006|Overall Study|Noncompliance with Site Instructions|0|||
160609218|NCT03799627|579945861|FG007|Overall Study|Noncompliance with Site Instructions|0|||
160609219|NCT03799627|579945862|FG008|Overall Study|Noncompliance with Site Instructions|0|||
160609220|NCT03799627|579945854|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
160609221|NCT03799627|579945855|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
160609222|NCT03799627|579945856|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
160609223|NCT03799627|579945857|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
160609224|NCT03799627|579945858|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
160487741|NCT03030599|579514274|FG002|Stable Dose|Lost to Follow-up|0|||
160487742|NCT03030599|579514272|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
160487743|NCT03030599|579514273|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
160487744|NCT03030599|579514274|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
160487745|NCT03030599|579514272|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
160487746|NCT03030599|579514273|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
160487747|NCT03030599|579514274|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
160487748|NCT03030599|579514272|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
160487749|NCT03030599|579514273|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
160487750|NCT03030599|579514274|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
160487751|NCT03030599|579514272|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
160487752|NCT03030599|579514273|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
160487753|NCT03030599|579514274|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
160487754|NCT03030599|579514272|FG000|Open-label Extension|Adverse Event|3|||
160487755|NCT03030599|579514273|FG001|Open-label Extension|Adverse Event|0|||
160487756|NCT03030599|579514274|FG002|Open-label Extension|Adverse Event|0|||
160487757|NCT03030599|579514272|FG000|Open-label Extension|Lost to Follow-up|2|||
160487758|NCT03030599|579514273|FG001|Open-label Extension|Lost to Follow-up|0|||
160487759|NCT03030599|579514274|FG002|Open-label Extension|Lost to Follow-up|0|||
160487760|NCT03030599|579514272|FG000|Open-label Extension|Lack of Efficacy|1|||
160487761|NCT03030599|579514273|FG001|Open-label Extension|Lack of Efficacy|0|||
160487762|NCT03030599|579514274|FG002|Open-label Extension|Lack of Efficacy|0|||
160487763|NCT03030599|579514272|FG000|Open-label Extension|Other Reason|1|||
160487764|NCT03030599|579514273|FG001|Open-label Extension|Other Reason|0|||
160487765|NCT03030599|579514274|FG002|Open-label Extension|Other Reason|0|||
160609225|NCT03799627|579945859|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
160609226|NCT03799627|579945860|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
160487766|NCT01064856|579514275|FG000|Double-blind (DB) Period|Adverse Event|1|||
160487767|NCT01064856|579514276|FG001|Double-blind (DB) Period|Adverse Event|0|||
160487768|NCT01064856|579514277|FG002|Double-blind (DB) Period|Adverse Event|0|||
160487769|NCT01064856|579514278|FG003|Double-blind (DB) Period|Adverse Event|0|||
160609227|NCT03799627|579945861|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
160609228|NCT03799627|579945862|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
160609229|NCT03799627|579945854|FG000|Overall Study|Changes In Hemoglobin Values|1|||
160487770|NCT01064856|579514275|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
160609230|NCT03799627|579945855|FG001|Overall Study|Changes In Hemoglobin Values|2|||
160609231|NCT03799627|579945856|FG002|Overall Study|Changes In Hemoglobin Values|1|||
160609232|NCT03799627|579945857|FG003|Overall Study|Changes In Hemoglobin Values|0|||
160609233|NCT03799627|579945858|FG004|Overall Study|Changes In Hemoglobin Values|0|||
160609234|NCT03799627|579945859|FG005|Overall Study|Changes In Hemoglobin Values|2|||
160609235|NCT03799627|579945860|FG006|Overall Study|Changes In Hemoglobin Values|1|||
160609236|NCT03799627|579945861|FG007|Overall Study|Changes In Hemoglobin Values|0|||
160609237|NCT03799627|579945862|FG008|Overall Study|Changes In Hemoglobin Values|1|||
160609238|NCT00398138|579945867|FG000|Overall Study|Adverse Event|2|||
160609239|NCT03418376|579945873|FG000|Overall Study|Musculoskeletal injury|1|||
160609240|NCT03418376|579945874|FG001|Overall Study|Musculoskeletal injury|2|||
160609241|NCT03418376|579945875|FG002|Overall Study|Musculoskeletal injury|1|||
160609242|NCT03418376|579945876|FG003|Overall Study|Musculoskeletal injury|0|||
160609243|NCT03418376|579945873|FG000|Overall Study|Personal reasons|0|||
160609244|NCT03418376|579945874|FG001|Overall Study|Personal reasons|2|||
160609245|NCT03418376|579945875|FG002|Overall Study|Personal reasons|2|||
160609246|NCT03418376|579945876|FG003|Overall Study|Personal reasons|1|||
160609247|NCT03418376|579945873|FG000|Overall Study|Exacerbation|0|||
160609248|NCT03418376|579945874|FG001|Overall Study|Exacerbation|1|||
160609249|NCT03418376|579945875|FG002|Overall Study|Exacerbation|0|||
160609250|NCT03418376|579945876|FG003|Overall Study|Exacerbation|0|||
160609251|NCT00814307|579945877|FG000|Overall Study|Randomized but not treated|1|||
160609252|NCT00814307|579945878|FG001|Overall Study|Randomized but not treated|0|||
160609253|NCT00814307|579945879|FG002|Overall Study|Randomized but not treated|0|||
160609254|NCT00814307|579945880|FG003|Overall Study|Randomized but not treated|0|||
160609255|NCT00814307|579945877|FG000|Overall Study|Adverse Event|3|||
160609256|NCT00814307|579945878|FG001|Overall Study|Adverse Event|9|||
160609257|NCT00814307|579945879|FG002|Overall Study|Adverse Event|3|||
160609258|NCT00814307|579945880|FG003|Overall Study|Adverse Event|2|||
160609259|NCT00814307|579945877|FG000|Overall Study|Lack of Efficacy|1|||
160609260|NCT00814307|579945878|FG001|Overall Study|Lack of Efficacy|1|||
160609261|NCT00814307|579945879|FG002|Overall Study|Lack of Efficacy|3|||
160609262|NCT00814307|579945880|FG003|Overall Study|Lack of Efficacy|4|||
160609263|NCT00814307|579945877|FG000|Overall Study|Other|1|||
160609264|NCT00814307|579945878|FG001|Overall Study|Other|2|||
160609265|NCT00814307|579945879|FG002|Overall Study|Other|0|||
160609266|NCT00814307|579945880|FG003|Overall Study|Other|1|||
160609267|NCT00814307|579945877|FG000|Overall Study|Protocol Violation|2|||
160609268|NCT00814307|579945878|FG001|Overall Study|Protocol Violation|8|||
160609269|NCT00814307|579945879|FG002|Overall Study|Protocol Violation|1|||
160609270|NCT00814307|579945880|FG003|Overall Study|Protocol Violation|1|||
160609271|NCT00814307|579945877|FG000|Overall Study|Withdrawal by Subject|4|||
160609272|NCT00814307|579945878|FG001|Overall Study|Withdrawal by Subject|6|||
160609273|NCT00814307|579945879|FG002|Overall Study|Withdrawal by Subject|0|||
160609274|NCT00814307|579945880|FG003|Overall Study|Withdrawal by Subject|2|||
160609275|NCT00814307|579945877|FG000|Overall Study|Death|0|||
160609276|NCT00814307|579945878|FG001|Overall Study|Death|1|||
160609277|NCT00814307|579945879|FG002|Overall Study|Death|0|||
160609278|NCT00814307|579945880|FG003|Overall Study|Death|0|||
160609279|NCT00149890|579945884|FG000|Overall Study|Adverse Event|1|||
160609280|NCT00149890|579945885|FG001|Overall Study|Adverse Event|8|||
160609281|NCT00149890|579945884|FG000|Overall Study|Lack of Efficacy|8|||
160609282|NCT00149890|579945885|FG001|Overall Study|Lack of Efficacy|9|||
160609283|NCT00149890|579945884|FG000|Overall Study|Protocol Violation|1|||
160609284|NCT00149890|579945885|FG001|Overall Study|Protocol Violation|0|||
160609285|NCT00149890|579945884|FG000|Overall Study|Lost to Follow-up|1|||
160609286|NCT00149890|579945885|FG001|Overall Study|Lost to Follow-up|0|||
160609287|NCT00149890|579945884|FG000|Overall Study|Graft Loss|2|||
160609288|NCT00149890|579945885|FG001|Overall Study|Graft Loss|1|||
160609289|NCT04757376|579945886|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
160609290|NCT04757376|579945887|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
160609291|NCT04757376|579945888|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
160487771|NCT01064856|579514276|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
160487772|NCT01064856|579514277|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
160487773|NCT01064856|579514278|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
160487774|NCT01064856|579514275|FG000|Open-label (OL) Period|Adverse Event|0|||
160609292|NCT04757376|579945889|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
160609293|NCT04757376|579945890|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
160609294|NCT04757376|579945886|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
160609295|NCT04757376|579945887|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
160609296|NCT04757376|579945888|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
160609297|NCT04757376|579945889|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
160609298|NCT04757376|579945890|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
160609299|NCT04757376|579945886|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
160487775|NCT01064856|579514276|FG001|Open-label (OL) Period|Adverse Event|0|||
160487776|NCT01064856|579514277|FG002|Open-label (OL) Period|Adverse Event|12|||
160487777|NCT01064856|579514278|FG003|Open-label (OL) Period|Adverse Event|6|||
160487778|NCT01064856|579514275|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
160487779|NCT01064856|579514276|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
160487780|NCT01064856|579514277|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
160487781|NCT01064856|579514278|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
160609300|NCT04757376|579945887|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
160609301|NCT04757376|579945888|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
160609302|NCT04757376|579945889|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
160609303|NCT04757376|579945890|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
160609304|NCT04757376|579945886|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
160609305|NCT04757376|579945887|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
160609306|NCT04757376|579945888|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
160609307|NCT04757376|579945889|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
160609308|NCT04757376|579945890|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
160609309|NCT04757376|579945886|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
160609310|NCT04757376|579945887|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
160609311|NCT04757376|579945888|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
160609312|NCT04757376|579945889|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
160609313|NCT04757376|579945890|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
160609314|NCT04757376|579945886|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
160609315|NCT04757376|579945887|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
160609316|NCT04757376|579945888|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
160609317|NCT04757376|579945889|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
160609318|NCT04757376|579945890|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
160609319|NCT04757376|579945886|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
160609320|NCT04757376|579945887|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
160609321|NCT04757376|579945888|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
160609322|NCT04757376|579945889|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
160609323|NCT04757376|579945890|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
160609324|NCT04757376|579945886|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
160609325|NCT04757376|579945887|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
160632867|NCT01393626|580036094|FG000|Overall Study|Did not meet entrance criteria|1|||
160632868|NCT01393626|580036095|FG001|Overall Study|Did not meet entrance criteria|0|||
160632869|NCT01393626|580036096|FG002|Overall Study|Did not meet entrance criteria|0|||
160632870|NCT01393626|580036097|FG003|Overall Study|Did not meet entrance criteria|0|||
160632871|NCT01393626|580036094|FG000|Overall Study|Lack of Efficacy|6|||
160632872|NCT01393626|580036095|FG001|Overall Study|Lack of Efficacy|6|||
160632873|NCT01393626|580036096|FG002|Overall Study|Lack of Efficacy|4|||
160632874|NCT01393626|580036097|FG003|Overall Study|Lack of Efficacy|1|||
160632875|NCT01393626|580036094|FG000|Overall Study|Lost to Follow-up|1|||
160632876|NCT01393626|580036095|FG001|Overall Study|Lost to Follow-up|1|||
160632877|NCT01393626|580036096|FG002|Overall Study|Lost to Follow-up|1|||
160632878|NCT01393626|580036097|FG003|Overall Study|Lost to Follow-up|0|||
160632879|NCT01393626|580036094|FG000|Overall Study|Withdrawal by Subject|6|||
160632880|NCT01393626|580036095|FG001|Overall Study|Withdrawal by Subject|4|||
160632881|NCT01393626|580036096|FG002|Overall Study|Withdrawal by Subject|0|||
160632882|NCT01393626|580036097|FG003|Overall Study|Withdrawal by Subject|0|||
160632883|NCT01393626|580036094|FG000|Overall Study|Other|1|||
160632884|NCT01393626|580036095|FG001|Overall Study|Other|0|||
160632885|NCT01393626|580036096|FG002|Overall Study|Other|0|||
160632886|NCT01393626|580036097|FG003|Overall Study|Other|0|||
160632887|NCT01393626|580036094|FG000|Overall Study|Protocol Violation|1|||
160632888|NCT01393626|580036095|FG001|Overall Study|Protocol Violation|0|||
160632889|NCT01393626|580036096|FG002|Overall Study|Protocol Violation|2|||
160632890|NCT01393626|580036097|FG003|Overall Study|Protocol Violation|0|||
160632891|NCT02426125|580036098|FG000|Overall Study|Lost to Follow-up|14|||
160632892|NCT02426125|580036099|FG001|Overall Study|Lost to Follow-up|12|||
160632893|NCT02426125|580036098|FG000|Overall Study|Withdrawal by Subject|13|||
160632894|NCT02426125|580036099|FG001|Overall Study|Withdrawal by Subject|14|||
160632895|NCT02426125|580036098|FG000|Overall Study|Death|185|||
160632896|NCT02426125|580036099|FG001|Overall Study|Death|200|||
160632897|NCT02426125|580036098|FG000|Overall Study|Randomized, But Never Treated|5|||
160632898|NCT02426125|580036099|FG001|Overall Study|Randomized, But Never Treated|2|||
160632899|NCT02858076|580036100|FG000|Overall Study|Death|6|||
160632900|NCT02858076|580036101|FG001|Overall Study|Death|3|||
160609326|NCT04757376|579945888|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
160609327|NCT04757376|579945889|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
160609328|NCT04757376|579945890|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
160609329|NCT01307046|579945891|FG000|Overall Study|Adverse Event|3|||
160609330|NCT01307046|579945892|FG001|Overall Study|Adverse Event|3|||
160609331|NCT01307046|579945891|FG000|Overall Study|Lack of Efficacy|0|||
160609332|NCT01307046|579945892|FG001|Overall Study|Lack of Efficacy|2|||
160609333|NCT01307046|579945891|FG000|Overall Study|Physician Decision|2|||
160609334|NCT01307046|579945892|FG001|Overall Study|Physician Decision|0|||
160609335|NCT01307046|579945891|FG000|Overall Study|Withdrawal by Subject|1|||
160609336|NCT01307046|579945892|FG001|Overall Study|Withdrawal by Subject|1|||
160609337|NCT01307046|579945891|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
160609338|NCT01307046|579945892|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
160609339|NCT01307046|579945891|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
160609340|NCT01307046|579945892|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
160609341|NCT03898323|579945893|FG000|Overall Study|Physician Decision|1|||
160609342|NCT02569398|579945896|FG000|Overall Study|Adverse Event|0|||
160609343|NCT02569398|579945897|FG001|Overall Study|Adverse Event|1|||
160609344|NCT02569398|579945898|FG002|Overall Study|Adverse Event|6|||
160609345|NCT02569398|579945896|FG000|Overall Study|Withdrawal by Subject|43|||
160609346|NCT02569398|579945897|FG001|Overall Study|Withdrawal by Subject|43|||
160609347|NCT02569398|579945898|FG002|Overall Study|Withdrawal by Subject|30|||
160609348|NCT02569398|579945896|FG000|Overall Study|Study terminated by sponsor|130|||
160609349|NCT02569398|579945897|FG001|Overall Study|Study terminated by sponsor|131|||
160609350|NCT02569398|579945898|FG002|Overall Study|Study terminated by sponsor|134|||
160609351|NCT02569398|579945896|FG000|Overall Study|Other|12|||
160609352|NCT02569398|579945897|FG001|Overall Study|Other|14|||
160609353|NCT02569398|579945898|FG002|Overall Study|Other|13|||
160609354|NCT04195750|579945901|FG000|Overall Study|Death|245|||
160609355|NCT04195750|579945902|FG001|Overall Study|Death|253|||
160609356|NCT04195750|579945903|FG002|Overall Study|Death|5|||
160609357|NCT04195750|579945901|FG000|Overall Study|Physician Decision|0|||
160609358|NCT04195750|579945902|FG001|Overall Study|Physician Decision|1|||
160609359|NCT04195750|579945903|FG002|Overall Study|Physician Decision|0|||
160609360|NCT04195750|579945901|FG000|Overall Study|Withdrawal by Subject|9|||
160609361|NCT04195750|579945902|FG001|Overall Study|Withdrawal by Subject|8|||
160609362|NCT04195750|579945903|FG002|Overall Study|Withdrawal by Subject|0|||
160609363|NCT04195750|579945901|FG000|Overall Study|Ongoing|120|||
160609364|NCT04195750|579945902|FG001|Overall Study|Ongoing|110|||
160609365|NCT04195750|579945903|FG002|Overall Study|Ongoing|4|||
160609366|NCT02406027|579945904|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
160609367|NCT02406027|579945905|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
160609368|NCT02406027|579945906|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
160609369|NCT02406027|579945907|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
160609370|NCT02406027|579945908|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
160609371|NCT02406027|579945909|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
160609372|NCT02406027|579945910|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
160609373|NCT02406027|579945904|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
160609374|NCT02406027|579945905|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
160609375|NCT02406027|579945906|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
160609376|NCT02406027|579945907|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
160609377|NCT02406027|579945908|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
160609378|NCT02406027|579945909|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
160609379|NCT02406027|579945910|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
160609380|NCT02406027|579945904|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
160609381|NCT02406027|579945905|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
160609382|NCT02406027|579945906|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
160609383|NCT02406027|579945907|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
160609384|NCT02406027|579945908|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
160609385|NCT02406027|579945909|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
160609386|NCT02406027|579945910|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
160609387|NCT02406027|579945904|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
160609388|NCT02406027|579945905|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
160609389|NCT02406027|579945906|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
160609390|NCT02406027|579945907|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
160609391|NCT02406027|579945908|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
160609392|NCT02406027|579945909|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
160609393|NCT02406027|579945910|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
160609394|NCT02406027|579945904|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
160609395|NCT02406027|579945905|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
160609396|NCT02406027|579945906|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
160609397|NCT02406027|579945907|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
160609398|NCT02406027|579945908|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
160609399|NCT02406027|579945909|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
160487782|NCT01064856|579514275|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
160487783|NCT01064856|579514276|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
160609400|NCT02406027|579945910|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
160609401|NCT02406027|579945904|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
160609402|NCT02406027|579945905|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
160609403|NCT02406027|579945906|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
160609404|NCT02406027|579945907|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
160609405|NCT02406027|579945908|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
160609406|NCT02406027|579945909|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
160609407|NCT02406027|579945910|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
160609408|NCT02406027|579945904|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
160609409|NCT02406027|579945905|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
160609410|NCT02406027|579945906|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
160609411|NCT02406027|579945907|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
160609412|NCT02406027|579945908|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
160609413|NCT02406027|579945909|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
160609414|NCT02406027|579945910|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
160609415|NCT02406027|579945904|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
160609416|NCT02406027|579945905|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
160609417|NCT02406027|579945906|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
160609418|NCT02406027|579945907|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
160609419|NCT02406027|579945908|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
160609420|NCT02406027|579945909|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
160609421|NCT02406027|579945910|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
160609422|NCT02406027|579945904|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
160609423|NCT02406027|579945905|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
160609424|NCT02406027|579945906|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
160609425|NCT02406027|579945907|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
160609426|NCT02406027|579945908|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
160609427|NCT02406027|579945909|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
160609428|NCT02406027|579945910|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
160609429|NCT02406027|579945904|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
160609430|NCT02406027|579945905|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
160609431|NCT02406027|579945906|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
160609432|NCT02406027|579945907|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
160609433|NCT02406027|579945908|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
160609434|NCT02406027|579945909|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
160609435|NCT02406027|579945910|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
160609436|NCT03039192|579945911|FG000|Overall Study|Lost to Follow-up|4|||
160609437|NCT03039192|579945912|FG001|Overall Study|Lost to Follow-up|4|||
160609438|NCT03039192|579945911|FG000|Overall Study|Adverse event, serious fatal|0|||
160609439|NCT03039192|579945912|FG001|Overall Study|Adverse event, serious fatal|1|||
160609440|NCT03039192|579945911|FG000|Overall Study|Adverse event, non-fatal|0|||
160609441|NCT03039192|579945912|FG001|Overall Study|Adverse event, non-fatal|2|||
160661289|NCT00723528|580144036|FG001|Period 2: After Controlled Period|Other|0|||
160487784|NCT01064856|579514277|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
160487785|NCT01064856|579514278|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
160487786|NCT01064856|579514275|FG000|Open-label (OL) Period|Other|0|||
160487787|NCT01064856|579514276|FG001|Open-label (OL) Period|Other|0|||
160487788|NCT01064856|579514277|FG002|Open-label (OL) Period|Other|7|||
160487789|NCT01064856|579514278|FG003|Open-label (OL) Period|Other|7|||
160487790|NCT02133131|579514279|FG000|Overall Study|Adverse Event|0|||
160487791|NCT02133131|579514280|FG001|Overall Study|Adverse Event|0|||
160487792|NCT02133131|579514281|FG002|Overall Study|Adverse Event|0|||
160487793|NCT02133131|579514282|FG003|Overall Study|Adverse Event|1|||
160661290|NCT00723528|580144037|FG002|Period 2: After Controlled Period|Other|0|||
160487794|NCT02133131|579514283|FG004|Overall Study|Adverse Event|0|||
160487795|NCT02133131|579514284|FG005|Overall Study|Adverse Event|0|||
160487796|NCT02133131|579514285|FG006|Overall Study|Adverse Event|0|||
160487797|NCT02133131|579514279|FG000|Overall Study|Lost to Follow-up|1|||
160609442|NCT03039192|579945911|FG000|Overall Study|Withdrawal by Subject|6|||
160609443|NCT03039192|579945912|FG001|Overall Study|Withdrawal by Subject|9|||
160609444|NCT03039192|579945911|FG000|Overall Study|Discontinued from treatment phase|19|||
160487798|NCT02133131|579514280|FG001|Overall Study|Lost to Follow-up|0|||
160609445|NCT03039192|579945912|FG001|Overall Study|Discontinued from treatment phase|12|||
160609446|NCT03039192|579945911|FG000|Overall Study|Other|3|||
160609447|NCT03039192|579945912|FG001|Overall Study|Other|2|||
160609448|NCT03277794|579945913|FG000|Overall Study|Lost to Follow-up|2|||
160609449|NCT03277794|579945914|FG001|Overall Study|Lost to Follow-up|4|||
160609450|NCT03277794|579945913|FG000|Overall Study|Withdrew due to high acuity|1|||
160609451|NCT03277794|579945914|FG001|Overall Study|Withdrew due to high acuity|0|||
160609452|NCT02177812|579945918|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
160609453|NCT02177812|579945919|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
160609454|NCT02177812|579945920|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
160609455|NCT02177812|579945921|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
160609456|NCT02177812|579945922|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
160609457|NCT02177812|579945923|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
160609458|NCT02177812|579945924|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
160609459|NCT02177812|579945925|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
160609460|NCT02177812|579945926|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
160609461|NCT02177812|579945918|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
160609462|NCT02177812|579945919|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
160609463|NCT02177812|579945920|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
160609464|NCT02177812|579945921|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
160609465|NCT02177812|579945922|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
160609466|NCT02177812|579945923|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
160609467|NCT02177812|579945924|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
160609468|NCT02177812|579945925|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
160609469|NCT02177812|579945926|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
160609470|NCT02177812|579945918|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
160609471|NCT02177812|579945919|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
160609472|NCT02177812|579945920|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
160609473|NCT02177812|579945921|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
160609474|NCT02177812|579945922|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
160609475|NCT02177812|579945923|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
160609476|NCT02177812|579945924|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
160609477|NCT02177812|579945925|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
160609478|NCT02177812|579945926|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
160609479|NCT00089999|579945927|FG000|Overall Study|Adverse Event|4|||
160609480|NCT00089999|579945928|FG001|Overall Study|Adverse Event|7|||
160609481|NCT00089999|579945927|FG000|Overall Study|Withdrawal by Subject|0|||
160609482|NCT00089999|579945928|FG001|Overall Study|Withdrawal by Subject|4|||
160609483|NCT00089999|579945927|FG000|Overall Study|Lost to Follow-up|2|||
160609484|NCT00089999|579945928|FG001|Overall Study|Lost to Follow-up|1|||
160609485|NCT00089999|579945927|FG000|Overall Study|Radiological Progression of Cancer|52|||
160609486|NCT00089999|579945928|FG001|Overall Study|Radiological Progression of Cancer|44|||
160609487|NCT00089999|579945927|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
160609488|NCT00089999|579945928|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
160609489|NCT00089999|579945927|FG000|Overall Study|Death|3|||
160609490|NCT00089999|579945928|FG001|Overall Study|Death|3|||
160609491|NCT00089999|579945927|FG000|Overall Study|Poor General Condition|1|||
160609492|NCT00089999|579945928|FG001|Overall Study|Poor General Condition|0|||
160609493|NCT00089999|579945927|FG000|Overall Study|Clinical Progression|1|||
160609494|NCT00089999|579945928|FG001|Overall Study|Clinical Progression|2|||
160609495|NCT00089999|579945927|FG000|Overall Study|Physician Decision|2|||
160609496|NCT00089999|579945928|FG001|Overall Study|Physician Decision|2|||
160609497|NCT00089999|579945927|FG000|Overall Study|Patient Underwent Surgery|2|||
160609498|NCT00089999|579945928|FG001|Overall Study|Patient Underwent Surgery|0|||
160609499|NCT00089999|579945927|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
160609500|NCT00089999|579945928|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
160609501|NCT02973997|579948203|FG000|Overall Study|Withdrawal by Subject|4|||
160609502|NCT02973997|579948204|FG001|Overall Study|Withdrawal by Subject|0|||
160609503|NCT02973997|579948203|FG000|Overall Study|Adverse Event|4|||
160609504|NCT02973997|579948204|FG001|Overall Study|Adverse Event|1|||
160609505|NCT02973997|579948203|FG000|Overall Study|Disease Progression|11|||
160609506|NCT02973997|579948204|FG001|Overall Study|Disease Progression|20|||
160609507|NCT02973997|579948203|FG000|Overall Study|Alternative Therapy|3|||
160609508|NCT02973997|579948204|FG001|Overall Study|Alternative Therapy|0|||
160609509|NCT02973997|579948203|FG000|Overall Study|Other complicating disease|0|||
160609510|NCT02973997|579948204|FG001|Overall Study|Other complicating disease|1|||
160609511|NCT02973997|579948203|FG000|Overall Study|Death|0|||
160609512|NCT02973997|579948204|FG001|Overall Study|Death|1|||
160609513|NCT00444951|579948205|FG000|Overall Study|Lost to Follow-up|1|||
160609514|NCT00444951|579948206|FG001|Overall Study|Lost to Follow-up|1|||
160609515|NCT00444951|579948207|FG002|Overall Study|Lost to Follow-up|0|||
160609516|NCT00444951|579948205|FG000|Overall Study|Withdrawal by Subject|4|||
160609517|NCT00444951|579948206|FG001|Overall Study|Withdrawal by Subject|5|||
160609518|NCT00444951|579948207|FG002|Overall Study|Withdrawal by Subject|3|||
160609519|NCT00887822|579948208|FG000|Overall Study|Insufficient therapeutic response|53|||
160609520|NCT00887822|579948209|FG001|Overall Study|Insufficient therapeutic response|55|||
160609521|NCT00887822|579948208|FG000|Overall Study|Adverse Event|14|||
160609522|NCT00887822|579948209|FG001|Overall Study|Adverse Event|17|||
160609523|NCT00887822|579948208|FG000|Overall Study|Failure to return|11|||
160609524|NCT00887822|579948209|FG001|Overall Study|Failure to return|11|||
160609525|NCT00887822|579948208|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
160609526|NCT00887822|579948209|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
160609527|NCT00887822|579948208|FG000|Overall Study|Administrative/Other than specified|5|||
160609528|NCT00887822|579948209|FG001|Overall Study|Administrative/Other than specified|4|||
160609529|NCT00887822|579948208|FG000|Overall Study|Death|2|||
160609530|NCT00887822|579948209|FG001|Overall Study|Death|3|||
160609531|NCT00887822|579948208|FG000|Overall Study|Protocol Violation|0|||
160609532|NCT00887822|579948209|FG001|Overall Study|Protocol Violation|1|||
160609533|NCT00887822|579948208|FG000|Overall Study|Randomized but not treated|0|||
160609534|NCT00887822|579948209|FG001|Overall Study|Randomized but not treated|1|||
160609535|NCT02045979|579948213|FG000|Overall Study|Informed Consent Withdrawn|2|||
160609536|NCT02045979|579948214|FG001|Overall Study|Informed Consent Withdrawn|0|||
160609537|NCT02045979|579948215|FG002|Overall Study|Informed Consent Withdrawn|1|||
160609538|NCT02045979|579948213|FG000|Overall Study|not specified above|0|||
160609539|NCT02045979|579948214|FG001|Overall Study|not specified above|1|||
160609540|NCT02045979|579948215|FG002|Overall Study|not specified above|0|||
160609541|NCT00378534|579948221|FG000|Overall Study|Participants did not receive transplant|3|||
160609542|NCT00378534|579948222|FG001|Overall Study|Participants did not receive transplant|0|||
160609543|NCT00425945|579948226|FG000|Overall Study|Concern about Supplement|2|||
160609544|NCT00425945|579948227|FG001|Overall Study|Concern about Supplement|0|||
160609545|NCT00425945|579948226|FG000|Overall Study|Inconvenience|0|||
160609546|NCT00425945|579948227|FG001|Overall Study|Inconvenience|2|||
160609547|NCT00425945|579948226|FG000|Overall Study|Lost to Follow-up|0|||
160609548|NCT00425945|579948227|FG001|Overall Study|Lost to Follow-up|2|||
160609549|NCT00425945|579948226|FG000|Overall Study|Began hypertension medication|1|||
160609550|NCT00425945|579948227|FG001|Overall Study|Began hypertension medication|0|||
160609551|NCT00425945|579948226|FG000|Overall Study|Began cancer treatments|1|||
160609552|NCT00425945|579948227|FG001|Overall Study|Began cancer treatments|0|||
160609553|NCT00425945|579948226|FG000|Overall Study|Moved from area|0|||
160609554|NCT00425945|579948227|FG001|Overall Study|Moved from area|1|||
160609555|NCT03878160|579948231|FG000|Overall Study|Lost to Follow-up|1|||
160609556|NCT03878160|579948232|FG001|Overall Study|Lost to Follow-up|1|||
160609557|NCT03878160|579948233|FG002|Overall Study|Lost to Follow-up|1|||
160609558|NCT03878160|579948231|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
160609559|NCT03878160|579948232|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
160609560|NCT03878160|579948233|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
160609561|NCT05618808|579948234|FG000|Overall Study|Withdrawal by Subject|3|||
160609562|NCT05618808|579948235|FG001|Overall Study|Withdrawal by Subject|1|||
160609563|NCT05618808|579948236|FG002|Overall Study|Withdrawal by Subject|3|||
160609564|NCT02365506|579948237|FG000|Overall Study|Investigator's Discretion|0|||
160609565|NCT02365506|579948238|FG001|Overall Study|Investigator's Discretion|0|||
160609566|NCT02365506|579948239|FG002|Overall Study|Investigator's Discretion|1|||
160609567|NCT06048367|579948242|FG000|Overall Study|Withdrawal by Subject|0|||
160609568|NCT06048367|579948243|FG001|Overall Study|Withdrawal by Subject|1|||
160609569|NCT06048367|579948244|FG002|Overall Study|Withdrawal by Subject|0|||
160609570|NCT06048367|579948245|FG003|Overall Study|Withdrawal by Subject|0|||
160609571|NCT06048367|579948246|FG004|Overall Study|Withdrawal by Subject|0|||
160609572|NCT06048367|579948242|FG000|Overall Study|Withdrawal by Subject|0|||
160609573|NCT06048367|579948243|FG001|Overall Study|Withdrawal by Subject|0|||
160609574|NCT06048367|579948244|FG002|Overall Study|Withdrawal by Subject|1|||
160609575|NCT06048367|579948245|FG003|Overall Study|Withdrawal by Subject|0|||
160609576|NCT06048367|579948246|FG004|Overall Study|Withdrawal by Subject|0|||
160609577|NCT06048367|579948242|FG000|Overall Study|Withdrawal by Subject|0|||
160609578|NCT06048367|579948243|FG001|Overall Study|Withdrawal by Subject|0|||
160609579|NCT06048367|579948244|FG002|Overall Study|Withdrawal by Subject|0|||
160609580|NCT06048367|579948245|FG003|Overall Study|Withdrawal by Subject|1|||
160609581|NCT06048367|579948246|FG004|Overall Study|Withdrawal by Subject|0|||
160609582|NCT06048367|579948242|FG000|Overall Study|Withdrawal by Subject|0|||
160609583|NCT06048367|579948243|FG001|Overall Study|Withdrawal by Subject|0|||
160609584|NCT06048367|579948244|FG002|Overall Study|Withdrawal by Subject|0|||
160609585|NCT06048367|579948245|FG003|Overall Study|Withdrawal by Subject|1|||
160609586|NCT06048367|579948246|FG004|Overall Study|Withdrawal by Subject|0|||
160609587|NCT03287830|579948251|FG000|Overall Study|Withdrawal by Subject|1|||
160609588|NCT03287830|579948252|FG001|Overall Study|Withdrawal by Subject|1|||
160609589|NCT03287830|579948251|FG000|Overall Study|not meeting inclusion criteria|5|||
160609590|NCT03287830|579948252|FG001|Overall Study|not meeting inclusion criteria|12|||
160609591|NCT03598140|579948255|FG000|Overall Study|enrolled but didn't start|1|||
160609592|NCT03598140|579948256|FG001|Overall Study|enrolled but didn't start|0|||
160609593|NCT02155712|579948260|FG000|Overall Study|Death|12|||
160609594|NCT02155712|579948261|FG001|Overall Study|Death|0|||
160609595|NCT02155712|579948260|FG000|Overall Study|Lost to Follow-up|37|||
160609596|NCT02155712|579948261|FG001|Overall Study|Lost to Follow-up|22|||
160609597|NCT02155712|579948260|FG000|Overall Study|Revision of device|4|||
160609598|NCT02155712|579948261|FG001|Overall Study|Revision of device|3|||
160609599|NCT02155712|579948260|FG000|Overall Study|Withdrawal by Subject|39|||
160609600|NCT02155712|579948261|FG001|Overall Study|Withdrawal by Subject|21|||
160609601|NCT02155712|579948260|FG000|Overall Study|Site termination|77|||
160609602|NCT02155712|579948261|FG001|Overall Study|Site termination|19|||
160609603|NCT02155712|579948260|FG000|Overall Study|Sponsor terminated study early|150|||
160609604|NCT02155712|579948261|FG001|Overall Study|Sponsor terminated study early|0|||
160609605|NCT02155712|579948260|FG000|Overall Study|Missed final 5-year protocol visit|0|||
160609606|NCT02155712|579948261|FG001|Overall Study|Missed final 5-year protocol visit|32|||
160609607|NCT02155712|579948260|FG000|Overall Study|Censored because surgery cancelled|6|||
160609608|NCT02155712|579948261|FG001|Overall Study|Censored because surgery cancelled|10|||
160609609|NCT02155712|579948260|FG000|Overall Study|Censored because study device was not implanted|61|||
160609610|NCT02155712|579948261|FG001|Overall Study|Censored because study device was not implanted|66|||
160609611|NCT02155712|579948260|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
160609612|NCT02155712|579948261|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
160609613|NCT02060903|579948262|FG000|Overall Study|Lost to Follow-up|4|||
160609614|NCT02060903|579948263|FG001|Overall Study|Lost to Follow-up|0|||
160609615|NCT02060903|579948262|FG000|Overall Study|Withdrawal by Subject|0|||
160609616|NCT02060903|579948263|FG001|Overall Study|Withdrawal by Subject|7|||
160609617|NCT02418585|579948264|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
160609618|NCT02418585|579948265|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
160609619|NCT02418585|579948264|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
160609620|NCT02418585|579948265|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
160609621|NCT02418585|579948264|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
160609622|NCT02418585|579948265|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
160609623|NCT02418585|579948264|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
160609624|NCT02418585|579948265|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
160609625|NCT02418585|579948264|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
160609626|NCT02418585|579948265|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
160609627|NCT02418585|579948264|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
160609628|NCT02418585|579948265|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
160609629|NCT02418585|579948264|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
160609630|NCT02418585|579948265|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
160609631|NCT02418585|579948264|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
160609632|NCT02418585|579948265|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
160609633|NCT02418585|579948264|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
160609634|NCT02418585|579948265|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
160609635|NCT02418585|579948264|FG000|Follow-up Phase (24 Weeks)|Other|3|||
160609636|NCT02418585|579948265|FG001|Follow-up Phase (24 Weeks)|Other|2|||
160609637|NCT01688999|579948268|FG000|Overall Study|Withdrawal by Subject|5|||
160609638|NCT01688999|579948269|FG001|Overall Study|Withdrawal by Subject|1|||
160609639|NCT01688999|579948270|FG002|Overall Study|Withdrawal by Subject|1|||
160609640|NCT01688999|579948268|FG000|Overall Study|Adverse Event|2|||
160609641|NCT01688999|579948269|FG001|Overall Study|Adverse Event|0|||
160609642|NCT01688999|579948270|FG002|Overall Study|Adverse Event|2|||
160609643|NCT01688999|579948268|FG000|Overall Study|Ineligible/Not treated|1|||
160609644|NCT01688999|579948269|FG001|Overall Study|Ineligible/Not treated|0|||
160609645|NCT01688999|579948270|FG002|Overall Study|Ineligible/Not treated|0|||
160609646|NCT02768103|579948271|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
160609647|NCT00498368|579948299|FG000|Overall Study|Withdrawal by Subject|3|||
160609648|NCT00498368|579948300|FG001|Overall Study|Withdrawal by Subject|2|||
160609649|NCT02266004|579948301|FG000|Overall Study|unrelated adverse event|1|||
160609650|NCT02266004|579948301|FG000|Overall Study|Physician Decision|1|||
160609651|NCT00537771|579948305|FG000|Overall Study|Withdrawal by Subject|6|||
160609652|NCT00537771|579948306|FG001|Overall Study|Withdrawal by Subject|23|||
160609653|NCT00537771|579948305|FG000|Overall Study|Adverse Event|8|||
160609654|NCT00537771|579948306|FG001|Overall Study|Adverse Event|15|||
160609655|NCT00537771|579948305|FG000|Overall Study|Lost to Follow-up|9|||
160609656|NCT00537771|579948306|FG001|Overall Study|Lost to Follow-up|15|||
160609657|NCT00537771|579948305|FG000|Overall Study|Protocol Violation|2|||
160609658|NCT00537771|579948306|FG001|Overall Study|Protocol Violation|6|||
160609659|NCT00537771|579948305|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
160609660|NCT00537771|579948306|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
160609661|NCT02465489|579948309|FG000|Overall Study|Adverse Event|5|||
160609662|NCT02148952|579948312|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
160609663|NCT02148952|579948313|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
160609664|NCT02148952|579948312|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
160609665|NCT02148952|579948313|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
160609666|NCT02148952|579948312|FG000|Follow-Up|Lost to Follow-up|219|||
160609667|NCT02148952|579948313|FG001|Follow-Up|Lost to Follow-up|231|||
160609668|NCT02148952|579948312|FG000|Follow-Up|Withdrawal by Subject|46|||
160609669|NCT02148952|579948313|FG001|Follow-Up|Withdrawal by Subject|48|||
160609670|NCT00118040|579948314|FG000|Overall Study|Adverse Event|0|||
160609671|NCT00118040|579948315|FG001|Overall Study|Adverse Event|1|||
160609672|NCT00118040|579948316|FG002|Overall Study|Adverse Event|0|||
160609673|NCT00118040|579948314|FG000|Overall Study|Withdrawal by Subject|0|||
160609674|NCT00118040|579948315|FG001|Overall Study|Withdrawal by Subject|0|||
160609675|NCT00118040|579948316|FG002|Overall Study|Withdrawal by Subject|2|||
160609676|NCT00118040|579948314|FG000|Overall Study|Medical Contraindication|0|||
160609677|NCT00118040|579948315|FG001|Overall Study|Medical Contraindication|0|||
160609678|NCT00118040|579948316|FG002|Overall Study|Medical Contraindication|1|||
160609679|NCT00118040|579948314|FG000|Overall Study|Non-Compliant Participant|1|||
160609680|NCT00118040|579948315|FG001|Overall Study|Non-Compliant Participant|1|||
160609681|NCT00118040|579948316|FG002|Overall Study|Non-Compliant Participant|2|||
160609682|NCT00118040|579948314|FG000|Overall Study|Other|0|||
160661291|NCT00723528|580144038|FG003|Period 2: After Controlled Period|Other|0|||
160487799|NCT02133131|579514281|FG002|Overall Study|Lost to Follow-up|0|||
160487800|NCT02133131|579514282|FG003|Overall Study|Lost to Follow-up|1|||
160487801|NCT02133131|579514283|FG004|Overall Study|Lost to Follow-up|0|||
160487802|NCT02133131|579514284|FG005|Overall Study|Lost to Follow-up|0|||
160487803|NCT02133131|579514285|FG006|Overall Study|Lost to Follow-up|0|||
160487804|NCT02133131|579514279|FG000|Overall Study|Status not recorded|4|||
160487805|NCT02133131|579514280|FG001|Overall Study|Status not recorded|5|||
160487806|NCT02133131|579514281|FG002|Overall Study|Status not recorded|1|||
160487807|NCT02133131|579514282|FG003|Overall Study|Status not recorded|4|||
160487808|NCT02133131|579514283|FG004|Overall Study|Status not recorded|0|||
160487809|NCT02133131|579514284|FG005|Overall Study|Status not recorded|0|||
160487810|NCT02133131|579514285|FG006|Overall Study|Status not recorded|0|||
160487811|NCT02133131|579514279|FG000|Overall Study|Ongoing in study|0|||
160487812|NCT02133131|579514280|FG001|Overall Study|Ongoing in study|0|||
160487813|NCT02133131|579514281|FG002|Overall Study|Ongoing in study|0|||
160487814|NCT02133131|579514282|FG003|Overall Study|Ongoing in study|0|||
160487815|NCT02133131|579514283|FG004|Overall Study|Ongoing in study|15|||
160487816|NCT02133131|579514284|FG005|Overall Study|Ongoing in study|14|||
160487817|NCT02133131|579514285|FG006|Overall Study|Ongoing in study|11|||
160487818|NCT02133131|579514279|FG000|Overall Study|Protocol Violation|0|||
160487819|NCT02133131|579514280|FG001|Overall Study|Protocol Violation|0|||
160487820|NCT02133131|579514281|FG002|Overall Study|Protocol Violation|0|||
160487821|NCT02133131|579514282|FG003|Overall Study|Protocol Violation|0|||
160487822|NCT02133131|579514283|FG004|Overall Study|Protocol Violation|0|||
160487823|NCT02133131|579514284|FG005|Overall Study|Protocol Violation|0|||
160487824|NCT02133131|579514285|FG006|Overall Study|Protocol Violation|1|||
160487825|NCT00509925|579514286|FG000|Overall Study|Personal reasons|0|||
160487826|NCT00509925|579514287|FG001|Overall Study|Personal reasons|1|||
160487827|NCT00951171|579514291|FG000|Overall Study|Adverse Event|2|||
160487828|NCT00951171|579514292|FG001|Overall Study|Adverse Event|0|||
160487829|NCT04267393|579514297|FG000|Randomization|Adverse Event|1|||
160487830|NCT04267393|579514298|FG001|Randomization|Adverse Event|0|||
160487831|NCT04267393|579514299|FG002|Randomization|Adverse Event|0|||
160487832|NCT04267393|579514297|FG000|Randomization|Administrative Reasons by Sponsor|0|||
160487833|NCT04267393|579514298|FG001|Randomization|Administrative Reasons by Sponsor|1|||
160487834|NCT04267393|579514299|FG002|Randomization|Administrative Reasons by Sponsor|0|||
160487835|NCT04267393|579514297|FG000|Treatment Period|Adverse Event|0|||
160487836|NCT04267393|579514298|FG001|Treatment Period|Adverse Event|2|||
160609683|NCT00118040|579948315|FG001|Overall Study|Other|0|||
160487837|NCT04267393|579514299|FG002|Treatment Period|Adverse Event|3|||
160487838|NCT04267393|579514297|FG000|Treatment Period|Participant Withdrew Consent|0|||
160487839|NCT04267393|579514298|FG001|Treatment Period|Participant Withdrew Consent|0|||
160487840|NCT04267393|579514299|FG002|Treatment Period|Participant Withdrew Consent|1|||
160609684|NCT00118040|579948316|FG002|Overall Study|Other|1|||
160487841|NCT04267393|579514297|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
160487842|NCT04267393|579514298|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
160487843|NCT04267393|579514299|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
160487844|NCT01932762|579515927|FG000|Overall Study|Withdrawal by Subject|1|||
160487845|NCT01932762|579515928|FG001|Overall Study|Withdrawal by Subject|2|||
160609685|NCT03733249|579948317|FG000|Overall Study|Death|7|||
160609686|NCT03733249|579948317|FG000|Overall Study|Disease relapse|16|||
160609687|NCT03733249|579948317|FG000|Overall Study|Lost to Follow-up|4|||
160609688|NCT03733249|579948317|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
160609689|NCT03733249|579948317|FG000|Overall Study|Withdrawal by Subject|1|||
160609690|NCT04476108|579948318|FG000|Overall Study|Adverse Event|4|||
160609691|NCT04476108|579948319|FG001|Overall Study|Adverse Event|1|||
160609692|NCT04476108|579948318|FG000|Overall Study|Lost to Follow-up|1|||
160609693|NCT04476108|579948319|FG001|Overall Study|Lost to Follow-up|0|||
160609694|NCT04476108|579948318|FG000|Overall Study|Inadvertent Enrollment|1|||
160609695|NCT04476108|579948319|FG001|Overall Study|Inadvertent Enrollment|0|||
160609696|NCT04476108|579948318|FG000|Overall Study|Protocol Violation|1|||
160609697|NCT04476108|579948319|FG001|Overall Study|Protocol Violation|1|||
160609698|NCT04476108|579948318|FG000|Overall Study|Withdrawal by Subject|1|||
160609699|NCT04476108|579948319|FG001|Overall Study|Withdrawal by Subject|1|||
160609700|NCT00850135|579948320|FG000|Overall Study|Physician Decision|1|||
160609701|NCT02253992|579948321|FG000|Overall Study|Study drug toxicity|1|||
160609702|NCT02253992|579948322|FG001|Overall Study|Study drug toxicity|0|||
160609703|NCT02253992|579948323|FG002|Overall Study|Study drug toxicity|10|||
160609704|NCT02253992|579948321|FG000|Overall Study|Disease progression|4|||
160609705|NCT02253992|579948322|FG001|Overall Study|Disease progression|3|||
160609706|NCT02253992|579948323|FG002|Overall Study|Disease progression|98|||
160609707|NCT02253992|579948321|FG000|Overall Study|Withdrawal by Subject|0|||
160609708|NCT02253992|579948322|FG001|Overall Study|Withdrawal by Subject|0|||
160609709|NCT02253992|579948323|FG002|Overall Study|Withdrawal by Subject|3|||
160609710|NCT02253992|579948321|FG000|Overall Study|Adverse Event|0|||
160609711|NCT02253992|579948322|FG001|Overall Study|Adverse Event|0|||
160609712|NCT02253992|579948323|FG002|Overall Study|Adverse Event|8|||
160609713|NCT02253992|579948321|FG000|Overall Study|Death|0|||
160609714|NCT02253992|579948322|FG001|Overall Study|Death|0|||
160609715|NCT02253992|579948323|FG002|Overall Study|Death|1|||
160609716|NCT02253992|579948321|FG000|Overall Study|Subject discontinued study drug|1|||
160609717|NCT02253992|579948322|FG001|Overall Study|Subject discontinued study drug|0|||
160609718|NCT02253992|579948323|FG002|Overall Study|Subject discontinued study drug|1|||
160609719|NCT02253992|579948321|FG000|Overall Study|Completed treatment as per protocol|0|||
160609720|NCT02253992|579948322|FG001|Overall Study|Completed treatment as per protocol|1|||
160609721|NCT02253992|579948323|FG002|Overall Study|Completed treatment as per protocol|22|||
160609722|NCT02253992|579948321|FG000|Overall Study|Other|0|||
160609723|NCT02253992|579948322|FG001|Overall Study|Other|0|||
160609724|NCT02253992|579948323|FG002|Overall Study|Other|1|||
160609725|NCT03198728|579948324|FG000|Overall Study|Adverse Event|10|||
160609726|NCT03198728|579948325|FG001|Overall Study|Adverse Event|5|||
160609727|NCT03198728|579948324|FG000|Overall Study|Lost to Follow-up|21|||
160609728|NCT03198728|579948325|FG001|Overall Study|Lost to Follow-up|7|||
160609729|NCT03198728|579948324|FG000|Overall Study|Physician Decision|7|||
160609730|NCT03198728|579948325|FG001|Overall Study|Physician Decision|2|||
160609731|NCT03198728|579948324|FG000|Overall Study|Withdrawal by Subject|14|||
160609732|NCT03198728|579948325|FG001|Overall Study|Withdrawal by Subject|10|||
160609733|NCT02139280|579948326|FG000|Overall Study|No longer eligible|2|||
160609734|NCT02139280|579948327|FG001|Overall Study|No longer eligible|0|||
160609735|NCT00736450|579948328|FG000|Overall Study|Not ABC gene eligible|19|||
160609736|NCT00736450|579948328|FG000|Overall Study|Withdrawal by Subject|5|||
160609737|NCT00736450|579948328|FG000|Overall Study|Physician Decision|1|||
160609738|NCT04731922|579948332|FG000|Overall Study|Adverse Event|0|||
160609739|NCT04731922|579948333|FG001|Overall Study|Adverse Event|0|||
160609740|NCT04731922|579948334|FG002|Overall Study|Adverse Event|0|||
160609741|NCT04731922|579948335|FG003|Overall Study|Adverse Event|0|||
160609742|NCT04731922|579948336|FG004|Overall Study|Adverse Event|0|||
160609743|NCT04731922|579948337|FG005|Overall Study|Adverse Event|0|||
160609744|NCT04731922|579948338|FG006|Overall Study|Adverse Event|0|||
160609745|NCT04731922|579948339|FG007|Overall Study|Adverse Event|0|||
160609746|NCT04731922|579948340|FG008|Overall Study|Adverse Event|0|||
160609747|NCT04731922|579948341|FG009|Overall Study|Adverse Event|0|||
160609748|NCT04731922|579948342|FG010|Overall Study|Adverse Event|1|||
160609749|NCT04731922|579948343|FG011|Overall Study|Adverse Event|0|||
160609750|NCT04731922|579948344|FG012|Overall Study|Adverse Event|0|||
160609751|NCT04731922|579948345|FG013|Overall Study|Adverse Event|0|||
160661292|NCT00723528|580144039|FG004|Period 2: After Controlled Period|Other|1|||
160609752|NCT04731922|579948346|FG014|Overall Study|Adverse Event|0|||
160609753|NCT04731922|579948347|FG015|Overall Study|Adverse Event|0|||
160609754|NCT04731922|579948348|FG016|Overall Study|Adverse Event|0|||
160609755|NCT04731922|579948332|FG000|Overall Study|Lost to Follow-up|0|||
160609756|NCT04731922|579948333|FG001|Overall Study|Lost to Follow-up|0|||
160661293|NCT00723528|580144040|FG005|Period 2: After Controlled Period|Other|4|||
160609757|NCT04731922|579948334|FG002|Overall Study|Lost to Follow-up|0|||
160609758|NCT04731922|579948335|FG003|Overall Study|Lost to Follow-up|1|||
160609759|NCT04731922|579948336|FG004|Overall Study|Lost to Follow-up|0|||
160609760|NCT04731922|579948337|FG005|Overall Study|Lost to Follow-up|1|||
160609761|NCT04731922|579948338|FG006|Overall Study|Lost to Follow-up|0|||
160609762|NCT04731922|579948339|FG007|Overall Study|Lost to Follow-up|0|||
160609763|NCT04731922|579948340|FG008|Overall Study|Lost to Follow-up|0|||
160609764|NCT04731922|579948341|FG009|Overall Study|Lost to Follow-up|0|||
160609765|NCT04731922|579948342|FG010|Overall Study|Lost to Follow-up|0|||
160609766|NCT04731922|579948343|FG011|Overall Study|Lost to Follow-up|0|||
160609767|NCT04731922|579948344|FG012|Overall Study|Lost to Follow-up|0|||
160609768|NCT04731922|579948345|FG013|Overall Study|Lost to Follow-up|0|||
160609769|NCT04731922|579948346|FG014|Overall Study|Lost to Follow-up|0|||
160609770|NCT04731922|579948347|FG015|Overall Study|Lost to Follow-up|0|||
160609771|NCT04731922|579948348|FG016|Overall Study|Lost to Follow-up|0|||
160609772|NCT04731922|579948332|FG000|Overall Study|Withdrawal by Subject|1|||
160609773|NCT04731922|579948333|FG001|Overall Study|Withdrawal by Subject|0|||
160609774|NCT04731922|579948334|FG002|Overall Study|Withdrawal by Subject|0|||
160609775|NCT04731922|579948335|FG003|Overall Study|Withdrawal by Subject|0|||
160609776|NCT04731922|579948336|FG004|Overall Study|Withdrawal by Subject|1|||
160609777|NCT04731922|579948337|FG005|Overall Study|Withdrawal by Subject|0|||
160609778|NCT04731922|579948338|FG006|Overall Study|Withdrawal by Subject|1|||
160609779|NCT04731922|579948339|FG007|Overall Study|Withdrawal by Subject|0|||
160609780|NCT04731922|579948340|FG008|Overall Study|Withdrawal by Subject|0|||
160609781|NCT04731922|579948341|FG009|Overall Study|Withdrawal by Subject|0|||
160609782|NCT04731922|579948342|FG010|Overall Study|Withdrawal by Subject|0|||
160609783|NCT04731922|579948343|FG011|Overall Study|Withdrawal by Subject|0|||
160609784|NCT04731922|579948344|FG012|Overall Study|Withdrawal by Subject|0|||
160609785|NCT04731922|579948345|FG013|Overall Study|Withdrawal by Subject|1|||
160609786|NCT04731922|579948346|FG014|Overall Study|Withdrawal by Subject|0|||
160609787|NCT04731922|579948347|FG015|Overall Study|Withdrawal by Subject|0|||
160609788|NCT04731922|579948348|FG016|Overall Study|Withdrawal by Subject|0|||
160609789|NCT04731922|579948332|FG000|Overall Study|Other|0|||
160609790|NCT04731922|579948333|FG001|Overall Study|Other|0|||
160609791|NCT04731922|579948334|FG002|Overall Study|Other|0|||
160609792|NCT04731922|579948335|FG003|Overall Study|Other|0|||
160609793|NCT04731922|579948336|FG004|Overall Study|Other|0|||
160609794|NCT04731922|579948337|FG005|Overall Study|Other|0|||
160609795|NCT04731922|579948338|FG006|Overall Study|Other|1|||
160609796|NCT04731922|579948339|FG007|Overall Study|Other|0|||
160609797|NCT04731922|579948340|FG008|Overall Study|Other|0|||
160609798|NCT04731922|579948341|FG009|Overall Study|Other|0|||
160609799|NCT04731922|579948342|FG010|Overall Study|Other|0|||
160609800|NCT04731922|579948343|FG011|Overall Study|Other|0|||
160609801|NCT04731922|579948344|FG012|Overall Study|Other|0|||
160609802|NCT04731922|579948345|FG013|Overall Study|Other|0|||
160609803|NCT04731922|579948346|FG014|Overall Study|Other|0|||
160609804|NCT04731922|579948347|FG015|Overall Study|Other|0|||
160609805|NCT04731922|579948348|FG016|Overall Study|Other|0|||
160609806|NCT04157751|579948349|FG000|Overall Study|Withdrawal by Subject|12|||
160609807|NCT04157751|579948350|FG001|Overall Study|Withdrawal by Subject|17|||
160609808|NCT04157751|579948349|FG000|Overall Study|Lost to Follow-up|6|||
160609809|NCT04157751|579948350|FG001|Overall Study|Lost to Follow-up|2|||
160609810|NCT04157751|579948349|FG000|Overall Study|Adverse Event|34|||
160609811|NCT04157751|579948350|FG001|Overall Study|Adverse Event|23|||
160609812|NCT04157751|579948349|FG000|Overall Study|Not treated|1|||
160609813|NCT04157751|579948350|FG001|Overall Study|Not treated|5|||
160609814|NCT04157751|579948349|FG000|Overall Study|Other reason not stated above|10|||
160609815|NCT04157751|579948350|FG001|Overall Study|Other reason not stated above|10|||
160609816|NCT03148795|579948369|FG000|Overall Study|Progressive Disease|1|||
160609817|NCT04489940|579948370|FG000|Overall Study|Other|2|||
160609818|NCT04489940|579948370|FG000|Overall Study|Withdrawal by Subject|2|||
160609819|NCT04489940|579948370|FG000|Overall Study|Death|5|||
160609820|NCT04489940|579948370|FG000|Overall Study|Lost to Follow-up|1|||
160609821|NCT04498468|579948371|FG000|Overall Study|Lost to Follow-up|3|||
160609822|NCT02725268|579948372|FG000|Overall Study|Death|58|||
160609823|NCT02725268|579948373|FG001|Overall Study|Death|59|||
160609824|NCT02725268|579948374|FG002|Overall Study|Death|30|||
160609825|NCT02725268|579948375|FG003|Overall Study|Death|16|||
160609826|NCT02725268|579948372|FG000|Overall Study|Lost to Follow-up|4|||
160609827|NCT02725268|579948373|FG001|Overall Study|Lost to Follow-up|3|||
160609828|NCT02725268|579948374|FG002|Overall Study|Lost to Follow-up|0|||
160609829|NCT02725268|579948375|FG003|Overall Study|Lost to Follow-up|1|||
160609830|NCT02725268|579948372|FG000|Overall Study|Site Terminated by Sponsor|0|||
160609831|NCT02725268|579948373|FG001|Overall Study|Site Terminated by Sponsor|1|||
160609832|NCT02725268|579948374|FG002|Overall Study|Site Terminated by Sponsor|0|||
160609833|NCT02725268|579948375|FG003|Overall Study|Site Terminated by Sponsor|0|||
160609834|NCT02725268|579948372|FG000|Overall Study|Withdrawal by Subject|8|||
160609835|NCT02725268|579948373|FG001|Overall Study|Withdrawal by Subject|6|||
160609836|NCT02725268|579948374|FG002|Overall Study|Withdrawal by Subject|8|||
160609837|NCT02725268|579948375|FG003|Overall Study|Withdrawal by Subject|1|||
160609838|NCT02725268|579948372|FG000|Overall Study|Reason not Specified|2|||
160609839|NCT02725268|579948373|FG001|Overall Study|Reason not Specified|1|||
160609840|NCT02725268|579948374|FG002|Overall Study|Reason not Specified|0|||
160609841|NCT02725268|579948375|FG003|Overall Study|Reason not Specified|0|||
160609842|NCT00117572|579948385|FG000|Overall Study|Site withdrew before starting treatment|2|||
160609843|NCT00117572|579948386|FG001|Overall Study|Site withdrew before starting treatment|3|||
160609844|NCT00117572|579948385|FG000|Overall Study|Withdrawal by Subject|3|||
160609845|NCT00117572|579948386|FG001|Overall Study|Withdrawal by Subject|3|||
160487846|NCT01932762|579515929|FG002|Overall Study|Withdrawal by Subject|0|||
160487847|NCT01932762|579515930|FG003|Overall Study|Withdrawal by Subject|0|||
160487848|NCT01932762|579515927|FG000|Overall Study|Lost to Follow-up|4|||
160487849|NCT01932762|579515928|FG001|Overall Study|Lost to Follow-up|0|||
160487850|NCT01932762|579515929|FG002|Overall Study|Lost to Follow-up|0|||
160487851|NCT01932762|579515930|FG003|Overall Study|Lost to Follow-up|1|||
160487852|NCT01932762|579515927|FG000|Overall Study|Physician Decision|1|||
160487853|NCT01932762|579515928|FG001|Overall Study|Physician Decision|0|||
160487854|NCT01932762|579515929|FG002|Overall Study|Physician Decision|0|||
160487855|NCT01932762|579515930|FG003|Overall Study|Physician Decision|0|||
160487856|NCT02210208|579515931|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
160487857|NCT02210208|579515931|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
160487858|NCT02210208|579515931|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
160487859|NCT00695136|579515932|FG000|Overall Study|Withdrawal by Subject|1|||
160487860|NCT00695136|579515932|FG000|Overall Study|unrelated adverse event|1|||
160487861|NCT01726049|579515934|FG000|Overall Study|Death|1|||
160487862|NCT01726049|579515935|FG001|Overall Study|Death|1|||
160487863|NCT01726049|579515934|FG000|Overall Study|Adverse Event|4|||
160487864|NCT01726049|579515935|FG001|Overall Study|Adverse Event|1|||
160487865|NCT01726049|579515934|FG000|Overall Study|refused second HC|0|||
160487866|NCT01726049|579515935|FG001|Overall Study|refused second HC|2|||
160487867|NCT02161406|579515936|FG000|Overall Study|Death|2|||
160487868|NCT02161406|579515937|FG001|Overall Study|Death|1|||
160487869|NCT02161406|579515936|FG000|Overall Study|Lost to Follow-up|2|||
160487870|NCT02161406|579515937|FG001|Overall Study|Lost to Follow-up|1|||
160487871|NCT02161406|579515936|FG000|Overall Study|Withdrawal by Subject|2|||
160487872|NCT02161406|579515937|FG001|Overall Study|Withdrawal by Subject|4|||
160487873|NCT02161406|579515936|FG000|Overall Study|investigator withdrew subject|3|||
160487874|NCT02161406|579515937|FG001|Overall Study|investigator withdrew subject|1|||
160487875|NCT02161406|579515936|FG000|Overall Study|Lack of Efficacy|1|||
160487876|NCT02161406|579515937|FG001|Overall Study|Lack of Efficacy|1|||
160487877|NCT02161406|579515936|FG000|Overall Study|relocation|0|||
160487878|NCT02161406|579515937|FG001|Overall Study|relocation|1|||
160487879|NCT00664105|579515938|FG000|Overall Study|Death|3|||
160487880|NCT00664105|579515938|FG000|Overall Study|Withdrawal by Subject|5|||
160487881|NCT00664105|579515938|FG000|Overall Study|Adverse Event|9|||
160487882|NCT00664105|579515938|FG000|Overall Study|Disease progression|7|||
160487883|NCT05446714|579515941|FG000|Overall Study|Lost to Follow-up|1|||
160487884|NCT05446714|579515942|FG001|Overall Study|Lost to Follow-up|3|||
160487885|NCT05446714|579515943|FG002|Overall Study|Lost to Follow-up|2|||
160487886|NCT05446714|579515941|FG000|Overall Study|Protocol Violation|2|||
160487887|NCT05446714|579515942|FG001|Overall Study|Protocol Violation|0|||
160487888|NCT05446714|579515943|FG002|Overall Study|Protocol Violation|0|||
160487889|NCT02418845|579515946|FG000|Overall Study|Lost to Follow-up|7|||
160487890|NCT02418845|579515947|FG001|Overall Study|Lost to Follow-up|2|||
160487891|NCT02418845|579515946|FG000|Overall Study|Lack of Efficacy|0|||
160487892|NCT02418845|579515947|FG001|Overall Study|Lack of Efficacy|3|||
160487893|NCT02418845|579515946|FG000|Overall Study|Physician Decision|5|||
160487894|NCT02418845|579515947|FG001|Overall Study|Physician Decision|5|||
160487895|NCT02418845|579515946|FG000|Overall Study|Protocol Violation|1|||
160487896|NCT02418845|579515947|FG001|Overall Study|Protocol Violation|0|||
160487897|NCT02418845|579515946|FG000|Overall Study|Withdrawal by Subject|3|||
160487898|NCT02418845|579515947|FG001|Overall Study|Withdrawal by Subject|2|||
160487899|NCT00478647|579515948|FG000|Overall Study|Adverse Event|1|||
160487900|NCT00478647|579515948|FG000|Overall Study|Withdrawal by Subject|1|||
160487901|NCT01746108|579515953|FG000|Overall Study|Migrated /moved from study area|0|||
160487902|NCT01746108|579515954|FG001|Overall Study|Migrated /moved from study area|1|||
160487903|NCT01746108|579515955|FG002|Overall Study|Migrated /moved from study area|0|||
160609846|NCT00117572|579948385|FG000|Overall Study|Protocol Violation|1|||
160609847|NCT00117572|579948386|FG001|Overall Study|Protocol Violation|0|||
160609848|NCT04973085|579948387|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
160609849|NCT04973085|579948388|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
160487904|NCT01746108|579515953|FG000|Overall Study|Adverse event, non-fatal|0|||
160487905|NCT01746108|579515954|FG001|Overall Study|Adverse event, non-fatal|1|||
160487906|NCT01746108|579515955|FG002|Overall Study|Adverse event, non-fatal|0|||
160487907|NCT01746108|579515953|FG000|Overall Study|Withdrawal by Subject|0|||
160487908|NCT01746108|579515954|FG001|Overall Study|Withdrawal by Subject|1|||
160487909|NCT01746108|579515955|FG002|Overall Study|Withdrawal by Subject|0|||
160487910|NCT01746108|579515953|FG000|Overall Study|Lost to Follow-up|0|||
160487911|NCT01746108|579515954|FG001|Overall Study|Lost to Follow-up|1|||
160487912|NCT01746108|579515955|FG002|Overall Study|Lost to Follow-up|0|||
160609850|NCT01387594|579948394|FG000|Overall Study|Withdrawal by Subject|0|||
160609851|NCT01387594|579948395|FG001|Overall Study|Withdrawal by Subject|2|||
160487913|NCT03036150|579515956|FG000|Overall Study|Withdrawal by Subject|8|||
160487914|NCT03036150|579515957|FG001|Overall Study|Withdrawal by Subject|3|||
160487915|NCT03036150|579515956|FG000|Overall Study|Lost to Follow-up|2|||
160609852|NCT01387594|579948394|FG000|Overall Study|Lost to Follow-up|0|||
160609853|NCT01387594|579948395|FG001|Overall Study|Lost to Follow-up|1|||
160609854|NCT02116361|579948405|FG000|Overall Study|Pregnancy|0|||
160609855|NCT02116361|579948406|FG001|Overall Study|Pregnancy|0|||
160609856|NCT02116361|579948407|FG002|Overall Study|Pregnancy|0|||
160609857|NCT02116361|579948408|FG003|Overall Study|Pregnancy|1|||
160609858|NCT02116361|579948405|FG000|Overall Study|Protocol Violation|1|||
160609859|NCT02116361|579948406|FG001|Overall Study|Protocol Violation|0|||
160609860|NCT02116361|579948407|FG002|Overall Study|Protocol Violation|0|||
160609861|NCT02116361|579948408|FG003|Overall Study|Protocol Violation|2|||
160609862|NCT02116361|579948405|FG000|Overall Study|Physician Decision|2|||
160609863|NCT02116361|579948406|FG001|Overall Study|Physician Decision|3|||
160609864|NCT02116361|579948407|FG002|Overall Study|Physician Decision|0|||
160609865|NCT02116361|579948408|FG003|Overall Study|Physician Decision|0|||
160609866|NCT02116361|579948405|FG000|Overall Study|Adverse Event|1|||
160609867|NCT02116361|579948406|FG001|Overall Study|Adverse Event|0|||
160609868|NCT02116361|579948407|FG002|Overall Study|Adverse Event|0|||
160609869|NCT02116361|579948408|FG003|Overall Study|Adverse Event|3|||
160609870|NCT02116361|579948405|FG000|Overall Study|Other Reasons|3|||
160609871|NCT02116361|579948406|FG001|Overall Study|Other Reasons|3|||
160609872|NCT02116361|579948407|FG002|Overall Study|Other Reasons|3|||
160609873|NCT02116361|579948408|FG003|Overall Study|Other Reasons|3|||
160609874|NCT02116361|579948405|FG000|Overall Study|Lack of Efficacy|5|||
160609875|NCT02116361|579948406|FG001|Overall Study|Lack of Efficacy|7|||
160609876|NCT02116361|579948407|FG002|Overall Study|Lack of Efficacy|4|||
160609877|NCT02116361|579948408|FG003|Overall Study|Lack of Efficacy|3|||
160609878|NCT02116361|579948405|FG000|Overall Study|Lost to Follow-up|4|||
160609879|NCT02116361|579948406|FG001|Overall Study|Lost to Follow-up|5|||
160609880|NCT02116361|579948407|FG002|Overall Study|Lost to Follow-up|7|||
160609881|NCT02116361|579948408|FG003|Overall Study|Lost to Follow-up|5|||
160609882|NCT02116361|579948405|FG000|Overall Study|Personal Reasons|6|||
160609883|NCT02116361|579948406|FG001|Overall Study|Personal Reasons|6|||
160609884|NCT02116361|579948407|FG002|Overall Study|Personal Reasons|4|||
160609885|NCT02116361|579948408|FG003|Overall Study|Personal Reasons|9|||
160609886|NCT02116361|579948405|FG000|Overall Study|Investigator Decision - Relapse|9|||
160609887|NCT02116361|579948406|FG001|Overall Study|Investigator Decision - Relapse|7|||
160609888|NCT02116361|579948407|FG002|Overall Study|Investigator Decision - Relapse|8|||
160609889|NCT02116361|579948408|FG003|Overall Study|Investigator Decision - Relapse|5|||
160609890|NCT02571972|579948409|FG000|Overall Study|Protocol Violation|2|||
160609891|NCT02571972|579948409|FG000|Overall Study|Withdrawal by Subject|2|||
160609892|NCT03227224|579948410|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
160609893|NCT03227224|579948411|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
160609894|NCT03227224|579948412|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
160609895|NCT03227224|579948413|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
160609896|NCT03227224|579948410|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
160609897|NCT03227224|579948411|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
160609898|NCT03227224|579948412|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
160609899|NCT03227224|579948413|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
160609900|NCT03227224|579948410|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
160609901|NCT03227224|579948411|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
160609902|NCT03227224|579948412|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
160609903|NCT03227224|579948413|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
160609904|NCT03227224|579948410|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
160609905|NCT03227224|579948411|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
160609906|NCT03227224|579948412|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
160609907|NCT03227224|579948413|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
160609908|NCT03227224|579948410|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
160609909|NCT03227224|579948411|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
160609910|NCT03227224|579948412|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
160609911|NCT03227224|579948413|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
160609912|NCT03227224|579948410|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
160609913|NCT03227224|579948411|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
160661294|NCT00723528|580144041|FG006|Period 2: After Controlled Period|Other|0|||
160661295|NCT00723528|580144035|FG000|Period 2: After Controlled Period|Adverse Event|0|||
160609914|NCT03227224|579948412|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
160609915|NCT03227224|579948413|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
160609916|NCT03227224|579948410|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
160609917|NCT03227224|579948411|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
160609918|NCT03227224|579948412|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
160609919|NCT03227224|579948413|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
160661296|NCT00723528|580144036|FG001|Period 2: After Controlled Period|Adverse Event|0|||
160661297|NCT00723528|580144037|FG002|Period 2: After Controlled Period|Adverse Event|0|||
160487916|NCT03036150|579515957|FG001|Overall Study|Lost to Follow-up|2|||
160487917|NCT00053352|579515966|FG000|Overall Study|Lost to Follow-up|0|||
160487918|NCT00053352|579515967|FG001|Overall Study|Lost to Follow-up|1|||
160487919|NCT00053352|579515966|FG000|Overall Study|Physician Decision|11|||
160487920|NCT00053352|579515967|FG001|Overall Study|Physician Decision|1|||
160487921|NCT00053352|579515966|FG000|Overall Study|Withdrawal by Subject|1|||
160487922|NCT00053352|579515967|FG001|Overall Study|Withdrawal by Subject|0|||
160487923|NCT00053352|579515966|FG000|Overall Study|Ineligible|8|||
160487924|NCT00053352|579515967|FG001|Overall Study|Ineligible|8|||
160487925|NCT00053352|579515966|FG000|Overall Study|Disease at new site|1|||
160487926|NCT00053352|579515967|FG001|Overall Study|Disease at new site|0|||
160487927|NCT00931918|579515970|FG000|Overall Study|Adverse Event|4|||
160487928|NCT00931918|579515971|FG001|Overall Study|Adverse Event|6|||
160487929|NCT00931918|579515970|FG000|Overall Study|Progressive Disease|2|||
160487930|NCT00931918|579515971|FG001|Overall Study|Progressive Disease|1|||
160487931|NCT00931918|579515970|FG000|Overall Study|Symptomatic Deterioration|1|||
160487932|NCT00931918|579515971|FG001|Overall Study|Symptomatic Deterioration|0|||
160487933|NCT00931918|579515970|FG000|Overall Study|Withdrawal by Patient|3|||
160487934|NCT00931918|579515971|FG001|Overall Study|Withdrawal by Patient|4|||
160487935|NCT00931918|579515970|FG000|Overall Study|Other Reason not Specified|4|||
160487936|NCT00931918|579515971|FG001|Overall Study|Other Reason not Specified|4|||
160487937|NCT00931918|579515970|FG000|Overall Study|Did not receive study drug|3|||
160487938|NCT00931918|579515971|FG001|Overall Study|Did not receive study drug|2|||
160487939|NCT00809341|579515972|FG000|Overall Study|Physician Decision|0|||
160487940|NCT00809341|579515973|FG001|Overall Study|Physician Decision|1|||
160487941|NCT00570921|579515976|FG000|Overall Study|Protocol Violation|1|||
160487942|NCT00570921|579515976|FG000|Overall Study|Physician Decision|1|||
160487943|NCT03201900|579515977|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
160487944|NCT03201900|579515977|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
160487945|NCT03201900|579515977|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
160487946|NCT03201900|579515977|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
160487947|NCT03201900|579515977|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
160487948|NCT03201900|579515977|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
160487949|NCT03201900|579515977|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
160487950|NCT03201900|579515977|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
160487951|NCT03201900|579515977|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
160487952|NCT03201900|579515977|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
160487953|NCT03201900|579515977|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
160487954|NCT03201900|579515977|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
160487955|NCT03201900|579515977|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
160487956|NCT00550446|579515978|FG000|Up To Week 12|Adverse Event|2|||
160487957|NCT00550446|579515979|FG001|Up To Week 12|Adverse Event|2|||
160487958|NCT00550446|579515980|FG002|Up To Week 12|Adverse Event|0|||
160487959|NCT00550446|579515981|FG003|Up To Week 12|Adverse Event|0|||
160487960|NCT00550446|579515982|FG004|Up To Week 12|Adverse Event|2|||
160487961|NCT00550446|579515983|FG005|Up To Week 12|Adverse Event|2|||
160487962|NCT00550446|579515984|FG006|Up To Week 12|Adverse Event|1|||
160487963|NCT00550446|579515985|FG007|Up To Week 12|Adverse Event|0|||
160487964|NCT00550446|579515986|FG008|Up To Week 12|Adverse Event|0|||
160487965|NCT00550446|579515987|FG009|Up To Week 12|Adverse Event|0|||
160487966|NCT00550446|579515988|FG010|Up To Week 12|Adverse Event|0|||
160487967|NCT00550446|579515978|FG000|Up To Week 12|Lack of Efficacy|3|||
160487968|NCT00550446|579515979|FG001|Up To Week 12|Lack of Efficacy|1|||
160487969|NCT00550446|579515980|FG002|Up To Week 12|Lack of Efficacy|0|||
160487970|NCT00550446|579515981|FG003|Up To Week 12|Lack of Efficacy|1|||
160487971|NCT00550446|579515982|FG004|Up To Week 12|Lack of Efficacy|0|||
160609920|NCT03227224|579948410|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
160609921|NCT03227224|579948411|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
160487972|NCT00550446|579515983|FG005|Up To Week 12|Lack of Efficacy|3|||
160487973|NCT00550446|579515984|FG006|Up To Week 12|Lack of Efficacy|3|||
160487974|NCT00550446|579515985|FG007|Up To Week 12|Lack of Efficacy|0|||
160487975|NCT00550446|579515986|FG008|Up To Week 12|Lack of Efficacy|0|||
160487976|NCT00550446|579515987|FG009|Up To Week 12|Lack of Efficacy|0|||
160487977|NCT00550446|579515988|FG010|Up To Week 12|Lack of Efficacy|0|||
160487978|NCT00550446|579515978|FG000|Up To Week 12|Lost to Follow-up|0|||
160487979|NCT00550446|579515979|FG001|Up To Week 12|Lost to Follow-up|1|||
160487980|NCT00550446|579515980|FG002|Up To Week 12|Lost to Follow-up|0|||
160487981|NCT00550446|579515981|FG003|Up To Week 12|Lost to Follow-up|0|||
160487982|NCT00550446|579515982|FG004|Up To Week 12|Lost to Follow-up|1|||
160487983|NCT00550446|579515983|FG005|Up To Week 12|Lost to Follow-up|1|||
160609922|NCT03227224|579948412|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
160609923|NCT03227224|579948413|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
160609924|NCT03227224|579948410|FG000|Follow-up Phase (2 Weeks)|Other|4|||
160609925|NCT03227224|579948411|FG001|Follow-up Phase (2 Weeks)|Other|4|||
160487984|NCT00550446|579515984|FG006|Up To Week 12|Lost to Follow-up|2|||
160487985|NCT00550446|579515985|FG007|Up To Week 12|Lost to Follow-up|0|||
160487986|NCT00550446|579515986|FG008|Up To Week 12|Lost to Follow-up|0|||
160609926|NCT03227224|579948412|FG002|Follow-up Phase (2 Weeks)|Other|6|||
160609927|NCT03227224|579948413|FG003|Follow-up Phase (2 Weeks)|Other|3|||
160609928|NCT03782376|579948414|FG000|Overall Study|Lost to Follow-up|2|||
160609929|NCT03782376|579948415|FG001|Overall Study|Lost to Follow-up|2|||
160609930|NCT03782376|579948414|FG000|Overall Study|Withdrawal by Subject|7|||
160609931|NCT03782376|579948415|FG001|Overall Study|Withdrawal by Subject|11|||
160609932|NCT03782376|579948414|FG000|Overall Study|Death|1|||
160609933|NCT03782376|579948415|FG001|Overall Study|Death|0|||
160609934|NCT03782376|579948414|FG000|Overall Study|Other|16|||
160609935|NCT03782376|579948415|FG001|Overall Study|Other|17|||
160609936|NCT02659098|579948416|FG000|Overall Study|Withdrawal by Subject|7|||
160609937|NCT04363944|579948417|FG000|Overall Study|Withdrawal by Subject|2|||
160609938|NCT04363944|579948418|FG001|Overall Study|Withdrawal by Subject|0|||
160609939|NCT03559192|579948419|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
160609940|NCT03559192|579948420|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
160609941|NCT03559192|579948421|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
160609942|NCT03559192|579948419|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
160609943|NCT03559192|579948420|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
160609944|NCT03559192|579948421|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
160609945|NCT03559192|579948419|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
160609946|NCT03559192|579948420|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
160609947|NCT03559192|579948421|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
160609948|NCT03559192|579948419|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
160609949|NCT03559192|579948420|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
160609950|NCT03559192|579948421|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
160609951|NCT03559192|579948419|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
160609952|NCT03559192|579948420|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
160609953|NCT03559192|579948421|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
160609954|NCT03559192|579948419|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
160609955|NCT03559192|579948420|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
160609956|NCT03559192|579948421|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
160609957|NCT03559192|579948419|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
160609958|NCT03559192|579948420|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
160609959|NCT03559192|579948421|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
160609960|NCT03559192|579948419|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
160609961|NCT03559192|579948420|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
160609962|NCT03559192|579948421|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
160609963|NCT03559192|579948419|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
160609964|NCT03559192|579948420|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
160609965|NCT03559192|579948421|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
160609966|NCT03517722|579948422|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
160609967|NCT03517722|579948423|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
160609968|NCT03517722|579948422|FG000|Double Blind Period: Week 0-52|Death|0|||
160609969|NCT03517722|579948423|FG001|Double Blind Period: Week 0-52|Death|4|||
160609970|NCT03517722|579948422|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
160609971|NCT03517722|579948423|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
160609972|NCT03517722|579948422|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
160609973|NCT03517722|579948423|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
160609974|NCT03517722|579948422|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
160609975|NCT03517722|579948423|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
160609976|NCT03517722|579948422|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
160609977|NCT03517722|579948423|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
160609978|NCT03517722|579948422|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
160609979|NCT03517722|579948423|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
160609980|NCT03517722|579948422|FG000|Double Blind Period: Week 0-52|Other|4|||
160609981|NCT03517722|579948423|FG001|Double Blind Period: Week 0-52|Other|3|||
160609982|NCT03517722|579948422|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
160609983|NCT03517722|579948423|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
160609984|NCT03517722|579948422|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
160609985|NCT03517722|579948423|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
160609986|NCT03517722|579948422|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
160609987|NCT03517722|579948423|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
160609988|NCT03517722|579948422|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
160609989|NCT03517722|579948423|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
160609990|NCT03517722|579948422|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
160609991|NCT03517722|579948423|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
160609992|NCT05166603|579948429|FG000|Overall Study|Withdrawal by Subject|68|||
160609993|NCT05166603|579948430|FG001|Overall Study|Withdrawal by Subject|0|||
160609994|NCT04418427|579950116|FG000|Overall Study|Death|0|||
160609995|NCT04418427|579950117|FG001|Overall Study|Death|1|||
160609996|NCT04418427|579950118|FG002|Overall Study|Death|0|||
160609997|NCT04418427|579950116|FG000|Overall Study|Lost to Follow-up|0|||
160609998|NCT04418427|579950117|FG001|Overall Study|Lost to Follow-up|2|||
160609999|NCT04418427|579950118|FG002|Overall Study|Lost to Follow-up|2|||
160610000|NCT04418427|579950116|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
160610001|NCT04418427|579950117|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
160610002|NCT04418427|579950118|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
160610003|NCT04418427|579950116|FG000|Overall Study|Pre-existing medical condition|0|||
160610004|NCT04418427|579950117|FG001|Overall Study|Pre-existing medical condition|1|||
160610005|NCT04418427|579950118|FG002|Overall Study|Pre-existing medical condition|0|||
160610006|NCT01673373|579950121|FG000|Overall Study|Death|2|||
160610007|NCT00366444|579950123|FG000|Overall Study|Withdrawal by Subject|1|||
160610008|NCT00366444|579950124|FG001|Overall Study|Withdrawal by Subject|1|||
160610009|NCT00366444|579950123|FG000|Overall Study|Lack of Efficacy|0|||
160487987|NCT00550446|579515987|FG009|Up To Week 12|Lost to Follow-up|0|||
160487988|NCT00550446|579515988|FG010|Up To Week 12|Lost to Follow-up|0|||
160487989|NCT00550446|579515978|FG000|Up To Week 12|Withdrawal by Subject|2|||
160487990|NCT00550446|579515979|FG001|Up To Week 12|Withdrawal by Subject|0|||
160487991|NCT00550446|579515980|FG002|Up To Week 12|Withdrawal by Subject|3|||
160487992|NCT00550446|579515981|FG003|Up To Week 12|Withdrawal by Subject|2|||
160487993|NCT00550446|579515982|FG004|Up To Week 12|Withdrawal by Subject|0|||
160487994|NCT00550446|579515983|FG005|Up To Week 12|Withdrawal by Subject|1|||
160487995|NCT00550446|579515984|FG006|Up To Week 12|Withdrawal by Subject|3|||
160487996|NCT00550446|579515985|FG007|Up To Week 12|Withdrawal by Subject|0|||
160487997|NCT00550446|579515986|FG008|Up To Week 12|Withdrawal by Subject|0|||
160487998|NCT00550446|579515987|FG009|Up To Week 12|Withdrawal by Subject|0|||
160487999|NCT00550446|579515988|FG010|Up To Week 12|Withdrawal by Subject|0|||
160488000|NCT00550446|579515978|FG000|Up To Week 12|Other|3|||
160488001|NCT00550446|579515979|FG001|Up To Week 12|Other|0|||
160488002|NCT00550446|579515980|FG002|Up To Week 12|Other|0|||
160488003|NCT00550446|579515981|FG003|Up To Week 12|Other|0|||
160488004|NCT00550446|579515982|FG004|Up To Week 12|Other|0|||
160488005|NCT00550446|579515983|FG005|Up To Week 12|Other|1|||
160488006|NCT00550446|579515984|FG006|Up To Week 12|Other|4|||
160488007|NCT00550446|579515985|FG007|Up To Week 12|Other|0|||
160488008|NCT00550446|579515986|FG008|Up To Week 12|Other|0|||
160488009|NCT00550446|579515987|FG009|Up To Week 12|Other|0|||
160488010|NCT00550446|579515988|FG010|Up To Week 12|Other|0|||
160488011|NCT00550446|579515978|FG000|Up To Week 12|Randomized not treated|0|||
160488012|NCT00550446|579515979|FG001|Up To Week 12|Randomized not treated|1|||
160488013|NCT00550446|579515980|FG002|Up To Week 12|Randomized not treated|1|||
160488014|NCT00550446|579515981|FG003|Up To Week 12|Randomized not treated|0|||
160488015|NCT00550446|579515982|FG004|Up To Week 12|Randomized not treated|0|||
160488016|NCT00550446|579515983|FG005|Up To Week 12|Randomized not treated|0|||
160488017|NCT00550446|579515984|FG006|Up To Week 12|Randomized not treated|0|||
160488018|NCT00550446|579515985|FG007|Up To Week 12|Randomized not treated|0|||
160488019|NCT00550446|579515986|FG008|Up To Week 12|Randomized not treated|0|||
160488020|NCT00550446|579515987|FG009|Up To Week 12|Randomized not treated|0|||
160488021|NCT00550446|579515988|FG010|Up To Week 12|Randomized not treated|0|||
160488022|NCT00550446|579515978|FG000|Post Week 12|Adverse Event|2|||
160488023|NCT00550446|579515979|FG001|Post Week 12|Adverse Event|1|||
160488024|NCT00550446|579515980|FG002|Post Week 12|Adverse Event|1|||
160488025|NCT00550446|579515981|FG003|Post Week 12|Adverse Event|1|||
160488026|NCT00550446|579515982|FG004|Post Week 12|Adverse Event|1|||
160488027|NCT00550446|579515983|FG005|Post Week 12|Adverse Event|1|||
160610010|NCT00366444|579950124|FG001|Overall Study|Lack of Efficacy|1|||
160610011|NCT01654224|579950129|FG000|Overall Study|Lost to Follow-up|2|||
160610012|NCT01654224|579950130|FG001|Overall Study|Lost to Follow-up|2|||
160610013|NCT01654224|579950129|FG000|Overall Study|Did not receive allocation|1|||
160488028|NCT00550446|579515984|FG006|Post Week 12|Adverse Event|0|||
160488029|NCT00550446|579515985|FG007|Post Week 12|Adverse Event|0|||
160488030|NCT00550446|579515986|FG008|Post Week 12|Adverse Event|0|||
160488031|NCT00550446|579515987|FG009|Post Week 12|Adverse Event|4|||
160488032|NCT00550446|579515988|FG010|Post Week 12|Adverse Event|0|||
160610014|NCT01654224|579950130|FG001|Overall Study|Did not receive allocation|8|||
160610015|NCT01654224|579950129|FG000|Overall Study|Insufficient blood sample|3|||
160488033|NCT00550446|579515978|FG000|Post Week 12|Lack of Efficacy|0|||
160488034|NCT00550446|579515979|FG001|Post Week 12|Lack of Efficacy|0|||
160488035|NCT00550446|579515980|FG002|Post Week 12|Lack of Efficacy|1|||
160488036|NCT00550446|579515981|FG003|Post Week 12|Lack of Efficacy|0|||
160488037|NCT00550446|579515982|FG004|Post Week 12|Lack of Efficacy|0|||
160488038|NCT00550446|579515983|FG005|Post Week 12|Lack of Efficacy|0|||
160488039|NCT00550446|579515984|FG006|Post Week 12|Lack of Efficacy|0|||
160488040|NCT00550446|579515985|FG007|Post Week 12|Lack of Efficacy|1|||
160488041|NCT00550446|579515986|FG008|Post Week 12|Lack of Efficacy|1|||
160488042|NCT00550446|579515987|FG009|Post Week 12|Lack of Efficacy|2|||
160610016|NCT01654224|579950130|FG001|Overall Study|Insufficient blood sample|2|||
160610017|NCT00166504|579950132|FG000|Overall Study|Adverse Event|3|||
160610018|NCT00166504|579950133|FG001|Overall Study|Adverse Event|3|||
160610019|NCT00166504|579950132|FG000|Overall Study|Lost to Follow-up|1|||
160610020|NCT00166504|579950133|FG001|Overall Study|Lost to Follow-up|1|||
160610021|NCT00166504|579950132|FG000|Overall Study|Withdrawal by Subject|1|||
160610022|NCT00166504|579950133|FG001|Overall Study|Withdrawal by Subject|0|||
160610023|NCT02200510|579950134|FG000|Overall Study|Death|1|||
160610024|NCT02200510|579950135|FG001|Overall Study|Death|1|||
160610025|NCT02200510|579950134|FG000|Overall Study|Protocol Violation|0|||
160610026|NCT02200510|579950135|FG001|Overall Study|Protocol Violation|1|||
160610027|NCT02200510|579950134|FG000|Overall Study|Lost to Follow-up|7|||
160610028|NCT02200510|579950135|FG001|Overall Study|Lost to Follow-up|1|||
160610029|NCT02200510|579950134|FG000|Overall Study|potential COI - joined study team|1|||
160610030|NCT02200510|579950135|FG001|Overall Study|potential COI - joined study team|0|||
160610031|NCT03261037|579950136|FG000|Overall Study|Withdrawal by Subject|2|||
160610032|NCT03261037|579950137|FG001|Overall Study|Withdrawal by Subject|13|||
160610033|NCT03261037|579950138|FG002|Overall Study|Withdrawal by Subject|0|||
160610034|NCT03261037|579950139|FG003|Overall Study|Withdrawal by Subject|18|||
160610035|NCT03261037|579950136|FG000|Overall Study|Non-compliance with study procedures|0|||
160610036|NCT03261037|579950137|FG001|Overall Study|Non-compliance with study procedures|2|||
160610037|NCT03261037|579950138|FG002|Overall Study|Non-compliance with study procedures|0|||
160610038|NCT03261037|579950139|FG003|Overall Study|Non-compliance with study procedures|6|||
160610039|NCT03261037|579950136|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
160610040|NCT03261037|579950137|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
160610041|NCT03261037|579950138|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
160610042|NCT03261037|579950139|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
160610043|NCT03261037|579950136|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
160610044|NCT03261037|579950137|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
160610045|NCT03261037|579950138|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
160610046|NCT03261037|579950139|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
160610047|NCT03261037|579950136|FG000|Overall Study|Diagnosed but protocol deviation|1|||
160610048|NCT03261037|579950137|FG001|Overall Study|Diagnosed but protocol deviation|0|||
160610049|NCT03261037|579950138|FG002|Overall Study|Diagnosed but protocol deviation|0|||
160610050|NCT03261037|579950139|FG003|Overall Study|Diagnosed but protocol deviation|0|||
160610051|NCT03261037|579950136|FG000|Overall Study|Participant did not want to continue the study|0|||
160610052|NCT03261037|579950137|FG001|Overall Study|Participant did not want to continue the study|1|||
160610053|NCT03261037|579950138|FG002|Overall Study|Participant did not want to continue the study|0|||
160610054|NCT03261037|579950139|FG003|Overall Study|Participant did not want to continue the study|0|||
160610055|NCT03261037|579950136|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
160610056|NCT03261037|579950137|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
160610057|NCT03261037|579950138|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
160610058|NCT03261037|579950139|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
160610059|NCT03261037|579950136|FG000|Overall Study|Participant presented clinical improvement|0|||
160610060|NCT03261037|579950137|FG001|Overall Study|Participant presented clinical improvement|2|||
160610061|NCT03261037|579950138|FG002|Overall Study|Participant presented clinical improvement|0|||
160610062|NCT03261037|579950139|FG003|Overall Study|Participant presented clinical improvement|0|||
160610063|NCT03261037|579950136|FG000|Overall Study|Technical difficulties|0|||
160610064|NCT03261037|579950137|FG001|Overall Study|Technical difficulties|0|||
160610065|NCT03261037|579950138|FG002|Overall Study|Technical difficulties|0|||
160610066|NCT03261037|579950139|FG003|Overall Study|Technical difficulties|1|||
160610067|NCT03261037|579950136|FG000|Overall Study|Equipment failed to work|0|||
160610068|NCT03261037|579950137|FG001|Overall Study|Equipment failed to work|0|||
160610069|NCT03261037|579950138|FG002|Overall Study|Equipment failed to work|0|||
160610070|NCT03261037|579950139|FG003|Overall Study|Equipment failed to work|1|||
160610071|NCT03261037|579950136|FG000|Overall Study|End of study for participant and no follow up|0|||
160610072|NCT03261037|579950137|FG001|Overall Study|End of study for participant and no follow up|0|||
160610073|NCT03261037|579950138|FG002|Overall Study|End of study for participant and no follow up|0|||
160610074|NCT03261037|579950139|FG003|Overall Study|End of study for participant and no follow up|1|||
160610075|NCT03261037|579950136|FG000|Overall Study|Participant was too weak to continue in study|1|||
160610076|NCT03261037|579950137|FG001|Overall Study|Participant was too weak to continue in study|0|||
160610077|NCT03261037|579950138|FG002|Overall Study|Participant was too weak to continue in study|0|||
160610078|NCT03261037|579950139|FG003|Overall Study|Participant was too weak to continue in study|0|||
160610079|NCT02881151|579950142|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
160610080|NCT01266876|579950148|FG000|Overall Study|Adverse Event|0|||
160610081|NCT01266876|579950149|FG001|Overall Study|Adverse Event|0|||
160610082|NCT01266876|579950150|FG002|Overall Study|Adverse Event|0|||
160610083|NCT01266876|579950151|FG003|Overall Study|Adverse Event|1|||
160610084|NCT01266876|579950152|FG004|Overall Study|Adverse Event|0|||
160610085|NCT05016037|579950154|FG000|Overall Study|Lost to Follow-up|2|||
160610086|NCT00557323|579950155|FG000|Overall Study|Death|3|||
160610087|NCT00557323|579950155|FG000|Overall Study|Withdrawal by Subject|2|||
160610088|NCT00557323|579950155|FG000|Overall Study|Administrative change|2|||
160610089|NCT04007367|579950159|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
160610090|NCT04007367|579950160|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
160610091|NCT04007367|579950161|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
160610092|NCT04007367|579950159|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
160610093|NCT04007367|579950160|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
160610094|NCT04007367|579950161|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
160610095|NCT04007367|579950159|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
160610096|NCT04007367|579950160|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
160610097|NCT04007367|579950161|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
160610098|NCT04007367|579950159|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
160610099|NCT04007367|579950160|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
160610100|NCT04007367|579950161|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
160610101|NCT04007367|579950159|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
160610102|NCT04007367|579950160|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
160610103|NCT04007367|579950161|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
160610104|NCT02010567|579950162|FG000|Overall Study|Adverse Event|0|||
160610105|NCT02010567|579950163|FG001|Overall Study|Adverse Event|0|||
160610106|NCT02010567|579950164|FG002|Overall Study|Adverse Event|1|||
160610107|NCT02010567|579950165|FG003|Overall Study|Adverse Event|0|||
160610108|NCT02010567|579950166|FG004|Overall Study|Adverse Event|1|||
160610109|NCT00623766|579950175|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
160610110|NCT00623766|579950176|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
160610111|NCT00623766|579950175|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
160610112|NCT00623766|579950176|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
160610113|NCT00623766|579950175|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
160610114|NCT00623766|579950176|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
160610115|NCT00623766|579950175|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
160610116|NCT00623766|579950176|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
160610117|NCT00623766|579950175|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
160610118|NCT00623766|579950176|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
160610119|NCT00796549|579950177|FG000|Overall Study|Adverse Event|11|||
160610120|NCT00796549|579950177|FG000|Overall Study|not entered|149|||
160610121|NCT00796549|579950177|FG000|Overall Study|Other|2|||
160610122|NCT00796549|579950177|FG000|Overall Study|Progressive disease|56|||
160610123|NCT00606229|579950179|FG000|Overall Study|Adverse Event|11|||
160610124|NCT00606229|579950179|FG000|Overall Study|Lack of Efficacy|1|||
160610125|NCT00606229|579950179|FG000|Overall Study|Withdrawal by Subject|4|||
160610126|NCT00606229|579950179|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
160610127|NCT00606229|579950179|FG000|Overall Study|change of residence or other commitments|2|||
160610128|NCT03523715|579950180|FG000|Overall Study|Lost to Follow-up|11|||
160610129|NCT03523715|579950181|FG001|Overall Study|Lost to Follow-up|14|||
160610130|NCT03523715|579950180|FG000|Overall Study|Did not meet inclusion criteria|1|||
160610131|NCT03523715|579950181|FG001|Overall Study|Did not meet inclusion criteria|0|||
160610132|NCT03523715|579950180|FG000|Overall Study|Internally inconsistent reporting|0|||
160610133|NCT03523715|579950181|FG001|Overall Study|Internally inconsistent reporting|2|||
160610134|NCT01526928|579950182|FG000|Overall Study|Progressive Disease|35|||
160610135|NCT01526928|579950183|FG001|Overall Study|Progressive Disease|17|||
160610136|NCT01526928|579950184|FG002|Overall Study|Progressive Disease|150|||
160610137|NCT01526928|579950185|FG003|Overall Study|Progressive Disease|182|||
160610138|NCT01526928|579950186|FG004|Overall Study|Progressive Disease|76|||
160610139|NCT01526928|579950187|FG005|Overall Study|Progressive Disease|4|||
160610140|NCT01526928|579950182|FG000|Overall Study|Adverse Event|2|||
160610141|NCT01526928|579950183|FG001|Overall Study|Adverse Event|1|||
160610142|NCT01526928|579950184|FG002|Overall Study|Adverse Event|29|||
160610143|NCT01526928|579950185|FG003|Overall Study|Adverse Event|40|||
160610144|NCT01526928|579950186|FG004|Overall Study|Adverse Event|13|||
160610145|NCT01526928|579950187|FG005|Overall Study|Adverse Event|2|||
160610146|NCT01526928|579950182|FG000|Overall Study|Death|0|||
160610147|NCT01526928|579950183|FG001|Overall Study|Death|0|||
160610148|NCT01526928|579950184|FG002|Overall Study|Death|3|||
160610149|NCT01526928|579950185|FG003|Overall Study|Death|0|||
160610150|NCT01526928|579950186|FG004|Overall Study|Death|0|||
160610151|NCT01526928|579950187|FG005|Overall Study|Death|0|||
160610152|NCT01526928|579950182|FG000|Overall Study|Withdrawal by Subject|1|||
160610153|NCT01526928|579950183|FG001|Overall Study|Withdrawal by Subject|0|||
160610154|NCT01526928|579950184|FG002|Overall Study|Withdrawal by Subject|13|||
160610155|NCT01526928|579950185|FG003|Overall Study|Withdrawal by Subject|11|||
160610156|NCT01526928|579950186|FG004|Overall Study|Withdrawal by Subject|3|||
160610157|NCT01526928|579950187|FG005|Overall Study|Withdrawal by Subject|0|||
160610158|NCT01526928|579950182|FG000|Overall Study|Physician Decision|0|||
160610159|NCT01526928|579950183|FG001|Overall Study|Physician Decision|0|||
160610160|NCT01526928|579950184|FG002|Overall Study|Physician Decision|2|||
160610161|NCT01526928|579950185|FG003|Overall Study|Physician Decision|5|||
160610162|NCT01526928|579950186|FG004|Overall Study|Physician Decision|0|||
160610163|NCT01526928|579950187|FG005|Overall Study|Physician Decision|0|||
160610164|NCT01526928|579950182|FG000|Overall Study|Other Reason|0|||
160610165|NCT01526928|579950183|FG001|Overall Study|Other Reason|1|||
160610166|NCT01526928|579950184|FG002|Overall Study|Other Reason|11|||
160610167|NCT01526928|579950185|FG003|Overall Study|Other Reason|4|||
160610168|NCT01526928|579950186|FG004|Overall Study|Other Reason|1|||
160610169|NCT01526928|579950187|FG005|Overall Study|Other Reason|0|||
160610170|NCT01526928|579950182|FG000|Overall Study|Lost to Follow-up|0|||
160610171|NCT01526928|579950183|FG001|Overall Study|Lost to Follow-up|0|||
160610172|NCT01526928|579950184|FG002|Overall Study|Lost to Follow-up|0|||
160610173|NCT01526928|579950185|FG003|Overall Study|Lost to Follow-up|1|||
160610174|NCT01526928|579950186|FG004|Overall Study|Lost to Follow-up|0|||
160610175|NCT01526928|579950187|FG005|Overall Study|Lost to Follow-up|0|||
160610176|NCT01526928|579950182|FG000|Overall Study|Protocol Deviation|0|||
160610177|NCT01526928|579950183|FG001|Overall Study|Protocol Deviation|0|||
160610178|NCT01526928|579950184|FG002|Overall Study|Protocol Deviation|0|||
160610179|NCT01526928|579950185|FG003|Overall Study|Protocol Deviation|2|||
160610180|NCT01526928|579950186|FG004|Overall Study|Protocol Deviation|0|||
160610181|NCT01526928|579950187|FG005|Overall Study|Protocol Deviation|0|||
160610182|NCT01526928|579950182|FG000|Overall Study|Missing|0|||
160610183|NCT01526928|579950183|FG001|Overall Study|Missing|0|||
160610184|NCT01526928|579950184|FG002|Overall Study|Missing|1|||
160610185|NCT01526928|579950185|FG003|Overall Study|Missing|0|||
160610186|NCT01526928|579950186|FG004|Overall Study|Missing|2|||
160610187|NCT01526928|579950187|FG005|Overall Study|Missing|0|||
160610188|NCT00942422|579950188|FG000|Overall Study|Withdrawal by Subject|1|||
160610189|NCT00942422|579950188|FG000|Overall Study|Death|1|||
160610190|NCT00942422|579950188|FG000|Overall Study|Progressive diease|1|||
160610191|NCT05559203|579950189|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
160610192|NCT00422903|579950194|FG000|Overall Study|Disease Progression|3|||
160610193|NCT00422903|579950195|FG001|Overall Study|Disease Progression|1|||
160610194|NCT00422903|579950194|FG000|Overall Study|Adverse Event|0|||
160610195|NCT00422903|579950195|FG001|Overall Study|Adverse Event|2|||
160610196|NCT00422903|579950194|FG000|Overall Study|Informed Consent Withdrawn|1|||
160610197|NCT00422903|579950195|FG001|Overall Study|Informed Consent Withdrawn|2|||
160610198|NCT01302691|579950200|FG000|Overall Study|Adverse Event|2|||
160610199|NCT01302691|579950201|FG001|Overall Study|Adverse Event|0|||
160610200|NCT01302691|579950200|FG000|Overall Study|Death|0|||
160610201|NCT01302691|579950201|FG001|Overall Study|Death|1|||
160610202|NCT01302691|579950200|FG000|Overall Study|Lost to Follow-up|1|||
160610203|NCT01302691|579950201|FG001|Overall Study|Lost to Follow-up|0|||
160610204|NCT01302691|579950200|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
160610205|NCT01302691|579950201|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
160610206|NCT01302691|579950200|FG000|Overall Study|Physician Decision|0|||
160610207|NCT01302691|579950201|FG001|Overall Study|Physician Decision|1|||
160610208|NCT01302691|579950200|FG000|Overall Study|Protocol Violation|1|||
160610209|NCT01302691|579950201|FG001|Overall Study|Protocol Violation|0|||
160610210|NCT03446612|579950202|FG000|Overall Study|Protocol defined stopping criteria|0|||
160610211|NCT03446612|579950203|FG001|Overall Study|Protocol defined stopping criteria|1|||
160610212|NCT01810380|579950209|FG000|Overall Study|Randomised not treated|2|||
160610213|NCT01810380|579950210|FG001|Overall Study|Randomised not treated|1|||
160610214|NCT01810380|579950211|FG002|Overall Study|Randomised not treated|1|||
160610215|NCT01810380|579950209|FG000|Overall Study|Adverse Event|11|||
160610216|NCT01810380|579950210|FG001|Overall Study|Adverse Event|14|||
160610217|NCT01810380|579950211|FG002|Overall Study|Adverse Event|4|||
160610218|NCT01810380|579950209|FG000|Overall Study|Lack of Efficacy|24|||
160610219|NCT01810380|579950210|FG001|Overall Study|Lack of Efficacy|10|||
160610220|NCT01810380|579950211|FG002|Overall Study|Lack of Efficacy|11|||
160610221|NCT01810380|579950209|FG000|Overall Study|Protocol Violation|1|||
160610222|NCT01810380|579950210|FG001|Overall Study|Protocol Violation|0|||
160610223|NCT01810380|579950211|FG002|Overall Study|Protocol Violation|1|||
160610224|NCT01810380|579950209|FG000|Overall Study|Withdrawal by Subject|6|||
160488043|NCT00550446|579515988|FG010|Post Week 12|Lack of Efficacy|1|||
160610225|NCT01810380|579950210|FG001|Overall Study|Withdrawal by Subject|0|||
160610226|NCT01810380|579950211|FG002|Overall Study|Withdrawal by Subject|6|||
160610227|NCT01810380|579950209|FG000|Overall Study|Administrative or other reasons|11|||
160610228|NCT01810380|579950210|FG001|Overall Study|Administrative or other reasons|13|||
160610229|NCT01810380|579950211|FG002|Overall Study|Administrative or other reasons|9|||
160610230|NCT02829775|579950212|FG000|Overall Study|Death|1|||
160610231|NCT02829775|579950212|FG000|Overall Study|Withdrawal by Subject|3|||
160610232|NCT02829775|579950212|FG000|Overall Study|Disease remission|1|||
160610233|NCT00441012|579950215|FG000|Overall Study|Adverse Event|0|||
160610234|NCT00441012|579950216|FG001|Overall Study|Adverse Event|1|||
160610235|NCT00441012|579950215|FG000|Overall Study|Lost to Follow-up|3|||
160610236|NCT00441012|579950216|FG001|Overall Study|Lost to Follow-up|3|||
160610237|NCT00441012|579950215|FG000|Overall Study|Protocol Violation|10|||
160488044|NCT00550446|579515978|FG000|Post Week 12|Lost to Follow-up|0|||
160488045|NCT00550446|579515979|FG001|Post Week 12|Lost to Follow-up|0|||
160488046|NCT00550446|579515980|FG002|Post Week 12|Lost to Follow-up|1|||
160488047|NCT00550446|579515981|FG003|Post Week 12|Lost to Follow-up|1|||
160488048|NCT00550446|579515982|FG004|Post Week 12|Lost to Follow-up|0|||
160488049|NCT00550446|579515983|FG005|Post Week 12|Lost to Follow-up|0|||
160488050|NCT00550446|579515984|FG006|Post Week 12|Lost to Follow-up|1|||
160488051|NCT00550446|579515985|FG007|Post Week 12|Lost to Follow-up|0|||
160488052|NCT00550446|579515986|FG008|Post Week 12|Lost to Follow-up|0|||
160488053|NCT00550446|579515987|FG009|Post Week 12|Lost to Follow-up|0|||
160488054|NCT00550446|579515988|FG010|Post Week 12|Lost to Follow-up|0|||
160488055|NCT00550446|579515978|FG000|Post Week 12|Withdrawal by Subject|0|||
160488056|NCT00550446|579515979|FG001|Post Week 12|Withdrawal by Subject|0|||
160488057|NCT00550446|579515980|FG002|Post Week 12|Withdrawal by Subject|0|||
160488058|NCT00550446|579515981|FG003|Post Week 12|Withdrawal by Subject|0|||
160488059|NCT00550446|579515982|FG004|Post Week 12|Withdrawal by Subject|1|||
160488060|NCT00550446|579515983|FG005|Post Week 12|Withdrawal by Subject|0|||
160488061|NCT00550446|579515984|FG006|Post Week 12|Withdrawal by Subject|0|||
160488062|NCT00550446|579515985|FG007|Post Week 12|Withdrawal by Subject|0|||
160488063|NCT00550446|579515986|FG008|Post Week 12|Withdrawal by Subject|0|||
160488064|NCT00550446|579515987|FG009|Post Week 12|Withdrawal by Subject|0|||
160488065|NCT00550446|579515988|FG010|Post Week 12|Withdrawal by Subject|0|||
160488066|NCT00550446|579515978|FG000|Post Week 12|Other|1|||
160488067|NCT00550446|579515979|FG001|Post Week 12|Other|1|||
160488068|NCT00550446|579515980|FG002|Post Week 12|Other|0|||
160488069|NCT00550446|579515981|FG003|Post Week 12|Other|1|||
160488070|NCT00550446|579515982|FG004|Post Week 12|Other|0|||
160488071|NCT00550446|579515983|FG005|Post Week 12|Other|0|||
160488072|NCT00550446|579515984|FG006|Post Week 12|Other|1|||
160488073|NCT00550446|579515985|FG007|Post Week 12|Other|0|||
160488074|NCT00550446|579515986|FG008|Post Week 12|Other|1|||
160488075|NCT00550446|579515987|FG009|Post Week 12|Other|1|||
160488076|NCT00550446|579515988|FG010|Post Week 12|Other|0|||
160488077|NCT00025506|579515989|FG000|Overall Study|Ineligible: clerical error|1|||
160488078|NCT00025506|579515989|FG000|Overall Study|Ineligible: wrong cell type|5|||
160488079|NCT00025506|579515989|FG000|Overall Study|Ineligible: inadequate pathology|2|||
160488080|NCT00025506|579515989|FG000|Overall Study|Never Treated|2|||
160488081|NCT03891641|579515997|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
160488082|NCT03891641|579515998|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
160488083|NCT00578318|579515999|FG000|Overall Study|Lost to Follow-up|2|||
160488084|NCT00578318|579516000|FG001|Overall Study|Lost to Follow-up|0|||
160488085|NCT00578318|579515999|FG000|Overall Study|Physician Decision|1|||
160488086|NCT00578318|579516000|FG001|Overall Study|Physician Decision|0|||
160488087|NCT00920699|579516006|FG000|Overall Study|Withdrawal by Subject|2|||
160488088|NCT00920699|579516007|FG001|Overall Study|Withdrawal by Subject|0|||
160488089|NCT00920699|579516008|FG002|Overall Study|Withdrawal by Subject|2|||
160488090|NCT00920699|579516006|FG000|Overall Study|no longer met eligibility|0|||
160488091|NCT00920699|579516007|FG001|Overall Study|no longer met eligibility|1|||
160488092|NCT00920699|579516008|FG002|Overall Study|no longer met eligibility|0|||
160488093|NCT00920699|579516006|FG000|Overall Study|Lost to Follow-up|0|||
160488094|NCT00920699|579516007|FG001|Overall Study|Lost to Follow-up|0|||
160488095|NCT00920699|579516008|FG002|Overall Study|Lost to Follow-up|2|||
160488096|NCT00001941|579516011|FG000|Overall Study|not treated- rapidly progressing disease|0|||
160488097|NCT00001941|579516012|FG001|Overall Study|not treated- rapidly progressing disease|0|||
160488098|NCT00001941|579516013|FG002|Overall Study|not treated- rapidly progressing disease|0|||
160488099|NCT00001941|579516014|FG003|Overall Study|not treated- rapidly progressing disease|0|||
160488100|NCT00001941|579516015|FG004|Overall Study|not treated- rapidly progressing disease|1|||
160488101|NCT02287883|579516017|FG000|Overall Study|Death|8|||
160488102|NCT02287883|579516018|FG001|Overall Study|Death|7|||
160488103|NCT02287883|579516017|FG000|Overall Study|No longer eligible|222|||
160488104|NCT02287883|579516018|FG001|Overall Study|No longer eligible|182|||
160488105|NCT02287883|579516017|FG000|Overall Study|Non-response to survey|229|||
160488106|NCT02287883|579516018|FG001|Overall Study|Non-response to survey|237|||
160488107|NCT01281917|579516022|FG000|Overall Study|Withdrawal by Subject|1|||
160488108|NCT02101268|579516025|FG000|Randomized Treatment Phase|Subject Decision|8|||
160488109|NCT02101268|579516026|FG001|Randomized Treatment Phase|Subject Decision|4|||
160488110|NCT02101268|579516027|FG002|Randomized Treatment Phase|Subject Decision|0|||
160488111|NCT02101268|579516028|FG003|Randomized Treatment Phase|Subject Decision|0|||
160488112|NCT02101268|579516025|FG000|Randomized Treatment Phase|Physician Decision|4|||
160488113|NCT02101268|579516026|FG001|Randomized Treatment Phase|Physician Decision|1|||
160488114|NCT02101268|579516027|FG002|Randomized Treatment Phase|Physician Decision|0|||
160488115|NCT02101268|579516028|FG003|Randomized Treatment Phase|Physician Decision|0|||
160488116|NCT02101268|579516025|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
160488117|NCT02101268|579516026|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
160488118|NCT02101268|579516027|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
160488119|NCT02101268|579516028|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
160488120|NCT02101268|579516025|FG000|Randomized Treatment Phase|Adverse Event|6|||
160610238|NCT00441012|579950216|FG001|Overall Study|Protocol Violation|9|||
160610239|NCT00441012|579950215|FG000|Overall Study|Withdrawal by Subject|4|||
160610240|NCT00441012|579950216|FG001|Overall Study|Withdrawal by Subject|0|||
160610241|NCT00441012|579950215|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
160610242|NCT00441012|579950216|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
160610243|NCT00262314|579950217|FG000|Overall Study|Changing physicians|38|||
160610244|NCT00262314|579950217|FG000|Overall Study|Death|12|||
160610245|NCT00262314|579950217|FG000|Overall Study|Patient's decision|92|||
160610246|NCT00262314|579950217|FG000|Overall Study|Other|95|||
160610247|NCT00262314|579950217|FG000|Overall Study|Lost to Follow-up|70|||
160610248|NCT00262314|579950217|FG000|Overall Study|Administrative withdrawal|30|||
160610249|NCT00090766|579950218|FG000|Overall Study|Nephrectomy Planned|0|||
160610250|NCT00090766|579950219|FG001|Overall Study|Nephrectomy Planned|0|||
160610251|NCT00090766|579950220|FG002|Overall Study|Nephrectomy Planned|1|||
160610252|NCT00090766|579950218|FG000|Overall Study|Death|1|||
160610253|NCT00090766|579950219|FG001|Overall Study|Death|0|||
160610254|NCT00090766|579950220|FG002|Overall Study|Death|0|||
160610255|NCT00090766|579950218|FG000|Overall Study|Admin|0|||
160610256|NCT00090766|579950219|FG001|Overall Study|Admin|2|||
160610257|NCT00090766|579950220|FG002|Overall Study|Admin|0|||
160610258|NCT00090766|579950218|FG000|Overall Study|Lost to Follow-up|2|||
160610259|NCT00090766|579950219|FG001|Overall Study|Lost to Follow-up|0|||
160610260|NCT00090766|579950220|FG002|Overall Study|Lost to Follow-up|2|||
160610261|NCT00804986|579950221|FG000|Overall Study|Adverse Event|0|||
160610262|NCT00804986|579950222|FG001|Overall Study|Adverse Event|1|||
160610263|NCT00804986|579950223|FG002|Overall Study|Adverse Event|2|||
160610264|NCT00804986|579950224|FG003|Overall Study|Adverse Event|1|||
160610265|NCT00804986|579950225|FG004|Overall Study|Adverse Event|3|||
160610266|NCT00804986|579950226|FG005|Overall Study|Adverse Event|0|||
160610267|NCT00804986|579950221|FG000|Overall Study|Lack of Efficacy|0|||
160610268|NCT00804986|579950222|FG001|Overall Study|Lack of Efficacy|0|||
160610269|NCT00804986|579950223|FG002|Overall Study|Lack of Efficacy|0|||
160610270|NCT00804986|579950224|FG003|Overall Study|Lack of Efficacy|1|||
160610271|NCT00804986|579950225|FG004|Overall Study|Lack of Efficacy|0|||
160610272|NCT00804986|579950226|FG005|Overall Study|Lack of Efficacy|3|||
160610273|NCT00804986|579950221|FG000|Overall Study|Lost to Follow-up|0|||
160610274|NCT00804986|579950222|FG001|Overall Study|Lost to Follow-up|0|||
160610275|NCT00804986|579950223|FG002|Overall Study|Lost to Follow-up|0|||
160610276|NCT00804986|579950224|FG003|Overall Study|Lost to Follow-up|1|||
160610277|NCT00804986|579950225|FG004|Overall Study|Lost to Follow-up|1|||
160610278|NCT00804986|579950226|FG005|Overall Study|Lost to Follow-up|3|||
160610279|NCT00804986|579950221|FG000|Overall Study|Protocol Violation|0|||
160610280|NCT00804986|579950222|FG001|Overall Study|Protocol Violation|1|||
160610281|NCT00804986|579950223|FG002|Overall Study|Protocol Violation|0|||
160610282|NCT00804986|579950224|FG003|Overall Study|Protocol Violation|1|||
160610283|NCT00804986|579950225|FG004|Overall Study|Protocol Violation|0|||
160610284|NCT00804986|579950226|FG005|Overall Study|Protocol Violation|0|||
160610285|NCT00804986|579950221|FG000|Overall Study|Withdrawal by Subject|0|||
160610286|NCT00804986|579950222|FG001|Overall Study|Withdrawal by Subject|3|||
160610287|NCT00804986|579950223|FG002|Overall Study|Withdrawal by Subject|0|||
160610288|NCT00804986|579950224|FG003|Overall Study|Withdrawal by Subject|3|||
160610289|NCT00804986|579950225|FG004|Overall Study|Withdrawal by Subject|5|||
160610290|NCT00804986|579950226|FG005|Overall Study|Withdrawal by Subject|3|||
160610291|NCT00804986|579950221|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
160610292|NCT00804986|579950222|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
160610293|NCT00804986|579950223|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
160610294|NCT00804986|579950224|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
160610295|NCT00804986|579950225|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
160610296|NCT00804986|579950226|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
160610297|NCT00804986|579950221|FG000|Overall Study|Sponsor Decision|0|||
160610298|NCT00804986|579950222|FG001|Overall Study|Sponsor Decision|1|||
160610299|NCT00804986|579950223|FG002|Overall Study|Sponsor Decision|0|||
160610300|NCT00804986|579950224|FG003|Overall Study|Sponsor Decision|0|||
160610301|NCT00804986|579950225|FG004|Overall Study|Sponsor Decision|0|||
160610302|NCT00804986|579950226|FG005|Overall Study|Sponsor Decision|0|||
160610303|NCT00804986|579950221|FG000|Overall Study|Physician Decision|1|||
160610304|NCT00804986|579950222|FG001|Overall Study|Physician Decision|0|||
160610305|NCT00804986|579950223|FG002|Overall Study|Physician Decision|0|||
160610306|NCT00804986|579950224|FG003|Overall Study|Physician Decision|0|||
160610307|NCT00804986|579950225|FG004|Overall Study|Physician Decision|0|||
160610308|NCT00804986|579950226|FG005|Overall Study|Physician Decision|0|||
160610309|NCT02774291|579950228|FG000|Overall Study|Lost to Follow-up|1|||
160610310|NCT03954704|579950235|FG000|Overall Study|Death|1|||
160610311|NCT03954704|579950236|FG001|Overall Study|Death|1|||
160610312|NCT03954704|579950237|FG002|Overall Study|Death|1|||
160610313|NCT03954704|579950238|FG003|Overall Study|Death|3|||
160610314|NCT03954704|579950239|FG004|Overall Study|Death|2|||
160610315|NCT03954704|579950240|FG005|Overall Study|Death|2|||
160610316|NCT03954704|579950241|FG006|Overall Study|Death|0|||
160610317|NCT03954704|579950235|FG000|Overall Study|Withdrew Consent|0|||
160610318|NCT03954704|579950236|FG001|Overall Study|Withdrew Consent|0|||
160610319|NCT03954704|579950237|FG002|Overall Study|Withdrew Consent|1|||
160610320|NCT03954704|579950238|FG003|Overall Study|Withdrew Consent|0|||
160610321|NCT03954704|579950239|FG004|Overall Study|Withdrew Consent|0|||
160610322|NCT03954704|579950240|FG005|Overall Study|Withdrew Consent|1|||
160610323|NCT03954704|579950241|FG006|Overall Study|Withdrew Consent|0|||
160610324|NCT03954704|579950235|FG000|Overall Study|Lost to Follow-up|0|||
160610325|NCT03954704|579950236|FG001|Overall Study|Lost to Follow-up|0|||
160610326|NCT03954704|579950237|FG002|Overall Study|Lost to Follow-up|0|||
160610327|NCT03954704|579950238|FG003|Overall Study|Lost to Follow-up|0|||
160610328|NCT03954704|579950239|FG004|Overall Study|Lost to Follow-up|0|||
160610329|NCT03954704|579950240|FG005|Overall Study|Lost to Follow-up|0|||
160610330|NCT03954704|579950241|FG006|Overall Study|Lost to Follow-up|1|||
160610331|NCT03954704|579950235|FG000|Overall Study|Study Terminated by Sponsor|0|||
160610332|NCT03954704|579950236|FG001|Overall Study|Study Terminated by Sponsor|0|||
160610333|NCT03954704|579950237|FG002|Overall Study|Study Terminated by Sponsor|1|||
160610334|NCT03954704|579950238|FG003|Overall Study|Study Terminated by Sponsor|0|||
160610335|NCT03954704|579950239|FG004|Overall Study|Study Terminated by Sponsor|1|||
160610336|NCT03954704|579950240|FG005|Overall Study|Study Terminated by Sponsor|4|||
160610337|NCT03954704|579950241|FG006|Overall Study|Study Terminated by Sponsor|2|||
160610338|NCT03954704|579950235|FG000|Overall Study|Enrolled but not Treated|0|||
160610339|NCT03954704|579950236|FG001|Overall Study|Enrolled but not Treated|0|||
160661298|NCT00723528|580144038|FG003|Period 2: After Controlled Period|Adverse Event|0|||
160661299|NCT00723528|580144039|FG004|Period 2: After Controlled Period|Adverse Event|1|||
160661300|NCT00723528|580144040|FG005|Period 2: After Controlled Period|Adverse Event|0|||
160661301|NCT00723528|580144041|FG006|Period 2: After Controlled Period|Adverse Event|1|||
160661302|NCT00723528|580144035|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
160610340|NCT03954704|579950237|FG002|Overall Study|Enrolled but not Treated|0|||
160610341|NCT03954704|579950238|FG003|Overall Study|Enrolled but not Treated|0|||
160610342|NCT03954704|579950239|FG004|Overall Study|Enrolled but not Treated|0|||
160610343|NCT03954704|579950240|FG005|Overall Study|Enrolled but not Treated|1|||
160610344|NCT03954704|579950241|FG006|Overall Study|Enrolled but not Treated|0|||
160610345|NCT00397891|579950244|FG000|Overall Study|Withdrawal by Subject|1|||
160610346|NCT00397891|579950245|FG001|Overall Study|Withdrawal by Subject|0|||
160610347|NCT00397891|579950246|FG002|Overall Study|Withdrawal by Subject|0|||
160610348|NCT00397891|579950247|FG003|Overall Study|Withdrawal by Subject|0|||
160610349|NCT00397891|579950248|FG004|Overall Study|Withdrawal by Subject|1|||
160610350|NCT02254304|579950251|FG000|Overall Study|Adverse Event|2|||
160610351|NCT02254304|579950252|FG001|Overall Study|Adverse Event|1|||
160610352|NCT02254304|579950251|FG000|Overall Study|Lost to Follow-up|2|||
160610353|NCT02254304|579950252|FG001|Overall Study|Lost to Follow-up|2|||
160610354|NCT02254304|579950251|FG000|Overall Study|Protocol Violation|1|||
160677538|NCT01567527|580198883|FG004|Conversion Phase.|Met withdrawal criteria|0|||
160488121|NCT02101268|579516026|FG001|Randomized Treatment Phase|Adverse Event|0|||
160610355|NCT02254304|579950252|FG001|Overall Study|Protocol Violation|0|||
160610356|NCT02254304|579950251|FG000|Overall Study|Withdrawal by Subject|3|||
160610357|NCT02254304|579950252|FG001|Overall Study|Withdrawal by Subject|0|||
160610358|NCT02254304|579950251|FG000|Overall Study|Injection site pain and Injection fear|1|||
160610359|NCT02254304|579950252|FG001|Overall Study|Injection site pain and Injection fear|0|||
160610360|NCT02254304|579950251|FG000|Overall Study|Personal causes|4|||
160610361|NCT02254304|579950252|FG001|Overall Study|Personal causes|1|||
160610362|NCT02254304|579950251|FG000|Overall Study|Personal decision|1|||
160610363|NCT02254304|579950252|FG001|Overall Study|Personal decision|0|||
160610364|NCT00952419|579950253|FG000|Overall Study|Adverse Event|2|||
160610365|NCT00952419|579950254|FG001|Overall Study|Adverse Event|0|||
160610366|NCT00952419|579950255|FG002|Overall Study|Adverse Event|0|||
160610367|NCT00952419|579950253|FG000|Overall Study|Protocol Violation|3|||
160488122|NCT02101268|579516027|FG002|Randomized Treatment Phase|Adverse Event|0|||
160488123|NCT02101268|579516028|FG003|Randomized Treatment Phase|Adverse Event|0|||
160610368|NCT00952419|579950254|FG001|Overall Study|Protocol Violation|7|||
160610369|NCT00952419|579950255|FG002|Overall Study|Protocol Violation|0|||
160610370|NCT00952419|579950253|FG000|Overall Study|Withdrawal by Subject|1|||
160610371|NCT00952419|579950254|FG001|Overall Study|Withdrawal by Subject|3|||
160610372|NCT00952419|579950255|FG002|Overall Study|Withdrawal by Subject|0|||
160610373|NCT03573804|579950257|FG000|Overall Study|claustrophobia or MRI table problems|10|||
160610374|NCT04969900|579952190|FG000|Overall Study|Physician Decision|1|||
160610375|NCT04969900|579952191|FG001|Overall Study|Physician Decision|1|||
160610376|NCT04969900|579952190|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
160610377|NCT04969900|579952191|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
160488124|NCT02101268|579516025|FG000|Randomized Treatment Phase|Death|5|||
160488125|NCT02101268|579516026|FG001|Randomized Treatment Phase|Death|4|||
160488126|NCT02101268|579516027|FG002|Randomized Treatment Phase|Death|0|||
160488127|NCT02101268|579516028|FG003|Randomized Treatment Phase|Death|0|||
160488128|NCT02101268|579516025|FG000|Randomized Treatment Phase|Disease Progression|4|||
160488129|NCT02101268|579516026|FG001|Randomized Treatment Phase|Disease Progression|1|||
160488130|NCT02101268|579516027|FG002|Randomized Treatment Phase|Disease Progression|0|||
160488131|NCT02101268|579516028|FG003|Randomized Treatment Phase|Disease Progression|0|||
160488132|NCT02101268|579516025|FG000|Extended Treatment Phase|Subject Decision|0|||
160488133|NCT02101268|579516026|FG001|Extended Treatment Phase|Subject Decision|0|||
160488134|NCT02101268|579516027|FG002|Extended Treatment Phase|Subject Decision|3|||
160488135|NCT02101268|579516028|FG003|Extended Treatment Phase|Subject Decision|2|||
160488136|NCT02101268|579516025|FG000|Extended Treatment Phase|Physician Decision|0|||
160488137|NCT02101268|579516026|FG001|Extended Treatment Phase|Physician Decision|0|||
160488138|NCT02101268|579516027|FG002|Extended Treatment Phase|Physician Decision|5|||
160488139|NCT02101268|579516028|FG003|Extended Treatment Phase|Physician Decision|2|||
160488140|NCT02101268|579516025|FG000|Extended Treatment Phase|Adverse Event|0|||
160488141|NCT02101268|579516026|FG001|Extended Treatment Phase|Adverse Event|0|||
160488142|NCT02101268|579516027|FG002|Extended Treatment Phase|Adverse Event|14|||
160488143|NCT02101268|579516028|FG003|Extended Treatment Phase|Adverse Event|18|||
160488144|NCT02101268|579516025|FG000|Extended Treatment Phase|Death|0|||
160488145|NCT02101268|579516026|FG001|Extended Treatment Phase|Death|0|||
160488146|NCT02101268|579516027|FG002|Extended Treatment Phase|Death|5|||
160488147|NCT02101268|579516028|FG003|Extended Treatment Phase|Death|1|||
160488148|NCT02101268|579516025|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
160488149|NCT02101268|579516026|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
160488150|NCT02101268|579516027|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
160488151|NCT02101268|579516028|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
160488152|NCT02101268|579516025|FG000|Extended Treatment Phase|Disease Progression|0|||
160488153|NCT02101268|579516026|FG001|Extended Treatment Phase|Disease Progression|0|||
160488154|NCT02101268|579516027|FG002|Extended Treatment Phase|Disease Progression|13|||
160488155|NCT02101268|579516028|FG003|Extended Treatment Phase|Disease Progression|6|||
160610378|NCT04423718|579952194|FG000|Main Study|Adverse Event|9|||
160610379|NCT04423718|579952195|FG001|Main Study|Adverse Event|5|||
160610380|NCT04423718|579952196|FG002|Main Study|Adverse Event|8|||
160610381|NCT04423718|579952194|FG000|Main Study|Physician Decision|3|||
160610382|NCT04423718|579952195|FG001|Main Study|Physician Decision|3|||
160610383|NCT04423718|579952196|FG002|Main Study|Physician Decision|2|||
160488156|NCT02101268|579516025|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
160488157|NCT02101268|579516026|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
160488158|NCT02101268|579516027|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
160488159|NCT02101268|579516028|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
160488160|NCT00819013|579516029|FG000|Overall Study|Not meeting continuing study eligibility|2|||
160610384|NCT04423718|579952194|FG000|Main Study|Protocol Violation|0|||
160610385|NCT04423718|579952195|FG001|Main Study|Protocol Violation|0|||
160610386|NCT04423718|579952196|FG002|Main Study|Protocol Violation|1|||
160610387|NCT04423718|579952194|FG000|Main Study|Lost to Follow-up|3|||
160488161|NCT00819013|579516030|FG001|Overall Study|Not meeting continuing study eligibility|1|||
160488162|NCT00819013|579516031|FG002|Overall Study|Not meeting continuing study eligibility|2|||
160488163|NCT00819013|579516032|FG003|Overall Study|Not meeting continuing study eligibility|1|||
160488164|NCT00819013|579516029|FG000|Overall Study|Adverse Event|0|||
160488165|NCT00819013|579516030|FG001|Overall Study|Adverse Event|0|||
160610388|NCT04423718|579952195|FG001|Main Study|Lost to Follow-up|3|||
160610389|NCT04423718|579952196|FG002|Main Study|Lost to Follow-up|4|||
160610390|NCT04423718|579952194|FG000|Main Study|Lack of Efficacy|2|||
160610391|NCT04423718|579952195|FG001|Main Study|Lack of Efficacy|1|||
160610392|NCT04423718|579952196|FG002|Main Study|Lack of Efficacy|0|||
160610393|NCT04423718|579952194|FG000|Main Study|Withdrawal by Subject|14|||
160610394|NCT04423718|579952195|FG001|Main Study|Withdrawal by Subject|20|||
160610395|NCT04423718|579952196|FG002|Main Study|Withdrawal by Subject|20|||
160610396|NCT04423718|579952194|FG000|Main Study|Death|10|||
160610397|NCT04423718|579952195|FG001|Main Study|Death|7|||
160610398|NCT04423718|579952196|FG002|Main Study|Death|7|||
160610399|NCT04423718|579952194|FG000|Main Study|COVID-19 pandemic|2|||
160610400|NCT04423718|579952195|FG001|Main Study|COVID-19 pandemic|2|||
160610401|NCT04423718|579952196|FG002|Main Study|COVID-19 pandemic|2|||
160610402|NCT04423718|579952194|FG000|Main Study|Other|7|||
160610403|NCT04423718|579952195|FG001|Main Study|Other|3|||
160610404|NCT04423718|579952196|FG002|Main Study|Other|2|||
160610405|NCT04423718|579952194|FG000|Extension Phase|Other|1|||
160610406|NCT04423718|579952195|FG001|Extension Phase|Other|0|||
160610407|NCT04423718|579952196|FG002|Extension Phase|Other|0|||
160610408|NCT04423718|579952194|FG000|Extension Phase|Logistical problems|0|||
160610409|NCT04423718|579952195|FG001|Extension Phase|Logistical problems|1|||
160610410|NCT04423718|579952196|FG002|Extension Phase|Logistical problems|1|||
160610411|NCT04423718|579952194|FG000|Extension Phase|Physician Decision|1|||
160610412|NCT04423718|579952195|FG001|Extension Phase|Physician Decision|0|||
160610413|NCT04423718|579952196|FG002|Extension Phase|Physician Decision|1|||
160610414|NCT04423718|579952194|FG000|Extension Phase|Lack of Efficacy|2|||
160610415|NCT04423718|579952195|FG001|Extension Phase|Lack of Efficacy|0|||
160610416|NCT04423718|579952196|FG002|Extension Phase|Lack of Efficacy|1|||
160610417|NCT04423718|579952194|FG000|Extension Phase|Lost to Follow-up|0|||
160610418|NCT04423718|579952195|FG001|Extension Phase|Lost to Follow-up|2|||
160610419|NCT04423718|579952196|FG002|Extension Phase|Lost to Follow-up|3|||
160610420|NCT04423718|579952194|FG000|Extension Phase|Adverse Event|2|||
160610421|NCT04423718|579952195|FG001|Extension Phase|Adverse Event|3|||
160610422|NCT04423718|579952196|FG002|Extension Phase|Adverse Event|1|||
160610423|NCT04423718|579952194|FG000|Extension Phase|Death|4|||
160610424|NCT04423718|579952195|FG001|Extension Phase|Death|7|||
160610425|NCT04423718|579952196|FG002|Extension Phase|Death|2|||
160610426|NCT04423718|579952194|FG000|Extension Phase|Withdrawal by Subject|11|||
160610427|NCT04423718|579952195|FG001|Extension Phase|Withdrawal by Subject|11|||
160610428|NCT04423718|579952196|FG002|Extension Phase|Withdrawal by Subject|7|||
160610429|NCT00589602|579952197|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
160610430|NCT04284787|579952198|FG000|Overall Study|Disease Progression|9|||
160610431|NCT04284787|579952199|FG001|Overall Study|Disease Progression|12|||
160610432|NCT04284787|579952198|FG000|Overall Study|Physician Decision|12|||
160610433|NCT04284787|579952199|FG001|Overall Study|Physician Decision|7|||
160610434|NCT04284787|579952198|FG000|Overall Study|Transplant|5|||
160610435|NCT04284787|579952199|FG001|Overall Study|Transplant|4|||
160610436|NCT04284787|579952198|FG000|Overall Study|Death|1|||
160610437|NCT04284787|579952199|FG001|Overall Study|Death|2|||
160610438|NCT04284787|579952198|FG000|Overall Study|Adverse Event|0|||
160610439|NCT04284787|579952199|FG001|Overall Study|Adverse Event|4|||
160610440|NCT04284787|579952198|FG000|Overall Study|Non-adherence|2|||
160610441|NCT04284787|579952199|FG001|Overall Study|Non-adherence|0|||
160610442|NCT04284787|579952198|FG000|Overall Study|Lack of Efficacy|2|||
160610443|NCT04284787|579952199|FG001|Overall Study|Lack of Efficacy|0|||
160610444|NCT01874353|579952200|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
160610445|NCT01874353|579952201|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
160610446|NCT01874353|579952202|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
160610447|NCT01874353|579952203|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
160610448|NCT01874353|579952200|FG000|Overall Study|Lost to Follow-up|2|||
160610449|NCT01874353|579952201|FG001|Overall Study|Lost to Follow-up|2|||
160610450|NCT01874353|579952202|FG002|Overall Study|Lost to Follow-up|2|||
160610451|NCT01874353|579952203|FG003|Overall Study|Lost to Follow-up|0|||
160610452|NCT01874353|579952200|FG000|Overall Study|Death|110|||
160610453|NCT01874353|579952201|FG001|Overall Study|Death|60|||
160610454|NCT01874353|579952202|FG002|Overall Study|Death|13|||
160610455|NCT01874353|579952203|FG003|Overall Study|Death|7|||
160610456|NCT01874353|579952200|FG000|Overall Study|Withdrawal by Subject|13|||
160610457|NCT01874353|579952201|FG001|Overall Study|Withdrawal by Subject|11|||
160610458|NCT01874353|579952202|FG002|Overall Study|Withdrawal by Subject|0|||
160610459|NCT01874353|579952203|FG003|Overall Study|Withdrawal by Subject|0|||
160610460|NCT05298774|579952206|FG000|Overall Study|Physician Decision|3|||
160610461|NCT05298774|579952206|FG000|Overall Study|Withdrawal by Subject|2|||
160610462|NCT05298774|579952206|FG000|Overall Study|Lost to Follow-up|3|||
160610463|NCT05298774|579952206|FG000|Overall Study|Screen failure|1|||
160610464|NCT04992507|579952207|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
160610465|NCT04992507|579952208|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
160610466|NCT04992507|579952207|FG000|Overall Study|Death|0|||
160610467|NCT04992507|579952208|FG001|Overall Study|Death|1|||
160610468|NCT03887052|579952209|FG000|Overall Study|Adverse Event|2|||
160610469|NCT03887052|579952209|FG000|Overall Study|Physician Decision|2|||
160610470|NCT03887052|579952209|FG000|Overall Study|Withdrawal by Subject|3|||
160610471|NCT03887052|579952209|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
160610472|NCT03887052|579952209|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
160610473|NCT03728881|579952210|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
160610474|NCT03728881|579952211|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
160610475|NCT03728881|579952210|FG000|Enrolled and Received 1st Vaccination|Death|1|||
160610476|NCT03728881|579952211|FG001|Enrolled and Received 1st Vaccination|Death|1|||
160610477|NCT03728881|579952210|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
160610478|NCT03728881|579952211|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
160610479|NCT03728881|579952210|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
160610480|NCT03728881|579952211|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
160610481|NCT03728881|579952210|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
160610482|NCT03728881|579952211|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
160610483|NCT03728881|579952210|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
160610484|NCT03728881|579952211|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
160610485|NCT03728881|579952210|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
160610486|NCT03728881|579952211|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
160610487|NCT03728881|579952210|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
160488166|NCT00819013|579516031|FG002|Overall Study|Adverse Event|1|||
160488167|NCT00819013|579516032|FG003|Overall Study|Adverse Event|0|||
160488168|NCT00819013|579516029|FG000|Overall Study|Withdrawal by Subject|1|||
160488169|NCT00819013|579516030|FG001|Overall Study|Withdrawal by Subject|0|||
160488170|NCT00819013|579516031|FG002|Overall Study|Withdrawal by Subject|1|||
160488171|NCT00819013|579516032|FG003|Overall Study|Withdrawal by Subject|0|||
160488172|NCT00819013|579516029|FG000|Overall Study|Lost to Follow-up|0|||
160488173|NCT00819013|579516030|FG001|Overall Study|Lost to Follow-up|0|||
160488174|NCT00819013|579516031|FG002|Overall Study|Lost to Follow-up|1|||
160488175|NCT00819013|579516032|FG003|Overall Study|Lost to Follow-up|2|||
160488176|NCT00819013|579516029|FG000|Overall Study|Death|0|||
160488177|NCT00819013|579516030|FG001|Overall Study|Death|0|||
160488178|NCT00819013|579516031|FG002|Overall Study|Death|0|||
160488179|NCT00819013|579516032|FG003|Overall Study|Death|1|||
160488180|NCT00576823|579516033|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
160488181|NCT00576823|579516034|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
160488182|NCT00576823|579516035|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
160488183|NCT00576823|579516033|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
160488184|NCT00576823|579516034|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
160488185|NCT00576823|579516035|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
160488186|NCT00510146|579516036|FG000|Double-Blind Treatment|Adverse Event|30|||
160488187|NCT00510146|579516037|FG001|Double-Blind Treatment|Adverse Event|13|||
160488188|NCT00510146|579516036|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
160488189|NCT00510146|579516037|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
160488190|NCT00510146|579516036|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
160488191|NCT00510146|579516037|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
160488192|NCT00510146|579516036|FG000|Double-Blind Treatment|Physician Decision|6|||
160488193|NCT00510146|579516037|FG001|Double-Blind Treatment|Physician Decision|0|||
160488194|NCT00510146|579516036|FG000|Double-Blind Treatment|Protocol Violation|1|||
160488195|NCT00510146|579516037|FG001|Double-Blind Treatment|Protocol Violation|2|||
160488196|NCT00510146|579516036|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
160488197|NCT00510146|579516037|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
160488198|NCT00510146|579516036|FG000|Double-Blind Treatment|Clinical Relapse|0|||
160488199|NCT00510146|579516037|FG001|Double-Blind Treatment|Clinical Relapse|1|||
160488200|NCT00510146|579516036|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
160488201|NCT00510146|579516037|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
160488202|NCT00510146|579516036|FG000|Open-Label Treatment|Adverse Event|22|||
160488203|NCT00510146|579516037|FG001|Open-Label Treatment|Adverse Event|8|||
160610488|NCT03728881|579952211|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
160488204|NCT00510146|579516036|FG000|Open-Label Treatment|Death|1|||
160488205|NCT00510146|579516037|FG001|Open-Label Treatment|Death|1|||
160610489|NCT03728881|579952210|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
160610490|NCT03728881|579952211|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
160488206|NCT00510146|579516036|FG000|Open-Label Treatment|Lack of Efficacy|4|||
160488207|NCT00510146|579516037|FG001|Open-Label Treatment|Lack of Efficacy|0|||
160488208|NCT00510146|579516036|FG000|Open-Label Treatment|Lost to Follow-up|10|||
160488209|NCT00510146|579516037|FG001|Open-Label Treatment|Lost to Follow-up|1|||
160488210|NCT00510146|579516036|FG000|Open-Label Treatment|Physician Decision|3|||
160488211|NCT00510146|579516037|FG001|Open-Label Treatment|Physician Decision|1|||
160610491|NCT03728881|579952210|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
160610492|NCT03728881|579952211|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
160610493|NCT03728881|579952210|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
160610494|NCT03728881|579952211|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
160610495|NCT04517253|579952214|FG000|Primary Treatment Period|Adverse Event|1|||
160610496|NCT04517253|579952215|FG001|Primary Treatment Period|Adverse Event|0|||
160610497|NCT04517253|579952216|FG002|Primary Treatment Period|Adverse Event|0|||
160610498|NCT04517253|579952214|FG000|Primary Treatment Period|Death|0|||
160610499|NCT04517253|579952215|FG001|Primary Treatment Period|Death|1|||
160610500|NCT04517253|579952216|FG002|Primary Treatment Period|Death|0|||
160610501|NCT04517253|579952214|FG000|Maintenance Period|Withdrawal by Subject|1|||
160610502|NCT04517253|579952215|FG001|Maintenance Period|Withdrawal by Subject|0|||
160610503|NCT04517253|579952216|FG002|Maintenance Period|Withdrawal by Subject|0|||
160610504|NCT04517253|579952214|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
160610505|NCT04517253|579952215|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
160610506|NCT04517253|579952216|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
160610507|NCT04651777|579952217|FG000|Overall Study|Adverse Event|1|||
160610508|NCT04651777|579952217|FG000|Overall Study|Withdrawal by Subject|2|||
160610509|NCT04088331|579952218|FG000|Overall Study|Lost to Follow-up|3|||
160610510|NCT04088331|579952218|FG000|Overall Study|Withdrawal by Subject|7|||
160610511|NCT04088331|579952218|FG000|Overall Study|Adverse Event|4|||
160610512|NCT05505734|579952219|FG000|Overall Study|Withdrawal by Subject|51|||
160610513|NCT05505734|579952220|FG001|Overall Study|Withdrawal by Subject|64|||
160610514|NCT05505734|579952219|FG000|Overall Study|Adverse Event|6|||
160610515|NCT05505734|579952220|FG001|Overall Study|Adverse Event|20|||
160610516|NCT05505734|579952219|FG000|Overall Study|Protocol Violation|8|||
160610517|NCT05505734|579952220|FG001|Overall Study|Protocol Violation|15|||
160610518|NCT05505734|579952219|FG000|Overall Study|Lack of therapeutic response|0|||
160610519|NCT05505734|579952220|FG001|Overall Study|Lack of therapeutic response|1|||
160610520|NCT05505734|579952219|FG000|Overall Study|Lost to Follow-up|247|||
160610521|NCT05505734|579952220|FG001|Overall Study|Lost to Follow-up|237|||
160610522|NCT05505734|579952219|FG000|Overall Study|Physician Decision|22|||
160610523|NCT05505734|579952220|FG001|Overall Study|Physician Decision|13|||
160610524|NCT05505734|579952219|FG000|Overall Study|Death|2|||
160610525|NCT05505734|579952220|FG001|Overall Study|Death|1|||
160610526|NCT05505734|579952219|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160610527|NCT05505734|579952220|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160610528|NCT05505734|579952219|FG000|Overall Study|Pregnancy|1|||
160610529|NCT05505734|579952220|FG001|Overall Study|Pregnancy|0|||
160610530|NCT05505734|579952219|FG000|Overall Study|Other|17|||
160610531|NCT05505734|579952220|FG001|Overall Study|Other|13|||
160610532|NCT01023516|579952221|FG000|Overall Study|Voluntary discontinuation|7|||
160610533|NCT01023516|579952222|FG001|Overall Study|Voluntary discontinuation|5|||
160610534|NCT01023516|579952221|FG000|Overall Study|Adverse Event|9|||
160610535|NCT01023516|579952222|FG001|Overall Study|Adverse Event|6|||
160610536|NCT01023516|579952221|FG000|Overall Study|Safety reason|0|||
160610537|NCT01023516|579952222|FG001|Overall Study|Safety reason|3|||
160610538|NCT01023516|579952221|FG000|Overall Study|Study-specific criteria|4|||
160610539|NCT01023516|579952222|FG001|Overall Study|Study-specific criteria|2|||
160610540|NCT01023516|579952221|FG000|Overall Study|Incorrect enrolment|4|||
160610541|NCT01023516|579952222|FG001|Overall Study|Incorrect enrolment|2|||
160610542|NCT01058395|579952223|FG000|Overall Study|Death|2|||
160610543|NCT01058395|579952224|FG001|Overall Study|Death|1|||
160610544|NCT01058395|579952223|FG000|Overall Study|Lost to Follow-up|1|||
160610545|NCT01058395|579952224|FG001|Overall Study|Lost to Follow-up|0|||
160610546|NCT03575351|579952225|FG000|Overall Study|Adverse Event|1|||
160610547|NCT03575351|579952226|FG001|Overall Study|Adverse Event|0|||
160610548|NCT03575351|579952225|FG000|Overall Study|Death|2|||
160610549|NCT03575351|579952226|FG001|Overall Study|Death|2|||
160610550|NCT03575351|579952225|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
160610551|NCT03575351|579952226|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
160610552|NCT03575351|579952225|FG000|Overall Study|Lack of Efficacy|28|||
160610553|NCT03575351|579952226|FG001|Overall Study|Lack of Efficacy|0|||
160610554|NCT03575351|579952225|FG000|Overall Study|Withdrawal by Subject|1|||
160610555|NCT03575351|579952226|FG001|Overall Study|Withdrawal by Subject|1|||
160610556|NCT03575351|579952225|FG000|Overall Study|Physician Decision|3|||
160610557|NCT03575351|579952226|FG001|Overall Study|Physician Decision|0|||
160610558|NCT03575351|579952225|FG000|Overall Study|Disease relapse|15|||
160610559|NCT03575351|579952226|FG001|Overall Study|Disease relapse|6|||
160610560|NCT03575351|579952225|FG000|Overall Study|Study drug manufacturing failure|0|||
160610561|NCT03575351|579952226|FG001|Overall Study|Study drug manufacturing failure|1|||
160610562|NCT03575351|579952225|FG000|Overall Study|other reasons|5|||
160610563|NCT03575351|579952226|FG001|Overall Study|other reasons|0|||
160610564|NCT04288089|579952227|FG000|Overall Study|Ongoing Treatment|2|||
160610565|NCT04288089|579952228|FG001|Overall Study|Ongoing Treatment|1|||
160610566|NCT04288089|579952229|FG002|Overall Study|Ongoing Treatment|1|||
160610567|NCT04288089|579952230|FG003|Overall Study|Ongoing Treatment|4|||
160610568|NCT03715205|579952231|FG000|Overall Study|Death|13|||
160610569|NCT03715205|579952231|FG000|Overall Study|Lost to Follow-up|2|||
160610570|NCT03715205|579952231|FG000|Overall Study|Physician Decision|93|||
160610571|NCT03715205|579952231|FG000|Overall Study|Withdrawal by Subject|26|||
160610572|NCT02623699|579952232|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610573|NCT02623699|579952233|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
160610574|NCT02623699|579952234|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610575|NCT02623699|579952235|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610576|NCT02623699|579952236|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610577|NCT02623699|579952237|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610578|NCT02623699|579952238|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610579|NCT02623699|579952239|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610580|NCT02623699|579952240|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610581|NCT02623699|579952241|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610582|NCT02623699|579952242|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610583|NCT02623699|579952243|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
160610584|NCT02623699|579952232|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610585|NCT02623699|579952233|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610586|NCT02623699|579952234|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610587|NCT02623699|579952235|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610588|NCT02623699|579952236|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610589|NCT02623699|579952237|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610590|NCT02623699|579952238|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
160610591|NCT02623699|579952239|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610592|NCT02623699|579952240|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610593|NCT02623699|579952241|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610594|NCT02623699|579952242|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610595|NCT02623699|579952243|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
160610596|NCT02623699|579952232|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610597|NCT02623699|579952233|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610598|NCT02623699|579952234|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610599|NCT02623699|579952235|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610600|NCT02623699|579952236|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610601|NCT02623699|579952237|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
160610602|NCT02623699|579952238|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610603|NCT02623699|579952239|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610604|NCT02623699|579952240|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610605|NCT02623699|579952241|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610606|NCT02623699|579952242|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610607|NCT02623699|579952243|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
160610608|NCT02623699|579952232|FG000|Part B (Up to 289 Days)|Death|0|||
160610609|NCT02623699|579952233|FG001|Part B (Up to 289 Days)|Death|0|||
160610610|NCT02623699|579952234|FG002|Part B (Up to 289 Days)|Death|0|||
160610611|NCT02623699|579952235|FG003|Part B (Up to 289 Days)|Death|0|||
160610612|NCT02623699|579952236|FG004|Part B (Up to 289 Days)|Death|0|||
160610613|NCT02623699|579952237|FG005|Part B (Up to 289 Days)|Death|1|||
160610614|NCT02623699|579952238|FG006|Part B (Up to 289 Days)|Death|1|||
160610615|NCT02623699|579952239|FG007|Part B (Up to 289 Days)|Death|0|||
160610616|NCT02623699|579952240|FG008|Part B (Up to 289 Days)|Death|1|||
160610617|NCT02623699|579952241|FG009|Part B (Up to 289 Days)|Death|0|||
160610618|NCT02623699|579952242|FG010|Part B (Up to 289 Days)|Death|0|||
160610619|NCT02623699|579952243|FG011|Part B (Up to 289 Days)|Death|0|||
160610620|NCT02623699|579952232|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
160610621|NCT02623699|579952233|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
160610622|NCT02623699|579952234|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
160610623|NCT02623699|579952235|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
160610624|NCT02623699|579952236|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
160610625|NCT02623699|579952237|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
160610626|NCT02623699|579952238|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
160610627|NCT02623699|579952239|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
160610628|NCT02623699|579952240|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
160610629|NCT02623699|579952241|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
160610630|NCT02623699|579952242|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
160610631|NCT02623699|579952243|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
160610632|NCT02623699|579952232|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
160610633|NCT02623699|579952233|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
160610634|NCT02623699|579952234|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
160610635|NCT02623699|579952235|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
160610636|NCT02623699|579952236|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
160610637|NCT02623699|579952237|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
160610638|NCT02623699|579952238|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
160610639|NCT02623699|579952239|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
160488212|NCT00510146|579516036|FG000|Open-Label Treatment|Protocol Violation|4|||
160488213|NCT00510146|579516037|FG001|Open-Label Treatment|Protocol Violation|2|||
160488214|NCT00510146|579516036|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
160488215|NCT00510146|579516037|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
160488216|NCT00510146|579516036|FG000|Open-Label Treatment|Clinical Relapse|1|||
160488217|NCT00510146|579516037|FG001|Open-Label Treatment|Clinical Relapse|1|||
160488218|NCT00510146|579516036|FG000|Open-Label Treatment|Sponsor Decision|2|||
160488219|NCT00510146|579516037|FG001|Open-Label Treatment|Sponsor Decision|0|||
160488220|NCT04947436|579516039|FG000|Overall Study|Lost to Follow-up|3|||
160488221|NCT04947436|579516040|FG001|Overall Study|Lost to Follow-up|7|||
160488222|NCT04947436|579516041|FG002|Overall Study|Lost to Follow-up|5|||
160488223|NCT04947436|579516039|FG000|Overall Study|Death|1|||
160488224|NCT04947436|579516040|FG001|Overall Study|Death|1|||
160488225|NCT04947436|579516041|FG002|Overall Study|Death|1|||
160488226|NCT01544309|579516044|FG000|Overall Study|Withdrawal by Subject|12|||
160488227|NCT01544309|579516045|FG001|Overall Study|Withdrawal by Subject|7|||
160488228|NCT01544309|579516044|FG000|Overall Study|Protocol Violation|2|||
160488229|NCT01544309|579516045|FG001|Overall Study|Protocol Violation|1|||
160488230|NCT01544309|579516044|FG000|Overall Study|Physician Decision|4|||
160488231|NCT01544309|579516045|FG001|Overall Study|Physician Decision|1|||
160488232|NCT01544309|579516044|FG000|Overall Study|Not performed pre-dose examination|1|||
160488233|NCT01544309|579516045|FG001|Overall Study|Not performed pre-dose examination|2|||
160488234|NCT01544309|579516044|FG000|Overall Study|Administered prohibit prior medication|1|||
160488235|NCT01544309|579516045|FG001|Overall Study|Administered prohibit prior medication|0|||
160488236|NCT01196741|579516046|FG000|Overall Study|Disease progression|34|||
160488237|NCT01196741|579516047|FG001|Overall Study|Disease progression|14|||
160488238|NCT01196741|579516046|FG000|Overall Study|Adverse Event|10|||
160488239|NCT01196741|579516047|FG001|Overall Study|Adverse Event|6|||
160488240|NCT01196741|579516046|FG000|Overall Study|Serious Adverse Event|3|||
160488241|NCT01196741|579516047|FG001|Overall Study|Serious Adverse Event|1|||
160488242|NCT01196741|579516046|FG000|Overall Study|Dose limiting Adverse Event|2|||
160488243|NCT01196741|579516047|FG001|Overall Study|Dose limiting Adverse Event|1|||
160488244|NCT01196741|579516046|FG000|Overall Study|Withdrawal by Subject|3|||
160488245|NCT01196741|579516047|FG001|Overall Study|Withdrawal by Subject|0|||
160488246|NCT01196741|579516046|FG000|Overall Study|Other reason|3|||
160488247|NCT01196741|579516047|FG001|Overall Study|Other reason|3|||
160488248|NCT01196741|579516046|FG000|Overall Study|Other|3|||
160488249|NCT01196741|579516047|FG001|Overall Study|Other|2|||
160488250|NCT01196741|579516046|FG000|Overall Study|Protocol Violation|2|||
160488251|NCT01196741|579516047|FG001|Overall Study|Protocol Violation|1|||
160488252|NCT01592383|579516048|FG000|Overall Study|Adverse Event|1|||
160488253|NCT04582864|579516049|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
160488254|NCT04582864|579516049|FG000|Overall Study|Death|1|||
160488255|NCT03640754|579516050|FG000|Overall Study|Withdrawal by Subject|1|||
160488256|NCT03640754|579516051|FG001|Overall Study|Withdrawal by Subject|0|||
160488257|NCT03640754|579516050|FG000|Overall Study|Lost to Follow-up|0|||
160488258|NCT03640754|579516051|FG001|Overall Study|Lost to Follow-up|1|||
160488259|NCT01679613|579516054|FG000|Overall Study|other than stated above|0|||
160488260|NCT01679613|579516055|FG001|Overall Study|other than stated above|1|||
160488261|NCT01679613|579516056|FG002|Overall Study|other than stated above|2|||
160488262|NCT01679613|579516057|FG003|Overall Study|other than stated above|2|||
160488263|NCT04380688|579516059|FG000|Overall Study|Death|2|||
160488264|NCT04380688|579516060|FG001|Overall Study|Death|2|||
160488265|NCT04380688|579516059|FG000|Overall Study|Lost to Follow-up|2|||
160488266|NCT04380688|579516060|FG001|Overall Study|Lost to Follow-up|4|||
160488267|NCT04380688|579516059|FG000|Overall Study|Withdrawal by Subject|3|||
160488268|NCT04380688|579516060|FG001|Overall Study|Withdrawal by Subject|3|||
160488269|NCT00919061|579516061|FG000|Overall Study|Adverse Event|1|||
160488270|NCT00919061|579516061|FG000|Overall Study|Withdrawal by Subject|1|||
160488271|NCT05294328|579516062|FG000|Overall Study|Adverse Event|1|||
160488272|NCT05294328|579516063|FG001|Overall Study|Adverse Event|0|||
160488273|NCT05294328|579516064|FG002|Overall Study|Adverse Event|0|||
160488274|NCT05294328|579516062|FG000|Overall Study|Physician Decision|1|||
160488275|NCT05294328|579516063|FG001|Overall Study|Physician Decision|1|||
160661303|NCT00723528|580144036|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
160488276|NCT05294328|579516064|FG002|Overall Study|Physician Decision|0|||
160488277|NCT05294328|579516062|FG000|Overall Study|Withdrawal by Subject|0|||
160488278|NCT05294328|579516063|FG001|Overall Study|Withdrawal by Subject|2|||
160488279|NCT05294328|579516064|FG002|Overall Study|Withdrawal by Subject|1|||
160488280|NCT05294328|579516062|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
160488281|NCT05294328|579516063|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
160488282|NCT05294328|579516064|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
160488283|NCT02056873|579516065|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
160488284|NCT01333111|579518246|FG000|Overall Study|patient undergoing major surgery|0|||
160488285|NCT01333111|579518247|FG001|Overall Study|patient undergoing major surgery|2|||
160488286|NCT01333111|579518248|FG002|Overall Study|patient undergoing major surgery|0|||
160610640|NCT02623699|579952240|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
160610641|NCT02623699|579952241|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
160610642|NCT02623699|579952242|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
160610643|NCT02623699|579952243|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
160610644|NCT02623699|579952232|FG000|Part C (Up to 236 Days)|Death|0|||
160610645|NCT02623699|579952233|FG001|Part C (Up to 236 Days)|Death|0|||
160610646|NCT02623699|579952234|FG002|Part C (Up to 236 Days)|Death|0|||
160610647|NCT02623699|579952235|FG003|Part C (Up to 236 Days)|Death|0|||
160610648|NCT02623699|579952236|FG004|Part C (Up to 236 Days)|Death|0|||
160610649|NCT02623699|579952237|FG005|Part C (Up to 236 Days)|Death|0|||
160610650|NCT02623699|579952238|FG006|Part C (Up to 236 Days)|Death|0|||
160610651|NCT02623699|579952239|FG007|Part C (Up to 236 Days)|Death|0|||
160610652|NCT02623699|579952240|FG008|Part C (Up to 236 Days)|Death|0|||
160610653|NCT02623699|579952241|FG009|Part C (Up to 236 Days)|Death|0|||
160610654|NCT02623699|579952242|FG010|Part C (Up to 236 Days)|Death|0|||
160610655|NCT02623699|579952243|FG011|Part C (Up to 236 Days)|Death|1|||
160610656|NCT02623699|579952232|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
160610657|NCT02623699|579952233|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
160610658|NCT02623699|579952234|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
160610659|NCT02623699|579952235|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
160610660|NCT02623699|579952236|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
160610661|NCT02623699|579952237|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
160610662|NCT02623699|579952238|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
160610663|NCT02623699|579952239|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
160610664|NCT02623699|579952240|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
160610665|NCT02623699|579952241|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
160610666|NCT02623699|579952242|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
160610667|NCT02623699|579952243|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
160610668|NCT00592072|579952244|FG000|Wash Out Period|Lost to Follow-up|1|||
160610669|NCT00592072|579952245|FG001|Wash Out Period|Lost to Follow-up|1|||
160610682|NCT05333289|579952248|FG000|Overall Study|Other|1|||
160610683|NCT05333289|579952249|FG001|Overall Study|Other|0|||
160610684|NCT05333289|579952250|FG002|Overall Study|Other|0|||
160610685|NCT05333289|579952251|FG003|Overall Study|Other|1|||
160610686|NCT05333289|579952252|FG004|Overall Study|Other|1|||
160610687|NCT05333289|579952253|FG005|Overall Study|Other|2|||
160610688|NCT05333289|579952254|FG006|Overall Study|Other|2|||
160610689|NCT05333289|579952255|FG007|Overall Study|Other|0|||
160610690|NCT05333289|579952248|FG000|Overall Study|Withdrawal by Subject|1|||
160610691|NCT05333289|579952249|FG001|Overall Study|Withdrawal by Subject|2|||
160610692|NCT05333289|579952250|FG002|Overall Study|Withdrawal by Subject|2|||
160610693|NCT05333289|579952251|FG003|Overall Study|Withdrawal by Subject|1|||
160610694|NCT05333289|579952252|FG004|Overall Study|Withdrawal by Subject|1|||
160610695|NCT05333289|579952253|FG005|Overall Study|Withdrawal by Subject|2|||
160610696|NCT05333289|579952254|FG006|Overall Study|Withdrawal by Subject|1|||
160610697|NCT05333289|579952255|FG007|Overall Study|Withdrawal by Subject|3|||
160610698|NCT05333289|579952248|FG000|Overall Study|Protocol Violation|1|||
160610699|NCT05333289|579952249|FG001|Overall Study|Protocol Violation|0|||
160610700|NCT05333289|579952250|FG002|Overall Study|Protocol Violation|0|||
160610701|NCT05333289|579952251|FG003|Overall Study|Protocol Violation|0|||
160610702|NCT05333289|579952252|FG004|Overall Study|Protocol Violation|0|||
160610703|NCT05333289|579952253|FG005|Overall Study|Protocol Violation|0|||
160610704|NCT05333289|579952254|FG006|Overall Study|Protocol Violation|0|||
160610705|NCT05333289|579952255|FG007|Overall Study|Protocol Violation|0|||
160610706|NCT05333289|579952248|FG000|Overall Study|Physician Decision|0|||
160610707|NCT05333289|579952249|FG001|Overall Study|Physician Decision|0|||
160610708|NCT05333289|579952250|FG002|Overall Study|Physician Decision|1|||
160610709|NCT05333289|579952251|FG003|Overall Study|Physician Decision|0|||
160610710|NCT05333289|579952252|FG004|Overall Study|Physician Decision|0|||
160610711|NCT05333289|579952253|FG005|Overall Study|Physician Decision|2|||
160610712|NCT05333289|579952254|FG006|Overall Study|Physician Decision|0|||
160610713|NCT05333289|579952255|FG007|Overall Study|Physician Decision|0|||
160610714|NCT05333289|579952248|FG000|Overall Study|Lost to Follow-up|6|||
160610715|NCT05333289|579952249|FG001|Overall Study|Lost to Follow-up|0|||
160610716|NCT05333289|579952250|FG002|Overall Study|Lost to Follow-up|1|||
160610717|NCT05333289|579952251|FG003|Overall Study|Lost to Follow-up|6|||
160488287|NCT01333111|579518246|FG000|Overall Study|personal reasons|0|||
160488288|NCT01333111|579518247|FG001|Overall Study|personal reasons|0|||
160488289|NCT01333111|579518248|FG002|Overall Study|personal reasons|1|||
160488290|NCT01333111|579518246|FG000|Overall Study|unclassified|1|||
160488291|NCT01333111|579518247|FG001|Overall Study|unclassified|0|||
160488292|NCT01333111|579518248|FG002|Overall Study|unclassified|0|||
160488293|NCT01333111|579518246|FG000|Overall Study|withdrawal criteria|0|||
160488294|NCT01333111|579518247|FG001|Overall Study|withdrawal criteria|1|||
160488295|NCT01333111|579518248|FG002|Overall Study|withdrawal criteria|0|||
160488296|NCT01333111|579518246|FG000|Overall Study|Non-compliance|1|||
160488297|NCT01333111|579518247|FG001|Overall Study|Non-compliance|0|||
160488298|NCT01333111|579518248|FG002|Overall Study|Non-compliance|0|||
160488299|NCT01333111|579518246|FG000|Overall Study|Ineffective therapy|0|||
160488300|NCT01333111|579518247|FG001|Overall Study|Ineffective therapy|0|||
160488301|NCT01333111|579518248|FG002|Overall Study|Ineffective therapy|1|||
160488302|NCT01468077|579518249|FG000|Overall Study|Adverse Event|2|||
160488303|NCT01468077|579518250|FG001|Overall Study|Adverse Event|2|||
160488304|NCT01468077|579518249|FG000|Overall Study|Lack of Efficacy|1|||
160488305|NCT01468077|579518250|FG001|Overall Study|Lack of Efficacy|1|||
160488306|NCT01468077|579518249|FG000|Overall Study|Physician Decision|1|||
160488307|NCT01468077|579518250|FG001|Overall Study|Physician Decision|0|||
160488308|NCT03024996|579518251|FG000|Overall Study|Death|57|||
160488309|NCT03024996|579518252|FG001|Overall Study|Death|55|||
160488310|NCT03024996|579518251|FG000|Overall Study|Disease relapse|1|||
160488311|NCT03024996|579518252|FG001|Overall Study|Disease relapse|0|||
160488312|NCT03024996|579518251|FG000|Overall Study|Lost to Follow-up|5|||
160488313|NCT03024996|579518252|FG001|Overall Study|Lost to Follow-up|10|||
160488314|NCT03024996|579518251|FG000|Overall Study|Other|3|||
160488315|NCT03024996|579518252|FG001|Overall Study|Other|3|||
160488316|NCT03024996|579518251|FG000|Overall Study|Physician Decision|0|||
160488317|NCT03024996|579518252|FG001|Overall Study|Physician Decision|1|||
160488318|NCT03024996|579518251|FG000|Overall Study|Study terminated by sponsor|303|||
160488319|NCT03024996|579518252|FG001|Overall Study|Study terminated by sponsor|283|||
160488320|NCT03024996|579518251|FG000|Overall Study|Withdrawal by Subject|21|||
160488321|NCT03024996|579518252|FG001|Overall Study|Withdrawal by Subject|36|||
160488322|NCT04333147|579518253|FG000|Overall Study|Adverse Event|43|||
160488323|NCT04333147|579518254|FG001|Overall Study|Adverse Event|40|||
160488324|NCT04333147|579518253|FG000|Overall Study|Lack of Efficacy|49|||
160488325|NCT04333147|579518254|FG001|Overall Study|Lack of Efficacy|48|||
160488326|NCT04333147|579518253|FG000|Overall Study|Lost to Follow-up|19|||
160488327|NCT04333147|579518254|FG001|Overall Study|Lost to Follow-up|16|||
160488328|NCT04333147|579518253|FG000|Overall Study|Physician Decision|17|||
160488329|NCT04333147|579518254|FG001|Overall Study|Physician Decision|20|||
160488330|NCT04333147|579518253|FG000|Overall Study|Withdrawal by Subject|65|||
160488331|NCT04333147|579518254|FG001|Overall Study|Withdrawal by Subject|68|||
160488332|NCT04333147|579518253|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
160488333|NCT04333147|579518254|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
160488334|NCT04333147|579518253|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
160488335|NCT04333147|579518254|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
160488336|NCT04333147|579518253|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
160488337|NCT04333147|579518254|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
160488338|NCT00487552|579518264|FG000|Overall Study|Unsuccessful magnet placements|3|||
160488339|NCT00487552|579518264|FG000|Overall Study|Death due to progressive malignancy|2|||
160488340|NCT00487552|579518264|FG000|Overall Study|Stent not placed|1|||
160488341|NCT03119688|579518265|FG000|Overall Study|Adverse Event|4|||
160488342|NCT00320398|579518266|FG000|Overall Study|Adverse Event|1|||
160610718|NCT05333289|579952252|FG004|Overall Study|Lost to Follow-up|3|||
160610719|NCT05333289|579952253|FG005|Overall Study|Lost to Follow-up|3|||
160610720|NCT05333289|579952254|FG006|Overall Study|Lost to Follow-up|2|||
160610721|NCT05333289|579952255|FG007|Overall Study|Lost to Follow-up|1|||
160610722|NCT05333289|579952248|FG000|Overall Study|Death|1|||
160610723|NCT05333289|579952249|FG001|Overall Study|Death|0|||
160610724|NCT05333289|579952250|FG002|Overall Study|Death|0|||
160610725|NCT05333289|579952251|FG003|Overall Study|Death|0|||
160610726|NCT05333289|579952252|FG004|Overall Study|Death|0|||
160610727|NCT05333289|579952253|FG005|Overall Study|Death|0|||
160488343|NCT00320398|579518267|FG001|Overall Study|Adverse Event|4|||
160488344|NCT00320398|579518266|FG000|Overall Study|Other|1|||
160488345|NCT00320398|579518267|FG001|Overall Study|Other|0|||
160488346|NCT00630552|579518268|FG000|Overall Study|Adverse Event|0|||
160488347|NCT00630552|579518269|FG001|Overall Study|Adverse Event|1|||
160488348|NCT00630552|579518270|FG002|Overall Study|Adverse Event|5|||
160488349|NCT00630552|579518271|FG003|Overall Study|Adverse Event|4|||
160488350|NCT00630552|579518272|FG004|Overall Study|Adverse Event|2|||
160488351|NCT00630552|579518268|FG000|Overall Study|Disease progression|5|||
160488352|NCT00630552|579518269|FG001|Overall Study|Disease progression|6|||
160488353|NCT00630552|579518270|FG002|Overall Study|Disease progression|27|||
160488354|NCT00630552|579518271|FG003|Overall Study|Disease progression|22|||
160488355|NCT00630552|579518272|FG004|Overall Study|Disease progression|31|||
160610728|NCT05333289|579952254|FG006|Overall Study|Death|0|||
160610729|NCT05333289|579952255|FG007|Overall Study|Death|0|||
160488356|NCT00630552|579518268|FG000|Overall Study|Never received IP|0|||
160488357|NCT00630552|579518269|FG001|Overall Study|Never received IP|0|||
160488358|NCT00630552|579518270|FG002|Overall Study|Never received IP|0|||
160488359|NCT00630552|579518271|FG003|Overall Study|Never received IP|2|||
160488360|NCT00630552|579518272|FG004|Overall Study|Never received IP|2|||
160488361|NCT00630552|579518268|FG000|Overall Study|Ineligibility determined|0|||
160488362|NCT00630552|579518269|FG001|Overall Study|Ineligibility determined|0|||
160488363|NCT00630552|579518270|FG002|Overall Study|Ineligibility determined|0|||
160488364|NCT00630552|579518271|FG003|Overall Study|Ineligibility determined|0|||
160488365|NCT00630552|579518272|FG004|Overall Study|Ineligibility determined|1|||
160488366|NCT00630552|579518268|FG000|Overall Study|Protocol Violation|0|||
160488367|NCT00630552|579518269|FG001|Overall Study|Protocol Violation|0|||
160488368|NCT00630552|579518270|FG002|Overall Study|Protocol Violation|0|||
160488369|NCT00630552|579518271|FG003|Overall Study|Protocol Violation|1|||
160488370|NCT00630552|579518272|FG004|Overall Study|Protocol Violation|0|||
160488371|NCT00630552|579518268|FG000|Overall Study|Physician Decision|0|||
160488372|NCT00630552|579518269|FG001|Overall Study|Physician Decision|0|||
160488373|NCT00630552|579518270|FG002|Overall Study|Physician Decision|0|||
160488374|NCT00630552|579518271|FG003|Overall Study|Physician Decision|0|||
160488375|NCT00630552|579518272|FG004|Overall Study|Physician Decision|1|||
160488376|NCT00630552|579518268|FG000|Overall Study|Death|0|||
160488377|NCT00630552|579518269|FG001|Overall Study|Death|0|||
160488378|NCT00630552|579518270|FG002|Overall Study|Death|1|||
160488379|NCT00630552|579518271|FG003|Overall Study|Death|2|||
160488380|NCT00630552|579518272|FG004|Overall Study|Death|2|||
160488381|NCT00630552|579518268|FG000|Overall Study|Withdrawal by Subject|0|||
160488382|NCT00630552|579518269|FG001|Overall Study|Withdrawal by Subject|0|||
160488383|NCT00630552|579518270|FG002|Overall Study|Withdrawal by Subject|0|||
160488384|NCT00630552|579518271|FG003|Overall Study|Withdrawal by Subject|1|||
160488385|NCT00630552|579518272|FG004|Overall Study|Withdrawal by Subject|0|||
160488386|NCT00630552|579518268|FG000|Overall Study|Other|0|||
160488387|NCT00630552|579518269|FG001|Overall Study|Other|0|||
160488388|NCT00630552|579518270|FG002|Overall Study|Other|4|||
160488389|NCT00630552|579518271|FG003|Overall Study|Other|2|||
160488390|NCT00630552|579518272|FG004|Overall Study|Other|0|||
160488391|NCT02705625|579518275|FG000|Overall Study|Protocol Violation|1|||
160488392|NCT02705625|579518276|FG001|Overall Study|Protocol Violation|0|||
160488393|NCT02705625|579518277|FG002|Overall Study|Protocol Violation|0|||
160488394|NCT02705625|579518275|FG000|Overall Study|Adverse Event|6|||
160488395|NCT02705625|579518276|FG001|Overall Study|Adverse Event|5|||
160488396|NCT02705625|579518277|FG002|Overall Study|Adverse Event|2|||
160488397|NCT02705625|579518275|FG000|Overall Study|Death|0|||
160488398|NCT02705625|579518276|FG001|Overall Study|Death|0|||
160488399|NCT02705625|579518277|FG002|Overall Study|Death|1|||
160488400|NCT02705625|579518275|FG000|Overall Study|Withdrawal by Subject|1|||
160488401|NCT02705625|579518276|FG001|Overall Study|Withdrawal by Subject|4|||
160488402|NCT02705625|579518277|FG002|Overall Study|Withdrawal by Subject|5|||
160488403|NCT02705625|579518275|FG000|Overall Study|Lost to Follow-up|0|||
160488404|NCT02705625|579518276|FG001|Overall Study|Lost to Follow-up|0|||
160488405|NCT02705625|579518277|FG002|Overall Study|Lost to Follow-up|1|||
160488406|NCT02705625|579518275|FG000|Overall Study|Non-compliance|0|||
160488407|NCT02705625|579518276|FG001|Overall Study|Non-compliance|1|||
160488408|NCT02705625|579518277|FG002|Overall Study|Non-compliance|1|||
160488409|NCT02705625|579518275|FG000|Overall Study|Overdosing|0|||
160488410|NCT02705625|579518276|FG001|Overall Study|Overdosing|0|||
160488411|NCT02705625|579518277|FG002|Overall Study|Overdosing|1|||
160488412|NCT00847132|579518279|FG000|Overall Study|Death|1|||
160488413|NCT00847132|579518280|FG001|Overall Study|Death|1|||
160488414|NCT01057251|579518282|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
160488415|NCT01057251|579518283|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
160488416|NCT01057251|579518282|FG000|Overall Study|Adverse Event|4|||
160488417|NCT01057251|579518283|FG001|Overall Study|Adverse Event|2|||
160488418|NCT01057251|579518282|FG000|Overall Study|Lack of Efficacy|2|||
160488419|NCT01057251|579518283|FG001|Overall Study|Lack of Efficacy|11|||
160488420|NCT01057251|579518282|FG000|Overall Study|Protocol Violation|6|||
160488421|NCT01057251|579518283|FG001|Overall Study|Protocol Violation|2|||
160488422|NCT01057251|579518282|FG000|Overall Study|Withdrawal by Subject|4|||
160488423|NCT01057251|579518283|FG001|Overall Study|Withdrawal by Subject|5|||
160488424|NCT01057251|579518282|FG000|Overall Study|Lost to Follow-up|7|||
160488425|NCT01057251|579518283|FG001|Overall Study|Lost to Follow-up|6|||
160488426|NCT01057251|579518282|FG000|Overall Study|Other Reason|1|||
160488427|NCT01057251|579518283|FG001|Overall Study|Other Reason|1|||
160488428|NCT00784147|579518284|FG000|Overall Study|Lost to Follow-up|2|||
160488429|NCT00784147|579518285|FG001|Overall Study|Lost to Follow-up|4|||
160488430|NCT00784147|579518284|FG000|Overall Study|Withdrawal by Subject|1|||
160488431|NCT00784147|579518285|FG001|Overall Study|Withdrawal by Subject|3|||
160488432|NCT00784147|579518284|FG000|Overall Study|Physician Decision|2|||
160488433|NCT00784147|579518285|FG001|Overall Study|Physician Decision|1|||
160488434|NCT00784147|579518284|FG000|Overall Study|Protocol Violation|1|||
160488435|NCT00784147|579518285|FG001|Overall Study|Protocol Violation|1|||
160488436|NCT00784147|579518284|FG000|Overall Study|Death|2|||
160610730|NCT00372489|579952256|FG000|Overall Study|Adverse Event|18|||
160610731|NCT00372489|579952256|FG000|Overall Study|Lack of Efficacy|1|||
160610732|NCT00372489|579952256|FG000|Overall Study|Lost to Follow-up|3|||
160610733|NCT00372489|579952256|FG000|Overall Study|Physician Decision|3|||
160610734|NCT00372489|579952256|FG000|Overall Study|Withdrawal by Subject|5|||
160610735|NCT00372489|579952256|FG000|Overall Study|Patient Relocation|2|||
160610736|NCT00372489|579952256|FG000|Overall Study|Renal transplant|6|||
160610737|NCT00372489|579952256|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
160610738|NCT00772889|579952258|FG000|Overall Study|Adverse Event|7|||
160610739|NCT00772889|579952259|FG001|Overall Study|Adverse Event|4|||
160610740|NCT00772889|579952260|FG002|Overall Study|Adverse Event|0|||
160610741|NCT00772889|579952258|FG000|Overall Study|Withdrawal by Subject|9|||
160610742|NCT00772889|579952259|FG001|Overall Study|Withdrawal by Subject|8|||
160610743|NCT00772889|579952260|FG002|Overall Study|Withdrawal by Subject|9|||
160610744|NCT00772889|579952258|FG000|Overall Study|Lost to Follow-up|6|||
160610745|NCT00772889|579952259|FG001|Overall Study|Lost to Follow-up|6|||
160610746|NCT00772889|579952260|FG002|Overall Study|Lost to Follow-up|7|||
160610747|NCT03323086|579952261|FG000|Overall Study|Lost to Follow-up|3|||
160610748|NCT03323086|579952262|FG001|Overall Study|Lost to Follow-up|2|||
160610749|NCT00355615|579952263|FG000|Randomized Double Blind Period|Adverse Event|1|||
160610750|NCT00355615|579952264|FG001|Randomized Double Blind Period|Adverse Event|0|||
160610751|NCT00355615|579952265|FG002|Randomized Double Blind Period|Adverse Event|0|||
160610752|NCT00355615|579952266|FG003|Randomized Double Blind Period|Adverse Event|0|||
160610753|NCT00355615|579952267|FG004|Randomized Double Blind Period|Adverse Event|0|||
160610754|NCT00355615|579952263|FG000|Randomized Double Blind Period|Protocol Violation|0|||
160610755|NCT00355615|579952264|FG001|Randomized Double Blind Period|Protocol Violation|0|||
160610756|NCT00355615|579952265|FG002|Randomized Double Blind Period|Protocol Violation|1|||
160610757|NCT00355615|579952266|FG003|Randomized Double Blind Period|Protocol Violation|1|||
160610758|NCT00355615|579952267|FG004|Randomized Double Blind Period|Protocol Violation|0|||
160610759|NCT00355615|579952263|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
160610760|NCT00355615|579952264|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
160610761|NCT00355615|579952265|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
160610762|NCT00355615|579952266|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
160610763|NCT00355615|579952267|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
160610764|NCT00355615|579952263|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
160610765|NCT00355615|579952264|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
160610766|NCT00355615|579952265|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
160610767|NCT00355615|579952266|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
160610768|NCT00355615|579952267|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
160610769|NCT00355615|579952263|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
160610770|NCT00355615|579952264|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
160610771|NCT00355615|579952265|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
160610772|NCT00355615|579952266|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
160610773|NCT00355615|579952267|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
160610774|NCT00355615|579952263|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
160610775|NCT00355615|579952264|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
160610776|NCT00355615|579952265|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
160610777|NCT00355615|579952266|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
160610778|NCT00355615|579952267|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
160610779|NCT00085644|579952275|FG000|Double-Blind Period|Adverse Event|5|||
160610780|NCT00085644|579952276|FG001|Double-Blind Period|Adverse Event|2|||
160610781|NCT00085644|579952277|FG002|Double-Blind Period|Adverse Event|0|||
160610782|NCT00085644|579952275|FG000|Double-Blind Period|Withdrawal by Subject|3|||
160610783|NCT00085644|579952276|FG001|Double-Blind Period|Withdrawal by Subject|0|||
160610784|NCT00085644|579952277|FG002|Double-Blind Period|Withdrawal by Subject|0|||
160610785|NCT00085644|579952275|FG000|Double-Blind Period|Lost to Follow-up|2|||
160610786|NCT00085644|579952276|FG001|Double-Blind Period|Lost to Follow-up|1|||
160610787|NCT00085644|579952277|FG002|Double-Blind Period|Lost to Follow-up|0|||
160610788|NCT00085644|579952275|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
160610789|NCT00085644|579952276|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
160610790|NCT00085644|579952277|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
160488437|NCT00784147|579518285|FG001|Overall Study|Death|0|||
160488438|NCT03596242|579518287|FG000|Overall Study|Lost to Follow-up|2|||
160610791|NCT00085644|579952275|FG000|Double-Blind Period|Contemplating pregnancy|1|||
160610792|NCT00085644|579952276|FG001|Double-Blind Period|Contemplating pregnancy|0|||
160610793|NCT00085644|579952277|FG002|Double-Blind Period|Contemplating pregnancy|0|||
160610794|NCT00085644|579952275|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
160610795|NCT00085644|579952276|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
160610796|NCT00085644|579952277|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
160610797|NCT00085644|579952275|FG000|Open-Label Period|Adverse Event|0|||
160488439|NCT03596242|579518288|FG001|Overall Study|Lost to Follow-up|2|||
160488440|NCT04544865|579518289|FG000|Overall Study|Death|0|||
160488441|NCT04544865|579518290|FG001|Overall Study|Death|2|||
160488442|NCT04544865|579518289|FG000|Overall Study|Lost to Follow-up|11|||
160488443|NCT04544865|579518290|FG001|Overall Study|Lost to Follow-up|7|||
160488444|NCT04544865|579518289|FG000|Overall Study|Withdrawal by Subject|0|||
160488445|NCT04544865|579518290|FG001|Overall Study|Withdrawal by Subject|1|||
160488446|NCT04544865|579518289|FG000|Overall Study|Other|0|||
160488447|NCT04544865|579518290|FG001|Overall Study|Other|1|||
160488448|NCT03357471|579518296|FG000|Overall Study|Adverse Event|1|||
160488449|NCT03357471|579518297|FG001|Overall Study|Adverse Event|0|||
160488450|NCT03357471|579518296|FG000|Overall Study|Lost to Follow-up|1|||
160488451|NCT03357471|579518297|FG001|Overall Study|Lost to Follow-up|0|||
160488452|NCT02973802|579518298|FG000|Overall Study|Lost to Follow-up|1|||
160488453|NCT02973802|579518298|FG000|Overall Study|Withdrawal by Subject|1|||
160488454|NCT00706914|579518299|FG000|Overall Study|Lack of Efficacy|0|||
160488455|NCT00706914|579518300|FG001|Overall Study|Lack of Efficacy|1|||
160488456|NCT00706914|579518301|FG002|Overall Study|Lack of Efficacy|0|||
160488457|NCT00706914|579518299|FG000|Overall Study|Lost to Follow-up|1|||
160488458|NCT00706914|579518300|FG001|Overall Study|Lost to Follow-up|0|||
160488459|NCT00706914|579518301|FG002|Overall Study|Lost to Follow-up|0|||
160488460|NCT00706914|579518299|FG000|Overall Study|Adverse Event|2|||
160488461|NCT00706914|579518300|FG001|Overall Study|Adverse Event|2|||
160488462|NCT00706914|579518301|FG002|Overall Study|Adverse Event|0|||
160488463|NCT00706914|579518299|FG000|Overall Study|Protocol Violation|3|||
160488464|NCT00706914|579518300|FG001|Overall Study|Protocol Violation|1|||
160488465|NCT00706914|579518301|FG002|Overall Study|Protocol Violation|1|||
160488466|NCT01850823|579518303|FG000|Overall Study|Early Visit Window|0|||
160488467|NCT01850823|579518304|FG001|Overall Study|Early Visit Window|1|||
160488468|NCT01850823|579518305|FG002|Overall Study|Early Visit Window|4|||
160488469|NCT01850823|579518303|FG000|Overall Study|Enrolled in Error|0|||
160488470|NCT01850823|579518304|FG001|Overall Study|Enrolled in Error|1|||
160488471|NCT01850823|579518305|FG002|Overall Study|Enrolled in Error|2|||
160488472|NCT01850823|579518303|FG000|Overall Study|Lack of Efficacy|1|||
160488473|NCT01850823|579518304|FG001|Overall Study|Lack of Efficacy|0|||
160488474|NCT01850823|579518305|FG002|Overall Study|Lack of Efficacy|0|||
160488475|NCT01850823|579518303|FG000|Overall Study|Lost to Follow-up|0|||
160488476|NCT01850823|579518304|FG001|Overall Study|Lost to Follow-up|0|||
160488477|NCT01850823|579518305|FG002|Overall Study|Lost to Follow-up|1|||
160488478|NCT01850823|579518303|FG000|Overall Study|Restricted Medication|0|||
160488479|NCT01850823|579518304|FG001|Overall Study|Restricted Medication|0|||
160488480|NCT01850823|579518305|FG002|Overall Study|Restricted Medication|2|||
160488481|NCT01850823|579518303|FG000|Overall Study|Significant worstening of SAR|0|||
160488482|NCT01850823|579518304|FG001|Overall Study|Significant worstening of SAR|1|||
160488483|NCT01850823|579518305|FG002|Overall Study|Significant worstening of SAR|0|||
160488484|NCT01850823|579518303|FG000|Overall Study|Withdrawal by Subject|2|||
160488485|NCT01850823|579518304|FG001|Overall Study|Withdrawal by Subject|0|||
160488486|NCT01850823|579518305|FG002|Overall Study|Withdrawal by Subject|1|||
160488487|NCT00988533|579518306|FG000|Overall Study|Lost to Follow-up|3|||
160488488|NCT00913523|579518309|FG000|Overall Study|Withdrawal by Subject|3|||
160488489|NCT00913523|579518310|FG001|Overall Study|Withdrawal by Subject|2|||
160488490|NCT00913523|579518311|FG002|Overall Study|Withdrawal by Subject|2|||
160488491|NCT00913523|579518309|FG000|Overall Study|Lost to Follow-up|1|||
160488492|NCT00913523|579518310|FG001|Overall Study|Lost to Follow-up|1|||
160488493|NCT00913523|579518311|FG002|Overall Study|Lost to Follow-up|1|||
160488494|NCT00913523|579518309|FG000|Overall Study|Adverse Event|1|||
160488495|NCT00913523|579518310|FG001|Overall Study|Adverse Event|0|||
160488496|NCT00913523|579518311|FG002|Overall Study|Adverse Event|0|||
160488497|NCT00913523|579518309|FG000|Overall Study|Protocol Violation|5|||
160488498|NCT00913523|579518310|FG001|Overall Study|Protocol Violation|8|||
160488499|NCT00913523|579518311|FG002|Overall Study|Protocol Violation|8|||
160488500|NCT00913523|579518309|FG000|Overall Study|Pregnancy|1|||
160488501|NCT00913523|579518310|FG001|Overall Study|Pregnancy|3|||
160488502|NCT00913523|579518311|FG002|Overall Study|Pregnancy|0|||
160488503|NCT00913523|579518309|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
160488504|NCT00913523|579518310|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
160488505|NCT00913523|579518311|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
160488506|NCT01649297|579518312|FG000|Overall Study|Adverse Event|5|||
160488507|NCT01649297|579518313|FG001|Overall Study|Adverse Event|5|||
160488508|NCT01649297|579518314|FG002|Overall Study|Adverse Event|4|||
160488509|NCT01649297|579518315|FG003|Overall Study|Adverse Event|13|||
160488510|NCT01649297|579518316|FG004|Overall Study|Adverse Event|1|||
160488511|NCT01649297|579518312|FG000|Overall Study|Lack of Efficacy|0|||
160488512|NCT01649297|579518313|FG001|Overall Study|Lack of Efficacy|0|||
160488513|NCT01649297|579518314|FG002|Overall Study|Lack of Efficacy|0|||
160488514|NCT01649297|579518315|FG003|Overall Study|Lack of Efficacy|0|||
160488515|NCT01649297|579518316|FG004|Overall Study|Lack of Efficacy|1|||
160488516|NCT01649297|579518312|FG000|Overall Study|Non compliant with Protocol|1|||
160488517|NCT01649297|579518313|FG001|Overall Study|Non compliant with Protocol|0|||
160488518|NCT01649297|579518314|FG002|Overall Study|Non compliant with Protocol|3|||
160488519|NCT01649297|579518315|FG003|Overall Study|Non compliant with Protocol|2|||
160488520|NCT01649297|579518316|FG004|Overall Study|Non compliant with Protocol|1|||
160488521|NCT01649297|579518312|FG000|Overall Study|Lost to Follow-up|1|||
160488522|NCT01649297|579518313|FG001|Overall Study|Lost to Follow-up|1|||
160488523|NCT01649297|579518314|FG002|Overall Study|Lost to Follow-up|4|||
160488524|NCT01649297|579518315|FG003|Overall Study|Lost to Follow-up|3|||
160488525|NCT01649297|579518316|FG004|Overall Study|Lost to Follow-up|0|||
160488526|NCT01649297|579518312|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
160488527|NCT01649297|579518313|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
160488528|NCT01649297|579518314|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
160488529|NCT01649297|579518315|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
160488530|NCT01649297|579518316|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
160488531|NCT01649297|579518312|FG000|Overall Study|For other reason|4|||
160488532|NCT01649297|579518313|FG001|Overall Study|For other reason|1|||
160488533|NCT01649297|579518314|FG002|Overall Study|For other reason|2|||
160488534|NCT01649297|579518315|FG003|Overall Study|For other reason|0|||
160488535|NCT01649297|579518316|FG004|Overall Study|For other reason|0|||
160488536|NCT01685047|579518317|FG000|Overall Study|Withdrawal by Subject|20|||
160488537|NCT01685047|579518317|FG000|Overall Study|Death|26|||
160488538|NCT01685047|579518317|FG000|Overall Study|Lost to Follow-up|8|||
160488539|NCT01685047|579518317|FG000|Overall Study|Physician Decision|25|||
160488540|NCT01685047|579518317|FG000|Overall Study|Adverse Event|5|||
160488541|NCT01685047|579518317|FG000|Overall Study|patient withdrawn by sponsor|1|||
160488542|NCT01202409|579518318|FG000|Overall Study|Adverse Event|1|||
160488543|NCT01202409|579518318|FG000|Overall Study|Ineligible - KRAS mutants|7|||
160488544|NCT01732926|579518321|FG000|Overall Study|Study Terminated by Sponsor|168|||
160488545|NCT01732926|579518322|FG001|Overall Study|Study Terminated by Sponsor|80|||
160488546|NCT01732926|579518321|FG000|Overall Study|Withdrawal by Subject|46|||
160488547|NCT01732926|579518322|FG001|Overall Study|Withdrawal by Subject|8|||
160488548|NCT01732926|579518321|FG000|Overall Study|Physician Decision|24|||
160488549|NCT01732926|579518322|FG001|Overall Study|Physician Decision|11|||
160488550|NCT01732926|579518321|FG000|Overall Study|Other Reason|21|||
160488551|NCT01732926|579518322|FG001|Overall Study|Other Reason|4|||
160488552|NCT01732926|579518321|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
160488553|NCT01732926|579518322|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
160488554|NCT01732926|579518321|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
160488555|NCT01732926|579518322|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
160488556|NCT02544113|579518323|FG000|Overall Study|Death|3|||
160488557|NCT02544113|579518324|FG001|Overall Study|Death|4|||
160488558|NCT02847637|579518328|FG000|Overall Study|Withdrawal by Subject|0|||
160488559|NCT02847637|579518329|FG001|Overall Study|Withdrawal by Subject|1|||
160488560|NCT02847637|579518330|FG002|Overall Study|Withdrawal by Subject|1|||
160488561|NCT02847637|579518331|FG003|Overall Study|Withdrawal by Subject|0|||
160488562|NCT02847637|579518328|FG000|Overall Study|Lost to Follow-up|1|||
160488563|NCT02847637|579518329|FG001|Overall Study|Lost to Follow-up|1|||
160488564|NCT02847637|579518330|FG002|Overall Study|Lost to Follow-up|0|||
160488565|NCT02847637|579518331|FG003|Overall Study|Lost to Follow-up|0|||
160488566|NCT02741713|579518332|FG000|Overall Study|Surgery type changed intra-operatively|2|||
160488567|NCT02741713|579518333|FG001|Overall Study|Surgery type changed intra-operatively|1|||
160488568|NCT00496626|579518334|FG000|Overall Study|Lost to Follow-up|0|||
160488569|NCT00496626|579518335|FG001|Overall Study|Lost to Follow-up|1|||
160488570|NCT00496626|579518334|FG000|Overall Study|Protocol Violation|1|||
160488571|NCT00496626|579518335|FG001|Overall Study|Protocol Violation|0|||
160488572|NCT00496626|579518334|FG000|Overall Study|Withdrawal by Subject|5|||
160488573|NCT00496626|579518335|FG001|Overall Study|Withdrawal by Subject|4|||
160488574|NCT00496626|579518334|FG000|Overall Study|Relocated|0|||
160488575|NCT00496626|579518335|FG001|Overall Study|Relocated|1|||
160488576|NCT04191148|579518338|FG000|Overall Study|Withdrawal by Subject|1|||
160488577|NCT04191148|579518339|FG001|Overall Study|Withdrawal by Subject|0|||
160488578|NCT04191148|579518338|FG000|Overall Study|Adverse Event|1|||
160488579|NCT04191148|579518339|FG001|Overall Study|Adverse Event|0|||
160488580|NCT02647788|579518340|FG000|Overall Study|Lost to Follow-up|13|||
160488581|NCT02647788|579518341|FG001|Overall Study|Lost to Follow-up|11|||
160488582|NCT02647788|579518340|FG000|Overall Study|Did not want opiate|0|||
160488583|NCT02647788|579518341|FG001|Overall Study|Did not want opiate|1|||
160488584|NCT02647788|579518340|FG000|Overall Study|Withdrawal by Subject|1|||
160488585|NCT02647788|579518341|FG001|Overall Study|Withdrawal by Subject|0|||
160488586|NCT02647788|579518340|FG000|Overall Study|Felt itchy with assigned medication|1|||
160488587|NCT02647788|579518341|FG001|Overall Study|Felt itchy with assigned medication|0|||
160488588|NCT02647788|579518340|FG000|Overall Study|Felt nauseous with assigned medication|1|||
160488589|NCT02647788|579518341|FG001|Overall Study|Felt nauseous with assigned medication|1|||
160488590|NCT01274559|579518342|FG000|Overall Study|Adverse Event|57|||
160488591|NCT01274559|579518343|FG001|Overall Study|Adverse Event|13|||
160488592|NCT01274559|579518342|FG000|Overall Study|Death|1|||
160488593|NCT01274559|579518343|FG001|Overall Study|Death|1|||
160488594|NCT01274559|579518342|FG000|Overall Study|Lost to Follow-up|3|||
160488595|NCT01274559|579518343|FG001|Overall Study|Lost to Follow-up|3|||
160488596|NCT01274559|579518342|FG000|Overall Study|Non-compliance with Study Drug|2|||
160610798|NCT00085644|579952276|FG001|Open-Label Period|Adverse Event|0|||
160610799|NCT00085644|579952277|FG002|Open-Label Period|Adverse Event|38|||
160610800|NCT00085644|579952275|FG000|Open-Label Period|Withdrawal by Subject|0|||
160610801|NCT00085644|579952276|FG001|Open-Label Period|Withdrawal by Subject|0|||
160610802|NCT00085644|579952277|FG002|Open-Label Period|Withdrawal by Subject|29|||
160610803|NCT00085644|579952275|FG000|Open-Label Period|Lost to Follow-up|0|||
160610804|NCT00085644|579952276|FG001|Open-Label Period|Lost to Follow-up|0|||
160610805|NCT00085644|579952277|FG002|Open-Label Period|Lost to Follow-up|13|||
160610806|NCT00085644|579952275|FG000|Open-Label Period|Lack of Efficacy|0|||
160610807|NCT00085644|579952276|FG001|Open-Label Period|Lack of Efficacy|0|||
160610808|NCT00085644|579952277|FG002|Open-Label Period|Lack of Efficacy|15|||
160610809|NCT00085644|579952275|FG000|Open-Label Period|Pregnancy|0|||
160610810|NCT00085644|579952276|FG001|Open-Label Period|Pregnancy|0|||
160610811|NCT00085644|579952277|FG002|Open-Label Period|Pregnancy|3|||
160610812|NCT00085644|579952275|FG000|Open-Label Period|Contemplating pregnancy|0|||
160610813|NCT00085644|579952276|FG001|Open-Label Period|Contemplating pregnancy|0|||
160610814|NCT00085644|579952277|FG002|Open-Label Period|Contemplating pregnancy|3|||
160610815|NCT00085644|579952275|FG000|Open-Label Period|Protocol Violation|0|||
160610816|NCT00085644|579952276|FG001|Open-Label Period|Protocol Violation|0|||
160610817|NCT00085644|579952277|FG002|Open-Label Period|Protocol Violation|4|||
160610818|NCT00085644|579952275|FG000|Open-Label Period|Personal reason|0|||
160610819|NCT00085644|579952276|FG001|Open-Label Period|Personal reason|0|||
160610820|NCT00085644|579952277|FG002|Open-Label Period|Personal reason|4|||
160610821|NCT04259346|579952278|FG000|Overall Study|Lost to Follow-up|1|||
160610822|NCT04259346|579952279|FG001|Overall Study|Lost to Follow-up|3|||
160610823|NCT04259346|579952278|FG000|Overall Study|Protocol Violation|1|||
160610824|NCT04259346|579952279|FG001|Overall Study|Protocol Violation|0|||
160610825|NCT04259346|579952278|FG000|Overall Study|Withdrawal by Subject|1|||
160610826|NCT04259346|579952279|FG001|Overall Study|Withdrawal by Subject|0|||
160610827|NCT04259346|579952278|FG000|Overall Study|Adverse Event|1|||
160610828|NCT04259346|579952279|FG001|Overall Study|Adverse Event|1|||
160610829|NCT03330106|579952280|FG000|Part A|Withdrawal by Subject|1|||
160610830|NCT03330106|579952281|FG001|Part A|Withdrawal by Subject|1|||
160610831|NCT03330106|579952282|FG002|Part A|Withdrawal by Subject|0|||
160610832|NCT03330106|579952283|FG003|Part A|Withdrawal by Subject|0|||
160610833|NCT03330106|579952280|FG000|Part A|Death|2|||
160610834|NCT03330106|579952281|FG001|Part A|Death|1|||
160610835|NCT03330106|579952282|FG002|Part A|Death|0|||
160610836|NCT03330106|579952283|FG003|Part A|Death|0|||
160610837|NCT03330106|579952280|FG000|Part A|Adverse Event|0|||
160488597|NCT01274559|579518343|FG001|Overall Study|Non-compliance with Study Drug|4|||
160488598|NCT01274559|579518342|FG000|Overall Study|Physician Decision|2|||
160488599|NCT01274559|579518343|FG001|Overall Study|Physician Decision|1|||
160488600|NCT01274559|579518342|FG000|Overall Study|Protocol Violation|28|||
160488601|NCT01274559|579518343|FG001|Overall Study|Protocol Violation|23|||
160488602|NCT01274559|579518342|FG000|Overall Study|Study Terminated by Sponsor|79|||
160488603|NCT01274559|579518343|FG001|Overall Study|Study Terminated by Sponsor|87|||
160488604|NCT01274559|579518342|FG000|Overall Study|Withdrawal by Subject|25|||
160488605|NCT01274559|579518343|FG001|Overall Study|Withdrawal by Subject|13|||
160488606|NCT01233999|579518344|FG000|Overall Study|Withdrawal by Subject|1|||
160488607|NCT01233999|579518344|FG000|Overall Study|Lost to Follow-up|1|||
160488608|NCT02835092|579518345|FG000|Overall Study|Withdrawal by Subject|3|||
160488609|NCT02835092|579518346|FG001|Overall Study|Withdrawal by Subject|6|||
160488610|NCT02835092|579518347|FG002|Overall Study|Withdrawal by Subject|3|||
160488611|NCT02835092|579518345|FG000|Overall Study|Lost to Follow-up|0|||
160488612|NCT02835092|579518346|FG001|Overall Study|Lost to Follow-up|2|||
160488613|NCT02835092|579518347|FG002|Overall Study|Lost to Follow-up|0|||
160488614|NCT01321723|579518348|FG000|Overall Study|Adverse Event|3|||
160488615|NCT01321723|579518349|FG001|Overall Study|Adverse Event|5|||
160488616|NCT01321723|579518350|FG002|Overall Study|Adverse Event|2|||
160488617|NCT01321723|579518348|FG000|Overall Study|Withdrawal by Subject|2|||
160488618|NCT01321723|579518349|FG001|Overall Study|Withdrawal by Subject|0|||
160488619|NCT01321723|579518350|FG002|Overall Study|Withdrawal by Subject|2|||
160488620|NCT02246218|579518351|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160610838|NCT03330106|579952281|FG001|Part A|Adverse Event|1|||
160610839|NCT03330106|579952282|FG002|Part A|Adverse Event|0|||
160610840|NCT03330106|579952283|FG003|Part A|Adverse Event|0|||
160610841|NCT03330106|579952280|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
160610842|NCT03330106|579952281|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
160610843|NCT03330106|579952282|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
160488621|NCT02246218|579518352|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160610844|NCT03330106|579952283|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
160488622|NCT02246218|579518351|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
160488623|NCT02246218|579518352|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
160488624|NCT02246218|579518351|FG000|Overall Study|Adverse Event|1|||
160488625|NCT02246218|579518352|FG001|Overall Study|Adverse Event|1|||
160488626|NCT02246218|579518351|FG000|Overall Study|Lost to Follow-up|1|||
160488627|NCT02246218|579518352|FG001|Overall Study|Lost to Follow-up|0|||
160488628|NCT01322009|579518353|FG000|Overall Study|Death|0|||
160488629|NCT01322009|579518354|FG001|Overall Study|Death|1|||
160488630|NCT01322009|579518353|FG000|Overall Study|Adverse Event|0|||
160488631|NCT01322009|579518354|FG001|Overall Study|Adverse Event|1|||
160488632|NCT01322009|579518353|FG000|Overall Study|ng tube discontinued|0|||
160488633|NCT01322009|579518354|FG001|Overall Study|ng tube discontinued|1|||
160488634|NCT01657877|579518355|FG000|Overall Study|Withdrawal by Subject|4|||
160488635|NCT01657877|579518355|FG000|Overall Study|Protocol Violation|6|||
160488636|NCT01657877|579518355|FG000|Overall Study|Adverse Event|2|||
160488637|NCT01657877|579518355|FG000|Overall Study|Other Reason|2|||
160488638|NCT00905034|579518356|FG000|Overall Study|Withdrawal by Subject|1|||
160488639|NCT03409731|579518357|FG000|Overall Study|Withdrawal by Subject|17|||
160488640|NCT03409731|579518357|FG000|Overall Study|Death|4|||
160488641|NCT01710800|579518360|FG000|Overall Study|Withdrawal by Subject|21|||
160488642|NCT01710800|579518360|FG000|Overall Study|Protocol Violation|1|||
160488643|NCT01585298|579518364|FG000|Overall Study|Study completion was not documented.|1|||
160488644|NCT01585298|579518364|FG000|Overall Study|Protocol deviation|1|||
160488645|NCT01585298|579518364|FG000|Overall Study|Administrative problems|4|||
160488646|NCT01585298|579518364|FG000|Overall Study|Lost to Follow-up|2|||
160488647|NCT01585298|579518364|FG000|Overall Study|Withdrawal by Subject|4|||
160488648|NCT01585298|579518364|FG000|Overall Study|Abnormal test procedure results|1|||
160488649|NCT01585298|579518364|FG000|Overall Study|Adverse Event|24|||
160488650|NCT01670188|579518365|FG000|Overall Study|Death|0|||
160488651|NCT01670188|579518366|FG001|Overall Study|Death|1|||
160488652|NCT02427958|579518371|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
160488653|NCT02427958|579518371|FG000|Overall Study|Lost to Follow-up|6|||
160488654|NCT02427958|579518371|FG000|Overall Study|Withdrawal by Subject|14|||
160488655|NCT02427958|579518371|FG000|Overall Study|Lack of Efficacy|1|||
160488656|NCT02025985|579518372|FG000|Overall Study|Consent withdrawn|0|||
160488657|NCT02025985|579518373|FG001|Overall Study|Consent withdrawn|0|||
160488658|NCT02025985|579518374|FG002|Overall Study|Consent withdrawn|1|||
160488659|NCT02025985|579518375|FG003|Overall Study|Consent withdrawn|0|||
160488660|NCT02025985|579518376|FG004|Overall Study|Consent withdrawn|0|||
160488661|NCT02025985|579518372|FG000|Overall Study|Termination of study by Sponsor|4|||
160488662|NCT02025985|579518373|FG001|Overall Study|Termination of study by Sponsor|3|||
160488663|NCT02025985|579518374|FG002|Overall Study|Termination of study by Sponsor|1|||
160488664|NCT02025985|579518375|FG003|Overall Study|Termination of study by Sponsor|1|||
160488665|NCT02025985|579518376|FG004|Overall Study|Termination of study by Sponsor|3|||
160488666|NCT02025985|579518372|FG000|Overall Study|Death|21|||
160488667|NCT02025985|579518373|FG001|Overall Study|Death|20|||
160488668|NCT02025985|579518374|FG002|Overall Study|Death|23|||
160488669|NCT02025985|579518375|FG003|Overall Study|Death|20|||
160488670|NCT02025985|579518376|FG004|Overall Study|Death|17|||
160488671|NCT00607997|579518377|FG000|Overall Study|Lack of Efficacy|6|||
160488672|NCT00607997|579518378|FG001|Overall Study|Lack of Efficacy|20|||
160488673|NCT00607997|579518379|FG002|Overall Study|Lack of Efficacy|14|||
160488674|NCT00607997|579518380|FG003|Overall Study|Lack of Efficacy|10|||
160488675|NCT00607997|579518377|FG000|Overall Study|Death|8|||
160488676|NCT00607997|579518378|FG001|Overall Study|Death|5|||
160488677|NCT00607997|579518379|FG002|Overall Study|Death|2|||
160488678|NCT00607997|579518380|FG003|Overall Study|Death|5|||
160488679|NCT00607997|579518377|FG000|Overall Study|Adverse Event|3|||
160488680|NCT00607997|579518378|FG001|Overall Study|Adverse Event|1|||
160488681|NCT00607997|579518379|FG002|Overall Study|Adverse Event|2|||
160488682|NCT00607997|579518380|FG003|Overall Study|Adverse Event|0|||
160488683|NCT00607997|579518377|FG000|Overall Study|Physician Decision|4|||
160488684|NCT00607997|579518378|FG001|Overall Study|Physician Decision|1|||
160488685|NCT00607997|579518379|FG002|Overall Study|Physician Decision|0|||
160488686|NCT00607997|579518380|FG003|Overall Study|Physician Decision|0|||
160488687|NCT00607997|579518377|FG000|Overall Study|Relapse, recurrent illness|4|||
160488688|NCT00607997|579518378|FG001|Overall Study|Relapse, recurrent illness|0|||
160488689|NCT00607997|579518379|FG002|Overall Study|Relapse, recurrent illness|2|||
160488690|NCT00607997|579518380|FG003|Overall Study|Relapse, recurrent illness|0|||
160488691|NCT00607997|579518377|FG000|Overall Study|Other without explanation|2|||
160488692|NCT00607997|579518378|FG001|Overall Study|Other without explanation|0|||
160488693|NCT00607997|579518379|FG002|Overall Study|Other without explanation|4|||
160488694|NCT00607997|579518380|FG003|Overall Study|Other without explanation|1|||
160488695|NCT01242371|579518381|FG000|Overall Study|Withdrawal by Subject|2|||
160661304|NCT00723528|580144037|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
160661305|NCT00723528|580144038|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
160488696|NCT01242371|579518382|FG001|Overall Study|Withdrawal by Subject|2|||
160488697|NCT01242371|579518381|FG000|Overall Study|Protocol Violation|0|||
160488698|NCT01242371|579518382|FG001|Overall Study|Protocol Violation|3|||
160488699|NCT06080438|579518385|FG000|Overall Study|Lost to Follow-up|2|||
160488700|NCT03589300|579518386|FG000|Overall Study|Adverse Event|2|||
160488701|NCT03589300|579518386|FG000|Overall Study|Death|4|||
160488702|NCT03589300|579518386|FG000|Overall Study|Lost to Follow-up|12|||
160610845|NCT03330106|579952280|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
160610846|NCT03330106|579952281|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
160610847|NCT03330106|579952282|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
160610848|NCT03330106|579952283|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
160610849|NCT03330106|579952280|FG000|Part A|Progressive Disease|0|||
160610850|NCT03330106|579952281|FG001|Part A|Progressive Disease|1|||
160610851|NCT03330106|579952282|FG002|Part A|Progressive Disease|0|||
160610852|NCT03330106|579952283|FG003|Part A|Progressive Disease|0|||
160610853|NCT03330106|579952280|FG000|Part B|Lost to Follow-up|0|||
160610854|NCT03330106|579952281|FG001|Part B|Lost to Follow-up|0|||
160610855|NCT03330106|579952282|FG002|Part B|Lost to Follow-up|0|||
160610856|NCT03330106|579952283|FG003|Part B|Lost to Follow-up|1|||
160610857|NCT03330106|579952280|FG000|Part B|Withdrawal by Subject|0|||
160610858|NCT03330106|579952281|FG001|Part B|Withdrawal by Subject|0|||
160610859|NCT03330106|579952282|FG002|Part B|Withdrawal by Subject|4|||
160610860|NCT03330106|579952283|FG003|Part B|Withdrawal by Subject|0|||
160610861|NCT03330106|579952280|FG000|Part B|Death|0|||
160610862|NCT03330106|579952281|FG001|Part B|Death|0|||
160610863|NCT03330106|579952282|FG002|Part B|Death|2|||
160610864|NCT03330106|579952283|FG003|Part B|Death|0|||
160610865|NCT03330106|579952280|FG000|Part B|Clinical Progression|0|||
160610866|NCT03330106|579952281|FG001|Part B|Clinical Progression|0|||
160610867|NCT03330106|579952282|FG002|Part B|Clinical Progression|1|||
160610868|NCT03330106|579952283|FG003|Part B|Clinical Progression|1|||
160610869|NCT03330106|579952280|FG000|Part B|Symptomatic Deterioration|0|||
160610870|NCT03330106|579952281|FG001|Part B|Symptomatic Deterioration|0|||
160610871|NCT03330106|579952282|FG002|Part B|Symptomatic Deterioration|0|||
160610872|NCT03330106|579952283|FG003|Part B|Symptomatic Deterioration|1|||
160610873|NCT03330106|579952280|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
160610874|NCT03330106|579952281|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
160610875|NCT03330106|579952282|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
160610876|NCT03330106|579952283|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
160610877|NCT03330106|579952280|FG000|Part B|Progressive Disease|0|||
160610878|NCT03330106|579952281|FG001|Part B|Progressive Disease|0|||
160610879|NCT03330106|579952282|FG002|Part B|Progressive Disease|11|||
160610880|NCT03330106|579952283|FG003|Part B|Progressive Disease|4|||
160610881|NCT00486889|579952286|FG000|Overall Study|Death|3|||
160610882|NCT00486889|579952286|FG000|Overall Study|Non-compliant|2|||
160610883|NCT00486889|579952286|FG000|Overall Study|Withdrawal by Subject|6|||
160610884|NCT00893763|579952287|FG000|Overall Study|extubated|110|||
160610885|NCT00893763|579952288|FG001|Overall Study|extubated|110|||
160610886|NCT01738594|579952290|FG000|Registration and Treatment Start|Adverse Event|0|||
160610887|NCT01738594|579952291|FG001|Registration and Treatment Start|Adverse Event|1|||
160610888|NCT01738594|579952292|FG002|Registration and Treatment Start|Adverse Event|0|||
160610889|NCT01738594|579952293|FG003|Registration and Treatment Start|Adverse Event|0|||
160610890|NCT01738594|579952294|FG004|Registration and Treatment Start|Adverse Event|0|||
160610891|NCT01738594|579952295|FG005|Registration and Treatment Start|Adverse Event|0|||
160610892|NCT01738594|579952296|FG006|Registration and Treatment Start|Adverse Event|0|||
160610893|NCT01738594|579952297|FG007|Registration and Treatment Start|Adverse Event|0|||
160610894|NCT01738594|579952290|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
160610895|NCT01738594|579952291|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
160610896|NCT01738594|579952292|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
160610897|NCT01738594|579952293|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
160610898|NCT01738594|579952294|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
160610899|NCT01738594|579952295|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
160610900|NCT01738594|579952296|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
160610901|NCT01738594|579952297|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
160610902|NCT01738594|579952290|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
160610903|NCT01738594|579952291|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
160610904|NCT01738594|579952292|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
160610905|NCT01738594|579952293|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
160610906|NCT01738594|579952294|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
160610907|NCT01738594|579952295|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
160610908|NCT01738594|579952296|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
160610909|NCT01738594|579952297|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
160610910|NCT01738594|579952290|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
160610911|NCT01738594|579952291|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
160610912|NCT01738594|579952292|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
160610913|NCT01738594|579952293|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
160610914|NCT01738594|579952294|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
160610915|NCT01738594|579952295|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
160610916|NCT01738594|579952296|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
160610917|NCT01738594|579952297|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
160610918|NCT01738594|579952290|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
160610919|NCT01738594|579952291|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
160610920|NCT01738594|579952292|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
160610921|NCT01738594|579952293|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
160610922|NCT01738594|579952294|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
160610923|NCT01738594|579952295|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
160610924|NCT01738594|579952296|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
160610925|NCT01738594|579952297|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
160610926|NCT01738594|579952290|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
160610927|NCT01738594|579952291|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
160488703|NCT03589300|579518386|FG000|Overall Study|Withdrawal by Subject|5|||
160488704|NCT01527500|579518387|FG000|Part A|Administrative|11|||
160488705|NCT01527500|579518388|FG001|Part A|Administrative|7|||
160488706|NCT01527500|579518387|FG000|Part A|Adverse Event|4|||
160488707|NCT01527500|579518388|FG001|Part A|Adverse Event|2|||
160488708|NCT01527500|579518387|FG000|Part A|Death|4|||
160488709|NCT01527500|579518388|FG001|Part A|Death|1|||
160488710|NCT01527500|579518387|FG000|Part A|Lost to Follow-up|0|||
160488711|NCT01527500|579518388|FG001|Part A|Lost to Follow-up|1|||
160488712|NCT01527500|579518387|FG000|Part A|Protocol Deviation|9|||
160488713|NCT01527500|579518388|FG001|Part A|Protocol Deviation|2|||
160488714|NCT01527500|579518387|FG000|Part A|Withdrawal by Subject|2|||
160488715|NCT01527500|579518388|FG001|Part A|Withdrawal by Subject|0|||
160488716|NCT01527500|579518387|FG000|Part B|Adverse Event|1|||
160488717|NCT01527500|579518388|FG001|Part B|Adverse Event|0|||
160488718|NCT00372255|579518389|FG000|Overall Study|Withdrawn for other reasons|2|||
160488719|NCT00372255|579518390|FG001|Overall Study|Withdrawn for other reasons|1|||
160488720|NCT00776984|579518391|FG000|Overall Study|Adverse Event|8|||
160488721|NCT00776984|579518392|FG001|Overall Study|Adverse Event|2|||
160488722|NCT00776984|579518391|FG000|Overall Study|Protocol Violation|4|||
160488723|NCT00776984|579518392|FG001|Overall Study|Protocol Violation|2|||
160488724|NCT00776984|579518391|FG000|Overall Study|Lost to Follow-up|2|||
160488725|NCT00776984|579518392|FG001|Overall Study|Lost to Follow-up|0|||
160488726|NCT00776984|579518391|FG000|Overall Study|Withdrawal by Subject|12|||
160488727|NCT00776984|579518392|FG001|Overall Study|Withdrawal by Subject|7|||
160488728|NCT00776984|579518391|FG000|Overall Study|Lack of Efficacy|0|||
160488729|NCT00776984|579518392|FG001|Overall Study|Lack of Efficacy|1|||
160488730|NCT00776984|579518391|FG000|Overall Study|Other|5|||
160488731|NCT00776984|579518392|FG001|Overall Study|Other|9|||
160488732|NCT02573883|579518398|FG000|Six Month Follow Up|Lost to Follow-up|1|||
160488733|NCT02573883|579518399|FG001|Six Month Follow Up|Lost to Follow-up|0|||
160488734|NCT02573883|579518400|FG002|Six Month Follow Up|Lost to Follow-up|0|||
160488735|NCT02573883|579518401|FG003|Six Month Follow Up|Lost to Follow-up|0|||
160488736|NCT02573883|579518398|FG000|One Year Follow Up|Lost to Follow-up|2|||
160488737|NCT02573883|579518399|FG001|One Year Follow Up|Lost to Follow-up|1|||
160488738|NCT02573883|579518400|FG002|One Year Follow Up|Lost to Follow-up|0|||
160488739|NCT02573883|579518401|FG003|One Year Follow Up|Lost to Follow-up|0|||
160488740|NCT00582114|579518402|FG000|Overall Study|Death|4|||
160488741|NCT00582114|579518403|FG001|Overall Study|Death|4|||
160488742|NCT00582114|579518402|FG000|Overall Study|Kidney Transplant|3|||
160488743|NCT00582114|579518403|FG001|Overall Study|Kidney Transplant|1|||
160488744|NCT00582114|579518402|FG000|Overall Study|Lost to Follow-up|7|||
160488745|NCT00582114|579518403|FG001|Overall Study|Lost to Follow-up|6|||
160488746|NCT00582114|579518402|FG000|Overall Study|Withdrawal by Subject|8|||
160610928|NCT01738594|579952292|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
160488747|NCT00582114|579518403|FG001|Overall Study|Withdrawal by Subject|16|||
160488748|NCT00582114|579518402|FG000|Overall Study|Adverse Event|1|||
160488749|NCT00582114|579518403|FG001|Overall Study|Adverse Event|1|||
160488750|NCT00582114|579518402|FG000|Overall Study|Physician Decision|0|||
160488751|NCT00582114|579518403|FG001|Overall Study|Physician Decision|6|||
160488752|NCT00582114|579518402|FG000|Overall Study|Stopped by data safety monitoring board|19|||
160488753|NCT00582114|579518403|FG001|Overall Study|Stopped by data safety monitoring board|20|||
160488754|NCT00130728|579518411|FG000|Overall Study|Death|258|||
160488755|NCT00130728|579518412|FG001|Overall Study|Death|258|||
160610929|NCT01738594|579952293|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
160610930|NCT01738594|579952294|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
160488756|NCT00130728|579518411|FG000|Overall Study|Lost to Follow-up|4|||
160610931|NCT01738594|579952295|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
160610932|NCT01738594|579952296|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
160610933|NCT01738594|579952297|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
160610934|NCT01738594|579952290|FG000|Follow up for 1 Year|Death|0|||
160610935|NCT01738594|579952291|FG001|Follow up for 1 Year|Death|0|||
160488757|NCT00130728|579518412|FG001|Overall Study|Lost to Follow-up|0|||
160488758|NCT00130728|579518411|FG000|Overall Study|Withdrawal by Subject|0|||
160488759|NCT00130728|579518412|FG001|Overall Study|Withdrawal by Subject|2|||
160488760|NCT01181609|579520211|FG000|Overall Study|Adverse Event|1|||
160488761|NCT01181609|579520211|FG000|Overall Study|Withdrawal by Subject|1|||
160488762|NCT01181609|579520211|FG000|Overall Study|Lost to Follow-up|1|||
160488763|NCT01181609|579520211|FG000|Overall Study|Death|50|||
160488764|NCT03991988|579520215|FG000|Overall Study|Withdrawal by Subject|2|||
160488765|NCT03991988|579520216|FG001|Overall Study|Withdrawal by Subject|2|||
160488766|NCT00408928|579520220|FG000|Overall Study|Withdrawal by Subject|1|||
160488767|NCT00408928|579520220|FG000|Overall Study|Death|1|||
160488768|NCT00408928|579520220|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
160488769|NCT01751165|579520221|FG000|Overall Study|Adverse event, serious fatal|1|||
160488770|NCT01751165|579520222|FG001|Overall Study|Adverse event, serious fatal|0|||
160488771|NCT01751165|579520223|FG002|Overall Study|Adverse event, serious fatal|1|||
160488772|NCT01751165|579520221|FG000|Overall Study|Withdrawal by Subject|0|||
160488773|NCT01751165|579520222|FG001|Overall Study|Withdrawal by Subject|0|||
160488774|NCT01751165|579520223|FG002|Overall Study|Withdrawal by Subject|1|||
160488775|NCT01751165|579520221|FG000|Overall Study|Serious adverse event|0|||
160488776|NCT01751165|579520222|FG001|Overall Study|Serious adverse event|2|||
160488777|NCT01751165|579520223|FG002|Overall Study|Serious adverse event|0|||
160488778|NCT01751165|579520221|FG000|Overall Study|Lost to Follow-up|1|||
160488779|NCT01751165|579520222|FG001|Overall Study|Lost to Follow-up|1|||
160488780|NCT01751165|579520223|FG002|Overall Study|Lost to Follow-up|1|||
160488781|NCT01036165|579520224|FG000|Overall Study|Adverse Event|6|||
160488782|NCT01036165|579520224|FG000|Overall Study|Lost to Follow-up|2|||
160488783|NCT01036165|579520224|FG000|Overall Study|Withdrawal by Subject|3|||
160488784|NCT01036165|579520224|FG000|Overall Study|Device Related Issues|3|||
160488785|NCT01036165|579520224|FG000|Overall Study|Problems finding proper area to inject|1|||
160488786|NCT04051242|579520226|FG000|Overall Study|Withdrawal by Subject|1|||
160488787|NCT04051242|579520226|FG000|Overall Study|Physician Decision|1|||
160488788|NCT02262364|579520229|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
160488789|NCT01049984|579520230|FG000|Overall Study|Withdrawal by Subject|1|||
160488790|NCT01049984|579520231|FG001|Overall Study|Withdrawal by Subject|5|||
160488791|NCT01049984|579520230|FG000|Overall Study|Protocol Violation|3|||
160488792|NCT01049984|579520231|FG001|Overall Study|Protocol Violation|4|||
160488793|NCT01049984|579520230|FG000|Overall Study|Lost to Follow-up|2|||
160488794|NCT01049984|579520231|FG001|Overall Study|Lost to Follow-up|1|||
160488795|NCT01049984|579520230|FG000|Overall Study|Adverse Event|13|||
160488796|NCT01049984|579520231|FG001|Overall Study|Adverse Event|7|||
160488797|NCT01049984|579520230|FG000|Overall Study|Treatment failure|0|||
160488798|NCT01049984|579520231|FG001|Overall Study|Treatment failure|2|||
160488799|NCT00337285|579520232|FG000|Overall Study|Withdrawal by Subject|42|||
160488800|NCT00337285|579520232|FG000|Overall Study|Lost to Follow-up|41|||
160488801|NCT00337285|579520232|FG000|Overall Study|Adverse Event|28|||
160488802|NCT00337285|579520232|FG000|Overall Study|Protocol Violation|27|||
160488803|NCT00337285|579520232|FG000|Overall Study|Lack of Efficacy|11|||
160488804|NCT00337285|579520232|FG000|Overall Study|Death|1|||
160488805|NCT00337285|579520232|FG000|Overall Study|Physician Decision|1|||
160488806|NCT00337285|579520232|FG000|Overall Study|Lack of protocol compliance|7|||
160488807|NCT01040403|579520236|FG000|Overall Study|Adverse Event|10|||
160488808|NCT01040403|579520236|FG000|Overall Study|Protocol Violation|2|||
160488809|NCT01040403|579520236|FG000|Overall Study|Lost to Follow-up|1|||
160488810|NCT01040403|579520236|FG000|Overall Study|Not treated|1|||
160488811|NCT01040403|579520236|FG000|Overall Study|Other reason not defined above|6|||
160488812|NCT00292981|579520237|FG000|Overall Study|Adverse Event|1|||
160488813|NCT00292981|579520237|FG000|Overall Study|Lost to Follow-up|13|||
160488814|NCT00292981|579520237|FG000|Overall Study|Withdrawal by Subject|22|||
160488815|NCT00292981|579520237|FG000|Overall Study|Other|3|||
160488816|NCT01085812|579520238|FG000|Open-Label Period|Adverse Event|0|||
160488817|NCT01085812|579520239|FG001|Open-Label Period|Adverse Event|80|||
160488818|NCT01085812|579520238|FG000|Open-Label Period|Lack of Efficacy|0|||
160488819|NCT01085812|579520239|FG001|Open-Label Period|Lack of Efficacy|26|||
160488820|NCT01085812|579520238|FG000|Open-Label Period|Protocol Violation|0|||
160488821|NCT01085812|579520239|FG001|Open-Label Period|Protocol Violation|39|||
160488822|NCT01085812|579520238|FG000|Open-Label Period|Withdrawal by Subject|0|||
160488823|NCT01085812|579520239|FG001|Open-Label Period|Withdrawal by Subject|53|||
160488824|NCT01085812|579520238|FG000|Open-Label Period|Lost to Follow-up|0|||
160488825|NCT01085812|579520239|FG001|Open-Label Period|Lost to Follow-up|42|||
160488826|NCT01085812|579520238|FG000|Double-Blind Period|Adverse Event|3|||
160488827|NCT01085812|579520239|FG001|Double-Blind Period|Adverse Event|8|||
160488828|NCT01085812|579520238|FG000|Double-Blind Period|Protocol Violation|2|||
160488829|NCT01085812|579520239|FG001|Double-Blind Period|Protocol Violation|7|||
160488830|NCT01085812|579520238|FG000|Double-Blind Period|Withdrawal by Subject|11|||
160488831|NCT01085812|579520239|FG001|Double-Blind Period|Withdrawal by Subject|24|||
160488832|NCT01085812|579520238|FG000|Double-Blind Period|Lost to Follow-up|5|||
160488833|NCT01085812|579520239|FG001|Double-Blind Period|Lost to Follow-up|17|||
160488834|NCT01085812|579520238|FG000|Double-Blind Period|Other Reasons|0|||
160488835|NCT01085812|579520239|FG001|Double-Blind Period|Other Reasons|2|||
160488836|NCT01085812|579520238|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
160610936|NCT01738594|579952292|FG002|Follow up for 1 Year|Death|0|||
160610937|NCT01738594|579952293|FG003|Follow up for 1 Year|Death|0|||
160610938|NCT01738594|579952294|FG004|Follow up for 1 Year|Death|0|||
160610939|NCT01738594|579952295|FG005|Follow up for 1 Year|Death|1|||
160610940|NCT01738594|579952296|FG006|Follow up for 1 Year|Death|0|||
160610941|NCT01738594|579952297|FG007|Follow up for 1 Year|Death|0|||
160610942|NCT01738594|579952290|FG000|Follow up for 1 Year|Other|0|||
160610943|NCT01738594|579952291|FG001|Follow up for 1 Year|Other|0|||
160610944|NCT01738594|579952292|FG002|Follow up for 1 Year|Other|0|||
160610945|NCT01738594|579952293|FG003|Follow up for 1 Year|Other|0|||
160610946|NCT01738594|579952294|FG004|Follow up for 1 Year|Other|0|||
160610947|NCT01738594|579952295|FG005|Follow up for 1 Year|Other|2|||
160610948|NCT01738594|579952296|FG006|Follow up for 1 Year|Other|0|||
160610949|NCT01738594|579952297|FG007|Follow up for 1 Year|Other|0|||
160610950|NCT04430036|579952300|FG000|Safety Run in Phase|Progression of disease|2|||
160610951|NCT04107935|579952301|FG000|Overall Study|Death|1|||
160610952|NCT04107935|579952302|FG001|Overall Study|Death|0|||
160610953|NCT01842334|579952303|FG000|Overall Study|Withdrawal by Subject|3|||
160610954|NCT01842334|579952304|FG001|Overall Study|Withdrawal by Subject|3|||
160610955|NCT01842334|579952303|FG000|Overall Study|Moved away mid-study|0|||
160610956|NCT01842334|579952304|FG001|Overall Study|Moved away mid-study|1|||
160610957|NCT00376675|579952305|FG000|Overall Study|Withdrawal by Subject|9|||
160610958|NCT00376675|579952306|FG001|Overall Study|Withdrawal by Subject|2|||
160610959|NCT00376675|579952305|FG000|Overall Study|Adverse Event|10|||
160610960|NCT00376675|579952306|FG001|Overall Study|Adverse Event|5|||
160610961|NCT00376675|579952305|FG000|Overall Study|Other Reason|1|||
160610962|NCT00376675|579952306|FG001|Overall Study|Other Reason|7|||
160610963|NCT01332851|579952309|FG000|Overall Study|Withdrawal by Subject|4|||
160488837|NCT01085812|579520239|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
160488838|NCT01085812|579520238|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
160488839|NCT01085812|579520239|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
160488840|NCT01085812|579520238|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
160488841|NCT01085812|579520239|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
160488842|NCT01085812|579520238|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
160488843|NCT01085812|579520239|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
160488844|NCT01085812|579520238|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
160488845|NCT01085812|579520239|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
160488846|NCT00594178|579520240|FG000|Overall Study|Physician Decision|5|||
160488847|NCT01874665|579520243|FG000|Overall Study|Adverse Event|6|||
160488848|NCT01874665|579520244|FG001|Overall Study|Adverse Event|2|||
160488849|NCT01874665|579520243|FG000|Overall Study|Withdrawal by Subject|4|||
160488850|NCT01874665|579520244|FG001|Overall Study|Withdrawal by Subject|1|||
160488851|NCT01874665|579520243|FG000|Overall Study|Physician Decision|3|||
160488852|NCT01874665|579520244|FG001|Overall Study|Physician Decision|0|||
160488853|NCT01874665|579520243|FG000|Overall Study|Clinical Progressive Disease|4|||
160488854|NCT01874665|579520244|FG001|Overall Study|Clinical Progressive Disease|3|||
160488855|NCT01874665|579520243|FG000|Overall Study|Study Terminated by Sponsor|0|||
160488856|NCT01874665|579520244|FG001|Overall Study|Study Terminated by Sponsor|2|||
160488857|NCT01874665|579520243|FG000|Overall Study|Documented Progressive Disease|11|||
160488858|NCT01874665|579520244|FG001|Overall Study|Documented Progressive Disease|7|||
160488859|NCT01874665|579520243|FG000|Overall Study|Other|2|||
160488860|NCT01874665|579520244|FG001|Overall Study|Other|0|||
160488861|NCT02447432|579520245|FG000|Epoch 001|Adverse Event|1|||
160488862|NCT02447432|579520246|FG001|Epoch 001|Adverse Event|1|||
160488863|NCT02447432|579520245|FG000|Epoch 001|Withdrawal by Subject|0|||
160488864|NCT02447432|579520246|FG001|Epoch 001|Withdrawal by Subject|4|||
160488865|NCT02447432|579520245|FG000|Epoch 001|Migrated/moved from study area|3|||
160488866|NCT02447432|579520246|FG001|Epoch 001|Migrated/moved from study area|5|||
160488867|NCT02447432|579520245|FG000|Epoch 001|Lost to Follow-up|1|||
160488868|NCT02447432|579520246|FG001|Epoch 001|Lost to Follow-up|3|||
160488869|NCT03245619|579520248|FG000|Part A (Up to Day 22)|Physician Decision|4|||
160488870|NCT03245619|579520249|FG001|Part A (Up to Day 22)|Physician Decision|6|||
160488871|NCT03245619|579520250|FG002|Part A (Up to Day 22)|Physician Decision|6|||
160488872|NCT03245619|579520251|FG003|Part A (Up to Day 22)|Physician Decision|0|||
160488873|NCT03245619|579520252|FG004|Part A (Up to Day 22)|Physician Decision|0|||
160488874|NCT03245619|579520253|FG005|Part A (Up to Day 22)|Physician Decision|0|||
160488875|NCT03245619|579520254|FG006|Part A (Up to Day 22)|Physician Decision|0|||
160488876|NCT03245619|579520255|FG007|Part A (Up to Day 22)|Physician Decision|0|||
160488877|NCT03245619|579520256|FG008|Part A (Up to Day 22)|Physician Decision|0|||
160610964|NCT01332851|579952310|FG001|Overall Study|Withdrawal by Subject|2|||
160610965|NCT01332851|579952309|FG000|Overall Study|Lost to Follow-up|7|||
160610966|NCT01332851|579952310|FG001|Overall Study|Lost to Follow-up|11|||
160610967|NCT01947894|579952311|FG000|Overall Study|Other|3|||
160610968|NCT01947894|579952312|FG001|Overall Study|Other|4|||
160610969|NCT01947894|579952313|FG002|Overall Study|Other|3|||
160610970|NCT01947894|579952311|FG000|Overall Study|Withdrawal by Subject|12|||
160488878|NCT03245619|579520257|FG009|Part A (Up to Day 22)|Physician Decision|0|||
160488879|NCT03245619|579520258|FG010|Part A (Up to Day 22)|Physician Decision|0|||
160488880|NCT03245619|579520259|FG011|Part A (Up to Day 22)|Physician Decision|0|||
160488881|NCT03245619|579520260|FG012|Part A (Up to Day 22)|Physician Decision|0|||
160488882|NCT03245619|579520261|FG013|Part A (Up to Day 22)|Physician Decision|0|||
160488883|NCT03245619|579520262|FG014|Part A (Up to Day 22)|Physician Decision|0|||
160488884|NCT03245619|579520263|FG015|Part A (Up to Day 22)|Physician Decision|0|||
160488885|NCT03245619|579520264|FG016|Part A (Up to Day 22)|Physician Decision|0|||
160488886|NCT00776659|579520280|FG000|Overall Study|Lost to Follow-up|15|||
160488887|NCT00776659|579520280|FG000|Overall Study|Withdrawal by Subject|10|||
160488888|NCT00776659|579520280|FG000|Overall Study|Study Terminated by Sponsor|1|||
160488889|NCT02971228|579520281|FG000|Overall Study|Withdrawal by Subject|1|||
160488890|NCT02971228|579520282|FG001|Overall Study|Withdrawal by Subject|1|||
160488891|NCT02971228|579520283|FG002|Overall Study|Withdrawal by Subject|0|||
160488892|NCT02971228|579520284|FG003|Overall Study|Withdrawal by Subject|0|||
160488893|NCT02971228|579520285|FG004|Overall Study|Withdrawal by Subject|0|||
160488894|NCT02971228|579520281|FG000|Overall Study|Logistical challenges|0|||
160488895|NCT02971228|579520282|FG001|Overall Study|Logistical challenges|1|||
160488896|NCT02971228|579520283|FG002|Overall Study|Logistical challenges|0|||
160488897|NCT02971228|579520284|FG003|Overall Study|Logistical challenges|0|||
160488898|NCT02971228|579520285|FG004|Overall Study|Logistical challenges|0|||
160488899|NCT01167192|579520286|FG000|Overall Study|Adverse Event|1|||
160488900|NCT01167192|579520286|FG000|Overall Study|Death|1|||
160488901|NCT01167192|579520286|FG000|Overall Study|Withdrawal by Subject|1|||
160488902|NCT01167192|579520286|FG000|Overall Study|Insurance denial|1|||
160488903|NCT00129649|579520300|FG000|Overall Study|Withdrawal by Subject|76|||
160488904|NCT00129649|579520301|FG001|Overall Study|Withdrawal by Subject|65|||
160488905|NCT02482935|579520302|FG000|Period 1|Withdrawal by Subject|1|||
160488906|NCT02482935|579520303|FG001|Period 1|Withdrawal by Subject|0|||
160488907|NCT03503162|579520304|FG000|Overall Study|did not meet eligibility|1|||
160488908|NCT02561806|579520305|FG000|Induction Period|Adverse Event|0|||
160488909|NCT02561806|579520306|FG001|Induction Period|Adverse Event|2|||
160488910|NCT02561806|579520305|FG000|Induction Period|Lack of Efficacy|1|||
160488911|NCT02561806|579520306|FG001|Induction Period|Lack of Efficacy|0|||
160488912|NCT02561806|579520305|FG000|Induction Period|Withdrawal by Subject|0|||
160488913|NCT02561806|579520306|FG001|Induction Period|Withdrawal by Subject|2|||
160488914|NCT02561806|579520305|FG000|Induction Period|Site staff became unblinded|1|||
160488915|NCT02561806|579520306|FG001|Induction Period|Site staff became unblinded|0|||
160488916|NCT02561806|579520305|FG000|Induction Period|Randomized but not treated|0|||
160488917|NCT02561806|579520306|FG001|Induction Period|Randomized but not treated|1|||
160488918|NCT02561806|579520305|FG000|Maintenance Period|Adverse Event|2|||
160488919|NCT02561806|579520306|FG001|Maintenance Period|Adverse Event|1|||
160488920|NCT02561806|579520305|FG000|Maintenance Period|Lack of Efficacy|3|||
160488921|NCT02561806|579520306|FG001|Maintenance Period|Lack of Efficacy|1|||
160488922|NCT02561806|579520305|FG000|Maintenance Period|Lost to Follow-up|2|||
160488923|NCT02561806|579520306|FG001|Maintenance Period|Lost to Follow-up|2|||
160488924|NCT02561806|579520305|FG000|Maintenance Period|Protocol Violation|1|||
160488925|NCT02561806|579520306|FG001|Maintenance Period|Protocol Violation|0|||
160488926|NCT02561806|579520305|FG000|Maintenance Period|Withdrawal by Subject|5|||
160488927|NCT02561806|579520306|FG001|Maintenance Period|Withdrawal by Subject|3|||
160488928|NCT02561806|579520305|FG000|Maintenance Period|Site staff became unblinded|0|||
160488929|NCT02561806|579520306|FG001|Maintenance Period|Site staff became unblinded|1|||
160488930|NCT02561806|579520305|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
160488931|NCT02561806|579520306|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
160488932|NCT02561806|579520305|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
160488933|NCT02561806|579520306|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
160488934|NCT02547441|579520307|FG000|Double-Blind Study Period|Adverse Event|4|||
160488935|NCT02547441|579520308|FG001|Double-Blind Study Period|Adverse Event|9|||
160488936|NCT02547441|579520307|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
160488937|NCT02547441|579520308|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
160488938|NCT02547441|579520307|FG000|Double-Blind Study Period|Physician Decision|1|||
160488939|NCT02547441|579520308|FG001|Double-Blind Study Period|Physician Decision|0|||
160488940|NCT02547441|579520307|FG000|Double-Blind Study Period|Protocol Violation|1|||
160488941|NCT02547441|579520308|FG001|Double-Blind Study Period|Protocol Violation|2|||
160488942|NCT02547441|579520307|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
160488943|NCT02547441|579520308|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
160488944|NCT02547441|579520307|FG000|Double-Blind Study Period|Sponsor Decision|1|||
160488945|NCT02547441|579520308|FG001|Double-Blind Study Period|Sponsor Decision|0|||
160488946|NCT02547441|579520307|FG000|Open-Label Study Period|Adverse Event|10|||
160488947|NCT02547441|579520308|FG001|Open-Label Study Period|Adverse Event|11|||
160488948|NCT02547441|579520307|FG000|Open-Label Study Period|Lack of Efficacy|3|||
160488949|NCT02547441|579520308|FG001|Open-Label Study Period|Lack of Efficacy|2|||
160488950|NCT02547441|579520307|FG000|Open-Label Study Period|Lost to Follow-up|7|||
160488951|NCT02547441|579520308|FG001|Open-Label Study Period|Lost to Follow-up|8|||
160488952|NCT02547441|579520307|FG000|Open-Label Study Period|Physician Decision|1|||
160488953|NCT02547441|579520308|FG001|Open-Label Study Period|Physician Decision|0|||
160488954|NCT02547441|579520307|FG000|Open-Label Study Period|Protocol Violation|2|||
160488955|NCT02547441|579520308|FG001|Open-Label Study Period|Protocol Violation|0|||
160488956|NCT02547441|579520307|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
160488957|NCT02547441|579520308|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
160488958|NCT02547441|579520307|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
160488959|NCT02547441|579520308|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
160488960|NCT00394589|579520309|FG000|Overall Study|Adverse Event|2|||
160488961|NCT00394589|579520310|FG001|Overall Study|Adverse Event|1|||
160488962|NCT00394589|579520311|FG002|Overall Study|Adverse Event|2|||
160488963|NCT00394589|579520309|FG000|Overall Study|Lack of Efficacy|2|||
160488964|NCT00394589|579520310|FG001|Overall Study|Lack of Efficacy|2|||
160488965|NCT00394589|579520311|FG002|Overall Study|Lack of Efficacy|3|||
160488966|NCT00394589|579520309|FG000|Overall Study|Protocol Violation|4|||
160488967|NCT00394589|579520310|FG001|Overall Study|Protocol Violation|0|||
160488968|NCT00394589|579520311|FG002|Overall Study|Protocol Violation|2|||
160488969|NCT03175198|579520312|FG000|Overall Study|Adverse Event|480|||
160488970|NCT03175198|579520312|FG000|Overall Study|No actual visit|120|||
160488971|NCT03175198|579520312|FG000|Overall Study|Registration rule not followed|4|||
160488972|NCT03175198|579520312|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
160488973|NCT03175198|579520312|FG000|Overall Study|Other personal reason|509|||
160488974|NCT03175198|579520312|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
160488975|NCT03175198|579520312|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
160488976|NCT03175198|579520312|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
160488977|NCT03175198|579520312|FG000|Overall Study|To conduct invasive treatment of operation|53|||
160488978|NCT03175198|579520312|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
160488979|NCT00545571|579520313|FG000|Overall Study|Administrative Reasons|1|||
160488980|NCT00545571|579520313|FG000|Overall Study|Adverse Event|2|||
160488981|NCT00545571|579520313|FG000|Overall Study|Death|5|||
160488982|NCT00545571|579520313|FG000|Overall Study|Lack of Efficacy|1|||
160488983|NCT00545571|579520313|FG000|Overall Study|Protocol Violation|2|||
160488984|NCT00545571|579520313|FG000|Overall Study|Refused Treatment|1|||
160488985|NCT00545571|579520313|FG000|Overall Study|Screen Failure|16|||
160488986|NCT00545571|579520313|FG000|Overall Study|Transfusion|12|||
160488987|NCT00545571|579520313|FG000|Overall Study|Early Termination of Study|24|||
160488988|NCT00545571|579520313|FG000|Overall Study|Kidney Transplantation|3|||
160488989|NCT01978236|579520314|FG000|Overall Study|Discontinued due to study close|2|||
160488990|NCT00874497|579520315|FG000|Overall Study|Lost to Follow-up|2|||
160488991|NCT00874497|579520316|FG001|Overall Study|Lost to Follow-up|4|||
160488992|NCT00874497|579520315|FG000|Overall Study|Adverse Event|9|||
160488993|NCT00874497|579520316|FG001|Overall Study|Adverse Event|4|||
160488994|NCT00874497|579520315|FG000|Overall Study|Sponsor Discontinued Trial|7|||
160488995|NCT00874497|579520316|FG001|Overall Study|Sponsor Discontinued Trial|3|||
160488996|NCT00874497|579520315|FG000|Overall Study|Met Withdrawal Criteria|4|||
160488997|NCT00874497|579520316|FG001|Overall Study|Met Withdrawal Criteria|2|||
160488998|NCT00874497|579520315|FG000|Overall Study|Physician Decision|1|||
160488999|NCT00874497|579520316|FG001|Overall Study|Physician Decision|1|||
160489000|NCT00874497|579520315|FG000|Overall Study|Withdrawal by Subject|5|||
160489001|NCT00874497|579520316|FG001|Overall Study|Withdrawal by Subject|4|||
160489002|NCT00634920|579520320|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
160489003|NCT00634920|579520321|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
160489004|NCT00634920|579520322|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
160489005|NCT00634920|579520320|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
160489006|NCT00634920|579520321|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
160661306|NCT00723528|580144039|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
160489007|NCT00634920|579520322|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
160489008|NCT00634920|579520320|FG000|Period 1 - Pre-Randomization|Rejections|0|||
160489009|NCT00634920|579520321|FG001|Period 1 - Pre-Randomization|Rejections|0|||
160489010|NCT00634920|579520322|FG002|Period 1 - Pre-Randomization|Rejections|55|||
160489011|NCT00634920|579520320|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
160489012|NCT00634920|579520321|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
160489013|NCT00634920|579520322|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
160661307|NCT00723528|580144040|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
160661308|NCT00723528|580144041|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
160677539|NCT01567527|580198879|FG000|Conversion Phase.|Withdrawal by Subject|32|||
160489014|NCT00634920|579520320|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
160489015|NCT00634920|579520321|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
160489016|NCT00634920|579520322|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
160489017|NCT00634920|579520320|FG000|Period 1 - Pre-Randomization|Other issues|0|||
160489018|NCT00634920|579520321|FG001|Period 1 - Pre-Randomization|Other issues|0|||
160489019|NCT00634920|579520322|FG002|Period 1 - Pre-Randomization|Other issues|6|||
160489020|NCT00634920|579520320|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
160489021|NCT00634920|579520321|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
160489022|NCT00634920|579520322|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
160489023|NCT00634920|579520320|FG000|Period 2 - Post-Randomization|Rejection|11|||
160489024|NCT00634920|579520321|FG001|Period 2 - Post-Randomization|Rejection|5|||
160489025|NCT00634920|579520322|FG002|Period 2 - Post-Randomization|Rejection|0|||
160489026|NCT00634920|579520320|FG000|Period 2 - Post-Randomization|Death|2|||
160489027|NCT00634920|579520321|FG001|Period 2 - Post-Randomization|Death|5|||
160489028|NCT00634920|579520322|FG002|Period 2 - Post-Randomization|Death|0|||
160489029|NCT00634920|579520320|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
160489030|NCT00634920|579520321|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
160489031|NCT00634920|579520322|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
160489032|NCT00634920|579520320|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
160489033|NCT00634920|579520321|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
160489034|NCT00634920|579520322|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
160489035|NCT04353817|579520323|FG000|Overall Study|Adverse Event|0|||
160489036|NCT04353817|579520324|FG001|Overall Study|Adverse Event|1|||
160489037|NCT01193218|579520325|FG000|0-12 Weeks|Adverse Event|6|||
160489038|NCT01193218|579520326|FG001|0-12 Weeks|Adverse Event|0|||
160489039|NCT01193218|579520327|FG002|0-12 Weeks|Adverse Event|1|||
160489040|NCT01193218|579520328|FG003|0-12 Weeks|Adverse Event|0|||
160489041|NCT01193218|579520329|FG004|0-12 Weeks|Adverse Event|0|||
160489042|NCT01193218|579520330|FG005|0-12 Weeks|Adverse Event|2|||
160489043|NCT01193218|579520331|FG006|0-12 Weeks|Adverse Event|2|||
160489044|NCT01193218|579520332|FG007|0-12 Weeks|Adverse Event|0|||
160489045|NCT01193218|579520325|FG000|0-12 Weeks|Protocol Violation|0|||
160489046|NCT01193218|579520326|FG001|0-12 Weeks|Protocol Violation|0|||
160489047|NCT01193218|579520327|FG002|0-12 Weeks|Protocol Violation|0|||
160489048|NCT01193218|579520328|FG003|0-12 Weeks|Protocol Violation|0|||
160489049|NCT01193218|579520329|FG004|0-12 Weeks|Protocol Violation|1|||
160489050|NCT01193218|579520330|FG005|0-12 Weeks|Protocol Violation|1|||
160489051|NCT01193218|579520331|FG006|0-12 Weeks|Protocol Violation|0|||
160489052|NCT01193218|579520332|FG007|0-12 Weeks|Protocol Violation|0|||
160489053|NCT01193218|579520325|FG000|0-12 Weeks|Withdrawal by Subject|3|||
160489054|NCT01193218|579520326|FG001|0-12 Weeks|Withdrawal by Subject|0|||
160489055|NCT01193218|579520327|FG002|0-12 Weeks|Withdrawal by Subject|2|||
160489056|NCT01193218|579520328|FG003|0-12 Weeks|Withdrawal by Subject|0|||
160489057|NCT01193218|579520329|FG004|0-12 Weeks|Withdrawal by Subject|0|||
160489058|NCT01193218|579520330|FG005|0-12 Weeks|Withdrawal by Subject|0|||
160489059|NCT01193218|579520331|FG006|0-12 Weeks|Withdrawal by Subject|1|||
160489060|NCT01193218|579520332|FG007|0-12 Weeks|Withdrawal by Subject|0|||
160489061|NCT01193218|579520325|FG000|12-52 Weeks|Adverse Event|1|||
160489062|NCT01193218|579520326|FG001|12-52 Weeks|Adverse Event|0|||
160489063|NCT01193218|579520327|FG002|12-52 Weeks|Adverse Event|1|||
160489064|NCT01193218|579520328|FG003|12-52 Weeks|Adverse Event|2|||
160489065|NCT01193218|579520329|FG004|12-52 Weeks|Adverse Event|3|||
160489066|NCT01193218|579520330|FG005|12-52 Weeks|Adverse Event|3|||
160489067|NCT01193218|579520331|FG006|12-52 Weeks|Adverse Event|1|||
160489068|NCT01193218|579520332|FG007|12-52 Weeks|Adverse Event|2|||
160489069|NCT01193218|579520325|FG000|12-52 Weeks|Lack of Efficacy|0|||
160489070|NCT01193218|579520326|FG001|12-52 Weeks|Lack of Efficacy|0|||
160489071|NCT01193218|579520327|FG002|12-52 Weeks|Lack of Efficacy|0|||
160489072|NCT01193218|579520328|FG003|12-52 Weeks|Lack of Efficacy|0|||
160489073|NCT01193218|579520329|FG004|12-52 Weeks|Lack of Efficacy|0|||
160489074|NCT01193218|579520330|FG005|12-52 Weeks|Lack of Efficacy|0|||
160489075|NCT01193218|579520331|FG006|12-52 Weeks|Lack of Efficacy|1|||
160489076|NCT01193218|579520332|FG007|12-52 Weeks|Lack of Efficacy|0|||
160489077|NCT01193218|579520325|FG000|12-52 Weeks|Withdrawal by Subject|3|||
160489078|NCT01193218|579520326|FG001|12-52 Weeks|Withdrawal by Subject|0|||
160489079|NCT01193218|579520327|FG002|12-52 Weeks|Withdrawal by Subject|3|||
160489080|NCT01193218|579520328|FG003|12-52 Weeks|Withdrawal by Subject|0|||
160489081|NCT01193218|579520329|FG004|12-52 Weeks|Withdrawal by Subject|0|||
160489082|NCT01193218|579520330|FG005|12-52 Weeks|Withdrawal by Subject|2|||
160489083|NCT01193218|579520331|FG006|12-52 Weeks|Withdrawal by Subject|1|||
160489084|NCT01193218|579520332|FG007|12-52 Weeks|Withdrawal by Subject|2|||
160489085|NCT01193218|579520325|FG000|12-52 Weeks|Other reason than above|1|||
160489086|NCT01193218|579520326|FG001|12-52 Weeks|Other reason than above|0|||
160489087|NCT01193218|579520327|FG002|12-52 Weeks|Other reason than above|0|||
160489088|NCT01193218|579520328|FG003|12-52 Weeks|Other reason than above|1|||
160489089|NCT01193218|579520329|FG004|12-52 Weeks|Other reason than above|1|||
160610971|NCT01947894|579952312|FG001|Overall Study|Withdrawal by Subject|4|||
160610972|NCT01947894|579952313|FG002|Overall Study|Withdrawal by Subject|1|||
160489090|NCT01193218|579520330|FG005|12-52 Weeks|Other reason than above|0|||
160489091|NCT01193218|579520331|FG006|12-52 Weeks|Other reason than above|0|||
160489092|NCT01193218|579520332|FG007|12-52 Weeks|Other reason than above|0|||
160489093|NCT00665223|579520335|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
160489094|NCT00665223|579520336|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
160489095|NCT00665223|579520337|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
160489096|NCT00665223|579520335|FG000|Randomized Phase (26 Weeks)|Death|0|||
160489097|NCT00665223|579520336|FG001|Randomized Phase (26 Weeks)|Death|0|||
160489098|NCT00665223|579520337|FG002|Randomized Phase (26 Weeks)|Death|1|||
160489099|NCT00665223|579520335|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
160489100|NCT00665223|579520336|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
160489101|NCT00665223|579520337|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
160489102|NCT00665223|579520335|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
160489103|NCT00665223|579520336|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
160489104|NCT00665223|579520337|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
160489105|NCT00665223|579520335|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
160489106|NCT00665223|579520336|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
160489107|NCT00665223|579520337|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
160489108|NCT00665223|579520335|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
160489109|NCT00665223|579520336|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
160489110|NCT00665223|579520337|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
160489111|NCT00665223|579520335|FG000|Open-Label Period (26 Weeks)|Death|0|||
160489112|NCT00665223|579520336|FG001|Open-Label Period (26 Weeks)|Death|1|||
160489113|NCT00665223|579520337|FG002|Open-Label Period (26 Weeks)|Death|0|||
160489114|NCT00665223|579520335|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
160489115|NCT00665223|579520336|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
160489116|NCT00665223|579520337|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
160489117|NCT00665223|579520335|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
160489118|NCT00665223|579520336|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
160489119|NCT00665223|579520337|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
160489120|NCT00665223|579520335|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
160489121|NCT00665223|579520336|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
160489122|NCT00665223|579520337|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
160489123|NCT00665223|579520335|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
160489124|NCT00665223|579520336|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
160489125|NCT00665223|579520337|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
160489126|NCT00363649|579520338|FG000|Overall Study|Withdrawal by Subject|1|||
160489127|NCT00363649|579520339|FG001|Overall Study|Withdrawal by Subject|1|||
160489128|NCT00363649|579520338|FG000|Overall Study|Adverse Event|6|||
160489129|NCT00363649|579520339|FG001|Overall Study|Adverse Event|0|||
160489130|NCT01013740|579520340|FG000|Overall Study|Lost to Follow-up|3|||
160489131|NCT01013740|579520341|FG001|Overall Study|Lost to Follow-up|5|||
160489132|NCT01013740|579520340|FG000|Overall Study|Physician Decision|2|||
160489133|NCT01013740|579520341|FG001|Overall Study|Physician Decision|0|||
160489134|NCT01013740|579520340|FG000|Overall Study|Withdrawal by Subject|2|||
160489135|NCT01013740|579520341|FG001|Overall Study|Withdrawal by Subject|10|||
160489136|NCT01013740|579520340|FG000|Overall Study|study close / terminated : done in error|2|||
160489137|NCT01013740|579520341|FG001|Overall Study|study close / terminated : done in error|1|||
160489138|NCT01013740|579520340|FG000|Overall Study|Missing|2|||
160489139|NCT01013740|579520341|FG001|Overall Study|Missing|1|||
160489140|NCT01013740|579520340|FG000|Overall Study|Ongoing: Study records not completed|0|||
160489141|NCT01013740|579520341|FG001|Overall Study|Ongoing: Study records not completed|2|||
160489142|NCT00002597|579520342|FG000|Overall Study|Protocol Violation|19|||
160489143|NCT00002597|579520343|FG001|Overall Study|Protocol Violation|17|||
160489144|NCT00002597|579520342|FG000|Overall Study|Withdrawal by Subject|7|||
160489145|NCT00002597|579520343|FG001|Overall Study|Withdrawal by Subject|6|||
160489146|NCT03811834|579520344|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
160489147|NCT02161185|579520348|FG000|Treatment Phase|Administrative/Other|7|||
160489148|NCT04088500|579520351|FG000|Overall Study|Reason unknown|1|||
160489149|NCT04088500|579520351|FG000|Overall Study|Participant withdrew consent|1|||
160489150|NCT04088500|579520351|FG000|Overall Study|Disease progression|3|||
160489151|NCT02212197|579520353|FG000|Overall Study|Need for radiotherapy|1|||
160489152|NCT02212197|579520354|FG001|Overall Study|Need for radiotherapy|0|||
160489153|NCT02212197|579520355|FG002|Overall Study|Need for radiotherapy|0|||
160489154|NCT01078584|579520356|FG000|Overall Study|Final Status Unknown|1073|||
160489155|NCT01078584|579520356|FG000|Overall Study|Lost to Follow-up|670|||
160489156|NCT01078584|579520356|FG000|Overall Study|Non-serious Adverse Event|577|||
160489157|NCT01078584|579520356|FG000|Overall Study|Withdrawal of Consent|244|||
160489158|NCT01078584|579520356|FG000|Overall Study|Physician Withdrew from Study|90|||
160489159|NCT01078584|579520356|FG000|Overall Study|Non-compliance|67|||
160661309|NCT00723528|580144035|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
160661310|NCT00723528|580144036|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
160489160|NCT01078584|579520356|FG000|Overall Study|Blood Pressure Controlled|49|||
160489161|NCT01078584|579520356|FG000|Overall Study|Physician Switched Medication|26|||
160489162|NCT01078584|579520356|FG000|Overall Study|Physician Discontinued Patient|12|||
160489163|NCT01078584|579520356|FG000|Overall Study|Lack of Efficacy|98|||
160489164|NCT01078584|579520356|FG000|Overall Study|Protocol Violation|75|||
160489165|NCT01078584|579520356|FG000|Overall Study|Serious Adverse Event|27|||
160489166|NCT01078584|579520356|FG000|Overall Study|Multiple Reasons|2|||
160489167|NCT01208870|579520359|FG000|Overall Study|Lost to Follow-up|2|||
160489168|NCT01208870|579520360|FG001|Overall Study|Lost to Follow-up|8|||
160489169|NCT00356759|579520361|FG000|Overall Study|Death|5|||
160489170|NCT00356759|579520362|FG001|Overall Study|Death|2|||
160489171|NCT00356759|579520361|FG000|Overall Study|Withdrawal by Subject|2|||
160489172|NCT00356759|579520362|FG001|Overall Study|Withdrawal by Subject|2|||
160489173|NCT00356759|579520361|FG000|Overall Study|Adverse Event|1|||
160489174|NCT00356759|579520362|FG001|Overall Study|Adverse Event|3|||
160489175|NCT00356759|579520361|FG000|Overall Study|Lost to Follow-up|1|||
160489176|NCT00356759|579520362|FG001|Overall Study|Lost to Follow-up|1|||
160489177|NCT00356759|579520361|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
160489178|NCT00356759|579520362|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
160489179|NCT01204775|579520363|FG000|Overall Study|Poor/non-compliance|0|||
160489180|NCT01204775|579520364|FG001|Overall Study|Poor/non-compliance|1|||
160489181|NCT01204775|579520363|FG000|Overall Study|Withdrawal by Subject|1|||
160489182|NCT01204775|579520364|FG001|Overall Study|Withdrawal by Subject|0|||
160489183|NCT00276016|579520365|FG000|Intervention 1|Withdrawal by Subject|0|||
160489184|NCT00276016|579520366|FG001|Intervention 1|Withdrawal by Subject|1|||
160489185|NCT00276016|579520367|FG002|Intervention 1|Withdrawal by Subject|0|||
160489186|NCT00276016|579520368|FG003|Intervention 1|Withdrawal by Subject|0|||
160489187|NCT00276016|579520369|FG004|Intervention 1|Withdrawal by Subject|0|||
160489188|NCT00276016|579520370|FG005|Intervention 1|Withdrawal by Subject|0|||
160489189|NCT05041439|579520371|FG000|Overall Study|Withdrawal by Subject|1|||
160489190|NCT05041439|579520372|FG001|Overall Study|Withdrawal by Subject|1|||
160489191|NCT05041439|579520371|FG000|Overall Study|Death|1|||
160489192|NCT05041439|579520372|FG001|Overall Study|Death|0|||
160489193|NCT02979613|579520373|FG000|Double-Blind Phase|Withdrew Consent|2|||
160489194|NCT02979613|579520374|FG001|Double-Blind Phase|Withdrew Consent|4|||
160489195|NCT02979613|579520373|FG000|Double-Blind Phase|Pregnancy|2|||
160489196|NCT02979613|579520374|FG001|Double-Blind Phase|Pregnancy|2|||
160489197|NCT02979613|579520373|FG000|Double-Blind Phase|Adverse Event|2|||
160489198|NCT02979613|579520374|FG001|Double-Blind Phase|Adverse Event|0|||
160489199|NCT02979613|579520373|FG000|Double-Blind Phase|Lost to Follow-up|1|||
160489200|NCT02979613|579520374|FG001|Double-Blind Phase|Lost to Follow-up|1|||
160489201|NCT02979613|579520373|FG000|Double-Blind Phase|Protocol Violation|1|||
160489202|NCT02979613|579520374|FG001|Double-Blind Phase|Protocol Violation|1|||
160489203|NCT02979613|579520373|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
160489204|NCT02979613|579520374|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
160489205|NCT02979613|579520373|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
160489206|NCT02979613|579520374|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
160489207|NCT02979613|579520373|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
160489208|NCT02979613|579520374|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
160489209|NCT02979613|579520373|FG000|Open-Label Extension (OLE) Phase|Death|0|||
160489210|NCT02979613|579520374|FG001|Open-Label Extension (OLE) Phase|Death|1|||
160489211|NCT02979613|579520373|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
160489212|NCT02979613|579520374|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
160489213|NCT00612352|579522272|FG000|Overall Study|Adverse Event|1|||
160489214|NCT00612352|579522273|FG001|Overall Study|Adverse Event|0|||
160489215|NCT00612352|579522272|FG000|Overall Study|Withdrawal by Subject|3|||
160489216|NCT00612352|579522273|FG001|Overall Study|Withdrawal by Subject|5|||
160489217|NCT00612352|579522272|FG000|Overall Study|moved out of state|1|||
160489218|NCT00612352|579522273|FG001|Overall Study|moved out of state|0|||
160489219|NCT00612352|579522272|FG000|Overall Study|didn't return calls/show up on test date|4|||
160489220|NCT00612352|579522273|FG001|Overall Study|didn't return calls/show up on test date|1|||
160489221|NCT00263211|579522274|FG000|Overall Study|Death|1|||
160489222|NCT00263211|579522275|FG001|Overall Study|Death|0|||
160489223|NCT00263211|579522274|FG000|Overall Study|Withdrawal by Subject|3|||
160489224|NCT00263211|579522275|FG001|Overall Study|Withdrawal by Subject|0|||
160489225|NCT00263211|579522274|FG000|Overall Study|Protocol Violation|1|||
160489226|NCT00263211|579522275|FG001|Overall Study|Protocol Violation|0|||
160489227|NCT00263211|579522274|FG000|Overall Study|Disease Progression|0|||
160489228|NCT00263211|579522275|FG001|Overall Study|Disease Progression|1|||
160489229|NCT02820597|579522276|FG000|Overall Study|Lost to Follow-up|12|||
160489230|NCT04606199|579522277|FG000|Overall Study|Withdrawal by Subject|2|||
160489231|NCT01475461|579522282|FG000|Run-in Period|Not meet eligibility criteria|16|||
160489232|NCT01475461|579522283|FG001|Run-in Period|Not meet eligibility criteria|0|||
160489233|NCT01475461|579522284|FG002|Run-in Period|Not meet eligibility criteria|0|||
160489234|NCT01475461|579522285|FG003|Run-in Period|Not meet eligibility criteria|0|||
160489235|NCT01475461|579522286|FG004|Run-in Period|Not meet eligibility criteria|0|||
160489236|NCT01475461|579522287|FG005|Run-in Period|Not meet eligibility criteria|0|||
160489237|NCT01475461|579522288|FG006|Run-in Period|Not meet eligibility criteria|0|||
160489238|NCT01475461|579522282|FG000|Run-in Period|Lost to Follow-up|7|||
160489239|NCT01475461|579522283|FG001|Run-in Period|Lost to Follow-up|0|||
160489240|NCT01475461|579522284|FG002|Run-in Period|Lost to Follow-up|0|||
160489241|NCT01475461|579522285|FG003|Run-in Period|Lost to Follow-up|0|||
160489242|NCT01475461|579522286|FG004|Run-in Period|Lost to Follow-up|0|||
160489243|NCT01475461|579522287|FG005|Run-in Period|Lost to Follow-up|0|||
160489244|NCT01475461|579522288|FG006|Run-in Period|Lost to Follow-up|0|||
160489245|NCT01475461|579522282|FG000|Run-in Period|Withdrawal by Subject|11|||
160489246|NCT01475461|579522283|FG001|Run-in Period|Withdrawal by Subject|0|||
160489247|NCT01475461|579522284|FG002|Run-in Period|Withdrawal by Subject|0|||
160489248|NCT01475461|579522285|FG003|Run-in Period|Withdrawal by Subject|0|||
160489249|NCT01475461|579522286|FG004|Run-in Period|Withdrawal by Subject|0|||
160489250|NCT01475461|579522287|FG005|Run-in Period|Withdrawal by Subject|0|||
160489251|NCT01475461|579522288|FG006|Run-in Period|Withdrawal by Subject|0|||
160489252|NCT01475461|579522282|FG000|Run-in Period|Other|3|||
160489253|NCT01475461|579522283|FG001|Run-in Period|Other|0|||
160489254|NCT01475461|579522284|FG002|Run-in Period|Other|0|||
160489255|NCT01475461|579522285|FG003|Run-in Period|Other|0|||
160489256|NCT01475461|579522286|FG004|Run-in Period|Other|0|||
160489257|NCT01475461|579522287|FG005|Run-in Period|Other|0|||
160489258|NCT01475461|579522288|FG006|Run-in Period|Other|0|||
160489259|NCT01475461|579522282|FG000|Run-in Period|Protocol Violation|4|||
160489260|NCT01475461|579522283|FG001|Run-in Period|Protocol Violation|0|||
160489261|NCT01475461|579522284|FG002|Run-in Period|Protocol Violation|0|||
160489262|NCT01475461|579522285|FG003|Run-in Period|Protocol Violation|0|||
160489263|NCT01475461|579522286|FG004|Run-in Period|Protocol Violation|0|||
160489264|NCT01475461|579522287|FG005|Run-in Period|Protocol Violation|0|||
160489265|NCT01475461|579522288|FG006|Run-in Period|Protocol Violation|0|||
160489266|NCT01475461|579522282|FG000|Treatment Period|Death|0|||
160489267|NCT01475461|579522283|FG001|Treatment Period|Death|0|||
160489268|NCT01475461|579522284|FG002|Treatment Period|Death|0|||
160489269|NCT01475461|579522285|FG003|Treatment Period|Death|1|||
160489270|NCT01475461|579522286|FG004|Treatment Period|Death|0|||
160489271|NCT01475461|579522287|FG005|Treatment Period|Death|0|||
160489272|NCT01475461|579522288|FG006|Treatment Period|Death|0|||
160489273|NCT01475461|579522282|FG000|Treatment Period|Lost to Follow-up|0|||
160489274|NCT01475461|579522283|FG001|Treatment Period|Lost to Follow-up|3|||
160489275|NCT01475461|579522284|FG002|Treatment Period|Lost to Follow-up|2|||
160489276|NCT01475461|579522285|FG003|Treatment Period|Lost to Follow-up|3|||
160489277|NCT01475461|579522286|FG004|Treatment Period|Lost to Follow-up|1|||
160489278|NCT01475461|579522287|FG005|Treatment Period|Lost to Follow-up|2|||
160489279|NCT01475461|579522288|FG006|Treatment Period|Lost to Follow-up|1|||
160489280|NCT01475461|579522282|FG000|Treatment Period|Withdrawal by Subject|0|||
160489281|NCT01475461|579522283|FG001|Treatment Period|Withdrawal by Subject|2|||
160489282|NCT01475461|579522284|FG002|Treatment Period|Withdrawal by Subject|2|||
160489283|NCT01475461|579522285|FG003|Treatment Period|Withdrawal by Subject|0|||
160489284|NCT01475461|579522286|FG004|Treatment Period|Withdrawal by Subject|2|||
160489285|NCT01475461|579522287|FG005|Treatment Period|Withdrawal by Subject|2|||
160489286|NCT01475461|579522288|FG006|Treatment Period|Withdrawal by Subject|0|||
160489287|NCT01475461|579522282|FG000|Treatment Period|Other|0|||
160489288|NCT01475461|579522283|FG001|Treatment Period|Other|1|||
160489289|NCT01475461|579522284|FG002|Treatment Period|Other|0|||
160489290|NCT01475461|579522285|FG003|Treatment Period|Other|0|||
160489291|NCT01475461|579522286|FG004|Treatment Period|Other|0|||
160489292|NCT01475461|579522287|FG005|Treatment Period|Other|0|||
160489293|NCT01475461|579522288|FG006|Treatment Period|Other|0|||
160489294|NCT01475461|579522282|FG000|Treatment Period|Protocol Violation|0|||
160489295|NCT01475461|579522283|FG001|Treatment Period|Protocol Violation|1|||
160489296|NCT01475461|579522284|FG002|Treatment Period|Protocol Violation|0|||
160489297|NCT01475461|579522285|FG003|Treatment Period|Protocol Violation|0|||
160489298|NCT01475461|579522286|FG004|Treatment Period|Protocol Violation|0|||
160489299|NCT01475461|579522287|FG005|Treatment Period|Protocol Violation|0|||
160489300|NCT01475461|579522288|FG006|Treatment Period|Protocol Violation|1|||
160489301|NCT01475461|579522282|FG000|Treatment Period|Lack of Efficacy|0|||
160489302|NCT01475461|579522283|FG001|Treatment Period|Lack of Efficacy|2|||
160489303|NCT01475461|579522284|FG002|Treatment Period|Lack of Efficacy|0|||
160489304|NCT01475461|579522285|FG003|Treatment Period|Lack of Efficacy|2|||
160489305|NCT01475461|579522286|FG004|Treatment Period|Lack of Efficacy|1|||
160661311|NCT00723528|580144037|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
160661312|NCT00723528|580144038|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
160489306|NCT01475461|579522287|FG005|Treatment Period|Lack of Efficacy|1|||
160489307|NCT01475461|579522288|FG006|Treatment Period|Lack of Efficacy|0|||
160489308|NCT01475461|579522282|FG000|Treatment Period|Medication Error|0|||
160489309|NCT01475461|579522283|FG001|Treatment Period|Medication Error|0|||
160489310|NCT01475461|579522284|FG002|Treatment Period|Medication Error|0|||
160489311|NCT01475461|579522285|FG003|Treatment Period|Medication Error|1|||
160489312|NCT01475461|579522286|FG004|Treatment Period|Medication Error|0|||
160489313|NCT01475461|579522287|FG005|Treatment Period|Medication Error|0|||
160489314|NCT01475461|579522288|FG006|Treatment Period|Medication Error|0|||
160489315|NCT01475461|579522282|FG000|Treatment Period|Adverse Event|0|||
160489316|NCT01475461|579522283|FG001|Treatment Period|Adverse Event|0|||
160489317|NCT01475461|579522284|FG002|Treatment Period|Adverse Event|0|||
160489318|NCT01475461|579522285|FG003|Treatment Period|Adverse Event|1|||
160489319|NCT01475461|579522286|FG004|Treatment Period|Adverse Event|0|||
160489320|NCT01475461|579522287|FG005|Treatment Period|Adverse Event|0|||
160489321|NCT01475461|579522288|FG006|Treatment Period|Adverse Event|0|||
160489322|NCT02512861|579522289|FG000|Overall Study|Protocol Violation|3|||
160489323|NCT02512861|579522290|FG001|Overall Study|Protocol Violation|7|||
160489324|NCT02512861|579522289|FG000|Overall Study|Physician Decision|3|||
160489325|NCT02512861|579522290|FG001|Overall Study|Physician Decision|1|||
160489326|NCT02512861|579522289|FG000|Overall Study|Withdrawal by Subject|0|||
160489327|NCT02512861|579522290|FG001|Overall Study|Withdrawal by Subject|1|||
160489328|NCT00553605|579522291|FG000|Overall Study|Did not meet entrance criteria|1|||
160489329|NCT00553605|579522292|FG001|Overall Study|Did not meet entrance criteria|3|||
160489330|NCT00553605|579522291|FG000|Overall Study|Did not receive full dose|1|||
160489331|NCT00553605|579522292|FG001|Overall Study|Did not receive full dose|0|||
160489332|NCT00553605|579522291|FG000|Overall Study|Randomized but not treated|2|||
160489333|NCT00553605|579522292|FG001|Overall Study|Randomized but not treated|0|||
160489334|NCT04582669|579522302|FG000|Overall Study|Subject missed appointment(s).|1|||
160489335|NCT04582669|579522303|FG001|Overall Study|Subject missed appointment(s).|0|||
160489336|NCT04582669|579522304|FG002|Overall Study|Subject missed appointment(s).|1|||
160489337|NCT04582669|579522305|FG003|Overall Study|Subject missed appointment(s).|2|||
160489338|NCT04582669|579522302|FG000|Overall Study|Protocol Violation|0|||
160489339|NCT04582669|579522303|FG001|Overall Study|Protocol Violation|1|||
160489340|NCT04582669|579522304|FG002|Overall Study|Protocol Violation|1|||
160489341|NCT04582669|579522305|FG003|Overall Study|Protocol Violation|0|||
160489342|NCT01336205|579522312|FG000|Overall Study|Other|22|||
160489343|NCT01336205|579522313|FG001|Overall Study|Other|9|||
160489344|NCT01336205|579522312|FG000|Overall Study|Lost to Follow-up|40|||
160489345|NCT01336205|579522313|FG001|Overall Study|Lost to Follow-up|20|||
160489346|NCT01336205|579522312|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
160489347|NCT01336205|579522313|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
160489348|NCT01336205|579522312|FG000|Overall Study|Lack of Efficacy|4|||
160489349|NCT01336205|579522313|FG001|Overall Study|Lack of Efficacy|0|||
160489350|NCT01336205|579522312|FG000|Overall Study|Severe noncompliance with protocol|9|||
160489351|NCT01336205|579522313|FG001|Overall Study|Severe noncompliance with protocol|2|||
160489352|NCT01336205|579522312|FG000|Overall Study|Adverse Event|56|||
160489353|NCT01336205|579522313|FG001|Overall Study|Adverse Event|6|||
160489354|NCT01336205|579522312|FG000|Overall Study|Death|1|||
160489355|NCT01336205|579522313|FG001|Overall Study|Death|1|||
160489356|NCT01336205|579522312|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
160489357|NCT01336205|579522313|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
160489358|NCT01336205|579522312|FG000|Overall Study|Withdrawal by Subject|72|||
160489359|NCT01336205|579522313|FG001|Overall Study|Withdrawal by Subject|38|||
160489360|NCT01336205|579522312|FG000|Overall Study|Did not receive treatment|4|||
160489361|NCT01336205|579522313|FG001|Overall Study|Did not receive treatment|0|||
160489362|NCT04952701|579522314|FG000|Control Lens|Physician Decision|4|||
160489363|NCT04952701|579522314|FG000|Test Lens|Physician Decision|1|||
160489364|NCT04545476|579522317|FG000|Overall Study|Lost to Follow-up|1|||
160489365|NCT04545476|579522318|FG001|Overall Study|Lost to Follow-up|1|||
160489366|NCT04545476|579522319|FG002|Overall Study|Lost to Follow-up|0|||
160489367|NCT04545476|579522320|FG003|Overall Study|Lost to Follow-up|0|||
160489368|NCT00505414|579522325|FG000|Titration Phase|Adverse Event|0|||
160489369|NCT00505414|579522326|FG001|Titration Phase|Adverse Event|0|||
160489370|NCT00505414|579522327|FG002|Titration Phase|Adverse Event|0|||
160489371|NCT00505414|579522328|FG003|Titration Phase|Adverse Event|8|||
160489372|NCT00505414|579522329|FG004|Titration Phase|Adverse Event|3|||
160489373|NCT00505414|579522325|FG000|Titration Phase|Death|0|||
160489374|NCT00505414|579522326|FG001|Titration Phase|Death|0|||
160489375|NCT00505414|579522327|FG002|Titration Phase|Death|0|||
160489376|NCT00505414|579522328|FG003|Titration Phase|Death|2|||
160489377|NCT00505414|579522329|FG004|Titration Phase|Death|0|||
160489378|NCT00505414|579522325|FG000|Titration Phase|Lack of Efficacy|0|||
160489379|NCT00505414|579522326|FG001|Titration Phase|Lack of Efficacy|0|||
160489380|NCT00505414|579522327|FG002|Titration Phase|Lack of Efficacy|0|||
160489381|NCT00505414|579522328|FG003|Titration Phase|Lack of Efficacy|10|||
160489382|NCT00505414|579522329|FG004|Titration Phase|Lack of Efficacy|1|||
160489383|NCT00505414|579522325|FG000|Titration Phase|Protocol Violation|0|||
160489384|NCT00505414|579522326|FG001|Titration Phase|Protocol Violation|0|||
160489385|NCT00505414|579522327|FG002|Titration Phase|Protocol Violation|0|||
160489386|NCT00505414|579522328|FG003|Titration Phase|Protocol Violation|0|||
160489387|NCT00505414|579522329|FG004|Titration Phase|Protocol Violation|1|||
160489388|NCT00505414|579522325|FG000|Titration Phase|Withdrawal by Subject|0|||
160489389|NCT00505414|579522326|FG001|Titration Phase|Withdrawal by Subject|0|||
160489390|NCT00505414|579522327|FG002|Titration Phase|Withdrawal by Subject|0|||
160489391|NCT00505414|579522328|FG003|Titration Phase|Withdrawal by Subject|3|||
160489392|NCT00505414|579522329|FG004|Titration Phase|Withdrawal by Subject|4|||
160661313|NCT00723528|580144039|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
160489393|NCT00505414|579522325|FG000|Titration Phase|Underlying disease and therapy required|0|||
160489394|NCT00505414|579522326|FG001|Titration Phase|Underlying disease and therapy required|0|||
160489395|NCT00505414|579522327|FG002|Titration Phase|Underlying disease and therapy required|0|||
160489396|NCT00505414|579522328|FG003|Titration Phase|Underlying disease and therapy required|7|||
160489397|NCT00505414|579522329|FG004|Titration Phase|Underlying disease and therapy required|3|||
160489398|NCT00505414|579522325|FG000|Maintenance Phase|Adverse Event|2|||
160489399|NCT00505414|579522326|FG001|Maintenance Phase|Adverse Event|2|||
160489400|NCT00505414|579522327|FG002|Maintenance Phase|Adverse Event|3|||
160489401|NCT00505414|579522328|FG003|Maintenance Phase|Adverse Event|0|||
160489402|NCT00505414|579522329|FG004|Maintenance Phase|Adverse Event|0|||
160489403|NCT00505414|579522325|FG000|Maintenance Phase|Death|2|||
160489404|NCT00505414|579522326|FG001|Maintenance Phase|Death|0|||
160489405|NCT00505414|579522327|FG002|Maintenance Phase|Death|1|||
160489406|NCT00505414|579522328|FG003|Maintenance Phase|Death|0|||
160489407|NCT00505414|579522329|FG004|Maintenance Phase|Death|0|||
160489408|NCT00505414|579522325|FG000|Maintenance Phase|Lack of Efficacy|2|||
160489409|NCT00505414|579522326|FG001|Maintenance Phase|Lack of Efficacy|1|||
160489410|NCT00505414|579522327|FG002|Maintenance Phase|Lack of Efficacy|1|||
160489411|NCT00505414|579522328|FG003|Maintenance Phase|Lack of Efficacy|0|||
160489412|NCT00505414|579522329|FG004|Maintenance Phase|Lack of Efficacy|0|||
160489413|NCT00505414|579522325|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160489414|NCT00505414|579522326|FG001|Maintenance Phase|Withdrawal by Subject|0|||
160489415|NCT00505414|579522327|FG002|Maintenance Phase|Withdrawal by Subject|1|||
160489416|NCT00505414|579522328|FG003|Maintenance Phase|Withdrawal by Subject|0|||
160489417|NCT00505414|579522329|FG004|Maintenance Phase|Withdrawal by Subject|0|||
160489418|NCT00505414|579522325|FG000|Maintenance Phase|underlying disease and therapy required|0|||
160489419|NCT00505414|579522326|FG001|Maintenance Phase|underlying disease and therapy required|2|||
160489420|NCT00505414|579522327|FG002|Maintenance Phase|underlying disease and therapy required|2|||
160489421|NCT00505414|579522328|FG003|Maintenance Phase|underlying disease and therapy required|0|||
160489422|NCT00505414|579522329|FG004|Maintenance Phase|underlying disease and therapy required|0|||
160489423|NCT00846768|579522330|FG000|Overall Study|Adverse Event|0|||
160489424|NCT00846768|579522331|FG001|Overall Study|Adverse Event|1|||
160489425|NCT00846768|579522332|FG002|Overall Study|Adverse Event|0|||
160489426|NCT00846768|579522333|FG003|Overall Study|Adverse Event|0|||
160489427|NCT00644878|579522334|FG000|Overall Study|Adverse Event|2|||
160489428|NCT00644878|579522334|FG000|Overall Study|Abnormal laboratory value|3|||
160489429|NCT00644878|579522334|FG000|Overall Study|Protocol deviation|2|||
160489430|NCT00644878|579522334|FG000|Overall Study|Treatment duration completed as per protocol|11|||
160489431|NCT04358068|579522335|FG000|Overall Study|Did not initiate study treatment|2|||
160489432|NCT04358068|579522336|FG001|Overall Study|Did not initiate study treatment|2|||
160489433|NCT00591591|579522337|FG000|Overall Study|Withdrawal by Subject|1|||
160489434|NCT00591591|579522338|FG001|Overall Study|Withdrawal by Subject|37|||
160489435|NCT00591591|579522337|FG000|Overall Study|Lack of Efficacy|10|||
160489436|NCT00591591|579522338|FG001|Overall Study|Lack of Efficacy|2|||
160489437|NCT02143063|579522341|FG000|Overall Study|Lost to Follow-up|16|||
160489438|NCT02143063|579522342|FG001|Overall Study|Lost to Follow-up|28|||
160489439|NCT02143063|579522343|FG002|Overall Study|Lost to Follow-up|29|||
160489440|NCT02143063|579522341|FG000|Overall Study|Withdrawal by Subject|0|||
160489441|NCT02143063|579522342|FG001|Overall Study|Withdrawal by Subject|1|||
160489442|NCT02143063|579522343|FG002|Overall Study|Withdrawal by Subject|0|||
160489443|NCT02143063|579522341|FG000|Overall Study|Death|0|||
160489444|NCT02143063|579522342|FG001|Overall Study|Death|1|||
160489445|NCT02143063|579522343|FG002|Overall Study|Death|1|||
160489446|NCT03517111|579522344|FG000|Enrolled|Withdrawal by Subject|0|||
160489447|NCT03517111|579522345|FG001|Enrolled|Withdrawal by Subject|1|||
160489448|NCT03517111|579522346|FG002|Enrolled|Withdrawal by Subject|0|||
160489449|NCT03517111|579522344|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
160489450|NCT03517111|579522345|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
160489451|NCT03517111|579522346|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
160489452|NCT03517111|579522344|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
160489453|NCT03517111|579522345|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
160489454|NCT03517111|579522346|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
160489455|NCT03517111|579522344|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
160489456|NCT03517111|579522345|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
160489457|NCT03517111|579522346|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
160489458|NCT03517111|579522344|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
160489459|NCT03517111|579522345|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
160489460|NCT03517111|579522346|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
160489461|NCT00912223|579522347|FG000|Overall Study|Withdrawal by Subject|1|||
160489462|NCT00912223|579522347|FG000|Overall Study|Not transplanted|1|||
160489463|NCT00912223|579522347|FG000|Overall Study|Transformed disease|1|||
160489464|NCT00025662|579522348|FG000|Overall Study|Withdrawal by Subject|2|||
160489465|NCT00025662|579522348|FG000|Overall Study|Technical failure of manipulation|1|||
160489466|NCT02062645|579522351|FG000|Overall Study|Adverse Event|2|||
160489467|NCT02062645|579522351|FG000|Overall Study|Protocol Violation|8|||
160489468|NCT02062645|579522351|FG000|Overall Study|Lost to Follow-up|5|||
160489469|NCT02864342|579522353|FG000|Overall Study|Eligibility Criteria Deviation|2|||
160489470|NCT02864342|579522354|FG001|Overall Study|Eligibility Criteria Deviation|3|||
160489471|NCT02864342|579522353|FG000|Overall Study|Withdrawal by Subject|4|||
160489472|NCT02864342|579522354|FG001|Overall Study|Withdrawal by Subject|2|||
160489473|NCT02864342|579522353|FG000|Overall Study|Device Technology Issue|6|||
160489474|NCT02864342|579522354|FG001|Overall Study|Device Technology Issue|7|||
160489475|NCT02864342|579522353|FG000|Overall Study|Death|0|||
160489476|NCT02864342|579522354|FG001|Overall Study|Death|1|||
160489477|NCT02864342|579522353|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
160489478|NCT02864342|579522354|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
160489479|NCT02864342|579522353|FG000|Overall Study|Lost to Follow-up|1|||
160489480|NCT02864342|579522354|FG001|Overall Study|Lost to Follow-up|5|||
160489481|NCT02864342|579522353|FG000|Overall Study|Lost Device|1|||
160489482|NCT02864342|579522354|FG001|Overall Study|Lost Device|0|||
160489483|NCT02864342|579522353|FG000|Overall Study|Adverse Event|1|||
160489484|NCT02864342|579522354|FG001|Overall Study|Adverse Event|0|||
160489485|NCT02261285|579522355|FG000|Overall Study|Disease progression|0|||
160489486|NCT02261285|579522356|FG001|Overall Study|Disease progression|0|||
160489487|NCT02261285|579522357|FG002|Overall Study|Disease progression|1|||
160489488|NCT00927901|579522358|FG000|Treatment Period 1|Subject withdrew consent|0|||
160489489|NCT00927901|579522359|FG001|Treatment Period 1|Subject withdrew consent|0|||
160489490|NCT00927901|579522360|FG002|Treatment Period 1|Subject withdrew consent|1|||
160489491|NCT00927901|579522361|FG003|Treatment Period 1|Subject withdrew consent|0|||
160489492|NCT00927901|579522358|FG000|Treatment Period 4|Adverse Event|0|||
160489493|NCT00927901|579522359|FG001|Treatment Period 4|Adverse Event|0|||
160489494|NCT00927901|579522360|FG002|Treatment Period 4|Adverse Event|0|||
160489495|NCT00927901|579522361|FG003|Treatment Period 4|Adverse Event|1|||
160489496|NCT00927901|579522358|FG000|Treatment Period 4|Subject withdrew consent|0|||
160489497|NCT00927901|579522359|FG001|Treatment Period 4|Subject withdrew consent|0|||
160489498|NCT00927901|579522360|FG002|Treatment Period 4|Subject withdrew consent|1|||
160489499|NCT00927901|579522361|FG003|Treatment Period 4|Subject withdrew consent|0|||
160489500|NCT01209286|579522362|FG000|Overall Study|Adverse Event|4|||
160489501|NCT01209286|579522363|FG001|Overall Study|Adverse Event|3|||
160489502|NCT01209286|579522364|FG002|Overall Study|Adverse Event|1|||
160489503|NCT01209286|579522362|FG000|Overall Study|Hematological Relapse After Remission|0|||
160489504|NCT01209286|579522363|FG001|Overall Study|Hematological Relapse After Remission|1|||
160489505|NCT01209286|579522364|FG002|Overall Study|Hematological Relapse After Remission|1|||
160489506|NCT01209286|579522362|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
160489507|NCT01209286|579522363|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
160489508|NCT01209286|579522364|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
160489509|NCT01209286|579522362|FG000|Overall Study|Physician Decision|0|||
160489510|NCT01209286|579522363|FG001|Overall Study|Physician Decision|2|||
160489511|NCT01209286|579522364|FG002|Overall Study|Physician Decision|0|||
160489512|NCT01209286|579522362|FG000|Overall Study|Other|0|||
160489513|NCT01209286|579522363|FG001|Overall Study|Other|1|||
160489514|NCT01209286|579522364|FG002|Overall Study|Other|0|||
160489515|NCT01349036|579522365|FG000|Overall Study|Disease progression|13|||
160489516|NCT01349036|579522366|FG001|Overall Study|Disease progression|22|||
160489517|NCT01349036|579522365|FG000|Overall Study|Other|1|||
160489518|NCT01349036|579522366|FG001|Overall Study|Other|0|||
160489519|NCT01349036|579522365|FG000|Overall Study|Withdrawal by Subject|0|||
160489520|NCT01349036|579522366|FG001|Overall Study|Withdrawal by Subject|2|||
160489521|NCT03796208|579522367|FG000|Overall Study|Withdrawal by Subject|3|||
160489522|NCT03796208|579522368|FG001|Overall Study|Withdrawal by Subject|0|||
160489523|NCT03796208|579522367|FG000|Overall Study|Loss of pregnancy|1|||
160489524|NCT03796208|579522368|FG001|Overall Study|Loss of pregnancy|1|||
160489525|NCT03796208|579522367|FG000|Overall Study|Changed prenatal clinics|0|||
160489526|NCT03796208|579522368|FG001|Overall Study|Changed prenatal clinics|5|||
160489527|NCT03796208|579522367|FG000|Overall Study|Lost to Follow-up|20|||
160489528|NCT03796208|579522368|FG001|Overall Study|Lost to Follow-up|16|||
160489529|NCT01161628|579522369|FG000|Overall Study|Death|6|||
160489530|NCT01161628|579522369|FG000|Overall Study|Lack of Efficacy|2|||
160489531|NCT00746356|579522373|FG000|Overall Study|Withdrawal by Subject|2|||
160489532|NCT00746356|579522374|FG001|Overall Study|Withdrawal by Subject|3|||
160489533|NCT00746356|579522373|FG000|Overall Study|Death|7|||
160489534|NCT00746356|579522374|FG001|Overall Study|Death|3|||
160489535|NCT00746356|579522373|FG000|Overall Study|Lost to Follow-up|1|||
160489536|NCT00746356|579522374|FG001|Overall Study|Lost to Follow-up|0|||
160489537|NCT00746356|579522373|FG000|Overall Study|Removal of Device|0|||
160489538|NCT00746356|579522374|FG001|Overall Study|Removal of Device|1|||
160489539|NCT00746356|579522373|FG000|Overall Study|Patient relocated|1|||
160489540|NCT00746356|579522374|FG001|Overall Study|Patient relocated|0|||
160489541|NCT01263925|579522375|FG000|Overall Study|Protocol Violation|1|||
160489542|NCT01263925|579522376|FG001|Overall Study|Protocol Violation|0|||
160489543|NCT01263925|579522375|FG000|Overall Study|Lack of Efficacy|0|||
160489544|NCT01263925|579522376|FG001|Overall Study|Lack of Efficacy|1|||
160489545|NCT01263925|579522375|FG000|Overall Study|Adverse Event|23|||
160489546|NCT01263925|579522376|FG001|Overall Study|Adverse Event|22|||
160489547|NCT01263925|579522375|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
160489548|NCT01263925|579522376|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
160489549|NCT01263925|579522375|FG000|Overall Study|Withdrawal by Subject|6|||
160489550|NCT01263925|579522376|FG001|Overall Study|Withdrawal by Subject|8|||
160489551|NCT01263925|579522375|FG000|Overall Study|Other|4|||
160489552|NCT01263925|579522376|FG001|Overall Study|Other|4|||
160489553|NCT01263925|579522375|FG000|Overall Study|Lost to Follow-up|3|||
160489554|NCT01263925|579522376|FG001|Overall Study|Lost to Follow-up|1|||
160489555|NCT01263925|579522375|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
160489556|NCT01263925|579522376|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
160489557|NCT01263925|579522375|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
160489558|NCT01263925|579522376|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
160489559|NCT01263925|579522375|FG000|Overall Study|AE/ Withdrawal|1|||
160489560|NCT01263925|579522376|FG001|Overall Study|AE/ Withdrawal|4|||
160489561|NCT01263925|579522375|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
160489562|NCT01263925|579522376|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
160489563|NCT01263925|579522375|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
160489564|NCT01263925|579522376|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
160489565|NCT01263925|579522375|FG000|Overall Study|Withdrawal/ Not specified|0|||
160489566|NCT01263925|579522376|FG001|Overall Study|Withdrawal/ Not specified|1|||
160489567|NCT01125566|579522382|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
160489568|NCT01125566|579522383|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
160489569|NCT01125566|579522384|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
160489570|NCT01125566|579522382|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
160489571|NCT01125566|579522383|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
160489572|NCT01125566|579522384|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
160489573|NCT01125566|579522382|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
160489574|NCT01125566|579522383|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
160489575|NCT01125566|579522384|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
160489576|NCT01125566|579522382|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
160489577|NCT01125566|579522383|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
160489578|NCT01125566|579522384|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
160489579|NCT01125566|579522382|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
160489580|NCT01125566|579522383|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
160489581|NCT01125566|579522384|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
160489582|NCT01125566|579522382|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
160489583|NCT01125566|579522383|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
160489584|NCT01125566|579522384|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
160489585|NCT01125566|579522382|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
160489586|NCT01125566|579522383|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
160489587|NCT01125566|579522384|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
160489588|NCT01125566|579522382|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
160489589|NCT01125566|579522383|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
160489590|NCT01125566|579522384|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
160489591|NCT01125566|579522382|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
160489592|NCT01125566|579522383|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
160489593|NCT01125566|579522384|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
160489594|NCT01125566|579522382|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
160489595|NCT01125566|579522383|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
160489596|NCT01125566|579522384|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
160489597|NCT01125566|579522382|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
160489598|NCT01125566|579522383|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
160489599|NCT01125566|579522384|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
160489600|NCT01125566|579522382|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
160489601|NCT01125566|579522383|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
160489602|NCT01125566|579522384|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
160489603|NCT01560585|579522385|FG000|Overall Study|Physician Decision|3|||
160489604|NCT00519285|579522386|FG000|Overall Study|Adverse Event|127|||
160489605|NCT00519285|579522387|FG001|Overall Study|Adverse Event|266|||
160489606|NCT00519285|579522386|FG000|Overall Study|Disease progression|334|||
160489607|NCT00519285|579522387|FG001|Overall Study|Disease progression|186|||
160489608|NCT00519285|579522386|FG000|Overall Study|Physician Decision|75|||
160489609|NCT00519285|579522387|FG001|Overall Study|Physician Decision|47|||
160489610|NCT00519285|579522386|FG000|Overall Study|Participant's request|53|||
160489611|NCT00519285|579522387|FG001|Overall Study|Participant's request|84|||
160489612|NCT00519285|579522386|FG000|Overall Study|Consent withdrawn|4|||
160489613|NCT00519285|579522387|FG001|Overall Study|Consent withdrawn|5|||
160489614|NCT00519285|579522386|FG000|Overall Study|Poor compliance to protocol|5|||
160610973|NCT01947894|579952311|FG000|Overall Study|Death|12|||
160610974|NCT01947894|579952312|FG001|Overall Study|Death|1|||
160610975|NCT01947894|579952313|FG002|Overall Study|Death|0|||
160610976|NCT01947894|579952311|FG000|Overall Study|Physician Decision|2|||
160489615|NCT00519285|579522387|FG001|Overall Study|Poor compliance to protocol|7|||
160489616|NCT00519285|579522386|FG000|Overall Study|Reason unspecified|5|||
160489617|NCT00519285|579522387|FG001|Overall Study|Reason unspecified|8|||
160489618|NCT00519285|579522386|FG000|Overall Study|Not treated|8|||
160489619|NCT00519285|579522387|FG001|Overall Study|Not treated|7|||
160489620|NCT00519285|579522386|FG000|Overall Study|Treatment ongoing|1|||
160489621|NCT00519285|579522387|FG001|Overall Study|Treatment ongoing|2|||
160489622|NCT02970305|579522388|FG000|Overall Study|Adverse Event|10|||
160489623|NCT02970305|579522389|FG001|Overall Study|Adverse Event|6|||
160489624|NCT02970305|579522388|FG000|Overall Study|Lack of Efficacy|1|||
160489625|NCT02970305|579522389|FG001|Overall Study|Lack of Efficacy|1|||
160489626|NCT02970305|579522388|FG000|Overall Study|Noncompliance with study drug|2|||
160489627|NCT02970305|579522389|FG001|Overall Study|Noncompliance with study drug|4|||
160489628|NCT02970305|579522388|FG000|Overall Study|Protocol Violation|2|||
160489629|NCT02970305|579522389|FG001|Overall Study|Protocol Violation|2|||
160489630|NCT02970305|579522388|FG000|Overall Study|Withdrawal by Subject|12|||
160489631|NCT02970305|579522389|FG001|Overall Study|Withdrawal by Subject|11|||
160489632|NCT02970305|579522388|FG000|Overall Study|Not further specified|1|||
160489633|NCT02970305|579522389|FG001|Overall Study|Not further specified|2|||
160489634|NCT02970305|579522388|FG000|Overall Study|Lost to Follow-up|1|||
160489635|NCT02970305|579522389|FG001|Overall Study|Lost to Follow-up|2|||
160489636|NCT02175745|579522390|FG000|Overall Study|Not Eligible|1|||
160489637|NCT00983892|579522391|FG000|Overall Study|Withdrawal by Subject|10|||
160489638|NCT00983892|579522392|FG001|Overall Study|Withdrawal by Subject|12|||
160489639|NCT00808899|579522394|FG000|Overall Study|Death|1|||
160489640|NCT00808899|579522394|FG000|Overall Study|Physician Decision|3|||
160489641|NCT03765164|579522395|FG000|Pre-intervention|Withdrawal by Subject|5|||
160489642|NCT03765164|579522396|FG001|Pre-intervention|Withdrawal by Subject|6|||
160489643|NCT00770588|579522397|FG000|Overall Study|Adverse Event|9|||
160489644|NCT00770588|579522398|FG001|Overall Study|Adverse Event|2|||
160489645|NCT00770588|579522397|FG000|Overall Study|Death caused by progression of disease|70|||
160489646|NCT00770588|579522398|FG001|Overall Study|Death caused by progression of disease|91|||
160489647|NCT00770588|579522397|FG000|Overall Study|Lost to Follow-up|1|||
160489648|NCT00770588|579522398|FG001|Overall Study|Lost to Follow-up|1|||
160489649|NCT00770588|579522397|FG000|Overall Study|Withdrawal by Subject|1|||
160489650|NCT00770588|579522398|FG001|Overall Study|Withdrawal by Subject|1|||
160489651|NCT01424189|579522399|FG000|Overall Study|Adverse Event|1|||
160489652|NCT01424189|579522400|FG001|Overall Study|Adverse Event|0|||
160489653|NCT01424189|579522399|FG000|Overall Study|Lost to Follow-up|4|||
160489654|NCT01424189|579522400|FG001|Overall Study|Lost to Follow-up|1|||
160489655|NCT01424189|579522399|FG000|Overall Study|Withdrawal by Subject|4|||
160489656|NCT01424189|579522400|FG001|Overall Study|Withdrawal by Subject|4|||
160489657|NCT01424189|579522399|FG000|Overall Study|Subject moved|1|||
160489658|NCT01424189|579522400|FG001|Overall Study|Subject moved|0|||
160489659|NCT01424189|579522399|FG000|Overall Study|Death|3|||
160489660|NCT01424189|579522400|FG001|Overall Study|Death|1|||
160489661|NCT03120949|579522401|FG000|Overall Study|randomized in error|1|||
160489662|NCT03120949|579522402|FG001|Overall Study|randomized in error|0|||
160489663|NCT03120949|579522401|FG000|Overall Study|Death|13|||
160489664|NCT03120949|579522402|FG001|Overall Study|Death|13|||
160489665|NCT03120949|579522401|FG000|Overall Study|Lost to Follow-up|23|||
160489666|NCT03120949|579522402|FG001|Overall Study|Lost to Follow-up|13|||
160489667|NCT03120949|579522401|FG000|Overall Study|Withdrawal by Subject|139|||
160489668|NCT03120949|579522402|FG001|Overall Study|Withdrawal by Subject|124|||
160489669|NCT03120949|579522401|FG000|Overall Study|Covid-19|43|||
160489670|NCT03120949|579522402|FG001|Overall Study|Covid-19|34|||
160489671|NCT03120949|579522401|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
160489672|NCT03120949|579522402|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
160489673|NCT03120949|579522401|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
160489674|NCT03120949|579522402|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
160489675|NCT03120949|579522401|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
160489676|NCT03120949|579522402|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
160489677|NCT03120949|579522401|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
160489678|NCT03120949|579522402|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
160489679|NCT03120949|579522401|FG000|Overall Study|Site was closed|2|||
160489680|NCT03120949|579522402|FG001|Overall Study|Site was closed|3|||
160489681|NCT03120949|579522401|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
160489682|NCT03120949|579522402|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
160489683|NCT03120949|579522401|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
160489684|NCT03120949|579522402|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
160489685|NCT03120949|579522401|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
160489686|NCT03120949|579522402|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
160489687|NCT03120949|579522401|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
160489688|NCT03120949|579522402|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
160489689|NCT03120949|579522401|FG000|Overall Study|Other: Adverse Event|0|||
160489690|NCT03120949|579522402|FG001|Overall Study|Other: Adverse Event|1|||
160489691|NCT03120949|579522401|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
160489692|NCT03120949|579522402|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
160489693|NCT03120949|579522401|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
160489694|NCT03120949|579522402|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
160489695|NCT03120949|579522401|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
160489696|NCT03120949|579522402|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
160489697|NCT03120949|579522401|FG000|Overall Study|Personal Reasons|0|||
160489698|NCT03120949|579522402|FG001|Overall Study|Personal Reasons|1|||
160489699|NCT03120949|579522401|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
160489700|NCT03120949|579522402|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
160489701|NCT03120949|579522401|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
160489702|NCT03120949|579522402|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
160489703|NCT03120949|579522401|FG000|Overall Study|Compliance With Medication|0|||
160489704|NCT03120949|579522402|FG001|Overall Study|Compliance With Medication|1|||
160489705|NCT03120949|579522401|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
160489706|NCT03120949|579522402|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
160489707|NCT03120949|579522401|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
160489708|NCT03120949|579522402|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
160489709|NCT03120949|579522401|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
160489710|NCT03120949|579522402|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
160489711|NCT01705145|579522403|FG000|Part B|Adverse Event|1|||
160489712|NCT00988117|579522404|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
160489713|NCT00988117|579522404|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
160489714|NCT01203956|579522405|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
160489715|NCT01203956|579522406|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
160489716|NCT04206384|579522409|FG000|Overall Study|Withdrawal by Subject|8|||
160489717|NCT04206384|579522409|FG000|Overall Study|Adverse Event|2|||
160489718|NCT01503164|579522416|FG000|Overall Study|Withdrawal by Subject|2|||
160489719|NCT01503164|579522417|FG001|Overall Study|Withdrawal by Subject|1|||
160489720|NCT04088136|579522420|FG000|Overall Study|Withdrawal by Subject|5|||
160489721|NCT04088136|579522421|FG001|Overall Study|Withdrawal by Subject|0|||
160489722|NCT04088136|579522420|FG000|Overall Study|Lack of Efficacy|0|||
160489723|NCT04088136|579522421|FG001|Overall Study|Lack of Efficacy|1|||
160489724|NCT01494298|579522422|FG000|Overall Study|Protocol Violation|2|||
160489725|NCT01494298|579522423|FG001|Overall Study|Protocol Violation|8|||
160489726|NCT04159805|579522424|FG000|Overall Study|Withdrawal by Subject|0|||
160489727|NCT04159805|579522425|FG001|Overall Study|Withdrawal by Subject|2|||
160489728|NCT04159805|579522426|FG002|Overall Study|Withdrawal by Subject|2|||
160489729|NCT02998918|579522430|FG000|Overall Study|Withdrawal by Subject|1|||
160489730|NCT02998918|579522431|FG001|Overall Study|Withdrawal by Subject|0|||
160489731|NCT01283971|579522436|FG000|Overall Study|Adverse Event|3|||
160489732|NCT01283971|579522437|FG001|Overall Study|Adverse Event|5|||
160489733|NCT01283971|579522436|FG000|Overall Study|Insufficient therapeutic responses|3|||
160489734|NCT01283971|579522437|FG001|Overall Study|Insufficient therapeutic responses|3|||
160489735|NCT01283971|579522436|FG000|Overall Study|Protocol Violation|5|||
160489736|NCT01283971|579522437|FG001|Overall Study|Protocol Violation|1|||
160489737|NCT01283971|579522436|FG000|Overall Study|Refused treatment|3|||
160489738|NCT01283971|579522437|FG001|Overall Study|Refused treatment|1|||
160489739|NCT01283971|579522436|FG000|Overall Study|Failure to return|0|||
160489740|NCT01283971|579522437|FG001|Overall Study|Failure to return|1|||
160489741|NCT01283971|579522436|FG000|Overall Study|Administrative reasons|1|||
160489742|NCT01283971|579522437|FG001|Overall Study|Administrative reasons|1|||
160489743|NCT00702520|579522439|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
160489744|NCT00702520|579522440|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
160489745|NCT00702520|579522441|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
160489746|NCT00702520|579522442|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
160489747|NCT00702520|579522439|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
160489748|NCT00702520|579522440|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
160489749|NCT00702520|579522441|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
160489750|NCT00702520|579522442|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
160489751|NCT00702520|579522439|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
160489752|NCT00702520|579522440|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
160489753|NCT00702520|579522441|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
160489754|NCT00702520|579522442|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
160489755|NCT02154347|579522443|FG000|Double-blind Period|Adverse Event|1|||
160489756|NCT02154347|579522444|FG001|Double-blind Period|Adverse Event|2|||
160489757|NCT02154347|579522443|FG000|Double-blind Period|Lack of Efficacy|1|||
160489758|NCT02154347|579522444|FG001|Double-blind Period|Lack of Efficacy|0|||
160489759|NCT02154347|579522443|FG000|Double-blind Period|Physician Decision|0|||
160489760|NCT02154347|579522444|FG001|Double-blind Period|Physician Decision|1|||
160489761|NCT02154347|579522443|FG000|Double-blind Period|Withdrawal by Subject|1|||
160489762|NCT02154347|579522444|FG001|Double-blind Period|Withdrawal by Subject|1|||
160489763|NCT02154347|579522443|FG000|Open-label Period|Adverse Event|3|||
160489764|NCT02154347|579522444|FG001|Open-label Period|Adverse Event|4|||
160489765|NCT02154347|579522443|FG000|Open-label Period|Lack of Efficacy|4|||
160489766|NCT02154347|579522444|FG001|Open-label Period|Lack of Efficacy|19|||
160489767|NCT02154347|579522443|FG000|Open-label Period|Protocol Violation|0|||
160489768|NCT02154347|579522444|FG001|Open-label Period|Protocol Violation|1|||
160489769|NCT02154347|579522443|FG000|Open-label Period|Withdrawal by Subject|0|||
160489770|NCT02154347|579522444|FG001|Open-label Period|Withdrawal by Subject|1|||
160489771|NCT02473913|579522445|FG000|Overall Study|Lost to Follow-up|3|||
160489772|NCT02473913|579522446|FG001|Overall Study|Lost to Follow-up|3|||
160489773|NCT02388347|579523801|FG000|Overall Study|Withdrawal by Subject|0|||
160489774|NCT02388347|579523802|FG001|Overall Study|Withdrawal by Subject|0|||
160489775|NCT02388347|579523803|FG002|Overall Study|Withdrawal by Subject|1|||
160489776|NCT02388347|579523804|FG003|Overall Study|Withdrawal by Subject|0|||
160489777|NCT02388347|579523805|FG004|Overall Study|Withdrawal by Subject|0|||
160489778|NCT00497874|579523806|FG000|Overall Study|Withdrawal by Subject|48|||
160489779|NCT00497874|579523807|FG001|Overall Study|Withdrawal by Subject|17|||
160489780|NCT00497874|579523806|FG000|Overall Study|Illness|8|||
160489781|NCT00497874|579523807|FG001|Overall Study|Illness|4|||
160489782|NCT00497874|579523806|FG000|Overall Study|Death|2|||
160489783|NCT00497874|579523807|FG001|Overall Study|Death|4|||
160489784|NCT00497874|579523806|FG000|Overall Study|Unable to contact|52|||
160489785|NCT00497874|579523807|FG001|Overall Study|Unable to contact|67|||
160489786|NCT00497874|579523806|FG000|Overall Study|Unable to schedule|37|||
160489787|NCT00497874|579523807|FG001|Overall Study|Unable to schedule|24|||
160489788|NCT01101334|579523808|FG000|Overall Study|Adverse Event|9|||
160489789|NCT01101334|579523809|FG001|Overall Study|Adverse Event|4|||
160489790|NCT01101334|579523808|FG000|Overall Study|Death|7|||
160489791|NCT01101334|579523809|FG001|Overall Study|Death|1|||
160489792|NCT01101334|579523808|FG000|Overall Study|Withdrawal by Subject|4|||
160489793|NCT01101334|579523809|FG001|Overall Study|Withdrawal by Subject|3|||
160489794|NCT01101334|579523808|FG000|Overall Study|Withdrawal by Sponsor|1|||
160489795|NCT01101334|579523809|FG001|Overall Study|Withdrawal by Sponsor|1|||
160489796|NCT01101334|579523808|FG000|Overall Study|Progressive Disease|22|||
160489797|NCT01101334|579523809|FG001|Overall Study|Progressive Disease|35|||
160489798|NCT01101334|579523808|FG000|Overall Study|Other|2|||
160489799|NCT01101334|579523809|FG001|Overall Study|Other|1|||
160489800|NCT04843579|579523814|FG000|Overall Study|Adverse Event|1|||
160489801|NCT04843579|579523814|FG000|Overall Study|Disease Progression|1|||
160489802|NCT04398368|579523815|FG000|Overall Study|Withdrawal by Subject|2|||
160489803|NCT02106195|579523816|FG000|Overall Study|Adverse Event|2|||
160489804|NCT02106195|579523816|FG000|Overall Study|Protocol Violation|1|||
160489805|NCT01114139|579523818|FG000|Overall Study|Adverse Event|3|||
160489806|NCT01114139|579523819|FG001|Overall Study|Adverse Event|2|||
160489807|NCT01114139|579523818|FG000|Overall Study|Lost to Follow-up|15|||
160489808|NCT01114139|579523819|FG001|Overall Study|Lost to Follow-up|3|||
160489809|NCT01114139|579523818|FG000|Overall Study|Withdrawal by Subject|17|||
160489810|NCT01114139|579523819|FG001|Overall Study|Withdrawal by Subject|6|||
160489811|NCT01114139|579523818|FG000|Overall Study|Other-Missed 1 visit|1|||
160489812|NCT01114139|579523819|FG001|Overall Study|Other-Missed 1 visit|0|||
160489813|NCT01114139|579523818|FG000|Overall Study|Other-Protocol Violation|1|||
160489814|NCT01114139|579523819|FG001|Overall Study|Other-Protocol Violation|0|||
160489815|NCT01114139|579523818|FG000|Overall Study|Other-Out of window for study drug dose|1|||
160489816|NCT01114139|579523819|FG001|Overall Study|Other-Out of window for study drug dose|0|||
160489817|NCT01114139|579523818|FG000|Overall Study|Other-Participant falsified records|0|||
160489818|NCT01114139|579523819|FG001|Overall Study|Other-Participant falsified records|1|||
160489819|NCT01114139|579523818|FG000|Overall Study|Other-Participant went on hospice|0|||
160489820|NCT01114139|579523819|FG001|Overall Study|Other-Participant went on hospice|1|||
160489821|NCT01114139|579523818|FG000|Overall Study|Other-Physician changed treatment|1|||
160489822|NCT01114139|579523819|FG001|Overall Study|Other-Physician changed treatment|0|||
160489823|NCT01114139|579523818|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
160489824|NCT01114139|579523819|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
160489825|NCT00477464|579523821|FG000|Overall Study|Lost to Follow-up|1|||
160489826|NCT00477464|579523821|FG000|Overall Study|Death|36|||
160489827|NCT00477464|579523821|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
160489828|NCT03568812|579523822|FG000|Overall Study|Physician Decision|0|||
160489829|NCT03568812|579523823|FG001|Overall Study|Physician Decision|1|||
160489830|NCT00639769|579523825|FG000|Overall Study|Death|2|||
160489831|NCT00639769|579523825|FG000|Overall Study|Adverse Event|7|||
160489832|NCT00639769|579523825|FG000|Overall Study|Lack of Efficacy|1|||
160489833|NCT00639769|579523825|FG000|Overall Study|Disease progression|26|||
160489834|NCT00639769|579523825|FG000|Overall Study|Withdrawal by Subject|4|||
160489835|NCT01774019|579523827|FG000|Overall Study|No longer meets protocol criteria|2|||
160489836|NCT01774019|579523828|FG001|Overall Study|No longer meets protocol criteria|0|||
160489837|NCT01774019|579523827|FG000|Overall Study|Withdrawal by Subject|1|||
160489838|NCT01774019|579523828|FG001|Overall Study|Withdrawal by Subject|0|||
160489839|NCT01774019|579523827|FG000|Overall Study|Surgery delayed > 120 days|1|||
160489840|NCT01774019|579523828|FG001|Overall Study|Surgery delayed > 120 days|0|||
160489841|NCT01774019|579523827|FG000|Overall Study|Patient refused surgery|1|||
160489842|NCT01774019|579523828|FG001|Overall Study|Patient refused surgery|1|||
160489843|NCT01774019|579523827|FG000|Overall Study|Unable to implant study device|1|||
160489844|NCT01774019|579523828|FG001|Overall Study|Unable to implant study device|0|||
160489845|NCT01774019|579523827|FG000|Overall Study|Lost to Follow-up|0|||
160489846|NCT01774019|579523828|FG001|Overall Study|Lost to Follow-up|3|||
160489847|NCT03470545|579523831|FG000|Overall Study|Death|0|||
160489848|NCT03470545|579523832|FG001|Overall Study|Death|1|||
160489849|NCT03470545|579523831|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
160489850|NCT03470545|579523832|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
160489851|NCT03470545|579523831|FG000|Overall Study|Adverse Event|2|||
160489852|NCT03470545|579523832|FG001|Overall Study|Adverse Event|0|||
160489853|NCT03470545|579523831|FG000|Overall Study|Withdrawal by Subject|1|||
160489854|NCT03470545|579523832|FG001|Overall Study|Withdrawal by Subject|1|||
160489855|NCT03470545|579523831|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
160489856|NCT03470545|579523832|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
160489857|NCT01664923|579523833|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
160489858|NCT01664923|579523834|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
160489859|NCT01664923|579523833|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
160489860|NCT01664923|579523834|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
160489861|NCT01664923|579523833|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
160489862|NCT01664923|579523834|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
160489863|NCT01664923|579523833|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
160489864|NCT01664923|579523834|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
160489865|NCT01664923|579523833|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
160489866|NCT01664923|579523834|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
160489867|NCT01664923|579523833|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
160489868|NCT01664923|579523834|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
160489869|NCT01664923|579523833|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
160489870|NCT01664923|579523834|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
160489871|NCT01664923|579523833|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
160489872|NCT01664923|579523834|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
160489873|NCT01664923|579523833|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
160489874|NCT01664923|579523834|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
160489875|NCT01664923|579523833|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
160489876|NCT01664923|579523834|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
160489877|NCT01664923|579523833|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
160489878|NCT01664923|579523834|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
160489879|NCT01664923|579523833|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
160489880|NCT01664923|579523834|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
160489881|NCT01664923|579523833|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
160489882|NCT01664923|579523834|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
160489883|NCT01664923|579523833|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
160489884|NCT01664923|579523834|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
160489885|NCT04035577|579523835|FG000|Overall Study|Lost to Follow-up|1|||
160489886|NCT04035577|579523835|FG000|Overall Study|Withdrawal by Subject|1|||
160489887|NCT00878553|579523840|FG000|Sleep Study|Withdrawal by Subject|2|||
160489888|NCT00878553|579523841|FG001|Sleep Study|Withdrawal by Subject|0|||
160489889|NCT00878553|579523842|FG002|Sleep Study|Withdrawal by Subject|0|||
160489890|NCT00878553|579523843|FG003|Sleep Study|Withdrawal by Subject|0|||
160489891|NCT00878553|579523844|FG004|Sleep Study|Withdrawal by Subject|0|||
160489892|NCT00878553|579523840|FG000|Sleep Study|Lost to Follow-up|1|||
160489893|NCT00878553|579523841|FG001|Sleep Study|Lost to Follow-up|0|||
160489894|NCT00878553|579523842|FG002|Sleep Study|Lost to Follow-up|0|||
160489895|NCT00878553|579523843|FG003|Sleep Study|Lost to Follow-up|0|||
160489896|NCT00878553|579523844|FG004|Sleep Study|Lost to Follow-up|0|||
160489897|NCT00878553|579523840|FG000|Sleep Study|car accident|1|||
160489898|NCT00878553|579523841|FG001|Sleep Study|car accident|0|||
160489899|NCT00878553|579523842|FG002|Sleep Study|car accident|0|||
160489900|NCT00878553|579523843|FG003|Sleep Study|car accident|0|||
160489901|NCT00878553|579523844|FG004|Sleep Study|car accident|0|||
160489902|NCT00878553|579523840|FG000|Sleep Study|family emergency|1|||
160489903|NCT00878553|579523841|FG001|Sleep Study|family emergency|0|||
160489904|NCT00878553|579523842|FG002|Sleep Study|family emergency|0|||
160489905|NCT00878553|579523843|FG003|Sleep Study|family emergency|0|||
160489906|NCT00878553|579523844|FG004|Sleep Study|family emergency|0|||
160489907|NCT00878553|579523840|FG000|PK Study|Withdrawal by Subject|0|||
160489908|NCT00878553|579523841|FG001|PK Study|Withdrawal by Subject|0|||
160489909|NCT00878553|579523842|FG002|PK Study|Withdrawal by Subject|0|||
160489910|NCT00878553|579523843|FG003|PK Study|Withdrawal by Subject|1|||
160489911|NCT00878553|579523844|FG004|PK Study|Withdrawal by Subject|0|||
160489912|NCT03188536|579523845|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
160489913|NCT03188536|579523845|FG000|Overall Study|Not participated/met inclusion criteria|1|||
160489914|NCT00118703|579523846|FG000|Overall Study|Protocol Violation|1|||
160489915|NCT00118703|579523847|FG001|Overall Study|Protocol Violation|0|||
160489916|NCT00118703|579523846|FG000|Overall Study|Adverse Event|1|||
160489917|NCT00118703|579523847|FG001|Overall Study|Adverse Event|1|||
160661314|NCT00723528|580144040|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
160661315|NCT00723528|580144041|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
160489918|NCT00118703|579523846|FG000|Overall Study|Participant took two different treatment|0|||
160489919|NCT00118703|579523847|FG001|Overall Study|Participant took two different treatment|1|||
160489920|NCT00118703|579523846|FG000|Overall Study|Withdrawal by Subject|2|||
160489921|NCT00118703|579523847|FG001|Overall Study|Withdrawal by Subject|5|||
160489922|NCT00118703|579523846|FG000|Overall Study|Lost to Follow-up|1|||
160489923|NCT00118703|579523847|FG001|Overall Study|Lost to Follow-up|2|||
160489924|NCT02344173|579523848|FG000|Procedure|Ablation Procedure Not Performed|7|||
160489925|NCT02344173|579523848|FG000|12-month Visit|Death|8|||
160489926|NCT02344173|579523848|FG000|12-month Visit|Withdrawal by Subject|30|||
160489927|NCT02344173|579523848|FG000|12-month Visit|Lost to Follow-up|58|||
160489928|NCT03605368|579523850|FG000|Overall Study|Lost to Follow-up|2|||
160489929|NCT03605368|579523851|FG001|Overall Study|Lost to Follow-up|1|||
160489930|NCT03605368|579523852|FG002|Overall Study|Lost to Follow-up|3|||
160489931|NCT03605368|579523853|FG003|Overall Study|Lost to Follow-up|2|||
160489932|NCT03605368|579523850|FG000|Overall Study|Withdrawal by Subject|0|||
160489933|NCT03605368|579523851|FG001|Overall Study|Withdrawal by Subject|0|||
160489934|NCT03605368|579523852|FG002|Overall Study|Withdrawal by Subject|4|||
160489935|NCT03605368|579523853|FG003|Overall Study|Withdrawal by Subject|3|||
160489936|NCT01020747|579523854|FG000|Overall Study|Withdrawal by Subject|1|||
160489937|NCT03028012|579523859|FG000|Overall Study|Lost to Follow-up|2|||
160489938|NCT03028012|579523860|FG001|Overall Study|Lost to Follow-up|3|||
160489939|NCT03028012|579523861|FG002|Overall Study|Lost to Follow-up|3|||
160489940|NCT01726517|579523862|FG000|Overall Study|Withdrawal by Subject|0|||
160489941|NCT01726517|579523863|FG001|Overall Study|Withdrawal by Subject|0|||
160489942|NCT01726517|579523864|FG002|Overall Study|Withdrawal by Subject|1|||
160489943|NCT01726517|579523865|FG003|Overall Study|Withdrawal by Subject|0|||
160489944|NCT01726517|579523866|FG004|Overall Study|Withdrawal by Subject|0|||
160489945|NCT02484547|579523875|FG000|Placebo-Controlled Period|Adverse Event|10|||
160489946|NCT02484547|579523876|FG001|Placebo-Controlled Period|Adverse Event|13|||
160489947|NCT02484547|579523877|FG002|Placebo-Controlled Period|Adverse Event|20|||
160489948|NCT02484547|579523878|FG003|Placebo-Controlled Period|Adverse Event|0|||
160489949|NCT02484547|579523879|FG004|Placebo-Controlled Period|Adverse Event|0|||
160489950|NCT02484547|579523880|FG005|Placebo-Controlled Period|Adverse Event|0|||
160489951|NCT02484547|579523881|FG006|Placebo-Controlled Period|Adverse Event|0|||
160489952|NCT02484547|579523875|FG000|Placebo-Controlled Period|Change of Treatment|0|||
160489953|NCT02484547|579523876|FG001|Placebo-Controlled Period|Change of Treatment|0|||
160489954|NCT02484547|579523877|FG002|Placebo-Controlled Period|Change of Treatment|1|||
160489955|NCT02484547|579523878|FG003|Placebo-Controlled Period|Change of Treatment|0|||
160489956|NCT02484547|579523879|FG004|Placebo-Controlled Period|Change of Treatment|0|||
160489957|NCT02484547|579523880|FG005|Placebo-Controlled Period|Change of Treatment|0|||
160489958|NCT02484547|579523881|FG006|Placebo-Controlled Period|Change of Treatment|0|||
160489959|NCT02484547|579523875|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
160489960|NCT02484547|579523876|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
160489961|NCT02484547|579523877|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
160489962|NCT02484547|579523878|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
160489963|NCT02484547|579523879|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
160489964|NCT02484547|579523880|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
160489965|NCT02484547|579523881|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
160489966|NCT02484547|579523875|FG000|Placebo-Controlled Period|Death|5|||
160489967|NCT02484547|579523876|FG001|Placebo-Controlled Period|Death|0|||
160489968|NCT02484547|579523877|FG002|Placebo-Controlled Period|Death|6|||
160489969|NCT02484547|579523878|FG003|Placebo-Controlled Period|Death|0|||
160489970|NCT02484547|579523879|FG004|Placebo-Controlled Period|Death|0|||
160489971|NCT02484547|579523880|FG005|Placebo-Controlled Period|Death|0|||
160489972|NCT02484547|579523881|FG006|Placebo-Controlled Period|Death|0|||
160489973|NCT02484547|579523875|FG000|Placebo-Controlled Period|Disease Progression|2|||
160489974|NCT02484547|579523876|FG001|Placebo-Controlled Period|Disease Progression|0|||
160489975|NCT02484547|579523877|FG002|Placebo-Controlled Period|Disease Progression|1|||
160489976|NCT02484547|579523878|FG003|Placebo-Controlled Period|Disease Progression|0|||
160489977|NCT02484547|579523879|FG004|Placebo-Controlled Period|Disease Progression|0|||
160489978|NCT02484547|579523880|FG005|Placebo-Controlled Period|Disease Progression|0|||
160489979|NCT02484547|579523881|FG006|Placebo-Controlled Period|Disease Progression|0|||
160489980|NCT02484547|579523875|FG000|Placebo-Controlled Period|Investigator Decision|2|||
160489981|NCT02484547|579523876|FG001|Placebo-Controlled Period|Investigator Decision|2|||
160489982|NCT02484547|579523877|FG002|Placebo-Controlled Period|Investigator Decision|5|||
160489983|NCT02484547|579523878|FG003|Placebo-Controlled Period|Investigator Decision|0|||
160489984|NCT02484547|579523879|FG004|Placebo-Controlled Period|Investigator Decision|0|||
160489985|NCT02484547|579523880|FG005|Placebo-Controlled Period|Investigator Decision|0|||
160489986|NCT02484547|579523881|FG006|Placebo-Controlled Period|Investigator Decision|0|||
160489987|NCT02484547|579523875|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
160489988|NCT02484547|579523876|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
160489989|NCT02484547|579523877|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
160489990|NCT02484547|579523878|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
160489991|NCT02484547|579523879|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
160489992|NCT02484547|579523880|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
160489993|NCT02484547|579523881|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
160489994|NCT02484547|579523875|FG000|Placebo-Controlled Period|Relocation|1|||
160489995|NCT02484547|579523876|FG001|Placebo-Controlled Period|Relocation|1|||
160489996|NCT02484547|579523877|FG002|Placebo-Controlled Period|Relocation|1|||
160489997|NCT02484547|579523878|FG003|Placebo-Controlled Period|Relocation|0|||
160489998|NCT02484547|579523879|FG004|Placebo-Controlled Period|Relocation|0|||
160489999|NCT02484547|579523880|FG005|Placebo-Controlled Period|Relocation|0|||
160490000|NCT02484547|579523881|FG006|Placebo-Controlled Period|Relocation|0|||
160490001|NCT02484547|579523875|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
160490002|NCT02484547|579523876|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
160490003|NCT02484547|579523877|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
160490004|NCT02484547|579523878|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
160490005|NCT02484547|579523879|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
160490006|NCT02484547|579523880|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
160490007|NCT02484547|579523881|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
160490008|NCT02484547|579523875|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
160490009|NCT02484547|579523876|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
160490010|NCT02484547|579523877|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
160490011|NCT02484547|579523878|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160490012|NCT02484547|579523879|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160490013|NCT02484547|579523880|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160490014|NCT02484547|579523881|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160490015|NCT02484547|579523875|FG000|Placebo-Controlled Period|Reason not Specified|216|||
160490016|NCT02484547|579523876|FG001|Placebo-Controlled Period|Reason not Specified|194|||
160490017|NCT02484547|579523877|FG002|Placebo-Controlled Period|Reason not Specified|183|||
160490018|NCT02484547|579523878|FG003|Placebo-Controlled Period|Reason not Specified|0|||
160490019|NCT02484547|579523879|FG004|Placebo-Controlled Period|Reason not Specified|0|||
160490020|NCT02484547|579523880|FG005|Placebo-Controlled Period|Reason not Specified|0|||
160490021|NCT02484547|579523881|FG006|Placebo-Controlled Period|Reason not Specified|0|||
160490022|NCT02484547|579523875|FG000|Long-Term Extension Period|Adverse Event|0|||
160490023|NCT02484547|579523876|FG001|Long-Term Extension Period|Adverse Event|0|||
160490024|NCT02484547|579523877|FG002|Long-Term Extension Period|Adverse Event|0|||
160490025|NCT02484547|579523878|FG003|Long-Term Extension Period|Adverse Event|0|||
160490026|NCT02484547|579523879|FG004|Long-Term Extension Period|Adverse Event|1|||
160490027|NCT02484547|579523880|FG005|Long-Term Extension Period|Adverse Event|3|||
160490028|NCT02484547|579523881|FG006|Long-Term Extension Period|Adverse Event|2|||
160490029|NCT02484547|579523875|FG000|Long-Term Extension Period|Death|0|||
160490030|NCT02484547|579523876|FG001|Long-Term Extension Period|Death|0|||
160490031|NCT02484547|579523877|FG002|Long-Term Extension Period|Death|0|||
160490032|NCT02484547|579523878|FG003|Long-Term Extension Period|Death|0|||
160490033|NCT02484547|579523879|FG004|Long-Term Extension Period|Death|0|||
160490034|NCT02484547|579523880|FG005|Long-Term Extension Period|Death|3|||
160490035|NCT02484547|579523881|FG006|Long-Term Extension Period|Death|0|||
160490036|NCT02484547|579523875|FG000|Long-Term Extension Period|Disease Progression|0|||
160490037|NCT02484547|579523876|FG001|Long-Term Extension Period|Disease Progression|0|||
160490038|NCT02484547|579523877|FG002|Long-Term Extension Period|Disease Progression|0|||
160490039|NCT02484547|579523878|FG003|Long-Term Extension Period|Disease Progression|0|||
160490040|NCT02484547|579523879|FG004|Long-Term Extension Period|Disease Progression|2|||
160490041|NCT02484547|579523880|FG005|Long-Term Extension Period|Disease Progression|4|||
160490042|NCT02484547|579523881|FG006|Long-Term Extension Period|Disease Progression|0|||
160490043|NCT02484547|579523875|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
160490044|NCT02484547|579523876|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
160490045|NCT02484547|579523877|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
160490046|NCT02484547|579523878|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
160610977|NCT01947894|579952312|FG001|Overall Study|Physician Decision|0|||
160490047|NCT02484547|579523879|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
160490048|NCT02484547|579523880|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
160490049|NCT02484547|579523881|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
160490050|NCT02484547|579523875|FG000|Long-Term Extension Period|Loss of Capacity|0|||
160490051|NCT02484547|579523876|FG001|Long-Term Extension Period|Loss of Capacity|0|||
160490052|NCT02484547|579523877|FG002|Long-Term Extension Period|Loss of Capacity|0|||
160490053|NCT02484547|579523878|FG003|Long-Term Extension Period|Loss of Capacity|0|||
160490054|NCT02484547|579523879|FG004|Long-Term Extension Period|Loss of Capacity|1|||
160490055|NCT02484547|579523880|FG005|Long-Term Extension Period|Loss of Capacity|0|||
160490056|NCT02484547|579523881|FG006|Long-Term Extension Period|Loss of Capacity|0|||
160490057|NCT02484547|579523875|FG000|Long-Term Extension Period|Change of Treatment|0|||
160490058|NCT02484547|579523876|FG001|Long-Term Extension Period|Change of Treatment|0|||
160490059|NCT02484547|579523877|FG002|Long-Term Extension Period|Change of Treatment|0|||
160490060|NCT02484547|579523878|FG003|Long-Term Extension Period|Change of Treatment|0|||
160490061|NCT02484547|579523879|FG004|Long-Term Extension Period|Change of Treatment|0|||
160490062|NCT02484547|579523880|FG005|Long-Term Extension Period|Change of Treatment|0|||
160490063|NCT02484547|579523881|FG006|Long-Term Extension Period|Change of Treatment|1|||
160490064|NCT02484547|579523875|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
160490065|NCT02484547|579523876|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
160490066|NCT02484547|579523877|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
160490067|NCT02484547|579523878|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
160490068|NCT02484547|579523879|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
160490069|NCT02484547|579523880|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
160490070|NCT02484547|579523881|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
160490071|NCT02484547|579523875|FG000|Long-Term Extension Period|Investigator Decision|0|||
160490072|NCT02484547|579523876|FG001|Long-Term Extension Period|Investigator Decision|0|||
160490073|NCT02484547|579523877|FG002|Long-Term Extension Period|Investigator Decision|0|||
160490074|NCT02484547|579523878|FG003|Long-Term Extension Period|Investigator Decision|2|||
160490075|NCT02484547|579523879|FG004|Long-Term Extension Period|Investigator Decision|1|||
160490076|NCT02484547|579523880|FG005|Long-Term Extension Period|Investigator Decision|0|||
160490077|NCT02484547|579523881|FG006|Long-Term Extension Period|Investigator Decision|1|||
160490078|NCT02484547|579523875|FG000|Long-Term Extension Period|Relocation|0|||
160490079|NCT02484547|579523876|FG001|Long-Term Extension Period|Relocation|0|||
160490080|NCT02484547|579523877|FG002|Long-Term Extension Period|Relocation|0|||
160490081|NCT02484547|579523878|FG003|Long-Term Extension Period|Relocation|1|||
160490082|NCT02484547|579523879|FG004|Long-Term Extension Period|Relocation|1|||
160490083|NCT02484547|579523880|FG005|Long-Term Extension Period|Relocation|0|||
160490084|NCT02484547|579523881|FG006|Long-Term Extension Period|Relocation|0|||
160490085|NCT02484547|579523875|FG000|Long-Term Extension Period|Study Visit Burden|0|||
160490086|NCT02484547|579523876|FG001|Long-Term Extension Period|Study Visit Burden|0|||
160490087|NCT02484547|579523877|FG002|Long-Term Extension Period|Study Visit Burden|0|||
160490088|NCT02484547|579523878|FG003|Long-Term Extension Period|Study Visit Burden|2|||
160490089|NCT02484547|579523879|FG004|Long-Term Extension Period|Study Visit Burden|0|||
160490090|NCT02484547|579523880|FG005|Long-Term Extension Period|Study Visit Burden|0|||
160490091|NCT02484547|579523881|FG006|Long-Term Extension Period|Study Visit Burden|3|||
160490092|NCT02484547|579523875|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
160490093|NCT02484547|579523876|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
160490094|NCT02484547|579523877|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
160490095|NCT02484547|579523878|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
160490096|NCT02484547|579523879|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
160490097|NCT02484547|579523880|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
160490098|NCT02484547|579523881|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
160490099|NCT02484547|579523875|FG000|Long-Term Extension Period|Reason not Specified|0|||
160490100|NCT02484547|579523876|FG001|Long-Term Extension Period|Reason not Specified|0|||
160490101|NCT02484547|579523877|FG002|Long-Term Extension Period|Reason not Specified|0|||
160490102|NCT02484547|579523878|FG003|Long-Term Extension Period|Reason not Specified|119|||
160490103|NCT02484547|579523879|FG004|Long-Term Extension Period|Reason not Specified|117|||
160490104|NCT02484547|579523880|FG005|Long-Term Extension Period|Reason not Specified|223|||
160490105|NCT02484547|579523881|FG006|Long-Term Extension Period|Reason not Specified|231|||
160490106|NCT03448536|579523882|FG000|Overall Study|Protocol Violation|2|||
160661316|NCT01149473|580144045|FG000|First Intervention|Adverse Event|1|||
160490107|NCT03448536|579523883|FG001|Overall Study|Protocol Violation|0|||
160490108|NCT03448536|579523882|FG000|Overall Study|Pregnancy|1|||
160490109|NCT03448536|579523883|FG001|Overall Study|Pregnancy|0|||
160490110|NCT03448536|579523882|FG000|Overall Study|Withdrawal by Subject|1|||
160490111|NCT03448536|579523883|FG001|Overall Study|Withdrawal by Subject|2|||
160490112|NCT03448536|579523882|FG000|Overall Study|Lost to Follow-up|3|||
160490113|NCT03448536|579523883|FG001|Overall Study|Lost to Follow-up|2|||
160490114|NCT03448536|579523882|FG000|Overall Study|Inadequate pain reporter|1|||
160490115|NCT03448536|579523883|FG001|Overall Study|Inadequate pain reporter|0|||
160661317|NCT01149473|580144046|FG001|First Intervention|Adverse Event|1|||
160661318|NCT01149473|580144045|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
160490116|NCT03448536|579523882|FG000|Overall Study|Other|3|||
160490117|NCT03448536|579523883|FG001|Overall Study|Other|0|||
160490118|NCT03448536|579523882|FG000|Overall Study|Physician Decision|1|||
160490119|NCT03448536|579523883|FG001|Overall Study|Physician Decision|0|||
160490120|NCT01813305|579523884|FG000|Overall Study|Withdrawal by Subject|12|||
160490121|NCT01813305|579523885|FG001|Overall Study|Withdrawal by Subject|5|||
160490122|NCT01813305|579523884|FG000|Overall Study|Safety Concern|4|||
160490123|NCT01813305|579523885|FG001|Overall Study|Safety Concern|0|||
160490124|NCT01813305|579523884|FG000|Overall Study|Ulcer became worse|4|||
160490125|NCT01813305|579523885|FG001|Overall Study|Ulcer became worse|0|||
160490126|NCT01813305|579523884|FG000|Overall Study|Physician Decision|4|||
160490127|NCT01813305|579523885|FG001|Overall Study|Physician Decision|0|||
160490128|NCT01813305|579523884|FG000|Overall Study|Lost to Follow-up|3|||
160490129|NCT01813305|579523885|FG001|Overall Study|Lost to Follow-up|1|||
160490130|NCT01813305|579523884|FG000|Overall Study|Protocol Violation|1|||
160490131|NCT01813305|579523885|FG001|Overall Study|Protocol Violation|0|||
160490132|NCT01813305|579523884|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
160490133|NCT01813305|579523885|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
160490134|NCT01665599|579523886|FG000|Overall Study|Adverse Event|1|||
160490135|NCT01665599|579523886|FG000|Overall Study|Consent Withdrawn|1|||
160490136|NCT01665599|579523886|FG000|Overall Study|Investigator/Sponsor decision|1|||
160490137|NCT01665599|579523886|FG000|Overall Study|Death|1|||
160490138|NCT01665599|579523886|FG000|Overall Study|Lost to Follow-up|2|||
160490139|NCT01665599|579523886|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
160490140|NCT01665599|579523886|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
160490141|NCT02230306|579523887|FG000|Overall Study|Did not receive study treatment|1|||
160490142|NCT00312845|579523889|FG000|Overall Study|Adverse Event|19|||
160490143|NCT00312845|579523890|FG001|Overall Study|Adverse Event|5|||
160490144|NCT00312845|579523889|FG000|Overall Study|Death|2|||
160490145|NCT00312845|579523890|FG001|Overall Study|Death|2|||
160490146|NCT00312845|579523889|FG000|Overall Study|Withdrawal by Subject|14|||
160490147|NCT00312845|579523890|FG001|Overall Study|Withdrawal by Subject|6|||
160490148|NCT00312845|579523889|FG000|Overall Study|Disease Progression|56|||
160490149|NCT00312845|579523890|FG001|Overall Study|Disease Progression|77|||
160490150|NCT00312845|579523889|FG000|Overall Study|Lost to Follow-up|2|||
160490151|NCT00312845|579523890|FG001|Overall Study|Lost to Follow-up|0|||
160490152|NCT00312845|579523889|FG000|Overall Study|Other|6|||
160490153|NCT00312845|579523890|FG001|Overall Study|Other|5|||
160490154|NCT01121185|579523891|FG000|Overall Study|Not infused|0|||
160490155|NCT01121185|579523892|FG001|Overall Study|Not infused|1|||
160490156|NCT01121185|579523891|FG000|Overall Study|Not transplanted|1|||
160490157|NCT01121185|579523892|FG001|Overall Study|Not transplanted|0|||
160490158|NCT01077622|579523893|FG000|Overall Study|Physician Decision|2|||
160490159|NCT01077622|579523893|FG000|Overall Study|Withdrawal by Subject|1|||
160490160|NCT01260142|579523894|FG000|Treatment Period 1|Study on hold|1|||
160490161|NCT01260142|579523895|FG001|Treatment Period 1|Study on hold|1|||
160490162|NCT01260142|579523896|FG002|Treatment Period 1|Study on hold|0|||
160490163|NCT01260142|579523897|FG003|Treatment Period 1|Study on hold|0|||
160490164|NCT01260142|579523898|FG004|Treatment Period 1|Study on hold|1|||
160490165|NCT01260142|579523899|FG005|Treatment Period 1|Study on hold|2|||
160490166|NCT01260142|579523894|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
160490167|NCT01260142|579523895|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
160490168|NCT01260142|579523896|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
160490169|NCT01260142|579523897|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
160490170|NCT01260142|579523898|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
160490171|NCT01260142|579523899|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
160490172|NCT01260142|579523894|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160490173|NCT01260142|579523895|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160490174|NCT01260142|579523896|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160490175|NCT01260142|579523897|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160490176|NCT01260142|579523898|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160490177|NCT01260142|579523899|FG005|Treatment Period 1|Withdrawal by Subject|1|||
160490178|NCT00424177|579523900|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
160490179|NCT00424177|579523900|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
160490180|NCT00424177|579523900|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
160490181|NCT00424177|579523900|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
160490182|NCT00424177|579523900|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
160490183|NCT00424177|579523900|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
160490184|NCT00424177|579523900|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
160490185|NCT00424177|579523900|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
160490186|NCT00424177|579523900|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
160490187|NCT00424177|579523900|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
160490188|NCT01091519|579523905|FG000|Overall Study|Adverse Event|12|||
160490189|NCT01091519|579523906|FG001|Overall Study|Adverse Event|16|||
160490190|NCT01091519|579523905|FG000|Overall Study|Death|1|||
160490191|NCT01091519|579523906|FG001|Overall Study|Death|0|||
160490192|NCT01091519|579523905|FG000|Overall Study|Lack of Efficacy|16|||
160490193|NCT01091519|579523906|FG001|Overall Study|Lack of Efficacy|19|||
160490194|NCT01091519|579523905|FG000|Overall Study|Lost to Follow-up|14|||
160490195|NCT01091519|579523906|FG001|Overall Study|Lost to Follow-up|24|||
160490196|NCT01091519|579523905|FG000|Overall Study|Withdrawal by Subject|2|||
160490197|NCT01091519|579523906|FG001|Overall Study|Withdrawal by Subject|2|||
160490198|NCT01091519|579523905|FG000|Overall Study|Other|6|||
160490199|NCT01091519|579523906|FG001|Overall Study|Other|8|||
160490200|NCT01091519|579523905|FG000|Overall Study|Randomized not treated|4|||
160490201|NCT01091519|579523906|FG001|Overall Study|Randomized not treated|4|||
160490202|NCT00496834|579523907|FG000|Overall Study|Withdrawal by Subject|4|||
160490203|NCT00496834|579523908|FG001|Overall Study|Withdrawal by Subject|6|||
160490204|NCT00496834|579523907|FG000|Overall Study|Contraindicated medication administered|0|||
160490205|NCT00496834|579523908|FG001|Overall Study|Contraindicated medication administered|1|||
160490206|NCT00496834|579523907|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
160490207|NCT00496834|579523908|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
160490208|NCT00496834|579523907|FG000|Overall Study|Adverse Event|5|||
160490209|NCT00496834|579523908|FG001|Overall Study|Adverse Event|3|||
160490210|NCT00496834|579523907|FG000|Overall Study|IP administration violation|2|||
160490211|NCT00496834|579523908|FG001|Overall Study|IP administration violation|0|||
160490212|NCT00496834|579523907|FG000|Overall Study|Lost to Follow-up|2|||
160490213|NCT00496834|579523908|FG001|Overall Study|Lost to Follow-up|0|||
160490214|NCT00496834|579523907|FG000|Overall Study|Blood Pressure control failure|2|||
160490215|NCT00496834|579523908|FG001|Overall Study|Blood Pressure control failure|1|||
160490216|NCT01227928|579523909|FG000|Overall Study|Lost to Follow-up|4|||
160490217|NCT01227928|579523910|FG001|Overall Study|Lost to Follow-up|2|||
160490218|NCT01227928|579523909|FG000|Overall Study|Withdrawal by Subject|4|||
160490219|NCT01227928|579523910|FG001|Overall Study|Withdrawal by Subject|3|||
160490220|NCT01227928|579523909|FG000|Overall Study|Death|14|||
160490221|NCT01227928|579523910|FG001|Overall Study|Death|12|||
160490222|NCT02930837|579523911|FG000|Overall Study|Adverse Event|6|||
160490223|NCT02930837|579523911|FG000|Overall Study|Lost to Follow-up|5|||
160490224|NCT02930837|579523911|FG000|Overall Study|Withdrawal by Subject|1|||
160490225|NCT01393613|579523912|FG000|Overall Study|Adverse Event|11|||
160490226|NCT01393613|579523913|FG001|Overall Study|Adverse Event|11|||
160490227|NCT01393613|579523914|FG002|Overall Study|Adverse Event|13|||
160490228|NCT01393613|579523915|FG003|Overall Study|Adverse Event|22|||
160490229|NCT01393613|579523912|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
160490230|NCT01393613|579523913|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
160490231|NCT01393613|579523914|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
160490232|NCT01393613|579523915|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
160490233|NCT01393613|579523912|FG000|Overall Study|Physician Decision|2|||
160490234|NCT01393613|579523913|FG001|Overall Study|Physician Decision|0|||
160490235|NCT01393613|579523914|FG002|Overall Study|Physician Decision|0|||
160490236|NCT01393613|579523915|FG003|Overall Study|Physician Decision|1|||
160490237|NCT01393613|579523912|FG000|Overall Study|Withdrawal by Subject|15|||
160490238|NCT01393613|579523913|FG001|Overall Study|Withdrawal by Subject|25|||
160490239|NCT01393613|579523914|FG002|Overall Study|Withdrawal by Subject|23|||
160490240|NCT01393613|579523915|FG003|Overall Study|Withdrawal by Subject|21|||
160490241|NCT01393613|579523912|FG000|Overall Study|Protocol Deviation|2|||
160490242|NCT01393613|579523913|FG001|Overall Study|Protocol Deviation|1|||
160490243|NCT01393613|579523914|FG002|Overall Study|Protocol Deviation|0|||
160490244|NCT01393613|579523915|FG003|Overall Study|Protocol Deviation|0|||
160490245|NCT01393613|579523912|FG000|Overall Study|Lack of Efficacy|9|||
160490246|NCT01393613|579523913|FG001|Overall Study|Lack of Efficacy|20|||
160490247|NCT01393613|579523914|FG002|Overall Study|Lack of Efficacy|16|||
160490248|NCT01393613|579523915|FG003|Overall Study|Lack of Efficacy|21|||
160490249|NCT01071317|579523918|FG000|Overall Study|Lost to Follow-up|2|||
160490250|NCT01071317|579523919|FG001|Overall Study|Lost to Follow-up|2|||
160490251|NCT00316589|579523920|FG000|Overall Study|Withdrawal by Subject|0|||
160490252|NCT00316589|579523921|FG001|Overall Study|Withdrawal by Subject|5|||
160490253|NCT00316589|579523922|FG002|Overall Study|Withdrawal by Subject|0|||
160490254|NCT00316589|579523923|FG003|Overall Study|Withdrawal by Subject|1|||
160490255|NCT00316589|579523920|FG000|Overall Study|Subject unwilling/unable to comply|0|||
160490256|NCT00316589|579523921|FG001|Overall Study|Subject unwilling/unable to comply|6|||
160490257|NCT00316589|579523922|FG002|Overall Study|Subject unwilling/unable to comply|0|||
160490258|NCT00316589|579523923|FG003|Overall Study|Subject unwilling/unable to comply|2|||
160490259|NCT00316589|579523920|FG000|Overall Study|Adverse Event|1|||
160490260|NCT00316589|579523921|FG001|Overall Study|Adverse Event|0|||
160490261|NCT00316589|579523922|FG002|Overall Study|Adverse Event|0|||
160490262|NCT00316589|579523923|FG003|Overall Study|Adverse Event|1|||
160490263|NCT00316589|579523920|FG000|Overall Study|Physician Decision|0|||
160490264|NCT00316589|579523921|FG001|Overall Study|Physician Decision|1|||
160490265|NCT00316589|579523922|FG002|Overall Study|Physician Decision|0|||
160490266|NCT00316589|579523923|FG003|Overall Study|Physician Decision|0|||
160490267|NCT00316589|579523920|FG000|Overall Study|Other reason|0|||
160490268|NCT00316589|579523921|FG001|Overall Study|Other reason|12|||
160490269|NCT00316589|579523922|FG002|Overall Study|Other reason|1|||
160490270|NCT00316589|579523923|FG003|Overall Study|Other reason|1|||
160490271|NCT00562484|579523929|FG000|Overall Study|Adverse Event|6|||
160490272|NCT00562484|579523930|FG001|Overall Study|Adverse Event|1|||
160490273|NCT00562484|579523929|FG000|Overall Study|Protocol Violation|11|||
160490274|NCT00562484|579523930|FG001|Overall Study|Protocol Violation|2|||
160490275|NCT00562484|579523929|FG000|Overall Study|Withdrawal by Subject|12|||
160490276|NCT00562484|579523930|FG001|Overall Study|Withdrawal by Subject|9|||
160490277|NCT00562484|579523929|FG000|Overall Study|Moved away from the study area|20|||
160490278|NCT00562484|579523930|FG001|Overall Study|Moved away from the study area|9|||
160490279|NCT00562484|579523929|FG000|Overall Study|Lost to Follow-up|132|||
160490280|NCT00562484|579523930|FG001|Overall Study|Lost to Follow-up|71|||
160490281|NCT00562484|579523929|FG000|Overall Study|Reason not provided or not specified|25|||
160490282|NCT00562484|579523930|FG001|Overall Study|Reason not provided or not specified|12|||
160490283|NCT02598934|579523934|FG000|Overall Study|Adverse Event|11|||
160490284|NCT02598934|579523935|FG001|Overall Study|Adverse Event|13|||
160490285|NCT02598934|579523934|FG000|Overall Study|Failure to Return|3|||
160490286|NCT02598934|579523935|FG001|Overall Study|Failure to Return|3|||
160490287|NCT02598934|579523934|FG000|Overall Study|Withdrawal by Subject|2|||
160490288|NCT02598934|579523935|FG001|Overall Study|Withdrawal by Subject|3|||
160490289|NCT02598934|579523934|FG000|Overall Study|Administrative|2|||
160490290|NCT02598934|579523935|FG001|Overall Study|Administrative|1|||
160490291|NCT02598934|579523934|FG000|Overall Study|Protocol Violation|1|||
160490292|NCT02598934|579523935|FG001|Overall Study|Protocol Violation|2|||
160490293|NCT02481934|579523936|FG000|Overall Study|Death|2|||
160490294|NCT02250183|579523939|FG000|Overall Study|Withdrawal by Subject|2|||
160490295|NCT02250183|579523939|FG000|Overall Study|Adverse Event|5|||
160490296|NCT02250183|579523939|FG000|Overall Study|Lost to Follow-up|1|||
160490297|NCT03749616|579523940|FG000|Overall Study|Lost to Follow-up|4|||
160490298|NCT03749616|579523941|FG001|Overall Study|Lost to Follow-up|7|||
160490299|NCT03749616|579523940|FG000|Overall Study|Screen Failure|1|||
160490300|NCT03749616|579523941|FG001|Overall Study|Screen Failure|1|||
160490301|NCT03749616|579523940|FG000|Overall Study|Withdrawal by Subject|2|||
160490302|NCT03749616|579523941|FG001|Overall Study|Withdrawal by Subject|0|||
160490303|NCT03302559|579523942|FG000|Overall Study|Adverse Event|2|||
160490304|NCT03302559|579523942|FG000|Overall Study|Lost to Follow-up|1|||
160490305|NCT03302559|579523942|FG000|Overall Study|Withdrew Consent|3|||
160490306|NCT01171183|579525501|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
160490307|NCT01171183|579525502|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
160490308|NCT01171183|579525501|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
160490309|NCT01171183|579525502|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
160490310|NCT01171183|579525501|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
160490311|NCT01171183|579525502|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
160490312|NCT01171183|579525501|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
160490313|NCT01171183|579525502|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
160490314|NCT01171183|579525501|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
160490315|NCT01171183|579525502|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
160490316|NCT01171183|579525501|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
160490317|NCT01171183|579525502|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
160490318|NCT03440047|579525507|FG000|Overall Study|Withdrawal by Subject|2|||
160490319|NCT01053247|579525508|FG000|Overall Study|Withdrawal by Subject|9|||
160490320|NCT01053247|579525509|FG001|Overall Study|Withdrawal by Subject|4|||
160490321|NCT01053247|579525510|FG002|Overall Study|Withdrawal by Subject|15|||
160490322|NCT01053247|579525508|FG000|Overall Study|Lack of Efficacy|1|||
160490323|NCT01053247|579525509|FG001|Overall Study|Lack of Efficacy|0|||
160490324|NCT01053247|579525510|FG002|Overall Study|Lack of Efficacy|1|||
160490325|NCT01053247|579525508|FG000|Overall Study|Protocol Violation|2|||
160490326|NCT01053247|579525509|FG001|Overall Study|Protocol Violation|1|||
160490327|NCT01053247|579525510|FG002|Overall Study|Protocol Violation|2|||
160490328|NCT01053247|579525508|FG000|Overall Study|Lost to Follow-up|8|||
160490329|NCT01053247|579525509|FG001|Overall Study|Lost to Follow-up|5|||
160490330|NCT01053247|579525510|FG002|Overall Study|Lost to Follow-up|7|||
160490331|NCT01053247|579525508|FG000|Overall Study|Adverse Event|0|||
160490332|NCT01053247|579525509|FG001|Overall Study|Adverse Event|9|||
160490333|NCT01053247|579525510|FG002|Overall Study|Adverse Event|3|||
160490334|NCT03458728|579525511|FG000|Overall Study|Adverse Event|1|||
160490335|NCT03458728|579525512|FG001|Overall Study|Adverse Event|0|||
160490336|NCT03458728|579525511|FG000|Overall Study|Physician Decision|1|||
160490337|NCT03458728|579525512|FG001|Overall Study|Physician Decision|0|||
160490338|NCT03458728|579525511|FG000|Overall Study|Progressive disease - clinical assessment|1|||
160490339|NCT03458728|579525512|FG001|Overall Study|Progressive disease - clinical assessment|0|||
160490340|NCT03458728|579525511|FG000|Overall Study|Progressive disease - radiological progression|21|||
160490341|NCT03458728|579525512|FG001|Overall Study|Progressive disease - radiological progression|6|||
160490342|NCT03458728|579525511|FG000|Overall Study|Withdrawal by Subject|0|||
160490343|NCT03458728|579525512|FG001|Overall Study|Withdrawal by Subject|1|||
160490344|NCT03898700|579525515|FG000|Overall Study|Withdrawal by Subject|2|||
160490345|NCT00701909|579525516|FG000|Overall Study|Withdrawal by Subject|0|||
160490346|NCT00701909|579525517|FG001|Overall Study|Withdrawal by Subject|1|||
160490347|NCT00908349|579525518|FG000|Overall Study|Adverse Event|10|||
160490348|NCT00908349|579525518|FG000|Overall Study|Withdrawal by Subject|9|||
160490349|NCT00908349|579525518|FG000|Overall Study|Physician Decision|5|||
160490350|NCT00908349|579525518|FG000|Overall Study|Lost to Follow-up|5|||
160490351|NCT00908349|579525518|FG000|Overall Study|Various|6|||
160490352|NCT04009629|579525522|FG000|Overall Study|Withdrawal by Subject|2|||
160490353|NCT04009629|579525523|FG001|Overall Study|Withdrawal by Subject|0|||
160490354|NCT03602586|579525526|FG000|Overall Study|Withdrawal by Subject|3|||
160490355|NCT00511836|579525531|FG000|Double-blind Period|Lost to Follow-up|1|||
160490356|NCT00511836|579525532|FG001|Double-blind Period|Lost to Follow-up|0|||
160490357|NCT00030823|579525533|FG000|Overall Study|Withdrawal by Subject|1|||
160490358|NCT01755546|579525535|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
160490359|NCT01755546|579525535|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
160490360|NCT01755546|579525535|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
160490361|NCT01755546|579525535|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
160490362|NCT01755546|579525535|FG000|Titration Phase|Adverse Event|11|||
160490363|NCT01755546|579525535|FG000|Titration Phase|Lack of Efficacy|18|||
160490364|NCT01755546|579525535|FG000|Titration Phase|Protocol Violation|9|||
160490365|NCT01755546|579525535|FG000|Titration Phase|Lost to Follow-up|2|||
160490366|NCT01755546|579525535|FG000|Titration Phase|Other and Continuing|22|||
160490367|NCT01755546|579525535|FG000|Titration Phase|Withdrawal by Subject|8|||
160490368|NCT01755546|579525535|FG000|Long Term Treatment|Adverse Event|12|||
160490369|NCT01755546|579525535|FG000|Long Term Treatment|Lack of Efficacy|6|||
160490370|NCT01755546|579525535|FG000|Long Term Treatment|Protocol Violation|10|||
160490371|NCT01755546|579525535|FG000|Long Term Treatment|Withdrawal by Subject|35|||
160490372|NCT01755546|579525535|FG000|Long Term Treatment|Lost to Follow-up|17|||
160490373|NCT01755546|579525535|FG000|Long Term Treatment|other and ongoing|41|||
160490374|NCT00891046|579525540|FG000|Overall Study|Protocol Violation|1|||
160490375|NCT00891046|579525541|FG001|Overall Study|Protocol Violation|1|||
160661319|NCT01149473|580144046|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
160661320|NCT02128997|580144047|FG000|Overall Study|Lost to Follow-up|6|||
160661321|NCT02128997|580144048|FG001|Overall Study|Lost to Follow-up|11|||
160661322|NCT04123548|580144049|FG000|Overall Study|Withdrawal by Subject|1|||
160661323|NCT04123548|580144049|FG000|Overall Study|Lost to Follow-up|8|||
160661324|NCT04123548|580144049|FG000|Overall Study|Death|4|||
160661325|NCT04123548|580144049|FG000|Overall Study|Reason Not Specified|1|||
160661326|NCT00418184|580144050|FG000|Double-blind Phase|Withdrawal by Subject|22|||
160661327|NCT00418184|580144051|FG001|Double-blind Phase|Withdrawal by Subject|9|||
160661328|NCT00418184|580144050|FG000|Double-blind Phase|Adverse Event|2|||
160661329|NCT00418184|580144051|FG001|Double-blind Phase|Adverse Event|1|||
160661330|NCT00418184|580144050|FG000|Double-blind Phase|Poor compliance|3|||
160661331|NCT00418184|580144051|FG001|Double-blind Phase|Poor compliance|1|||
160661332|NCT00620074|580144052|FG000|Overall Study|Adverse Event|1|||
160661333|NCT04112823|580144056|FG000|Overall Study|Lost to Follow-up|2|||
160661334|NCT04112823|580144057|FG001|Overall Study|Lost to Follow-up|3|||
160661335|NCT00436553|580144060|FG000|Overall Study|Adverse Event|4|||
160661336|NCT00436553|580144061|FG001|Overall Study|Adverse Event|3|||
160661337|NCT00436553|580144062|FG002|Overall Study|Adverse Event|4|||
160661338|NCT00436553|580144060|FG000|Overall Study|Death|3|||
160661339|NCT00436553|580144061|FG001|Overall Study|Death|1|||
160661340|NCT00436553|580144062|FG002|Overall Study|Death|3|||
160661341|NCT00436553|580144060|FG000|Overall Study|Lost to Follow-up|0|||
160661342|NCT00436553|580144061|FG001|Overall Study|Lost to Follow-up|2|||
160661343|NCT00436553|580144062|FG002|Overall Study|Lost to Follow-up|0|||
160661344|NCT00436553|580144060|FG000|Overall Study|Protocol Violation|1|||
160661345|NCT00436553|580144061|FG001|Overall Study|Protocol Violation|0|||
160661346|NCT00436553|580144062|FG002|Overall Study|Protocol Violation|0|||
160661347|NCT00436553|580144060|FG000|Overall Study|Withdrawal by Subject|5|||
160661348|NCT00436553|580144061|FG001|Overall Study|Withdrawal by Subject|6|||
160661349|NCT00436553|580144062|FG002|Overall Study|Withdrawal by Subject|3|||
160661350|NCT00625443|580144071|FG000|Overall Study|Adverse Event|1|||
160490376|NCT00891046|579525542|FG002|Overall Study|Protocol Violation|0|||
160490377|NCT00891046|579525543|FG003|Overall Study|Protocol Violation|0|||
160490378|NCT00891046|579525544|FG004|Overall Study|Protocol Violation|1|||
160490379|NCT00891046|579525540|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
160490380|NCT00891046|579525541|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160490381|NCT00891046|579525542|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
160490382|NCT00891046|579525543|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
160490383|NCT00891046|579525544|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
160490384|NCT00891046|579525540|FG000|Overall Study|Administrative problems|0|||
160661351|NCT00625443|580144072|FG001|Overall Study|Adverse Event|4|||
160661352|NCT00625443|580144073|FG002|Overall Study|Adverse Event|0|||
160661353|NCT00625443|580144071|FG000|Overall Study|Non-compliance with protocol|0|||
160661354|NCT00625443|580144072|FG001|Overall Study|Non-compliance with protocol|1|||
160610978|NCT01947894|579952313|FG002|Overall Study|Physician Decision|0|||
160610979|NCT01947894|579952311|FG000|Overall Study|Adverse Event|5|||
160610980|NCT01947894|579952312|FG001|Overall Study|Adverse Event|1|||
160610981|NCT01947894|579952313|FG002|Overall Study|Adverse Event|0|||
160610982|NCT01947894|579952311|FG000|Overall Study|Switched to other growth hormone brand|53|||
160610983|NCT01947894|579952312|FG001|Overall Study|Switched to other growth hormone brand|8|||
160610984|NCT01947894|579952313|FG002|Overall Study|Switched to other growth hormone brand|23|||
160610985|NCT01039428|579952314|FG000|Overall Study|Protocol Violation|1|||
160610986|NCT01039428|579952315|FG001|Overall Study|Protocol Violation|0|||
160610987|NCT01039428|579952314|FG000|Overall Study|Withdrawal by Subject|1|||
160610988|NCT01039428|579952315|FG001|Overall Study|Withdrawal by Subject|0|||
160610989|NCT01313039|579952316|FG000|Overall Study|Physician Decision|1|||
160610990|NCT01313039|579952316|FG000|Overall Study|Adverse Event|1|||
160610991|NCT01678560|579952319|FG000|Overall Study|Physician Decision|4|||
160610992|NCT01678560|579952320|FG001|Overall Study|Physician Decision|4|||
160610993|NCT01678560|579952319|FG000|Overall Study|Death|0|||
160610994|NCT01678560|579952320|FG001|Overall Study|Death|1|||
160610995|NCT01678560|579952319|FG000|Overall Study|Withdrawal by Subject|0|||
160610996|NCT01678560|579952320|FG001|Overall Study|Withdrawal by Subject|1|||
160610997|NCT02201472|579952321|FG000|Overall Study|Lack of Efficacy|2|||
160610998|NCT01300767|579952322|FG000|Overall Study|Discomfort|2|||
160610999|NCT01300767|579952322|FG000|Overall Study|Biomicroscopy|1|||
160611000|NCT01300767|579952322|FG000|Overall Study|Unacceptable fit|1|||
160611001|NCT01188811|579952327|FG000|Overall Study|Withdrawal by Subject|0|||
160611002|NCT01188811|579952328|FG001|Overall Study|Withdrawal by Subject|2|||
160611003|NCT01188811|579952327|FG000|Overall Study|Adverse Event|6|||
160611004|NCT01188811|579952328|FG001|Overall Study|Adverse Event|0|||
160611005|NCT01602744|579952329|FG000|Overall Study|Death|17|||
160611006|NCT01602744|579952330|FG001|Overall Study|Death|15|||
160611007|NCT01602744|579952329|FG000|Overall Study|Lost to Follow-up|13|||
160611008|NCT01602744|579952330|FG001|Overall Study|Lost to Follow-up|8|||
160490385|NCT00891046|579525541|FG001|Overall Study|Administrative problems|0|||
160490386|NCT00891046|579525542|FG002|Overall Study|Administrative problems|0|||
160490387|NCT00891046|579525543|FG003|Overall Study|Administrative problems|0|||
160490388|NCT00891046|579525544|FG004|Overall Study|Administrative problems|1|||
160490389|NCT00891046|579525540|FG000|Overall Study|Participant no longer required drug|0|||
160490390|NCT00891046|579525541|FG001|Overall Study|Participant no longer required drug|2|||
160490391|NCT00891046|579525542|FG002|Overall Study|Participant no longer required drug|0|||
160490392|NCT00891046|579525543|FG003|Overall Study|Participant no longer required drug|0|||
160490393|NCT00891046|579525544|FG004|Overall Study|Participant no longer required drug|1|||
160490394|NCT00891046|579525540|FG000|Overall Study|Adverse Event|4|||
160490395|NCT00891046|579525541|FG001|Overall Study|Adverse Event|3|||
160490396|NCT00891046|579525542|FG002|Overall Study|Adverse Event|2|||
160490397|NCT00891046|579525543|FG003|Overall Study|Adverse Event|0|||
160490398|NCT00891046|579525544|FG004|Overall Study|Adverse Event|14|||
160490399|NCT00891046|579525540|FG000|Overall Study|Withdrawal by Subject|2|||
160490400|NCT00891046|579525541|FG001|Overall Study|Withdrawal by Subject|1|||
160490401|NCT00891046|579525542|FG002|Overall Study|Withdrawal by Subject|2|||
160490402|NCT00891046|579525543|FG003|Overall Study|Withdrawal by Subject|1|||
160490403|NCT00891046|579525544|FG004|Overall Study|Withdrawal by Subject|1|||
160490404|NCT00891046|579525540|FG000|Overall Study|Lost to Follow-up|0|||
160490405|NCT00891046|579525541|FG001|Overall Study|Lost to Follow-up|0|||
160490406|NCT00891046|579525542|FG002|Overall Study|Lost to Follow-up|0|||
160490407|NCT00891046|579525543|FG003|Overall Study|Lost to Follow-up|0|||
160490408|NCT00891046|579525544|FG004|Overall Study|Lost to Follow-up|1|||
160490409|NCT00362375|579525545|FG000|Overall Study|Lost to Follow-up|40|||
160490410|NCT00362375|579525546|FG001|Overall Study|Lost to Follow-up|35|||
160490411|NCT04984239|579525547|FG000|Overall Study|Lost to Follow-up|1|||
160490412|NCT04702893|579525548|FG000|Overall Study|Other reasons than listed|11|||
160490413|NCT04702893|579525548|FG000|Overall Study|Withdrawal by Subject|3|||
160611009|NCT00654368|579952331|FG000|Overall Study|Ineligibility determined|6|||
160611010|NCT00654368|579952332|FG001|Overall Study|Ineligibility determined|0|||
160611011|NCT00654368|579952333|FG002|Overall Study|Ineligibility determined|0|||
160611012|NCT00654368|579952331|FG000|Overall Study|Protocol deviation|3|||
160611013|NCT00654368|579952332|FG001|Overall Study|Protocol deviation|2|||
160611014|NCT00654368|579952333|FG002|Overall Study|Protocol deviation|1|||
160611015|NCT00654368|579952331|FG000|Overall Study|Non-compliance|2|||
160611016|NCT00654368|579952332|FG001|Overall Study|Non-compliance|1|||
160490414|NCT04702893|579525548|FG000|Overall Study|Lost to Follow-up|7|||
160490415|NCT04702893|579525548|FG000|Overall Study|Death|10|||
160490416|NCT04702893|579525548|FG000|Overall Study|Not treated|6|||
160490417|NCT01951378|579525549|FG000|Overall Study|Study Terminated-Not completed|23|||
160490418|NCT01951378|579525550|FG001|Overall Study|Study Terminated-Not completed|17|||
160490419|NCT00634842|579525551|FG000|Overall Study|Adverse Event|2|||
160490420|NCT00634842|579525552|FG001|Overall Study|Adverse Event|3|||
160490421|NCT00634842|579525551|FG000|Overall Study|Protocol Violation|8|||
160611017|NCT00654368|579952333|FG002|Overall Study|Non-compliance|2|||
160611018|NCT00654368|579952331|FG000|Overall Study|Withdrawal by Subject|5|||
160490422|NCT00634842|579525552|FG001|Overall Study|Protocol Violation|4|||
160490423|NCT00634842|579525551|FG000|Overall Study|Move to another state|1|||
160490424|NCT00634842|579525552|FG001|Overall Study|Move to another state|0|||
160490425|NCT00634842|579525551|FG000|Overall Study|Inclusion criteria were not met|1|||
160490426|NCT00634842|579525552|FG001|Overall Study|Inclusion criteria were not met|0|||
160490427|NCT00634842|579525551|FG000|Overall Study|Lost to Follow-up|1|||
160490428|NCT00634842|579525552|FG001|Overall Study|Lost to Follow-up|2|||
160490429|NCT00634842|579525551|FG000|Overall Study|Physician Decision|1|||
160490430|NCT00634842|579525552|FG001|Overall Study|Physician Decision|0|||
160490431|NCT00634842|579525551|FG000|Overall Study|Withdrawal by Subject|1|||
160490432|NCT00634842|579525552|FG001|Overall Study|Withdrawal by Subject|3|||
160490433|NCT00634842|579525551|FG000|Overall Study|Lack of time and intolerance to drug|0|||
160490434|NCT00634842|579525552|FG001|Overall Study|Lack of time and intolerance to drug|1|||
160490435|NCT00634842|579525551|FG000|Overall Study|Discontinued due to injection|0|||
160490436|NCT00634842|579525552|FG001|Overall Study|Discontinued due to injection|2|||
160490437|NCT00634842|579525551|FG000|Overall Study|No need of study drug to treat diabetes|0|||
160490438|NCT00634842|579525552|FG001|Overall Study|No need of study drug to treat diabetes|1|||
160490439|NCT00634842|579525551|FG000|Overall Study|No wish to keep taking Avandia|0|||
160490440|NCT00634842|579525552|FG001|Overall Study|No wish to keep taking Avandia|1|||
160490441|NCT00634842|579525551|FG000|Overall Study|Subject off study drug for too long|0|||
160490442|NCT00634842|579525552|FG001|Overall Study|Subject off study drug for too long|1|||
160490443|NCT04629443|579525553|FG000|Overall Study|Adverse Event|2|||
160490444|NCT04629443|579525554|FG001|Overall Study|Adverse Event|1|||
160490445|NCT04629443|579525555|FG002|Overall Study|Adverse Event|2|||
160490446|NCT04629443|579525553|FG000|Overall Study|Progressive Disease|2|||
160490447|NCT04629443|579525554|FG001|Overall Study|Progressive Disease|3|||
160490448|NCT04629443|579525555|FG002|Overall Study|Progressive Disease|3|||
160490449|NCT04629443|579525553|FG000|Overall Study|Physician Decision|1|||
160490450|NCT04629443|579525554|FG001|Overall Study|Physician Decision|3|||
160490451|NCT04629443|579525555|FG002|Overall Study|Physician Decision|0|||
160490452|NCT01844726|579525561|FG000|Overall Study|Withdrawal by Subject|0|||
160490453|NCT01844726|579525562|FG001|Overall Study|Withdrawal by Subject|1|||
160490454|NCT01844726|579525561|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
160490455|NCT01844726|579525562|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
160490456|NCT00858247|579525567|FG000|Baseline Assessment|Withdrawal by Subject|1|||
160490457|NCT00858247|579525568|FG001|Baseline Assessment|Withdrawal by Subject|1|||
160490458|NCT00858247|579525567|FG000|Baseline Assessment|Poor IV access|1|||
160490459|NCT00858247|579525568|FG001|Baseline Assessment|Poor IV access|0|||
160490460|NCT00858247|579525567|FG000|Baseline Assessment|Protocol Violation|0|||
160490461|NCT00858247|579525568|FG001|Baseline Assessment|Protocol Violation|1|||
160490462|NCT00858247|579525567|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
160490463|NCT00858247|579525568|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
160490464|NCT01379703|579525569|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
160490465|NCT01379703|579525570|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
160490466|NCT01379703|579525571|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
160490467|NCT01379703|579525569|FG000|Study Start Through 9 Months|Adverse Event|0|||
160490468|NCT01379703|579525570|FG001|Study Start Through 9 Months|Adverse Event|14|||
160490469|NCT01379703|579525571|FG002|Study Start Through 9 Months|Adverse Event|10|||
160490470|NCT01379703|579525569|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
160490471|NCT01379703|579525570|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
160490472|NCT01379703|579525571|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
160490473|NCT01379703|579525569|FG000|Study Start Through 9 Months|Treatment Failure|0|||
160490474|NCT01379703|579525570|FG001|Study Start Through 9 Months|Treatment Failure|2|||
160490475|NCT01379703|579525571|FG002|Study Start Through 9 Months|Treatment Failure|2|||
160490476|NCT01379703|579525569|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
160490477|NCT01379703|579525570|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
160490478|NCT01379703|579525571|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
160490479|NCT01379703|579525569|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
160490480|NCT01379703|579525570|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
160490481|NCT01379703|579525571|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
160490482|NCT01379703|579525569|FG000|Study Start Through 9 Months|Medication not available|0|||
160490483|NCT01379703|579525570|FG001|Study Start Through 9 Months|Medication not available|2|||
160490484|NCT01379703|579525571|FG002|Study Start Through 9 Months|Medication not available|1|||
160490485|NCT01379703|579525569|FG000|Study Start Through 9 Months|Poor general condition|0|||
160490486|NCT01379703|579525570|FG001|Study Start Through 9 Months|Poor general condition|1|||
160490487|NCT01379703|579525571|FG002|Study Start Through 9 Months|Poor general condition|0|||
160490488|NCT01379703|579525569|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
160490489|NCT01379703|579525570|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
160490490|NCT01379703|579525571|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
160490491|NCT01379703|579525569|FG000|Study Start Through 9 Months|Reason unknown|2|||
160490492|NCT01379703|579525570|FG001|Study Start Through 9 Months|Reason unknown|31|||
160611019|NCT00654368|579952332|FG001|Overall Study|Withdrawal by Subject|2|||
160611020|NCT00654368|579952333|FG002|Overall Study|Withdrawal by Subject|2|||
160611021|NCT00654368|579952331|FG000|Overall Study|Disease progression|21|||
160611022|NCT00654368|579952332|FG001|Overall Study|Disease progression|31|||
160611023|NCT00654368|579952333|FG002|Overall Study|Disease progression|13|||
160611024|NCT00654368|579952331|FG000|Overall Study|Requirement for alternative therapy|1|||
160611025|NCT00654368|579952332|FG001|Overall Study|Requirement for alternative therapy|1|||
160611026|NCT00654368|579952333|FG002|Overall Study|Requirement for alternative therapy|1|||
160611027|NCT00654368|579952331|FG000|Overall Study|Physician Decision|0|||
160611028|NCT00654368|579952332|FG001|Overall Study|Physician Decision|0|||
160611029|NCT00654368|579952333|FG002|Overall Study|Physician Decision|2|||
160611030|NCT00654368|579952331|FG000|Overall Study|Death|1|||
160611031|NCT00654368|579952332|FG001|Overall Study|Death|0|||
160611032|NCT00654368|579952333|FG002|Overall Study|Death|0|||
160611033|NCT00654368|579952331|FG000|Overall Study|Pregnancy|0|||
160611034|NCT00654368|579952332|FG001|Overall Study|Pregnancy|0|||
160611035|NCT00654368|579952333|FG002|Overall Study|Pregnancy|2|||
160611036|NCT00654368|579952331|FG000|Overall Study|Other|0|||
160611037|NCT00654368|579952332|FG001|Overall Study|Other|2|||
160611038|NCT00654368|579952333|FG002|Overall Study|Other|3|||
160611039|NCT00654368|579952331|FG000|Overall Study|Adverse Event|14|||
160611040|NCT00654368|579952332|FG001|Overall Study|Adverse Event|9|||
160611041|NCT00654368|579952333|FG002|Overall Study|Adverse Event|6|||
160611042|NCT00606294|579952334|FG000|Overall Study|Withdrawal by Subject|36|||
160611043|NCT00606294|579952335|FG001|Overall Study|Withdrawal by Subject|0|||
160611044|NCT03924427|579952336|FG000|Overall Study|Adverse Event|4|||
160611045|NCT03924427|579952336|FG000|Overall Study|Lack of Efficacy|1|||
160611046|NCT03924427|579952336|FG000|Overall Study|Withdrawal by Subject|1|||
160611047|NCT01388491|579952341|FG000|Overall Study|Adverse Event|10|||
160611048|NCT01388491|579952342|FG001|Overall Study|Adverse Event|9|||
160611049|NCT01388491|579952341|FG000|Overall Study|Sponsor Request|9|||
160611050|NCT01388491|579952342|FG001|Overall Study|Sponsor Request|7|||
160611051|NCT01388491|579952341|FG000|Overall Study|Withdrawal by Subject|6|||
160611052|NCT01388491|579952342|FG001|Overall Study|Withdrawal by Subject|10|||
160611053|NCT01388491|579952341|FG000|Overall Study|Lost to Follow-up|4|||
160611054|NCT01388491|579952342|FG001|Overall Study|Lost to Follow-up|3|||
160611055|NCT01388491|579952341|FG000|Overall Study|Protocol Violation|2|||
160611056|NCT01388491|579952342|FG001|Overall Study|Protocol Violation|0|||
160611057|NCT01388491|579952341|FG000|Overall Study|Noncompliance|2|||
160611058|NCT01388491|579952342|FG001|Overall Study|Noncompliance|0|||
160611059|NCT01388491|579952341|FG000|Overall Study|Pregnancy|1|||
160611060|NCT01388491|579952342|FG001|Overall Study|Pregnancy|0|||
160611061|NCT04035473|579952344|FG000|Screening/Baseline|Death|0|||
160611062|NCT04035473|579952345|FG001|Screening/Baseline|Death|1|||
160611063|NCT04035473|579952344|FG000|Screening/Baseline|Adverse Event|0|||
160611064|NCT04035473|579952345|FG001|Screening/Baseline|Adverse Event|1|||
160611065|NCT04035473|579952344|FG000|Follow-up Period|Adverse Event|2|||
160611066|NCT04035473|579952345|FG001|Follow-up Period|Adverse Event|0|||
160611067|NCT00412113|579952346|FG000|Overall Study|Adverse Event|11|||
160611068|NCT00412113|579952347|FG001|Overall Study|Adverse Event|15|||
160611069|NCT00412113|579952346|FG000|Overall Study|did not receive treatment|1|||
160611070|NCT00412113|579952347|FG001|Overall Study|did not receive treatment|0|||
160611071|NCT01201967|579952348|FG000|Overall Study|Lost to Follow-up|6|||
160611072|NCT01201967|579952349|FG001|Overall Study|Lost to Follow-up|5|||
160611073|NCT00796224|579952350|FG000|Overall Study|Adverse Event|1|||
160611074|NCT00796224|579952351|FG001|Overall Study|Adverse Event|0|||
160611075|NCT00796224|579952350|FG000|Overall Study|Protocol Violation|0|||
160611076|NCT00796224|579952351|FG001|Overall Study|Protocol Violation|1|||
160490493|NCT01379703|579525571|FG002|Study Start Through 9 Months|Reason unknown|24|||
160490494|NCT01379703|579525569|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
160490495|NCT01379703|579525570|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
160490496|NCT01379703|579525571|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
160490497|NCT01379703|579525569|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
160611077|NCT01592773|579953987|FG000|Overall Study|Study Terminated by Sponsor|582|||
160611078|NCT01592773|579953987|FG000|Overall Study|Withdrawal by Subject|35|||
160611079|NCT01592773|579953987|FG000|Overall Study|Lost to Follow-up|19|||
160611080|NCT01592773|579953987|FG000|Overall Study|Adverse Event|17|||
160611081|NCT01592773|579953987|FG000|Overall Study|Lack of Efficacy|9|||
160611082|NCT01592773|579953987|FG000|Overall Study|Protocol Violation|2|||
160611083|NCT01592773|579953987|FG000|Overall Study|Inclusion/exclusion not meet|1|||
160611084|NCT01592773|579953987|FG000|Overall Study|Other Reason|1|||
160611085|NCT00121485|579953988|FG000|Overall Study|Not implanted|1|||
160611086|NCT00121485|579953989|FG001|Overall Study|Not implanted|5|||
160611087|NCT00121485|579953988|FG000|Overall Study|Crossover|0|||
160611088|NCT00121485|579953989|FG001|Overall Study|Crossover|2|||
160611089|NCT02425891|579953990|FG000|Overall Study|Death|333|||
160611090|NCT02425891|579953991|FG001|Overall Study|Death|314|||
160611091|NCT02425891|579953990|FG000|Overall Study|Lost to Follow-up|4|||
160611092|NCT02425891|579953991|FG001|Overall Study|Lost to Follow-up|6|||
160611093|NCT02425891|579953990|FG000|Overall Study|Non-Compliance|1|||
160490498|NCT01379703|579525570|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
160490499|NCT01379703|579525571|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
160490500|NCT01379703|579525569|FG000|9 Months Through 18 Months|Adverse Event|0|||
160490501|NCT01379703|579525570|FG001|9 Months Through 18 Months|Adverse Event|6|||
160490502|NCT01379703|579525571|FG002|9 Months Through 18 Months|Adverse Event|0|||
160490503|NCT01379703|579525569|FG000|9 Months Through 18 Months|Treatment failure|0|||
160490504|NCT01379703|579525570|FG001|9 Months Through 18 Months|Treatment failure|5|||
160490505|NCT01379703|579525571|FG002|9 Months Through 18 Months|Treatment failure|0|||
160490506|NCT01379703|579525569|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
160490507|NCT01379703|579525570|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
160490508|NCT01379703|579525571|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
160490509|NCT01379703|579525569|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
160490510|NCT01379703|579525570|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
160490511|NCT01379703|579525571|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
160490512|NCT01379703|579525569|FG000|9 Months Through 18 Months|Fatigue|0|||
160490513|NCT01379703|579525570|FG001|9 Months Through 18 Months|Fatigue|1|||
160490514|NCT01379703|579525571|FG002|9 Months Through 18 Months|Fatigue|0|||
160490515|NCT01379703|579525569|FG000|9 Months Through 18 Months|Reason Unknown|0|||
160490516|NCT01379703|579525570|FG001|9 Months Through 18 Months|Reason Unknown|23|||
160490517|NCT01379703|579525571|FG002|9 Months Through 18 Months|Reason Unknown|0|||
160490518|NCT03481556|579525572|FG000|Overall Study|Adverse Event|1|||
160490519|NCT03481556|579525573|FG001|Overall Study|Adverse Event|0|||
160490520|NCT03481556|579525574|FG002|Overall Study|Adverse Event|0|||
160490521|NCT03481556|579525575|FG003|Overall Study|Adverse Event|0|||
160490522|NCT03481556|579525572|FG000|Overall Study|Death|4|||
160490523|NCT03481556|579525573|FG001|Overall Study|Death|2|||
160490524|NCT03481556|579525574|FG002|Overall Study|Death|3|||
160490525|NCT03481556|579525575|FG003|Overall Study|Death|16|||
160490526|NCT03481556|579525572|FG000|Overall Study|Study Terminated by Sponsor|10|||
160490527|NCT03481556|579525573|FG001|Overall Study|Study Terminated by Sponsor|5|||
160490528|NCT03481556|579525574|FG002|Overall Study|Study Terminated by Sponsor|2|||
160490529|NCT03481556|579525575|FG003|Overall Study|Study Terminated by Sponsor|9|||
160490530|NCT01172639|579525576|FG000|Overall Study|Death|1|||
160490531|NCT01172639|579525577|FG001|Overall Study|Death|1|||
160490532|NCT01172639|579525578|FG002|Overall Study|Death|0|||
160490533|NCT01172639|579525579|FG003|Overall Study|Death|0|||
160490534|NCT01172639|579525580|FG004|Overall Study|Death|0|||
160490535|NCT01172639|579525576|FG000|Overall Study|Lost to Follow-up|9|||
160490536|NCT01172639|579525577|FG001|Overall Study|Lost to Follow-up|7|||
160490537|NCT01172639|579525578|FG002|Overall Study|Lost to Follow-up|11|||
160490538|NCT01172639|579525579|FG003|Overall Study|Lost to Follow-up|6|||
160490539|NCT01172639|579525580|FG004|Overall Study|Lost to Follow-up|6|||
160490540|NCT01172639|579525576|FG000|Overall Study|Withdrawal by Subject|3|||
160490541|NCT01172639|579525577|FG001|Overall Study|Withdrawal by Subject|3|||
160490542|NCT01172639|579525578|FG002|Overall Study|Withdrawal by Subject|5|||
160490543|NCT01172639|579525579|FG003|Overall Study|Withdrawal by Subject|5|||
160490544|NCT01172639|579525580|FG004|Overall Study|Withdrawal by Subject|0|||
160490545|NCT01316887|579525581|FG000|Overall Study|Adverse Event|13|||
160490546|NCT01316887|579525582|FG001|Overall Study|Adverse Event|21|||
160490547|NCT01316887|579525583|FG002|Overall Study|Adverse Event|17|||
160490548|NCT01316887|579525581|FG000|Overall Study|Lack of Efficacy|9|||
160490549|NCT01316887|579525582|FG001|Overall Study|Lack of Efficacy|3|||
160490550|NCT01316887|579525583|FG002|Overall Study|Lack of Efficacy|1|||
160490551|NCT01316887|579525581|FG000|Overall Study|Protocol Violation|2|||
160490552|NCT01316887|579525582|FG001|Overall Study|Protocol Violation|6|||
160490553|NCT01316887|579525583|FG002|Overall Study|Protocol Violation|6|||
160490554|NCT01316887|579525581|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
160490555|NCT01316887|579525582|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
160490556|NCT01316887|579525583|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
160490557|NCT01316887|579525581|FG000|Overall Study|Study Closed/Terminated|2|||
160490558|NCT01316887|579525582|FG001|Overall Study|Study Closed/Terminated|4|||
160490559|NCT01316887|579525583|FG002|Overall Study|Study Closed/Terminated|3|||
160490560|NCT01316887|579525581|FG000|Overall Study|Lost to Follow-up|1|||
160490561|NCT01316887|579525582|FG001|Overall Study|Lost to Follow-up|7|||
160490562|NCT01316887|579525583|FG002|Overall Study|Lost to Follow-up|5|||
160490563|NCT01316887|579525581|FG000|Overall Study|Withdrawal by Subject|8|||
160490564|NCT01316887|579525582|FG001|Overall Study|Withdrawal by Subject|16|||
160490565|NCT01316887|579525583|FG002|Overall Study|Withdrawal by Subject|15|||
160490566|NCT02172950|579525584|FG000|Overall Study|Physician Decision|3|||
160490567|NCT02172950|579525585|FG001|Overall Study|Physician Decision|3|||
160490568|NCT02172950|579525584|FG000|Overall Study|Lack of Efficacy|1|||
160490569|NCT02172950|579525585|FG001|Overall Study|Lack of Efficacy|0|||
160490570|NCT02172950|579525584|FG000|Overall Study|Adverse Event|4|||
160490571|NCT02172950|579525585|FG001|Overall Study|Adverse Event|1|||
160490572|NCT02172950|579525584|FG000|Overall Study|Withdrawal by Subject|10|||
160490573|NCT02172950|579525585|FG001|Overall Study|Withdrawal by Subject|0|||
160490574|NCT02172950|579525584|FG000|Overall Study|Protocol Violation|1|||
160611094|NCT02425891|579953991|FG001|Overall Study|Non-Compliance|1|||
160611095|NCT02425891|579953990|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
160611096|NCT02425891|579953991|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
160611097|NCT02425891|579953990|FG000|Overall Study|Physician Decision|0|||
160611098|NCT02425891|579953991|FG001|Overall Study|Physician Decision|1|||
160611099|NCT02425891|579953990|FG000|Overall Study|Protocol Violation|1|||
160611100|NCT02425891|579953991|FG001|Overall Study|Protocol Violation|1|||
160611101|NCT02425891|579953990|FG000|Overall Study|Study Terminated By Sponsor|85|||
160611102|NCT02425891|579953991|FG001|Overall Study|Study Terminated By Sponsor|95|||
160611103|NCT02425891|579953990|FG000|Overall Study|Withdrawal by Subject|27|||
160611104|NCT02425891|579953991|FG001|Overall Study|Withdrawal by Subject|32|||
160611105|NCT04124952|579953992|FG000|Overall Study|Lost to Follow-up|1|||
160611106|NCT03763942|579953993|FG000|Overall Study|Lost to Follow-up|114|||
160611107|NCT03763942|579953994|FG001|Overall Study|Lost to Follow-up|54|||
160611108|NCT03763942|579953993|FG000|Overall Study|Protocol Violation|1|||
160611109|NCT03763942|579953994|FG001|Overall Study|Protocol Violation|0|||
160611110|NCT03763942|579953993|FG000|Overall Study|Withdrawal by Subject|2|||
160611111|NCT03763942|579953994|FG001|Overall Study|Withdrawal by Subject|0|||
160611112|NCT03763942|579953993|FG000|Overall Study|Other|2|||
160611113|NCT03763942|579953994|FG001|Overall Study|Other|3|||
160611114|NCT02943577|579953997|FG000|Overall Study|Protocol Violation|0|||
160611115|NCT02943577|579953998|FG001|Overall Study|Protocol Violation|1|||
160611116|NCT02943577|579953997|FG000|Overall Study|Adverse Event|3|||
160611117|NCT02943577|579953998|FG001|Overall Study|Adverse Event|2|||
160611118|NCT02943577|579953997|FG000|Overall Study|Lost to Follow-up|0|||
160611119|NCT02943577|579953998|FG001|Overall Study|Lost to Follow-up|1|||
160611120|NCT02943577|579953997|FG000|Overall Study|Withdrawal by Subject|1|||
160611121|NCT02943577|579953998|FG001|Overall Study|Withdrawal by Subject|1|||
160611122|NCT02943577|579953997|FG000|Overall Study|Pregnancy|1|||
160611123|NCT02943577|579953998|FG001|Overall Study|Pregnancy|0|||
160611124|NCT03070119|579954002|FG000|Overall Study|Adverse Event|0|||
160611125|NCT03070119|579954003|FG001|Overall Study|Adverse Event|0|||
160611126|NCT03070119|579954004|FG002|Overall Study|Adverse Event|1|||
160611127|NCT03070119|579954002|FG000|Overall Study|Lost to Follow-up|0|||
160611128|NCT03070119|579954003|FG001|Overall Study|Lost to Follow-up|1|||
160611129|NCT03070119|579954004|FG002|Overall Study|Lost to Follow-up|0|||
160611130|NCT03070119|579954002|FG000|Overall Study|Consent Withdrawn|6|||
160611131|NCT03070119|579954003|FG001|Overall Study|Consent Withdrawn|5|||
160611132|NCT03070119|579954004|FG002|Overall Study|Consent Withdrawn|3|||
160611133|NCT03070119|579954002|FG000|Overall Study|Investigator Decision|0|||
160611134|NCT03070119|579954003|FG001|Overall Study|Investigator Decision|0|||
160611135|NCT03070119|579954004|FG002|Overall Study|Investigator Decision|1|||
160611136|NCT03070119|579954002|FG000|Overall Study|Death|7|||
160611137|NCT03070119|579954003|FG001|Overall Study|Death|14|||
160611138|NCT03070119|579954004|FG002|Overall Study|Death|5|||
160611139|NCT03070119|579954002|FG000|Overall Study|Disease Progression|5|||
160611140|NCT03070119|579954003|FG001|Overall Study|Disease Progression|7|||
160611141|NCT03070119|579954004|FG002|Overall Study|Disease Progression|7|||
160611142|NCT03070119|579954002|FG000|Overall Study|Reason not Specified|2|||
160611143|NCT03070119|579954003|FG001|Overall Study|Reason not Specified|2|||
160611144|NCT03070119|579954004|FG002|Overall Study|Reason not Specified|1|||
160611145|NCT01996865|579954005|FG000|Induction Period|Protocol Violation|1|||
160611146|NCT01996865|579954006|FG001|Induction Period|Protocol Violation|0|||
160611147|NCT01996865|579954007|FG002|Induction Period|Protocol Violation|0|||
160611148|NCT01996865|579954005|FG000|Induction Period|Progressive Disease|4|||
160611149|NCT01996865|579954006|FG001|Induction Period|Progressive Disease|0|||
160611150|NCT01996865|579954007|FG002|Induction Period|Progressive Disease|0|||
160611151|NCT01996865|579954005|FG000|Induction Period|Lost to Follow-up|10|||
160611152|NCT01996865|579954006|FG001|Induction Period|Lost to Follow-up|0|||
160611153|NCT01996865|579954007|FG002|Induction Period|Lost to Follow-up|0|||
160611154|NCT01996865|579954005|FG000|Induction Period|Other Reasons|13|||
160611155|NCT01996865|579954006|FG001|Induction Period|Other Reasons|0|||
160611156|NCT01996865|579954007|FG002|Induction Period|Other Reasons|0|||
160611157|NCT01996865|579954005|FG000|Induction Period|Adverse Event|20|||
160611158|NCT01996865|579954006|FG001|Induction Period|Adverse Event|0|||
160611159|NCT01996865|579954007|FG002|Induction Period|Adverse Event|0|||
160611160|NCT01996865|579954005|FG000|Induction Period|Withdrawal by Subject|60|||
160611161|NCT01996865|579954006|FG001|Induction Period|Withdrawal by Subject|0|||
160611162|NCT01996865|579954007|FG002|Induction Period|Withdrawal by Subject|0|||
160611163|NCT01996865|579954005|FG000|Induction Period|Death|111|||
160611164|NCT01996865|579954006|FG001|Induction Period|Death|0|||
160611165|NCT01996865|579954007|FG002|Induction Period|Death|0|||
160611166|NCT01996865|579954005|FG000|Maintenance Period|Protocol Violation|0|||
160611167|NCT01996865|579954006|FG001|Maintenance Period|Protocol Violation|1|||
160611168|NCT01996865|579954007|FG002|Maintenance Period|Protocol Violation|1|||
160611169|NCT01996865|579954005|FG000|Maintenance Period|Other reasons|0|||
160611170|NCT01996865|579954006|FG001|Maintenance Period|Other reasons|8|||
160611171|NCT01996865|579954007|FG002|Maintenance Period|Other reasons|5|||
160611172|NCT01996865|579954005|FG000|Maintenance Period|Progressive Disease|0|||
160611173|NCT01996865|579954006|FG001|Maintenance Period|Progressive Disease|6|||
160611174|NCT01996865|579954007|FG002|Maintenance Period|Progressive Disease|23|||
160611175|NCT01996865|579954005|FG000|Maintenance Period|Withdrawal by Subject|0|||
160611176|NCT01996865|579954006|FG001|Maintenance Period|Withdrawal by Subject|18|||
160611177|NCT01996865|579954007|FG002|Maintenance Period|Withdrawal by Subject|4|||
160611178|NCT01996865|579954005|FG000|Maintenance Period|Adverse Event|0|||
160611179|NCT01996865|579954006|FG001|Maintenance Period|Adverse Event|7|||
160611180|NCT01996865|579954007|FG002|Maintenance Period|Adverse Event|7|||
160611181|NCT01996865|579954005|FG000|Maintenance Period|Death|0|||
160611182|NCT01996865|579954006|FG001|Maintenance Period|Death|15|||
160611183|NCT01996865|579954007|FG002|Maintenance Period|Death|3|||
160611184|NCT01996865|579954005|FG000|Maintenance Period|Lost to Follow-up|0|||
160611185|NCT01996865|579954006|FG001|Maintenance Period|Lost to Follow-up|2|||
160611186|NCT01996865|579954007|FG002|Maintenance Period|Lost to Follow-up|0|||
160611187|NCT05304611|579954008|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
160611188|NCT05304611|579954009|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
160611189|NCT05304611|579954010|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
160611190|NCT05304611|579954011|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
160611191|NCT05304611|579954012|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
160661355|NCT00625443|580144073|FG002|Overall Study|Non-compliance with protocol|0|||
160661356|NCT00625443|580144071|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
160661357|NCT00625443|580144072|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
160611192|NCT05304611|579954013|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
160611193|NCT05304611|579954014|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
160611194|NCT05304611|579954015|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
160611195|NCT05304611|579954016|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
160611196|NCT05304611|579954017|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
160611197|NCT05304611|579954018|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
160611198|NCT05304611|579954019|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
160611199|NCT05304611|579954008|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
160611200|NCT05304611|579954009|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
160611201|NCT05304611|579954010|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
160611202|NCT05304611|579954011|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
160611203|NCT05304611|579954012|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
160661358|NCT00625443|580144073|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
160611204|NCT05304611|579954013|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
160611205|NCT05304611|579954014|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
160611206|NCT05304611|579954015|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
160611207|NCT05304611|579954016|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
160611208|NCT05304611|579954017|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
160611209|NCT05304611|579954018|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
160611210|NCT05304611|579954019|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
160611211|NCT05304611|579954008|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
160611212|NCT05304611|579954009|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
160611213|NCT05304611|579954010|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
160611214|NCT05304611|579954011|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
160611215|NCT05304611|579954012|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
160611216|NCT05304611|579954013|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
160611217|NCT05304611|579954014|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
160611218|NCT05304611|579954015|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
160611219|NCT05304611|579954016|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
160611220|NCT05304611|579954017|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
160611221|NCT05304611|579954018|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
160611222|NCT05304611|579954019|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
160611223|NCT00963820|579954020|FG000|Dose Escalation Phase|Progressive Disease|3|||
160611224|NCT00963820|579954021|FG001|Dose Escalation Phase|Progressive Disease|3|||
160611225|NCT00963820|579954022|FG002|Dose Escalation Phase|Progressive Disease|3|||
160611226|NCT00963820|579954023|FG003|Dose Escalation Phase|Progressive Disease|3|||
160611227|NCT00963820|579954024|FG004|Dose Escalation Phase|Progressive Disease|4|||
160611228|NCT00963820|579954025|FG005|Dose Escalation Phase|Progressive Disease|3|||
160611229|NCT00963820|579954026|FG006|Dose Escalation Phase|Progressive Disease|3|||
160611230|NCT00963820|579954027|FG007|Dose Escalation Phase|Progressive Disease|2|||
160611231|NCT00963820|579954028|FG008|Dose Escalation Phase|Progressive Disease|0|||
160611232|NCT00963820|579954029|FG009|Dose Escalation Phase|Progressive Disease|0|||
160611233|NCT00963820|579954030|FG010|Dose Escalation Phase|Progressive Disease|0|||
160611234|NCT00963820|579954031|FG011|Dose Escalation Phase|Progressive Disease|0|||
160611235|NCT00963820|579954020|FG000|Dose Escalation Phase|Adverse Event|0|||
160611236|NCT00963820|579954021|FG001|Dose Escalation Phase|Adverse Event|0|||
160611237|NCT00963820|579954022|FG002|Dose Escalation Phase|Adverse Event|0|||
160611238|NCT00963820|579954023|FG003|Dose Escalation Phase|Adverse Event|0|||
160611239|NCT00963820|579954024|FG004|Dose Escalation Phase|Adverse Event|0|||
160611240|NCT00963820|579954025|FG005|Dose Escalation Phase|Adverse Event|0|||
160611241|NCT00963820|579954026|FG006|Dose Escalation Phase|Adverse Event|3|||
160611242|NCT00963820|579954027|FG007|Dose Escalation Phase|Adverse Event|1|||
160611243|NCT00963820|579954028|FG008|Dose Escalation Phase|Adverse Event|0|||
160611244|NCT00963820|579954029|FG009|Dose Escalation Phase|Adverse Event|0|||
160611245|NCT00963820|579954030|FG010|Dose Escalation Phase|Adverse Event|0|||
160611246|NCT00963820|579954031|FG011|Dose Escalation Phase|Adverse Event|0|||
160611247|NCT00963820|579954020|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
160611248|NCT00963820|579954021|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
160611249|NCT00963820|579954022|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
160611250|NCT00963820|579954023|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160611251|NCT00963820|579954024|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
160611252|NCT00963820|579954025|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
160611253|NCT00963820|579954026|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
160611254|NCT00963820|579954027|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
160611255|NCT00963820|579954028|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
160611256|NCT00963820|579954029|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
160611257|NCT00963820|579954030|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
160611258|NCT00963820|579954031|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
160611259|NCT00963820|579954020|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160611260|NCT00963820|579954021|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160611261|NCT00963820|579954022|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160611262|NCT00963820|579954023|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160611263|NCT00963820|579954024|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160611264|NCT00963820|579954025|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160611265|NCT00963820|579954026|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
160661359|NCT00625443|580144071|FG000|Overall Study|Withdrawal by Subject|0|||
160661360|NCT00625443|580144072|FG001|Overall Study|Withdrawal by Subject|1|||
160661361|NCT00625443|580144073|FG002|Overall Study|Withdrawal by Subject|2|||
160661362|NCT00625443|580144071|FG000|Overall Study|Physician Decision|0|||
160611266|NCT00963820|579954027|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160611267|NCT00963820|579954028|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160611268|NCT00963820|579954029|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160611269|NCT00963820|579954030|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160661363|NCT00625443|580144072|FG001|Overall Study|Physician Decision|4|||
160661364|NCT00625443|580144073|FG002|Overall Study|Physician Decision|2|||
160611270|NCT00963820|579954031|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
160611271|NCT00963820|579954020|FG000|Expansion Phase|Progressive Disease|0|||
160611272|NCT00963820|579954021|FG001|Expansion Phase|Progressive Disease|0|||
160611273|NCT00963820|579954022|FG002|Expansion Phase|Progressive Disease|0|||
160611274|NCT00963820|579954023|FG003|Expansion Phase|Progressive Disease|0|||
160611275|NCT00963820|579954024|FG004|Expansion Phase|Progressive Disease|0|||
160611276|NCT00963820|579954025|FG005|Expansion Phase|Progressive Disease|0|||
160611277|NCT00963820|579954026|FG006|Expansion Phase|Progressive Disease|0|||
160611278|NCT00963820|579954027|FG007|Expansion Phase|Progressive Disease|0|||
160611279|NCT00963820|579954028|FG008|Expansion Phase|Progressive Disease|8|||
160611280|NCT00963820|579954029|FG009|Expansion Phase|Progressive Disease|6|||
160611281|NCT00963820|579954030|FG010|Expansion Phase|Progressive Disease|4|||
160611282|NCT00963820|579954031|FG011|Expansion Phase|Progressive Disease|2|||
160611283|NCT00963820|579954020|FG000|Expansion Phase|Adverse Event|0|||
160611284|NCT00963820|579954021|FG001|Expansion Phase|Adverse Event|0|||
160611285|NCT00963820|579954022|FG002|Expansion Phase|Adverse Event|0|||
160611286|NCT00963820|579954023|FG003|Expansion Phase|Adverse Event|0|||
160611287|NCT00963820|579954024|FG004|Expansion Phase|Adverse Event|0|||
160611288|NCT00963820|579954025|FG005|Expansion Phase|Adverse Event|0|||
160611289|NCT00963820|579954026|FG006|Expansion Phase|Adverse Event|0|||
160611290|NCT00963820|579954027|FG007|Expansion Phase|Adverse Event|0|||
160611291|NCT00963820|579954028|FG008|Expansion Phase|Adverse Event|1|||
160611292|NCT00963820|579954029|FG009|Expansion Phase|Adverse Event|3|||
160611293|NCT00963820|579954030|FG010|Expansion Phase|Adverse Event|0|||
160611294|NCT00963820|579954031|FG011|Expansion Phase|Adverse Event|0|||
160611295|NCT00963820|579954020|FG000|Expansion Phase|Withdrawal by Subject|0|||
160611296|NCT00963820|579954021|FG001|Expansion Phase|Withdrawal by Subject|0|||
160611297|NCT00963820|579954022|FG002|Expansion Phase|Withdrawal by Subject|0|||
160611298|NCT00963820|579954023|FG003|Expansion Phase|Withdrawal by Subject|0|||
160611299|NCT00963820|579954024|FG004|Expansion Phase|Withdrawal by Subject|0|||
160611300|NCT00963820|579954025|FG005|Expansion Phase|Withdrawal by Subject|0|||
160611301|NCT00963820|579954026|FG006|Expansion Phase|Withdrawal by Subject|0|||
160611302|NCT00963820|579954027|FG007|Expansion Phase|Withdrawal by Subject|0|||
160611303|NCT00963820|579954028|FG008|Expansion Phase|Withdrawal by Subject|1|||
160611304|NCT00963820|579954029|FG009|Expansion Phase|Withdrawal by Subject|0|||
160611305|NCT00963820|579954030|FG010|Expansion Phase|Withdrawal by Subject|1|||
160611306|NCT00963820|579954031|FG011|Expansion Phase|Withdrawal by Subject|1|||
160611307|NCT00963820|579954020|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611308|NCT00963820|579954021|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611309|NCT00963820|579954022|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611310|NCT00963820|579954023|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611311|NCT00963820|579954024|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611312|NCT00963820|579954025|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611313|NCT00963820|579954026|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611314|NCT00963820|579954027|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611315|NCT00963820|579954028|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611316|NCT00963820|579954029|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611317|NCT00963820|579954030|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
160611318|NCT00963820|579954031|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
160611319|NCT02354690|579954032|FG000|Overall Study|Physician Decision|1|||
160611320|NCT04556175|579954036|FG000|Overall Study|Study terminated due to COVID-19|8|||
160611321|NCT04556175|579954037|FG001|Overall Study|Study terminated due to COVID-19|8|||
160611322|NCT05549505|579954039|FG000|Overall Study|Lost to Follow-up|2|||
160611323|NCT05549505|579954040|FG001|Overall Study|Lost to Follow-up|0|||
160611324|NCT05549505|579954039|FG000|Overall Study|Withdrawal by Subject|3|||
160490575|NCT02172950|579525585|FG001|Overall Study|Protocol Violation|0|||
160490576|NCT02172950|579525584|FG000|Overall Study|Lost to Follow-up|1|||
160490577|NCT02172950|579525585|FG001|Overall Study|Lost to Follow-up|0|||
160490578|NCT02172950|579525584|FG000|Overall Study|Death|1|||
160611325|NCT05549505|579954040|FG001|Overall Study|Withdrawal by Subject|3|||
160611326|NCT05549505|579954039|FG000|Overall Study|Other: Miscellaneous|3|||
160611327|NCT05549505|579954040|FG001|Overall Study|Other: Miscellaneous|6|||
160611328|NCT01426009|579954043|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
160611329|NCT01426009|579954043|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
160611330|NCT01426009|579954043|FG000|Washout 1|Withdrawal by Subject|1|||
160611331|NCT01426009|579954043|FG000|Washout 1|Personal Reasons|1|||
160611332|NCT01426009|579954043|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
160611333|NCT01426009|579954043|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
160611334|NCT01426009|579954043|FG000|Washout 2|electrive surgery|1|||
160611335|NCT01426009|579954043|FG000|Washout 3|personal reasons|1|||
160611336|NCT01426009|579954043|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
160611337|NCT01426009|579954043|FG000|Washout 4|Lost to Follow-up|1|||
160611338|NCT02756845|579954046|FG000|Overall Study|Death|12|||
160490579|NCT02172950|579525585|FG001|Overall Study|Death|0|||
160611339|NCT02756845|579954047|FG001|Overall Study|Death|2|||
160611340|NCT02756845|579954046|FG000|Overall Study|Withdrawal by Subject|1|||
160611341|NCT02756845|579954047|FG001|Overall Study|Withdrawal by Subject|0|||
160611342|NCT00515099|579954051|FG000|Overall Study|Lost to Follow-up|0|||
160611343|NCT00515099|579954052|FG001|Overall Study|Lost to Follow-up|4|||
160611344|NCT00515099|579954051|FG000|Overall Study|Withdrawal by Subject|2|||
160611345|NCT00515099|579954052|FG001|Overall Study|Withdrawal by Subject|0|||
160611346|NCT00515099|579954051|FG000|Overall Study|IRB Recommendation|1|||
160611347|NCT00515099|579954052|FG001|Overall Study|IRB Recommendation|0|||
160611348|NCT03342404|579954053|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
160611349|NCT03342404|579954054|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
160611350|NCT03342404|579954053|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
160611351|NCT03342404|579954054|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
160611352|NCT03342404|579954053|FG000|Blinded Treatment Phase|Adverse Event|5|||
160611353|NCT03342404|579954054|FG001|Blinded Treatment Phase|Adverse Event|4|||
160611354|NCT03342404|579954053|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
160611355|NCT03342404|579954054|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
160611356|NCT03342404|579954053|FG000|Blinded Treatment Phase|Other reasons|1|||
160611357|NCT03342404|579954054|FG001|Blinded Treatment Phase|Other reasons|0|||
160611358|NCT03342404|579954053|FG000|Blinded Treatment Phase|Physician Decision|1|||
160611359|NCT03342404|579954054|FG001|Blinded Treatment Phase|Physician Decision|0|||
160611360|NCT03342404|579954053|FG000|Blinded Treatment Phase|Death|1|||
160611361|NCT03342404|579954054|FG001|Blinded Treatment Phase|Death|0|||
160611362|NCT03342404|579954053|FG000|Open-Label Phase|Lost to Follow-up|0|||
160611363|NCT03342404|579954054|FG001|Open-Label Phase|Lost to Follow-up|1|||
160611364|NCT03342404|579954053|FG000|Open-Label Phase|Other reasons|0|||
160611365|NCT03342404|579954054|FG001|Open-Label Phase|Other reasons|1|||
160611366|NCT03342404|579954053|FG000|Open-Label Phase|Adverse Event|0|||
160611367|NCT03342404|579954054|FG001|Open-Label Phase|Adverse Event|3|||
160611368|NCT03342404|579954053|FG000|Open-Label Phase|Withdrawal by Subject|0|||
160611369|NCT03342404|579954054|FG001|Open-Label Phase|Withdrawal by Subject|6|||
160611370|NCT02750501|579954059|FG000|Overall Study|Adverse Event|4|||
160611371|NCT02750501|579954059|FG000|Overall Study|Physician Decision|1|||
160611372|NCT02750501|579954059|FG000|Overall Study|Protocol Violation|1|||
160611373|NCT02750501|579954059|FG000|Overall Study|G-tube came out|1|||
160611374|NCT02750501|579954059|FG000|Overall Study|Non-compliant use of PERT|1|||
160611375|NCT03797144|579954060|FG000|Enrollment|Protocol Violation|4|||
160611376|NCT03797144|579954061|FG001|Enrollment|Protocol Violation|1|||
160611377|NCT03797144|579954060|FG000|Surgery|Protocol Violation|1|||
160611378|NCT03797144|579954061|FG001|Surgery|Protocol Violation|0|||
160611379|NCT03797144|579954060|FG000|3 Month|Early termination cut-off date|2|||
160611380|NCT03797144|579954061|FG001|3 Month|Early termination cut-off date|0|||
160611381|NCT03797144|579954060|FG000|12 Month|Early termination cut-off date|8|||
160611382|NCT03797144|579954061|FG001|12 Month|Early termination cut-off date|9|||
160611383|NCT03797144|579954060|FG000|24 Month|Early termination cut-off date|1|||
160611384|NCT03797144|579954061|FG001|24 Month|Early termination cut-off date|1|||
160611385|NCT01878175|579954062|FG000|Overall Study|Developed contraindicated health problem|2|||
160611386|NCT01249157|579954063|FG000|Overall Study|Withdrawal by Subject|1|||
160611387|NCT03796195|579954064|FG000|Overall Study|Study closed early|1|||
160611388|NCT04445051|579954065|FG000|Overall Study|Adverse Event|0|||
160611389|NCT04445051|579954066|FG001|Overall Study|Adverse Event|0|||
160611390|NCT04445051|579954067|FG002|Overall Study|Adverse Event|1|||
160611391|NCT04445051|579954068|FG003|Overall Study|Adverse Event|0|||
160611392|NCT04445051|579954069|FG004|Overall Study|Adverse Event|0|||
160611393|NCT04445051|579954070|FG005|Overall Study|Adverse Event|0|||
160611394|NCT02392468|579954073|FG000|Overall Study|Adverse Event|0|||
160611395|NCT02392468|579954074|FG001|Overall Study|Adverse Event|1|||
160611396|NCT02392468|579954075|FG002|Overall Study|Adverse Event|0|||
160611397|NCT02392468|579954076|FG003|Overall Study|Adverse Event|0|||
160611398|NCT02392468|579954077|FG004|Overall Study|Adverse Event|0|||
160611399|NCT02392468|579954078|FG005|Overall Study|Adverse Event|1|||
160611400|NCT03630016|579954079|FG000|Overall Study|Poor Sensor Placement|1|||
160611401|NCT05083949|579954080|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
160611402|NCT05083949|579954081|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
160611403|NCT05083949|579954080|FG000|Period 1|Adverse Event|1|||
160611404|NCT05083949|579954081|FG001|Period 1|Adverse Event|1|||
160611405|NCT05083949|579954080|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
160611406|NCT05083949|579954081|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
160611407|NCT05083949|579954080|FG000|Period 2|Adverse Event|0|||
160611408|NCT05083949|579954081|FG001|Period 2|Adverse Event|2|||
160611409|NCT02470429|579954082|FG000|Overall Study|Adverse Event|1|||
160611410|NCT02470429|579954083|FG001|Overall Study|Adverse Event|0|||
160611411|NCT02470429|579954082|FG000|Overall Study|Withdrawal by Subject|1|||
160611412|NCT02470429|579954083|FG001|Overall Study|Withdrawal by Subject|0|||
160611413|NCT00959699|579954084|FG000|Treatment Period|Adverse Event|3|||
160611414|NCT00959699|579954085|FG001|Treatment Period|Adverse Event|13|||
160611415|NCT00959699|579954084|FG000|Treatment Period|Lack of Efficacy|15|||
160490580|NCT02172950|579525584|FG000|Overall Study|Patient traveling|1|||
160490581|NCT02172950|579525585|FG001|Overall Study|Patient traveling|0|||
160490582|NCT02172950|579525584|FG000|Overall Study|Patient went to other country|1|||
160490583|NCT02172950|579525585|FG001|Overall Study|Patient went to other country|0|||
160490584|NCT02172950|579525584|FG000|Overall Study|Patient relocated overseas|1|||
160490585|NCT02172950|579525585|FG001|Overall Study|Patient relocated overseas|1|||
160490586|NCT02172950|579525584|FG000|Overall Study|Patient moving|1|||
160490587|NCT02172950|579525585|FG001|Overall Study|Patient moving|0|||
160490588|NCT01086384|579525595|FG000|2-week Run-in Period|Adverse Event|1|||
160490589|NCT01086384|579525596|FG001|2-week Run-in Period|Adverse Event|0|||
160490590|NCT01086384|579525597|FG002|2-week Run-in Period|Adverse Event|0|||
160490591|NCT01086384|579525595|FG000|2-week Run-in Period|Protocol Violation|1|||
160490592|NCT01086384|579525596|FG001|2-week Run-in Period|Protocol Violation|0|||
160490593|NCT01086384|579525597|FG002|2-week Run-in Period|Protocol Violation|0|||
160490594|NCT01086384|579525595|FG000|2-week Run-in Period|Lost to Follow-up|1|||
160490595|NCT01086384|579525596|FG001|2-week Run-in Period|Lost to Follow-up|0|||
160490596|NCT01086384|579525597|FG002|2-week Run-in Period|Lost to Follow-up|0|||
160490597|NCT01086384|579525595|FG000|2-week Run-in Period|Physician Decision|6|||
160490598|NCT01086384|579525596|FG001|2-week Run-in Period|Physician Decision|0|||
160490599|NCT01086384|579525597|FG002|2-week Run-in Period|Physician Decision|0|||
160490600|NCT01086384|579525595|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
160490601|NCT01086384|579525596|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
160490602|NCT01086384|579525597|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
160490603|NCT01086384|579525595|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
160490604|NCT01086384|579525596|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
160490605|NCT01086384|579525597|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
160490606|NCT01086384|579525595|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
160490607|NCT01086384|579525596|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
160490608|NCT01086384|579525597|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
160490609|NCT01086384|579525595|FG000|2-week Run-in Period|Randomized in Error|1|||
160490610|NCT01086384|579525596|FG001|2-week Run-in Period|Randomized in Error|0|||
160490611|NCT01086384|579525597|FG002|2-week Run-in Period|Randomized in Error|0|||
160490612|NCT01086384|579525595|FG000|Treatment Period|Withdrawal by Subject|0|||
160490613|NCT01086384|579525596|FG001|Treatment Period|Withdrawal by Subject|53|||
160490614|NCT01086384|579525597|FG002|Treatment Period|Withdrawal by Subject|55|||
160490615|NCT01086384|579525595|FG000|Treatment Period|Protocol Violation|0|||
160490616|NCT01086384|579525596|FG001|Treatment Period|Protocol Violation|26|||
160490617|NCT01086384|579525597|FG002|Treatment Period|Protocol Violation|17|||
160490618|NCT01086384|579525595|FG000|Treatment Period|Lack of Efficacy|0|||
160490619|NCT01086384|579525596|FG001|Treatment Period|Lack of Efficacy|22|||
160490620|NCT01086384|579525597|FG002|Treatment Period|Lack of Efficacy|13|||
160490621|NCT01086384|579525595|FG000|Treatment Period|Adverse Event|0|||
160490622|NCT01086384|579525596|FG001|Treatment Period|Adverse Event|19|||
160490623|NCT01086384|579525597|FG002|Treatment Period|Adverse Event|15|||
160490624|NCT01086384|579525595|FG000|Treatment Period|Lost to Follow-up|0|||
160490625|NCT01086384|579525596|FG001|Treatment Period|Lost to Follow-up|11|||
160490626|NCT01086384|579525597|FG002|Treatment Period|Lost to Follow-up|9|||
160490627|NCT01086384|579525595|FG000|Treatment Period|Physician Decision|0|||
160490628|NCT01086384|579525596|FG001|Treatment Period|Physician Decision|9|||
160490629|NCT01086384|579525597|FG002|Treatment Period|Physician Decision|6|||
160490630|NCT01086384|579525595|FG000|Treatment Period|Study Closed/Terminated|0|||
160490631|NCT01086384|579525596|FG001|Treatment Period|Study Closed/Terminated|7|||
160490632|NCT01086384|579525597|FG002|Treatment Period|Study Closed/Terminated|8|||
160490633|NCT01086384|579525595|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
160490634|NCT01086384|579525596|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
160490635|NCT01086384|579525597|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
160490636|NCT01086384|579525595|FG000|Treatment Period|Received Treatment in Error|0|||
160490637|NCT01086384|579525596|FG001|Treatment Period|Received Treatment in Error|1|||
160490638|NCT01086384|579525597|FG002|Treatment Period|Received Treatment in Error|0|||
160490639|NCT02586415|579525600|FG000|Overall Study|Death|13|||
160490640|NCT02586415|579525601|FG001|Overall Study|Death|23|||
160490641|NCT02586415|579525600|FG000|Overall Study|Lost to Follow-up|1|||
160611416|NCT00959699|579954085|FG001|Treatment Period|Lack of Efficacy|6|||
160490642|NCT02586415|579525601|FG001|Overall Study|Lost to Follow-up|2|||
160490643|NCT00832000|579525602|FG000|Overall Study|Adverse Event|2|||
160490644|NCT00832000|579525603|FG001|Overall Study|Adverse Event|0|||
160490645|NCT00832000|579525602|FG000|Overall Study|Withdrawal by Subject|1|||
160490646|NCT00832000|579525603|FG001|Overall Study|Withdrawal by Subject|0|||
160490647|NCT00832000|579525602|FG000|Overall Study|No calls to IVR in either period|1|||
160490648|NCT00832000|579525603|FG001|Overall Study|No calls to IVR in either period|1|||
160490649|NCT00832000|579525602|FG000|Overall Study|No calls to IVR in period 2|2|||
160490650|NCT00832000|579525603|FG001|Overall Study|No calls to IVR in period 2|0|||
160490651|NCT00937521|579525606|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
160490652|NCT00937521|579525607|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
160611417|NCT00959699|579954084|FG000|Treatment Period|Lost to Follow-up|0|||
160611418|NCT00959699|579954085|FG001|Treatment Period|Lost to Follow-up|1|||
160611419|NCT00959699|579954084|FG000|Treatment Period|Withdrawal by Subject|1|||
160611420|NCT00959699|579954085|FG001|Treatment Period|Withdrawal by Subject|3|||
160611421|NCT00959699|579954084|FG000|Treatment Period|Non-Compliance with Protocol|0|||
160611422|NCT00959699|579954085|FG001|Treatment Period|Non-Compliance with Protocol|1|||
160611423|NCT00959699|579954084|FG000|Treatment Period|Did not receive treatment|0|||
160611424|NCT00959699|579954085|FG001|Treatment Period|Did not receive treatment|1|||
160611425|NCT00959699|579954084|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
160611426|NCT00959699|579954085|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
160611427|NCT00959699|579954084|FG000|Follow-up Period|Lost to Follow-up|3|||
160611428|NCT00959699|579954085|FG001|Follow-up Period|Lost to Follow-up|2|||
160611429|NCT00959699|579954084|FG000|Follow-up Period|Withdrawal by Subject|3|||
160611430|NCT00959699|579954085|FG001|Follow-up Period|Withdrawal by Subject|4|||
160611431|NCT04228445|579954086|FG000|Overall Study|Lost to Follow-up|1|||
160611432|NCT04228445|579954087|FG001|Overall Study|Lost to Follow-up|1|||
160490653|NCT00937521|579525608|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
160490654|NCT00937521|579525609|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
160490655|NCT00937521|579525610|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
160490656|NCT00937521|579525611|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
160490657|NCT00937521|579525612|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
160490658|NCT00937521|579525613|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
160490659|NCT00937521|579525606|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
160490660|NCT00937521|579525607|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
160490661|NCT00937521|579525608|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
160490662|NCT00937521|579525609|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
160490663|NCT00937521|579525610|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
160490664|NCT00937521|579525611|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
160490665|NCT00937521|579525612|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
160490666|NCT00937521|579525613|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
160490667|NCT00937521|579525606|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
160490668|NCT00937521|579525607|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
160490669|NCT00937521|579525608|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
160490670|NCT00937521|579525609|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
160490671|NCT00937521|579525610|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
160490672|NCT00937521|579525611|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
160490673|NCT00937521|579525612|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
160490674|NCT00937521|579525613|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
160490675|NCT00937521|579525606|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
160490676|NCT00937521|579525607|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
160490677|NCT00937521|579525608|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
160490678|NCT00937521|579525609|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
160490679|NCT00937521|579525610|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
160490680|NCT00937521|579525611|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
160490681|NCT00937521|579525612|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
160490682|NCT00937521|579525613|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
160490683|NCT00937521|579525606|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
160490684|NCT00937521|579525607|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
160490685|NCT00937521|579525608|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
160490686|NCT00937521|579525609|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
160490687|NCT00937521|579525610|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
160490688|NCT00937521|579525611|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
160490689|NCT00937521|579525612|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
160490690|NCT00937521|579525613|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
160490691|NCT00937521|579525606|FG000|Booster Phase|Adverse Event|0|||
160490692|NCT00937521|579525607|FG001|Booster Phase|Adverse Event|0|||
160490693|NCT00937521|579525608|FG002|Booster Phase|Adverse Event|0|||
160490694|NCT00937521|579525609|FG003|Booster Phase|Adverse Event|0|||
160611433|NCT04228445|579954086|FG000|Overall Study|Physician Decision|1|||
160611434|NCT04228445|579954087|FG001|Overall Study|Physician Decision|2|||
160611435|NCT04228445|579954086|FG000|Overall Study|Withdrawal by Subject|0|||
160661365|NCT00625443|580144071|FG000|Overall Study|Other|0|||
160490695|NCT00937521|579525610|FG004|Booster Phase|Adverse Event|0|||
160611436|NCT04228445|579954087|FG001|Overall Study|Withdrawal by Subject|1|||
160611437|NCT04228445|579954086|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
160611438|NCT04228445|579954087|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
160611439|NCT01976624|579954088|FG000|Overall Study|Participants contraindicated|2|||
160661366|NCT00625443|580144072|FG001|Overall Study|Other|1|||
160611440|NCT01976624|579954088|FG000|Overall Study|Participants age less than 19 years|12|||
160611441|NCT01316380|579954091|FG000|Overall Study|Adverse Event|0|||
160611442|NCT01316380|579954092|FG001|Overall Study|Adverse Event|2|||
160611443|NCT01316380|579954093|FG002|Overall Study|Adverse Event|1|||
160611444|NCT01316380|579954091|FG000|Overall Study|Protocol Violation|0|||
160611445|NCT01316380|579954092|FG001|Overall Study|Protocol Violation|0|||
160611446|NCT01316380|579954093|FG002|Overall Study|Protocol Violation|1|||
160611447|NCT01316380|579954091|FG000|Overall Study|Withdrawal by Subject|1|||
160611448|NCT01316380|579954092|FG001|Overall Study|Withdrawal by Subject|2|||
160611449|NCT01316380|579954093|FG002|Overall Study|Withdrawal by Subject|0|||
160611450|NCT01316380|579954091|FG000|Overall Study|Other|0|||
160611451|NCT01316380|579954092|FG001|Overall Study|Other|1|||
160611452|NCT01316380|579954093|FG002|Overall Study|Other|1|||
160611453|NCT01316380|579954091|FG000|Overall Study|Not treated|1|||
160611454|NCT01316380|579954092|FG001|Overall Study|Not treated|0|||
160611455|NCT01316380|579954093|FG002|Overall Study|Not treated|0|||
160611456|NCT00471315|579954095|FG000|Overall Study|Adverse Event|7|||
160611457|NCT00471315|579954095|FG000|Overall Study|Withdrawal by Subject|1|||
160611458|NCT00609167|579954099|FG000|Overall Study|Withdrawal by Subject|1|||
160611459|NCT00609167|579954100|FG001|Overall Study|Withdrawal by Subject|0|||
160611460|NCT00609167|579954099|FG000|Overall Study|Lack of Efficacy|1|||
160611461|NCT00609167|579954100|FG001|Overall Study|Lack of Efficacy|0|||
160611462|NCT00609167|579954099|FG000|Overall Study|Adverse Event|5|||
160611463|NCT00609167|579954100|FG001|Overall Study|Adverse Event|1|||
160611464|NCT00609167|579954099|FG000|Overall Study|Disease Progression|1|||
160611465|NCT00609167|579954100|FG001|Overall Study|Disease Progression|0|||
160611466|NCT00609167|579954099|FG000|Overall Study|Stem Cell Transplant|0|||
160611467|NCT00609167|579954100|FG001|Overall Study|Stem Cell Transplant|6|||
160611468|NCT00712270|579954101|FG000|Overall Study|Withdrawal by Subject|11|||
160611469|NCT00712270|579954101|FG000|Overall Study|Screen Failure|3|||
160611470|NCT02574520|579954102|FG000|Overall Study|Not dosed|2|||
160611471|NCT02574520|579954103|FG001|Overall Study|Not dosed|0|||
160611472|NCT02574520|579954104|FG002|Overall Study|Not dosed|5|||
160611473|NCT02574520|579954105|FG003|Overall Study|Not dosed|4|||
160611474|NCT02574520|579954102|FG000|Overall Study|Adverse Event|0|||
160611475|NCT02574520|579954103|FG001|Overall Study|Adverse Event|0|||
160611476|NCT02574520|579954104|FG002|Overall Study|Adverse Event|0|||
160611477|NCT02574520|579954105|FG003|Overall Study|Adverse Event|1|||
160611478|NCT02574520|579954102|FG000|Overall Study|Withdrawal by Subject|0|||
160611479|NCT02574520|579954103|FG001|Overall Study|Withdrawal by Subject|0|||
160611480|NCT02574520|579954104|FG002|Overall Study|Withdrawal by Subject|0|||
160611481|NCT02574520|579954105|FG003|Overall Study|Withdrawal by Subject|1|||
160611482|NCT02574520|579954102|FG000|Overall Study|Other|0|||
160611483|NCT02574520|579954103|FG001|Overall Study|Other|0|||
160611484|NCT02574520|579954104|FG002|Overall Study|Other|0|||
160611485|NCT02574520|579954105|FG003|Overall Study|Other|2|||
160611486|NCT01365091|579954108|FG000|Period 1|Adverse Event|1|||
160611487|NCT01365091|579954109|FG001|Period 1|Adverse Event|0|||
160611488|NCT01365091|579954110|FG002|Period 1|Adverse Event|2|||
160611489|NCT01365091|579954111|FG003|Period 1|Adverse Event|3|||
160611490|NCT01365091|579954108|FG000|Period 1|Positive test result for drugs of abuse|1|||
160611491|NCT01365091|579954109|FG001|Period 1|Positive test result for drugs of abuse|0|||
160611492|NCT01365091|579954110|FG002|Period 1|Positive test result for drugs of abuse|0|||
160611493|NCT01365091|579954111|FG003|Period 1|Positive test result for drugs of abuse|0|||
160611494|NCT01365091|579954108|FG000|Period 1|No longer met study criteria|0|||
160611495|NCT01365091|579954109|FG001|Period 1|No longer met study criteria|1|||
160611496|NCT01365091|579954110|FG002|Period 1|No longer met study criteria|0|||
160611497|NCT01365091|579954111|FG003|Period 1|No longer met study criteria|0|||
160611498|NCT01365091|579954108|FG000|Period 1|Withdrawal by Subject|0|||
160611499|NCT01365091|579954109|FG001|Period 1|Withdrawal by Subject|1|||
160611500|NCT01365091|579954110|FG002|Period 1|Withdrawal by Subject|0|||
160611501|NCT01365091|579954111|FG003|Period 1|Withdrawal by Subject|0|||
160611502|NCT01365091|579954108|FG000|Period 1|Personal reasons|0|||
160611503|NCT01365091|579954109|FG001|Period 1|Personal reasons|0|||
160611504|NCT01365091|579954110|FG002|Period 1|Personal reasons|1|||
160611505|NCT01365091|579954111|FG003|Period 1|Personal reasons|0|||
160611506|NCT01365091|579954108|FG000|Period 2|Withdrawal by Subject|1|||
160661367|NCT00625443|580144073|FG002|Overall Study|Other|1|||
160661368|NCT02015390|580144074|FG000|Overall Study|Lost to Follow-up|1|||
160611507|NCT01365091|579954109|FG001|Period 2|Withdrawal by Subject|0|||
160611508|NCT01365091|579954110|FG002|Period 2|Withdrawal by Subject|0|||
160611509|NCT01365091|579954111|FG003|Period 2|Withdrawal by Subject|0|||
160611510|NCT01365091|579954108|FG000|Period 2|Adverse Event|0|||
160611511|NCT01365091|579954109|FG001|Period 2|Adverse Event|0|||
160611512|NCT01365091|579954110|FG002|Period 2|Adverse Event|1|||
160611513|NCT01365091|579954111|FG003|Period 2|Adverse Event|0|||
160611514|NCT05307523|579954113|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
160611515|NCT05307523|579954114|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
160611516|NCT05307523|579954113|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
160611517|NCT05307523|579954114|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
160661369|NCT02015390|580144075|FG001|Overall Study|Lost to Follow-up|0|||
160611518|NCT05116683|579954115|FG000|Overall Study|Physician Decision|4|||
160611519|NCT03935594|579954125|FG000|Overall Study|Physician Decision|3|||
160611520|NCT01435122|579954126|FG000|Overall Study|Early withdrawal due to toxicity|8|||
160611521|NCT04412668|579954127|FG000|Overall Study|Death - multiple comorbidities|2|||
160490696|NCT00937521|579525611|FG005|Booster Phase|Adverse Event|0|||
160490697|NCT00937521|579525612|FG006|Booster Phase|Adverse Event|1|||
160490698|NCT00937521|579525613|FG007|Booster Phase|Adverse Event|0|||
160490699|NCT00937521|579525606|FG000|Booster Phase|Withdrawal by Subject|1|||
160490700|NCT00937521|579525607|FG001|Booster Phase|Withdrawal by Subject|0|||
160490701|NCT00937521|579525608|FG002|Booster Phase|Withdrawal by Subject|0|||
160490702|NCT00937521|579525609|FG003|Booster Phase|Withdrawal by Subject|1|||
160490703|NCT00937521|579525610|FG004|Booster Phase|Withdrawal by Subject|0|||
160490704|NCT00937521|579525611|FG005|Booster Phase|Withdrawal by Subject|0|||
160490705|NCT00937521|579525612|FG006|Booster Phase|Withdrawal by Subject|0|||
160490706|NCT00937521|579525613|FG007|Booster Phase|Withdrawal by Subject|2|||
160490707|NCT00937521|579525606|FG000|Booster Phase|Lost to Follow-up|2|||
160490708|NCT00937521|579525607|FG001|Booster Phase|Lost to Follow-up|2|||
160490709|NCT00937521|579525608|FG002|Booster Phase|Lost to Follow-up|4|||
160490710|NCT00937521|579525609|FG003|Booster Phase|Lost to Follow-up|2|||
160490711|NCT00937521|579525610|FG004|Booster Phase|Lost to Follow-up|4|||
160490712|NCT00937521|579525611|FG005|Booster Phase|Lost to Follow-up|4|||
160490713|NCT00937521|579525612|FG006|Booster Phase|Lost to Follow-up|3|||
160490714|NCT00937521|579525613|FG007|Booster Phase|Lost to Follow-up|0|||
160490715|NCT00937521|579525606|FG000|Booster Phase|Administrative Reason|0|||
160490716|NCT00937521|579525607|FG001|Booster Phase|Administrative Reason|0|||
160490717|NCT00937521|579525608|FG002|Booster Phase|Administrative Reason|1|||
160490718|NCT00937521|579525609|FG003|Booster Phase|Administrative Reason|0|||
160490719|NCT00937521|579525610|FG004|Booster Phase|Administrative Reason|1|||
160490720|NCT00937521|579525611|FG005|Booster Phase|Administrative Reason|1|||
160490721|NCT00937521|579525612|FG006|Booster Phase|Administrative Reason|0|||
160490722|NCT00937521|579525613|FG007|Booster Phase|Administrative Reason|0|||
160490723|NCT00937521|579525606|FG000|Booster Phase|Protocol Deviation|0|||
160490724|NCT00937521|579525607|FG001|Booster Phase|Protocol Deviation|0|||
160490725|NCT00937521|579525608|FG002|Booster Phase|Protocol Deviation|0|||
160490726|NCT00937521|579525609|FG003|Booster Phase|Protocol Deviation|0|||
160490727|NCT00937521|579525610|FG004|Booster Phase|Protocol Deviation|0|||
160490728|NCT00937521|579525611|FG005|Booster Phase|Protocol Deviation|0|||
160490729|NCT00937521|579525612|FG006|Booster Phase|Protocol Deviation|1|||
160490730|NCT00937521|579525613|FG007|Booster Phase|Protocol Deviation|0|||
160490731|NCT01426113|579525614|FG000|Overall Study|Study Discontinued|1|||
160490732|NCT01426113|579525615|FG001|Overall Study|Study Discontinued|1|||
160490733|NCT01426113|579525614|FG000|Overall Study|Adverse Event|0|||
160490734|NCT01426113|579525615|FG001|Overall Study|Adverse Event|1|||
160490735|NCT00338949|579525616|FG000|Subject Screening|Screen failures|11|||
160490736|NCT00338949|579525617|FG001|Subject Screening|Screen failures|11|||
160490737|NCT00338949|579525616|FG000|Randomization|Withdrawal by Subject|1|||
160490738|NCT00338949|579525617|FG001|Randomization|Withdrawal by Subject|0|||
160490739|NCT00338949|579525616|FG000|Randomization|Adverse Event|0|||
160490740|NCT00338949|579525617|FG001|Randomization|Adverse Event|5|||
160490741|NCT00436956|579525620|FG000|Overall Study|Not evaluable|1|||
160490742|NCT00436956|579525621|FG001|Overall Study|Not evaluable|0|||
160490743|NCT00461123|579525624|FG000|Overall Study|Adverse Event|1|||
160490744|NCT00461123|579525625|FG001|Overall Study|Adverse Event|0|||
160490745|NCT00461123|579525624|FG000|Overall Study|Lost to Follow-up|1|||
160490746|NCT00461123|579525625|FG001|Overall Study|Lost to Follow-up|1|||
160490747|NCT00461123|579525624|FG000|Overall Study|Protocol Violation|3|||
160490748|NCT00461123|579525625|FG001|Overall Study|Protocol Violation|2|||
160611522|NCT04412668|579954128|FG001|Overall Study|Death - multiple comorbidities|0|||
160611523|NCT04412668|579954129|FG002|Overall Study|Death - multiple comorbidities|0|||
160611524|NCT04412668|579954127|FG000|Overall Study|Withdrawal by Subject|3|||
160490749|NCT00461123|579525624|FG000|Overall Study|Withdrawal by Subject|1|||
160490750|NCT00461123|579525625|FG001|Overall Study|Withdrawal by Subject|3|||
160490751|NCT02024750|579525626|FG000|Overall Study|Withdrawal by Subject|2|||
160490752|NCT02024750|579525627|FG001|Overall Study|Withdrawal by Subject|1|||
160490753|NCT01891890|579525629|FG000|Overall Study|Lost to Follow-up|0|||
160490754|NCT01891890|579525630|FG001|Overall Study|Lost to Follow-up|0|||
160611525|NCT04412668|579954128|FG001|Overall Study|Withdrawal by Subject|0|||
160490755|NCT01891890|579525631|FG002|Overall Study|Lost to Follow-up|1|||
160490756|NCT01891890|579525629|FG000|Overall Study|Study ended before endpoint reached|7|||
160490757|NCT01891890|579525630|FG001|Overall Study|Study ended before endpoint reached|3|||
160490758|NCT01891890|579525631|FG002|Overall Study|Study ended before endpoint reached|6|||
160490759|NCT03029819|579525634|FG000|Overall Study|Lost to Follow-up|3|||
160490760|NCT03029819|579525635|FG001|Overall Study|Lost to Follow-up|5|||
160490761|NCT03029819|579525634|FG000|Overall Study|Removed due to disruptive behavior|0|||
160490762|NCT03029819|579525635|FG001|Overall Study|Removed due to disruptive behavior|1|||
160490763|NCT01215032|579525640|FG000|Overall Study|Adverse Event|3|||
160490764|NCT01215032|579525640|FG000|Overall Study|Lack of Efficacy|17|||
160611526|NCT04412668|579954129|FG002|Overall Study|Withdrawal by Subject|0|||
160490765|NCT02881047|579525641|FG000|Overall Study|Adverse Event|1|||
160490766|NCT02881047|579525641|FG000|Overall Study|Withdrawal by Subject|1|||
160490767|NCT03282799|579525648|FG000|Overall Study|Pregnancy|1|||
160490768|NCT03282799|579525649|FG001|Overall Study|Pregnancy|0|||
160490769|NCT03282799|579525648|FG000|Overall Study|Physician Decision|1|||
160490770|NCT03282799|579525649|FG001|Overall Study|Physician Decision|0|||
160490771|NCT02080403|579527260|FG000|Overall Study|Adverse Event|5|||
160490772|NCT02080403|579527261|FG001|Overall Study|Adverse Event|1|||
160490773|NCT02080403|579527260|FG000|Overall Study|Death|0|||
160490774|NCT02080403|579527261|FG001|Overall Study|Death|2|||
160490775|NCT02080403|579527260|FG000|Overall Study|Lost to Follow-up|2|||
160490776|NCT02080403|579527261|FG001|Overall Study|Lost to Follow-up|0|||
160490777|NCT02080403|579527260|FG000|Overall Study|Pregnancy|0|||
160490778|NCT02080403|579527261|FG001|Overall Study|Pregnancy|1|||
160490779|NCT02080403|579527260|FG000|Overall Study|Protocol Violation|3|||
160490780|NCT02080403|579527261|FG001|Overall Study|Protocol Violation|7|||
160490781|NCT02080403|579527260|FG000|Overall Study|Withdrawal by Subject|5|||
160490782|NCT02080403|579527261|FG001|Overall Study|Withdrawal by Subject|1|||
160490783|NCT02826798|579527262|FG000|Overall Study|Withdrawal by Subject|0|||
160490784|NCT02826798|579527263|FG001|Overall Study|Withdrawal by Subject|1|||
160490785|NCT02826798|579527264|FG002|Overall Study|Withdrawal by Subject|0|||
160490786|NCT02826798|579527265|FG003|Overall Study|Withdrawal by Subject|1|||
160490787|NCT02826798|579527266|FG004|Overall Study|Withdrawal by Subject|0|||
160490788|NCT02806505|579527267|FG000|Overall Study|Adverse event/intercurrent illness|1|||
160490789|NCT02806505|579527268|FG001|Overall Study|Adverse event/intercurrent illness|3|||
160490790|NCT02806505|579527267|FG000|Overall Study|Death|4|||
160490791|NCT02806505|579527268|FG001|Overall Study|Death|0|||
160490792|NCT02806505|579527267|FG000|Overall Study|Did not cooperate/refused treatment|3|||
160490793|NCT02806505|579527268|FG001|Overall Study|Did not cooperate/refused treatment|3|||
160490794|NCT02806505|579527267|FG000|Overall Study|Failure to return|0|||
160490795|NCT02806505|579527268|FG001|Overall Study|Failure to return|1|||
160490796|NCT02806505|579527267|FG000|Overall Study|Insufficient therapeutic response|2|||
160490797|NCT02806505|579527268|FG001|Overall Study|Insufficient therapeutic response|4|||
160490798|NCT01722045|579527270|FG000|Overall Study|Adverse Event|8|||
160490799|NCT01722045|579527270|FG000|Overall Study|Death|3|||
160490800|NCT01722045|579527270|FG000|Overall Study|Withdrawal by Subject|8|||
160490801|NCT01722045|579527270|FG000|Overall Study|Lost to Follow-up|4|||
160490802|NCT01722045|579527270|FG000|Overall Study|Protocol Deviation|1|||
160490803|NCT01722045|579527270|FG000|Overall Study|Physician Decision|3|||
160490804|NCT01722045|579527270|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
160490805|NCT02034162|579527271|FG000|Double-blind|Lost to Follow-up|3|||
160490806|NCT02034162|579527272|FG001|Double-blind|Lost to Follow-up|0|||
160490807|NCT02034162|579527273|FG002|Double-blind|Lost to Follow-up|0|||
160490808|NCT02034162|579527271|FG000|Double-blind|Physician Decision|1|||
160490809|NCT02034162|579527272|FG001|Double-blind|Physician Decision|0|||
160490810|NCT02034162|579527273|FG002|Double-blind|Physician Decision|0|||
160490811|NCT02034162|579527271|FG000|Double-blind|Protocol Violation|0|||
160490812|NCT02034162|579527272|FG001|Double-blind|Protocol Violation|1|||
160490813|NCT02034162|579527273|FG002|Double-blind|Protocol Violation|0|||
160490814|NCT02034162|579527271|FG000|Double-blind|Withdrawal by Subject|5|||
160490815|NCT02034162|579527272|FG001|Double-blind|Withdrawal by Subject|7|||
160490816|NCT02034162|579527273|FG002|Double-blind|Withdrawal by Subject|0|||
160490817|NCT00760513|579527274|FG000|Overall Study|Withdrawal by Subject|5|||
160490818|NCT00760513|579527275|FG001|Overall Study|Withdrawal by Subject|7|||
160490819|NCT00971997|579527284|FG000|Overall Study|Adverse Event|2|||
160490820|NCT00971997|579527284|FG000|Overall Study|Death|1|||
160490821|NCT00971997|579527284|FG000|Overall Study|Protocol Violation|4|||
160490822|NCT00971997|579527284|FG000|Overall Study|Withdrawal by Subject|5|||
160490823|NCT00971997|579527284|FG000|Overall Study|Physician Decision|7|||
160490824|NCT00761956|579527289|FG000|Overall Study|Lost to Follow-up|6|||
160611527|NCT04412668|579954127|FG000|Overall Study|Other than Specified|2|||
160611528|NCT04412668|579954128|FG001|Overall Study|Other than Specified|0|||
160611529|NCT04412668|579954129|FG002|Overall Study|Other than Specified|0|||
160490825|NCT00761956|579527290|FG001|Overall Study|Lost to Follow-up|11|||
160490826|NCT00761956|579527289|FG000|Overall Study|Withdrawal by Subject|3|||
160490827|NCT00761956|579527290|FG001|Overall Study|Withdrawal by Subject|8|||
160490828|NCT00761956|579527289|FG000|Overall Study|Death|0|||
160490829|NCT00761956|579527290|FG001|Overall Study|Death|1|||
160490830|NCT00761956|579527289|FG000|Overall Study|Adverse Event|26|||
160490831|NCT00761956|579527290|FG001|Overall Study|Adverse Event|34|||
160490832|NCT02808975|579527291|FG000|Overall Study|Adverse Event|3|||
160490833|NCT02808975|579527292|FG001|Overall Study|Adverse Event|4|||
160490834|NCT02808975|579527291|FG000|Overall Study|Withdrew consent|9|||
160490835|NCT02808975|579527292|FG001|Overall Study|Withdrew consent|8|||
160490836|NCT02808975|579527291|FG000|Overall Study|Lost to Follow-up|4|||
160490837|NCT02808975|579527292|FG001|Overall Study|Lost to Follow-up|6|||
160490838|NCT02808975|579527291|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
160490839|NCT02808975|579527292|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
160611530|NCT03864627|579954131|FG000|Overall Study|Adverse Event|0|||
160490840|NCT02808975|579527291|FG000|Overall Study|Other, not specified|5|||
160490841|NCT02808975|579527292|FG001|Overall Study|Other, not specified|1|||
160490842|NCT03294941|579527293|FG000|Overall Study|Withdrawal by Subject|0|||
160490843|NCT03294941|579527294|FG001|Overall Study|Withdrawal by Subject|2|||
160490844|NCT00916305|579527295|FG000|Overall Study|Lost to Follow-up|21|||
160490845|NCT00916305|579527296|FG001|Overall Study|Lost to Follow-up|27|||
160490846|NCT00916305|579527295|FG000|Overall Study|Withdrawal by Subject|0|||
160490847|NCT00916305|579527296|FG001|Overall Study|Withdrawal by Subject|1|||
160490848|NCT01288209|579527297|FG000|Overall Study|Withdrawal by Subject|1|||
160490849|NCT01288209|579527298|FG001|Overall Study|Withdrawal by Subject|3|||
160490850|NCT01288209|579527297|FG000|Overall Study|Other|1|||
160490851|NCT01288209|579527298|FG001|Overall Study|Other|0|||
160490852|NCT01646385|579527299|FG000|Overall Study|Death|202|||
160490853|NCT01646385|579527300|FG001|Overall Study|Death|222|||
160490854|NCT01646385|579527299|FG000|Overall Study|Switched to alternate biologic|636|||
160490855|NCT01646385|579527300|FG001|Overall Study|Switched to alternate biologic|649|||
160490856|NCT01101997|579527301|FG000|Overall Study|Withdrawal by Subject|2|||
160490857|NCT00469456|579527302|FG000|Overall Study|Adverse Event|4|||
160490858|NCT00469456|579527303|FG001|Overall Study|Adverse Event|3|||
160490859|NCT00469456|579527302|FG000|Overall Study|Protocol Violation|1|||
160490860|NCT00469456|579527303|FG001|Overall Study|Protocol Violation|0|||
160490861|NCT00469456|579527302|FG000|Overall Study|Withdrawal by Subject|4|||
160490862|NCT00469456|579527303|FG001|Overall Study|Withdrawal by Subject|1|||
160490863|NCT00704171|579527304|FG000|Overall Study|Withdrawal by Subject|1|||
160490864|NCT00704171|579527305|FG001|Overall Study|Withdrawal by Subject|0|||
160490865|NCT00813098|579527308|FG000|Overall Study|Adverse Event|2|||
160490866|NCT00813098|579527309|FG001|Overall Study|Adverse Event|4|||
160490867|NCT00813098|579527310|FG002|Overall Study|Adverse Event|1|||
160490868|NCT00813098|579527308|FG000|Overall Study|Withdrawal by Subject|0|||
160490869|NCT00813098|579527309|FG001|Overall Study|Withdrawal by Subject|1|||
160490870|NCT00813098|579527310|FG002|Overall Study|Withdrawal by Subject|0|||
160490871|NCT00813098|579527308|FG000|Overall Study|Inability to complete study procedures|1|||
160490872|NCT00813098|579527309|FG001|Overall Study|Inability to complete study procedures|0|||
160490873|NCT00813098|579527310|FG002|Overall Study|Inability to complete study procedures|0|||
160490874|NCT00813098|579527308|FG000|Overall Study|Lost to Follow-up|0|||
160490875|NCT00813098|579527309|FG001|Overall Study|Lost to Follow-up|1|||
160490876|NCT00813098|579527310|FG002|Overall Study|Lost to Follow-up|0|||
160490877|NCT00813098|579527308|FG000|Overall Study|Protocol Violation|0|||
160490878|NCT00813098|579527309|FG001|Overall Study|Protocol Violation|0|||
160490879|NCT00813098|579527310|FG002|Overall Study|Protocol Violation|1|||
160490880|NCT00813098|579527308|FG000|Overall Study|Principal Investigator decision|0|||
160490881|NCT00813098|579527309|FG001|Overall Study|Principal Investigator decision|1|||
160490882|NCT00813098|579527310|FG002|Overall Study|Principal Investigator decision|0|||
160490883|NCT00813098|579527308|FG000|Overall Study|Withdrew Consent|0|||
160490884|NCT00813098|579527309|FG001|Overall Study|Withdrew Consent|1|||
160490885|NCT00813098|579527310|FG002|Overall Study|Withdrew Consent|0|||
160490886|NCT01772563|579527311|FG000|Cycle 1|Dose limiting toxicity|2|||
160490887|NCT01772563|579527311|FG000|Cycle 1|Progressive disease|2|||
160490888|NCT01772563|579527311|FG000|Cycle 2 and Beyond|Progressive disease|17|||
160490889|NCT01772563|579527311|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
160490890|NCT01772563|579527311|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
160490891|NCT01898442|579527314|FG000|Overall Study|Hemolysis/technical problems|1|||
160490892|NCT01898442|579527315|FG001|Overall Study|Hemolysis/technical problems|2|||
160490893|NCT01898442|579527316|FG002|Overall Study|Hemolysis/technical problems|2|||
160490894|NCT01898442|579527314|FG000|Overall Study|Patient vomited pills|0|||
160490895|NCT01898442|579527315|FG001|Overall Study|Patient vomited pills|0|||
160611531|NCT03864627|579954132|FG001|Overall Study|Adverse Event|1|||
160611532|NCT03864627|579954131|FG000|Overall Study|Lack of Efficacy|0|||
160611533|NCT03864627|579954132|FG001|Overall Study|Lack of Efficacy|1|||
160611534|NCT03864627|579954131|FG000|Overall Study|Lost to Follow-up|0|||
160611535|NCT03864627|579954132|FG001|Overall Study|Lost to Follow-up|1|||
160611536|NCT03864627|579954131|FG000|Overall Study|Withdrawal by Subject|4|||
160611537|NCT03864627|579954132|FG001|Overall Study|Withdrawal by Subject|8|||
160490896|NCT01898442|579527316|FG002|Overall Study|Patient vomited pills|1|||
160490897|NCT03974100|579527317|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
160490898|NCT03974100|579527318|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
160490899|NCT03974100|579527319|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
160490900|NCT03974100|579527320|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
160490901|NCT03974100|579527321|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
160490902|NCT03974100|579527317|FG000|TP1 - Day 1 to Week 52|Death|1|||
160490903|NCT03974100|579527318|FG001|TP1 - Day 1 to Week 52|Death|0|||
160490904|NCT03974100|579527319|FG002|TP1 - Day 1 to Week 52|Death|0|||
160490905|NCT03974100|579527320|FG003|TP1 - Day 1 to Week 52|Death|0|||
160490906|NCT03974100|579527321|FG004|TP1 - Day 1 to Week 52|Death|0|||
160490907|NCT03974100|579527317|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
160611538|NCT03864627|579954131|FG000|Overall Study|Study terminated by sponsor|0|||
160611539|NCT03864627|579954132|FG001|Overall Study|Study terminated by sponsor|1|||
160490908|NCT03974100|579527318|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
160490909|NCT03974100|579527319|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
160490910|NCT03974100|579527320|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
160490911|NCT03974100|579527321|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
160490912|NCT03974100|579527317|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
160490913|NCT03974100|579527318|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
160490914|NCT03974100|579527319|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
160490915|NCT03974100|579527320|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
160490916|NCT03974100|579527321|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
160490917|NCT03974100|579527317|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
160490918|NCT03974100|579527318|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
160490919|NCT03974100|579527319|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
160490920|NCT03974100|579527320|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
160490921|NCT03974100|579527321|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
160490922|NCT03974100|579527317|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
160490923|NCT03974100|579527318|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
160490924|NCT03974100|579527319|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
160490925|NCT03974100|579527320|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
160490926|NCT03974100|579527321|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
160490927|NCT03974100|579527317|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
160490928|NCT03974100|579527318|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
160490929|NCT03974100|579527319|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
160490930|NCT03974100|579527320|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
160490931|NCT03974100|579527321|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
160490932|NCT03318783|579527322|FG000|Overall Study|Withdrawal by Subject|0|||
160490933|NCT03318783|579527323|FG001|Overall Study|Withdrawal by Subject|1|||
160490934|NCT03318783|579527322|FG000|Overall Study|Death|0|||
160490935|NCT03318783|579527323|FG001|Overall Study|Death|1|||
160490936|NCT03856047|579527324|FG000|Overall Study|Withdrawal by Subject|0|||
160490937|NCT03856047|579527325|FG001|Overall Study|Withdrawal by Subject|1|||
160490938|NCT03856047|579527326|FG002|Overall Study|Withdrawal by Subject|1|||
160490939|NCT03856047|579527327|FG003|Overall Study|Withdrawal by Subject|0|||
160490940|NCT03856047|579527328|FG004|Overall Study|Withdrawal by Subject|3|||
160490941|NCT03856047|579527329|FG005|Overall Study|Withdrawal by Subject|0|||
160490942|NCT03856047|579527330|FG006|Overall Study|Withdrawal by Subject|2|||
160490943|NCT03856047|579527324|FG000|Overall Study|Lost to Follow-up|4|||
160490944|NCT03856047|579527325|FG001|Overall Study|Lost to Follow-up|2|||
160490945|NCT03856047|579527326|FG002|Overall Study|Lost to Follow-up|3|||
160490946|NCT03856047|579527327|FG003|Overall Study|Lost to Follow-up|1|||
160490947|NCT03856047|579527328|FG004|Overall Study|Lost to Follow-up|4|||
160490948|NCT03856047|579527329|FG005|Overall Study|Lost to Follow-up|4|||
160490949|NCT03856047|579527330|FG006|Overall Study|Lost to Follow-up|4|||
160490950|NCT02980705|579527338|FG000|Overall Study|Adverse Event|0|||
160490951|NCT02980705|579527339|FG001|Overall Study|Adverse Event|1|||
160490952|NCT02980705|579527338|FG000|Overall Study|Withdrawal by Subject|6|||
160490953|NCT02980705|579527339|FG001|Overall Study|Withdrawal by Subject|9|||
160490954|NCT02980705|579527338|FG000|Overall Study|withdrew participation|0|||
160490955|NCT02980705|579527339|FG001|Overall Study|withdrew participation|1|||
160490956|NCT02980705|579527338|FG000|Overall Study|Lost to Follow-up|2|||
160490957|NCT02980705|579527339|FG001|Overall Study|Lost to Follow-up|0|||
160490958|NCT00263575|579527340|FG000|Titration Period|Adverse Event|14|||
160490959|NCT00263575|579527340|FG000|Titration Period|Withdrawal by Subject|10|||
160490960|NCT00263575|579527340|FG000|Titration Period|Protocol Violation|9|||
160490961|NCT00263575|579527340|FG000|Titration Period|Sponsor Decision|2|||
160490962|NCT00263575|579527340|FG000|Titration Period|Other|2|||
160490963|NCT00263575|579527340|FG000|Titration Period|Lack of Efficacy|6|||
160490964|NCT00263575|579527340|FG000|Maintence Period|Adverse Event|23|||
160490965|NCT00263575|579527340|FG000|Maintence Period|Withdrawal by Subject|8|||
160490966|NCT00263575|579527340|FG000|Maintence Period|Protocol Violation|4|||
160490967|NCT00263575|579527340|FG000|Maintence Period|Lack of Efficacy|4|||
160490968|NCT00263575|579527340|FG000|Maintence Period|Physician Decision|6|||
160490969|NCT00263575|579527340|FG000|Maintence Period|Lost to Follow-up|1|||
160611540|NCT00112840|579954133|FG000|Overall Study|Physician Decision|1|||
160611541|NCT00112840|579954134|FG001|Overall Study|Physician Decision|0|||
160611542|NCT00112840|579954135|FG002|Overall Study|Physician Decision|0|||
160490970|NCT00263575|579527340|FG000|Maintence Period|Sponsor Decision|24|||
160490971|NCT00263575|579527340|FG000|Maintence Period|Other|7|||
160490972|NCT01841112|579527342|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
160490973|NCT01841112|579527343|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
160490974|NCT01841112|579527344|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
160490975|NCT01841112|579527345|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
160490976|NCT01841112|579527346|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
160490977|NCT01880437|579527347|FG000|Overall Study|Death|12|||
160490978|NCT01880437|579527348|FG001|Overall Study|Death|4|||
160490979|NCT01880437|579527349|FG002|Overall Study|Death|17|||
160490980|NCT01880437|579527347|FG000|Overall Study|Study terminated by Sponsor|3|||
160490981|NCT01880437|579527348|FG001|Overall Study|Study terminated by Sponsor|0|||
160611543|NCT00112840|579954133|FG000|Overall Study|Withdrawal by Subject|1|||
160490982|NCT01880437|579527349|FG002|Overall Study|Study terminated by Sponsor|2|||
160490983|NCT00909532|579527354|FG000|Overall Study|Adverse Event|4|||
160490984|NCT00909532|579527355|FG001|Overall Study|Adverse Event|1|||
160490985|NCT00909532|579527354|FG000|Overall Study|Pregnancy|0|||
160490986|NCT00909532|579527355|FG001|Overall Study|Pregnancy|1|||
160490987|NCT00909532|579527354|FG000|Overall Study|Prohibited Medication|2|||
160490988|NCT00909532|579527355|FG001|Overall Study|Prohibited Medication|1|||
160490989|NCT00909532|579527354|FG000|Overall Study|Withdrawal of Consent|1|||
160490990|NCT00909532|579527355|FG001|Overall Study|Withdrawal of Consent|1|||
160490991|NCT00909532|579527354|FG000|Overall Study|Noncompliance with Study Requirements|0|||
160490992|NCT00909532|579527355|FG001|Overall Study|Noncompliance with Study Requirements|2|||
160490993|NCT00909532|579527354|FG000|Overall Study|Physician Decision|1|||
160490994|NCT00909532|579527355|FG001|Overall Study|Physician Decision|0|||
160490995|NCT00909532|579527354|FG000|Overall Study|Wrong Genotype|1|||
160490996|NCT00909532|579527355|FG001|Overall Study|Wrong Genotype|0|||
160490997|NCT00909532|579527354|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
160490998|NCT00909532|579527355|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
160490999|NCT02719743|579527358|FG000|Overall Study|Consent withdrawal|0|||
160491000|NCT02719743|579527359|FG001|Overall Study|Consent withdrawal|2|||
160491001|NCT02719743|579527360|FG002|Overall Study|Consent withdrawal|0|||
160491002|NCT02719743|579527361|FG003|Overall Study|Consent withdrawal|1|||
160491003|NCT02719743|579527362|FG004|Overall Study|Consent withdrawal|0|||
160491004|NCT02719743|579527358|FG000|Overall Study|Migrated/moved from study area|0|||
160491005|NCT02719743|579527359|FG001|Overall Study|Migrated/moved from study area|0|||
160491006|NCT02719743|579527360|FG002|Overall Study|Migrated/moved from study area|0|||
160491007|NCT02719743|579527361|FG003|Overall Study|Migrated/moved from study area|0|||
160491008|NCT02719743|579527362|FG004|Overall Study|Migrated/moved from study area|2|||
160491009|NCT02719743|579527358|FG000|Overall Study|Lost to Follow-up|1|||
160491010|NCT02719743|579527359|FG001|Overall Study|Lost to Follow-up|1|||
160491011|NCT02719743|579527360|FG002|Overall Study|Lost to Follow-up|0|||
160491012|NCT02719743|579527361|FG003|Overall Study|Lost to Follow-up|0|||
160491013|NCT02719743|579527362|FG004|Overall Study|Lost to Follow-up|0|||
160491014|NCT01438840|579527363|FG000|Core Study|Adverse Event|0|||
160491015|NCT01438840|579527364|FG001|Core Study|Adverse Event|3|||
160491016|NCT01438840|579527365|FG002|Core Study|Adverse Event|0|||
160491017|NCT01438840|579527363|FG000|Core Study|Lack of Efficacy|15|||
160491018|NCT01438840|579527364|FG001|Core Study|Lack of Efficacy|7|||
160491019|NCT01438840|579527365|FG002|Core Study|Lack of Efficacy|0|||
160491020|NCT01438840|579527363|FG000|Core Study|Withdrawal of consent|1|||
160491021|NCT01438840|579527364|FG001|Core Study|Withdrawal of consent|0|||
160491022|NCT01438840|579527365|FG002|Core Study|Withdrawal of consent|0|||
160491023|NCT01438840|579527363|FG000|Extension Phase|Adverse Event|0|||
160491024|NCT01438840|579527364|FG001|Extension Phase|Adverse Event|0|||
160491025|NCT01438840|579527365|FG002|Extension Phase|Adverse Event|3|||
160491026|NCT01438840|579527363|FG000|Extension Phase|Lost to Follow-up|0|||
160491027|NCT01438840|579527364|FG001|Extension Phase|Lost to Follow-up|0|||
160491028|NCT01438840|579527365|FG002|Extension Phase|Lost to Follow-up|1|||
160491029|NCT01438840|579527363|FG000|Extension Phase|Withdrawal by Subject|0|||
160491030|NCT01438840|579527364|FG001|Extension Phase|Withdrawal by Subject|0|||
160491031|NCT01438840|579527365|FG002|Extension Phase|Withdrawal by Subject|3|||
160491032|NCT01438840|579527363|FG000|Extension Phase|Lack of Efficacy|0|||
160491033|NCT01438840|579527364|FG001|Extension Phase|Lack of Efficacy|0|||
160491034|NCT01438840|579527365|FG002|Extension Phase|Lack of Efficacy|2|||
160491035|NCT01438840|579527363|FG000|Extension Phase|Other|0|||
160491036|NCT01438840|579527364|FG001|Extension Phase|Other|0|||
160491037|NCT01438840|579527365|FG002|Extension Phase|Other|1|||
160491038|NCT01930214|579527366|FG000|Overall Study|Death|4|||
160491039|NCT01930214|579527367|FG001|Overall Study|Death|4|||
160491040|NCT01930214|579527368|FG002|Overall Study|Death|11|||
160491041|NCT01930214|579527366|FG000|Overall Study|Lost to Follow-up|12|||
160491042|NCT01930214|579527367|FG001|Overall Study|Lost to Follow-up|13|||
160491043|NCT01930214|579527368|FG002|Overall Study|Lost to Follow-up|12|||
160491044|NCT01930214|579527366|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
160491045|NCT01930214|579527367|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
160611544|NCT00112840|579954134|FG001|Overall Study|Withdrawal by Subject|0|||
160611545|NCT00112840|579954135|FG002|Overall Study|Withdrawal by Subject|1|||
160491046|NCT01930214|579527368|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
160491047|NCT01930214|579527366|FG000|Overall Study|Physician Decision|2|||
160491048|NCT01930214|579527367|FG001|Overall Study|Physician Decision|0|||
160491049|NCT01930214|579527368|FG002|Overall Study|Physician Decision|0|||
160491050|NCT02601209|579527369|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
160491051|NCT02601209|579527370|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
160491052|NCT02601209|579527371|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
160491053|NCT02601209|579527372|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
160491054|NCT02601209|579527373|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
160491055|NCT02601209|579527374|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
160491056|NCT02601209|579527375|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
160491057|NCT02601209|579527376|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
160491058|NCT02601209|579527377|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
160491059|NCT02601209|579527369|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
160491060|NCT02601209|579527370|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
160491061|NCT02601209|579527371|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
160491062|NCT02601209|579527372|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
160491063|NCT02601209|579527373|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
160491064|NCT02601209|579527374|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
160491065|NCT02601209|579527375|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
160491066|NCT02601209|579527376|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
160491067|NCT02601209|579527377|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
160491068|NCT02604342|579527381|FG000|Overall Study|Death|32|||
160491069|NCT02604342|579527382|FG001|Overall Study|Death|16|||
160491070|NCT02604342|579527381|FG000|Overall Study|Progression of disease|1|||
160491071|NCT02604342|579527382|FG001|Overall Study|Progression of disease|0|||
160491072|NCT02604342|579527381|FG000|Overall Study|Withdrawal by Subject|5|||
160491073|NCT02604342|579527382|FG001|Overall Study|Withdrawal by Subject|6|||
160491074|NCT02604342|579527381|FG000|Overall Study|Other|1|||
160491075|NCT02604342|579527382|FG001|Overall Study|Other|0|||
160491076|NCT02604342|579527381|FG000|Overall Study|Study Termination by Sponsor|1|||
160491077|NCT02604342|579527382|FG001|Overall Study|Study Termination by Sponsor|0|||
160491078|NCT02604342|579527381|FG000|Overall Study|Lost to Follow-up|1|||
160491079|NCT02604342|579527382|FG001|Overall Study|Lost to Follow-up|1|||
160491080|NCT02604342|579527381|FG000|Overall Study|Physician Decision|2|||
160491081|NCT02604342|579527382|FG001|Overall Study|Physician Decision|0|||
160491082|NCT01702519|579527383|FG000|Washout Period|Lost to Follow-up|1|||
160491083|NCT01702519|579527384|FG001|Washout Period|Lost to Follow-up|0|||
160491084|NCT01702519|579527383|FG000|Washout Period|Withdrawal by Subject|0|||
160491085|NCT01702519|579527384|FG001|Washout Period|Withdrawal by Subject|2|||
160491086|NCT02725008|579527387|FG000|Overall Study|Lost to Follow-up|7|||
160491087|NCT02725008|579527388|FG001|Overall Study|Lost to Follow-up|9|||
160611546|NCT00112840|579954133|FG000|Overall Study|Protocol Violation|0|||
160611547|NCT00112840|579954134|FG001|Overall Study|Protocol Violation|0|||
160611548|NCT00112840|579954135|FG002|Overall Study|Protocol Violation|5|||
160611549|NCT00683774|579954136|FG000|Overall Study|Withdrawal by Subject|0|||
160611550|NCT00683774|579954137|FG001|Overall Study|Withdrawal by Subject|1|||
160611551|NCT00683774|579954136|FG000|Overall Study|Physician Decision|3|||
160611552|NCT00683774|579954137|FG001|Overall Study|Physician Decision|0|||
160611553|NCT02875366|579954138|FG000|Overall Study|Adverse Event|0|||
160611554|NCT02875366|579954139|FG001|Overall Study|Adverse Event|2|||
160611555|NCT02875366|579954138|FG000|Overall Study|Noncompliance|0|||
160611556|NCT02875366|579954139|FG001|Overall Study|Noncompliance|1|||
160611557|NCT02497287|579954140|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
160611558|NCT02497287|579954140|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
160611559|NCT02497287|579954140|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
160611560|NCT02497287|579954140|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
160611561|NCT02497287|579954140|FG000|Induction Phase (4 Weeks)|Other|13|||
160611562|NCT02497287|579954140|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
160611563|NCT02497287|579954140|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
160611564|NCT02497287|579954140|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
160611565|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
160611566|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
160611567|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
160611568|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
160661370|NCT02015390|580144074|FG000|Overall Study|Adverse Event|0|||
160661371|NCT02015390|580144075|FG001|Overall Study|Adverse Event|3|||
160491088|NCT02725008|579527387|FG000|Overall Study|Withdrawal by Subject|2|||
160491089|NCT02725008|579527388|FG001|Overall Study|Withdrawal by Subject|2|||
160491090|NCT02725008|579527387|FG000|Overall Study|Admitted to hospital|0|||
160491091|NCT02725008|579527388|FG001|Overall Study|Admitted to hospital|1|||
160491092|NCT04688086|579527391|FG000|Overall Study|Lost to Follow-up|164|||
160611569|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
160661372|NCT02015390|580144074|FG000|Overall Study|Physician Decision|0|||
160661373|NCT02015390|580144075|FG001|Overall Study|Physician Decision|1|||
160661374|NCT03136380|580144076|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
160491093|NCT04688086|579527391|FG000|Overall Study|Imaging error;|64|||
160491094|NCT01329419|579527394|FG000|Overall Study|Protocol Violation|235|||
160611570|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
160611571|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
160611572|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
160661375|NCT03136380|580144077|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
160491095|NCT03015181|579527397|FG000|Overall Study|Enrolled, but product never administered|1|||
160491096|NCT03015181|579527398|FG001|Overall Study|Enrolled, but product never administered|0|||
160491097|NCT03015181|579527399|FG002|Overall Study|Enrolled, but product never administered|0|||
160491098|NCT03015181|579527400|FG003|Overall Study|Enrolled, but product never administered|0|||
160491099|NCT03015181|579527401|FG004|Overall Study|Enrolled, but product never administered|0|||
160491100|NCT03015181|579527402|FG005|Overall Study|Enrolled, but product never administered|0|||
160491101|NCT03015181|579527403|FG006|Overall Study|Enrolled, but product never administered|0|||
160661376|NCT03136380|580144078|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
160491102|NCT03015181|579527397|FG000|Overall Study|Withdrawal by Subject|0|||
160491103|NCT03015181|579527398|FG001|Overall Study|Withdrawal by Subject|0|||
160491104|NCT03015181|579527399|FG002|Overall Study|Withdrawal by Subject|0|||
160491105|NCT03015181|579527400|FG003|Overall Study|Withdrawal by Subject|0|||
160491106|NCT03015181|579527401|FG004|Overall Study|Withdrawal by Subject|0|||
160491107|NCT03015181|579527402|FG005|Overall Study|Withdrawal by Subject|1|||
160491108|NCT03015181|579527403|FG006|Overall Study|Withdrawal by Subject|0|||
160491109|NCT03015181|579527397|FG000|Overall Study|Physician Decision|0|||
160491110|NCT03015181|579527398|FG001|Overall Study|Physician Decision|0|||
160491111|NCT03015181|579527399|FG002|Overall Study|Physician Decision|0|||
160491112|NCT03015181|579527400|FG003|Overall Study|Physician Decision|0|||
160491113|NCT03015181|579527401|FG004|Overall Study|Physician Decision|0|||
160491114|NCT03015181|579527402|FG005|Overall Study|Physician Decision|0|||
160491115|NCT03015181|579527403|FG006|Overall Study|Physician Decision|1|||
160491116|NCT01177228|579527413|FG000|Overall Study|Positive tuberculosis test|0|||
160491117|NCT01177228|579527414|FG001|Overall Study|Positive tuberculosis test|1|||
160491118|NCT01177228|579527415|FG002|Overall Study|Positive tuberculosis test|0|||
160491119|NCT01177228|579527416|FG003|Overall Study|Positive tuberculosis test|0|||
160491120|NCT01177228|579527413|FG000|Overall Study|Worsening disease activity|1|||
160491121|NCT01177228|579527414|FG001|Overall Study|Worsening disease activity|0|||
160491122|NCT01177228|579527415|FG002|Overall Study|Worsening disease activity|0|||
160491123|NCT01177228|579527416|FG003|Overall Study|Worsening disease activity|0|||
160491124|NCT01177228|579527413|FG000|Overall Study|Withdrawal by Subject|0|||
160491125|NCT01177228|579527414|FG001|Overall Study|Withdrawal by Subject|1|||
160491126|NCT01177228|579527415|FG002|Overall Study|Withdrawal by Subject|0|||
160491127|NCT01177228|579527416|FG003|Overall Study|Withdrawal by Subject|0|||
160491128|NCT01251887|579527417|FG000|Overall Study|Scheduling conflict|1|||
160661377|NCT03136380|580144079|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
160661378|NCT03136380|580144080|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
160661379|NCT02728102|580144081|FG000|Overall Study|Death|3|||
160661380|NCT02728102|580144082|FG001|Overall Study|Death|0|||
160661381|NCT02728102|580144083|FG002|Overall Study|Death|1|||
160491129|NCT01251887|579527418|FG001|Overall Study|Scheduling conflict|2|||
160491130|NCT01251887|579527419|FG002|Overall Study|Scheduling conflict|2|||
160491131|NCT01251887|579527417|FG000|Overall Study|Physician Decision|0|||
160491132|NCT01251887|579527418|FG001|Overall Study|Physician Decision|1|||
160491133|NCT01251887|579527419|FG002|Overall Study|Physician Decision|0|||
160491134|NCT01831726|579527420|FG000|Overall Study|Adverse Event|16|||
160491135|NCT01831726|579527420|FG000|Overall Study|Death|7|||
160491136|NCT01831726|579527420|FG000|Overall Study|Disease Progression|49|||
160491137|NCT01831726|579527420|FG000|Overall Study|Physician Decision|1|||
160491138|NCT01831726|579527420|FG000|Overall Study|Subject/guardian decision|7|||
160611573|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
160611574|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
160611575|NCT02497287|579954140|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
160611576|NCT02497287|579954140|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
160611577|NCT02497287|579954140|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
160611578|NCT02497287|579954140|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
160611579|NCT02497287|579954140|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
160491139|NCT03614676|579528778|FG000|Overall Study|Delivery before planned visit|2|||
160491140|NCT03614676|579528779|FG001|Overall Study|Delivery before planned visit|0|||
160491141|NCT03614676|579528778|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
160491142|NCT03614676|579528779|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
160611580|NCT02497287|579954140|FG000|Follow-up Phase (4 Week)|Other|1|||
160661382|NCT02728102|580144081|FG000|Overall Study|Withdrawal by Subject|0|||
160661383|NCT02728102|580144082|FG001|Overall Study|Withdrawal by Subject|2|||
160491143|NCT03614676|579528778|FG000|Overall Study|Migrated / moved from the study area|30|||
160491144|NCT03614676|579528779|FG001|Overall Study|Migrated / moved from the study area|22|||
160491145|NCT03614676|579528778|FG000|Overall Study|Lost to Follow-up|17|||
160491146|NCT03614676|579528779|FG001|Overall Study|Lost to Follow-up|42|||
160491147|NCT03614676|579528778|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
160491148|NCT03614676|579528779|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
160491149|NCT03614676|579528778|FG000|Overall Study|Other|16|||
160611581|NCT01226472|579954142|FG000|Overall Study|Progressive Disease|1|||
160661384|NCT02728102|580144083|FG002|Overall Study|Withdrawal by Subject|3|||
160491150|NCT03614676|579528779|FG001|Overall Study|Other|47|||
160491151|NCT03614676|579528778|FG000|Overall Study|Protocol Violation|0|||
160491152|NCT03614676|579528779|FG001|Overall Study|Protocol Violation|2|||
160491153|NCT03614676|579528778|FG000|Overall Study|Neonatal event of interest|0|||
160491154|NCT03614676|579528779|FG001|Overall Study|Neonatal event of interest|6|||
160491155|NCT03614676|579528778|FG000|Overall Study|Death in infant greater than 28 days old|0|||
160491156|NCT03614676|579528779|FG001|Overall Study|Death in infant greater than 28 days old|12|||
160491157|NCT03614676|579528778|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
160491158|NCT03614676|579528779|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
160491159|NCT01999972|579528780|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
160491160|NCT01999972|579528781|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
160491161|NCT01999972|579528782|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
160491162|NCT01999972|579528783|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
160491163|NCT01999972|579528784|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
160491164|NCT01999972|579528785|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
160491165|NCT01999972|579528780|FG000|Dose Escalation Part|Death|0|||
160491166|NCT01999972|579528781|FG001|Dose Escalation Part|Death|1|||
160491167|NCT01999972|579528782|FG002|Dose Escalation Part|Death|0|||
160491168|NCT01999972|579528783|FG003|Dose Escalation Part|Death|0|||
160491169|NCT01999972|579528784|FG004|Dose Escalation Part|Death|0|||
160491170|NCT01999972|579528785|FG005|Dose Escalation Part|Death|0|||
160491171|NCT01999972|579528780|FG000|Dose Escalation Part|Enrolled but not treated|0|||
160491172|NCT01999972|579528781|FG001|Dose Escalation Part|Enrolled but not treated|0|||
160491173|NCT01999972|579528782|FG002|Dose Escalation Part|Enrolled but not treated|1|||
160491174|NCT01999972|579528783|FG003|Dose Escalation Part|Enrolled but not treated|1|||
160491175|NCT01999972|579528784|FG004|Dose Escalation Part|Enrolled but not treated|0|||
160491176|NCT01999972|579528785|FG005|Dose Escalation Part|Enrolled but not treated|0|||
160491177|NCT01999972|579528780|FG000|Dose Escalation Part|Disease progression|3|||
160491178|NCT01999972|579528781|FG001|Dose Escalation Part|Disease progression|2|||
160491179|NCT01999972|579528782|FG002|Dose Escalation Part|Disease progression|3|||
160491180|NCT01999972|579528783|FG003|Dose Escalation Part|Disease progression|6|||
160491181|NCT01999972|579528784|FG004|Dose Escalation Part|Disease progression|0|||
160491182|NCT01999972|579528785|FG005|Dose Escalation Part|Disease progression|0|||
160491183|NCT01999972|579528780|FG000|Dose Escalation Part|Adverse Event|0|||
160491184|NCT01999972|579528781|FG001|Dose Escalation Part|Adverse Event|0|||
160491185|NCT01999972|579528782|FG002|Dose Escalation Part|Adverse Event|0|||
160491186|NCT01999972|579528783|FG003|Dose Escalation Part|Adverse Event|2|||
160491187|NCT01999972|579528784|FG004|Dose Escalation Part|Adverse Event|0|||
160491188|NCT01999972|579528785|FG005|Dose Escalation Part|Adverse Event|0|||
160491189|NCT01999972|579528780|FG000|Dose Escalation Part|Global deterioration of health status|1|||
160491190|NCT01999972|579528781|FG001|Dose Escalation Part|Global deterioration of health status|0|||
160491191|NCT01999972|579528782|FG002|Dose Escalation Part|Global deterioration of health status|0|||
160491192|NCT01999972|579528783|FG003|Dose Escalation Part|Global deterioration of health status|1|||
160491193|NCT01999972|579528784|FG004|Dose Escalation Part|Global deterioration of health status|0|||
160491194|NCT01999972|579528785|FG005|Dose Escalation Part|Global deterioration of health status|0|||
160491195|NCT01999972|579528780|FG000|Dose Expansion Part|Death|0|||
160491196|NCT01999972|579528781|FG001|Dose Expansion Part|Death|0|||
160491197|NCT01999972|579528782|FG002|Dose Expansion Part|Death|0|||
160491198|NCT01999972|579528783|FG003|Dose Expansion Part|Death|0|||
160491199|NCT01999972|579528784|FG004|Dose Expansion Part|Death|2|||
160491200|NCT01999972|579528785|FG005|Dose Expansion Part|Death|1|||
160491201|NCT01999972|579528780|FG000|Dose Expansion Part|Disease progression|0|||
160491202|NCT01999972|579528781|FG001|Dose Expansion Part|Disease progression|0|||
160491203|NCT01999972|579528782|FG002|Dose Expansion Part|Disease progression|0|||
160491204|NCT01999972|579528783|FG003|Dose Expansion Part|Disease progression|0|||
160491205|NCT01999972|579528784|FG004|Dose Expansion Part|Disease progression|9|||
160491206|NCT01999972|579528785|FG005|Dose Expansion Part|Disease progression|3|||
160491207|NCT01999972|579528780|FG000|Dose Expansion Part|Sponsor decision|0|||
160491208|NCT01999972|579528781|FG001|Dose Expansion Part|Sponsor decision|0|||
160491209|NCT01999972|579528782|FG002|Dose Expansion Part|Sponsor decision|0|||
160491210|NCT01999972|579528783|FG003|Dose Expansion Part|Sponsor decision|0|||
160491211|NCT01999972|579528784|FG004|Dose Expansion Part|Sponsor decision|1|||
160491212|NCT01999972|579528785|FG005|Dose Expansion Part|Sponsor decision|0|||
160491213|NCT01999972|579528780|FG000|Dose Expansion Part|Adverse Event|0|||
160491214|NCT01999972|579528781|FG001|Dose Expansion Part|Adverse Event|0|||
160491215|NCT01999972|579528782|FG002|Dose Expansion Part|Adverse Event|0|||
160491216|NCT01999972|579528783|FG003|Dose Expansion Part|Adverse Event|0|||
160491217|NCT01999972|579528784|FG004|Dose Expansion Part|Adverse Event|4|||
160491218|NCT01999972|579528785|FG005|Dose Expansion Part|Adverse Event|2|||
160491219|NCT01999972|579528780|FG000|Dose Expansion Part|Participant's non-compliance|0|||
160491220|NCT01999972|579528781|FG001|Dose Expansion Part|Participant's non-compliance|0|||
160491221|NCT01999972|579528782|FG002|Dose Expansion Part|Participant's non-compliance|0|||
160491222|NCT01999972|579528783|FG003|Dose Expansion Part|Participant's non-compliance|0|||
160491223|NCT01999972|579528784|FG004|Dose Expansion Part|Participant's non-compliance|0|||
160491224|NCT01999972|579528785|FG005|Dose Expansion Part|Participant's non-compliance|1|||
160491225|NCT01999972|579528780|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
160491226|NCT01999972|579528781|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
160491227|NCT01999972|579528782|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
160491228|NCT01999972|579528783|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
160491229|NCT01999972|579528784|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
160491230|NCT01999972|579528785|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
160491231|NCT01999972|579528780|FG000|Dose Expansion Part|Changed to standard of care|0|||
160491232|NCT01999972|579528781|FG001|Dose Expansion Part|Changed to standard of care|0|||
160491233|NCT01999972|579528782|FG002|Dose Expansion Part|Changed to standard of care|0|||
160491234|NCT01999972|579528783|FG003|Dose Expansion Part|Changed to standard of care|0|||
160491235|NCT01999972|579528784|FG004|Dose Expansion Part|Changed to standard of care|1|||
160491236|NCT01999972|579528785|FG005|Dose Expansion Part|Changed to standard of care|0|||
160491237|NCT02166476|579528798|FG000|Overall Study|Withdrawal by Subject|5|||
160491238|NCT02166476|579528799|FG001|Overall Study|Withdrawal by Subject|7|||
160491239|NCT02166476|579528798|FG000|Overall Study|Adverse Event|3|||
160491240|NCT02166476|579528799|FG001|Overall Study|Adverse Event|3|||
160491241|NCT02166476|579528798|FG000|Overall Study|Lost to Follow-up|5|||
160491242|NCT02166476|579528799|FG001|Overall Study|Lost to Follow-up|10|||
160491243|NCT02166476|579528798|FG000|Overall Study|Physician Decision|1|||
160491244|NCT02166476|579528799|FG001|Overall Study|Physician Decision|0|||
160491245|NCT02166476|579528798|FG000|Overall Study|Unable to Come for Visit|0|||
160491246|NCT02166476|579528799|FG001|Overall Study|Unable to Come for Visit|3|||
160491247|NCT04367480|579528806|FG000|Overall Study|Adverse Event|1|||
160491248|NCT04367480|579528807|FG001|Overall Study|Adverse Event|1|||
160491249|NCT04367480|579528806|FG000|Overall Study|Death|1|||
160491250|NCT04367480|579528807|FG001|Overall Study|Death|0|||
160491251|NCT04367480|579528806|FG000|Overall Study|Lost to Follow-up|1|||
160491252|NCT04367480|579528807|FG001|Overall Study|Lost to Follow-up|1|||
160491253|NCT04367480|579528806|FG000|Overall Study|Withdrawal by Subject|0|||
160491254|NCT04367480|579528807|FG001|Overall Study|Withdrawal by Subject|3|||
160491255|NCT04367480|579528806|FG000|Overall Study|App glitch during the study|1|||
160491256|NCT04367480|579528807|FG001|Overall Study|App glitch during the study|0|||
160491257|NCT04367480|579528806|FG000|Overall Study|Device Distribution Error|0|||
160491258|NCT04367480|579528807|FG001|Overall Study|Device Distribution Error|2|||
160491259|NCT04367480|579528806|FG000|Overall Study|Ineligible after Randomization|0|||
160491260|NCT04367480|579528807|FG001|Overall Study|Ineligible after Randomization|1|||
160491261|NCT04367480|579528806|FG000|Overall Study|Other Medical Reasons|0|||
160491262|NCT04367480|579528807|FG001|Overall Study|Other Medical Reasons|2|||
160491263|NCT03382561|579528808|FG000|Overall Study|Disease progression|47|||
160491264|NCT03382561|579528809|FG001|Overall Study|Disease progression|6|||
160491265|NCT03382561|579528808|FG000|Overall Study|Adverse Event|10|||
160491266|NCT03382561|579528809|FG001|Overall Study|Adverse Event|2|||
160491267|NCT03382561|579528808|FG000|Overall Study|Death|8|||
160491268|NCT03382561|579528809|FG001|Overall Study|Death|3|||
160491269|NCT03382561|579528808|FG000|Overall Study|Withdrawal by Subject|6|||
160491270|NCT03382561|579528809|FG001|Overall Study|Withdrawal by Subject|5|||
160491271|NCT03382561|579528808|FG000|Overall Study|Alternative therapy|2|||
160491272|NCT03382561|579528809|FG001|Overall Study|Alternative therapy|8|||
160491273|NCT03382561|579528808|FG000|Overall Study|Never started treatment|3|||
160491274|NCT03382561|579528809|FG001|Overall Study|Never started treatment|6|||
160491275|NCT03382561|579528808|FG000|Overall Study|Lack of Efficacy|0|||
160491276|NCT03382561|579528809|FG001|Overall Study|Lack of Efficacy|1|||
160491277|NCT03382561|579528808|FG000|Overall Study|Physician Decision|0|||
160491278|NCT03382561|579528809|FG001|Overall Study|Physician Decision|1|||
160491279|NCT03382561|579528808|FG000|Overall Study|Other complicating disease|0|||
160491280|NCT03382561|579528809|FG001|Overall Study|Other complicating disease|1|||
160491281|NCT01131104|579528810|FG000|Overall Study|Withdrawal by Subject|3|||
160491282|NCT01131104|579528810|FG000|Overall Study|Physician Decision|4|||
160491283|NCT01131104|579528810|FG000|Overall Study|Information Not Available|5|||
160491284|NCT01131104|579528810|FG000|Overall Study|No Information on Index Date of Onset|1|||
160491285|NCT02438371|579528814|FG000|Overall Study|Lost to Follow-up|3|||
160491286|NCT02438371|579528815|FG001|Overall Study|Lost to Follow-up|2|||
160491287|NCT02438371|579528814|FG000|Overall Study|Withdrawal by Subject|1|||
160491288|NCT02438371|579528815|FG001|Overall Study|Withdrawal by Subject|1|||
160491289|NCT03065933|579528819|FG000|Overall Study|study terminated|5|||
160491290|NCT02536742|579528820|FG000|Overall Study|Did not start protocol therapy|1|||
160491291|NCT02536742|579528820|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
160491292|NCT01513330|579528821|FG000|SenSura Mio First,|Adverse Event|2|||
160491293|NCT01513330|579528822|FG001|SenSura Mio First,|Adverse Event|0|||
160491294|NCT01513330|579528821|FG000|SenSura Mio First,|Lack of Efficacy|0|||
160491295|NCT01513330|579528822|FG001|SenSura Mio First,|Lack of Efficacy|1|||
160491296|NCT01513330|579528821|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
160611582|NCT03128307|579954145|FG000|Overall Study|Lost to Follow-up|29|||
160491297|NCT01513330|579528822|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
160491298|NCT01513330|579528821|FG000|SenSura Mio First,|Other|1|||
160491299|NCT01513330|579528822|FG001|SenSura Mio First,|Other|0|||
160491300|NCT01513330|579528821|FG000|Standard Care First,|Lack of Efficacy|2|||
160491301|NCT01513330|579528822|FG001|Standard Care First,|Lack of Efficacy|2|||
160491302|NCT01513330|579528821|FG000|Standard Care First,|Withdrawal by Subject|1|||
160491303|NCT01513330|579528822|FG001|Standard Care First,|Withdrawal by Subject|2|||
160491304|NCT01513330|579528821|FG000|Standard Care First,|Other|1|||
160611583|NCT03128307|579954145|FG000|Overall Study|Withdrawal by Subject|5|||
160611584|NCT00740116|579956119|FG000|Overall Study|Withdrawal by Subject|1|||
160611585|NCT00740116|579956120|FG001|Overall Study|Withdrawal by Subject|1|||
160611586|NCT00740116|579956119|FG000|Overall Study|Protocol Violation|1|||
160611587|NCT00740116|579956120|FG001|Overall Study|Protocol Violation|4|||
160611588|NCT00621764|579956121|FG000|Overall Study|Protocol Violation|0|||
160611589|NCT00621764|579956122|FG001|Overall Study|Protocol Violation|0|||
160611590|NCT00621764|579956123|FG002|Overall Study|Protocol Violation|0|||
160611591|NCT00621764|579956124|FG003|Overall Study|Protocol Violation|1|||
160611592|NCT02499172|579956125|FG000|Overall Study|Financial reason|0|||
160611593|NCT02499172|579956126|FG001|Overall Study|Financial reason|0|||
160611594|NCT02499172|579956127|FG002|Overall Study|Financial reason|523|||
160611595|NCT02499172|579956128|FG003|Overall Study|Financial reason|436|||
160611596|NCT02499172|579956125|FG000|Overall Study|Lost to Follow-up|65|||
160611597|NCT02499172|579956126|FG001|Overall Study|Lost to Follow-up|64|||
160611598|NCT02499172|579956127|FG002|Overall Study|Lost to Follow-up|0|||
160611599|NCT02499172|579956128|FG003|Overall Study|Lost to Follow-up|0|||
160611600|NCT01293123|579956129|FG000|Overall Study|Lost to Follow-up|0|||
160611601|NCT01293123|579956130|FG001|Overall Study|Lost to Follow-up|1|||
160491305|NCT01513330|579528822|FG001|Standard Care First,|Other|0|||
160491306|NCT01496365|579528827|FG000|Overall Study|Adverse Event|2|||
160491307|NCT01496365|579528828|FG001|Overall Study|Adverse Event|3|||
160491308|NCT01496365|579528829|FG002|Overall Study|Adverse Event|3|||
160491309|NCT01496365|579528830|FG003|Overall Study|Adverse Event|2|||
160491310|NCT01496365|579528831|FG004|Overall Study|Adverse Event|5|||
160491311|NCT01496365|579528832|FG005|Overall Study|Adverse Event|6|||
160491312|NCT01496365|579528833|FG006|Overall Study|Adverse Event|4|||
160491313|NCT01496365|579528827|FG000|Overall Study|Withdrawal by Subject|6|||
160491314|NCT01496365|579528828|FG001|Overall Study|Withdrawal by Subject|6|||
160491315|NCT01496365|579528829|FG002|Overall Study|Withdrawal by Subject|0|||
160491316|NCT01496365|579528830|FG003|Overall Study|Withdrawal by Subject|1|||
160491317|NCT01496365|579528831|FG004|Overall Study|Withdrawal by Subject|3|||
160491318|NCT01496365|579528832|FG005|Overall Study|Withdrawal by Subject|2|||
160491319|NCT01496365|579528833|FG006|Overall Study|Withdrawal by Subject|1|||
160491320|NCT01496365|579528827|FG000|Overall Study|Protocol Violation|2|||
160491321|NCT01496365|579528828|FG001|Overall Study|Protocol Violation|1|||
160491322|NCT01496365|579528829|FG002|Overall Study|Protocol Violation|1|||
160491323|NCT01496365|579528830|FG003|Overall Study|Protocol Violation|0|||
160491324|NCT01496365|579528831|FG004|Overall Study|Protocol Violation|0|||
160491325|NCT01496365|579528832|FG005|Overall Study|Protocol Violation|1|||
160491326|NCT01496365|579528833|FG006|Overall Study|Protocol Violation|0|||
160491327|NCT01496365|579528827|FG000|Overall Study|Lack of Efficacy|1|||
160491328|NCT01496365|579528828|FG001|Overall Study|Lack of Efficacy|0|||
160491329|NCT01496365|579528829|FG002|Overall Study|Lack of Efficacy|0|||
160491330|NCT01496365|579528830|FG003|Overall Study|Lack of Efficacy|0|||
160491331|NCT01496365|579528831|FG004|Overall Study|Lack of Efficacy|0|||
160491332|NCT01496365|579528832|FG005|Overall Study|Lack of Efficacy|1|||
160491333|NCT01496365|579528833|FG006|Overall Study|Lack of Efficacy|0|||
160491334|NCT01496365|579528827|FG000|Overall Study|Lost to Follow-up|0|||
160491335|NCT01496365|579528828|FG001|Overall Study|Lost to Follow-up|1|||
160611602|NCT01888965|579956140|FG000|Overall Study|Adverse Event|5|||
160611603|NCT01888965|579956140|FG000|Overall Study|Lack of Efficacy|4|||
160611604|NCT04076579|579956141|FG000|Overall Study|Adverse Event|2|||
160611605|NCT04076579|579956142|FG001|Overall Study|Adverse Event|0|||
160611606|NCT04076579|579956141|FG000|Overall Study|discontinued due to toxicity|1|||
160611607|NCT04076579|579956142|FG001|Overall Study|discontinued due to toxicity|0|||
160611608|NCT04076579|579956141|FG000|Overall Study|Physician Decision|1|||
160611609|NCT04076579|579956142|FG001|Overall Study|Physician Decision|0|||
160491336|NCT01496365|579528829|FG002|Overall Study|Lost to Follow-up|0|||
160491337|NCT01496365|579528830|FG003|Overall Study|Lost to Follow-up|0|||
160491338|NCT01496365|579528831|FG004|Overall Study|Lost to Follow-up|2|||
160491339|NCT01496365|579528832|FG005|Overall Study|Lost to Follow-up|0|||
160491340|NCT01496365|579528833|FG006|Overall Study|Lost to Follow-up|0|||
160491341|NCT01496365|579528827|FG000|Overall Study|Other|4|||
160491342|NCT01496365|579528828|FG001|Overall Study|Other|4|||
160491343|NCT01496365|579528829|FG002|Overall Study|Other|2|||
160491344|NCT01496365|579528830|FG003|Overall Study|Other|1|||
160491345|NCT01496365|579528831|FG004|Overall Study|Other|3|||
160611610|NCT04076579|579956141|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
160611611|NCT04076579|579956142|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
160611612|NCT04076579|579956141|FG000|Overall Study|Noncompliance|0|||
160491346|NCT01496365|579528832|FG005|Overall Study|Other|0|||
160491347|NCT01496365|579528833|FG006|Overall Study|Other|1|||
160491348|NCT01015677|579528834|FG000|Overall Study|Adverse Event|0|||
160491349|NCT01015677|579528835|FG001|Overall Study|Adverse Event|1|||
160491350|NCT01015677|579528836|FG002|Overall Study|Adverse Event|0|||
160491351|NCT01015677|579528834|FG000|Overall Study|Lack of Efficacy|0|||
160491352|NCT01015677|579528835|FG001|Overall Study|Lack of Efficacy|1|||
160491353|NCT01015677|579528836|FG002|Overall Study|Lack of Efficacy|0|||
160491354|NCT01015677|579528834|FG000|Overall Study|Protocol Violation|0|||
160491355|NCT01015677|579528835|FG001|Overall Study|Protocol Violation|1|||
160491356|NCT01015677|579528836|FG002|Overall Study|Protocol Violation|0|||
160491357|NCT01015677|579528834|FG000|Overall Study|Withdrawal by Subject|1|||
160491358|NCT01015677|579528835|FG001|Overall Study|Withdrawal by Subject|1|||
160491359|NCT01015677|579528836|FG002|Overall Study|Withdrawal by Subject|0|||
160491360|NCT01660256|579528837|FG000|Overall Study|Adverse Event|4|||
160491361|NCT01660256|579528838|FG001|Overall Study|Adverse Event|0|||
160491362|NCT01660256|579528839|FG002|Overall Study|Adverse Event|2|||
160491363|NCT01660256|579528837|FG000|Overall Study|Withdrawal by Subject|1|||
160491364|NCT01660256|579528838|FG001|Overall Study|Withdrawal by Subject|0|||
160491365|NCT01660256|579528839|FG002|Overall Study|Withdrawal by Subject|2|||
160491366|NCT03898960|579528841|FG000|Overall Study|Death|10|||
160491367|NCT03463577|579528842|FG000|Overall Study|Lost to Follow-up|238|||
160491368|NCT03463577|579528843|FG001|Overall Study|Lost to Follow-up|435|||
160491369|NCT03463577|579528844|FG002|Overall Study|Lost to Follow-up|0|||
160491370|NCT03463577|579528845|FG003|Overall Study|Lost to Follow-up|0|||
160491371|NCT03463577|579528846|FG004|Overall Study|Lost to Follow-up|0|||
160491372|NCT03463577|579528847|FG005|Overall Study|Lost to Follow-up|0|||
160491373|NCT03463577|579528842|FG000|Overall Study|With unknown pregnancy outcome|0|||
160491374|NCT03463577|579528843|FG001|Overall Study|With unknown pregnancy outcome|5|||
160491375|NCT03463577|579528844|FG002|Overall Study|With unknown pregnancy outcome|0|||
160491376|NCT03463577|579528845|FG003|Overall Study|With unknown pregnancy outcome|0|||
160491377|NCT03463577|579528846|FG004|Overall Study|With unknown pregnancy outcome|0|||
160491378|NCT03463577|579528847|FG005|Overall Study|With unknown pregnancy outcome|0|||
160491379|NCT03463577|579528842|FG000|Overall Study|Maternal death|2|||
160491380|NCT03463577|579528843|FG001|Overall Study|Maternal death|0|||
160491381|NCT03463577|579528844|FG002|Overall Study|Maternal death|0|||
160491382|NCT03463577|579528845|FG003|Overall Study|Maternal death|0|||
160491383|NCT03463577|579528846|FG004|Overall Study|Maternal death|0|||
160491384|NCT03463577|579528847|FG005|Overall Study|Maternal death|0|||
160491385|NCT03463577|579528842|FG000|Overall Study|Neonatal death|0|||
160491386|NCT03463577|579528843|FG001|Overall Study|Neonatal death|0|||
160491387|NCT03463577|579528844|FG002|Overall Study|Neonatal death|0|||
160491388|NCT03463577|579528845|FG003|Overall Study|Neonatal death|15|||
160491389|NCT03463577|579528846|FG004|Overall Study|Neonatal death|17|||
160491390|NCT03463577|579528847|FG005|Overall Study|Neonatal death|0|||
160491391|NCT00236184|579528848|FG000|Overall Study|Adverse Event|5|||
160491392|NCT00236184|579528849|FG001|Overall Study|Adverse Event|2|||
160491393|NCT00236184|579528848|FG000|Overall Study|Lack of Efficacy|0|||
160491394|NCT00236184|579528849|FG001|Overall Study|Lack of Efficacy|1|||
160491395|NCT00236184|579528848|FG000|Overall Study|Lost to Follow-up|3|||
160491396|NCT00236184|579528849|FG001|Overall Study|Lost to Follow-up|4|||
160491397|NCT00236184|579528848|FG000|Overall Study|Physician Decision|1|||
160491398|NCT00236184|579528849|FG001|Overall Study|Physician Decision|1|||
160491399|NCT00236184|579528848|FG000|Overall Study|Withdrawal by Subject|3|||
160491400|NCT00236184|579528849|FG001|Overall Study|Withdrawal by Subject|0|||
160491401|NCT00236184|579528848|FG000|Overall Study|Protocol Violation|3|||
160491402|NCT00236184|579528849|FG001|Overall Study|Protocol Violation|0|||
160491403|NCT00236184|579528848|FG000|Overall Study|non-compliance with study drug|2|||
160491404|NCT00236184|579528849|FG001|Overall Study|non-compliance with study drug|1|||
160491405|NCT00236184|579528848|FG000|Overall Study|other|1|||
160491406|NCT00236184|579528849|FG001|Overall Study|other|2|||
160491407|NCT01777490|579528850|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
160491408|NCT01777490|579528851|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
160491409|NCT01777490|579528852|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
160491410|NCT01777490|579528853|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
160491411|NCT00255944|579528857|FG000|Overall Study|Lost to Follow-up|797|||
160491412|NCT00255944|579528858|FG001|Overall Study|Lost to Follow-up|834|||
160491413|NCT00935259|579528866|FG000|Period 1|Administrative (scheduling conflict)|1|||
160491414|NCT00935259|579528867|FG001|Period 1|Administrative (scheduling conflict)|1|||
160491415|NCT01721746|579528868|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
160491416|NCT01721746|579528869|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
160491417|NCT01721746|579528868|FG000|Pre-Treatment|Withdrawal by Subject|1|||
160491418|NCT01721746|579528869|FG001|Pre-Treatment|Withdrawal by Subject|16|||
160491419|NCT01721746|579528868|FG000|Pre-Treatment|Poor/Non-compliance|1|||
160491420|NCT01721746|579528869|FG001|Pre-Treatment|Poor/Non-compliance|0|||
160491421|NCT01721746|579528868|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
160491422|NCT01721746|579528869|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
160491423|NCT01721746|579528868|FG000|Treatment|Disease Progression|192|||
160491424|NCT01721746|579528869|FG001|Treatment|Disease Progression|74|||
160491425|NCT01721746|579528868|FG000|Treatment|Study Drug Toxicity|19|||
160491426|NCT01721746|579528869|FG001|Treatment|Study Drug Toxicity|11|||
160491427|NCT01721746|579528868|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
160491428|NCT01721746|579528869|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
160491429|NCT01721746|579528868|FG000|Treatment|Participant request to discontinue Study treatment|26|||
160491430|NCT01721746|579528869|FG001|Treatment|Participant request to discontinue Study treatment|7|||
160491431|NCT01721746|579528868|FG000|Treatment|Participant withdrew consent|4|||
160491432|NCT01721746|579528869|FG001|Treatment|Participant withdrew consent|2|||
160491433|NCT01721746|579528868|FG000|Treatment|Maximum Clinical Benefit|9|||
160491434|NCT01721746|579528869|FG001|Treatment|Maximum Clinical Benefit|3|||
160491435|NCT01721746|579528868|FG000|Treatment|Poor/Non-compliance|2|||
160491436|NCT01721746|579528869|FG001|Treatment|Poor/Non-compliance|0|||
160491437|NCT01721746|579528868|FG000|Treatment|Participant no longer met Study criteria|4|||
160491438|NCT01721746|579528869|FG001|Treatment|Participant no longer met Study criteria|0|||
160491439|NCT01721746|579528868|FG000|Treatment|Other reasons|6|||
160491440|NCT01721746|579528869|FG001|Treatment|Other reasons|2|||
160491441|NCT01209598|579528874|FG000|Overall Study|Withdrawal by Subject|1|||
160491442|NCT01209598|579528875|FG001|Overall Study|Withdrawal by Subject|0|||
160491443|NCT00085566|579528876|FG000|Overall Study|Adverse Event|0|||
160491444|NCT00085566|579528877|FG001|Overall Study|Adverse Event|0|||
160491445|NCT00085566|579528878|FG002|Overall Study|Adverse Event|10|||
160491446|NCT00085566|579528876|FG000|Overall Study|Patient Not treated|0|||
160491447|NCT00085566|579528877|FG001|Overall Study|Patient Not treated|0|||
160491448|NCT00085566|579528878|FG002|Overall Study|Patient Not treated|3|||
160491449|NCT00085566|579528876|FG000|Overall Study|Clinical progression|0|||
160491450|NCT00085566|579528877|FG001|Overall Study|Clinical progression|0|||
160491451|NCT00085566|579528878|FG002|Overall Study|Clinical progression|1|||
160491452|NCT00361842|579528879|FG000|Overall Study|Withdrawal by Subject|2|||
160491453|NCT00361842|579528880|FG001|Overall Study|Withdrawal by Subject|3|||
160491454|NCT00361842|579528879|FG000|Overall Study|Death|2|||
160491455|NCT00361842|579528880|FG001|Overall Study|Death|1|||
160491456|NCT00361842|579528879|FG000|Overall Study|Disease progression|19|||
160491457|NCT00361842|579528880|FG001|Overall Study|Disease progression|20|||
160491458|NCT00361842|579528879|FG000|Overall Study|Adverse Event|2|||
160491459|NCT00361842|579528880|FG001|Overall Study|Adverse Event|3|||
160491460|NCT00361842|579528879|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
160491461|NCT00361842|579528880|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
160491462|NCT00361842|579528879|FG000|Overall Study|Other|1|||
160491463|NCT00361842|579528880|FG001|Overall Study|Other|0|||
160491464|NCT00361842|579528879|FG000|Overall Study|Other|0|||
160491465|NCT00361842|579528880|FG001|Overall Study|Other|2|||
160491466|NCT00934700|579528883|FG000|Overall Study|missing scan|5|||
160491467|NCT00934700|579528884|FG001|Overall Study|missing scan|9|||
160491468|NCT00934700|579528883|FG000|Overall Study|Death|8|||
160491469|NCT00934700|579528884|FG001|Overall Study|Death|3|||
160491470|NCT03821064|579528885|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
160491471|NCT00474383|579528886|FG000|Main Study|Adverse Event|11|||
160491472|NCT00474383|579528887|FG001|Main Study|Adverse Event|0|||
160491473|NCT00474383|579528886|FG000|Main Study|Symptomatic Deterioration|1|||
160491474|NCT00474383|579528887|FG001|Main Study|Symptomatic Deterioration|0|||
160491475|NCT00474383|579528886|FG000|Main Study|Progressive Disease|23|||
160491476|NCT00474383|579528887|FG001|Main Study|Progressive Disease|0|||
160491477|NCT00474383|579528886|FG000|Main Study|Other|1|||
160491478|NCT00474383|579528887|FG001|Main Study|Other|0|||
160491479|NCT00474383|579528886|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
160491480|NCT00474383|579528887|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
160491481|NCT00474383|579528886|FG000|Extension|Progressive Disease|0|||
160491482|NCT00474383|579528887|FG001|Extension|Progressive Disease|5|||
160491483|NCT01482819|579528891|FG000|Overall Study|Lost to Follow-up|2|||
160491484|NCT01502371|579528894|FG000|Overall Study|Withdrawal by Subject|1|||
160491485|NCT01502371|579528895|FG001|Overall Study|Withdrawal by Subject|2|||
160491486|NCT01502371|579528896|FG002|Overall Study|Withdrawal by Subject|1|||
160491487|NCT01502371|579528897|FG003|Overall Study|Withdrawal by Subject|1|||
160491488|NCT01502371|579528898|FG004|Overall Study|Withdrawal by Subject|1|||
160491489|NCT01502371|579528894|FG000|Overall Study|Adverse Event|2|||
160491490|NCT01502371|579528895|FG001|Overall Study|Adverse Event|1|||
160491491|NCT01502371|579528896|FG002|Overall Study|Adverse Event|0|||
160491492|NCT01502371|579528897|FG003|Overall Study|Adverse Event|4|||
160491493|NCT01502371|579528898|FG004|Overall Study|Adverse Event|3|||
160491494|NCT01502371|579528894|FG000|Overall Study|Treatment Failure|22|||
160491495|NCT01502371|579528895|FG001|Overall Study|Treatment Failure|20|||
160491496|NCT01502371|579528896|FG002|Overall Study|Treatment Failure|12|||
160491497|NCT01502371|579528897|FG003|Overall Study|Treatment Failure|19|||
160491498|NCT01502371|579528898|FG004|Overall Study|Treatment Failure|30|||
160491499|NCT01502371|579528894|FG000|Overall Study|Lack of Efficacy|3|||
160491500|NCT01502371|579528895|FG001|Overall Study|Lack of Efficacy|3|||
160491501|NCT01502371|579528896|FG002|Overall Study|Lack of Efficacy|2|||
160491502|NCT01502371|579528897|FG003|Overall Study|Lack of Efficacy|2|||
160491503|NCT01502371|579528898|FG004|Overall Study|Lack of Efficacy|4|||
160491504|NCT01502371|579528894|FG000|Overall Study|Physician Decision|3|||
160491505|NCT01502371|579528895|FG001|Overall Study|Physician Decision|0|||
160491506|NCT01502371|579528896|FG002|Overall Study|Physician Decision|0|||
160491507|NCT01502371|579528897|FG003|Overall Study|Physician Decision|0|||
160491508|NCT01502371|579528898|FG004|Overall Study|Physician Decision|1|||
160491509|NCT01502371|579528894|FG000|Overall Study|Noncompliance with Study Drug|0|||
160491510|NCT01502371|579528895|FG001|Overall Study|Noncompliance with Study Drug|0|||
160491511|NCT01502371|579528896|FG002|Overall Study|Noncompliance with Study Drug|1|||
160491512|NCT01502371|579528897|FG003|Overall Study|Noncompliance with Study Drug|2|||
160491513|NCT01502371|579528898|FG004|Overall Study|Noncompliance with Study Drug|1|||
160491514|NCT01502371|579528894|FG000|Overall Study|Technical Problems|1|||
160491515|NCT01502371|579528895|FG001|Overall Study|Technical Problems|0|||
160491516|NCT01502371|579528896|FG002|Overall Study|Technical Problems|2|||
160491517|NCT01502371|579528897|FG003|Overall Study|Technical Problems|4|||
160491518|NCT01502371|579528898|FG004|Overall Study|Technical Problems|1|||
160491519|NCT01502371|579528894|FG000|Overall Study|Protocol Violation|9|||
160491520|NCT01502371|579528895|FG001|Overall Study|Protocol Violation|5|||
160491521|NCT01502371|579528896|FG002|Overall Study|Protocol Violation|6|||
160491522|NCT01502371|579528897|FG003|Overall Study|Protocol Violation|5|||
160491523|NCT01502371|579528898|FG004|Overall Study|Protocol Violation|10|||
160491524|NCT01502371|579528894|FG000|Overall Study|Excluded Medication|0|||
160491525|NCT01502371|579528895|FG001|Overall Study|Excluded Medication|1|||
160491526|NCT01502371|579528896|FG002|Overall Study|Excluded Medication|1|||
160491527|NCT01502371|579528897|FG003|Overall Study|Excluded Medication|0|||
160491528|NCT01502371|579528898|FG004|Overall Study|Excluded Medication|1|||
160491529|NCT03325608|579528901|FG000|Overall Study|Lost to Follow-up|23|||
160491530|NCT03325608|579528902|FG001|Overall Study|Lost to Follow-up|23|||
160491531|NCT03325608|579528903|FG002|Overall Study|Lost to Follow-up|30|||
160491532|NCT03325608|579528904|FG003|Overall Study|Lost to Follow-up|30|||
160491533|NCT03325608|579528901|FG000|Overall Study|Death of Caregiver|0|||
160491534|NCT03325608|579528902|FG001|Overall Study|Death of Caregiver|0|||
160491535|NCT03325608|579528903|FG002|Overall Study|Death of Caregiver|2|||
160491536|NCT03325608|579528904|FG003|Overall Study|Death of Caregiver|2|||
160491537|NCT03325608|579528901|FG000|Overall Study|Death of Care Recipient|34|||
160491538|NCT03325608|579528902|FG001|Overall Study|Death of Care Recipient|34|||
160491539|NCT03325608|579528903|FG002|Overall Study|Death of Care Recipient|28|||
160491540|NCT03325608|579528904|FG003|Overall Study|Death of Care Recipient|28|||
160491541|NCT03325608|579528901|FG000|Overall Study|Withdrawal by Subject|49|||
160491542|NCT03325608|579528902|FG001|Overall Study|Withdrawal by Subject|49|||
160491543|NCT03325608|579528903|FG002|Overall Study|Withdrawal by Subject|35|||
160491544|NCT03325608|579528904|FG003|Overall Study|Withdrawal by Subject|35|||
160491545|NCT03325608|579528901|FG000|Overall Study|Ineligible|7|||
160491546|NCT03325608|579528902|FG001|Overall Study|Ineligible|7|||
160491547|NCT03325608|579528903|FG002|Overall Study|Ineligible|5|||
160491548|NCT03325608|579528904|FG003|Overall Study|Ineligible|5|||
160491549|NCT00942188|579528905|FG000|Overall Study|Adverse Event|0|||
160491550|NCT00942188|579528906|FG001|Overall Study|Adverse Event|3|||
160491551|NCT00942188|579528907|FG002|Overall Study|Adverse Event|2|||
160491552|NCT00942188|579528908|FG003|Overall Study|Adverse Event|0|||
160491553|NCT00942188|579528905|FG000|Overall Study|Lack of Efficacy|0|||
160491554|NCT00942188|579528906|FG001|Overall Study|Lack of Efficacy|0|||
160491555|NCT00942188|579528907|FG002|Overall Study|Lack of Efficacy|0|||
160491556|NCT00942188|579528908|FG003|Overall Study|Lack of Efficacy|1|||
160491557|NCT00942188|579528905|FG000|Overall Study|Protocol Violation|1|||
160491558|NCT00942188|579528906|FG001|Overall Study|Protocol Violation|1|||
160491559|NCT00942188|579528907|FG002|Overall Study|Protocol Violation|0|||
160491560|NCT00942188|579528908|FG003|Overall Study|Protocol Violation|0|||
160491561|NCT00942188|579528905|FG000|Overall Study|Lost to Follow-up|2|||
160491562|NCT00942188|579528906|FG001|Overall Study|Lost to Follow-up|1|||
160491563|NCT00942188|579528907|FG002|Overall Study|Lost to Follow-up|2|||
160491564|NCT00942188|579528908|FG003|Overall Study|Lost to Follow-up|0|||
160491565|NCT00942188|579528905|FG000|Overall Study|Withdrawal by Subject|1|||
160491566|NCT00942188|579528906|FG001|Overall Study|Withdrawal by Subject|3|||
160491567|NCT00942188|579528907|FG002|Overall Study|Withdrawal by Subject|4|||
160491568|NCT00942188|579528908|FG003|Overall Study|Withdrawal by Subject|2|||
160491569|NCT00942188|579528905|FG000|Overall Study|Physician Decision|0|||
160491570|NCT00942188|579528906|FG001|Overall Study|Physician Decision|0|||
160491571|NCT00942188|579528907|FG002|Overall Study|Physician Decision|1|||
160491572|NCT00942188|579528908|FG003|Overall Study|Physician Decision|0|||
160491573|NCT00942188|579528905|FG000|Overall Study|Sponsor Decision|0|||
160491574|NCT00942188|579528906|FG001|Overall Study|Sponsor Decision|2|||
160491575|NCT00942188|579528907|FG002|Overall Study|Sponsor Decision|0|||
160491576|NCT00942188|579528908|FG003|Overall Study|Sponsor Decision|1|||
160491577|NCT02188784|579528909|FG000|Overall Study|Death|3|||
160491578|NCT02188784|579528910|FG001|Overall Study|Death|1|||
160491579|NCT02188784|579528909|FG000|Overall Study|Lost to Follow-up|1|||
160491580|NCT02188784|579528910|FG001|Overall Study|Lost to Follow-up|0|||
160491581|NCT02188784|579528909|FG000|Overall Study|Withdrawal by Subject|3|||
160491582|NCT02188784|579528910|FG001|Overall Study|Withdrawal by Subject|9|||
160491583|NCT02188784|579528909|FG000|Overall Study|Physician Decision|2|||
160491584|NCT02188784|579528910|FG001|Overall Study|Physician Decision|3|||
160491585|NCT00514813|579528914|FG000|Overall Study|Study terminated|14|||
160491586|NCT00514813|579528915|FG001|Overall Study|Study terminated|74|||
160491587|NCT00514813|579528916|FG002|Overall Study|Study terminated|40|||
160491588|NCT00514813|579528917|FG003|Overall Study|Study terminated|2|||
160491589|NCT00514813|579528914|FG000|Overall Study|Adverse Event|0|||
160491590|NCT00514813|579528915|FG001|Overall Study|Adverse Event|2|||
160491591|NCT00514813|579528916|FG002|Overall Study|Adverse Event|2|||
160491592|NCT00514813|579528917|FG003|Overall Study|Adverse Event|0|||
160491593|NCT00514813|579528914|FG000|Overall Study|Protocol Violation|1|||
160491594|NCT00514813|579528915|FG001|Overall Study|Protocol Violation|0|||
160491595|NCT00514813|579528916|FG002|Overall Study|Protocol Violation|0|||
160491596|NCT00514813|579528917|FG003|Overall Study|Protocol Violation|0|||
160491597|NCT00514813|579528914|FG000|Overall Study|Withdrawal by Subject|0|||
160491598|NCT00514813|579528915|FG001|Overall Study|Withdrawal by Subject|1|||
160491599|NCT00514813|579528916|FG002|Overall Study|Withdrawal by Subject|0|||
160491600|NCT00514813|579528917|FG003|Overall Study|Withdrawal by Subject|0|||
160491601|NCT00514813|579528914|FG000|Overall Study|Lack of Efficacy|0|||
160491602|NCT00514813|579528915|FG001|Overall Study|Lack of Efficacy|1|||
160491603|NCT00514813|579528916|FG002|Overall Study|Lack of Efficacy|0|||
160491604|NCT00514813|579528917|FG003|Overall Study|Lack of Efficacy|0|||
160491605|NCT00514813|579528914|FG000|Overall Study|Kidney transplant|0|||
160491606|NCT00514813|579528915|FG001|Overall Study|Kidney transplant|6|||
160491607|NCT00514813|579528916|FG002|Overall Study|Kidney transplant|2|||
160491608|NCT00514813|579528917|FG003|Overall Study|Kidney transplant|0|||
160491609|NCT00514813|579528914|FG000|Overall Study|Death|0|||
160491610|NCT00514813|579528915|FG001|Overall Study|Death|2|||
160491611|NCT00514813|579528916|FG002|Overall Study|Death|3|||
160491612|NCT00514813|579528917|FG003|Overall Study|Death|2|||
160491613|NCT01075100|579528922|FG000|Overall Study|Adverse Event|15|||
160491614|NCT01075100|579528923|FG001|Overall Study|Adverse Event|18|||
160491615|NCT01075100|579528922|FG000|Overall Study|Patient Request|4|||
160611613|NCT04076579|579956142|FG001|Overall Study|Noncompliance|1|||
160611614|NCT04076579|579956141|FG000|Overall Study|Withdrawal by Subject|0|||
160611615|NCT04076579|579956142|FG001|Overall Study|Withdrawal by Subject|2|||
160611616|NCT01997892|579956145|FG000|Overall Study|Physician Decision|2|||
160611617|NCT01997892|579956145|FG000|Overall Study|Lost to Follow-up|6|||
160611618|NCT01997892|579956145|FG000|Overall Study|Death|14|||
160611619|NCT01997892|579956145|FG000|Overall Study|Renal transplant|8|||
160611620|NCT01997892|579956145|FG000|Overall Study|Other|3|||
160611621|NCT01997892|579956145|FG000|Overall Study|Study completion data not recorded|35|||
160611622|NCT02531633|579956146|FG000|Part A (52 Weeks)|Sponsor request|24|||
160611623|NCT02531633|579956147|FG001|Part A (52 Weeks)|Sponsor request|24|||
160491616|NCT01075100|579528923|FG001|Overall Study|Patient Request|4|||
160491617|NCT01075100|579528922|FG000|Overall Study|Investigator Request|2|||
160491618|NCT01075100|579528923|FG001|Overall Study|Investigator Request|1|||
160491619|NCT01075100|579528922|FG000|Overall Study|Disease Progression|25|||
160491620|NCT01075100|579528923|FG001|Overall Study|Disease Progression|29|||
160491621|NCT01075100|579528922|FG000|Overall Study|Other|3|||
160491622|NCT01075100|579528923|FG001|Overall Study|Other|1|||
160611624|NCT02531633|579956148|FG002|Part A (52 Weeks)|Sponsor request|18|||
160611625|NCT02531633|579956149|FG003|Part A (52 Weeks)|Sponsor request|18|||
160611626|NCT02531633|579956150|FG004|Part A (52 Weeks)|Sponsor request|19|||
160611627|NCT02531633|579956151|FG005|Part A (52 Weeks)|Sponsor request|0|||
160611628|NCT02531633|579956152|FG006|Part A (52 Weeks)|Sponsor request|0|||
160611629|NCT02531633|579956153|FG007|Part A (52 Weeks)|Sponsor request|0|||
160611630|NCT02531633|579956154|FG008|Part A (52 Weeks)|Sponsor request|0|||
160611631|NCT02531633|579956155|FG009|Part A (52 Weeks)|Sponsor request|0|||
160611632|NCT02531633|579956146|FG000|Part A (52 Weeks)|Protocol Violation|1|||
160611633|NCT02531633|579956147|FG001|Part A (52 Weeks)|Protocol Violation|0|||
160611634|NCT02531633|579956148|FG002|Part A (52 Weeks)|Protocol Violation|0|||
160611635|NCT02531633|579956149|FG003|Part A (52 Weeks)|Protocol Violation|0|||
160611636|NCT02531633|579956150|FG004|Part A (52 Weeks)|Protocol Violation|0|||
160611637|NCT02531633|579956151|FG005|Part A (52 Weeks)|Protocol Violation|0|||
160611638|NCT02531633|579956152|FG006|Part A (52 Weeks)|Protocol Violation|0|||
160611639|NCT02531633|579956153|FG007|Part A (52 Weeks)|Protocol Violation|0|||
160611640|NCT02531633|579956154|FG008|Part A (52 Weeks)|Protocol Violation|0|||
160611641|NCT02531633|579956155|FG009|Part A (52 Weeks)|Protocol Violation|0|||
160611642|NCT02531633|579956146|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
160611643|NCT02531633|579956147|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
160611644|NCT02531633|579956148|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
160611645|NCT02531633|579956149|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
160611646|NCT02531633|579956150|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
160491623|NCT00143598|579528926|FG000|Overall Study|Lost to Follow-up|23|||
160491624|NCT00143598|579528927|FG001|Overall Study|Lost to Follow-up|21|||
160491625|NCT00143598|579528926|FG000|Overall Study|Withdrawal by Subject|33|||
160491626|NCT00143598|579528927|FG001|Overall Study|Withdrawal by Subject|37|||
160491627|NCT00143598|579528926|FG000|Overall Study|Death|36|||
160491628|NCT00143598|579528927|FG001|Overall Study|Death|36|||
160611647|NCT02531633|579956151|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
160491629|NCT04944784|579528930|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
160491630|NCT04944784|579528931|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
160491631|NCT04944784|579528932|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
160491632|NCT04944784|579528933|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
160491633|NCT04944784|579528930|FG000|Double-blind Period|Adverse Event|20|||
160491634|NCT04944784|579528931|FG001|Double-blind Period|Adverse Event|4|||
160491635|NCT04944784|579528932|FG002|Double-blind Period|Adverse Event|0|||
160491636|NCT04944784|579528933|FG003|Double-blind Period|Adverse Event|0|||
160491637|NCT04944784|579528930|FG000|Double-blind Period|Withdrawal by Subject|15|||
160491638|NCT04944784|579528931|FG001|Double-blind Period|Withdrawal by Subject|4|||
160491639|NCT04944784|579528932|FG002|Double-blind Period|Withdrawal by Subject|0|||
160491640|NCT04944784|579528933|FG003|Double-blind Period|Withdrawal by Subject|0|||
160491641|NCT04944784|579528930|FG000|Double-blind Period|Death|7|||
160491642|NCT04944784|579528931|FG001|Double-blind Period|Death|2|||
160491643|NCT04944784|579528932|FG002|Double-blind Period|Death|0|||
160491644|NCT04944784|579528933|FG003|Double-blind Period|Death|0|||
160491645|NCT04944784|579528930|FG000|Double-blind Period|Physician Decision|2|||
160491646|NCT04944784|579528931|FG001|Double-blind Period|Physician Decision|1|||
160491647|NCT04944784|579528932|FG002|Double-blind Period|Physician Decision|0|||
160491648|NCT04944784|579528933|FG003|Double-blind Period|Physician Decision|0|||
160491649|NCT04944784|579528930|FG000|Double-blind Period|Lack of Efficacy|0|||
160491650|NCT04944784|579528931|FG001|Double-blind Period|Lack of Efficacy|1|||
160491651|NCT04944784|579528932|FG002|Double-blind Period|Lack of Efficacy|0|||
160491652|NCT04944784|579528933|FG003|Double-blind Period|Lack of Efficacy|0|||
160491653|NCT04944784|579528930|FG000|Double-blind Period|Sponsor Request|2|||
160491654|NCT04944784|579528931|FG001|Double-blind Period|Sponsor Request|1|||
160491655|NCT04944784|579528932|FG002|Double-blind Period|Sponsor Request|0|||
160491656|NCT04944784|579528933|FG003|Double-blind Period|Sponsor Request|0|||
160491657|NCT04944784|579528930|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
160491658|NCT04944784|579528931|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
160491659|NCT04944784|579528932|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
160491660|NCT04944784|579528933|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
160491661|NCT04944784|579528930|FG000|Double-blind Period|Participant Choice|1|||
160491662|NCT04944784|579528931|FG001|Double-blind Period|Participant Choice|1|||
160491663|NCT04944784|579528932|FG002|Double-blind Period|Participant Choice|0|||
160491664|NCT04944784|579528933|FG003|Double-blind Period|Participant Choice|0|||
160491665|NCT04944784|579528930|FG000|Double-blind Period|Progressive Disease|2|||
160491666|NCT04944784|579528931|FG001|Double-blind Period|Progressive Disease|2|||
160491667|NCT04944784|579528932|FG002|Double-blind Period|Progressive Disease|0|||
160491668|NCT04944784|579528933|FG003|Double-blind Period|Progressive Disease|0|||
160491669|NCT04944784|579528930|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
160491670|NCT04944784|579528931|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
160491671|NCT04944784|579528932|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
160491672|NCT04944784|579528933|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
160491673|NCT04944784|579528930|FG000|Active Drug Period|Adverse Event|0|||
160491674|NCT04944784|579528931|FG001|Active Drug Period|Adverse Event|0|||
160491675|NCT04944784|579528932|FG002|Active Drug Period|Adverse Event|3|||
160491676|NCT04944784|579528933|FG003|Active Drug Period|Adverse Event|6|||
160491677|NCT04944784|579528930|FG000|Active Drug Period|Withdrawal by Subject|0|||
160491678|NCT04944784|579528931|FG001|Active Drug Period|Withdrawal by Subject|0|||
160491679|NCT04944784|579528932|FG002|Active Drug Period|Withdrawal by Subject|4|||
160491680|NCT04944784|579528933|FG003|Active Drug Period|Withdrawal by Subject|7|||
160491681|NCT04944784|579528930|FG000|Active Drug Period|Death|0|||
160491682|NCT04944784|579528931|FG001|Active Drug Period|Death|0|||
160491683|NCT04944784|579528932|FG002|Active Drug Period|Death|3|||
160491684|NCT04944784|579528933|FG003|Active Drug Period|Death|4|||
160491685|NCT04944784|579528930|FG000|Active Drug Period|Lack of Efficacy|0|||
160491686|NCT04944784|579528931|FG001|Active Drug Period|Lack of Efficacy|0|||
160491687|NCT04944784|579528932|FG002|Active Drug Period|Lack of Efficacy|2|||
160491688|NCT04944784|579528933|FG003|Active Drug Period|Lack of Efficacy|2|||
160491689|NCT04944784|579528930|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
160491690|NCT04944784|579528931|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
160611648|NCT02531633|579956152|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
160491691|NCT04944784|579528932|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
160491692|NCT04944784|579528933|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
160491693|NCT04944784|579528930|FG000|Active Drug Period|Participant Choice|0|||
160491694|NCT04944784|579528931|FG001|Active Drug Period|Participant Choice|0|||
160491695|NCT04944784|579528932|FG002|Active Drug Period|Participant Choice|0|||
160491696|NCT04944784|579528933|FG003|Active Drug Period|Participant Choice|1|||
160491697|NCT04944784|579528930|FG000|Active Drug Period|Progressive Disease|0|||
160491698|NCT04944784|579528931|FG001|Active Drug Period|Progressive Disease|0|||
160491699|NCT04944784|579528932|FG002|Active Drug Period|Progressive Disease|4|||
160491700|NCT04944784|579528933|FG003|Active Drug Period|Progressive Disease|4|||
160491701|NCT04944784|579528930|FG000|Active Drug Period|Lost to Follow-up|0|||
160491702|NCT04944784|579528931|FG001|Active Drug Period|Lost to Follow-up|0|||
160491703|NCT04944784|579528932|FG002|Active Drug Period|Lost to Follow-up|0|||
160491704|NCT04944784|579528933|FG003|Active Drug Period|Lost to Follow-up|1|||
160491705|NCT03900715|579528934|FG000|Overall Study|Protocol Deviation|1|||
160491706|NCT03900715|579528934|FG000|Overall Study|Lack of Efficacy|1|||
160491707|NCT03900715|579528934|FG000|Overall Study|Progressive Disease|6|||
160491708|NCT03900715|579528934|FG000|Overall Study|Adverse Event|2|||
160491709|NCT03900715|579528934|FG000|Overall Study|Other reasons|11|||
160491710|NCT01568112|579528935|FG000|Overall Study|Randomized But Not Treated|0|||
160491711|NCT01568112|579528936|FG001|Overall Study|Randomized But Not Treated|1|||
160491712|NCT01568112|579528937|FG002|Overall Study|Randomized But Not Treated|0|||
160491713|NCT01568112|579528938|FG003|Overall Study|Randomized But Not Treated|0|||
160491714|NCT01568112|579528935|FG000|Overall Study|Withdrew due to Adverse Event|2|||
160491715|NCT01568112|579528936|FG001|Overall Study|Withdrew due to Adverse Event|4|||
160491716|NCT01568112|579528937|FG002|Overall Study|Withdrew due to Adverse Event|6|||
160491717|NCT01568112|579528938|FG003|Overall Study|Withdrew due to Adverse Event|3|||
160491718|NCT01568112|579528935|FG000|Overall Study|Lost to Follow-up|0|||
160491719|NCT01568112|579528936|FG001|Overall Study|Lost to Follow-up|0|||
160491720|NCT01568112|579528937|FG002|Overall Study|Lost to Follow-up|0|||
160491721|NCT01568112|579528938|FG003|Overall Study|Lost to Follow-up|1|||
160491722|NCT01568112|579528935|FG000|Overall Study|Withdrawal by Subject|2|||
160491723|NCT01568112|579528936|FG001|Overall Study|Withdrawal by Subject|3|||
160491724|NCT01568112|579528937|FG002|Overall Study|Withdrawal by Subject|0|||
160491725|NCT01568112|579528938|FG003|Overall Study|Withdrawal by Subject|7|||
160491726|NCT01568112|579528935|FG000|Overall Study|Withdrawal by Physician|1|||
160491727|NCT01568112|579528936|FG001|Overall Study|Withdrawal by Physician|0|||
160491728|NCT01568112|579528937|FG002|Overall Study|Withdrawal by Physician|1|||
160491729|NCT01568112|579528938|FG003|Overall Study|Withdrawal by Physician|1|||
160611649|NCT02531633|579956153|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
160611650|NCT02531633|579956154|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
160611651|NCT02531633|579956155|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
160611652|NCT02531633|579956146|FG000|Part A (52 Weeks)|Physician Decision|1|||
160611653|NCT02531633|579956147|FG001|Part A (52 Weeks)|Physician Decision|4|||
160611654|NCT02531633|579956148|FG002|Part A (52 Weeks)|Physician Decision|3|||
160611655|NCT02531633|579956149|FG003|Part A (52 Weeks)|Physician Decision|1|||
160611656|NCT02531633|579956150|FG004|Part A (52 Weeks)|Physician Decision|0|||
160611657|NCT02531633|579956151|FG005|Part A (52 Weeks)|Physician Decision|0|||
160611658|NCT02531633|579956152|FG006|Part A (52 Weeks)|Physician Decision|0|||
160611659|NCT02531633|579956153|FG007|Part A (52 Weeks)|Physician Decision|0|||
160611660|NCT02531633|579956154|FG008|Part A (52 Weeks)|Physician Decision|0|||
160611661|NCT02531633|579956155|FG009|Part A (52 Weeks)|Physician Decision|0|||
160611662|NCT02531633|579956146|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
160611663|NCT02531633|579956147|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
160611664|NCT02531633|579956148|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
160611665|NCT02531633|579956149|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
160611666|NCT02531633|579956150|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
160611667|NCT02531633|579956151|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
160611668|NCT02531633|579956152|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
160611669|NCT02531633|579956153|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
160611670|NCT02531633|579956154|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
160611671|NCT02531633|579956155|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
160611672|NCT02531633|579956146|FG000|Part A (52 Weeks)|Other|2|||
160611673|NCT02531633|579956147|FG001|Part A (52 Weeks)|Other|0|||
160611674|NCT02531633|579956148|FG002|Part A (52 Weeks)|Other|0|||
160611675|NCT02531633|579956149|FG003|Part A (52 Weeks)|Other|0|||
160611676|NCT02531633|579956150|FG004|Part A (52 Weeks)|Other|0|||
160611677|NCT02531633|579956151|FG005|Part A (52 Weeks)|Other|0|||
160611678|NCT02531633|579956152|FG006|Part A (52 Weeks)|Other|0|||
160611679|NCT02531633|579956153|FG007|Part A (52 Weeks)|Other|0|||
160611680|NCT02531633|579956154|FG008|Part A (52 Weeks)|Other|0|||
160611681|NCT02531633|579956155|FG009|Part A (52 Weeks)|Other|0|||
160611682|NCT02531633|579956146|FG000|Part B (104 Weeks)|Sponsor request|0|||
160611683|NCT02531633|579956147|FG001|Part B (104 Weeks)|Sponsor request|0|||
160611684|NCT02531633|579956148|FG002|Part B (104 Weeks)|Sponsor request|0|||
160611685|NCT02531633|579956149|FG003|Part B (104 Weeks)|Sponsor request|0|||
160611686|NCT02531633|579956150|FG004|Part B (104 Weeks)|Sponsor request|0|||
160611687|NCT02531633|579956151|FG005|Part B (104 Weeks)|Sponsor request|8|||
160611688|NCT02531633|579956152|FG006|Part B (104 Weeks)|Sponsor request|5|||
160611689|NCT02531633|579956153|FG007|Part B (104 Weeks)|Sponsor request|3|||
160611690|NCT02531633|579956154|FG008|Part B (104 Weeks)|Sponsor request|5|||
160611691|NCT02531633|579956155|FG009|Part B (104 Weeks)|Sponsor request|4|||
160611692|NCT02531633|579956146|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
160611693|NCT02531633|579956147|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
160611694|NCT02531633|579956148|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
160611695|NCT02531633|579956149|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
160611696|NCT02531633|579956150|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
160611697|NCT02531633|579956151|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
160611698|NCT02531633|579956152|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
160491730|NCT00416598|579530990|FG000|Induction & Intensification|Adverse Event|38|||
160491731|NCT00416598|579530990|FG000|Induction & Intensification|Death|32|||
160491732|NCT00416598|579530990|FG000|Induction & Intensification|Withdrawal by Subject|46|||
160491733|NCT00416598|579530990|FG000|Induction & Intensification|Alternative Treatment|135|||
160491734|NCT00416598|579530990|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
160491735|NCT00416598|579530990|FG000|Induction & Intensification|Relapse/progression|29|||
160491736|NCT00416598|579530990|FG000|Induction & Intensification|Failed induction|87|||
160491737|NCT00416598|579530990|FG000|Decitabine Maintenance|Adverse Event|5|||
160491738|NCT00416598|579530990|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
160491739|NCT00416598|579530990|FG000|Decitabine Maintenance|Progression/relapse|38|||
160491740|NCT00416598|579530990|FG000|Decitabine Maintenance|Alternative treatment|2|||
160491741|NCT00416598|579530990|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
160491742|NCT04523207|579530991|FG000|Overall Study|Adverse Event|5|||
160491743|NCT04523207|579530992|FG001|Overall Study|Adverse Event|1|||
160491744|NCT04523207|579530991|FG000|Overall Study|Lost to Follow-up|2|||
160491745|NCT04523207|579530992|FG001|Overall Study|Lost to Follow-up|0|||
160491746|NCT04523207|579530991|FG000|Overall Study|Withdrawal by Subject|2|||
160491747|NCT04523207|579530992|FG001|Overall Study|Withdrawal by Subject|0|||
160491748|NCT04523207|579530991|FG000|Overall Study|Progressive Disease|2|||
160491749|NCT04523207|579530992|FG001|Overall Study|Progressive Disease|1|||
160491750|NCT04523207|579530991|FG000|Overall Study|Other|7|||
160491751|NCT04523207|579530992|FG001|Overall Study|Other|1|||
160491752|NCT03113383|579530993|FG000|Overall Study|Death|4|||
160491753|NCT03113383|579530994|FG001|Overall Study|Death|0|||
160491754|NCT04469465|579530996|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
160491755|NCT04469465|579530997|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
160491756|NCT04469465|579530996|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
160491757|NCT04469465|579530997|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
160491758|NCT04469465|579530996|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
160491759|NCT04469465|579530997|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
160491760|NCT04469465|579530996|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
160491761|NCT04469465|579530997|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
160491762|NCT04469465|579530996|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
160491763|NCT04469465|579530997|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
160491764|NCT04469465|579530996|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
160491765|NCT04469465|579530997|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
160491766|NCT04469465|579530996|FG000|Long-Term Extension (LTE)|Death|0|||
160491767|NCT04469465|579530997|FG001|Long-Term Extension (LTE)|Death|1|||
160491768|NCT04469465|579530996|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
160491769|NCT04469465|579530997|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
160491770|NCT02641587|579530998|FG000|Confinement Period|Adverse Event|1|||
160491771|NCT02641587|579530999|FG001|Confinement Period|Adverse Event|0|||
160491772|NCT02641587|579530998|FG000|Confinement Period|Withdrawal by Subject|2|||
160491773|NCT02641587|579530999|FG001|Confinement Period|Withdrawal by Subject|1|||
160491774|NCT02641587|579530998|FG000|Ambulatory Period|Withdrawal by Subject|1|||
160491775|NCT02641587|579530999|FG001|Ambulatory Period|Withdrawal by Subject|0|||
160491776|NCT03194867|579531003|FG000|Overall Study|Incorrect completion of end of study form|0|||
160491777|NCT03194867|579531004|FG001|Overall Study|Incorrect completion of end of study form|0|||
160491778|NCT03194867|579531005|FG002|Overall Study|Incorrect completion of end of study form|1|||
160491779|NCT03194867|579531006|FG003|Overall Study|Incorrect completion of end of study form|0|||
160491780|NCT00464945|579531007|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
160491781|NCT00464945|579531008|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
160491782|NCT00464945|579531007|FG000|Infant Series|Protocol Violation|1|||
160491783|NCT00464945|579531008|FG001|Infant Series|Protocol Violation|0|||
160491784|NCT00464945|579531007|FG000|Infant Series|Lost to Follow-up|1|||
160491785|NCT00464945|579531008|FG001|Infant Series|Lost to Follow-up|0|||
160491786|NCT00464945|579531007|FG000|After Infant Series|Withdrawal by Subject|0|||
160491787|NCT00464945|579531008|FG001|After Infant Series|Withdrawal by Subject|2|||
160491788|NCT00464945|579531007|FG000|Toddler Dose|Lost to Follow-up|0|||
160491789|NCT00464945|579531008|FG001|Toddler Dose|Lost to Follow-up|1|||
160491790|NCT00543062|579531009|FG000|Overall Study|Withdrawal by Subject|1|||
160491791|NCT00543062|579531010|FG001|Overall Study|Withdrawal by Subject|0|||
160491792|NCT00543062|579531011|FG002|Overall Study|Withdrawal by Subject|2|||
160491793|NCT00543062|579531012|FG003|Overall Study|Withdrawal by Subject|0|||
160491794|NCT00543062|579531009|FG000|Overall Study|Adverse Event|0|||
160491795|NCT00543062|579531010|FG001|Overall Study|Adverse Event|1|||
160491796|NCT00543062|579531011|FG002|Overall Study|Adverse Event|1|||
160491797|NCT00543062|579531012|FG003|Overall Study|Adverse Event|1|||
160491798|NCT00543062|579531009|FG000|Overall Study|Protocol Violation|1|||
160491799|NCT00543062|579531010|FG001|Overall Study|Protocol Violation|0|||
160491800|NCT00543062|579531011|FG002|Overall Study|Protocol Violation|0|||
160491801|NCT00543062|579531012|FG003|Overall Study|Protocol Violation|0|||
160491802|NCT01663506|579531016|FG000|Overall Study|Lack of Efficacy|3|||
160491803|NCT01663506|579531016|FG000|Overall Study|Consent Withdrawal by Subject|1|||
160491804|NCT01663506|579531016|FG000|Overall Study|Lost to Follow-up|1|||
160491805|NCT01663506|579531016|FG000|Overall Study|Adverse Event|1|||
160491806|NCT01663506|579531016|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
160491807|NCT02094898|579531022|FG000|Overall Study|Clinical Worsening|2|||
160491808|NCT02094898|579531022|FG000|Overall Study|Adverse Event|2|||
160491809|NCT02094898|579531022|FG000|Overall Study|Lack of Efficacy|1|||
160491810|NCT03520075|579531023|FG000|Phase 1 (Dose Escalation)|Death|2|||
160491811|NCT03520075|579531024|FG001|Phase 1 (Dose Escalation)|Death|2|||
160491812|NCT03520075|579531025|FG002|Phase 1 (Dose Escalation)|Death|3|||
160491813|NCT03520075|579531026|FG003|Phase 1 (Dose Escalation)|Death|2|||
160491814|NCT03520075|579531027|FG004|Phase 1 (Dose Escalation)|Death|6|||
160491815|NCT03520075|579531028|FG005|Phase 1 (Dose Escalation)|Death|5|||
160491816|NCT03520075|579531029|FG006|Phase 1 (Dose Escalation)|Death|3|||
160491817|NCT03520075|579531030|FG007|Phase 1 (Dose Escalation)|Death|2|||
160491818|NCT03520075|579531031|FG008|Phase 1 (Dose Escalation)|Death|3|||
160491819|NCT03520075|579531032|FG009|Phase 1 (Dose Escalation)|Death|1|||
160491820|NCT03520075|579531033|FG010|Phase 1 (Dose Escalation)|Death|5|||
160491821|NCT03520075|579531034|FG011|Phase 1 (Dose Escalation)|Death|7|||
160491822|NCT03520075|579531035|FG012|Phase 1 (Dose Escalation)|Death|11|||
160491823|NCT03520075|579531036|FG013|Phase 1 (Dose Escalation)|Death|0|||
160491824|NCT03520075|579531037|FG014|Phase 1 (Dose Escalation)|Death|0|||
160491825|NCT03520075|579531038|FG015|Phase 1 (Dose Escalation)|Death|0|||
160491826|NCT03520075|579531039|FG016|Phase 1 (Dose Escalation)|Death|0|||
160491827|NCT03520075|579531040|FG017|Phase 1 (Dose Escalation)|Death|0|||
160491828|NCT03520075|579531041|FG018|Phase 1 (Dose Escalation)|Death|0|||
160491829|NCT03520075|579531023|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
160491830|NCT03520075|579531024|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491831|NCT03520075|579531025|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491832|NCT03520075|579531026|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
160491833|NCT03520075|579531027|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
160491834|NCT03520075|579531028|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
160491835|NCT03520075|579531029|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491836|NCT03520075|579531030|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
160491837|NCT03520075|579531031|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491838|NCT03520075|579531032|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
160491839|NCT03520075|579531033|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491840|NCT03520075|579531034|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491841|NCT03520075|579531035|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
160491842|NCT03520075|579531036|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491843|NCT03520075|579531037|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491844|NCT03520075|579531038|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491845|NCT03520075|579531039|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491846|NCT03520075|579531040|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491847|NCT03520075|579531041|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
160491848|NCT03520075|579531023|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491849|NCT03520075|579531024|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
160491850|NCT03520075|579531025|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491851|NCT03520075|579531026|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
160491852|NCT03520075|579531027|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
160491853|NCT03520075|579531028|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491854|NCT03520075|579531029|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491855|NCT03520075|579531030|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491856|NCT03520075|579531031|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491857|NCT03520075|579531032|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491858|NCT03520075|579531033|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
160491859|NCT03520075|579531034|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160611699|NCT02531633|579956153|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
160491860|NCT03520075|579531035|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
160491861|NCT03520075|579531036|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491862|NCT03520075|579531037|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160611700|NCT02531633|579956154|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
160611701|NCT02531633|579956155|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
160491863|NCT03520075|579531038|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491864|NCT03520075|579531039|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491865|NCT03520075|579531040|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491866|NCT03520075|579531041|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
160491867|NCT03520075|579531023|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491868|NCT03520075|579531024|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491869|NCT03520075|579531025|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491870|NCT03520075|579531026|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491871|NCT03520075|579531027|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491872|NCT03520075|579531028|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160611702|NCT04097925|579956162|FG000|Overall Study|Withdrawal by Subject|1|||
160491873|NCT03520075|579531029|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491874|NCT03520075|579531030|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491875|NCT03520075|579531031|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491876|NCT03520075|579531032|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
160491877|NCT03520075|579531033|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491878|NCT03520075|579531034|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491879|NCT03520075|579531035|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
160491880|NCT03520075|579531036|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491881|NCT03520075|579531037|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491882|NCT03520075|579531038|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491883|NCT03520075|579531039|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491884|NCT03520075|579531040|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491885|NCT03520075|579531041|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
160491886|NCT03520075|579531023|FG000|Phase 2 (Dose Expansion)|Death|0|||
160491887|NCT03520075|579531024|FG001|Phase 2 (Dose Expansion)|Death|0|||
160491888|NCT03520075|579531025|FG002|Phase 2 (Dose Expansion)|Death|0|||
160491889|NCT03520075|579531026|FG003|Phase 2 (Dose Expansion)|Death|0|||
160491890|NCT03520075|579531027|FG004|Phase 2 (Dose Expansion)|Death|0|||
160491891|NCT03520075|579531028|FG005|Phase 2 (Dose Expansion)|Death|0|||
160491892|NCT03520075|579531029|FG006|Phase 2 (Dose Expansion)|Death|0|||
160491893|NCT03520075|579531030|FG007|Phase 2 (Dose Expansion)|Death|0|||
160491894|NCT03520075|579531031|FG008|Phase 2 (Dose Expansion)|Death|0|||
160491895|NCT03520075|579531032|FG009|Phase 2 (Dose Expansion)|Death|0|||
160491896|NCT03520075|579531033|FG010|Phase 2 (Dose Expansion)|Death|0|||
160491897|NCT03520075|579531034|FG011|Phase 2 (Dose Expansion)|Death|0|||
160491898|NCT03520075|579531035|FG012|Phase 2 (Dose Expansion)|Death|0|||
160491899|NCT03520075|579531036|FG013|Phase 2 (Dose Expansion)|Death|20|||
160491900|NCT03520075|579531037|FG014|Phase 2 (Dose Expansion)|Death|13|||
160491901|NCT03520075|579531038|FG015|Phase 2 (Dose Expansion)|Death|9|||
160491902|NCT03520075|579531039|FG016|Phase 2 (Dose Expansion)|Death|5|||
160491903|NCT03520075|579531040|FG017|Phase 2 (Dose Expansion)|Death|14|||
160491904|NCT03520075|579531041|FG018|Phase 2 (Dose Expansion)|Death|12|||
160491905|NCT03520075|579531023|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491906|NCT03520075|579531024|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491907|NCT03520075|579531025|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491908|NCT03520075|579531026|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491909|NCT03520075|579531027|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491910|NCT03520075|579531028|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491911|NCT03520075|579531029|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491912|NCT03520075|579531030|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491913|NCT03520075|579531031|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491914|NCT03520075|579531032|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491915|NCT03520075|579531033|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491916|NCT03520075|579531034|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491917|NCT03520075|579531035|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491918|NCT03520075|579531036|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
160491919|NCT03520075|579531037|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
160491920|NCT03520075|579531038|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
160491921|NCT03520075|579531039|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
160491922|NCT03520075|579531040|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
160491923|NCT03520075|579531041|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
160491924|NCT03520075|579531023|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491925|NCT03520075|579531024|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491926|NCT03520075|579531025|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491927|NCT03520075|579531026|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491928|NCT03520075|579531027|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491929|NCT03520075|579531028|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491930|NCT03520075|579531029|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491931|NCT03520075|579531030|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491932|NCT03520075|579531031|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491933|NCT03520075|579531032|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491934|NCT03520075|579531033|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491935|NCT03520075|579531034|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491936|NCT03520075|579531035|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491937|NCT03520075|579531036|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491938|NCT03520075|579531037|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
160611703|NCT02608099|579956163|FG000|Overall Study|Ablation procedure not initiated|3|||
160491939|NCT03520075|579531038|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
160491940|NCT03520075|579531039|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491941|NCT03520075|579531040|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160491942|NCT03520075|579531041|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
160491943|NCT03520075|579531023|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491944|NCT03520075|579531024|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491945|NCT03520075|579531025|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491946|NCT03520075|579531026|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491947|NCT03520075|579531027|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491948|NCT03520075|579531028|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491949|NCT03520075|579531029|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491950|NCT03520075|579531030|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491951|NCT03520075|579531031|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491952|NCT03520075|579531032|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491953|NCT03520075|579531033|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491954|NCT03520075|579531034|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491955|NCT03520075|579531035|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491956|NCT03520075|579531036|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
160491957|NCT03520075|579531037|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491958|NCT03520075|579531038|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491959|NCT03520075|579531039|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
160491960|NCT03520075|579531040|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
160491961|NCT03520075|579531041|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
160491962|NCT01432626|579531044|FG000|Overall Study|LV function recovered|2|||
160491963|NCT01432626|579531044|FG000|Overall Study|Withdrawal by Subject|2|||
160491964|NCT01432626|579531044|FG000|Overall Study|Only 1 image competed|2|||
160491965|NCT01432626|579531044|FG000|Overall Study|Imaging agent not available|1|||
160491966|NCT00328562|579531045|FG000|Overall Study|Disease progression|1|||
160491967|NCT03305809|579531046|FG000|Overall Study|Adverse Event|2|||
160491968|NCT03305809|579531047|FG001|Overall Study|Adverse Event|2|||
160491969|NCT03305809|579531048|FG002|Overall Study|Adverse Event|6|||
160491970|NCT03305809|579531049|FG003|Overall Study|Adverse Event|6|||
160491971|NCT03305809|579531046|FG000|Overall Study|Death|0|||
160491972|NCT03305809|579531047|FG001|Overall Study|Death|0|||
160491973|NCT03305809|579531048|FG002|Overall Study|Death|1|||
160491974|NCT03305809|579531049|FG003|Overall Study|Death|1|||
160491975|NCT03305809|579531046|FG000|Overall Study|Lost to Follow-up|1|||
160491976|NCT03305809|579531047|FG001|Overall Study|Lost to Follow-up|2|||
160491977|NCT03305809|579531048|FG002|Overall Study|Lost to Follow-up|0|||
160491978|NCT03305809|579531049|FG003|Overall Study|Lost to Follow-up|0|||
160491979|NCT03305809|579531046|FG000|Overall Study|Sponsor Decision|1|||
160491980|NCT03305809|579531047|FG001|Overall Study|Sponsor Decision|0|||
160491981|NCT03305809|579531048|FG002|Overall Study|Sponsor Decision|1|||
160491982|NCT03305809|579531049|FG003|Overall Study|Sponsor Decision|8|||
160491983|NCT03305809|579531046|FG000|Overall Study|Physician Decision|0|||
160491984|NCT03305809|579531047|FG001|Overall Study|Physician Decision|0|||
160491985|NCT03305809|579531048|FG002|Overall Study|Physician Decision|2|||
160491986|NCT03305809|579531049|FG003|Overall Study|Physician Decision|4|||
160491987|NCT03305809|579531046|FG000|Overall Study|Progressive Disease|0|||
160491988|NCT03305809|579531047|FG001|Overall Study|Progressive Disease|0|||
160491989|NCT03305809|579531048|FG002|Overall Study|Progressive Disease|1|||
160491990|NCT03305809|579531049|FG003|Overall Study|Progressive Disease|0|||
160491991|NCT03305809|579531046|FG000|Overall Study|Protocol Violation|1|||
160491992|NCT03305809|579531047|FG001|Overall Study|Protocol Violation|0|||
160491993|NCT03305809|579531048|FG002|Overall Study|Protocol Violation|2|||
160491994|NCT03305809|579531049|FG003|Overall Study|Protocol Violation|3|||
160491995|NCT03305809|579531046|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
160491996|NCT03305809|579531047|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
160491997|NCT03305809|579531048|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
160491998|NCT03305809|579531049|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
160491999|NCT03305809|579531046|FG000|Overall Study|Withdrawal by Subject|2|||
160492000|NCT03305809|579531047|FG001|Overall Study|Withdrawal by Subject|4|||
160492001|NCT03305809|579531048|FG002|Overall Study|Withdrawal by Subject|5|||
160492002|NCT03305809|579531049|FG003|Overall Study|Withdrawal by Subject|2|||
160492003|NCT03305809|579531046|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
160492004|NCT03305809|579531047|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
160661385|NCT02728102|580144081|FG000|Overall Study|Physician Decision|1|||
160661386|NCT02728102|580144082|FG001|Overall Study|Physician Decision|1|||
160492005|NCT03305809|579531048|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
160492006|NCT03305809|579531049|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
160492007|NCT00816556|579531050|FG000|Overall Study|Adverse Event|1|||
160492008|NCT00816556|579531051|FG001|Overall Study|Adverse Event|1|||
160492009|NCT00816556|579531052|FG002|Overall Study|Adverse Event|1|||
160492010|NCT00816556|579531050|FG000|Overall Study|Withdrawal by Subject|1|||
160492011|NCT00816556|579531051|FG001|Overall Study|Withdrawal by Subject|1|||
160492012|NCT00816556|579531052|FG002|Overall Study|Withdrawal by Subject|1|||
160661387|NCT02728102|580144083|FG002|Overall Study|Physician Decision|0|||
160492013|NCT00816556|579531050|FG000|Overall Study|Lost to Follow-up|0|||
160492014|NCT00816556|579531051|FG001|Overall Study|Lost to Follow-up|0|||
160492015|NCT00816556|579531052|FG002|Overall Study|Lost to Follow-up|1|||
160492016|NCT04014790|579531055|FG000|Overall Study|Death|4|||
160492017|NCT04014790|579531055|FG000|Overall Study|Adverse Event|1|||
160492018|NCT04014790|579531055|FG000|Overall Study|Withdrawal by Subject|1|||
160492019|NCT03546816|579531056|FG000|Overall Study|Adverse Event|5|||
160492020|NCT03546816|579531057|FG001|Overall Study|Adverse Event|3|||
160492021|NCT03546816|579531056|FG000|Overall Study|Lack of Efficacy|2|||
160492022|NCT03546816|579531057|FG001|Overall Study|Lack of Efficacy|4|||
160492023|NCT03546816|579531056|FG000|Overall Study|Pregnancy|1|||
160492024|NCT03546816|579531057|FG001|Overall Study|Pregnancy|0|||
160492025|NCT03546816|579531056|FG000|Overall Study|Physician Decision|2|||
160492026|NCT03546816|579531057|FG001|Overall Study|Physician Decision|0|||
160492027|NCT03546816|579531056|FG000|Overall Study|Withdrawal by Subject|8|||
160492028|NCT03546816|579531057|FG001|Overall Study|Withdrawal by Subject|10|||
160492029|NCT03546816|579531056|FG000|Overall Study|Lost to Follow-up|3|||
160492030|NCT03546816|579531057|FG001|Overall Study|Lost to Follow-up|2|||
160492031|NCT01161446|579531058|FG000|Overall Study|Lost to Follow-up|18|||
160492032|NCT01161446|579531059|FG001|Overall Study|Lost to Follow-up|14|||
160492033|NCT01161446|579531058|FG000|Overall Study|Withdrawal by Subject|0|||
160492034|NCT01161446|579531059|FG001|Overall Study|Withdrawal by Subject|1|||
160492035|NCT00810342|579531060|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
160492036|NCT00810342|579531061|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
160492037|NCT00810342|579531060|FG000|Month 1 Follow-up|Pregnancy|1|||
160492038|NCT00810342|579531061|FG001|Month 1 Follow-up|Pregnancy|0|||
160492039|NCT00810342|579531060|FG000|6-month Follow-up|Lost to Follow-up|18|||
160492040|NCT00810342|579531061|FG001|6-month Follow-up|Lost to Follow-up|6|||
160492041|NCT00810342|579531060|FG000|6-month Follow-up|Pregnancy|6|||
160492042|NCT00810342|579531061|FG001|6-month Follow-up|Pregnancy|2|||
160492043|NCT00810342|579531060|FG000|12-month Followup|Pregnancy|9|||
160492044|NCT00810342|579531061|FG001|12-month Followup|Pregnancy|10|||
160492045|NCT00810342|579531060|FG000|12-month Followup|Lost to Follow-up|3|||
160492046|NCT00810342|579531061|FG001|12-month Followup|Lost to Follow-up|1|||
160492051|NCT01010204|579531064|FG000|Overall Study|Lost to Follow-up|2|||
160492052|NCT01010204|579531065|FG001|Overall Study|Lost to Follow-up|2|||
160492053|NCT01010204|579531064|FG000|Overall Study|Adverse Event|1|||
160492054|NCT01010204|579531065|FG001|Overall Study|Adverse Event|3|||
160492055|NCT01010204|579531064|FG000|Overall Study|Withdrawal by Subject|2|||
160492056|NCT01010204|579531065|FG001|Overall Study|Withdrawal by Subject|3|||
160492057|NCT01010204|579531064|FG000|Overall Study|psychiatric hospitalization|2|||
160492058|NCT01010204|579531065|FG001|Overall Study|psychiatric hospitalization|1|||
160492059|NCT01519778|579531066|FG000|Overall Study|Withdrawal by Subject|3|||
160492060|NCT01519778|579531066|FG000|Overall Study|Lost to Follow-up|10|||
160492061|NCT01519778|579531066|FG000|Overall Study|Physician Decision|1|||
160492062|NCT02270671|579531067|FG000|Overall Study|Withdrawal by Subject|1|||
160492063|NCT02270671|579531068|FG001|Overall Study|Withdrawal by Subject|1|||
160492064|NCT02270671|579531067|FG000|Overall Study|Protocol Violation|0|||
160492065|NCT02270671|579531068|FG001|Overall Study|Protocol Violation|1|||
160492066|NCT02270671|579531067|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
160492067|NCT02270671|579531068|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
160492068|NCT02270671|579531067|FG000|Overall Study|Lost to Follow-up|2|||
160492069|NCT02270671|579531068|FG001|Overall Study|Lost to Follow-up|1|||
160492070|NCT03927690|579531069|FG000|Overall Study|Withdrawal by Subject|3|||
160492071|NCT03927690|579531070|FG001|Overall Study|Withdrawal by Subject|1|||
160492072|NCT03927690|579531071|FG002|Overall Study|Withdrawal by Subject|1|||
160492073|NCT03927690|579531069|FG000|Overall Study|Adverse Event|1|||
160492074|NCT03927690|579531070|FG001|Overall Study|Adverse Event|0|||
160492075|NCT03927690|579531071|FG002|Overall Study|Adverse Event|0|||
160492076|NCT03927690|579531069|FG000|Overall Study|Death|1|||
160492077|NCT03927690|579531070|FG001|Overall Study|Death|0|||
160492078|NCT03927690|579531071|FG002|Overall Study|Death|0|||
160611704|NCT02608099|579956164|FG001|Overall Study|Ablation procedure not initiated|2|||
160492079|NCT03927690|579531069|FG000|Overall Study|Lost to Follow-up|2|||
160492080|NCT03927690|579531070|FG001|Overall Study|Lost to Follow-up|2|||
160492081|NCT03927690|579531071|FG002|Overall Study|Lost to Follow-up|1|||
160492082|NCT01657799|579531072|FG000|Overall Study|Adverse Event Related to progression|6|||
160492083|NCT01657799|579531073|FG001|Overall Study|Adverse Event Related to progression|8|||
160492084|NCT01657799|579531074|FG002|Overall Study|Adverse Event Related to progression|12|||
160492085|NCT01657799|579531072|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
160492086|NCT01657799|579531073|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
160492087|NCT01657799|579531074|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
160492088|NCT01657799|579531072|FG000|Overall Study|Withdrawal by Subject|13|||
160492089|NCT01657799|579531073|FG001|Overall Study|Withdrawal by Subject|10|||
160492090|NCT01657799|579531074|FG002|Overall Study|Withdrawal by Subject|10|||
160492091|NCT01657799|579531072|FG000|Overall Study|Lost to Follow-up|1|||
160492092|NCT01657799|579531073|FG001|Overall Study|Lost to Follow-up|0|||
160492093|NCT01657799|579531074|FG002|Overall Study|Lost to Follow-up|1|||
160492094|NCT01657799|579531072|FG000|Overall Study|Disease Progression|2|||
160492095|NCT01657799|579531073|FG001|Overall Study|Disease Progression|4|||
160492096|NCT01657799|579531074|FG002|Overall Study|Disease Progression|4|||
160492097|NCT01657799|579531072|FG000|Overall Study|Progressive Disease Clinical|7|||
160492098|NCT01657799|579531073|FG001|Overall Study|Progressive Disease Clinical|4|||
160492099|NCT01657799|579531074|FG002|Overall Study|Progressive Disease Clinical|7|||
160492100|NCT01657799|579531072|FG000|Overall Study|Radiographic & Clinical Progression|16|||
160492101|NCT01657799|579531073|FG001|Overall Study|Radiographic & Clinical Progression|11|||
160492102|NCT01657799|579531074|FG002|Overall Study|Radiographic & Clinical Progression|15|||
160492103|NCT01657799|579531072|FG000|Overall Study|Other|52|||
160492104|NCT01657799|579531073|FG001|Overall Study|Other|62|||
160492105|NCT01657799|579531074|FG002|Overall Study|Other|49|||
160492106|NCT02229578|579531079|FG000|Overall Study|Withdrawal by Subject|1|||
160492107|NCT02229578|579531080|FG001|Overall Study|Withdrawal by Subject|3|||
160492108|NCT02229578|579531079|FG000|Overall Study|Protocol Violation|2|||
160492109|NCT02229578|579531080|FG001|Overall Study|Protocol Violation|0|||
160492110|NCT03603639|579531082|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
160492111|NCT03603639|579531083|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
160492112|NCT03603639|579531084|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
160492113|NCT03603639|579531085|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
160492114|NCT03603639|579531086|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
160492115|NCT03603639|579531087|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
160492116|NCT03603639|579531082|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
160492117|NCT03603639|579531083|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
160492118|NCT03603639|579531084|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
160492119|NCT03603639|579531085|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
160492120|NCT03603639|579531086|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
160492121|NCT03603639|579531087|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
160492122|NCT00551135|579531093|FG000|Overall Study|Adverse Event|1|||
160492123|NCT00551135|579531094|FG001|Overall Study|Adverse Event|0|||
160492124|NCT00551135|579531095|FG002|Overall Study|Adverse Event|1|||
160492125|NCT00551135|579531096|FG003|Overall Study|Adverse Event|1|||
160492126|NCT00551135|579531093|FG000|Overall Study|Lost to Follow-up|0|||
160492127|NCT00551135|579531094|FG001|Overall Study|Lost to Follow-up|0|||
160492128|NCT00551135|579531095|FG002|Overall Study|Lost to Follow-up|0|||
160492129|NCT00551135|579531096|FG003|Overall Study|Lost to Follow-up|1|||
160492130|NCT00551135|579531093|FG000|Overall Study|Other|3|||
160492131|NCT00551135|579531094|FG001|Overall Study|Other|2|||
160492132|NCT00551135|579531095|FG002|Overall Study|Other|1|||
160492133|NCT00551135|579531096|FG003|Overall Study|Other|2|||
160492134|NCT00551135|579531093|FG000|Overall Study|Withdrawal by Subject|1|||
160492135|NCT00551135|579531094|FG001|Overall Study|Withdrawal by Subject|0|||
160492136|NCT00551135|579531095|FG002|Overall Study|Withdrawal by Subject|3|||
160492137|NCT00551135|579531096|FG003|Overall Study|Withdrawal by Subject|1|||
160492138|NCT02165397|579531099|FG000|Overall Study|Death|7|||
160492139|NCT02165397|579531100|FG001|Overall Study|Death|10|||
160492140|NCT02165397|579531101|FG002|Overall Study|Death|8|||
160492141|NCT02165397|579531099|FG000|Overall Study|Lost to Follow-up|1|||
160492142|NCT02165397|579531100|FG001|Overall Study|Lost to Follow-up|3|||
160492143|NCT02165397|579531101|FG002|Overall Study|Lost to Follow-up|0|||
160492144|NCT02165397|579531099|FG000|Overall Study|Withdrawal by Subject|6|||
160492145|NCT02165397|579531100|FG001|Overall Study|Withdrawal by Subject|6|||
160611705|NCT01952041|579956168|FG000|Overall Study|Lost to Follow-up|9|||
160611706|NCT01952041|579956169|FG001|Overall Study|Lost to Follow-up|16|||
160611707|NCT01952041|579956168|FG000|Overall Study|Withdrawal by Subject|7|||
160611708|NCT01952041|579956169|FG001|Overall Study|Withdrawal by Subject|5|||
160611709|NCT01952041|579956168|FG000|Overall Study|Death|1|||
160611710|NCT01952041|579956169|FG001|Overall Study|Death|0|||
160492146|NCT02165397|579531101|FG002|Overall Study|Withdrawal by Subject|1|||
160492147|NCT02165397|579531099|FG000|Overall Study|Other, Not Specified|0|||
160492148|NCT02165397|579531100|FG001|Overall Study|Other, Not Specified|0|||
160492149|NCT02165397|579531101|FG002|Overall Study|Other, Not Specified|1|||
160492150|NCT01841697|579531104|FG000|Overall Study|Death|0|||
160492151|NCT01841697|579531105|FG001|Overall Study|Death|1|||
160492152|NCT01841697|579531104|FG000|Overall Study|Lost to Follow-up|4|||
160492153|NCT01841697|579531105|FG001|Overall Study|Lost to Follow-up|1|||
160611711|NCT01736176|579956170|FG000|Overall Study|Adverse Event|3|||
160492154|NCT01841697|579531104|FG000|Overall Study|Withdrawal by Subject|16|||
160492155|NCT01841697|579531105|FG001|Overall Study|Withdrawal by Subject|16|||
160492156|NCT03672175|579531108|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
160492157|NCT03672175|579531109|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
160611712|NCT01736176|579956170|FG000|Overall Study|Withdrawal by Subject|4|||
160611713|NCT01736176|579956170|FG000|Overall Study|Lack of Efficacy|3|||
160611714|NCT01736176|579956170|FG000|Overall Study|Unable to Complete PEG Placement|1|||
160611715|NCT00186121|579956171|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
160611716|NCT00186121|579956171|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
160611717|NCT00186121|579956171|FG000|Overall Study|Not eligible (no treatment)|1|||
160611718|NCT03650387|579956172|FG000|Overall Study|Withdrawal by Subject|13|||
160611719|NCT03650387|579956172|FG000|Overall Study|Lost to Follow-up|12|||
160611720|NCT03650387|579956172|FG000|Overall Study|Adverse Event (Not related)|1|||
160611721|NCT03650387|579956172|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
160611722|NCT00417248|579956173|FG000|Overall Study|Study Terminated|6|||
160611723|NCT00417248|579956173|FG000|Overall Study|Death|1|||
160611724|NCT00417248|579956173|FG000|Overall Study|Lack of Efficacy|1|||
160611725|NCT01569568|579956174|FG000|Overall Study|Physician Decision|0|||
160611726|NCT01569568|579956175|FG001|Overall Study|Physician Decision|2|||
160611727|NCT05815758|579956176|FG000|Overall Study|Adverse Event|6|||
160611728|NCT05815758|579956177|FG001|Overall Study|Adverse Event|2|||
160611729|NCT05815758|579956176|FG000|Overall Study|Lost to Follow-up|14|||
160611730|NCT05815758|579956177|FG001|Overall Study|Lost to Follow-up|1|||
160611731|NCT05815758|579956176|FG000|Overall Study|Withdrawal by Subject|6|||
160611732|NCT05815758|579956177|FG001|Overall Study|Withdrawal by Subject|6|||
160611733|NCT05815758|579956176|FG000|Overall Study|Protocol Violation|1|||
160611734|NCT05815758|579956177|FG001|Overall Study|Protocol Violation|1|||
160611735|NCT05815758|579956176|FG000|Overall Study|Discontinued|4|||
160611736|NCT05815758|579956177|FG001|Overall Study|Discontinued|4|||
160611737|NCT03661983|579956178|FG000|Open Label Stabilization Phase|Adverse Event|5|||
160611738|NCT03661983|579956179|FG001|Open Label Stabilization Phase|Adverse Event|0|||
160611739|NCT03661983|579956180|FG002|Open Label Stabilization Phase|Adverse Event|0|||
160611740|NCT03661983|579956181|FG003|Open Label Stabilization Phase|Adverse Event|0|||
160611741|NCT03661983|579956178|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
160611742|NCT03661983|579956179|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
160611743|NCT03661983|579956180|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
160611744|NCT03661983|579956181|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
160611745|NCT03661983|579956178|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
160611746|NCT03661983|579956179|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
160611747|NCT03661983|579956180|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
160611748|NCT03661983|579956181|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
160611749|NCT03661983|579956178|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
160611750|NCT03661983|579956179|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
160611751|NCT03661983|579956180|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
160611752|NCT03661983|579956181|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
160611753|NCT03661983|579956178|FG000|Double-blind Randomized Phase|Adverse Event|0|||
160611754|NCT03661983|579956179|FG001|Double-blind Randomized Phase|Adverse Event|1|||
160492158|NCT03672175|579531110|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
160492159|NCT03672175|579531108|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
160492160|NCT03672175|579531109|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
160492161|NCT03672175|579531110|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
160492162|NCT03672175|579531108|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
160492163|NCT03672175|579531109|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
160492164|NCT03672175|579531110|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
160492165|NCT03672175|579531108|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
160492166|NCT03672175|579531109|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
160492167|NCT03672175|579531110|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
160492168|NCT03672175|579531108|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
160492169|NCT03672175|579531109|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
160492170|NCT03672175|579531110|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
160492171|NCT03672175|579531108|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
160492172|NCT03672175|579531109|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
160492173|NCT03672175|579531110|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
160492174|NCT03672175|579531108|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
160492175|NCT03672175|579531109|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
160492176|NCT03672175|579531110|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
160492177|NCT03672175|579531108|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
160492178|NCT03672175|579531109|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
160492179|NCT03672175|579531110|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
160492180|NCT03672175|579531108|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
160492181|NCT03672175|579531109|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
160492182|NCT03672175|579531110|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
160492183|NCT03672175|579531108|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
160492184|NCT03672175|579531109|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
160492185|NCT03672175|579531110|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
160492186|NCT03672175|579531108|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
160492187|NCT03672175|579531109|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
160492188|NCT03672175|579531110|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
160492189|NCT03672175|579531108|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
160492190|NCT03672175|579531109|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
160492191|NCT03672175|579531110|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
160492192|NCT01129115|579531112|FG000|Overall Study|Adverse Event|1|||
160492193|NCT01129115|579531113|FG001|Overall Study|Adverse Event|2|||
160492194|NCT01129115|579531114|FG002|Overall Study|Adverse Event|3|||
160492195|NCT01129115|579531115|FG003|Overall Study|Adverse Event|3|||
160492196|NCT01129115|579531112|FG000|Overall Study|Withdrawal by Subject|1|||
160492197|NCT01129115|579531113|FG001|Overall Study|Withdrawal by Subject|3|||
160492198|NCT01129115|579531114|FG002|Overall Study|Withdrawal by Subject|1|||
160492199|NCT01129115|579531115|FG003|Overall Study|Withdrawal by Subject|4|||
160492200|NCT01129115|579531112|FG000|Overall Study|Protocol Violation|0|||
160492201|NCT01129115|579531113|FG001|Overall Study|Protocol Violation|2|||
160492202|NCT01129115|579531114|FG002|Overall Study|Protocol Violation|2|||
160492203|NCT01129115|579531115|FG003|Overall Study|Protocol Violation|2|||
160492204|NCT01747837|579531116|FG000|Overall Study|Lost to Follow-up|5|||
160492205|NCT01747837|579531117|FG001|Overall Study|Lost to Follow-up|2|||
160492206|NCT01747837|579531116|FG000|Overall Study|Death|4|||
160492207|NCT01747837|579531117|FG001|Overall Study|Death|4|||
160492208|NCT01121913|579531118|FG000|First Intervention Period|Adverse Event|0|||
160492209|NCT01121913|579531119|FG001|First Intervention Period|Adverse Event|0|||
160492210|NCT01121913|579531120|FG002|First Intervention Period|Adverse Event|1|||
160492211|NCT01121913|579531121|FG003|First Intervention Period|Adverse Event|0|||
160492212|NCT01121913|579531118|FG000|First Washout Period|Withdrawal by Subject|1|||
160492213|NCT01121913|579531119|FG001|First Washout Period|Withdrawal by Subject|0|||
160492214|NCT01121913|579531120|FG002|First Washout Period|Withdrawal by Subject|0|||
160492215|NCT01121913|579531121|FG003|First Washout Period|Withdrawal by Subject|0|||
160492216|NCT01121913|579531118|FG000|Second Intervention Period|Adverse Event|0|||
160492217|NCT01121913|579531119|FG001|Second Intervention Period|Adverse Event|0|||
160492218|NCT01121913|579531120|FG002|Second Intervention Period|Adverse Event|1|||
160492219|NCT01121913|579531121|FG003|Second Intervention Period|Adverse Event|0|||
160611755|NCT03661983|579956180|FG002|Double-blind Randomized Phase|Adverse Event|0|||
160492220|NCT01121913|579531118|FG000|Second Washout Period|Withdrawal by Subject|0|||
160492221|NCT01121913|579531119|FG001|Second Washout Period|Withdrawal by Subject|0|||
160492222|NCT01121913|579531120|FG002|Second Washout Period|Withdrawal by Subject|1|||
160492223|NCT01121913|579531121|FG003|Second Washout Period|Withdrawal by Subject|0|||
160492224|NCT01121913|579531118|FG000|Third Washout Period|Adverse Event|1|||
160492225|NCT01121913|579531119|FG001|Third Washout Period|Adverse Event|0|||
160492226|NCT01121913|579531120|FG002|Third Washout Period|Adverse Event|0|||
160611756|NCT03661983|579956181|FG003|Double-blind Randomized Phase|Adverse Event|0|||
160611757|NCT03661983|579956178|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
160611758|NCT03661983|579956179|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
160611759|NCT03661983|579956180|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
160611760|NCT03661983|579956181|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
160611761|NCT03661983|579956178|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
160611762|NCT03661983|579956179|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
160611763|NCT03661983|579956180|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
160611764|NCT03661983|579956181|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
160611765|NCT03661983|579956178|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
160611766|NCT03661983|579956179|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
160611767|NCT03661983|579956180|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
160611768|NCT03661983|579956181|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
160611769|NCT02903966|579956182|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
160611770|NCT02903966|579956183|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
160611771|NCT02903966|579956182|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
160611772|NCT02903966|579956183|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
160611773|NCT02903966|579956182|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
160611774|NCT02903966|579956183|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
160492227|NCT01121913|579531121|FG003|Third Washout Period|Adverse Event|0|||
160492228|NCT00690378|579531122|FG000|Overall Study|Adverse Event|1|||
160492229|NCT00690378|579531123|FG001|Overall Study|Adverse Event|0|||
160492230|NCT00690378|579531122|FG000|Overall Study|Withdrawal by Subject|2|||
160492231|NCT00690378|579531123|FG001|Overall Study|Withdrawal by Subject|0|||
160492232|NCT00690378|579531122|FG000|Overall Study|Protocol Violation|1|||
160492233|NCT00690378|579531123|FG001|Overall Study|Protocol Violation|0|||
160492234|NCT00690378|579531122|FG000|Overall Study|Lost to Follow-up|2|||
160492235|NCT00690378|579531123|FG001|Overall Study|Lost to Follow-up|3|||
160492236|NCT00690378|579531122|FG000|Overall Study|Did not meet inc/exc criteria|13|||
160492237|NCT00690378|579531123|FG001|Overall Study|Did not meet inc/exc criteria|11|||
160492238|NCT00690378|579531122|FG000|Overall Study|Social problem|1|||
160492239|NCT00690378|579531123|FG001|Overall Study|Social problem|0|||
160492240|NCT02019641|579531127|FG000|10-Week Follow up|Withdrawal by investigator|2|||
160492241|NCT02019641|579531128|FG001|10-Week Follow up|Withdrawal by investigator|0|||
160492242|NCT02019641|579531129|FG002|10-Week Follow up|Withdrawal by investigator|0|||
160492243|NCT02019641|579531127|FG000|10-Week Follow up|Withdrawal by Subject|1|||
160492244|NCT02019641|579531128|FG001|10-Week Follow up|Withdrawal by Subject|1|||
160492245|NCT02019641|579531129|FG002|10-Week Follow up|Withdrawal by Subject|0|||
160492246|NCT02019641|579531127|FG000|20-Week Follow up|Withdrawal by investigator|0|||
160492247|NCT02019641|579531128|FG001|20-Week Follow up|Withdrawal by investigator|0|||
160492248|NCT02019641|579531129|FG002|20-Week Follow up|Withdrawal by investigator|1|||
160492249|NCT03410108|579531132|FG000|Overall Study|Ongoing|41|||
160492250|NCT03410108|579531132|FG000|Overall Study|Adverse Event|4|||
160611775|NCT00934791|579956184|FG000|Overall Study|Withdrawal by Subject|1|||
160611776|NCT00934791|579956185|FG001|Overall Study|Withdrawal by Subject|0|||
160611777|NCT01320033|579956187|FG000|Overall Study|Lack of Efficacy|0|||
160611778|NCT01320033|579956188|FG001|Overall Study|Lack of Efficacy|0|||
160611779|NCT01320033|579956189|FG002|Overall Study|Lack of Efficacy|1|||
160611780|NCT01320033|579956187|FG000|Overall Study|Adverse Event|9|||
160611781|NCT01320033|579956188|FG001|Overall Study|Adverse Event|7|||
160611782|NCT01320033|579956189|FG002|Overall Study|Adverse Event|8|||
160611783|NCT01320033|579956187|FG000|Overall Study|Withdrawal by Subject|22|||
160611784|NCT01320033|579956188|FG001|Overall Study|Withdrawal by Subject|23|||
160611785|NCT01320033|579956189|FG002|Overall Study|Withdrawal by Subject|23|||
160611786|NCT01320033|579956187|FG000|Overall Study|Protocol Violation|3|||
160611787|NCT01320033|579956188|FG001|Overall Study|Protocol Violation|5|||
160611788|NCT01320033|579956189|FG002|Overall Study|Protocol Violation|3|||
160611789|NCT01320033|579956187|FG000|Overall Study|Lost to Follow-up|22|||
160611790|NCT01320033|579956188|FG001|Overall Study|Lost to Follow-up|26|||
160611791|NCT01320033|579956189|FG002|Overall Study|Lost to Follow-up|17|||
160611792|NCT01320033|579956187|FG000|Overall Study|Other|2|||
160611793|NCT01320033|579956188|FG001|Overall Study|Other|3|||
160611794|NCT01320033|579956189|FG002|Overall Study|Other|1|||
160611795|NCT00963469|579956190|FG000|Overall Study|Adverse Event|15|||
160611796|NCT00963469|579956191|FG001|Overall Study|Adverse Event|11|||
160611797|NCT00963469|579956192|FG002|Overall Study|Adverse Event|1|||
160611798|NCT00963469|579956190|FG000|Overall Study|Lack of Efficacy|10|||
160611799|NCT00963469|579956191|FG001|Overall Study|Lack of Efficacy|7|||
160611800|NCT00963469|579956192|FG002|Overall Study|Lack of Efficacy|2|||
160611801|NCT00963469|579956190|FG000|Overall Study|Lost to Follow-up|1|||
160611802|NCT00963469|579956191|FG001|Overall Study|Lost to Follow-up|1|||
160611803|NCT00963469|579956192|FG002|Overall Study|Lost to Follow-up|0|||
160611804|NCT00963469|579956190|FG000|Overall Study|Protocol Violation|5|||
160611805|NCT00963469|579956191|FG001|Overall Study|Protocol Violation|5|||
160611806|NCT00963469|579956192|FG002|Overall Study|Protocol Violation|3|||
160611807|NCT00963469|579956190|FG000|Overall Study|Withdrawal by Subject|4|||
160611808|NCT00963469|579956191|FG001|Overall Study|Withdrawal by Subject|1|||
160611809|NCT00963469|579956192|FG002|Overall Study|Withdrawal by Subject|1|||
160611810|NCT00963469|579956190|FG000|Overall Study|Pre-randomization Adverse Event|1|||
160611811|NCT00963469|579956191|FG001|Overall Study|Pre-randomization Adverse Event|2|||
160611812|NCT00963469|579956192|FG002|Overall Study|Pre-randomization Adverse Event|0|||
160611813|NCT00963469|579956190|FG000|Overall Study|Moved|1|||
160611814|NCT00963469|579956191|FG001|Overall Study|Moved|0|||
160611815|NCT00963469|579956192|FG002|Overall Study|Moved|0|||
160611816|NCT00963469|579956190|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
160611817|NCT00963469|579956191|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
160611818|NCT00963469|579956192|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
160611819|NCT02145429|579956195|FG000|Overall Study|Death|4|||
160611820|NCT02145429|579956196|FG001|Overall Study|Death|5|||
160492251|NCT03410108|579531132|FG000|Overall Study|Progressive Disease|58|||
160492252|NCT03410108|579531132|FG000|Overall Study|Withdrawal by Subject|1|||
160611821|NCT02145429|579956195|FG000|Overall Study|Lost to Follow-up|4|||
160611822|NCT02145429|579956196|FG001|Overall Study|Lost to Follow-up|3|||
160611823|NCT02145429|579956195|FG000|Overall Study|Withdrawal by Subject|8|||
160492253|NCT01313624|579531134|FG000|Double-Blind Phase|Adverse Event|27|||
160492254|NCT01313624|579531135|FG001|Double-Blind Phase|Adverse Event|4|||
160492255|NCT01313624|579531134|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
160661388|NCT02728102|580144081|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
160661389|NCT02728102|580144082|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
160661390|NCT02728102|580144083|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
160611824|NCT02145429|579956196|FG001|Overall Study|Withdrawal by Subject|3|||
160611825|NCT02974621|579956204|FG000|Overall Study|Didn't receive study treatment|1|||
160611826|NCT02974621|579956205|FG001|Overall Study|Didn't receive study treatment|10|||
160611827|NCT00732472|579956206|FG000|Overall Study|Adverse Event|0|||
160611828|NCT00732472|579956207|FG001|Overall Study|Adverse Event|1|||
160611829|NCT00732472|579956208|FG002|Overall Study|Adverse Event|1|||
160611830|NCT00732472|579956209|FG003|Overall Study|Adverse Event|1|||
160611831|NCT00732472|579956206|FG000|Overall Study|Protocol Violation|0|||
160611832|NCT00732472|579956207|FG001|Overall Study|Protocol Violation|0|||
160611833|NCT00732472|579956208|FG002|Overall Study|Protocol Violation|0|||
160611834|NCT00732472|579956209|FG003|Overall Study|Protocol Violation|1|||
160611835|NCT00732472|579956206|FG000|Overall Study|Withdrawal by Subject|0|||
160611836|NCT00732472|579956207|FG001|Overall Study|Withdrawal by Subject|2|||
160611837|NCT00732472|579956208|FG002|Overall Study|Withdrawal by Subject|0|||
160611838|NCT00732472|579956209|FG003|Overall Study|Withdrawal by Subject|1|||
160611839|NCT02559115|579956212|FG000|Overall Study|Withdrawal by Subject|3|||
160611840|NCT00397631|579956229|FG000|Overall Study|Adverse Event|5|||
160611841|NCT00397631|579956230|FG001|Overall Study|Adverse Event|6|||
160611842|NCT00397631|579956229|FG000|Overall Study|Lack of Efficacy|7|||
160611843|NCT00397631|579956230|FG001|Overall Study|Lack of Efficacy|10|||
160611844|NCT00397631|579956229|FG000|Overall Study|Lost to Follow-up|8|||
160611845|NCT00397631|579956230|FG001|Overall Study|Lost to Follow-up|9|||
160611846|NCT00397631|579956229|FG000|Overall Study|Physician Decision|2|||
160611847|NCT00397631|579956230|FG001|Overall Study|Physician Decision|0|||
160611848|NCT00397631|579956229|FG000|Overall Study|Protocol Violation|0|||
160611849|NCT00397631|579956230|FG001|Overall Study|Protocol Violation|1|||
160611850|NCT00397631|579956229|FG000|Overall Study|Withdrawal by Subject|7|||
160611851|NCT00397631|579956230|FG001|Overall Study|Withdrawal by Subject|14|||
160611852|NCT00397631|579956229|FG000|Overall Study|protocol discontinuation criteria|1|||
160611853|NCT00397631|579956230|FG001|Overall Study|protocol discontinuation criteria|4|||
160611854|NCT02202161|579956231|FG000|Overall Study|Adverse Event|1|||
160611855|NCT02202161|579956232|FG001|Overall Study|Adverse Event|1|||
160611856|NCT02202161|579956233|FG002|Overall Study|Adverse Event|0|||
160611857|NCT02202161|579956234|FG003|Overall Study|Adverse Event|0|||
160611858|NCT02202161|579956235|FG004|Overall Study|Adverse Event|0|||
160611859|NCT02202161|579956236|FG005|Overall Study|Adverse Event|1|||
160611860|NCT02202161|579956237|FG006|Overall Study|Adverse Event|0|||
160611861|NCT02202161|579956238|FG007|Overall Study|Adverse Event|0|||
160611862|NCT02202161|579956231|FG000|Overall Study|Did not meet continuation criteria|0|||
160611863|NCT02202161|579956232|FG001|Overall Study|Did not meet continuation criteria|0|||
160611864|NCT02202161|579956233|FG002|Overall Study|Did not meet continuation criteria|0|||
160611865|NCT02202161|579956234|FG003|Overall Study|Did not meet continuation criteria|0|||
160611866|NCT02202161|579956235|FG004|Overall Study|Did not meet continuation criteria|0|||
160611867|NCT02202161|579956236|FG005|Overall Study|Did not meet continuation criteria|0|||
160611868|NCT02202161|579956237|FG006|Overall Study|Did not meet continuation criteria|0|||
160611869|NCT02202161|579956238|FG007|Overall Study|Did not meet continuation criteria|3|||
160611870|NCT02202161|579956231|FG000|Overall Study|Physician Decision|0|||
160611871|NCT02202161|579956232|FG001|Overall Study|Physician Decision|0|||
160611872|NCT02202161|579956233|FG002|Overall Study|Physician Decision|0|||
160611873|NCT02202161|579956234|FG003|Overall Study|Physician Decision|0|||
160611874|NCT02202161|579956235|FG004|Overall Study|Physician Decision|0|||
160611875|NCT02202161|579956236|FG005|Overall Study|Physician Decision|0|||
160611876|NCT02202161|579956237|FG006|Overall Study|Physician Decision|0|||
160611877|NCT02202161|579956238|FG007|Overall Study|Physician Decision|3|||
160611878|NCT02202161|579956231|FG000|Overall Study|Withdrawal by Subject|0|||
160611879|NCT02202161|579956232|FG001|Overall Study|Withdrawal by Subject|0|||
160611880|NCT02202161|579956233|FG002|Overall Study|Withdrawal by Subject|0|||
160611881|NCT02202161|579956234|FG003|Overall Study|Withdrawal by Subject|0|||
160611882|NCT02202161|579956235|FG004|Overall Study|Withdrawal by Subject|1|||
160611883|NCT02202161|579956236|FG005|Overall Study|Withdrawal by Subject|0|||
160611884|NCT02202161|579956237|FG006|Overall Study|Withdrawal by Subject|0|||
160611885|NCT02202161|579956238|FG007|Overall Study|Withdrawal by Subject|0|||
160661391|NCT02728102|580144081|FG000|Overall Study|Covid|0|||
160661392|NCT02728102|580144082|FG001|Overall Study|Covid|0|||
160661393|NCT02728102|580144083|FG002|Overall Study|Covid|1|||
160661394|NCT02419937|580144088|FG000|Overall Study|Lost to Follow-up|1|||
160492256|NCT01313624|579531135|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
160492257|NCT01313624|579531134|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160492258|NCT01313624|579531135|FG001|Double-Blind Phase|Lost to Follow-up|2|||
160492259|NCT01313624|579531134|FG000|Double-Blind Phase|Physician Decision|1|||
160661395|NCT02419937|580144089|FG001|Overall Study|Lost to Follow-up|0|||
160661396|NCT00553280|580144090|FG000|Overall Study|Adverse Event|19|||
160661397|NCT00553280|580144090|FG000|Overall Study|Lack of Efficacy|3|||
160661398|NCT00553280|580144090|FG000|Overall Study|Withdrawal by Subject|3|||
160661399|NCT00553280|580144090|FG000|Overall Study|Physician Decision|1|||
160661400|NCT01182415|580144091|FG000|Overall Study|Lost to Follow-up|1|||
160661401|NCT01544127|580144092|FG000|Overall Study|Lost to Follow-up|4|||
160661402|NCT01544127|580144093|FG001|Overall Study|Lost to Follow-up|2|||
160661403|NCT01544127|580144094|FG002|Overall Study|Lost to Follow-up|9|||
160492260|NCT01313624|579531135|FG001|Double-Blind Phase|Physician Decision|0|||
160492261|NCT01313624|579531134|FG000|Double-Blind Phase|Lack of Efficacy|1|||
160492262|NCT01313624|579531135|FG001|Double-Blind Phase|Lack of Efficacy|0|||
160492263|NCT01313624|579531134|FG000|Open-Label Phase|Adverse Event|1|||
160492264|NCT01313624|579531135|FG001|Open-Label Phase|Adverse Event|10|||
160492265|NCT01313624|579531134|FG000|Open-Label Phase|Withdrawal by Subject|2|||
160492266|NCT01313624|579531135|FG001|Open-Label Phase|Withdrawal by Subject|2|||
160492267|NCT01313624|579531134|FG000|Open-Label Phase|Lost to Follow-up|1|||
160492268|NCT01313624|579531135|FG001|Open-Label Phase|Lost to Follow-up|1|||
160492269|NCT05043883|579531136|FG000|Overall Study|Minimum required measurements could not be taken|4|||
160492270|NCT02447718|579531139|FG000|Overall Study|Lost to Follow-up|8|||
160492271|NCT02447718|579531140|FG001|Overall Study|Lost to Follow-up|0|||
160492272|NCT02447718|579531139|FG000|Overall Study|Withdrawal by Subject|3|||
160492273|NCT02447718|579531140|FG001|Overall Study|Withdrawal by Subject|0|||
160492274|NCT02447718|579531139|FG000|Overall Study|Screen Failure|1|||
160492275|NCT02447718|579531140|FG001|Overall Study|Screen Failure|0|||
160492276|NCT00468130|579531143|FG000|Overall Study|Adverse Event|2|||
160492277|NCT00468130|579531144|FG001|Overall Study|Adverse Event|1|||
160492278|NCT00468130|579531143|FG000|Overall Study|Withdrawal by Subject|0|||
160492279|NCT00468130|579531144|FG001|Overall Study|Withdrawal by Subject|1|||
160492280|NCT03772613|579531147|FG000|Overall Study|Lost to Follow-up|0|||
160492281|NCT03772613|579531148|FG001|Overall Study|Lost to Follow-up|1|||
160492282|NCT03772613|579531149|FG002|Overall Study|Lost to Follow-up|1|||
160492283|NCT04522778|579531152|FG000|Overall Study|Patient did not want to wear the device|1|||
160492284|NCT04522778|579531153|FG001|Overall Study|Patient did not want to wear the device|0|||
160492285|NCT04522778|579531152|FG000|Overall Study|Lost to Follow-up|0|||
160492286|NCT04522778|579531153|FG001|Overall Study|Lost to Follow-up|1|||
160492287|NCT04052997|579531154|FG000|Overall Study|Withdrawal by Subject|17|||
160492288|NCT04052997|579531154|FG000|Overall Study|Physician Decision|50|||
160492289|NCT04052997|579531154|FG000|Overall Study|Death|43|||
160492290|NCT04052997|579531154|FG000|Overall Study|Lost to Follow-up|5|||
160492291|NCT04052997|579531154|FG000|Overall Study|Progression of Disease|1|||
160492292|NCT04594733|579531155|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
160611886|NCT03685643|579956239|FG000|Overall Study|Lost to Follow-up|14|||
160611887|NCT03685643|579956240|FG001|Overall Study|Lost to Follow-up|22|||
160611888|NCT00403390|579956242|FG000|Overall Study|Withdrawal by Subject|1|||
160611889|NCT00403390|579956243|FG001|Overall Study|Withdrawal by Subject|0|||
160611890|NCT00403390|579956242|FG000|Overall Study|samples lost|1|||
160611891|NCT00403390|579956243|FG001|Overall Study|samples lost|0|||
160611892|NCT00403390|579956242|FG000|Overall Study|non-compliant|1|||
160611893|NCT00403390|579956243|FG001|Overall Study|non-compliant|0|||
160611894|NCT01796106|579956244|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
160611895|NCT01796106|579956245|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
160611896|NCT03595176|579956249|FG000|Overall Study|Death|0|||
160611897|NCT03595176|579956250|FG001|Overall Study|Death|2|||
160611898|NCT03595176|579956249|FG000|Overall Study|Lost to Follow-up|0|||
160611899|NCT03595176|579956250|FG001|Overall Study|Lost to Follow-up|1|||
160611900|NCT02735044|579956252|FG000|Overall Study|Adverse Event|3|||
160611901|NCT02735044|579956253|FG001|Overall Study|Adverse Event|3|||
160611902|NCT02735044|579956252|FG000|Overall Study|Lack of Efficacy|1|||
160611903|NCT02735044|579956253|FG001|Overall Study|Lack of Efficacy|0|||
160611904|NCT02735044|579956252|FG000|Overall Study|Poor compliance to protocol|7|||
160492293|NCT04594733|579531156|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
160492294|NCT04594733|579531155|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
160492295|NCT04594733|579531156|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
160611905|NCT02735044|579956253|FG001|Overall Study|Poor compliance to protocol|7|||
160611906|NCT02735044|579956252|FG000|Overall Study|Randomized and not treated|0|||
160611907|NCT02735044|579956253|FG001|Overall Study|Randomized and not treated|2|||
160661404|NCT01544127|580144092|FG000|Overall Study|Withdrawal by Subject|2|||
160492296|NCT04594733|579531155|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
160661405|NCT01544127|580144093|FG001|Overall Study|Withdrawal by Subject|2|||
160661406|NCT01544127|580144094|FG002|Overall Study|Withdrawal by Subject|1|||
160661407|NCT01544127|580144092|FG000|Overall Study|Discharged out of catchment area|1|||
160492297|NCT04594733|579531156|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
160492298|NCT01225159|579531161|FG000|Overall Study|Change operation|1|||
160492299|NCT01225159|579531162|FG001|Overall Study|Change operation|0|||
160492300|NCT01024036|579531165|FG000|Blinded Treatment|Adverse Event|1|||
160492301|NCT01024036|579531166|FG001|Blinded Treatment|Adverse Event|1|||
160492302|NCT01024036|579531165|FG000|Blinded Treatment|Lack of Efficacy|16|||
160492303|NCT01024036|579531166|FG001|Blinded Treatment|Lack of Efficacy|14|||
160492304|NCT01024036|579531165|FG000|Blinded Treatment|Physician Decision|1|||
160492305|NCT01024036|579531166|FG001|Blinded Treatment|Physician Decision|0|||
160492306|NCT01024036|579531165|FG000|Blinded Treatment|Death|0|||
160492307|NCT01024036|579531166|FG001|Blinded Treatment|Death|2|||
160492308|NCT01024036|579531165|FG000|Blinded Treatment|Withdrawal by Subject|4|||
160492309|NCT01024036|579531166|FG001|Blinded Treatment|Withdrawal by Subject|3|||
160492310|NCT01024036|579531165|FG000|Unblinded Treatment|Adverse Event|0|||
160492311|NCT01024036|579531166|FG001|Unblinded Treatment|Adverse Event|1|||
160492312|NCT01024036|579531165|FG000|Unblinded Treatment|Lack of Efficacy|0|||
160492313|NCT01024036|579531166|FG001|Unblinded Treatment|Lack of Efficacy|2|||
160492314|NCT01024036|579531165|FG000|Follow-Up Period|Lost to Follow-up|1|||
160492315|NCT01024036|579531166|FG001|Follow-Up Period|Lost to Follow-up|1|||
160492316|NCT01024036|579531165|FG000|Follow-Up Period|Withdrawal by Subject|0|||
160492317|NCT01024036|579531166|FG001|Follow-Up Period|Withdrawal by Subject|1|||
160611908|NCT02735044|579956252|FG000|Overall Study|Other, not specified above|5|||
160611909|NCT02735044|579956253|FG001|Overall Study|Other, not specified above|11|||
160611910|NCT01682759|579956255|FG000|Overall Study|Death|2|||
160611911|NCT01682759|579956256|FG001|Overall Study|Death|1|||
160611912|NCT01682759|579956255|FG000|Overall Study|Lost to Follow-up|10|||
160611913|NCT01682759|579956256|FG001|Overall Study|Lost to Follow-up|13|||
160611914|NCT01682759|579956255|FG000|Overall Study|Physician Decision|1|||
160611915|NCT01682759|579956256|FG001|Overall Study|Physician Decision|1|||
160611916|NCT01682759|579956255|FG000|Overall Study|Withdrawal by Subject|56|||
160611917|NCT01682759|579956256|FG001|Overall Study|Withdrawal by Subject|55|||
160611918|NCT00724243|579957491|FG000|Overall Study|Lack of Efficacy|10|||
160611919|NCT00724243|579957491|FG000|Overall Study|Adverse Event|5|||
160611920|NCT03031327|579957492|FG000|Overall Study|Withdrawal by Subject|0|||
160611921|NCT03031327|579957493|FG001|Overall Study|Withdrawal by Subject|1|||
160611922|NCT03031327|579957494|FG002|Overall Study|Withdrawal by Subject|1|||
160611923|NCT00686699|579957495|FG000|Treatment Period 1|Adverse Event|0|||
160611924|NCT00686699|579957496|FG001|Treatment Period 1|Adverse Event|2|||
160611925|NCT00908895|579957497|FG000|Overall Study|Lost to Follow-up|1|||
160611926|NCT00908895|579957498|FG001|Overall Study|Lost to Follow-up|3|||
160611927|NCT00908895|579957497|FG000|Overall Study|algodystrophy|2|||
160611928|NCT00908895|579957498|FG001|Overall Study|algodystrophy|2|||
160611929|NCT00908895|579957497|FG000|Overall Study|Adverse Event|1|||
160611930|NCT00908895|579957498|FG001|Overall Study|Adverse Event|1|||
160611931|NCT03793010|579957499|FG000|Overall Study|Withdrawal by Subject|5|||
160611932|NCT03793010|579957500|FG001|Overall Study|Withdrawal by Subject|7|||
160611933|NCT03793010|579957499|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
160611934|NCT03793010|579957500|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
160611935|NCT03793010|579957499|FG000|Overall Study|Lost to Follow-up|1|||
160611936|NCT03793010|579957500|FG001|Overall Study|Lost to Follow-up|2|||
160611937|NCT03793010|579957499|FG000|Overall Study|Patient couldn't sit still for injection|1|||
160611938|NCT03793010|579957500|FG001|Overall Study|Patient couldn't sit still for injection|0|||
160611939|NCT03793010|579957499|FG000|Overall Study|Withdrew to pursue other treatment|1|||
160611940|NCT03793010|579957500|FG001|Overall Study|Withdrew to pursue other treatment|0|||
160611941|NCT03793010|579957499|FG000|Overall Study|Did not meet eligibility criteria|1|||
160611942|NCT03793010|579957500|FG001|Overall Study|Did not meet eligibility criteria|0|||
160611943|NCT02059174|579957501|FG000|Period 1|Withdrawal by Subject|0|||
160611944|NCT02059174|579957502|FG001|Period 1|Withdrawal by Subject|2|||
160611945|NCT02059174|579957501|FG000|Period 2|Withdrawal by Subject|0|||
160611946|NCT02059174|579957502|FG001|Period 2|Withdrawal by Subject|2|||
160611947|NCT02059174|579957501|FG000|Period 2|Protocol Violation|1|||
160611948|NCT02059174|579957502|FG001|Period 2|Protocol Violation|0|||
160611949|NCT02059174|579957501|FG000|Period 3|Physician Decision|1|||
160611950|NCT02059174|579957502|FG001|Period 3|Physician Decision|0|||
160611951|NCT03345849|579957503|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
160611952|NCT03345849|579957504|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
160611953|NCT03345849|579957505|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
160611954|NCT03345849|579957506|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
160611955|NCT03345849|579957503|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
160611956|NCT03345849|579957504|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
160492318|NCT01024036|579531165|FG000|Follow-Up Period|Adverse Event|4|||
160492319|NCT01024036|579531166|FG001|Follow-Up Period|Adverse Event|1|||
160492320|NCT01220856|579531167|FG000|Overall Study|graft loss|3|||
160611957|NCT03345849|579957505|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
160611958|NCT03345849|579957506|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
160611959|NCT03345849|579957503|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
160492321|NCT01220856|579531168|FG001|Overall Study|graft loss|3|||
160492322|NCT01220856|579531167|FG000|Overall Study|Lost to Follow-up|1|||
160492323|NCT01220856|579531168|FG001|Overall Study|Lost to Follow-up|0|||
160492324|NCT03512288|579531173|FG000|Overall Study|Adverse Event|1|||
160492325|NCT03512288|579531174|FG001|Overall Study|Adverse Event|0|||
160492326|NCT03512288|579531173|FG000|Overall Study|Lost to Follow-up|12|||
160492327|NCT03512288|579531174|FG001|Overall Study|Lost to Follow-up|15|||
160492328|NCT03512288|579531173|FG000|Overall Study|Physician Decision|0|||
160492329|NCT03512288|579531174|FG001|Overall Study|Physician Decision|2|||
160492330|NCT03512288|579531173|FG000|Overall Study|Protocol Violation|6|||
160492331|NCT03512288|579531174|FG001|Overall Study|Protocol Violation|4|||
160492332|NCT03512288|579531173|FG000|Overall Study|Medication error without associated adverse event|1|||
160492333|NCT03512288|579531174|FG001|Overall Study|Medication error without associated adverse event|0|||
160492334|NCT03512288|579531173|FG000|Overall Study|No longer met eligibility criteria|5|||
160492335|NCT03512288|579531174|FG001|Overall Study|No longer met eligibility criteria|2|||
160492336|NCT03512288|579531173|FG000|Overall Study|Withdrawal by parent/guardian|14|||
160492337|NCT03512288|579531174|FG001|Overall Study|Withdrawal by parent/guardian|18|||
160492338|NCT03512288|579531173|FG000|Overall Study|Other|1|||
160492339|NCT03512288|579531174|FG001|Overall Study|Other|1|||
160492340|NCT03512288|579531173|FG000|Overall Study|Randomized but not treated|1|||
160492341|NCT03512288|579531174|FG001|Overall Study|Randomized but not treated|1|||
160492342|NCT04814992|579531175|FG000|Overall Study|Withdrawal by Subject|6|||
160492343|NCT04814992|579531176|FG001|Overall Study|Withdrawal by Subject|3|||
160492344|NCT04814992|579531175|FG000|Overall Study|Lost to Follow-up|1|||
160492345|NCT04814992|579531176|FG001|Overall Study|Lost to Follow-up|4|||
160492346|NCT00966264|579533539|FG000|Overall Study|Lost to Follow-up|4|||
160492347|NCT00966264|579533540|FG001|Overall Study|Lost to Follow-up|3|||
160492348|NCT02366143|579533541|FG000|Overall Study|Death|307|||
160492349|NCT02366143|579533542|FG001|Overall Study|Death|278|||
160492350|NCT02366143|579533543|FG002|Overall Study|Death|280|||
160492351|NCT02366143|579533541|FG000|Overall Study|Lost to Follow-up|2|||
160492352|NCT02366143|579533542|FG001|Overall Study|Lost to Follow-up|4|||
160492353|NCT02366143|579533543|FG002|Overall Study|Lost to Follow-up|2|||
160492354|NCT02366143|579533541|FG000|Overall Study|Physician Decision|1|||
160492355|NCT02366143|579533542|FG001|Overall Study|Physician Decision|2|||
160492356|NCT02366143|579533543|FG002|Overall Study|Physician Decision|1|||
160492357|NCT02366143|579533541|FG000|Overall Study|Protocol Violation|0|||
160492358|NCT02366143|579533542|FG001|Overall Study|Protocol Violation|0|||
160492359|NCT02366143|579533543|FG002|Overall Study|Protocol Violation|2|||
160492360|NCT02366143|579533541|FG000|Overall Study|Withdrawal by Subject|16|||
160492361|NCT02366143|579533542|FG001|Overall Study|Withdrawal by Subject|17|||
160492362|NCT02366143|579533543|FG002|Overall Study|Withdrawal by Subject|22|||
160492363|NCT02366143|579533541|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
160492364|NCT02366143|579533542|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
160492365|NCT02366143|579533543|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
160492366|NCT02366143|579533541|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
160492367|NCT02366143|579533542|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
160492368|NCT02366143|579533543|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
160492369|NCT02366143|579533541|FG000|Overall Study|Randomization Error|1|||
160492370|NCT02366143|579533542|FG001|Overall Study|Randomization Error|0|||
160492371|NCT02366143|579533543|FG002|Overall Study|Randomization Error|0|||
160492372|NCT02366143|579533541|FG000|Overall Study|PI Move and Site Closure|1|||
160492373|NCT02366143|579533542|FG001|Overall Study|PI Move and Site Closure|0|||
160492374|NCT02366143|579533543|FG002|Overall Study|PI Move and Site Closure|1|||
160492375|NCT02366143|579533541|FG000|Overall Study|Study Terminated By Sponsor|0|||
160492376|NCT02366143|579533542|FG001|Overall Study|Study Terminated By Sponsor|0|||
160492377|NCT02366143|579533543|FG002|Overall Study|Study Terminated By Sponsor|2|||
160492378|NCT02366143|579533541|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
160492379|NCT02366143|579533542|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
160492380|NCT02366143|579533543|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
160492381|NCT02366143|579533541|FG000|Overall Study|Patient moved to roll-over study|1|||
160492382|NCT02366143|579533542|FG001|Overall Study|Patient moved to roll-over study|19|||
160492383|NCT02366143|579533543|FG002|Overall Study|Patient moved to roll-over study|28|||
160492384|NCT02366143|579533541|FG000|Overall Study|Patient moved to commercial stock|0|||
160492385|NCT02366143|579533542|FG001|Overall Study|Patient moved to commercial stock|0|||
160492386|NCT02366143|579533543|FG002|Overall Study|Patient moved to commercial stock|1|||
160492387|NCT02366143|579533541|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
160492388|NCT02366143|579533542|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
160492389|NCT02366143|579533543|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
160492390|NCT02366143|579533541|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
160492391|NCT02366143|579533542|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
160492392|NCT02366143|579533543|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
160492393|NCT02366143|579533541|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
160492394|NCT02366143|579533542|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
160492395|NCT02366143|579533543|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
160492396|NCT02366143|579533541|FG000|Overall Study|Requester's instructions|1|||
160492397|NCT02366143|579533542|FG001|Overall Study|Requester's instructions|1|||
160492398|NCT02366143|579533543|FG002|Overall Study|Requester's instructions|1|||
160492399|NCT02366143|579533541|FG000|Overall Study|Uneligible|0|||
160492400|NCT02366143|579533542|FG001|Overall Study|Uneligible|1|||
160492401|NCT02366143|579533543|FG002|Overall Study|Uneligible|0|||
160492402|NCT02366143|579533541|FG000|Overall Study|Post Trial Migration|0|||
160492403|NCT02366143|579533542|FG001|Overall Study|Post Trial Migration|1|||
160492404|NCT02366143|579533543|FG002|Overall Study|Post Trial Migration|0|||
160492405|NCT02366143|579533541|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
160492406|NCT02366143|579533542|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
160492407|NCT02366143|579533543|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
160492408|NCT02366143|579533541|FG000|Overall Study|Patient switched to PTAP|0|||
160492409|NCT02366143|579533542|FG001|Overall Study|Patient switched to PTAP|1|||
160492410|NCT02366143|579533543|FG002|Overall Study|Patient switched to PTAP|0|||
160492411|NCT02366143|579533541|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
160492412|NCT02366143|579533542|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
160492413|NCT02366143|579533543|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
160492414|NCT01458522|579533544|FG000|Overall Study|Withdrawal by Subject|2|||
160492415|NCT01458522|579533545|FG001|Overall Study|Withdrawal by Subject|2|||
160492416|NCT01458522|579533544|FG000|Overall Study|Physician Decision|1|||
160492417|NCT01458522|579533545|FG001|Overall Study|Physician Decision|9|||
160492418|NCT00516139|579533546|FG000|Overall Study|Adverse Event|27|||
160492419|NCT00516139|579533546|FG000|Overall Study|Lost to Follow-up|1|||
160492420|NCT00516139|579533546|FG000|Overall Study|Protocol Violation|1|||
160492421|NCT00516139|579533546|FG000|Overall Study|Withdrawal by Subject|8|||
160492422|NCT00516139|579533546|FG000|Overall Study|Lack of Efficacy|1|||
160492423|NCT00589303|579533547|FG000|Overall Study|Withdrawal by Subject|2|||
160492424|NCT00589303|579533548|FG001|Overall Study|Withdrawal by Subject|1|||
160492425|NCT03062449|579533549|FG000|Overall Study|Withdrawal by Subject|7|||
160492426|NCT03062449|579533550|FG001|Overall Study|Withdrawal by Subject|1|||
160492427|NCT02370251|579533551|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
160492428|NCT02370251|579533551|FG000|Overall Study|Death|4|||
160492429|NCT04120376|579533552|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
160492430|NCT04120376|579533553|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
160492431|NCT02053610|579533554|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
160492432|NCT02053610|579533555|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
160492433|NCT02053610|579533554|FG000|Overall Study|Withdrew Consent|2|||
160492434|NCT02053610|579533555|FG001|Overall Study|Withdrew Consent|9|||
160492435|NCT02053610|579533554|FG000|Overall Study|Death|5|||
160492436|NCT02053610|579533555|FG001|Overall Study|Death|5|||
160492437|NCT02053610|579533554|FG000|Overall Study|Administrative/Other|1|||
160492438|NCT02053610|579533555|FG001|Overall Study|Administrative/Other|1|||
160492439|NCT02053610|579533554|FG000|Overall Study|Disease Progression|2|||
160492440|NCT02053610|579533555|FG001|Overall Study|Disease Progression|3|||
160492441|NCT02053610|579533554|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
160492442|NCT02053610|579533555|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
160492443|NCT02053610|579533554|FG000|Overall Study|Did not Receive Treatment|4|||
160492444|NCT02053610|579533555|FG001|Overall Study|Did not Receive Treatment|2|||
160492445|NCT02053610|579533554|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160492446|NCT02053610|579533555|FG001|Overall Study|Insufficient Therapeutic Response|1|||
160492447|NCT02053610|579533554|FG000|Overall Study|Violation of Selection Criteria|1|||
160492448|NCT02053610|579533555|FG001|Overall Study|Violation of Selection Criteria|0|||
160492449|NCT01165177|579533556|FG000|Overall Study|Serious Adverse Event|227|||
160492450|NCT01165177|579533557|FG001|Overall Study|Serious Adverse Event|235|||
160492451|NCT01165177|579533556|FG000|Overall Study|Withdrawal by Subject|368|||
160492452|NCT01165177|579533557|FG001|Overall Study|Withdrawal by Subject|354|||
160492453|NCT01165177|579533556|FG000|Overall Study|Protocol Violation|19|||
160492454|NCT01165177|579533557|FG001|Overall Study|Protocol Violation|21|||
160492455|NCT01165177|579533556|FG000|Overall Study|Non-serious adverse event|30|||
160492456|NCT01165177|579533557|FG001|Overall Study|Non-serious adverse event|18|||
160492457|NCT01165177|579533556|FG000|Overall Study|Other unspecified reasons|47|||
160492458|NCT01165177|579533557|FG001|Overall Study|Other unspecified reasons|35|||
160492459|NCT01165177|579533556|FG000|Overall Study|Suspected HZ episode|0|||
160492460|NCT01165177|579533557|FG001|Overall Study|Suspected HZ episode|2|||
160492461|NCT01165177|579533556|FG000|Overall Study|Lost to Follow-up|183|||
160492462|NCT01165177|579533557|FG001|Overall Study|Lost to Follow-up|194|||
160492463|NCT01165177|579533556|FG000|Overall Study|Migrated/ moved from study area|48|||
160492464|NCT01165177|579533557|FG001|Overall Study|Migrated/ moved from study area|43|||
160492465|NCT05499130|579533558|FG000|Overall Study|Adverse Event|2|||
160492466|NCT05499130|579533559|FG001|Overall Study|Adverse Event|0|||
160492467|NCT05499130|579533560|FG002|Overall Study|Adverse Event|1|||
160492468|NCT05499130|579533561|FG003|Overall Study|Adverse Event|0|||
160492469|NCT05499130|579533562|FG004|Overall Study|Adverse Event|1|||
160492470|NCT05499130|579533563|FG005|Overall Study|Adverse Event|4|||
160492471|NCT05499130|579533564|FG006|Overall Study|Adverse Event|1|||
160492472|NCT05499130|579533565|FG007|Overall Study|Adverse Event|0|||
160492473|NCT05499130|579533558|FG000|Overall Study|Lack of Efficacy|1|||
160492474|NCT05499130|579533559|FG001|Overall Study|Lack of Efficacy|0|||
160492475|NCT05499130|579533560|FG002|Overall Study|Lack of Efficacy|0|||
160492476|NCT05499130|579533561|FG003|Overall Study|Lack of Efficacy|0|||
160492477|NCT05499130|579533562|FG004|Overall Study|Lack of Efficacy|5|||
160492478|NCT05499130|579533563|FG005|Overall Study|Lack of Efficacy|0|||
160492479|NCT05499130|579533564|FG006|Overall Study|Lack of Efficacy|1|||
160492480|NCT05499130|579533565|FG007|Overall Study|Lack of Efficacy|0|||
160492481|NCT05499130|579533558|FG000|Overall Study|Withdrawal by Subject|2|||
160492482|NCT05499130|579533559|FG001|Overall Study|Withdrawal by Subject|0|||
160492483|NCT05499130|579533560|FG002|Overall Study|Withdrawal by Subject|0|||
160492484|NCT05499130|579533561|FG003|Overall Study|Withdrawal by Subject|0|||
160492485|NCT05499130|579533562|FG004|Overall Study|Withdrawal by Subject|1|||
160492486|NCT05499130|579533563|FG005|Overall Study|Withdrawal by Subject|2|||
160492487|NCT05499130|579533564|FG006|Overall Study|Withdrawal by Subject|0|||
160492488|NCT05499130|579533565|FG007|Overall Study|Withdrawal by Subject|0|||
160492489|NCT05499130|579533558|FG000|Overall Study|Lost to Follow-up|0|||
160492490|NCT05499130|579533559|FG001|Overall Study|Lost to Follow-up|0|||
160492491|NCT05499130|579533560|FG002|Overall Study|Lost to Follow-up|0|||
160492492|NCT05499130|579533561|FG003|Overall Study|Lost to Follow-up|0|||
160492493|NCT05499130|579533562|FG004|Overall Study|Lost to Follow-up|0|||
160492494|NCT05499130|579533563|FG005|Overall Study|Lost to Follow-up|2|||
160492495|NCT05499130|579533564|FG006|Overall Study|Lost to Follow-up|0|||
160492496|NCT05499130|579533565|FG007|Overall Study|Lost to Follow-up|0|||
160492497|NCT05499130|579533558|FG000|Overall Study|Other Than Specified|0|||
160492498|NCT05499130|579533559|FG001|Overall Study|Other Than Specified|0|||
160492499|NCT05499130|579533560|FG002|Overall Study|Other Than Specified|0|||
160492500|NCT05499130|579533561|FG003|Overall Study|Other Than Specified|0|||
160492501|NCT05499130|579533562|FG004|Overall Study|Other Than Specified|1|||
160492502|NCT05499130|579533563|FG005|Overall Study|Other Than Specified|1|||
160492503|NCT05499130|579533564|FG006|Overall Study|Other Than Specified|2|||
160492504|NCT05499130|579533565|FG007|Overall Study|Other Than Specified|0|||
160492505|NCT05499130|579533558|FG000|Overall Study|Protocol Violation|0|||
160492506|NCT05499130|579533559|FG001|Overall Study|Protocol Violation|0|||
160492507|NCT05499130|579533560|FG002|Overall Study|Protocol Violation|0|||
160492508|NCT05499130|579533561|FG003|Overall Study|Protocol Violation|0|||
160492509|NCT05499130|579533562|FG004|Overall Study|Protocol Violation|1|||
160492510|NCT05499130|579533563|FG005|Overall Study|Protocol Violation|0|||
160492511|NCT05499130|579533564|FG006|Overall Study|Protocol Violation|0|||
160492512|NCT05499130|579533565|FG007|Overall Study|Protocol Violation|0|||
160492513|NCT00781937|579533567|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
160492514|NCT00781937|579533568|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
160492515|NCT00781937|579533567|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
160492516|NCT00781937|579533568|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
160492517|NCT00781937|579533567|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
160492518|NCT00781937|579533568|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
160492519|NCT00781937|579533567|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
160492520|NCT00781937|579533568|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
160492521|NCT00781937|579533567|FG000|Main Trial Period Through Week 56|Unclassified|10|||
160492522|NCT00781937|579533568|FG001|Main Trial Period Through Week 56|Unclassified|15|||
160611960|NCT03345849|579957504|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
160492523|NCT00781937|579533567|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
160492524|NCT00781937|579533568|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
160492525|NCT00781937|579533567|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
160492526|NCT00781937|579533568|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
160492527|NCT00013611|579533569|FG000|Overall Study|Lost to Follow-up|91|||
160492528|NCT00013611|579533570|FG001|Overall Study|Lost to Follow-up|100|||
160492529|NCT01150045|579533571|FG000|Overall Study|Protocol Violation|0|||
160492530|NCT01150045|579533572|FG001|Overall Study|Protocol Violation|1|||
160492531|NCT01150045|579533573|FG002|Overall Study|Protocol Violation|0|||
160492532|NCT01150045|579533574|FG003|Overall Study|Protocol Violation|1|||
160492533|NCT02330562|579533578|FG000|Overall Study|Adverse Event|0|||
160492534|NCT02330562|579533579|FG001|Overall Study|Adverse Event|0|||
160492535|NCT02330562|579533580|FG002|Overall Study|Adverse Event|3|||
160492536|NCT02330562|579533581|FG003|Overall Study|Adverse Event|0|||
160492537|NCT02330562|579533582|FG004|Overall Study|Adverse Event|3|||
160492538|NCT02330562|579533583|FG005|Overall Study|Adverse Event|1|||
160492539|NCT02330562|579533584|FG006|Overall Study|Adverse Event|0|||
160492540|NCT02330562|579533585|FG007|Overall Study|Adverse Event|0|||
160492541|NCT02330562|579533586|FG008|Overall Study|Adverse Event|0|||
160492542|NCT02330562|579533587|FG009|Overall Study|Adverse Event|1|||
160492543|NCT02330562|579533588|FG010|Overall Study|Adverse Event|1|||
160492544|NCT02330562|579533578|FG000|Overall Study|Participant decision|1|||
160492545|NCT02330562|579533579|FG001|Overall Study|Participant decision|0|||
160492546|NCT02330562|579533580|FG002|Overall Study|Participant decision|4|||
160492547|NCT02330562|579533581|FG003|Overall Study|Participant decision|1|||
160492548|NCT02330562|579533582|FG004|Overall Study|Participant decision|5|||
160492549|NCT02330562|579533583|FG005|Overall Study|Participant decision|2|||
160611961|NCT03345849|579957505|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
160611962|NCT03345849|579957506|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
160611963|NCT03345849|579957503|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
160611964|NCT03345849|579957504|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
160611965|NCT03345849|579957505|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
160611966|NCT03345849|579957506|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
160611967|NCT03345849|579957503|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
160611968|NCT03345849|579957504|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
160611969|NCT03345849|579957505|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
160611970|NCT03345849|579957506|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
160611971|NCT03345849|579957503|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
160611972|NCT03345849|579957504|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
160611973|NCT03345849|579957505|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
160611974|NCT03345849|579957506|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
160611975|NCT03345849|579957503|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
160611976|NCT03345849|579957504|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
160611977|NCT03345849|579957505|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
160611978|NCT03345849|579957506|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
160611979|NCT03345849|579957503|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
160611980|NCT03345849|579957504|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
160611981|NCT03345849|579957505|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
160611982|NCT03345849|579957506|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
160611983|NCT03345849|579957503|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
160611984|NCT03345849|579957504|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
160611985|NCT03345849|579957505|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
160611986|NCT03345849|579957506|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
160611987|NCT03345849|579957503|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
160611988|NCT03345849|579957504|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
160611989|NCT03345849|579957505|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
160611990|NCT03345849|579957506|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
160611991|NCT03345849|579957503|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
160611992|NCT03345849|579957504|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
160611993|NCT03345849|579957505|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
160611994|NCT03345849|579957506|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
160611995|NCT03991936|579957507|FG000|Overall Study|Lost to Follow-up|1|||
160611996|NCT03991936|579957508|FG001|Overall Study|Lost to Follow-up|1|||
160611997|NCT03991936|579957509|FG002|Overall Study|Lost to Follow-up|1|||
160611998|NCT03991936|579957510|FG003|Overall Study|Lost to Follow-up|1|||
160611999|NCT03991936|579957511|FG004|Overall Study|Lost to Follow-up|1|||
160612000|NCT00939055|579957512|FG000|Overall Study|Discontinuation prior to procedure|4|||
160612001|NCT00939055|579957513|FG001|Overall Study|Discontinuation prior to procedure|0|||
160612002|NCT00584987|579957514|FG000|Overall Study|Protocol Violation|1|||
160612003|NCT00584987|579957515|FG001|Overall Study|Protocol Violation|1|||
160612004|NCT00584987|579957516|FG002|Overall Study|Protocol Violation|1|||
160612005|NCT00584987|579957517|FG003|Overall Study|Protocol Violation|0|||
160612006|NCT00584987|579957514|FG000|Overall Study|Adverse Event|0|||
160612007|NCT00584987|579957515|FG001|Overall Study|Adverse Event|0|||
160612008|NCT00584987|579957516|FG002|Overall Study|Adverse Event|0|||
160612009|NCT00584987|579957517|FG003|Overall Study|Adverse Event|1|||
160612010|NCT01944462|579957521|FG000|PPPP Educational Program|Lost to Follow-up|60|||
160612011|NCT00808028|579957522|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
160612012|NCT00808028|579957523|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
160612013|NCT00808028|579957524|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
160612014|NCT00808028|579957525|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
160612015|NCT00808028|579957522|FG000|Stage 1 (6 Months)|Other|1|||
160612016|NCT00808028|579957523|FG001|Stage 1 (6 Months)|Other|0|||
160661408|NCT01544127|580144093|FG001|Overall Study|Discharged out of catchment area|1|||
160661409|NCT01544127|580144094|FG002|Overall Study|Discharged out of catchment area|1|||
160661410|NCT01544127|580144092|FG000|Overall Study|Death|1|||
160612017|NCT00808028|579957524|FG002|Stage 1 (6 Months)|Other|2|||
160661411|NCT01544127|580144093|FG001|Overall Study|Death|0|||
160492550|NCT02330562|579533584|FG006|Overall Study|Participant decision|0|||
160492551|NCT02330562|579533585|FG007|Overall Study|Participant decision|0|||
160492552|NCT02330562|579533586|FG008|Overall Study|Participant decision|0|||
160492553|NCT02330562|579533587|FG009|Overall Study|Participant decision|3|||
160492554|NCT02330562|579533588|FG010|Overall Study|Participant decision|0|||
160492555|NCT02330562|579533578|FG000|Overall Study|Disease progression|5|||
160492556|NCT02330562|579533579|FG001|Overall Study|Disease progression|3|||
160492557|NCT02330562|579533580|FG002|Overall Study|Disease progression|20|||
160492558|NCT02330562|579533581|FG003|Overall Study|Disease progression|28|||
160492559|NCT02330562|579533582|FG004|Overall Study|Disease progression|23|||
160492560|NCT02330562|579533583|FG005|Overall Study|Disease progression|7|||
160492561|NCT02330562|579533584|FG006|Overall Study|Disease progression|1|||
160492562|NCT02330562|579533585|FG007|Overall Study|Disease progression|1|||
160492563|NCT02330562|579533586|FG008|Overall Study|Disease progression|1|||
160492564|NCT02330562|579533587|FG009|Overall Study|Disease progression|0|||
160492565|NCT02330562|579533588|FG010|Overall Study|Disease progression|5|||
160492566|NCT02330562|579533578|FG000|Overall Study|Other reasons|0|||
160492567|NCT02330562|579533579|FG001|Overall Study|Other reasons|0|||
160492568|NCT02330562|579533580|FG002|Overall Study|Other reasons|0|||
160492569|NCT02330562|579533581|FG003|Overall Study|Other reasons|1|||
160492570|NCT02330562|579533582|FG004|Overall Study|Other reasons|0|||
160492571|NCT02330562|579533583|FG005|Overall Study|Other reasons|0|||
160492572|NCT02330562|579533584|FG006|Overall Study|Other reasons|0|||
160492573|NCT02330562|579533585|FG007|Overall Study|Other reasons|0|||
160492574|NCT02330562|579533586|FG008|Overall Study|Other reasons|0|||
160492575|NCT02330562|579533587|FG009|Overall Study|Other reasons|0|||
160492576|NCT02330562|579533588|FG010|Overall Study|Other reasons|0|||
160492577|NCT02330562|579533578|FG000|Overall Study|Withdrawal by Subject|0|||
160492578|NCT02330562|579533579|FG001|Overall Study|Withdrawal by Subject|0|||
160492579|NCT02330562|579533580|FG002|Overall Study|Withdrawal by Subject|0|||
160492580|NCT02330562|579533581|FG003|Overall Study|Withdrawal by Subject|0|||
160492581|NCT02330562|579533582|FG004|Overall Study|Withdrawal by Subject|0|||
160492582|NCT02330562|579533583|FG005|Overall Study|Withdrawal by Subject|0|||
160492583|NCT02330562|579533584|FG006|Overall Study|Withdrawal by Subject|0|||
160492584|NCT02330562|579533585|FG007|Overall Study|Withdrawal by Subject|0|||
160492585|NCT02330562|579533586|FG008|Overall Study|Withdrawal by Subject|0|||
160492586|NCT02330562|579533587|FG009|Overall Study|Withdrawal by Subject|1|||
160492587|NCT02330562|579533588|FG010|Overall Study|Withdrawal by Subject|0|||
160492588|NCT01547117|579533590|FG000|Overall Study|Physician Decision|0|||
160492589|NCT01547117|579533591|FG001|Overall Study|Physician Decision|1|||
160492590|NCT01547117|579533592|FG002|Overall Study|Physician Decision|1|||
160492591|NCT01547117|579533593|FG003|Overall Study|Physician Decision|3|||
160492592|NCT01547117|579533590|FG000|Overall Study|Withdrawal by Subject|1|||
160492593|NCT01547117|579533591|FG001|Overall Study|Withdrawal by Subject|2|||
160492594|NCT01547117|579533592|FG002|Overall Study|Withdrawal by Subject|1|||
160492595|NCT01547117|579533593|FG003|Overall Study|Withdrawal by Subject|2|||
160492596|NCT00126659|579533596|FG000|Overall Study|Adverse Event|0|||
160492597|NCT00126659|579533597|FG001|Overall Study|Adverse Event|0|||
160492598|NCT00126659|579533598|FG002|Overall Study|Adverse Event|2|||
160492599|NCT00174447|579533599|FG000|Overall Study|Adverse Event|19|||
160492600|NCT00174447|579533599|FG000|Overall Study|Withdrawal by Subject|15|||
160492601|NCT00174447|579533599|FG000|Overall Study|Protocol Violation|1|||
160492602|NCT00174447|579533599|FG000|Overall Study|Lack of Efficacy|1|||
160492603|NCT00174447|579533599|FG000|Overall Study|Administrative reason/Other|2|||
160492604|NCT03491215|579533607|FG000|Overall Study|Death|6|||
160492605|NCT03491215|579533608|FG001|Overall Study|Death|2|||
160492606|NCT03491215|579533609|FG002|Overall Study|Death|1|||
160492607|NCT03491215|579533610|FG003|Overall Study|Death|0|||
160492608|NCT03491215|579533607|FG000|Overall Study|Physician Decision|1|||
160492609|NCT03491215|579533608|FG001|Overall Study|Physician Decision|0|||
160492610|NCT03491215|579533609|FG002|Overall Study|Physician Decision|0|||
160492611|NCT03491215|579533610|FG003|Overall Study|Physician Decision|0|||
160492612|NCT04599855|579533613|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
160492613|NCT04599855|579533614|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
160492614|NCT04599855|579533615|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
160492615|NCT04599855|579533613|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
160492616|NCT04599855|579533614|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
160492617|NCT04599855|579533615|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
160492618|NCT04599855|579533613|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
160492619|NCT04599855|579533614|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
160612018|NCT00808028|579957525|FG003|Stage 1 (6 Months)|Other|4|||
160492620|NCT04599855|579533615|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
160492621|NCT04599855|579533613|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
160492622|NCT04599855|579533614|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
160492623|NCT04599855|579533615|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
160492624|NCT04599855|579533613|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
160492625|NCT04599855|579533614|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
160492626|NCT04599855|579533615|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
160612019|NCT00808028|579957522|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
160612020|NCT00808028|579957523|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
160612021|NCT00808028|579957524|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
160612022|NCT00808028|579957525|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
160612023|NCT00808028|579957522|FG000|Stage 1 (6 Months)|Adverse Event|0|||
160612024|NCT00808028|579957523|FG001|Stage 1 (6 Months)|Adverse Event|0|||
160612025|NCT00808028|579957524|FG002|Stage 1 (6 Months)|Adverse Event|1|||
160612026|NCT00808028|579957525|FG003|Stage 1 (6 Months)|Adverse Event|2|||
160612027|NCT00808028|579957522|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
160612028|NCT00808028|579957523|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
160612029|NCT00808028|579957524|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
160612030|NCT00808028|579957525|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
160612031|NCT00808028|579957522|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
160612032|NCT00808028|579957523|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
160612033|NCT00808028|579957524|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
160612034|NCT00808028|579957525|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
160612035|NCT00808028|579957522|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
160612036|NCT00808028|579957523|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
160612037|NCT00808028|579957524|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
160612038|NCT00808028|579957525|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
160612039|NCT00808028|579957522|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
160612040|NCT00808028|579957523|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
160612041|NCT00808028|579957524|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
160612042|NCT00808028|579957525|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
160612043|NCT00808028|579957522|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
160612044|NCT00808028|579957523|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
160612045|NCT00808028|579957524|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
160612046|NCT00808028|579957525|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
160612047|NCT00808028|579957522|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
160612048|NCT00808028|579957523|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
160612049|NCT00808028|579957524|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
160612050|NCT00808028|579957525|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
160612051|NCT00808028|579957522|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
160612052|NCT00808028|579957523|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
160612053|NCT00808028|579957524|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
160612054|NCT00808028|579957525|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
160612055|NCT00808028|579957522|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
160612056|NCT00808028|579957523|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
160612057|NCT00808028|579957524|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
160612058|NCT00808028|579957525|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
160612059|NCT00808028|579957522|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
160612060|NCT00808028|579957523|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
160612061|NCT00808028|579957524|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
160612062|NCT00808028|579957525|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
160612063|NCT00808028|579957522|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
160612064|NCT00808028|579957523|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
160612065|NCT00808028|579957524|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
160612066|NCT00808028|579957525|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
160612067|NCT00808028|579957522|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
160612068|NCT00808028|579957523|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
160612069|NCT00808028|579957524|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
160612070|NCT00808028|579957525|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
160612071|NCT01222767|579957529|FG000|Overall Study|Progressive disease|13|||
160612072|NCT01222767|579957529|FG000|Overall Study|Adverse Event|2|||
160612073|NCT01222767|579957529|FG000|Overall Study|Surgical resection|1|||
160612074|NCT01222767|579957529|FG000|Overall Study|Never treated|1|||
160612075|NCT00081263|579957539|FG000|Overall Study|clerical error|1|||
160612076|NCT00081263|579957540|FG001|Overall Study|clerical error|0|||
160612077|NCT00081263|579957539|FG000|Overall Study|wrong cell type|7|||
160612078|NCT00081263|579957540|FG001|Overall Study|wrong cell type|5|||
160612079|NCT00081263|579957539|FG000|Overall Study|improper pre-protocol therapy|0|||
160612080|NCT00081263|579957540|FG001|Overall Study|improper pre-protocol therapy|1|||
160612081|NCT00081263|579957539|FG000|Overall Study|Inadequate pathology|0|||
160612082|NCT00081263|579957540|FG001|Overall Study|Inadequate pathology|1|||
160612083|NCT00081263|579957539|FG000|Overall Study|Never treated|4|||
160612084|NCT00081263|579957540|FG001|Overall Study|Never treated|5|||
160612085|NCT00081263|579957539|FG000|Overall Study|Inadequate data|5|||
160612086|NCT00081263|579957540|FG001|Overall Study|Inadequate data|10|||
160612087|NCT01852591|579957541|FG000|Overall Study|Withdrawal by Subject|2|||
160661412|NCT01544127|580144094|FG002|Overall Study|Death|0|||
160661413|NCT01544127|580144092|FG000|Overall Study|Jail or Prison|1|||
160661414|NCT01544127|580144093|FG001|Overall Study|Jail or Prison|1|||
160612088|NCT01852591|579957541|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
160612089|NCT01267955|579957548|FG000|Stage 1 (6 Months)|Death|3|||
160612090|NCT01267955|579957548|FG000|Stage 2 (6 Months)|Death|5|||
160661415|NCT01544127|580144094|FG002|Overall Study|Jail or Prison|2|||
160661416|NCT01544127|580144092|FG000|Overall Study|Became Psychotic|1|||
160661417|NCT01544127|580144093|FG001|Overall Study|Became Psychotic|0|||
160661418|NCT01544127|580144094|FG002|Overall Study|Became Psychotic|0|||
160661419|NCT01544127|580144092|FG000|Overall Study|Researcher withdrew|1|||
160661420|NCT01544127|580144093|FG001|Overall Study|Researcher withdrew|0|||
160661421|NCT01544127|580144094|FG002|Overall Study|Researcher withdrew|0|||
160612091|NCT01267955|579957548|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
160612092|NCT01263470|579957549|FG000|Overall Study|Adverse Event|2|||
160612093|NCT01263470|579957550|FG001|Overall Study|Adverse Event|2|||
160612094|NCT01263470|579957551|FG002|Overall Study|Adverse Event|1|||
160612095|NCT01263470|579957552|FG003|Overall Study|Adverse Event|1|||
160612096|NCT01263470|579957553|FG004|Overall Study|Adverse Event|2|||
160612097|NCT01263470|579957554|FG005|Overall Study|Adverse Event|2|||
160612098|NCT01263470|579957549|FG000|Overall Study|Protocol Violation|0|||
160661422|NCT01544127|580144092|FG000|Overall Study|Went active duty|0|||
160661423|NCT01544127|580144093|FG001|Overall Study|Went active duty|0|||
160661424|NCT01544127|580144094|FG002|Overall Study|Went active duty|1|||
160492627|NCT04599855|579533613|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
160612099|NCT01263470|579957550|FG001|Overall Study|Protocol Violation|1|||
160612100|NCT01263470|579957551|FG002|Overall Study|Protocol Violation|0|||
160612101|NCT01263470|579957552|FG003|Overall Study|Protocol Violation|0|||
160612102|NCT01263470|579957553|FG004|Overall Study|Protocol Violation|0|||
160612103|NCT01263470|579957554|FG005|Overall Study|Protocol Violation|1|||
160661425|NCT01256684|580144097|FG000|Overall Study|Adverse Event|1|||
160612104|NCT01263470|579957549|FG000|Overall Study|Withdrawal by Subject|0|||
160661426|NCT01256684|580144098|FG001|Overall Study|Adverse Event|4|||
160661427|NCT01256684|580144099|FG002|Overall Study|Adverse Event|2|||
160661428|NCT01256684|580144097|FG000|Overall Study|Withdrawal by Subject|4|||
160492628|NCT04599855|579533614|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
160492629|NCT04599855|579533615|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
160492630|NCT04599855|579533613|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
160492631|NCT04599855|579533614|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
160492632|NCT04599855|579533615|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
160492633|NCT04599855|579533613|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
160492634|NCT04599855|579533614|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
160492635|NCT04599855|579533615|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
160492636|NCT04599855|579533613|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
160492637|NCT04599855|579533614|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
160492638|NCT04599855|579533615|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
160492639|NCT04599855|579533613|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
160492640|NCT04599855|579533614|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
160492641|NCT04599855|579533615|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
160492642|NCT04599855|579533613|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
160492643|NCT04599855|579533614|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
160492644|NCT04599855|579533615|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
160492645|NCT04599855|579533613|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
160492646|NCT04599855|579533614|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
160492647|NCT04599855|579533615|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
160492648|NCT04599855|579533613|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
160492649|NCT04599855|579533614|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
160492650|NCT04599855|579533615|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
160492651|NCT04599855|579533613|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
160492652|NCT04599855|579533614|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
160492653|NCT04599855|579533615|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
160492654|NCT04294667|579533616|FG000|Overall Study|Lack of Efficacy|4|||
160492655|NCT04294667|579533617|FG001|Overall Study|Lack of Efficacy|4|||
160492656|NCT04294667|579533616|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
160492657|NCT04294667|579533617|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
160492658|NCT04294667|579533616|FG000|Overall Study|Patient has a Renal Flare|1|||
160492659|NCT04294667|579533617|FG001|Overall Study|Patient has a Renal Flare|0|||
160492660|NCT04294667|579533616|FG000|Overall Study|SLE Worsening|0|||
160492661|NCT04294667|579533617|FG001|Overall Study|SLE Worsening|1|||
160492662|NCT04294667|579533616|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
160492663|NCT04294667|579533617|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
160492664|NCT04294667|579533616|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
160492665|NCT04294667|579533617|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
160492666|NCT04294667|579533616|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
160492667|NCT04294667|579533617|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
160492668|NCT04294667|579533616|FG000|Overall Study|Subject Moved to Another State|0|||
160492669|NCT04294667|579533617|FG001|Overall Study|Subject Moved to Another State|1|||
160492670|NCT04294667|579533616|FG000|Overall Study|Adverse event, serious fatal|0|||
160492671|NCT04294667|579533617|FG001|Overall Study|Adverse event, serious fatal|1|||
160492672|NCT04294667|579533616|FG000|Overall Study|Adverse event, non-fatal|3|||
160492673|NCT04294667|579533617|FG001|Overall Study|Adverse event, non-fatal|4|||
160492674|NCT00548847|579533618|FG000|Overall Study|Disease progression|7|||
160492675|NCT00727415|579533619|FG000|Phase I|Dose Limiting Toxicity|2|||
160492676|NCT01588366|579533622|FG000|Overall Study|Adverse Event|0|||
160492677|NCT01588366|579533623|FG001|Overall Study|Adverse Event|1|||
160492678|NCT01588366|579533624|FG002|Overall Study|Adverse Event|0|||
160492679|NCT01588366|579533625|FG003|Overall Study|Adverse Event|1|||
160492680|NCT01588366|579533626|FG004|Overall Study|Adverse Event|0|||
160492681|NCT01588366|579533627|FG005|Overall Study|Adverse Event|2|||
160492682|NCT00302159|579533628|FG000|Overall Study|pt declined before treatment started|1|||
160492683|NCT00302159|579533628|FG000|Overall Study|pt started Avastin|1|||
160492684|NCT04962698|579533631|FG000|Motor Imagery|Technical difficulty|1|||
160492685|NCT04962698|579533632|FG001|Motor Imagery|Technical difficulty|0|||
160492686|NCT04962698|579533631|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
160492687|NCT04962698|579533632|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
160492688|NCT04962698|579533631|FG000|Kinesthetic MI|Technical difficulty|1|||
160492689|NCT04962698|579533632|FG001|Kinesthetic MI|Technical difficulty|0|||
160492690|NCT04962698|579533631|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
160492691|NCT04962698|579533632|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
160492692|NCT04962698|579533631|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
160492693|NCT04962698|579533632|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
160492694|NCT04962698|579533631|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
160492695|NCT04962698|579533632|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
160492696|NCT04962698|579533631|FG000|Virtual-hand Interaction|Technical difficulty|1|||
160492697|NCT04962698|579533632|FG001|Virtual-hand Interaction|Technical difficulty|0|||
160492698|NCT04962698|579533631|FG000|Robotic Action Observation|Technical difficulty|1|||
160492699|NCT04962698|579533632|FG001|Robotic Action Observation|Technical difficulty|0|||
160492700|NCT04962698|579533631|FG000|Rest|Technical difficulty|1|||
160492701|NCT04962698|579533632|FG001|Rest|Technical difficulty|0|||
160492702|NCT04962698|579533631|FG000|Rest|Exclusion criteria met after enrollment|0|||
160492703|NCT04962698|579533632|FG001|Rest|Exclusion criteria met after enrollment|2|||
160492704|NCT00853229|579533633|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
160492705|NCT00853229|579533634|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
160492706|NCT02312206|579533641|FG000|Overall Study|Adverse Event|3|||
160492707|NCT02312206|579533642|FG001|Overall Study|Adverse Event|6|||
160492708|NCT02312206|579533641|FG000|Overall Study|Withdrawal by Subject|6|||
160492709|NCT02312206|579533642|FG001|Overall Study|Withdrawal by Subject|6|||
160492710|NCT02312206|579533641|FG000|Overall Study|Physician Decision|7|||
160492711|NCT02312206|579533642|FG001|Overall Study|Physician Decision|6|||
160492712|NCT02312206|579533641|FG000|Overall Study|Death|31|||
160492713|NCT02312206|579533642|FG001|Overall Study|Death|36|||
160492714|NCT02312206|579533641|FG000|Overall Study|Study Terminated by Sponsor|81|||
160492715|NCT02312206|579533642|FG001|Overall Study|Study Terminated by Sponsor|74|||
160492716|NCT02312206|579533641|FG000|Overall Study|Patient transferred to hospice|0|||
160492717|NCT02312206|579533642|FG001|Overall Study|Patient transferred to hospice|1|||
160492718|NCT02312206|579533641|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
160492719|NCT02312206|579533642|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
160492720|NCT02312206|579533641|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
160492721|NCT02312206|579533642|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
160492722|NCT02312206|579533641|FG000|Overall Study|Disease Progression|1|||
160492723|NCT02312206|579533642|FG001|Overall Study|Disease Progression|0|||
160492724|NCT00585975|579533643|FG000|Overall Study|Withdrawal by Subject|3|||
160492725|NCT00585975|579533644|FG001|Overall Study|Withdrawal by Subject|3|||
160492726|NCT00585975|579533643|FG000|Overall Study|Lost to Follow-up|2|||
160492727|NCT00585975|579533644|FG001|Overall Study|Lost to Follow-up|1|||
160492728|NCT00585975|579533643|FG000|Overall Study|Enrollment met/over-enrolled|10|||
160492729|NCT00585975|579533644|FG001|Overall Study|Enrollment met/over-enrolled|9|||
160492730|NCT03082612|579533647|FG000|Overall Study|Lost to Follow-up|2|||
160492731|NCT03082612|579533648|FG001|Overall Study|Lost to Follow-up|0|||
160492732|NCT01006616|579533649|FG000|Period 1 (6 Months)|Adverse Event|10|||
160492733|NCT01006616|579533650|FG001|Period 1 (6 Months)|Adverse Event|31|||
160492734|NCT01006616|579533651|FG002|Period 1 (6 Months)|Adverse Event|37|||
160492735|NCT01006616|579533652|FG003|Period 1 (6 Months)|Adverse Event|9|||
160492736|NCT01006616|579533649|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
160492737|NCT01006616|579533650|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
160492738|NCT01006616|579533651|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
160492739|NCT01006616|579533652|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
160492740|NCT01006616|579533649|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
160492741|NCT01006616|579533650|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
160492742|NCT01006616|579533651|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
160492743|NCT01006616|579533652|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
160492744|NCT01006616|579533649|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
160492745|NCT01006616|579533650|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
160492746|NCT01006616|579533651|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
160492747|NCT01006616|579533652|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
160492748|NCT01006616|579533649|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
160492749|NCT01006616|579533650|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
160492750|NCT01006616|579533651|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
160492751|NCT01006616|579533652|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
160492752|NCT01006616|579533649|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
160492753|NCT01006616|579533650|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
160612105|NCT01263470|579957550|FG001|Overall Study|Withdrawal by Subject|1|||
160492754|NCT01006616|579533651|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
160492755|NCT01006616|579533652|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
160492756|NCT01006616|579533649|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
160492757|NCT01006616|579533650|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
160492758|NCT01006616|579533651|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
160492759|NCT01006616|579533652|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
160492760|NCT01006616|579533649|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
160492761|NCT01006616|579533650|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
160492762|NCT01006616|579533651|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
160492763|NCT01006616|579533652|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
160612106|NCT01263470|579957551|FG002|Overall Study|Withdrawal by Subject|1|||
160612107|NCT01263470|579957552|FG003|Overall Study|Withdrawal by Subject|2|||
160612108|NCT01263470|579957553|FG004|Overall Study|Withdrawal by Subject|0|||
160492764|NCT01006616|579533649|FG000|Period 1 (6 Months)|Not Treated|0|||
160492765|NCT01006616|579533650|FG001|Period 1 (6 Months)|Not Treated|0|||
160492766|NCT01006616|579533651|FG002|Period 1 (6 Months)|Not Treated|1|||
160492767|NCT01006616|579533652|FG003|Period 1 (6 Months)|Not Treated|1|||
160492768|NCT01006616|579533649|FG000|Period 2 (18 Months)|Adverse Event|6|||
160492769|NCT01006616|579533650|FG001|Period 2 (18 Months)|Adverse Event|6|||
160492770|NCT01006616|579533651|FG002|Period 2 (18 Months)|Adverse Event|6|||
160492771|NCT01006616|579533652|FG003|Period 2 (18 Months)|Adverse Event|4|||
160492772|NCT01006616|579533649|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
160492773|NCT01006616|579533650|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
160492774|NCT01006616|579533651|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
160492775|NCT01006616|579533652|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
160492776|NCT01006616|579533649|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
160492777|NCT01006616|579533650|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
160492778|NCT01006616|579533651|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
160492779|NCT01006616|579533652|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
160492780|NCT01006616|579533649|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
160492781|NCT01006616|579533650|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
160492782|NCT01006616|579533651|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
160492783|NCT01006616|579533652|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
160492784|NCT01006616|579533649|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
160492785|NCT01006616|579533650|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
160492786|NCT01006616|579533651|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
160492787|NCT01006616|579533652|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
160492788|NCT01006616|579533649|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
160492789|NCT01006616|579533650|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
160492790|NCT01006616|579533651|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
160492791|NCT01006616|579533652|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
160492792|NCT01006616|579533649|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
160492793|NCT01006616|579533650|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
160492794|NCT01006616|579533651|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
160492795|NCT01006616|579533652|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
160492796|NCT01006616|579533649|FG000|Period 2 (18 Months)|Study Terminated|63|||
160492797|NCT01006616|579533650|FG001|Period 2 (18 Months)|Study Terminated|46|||
160492798|NCT01006616|579533651|FG002|Period 2 (18 Months)|Study Terminated|44|||
160492799|NCT01006616|579533652|FG003|Period 2 (18 Months)|Study Terminated|70|||
160492800|NCT03414047|579533653|FG000|Overall Study|Adverse Event|0|||
160492801|NCT03414047|579533654|FG001|Overall Study|Adverse Event|0|||
160492802|NCT03414047|579533655|FG002|Overall Study|Adverse Event|1|||
160492803|NCT03414047|579533656|FG003|Overall Study|Adverse Event|1|||
160492804|NCT03414047|579533653|FG000|Overall Study|Physician Decision|1|||
160492805|NCT03414047|579533654|FG001|Overall Study|Physician Decision|0|||
160492806|NCT03414047|579533655|FG002|Overall Study|Physician Decision|0|||
160492807|NCT03414047|579533656|FG003|Overall Study|Physician Decision|1|||
160492808|NCT03414047|579533653|FG000|Overall Study|Withdrawal by Subject|1|||
160492809|NCT03414047|579533654|FG001|Overall Study|Withdrawal by Subject|0|||
160492810|NCT03414047|579533655|FG002|Overall Study|Withdrawal by Subject|2|||
160492811|NCT03414047|579533656|FG003|Overall Study|Withdrawal by Subject|0|||
160492812|NCT03269695|579533660|FG000|Overall Study|Adverse Event|2|||
160492813|NCT03269695|579533661|FG001|Overall Study|Adverse Event|1|||
160492814|NCT03269695|579533660|FG000|Overall Study|Lack of Efficacy|0|||
160492815|NCT03269695|579533661|FG001|Overall Study|Lack of Efficacy|1|||
160492816|NCT03269695|579533660|FG000|Overall Study|Withdrawal by Subject|0|||
160492817|NCT03269695|579533661|FG001|Overall Study|Withdrawal by Subject|1|||
160492818|NCT01017263|579533662|FG000|Overall Study|not eligible|12|||
160492819|NCT00239681|579533663|FG000|Overall Study|Adverse Event|100|||
160492820|NCT00239681|579533664|FG001|Overall Study|Adverse Event|99|||
160492821|NCT00239681|579533663|FG000|Overall Study|Withdrawal by Subject|458|||
160492822|NCT00239681|579533664|FG001|Overall Study|Withdrawal by Subject|489|||
160492823|NCT00239681|579533663|FG000|Overall Study|Lost to Follow-up|28|||
160492824|NCT00239681|579533664|FG001|Overall Study|Lost to Follow-up|22|||
160492825|NCT00239681|579533663|FG000|Overall Study|Protocol Violation|4|||
160492826|NCT00239681|579533664|FG001|Overall Study|Protocol Violation|4|||
160492827|NCT00239681|579533663|FG000|Overall Study|Physician Decision|13|||
160492828|NCT00239681|579533664|FG001|Overall Study|Physician Decision|17|||
160492829|NCT00239681|579533663|FG000|Overall Study|No information chacked on CaseReportForm|90|||
160492830|NCT00239681|579533664|FG001|Overall Study|No information chacked on CaseReportForm|84|||
160492831|NCT02654132|579533665|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
160492832|NCT02654132|579533666|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
160492833|NCT02654132|579533665|FG000|Treatment Period|Disease progression|43|||
160492834|NCT02654132|579533666|FG001|Treatment Period|Disease progression|38|||
160492835|NCT02654132|579533665|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
160492836|NCT02654132|579533666|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
160492837|NCT02654132|579533665|FG000|Treatment Period|Other reasons|4|||
160492838|NCT02654132|579533666|FG001|Treatment Period|Other reasons|2|||
160612109|NCT01263470|579957554|FG005|Overall Study|Withdrawal by Subject|2|||
160612110|NCT01263470|579957549|FG000|Overall Study|Lack of Efficacy|0|||
160612111|NCT01263470|579957550|FG001|Overall Study|Lack of Efficacy|0|||
160612112|NCT01263470|579957551|FG002|Overall Study|Lack of Efficacy|2|||
160612113|NCT01263470|579957552|FG003|Overall Study|Lack of Efficacy|0|||
160612114|NCT01263470|579957553|FG004|Overall Study|Lack of Efficacy|0|||
160612115|NCT01263470|579957554|FG005|Overall Study|Lack of Efficacy|0|||
160612116|NCT01263470|579957549|FG000|Overall Study|Participant Unavailability|0|||
160612117|NCT01263470|579957550|FG001|Overall Study|Participant Unavailability|1|||
160612118|NCT01263470|579957551|FG002|Overall Study|Participant Unavailability|0|||
160612119|NCT01263470|579957552|FG003|Overall Study|Participant Unavailability|0|||
160612120|NCT01263470|579957553|FG004|Overall Study|Participant Unavailability|0|||
160612121|NCT01263470|579957554|FG005|Overall Study|Participant Unavailability|0|||
160612122|NCT01263470|579957549|FG000|Overall Study|Study Drug Non-compliance|0|||
160612123|NCT01263470|579957550|FG001|Overall Study|Study Drug Non-compliance|0|||
160612124|NCT01263470|579957551|FG002|Overall Study|Study Drug Non-compliance|0|||
160612125|NCT01263470|579957552|FG003|Overall Study|Study Drug Non-compliance|0|||
160612126|NCT01263470|579957553|FG004|Overall Study|Study Drug Non-compliance|1|||
160612127|NCT01263470|579957554|FG005|Overall Study|Study Drug Non-compliance|0|||
160612128|NCT00610714|579957555|FG000|Overall Study|Adverse Event|3|||
160612129|NCT00610714|579957556|FG001|Overall Study|Adverse Event|1|||
160612130|NCT00610714|579957555|FG000|Overall Study|Death|12|||
160612131|NCT00610714|579957556|FG001|Overall Study|Death|18|||
160612132|NCT00610714|579957555|FG000|Overall Study|Withdrawal by Subject|9|||
160612133|NCT00610714|579957556|FG001|Overall Study|Withdrawal by Subject|3|||
160612134|NCT00610714|579957555|FG000|Overall Study|Study completion at 120 PFS events|2|||
160612135|NCT00610714|579957556|FG001|Overall Study|Study completion at 120 PFS events|2|||
160612136|NCT01327573|579957557|FG000|Overall Study|Physician Decision|3|||
160612137|NCT01327573|579957558|FG001|Overall Study|Physician Decision|1|||
160612138|NCT01108263|579957559|FG000|Overall Study|Adverse Event|0|||
160612139|NCT01108263|579957560|FG001|Overall Study|Adverse Event|1|||
160612140|NCT00729560|579957561|FG000|Overall Study|Withdrawal by Subject|3|||
160612141|NCT03233308|579957562|FG000|Overall Study|Adverse Event|1|||
160612142|NCT03233308|579957562|FG000|Overall Study|Protocol Violation|1|||
160612143|NCT03662789|579957563|FG000|Overall Study|Lost to Follow-up|1|||
160612144|NCT03662789|579957564|FG001|Overall Study|Lost to Follow-up|2|||
160612145|NCT03662789|579957563|FG000|Overall Study|Could not perform treadmill test|4|||
160612146|NCT03662789|579957564|FG001|Overall Study|Could not perform treadmill test|4|||
160612147|NCT03662789|579957563|FG000|Overall Study|Death|0|||
160612148|NCT03662789|579957564|FG001|Overall Study|Death|1|||
160612149|NCT02136134|579957565|FG000|Overall Study|Death|170|||
160612150|NCT02136134|579957566|FG001|Overall Study|Death|148|||
160612151|NCT02136134|579957565|FG000|Overall Study|Withdrawal by Subject|19|||
160612152|NCT02136134|579957566|FG001|Overall Study|Withdrawal by Subject|10|||
160612153|NCT02136134|579957565|FG000|Overall Study|Lost to Follow-up|3|||
160612154|NCT02136134|579957566|FG001|Overall Study|Lost to Follow-up|3|||
160612155|NCT02136134|579957565|FG000|Overall Study|Uspecified|55|||
160612156|NCT02136134|579957566|FG001|Overall Study|Uspecified|90|||
160612157|NCT00638989|579957567|FG000|Overall Study|Lost to Follow-up|0|||
160612158|NCT00638989|579957568|FG001|Overall Study|Lost to Follow-up|0|||
160612159|NCT00638989|579957569|FG002|Overall Study|Lost to Follow-up|1|||
160612160|NCT05245071|579957570|FG000|Overall Study|Progressive disease|18|||
160612161|NCT05245071|579957570|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
160612162|NCT05245071|579957570|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
160612163|NCT01602822|579957571|FG000|Overall Study|Adverse Event|11|||
160612164|NCT02005211|579957575|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
160612165|NCT02005211|579957576|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
160612166|NCT02005211|579957577|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
160612167|NCT02005211|579957578|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
160612168|NCT02005211|579957579|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
160612169|NCT02005211|579957580|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
160612170|NCT02005211|579957581|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
160612171|NCT03299166|579957584|FG000|Overall Study|Adverse Event|9|||
160612172|NCT03299166|579957585|FG001|Overall Study|Adverse Event|4|||
160612173|NCT03299166|579957584|FG000|Overall Study|Withdrawal by Subject|6|||
160612174|NCT03299166|579957585|FG001|Overall Study|Withdrawal by Subject|5|||
160612175|NCT03299166|579957584|FG000|Overall Study|Physician Decision|1|||
160612176|NCT03299166|579957585|FG001|Overall Study|Physician Decision|1|||
160612177|NCT03299166|579957584|FG000|Overall Study|Sponsor Decision|3|||
160612178|NCT03299166|579957585|FG001|Overall Study|Sponsor Decision|0|||
160612179|NCT03299166|579957584|FG000|Overall Study|Lost to Follow-up|2|||
160612180|NCT03299166|579957585|FG001|Overall Study|Lost to Follow-up|4|||
160612181|NCT03299166|579957584|FG000|Overall Study|Randomization Error|0|||
160612182|NCT03299166|579957585|FG001|Overall Study|Randomization Error|1|||
160612183|NCT03299166|579957584|FG000|Overall Study|Subject unable to return due to COVID|1|||
160612184|NCT03299166|579957585|FG001|Overall Study|Subject unable to return due to COVID|0|||
160492839|NCT02654132|579533665|FG000|Treatment Period|Study drug toxicity|2|||
160492840|NCT02654132|579533666|FG001|Treatment Period|Study drug toxicity|2|||
160492841|NCT02654132|579533665|FG000|Treatment Period|Withdrawal by Subject|2|||
160492842|NCT02654132|579533666|FG001|Treatment Period|Withdrawal by Subject|1|||
160492843|NCT02654132|579533665|FG000|Treatment Period|Maximum Clinical Benefit|0|||
160492844|NCT02654132|579533666|FG001|Treatment Period|Maximum Clinical Benefit|2|||
160492845|NCT02654132|579533665|FG000|Treatment Period|Participant request to discontinue|2|||
160492846|NCT02654132|579533666|FG001|Treatment Period|Participant request to discontinue|0|||
160492847|NCT02654132|579533665|FG000|Treatment Period|Administrative reasons by sponsor|0|||
160492848|NCT02654132|579533666|FG001|Treatment Period|Administrative reasons by sponsor|1|||
160492849|NCT02654132|579533665|FG000|Treatment Period|Death|1|||
160492850|NCT02654132|579533666|FG001|Treatment Period|Death|0|||
160492851|NCT02485899|579533667|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
160492852|NCT02485899|579533668|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160492853|NCT02485899|579533667|FG000|Overall Study|Withdrawal by Subject|1|||
160492854|NCT02485899|579533668|FG001|Overall Study|Withdrawal by Subject|0|||
160492855|NCT02485899|579533667|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
160492856|NCT02485899|579533668|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
160492857|NCT00623363|579533669|FG000|Overall Study|Adverse Event|2|||
160492858|NCT00623363|579533670|FG001|Overall Study|Adverse Event|2|||
160492859|NCT03713320|579533671|FG000|Randomized Period|Adverse Event|1|||
160492860|NCT03713320|579533672|FG001|Randomized Period|Adverse Event|5|||
160492861|NCT03713320|579533673|FG002|Randomized Period|Adverse Event|0|||
160492862|NCT03713320|579533671|FG000|Randomized Period|Physician Decision|1|||
160492863|NCT03713320|579533672|FG001|Randomized Period|Physician Decision|1|||
160492864|NCT03713320|579533673|FG002|Randomized Period|Physician Decision|0|||
160492865|NCT03713320|579533671|FG000|Randomized Period|Withdrawal by Subject|4|||
160492866|NCT03713320|579533672|FG001|Randomized Period|Withdrawal by Subject|0|||
160492867|NCT03713320|579533673|FG002|Randomized Period|Withdrawal by Subject|0|||
160492868|NCT03713320|579533671|FG000|Randomized Period|Participant decision|3|||
160492869|NCT03713320|579533672|FG001|Randomized Period|Participant decision|1|||
160492870|NCT03713320|579533673|FG002|Randomized Period|Participant decision|0|||
160492871|NCT03713320|579533671|FG000|Randomized Period|Study terminated by sponsor|6|||
160492872|NCT03713320|579533672|FG001|Randomized Period|Study terminated by sponsor|3|||
160492873|NCT03713320|579533673|FG002|Randomized Period|Study terminated by sponsor|0|||
160492874|NCT03713320|579533671|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
160492875|NCT03713320|579533672|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
160492876|NCT03713320|579533673|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
160492877|NCT03713320|579533671|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
160492878|NCT03713320|579533672|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
160492879|NCT03713320|579533673|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
160492880|NCT04354168|579533674|FG000|Overall Study|Lost to Follow-up|22|||
160492881|NCT01781832|579533675|FG000|Overall Study|Withdrawal by Subject|1|||
160492882|NCT02287233|579533676|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
160492883|NCT02287233|579533677|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
160492884|NCT02287233|579533678|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
160492885|NCT02287233|579533676|FG000|Overall Study|Adverse Event Related to Progression|0|||
160492886|NCT02287233|579533677|FG001|Overall Study|Adverse Event Related to Progression|2|||
160492887|NCT02287233|579533678|FG002|Overall Study|Adverse Event Related to Progression|8|||
160492888|NCT02287233|579533676|FG000|Overall Study|Physician Decision|1|||
160492889|NCT02287233|579533677|FG001|Overall Study|Physician Decision|2|||
160492890|NCT02287233|579533678|FG002|Overall Study|Physician Decision|4|||
160492891|NCT02287233|579533676|FG000|Overall Study|Progressive Disease with Death|0|||
160492892|NCT02287233|579533677|FG001|Overall Study|Progressive Disease with Death|0|||
160492893|NCT02287233|579533678|FG002|Overall Study|Progressive Disease with Death|10|||
160492894|NCT02287233|579533676|FG000|Overall Study|Progressive Disease Without Death|2|||
160492895|NCT02287233|579533677|FG001|Overall Study|Progressive Disease Without Death|3|||
160492896|NCT02287233|579533678|FG002|Overall Study|Progressive Disease Without Death|20|||
160492897|NCT02287233|579533676|FG000|Overall Study|Withdrawal by Subject|1|||
160492898|NCT02287233|579533677|FG001|Overall Study|Withdrawal by Subject|1|||
160492899|NCT02287233|579533678|FG002|Overall Study|Withdrawal by Subject|7|||
160492900|NCT02287233|579533676|FG000|Overall Study|Other|3|||
160492901|NCT02287233|579533677|FG001|Overall Study|Other|0|||
160492902|NCT02287233|579533678|FG002|Overall Study|Other|15|||
160492903|NCT02287233|579533676|FG000|Overall Study|Did Not Receive Treatment|0|||
160492904|NCT02287233|579533677|FG001|Overall Study|Did Not Receive Treatment|0|||
160492905|NCT02287233|579533678|FG002|Overall Study|Did Not Receive Treatment|2|||
160492906|NCT01174264|579533679|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
160492907|NCT01174264|579533680|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
160492908|NCT01174264|579533681|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
160492909|NCT01174264|579533679|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
160492910|NCT01174264|579533680|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
160612185|NCT03299166|579957584|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
160612186|NCT03299166|579957585|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
160612187|NCT00423592|579957587|FG000|Overall Study|Adverse Event (through Week 12)|2|||
160612188|NCT00423592|579957587|FG000|Overall Study|Adverse Event (post Week 12)|5|||
160612189|NCT00062647|579957588|FG000|Overall Study|Death|2|||
160612190|NCT00062647|579957589|FG001|Overall Study|Death|2|||
160612191|NCT00062647|579957588|FG000|Overall Study|Adverse Event|1|||
160612192|NCT00062647|579957589|FG001|Overall Study|Adverse Event|1|||
160612193|NCT00062647|579957588|FG000|Overall Study|Withdrawal by Subject|2|||
160612194|NCT00062647|579957589|FG001|Overall Study|Withdrawal by Subject|1|||
160612195|NCT00062647|579957588|FG000|Overall Study|Protocol Violation|1|||
160612196|NCT00062647|579957589|FG001|Overall Study|Protocol Violation|0|||
160612197|NCT00062647|579957588|FG000|Overall Study|Lost to Follow-up|1|||
160612198|NCT00062647|579957589|FG001|Overall Study|Lost to Follow-up|2|||
160612199|NCT00062647|579957588|FG000|Overall Study|Failed continuation criteria|4|||
160612200|NCT00062647|579957589|FG001|Overall Study|Failed continuation criteria|2|||
160612201|NCT00062647|579957588|FG000|Overall Study|Other|4|||
160612202|NCT00062647|579957589|FG001|Overall Study|Other|4|||
160612203|NCT00062647|579957588|FG000|Overall Study|Never received study treatment|1|||
160612204|NCT00062647|579957589|FG001|Overall Study|Never received study treatment|1|||
160612205|NCT00002981|579957590|FG000|Overall Study|Inevaluable|6|||
160612206|NCT00255008|579957593|FG000|Overall Study|Adverse Event|1|||
160612207|NCT00255008|579957594|FG001|Overall Study|Adverse Event|1|||
160612208|NCT00255008|579957595|FG002|Overall Study|Adverse Event|2|||
160612209|NCT00255008|579957596|FG003|Overall Study|Adverse Event|0|||
160612210|NCT00255008|579957593|FG000|Overall Study|Lost to Follow-up|1|||
160612211|NCT00255008|579957594|FG001|Overall Study|Lost to Follow-up|0|||
160612212|NCT00255008|579957595|FG002|Overall Study|Lost to Follow-up|1|||
160612213|NCT00255008|579957596|FG003|Overall Study|Lost to Follow-up|2|||
160612214|NCT00255008|579957593|FG000|Overall Study|Did not meet viral reduction criteria|4|||
160612215|NCT00255008|579957594|FG001|Overall Study|Did not meet viral reduction criteria|5|||
160612216|NCT00255008|579957595|FG002|Overall Study|Did not meet viral reduction criteria|0|||
160612217|NCT00255008|579957596|FG003|Overall Study|Did not meet viral reduction criteria|1|||
160612218|NCT00255008|579957593|FG000|Overall Study|Withdrew consent|0|||
160612219|NCT00255008|579957594|FG001|Overall Study|Withdrew consent|0|||
160612220|NCT00255008|579957595|FG002|Overall Study|Withdrew consent|2|||
160612221|NCT00255008|579957596|FG003|Overall Study|Withdrew consent|0|||
160612222|NCT00255008|579957593|FG000|Overall Study|Sponsor request|18|||
160612223|NCT00255008|579957594|FG001|Overall Study|Sponsor request|3|||
160612224|NCT00255008|579957595|FG002|Overall Study|Sponsor request|8|||
160612225|NCT00255008|579957596|FG003|Overall Study|Sponsor request|17|||
160612226|NCT00255008|579957593|FG000|Overall Study|Adverse lab experience|1|||
160612227|NCT00255008|579957594|FG001|Overall Study|Adverse lab experience|0|||
160612228|NCT00255008|579957595|FG002|Overall Study|Adverse lab experience|0|||
160612229|NCT00255008|579957596|FG003|Overall Study|Adverse lab experience|0|||
160612230|NCT00255008|579957593|FG000|Overall Study|Other|7|||
160612231|NCT00255008|579957594|FG001|Overall Study|Other|0|||
160612232|NCT00255008|579957595|FG002|Overall Study|Other|3|||
160612233|NCT00255008|579957596|FG003|Overall Study|Other|2|||
160612234|NCT00322387|579957601|FG000|Treatment Period|Adverse Event|0|||
160612235|NCT00322387|579957602|FG001|Treatment Period|Adverse Event|1|||
160612236|NCT00322387|579957601|FG000|Follow-up Period|Final assessment not done|1|||
160612237|NCT00322387|579957602|FG001|Follow-up Period|Final assessment not done|3|||
160612238|NCT00322387|579957601|FG000|Follow-up Period|Death|1|||
160612239|NCT00322387|579957602|FG001|Follow-up Period|Death|0|||
160612240|NCT00707486|579957607|FG000|Overall Study|Withdrawal by Subject|1|||
160612241|NCT01885104|579957617|FG000|Overall Study|Withdrawal of Consent|1|||
160661429|NCT01256684|580144098|FG001|Overall Study|Withdrawal by Subject|0|||
160612242|NCT01885104|579957618|FG001|Overall Study|Withdrawal of Consent|0|||
160612243|NCT01885104|579957617|FG000|Overall Study|Lost to Follow-up|0|||
160612244|NCT01885104|579957618|FG001|Overall Study|Lost to Follow-up|1|||
160612245|NCT01885104|579957617|FG000|Overall Study|Physician Decision|1|||
160612246|NCT01885104|579957618|FG001|Overall Study|Physician Decision|0|||
160612247|NCT00126425|579957619|FG000|Overall Study|Withdrawal by Subject|17|||
160612248|NCT00126425|579957620|FG001|Overall Study|Withdrawal by Subject|1|||
160612249|NCT00126425|579957619|FG000|Overall Study|Lost to Follow-up|8|||
160612250|NCT00126425|579957620|FG001|Overall Study|Lost to Follow-up|4|||
160612251|NCT00126425|579957619|FG000|Overall Study|Protocol Violation|9|||
160612252|NCT00126425|579957620|FG001|Overall Study|Protocol Violation|6|||
160612253|NCT00126425|579957619|FG000|Overall Study|Adverse Event|1|||
160612254|NCT00126425|579957620|FG001|Overall Study|Adverse Event|0|||
160612255|NCT00126425|579957619|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
160612256|NCT00126425|579957620|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
160612257|NCT00126425|579957619|FG000|Overall Study|Other|5|||
160612258|NCT00126425|579957620|FG001|Overall Study|Other|0|||
160612259|NCT01894776|579957621|FG000|Overall Study|Withdrawal by Subject|1|||
160612260|NCT02415595|579957622|FG000|Overall Study|Administrative reason by sponsor|39|||
160612261|NCT02415595|579957623|FG001|Overall Study|Administrative reason by sponsor|40|||
160612262|NCT02415595|579957624|FG002|Overall Study|Administrative reason by sponsor|41|||
160612263|NCT02415595|579957625|FG003|Overall Study|Administrative reason by sponsor|39|||
160612264|NCT02415595|579957622|FG000|Overall Study|Adverse Event|1|||
160612265|NCT02415595|579957623|FG001|Overall Study|Adverse Event|3|||
160612266|NCT02415595|579957624|FG002|Overall Study|Adverse Event|5|||
160612267|NCT02415595|579957625|FG003|Overall Study|Adverse Event|10|||
160612268|NCT02415595|579957622|FG000|Overall Study|Lack of Efficacy|4|||
160612269|NCT02415595|579957623|FG001|Overall Study|Lack of Efficacy|4|||
160612270|NCT02415595|579957624|FG002|Overall Study|Lack of Efficacy|0|||
160612271|NCT02415595|579957625|FG003|Overall Study|Lack of Efficacy|0|||
160612272|NCT02415595|579957622|FG000|Overall Study|Lost to Follow-up|1|||
160612273|NCT02415595|579957623|FG001|Overall Study|Lost to Follow-up|3|||
160612274|NCT02415595|579957624|FG002|Overall Study|Lost to Follow-up|1|||
160612275|NCT02415595|579957625|FG003|Overall Study|Lost to Follow-up|1|||
160612276|NCT02415595|579957622|FG000|Overall Study|Poor/Non-compliance|1|||
160612277|NCT02415595|579957623|FG001|Overall Study|Poor/Non-compliance|0|||
160612278|NCT02415595|579957624|FG002|Overall Study|Poor/Non-compliance|1|||
160612279|NCT02415595|579957625|FG003|Overall Study|Poor/Non-compliance|0|||
160612280|NCT02415595|579957622|FG000|Overall Study|Reached stopping criteria|0|||
160612281|NCT02415595|579957623|FG001|Overall Study|Reached stopping criteria|1|||
160612282|NCT02415595|579957624|FG002|Overall Study|Reached stopping criteria|1|||
160612283|NCT02415595|579957625|FG003|Overall Study|Reached stopping criteria|0|||
160612284|NCT02415595|579957622|FG000|Overall Study|Withdrawal by Subject|4|||
160612285|NCT02415595|579957623|FG001|Overall Study|Withdrawal by Subject|0|||
160612286|NCT02415595|579957624|FG002|Overall Study|Withdrawal by Subject|1|||
160612287|NCT02415595|579957625|FG003|Overall Study|Withdrawal by Subject|3|||
160612288|NCT02415595|579957622|FG000|Overall Study|Other|0|||
160612289|NCT02415595|579957623|FG001|Overall Study|Other|1|||
160612290|NCT02415595|579957624|FG002|Overall Study|Other|1|||
160612291|NCT02415595|579957625|FG003|Overall Study|Other|0|||
160612292|NCT04350372|579957629|FG000|Overall Study|Death|1|||
160612293|NCT03512275|579957630|FG000|Overall Study|Withdrawal by Subject|1|||
160612294|NCT03512275|579957631|FG001|Overall Study|Withdrawal by Subject|3|||
160612295|NCT03512275|579957630|FG000|Overall Study|Physician Decision|0|||
160612296|NCT03512275|579957631|FG001|Overall Study|Physician Decision|1|||
160612297|NCT03512275|579957630|FG000|Overall Study|Lost to Follow-up|0|||
160612298|NCT03512275|579957631|FG001|Overall Study|Lost to Follow-up|3|||
160612299|NCT03512275|579957630|FG000|Overall Study|Other|1|||
160612300|NCT03512275|579957631|FG001|Overall Study|Other|0|||
160612301|NCT00113555|579957632|FG000|Overall Study|Baseline Failure|59|||
160492911|NCT01174264|579533681|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
160492912|NCT01174264|579533679|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
160492913|NCT01174264|579533680|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
160612302|NCT00113555|579957632|FG000|Overall Study|Permanently Explanted|7|||
160612303|NCT00113555|579957632|FG000|Overall Study|Death|1|||
160612304|NCT00113555|579957632|FG000|Overall Study|Missed Followup|4|||
160612305|NCT00113555|579957632|FG000|Overall Study|Lost to Follow-up|8|||
160492914|NCT01174264|579533681|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
160492915|NCT01185171|579533685|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
160492916|NCT01185171|579533685|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
160492917|NCT01185171|579533685|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
160492918|NCT01185171|579533685|FG000|Maintenance|Elevated liver transaminases|3|||
160492919|NCT01185171|579533685|FG000|Maintenance|Rush|2|||
160492920|NCT01185171|579533685|FG000|Maintenance|Diarrhea|1|||
160492921|NCT01185171|579533685|FG000|Maintenance|Xerostomia|1|||
160492922|NCT01185171|579533685|FG000|Maintenance|Nausea|1|||
160492923|NCT01185171|579533685|FG000|Maintenance|Comorbid Illness|2|||
160492924|NCT01185171|579533685|FG000|Maintenance|Withdrawal by Subject|1|||
160492925|NCT01185171|579533685|FG000|Maintenance|Disease Recurrence|1|||
160492926|NCT01482429|579533686|FG000|Care Usual|Protocol Violation|0|||
160492927|NCT01482429|579533687|FG001|Care Usual|Protocol Violation|172|||
160492928|NCT01482429|579533686|FG000|Care Usual|Lost to Follow-up|0|||
160492929|NCT01482429|579533687|FG001|Care Usual|Lost to Follow-up|1|||
160492930|NCT01482429|579533686|FG000|Protocol|Protocol Violation|275|||
160492931|NCT01482429|579533687|FG001|Protocol|Protocol Violation|0|||
160492932|NCT03561597|579533688|FG000|Overall Study|Lost to Follow-up|20|||
160492933|NCT00573651|579533689|FG000|Overall Study|Lost to Follow-up|3|||
160492934|NCT00573651|579533689|FG000|Overall Study|Withdrawal by Subject|1|||
160492935|NCT01837797|579533697|FG000|Period 1|Adverse Event|9|||
160492936|NCT01837797|579533698|FG001|Period 1|Adverse Event|0|||
160492937|NCT01837797|579533699|FG002|Period 1|Adverse Event|0|||
160492938|NCT01837797|579533700|FG003|Period 1|Adverse Event|0|||
160492939|NCT01837797|579533701|FG004|Period 1|Adverse Event|0|||
160492940|NCT01837797|579533697|FG000|Period 1|Withdrawal by Subject|6|||
160492941|NCT01837797|579533698|FG001|Period 1|Withdrawal by Subject|0|||
160492942|NCT01837797|579533699|FG002|Period 1|Withdrawal by Subject|0|||
160492943|NCT01837797|579533700|FG003|Period 1|Withdrawal by Subject|0|||
160492944|NCT01837797|579533701|FG004|Period 1|Withdrawal by Subject|0|||
160492945|NCT01837797|579533697|FG000|Period 1|Administrative reasons|76|||
160492946|NCT01837797|579533698|FG001|Period 1|Administrative reasons|0|||
160492947|NCT01837797|579533699|FG002|Period 1|Administrative reasons|0|||
160492948|NCT01837797|579533700|FG003|Period 1|Administrative reasons|0|||
160492949|NCT01837797|579533701|FG004|Period 1|Administrative reasons|0|||
160492950|NCT01837797|579533697|FG000|Period 1|Withdrawal of consent before treatment|1|||
160492951|NCT01837797|579533698|FG001|Period 1|Withdrawal of consent before treatment|0|||
160492952|NCT01837797|579533699|FG002|Period 1|Withdrawal of consent before treatment|0|||
160492953|NCT01837797|579533700|FG003|Period 1|Withdrawal of consent before treatment|0|||
160492954|NCT01837797|579533701|FG004|Period 1|Withdrawal of consent before treatment|0|||
160492955|NCT01837797|579533697|FG000|Period 1|Other|10|||
160492956|NCT01837797|579533698|FG001|Period 1|Other|0|||
160492957|NCT01837797|579533699|FG002|Period 1|Other|0|||
160492958|NCT01837797|579533700|FG003|Period 1|Other|0|||
160492959|NCT01837797|579533701|FG004|Period 1|Other|0|||
160492960|NCT01837797|579533697|FG000|Period 2|Administrative or other reasons|0|||
160492961|NCT01837797|579533698|FG001|Period 2|Administrative or other reasons|5|||
160492962|NCT01837797|579533699|FG002|Period 2|Administrative or other reasons|2|||
160492963|NCT01837797|579533700|FG003|Period 2|Administrative or other reasons|4|||
160492964|NCT01837797|579533701|FG004|Period 2|Administrative or other reasons|0|||
160612306|NCT04474366|579957633|FG000|Overall Study|Lost to Follow-up|2|||
160612307|NCT04474366|579957634|FG001|Overall Study|Lost to Follow-up|5|||
160612308|NCT01700140|579957635|FG000|Overall Study|Use of rescue drugs|3|||
160492965|NCT01837797|579533697|FG000|Period 2|Adverse Event|0|||
160492966|NCT01837797|579533698|FG001|Period 2|Adverse Event|0|||
160492967|NCT01837797|579533699|FG002|Period 2|Adverse Event|0|||
160612309|NCT01700140|579957636|FG001|Overall Study|Use of rescue drugs|3|||
160612310|NCT01700140|579957637|FG002|Overall Study|Use of rescue drugs|1|||
160612311|NCT01700140|579957635|FG000|Overall Study|Discontinuation of radiotherapy|1|||
160612312|NCT01700140|579957636|FG001|Overall Study|Discontinuation of radiotherapy|0|||
160612313|NCT01700140|579957637|FG002|Overall Study|Discontinuation of radiotherapy|0|||
160612314|NCT01700140|579957635|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
160492968|NCT01837797|579533700|FG003|Period 2|Adverse Event|1|||
160492969|NCT01837797|579533701|FG004|Period 2|Adverse Event|0|||
160492970|NCT01837797|579533697|FG000|Period 3|Adverse Event|0|||
160492971|NCT01837797|579533698|FG001|Period 3|Adverse Event|0|||
160492972|NCT01837797|579533699|FG002|Period 3|Adverse Event|0|||
160492973|NCT01837797|579533700|FG003|Period 3|Adverse Event|0|||
160492974|NCT01837797|579533701|FG004|Period 3|Adverse Event|1|||
160492975|NCT01837797|579533697|FG000|Period 3|Administrative reasons|0|||
160492976|NCT01837797|579533698|FG001|Period 3|Administrative reasons|0|||
160492977|NCT01837797|579533699|FG002|Period 3|Administrative reasons|0|||
160492978|NCT01837797|579533700|FG003|Period 3|Administrative reasons|0|||
160492979|NCT01837797|579533701|FG004|Period 3|Administrative reasons|20|||
160492980|NCT01837797|579533697|FG000|Period 3|Other|0|||
160492981|NCT01837797|579533698|FG001|Period 3|Other|0|||
160492982|NCT01837797|579533699|FG002|Period 3|Other|0|||
160492983|NCT01837797|579533700|FG003|Period 3|Other|0|||
160492984|NCT01837797|579533701|FG004|Period 3|Other|2|||
160492985|NCT03797989|579533722|FG000|VAC069A|Withdrawal by Subject|0|||
160492986|NCT03797989|579533723|FG001|VAC069A|Withdrawal by Subject|0|||
160492987|NCT03797989|579533724|FG002|VAC069A|Withdrawal by Subject|1|||
160492988|NCT03797989|579533725|FG003|VAC069A|Withdrawal by Subject|0|||
160492989|NCT03797989|579533726|FG004|VAC069A|Withdrawal by Subject|0|||
160492990|NCT03797989|579533727|FG005|VAC069A|Withdrawal by Subject|0|||
160492991|NCT03797989|579533728|FG006|VAC069A|Withdrawal by Subject|0|||
160492992|NCT03797989|579533729|FG007|VAC069A|Withdrawal by Subject|0|||
160492993|NCT03797989|579533730|FG008|VAC069A|Withdrawal by Subject|0|||
160492994|NCT03797989|579533731|FG009|VAC069A|Withdrawal by Subject|0|||
160492995|NCT03797989|579533732|FG010|VAC069A|Withdrawal by Subject|0|||
160492996|NCT03797989|579533733|FG011|VAC069A|Withdrawal by Subject|0|||
160492997|NCT00069277|579533734|FG000|Overall Study|Adverse Event|3|||
160492998|NCT00069277|579533734|FG000|Overall Study|Withdrawal by Subject|1|||
160492999|NCT00069277|579533734|FG000|Overall Study|Progressive Disease|15|||
160493000|NCT00069277|579533734|FG000|Overall Study|Physician Decision|2|||
160493001|NCT04811339|579533741|FG000|Overall Study|lack of transportation not wanting to return|4|||
160493002|NCT04811339|579533742|FG001|Overall Study|lack of transportation not wanting to return|8|||
160493003|NCT04811339|579533743|FG002|Overall Study|lack of transportation not wanting to return|0|||
160493004|NCT04811339|579533741|FG000|Overall Study|Adverse Event|3|||
160493005|NCT04811339|579533742|FG001|Overall Study|Adverse Event|0|||
160493006|NCT04811339|579533743|FG002|Overall Study|Adverse Event|0|||
160493007|NCT04811339|579533741|FG000|Overall Study|Lost to Follow-up|1|||
160493008|NCT04811339|579533742|FG001|Overall Study|Lost to Follow-up|0|||
160493009|NCT04811339|579533743|FG002|Overall Study|Lost to Follow-up|0|||
160493010|NCT04811339|579533741|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
160493011|NCT04811339|579533742|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
160493012|NCT04811339|579533743|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
160493013|NCT04811339|579533741|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
160493014|NCT04811339|579533742|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
160493015|NCT04811339|579533743|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
160493016|NCT04811339|579533741|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
160493017|NCT04811339|579533742|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
160493018|NCT04811339|579533743|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
160493019|NCT04811339|579533741|FG000|Overall Study|Withdrawal by Subject|0|||
160493020|NCT04811339|579533742|FG001|Overall Study|Withdrawal by Subject|3|||
160493021|NCT04811339|579533743|FG002|Overall Study|Withdrawal by Subject|0|||
160493022|NCT04811339|579533741|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
160493023|NCT04811339|579533742|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
160493024|NCT04811339|579533743|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
160493025|NCT04811339|579533741|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
160493026|NCT04811339|579533742|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
160493027|NCT04811339|579533743|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
160493028|NCT05896696|579533746|FG000|Overall Study|Screening Failure|7|||
160493029|NCT05896696|579533746|FG000|Overall Study|Withdrawal by Subject|2|||
160493030|NCT01639742|579535471|FG000|Overall Study|Study Ongoing|17|||
160493031|NCT01639742|579535471|FG000|Overall Study|Lost to Follow-up|1|||
160493032|NCT04411186|579535472|FG000|Overall Study|Withdrawn due to protocol violation|0|||
160493033|NCT04411186|579535473|FG001|Overall Study|Withdrawn due to protocol violation|1|||
160493034|NCT02172911|579535474|FG000|Overall Study|Serious Adverse Event|0|||
160493035|NCT02172911|579535475|FG001|Overall Study|Serious Adverse Event|1|||
160493036|NCT02172911|579535474|FG000|Overall Study|Progression of Disease|0|||
160493037|NCT02172911|579535475|FG001|Overall Study|Progression of Disease|1|||
160493038|NCT02172911|579535474|FG000|Overall Study|Loss of insurance coverage|1|||
160493039|NCT02172911|579535475|FG001|Overall Study|Loss of insurance coverage|0|||
160493040|NCT00575042|579535478|FG000|Overall Study|Adverse Event|2|||
160661430|NCT01256684|580144099|FG002|Overall Study|Withdrawal by Subject|2|||
160661431|NCT01256684|580144097|FG000|Overall Study|Physician Decision|0|||
160493041|NCT00575042|579535478|FG000|Overall Study|Lost to Follow-up|1|||
160493042|NCT01266018|579535479|FG000|Overall Study|Physician Decision|1|||
160493043|NCT01266018|579535480|FG001|Overall Study|Physician Decision|0|||
160493044|NCT01266018|579535479|FG000|Overall Study|Progressive disease|0|||
160493045|NCT01266018|579535480|FG001|Overall Study|Progressive disease|1|||
160493046|NCT03167151|579535481|FG000|Overall Study|Withdrawal by Subject|1|||
160493047|NCT03167151|579535482|FG001|Overall Study|Withdrawal by Subject|0|||
160493048|NCT03167151|579535483|FG002|Overall Study|Withdrawal by Subject|0|||
160493049|NCT03167151|579535481|FG000|Overall Study|No evidence of tumour at surgery|0|||
160493050|NCT03167151|579535482|FG001|Overall Study|No evidence of tumour at surgery|1|||
160493051|NCT03167151|579535483|FG002|Overall Study|No evidence of tumour at surgery|1|||
160493052|NCT00730015|579535484|FG000|Overall Study|Adverse Event|11|||
160493053|NCT00730015|579535485|FG001|Overall Study|Adverse Event|10|||
160493054|NCT00730015|579535486|FG002|Overall Study|Adverse Event|8|||
160493055|NCT00730015|579535484|FG000|Overall Study|Protocol Violation|2|||
160493056|NCT00730015|579535485|FG001|Overall Study|Protocol Violation|6|||
160493057|NCT00730015|579535486|FG002|Overall Study|Protocol Violation|4|||
160493058|NCT00730015|579535484|FG000|Overall Study|Withdrawal by Subject|12|||
160493059|NCT00730015|579535485|FG001|Overall Study|Withdrawal by Subject|12|||
160493060|NCT00730015|579535486|FG002|Overall Study|Withdrawal by Subject|8|||
160493061|NCT00730015|579535484|FG000|Overall Study|Lost to Follow-up|4|||
160493062|NCT00730015|579535485|FG001|Overall Study|Lost to Follow-up|10|||
160493063|NCT00730015|579535486|FG002|Overall Study|Lost to Follow-up|3|||
160493064|NCT00730015|579535484|FG000|Overall Study|Lack of Efficacy|1|||
160493065|NCT00730015|579535485|FG001|Overall Study|Lack of Efficacy|2|||
160493066|NCT00730015|579535486|FG002|Overall Study|Lack of Efficacy|8|||
160493067|NCT00730015|579535484|FG000|Overall Study|Other Reason|1|||
160493068|NCT00730015|579535485|FG001|Overall Study|Other Reason|0|||
160493069|NCT00730015|579535486|FG002|Overall Study|Other Reason|1|||
160493070|NCT03021551|579535488|FG000|Overall Study|Equipment Issues|2|||
160493071|NCT03021551|579535488|FG000|Overall Study|Protocol Violation|1|||
160493072|NCT00490945|579535491|FG000|Overall Study|Adverse Event|0|||
160493073|NCT00490945|579535492|FG001|Overall Study|Adverse Event|1|||
160493074|NCT00490945|579535493|FG002|Overall Study|Adverse Event|0|||
160493075|NCT00490945|579535494|FG003|Overall Study|Adverse Event|0|||
160493076|NCT00490945|579535495|FG004|Overall Study|Adverse Event|0|||
160493077|NCT02706951|579535497|FG000|Period 1|Adverse Event|1|||
160493078|NCT02706951|579535498|FG001|Period 1|Adverse Event|5|||
160493079|NCT02706951|579535499|FG002|Period 1|Adverse Event|3|||
160493080|NCT02706951|579535500|FG003|Period 1|Adverse Event|0|||
160493081|NCT02706951|579535501|FG004|Period 1|Adverse Event|0|||
160493082|NCT02706951|579535497|FG000|Period 1|Withdrawal by Subject|10|||
160493083|NCT02706951|579535498|FG001|Period 1|Withdrawal by Subject|6|||
160493084|NCT02706951|579535499|FG002|Period 1|Withdrawal by Subject|6|||
160493085|NCT02706951|579535500|FG003|Period 1|Withdrawal by Subject|0|||
160493086|NCT02706951|579535501|FG004|Period 1|Withdrawal by Subject|0|||
160493087|NCT02706951|579535497|FG000|Period 1|Lost to Follow-up|0|||
160493088|NCT02706951|579535498|FG001|Period 1|Lost to Follow-up|4|||
160493089|NCT02706951|579535499|FG002|Period 1|Lost to Follow-up|1|||
160493090|NCT02706951|579535500|FG003|Period 1|Lost to Follow-up|0|||
160493091|NCT02706951|579535501|FG004|Period 1|Lost to Follow-up|0|||
160493092|NCT02706951|579535497|FG000|Period 1|Other|2|||
160493093|NCT02706951|579535498|FG001|Period 1|Other|1|||
160493094|NCT02706951|579535499|FG002|Period 1|Other|0|||
160493095|NCT02706951|579535500|FG003|Period 1|Other|0|||
160493096|NCT02706951|579535501|FG004|Period 1|Other|0|||
160493097|NCT02706951|579535497|FG000|Period 2|Adverse Event|0|||
160493098|NCT02706951|579535498|FG001|Period 2|Adverse Event|0|||
160493099|NCT02706951|579535499|FG002|Period 2|Adverse Event|0|||
160493100|NCT02706951|579535500|FG003|Period 2|Adverse Event|25|||
160493101|NCT02706951|579535501|FG004|Period 2|Adverse Event|34|||
160493102|NCT02706951|579535497|FG000|Period 2|Withdrawal by Subject|0|||
160493103|NCT02706951|579535498|FG001|Period 2|Withdrawal by Subject|0|||
160493104|NCT02706951|579535499|FG002|Period 2|Withdrawal by Subject|0|||
160493105|NCT02706951|579535500|FG003|Period 2|Withdrawal by Subject|38|||
160493106|NCT02706951|579535501|FG004|Period 2|Withdrawal by Subject|44|||
160493107|NCT02706951|579535497|FG000|Period 2|Lost to Follow-up|0|||
160493108|NCT02706951|579535498|FG001|Period 2|Lost to Follow-up|0|||
160493109|NCT02706951|579535499|FG002|Period 2|Lost to Follow-up|0|||
160493110|NCT02706951|579535500|FG003|Period 2|Lost to Follow-up|17|||
160493111|NCT02706951|579535501|FG004|Period 2|Lost to Follow-up|9|||
160493112|NCT02706951|579535497|FG000|Period 2|COVID-19 Related|0|||
160493113|NCT02706951|579535498|FG001|Period 2|COVID-19 Related|0|||
160493114|NCT02706951|579535499|FG002|Period 2|COVID-19 Related|0|||
160493115|NCT02706951|579535500|FG003|Period 2|COVID-19 Related|1|||
160493116|NCT02706951|579535501|FG004|Period 2|COVID-19 Related|2|||
160612315|NCT01700140|579957636|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
160612316|NCT01700140|579957637|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
160493117|NCT02706951|579535497|FG000|Period 2|Other|0|||
160612317|NCT01700140|579957635|FG000|Overall Study|Aggravation of symptoms|1|||
160493118|NCT02706951|579535498|FG001|Period 2|Other|0|||
160493119|NCT02706951|579535499|FG002|Period 2|Other|0|||
160493120|NCT02706951|579535500|FG003|Period 2|Other|37|||
160493121|NCT02706951|579535501|FG004|Period 2|Other|31|||
160493122|NCT03297398|579535506|FG000|Overall Study|Sponsor's decision|6|||
160493123|NCT03297398|579535507|FG001|Overall Study|Sponsor's decision|9|||
160493124|NCT03297398|579535508|FG002|Overall Study|Sponsor's decision|7|||
160493125|NCT03297398|579535506|FG000|Overall Study|Adverse Event|1|||
160493126|NCT03297398|579535507|FG001|Overall Study|Adverse Event|4|||
160493127|NCT03297398|579535508|FG002|Overall Study|Adverse Event|4|||
160493128|NCT03297398|579535506|FG000|Overall Study|Withdrawal by Subject|1|||
160612318|NCT01700140|579957636|FG001|Overall Study|Aggravation of symptoms|0|||
160612319|NCT01700140|579957637|FG002|Overall Study|Aggravation of symptoms|0|||
160612320|NCT01700140|579957635|FG000|Overall Study|Adverse Event|0|||
160612321|NCT01700140|579957636|FG001|Overall Study|Adverse Event|1|||
160612322|NCT01700140|579957637|FG002|Overall Study|Adverse Event|0|||
160612323|NCT01700140|579957635|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
160612324|NCT01700140|579957636|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
160612325|NCT01700140|579957637|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
160612326|NCT02299206|579957638|FG000|Overall Study|Lost to Follow-up|1|||
160612327|NCT02299206|579957638|FG000|Overall Study|Withdrawal by Subject|1|||
160612328|NCT00691054|579957639|FG000|Overall Study|Withdrawal by Subject|1|||
160612329|NCT03074318|579957645|FG000|Overall Study|Adverse Event|0|||
160612330|NCT03074318|579957646|FG001|Overall Study|Adverse Event|1|||
160612331|NCT03074318|579957647|FG002|Overall Study|Adverse Event|1|||
160493129|NCT03297398|579535507|FG001|Overall Study|Withdrawal by Subject|2|||
160493130|NCT03297398|579535508|FG002|Overall Study|Withdrawal by Subject|2|||
160493131|NCT03297398|579535506|FG000|Overall Study|Protocol Violation|0|||
160493132|NCT03297398|579535507|FG001|Overall Study|Protocol Violation|2|||
160493133|NCT03297398|579535508|FG002|Overall Study|Protocol Violation|0|||
160493134|NCT03297398|579535506|FG000|Overall Study|Physician Decision|0|||
160493135|NCT03297398|579535507|FG001|Overall Study|Physician Decision|0|||
160493136|NCT03297398|579535508|FG002|Overall Study|Physician Decision|1|||
160493137|NCT03297398|579535506|FG000|Overall Study|Lost to Follow-up|0|||
160493138|NCT03297398|579535507|FG001|Overall Study|Lost to Follow-up|0|||
160493139|NCT03297398|579535508|FG002|Overall Study|Lost to Follow-up|1|||
160493140|NCT00611715|579535511|FG000|Overall Study|Disease Progression|24|||
160493141|NCT00611715|579535512|FG001|Overall Study|Disease Progression|4|||
160493142|NCT00611715|579535511|FG000|Overall Study|Withdrawal by Subject|5|||
160493143|NCT00611715|579535512|FG001|Overall Study|Withdrawal by Subject|1|||
160493144|NCT00611715|579535511|FG000|Overall Study|Adverse Event|9|||
160493145|NCT00611715|579535512|FG001|Overall Study|Adverse Event|1|||
160493146|NCT00611715|579535511|FG000|Overall Study|Death|1|||
160493147|NCT00611715|579535512|FG001|Overall Study|Death|0|||
160493148|NCT00611715|579535511|FG000|Overall Study|two patients are still on treatment|2|||
160493149|NCT00611715|579535512|FG001|Overall Study|two patients are still on treatment|0|||
160493150|NCT00233389|579535516|FG000|Overall Study|Adverse Event|5|||
160493151|NCT00233389|579535517|FG001|Overall Study|Adverse Event|5|||
160493152|NCT00233389|579535516|FG000|Overall Study|Lack of Efficacy|11|||
160493153|NCT00233389|579535517|FG001|Overall Study|Lack of Efficacy|8|||
160493154|NCT00233389|579535516|FG000|Overall Study|Lost to Follow-up|1|||
160493155|NCT00233389|579535517|FG001|Overall Study|Lost to Follow-up|1|||
160493156|NCT00233389|579535516|FG000|Overall Study|Physician Decision|1|||
160493157|NCT00233389|579535517|FG001|Overall Study|Physician Decision|0|||
160493158|NCT00233389|579535516|FG000|Overall Study|Protocol Violation|0|||
160493159|NCT00233389|579535517|FG001|Overall Study|Protocol Violation|1|||
160493160|NCT00233389|579535516|FG000|Overall Study|Withdrawal by Subject|0|||
160493161|NCT00233389|579535517|FG001|Overall Study|Withdrawal by Subject|1|||
160493162|NCT00719043|579535523|FG000|Overall Study|Adverse Event|5|||
160493163|NCT00719043|579535524|FG001|Overall Study|Adverse Event|1|||
160493164|NCT00719043|579535525|FG002|Overall Study|Adverse Event|2|||
160493165|NCT00719043|579535526|FG003|Overall Study|Adverse Event|2|||
160493166|NCT00719043|579535527|FG004|Overall Study|Adverse Event|1|||
160493167|NCT00719043|579535528|FG005|Overall Study|Adverse Event|4|||
160493168|NCT00719043|579535529|FG006|Overall Study|Adverse Event|4|||
160493169|NCT00719043|579535523|FG000|Overall Study|Lost to Follow-up|14|||
160493170|NCT00719043|579535524|FG001|Overall Study|Lost to Follow-up|10|||
160493171|NCT00719043|579535525|FG002|Overall Study|Lost to Follow-up|8|||
160493172|NCT00719043|579535526|FG003|Overall Study|Lost to Follow-up|9|||
160493173|NCT00719043|579535527|FG004|Overall Study|Lost to Follow-up|10|||
160493174|NCT00719043|579535528|FG005|Overall Study|Lost to Follow-up|9|||
160493175|NCT00719043|579535529|FG006|Overall Study|Lost to Follow-up|9|||
160493176|NCT00719043|579535523|FG000|Overall Study|Protocol Violation|0|||
160493177|NCT00719043|579535524|FG001|Overall Study|Protocol Violation|0|||
160493178|NCT00719043|579535525|FG002|Overall Study|Protocol Violation|0|||
160493179|NCT00719043|579535526|FG003|Overall Study|Protocol Violation|0|||
160493180|NCT00719043|579535527|FG004|Overall Study|Protocol Violation|0|||
160493181|NCT00719043|579535528|FG005|Overall Study|Protocol Violation|1|||
160493182|NCT00719043|579535529|FG006|Overall Study|Protocol Violation|0|||
160493183|NCT00719043|579535523|FG000|Overall Study|Other|1|||
160493184|NCT00719043|579535524|FG001|Overall Study|Other|0|||
160493185|NCT00719043|579535525|FG002|Overall Study|Other|1|||
160493186|NCT00719043|579535526|FG003|Overall Study|Other|2|||
160493187|NCT00719043|579535527|FG004|Overall Study|Other|0|||
160493188|NCT00719043|579535528|FG005|Overall Study|Other|2|||
160493189|NCT00719043|579535529|FG006|Overall Study|Other|1|||
160493190|NCT00719043|579535523|FG000|Overall Study|Withdrawal by Subject|12|||
160493191|NCT00719043|579535524|FG001|Overall Study|Withdrawal by Subject|14|||
160612332|NCT03074318|579957648|FG003|Overall Study|Adverse Event|1|||
160612333|NCT03074318|579957645|FG000|Overall Study|Death|1|||
160612334|NCT03074318|579957646|FG001|Overall Study|Death|0|||
160493192|NCT00719043|579535525|FG002|Overall Study|Withdrawal by Subject|9|||
160493193|NCT00719043|579535526|FG003|Overall Study|Withdrawal by Subject|10|||
160493194|NCT00719043|579535527|FG004|Overall Study|Withdrawal by Subject|16|||
160493195|NCT00719043|579535528|FG005|Overall Study|Withdrawal by Subject|18|||
160493196|NCT00719043|579535529|FG006|Overall Study|Withdrawal by Subject|14|||
160493197|NCT04593823|579535530|FG000|Overall Study|Withdrawal by Subject|1|||
160493198|NCT04593823|579535531|FG001|Overall Study|Withdrawal by Subject|1|||
160493199|NCT04593823|579535530|FG000|Overall Study|Lost to Follow-up|0|||
160493200|NCT04593823|579535531|FG001|Overall Study|Lost to Follow-up|1|||
160493201|NCT00952848|579535538|FG000|Overall Study|Withdrawal by Subject|4|||
160493202|NCT00458393|579535539|FG000|Overall Study|Withdrawal by Subject|67|||
160493203|NCT00458393|579535540|FG001|Overall Study|Withdrawal by Subject|80|||
160493204|NCT00458393|579535539|FG000|Overall Study|Physician Decision|31|||
160612335|NCT03074318|579957647|FG002|Overall Study|Death|0|||
160493205|NCT00458393|579535540|FG001|Overall Study|Physician Decision|22|||
160493206|NCT00458393|579535539|FG000|Overall Study|Relocated|77|||
160493207|NCT00458393|579535540|FG001|Overall Study|Relocated|81|||
160493208|NCT00458393|579535539|FG000|Overall Study|Lost to Follow-up|115|||
160493209|NCT00458393|579535540|FG001|Overall Study|Lost to Follow-up|92|||
160493210|NCT00458393|579535539|FG000|Overall Study|Sites marked other on the form.|19|||
160493211|NCT00458393|579535540|FG001|Overall Study|Sites marked other on the form.|20|||
160493212|NCT02725567|579535541|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
160493213|NCT02725567|579535542|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
160493214|NCT02725567|579535541|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
160493215|NCT02725567|579535542|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
160493216|NCT02725567|579535541|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
160493217|NCT02725567|579535542|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
160493218|NCT02777242|579535543|FG000|Overall Study|Other|2|||
160493219|NCT02777242|579535543|FG000|Overall Study|Lost to Follow-up|1|||
160493220|NCT02777242|579535543|FG000|Overall Study|Multiple|1|||
160493221|NCT02777242|579535543|FG000|Overall Study|Sponsor's request|1|||
160493222|NCT02777242|579535543|FG000|Overall Study|Withdrawal by Subject|1|||
160493223|NCT01182181|579535552|FG000|First Intervention|Adverse Event|1|||
160493224|NCT01182181|579535553|FG001|First Intervention|Adverse Event|0|||
160493225|NCT01182181|579535552|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
160493226|NCT01182181|579535553|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
160493227|NCT00511797|579535554|FG000|Overall Study|Adverse Event|1|||
160493228|NCT00511797|579535555|FG001|Overall Study|Adverse Event|2|||
160493229|NCT00511797|579535556|FG002|Overall Study|Adverse Event|2|||
160493230|NCT00511797|579535557|FG003|Overall Study|Adverse Event|2|||
160493231|NCT00511797|579535554|FG000|Overall Study|Lost to Follow-up|1|||
160493232|NCT00511797|579535555|FG001|Overall Study|Lost to Follow-up|0|||
160493233|NCT00511797|579535556|FG002|Overall Study|Lost to Follow-up|0|||
160493234|NCT00511797|579535557|FG003|Overall Study|Lost to Follow-up|1|||
160493235|NCT00511797|579535554|FG000|Overall Study|Pregnancy|0|||
160493236|NCT00511797|579535555|FG001|Overall Study|Pregnancy|0|||
160493237|NCT00511797|579535556|FG002|Overall Study|Pregnancy|0|||
160493238|NCT00511797|579535557|FG003|Overall Study|Pregnancy|1|||
160493239|NCT00511797|579535554|FG000|Overall Study|Protocol Violation|0|||
160493240|NCT00511797|579535555|FG001|Overall Study|Protocol Violation|2|||
160493241|NCT00511797|579535556|FG002|Overall Study|Protocol Violation|2|||
160493242|NCT00511797|579535557|FG003|Overall Study|Protocol Violation|3|||
160493243|NCT00511797|579535554|FG000|Overall Study|Withdrawal by Subject|3|||
160493244|NCT00511797|579535555|FG001|Overall Study|Withdrawal by Subject|3|||
160493245|NCT00511797|579535556|FG002|Overall Study|Withdrawal by Subject|4|||
160493246|NCT00511797|579535557|FG003|Overall Study|Withdrawal by Subject|2|||
160493247|NCT00511797|579535554|FG000|Overall Study|Never dispensed|1|||
160493248|NCT00511797|579535555|FG001|Overall Study|Never dispensed|0|||
160493249|NCT00511797|579535556|FG002|Overall Study|Never dispensed|1|||
160493250|NCT00511797|579535557|FG003|Overall Study|Never dispensed|3|||
160493251|NCT00511797|579535554|FG000|Overall Study|Study drug not taken|0|||
160493252|NCT00511797|579535555|FG001|Overall Study|Study drug not taken|1|||
160493253|NCT00511797|579535556|FG002|Overall Study|Study drug not taken|0|||
160493254|NCT00511797|579535557|FG003|Overall Study|Study drug not taken|1|||
160493255|NCT00511797|579535554|FG000|Overall Study|Partially missing diary|0|||
160493256|NCT00511797|579535555|FG001|Overall Study|Partially missing diary|0|||
160493257|NCT00511797|579535556|FG002|Overall Study|Partially missing diary|1|||
160493258|NCT00511797|579535557|FG003|Overall Study|Partially missing diary|0|||
160493259|NCT00511797|579535554|FG000|Overall Study|Other (moving etc)|1|||
160493260|NCT00511797|579535555|FG001|Overall Study|Other (moving etc)|0|||
160493261|NCT00511797|579535556|FG002|Overall Study|Other (moving etc)|1|||
160493262|NCT00511797|579535557|FG003|Overall Study|Other (moving etc)|2|||
160493263|NCT02413593|579535558|FG000|Overall Study|Lost to Follow-up|3|||
160493264|NCT02413593|579535558|FG000|Overall Study|Adverse Event|1|||
160493265|NCT03845075|579535559|FG000|Part 1 - DB|Withdrawal by Subject|1|||
160493266|NCT03845075|579535560|FG001|Part 1 - DB|Withdrawal by Subject|1|||
160493267|NCT03845075|579535561|FG002|Part 1 - DB|Withdrawal by Subject|0|||
160493268|NCT03845075|579535562|FG003|Part 1 - DB|Withdrawal by Subject|0|||
160493269|NCT03845075|579535559|FG000|Part 1 - DB|Adverse Event|0|||
160493270|NCT03845075|579535560|FG001|Part 1 - DB|Adverse Event|1|||
160493271|NCT03845075|579535561|FG002|Part 1 - DB|Adverse Event|0|||
160493272|NCT03845075|579535562|FG003|Part 1 - DB|Adverse Event|0|||
160493273|NCT03845075|579535559|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
160493274|NCT03845075|579535560|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
160493275|NCT03845075|579535561|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
160493276|NCT03845075|579535562|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
160493277|NCT03599622|579535565|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
160493278|NCT03599622|579535566|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
160493279|NCT03599622|579535567|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
160493280|NCT03599622|579535568|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
160493281|NCT03599622|579535565|FG000|Pre-Treatment Period|Other reasons|1|||
160493282|NCT03599622|579535566|FG001|Pre-Treatment Period|Other reasons|1|||
160493283|NCT03599622|579535567|FG002|Pre-Treatment Period|Other reasons|1|||
160493284|NCT03599622|579535568|FG003|Pre-Treatment Period|Other reasons|0|||
160493285|NCT03599622|579535565|FG000|Treatment Period|Adverse Event|11|||
160493286|NCT03599622|579535566|FG001|Treatment Period|Adverse Event|20|||
160493287|NCT03599622|579535567|FG002|Treatment Period|Adverse Event|18|||
160493288|NCT03599622|579535568|FG003|Treatment Period|Adverse Event|2|||
160493289|NCT03599622|579535565|FG000|Treatment Period|Lack of Efficacy|18|||
160493290|NCT03599622|579535566|FG001|Treatment Period|Lack of Efficacy|12|||
160493291|NCT03599622|579535567|FG002|Treatment Period|Lack of Efficacy|13|||
160493292|NCT03599622|579535568|FG003|Treatment Period|Lack of Efficacy|2|||
160493293|NCT03599622|579535565|FG000|Treatment Period|Withdrawal by Subject|5|||
160493294|NCT03599622|579535566|FG001|Treatment Period|Withdrawal by Subject|11|||
160493295|NCT03599622|579535567|FG002|Treatment Period|Withdrawal by Subject|16|||
160493296|NCT03599622|579535568|FG003|Treatment Period|Withdrawal by Subject|1|||
160493297|NCT03599622|579535565|FG000|Treatment Period|Other reasons|4|||
160493298|NCT03599622|579535566|FG001|Treatment Period|Other reasons|6|||
160493299|NCT03599622|579535567|FG002|Treatment Period|Other reasons|7|||
160493300|NCT03599622|579535568|FG003|Treatment Period|Other reasons|0|||
160493301|NCT03599622|579535565|FG000|Treatment Period|Lost to Follow-up|1|||
160493302|NCT03599622|579535566|FG001|Treatment Period|Lost to Follow-up|0|||
160493303|NCT03599622|579535567|FG002|Treatment Period|Lost to Follow-up|0|||
160493304|NCT03599622|579535568|FG003|Treatment Period|Lost to Follow-up|0|||
160493305|NCT03599622|579535565|FG000|Treatment Period|Study terminated by sponsor|7|||
160493306|NCT03599622|579535566|FG001|Treatment Period|Study terminated by sponsor|20|||
160493307|NCT03599622|579535567|FG002|Treatment Period|Study terminated by sponsor|15|||
160493308|NCT03599622|579535568|FG003|Treatment Period|Study terminated by sponsor|0|||
160493309|NCT03599622|579535565|FG000|Treatment Period|Site terminated by sponsor|0|||
160493310|NCT03599622|579535566|FG001|Treatment Period|Site terminated by sponsor|1|||
160493311|NCT03599622|579535567|FG002|Treatment Period|Site terminated by sponsor|0|||
160493312|NCT03599622|579535568|FG003|Treatment Period|Site terminated by sponsor|0|||
160493313|NCT00905359|579535569|FG000|Overall Study|Lost to Follow-up|17|||
160493314|NCT00905359|579535570|FG001|Overall Study|Lost to Follow-up|10|||
160493315|NCT00905359|579535569|FG000|Overall Study|Death|2|||
160493316|NCT00905359|579535570|FG001|Overall Study|Death|0|||
160493317|NCT00905359|579535569|FG000|Overall Study|Withdrawal consent|5|||
160493318|NCT00905359|579535570|FG001|Overall Study|Withdrawal consent|6|||
160493319|NCT01006889|579535571|FG000|Overall Study|Withdrawal by Subject|3|||
160493320|NCT02804399|579535574|FG000|Period 2|Adverse Event|0|||
160493321|NCT02804399|579535575|FG001|Period 2|Adverse Event|1|||
160493322|NCT03432390|579535576|FG000|Apnea Period|Protocol Violation|2|||
160493323|NCT03432390|579535577|FG001|Apnea Period|Protocol Violation|2|||
160493324|NCT00725543|579535586|FG000|Overall Study|Adverse Event|10|||
160493325|NCT00725543|579535586|FG000|Overall Study|Lack of Efficacy|3|||
160493326|NCT00725543|579535586|FG000|Overall Study|Withdrawal by Subject|10|||
160493327|NCT00725543|579535586|FG000|Overall Study|Physician Decision|5|||
160493328|NCT00725543|579535586|FG000|Overall Study|Lost to Follow-up|4|||
160493329|NCT00725543|579535586|FG000|Overall Study|Non-compliance|2|||
160493330|NCT00725543|579535586|FG000|Overall Study|Other|119|||
160493331|NCT01157377|579535587|FG000|Overall Study|Lost to Follow-up|0|||
160493332|NCT01157377|579535588|FG001|Overall Study|Lost to Follow-up|0|||
160493333|NCT01157377|579535589|FG002|Overall Study|Lost to Follow-up|1|||
160493334|NCT01157377|579535590|FG003|Overall Study|Lost to Follow-up|0|||
160493335|NCT01157377|579535591|FG004|Overall Study|Lost to Follow-up|1|||
160493336|NCT01157377|579535592|FG005|Overall Study|Lost to Follow-up|1|||
160493337|NCT01157377|579535593|FG006|Overall Study|Lost to Follow-up|0|||
160493338|NCT01157377|579535587|FG000|Overall Study|Personal Reasons|2|||
160612336|NCT03074318|579957648|FG003|Overall Study|Death|0|||
160612337|NCT03074318|579957645|FG000|Overall Study|Withdrawal by Subject|1|||
160612338|NCT03074318|579957646|FG001|Overall Study|Withdrawal by Subject|2|||
160612339|NCT03074318|579957647|FG002|Overall Study|Withdrawal by Subject|2|||
160612340|NCT03074318|579957648|FG003|Overall Study|Withdrawal by Subject|4|||
160612341|NCT03074318|579957645|FG000|Overall Study|Trial Closure|2|||
160612342|NCT03074318|579957646|FG001|Overall Study|Trial Closure|2|||
160493339|NCT01157377|579535588|FG001|Overall Study|Personal Reasons|1|||
160493340|NCT01157377|579535589|FG002|Overall Study|Personal Reasons|0|||
160493341|NCT01157377|579535590|FG003|Overall Study|Personal Reasons|1|||
160493342|NCT01157377|579535591|FG004|Overall Study|Personal Reasons|0|||
160493343|NCT01157377|579535592|FG005|Overall Study|Personal Reasons|0|||
160612343|NCT03074318|579957647|FG002|Overall Study|Trial Closure|3|||
160493344|NCT01157377|579535593|FG006|Overall Study|Personal Reasons|0|||
160493345|NCT01157377|579535587|FG000|Overall Study|Protocol Violation|0|||
160493346|NCT01157377|579535588|FG001|Overall Study|Protocol Violation|0|||
160493347|NCT01157377|579535589|FG002|Overall Study|Protocol Violation|0|||
160493348|NCT01157377|579535590|FG003|Overall Study|Protocol Violation|0|||
160493349|NCT01157377|579535591|FG004|Overall Study|Protocol Violation|0|||
160493350|NCT01157377|579535592|FG005|Overall Study|Protocol Violation|1|||
160493351|NCT01157377|579535593|FG006|Overall Study|Protocol Violation|0|||
160493352|NCT01157377|579535587|FG000|Overall Study|Lack of Efficacy|0|||
160493353|NCT01157377|579535588|FG001|Overall Study|Lack of Efficacy|0|||
160493354|NCT01157377|579535589|FG002|Overall Study|Lack of Efficacy|0|||
160493355|NCT01157377|579535590|FG003|Overall Study|Lack of Efficacy|0|||
160493356|NCT01157377|579535591|FG004|Overall Study|Lack of Efficacy|0|||
160493357|NCT01157377|579535592|FG005|Overall Study|Lack of Efficacy|0|||
160493358|NCT01157377|579535593|FG006|Overall Study|Lack of Efficacy|1|||
160493359|NCT01157377|579535587|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160493360|NCT01157377|579535588|FG001|Overall Study|Other Miscellaneous Reasons|2|||
160493361|NCT01157377|579535589|FG002|Overall Study|Other Miscellaneous Reasons|0|||
160493362|NCT01157377|579535590|FG003|Overall Study|Other Miscellaneous Reasons|0|||
160493363|NCT01157377|579535591|FG004|Overall Study|Other Miscellaneous Reasons|1|||
160493364|NCT01157377|579535592|FG005|Overall Study|Other Miscellaneous Reasons|1|||
160493365|NCT01157377|579535593|FG006|Overall Study|Other Miscellaneous Reasons|1|||
160493366|NCT00087555|579535594|FG000|Overall Study|Adverse Event|3|||
160493367|NCT00087555|579535595|FG001|Overall Study|Adverse Event|6|||
160493368|NCT00087555|579535596|FG002|Overall Study|Adverse Event|14|||
160493369|NCT00087555|579535594|FG000|Overall Study|Lost to Follow-up|0|||
160493370|NCT00087555|579535595|FG001|Overall Study|Lost to Follow-up|1|||
160493371|NCT00087555|579535596|FG002|Overall Study|Lost to Follow-up|1|||
160493372|NCT00087555|579535594|FG000|Overall Study|Non - Compliance|1|||
160493373|NCT00087555|579535595|FG001|Overall Study|Non - Compliance|0|||
160493374|NCT00087555|579535596|FG002|Overall Study|Non - Compliance|0|||
160493375|NCT00087555|579535594|FG000|Overall Study|Protocol Violation|0|||
160493376|NCT00087555|579535595|FG001|Overall Study|Protocol Violation|0|||
160493377|NCT00087555|579535596|FG002|Overall Study|Protocol Violation|2|||
160493378|NCT00087555|579535594|FG000|Overall Study|Screen Failure|1|||
160493379|NCT00087555|579535595|FG001|Overall Study|Screen Failure|1|||
160493380|NCT00087555|579535596|FG002|Overall Study|Screen Failure|0|||
160493381|NCT00087555|579535594|FG000|Overall Study|Pregnancy|0|||
160493382|NCT00087555|579535595|FG001|Overall Study|Pregnancy|1|||
160493383|NCT00087555|579535596|FG002|Overall Study|Pregnancy|1|||
160493384|NCT00087555|579535594|FG000|Overall Study|Withdrawal by Subject|3|||
160493385|NCT00087555|579535595|FG001|Overall Study|Withdrawal by Subject|2|||
160493386|NCT00087555|579535596|FG002|Overall Study|Withdrawal by Subject|1|||
160493387|NCT00087555|579535594|FG000|Overall Study|Lack of Efficacy|2|||
160493388|NCT00087555|579535595|FG001|Overall Study|Lack of Efficacy|0|||
160493389|NCT00087555|579535596|FG002|Overall Study|Lack of Efficacy|1|||
160493390|NCT00087555|579535594|FG000|Overall Study|Non Compliance|0|||
160493391|NCT00087555|579535595|FG001|Overall Study|Non Compliance|0|||
160493392|NCT00087555|579535596|FG002|Overall Study|Non Compliance|1|||
160493393|NCT00087555|579535594|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
160493394|NCT00087555|579535595|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
160493395|NCT00087555|579535596|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
160493396|NCT00087555|579535594|FG000|Overall Study|Patient wanted to go back on Med|1|||
160493397|NCT00087555|579535595|FG001|Overall Study|Patient wanted to go back on Med|0|||
160493398|NCT00087555|579535596|FG002|Overall Study|Patient wanted to go back on Med|0|||
160493399|NCT01062971|579535597|FG000|Overall Study|Protocol Violation|1|||
160493400|NCT01062971|579535598|FG001|Overall Study|Protocol Violation|3|||
160493401|NCT01062971|579535597|FG000|Overall Study|Lost to Follow-up|3|||
160493402|NCT01062971|579535598|FG001|Overall Study|Lost to Follow-up|4|||
160493403|NCT03738397|579535607|FG000|Overall Study|Adverse Event|3|||
160493404|NCT03738397|579535608|FG001|Overall Study|Adverse Event|7|||
160493405|NCT03738397|579535607|FG000|Overall Study|Withdrawal by Subject|8|||
160661432|NCT01256684|580144098|FG001|Overall Study|Physician Decision|1|||
160661433|NCT01256684|580144099|FG002|Overall Study|Physician Decision|0|||
160661434|NCT01256684|580144097|FG000|Overall Study|Lack of Efficacy|0|||
160661435|NCT01256684|580144098|FG001|Overall Study|Lack of Efficacy|1|||
160661436|NCT01256684|580144099|FG002|Overall Study|Lack of Efficacy|1|||
160493406|NCT03738397|579535608|FG001|Overall Study|Withdrawal by Subject|11|||
160493407|NCT03738397|579535607|FG000|Overall Study|Lost to Follow-up|7|||
160493408|NCT03738397|579535608|FG001|Overall Study|Lost to Follow-up|5|||
160493409|NCT03738397|579535607|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
160493410|NCT03738397|579535608|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
160493411|NCT03738397|579535607|FG000|Overall Study|Other|4|||
160493412|NCT03738397|579535608|FG001|Overall Study|Other|6|||
160493413|NCT00904722|579535611|FG000|Overall Study|Physician Decision|1|||
160493414|NCT00661713|579535612|FG000|Overall Study|Death|1|||
160493415|NCT00661713|579535613|FG001|Overall Study|Death|0|||
160493416|NCT00661713|579535614|FG002|Overall Study|Death|0|||
160493417|NCT00661713|579535615|FG003|Overall Study|Death|0|||
160493418|NCT00661713|579535616|FG004|Overall Study|Death|1|||
160493419|NCT00661713|579535617|FG005|Overall Study|Death|0|||
160493420|NCT00661713|579535618|FG006|Overall Study|Death|0|||
160493421|NCT00661713|579535619|FG007|Overall Study|Death|0|||
160493422|NCT00661713|579535612|FG000|Overall Study|Unable to Classify|1|||
160493423|NCT00661713|579535613|FG001|Overall Study|Unable to Classify|0|||
160493424|NCT00661713|579535614|FG002|Overall Study|Unable to Classify|0|||
160493425|NCT00661713|579535615|FG003|Overall Study|Unable to Classify|0|||
160493426|NCT00661713|579535616|FG004|Overall Study|Unable to Classify|0|||
160661437|NCT01256684|580144097|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
160612344|NCT03074318|579957648|FG003|Overall Study|Trial Closure|11|||
160612345|NCT01855919|579959448|FG000|Overall Study|Adverse Event|16|||
160612346|NCT01855919|579959449|FG001|Overall Study|Adverse Event|8|||
160612347|NCT01855919|579959448|FG000|Overall Study|Lack of Efficacy|1|||
160612348|NCT01855919|579959449|FG001|Overall Study|Lack of Efficacy|3|||
160612349|NCT01855919|579959448|FG000|Overall Study|Withdrawal by Subject|4|||
160612350|NCT01855919|579959449|FG001|Overall Study|Withdrawal by Subject|10|||
160612351|NCT01855919|579959448|FG000|Overall Study|Entry Criteria Not Met|1|||
160612352|NCT01855919|579959449|FG001|Overall Study|Entry Criteria Not Met|1|||
160612353|NCT01855919|579959448|FG000|Overall Study|Protocol Violation|1|||
160612354|NCT01855919|579959449|FG001|Overall Study|Protocol Violation|4|||
160612355|NCT01625897|579959452|FG000|Overall Study|Adverse Event|27|||
160612356|NCT01625897|579959453|FG001|Overall Study|Adverse Event|10|||
160612357|NCT01625897|579959452|FG000|Overall Study|Physician Decision|0|||
160612358|NCT01625897|579959453|FG001|Overall Study|Physician Decision|1|||
160612359|NCT01625897|579959452|FG000|Overall Study|Withdrawal by Subject|25|||
160661438|NCT01256684|580144098|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
160493427|NCT00661713|579535617|FG005|Overall Study|Unable to Classify|0|||
160493428|NCT00661713|579535618|FG006|Overall Study|Unable to Classify|0|||
160493429|NCT00661713|579535619|FG007|Overall Study|Unable to Classify|0|||
160493430|NCT00661713|579535612|FG000|Overall Study|Protocol Violation|1|||
160493431|NCT00661713|579535613|FG001|Overall Study|Protocol Violation|6|||
160493432|NCT00661713|579535614|FG002|Overall Study|Protocol Violation|3|||
160493433|NCT00661713|579535615|FG003|Overall Study|Protocol Violation|3|||
160493434|NCT00661713|579535616|FG004|Overall Study|Protocol Violation|0|||
160493435|NCT00661713|579535617|FG005|Overall Study|Protocol Violation|2|||
160493436|NCT00661713|579535618|FG006|Overall Study|Protocol Violation|2|||
160493437|NCT00661713|579535619|FG007|Overall Study|Protocol Violation|1|||
160493438|NCT00661713|579535612|FG000|Overall Study|Withdrawal by Subject|11|||
160493439|NCT00661713|579535613|FG001|Overall Study|Withdrawal by Subject|25|||
160493440|NCT00661713|579535614|FG002|Overall Study|Withdrawal by Subject|12|||
160493441|NCT00661713|579535615|FG003|Overall Study|Withdrawal by Subject|21|||
160493442|NCT00661713|579535616|FG004|Overall Study|Withdrawal by Subject|12|||
160493443|NCT00661713|579535617|FG005|Overall Study|Withdrawal by Subject|26|||
160493444|NCT00661713|579535618|FG006|Overall Study|Withdrawal by Subject|45|||
160493445|NCT00661713|579535619|FG007|Overall Study|Withdrawal by Subject|9|||
160493446|NCT00661713|579535612|FG000|Overall Study|Lost to Follow-up|2|||
160493447|NCT00661713|579535613|FG001|Overall Study|Lost to Follow-up|7|||
160493448|NCT00661713|579535614|FG002|Overall Study|Lost to Follow-up|2|||
160493449|NCT00661713|579535615|FG003|Overall Study|Lost to Follow-up|2|||
160493450|NCT00661713|579535616|FG004|Overall Study|Lost to Follow-up|5|||
160493451|NCT00661713|579535617|FG005|Overall Study|Lost to Follow-up|7|||
160493452|NCT00661713|579535618|FG006|Overall Study|Lost to Follow-up|14|||
160493453|NCT00661713|579535619|FG007|Overall Study|Lost to Follow-up|1|||
160493454|NCT00661713|579535612|FG000|Overall Study|Administrative Reason|0|||
160493455|NCT00661713|579535613|FG001|Overall Study|Administrative Reason|1|||
160493456|NCT00661713|579535614|FG002|Overall Study|Administrative Reason|0|||
160493457|NCT00661713|579535615|FG003|Overall Study|Administrative Reason|2|||
160493458|NCT00661713|579535616|FG004|Overall Study|Administrative Reason|2|||
160493459|NCT00661713|579535617|FG005|Overall Study|Administrative Reason|2|||
160493460|NCT00661713|579535618|FG006|Overall Study|Administrative Reason|1|||
160493461|NCT00661713|579535619|FG007|Overall Study|Administrative Reason|0|||
160493462|NCT00661713|579535612|FG000|Overall Study|Adverse Event|0|||
160493463|NCT00661713|579535613|FG001|Overall Study|Adverse Event|0|||
160493464|NCT00661713|579535614|FG002|Overall Study|Adverse Event|0|||
160493465|NCT00661713|579535615|FG003|Overall Study|Adverse Event|0|||
160493466|NCT00661713|579535616|FG004|Overall Study|Adverse Event|0|||
160493467|NCT00661713|579535617|FG005|Overall Study|Adverse Event|0|||
160493468|NCT00661713|579535618|FG006|Overall Study|Adverse Event|1|||
160493469|NCT00661713|579535619|FG007|Overall Study|Adverse Event|0|||
160493470|NCT00661713|579535612|FG000|Overall Study|Inappropriate Enrollment|0|||
160493471|NCT00661713|579535613|FG001|Overall Study|Inappropriate Enrollment|0|||
160493472|NCT00661713|579535614|FG002|Overall Study|Inappropriate Enrollment|0|||
160493473|NCT00661713|579535615|FG003|Overall Study|Inappropriate Enrollment|0|||
160493474|NCT00661713|579535616|FG004|Overall Study|Inappropriate Enrollment|0|||
160493475|NCT00661713|579535617|FG005|Overall Study|Inappropriate Enrollment|0|||
160493476|NCT00661713|579535618|FG006|Overall Study|Inappropriate Enrollment|1|||
160493477|NCT00661713|579535619|FG007|Overall Study|Inappropriate Enrollment|0|||
160493478|NCT01801982|579535622|FG000|Overall Study|Lost to Follow-up|1|||
160493479|NCT00727506|579535623|FG000|Overall Study|Adverse Event|0|||
160493480|NCT00727506|579535624|FG001|Overall Study|Adverse Event|0|||
160493481|NCT00727506|579535625|FG002|Overall Study|Adverse Event|4|||
160493482|NCT00727506|579535626|FG003|Overall Study|Adverse Event|4|||
160493483|NCT00727506|579535627|FG004|Overall Study|Adverse Event|1|||
160493484|NCT00727506|579535628|FG005|Overall Study|Adverse Event|8|||
160493485|NCT00727506|579535623|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
160493486|NCT00727506|579535624|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160493487|NCT00727506|579535625|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
160493488|NCT00727506|579535626|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160661439|NCT01256684|580144099|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
160661440|NCT02587962|580144103|FG000|Overall Study|Adverse Event|0|||
160661441|NCT02587962|580144104|FG001|Overall Study|Adverse Event|0|||
160661442|NCT02587962|580144105|FG002|Overall Study|Adverse Event|1|||
160493489|NCT00727506|579535627|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160493490|NCT00727506|579535628|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160493491|NCT00727506|579535623|FG000|Overall Study|Progressive disease|4|||
160493492|NCT00727506|579535624|FG001|Overall Study|Progressive disease|7|||
160493493|NCT00727506|579535625|FG002|Overall Study|Progressive disease|9|||
160493494|NCT00727506|579535626|FG003|Overall Study|Progressive disease|28|||
160493495|NCT00727506|579535627|FG004|Overall Study|Progressive disease|38|||
160493496|NCT00727506|579535628|FG005|Overall Study|Progressive disease|28|||
160493497|NCT00727506|579535623|FG000|Overall Study|Refused to continue medication|0|||
160493498|NCT00727506|579535624|FG001|Overall Study|Refused to continue medication|1|||
160493499|NCT00727506|579535625|FG002|Overall Study|Refused to continue medication|2|||
160661443|NCT02587962|580144106|FG003|Overall Study|Adverse Event|0|||
160493500|NCT00727506|579535626|FG003|Overall Study|Refused to continue medication|3|||
160493501|NCT00727506|579535627|FG004|Overall Study|Refused to continue medication|1|||
160493502|NCT00727506|579535628|FG005|Overall Study|Refused to continue medication|2|||
160493503|NCT00727506|579535623|FG000|Overall Study|Other reason not described above|0|||
160493504|NCT00727506|579535624|FG001|Overall Study|Other reason not described above|0|||
160493505|NCT00727506|579535625|FG002|Overall Study|Other reason not described above|1|||
160493506|NCT00727506|579535626|FG003|Overall Study|Other reason not described above|4|||
160493507|NCT00727506|579535627|FG004|Overall Study|Other reason not described above|1|||
160493508|NCT00727506|579535628|FG005|Overall Study|Other reason not described above|1|||
160493509|NCT02650466|579535630|FG000|Overall Study|Physician Decision|1|||
160493510|NCT02650466|579535630|FG000|Overall Study|Withdrawal by Subject|5|||
160493511|NCT02650466|579535630|FG000|Overall Study|Lost to Follow-up|1|||
160493512|NCT01214421|579535634|FG000|Overall Study|Lost to Follow-up|7|||
160493513|NCT01214421|579535635|FG001|Overall Study|Lost to Follow-up|3|||
160493514|NCT01214421|579535636|FG002|Overall Study|Lost to Follow-up|7|||
160493515|NCT01214421|579535637|FG003|Overall Study|Lost to Follow-up|3|||
160493516|NCT01214421|579535634|FG000|Overall Study|Adverse Event|16|||
160493517|NCT01214421|579535635|FG001|Overall Study|Adverse Event|35|||
160493518|NCT01214421|579535636|FG002|Overall Study|Adverse Event|14|||
160493519|NCT01214421|579535637|FG003|Overall Study|Adverse Event|3|||
160493520|NCT01214421|579535634|FG000|Overall Study|Sponsor Discontinued Site|1|||
160493521|NCT01214421|579535635|FG001|Overall Study|Sponsor Discontinued Site|2|||
160493522|NCT01214421|579535636|FG002|Overall Study|Sponsor Discontinued Site|0|||
160493523|NCT01214421|579535637|FG003|Overall Study|Sponsor Discontinued Site|0|||
160493524|NCT01214421|579535634|FG000|Overall Study|Withdrawal Criteria Met|3|||
160493525|NCT01214421|579535635|FG001|Overall Study|Withdrawal Criteria Met|0|||
160493526|NCT01214421|579535636|FG002|Overall Study|Withdrawal Criteria Met|2|||
160493527|NCT01214421|579535637|FG003|Overall Study|Withdrawal Criteria Met|1|||
160493528|NCT01214421|579535634|FG000|Overall Study|Physician Decision|2|||
160493529|NCT01214421|579535635|FG001|Overall Study|Physician Decision|0|||
160493530|NCT01214421|579535636|FG002|Overall Study|Physician Decision|4|||
160493531|NCT01214421|579535637|FG003|Overall Study|Physician Decision|0|||
160493532|NCT01214421|579535634|FG000|Overall Study|Withdrawal by Subject|21|||
160493533|NCT01214421|579535635|FG001|Overall Study|Withdrawal by Subject|18|||
160493534|NCT01214421|579535636|FG002|Overall Study|Withdrawal by Subject|11|||
160493535|NCT01214421|579535637|FG003|Overall Study|Withdrawal by Subject|2|||
160493536|NCT03783689|579535639|FG000|Overall Study|Adverse Event|2|||
160493537|NCT03783689|579535640|FG001|Overall Study|Adverse Event|0|||
160493538|NCT03783689|579535639|FG000|Overall Study|Lost to Follow-up|2|||
160493539|NCT03783689|579535640|FG001|Overall Study|Lost to Follow-up|1|||
160493540|NCT03783689|579535639|FG000|Overall Study|Physician Decision|2|||
160493541|NCT03783689|579535640|FG001|Overall Study|Physician Decision|1|||
160493542|NCT03783689|579535639|FG000|Overall Study|Withdrawal by Subject|3|||
160493543|NCT03783689|579535640|FG001|Overall Study|Withdrawal by Subject|3|||
160493544|NCT00691678|579535642|FG000|Overall Study|Adverse Event|5|||
160493545|NCT00691678|579535642|FG000|Overall Study|life events, pain|11|||
160493546|NCT03049306|579535643|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
160493547|NCT03049306|579535644|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
160493548|NCT05347485|579535645|FG000|Overall Study|Death|14|||
160493549|NCT05347485|579535645|FG000|Overall Study|Lost to Follow-up|2|||
160493550|NCT05347485|579535645|FG000|Overall Study|Withdrawal by Subject|13|||
160493551|NCT05347485|579535645|FG000|Overall Study|Progressive Disease|1|||
160612360|NCT01625897|579959453|FG001|Overall Study|Withdrawal by Subject|3|||
160612361|NCT03455530|579959454|FG000|Overall Study|Withdrawal by Subject|9|||
160612362|NCT03455530|579959455|FG001|Overall Study|Withdrawal by Subject|1|||
160612363|NCT03455530|579959456|FG002|Overall Study|Withdrawal by Subject|3|||
160612364|NCT03455530|579959457|FG003|Overall Study|Withdrawal by Subject|3|||
160612365|NCT02972658|579959462|FG000|Overall Study|Adverse Event|0|||
160493552|NCT05347485|579535645|FG000|Overall Study|Study Terminated by Sponsor|49|||
160612366|NCT02972658|579959463|FG001|Overall Study|Adverse Event|3|||
160612367|NCT02972658|579959464|FG002|Overall Study|Adverse Event|0|||
160612368|NCT02972658|579959465|FG003|Overall Study|Adverse Event|2|||
160612369|NCT02972658|579959462|FG000|Overall Study|Other-determined by Investigator|1|||
160612370|NCT02972658|579959463|FG001|Overall Study|Other-determined by Investigator|1|||
160493553|NCT05347485|579535645|FG000|Overall Study|Other|1|||
160493554|NCT05347485|579535645|FG000|Overall Study|Enrolled (consented) but not treated|4|||
160493555|NCT05347485|579535645|FG000|Overall Study|Disease Relapse|2|||
160493556|NCT03526679|579537385|FG000|Overall Study|still under treatment|2|||
160493557|NCT00903760|579537386|FG000|Overall Study|Disease Progression/Death|8|||
160493558|NCT00903760|579537387|FG001|Overall Study|Disease Progression/Death|6|||
160493559|NCT00903760|579537386|FG000|Overall Study|Stem Cell Transplant|8|||
160493560|NCT00903760|579537387|FG001|Overall Study|Stem Cell Transplant|4|||
160493561|NCT00903760|579537386|FG000|Overall Study|Physician Decision|1|||
160493562|NCT00903760|579537387|FG001|Overall Study|Physician Decision|2|||
160493563|NCT00903760|579537386|FG000|Overall Study|Death|0|||
160493564|NCT00903760|579537387|FG001|Overall Study|Death|1|||
160493565|NCT00903760|579537386|FG000|Overall Study|Lost to Follow-up|1|||
160493566|NCT00903760|579537387|FG001|Overall Study|Lost to Follow-up|0|||
160493567|NCT00903760|579537386|FG000|Overall Study|Withdrawal by Subject|1|||
160493568|NCT00903760|579537387|FG001|Overall Study|Withdrawal by Subject|2|||
160493569|NCT00903760|579537386|FG000|Overall Study|Off treatment for long period|0|||
160493570|NCT00903760|579537387|FG001|Overall Study|Off treatment for long period|1|||
160493571|NCT00487825|579537389|FG000|Overall Study|Adverse Event|2|||
160493572|NCT00487825|579537390|FG001|Overall Study|Adverse Event|2|||
160493573|NCT00487825|579537389|FG000|Overall Study|Lack of Efficacy|1|||
160493574|NCT00487825|579537390|FG001|Overall Study|Lack of Efficacy|1|||
160493575|NCT00487825|579537389|FG000|Overall Study|Other|3|||
160493576|NCT00487825|579537390|FG001|Overall Study|Other|2|||
160493577|NCT01256671|579537391|FG000|Overall Study|Adverse Event|29|||
160493578|NCT01256671|579537391|FG000|Overall Study|Lost to Follow-up|16|||
160493579|NCT01256671|579537391|FG000|Overall Study|Withdrawal by Subject|31|||
160493580|NCT01256671|579537391|FG000|Overall Study|Physician Decision|3|||
160493581|NCT01256671|579537391|FG000|Overall Study|Lack of Efficacy|4|||
160493582|NCT01256671|579537391|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
160493583|NCT01986114|579537392|FG000|Overall Study|Adverse Event|59|||
160493584|NCT01986114|579537392|FG000|Overall Study|Lack of Efficacy|23|||
160493585|NCT01986114|579537392|FG000|Overall Study|Withdrawal by Subject|58|||
160493586|NCT01986114|579537392|FG000|Overall Study|Noncompliance|3|||
160493587|NCT01986114|579537392|FG000|Overall Study|Protocol Violation|1|||
160493588|NCT01986114|579537392|FG000|Overall Study|Lost to Follow-up|5|||
160493589|NCT01986114|579537392|FG000|Overall Study|Other reason|7|||
160493590|NCT04795336|579537395|FG000|Overall Study|Withdrawal by Subject|3|||
160493591|NCT04795336|579537396|FG001|Overall Study|Withdrawal by Subject|4|||
160493592|NCT04795336|579537397|FG002|Overall Study|Withdrawal by Subject|3|||
160493593|NCT04795336|579537398|FG003|Overall Study|Withdrawal by Subject|12|||
160493594|NCT04795336|579537395|FG000|Overall Study|Lost study logs|0|||
160493595|NCT04795336|579537396|FG001|Overall Study|Lost study logs|1|||
160493596|NCT04795336|579537397|FG002|Overall Study|Lost study logs|0|||
160493597|NCT04795336|579537398|FG003|Overall Study|Lost study logs|2|||
160493598|NCT04795336|579537395|FG000|Overall Study|Did not take study medication|2|||
160493599|NCT04795336|579537396|FG001|Overall Study|Did not take study medication|0|||
160493600|NCT04795336|579537397|FG002|Overall Study|Did not take study medication|0|||
160493601|NCT04795336|579537398|FG003|Overall Study|Did not take study medication|0|||
160493602|NCT01638390|579537399|FG000|Overall Study|screening failures|21|||
160493603|NCT01536587|579537402|FG000|Overall Study|Adverse Event|2|||
160493604|NCT04836559|579537403|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
160493605|NCT04836559|579537404|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
160493606|NCT04836559|579537405|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
160493607|NCT04836559|579537406|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
160493608|NCT04836559|579537407|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
160493609|NCT04836559|579537408|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
160493610|NCT04836559|579537409|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
160493611|NCT04836559|579537410|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
160493612|NCT04836559|579537403|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
160493613|NCT04836559|579537404|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
160493614|NCT04836559|579537405|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
160493615|NCT04836559|579537406|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
160612371|NCT02972658|579959464|FG002|Overall Study|Other-determined by Investigator|0|||
160612372|NCT02972658|579959465|FG003|Overall Study|Other-determined by Investigator|0|||
160612373|NCT02972658|579959462|FG000|Overall Study|Death|0|||
160612374|NCT02972658|579959463|FG001|Overall Study|Death|0|||
160493616|NCT04836559|579537407|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
160493617|NCT04836559|579537408|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
160493618|NCT04836559|579537409|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
160493619|NCT04836559|579537410|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
160493620|NCT04836559|579537403|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
160493621|NCT04836559|579537404|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
160493622|NCT04836559|579537405|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
160493623|NCT04836559|579537406|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
160493624|NCT04836559|579537407|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
160493625|NCT04836559|579537408|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
160493626|NCT04836559|579537409|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
160493627|NCT04836559|579537410|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
160493628|NCT04836559|579537403|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
160493629|NCT04836559|579537404|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
160493630|NCT04836559|579537405|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
160493631|NCT04836559|579537406|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
160493632|NCT04836559|579537407|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
160493633|NCT04836559|579537408|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
160661444|NCT02587962|580144107|FG004|Overall Study|Adverse Event|0|||
160661445|NCT02587962|580144103|FG000|Overall Study|Withdrawal by Subject|0|||
160661446|NCT02587962|580144104|FG001|Overall Study|Withdrawal by Subject|0|||
160661447|NCT02587962|580144105|FG002|Overall Study|Withdrawal by Subject|1|||
160661448|NCT02587962|580144106|FG003|Overall Study|Withdrawal by Subject|1|||
160661449|NCT02587962|580144107|FG004|Overall Study|Withdrawal by Subject|4|||
160661450|NCT02587962|580144103|FG000|Overall Study|Radiological progression|2|||
160661451|NCT02587962|580144104|FG001|Overall Study|Radiological progression|2|||
160661452|NCT02587962|580144105|FG002|Overall Study|Radiological progression|2|||
160661453|NCT02587962|580144106|FG003|Overall Study|Radiological progression|5|||
160661454|NCT02587962|580144107|FG004|Overall Study|Radiological progression|10|||
160661455|NCT02587962|580144103|FG000|Overall Study|Clinical progression|0|||
160661456|NCT02587962|580144104|FG001|Overall Study|Clinical progression|1|||
160661457|NCT02587962|580144105|FG002|Overall Study|Clinical progression|2|||
160661458|NCT02587962|580144106|FG003|Overall Study|Clinical progression|0|||
160661459|NCT02587962|580144107|FG004|Overall Study|Clinical progression|1|||
160661460|NCT00184600|580144108|FG000|Overall Study|Adverse Event|9|||
160661461|NCT00184600|580144109|FG001|Overall Study|Adverse Event|0|||
160661462|NCT00184600|580144110|FG002|Overall Study|Adverse Event|5|||
160661463|NCT00184600|580144108|FG000|Overall Study|Death|3|||
160661464|NCT00184600|580144109|FG001|Overall Study|Death|9|||
160661465|NCT00184600|580144110|FG002|Overall Study|Death|7|||
160661466|NCT00184600|580144108|FG000|Overall Study|Lack of Efficacy|3|||
160661467|NCT00184600|580144109|FG001|Overall Study|Lack of Efficacy|1|||
160661468|NCT00184600|580144110|FG002|Overall Study|Lack of Efficacy|3|||
160661469|NCT00184600|580144108|FG000|Overall Study|Lost to Follow-up|4|||
160612375|NCT02972658|579959464|FG002|Overall Study|Death|0|||
160612376|NCT02972658|579959465|FG003|Overall Study|Death|1|||
160612377|NCT02972658|579959462|FG000|Overall Study|Lost to Follow-up|0|||
160612378|NCT02972658|579959463|FG001|Overall Study|Lost to Follow-up|1|||
160612379|NCT02972658|579959464|FG002|Overall Study|Lost to Follow-up|1|||
160612380|NCT02972658|579959465|FG003|Overall Study|Lost to Follow-up|2|||
160612381|NCT02972658|579959462|FG000|Overall Study|Progressive Disease|0|||
160612382|NCT02972658|579959463|FG001|Overall Study|Progressive Disease|1|||
160612383|NCT02972658|579959464|FG002|Overall Study|Progressive Disease|0|||
160612384|NCT02972658|579959465|FG003|Overall Study|Progressive Disease|1|||
160612385|NCT02972658|579959462|FG000|Overall Study|Withdrawal by Subject|4|||
160612386|NCT02972658|579959463|FG001|Overall Study|Withdrawal by Subject|4|||
160612387|NCT02972658|579959464|FG002|Overall Study|Withdrawal by Subject|1|||
160612388|NCT02972658|579959465|FG003|Overall Study|Withdrawal by Subject|6|||
160612389|NCT02972658|579959462|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
160612390|NCT02972658|579959463|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
160612391|NCT02972658|579959464|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
160612392|NCT02972658|579959465|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
160612393|NCT02972658|579959462|FG000|Overall Study|Sponsor Decision|70|||
160612394|NCT02972658|579959463|FG001|Overall Study|Sponsor Decision|127|||
160612395|NCT02972658|579959464|FG002|Overall Study|Sponsor Decision|72|||
160612396|NCT02972658|579959465|FG003|Overall Study|Sponsor Decision|119|||
160612397|NCT03958149|579959470|FG000|Overall Study|Withdrawal by Subject|0|||
160612398|NCT03958149|579959471|FG001|Overall Study|Withdrawal by Subject|1|||
160612399|NCT02785588|579959474|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
160612400|NCT02785588|579959474|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
160612401|NCT03037489|579959475|FG000|Overall Study|Adverse Event|4|||
160612402|NCT03037489|579959476|FG001|Overall Study|Adverse Event|0|||
160612403|NCT03037489|579959475|FG000|Overall Study|Withdrawal by Subject|3|||
160612404|NCT03037489|579959476|FG001|Overall Study|Withdrawal by Subject|0|||
160612405|NCT00669240|579959478|FG000|Overall Study|Lack of Efficacy|33|||
160612406|NCT00669240|579959478|FG000|Overall Study|Withdrawal by Subject|42|||
160612407|NCT00669240|579959478|FG000|Overall Study|Lost to Follow-up|34|||
160612408|NCT00669240|579959478|FG000|Overall Study|Adverse Event|21|||
160612409|NCT00669240|579959478|FG000|Overall Study|Other|19|||
160612410|NCT00669240|579959478|FG000|Overall Study|Enrolled but not treated|15|||
160661470|NCT00184600|580144109|FG001|Overall Study|Lost to Follow-up|6|||
160612411|NCT00669240|579959478|FG000|Overall Study|Enrolled but no dosing record|1|||
160661471|NCT00184600|580144110|FG002|Overall Study|Lost to Follow-up|1|||
160661472|NCT00184600|580144108|FG000|Overall Study|Protocol Violation|2|||
160661473|NCT00184600|580144109|FG001|Overall Study|Protocol Violation|2|||
160612412|NCT00364611|579959481|FG000|Overall Study|Did not receive study medication|0|||
160612413|NCT00364611|579959482|FG001|Overall Study|Did not receive study medication|1|||
160612414|NCT00364611|579959481|FG000|Overall Study|Adverse Event|7|||
160612415|NCT00364611|579959482|FG001|Overall Study|Adverse Event|4|||
160612416|NCT00364611|579959481|FG000|Overall Study|Participant's Request|3|||
160612417|NCT00364611|579959482|FG001|Overall Study|Participant's Request|4|||
160661474|NCT00184600|580144110|FG002|Overall Study|Protocol Violation|3|||
160661475|NCT00184600|580144108|FG000|Overall Study|Withdrawal by Subject|20|||
160661476|NCT00184600|580144109|FG001|Overall Study|Withdrawal by Subject|28|||
160661477|NCT00184600|580144110|FG002|Overall Study|Withdrawal by Subject|12|||
160661478|NCT00184600|580144108|FG000|Overall Study|Unclassified|4|||
160661479|NCT00184600|580144109|FG001|Overall Study|Unclassified|5|||
160661480|NCT00184600|580144110|FG002|Overall Study|Unclassified|3|||
160661481|NCT00624065|580144113|FG000|Overall Study|Adverse Event|5|||
160493634|NCT04836559|579537409|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
160493635|NCT04836559|579537410|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
160493636|NCT04836559|579537403|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
160493637|NCT04836559|579537404|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
160493638|NCT04836559|579537405|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
160493639|NCT04836559|579537406|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
160493640|NCT04836559|579537407|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
160493641|NCT04836559|579537408|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
160493642|NCT04836559|579537409|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
160493643|NCT04836559|579537410|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
160493644|NCT04836559|579537403|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
160493645|NCT04836559|579537404|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
160493646|NCT04836559|579537405|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
160493647|NCT04836559|579537406|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
160493648|NCT04836559|579537407|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
160493649|NCT04836559|579537408|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
160493650|NCT04836559|579537409|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
160493651|NCT04836559|579537410|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
160493652|NCT04836559|579537403|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
160493653|NCT04836559|579537404|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
160493654|NCT04836559|579537405|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
160493655|NCT04836559|579537406|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
160493656|NCT04836559|579537407|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
160493657|NCT04836559|579537408|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
160493658|NCT04836559|579537409|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
160493659|NCT04836559|579537410|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
160493660|NCT04836559|579537403|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
160493661|NCT04836559|579537404|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
160493662|NCT04836559|579537405|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
160493663|NCT04836559|579537406|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
160493664|NCT04836559|579537407|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
160493665|NCT04836559|579537408|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
160493666|NCT04836559|579537409|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
160493667|NCT04836559|579537410|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
160493668|NCT04836559|579537403|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
160493669|NCT04836559|579537404|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
160493670|NCT04836559|579537405|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
160493671|NCT04836559|579537406|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
160493672|NCT04836559|579537407|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
160493673|NCT04836559|579537408|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
160493674|NCT04836559|579537409|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
160493675|NCT04836559|579537410|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
160493676|NCT04978350|579537411|FG000|Overall Study|Lost to Follow-up|6|||
160493677|NCT03865953|579537426|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
160493678|NCT03865953|579537427|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
160493679|NCT03865953|579537426|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
160493680|NCT03865953|579537427|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
160493681|NCT03865953|579537426|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
160493682|NCT03865953|579537427|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
160493683|NCT00412880|579537428|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
160493684|NCT00412880|579537428|FG000|Overall Study|Consent withdrawn|1|||
160493685|NCT00412880|579537428|FG000|Overall Study|Adverse Event|1|||
160493686|NCT00412880|579537428|FG000|Overall Study|Progressive disease|20|||
160493687|NCT02232399|579537429|FG000|Overall Study|Adverse Event|1|||
160493688|NCT02232399|579537430|FG001|Overall Study|Adverse Event|0|||
160493689|NCT02232399|579537429|FG000|Overall Study|Withdrawal by Subject|0|||
160493690|NCT02232399|579537430|FG001|Overall Study|Withdrawal by Subject|1|||
160493691|NCT01162135|579537438|FG000|Overall Study|Withdrawal by Subject|1|||
160661482|NCT00624065|580144114|FG001|Overall Study|Adverse Event|6|||
160661483|NCT00624065|580144113|FG000|Overall Study|Lost to Follow-up|4|||
160661484|NCT00624065|580144114|FG001|Overall Study|Lost to Follow-up|1|||
160612418|NCT00364611|579959481|FG000|Overall Study|Disease Progression|38|||
160612419|NCT00364611|579959482|FG001|Overall Study|Disease Progression|8|||
160612420|NCT00364611|579959481|FG000|Overall Study|Investigator decision|2|||
160612421|NCT00364611|579959482|FG001|Overall Study|Investigator decision|2|||
160612422|NCT00364611|579959481|FG000|Overall Study|Found Ineligible|1|||
160612423|NCT00364611|579959482|FG001|Overall Study|Found Ineligible|0|||
160612424|NCT00364611|579959481|FG000|Overall Study|Presumed CR on Study|0|||
160612425|NCT00364611|579959482|FG001|Overall Study|Presumed CR on Study|1|||
160612426|NCT00364611|579959481|FG000|Overall Study|Receiving Liver Ablation|0|||
160612427|NCT00364611|579959482|FG001|Overall Study|Receiving Liver Ablation|1|||
160612428|NCT00087594|579959512|FG000|Overall Study|Adverse Event|2|||
160612429|NCT00087594|579959513|FG001|Overall Study|Adverse Event|3|||
160612430|NCT00087594|579959512|FG000|Overall Study|Lost to Follow-up|0|||
160612431|NCT00087594|579959513|FG001|Overall Study|Lost to Follow-up|2|||
160612432|NCT00087594|579959512|FG000|Overall Study|Withdrawal by Subject|4|||
160612433|NCT00087594|579959513|FG001|Overall Study|Withdrawal by Subject|2|||
160493692|NCT01162135|579537438|FG000|Overall Study|Severe back pain|1|||
160493693|NCT01162135|579537438|FG000|Overall Study|Ineligible|1|||
160493694|NCT01777334|579537439|FG000|Overall Study|Adverse Event|18|||
160493695|NCT01777334|579537440|FG001|Overall Study|Adverse Event|14|||
160493696|NCT01777334|579537439|FG000|Overall Study|Lack of Efficacy|15|||
160493697|NCT01777334|579537440|FG001|Overall Study|Lack of Efficacy|29|||
160493698|NCT01777334|579537439|FG000|Overall Study|Protocol Violation|3|||
160493699|NCT01777334|579537440|FG001|Overall Study|Protocol Violation|7|||
160493700|NCT01777334|579537439|FG000|Overall Study|Lost to Follow-up|3|||
160493701|NCT01777334|579537440|FG001|Overall Study|Lost to Follow-up|2|||
160493702|NCT01777334|579537439|FG000|Overall Study|Withdrawal by Subject|14|||
160493703|NCT01777334|579537440|FG001|Overall Study|Withdrawal by Subject|11|||
160493704|NCT01216072|579537448|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
160493705|NCT01216072|579537449|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
160493706|NCT01216072|579537448|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
160493707|NCT01216072|579537449|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
160493708|NCT01216072|579537448|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
160493709|NCT01216072|579537449|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
160493710|NCT01216072|579537448|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
160493711|NCT01216072|579537449|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
160493712|NCT01216072|579537448|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
160493713|NCT01216072|579537449|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
160493714|NCT01216072|579537448|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
160493715|NCT01216072|579537449|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
160493716|NCT01216072|579537448|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
160493717|NCT01216072|579537449|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
160493718|NCT01216072|579537448|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
160493719|NCT01216072|579537449|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
160493720|NCT01216072|579537448|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
160493721|NCT01216072|579537449|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
160493722|NCT01216072|579537448|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
160493723|NCT01216072|579537449|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
160493724|NCT04799418|579537453|FG000|Overall Study|Death|1|||
160493725|NCT04799418|579537454|FG001|Overall Study|Death|1|||
160493726|NCT04799418|579537453|FG000|Overall Study|Lack of Efficacy|14|||
160493727|NCT04799418|579537454|FG001|Overall Study|Lack of Efficacy|14|||
160493728|NCT04799418|579537453|FG000|Overall Study|Withdrawal by Subject|10|||
160493729|NCT04799418|579537454|FG001|Overall Study|Withdrawal by Subject|7|||
160493730|NCT04799418|579537453|FG000|Overall Study|Adverse Event|3|||
160493731|NCT04799418|579537454|FG001|Overall Study|Adverse Event|2|||
160493732|NCT00107978|579537457|FG000|Overall Study|Adverse Event|1|||
160493733|NCT00107978|579537458|FG001|Overall Study|Adverse Event|5|||
160493734|NCT00107978|579537457|FG000|Overall Study|Death|3|||
160493735|NCT00107978|579537458|FG001|Overall Study|Death|3|||
160612434|NCT00087594|579959512|FG000|Overall Study|Lack of Efficacy|2|||
160493736|NCT00107978|579537457|FG000|Overall Study|Lost to Follow-up|20|||
160612435|NCT00087594|579959513|FG001|Overall Study|Lack of Efficacy|5|||
160493737|NCT00107978|579537458|FG001|Overall Study|Lost to Follow-up|28|||
160493738|NCT00107978|579537457|FG000|Overall Study|Withdrawal by Subject|4|||
160612436|NCT00290355|579959518|FG000|Overall Study|Serious adverse event|7|||
160612437|NCT00290355|579959519|FG001|Overall Study|Serious adverse event|4|||
160612438|NCT00290355|579959518|FG000|Overall Study|Study product reactogenicity|1|||
160612439|NCT00290355|579959519|FG001|Overall Study|Study product reactogenicity|0|||
160493739|NCT00107978|579537458|FG001|Overall Study|Withdrawal by Subject|9|||
160493740|NCT00107978|579537457|FG000|Overall Study|Protocol Violation|0|||
160493741|NCT00107978|579537458|FG001|Overall Study|Protocol Violation|1|||
160612440|NCT00290355|579959518|FG000|Overall Study|Protocol Violation|1|||
160612441|NCT00290355|579959519|FG001|Overall Study|Protocol Violation|0|||
160493742|NCT00107978|579537457|FG000|Overall Study|Other|5|||
160493743|NCT00107978|579537458|FG001|Overall Study|Other|4|||
160493744|NCT02669407|579537459|FG000|Overall Study|Physician Decision|3|||
160493745|NCT03634839|579537461|FG000|First Intervention (2 Hours)|Adverse Event|0|||
160493746|NCT03634839|579537462|FG001|First Intervention (2 Hours)|Adverse Event|2|||
160493747|NCT00350298|579537463|FG000|Overall Study|Death|7|||
160493748|NCT00350298|579537464|FG001|Overall Study|Death|8|||
160493749|NCT00350298|579537463|FG000|Overall Study|Lost to Follow-up|1|||
160493750|NCT00350298|579537464|FG001|Overall Study|Lost to Follow-up|2|||
160493751|NCT00350298|579537463|FG000|Overall Study|Withdrawal by Subject|1|||
160493752|NCT00350298|579537464|FG001|Overall Study|Withdrawal by Subject|3|||
160493753|NCT00822770|579537467|FG000|Overall Study|Not treated|1|||
160493754|NCT00822770|579537468|FG001|Overall Study|Not treated|0|||
160493755|NCT00822770|579537467|FG000|Overall Study|Complication/Incomplete treatment|1|||
160493756|NCT00822770|579537468|FG001|Overall Study|Complication/Incomplete treatment|0|||
160493757|NCT00822770|579537467|FG000|Overall Study|Death|1|||
160493758|NCT00822770|579537468|FG001|Overall Study|Death|1|||
160493759|NCT00992992|579537469|FG000|Overall Study|Lost to Follow-up|3|||
160493760|NCT00992992|579537469|FG000|Overall Study|Death|16|||
160493761|NCT00992992|579537469|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
160493762|NCT00992992|579537469|FG000|Overall Study|Sponsor Closed the Study|4|||
160493763|NCT00217022|579537471|FG000|Overall Study|Withdrawal by Subject|1|||
160493764|NCT00217022|579537472|FG001|Overall Study|Withdrawal by Subject|1|||
160493765|NCT05178979|579537473|FG000|Overall Study|Death|0|||
160493766|NCT05178979|579537474|FG001|Overall Study|Death|5|||
160493767|NCT05178979|579537475|FG002|Overall Study|Death|0|||
160493768|NCT05178979|579537476|FG003|Overall Study|Death|3|||
160493769|NCT05178979|579537473|FG000|Overall Study|Adverse Event|0|||
160493770|NCT05178979|579537474|FG001|Overall Study|Adverse Event|1|||
160493771|NCT05178979|579537475|FG002|Overall Study|Adverse Event|0|||
160493772|NCT05178979|579537476|FG003|Overall Study|Adverse Event|0|||
160493773|NCT05178979|579537473|FG000|Overall Study|Lost to Follow-up|1|||
160493774|NCT05178979|579537474|FG001|Overall Study|Lost to Follow-up|8|||
160493775|NCT05178979|579537475|FG002|Overall Study|Lost to Follow-up|3|||
160493776|NCT05178979|579537476|FG003|Overall Study|Lost to Follow-up|8|||
160493777|NCT01253447|579537477|FG000|Overall Study|Adverse Event|2|||
160493778|NCT00817336|579537478|FG000|Overall Study|Withdrawal by Subject|1|||
160493779|NCT00817336|579537479|FG001|Overall Study|Withdrawal by Subject|1|||
160493780|NCT02299427|579537480|FG000|Overall Study|Withdrawal by Subject|1|||
160493781|NCT02299427|579537481|FG001|Overall Study|Withdrawal by Subject|0|||
160493782|NCT02299427|579537480|FG000|Overall Study|Lost to Follow-up|1|||
160493783|NCT02299427|579537481|FG001|Overall Study|Lost to Follow-up|3|||
160493784|NCT02299427|579537480|FG000|Overall Study|not adherent to dog website use|21|||
160493785|NCT02299427|579537481|FG001|Overall Study|not adherent to dog website use|0|||
160493786|NCT02108652|579537482|FG000|Overall Study|Death|253|||
160493787|NCT02108652|579537482|FG000|Overall Study|Lost to Follow-up|2|||
160493788|NCT02108652|579537482|FG000|Overall Study|Withdrawal by Subject|16|||
160493789|NCT02108652|579537482|FG000|Overall Study|Study Terminated By Sponsor|31|||
160493790|NCT02108652|579537482|FG000|Overall Study|Non-Compliance|1|||
160493791|NCT02108652|579537482|FG000|Overall Study|Physician Decision|6|||
160493792|NCT02108652|579537482|FG000|Overall Study|Progression Of Disease|1|||
160493793|NCT01704547|579537483|FG000|Overall Study|Physician Decision|4|||
160493794|NCT01704547|579537483|FG000|Overall Study|Withdrawal by Subject|1|||
160493795|NCT02564718|579537484|FG000|Overall Study|Withdrew from treatment|0|||
160493796|NCT02564718|579537485|FG001|Overall Study|Withdrew from treatment|1|||
160493797|NCT00104637|579537486|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
160493798|NCT00104637|579537487|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
160493799|NCT00409409|579537488|FG000|Overall Study|Adverse Event|7|||
160493800|NCT00409409|579537489|FG001|Overall Study|Adverse Event|2|||
160493801|NCT00409409|579537488|FG000|Overall Study|Withdrawal by Subject|1|||
160493802|NCT00409409|579537489|FG001|Overall Study|Withdrawal by Subject|1|||
160493803|NCT00409409|579537488|FG000|Overall Study|Any other reason not above-mentioned|0|||
160493804|NCT00409409|579537489|FG001|Overall Study|Any other reason not above-mentioned|1|||
160493805|NCT02138253|579537493|FG000|Overall Study|Adverse Event|3|||
160493806|NCT02138253|579537494|FG001|Overall Study|Adverse Event|3|||
160493807|NCT02138253|579537493|FG000|Overall Study|Lost to Follow-up|2|||
160661485|NCT00624065|580144113|FG000|Overall Study|Consent withdrawn|6|||
160493808|NCT02138253|579537494|FG001|Overall Study|Lost to Follow-up|1|||
160493809|NCT02138253|579537493|FG000|Overall Study|Physician Decision|2|||
160493810|NCT02138253|579537494|FG001|Overall Study|Physician Decision|0|||
160493811|NCT02138253|579537493|FG000|Overall Study|Non compliance|1|||
160493812|NCT02138253|579537494|FG001|Overall Study|Non compliance|0|||
160493813|NCT02138253|579537493|FG000|Overall Study|Withdrawal by Subject|1|||
160493814|NCT02138253|579537494|FG001|Overall Study|Withdrawal by Subject|0|||
160493815|NCT01918371|579537495|FG000|Overall Study|Missing Data|1|||
160493816|NCT01918371|579537496|FG001|Overall Study|Missing Data|1|||
160493817|NCT04706793|579537497|FG000|Treatment|Disease worsening|10|||
160493818|NCT04706793|579537498|FG001|Treatment|Disease worsening|10|||
160493819|NCT04706793|579537497|FG000|Follow-up|Lack of Efficacy|1|||
160612442|NCT00290355|579959518|FG000|Overall Study|Withdrawal by Subject|2|||
160612443|NCT00290355|579959519|FG001|Overall Study|Withdrawal by Subject|0|||
160612444|NCT00290355|579959518|FG000|Overall Study|Migrated / moved from the study area|1|||
160612445|NCT00290355|579959519|FG001|Overall Study|Migrated / moved from the study area|0|||
160612446|NCT00290355|579959518|FG000|Overall Study|Lost to Follow-up|3|||
160612447|NCT00290355|579959519|FG001|Overall Study|Lost to Follow-up|1|||
160612448|NCT00290355|579959518|FG000|Overall Study|Other|2|||
160612449|NCT00290355|579959519|FG001|Overall Study|Other|0|||
160612450|NCT02773849|579959520|FG000|Overall Study|Lost to Follow-up|11|||
160612451|NCT02773849|579959520|FG000|Overall Study|Death|26|||
160612452|NCT02773849|579959520|FG000|Overall Study|Withdrawal by Subject|5|||
160612453|NCT02773849|579959520|FG000|Overall Study|Withdrawal of Consent|9|||
160612454|NCT02773849|579959520|FG000|Overall Study|Other: not due to lack of tolerability|11|||
160612455|NCT00723489|579959521|FG000|Overall Study|Physician Decision|0|||
160612456|NCT00723489|579959522|FG001|Overall Study|Physician Decision|1|||
160612457|NCT00723489|579959523|FG002|Overall Study|Physician Decision|0|||
160612458|NCT00723489|579959524|FG003|Overall Study|Physician Decision|0|||
160612459|NCT00723489|579959521|FG000|Overall Study|Pregnancy|0|||
160612460|NCT00723489|579959522|FG001|Overall Study|Pregnancy|0|||
160612461|NCT00723489|579959523|FG002|Overall Study|Pregnancy|0|||
160612462|NCT00723489|579959524|FG003|Overall Study|Pregnancy|1|||
160612463|NCT00723489|579959521|FG000|Overall Study|Withdrawal by Subject|0|||
160612464|NCT00723489|579959522|FG001|Overall Study|Withdrawal by Subject|0|||
160612465|NCT00723489|579959523|FG002|Overall Study|Withdrawal by Subject|0|||
160612466|NCT00723489|579959524|FG003|Overall Study|Withdrawal by Subject|1|||
160612467|NCT00723489|579959521|FG000|Overall Study|Seropositive at baseline|1|||
160612468|NCT00723489|579959522|FG001|Overall Study|Seropositive at baseline|0|||
160612469|NCT00723489|579959523|FG002|Overall Study|Seropositive at baseline|0|||
160612470|NCT00723489|579959524|FG003|Overall Study|Seropositive at baseline|0|||
160612471|NCT00723489|579959521|FG000|Overall Study|Prohibited Medication|0|||
160612472|NCT00723489|579959522|FG001|Overall Study|Prohibited Medication|0|||
160612473|NCT00723489|579959523|FG002|Overall Study|Prohibited Medication|0|||
160612474|NCT00723489|579959524|FG003|Overall Study|Prohibited Medication|1|||
160612475|NCT00723489|579959521|FG000|Overall Study|Samples Collected Out of Window|0|||
160612476|NCT00723489|579959522|FG001|Overall Study|Samples Collected Out of Window|3|||
160612477|NCT00723489|579959523|FG002|Overall Study|Samples Collected Out of Window|0|||
160612478|NCT00723489|579959524|FG003|Overall Study|Samples Collected Out of Window|0|||
160612479|NCT02274311|579959531|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
160612480|NCT00508001|579959532|FG000|Overall Study|Adverse Event|2|||
160612481|NCT00508001|579959533|FG001|Overall Study|Adverse Event|0|||
160612482|NCT00508001|579959534|FG002|Overall Study|Adverse Event|4|||
160612483|NCT00508001|579959532|FG000|Overall Study|condition under investigation worsened|13|||
160612484|NCT00508001|579959533|FG001|Overall Study|condition under investigation worsened|7|||
160612485|NCT00508001|579959534|FG002|Overall Study|condition under investigation worsened|1|||
160612486|NCT00508001|579959532|FG000|Overall Study|Death|0|||
160612487|NCT00508001|579959533|FG001|Overall Study|Death|1|||
160612488|NCT00508001|579959534|FG002|Overall Study|Death|1|||
160612489|NCT00508001|579959532|FG000|Overall Study|Withdrawal by Subject|4|||
160612490|NCT00508001|579959533|FG001|Overall Study|Withdrawal by Subject|4|||
160612491|NCT00508001|579959534|FG002|Overall Study|Withdrawal by Subject|1|||
160612492|NCT01599585|579959535|FG000|Overall Study|Withdrawal by Subject|16|||
160612493|NCT01599585|579959536|FG001|Overall Study|Withdrawal by Subject|9|||
160612494|NCT01599585|579959535|FG000|Overall Study|Lost to Follow-up|3|||
160612495|NCT01599585|579959536|FG001|Overall Study|Lost to Follow-up|5|||
160612496|NCT01599585|579959535|FG000|Overall Study|randomized did not start treatment|3|||
160612497|NCT01599585|579959536|FG001|Overall Study|randomized did not start treatment|3|||
160612498|NCT03657576|579959537|FG000|Overall Study|Death|0|||
160612499|NCT03657576|579959538|FG001|Overall Study|Death|1|||
160612500|NCT03657576|579959539|FG002|Overall Study|Death|1|||
160612501|NCT03657576|579959540|FG003|Overall Study|Death|0|||
160612502|NCT03657576|579959541|FG004|Overall Study|Death|0|||
160612503|NCT03657576|579959542|FG005|Overall Study|Death|0|||
160612504|NCT03657576|579959537|FG000|Overall Study|Withdrawal by Subject|0|||
160612505|NCT03657576|579959538|FG001|Overall Study|Withdrawal by Subject|0|||
160612506|NCT03657576|579959539|FG002|Overall Study|Withdrawal by Subject|0|||
160612507|NCT03657576|579959540|FG003|Overall Study|Withdrawal by Subject|1|||
160612508|NCT03657576|579959541|FG004|Overall Study|Withdrawal by Subject|0|||
160612509|NCT03657576|579959542|FG005|Overall Study|Withdrawal by Subject|0|||
160612510|NCT03657576|579959537|FG000|Overall Study|Screen Fail|0|||
160612511|NCT03657576|579959538|FG001|Overall Study|Screen Fail|0|||
160612512|NCT03657576|579959539|FG002|Overall Study|Screen Fail|0|||
160612513|NCT03657576|579959540|FG003|Overall Study|Screen Fail|0|||
160612514|NCT03657576|579959541|FG004|Overall Study|Screen Fail|0|||
160612515|NCT03657576|579959542|FG005|Overall Study|Screen Fail|5|||
160612516|NCT03657576|579959537|FG000|Overall Study|Disease Progression|1|||
160612517|NCT03657576|579959538|FG001|Overall Study|Disease Progression|1|||
160612518|NCT03657576|579959539|FG002|Overall Study|Disease Progression|0|||
160612519|NCT03657576|579959540|FG003|Overall Study|Disease Progression|5|||
160493820|NCT04706793|579537498|FG001|Follow-up|Lack of Efficacy|0|||
160493821|NCT04706793|579537497|FG000|Follow-up|Disease worsening|8|||
160493822|NCT04706793|579537498|FG001|Follow-up|Disease worsening|10|||
160493823|NCT04706793|579537497|FG000|Follow-up|Adverse Event|1|||
160493824|NCT04706793|579537498|FG001|Follow-up|Adverse Event|0|||
160493825|NCT00823836|579537501|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
160493826|NCT00823836|579537502|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
160493827|NCT00823836|579537501|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
160493828|NCT00823836|579537502|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
160493829|NCT00823836|579537501|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
160493830|NCT00823836|579537502|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
160493831|NCT00823836|579537501|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
160493832|NCT00823836|579537502|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
160493833|NCT00823836|579537501|FG000|Long-term Phase|Adverse Event|3|||
160493834|NCT00823836|579537502|FG001|Long-term Phase|Adverse Event|2|||
160493835|NCT00823836|579537501|FG000|Long-term Phase|Physician Decision|1|||
160493836|NCT00823836|579537502|FG001|Long-term Phase|Physician Decision|2|||
160493837|NCT00823836|579537501|FG000|Long-term Phase|Withdrawal by Subject|1|||
160493838|NCT00823836|579537502|FG001|Long-term Phase|Withdrawal by Subject|1|||
160493839|NCT01130168|579537503|FG000|Period 1|Withdrawal by Subject|0|||
160493840|NCT01130168|579537504|FG001|Period 1|Withdrawal by Subject|1|||
160493841|NCT01130168|579537505|FG002|Period 1|Withdrawal by Subject|0|||
160493842|NCT01130168|579537506|FG003|Period 1|Withdrawal by Subject|1|||
160493843|NCT01130168|579537507|FG004|Period 1|Withdrawal by Subject|0|||
160493844|NCT01130168|579537508|FG005|Period 1|Withdrawal by Subject|0|||
160493845|NCT01130168|579537503|FG000|Period 1|Discontinued For Other Reason|0|||
160493846|NCT01130168|579537504|FG001|Period 1|Discontinued For Other Reason|0|||
160493847|NCT01130168|579537505|FG002|Period 1|Discontinued For Other Reason|1|||
160493848|NCT01130168|579537506|FG003|Period 1|Discontinued For Other Reason|1|||
160493849|NCT01130168|579537507|FG004|Period 1|Discontinued For Other Reason|0|||
160493850|NCT01130168|579537508|FG005|Period 1|Discontinued For Other Reason|0|||
160493851|NCT01130168|579537503|FG000|Period 1|Adverse Event|0|||
160493852|NCT01130168|579537504|FG001|Period 1|Adverse Event|0|||
160493853|NCT01130168|579537505|FG002|Period 1|Adverse Event|0|||
160493854|NCT01130168|579537506|FG003|Period 1|Adverse Event|1|||
160493855|NCT01130168|579537507|FG004|Period 1|Adverse Event|0|||
160493856|NCT01130168|579537508|FG005|Period 1|Adverse Event|0|||
160493857|NCT02725528|579537509|FG000|Overall Study|Lost to Follow-up|1|||
160493858|NCT02725528|579537510|FG001|Overall Study|Lost to Follow-up|4|||
160493859|NCT02725528|579537509|FG000|Overall Study|Withdrawal by Subject|0|||
160493860|NCT02725528|579537510|FG001|Overall Study|Withdrawal by Subject|1|||
160493861|NCT02635386|579537511|FG000|Overall Study|Pregnancy|2|||
160493862|NCT02635386|579537512|FG001|Overall Study|Pregnancy|0|||
160493863|NCT02635386|579537513|FG002|Overall Study|Pregnancy|0|||
160493864|NCT02635386|579537514|FG003|Overall Study|Pregnancy|0|||
160493865|NCT02635386|579537515|FG004|Overall Study|Pregnancy|2|||
160493866|NCT02635386|579537511|FG000|Overall Study|Withdrawal by Subject|1|||
160493867|NCT02635386|579537512|FG001|Overall Study|Withdrawal by Subject|1|||
160493868|NCT02635386|579537513|FG002|Overall Study|Withdrawal by Subject|0|||
160493869|NCT02635386|579537514|FG003|Overall Study|Withdrawal by Subject|1|||
160493870|NCT02635386|579537515|FG004|Overall Study|Withdrawal by Subject|0|||
160493871|NCT02635386|579537511|FG000|Overall Study|Physician Decision|0|||
160493872|NCT02635386|579537512|FG001|Overall Study|Physician Decision|1|||
160493873|NCT02635386|579537513|FG002|Overall Study|Physician Decision|0|||
160493874|NCT02635386|579537514|FG003|Overall Study|Physician Decision|0|||
160493875|NCT02635386|579537515|FG004|Overall Study|Physician Decision|0|||
160493876|NCT02635386|579537511|FG000|Overall Study|Moved Out of State|0|||
160493877|NCT02635386|579537512|FG001|Overall Study|Moved Out of State|1|||
160493878|NCT02635386|579537513|FG002|Overall Study|Moved Out of State|0|||
160493879|NCT02635386|579537514|FG003|Overall Study|Moved Out of State|0|||
160493880|NCT02635386|579537515|FG004|Overall Study|Moved Out of State|0|||
160493881|NCT02635386|579537511|FG000|Overall Study|Noncompliant|0|||
160493882|NCT02635386|579537512|FG001|Overall Study|Noncompliant|2|||
160493883|NCT02635386|579537513|FG002|Overall Study|Noncompliant|1|||
160493884|NCT02635386|579537514|FG003|Overall Study|Noncompliant|1|||
160493885|NCT02635386|579537515|FG004|Overall Study|Noncompliant|1|||
160493886|NCT02635386|579537511|FG000|Overall Study|side effects|0|||
160493887|NCT02635386|579537512|FG001|Overall Study|side effects|0|||
160493888|NCT02635386|579537513|FG002|Overall Study|side effects|1|||
160493889|NCT02635386|579537514|FG003|Overall Study|side effects|4|||
160493890|NCT02635386|579537515|FG004|Overall Study|side effects|6|||
160493891|NCT02635386|579537511|FG000|Overall Study|needed other major surgery|0|||
160493892|NCT02635386|579537512|FG001|Overall Study|needed other major surgery|1|||
160493893|NCT02635386|579537513|FG002|Overall Study|needed other major surgery|0|||
160612520|NCT03657576|579959541|FG004|Overall Study|Disease Progression|0|||
160612521|NCT03657576|579959542|FG005|Overall Study|Disease Progression|0|||
160493894|NCT02635386|579537514|FG003|Overall Study|needed other major surgery|0|||
160493895|NCT02635386|579537515|FG004|Overall Study|needed other major surgery|0|||
160493896|NCT02635386|579537511|FG000|Overall Study|Other medical problems not drug related|0|||
160493897|NCT02635386|579537512|FG001|Overall Study|Other medical problems not drug related|0|||
160493898|NCT02635386|579537513|FG002|Overall Study|Other medical problems not drug related|0|||
160493899|NCT02635386|579537514|FG003|Overall Study|Other medical problems not drug related|1|||
160493900|NCT02635386|579537515|FG004|Overall Study|Other medical problems not drug related|0|||
160493901|NCT00745498|579537518|FG000|Overall Study|Lost to Follow-up|1|||
160493902|NCT00745498|579537519|FG001|Overall Study|Lost to Follow-up|1|||
160493903|NCT00745498|579537520|FG002|Overall Study|Lost to Follow-up|3|||
160493904|NCT00745498|579537518|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
160493905|NCT00745498|579537519|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
160493906|NCT00745498|579537520|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
160493907|NCT00745498|579537518|FG000|Overall Study|Non-PDR related VH|0|||
160493908|NCT00745498|579537519|FG001|Overall Study|Non-PDR related VH|1|||
160493909|NCT00745498|579537520|FG002|Overall Study|Non-PDR related VH|1|||
160493910|NCT00745498|579537518|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
160493911|NCT00745498|579537519|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
160493912|NCT00745498|579537520|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
160493913|NCT02706847|579537521|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
160493914|NCT02706847|579537522|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
160493915|NCT02706847|579537523|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
160493916|NCT02706847|579537524|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
160493917|NCT02706847|579537521|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
160493918|NCT02706847|579537522|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
160493919|NCT02706847|579537523|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
160493920|NCT02706847|579537524|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
160493921|NCT02706847|579537521|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
160493922|NCT02706847|579537522|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
160493923|NCT02706847|579537523|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
160493924|NCT02706847|579537524|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
160493925|NCT02706847|579537521|FG000|Period 1: Day 1 to Week 12|Other|4|||
160493926|NCT02706847|579537522|FG001|Period 1: Day 1 to Week 12|Other|4|||
160493927|NCT02706847|579537523|FG002|Period 1: Day 1 to Week 12|Other|2|||
160493928|NCT02706847|579537524|FG003|Period 1: Day 1 to Week 12|Other|2|||
160493929|NCT02706847|579537521|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
160493930|NCT02706847|579537522|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
160493931|NCT02706847|579537523|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
160493932|NCT02706847|579537524|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
160493933|NCT02706847|579537521|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
160493934|NCT02706847|579537522|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
160493935|NCT02706847|579537523|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
160493936|NCT02706847|579537524|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
160493937|NCT02706847|579537521|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
160493938|NCT02706847|579537522|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
160493939|NCT02706847|579537523|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
160493940|NCT02706847|579537524|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
160493941|NCT02706847|579537521|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
160493942|NCT02706847|579537522|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
160493943|NCT02706847|579537523|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
160493944|NCT02706847|579537524|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
160493945|NCT02706847|579537521|FG000|Period 1: Week 12 to Week 24|Other|1|||
160493946|NCT02706847|579537522|FG001|Period 1: Week 12 to Week 24|Other|0|||
160493947|NCT02706847|579537523|FG002|Period 1: Week 12 to Week 24|Other|1|||
160493948|NCT02706847|579537524|FG003|Period 1: Week 12 to Week 24|Other|4|||
160493949|NCT02706847|579537521|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
160493950|NCT02706847|579537522|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
160493951|NCT02706847|579537523|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
160493952|NCT02706847|579537524|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
160493953|NCT02706847|579537521|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
160493954|NCT02706847|579537522|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
160493955|NCT02706847|579537523|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
160493956|NCT02706847|579537524|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
160493957|NCT02706847|579537521|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
160493958|NCT02706847|579537522|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
160493959|NCT02706847|579537523|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
160493960|NCT02706847|579537524|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
160493961|NCT02706847|579537521|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
160612522|NCT03657576|579959537|FG000|Overall Study|Insurance Coverage|0|||
160493962|NCT02706847|579537522|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
160493963|NCT02706847|579537523|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
160493964|NCT02706847|579537524|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
160612523|NCT03657576|579959538|FG001|Overall Study|Insurance Coverage|0|||
160612524|NCT03657576|579959539|FG002|Overall Study|Insurance Coverage|0|||
160493965|NCT02706847|579537521|FG000|Period 2: Week 24 to Week 260|Other|8|||
160493966|NCT02706847|579537522|FG001|Period 2: Week 24 to Week 260|Other|5|||
160493967|NCT02706847|579537523|FG002|Period 2: Week 24 to Week 260|Other|15|||
160493968|NCT02706847|579537524|FG003|Period 2: Week 24 to Week 260|Other|15|||
160493969|NCT02058836|579537525|FG000|Overall Study|Withdrawal by Subject|1|||
160493970|NCT02058836|579537526|FG001|Overall Study|Withdrawal by Subject|1|||
160493971|NCT01774305|579537528|FG000|Overall Study|Physician Decision|1|||
160493972|NCT01774305|579537529|FG001|Overall Study|Physician Decision|0|||
160493973|NCT02168478|579537533|FG000|Overall Study|Withdrawal by Subject|1|||
160493974|NCT02168478|579537533|FG000|Overall Study|Did Not Consent to Participation|2|||
160493975|NCT02168478|579537533|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
160493976|NCT05523219|579537534|FG000|Overall Study|Wrong inclusion|1|||
160493977|NCT05523219|579537534|FG000|Overall Study|Lost to Follow-up|7|||
160493978|NCT02760485|579537535|FG000|Phase 1|Death|3|||
160493979|NCT02760485|579537536|FG001|Phase 1|Death|6|||
160493980|NCT02760485|579537537|FG002|Phase 1|Death|0|||
160493981|NCT02760485|579537535|FG000|Phase 1|Withdrawal by Subject|2|||
160493982|NCT02760485|579537536|FG001|Phase 1|Withdrawal by Subject|0|||
160493983|NCT02760485|579537537|FG002|Phase 1|Withdrawal by Subject|0|||
160493984|NCT02760485|579537535|FG000|Phase 1|Progressive Disease|1|||
160493985|NCT02760485|579537536|FG001|Phase 1|Progressive Disease|0|||
160493986|NCT02760485|579537537|FG002|Phase 1|Progressive Disease|0|||
160493987|NCT02760485|579537535|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
160493988|NCT02760485|579537536|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
160493989|NCT02760485|579537537|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
160493990|NCT02760485|579537535|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
160493991|NCT02760485|579537536|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
160493992|NCT02760485|579537537|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
160493993|NCT02760485|579537535|FG000|Phase 2|Death|0|||
160493994|NCT02760485|579537536|FG001|Phase 2|Death|0|||
160493995|NCT02760485|579537537|FG002|Phase 2|Death|12|||
160493996|NCT02760485|579537535|FG000|Phase 2|Withdrawal by Subject|0|||
160493997|NCT02760485|579537536|FG001|Phase 2|Withdrawal by Subject|0|||
160493998|NCT02760485|579537537|FG002|Phase 2|Withdrawal by Subject|3|||
160493999|NCT02760485|579537535|FG000|Phase 2|Progressive Disease|0|||
160494000|NCT02760485|579537536|FG001|Phase 2|Progressive Disease|0|||
160494001|NCT02760485|579537537|FG002|Phase 2|Progressive Disease|1|||
160494002|NCT02760485|579537535|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
160494003|NCT02760485|579537536|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
160494004|NCT02760485|579537537|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
160494005|NCT01087814|579537538|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
160494006|NCT01087814|579537539|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
160494007|NCT01087814|579537538|FG000|Second Intervention (5 Days)|Physician Decision|1|||
160494008|NCT01087814|579537539|FG001|Second Intervention (5 Days)|Physician Decision|0|||
160494009|NCT01427738|579537540|FG000|Overall Study|Death|12|||
160494010|NCT01427738|579537541|FG001|Overall Study|Death|9|||
160494011|NCT01427738|579537540|FG000|Overall Study|Severe debilitation, unable to continue|0|||
160494012|NCT01427738|579537541|FG001|Overall Study|Severe debilitation, unable to continue|1|||
160494013|NCT01427738|579537540|FG000|Overall Study|Subject unable to get to clinic|5|||
160494014|NCT01427738|579537541|FG001|Overall Study|Subject unable to get to clinic|2|||
160494015|NCT01427738|579537540|FG000|Overall Study|Withdrawal by Subject|0|||
160494016|NCT01427738|579537541|FG001|Overall Study|Withdrawal by Subject|2|||
160494017|NCT01427738|579537540|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
160494018|NCT01427738|579537541|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
160494019|NCT01427738|579537540|FG000|Overall Study|Lost to Follow-up|1|||
160494020|NCT01427738|579537541|FG001|Overall Study|Lost to Follow-up|5|||
160494021|NCT05314374|579537542|FG000|Overall Study|Adverse Event|2|||
160494022|NCT05314374|579537543|FG001|Overall Study|Adverse Event|2|||
160494023|NCT02392104|579537544|FG000|Overall Study|discontinuation of warfarin|3|||
160494024|NCT02392104|579537544|FG000|Overall Study|bleeding event|1|||
160494025|NCT02392104|579537544|FG000|Overall Study|transferred care to another doctor|2|||
160494026|NCT02392104|579537544|FG000|Overall Study|INR goal range changed|1|||
160612525|NCT03657576|579959540|FG003|Overall Study|Insurance Coverage|1|||
160612526|NCT03657576|579959541|FG004|Overall Study|Insurance Coverage|0|||
160612527|NCT03657576|579959542|FG005|Overall Study|Insurance Coverage|0|||
160612528|NCT04437511|579959543|FG000|Overall Study|Adverse Event|50|||
160612529|NCT04437511|579959544|FG001|Overall Study|Adverse Event|21|||
160494027|NCT02392104|579537544|FG000|Overall Study|admitted to skilled nursing facility|3|||
160494028|NCT02392104|579537544|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
160494029|NCT04887506|579537545|FG000|Overall Study|Death|1|||
160494030|NCT04887506|579537546|FG001|Overall Study|Death|1|||
160494031|NCT04887506|579537545|FG000|Overall Study|Withdrawal by Subject|0|||
160494032|NCT04887506|579537546|FG001|Overall Study|Withdrawal by Subject|3|||
160494033|NCT04887506|579537545|FG000|Overall Study|Adverse Event|4|||
160494034|NCT04887506|579537546|FG001|Overall Study|Adverse Event|3|||
160494035|NCT04887506|579537545|FG000|Overall Study|Other - Not Reported|1|||
160612530|NCT04437511|579959543|FG000|Overall Study|Death|15|||
160612531|NCT04437511|579959544|FG001|Overall Study|Death|10|||
160612532|NCT04437511|579959543|FG000|Overall Study|Lost to Follow-up|11|||
160612533|NCT04437511|579959544|FG001|Overall Study|Lost to Follow-up|11|||
160612534|NCT04437511|579959543|FG000|Overall Study|Physician Decision|19|||
160612535|NCT04437511|579959544|FG001|Overall Study|Physician Decision|10|||
160612536|NCT04437511|579959543|FG000|Overall Study|Progressive Disease|4|||
160612537|NCT04437511|579959544|FG001|Overall Study|Progressive Disease|7|||
160612538|NCT04437511|579959543|FG000|Overall Study|Withdrawal by Subject|111|||
160612539|NCT04437511|579959544|FG001|Overall Study|Withdrawal by Subject|94|||
160612540|NCT04437511|579959543|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
160612541|NCT04437511|579959544|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
160612542|NCT04437511|579959543|FG000|Overall Study|Continuing Study|7|||
160612543|NCT04437511|579959544|FG001|Overall Study|Continuing Study|5|||
160612544|NCT03093350|579959547|FG000|Overall Study|Death|1|||
160612545|NCT03093350|579959547|FG000|Overall Study|Signed consent, never began treartment|1|||
160612546|NCT00777036|579959548|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
160612547|NCT00777036|579959549|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
160612548|NCT00777036|579959550|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
160612549|NCT00777036|579959551|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
160612550|NCT00777036|579959548|FG000|On Treatment|Administrative Reason By Sponsor|1|||
160612551|NCT00777036|579959549|FG001|On Treatment|Administrative Reason By Sponsor|0|||
160612552|NCT00777036|579959550|FG002|On Treatment|Administrative Reason By Sponsor|9|||
160612553|NCT00777036|579959551|FG003|On Treatment|Administrative Reason By Sponsor|0|||
160612554|NCT00777036|579959548|FG000|On Treatment|Failure to Meet Study Criteria|0|||
160612555|NCT00777036|579959549|FG001|On Treatment|Failure to Meet Study Criteria|1|||
160612556|NCT00777036|579959550|FG002|On Treatment|Failure to Meet Study Criteria|4|||
160612557|NCT00777036|579959551|FG003|On Treatment|Failure to Meet Study Criteria|0|||
160612558|NCT00777036|579959548|FG000|On Treatment|Pregnancy|1|||
160612559|NCT00777036|579959549|FG001|On Treatment|Pregnancy|0|||
160612560|NCT00777036|579959550|FG002|On Treatment|Pregnancy|1|||
160612561|NCT00777036|579959551|FG003|On Treatment|Pregnancy|0|||
160612562|NCT00777036|579959548|FG000|On Treatment|Non-compliance with Study Drug|1|||
160612563|NCT00777036|579959549|FG001|On Treatment|Non-compliance with Study Drug|0|||
160612564|NCT00777036|579959550|FG002|On Treatment|Non-compliance with Study Drug|1|||
160612565|NCT00777036|579959551|FG003|On Treatment|Non-compliance with Study Drug|0|||
160612566|NCT00777036|579959548|FG000|On Treatment|Maximum Clinical Benefit|2|||
160612567|NCT00777036|579959549|FG001|On Treatment|Maximum Clinical Benefit|0|||
160612568|NCT00777036|579959550|FG002|On Treatment|Maximum Clinical Benefit|5|||
160612569|NCT00777036|579959551|FG003|On Treatment|Maximum Clinical Benefit|0|||
160612570|NCT00777036|579959548|FG000|On Treatment|Withdrawal by Subject|0|||
160612571|NCT00777036|579959549|FG001|On Treatment|Withdrawal by Subject|2|||
160612572|NCT00777036|579959550|FG002|On Treatment|Withdrawal by Subject|2|||
160612573|NCT00777036|579959551|FG003|On Treatment|Withdrawal by Subject|0|||
160612574|NCT00777036|579959548|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
160612575|NCT00777036|579959549|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
160612576|NCT00777036|579959550|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
160612577|NCT00777036|579959551|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
160612578|NCT00777036|579959548|FG000|On Treatment|Death|0|||
160612579|NCT00777036|579959549|FG001|On Treatment|Death|2|||
160612580|NCT00777036|579959550|FG002|On Treatment|Death|0|||
160612581|NCT00777036|579959551|FG003|On Treatment|Death|0|||
160612582|NCT00777036|579959548|FG000|On Treatment|Study Drug Toxicity|1|||
160612583|NCT00777036|579959549|FG001|On Treatment|Study Drug Toxicity|0|||
160612584|NCT00777036|579959550|FG002|On Treatment|Study Drug Toxicity|4|||
160612585|NCT00777036|579959551|FG003|On Treatment|Study Drug Toxicity|0|||
160612586|NCT00777036|579959548|FG000|On Treatment|Progressive Disease|6|||
160612587|NCT00777036|579959549|FG001|On Treatment|Progressive Disease|4|||
160612588|NCT00777036|579959550|FG002|On Treatment|Progressive Disease|7|||
160612589|NCT00777036|579959551|FG003|On Treatment|Progressive Disease|0|||
160612590|NCT00777036|579959548|FG000|On Treatment|Not Reported|0|||
160612591|NCT00777036|579959549|FG001|On Treatment|Not Reported|0|||
160612592|NCT00777036|579959550|FG002|On Treatment|Not Reported|2|||
160612593|NCT00777036|579959551|FG003|On Treatment|Not Reported|0|||
160612594|NCT00777036|579959548|FG000|On Treatment|Site Closed|0|||
160612595|NCT00777036|579959549|FG001|On Treatment|Site Closed|1|||
160612596|NCT00777036|579959550|FG002|On Treatment|Site Closed|1|||
160612597|NCT00777036|579959551|FG003|On Treatment|Site Closed|0|||
160612598|NCT00777036|579959548|FG000|Follow-Up|Withdrawal by Subject|0|||
160612599|NCT00777036|579959549|FG001|Follow-Up|Withdrawal by Subject|0|||
160612600|NCT00777036|579959550|FG002|Follow-Up|Withdrawal by Subject|5|||
160612601|NCT00777036|579959551|FG003|Follow-Up|Withdrawal by Subject|0|||
160612602|NCT00777036|579959548|FG000|Follow-Up|Death|1|||
160612603|NCT00777036|579959549|FG001|Follow-Up|Death|9|||
160612604|NCT00777036|579959550|FG002|Follow-Up|Death|0|||
160612605|NCT00777036|579959551|FG003|Follow-Up|Death|0|||
160612606|NCT00777036|579959548|FG000|Follow-Up|Lost to Follow-up|3|||
160612607|NCT00777036|579959549|FG001|Follow-Up|Lost to Follow-up|0|||
160661486|NCT00624065|580144114|FG001|Overall Study|Consent withdrawn|5|||
160661487|NCT00624065|580144113|FG000|Overall Study|Lack of Efficacy|0|||
160661488|NCT00624065|580144114|FG001|Overall Study|Lack of Efficacy|3|||
160661489|NCT00624065|580144113|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
160661490|NCT00624065|580144114|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
160661491|NCT00696020|580144115|FG000|Overall Study|Adverse Event|3|||
160661492|NCT00696020|580144116|FG001|Overall Study|Adverse Event|1|||
160494036|NCT04887506|579537546|FG001|Overall Study|Other - Not Reported|1|||
160494037|NCT03783871|579537547|FG000|Overall Study|Withdrawal by Subject|15|||
160494038|NCT03783871|579537547|FG000|Overall Study|Death|13|||
160494039|NCT03783871|579537547|FG000|Overall Study|Lost to Follow-up|2|||
160494040|NCT05990387|579537548|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
160494041|NCT05990387|579537549|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
160494042|NCT03522389|579537550|FG000|Overall Study|Lost to Follow-up|1|||
160494043|NCT03522389|579537551|FG001|Overall Study|Lost to Follow-up|1|||
160494044|NCT03522389|579537552|FG002|Overall Study|Lost to Follow-up|2|||
160494045|NCT03522389|579537550|FG000|Overall Study|had herniated nucleus pulposus|0|||
160494046|NCT03522389|579537551|FG001|Overall Study|had herniated nucleus pulposus|1|||
160494047|NCT03522389|579537552|FG002|Overall Study|had herniated nucleus pulposus|0|||
160494048|NCT03522389|579537550|FG000|Overall Study|go to work in other province|1|||
160494049|NCT03522389|579537551|FG001|Overall Study|go to work in other province|0|||
160494050|NCT03522389|579537552|FG002|Overall Study|go to work in other province|0|||
160494051|NCT00604188|579537553|FG000|Overall Study|Adverse Event|1|||
160494052|NCT00604188|579537554|FG001|Overall Study|Adverse Event|4|||
160494053|NCT00604188|579537553|FG000|Overall Study|Lost to Follow-up|17|||
160494054|NCT00604188|579537554|FG001|Overall Study|Lost to Follow-up|15|||
160494055|NCT00604188|579537553|FG000|Overall Study|Withdrawal by Subject|5|||
160494056|NCT00604188|579537554|FG001|Overall Study|Withdrawal by Subject|1|||
160494057|NCT00604188|579537553|FG000|Overall Study|Non-compliance with protocol|4|||
160494058|NCT00604188|579537554|FG001|Overall Study|Non-compliance with protocol|4|||
160494059|NCT00604188|579537553|FG000|Overall Study|Did not receive study drug|0|||
160494060|NCT00604188|579537554|FG001|Overall Study|Did not receive study drug|1|||
160494061|NCT02242643|579537557|FG000|Overall Study|Protocol Violation|1|||
160494062|NCT02242643|579537558|FG001|Overall Study|Protocol Violation|2|||
160494063|NCT02242643|579537557|FG000|Overall Study|Withdrawal by Subject|15|||
160494064|NCT02242643|579537558|FG001|Overall Study|Withdrawal by Subject|10|||
160494065|NCT02242643|579537557|FG000|Overall Study|Migrated/moved from study area|1|||
160494066|NCT02242643|579537558|FG001|Overall Study|Migrated/moved from study area|3|||
160494067|NCT02242643|579537557|FG000|Overall Study|Lost to Follow-up|54|||
160494068|NCT02242643|579537558|FG001|Overall Study|Lost to Follow-up|61|||
160494069|NCT02242643|579537557|FG000|Overall Study|Child placed in foster care by family|0|||
160494070|NCT02242643|579537558|FG001|Overall Study|Child placed in foster care by family|1|||
160494071|NCT02242643|579537557|FG000|Overall Study|Non-compliance|1|||
160494072|NCT02242643|579537558|FG001|Overall Study|Non-compliance|0|||
160494073|NCT02242643|579537557|FG000|Overall Study|Consent withdrawal by parent|1|||
160494074|NCT02242643|579537558|FG001|Overall Study|Consent withdrawal by parent|0|||
160494075|NCT02242643|579537557|FG000|Overall Study|Protocol requirements not followed|1|||
160494076|NCT02242643|579537558|FG001|Overall Study|Protocol requirements not followed|0|||
160494077|NCT02242643|579537557|FG000|Overall Study|Language barrier|1|||
160494078|NCT02242643|579537558|FG001|Overall Study|Language barrier|0|||
160494079|NCT02242643|579537557|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
160494080|NCT02242643|579537558|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
160494081|NCT01190644|579539094|FG000|Overall Study|Death|2|||
160494082|NCT01190644|579539094|FG000|Overall Study|Disease progression|1|||
160494083|NCT02666664|579539095|FG000|Overall Study|Physician Decision|0|||
160494084|NCT02666664|579539096|FG001|Overall Study|Physician Decision|1|||
160494085|NCT02666664|579539095|FG000|Overall Study|Protocol Violation|0|||
160494086|NCT02666664|579539096|FG001|Overall Study|Protocol Violation|2|||
160494087|NCT02666664|579539095|FG000|Overall Study|Other|0|||
160494088|NCT02666664|579539096|FG001|Overall Study|Other|1|||
160494089|NCT02666664|579539095|FG000|Overall Study|Adverse Event|12|||
160494090|NCT02666664|579539096|FG001|Overall Study|Adverse Event|37|||
160494091|NCT02666664|579539095|FG000|Overall Study|Withdrawal by participant|23|||
160494092|NCT02666664|579539096|FG001|Overall Study|Withdrawal by participant|40|||
160494093|NCT02666664|579539095|FG000|Overall Study|Sponsor decision|0|||
160494094|NCT02666664|579539096|FG001|Overall Study|Sponsor decision|1|||
160494095|NCT02666664|579539095|FG000|Overall Study|Lost to Follow-up|1|||
160494096|NCT02666664|579539096|FG001|Overall Study|Lost to Follow-up|2|||
160494097|NCT03616964|579539097|FG000|Overall Study|Adverse Event|15|||
160494098|NCT03616964|579539098|FG001|Overall Study|Adverse Event|10|||
160494099|NCT03616964|579539099|FG002|Overall Study|Adverse Event|16|||
160494100|NCT03616964|579539097|FG000|Overall Study|Death|3|||
160494101|NCT03616964|579539098|FG001|Overall Study|Death|0|||
160494102|NCT03616964|579539099|FG002|Overall Study|Death|4|||
160494103|NCT03616964|579539097|FG000|Overall Study|Lack of Efficacy|4|||
160494104|NCT03616964|579539098|FG001|Overall Study|Lack of Efficacy|8|||
160494105|NCT03616964|579539099|FG002|Overall Study|Lack of Efficacy|8|||
160494106|NCT03616964|579539097|FG000|Overall Study|Lost to Follow-up|2|||
160494107|NCT03616964|579539098|FG001|Overall Study|Lost to Follow-up|1|||
160494108|NCT03616964|579539099|FG002|Overall Study|Lost to Follow-up|3|||
160494109|NCT03616964|579539097|FG000|Overall Study|Withdrawal by Subject|18|||
160494110|NCT03616964|579539098|FG001|Overall Study|Withdrawal by Subject|14|||
160494111|NCT03616964|579539099|FG002|Overall Study|Withdrawal by Subject|21|||
160494112|NCT03616964|579539097|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
160612608|NCT00777036|579959550|FG002|Follow-Up|Lost to Follow-up|0|||
160612609|NCT00777036|579959551|FG003|Follow-Up|Lost to Follow-up|0|||
160612610|NCT00777036|579959548|FG000|Follow-Up|Reason Not Specified|4|||
160612611|NCT00777036|579959549|FG001|Follow-Up|Reason Not Specified|0|||
160612612|NCT00777036|579959550|FG002|Follow-Up|Reason Not Specified|13|||
160612613|NCT00777036|579959551|FG003|Follow-Up|Reason Not Specified|0|||
160612614|NCT00777036|579959548|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
160612615|NCT00777036|579959549|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
160612616|NCT00777036|579959550|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
160612617|NCT00777036|579959551|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
160612618|NCT05564039|579959554|FG000|Overall Study|Adverse Event|1|||
160612619|NCT05564039|579959555|FG001|Overall Study|Adverse Event|0|||
160612620|NCT05564039|579959554|FG000|Overall Study|Death|1|||
160612621|NCT05564039|579959555|FG001|Overall Study|Death|1|||
160612622|NCT05564039|579959554|FG000|Overall Study|Lost to Follow-up|3|||
160612623|NCT05564039|579959555|FG001|Overall Study|Lost to Follow-up|2|||
160612624|NCT05564039|579959554|FG000|Overall Study|Withdrawal by Subject|2|||
160612625|NCT05564039|579959555|FG001|Overall Study|Withdrawal by Subject|0|||
160612626|NCT05564039|579959554|FG000|Overall Study|Inadvertent enrollment|3|||
160612627|NCT05564039|579959555|FG001|Overall Study|Inadvertent enrollment|6|||
160612628|NCT00853112|579959556|FG000|Overall Study|Randomized but not treated|0|||
160612629|NCT00853112|579959557|FG001|Overall Study|Randomized but not treated|1|||
160612630|NCT00853112|579959558|FG002|Overall Study|Randomized but not treated|0|||
160612631|NCT00853112|579959559|FG003|Overall Study|Randomized but not treated|2|||
160612632|NCT00853112|579959560|FG004|Overall Study|Randomized but not treated|0|||
160612633|NCT00853112|579959561|FG005|Overall Study|Randomized but not treated|0|||
160612634|NCT00853112|579959562|FG006|Overall Study|Randomized but not treated|1|||
160612635|NCT01553591|579959563|FG000|Overall Study|Voluntarily withdrew|94|||
160612636|NCT01553591|579959564|FG001|Overall Study|Voluntarily withdrew|79|||
160612637|NCT01553591|579959565|FG002|Overall Study|Voluntarily withdrew|96|||
160612638|NCT01553591|579959563|FG000|Overall Study|Adverse Event|36|||
160612639|NCT01553591|579959564|FG001|Overall Study|Adverse Event|45|||
160612640|NCT01553591|579959565|FG002|Overall Study|Adverse Event|16|||
160612641|NCT01553591|579959563|FG000|Overall Study|Lost to Follow-up|25|||
160612642|NCT01553591|579959564|FG001|Overall Study|Lost to Follow-up|23|||
160612643|NCT01553591|579959565|FG002|Overall Study|Lost to Follow-up|16|||
160612644|NCT01553591|579959563|FG000|Overall Study|Physician decision: other|11|||
160612645|NCT01553591|579959564|FG001|Overall Study|Physician decision: other|14|||
160612646|NCT01553591|579959565|FG002|Overall Study|Physician decision: other|16|||
160612647|NCT01553591|579959563|FG000|Overall Study|Physician decision: lack of efficacy|2|||
160612648|NCT01553591|579959564|FG001|Overall Study|Physician decision: lack of efficacy|3|||
160612649|NCT01553591|579959565|FG002|Overall Study|Physician decision: lack of efficacy|7|||
160612650|NCT01553591|579959563|FG000|Overall Study|Protocol Violation|3|||
160612651|NCT01553591|579959564|FG001|Overall Study|Protocol Violation|4|||
160612652|NCT01553591|579959565|FG002|Overall Study|Protocol Violation|4|||
160612653|NCT01553591|579959563|FG000|Overall Study|Sponsor decision|1|||
160612654|NCT01553591|579959564|FG001|Overall Study|Sponsor decision|0|||
160612655|NCT01553591|579959565|FG002|Overall Study|Sponsor decision|3|||
160612656|NCT01553591|579959563|FG000|Overall Study|Randomized and never dispensed drug|0|||
160612657|NCT01553591|579959564|FG001|Overall Study|Randomized and never dispensed drug|1|||
160612658|NCT01553591|579959565|FG002|Overall Study|Randomized and never dispensed drug|0|||
160612659|NCT02477800|579959566|FG000|Placebo-Controlled Period|Adverse Event|16|||
160612660|NCT02477800|579959567|FG001|Placebo-Controlled Period|Adverse Event|25|||
160612661|NCT02477800|579959568|FG002|Placebo-Controlled Period|Adverse Event|28|||
160612662|NCT02477800|579959569|FG003|Placebo-Controlled Period|Adverse Event|0|||
160612663|NCT02477800|579959570|FG004|Placebo-Controlled Period|Adverse Event|0|||
160612664|NCT02477800|579959571|FG005|Placebo-Controlled Period|Adverse Event|0|||
160612665|NCT02477800|579959572|FG006|Placebo-Controlled Period|Adverse Event|0|||
160612666|NCT02477800|579959566|FG000|Placebo-Controlled Period|Change of Treatment|1|||
160494113|NCT03616964|579539098|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
160494114|NCT03616964|579539099|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
160612667|NCT02477800|579959567|FG001|Placebo-Controlled Period|Change of Treatment|2|||
160612668|NCT02477800|579959568|FG002|Placebo-Controlled Period|Change of Treatment|1|||
160612669|NCT02477800|579959569|FG003|Placebo-Controlled Period|Change of Treatment|0|||
160494115|NCT03616964|579539097|FG000|Overall Study|Sponsor's Decision|1|||
160612670|NCT02477800|579959570|FG004|Placebo-Controlled Period|Change of Treatment|0|||
160612671|NCT02477800|579959571|FG005|Placebo-Controlled Period|Change of Treatment|0|||
160612672|NCT02477800|579959572|FG006|Placebo-Controlled Period|Change of Treatment|0|||
160494116|NCT03616964|579539098|FG001|Overall Study|Sponsor's Decision|0|||
160494117|NCT03616964|579539099|FG002|Overall Study|Sponsor's Decision|0|||
160612673|NCT02477800|579959566|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
160612674|NCT02477800|579959567|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
160612675|NCT02477800|579959568|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
160612676|NCT02477800|579959569|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
160612677|NCT02477800|579959570|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
160612678|NCT02477800|579959571|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
160612679|NCT02477800|579959572|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
160612680|NCT02477800|579959566|FG000|Placebo-Controlled Period|Death|0|||
160612681|NCT02477800|579959567|FG001|Placebo-Controlled Period|Death|3|||
160612682|NCT02477800|579959568|FG002|Placebo-Controlled Period|Death|2|||
160612683|NCT02477800|579959569|FG003|Placebo-Controlled Period|Death|0|||
160612684|NCT02477800|579959570|FG004|Placebo-Controlled Period|Death|0|||
160612685|NCT02477800|579959571|FG005|Placebo-Controlled Period|Death|0|||
160612686|NCT02477800|579959572|FG006|Placebo-Controlled Period|Death|0|||
160612687|NCT02477800|579959566|FG000|Placebo-Controlled Period|Disease Progression|1|||
160612688|NCT02477800|579959567|FG001|Placebo-Controlled Period|Disease Progression|0|||
160612689|NCT02477800|579959568|FG002|Placebo-Controlled Period|Disease Progression|1|||
160612690|NCT02477800|579959569|FG003|Placebo-Controlled Period|Disease Progression|0|||
160612691|NCT02477800|579959570|FG004|Placebo-Controlled Period|Disease Progression|0|||
160612692|NCT02477800|579959571|FG005|Placebo-Controlled Period|Disease Progression|0|||
160612693|NCT02477800|579959572|FG006|Placebo-Controlled Period|Disease Progression|0|||
160612694|NCT02477800|579959566|FG000|Placebo-Controlled Period|Investigator Decision|3|||
160612695|NCT02477800|579959567|FG001|Placebo-Controlled Period|Investigator Decision|2|||
160612696|NCT02477800|579959568|FG002|Placebo-Controlled Period|Investigator Decision|1|||
160612697|NCT02477800|579959569|FG003|Placebo-Controlled Period|Investigator Decision|0|||
160612698|NCT02477800|579959570|FG004|Placebo-Controlled Period|Investigator Decision|0|||
160612699|NCT02477800|579959571|FG005|Placebo-Controlled Period|Investigator Decision|0|||
160612700|NCT02477800|579959572|FG006|Placebo-Controlled Period|Investigator Decision|0|||
160612701|NCT02477800|579959566|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
160612702|NCT02477800|579959567|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
160612703|NCT02477800|579959568|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
160612704|NCT02477800|579959569|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
160612705|NCT02477800|579959570|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
160612706|NCT02477800|579959571|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
160612707|NCT02477800|579959572|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
160612708|NCT02477800|579959566|FG000|Placebo-Controlled Period|Relocation|2|||
160612709|NCT02477800|579959567|FG001|Placebo-Controlled Period|Relocation|0|||
160612710|NCT02477800|579959568|FG002|Placebo-Controlled Period|Relocation|0|||
160612711|NCT02477800|579959569|FG003|Placebo-Controlled Period|Relocation|0|||
160612712|NCT02477800|579959570|FG004|Placebo-Controlled Period|Relocation|0|||
160612713|NCT02477800|579959571|FG005|Placebo-Controlled Period|Relocation|0|||
160612714|NCT02477800|579959572|FG006|Placebo-Controlled Period|Relocation|0|||
160612715|NCT02477800|579959566|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
160612716|NCT02477800|579959567|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
160612717|NCT02477800|579959568|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
160612718|NCT02477800|579959569|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
160612719|NCT02477800|579959570|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
160612720|NCT02477800|579959571|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
160612721|NCT02477800|579959572|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
160612722|NCT02477800|579959566|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
160612723|NCT02477800|579959567|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
160612724|NCT02477800|579959568|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
160612725|NCT02477800|579959569|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
160612726|NCT02477800|579959570|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
160612727|NCT02477800|579959571|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
160612728|NCT02477800|579959572|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
160612729|NCT02477800|579959566|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
160612730|NCT02477800|579959567|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
160612731|NCT02477800|579959568|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
160612732|NCT02477800|579959569|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
160612733|NCT02477800|579959570|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
160612734|NCT02477800|579959571|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
160612735|NCT02477800|579959572|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
160612736|NCT02477800|579959566|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
160612737|NCT02477800|579959567|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
160612738|NCT02477800|579959568|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
160612739|NCT02477800|579959569|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160612740|NCT02477800|579959570|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160612741|NCT02477800|579959571|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160612742|NCT02477800|579959572|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160612743|NCT02477800|579959566|FG000|Placebo-Controlled Period|Reason not Specified|161|||
160612744|NCT02477800|579959567|FG001|Placebo-Controlled Period|Reason not Specified|161|||
160612745|NCT02477800|579959568|FG002|Placebo-Controlled Period|Reason not Specified|189|||
160612746|NCT02477800|579959569|FG003|Placebo-Controlled Period|Reason not Specified|0|||
160612747|NCT02477800|579959570|FG004|Placebo-Controlled Period|Reason not Specified|0|||
160612748|NCT02477800|579959571|FG005|Placebo-Controlled Period|Reason not Specified|0|||
160612749|NCT02477800|579959572|FG006|Placebo-Controlled Period|Reason not Specified|0|||
160612750|NCT02477800|579959566|FG000|Long Term Extension Period|Adverse Event|0|||
160612751|NCT02477800|579959567|FG001|Long Term Extension Period|Adverse Event|0|||
160612752|NCT02477800|579959568|FG002|Long Term Extension Period|Adverse Event|0|||
160612753|NCT02477800|579959569|FG003|Long Term Extension Period|Adverse Event|6|||
160612754|NCT02477800|579959570|FG004|Long Term Extension Period|Adverse Event|2|||
160612755|NCT02477800|579959571|FG005|Long Term Extension Period|Adverse Event|4|||
160612756|NCT02477800|579959572|FG006|Long Term Extension Period|Adverse Event|3|||
160612757|NCT02477800|579959566|FG000|Long Term Extension Period|Death|0|||
160612758|NCT02477800|579959567|FG001|Long Term Extension Period|Death|0|||
160612759|NCT02477800|579959568|FG002|Long Term Extension Period|Death|0|||
160612760|NCT02477800|579959569|FG003|Long Term Extension Period|Death|1|||
160612761|NCT02477800|579959570|FG004|Long Term Extension Period|Death|1|||
160612762|NCT02477800|579959571|FG005|Long Term Extension Period|Death|1|||
160612763|NCT02477800|579959572|FG006|Long Term Extension Period|Death|2|||
160612764|NCT02477800|579959566|FG000|Long Term Extension Period|Consent Withdrawn|0|||
160612765|NCT02477800|579959567|FG001|Long Term Extension Period|Consent Withdrawn|0|||
160612766|NCT02477800|579959568|FG002|Long Term Extension Period|Consent Withdrawn|0|||
160612767|NCT02477800|579959569|FG003|Long Term Extension Period|Consent Withdrawn|10|||
160612768|NCT02477800|579959570|FG004|Long Term Extension Period|Consent Withdrawn|4|||
160612769|NCT02477800|579959571|FG005|Long Term Extension Period|Consent Withdrawn|13|||
160612770|NCT02477800|579959572|FG006|Long Term Extension Period|Consent Withdrawn|16|||
160494118|NCT03616964|579539097|FG000|Overall Study|Physician Decision|0|||
160612771|NCT02477800|579959566|FG000|Long Term Extension Period|Disease Progression|0|||
160612772|NCT02477800|579959567|FG001|Long Term Extension Period|Disease Progression|0|||
160612773|NCT02477800|579959568|FG002|Long Term Extension Period|Disease Progression|0|||
160612774|NCT02477800|579959569|FG003|Long Term Extension Period|Disease Progression|3|||
160612775|NCT02477800|579959570|FG004|Long Term Extension Period|Disease Progression|1|||
160612776|NCT02477800|579959571|FG005|Long Term Extension Period|Disease Progression|1|||
160612777|NCT02477800|579959572|FG006|Long Term Extension Period|Disease Progression|0|||
160612778|NCT02477800|579959566|FG000|Long Term Extension Period|Investigator Decision|0|||
160612779|NCT02477800|579959567|FG001|Long Term Extension Period|Investigator Decision|0|||
160612780|NCT02477800|579959568|FG002|Long Term Extension Period|Investigator Decision|0|||
160612781|NCT02477800|579959569|FG003|Long Term Extension Period|Investigator Decision|0|||
160612782|NCT02477800|579959570|FG004|Long Term Extension Period|Investigator Decision|0|||
160612783|NCT02477800|579959571|FG005|Long Term Extension Period|Investigator Decision|0|||
160612784|NCT02477800|579959572|FG006|Long Term Extension Period|Investigator Decision|2|||
160612785|NCT02477800|579959566|FG000|Long Term Extension Period|Lost to Follow-up|0|||
160612786|NCT02477800|579959567|FG001|Long Term Extension Period|Lost to Follow-up|0|||
160612787|NCT02477800|579959568|FG002|Long Term Extension Period|Lost to Follow-up|0|||
160612788|NCT02477800|579959569|FG003|Long Term Extension Period|Lost to Follow-up|0|||
160612789|NCT02477800|579959570|FG004|Long Term Extension Period|Lost to Follow-up|1|||
160612790|NCT02477800|579959571|FG005|Long Term Extension Period|Lost to Follow-up|3|||
160612791|NCT02477800|579959572|FG006|Long Term Extension Period|Lost to Follow-up|0|||
160612792|NCT02477800|579959566|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
160612793|NCT02477800|579959567|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
160612794|NCT02477800|579959568|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
160612795|NCT02477800|579959569|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
160612796|NCT02477800|579959570|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
160612797|NCT02477800|579959571|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
160612798|NCT02477800|579959572|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
160612799|NCT02477800|579959566|FG000|Long Term Extension Period|Study Visit Burden|0|||
160612800|NCT02477800|579959567|FG001|Long Term Extension Period|Study Visit Burden|0|||
160612801|NCT02477800|579959568|FG002|Long Term Extension Period|Study Visit Burden|0|||
160612802|NCT02477800|579959569|FG003|Long Term Extension Period|Study Visit Burden|3|||
160612803|NCT02477800|579959570|FG004|Long Term Extension Period|Study Visit Burden|0|||
160612804|NCT02477800|579959571|FG005|Long Term Extension Period|Study Visit Burden|2|||
160612805|NCT02477800|579959572|FG006|Long Term Extension Period|Study Visit Burden|2|||
160612806|NCT02477800|579959566|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
160612807|NCT02477800|579959567|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
160612808|NCT02477800|579959568|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
160612809|NCT02477800|579959569|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
160612810|NCT02477800|579959570|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
160612811|NCT02477800|579959571|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
160612812|NCT02477800|579959572|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
160612813|NCT02477800|579959566|FG000|Long Term Extension Period|Reason not Specified|0|||
160612814|NCT02477800|579959567|FG001|Long Term Extension Period|Reason not Specified|0|||
160612815|NCT02477800|579959568|FG002|Long Term Extension Period|Reason not Specified|0|||
160612816|NCT02477800|579959569|FG003|Long Term Extension Period|Reason not Specified|126|||
160612817|NCT02477800|579959570|FG004|Long Term Extension Period|Reason not Specified|140|||
160612818|NCT02477800|579959571|FG005|Long Term Extension Period|Reason not Specified|270|||
160612819|NCT02477800|579959572|FG006|Long Term Extension Period|Reason not Specified|224|||
160612820|NCT00528840|579959579|FG000|Overall Study|Lost to Follow-up|10|||
160612821|NCT00528840|579959579|FG000|Overall Study|Adverse Event|1|||
160612822|NCT00528840|579959579|FG000|Overall Study|Withdrawal by Subject|17|||
160612823|NCT00528840|579959579|FG000|Overall Study|Death|2|||
160612824|NCT00528840|579959579|FG000|Overall Study|Administrative Reasons|1|||
160612825|NCT00528840|579959579|FG000|Overall Study|Other|2|||
160612826|NCT01603628|579959580|FG000|Overall Study|Personal Reasons|1|||
160612827|NCT01603628|579959581|FG001|Overall Study|Personal Reasons|1|||
160612828|NCT01603628|579959582|FG002|Overall Study|Personal Reasons|2|||
160612829|NCT01603628|579959580|FG000|Overall Study|Protocol Violation|1|||
160612830|NCT01603628|579959581|FG001|Overall Study|Protocol Violation|1|||
160612831|NCT01603628|579959582|FG002|Overall Study|Protocol Violation|0|||
160612832|NCT01603628|579959580|FG000|Overall Study|Lost to Follow-up|0|||
160612833|NCT01603628|579959581|FG001|Overall Study|Lost to Follow-up|1|||
160612834|NCT01603628|579959582|FG002|Overall Study|Lost to Follow-up|0|||
160612835|NCT01603628|579959580|FG000|Overall Study|Other Miscellaneous Reason|1|||
160612836|NCT01603628|579959581|FG001|Overall Study|Other Miscellaneous Reason|0|||
160612837|NCT01603628|579959582|FG002|Overall Study|Other Miscellaneous Reason|0|||
160612838|NCT01969565|579959583|FG000|Overall Study|Withdrawal by Subject|1|||
160612839|NCT00832091|579959584|FG000|Overall Study|Adverse Event|1|||
160612840|NCT00832091|579959585|FG001|Overall Study|Adverse Event|1|||
160612841|NCT00832091|579959584|FG000|Overall Study|Protocol Violation|1|||
160612842|NCT00832091|579959585|FG001|Overall Study|Protocol Violation|0|||
160612843|NCT00832091|579959584|FG000|Overall Study|Withdrawal by Subject|2|||
160612844|NCT00832091|579959585|FG001|Overall Study|Withdrawal by Subject|1|||
160612845|NCT00832091|579959584|FG000|Overall Study|Prohibited Medication|1|||
160612846|NCT00832091|579959585|FG001|Overall Study|Prohibited Medication|0|||
160612847|NCT02943668|579959587|FG000|Overall Study|Disease Progression|1|||
160612848|NCT03457636|579959588|FG000|Overall Study|Lost to Follow-up|2|||
160612849|NCT01828567|579959591|FG000|Overall Study|Lost to Follow-up|27|||
160612850|NCT01828567|579959592|FG001|Overall Study|Lost to Follow-up|9|||
160612851|NCT01828567|579959591|FG000|Overall Study|Excluded - did not meet criteria|4|||
160612852|NCT01828567|579959592|FG001|Overall Study|Excluded - did not meet criteria|1|||
160494119|NCT03616964|579539098|FG001|Overall Study|Physician Decision|2|||
160494120|NCT03616964|579539099|FG002|Overall Study|Physician Decision|0|||
160494121|NCT03616964|579539097|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
160494122|NCT03616964|579539098|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
160494123|NCT03616964|579539099|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
160494124|NCT03616964|579539097|FG000|Overall Study|Protocol Violation|0|||
160494125|NCT03616964|579539098|FG001|Overall Study|Protocol Violation|1|||
160494126|NCT03616964|579539099|FG002|Overall Study|Protocol Violation|0|||
160494127|NCT03616964|579539097|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
160494128|NCT03616964|579539098|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
160494129|NCT03616964|579539099|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
160494130|NCT03616964|579539097|FG000|Overall Study|Randomized but Never Treated|1|||
160494131|NCT03616964|579539098|FG001|Overall Study|Randomized but Never Treated|1|||
160494132|NCT03616964|579539099|FG002|Overall Study|Randomized but Never Treated|1|||
160494133|NCT04596995|579539100|FG000|Overall Study|Lack of Efficacy|8|||
160494134|NCT04596995|579539100|FG000|Overall Study|Lost to Follow-up|3|||
160494135|NCT04596995|579539100|FG000|Overall Study|Withdrawal by Subject|12|||
160494136|NCT04596995|579539100|FG000|Overall Study|Sponsor decision|3|||
160494137|NCT04596995|579539100|FG000|Overall Study|Enrolled in managed access program|3|||
160494138|NCT00129935|579539101|FG000|Overall Study|Adverse Event|18|||
160494139|NCT00129935|579539102|FG001|Overall Study|Adverse Event|56|||
160494140|NCT00129935|579539101|FG000|Overall Study|Death|1|||
160494141|NCT00129935|579539102|FG001|Overall Study|Death|1|||
160494142|NCT00129935|579539101|FG000|Overall Study|Withdrawal by Subject|7|||
160494143|NCT00129935|579539102|FG001|Overall Study|Withdrawal by Subject|20|||
160494144|NCT00129935|579539101|FG000|Overall Study|Protocol Violation|0|||
160494145|NCT00129935|579539102|FG001|Overall Study|Protocol Violation|4|||
160494146|NCT00129935|579539101|FG000|Overall Study|Physician Decision|3|||
160494147|NCT00129935|579539102|FG001|Overall Study|Physician Decision|4|||
160494148|NCT00129935|579539101|FG000|Overall Study|Recurrence|1|||
160494149|NCT00129935|579539102|FG001|Overall Study|Recurrence|3|||
160494150|NCT00129935|579539101|FG000|Overall Study|Second primary|0|||
160494151|NCT00129935|579539102|FG001|Overall Study|Second primary|1|||
160494152|NCT00129935|579539101|FG000|Overall Study|Other|3|||
160494153|NCT00129935|579539102|FG001|Overall Study|Other|2|||
160494154|NCT00129935|579539101|FG000|Overall Study|Crossed to the other arm|2|||
160494155|NCT00129935|579539102|FG001|Overall Study|Crossed to the other arm|1|||
160494156|NCT00129935|579539101|FG000|Overall Study|Incorrect study treatment|1|||
160494157|NCT00129935|579539102|FG001|Overall Study|Incorrect study treatment|0|||
160494158|NCT02056626|579539103|FG000|Overall Study|patient did not follow directions|3|||
160494159|NCT02056626|579539104|FG001|Overall Study|patient did not follow directions|1|||
160494160|NCT02056626|579539105|FG002|Overall Study|patient did not follow directions|0|||
160494161|NCT02056626|579539106|FG003|Overall Study|patient did not follow directions|0|||
160494162|NCT04916002|579539108|FG000|Overall Study|Adverse Event|0|||
160494163|NCT04916002|579539109|FG001|Overall Study|Adverse Event|1|||
160494164|NCT04916002|579539110|FG002|Overall Study|Adverse Event|0|||
160494165|NCT04916002|579539111|FG003|Overall Study|Adverse Event|1|||
160494166|NCT04916002|579539112|FG004|Overall Study|Adverse Event|0|||
160494167|NCT04916002|579539108|FG000|Overall Study|Withdrawal by Subject|3|||
160494168|NCT04916002|579539109|FG001|Overall Study|Withdrawal by Subject|1|||
160494169|NCT04916002|579539110|FG002|Overall Study|Withdrawal by Subject|0|||
160494170|NCT04916002|579539111|FG003|Overall Study|Withdrawal by Subject|1|||
160494171|NCT04916002|579539112|FG004|Overall Study|Withdrawal by Subject|0|||
160494172|NCT04916002|579539108|FG000|Overall Study|Death|8|||
160494173|NCT04916002|579539109|FG001|Overall Study|Death|7|||
160494174|NCT04916002|579539110|FG002|Overall Study|Death|4|||
160494175|NCT04916002|579539111|FG003|Overall Study|Death|9|||
160494176|NCT04916002|579539112|FG004|Overall Study|Death|0|||
160494177|NCT04916002|579539108|FG000|Overall Study|Study Terminated by Sponsor|11|||
160494178|NCT04916002|579539109|FG001|Overall Study|Study Terminated by Sponsor|10|||
160494179|NCT04916002|579539110|FG002|Overall Study|Study Terminated by Sponsor|8|||
160494180|NCT04916002|579539111|FG003|Overall Study|Study Terminated by Sponsor|5|||
160494181|NCT04916002|579539112|FG004|Overall Study|Study Terminated by Sponsor|4|||
160494182|NCT04916002|579539108|FG000|Overall Study|End of trial|1|||
160494183|NCT04916002|579539109|FG001|Overall Study|End of trial|0|||
160494184|NCT04916002|579539110|FG002|Overall Study|End of trial|0|||
160494185|NCT04916002|579539111|FG003|Overall Study|End of trial|0|||
160494186|NCT04916002|579539112|FG004|Overall Study|End of trial|0|||
160494187|NCT04916002|579539108|FG000|Overall Study|Progressive disease|0|||
160494188|NCT04916002|579539109|FG001|Overall Study|Progressive disease|0|||
160494189|NCT04916002|579539110|FG002|Overall Study|Progressive disease|1|||
160494190|NCT04916002|579539111|FG003|Overall Study|Progressive disease|0|||
160494191|NCT04916002|579539112|FG004|Overall Study|Progressive disease|0|||
160494192|NCT04916002|579539108|FG000|Overall Study|Participant non-compliance|2|||
160494193|NCT04916002|579539109|FG001|Overall Study|Participant non-compliance|0|||
160494194|NCT04916002|579539110|FG002|Overall Study|Participant non-compliance|0|||
160494195|NCT04916002|579539111|FG003|Overall Study|Participant non-compliance|0|||
160661493|NCT00696020|580144117|FG002|Overall Study|Adverse Event|2|||
160494196|NCT04916002|579539112|FG004|Overall Study|Participant non-compliance|0|||
160494197|NCT03210519|579539113|FG000|Overall Study|Adverse Event|2|||
160494198|NCT03210519|579539114|FG001|Overall Study|Adverse Event|0|||
160494199|NCT05147350|579539115|FG000|Overall Study|Death|2|||
160494200|NCT05147350|579539116|FG001|Overall Study|Death|3|||
160494201|NCT05147350|579539117|FG002|Overall Study|Death|3|||
160494202|NCT05147350|579539118|FG003|Overall Study|Death|2|||
160494203|NCT05147350|579539119|FG004|Overall Study|Death|2|||
160494204|NCT05147350|579539120|FG005|Overall Study|Death|1|||
160494205|NCT05147350|579539121|FG006|Overall Study|Death|1|||
160494206|NCT05147350|579539122|FG007|Overall Study|Death|3|||
160494207|NCT05147350|579539115|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
160494208|NCT05147350|579539116|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
160494209|NCT05147350|579539117|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
160494210|NCT05147350|579539118|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
160494211|NCT05147350|579539119|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
160494212|NCT05147350|579539120|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
160494213|NCT05147350|579539121|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
160494214|NCT05147350|579539122|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
160494215|NCT05147350|579539115|FG000|Overall Study|Withdrawal by Subject|0|||
160494216|NCT05147350|579539116|FG001|Overall Study|Withdrawal by Subject|0|||
160494217|NCT05147350|579539117|FG002|Overall Study|Withdrawal by Subject|3|||
160494218|NCT05147350|579539118|FG003|Overall Study|Withdrawal by Subject|1|||
160494219|NCT05147350|579539119|FG004|Overall Study|Withdrawal by Subject|1|||
160494220|NCT05147350|579539120|FG005|Overall Study|Withdrawal by Subject|0|||
160494221|NCT05147350|579539121|FG006|Overall Study|Withdrawal by Subject|1|||
160494222|NCT05147350|579539122|FG007|Overall Study|Withdrawal by Subject|0|||
160494223|NCT05147350|579539115|FG000|Overall Study|Other Reasons|0|||
160494224|NCT05147350|579539116|FG001|Overall Study|Other Reasons|0|||
160494225|NCT05147350|579539117|FG002|Overall Study|Other Reasons|2|||
160494226|NCT05147350|579539118|FG003|Overall Study|Other Reasons|0|||
160494227|NCT05147350|579539119|FG004|Overall Study|Other Reasons|0|||
160494228|NCT05147350|579539120|FG005|Overall Study|Other Reasons|2|||
160494229|NCT05147350|579539121|FG006|Overall Study|Other Reasons|1|||
160494230|NCT05147350|579539122|FG007|Overall Study|Other Reasons|1|||
160494231|NCT06136897|579539123|FG000|Overall Study|Ineligible|3|||
160494232|NCT06136897|579539123|FG000|Overall Study|Mutation status not confirmed|7|||
160494233|NCT06136897|579539123|FG000|Overall Study|Adverse Event|2|||
160494234|NCT06136897|579539123|FG000|Overall Study|Death|1|||
160494235|NCT06136897|579539123|FG000|Overall Study|Disease progression|18|||
160494236|NCT06136897|579539123|FG000|Overall Study|Other complicating disease|1|||
160494237|NCT06136897|579539123|FG000|Overall Study|Withdrawal by Subject|1|||
160494238|NCT06136897|579539123|FG000|Overall Study|Still on treatment|1|||
160494239|NCT06136897|579539123|FG000|Overall Study|Lost to Follow-up|1|||
160494240|NCT02947100|579539124|FG000|Overall Study|study terminated early|3|||
160494241|NCT02947100|579539124|FG000|Overall Study|did not meet inclusion criteria|1|||
160494242|NCT01296555|579539128|FG000|Overall Study|Adverse Event|0|||
160494243|NCT01296555|579539129|FG001|Overall Study|Adverse Event|0|||
160494244|NCT01296555|579539130|FG002|Overall Study|Adverse Event|1|||
160494245|NCT01296555|579539131|FG003|Overall Study|Adverse Event|1|||
160494246|NCT01296555|579539132|FG004|Overall Study|Adverse Event|2|||
160494247|NCT01296555|579539133|FG005|Overall Study|Adverse Event|4|||
160494248|NCT01296555|579539134|FG006|Overall Study|Adverse Event|1|||
160494249|NCT01296555|579539135|FG007|Overall Study|Adverse Event|4|||
160494250|NCT01296555|579539136|FG008|Overall Study|Adverse Event|3|||
160494251|NCT01296555|579539137|FG009|Overall Study|Adverse Event|1|||
160494252|NCT01296555|579539138|FG010|Overall Study|Adverse Event|0|||
160494253|NCT01296555|579539139|FG011|Overall Study|Adverse Event|4|||
160494254|NCT01296555|579539140|FG012|Overall Study|Adverse Event|1|||
160494255|NCT01296555|579539141|FG013|Overall Study|Adverse Event|4|||
160494256|NCT01296555|579539142|FG014|Overall Study|Adverse Event|0|||
160494257|NCT01296555|579539143|FG015|Overall Study|Adverse Event|0|||
160494258|NCT01296555|579539144|FG016|Overall Study|Adverse Event|0|||
160494259|NCT01296555|579539145|FG017|Overall Study|Adverse Event|0|||
160494260|NCT01296555|579539146|FG018|Overall Study|Adverse Event|0|||
160494261|NCT01296555|579539147|FG019|Overall Study|Adverse Event|1|||
160494262|NCT01296555|579539148|FG020|Overall Study|Adverse Event|0|||
160494263|NCT01296555|579539149|FG021|Overall Study|Adverse Event|0|||
160494264|NCT01296555|579539150|FG022|Overall Study|Adverse Event|0|||
160494265|NCT01296555|579539151|FG023|Overall Study|Adverse Event|0|||
160494266|NCT01296555|579539152|FG024|Overall Study|Adverse Event|0|||
160494267|NCT01296555|579539153|FG025|Overall Study|Adverse Event|0|||
160494268|NCT01296555|579539154|FG026|Overall Study|Adverse Event|0|||
160494269|NCT01296555|579539155|FG027|Overall Study|Adverse Event|0|||
160494270|NCT01296555|579539156|FG028|Overall Study|Adverse Event|0|||
160494271|NCT01296555|579539128|FG000|Overall Study|Reason Not Specified|0|||
160494272|NCT01296555|579539129|FG001|Overall Study|Reason Not Specified|0|||
160494273|NCT01296555|579539130|FG002|Overall Study|Reason Not Specified|0|||
160612853|NCT03325010|579959601|FG000|Overall Study|Adverse Event|3|||
160612854|NCT03325010|579959602|FG001|Overall Study|Adverse Event|8|||
160612855|NCT03325010|579959601|FG000|Overall Study|Protocol Violation|1|||
160612856|NCT03325010|579959602|FG001|Overall Study|Protocol Violation|8|||
160612857|NCT03325010|579959601|FG000|Overall Study|Withdrawal by Subject|1|||
160612858|NCT03325010|579959602|FG001|Overall Study|Withdrawal by Subject|3|||
160612859|NCT03325010|579959601|FG000|Overall Study|Lost to Follow-up|1|||
160612860|NCT03325010|579959602|FG001|Overall Study|Lost to Follow-up|0|||
160612861|NCT03325010|579959601|FG000|Overall Study|Physician Decision|1|||
160612862|NCT03325010|579959602|FG001|Overall Study|Physician Decision|1|||
160612863|NCT03325010|579959601|FG000|Overall Study|Lack of Efficacy|2|||
160612864|NCT03325010|579959602|FG001|Overall Study|Lack of Efficacy|0|||
160612865|NCT02614261|579959603|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
160612866|NCT02614261|579959604|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
160612867|NCT02614261|579959605|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
160612868|NCT02614261|579959606|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
160612869|NCT02614261|579959603|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
160612870|NCT02614261|579959604|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
160612871|NCT02614261|579959605|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
160612872|NCT02614261|579959606|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
160612873|NCT02614261|579959603|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
160612874|NCT02614261|579959604|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
160612875|NCT02614261|579959605|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
160612876|NCT02614261|579959606|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160612877|NCT02614261|579959603|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
160612878|NCT02614261|579959604|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
160612879|NCT02614261|579959605|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
160612880|NCT02614261|579959606|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
160612881|NCT02614261|579959603|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
160612882|NCT02614261|579959604|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
160612883|NCT02614261|579959605|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
160612884|NCT02614261|579959606|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
160612885|NCT02614261|579959603|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
160612886|NCT02614261|579959604|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
160612887|NCT02614261|579959605|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
160612888|NCT02614261|579959606|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
160612889|NCT02614261|579959603|FG000|Double-Blind Treatment Phase|Screen failure|0|||
160612890|NCT02614261|579959604|FG001|Double-Blind Treatment Phase|Screen failure|1|||
160612891|NCT02614261|579959605|FG002|Double-Blind Treatment Phase|Screen failure|2|||
160612892|NCT02614261|579959606|FG003|Double-Blind Treatment Phase|Screen failure|0|||
160612893|NCT02614261|579959603|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
160612894|NCT02614261|579959604|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
160612895|NCT02614261|579959605|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
160612896|NCT02614261|579959606|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
160612897|NCT02614261|579959603|FG000|Open-Label Extension Phase|Adverse Event|23|||
160612898|NCT02614261|579959604|FG001|Open-Label Extension Phase|Adverse Event|12|||
160612899|NCT02614261|579959605|FG002|Open-Label Extension Phase|Adverse Event|11|||
160612900|NCT02614261|579959606|FG003|Open-Label Extension Phase|Adverse Event|0|||
160612901|NCT02614261|579959603|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
160612902|NCT02614261|579959604|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
160612903|NCT02614261|579959605|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
160612904|NCT02614261|579959606|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
160612905|NCT02614261|579959603|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
160612906|NCT02614261|579959604|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
160612907|NCT02614261|579959605|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
160612908|NCT02614261|579959606|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
160612909|NCT02614261|579959603|FG000|Open-Label Extension Phase|Physician Decision|2|||
160612910|NCT02614261|579959604|FG001|Open-Label Extension Phase|Physician Decision|0|||
160612911|NCT02614261|579959605|FG002|Open-Label Extension Phase|Physician Decision|0|||
160612912|NCT02614261|579959606|FG003|Open-Label Extension Phase|Physician Decision|0|||
160612913|NCT02614261|579959603|FG000|Open-Label Extension Phase|Pregnancy|1|||
160612914|NCT02614261|579959604|FG001|Open-Label Extension Phase|Pregnancy|2|||
160612915|NCT02614261|579959605|FG002|Open-Label Extension Phase|Pregnancy|1|||
160612916|NCT02614261|579959606|FG003|Open-Label Extension Phase|Pregnancy|0|||
160612917|NCT02614261|579959603|FG000|Open-Label Extension Phase|Protocol Violation|3|||
160612918|NCT02614261|579959604|FG001|Open-Label Extension Phase|Protocol Violation|4|||
160612919|NCT02614261|579959605|FG002|Open-Label Extension Phase|Protocol Violation|1|||
160612920|NCT02614261|579959606|FG003|Open-Label Extension Phase|Protocol Violation|0|||
160612921|NCT02614261|579959603|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
160612922|NCT02614261|579959604|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
160612923|NCT02614261|579959605|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
160612924|NCT02614261|579959606|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
160612925|NCT02614261|579959603|FG000|Follow-up Phase|Adverse Event|2|||
160612926|NCT02614261|579959604|FG001|Follow-up Phase|Adverse Event|0|||
160612927|NCT02614261|579959605|FG002|Follow-up Phase|Adverse Event|1|||
160612928|NCT02614261|579959606|FG003|Follow-up Phase|Adverse Event|0|||
160612929|NCT02614261|579959603|FG000|Follow-up Phase|Lost to Follow-up|12|||
160612930|NCT02614261|579959604|FG001|Follow-up Phase|Lost to Follow-up|5|||
160612931|NCT02614261|579959605|FG002|Follow-up Phase|Lost to Follow-up|2|||
160612932|NCT02614261|579959606|FG003|Follow-up Phase|Lost to Follow-up|0|||
160612933|NCT02614261|579959603|FG000|Follow-up Phase|Physician Decision|5|||
160612934|NCT02614261|579959604|FG001|Follow-up Phase|Physician Decision|1|||
160612935|NCT02614261|579959605|FG002|Follow-up Phase|Physician Decision|0|||
160612936|NCT02614261|579959606|FG003|Follow-up Phase|Physician Decision|0|||
160612937|NCT02614261|579959603|FG000|Follow-up Phase|Pregnancy|0|||
160612938|NCT02614261|579959604|FG001|Follow-up Phase|Pregnancy|1|||
160612939|NCT02614261|579959605|FG002|Follow-up Phase|Pregnancy|0|||
160612940|NCT02614261|579959606|FG003|Follow-up Phase|Pregnancy|0|||
160612941|NCT02614261|579959603|FG000|Follow-up Phase|Protocol Violation|1|||
160612942|NCT02614261|579959604|FG001|Follow-up Phase|Protocol Violation|0|||
160612943|NCT02614261|579959605|FG002|Follow-up Phase|Protocol Violation|0|||
160612944|NCT02614261|579959606|FG003|Follow-up Phase|Protocol Violation|0|||
160612945|NCT02614261|579959603|FG000|Follow-up Phase|Withdrawal by Subject|12|||
160612946|NCT02614261|579959604|FG001|Follow-up Phase|Withdrawal by Subject|4|||
160612947|NCT02614261|579959605|FG002|Follow-up Phase|Withdrawal by Subject|11|||
160612948|NCT02614261|579959606|FG003|Follow-up Phase|Withdrawal by Subject|0|||
160612949|NCT02614261|579959603|FG000|Israel Addendum|Withdrawal by Subject|0|||
160612950|NCT02614261|579959604|FG001|Israel Addendum|Withdrawal by Subject|0|||
160612951|NCT02614261|579959605|FG002|Israel Addendum|Withdrawal by Subject|0|||
160612952|NCT02614261|579959606|FG003|Israel Addendum|Withdrawal by Subject|4|||
160612953|NCT01060124|579959608|FG000|Overall Study|Other|16|||
160612954|NCT01060124|579959608|FG000|Overall Study|Adverse Event|14|||
160612955|NCT01060124|579959608|FG000|Overall Study|Withdrawal by Subject|7|||
160612956|NCT03858686|579959611|FG000|Period 1|Adverse Event|1|||
160612957|NCT03858686|579959612|FG001|Period 1|Adverse Event|1|||
160612958|NCT03858686|579959611|FG000|Period 1|Lack of compliance|0|||
160612959|NCT03858686|579959612|FG001|Period 1|Lack of compliance|1|||
160612960|NCT03858686|579959611|FG000|Period 1|Adverse Event|0|||
160612961|NCT03858686|579959612|FG001|Period 1|Adverse Event|1|||
160612962|NCT03858686|579959611|FG000|Period 2|Adverse Event|0|||
160612963|NCT03858686|579959612|FG001|Period 2|Adverse Event|1|||
160612964|NCT00102804|579959613|FG000|Overall Study|Progressive Disease (PD)|307|||
160612965|NCT00102804|579959614|FG001|Overall Study|Progressive Disease (PD)|196|||
160612966|NCT00102804|579959613|FG000|Overall Study|Withdrawal by Subject|46|||
160612967|NCT00102804|579959614|FG001|Overall Study|Withdrawal by Subject|7|||
160612968|NCT00102804|579959613|FG000|Overall Study|Adverse Event|37|||
160612969|NCT00102804|579959614|FG001|Overall Study|Adverse Event|3|||
160612970|NCT00102804|579959613|FG000|Overall Study|Physician Decision|24|||
160612971|NCT00102804|579959614|FG001|Overall Study|Physician Decision|6|||
160612972|NCT00102804|579959613|FG000|Overall Study|Death|5|||
160612973|NCT00102804|579959614|FG001|Overall Study|Death|6|||
160612974|NCT00102804|579959613|FG000|Overall Study|Enrollment Criteria Not Met|6|||
160612975|NCT00102804|579959614|FG001|Overall Study|Enrollment Criteria Not Met|0|||
160612976|NCT00102804|579959613|FG000|Overall Study|Lost to Follow-up|4|||
160612977|NCT00102804|579959614|FG001|Overall Study|Lost to Follow-up|1|||
160612978|NCT00102804|579959613|FG000|Overall Study|Protocol Violation|2|||
160612979|NCT00102804|579959614|FG001|Overall Study|Protocol Violation|1|||
160612980|NCT00102804|579959613|FG000|Overall Study|Satisfactory Response|2|||
160612981|NCT00102804|579959614|FG001|Overall Study|Satisfactory Response|0|||
160661494|NCT00696020|580144118|FG003|Overall Study|Adverse Event|1|||
160661495|NCT00696020|580144115|FG000|Overall Study|Lack of Efficacy|1|||
160661496|NCT00696020|580144116|FG001|Overall Study|Lack of Efficacy|0|||
160661497|NCT00696020|580144117|FG002|Overall Study|Lack of Efficacy|0|||
160661498|NCT00696020|580144118|FG003|Overall Study|Lack of Efficacy|0|||
160661499|NCT00696020|580144115|FG000|Overall Study|Protocol Violation|0|||
160612982|NCT00102804|579959613|FG000|Overall Study|Sponsor Decision|1|||
160612983|NCT00102804|579959614|FG001|Overall Study|Sponsor Decision|0|||
160612984|NCT00102804|579959613|FG000|Overall Study|Alive, Receiving Treatment|7|||
160612985|NCT00102804|579959614|FG001|Overall Study|Alive, Receiving Treatment|2|||
160612986|NCT00518336|579959621|FG000|Year 7|Lost to Follow-up|2|||
160612987|NCT00518336|579959622|FG001|Year 7|Lost to Follow-up|0|||
160612988|NCT00518336|579959621|FG000|Year 7|Could not attend in time|0|||
160612989|NCT00518336|579959622|FG001|Year 7|Could not attend in time|3|||
160612990|NCT00518336|579959621|FG000|Year 8|Lost to Follow-up|1|||
160612991|NCT00518336|579959622|FG001|Year 8|Lost to Follow-up|1|||
160612992|NCT00518336|579959621|FG000|Year 8|Could not attend in time|0|||
160612993|NCT00518336|579959622|FG001|Year 8|Could not attend in time|1|||
160612994|NCT00518336|579959621|FG000|Year 9|Migrated/moved from study area|1|||
160612995|NCT00518336|579959622|FG001|Year 9|Migrated/moved from study area|1|||
160612996|NCT00518336|579959621|FG000|Year 9|Lost to Follow-up|3|||
160661500|NCT00696020|580144116|FG001|Overall Study|Protocol Violation|0|||
160612997|NCT00518336|579959622|FG001|Year 9|Lost to Follow-up|0|||
160612998|NCT00518336|579959621|FG000|Year 9|Personal reasons|1|||
160612999|NCT00518336|579959622|FG001|Year 9|Personal reasons|0|||
160613000|NCT03399786|579959623|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
160613001|NCT03399786|579959624|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
160613002|NCT03399786|579959625|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
160613003|NCT03399786|579959626|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
160613004|NCT03399786|579959623|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
160613005|NCT03399786|579959624|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
160613006|NCT03399786|579959625|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
160613007|NCT03399786|579959626|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
160613008|NCT03399786|579959623|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
160613009|NCT03399786|579959624|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
160613010|NCT03399786|579959625|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
160613011|NCT03399786|579959626|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
160613012|NCT02314637|579960328|FG000|Overall Study|Adverse Event|4|||
160613013|NCT02314637|579960329|FG001|Overall Study|Adverse Event|8|||
160613014|NCT02314637|579960328|FG000|Overall Study|Lack of Efficacy|1|||
160613015|NCT02314637|579960329|FG001|Overall Study|Lack of Efficacy|0|||
160613016|NCT02314637|579960328|FG000|Overall Study|Physician Decision|5|||
160613017|NCT02314637|579960329|FG001|Overall Study|Physician Decision|2|||
160613018|NCT02314637|579960328|FG000|Overall Study|Withdrawal by Subject|5|||
160613019|NCT02314637|579960329|FG001|Overall Study|Withdrawal by Subject|4|||
160613020|NCT02314637|579960328|FG000|Overall Study|Other Reason|1|||
160613021|NCT02314637|579960329|FG001|Overall Study|Other Reason|0|||
160613022|NCT00768040|579960333|FG000|Overall Study|Adverse Event|3|||
160613023|NCT00768040|579960334|FG001|Overall Study|Adverse Event|2|||
160613024|NCT00768040|579960333|FG000|Overall Study|Abnormal laboratory value|1|||
160613025|NCT00768040|579960334|FG001|Overall Study|Abnormal laboratory value|1|||
160613026|NCT02511106|579960339|FG000|Overall Study|Lost to Follow-up|6|||
160613027|NCT02511106|579960340|FG001|Overall Study|Lost to Follow-up|4|||
160613028|NCT02511106|579960339|FG000|Overall Study|Withdrawal by Subject|24|||
160613029|NCT02511106|579960340|FG001|Overall Study|Withdrawal by Subject|21|||
160613030|NCT02511106|579960339|FG000|Overall Study|Death|42|||
160613031|NCT02511106|579960340|FG001|Overall Study|Death|82|||
160613032|NCT02511106|579960339|FG000|Overall Study|Ongoing study at data cut-off|3|||
160613033|NCT02511106|579960340|FG001|Overall Study|Ongoing study at data cut-off|2|||
160613034|NCT02511106|579960339|FG000|Overall Study|Without specified reason|3|||
160613035|NCT02511106|579960340|FG001|Overall Study|Without specified reason|0|||
160613036|NCT04221945|579960341|FG000|Overall Study|Death|103|||
160613037|NCT04221945|579960342|FG001|Overall Study|Death|140|||
160613038|NCT04221945|579960341|FG000|Overall Study|Lost to Follow-up|5|||
160613039|NCT04221945|579960342|FG001|Overall Study|Lost to Follow-up|8|||
160613040|NCT04221945|579960341|FG000|Overall Study|Withdrawal by Subject|21|||
160613041|NCT04221945|579960342|FG001|Overall Study|Withdrawal by Subject|11|||
160613042|NCT04221945|579960341|FG000|Overall Study|Participants Ongoing|400|||
160613043|NCT04221945|579960342|FG001|Overall Study|Participants Ongoing|372|||
160613044|NCT00974090|579960344|FG000|Period 1: Double Blind Period|Adverse Event|2|||
160613045|NCT00974090|579960345|FG001|Period 1: Double Blind Period|Adverse Event|1|||
160613046|NCT00974090|579960344|FG000|Period 1: Double Blind Period|Physician Decision|1|||
160613047|NCT00974090|579960345|FG001|Period 1: Double Blind Period|Physician Decision|0|||
160613048|NCT00974090|579960344|FG000|Period 2: Open-label Period|Adverse Event|4|||
160613049|NCT00974090|579960345|FG001|Period 2: Open-label Period|Adverse Event|6|||
160613050|NCT00974090|579960344|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
160613051|NCT00974090|579960345|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
160613052|NCT00974090|579960344|FG000|Period 2: Open-label Period|Physician Decision|0|||
160494274|NCT01296555|579539131|FG003|Overall Study|Reason Not Specified|0|||
160494275|NCT01296555|579539132|FG004|Overall Study|Reason Not Specified|0|||
160494276|NCT01296555|579539133|FG005|Overall Study|Reason Not Specified|0|||
160494277|NCT01296555|579539134|FG006|Overall Study|Reason Not Specified|0|||
160494278|NCT01296555|579539135|FG007|Overall Study|Reason Not Specified|0|||
160494279|NCT01296555|579539136|FG008|Overall Study|Reason Not Specified|0|||
160494280|NCT01296555|579539137|FG009|Overall Study|Reason Not Specified|0|||
160494281|NCT01296555|579539138|FG010|Overall Study|Reason Not Specified|0|||
160494282|NCT01296555|579539139|FG011|Overall Study|Reason Not Specified|0|||
160613053|NCT00974090|579960345|FG001|Period 2: Open-label Period|Physician Decision|3|||
160613054|NCT00974090|579960344|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
160613055|NCT00974090|579960345|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
160613056|NCT01626872|579960346|FG000|Overall Study|Physician Decision|13|||
160613057|NCT01626872|579960347|FG001|Overall Study|Physician Decision|9|||
160613058|NCT01626872|579960348|FG002|Overall Study|Physician Decision|6|||
160613059|NCT01626872|579960346|FG000|Overall Study|Withdrawal by Subject|19|||
160613060|NCT01626872|579960347|FG001|Overall Study|Withdrawal by Subject|27|||
160613061|NCT01626872|579960348|FG002|Overall Study|Withdrawal by Subject|8|||
160613062|NCT01626872|579960346|FG000|Overall Study|Adverse Event (including Death)|20|||
160613063|NCT01626872|579960347|FG001|Overall Study|Adverse Event (including Death)|28|||
160613064|NCT01626872|579960348|FG002|Overall Study|Adverse Event (including Death)|8|||
160613065|NCT01626872|579960346|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
160613066|NCT01626872|579960347|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
160613067|NCT01626872|579960348|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
160613068|NCT05626751|579960349|FG000|Overall Study|Lost to Follow-up|1|||
160613069|NCT05626751|579960350|FG001|Overall Study|Lost to Follow-up|2|||
160613070|NCT05626751|579960351|FG002|Overall Study|Lost to Follow-up|1|||
160613071|NCT05626751|579960349|FG000|Overall Study|Trial Terminated by Sponsor|39|||
160613072|NCT05626751|579960350|FG001|Overall Study|Trial Terminated by Sponsor|30|||
160613073|NCT05626751|579960351|FG002|Overall Study|Trial Terminated by Sponsor|37|||
160613074|NCT05626751|579960349|FG000|Overall Study|Withdrawal by Subject|7|||
160613075|NCT05626751|579960350|FG001|Overall Study|Withdrawal by Subject|5|||
160613076|NCT05626751|579960351|FG002|Overall Study|Withdrawal by Subject|5|||
160613077|NCT06029127|579960352|FG000|Overall Study|Withdrawal by Subject|2|||
160613078|NCT06029127|579960353|FG001|Overall Study|Withdrawal by Subject|0|||
160613079|NCT06029127|579960352|FG000|Overall Study|Lost to Follow-up|1|||
160613080|NCT06029127|579960353|FG001|Overall Study|Lost to Follow-up|0|||
160613081|NCT06029127|579960352|FG000|Overall Study|Study Closed by Sponsor|6|||
160494283|NCT01296555|579539140|FG012|Overall Study|Reason Not Specified|0|||
160494284|NCT01296555|579539141|FG013|Overall Study|Reason Not Specified|1|||
160494285|NCT01296555|579539142|FG014|Overall Study|Reason Not Specified|2|||
160494286|NCT01296555|579539143|FG015|Overall Study|Reason Not Specified|3|||
160494287|NCT01296555|579539144|FG016|Overall Study|Reason Not Specified|7|||
160494288|NCT01296555|579539145|FG017|Overall Study|Reason Not Specified|4|||
160494289|NCT01296555|579539146|FG018|Overall Study|Reason Not Specified|3|||
160494290|NCT01296555|579539147|FG019|Overall Study|Reason Not Specified|7|||
160494291|NCT01296555|579539148|FG020|Overall Study|Reason Not Specified|11|||
160494292|NCT01296555|579539149|FG021|Overall Study|Reason Not Specified|5|||
160494293|NCT01296555|579539150|FG022|Overall Study|Reason Not Specified|5|||
160494294|NCT01296555|579539151|FG023|Overall Study|Reason Not Specified|7|||
160494295|NCT01296555|579539152|FG024|Overall Study|Reason Not Specified|2|||
160494296|NCT01296555|579539153|FG025|Overall Study|Reason Not Specified|2|||
160494297|NCT01296555|579539154|FG026|Overall Study|Reason Not Specified|19|||
160494298|NCT01296555|579539155|FG027|Overall Study|Reason Not Specified|11|||
160494299|NCT01296555|579539156|FG028|Overall Study|Reason Not Specified|9|||
160494300|NCT01296555|579539128|FG000|Overall Study|Physician Decision|0|||
160494301|NCT01296555|579539129|FG001|Overall Study|Physician Decision|0|||
160494302|NCT01296555|579539130|FG002|Overall Study|Physician Decision|0|||
160494303|NCT01296555|579539131|FG003|Overall Study|Physician Decision|0|||
160494304|NCT01296555|579539132|FG004|Overall Study|Physician Decision|1|||
160494305|NCT01296555|579539133|FG005|Overall Study|Physician Decision|0|||
160494306|NCT01296555|579539134|FG006|Overall Study|Physician Decision|0|||
160494307|NCT01296555|579539135|FG007|Overall Study|Physician Decision|0|||
160494308|NCT01296555|579539136|FG008|Overall Study|Physician Decision|0|||
160494309|NCT01296555|579539137|FG009|Overall Study|Physician Decision|0|||
160494310|NCT01296555|579539138|FG010|Overall Study|Physician Decision|0|||
160494311|NCT01296555|579539139|FG011|Overall Study|Physician Decision|0|||
160494312|NCT01296555|579539140|FG012|Overall Study|Physician Decision|0|||
160494313|NCT01296555|579539141|FG013|Overall Study|Physician Decision|1|||
160494314|NCT01296555|579539142|FG014|Overall Study|Physician Decision|0|||
160494315|NCT01296555|579539143|FG015|Overall Study|Physician Decision|0|||
160494316|NCT01296555|579539144|FG016|Overall Study|Physician Decision|0|||
160494317|NCT01296555|579539145|FG017|Overall Study|Physician Decision|0|||
160494318|NCT01296555|579539146|FG018|Overall Study|Physician Decision|0|||
160494319|NCT01296555|579539147|FG019|Overall Study|Physician Decision|1|||
160494320|NCT01296555|579539148|FG020|Overall Study|Physician Decision|0|||
160494321|NCT01296555|579539149|FG021|Overall Study|Physician Decision|0|||
160494322|NCT01296555|579539150|FG022|Overall Study|Physician Decision|0|||
160613082|NCT06029127|579960353|FG001|Overall Study|Study Closed by Sponsor|6|||
160613083|NCT06029127|579960352|FG000|Overall Study|Death|12|||
160613084|NCT06029127|579960353|FG001|Overall Study|Death|7|||
160494323|NCT01296555|579539151|FG023|Overall Study|Physician Decision|0|||
160494324|NCT01296555|579539152|FG024|Overall Study|Physician Decision|0|||
160494325|NCT01296555|579539153|FG025|Overall Study|Physician Decision|0|||
160494326|NCT01296555|579539154|FG026|Overall Study|Physician Decision|0|||
160494327|NCT01296555|579539155|FG027|Overall Study|Physician Decision|0|||
160494328|NCT01296555|579539156|FG028|Overall Study|Physician Decision|0|||
160494329|NCT01296555|579539128|FG000|Overall Study|Progressive Disease|6|||
160613085|NCT06029127|579960352|FG000|Overall Study|Declined Follow-Up Contact|0|||
160613086|NCT06029127|579960353|FG001|Overall Study|Declined Follow-Up Contact|1|||
160494330|NCT01296555|579539129|FG001|Overall Study|Progressive Disease|3|||
160494331|NCT01296555|579539130|FG002|Overall Study|Progressive Disease|3|||
160494332|NCT01296555|579539131|FG003|Overall Study|Progressive Disease|7|||
160613087|NCT01625000|579960354|FG000|Overall Study|Physician Decision|15|||
160494333|NCT01296555|579539132|FG004|Overall Study|Progressive Disease|6|||
160494334|NCT01296555|579539133|FG005|Overall Study|Progressive Disease|16|||
160494335|NCT01296555|579539134|FG006|Overall Study|Progressive Disease|16|||
160494336|NCT01296555|579539135|FG007|Overall Study|Progressive Disease|8|||
160494337|NCT01296555|579539136|FG008|Overall Study|Progressive Disease|7|||
160494338|NCT01296555|579539137|FG009|Overall Study|Progressive Disease|18|||
160494339|NCT01296555|579539138|FG010|Overall Study|Progressive Disease|7|||
160494340|NCT01296555|579539139|FG011|Overall Study|Progressive Disease|14|||
160494341|NCT01296555|579539140|FG012|Overall Study|Progressive Disease|5|||
160494342|NCT01296555|579539141|FG013|Overall Study|Progressive Disease|12|||
160494343|NCT01296555|579539142|FG014|Overall Study|Progressive Disease|1|||
160494344|NCT01296555|579539143|FG015|Overall Study|Progressive Disease|1|||
160494345|NCT01296555|579539144|FG016|Overall Study|Progressive Disease|0|||
160494346|NCT01296555|579539145|FG017|Overall Study|Progressive Disease|0|||
160494347|NCT01296555|579539146|FG018|Overall Study|Progressive Disease|0|||
160494348|NCT01296555|579539147|FG019|Overall Study|Progressive Disease|1|||
160494349|NCT01296555|579539148|FG020|Overall Study|Progressive Disease|0|||
160494350|NCT01296555|579539149|FG021|Overall Study|Progressive Disease|0|||
160494351|NCT01296555|579539150|FG022|Overall Study|Progressive Disease|0|||
160494352|NCT01296555|579539151|FG023|Overall Study|Progressive Disease|0|||
160494353|NCT01296555|579539152|FG024|Overall Study|Progressive Disease|1|||
160494354|NCT01296555|579539153|FG025|Overall Study|Progressive Disease|0|||
160494355|NCT01296555|579539154|FG026|Overall Study|Progressive Disease|5|||
160494356|NCT01296555|579539155|FG027|Overall Study|Progressive Disease|1|||
160494357|NCT01296555|579539156|FG028|Overall Study|Progressive Disease|0|||
160494358|NCT01296555|579539128|FG000|Overall Study|Protocol Violation|0|||
160494359|NCT01296555|579539129|FG001|Overall Study|Protocol Violation|0|||
160494360|NCT01296555|579539130|FG002|Overall Study|Protocol Violation|0|||
160494361|NCT01296555|579539131|FG003|Overall Study|Protocol Violation|0|||
160494362|NCT01296555|579539132|FG004|Overall Study|Protocol Violation|0|||
160494363|NCT01296555|579539133|FG005|Overall Study|Protocol Violation|0|||
160494364|NCT01296555|579539134|FG006|Overall Study|Protocol Violation|0|||
160494365|NCT01296555|579539135|FG007|Overall Study|Protocol Violation|0|||
160494366|NCT01296555|579539136|FG008|Overall Study|Protocol Violation|0|||
160494367|NCT01296555|579539137|FG009|Overall Study|Protocol Violation|0|||
160494368|NCT01296555|579539138|FG010|Overall Study|Protocol Violation|0|||
160494369|NCT01296555|579539139|FG011|Overall Study|Protocol Violation|0|||
160494370|NCT01296555|579539140|FG012|Overall Study|Protocol Violation|0|||
160494371|NCT01296555|579539141|FG013|Overall Study|Protocol Violation|1|||
160494372|NCT01296555|579539142|FG014|Overall Study|Protocol Violation|0|||
160494373|NCT01296555|579539143|FG015|Overall Study|Protocol Violation|0|||
160494374|NCT01296555|579539144|FG016|Overall Study|Protocol Violation|0|||
160494375|NCT01296555|579539145|FG017|Overall Study|Protocol Violation|0|||
160494376|NCT01296555|579539146|FG018|Overall Study|Protocol Violation|0|||
160494377|NCT01296555|579539147|FG019|Overall Study|Protocol Violation|0|||
160494378|NCT01296555|579539148|FG020|Overall Study|Protocol Violation|0|||
160494379|NCT01296555|579539149|FG021|Overall Study|Protocol Violation|0|||
160494380|NCT01296555|579539150|FG022|Overall Study|Protocol Violation|0|||
160494381|NCT01296555|579539151|FG023|Overall Study|Protocol Violation|0|||
160494382|NCT01296555|579539152|FG024|Overall Study|Protocol Violation|0|||
160494383|NCT01296555|579539153|FG025|Overall Study|Protocol Violation|0|||
160494384|NCT01296555|579539154|FG026|Overall Study|Protocol Violation|0|||
160494385|NCT01296555|579539155|FG027|Overall Study|Protocol Violation|0|||
160494386|NCT01296555|579539156|FG028|Overall Study|Protocol Violation|0|||
160494387|NCT01296555|579539128|FG000|Overall Study|Study Terminated By Sponsor|0|||
160494388|NCT01296555|579539129|FG001|Overall Study|Study Terminated By Sponsor|0|||
160494389|NCT01296555|579539130|FG002|Overall Study|Study Terminated By Sponsor|0|||
160494390|NCT01296555|579539131|FG003|Overall Study|Study Terminated By Sponsor|0|||
160494391|NCT01296555|579539132|FG004|Overall Study|Study Terminated By Sponsor|0|||
160494392|NCT01296555|579539133|FG005|Overall Study|Study Terminated By Sponsor|0|||
160494393|NCT01296555|579539134|FG006|Overall Study|Study Terminated By Sponsor|0|||
160494394|NCT01296555|579539135|FG007|Overall Study|Study Terminated By Sponsor|0|||
160494395|NCT01296555|579539136|FG008|Overall Study|Study Terminated By Sponsor|0|||
160494396|NCT01296555|579539137|FG009|Overall Study|Study Terminated By Sponsor|0|||
160494397|NCT01296555|579539138|FG010|Overall Study|Study Terminated By Sponsor|0|||
160494398|NCT01296555|579539139|FG011|Overall Study|Study Terminated By Sponsor|0|||
160494399|NCT01296555|579539140|FG012|Overall Study|Study Terminated By Sponsor|0|||
160494400|NCT01296555|579539141|FG013|Overall Study|Study Terminated By Sponsor|0|||
160494401|NCT01296555|579539142|FG014|Overall Study|Study Terminated By Sponsor|0|||
160494402|NCT01296555|579539143|FG015|Overall Study|Study Terminated By Sponsor|0|||
160494403|NCT01296555|579539144|FG016|Overall Study|Study Terminated By Sponsor|0|||
160494404|NCT01296555|579539145|FG017|Overall Study|Study Terminated By Sponsor|0|||
160494405|NCT01296555|579539146|FG018|Overall Study|Study Terminated By Sponsor|0|||
160494406|NCT01296555|579539147|FG019|Overall Study|Study Terminated By Sponsor|0|||
160494407|NCT01296555|579539148|FG020|Overall Study|Study Terminated By Sponsor|0|||
160494408|NCT01296555|579539149|FG021|Overall Study|Study Terminated By Sponsor|0|||
160494409|NCT01296555|579539150|FG022|Overall Study|Study Terminated By Sponsor|0|||
160494410|NCT01296555|579539151|FG023|Overall Study|Study Terminated By Sponsor|0|||
160494411|NCT01296555|579539152|FG024|Overall Study|Study Terminated By Sponsor|0|||
160494412|NCT01296555|579539153|FG025|Overall Study|Study Terminated By Sponsor|1|||
160494413|NCT01296555|579539154|FG026|Overall Study|Study Terminated By Sponsor|0|||
160613088|NCT01625000|579960355|FG001|Overall Study|Physician Decision|7|||
160613089|NCT01625000|579960356|FG002|Overall Study|Physician Decision|7|||
160613090|NCT01625000|579960357|FG003|Overall Study|Physician Decision|2|||
160613091|NCT01625000|579960358|FG004|Overall Study|Physician Decision|15|||
160613092|NCT01625000|579960354|FG000|Overall Study|Protocol Violation|3|||
160613093|NCT01625000|579960355|FG001|Overall Study|Protocol Violation|10|||
160613094|NCT01625000|579960356|FG002|Overall Study|Protocol Violation|4|||
160613095|NCT01625000|579960357|FG003|Overall Study|Protocol Violation|1|||
160613096|NCT01625000|579960358|FG004|Overall Study|Protocol Violation|2|||
160613097|NCT01625000|579960354|FG000|Overall Study|Withdrawal by Subject|19|||
160613098|NCT01625000|579960355|FG001|Overall Study|Withdrawal by Subject|16|||
160613099|NCT01625000|579960356|FG002|Overall Study|Withdrawal by Subject|11|||
160613100|NCT01625000|579960357|FG003|Overall Study|Withdrawal by Subject|9|||
160613101|NCT01625000|579960358|FG004|Overall Study|Withdrawal by Subject|17|||
160613102|NCT01625000|579960354|FG000|Overall Study|Adverse Event (including Death)|15|||
160613103|NCT01625000|579960355|FG001|Overall Study|Adverse Event (including Death)|19|||
160613104|NCT01625000|579960356|FG002|Overall Study|Adverse Event (including Death)|11|||
160613105|NCT01625000|579960357|FG003|Overall Study|Adverse Event (including Death)|7|||
160613106|NCT01625000|579960358|FG004|Overall Study|Adverse Event (including Death)|21|||
160613107|NCT03912064|579960359|FG000|Overall Study|Withdrawal by Subject|2|||
160613108|NCT03912064|579960360|FG001|Overall Study|Withdrawal by Subject|0|||
160613109|NCT03912064|579960361|FG002|Overall Study|Withdrawal by Subject|0|||
160613110|NCT03912064|579960359|FG000|Overall Study|Adverse reaction to Ipilimumab|2|||
160613111|NCT03912064|579960360|FG001|Overall Study|Adverse reaction to Ipilimumab|0|||
160613112|NCT03912064|579960361|FG002|Overall Study|Adverse reaction to Ipilimumab|1|||
160613113|NCT03912064|579960359|FG000|Overall Study|Progression/Relapse|7|||
160613114|NCT03912064|579960360|FG001|Overall Study|Progression/Relapse|3|||
160613115|NCT03912064|579960361|FG002|Overall Study|Progression/Relapse|0|||
160613116|NCT03912064|579960359|FG000|Overall Study|Prolonged treatment delays|3|||
160613117|NCT03912064|579960360|FG001|Overall Study|Prolonged treatment delays|2|||
160613118|NCT03912064|579960361|FG002|Overall Study|Prolonged treatment delays|0|||
160613119|NCT03912064|579960359|FG000|Overall Study|Prohibited concomitant treatments|3|||
160613120|NCT03912064|579960360|FG001|Overall Study|Prohibited concomitant treatments|1|||
160613121|NCT03912064|579960361|FG002|Overall Study|Prohibited concomitant treatments|0|||
160613122|NCT01026194|579960362|FG000|Period 1：Double Blind Period|Adverse Event|2|||
160613123|NCT01026194|579960363|FG001|Period 1：Double Blind Period|Adverse Event|1|||
160613124|NCT01026194|579960362|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
160494414|NCT01296555|579539155|FG027|Overall Study|Study Terminated By Sponsor|0|||
160494415|NCT01296555|579539156|FG028|Overall Study|Study Terminated By Sponsor|0|||
160494416|NCT01296555|579539128|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494417|NCT01296555|579539129|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494418|NCT01296555|579539130|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494419|NCT01296555|579539131|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494420|NCT01296555|579539132|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494421|NCT01296555|579539133|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494422|NCT01296555|579539134|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494423|NCT01296555|579539135|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494424|NCT01296555|579539136|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494425|NCT01296555|579539137|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494426|NCT01296555|579539138|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494427|NCT01296555|579539139|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494428|NCT01296555|579539140|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494429|NCT01296555|579539141|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494430|NCT01296555|579539142|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494431|NCT01296555|579539143|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494432|NCT01296555|579539144|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494433|NCT01296555|579539145|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494434|NCT01296555|579539146|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494435|NCT01296555|579539147|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
160494436|NCT01296555|579539148|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494437|NCT01296555|579539149|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494438|NCT01296555|579539150|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494439|NCT01296555|579539151|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494440|NCT01296555|579539152|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494441|NCT01296555|579539153|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494442|NCT01296555|579539154|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494443|NCT01296555|579539155|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160613125|NCT01026194|579960363|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
160613126|NCT01026194|579960362|FG000|Period 1：Double Blind Period|Physician Decision|0|||
160613127|NCT01026194|579960363|FG001|Period 1：Double Blind Period|Physician Decision|4|||
160494444|NCT01296555|579539156|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
160494445|NCT01296555|579539128|FG000|Overall Study|Death|0|||
160494446|NCT01296555|579539129|FG001|Overall Study|Death|0|||
160494447|NCT01296555|579539130|FG002|Overall Study|Death|0|||
160494448|NCT01296555|579539131|FG003|Overall Study|Death|2|||
160494449|NCT01296555|579539132|FG004|Overall Study|Death|1|||
160494450|NCT01296555|579539133|FG005|Overall Study|Death|0|||
160494451|NCT01296555|579539134|FG006|Overall Study|Death|2|||
160494452|NCT01296555|579539135|FG007|Overall Study|Death|0|||
160494453|NCT01296555|579539136|FG008|Overall Study|Death|0|||
160494454|NCT01296555|579539137|FG009|Overall Study|Death|1|||
160494455|NCT01296555|579539138|FG010|Overall Study|Death|0|||
160494456|NCT01296555|579539139|FG011|Overall Study|Death|1|||
160494457|NCT01296555|579539140|FG012|Overall Study|Death|0|||
160494458|NCT01296555|579539141|FG013|Overall Study|Death|2|||
160494459|NCT01296555|579539142|FG014|Overall Study|Death|27|||
160494460|NCT01296555|579539143|FG015|Overall Study|Death|15|||
160494461|NCT01296555|579539144|FG016|Overall Study|Death|11|||
160494462|NCT01296555|579539145|FG017|Overall Study|Death|11|||
160494463|NCT01296555|579539146|FG018|Overall Study|Death|17|||
160494464|NCT01296555|579539147|FG019|Overall Study|Death|12|||
160494465|NCT01296555|579539148|FG020|Overall Study|Death|13|||
160494466|NCT01296555|579539149|FG021|Overall Study|Death|12|||
160494467|NCT01296555|579539150|FG022|Overall Study|Death|12|||
160494468|NCT01296555|579539151|FG023|Overall Study|Death|13|||
160494469|NCT01296555|579539152|FG024|Overall Study|Death|7|||
160494470|NCT01296555|579539153|FG025|Overall Study|Death|7|||
160494471|NCT01296555|579539154|FG026|Overall Study|Death|35|||
160494472|NCT01296555|579539155|FG027|Overall Study|Death|92|||
160494473|NCT01296555|579539156|FG028|Overall Study|Death|44|||
160494474|NCT01296555|579539128|FG000|Overall Study|Lost to Follow-up|0|||
160494475|NCT01296555|579539129|FG001|Overall Study|Lost to Follow-up|0|||
160494476|NCT01296555|579539130|FG002|Overall Study|Lost to Follow-up|0|||
160494477|NCT01296555|579539131|FG003|Overall Study|Lost to Follow-up|0|||
160494478|NCT01296555|579539132|FG004|Overall Study|Lost to Follow-up|0|||
160494479|NCT01296555|579539133|FG005|Overall Study|Lost to Follow-up|0|||
160494480|NCT01296555|579539134|FG006|Overall Study|Lost to Follow-up|0|||
160494481|NCT01296555|579539135|FG007|Overall Study|Lost to Follow-up|0|||
160494482|NCT01296555|579539136|FG008|Overall Study|Lost to Follow-up|0|||
160494483|NCT01296555|579539137|FG009|Overall Study|Lost to Follow-up|0|||
160494484|NCT01296555|579539138|FG010|Overall Study|Lost to Follow-up|0|||
160494485|NCT01296555|579539139|FG011|Overall Study|Lost to Follow-up|0|||
160494486|NCT01296555|579539140|FG012|Overall Study|Lost to Follow-up|0|||
160494487|NCT01296555|579539141|FG013|Overall Study|Lost to Follow-up|0|||
160494488|NCT01296555|579539142|FG014|Overall Study|Lost to Follow-up|2|||
160494489|NCT01296555|579539143|FG015|Overall Study|Lost to Follow-up|1|||
160494490|NCT01296555|579539144|FG016|Overall Study|Lost to Follow-up|0|||
160494491|NCT01296555|579539145|FG017|Overall Study|Lost to Follow-up|2|||
160494492|NCT01296555|579539146|FG018|Overall Study|Lost to Follow-up|0|||
160494493|NCT01296555|579539147|FG019|Overall Study|Lost to Follow-up|2|||
160494494|NCT01296555|579539148|FG020|Overall Study|Lost to Follow-up|3|||
160494495|NCT01296555|579539149|FG021|Overall Study|Lost to Follow-up|2|||
160494496|NCT01296555|579539150|FG022|Overall Study|Lost to Follow-up|0|||
160494497|NCT01296555|579539151|FG023|Overall Study|Lost to Follow-up|0|||
160494498|NCT01296555|579539152|FG024|Overall Study|Lost to Follow-up|0|||
160494499|NCT01296555|579539153|FG025|Overall Study|Lost to Follow-up|0|||
160494500|NCT01296555|579539154|FG026|Overall Study|Lost to Follow-up|3|||
160494501|NCT01296555|579539155|FG027|Overall Study|Lost to Follow-up|13|||
160494502|NCT01296555|579539156|FG028|Overall Study|Lost to Follow-up|5|||
160494503|NCT01296555|579539128|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160494504|NCT01296555|579539129|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160494505|NCT01296555|579539130|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160494506|NCT01296555|579539131|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160494507|NCT01296555|579539132|FG004|Overall Study|Non-Compliance With Study Drug|0|||
160494508|NCT01296555|579539133|FG005|Overall Study|Non-Compliance With Study Drug|0|||
160613128|NCT01026194|579960362|FG000|Period 2：Open-label Period|Adverse Event|4|||
160613129|NCT01026194|579960363|FG001|Period 2：Open-label Period|Adverse Event|5|||
160661501|NCT00696020|580144117|FG002|Overall Study|Protocol Violation|0|||
160494509|NCT01296555|579539134|FG006|Overall Study|Non-Compliance With Study Drug|0|||
160494510|NCT01296555|579539135|FG007|Overall Study|Non-Compliance With Study Drug|1|||
160494511|NCT01296555|579539136|FG008|Overall Study|Non-Compliance With Study Drug|0|||
160494512|NCT01296555|579539137|FG009|Overall Study|Non-Compliance With Study Drug|0|||
160494513|NCT01296555|579539138|FG010|Overall Study|Non-Compliance With Study Drug|0|||
160494514|NCT01296555|579539139|FG011|Overall Study|Non-Compliance With Study Drug|0|||
160494515|NCT01296555|579539140|FG012|Overall Study|Non-Compliance With Study Drug|0|||
160494516|NCT01296555|579539141|FG013|Overall Study|Non-Compliance With Study Drug|0|||
160494517|NCT01296555|579539142|FG014|Overall Study|Non-Compliance With Study Drug|0|||
160494518|NCT01296555|579539143|FG015|Overall Study|Non-Compliance With Study Drug|0|||
160494519|NCT01296555|579539144|FG016|Overall Study|Non-Compliance With Study Drug|0|||
160494520|NCT01296555|579539145|FG017|Overall Study|Non-Compliance With Study Drug|0|||
160494521|NCT01296555|579539146|FG018|Overall Study|Non-Compliance With Study Drug|0|||
160494522|NCT01296555|579539147|FG019|Overall Study|Non-Compliance With Study Drug|0|||
160494523|NCT01296555|579539148|FG020|Overall Study|Non-Compliance With Study Drug|0|||
160613130|NCT01026194|579960362|FG000|Period 2：Open-label Period|Physician Decision|3|||
160613131|NCT01026194|579960363|FG001|Period 2：Open-label Period|Physician Decision|1|||
160613132|NCT01026194|579960362|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
160613133|NCT01026194|579960363|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
160613134|NCT04295759|579960364|FG000|Overall Study|Lack of Efficacy|9|||
160613135|NCT04295759|579960364|FG000|Overall Study|Death|1|||
160613136|NCT04295759|579960364|FG000|Overall Study|Withdrawal by Subject|2|||
160613137|NCT04295759|579960364|FG000|Overall Study|Deemed ineligible|1|||
160613138|NCT01685372|579960365|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
160613139|NCT01685372|579960366|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
160613140|NCT05740566|579960367|FG000|Overall Study|Death|151|||
160613141|NCT05740566|579960368|FG001|Overall Study|Death|111|||
160613142|NCT05740566|579960367|FG000|Overall Study|Withdrawal by Subject|2|||
160613143|NCT05740566|579960368|FG001|Overall Study|Withdrawal by Subject|0|||
160613144|NCT05740566|579960367|FG000|Overall Study|Ongoing in study|102|||
160613145|NCT05740566|579960368|FG001|Overall Study|Ongoing in study|143|||
160613146|NCT06210035|579960369|FG000|Overall Study|Withdrawal by Subject|3|||
160613147|NCT06210035|579960370|FG001|Overall Study|Withdrawal by Subject|0|||
160613148|NCT06210035|579960371|FG002|Overall Study|Withdrawal by Subject|0|||
160613149|NCT01626859|579960372|FG000|Overall Study|Adverse Event|1|||
160613150|NCT01626859|579960373|FG001|Overall Study|Adverse Event|3|||
160613151|NCT01626859|579960374|FG002|Overall Study|Adverse Event|2|||
160613152|NCT01626859|579960372|FG000|Overall Study|Physician Decision|0|||
160613153|NCT01626859|579960373|FG001|Overall Study|Physician Decision|1|||
160613154|NCT01626859|579960374|FG002|Overall Study|Physician Decision|0|||
160613155|NCT01626859|579960372|FG000|Overall Study|Withdrawal by Subject|1|||
160613156|NCT01626859|579960373|FG001|Overall Study|Withdrawal by Subject|4|||
160613157|NCT01626859|579960374|FG002|Overall Study|Withdrawal by Subject|2|||
160613158|NCT05616221|579960385|FG000|Overall Study|Withdrawal by Subject|0|||
160613159|NCT05616221|579960386|FG001|Overall Study|Withdrawal by Subject|1|||
160613160|NCT05616221|579960387|FG002|Overall Study|Withdrawal by Subject|0|||
160613161|NCT05616221|579960388|FG003|Overall Study|Withdrawal by Subject|0|||
160613162|NCT05616221|579960389|FG004|Overall Study|Withdrawal by Subject|0|||
160613163|NCT05616221|579960390|FG005|Overall Study|Withdrawal by Subject|0|||
160613164|NCT05616221|579960385|FG000|Overall Study|Adverse Event|0|||
160613165|NCT05616221|579960386|FG001|Overall Study|Adverse Event|2|||
160613166|NCT05616221|579960387|FG002|Overall Study|Adverse Event|0|||
160613167|NCT05616221|579960388|FG003|Overall Study|Adverse Event|0|||
160613168|NCT05616221|579960389|FG004|Overall Study|Adverse Event|2|||
160613169|NCT05616221|579960390|FG005|Overall Study|Adverse Event|0|||
160613170|NCT04880733|579960391|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
160613171|NCT04880733|579960392|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
160613172|NCT04880733|579960393|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
160613173|NCT04880733|579960391|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
160613174|NCT04880733|579960392|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
160613175|NCT04880733|579960393|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
160613176|NCT04880733|579960391|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
160613177|NCT04880733|579960392|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
160613178|NCT04880733|579960393|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
160613179|NCT04880733|579960391|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
160613180|NCT04880733|579960392|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
160613181|NCT04880733|579960393|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
160613182|NCT04880733|579960391|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
160613183|NCT04880733|579960392|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
160613184|NCT04880733|579960393|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
160613185|NCT00862992|579960394|FG000|Overall Study|Adverse Event|2|||
160613186|NCT00862992|579960395|FG001|Overall Study|Adverse Event|1|||
160613187|NCT00862992|579960396|FG002|Overall Study|Adverse Event|1|||
160613188|NCT00862992|579960394|FG000|Overall Study|Physician Decision|1|||
160613189|NCT00862992|579960395|FG001|Overall Study|Physician Decision|0|||
160613190|NCT00862992|579960396|FG002|Overall Study|Physician Decision|0|||
160613191|NCT00862992|579960394|FG000|Overall Study|Withdrawal by Subject|0|||
160613192|NCT00862992|579960395|FG001|Overall Study|Withdrawal by Subject|0|||
160613193|NCT00862992|579960396|FG002|Overall Study|Withdrawal by Subject|2|||
160613194|NCT03737318|579960398|FG000|Phase 2 (Generalization)|Withdrawal by Subject|4|||
160613195|NCT03737318|579960399|FG001|Phase 2 (Generalization)|Withdrawal by Subject|1|||
160613196|NCT03737318|579960400|FG002|Phase 2 (Generalization)|Withdrawal by Subject|1|||
160613197|NCT04167514|579961609|FG000|Overall Study|Adverse event, not serious|0|||
160613198|NCT04167514|579961610|FG001|Overall Study|Adverse event, not serious|1|||
160613199|NCT04167514|579961609|FG000|Overall Study|Lost to Follow-up|1|||
160613200|NCT04167514|579961610|FG001|Overall Study|Lost to Follow-up|0|||
160613201|NCT04167514|579961609|FG000|Overall Study|Participant Decision|2|||
160613202|NCT04167514|579961610|FG001|Overall Study|Participant Decision|4|||
160613203|NCT04167514|579961609|FG000|Overall Study|Physician Decision|3|||
160494524|NCT01296555|579539149|FG021|Overall Study|Non-Compliance With Study Drug|0|||
160494525|NCT01296555|579539150|FG022|Overall Study|Non-Compliance With Study Drug|0|||
160494526|NCT01296555|579539151|FG023|Overall Study|Non-Compliance With Study Drug|0|||
160494527|NCT01296555|579539152|FG024|Overall Study|Non-Compliance With Study Drug|0|||
160494528|NCT01296555|579539153|FG025|Overall Study|Non-Compliance With Study Drug|0|||
160494529|NCT01296555|579539154|FG026|Overall Study|Non-Compliance With Study Drug|0|||
160494530|NCT01296555|579539155|FG027|Overall Study|Non-Compliance With Study Drug|0|||
160494531|NCT01296555|579539156|FG028|Overall Study|Non-Compliance With Study Drug|0|||
160494532|NCT01296555|579539128|FG000|Overall Study|Withdrawal by Subject|0|||
160494533|NCT01296555|579539129|FG001|Overall Study|Withdrawal by Subject|0|||
160494534|NCT01296555|579539130|FG002|Overall Study|Withdrawal by Subject|0|||
160494535|NCT01296555|579539131|FG003|Overall Study|Withdrawal by Subject|0|||
160494536|NCT01296555|579539132|FG004|Overall Study|Withdrawal by Subject|1|||
160494537|NCT01296555|579539133|FG005|Overall Study|Withdrawal by Subject|0|||
160494538|NCT01296555|579539134|FG006|Overall Study|Withdrawal by Subject|1|||
160494539|NCT01296555|579539135|FG007|Overall Study|Withdrawal by Subject|0|||
160494540|NCT01296555|579539136|FG008|Overall Study|Withdrawal by Subject|0|||
160494541|NCT01296555|579539137|FG009|Overall Study|Withdrawal by Subject|0|||
160494542|NCT01296555|579539138|FG010|Overall Study|Withdrawal by Subject|1|||
160494543|NCT01296555|579539139|FG011|Overall Study|Withdrawal by Subject|1|||
160494544|NCT01296555|579539140|FG012|Overall Study|Withdrawal by Subject|0|||
160494545|NCT01296555|579539141|FG013|Overall Study|Withdrawal by Subject|0|||
160494546|NCT01296555|579539142|FG014|Overall Study|Withdrawal by Subject|3|||
160494547|NCT01296555|579539143|FG015|Overall Study|Withdrawal by Subject|0|||
160494548|NCT01296555|579539144|FG016|Overall Study|Withdrawal by Subject|2|||
160494549|NCT01296555|579539145|FG017|Overall Study|Withdrawal by Subject|1|||
160494550|NCT01296555|579539146|FG018|Overall Study|Withdrawal by Subject|0|||
160494551|NCT01296555|579539147|FG019|Overall Study|Withdrawal by Subject|1|||
160494552|NCT01296555|579539148|FG020|Overall Study|Withdrawal by Subject|1|||
160494553|NCT01296555|579539149|FG021|Overall Study|Withdrawal by Subject|1|||
160494554|NCT01296555|579539150|FG022|Overall Study|Withdrawal by Subject|3|||
160494555|NCT01296555|579539151|FG023|Overall Study|Withdrawal by Subject|0|||
160494556|NCT01296555|579539152|FG024|Overall Study|Withdrawal by Subject|0|||
160494557|NCT01296555|579539153|FG025|Overall Study|Withdrawal by Subject|0|||
160494558|NCT01296555|579539154|FG026|Overall Study|Withdrawal by Subject|8|||
160494559|NCT01296555|579539155|FG027|Overall Study|Withdrawal by Subject|4|||
160494560|NCT01296555|579539156|FG028|Overall Study|Withdrawal by Subject|2|||
160494561|NCT00857233|579539158|FG000|Overall Study|Adverse Event|24|||
160494562|NCT00857233|579539158|FG000|Overall Study|Lack of Efficacy|1|||
160494563|NCT00857233|579539158|FG000|Overall Study|Non-compliance|1|||
160494564|NCT00857233|579539158|FG000|Overall Study|Withdrawal of Consent|9|||
160494565|NCT00857233|579539158|FG000|Overall Study|Lost to Follow-up|4|||
160494566|NCT00857233|579539158|FG000|Overall Study|Nursing Home Placement|14|||
160494567|NCT00857233|579539158|FG000|Overall Study|Other Reasons|2|||
160494568|NCT01560871|579539159|FG000|Overall Study|transportation issues|2|||
160494569|NCT01560871|579539160|FG001|Overall Study|transportation issues|1|||
160494570|NCT01560871|579539159|FG000|Overall Study|relocation|1|||
160494571|NCT01560871|579539160|FG001|Overall Study|relocation|0|||
160494572|NCT01560871|579539159|FG000|Overall Study|readmission to a hospital|2|||
160494573|NCT01560871|579539160|FG001|Overall Study|readmission to a hospital|1|||
160494574|NCT01560871|579539159|FG000|Overall Study|Lost to Follow-up|1|||
160494575|NCT01560871|579539160|FG001|Overall Study|Lost to Follow-up|0|||
160494576|NCT01587118|579539161|FG000|Overall Study|Adverse Event|3|||
160494577|NCT01587118|579539161|FG000|Overall Study|Lost to Follow-up|2|||
160494578|NCT01587118|579539161|FG000|Overall Study|Relocation|1|||
160494579|NCT01587118|579539161|FG000|Overall Study|nonresponse|1|||
160494580|NCT01278615|579539163|FG000|Overall Study|Withdrawal by Subject|2|||
160494581|NCT00243022|579539164|FG000|Overall Study|Withdrawal by Subject|1|||
160494582|NCT00243022|579539165|FG001|Overall Study|Withdrawal by Subject|0|||
160494583|NCT00243022|579539164|FG000|Overall Study|Death|1|||
160494584|NCT00243022|579539165|FG001|Overall Study|Death|0|||
160494585|NCT00243022|579539164|FG000|Overall Study|Difficult Travel Distance|0|||
160494586|NCT00243022|579539165|FG001|Overall Study|Difficult Travel Distance|1|||
160494587|NCT01390441|579539170|FG000|Treatment Period|Protocol Violation|0|||
160494588|NCT01390441|579539171|FG001|Treatment Period|Protocol Violation|1|||
160494589|NCT01390441|579539172|FG002|Treatment Period|Protocol Violation|0|||
160494590|NCT01390441|579539173|FG003|Treatment Period|Protocol Violation|0|||
160494591|NCT01390441|579539174|FG004|Treatment Period|Protocol Violation|0|||
160494592|NCT01390441|579539170|FG000|Treatment Period|Physician Decision|0|||
160494593|NCT01390441|579539171|FG001|Treatment Period|Physician Decision|0|||
160494594|NCT01390441|579539172|FG002|Treatment Period|Physician Decision|0|||
160494595|NCT01390441|579539173|FG003|Treatment Period|Physician Decision|1|||
160494596|NCT01390441|579539174|FG004|Treatment Period|Physician Decision|0|||
160494597|NCT01390441|579539170|FG000|Treatment Period|Lack of Efficacy|0|||
160494598|NCT01390441|579539171|FG001|Treatment Period|Lack of Efficacy|0|||
160494599|NCT01390441|579539172|FG002|Treatment Period|Lack of Efficacy|0|||
160613204|NCT04167514|579961610|FG001|Overall Study|Physician Decision|2|||
160613205|NCT04167514|579961609|FG000|Overall Study|Death|14|||
160613206|NCT04167514|579961610|FG001|Overall Study|Death|18|||
160613207|NCT04167514|579961609|FG000|Overall Study|Enrolled but treatment not administered|2|||
160613208|NCT04167514|579961610|FG001|Overall Study|Enrolled but treatment not administered|0|||
160613209|NCT04167514|579961609|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
160613210|NCT04167514|579961610|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
160613211|NCT04167514|579961609|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
160613212|NCT04167514|579961610|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
160613213|NCT03225833|579961613|FG000|Overall Study|Adverse Event|0|||
160613214|NCT03225833|579961614|FG001|Overall Study|Adverse Event|1|||
160613215|NCT03225833|579961615|FG002|Overall Study|Adverse Event|2|||
160613216|NCT03225833|579961616|FG003|Overall Study|Adverse Event|0|||
160613217|NCT03225833|579961617|FG004|Overall Study|Adverse Event|0|||
160613218|NCT03225833|579961618|FG005|Overall Study|Adverse Event|2|||
160613219|NCT03225833|579961613|FG000|Overall Study|Withdrawal by Subject|1|||
160613220|NCT03225833|579961614|FG001|Overall Study|Withdrawal by Subject|0|||
160613221|NCT03225833|579961615|FG002|Overall Study|Withdrawal by Subject|0|||
160613222|NCT03225833|579961616|FG003|Overall Study|Withdrawal by Subject|0|||
160613223|NCT03225833|579961617|FG004|Overall Study|Withdrawal by Subject|1|||
160613224|NCT03225833|579961618|FG005|Overall Study|Withdrawal by Subject|0|||
160613225|NCT03225833|579961613|FG000|Overall Study|Termination of Study by Sponsor|4|||
160613226|NCT03225833|579961614|FG001|Overall Study|Termination of Study by Sponsor|0|||
160613227|NCT03225833|579961615|FG002|Overall Study|Termination of Study by Sponsor|0|||
160613228|NCT03225833|579961616|FG003|Overall Study|Termination of Study by Sponsor|0|||
160613229|NCT03225833|579961617|FG004|Overall Study|Termination of Study by Sponsor|0|||
160613230|NCT03225833|579961618|FG005|Overall Study|Termination of Study by Sponsor|7|||
160613231|NCT03225833|579961613|FG000|Overall Study|Sponsor Decision|0|||
160613232|NCT03225833|579961614|FG001|Overall Study|Sponsor Decision|0|||
160613233|NCT03225833|579961615|FG002|Overall Study|Sponsor Decision|0|||
160613234|NCT03225833|579961616|FG003|Overall Study|Sponsor Decision|0|||
160613235|NCT03225833|579961617|FG004|Overall Study|Sponsor Decision|0|||
160613236|NCT03225833|579961618|FG005|Overall Study|Sponsor Decision|1|||
160613237|NCT00829010|579961622|FG000|Overall Study|Adverse Event|1|||
160613238|NCT00829010|579961623|FG001|Overall Study|Adverse Event|0|||
160613239|NCT00829010|579961624|FG002|Overall Study|Adverse Event|0|||
160613240|NCT00829010|579961625|FG003|Overall Study|Adverse Event|0|||
160613241|NCT00829010|579961626|FG004|Overall Study|Adverse Event|0|||
160613242|NCT00829010|579961622|FG000|Overall Study|Withdrawal by Subject|0|||
160613243|NCT00829010|579961623|FG001|Overall Study|Withdrawal by Subject|1|||
160613244|NCT00829010|579961624|FG002|Overall Study|Withdrawal by Subject|1|||
160613245|NCT00829010|579961625|FG003|Overall Study|Withdrawal by Subject|0|||
160661502|NCT00696020|580144118|FG003|Overall Study|Protocol Violation|1|||
160494600|NCT01390441|579539173|FG003|Treatment Period|Lack of Efficacy|0|||
160494601|NCT01390441|579539174|FG004|Treatment Period|Lack of Efficacy|1|||
160494602|NCT01390441|579539170|FG000|Treatment Period|Unknown due to early stopping of study|0|||
160494603|NCT01390441|579539171|FG001|Treatment Period|Unknown due to early stopping of study|0|||
160494604|NCT01390441|579539172|FG002|Treatment Period|Unknown due to early stopping of study|8|||
160494605|NCT01390441|579539173|FG003|Treatment Period|Unknown due to early stopping of study|11|||
160494606|NCT01390441|579539174|FG004|Treatment Period|Unknown due to early stopping of study|7|||
160494607|NCT01390441|579539170|FG000|Treatment Period|Adverse Event|0|||
160494608|NCT01390441|579539171|FG001|Treatment Period|Adverse Event|0|||
160494609|NCT01390441|579539172|FG002|Treatment Period|Adverse Event|1|||
160494610|NCT01390441|579539173|FG003|Treatment Period|Adverse Event|1|||
160494611|NCT01390441|579539174|FG004|Treatment Period|Adverse Event|2|||
160494612|NCT01390441|579539170|FG000|Treatment Period|Withdrawal by Subject|0|||
160494613|NCT01390441|579539171|FG001|Treatment Period|Withdrawal by Subject|0|||
160494614|NCT01390441|579539172|FG002|Treatment Period|Withdrawal by Subject|1|||
160494615|NCT01390441|579539173|FG003|Treatment Period|Withdrawal by Subject|0|||
160494616|NCT01390441|579539174|FG004|Treatment Period|Withdrawal by Subject|1|||
160494617|NCT01390441|579539170|FG000|Treatment Period|Lost to Follow-up|1|||
160494618|NCT01390441|579539171|FG001|Treatment Period|Lost to Follow-up|0|||
160494619|NCT01390441|579539172|FG002|Treatment Period|Lost to Follow-up|0|||
160613246|NCT00829010|579961626|FG004|Overall Study|Withdrawal by Subject|2|||
160613247|NCT00829010|579961622|FG000|Overall Study|Lost to Follow-up|1|||
160613248|NCT00829010|579961623|FG001|Overall Study|Lost to Follow-up|0|||
160613249|NCT00829010|579961624|FG002|Overall Study|Lost to Follow-up|2|||
160613250|NCT00829010|579961625|FG003|Overall Study|Lost to Follow-up|0|||
160613251|NCT00829010|579961626|FG004|Overall Study|Lost to Follow-up|0|||
160494620|NCT01390441|579539173|FG003|Treatment Period|Lost to Follow-up|0|||
160494621|NCT01390441|579539174|FG004|Treatment Period|Lost to Follow-up|0|||
160494622|NCT01390441|579539170|FG000|Extension Period|Protocol Violation|3|||
160494623|NCT01390441|579539171|FG001|Extension Period|Protocol Violation|1|||
160613252|NCT00829010|579961622|FG000|Overall Study|Fatality|5|||
160613253|NCT00829010|579961623|FG001|Overall Study|Fatality|4|||
160613254|NCT00829010|579961624|FG002|Overall Study|Fatality|0|||
160613255|NCT00829010|579961625|FG003|Overall Study|Fatality|3|||
160613256|NCT00829010|579961626|FG004|Overall Study|Fatality|0|||
160613257|NCT00829010|579961622|FG000|Overall Study|Migrated/Moved from study area|3|||
160613258|NCT00829010|579961623|FG001|Overall Study|Migrated/Moved from study area|4|||
160613259|NCT00829010|579961624|FG002|Overall Study|Migrated/Moved from study area|0|||
160613260|NCT00829010|579961625|FG003|Overall Study|Migrated/Moved from study area|5|||
160613261|NCT00829010|579961626|FG004|Overall Study|Migrated/Moved from study area|0|||
160613262|NCT01029691|579961627|FG000|Continued APAP to Delivery|Death|0|||
160613263|NCT01029691|579961628|FG001|Continued APAP to Delivery|Death|0|||
160613264|NCT01029691|579961629|FG002|Continued APAP to Delivery|Death|1|||
160613265|NCT05492877|579961634|FG000|Overall Study|Adverse Event|11|||
160613266|NCT05492877|579961635|FG001|Overall Study|Adverse Event|7|||
160613267|NCT05492877|579961634|FG000|Overall Study|Death|1|||
160613268|NCT05492877|579961635|FG001|Overall Study|Death|0|||
160613269|NCT05492877|579961634|FG000|Overall Study|Lost to Follow-up|1|||
160613270|NCT05492877|579961635|FG001|Overall Study|Lost to Follow-up|1|||
160613271|NCT05492877|579961634|FG000|Overall Study|Physician Decision|1|||
160613272|NCT05492877|579961635|FG001|Overall Study|Physician Decision|2|||
160613273|NCT05492877|579961634|FG000|Overall Study|Protocol Violation|1|||
160613274|NCT05492877|579961635|FG001|Overall Study|Protocol Violation|1|||
160613275|NCT05492877|579961634|FG000|Overall Study|Withdrawal by Subject|3|||
160613276|NCT05492877|579961635|FG001|Overall Study|Withdrawal by Subject|7|||
160613277|NCT05492877|579961634|FG000|Overall Study|Reason not specified|6|||
160613278|NCT05492877|579961635|FG001|Overall Study|Reason not specified|4|||
160613279|NCT04554394|579961637|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
160613280|NCT04554394|579961638|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
160613281|NCT04554394|579961637|FG000|Overall Study|Withdrawal by Subject|2|||
160613282|NCT04554394|579961638|FG001|Overall Study|Withdrawal by Subject|2|||
160613283|NCT04554394|579961637|FG000|Overall Study|Lost to Follow-up|2|||
160613284|NCT04554394|579961638|FG001|Overall Study|Lost to Follow-up|2|||
160613285|NCT04554394|579961637|FG000|Overall Study|Physician Decision|1|||
160613286|NCT04554394|579961638|FG001|Overall Study|Physician Decision|1|||
160613287|NCT00886587|579961639|FG000|Overall Study|Adverse Event|2|||
160613288|NCT00886587|579961640|FG001|Overall Study|Adverse Event|1|||
160613289|NCT00886587|579961639|FG000|Overall Study|Protocol Violation|2|||
160613290|NCT00886587|579961640|FG001|Overall Study|Protocol Violation|0|||
160613291|NCT00886587|579961639|FG000|Overall Study|Withdrawal by Subject|0|||
160613292|NCT00886587|579961640|FG001|Overall Study|Withdrawal by Subject|1|||
160613293|NCT00398086|579961644|FG000|Overall Study|Unacceptable Toxicity|2|||
160613294|NCT00398086|579961645|FG001|Overall Study|Unacceptable Toxicity|8|||
160613295|NCT00398086|579961646|FG002|Overall Study|Unacceptable Toxicity|2|||
160613296|NCT00398086|579961644|FG000|Overall Study|Adverse Event|1|||
160494624|NCT01390441|579539172|FG002|Extension Period|Protocol Violation|0|||
160494625|NCT01390441|579539173|FG003|Extension Period|Protocol Violation|1|||
160494626|NCT01390441|579539174|FG004|Extension Period|Protocol Violation|0|||
160494627|NCT03802617|579539175|FG000|Overall Study|Adverse Event|0|||
160494628|NCT03802617|579539176|FG001|Overall Study|Adverse Event|4|||
160494629|NCT03802617|579539177|FG002|Overall Study|Adverse Event|5|||
160494630|NCT03802617|579539178|FG003|Overall Study|Adverse Event|1|||
160494631|NCT03802617|579539175|FG000|Overall Study|Lack of Efficacy|0|||
160494632|NCT03802617|579539176|FG001|Overall Study|Lack of Efficacy|1|||
160613297|NCT00398086|579961645|FG001|Overall Study|Adverse Event|4|||
160613298|NCT00398086|579961646|FG002|Overall Study|Adverse Event|0|||
160613299|NCT00398086|579961644|FG000|Overall Study|Physician Decision|1|||
160613300|NCT00398086|579961645|FG001|Overall Study|Physician Decision|4|||
160613301|NCT00398086|579961646|FG002|Overall Study|Physician Decision|0|||
160613302|NCT00398086|579961644|FG000|Overall Study|Withdrawal by Subject|5|||
160613303|NCT00398086|579961645|FG001|Overall Study|Withdrawal by Subject|7|||
160613304|NCT00398086|579961646|FG002|Overall Study|Withdrawal by Subject|0|||
160613305|NCT00696774|579961647|FG000|Period II|Adverse Event|0|||
160613306|NCT00696774|579961648|FG001|Period II|Adverse Event|0|||
160613307|NCT00696774|579961649|FG002|Period II|Adverse Event|15|||
160613308|NCT00696774|579961647|FG000|Period II|Lost to Follow-up|0|||
160613309|NCT00696774|579961648|FG001|Period II|Lost to Follow-up|0|||
160613310|NCT00696774|579961649|FG002|Period II|Lost to Follow-up|4|||
160613311|NCT00696774|579961647|FG000|Period II|Protocol Violation|0|||
160613312|NCT00696774|579961648|FG001|Period II|Protocol Violation|0|||
160613313|NCT00696774|579961649|FG002|Period II|Protocol Violation|11|||
160494633|NCT03802617|579539177|FG002|Overall Study|Lack of Efficacy|0|||
160494634|NCT03802617|579539178|FG003|Overall Study|Lack of Efficacy|2|||
160494635|NCT03802617|579539175|FG000|Overall Study|Protocol Violation|1|||
160494636|NCT03802617|579539176|FG001|Overall Study|Protocol Violation|1|||
160613314|NCT00696774|579961647|FG000|Period II|Withdrawal by Subject|0|||
160613315|NCT00696774|579961648|FG001|Period II|Withdrawal by Subject|0|||
160613316|NCT00696774|579961649|FG002|Period II|Withdrawal by Subject|4|||
160613317|NCT00696774|579961647|FG000|Period II|Sponsor Decision|0|||
160613318|NCT00696774|579961648|FG001|Period II|Sponsor Decision|0|||
160494637|NCT03802617|579539177|FG002|Overall Study|Protocol Violation|1|||
160494638|NCT03802617|579539178|FG003|Overall Study|Protocol Violation|0|||
160494639|NCT03802617|579539175|FG000|Overall Study|Withdrawal by Subject|1|||
160494640|NCT03802617|579539176|FG001|Overall Study|Withdrawal by Subject|1|||
160494641|NCT03802617|579539177|FG002|Overall Study|Withdrawal by Subject|1|||
160494642|NCT03802617|579539178|FG003|Overall Study|Withdrawal by Subject|0|||
160494643|NCT03802617|579539175|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
160494644|NCT03802617|579539176|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
160494645|NCT03802617|579539177|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
160494646|NCT03802617|579539178|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
160494647|NCT00621192|579539179|FG000|Overall Study|Withdrawal by Subject|0|||
160494648|NCT00621192|579539180|FG001|Overall Study|Withdrawal by Subject|0|||
160494649|NCT00621192|579539181|FG002|Overall Study|Withdrawal by Subject|2|||
160494650|NCT00621192|579539182|FG003|Overall Study|Withdrawal by Subject|0|||
160494651|NCT00621192|579539179|FG000|Overall Study|Physician Decision|1|||
160494652|NCT00621192|579539180|FG001|Overall Study|Physician Decision|3|||
160494653|NCT00621192|579539181|FG002|Overall Study|Physician Decision|0|||
160494654|NCT00621192|579539182|FG003|Overall Study|Physician Decision|0|||
160494655|NCT00621192|579539179|FG000|Overall Study|Protocol Violation|1|||
160494656|NCT00621192|579539180|FG001|Overall Study|Protocol Violation|0|||
160494657|NCT00621192|579539181|FG002|Overall Study|Protocol Violation|0|||
160494658|NCT00621192|579539182|FG003|Overall Study|Protocol Violation|1|||
160494659|NCT00621192|579539179|FG000|Overall Study|Adverse Event|0|||
160494660|NCT00621192|579539180|FG001|Overall Study|Adverse Event|1|||
160494661|NCT00621192|579539181|FG002|Overall Study|Adverse Event|0|||
160494662|NCT00621192|579539182|FG003|Overall Study|Adverse Event|1|||
160494663|NCT00621192|579539179|FG000|Overall Study|Death|2|||
160494664|NCT00621192|579539180|FG001|Overall Study|Death|5|||
160494665|NCT00621192|579539181|FG002|Overall Study|Death|0|||
160494666|NCT00621192|579539182|FG003|Overall Study|Death|0|||
160494667|NCT00621192|579539179|FG000|Overall Study|Final Assessments not Completed|0|||
160494668|NCT00621192|579539180|FG001|Overall Study|Final Assessments not Completed|0|||
160494669|NCT00621192|579539181|FG002|Overall Study|Final Assessments not Completed|3|||
160494670|NCT00621192|579539182|FG003|Overall Study|Final Assessments not Completed|1|||
160494671|NCT02569957|579539183|FG000|Overall Study|Withdrawal by Subject|0|||
160494672|NCT02569957|579539184|FG001|Overall Study|Withdrawal by Subject|1|||
160494673|NCT03174782|579539185|FG000|Overall Study|Protocol Violation|1|||
160494674|NCT03174782|579539186|FG001|Overall Study|Protocol Violation|0|||
160494675|NCT03174782|579539185|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
160494676|NCT03174782|579539186|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
160494677|NCT03178045|579539187|FG000|Overall Study|Withdrawal by Subject|5|||
160494678|NCT03178045|579539188|FG001|Overall Study|Withdrawal by Subject|7|||
160494679|NCT03178045|579539187|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
160494680|NCT03178045|579539188|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
160494681|NCT03178045|579539187|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
160494682|NCT03178045|579539188|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
160494683|NCT00267098|579539189|FG000|Overall Study|Death|0|||
160494684|NCT00267098|579539190|FG001|Overall Study|Death|0|||
160494685|NCT00267098|579539191|FG002|Overall Study|Death|57|||
160494686|NCT00267098|579539192|FG003|Overall Study|Death|66|||
160494687|NCT00267098|579539193|FG004|Overall Study|Death|14|||
160494688|NCT00267098|579539194|FG005|Overall Study|Death|23|||
160494689|NCT00267098|579539195|FG006|Overall Study|Death|28|||
160494690|NCT00267098|579539196|FG007|Overall Study|Death|9|||
160494691|NCT00267098|579539189|FG000|Overall Study|Lost to Follow-up|0|||
160494692|NCT00267098|579539190|FG001|Overall Study|Lost to Follow-up|0|||
160494693|NCT00267098|579539191|FG002|Overall Study|Lost to Follow-up|6|||
160494694|NCT00267098|579539192|FG003|Overall Study|Lost to Follow-up|5|||
160494695|NCT00267098|579539193|FG004|Overall Study|Lost to Follow-up|2|||
160494696|NCT00267098|579539194|FG005|Overall Study|Lost to Follow-up|3|||
160494697|NCT00267098|579539195|FG006|Overall Study|Lost to Follow-up|1|||
160494698|NCT00267098|579539196|FG007|Overall Study|Lost to Follow-up|1|||
160494699|NCT00267098|579539189|FG000|Overall Study|Withdrawal by Subject|8|||
160494700|NCT00267098|579539190|FG001|Overall Study|Withdrawal by Subject|0|||
160494701|NCT00267098|579539191|FG002|Overall Study|Withdrawal by Subject|24|||
160494702|NCT00267098|579539192|FG003|Overall Study|Withdrawal by Subject|21|||
160494703|NCT00267098|579539193|FG004|Overall Study|Withdrawal by Subject|12|||
160494704|NCT00267098|579539194|FG005|Overall Study|Withdrawal by Subject|9|||
160494705|NCT00267098|579539195|FG006|Overall Study|Withdrawal by Subject|12|||
160494706|NCT00267098|579539196|FG007|Overall Study|Withdrawal by Subject|5|||
160494707|NCT00267098|579539189|FG000|Overall Study|Physician Decision|5|||
160494708|NCT00267098|579539190|FG001|Overall Study|Physician Decision|0|||
160494709|NCT00267098|579539191|FG002|Overall Study|Physician Decision|7|||
160494710|NCT00267098|579539192|FG003|Overall Study|Physician Decision|11|||
160494711|NCT00267098|579539193|FG004|Overall Study|Physician Decision|5|||
160494712|NCT00267098|579539194|FG005|Overall Study|Physician Decision|4|||
160494713|NCT00267098|579539195|FG006|Overall Study|Physician Decision|3|||
160613319|NCT00696774|579961649|FG002|Period II|Sponsor Decision|0|||
160613320|NCT00696774|579961647|FG000|Period II|Lack of Efficacy|0|||
160613321|NCT00696774|579961648|FG001|Period II|Lack of Efficacy|0|||
160613322|NCT00696774|579961649|FG002|Period II|Lack of Efficacy|2|||
160613323|NCT00696774|579961647|FG000|Period III|Adverse Event|1|||
160613324|NCT00696774|579961648|FG001|Period III|Adverse Event|1|||
160613325|NCT00696774|579961649|FG002|Period III|Adverse Event|0|||
160613326|NCT00696774|579961647|FG000|Period III|Lost to Follow-up|2|||
160613327|NCT00696774|579961648|FG001|Period III|Lost to Follow-up|1|||
160613328|NCT00696774|579961649|FG002|Period III|Lost to Follow-up|0|||
160613329|NCT00696774|579961647|FG000|Period III|Protocol Violation|1|||
160613330|NCT00696774|579961648|FG001|Period III|Protocol Violation|1|||
160613331|NCT00696774|579961649|FG002|Period III|Protocol Violation|0|||
160613332|NCT00696774|579961647|FG000|Period III|Withdrawal by Subject|1|||
160613333|NCT00696774|579961648|FG001|Period III|Withdrawal by Subject|2|||
160613334|NCT00696774|579961649|FG002|Period III|Withdrawal by Subject|0|||
160613335|NCT00696774|579961647|FG000|Period III|Sponsor Decision|2|||
160613336|NCT00696774|579961648|FG001|Period III|Sponsor Decision|0|||
160613337|NCT00696774|579961649|FG002|Period III|Sponsor Decision|0|||
160613338|NCT00696774|579961647|FG000|Period III|Lack of Efficacy|0|||
160613339|NCT00696774|579961648|FG001|Period III|Lack of Efficacy|2|||
160613340|NCT00696774|579961649|FG002|Period III|Lack of Efficacy|0|||
160613341|NCT01021553|579961650|FG000|Overall Study|Adverse Event|1|||
160613342|NCT01021553|579961651|FG001|Overall Study|Adverse Event|0|||
160613343|NCT01021553|579961652|FG002|Overall Study|Adverse Event|0|||
160613344|NCT01021553|579961650|FG000|Overall Study|Lack of Efficacy|2|||
160613345|NCT01021553|579961651|FG001|Overall Study|Lack of Efficacy|2|||
160613346|NCT01021553|579961652|FG002|Overall Study|Lack of Efficacy|0|||
160613347|NCT01021553|579961650|FG000|Overall Study|Protocol Violation|0|||
160613348|NCT01021553|579961651|FG001|Overall Study|Protocol Violation|2|||
160613349|NCT01021553|579961652|FG002|Overall Study|Protocol Violation|2|||
160613350|NCT01021553|579961650|FG000|Overall Study|Lost to Follow-up|0|||
160613351|NCT01021553|579961651|FG001|Overall Study|Lost to Follow-up|0|||
160613352|NCT01021553|579961652|FG002|Overall Study|Lost to Follow-up|1|||
160613353|NCT01021553|579961650|FG000|Overall Study|Withdrawal by Subject|1|||
160613354|NCT01021553|579961651|FG001|Overall Study|Withdrawal by Subject|1|||
160613355|NCT01021553|579961652|FG002|Overall Study|Withdrawal by Subject|0|||
160613356|NCT01950364|579961653|FG000|Overall Study|Adverse Event|3|||
160613357|NCT01950364|579961654|FG001|Overall Study|Adverse Event|0|||
160613358|NCT01950364|579961653|FG000|Overall Study|Stem Cell Transplant|2|||
160613359|NCT01950364|579961654|FG001|Overall Study|Stem Cell Transplant|6|||
160613360|NCT01950364|579961653|FG000|Overall Study|Disease Progression|5|||
160613361|NCT01950364|579961654|FG001|Overall Study|Disease Progression|2|||
160613362|NCT01950364|579961653|FG000|Overall Study|Withdrawal by Subject|0|||
160613363|NCT01950364|579961654|FG001|Overall Study|Withdrawal by Subject|1|||
160613364|NCT01950364|579961653|FG000|Overall Study|Protocol Violation|0|||
160613365|NCT01950364|579961654|FG001|Overall Study|Protocol Violation|1|||
160613366|NCT00033293|579961661|FG000|Overall Study|Death|0|||
160613367|NCT00033293|579961662|FG001|Overall Study|Death|1|||
160613368|NCT00033293|579961661|FG000|Overall Study|Lack of Efficacy|5|||
160613369|NCT00033293|579961662|FG001|Overall Study|Lack of Efficacy|8|||
160613370|NCT00033293|579961661|FG000|Overall Study|Lost to Follow-up|0|||
160613371|NCT00033293|579961662|FG001|Overall Study|Lost to Follow-up|1|||
160613372|NCT00033293|579961661|FG000|Overall Study|Physician Decision|3|||
160613373|NCT00033293|579961662|FG001|Overall Study|Physician Decision|1|||
160613374|NCT00033293|579961661|FG000|Overall Study|Withdrawal by Subject|1|||
160613375|NCT00033293|579961662|FG001|Overall Study|Withdrawal by Subject|0|||
160613376|NCT00033293|579961661|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
160613377|NCT00033293|579961662|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
160613378|NCT00033293|579961661|FG000|Overall Study|Treatment refused|0|||
160613379|NCT00033293|579961662|FG001|Overall Study|Treatment refused|6|||
160613380|NCT00935701|579961663|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
160613381|NCT02087241|579961664|FG000|Overall Study|Death|2|||
160613382|NCT02087241|579961665|FG001|Overall Study|Death|1|||
160613383|NCT02087241|579961666|FG002|Overall Study|Death|1|||
160613384|NCT02087241|579961667|FG003|Overall Study|Death|1|||
160613385|NCT02087241|579961664|FG000|Overall Study|Withdrawal by Subject|1|||
160613386|NCT02087241|579961665|FG001|Overall Study|Withdrawal by Subject|0|||
160613387|NCT02087241|579961666|FG002|Overall Study|Withdrawal by Subject|0|||
160613388|NCT02087241|579961667|FG003|Overall Study|Withdrawal by Subject|1|||
160613389|NCT02087241|579961664|FG000|Overall Study|Progressive Disease|0|||
160613390|NCT02087241|579961665|FG001|Overall Study|Progressive Disease|0|||
160613391|NCT02087241|579961666|FG002|Overall Study|Progressive Disease|0|||
160613392|NCT02087241|579961667|FG003|Overall Study|Progressive Disease|1|||
160613393|NCT02087241|579961664|FG000|Overall Study|Study Terminated by Sponsor|0|||
160613394|NCT02087241|579961665|FG001|Overall Study|Study Terminated by Sponsor|2|||
160613395|NCT02087241|579961666|FG002|Overall Study|Study Terminated by Sponsor|0|||
160613396|NCT02087241|579961667|FG003|Overall Study|Study Terminated by Sponsor|4|||
160613397|NCT01955005|579961668|FG000|Overall Study|Withdrawal by Subject|3|||
160613398|NCT01955005|579961669|FG001|Overall Study|Withdrawal by Subject|5|||
160613399|NCT00836953|579961670|FG000|Overall Study|Withdrawal by Subject|1|||
160613400|NCT00836953|579961670|FG000|Overall Study|Lost to Follow-up|1|||
160613401|NCT01200758|579961671|FG000|Stage I|Death|0|||
160613402|NCT01200758|579961672|FG001|Stage I|Death|1|||
160613403|NCT01200758|579961673|FG002|Stage I|Death|0|||
160613404|NCT01200758|579961674|FG003|Stage I|Death|0|||
160613405|NCT01200758|579961671|FG000|Stage I|Physician Decision|1|||
160613406|NCT01200758|579961672|FG001|Stage I|Physician Decision|1|||
160613407|NCT01200758|579961673|FG002|Stage I|Physician Decision|0|||
160613408|NCT01200758|579961674|FG003|Stage I|Physician Decision|0|||
160613409|NCT01200758|579961671|FG000|Stage I|Lack of Efficacy|2|||
160613410|NCT01200758|579961672|FG001|Stage I|Lack of Efficacy|1|||
160613411|NCT01200758|579961673|FG002|Stage I|Lack of Efficacy|0|||
160613412|NCT01200758|579961674|FG003|Stage I|Lack of Efficacy|0|||
160613413|NCT01200758|579961671|FG000|Stage I|Adverse Event|5|||
160613414|NCT01200758|579961672|FG001|Stage I|Adverse Event|5|||
160613415|NCT01200758|579961673|FG002|Stage I|Adverse Event|0|||
160613416|NCT01200758|579961674|FG003|Stage I|Adverse Event|0|||
160613417|NCT01200758|579961671|FG000|Stage I|Withdrawal by Subject|1|||
160613418|NCT01200758|579961672|FG001|Stage I|Withdrawal by Subject|2|||
160613419|NCT01200758|579961673|FG002|Stage I|Withdrawal by Subject|0|||
160613420|NCT01200758|579961674|FG003|Stage I|Withdrawal by Subject|0|||
160613421|NCT01200758|579961671|FG000|Stage I|Disease Progression|9|||
160613422|NCT01200758|579961672|FG001|Stage I|Disease Progression|7|||
160613423|NCT01200758|579961673|FG002|Stage I|Disease Progression|0|||
160613424|NCT01200758|579961674|FG003|Stage I|Disease Progression|0|||
160613425|NCT01200758|579961671|FG000|Stage 2|Disease Progression|0|||
160613426|NCT01200758|579961672|FG001|Stage 2|Disease Progression|0|||
160613427|NCT01200758|579961673|FG002|Stage 2|Disease Progression|16|||
160613428|NCT01200758|579961674|FG003|Stage 2|Disease Progression|21|||
160613429|NCT01200758|579961671|FG000|Stage 2|Lack of Efficacy|0|||
160613430|NCT01200758|579961672|FG001|Stage 2|Lack of Efficacy|0|||
160613431|NCT01200758|579961673|FG002|Stage 2|Lack of Efficacy|4|||
160613432|NCT01200758|579961674|FG003|Stage 2|Lack of Efficacy|2|||
160613433|NCT01200758|579961671|FG000|Stage 2|Physician Decision|0|||
160613434|NCT01200758|579961672|FG001|Stage 2|Physician Decision|0|||
160613435|NCT01200758|579961673|FG002|Stage 2|Physician Decision|5|||
160613436|NCT01200758|579961674|FG003|Stage 2|Physician Decision|7|||
160613437|NCT01200758|579961671|FG000|Stage 2|Adverse Event|0|||
160613438|NCT01200758|579961672|FG001|Stage 2|Adverse Event|0|||
160613439|NCT01200758|579961673|FG002|Stage 2|Adverse Event|5|||
160613440|NCT01200758|579961674|FG003|Stage 2|Adverse Event|9|||
160613441|NCT01200758|579961671|FG000|Stage 2|Withdrawal by Subject|0|||
160613442|NCT01200758|579961672|FG001|Stage 2|Withdrawal by Subject|0|||
160613443|NCT01200758|579961673|FG002|Stage 2|Withdrawal by Subject|4|||
160613444|NCT01200758|579961674|FG003|Stage 2|Withdrawal by Subject|1|||
160613445|NCT01200758|579961671|FG000|Stage 2|Lost to Follow-up|0|||
160613446|NCT01200758|579961672|FG001|Stage 2|Lost to Follow-up|0|||
160613447|NCT01200758|579961673|FG002|Stage 2|Lost to Follow-up|3|||
160613448|NCT01200758|579961674|FG003|Stage 2|Lost to Follow-up|1|||
160613449|NCT01200758|579961671|FG000|Stage 2|Protocol Violation|0|||
160613450|NCT01200758|579961672|FG001|Stage 2|Protocol Violation|0|||
160613451|NCT01200758|579961673|FG002|Stage 2|Protocol Violation|1|||
160613452|NCT01200758|579961674|FG003|Stage 2|Protocol Violation|4|||
160613453|NCT01200758|579961671|FG000|Stage 2|Death|0|||
160613454|NCT01200758|579961672|FG001|Stage 2|Death|0|||
160613455|NCT01200758|579961673|FG002|Stage 2|Death|3|||
160613456|NCT01200758|579961674|FG003|Stage 2|Death|5|||
160613457|NCT02711553|579961677|FG000|Overall Study|Withdrawal by Subject|2|||
160613458|NCT02711553|579961678|FG001|Overall Study|Withdrawal by Subject|1|||
160613459|NCT02711553|579961679|FG002|Overall Study|Withdrawal by Subject|1|||
160613460|NCT02711553|579961680|FG003|Overall Study|Withdrawal by Subject|0|||
160613461|NCT02711553|579961677|FG000|Overall Study|Lost to Follow-up|3|||
160613462|NCT02711553|579961678|FG001|Overall Study|Lost to Follow-up|3|||
160613463|NCT02711553|579961679|FG002|Overall Study|Lost to Follow-up|6|||
160613464|NCT02711553|579961680|FG003|Overall Study|Lost to Follow-up|3|||
160613465|NCT02711553|579961677|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
160613466|NCT02711553|579961678|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
160613467|NCT02711553|579961679|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
160613468|NCT02711553|579961680|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
160613469|NCT04048876|579961687|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
160613470|NCT04048876|579961688|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
160613471|NCT04048876|579961689|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
160613472|NCT04048876|579961690|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
160613473|NCT04048876|579961687|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
160613474|NCT04048876|579961688|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
160613475|NCT04048876|579961689|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
160613476|NCT04048876|579961690|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
160613477|NCT04048876|579961687|FG000|Placebo Controlled Phase|Adverse Event|0|||
160613478|NCT04048876|579961688|FG001|Placebo Controlled Phase|Adverse Event|1|||
160494714|NCT00267098|579539196|FG007|Overall Study|Physician Decision|0|||
160494715|NCT00267098|579539189|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
160494716|NCT00267098|579539190|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160494717|NCT00267098|579539191|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160494718|NCT00267098|579539192|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160494719|NCT00267098|579539193|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
160494720|NCT00267098|579539194|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160494721|NCT00267098|579539195|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160494722|NCT00267098|579539196|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160494723|NCT00267098|579539189|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
160494724|NCT00267098|579539190|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
160494725|NCT00267098|579539191|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
160494726|NCT00267098|579539192|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
160494727|NCT00267098|579539193|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
160494728|NCT00267098|579539194|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
160494729|NCT00267098|579539195|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
160494730|NCT00267098|579539196|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
160494731|NCT00267098|579539189|FG000|Overall Study|Site closure|0|||
160494732|NCT00267098|579539190|FG001|Overall Study|Site closure|0|||
160494733|NCT00267098|579539191|FG002|Overall Study|Site closure|0|||
160494734|NCT00267098|579539192|FG003|Overall Study|Site closure|1|||
160494735|NCT00267098|579539193|FG004|Overall Study|Site closure|0|||
160494736|NCT00267098|579539194|FG005|Overall Study|Site closure|1|||
160494737|NCT00267098|579539195|FG006|Overall Study|Site closure|1|||
160494738|NCT00267098|579539196|FG007|Overall Study|Site closure|0|||
160494739|NCT00267098|579539189|FG000|Overall Study|Explanted Medtronic device|0|||
160494740|NCT00267098|579539190|FG001|Overall Study|Explanted Medtronic device|0|||
160494741|NCT00267098|579539191|FG002|Overall Study|Explanted Medtronic device|0|||
160494742|NCT00267098|579539192|FG003|Overall Study|Explanted Medtronic device|1|||
160494743|NCT00267098|579539193|FG004|Overall Study|Explanted Medtronic device|0|||
160494744|NCT00267098|579539194|FG005|Overall Study|Explanted Medtronic device|0|||
160494745|NCT00267098|579539195|FG006|Overall Study|Explanted Medtronic device|0|||
160494746|NCT00267098|579539196|FG007|Overall Study|Explanted Medtronic device|0|||
160494747|NCT00267098|579539189|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
160494748|NCT00267098|579539190|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
160494749|NCT00267098|579539191|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
160494750|NCT00267098|579539192|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
160494751|NCT00267098|579539193|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
160494752|NCT00267098|579539194|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
160494753|NCT00267098|579539195|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
160494754|NCT00267098|579539196|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
160494755|NCT00267098|579539189|FG000|Overall Study|Subject listed for heart transplant|0|||
160494756|NCT00267098|579539190|FG001|Overall Study|Subject listed for heart transplant|0|||
160494757|NCT00267098|579539191|FG002|Overall Study|Subject listed for heart transplant|0|||
160494758|NCT00267098|579539192|FG003|Overall Study|Subject listed for heart transplant|0|||
160494759|NCT00267098|579539193|FG004|Overall Study|Subject listed for heart transplant|0|||
160494760|NCT00267098|579539194|FG005|Overall Study|Subject listed for heart transplant|0|||
160494761|NCT00267098|579539195|FG006|Overall Study|Subject listed for heart transplant|1|||
160494762|NCT00267098|579539196|FG007|Overall Study|Subject listed for heart transplant|0|||
160494763|NCT00267098|579539189|FG000|Overall Study|Sponsor withdrew subject|0|||
160494764|NCT00267098|579539190|FG001|Overall Study|Sponsor withdrew subject|0|||
160494765|NCT00267098|579539191|FG002|Overall Study|Sponsor withdrew subject|0|||
160494766|NCT00267098|579539192|FG003|Overall Study|Sponsor withdrew subject|1|||
160494767|NCT00267098|579539193|FG004|Overall Study|Sponsor withdrew subject|0|||
160494768|NCT00267098|579539194|FG005|Overall Study|Sponsor withdrew subject|0|||
160494769|NCT00267098|579539195|FG006|Overall Study|Sponsor withdrew subject|0|||
160494770|NCT00267098|579539196|FG007|Overall Study|Sponsor withdrew subject|0|||
160494771|NCT00798304|579539198|FG000|Overall Study|Adverse Event|0|||
160613479|NCT04048876|579961689|FG002|Placebo Controlled Phase|Adverse Event|0|||
160613480|NCT04048876|579961690|FG003|Placebo Controlled Phase|Adverse Event|0|||
160613481|NCT04048876|579961687|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
160613482|NCT04048876|579961688|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
160494772|NCT00798304|579539199|FG001|Overall Study|Adverse Event|1|||
160494773|NCT00798304|579539200|FG002|Overall Study|Adverse Event|1|||
160494774|NCT00798304|579539198|FG000|Overall Study|Discontinuation by Sponsor|14|||
160494775|NCT00798304|579539199|FG001|Overall Study|Discontinuation by Sponsor|21|||
160494776|NCT00798304|579539200|FG002|Overall Study|Discontinuation by Sponsor|9|||
160494777|NCT02031536|579539201|FG000|Overall Study|ineligible|1|||
160494778|NCT02031536|579539202|FG001|Overall Study|ineligible|0|||
160494779|NCT04211389|579539203|FG000|Overall Study|Adverse Event|1|||
160494780|NCT04211389|579539204|FG001|Overall Study|Adverse Event|2|||
160613483|NCT04048876|579961689|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
160494781|NCT04211389|579539203|FG000|Overall Study|Lost to Follow-up|15|||
160613484|NCT04048876|579961690|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
160613485|NCT04063865|579961696|FG000|Overall Study|Physician Decision|1|||
160613486|NCT04063865|579961697|FG001|Overall Study|Physician Decision|3|||
160613487|NCT04063865|579961696|FG000|Overall Study|Study Closed Prior to Completion|4|||
160613488|NCT04063865|579961697|FG001|Overall Study|Study Closed Prior to Completion|4|||
160613489|NCT04063865|579961696|FG000|Overall Study|Withdrawal by Subject|1|||
160613490|NCT04063865|579961697|FG001|Overall Study|Withdrawal by Subject|1|||
160613491|NCT00320190|579961698|FG000|First 12 Months|Completed but did not enter extension|5|||
160613492|NCT00320190|579961699|FG001|First 12 Months|Completed but did not enter extension|3|||
160613493|NCT00320190|579961698|FG000|First 12 Months|Sponsor terminated study|2|||
160613494|NCT00320190|579961699|FG001|First 12 Months|Sponsor terminated study|2|||
160613495|NCT00320190|579961698|FG000|First 12 Months|Lost to Follow-up|0|||
160613496|NCT00320190|579961699|FG001|First 12 Months|Lost to Follow-up|1|||
160613497|NCT00320190|579961698|FG000|First 12 Months|Enrollment failure|0|||
160613498|NCT00320190|579961699|FG001|First 12 Months|Enrollment failure|1|||
160613499|NCT00320190|579961698|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
160613500|NCT00320190|579961699|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
160613501|NCT00320190|579961698|FG000|First 12 Months|Investigator request|0|||
160613502|NCT00320190|579961699|FG001|First 12 Months|Investigator request|1|||
160613503|NCT00320190|579961698|FG000|First 12 Months|Study drug toxicity|0|||
160613504|NCT00320190|579961699|FG001|First 12 Months|Study drug toxicity|1|||
160613505|NCT00320190|579961698|FG000|First 12 Months|Withdrawal by Subject|0|||
160613506|NCT00320190|579961699|FG001|First 12 Months|Withdrawal by Subject|1|||
160613507|NCT00320190|579961698|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
160613508|NCT00320190|579961699|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
160613509|NCT00320190|579961698|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
160613510|NCT00320190|579961699|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
160613511|NCT00320190|579961698|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
160613512|NCT00320190|579961699|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
160613513|NCT04490057|579961707|FG000|Stage 1|Death|1|||
160613514|NCT04490057|579961708|FG001|Stage 1|Death|2|||
160613515|NCT04490057|579961709|FG002|Stage 1|Death|0|||
160613516|NCT04490057|579961710|FG003|Stage 1|Death|0|||
160613517|NCT04490057|579961711|FG004|Stage 1|Death|0|||
160613518|NCT04490057|579961712|FG005|Stage 1|Death|0|||
160613519|NCT04490057|579961713|FG006|Stage 1|Death|0|||
160613520|NCT04490057|579961714|FG007|Stage 1|Death|0|||
160613521|NCT04490057|579961707|FG000|Stage 1|Withdrawal by Subject|2|||
160613522|NCT04490057|579961708|FG001|Stage 1|Withdrawal by Subject|0|||
160613523|NCT04490057|579961709|FG002|Stage 1|Withdrawal by Subject|0|||
160613524|NCT04490057|579961710|FG003|Stage 1|Withdrawal by Subject|0|||
160613525|NCT04490057|579961711|FG004|Stage 1|Withdrawal by Subject|0|||
160613526|NCT04490057|579961712|FG005|Stage 1|Withdrawal by Subject|0|||
160613527|NCT04490057|579961713|FG006|Stage 1|Withdrawal by Subject|0|||
160613528|NCT04490057|579961714|FG007|Stage 1|Withdrawal by Subject|0|||
160613529|NCT04490057|579961707|FG000|Stage 2|Death|0|||
160613530|NCT04490057|579961708|FG001|Stage 2|Death|0|||
160613531|NCT04490057|579961709|FG002|Stage 2|Death|0|||
160613532|NCT04490057|579961710|FG003|Stage 2|Death|0|||
160613533|NCT04490057|579961711|FG004|Stage 2|Death|1|||
160613534|NCT04490057|579961712|FG005|Stage 2|Death|0|||
160613535|NCT04490057|579961713|FG006|Stage 2|Death|0|||
160613536|NCT04490057|579961714|FG007|Stage 2|Death|0|||
160613537|NCT04490057|579961707|FG000|Stage 2|Lost to Follow-up|0|||
160613538|NCT04490057|579961708|FG001|Stage 2|Lost to Follow-up|0|||
160613539|NCT04490057|579961709|FG002|Stage 2|Lost to Follow-up|0|||
160613540|NCT04490057|579961710|FG003|Stage 2|Lost to Follow-up|11|||
160613541|NCT04490057|579961711|FG004|Stage 2|Lost to Follow-up|17|||
160613542|NCT04490057|579961712|FG005|Stage 2|Lost to Follow-up|4|||
160613543|NCT04490057|579961713|FG006|Stage 2|Lost to Follow-up|21|||
160613544|NCT04490057|579961714|FG007|Stage 2|Lost to Follow-up|14|||
160613545|NCT03053180|579963595|FG000|Overall Study|Failure to Return|1|||
160613546|NCT01465958|579963600|FG000|Run-in Phase|Protocol Violation|1|||
160613547|NCT01465958|579963601|FG001|Run-in Phase|Protocol Violation|0|||
160613548|NCT01465958|579963600|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
160613549|NCT01465958|579963601|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
160613550|NCT00211536|579963604|FG000|Overall Study|Withdrawal by Subject|2|||
160613551|NCT00211536|579963605|FG001|Overall Study|Withdrawal by Subject|2|||
160613552|NCT00211536|579963604|FG000|Overall Study|Physician Decision|0|||
160613553|NCT00211536|579963605|FG001|Overall Study|Physician Decision|5|||
160613554|NCT00211536|579963604|FG000|Overall Study|Adverse Event|2|||
160613555|NCT00211536|579963605|FG001|Overall Study|Adverse Event|0|||
160613556|NCT02583399|579963606|FG000|Overall Study|Able to be discharged|3|||
160613557|NCT02583399|579963606|FG000|Overall Study|Wanted to use a restricted medication|3|||
160613558|NCT01004861|579963607|FG000|Overall Study|Disease progression|3|||
160613559|NCT01004861|579963608|FG001|Overall Study|Disease progression|4|||
160613560|NCT01004861|579963609|FG002|Overall Study|Disease progression|5|||
160613561|NCT01004861|579963610|FG003|Overall Study|Disease progression|4|||
160613562|NCT01004861|579963611|FG004|Overall Study|Disease progression|4|||
160613563|NCT01004861|579963612|FG005|Overall Study|Disease progression|4|||
160494782|NCT04211389|579539204|FG001|Overall Study|Lost to Follow-up|7|||
160494783|NCT04211389|579539203|FG000|Overall Study|Protocol Violation|0|||
160494784|NCT04211389|579539204|FG001|Overall Study|Protocol Violation|1|||
160494785|NCT04211389|579539203|FG000|Overall Study|Withdrawal by Subject|10|||
160494786|NCT04211389|579539204|FG001|Overall Study|Withdrawal by Subject|11|||
160494787|NCT00547534|579539208|FG000|Overall Study|Adverse Event|7|||
160494788|NCT00547534|579539208|FG000|Overall Study|Disease Progression|4|||
160494789|NCT04206085|579539211|FG000|Overall Study|Lost to Follow-up|0|||
160494790|NCT04206085|579539212|FG001|Overall Study|Lost to Follow-up|1|||
160494791|NCT04206085|579539213|FG002|Overall Study|Lost to Follow-up|0|||
160494792|NCT04206085|579539211|FG000|Overall Study|Lost to Follow-up|0|||
160494793|NCT04206085|579539212|FG001|Overall Study|Lost to Follow-up|0|||
160494794|NCT04206085|579539213|FG002|Overall Study|Lost to Follow-up|1|||
160494795|NCT03845023|579539214|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
160494796|NCT03845023|579539215|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
160494797|NCT03845023|579539216|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
160494798|NCT03845023|579539217|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
160494799|NCT03845023|579539214|FG000|Follow-Up (14 Days)|Adverse Event|0|||
160494800|NCT03845023|579539215|FG001|Follow-Up (14 Days)|Adverse Event|0|||
160494801|NCT03845023|579539216|FG002|Follow-Up (14 Days)|Adverse Event|1|||
160494802|NCT03845023|579539217|FG003|Follow-Up (14 Days)|Adverse Event|1|||
160494803|NCT01182207|579539218|FG000|First Intervention|Positive Hepatitis Results|0|||
160494804|NCT01182207|579539219|FG001|First Intervention|Positive Hepatitis Results|1|||
160494805|NCT01182207|579539218|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
160494806|NCT01182207|579539219|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
160494807|NCT02658175|579539220|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
160494808|NCT02658175|579539221|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
160494809|NCT02658175|579539222|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
160494810|NCT02658175|579539220|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
160494811|NCT02658175|579539221|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
160494812|NCT02658175|579539222|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
160494813|NCT02658175|579539220|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
160494814|NCT02658175|579539221|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
160494815|NCT02658175|579539222|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
160494816|NCT02658175|579539220|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
160494817|NCT02658175|579539221|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
160494818|NCT02658175|579539222|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
160494819|NCT02658175|579539220|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
160494820|NCT02658175|579539221|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
160494821|NCT02658175|579539222|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
160494822|NCT02658175|579539220|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
160494823|NCT02658175|579539221|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
160494824|NCT02658175|579539222|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
160494825|NCT02658175|579539220|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
160494826|NCT02658175|579539221|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
160494827|NCT02658175|579539222|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
160494828|NCT02658175|579539220|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
160494829|NCT02658175|579539221|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
160613564|NCT01004861|579963613|FG006|Overall Study|Disease progression|5|||
160613565|NCT01004861|579963614|FG007|Overall Study|Disease progression|1|||
160613566|NCT01004861|579963615|FG008|Overall Study|Disease progression|4|||
160613567|NCT01004861|579963616|FG009|Overall Study|Disease progression|7|||
160613568|NCT01004861|579963617|FG010|Overall Study|Disease progression|6|||
160613569|NCT01004861|579963618|FG011|Overall Study|Disease progression|3|||
160613570|NCT01004861|579963619|FG012|Overall Study|Disease progression|8|||
160613571|NCT01004861|579963607|FG000|Overall Study|Physician Decision|0|||
160613572|NCT01004861|579963608|FG001|Overall Study|Physician Decision|2|||
160613573|NCT01004861|579963609|FG002|Overall Study|Physician Decision|1|||
160613574|NCT01004861|579963610|FG003|Overall Study|Physician Decision|1|||
160613575|NCT01004861|579963611|FG004|Overall Study|Physician Decision|1|||
160613576|NCT01004861|579963612|FG005|Overall Study|Physician Decision|0|||
160613577|NCT01004861|579963613|FG006|Overall Study|Physician Decision|0|||
160613578|NCT01004861|579963614|FG007|Overall Study|Physician Decision|1|||
160613579|NCT01004861|579963615|FG008|Overall Study|Physician Decision|0|||
160613580|NCT01004861|579963616|FG009|Overall Study|Physician Decision|0|||
160613581|NCT01004861|579963617|FG010|Overall Study|Physician Decision|0|||
160613582|NCT01004861|579963618|FG011|Overall Study|Physician Decision|0|||
160613583|NCT01004861|579963619|FG012|Overall Study|Physician Decision|3|||
160613584|NCT01004861|579963607|FG000|Overall Study|Adverse Event|0|||
160613585|NCT01004861|579963608|FG001|Overall Study|Adverse Event|0|||
160613586|NCT01004861|579963609|FG002|Overall Study|Adverse Event|0|||
160613587|NCT01004861|579963610|FG003|Overall Study|Adverse Event|1|||
160613588|NCT01004861|579963611|FG004|Overall Study|Adverse Event|0|||
160494830|NCT02658175|579539222|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
160494831|NCT02658175|579539220|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
160613589|NCT01004861|579963612|FG005|Overall Study|Adverse Event|2|||
160613590|NCT01004861|579963613|FG006|Overall Study|Adverse Event|1|||
160613591|NCT01004861|579963614|FG007|Overall Study|Adverse Event|1|||
160613592|NCT01004861|579963615|FG008|Overall Study|Adverse Event|13|||
160613593|NCT01004861|579963616|FG009|Overall Study|Adverse Event|1|||
160613594|NCT01004861|579963617|FG010|Overall Study|Adverse Event|1|||
160613595|NCT01004861|579963618|FG011|Overall Study|Adverse Event|0|||
160613596|NCT01004861|579963619|FG012|Overall Study|Adverse Event|2|||
160613597|NCT01004861|579963607|FG000|Overall Study|Protocol Violation|0|||
160613598|NCT01004861|579963608|FG001|Overall Study|Protocol Violation|0|||
160613599|NCT01004861|579963609|FG002|Overall Study|Protocol Violation|0|||
160613600|NCT01004861|579963610|FG003|Overall Study|Protocol Violation|0|||
160613601|NCT01004861|579963611|FG004|Overall Study|Protocol Violation|1|||
160613602|NCT01004861|579963612|FG005|Overall Study|Protocol Violation|0|||
160613603|NCT01004861|579963613|FG006|Overall Study|Protocol Violation|0|||
160613604|NCT01004861|579963614|FG007|Overall Study|Protocol Violation|0|||
160613605|NCT01004861|579963615|FG008|Overall Study|Protocol Violation|0|||
160613606|NCT01004861|579963616|FG009|Overall Study|Protocol Violation|0|||
160613607|NCT01004861|579963617|FG010|Overall Study|Protocol Violation|0|||
160613608|NCT01004861|579963618|FG011|Overall Study|Protocol Violation|0|||
160613609|NCT01004861|579963619|FG012|Overall Study|Protocol Violation|0|||
160613610|NCT01004861|579963607|FG000|Overall Study|Lost to Follow-up|0|||
160613611|NCT01004861|579963608|FG001|Overall Study|Lost to Follow-up|0|||
160613612|NCT01004861|579963609|FG002|Overall Study|Lost to Follow-up|0|||
160613613|NCT01004861|579963610|FG003|Overall Study|Lost to Follow-up|0|||
160613614|NCT01004861|579963611|FG004|Overall Study|Lost to Follow-up|0|||
160613615|NCT01004861|579963612|FG005|Overall Study|Lost to Follow-up|0|||
160613616|NCT01004861|579963613|FG006|Overall Study|Lost to Follow-up|0|||
160613617|NCT01004861|579963614|FG007|Overall Study|Lost to Follow-up|1|||
160613618|NCT01004861|579963615|FG008|Overall Study|Lost to Follow-up|3|||
160613619|NCT01004861|579963616|FG009|Overall Study|Lost to Follow-up|0|||
160613620|NCT01004861|579963617|FG010|Overall Study|Lost to Follow-up|0|||
160613621|NCT01004861|579963618|FG011|Overall Study|Lost to Follow-up|1|||
160613622|NCT01004861|579963619|FG012|Overall Study|Lost to Follow-up|0|||
160613623|NCT01004861|579963607|FG000|Overall Study|Non-compliance|0|||
160613624|NCT01004861|579963608|FG001|Overall Study|Non-compliance|0|||
160613625|NCT01004861|579963609|FG002|Overall Study|Non-compliance|0|||
160613626|NCT01004861|579963610|FG003|Overall Study|Non-compliance|0|||
160613627|NCT01004861|579963611|FG004|Overall Study|Non-compliance|0|||
160613628|NCT01004861|579963612|FG005|Overall Study|Non-compliance|0|||
160613629|NCT01004861|579963613|FG006|Overall Study|Non-compliance|0|||
160613630|NCT01004861|579963614|FG007|Overall Study|Non-compliance|0|||
160613631|NCT01004861|579963615|FG008|Overall Study|Non-compliance|5|||
160613632|NCT01004861|579963616|FG009|Overall Study|Non-compliance|0|||
160613633|NCT01004861|579963617|FG010|Overall Study|Non-compliance|0|||
160613634|NCT01004861|579963618|FG011|Overall Study|Non-compliance|0|||
160613635|NCT01004861|579963619|FG012|Overall Study|Non-compliance|1|||
160613636|NCT01004861|579963607|FG000|Overall Study|Other|0|||
160613637|NCT01004861|579963608|FG001|Overall Study|Other|0|||
160613638|NCT01004861|579963609|FG002|Overall Study|Other|0|||
160613639|NCT01004861|579963610|FG003|Overall Study|Other|0|||
160613640|NCT01004861|579963611|FG004|Overall Study|Other|0|||
160613641|NCT01004861|579963612|FG005|Overall Study|Other|0|||
160613642|NCT01004861|579963613|FG006|Overall Study|Other|0|||
160613643|NCT01004861|579963614|FG007|Overall Study|Other|0|||
160613644|NCT01004861|579963615|FG008|Overall Study|Other|0|||
160613645|NCT01004861|579963616|FG009|Overall Study|Other|2|||
160613646|NCT01004861|579963617|FG010|Overall Study|Other|1|||
160613647|NCT01004861|579963618|FG011|Overall Study|Other|2|||
160613648|NCT01004861|579963619|FG012|Overall Study|Other|3|||
160613649|NCT01004861|579963607|FG000|Overall Study|Patient decision|0|||
160613650|NCT01004861|579963608|FG001|Overall Study|Patient decision|0|||
160613651|NCT01004861|579963609|FG002|Overall Study|Patient decision|0|||
160661503|NCT00696020|580144115|FG000|Overall Study|Withdrawal by Subject|0|||
160661504|NCT00696020|580144116|FG001|Overall Study|Withdrawal by Subject|1|||
160661505|NCT00696020|580144117|FG002|Overall Study|Withdrawal by Subject|0|||
160661506|NCT00696020|580144118|FG003|Overall Study|Withdrawal by Subject|1|||
160613652|NCT01004861|579963610|FG003|Overall Study|Patient decision|0|||
160613653|NCT01004861|579963611|FG004|Overall Study|Patient decision|1|||
160613654|NCT01004861|579963612|FG005|Overall Study|Patient decision|0|||
160613655|NCT01004861|579963613|FG006|Overall Study|Patient decision|1|||
160613656|NCT01004861|579963614|FG007|Overall Study|Patient decision|0|||
160613657|NCT01004861|579963615|FG008|Overall Study|Patient decision|7|||
160613658|NCT01004861|579963616|FG009|Overall Study|Patient decision|1|||
160613659|NCT01004861|579963617|FG010|Overall Study|Patient decision|1|||
160613660|NCT01004861|579963618|FG011|Overall Study|Patient decision|2|||
160613661|NCT01004861|579963619|FG012|Overall Study|Patient decision|3|||
160613662|NCT01004861|579963607|FG000|Overall Study|Transitioned to Phase 4 study|0|||
160661507|NCT00696020|580144115|FG000|Overall Study|Other not stated above|0|||
160494832|NCT02658175|579539221|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
160494833|NCT02658175|579539222|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
160494834|NCT02658175|579539220|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
160494835|NCT02658175|579539221|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
160494836|NCT02658175|579539222|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
160494837|NCT02918292|579539226|FG000|Study Enrollment Prior to Transplant|Death|1|||
160494838|NCT02918292|579539226|FG000|Study Follow up After Transplant|Death|6|||
160494839|NCT02636608|579539233|FG000|Overall Study|Failure to Return|4|||
160494840|NCT02636608|579539233|FG000|Overall Study|Insufficient Virological Response|1|||
160494841|NCT02636608|579539233|FG000|Overall Study|Death|3|||
160494842|NCT02636608|579539233|FG000|Overall Study|Other|2|||
160494843|NCT02636608|579539233|FG000|Overall Study|Did Not Receive Treatment|1|||
160494844|NCT03912532|579539234|FG000|Overall Study|Adverse Event|3|||
160494845|NCT03912532|579539235|FG001|Overall Study|Adverse Event|3|||
160494846|NCT03912532|579539236|FG002|Overall Study|Adverse Event|2|||
160494847|NCT03912532|579539237|FG003|Overall Study|Adverse Event|2|||
160494848|NCT03912532|579539234|FG000|Overall Study|Lost to Follow-up|3|||
160494849|NCT03912532|579539235|FG001|Overall Study|Lost to Follow-up|2|||
160494850|NCT03912532|579539236|FG002|Overall Study|Lost to Follow-up|1|||
160494851|NCT03912532|579539237|FG003|Overall Study|Lost to Follow-up|2|||
160494852|NCT03912532|579539234|FG000|Overall Study|Withdrawal by Subject|1|||
160494853|NCT03912532|579539235|FG001|Overall Study|Withdrawal by Subject|1|||
160494854|NCT03912532|579539236|FG002|Overall Study|Withdrawal by Subject|2|||
160494855|NCT03912532|579539237|FG003|Overall Study|Withdrawal by Subject|0|||
160494856|NCT03912532|579539234|FG000|Overall Study|Physician Decision|1|||
160494857|NCT03912532|579539235|FG001|Overall Study|Physician Decision|0|||
160494858|NCT03912532|579539236|FG002|Overall Study|Physician Decision|0|||
160494859|NCT03912532|579539237|FG003|Overall Study|Physician Decision|3|||
160494860|NCT03912532|579539234|FG000|Overall Study|Other|0|||
160494861|NCT03912532|579539235|FG001|Overall Study|Other|1|||
160494862|NCT03912532|579539236|FG002|Overall Study|Other|1|||
160494863|NCT03912532|579539237|FG003|Overall Study|Other|0|||
160494864|NCT04913948|579539238|FG000|Overall Study|Withdrawal by Subject|2|||
160494865|NCT04913948|579539238|FG000|Overall Study|Sample processing issues|1|||
160494866|NCT04913948|579539238|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
160613663|NCT01004861|579963608|FG001|Overall Study|Transitioned to Phase 4 study|0|||
160613664|NCT01004861|579963609|FG002|Overall Study|Transitioned to Phase 4 study|0|||
160613665|NCT01004861|579963610|FG003|Overall Study|Transitioned to Phase 4 study|0|||
160613666|NCT01004861|579963611|FG004|Overall Study|Transitioned to Phase 4 study|0|||
160613667|NCT01004861|579963612|FG005|Overall Study|Transitioned to Phase 4 study|0|||
160613668|NCT01004861|579963613|FG006|Overall Study|Transitioned to Phase 4 study|0|||
160613669|NCT01004861|579963614|FG007|Overall Study|Transitioned to Phase 4 study|0|||
160613670|NCT01004861|579963615|FG008|Overall Study|Transitioned to Phase 4 study|2|||
160613671|NCT01004861|579963616|FG009|Overall Study|Transitioned to Phase 4 study|0|||
160613672|NCT01004861|579963617|FG010|Overall Study|Transitioned to Phase 4 study|0|||
160613673|NCT01004861|579963618|FG011|Overall Study|Transitioned to Phase 4 study|0|||
160613674|NCT01004861|579963619|FG012|Overall Study|Transitioned to Phase 4 study|0|||
160613675|NCT01004861|579963607|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613676|NCT01004861|579963608|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613677|NCT01004861|579963609|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613678|NCT01004861|579963610|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613679|NCT01004861|579963611|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613680|NCT01004861|579963612|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613681|NCT01004861|579963613|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613682|NCT01004861|579963614|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613683|NCT01004861|579963615|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
160613684|NCT01004861|579963616|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613685|NCT01004861|579963617|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613686|NCT01004861|579963618|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613687|NCT01004861|579963619|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
160613688|NCT01004861|579963607|FG000|Overall Study|Patient withdrew|0|||
160613689|NCT01004861|579963608|FG001|Overall Study|Patient withdrew|0|||
160613690|NCT01004861|579963609|FG002|Overall Study|Patient withdrew|0|||
160613691|NCT01004861|579963610|FG003|Overall Study|Patient withdrew|0|||
160613692|NCT01004861|579963611|FG004|Overall Study|Patient withdrew|0|||
160613693|NCT01004861|579963612|FG005|Overall Study|Patient withdrew|0|||
160613694|NCT01004861|579963613|FG006|Overall Study|Patient withdrew|0|||
160613695|NCT01004861|579963614|FG007|Overall Study|Patient withdrew|0|||
160613696|NCT01004861|579963615|FG008|Overall Study|Patient withdrew|1|||
160613697|NCT01004861|579963616|FG009|Overall Study|Patient withdrew|0|||
160613698|NCT01004861|579963617|FG010|Overall Study|Patient withdrew|0|||
160613699|NCT01004861|579963618|FG011|Overall Study|Patient withdrew|0|||
160613700|NCT01004861|579963619|FG012|Overall Study|Patient withdrew|0|||
160613701|NCT01004861|579963607|FG000|Overall Study|Surgical resection|0|||
160613702|NCT01004861|579963608|FG001|Overall Study|Surgical resection|0|||
160613703|NCT01004861|579963609|FG002|Overall Study|Surgical resection|0|||
160613704|NCT01004861|579963610|FG003|Overall Study|Surgical resection|0|||
160613705|NCT01004861|579963611|FG004|Overall Study|Surgical resection|0|||
160613706|NCT01004861|579963612|FG005|Overall Study|Surgical resection|0|||
160613707|NCT01004861|579963613|FG006|Overall Study|Surgical resection|0|||
160613708|NCT01004861|579963614|FG007|Overall Study|Surgical resection|0|||
160613709|NCT01004861|579963615|FG008|Overall Study|Surgical resection|1|||
160613710|NCT01004861|579963616|FG009|Overall Study|Surgical resection|0|||
160613711|NCT01004861|579963617|FG010|Overall Study|Surgical resection|0|||
160613712|NCT01004861|579963618|FG011|Overall Study|Surgical resection|0|||
160613713|NCT01004861|579963619|FG012|Overall Study|Surgical resection|0|||
160613714|NCT01004861|579963607|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613715|NCT01004861|579963608|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613716|NCT01004861|579963609|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613717|NCT01004861|579963610|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613718|NCT01004861|579963611|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613719|NCT01004861|579963612|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613720|NCT01004861|579963613|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613721|NCT01004861|579963614|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613722|NCT01004861|579963615|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
160613723|NCT01004861|579963616|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613724|NCT01004861|579963617|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613725|NCT01004861|579963618|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613726|NCT01004861|579963619|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
160613727|NCT01004861|579963607|FG000|Overall Study|Study termination by Sponsor|0|||
160613728|NCT01004861|579963608|FG001|Overall Study|Study termination by Sponsor|0|||
160613729|NCT01004861|579963609|FG002|Overall Study|Study termination by Sponsor|0|||
160613730|NCT01004861|579963610|FG003|Overall Study|Study termination by Sponsor|0|||
160613731|NCT01004861|579963611|FG004|Overall Study|Study termination by Sponsor|0|||
160613732|NCT01004861|579963612|FG005|Overall Study|Study termination by Sponsor|0|||
160613733|NCT01004861|579963613|FG006|Overall Study|Study termination by Sponsor|0|||
160613734|NCT01004861|579963614|FG007|Overall Study|Study termination by Sponsor|0|||
160613735|NCT01004861|579963615|FG008|Overall Study|Study termination by Sponsor|1|||
160613736|NCT01004861|579963616|FG009|Overall Study|Study termination by Sponsor|0|||
160613737|NCT01004861|579963617|FG010|Overall Study|Study termination by Sponsor|0|||
160613738|NCT01004861|579963618|FG011|Overall Study|Study termination by Sponsor|0|||
160613739|NCT01004861|579963619|FG012|Overall Study|Study termination by Sponsor|0|||
160613740|NCT04610827|579963621|FG000|Overall Study|Withdrawal by Subject|1|||
160613741|NCT04610827|579963622|FG001|Overall Study|Withdrawal by Subject|1|||
160613742|NCT04610827|579963623|FG002|Overall Study|Withdrawal by Subject|0|||
160613743|NCT01823991|579963624|FG000|Overall Study|Withdrawal by Subject|8|||
160613744|NCT01823991|579963625|FG001|Overall Study|Withdrawal by Subject|5|||
160613745|NCT00805194|579963626|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
160613746|NCT00805194|579963627|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
160613747|NCT00805194|579963626|FG000|Overall Study|Worsening or AE of underlying disease|64|||
160613748|NCT00805194|579963627|FG001|Overall Study|Worsening or AE of underlying disease|70|||
160613749|NCT00805194|579963626|FG000|Overall Study|Other AE|84|||
160613750|NCT00805194|579963627|FG001|Overall Study|Other AE|73|||
160613751|NCT00805194|579963626|FG000|Overall Study|Protocol Violation|9|||
160613752|NCT00805194|579963627|FG001|Overall Study|Protocol Violation|9|||
160613753|NCT00805194|579963626|FG000|Overall Study|Lost to Follow-up|5|||
160613754|NCT00805194|579963627|FG001|Overall Study|Lost to Follow-up|5|||
160613755|NCT00805194|579963626|FG000|Overall Study|Withdrawal by Subject|60|||
160613756|NCT00805194|579963627|FG001|Overall Study|Withdrawal by Subject|42|||
160613757|NCT00805194|579963626|FG000|Overall Study|Not treated|3|||
160613758|NCT00805194|579963627|FG001|Overall Study|Not treated|4|||
160613759|NCT00805194|579963626|FG000|Overall Study|Reasons other than stated above|20|||
160613760|NCT00805194|579963627|FG001|Overall Study|Reasons other than stated above|16|||
160613761|NCT02185040|579963631|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
160613762|NCT02185040|579963632|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
160613763|NCT02185040|579963633|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
160613764|NCT02185040|579963634|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
160613765|NCT02185040|579963635|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
160613766|NCT02185040|579963636|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
160613767|NCT02185040|579963637|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
160613768|NCT02185040|579963631|FG000|Part 1 Treatment Phase|Adverse Event|1|||
160613769|NCT02185040|579963632|FG001|Part 1 Treatment Phase|Adverse Event|0|||
160613770|NCT02185040|579963633|FG002|Part 1 Treatment Phase|Adverse Event|0|||
160494867|NCT00815919|579539242|FG000|Overall Study|Unrelated Fungal Infection|1|||
160494868|NCT00815919|579539242|FG000|Overall Study|AML Relapse|1|||
160494869|NCT00815919|579539242|FG000|Overall Study|Lack of Efficacy|2|||
160494870|NCT02473042|579539244|FG000|Overall Study|Withdrawal by Subject|1|||
160494871|NCT02473042|579539245|FG001|Overall Study|Withdrawal by Subject|0|||
160494872|NCT02473042|579539244|FG000|Overall Study|Patient became ineligible after enrollment|2|||
160494873|NCT02473042|579539245|FG001|Overall Study|Patient became ineligible after enrollment|5|||
160494874|NCT02473042|579539244|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
160494875|NCT02473042|579539245|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
160494876|NCT02473042|579539244|FG000|Overall Study|PACU data unable to be collected|3|||
160494877|NCT02473042|579539245|FG001|Overall Study|PACU data unable to be collected|0|||
160494878|NCT04680637|579539248|FG000|Overall Study|Lost to Follow-up|0|||
160494879|NCT04680637|579539249|FG001|Overall Study|Lost to Follow-up|1|||
160494880|NCT04680637|579539250|FG002|Overall Study|Lost to Follow-up|0|||
160494881|NCT04680637|579539251|FG003|Overall Study|Lost to Follow-up|1|||
160494882|NCT04680637|579539248|FG000|Overall Study|Death|1|||
160494883|NCT04680637|579539249|FG001|Overall Study|Death|0|||
160494884|NCT04680637|579539250|FG002|Overall Study|Death|0|||
160494885|NCT04680637|579539251|FG003|Overall Study|Death|0|||
160494886|NCT04680637|579539248|FG000|Overall Study|Withdrawal by Subject|7|||
160494887|NCT04680637|579539249|FG001|Overall Study|Withdrawal by Subject|10|||
160494888|NCT04680637|579539250|FG002|Overall Study|Withdrawal by Subject|17|||
160494889|NCT04680637|579539251|FG003|Overall Study|Withdrawal by Subject|15|||
160494890|NCT04680637|579539248|FG000|Overall Study|Decision by Sponsor|21|||
160494891|NCT04680637|579539249|FG001|Overall Study|Decision by Sponsor|15|||
160494892|NCT04680637|579539250|FG002|Overall Study|Decision by Sponsor|7|||
160494893|NCT04680637|579539251|FG003|Overall Study|Decision by Sponsor|32|||
160494894|NCT01103232|579539254|FG000|Overall Study|Withdrawal by Subject|1|||
160613771|NCT02185040|579963634|FG003|Part 1 Treatment Phase|Adverse Event|2|||
160613772|NCT02185040|579963635|FG004|Part 1 Treatment Phase|Adverse Event|3|||
160494895|NCT01103232|579539255|FG001|Overall Study|Withdrawal by Subject|1|||
160494896|NCT01103232|579539254|FG000|Overall Study|Protocol Violation|0|||
160613773|NCT02185040|579963636|FG005|Part 1 Treatment Phase|Adverse Event|0|||
160613774|NCT02185040|579963637|FG006|Part 1 Treatment Phase|Adverse Event|0|||
160613775|NCT02185040|579963631|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
160613776|NCT02185040|579963632|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
160613777|NCT02185040|579963633|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
160613778|NCT02185040|579963634|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
160494897|NCT01103232|579539255|FG001|Overall Study|Protocol Violation|1|||
160494898|NCT00443599|579539256|FG000|Overall Study|Physician Decision|2|||
160494899|NCT00443599|579539257|FG001|Overall Study|Physician Decision|1|||
160494900|NCT00443599|579539256|FG000|Overall Study|Death|1|||
160494901|NCT00443599|579539257|FG001|Overall Study|Death|1|||
160494902|NCT00443599|579539256|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
160494903|NCT00443599|579539257|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
160494904|NCT05093504|579539258|FG000|Overall Study|Death|0|||
160494905|NCT05093504|579539259|FG001|Overall Study|Death|1|||
160494906|NCT03151551|579539260|FG000|Open-Label Treatment Period|Adverse Event|0|||
160494907|NCT03151551|579539261|FG001|Open-Label Treatment Period|Adverse Event|2|||
160494908|NCT03151551|579539260|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
160494909|NCT03151551|579539261|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
160494910|NCT03151551|579539260|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
160494911|NCT03151551|579539261|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
160494912|NCT03151551|579539260|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
160494913|NCT03151551|579539261|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
160494914|NCT03151551|579539260|FG000|Open-Label Treatment Period|Physician Decision|3|||
160494915|NCT03151551|579539261|FG001|Open-Label Treatment Period|Physician Decision|0|||
160494916|NCT03151551|579539260|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
160494917|NCT03151551|579539261|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
160494918|NCT03151551|579539260|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
160494919|NCT03151551|579539261|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
160494920|NCT03151551|579539260|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
160494921|NCT03151551|579539261|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
160494922|NCT03151551|579539260|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
160494923|NCT03151551|579539261|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
160494924|NCT03151551|579539260|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
160494925|NCT03151551|579539261|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
160494926|NCT01190449|579539262|FG000|Overall Study|Ineligible|0|||
160494927|NCT01190449|579539263|FG001|Overall Study|Ineligible|4|||
160494928|NCT01689363|579540834|FG000|Overall Study|Protocol Violation|0|||
160494929|NCT01689363|579540835|FG001|Overall Study|Protocol Violation|1|||
160494930|NCT01689363|579540836|FG002|Overall Study|Protocol Violation|0|||
160494931|NCT01689363|579540837|FG003|Overall Study|Protocol Violation|0|||
160494932|NCT01689363|579540838|FG004|Overall Study|Protocol Violation|0|||
160494933|NCT01689363|579540839|FG005|Overall Study|Protocol Violation|0|||
160494934|NCT01689363|579540840|FG006|Overall Study|Protocol Violation|0|||
160494935|NCT01689363|579540841|FG007|Overall Study|Protocol Violation|0|||
160494936|NCT00321685|579540842|FG000|Overall Study|Adverse Event|18|||
160494937|NCT00321685|579540842|FG000|Overall Study|Death|2|||
160494938|NCT00321685|579540842|FG000|Overall Study|Withdrawal by Subject|8|||
160494939|NCT00321685|579540842|FG000|Overall Study|Alternative therapy|1|||
160494940|NCT00321685|579540842|FG000|Overall Study|Complicating disese|1|||
160494941|NCT00321685|579540842|FG000|Overall Study|Other|5|||
160494942|NCT00321685|579540842|FG000|Overall Study|Not start protocol therapy|2|||
160494943|NCT00321685|579540842|FG000|Overall Study|Ineligible|2|||
160494944|NCT05064488|579540846|FG000|Overall Study|Withdrawal by Subject|2|||
160494945|NCT05064488|579540847|FG001|Overall Study|Withdrawal by Subject|0|||
160494946|NCT03023722|579540848|FG000|Overall Study|No follow-up assessment|4|||
160494947|NCT00590564|579540850|FG000|Overall Study|Withdrawal by Subject|4|||
160494948|NCT00590564|579540850|FG000|Overall Study|Lost to Follow-up|6|||
160494949|NCT00590564|579540850|FG000|Overall Study|Protocol Violation|1|||
160494950|NCT00590564|579540850|FG000|Overall Study|Patient Found to be Ineligible|1|||
160494951|NCT00590564|579540850|FG000|Overall Study|Patient Non-compliance|6|||
160494952|NCT01434680|579540855|FG000|Overall Study|Withdrawal by Subject|1|||
160494953|NCT01434680|579540856|FG001|Overall Study|Withdrawal by Subject|0|||
160494954|NCT01434680|579540857|FG002|Overall Study|Withdrawal by Subject|2|||
160494955|NCT01434680|579540858|FG003|Overall Study|Withdrawal by Subject|0|||
160494956|NCT01434680|579540855|FG000|Overall Study|Lost to Follow-up|1|||
160613779|NCT02185040|579963635|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
160494957|NCT01434680|579540856|FG001|Overall Study|Lost to Follow-up|1|||
160494958|NCT01434680|579540857|FG002|Overall Study|Lost to Follow-up|0|||
160494959|NCT01434680|579540858|FG003|Overall Study|Lost to Follow-up|0|||
160494960|NCT01434680|579540855|FG000|Overall Study|Protocol Violation|1|||
160494961|NCT01434680|579540856|FG001|Overall Study|Protocol Violation|1|||
160494962|NCT01434680|579540857|FG002|Overall Study|Protocol Violation|0|||
160494963|NCT01434680|579540858|FG003|Overall Study|Protocol Violation|0|||
160494964|NCT04090528|579540859|FG000|Overall Study|participants still on study|9|||
160494965|NCT04090528|579540860|FG001|Overall Study|participants still on study|13|||
160613780|NCT02185040|579963636|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
160613781|NCT02185040|579963637|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
160613782|NCT02185040|579963631|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
160613783|NCT02185040|579963632|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
160613784|NCT02185040|579963633|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
160613785|NCT02185040|579963634|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
160613786|NCT02185040|579963635|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
160613787|NCT02185040|579963636|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
160613788|NCT02185040|579963637|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
160613789|NCT02185040|579963631|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
160613790|NCT02185040|579963632|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
160613791|NCT02185040|579963633|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
160613792|NCT02185040|579963634|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
160613793|NCT02185040|579963635|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
160613794|NCT02185040|579963636|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
160613795|NCT02185040|579963637|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
160613796|NCT02185040|579963631|FG000|Active Treatment Extension Phase|Adverse Event|0|||
160613797|NCT02185040|579963632|FG001|Active Treatment Extension Phase|Adverse Event|0|||
160613798|NCT02185040|579963633|FG002|Active Treatment Extension Phase|Adverse Event|0|||
160613799|NCT02185040|579963634|FG003|Active Treatment Extension Phase|Adverse Event|0|||
160613800|NCT02185040|579963635|FG004|Active Treatment Extension Phase|Adverse Event|0|||
160613801|NCT02185040|579963636|FG005|Active Treatment Extension Phase|Adverse Event|1|||
160613802|NCT02185040|579963637|FG006|Active Treatment Extension Phase|Adverse Event|4|||
160613803|NCT02185040|579963631|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
160613804|NCT02185040|579963632|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
160613805|NCT02185040|579963633|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
160613806|NCT02185040|579963634|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
160613807|NCT02185040|579963635|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
160613808|NCT02185040|579963636|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
160613809|NCT02185040|579963637|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
160613810|NCT02185040|579963631|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
160613811|NCT02185040|579963632|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
160613812|NCT02185040|579963633|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
160613813|NCT02185040|579963634|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
160613814|NCT02185040|579963635|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
160613815|NCT02185040|579963636|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
160613816|NCT02185040|579963637|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
160613817|NCT02094612|579963642|FG000|Overall Study|Lost to Follow-up|47|||
160613818|NCT02094612|579963643|FG001|Overall Study|Lost to Follow-up|47|||
160613819|NCT02094612|579963642|FG000|Overall Study|Never started ADHD medication|32|||
160613820|NCT02094612|579963643|FG001|Overall Study|Never started ADHD medication|23|||
160613821|NCT02646891|579963644|FG000|Overall Study|Adverse Event|0|||
160613822|NCT02646891|579963645|FG001|Overall Study|Adverse Event|1|||
160613823|NCT02646891|579963646|FG002|Overall Study|Adverse Event|0|||
160613824|NCT02646891|579963647|FG003|Overall Study|Adverse Event|0|||
160613825|NCT02646891|579963648|FG004|Overall Study|Adverse Event|0|||
160613826|NCT02646891|579963649|FG005|Overall Study|Adverse Event|0|||
160613827|NCT02646891|579963650|FG006|Overall Study|Adverse Event|0|||
160613828|NCT02646891|579963651|FG007|Overall Study|Adverse Event|0|||
160613829|NCT02646891|579963652|FG008|Overall Study|Adverse Event|0|||
160613830|NCT02646891|579963653|FG009|Overall Study|Adverse Event|0|||
160613831|NCT02646891|579963644|FG000|Overall Study|Lost to Follow-up|0|||
160613832|NCT02646891|579963645|FG001|Overall Study|Lost to Follow-up|0|||
160613833|NCT02646891|579963646|FG002|Overall Study|Lost to Follow-up|0|||
160613834|NCT02646891|579963647|FG003|Overall Study|Lost to Follow-up|0|||
160613835|NCT02646891|579963648|FG004|Overall Study|Lost to Follow-up|0|||
160613836|NCT02646891|579963649|FG005|Overall Study|Lost to Follow-up|0|||
160613837|NCT02646891|579963650|FG006|Overall Study|Lost to Follow-up|2|||
160613838|NCT02646891|579963651|FG007|Overall Study|Lost to Follow-up|2|||
160613839|NCT02646891|579963652|FG008|Overall Study|Lost to Follow-up|2|||
160613840|NCT02646891|579963653|FG009|Overall Study|Lost to Follow-up|2|||
160613841|NCT02646891|579963644|FG000|Overall Study|Protocol Violation|0|||
160613842|NCT02646891|579963645|FG001|Overall Study|Protocol Violation|0|||
160613843|NCT02646891|579963646|FG002|Overall Study|Protocol Violation|0|||
160661508|NCT00696020|580144116|FG001|Overall Study|Other not stated above|0|||
160661509|NCT00696020|580144117|FG002|Overall Study|Other not stated above|1|||
160661510|NCT00696020|580144118|FG003|Overall Study|Other not stated above|1|||
160661511|NCT01387022|580144119|FG000|Overall Study|Death|1|||
160613844|NCT02646891|579963647|FG003|Overall Study|Protocol Violation|0|||
160613845|NCT02646891|579963648|FG004|Overall Study|Protocol Violation|0|||
160661512|NCT01387022|580144120|FG001|Overall Study|Death|1|||
160494966|NCT05923112|579540863|FG000|Overall Study|Protocol Violation|4|||
160494967|NCT05923112|579540863|FG000|Overall Study|No informed consent on publication of study results|243|||
160494968|NCT04991766|579540864|FG000|Overall Study|Withdrawal by Subject|2|||
160494969|NCT04991766|579540865|FG001|Overall Study|Withdrawal by Subject|0|||
160494970|NCT01952847|579540873|FG000|Overall Study|Ineligible|1|||
160494971|NCT01952847|579540874|FG001|Overall Study|Ineligible|0|||
160494972|NCT01952847|579540875|FG002|Overall Study|Ineligible|0|||
160494973|NCT01952847|579540876|FG003|Overall Study|Ineligible|0|||
160494974|NCT01952847|579540873|FG000|Overall Study|Lack of Insurance Coverage|0|||
160494975|NCT01952847|579540874|FG001|Overall Study|Lack of Insurance Coverage|1|||
160494976|NCT01952847|579540875|FG002|Overall Study|Lack of Insurance Coverage|0|||
160494977|NCT01952847|579540876|FG003|Overall Study|Lack of Insurance Coverage|0|||
160494978|NCT01952847|579540873|FG000|Overall Study|Withdrawal by Subject|1|||
160494979|NCT01952847|579540874|FG001|Overall Study|Withdrawal by Subject|1|||
160494980|NCT01952847|579540875|FG002|Overall Study|Withdrawal by Subject|0|||
160494981|NCT01952847|579540876|FG003|Overall Study|Withdrawal by Subject|1|||
160494982|NCT05382039|579540877|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
160494983|NCT05382039|579540878|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
160494984|NCT05382039|579540879|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
160494985|NCT05382039|579540877|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
160494986|NCT05382039|579540878|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
160494987|NCT05382039|579540879|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
160494988|NCT05382039|579540877|FG000|Overall Study|waiting for confirmation|0|||
160494989|NCT05382039|579540878|FG001|Overall Study|waiting for confirmation|0|||
160494990|NCT05382039|579540879|FG002|Overall Study|waiting for confirmation|1|||
160494991|NCT04464421|579540880|FG000|Overall Study|Lost to Follow-up|2|||
160494992|NCT04464421|579540881|FG001|Overall Study|Lost to Follow-up|2|||
160494993|NCT02577003|579540882|FG000|Overall Study|Adverse Event|2|||
160494994|NCT02577003|579540883|FG001|Overall Study|Adverse Event|4|||
160494995|NCT02577003|579540882|FG000|Overall Study|Withdrawal by Subject|0|||
160494996|NCT02577003|579540883|FG001|Overall Study|Withdrawal by Subject|1|||
160494997|NCT02786004|579540884|FG000|Overall Study|Withdrawal by Subject|0|||
160494998|NCT02786004|579540885|FG001|Overall Study|Withdrawal by Subject|1|||
160494999|NCT01234883|579540886|FG000|Overall Study|Early treatment release|8|||
160495000|NCT01234883|579540887|FG001|Overall Study|Early treatment release|10|||
160495001|NCT01234883|579540886|FG000|Overall Study|Parent/guardian withdrew consent|1|||
160495002|NCT01234883|579540887|FG001|Overall Study|Parent/guardian withdrew consent|2|||
160495003|NCT01234883|579540886|FG000|Overall Study|Technical difficulties with IV infusion|0|||
160495004|NCT01234883|579540887|FG001|Overall Study|Technical difficulties with IV infusion|1|||
160495005|NCT01234883|579540886|FG000|Overall Study|Inclusion/exclusion failure|1|||
160495006|NCT01234883|579540887|FG001|Overall Study|Inclusion/exclusion failure|0|||
160495007|NCT01013961|579540888|FG000|Overall Study|Adverse Event|2|||
160495008|NCT01013961|579540889|FG001|Overall Study|Adverse Event|2|||
160495009|NCT01013961|579540888|FG000|Overall Study|Withdrawal by Subject|1|||
160495010|NCT01013961|579540889|FG001|Overall Study|Withdrawal by Subject|0|||
160495011|NCT01013961|579540888|FG000|Overall Study|Physician Decision|0|||
160495012|NCT01013961|579540889|FG001|Overall Study|Physician Decision|1|||
160495013|NCT01271504|579540890|FG000|Overall Study|Death|7|||
160495014|NCT01271504|579540891|FG001|Overall Study|Death|6|||
160495015|NCT01271504|579540892|FG002|Overall Study|Death|32|||
160495016|NCT01271504|579540893|FG003|Overall Study|Death|32|||
160495017|NCT01271504|579540890|FG000|Overall Study|Lost to Follow-up|0|||
160495018|NCT01271504|579540891|FG001|Overall Study|Lost to Follow-up|1|||
160495019|NCT01271504|579540892|FG002|Overall Study|Lost to Follow-up|3|||
160495020|NCT01271504|579540893|FG003|Overall Study|Lost to Follow-up|1|||
160495021|NCT01271504|579540890|FG000|Overall Study|Protocol Violation|0|||
160495022|NCT01271504|579540891|FG001|Overall Study|Protocol Violation|0|||
160495023|NCT01271504|579540892|FG002|Overall Study|Protocol Violation|0|||
160495024|NCT01271504|579540893|FG003|Overall Study|Protocol Violation|2|||
160495025|NCT01271504|579540890|FG000|Overall Study|Administrative Reasons|0|||
160495026|NCT01271504|579540891|FG001|Overall Study|Administrative Reasons|0|||
160613846|NCT02646891|579963649|FG005|Overall Study|Protocol Violation|0|||
160613847|NCT02646891|579963650|FG006|Overall Study|Protocol Violation|1|||
160495027|NCT01271504|579540892|FG002|Overall Study|Administrative Reasons|6|||
160495028|NCT01271504|579540893|FG003|Overall Study|Administrative Reasons|5|||
160495029|NCT01271504|579540890|FG000|Overall Study|Withdrawal by Subject|0|||
160495030|NCT01271504|579540891|FG001|Overall Study|Withdrawal by Subject|0|||
160495031|NCT01271504|579540892|FG002|Overall Study|Withdrawal by Subject|1|||
160495032|NCT01271504|579540893|FG003|Overall Study|Withdrawal by Subject|3|||
160495033|NCT01271504|579540890|FG000|Overall Study|Other|0|||
160495034|NCT01271504|579540891|FG001|Overall Study|Other|1|||
160495035|NCT01271504|579540892|FG002|Overall Study|Other|2|||
160495036|NCT01271504|579540893|FG003|Overall Study|Other|0|||
160495037|NCT00756457|579540904|FG000|Overall Study|Lost to Follow-up|1|||
160613848|NCT02646891|579963651|FG007|Overall Study|Protocol Violation|1|||
160613849|NCT02646891|579963652|FG008|Overall Study|Protocol Violation|0|||
160613850|NCT02646891|579963653|FG009|Overall Study|Protocol Violation|0|||
160613851|NCT02646891|579963644|FG000|Overall Study|Withdrawal by Subject|2|||
160613852|NCT02646891|579963645|FG001|Overall Study|Withdrawal by Subject|0|||
160613853|NCT02646891|579963646|FG002|Overall Study|Withdrawal by Subject|1|||
160613854|NCT02646891|579963647|FG003|Overall Study|Withdrawal by Subject|0|||
160613855|NCT02646891|579963648|FG004|Overall Study|Withdrawal by Subject|0|||
160613856|NCT02646891|579963649|FG005|Overall Study|Withdrawal by Subject|0|||
160613857|NCT02646891|579963650|FG006|Overall Study|Withdrawal by Subject|5|||
160613858|NCT02646891|579963651|FG007|Overall Study|Withdrawal by Subject|9|||
160613859|NCT02646891|579963652|FG008|Overall Study|Withdrawal by Subject|7|||
160613860|NCT02646891|579963653|FG009|Overall Study|Withdrawal by Subject|3|||
160613861|NCT02646891|579963644|FG000|Overall Study|Death|0|||
160613862|NCT02646891|579963645|FG001|Overall Study|Death|0|||
160613863|NCT02646891|579963646|FG002|Overall Study|Death|0|||
160613864|NCT02646891|579963647|FG003|Overall Study|Death|0|||
160613865|NCT02646891|579963648|FG004|Overall Study|Death|0|||
160613866|NCT02646891|579963649|FG005|Overall Study|Death|0|||
160613867|NCT02646891|579963650|FG006|Overall Study|Death|1|||
160613868|NCT02646891|579963651|FG007|Overall Study|Death|1|||
160613869|NCT02646891|579963652|FG008|Overall Study|Death|1|||
160613870|NCT02646891|579963653|FG009|Overall Study|Death|0|||
160613871|NCT01542632|579963654|FG000|Overall Study|Withdrawal of Consent|0|||
160613872|NCT01542632|579963655|FG001|Overall Study|Withdrawal of Consent|0|||
160613873|NCT01542632|579963656|FG002|Overall Study|Withdrawal of Consent|0|||
160613874|NCT01542632|579963657|FG003|Overall Study|Withdrawal of Consent|2|||
160613875|NCT01542632|579963658|FG004|Overall Study|Withdrawal of Consent|3|||
160613876|NCT01542632|579963659|FG005|Overall Study|Withdrawal of Consent|0|||
160613877|NCT01542632|579963654|FG000|Overall Study|Adverse Event|0|||
160613878|NCT01542632|579963655|FG001|Overall Study|Adverse Event|0|||
160613879|NCT01542632|579963656|FG002|Overall Study|Adverse Event|1|||
160613880|NCT01542632|579963657|FG003|Overall Study|Adverse Event|0|||
160613881|NCT01542632|579963658|FG004|Overall Study|Adverse Event|0|||
160613882|NCT01542632|579963659|FG005|Overall Study|Adverse Event|0|||
160613883|NCT01542632|579963654|FG000|Overall Study|Lost to Follow-up|0|||
160613884|NCT01542632|579963655|FG001|Overall Study|Lost to Follow-up|1|||
160613885|NCT01542632|579963656|FG002|Overall Study|Lost to Follow-up|0|||
160613886|NCT01542632|579963657|FG003|Overall Study|Lost to Follow-up|0|||
160613887|NCT01542632|579963658|FG004|Overall Study|Lost to Follow-up|0|||
160613888|NCT01542632|579963659|FG005|Overall Study|Lost to Follow-up|0|||
160613889|NCT01542632|579963654|FG000|Overall Study|Sponsor/Investigator Decision|0|||
160613890|NCT01542632|579963655|FG001|Overall Study|Sponsor/Investigator Decision|0|||
160613891|NCT01542632|579963656|FG002|Overall Study|Sponsor/Investigator Decision|0|||
160613892|NCT01542632|579963657|FG003|Overall Study|Sponsor/Investigator Decision|0|||
160613893|NCT01542632|579963658|FG004|Overall Study|Sponsor/Investigator Decision|1|||
160613894|NCT01542632|579963659|FG005|Overall Study|Sponsor/Investigator Decision|0|||
160613895|NCT00033514|579963660|FG000|Overall Study|Lost to Follow-up|1|||
160613896|NCT00033514|579963661|FG001|Overall Study|Lost to Follow-up|1|||
160613897|NCT00033514|579963660|FG000|Overall Study|Withdrawal by Subject|0|||
160613898|NCT00033514|579963661|FG001|Overall Study|Withdrawal by Subject|3|||
160613899|NCT04785144|579963664|FG000|Overall Study|Withdrawal by Subject|4|||
160613900|NCT04785144|579963665|FG001|Overall Study|Withdrawal by Subject|1|||
160613901|NCT04785144|579963666|FG002|Overall Study|Withdrawal by Subject|0|||
160613902|NCT04785144|579963667|FG003|Overall Study|Withdrawal by Subject|0|||
160613903|NCT04785144|579963668|FG004|Overall Study|Withdrawal by Subject|0|||
160613904|NCT04785144|579963669|FG005|Overall Study|Withdrawal by Subject|2|||
160613905|NCT04785144|579963670|FG006|Overall Study|Withdrawal by Subject|2|||
160613906|NCT04785144|579963671|FG007|Overall Study|Withdrawal by Subject|0|||
160613907|NCT04785144|579963672|FG008|Overall Study|Withdrawal by Subject|1|||
160613908|NCT04785144|579963673|FG009|Overall Study|Withdrawal by Subject|0|||
160613909|NCT04785144|579963664|FG000|Overall Study|Lost to Follow-up|1|||
160613910|NCT04785144|579963665|FG001|Overall Study|Lost to Follow-up|0|||
160613911|NCT04785144|579963666|FG002|Overall Study|Lost to Follow-up|0|||
160613912|NCT04785144|579963667|FG003|Overall Study|Lost to Follow-up|0|||
160613913|NCT04785144|579963668|FG004|Overall Study|Lost to Follow-up|1|||
160613914|NCT04785144|579963669|FG005|Overall Study|Lost to Follow-up|2|||
160613915|NCT04785144|579963670|FG006|Overall Study|Lost to Follow-up|1|||
160613916|NCT04785144|579963671|FG007|Overall Study|Lost to Follow-up|2|||
160495038|NCT00756457|579540905|FG001|Overall Study|Lost to Follow-up|2|||
160613917|NCT04785144|579963672|FG008|Overall Study|Lost to Follow-up|4|||
160495039|NCT02402322|579540906|FG000|Pretreatment|Withdrawal by Subject|3|||
160495040|NCT02402322|579540907|FG001|Pretreatment|Withdrawal by Subject|1|||
160495041|NCT02402322|579540908|FG002|Pretreatment|Withdrawal by Subject|1|||
160613918|NCT04785144|579963673|FG009|Overall Study|Lost to Follow-up|1|||
160613919|NCT04785144|579963664|FG000|Overall Study|Protocol Violation|0|||
160613920|NCT04785144|579963665|FG001|Overall Study|Protocol Violation|0|||
160613921|NCT04785144|579963666|FG002|Overall Study|Protocol Violation|0|||
160613922|NCT04785144|579963667|FG003|Overall Study|Protocol Violation|0|||
160613923|NCT04785144|579963668|FG004|Overall Study|Protocol Violation|0|||
160613924|NCT04785144|579963669|FG005|Overall Study|Protocol Violation|0|||
160613925|NCT04785144|579963670|FG006|Overall Study|Protocol Violation|1|||
160613926|NCT04785144|579963671|FG007|Overall Study|Protocol Violation|0|||
160613927|NCT04785144|579963672|FG008|Overall Study|Protocol Violation|0|||
160613928|NCT04785144|579963673|FG009|Overall Study|Protocol Violation|0|||
160613929|NCT04785144|579963664|FG000|Overall Study|Physician Decision|0|||
160613930|NCT04785144|579963665|FG001|Overall Study|Physician Decision|0|||
160613931|NCT04785144|579963666|FG002|Overall Study|Physician Decision|0|||
160613932|NCT04785144|579963667|FG003|Overall Study|Physician Decision|0|||
160613933|NCT04785144|579963668|FG004|Overall Study|Physician Decision|0|||
160613934|NCT04785144|579963669|FG005|Overall Study|Physician Decision|0|||
160613935|NCT04785144|579963670|FG006|Overall Study|Physician Decision|0|||
160613936|NCT04785144|579963671|FG007|Overall Study|Physician Decision|0|||
160613937|NCT04785144|579963672|FG008|Overall Study|Physician Decision|0|||
160613938|NCT04785144|579963673|FG009|Overall Study|Physician Decision|1|||
160613939|NCT04785144|579963664|FG000|Overall Study|Unable to continue due to work schedule|0|||
160613940|NCT04785144|579963665|FG001|Overall Study|Unable to continue due to work schedule|0|||
160613941|NCT04785144|579963666|FG002|Overall Study|Unable to continue due to work schedule|0|||
160613942|NCT04785144|579963667|FG003|Overall Study|Unable to continue due to work schedule|0|||
160613943|NCT04785144|579963668|FG004|Overall Study|Unable to continue due to work schedule|0|||
160613944|NCT04785144|579963669|FG005|Overall Study|Unable to continue due to work schedule|0|||
160613945|NCT04785144|579963670|FG006|Overall Study|Unable to continue due to work schedule|0|||
160613946|NCT04785144|579963671|FG007|Overall Study|Unable to continue due to work schedule|0|||
160613947|NCT04785144|579963672|FG008|Overall Study|Unable to continue due to work schedule|0|||
160613948|NCT04785144|579963673|FG009|Overall Study|Unable to continue due to work schedule|1|||
160613949|NCT00137267|579963674|FG000|Overall Study|Lost to Follow-up|15|||
160613950|NCT00137267|579963675|FG001|Overall Study|Lost to Follow-up|21|||
160613951|NCT02871791|579963678|FG000|Phase 1b|Death|0|||
160613952|NCT02871791|579963679|FG001|Phase 1b|Death|1|||
160613953|NCT02871791|579963678|FG000|Phase 1b|progressive disease|6|||
160613954|NCT02871791|579963679|FG001|Phase 1b|progressive disease|2|||
160613955|NCT02871791|579963678|FG000|Phase 2|Death|1|||
160613956|NCT02871791|579963679|FG001|Phase 2|Death|0|||
160613957|NCT02871791|579963678|FG000|Phase 2|Lost to Follow-up|2|||
160613958|NCT02871791|579963679|FG001|Phase 2|Lost to Follow-up|0|||
160613959|NCT00129376|579963680|FG000|Overall Study|Adverse Event|1|||
160613960|NCT00129376|579963680|FG000|Overall Study|Lack of Efficacy|1|||
160613961|NCT04005755|579963688|FG000|Overall Study|Adverse Event|6|||
160613962|NCT04005755|579963688|FG000|Overall Study|Physician Decision|3|||
160613963|NCT04005755|579963688|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
160613964|NCT04005755|579963688|FG000|Overall Study|Withdrawal by Subject|3|||
160613965|NCT04005755|579963688|FG000|Overall Study|Lost to Follow-up|1|||
160613966|NCT00952588|579963692|FG000|Overall Study|Death|28|||
160613967|NCT00952588|579963693|FG001|Overall Study|Death|13|||
160613968|NCT00952588|579963692|FG000|Overall Study|Withdrawal by Subject|2|||
160613969|NCT00952588|579963693|FG001|Overall Study|Withdrawal by Subject|5|||
160613970|NCT00952588|579963692|FG000|Overall Study|Adverse Event|2|||
160613971|NCT00952588|579963693|FG001|Overall Study|Adverse Event|3|||
160613972|NCT00952588|579963692|FG000|Overall Study|Lost to Follow-up|2|||
160613973|NCT00952588|579963693|FG001|Overall Study|Lost to Follow-up|0|||
160613974|NCT00952588|579963692|FG000|Overall Study|Physician Decision|0|||
160613975|NCT00952588|579963693|FG001|Overall Study|Physician Decision|1|||
160613976|NCT00952588|579963692|FG000|Overall Study|Lack of Efficacy|2|||
160613977|NCT00952588|579963693|FG001|Overall Study|Lack of Efficacy|2|||
160613978|NCT01766401|579963694|FG000|Overall Study|Adverse Event|7|||
160613979|NCT01766401|579963695|FG001|Overall Study|Adverse Event|22|||
160613980|NCT01766401|579963694|FG000|Overall Study|Lack of Efficacy|1|||
160613981|NCT01766401|579963695|FG001|Overall Study|Lack of Efficacy|2|||
160613982|NCT01766401|579963694|FG000|Overall Study|Protocol Violation|3|||
160613983|NCT01766401|579963695|FG001|Overall Study|Protocol Violation|8|||
160613984|NCT01766401|579963694|FG000|Overall Study|Withdrawal by Subject|15|||
160613985|NCT01766401|579963695|FG001|Overall Study|Withdrawal by Subject|12|||
160613986|NCT01766401|579963694|FG000|Overall Study|Lost to Follow-up|10|||
160613987|NCT01766401|579963695|FG001|Overall Study|Lost to Follow-up|11|||
160613988|NCT01766401|579963694|FG000|Overall Study|Pregnancy|1|||
160613989|NCT01766401|579963695|FG001|Overall Study|Pregnancy|1|||
160613990|NCT01108068|579963696|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
160613991|NCT01108068|579963697|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
160613992|NCT02201251|579963698|FG000|Overall Study|Adverse Event|1|||
160613993|NCT02201251|579963699|FG001|Overall Study|Adverse Event|1|||
160613994|NCT02201251|579963698|FG000|Overall Study|Protocol Violation|1|||
160613995|NCT02201251|579963699|FG001|Overall Study|Protocol Violation|0|||
160613996|NCT02201251|579963698|FG000|Overall Study|Noncompliance with Study Drug|0|||
160613997|NCT02201251|579963699|FG001|Overall Study|Noncompliance with Study Drug|1|||
160613998|NCT02201251|579963698|FG000|Overall Study|Withdrawal by Subject|2|||
160613999|NCT02201251|579963699|FG001|Overall Study|Withdrawal by Subject|1|||
160614000|NCT01197794|579963700|FG000|Overall Study|Adverse Event|3|||
160614001|NCT01197794|579963701|FG001|Overall Study|Adverse Event|2|||
160614002|NCT01197794|579963702|FG002|Overall Study|Adverse Event|4|||
160614003|NCT01197794|579963703|FG003|Overall Study|Adverse Event|4|||
160614004|NCT01197794|579963704|FG004|Overall Study|Adverse Event|4|||
160614005|NCT01197794|579963705|FG005|Overall Study|Adverse Event|2|||
160614006|NCT01197794|579963706|FG006|Overall Study|Adverse Event|3|||
160614007|NCT01197794|579963700|FG000|Overall Study|Protocol Violation|0|||
160614008|NCT01197794|579963701|FG001|Overall Study|Protocol Violation|0|||
160614009|NCT01197794|579963702|FG002|Overall Study|Protocol Violation|0|||
160614010|NCT01197794|579963703|FG003|Overall Study|Protocol Violation|0|||
160614011|NCT01197794|579963704|FG004|Overall Study|Protocol Violation|2|||
160614012|NCT01197794|579963705|FG005|Overall Study|Protocol Violation|0|||
160614013|NCT01197794|579963706|FG006|Overall Study|Protocol Violation|1|||
160614014|NCT01197794|579963700|FG000|Overall Study|Development of study withdrawal criteria|3|||
160614015|NCT01197794|579963701|FG001|Overall Study|Development of study withdrawal criteria|0|||
160614016|NCT01197794|579963702|FG002|Overall Study|Development of study withdrawal criteria|0|||
160614017|NCT01197794|579963703|FG003|Overall Study|Development of study withdrawal criteria|1|||
160614018|NCT01197794|579963704|FG004|Overall Study|Development of study withdrawal criteria|0|||
160614019|NCT01197794|579963705|FG005|Overall Study|Development of study withdrawal criteria|0|||
160614020|NCT01197794|579963706|FG006|Overall Study|Development of study withdrawal criteria|1|||
160614021|NCT01197794|579963700|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
160614022|NCT01197794|579963701|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
160614023|NCT01197794|579963702|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
160614024|NCT01197794|579963703|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
160614025|NCT01197794|579963704|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
160614026|NCT01197794|579963705|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
160614027|NCT01197794|579963706|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
160614028|NCT01197794|579963700|FG000|Overall Study|Withdrawal by Subject|3|||
160614029|NCT01197794|579963701|FG001|Overall Study|Withdrawal by Subject|3|||
160614030|NCT01197794|579963702|FG002|Overall Study|Withdrawal by Subject|4|||
160614031|NCT01197794|579963703|FG003|Overall Study|Withdrawal by Subject|1|||
160614032|NCT01197794|579963704|FG004|Overall Study|Withdrawal by Subject|1|||
160614033|NCT01197794|579963705|FG005|Overall Study|Withdrawal by Subject|5|||
160614034|NCT01197794|579963706|FG006|Overall Study|Withdrawal by Subject|6|||
160614035|NCT01197794|579963700|FG000|Overall Study|Lost to Follow-up|1|||
160614036|NCT01197794|579963701|FG001|Overall Study|Lost to Follow-up|1|||
160614037|NCT01197794|579963702|FG002|Overall Study|Lost to Follow-up|0|||
160614038|NCT01197794|579963703|FG003|Overall Study|Lost to Follow-up|1|||
160614039|NCT01197794|579963704|FG004|Overall Study|Lost to Follow-up|0|||
160614040|NCT01197794|579963705|FG005|Overall Study|Lost to Follow-up|1|||
160614041|NCT01197794|579963706|FG006|Overall Study|Lost to Follow-up|0|||
160614042|NCT01197794|579963700|FG000|Overall Study|Other|1|||
160614043|NCT01197794|579963701|FG001|Overall Study|Other|1|||
160614044|NCT01197794|579963702|FG002|Overall Study|Other|3|||
160614045|NCT01197794|579963703|FG003|Overall Study|Other|0|||
160614046|NCT01197794|579963704|FG004|Overall Study|Other|2|||
160614047|NCT01197794|579963705|FG005|Overall Study|Other|2|||
160614048|NCT01197794|579963706|FG006|Overall Study|Other|4|||
160614049|NCT04055844|579963707|FG000|Overall Study|Adverse Event|12|||
160614050|NCT04055844|579963707|FG000|Overall Study|Poor Performance|1|||
160614051|NCT04055844|579963707|FG000|Overall Study|Death|1|||
160614052|NCT00572728|579963712|FG000|Overall Study|Withdrawal by Subject|10|||
160614053|NCT00572728|579963712|FG000|Overall Study|Ineligible|3|||
160614054|NCT00572728|579963712|FG000|Overall Study|Enrolled under Amendment 4|5|||
160614055|NCT00572728|579963712|FG000|Overall Study|Offstudy due to complicating disease|1|||
160614056|NCT00572728|579963712|FG000|Overall Study|FLT1 not completed|4|||
160614057|NCT00572728|579963712|FG000|Overall Study|First Chemotherapy not initiated|2|||
160614058|NCT00572728|579963712|FG000|Overall Study|FLT2 not completed|5|||
160614059|NCT00572728|579963712|FG000|Overall Study|Second chemotherapy not initiated|1|||
160614060|NCT00572728|579963712|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
160661513|NCT01387022|580144119|FG000|Overall Study|Lost to Follow-up|0|||
160614061|NCT00572728|579963712|FG000|Overall Study|Pathology missing|1|||
160614062|NCT01833806|579963719|FG000|Overall Study|Alternative treatment|2|||
160614063|NCT01833806|579963719|FG000|Overall Study|Death|5|||
160614064|NCT01833806|579963719|FG000|Overall Study|Physician Decision|1|||
160614065|NCT01833806|579963719|FG000|Overall Study|Lost to Follow-up|1|||
160614066|NCT02724111|579963720|FG000|Overall Study|Protocol Violation|2|||
160614067|NCT02724111|579963721|FG001|Overall Study|Protocol Violation|5|||
160614068|NCT02996500|579963722|FG000|Overall Study|Adverse Event|1|||
160614069|NCT02996500|579963723|FG001|Overall Study|Adverse Event|1|||
160614070|NCT02996500|579963724|FG002|Overall Study|Adverse Event|4|||
160614071|NCT02996500|579963725|FG003|Overall Study|Adverse Event|3|||
160614072|NCT02996500|579963726|FG004|Overall Study|Adverse Event|1|||
160614073|NCT02996500|579963727|FG005|Overall Study|Adverse Event|2|||
160614074|NCT02996500|579963722|FG000|Overall Study|Lack of Efficacy|0|||
160614075|NCT02996500|579963723|FG001|Overall Study|Lack of Efficacy|0|||
160614076|NCT02996500|579963724|FG002|Overall Study|Lack of Efficacy|0|||
160661514|NCT01387022|580144120|FG001|Overall Study|Lost to Follow-up|3|||
160614077|NCT02996500|579963725|FG003|Overall Study|Lack of Efficacy|0|||
160614078|NCT02996500|579963726|FG004|Overall Study|Lack of Efficacy|2|||
160614079|NCT02996500|579963727|FG005|Overall Study|Lack of Efficacy|0|||
160614080|NCT02996500|579963722|FG000|Overall Study|Lost to Follow-up|1|||
160614081|NCT02996500|579963723|FG001|Overall Study|Lost to Follow-up|0|||
160614082|NCT02996500|579963724|FG002|Overall Study|Lost to Follow-up|0|||
160495042|NCT02402322|579540906|FG000|Follow-up|Withdrawal by Subject|6|||
160495043|NCT02402322|579540907|FG001|Follow-up|Withdrawal by Subject|3|||
160495044|NCT02402322|579540908|FG002|Follow-up|Withdrawal by Subject|24|||
160495045|NCT02818998|579540909|FG000|Overall Study|Adverse Event|3|||
160495046|NCT02818998|579540910|FG001|Overall Study|Adverse Event|2|||
160495047|NCT02818998|579540911|FG002|Overall Study|Adverse Event|1|||
160495048|NCT02818998|579540909|FG000|Overall Study|Lost to Follow-up|4|||
160495049|NCT02818998|579540910|FG001|Overall Study|Lost to Follow-up|1|||
160495050|NCT02818998|579540911|FG002|Overall Study|Lost to Follow-up|2|||
160495051|NCT02818998|579540909|FG000|Overall Study|Withdrawal by sponsor|0|||
160495052|NCT02818998|579540910|FG001|Overall Study|Withdrawal by sponsor|1|||
160495053|NCT02818998|579540911|FG002|Overall Study|Withdrawal by sponsor|1|||
160495054|NCT02818998|579540909|FG000|Overall Study|Death|3|||
160495055|NCT02818998|579540910|FG001|Overall Study|Death|6|||
160495056|NCT02818998|579540911|FG002|Overall Study|Death|8|||
160495057|NCT02818998|579540909|FG000|Overall Study|Withdrawal by Subject|7|||
160495058|NCT02818998|579540910|FG001|Overall Study|Withdrawal by Subject|6|||
160495059|NCT02818998|579540911|FG002|Overall Study|Withdrawal by Subject|6|||
160495060|NCT02818998|579540909|FG000|Overall Study|Physician Decision|1|||
160495061|NCT02818998|579540910|FG001|Overall Study|Physician Decision|0|||
160495062|NCT02818998|579540911|FG002|Overall Study|Physician Decision|0|||
160495063|NCT02472145|579540912|FG000|Overall Study|Death|10|||
160495064|NCT02472145|579540913|FG001|Overall Study|Death|101|||
160495065|NCT02472145|579540914|FG002|Overall Study|Death|99|||
160495066|NCT02472145|579540912|FG000|Overall Study|Lost to Follow-up|0|||
160495067|NCT02472145|579540913|FG001|Overall Study|Lost to Follow-up|1|||
160495068|NCT02472145|579540914|FG002|Overall Study|Lost to Follow-up|0|||
160495069|NCT02472145|579540912|FG000|Overall Study|Withdrawal by Subject|0|||
160495070|NCT02472145|579540913|FG001|Overall Study|Withdrawal by Subject|9|||
160495071|NCT02472145|579540914|FG002|Overall Study|Withdrawal by Subject|13|||
160495072|NCT02472145|579540912|FG000|Overall Study|Sponsor decision|0|||
160495073|NCT02472145|579540913|FG001|Overall Study|Sponsor decision|3|||
160495074|NCT02472145|579540914|FG002|Overall Study|Sponsor decision|2|||
160495075|NCT02472145|579540912|FG000|Overall Study|Other|0|||
160495076|NCT02472145|579540913|FG001|Overall Study|Other|45|||
160495077|NCT02472145|579540914|FG002|Overall Study|Other|43|||
160495078|NCT01080326|579540915|FG000|Overall Study|Patient deterioration prior to procedure|3|||
160495079|NCT01080326|579540915|FG000|Overall Study|Surgeon decision|1|||
160495080|NCT00632021|579540917|FG000|Overall Study|Withdrawal/death|4|||
160495081|NCT00632021|579540918|FG001|Overall Study|Withdrawal/death|7|||
160495082|NCT02250534|579540921|FG000|Overall Study|Lost to Follow-up|18|||
160495083|NCT02250534|579540922|FG001|Overall Study|Lost to Follow-up|28|||
160495084|NCT02250534|579540923|FG002|Overall Study|Lost to Follow-up|33|||
160495085|NCT02250534|579540921|FG000|Overall Study|Personal reasons|7|||
160495086|NCT02250534|579540922|FG001|Overall Study|Personal reasons|8|||
160495087|NCT02250534|579540923|FG002|Overall Study|Personal reasons|14|||
160495088|NCT02250534|579540921|FG000|Overall Study|Adverse Event|6|||
160495089|NCT02250534|579540922|FG001|Overall Study|Adverse Event|3|||
160495090|NCT02250534|579540923|FG002|Overall Study|Adverse Event|8|||
160495091|NCT02250534|579540921|FG000|Overall Study|incarcerated|2|||
160495092|NCT02250534|579540922|FG001|Overall Study|incarcerated|1|||
160614083|NCT02996500|579963725|FG003|Overall Study|Lost to Follow-up|0|||
160614084|NCT02996500|579963726|FG004|Overall Study|Lost to Follow-up|0|||
160614085|NCT02996500|579963727|FG005|Overall Study|Lost to Follow-up|1|||
160614086|NCT02996500|579963722|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160495093|NCT02250534|579540923|FG002|Overall Study|incarcerated|2|||
160495094|NCT02250534|579540921|FG000|Overall Study|Withdrawal by Subject|0|||
160495095|NCT02250534|579540922|FG001|Overall Study|Withdrawal by Subject|1|||
160495096|NCT02250534|579540923|FG002|Overall Study|Withdrawal by Subject|2|||
160495097|NCT02250534|579540921|FG000|Overall Study|Death|0|||
160495098|NCT02250534|579540922|FG001|Overall Study|Death|1|||
160495099|NCT02250534|579540923|FG002|Overall Study|Death|1|||
160495100|NCT02250534|579540921|FG000|Overall Study|Physician Decision|1|||
160495101|NCT02250534|579540922|FG001|Overall Study|Physician Decision|3|||
160495102|NCT02250534|579540923|FG002|Overall Study|Physician Decision|1|||
160614087|NCT02996500|579963723|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160614088|NCT02996500|579963724|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
160661515|NCT02076022|580144123|FG000|Overall Study|Withdrawal by Subject|2|||
160495103|NCT02250534|579540921|FG000|Overall Study|Protocol Violation|1|||
160495104|NCT02250534|579540922|FG001|Overall Study|Protocol Violation|0|||
160495105|NCT02250534|579540923|FG002|Overall Study|Protocol Violation|1|||
160495106|NCT02250534|579540921|FG000|Overall Study|Reason unknown|1|||
160495107|NCT02250534|579540922|FG001|Overall Study|Reason unknown|0|||
160614089|NCT02996500|579963725|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
160614090|NCT02996500|579963726|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
160614091|NCT02996500|579963727|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
160614092|NCT02996500|579963722|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160614093|NCT02996500|579963723|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160614094|NCT02996500|579963724|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160614095|NCT02996500|579963725|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160614096|NCT02996500|579963726|FG004|Overall Study|Non-Compliance With Study Drug|0|||
160614097|NCT02996500|579963727|FG005|Overall Study|Non-Compliance With Study Drug|1|||
160614098|NCT02996500|579963722|FG000|Overall Study|Progressive Disease|1|||
160614099|NCT02996500|579963723|FG001|Overall Study|Progressive Disease|0|||
160614100|NCT02996500|579963724|FG002|Overall Study|Progressive Disease|0|||
160614101|NCT02996500|579963725|FG003|Overall Study|Progressive Disease|0|||
160614102|NCT02996500|579963726|FG004|Overall Study|Progressive Disease|0|||
160614103|NCT02996500|579963727|FG005|Overall Study|Progressive Disease|0|||
160614104|NCT02996500|579963722|FG000|Overall Study|Other|2|||
160614105|NCT02996500|579963723|FG001|Overall Study|Other|0|||
160614106|NCT02996500|579963724|FG002|Overall Study|Other|2|||
160614107|NCT02996500|579963725|FG003|Overall Study|Other|0|||
160614108|NCT02996500|579963726|FG004|Overall Study|Other|0|||
160614109|NCT02996500|579963727|FG005|Overall Study|Other|0|||
160614110|NCT02996500|579963722|FG000|Overall Study|Protocol Violation|0|||
160614111|NCT02996500|579963723|FG001|Overall Study|Protocol Violation|0|||
160614112|NCT02996500|579963724|FG002|Overall Study|Protocol Violation|0|||
160614113|NCT02996500|579963725|FG003|Overall Study|Protocol Violation|1|||
160614114|NCT02996500|579963726|FG004|Overall Study|Protocol Violation|0|||
160614115|NCT02996500|579963727|FG005|Overall Study|Protocol Violation|0|||
160614116|NCT02996500|579963722|FG000|Overall Study|Withdrawal by Subject|3|||
160614117|NCT02996500|579963723|FG001|Overall Study|Withdrawal by Subject|0|||
160614118|NCT02996500|579963724|FG002|Overall Study|Withdrawal by Subject|3|||
160614119|NCT02996500|579963725|FG003|Overall Study|Withdrawal by Subject|0|||
160614120|NCT02996500|579963726|FG004|Overall Study|Withdrawal by Subject|2|||
160614121|NCT02996500|579963727|FG005|Overall Study|Withdrawal by Subject|0|||
160614122|NCT02332876|579963728|FG000|Overall Study|Lost to Follow-up|1|||
160614123|NCT02332876|579963729|FG001|Overall Study|Lost to Follow-up|1|||
160614124|NCT03231228|579963733|FG000|Overall Study|Lost to Follow-up|2|||
160614125|NCT03231228|579963734|FG001|Overall Study|Lost to Follow-up|0|||
160614126|NCT03231228|579963733|FG000|Overall Study|Physician Decision|1|||
160614127|NCT03231228|579963734|FG001|Overall Study|Physician Decision|0|||
160614128|NCT02382276|579963735|FG000|Overall Study|Withdrawal by Subject|4|||
160614129|NCT02382276|579963736|FG001|Overall Study|Withdrawal by Subject|8|||
160614130|NCT02382276|579963737|FG002|Overall Study|Withdrawal by Subject|5|||
160614131|NCT02382276|579963735|FG000|Overall Study|Adverse Event|7|||
160614132|NCT02382276|579963736|FG001|Overall Study|Adverse Event|2|||
160614133|NCT02382276|579963737|FG002|Overall Study|Adverse Event|32|||
160614134|NCT02382276|579963735|FG000|Overall Study|Physician Decision|0|||
160614135|NCT02382276|579963736|FG001|Overall Study|Physician Decision|0|||
160614136|NCT02382276|579963737|FG002|Overall Study|Physician Decision|2|||
160614137|NCT01222416|579963738|FG000|Overall Study|ineligible;metastasis|3|||
160614138|NCT01222416|579963739|FG001|Overall Study|ineligible;metastasis|0|||
160614139|NCT01222416|579963738|FG000|Overall Study|Adverse Event|4|||
160614140|NCT01222416|579963739|FG001|Overall Study|Adverse Event|0|||
160614141|NCT01222416|579963738|FG000|Overall Study|Withdrawal by Subject|5|||
160614142|NCT01222416|579963739|FG001|Overall Study|Withdrawal by Subject|0|||
160614143|NCT01222416|579963738|FG000|Overall Study|scheduling|6|||
160614144|NCT01222416|579963739|FG001|Overall Study|scheduling|0|||
160614145|NCT01222416|579963738|FG000|Overall Study|missed view/scan|1|||
160614146|NCT01222416|579963739|FG001|Overall Study|missed view/scan|0|||
160614147|NCT01222416|579963738|FG000|Overall Study|Death|1|||
160614148|NCT01222416|579963739|FG001|Overall Study|Death|0|||
160614149|NCT03049852|579963750|FG000|Overall Study|Lost to Follow-up|0|||
160661516|NCT02076022|580144124|FG001|Overall Study|Withdrawal by Subject|0|||
160495108|NCT02250534|579540923|FG002|Overall Study|Reason unknown|0|||
160495109|NCT01628692|579540926|FG000|Overall Study|Lack of Efficacy|4|||
160495110|NCT01628692|579540927|FG001|Overall Study|Lack of Efficacy|4|||
160495111|NCT01628692|579540928|FG002|Overall Study|Lack of Efficacy|5|||
160495112|NCT01628692|579540929|FG003|Overall Study|Lack of Efficacy|1|||
160495113|NCT01628692|579540930|FG004|Overall Study|Lack of Efficacy|4|||
160614150|NCT03049852|579963751|FG001|Overall Study|Lost to Follow-up|1|||
160614151|NCT03049852|579963752|FG002|Overall Study|Lost to Follow-up|0|||
160614152|NCT02141854|579963753|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
160614153|NCT02141854|579963754|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160614154|NCT02141854|579963755|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160614155|NCT02141854|579963756|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160614156|NCT02141854|579963757|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160614157|NCT02141854|579963758|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160614158|NCT02141854|579963753|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
160614159|NCT02141854|579963754|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160495114|NCT01628692|579540931|FG005|Overall Study|Lack of Efficacy|7|||
160495115|NCT01628692|579540926|FG000|Overall Study|Adverse Event|2|||
160495116|NCT01628692|579540927|FG001|Overall Study|Adverse Event|0|||
160495117|NCT01628692|579540928|FG002|Overall Study|Adverse Event|2|||
160495118|NCT01628692|579540929|FG003|Overall Study|Adverse Event|0|||
160495119|NCT01628692|579540930|FG004|Overall Study|Adverse Event|0|||
160495120|NCT01628692|579540931|FG005|Overall Study|Adverse Event|0|||
160495121|NCT01628692|579540926|FG000|Overall Study|Withdrawal by Subject|0|||
160495122|NCT01628692|579540927|FG001|Overall Study|Withdrawal by Subject|1|||
160495123|NCT01628692|579540928|FG002|Overall Study|Withdrawal by Subject|1|||
160495124|NCT01628692|579540929|FG003|Overall Study|Withdrawal by Subject|0|||
160495125|NCT01628692|579540930|FG004|Overall Study|Withdrawal by Subject|0|||
160495126|NCT01628692|579540931|FG005|Overall Study|Withdrawal by Subject|0|||
160495127|NCT01628692|579540926|FG000|Overall Study|Death|0|||
160495128|NCT01628692|579540927|FG001|Overall Study|Death|1|||
160495129|NCT01628692|579540928|FG002|Overall Study|Death|0|||
160495130|NCT01628692|579540929|FG003|Overall Study|Death|0|||
160495131|NCT01628692|579540930|FG004|Overall Study|Death|0|||
160495132|NCT01628692|579540931|FG005|Overall Study|Death|0|||
160495133|NCT01628692|579540926|FG000|Overall Study|Poor compliance/noncompliance|1|||
160495134|NCT01628692|579540927|FG001|Overall Study|Poor compliance/noncompliance|0|||
160495135|NCT01628692|579540928|FG002|Overall Study|Poor compliance/noncompliance|0|||
160495136|NCT01628692|579540929|FG003|Overall Study|Poor compliance/noncompliance|0|||
160495137|NCT01628692|579540930|FG004|Overall Study|Poor compliance/noncompliance|0|||
160495138|NCT01628692|579540931|FG005|Overall Study|Poor compliance/noncompliance|0|||
160495139|NCT01628692|579540926|FG000|Overall Study|Administrative reason by sponsor|0|||
160495140|NCT01628692|579540927|FG001|Overall Study|Administrative reason by sponsor|0|||
160495141|NCT01628692|579540928|FG002|Overall Study|Administrative reason by sponsor|0|||
160495142|NCT01628692|579540929|FG003|Overall Study|Administrative reason by sponsor|0|||
160495143|NCT01628692|579540930|FG004|Overall Study|Administrative reason by sponsor|0|||
160495144|NCT01628692|579540931|FG005|Overall Study|Administrative reason by sponsor|1|||
160495145|NCT01628692|579540926|FG000|Overall Study|Completed 12 Week only|0|||
160495146|NCT01628692|579540927|FG001|Overall Study|Completed 12 Week only|0|||
160495147|NCT01628692|579540928|FG002|Overall Study|Completed 12 Week only|0|||
160495148|NCT01628692|579540929|FG003|Overall Study|Completed 12 Week only|0|||
160495149|NCT01628692|579540930|FG004|Overall Study|Completed 12 Week only|0|||
160495150|NCT01628692|579540931|FG005|Overall Study|Completed 12 Week only|1|||
160495151|NCT02437071|579540932|FG000|Overall Study|Withdrawal by Subject|1|||
160495152|NCT02437071|579540933|FG001|Overall Study|Withdrawal by Subject|0|||
160495153|NCT00537329|579540934|FG000|Overall Study|Death|10|||
160495154|NCT00537329|579540934|FG000|Overall Study|Adverse Event|3|||
160495155|NCT00537329|579540934|FG000|Overall Study|Lack of Efficacy|2|||
160495156|NCT00537329|579540934|FG000|Overall Study|Lost to Follow-up|6|||
160495157|NCT00537329|579540934|FG000|Overall Study|Withdrawal by Subject|4|||
160495158|NCT00537329|579540934|FG000|Overall Study|Other|1|||
160495159|NCT00224029|579540936|FG000|Overall Study|Lost to Follow-up|1|||
160495160|NCT00224029|579540936|FG000|Overall Study|Withdrawal by Subject|4|||
160495161|NCT00224029|579540936|FG000|Overall Study|Other|1|||
160495162|NCT01099579|579540937|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
160495163|NCT01099579|579540938|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
160495164|NCT01099579|579540939|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
160495165|NCT01099579|579540937|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
160495166|NCT01099579|579540938|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
160495167|NCT01099579|579540939|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
160495168|NCT01099579|579540937|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
160495169|NCT01099579|579540938|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
160495170|NCT01099579|579540939|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
160495171|NCT01099579|579540937|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
160495172|NCT01099579|579540938|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
160495173|NCT01099579|579540939|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
160495174|NCT01099579|579540937|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
160495175|NCT01099579|579540938|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
160495176|NCT01099579|579540939|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
160495177|NCT01099579|579540937|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
160495178|NCT01099579|579540938|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
160495179|NCT01099579|579540939|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
160495180|NCT01099579|579540937|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
160495181|NCT01099579|579540938|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
160495182|NCT01099579|579540939|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
160495183|NCT01099579|579540937|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
160495184|NCT01099579|579540938|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
160495185|NCT01099579|579540939|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
160495186|NCT01099579|579540937|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
160495187|NCT01099579|579540938|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
160614160|NCT02141854|579963755|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160614161|NCT02141854|579963756|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160614162|NCT02141854|579963757|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160614163|NCT02141854|579963758|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160614164|NCT02141854|579963753|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
160614165|NCT02141854|579963754|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160614166|NCT02141854|579963755|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160614167|NCT02141854|579963756|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160614168|NCT02141854|579963757|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160614169|NCT02141854|579963758|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160614170|NCT02141854|579963753|FG000|Run-In Period (Pre-assignment)|Other|14|||
160614171|NCT02141854|579963754|FG001|Run-In Period (Pre-assignment)|Other|0|||
160614172|NCT02141854|579963755|FG002|Run-In Period (Pre-assignment)|Other|0|||
160614173|NCT02141854|579963756|FG003|Run-In Period (Pre-assignment)|Other|0|||
160614174|NCT02141854|579963757|FG004|Run-In Period (Pre-assignment)|Other|0|||
160614175|NCT02141854|579963758|FG005|Run-In Period (Pre-assignment)|Other|0|||
160614176|NCT02141854|579963753|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
160614177|NCT02141854|579963754|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
160614178|NCT02141854|579963755|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
160614179|NCT02141854|579963756|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
160614180|NCT02141854|579963757|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
160614181|NCT02141854|579963758|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
160614182|NCT02141854|579963753|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
160614183|NCT02141854|579963754|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160614184|NCT02141854|579963755|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160614185|NCT02141854|579963756|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160614186|NCT02141854|579963757|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160614187|NCT02141854|579963758|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160614188|NCT02141854|579963753|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
160614189|NCT02141854|579963754|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160614190|NCT02141854|579963755|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160614191|NCT02141854|579963756|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160614192|NCT02141854|579963757|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160614193|NCT02141854|579963758|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160614194|NCT02141854|579963753|FG000|Treatment Period|Protocol Violation|0|||
160614195|NCT02141854|579963754|FG001|Treatment Period|Protocol Violation|1|||
160614196|NCT02141854|579963755|FG002|Treatment Period|Protocol Violation|0|||
160614197|NCT02141854|579963756|FG003|Treatment Period|Protocol Violation|2|||
160614198|NCT02141854|579963757|FG004|Treatment Period|Protocol Violation|2|||
160614199|NCT02141854|579963758|FG005|Treatment Period|Protocol Violation|1|||
160614200|NCT02141854|579963753|FG000|Treatment Period|Noncompliance|0|||
160614201|NCT02141854|579963754|FG001|Treatment Period|Noncompliance|0|||
160614202|NCT02141854|579963755|FG002|Treatment Period|Noncompliance|0|||
160614203|NCT02141854|579963756|FG003|Treatment Period|Noncompliance|1|||
160614204|NCT02141854|579963757|FG004|Treatment Period|Noncompliance|0|||
160614205|NCT02141854|579963758|FG005|Treatment Period|Noncompliance|0|||
160614206|NCT02141854|579963753|FG000|Treatment Period|Lack of Efficacy|0|||
160614207|NCT02141854|579963754|FG001|Treatment Period|Lack of Efficacy|0|||
160614208|NCT02141854|579963755|FG002|Treatment Period|Lack of Efficacy|0|||
160614209|NCT02141854|579963756|FG003|Treatment Period|Lack of Efficacy|1|||
160614210|NCT02141854|579963757|FG004|Treatment Period|Lack of Efficacy|1|||
160614211|NCT02141854|579963758|FG005|Treatment Period|Lack of Efficacy|7|||
160614212|NCT02141854|579963753|FG000|Treatment Period|Pregnancy|0|||
160614213|NCT02141854|579963754|FG001|Treatment Period|Pregnancy|1|||
160614214|NCT02141854|579963755|FG002|Treatment Period|Pregnancy|0|||
160614215|NCT02141854|579963756|FG003|Treatment Period|Pregnancy|0|||
160614216|NCT02141854|579963757|FG004|Treatment Period|Pregnancy|0|||
160614217|NCT02141854|579963758|FG005|Treatment Period|Pregnancy|0|||
160614218|NCT02141854|579963753|FG000|Treatment Period|Other|0|||
160614219|NCT02141854|579963754|FG001|Treatment Period|Other|1|||
160614220|NCT02141854|579963755|FG002|Treatment Period|Other|2|||
160614221|NCT02141854|579963756|FG003|Treatment Period|Other|0|||
160614222|NCT02141854|579963757|FG004|Treatment Period|Other|1|||
160614223|NCT02141854|579963758|FG005|Treatment Period|Other|2|||
160614224|NCT02141854|579963753|FG000|Treatment Period|Adverse Event|0|||
160614225|NCT02141854|579963754|FG001|Treatment Period|Adverse Event|2|||
160614226|NCT02141854|579963755|FG002|Treatment Period|Adverse Event|2|||
160614227|NCT02141854|579963756|FG003|Treatment Period|Adverse Event|0|||
160614228|NCT02141854|579963757|FG004|Treatment Period|Adverse Event|2|||
160614229|NCT02141854|579963758|FG005|Treatment Period|Adverse Event|2|||
160495188|NCT01099579|579540939|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
160495189|NCT01099579|579540937|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
160495190|NCT01099579|579540938|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
160495191|NCT01099579|579540939|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
160495192|NCT04788511|579540942|FG000|Overall Study|Withdrawal by Subject|2|||
160495193|NCT04788511|579540943|FG001|Overall Study|Withdrawal by Subject|1|||
160495194|NCT04788511|579540942|FG000|Overall Study|Lost to Follow-up|2|||
160495195|NCT04788511|579540943|FG001|Overall Study|Lost to Follow-up|7|||
160495196|NCT04788511|579540942|FG000|Overall Study|Death|3|||
160495197|NCT04788511|579540943|FG001|Overall Study|Death|4|||
160495198|NCT00778921|579540944|FG000|Overall Study|Adverse Event|9|||
160495199|NCT00778921|579540945|FG001|Overall Study|Adverse Event|10|||
160495200|NCT00778921|579540946|FG002|Overall Study|Adverse Event|14|||
160495201|NCT00778921|579540944|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
160495202|NCT00778921|579540945|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
160495203|NCT00778921|579540946|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
160495204|NCT00778921|579540944|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
160495205|NCT00778921|579540945|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
160495206|NCT00778921|579540946|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
160495207|NCT00778921|579540944|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
160495208|NCT00778921|579540945|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
160495209|NCT00778921|579540946|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
160495210|NCT00778921|579540944|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
160495211|NCT00778921|579540945|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
160495212|NCT00778921|579540946|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
160495213|NCT00778921|579540944|FG000|Overall Study|Patient withdrew request|3|||
160495214|NCT00778921|579540945|FG001|Overall Study|Patient withdrew request|1|||
160495215|NCT00778921|579540946|FG002|Overall Study|Patient withdrew request|6|||
160495216|NCT00778921|579540944|FG000|Overall Study|Lost to Follow-up|0|||
160495217|NCT00778921|579540945|FG001|Overall Study|Lost to Follow-up|2|||
160495218|NCT00778921|579540946|FG002|Overall Study|Lost to Follow-up|1|||
160495219|NCT00778921|579540944|FG000|Overall Study|Administrative Problems|1|||
160495220|NCT00778921|579540945|FG001|Overall Study|Administrative Problems|2|||
160495221|NCT00778921|579540946|FG002|Overall Study|Administrative Problems|0|||
160495222|NCT00778921|579540944|FG000|Overall Study|Protocol Violation|3|||
160495223|NCT00778921|579540945|FG001|Overall Study|Protocol Violation|0|||
160495224|NCT00778921|579540946|FG002|Overall Study|Protocol Violation|2|||
160495225|NCT00778921|579540944|FG000|Overall Study|Not treated|0|||
160495226|NCT00778921|579540945|FG001|Overall Study|Not treated|2|||
160495227|NCT00778921|579540946|FG002|Overall Study|Not treated|2|||
160495228|NCT00572533|579540947|FG000|Overall Study|Death|4|||
160495229|NCT00572533|579540948|FG001|Overall Study|Death|1|||
160495230|NCT00572533|579540947|FG000|Overall Study|Received Kidney Transplant|2|||
160495231|NCT00572533|579540948|FG001|Overall Study|Received Kidney Transplant|1|||
160495232|NCT00572533|579540947|FG000|Overall Study|Social Issues|1|||
160495233|NCT00572533|579540948|FG001|Overall Study|Social Issues|0|||
160495234|NCT00572533|579540947|FG000|Overall Study|Transfer out of Facility|0|||
160495235|NCT00572533|579540948|FG001|Overall Study|Transfer out of Facility|1|||
160495236|NCT01078922|579540949|FG000|Overall Study|Adverse Event|1|||
160495237|NCT00003477|579540950|FG000|Overall Study|Not evalauable|4|||
160495238|NCT02688530|579540955|FG000|Overall Study|Withdrawal by Subject|0|||
160495239|NCT02688530|579540956|FG001|Overall Study|Withdrawal by Subject|1|||
160495240|NCT02688530|579540957|FG002|Overall Study|Withdrawal by Subject|0|||
160495241|NCT02688530|579540958|FG003|Overall Study|Withdrawal by Subject|0|||
160495242|NCT02688530|579540955|FG000|Overall Study|Lost to Follow-up|0|||
160495243|NCT02688530|579540956|FG001|Overall Study|Lost to Follow-up|0|||
160495244|NCT02688530|579540957|FG002|Overall Study|Lost to Follow-up|2|||
160495245|NCT02688530|579540958|FG003|Overall Study|Lost to Follow-up|0|||
160495246|NCT01658020|579540959|FG000|Overall Study|Adverse Event|3|||
160495247|NCT01658020|579540960|FG001|Overall Study|Adverse Event|3|||
160495248|NCT01658020|579540959|FG000|Overall Study|Lost to Follow-up|1|||
160495249|NCT01658020|579540960|FG001|Overall Study|Lost to Follow-up|0|||
160495250|NCT01658020|579540959|FG000|Overall Study|Withdrawal by Subject|4|||
160495251|NCT01658020|579540960|FG001|Overall Study|Withdrawal by Subject|5|||
160495252|NCT01658020|579540959|FG000|Overall Study|Protocol Violation|0|||
160495253|NCT01658020|579540960|FG001|Overall Study|Protocol Violation|1|||
160495254|NCT01530087|579540967|FG000|Overall Study|Physician Decision|2|||
160495255|NCT02554383|579540970|FG000|Overall Study|Ineligible|3|||
160495256|NCT02554383|579540971|FG001|Overall Study|Ineligible|2|||
160495257|NCT02554383|579540970|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
160495258|NCT02554383|579540971|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
160495259|NCT02554383|579540970|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
160495260|NCT02554383|579540971|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
160495261|NCT02554383|579540970|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
160495262|NCT02554383|579540971|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
160614230|NCT02141854|579963753|FG000|Treatment Period|Withdrawal by Subject|0|||
160614231|NCT02141854|579963754|FG001|Treatment Period|Withdrawal by Subject|2|||
160614232|NCT02141854|579963755|FG002|Treatment Period|Withdrawal by Subject|3|||
160614233|NCT02141854|579963756|FG003|Treatment Period|Withdrawal by Subject|3|||
160614234|NCT02141854|579963757|FG004|Treatment Period|Withdrawal by Subject|4|||
160614235|NCT02141854|579963758|FG005|Treatment Period|Withdrawal by Subject|7|||
160614236|NCT02141854|579963753|FG000|Treatment Period|Disease progression|0|||
160614237|NCT02141854|579963754|FG001|Treatment Period|Disease progression|2|||
160614238|NCT02141854|579963755|FG002|Treatment Period|Disease progression|1|||
160614239|NCT02141854|579963756|FG003|Treatment Period|Disease progression|3|||
160614240|NCT02141854|579963757|FG004|Treatment Period|Disease progression|0|||
160614241|NCT02141854|579963758|FG005|Treatment Period|Disease progression|18|||
160614242|NCT02141854|579963753|FG000|Treatment Period|Lost to Follow-up|0|||
160614243|NCT02141854|579963754|FG001|Treatment Period|Lost to Follow-up|1|||
160614244|NCT02141854|579963755|FG002|Treatment Period|Lost to Follow-up|1|||
160614245|NCT02141854|579963756|FG003|Treatment Period|Lost to Follow-up|1|||
160614246|NCT02141854|579963757|FG004|Treatment Period|Lost to Follow-up|0|||
160614247|NCT02141854|579963758|FG005|Treatment Period|Lost to Follow-up|1|||
160614248|NCT03258762|579963759|FG000|Overall Study|Lost to Follow-up|0|||
160614249|NCT03258762|579963760|FG001|Overall Study|Lost to Follow-up|1|||
160614250|NCT01868594|579963761|FG000|Overall Study|Do not meet inclusion criteria|4|||
160614251|NCT01868594|579963762|FG001|Overall Study|Do not meet inclusion criteria|3|||
160614252|NCT02545049|579963763|FG000|Overall Study|Withdrawal by Subject|1|||
160614253|NCT02545049|579963764|FG001|Overall Study|Withdrawal by Subject|7|||
160614254|NCT02545049|579963763|FG000|Overall Study|Lost to Follow-up|4|||
160614255|NCT02545049|579963764|FG001|Overall Study|Lost to Follow-up|6|||
160614256|NCT02545049|579963763|FG000|Overall Study|GCP violations|37|||
160614257|NCT02545049|579963764|FG001|Overall Study|GCP violations|48|||
160614258|NCT00656799|579963766|FG000|Overall Study|Death|2|||
160614259|NCT02422186|579963767|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
160614260|NCT02422186|579963768|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
160614261|NCT02422186|579963767|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
160614262|NCT02422186|579963768|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
160614263|NCT02422186|579963767|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
160614264|NCT02422186|579963768|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
160614265|NCT02422186|579963767|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
160614266|NCT02422186|579963768|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
160614267|NCT02422186|579963767|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
160614268|NCT02422186|579963768|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
160614269|NCT02422186|579963767|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
160614270|NCT02422186|579963768|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
160614271|NCT02422186|579963767|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
160614272|NCT02422186|579963768|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
160614273|NCT02422186|579963767|FG000|Follow-up Phase (2 Weeks)|Other|3|||
160614274|NCT02422186|579963768|FG001|Follow-up Phase (2 Weeks)|Other|0|||
160614275|NCT05281094|579963769|FG000|Overall Study|Adverse Event|1|||
160614276|NCT05281094|579963770|FG001|Overall Study|Adverse Event|0|||
160614277|NCT05281094|579963769|FG000|Overall Study|Lost to Follow-up|29|||
160614278|NCT05281094|579963770|FG001|Overall Study|Lost to Follow-up|22|||
160614279|NCT05281094|579963769|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
160614280|NCT05281094|579963770|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
160614281|NCT05281094|579963769|FG000|Overall Study|Death|1|||
160614282|NCT05281094|579963770|FG001|Overall Study|Death|2|||
160614283|NCT05281094|579963769|FG000|Overall Study|Not pre-specified reason|8|||
160614284|NCT05281094|579963770|FG001|Overall Study|Not pre-specified reason|5|||
160614285|NCT02598661|579963773|FG000|Overall Study|Death|27|||
160495263|NCT02165826|579540974|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
160495264|NCT02165826|579540975|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
160495265|NCT02165826|579540976|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
160495266|NCT02165826|579540974|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
160495267|NCT02165826|579540975|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
160495268|NCT02165826|579540976|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
160495269|NCT02165826|579540974|FG000|Main Treatment Period|Lost to Follow-up|4|||
160495270|NCT02165826|579540975|FG001|Main Treatment Period|Lost to Follow-up|2|||
160495271|NCT02165826|579540976|FG002|Main Treatment Period|Lost to Follow-up|1|||
160495272|NCT02165826|579540974|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
160495273|NCT02165826|579540975|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
160614286|NCT02598661|579963774|FG001|Overall Study|Death|34|||
160495274|NCT02165826|579540976|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
160614287|NCT02598661|579963775|FG002|Overall Study|Death|14|||
160614288|NCT02598661|579963776|FG003|Overall Study|Death|1|||
160614289|NCT02598661|579963777|FG004|Overall Study|Death|0|||
160614290|NCT02598661|579963773|FG000|Overall Study|Lost to Follow-up|2|||
160614291|NCT02598661|579963774|FG001|Overall Study|Lost to Follow-up|3|||
160614292|NCT02598661|579963775|FG002|Overall Study|Lost to Follow-up|2|||
160614293|NCT02598661|579963776|FG003|Overall Study|Lost to Follow-up|0|||
160614294|NCT02598661|579963777|FG004|Overall Study|Lost to Follow-up|0|||
160614295|NCT02598661|579963773|FG000|Overall Study|Withdrawal by Subject|13|||
160614296|NCT02598661|579963774|FG001|Overall Study|Withdrawal by Subject|24|||
160614297|NCT02598661|579963775|FG002|Overall Study|Withdrawal by Subject|14|||
160614298|NCT02598661|579963776|FG003|Overall Study|Withdrawal by Subject|1|||
160614299|NCT02598661|579963777|FG004|Overall Study|Withdrawal by Subject|1|||
160614300|NCT02598661|579963773|FG000|Overall Study|Adverse Event|0|||
160614301|NCT02598661|579963774|FG001|Overall Study|Adverse Event|0|||
160614302|NCT02598661|579963775|FG002|Overall Study|Adverse Event|1|||
160614303|NCT02598661|579963776|FG003|Overall Study|Adverse Event|0|||
160614304|NCT02598661|579963777|FG004|Overall Study|Adverse Event|0|||
160614305|NCT02598661|579963773|FG000|Overall Study|Randomized, Never Treated|0|||
160614306|NCT02598661|579963774|FG001|Overall Study|Randomized, Never Treated|0|||
160614307|NCT02598661|579963775|FG002|Overall Study|Randomized, Never Treated|0|||
160614308|NCT02598661|579963776|FG003|Overall Study|Randomized, Never Treated|0|||
160614309|NCT02598661|579963777|FG004|Overall Study|Randomized, Never Treated|1|||
160614310|NCT00027027|579965894|FG000|Overall Study|Adverse Event|0|||
160614311|NCT00027027|579965895|FG001|Overall Study|Adverse Event|0|||
160614312|NCT00027027|579965896|FG002|Overall Study|Adverse Event|1|||
160614313|NCT00027027|579965897|FG003|Overall Study|Adverse Event|0|||
160614314|NCT00027027|579965898|FG004|Overall Study|Adverse Event|1|||
160614315|NCT00027027|579965894|FG000|Overall Study|Admitted for Signs of PD|0|||
160614316|NCT00027027|579965895|FG001|Overall Study|Admitted for Signs of PD|0|||
160614317|NCT00027027|579965896|FG002|Overall Study|Admitted for Signs of PD|0|||
160614318|NCT00027027|579965897|FG003|Overall Study|Admitted for Signs of PD|0|||
160614319|NCT00027027|579965898|FG004|Overall Study|Admitted for Signs of PD|1|||
160614320|NCT00027027|579965894|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
160614321|NCT00027027|579965895|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
160614322|NCT00027027|579965896|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
160614323|NCT00027027|579965897|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
160614324|NCT00027027|579965898|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
160614325|NCT00027027|579965894|FG000|Overall Study|PD Requiring Surgery|0|||
160614326|NCT00027027|579965895|FG001|Overall Study|PD Requiring Surgery|0|||
160614327|NCT00027027|579965896|FG002|Overall Study|PD Requiring Surgery|1|||
160614328|NCT00027027|579965897|FG003|Overall Study|PD Requiring Surgery|0|||
160614329|NCT00027027|579965898|FG004|Overall Study|PD Requiring Surgery|0|||
160614330|NCT00027027|579965894|FG000|Overall Study|Physician Decision Due To PD|2|||
160614331|NCT00027027|579965895|FG001|Overall Study|Physician Decision Due To PD|3|||
160614332|NCT00027027|579965896|FG002|Overall Study|Physician Decision Due To PD|2|||
160614333|NCT00027027|579965897|FG003|Overall Study|Physician Decision Due To PD|3|||
160614334|NCT00027027|579965898|FG004|Overall Study|Physician Decision Due To PD|5|||
160614335|NCT00027027|579965894|FG000|Overall Study|Withdrawal by Subject|0|||
160614336|NCT00027027|579965895|FG001|Overall Study|Withdrawal by Subject|0|||
160614337|NCT00027027|579965896|FG002|Overall Study|Withdrawal by Subject|0|||
160614338|NCT00027027|579965897|FG003|Overall Study|Withdrawal by Subject|0|||
160614339|NCT00027027|579965898|FG004|Overall Study|Withdrawal by Subject|1|||
160614340|NCT04397757|579965900|FG000|Overall Study|Death|3|||
160614341|NCT04397757|579965901|FG001|Overall Study|Death|11|||
160614342|NCT04397757|579965900|FG000|Overall Study|Withdrawal by Subject|2|||
160614343|NCT04397757|579965901|FG001|Overall Study|Withdrawal by Subject|0|||
160614344|NCT04397757|579965900|FG000|Overall Study|Lost to Follow-up|4|||
160614345|NCT04397757|579965901|FG001|Overall Study|Lost to Follow-up|3|||
160614346|NCT02306148|579965902|FG000|Overall Study|Adverse Event|12|||
160614347|NCT02306148|579965903|FG001|Overall Study|Adverse Event|6|||
160614348|NCT02306148|579965902|FG000|Overall Study|Lost to Follow-up|1|||
160614349|NCT02306148|579965903|FG001|Overall Study|Lost to Follow-up|4|||
160614350|NCT04657003|579965910|FG000|Overall Study|Adverse Event|5|||
160614351|NCT04657003|579965911|FG001|Overall Study|Adverse Event|1|||
160614352|NCT04657003|579965912|FG002|Overall Study|Adverse Event|5|||
160614353|NCT04657003|579965910|FG000|Overall Study|Death|0|||
160614354|NCT04657003|579965911|FG001|Overall Study|Death|2|||
160614355|NCT04657003|579965912|FG002|Overall Study|Death|0|||
160495275|NCT02165826|579540974|FG000|Main Treatment Period|Lack of Efficacy|2|||
160614356|NCT04657003|579965910|FG000|Overall Study|Lost to Follow-up|8|||
160614357|NCT04657003|579965911|FG001|Overall Study|Lost to Follow-up|4|||
160614358|NCT04657003|579965912|FG002|Overall Study|Lost to Follow-up|10|||
160614359|NCT04657003|579965910|FG000|Overall Study|Other - As Reported by Investigator|3|||
160614360|NCT04657003|579965911|FG001|Overall Study|Other - As Reported by Investigator|2|||
160614361|NCT04657003|579965912|FG002|Overall Study|Other - As Reported by Investigator|2|||
160614362|NCT04657003|579965910|FG000|Overall Study|Pregnancy|2|||
160614363|NCT04657003|579965911|FG001|Overall Study|Pregnancy|0|||
160614364|NCT04657003|579965912|FG002|Overall Study|Pregnancy|2|||
160614365|NCT04657003|579965910|FG000|Overall Study|Withdrawal by Subject|16|||
160614366|NCT04657003|579965911|FG001|Overall Study|Withdrawal by Subject|7|||
160614367|NCT04657003|579965912|FG002|Overall Study|Withdrawal by Subject|10|||
160614368|NCT05158244|579965915|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
160614369|NCT05158244|579965916|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
160614370|NCT05158244|579965917|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
160614371|NCT05158244|579965918|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
160614372|NCT05158244|579965919|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
160614373|NCT05158244|579965915|FG000|Overall Study|Withdrawal by Subject|0|||
160614374|NCT05158244|579965916|FG001|Overall Study|Withdrawal by Subject|0|||
160614375|NCT05158244|579965917|FG002|Overall Study|Withdrawal by Subject|1|||
160614376|NCT05158244|579965918|FG003|Overall Study|Withdrawal by Subject|0|||
160614377|NCT05158244|579965919|FG004|Overall Study|Withdrawal by Subject|0|||
160614378|NCT02408016|579965921|FG000|Overall Study|Death|6|||
160614379|NCT02408016|579965922|FG001|Overall Study|Death|1|||
160614380|NCT02408016|579965923|FG002|Overall Study|Death|0|||
160614381|NCT02408016|579965921|FG000|Overall Study|Physician Decision|0|||
160614382|NCT02408016|579965922|FG001|Overall Study|Physician Decision|2|||
160614383|NCT02408016|579965923|FG002|Overall Study|Physician Decision|0|||
160614384|NCT00718887|579965924|FG000|Overall Study|Withdrawal by Subject|3|||
160614385|NCT00718887|579965925|FG001|Overall Study|Withdrawal by Subject|2|||
160614386|NCT00718887|579965924|FG000|Overall Study|Not identified|2|||
160614387|NCT00718887|579965925|FG001|Overall Study|Not identified|7|||
160614388|NCT00775138|579965928|FG000|Overall Study|Withdrawal by Subject|0|||
160614389|NCT00775138|579965929|FG001|Overall Study|Withdrawal by Subject|0|||
160614390|NCT00775138|579965930|FG002|Overall Study|Withdrawal by Subject|2|||
160614391|NCT00775138|579965931|FG003|Overall Study|Withdrawal by Subject|2|||
160614392|NCT00775138|579965928|FG000|Overall Study|Adverse Event|0|||
160614393|NCT00775138|579965929|FG001|Overall Study|Adverse Event|0|||
160614394|NCT00775138|579965930|FG002|Overall Study|Adverse Event|1|||
160614395|NCT00775138|579965931|FG003|Overall Study|Adverse Event|0|||
160614396|NCT03557801|579965932|FG000|Overall Study|Protocol Violation|1|||
160614397|NCT03557801|579965933|FG001|Overall Study|Protocol Violation|0|||
160614398|NCT03557801|579965934|FG002|Overall Study|Protocol Violation|0|||
160614399|NCT03557801|579965932|FG000|Overall Study|Withdrawal by Subject|1|||
160614400|NCT03557801|579965933|FG001|Overall Study|Withdrawal by Subject|0|||
160614401|NCT03557801|579965934|FG002|Overall Study|Withdrawal by Subject|3|||
160614402|NCT03557801|579965932|FG000|Overall Study|Lost to Follow-up|0|||
160614403|NCT03557801|579965933|FG001|Overall Study|Lost to Follow-up|1|||
160614404|NCT03557801|579965934|FG002|Overall Study|Lost to Follow-up|0|||
160614405|NCT00535236|579965935|FG000|Overall Study|Adverse Event|1|||
160614406|NCT00535236|579965936|FG001|Overall Study|Adverse Event|0|||
160614407|NCT00535236|579965937|FG002|Overall Study|Adverse Event|9|||
160614408|NCT00535236|579965938|FG003|Overall Study|Adverse Event|3|||
160614409|NCT00535236|579965939|FG004|Overall Study|Adverse Event|3|||
160614410|NCT00535236|579965940|FG005|Overall Study|Adverse Event|0|||
160614411|NCT00535236|579965941|FG006|Overall Study|Adverse Event|5|||
160614412|NCT00535236|579965942|FG007|Overall Study|Adverse Event|1|||
160614413|NCT00535236|579965943|FG008|Overall Study|Adverse Event|2|||
160614414|NCT00535236|579965944|FG009|Overall Study|Adverse Event|1|||
160614415|NCT00535236|579965935|FG000|Overall Study|Lost to Follow-up|1|||
160614416|NCT00535236|579965936|FG001|Overall Study|Lost to Follow-up|2|||
160614417|NCT00535236|579965937|FG002|Overall Study|Lost to Follow-up|0|||
160614418|NCT00535236|579965938|FG003|Overall Study|Lost to Follow-up|0|||
160614419|NCT00535236|579965939|FG004|Overall Study|Lost to Follow-up|2|||
160614420|NCT00535236|579965940|FG005|Overall Study|Lost to Follow-up|0|||
160614421|NCT00535236|579965941|FG006|Overall Study|Lost to Follow-up|0|||
160614422|NCT00535236|579965942|FG007|Overall Study|Lost to Follow-up|0|||
160614423|NCT00535236|579965943|FG008|Overall Study|Lost to Follow-up|6|||
160614424|NCT00535236|579965944|FG009|Overall Study|Lost to Follow-up|1|||
160614425|NCT00535236|579965935|FG000|Overall Study|Physician Decision|0|||
160614426|NCT00535236|579965936|FG001|Overall Study|Physician Decision|0|||
160614427|NCT00535236|579965937|FG002|Overall Study|Physician Decision|0|||
160614428|NCT00535236|579965938|FG003|Overall Study|Physician Decision|0|||
160614429|NCT00535236|579965939|FG004|Overall Study|Physician Decision|1|||
160614430|NCT00535236|579965940|FG005|Overall Study|Physician Decision|0|||
160614431|NCT00535236|579965941|FG006|Overall Study|Physician Decision|1|||
160614432|NCT00535236|579965942|FG007|Overall Study|Physician Decision|0|||
160614433|NCT00535236|579965943|FG008|Overall Study|Physician Decision|0|||
160614434|NCT00535236|579965944|FG009|Overall Study|Physician Decision|0|||
160614435|NCT00535236|579965935|FG000|Overall Study|Protocol Violation|2|||
160614436|NCT00535236|579965936|FG001|Overall Study|Protocol Violation|0|||
160614437|NCT00535236|579965937|FG002|Overall Study|Protocol Violation|1|||
160614438|NCT00535236|579965938|FG003|Overall Study|Protocol Violation|0|||
160614439|NCT00535236|579965939|FG004|Overall Study|Protocol Violation|0|||
160614440|NCT00535236|579965940|FG005|Overall Study|Protocol Violation|0|||
160614441|NCT00535236|579965941|FG006|Overall Study|Protocol Violation|0|||
160614442|NCT00535236|579965942|FG007|Overall Study|Protocol Violation|0|||
160614443|NCT00535236|579965943|FG008|Overall Study|Protocol Violation|1|||
160614444|NCT00535236|579965944|FG009|Overall Study|Protocol Violation|0|||
160614445|NCT00535236|579965935|FG000|Overall Study|Withdrawal by Subject|3|||
160614446|NCT00535236|579965936|FG001|Overall Study|Withdrawal by Subject|0|||
160614447|NCT00535236|579965937|FG002|Overall Study|Withdrawal by Subject|2|||
160614448|NCT00535236|579965938|FG003|Overall Study|Withdrawal by Subject|1|||
160614449|NCT00535236|579965939|FG004|Overall Study|Withdrawal by Subject|6|||
160614450|NCT00535236|579965940|FG005|Overall Study|Withdrawal by Subject|1|||
160614451|NCT00535236|579965941|FG006|Overall Study|Withdrawal by Subject|5|||
160614452|NCT00535236|579965942|FG007|Overall Study|Withdrawal by Subject|0|||
160614453|NCT00535236|579965943|FG008|Overall Study|Withdrawal by Subject|4|||
160614454|NCT00535236|579965944|FG009|Overall Study|Withdrawal by Subject|2|||
160614455|NCT03558503|579965945|FG000|Overall Study|Adverse Event|1|||
160614456|NCT03558503|579965945|FG000|Overall Study|Death|1|||
160614457|NCT03558503|579965945|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
160614458|NCT00561795|579965946|FG000|Overall Study|Adverse Event|3|||
160614459|NCT00561795|579965947|FG001|Overall Study|Adverse Event|3|||
160614460|NCT00561795|579965948|FG002|Overall Study|Adverse Event|0|||
160614461|NCT00561795|579965949|FG003|Overall Study|Adverse Event|0|||
160614462|NCT00561795|579965946|FG000|Overall Study|Study Closed/Terminated|0|||
160614463|NCT00561795|579965947|FG001|Overall Study|Study Closed/Terminated|3|||
160614464|NCT00561795|579965948|FG002|Overall Study|Study Closed/Terminated|0|||
160614465|NCT00561795|579965949|FG003|Overall Study|Study Closed/Terminated|0|||
160614466|NCT00561795|579965946|FG000|Overall Study|Physician Decision|1|||
160614467|NCT00561795|579965947|FG001|Overall Study|Physician Decision|0|||
160614468|NCT00561795|579965948|FG002|Overall Study|Physician Decision|0|||
160614469|NCT00561795|579965949|FG003|Overall Study|Physician Decision|0|||
160614470|NCT04564027|579965950|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
160614471|NCT04564027|579965951|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
160614472|NCT04564027|579965952|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
160614473|NCT04564027|579965953|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
160614474|NCT05827978|579965954|FG000|Overall Study|Adverse Event|1|||
160614475|NCT05827978|579965955|FG001|Overall Study|Adverse Event|0|||
160614476|NCT05827978|579965956|FG002|Overall Study|Adverse Event|0|||
160614477|NCT05827978|579965957|FG003|Overall Study|Adverse Event|1|||
160614478|NCT05827978|579965958|FG004|Overall Study|Adverse Event|0|||
160614479|NCT05827978|579965959|FG005|Overall Study|Adverse Event|0|||
160614480|NCT05827978|579965954|FG000|Overall Study|Death|1|||
160614481|NCT05827978|579965955|FG001|Overall Study|Death|5|||
160614482|NCT05827978|579965956|FG002|Overall Study|Death|2|||
160614483|NCT05827978|579965957|FG003|Overall Study|Death|3|||
160614484|NCT05827978|579965958|FG004|Overall Study|Death|1|||
160614485|NCT05827978|579965959|FG005|Overall Study|Death|3|||
160614486|NCT05827978|579965954|FG000|Overall Study|Lost to Follow-up|57|||
160614487|NCT05827978|579965955|FG001|Overall Study|Lost to Follow-up|88|||
160614488|NCT05827978|579965956|FG002|Overall Study|Lost to Follow-up|54|||
160614489|NCT05827978|579965957|FG003|Overall Study|Lost to Follow-up|47|||
160614490|NCT05827978|579965958|FG004|Overall Study|Lost to Follow-up|25|||
160614491|NCT05827978|579965959|FG005|Overall Study|Lost to Follow-up|10|||
160614492|NCT05827978|579965954|FG000|Overall Study|Noncompliance with Study Procedures|0|||
160614493|NCT05827978|579965955|FG001|Overall Study|Noncompliance with Study Procedures|1|||
160614494|NCT05827978|579965956|FG002|Overall Study|Noncompliance with Study Procedures|1|||
160614495|NCT05827978|579965957|FG003|Overall Study|Noncompliance with Study Procedures|1|||
160614496|NCT05827978|579965958|FG004|Overall Study|Noncompliance with Study Procedures|1|||
160614497|NCT05827978|579965959|FG005|Overall Study|Noncompliance with Study Procedures|0|||
160614498|NCT05827978|579965954|FG000|Overall Study|Physician Decision|2|||
160614499|NCT05827978|579965955|FG001|Overall Study|Physician Decision|0|||
160614500|NCT05827978|579965956|FG002|Overall Study|Physician Decision|1|||
160614501|NCT05827978|579965957|FG003|Overall Study|Physician Decision|2|||
160614502|NCT05827978|579965958|FG004|Overall Study|Physician Decision|1|||
160614503|NCT05827978|579965959|FG005|Overall Study|Physician Decision|1|||
160614504|NCT05827978|579965954|FG000|Overall Study|Protocol Violation|5|||
160614505|NCT05827978|579965955|FG001|Overall Study|Protocol Violation|2|||
160614506|NCT05827978|579965956|FG002|Overall Study|Protocol Violation|0|||
160614507|NCT05827978|579965957|FG003|Overall Study|Protocol Violation|0|||
160614508|NCT05827978|579965958|FG004|Overall Study|Protocol Violation|0|||
160614509|NCT05827978|579965959|FG005|Overall Study|Protocol Violation|0|||
160614510|NCT05827978|579965954|FG000|Overall Study|Withdrawal by Subject|17|||
160614511|NCT05827978|579965955|FG001|Overall Study|Withdrawal by Subject|16|||
160614512|NCT05827978|579965956|FG002|Overall Study|Withdrawal by Subject|10|||
160614513|NCT05827978|579965957|FG003|Overall Study|Withdrawal by Subject|12|||
160495276|NCT02165826|579540975|FG001|Main Treatment Period|Lack of Efficacy|0|||
160495277|NCT02165826|579540976|FG002|Main Treatment Period|Lack of Efficacy|0|||
160495278|NCT02165826|579540974|FG000|Main Treatment Period|Reason Not Specified|8|||
160495279|NCT02165826|579540975|FG001|Main Treatment Period|Reason Not Specified|5|||
160495280|NCT02165826|579540976|FG002|Main Treatment Period|Reason Not Specified|16|||
160495281|NCT02165826|579540974|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
160495282|NCT02165826|579540975|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
160495283|NCT02165826|579540976|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
160495284|NCT02165826|579540974|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
160495285|NCT02165826|579540975|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
160495286|NCT02165826|579540976|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
160495287|NCT02165826|579540974|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
160495288|NCT02165826|579540975|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
160495289|NCT02165826|579540976|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
160495290|NCT02165826|579540974|FG000|Down-Titration Period|Reason Not Specified|1|||
160495291|NCT02165826|579540975|FG001|Down-Titration Period|Reason Not Specified|0|||
160495292|NCT02165826|579540976|FG002|Down-Titration Period|Reason Not Specified|2|||
160495293|NCT02581059|579540977|FG000|Study Treatment|Disease Progression|1|||
160495294|NCT02581059|579540978|FG001|Study Treatment|Disease Progression|1|||
160495295|NCT02581059|579540977|FG000|Study Treatment|Adverse Event|2|||
160495296|NCT02581059|579540978|FG001|Study Treatment|Adverse Event|1|||
160495297|NCT02581059|579540977|FG000|Study Treatment|Death|1|||
160495298|NCT02581059|579540978|FG001|Study Treatment|Death|1|||
160495299|NCT02581059|579540977|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
160495300|NCT02581059|579540978|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
160495301|NCT02581059|579540977|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
160495302|NCT02581059|579540978|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
160495303|NCT02581059|579540977|FG000|Follow up|Death|1|||
160495304|NCT02581059|579540978|FG001|Follow up|Death|3|||
160614514|NCT05827978|579965958|FG004|Overall Study|Withdrawal by Subject|10|||
160614515|NCT05827978|579965959|FG005|Overall Study|Withdrawal by Subject|9|||
160495305|NCT02581059|579540977|FG000|Follow up|study terminated|1|||
160495306|NCT02581059|579540978|FG001|Follow up|study terminated|1|||
160614516|NCT05827978|579965954|FG000|Overall Study|Other Than Specified|0|||
160614517|NCT05827978|579965955|FG001|Overall Study|Other Than Specified|0|||
160614518|NCT05827978|579965956|FG002|Overall Study|Other Than Specified|1|||
160614519|NCT05827978|579965957|FG003|Overall Study|Other Than Specified|0|||
160614520|NCT05827978|579965958|FG004|Overall Study|Other Than Specified|2|||
160614521|NCT05827978|579965959|FG005|Overall Study|Other Than Specified|0|||
160614522|NCT04566445|579965960|FG000|Overall Study|Death|4|||
160614523|NCT04566445|579965961|FG001|Overall Study|Death|1|||
160614524|NCT04566445|579965962|FG002|Overall Study|Death|1|||
160614525|NCT04566445|579965960|FG000|Overall Study|Lost to Follow-up|3|||
160614526|NCT04566445|579965961|FG001|Overall Study|Lost to Follow-up|1|||
160614527|NCT04566445|579965962|FG002|Overall Study|Lost to Follow-up|1|||
160614528|NCT04566445|579965960|FG000|Overall Study|Study terminated by sponsor|11|||
160614529|NCT04566445|579965961|FG001|Overall Study|Study terminated by sponsor|17|||
160614530|NCT04566445|579965962|FG002|Overall Study|Study terminated by sponsor|32|||
160614531|NCT04566445|579965960|FG000|Overall Study|Withdrawal by Subject|12|||
160614532|NCT04566445|579965961|FG001|Overall Study|Withdrawal by Subject|14|||
160614533|NCT04566445|579965962|FG002|Overall Study|Withdrawal by Subject|13|||
160614534|NCT04566445|579965960|FG000|Overall Study|Randomized but not treated due to AE|2|||
160614535|NCT04566445|579965961|FG001|Overall Study|Randomized but not treated due to AE|1|||
160614536|NCT04566445|579965962|FG002|Overall Study|Randomized but not treated due to AE|0|||
160614537|NCT04566445|579965960|FG000|Overall Study|Adverse Event|1|||
160614538|NCT04566445|579965961|FG001|Overall Study|Adverse Event|1|||
160614539|NCT04566445|579965962|FG002|Overall Study|Adverse Event|0|||
160614540|NCT02061540|579965967|FG000|Overall Study|Adverse Event|2|||
160614541|NCT02061540|579965967|FG000|Overall Study|Withdrawal by Subject|2|||
160614542|NCT02289833|579965968|FG000|Overall Study|Study discontinuation|0|||
160614543|NCT02289833|579965969|FG001|Overall Study|Study discontinuation|1|||
160614544|NCT02289833|579965968|FG000|Overall Study|Lost to Follow-up|4|||
160614545|NCT02289833|579965969|FG001|Overall Study|Lost to Follow-up|0|||
160614546|NCT02289833|579965968|FG000|Overall Study|Death|23|||
160614547|NCT02289833|579965969|FG001|Overall Study|Death|16|||
160614548|NCT02561273|579965976|FG000|Overall Study|Protocol Violation|1|||
160614549|NCT02561273|579965977|FG001|Overall Study|Protocol Violation|0|||
160614550|NCT02723019|579965978|FG000|Overall Study|Death|17|||
160495307|NCT02581059|579540977|FG000|Follow up|screen failure|0|||
160495308|NCT02581059|579540978|FG001|Follow up|screen failure|1|||
160495309|NCT02581059|579540977|FG000|Follow up|Patient started new clinical trial|1|||
160495310|NCT02581059|579540978|FG001|Follow up|Patient started new clinical trial|0|||
160495311|NCT04590404|579540980|FG000|Overall Study|Death|16|||
160614551|NCT02723019|579965979|FG001|Overall Study|Death|13|||
160614552|NCT02723019|579965978|FG000|Overall Study|Withdrawal by Subject|11|||
160614553|NCT02723019|579965979|FG001|Overall Study|Withdrawal by Subject|7|||
160614554|NCT02723019|579965978|FG000|Overall Study|Lost to Follow-up|57|||
160614555|NCT02723019|579965979|FG001|Overall Study|Lost to Follow-up|70|||
160614556|NCT00611767|579965981|FG000|Overall Study|Withdrawal by Subject|4|||
160614557|NCT00611767|579965982|FG001|Overall Study|Withdrawal by Subject|1|||
160614558|NCT00611767|579965981|FG000|Overall Study|Thiopental not available|3|||
160614559|NCT00611767|579965982|FG001|Overall Study|Thiopental not available|0|||
160614560|NCT00611767|579965981|FG000|Overall Study|didn't like the medication|1|||
160614561|NCT00611767|579965982|FG001|Overall Study|didn't like the medication|1|||
160614562|NCT00611767|579965981|FG000|Overall Study|Physician Decision|1|||
160495312|NCT04590404|579540981|FG001|Overall Study|Death|17|||
160495313|NCT04590404|579540980|FG000|Overall Study|Withdrawal by Subject|7|||
160495314|NCT04590404|579540981|FG001|Overall Study|Withdrawal by Subject|2|||
160495315|NCT05739994|579540984|FG000|Overall Study|Withdrawal by Subject|2|||
160495316|NCT05739994|579540985|FG001|Overall Study|Withdrawal by Subject|2|||
160495317|NCT05739994|579540986|FG002|Overall Study|Withdrawal by Subject|4|||
160614563|NCT00611767|579965982|FG001|Overall Study|Physician Decision|0|||
160614564|NCT01562327|579965987|FG000|Overall Study|Adverse Event|2|||
160614565|NCT01562327|579965987|FG000|Overall Study|Lack of Efficacy|1|||
160614566|NCT01562327|579965987|FG000|Overall Study|Participant drop-out|1|||
160614567|NCT01562327|579965987|FG000|Overall Study|Infusion not received at 6 month window|4|||
160614568|NCT01947127|579965988|FG000|Overall Study|Protocol Violation|18|||
160614569|NCT01947127|579965989|FG001|Overall Study|Protocol Violation|38|||
160614570|NCT01947127|579965988|FG000|Overall Study|Withdrawal by Subject|1|||
160614571|NCT01947127|579965989|FG001|Overall Study|Withdrawal by Subject|1|||
160661517|NCT02661295|580144125|FG000|Overall Study|Death|1|||
160661518|NCT02661295|580144125|FG000|Overall Study|Transferred Out|1|||
160661519|NCT02661295|580144125|FG000|Overall Study|Kidney Transplant|1|||
160661520|NCT02661295|580144125|FG000|Overall Study|Withdrawn due to side effects|8|||
160495318|NCT04750577|579540987|FG000|Overall Study|Adverse Event|2|||
160495319|NCT04750577|579540988|FG001|Overall Study|Adverse Event|10|||
160495320|NCT04750577|579540989|FG002|Overall Study|Adverse Event|8|||
160614572|NCT01947127|579965988|FG000|Overall Study|Data loss|4|||
160661521|NCT02661295|580144125|FG000|Overall Study|Withdrawn due to access type|1|||
160661522|NCT02661295|580144125|FG000|Overall Study|Withdrawn due to allergies|1|||
160495321|NCT04750577|579540990|FG003|Overall Study|Adverse Event|1|||
160495322|NCT04750577|579540987|FG000|Overall Study|Change of residence|0|||
160614573|NCT01947127|579965989|FG001|Overall Study|Data loss|4|||
160614574|NCT00170846|579965990|FG000|Overall Study|Subject withdrew Informed Consent|5|||
160614575|NCT00170846|579965991|FG001|Overall Study|Subject withdrew Informed Consent|12|||
160614576|NCT00170846|579965992|FG002|Overall Study|Subject withdrew Informed Consent|8|||
160614577|NCT00170846|579965990|FG000|Overall Study|Lost to Follow-up|6|||
160614578|NCT00170846|579965991|FG001|Overall Study|Lost to Follow-up|3|||
160614579|NCT00170846|579965992|FG002|Overall Study|Lost to Follow-up|2|||
160661523|NCT02661295|580144125|FG000|Overall Study|Withdrawn due to non-compliance|1|||
160495323|NCT04750577|579540988|FG001|Overall Study|Change of residence|0|||
160495324|NCT04750577|579540989|FG002|Overall Study|Change of residence|1|||
160495325|NCT04750577|579540990|FG003|Overall Study|Change of residence|0|||
160495326|NCT04750577|579540987|FG000|Overall Study|Burden of study procedures|0|||
160495327|NCT04750577|579540988|FG001|Overall Study|Burden of study procedures|2|||
160495328|NCT04750577|579540989|FG002|Overall Study|Burden of study procedures|2|||
160495329|NCT04750577|579540990|FG003|Overall Study|Burden of study procedures|0|||
160495330|NCT04750577|579540987|FG000|Overall Study|Prematurely discontinued|0|||
160495331|NCT04750577|579540988|FG001|Overall Study|Prematurely discontinued|0|||
160495332|NCT04750577|579540989|FG002|Overall Study|Prematurely discontinued|0|||
160495333|NCT04750577|579540990|FG003|Overall Study|Prematurely discontinued|2|||
160495334|NCT04750577|579540987|FG000|Overall Study|Protocol deviation|1|||
160495335|NCT04750577|579540988|FG001|Overall Study|Protocol deviation|1|||
160495336|NCT04750577|579540989|FG002|Overall Study|Protocol deviation|1|||
160495337|NCT04750577|579540990|FG003|Overall Study|Protocol deviation|1|||
160495338|NCT04750577|579540987|FG000|Overall Study|Other than listed|3|||
160495339|NCT04750577|579540988|FG001|Overall Study|Other than listed|2|||
160495340|NCT04750577|579540989|FG002|Overall Study|Other than listed|2|||
160495341|NCT04750577|579540990|FG003|Overall Study|Other than listed|1|||
160495342|NCT04750577|579540987|FG000|Overall Study|Not treated|0|||
160495343|NCT04750577|579540988|FG001|Overall Study|Not treated|0|||
160495344|NCT04750577|579540989|FG002|Overall Study|Not treated|0|||
160495345|NCT04750577|579540990|FG003|Overall Study|Not treated|2|||
160495346|NCT04021043|579542967|FG000|Overall Study|Adverse Event|3|||
160495347|NCT04021043|579542968|FG001|Overall Study|Adverse Event|1|||
160495348|NCT04021043|579542969|FG002|Overall Study|Adverse Event|1|||
160495349|NCT04021043|579542970|FG003|Overall Study|Adverse Event|0|||
160495350|NCT04021043|579542967|FG000|Overall Study|Death|2|||
160495351|NCT04021043|579542968|FG001|Overall Study|Death|3|||
160495352|NCT04021043|579542969|FG002|Overall Study|Death|1|||
160495353|NCT04021043|579542970|FG003|Overall Study|Death|3|||
160495354|NCT04021043|579542967|FG000|Overall Study|Withdrawal by Subject|1|||
160495355|NCT04021043|579542968|FG001|Overall Study|Withdrawal by Subject|1|||
160495356|NCT04021043|579542969|FG002|Overall Study|Withdrawal by Subject|1|||
160495357|NCT04021043|579542970|FG003|Overall Study|Withdrawal by Subject|6|||
160495358|NCT04021043|579542967|FG000|Overall Study|Discontinued due to disease progression|4|||
160495359|NCT04021043|579542968|FG001|Overall Study|Discontinued due to disease progression|5|||
160495360|NCT04021043|579542969|FG002|Overall Study|Discontinued due to disease progression|7|||
160495361|NCT04021043|579542970|FG003|Overall Study|Discontinued due to disease progression|10|||
160495362|NCT00826228|579542971|FG000|Overall Study|Withdrawal by Subject|1|||
160495363|NCT02035696|579542972|FG000|Overall Study|Lost to Follow-up|0|||
160495364|NCT02035696|579542973|FG001|Overall Study|Lost to Follow-up|3|||
160495365|NCT02035696|579542974|FG002|Overall Study|Lost to Follow-up|1|||
160495366|NCT02035696|579542975|FG003|Overall Study|Lost to Follow-up|2|||
160495367|NCT02035696|579542972|FG000|Overall Study|Withdrawal by Subject|3|||
160495368|NCT02035696|579542973|FG001|Overall Study|Withdrawal by Subject|0|||
160495369|NCT02035696|579542974|FG002|Overall Study|Withdrawal by Subject|2|||
160495370|NCT02035696|579542975|FG003|Overall Study|Withdrawal by Subject|1|||
160495371|NCT01246999|579542976|FG000|Overall Study|Lost to Follow-up|0|||
160495372|NCT01246999|579542977|FG001|Overall Study|Lost to Follow-up|1|||
160495373|NCT01246999|579542978|FG002|Overall Study|Lost to Follow-up|0|||
160495374|NCT01246999|579542979|FG003|Overall Study|Lost to Follow-up|0|||
160495375|NCT01246999|579542976|FG000|Overall Study|Withdrawal by Subject|0|||
160495376|NCT01246999|579542977|FG001|Overall Study|Withdrawal by Subject|0|||
160495377|NCT01246999|579542978|FG002|Overall Study|Withdrawal by Subject|0|||
160495378|NCT01246999|579542979|FG003|Overall Study|Withdrawal by Subject|2|||
160495379|NCT01867047|579542980|FG000|Overall Study|Lost to Follow-up|3|||
160495380|NCT01867047|579542981|FG001|Overall Study|Lost to Follow-up|3|||
160495381|NCT01867047|579542980|FG000|Overall Study|Withdrawal by Subject|2|||
160495382|NCT01867047|579542981|FG001|Overall Study|Withdrawal by Subject|0|||
160495383|NCT01867047|579542980|FG000|Overall Study|Physician Decision|2|||
160495384|NCT01867047|579542981|FG001|Overall Study|Physician Decision|0|||
160495385|NCT01867047|579542980|FG000|Overall Study|surgery not indicated in protocol|1|||
160495386|NCT01867047|579542981|FG001|Overall Study|surgery not indicated in protocol|2|||
160495387|NCT00307047|579542982|FG000|Overall Study|Lost to Follow-up|35|||
160495388|NCT00307047|579542983|FG001|Overall Study|Lost to Follow-up|24|||
160495389|NCT00307047|579542982|FG000|Overall Study|Withdrawal by Subject|6|||
160495390|NCT00307047|579542983|FG001|Overall Study|Withdrawal by Subject|6|||
160495391|NCT00307047|579542982|FG000|Overall Study|Physician Decision|1|||
160495392|NCT00307047|579542983|FG001|Overall Study|Physician Decision|2|||
160495393|NCT00307047|579542982|FG000|Overall Study|Lost to follow-up for other reasons|0|||
160495394|NCT00307047|579542983|FG001|Overall Study|Lost to follow-up for other reasons|1|||
160495395|NCT00307047|579542982|FG000|Overall Study|All death, all MI, all Revascularization|27|||
160495396|NCT00307047|579542983|FG001|Overall Study|All death, all MI, all Revascularization|16|||
160495397|NCT00379769|579542984|FG000|Main Study|Death|57|||
160495398|NCT00379769|579542985|FG001|Main Study|Death|67|||
160495399|NCT00379769|579542986|FG002|Main Study|Death|54|||
160495400|NCT00379769|579542987|FG003|Main Study|Death|72|||
160495401|NCT00379769|579542988|FG004|Main Study|Death|0|||
160614580|NCT00170846|579965990|FG000|Overall Study|Death|0|||
160614581|NCT00170846|579965991|FG001|Overall Study|Death|3|||
160614582|NCT00170846|579965992|FG002|Overall Study|Death|3|||
160614583|NCT00170846|579965990|FG000|Overall Study|Reason Missing|0|||
160614584|NCT00170846|579965991|FG001|Overall Study|Reason Missing|1|||
160614585|NCT00170846|579965992|FG002|Overall Study|Reason Missing|0|||
160614586|NCT02795182|579965999|FG000|Overall Study|Death|5|||
160614587|NCT02795182|579966000|FG001|Overall Study|Death|4|||
160614588|NCT02795182|579966001|FG002|Overall Study|Death|4|||
160614589|NCT02795182|579966002|FG003|Overall Study|Death|18|||
160614590|NCT02795182|579965999|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
160614591|NCT02795182|579966000|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
160614592|NCT02795182|579966001|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
160614593|NCT02795182|579966002|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
160614594|NCT02795182|579965999|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
160614595|NCT02795182|579966000|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
160614596|NCT02795182|579966001|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
160614597|NCT02795182|579966002|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
160614598|NCT02795182|579965999|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
160614599|NCT02795182|579966000|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
160614600|NCT02795182|579966001|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
160614601|NCT02795182|579966002|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
160614602|NCT02795182|579965999|FG000|Overall Study|Withdrawal by Subject|4|||
160614603|NCT02795182|579966000|FG001|Overall Study|Withdrawal by Subject|0|||
160614604|NCT02795182|579966001|FG002|Overall Study|Withdrawal by Subject|0|||
160614605|NCT02795182|579966002|FG003|Overall Study|Withdrawal by Subject|3|||
160614606|NCT02795182|579965999|FG000|Overall Study|Lost to Follow-up|0|||
160614607|NCT02795182|579966000|FG001|Overall Study|Lost to Follow-up|0|||
160614608|NCT02795182|579966001|FG002|Overall Study|Lost to Follow-up|1|||
160614609|NCT02795182|579966002|FG003|Overall Study|Lost to Follow-up|1|||
160614610|NCT02795182|579965999|FG000|Overall Study|Roll Over to Long Term Extension|3|||
160614611|NCT02795182|579966000|FG001|Overall Study|Roll Over to Long Term Extension|3|||
160614612|NCT02795182|579966001|FG002|Overall Study|Roll Over to Long Term Extension|2|||
160614613|NCT02795182|579966002|FG003|Overall Study|Roll Over to Long Term Extension|5|||
160614614|NCT02795182|579965999|FG000|Overall Study|Progressive Disease|0|||
160614615|NCT02795182|579966000|FG001|Overall Study|Progressive Disease|1|||
160614616|NCT02795182|579966001|FG002|Overall Study|Progressive Disease|0|||
160614617|NCT02795182|579966002|FG003|Overall Study|Progressive Disease|4|||
160614618|NCT02795182|579965999|FG000|Overall Study|Physician Decision|0|||
160614619|NCT02795182|579966000|FG001|Overall Study|Physician Decision|0|||
160614620|NCT02795182|579966001|FG002|Overall Study|Physician Decision|0|||
160614621|NCT02795182|579966002|FG003|Overall Study|Physician Decision|1|||
160614622|NCT00887913|579966003|FG000|Overall Study|Withdrawal by Subject|6|||
160614623|NCT01371721|579966004|FG000|Overall Study|Adverse Event|5|||
160614624|NCT01371721|579966005|FG001|Overall Study|Adverse Event|4|||
160614625|NCT01371721|579966006|FG002|Overall Study|Adverse Event|5|||
160614626|NCT01371721|579966004|FG000|Overall Study|Protocol Violation|6|||
160614627|NCT01371721|579966005|FG001|Overall Study|Protocol Violation|4|||
160614628|NCT01371721|579966006|FG002|Overall Study|Protocol Violation|5|||
160614629|NCT01371721|579966004|FG000|Overall Study|Lost to Follow-up|8|||
160614630|NCT01371721|579966005|FG001|Overall Study|Lost to Follow-up|2|||
160614631|NCT01371721|579966006|FG002|Overall Study|Lost to Follow-up|6|||
160614632|NCT01371721|579966004|FG000|Overall Study|Withdrawal by Subject|5|||
160614633|NCT01371721|579966005|FG001|Overall Study|Withdrawal by Subject|7|||
160614634|NCT01371721|579966006|FG002|Overall Study|Withdrawal by Subject|11|||
160614635|NCT01371721|579966004|FG000|Overall Study|Other|2|||
160614636|NCT01371721|579966005|FG001|Overall Study|Other|3|||
160614637|NCT01371721|579966006|FG002|Overall Study|Other|0|||
160614638|NCT01371721|579966004|FG000|Overall Study|Lack of Efficacy|2|||
160614639|NCT01371721|579966005|FG001|Overall Study|Lack of Efficacy|4|||
160614640|NCT01371721|579966006|FG002|Overall Study|Lack of Efficacy|3|||
160614641|NCT01371721|579966004|FG000|Overall Study|Randomized but not treated|1|||
160614642|NCT01371721|579966005|FG001|Overall Study|Randomized but not treated|0|||
160614643|NCT01371721|579966006|FG002|Overall Study|Randomized but not treated|0|||
160614644|NCT02187224|579966011|FG000|Overall Study|Did not show up for test day|1|||
160614645|NCT02187224|579966012|FG001|Overall Study|Did not show up for test day|0|||
160614646|NCT01010776|579966013|FG000|Main Phase|Withdrawal by Subject|14|||
160614647|NCT01010776|579966013|FG000|Main Phase|Lack of Efficacy|8|||
160614648|NCT01010776|579966013|FG000|Main Phase|Adverse Event|7|||
160614649|NCT01010776|579966013|FG000|Main Phase|Lost to Follow-up|6|||
160661524|NCT02661295|580144125|FG000|Overall Study|Withdrawal by Subject|3|||
160495402|NCT00379769|579542989|FG005|Main Study|Death|0|||
160495403|NCT00379769|579542984|FG000|Main Study|Adverse Event|5|||
160495404|NCT00379769|579542985|FG001|Main Study|Adverse Event|8|||
160495405|NCT00379769|579542986|FG002|Main Study|Adverse Event|10|||
160495406|NCT00379769|579542987|FG003|Main Study|Adverse Event|11|||
160495407|NCT00379769|579542988|FG004|Main Study|Adverse Event|0|||
160495408|NCT00379769|579542989|FG005|Main Study|Adverse Event|0|||
160495409|NCT00379769|579542984|FG000|Main Study|Lost to Follow-up|29|||
160495410|NCT00379769|579542985|FG001|Main Study|Lost to Follow-up|29|||
160495411|NCT00379769|579542986|FG002|Main Study|Lost to Follow-up|25|||
160495412|NCT00379769|579542987|FG003|Main Study|Lost to Follow-up|26|||
160495413|NCT00379769|579542988|FG004|Main Study|Lost to Follow-up|0|||
160495414|NCT00379769|579542989|FG005|Main Study|Lost to Follow-up|0|||
160495415|NCT00379769|579542984|FG000|Main Study|Withdrawal by Subject|46|||
160495416|NCT00379769|579542985|FG001|Main Study|Withdrawal by Subject|56|||
160495417|NCT00379769|579542986|FG002|Main Study|Withdrawal by Subject|72|||
160495418|NCT00379769|579542987|FG003|Main Study|Withdrawal by Subject|70|||
160495419|NCT00379769|579542988|FG004|Main Study|Withdrawal by Subject|0|||
160495420|NCT00379769|579542989|FG005|Main Study|Withdrawal by Subject|0|||
160495421|NCT00379769|579542984|FG000|Main Study|Moved to survival status follow-up only|27|||
160495422|NCT00379769|579542985|FG001|Main Study|Moved to survival status follow-up only|25|||
160495423|NCT00379769|579542986|FG002|Main Study|Moved to survival status follow-up only|32|||
160495424|NCT00379769|579542987|FG003|Main Study|Moved to survival status follow-up only|36|||
160495425|NCT00379769|579542988|FG004|Main Study|Moved to survival status follow-up only|0|||
160495426|NCT00379769|579542989|FG005|Main Study|Moved to survival status follow-up only|0|||
160495427|NCT00379769|579542984|FG000|Main Study|Participant moved|3|||
160495428|NCT00379769|579542985|FG001|Main Study|Participant moved|2|||
160495429|NCT00379769|579542986|FG002|Main Study|Participant moved|3|||
160495430|NCT00379769|579542987|FG003|Main Study|Participant moved|3|||
160495431|NCT00379769|579542988|FG004|Main Study|Participant moved|0|||
160495432|NCT00379769|579542989|FG005|Main Study|Participant moved|0|||
160495433|NCT00379769|579542984|FG000|Main Study|Poor compliance|3|||
160495434|NCT00379769|579542985|FG001|Main Study|Poor compliance|2|||
160495435|NCT00379769|579542986|FG002|Main Study|Poor compliance|2|||
160495436|NCT00379769|579542987|FG003|Main Study|Poor compliance|1|||
160495437|NCT00379769|579542988|FG004|Main Study|Poor compliance|0|||
160495438|NCT00379769|579542989|FG005|Main Study|Poor compliance|0|||
160495439|NCT00379769|579542984|FG000|Main Study|Prohibited glucose lowering medication|0|||
160495440|NCT00379769|579542985|FG001|Main Study|Prohibited glucose lowering medication|3|||
160495441|NCT00379769|579542986|FG002|Main Study|Prohibited glucose lowering medication|0|||
160495442|NCT00379769|579542987|FG003|Main Study|Prohibited glucose lowering medication|1|||
160495443|NCT00379769|579542988|FG004|Main Study|Prohibited glucose lowering medication|0|||
160495444|NCT00379769|579542989|FG005|Main Study|Prohibited glucose lowering medication|0|||
160495445|NCT00379769|579542984|FG000|Main Study|Site closed|4|||
160495446|NCT00379769|579542985|FG001|Main Study|Site closed|4|||
160495447|NCT00379769|579542986|FG002|Main Study|Site closed|4|||
160495448|NCT00379769|579542987|FG003|Main Study|Site closed|8|||
160495449|NCT00379769|579542988|FG004|Main Study|Site closed|0|||
160495450|NCT00379769|579542989|FG005|Main Study|Site closed|0|||
160495451|NCT00379769|579542984|FG000|Main Study|Entry criteria violation|0|||
160495452|NCT00379769|579542985|FG001|Main Study|Entry criteria violation|0|||
160495453|NCT00379769|579542986|FG002|Main Study|Entry criteria violation|1|||
160495454|NCT00379769|579542987|FG003|Main Study|Entry criteria violation|1|||
160495455|NCT00379769|579542988|FG004|Main Study|Entry criteria violation|0|||
160495456|NCT00379769|579542989|FG005|Main Study|Entry criteria violation|0|||
160661525|NCT02661295|580144125|FG000|Overall Study|Failed screening|2|||
160661526|NCT03627091|580144126|FG000|Overall Study|Adverse Event|0|||
160495457|NCT00379769|579542984|FG000|Main Study|Participant did not take study drug|0|||
160495458|NCT00379769|579542985|FG001|Main Study|Participant did not take study drug|0|||
160495459|NCT00379769|579542986|FG002|Main Study|Participant did not take study drug|1|||
160495460|NCT00379769|579542987|FG003|Main Study|Participant did not take study drug|0|||
160495461|NCT00379769|579542988|FG004|Main Study|Participant did not take study drug|0|||
160495462|NCT00379769|579542989|FG005|Main Study|Participant did not take study drug|0|||
160495463|NCT00379769|579542984|FG000|Main Study|Physician Decision|2|||
160495464|NCT00379769|579542985|FG001|Main Study|Physician Decision|2|||
160661527|NCT03627091|580144127|FG001|Overall Study|Adverse Event|0|||
160495465|NCT00379769|579542986|FG002|Main Study|Physician Decision|1|||
160495466|NCT00379769|579542987|FG003|Main Study|Physician Decision|1|||
160495467|NCT00379769|579542988|FG004|Main Study|Physician Decision|0|||
160495468|NCT00379769|579542989|FG005|Main Study|Physician Decision|0|||
160495469|NCT00379769|579542984|FG000|Main Study|Participant completed study at visit 27|1|||
160495470|NCT00379769|579542985|FG001|Main Study|Participant completed study at visit 27|0|||
160495471|NCT00379769|579542986|FG002|Main Study|Participant completed study at visit 27|0|||
160495472|NCT00379769|579542987|FG003|Main Study|Participant completed study at visit 27|0|||
160495473|NCT00379769|579542988|FG004|Main Study|Participant completed study at visit 27|0|||
160495474|NCT00379769|579542989|FG005|Main Study|Participant completed study at visit 27|0|||
160495475|NCT00379769|579542984|FG000|Main Study|Personal reasons|1|||
160614650|NCT01010776|579966013|FG000|Main Phase|Non-compliance to study medication|5|||
160614651|NCT01010776|579966013|FG000|Main Phase|Selection failure|2|||
160614652|NCT01010776|579966013|FG000|Main Phase|Inform consent withdrawal|1|||
160614653|NCT01010776|579966013|FG000|Main Phase|Other|1|||
160614654|NCT01010776|579966013|FG000|Main Phase|Did not received study medication|5|||
160614655|NCT01010776|579966013|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
160614656|NCT01010776|579966013|FG000|Extension Phase|Other|3|||
160614657|NCT00415623|579966016|FG000|Overall Study|Adverse Event|3|||
160614658|NCT00415623|579966017|FG001|Overall Study|Adverse Event|4|||
160614659|NCT00415623|579966016|FG000|Overall Study|Death|1|||
160614660|NCT00415623|579966017|FG001|Overall Study|Death|0|||
160614661|NCT00415623|579966016|FG000|Overall Study|Withdrawal by Subject|1|||
160614662|NCT00415623|579966017|FG001|Overall Study|Withdrawal by Subject|1|||
160614663|NCT03267576|579966019|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
160614664|NCT03267576|579966020|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
160614665|NCT03267576|579966019|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
160614666|NCT03267576|579966020|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
160614667|NCT02573012|579966023|FG000|Overall Study|Adverse Event|5|||
160614668|NCT02573012|579966024|FG001|Overall Study|Adverse Event|5|||
160614669|NCT02573012|579966023|FG000|Overall Study|Lack of Efficacy|5|||
160614670|NCT02573012|579966024|FG001|Overall Study|Lack of Efficacy|4|||
160614671|NCT02573012|579966023|FG000|Overall Study|Non-compliance|1|||
160614672|NCT02573012|579966024|FG001|Overall Study|Non-compliance|2|||
160614673|NCT02573012|579966023|FG000|Overall Study|Withdrawal by Subject|2|||
160614674|NCT02573012|579966024|FG001|Overall Study|Withdrawal by Subject|2|||
160614675|NCT02573012|579966023|FG000|Overall Study|Study Ended per Protocol|1|||
160614676|NCT02573012|579966024|FG001|Overall Study|Study Ended per Protocol|0|||
160614677|NCT02573012|579966023|FG000|Overall Study|Physician Decision|1|||
160614678|NCT02573012|579966024|FG001|Overall Study|Physician Decision|2|||
160614679|NCT00882362|579966025|FG000|Overall Study|Adverse Event|13|||
160614680|NCT00882362|579966026|FG001|Overall Study|Adverse Event|10|||
160614681|NCT00882362|579966025|FG000|Overall Study|Withdrawal by Subject|13|||
160614682|NCT00882362|579966026|FG001|Overall Study|Withdrawal by Subject|10|||
160614683|NCT00882362|579966025|FG000|Overall Study|Lack of Efficacy|3|||
160614684|NCT00882362|579966026|FG001|Overall Study|Lack of Efficacy|0|||
160614685|NCT00882362|579966025|FG000|Overall Study|Protocol Violation|7|||
160614686|NCT00882362|579966026|FG001|Overall Study|Protocol Violation|2|||
160614687|NCT00882362|579966025|FG000|Overall Study|Pregnancy|1|||
160614688|NCT00882362|579966026|FG001|Overall Study|Pregnancy|0|||
160614689|NCT00882362|579966025|FG000|Overall Study|Physician Decision|5|||
160614690|NCT00882362|579966026|FG001|Overall Study|Physician Decision|1|||
160614691|NCT00882362|579966025|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
160614692|NCT00882362|579966026|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
160614693|NCT00882362|579966025|FG000|Overall Study|change of residence or other commitments|5|||
160614694|NCT00882362|579966026|FG001|Overall Study|change of residence or other commitments|0|||
160614695|NCT00374127|579966029|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
160614696|NCT00374127|579966029|FG000|Overall Study|Blood could not be drawn.|2|||
160614697|NCT00374127|579966029|FG000|Overall Study|Protocol Violation|5|||
160614698|NCT00374127|579966029|FG000|Overall Study|Pregnancy|1|||
160614699|NCT00281528|579966033|FG000|Overall Study|Progressive Disease|28|||
160614700|NCT00281528|579966034|FG001|Overall Study|Progressive Disease|18|||
160614701|NCT00281528|579966035|FG002|Overall Study|Progressive Disease|27|||
160614702|NCT00281528|579966033|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
160614703|NCT00281528|579966034|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
160614704|NCT00281528|579966035|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
160614705|NCT00281528|579966033|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
160614706|NCT00281528|579966034|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
160614707|NCT00281528|579966035|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
160614708|NCT00281528|579966033|FG000|Overall Study|Physician Decision|11|||
160614709|NCT00281528|579966034|FG001|Overall Study|Physician Decision|4|||
160614710|NCT00281528|579966035|FG002|Overall Study|Physician Decision|5|||
160614711|NCT00281528|579966033|FG000|Overall Study|Protocol Violation|1|||
160614712|NCT00281528|579966034|FG001|Overall Study|Protocol Violation|0|||
160614713|NCT00281528|579966035|FG002|Overall Study|Protocol Violation|1|||
160614714|NCT00281528|579966033|FG000|Overall Study|Withdrawal by Subject|5|||
160614715|NCT00281528|579966034|FG001|Overall Study|Withdrawal by Subject|5|||
160614716|NCT00281528|579966035|FG002|Overall Study|Withdrawal by Subject|7|||
160614717|NCT00281528|579966033|FG000|Overall Study|Other|6|||
160614718|NCT00281528|579966034|FG001|Overall Study|Other|3|||
160614719|NCT00281528|579966035|FG002|Overall Study|Other|5|||
160614720|NCT01987609|579966038|FG000|Overall Study|Adverse Event|1|||
160661528|NCT03627091|580144128|FG002|Overall Study|Adverse Event|2|||
160661529|NCT03627091|580144126|FG000|Overall Study|Withdrawal by Subject|2|||
160614721|NCT02709889|579966039|FG000|Overall Study|Withdrawal by Subject|11|||
160614722|NCT02709889|579966040|FG001|Overall Study|Withdrawal by Subject|10|||
160614723|NCT02709889|579966041|FG002|Overall Study|Withdrawal by Subject|2|||
160614724|NCT02709889|579966042|FG003|Overall Study|Withdrawal by Subject|12|||
160614725|NCT02709889|579966039|FG000|Overall Study|Death|25|||
160614726|NCT02709889|579966040|FG001|Overall Study|Death|38|||
160614727|NCT02709889|579966041|FG002|Overall Study|Death|4|||
160614728|NCT02709889|579966042|FG003|Overall Study|Death|44|||
160614729|NCT02709889|579966039|FG000|Overall Study|Physician Decision|1|||
160614730|NCT02709889|579966040|FG001|Overall Study|Physician Decision|2|||
160614731|NCT02709889|579966041|FG002|Overall Study|Physician Decision|3|||
160614732|NCT02709889|579966042|FG003|Overall Study|Physician Decision|5|||
160614733|NCT02709889|579966039|FG000|Overall Study|Lost to Follow-up|2|||
160614734|NCT02709889|579966040|FG001|Overall Study|Lost to Follow-up|0|||
160614735|NCT02709889|579966041|FG002|Overall Study|Lost to Follow-up|0|||
160614736|NCT02709889|579966042|FG003|Overall Study|Lost to Follow-up|4|||
160614737|NCT02709889|579966039|FG000|Overall Study|Study Terminated by Sponsor|4|||
160614738|NCT02709889|579966040|FG001|Overall Study|Study Terminated by Sponsor|6|||
160614739|NCT02709889|579966041|FG002|Overall Study|Study Terminated by Sponsor|2|||
160614740|NCT02709889|579966042|FG003|Overall Study|Study Terminated by Sponsor|17|||
160614741|NCT02709889|579966039|FG000|Overall Study|Other, Not Specified|0|||
160614742|NCT02709889|579966040|FG001|Overall Study|Other, Not Specified|1|||
160614743|NCT02709889|579966041|FG002|Overall Study|Other, Not Specified|1|||
160614744|NCT02709889|579966042|FG003|Overall Study|Other, Not Specified|6|||
160614745|NCT01066546|579966043|FG000|Overall Study|Study terminated by sponsor|5|||
160614746|NCT00125268|579966048|FG000|Overall Study|Withdrawal by Subject|1|||
160614747|NCT00125268|579966049|FG001|Overall Study|Withdrawal by Subject|1|||
160614748|NCT00925522|579966050|FG000|Overall Study|study closed -- business decision|20|||
160614749|NCT02561572|579966055|FG000|Overall Study|Inadequate time before surgery|2|||
160614750|NCT02561572|579966056|FG001|Overall Study|Inadequate time before surgery|1|||
160614751|NCT02561572|579966055|FG000|Overall Study|Protocol Violation|0|||
160614752|NCT02561572|579966056|FG001|Overall Study|Protocol Violation|1|||
160614753|NCT02691468|579966057|FG000|Overall Study|Bronchial blocker use|2|||
160614754|NCT02691468|579966058|FG001|Overall Study|Bronchial blocker use|1|||
160614755|NCT02691468|579966057|FG000|Overall Study|Lost to Follow-up|2|||
160614756|NCT02691468|579966058|FG001|Overall Study|Lost to Follow-up|1|||
160614757|NCT02691468|579966057|FG000|Overall Study|Failure to advance FOB|2|||
160614758|NCT02691468|579966058|FG001|Overall Study|Failure to advance FOB|0|||
160614759|NCT01190020|579966061|FG000|Overall Study|Adverse Event|2|||
160614760|NCT01190020|579966062|FG001|Overall Study|Adverse Event|0|||
160614761|NCT01190020|579966061|FG000|Overall Study|Lost to Follow-up|2|||
160614762|NCT01190020|579966062|FG001|Overall Study|Lost to Follow-up|0|||
160614763|NCT01190020|579966061|FG000|Overall Study|Withdrawal by Subject|3|||
160614764|NCT01190020|579966062|FG001|Overall Study|Withdrawal by Subject|0|||
160614765|NCT04191096|579966067|FG000|Overall Study|Death|102|||
160614766|NCT04191096|579966068|FG001|Overall Study|Death|89|||
160614767|NCT04191096|579966067|FG000|Overall Study|Lost to Follow-up|1|||
160614768|NCT04191096|579966068|FG001|Overall Study|Lost to Follow-up|1|||
160614769|NCT04191096|579966067|FG000|Overall Study|Withdrawal by Subject|5|||
160614770|NCT04191096|579966068|FG001|Overall Study|Withdrawal by Subject|5|||
160614771|NCT04191096|579966067|FG000|Overall Study|Participants Ongoing|518|||
160614772|NCT04191096|579966068|FG001|Overall Study|Participants Ongoing|530|||
160614773|NCT02683668|579966072|FG000|Period 2|Withdrawal by Subject|0|||
160614774|NCT02683668|579966073|FG001|Period 2|Withdrawal by Subject|1|||
160614775|NCT02683668|579966074|FG002|Period 2|Withdrawal by Subject|0|||
160614776|NCT02442765|579968236|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
160614777|NCT02442765|579968237|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
160614778|NCT02442765|579968238|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
160614779|NCT02442765|579968239|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
160614780|NCT02442765|579968240|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
160614781|NCT02442765|579968241|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
160614782|NCT02442765|579968242|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
160661530|NCT03627091|580144127|FG001|Overall Study|Withdrawal by Subject|0|||
160661531|NCT03627091|580144128|FG002|Overall Study|Withdrawal by Subject|2|||
160661532|NCT03627091|580144126|FG000|Overall Study|Physician Decision|2|||
160661533|NCT03627091|580144127|FG001|Overall Study|Physician Decision|0|||
160661534|NCT03627091|580144128|FG002|Overall Study|Physician Decision|0|||
160661535|NCT03627091|580144126|FG000|Overall Study|Site terminated by sponsor|0|||
160614783|NCT02442765|579968243|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
160614784|NCT02442765|579968236|FG000|Stage 2- (Days 43 to 85)|Death|0|||
160614785|NCT02442765|579968237|FG001|Stage 2- (Days 43 to 85)|Death|0|||
160614786|NCT02442765|579968238|FG002|Stage 2- (Days 43 to 85)|Death|0|||
160495476|NCT00379769|579542985|FG001|Main Study|Personal reasons|0|||
160614787|NCT02442765|579968239|FG003|Stage 2- (Days 43 to 85)|Death|1|||
160614788|NCT02442765|579968240|FG004|Stage 2- (Days 43 to 85)|Death|1|||
160614789|NCT02442765|579968241|FG005|Stage 2- (Days 43 to 85)|Death|0|||
160661536|NCT03627091|580144127|FG001|Overall Study|Site terminated by sponsor|1|||
160661537|NCT03627091|580144128|FG002|Overall Study|Site terminated by sponsor|0|||
160614790|NCT02442765|579968242|FG006|Stage 2- (Days 43 to 85)|Death|2|||
160614791|NCT02442765|579968243|FG007|Stage 2- (Days 43 to 85)|Death|0|||
160614792|NCT02442765|579968236|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
160661538|NCT03627091|580144126|FG000|Overall Study|Disease relapse|7|||
160614793|NCT02442765|579968237|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
160614794|NCT02442765|579968238|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
160614795|NCT02442765|579968239|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
160614796|NCT02442765|579968240|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
160614797|NCT02442765|579968241|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
160614798|NCT02442765|579968242|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
160614799|NCT02442765|579968243|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
160614800|NCT02442765|579968236|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
160614801|NCT02442765|579968237|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
160614802|NCT02442765|579968238|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
160614803|NCT02442765|579968239|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
160614804|NCT02442765|579968240|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
160614805|NCT02442765|579968241|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
160614806|NCT02442765|579968242|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
160614807|NCT02442765|579968243|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
160614808|NCT02442765|579968236|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
160614809|NCT02442765|579968237|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
160614810|NCT02442765|579968238|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
160614811|NCT02442765|579968239|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
160614812|NCT02442765|579968240|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
160614813|NCT02442765|579968241|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
160614814|NCT02442765|579968242|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
160614815|NCT02442765|579968243|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
160614816|NCT02442765|579968236|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
160614817|NCT02442765|579968237|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
160614818|NCT02442765|579968238|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
160614819|NCT02442765|579968239|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
160614820|NCT02442765|579968240|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
160614821|NCT02442765|579968241|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
160614822|NCT02442765|579968242|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
160614823|NCT02442765|579968243|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
160614824|NCT02442765|579968236|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
160614825|NCT02442765|579968237|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
160614826|NCT02442765|579968238|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
160614827|NCT02442765|579968239|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
160614828|NCT02442765|579968240|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
160614829|NCT02442765|579968241|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
160614830|NCT02442765|579968242|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
160614831|NCT02442765|579968243|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
160614832|NCT02442765|579968236|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
160614833|NCT02442765|579968237|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
160614834|NCT02442765|579968238|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
160614835|NCT02442765|579968239|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
160614836|NCT02442765|579968240|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
160614837|NCT02442765|579968241|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
160614838|NCT02442765|579968242|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
160614839|NCT02442765|579968243|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
160614840|NCT01693562|579968244|FG000|Escalation Phase|Withdrawal by Subject|0|||
160614841|NCT01693562|579968245|FG001|Escalation Phase|Withdrawal by Subject|1|||
160661539|NCT03627091|580144127|FG001|Overall Study|Disease relapse|5|||
160661540|NCT03627091|580144128|FG002|Overall Study|Disease relapse|1|||
160614842|NCT01693562|579968246|FG002|Escalation Phase|Withdrawal by Subject|0|||
160614843|NCT01693562|579968247|FG003|Escalation Phase|Withdrawal by Subject|0|||
160614844|NCT01693562|579968248|FG004|Escalation Phase|Withdrawal by Subject|0|||
160661541|NCT03627091|580144126|FG000|Overall Study|Other|1|||
160614845|NCT01693562|579968249|FG005|Escalation Phase|Withdrawal by Subject|2|||
160661542|NCT03627091|580144127|FG001|Overall Study|Other|0|||
160495477|NCT00379769|579542986|FG002|Main Study|Personal reasons|0|||
160495478|NCT00379769|579542987|FG003|Main Study|Personal reasons|0|||
160495479|NCT00379769|579542988|FG004|Main Study|Personal reasons|0|||
160614846|NCT01693562|579968250|FG006|Escalation Phase|Withdrawal by Subject|0|||
160614847|NCT01693562|579968251|FG007|Escalation Phase|Withdrawal by Subject|0|||
160614848|NCT01693562|579968252|FG008|Escalation Phase|Withdrawal by Subject|0|||
160614849|NCT01693562|579968253|FG009|Escalation Phase|Withdrawal by Subject|0|||
160614850|NCT01693562|579968254|FG010|Escalation Phase|Withdrawal by Subject|0|||
160614851|NCT01693562|579968255|FG011|Escalation Phase|Withdrawal by Subject|0|||
160614852|NCT01693562|579968256|FG012|Escalation Phase|Withdrawal by Subject|0|||
160614853|NCT01693562|579968257|FG013|Escalation Phase|Withdrawal by Subject|0|||
160614854|NCT01693562|579968258|FG014|Escalation Phase|Withdrawal by Subject|0|||
160614855|NCT01693562|579968259|FG015|Escalation Phase|Withdrawal by Subject|0|||
160614856|NCT01693562|579968260|FG016|Escalation Phase|Withdrawal by Subject|0|||
160614857|NCT01693562|579968261|FG017|Escalation Phase|Withdrawal by Subject|0|||
160614858|NCT01693562|579968262|FG018|Escalation Phase|Withdrawal by Subject|0|||
160614859|NCT01693562|579968263|FG019|Escalation Phase|Withdrawal by Subject|0|||
160614860|NCT01693562|579968264|FG020|Escalation Phase|Withdrawal by Subject|0|||
160614861|NCT01693562|579968265|FG021|Escalation Phase|Withdrawal by Subject|0|||
160614862|NCT01693562|579968266|FG022|Escalation Phase|Withdrawal by Subject|0|||
160614863|NCT01693562|579968244|FG000|Escalation Phase|Death|4|||
160614864|NCT01693562|579968245|FG001|Escalation Phase|Death|2|||
160614865|NCT01693562|579968246|FG002|Escalation Phase|Death|0|||
160614866|NCT01693562|579968247|FG003|Escalation Phase|Death|3|||
160614867|NCT01693562|579968248|FG004|Escalation Phase|Death|6|||
160614868|NCT01693562|579968249|FG005|Escalation Phase|Death|4|||
160614869|NCT01693562|579968250|FG006|Escalation Phase|Death|0|||
160614870|NCT01693562|579968251|FG007|Escalation Phase|Death|0|||
160614871|NCT01693562|579968252|FG008|Escalation Phase|Death|0|||
160614872|NCT01693562|579968253|FG009|Escalation Phase|Death|0|||
160614873|NCT01693562|579968254|FG010|Escalation Phase|Death|0|||
160614874|NCT01693562|579968255|FG011|Escalation Phase|Death|0|||
160614875|NCT01693562|579968256|FG012|Escalation Phase|Death|0|||
160614876|NCT01693562|579968257|FG013|Escalation Phase|Death|0|||
160614877|NCT01693562|579968258|FG014|Escalation Phase|Death|0|||
160614878|NCT01693562|579968259|FG015|Escalation Phase|Death|0|||
160614879|NCT01693562|579968260|FG016|Escalation Phase|Death|0|||
160614880|NCT01693562|579968261|FG017|Escalation Phase|Death|0|||
160614881|NCT01693562|579968262|FG018|Escalation Phase|Death|0|||
160614882|NCT01693562|579968263|FG019|Escalation Phase|Death|0|||
160614883|NCT01693562|579968264|FG020|Escalation Phase|Death|0|||
160614884|NCT01693562|579968265|FG021|Escalation Phase|Death|0|||
160614885|NCT01693562|579968266|FG022|Escalation Phase|Death|0|||
160614886|NCT01693562|579968244|FG000|Escalation Phase|Lost to Follow-up|0|||
160614887|NCT01693562|579968245|FG001|Escalation Phase|Lost to Follow-up|1|||
160614888|NCT01693562|579968246|FG002|Escalation Phase|Lost to Follow-up|1|||
160614889|NCT01693562|579968247|FG003|Escalation Phase|Lost to Follow-up|0|||
160614890|NCT01693562|579968248|FG004|Escalation Phase|Lost to Follow-up|0|||
160495480|NCT00379769|579542989|FG005|Main Study|Personal reasons|0|||
160495481|NCT00379769|579542984|FG000|Main Study|Risk of heart failure|0|||
160495482|NCT00379769|579542985|FG001|Main Study|Risk of heart failure|1|||
160495483|NCT00379769|579542986|FG002|Main Study|Risk of heart failure|0|||
160495484|NCT00379769|579542987|FG003|Main Study|Risk of heart failure|0|||
160495485|NCT00379769|579542988|FG004|Main Study|Risk of heart failure|0|||
160495486|NCT00379769|579542989|FG005|Main Study|Risk of heart failure|0|||
160495487|NCT00379769|579542984|FG000|Main Study|Investigator refused to log temperature|0|||
160495488|NCT00379769|579542985|FG001|Main Study|Investigator refused to log temperature|0|||
160495489|NCT00379769|579542986|FG002|Main Study|Investigator refused to log temperature|1|||
160495490|NCT00379769|579542987|FG003|Main Study|Investigator refused to log temperature|0|||
160495491|NCT00379769|579542988|FG004|Main Study|Investigator refused to log temperature|0|||
160495492|NCT00379769|579542989|FG005|Main Study|Investigator refused to log temperature|0|||
160495493|NCT00379769|579542984|FG000|Main Study|Reason unspecified|0|||
160495494|NCT00379769|579542985|FG001|Main Study|Reason unspecified|0|||
160495495|NCT00379769|579542986|FG002|Main Study|Reason unspecified|1|||
160614891|NCT01693562|579968249|FG005|Escalation Phase|Lost to Follow-up|0|||
160614892|NCT01693562|579968250|FG006|Escalation Phase|Lost to Follow-up|0|||
160614893|NCT01693562|579968251|FG007|Escalation Phase|Lost to Follow-up|0|||
160614894|NCT01693562|579968252|FG008|Escalation Phase|Lost to Follow-up|0|||
160614895|NCT01693562|579968253|FG009|Escalation Phase|Lost to Follow-up|0|||
160614896|NCT01693562|579968254|FG010|Escalation Phase|Lost to Follow-up|0|||
160495496|NCT00379769|579542987|FG003|Main Study|Reason unspecified|0|||
160495497|NCT00379769|579542988|FG004|Main Study|Reason unspecified|0|||
160495498|NCT00379769|579542989|FG005|Main Study|Reason unspecified|0|||
160495499|NCT00379769|579542984|FG000|Observational Follow-up|Death|0|||
160495500|NCT00379769|579542985|FG001|Observational Follow-up|Death|0|||
160614897|NCT01693562|579968255|FG011|Escalation Phase|Lost to Follow-up|0|||
160614898|NCT01693562|579968256|FG012|Escalation Phase|Lost to Follow-up|0|||
160614899|NCT01693562|579968257|FG013|Escalation Phase|Lost to Follow-up|0|||
160614900|NCT01693562|579968258|FG014|Escalation Phase|Lost to Follow-up|0|||
160614901|NCT01693562|579968259|FG015|Escalation Phase|Lost to Follow-up|0|||
160614902|NCT01693562|579968260|FG016|Escalation Phase|Lost to Follow-up|0|||
160614903|NCT01693562|579968261|FG017|Escalation Phase|Lost to Follow-up|0|||
160614904|NCT01693562|579968262|FG018|Escalation Phase|Lost to Follow-up|0|||
160614905|NCT01693562|579968263|FG019|Escalation Phase|Lost to Follow-up|0|||
160614906|NCT01693562|579968264|FG020|Escalation Phase|Lost to Follow-up|0|||
160614907|NCT01693562|579968265|FG021|Escalation Phase|Lost to Follow-up|0|||
160614908|NCT01693562|579968266|FG022|Escalation Phase|Lost to Follow-up|0|||
160614909|NCT01693562|579968244|FG000|Escalation Phase|Other|0|||
160614910|NCT01693562|579968245|FG001|Escalation Phase|Other|0|||
160614911|NCT01693562|579968246|FG002|Escalation Phase|Other|2|||
160614912|NCT01693562|579968247|FG003|Escalation Phase|Other|0|||
160614913|NCT01693562|579968248|FG004|Escalation Phase|Other|0|||
160614914|NCT01693562|579968249|FG005|Escalation Phase|Other|1|||
160614915|NCT01693562|579968250|FG006|Escalation Phase|Other|0|||
160614916|NCT01693562|579968251|FG007|Escalation Phase|Other|0|||
160614917|NCT01693562|579968252|FG008|Escalation Phase|Other|0|||
160614918|NCT01693562|579968253|FG009|Escalation Phase|Other|0|||
160495501|NCT00379769|579542986|FG002|Observational Follow-up|Death|0|||
160495502|NCT00379769|579542987|FG003|Observational Follow-up|Death|0|||
160495503|NCT00379769|579542988|FG004|Observational Follow-up|Death|78|||
160495504|NCT00379769|579542989|FG005|Observational Follow-up|Death|70|||
160495505|NCT00379769|579542984|FG000|Observational Follow-up|Adverse Event|0|||
160495506|NCT00379769|579542985|FG001|Observational Follow-up|Adverse Event|0|||
160495507|NCT00379769|579542986|FG002|Observational Follow-up|Adverse Event|0|||
160495508|NCT00379769|579542987|FG003|Observational Follow-up|Adverse Event|0|||
160495509|NCT00379769|579542988|FG004|Observational Follow-up|Adverse Event|1|||
160495510|NCT00379769|579542989|FG005|Observational Follow-up|Adverse Event|0|||
160495511|NCT00379769|579542984|FG000|Observational Follow-up|Lost to Follow-up|0|||
160495512|NCT00379769|579542985|FG001|Observational Follow-up|Lost to Follow-up|0|||
160495513|NCT00379769|579542986|FG002|Observational Follow-up|Lost to Follow-up|0|||
160495514|NCT00379769|579542987|FG003|Observational Follow-up|Lost to Follow-up|0|||
160495515|NCT00379769|579542988|FG004|Observational Follow-up|Lost to Follow-up|25|||
160495516|NCT00379769|579542989|FG005|Observational Follow-up|Lost to Follow-up|27|||
160495517|NCT00379769|579542984|FG000|Observational Follow-up|Withdrawal by Subject|0|||
160495518|NCT00379769|579542985|FG001|Observational Follow-up|Withdrawal by Subject|0|||
160495519|NCT00379769|579542986|FG002|Observational Follow-up|Withdrawal by Subject|0|||
160495520|NCT00379769|579542987|FG003|Observational Follow-up|Withdrawal by Subject|0|||
160495521|NCT00379769|579542988|FG004|Observational Follow-up|Withdrawal by Subject|12|||
160495522|NCT00379769|579542989|FG005|Observational Follow-up|Withdrawal by Subject|12|||
160495523|NCT00379769|579542984|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
160495524|NCT00379769|579542985|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
160495525|NCT00379769|579542986|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
160495526|NCT00379769|579542987|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
160495527|NCT00379769|579542988|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
160495528|NCT00379769|579542989|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
160614919|NCT01693562|579968254|FG010|Escalation Phase|Other|0|||
160614920|NCT01693562|579968255|FG011|Escalation Phase|Other|0|||
160495529|NCT00379769|579542984|FG000|Observational Follow-up|Physician Decision|0|||
160495530|NCT00379769|579542985|FG001|Observational Follow-up|Physician Decision|0|||
160495531|NCT00379769|579542986|FG002|Observational Follow-up|Physician Decision|0|||
160495532|NCT00379769|579542987|FG003|Observational Follow-up|Physician Decision|0|||
160495533|NCT00379769|579542988|FG004|Observational Follow-up|Physician Decision|8|||
160495534|NCT00379769|579542989|FG005|Observational Follow-up|Physician Decision|8|||
160495535|NCT00379769|579542984|FG000|Observational Follow-up|Site Closed Early|0|||
160495536|NCT00379769|579542985|FG001|Observational Follow-up|Site Closed Early|0|||
160495537|NCT00379769|579542986|FG002|Observational Follow-up|Site Closed Early|0|||
160495538|NCT00379769|579542987|FG003|Observational Follow-up|Site Closed Early|0|||
160495539|NCT00379769|579542988|FG004|Observational Follow-up|Site Closed Early|6|||
160495540|NCT00379769|579542989|FG005|Observational Follow-up|Site Closed Early|7|||
160495541|NCT00379769|579542984|FG000|Observational Follow-up|Participant Moved|0|||
160495542|NCT00379769|579542985|FG001|Observational Follow-up|Participant Moved|0|||
160495543|NCT00379769|579542986|FG002|Observational Follow-up|Participant Moved|0|||
160495544|NCT00379769|579542987|FG003|Observational Follow-up|Participant Moved|0|||
160495545|NCT00379769|579542988|FG004|Observational Follow-up|Participant Moved|0|||
160495546|NCT00379769|579542989|FG005|Observational Follow-up|Participant Moved|1|||
160495547|NCT00379769|579542984|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
160495548|NCT00379769|579542985|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
160614921|NCT01693562|579968256|FG012|Escalation Phase|Other|0|||
160614922|NCT01693562|579968257|FG013|Escalation Phase|Other|0|||
160614923|NCT01693562|579968258|FG014|Escalation Phase|Other|0|||
160614924|NCT01693562|579968259|FG015|Escalation Phase|Other|0|||
160614925|NCT01693562|579968260|FG016|Escalation Phase|Other|0|||
160614926|NCT01693562|579968261|FG017|Escalation Phase|Other|0|||
160614927|NCT01693562|579968262|FG018|Escalation Phase|Other|0|||
160614928|NCT01693562|579968263|FG019|Escalation Phase|Other|0|||
160495549|NCT00379769|579542986|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
160495550|NCT00379769|579542987|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
160495551|NCT00379769|579542988|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
160495552|NCT00379769|579542989|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
160495553|NCT02825251|579542990|FG000|Overall Study|Adverse Event|0|||
160495554|NCT02825251|579542991|FG001|Overall Study|Adverse Event|1|||
160495555|NCT02825251|579542990|FG000|Overall Study|Lost to Follow-up|0|||
160495556|NCT02825251|579542991|FG001|Overall Study|Lost to Follow-up|1|||
160495557|NCT02825251|579542990|FG000|Overall Study|Withdrawal by Subject|1|||
160495558|NCT02825251|579542991|FG001|Overall Study|Withdrawal by Subject|4|||
160495559|NCT02825251|579542990|FG000|Overall Study|Unclassified|2|||
160495560|NCT02825251|579542991|FG001|Overall Study|Unclassified|0|||
160495561|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
160495562|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
160495563|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
160495564|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Death|4|||
160495565|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Death|2|||
160495566|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Death|3|||
160495567|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
160495568|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
160495569|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
160495570|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
160495571|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
160495572|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
160495573|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
160495574|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
160495575|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
160495576|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
160495577|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
160495578|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
160495579|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
160495580|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
160495581|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
160495582|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
160495583|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
160495584|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
160495585|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
160495586|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
160495587|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
160495588|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
160495589|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
160495590|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
160495591|NCT02783573|579542992|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
160495592|NCT02783573|579542993|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
160495593|NCT02783573|579542994|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
160495594|NCT02783573|579542992|FG000|Delayed-Start Period|Sponsor Decision|0|||
160495595|NCT02783573|579542993|FG001|Delayed-Start Period|Sponsor Decision|17|||
160495596|NCT02783573|579542994|FG002|Delayed-Start Period|Sponsor Decision|12|||
160495597|NCT01245140|579542996|FG000|Overall Study|Adverse Event|1|||
160495598|NCT01245140|579542997|FG001|Overall Study|Adverse Event|3|||
160495599|NCT01245140|579542996|FG000|Overall Study|Lack of Efficacy|2|||
160495600|NCT01245140|579542997|FG001|Overall Study|Lack of Efficacy|4|||
160495601|NCT01245140|579542996|FG000|Overall Study|Protocol Violation|0|||
160614929|NCT01693562|579968264|FG020|Escalation Phase|Other|0|||
160614930|NCT01693562|579968265|FG021|Escalation Phase|Other|0|||
160614931|NCT01693562|579968266|FG022|Escalation Phase|Other|0|||
160614932|NCT01693562|579968244|FG000|Exploration Phase|Withdrawal by Subject|0|||
160614933|NCT01693562|579968245|FG001|Exploration Phase|Withdrawal by Subject|0|||
160614934|NCT01693562|579968246|FG002|Exploration Phase|Withdrawal by Subject|0|||
160614935|NCT01693562|579968247|FG003|Exploration Phase|Withdrawal by Subject|0|||
160614936|NCT01693562|579968248|FG004|Exploration Phase|Withdrawal by Subject|0|||
160614937|NCT01693562|579968249|FG005|Exploration Phase|Withdrawal by Subject|0|||
160614938|NCT01693562|579968250|FG006|Exploration Phase|Withdrawal by Subject|2|||
160495602|NCT01245140|579542997|FG001|Overall Study|Protocol Violation|1|||
160495603|NCT01245140|579542996|FG000|Overall Study|Withdrawal by Subject|0|||
160495604|NCT01245140|579542997|FG001|Overall Study|Withdrawal by Subject|1|||
160495605|NCT01245140|579542996|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
160495606|NCT01245140|579542997|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
160614939|NCT01693562|579968251|FG007|Exploration Phase|Withdrawal by Subject|0|||
160495607|NCT02037477|579542998|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
160614940|NCT01693562|579968252|FG008|Exploration Phase|Withdrawal by Subject|0|||
160495608|NCT02037477|579542999|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
160495609|NCT02037477|579543000|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
160614941|NCT01693562|579968253|FG009|Exploration Phase|Withdrawal by Subject|0|||
160614942|NCT01693562|579968254|FG010|Exploration Phase|Withdrawal by Subject|0|||
160614943|NCT01693562|579968255|FG011|Exploration Phase|Withdrawal by Subject|0|||
160614944|NCT01693562|579968256|FG012|Exploration Phase|Withdrawal by Subject|0|||
160614945|NCT01693562|579968257|FG013|Exploration Phase|Withdrawal by Subject|0|||
160614946|NCT01693562|579968258|FG014|Exploration Phase|Withdrawal by Subject|0|||
160614947|NCT01693562|579968259|FG015|Exploration Phase|Withdrawal by Subject|0|||
160614948|NCT01693562|579968260|FG016|Exploration Phase|Withdrawal by Subject|0|||
160614949|NCT01693562|579968261|FG017|Exploration Phase|Withdrawal by Subject|0|||
160614950|NCT01693562|579968262|FG018|Exploration Phase|Withdrawal by Subject|0|||
160614951|NCT01693562|579968263|FG019|Exploration Phase|Withdrawal by Subject|0|||
160614952|NCT01693562|579968264|FG020|Exploration Phase|Withdrawal by Subject|0|||
160614953|NCT01693562|579968265|FG021|Exploration Phase|Withdrawal by Subject|0|||
160614954|NCT01693562|579968266|FG022|Exploration Phase|Withdrawal by Subject|0|||
160614955|NCT01693562|579968244|FG000|Exploration Phase|Death|0|||
160614956|NCT01693562|579968245|FG001|Exploration Phase|Death|0|||
160614957|NCT01693562|579968246|FG002|Exploration Phase|Death|0|||
160614958|NCT01693562|579968247|FG003|Exploration Phase|Death|0|||
160614959|NCT01693562|579968248|FG004|Exploration Phase|Death|0|||
160614960|NCT01693562|579968249|FG005|Exploration Phase|Death|0|||
160614961|NCT01693562|579968250|FG006|Exploration Phase|Death|17|||
160614962|NCT01693562|579968251|FG007|Exploration Phase|Death|0|||
160614963|NCT01693562|579968252|FG008|Exploration Phase|Death|0|||
160614964|NCT01693562|579968253|FG009|Exploration Phase|Death|0|||
160614965|NCT01693562|579968254|FG010|Exploration Phase|Death|0|||
160614966|NCT01693562|579968255|FG011|Exploration Phase|Death|0|||
160614967|NCT01693562|579968256|FG012|Exploration Phase|Death|0|||
160614968|NCT01693562|579968257|FG013|Exploration Phase|Death|0|||
160614969|NCT01693562|579968258|FG014|Exploration Phase|Death|0|||
160614970|NCT01693562|579968259|FG015|Exploration Phase|Death|0|||
160614971|NCT01693562|579968260|FG016|Exploration Phase|Death|0|||
160614972|NCT01693562|579968261|FG017|Exploration Phase|Death|0|||
160614973|NCT01693562|579968262|FG018|Exploration Phase|Death|0|||
160614974|NCT01693562|579968263|FG019|Exploration Phase|Death|0|||
160614975|NCT01693562|579968264|FG020|Exploration Phase|Death|0|||
160614976|NCT01693562|579968265|FG021|Exploration Phase|Death|0|||
160614977|NCT01693562|579968266|FG022|Exploration Phase|Death|0|||
160614978|NCT01693562|579968244|FG000|Exploration Phase|Other|0|||
160614979|NCT01693562|579968245|FG001|Exploration Phase|Other|0|||
160614980|NCT01693562|579968246|FG002|Exploration Phase|Other|0|||
160614981|NCT01693562|579968247|FG003|Exploration Phase|Other|0|||
160614982|NCT01693562|579968248|FG004|Exploration Phase|Other|0|||
160614983|NCT01693562|579968249|FG005|Exploration Phase|Other|0|||
160614984|NCT01693562|579968250|FG006|Exploration Phase|Other|2|||
160614985|NCT01693562|579968251|FG007|Exploration Phase|Other|0|||
160614986|NCT01693562|579968252|FG008|Exploration Phase|Other|0|||
160614987|NCT01693562|579968253|FG009|Exploration Phase|Other|0|||
160614988|NCT01693562|579968254|FG010|Exploration Phase|Other|0|||
160614989|NCT01693562|579968255|FG011|Exploration Phase|Other|0|||
160614990|NCT01693562|579968256|FG012|Exploration Phase|Other|0|||
160614991|NCT01693562|579968257|FG013|Exploration Phase|Other|0|||
160614992|NCT01693562|579968258|FG014|Exploration Phase|Other|0|||
160614993|NCT01693562|579968259|FG015|Exploration Phase|Other|0|||
160614994|NCT01693562|579968260|FG016|Exploration Phase|Other|0|||
160614995|NCT01693562|579968261|FG017|Exploration Phase|Other|0|||
160614996|NCT01693562|579968262|FG018|Exploration Phase|Other|0|||
160614997|NCT01693562|579968263|FG019|Exploration Phase|Other|0|||
160614998|NCT01693562|579968264|FG020|Exploration Phase|Other|0|||
160614999|NCT01693562|579968265|FG021|Exploration Phase|Other|0|||
160495610|NCT02037477|579543001|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
160495611|NCT02635360|579543002|FG000|Overall Study|Adverse Event|0|||
160495612|NCT02635360|579543003|FG001|Overall Study|Adverse Event|3|||
160615000|NCT01693562|579968266|FG022|Exploration Phase|Other|0|||
160615001|NCT01693562|579968244|FG000|Expansion Phase|Withdrawal by Subject|0|||
160615002|NCT01693562|579968245|FG001|Expansion Phase|Withdrawal by Subject|0|||
160615003|NCT01693562|579968246|FG002|Expansion Phase|Withdrawal by Subject|0|||
160615004|NCT01693562|579968247|FG003|Expansion Phase|Withdrawal by Subject|0|||
160615005|NCT01693562|579968248|FG004|Expansion Phase|Withdrawal by Subject|0|||
160615006|NCT01693562|579968249|FG005|Expansion Phase|Withdrawal by Subject|0|||
160615007|NCT01693562|579968250|FG006|Expansion Phase|Withdrawal by Subject|0|||
160615008|NCT01693562|579968251|FG007|Expansion Phase|Withdrawal by Subject|16|||
160615009|NCT01693562|579968252|FG008|Expansion Phase|Withdrawal by Subject|2|||
160615010|NCT01693562|579968253|FG009|Expansion Phase|Withdrawal by Subject|54|||
160615011|NCT01693562|579968254|FG010|Expansion Phase|Withdrawal by Subject|2|||
160615012|NCT01693562|579968255|FG011|Expansion Phase|Withdrawal by Subject|2|||
160615013|NCT01693562|579968256|FG012|Expansion Phase|Withdrawal by Subject|3|||
160615014|NCT01693562|579968257|FG013|Expansion Phase|Withdrawal by Subject|5|||
160615015|NCT01693562|579968258|FG014|Expansion Phase|Withdrawal by Subject|16|||
160615016|NCT01693562|579968259|FG015|Expansion Phase|Withdrawal by Subject|7|||
160495613|NCT02635360|579543002|FG000|Overall Study|Withdrawal by Subject|2|||
160661543|NCT03627091|580144128|FG002|Overall Study|Other|0|||
160495614|NCT02635360|579543003|FG001|Overall Study|Withdrawal by Subject|0|||
160495615|NCT02635360|579543002|FG000|Overall Study|Non-Compliance|3|||
160495616|NCT02635360|579543003|FG001|Overall Study|Non-Compliance|1|||
160495617|NCT02635360|579543002|FG000|Overall Study|Disease Progression|0|||
160495618|NCT02635360|579543003|FG001|Overall Study|Disease Progression|2|||
160495619|NCT02635360|579543002|FG000|Overall Study|Lost to Follow-up|1|||
160495620|NCT02635360|579543003|FG001|Overall Study|Lost to Follow-up|1|||
160495621|NCT04082429|579543004|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
160495622|NCT04082429|579543005|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
160495623|NCT04082429|579543006|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
160495624|NCT04082429|579543007|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
160495625|NCT04082429|579543008|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
160495626|NCT04082429|579543009|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
160495627|NCT04082429|579543010|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
160495628|NCT04082429|579543011|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
160495629|NCT04082429|579543012|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
160495630|NCT04082429|579543004|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
160495631|NCT04082429|579543005|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
160495632|NCT04082429|579543006|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
160495633|NCT04082429|579543007|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
160495634|NCT04082429|579543008|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
160495635|NCT04082429|579543009|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
160495636|NCT04082429|579543010|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
160495637|NCT04082429|579543011|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
160495638|NCT04082429|579543012|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
160495639|NCT04082429|579543004|FG000|Main Part (After the Treatment Pause)|Death|0|||
160495640|NCT04082429|579543005|FG001|Main Part (After the Treatment Pause)|Death|0|||
160495641|NCT04082429|579543006|FG002|Main Part (After the Treatment Pause)|Death|0|||
160495642|NCT04082429|579543007|FG003|Main Part (After the Treatment Pause)|Death|0|||
160495643|NCT04082429|579543008|FG004|Main Part (After the Treatment Pause)|Death|1|||
160495644|NCT04082429|579543009|FG005|Main Part (After the Treatment Pause)|Death|0|||
160495645|NCT04082429|579543010|FG006|Main Part (After the Treatment Pause)|Death|0|||
160495646|NCT04082429|579543011|FG007|Main Part (After the Treatment Pause)|Death|0|||
160495647|NCT04082429|579543012|FG008|Main Part (After the Treatment Pause)|Death|0|||
160495648|NCT04082429|579543004|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
160495649|NCT04082429|579543005|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
160495650|NCT04082429|579543006|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
160495651|NCT04082429|579543007|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
160495652|NCT04082429|579543008|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
160495653|NCT04082429|579543009|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
160495654|NCT04082429|579543010|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
160495655|NCT04082429|579543011|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
160495656|NCT04082429|579543012|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
160495657|NCT04082429|579543004|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
160495658|NCT04082429|579543005|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
160495659|NCT04082429|579543006|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
160495660|NCT04082429|579543007|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
160495661|NCT04082429|579543008|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
160495662|NCT04082429|579543009|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
160495663|NCT04082429|579543010|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
160495664|NCT04082429|579543011|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
160495665|NCT04082429|579543012|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
160495666|NCT04082429|579543004|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
160495667|NCT04082429|579543005|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
160495668|NCT04082429|579543006|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
160495669|NCT04082429|579543007|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
160495670|NCT04082429|579543008|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
160495671|NCT04082429|579543009|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
160495672|NCT04082429|579543010|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
160495673|NCT04082429|579543011|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
160495674|NCT04082429|579543012|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
160495675|NCT04082429|579543004|FG000|Extension Part|Ongoing|0|||
160495676|NCT04082429|579543005|FG001|Extension Part|Ongoing|7|||
160495677|NCT04082429|579543006|FG002|Extension Part|Ongoing|17|||
160495678|NCT04082429|579543007|FG003|Extension Part|Ongoing|6|||
160495679|NCT04082429|579543008|FG004|Extension Part|Ongoing|45|||
160615017|NCT01693562|579968260|FG016|Expansion Phase|Withdrawal by Subject|40|||
160615018|NCT01693562|579968261|FG017|Expansion Phase|Withdrawal by Subject|4|||
160615019|NCT01693562|579968262|FG018|Expansion Phase|Withdrawal by Subject|8|||
160615020|NCT01693562|579968263|FG019|Expansion Phase|Withdrawal by Subject|3|||
160615021|NCT01693562|579968264|FG020|Expansion Phase|Withdrawal by Subject|1|||
160615022|NCT01693562|579968265|FG021|Expansion Phase|Withdrawal by Subject|8|||
160615023|NCT01693562|579968266|FG022|Expansion Phase|Withdrawal by Subject|1|||
160615024|NCT01693562|579968244|FG000|Expansion Phase|Death|0|||
160615025|NCT01693562|579968245|FG001|Expansion Phase|Death|0|||
160615026|NCT01693562|579968246|FG002|Expansion Phase|Death|0|||
160615027|NCT01693562|579968247|FG003|Expansion Phase|Death|0|||
160615028|NCT01693562|579968248|FG004|Expansion Phase|Death|0|||
160615029|NCT01693562|579968249|FG005|Expansion Phase|Death|0|||
160615030|NCT01693562|579968250|FG006|Expansion Phase|Death|0|||
160615031|NCT01693562|579968251|FG007|Expansion Phase|Death|42|||
160615032|NCT01693562|579968252|FG008|Expansion Phase|Death|17|||
160615033|NCT01693562|579968253|FG009|Expansion Phase|Death|208|||
160615034|NCT01693562|579968254|FG010|Expansion Phase|Death|30|||
160615035|NCT01693562|579968255|FG011|Expansion Phase|Death|8|||
160615036|NCT01693562|579968256|FG012|Expansion Phase|Death|19|||
160615037|NCT01693562|579968257|FG013|Expansion Phase|Death|42|||
160615038|NCT01693562|579968258|FG014|Expansion Phase|Death|23|||
160615039|NCT01693562|579968259|FG015|Expansion Phase|Death|23|||
160615040|NCT01693562|579968260|FG016|Expansion Phase|Death|128|||
160615041|NCT01693562|579968261|FG017|Expansion Phase|Death|16|||
160615042|NCT01693562|579968262|FG018|Expansion Phase|Death|36|||
160615043|NCT01693562|579968263|FG019|Expansion Phase|Death|16|||
160615044|NCT01693562|579968264|FG020|Expansion Phase|Death|17|||
160615045|NCT01693562|579968265|FG021|Expansion Phase|Death|35|||
160615046|NCT01693562|579968266|FG022|Expansion Phase|Death|7|||
160615047|NCT01693562|579968244|FG000|Expansion Phase|Lost to Follow-up|0|||
160615048|NCT01693562|579968245|FG001|Expansion Phase|Lost to Follow-up|0|||
160615049|NCT01693562|579968246|FG002|Expansion Phase|Lost to Follow-up|0|||
160615050|NCT01693562|579968247|FG003|Expansion Phase|Lost to Follow-up|0|||
160615051|NCT01693562|579968248|FG004|Expansion Phase|Lost to Follow-up|0|||
160615052|NCT01693562|579968249|FG005|Expansion Phase|Lost to Follow-up|0|||
160615053|NCT01693562|579968250|FG006|Expansion Phase|Lost to Follow-up|0|||
160615054|NCT01693562|579968251|FG007|Expansion Phase|Lost to Follow-up|1|||
160615055|NCT01693562|579968252|FG008|Expansion Phase|Lost to Follow-up|2|||
160615056|NCT01693562|579968253|FG009|Expansion Phase|Lost to Follow-up|10|||
160615057|NCT01693562|579968254|FG010|Expansion Phase|Lost to Follow-up|4|||
160615058|NCT01693562|579968255|FG011|Expansion Phase|Lost to Follow-up|4|||
160615059|NCT01693562|579968256|FG012|Expansion Phase|Lost to Follow-up|1|||
160615060|NCT01693562|579968257|FG013|Expansion Phase|Lost to Follow-up|3|||
160615061|NCT01693562|579968258|FG014|Expansion Phase|Lost to Follow-up|0|||
160615062|NCT01693562|579968259|FG015|Expansion Phase|Lost to Follow-up|1|||
160615063|NCT01693562|579968260|FG016|Expansion Phase|Lost to Follow-up|1|||
160615064|NCT01693562|579968261|FG017|Expansion Phase|Lost to Follow-up|0|||
160615065|NCT01693562|579968262|FG018|Expansion Phase|Lost to Follow-up|2|||
160615066|NCT01693562|579968263|FG019|Expansion Phase|Lost to Follow-up|1|||
160615067|NCT01693562|579968264|FG020|Expansion Phase|Lost to Follow-up|2|||
160615068|NCT01693562|579968265|FG021|Expansion Phase|Lost to Follow-up|2|||
160615069|NCT01693562|579968266|FG022|Expansion Phase|Lost to Follow-up|1|||
160615070|NCT01693562|579968244|FG000|Expansion Phase|Other|0|||
160615071|NCT01693562|579968245|FG001|Expansion Phase|Other|0|||
160615072|NCT01693562|579968246|FG002|Expansion Phase|Other|0|||
160615073|NCT01693562|579968247|FG003|Expansion Phase|Other|0|||
160615074|NCT01693562|579968248|FG004|Expansion Phase|Other|0|||
160615075|NCT01693562|579968249|FG005|Expansion Phase|Other|0|||
160615076|NCT01693562|579968250|FG006|Expansion Phase|Other|0|||
160615077|NCT01693562|579968251|FG007|Expansion Phase|Other|3|||
160615078|NCT01693562|579968252|FG008|Expansion Phase|Other|1|||
160615079|NCT01693562|579968253|FG009|Expansion Phase|Other|28|||
160615080|NCT01693562|579968254|FG010|Expansion Phase|Other|4|||
160615081|NCT01693562|579968255|FG011|Expansion Phase|Other|7|||
160615082|NCT01693562|579968256|FG012|Expansion Phase|Other|0|||
160615083|NCT01693562|579968257|FG013|Expansion Phase|Other|1|||
160615084|NCT01693562|579968258|FG014|Expansion Phase|Other|1|||
160615085|NCT01693562|579968259|FG015|Expansion Phase|Other|0|||
160615086|NCT01693562|579968260|FG016|Expansion Phase|Other|28|||
160615087|NCT01693562|579968261|FG017|Expansion Phase|Other|0|||
160615088|NCT01693562|579968262|FG018|Expansion Phase|Other|1|||
160615089|NCT01693562|579968263|FG019|Expansion Phase|Other|0|||
160615090|NCT01693562|579968264|FG020|Expansion Phase|Other|1|||
160615091|NCT01693562|579968265|FG021|Expansion Phase|Other|17|||
160615092|NCT01693562|579968266|FG022|Expansion Phase|Other|1|||
160615093|NCT05466240|579968267|FG000|Overall Study|Adverse Event|1|||
160615094|NCT05466240|579968268|FG001|Overall Study|Adverse Event|0|||
160615095|NCT05466240|579968267|FG000|Overall Study|Withdrawal by Subject|1|||
160615096|NCT05466240|579968268|FG001|Overall Study|Withdrawal by Subject|0|||
160615097|NCT02759939|579968269|FG000|Overall Study|Missing data on first outcome assessed|11|||
160615098|NCT02759939|579968270|FG001|Overall Study|Missing data on first outcome assessed|2|||
160615099|NCT02759939|579968271|FG002|Overall Study|Missing data on first outcome assessed|5|||
160495680|NCT04082429|579543009|FG005|Extension Part|Ongoing|0|||
160495681|NCT04082429|579543010|FG006|Extension Part|Ongoing|10|||
160495682|NCT04082429|579543011|FG007|Extension Part|Ongoing|23|||
160495683|NCT04082429|579543012|FG008|Extension Part|Ongoing|25|||
160495684|NCT00334542|579543013|FG000|Overall Study|Adverse Event|3|||
160495685|NCT00334542|579543013|FG000|Overall Study|Withdrawal by Subject|1|||
160495686|NCT00334542|579543013|FG000|Overall Study|New cancer diagnosis|1|||
160495687|NCT03118050|579543014|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
160495688|NCT03118050|579543015|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
160495689|NCT03118050|579543016|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
160495690|NCT03118050|579543017|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
160495691|NCT03118050|579543018|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
160495692|NCT03118050|579543019|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
160495693|NCT03118050|579543020|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
160615100|NCT02759939|579968272|FG003|Overall Study|Missing data on first outcome assessed|2|||
160615101|NCT02759939|579968269|FG000|Overall Study|Ineligible for T2 and T3|310|||
160615102|NCT02759939|579968270|FG001|Overall Study|Ineligible for T2 and T3|179|||
160615103|NCT02759939|579968271|FG002|Overall Study|Ineligible for T2 and T3|366|||
160615104|NCT02759939|579968272|FG003|Overall Study|Ineligible for T2 and T3|391|||
160615105|NCT02759939|579968269|FG000|Overall Study|Lost to Follow-up|735|||
160615106|NCT02759939|579968270|FG001|Overall Study|Lost to Follow-up|791|||
160615107|NCT02759939|579968271|FG002|Overall Study|Lost to Follow-up|783|||
160615108|NCT02759939|579968272|FG003|Overall Study|Lost to Follow-up|650|||
160615109|NCT04735432|579968273|FG000|Overall Study|Other - due to personal reason|1|||
160615110|NCT04735432|579968274|FG001|Overall Study|Other - due to personal reason|0|||
160615111|NCT04735432|579968273|FG000|Overall Study|Adverse Event|2|||
160615112|NCT04735432|579968274|FG001|Overall Study|Adverse Event|0|||
160615113|NCT00141297|579968276|FG000|Overall Study|Adverse Event|0|||
160615114|NCT00141297|579968277|FG001|Overall Study|Adverse Event|0|||
160615115|NCT00141297|579968278|FG002|Overall Study|Adverse Event|1|||
160615116|NCT00141297|579968279|FG003|Overall Study|Adverse Event|0|||
160615117|NCT00141297|579968280|FG004|Overall Study|Adverse Event|1|||
160615118|NCT00141297|579968281|FG005|Overall Study|Adverse Event|1|||
160615119|NCT00141297|579968282|FG006|Overall Study|Adverse Event|0|||
160615120|NCT00141297|579968283|FG007|Overall Study|Adverse Event|1|||
160615121|NCT00141297|579968284|FG008|Overall Study|Adverse Event|1|||
160615122|NCT00141297|579968285|FG009|Overall Study|Adverse Event|0|||
160615123|NCT00141297|579968276|FG000|Overall Study|Death|1|||
160615124|NCT00141297|579968277|FG001|Overall Study|Death|0|||
160615125|NCT00141297|579968278|FG002|Overall Study|Death|0|||
160615126|NCT00141297|579968279|FG003|Overall Study|Death|0|||
160615127|NCT00141297|579968280|FG004|Overall Study|Death|0|||
160615128|NCT00141297|579968281|FG005|Overall Study|Death|0|||
160615129|NCT00141297|579968282|FG006|Overall Study|Death|0|||
160615130|NCT00141297|579968283|FG007|Overall Study|Death|0|||
160615131|NCT00141297|579968284|FG008|Overall Study|Death|1|||
160615132|NCT00141297|579968285|FG009|Overall Study|Death|0|||
160615133|NCT00141297|579968276|FG000|Overall Study|Withdrawal by Subject|0|||
160615134|NCT00141297|579968277|FG001|Overall Study|Withdrawal by Subject|0|||
160615135|NCT00141297|579968278|FG002|Overall Study|Withdrawal by Subject|0|||
160615136|NCT00141297|579968279|FG003|Overall Study|Withdrawal by Subject|0|||
160615137|NCT00141297|579968280|FG004|Overall Study|Withdrawal by Subject|0|||
160615138|NCT00141297|579968281|FG005|Overall Study|Withdrawal by Subject|0|||
160615139|NCT00141297|579968282|FG006|Overall Study|Withdrawal by Subject|0|||
160615140|NCT00141297|579968283|FG007|Overall Study|Withdrawal by Subject|0|||
160615141|NCT00141297|579968284|FG008|Overall Study|Withdrawal by Subject|1|||
160615142|NCT00141297|579968285|FG009|Overall Study|Withdrawal by Subject|0|||
160615143|NCT00141297|579968276|FG000|Overall Study|Other|0|||
160615144|NCT00141297|579968277|FG001|Overall Study|Other|0|||
160615145|NCT00141297|579968278|FG002|Overall Study|Other|0|||
160615146|NCT00141297|579968279|FG003|Overall Study|Other|1|||
160615147|NCT00141297|579968280|FG004|Overall Study|Other|5|||
160615148|NCT00141297|579968281|FG005|Overall Study|Other|0|||
160615149|NCT00141297|579968282|FG006|Overall Study|Other|0|||
160661544|NCT05093205|580144129|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
160495694|NCT01454739|579543022|FG000|Overall Study|Protocol Violation|2|||
160615150|NCT00141297|579968283|FG007|Overall Study|Other|0|||
160495695|NCT01454739|579543023|FG001|Overall Study|Protocol Violation|3|||
160615151|NCT00141297|579968284|FG008|Overall Study|Other|2|||
160615152|NCT00141297|579968285|FG009|Overall Study|Other|0|||
160615153|NCT00141297|579968276|FG000|Overall Study|Progressive Disease|2|||
160615154|NCT00141297|579968277|FG001|Overall Study|Progressive Disease|3|||
160615155|NCT00141297|579968278|FG002|Overall Study|Progressive Disease|6|||
160615156|NCT00141297|579968279|FG003|Overall Study|Progressive Disease|2|||
160615157|NCT00141297|579968280|FG004|Overall Study|Progressive Disease|15|||
160615158|NCT00141297|579968281|FG005|Overall Study|Progressive Disease|2|||
160495696|NCT01454739|579543022|FG000|Overall Study|Withdrawal by Subject|2|||
160495697|NCT01454739|579543023|FG001|Overall Study|Withdrawal by Subject|6|||
160495698|NCT01454739|579543022|FG000|Overall Study|Other|3|||
160495699|NCT01454739|579543023|FG001|Overall Study|Other|5|||
160495700|NCT01454739|579543022|FG000|Overall Study|Physician Decision|0|||
160495701|NCT01454739|579543023|FG001|Overall Study|Physician Decision|5|||
160495702|NCT01454739|579543022|FG000|Overall Study|Lost to Follow-up|0|||
160495703|NCT01454739|579543023|FG001|Overall Study|Lost to Follow-up|1|||
160495704|NCT01454739|579543022|FG000|Overall Study|Adverse Event|0|||
160495705|NCT01454739|579543023|FG001|Overall Study|Adverse Event|1|||
160495706|NCT05765435|579543024|FG000|Overall Study|Lost to Follow-up|0|||
160495707|NCT05765435|579543025|FG001|Overall Study|Lost to Follow-up|1|||
160495708|NCT05765435|579543026|FG002|Overall Study|Lost to Follow-up|0|||
160495709|NCT05765435|579543024|FG000|Overall Study|Withdrawal by Subject|0|||
160495710|NCT05765435|579543025|FG001|Overall Study|Withdrawal by Subject|0|||
160495711|NCT05765435|579543026|FG002|Overall Study|Withdrawal by Subject|1|||
160495712|NCT04351269|579543027|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
160495713|NCT04351269|579543028|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
160495714|NCT04351269|579543029|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
160495715|NCT04351269|579543027|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
160495716|NCT04351269|579543028|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
160495717|NCT04351269|579543029|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
160495718|NCT04351269|579543027|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
160495719|NCT04351269|579543028|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
160495720|NCT04351269|579543029|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
160495721|NCT04351269|579543027|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
160495722|NCT04351269|579543028|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
160495723|NCT04351269|579543029|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
160495724|NCT04351269|579543027|FG000|Overall Study|Lost to Follow-up|1|||
160495725|NCT04351269|579543028|FG001|Overall Study|Lost to Follow-up|3|||
160495726|NCT04351269|579543029|FG002|Overall Study|Lost to Follow-up|0|||
160495727|NCT03845140|579543036|FG000|Overall Study|Participant travelled outside study area|0|||
160495728|NCT03845140|579543037|FG001|Overall Study|Participant travelled outside study area|1|||
160495729|NCT03845140|579543038|FG002|Overall Study|Participant travelled outside study area|0|||
160495730|NCT03845140|579543039|FG003|Overall Study|Participant travelled outside study area|0|||
160495731|NCT03845140|579543040|FG004|Overall Study|Participant travelled outside study area|0|||
160495732|NCT03845140|579543041|FG005|Overall Study|Participant travelled outside study area|0|||
160495733|NCT01592045|579543049|FG000|Overall Study|Disease Progression|1|||
160495734|NCT01592045|579543050|FG001|Overall Study|Disease Progression|1|||
160495735|NCT01592045|579543049|FG000|Overall Study|Adverse Event|1|||
160495736|NCT01592045|579543050|FG001|Overall Study|Adverse Event|1|||
160495737|NCT01592045|579543049|FG000|Overall Study|Withdrawal by Subject|1|||
160495738|NCT01592045|579543050|FG001|Overall Study|Withdrawal by Subject|0|||
160495739|NCT01592045|579543049|FG000|Overall Study|Moved out of country|2|||
160495740|NCT01592045|579543050|FG001|Overall Study|Moved out of country|0|||
160495741|NCT03721705|579543053|FG000|Overall Study|Adverse Event|2|||
160495742|NCT03721705|579543054|FG001|Overall Study|Adverse Event|0|||
160495743|NCT03721705|579543053|FG000|Overall Study|Withdrawal by Subject|4|||
160495744|NCT03721705|579543054|FG001|Overall Study|Withdrawal by Subject|10|||
160495745|NCT03721705|579543053|FG000|Overall Study|No Suitable Study Partner|1|||
160495746|NCT03721705|579543054|FG001|Overall Study|No Suitable Study Partner|0|||
160495747|NCT03721705|579543053|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
160495748|NCT03721705|579543054|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
160495749|NCT03721705|579543053|FG000|Overall Study|Death|0|||
160495750|NCT03721705|579543054|FG001|Overall Study|Death|1|||
160495751|NCT01790295|579543055|FG000|Overall Study|Adverse Event|1|||
160495752|NCT01790295|579543055|FG000|Overall Study|Death|4|||
160495753|NCT01790295|579543055|FG000|Overall Study|Lack of Efficacy|2|||
160495754|NCT01790295|579543055|FG000|Overall Study|Study closure|4|||
160495755|NCT01843777|579543056|FG000|Overall Study|Withdrawal by Subject|1|||
160495756|NCT01843777|579543057|FG001|Overall Study|Withdrawal by Subject|0|||
160495757|NCT01101061|579543065|FG000|Overall Study|Adverse Event|0|||
160495758|NCT01101061|579543066|FG001|Overall Study|Adverse Event|0|||
160495759|NCT01101061|579543067|FG002|Overall Study|Adverse Event|1|||
160495760|NCT01101061|579543068|FG003|Overall Study|Adverse Event|0|||
160495761|NCT01101061|579543069|FG004|Overall Study|Adverse Event|0|||
160495762|NCT01101061|579543070|FG005|Overall Study|Adverse Event|0|||
160495763|NCT02049515|579543071|FG000|Overall Study|Adverse Event|46|||
160495764|NCT02049515|579543072|FG001|Overall Study|Adverse Event|2|||
160495765|NCT02049515|579543071|FG000|Overall Study|Protocol-specified Disease Progression|23|||
160495766|NCT02049515|579543072|FG001|Overall Study|Protocol-specified Disease Progression|2|||
160495767|NCT02049515|579543071|FG000|Overall Study|Death|6|||
160615159|NCT00141297|579968282|FG006|Overall Study|Progressive Disease|3|||
160615160|NCT00141297|579968283|FG007|Overall Study|Progressive Disease|3|||
160615161|NCT00141297|579968284|FG008|Overall Study|Progressive Disease|15|||
160615162|NCT00141297|579968285|FG009|Overall Study|Progressive Disease|6|||
160615163|NCT00141297|579968276|FG000|Overall Study|Transitioned|0|||
160615164|NCT00141297|579968277|FG001|Overall Study|Transitioned|0|||
160615165|NCT00141297|579968278|FG002|Overall Study|Transitioned|0|||
160615166|NCT00141297|579968279|FG003|Overall Study|Transitioned|0|||
160615167|NCT00141297|579968280|FG004|Overall Study|Transitioned|1|||
160615168|NCT00141297|579968281|FG005|Overall Study|Transitioned|0|||
160615169|NCT00141297|579968282|FG006|Overall Study|Transitioned|0|||
160615170|NCT00141297|579968283|FG007|Overall Study|Transitioned|0|||
160615171|NCT00141297|579968284|FG008|Overall Study|Transitioned|0|||
160615172|NCT00141297|579968285|FG009|Overall Study|Transitioned|0|||
160615173|NCT02987205|579968286|FG000|Overall Study|Adverse Event|1|||
160615174|NCT02987205|579968286|FG000|Overall Study|Withdrawal by Subject|3|||
160615175|NCT02807376|579968287|FG000|Overall Study|Intra-operative exclusion criteria|3|||
160615176|NCT02807376|579968288|FG001|Overall Study|Intra-operative exclusion criteria|0|||
160615177|NCT02807376|579968287|FG000|Overall Study|Lost to Follow-up|0|||
160615178|NCT02807376|579968288|FG001|Overall Study|Lost to Follow-up|1|||
160615179|NCT00712712|579968303|FG000|Overall Study|Protocol Violation|11|||
160615180|NCT00712712|579968303|FG000|Overall Study|Radiofrequency not done|3|||
160615181|NCT00712712|579968303|FG000|Overall Study|Death|8|||
160615182|NCT00712712|579968303|FG000|Overall Study|Withdrawal by Subject|1|||
160615183|NCT00958191|579968304|FG000|Overall Study|Death|4|||
160615184|NCT00958191|579968304|FG000|Overall Study|Lost to Follow-up|5|||
160615185|NCT00958191|579968304|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
160615186|NCT00958191|579968304|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
160615187|NCT00958191|579968304|FG000|Overall Study|Revision of study device|4|||
160615188|NCT00958191|579968304|FG000|Overall Study|Site termination|11|||
160615189|NCT00958191|579968304|FG000|Overall Study|No 5 yr x-rays|56|||
160615190|NCT01642004|579968305|FG000|Randomization|Adverse Event unrelated to study drug|1|||
160615191|NCT01642004|579968306|FG001|Randomization|Adverse Event unrelated to study drug|0|||
160615192|NCT01642004|579968305|FG000|Randomization|Participant withdrew consent|1|||
160615193|NCT01642004|579968306|FG001|Randomization|Participant withdrew consent|6|||
160615194|NCT01642004|579968305|FG000|Randomization|No longer meets study criteria|2|||
160615195|NCT01642004|579968306|FG001|Randomization|No longer meets study criteria|2|||
160615196|NCT01642004|579968305|FG000|Treatment|Disease progression|95|||
160615197|NCT01642004|579968306|FG001|Treatment|Disease progression|79|||
160615198|NCT01642004|579968305|FG000|Treatment|Study drug toxicity|10|||
160615199|NCT01642004|579968306|FG001|Treatment|Study drug toxicity|13|||
160615200|NCT01642004|579968305|FG000|Treatment|Death|1|||
160615201|NCT01642004|579968306|FG001|Treatment|Death|1|||
160615202|NCT01642004|579968305|FG000|Treatment|Adverse event unrelated to study drug|9|||
160615203|NCT01642004|579968306|FG001|Treatment|Adverse event unrelated to study drug|13|||
160615204|NCT01642004|579968305|FG000|Treatment|Maximum clinical benefit|1|||
160615205|NCT01642004|579968306|FG001|Treatment|Maximum clinical benefit|9|||
160615206|NCT01642004|579968305|FG000|Treatment|Poor/non-compliance|1|||
160615207|NCT01642004|579968306|FG001|Treatment|Poor/non-compliance|0|||
160615208|NCT01642004|579968305|FG000|Treatment|No longer meets study criteria|1|||
160615209|NCT01642004|579968306|FG001|Treatment|No longer meets study criteria|2|||
160615210|NCT01642004|579968305|FG000|Treatment|Other reasons|2|||
160615211|NCT01642004|579968306|FG001|Treatment|Other reasons|0|||
160615212|NCT01642004|579968305|FG000|Treatment|Not reported|0|||
160615213|NCT01642004|579968306|FG001|Treatment|Not reported|3|||
160615214|NCT01642004|579968305|FG000|Treatment|Participant request to discontinue study treatment|6|||
160615215|NCT01642004|579968306|FG001|Treatment|Participant request to discontinue study treatment|4|||
160615216|NCT01642004|579968305|FG000|Treatment|Participant withdrew consent|5|||
160615217|NCT01642004|579968306|FG001|Treatment|Participant withdrew consent|5|||
160615218|NCT02718625|579968307|FG000|Overall Study|Adverse Event|0|||
160615219|NCT02718625|579968308|FG001|Overall Study|Adverse Event|1|||
160615220|NCT02718625|579968307|FG000|Overall Study|Termination of Study by Sponsor|0|||
160615221|NCT02718625|579968308|FG001|Overall Study|Termination of Study by Sponsor|1|||
160615222|NCT01818765|579968311|FG000|Overall Study|Death|2|||
160615223|NCT00811395|579968312|FG000|Extension Treatment|Adverse Event|1|||
160615224|NCT00811395|579968313|FG001|Extension Treatment|Adverse Event|2|||
160615225|NCT00811395|579968314|FG002|Extension Treatment|Adverse Event|2|||
160615226|NCT00811395|579968315|FG003|Extension Treatment|Adverse Event|2|||
160615227|NCT00811395|579968316|FG004|Extension Treatment|Adverse Event|0|||
160615228|NCT00811395|579968317|FG005|Extension Treatment|Adverse Event|1|||
160615229|NCT00811395|579968312|FG000|Extension Treatment|Progressive disease|1|||
160615230|NCT00811395|579968313|FG001|Extension Treatment|Progressive disease|1|||
160615231|NCT00811395|579968314|FG002|Extension Treatment|Progressive disease|0|||
160615232|NCT00811395|579968315|FG003|Extension Treatment|Progressive disease|0|||
160615233|NCT00811395|579968316|FG004|Extension Treatment|Progressive disease|0|||
160615234|NCT00811395|579968317|FG005|Extension Treatment|Progressive disease|0|||
160615235|NCT00811395|579968312|FG000|Extension Treatment|Participant did not wish to continue|0|||
160615236|NCT00811395|579968313|FG001|Extension Treatment|Participant did not wish to continue|3|||
160615237|NCT00811395|579968314|FG002|Extension Treatment|Participant did not wish to continue|0|||
160615238|NCT00811395|579968315|FG003|Extension Treatment|Participant did not wish to continue|1|||
160615239|NCT00811395|579968316|FG004|Extension Treatment|Participant did not wish to continue|0|||
160615240|NCT00811395|579968317|FG005|Extension Treatment|Participant did not wish to continue|1|||
160615241|NCT00811395|579968312|FG000|Extension Treatment|Other than above|0|||
160615242|NCT00811395|579968313|FG001|Extension Treatment|Other than above|0|||
160615243|NCT00811395|579968314|FG002|Extension Treatment|Other than above|1|||
160615244|NCT00811395|579968315|FG003|Extension Treatment|Other than above|0|||
160615245|NCT00811395|579968316|FG004|Extension Treatment|Other than above|0|||
160615246|NCT00811395|579968317|FG005|Extension Treatment|Other than above|0|||
160615247|NCT01756833|579968320|FG000|Overall Study|Withdrawal by Subject|4|||
160615248|NCT01756833|579968321|FG001|Overall Study|Withdrawal by Subject|3|||
160615249|NCT00808132|579968322|FG000|Overall Study|Adverse Event|34|||
160615250|NCT00808132|579968323|FG001|Overall Study|Adverse Event|33|||
160615251|NCT00808132|579968324|FG002|Overall Study|Adverse Event|16|||
160615252|NCT00808132|579968325|FG003|Overall Study|Adverse Event|31|||
160615253|NCT00808132|579968326|FG004|Overall Study|Adverse Event|33|||
160615254|NCT00808132|579968322|FG000|Overall Study|Death|0|||
160615255|NCT00808132|579968323|FG001|Overall Study|Death|0|||
160615256|NCT00808132|579968324|FG002|Overall Study|Death|0|||
160615257|NCT00808132|579968325|FG003|Overall Study|Death|0|||
160615258|NCT00808132|579968326|FG004|Overall Study|Death|1|||
160615259|NCT00808132|579968322|FG000|Overall Study|Physician Decision|0|||
160615260|NCT00808132|579968323|FG001|Overall Study|Physician Decision|1|||
160615261|NCT00808132|579968324|FG002|Overall Study|Physician Decision|0|||
160615262|NCT00808132|579968325|FG003|Overall Study|Physician Decision|0|||
160615263|NCT00808132|579968326|FG004|Overall Study|Physician Decision|0|||
160615264|NCT00808132|579968322|FG000|Overall Study|Lost to Follow-up|8|||
160615265|NCT00808132|579968323|FG001|Overall Study|Lost to Follow-up|10|||
160615266|NCT00808132|579968324|FG002|Overall Study|Lost to Follow-up|11|||
160615267|NCT00808132|579968325|FG003|Overall Study|Lost to Follow-up|8|||
160615268|NCT00808132|579968326|FG004|Overall Study|Lost to Follow-up|9|||
160615269|NCT00808132|579968322|FG000|Overall Study|Protocol Violation|8|||
160615270|NCT00808132|579968323|FG001|Overall Study|Protocol Violation|9|||
160615271|NCT00808132|579968324|FG002|Overall Study|Protocol Violation|4|||
160615272|NCT00808132|579968325|FG003|Overall Study|Protocol Violation|9|||
160615273|NCT00808132|579968326|FG004|Overall Study|Protocol Violation|5|||
160615274|NCT00808132|579968322|FG000|Overall Study|Withdrawal by Subject|27|||
160615275|NCT00808132|579968323|FG001|Overall Study|Withdrawal by Subject|18|||
160615276|NCT00808132|579968324|FG002|Overall Study|Withdrawal by Subject|2|||
160615277|NCT00808132|579968325|FG003|Overall Study|Withdrawal by Subject|7|||
160615278|NCT00808132|579968326|FG004|Overall Study|Withdrawal by Subject|16|||
160615279|NCT00808132|579968322|FG000|Overall Study|Other|6|||
160615280|NCT00808132|579968323|FG001|Overall Study|Other|4|||
160615281|NCT00808132|579968324|FG002|Overall Study|Other|6|||
160615282|NCT00808132|579968325|FG003|Overall Study|Other|2|||
160615283|NCT00808132|579968326|FG004|Overall Study|Other|15|||
160615284|NCT00808132|579968322|FG000|Overall Study|Randomized, but not treated|10|||
160615285|NCT00808132|579968323|FG001|Overall Study|Randomized, but not treated|7|||
160615286|NCT00808132|579968324|FG002|Overall Study|Randomized, but not treated|9|||
160615287|NCT00808132|579968325|FG003|Overall Study|Randomized, but not treated|8|||
160615288|NCT00808132|579968326|FG004|Overall Study|Randomized, but not treated|9|||
160615289|NCT00808132|579968322|FG000|Overall Study|Unsatisfactory response|5|||
160615290|NCT00808132|579968323|FG001|Overall Study|Unsatisfactory response|6|||
160615291|NCT00808132|579968324|FG002|Overall Study|Unsatisfactory response|6|||
160615292|NCT00808132|579968325|FG003|Overall Study|Unsatisfactory response|4|||
160615293|NCT00808132|579968326|FG004|Overall Study|Unsatisfactory response|12|||
160615294|NCT01469637|579968329|FG000|First Intervention|Unacceptable behavior|0|||
160615295|NCT01469637|579968330|FG001|First Intervention|Unacceptable behavior|1|||
160615296|NCT01469637|579968329|FG000|Second Intervention|Incarcerated|1|||
160615297|NCT01469637|579968330|FG001|Second Intervention|Incarcerated|0|||
160615298|NCT01055457|579968331|FG000|Overall Study|Lost to Follow-up|0|||
160615299|NCT01055457|579968332|FG001|Overall Study|Lost to Follow-up|1|||
160615300|NCT01055457|579968333|FG002|Overall Study|Lost to Follow-up|0|||
160661545|NCT05093205|580144130|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
160661546|NCT05093205|580144131|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
160661547|NCT05093205|580144132|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
160661548|NCT05093205|580144133|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
160615301|NCT01055457|579968334|FG003|Overall Study|Lost to Follow-up|0|||
160615302|NCT01055457|579968335|FG004|Overall Study|Lost to Follow-up|0|||
160615303|NCT01055457|579968336|FG005|Overall Study|Lost to Follow-up|1|||
160615304|NCT01055457|579968337|FG006|Overall Study|Lost to Follow-up|0|||
160615305|NCT01055457|579968338|FG007|Overall Study|Lost to Follow-up|0|||
160615306|NCT01055457|579968339|FG008|Overall Study|Lost to Follow-up|0|||
160615307|NCT01055457|579968340|FG009|Overall Study|Lost to Follow-up|0|||
160615308|NCT01055457|579968331|FG000|Overall Study|Protocol Violation|0|||
160495768|NCT02049515|579543072|FG001|Overall Study|Death|0|||
160615309|NCT01055457|579968332|FG001|Overall Study|Protocol Violation|0|||
160615310|NCT01055457|579968333|FG002|Overall Study|Protocol Violation|1|||
160615311|NCT01055457|579968334|FG003|Overall Study|Protocol Violation|1|||
160615312|NCT01055457|579968335|FG004|Overall Study|Protocol Violation|1|||
160615313|NCT01055457|579968336|FG005|Overall Study|Protocol Violation|2|||
160615314|NCT01055457|579968337|FG006|Overall Study|Protocol Violation|1|||
160615315|NCT01055457|579968338|FG007|Overall Study|Protocol Violation|0|||
160615316|NCT01055457|579968339|FG008|Overall Study|Protocol Violation|0|||
160615317|NCT01055457|579968340|FG009|Overall Study|Protocol Violation|1|||
160615318|NCT01055457|579968331|FG000|Overall Study|Subject Disinterest|0|||
160615319|NCT01055457|579968332|FG001|Overall Study|Subject Disinterest|0|||
160615320|NCT01055457|579968333|FG002|Overall Study|Subject Disinterest|0|||
160615321|NCT01055457|579968334|FG003|Overall Study|Subject Disinterest|0|||
160615322|NCT01055457|579968335|FG004|Overall Study|Subject Disinterest|0|||
160615323|NCT01055457|579968336|FG005|Overall Study|Subject Disinterest|0|||
160615324|NCT01055457|579968337|FG006|Overall Study|Subject Disinterest|0|||
160615325|NCT01055457|579968338|FG007|Overall Study|Subject Disinterest|1|||
160615326|NCT01055457|579968339|FG008|Overall Study|Subject Disinterest|0|||
160615327|NCT01055457|579968340|FG009|Overall Study|Subject Disinterest|0|||
160615328|NCT01055457|579968331|FG000|Overall Study|Subject Ineligible|1|||
160615329|NCT01055457|579968332|FG001|Overall Study|Subject Ineligible|0|||
160615330|NCT01055457|579968333|FG002|Overall Study|Subject Ineligible|1|||
160615331|NCT01055457|579968334|FG003|Overall Study|Subject Ineligible|0|||
160615332|NCT01055457|579968335|FG004|Overall Study|Subject Ineligible|1|||
160615333|NCT01055457|579968336|FG005|Overall Study|Subject Ineligible|0|||
160615334|NCT01055457|579968337|FG006|Overall Study|Subject Ineligible|0|||
160615335|NCT01055457|579968338|FG007|Overall Study|Subject Ineligible|0|||
160615336|NCT01055457|579968339|FG008|Overall Study|Subject Ineligible|0|||
160615337|NCT01055457|579968340|FG009|Overall Study|Subject Ineligible|0|||
160495769|NCT02049515|579543071|FG000|Overall Study|Physician Decision|5|||
160495770|NCT02049515|579543072|FG001|Overall Study|Physician Decision|1|||
160495771|NCT02049515|579543071|FG000|Overall Study|Withdrawal by Subject|3|||
160495772|NCT02049515|579543072|FG001|Overall Study|Withdrawal by Subject|0|||
160495773|NCT02049515|579543071|FG000|Overall Study|Termination of the Study by Sponsor|2|||
160495774|NCT02049515|579543072|FG001|Overall Study|Termination of the Study by Sponsor|0|||
160495775|NCT02049515|579543071|FG000|Overall Study|Protocol Violation|1|||
160495776|NCT02049515|579543072|FG001|Overall Study|Protocol Violation|1|||
160495777|NCT02049515|579543071|FG000|Overall Study|Clinical Deterioration|1|||
160495778|NCT02049515|579543072|FG001|Overall Study|Clinical Deterioration|0|||
160495779|NCT02049515|579543071|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
160495780|NCT02049515|579543072|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
160495781|NCT02049515|579543071|FG000|Overall Study|Treatment Interruption >42 Days|1|||
160495782|NCT02049515|579543072|FG001|Overall Study|Treatment Interruption >42 Days|0|||
160495783|NCT02049515|579543071|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
160495784|NCT02049515|579543072|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
160495785|NCT02353468|579543073|FG000|Overall Study|Study terminated|3|||
160495786|NCT02353871|579543076|FG000|Overall Study|Protocol deviation|0|||
160495787|NCT02353871|579543077|FG001|Overall Study|Protocol deviation|1|||
160495788|NCT02353871|579543076|FG000|Overall Study|Consent withdrawn|1|||
160495789|NCT02353871|579543077|FG001|Overall Study|Consent withdrawn|8|||
160495790|NCT02353871|579543076|FG000|Overall Study|Lost to Follow-up|2|||
160495791|NCT02353871|579543077|FG001|Overall Study|Lost to Follow-up|0|||
160495792|NCT05903183|579543080|FG000|Main Trial Part (365 Days)|Death|1|||
160495793|NCT05903183|579543081|FG001|Main Trial Part (365 Days)|Death|0|||
160495794|NCT05903183|579543082|FG002|Main Trial Part (365 Days)|Death|0|||
160495795|NCT05903183|579543083|FG003|Main Trial Part (365 Days)|Death|0|||
160495796|NCT05903183|579543084|FG004|Main Trial Part (365 Days)|Death|0|||
160495797|NCT05903183|579543080|FG000|Main Trial Part (365 Days)|Other|1|||
160495798|NCT05903183|579543081|FG001|Main Trial Part (365 Days)|Other|2|||
160495799|NCT05903183|579543082|FG002|Main Trial Part (365 Days)|Other|1|||
160495800|NCT05903183|579543083|FG003|Main Trial Part (365 Days)|Other|0|||
160495801|NCT05903183|579543084|FG004|Main Trial Part (365 Days)|Other|0|||
160615338|NCT01055457|579968331|FG000|Overall Study|Discomfort|0|||
160615339|NCT01055457|579968332|FG001|Overall Study|Discomfort|0|||
160615340|NCT01055457|579968333|FG002|Overall Study|Discomfort|0|||
160615341|NCT01055457|579968334|FG003|Overall Study|Discomfort|0|||
160615342|NCT01055457|579968335|FG004|Overall Study|Discomfort|1|||
160615343|NCT01055457|579968336|FG005|Overall Study|Discomfort|0|||
160615344|NCT01055457|579968337|FG006|Overall Study|Discomfort|0|||
160615345|NCT01055457|579968338|FG007|Overall Study|Discomfort|0|||
160615346|NCT01055457|579968339|FG008|Overall Study|Discomfort|0|||
160615347|NCT01055457|579968340|FG009|Overall Study|Discomfort|0|||
160495802|NCT05903183|579543080|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
160495803|NCT05903183|579543081|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
160495804|NCT05903183|579543082|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
160495805|NCT05903183|579543083|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
160495806|NCT05903183|579543084|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
160495807|NCT05903183|579543080|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
160615348|NCT01055457|579968331|FG000|Overall Study|Pregnancy|0|||
160495808|NCT05903183|579543081|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
160495809|NCT05903183|579543082|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
160495810|NCT05903183|579543083|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
160495811|NCT05903183|579543084|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
160495812|NCT05903183|579543080|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
160495813|NCT05903183|579543081|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
160495814|NCT05903183|579543082|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
160495815|NCT05903183|579543083|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
160495816|NCT05903183|579543084|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
160495817|NCT03698019|579543085|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
160495818|NCT03698019|579543086|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
160495819|NCT03698019|579543085|FG000|Step 1: Registration|Withdrawal by Subject|7|||
160495820|NCT03698019|579543086|FG001|Step 1: Registration|Withdrawal by Subject|2|||
160495821|NCT03698019|579543085|FG000|Step 1: Registration|Toxicity|0|||
160495822|NCT03698019|579543086|FG001|Step 1: Registration|Toxicity|1|||
160495823|NCT03698019|579543085|FG000|Step 1: Registration|Disease Progression|0|||
160495824|NCT03698019|579543086|FG001|Step 1: Registration|Disease Progression|12|||
160495825|NCT03698019|579543085|FG000|Step 1: Registration|Co-morbidities|0|||
160495826|NCT03698019|579543086|FG001|Step 1: Registration|Co-morbidities|1|||
160495827|NCT03698019|579543085|FG000|Step 1: Registration|Scheduling Issues|1|||
160495828|NCT03698019|579543086|FG001|Step 1: Registration|Scheduling Issues|0|||
160495829|NCT03698019|579543085|FG000|Step 1: Registration|Participant Refusal|0|||
160495830|NCT03698019|579543086|FG001|Step 1: Registration|Participant Refusal|1|||
160495831|NCT03698019|579543085|FG000|Step 2: Surgery|Participant Refusal|2|||
160495832|NCT03698019|579543086|FG001|Step 2: Surgery|Participant Refusal|1|||
160495833|NCT03698019|579543085|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
160495834|NCT03698019|579543086|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
160495835|NCT03698019|579543085|FG000|Step 2: Surgery|Metastatic Disease|16|||
160495836|NCT03698019|579543086|FG001|Step 2: Surgery|Metastatic Disease|9|||
160495837|NCT03698019|579543085|FG000|Step 2: Surgery|Residual Disease|2|||
160495838|NCT03698019|579543086|FG001|Step 2: Surgery|Residual Disease|1|||
160495839|NCT03698019|579543085|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
160495840|NCT03698019|579543086|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
160495841|NCT03698019|579543085|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
160495842|NCT03698019|579543086|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
160495843|NCT03698019|579543085|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
160495844|NCT03698019|579543086|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
160495845|NCT03698019|579543085|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
160495846|NCT03698019|579543086|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
160495847|NCT03698019|579543085|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
160495848|NCT03698019|579543086|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
160495849|NCT03698019|579543085|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
160495850|NCT03698019|579543086|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
160495851|NCT03698019|579543085|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
160495852|NCT03698019|579543086|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
160495853|NCT03698019|579543085|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
160495854|NCT03698019|579543086|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
160495855|NCT02647645|579543087|FG000|Overall Study|Lost to Follow-up|2|||
160495856|NCT02647645|579543088|FG001|Overall Study|Lost to Follow-up|1|||
160495857|NCT04599907|579543091|FG000|Overall Study|Withdrawal by Subject|1|||
160495858|NCT04599907|579543092|FG001|Overall Study|Withdrawal by Subject|7|||
160495859|NCT04599907|579543093|FG002|Overall Study|Withdrawal by Subject|6|||
160495860|NCT04599907|579543091|FG000|Overall Study|Lost to Follow-up|0|||
160495861|NCT04599907|579543092|FG001|Overall Study|Lost to Follow-up|1|||
160495862|NCT04599907|579543093|FG002|Overall Study|Lost to Follow-up|0|||
160495863|NCT03007732|579543094|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
160495864|NCT03007732|579543095|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
160495865|NCT03007732|579543096|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
160495866|NCT03007732|579543097|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
160495867|NCT03371823|579543098|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
160495868|NCT03371823|579543099|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
160495869|NCT01466790|579543100|FG000|Overall Study|Adverse Event|1|||
160495870|NCT01466790|579543101|FG001|Overall Study|Adverse Event|0|||
160495871|NCT01466790|579543102|FG002|Overall Study|Adverse Event|0|||
160495872|NCT01466790|579543103|FG003|Overall Study|Adverse Event|0|||
160495873|NCT01466790|579543104|FG004|Overall Study|Adverse Event|2|||
160495874|NCT01466790|579543105|FG005|Overall Study|Adverse Event|0|||
160495875|NCT01466790|579543106|FG006|Overall Study|Adverse Event|0|||
160495876|NCT01466790|579543107|FG007|Overall Study|Adverse Event|0|||
160495877|NCT01466790|579543100|FG000|Overall Study|Lost to Follow-up|2|||
160495878|NCT01466790|579543101|FG001|Overall Study|Lost to Follow-up|0|||
160495879|NCT01466790|579543102|FG002|Overall Study|Lost to Follow-up|0|||
160495880|NCT01466790|579543103|FG003|Overall Study|Lost to Follow-up|0|||
160495881|NCT01466790|579543104|FG004|Overall Study|Lost to Follow-up|0|||
160495882|NCT01466790|579543105|FG005|Overall Study|Lost to Follow-up|0|||
160495883|NCT01466790|579543106|FG006|Overall Study|Lost to Follow-up|0|||
160495884|NCT01466790|579543107|FG007|Overall Study|Lost to Follow-up|0|||
160495885|NCT01466790|579543100|FG000|Overall Study|Withdrawal by Subject|1|||
160495886|NCT01466790|579543101|FG001|Overall Study|Withdrawal by Subject|1|||
160495887|NCT01466790|579543102|FG002|Overall Study|Withdrawal by Subject|0|||
160495888|NCT01466790|579543103|FG003|Overall Study|Withdrawal by Subject|0|||
160495889|NCT01466790|579543104|FG004|Overall Study|Withdrawal by Subject|1|||
160495890|NCT01466790|579543105|FG005|Overall Study|Withdrawal by Subject|0|||
160495891|NCT01466790|579543106|FG006|Overall Study|Withdrawal by Subject|1|||
160495892|NCT01466790|579543107|FG007|Overall Study|Withdrawal by Subject|1|||
160495893|NCT03668223|579543109|FG000|Overall Study|Death|10|||
160495894|NCT03668223|579543110|FG001|Overall Study|Death|5|||
160495895|NCT03668223|579543109|FG000|Overall Study|Lost to Follow-up|12|||
160495896|NCT03668223|579543110|FG001|Overall Study|Lost to Follow-up|12|||
160495897|NCT03668223|579543109|FG000|Overall Study|Withdrawal by Subject|8|||
160495898|NCT03668223|579543110|FG001|Overall Study|Withdrawal by Subject|3|||
160495899|NCT05502783|579543111|FG000|Overall Study|Lack of Efficacy|1|||
160495900|NCT04870957|579543112|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
160495901|NCT04870957|579543113|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
160495902|NCT04870957|579543114|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
160495903|NCT04870957|579543115|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
160495904|NCT04870957|579543116|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
160495905|NCT04870957|579543117|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
160495906|NCT04870957|579543112|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
160495907|NCT04870957|579543113|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
160495908|NCT04870957|579543114|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
160495909|NCT04870957|579543115|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
160495910|NCT04870957|579543116|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
160495911|NCT04870957|579543117|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
160495912|NCT04870957|579543112|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
160495913|NCT04870957|579543113|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
160495914|NCT04870957|579543114|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
160495915|NCT04870957|579543115|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
160495916|NCT04870957|579543116|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
160495917|NCT04870957|579543117|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
160495918|NCT04870957|579543112|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
160495919|NCT04870957|579543113|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
160495920|NCT04870957|579543114|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
160495921|NCT04870957|579543115|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
160495922|NCT04870957|579543116|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
160495923|NCT04870957|579543117|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
160495924|NCT04870957|579543112|FG000|T2 (Randomization) - T3|Adverse Event|1|||
160495925|NCT04870957|579543113|FG001|T2 (Randomization) - T3|Adverse Event|1|||
160495926|NCT04870957|579543114|FG002|T2 (Randomization) - T3|Adverse Event|0|||
160495927|NCT04870957|579543115|FG003|T2 (Randomization) - T3|Adverse Event|0|||
160495928|NCT04870957|579543116|FG004|T2 (Randomization) - T3|Adverse Event|0|||
160495929|NCT04870957|579543117|FG005|T2 (Randomization) - T3|Adverse Event|0|||
160495930|NCT04870957|579543112|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
160495931|NCT04870957|579543113|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
160495932|NCT04870957|579543114|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
160495933|NCT04870957|579543115|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
160495934|NCT04870957|579543116|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
160495935|NCT04870957|579543117|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
160495936|NCT04870957|579543112|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
160495937|NCT04870957|579543113|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
160615349|NCT01055457|579968332|FG001|Overall Study|Pregnancy|0|||
160615350|NCT01055457|579968333|FG002|Overall Study|Pregnancy|0|||
160615351|NCT01055457|579968334|FG003|Overall Study|Pregnancy|1|||
160495938|NCT04870957|579543114|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
160495939|NCT04870957|579543115|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
160495940|NCT04870957|579543116|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
160495941|NCT04870957|579543117|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
160495942|NCT04870957|579543112|FG000|T2 (Randomization) - T3|Physician Decision|0|||
160495943|NCT04870957|579543113|FG001|T2 (Randomization) - T3|Physician Decision|0|||
160615352|NCT01055457|579968335|FG004|Overall Study|Pregnancy|0|||
160615353|NCT01055457|579968336|FG005|Overall Study|Pregnancy|0|||
160615354|NCT01055457|579968337|FG006|Overall Study|Pregnancy|0|||
160615355|NCT01055457|579968338|FG007|Overall Study|Pregnancy|0|||
160615356|NCT01055457|579968339|FG008|Overall Study|Pregnancy|0|||
160615357|NCT01055457|579968340|FG009|Overall Study|Pregnancy|0|||
160615358|NCT01055457|579968331|FG000|Overall Study|Adverse Event|0|||
160615359|NCT01055457|579968332|FG001|Overall Study|Adverse Event|0|||
160615360|NCT01055457|579968333|FG002|Overall Study|Adverse Event|0|||
160615361|NCT01055457|579968334|FG003|Overall Study|Adverse Event|1|||
160615362|NCT01055457|579968335|FG004|Overall Study|Adverse Event|0|||
160615363|NCT01055457|579968336|FG005|Overall Study|Adverse Event|0|||
160615364|NCT01055457|579968337|FG006|Overall Study|Adverse Event|0|||
160615365|NCT01055457|579968338|FG007|Overall Study|Adverse Event|0|||
160615366|NCT01055457|579968339|FG008|Overall Study|Adverse Event|0|||
160615367|NCT01055457|579968340|FG009|Overall Study|Adverse Event|0|||
160615368|NCT01347840|579968343|FG000|Overall Study|Withdrawal by Subject|1|||
160615369|NCT01708915|579968346|FG000|Overall Study|Adverse Event|1|||
160615370|NCT01708915|579968347|FG001|Overall Study|Adverse Event|0|||
160615371|NCT01708915|579968348|FG002|Overall Study|Adverse Event|9|||
160615372|NCT01708915|579968349|FG003|Overall Study|Adverse Event|13|||
160615373|NCT01708915|579968346|FG000|Overall Study|Lack of Efficacy|84|||
160615374|NCT01708915|579968347|FG001|Overall Study|Lack of Efficacy|60|||
160615375|NCT01708915|579968348|FG002|Overall Study|Lack of Efficacy|35|||
160615376|NCT01708915|579968349|FG003|Overall Study|Lack of Efficacy|15|||
160615377|NCT01708915|579968346|FG000|Overall Study|Protocol Violation|0|||
160615378|NCT01708915|579968347|FG001|Overall Study|Protocol Violation|0|||
160615379|NCT01708915|579968348|FG002|Overall Study|Protocol Violation|0|||
160615380|NCT01708915|579968349|FG003|Overall Study|Protocol Violation|1|||
160615381|NCT01708915|579968346|FG000|Overall Study|Withdrawal by Subject|0|||
160615382|NCT01708915|579968347|FG001|Overall Study|Withdrawal by Subject|1|||
160615383|NCT01708915|579968348|FG002|Overall Study|Withdrawal by Subject|2|||
160615384|NCT01708915|579968349|FG003|Overall Study|Withdrawal by Subject|2|||
160615385|NCT01708915|579968346|FG000|Overall Study|Other reasons than stated above|1|||
160615386|NCT01708915|579968347|FG001|Overall Study|Other reasons than stated above|1|||
160615387|NCT01708915|579968348|FG002|Overall Study|Other reasons than stated above|0|||
160615388|NCT01708915|579968349|FG003|Overall Study|Other reasons than stated above|2|||
160615389|NCT01369069|579968350|FG000|Overall Study|Lost to Follow-up|8|||
160615390|NCT01369069|579968351|FG001|Overall Study|Lost to Follow-up|9|||
160615391|NCT01369069|579968350|FG000|Overall Study|Withdrawal by Subject|9|||
160615392|NCT01369069|579968351|FG001|Overall Study|Withdrawal by Subject|7|||
160615393|NCT01846208|579968353|FG000|Overall Study|Withdrew prior to treatment|1|||
160615394|NCT01846208|579968354|FG001|Overall Study|Withdrew prior to treatment|1|||
160615395|NCT01846208|579968355|FG002|Overall Study|Withdrew prior to treatment|1|||
160615396|NCT01846208|579968353|FG000|Overall Study|Dosing Symptoms|1|||
160615397|NCT01846208|579968354|FG001|Overall Study|Dosing Symptoms|2|||
160615398|NCT01846208|579968355|FG002|Overall Study|Dosing Symptoms|6|||
160615399|NCT01846208|579968353|FG000|Overall Study|Withdrawal by Subject|5|||
160615400|NCT01846208|579968354|FG001|Overall Study|Withdrawal by Subject|0|||
160615401|NCT01846208|579968355|FG002|Overall Study|Withdrawal by Subject|0|||
160615402|NCT01846208|579968353|FG000|Overall Study|Non-compliance|1|||
160615403|NCT01846208|579968354|FG001|Overall Study|Non-compliance|1|||
160615404|NCT01846208|579968355|FG002|Overall Study|Non-compliance|0|||
160615405|NCT01846208|579968353|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
160615406|NCT01846208|579968354|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
160615407|NCT01846208|579968355|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
160615408|NCT01846208|579968353|FG000|Overall Study|Refused SU OFC|0|||
160615409|NCT01846208|579968354|FG001|Overall Study|Refused SU OFC|0|||
160615410|NCT01846208|579968355|FG002|Overall Study|Refused SU OFC|1|||
160615411|NCT01268514|579968356|FG000|Overall Study|Adverse Event|20|||
160615412|NCT01268514|579968356|FG000|Overall Study|Death|8|||
160615413|NCT01268514|579968356|FG000|Overall Study|Lost to Follow-up|5|||
160615414|NCT01268514|579968356|FG000|Overall Study|Withdrawal by Subject|3|||
160615415|NCT01268514|579968356|FG000|Overall Study|Withdrawal by Surgeon|5|||
160615416|NCT01424306|579968357|FG000|Overall Study|Protocol Violation|0|||
160495944|NCT04870957|579543114|FG002|T2 (Randomization) - T3|Physician Decision|2|||
160615417|NCT01424306|579968358|FG001|Overall Study|Protocol Violation|0|||
160615418|NCT01424306|579968359|FG002|Overall Study|Protocol Violation|0|||
160615419|NCT01424306|579968360|FG003|Overall Study|Protocol Violation|0|||
160615420|NCT01424306|579968361|FG004|Overall Study|Protocol Violation|1|||
160615421|NCT01424306|579968362|FG005|Overall Study|Protocol Violation|0|||
160615422|NCT01432938|579968363|FG000|First Intervention|Protocol Violation|1|||
160615423|NCT01432938|579968364|FG001|First Intervention|Protocol Violation|0|||
160615424|NCT01432938|579968363|FG000|First Intervention|Physician Decision|1|||
160615425|NCT01432938|579968364|FG001|First Intervention|Physician Decision|0|||
160615426|NCT01432938|579968363|FG000|Second Intervention|Adverse Event|1|||
160495945|NCT04870957|579543115|FG003|T2 (Randomization) - T3|Physician Decision|1|||
160615427|NCT01432938|579968364|FG001|Second Intervention|Adverse Event|0|||
160615428|NCT01601873|579968368|FG000|Overall Study|Lost to Follow-up|2|||
160615429|NCT01601873|579968369|FG001|Overall Study|Lost to Follow-up|3|||
160615430|NCT01875874|579968370|FG000|Overall Study|Death|3|||
160615431|NCT02520141|579968371|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
160615432|NCT00703781|579968372|FG000|Overall Study|Withdrawal by Subject|1|||
160615433|NCT00703781|579968373|FG001|Overall Study|Withdrawal by Subject|2|||
160615434|NCT00703781|579968372|FG000|Overall Study|Cancelled surgery|1|||
160615435|NCT00703781|579968373|FG001|Overall Study|Cancelled surgery|0|||
160615436|NCT02168816|579968374|FG000|Overall Study|Lost to Follow-up|2|||
160615437|NCT02168816|579968375|FG001|Overall Study|Lost to Follow-up|2|||
160615438|NCT01225211|579968378|FG000|Overall Study|Adverse Event|0|||
160615439|NCT01225211|579968379|FG001|Overall Study|Adverse Event|0|||
160615440|NCT01225211|579968380|FG002|Overall Study|Adverse Event|1|||
160615441|NCT01225211|579968381|FG003|Overall Study|Adverse Event|0|||
160615442|NCT01225211|579968382|FG004|Overall Study|Adverse Event|0|||
160615443|NCT01225211|579968383|FG005|Overall Study|Adverse Event|0|||
160615444|NCT01225211|579968384|FG006|Overall Study|Adverse Event|0|||
160615445|NCT01225211|579968385|FG007|Overall Study|Adverse Event|0|||
160615446|NCT01225211|579968386|FG008|Overall Study|Adverse Event|0|||
160615447|NCT01225211|579968387|FG009|Overall Study|Adverse Event|1|||
160615448|NCT01225211|579968378|FG000|Overall Study|Withdrawal by Subject|0|||
160615449|NCT01225211|579968379|FG001|Overall Study|Withdrawal by Subject|0|||
160615450|NCT01225211|579968380|FG002|Overall Study|Withdrawal by Subject|0|||
160615451|NCT01225211|579968381|FG003|Overall Study|Withdrawal by Subject|0|||
160615452|NCT01225211|579968382|FG004|Overall Study|Withdrawal by Subject|0|||
160615453|NCT01225211|579968383|FG005|Overall Study|Withdrawal by Subject|0|||
160615454|NCT01225211|579968384|FG006|Overall Study|Withdrawal by Subject|1|||
160615455|NCT01225211|579968385|FG007|Overall Study|Withdrawal by Subject|0|||
160615456|NCT01225211|579968386|FG008|Overall Study|Withdrawal by Subject|1|||
160615457|NCT01225211|579968387|FG009|Overall Study|Withdrawal by Subject|3|||
160615458|NCT01225211|579968378|FG000|Overall Study|Other|0|||
160615459|NCT01225211|579968379|FG001|Overall Study|Other|0|||
160615460|NCT01225211|579968380|FG002|Overall Study|Other|0|||
160615461|NCT01225211|579968381|FG003|Overall Study|Other|0|||
160615462|NCT01225211|579968382|FG004|Overall Study|Other|0|||
160615463|NCT01225211|579968383|FG005|Overall Study|Other|0|||
160615464|NCT01225211|579968384|FG006|Overall Study|Other|0|||
160615465|NCT01225211|579968385|FG007|Overall Study|Other|0|||
160615466|NCT01225211|579968386|FG008|Overall Study|Other|0|||
160615467|NCT01225211|579968387|FG009|Overall Study|Other|1|||
160615468|NCT01984294|579968390|FG000|Overall Study|Randomized but Never Treated|0|||
160615469|NCT01984294|579968391|FG001|Overall Study|Randomized but Never Treated|0|||
160615470|NCT01984294|579968392|FG002|Overall Study|Randomized but Never Treated|1|||
160615471|NCT01984294|579968390|FG000|Overall Study|Lack of Efficacy|4|||
160615472|NCT01984294|579968391|FG001|Overall Study|Lack of Efficacy|2|||
160615473|NCT01984294|579968392|FG002|Overall Study|Lack of Efficacy|6|||
160615474|NCT01984294|579968390|FG000|Overall Study|Adverse Event|0|||
160615475|NCT01984294|579968391|FG001|Overall Study|Adverse Event|1|||
160615476|NCT01984294|579968392|FG002|Overall Study|Adverse Event|0|||
160615477|NCT00537810|579968399|FG000|Overall Study|Withdrawal by Subject|4|||
160615478|NCT00537810|579968400|FG001|Overall Study|Withdrawal by Subject|11|||
160615479|NCT00537810|579968401|FG002|Overall Study|Withdrawal by Subject|4|||
160615480|NCT00537810|579968402|FG003|Overall Study|Withdrawal by Subject|3|||
160615481|NCT00537810|579968399|FG000|Overall Study|Medically withdrawn|2|||
160615482|NCT00537810|579968400|FG001|Overall Study|Medically withdrawn|2|||
160615483|NCT00537810|579968401|FG002|Overall Study|Medically withdrawn|0|||
160615484|NCT00537810|579968402|FG003|Overall Study|Medically withdrawn|1|||
160615485|NCT03452397|579968403|FG000|Overall Study|Adverse Event|1|||
160615486|NCT03452397|579968404|FG001|Overall Study|Adverse Event|0|||
160615487|NCT03452397|579968405|FG002|Overall Study|Adverse Event|0|||
160615488|NCT03452397|579968406|FG003|Overall Study|Adverse Event|0|||
160615489|NCT03452397|579968403|FG000|Overall Study|Administrative reason|0|||
160615490|NCT03452397|579968404|FG001|Overall Study|Administrative reason|0|||
160615491|NCT03452397|579968405|FG002|Overall Study|Administrative reason|1|||
160615492|NCT03452397|579968406|FG003|Overall Study|Administrative reason|1|||
160615493|NCT03452397|579968403|FG000|Overall Study|Withdrawal by Subject|0|||
160615494|NCT03452397|579968404|FG001|Overall Study|Withdrawal by Subject|0|||
160615495|NCT03452397|579968405|FG002|Overall Study|Withdrawal by Subject|1|||
160615496|NCT03452397|579968406|FG003|Overall Study|Withdrawal by Subject|0|||
160615497|NCT00410514|579968407|FG000|Overall Study|Adverse Event|2|||
160615498|NCT00410514|579968408|FG001|Overall Study|Adverse Event|2|||
160615499|NCT00410514|579968409|FG002|Overall Study|Adverse Event|2|||
160615500|NCT00410514|579968407|FG000|Overall Study|Protocol Violation|0|||
160615501|NCT00410514|579968408|FG001|Overall Study|Protocol Violation|1|||
160615502|NCT00410514|579968409|FG002|Overall Study|Protocol Violation|1|||
160615503|NCT00410514|579968407|FG000|Overall Study|Lost to Follow-up|0|||
160615504|NCT00410514|579968408|FG001|Overall Study|Lost to Follow-up|0|||
160615505|NCT00410514|579968409|FG002|Overall Study|Lost to Follow-up|2|||
160615506|NCT00410514|579968407|FG000|Overall Study|Non-compliant with study procedures|0|||
160615507|NCT00410514|579968408|FG001|Overall Study|Non-compliant with study procedures|0|||
160615508|NCT00410514|579968409|FG002|Overall Study|Non-compliant with study procedures|2|||
160615509|NCT02449915|579968411|FG000|Overall Study|Exclusion criteria - drug use|1|||
160495946|NCT04870957|579543116|FG004|T2 (Randomization) - T3|Physician Decision|0|||
160495947|NCT04870957|579543117|FG005|T2 (Randomization) - T3|Physician Decision|0|||
160495948|NCT04870957|579543112|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
160495949|NCT04870957|579543113|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
160495950|NCT04870957|579543114|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
160495951|NCT04870957|579543115|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
160495952|NCT04870957|579543116|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
160495953|NCT04870957|579543117|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
160495954|NCT04870957|579543112|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
160495955|NCT04870957|579543113|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
160495956|NCT04870957|579543114|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
160495957|NCT04870957|579543115|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
160495958|NCT04870957|579543116|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
160495959|NCT04870957|579543117|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
160495960|NCT04870957|579543112|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
160495961|NCT04870957|579543113|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
160495962|NCT04870957|579543114|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
160495963|NCT04870957|579543115|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
160495964|NCT04870957|579543116|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
160495965|NCT04870957|579543117|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
160495966|NCT04870957|579543112|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
160495967|NCT04870957|579543113|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
160495968|NCT04870957|579543114|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
160495969|NCT04870957|579543115|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
160495970|NCT04870957|579543116|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
160495971|NCT04870957|579543117|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
160495972|NCT04870957|579543112|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
160495973|NCT04870957|579543113|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
160495974|NCT04870957|579543114|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
160495975|NCT04870957|579543115|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
160495976|NCT04870957|579543116|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
160495977|NCT04870957|579543117|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
160495978|NCT04870957|579543112|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
160495979|NCT04870957|579543113|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
160495980|NCT04870957|579543114|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
160495981|NCT04870957|579543115|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
160495982|NCT04870957|579543116|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
160495983|NCT04870957|579543117|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
160495984|NCT04870957|579543112|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
160495985|NCT04870957|579543113|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
160495986|NCT04870957|579543114|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
160495987|NCT04870957|579543115|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
160495988|NCT04870957|579543116|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
160495989|NCT04870957|579543117|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
160495990|NCT04870957|579543112|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
160495991|NCT04870957|579543113|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
160495992|NCT04870957|579543114|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
160495993|NCT04870957|579543115|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
160495994|NCT04870957|579543116|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
160495995|NCT04870957|579543117|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
160495996|NCT04870957|579543112|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
160495997|NCT04870957|579543113|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
160495998|NCT04870957|579543114|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
160495999|NCT04870957|579543115|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
160496000|NCT04870957|579543116|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
160496001|NCT04870957|579543117|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
160496002|NCT04340843|579543120|FG000|Overall Study|Adverse Event|0|||
160496003|NCT04340843|579543121|FG001|Overall Study|Adverse Event|2|||
160496004|NCT04340843|579543120|FG000|Overall Study|Withdrawal by Subject|0|||
160496005|NCT04340843|579543121|FG001|Overall Study|Withdrawal by Subject|2|||
160496006|NCT03733899|579543126|FG000|Period 1|Protocol Violation|0|||
160496007|NCT03733899|579543127|FG001|Period 1|Protocol Violation|0|||
160496008|NCT03733899|579543128|FG002|Period 1|Protocol Violation|0|||
160496009|NCT03733899|579543129|FG003|Period 1|Protocol Violation|0|||
160496010|NCT03733899|579543130|FG004|Period 1|Protocol Violation|0|||
160496011|NCT03733899|579543131|FG005|Period 1|Protocol Violation|1|||
160496012|NCT03733899|579543126|FG000|Period 2|Unscuccessful Treatment|0|||
160496013|NCT03733899|579543127|FG001|Period 2|Unscuccessful Treatment|1|||
160496014|NCT03733899|579543128|FG002|Period 2|Unscuccessful Treatment|0|||
160496015|NCT03733899|579543129|FG003|Period 2|Unscuccessful Treatment|0|||
160496016|NCT03733899|579543130|FG004|Period 2|Unscuccessful Treatment|0|||
160496017|NCT03733899|579543131|FG005|Period 2|Unscuccessful Treatment|0|||
160496018|NCT03733899|579543126|FG000|Period 3|Withdrawal by Subject|1|||
160496019|NCT03733899|579543127|FG001|Period 3|Withdrawal by Subject|0|||
160615510|NCT02449915|579968412|FG001|Overall Study|Exclusion criteria - drug use|0|||
160615511|NCT02449915|579968411|FG000|Overall Study|Withdrawal by Subject|0|||
160615512|NCT02449915|579968412|FG001|Overall Study|Withdrawal by Subject|2|||
160615513|NCT02449915|579968411|FG000|Overall Study|Intraoperative surgical findings|1|||
160615514|NCT02449915|579968412|FG001|Overall Study|Intraoperative surgical findings|1|||
160615515|NCT02449915|579968411|FG000|Overall Study|Abnormal preop lab|0|||
160615516|NCT02449915|579968412|FG001|Overall Study|Abnormal preop lab|1|||
160615517|NCT01436357|579968413|FG000|Overall Study|Death|5|||
160615518|NCT01436357|579968414|FG001|Overall Study|Death|1|||
160615519|NCT01436357|579968413|FG000|Overall Study|Enrolled but not vaccinated|1|||
160615520|NCT01436357|579968414|FG001|Overall Study|Enrolled but not vaccinated|1|||
160615521|NCT01436357|579968413|FG000|Overall Study|Incarceration|18|||
160615522|NCT01436357|579968414|FG001|Overall Study|Incarceration|20|||
160615523|NCT01436357|579968413|FG000|Overall Study|Lost to Follow-up|67|||
160615524|NCT01436357|579968414|FG001|Overall Study|Lost to Follow-up|61|||
160615525|NCT01436357|579968413|FG000|Overall Study|Protocol Violation|1|||
160615526|NCT01436357|579968414|FG001|Overall Study|Protocol Violation|0|||
160615527|NCT01436357|579968413|FG000|Overall Study|Withdrawal by Subject|26|||
160615528|NCT01436357|579968414|FG001|Overall Study|Withdrawal by Subject|38|||
160615529|NCT01436357|579968413|FG000|Overall Study|Physician Decision|3|||
160615530|NCT01436357|579968414|FG001|Overall Study|Physician Decision|4|||
160615531|NCT01436357|579968413|FG000|Overall Study|Moved out of area|1|||
160615532|NCT01436357|579968414|FG001|Overall Study|Moved out of area|2|||
160615533|NCT01436357|579968413|FG000|Overall Study|Subject in rehab|0|||
160615534|NCT01436357|579968414|FG001|Overall Study|Subject in rehab|1|||
160615535|NCT00631969|579968424|FG000|Overall Study|Adverse Event|3|||
160615536|NCT00631969|579968425|FG001|Overall Study|Adverse Event|1|||
160615537|NCT00631969|579968424|FG000|Overall Study|Lack of Efficacy|2|||
160615538|NCT00631969|579968425|FG001|Overall Study|Lack of Efficacy|8|||
160615539|NCT00631969|579968424|FG000|Overall Study|Lost to Follow-up|2|||
160615540|NCT00631969|579968425|FG001|Overall Study|Lost to Follow-up|1|||
160615541|NCT00631969|579968424|FG000|Overall Study|Protocol Violation|1|||
160615542|NCT00631969|579968425|FG001|Overall Study|Protocol Violation|1|||
160615543|NCT00631969|579968424|FG000|Overall Study|Consent Withdrawn|5|||
160615544|NCT00631969|579968425|FG001|Overall Study|Consent Withdrawn|7|||
160615545|NCT00631969|579968424|FG000|Overall Study|Noncompliant With Study Medication|0|||
160615546|NCT00631969|579968425|FG001|Overall Study|Noncompliant With Study Medication|1|||
160615547|NCT00631969|579968424|FG000|Overall Study|No Drug Exposure|2|||
160615548|NCT00631969|579968425|FG001|Overall Study|No Drug Exposure|2|||
160615549|NCT04223778|579968426|FG000|Overall Study|Death|1|||
160615550|NCT04223778|579968427|FG001|Overall Study|Death|1|||
160615551|NCT04223778|579968426|FG000|Overall Study|Lost to Follow-up|4|||
160615552|NCT04223778|579968427|FG001|Overall Study|Lost to Follow-up|5|||
160615553|NCT04223778|579968426|FG000|Overall Study|Physician Decision|10|||
160615554|NCT04223778|579968427|FG001|Overall Study|Physician Decision|6|||
160615555|NCT04223778|579968426|FG000|Overall Study|Withdrawal by Subject|35|||
160615556|NCT04223778|579968427|FG001|Overall Study|Withdrawal by Subject|17|||
160615557|NCT04223778|579968426|FG000|Overall Study|Not Reported|7|||
160615558|NCT04223778|579968427|FG001|Overall Study|Not Reported|8|||
160615559|NCT03893630|579968430|FG000|Overall Study|Lost to Follow-up|5|||
160615560|NCT03893630|579968431|FG001|Overall Study|Lost to Follow-up|4|||
160615561|NCT03893630|579968432|FG002|Overall Study|Lost to Follow-up|2|||
160615562|NCT03893630|579968430|FG000|Overall Study|Withdrawal by Subject|3|||
160615563|NCT03893630|579968431|FG001|Overall Study|Withdrawal by Subject|6|||
160615564|NCT03893630|579968432|FG002|Overall Study|Withdrawal by Subject|3|||
160615565|NCT03893630|579968430|FG000|Overall Study|Discontinued Intervention|0|||
160615566|NCT03893630|579968431|FG001|Overall Study|Discontinued Intervention|4|||
160615567|NCT03893630|579968432|FG002|Overall Study|Discontinued Intervention|2|||
160615568|NCT02390167|579969840|FG000|Overall Study|Lost to Follow-up|1|||
160615569|NCT01265719|579969842|FG000|Overall Study|Does not meet entrance criteria|0|||
160615570|NCT01265719|579969843|FG001|Overall Study|Does not meet entrance criteria|3|||
160615571|NCT01265719|579969842|FG000|Overall Study|Other reasons|2|||
160615572|NCT01265719|579969843|FG001|Overall Study|Other reasons|0|||
160615573|NCT01265719|579969842|FG000|Overall Study|Withdrawal by Subject|8|||
160615574|NCT01265719|579969843|FG001|Overall Study|Withdrawal by Subject|3|||
160615575|NCT01265719|579969842|FG000|Overall Study|Lost to Follow-up|2|||
160661549|NCT05093205|580144134|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
160615576|NCT01265719|579969843|FG001|Overall Study|Lost to Follow-up|7|||
160615577|NCT01265719|579969842|FG000|Overall Study|Adverse Event|2|||
160615578|NCT01265719|579969843|FG001|Overall Study|Adverse Event|0|||
160615579|NCT00003389|579969844|FG000|Overall Study|Disease progression|6|||
160615580|NCT00003389|579969845|FG001|Overall Study|Disease progression|1|||
160615581|NCT00003389|579969844|FG000|Overall Study|Adverse Event|13|||
160615582|NCT00003389|579969845|FG001|Overall Study|Adverse Event|2|||
160496020|NCT03733899|579543128|FG002|Period 3|Withdrawal by Subject|0|||
160615583|NCT00003389|579969844|FG000|Overall Study|Death|0|||
160615584|NCT00003389|579969845|FG001|Overall Study|Death|3|||
160615585|NCT00003389|579969844|FG000|Overall Study|Withdrawal by Subject|12|||
160615586|NCT00003389|579969845|FG001|Overall Study|Withdrawal by Subject|5|||
160615587|NCT00003389|579969844|FG000|Overall Study|Alternative therapy|2|||
160615588|NCT00003389|579969845|FG001|Overall Study|Alternative therapy|1|||
160615589|NCT00003389|579969844|FG000|Overall Study|Complicating disease|1|||
160615590|NCT00003389|579969845|FG001|Overall Study|Complicating disease|0|||
160615591|NCT00003389|579969844|FG000|Overall Study|Off-treatment reason missing|31|||
160615592|NCT00003389|579969845|FG001|Overall Study|Off-treatment reason missing|21|||
160615593|NCT00003389|579969844|FG000|Overall Study|Ineligible|33|||
160615594|NCT00003389|579969845|FG001|Overall Study|Ineligible|27|||
160615595|NCT02554721|579969846|FG000|Overall Study|Adverse Event|1|||
160615596|NCT02554721|579969847|FG001|Overall Study|Adverse Event|0|||
160615597|NCT02554721|579969848|FG002|Overall Study|Adverse Event|0|||
160615598|NCT02554721|579969849|FG003|Overall Study|Adverse Event|0|||
160615599|NCT02554721|579969850|FG004|Overall Study|Adverse Event|1|||
160615600|NCT02554721|579969846|FG000|Overall Study|Noncompliance|0|||
160615601|NCT02554721|579969847|FG001|Overall Study|Noncompliance|0|||
160615602|NCT02554721|579969848|FG002|Overall Study|Noncompliance|0|||
160615603|NCT02554721|579969849|FG003|Overall Study|Noncompliance|0|||
160615604|NCT02554721|579969850|FG004|Overall Study|Noncompliance|1|||
160615605|NCT00626327|579969856|FG000|Overall Study|Withdrawal by Subject|21|||
160615606|NCT00626327|579969857|FG001|Overall Study|Withdrawal by Subject|29|||
160615607|NCT00626327|579969858|FG002|Overall Study|Withdrawal by Subject|30|||
160615608|NCT00626327|579969856|FG000|Overall Study|Adverse Event|1|||
160615609|NCT00626327|579969857|FG001|Overall Study|Adverse Event|0|||
160615610|NCT00626327|579969858|FG002|Overall Study|Adverse Event|0|||
160615611|NCT00626327|579969856|FG000|Overall Study|Lost to Follow-up|24|||
160615612|NCT00626327|579969857|FG001|Overall Study|Lost to Follow-up|21|||
160615613|NCT00626327|579969858|FG002|Overall Study|Lost to Follow-up|23|||
160496021|NCT03733899|579543129|FG003|Period 3|Withdrawal by Subject|0|||
160496022|NCT03733899|579543130|FG004|Period 3|Withdrawal by Subject|0|||
160496023|NCT03733899|579543131|FG005|Period 3|Withdrawal by Subject|0|||
160615614|NCT00626327|579969856|FG000|Overall Study|Inappropriate enrollment|4|||
160615615|NCT00626327|579969857|FG001|Overall Study|Inappropriate enrollment|5|||
160615616|NCT00626327|579969858|FG002|Overall Study|Inappropriate enrollment|3|||
160615617|NCT00626327|579969856|FG000|Overall Study|Administrative Reason|2|||
160615618|NCT00626327|579969857|FG001|Overall Study|Administrative Reason|0|||
160615619|NCT00626327|579969858|FG002|Overall Study|Administrative Reason|6|||
160615620|NCT00626327|579969856|FG000|Overall Study|Protocol Violation|26|||
160615621|NCT00626327|579969857|FG001|Overall Study|Protocol Violation|4|||
160615622|NCT00626327|579969858|FG002|Overall Study|Protocol Violation|26|||
160615623|NCT00945945|579969859|FG000|Overall Study|Adverse Event|15|||
160615624|NCT00945945|579969860|FG001|Overall Study|Adverse Event|35|||
160615625|NCT00945945|579969859|FG000|Overall Study|Withdrawal by Subject|7|||
160615626|NCT00945945|579969860|FG001|Overall Study|Withdrawal by Subject|10|||
160615627|NCT00945945|579969859|FG000|Overall Study|Lost to Follow-up|4|||
160615628|NCT00945945|579969860|FG001|Overall Study|Lost to Follow-up|5|||
160615629|NCT00945945|579969859|FG000|Overall Study|Lack of Efficacy|6|||
160615630|NCT00945945|579969860|FG001|Overall Study|Lack of Efficacy|2|||
160615631|NCT00945945|579969859|FG000|Overall Study|Protocol Violation|4|||
160615632|NCT00945945|579969860|FG001|Overall Study|Protocol Violation|2|||
160615633|NCT00945945|579969859|FG000|Overall Study|Entry Criteria Not Met|0|||
160615634|NCT00945945|579969860|FG001|Overall Study|Entry Criteria Not Met|1|||
160615635|NCT03347279|579969863|FG000|Overall Study|Withdrawal by Subject|8|||
160615636|NCT03347279|579969864|FG001|Overall Study|Withdrawal by Subject|15|||
160615637|NCT03347279|579969863|FG000|Overall Study|Death|0|||
160615638|NCT03347279|579969864|FG001|Overall Study|Death|2|||
160661550|NCT05093205|580144135|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
160496024|NCT02859064|579544939|FG000|Overall Study|Progressive Disease|3|||
160496025|NCT02859064|579544939|FG000|Overall Study|Physician Decision|1|||
160496026|NCT02859064|579544939|FG000|Overall Study|Withdrawal by Subject|1|||
160496027|NCT02859064|579544939|FG000|Overall Study|Death|1|||
160496028|NCT00667459|579544943|FG000|Overall Study|Death|0|||
160496029|NCT00667459|579544944|FG001|Overall Study|Death|2|||
160496030|NCT00667459|579544943|FG000|Overall Study|Lost to Follow-up|8|||
160496031|NCT00667459|579544944|FG001|Overall Study|Lost to Follow-up|43|||
160615639|NCT03347279|579969863|FG000|Overall Study|Lost to Follow-up|5|||
160615640|NCT03347279|579969864|FG001|Overall Study|Lost to Follow-up|2|||
160615641|NCT03347279|579969863|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
160615642|NCT03347279|579969864|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
160496032|NCT02568397|579544945|FG000|Period 2|Withdrawal by Subject|0|||
160496033|NCT02568397|579544946|FG001|Period 2|Withdrawal by Subject|1|||
160615643|NCT03818399|579969865|FG000|Overall Study|Lost to Follow-up|11|||
160615644|NCT03818399|579969865|FG000|Overall Study|Withdrawal by Subject|1|||
160615645|NCT03818399|579969865|FG000|Overall Study|Protocol Violation|2|||
160615646|NCT04880642|579969866|FG000|Randomization|Withdrawal by Subject|2|||
160615647|NCT04880642|579969867|FG001|Randomization|Withdrawal by Subject|3|||
160615648|NCT04880642|579969866|FG000|Treatment Period|Adverse Event|0|||
160496034|NCT02568397|579544945|FG000|Period 2|Physician Decision|0|||
160496035|NCT02568397|579544946|FG001|Period 2|Physician Decision|1|||
160615649|NCT04880642|579969867|FG001|Treatment Period|Adverse Event|1|||
160615650|NCT04880642|579969866|FG000|Treatment Period|Death|6|||
160615651|NCT04880642|579969867|FG001|Treatment Period|Death|6|||
160615652|NCT04880642|579969866|FG000|Treatment Period|Lost to Follow-up|1|||
160615653|NCT04880642|579969867|FG001|Treatment Period|Lost to Follow-up|0|||
160615654|NCT04880642|579969866|FG000|Treatment Period|Protocol Violation|0|||
160615655|NCT04880642|579969867|FG001|Treatment Period|Protocol Violation|1|||
160615656|NCT04880642|579969866|FG000|Treatment Period|Withdrawal by Subject|5|||
160615657|NCT04880642|579969867|FG001|Treatment Period|Withdrawal by Subject|3|||
160615658|NCT04880642|579969866|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
160615659|NCT04880642|579969867|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
160615660|NCT04880642|579969866|FG000|Follow-up|Death|4|||
160615661|NCT04880642|579969867|FG001|Follow-up|Death|3|||
160615662|NCT04880642|579969866|FG000|Follow-up|Withdrawal by Subject|1|||
160615663|NCT04880642|579969867|FG001|Follow-up|Withdrawal by Subject|0|||
160615664|NCT03228836|579969869|FG000|Overall Study|Adverse Event|3|||
160615665|NCT03228836|579969869|FG000|Overall Study|Withdrawal by Subject|1|||
160615666|NCT03228836|579969869|FG000|Overall Study|Death|1|||
160615667|NCT03228836|579969869|FG000|Overall Study|Physician Decision|1|||
160615668|NCT03228836|579969869|FG000|Overall Study|Disease Progression|7|||
160615669|NCT03228836|579969869|FG000|Overall Study|Other|4|||
160615670|NCT00948389|579969870|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
160615671|NCT00948389|579969871|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
160615672|NCT00948389|579969872|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
160615673|NCT00948389|579969873|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
160615674|NCT00948389|579969874|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
160615675|NCT00948389|579969870|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
160615676|NCT00948389|579969871|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
160615677|NCT00948389|579969872|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
160615678|NCT00948389|579969873|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
160615679|NCT00948389|579969874|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
160615680|NCT00948389|579969870|FG000|Overall Study|Both Progression and Toxicity|1|||
160615681|NCT00948389|579969871|FG001|Overall Study|Both Progression and Toxicity|0|||
160615682|NCT00948389|579969872|FG002|Overall Study|Both Progression and Toxicity|0|||
160615683|NCT00948389|579969873|FG003|Overall Study|Both Progression and Toxicity|0|||
160615684|NCT00948389|579969874|FG004|Overall Study|Both Progression and Toxicity|0|||
160615685|NCT03018340|579969877|FG000|Overall Study|Adverse Event|1|||
160615686|NCT03018340|579969878|FG001|Overall Study|Adverse Event|2|||
160615687|NCT03018340|579969877|FG000|Overall Study|Withdrawal by Subject|0|||
160615688|NCT03018340|579969878|FG001|Overall Study|Withdrawal by Subject|8|||
160615689|NCT03018340|579969877|FG000|Overall Study|Lack of Efficacy|0|||
160615690|NCT03018340|579969878|FG001|Overall Study|Lack of Efficacy|1|||
160615691|NCT03018340|579969877|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
160615692|NCT03018340|579969878|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
160615693|NCT03018340|579969877|FG000|Overall Study|Lost to Follow-up|1|||
160615694|NCT03018340|579969878|FG001|Overall Study|Lost to Follow-up|7|||
160615695|NCT03018340|579969877|FG000|Overall Study|Protocol Violation|3|||
160615696|NCT03018340|579969878|FG001|Overall Study|Protocol Violation|7|||
160615697|NCT03018340|579969877|FG000|Overall Study|Not further specified|0|||
160615698|NCT03018340|579969878|FG001|Overall Study|Not further specified|1|||
160615699|NCT04652102|579969879|FG000|Overall Study|Adverse Event|14|||
160615700|NCT04652102|579969880|FG001|Overall Study|Adverse Event|13|||
160615701|NCT04652102|579969879|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
160615702|NCT04652102|579969880|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
160615703|NCT04652102|579969879|FG000|Overall Study|Physician Decision|78|||
160615704|NCT04652102|579969880|FG001|Overall Study|Physician Decision|40|||
160615705|NCT04652102|579969879|FG000|Overall Study|Study Ended by Sponsor|64|||
160615706|NCT04652102|579969880|FG001|Overall Study|Study Ended by Sponsor|17|||
160615707|NCT04652102|579969879|FG000|Overall Study|Withdrawal by Subject|4625|||
160615708|NCT04652102|579969880|FG001|Overall Study|Withdrawal by Subject|5594|||
160615709|NCT04652102|579969879|FG000|Overall Study|Lost to Follow-up|2019|||
160615710|NCT04652102|579969880|FG001|Overall Study|Lost to Follow-up|1082|||
160615711|NCT04652102|579969879|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
160615712|NCT04652102|579969880|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
160615713|NCT04652102|579969879|FG000|Overall Study|Miscellaneous|80|||
160615714|NCT04652102|579969880|FG001|Overall Study|Miscellaneous|64|||
160615715|NCT02192190|579969881|FG000|Overall Study|Adverse Event|1|||
160615716|NCT02192190|579969882|FG001|Overall Study|Adverse Event|1|||
160615717|NCT02192190|579969883|FG002|Overall Study|Adverse Event|0|||
160615718|NCT02192190|579969884|FG003|Overall Study|Adverse Event|0|||
160615719|NCT02192190|579969885|FG004|Overall Study|Adverse Event|0|||
160615720|NCT02192190|579969886|FG005|Overall Study|Adverse Event|0|||
160615721|NCT02192190|579969881|FG000|Overall Study|Lost to Follow-up|3|||
160615722|NCT02192190|579969882|FG001|Overall Study|Lost to Follow-up|3|||
160615723|NCT02192190|579969883|FG002|Overall Study|Lost to Follow-up|2|||
160615724|NCT02192190|579969884|FG003|Overall Study|Lost to Follow-up|1|||
160615725|NCT02192190|579969885|FG004|Overall Study|Lost to Follow-up|4|||
160496036|NCT00078377|579544947|FG000|Overall Study|Adverse Event|2|||
160496037|NCT00078377|579544948|FG001|Overall Study|Adverse Event|5|||
160496038|NCT00078377|579544949|FG002|Overall Study|Adverse Event|1|||
160496039|NCT00078377|579544947|FG000|Overall Study|Lack of Efficacy|2|||
160496040|NCT00078377|579544948|FG001|Overall Study|Lack of Efficacy|0|||
160496041|NCT00078377|579544949|FG002|Overall Study|Lack of Efficacy|2|||
160496042|NCT00078377|579544947|FG000|Overall Study|Lost to Follow-up|0|||
160496043|NCT00078377|579544948|FG001|Overall Study|Lost to Follow-up|1|||
160496044|NCT00078377|579544949|FG002|Overall Study|Lost to Follow-up|1|||
160496045|NCT00078377|579544947|FG000|Overall Study|Physician Decision|2|||
160496046|NCT00078377|579544948|FG001|Overall Study|Physician Decision|0|||
160496047|NCT00078377|579544949|FG002|Overall Study|Physician Decision|0|||
160496048|NCT00078377|579544947|FG000|Overall Study|Withdrawal by Subject|3|||
160496049|NCT00078377|579544948|FG001|Overall Study|Withdrawal by Subject|4|||
160496050|NCT00078377|579544949|FG002|Overall Study|Withdrawal by Subject|4|||
160496051|NCT00078377|579544947|FG000|Overall Study|Miscellaneous|2|||
160496052|NCT00078377|579544948|FG001|Overall Study|Miscellaneous|6|||
160496053|NCT00078377|579544949|FG002|Overall Study|Miscellaneous|1|||
160496054|NCT00581893|579544950|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
160615726|NCT02192190|579969886|FG005|Overall Study|Lost to Follow-up|3|||
160496055|NCT00581893|579544951|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
160496056|NCT01381575|579544952|FG000|Overall Study|Serious Adverse Event|1|||
160615727|NCT02192190|579969881|FG000|Overall Study|Physician Decision|2|||
160615728|NCT02192190|579969882|FG001|Overall Study|Physician Decision|0|||
160615729|NCT02192190|579969883|FG002|Overall Study|Physician Decision|0|||
160615730|NCT02192190|579969884|FG003|Overall Study|Physician Decision|0|||
160615731|NCT02192190|579969885|FG004|Overall Study|Physician Decision|0|||
160615732|NCT02192190|579969886|FG005|Overall Study|Physician Decision|0|||
160615733|NCT02192190|579969881|FG000|Overall Study|Terminated by Sponsor|43|||
160615734|NCT02192190|579969882|FG001|Overall Study|Terminated by Sponsor|23|||
160496057|NCT01381575|579544953|FG001|Overall Study|Serious Adverse Event|0|||
160496058|NCT01381575|579544954|FG002|Overall Study|Serious Adverse Event|0|||
160496059|NCT01381575|579544952|FG000|Overall Study|Non-Serious Adverse Event|0|||
160496060|NCT01381575|579544953|FG001|Overall Study|Non-Serious Adverse Event|0|||
160496061|NCT01381575|579544954|FG002|Overall Study|Non-Serious Adverse Event|1|||
160496062|NCT01381575|579544952|FG000|Overall Study|Protocol Violation|0|||
160496063|NCT01381575|579544953|FG001|Overall Study|Protocol Violation|1|||
160496064|NCT01381575|579544954|FG002|Overall Study|Protocol Violation|1|||
160496065|NCT01381575|579544952|FG000|Overall Study|Withdrawal by Subject|15|||
160496066|NCT01381575|579544953|FG001|Overall Study|Withdrawal by Subject|9|||
160496067|NCT01381575|579544954|FG002|Overall Study|Withdrawal by Subject|7|||
160496068|NCT01381575|579544952|FG000|Overall Study|Migrated/moved from study area|2|||
160496069|NCT01381575|579544953|FG001|Overall Study|Migrated/moved from study area|12|||
160496070|NCT01381575|579544954|FG002|Overall Study|Migrated/moved from study area|2|||
160615735|NCT02192190|579969883|FG002|Overall Study|Terminated by Sponsor|20|||
160615736|NCT02192190|579969884|FG003|Overall Study|Terminated by Sponsor|23|||
160496071|NCT01381575|579544952|FG000|Overall Study|Lost to Follow-up|8|||
160496072|NCT01381575|579544953|FG001|Overall Study|Lost to Follow-up|17|||
160661551|NCT05093205|580144136|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
160661552|NCT05093205|580144137|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
160661553|NCT05093205|580144138|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
160661554|NCT05093205|580144139|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
160661555|NCT05093205|580144140|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
160661556|NCT05093205|580144141|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
160661557|NCT05093205|580144129|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661558|NCT05093205|580144130|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661559|NCT05093205|580144131|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
160661560|NCT05093205|580144132|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661561|NCT05093205|580144133|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661562|NCT05093205|580144134|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661563|NCT05093205|580144135|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661564|NCT05093205|580144136|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661565|NCT05093205|580144137|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661566|NCT05093205|580144138|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661567|NCT05093205|580144139|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661568|NCT05093205|580144140|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661569|NCT05093205|580144141|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
160661570|NCT05093205|580144129|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
160661571|NCT05093205|580144130|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
160661572|NCT05093205|580144131|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
160661573|NCT05093205|580144132|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
160661574|NCT05093205|580144133|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
160661575|NCT05093205|580144134|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
160661576|NCT05093205|580144135|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
160661577|NCT05093205|580144136|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
160661578|NCT05093205|580144137|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
160661579|NCT05093205|580144138|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
160661580|NCT05093205|580144139|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
160661581|NCT05093205|580144140|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
160661582|NCT05093205|580144141|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
160661583|NCT05093205|580144129|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
160661584|NCT05093205|580144130|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
160661585|NCT05093205|580144131|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
160661586|NCT05093205|580144132|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
160661587|NCT05093205|580144133|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
160661588|NCT05093205|580144134|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
160661589|NCT05093205|580144135|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
160661590|NCT05093205|580144136|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
160661591|NCT05093205|580144137|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
160661592|NCT05093205|580144138|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
160661593|NCT05093205|580144139|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
160661594|NCT05093205|580144140|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
160661595|NCT05093205|580144141|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
160661596|NCT05093205|580144129|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
160661597|NCT05093205|580144130|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
160661598|NCT05093205|580144131|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
160661599|NCT05093205|580144132|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
160661600|NCT05093205|580144133|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
160661601|NCT05093205|580144134|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
160661602|NCT05093205|580144135|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
160661603|NCT05093205|580144136|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
160661604|NCT05093205|580144137|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
160661605|NCT05093205|580144138|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
160615737|NCT02192190|579969885|FG004|Overall Study|Terminated by Sponsor|21|||
160615738|NCT02192190|579969886|FG005|Overall Study|Terminated by Sponsor|23|||
160615739|NCT02192190|579969881|FG000|Overall Study|Withdrawal by Subject|4|||
160615740|NCT02192190|579969882|FG001|Overall Study|Withdrawal by Subject|1|||
160615741|NCT02192190|579969883|FG002|Overall Study|Withdrawal by Subject|2|||
160615742|NCT02192190|579969884|FG003|Overall Study|Withdrawal by Subject|1|||
160615743|NCT02192190|579969885|FG004|Overall Study|Withdrawal by Subject|5|||
160615744|NCT02192190|579969886|FG005|Overall Study|Withdrawal by Subject|3|||
160615745|NCT02192190|579969881|FG000|Overall Study|Could not Keep Visit Schedule|1|||
160615746|NCT02192190|579969882|FG001|Overall Study|Could not Keep Visit Schedule|0|||
160661606|NCT05093205|580144139|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
160661607|NCT05093205|580144140|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
160661608|NCT05093205|580144141|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
160661609|NCT05093205|580144129|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
160661610|NCT05093205|580144130|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
160661611|NCT05093205|580144131|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
160661612|NCT05093205|580144132|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
160661613|NCT05093205|580144133|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
160615747|NCT02192190|579969883|FG002|Overall Study|Could not Keep Visit Schedule|0|||
160615748|NCT02192190|579969884|FG003|Overall Study|Could not Keep Visit Schedule|0|||
160615749|NCT02192190|579969885|FG004|Overall Study|Could not Keep Visit Schedule|0|||
160615750|NCT02192190|579969886|FG005|Overall Study|Could not Keep Visit Schedule|0|||
160615751|NCT02192190|579969881|FG000|Overall Study|Positive Drug Screen|0|||
160615752|NCT02192190|579969882|FG001|Overall Study|Positive Drug Screen|0|||
160615753|NCT02192190|579969883|FG002|Overall Study|Positive Drug Screen|0|||
160615754|NCT02192190|579969884|FG003|Overall Study|Positive Drug Screen|1|||
160615755|NCT02192190|579969885|FG004|Overall Study|Positive Drug Screen|0|||
160615756|NCT02192190|579969886|FG005|Overall Study|Positive Drug Screen|0|||
160615757|NCT02192190|579969881|FG000|Overall Study|Inadequate Pain Relief|0|||
160615758|NCT02192190|579969882|FG001|Overall Study|Inadequate Pain Relief|1|||
160615759|NCT02192190|579969883|FG002|Overall Study|Inadequate Pain Relief|1|||
160615760|NCT02192190|579969884|FG003|Overall Study|Inadequate Pain Relief|0|||
160615761|NCT02192190|579969885|FG004|Overall Study|Inadequate Pain Relief|0|||
160615762|NCT02192190|579969886|FG005|Overall Study|Inadequate Pain Relief|0|||
160615763|NCT00381706|579969887|FG000|Overall Study|Never treated|7|||
160615764|NCT00381706|579969888|FG001|Overall Study|Never treated|2|||
160615765|NCT00381706|579969889|FG002|Overall Study|Never treated|1|||
160615766|NCT02364999|579969890|FG000|Overall Study|Death|136|||
160615767|NCT02364999|579969891|FG001|Overall Study|Death|138|||
160615768|NCT02364999|579969890|FG000|Overall Study|Lost to Follow-up|10|||
160615769|NCT02364999|579969891|FG001|Overall Study|Lost to Follow-up|15|||
160615770|NCT02364999|579969890|FG000|Overall Study|Protocol Violation|3|||
160615771|NCT02364999|579969891|FG001|Overall Study|Protocol Violation|2|||
160615772|NCT02364999|579969890|FG000|Overall Study|Withdrawal by Subject|14|||
160615773|NCT02364999|579969891|FG001|Overall Study|Withdrawal by Subject|14|||
160615774|NCT02364999|579969890|FG000|Overall Study|Other|0|||
160615775|NCT02364999|579969891|FG001|Overall Study|Other|1|||
160615776|NCT02364999|579969890|FG000|Overall Study|Randomized but did not receive treatment|2|||
160615777|NCT02364999|579969891|FG001|Overall Study|Randomized but did not receive treatment|3|||
160615778|NCT01234337|579969892|FG000|Overall Study|Adverse Event|58|||
160615779|NCT01234337|579969893|FG001|Overall Study|Adverse Event|21|||
160615780|NCT01234337|579969892|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
160615781|NCT01234337|579969893|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
160615782|NCT01234337|579969892|FG000|Overall Study|Investi. decision not protocol driven|5|||
160615783|NCT01234337|579969893|FG001|Overall Study|Investi. decision not protocol driven|6|||
160615784|NCT01234337|579969892|FG000|Overall Study|Non-compliant with study medication|3|||
160615785|NCT01234337|579969893|FG001|Overall Study|Non-compliant with study medication|2|||
160615786|NCT01234337|579969892|FG000|Overall Study|Randomized but not treated|6|||
160615787|NCT01234337|579969893|FG001|Overall Study|Randomized but not treated|4|||
160615788|NCT01234337|579969892|FG000|Overall Study|Lost to Follow-up|0|||
160615789|NCT01234337|579969893|FG001|Overall Study|Lost to Follow-up|1|||
160615790|NCT01234337|579969892|FG000|Overall Study|Protocol Violation|2|||
160615791|NCT01234337|579969893|FG001|Overall Study|Protocol Violation|3|||
160615792|NCT01234337|579969892|FG000|Overall Study|Withdrawal by Subject|11|||
160615793|NCT01234337|579969893|FG001|Overall Study|Withdrawal by Subject|9|||
160615794|NCT01234337|579969892|FG000|Overall Study|Death|0|||
160615795|NCT01234337|579969893|FG001|Overall Study|Death|1|||
160615796|NCT01234337|579969892|FG000|Overall Study|Switch to commercial drug|0|||
160615797|NCT01234337|579969893|FG001|Overall Study|Switch to commercial drug|1|||
160615798|NCT00890201|579969897|FG000|Overall Study|Protocol Violation|5|||
160615799|NCT00890201|579969898|FG001|Overall Study|Protocol Violation|56|||
160615800|NCT02181504|579969899|FG000|Overall Study|Adverse Event|1|||
160615801|NCT02181504|579969900|FG001|Overall Study|Adverse Event|1|||
160615802|NCT02181504|579969901|FG002|Overall Study|Adverse Event|1|||
160615803|NCT00545584|579969908|FG000|Overall Study|Only one reason for discontinuation|62|||
160615804|NCT00545584|579969909|FG001|Overall Study|Only one reason for discontinuation|61|||
160615805|NCT00545584|579969910|FG002|Overall Study|Only one reason for discontinuation|48|||
160615806|NCT00545584|579969908|FG000|Overall Study|Two or more reasons for discontinuation|17|||
160615807|NCT00545584|579969909|FG001|Overall Study|Two or more reasons for discontinuation|19|||
160615808|NCT00545584|579969910|FG002|Overall Study|Two or more reasons for discontinuation|8|||
160615809|NCT00135694|579969916|FG000|Overall Study|Adverse Event|17|||
160615810|NCT00135694|579969917|FG001|Overall Study|Adverse Event|4|||
160615811|NCT00135694|579969918|FG002|Overall Study|Adverse Event|0|||
160615812|NCT00135694|579969916|FG000|Overall Study|Death|14|||
160615813|NCT00135694|579969917|FG001|Overall Study|Death|1|||
160615814|NCT00135694|579969918|FG002|Overall Study|Death|2|||
160615815|NCT00135694|579969916|FG000|Overall Study|Lost to Follow-up|8|||
160615816|NCT00135694|579969917|FG001|Overall Study|Lost to Follow-up|7|||
160615817|NCT00135694|579969918|FG002|Overall Study|Lost to Follow-up|1|||
160615818|NCT00135694|579969916|FG000|Overall Study|Withdrawal by Subject|41|||
160615819|NCT00135694|579969917|FG001|Overall Study|Withdrawal by Subject|7|||
160615820|NCT00135694|579969918|FG002|Overall Study|Withdrawal by Subject|4|||
160615821|NCT00135694|579969916|FG000|Overall Study|Protocol Violation|19|||
160615822|NCT00135694|579969917|FG001|Overall Study|Protocol Violation|1|||
160615823|NCT00135694|579969918|FG002|Overall Study|Protocol Violation|0|||
160615824|NCT00135694|579969916|FG000|Overall Study|Hepatitis C related reasons|39|||
160615825|NCT00135694|579969917|FG001|Overall Study|Hepatitis C related reasons|1|||
160615826|NCT00135694|579969918|FG002|Overall Study|Hepatitis C related reasons|0|||
160615827|NCT00135694|579969916|FG000|Overall Study|Ineligible for Random assignment|42|||
160615828|NCT00135694|579969917|FG001|Overall Study|Ineligible for Random assignment|0|||
160615829|NCT00135694|579969918|FG002|Overall Study|Ineligible for Random assignment|0|||
160615830|NCT02584660|579969919|FG000|Overall Study|Adverse Event|4|||
160615831|NCT02584660|579969920|FG001|Overall Study|Adverse Event|0|||
160615832|NCT02584660|579969919|FG000|Overall Study|Lost to Follow-up|3|||
160615833|NCT02584660|579969920|FG001|Overall Study|Lost to Follow-up|4|||
160615834|NCT02584660|579969919|FG000|Overall Study|Protocol Violation|0|||
160615835|NCT02584660|579969920|FG001|Overall Study|Protocol Violation|1|||
160615836|NCT02584660|579969919|FG000|Overall Study|Withdrawal by Subject|0|||
160615837|NCT02584660|579969920|FG001|Overall Study|Withdrawal by Subject|2|||
160615838|NCT02584660|579969919|FG000|Overall Study|Other|0|||
160615839|NCT02584660|579969920|FG001|Overall Study|Other|1|||
160615840|NCT00660816|579969921|FG000|Overall Study|Adverse Event|1|||
160615841|NCT00660816|579969922|FG001|Overall Study|Adverse Event|2|||
160615842|NCT00660816|579969921|FG000|Overall Study|Withdrawal by Subject|1|||
160615843|NCT00660816|579969922|FG001|Overall Study|Withdrawal by Subject|0|||
160615844|NCT00660816|579969921|FG000|Overall Study|Death|0|||
160615845|NCT00660816|579969922|FG001|Overall Study|Death|2|||
160615846|NCT00660816|579969921|FG000|Overall Study|Lack of Efficacy|1|||
160615847|NCT00660816|579969922|FG001|Overall Study|Lack of Efficacy|0|||
160615848|NCT00660816|579969921|FG000|Overall Study|Physician Decision|0|||
160615849|NCT00660816|579969922|FG001|Overall Study|Physician Decision|2|||
160615850|NCT00660816|579969921|FG000|Overall Study|Protocol Violation|1|||
160615851|NCT00660816|579969922|FG001|Overall Study|Protocol Violation|0|||
160615852|NCT00660816|579969921|FG000|Overall Study|Disease Progression|16|||
160615853|NCT00660816|579969922|FG001|Overall Study|Disease Progression|12|||
160615854|NCT00660816|579969921|FG000|Overall Study|Complicating Disease|0|||
160615855|NCT00660816|579969922|FG001|Overall Study|Complicating Disease|1|||
160615856|NCT00374452|579969923|FG000|Overall Study|Left clinic before intervention started|4|||
160615857|NCT00374452|579969924|FG001|Overall Study|Left clinic before intervention started|1|||
160615858|NCT00374452|579969923|FG000|Overall Study|Change in job role before intervention|0|||
160615859|NCT00374452|579969924|FG001|Overall Study|Change in job role before intervention|1|||
160615860|NCT00374452|579969923|FG000|Overall Study|Left clinic after intervention started|1|||
160615861|NCT00374452|579969924|FG001|Overall Study|Left clinic after intervention started|1|||
160615862|NCT00374452|579969923|FG000|Overall Study|Withdrawal by Subject|0|||
160615863|NCT00374452|579969924|FG001|Overall Study|Withdrawal by Subject|2|||
160615864|NCT00998985|579969928|FG000|Overall Study|Withdrawal by Subject|0|||
160615865|NCT00998985|579969929|FG001|Overall Study|Withdrawal by Subject|0|||
160615866|NCT00998985|579969930|FG002|Overall Study|Withdrawal by Subject|0|||
160615867|NCT00998985|579969931|FG003|Overall Study|Withdrawal by Subject|0|||
160615868|NCT00998985|579969932|FG004|Overall Study|Withdrawal by Subject|0|||
160615869|NCT00998985|579969933|FG005|Overall Study|Withdrawal by Subject|0|||
160615870|NCT00998985|579969934|FG006|Overall Study|Withdrawal by Subject|0|||
160615871|NCT00998985|579969935|FG007|Overall Study|Withdrawal by Subject|0|||
160615872|NCT00998985|579969936|FG008|Overall Study|Withdrawal by Subject|1|||
160615873|NCT00998985|579969937|FG009|Overall Study|Withdrawal by Subject|0|||
160615874|NCT00998985|579969938|FG010|Overall Study|Withdrawal by Subject|0|||
160615875|NCT00998985|579969939|FG011|Overall Study|Withdrawal by Subject|0|||
160615876|NCT00998985|579969940|FG012|Overall Study|Withdrawal by Subject|0|||
160615877|NCT00998985|579969941|FG013|Overall Study|Withdrawal by Subject|0|||
160615878|NCT00998985|579969928|FG000|Overall Study|Protocol Violation|0|||
160615879|NCT00998985|579969929|FG001|Overall Study|Protocol Violation|0|||
160615880|NCT00998985|579969930|FG002|Overall Study|Protocol Violation|0|||
160615881|NCT00998985|579969931|FG003|Overall Study|Protocol Violation|0|||
160615882|NCT00998985|579969932|FG004|Overall Study|Protocol Violation|0|||
160615883|NCT00998985|579969933|FG005|Overall Study|Protocol Violation|1|||
160496073|NCT01381575|579544954|FG002|Overall Study|Lost to Follow-up|9|||
160496074|NCT04546217|579544955|FG000|Overall Study|Withdrawal by Subject|2|||
160496075|NCT04546217|579544956|FG001|Overall Study|Withdrawal by Subject|0|||
160615884|NCT00998985|579969934|FG006|Overall Study|Protocol Violation|0|||
160661614|NCT05093205|580144134|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
160615885|NCT00998985|579969935|FG007|Overall Study|Protocol Violation|0|||
160615886|NCT00998985|579969936|FG008|Overall Study|Protocol Violation|0|||
160615887|NCT00998985|579969937|FG009|Overall Study|Protocol Violation|0|||
160615888|NCT00998985|579969938|FG010|Overall Study|Protocol Violation|0|||
160615889|NCT00998985|579969939|FG011|Overall Study|Protocol Violation|0|||
160615890|NCT00998985|579969940|FG012|Overall Study|Protocol Violation|0|||
160615891|NCT00998985|579969941|FG013|Overall Study|Protocol Violation|0|||
160615892|NCT02096471|579969947|FG000|Overall Study|Adverse Event|1|||
160615893|NCT02096471|579969947|FG000|Overall Study|Lack of Efficacy|7|||
160615894|NCT02096471|579969947|FG000|Overall Study|Withdrawal by Subject|3|||
160615895|NCT02096471|579969947|FG000|Overall Study|Non-Compliant|2|||
160615896|NCT03344562|579969948|FG000|Overall Study|Withdrawal by Subject|2|||
160615897|NCT03344562|579969949|FG001|Overall Study|Withdrawal by Subject|0|||
160615898|NCT02736474|579969953|FG000|Overall Study|Lost to Follow-up|0|||
160615899|NCT02736474|579969954|FG001|Overall Study|Lost to Follow-up|1|||
160615900|NCT02463331|579969955|FG000|Overall Study|Adverse Event|4|||
160615901|NCT02463331|579969956|FG001|Overall Study|Adverse Event|2|||
160615902|NCT02463331|579969955|FG000|Overall Study|Lost to Follow-up|1|||
160615903|NCT02463331|579969956|FG001|Overall Study|Lost to Follow-up|1|||
160615904|NCT02463331|579969955|FG000|Overall Study|Pregnancy|2|||
160615905|NCT02463331|579969956|FG001|Overall Study|Pregnancy|3|||
160615906|NCT02463331|579969955|FG000|Overall Study|Lack of Efficacy|6|||
160615907|NCT02463331|579969956|FG001|Overall Study|Lack of Efficacy|0|||
160615908|NCT02463331|579969955|FG000|Overall Study|Physician Decision|3|||
160615909|NCT02463331|579969956|FG001|Overall Study|Physician Decision|0|||
160615910|NCT03147495|579969957|FG000|Overall Study|Physician Decision|0|||
160615911|NCT03147495|579969958|FG001|Overall Study|Physician Decision|6|||
160615912|NCT02483611|579969959|FG000|Overall Study|Protocol Violation|0|||
160615913|NCT02483611|579969960|FG001|Overall Study|Protocol Violation|0|||
160615914|NCT02483611|579969961|FG002|Overall Study|Protocol Violation|1|||
160615915|NCT02608892|579969962|FG000|Overall Study|Lost to Follow-up|1|||
160615916|NCT02608892|579969963|FG001|Overall Study|Lost to Follow-up|0|||
160615917|NCT02590406|579969964|FG000|Overall Study|Adverse Event|1|||
160615918|NCT02590406|579969965|FG001|Overall Study|Adverse Event|0|||
160615919|NCT02590406|579969964|FG000|Overall Study|Saturometer malfunction|0|||
160615920|NCT02590406|579969965|FG001|Overall Study|Saturometer malfunction|1|||
160615921|NCT00877890|579969966|FG000|Overall Study|Adverse Event|6|||
160615922|NCT00877890|579969967|FG001|Overall Study|Adverse Event|6|||
160615923|NCT00877890|579969966|FG000|Overall Study|Lost to Follow-up|5|||
160615924|NCT00877890|579969967|FG001|Overall Study|Lost to Follow-up|5|||
160615925|NCT00877890|579969966|FG000|Overall Study|Protocol Violation|0|||
160615926|NCT00877890|579969967|FG001|Overall Study|Protocol Violation|1|||
160615927|NCT00877890|579969966|FG000|Overall Study|Withdrawal of Consent|6|||
160615928|NCT00877890|579969967|FG001|Overall Study|Withdrawal of Consent|12|||
160615929|NCT00877890|579969966|FG000|Overall Study|Investigator Decision|0|||
160615930|NCT00877890|579969967|FG001|Overall Study|Investigator Decision|2|||
160615931|NCT00877890|579969966|FG000|Overall Study|Loss of Glucose Control|3|||
160615932|NCT00877890|579969967|FG001|Overall Study|Loss of Glucose Control|4|||
160615933|NCT02036476|579969978|FG000|Overall Study|Withdrawal by Subject|2|||
160615934|NCT02036476|579969978|FG000|Overall Study|Progressive Disease|4|||
160615935|NCT02036476|579969978|FG000|Overall Study|Unacceptable Toxicity|2|||
160615936|NCT02698176|579969981|FG000|Overall Study|Progressive disease|4|||
160615937|NCT02698176|579969982|FG001|Overall Study|Progressive disease|3|||
160615938|NCT02698176|579969983|FG002|Overall Study|Progressive disease|1|||
160615939|NCT02698176|579969984|FG003|Overall Study|Progressive disease|0|||
160615940|NCT02698176|579969981|FG000|Overall Study|Adverse Event|2|||
160615941|NCT02698176|579969982|FG001|Overall Study|Adverse Event|0|||
160615942|NCT02698176|579969983|FG002|Overall Study|Adverse Event|0|||
160615943|NCT02698176|579969984|FG003|Overall Study|Adverse Event|0|||
160615944|NCT02698176|579969981|FG000|Overall Study|Clinical progression|3|||
160615945|NCT02698176|579969982|FG001|Overall Study|Clinical progression|0|||
160615946|NCT02698176|579969983|FG002|Overall Study|Clinical progression|0|||
160615947|NCT02698176|579969984|FG003|Overall Study|Clinical progression|0|||
160615948|NCT02985684|579969986|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
160615949|NCT02985684|579969986|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
160615950|NCT02985684|579969986|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
160615951|NCT01021293|579969993|FG000|Overall Study|Serious Adverse Event|2|||
160615952|NCT01021293|579969994|FG001|Overall Study|Serious Adverse Event|1|||
160615953|NCT01021293|579969993|FG000|Overall Study|Adverse Event|2|||
160615954|NCT01021293|579969994|FG001|Overall Study|Adverse Event|1|||
160615955|NCT01021293|579969993|FG000|Overall Study|Withdrawal by Subject|1|||
160615956|NCT01021293|579969994|FG001|Overall Study|Withdrawal by Subject|3|||
160615957|NCT01021293|579969993|FG000|Overall Study|Migrated/moved from study area|6|||
160615958|NCT01021293|579969994|FG001|Overall Study|Migrated/moved from study area|18|||
160615959|NCT01021293|579969993|FG000|Overall Study|Lost to Follow-up|1|||
160615960|NCT01021293|579969994|FG001|Overall Study|Lost to Follow-up|1|||
160615961|NCT00303602|579971118|FG000|Overall Study|Adverse Event|2|||
160615962|NCT00303602|579971119|FG001|Overall Study|Adverse Event|2|||
160615963|NCT00303602|579971118|FG000|Overall Study|Withdrawal by Subject|5|||
160615964|NCT00303602|579971119|FG001|Overall Study|Withdrawal by Subject|6|||
160615965|NCT00303602|579971118|FG000|Overall Study|Lost to Follow-up|5|||
160615966|NCT00303602|579971119|FG001|Overall Study|Lost to Follow-up|2|||
160615967|NCT00303602|579971118|FG000|Overall Study|Protocol entry criteria not met|2|||
160615968|NCT00303602|579971119|FG001|Overall Study|Protocol entry criteria not met|2|||
160615969|NCT00303602|579971118|FG000|Overall Study|Physician Decision|2|||
160615970|NCT00303602|579971119|FG001|Overall Study|Physician Decision|1|||
160615971|NCT00303602|579971118|FG000|Overall Study|Noncompliance|2|||
160615972|NCT00303602|579971119|FG001|Overall Study|Noncompliance|2|||
160496076|NCT04546217|579544955|FG000|Overall Study|Uncontrolled hypertension|1|||
160496077|NCT04546217|579544956|FG001|Overall Study|Uncontrolled hypertension|0|||
160496078|NCT03020069|579544957|FG000|Overall Study|Lost to Follow-up|0|||
160496079|NCT03020069|579544958|FG001|Overall Study|Lost to Follow-up|1|||
160496080|NCT02550938|579544959|FG000|Overall Study|Lost to Follow-up|8|||
160496081|NCT02550938|579544960|FG001|Overall Study|Lost to Follow-up|7|||
160496082|NCT02550938|579544961|FG002|Overall Study|Lost to Follow-up|12|||
160496083|NCT02550938|579544962|FG003|Overall Study|Lost to Follow-up|11|||
160496084|NCT01367847|579544963|FG000|Overall Study|Withdrawal by Subject|2|||
160496085|NCT01367847|579544964|FG001|Overall Study|Withdrawal by Subject|2|||
160496086|NCT02684123|579544965|FG000|Phase 1|Lack of Efficacy|5|||
160496087|NCT02684123|579544966|FG001|Phase 1|Lack of Efficacy|0|||
160496088|NCT02684123|579544965|FG000|Phase 1|Adverse Event|3|||
160496089|NCT02684123|579544966|FG001|Phase 1|Adverse Event|0|||
160496090|NCT02684123|579544965|FG000|Phase 1|Lost to Follow-up|0|||
160496091|NCT02684123|579544966|FG001|Phase 1|Lost to Follow-up|1|||
160496092|NCT02684123|579544965|FG000|Phase 2|Lack of Efficacy|1|||
160496093|NCT02684123|579544966|FG001|Phase 2|Lack of Efficacy|8|||
160496094|NCT01920932|579544971|FG000|Overall Study|Death|1|||
160496095|NCT01920932|579544971|FG000|Overall Study|Withdrawal of consent|1|||
160496096|NCT04486313|579544972|FG000|Overall Study|Lost to Follow-up|7|||
160496097|NCT04486313|579544973|FG001|Overall Study|Lost to Follow-up|9|||
160496098|NCT04486313|579544972|FG000|Overall Study|Withdrawal by Subject|8|||
160496099|NCT04486313|579544973|FG001|Overall Study|Withdrawal by Subject|6|||
160496100|NCT04486313|579544972|FG000|Overall Study|Physician Decision|1|||
160496101|NCT04486313|579544973|FG001|Overall Study|Physician Decision|1|||
160496102|NCT04486313|579544972|FG000|Overall Study|Death|2|||
160496103|NCT04486313|579544973|FG001|Overall Study|Death|0|||
160496104|NCT04486313|579544972|FG000|Overall Study|Protocol Violation|1|||
160496105|NCT04486313|579544973|FG001|Overall Study|Protocol Violation|1|||
160496106|NCT02980523|579544979|FG000|Overall Study|Lost to Follow-up|1|||
160496107|NCT02980523|579544980|FG001|Overall Study|Lost to Follow-up|4|||
160496108|NCT02980523|579544981|FG002|Overall Study|Lost to Follow-up|1|||
160496109|NCT02980523|579544982|FG003|Overall Study|Lost to Follow-up|2|||
160496110|NCT02980523|579544983|FG004|Overall Study|Lost to Follow-up|1|||
160496111|NCT02980523|579544979|FG000|Overall Study|Excluded from analysis|1|||
160496112|NCT02980523|579544980|FG001|Overall Study|Excluded from analysis|3|||
160496113|NCT02980523|579544981|FG002|Overall Study|Excluded from analysis|1|||
160496114|NCT02980523|579544982|FG003|Overall Study|Excluded from analysis|1|||
160496115|NCT02980523|579544983|FG004|Overall Study|Excluded from analysis|1|||
160496116|NCT02980523|579544979|FG000|Overall Study|Lack of Efficacy|1|||
160496117|NCT02980523|579544980|FG001|Overall Study|Lack of Efficacy|4|||
160496118|NCT02980523|579544981|FG002|Overall Study|Lack of Efficacy|4|||
160496119|NCT02980523|579544982|FG003|Overall Study|Lack of Efficacy|5|||
160496120|NCT02980523|579544983|FG004|Overall Study|Lack of Efficacy|8|||
160496121|NCT02980523|579544979|FG000|Overall Study|Did not receive intervention|0|||
160496122|NCT02980523|579544980|FG001|Overall Study|Did not receive intervention|0|||
160496123|NCT02980523|579544981|FG002|Overall Study|Did not receive intervention|0|||
160496124|NCT02980523|579544982|FG003|Overall Study|Did not receive intervention|1|||
160496125|NCT02980523|579544983|FG004|Overall Study|Did not receive intervention|0|||
160496126|NCT00633945|579544984|FG000|Overall Study|Physician Decision|2|||
160496127|NCT00882115|579544985|FG000|Overall Study|Withdrawal by Subject|3|||
160496128|NCT00882115|579544985|FG000|Overall Study|did not respond to DEP challe|6|||
160496129|NCT02552147|579544986|FG000|First Intervention (7 Days)|Protocol Violation|1|||
160496130|NCT02552147|579544987|FG001|First Intervention (7 Days)|Protocol Violation|0|||
160496131|NCT02552147|579544986|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
160496132|NCT02552147|579544987|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
160496133|NCT00940875|579544988|FG000|Treatment Phase|Adverse Event|9|||
160496134|NCT00940875|579544989|FG001|Treatment Phase|Adverse Event|3|||
160496135|NCT00940875|579544988|FG000|Treatment Phase|Death|3|||
160496136|NCT00940875|579544989|FG001|Treatment Phase|Death|5|||
160496137|NCT00940875|579544988|FG000|Treatment Phase|Lack of Efficacy|1|||
160496138|NCT00940875|579544989|FG001|Treatment Phase|Lack of Efficacy|0|||
160496139|NCT00940875|579544988|FG000|Treatment Phase|Withdrawal by Subject|3|||
160496140|NCT00940875|579544989|FG001|Treatment Phase|Withdrawal by Subject|0|||
160661615|NCT05093205|580144135|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
160496141|NCT00940875|579544988|FG000|Treatment Phase|Disease progression|9|||
160496142|NCT00940875|579544989|FG001|Treatment Phase|Disease progression|11|||
160496143|NCT00940875|579544988|FG000|Treatment Phase|Physician Decision|1|||
160496144|NCT00940875|579544989|FG001|Treatment Phase|Physician Decision|0|||
160496145|NCT00940875|579544988|FG000|Post-Study Treatment|Death|0|||
160496146|NCT00940875|579544989|FG001|Post-Study Treatment|Death|1|||
160496147|NCT00940875|579544988|FG000|Post-Study Treatment|Disease Progression|0|||
160496148|NCT00940875|579544989|FG001|Post-Study Treatment|Disease Progression|2|||
160496149|NCT00943787|579544990|FG000|Overall Study|Physician Decision|4|||
160496150|NCT00943787|579544990|FG000|Overall Study|Withdrawal by Subject|3|||
160496151|NCT01547598|579544991|FG000|Overall Study|Withdrew consent|1|||
160496152|NCT01547598|579544992|FG001|Overall Study|Withdrew consent|1|||
160496153|NCT01547598|579544991|FG000|Overall Study|Lost to Follow-up|1|||
160496154|NCT01547598|579544992|FG001|Overall Study|Lost to Follow-up|1|||
160496155|NCT01547598|579544991|FG000|Overall Study|Adverse Event|1|||
160496156|NCT01547598|579544992|FG001|Overall Study|Adverse Event|1|||
160496157|NCT01547598|579544991|FG000|Overall Study|Protocol Violation|1|||
160615973|NCT00303602|579971118|FG000|Overall Study|Protocol Violation|1|||
160615974|NCT00303602|579971119|FG001|Overall Study|Protocol Violation|0|||
160615975|NCT01451203|579971120|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
160615976|NCT01451203|579971121|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
160615977|NCT01451203|579971120|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
160615978|NCT01451203|579971121|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
160615979|NCT01451203|579971120|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
160615980|NCT01451203|579971121|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
160615981|NCT01451203|579971120|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
160615982|NCT01451203|579971121|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
160615983|NCT01451203|579971120|FG000|Double-blind Treatment Period|Adverse Event|6|||
160615984|NCT01451203|579971121|FG001|Double-blind Treatment Period|Adverse Event|9|||
160615985|NCT01451203|579971120|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
160615986|NCT01451203|579971121|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
160615987|NCT01451203|579971120|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
160615988|NCT01451203|579971121|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
160615989|NCT01451203|579971120|FG000|Double-blind Treatment Period|Investigator decision|2|||
160615990|NCT01451203|579971121|FG001|Double-blind Treatment Period|Investigator decision|0|||
160615991|NCT01451203|579971120|FG000|Post-treatment Period|Consent withdrawn|2|||
160615992|NCT01451203|579971121|FG001|Post-treatment Period|Consent withdrawn|4|||
160615993|NCT01451203|579971120|FG000|Post-treatment Period|Lack of Efficacy|12|||
160615994|NCT01451203|579971121|FG001|Post-treatment Period|Lack of Efficacy|28|||
160615995|NCT01451203|579971120|FG000|Post-treatment Period|Adverse Event|0|||
160615996|NCT01451203|579971121|FG001|Post-treatment Period|Adverse Event|1|||
160615997|NCT01451203|579971120|FG000|Post-treatment Period|Investigator decision|0|||
160615998|NCT01451203|579971121|FG001|Post-treatment Period|Investigator decision|1|||
160615999|NCT04235959|579971122|FG000|Overall Study|Protocol Violation|0|||
160616000|NCT04235959|579971123|FG001|Overall Study|Protocol Violation|1|||
160616001|NCT04235959|579971124|FG002|Overall Study|Protocol Violation|0|||
160616002|NCT04235959|579971122|FG000|Overall Study|Adverse Event|1|||
160616003|NCT04235959|579971123|FG001|Overall Study|Adverse Event|0|||
160616004|NCT04235959|579971124|FG002|Overall Study|Adverse Event|0|||
160616005|NCT00125138|579971125|FG000|Overall Study|Adverse Event|1|||
160616006|NCT00125138|579971126|FG001|Overall Study|Adverse Event|0|||
160616007|NCT00125138|579971127|FG002|Overall Study|Adverse Event|3|||
160616008|NCT00125138|579971128|FG003|Overall Study|Adverse Event|2|||
160616009|NCT00125138|579971125|FG000|Overall Study|Withdrawal by Subject|2|||
160616010|NCT00125138|579971126|FG001|Overall Study|Withdrawal by Subject|3|||
160616011|NCT00125138|579971127|FG002|Overall Study|Withdrawal by Subject|1|||
160616012|NCT00125138|579971128|FG003|Overall Study|Withdrawal by Subject|1|||
160616013|NCT00125138|579971125|FG000|Overall Study|Lack of Efficacy|0|||
160616014|NCT00125138|579971126|FG001|Overall Study|Lack of Efficacy|0|||
160616015|NCT00125138|579971127|FG002|Overall Study|Lack of Efficacy|0|||
160616016|NCT00125138|579971128|FG003|Overall Study|Lack of Efficacy|1|||
160616017|NCT00125138|579971125|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
160616018|NCT00125138|579971126|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
160616019|NCT00125138|579971127|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
160616020|NCT00125138|579971128|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
160616021|NCT02967562|579971133|FG000|Overall Study|Consent not obtained|1|||
160616022|NCT02967562|579971134|FG001|Overall Study|Consent not obtained|0|||
160616023|NCT02967562|579971133|FG000|Overall Study|High leak precluding analysis|1|||
160616024|NCT02967562|579971134|FG001|Overall Study|High leak precluding analysis|1|||
160616025|NCT00286156|579971135|FG000|Overall Study|Missed 12 month visit|0|||
160616026|NCT00286156|579971136|FG001|Overall Study|Missed 12 month visit|0|||
160616027|NCT00286156|579971137|FG002|Overall Study|Missed 12 month visit|1|||
160496158|NCT01547598|579544992|FG001|Overall Study|Protocol Violation|1|||
160496159|NCT01547598|579544991|FG000|Overall Study|Other Miscellaneous Reasons|2|||
160616028|NCT00286156|579971135|FG000|Overall Study|AE: pulmonary embolus|0|||
160616029|NCT00286156|579971136|FG001|Overall Study|AE: pulmonary embolus|1|||
160616030|NCT00286156|579971137|FG002|Overall Study|AE: pulmonary embolus|0|||
160496160|NCT01547598|579544992|FG001|Overall Study|Other Miscellaneous Reasons|1|||
160496161|NCT00872001|579544996|FG000|Overall Study|Adverse Event|34|||
160496162|NCT00872001|579544997|FG001|Overall Study|Adverse Event|23|||
160616031|NCT00286156|579971135|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
160616032|NCT00286156|579971136|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
160616033|NCT00286156|579971137|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
160496163|NCT00872001|579544996|FG000|Overall Study|Protocol Defined Clinical Event|5|||
160496164|NCT00872001|579544997|FG001|Overall Study|Protocol Defined Clinical Event|7|||
160496165|NCT00872001|579544996|FG000|Overall Study|Lost to Follow-up|13|||
160616034|NCT00286156|579971135|FG000|Overall Study|AE: pneumonia|1|||
160616035|NCT00286156|579971136|FG001|Overall Study|AE: pneumonia|0|||
160616036|NCT00286156|579971137|FG002|Overall Study|AE: pneumonia|0|||
160616037|NCT02870348|579971145|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
160616038|NCT00672139|579971146|FG000|Overall Study|Death|14|||
160616039|NCT00672139|579971147|FG001|Overall Study|Death|23|||
160616040|NCT00672139|579971146|FG000|Overall Study|Withdrawal by Subject|2|||
160616041|NCT00672139|579971147|FG001|Overall Study|Withdrawal by Subject|11|||
160616042|NCT00672139|579971146|FG000|Overall Study|Adverse Event|4|||
160616043|NCT00672139|579971147|FG001|Overall Study|Adverse Event|7|||
160616044|NCT00672139|579971146|FG000|Overall Study|Physician Decision|2|||
160616045|NCT00672139|579971147|FG001|Overall Study|Physician Decision|0|||
160616046|NCT00672139|579971146|FG000|Overall Study|Lack of Efficacy|4|||
160616047|NCT00672139|579971147|FG001|Overall Study|Lack of Efficacy|1|||
160616048|NCT00672139|579971146|FG000|Overall Study|Protocol Violation|1|||
160616049|NCT00672139|579971147|FG001|Overall Study|Protocol Violation|1|||
160616050|NCT00672139|579971146|FG000|Overall Study|hospice discharge, caregiver requests|3|||
160616051|NCT00672139|579971147|FG001|Overall Study|hospice discharge, caregiver requests|2|||
160616052|NCT01051856|579971148|FG000|Overall Study|Withdrawal by Subject|1|||
160616053|NCT01051856|579971149|FG001|Overall Study|Withdrawal by Subject|0|||
160616054|NCT02381795|579971150|FG000|Overall Study|Withdrawal by Subject|1|||
160616055|NCT02381795|579971150|FG000|Overall Study|Study Terminated|2|||
160616056|NCT02176226|579971151|FG000|Overall Study|Lost to Follow-up|3|||
160616057|NCT02176226|579971151|FG000|Overall Study|Withdrew prior to treatment|6|||
160616058|NCT01488994|579971156|FG000|Overall Study|Withdrawal by Subject|0|||
160616059|NCT01488994|579971157|FG001|Overall Study|Withdrawal by Subject|1|||
160616060|NCT01072500|579971158|FG000|Overall Study|Death|2|||
160616061|NCT01072500|579971159|FG001|Overall Study|Death|2|||
160616062|NCT01072500|579971158|FG000|Overall Study|Lost to Follow-up|5|||
160616063|NCT01072500|579971159|FG001|Overall Study|Lost to Follow-up|2|||
160616064|NCT01072500|579971158|FG000|Overall Study|Withdrawal by Subject|17|||
160616065|NCT01072500|579971159|FG001|Overall Study|Withdrawal by Subject|10|||
160616066|NCT00103207|579971160|FG000|Overall Study|Adverse Event|3|||
160616067|NCT00103207|579971160|FG000|Overall Study|Death|1|||
160616068|NCT00103207|579971160|FG000|Overall Study|Withdrawal by Subject|2|||
160616069|NCT00103207|579971160|FG000|Overall Study|Other complicating disease|1|||
160616070|NCT00103207|579971160|FG000|Overall Study|Ineligible|4|||
160616071|NCT00103207|579971160|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
160616072|NCT02908841|579971161|FG000|Overall Study|Physician Decision|4|||
160616073|NCT02908841|579971162|FG001|Overall Study|Physician Decision|0|||
160616074|NCT01611558|579971163|FG000|Induction Phase|Study drug toxicity|15|||
160616075|NCT01611558|579971163|FG000|Induction Phase|Disease progression|18|||
160616076|NCT01611558|579971163|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
160616077|NCT01611558|579971163|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
160616078|NCT01611558|579971163|FG000|Induction Phase|Death|1|||
160616079|NCT01611558|579971163|FG000|Maintenance Phase|Withdrawal by Subject|1|||
160616080|NCT01611558|579971163|FG000|Maintenance Phase|Elevated Uric acid|1|||
160616081|NCT03798366|579971164|FG000|Overall Study|Lost to Follow-up|0|||
160616082|NCT03798366|579971165|FG001|Overall Study|Lost to Follow-up|1|||
160616083|NCT00750867|579971169|FG000|Overall Study|Adverse Event|2|||
160616084|NCT00394654|579971170|FG000|Overall Study|Lost to Follow-up|1|||
160616085|NCT00394654|579971171|FG001|Overall Study|Lost to Follow-up|0|||
160616086|NCT00394654|579971170|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
160616087|NCT00394654|579971171|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
160616088|NCT00474539|579971172|FG000|Infant Series|Withdrawal by Subject|3|||
160616089|NCT00474539|579971173|FG001|Infant Series|Withdrawal by Subject|4|||
160616090|NCT00474539|579971172|FG000|Infant Series|Randomization error|5|||
160616091|NCT00474539|579971173|FG001|Infant Series|Randomization error|0|||
160616092|NCT00474539|579971172|FG000|Infant Series|Lost to Follow-up|2|||
160616093|NCT00474539|579971173|FG001|Infant Series|Lost to Follow-up|1|||
160616094|NCT00474539|579971172|FG000|Infant Series|Protocol Violation|0|||
160616095|NCT00474539|579971173|FG001|Infant Series|Protocol Violation|1|||
160661616|NCT05093205|580144136|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
160661617|NCT05093205|580144137|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
160616096|NCT00474539|579971172|FG000|After Infant Series|Lost to Follow-up|3|||
160616097|NCT00474539|579971173|FG001|After Infant Series|Lost to Follow-up|0|||
160616098|NCT00474539|579971172|FG000|After Infant Series|Withdrawal by Subject|1|||
160616099|NCT00474539|579971173|FG001|After Infant Series|Withdrawal by Subject|0|||
160616100|NCT00474539|579971172|FG000|Toddler Dose|Protocol Violation|1|||
160616101|NCT00474539|579971173|FG001|Toddler Dose|Protocol Violation|0|||
160616102|NCT03442595|579971174|FG000|Overall Study|Lost to Follow-up|94|||
160616103|NCT03442595|579971175|FG001|Overall Study|Lost to Follow-up|0|||
160616104|NCT01060150|579971180|FG000|Overall Study|Adverse Event|6|||
160616105|NCT01060150|579971180|FG000|Overall Study|Lost to Follow-up|1|||
160616106|NCT01060150|579971180|FG000|Overall Study|Protocol Violation|6|||
160616107|NCT01060150|579971180|FG000|Overall Study|Withdrawal by Subject|8|||
160616108|NCT01060150|579971180|FG000|Overall Study|Enrolled, but not treated|2|||
160616109|NCT01836549|579971181|FG000|Overall Study|Did not receive study drug|0|||
160616110|NCT01836549|579971182|FG001|Overall Study|Did not receive study drug|0|||
160616111|NCT01836549|579971183|FG002|Overall Study|Did not receive study drug|1|||
160616112|NCT01836549|579971184|FG003|Overall Study|Did not receive study drug|0|||
160616113|NCT01836549|579971185|FG004|Overall Study|Did not receive study drug|0|||
160616114|NCT01836549|579971186|FG005|Overall Study|Did not receive study drug|0|||
160616115|NCT01836549|579971187|FG006|Overall Study|Did not receive study drug|0|||
160616116|NCT01836549|579971181|FG000|Overall Study|Patient declared ineligible|0|||
160616117|NCT01836549|579971182|FG001|Overall Study|Patient declared ineligible|0|||
160616118|NCT01836549|579971183|FG002|Overall Study|Patient declared ineligible|0|||
160616119|NCT01836549|579971184|FG003|Overall Study|Patient declared ineligible|1|||
160616120|NCT01836549|579971185|FG004|Overall Study|Patient declared ineligible|0|||
160616121|NCT01836549|579971186|FG005|Overall Study|Patient declared ineligible|0|||
160616122|NCT01836549|579971187|FG006|Overall Study|Patient declared ineligible|0|||
160616123|NCT01836549|579971181|FG000|Overall Study|Patient inevaluable to start therapy|0|||
160616124|NCT01836549|579971182|FG001|Overall Study|Patient inevaluable to start therapy|0|||
160616125|NCT01836549|579971183|FG002|Overall Study|Patient inevaluable to start therapy|0|||
160616126|NCT01836549|579971184|FG003|Overall Study|Patient inevaluable to start therapy|0|||
160616127|NCT01836549|579971185|FG004|Overall Study|Patient inevaluable to start therapy|0|||
160616128|NCT01836549|579971186|FG005|Overall Study|Patient inevaluable to start therapy|0|||
160616129|NCT01836549|579971187|FG006|Overall Study|Patient inevaluable to start therapy|1|||
160616130|NCT00550615|579971188|FG000|Overall Study|Withdrawal by Subject|0|||
160616131|NCT00550615|579971189|FG001|Overall Study|Withdrawal by Subject|0|||
160616132|NCT00550615|579971190|FG002|Overall Study|Withdrawal by Subject|2|||
160616133|NCT00550615|579971191|FG003|Overall Study|Withdrawal by Subject|3|||
160616134|NCT00550615|579971188|FG000|Overall Study|Not evaluable|0|||
160616135|NCT00550615|579971189|FG001|Overall Study|Not evaluable|0|||
160616136|NCT00550615|579971190|FG002|Overall Study|Not evaluable|2|||
160616137|NCT00550615|579971191|FG003|Overall Study|Not evaluable|7|||
160616138|NCT00461552|579971192|FG000|Overall Study|Drug Dispensing error|0|||
160616139|NCT00461552|579971193|FG001|Overall Study|Drug Dispensing error|2|||
160616140|NCT02877134|579971194|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
160616141|NCT02877134|579971195|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
160616142|NCT02877134|579971196|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
160616143|NCT02877134|579971197|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
160616144|NCT02877134|579971198|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
160616145|NCT02877134|579971199|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
160616146|NCT02877134|579971200|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
160616147|NCT02877134|579971201|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
160616148|NCT02877134|579971202|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
160616149|NCT02877134|579971203|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
160616150|NCT02877134|579971204|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
160616151|NCT02877134|579971205|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
160616152|NCT02877134|579971194|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
160616153|NCT02877134|579971195|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
160616154|NCT02877134|579971196|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
160616155|NCT02877134|579971197|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
160616156|NCT02877134|579971198|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
160616157|NCT02877134|579971199|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
160616158|NCT02877134|579971200|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
160616159|NCT02877134|579971201|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
160616160|NCT02877134|579971202|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
160616161|NCT02877134|579971203|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
160616162|NCT02877134|579971204|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
160616163|NCT02877134|579971205|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
160616164|NCT02877134|579971194|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
160616165|NCT02877134|579971195|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
160616166|NCT02877134|579971196|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
160616167|NCT02877134|579971197|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
160616168|NCT02877134|579971198|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
160616169|NCT02877134|579971199|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
160616170|NCT02877134|579971200|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
160616171|NCT02877134|579971201|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
160616172|NCT02877134|579971202|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
160616173|NCT02877134|579971203|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
160661618|NCT05093205|580144138|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
160616174|NCT02877134|579971204|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
160616175|NCT02877134|579971205|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
160661619|NCT05093205|580144139|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
160496166|NCT00872001|579544997|FG001|Overall Study|Lost to Follow-up|12|||
160496167|NCT00872001|579544996|FG000|Overall Study|Withdrawal by Subject|18|||
160496168|NCT00872001|579544997|FG001|Overall Study|Withdrawal by Subject|30|||
160496169|NCT00872001|579544996|FG000|Overall Study|Protocol Violation|5|||
160496170|NCT00872001|579544997|FG001|Overall Study|Protocol Violation|8|||
160496171|NCT00872001|579544996|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
160496172|NCT00872001|579544997|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
160496173|NCT00872001|579544996|FG000|Overall Study|Administrative|23|||
160496174|NCT00872001|579544997|FG001|Overall Study|Administrative|15|||
160496175|NCT04071301|579544998|FG000|Overall Study|Withdrawal by Subject|6|||
160496176|NCT04071301|579544998|FG000|Overall Study|Death|1|||
160496177|NCT02879383|579544999|FG000|First 24 Weeks|Physician Decision|0|||
160496178|NCT02879383|579545000|FG001|First 24 Weeks|Physician Decision|1|||
160496179|NCT02879383|579545001|FG002|First 24 Weeks|Physician Decision|0|||
160496180|NCT02879383|579545002|FG003|First 24 Weeks|Physician Decision|0|||
160496181|NCT02125279|579545003|FG000|Overall Study|Lack of Efficacy|2|||
160496182|NCT02125279|579545003|FG000|Overall Study|Withdrawal by Subject|6|||
160496183|NCT02125279|579545003|FG000|Overall Study|Protocol Violation|1|||
160496184|NCT02125279|579545003|FG000|Overall Study|Lost to Follow-up|4|||
160496185|NCT01850589|579545004|FG000|Overall Study|Withdrawal by Subject|8|||
160496186|NCT01850589|579545005|FG001|Overall Study|Withdrawal by Subject|0|||
160496187|NCT01607879|579545006|FG000|Overall Study|Death|1|||
160496188|NCT01607879|579545007|FG001|Overall Study|Death|0|||
160496189|NCT03912662|579545008|FG000|Overall Study|Adverse Event|3|||
160496190|NCT03912662|579545008|FG000|Overall Study|Adverse Event and Death|1|||
160496191|NCT03912662|579545008|FG000|Overall Study|Death|1|||
160496192|NCT03912662|579545008|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
160496193|NCT03912662|579545008|FG000|Overall Study|Mesh Removal|1|||
160496194|NCT03912662|579545008|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
160496195|NCT03912662|579545008|FG000|Overall Study|Early study termination|20|||
160496196|NCT00420784|579545011|FG000|Overall Study|Adverse Event|11|||
160496197|NCT00420784|579545012|FG001|Overall Study|Adverse Event|29|||
160496198|NCT00420784|579545013|FG002|Overall Study|Adverse Event|10|||
160496199|NCT00420784|579545014|FG003|Overall Study|Adverse Event|5|||
160496200|NCT00420784|579545011|FG000|Overall Study|Withdrawal by Subject|0|||
160496201|NCT00420784|579545012|FG001|Overall Study|Withdrawal by Subject|1|||
160496202|NCT00420784|579545013|FG002|Overall Study|Withdrawal by Subject|0|||
160496203|NCT00420784|579545014|FG003|Overall Study|Withdrawal by Subject|0|||
160496204|NCT00420784|579545011|FG000|Overall Study|Lost to Follow-up|0|||
160496205|NCT00420784|579545012|FG001|Overall Study|Lost to Follow-up|0|||
160496206|NCT00420784|579545013|FG002|Overall Study|Lost to Follow-up|2|||
160496207|NCT00420784|579545014|FG003|Overall Study|Lost to Follow-up|1|||
160496208|NCT00420784|579545011|FG000|Overall Study|Virologic Stopping Rule|17|||
160496209|NCT00420784|579545012|FG001|Overall Study|Virologic Stopping Rule|26|||
160496210|NCT00420784|579545013|FG002|Overall Study|Virologic Stopping Rule|41|||
160496211|NCT00420784|579545014|FG003|Overall Study|Virologic Stopping Rule|67|||
160496212|NCT00420784|579545011|FG000|Overall Study|Other|1|||
160496213|NCT00420784|579545012|FG001|Overall Study|Other|2|||
160496214|NCT00420784|579545013|FG002|Overall Study|Other|0|||
160496215|NCT00420784|579545014|FG003|Overall Study|Other|5|||
160496216|NCT02599688|579545017|FG000|Overall Study|Lack of Efficacy|1|||
160496217|NCT02599688|579545017|FG000|Overall Study|Withdrawal by Subject|1|||
160496218|NCT02599688|579545017|FG000|Overall Study|Termination by Sponsor|2|||
160496219|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
160496220|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
160496221|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
160496222|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
160496223|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
160496224|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
160496225|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
160496226|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
160616176|NCT02877134|579971194|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
160616177|NCT02877134|579971195|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
160616178|NCT02877134|579971196|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
160496227|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
160496228|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
160496229|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
160496230|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
160496231|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
160496232|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
160496233|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
160496234|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
160496235|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
160496236|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
160616179|NCT02877134|579971197|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
160616180|NCT02877134|579971198|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
160616181|NCT02877134|579971199|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
160616182|NCT02877134|579971200|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
160616183|NCT02877134|579971201|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
160616184|NCT02877134|579971202|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
160616185|NCT02877134|579971203|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
160616186|NCT02877134|579971204|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
160616187|NCT02877134|579971205|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
160616188|NCT02877134|579971194|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616189|NCT02877134|579971195|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616190|NCT02877134|579971196|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616191|NCT02877134|579971197|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616192|NCT02877134|579971198|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616193|NCT02877134|579971199|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616194|NCT02877134|579971200|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616195|NCT02877134|579971201|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616196|NCT02877134|579971202|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
160616197|NCT02877134|579971203|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616198|NCT02877134|579971204|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616199|NCT02877134|579971205|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
160616200|NCT02877134|579971194|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
160616201|NCT02877134|579971195|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
160616202|NCT02877134|579971196|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
160616203|NCT02877134|579971197|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
160616204|NCT02877134|579971198|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
160616205|NCT02877134|579971199|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
160616206|NCT02877134|579971200|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
160616207|NCT02877134|579971201|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
160616208|NCT02877134|579971202|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
160616209|NCT02877134|579971203|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
160616210|NCT02877134|579971204|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
160616211|NCT02877134|579971205|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
160616212|NCT02877134|579971194|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
160616213|NCT02877134|579971195|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
160616214|NCT02877134|579971196|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
160616215|NCT02877134|579971197|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
160616216|NCT02877134|579971198|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
160616217|NCT02877134|579971199|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
160616218|NCT02877134|579971200|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
160616219|NCT02877134|579971201|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
160616220|NCT02877134|579971202|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
160616221|NCT02877134|579971203|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
160616222|NCT02877134|579971204|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
160616223|NCT02877134|579971205|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
160616224|NCT02877134|579971194|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
160616225|NCT02877134|579971195|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
160616226|NCT02877134|579971196|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
160616227|NCT02877134|579971197|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
160616228|NCT02877134|579971198|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
160616229|NCT02877134|579971199|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
160616230|NCT02877134|579971200|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
160616231|NCT02877134|579971201|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
160616232|NCT02877134|579971202|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
160616233|NCT02877134|579971203|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
160616234|NCT02877134|579971204|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
160616235|NCT02877134|579971205|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
160616236|NCT00523744|579971206|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
160616237|NCT00523744|579971206|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
160616238|NCT00523744|579971206|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
160616239|NCT00523744|579971206|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
160616240|NCT00523744|579971206|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
160616241|NCT00523744|579971206|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
160616242|NCT01289028|579971207|FG000|Overall Study|Progressive Disease|49|||
160616243|NCT01289028|579971207|FG000|Overall Study|Adverse Event|14|||
160661620|NCT05093205|580144140|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
160661621|NCT05093205|580144141|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
160661622|NCT05093205|580144129|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
160496237|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Missing|2|||
160496238|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Missing|1|||
160496239|NCT00443209|579545019|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
160496240|NCT00443209|579545020|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
160496241|NCT00443209|579545019|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
160496242|NCT00443209|579545020|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
160496243|NCT00443209|579545019|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
160496244|NCT00443209|579545020|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
160496245|NCT00443209|579545019|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
160496246|NCT00443209|579545020|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
160496247|NCT00443209|579545019|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
160496248|NCT00443209|579545020|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
160496249|NCT00443209|579545019|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
160496250|NCT00443209|579545020|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
160496251|NCT00443209|579545019|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
160661623|NCT05093205|580144130|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
160661624|NCT05093205|580144131|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
160661625|NCT05093205|580144132|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
160661626|NCT05093205|580144133|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
160661627|NCT05093205|580144134|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
160661628|NCT05093205|580144135|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
160661629|NCT05093205|580144136|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
160661630|NCT05093205|580144137|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
160661631|NCT05093205|580144138|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
160661632|NCT05093205|580144139|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
160661633|NCT05093205|580144140|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
160661634|NCT05093205|580144141|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
160661635|NCT05093205|580144129|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
160661636|NCT05093205|580144130|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
160661637|NCT05093205|580144131|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
160496252|NCT00443209|579545020|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
160496253|NCT01318876|579545021|FG000|Day 8 Survey|email address invalid|96|||
160496254|NCT01318876|579545021|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
160616244|NCT01289028|579971207|FG000|Overall Study|Withdrawal by Subject|6|||
160616245|NCT01289028|579971207|FG000|Overall Study|Death|4|||
160616246|NCT01289028|579971207|FG000|Overall Study|Lack of Efficacy|2|||
160616247|NCT01289028|579971207|FG000|Overall Study|No longer required|2|||
160616248|NCT01289028|579971207|FG000|Overall Study|Lost to Follow-up|2|||
160616249|NCT01289028|579971207|FG000|Overall Study|New Cancer Therapy|2|||
160616250|NCT01289028|579971207|FG000|Overall Study|Abnormal Lab Value|1|||
160616251|NCT01289028|579971207|FG000|Overall Study|Missing reason for discon|1|||
160616252|NCT00542425|579971215|FG000|Initial 24 Weeks|Administrative reasons|0|||
160616253|NCT00542425|579971216|FG001|Initial 24 Weeks|Administrative reasons|0|||
160616254|NCT00542425|579971217|FG002|Initial 24 Weeks|Administrative reasons|1|||
160616255|NCT00542425|579971218|FG003|Initial 24 Weeks|Administrative reasons|1|||
160616256|NCT00542425|579971219|FG004|Initial 24 Weeks|Administrative reasons|0|||
160616257|NCT00542425|579971215|FG000|Initial 24 Weeks|Adverse Event|0|||
160616258|NCT00542425|579971216|FG001|Initial 24 Weeks|Adverse Event|1|||
160616259|NCT00542425|579971217|FG002|Initial 24 Weeks|Adverse Event|1|||
160616260|NCT00542425|579971218|FG003|Initial 24 Weeks|Adverse Event|3|||
160616261|NCT00542425|579971219|FG004|Initial 24 Weeks|Adverse Event|2|||
160616262|NCT00542425|579971215|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
160616263|NCT00542425|579971216|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
160616264|NCT00542425|579971217|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
160616265|NCT00542425|579971218|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
160616266|NCT00542425|579971219|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
160616267|NCT00542425|579971215|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
160616268|NCT00542425|579971216|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
160616269|NCT00542425|579971217|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
160616270|NCT00542425|579971218|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
160616271|NCT00542425|579971219|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
160616272|NCT00542425|579971215|FG000|Initial 24 Weeks|Non-compliance|0|||
160616273|NCT00542425|579971216|FG001|Initial 24 Weeks|Non-compliance|0|||
160616274|NCT00542425|579971217|FG002|Initial 24 Weeks|Non-compliance|0|||
160496255|NCT01318876|579545021|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
160496256|NCT03513068|579545025|FG000|Overall Study|Death|1|||
160616275|NCT00542425|579971218|FG003|Initial 24 Weeks|Non-compliance|1|||
160616276|NCT00542425|579971219|FG004|Initial 24 Weeks|Non-compliance|1|||
160616277|NCT00542425|579971215|FG000|Initial 24 Weeks|Protocol Violation|0|||
160616278|NCT00542425|579971216|FG001|Initial 24 Weeks|Protocol Violation|0|||
160616279|NCT00542425|579971217|FG002|Initial 24 Weeks|Protocol Violation|0|||
160496257|NCT03513068|579545026|FG001|Overall Study|Death|0|||
160496258|NCT03513068|579545025|FG000|Overall Study|Withdrawal by Subject|4|||
160496259|NCT03513068|579545026|FG001|Overall Study|Withdrawal by Subject|6|||
160616280|NCT00542425|579971218|FG003|Initial 24 Weeks|Protocol Violation|1|||
160616281|NCT00542425|579971219|FG004|Initial 24 Weeks|Protocol Violation|0|||
160616282|NCT00542425|579971215|FG000|Initial 24 Weeks|Refusal of treatment|2|||
160616283|NCT00542425|579971216|FG001|Initial 24 Weeks|Refusal of treatment|2|||
160616284|NCT00542425|579971217|FG002|Initial 24 Weeks|Refusal of treatment|1|||
160616285|NCT00542425|579971218|FG003|Initial 24 Weeks|Refusal of treatment|4|||
160616286|NCT00542425|579971219|FG004|Initial 24 Weeks|Refusal of treatment|1|||
160616287|NCT00542425|579971215|FG000|Initial 24 Weeks|Other|0|||
160616288|NCT00542425|579971216|FG001|Initial 24 Weeks|Other|2|||
160616289|NCT00542425|579971217|FG002|Initial 24 Weeks|Other|1|||
160616290|NCT00542425|579971218|FG003|Initial 24 Weeks|Other|0|||
160616291|NCT00542425|579971219|FG004|Initial 24 Weeks|Other|0|||
160616292|NCT00542425|579971215|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
160616293|NCT00542425|579971216|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
160616294|NCT00542425|579971217|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
160616295|NCT00542425|579971218|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
160616296|NCT00542425|579971219|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
160616297|NCT00542425|579971215|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
160616298|NCT00542425|579971216|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
160616299|NCT00542425|579971217|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
160616300|NCT00542425|579971218|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
160616301|NCT00542425|579971219|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
160616302|NCT00542425|579971215|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
160616303|NCT00542425|579971216|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
160616304|NCT00542425|579971217|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
160616305|NCT00542425|579971218|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
160616306|NCT00542425|579971219|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
160616307|NCT00542425|579971215|FG000|Extended 24 Weeks of Treatment|Other|1|||
160616308|NCT00542425|579971216|FG001|Extended 24 Weeks of Treatment|Other|1|||
160616309|NCT00542425|579971217|FG002|Extended 24 Weeks of Treatment|Other|0|||
160616310|NCT00542425|579971218|FG003|Extended 24 Weeks of Treatment|Other|0|||
160616311|NCT00542425|579971219|FG004|Extended 24 Weeks of Treatment|Other|1|||
160616312|NCT01610414|579971220|FG000|Study Start - Month 13|Serious Adverse Event|65|||
160616313|NCT01610414|579971221|FG001|Study Start - Month 13|Serious Adverse Event|67|||
160616314|NCT01610414|579971220|FG000|Study Start - Month 13|Adverse Event|14|||
160616315|NCT01610414|579971221|FG001|Study Start - Month 13|Adverse Event|14|||
160616316|NCT01610414|579971220|FG000|Study Start - Month 13|Protocol Violation|3|||
160616317|NCT01610414|579971221|FG001|Study Start - Month 13|Protocol Violation|1|||
160616318|NCT01610414|579971220|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
160616319|NCT01610414|579971221|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
160616320|NCT01610414|579971220|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
160616321|NCT01610414|579971221|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
160616322|NCT01610414|579971220|FG000|Study Start - Month 13|Lost to Follow-up|4|||
160616323|NCT01610414|579971221|FG001|Study Start - Month 13|Lost to Follow-up|6|||
160616324|NCT01610414|579971220|FG000|Study Start - Month 13|Suspected HZ episode|1|||
160616325|NCT01610414|579971221|FG001|Study Start - Month 13|Suspected HZ episode|3|||
160616326|NCT01610414|579971220|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
160616327|NCT01610414|579971221|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
160616328|NCT01610414|579971220|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
160616329|NCT01610414|579971221|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
160616330|NCT01610414|579971220|FG000|Month 13 - Month 25|Adverse Event|8|||
160616331|NCT01610414|579971221|FG001|Month 13 - Month 25|Adverse Event|4|||
160616332|NCT01610414|579971220|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
160616333|NCT01610414|579971221|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
160616334|NCT01610414|579971220|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
160616335|NCT01610414|579971221|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
160616336|NCT01610414|579971220|FG000|Month 13 - Month 25|Protocol Violation|0|||
160616337|NCT01610414|579971221|FG001|Month 13 - Month 25|Protocol Violation|2|||
160616338|NCT01610414|579971220|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
160616339|NCT01610414|579971221|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
160616340|NCT01610414|579971220|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
160616341|NCT01610414|579971221|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
160616342|NCT01610414|579971220|FG000|After Month 25|Study end not reached|48|||
160616343|NCT01610414|579971221|FG001|After Month 25|Study end not reached|53|||
160616344|NCT00472043|579971222|FG000|Overall Study|Withdrawal by Subject|1|||
160616345|NCT00472043|579971223|FG001|Overall Study|Withdrawal by Subject|0|||
160616346|NCT00472043|579971222|FG000|Overall Study|Death|1|||
160661638|NCT05093205|580144132|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
160616347|NCT00472043|579971223|FG001|Overall Study|Death|0|||
160616348|NCT04009824|579971226|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
160616349|NCT04009824|579971227|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
160616350|NCT04009824|579971228|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
160616351|NCT04009824|579971229|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
160616352|NCT04009824|579971230|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
160616353|NCT01024946|579971231|FG000|Overall Study|Screen Failure|3|||
160616354|NCT01024946|579971231|FG000|Overall Study|Withdrawal by Subject|1|||
160616355|NCT01024946|579971231|FG000|Overall Study|Adverse Event|1|||
160616356|NCT03032523|579971232|FG000|Overall Study|Withdrawal by Subject|2|||
160616357|NCT03032523|579971233|FG001|Overall Study|Withdrawal by Subject|2|||
160616358|NCT03032523|579971232|FG000|Overall Study|Physician Decision|1|||
160616359|NCT03032523|579971233|FG001|Overall Study|Physician Decision|0|||
160616360|NCT05375838|579971234|FG000|Overall Study|Other|0|||
160616361|NCT05375838|579971235|FG001|Overall Study|Other|0|||
160616362|NCT05375838|579971236|FG002|Overall Study|Other|0|||
160616363|NCT05375838|579971237|FG003|Overall Study|Other|1|||
160616364|NCT05375838|579971238|FG004|Overall Study|Other|1|||
160616365|NCT05375838|579971239|FG005|Overall Study|Other|0|||
160616366|NCT05375838|579971234|FG000|Overall Study|Withdrawal by Subject|2|||
160616367|NCT05375838|579971235|FG001|Overall Study|Withdrawal by Subject|1|||
160616368|NCT05375838|579971236|FG002|Overall Study|Withdrawal by Subject|3|||
160616369|NCT05375838|579971237|FG003|Overall Study|Withdrawal by Subject|2|||
160616370|NCT05375838|579971238|FG004|Overall Study|Withdrawal by Subject|2|||
160616371|NCT05375838|579971239|FG005|Overall Study|Withdrawal by Subject|0|||
160616372|NCT05375838|579971234|FG000|Overall Study|Protocol Violation|0|||
160616373|NCT05375838|579971235|FG001|Overall Study|Protocol Violation|0|||
160616374|NCT05375838|579971236|FG002|Overall Study|Protocol Violation|0|||
160616375|NCT05375838|579971237|FG003|Overall Study|Protocol Violation|0|||
160616376|NCT05375838|579971238|FG004|Overall Study|Protocol Violation|1|||
160616377|NCT05375838|579971239|FG005|Overall Study|Protocol Violation|0|||
160616378|NCT05375838|579971234|FG000|Overall Study|Physician Decision|0|||
160616379|NCT05375838|579971235|FG001|Overall Study|Physician Decision|1|||
160616380|NCT05375838|579971236|FG002|Overall Study|Physician Decision|0|||
160616381|NCT05375838|579971237|FG003|Overall Study|Physician Decision|0|||
160616382|NCT05375838|579971238|FG004|Overall Study|Physician Decision|0|||
160616383|NCT05375838|579971239|FG005|Overall Study|Physician Decision|1|||
160616384|NCT05375838|579971234|FG000|Overall Study|Lost to Follow-up|2|||
160616385|NCT05375838|579971235|FG001|Overall Study|Lost to Follow-up|7|||
160616386|NCT05375838|579971236|FG002|Overall Study|Lost to Follow-up|0|||
160616387|NCT05375838|579971237|FG003|Overall Study|Lost to Follow-up|4|||
160616388|NCT05375838|579971238|FG004|Overall Study|Lost to Follow-up|2|||
160616389|NCT05375838|579971239|FG005|Overall Study|Lost to Follow-up|3|||
160616390|NCT00957723|579971240|FG000|Overall Study|Death|3|||
160616391|NCT00957723|579971240|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
160616392|NCT00957723|579971240|FG000|Overall Study|Lost to Follow-up|8|||
160616393|NCT00957723|579971240|FG000|Overall Study|Withdrawal by Subject|24|||
160616394|NCT00957723|579971240|FG000|Overall Study|Investigative Site Terminated|61|||
160616395|NCT00957723|579971240|FG000|Overall Study|Intercurrent Illness|2|||
160616396|NCT00957723|579971240|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
160616397|NCT00984009|579971241|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
160616398|NCT02178592|579971242|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
160616399|NCT02178592|579971243|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
160616400|NCT02178592|579971242|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
160616401|NCT02178592|579971243|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
160616402|NCT02178592|579971242|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
160616403|NCT02178592|579971243|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
160616404|NCT02178592|579971242|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
160616405|NCT02178592|579971243|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
160616406|NCT02178592|579971242|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
160616407|NCT02178592|579971243|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
160616408|NCT02178592|579971242|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
160616409|NCT02178592|579971243|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
160616410|NCT02178592|579971242|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
160616411|NCT02178592|579971243|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
160616412|NCT02178592|579971242|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
160616413|NCT02178592|579971243|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
160616414|NCT02178592|579971242|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
160616415|NCT02178592|579971243|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
160616416|NCT02178592|579971242|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
160616417|NCT02178592|579971243|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
160616418|NCT02178592|579971242|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
160616419|NCT02178592|579971243|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
160616420|NCT02178592|579971242|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
160616421|NCT02178592|579971243|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
160616422|NCT01084096|579973268|FG000|Overall Study|Lost to Follow-up|1501|||
160616423|NCT01084096|579973269|FG001|Overall Study|Lost to Follow-up|1833|||
160616424|NCT01084096|579973268|FG000|Overall Study|Withdrawal by Subject|3|||
160616425|NCT01084096|579973269|FG001|Overall Study|Withdrawal by Subject|0|||
160496260|NCT03636373|579545027|FG000|Overall Study|Study closure due to Covid-19|1|||
160496261|NCT03636373|579545028|FG001|Overall Study|Study closure due to Covid-19|0|||
160496262|NCT01236352|579545033|FG000|Overall Study|Death|0|||
160496263|NCT01236352|579545034|FG001|Overall Study|Death|0|||
160496264|NCT01236352|579545035|FG002|Overall Study|Death|0|||
160496265|NCT01236352|579545036|FG003|Overall Study|Death|0|||
160496266|NCT01236352|579545037|FG004|Overall Study|Death|0|||
160496267|NCT01236352|579545038|FG005|Overall Study|Death|0|||
160496268|NCT01236352|579545039|FG006|Overall Study|Death|0|||
160496269|NCT01236352|579545040|FG007|Overall Study|Death|1|||
160496270|NCT01236352|579545041|FG008|Overall Study|Death|0|||
160496271|NCT01236352|579545042|FG009|Overall Study|Death|0|||
160496272|NCT01236352|579545043|FG010|Overall Study|Death|0|||
160496273|NCT01236352|579545033|FG000|Overall Study|Withdrawal by Subject|0|||
160496274|NCT01236352|579545034|FG001|Overall Study|Withdrawal by Subject|0|||
160496275|NCT01236352|579545035|FG002|Overall Study|Withdrawal by Subject|0|||
160496276|NCT01236352|579545036|FG003|Overall Study|Withdrawal by Subject|0|||
160496277|NCT01236352|579545037|FG004|Overall Study|Withdrawal by Subject|0|||
160496278|NCT01236352|579545038|FG005|Overall Study|Withdrawal by Subject|0|||
160496279|NCT01236352|579545039|FG006|Overall Study|Withdrawal by Subject|0|||
160496280|NCT01236352|579545040|FG007|Overall Study|Withdrawal by Subject|0|||
160496281|NCT01236352|579545041|FG008|Overall Study|Withdrawal by Subject|0|||
160496282|NCT01236352|579545042|FG009|Overall Study|Withdrawal by Subject|2|||
160496283|NCT01236352|579545043|FG010|Overall Study|Withdrawal by Subject|1|||
160496284|NCT01236352|579545033|FG000|Overall Study|Adverse Event|0|||
160496285|NCT01236352|579545034|FG001|Overall Study|Adverse Event|0|||
160496286|NCT01236352|579545035|FG002|Overall Study|Adverse Event|0|||
160496287|NCT01236352|579545036|FG003|Overall Study|Adverse Event|0|||
160496288|NCT01236352|579545037|FG004|Overall Study|Adverse Event|0|||
160496289|NCT01236352|579545038|FG005|Overall Study|Adverse Event|0|||
160496290|NCT01236352|579545039|FG006|Overall Study|Adverse Event|2|||
160496291|NCT01236352|579545040|FG007|Overall Study|Adverse Event|0|||
160496292|NCT01236352|579545041|FG008|Overall Study|Adverse Event|0|||
160496293|NCT01236352|579545042|FG009|Overall Study|Adverse Event|4|||
160496294|NCT01236352|579545043|FG010|Overall Study|Adverse Event|1|||
160496295|NCT01236352|579545033|FG000|Overall Study|Study drug toxicity|0|||
160496296|NCT01236352|579545034|FG001|Overall Study|Study drug toxicity|0|||
160496297|NCT01236352|579545035|FG002|Overall Study|Study drug toxicity|0|||
160496298|NCT01236352|579545036|FG003|Overall Study|Study drug toxicity|0|||
160496299|NCT01236352|579545037|FG004|Overall Study|Study drug toxicity|0|||
160496300|NCT01236352|579545038|FG005|Overall Study|Study drug toxicity|1|||
160496301|NCT01236352|579545039|FG006|Overall Study|Study drug toxicity|1|||
160496302|NCT01236352|579545040|FG007|Overall Study|Study drug toxicity|0|||
160496303|NCT01236352|579545041|FG008|Overall Study|Study drug toxicity|0|||
160496304|NCT01236352|579545042|FG009|Overall Study|Study drug toxicity|2|||
160496305|NCT01236352|579545043|FG010|Overall Study|Study drug toxicity|2|||
160496306|NCT01236352|579545033|FG000|Overall Study|Disease progression|1|||
160496307|NCT01236352|579545034|FG001|Overall Study|Disease progression|2|||
160496308|NCT01236352|579545035|FG002|Overall Study|Disease progression|1|||
160496309|NCT01236352|579545036|FG003|Overall Study|Disease progression|2|||
160496310|NCT01236352|579545037|FG004|Overall Study|Disease progression|2|||
160496311|NCT01236352|579545038|FG005|Overall Study|Disease progression|2|||
160496312|NCT01236352|579545039|FG006|Overall Study|Disease progression|1|||
160496313|NCT01236352|579545040|FG007|Overall Study|Disease progression|3|||
160496314|NCT01236352|579545041|FG008|Overall Study|Disease progression|2|||
160496315|NCT01236352|579545042|FG009|Overall Study|Disease progression|2|||
160496316|NCT01236352|579545043|FG010|Overall Study|Disease progression|2|||
160496317|NCT01236352|579545033|FG000|Overall Study|Poor/Non-compliance|1|||
160496318|NCT01236352|579545034|FG001|Overall Study|Poor/Non-compliance|0|||
160496319|NCT01236352|579545035|FG002|Overall Study|Poor/Non-compliance|0|||
160496320|NCT01236352|579545036|FG003|Overall Study|Poor/Non-compliance|0|||
160496321|NCT01236352|579545037|FG004|Overall Study|Poor/Non-compliance|0|||
160496322|NCT01236352|579545038|FG005|Overall Study|Poor/Non-compliance|0|||
160496323|NCT01236352|579545039|FG006|Overall Study|Poor/Non-compliance|0|||
160496324|NCT01236352|579545040|FG007|Overall Study|Poor/Non-compliance|0|||
160496325|NCT01236352|579545041|FG008|Overall Study|Poor/Non-compliance|0|||
160616426|NCT01084096|579973268|FG000|Overall Study|Woman had a miscarriage|21|||
160616427|NCT01084096|579973269|FG001|Overall Study|Woman had a miscarriage|17|||
160616428|NCT02033369|579973270|FG000|Overall Study|Physician Decision|1|||
160496326|NCT01236352|579545042|FG009|Overall Study|Poor/Non-compliance|0|||
160496327|NCT01236352|579545043|FG010|Overall Study|Poor/Non-compliance|0|||
160496328|NCT01236352|579545033|FG000|Overall Study|Maximum clinical benefit|1|||
160496329|NCT01236352|579545034|FG001|Overall Study|Maximum clinical benefit|1|||
160496330|NCT01236352|579545035|FG002|Overall Study|Maximum clinical benefit|1|||
160496331|NCT01236352|579545036|FG003|Overall Study|Maximum clinical benefit|0|||
160616429|NCT02033369|579973271|FG001|Overall Study|Physician Decision|2|||
160496332|NCT01236352|579545037|FG004|Overall Study|Maximum clinical benefit|2|||
160496333|NCT01236352|579545038|FG005|Overall Study|Maximum clinical benefit|0|||
160496334|NCT01236352|579545039|FG006|Overall Study|Maximum clinical benefit|3|||
160496335|NCT01236352|579545040|FG007|Overall Study|Maximum clinical benefit|1|||
160496336|NCT01236352|579545041|FG008|Overall Study|Maximum clinical benefit|1|||
160496337|NCT01236352|579545042|FG009|Overall Study|Maximum clinical benefit|4|||
160496338|NCT01236352|579545043|FG010|Overall Study|Maximum clinical benefit|2|||
160496339|NCT01236352|579545033|FG000|Overall Study|Subject request to discontinue treatment|0|||
160496340|NCT01236352|579545034|FG001|Overall Study|Subject request to discontinue treatment|0|||
160496341|NCT01236352|579545035|FG002|Overall Study|Subject request to discontinue treatment|1|||
160496342|NCT01236352|579545036|FG003|Overall Study|Subject request to discontinue treatment|1|||
160496343|NCT01236352|579545037|FG004|Overall Study|Subject request to discontinue treatment|0|||
160496344|NCT01236352|579545038|FG005|Overall Study|Subject request to discontinue treatment|1|||
160496345|NCT01236352|579545039|FG006|Overall Study|Subject request to discontinue treatment|0|||
160496346|NCT01236352|579545040|FG007|Overall Study|Subject request to discontinue treatment|0|||
160496347|NCT01236352|579545041|FG008|Overall Study|Subject request to discontinue treatment|0|||
160496348|NCT01236352|579545042|FG009|Overall Study|Subject request to discontinue treatment|1|||
160496349|NCT01236352|579545043|FG010|Overall Study|Subject request to discontinue treatment|4|||
160496350|NCT01236352|579545033|FG000|Overall Study|Subject to receive drug via EAP|1|||
160496351|NCT01236352|579545034|FG001|Overall Study|Subject to receive drug via EAP|1|||
160496352|NCT01236352|579545035|FG002|Overall Study|Subject to receive drug via EAP|1|||
160496353|NCT01236352|579545036|FG003|Overall Study|Subject to receive drug via EAP|0|||
160496354|NCT01236352|579545037|FG004|Overall Study|Subject to receive drug via EAP|0|||
160496355|NCT01236352|579545038|FG005|Overall Study|Subject to receive drug via EAP|0|||
160496356|NCT01236352|579545039|FG006|Overall Study|Subject to receive drug via EAP|0|||
160496357|NCT01236352|579545040|FG007|Overall Study|Subject to receive drug via EAP|2|||
160496358|NCT01236352|579545041|FG008|Overall Study|Subject to receive drug via EAP|0|||
160496359|NCT01236352|579545042|FG009|Overall Study|Subject to receive drug via EAP|4|||
160496360|NCT01236352|579545043|FG010|Overall Study|Subject to receive drug via EAP|0|||
160496361|NCT01236352|579545033|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
160496362|NCT01236352|579545034|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
160496363|NCT01236352|579545035|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
160496364|NCT01236352|579545036|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
160496365|NCT01236352|579545037|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
160496366|NCT01236352|579545038|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
160496367|NCT01236352|579545039|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
160496368|NCT01236352|579545040|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
160496369|NCT01236352|579545041|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
160496370|NCT01236352|579545042|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
160496371|NCT01236352|579545043|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
160496372|NCT01236352|579545033|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
160496373|NCT01236352|579545034|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
160496374|NCT01236352|579545035|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
160496375|NCT01236352|579545036|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
160496376|NCT01236352|579545037|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
160496377|NCT01236352|579545038|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
160496378|NCT01236352|579545039|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
160496379|NCT01236352|579545040|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
160496380|NCT01236352|579545041|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
160496381|NCT01236352|579545042|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
160496382|NCT01236352|579545043|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
160496383|NCT01236352|579545033|FG000|Overall Study|Lack of response to drug|0|||
160496384|NCT01236352|579545034|FG001|Overall Study|Lack of response to drug|0|||
160496385|NCT01236352|579545035|FG002|Overall Study|Lack of response to drug|0|||
160496386|NCT01236352|579545036|FG003|Overall Study|Lack of response to drug|0|||
160496387|NCT01236352|579545037|FG004|Overall Study|Lack of response to drug|0|||
160496388|NCT01236352|579545038|FG005|Overall Study|Lack of response to drug|0|||
160496389|NCT01236352|579545039|FG006|Overall Study|Lack of response to drug|0|||
160496390|NCT01236352|579545040|FG007|Overall Study|Lack of response to drug|0|||
160496391|NCT01236352|579545041|FG008|Overall Study|Lack of response to drug|0|||
160496392|NCT01236352|579545042|FG009|Overall Study|Lack of response to drug|1|||
160496393|NCT01236352|579545043|FG010|Overall Study|Lack of response to drug|1|||
160616430|NCT02033369|579973270|FG000|Overall Study|Not a good demographic match|0|||
160616431|NCT02033369|579973271|FG001|Overall Study|Not a good demographic match|2|||
160616432|NCT02033369|579973270|FG000|Overall Study|Withdrawal by Subject|1|||
160616433|NCT02033369|579973271|FG001|Overall Study|Withdrawal by Subject|1|||
160616434|NCT02033369|579973270|FG000|Overall Study|Lost to Follow-up|1|||
160616435|NCT02033369|579973271|FG001|Overall Study|Lost to Follow-up|0|||
160496394|NCT01236352|579545033|FG000|Overall Study|Patient transferred to IST|0|||
160496395|NCT01236352|579545034|FG001|Overall Study|Patient transferred to IST|0|||
160496396|NCT01236352|579545035|FG002|Overall Study|Patient transferred to IST|0|||
160496397|NCT01236352|579545036|FG003|Overall Study|Patient transferred to IST|0|||
160616436|NCT02033369|579973270|FG000|Overall Study|Protocol Violation|2|||
160616437|NCT02033369|579973271|FG001|Overall Study|Protocol Violation|0|||
160616438|NCT04335929|579973272|FG000|Overall Study|Lost to Follow-up|10|||
160616439|NCT02551874|579973285|FG000|Overall Study|Lost to Follow-up|0|||
160616440|NCT02551874|579973286|FG001|Overall Study|Lost to Follow-up|2|||
160616441|NCT02551874|579973285|FG000|Overall Study|Pregnancy|0|||
160616442|NCT02551874|579973286|FG001|Overall Study|Pregnancy|1|||
160616443|NCT02551874|579973285|FG000|Overall Study|Reason not reported|10|||
160616444|NCT02551874|579973286|FG001|Overall Study|Reason not reported|4|||
160616445|NCT02551874|579973285|FG000|Overall Study|Did not receive randomized treatment|0|||
160616446|NCT02551874|579973286|FG001|Overall Study|Did not receive randomized treatment|7|||
160616447|NCT02551874|579973285|FG000|Overall Study|Did not enter long-term study|18|||
160616448|NCT02551874|579973286|FG001|Overall Study|Did not enter long-term study|25|||
160616449|NCT02491463|579973287|FG000|Overall Study|Withdrawal by Subject|1|||
160616450|NCT02491463|579973288|FG001|Overall Study|Withdrawal by Subject|2|||
160616451|NCT02491463|579973289|FG002|Overall Study|Withdrawal by Subject|0|||
160616452|NCT02491463|579973290|FG003|Overall Study|Withdrawal by Subject|0|||
160616453|NCT02491463|579973287|FG000|Overall Study|Migrated/moved from study area|1|||
160616454|NCT02491463|579973288|FG001|Overall Study|Migrated/moved from study area|5|||
160616455|NCT02491463|579973289|FG002|Overall Study|Migrated/moved from study area|1|||
160616456|NCT02491463|579973290|FG003|Overall Study|Migrated/moved from study area|1|||
160616457|NCT02491463|579973287|FG000|Overall Study|Lost to Follow-up|0|||
160616458|NCT02491463|579973288|FG001|Overall Study|Lost to Follow-up|3|||
160616459|NCT02491463|579973289|FG002|Overall Study|Lost to Follow-up|3|||
160616460|NCT02491463|579973290|FG003|Overall Study|Lost to Follow-up|0|||
160616461|NCT01491802|579973291|FG000|Overall Study|Adverse Event|1|||
160616462|NCT01491802|579973292|FG001|Overall Study|Adverse Event|1|||
160616463|NCT01491802|579973291|FG000|Overall Study|Withdrawal by Subject|0|||
160616464|NCT01491802|579973292|FG001|Overall Study|Withdrawal by Subject|1|||
160616465|NCT01864746|579973295|FG000|Overall Study|Disease recurrence|25|||
160616466|NCT01864746|579973296|FG001|Overall Study|Disease recurrence|40|||
160616467|NCT01864746|579973295|FG000|Overall Study|Second primary invasive nonbreast|2|||
160616468|NCT01864746|579973296|FG001|Overall Study|Second primary invasive nonbreast|3|||
160616469|NCT01864746|579973295|FG000|Overall Study|Death|2|||
160616470|NCT01864746|579973296|FG001|Overall Study|Death|1|||
160616471|NCT01864746|579973295|FG000|Overall Study|Adverse Event|33|||
160616472|NCT01864746|579973296|FG001|Overall Study|Adverse Event|5|||
160616473|NCT01864746|579973295|FG000|Overall Study|Withdrawal by Subject|56|||
160616474|NCT01864746|579973296|FG001|Overall Study|Withdrawal by Subject|41|||
160616475|NCT01864746|579973295|FG000|Overall Study|Physician Decision|5|||
160616476|NCT01864746|579973296|FG001|Overall Study|Physician Decision|6|||
160616477|NCT00663208|579973297|FG000|Treatment Period|Lost to Follow-up|0|||
160616478|NCT00663208|579973298|FG001|Treatment Period|Lost to Follow-up|1|||
160616479|NCT00663208|579973299|FG002|Treatment Period|Lost to Follow-up|0|||
160616480|NCT00663208|579973300|FG003|Treatment Period|Lost to Follow-up|0|||
160616481|NCT00663208|579973301|FG004|Treatment Period|Lost to Follow-up|0|||
160616482|NCT00663208|579973302|FG005|Treatment Period|Lost to Follow-up|0|||
160616483|NCT00663208|579973303|FG006|Treatment Period|Lost to Follow-up|0|||
160616484|NCT00663208|579973297|FG000|Follow-up Period|Lost to Follow-up|2|||
160616485|NCT00663208|579973298|FG001|Follow-up Period|Lost to Follow-up|0|||
160616486|NCT00663208|579973299|FG002|Follow-up Period|Lost to Follow-up|3|||
160616487|NCT00663208|579973300|FG003|Follow-up Period|Lost to Follow-up|2|||
160616488|NCT00663208|579973301|FG004|Follow-up Period|Lost to Follow-up|0|||
160616489|NCT00663208|579973302|FG005|Follow-up Period|Lost to Follow-up|0|||
160616490|NCT00663208|579973303|FG006|Follow-up Period|Lost to Follow-up|0|||
160616491|NCT00663208|579973297|FG000|Follow-up Period|Other reason|1|||
160616492|NCT00663208|579973298|FG001|Follow-up Period|Other reason|0|||
160616493|NCT00663208|579973299|FG002|Follow-up Period|Other reason|0|||
160616494|NCT00663208|579973300|FG003|Follow-up Period|Other reason|0|||
160616495|NCT00663208|579973301|FG004|Follow-up Period|Other reason|0|||
160616496|NCT00663208|579973302|FG005|Follow-up Period|Other reason|0|||
160616497|NCT00663208|579973303|FG006|Follow-up Period|Other reason|1|||
160616498|NCT01005966|579973304|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
160616499|NCT01005966|579973305|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
160616500|NCT01005966|579973306|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
160616501|NCT01005966|579973307|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
160616502|NCT01005966|579973308|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
160616503|NCT01005966|579973304|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
160616504|NCT01005966|579973305|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
160616505|NCT01005966|579973306|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
160616506|NCT01005966|579973307|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
160616507|NCT01005966|579973308|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
160616508|NCT01005966|579973304|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
160616509|NCT01005966|579973305|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
160616510|NCT01005966|579973306|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
160616511|NCT01005966|579973307|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
160616512|NCT01005966|579973308|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
160616513|NCT01005966|579973304|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
160616514|NCT01005966|579973305|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
160616515|NCT01005966|579973306|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
160616516|NCT01005966|579973307|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
160616517|NCT01005966|579973308|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
160616518|NCT01005966|579973304|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160616519|NCT01005966|579973305|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160616520|NCT01005966|579973306|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160616521|NCT01005966|579973307|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
160616522|NCT01005966|579973308|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160616523|NCT01005966|579973304|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160616524|NCT01005966|579973305|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160616525|NCT01005966|579973306|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
160616526|NCT01005966|579973307|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160616527|NCT01005966|579973308|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160616528|NCT01005966|579973304|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
160616529|NCT01005966|579973305|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
160616530|NCT01005966|579973306|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
160616531|NCT01005966|579973307|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
160616532|NCT01005966|579973308|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
160616533|NCT01005966|579973304|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
160616534|NCT01005966|579973305|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
160616535|NCT01005966|579973306|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
160616536|NCT01005966|579973307|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
160616537|NCT01005966|579973308|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
160616538|NCT01005966|579973304|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
160616539|NCT01005966|579973305|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
160616540|NCT01005966|579973306|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
160616541|NCT01005966|579973307|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
160616542|NCT01005966|579973308|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
160616543|NCT00039377|579973309|FG000|Initial Registration|Adverse Event|2|||
160616544|NCT00039377|579973310|FG001|Initial Registration|Adverse Event|0|||
160616545|NCT00039377|579973311|FG002|Initial Registration|Adverse Event|0|||
160616546|NCT00039377|579973312|FG003|Initial Registration|Adverse Event|0|||
160616547|NCT00039377|579973309|FG000|Initial Registration|Relapsed|6|||
160616548|NCT00039377|579973310|FG001|Initial Registration|Relapsed|0|||
160616549|NCT00039377|579973311|FG002|Initial Registration|Relapsed|0|||
160616550|NCT00039377|579973312|FG003|Initial Registration|Relapsed|0|||
160616551|NCT00039377|579973309|FG000|Initial Registration|Received non-protocol therapy|11|||
160616552|NCT00039377|579973310|FG001|Initial Registration|Received non-protocol therapy|0|||
160616553|NCT00039377|579973311|FG002|Initial Registration|Received non-protocol therapy|0|||
160616554|NCT00039377|579973312|FG003|Initial Registration|Received non-protocol therapy|0|||
160616555|NCT00039377|579973309|FG000|Initial Registration|Withdrawal by Subject|3|||
160616556|NCT00039377|579973310|FG001|Initial Registration|Withdrawal by Subject|0|||
160616557|NCT00039377|579973311|FG002|Initial Registration|Withdrawal by Subject|0|||
160616558|NCT00039377|579973312|FG003|Initial Registration|Withdrawal by Subject|0|||
160616559|NCT01347931|579973313|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
160616560|NCT01249404|579973314|FG000|Overall Study|Study treatment not received|0|||
160616561|NCT01249404|579973315|FG001|Overall Study|Study treatment not received|1|||
160616562|NCT01249404|579973316|FG002|Overall Study|Study treatment not received|2|||
160616563|NCT01249404|579973314|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
160661639|NCT05093205|580144133|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
160661640|NCT05093205|580144134|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
160661641|NCT05093205|580144135|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
160661642|NCT05093205|580144136|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
160496398|NCT01236352|579545037|FG004|Overall Study|Patient transferred to IST|0|||
160496399|NCT01236352|579545038|FG005|Overall Study|Patient transferred to IST|0|||
160496400|NCT01236352|579545039|FG006|Overall Study|Patient transferred to IST|0|||
160496401|NCT01236352|579545040|FG007|Overall Study|Patient transferred to IST|0|||
160496402|NCT01236352|579545041|FG008|Overall Study|Patient transferred to IST|0|||
160496403|NCT01236352|579545042|FG009|Overall Study|Patient transferred to IST|2|||
160496404|NCT01236352|579545043|FG010|Overall Study|Patient transferred to IST|6|||
160616564|NCT01249404|579973315|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
160616565|NCT01249404|579973316|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
160616566|NCT01249404|579973314|FG000|Overall Study|Adverse Event|2|||
160616567|NCT01249404|579973315|FG001|Overall Study|Adverse Event|2|||
160616568|NCT01249404|579973316|FG002|Overall Study|Adverse Event|2|||
160616569|NCT01249404|579973314|FG000|Overall Study|Withdrawal by Subject|2|||
160616570|NCT01249404|579973315|FG001|Overall Study|Withdrawal by Subject|2|||
160616571|NCT01249404|579973316|FG002|Overall Study|Withdrawal by Subject|0|||
160616572|NCT01249404|579973314|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
160616573|NCT01249404|579973315|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
160496405|NCT01575873|579545044|FG000|Overall Study|Withdrawal by Subject|15|||
160496406|NCT01575873|579545045|FG001|Overall Study|Withdrawal by Subject|20|||
160496407|NCT01575873|579545046|FG002|Overall Study|Withdrawal by Subject|34|||
160496408|NCT01575873|579545047|FG003|Overall Study|Withdrawal by Subject|34|||
160496409|NCT01575873|579545044|FG000|Overall Study|Adverse Event|7|||
160496410|NCT01575873|579545045|FG001|Overall Study|Adverse Event|7|||
160496411|NCT01575873|579545046|FG002|Overall Study|Adverse Event|9|||
160496412|NCT01575873|579545047|FG003|Overall Study|Adverse Event|12|||
160496413|NCT01575873|579545044|FG000|Overall Study|Lost to Follow-up|1|||
160496414|NCT01575873|579545045|FG001|Overall Study|Lost to Follow-up|3|||
160496415|NCT01575873|579545046|FG002|Overall Study|Lost to Follow-up|13|||
160496416|NCT01575873|579545047|FG003|Overall Study|Lost to Follow-up|5|||
160496417|NCT01575873|579545044|FG000|Overall Study|Death|3|||
160496418|NCT01575873|579545045|FG001|Overall Study|Death|2|||
160496419|NCT01575873|579545046|FG002|Overall Study|Death|8|||
160496420|NCT01575873|579545047|FG003|Overall Study|Death|9|||
160496421|NCT01575873|579545044|FG000|Overall Study|Noncompliance|1|||
160496422|NCT01575873|579545045|FG001|Overall Study|Noncompliance|2|||
160496423|NCT01575873|579545046|FG002|Overall Study|Noncompliance|4|||
160496424|NCT01575873|579545047|FG003|Overall Study|Noncompliance|3|||
160496425|NCT01575873|579545044|FG000|Overall Study|Administrative decision|1|||
160496426|NCT01575873|579545045|FG001|Overall Study|Administrative decision|1|||
160496427|NCT01575873|579545046|FG002|Overall Study|Administrative decision|1|||
160496428|NCT01575873|579545047|FG003|Overall Study|Administrative decision|0|||
160496429|NCT01575873|579545044|FG000|Overall Study|Protocol deviation|0|||
160496430|NCT01575873|579545045|FG001|Overall Study|Protocol deviation|1|||
160496431|NCT01575873|579545046|FG002|Overall Study|Protocol deviation|0|||
160496432|NCT01575873|579545047|FG003|Overall Study|Protocol deviation|1|||
160496433|NCT01575873|579545044|FG000|Overall Study|Requirement for Alternative Therapy|0|||
160496434|NCT01575873|579545045|FG001|Overall Study|Requirement for Alternative Therapy|0|||
160496435|NCT01575873|579545046|FG002|Overall Study|Requirement for Alternative Therapy|1|||
160496436|NCT01575873|579545047|FG003|Overall Study|Requirement for Alternative Therapy|1|||
160496437|NCT01575873|579545044|FG000|Overall Study|Other|0|||
160496438|NCT01575873|579545045|FG001|Overall Study|Other|0|||
160496439|NCT01575873|579545046|FG002|Overall Study|Other|4|||
160496440|NCT01575873|579545047|FG003|Overall Study|Other|2|||
160496441|NCT01850030|579545048|FG000|Overall Study|Adverse Event|64|||
160496442|NCT01850030|579545049|FG001|Overall Study|Adverse Event|82|||
160496443|NCT01850030|579545048|FG000|Overall Study|Lack of Efficacy|3|||
160496444|NCT01850030|579545049|FG001|Overall Study|Lack of Efficacy|1|||
160496445|NCT01850030|579545048|FG000|Overall Study|Lost to Follow-up|5|||
160496446|NCT01850030|579545049|FG001|Overall Study|Lost to Follow-up|5|||
160496447|NCT01850030|579545048|FG000|Overall Study|Withdrawal by Subject|3|||
160496448|NCT01850030|579545049|FG001|Overall Study|Withdrawal by Subject|4|||
160496449|NCT01850030|579545048|FG000|Overall Study|Protocol Violation|24|||
160496450|NCT01850030|579545049|FG001|Overall Study|Protocol Violation|28|||
160496451|NCT01850030|579545048|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
160496452|NCT01850030|579545049|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
160496453|NCT00246090|579545050|FG000|Overall Study|Adverse Event|25|||
160496454|NCT00246090|579545050|FG000|Overall Study|Withdrawal by Subject|7|||
160496455|NCT00246090|579545050|FG000|Overall Study|Progressive Disease|212|||
160496456|NCT00246090|579545050|FG000|Overall Study|Clinical Progression|30|||
160496457|NCT00246090|579545050|FG000|Overall Study|Physician Decision|11|||
160496458|NCT00246090|579545050|FG000|Overall Study|Not Otherwise Specified|10|||
160616574|NCT01249404|579973316|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
160616575|NCT01249404|579973314|FG000|Overall Study|Non compliance to visit schedule|0|||
160616576|NCT01249404|579973315|FG001|Overall Study|Non compliance to visit schedule|1|||
160616577|NCT01249404|579973316|FG002|Overall Study|Non compliance to visit schedule|0|||
160616578|NCT03890731|579973317|FG000|Overall Study|Progressive disease|1|||
160616579|NCT03890731|579973317|FG000|Overall Study|Patient's decision|1|||
160496459|NCT03332784|579545051|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496460|NCT03332784|579545052|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
160496461|NCT03332784|579545053|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496462|NCT03332784|579545054|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496463|NCT03332784|579545055|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496464|NCT03332784|579545056|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496465|NCT03332784|579545057|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496466|NCT03332784|579545058|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496467|NCT03332784|579545059|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496468|NCT03332784|579545060|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496469|NCT03332784|579545061|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496470|NCT03332784|579545062|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496471|NCT03332784|579545063|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160616580|NCT03890731|579973317|FG000|Overall Study|Adverse Event|4|||
160616581|NCT03758612|579973318|FG000|Washout Period|Withdrawal by Subject|0|||
160616582|NCT03758612|579973319|FG001|Washout Period|Withdrawal by Subject|0|||
160616583|NCT03758612|579973320|FG002|Washout Period|Withdrawal by Subject|2|||
160496472|NCT03332784|579545064|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496473|NCT03332784|579545065|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
160496474|NCT03332784|579545066|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496475|NCT03332784|579545067|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496476|NCT03332784|579545068|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496477|NCT03332784|579545069|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496478|NCT03332784|579545070|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
160496479|NCT00763451|579545076|FG000|Overall Study|Adverse Event|4|||
160496480|NCT00763451|579545077|FG001|Overall Study|Adverse Event|6|||
160496481|NCT00763451|579545078|FG002|Overall Study|Adverse Event|19|||
160496482|NCT00763451|579545079|FG003|Overall Study|Adverse Event|14|||
160496483|NCT00763451|579545076|FG000|Overall Study|Lack of Efficacy|1|||
160496484|NCT00763451|579545077|FG001|Overall Study|Lack of Efficacy|4|||
160496485|NCT00763451|579545078|FG002|Overall Study|Lack of Efficacy|3|||
160496486|NCT00763451|579545079|FG003|Overall Study|Lack of Efficacy|2|||
160496487|NCT00763451|579545076|FG000|Overall Study|Withdrawal by Subject|1|||
160496488|NCT00763451|579545077|FG001|Overall Study|Withdrawal by Subject|6|||
160496489|NCT00763451|579545078|FG002|Overall Study|Withdrawal by Subject|9|||
160496490|NCT00763451|579545079|FG003|Overall Study|Withdrawal by Subject|7|||
160496491|NCT00763451|579545076|FG000|Overall Study|Protocol Violation|0|||
160496492|NCT00763451|579545077|FG001|Overall Study|Protocol Violation|0|||
160496493|NCT00763451|579545078|FG002|Overall Study|Protocol Violation|1|||
160496494|NCT00763451|579545079|FG003|Overall Study|Protocol Violation|0|||
160496495|NCT00763451|579545076|FG000|Overall Study|Poor Compliance to Protocol|1|||
160496496|NCT00763451|579545077|FG001|Overall Study|Poor Compliance to Protocol|1|||
160496497|NCT00763451|579545078|FG002|Overall Study|Poor Compliance to Protocol|2|||
160496498|NCT00763451|579545079|FG003|Overall Study|Poor Compliance to Protocol|2|||
160496499|NCT00763451|579545076|FG000|Overall Study|Familial and Personal Reasons|5|||
160496500|NCT00763451|579545077|FG001|Overall Study|Familial and Personal Reasons|3|||
160496501|NCT00763451|579545078|FG002|Overall Study|Familial and Personal Reasons|5|||
160496502|NCT00763451|579545079|FG003|Overall Study|Familial and Personal Reasons|4|||
160496503|NCT00763451|579545076|FG000|Overall Study|Randomized but not Treated|1|||
160496504|NCT00763451|579545077|FG001|Overall Study|Randomized but not Treated|1|||
160496505|NCT00763451|579545078|FG002|Overall Study|Randomized but not Treated|0|||
160496506|NCT00763451|579545079|FG003|Overall Study|Randomized but not Treated|0|||
160496507|NCT00763451|579545076|FG000|Overall Study|Study Site Reason|0|||
160496508|NCT00763451|579545077|FG001|Overall Study|Study Site Reason|1|||
160496509|NCT00763451|579545078|FG002|Overall Study|Study Site Reason|1|||
160496510|NCT00763451|579545079|FG003|Overall Study|Study Site Reason|1|||
160496511|NCT00115336|579545082|FG000|Overall Study|Hospital discharge before study drug|0|||
160496512|NCT00115336|579545083|FG001|Overall Study|Hospital discharge before study drug|1|||
160496513|NCT00569127|579545092|FG000|Overall Study|Adverse Event|57|||
160496514|NCT00569127|579545093|FG001|Overall Study|Adverse Event|47|||
160496515|NCT00569127|579545092|FG000|Overall Study|Withdrawal by Subject|13|||
160496516|NCT00569127|579545093|FG001|Overall Study|Withdrawal by Subject|27|||
160496517|NCT00569127|579545092|FG000|Overall Study|Progression|99|||
160496518|NCT00569127|579545093|FG001|Overall Study|Progression|100|||
160496519|NCT00569127|579545092|FG000|Overall Study|Death|4|||
160496520|NCT00569127|579545093|FG001|Overall Study|Death|3|||
160496521|NCT00569127|579545092|FG000|Overall Study|Other|20|||
160496522|NCT00569127|579545093|FG001|Overall Study|Other|19|||
160496523|NCT00569127|579545092|FG000|Overall Study|Lost to Follow-up|0|||
160496524|NCT00569127|579545093|FG001|Overall Study|Lost to Follow-up|3|||
160496525|NCT00569127|579545092|FG000|Overall Study|Not Eligible|14|||
160496526|NCT00569127|579545093|FG001|Overall Study|Not Eligible|11|||
160496527|NCT00569127|579545092|FG000|Overall Study|Still on Treatment|7|||
160496528|NCT00569127|579545093|FG001|Overall Study|Still on Treatment|3|||
160496529|NCT03149029|579545108|FG000|Overall Study|Adverse Event|2|||
160496530|NCT03149029|579545109|FG001|Overall Study|Adverse Event|0|||
160616584|NCT03758612|579973321|FG003|Washout Period|Withdrawal by Subject|0|||
160616585|NCT03758612|579973322|FG004|Washout Period|Withdrawal by Subject|0|||
160496531|NCT00356811|579545110|FG000|Overall Study|Death|35|||
160496532|NCT00356811|579545110|FG000|Overall Study|Lost to Follow-up|2|||
160496533|NCT00356811|579545110|FG000|Overall Study|Withdrawal by Subject|6|||
160496534|NCT00356811|579545110|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
160496535|NCT00356811|579545110|FG000|Overall Study|Study Is Terminating|3|||
160496536|NCT00356811|579545110|FG000|Overall Study|Site Closed during Follow-up|2|||
160496537|NCT01310699|579545111|FG000|Overall Study|Patients did not complete tandem.|4|||
160616586|NCT03758612|579973323|FG005|Washout Period|Withdrawal by Subject|0|||
160496538|NCT01310699|579545112|FG001|Overall Study|Patients did not complete tandem.|6|||
160496539|NCT02386839|579545113|FG000|Overall Study|Death|1|||
160496540|NCT02386839|579545114|FG001|Overall Study|Death|0|||
160496541|NCT02386839|579545113|FG000|Overall Study|Withdrawal by Subject|9|||
160496542|NCT02386839|579545114|FG001|Overall Study|Withdrawal by Subject|10|||
160496543|NCT02386839|579545113|FG000|Overall Study|Lost to Follow-up|4|||
160496544|NCT02386839|579545114|FG001|Overall Study|Lost to Follow-up|4|||
160496545|NCT02386839|579545113|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
160496546|NCT02386839|579545114|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
160496547|NCT02386839|579545113|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
160496548|NCT02386839|579545114|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
160496549|NCT02386839|579545113|FG000|Overall Study|Other (unspecified)|1|||
160496550|NCT02386839|579545114|FG001|Overall Study|Other (unspecified)|0|||
160496551|NCT00926575|579545115|FG000|Overall Study|Adverse Event|1|||
160496552|NCT00926575|579545116|FG001|Overall Study|Adverse Event|1|||
160496553|NCT00926575|579545115|FG000|Overall Study|Death|4|||
160496554|NCT00926575|579545116|FG001|Overall Study|Death|4|||
160496555|NCT00926575|579545115|FG000|Overall Study|Lost to Follow-up|1|||
160496556|NCT00926575|579545116|FG001|Overall Study|Lost to Follow-up|1|||
160496557|NCT00926575|579545115|FG000|Overall Study|Physician Decision|1|||
160496558|NCT00926575|579545116|FG001|Overall Study|Physician Decision|2|||
160496559|NCT00926575|579545115|FG000|Overall Study|Protocol Violation|1|||
160496560|NCT00926575|579545116|FG001|Overall Study|Protocol Violation|0|||
160496561|NCT00926575|579545115|FG000|Overall Study|Withdrawal by Subject|8|||
160496562|NCT00926575|579545116|FG001|Overall Study|Withdrawal by Subject|9|||
160496563|NCT00490698|579545117|FG000|Overall Study|Withdrawal by Subject|1|||
160496564|NCT00490698|579545117|FG000|Overall Study|Disease Progression|7|||
160496565|NCT00490698|579545117|FG000|Overall Study|Physician Decision|2|||
160496566|NCT02101983|579545119|FG000|Overall Study|Physician Decision|1|||
160496567|NCT02101983|579545120|FG001|Overall Study|Physician Decision|0|||
160496568|NCT03725605|579545124|FG000|Overall Study|Unsuccessful TIL expansion|2|||
160496569|NCT00469859|579545125|FG000|Overall Study|Inevaluable|0|||
160496570|NCT00469859|579545126|FG001|Overall Study|Inevaluable|2|||
160496571|NCT04124471|579545127|FG000|Overall Study|screen failure|1|||
160496572|NCT01503086|579545128|FG000|Overall Study|Lost to Follow-up|0|||
160496573|NCT01503086|579545129|FG001|Overall Study|Lost to Follow-up|1|||
160496574|NCT01503086|579545130|FG002|Overall Study|Lost to Follow-up|0|||
160496575|NCT01503086|579545128|FG000|Overall Study|Did Not Start Treatment|4|||
160496576|NCT01503086|579545129|FG001|Overall Study|Did Not Start Treatment|3|||
160496577|NCT01503086|579545130|FG002|Overall Study|Did Not Start Treatment|3|||
160496578|NCT01503086|579545128|FG000|Overall Study|Progressive disease|3|||
160496579|NCT01503086|579545129|FG001|Overall Study|Progressive disease|1|||
160616587|NCT03758612|579973324|FG006|Washout Period|Withdrawal by Subject|0|||
160616588|NCT03758612|579973325|FG007|Washout Period|Withdrawal by Subject|0|||
160616589|NCT03758612|579973326|FG008|Washout Period|Withdrawal by Subject|0|||
160616590|NCT03758612|579973327|FG009|Washout Period|Withdrawal by Subject|0|||
160616591|NCT03758612|579973328|FG010|Washout Period|Withdrawal by Subject|0|||
160616592|NCT03758612|579973329|FG011|Washout Period|Withdrawal by Subject|0|||
160616593|NCT03758612|579973318|FG000|Period 2|Protocol Violation|0|||
160616594|NCT03758612|579973319|FG001|Period 2|Protocol Violation|0|||
160616595|NCT03758612|579973320|FG002|Period 2|Protocol Violation|0|||
160616596|NCT03758612|579973321|FG003|Period 2|Protocol Violation|0|||
160616597|NCT03758612|579973322|FG004|Period 2|Protocol Violation|1|||
160616598|NCT03758612|579973323|FG005|Period 2|Protocol Violation|0|||
160616599|NCT03758612|579973324|FG006|Period 2|Protocol Violation|0|||
160616600|NCT03758612|579973325|FG007|Period 2|Protocol Violation|0|||
160616601|NCT03758612|579973326|FG008|Period 2|Protocol Violation|0|||
160616602|NCT03758612|579973327|FG009|Period 2|Protocol Violation|0|||
160616603|NCT03758612|579973328|FG010|Period 2|Protocol Violation|0|||
160616604|NCT03758612|579973329|FG011|Period 2|Protocol Violation|0|||
160616605|NCT01716585|579973330|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
160616606|NCT01716585|579973331|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
160616607|NCT01716585|579973330|FG000|Double-blind Treatment|Adverse Event|2|||
160616608|NCT01716585|579973331|FG001|Double-blind Treatment|Adverse Event|1|||
160616609|NCT01716585|579973330|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
160616610|NCT01716585|579973331|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
160616611|NCT01716585|579973330|FG000|Double-blind Treatment|Lost to Follow-up|2|||
160616612|NCT01716585|579973331|FG001|Double-blind Treatment|Lost to Follow-up|0|||
160616613|NCT01716585|579973330|FG000|Double-blind Treatment|Subject Noncompliant|1|||
160616614|NCT01716585|579973331|FG001|Double-blind Treatment|Subject Noncompliant|0|||
160496580|NCT01503086|579545130|FG002|Overall Study|Progressive disease|0|||
160496581|NCT01503086|579545128|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
160616615|NCT01716585|579973330|FG000|Double-blind Treatment|Other|1|||
160616616|NCT01716585|579973331|FG001|Double-blind Treatment|Other|0|||
160616617|NCT01716585|579973330|FG000|Open-label Treatment|Adverse Event|0|||
160616618|NCT01716585|579973331|FG001|Open-label Treatment|Adverse Event|2|||
160616619|NCT01716585|579973330|FG000|Open-label Treatment|Virologic Failure|0|||
160616620|NCT01716585|579973331|FG001|Open-label Treatment|Virologic Failure|2|||
160496582|NCT01503086|579545129|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
160496583|NCT01503086|579545130|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
160496584|NCT01503086|579545128|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
160496585|NCT01503086|579545129|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
160496586|NCT01503086|579545130|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
160616621|NCT01716585|579973330|FG000|Open-label Treatment|Withdrawal by Subject|0|||
160616622|NCT01716585|579973331|FG001|Open-label Treatment|Withdrawal by Subject|3|||
160616623|NCT00405756|579973332|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
160616624|NCT00405756|579973333|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
160616625|NCT00405756|579973334|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
160616626|NCT00405756|579973332|FG000|Double-blind Treatment|Adverse Event|31|||
160616627|NCT00405756|579973333|FG001|Double-blind Treatment|Adverse Event|27|||
160616628|NCT00405756|579973334|FG002|Double-blind Treatment|Adverse Event|12|||
160616629|NCT00405756|579973332|FG000|Double-blind Treatment|Disease Progression|47|||
160616630|NCT00405756|579973333|FG001|Double-blind Treatment|Disease Progression|81|||
160616631|NCT00405756|579973334|FG002|Double-blind Treatment|Disease Progression|102|||
160616632|NCT00405756|579973332|FG000|Double-blind Treatment|Lack of Efficacy|1|||
160616633|NCT00405756|579973333|FG001|Double-blind Treatment|Lack of Efficacy|4|||
160616634|NCT00405756|579973334|FG002|Double-blind Treatment|Lack of Efficacy|2|||
160616635|NCT00405756|579973332|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
160616636|NCT00405756|579973333|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
160616637|NCT00405756|579973334|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
160616638|NCT00405756|579973332|FG000|Double-blind Treatment|Lost to Follow-up|1|||
160616639|NCT00405756|579973333|FG001|Double-blind Treatment|Lost to Follow-up|0|||
160616640|NCT00405756|579973334|FG002|Double-blind Treatment|Lost to Follow-up|0|||
160616641|NCT00405756|579973332|FG000|Double-blind Treatment|Death|4|||
160616642|NCT00405756|579973333|FG001|Double-blind Treatment|Death|4|||
160616643|NCT00405756|579973334|FG002|Double-blind Treatment|Death|4|||
160616644|NCT00405756|579973332|FG000|Double-blind Treatment|Protocol Violation|1|||
160616645|NCT00405756|579973333|FG001|Double-blind Treatment|Protocol Violation|0|||
160616646|NCT00405756|579973334|FG002|Double-blind Treatment|Protocol Violation|2|||
160616647|NCT00405756|579973332|FG000|Double-blind Treatment|Other|7|||
160616648|NCT00405756|579973333|FG001|Double-blind Treatment|Other|4|||
160616649|NCT00405756|579973334|FG002|Double-blind Treatment|Other|4|||
160616650|NCT00405756|579973332|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
160616651|NCT00405756|579973333|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
160616652|NCT00405756|579973334|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
160616653|NCT00405756|579973332|FG000|Open-label Extension|Adverse Event|1|||
160616654|NCT00405756|579973333|FG001|Open-label Extension|Adverse Event|3|||
160616655|NCT00405756|579973334|FG002|Open-label Extension|Adverse Event|7|||
160616656|NCT00405756|579973332|FG000|Open-label Extension|Disease Progression|8|||
160616657|NCT00405756|579973333|FG001|Open-label Extension|Disease Progression|23|||
160616658|NCT00405756|579973334|FG002|Open-label Extension|Disease Progression|26|||
160616659|NCT00405756|579973332|FG000|Open-label Extension|Withdrawal by Subject|2|||
160616660|NCT00405756|579973333|FG001|Open-label Extension|Withdrawal by Subject|3|||
160616661|NCT00405756|579973334|FG002|Open-label Extension|Withdrawal by Subject|3|||
160616662|NCT00405756|579973332|FG000|Open-label Extension|Death|1|||
160616663|NCT00405756|579973333|FG001|Open-label Extension|Death|2|||
160616664|NCT00405756|579973334|FG002|Open-label Extension|Death|4|||
160616665|NCT00405756|579973332|FG000|Open-label Extension|Other|0|||
160616666|NCT00405756|579973333|FG001|Open-label Extension|Other|1|||
160616667|NCT00405756|579973334|FG002|Open-label Extension|Other|7|||
160616668|NCT00405756|579973332|FG000|Follow-up|Ongoing in Follow-up Period|52|||
160616669|NCT00405756|579973333|FG001|Follow-up|Ongoing in Follow-up Period|51|||
160616670|NCT00405756|579973334|FG002|Follow-up|Ongoing in Follow-up Period|60|||
160616671|NCT00405756|579973332|FG000|Follow-up|Death|21|||
160616672|NCT00405756|579973333|FG001|Follow-up|Death|31|||
160616673|NCT00405756|579973334|FG002|Follow-up|Death|24|||
160616674|NCT00405756|579973332|FG000|Follow-up|Lost to Follow-up|2|||
160616675|NCT00405756|579973333|FG001|Follow-up|Lost to Follow-up|8|||
160616676|NCT00405756|579973334|FG002|Follow-up|Lost to Follow-up|4|||
160616677|NCT04005885|579973342|FG000|First Intervention|Withdrawal by Subject|1|||
160616678|NCT04005885|579973343|FG001|First Intervention|Withdrawal by Subject|1|||
160616679|NCT04005885|579973342|FG000|Second Intervention|Withdrawal by Subject|0|||
160616680|NCT04005885|579973343|FG001|Second Intervention|Withdrawal by Subject|2|||
160616681|NCT01412333|579973344|FG000|Overall Study|Adverse Event|40|||
160616682|NCT01412333|579973345|FG001|Overall Study|Adverse Event|42|||
160616683|NCT01412333|579973344|FG000|Overall Study|Death|5|||
160616684|NCT01412333|579973345|FG001|Overall Study|Death|6|||
160616685|NCT01412333|579973344|FG000|Overall Study|Lack of Efficacy|22|||
160616686|NCT01412333|579973345|FG001|Overall Study|Lack of Efficacy|10|||
160616687|NCT01412333|579973344|FG000|Overall Study|Lost to Follow-up|15|||
160616688|NCT01412333|579973345|FG001|Overall Study|Lost to Follow-up|12|||
160496587|NCT05970640|579545133|FG000|Overall Study|Adverse Event|1|||
160496588|NCT05970640|579545134|FG001|Overall Study|Adverse Event|3|||
160616689|NCT01412333|579973344|FG000|Overall Study|Non-Compliance|3|||
160616690|NCT01412333|579973345|FG001|Overall Study|Non-Compliance|7|||
160616691|NCT01412333|579973344|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160616692|NCT01412333|579973345|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160616693|NCT01412333|579973344|FG000|Overall Study|Other|30|||
160496589|NCT05970640|579545135|FG002|Overall Study|Adverse Event|1|||
160616694|NCT01412333|579973345|FG001|Overall Study|Other|33|||
160616695|NCT01412333|579973344|FG000|Overall Study|Physician Decision|11|||
160616696|NCT01412333|579973345|FG001|Overall Study|Physician Decision|16|||
160616697|NCT01412333|579973344|FG000|Overall Study|Pregnancy|6|||
160616698|NCT01412333|579973345|FG001|Overall Study|Pregnancy|4|||
160616699|NCT01412333|579973344|FG000|Overall Study|Protocol Violation|1|||
160616700|NCT01412333|579973345|FG001|Overall Study|Protocol Violation|2|||
160616701|NCT01412333|579973344|FG000|Overall Study|Study Terminated By Sponsor|3|||
160616702|NCT01412333|579973345|FG001|Overall Study|Study Terminated By Sponsor|2|||
160616703|NCT01412333|579973344|FG000|Overall Study|Withdrawal by Subject|51|||
160616704|NCT01412333|579973345|FG001|Overall Study|Withdrawal by Subject|54|||
160616705|NCT01412333|579973344|FG000|Overall Study|Missing|1|||
160616706|NCT01412333|579973345|FG001|Overall Study|Missing|3|||
160616707|NCT01117428|579973346|FG000|Overall Study|Lack of Efficacy|1|||
160616708|NCT01117428|579973347|FG001|Overall Study|Lack of Efficacy|0|||
160616709|NCT01117428|579973348|FG002|Overall Study|Lack of Efficacy|0|||
160616710|NCT01117428|579973349|FG003|Overall Study|Lack of Efficacy|0|||
160616711|NCT01117428|579973350|FG004|Overall Study|Lack of Efficacy|0|||
160616712|NCT01117428|579973351|FG005|Overall Study|Lack of Efficacy|0|||
160616713|NCT01117428|579973346|FG000|Overall Study|Adverse Event|4|||
160616714|NCT01117428|579973347|FG001|Overall Study|Adverse Event|0|||
160616715|NCT01117428|579973348|FG002|Overall Study|Adverse Event|0|||
160616716|NCT01117428|579973349|FG003|Overall Study|Adverse Event|0|||
160616717|NCT01117428|579973350|FG004|Overall Study|Adverse Event|1|||
160616718|NCT01117428|579973351|FG005|Overall Study|Adverse Event|2|||
160616719|NCT01117428|579973346|FG000|Overall Study|Death|0|||
160616720|NCT01117428|579973347|FG001|Overall Study|Death|1|||
160616721|NCT01117428|579973348|FG002|Overall Study|Death|2|||
160616722|NCT01117428|579973349|FG003|Overall Study|Death|0|||
160616723|NCT01117428|579973350|FG004|Overall Study|Death|0|||
160616724|NCT01117428|579973351|FG005|Overall Study|Death|1|||
160616725|NCT01117428|579973346|FG000|Overall Study|Physician Decision|0|||
160616726|NCT01117428|579973347|FG001|Overall Study|Physician Decision|1|||
160616727|NCT01117428|579973348|FG002|Overall Study|Physician Decision|0|||
160616728|NCT01117428|579973349|FG003|Overall Study|Physician Decision|0|||
160616729|NCT01117428|579973350|FG004|Overall Study|Physician Decision|0|||
160616730|NCT01117428|579973351|FG005|Overall Study|Physician Decision|0|||
160616731|NCT01117428|579973346|FG000|Overall Study|Withdrawal by Subject|0|||
160616732|NCT01117428|579973347|FG001|Overall Study|Withdrawal by Subject|0|||
160616733|NCT01117428|579973348|FG002|Overall Study|Withdrawal by Subject|1|||
160616734|NCT01117428|579973349|FG003|Overall Study|Withdrawal by Subject|0|||
160616735|NCT01117428|579973350|FG004|Overall Study|Withdrawal by Subject|0|||
160616736|NCT01117428|579973351|FG005|Overall Study|Withdrawal by Subject|0|||
160616737|NCT01117428|579973346|FG000|Overall Study|Progressive disease|15|||
160616738|NCT01117428|579973347|FG001|Overall Study|Progressive disease|27|||
160616739|NCT01117428|579973348|FG002|Overall Study|Progressive disease|10|||
160616740|NCT01117428|579973349|FG003|Overall Study|Progressive disease|12|||
160616741|NCT01117428|579973350|FG004|Overall Study|Progressive disease|16|||
160616742|NCT01117428|579973351|FG005|Overall Study|Progressive disease|17|||
160616743|NCT02195531|579973352|FG000|Overall Study|Withdrawal by Subject|1|||
160616744|NCT02195531|579973353|FG001|Overall Study|Withdrawal by Subject|1|||
160616745|NCT02195531|579973354|FG002|Overall Study|Withdrawal by Subject|1|||
160616746|NCT01034709|579973358|FG000|Overall Study|Protocol Violation|9|||
160616747|NCT01034709|579973359|FG001|Overall Study|Protocol Violation|16|||
160616748|NCT01657253|579973362|FG000|Overall Study|Lost to Follow-up|6|||
160616749|NCT01657253|579973363|FG001|Overall Study|Lost to Follow-up|5|||
160616750|NCT01657253|579973362|FG000|Overall Study|Withdrawal by Subject|11|||
160616751|NCT01657253|579973363|FG001|Overall Study|Withdrawal by Subject|12|||
160616752|NCT01657253|579973362|FG000|Overall Study|Adverse Event|0|||
160616753|NCT01657253|579973363|FG001|Overall Study|Adverse Event|1|||
160616754|NCT01970540|579973364|FG000|Overall Study|Non-treatment-related AE|0|||
160616755|NCT01970540|579973365|FG001|Overall Study|Non-treatment-related AE|0|||
160616756|NCT01970540|579973366|FG002|Overall Study|Non-treatment-related AE|1|||
160616757|NCT01970540|579973364|FG000|Overall Study|Progressive disease|55|||
160616758|NCT01970540|579973365|FG001|Overall Study|Progressive disease|23|||
160616759|NCT01970540|579973366|FG002|Overall Study|Progressive disease|10|||
160616760|NCT01970540|579973364|FG000|Overall Study|Treatment delay over protocol|0|||
160616761|NCT01970540|579973365|FG001|Overall Study|Treatment delay over protocol|0|||
160616762|NCT01970540|579973366|FG002|Overall Study|Treatment delay over protocol|1|||
160616763|NCT01970540|579973364|FG000|Overall Study|Physician Decision|7|||
160616764|NCT01970540|579973365|FG001|Overall Study|Physician Decision|2|||
160616765|NCT01970540|579973366|FG002|Overall Study|Physician Decision|0|||
160616766|NCT01970540|579973364|FG000|Overall Study|Clinical progression|0|||
160616767|NCT01970540|579973365|FG001|Overall Study|Clinical progression|1|||
160616768|NCT01970540|579973366|FG002|Overall Study|Clinical progression|1|||
160616769|NCT01970540|579973364|FG000|Overall Study|End of study|2|||
160616770|NCT01970540|579973365|FG001|Overall Study|End of study|0|||
160616771|NCT01970540|579973366|FG002|Overall Study|End of study|2|||
160616772|NCT01970540|579973364|FG000|Overall Study|Adverse Event|0|||
160616773|NCT01970540|579973365|FG001|Overall Study|Adverse Event|2|||
160616774|NCT01970540|579973366|FG002|Overall Study|Adverse Event|1|||
160616775|NCT01970540|579973364|FG000|Overall Study|Treatment-related AE|4|||
160616776|NCT01970540|579973365|FG001|Overall Study|Treatment-related AE|0|||
160616777|NCT01970540|579973366|FG002|Overall Study|Treatment-related AE|2|||
160616778|NCT01970540|579973364|FG000|Overall Study|Withdrawal by Subject|4|||
160616779|NCT01970540|579973365|FG001|Overall Study|Withdrawal by Subject|0|||
160616780|NCT01970540|579973366|FG002|Overall Study|Withdrawal by Subject|1|||
160616781|NCT01970540|579973364|FG000|Overall Study|Clinical deterioration|1|||
160616782|NCT01970540|579973365|FG001|Overall Study|Clinical deterioration|0|||
160616783|NCT01970540|579973366|FG002|Overall Study|Clinical deterioration|0|||
160616784|NCT00242710|579973368|FG000|Core Study (up to Year 1)|Adverse Event|30|||
160616785|NCT00242710|579973369|FG001|Core Study (up to Year 1)|Adverse Event|25|||
160616786|NCT00242710|579973370|FG002|Core Study (up to Year 1)|Adverse Event|23|||
160616787|NCT00242710|579973371|FG003|Core Study (up to Year 1)|Adverse Event|14|||
160616788|NCT00242710|579973368|FG000|Core Study (up to Year 1)|Death|0|||
160616789|NCT00242710|579973369|FG001|Core Study (up to Year 1)|Death|0|||
160616790|NCT00242710|579973370|FG002|Core Study (up to Year 1)|Death|1|||
160616791|NCT00242710|579973371|FG003|Core Study (up to Year 1)|Death|0|||
160616792|NCT00242710|579973368|FG000|Core Study (up to Year 1)|Physician Decision|0|||
160616793|NCT00242710|579973369|FG001|Core Study (up to Year 1)|Physician Decision|1|||
160616794|NCT00242710|579973370|FG002|Core Study (up to Year 1)|Physician Decision|0|||
160616795|NCT00242710|579973371|FG003|Core Study (up to Year 1)|Physician Decision|1|||
160616796|NCT00242710|579973368|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
160616797|NCT00242710|579973369|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
160616798|NCT00242710|579973370|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
160616799|NCT00242710|579973371|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
160616800|NCT00242710|579973368|FG000|Core Study (up to Year 1)|Other|6|||
160616801|NCT00242710|579973369|FG001|Core Study (up to Year 1)|Other|1|||
160616802|NCT00242710|579973370|FG002|Core Study (up to Year 1)|Other|0|||
160616803|NCT00242710|579973371|FG003|Core Study (up to Year 1)|Other|2|||
160616804|NCT00242710|579973368|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
160616805|NCT00242710|579973369|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
160616806|NCT00242710|579973370|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
160616807|NCT00242710|579973371|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
160616808|NCT00242710|579973368|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
160616809|NCT00242710|579973369|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
160616810|NCT00242710|579973370|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
160616811|NCT00242710|579973371|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
160616812|NCT00242710|579973368|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
160616813|NCT00242710|579973369|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
160616814|NCT00242710|579973370|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
160616815|NCT00242710|579973371|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
160616816|NCT00242710|579973368|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
160616817|NCT00242710|579973369|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
160616818|NCT00242710|579973370|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
160616819|NCT00242710|579973371|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
160616820|NCT00242710|579973368|FG000|Period Between Core Study and Extension|Adverse Event|2|||
160616821|NCT00242710|579973369|FG001|Period Between Core Study and Extension|Adverse Event|3|||
160616822|NCT00242710|579973370|FG002|Period Between Core Study and Extension|Adverse Event|5|||
160616823|NCT00242710|579973371|FG003|Period Between Core Study and Extension|Adverse Event|2|||
160616824|NCT00242710|579973368|FG000|Period Between Core Study and Extension|Physician Decision|1|||
160616825|NCT00242710|579973369|FG001|Period Between Core Study and Extension|Physician Decision|1|||
160616826|NCT00242710|579973370|FG002|Period Between Core Study and Extension|Physician Decision|0|||
160616827|NCT00242710|579973371|FG003|Period Between Core Study and Extension|Physician Decision|0|||
160616828|NCT00242710|579973368|FG000|Period Between Core Study and Extension|Other|24|||
160616829|NCT00242710|579973369|FG001|Period Between Core Study and Extension|Other|24|||
160616830|NCT00242710|579973370|FG002|Period Between Core Study and Extension|Other|9|||
160616831|NCT00242710|579973371|FG003|Period Between Core Study and Extension|Other|11|||
160616832|NCT00242710|579973368|FG000|Period Between Core Study and Extension|Extension not Available|17|||
160616833|NCT00242710|579973369|FG001|Period Between Core Study and Extension|Extension not Available|21|||
160616834|NCT00242710|579973370|FG002|Period Between Core Study and Extension|Extension not Available|8|||
160616835|NCT00242710|579973371|FG003|Period Between Core Study and Extension|Extension not Available|7|||
160616836|NCT00242710|579973368|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
160616837|NCT00242710|579973369|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
160616838|NCT00242710|579973370|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
160616839|NCT00242710|579973371|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
160616840|NCT00242710|579973368|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
160616841|NCT00242710|579973369|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
160616842|NCT00242710|579973370|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
160616843|NCT00242710|579973371|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
160616844|NCT00242710|579973368|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
160496590|NCT05970640|579545136|FG003|Overall Study|Adverse Event|0|||
160496591|NCT05970640|579545133|FG000|Overall Study|Withdrawal by Subject|0|||
160496592|NCT05970640|579545134|FG001|Overall Study|Withdrawal by Subject|0|||
160496593|NCT05970640|579545135|FG002|Overall Study|Withdrawal by Subject|1|||
160496594|NCT05970640|579545136|FG003|Overall Study|Withdrawal by Subject|1|||
160496595|NCT05970640|579545133|FG000|Overall Study|Sponsor decision|0|||
160496596|NCT05970640|579545134|FG001|Overall Study|Sponsor decision|0|||
160496597|NCT05970640|579545135|FG002|Overall Study|Sponsor decision|1|||
160496598|NCT05970640|579545136|FG003|Overall Study|Sponsor decision|1|||
160496599|NCT01730950|579546330|FG000|Overall Study|Protocol Violation|6|||
160616845|NCT00242710|579973369|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
160616846|NCT00242710|579973370|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
160616847|NCT00242710|579973371|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
160616848|NCT00242710|579973368|FG000|Study Extension (up to Year 2)|Death|0|||
160496600|NCT01730950|579546331|FG001|Overall Study|Protocol Violation|6|||
160496601|NCT02737826|579546332|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
160496602|NCT02737826|579546333|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
160496603|NCT02737826|579546334|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
160496604|NCT01317875|579546335|FG000|Overall Study|Other|0|||
160496605|NCT01317875|579546336|FG001|Overall Study|Other|0|||
160496606|NCT01317875|579546337|FG002|Overall Study|Other|1|||
160496607|NCT01317875|579546338|FG003|Overall Study|Other|0|||
160496608|NCT01317875|579546339|FG004|Overall Study|Other|0|||
160496609|NCT01317875|579546340|FG005|Overall Study|Other|0|||
160496610|NCT01317875|579546341|FG006|Overall Study|Other|0|||
160496611|NCT01317875|579546342|FG007|Overall Study|Other|0|||
160496612|NCT01317875|579546343|FG008|Overall Study|Other|0|||
160496613|NCT01317875|579546344|FG009|Overall Study|Other|0|||
160496614|NCT01317875|579546335|FG000|Overall Study|Noncompliance with study drug|0|||
160496615|NCT01317875|579546336|FG001|Overall Study|Noncompliance with study drug|0|||
160496616|NCT01317875|579546337|FG002|Overall Study|Noncompliance with study drug|1|||
160496617|NCT01317875|579546338|FG003|Overall Study|Noncompliance with study drug|0|||
160496618|NCT01317875|579546339|FG004|Overall Study|Noncompliance with study drug|0|||
160496619|NCT01317875|579546340|FG005|Overall Study|Noncompliance with study drug|0|||
160496620|NCT01317875|579546341|FG006|Overall Study|Noncompliance with study drug|0|||
160496621|NCT01317875|579546342|FG007|Overall Study|Noncompliance with study drug|0|||
160496622|NCT01317875|579546343|FG008|Overall Study|Noncompliance with study drug|0|||
160496623|NCT01317875|579546344|FG009|Overall Study|Noncompliance with study drug|0|||
160496624|NCT01317875|579546335|FG000|Overall Study|Progressive Disease|1|||
160496625|NCT01317875|579546336|FG001|Overall Study|Progressive Disease|0|||
160496626|NCT01317875|579546337|FG002|Overall Study|Progressive Disease|2|||
160496627|NCT01317875|579546338|FG003|Overall Study|Progressive Disease|0|||
160496628|NCT01317875|579546339|FG004|Overall Study|Progressive Disease|1|||
160496629|NCT01317875|579546340|FG005|Overall Study|Progressive Disease|0|||
160496630|NCT01317875|579546341|FG006|Overall Study|Progressive Disease|0|||
160496631|NCT01317875|579546342|FG007|Overall Study|Progressive Disease|1|||
160496632|NCT01317875|579546343|FG008|Overall Study|Progressive Disease|0|||
160496633|NCT01317875|579546344|FG009|Overall Study|Progressive Disease|0|||
160496634|NCT01317875|579546335|FG000|Overall Study|Withdrawal by Subject|0|||
160496635|NCT01317875|579546336|FG001|Overall Study|Withdrawal by Subject|0|||
160496636|NCT01317875|579546337|FG002|Overall Study|Withdrawal by Subject|0|||
160496637|NCT01317875|579546338|FG003|Overall Study|Withdrawal by Subject|0|||
160496638|NCT01317875|579546339|FG004|Overall Study|Withdrawal by Subject|1|||
160496639|NCT01317875|579546340|FG005|Overall Study|Withdrawal by Subject|0|||
160496640|NCT01317875|579546341|FG006|Overall Study|Withdrawal by Subject|0|||
160496641|NCT01317875|579546342|FG007|Overall Study|Withdrawal by Subject|3|||
160496642|NCT01317875|579546343|FG008|Overall Study|Withdrawal by Subject|0|||
160496643|NCT01317875|579546344|FG009|Overall Study|Withdrawal by Subject|0|||
160496644|NCT01317875|579546335|FG000|Overall Study|Physician Decision|0|||
160496645|NCT01317875|579546336|FG001|Overall Study|Physician Decision|1|||
160496646|NCT01317875|579546337|FG002|Overall Study|Physician Decision|1|||
160496647|NCT01317875|579546338|FG003|Overall Study|Physician Decision|0|||
160496648|NCT01317875|579546339|FG004|Overall Study|Physician Decision|2|||
160496649|NCT01317875|579546340|FG005|Overall Study|Physician Decision|0|||
160616849|NCT00242710|579973369|FG001|Study Extension (up to Year 2)|Death|0|||
160496650|NCT01317875|579546341|FG006|Overall Study|Physician Decision|0|||
160616850|NCT00242710|579973370|FG002|Study Extension (up to Year 2)|Death|0|||
160616851|NCT00242710|579973371|FG003|Study Extension (up to Year 2)|Death|1|||
160496651|NCT01317875|579546342|FG007|Overall Study|Physician Decision|2|||
160496652|NCT01317875|579546343|FG008|Overall Study|Physician Decision|0|||
160496653|NCT01317875|579546344|FG009|Overall Study|Physician Decision|0|||
160496654|NCT01317875|579546335|FG000|Overall Study|Death|0|||
160496655|NCT01317875|579546336|FG001|Overall Study|Death|0|||
160496656|NCT01317875|579546337|FG002|Overall Study|Death|2|||
160496657|NCT01317875|579546338|FG003|Overall Study|Death|1|||
160496658|NCT01317875|579546339|FG004|Overall Study|Death|0|||
160496659|NCT01317875|579546340|FG005|Overall Study|Death|1|||
160496660|NCT01317875|579546341|FG006|Overall Study|Death|0|||
160616852|NCT00242710|579973368|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
160616853|NCT00242710|579973369|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
160616854|NCT00242710|579973370|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
160616855|NCT00242710|579973371|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
160616856|NCT00242710|579973368|FG000|Study Extension (up to Year 2)|Other|3|||
160616857|NCT00242710|579973369|FG001|Study Extension (up to Year 2)|Other|5|||
160616858|NCT00242710|579973370|FG002|Study Extension (up to Year 2)|Other|4|||
160616859|NCT00242710|579973371|FG003|Study Extension (up to Year 2)|Other|3|||
160616860|NCT00242710|579973368|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
160616861|NCT00242710|579973369|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
160616862|NCT00242710|579973370|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
160616863|NCT00242710|579973371|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
160616864|NCT00242710|579973368|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
160616865|NCT00242710|579973369|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
160616866|NCT00242710|579973370|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
160616867|NCT00242710|579973371|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
160616868|NCT01057394|579973372|FG000|Overall Study|Not eligible|0|||
160616869|NCT01057394|579973373|FG001|Overall Study|Not eligible|2|||
160616870|NCT01195636|579973374|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
160616871|NCT01195636|579973375|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
160616872|NCT01195636|579973374|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
160616873|NCT01195636|579973375|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
160616874|NCT01195636|579973374|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
160616875|NCT01195636|579973375|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
160616876|NCT01195636|579973374|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
160616877|NCT01195636|579973375|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
160616878|NCT01195636|579973374|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
160616879|NCT01195636|579973375|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
160616880|NCT01195636|579973374|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
160616881|NCT01195636|579973375|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
160616882|NCT01195636|579973374|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
160616883|NCT01195636|579973375|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
160616884|NCT01195636|579973374|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
160616885|NCT01195636|579973375|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
160616886|NCT00579527|579973376|FG000|Overall Study|Death|4|||
160616887|NCT00203294|579973377|FG000|Overall Study|Withdrawal by Subject|8|||
160616888|NCT00203294|579973378|FG001|Overall Study|Withdrawal by Subject|13|||
160616889|NCT01566981|579973388|FG000|Overall Study|Lost to Follow-up|5|||
160616890|NCT01566981|579973389|FG001|Overall Study|Lost to Follow-up|8|||
160616891|NCT02177942|579973390|FG000|Overall Study|Adverse Event|1|||
160616892|NCT02177942|579973391|FG001|Overall Study|Adverse Event|0|||
160616893|NCT02177942|579973390|FG000|Overall Study|Lost to Follow-up|1|||
160616894|NCT02177942|579973391|FG001|Overall Study|Lost to Follow-up|1|||
160616895|NCT02177942|579973390|FG000|Overall Study|Protocol Violation|4|||
160616896|NCT02177942|579973391|FG001|Overall Study|Protocol Violation|6|||
160616897|NCT02177942|579973390|FG000|Overall Study|Withdrawal by Subject|71|||
160616898|NCT02177942|579973391|FG001|Overall Study|Withdrawal by Subject|81|||
160616899|NCT02405091|579973394|FG000|Overall Study|Adverse Event|16|||
160616900|NCT02405091|579973395|FG001|Overall Study|Adverse Event|10|||
160616901|NCT02405091|579973396|FG002|Overall Study|Adverse Event|0|||
160616902|NCT02405091|579973394|FG000|Overall Study|Protocol Violation|1|||
160616903|NCT02405091|579973395|FG001|Overall Study|Protocol Violation|0|||
160616904|NCT02405091|579973396|FG002|Overall Study|Protocol Violation|0|||
160616905|NCT02405091|579973394|FG000|Overall Study|Noncompliance|1|||
160616906|NCT02405091|579973395|FG001|Overall Study|Noncompliance|6|||
160616907|NCT02405091|579973396|FG002|Overall Study|Noncompliance|2|||
160616908|NCT02405091|579973394|FG000|Overall Study|Withdrawal by Subject|4|||
160616909|NCT02405091|579973395|FG001|Overall Study|Withdrawal by Subject|8|||
160616910|NCT02405091|579973396|FG002|Overall Study|Withdrawal by Subject|0|||
160616911|NCT02405091|579973394|FG000|Overall Study|Death|0|||
160616912|NCT02405091|579973395|FG001|Overall Study|Death|1|||
160616913|NCT02405091|579973396|FG002|Overall Study|Death|0|||
160616914|NCT02405091|579973394|FG000|Overall Study|Lost to Follow-up|5|||
160616915|NCT02405091|579973395|FG001|Overall Study|Lost to Follow-up|6|||
160616916|NCT02405091|579973396|FG002|Overall Study|Lost to Follow-up|0|||
160616917|NCT02405091|579973394|FG000|Overall Study|Physician Decision|2|||
160616918|NCT02405091|579973395|FG001|Overall Study|Physician Decision|2|||
160616919|NCT02405091|579973396|FG002|Overall Study|Physician Decision|0|||
160616920|NCT01948791|579973404|FG000|Overall Study|Adverse Event|12|||
160616921|NCT01948791|579973404|FG000|Overall Study|Lack of Efficacy|3|||
160616922|NCT01948791|579973404|FG000|Overall Study|Protocol Violation|2|||
160616923|NCT01948791|579973404|FG000|Overall Study|Withdrawal by Subject|5|||
160616924|NCT01948791|579973404|FG000|Overall Study|Lost to Follow-up|6|||
160616925|NCT01948791|579973404|FG000|Overall Study|Management issues|1|||
160616926|NCT01948791|579973404|FG000|Overall Study|Others|7|||
160616927|NCT01948791|579973404|FG000|Overall Study|Screening failure|35|||
160616928|NCT02555722|579973412|FG000|Week 2|Adverse Event|0|||
160616929|NCT02555722|579973413|FG001|Week 2|Adverse Event|1|||
160616930|NCT02555722|579973412|FG000|Week 2|Withdrawal by Subject|1|||
160616931|NCT02555722|579973413|FG001|Week 2|Withdrawal by Subject|0|||
160616932|NCT02555722|579973412|FG000|Month 1|Lens Discomfort|1|||
160616933|NCT02555722|579973413|FG001|Month 1|Lens Discomfort|0|||
160616934|NCT02555722|579973412|FG000|Month 2|Withdrawal by Subject|3|||
160616935|NCT02555722|579973413|FG001|Month 2|Withdrawal by Subject|0|||
160616936|NCT02555722|579973412|FG000|Month 2|Lost to Follow-up|1|||
160616937|NCT02555722|579973413|FG001|Month 2|Lost to Follow-up|0|||
160616938|NCT00702949|579973414|FG000|Overall Study|Refusal|3|||
160616939|NCT00702949|579973415|FG001|Overall Study|Refusal|2|||
160616940|NCT00702949|579973416|FG002|Overall Study|Refusal|2|||
160616941|NCT00702949|579973414|FG000|Overall Study|Adverse Event|1|||
160616942|NCT00702949|579973415|FG001|Overall Study|Adverse Event|6|||
160616943|NCT00702949|579973416|FG002|Overall Study|Adverse Event|3|||
160616944|NCT00702949|579973414|FG000|Overall Study|Other Medical Reason/unknown|1|||
160616945|NCT00702949|579973415|FG001|Overall Study|Other Medical Reason/unknown|1|||
160616946|NCT00702949|579973416|FG002|Overall Study|Other Medical Reason/unknown|3|||
160616947|NCT00598585|579973417|FG000|Overall Study|Lost to Follow-up|1|||
160616948|NCT00598585|579973418|FG001|Overall Study|Lost to Follow-up|0|||
160616949|NCT03525613|579973423|FG000|Overall Study|Adverse Event|11|||
160616950|NCT03525613|579973424|FG001|Overall Study|Adverse Event|8|||
160616951|NCT03525613|579973425|FG002|Overall Study|Adverse Event|3|||
160616952|NCT03525613|579973426|FG003|Overall Study|Adverse Event|3|||
160616953|NCT03525613|579973423|FG000|Overall Study|Lost to Follow-up|4|||
160616954|NCT03525613|579973424|FG001|Overall Study|Lost to Follow-up|5|||
160616955|NCT03525613|579973425|FG002|Overall Study|Lost to Follow-up|3|||
160616956|NCT03525613|579973426|FG003|Overall Study|Lost to Follow-up|2|||
160616957|NCT03525613|579973423|FG000|Overall Study|Physician Decision|0|||
160616958|NCT03525613|579973424|FG001|Overall Study|Physician Decision|1|||
160616959|NCT03525613|579973425|FG002|Overall Study|Physician Decision|0|||
160616960|NCT03525613|579973426|FG003|Overall Study|Physician Decision|1|||
160616961|NCT03525613|579973423|FG000|Overall Study|Consent Withdrawal|25|||
160616962|NCT03525613|579973424|FG001|Overall Study|Consent Withdrawal|16|||
160616963|NCT03525613|579973425|FG002|Overall Study|Consent Withdrawal|12|||
160616964|NCT03525613|579973426|FG003|Overall Study|Consent Withdrawal|9|||
160616965|NCT03525613|579973423|FG000|Overall Study|Death|20|||
160616966|NCT03525613|579973424|FG001|Overall Study|Death|9|||
160616967|NCT03525613|579973425|FG002|Overall Study|Death|7|||
160616968|NCT03525613|579973426|FG003|Overall Study|Death|1|||
160616969|NCT03525613|579973423|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
160616970|NCT03525613|579973424|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
160616971|NCT03525613|579973425|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
160616972|NCT03525613|579973426|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
160616973|NCT03480360|579973427|FG000|Overall Study|Death|2|||
160616974|NCT01040728|579973433|FG000|Overall Study|Adverse Event|4|||
160616975|NCT01040728|579973434|FG001|Overall Study|Adverse Event|8|||
160616976|NCT01040728|579973435|FG002|Overall Study|Adverse Event|0|||
160616977|NCT01040728|579973436|FG003|Overall Study|Adverse Event|4|||
160616978|NCT01040728|579973433|FG000|Overall Study|Withdrawal by Subject|0|||
160616979|NCT01040728|579973434|FG001|Overall Study|Withdrawal by Subject|1|||
160616980|NCT01040728|579973435|FG002|Overall Study|Withdrawal by Subject|1|||
160616981|NCT01040728|579973436|FG003|Overall Study|Withdrawal by Subject|0|||
160616982|NCT01040728|579973433|FG000|Overall Study|Protocol Violation|0|||
160616983|NCT01040728|579973434|FG001|Overall Study|Protocol Violation|0|||
160616984|NCT01040728|579973435|FG002|Overall Study|Protocol Violation|0|||
160616985|NCT01040728|579973436|FG003|Overall Study|Protocol Violation|1|||
160616986|NCT01040728|579973433|FG000|Overall Study|Lack of Efficacy|0|||
160616987|NCT01040728|579973434|FG001|Overall Study|Lack of Efficacy|1|||
160616988|NCT01040728|579973435|FG002|Overall Study|Lack of Efficacy|0|||
160616989|NCT01040728|579973436|FG003|Overall Study|Lack of Efficacy|1|||
160616990|NCT01040728|579973433|FG000|Overall Study|Other reasons not listed above|0|||
160616991|NCT01040728|579973434|FG001|Overall Study|Other reasons not listed above|1|||
160616992|NCT01040728|579973435|FG002|Overall Study|Other reasons not listed above|0|||
160616993|NCT01040728|579973436|FG003|Overall Study|Other reasons not listed above|0|||
160616994|NCT01012037|579973437|FG000|Overall Study|Adverse Event|0|||
160616995|NCT01012037|579973438|FG001|Overall Study|Adverse Event|8|||
160616996|NCT01012037|579973439|FG002|Overall Study|Adverse Event|3|||
160616997|NCT01012037|579973437|FG000|Overall Study|Protocol Violation|0|||
160616998|NCT01012037|579973438|FG001|Overall Study|Protocol Violation|3|||
160616999|NCT01012037|579973439|FG002|Overall Study|Protocol Violation|5|||
160617000|NCT01012037|579973437|FG000|Overall Study|Withdrawal by Subject|0|||
160661643|NCT05093205|580144137|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
160617001|NCT01012037|579973438|FG001|Overall Study|Withdrawal by Subject|4|||
160617002|NCT01012037|579973439|FG002|Overall Study|Withdrawal by Subject|1|||
160617003|NCT01012037|579973437|FG000|Overall Study|Other reason (not specified)|1|||
160617004|NCT01012037|579973438|FG001|Overall Study|Other reason (not specified)|1|||
160617005|NCT01012037|579973439|FG002|Overall Study|Other reason (not specified)|1|||
160617006|NCT00590031|579973445|FG000|Overall Study|Adverse Event|3|||
160617007|NCT00590031|579973445|FG000|Overall Study|Withdrawal by Subject|1|||
160617008|NCT00590031|579973445|FG000|Overall Study|Metastatic Disease|1|||
160617009|NCT00590031|579973445|FG000|Overall Study|Admin Hold|1|||
160617010|NCT03196973|579973446|FG000|Overall Study|Adverse Event|1|||
160617011|NCT03196973|579973447|FG001|Overall Study|Adverse Event|1|||
160617012|NCT03196973|579973448|FG002|Overall Study|Adverse Event|2|||
160617013|NCT03196973|579973446|FG000|Overall Study|Lack of Efficacy|2|||
160617014|NCT03196973|579973447|FG001|Overall Study|Lack of Efficacy|6|||
160617015|NCT03196973|579973448|FG002|Overall Study|Lack of Efficacy|1|||
160617016|NCT03196973|579973446|FG000|Overall Study|Lost to Follow-up|4|||
160617017|NCT03196973|579973447|FG001|Overall Study|Lost to Follow-up|3|||
160617018|NCT03196973|579973448|FG002|Overall Study|Lost to Follow-up|2|||
160617019|NCT03196973|579973446|FG000|Overall Study|Consent withdrawn|2|||
160617020|NCT03196973|579973447|FG001|Overall Study|Consent withdrawn|1|||
160617021|NCT03196973|579973448|FG002|Overall Study|Consent withdrawn|0|||
160617022|NCT03196973|579973446|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
160617023|NCT03196973|579973447|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
160617024|NCT03196973|579973448|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
160617025|NCT01809327|579973449|FG000|Overall Study|Lost to Follow-up|5|||
160617026|NCT01809327|579973450|FG001|Overall Study|Lost to Follow-up|2|||
160617027|NCT01809327|579973451|FG002|Overall Study|Lost to Follow-up|4|||
160617028|NCT01809327|579973452|FG003|Overall Study|Lost to Follow-up|2|||
160617029|NCT01809327|579973453|FG004|Overall Study|Lost to Follow-up|3|||
160617030|NCT01809327|579973449|FG000|Overall Study|Withdrawal by Subject|6|||
160617031|NCT01809327|579973450|FG001|Overall Study|Withdrawal by Subject|4|||
160617032|NCT01809327|579973451|FG002|Overall Study|Withdrawal by Subject|4|||
160617033|NCT01809327|579973452|FG003|Overall Study|Withdrawal by Subject|2|||
160617034|NCT01809327|579973453|FG004|Overall Study|Withdrawal by Subject|5|||
160617035|NCT01809327|579973449|FG000|Overall Study|Adverse Event|4|||
160617036|NCT01809327|579973450|FG001|Overall Study|Adverse Event|3|||
160617037|NCT01809327|579973451|FG002|Overall Study|Adverse Event|7|||
160617038|NCT01809327|579973452|FG003|Overall Study|Adverse Event|4|||
160617039|NCT01809327|579973453|FG004|Overall Study|Adverse Event|8|||
160617040|NCT01809327|579973449|FG000|Overall Study|Death|1|||
160617041|NCT01809327|579973450|FG001|Overall Study|Death|0|||
160617042|NCT01809327|579973451|FG002|Overall Study|Death|0|||
160617043|NCT01809327|579973452|FG003|Overall Study|Death|0|||
160617044|NCT01809327|579973453|FG004|Overall Study|Death|0|||
160617045|NCT01809327|579973449|FG000|Overall Study|Protocol Violation|0|||
160617046|NCT01809327|579973450|FG001|Overall Study|Protocol Violation|1|||
160617047|NCT01809327|579973451|FG002|Overall Study|Protocol Violation|0|||
160617048|NCT01809327|579973452|FG003|Overall Study|Protocol Violation|0|||
160617049|NCT01809327|579973453|FG004|Overall Study|Protocol Violation|0|||
160617050|NCT01809327|579973449|FG000|Overall Study|Physician Decision|1|||
160617051|NCT01809327|579973450|FG001|Overall Study|Physician Decision|1|||
160617052|NCT01809327|579973451|FG002|Overall Study|Physician Decision|0|||
160617053|NCT01809327|579973452|FG003|Overall Study|Physician Decision|0|||
160617054|NCT01809327|579973453|FG004|Overall Study|Physician Decision|0|||
160617055|NCT01809327|579973449|FG000|Overall Study|Pregnancy|1|||
160617056|NCT01809327|579973450|FG001|Overall Study|Pregnancy|0|||
160617057|NCT01809327|579973451|FG002|Overall Study|Pregnancy|0|||
160617058|NCT01809327|579973452|FG003|Overall Study|Pregnancy|0|||
160617059|NCT01809327|579973453|FG004|Overall Study|Pregnancy|0|||
160617060|NCT01809327|579973449|FG000|Overall Study|Other|14|||
160617061|NCT01809327|579973450|FG001|Overall Study|Other|15|||
160617062|NCT01809327|579973451|FG002|Overall Study|Other|7|||
160617063|NCT01809327|579973452|FG003|Overall Study|Other|4|||
160617064|NCT01809327|579973453|FG004|Overall Study|Other|9|||
160617065|NCT00826540|579973454|FG000|Overall Study|ineligible|3|||
160617066|NCT00826540|579973454|FG000|Overall Study|Withdrawal by Subject|1|||
160617067|NCT01166386|579973455|FG000|Overall Study|Withdrawal by Subject|3|||
160617068|NCT01166386|579973456|FG001|Overall Study|Withdrawal by Subject|5|||
160617069|NCT02802735|579973457|FG000|Overall Study|Withdrawal by Subject|0|||
160617070|NCT02802735|579973458|FG001|Overall Study|Withdrawal by Subject|1|||
160617071|NCT02802735|579973459|FG002|Overall Study|Withdrawal by Subject|0|||
160617072|NCT02802735|579973460|FG003|Overall Study|Withdrawal by Subject|0|||
160617073|NCT02802735|579973461|FG004|Overall Study|Withdrawal by Subject|0|||
160617074|NCT03922711|579973466|FG000|Overall Study|Adverse Event|3|||
160617075|NCT03922711|579973467|FG001|Overall Study|Adverse Event|2|||
160661644|NCT05093205|580144138|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
160617076|NCT03922711|579973468|FG002|Overall Study|Adverse Event|2|||
160617077|NCT03922711|579973466|FG000|Overall Study|Protocol Violation|1|||
160617078|NCT03922711|579973467|FG001|Overall Study|Protocol Violation|0|||
160617079|NCT03922711|579973468|FG002|Overall Study|Protocol Violation|0|||
160617080|NCT03922711|579973466|FG000|Overall Study|Withdrawal by Subject|0|||
160617081|NCT03922711|579973467|FG001|Overall Study|Withdrawal by Subject|3|||
160617082|NCT03922711|579973468|FG002|Overall Study|Withdrawal by Subject|1|||
160617083|NCT03922711|579973466|FG000|Overall Study|Not further specified|0|||
160617084|NCT03922711|579973467|FG001|Overall Study|Not further specified|0|||
160496661|NCT01317875|579546342|FG007|Overall Study|Death|4|||
160496662|NCT01317875|579546343|FG008|Overall Study|Death|0|||
160496663|NCT01317875|579546344|FG009|Overall Study|Death|0|||
160496664|NCT01317875|579546335|FG000|Overall Study|Adverse Event|2|||
160496665|NCT01317875|579546336|FG001|Overall Study|Adverse Event|1|||
160496666|NCT01317875|579546337|FG002|Overall Study|Adverse Event|2|||
160496667|NCT01317875|579546338|FG003|Overall Study|Adverse Event|1|||
160496668|NCT01317875|579546339|FG004|Overall Study|Adverse Event|5|||
160496669|NCT01317875|579546340|FG005|Overall Study|Adverse Event|1|||
160496670|NCT01317875|579546341|FG006|Overall Study|Adverse Event|2|||
160496671|NCT01317875|579546342|FG007|Overall Study|Adverse Event|5|||
160496672|NCT01317875|579546343|FG008|Overall Study|Adverse Event|0|||
160496673|NCT01317875|579546344|FG009|Overall Study|Adverse Event|0|||
160496674|NCT00863512|579546352|FG000|Overall Study|Adverse Event|2|||
160496675|NCT00863512|579546353|FG001|Overall Study|Adverse Event|0|||
160496676|NCT00863512|579546352|FG000|Overall Study|Withdrawal by Subject|11|||
160496677|NCT00863512|579546353|FG001|Overall Study|Withdrawal by Subject|0|||
160496678|NCT00863512|579546352|FG000|Overall Study|Physician Decision|1|||
160496679|NCT00863512|579546353|FG001|Overall Study|Physician Decision|0|||
160496680|NCT01437423|579546358|FG000|Overall Study|Lost to Follow-up|12|||
160496681|NCT01437423|579546358|FG000|Overall Study|Off label usage|3|||
160496682|NCT01375751|579546359|FG000|Overall Study|Other|0|||
160496683|NCT01375751|579546360|FG001|Overall Study|Other|1|||
160496684|NCT01375751|579546361|FG002|Overall Study|Other|0|||
160496685|NCT05186311|579546362|FG000|Part A: Serum|Withdrawal by Subject|1|||
160496686|NCT00983853|579546367|FG000|Overall Study|Lost to Follow-up|1|||
160496687|NCT00983853|579546368|FG001|Overall Study|Lost to Follow-up|1|||
160496688|NCT00983853|579546369|FG002|Overall Study|Lost to Follow-up|2|||
160496689|NCT00983853|579546370|FG003|Overall Study|Lost to Follow-up|2|||
160496690|NCT00983853|579546371|FG004|Overall Study|Lost to Follow-up|2|||
160496691|NCT00983853|579546372|FG005|Overall Study|Lost to Follow-up|1|||
160496692|NCT00983853|579546367|FG000|Overall Study|Withdrawal by Subject|0|||
160496693|NCT00983853|579546368|FG001|Overall Study|Withdrawal by Subject|0|||
160496694|NCT00983853|579546369|FG002|Overall Study|Withdrawal by Subject|1|||
160496695|NCT00983853|579546370|FG003|Overall Study|Withdrawal by Subject|0|||
160496696|NCT00983853|579546371|FG004|Overall Study|Withdrawal by Subject|1|||
160496697|NCT00983853|579546372|FG005|Overall Study|Withdrawal by Subject|0|||
160496698|NCT00983853|579546367|FG000|Overall Study|Unable to come to study follow-up visits|0|||
160496699|NCT00983853|579546368|FG001|Overall Study|Unable to come to study follow-up visits|1|||
160496700|NCT00983853|579546369|FG002|Overall Study|Unable to come to study follow-up visits|0|||
160496701|NCT00983853|579546370|FG003|Overall Study|Unable to come to study follow-up visits|0|||
160496702|NCT00983853|579546371|FG004|Overall Study|Unable to come to study follow-up visits|0|||
160496703|NCT00983853|579546372|FG005|Overall Study|Unable to come to study follow-up visits|0|||
160496704|NCT00478205|579546376|FG000|Overall Study|Adverse Event|182|||
160496705|NCT00478205|579546377|FG001|Overall Study|Adverse Event|39|||
160496706|NCT00478205|579546376|FG000|Overall Study|Medication Non-compliance|9|||
160496707|NCT00478205|579546377|FG001|Overall Study|Medication Non-compliance|4|||
160496708|NCT00478205|579546376|FG000|Overall Study|Protocol Violation|15|||
160496709|NCT00478205|579546377|FG001|Overall Study|Protocol Violation|5|||
160496710|NCT00478205|579546376|FG000|Overall Study|Request of Investigator or Sponsor|4|||
160496711|NCT00478205|579546377|FG001|Overall Study|Request of Investigator or Sponsor|5|||
160496712|NCT00478205|579546376|FG000|Overall Study|Withdrawal by Subject|61|||
160496713|NCT00478205|579546377|FG001|Overall Study|Withdrawal by Subject|22|||
160496714|NCT00478205|579546376|FG000|Overall Study|Lack of Efficacy|1|||
160496715|NCT00478205|579546377|FG001|Overall Study|Lack of Efficacy|0|||
160496716|NCT00478205|579546376|FG000|Overall Study|Other|24|||
160496717|NCT00478205|579546377|FG001|Overall Study|Other|12|||
160496718|NCT01791413|579546378|FG000|Overall Study|Lost to Follow-up|5|||
160617085|NCT03922711|579973468|FG002|Overall Study|Not further specified|1|||
160617086|NCT02390362|579973469|FG000|Overall Study|Withdrawal by Subject|0|||
160617087|NCT02390362|579973470|FG001|Overall Study|Withdrawal by Subject|1|||
160617088|NCT01711359|579973476|FG000|Treatment Period|Withdrawal by Subject|18|||
160617089|NCT01711359|579973477|FG001|Treatment Period|Withdrawal by Subject|7|||
160496719|NCT01791413|579546379|FG001|Overall Study|Lost to Follow-up|1|||
160496720|NCT00825305|579546389|FG000|Overall Study|Adverse Event|1|||
160496721|NCT00825305|579546390|FG001|Overall Study|Adverse Event|1|||
160496722|NCT00825305|579546389|FG000|Overall Study|Withdrawal by Subject|6|||
160496723|NCT00825305|579546390|FG001|Overall Study|Withdrawal by Subject|12|||
160617090|NCT01711359|579973478|FG002|Treatment Period|Withdrawal by Subject|13|||
160496724|NCT00825305|579546389|FG000|Overall Study|Inappropriate inclusion|1|||
160496725|NCT00825305|579546390|FG001|Overall Study|Inappropriate inclusion|0|||
160496726|NCT00825305|579546389|FG000|Overall Study|Protocol Violation|9|||
160496727|NCT00825305|579546390|FG001|Overall Study|Protocol Violation|9|||
160496728|NCT00825305|579546389|FG000|Overall Study|Can not be classified|0|||
160496729|NCT00825305|579546390|FG001|Overall Study|Can not be classified|1|||
160496730|NCT04016272|579546391|FG000|Overall Study|Withdrawal by Subject|1|||
160496731|NCT04016272|579546392|FG001|Overall Study|Withdrawal by Subject|2|||
160617091|NCT01711359|579973476|FG000|Treatment Period|Lack of Efficacy|13|||
160617092|NCT01711359|579973477|FG001|Treatment Period|Lack of Efficacy|2|||
160617093|NCT01711359|579973478|FG002|Treatment Period|Lack of Efficacy|2|||
160617094|NCT01711359|579973476|FG000|Treatment Period|Adverse Event|8|||
160617095|NCT01711359|579973477|FG001|Treatment Period|Adverse Event|10|||
160617096|NCT01711359|579973478|FG002|Treatment Period|Adverse Event|24|||
160617097|NCT01711359|579973476|FG000|Treatment Period|Physician Decision|4|||
160617098|NCT01711359|579973477|FG001|Treatment Period|Physician Decision|3|||
160617099|NCT01711359|579973478|FG002|Treatment Period|Physician Decision|2|||
160617100|NCT01711359|579973476|FG000|Treatment Period|Death|3|||
160617101|NCT01711359|579973477|FG001|Treatment Period|Death|0|||
160617102|NCT01711359|579973478|FG002|Treatment Period|Death|0|||
160617103|NCT01711359|579973476|FG000|Treatment Period|Entry Criteria Not Met|1|||
160617104|NCT01711359|579973477|FG001|Treatment Period|Entry Criteria Not Met|0|||
160617105|NCT01711359|579973478|FG002|Treatment Period|Entry Criteria Not Met|0|||
160617106|NCT01711359|579973476|FG000|Treatment Period|Sponsor Decision|1|||
160617107|NCT01711359|579973477|FG001|Treatment Period|Sponsor Decision|0|||
160617108|NCT01711359|579973478|FG002|Treatment Period|Sponsor Decision|0|||
160617109|NCT01711359|579973476|FG000|Treatment Period|Lost to Follow-up|1|||
160617110|NCT01711359|579973477|FG001|Treatment Period|Lost to Follow-up|1|||
160617111|NCT01711359|579973478|FG002|Treatment Period|Lost to Follow-up|1|||
160617112|NCT01711359|579973476|FG000|Treatment Period|Randomized, Not Treated|3|||
160617113|NCT01711359|579973477|FG001|Treatment Period|Randomized, Not Treated|1|||
160617114|NCT01711359|579973478|FG002|Treatment Period|Randomized, Not Treated|0|||
160617115|NCT01385098|579973479|FG000|Overall Study|Adverse Event|10|||
160617116|NCT01385098|579973479|FG000|Overall Study|Lost to Follow-up|4|||
160617117|NCT00795717|579973480|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
160617118|NCT00795717|579973481|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
160617119|NCT00795717|579973480|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
160617120|NCT00795717|579973481|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
160617121|NCT00795717|579973480|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
160617122|NCT00795717|579973481|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
160617123|NCT00795717|579973480|FG000|Phase II|too busy|0|||
160617124|NCT00795717|579973481|FG001|Phase II|too busy|1|||
160617125|NCT00027846|579975771|FG000|Overall Study|Lost to Follow-up|0|||
160617126|NCT00027846|579975772|FG001|Overall Study|Lost to Follow-up|41|||
160617127|NCT00027846|579975773|FG002|Overall Study|Lost to Follow-up|9|||
160617128|NCT00027846|579975771|FG000|Overall Study|Withdrawal by Subject|0|||
160496732|NCT01827046|579546402|FG000|Overall Study|Lost to Follow-up|1|||
160496733|NCT01827046|579546403|FG001|Overall Study|Lost to Follow-up|5|||
160496734|NCT01827046|579546402|FG000|Overall Study|Withdrawal by Subject|0|||
160496735|NCT01827046|579546403|FG001|Overall Study|Withdrawal by Subject|4|||
160496736|NCT05594589|579546405|FG000|Overall Study|Other|0|||
160496737|NCT05594589|579546406|FG001|Overall Study|Other|1|||
160496738|NCT05594589|579546407|FG002|Overall Study|Other|0|||
160617129|NCT00027846|579975772|FG001|Overall Study|Withdrawal by Subject|14|||
160617130|NCT00027846|579975773|FG002|Overall Study|Withdrawal by Subject|7|||
160617131|NCT00027846|579975771|FG000|Overall Study|Ineligible for study|2|||
160617132|NCT00027846|579975772|FG001|Overall Study|Ineligible for study|6|||
160617133|NCT00027846|579975773|FG002|Overall Study|Ineligible for study|14|||
160617134|NCT00027846|579975771|FG000|Overall Study|Entry into another COG therapeutic study|0|||
160617135|NCT00027846|579975772|FG001|Overall Study|Entry into another COG therapeutic study|5|||
160617136|NCT00027846|579975773|FG002|Overall Study|Entry into another COG therapeutic study|2|||
160617137|NCT00027846|579975771|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
160617138|NCT00027846|579975772|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
160617139|NCT00027846|579975773|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
160617140|NCT04067310|579975775|FG000|Overall Study|Physician Decision|2|||
160617141|NCT04067310|579975776|FG001|Overall Study|Physician Decision|6|||
160617142|NCT04067310|579975775|FG000|Overall Study|Lost to Follow-up|0|||
160617143|NCT04067310|579975776|FG001|Overall Study|Lost to Follow-up|1|||
160617144|NCT04067310|579975775|FG000|Overall Study|Withdrawal by Subject|3|||
160617145|NCT04067310|579975776|FG001|Overall Study|Withdrawal by Subject|0|||
160617146|NCT01041027|579975777|FG000|Overall Study|Withdrawal by Subject|2|||
160617147|NCT01041027|579975777|FG000|Overall Study|Protocol Violation|1|||
160617148|NCT01041027|579975777|FG000|Overall Study|Delayed Radiation Therapy|1|||
160617149|NCT01041027|579975777|FG000|Overall Study|Adverse Event|4|||
160496739|NCT02282917|579546409|FG000|Overall Study|Withdrawal by Subject|1|||
160617150|NCT02528643|579975778|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
160617151|NCT02528643|579975779|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
160617152|NCT02528643|579975778|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
160617153|NCT02528643|579975779|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
160617154|NCT02528643|579975778|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
160617155|NCT02528643|579975779|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
160617156|NCT02528643|579975778|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
160617157|NCT02528643|579975779|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
160617158|NCT02528643|579975778|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
160617159|NCT02528643|579975779|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
160617160|NCT02528643|579975778|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
160617161|NCT02528643|579975779|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
160617162|NCT02528643|579975778|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
160617163|NCT02528643|579975779|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
160617164|NCT02058940|579975780|FG000|Overall Study|Discharged from Critical Care Unit|1|||
160617165|NCT04144140|579975781|FG000|Overall Study|Other|0|||
160617166|NCT04144140|579975782|FG001|Overall Study|Other|0|||
160617167|NCT04144140|579975783|FG002|Overall Study|Other|0|||
160617168|NCT04144140|579975784|FG003|Overall Study|Other|0|||
160617169|NCT04144140|579975785|FG004|Overall Study|Other|0|||
160617170|NCT04144140|579975786|FG005|Overall Study|Other|1|||
160617171|NCT04144140|579975787|FG006|Overall Study|Other|0|||
160617172|NCT02039687|579975788|FG000|Overall Study|Adverse Event|0|||
160617173|NCT02039687|579975789|FG001|Overall Study|Adverse Event|0|||
160617174|NCT02039687|579975790|FG002|Overall Study|Adverse Event|1|||
160617175|NCT02039687|579975791|FG003|Overall Study|Adverse Event|0|||
160617176|NCT02039687|579975788|FG000|Overall Study|Withdrawal by Subject|0|||
160617177|NCT02039687|579975789|FG001|Overall Study|Withdrawal by Subject|1|||
160617178|NCT02039687|579975790|FG002|Overall Study|Withdrawal by Subject|0|||
160617179|NCT02039687|579975791|FG003|Overall Study|Withdrawal by Subject|0|||
160617180|NCT02039687|579975788|FG000|Overall Study|treatment assignment could not be confir|0|||
160617181|NCT02039687|579975789|FG001|Overall Study|treatment assignment could not be confir|0|||
160617182|NCT02039687|579975790|FG002|Overall Study|treatment assignment could not be confir|2|||
160617183|NCT02039687|579975791|FG003|Overall Study|treatment assignment could not be confir|0|||
160617184|NCT00443534|579975794|FG000|Overall Study|Lack of Efficacy|67|||
160617185|NCT00443534|579975794|FG000|Overall Study|Adverse Event|16|||
160617186|NCT00443534|579975794|FG000|Overall Study|Death|9|||
160617187|NCT00443534|579975794|FG000|Overall Study|Withdrawal by Subject|8|||
160617188|NCT00443534|579975794|FG000|Overall Study|Study Terminated by Sponsor|12|||
160617189|NCT00443534|579975794|FG000|Overall Study|Other|10|||
160617190|NCT00443534|579975794|FG000|Overall Study|Enrolled, Not Treated|1|||
160617191|NCT00305773|579975796|FG000|Overall Study|Death|3|||
160617192|NCT00305773|579975797|FG001|Overall Study|Death|2|||
160617193|NCT00305773|579975796|FG000|Overall Study|Adverse Event|1|||
160617194|NCT00305773|579975797|FG001|Overall Study|Adverse Event|2|||
160617195|NCT00305773|579975796|FG000|Overall Study|Alternative Treatment|4|||
160617196|NCT00305773|579975797|FG001|Overall Study|Alternative Treatment|4|||
160617197|NCT00305773|579975796|FG000|Overall Study|Physician Decision|1|||
160617198|NCT00305773|579975797|FG001|Overall Study|Physician Decision|1|||
160617199|NCT00305773|579975796|FG000|Overall Study|Withdrawal by Subject|1|||
160617200|NCT00305773|579975797|FG001|Overall Study|Withdrawal by Subject|4|||
160617201|NCT00305773|579975796|FG000|Overall Study|Disease Progression|1|||
160617202|NCT00305773|579975797|FG001|Overall Study|Disease Progression|3|||
160617203|NCT00305773|579975796|FG000|Overall Study|All other reasons|3|||
160617204|NCT00305773|579975797|FG001|Overall Study|All other reasons|2|||
160617205|NCT02679222|579975798|FG000|Overall Study|No time for project|1|||
160617206|NCT00303719|579975799|FG000|Overall Study|Not evaluable, prior therapies|0|||
160617207|NCT00303719|579975800|FG001|Overall Study|Not evaluable, prior therapies|30|||
160617208|NCT00303719|579975799|FG000|Overall Study|Lost to Follow-up|0|||
160617209|NCT00303719|579975800|FG001|Overall Study|Lost to Follow-up|7|||
160617210|NCT01641952|579975801|FG000|Overall Study|Lost to Follow-up|28|||
160617211|NCT01641952|579975801|FG000|Overall Study|Adverse Event|6|||
160617212|NCT02500901|579975804|FG000|Overall Study|Disease ProgressionDD|2|||
160617213|NCT01191190|579975805|FG000|Overall Study|Withdrawal by Subject|1|||
160617214|NCT02643420|579975811|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
160617215|NCT02643420|579975812|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
160617216|NCT02643420|579975811|FG000|Overall Study|Withdrawal by Subject|25|||
160617217|NCT02643420|579975812|FG001|Overall Study|Withdrawal by Subject|19|||
160617218|NCT02643420|579975811|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
160617219|NCT02643420|579975812|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
160617220|NCT02643420|579975811|FG000|Overall Study|Lost to Follow-up|6|||
160661645|NCT05093205|580144139|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
160661646|NCT05093205|580144140|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
160661647|NCT05093205|580144141|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
160617221|NCT02643420|579975812|FG001|Overall Study|Lost to Follow-up|10|||
160617222|NCT02643420|579975811|FG000|Overall Study|Investigator Decision|2|||
160617223|NCT02643420|579975812|FG001|Overall Study|Investigator Decision|4|||
160617224|NCT02643420|579975811|FG000|Overall Study|Sponsor decision|1|||
160617225|NCT02643420|579975812|FG001|Overall Study|Sponsor decision|1|||
160617226|NCT02643420|579975811|FG000|Overall Study|Death|0|||
160617227|NCT02643420|579975812|FG001|Overall Study|Death|2|||
160617228|NCT02643420|579975811|FG000|Overall Study|Reason not Specified|8|||
160617229|NCT02643420|579975812|FG001|Overall Study|Reason not Specified|7|||
160617230|NCT01710709|579975813|FG000|Overall Study|Lost to Follow-up|29|||
160617231|NCT01710709|579975813|FG000|Overall Study|Adverse Event|48|||
160617232|NCT01710709|579975813|FG000|Overall Study|Participant met withdrawal criteria|33|||
160617233|NCT01710709|579975813|FG000|Overall Study|Participant withdrawn by investigator|2|||
160617234|NCT01710709|579975813|FG000|Overall Study|Withdrawal by Subject|53|||
160617235|NCT01710709|579975813|FG000|Overall Study|Protocol Violation|5|||
160617236|NCT01710709|579975813|FG000|Overall Study|Lack of Efficacy|3|||
160617237|NCT02630459|579975819|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
160617238|NCT02630459|579975820|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
160617239|NCT02630459|579975821|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
160661648|NCT05093205|580144129|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160617240|NCT02630459|579975822|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
160617241|NCT02630459|579975823|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
160617242|NCT02630459|579975824|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
160617243|NCT02630459|579975825|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
160617244|NCT02630459|579975826|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
160617245|NCT02630459|579975819|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
160617246|NCT02630459|579975820|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
160617247|NCT02630459|579975821|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
160617248|NCT02630459|579975822|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
160617249|NCT02630459|579975823|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
160617250|NCT02630459|579975824|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
160617251|NCT02630459|579975825|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
160617252|NCT02630459|579975826|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
160617253|NCT02630459|579975819|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
160617254|NCT02630459|579975820|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
160617255|NCT02630459|579975821|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
160617256|NCT02630459|579975822|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
160617257|NCT02630459|579975823|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
160617258|NCT02630459|579975824|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
160617259|NCT02630459|579975825|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
160617260|NCT02630459|579975826|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
160617261|NCT02630459|579975819|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
160617262|NCT02630459|579975820|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
160617263|NCT02630459|579975821|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
160617264|NCT02630459|579975822|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
160617265|NCT02630459|579975823|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
160617266|NCT02630459|579975824|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
160617267|NCT02630459|579975825|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
160617268|NCT02630459|579975826|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
160617269|NCT02630459|579975819|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
160617270|NCT02630459|579975820|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
160617271|NCT02630459|579975821|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
160617272|NCT02630459|579975822|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
160617273|NCT02630459|579975823|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
160617274|NCT02630459|579975824|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
160617275|NCT02630459|579975825|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
160617276|NCT02630459|579975826|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
160617277|NCT02630459|579975819|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
160617278|NCT02630459|579975820|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
160617279|NCT02630459|579975821|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
160617280|NCT02630459|579975822|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
160617281|NCT02630459|579975823|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
160617282|NCT02630459|579975824|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
160617283|NCT02630459|579975825|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
160617284|NCT02630459|579975826|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
160617285|NCT02630459|579975819|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
160617286|NCT02630459|579975820|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
160617287|NCT02630459|579975821|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
160617288|NCT02630459|579975822|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
160617289|NCT02630459|579975823|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
160617290|NCT02630459|579975824|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
160617291|NCT02630459|579975825|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
160617292|NCT02630459|579975826|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
160617293|NCT01797302|579975827|FG000|Overall Study|Lost to Follow-up|16|||
160617294|NCT01797302|579975828|FG001|Overall Study|Lost to Follow-up|23|||
160617295|NCT01797302|579975829|FG002|Overall Study|Lost to Follow-up|22|||
160617296|NCT01797302|579975827|FG000|Overall Study|Withdrawal by Subject|1|||
160617297|NCT01797302|579975828|FG001|Overall Study|Withdrawal by Subject|3|||
160617298|NCT01797302|579975829|FG002|Overall Study|Withdrawal by Subject|4|||
160617299|NCT00348686|579975830|FG000|Overall Study|Withdrawal by Subject|45|||
160617300|NCT00348686|579975830|FG000|Overall Study|Adverse Event|5|||
160617301|NCT00348686|579975830|FG000|Overall Study|Protocol Violation|6|||
160617302|NCT00348686|579975830|FG000|Overall Study|Lost to Follow-up|2|||
160617303|NCT00348686|579975830|FG000|Overall Study|Multiple Reasons|8|||
160617304|NCT01258738|579975833|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
160617305|NCT01258738|579975834|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
160617306|NCT01258738|579975833|FG000|Double-blind Period|Withdrawal by Subject|2|||
160617307|NCT01258738|579975834|FG001|Double-blind Period|Withdrawal by Subject|2|||
160617308|NCT01258738|579975833|FG000|Double-blind Period|Protocol Violation|1|||
160617309|NCT01258738|579975834|FG001|Double-blind Period|Protocol Violation|1|||
160617310|NCT01258738|579975833|FG000|Double-blind Period|Adverse Event|3|||
160617311|NCT01258738|579975834|FG001|Double-blind Period|Adverse Event|1|||
160617312|NCT01258738|579975833|FG000|Open-label Period|Did not meet inclusion criteria|0|||
160617313|NCT01258738|579975834|FG001|Open-label Period|Did not meet inclusion criteria|1|||
160617314|NCT01258738|579975833|FG000|Open-label Period|Insufficient clinical response|5|||
160617315|NCT01258738|579975834|FG001|Open-label Period|Insufficient clinical response|3|||
160617316|NCT01258738|579975833|FG000|Open-label Period|Lost to Follow-up|0|||
160617317|NCT01258738|579975834|FG001|Open-label Period|Lost to Follow-up|2|||
160617318|NCT01258738|579975833|FG000|Open-label Period|Withdrawal by Subject|5|||
160617319|NCT01258738|579975834|FG001|Open-label Period|Withdrawal by Subject|6|||
160617320|NCT01258738|579975833|FG000|Open-label Period|Protocol Violation|2|||
160617321|NCT01258738|579975834|FG001|Open-label Period|Protocol Violation|2|||
160617322|NCT01258738|579975833|FG000|Open-label Period|Adverse Event|4|||
160617323|NCT01258738|579975834|FG001|Open-label Period|Adverse Event|5|||
160617324|NCT01258738|579975833|FG000|Open-label Period|Other Reasons|0|||
160617325|NCT01258738|579975834|FG001|Open-label Period|Other Reasons|1|||
160617326|NCT01258738|579975833|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
160617327|NCT01258738|579975834|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
160617328|NCT02418000|579975835|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
160617329|NCT02418000|579975836|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
160617330|NCT02418000|579975837|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
160617331|NCT02418000|579975838|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
160617332|NCT02418000|579975839|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
160617333|NCT02418000|579975835|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
160617334|NCT02418000|579975836|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
160617335|NCT02418000|579975837|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
160617336|NCT02418000|579975838|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
160617337|NCT02418000|579975839|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
160617338|NCT02418000|579975835|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
160617339|NCT02418000|579975836|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
160617340|NCT02418000|579975837|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
160617341|NCT02418000|579975838|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
160617342|NCT02418000|579975839|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
160617343|NCT02418000|579975835|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
160617344|NCT02418000|579975836|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
160617345|NCT02418000|579975837|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
160617346|NCT02418000|579975838|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
160617347|NCT02418000|579975839|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
160617348|NCT02418000|579975835|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
160617349|NCT02418000|579975836|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
160617350|NCT02418000|579975837|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
160617351|NCT02418000|579975838|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
160617352|NCT02418000|579975839|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
160617353|NCT02418000|579975835|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617354|NCT02418000|579975836|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617355|NCT02418000|579975837|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
160617356|NCT02418000|579975838|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617357|NCT02418000|579975839|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160661649|NCT05093205|580144130|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160661650|NCT05093205|580144131|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160617358|NCT02418000|579975835|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617359|NCT02418000|579975836|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617360|NCT02418000|579975837|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617361|NCT02418000|579975838|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
160617362|NCT02418000|579975839|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617363|NCT02418000|579975835|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
160496740|NCT02282917|579546409|FG000|Overall Study|Screen Failure/Not Eligible|1|||
160496741|NCT00715117|579546412|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
160496742|NCT00715117|579546413|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
160496743|NCT01536171|579546417|FG000|Overall Study|Withdrawal by Subject|1|||
160496744|NCT01018732|579546418|FG000|Overall Study|Lost to Follow-up|0|||
160496745|NCT01018732|579546419|FG001|Overall Study|Lost to Follow-up|0|||
160496746|NCT01018732|579546420|FG002|Overall Study|Lost to Follow-up|3|||
160496747|NCT01018732|579546418|FG000|Overall Study|Protocol Violation|1|||
160496748|NCT01018732|579546419|FG001|Overall Study|Protocol Violation|1|||
160496749|NCT01018732|579546420|FG002|Overall Study|Protocol Violation|0|||
160496750|NCT01018732|579546418|FG000|Overall Study|Inappropriate Enrollment|0|||
160496751|NCT01018732|579546419|FG001|Overall Study|Inappropriate Enrollment|1|||
160496752|NCT01018732|579546420|FG002|Overall Study|Inappropriate Enrollment|0|||
160496753|NCT01018732|579546418|FG000|Overall Study|Unable to Classify|0|||
160496754|NCT01018732|579546419|FG001|Overall Study|Unable to Classify|0|||
160496755|NCT01018732|579546420|FG002|Overall Study|Unable to Classify|1|||
160496756|NCT01262092|579546421|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
160496757|NCT01262092|579546422|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
160496758|NCT01262092|579546421|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
160496759|NCT01262092|579546422|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
160496760|NCT01262092|579546421|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
160496761|NCT01262092|579546422|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
160496762|NCT01262092|579546421|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
160496763|NCT01262092|579546422|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
160496764|NCT03784820|579546423|FG000|Overall Study|Lost to Follow-up|5|||
160496765|NCT03784820|579546424|FG001|Overall Study|Lost to Follow-up|5|||
160496766|NCT03784820|579546425|FG002|Overall Study|Lost to Follow-up|3|||
160496767|NCT03784820|579546426|FG003|Overall Study|Lost to Follow-up|3|||
160496768|NCT02336425|579546427|FG000|Overall Study|Study terminated.|2|||
160496769|NCT02336425|579546428|FG001|Overall Study|Study terminated.|2|||
160496770|NCT02336425|579546429|FG002|Overall Study|Study terminated.|3|||
160496771|NCT02336425|579546430|FG003|Overall Study|Study terminated.|3|||
160496772|NCT00978562|579546431|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
160496773|NCT02394665|579546432|FG000|Overall Study|Physician Decision|1|||
160496774|NCT02394665|579546433|FG001|Overall Study|Physician Decision|0|||
160496775|NCT02394665|579546434|FG002|Overall Study|Physician Decision|0|||
160496776|NCT03569891|579546435|FG000|Lead-in|Ineligible during lead-in|8|||
160496777|NCT03569891|579546435|FG000|Lead-in|Withdrawal by Subject|3|||
160496778|NCT03569891|579546435|FG000|Lead-in|Risks related to COVID-19|2|||
160496779|NCT03569891|579546435|FG000|AMT-061|Adverse Event|1|||
160496780|NCT03735121|579546438|FG000|Overall Study|Death|3|||
160496781|NCT03735121|579546439|FG001|Overall Study|Death|6|||
160496782|NCT03735121|579546440|FG002|Overall Study|Death|19|||
160496783|NCT03735121|579546441|FG003|Overall Study|Death|97|||
160496784|NCT03735121|579546442|FG004|Overall Study|Death|205|||
160496785|NCT03735121|579546438|FG000|Overall Study|Lost to Follow-up|0|||
160496786|NCT03735121|579546439|FG001|Overall Study|Lost to Follow-up|0|||
160496787|NCT03735121|579546440|FG002|Overall Study|Lost to Follow-up|0|||
160496788|NCT03735121|579546441|FG003|Overall Study|Lost to Follow-up|2|||
160496789|NCT03735121|579546442|FG004|Overall Study|Lost to Follow-up|3|||
160496790|NCT03735121|579546438|FG000|Overall Study|New Therapy|0|||
160496791|NCT03735121|579546439|FG001|Overall Study|New Therapy|1|||
160496792|NCT03735121|579546440|FG002|Overall Study|New Therapy|0|||
160496793|NCT03735121|579546441|FG003|Overall Study|New Therapy|0|||
160496794|NCT03735121|579546442|FG004|Overall Study|New Therapy|0|||
160496795|NCT03735121|579546438|FG000|Overall Study|Study Ended by Sponsor|1|||
160496796|NCT03735121|579546439|FG001|Overall Study|Study Ended by Sponsor|0|||
160496797|NCT03735121|579546440|FG002|Overall Study|Study Ended by Sponsor|1|||
160496798|NCT03735121|579546441|FG003|Overall Study|Study Ended by Sponsor|17|||
160496799|NCT03735121|579546442|FG004|Overall Study|Study Ended by Sponsor|28|||
160496800|NCT03735121|579546438|FG000|Overall Study|Withdrawal by Subject|1|||
160496801|NCT03735121|579546439|FG001|Overall Study|Withdrawal by Subject|1|||
160496802|NCT03735121|579546440|FG002|Overall Study|Withdrawal by Subject|6|||
160496803|NCT03735121|579546441|FG003|Overall Study|Withdrawal by Subject|8|||
160496804|NCT03735121|579546442|FG004|Overall Study|Withdrawal by Subject|11|||
160496805|NCT02176863|579546443|FG000|Overall Study|Physician Decision|1|||
160496806|NCT02176863|579546444|FG001|Overall Study|Physician Decision|0|||
160496807|NCT02176863|579546445|FG002|Overall Study|Physician Decision|0|||
160496808|NCT02176863|579546446|FG003|Overall Study|Physician Decision|0|||
160496809|NCT02176863|579546447|FG004|Overall Study|Physician Decision|0|||
160496810|NCT02176863|579546443|FG000|Overall Study|Adverse Event|10|||
160661651|NCT05093205|580144132|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160496811|NCT02176863|579546444|FG001|Overall Study|Adverse Event|4|||
160496812|NCT02176863|579546445|FG002|Overall Study|Adverse Event|4|||
160496813|NCT02176863|579546446|FG003|Overall Study|Adverse Event|1|||
160496814|NCT02176863|579546447|FG004|Overall Study|Adverse Event|1|||
160496815|NCT02176863|579546443|FG000|Overall Study|Protocol Violation|2|||
160661652|NCT05093205|580144133|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160617364|NCT02418000|579975836|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
160617365|NCT02418000|579975837|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
160617366|NCT02418000|579975838|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
160617367|NCT02418000|579975839|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
160617368|NCT02418000|579975835|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617369|NCT02418000|579975836|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617370|NCT02418000|579975837|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617371|NCT02418000|579975838|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
160617372|NCT02418000|579975839|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
160617373|NCT00689611|579975840|FG000|Overall Study|Death|6|||
160617374|NCT00689611|579975841|FG001|Overall Study|Death|9|||
160617375|NCT00689611|579975840|FG000|Overall Study|Withdrawal by Subject|8|||
160617376|NCT00689611|579975841|FG001|Overall Study|Withdrawal by Subject|9|||
160617377|NCT00689611|579975840|FG000|Overall Study|Lost to Follow-up|27|||
160617378|NCT00689611|579975841|FG001|Overall Study|Lost to Follow-up|28|||
160617379|NCT00568399|579975843|FG000|Overall Study|Death|2|||
160617380|NCT00568399|579975843|FG000|Overall Study|Adverse Event|5|||
160617381|NCT00568399|579975843|FG000|Overall Study|Withdrawal by Subject|8|||
160617382|NCT00106626|579975848|FG000|Overall Study|Adverse Event|5|||
160617383|NCT00106626|579975849|FG001|Overall Study|Adverse Event|4|||
160617384|NCT00106626|579975850|FG002|Overall Study|Adverse Event|3|||
160617385|NCT00106626|579975851|FG003|Overall Study|Adverse Event|3|||
160617386|NCT00106626|579975848|FG000|Overall Study|Progressive Disease|4|||
160617387|NCT00106626|579975849|FG001|Overall Study|Progressive Disease|1|||
160617388|NCT00106626|579975850|FG002|Overall Study|Progressive Disease|9|||
160617389|NCT00106626|579975851|FG003|Overall Study|Progressive Disease|10|||
160617390|NCT00106626|579975848|FG000|Overall Study|Received radiation on new therapy|1|||
160617391|NCT00106626|579975849|FG001|Overall Study|Received radiation on new therapy|0|||
160617392|NCT00106626|579975850|FG002|Overall Study|Received radiation on new therapy|0|||
160617393|NCT00106626|579975851|FG003|Overall Study|Received radiation on new therapy|0|||
160617394|NCT00106626|579975848|FG000|Overall Study|> 14 day delay in therapy start|0|||
160617395|NCT00106626|579975849|FG001|Overall Study|> 14 day delay in therapy start|1|||
160617396|NCT00106626|579975850|FG002|Overall Study|> 14 day delay in therapy start|0|||
160617397|NCT00106626|579975851|FG003|Overall Study|> 14 day delay in therapy start|0|||
160617398|NCT03018028|579975869|FG000|Overall Study|Withdrawal by Subject|3|||
160617399|NCT03018028|579975870|FG001|Overall Study|Withdrawal by Subject|0|||
160617400|NCT03018028|579975871|FG002|Overall Study|Withdrawal by Subject|1|||
160617401|NCT03018028|579975872|FG003|Overall Study|Withdrawal by Subject|2|||
160617402|NCT03018028|579975873|FG004|Overall Study|Withdrawal by Subject|0|||
160617403|NCT02519777|579975874|FG000|Overall Study|Death|1|||
160617404|NCT02519777|579975875|FG001|Overall Study|Death|0|||
160617405|NCT02519777|579975876|FG002|Overall Study|Death|0|||
160617406|NCT02519777|579975874|FG000|Overall Study|Lost to Follow-up|0|||
160617407|NCT02519777|579975875|FG001|Overall Study|Lost to Follow-up|4|||
160617408|NCT02519777|579975876|FG002|Overall Study|Lost to Follow-up|2|||
160617409|NCT02519777|579975874|FG000|Overall Study|Withdrawal by Subject|3|||
160617410|NCT02519777|579975875|FG001|Overall Study|Withdrawal by Subject|1|||
160617411|NCT02519777|579975876|FG002|Overall Study|Withdrawal by Subject|0|||
160617412|NCT02519777|579975874|FG000|Overall Study|Severe Debilitation|1|||
160617413|NCT02519777|579975875|FG001|Overall Study|Severe Debilitation|1|||
160617414|NCT02519777|579975876|FG002|Overall Study|Severe Debilitation|1|||
160617415|NCT02519777|579975874|FG000|Overall Study|Not able to get to clinic|1|||
160617416|NCT02519777|579975875|FG001|Overall Study|Not able to get to clinic|2|||
160617417|NCT02519777|579975876|FG002|Overall Study|Not able to get to clinic|1|||
160617418|NCT01038635|579975878|FG000|Overall Study|Disease Progression|2|||
160617419|NCT01038635|579975879|FG001|Overall Study|Disease Progression|0|||
160617420|NCT01038635|579975880|FG002|Overall Study|Disease Progression|0|||
160617421|NCT01038635|579975881|FG003|Overall Study|Disease Progression|0|||
160617422|NCT01038635|579975882|FG004|Overall Study|Disease Progression|0|||
160617423|NCT01038635|579975883|FG005|Overall Study|Disease Progression|0|||
160617424|NCT01038635|579975884|FG006|Overall Study|Disease Progression|1|||
160617425|NCT01038635|579975885|FG007|Overall Study|Disease Progression|4|||
160496816|NCT02176863|579546444|FG001|Overall Study|Protocol Violation|0|||
160496817|NCT02176863|579546445|FG002|Overall Study|Protocol Violation|1|||
160617426|NCT01038635|579975886|FG008|Overall Study|Disease Progression|0|||
160617427|NCT01038635|579975878|FG000|Overall Study|Death|0|||
160617428|NCT01038635|579975879|FG001|Overall Study|Death|0|||
160617429|NCT01038635|579975880|FG002|Overall Study|Death|0|||
160617430|NCT01038635|579975881|FG003|Overall Study|Death|0|||
160617431|NCT01038635|579975882|FG004|Overall Study|Death|1|||
160617432|NCT01038635|579975883|FG005|Overall Study|Death|0|||
160617433|NCT01038635|579975884|FG006|Overall Study|Death|1|||
160617434|NCT01038635|579975885|FG007|Overall Study|Death|1|||
160617435|NCT01038635|579975886|FG008|Overall Study|Death|2|||
160617436|NCT01227252|579975887|FG000|Overall Study|Sponsor Decision|0|||
160617437|NCT01227252|579975888|FG001|Overall Study|Sponsor Decision|1|||
160617438|NCT01227252|579975889|FG002|Overall Study|Sponsor Decision|0|||
160496818|NCT02176863|579546446|FG003|Overall Study|Protocol Violation|1|||
160496819|NCT02176863|579546447|FG004|Overall Study|Protocol Violation|0|||
160496820|NCT02176863|579546443|FG000|Overall Study|Withdrawal by Subject|4|||
160496821|NCT02176863|579546444|FG001|Overall Study|Withdrawal by Subject|2|||
160496822|NCT02176863|579546445|FG002|Overall Study|Withdrawal by Subject|2|||
160496823|NCT02176863|579546446|FG003|Overall Study|Withdrawal by Subject|3|||
160617439|NCT01227252|579975890|FG003|Overall Study|Sponsor Decision|0|||
160617440|NCT01227252|579975887|FG000|Overall Study|Lost to Follow-up|0|||
160617441|NCT01227252|579975888|FG001|Overall Study|Lost to Follow-up|1|||
160617442|NCT01227252|579975889|FG002|Overall Study|Lost to Follow-up|0|||
160617443|NCT01227252|579975890|FG003|Overall Study|Lost to Follow-up|0|||
160617444|NCT01227252|579975887|FG000|Overall Study|Withdrawal by Subject|0|||
160617445|NCT01227252|579975888|FG001|Overall Study|Withdrawal by Subject|1|||
160617446|NCT01227252|579975889|FG002|Overall Study|Withdrawal by Subject|0|||
160617447|NCT01227252|579975890|FG003|Overall Study|Withdrawal by Subject|0|||
160617448|NCT01284127|579975891|FG000|Overall Study|Adverse Event|2|||
160617449|NCT01284127|579975891|FG000|Overall Study|Withdrawal by Subject|4|||
160617450|NCT01284127|579975891|FG000|Overall Study|Physician Decision|1|||
160617451|NCT02516306|579975894|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
160617452|NCT02516306|579975895|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
160617453|NCT02607865|579975899|FG000|Overall Study|Lost to Follow-up|9|||
160617454|NCT02607865|579975900|FG001|Overall Study|Lost to Follow-up|7|||
160617455|NCT02607865|579975901|FG002|Overall Study|Lost to Follow-up|7|||
160617456|NCT02607865|579975902|FG003|Overall Study|Lost to Follow-up|5|||
160617457|NCT02607865|579975899|FG000|Overall Study|Withdrawal by Subject|18|||
160617458|NCT02607865|579975900|FG001|Overall Study|Withdrawal by Subject|18|||
160617459|NCT02607865|579975901|FG002|Overall Study|Withdrawal by Subject|17|||
160617460|NCT02607865|579975902|FG003|Overall Study|Withdrawal by Subject|8|||
160617461|NCT02607865|579975899|FG000|Overall Study|Death|5|||
160617462|NCT02607865|579975900|FG001|Overall Study|Death|4|||
160617463|NCT02607865|579975901|FG002|Overall Study|Death|1|||
160617464|NCT02607865|579975902|FG003|Overall Study|Death|3|||
160617465|NCT02607865|579975899|FG000|Overall Study|Unclassified|1|||
160617466|NCT02607865|579975900|FG001|Overall Study|Unclassified|1|||
160617467|NCT02607865|579975901|FG002|Overall Study|Unclassified|2|||
160617468|NCT02607865|579975902|FG003|Overall Study|Unclassified|0|||
160617469|NCT03227692|579975903|FG000|Overall Study|Protocol Violation|1|||
160617470|NCT03227692|579975904|FG001|Overall Study|Protocol Violation|1|||
160617471|NCT03227692|579975903|FG000|Overall Study|Lost to Follow-up|4|||
160617472|NCT03227692|579975904|FG001|Overall Study|Lost to Follow-up|2|||
160617473|NCT03227692|579975903|FG000|Overall Study|Adverse Event|0|||
160617474|NCT03227692|579975904|FG001|Overall Study|Adverse Event|2|||
160617475|NCT02447952|579975905|FG000|Overall Study|Adverse Event|2|||
160617476|NCT02447952|579975905|FG000|Overall Study|Physician Decision|1|||
160617477|NCT02447952|579975905|FG000|Overall Study|Withdrawal by Subject|4|||
160617478|NCT01683058|579975906|FG000|Overall Study|Lost to Follow-up|9|||
160617479|NCT01683058|579975906|FG000|Overall Study|Adverse Event|6|||
160617480|NCT01683058|579975906|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
160617481|NCT01683058|579975906|FG000|Overall Study|Withdrawal by Subject|7|||
160617482|NCT01683058|579975906|FG000|Overall Study|Lack of Efficacy|2|||
160617483|NCT01351415|579975911|FG000|Overall Study|Withdrawal by Subject|15|||
160617484|NCT01351415|579975912|FG001|Overall Study|Withdrawal by Subject|17|||
160617485|NCT01351415|579975911|FG000|Overall Study|Trial termination by the Sponsor|28|||
160617486|NCT01351415|579975912|FG001|Overall Study|Trial termination by the Sponsor|19|||
160617487|NCT01351415|579975911|FG000|Overall Study|Lost to Follow-up|5|||
160617488|NCT01351415|579975912|FG001|Overall Study|Lost to Follow-up|7|||
160617489|NCT01351415|579975911|FG000|Overall Study|Death|190|||
160617490|NCT01351415|579975912|FG001|Overall Study|Death|187|||
160617491|NCT01351415|579975911|FG000|Overall Study|Physician Decision|2|||
160617492|NCT01351415|579975912|FG001|Overall Study|Physician Decision|3|||
160617493|NCT01351415|579975911|FG000|Overall Study|Reason unknown|0|||
160617494|NCT01351415|579975912|FG001|Overall Study|Reason unknown|2|||
160617495|NCT01351415|579975911|FG000|Overall Study|Never Started|5|||
160617496|NCT01351415|579975912|FG001|Overall Study|Never Started|5|||
160617497|NCT00247962|579975913|FG000|Overall Study|Adverse Event|15|||
160617498|NCT00247962|579975914|FG001|Overall Study|Adverse Event|12|||
160496824|NCT02176863|579546447|FG004|Overall Study|Withdrawal by Subject|4|||
160617499|NCT00247962|579975913|FG000|Overall Study|Lost to Follow-up|3|||
160617500|NCT00247962|579975914|FG001|Overall Study|Lost to Follow-up|1|||
160617501|NCT00247962|579975913|FG000|Overall Study|Physician Decision|0|||
160617502|NCT00247962|579975914|FG001|Overall Study|Physician Decision|1|||
160617503|NCT00247962|579975913|FG000|Overall Study|Protocol Violation|1|||
160617504|NCT00247962|579975914|FG001|Overall Study|Protocol Violation|1|||
160617505|NCT00247962|579975913|FG000|Overall Study|Withdrawal by Subject|3|||
160617506|NCT00247962|579975914|FG001|Overall Study|Withdrawal by Subject|2|||
160617507|NCT00247962|579975913|FG000|Overall Study|Lack of Efficacy|4|||
160617508|NCT00247962|579975914|FG001|Overall Study|Lack of Efficacy|2|||
160617509|NCT03117309|579975916|FG000|Overall Study|Not meeting inclusion criteria|0|||
160617510|NCT03117309|579975917|FG001|Overall Study|Not meeting inclusion criteria|1|||
160496825|NCT02176863|579546443|FG000|Overall Study|Reason not specified|0|||
160496826|NCT02176863|579546444|FG001|Overall Study|Reason not specified|1|||
160496827|NCT02176863|579546445|FG002|Overall Study|Reason not specified|1|||
160496828|NCT02176863|579546446|FG003|Overall Study|Reason not specified|2|||
160496829|NCT02176863|579546447|FG004|Overall Study|Reason not specified|1|||
160496830|NCT02176863|579546443|FG000|Overall Study|Lost to Follow-up|0|||
160496831|NCT02176863|579546444|FG001|Overall Study|Lost to Follow-up|1|||
160496832|NCT02176863|579546445|FG002|Overall Study|Lost to Follow-up|1|||
160496833|NCT02176863|579546446|FG003|Overall Study|Lost to Follow-up|0|||
160496834|NCT02176863|579546447|FG004|Overall Study|Lost to Follow-up|0|||
160496835|NCT02037256|579546450|FG000|Overall Study|Protocol Violation|0|||
160496836|NCT02037256|579546451|FG001|Overall Study|Protocol Violation|1|||
160496837|NCT02037256|579546450|FG000|Overall Study|Withdrawn prior to Velcade|0|||
160496838|NCT02037256|579546451|FG001|Overall Study|Withdrawn prior to Velcade|2|||
160496839|NCT02394925|579546452|FG000|Overall Study|Adverse Event|1|||
160496840|NCT02394925|579546452|FG000|Overall Study|Lens Discomfort|3|||
160496841|NCT02394925|579546452|FG000|Overall Study|Lens handling difficulities|5|||
160496842|NCT02394925|579546452|FG000|Overall Study|Lost to Follow-up|9|||
160496843|NCT02394925|579546452|FG000|Overall Study|Protocol Violation|5|||
160496844|NCT02394925|579546452|FG000|Overall Study|No longer meet eligibility criteria|1|||
160496845|NCT02394925|579546452|FG000|Overall Study|Unsatisfactory Visual Response|5|||
160496846|NCT04650698|579548493|FG000|Overall Study|Protocol Violation|2|||
160496847|NCT04650698|579548494|FG001|Overall Study|Protocol Violation|1|||
160496848|NCT04650698|579548493|FG000|Overall Study|Withdrawal by Subject|0|||
160496849|NCT04650698|579548494|FG001|Overall Study|Withdrawal by Subject|1|||
160496850|NCT02358668|579548496|FG000|Overall Study|Adverse Event|2|||
160496851|NCT02358668|579548497|FG001|Overall Study|Adverse Event|0|||
160496852|NCT02358668|579548498|FG002|Overall Study|Adverse Event|0|||
160496853|NCT02358668|579548496|FG000|Overall Study|Withdrawal by Subject|0|||
160496854|NCT02358668|579548497|FG001|Overall Study|Withdrawal by Subject|1|||
160496855|NCT02358668|579548498|FG002|Overall Study|Withdrawal by Subject|0|||
160496856|NCT02104505|579548499|FG000|First Intervention (14 Days)|Adverse Event|2|||
160496857|NCT02104505|579548500|FG001|First Intervention (14 Days)|Adverse Event|0|||
160496858|NCT02104505|579548499|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
160496859|NCT02104505|579548500|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
160496860|NCT02104505|579548499|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
160496861|NCT02104505|579548500|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
160496862|NCT02104505|579548499|FG000|First Intervention (14 Days)|exclusionary condition|0|||
160496863|NCT02104505|579548500|FG001|First Intervention (14 Days)|exclusionary condition|1|||
160496864|NCT02104505|579548499|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
160496865|NCT02104505|579548500|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
160496866|NCT02104505|579548499|FG000|Second Intervention (14 Days)|Adverse Event|2|||
160496867|NCT02104505|579548500|FG001|Second Intervention (14 Days)|Adverse Event|0|||
160496868|NCT02419417|579548501|FG000|Overall Study|Disease progression|5|||
160496869|NCT02419417|579548502|FG001|Overall Study|Disease progression|4|||
160496870|NCT02419417|579548503|FG002|Overall Study|Disease progression|13|||
160496871|NCT02419417|579548504|FG003|Overall Study|Disease progression|10|||
160496872|NCT02419417|579548505|FG004|Overall Study|Disease progression|10|||
160496873|NCT02419417|579548506|FG005|Overall Study|Disease progression|3|||
160496874|NCT02419417|579548507|FG006|Overall Study|Disease progression|4|||
160496875|NCT02419417|579548508|FG007|Overall Study|Disease progression|5|||
160496876|NCT02419417|579548509|FG008|Overall Study|Disease progression|13|||
160617511|NCT02120469|579975918|FG000|Overall Study|HER-2/neu-amplified|1|||
160617512|NCT02120469|579975919|FG001|Overall Study|HER-2/neu-amplified|0|||
160617513|NCT02120469|579975920|FG002|Overall Study|HER-2/neu-amplified|1|||
160617514|NCT02583711|579975921|FG000|Overall Study|Withdrawal by Subject|0|||
160617515|NCT02583711|579975922|FG001|Overall Study|Withdrawal by Subject|10|||
160617516|NCT02583711|579975923|FG002|Overall Study|Withdrawal by Subject|0|||
160617517|NCT00420212|579975925|FG000|Overall Study|Adverse Event|22|||
160617518|NCT00420212|579975926|FG001|Overall Study|Adverse Event|40|||
160617519|NCT00420212|579975927|FG002|Overall Study|Adverse Event|36|||
160617520|NCT00420212|579975925|FG000|Overall Study|Lost to Follow-up|9|||
160617521|NCT00420212|579975926|FG001|Overall Study|Lost to Follow-up|11|||
160617522|NCT00420212|579975927|FG002|Overall Study|Lost to Follow-up|11|||
160617523|NCT00420212|579975925|FG000|Overall Study|Withdrawal by Subject|31|||
160617524|NCT00420212|579975926|FG001|Overall Study|Withdrawal by Subject|22|||
160617525|NCT00420212|579975927|FG002|Overall Study|Withdrawal by Subject|19|||
160496877|NCT02419417|579548510|FG009|Overall Study|Disease progression|9|||
160496878|NCT02419417|579548511|FG010|Overall Study|Disease progression|0|||
160496879|NCT02419417|579548501|FG000|Overall Study|Study drug toxicity|0|||
160496880|NCT02419417|579548502|FG001|Overall Study|Study drug toxicity|0|||
160496881|NCT02419417|579548503|FG002|Overall Study|Study drug toxicity|0|||
160496882|NCT02419417|579548504|FG003|Overall Study|Study drug toxicity|0|||
160496883|NCT02419417|579548505|FG004|Overall Study|Study drug toxicity|1|||
160496884|NCT02419417|579548506|FG005|Overall Study|Study drug toxicity|0|||
160617526|NCT00420212|579975925|FG000|Overall Study|Physician Decision|4|||
160617527|NCT00420212|579975926|FG001|Overall Study|Physician Decision|4|||
160617528|NCT00420212|579975927|FG002|Overall Study|Physician Decision|3|||
160617529|NCT00420212|579975925|FG000|Overall Study|Protocol Violation|4|||
160617530|NCT00420212|579975926|FG001|Overall Study|Protocol Violation|4|||
160617531|NCT00420212|579975927|FG002|Overall Study|Protocol Violation|8|||
160617532|NCT00420212|579975925|FG000|Overall Study|Death|0|||
160617533|NCT00420212|579975926|FG001|Overall Study|Death|0|||
160617534|NCT00420212|579975927|FG002|Overall Study|Death|1|||
160617535|NCT00420212|579975925|FG000|Overall Study|Other-Unspecified|21|||
160617536|NCT00420212|579975926|FG001|Overall Study|Other-Unspecified|14|||
160617537|NCT00420212|579975927|FG002|Overall Study|Other-Unspecified|18|||
160617538|NCT00392210|579975929|FG000|First Voiding Trial|Physician Decision|2|||
160617539|NCT00392210|579975930|FG001|First Voiding Trial|Physician Decision|2|||
160617540|NCT02067104|579975931|FG000|Overall Study|Study termination due to low accrual|4|||
160617541|NCT02067104|579975932|FG001|Overall Study|Study termination due to low accrual|5|||
160617542|NCT02610231|579975938|FG000|Overall Study|Withdrawal by Subject|27|||
160617543|NCT02610231|579975938|FG000|Overall Study|Adverse Event|20|||
160617544|NCT02610231|579975938|FG000|Overall Study|Death|5|||
160617545|NCT02610231|579975938|FG000|Overall Study|Surgery|2|||
160617546|NCT02610231|579975938|FG000|Overall Study|Physician Decision|1|||
160617547|NCT02610231|579975938|FG000|Overall Study|Non Compliance|2|||
160617548|NCT02610231|579975938|FG000|Overall Study|Other|3|||
160617549|NCT01279954|579975939|FG000|Overall Study|Lack of Efficacy|3|||
160617550|NCT01279954|579975940|FG001|Overall Study|Lack of Efficacy|4|||
160617551|NCT02140762|579975941|FG000|Overall Study|Adverse Event|1|||
160617552|NCT02140762|579975942|FG001|Overall Study|Adverse Event|1|||
160617553|NCT02140762|579975941|FG000|Overall Study|Lost to Follow-up|9|||
160617554|NCT02140762|579975942|FG001|Overall Study|Lost to Follow-up|5|||
160617555|NCT02140762|579975941|FG000|Overall Study|Protocol Violation|1|||
160617556|NCT02140762|579975942|FG001|Overall Study|Protocol Violation|1|||
160617557|NCT02140762|579975941|FG000|Overall Study|Withdrawal by Subject|6|||
160617558|NCT02140762|579975942|FG001|Overall Study|Withdrawal by Subject|4|||
160617559|NCT02140762|579975941|FG000|Overall Study|Other|0|||
160617560|NCT02140762|579975942|FG001|Overall Study|Other|1|||
160617561|NCT06334055|579975948|FG000|Overall Study|Adverse Event|4|||
160617562|NCT06334055|579975948|FG000|Overall Study|Disqualified|72|||
160617563|NCT04728815|579975949|FG000|Overall Study|Lost to Follow-up|3|||
160617564|NCT04728815|579975950|FG001|Overall Study|Lost to Follow-up|0|||
160617565|NCT04728815|579975951|FG002|Overall Study|Lost to Follow-up|0|||
160617566|NCT04728815|579975952|FG003|Overall Study|Lost to Follow-up|1|||
160617567|NCT04728815|579975953|FG004|Overall Study|Lost to Follow-up|1|||
160617568|NCT04728815|579975954|FG005|Overall Study|Lost to Follow-up|0|||
160617569|NCT04728815|579975955|FG006|Overall Study|Lost to Follow-up|2|||
160617570|NCT04728815|579975956|FG007|Overall Study|Lost to Follow-up|0|||
160617571|NCT04728815|579975949|FG000|Overall Study|Physician Decision|0|||
160617572|NCT04728815|579975950|FG001|Overall Study|Physician Decision|0|||
160617573|NCT04728815|579975951|FG002|Overall Study|Physician Decision|1|||
160617574|NCT04728815|579975952|FG003|Overall Study|Physician Decision|0|||
160617575|NCT04728815|579975953|FG004|Overall Study|Physician Decision|0|||
160617576|NCT04728815|579975954|FG005|Overall Study|Physician Decision|0|||
160617577|NCT04728815|579975955|FG006|Overall Study|Physician Decision|0|||
160617578|NCT04728815|579975956|FG007|Overall Study|Physician Decision|0|||
160617579|NCT04728815|579975949|FG000|Overall Study|Treatment drop|0|||
160617580|NCT04728815|579975950|FG001|Overall Study|Treatment drop|2|||
160617581|NCT04728815|579975951|FG002|Overall Study|Treatment drop|1|||
160617582|NCT04728815|579975952|FG003|Overall Study|Treatment drop|0|||
160617583|NCT04728815|579975953|FG004|Overall Study|Treatment drop|3|||
160617584|NCT04728815|579975954|FG005|Overall Study|Treatment drop|1|||
160617585|NCT04728815|579975955|FG006|Overall Study|Treatment drop|3|||
160617586|NCT04728815|579975956|FG007|Overall Study|Treatment drop|0|||
160617587|NCT04728815|579975949|FG000|Overall Study|Study drop|0|||
160617588|NCT04728815|579975950|FG001|Overall Study|Study drop|3|||
160617589|NCT04728815|579975951|FG002|Overall Study|Study drop|3|||
160617590|NCT04728815|579975952|FG003|Overall Study|Study drop|0|||
160617591|NCT04728815|579975953|FG004|Overall Study|Study drop|0|||
160617592|NCT04728815|579975954|FG005|Overall Study|Study drop|0|||
160617593|NCT04728815|579975955|FG006|Overall Study|Study drop|7|||
160617594|NCT04728815|579975956|FG007|Overall Study|Study drop|0|||
160617595|NCT00957034|579975957|FG000|Overall Study|Adverse Event|0|||
160617596|NCT00957034|579975958|FG001|Overall Study|Adverse Event|1|||
160617597|NCT00957034|579975959|FG002|Overall Study|Adverse Event|1|||
160617598|NCT00957034|579975957|FG000|Overall Study|Sponsor Terminated Study|6|||
160617599|NCT00957034|579975958|FG001|Overall Study|Sponsor Terminated Study|1|||
160617600|NCT00957034|579975959|FG002|Overall Study|Sponsor Terminated Study|5|||
160617601|NCT00957034|579975957|FG000|Overall Study|Withdrawal by Subject|0|||
160617602|NCT00957034|579975958|FG001|Overall Study|Withdrawal by Subject|2|||
160617603|NCT00957034|579975959|FG002|Overall Study|Withdrawal by Subject|0|||
160617604|NCT05315297|579975960|FG000|Overall Study|Lost to Follow-up|6|||
160617605|NCT05315297|579975961|FG001|Overall Study|Lost to Follow-up|4|||
160617606|NCT05315297|579975960|FG000|Overall Study|Withdrawal by Subject|0|||
160617607|NCT05315297|579975961|FG001|Overall Study|Withdrawal by Subject|1|||
160617608|NCT05604781|579977670|FG000|Overall Study|Lost to Follow-up|3|||
160661653|NCT05093205|580144134|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160661654|NCT05093205|580144135|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160661655|NCT05093205|580144136|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160661656|NCT05093205|580144137|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160661657|NCT05093205|580144138|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
160661658|NCT05093205|580144139|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160661659|NCT05093205|580144140|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160661660|NCT05093205|580144141|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
160661661|NCT05093205|580144129|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
160661662|NCT05093205|580144130|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
160661663|NCT05093205|580144131|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
160661664|NCT05093205|580144132|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
160661665|NCT05093205|580144133|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
160661666|NCT05093205|580144134|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
160661667|NCT05093205|580144135|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
160661668|NCT05093205|580144136|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
160661669|NCT05093205|580144137|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
160496885|NCT02419417|579548507|FG006|Overall Study|Study drug toxicity|0|||
160496886|NCT02419417|579548508|FG007|Overall Study|Study drug toxicity|0|||
160496887|NCT02419417|579548509|FG008|Overall Study|Study drug toxicity|0|||
160496888|NCT02419417|579548510|FG009|Overall Study|Study drug toxicity|0|||
160496889|NCT02419417|579548511|FG010|Overall Study|Study drug toxicity|0|||
160496890|NCT02419417|579548501|FG000|Overall Study|Adverse event unrelated to study drug|0|||
160496891|NCT02419417|579548502|FG001|Overall Study|Adverse event unrelated to study drug|0|||
160496892|NCT02419417|579548503|FG002|Overall Study|Adverse event unrelated to study drug|0|||
160496893|NCT02419417|579548504|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160496894|NCT02419417|579548505|FG004|Overall Study|Adverse event unrelated to study drug|2|||
160496895|NCT02419417|579548506|FG005|Overall Study|Adverse event unrelated to study drug|1|||
160496896|NCT02419417|579548507|FG006|Overall Study|Adverse event unrelated to study drug|0|||
160496897|NCT02419417|579548508|FG007|Overall Study|Adverse event unrelated to study drug|1|||
160496898|NCT02419417|579548509|FG008|Overall Study|Adverse event unrelated to study drug|0|||
160496899|NCT02419417|579548510|FG009|Overall Study|Adverse event unrelated to study drug|0|||
160496900|NCT02419417|579548511|FG010|Overall Study|Adverse event unrelated to study drug|0|||
160496901|NCT02419417|579548501|FG000|Overall Study|Participant request to discontinue|0|||
160496902|NCT02419417|579548502|FG001|Overall Study|Participant request to discontinue|0|||
160496903|NCT02419417|579548503|FG002|Overall Study|Participant request to discontinue|0|||
160496904|NCT02419417|579548504|FG003|Overall Study|Participant request to discontinue|0|||
160496905|NCT02419417|579548505|FG004|Overall Study|Participant request to discontinue|0|||
160496906|NCT02419417|579548506|FG005|Overall Study|Participant request to discontinue|0|||
160496907|NCT02419417|579548507|FG006|Overall Study|Participant request to discontinue|0|||
160496908|NCT02419417|579548508|FG007|Overall Study|Participant request to discontinue|0|||
160496909|NCT02419417|579548509|FG008|Overall Study|Participant request to discontinue|0|||
160617609|NCT05604781|579977670|FG000|Overall Study|Adverse Event|1|||
160617610|NCT02493712|579977671|FG000|Overall Study|Withdrawal by Subject|1|||
160617611|NCT02493712|579977672|FG001|Overall Study|Withdrawal by Subject|0|||
160617612|NCT02493712|579977673|FG002|Overall Study|Withdrawal by Subject|2|||
160617613|NCT02493712|579977671|FG000|Overall Study|Protocol Violation|0|||
160617614|NCT02493712|579977672|FG001|Overall Study|Protocol Violation|0|||
160617615|NCT02493712|579977673|FG002|Overall Study|Protocol Violation|1|||
160617616|NCT02493712|579977671|FG000|Overall Study|Lost to Follow-up|1|||
160617617|NCT02493712|579977672|FG001|Overall Study|Lost to Follow-up|0|||
160617618|NCT02493712|579977673|FG002|Overall Study|Lost to Follow-up|0|||
160617619|NCT02493712|579977671|FG000|Overall Study|Physician Decision|0|||
160617620|NCT02493712|579977672|FG001|Overall Study|Physician Decision|1|||
160617621|NCT02493712|579977673|FG002|Overall Study|Physician Decision|0|||
160617622|NCT02493712|579977671|FG000|Overall Study|Lack of Efficacy|0|||
160617623|NCT02493712|579977672|FG001|Overall Study|Lack of Efficacy|5|||
160617624|NCT02493712|579977673|FG002|Overall Study|Lack of Efficacy|3|||
160617625|NCT02146274|579977674|FG000|Overall Study|Protocol Violation|73|||
160617626|NCT01640353|579977685|FG000|Overall Study|Withdrew prior to treatment|10|||
160617627|NCT01640353|579977685|FG000|Overall Study|Withdrawn from analysis at term site|12|||
160617628|NCT01640353|579977685|FG000|Overall Study|Withdrawal by Subject|5|||
160617629|NCT01640353|579977685|FG000|Overall Study|Death|2|||
160617630|NCT01640353|579977685|FG000|Overall Study|Early site termination|3|||
160617631|NCT01640353|579977685|FG000|Overall Study|Lost to Follow-up|12|||
160617632|NCT01640353|579977685|FG000|Overall Study|Physician Decision|1|||
160617633|NCT01967134|579977686|FG000|Overall Study|Lost to Follow-up|0|||
160617634|NCT01967134|579977687|FG001|Overall Study|Lost to Follow-up|1|||
160661670|NCT05093205|580144138|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
160661671|NCT05093205|580144139|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
160661672|NCT05093205|580144140|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
160617635|NCT01967134|579977688|FG002|Overall Study|Lost to Follow-up|0|||
160617636|NCT03419741|579977689|FG000|Overall Study|Adverse Event|1|||
160617637|NCT03419741|579977690|FG001|Overall Study|Adverse Event|0|||
160617638|NCT03419741|579977689|FG000|Overall Study|Withdrawal by Subject|1|||
160617639|NCT03419741|579977690|FG001|Overall Study|Withdrawal by Subject|2|||
160617640|NCT04354870|579977691|FG000|Overall Study|Lost to Follow-up|32|||
160617641|NCT04354870|579977692|FG001|Overall Study|Lost to Follow-up|12|||
160617642|NCT04354870|579977691|FG000|Overall Study|Withdrawal by Subject|10|||
160617643|NCT04354870|579977692|FG001|Overall Study|Withdrawal by Subject|16|||
160617644|NCT04354870|579977691|FG000|Overall Study|Did not complete all study visits|6|||
160617645|NCT04354870|579977692|FG001|Overall Study|Did not complete all study visits|5|||
160617646|NCT03384316|579977693|FG000|Overall Study|Screen failure|0|||
160617647|NCT03384316|579977694|FG001|Overall Study|Screen failure|1|||
160617648|NCT00413231|579977695|FG000|0 to 30-day Post Treatment|Death|5|||
160617649|NCT00413231|579977695|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
160617650|NCT00413231|579977695|FG000|30-day to 365-day Post Treatment|Death|13|||
160617651|NCT00413231|579977695|FG000|365-day to 60-month Post Treatment|Death|36|||
160617652|NCT00413231|579977695|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
160617653|NCT00413231|579977695|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
160617654|NCT00413231|579977695|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
160617655|NCT04450394|579977700|FG000|Overall Study|Adverse Event|2|||
160617656|NCT04450394|579977701|FG001|Overall Study|Adverse Event|0|||
160617657|NCT04450394|579977702|FG002|Overall Study|Adverse Event|0|||
160617658|NCT04450394|579977700|FG000|Overall Study|Death|0|||
160617659|NCT04450394|579977701|FG001|Overall Study|Death|1|||
160617660|NCT04450394|579977702|FG002|Overall Study|Death|0|||
160617661|NCT04450394|579977700|FG000|Overall Study|Lost to Follow-up|0|||
160617662|NCT04450394|579977701|FG001|Overall Study|Lost to Follow-up|3|||
160617663|NCT04450394|579977702|FG002|Overall Study|Lost to Follow-up|0|||
160617664|NCT04450394|579977700|FG000|Overall Study|Physician Decision|0|||
160617665|NCT04450394|579977701|FG001|Overall Study|Physician Decision|1|||
160617666|NCT04450394|579977702|FG002|Overall Study|Physician Decision|0|||
160617667|NCT04450394|579977700|FG000|Overall Study|Protocol Violation|2|||
160617668|NCT04450394|579977701|FG001|Overall Study|Protocol Violation|0|||
160617669|NCT04450394|579977702|FG002|Overall Study|Protocol Violation|0|||
160617670|NCT04450394|579977700|FG000|Overall Study|Withdrawal by Subject|6|||
160617671|NCT04450394|579977701|FG001|Overall Study|Withdrawal by Subject|9|||
160617672|NCT04450394|579977702|FG002|Overall Study|Withdrawal by Subject|0|||
160617673|NCT01066819|579977706|FG000|Overall Study|Adverse Event|18|||
160617674|NCT01066819|579977707|FG001|Overall Study|Adverse Event|1|||
160617675|NCT01066819|579977708|FG002|Overall Study|Adverse Event|6|||
160617676|NCT01066819|579977709|FG003|Overall Study|Adverse Event|0|||
160617677|NCT01066819|579977710|FG004|Overall Study|Adverse Event|0|||
160617678|NCT01066819|579977711|FG005|Overall Study|Adverse Event|0|||
160617679|NCT01066819|579977706|FG000|Overall Study|Death|5|||
160617680|NCT01066819|579977707|FG001|Overall Study|Death|0|||
160617681|NCT01066819|579977708|FG002|Overall Study|Death|1|||
160617682|NCT01066819|579977709|FG003|Overall Study|Death|0|||
160617683|NCT01066819|579977710|FG004|Overall Study|Death|0|||
160617684|NCT01066819|579977711|FG005|Overall Study|Death|0|||
160617685|NCT01066819|579977706|FG000|Overall Study|Lack of Efficacy|22|||
160617686|NCT01066819|579977707|FG001|Overall Study|Lack of Efficacy|1|||
160617687|NCT01066819|579977708|FG002|Overall Study|Lack of Efficacy|2|||
160617688|NCT01066819|579977709|FG003|Overall Study|Lack of Efficacy|1|||
160617689|NCT01066819|579977710|FG004|Overall Study|Lack of Efficacy|0|||
160617690|NCT01066819|579977711|FG005|Overall Study|Lack of Efficacy|0|||
160617691|NCT01066819|579977706|FG000|Overall Study|Physician Decision|6|||
160617692|NCT01066819|579977707|FG001|Overall Study|Physician Decision|2|||
160617693|NCT01066819|579977708|FG002|Overall Study|Physician Decision|3|||
160617694|NCT01066819|579977709|FG003|Overall Study|Physician Decision|0|||
160617695|NCT01066819|579977710|FG004|Overall Study|Physician Decision|0|||
160617696|NCT01066819|579977711|FG005|Overall Study|Physician Decision|0|||
160617697|NCT01066819|579977706|FG000|Overall Study|Protocol Violation|12|||
160617698|NCT01066819|579977707|FG001|Overall Study|Protocol Violation|6|||
160617699|NCT01066819|579977708|FG002|Overall Study|Protocol Violation|0|||
160617700|NCT01066819|579977709|FG003|Overall Study|Protocol Violation|0|||
160617701|NCT01066819|579977710|FG004|Overall Study|Protocol Violation|0|||
160617702|NCT01066819|579977711|FG005|Overall Study|Protocol Violation|0|||
160617703|NCT01066819|579977706|FG000|Overall Study|Withdrawal by Subject|29|||
160617704|NCT01066819|579977707|FG001|Overall Study|Withdrawal by Subject|11|||
160617705|NCT01066819|579977708|FG002|Overall Study|Withdrawal by Subject|6|||
160617706|NCT01066819|579977709|FG003|Overall Study|Withdrawal by Subject|0|||
160617707|NCT01066819|579977710|FG004|Overall Study|Withdrawal by Subject|0|||
160617708|NCT01066819|579977711|FG005|Overall Study|Withdrawal by Subject|0|||
160617709|NCT01066819|579977706|FG000|Overall Study|Administrative|6|||
160617710|NCT01066819|579977707|FG001|Overall Study|Administrative|4|||
160617711|NCT01066819|579977708|FG002|Overall Study|Administrative|2|||
160617712|NCT01066819|579977709|FG003|Overall Study|Administrative|0|||
160617713|NCT01066819|579977710|FG004|Overall Study|Administrative|0|||
160617714|NCT01066819|579977711|FG005|Overall Study|Administrative|0|||
160617715|NCT01066819|579977706|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
160617716|NCT01066819|579977707|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
160661673|NCT05093205|580144141|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
160661674|NCT05093205|580144129|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661675|NCT05093205|580144130|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661676|NCT05093205|580144131|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661677|NCT05093205|580144132|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661678|NCT05093205|580144133|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661679|NCT05093205|580144134|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661680|NCT05093205|580144135|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661681|NCT05093205|580144136|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661682|NCT05093205|580144137|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661683|NCT05093205|580144138|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661684|NCT05093205|580144139|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
160661685|NCT05093205|580144140|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661686|NCT05093205|580144141|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
160661687|NCT05093205|580144129|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661688|NCT05093205|580144130|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661689|NCT05093205|580144131|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661690|NCT05093205|580144132|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661691|NCT05093205|580144133|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661692|NCT05093205|580144134|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661693|NCT05093205|580144135|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661694|NCT05093205|580144136|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661695|NCT05093205|580144137|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661696|NCT05093205|580144138|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661697|NCT05093205|580144139|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661698|NCT05093205|580144140|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
160661699|NCT05093205|580144141|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
160661700|NCT05093205|580144129|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
160661701|NCT05093205|580144130|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
160661702|NCT05093205|580144131|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
160661703|NCT05093205|580144132|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
160661704|NCT05093205|580144133|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
160661705|NCT05093205|580144134|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
160661706|NCT05093205|580144135|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
160661707|NCT05093205|580144136|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
160661708|NCT05093205|580144137|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
160661709|NCT05093205|580144138|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
160661710|NCT05093205|580144139|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
160496910|NCT02419417|579548510|FG009|Overall Study|Participant request to discontinue|1|||
160617717|NCT01066819|579977708|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
160617718|NCT01066819|579977709|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
160617719|NCT01066819|579977710|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
160617720|NCT01066819|579977711|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
160617721|NCT01066819|579977706|FG000|Overall Study|Early termination|2|||
160617722|NCT01066819|579977707|FG001|Overall Study|Early termination|0|||
160617723|NCT01066819|579977708|FG002|Overall Study|Early termination|0|||
160617724|NCT01066819|579977709|FG003|Overall Study|Early termination|0|||
160617725|NCT01066819|579977710|FG004|Overall Study|Early termination|0|||
160617726|NCT01066819|579977711|FG005|Overall Study|Early termination|0|||
160617727|NCT01066819|579977706|FG000|Overall Study|Failed to return|298|||
160617728|NCT01066819|579977707|FG001|Overall Study|Failed to return|107|||
160617729|NCT01066819|579977708|FG002|Overall Study|Failed to return|68|||
160617730|NCT01066819|579977709|FG003|Overall Study|Failed to return|7|||
160617731|NCT01066819|579977710|FG004|Overall Study|Failed to return|2|||
160617732|NCT01066819|579977711|FG005|Overall Study|Failed to return|3|||
160617733|NCT01066819|579977706|FG000|Overall Study|Lab test not done|9|||
160617734|NCT01066819|579977707|FG001|Overall Study|Lab test not done|0|||
160617735|NCT01066819|579977708|FG002|Overall Study|Lab test not done|2|||
160617736|NCT01066819|579977709|FG003|Overall Study|Lab test not done|1|||
160617737|NCT01066819|579977710|FG004|Overall Study|Lab test not done|0|||
160617738|NCT01066819|579977711|FG005|Overall Study|Lab test not done|0|||
160617739|NCT01066819|579977706|FG000|Overall Study|Miscellaneous|28|||
160617740|NCT01066819|579977707|FG001|Overall Study|Miscellaneous|10|||
160617741|NCT01066819|579977708|FG002|Overall Study|Miscellaneous|18|||
160617742|NCT01066819|579977709|FG003|Overall Study|Miscellaneous|1|||
160617743|NCT01066819|579977710|FG004|Overall Study|Miscellaneous|0|||
160617744|NCT01066819|579977711|FG005|Overall Study|Miscellaneous|0|||
160617745|NCT01066819|579977706|FG000|Overall Study|Non responders|123|||
160661711|NCT05093205|580144140|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
160661712|NCT05093205|580144141|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
160661713|NCT05093205|580144129|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160661714|NCT05093205|580144130|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160661715|NCT05093205|580144131|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160617746|NCT01066819|579977707|FG001|Overall Study|Non responders|2|||
160617747|NCT01066819|579977708|FG002|Overall Study|Non responders|7|||
160617748|NCT01066819|579977709|FG003|Overall Study|Non responders|2|||
160617749|NCT01066819|579977710|FG004|Overall Study|Non responders|0|||
160617750|NCT01066819|579977711|FG005|Overall Study|Non responders|1|||
160617751|NCT01066819|579977706|FG000|Overall Study|Not categorised|9|||
160617752|NCT01066819|579977707|FG001|Overall Study|Not categorised|2|||
160617753|NCT01066819|579977708|FG002|Overall Study|Not categorised|6|||
160617754|NCT01066819|579977709|FG003|Overall Study|Not categorised|1|||
160617755|NCT01066819|579977710|FG004|Overall Study|Not categorised|0|||
160617756|NCT01066819|579977711|FG005|Overall Study|Not categorised|0|||
160617757|NCT01066819|579977706|FG000|Overall Study|Relapse|16|||
160617758|NCT01066819|579977707|FG001|Overall Study|Relapse|4|||
160617759|NCT01066819|579977708|FG002|Overall Study|Relapse|3|||
160617760|NCT01066819|579977709|FG003|Overall Study|Relapse|0|||
160617761|NCT01066819|579977710|FG004|Overall Study|Relapse|0|||
160617762|NCT01066819|579977711|FG005|Overall Study|Relapse|0|||
160617763|NCT01066819|579977706|FG000|Overall Study|Results not available|1|||
160617764|NCT01066819|579977707|FG001|Overall Study|Results not available|0|||
160617765|NCT01066819|579977708|FG002|Overall Study|Results not available|0|||
160617766|NCT01066819|579977709|FG003|Overall Study|Results not available|0|||
160617767|NCT01066819|579977710|FG004|Overall Study|Results not available|0|||
160617768|NCT01066819|579977711|FG005|Overall Study|Results not available|0|||
160617769|NCT01066819|579977706|FG000|Overall Study|Screen failure|1|||
160617770|NCT01066819|579977707|FG001|Overall Study|Screen failure|0|||
160617771|NCT01066819|579977708|FG002|Overall Study|Screen failure|0|||
160617772|NCT01066819|579977709|FG003|Overall Study|Screen failure|0|||
160617773|NCT01066819|579977710|FG004|Overall Study|Screen failure|0|||
160617774|NCT01066819|579977711|FG005|Overall Study|Screen failure|0|||
160617775|NCT01066819|579977706|FG000|Overall Study|Spontaneous cure|1|||
160617776|NCT01066819|579977707|FG001|Overall Study|Spontaneous cure|0|||
160617777|NCT01066819|579977708|FG002|Overall Study|Spontaneous cure|0|||
160617778|NCT01066819|579977709|FG003|Overall Study|Spontaneous cure|0|||
160617779|NCT01066819|579977710|FG004|Overall Study|Spontaneous cure|0|||
160617780|NCT01066819|579977711|FG005|Overall Study|Spontaneous cure|0|||
160617781|NCT01066819|579977706|FG000|Overall Study|Treatment never started|85|||
160617782|NCT01066819|579977707|FG001|Overall Study|Treatment never started|19|||
160617783|NCT01066819|579977708|FG002|Overall Study|Treatment never started|19|||
160617784|NCT01066819|579977709|FG003|Overall Study|Treatment never started|3|||
160617785|NCT01066819|579977710|FG004|Overall Study|Treatment never started|2|||
160617786|NCT01066819|579977711|FG005|Overall Study|Treatment never started|2|||
160617787|NCT01066819|579977706|FG000|Overall Study|Treatment stopped|12|||
160617788|NCT01066819|579977707|FG001|Overall Study|Treatment stopped|1|||
160617789|NCT01066819|579977708|FG002|Overall Study|Treatment stopped|2|||
160617790|NCT01066819|579977709|FG003|Overall Study|Treatment stopped|1|||
160617791|NCT01066819|579977710|FG004|Overall Study|Treatment stopped|0|||
160617792|NCT01066819|579977711|FG005|Overall Study|Treatment stopped|0|||
160617793|NCT01066819|579977706|FG000|Overall Study|Other|5|||
160617794|NCT01066819|579977707|FG001|Overall Study|Other|1|||
160617795|NCT01066819|579977708|FG002|Overall Study|Other|1|||
160617796|NCT01066819|579977709|FG003|Overall Study|Other|0|||
160617797|NCT01066819|579977710|FG004|Overall Study|Other|0|||
160617798|NCT01066819|579977711|FG005|Overall Study|Other|0|||
160617799|NCT02719028|579977712|FG000|Overall Study|Adverse Event|2|||
160617800|NCT02719028|579977713|FG001|Overall Study|Adverse Event|1|||
160617801|NCT02719028|579977714|FG002|Overall Study|Adverse Event|4|||
160617802|NCT02719028|579977715|FG003|Overall Study|Adverse Event|8|||
160617803|NCT02719028|579977712|FG000|Overall Study|Physician Decision|0|||
160617804|NCT02719028|579977713|FG001|Overall Study|Physician Decision|1|||
160617805|NCT02719028|579977714|FG002|Overall Study|Physician Decision|1|||
160617806|NCT02719028|579977715|FG003|Overall Study|Physician Decision|1|||
160617807|NCT02719028|579977712|FG000|Overall Study|Use of prohibited medication|0|||
160617808|NCT02719028|579977713|FG001|Overall Study|Use of prohibited medication|0|||
160617809|NCT02719028|579977714|FG002|Overall Study|Use of prohibited medication|1|||
160617810|NCT02719028|579977715|FG003|Overall Study|Use of prohibited medication|0|||
160617811|NCT02719028|579977712|FG000|Overall Study|Protocol Violation|0|||
160617812|NCT02719028|579977713|FG001|Overall Study|Protocol Violation|0|||
160661716|NCT05093205|580144132|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160661717|NCT05093205|580144133|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160617813|NCT02719028|579977714|FG002|Overall Study|Protocol Violation|0|||
160617814|NCT02719028|579977715|FG003|Overall Study|Protocol Violation|1|||
160617815|NCT01539720|579977719|FG000|Overall Study|Screen Fail|15|||
160617816|NCT01539720|579977720|FG001|Overall Study|Screen Fail|3|||
160617817|NCT01539720|579977719|FG000|Overall Study|Lost to Follow-up|14|||
160617818|NCT01539720|579977720|FG001|Overall Study|Lost to Follow-up|7|||
160617819|NCT00298766|579977721|FG000|Overall Study|Adverse Event|18|||
160617820|NCT00298766|579977721|FG000|Overall Study|Death|2|||
160617821|NCT00298766|579977721|FG000|Overall Study|Withdrawal by Subject|9|||
160617822|NCT00298766|579977721|FG000|Overall Study|Treatment ongoing|4|||
160617823|NCT00298766|579977721|FG000|Overall Study|Progression of amyloid markers|4|||
160617824|NCT00298766|579977721|FG000|Overall Study|Deterioration in KPS and organ function|1|||
160617825|NCT00298766|579977721|FG000|Overall Study|Subjects overall condition deterioration|4|||
160617826|NCT00298766|579977721|FG000|Overall Study|Other|4|||
160617827|NCT03287960|579977728|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
160617828|NCT03287960|579977728|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
160617829|NCT03812224|579977729|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
160617830|NCT03812224|579977730|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
160617831|NCT03812224|579977729|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
160617832|NCT03812224|579977730|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
160617833|NCT03812224|579977729|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
160617834|NCT03812224|579977730|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
160617835|NCT03812224|579977729|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
160617836|NCT03812224|579977730|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
160617837|NCT00656136|579977733|FG000|Overall Study|Progressive disease|177|||
160617838|NCT00656136|579977734|FG001|Overall Study|Progressive disease|322|||
160617839|NCT00656136|579977733|FG000|Overall Study|Other Adverse Event|5|||
160617840|NCT00656136|579977734|FG001|Overall Study|Other Adverse Event|51|||
160617841|NCT00656136|579977733|FG000|Overall Study|Protocol Violation|2|||
160617842|NCT00656136|579977734|FG001|Overall Study|Protocol Violation|3|||
160617843|NCT00656136|579977733|FG000|Overall Study|Patient refused to take study medication|7|||
160617844|NCT00656136|579977734|FG001|Overall Study|Patient refused to take study medication|10|||
160617845|NCT00656136|579977733|FG000|Overall Study|Unknown and others|4|||
160617846|NCT00656136|579977734|FG001|Overall Study|Unknown and others|4|||
160617847|NCT03633461|579977745|FG000|Overall Study|Lost to Follow-up|0|||
160617848|NCT03633461|579977746|FG001|Overall Study|Lost to Follow-up|1|||
160617849|NCT02516605|579977748|FG000|Overall Study|Protocol Violation|0|||
160617850|NCT02516605|579977749|FG001|Overall Study|Protocol Violation|0|||
160617851|NCT02516605|579977750|FG002|Overall Study|Protocol Violation|0|||
160617852|NCT02516605|579977751|FG003|Overall Study|Protocol Violation|0|||
160617853|NCT02516605|579977752|FG004|Overall Study|Protocol Violation|1|||
160617854|NCT02516605|579977748|FG000|Overall Study|Withdrawal by Subject|0|||
160617855|NCT02516605|579977749|FG001|Overall Study|Withdrawal by Subject|0|||
160617856|NCT02516605|579977750|FG002|Overall Study|Withdrawal by Subject|0|||
160617857|NCT02516605|579977751|FG003|Overall Study|Withdrawal by Subject|1|||
160617858|NCT02516605|579977752|FG004|Overall Study|Withdrawal by Subject|0|||
160617859|NCT01398176|579977754|FG000|Overall Study|Lost to Follow-up|1|||
160617860|NCT01398176|579977755|FG001|Overall Study|Lost to Follow-up|3|||
160617861|NCT01398176|579977754|FG000|Overall Study|Physician Decision|2|||
160617862|NCT01398176|579977755|FG001|Overall Study|Physician Decision|3|||
160617863|NCT00542321|579977756|FG000|Overall Study|Death|0|||
160617864|NCT00542321|579977757|FG001|Overall Study|Death|1|||
160617865|NCT00253747|579977760|FG000|Overall Study|Lost to Follow-up|13|||
160617866|NCT00253747|579977761|FG001|Overall Study|Lost to Follow-up|14|||
160617867|NCT00253747|579977760|FG000|Overall Study|Withdrawal by Subject|10|||
160617868|NCT00253747|579977761|FG001|Overall Study|Withdrawal by Subject|11|||
160617869|NCT00253747|579977760|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
160617870|NCT00253747|579977761|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
160617871|NCT02275052|579977764|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160617872|NCT02275052|579977765|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160617873|NCT02275052|579977766|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160617874|NCT02275052|579977767|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160617875|NCT02275052|579977764|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
160617876|NCT02275052|579977765|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
160617877|NCT02275052|579977766|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
160617878|NCT02275052|579977767|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
160617879|NCT02275052|579977764|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
160617880|NCT02275052|579977765|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
160617881|NCT02275052|579977766|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160617882|NCT02275052|579977767|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160617883|NCT02275052|579977764|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
160617884|NCT02275052|579977765|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
160617885|NCT02275052|579977766|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
160617886|NCT02275052|579977767|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
160661718|NCT05093205|580144134|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160661719|NCT05093205|580144135|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160617887|NCT02275052|579977764|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
160617888|NCT02275052|579977765|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
160617889|NCT02275052|579977766|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
160617890|NCT02275052|579977767|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
160617891|NCT02275052|579977764|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
160661720|NCT05093205|580144136|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160661721|NCT05093205|580144137|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160496911|NCT02419417|579548511|FG010|Overall Study|Participant request to discontinue|0|||
160496912|NCT02419417|579548501|FG000|Overall Study|Withdrawal by Subject|0|||
160496913|NCT02419417|579548502|FG001|Overall Study|Withdrawal by Subject|0|||
160496914|NCT02419417|579548503|FG002|Overall Study|Withdrawal by Subject|0|||
160496915|NCT02419417|579548504|FG003|Overall Study|Withdrawal by Subject|0|||
160496916|NCT02419417|579548505|FG004|Overall Study|Withdrawal by Subject|0|||
160496917|NCT02419417|579548506|FG005|Overall Study|Withdrawal by Subject|0|||
160496918|NCT02419417|579548507|FG006|Overall Study|Withdrawal by Subject|0|||
160496919|NCT02419417|579548508|FG007|Overall Study|Withdrawal by Subject|0|||
160496920|NCT02419417|579548509|FG008|Overall Study|Withdrawal by Subject|0|||
160496921|NCT02419417|579548510|FG009|Overall Study|Withdrawal by Subject|0|||
160496922|NCT02419417|579548511|FG010|Overall Study|Withdrawal by Subject|1|||
160496923|NCT01240551|579548512|FG000|Overall Study|Refused further treatment|3|||
160496924|NCT01240551|579548513|FG001|Overall Study|Refused further treatment|2|||
160496925|NCT01240551|579548512|FG000|Overall Study|Lost to Follow-up|1|||
160496926|NCT01240551|579548513|FG001|Overall Study|Lost to Follow-up|1|||
160496927|NCT01385748|579548514|FG000|Overall Study|Withdrawal by Subject|7|||
160496928|NCT01385748|579548515|FG001|Overall Study|Withdrawal by Subject|4|||
160496929|NCT01385748|579548516|FG002|Overall Study|Withdrawal by Subject|5|||
160496930|NCT01385748|579548514|FG000|Overall Study|Noncompliance|3|||
160496931|NCT01385748|579548515|FG001|Overall Study|Noncompliance|1|||
160496932|NCT01385748|579548516|FG002|Overall Study|Noncompliance|6|||
160496933|NCT01385748|579548514|FG000|Overall Study|Other|1|||
160496934|NCT01385748|579548515|FG001|Overall Study|Other|7|||
160496935|NCT01385748|579548516|FG002|Overall Study|Other|1|||
160496936|NCT01385748|579548514|FG000|Overall Study|Adverse Event|4|||
160496937|NCT01385748|579548515|FG001|Overall Study|Adverse Event|2|||
160496938|NCT01385748|579548516|FG002|Overall Study|Adverse Event|1|||
160496939|NCT02354651|579548517|FG000|Overall Study|Withdrawal by Subject|2|||
160496940|NCT02354651|579548517|FG000|Overall Study|Physician Decision|1|||
160496941|NCT01377389|579548518|FG000|Overall Study|Withdrawal by Subject|1|||
160496942|NCT01377389|579548518|FG000|Overall Study|Screen failure|2|||
160496943|NCT02562235|579548519|FG000|Overall Study|Adverse Event|3|||
160496944|NCT05274750|579548523|FG000|Overall Study|Adverse Event|0|||
160496945|NCT05274750|579548524|FG001|Overall Study|Adverse Event|1|||
160496946|NCT05274750|579548523|FG000|Overall Study|Lost to Follow-up|2|||
160496947|NCT05274750|579548524|FG001|Overall Study|Lost to Follow-up|3|||
160496948|NCT05274750|579548523|FG000|Overall Study|Physician Decision|3|||
160496949|NCT05274750|579548524|FG001|Overall Study|Physician Decision|0|||
160496950|NCT05274750|579548523|FG000|Overall Study|Withdrawal by Subject|10|||
160496951|NCT05274750|579548524|FG001|Overall Study|Withdrawal by Subject|9|||
160496952|NCT05274750|579548523|FG000|Overall Study|GCP Violation|0|||
160496953|NCT05274750|579548524|FG001|Overall Study|GCP Violation|4|||
160496954|NCT05274750|579548523|FG000|Overall Study|Randomized, not treated|0|||
160496955|NCT05274750|579548524|FG001|Overall Study|Randomized, not treated|1|||
160496956|NCT04328623|579548529|FG000|Overall Study|Protocol Violation|0|||
160496957|NCT04328623|579548530|FG001|Overall Study|Protocol Violation|1|||
160496958|NCT04340947|579548531|FG000|7-day Washout Period|Lost to Follow-up|5|||
160496959|NCT04340947|579548532|FG001|7-day Washout Period|Lost to Follow-up|4|||
160496960|NCT02312557|579548533|FG000|Overall Study|Survival follow-up|4|||
160496961|NCT00121667|579548544|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
160496962|NCT00121667|579548545|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
160496963|NCT00121667|579548546|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
160496964|NCT00121667|579548547|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
160617892|NCT02275052|579977765|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
160617893|NCT02275052|579977766|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
160617894|NCT02275052|579977767|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
160617895|NCT02275052|579977764|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
160496965|NCT00121667|579548544|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
160496966|NCT00121667|579548545|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
160496967|NCT00121667|579548546|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
160496968|NCT00121667|579548547|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
160496969|NCT00121667|579548544|FG000|Short Term (ST) Period|Adverse Event|5|||
160496970|NCT00121667|579548545|FG001|Short Term (ST) Period|Adverse Event|6|||
160496971|NCT00121667|579548546|FG002|Short Term (ST) Period|Adverse Event|5|||
160496972|NCT00121667|579548547|FG003|Short Term (ST) Period|Adverse Event|3|||
160496973|NCT00121667|579548544|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
160496974|NCT00121667|579548545|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
160496975|NCT00121667|579548546|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
160496976|NCT00121667|579548547|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
160496977|NCT00121667|579548544|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
160617896|NCT02275052|579977765|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
160496978|NCT00121667|579548545|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
160496979|NCT00121667|579548546|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
160496980|NCT00121667|579548547|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
160496981|NCT00121667|579548544|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
160617897|NCT02275052|579977766|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
160617898|NCT02275052|579977767|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
160617899|NCT02275052|579977764|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
160617900|NCT02275052|579977765|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
160617901|NCT02275052|579977766|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
160617902|NCT02275052|579977767|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
160617903|NCT02275052|579977764|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160617904|NCT02275052|579977765|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160617905|NCT02275052|579977766|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160617906|NCT02275052|579977767|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
160617907|NCT02275052|579977764|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
160617908|NCT02275052|579977765|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
160617909|NCT02275052|579977766|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
160617910|NCT02275052|579977767|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
160617911|NCT02275052|579977764|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160617912|NCT02275052|579977765|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160617913|NCT02275052|579977766|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160617914|NCT02275052|579977767|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
160617915|NCT05102734|579977768|FG000|Overall Study|Did not require vasopressors|1|||
160617916|NCT05102734|579977769|FG001|Overall Study|Did not require vasopressors|0|||
160617917|NCT05102734|579977768|FG000|Overall Study|Did not have functioning PA catheter|1|||
160617918|NCT05102734|579977769|FG001|Overall Study|Did not have functioning PA catheter|0|||
160617919|NCT05102734|579977768|FG000|Overall Study|Inadequate video quality|2|||
160617920|NCT05102734|579977769|FG001|Overall Study|Inadequate video quality|0|||
160617921|NCT03055806|579977770|FG000|Overall Study|Adverse Event|0|||
160617922|NCT03055806|579977771|FG001|Overall Study|Adverse Event|0|||
160617923|NCT03055806|579977772|FG002|Overall Study|Adverse Event|1|||
160617924|NCT03055806|579977773|FG003|Overall Study|Adverse Event|1|||
160617925|NCT03055806|579977770|FG000|Overall Study|Lost to Follow-up|0|||
160617926|NCT03055806|579977771|FG001|Overall Study|Lost to Follow-up|3|||
160617927|NCT03055806|579977772|FG002|Overall Study|Lost to Follow-up|6|||
160617928|NCT03055806|579977773|FG003|Overall Study|Lost to Follow-up|7|||
160617929|NCT03055806|579977770|FG000|Overall Study|Physician Decision|1|||
160617930|NCT03055806|579977771|FG001|Overall Study|Physician Decision|0|||
160617931|NCT03055806|579977772|FG002|Overall Study|Physician Decision|0|||
160617932|NCT03055806|579977773|FG003|Overall Study|Physician Decision|1|||
160617933|NCT03055806|579977770|FG000|Overall Study|Protocol Violation|1|||
160617934|NCT03055806|579977771|FG001|Overall Study|Protocol Violation|0|||
160617935|NCT03055806|579977772|FG002|Overall Study|Protocol Violation|0|||
160617936|NCT03055806|579977773|FG003|Overall Study|Protocol Violation|0|||
160617937|NCT03055806|579977770|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
160617938|NCT03055806|579977771|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
160617939|NCT03055806|579977772|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
160617940|NCT03055806|579977773|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
160617941|NCT03055806|579977770|FG000|Overall Study|Withdrawal of consent to continue study|2|||
160617942|NCT03055806|579977771|FG001|Overall Study|Withdrawal of consent to continue study|3|||
160617943|NCT03055806|579977772|FG002|Overall Study|Withdrawal of consent to continue study|4|||
160617944|NCT03055806|579977773|FG003|Overall Study|Withdrawal of consent to continue study|6|||
160617945|NCT03055806|579977770|FG000|Overall Study|Partner not willing to try intercourse|1|||
160617946|NCT03055806|579977771|FG001|Overall Study|Partner not willing to try intercourse|0|||
160617947|NCT03055806|579977772|FG002|Overall Study|Partner not willing to try intercourse|0|||
160617948|NCT03055806|579977773|FG003|Overall Study|Partner not willing to try intercourse|0|||
160617949|NCT04601194|579977774|FG000|Overall Study|Lost to Follow-up|7|||
160617950|NCT00846027|579977775|FG000|Overall Study|Death|3|||
160617951|NCT00846027|579977775|FG000|Overall Study|Disease Progression|30|||
160617952|NCT00846027|579977775|FG000|Overall Study|Toxicity|12|||
160617953|NCT00846027|579977775|FG000|Overall Study|Patient Decision|7|||
160617954|NCT00846027|579977775|FG000|Overall Study|Investigator Discretion|29|||
160617955|NCT00846027|579977775|FG000|Overall Study|Protocol Violation|2|||
160617956|NCT00846027|579977775|FG000|Overall Study|Subject Not Treated|7|||
160617957|NCT04905563|579977778|FG000|Overall Study|Withdrawal by Subject|1|||
160617958|NCT04905563|579977779|FG001|Overall Study|Withdrawal by Subject|0|||
160617959|NCT04905563|579977778|FG000|Overall Study|Standard of care orders entered by resident|1|||
160617960|NCT04905563|579977779|FG001|Overall Study|Standard of care orders entered by resident|0|||
160617961|NCT04905563|579977778|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
160617962|NCT04905563|579977779|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
160617963|NCT04905563|579977778|FG000|Overall Study|Withdrawal by Subject|0|||
160617964|NCT04905563|579977779|FG001|Overall Study|Withdrawal by Subject|1|||
160617965|NCT00256204|579977784|FG000|Overall Study|Adverse Event|10|||
160617966|NCT00256204|579977785|FG001|Overall Study|Adverse Event|14|||
160661722|NCT05093205|580144138|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160661723|NCT05093205|580144139|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160661724|NCT05093205|580144140|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
160661725|NCT05093205|580144141|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
160661726|NCT02979353|580144146|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
160661727|NCT02979353|580144147|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
160661728|NCT02979353|580144146|FG000|Overall Study|Withdrawal by Subject|16|||
160661729|NCT02979353|580144147|FG001|Overall Study|Withdrawal by Subject|12|||
160661730|NCT02979353|580144146|FG000|Overall Study|Death|10|||
160661731|NCT02979353|580144147|FG001|Overall Study|Death|11|||
160661732|NCT02979353|580144146|FG000|Overall Study|Transfer to Hospice Care|19|||
160661733|NCT02979353|580144147|FG001|Overall Study|Transfer to Hospice Care|14|||
160661734|NCT02979353|580144146|FG000|Overall Study|Lost to Follow-up|1|||
160661735|NCT02979353|580144147|FG001|Overall Study|Lost to Follow-up|5|||
160661736|NCT00268905|580144148|FG000|Overall Study|Adverse Event|3|||
160661737|NCT00268905|580144149|FG001|Overall Study|Adverse Event|0|||
160661738|NCT00268905|580144150|FG002|Overall Study|Adverse Event|4|||
160661739|NCT00268905|580144148|FG000|Overall Study|Lost to Follow-up|0|||
160661740|NCT00268905|580144149|FG001|Overall Study|Lost to Follow-up|1|||
160661741|NCT00268905|580144150|FG002|Overall Study|Lost to Follow-up|0|||
160661742|NCT00268905|580144148|FG000|Overall Study|Withdrawal by Subject|0|||
160661743|NCT00268905|580144149|FG001|Overall Study|Withdrawal by Subject|0|||
160661744|NCT00268905|580144150|FG002|Overall Study|Withdrawal by Subject|3|||
160661745|NCT00268905|580144148|FG000|Overall Study|Progressive Disease|28|||
160661746|NCT00268905|580144149|FG001|Overall Study|Progressive Disease|4|||
160661747|NCT00268905|580144150|FG002|Overall Study|Progressive Disease|3|||
160661748|NCT00268905|580144148|FG000|Overall Study|Physician Decision|3|||
160661749|NCT00268905|580144149|FG001|Overall Study|Physician Decision|0|||
160661750|NCT00268905|580144150|FG002|Overall Study|Physician Decision|1|||
160661751|NCT00268905|580144148|FG000|Overall Study|Clinical Progression|9|||
160661752|NCT00268905|580144149|FG001|Overall Study|Clinical Progression|4|||
160661753|NCT00268905|580144150|FG002|Overall Study|Clinical Progression|1|||
160661754|NCT04510285|580144151|FG000|Overall Study|Death|1|||
160661755|NCT00048581|580144152|FG000|Double-Blind Period|Adverse Event|9|||
160661756|NCT00048581|580144153|FG001|Double-Blind Period|Adverse Event|5|||
160661757|NCT00048581|580144154|FG002|Double-Blind Period|Adverse Event|0|||
160661758|NCT00048581|580144152|FG000|Double-Blind Period|Lack of Efficacy|14|||
160661759|NCT00048581|580144153|FG001|Double-Blind Period|Lack of Efficacy|27|||
160661760|NCT00048581|580144154|FG002|Double-Blind Period|Lack of Efficacy|0|||
160661761|NCT00048581|580144152|FG000|Double-Blind Period|Lost to Follow-up|5|||
160661762|NCT00048581|580144153|FG001|Double-Blind Period|Lost to Follow-up|0|||
160661763|NCT00048581|580144154|FG002|Double-Blind Period|Lost to Follow-up|0|||
160661764|NCT00048581|580144152|FG000|Double-Blind Period|Withdrawal by Subject|5|||
160661765|NCT00048581|580144153|FG001|Double-Blind Period|Withdrawal by Subject|2|||
160661766|NCT00048581|580144154|FG002|Double-Blind Period|Withdrawal by Subject|0|||
160661767|NCT00048581|580144152|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
160496982|NCT00121667|579548545|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
160496983|NCT00121667|579548546|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
160496984|NCT00121667|579548547|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
160496985|NCT00121667|579548544|FG000|Short Term (ST) Period|Other Reason|3|||
160496986|NCT00121667|579548545|FG001|Short Term (ST) Period|Other Reason|0|||
160496987|NCT00121667|579548546|FG002|Short Term (ST) Period|Other Reason|0|||
160496988|NCT00121667|579548547|FG003|Short Term (ST) Period|Other Reason|0|||
160661768|NCT00048581|580144153|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
160661769|NCT00048581|580144154|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
160661770|NCT00048581|580144152|FG000|Double-Blind Period|Investigator Decision|1|||
160661771|NCT00048581|580144153|FG001|Double-Blind Period|Investigator Decision|0|||
160661772|NCT00048581|580144154|FG002|Double-Blind Period|Investigator Decision|0|||
160661773|NCT00048581|580144152|FG000|Open-Label Period|Death|0|||
160661774|NCT00048581|580144153|FG001|Open-Label Period|Death|0|||
160661775|NCT00048581|580144154|FG002|Open-Label Period|Death|4|||
160661776|NCT00048581|580144152|FG000|Open-Label Period|Adverse Event|0|||
160661777|NCT00048581|580144153|FG001|Open-Label Period|Adverse Event|0|||
160661778|NCT00048581|580144154|FG002|Open-Label Period|Adverse Event|37|||
160661779|NCT00048581|580144152|FG000|Open-Label Period|Lack of Efficacy|0|||
160661780|NCT00048581|580144153|FG001|Open-Label Period|Lack of Efficacy|0|||
160661781|NCT00048581|580144154|FG002|Open-Label Period|Lack of Efficacy|69|||
160661782|NCT00048581|580144152|FG000|Open-Label Period|Lost to Follow-up|0|||
160661783|NCT00048581|580144153|FG001|Open-Label Period|Lost to Follow-up|0|||
160661784|NCT00048581|580144154|FG002|Open-Label Period|Lost to Follow-up|14|||
160661785|NCT00048581|580144152|FG000|Open-Label Period|Withdrawal by Subject|0|||
160661786|NCT00048581|580144153|FG001|Open-Label Period|Withdrawal by Subject|0|||
160661787|NCT00048581|580144154|FG002|Open-Label Period|Withdrawal by Subject|20|||
160661788|NCT00048581|580144152|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
160617967|NCT00256204|579977786|FG002|Overall Study|Adverse Event|16|||
160617968|NCT00256204|579977787|FG003|Overall Study|Adverse Event|14|||
160617969|NCT00256204|579977784|FG000|Overall Study|Death|0|||
160617970|NCT00256204|579977785|FG001|Overall Study|Death|1|||
160617971|NCT00256204|579977786|FG002|Overall Study|Death|0|||
160617972|NCT00256204|579977787|FG003|Overall Study|Death|0|||
160617973|NCT00256204|579977784|FG000|Overall Study|Lost to Follow-up|1|||
160617974|NCT00256204|579977785|FG001|Overall Study|Lost to Follow-up|1|||
160617975|NCT00256204|579977786|FG002|Overall Study|Lost to Follow-up|1|||
160617976|NCT00256204|579977787|FG003|Overall Study|Lost to Follow-up|2|||
160617977|NCT00256204|579977784|FG000|Overall Study|Protocol Violation|1|||
160617978|NCT00256204|579977785|FG001|Overall Study|Protocol Violation|0|||
160617979|NCT00256204|579977786|FG002|Overall Study|Protocol Violation|2|||
160617980|NCT00256204|579977787|FG003|Overall Study|Protocol Violation|1|||
160617981|NCT00256204|579977784|FG000|Overall Study|Physician Decision|0|||
160617982|NCT00256204|579977785|FG001|Overall Study|Physician Decision|0|||
160617983|NCT00256204|579977786|FG002|Overall Study|Physician Decision|1|||
160617984|NCT00256204|579977787|FG003|Overall Study|Physician Decision|2|||
160617985|NCT00256204|579977784|FG000|Overall Study|Withdrawal by Subject|17|||
160617986|NCT00256204|579977785|FG001|Overall Study|Withdrawal by Subject|6|||
160617987|NCT00256204|579977786|FG002|Overall Study|Withdrawal by Subject|7|||
160617988|NCT00256204|579977787|FG003|Overall Study|Withdrawal by Subject|5|||
160617989|NCT00256204|579977784|FG000|Overall Study|Need for additional prohibited treatment|38|||
160617990|NCT00256204|579977785|FG001|Overall Study|Need for additional prohibited treatment|28|||
160617991|NCT00256204|579977786|FG002|Overall Study|Need for additional prohibited treatment|27|||
160617992|NCT00256204|579977787|FG003|Overall Study|Need for additional prohibited treatment|25|||
160617993|NCT03490734|579977797|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
160617994|NCT03490734|579977798|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
160617995|NCT03490734|579977799|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
160617996|NCT03490734|579977800|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
160617997|NCT03490734|579977797|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
160617998|NCT03490734|579977798|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
160617999|NCT03490734|579977799|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
160618000|NCT03490734|579977800|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
160618001|NCT03490734|579977797|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
160618002|NCT03490734|579977798|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
160618003|NCT03490734|579977799|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
160618004|NCT03490734|579977800|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
160618005|NCT03490734|579977797|FG000|Post-intervention Scan Visit|Adverse Event|2|||
160618006|NCT03490734|579977798|FG001|Post-intervention Scan Visit|Adverse Event|0|||
160618007|NCT03490734|579977799|FG002|Post-intervention Scan Visit|Adverse Event|0|||
160618008|NCT03490734|579977800|FG003|Post-intervention Scan Visit|Adverse Event|0|||
160618009|NCT03490734|579977797|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
160618010|NCT03490734|579977798|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
160618011|NCT03490734|579977799|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
160618012|NCT03490734|579977800|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
160618013|NCT03490734|579977797|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
160618014|NCT03490734|579977798|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
160618015|NCT03490734|579977799|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
160618016|NCT03490734|579977800|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
160618017|NCT00994890|579977801|FG000|Overall Study|Adverse Event|13|||
160618018|NCT00994890|579977802|FG001|Overall Study|Adverse Event|9|||
160618019|NCT00994890|579977803|FG002|Overall Study|Adverse Event|11|||
160618020|NCT00994890|579977801|FG000|Overall Study|Lack of Efficacy|0|||
160618021|NCT00994890|579977802|FG001|Overall Study|Lack of Efficacy|0|||
160618022|NCT00994890|579977803|FG002|Overall Study|Lack of Efficacy|1|||
160618023|NCT00994890|579977801|FG000|Overall Study|Lost to Follow-up|6|||
160618024|NCT00994890|579977802|FG001|Overall Study|Lost to Follow-up|1|||
160618025|NCT00994890|579977803|FG002|Overall Study|Lost to Follow-up|3|||
160618026|NCT00994890|579977801|FG000|Overall Study|No longer willing to participate|8|||
160618027|NCT00994890|579977802|FG001|Overall Study|No longer willing to participate|5|||
160618028|NCT00994890|579977803|FG002|Overall Study|No longer willing to participate|13|||
160618029|NCT00994890|579977801|FG000|Overall Study|Protocol Violation|2|||
160618030|NCT00994890|579977802|FG001|Overall Study|Protocol Violation|4|||
160618031|NCT00994890|579977803|FG002|Overall Study|Protocol Violation|0|||
160618032|NCT00994890|579977801|FG000|Overall Study|Study terminated by sponsor|199|||
160618033|NCT00994890|579977802|FG001|Overall Study|Study terminated by sponsor|201|||
160618034|NCT00994890|579977803|FG002|Overall Study|Study terminated by sponsor|197|||
160618035|NCT00994890|579977801|FG000|Overall Study|Randomized, but not treated|1|||
160618036|NCT00994890|579977802|FG001|Overall Study|Randomized, but not treated|0|||
160618037|NCT00994890|579977803|FG002|Overall Study|Randomized, but not treated|0|||
160618038|NCT00994890|579977801|FG000|Overall Study|Other|2|||
160618039|NCT00994890|579977802|FG001|Overall Study|Other|2|||
160618040|NCT00994890|579977803|FG002|Overall Study|Other|1|||
160618041|NCT00699582|579977805|FG000|Overall Study|Adverse Event|4|||
160618042|NCT00699582|579977806|FG001|Overall Study|Adverse Event|11|||
160618043|NCT00699582|579977807|FG002|Overall Study|Adverse Event|23|||
160618044|NCT00699582|579977805|FG000|Overall Study|Withdrawal by Subject|6|||
160618045|NCT00699582|579977806|FG001|Overall Study|Withdrawal by Subject|7|||
160618046|NCT00699582|579977807|FG002|Overall Study|Withdrawal by Subject|4|||
160618047|NCT00699582|579977805|FG000|Overall Study|Lack of Efficacy|1|||
160618048|NCT00699582|579977806|FG001|Overall Study|Lack of Efficacy|0|||
160618049|NCT00699582|579977807|FG002|Overall Study|Lack of Efficacy|1|||
160618050|NCT00699582|579977805|FG000|Overall Study|Progressive Disease|1|||
160618051|NCT00699582|579977806|FG001|Overall Study|Progressive Disease|0|||
160618052|NCT00699582|579977807|FG002|Overall Study|Progressive Disease|0|||
160618053|NCT00699582|579977805|FG000|Overall Study|Administrative/Other|4|||
160618054|NCT00699582|579977806|FG001|Overall Study|Administrative/Other|3|||
160618055|NCT00699582|579977807|FG002|Overall Study|Administrative/Other|0|||
160618056|NCT00699582|579977805|FG000|Overall Study|Randomized, Not Treated|2|||
160618057|NCT00699582|579977806|FG001|Overall Study|Randomized, Not Treated|1|||
160618058|NCT00699582|579977807|FG002|Overall Study|Randomized, Not Treated|0|||
160618059|NCT01849289|579977808|FG000|Overall Study|Adverse Event|3|||
160618060|NCT01849289|579977809|FG001|Overall Study|Adverse Event|3|||
160618061|NCT01849289|579977808|FG000|Overall Study|Protocol Violation|3|||
160618062|NCT01849289|579977809|FG001|Overall Study|Protocol Violation|3|||
160618063|NCT01849289|579977808|FG000|Overall Study|Withdrawal criteria|1|||
160618064|NCT01849289|579977809|FG001|Overall Study|Withdrawal criteria|0|||
160618065|NCT01849289|579977808|FG000|Overall Study|Unclassified|25|||
160618066|NCT01849289|579977809|FG001|Overall Study|Unclassified|18|||
160618067|NCT01142791|579977831|FG000|Overall Study|Alternative Treatment|1|||
160618068|NCT01142791|579977832|FG001|Overall Study|Alternative Treatment|0|||
160618069|NCT01142791|579977831|FG000|Overall Study|Lost to Follow-up|1|||
160618070|NCT01142791|579977832|FG001|Overall Study|Lost to Follow-up|0|||
160618071|NCT01142791|579977831|FG000|Overall Study|Withdrawal by Subject|5|||
160618072|NCT01142791|579977832|FG001|Overall Study|Withdrawal by Subject|0|||
160618073|NCT01142791|579977831|FG000|Overall Study|Received only 1 sonication|0|||
160618074|NCT01142791|579977832|FG001|Overall Study|Received only 1 sonication|6|||
160618075|NCT02975206|579977834|FG000|Overall Study|Withdrawal by Subject|14|||
160618076|NCT02975206|579977835|FG001|Overall Study|Withdrawal by Subject|11|||
160618077|NCT02975206|579977836|FG002|Overall Study|Withdrawal by Subject|11|||
160618078|NCT02975206|579977834|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
160618079|NCT02975206|579977835|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
160618080|NCT02975206|579977836|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
160618081|NCT01981096|579977837|FG000|Overall Study|Parent illness|1|||
160618082|NCT01981096|579977838|FG001|Overall Study|Parent illness|0|||
160618083|NCT01981096|579977837|FG000|Overall Study|Withdrawal by Subject|0|||
160618084|NCT01981096|579977838|FG001|Overall Study|Withdrawal by Subject|1|||
160618085|NCT01981096|579977837|FG000|Overall Study|Lost to Follow-up|2|||
160618086|NCT01981096|579977838|FG001|Overall Study|Lost to Follow-up|0|||
160618087|NCT04129242|579977840|FG000|Overall Study|Physician Decision|1|||
160618088|NCT04129242|579977841|FG001|Overall Study|Physician Decision|1|||
160618089|NCT04129242|579977840|FG000|Overall Study|Protocol Violation|0|||
160618090|NCT04129242|579977841|FG001|Overall Study|Protocol Violation|1|||
160618091|NCT01899729|579977844|FG000|Overall Study|Adverse Event|1|||
160618092|NCT01899729|579977845|FG001|Overall Study|Adverse Event|0|||
160618093|NCT01899729|579977846|FG002|Overall Study|Adverse Event|0|||
160618094|NCT01899729|579977847|FG003|Overall Study|Adverse Event|0|||
160618095|NCT01899729|579977848|FG004|Overall Study|Adverse Event|1|||
160618096|NCT01899729|579977844|FG000|Overall Study|Withdrawal by Subject|1|||
160618097|NCT01899729|579977845|FG001|Overall Study|Withdrawal by Subject|2|||
160618098|NCT01899729|579977846|FG002|Overall Study|Withdrawal by Subject|0|||
160618099|NCT01899729|579977847|FG003|Overall Study|Withdrawal by Subject|0|||
160618100|NCT01899729|579977848|FG004|Overall Study|Withdrawal by Subject|0|||
160618101|NCT01899729|579977844|FG000|Overall Study|Lack of Efficacy|0|||
160618102|NCT01899729|579977845|FG001|Overall Study|Lack of Efficacy|0|||
160618103|NCT01899729|579977846|FG002|Overall Study|Lack of Efficacy|2|||
160618104|NCT01899729|579977847|FG003|Overall Study|Lack of Efficacy|0|||
160618105|NCT01899729|579977848|FG004|Overall Study|Lack of Efficacy|1|||
160618106|NCT01454531|579977849|FG000|Overall Study|Adverse Event|14|||
160618107|NCT01454531|579977849|FG000|Overall Study|Withdrawal by Subject|5|||
160618108|NCT01454531|579977849|FG000|Overall Study|Lost to Follow-up|1|||
160618109|NCT01454531|579977849|FG000|Overall Study|Physician Decision|1|||
160618110|NCT01454531|579977849|FG000|Overall Study|Delay in IMP administration|1|||
160618111|NCT01454531|579977849|FG000|Overall Study|Other|1|||
160496989|NCT00121667|579548544|FG000|Short Term (ST) Period|Death|0|||
160496990|NCT00121667|579548545|FG001|Short Term (ST) Period|Death|0|||
160618112|NCT00554840|579977850|FG000|Overall Study|Physician Decision|0|||
160618113|NCT00554840|579977851|FG001|Overall Study|Physician Decision|1|||
160618114|NCT01021423|579977854|FG000|Overall Study|Study terminated|4|||
160618115|NCT01021423|579977855|FG001|Overall Study|Study terminated|5|||
160618116|NCT00122317|579977856|FG000|Overall Study|Death|3|||
160618117|NCT00122317|579977856|FG000|Overall Study|Adverse Event|4|||
160618118|NCT00122317|579977856|FG000|Overall Study|Physician Decision|2|||
160618119|NCT00122317|579977856|FG000|Overall Study|patient non-compliance|1|||
160618120|NCT00122317|579977856|FG000|Overall Study|Withdrawal by Subject|1|||
160618121|NCT03756285|579977857|FG000|Overall Study|Lost to Follow-up|0|||
160618122|NCT03756285|579977858|FG001|Overall Study|Lost to Follow-up|1|||
160618123|NCT03756285|579977857|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
160618124|NCT03756285|579977858|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
160618125|NCT03756285|579977857|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
160618126|NCT03756285|579977858|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
160618127|NCT01503229|579979835|FG000|Overall Study|Withdrew consent|1|||
160618128|NCT01354964|579979836|FG000|Overall Study|Lost to Follow-up|2|||
160618129|NCT01354964|579979837|FG001|Overall Study|Lost to Follow-up|0|||
160618130|NCT01354964|579979836|FG000|Overall Study|IV access issues|1|||
160618131|NCT01354964|579979837|FG001|Overall Study|IV access issues|1|||
160618132|NCT01354964|579979836|FG000|Overall Study|Physician Decision|1|||
160618133|NCT01354964|579979837|FG001|Overall Study|Physician Decision|0|||
160618134|NCT00711009|579979838|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
160618135|NCT00711009|579979839|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
160618136|NCT00711009|579979838|FG000|Overall Study|Withdrawal by Subject|4|||
160618137|NCT00711009|579979839|FG001|Overall Study|Withdrawal by Subject|2|||
160618138|NCT00711009|579979838|FG000|Overall Study|Lost to Follow-up|3|||
160618139|NCT00711009|579979839|FG001|Overall Study|Lost to Follow-up|9|||
160618140|NCT00711009|579979838|FG000|Overall Study|Participant Noncompliant|0|||
160618141|NCT00711009|579979839|FG001|Overall Study|Participant Noncompliant|1|||
160618142|NCT00711009|579979838|FG000|Overall Study|Virologic Failure|2|||
160618143|NCT00711009|579979839|FG001|Overall Study|Virologic Failure|1|||
160618144|NCT00711009|579979838|FG000|Overall Study|Pregnancy|1|||
160618145|NCT00711009|579979839|FG001|Overall Study|Pregnancy|0|||
160618146|NCT00711009|579979838|FG000|Overall Study|Site closing|0|||
160618147|NCT00711009|579979839|FG001|Overall Study|Site closing|1|||
160618148|NCT00711009|579979838|FG000|Overall Study|Dose adjustment|1|||
160618149|NCT00711009|579979839|FG001|Overall Study|Dose adjustment|0|||
160618150|NCT02534324|579979841|FG000|Overall Study|Protocol Violation|4|||
160618151|NCT02534324|579979842|FG001|Overall Study|Protocol Violation|1|||
160618152|NCT02534324|579979841|FG000|Overall Study|Lost to Follow-up|20|||
160618153|NCT02534324|579979842|FG001|Overall Study|Lost to Follow-up|7|||
160618154|NCT02534324|579979841|FG000|Overall Study|Adverse Event|1|||
160618155|NCT02534324|579979842|FG001|Overall Study|Adverse Event|0|||
160618156|NCT01459016|579979843|FG000|Overall Study|Withdrawal by Subject|11|||
160618157|NCT01459016|579979843|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
160618158|NCT03922945|579979857|FG000|Overall Study|Adverse Event|1|||
160618159|NCT03922945|579979858|FG001|Overall Study|Adverse Event|1|||
160618160|NCT03922945|579979859|FG002|Overall Study|Adverse Event|2|||
160618161|NCT03922945|579979857|FG000|Overall Study|Lost to Follow-up|13|||
160618162|NCT03922945|579979858|FG001|Overall Study|Lost to Follow-up|9|||
160618163|NCT03922945|579979859|FG002|Overall Study|Lost to Follow-up|20|||
160618164|NCT03922945|579979857|FG000|Overall Study|Lack of Efficacy|2|||
160618165|NCT03922945|579979858|FG001|Overall Study|Lack of Efficacy|0|||
160618166|NCT03922945|579979859|FG002|Overall Study|Lack of Efficacy|1|||
160618167|NCT03922945|579979857|FG000|Overall Study|Protocol Non-Compliance|0|||
160618168|NCT03922945|579979858|FG001|Overall Study|Protocol Non-Compliance|0|||
160618169|NCT03922945|579979859|FG002|Overall Study|Protocol Non-Compliance|1|||
160618170|NCT03922945|579979857|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
160618171|NCT03922945|579979858|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
160618172|NCT03922945|579979859|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
160618173|NCT03922945|579979857|FG000|Overall Study|All Other Personal Reasons|1|||
160618174|NCT03922945|579979858|FG001|Overall Study|All Other Personal Reasons|1|||
160618175|NCT03922945|579979859|FG002|Overall Study|All Other Personal Reasons|2|||
160618176|NCT02889861|579979860|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
160618177|NCT00313716|579979861|FG000|Overall Study|Death|3|||
160618178|NCT00313716|579979862|FG001|Overall Study|Death|2|||
160618179|NCT00313716|579979863|FG002|Overall Study|Death|9|||
160618180|NCT00313716|579979864|FG003|Overall Study|Death|3|||
160618181|NCT00313716|579979865|FG004|Overall Study|Death|5|||
160618182|NCT00313716|579979866|FG005|Overall Study|Death|9|||
160618183|NCT00313716|579979861|FG000|Overall Study|Lost to Follow-up|2|||
160618184|NCT00313716|579979862|FG001|Overall Study|Lost to Follow-up|5|||
160618185|NCT00313716|579979863|FG002|Overall Study|Lost to Follow-up|2|||
160618186|NCT00313716|579979864|FG003|Overall Study|Lost to Follow-up|1|||
160618187|NCT00313716|579979865|FG004|Overall Study|Lost to Follow-up|0|||
160618188|NCT00313716|579979866|FG005|Overall Study|Lost to Follow-up|4|||
160618189|NCT00313716|579979861|FG000|Overall Study|Withdrawal by Subject|0|||
160618190|NCT00313716|579979862|FG001|Overall Study|Withdrawal by Subject|1|||
160618191|NCT00313716|579979863|FG002|Overall Study|Withdrawal by Subject|1|||
160496991|NCT00121667|579548546|FG002|Short Term (ST) Period|Death|0|||
160618192|NCT00313716|579979864|FG003|Overall Study|Withdrawal by Subject|0|||
160618193|NCT00313716|579979865|FG004|Overall Study|Withdrawal by Subject|1|||
160618194|NCT00313716|579979866|FG005|Overall Study|Withdrawal by Subject|0|||
160618195|NCT00959192|579979886|FG000|Overall Study|Adverse Event|1|||
160618196|NCT00959192|579979887|FG001|Overall Study|Adverse Event|1|||
160618197|NCT00959192|579979888|FG002|Overall Study|Adverse Event|1|||
160618198|NCT00959192|579979889|FG003|Overall Study|Adverse Event|0|||
160618199|NCT00959192|579979886|FG000|Overall Study|Investigator Request|1|||
160618200|NCT00959192|579979887|FG001|Overall Study|Investigator Request|0|||
160618201|NCT00959192|579979888|FG002|Overall Study|Investigator Request|0|||
160618202|NCT00959192|579979889|FG003|Overall Study|Investigator Request|0|||
160618203|NCT00959192|579979886|FG000|Overall Study|Caregiver Request|0|||
160618204|NCT00959192|579979887|FG001|Overall Study|Caregiver Request|0|||
160618205|NCT00959192|579979888|FG002|Overall Study|Caregiver Request|2|||
160618206|NCT00959192|579979889|FG003|Overall Study|Caregiver Request|1|||
160618207|NCT01603615|579979890|FG000|Overall Study|Did not Receive Treatment|7|||
160618208|NCT01603615|579979890|FG000|Overall Study|Lost to Follow-up|9|||
160618209|NCT01603615|579979890|FG000|Overall Study|Personal Reasons|17|||
160618210|NCT01603615|579979890|FG000|Overall Study|Other Miscellaneous|1|||
160618211|NCT02194699|579979895|FG000|Randomised|Did not receive treatment|1|||
160618212|NCT02194699|579979896|FG001|Randomised|Did not receive treatment|5|||
160618213|NCT02194699|579979895|FG000|Randomised|Without potential for 52 weeks of IP|5|||
160618214|NCT02194699|579979896|FG001|Randomised|Without potential for 52 weeks of IP|5|||
160618215|NCT02194699|579979895|FG000|Randomised|Duplicate patient|2|||
160618216|NCT02194699|579979896|FG001|Randomised|Duplicate patient|1|||
160618217|NCT02194699|579979895|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
160618218|NCT02194699|579979896|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
160618219|NCT02194699|579979895|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
160618220|NCT02194699|579979896|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
160618221|NCT02194699|579979895|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
160618222|NCT02194699|579979896|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
160618223|NCT02194699|579979895|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
160618224|NCT02194699|579979896|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
160618225|NCT02194699|579979895|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
160618226|NCT02194699|579979896|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
160618227|NCT02194699|579979895|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
160618228|NCT02194699|579979896|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
160618229|NCT01667731|579979898|FG000|Overall Study|Enrolled but not treated|0|||
160618230|NCT01667731|579979899|FG001|Overall Study|Enrolled but not treated|0|||
160618231|NCT01667731|579979900|FG002|Overall Study|Enrolled but not treated|0|||
160618232|NCT01667731|579979901|FG003|Overall Study|Enrolled but not treated|0|||
160618233|NCT01667731|579979902|FG004|Overall Study|Enrolled but not treated|1|||
160618234|NCT01667731|579979898|FG000|Overall Study|Efficacy Failure|1|||
160618235|NCT01667731|579979899|FG001|Overall Study|Efficacy Failure|12|||
160618236|NCT01667731|579979900|FG002|Overall Study|Efficacy Failure|0|||
160618237|NCT01667731|579979901|FG003|Overall Study|Efficacy Failure|1|||
160618238|NCT01667731|579979902|FG004|Overall Study|Efficacy Failure|24|||
160618239|NCT01667731|579979898|FG000|Overall Study|Lost to Follow-up|2|||
160618240|NCT01667731|579979899|FG001|Overall Study|Lost to Follow-up|3|||
160618241|NCT01667731|579979900|FG002|Overall Study|Lost to Follow-up|1|||
160618242|NCT01667731|579979901|FG003|Overall Study|Lost to Follow-up|1|||
160618243|NCT01667731|579979902|FG004|Overall Study|Lost to Follow-up|2|||
160618244|NCT01667731|579979898|FG000|Overall Study|Subject Withdrew Consent|2|||
160618245|NCT01667731|579979899|FG001|Overall Study|Subject Withdrew Consent|0|||
160618246|NCT01667731|579979900|FG002|Overall Study|Subject Withdrew Consent|1|||
160618247|NCT01667731|579979901|FG003|Overall Study|Subject Withdrew Consent|0|||
160618248|NCT01667731|579979902|FG004|Overall Study|Subject Withdrew Consent|1|||
160618249|NCT01667731|579979898|FG000|Overall Study|Death|0|||
160618250|NCT01667731|579979899|FG001|Overall Study|Death|1|||
160496992|NCT00121667|579548547|FG003|Short Term (ST) Period|Death|1|||
160496993|NCT00121667|579548544|FG000|Short Term (ST) Period|Pregnancy|0|||
160618251|NCT01667731|579979900|FG002|Overall Study|Death|0|||
160618252|NCT01667731|579979901|FG003|Overall Study|Death|0|||
160618253|NCT01667731|579979902|FG004|Overall Study|Death|0|||
160618254|NCT02127970|579979910|FG000|Overall Study|Adverse Event|2|||
160618255|NCT02127970|579979911|FG001|Overall Study|Adverse Event|1|||
160618256|NCT02127970|579979910|FG000|Overall Study|Death|1|||
160618257|NCT02127970|579979911|FG001|Overall Study|Death|1|||
160618258|NCT02127970|579979910|FG000|Overall Study|Lost to Follow-up|14|||
160496994|NCT00121667|579548545|FG001|Short Term (ST) Period|Pregnancy|0|||
160618259|NCT02127970|579979911|FG001|Overall Study|Lost to Follow-up|14|||
160618260|NCT02127970|579979910|FG000|Overall Study|Reason not Specified|4|||
160618261|NCT02127970|579979911|FG001|Overall Study|Reason not Specified|7|||
160618262|NCT02127970|579979910|FG000|Overall Study|Pregnancy|0|||
160618263|NCT02127970|579979911|FG001|Overall Study|Pregnancy|1|||
160618264|NCT02127970|579979910|FG000|Overall Study|Subject Withdrew Consent|5|||
160618265|NCT02127970|579979911|FG001|Overall Study|Subject Withdrew Consent|3|||
160618266|NCT01871870|579979915|FG000|Overall Study|Hardware issues|7|||
160618267|NCT01871870|579979915|FG000|Overall Study|hyperglycemia|2|||
160618268|NCT00490815|579979919|FG000|Overall Study|Adverse Event|2|||
160618269|NCT00490815|579979920|FG001|Overall Study|Adverse Event|3|||
160618270|NCT00490815|579979919|FG000|Overall Study|Withdrawal by Subject|4|||
160618271|NCT00490815|579979920|FG001|Overall Study|Withdrawal by Subject|0|||
160618272|NCT00490815|579979919|FG000|Overall Study|Lost to Follow-up|1|||
160618273|NCT00490815|579979920|FG001|Overall Study|Lost to Follow-up|3|||
160618274|NCT00490815|579979919|FG000|Overall Study|Death|1|||
160618275|NCT00490815|579979920|FG001|Overall Study|Death|3|||
160618276|NCT01904760|579979921|FG000|Overall Study|Protocol Violation|1|||
160618277|NCT01904760|579979922|FG001|Overall Study|Protocol Violation|0|||
160618278|NCT04249076|579979924|FG000|Overall Study|Adverse Event|1|||
160618279|NCT04249076|579979925|FG001|Overall Study|Adverse Event|1|||
160618280|NCT04249076|579979924|FG000|Overall Study|Protocol Violation|1|||
160618281|NCT04249076|579979925|FG001|Overall Study|Protocol Violation|2|||
160618282|NCT04249076|579979924|FG000|Overall Study|Lack of Efficacy|0|||
160618283|NCT04249076|579979925|FG001|Overall Study|Lack of Efficacy|1|||
160618284|NCT04249076|579979924|FG000|Overall Study|Withdrawal by Subject|0|||
160618285|NCT04249076|579979925|FG001|Overall Study|Withdrawal by Subject|1|||
160618286|NCT00783263|579979926|FG000|Overall Study|Adverse Event|3|||
160618287|NCT00783263|579979927|FG001|Overall Study|Adverse Event|0|||
160618288|NCT00783263|579979928|FG002|Overall Study|Adverse Event|2|||
160618289|NCT00783263|579979929|FG003|Overall Study|Adverse Event|1|||
160618290|NCT00783263|579979926|FG000|Overall Study|Lost to Follow-up|1|||
160618291|NCT00783263|579979927|FG001|Overall Study|Lost to Follow-up|1|||
160618292|NCT00783263|579979928|FG002|Overall Study|Lost to Follow-up|0|||
160618293|NCT00783263|579979929|FG003|Overall Study|Lost to Follow-up|0|||
160618294|NCT00783263|579979926|FG000|Overall Study|Withdrawal by Subject|0|||
160618295|NCT00783263|579979927|FG001|Overall Study|Withdrawal by Subject|1|||
160618296|NCT00783263|579979928|FG002|Overall Study|Withdrawal by Subject|1|||
160618297|NCT00783263|579979929|FG003|Overall Study|Withdrawal by Subject|2|||
160618298|NCT00732199|579979930|FG000|Overall Study|Withdrawal by Subject|25|||
160618299|NCT00732199|579979931|FG001|Overall Study|Withdrawal by Subject|18|||
160618300|NCT00732199|579979930|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
160618301|NCT00732199|579979931|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
160618302|NCT02242305|579979943|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
160618303|NCT02242305|579979944|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
160618304|NCT02242305|579979943|FG000|Overall Study|Adverse Event|1|||
160618305|NCT02242305|579979944|FG001|Overall Study|Adverse Event|0|||
160618306|NCT02242305|579979943|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
160618307|NCT02242305|579979944|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
160618308|NCT02242305|579979943|FG000|Overall Study|Subject withdraws inform consent|0|||
160618309|NCT02242305|579979944|FG001|Overall Study|Subject withdraws inform consent|4|||
160618310|NCT02242305|579979943|FG000|Overall Study|Lost to Follow-up|2|||
160618311|NCT02242305|579979944|FG001|Overall Study|Lost to Follow-up|0|||
160618312|NCT02543801|579979948|FG000|Overall Study|Protocol Violation|1|||
160618313|NCT02543801|579979949|FG001|Overall Study|Protocol Violation|2|||
160618314|NCT02543801|579979950|FG002|Overall Study|Protocol Violation|0|||
160618315|NCT02543801|579979951|FG003|Overall Study|Protocol Violation|0|||
160618316|NCT01756846|579979952|FG000|Overall Study|Lost to Follow-up|5|||
160618317|NCT01756846|579979953|FG001|Overall Study|Lost to Follow-up|10|||
160618318|NCT01756846|579979952|FG000|Overall Study|Withdrawal by Subject|1|||
160618319|NCT01756846|579979953|FG001|Overall Study|Withdrawal by Subject|2|||
160618320|NCT00082628|579979963|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
160618321|NCT00082628|579979964|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
160618322|NCT00082628|579979965|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
160618323|NCT00082628|579979966|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
160618324|NCT00082628|579979967|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
160618325|NCT00082628|579979963|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
160618326|NCT00082628|579979964|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
160618327|NCT00082628|579979965|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
160618328|NCT00082628|579979966|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
160618329|NCT00082628|579979967|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
160618330|NCT00082628|579979963|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
160618331|NCT00082628|579979964|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
160618332|NCT00082628|579979965|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
160618333|NCT00082628|579979966|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
160618334|NCT00082628|579979967|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
160618335|NCT00082628|579979963|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
160661789|NCT00048581|580144153|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
160661790|NCT00048581|580144154|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
160661791|NCT00048581|580144152|FG000|Open-Label Period|Poor/Non-compliance|0|||
160661792|NCT00048581|580144153|FG001|Open-Label Period|Poor/Non-compliance|0|||
160661793|NCT00048581|580144154|FG002|Open-Label Period|Poor/Non-compliance|5|||
160661794|NCT00048581|580144152|FG000|Open-Label Period|Pregnancy|0|||
160661795|NCT00048581|580144153|FG001|Open-Label Period|Pregnancy|0|||
160661796|NCT00048581|580144154|FG002|Open-Label Period|Pregnancy|7|||
160661797|NCT00048581|580144152|FG000|Open-Label Period|Study Site Closure|0|||
160661798|NCT00048581|580144153|FG001|Open-Label Period|Study Site Closure|0|||
160661799|NCT00048581|580144154|FG002|Open-Label Period|Study Site Closure|2|||
160661800|NCT00048581|580144152|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
160661801|NCT00048581|580144153|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
160661802|NCT00048581|580144154|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
160661803|NCT00048581|580144152|FG000|Open-Label Period|Problem With Transportation To Site|0|||
160661804|NCT00048581|580144153|FG001|Open-Label Period|Problem With Transportation To Site|0|||
160661805|NCT00048581|580144154|FG002|Open-Label Period|Problem With Transportation To Site|1|||
160661806|NCT00048581|580144152|FG000|Open-Label Period|Primary Investigator Retired|0|||
160661807|NCT00048581|580144153|FG001|Open-Label Period|Primary Investigator Retired|0|||
160661808|NCT00048581|580144154|FG002|Open-Label Period|Primary Investigator Retired|2|||
160661809|NCT00048581|580144152|FG000|Open-Label Period|Study Ended By Sponsor|0|||
160661810|NCT00048581|580144153|FG001|Open-Label Period|Study Ended By Sponsor|0|||
160661811|NCT00048581|580144154|FG002|Open-Label Period|Study Ended By Sponsor|1|||
160661812|NCT01406795|580144155|FG000|Overall Study|Withdrawal by Subject|1|||
160661813|NCT03897088|580144158|FG000|Overall Study|Withdrawal by Subject|12|||
160618336|NCT00082628|579979964|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
160618337|NCT00082628|579979965|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
160618338|NCT00082628|579979966|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
160618339|NCT00082628|579979967|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
160618340|NCT00082628|579979963|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
160618341|NCT00082628|579979964|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
160618342|NCT00082628|579979965|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
160618343|NCT00082628|579979966|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
160618344|NCT00082628|579979967|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
160618345|NCT00082628|579979963|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
160618346|NCT00082628|579979964|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
160618347|NCT00082628|579979965|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
160618348|NCT00082628|579979966|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
160618349|NCT00082628|579979967|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
160618350|NCT00082628|579979963|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
160618351|NCT00082628|579979964|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
160618352|NCT00082628|579979965|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
160618353|NCT00082628|579979966|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
160618354|NCT00082628|579979967|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
160618355|NCT04118127|579979970|FG000|Overall Study|Trial terminated by sponsor|0|||
160618356|NCT04118127|579979971|FG001|Overall Study|Trial terminated by sponsor|12|||
160618357|NCT04118127|579979970|FG000|Overall Study|Adverse Event|1|||
160618358|NCT04118127|579979971|FG001|Overall Study|Adverse Event|2|||
160618359|NCT04118127|579979970|FG000|Overall Study|Physician Decision|0|||
160618360|NCT04118127|579979971|FG001|Overall Study|Physician Decision|1|||
160618361|NCT04118127|579979970|FG000|Overall Study|Withdrawal by Subject|2|||
160618362|NCT04118127|579979971|FG001|Overall Study|Withdrawal by Subject|1|||
160618363|NCT01326910|579979972|FG000|Overall Study|Withdrawal by Subject|3|||
160618364|NCT01326910|579979973|FG001|Overall Study|Withdrawal by Subject|2|||
160618365|NCT01326910|579979972|FG000|Overall Study|Protocol Violation|1|||
160661814|NCT03897088|580144159|FG001|Overall Study|Withdrawal by Subject|12|||
160661815|NCT03897088|580144158|FG000|Overall Study|Lost to Follow-up|7|||
160661816|NCT03897088|580144159|FG001|Overall Study|Lost to Follow-up|15|||
160661817|NCT03897088|580144158|FG000|Overall Study|Sponsor Decision|1|||
160618366|NCT01326910|579979973|FG001|Overall Study|Protocol Violation|1|||
160618367|NCT02394028|579979978|FG000|Induction Phase|Adverse Event|2|||
160618368|NCT02394028|579979979|FG001|Induction Phase|Adverse Event|4|||
160618369|NCT02394028|579979980|FG002|Induction Phase|Adverse Event|1|||
160618370|NCT02394028|579979981|FG003|Induction Phase|Adverse Event|2|||
160661818|NCT03897088|580144159|FG001|Overall Study|Sponsor Decision|2|||
160661819|NCT03897088|580144158|FG000|Overall Study|COVID-19|2|||
160661820|NCT03897088|580144159|FG001|Overall Study|COVID-19|0|||
160661821|NCT03897088|580144158|FG000|Overall Study|Other|3|||
160661822|NCT03897088|580144159|FG001|Overall Study|Other|0|||
160661823|NCT03897088|580144158|FG000|Overall Study|Non-compliance with Study Drug|1|||
160618371|NCT02394028|579979982|FG004|Induction Phase|Adverse Event|5|||
160618372|NCT02394028|579979983|FG005|Induction Phase|Adverse Event|2|||
160618373|NCT02394028|579979984|FG006|Induction Phase|Adverse Event|0|||
160618374|NCT02394028|579979985|FG007|Induction Phase|Adverse Event|0|||
160618375|NCT02394028|579979986|FG008|Induction Phase|Adverse Event|0|||
160618376|NCT02394028|579979987|FG009|Induction Phase|Adverse Event|0|||
160618377|NCT02394028|579979988|FG010|Induction Phase|Adverse Event|0|||
160618378|NCT02394028|579979978|FG000|Induction Phase|Lack of Efficacy|3|||
160618379|NCT02394028|579979979|FG001|Induction Phase|Lack of Efficacy|6|||
160618380|NCT02394028|579979980|FG002|Induction Phase|Lack of Efficacy|2|||
160618381|NCT02394028|579979981|FG003|Induction Phase|Lack of Efficacy|17|||
160618382|NCT02394028|579979982|FG004|Induction Phase|Lack of Efficacy|14|||
160618383|NCT02394028|579979983|FG005|Induction Phase|Lack of Efficacy|8|||
160618384|NCT02394028|579979984|FG006|Induction Phase|Lack of Efficacy|17|||
160618385|NCT02394028|579979985|FG007|Induction Phase|Lack of Efficacy|23|||
160618386|NCT02394028|579979986|FG008|Induction Phase|Lack of Efficacy|0|||
160618387|NCT02394028|579979987|FG009|Induction Phase|Lack of Efficacy|0|||
160618388|NCT02394028|579979988|FG010|Induction Phase|Lack of Efficacy|0|||
160618389|NCT02394028|579979978|FG000|Induction Phase|Lost to Follow-up|1|||
160618390|NCT02394028|579979979|FG001|Induction Phase|Lost to Follow-up|0|||
160618391|NCT02394028|579979980|FG002|Induction Phase|Lost to Follow-up|0|||
160618392|NCT02394028|579979981|FG003|Induction Phase|Lost to Follow-up|1|||
160618393|NCT02394028|579979982|FG004|Induction Phase|Lost to Follow-up|0|||
160618394|NCT02394028|579979983|FG005|Induction Phase|Lost to Follow-up|0|||
160618395|NCT02394028|579979984|FG006|Induction Phase|Lost to Follow-up|1|||
160618396|NCT02394028|579979985|FG007|Induction Phase|Lost to Follow-up|0|||
160618397|NCT02394028|579979986|FG008|Induction Phase|Lost to Follow-up|0|||
160618398|NCT02394028|579979987|FG009|Induction Phase|Lost to Follow-up|0|||
160618399|NCT02394028|579979988|FG010|Induction Phase|Lost to Follow-up|0|||
160618400|NCT02394028|579979978|FG000|Induction Phase|Non-compliance|0|||
160618401|NCT02394028|579979979|FG001|Induction Phase|Non-compliance|1|||
160618402|NCT02394028|579979980|FG002|Induction Phase|Non-compliance|3|||
160618403|NCT02394028|579979981|FG003|Induction Phase|Non-compliance|1|||
160618404|NCT02394028|579979982|FG004|Induction Phase|Non-compliance|3|||
160618405|NCT02394028|579979983|FG005|Induction Phase|Non-compliance|0|||
160618406|NCT02394028|579979984|FG006|Induction Phase|Non-compliance|1|||
160618407|NCT02394028|579979985|FG007|Induction Phase|Non-compliance|1|||
160618408|NCT02394028|579979986|FG008|Induction Phase|Non-compliance|0|||
160618409|NCT02394028|579979987|FG009|Induction Phase|Non-compliance|0|||
160618410|NCT02394028|579979988|FG010|Induction Phase|Non-compliance|0|||
160618411|NCT02394028|579979978|FG000|Induction Phase|Physician Decision|0|||
160618412|NCT02394028|579979979|FG001|Induction Phase|Physician Decision|0|||
160618413|NCT02394028|579979980|FG002|Induction Phase|Physician Decision|1|||
160618414|NCT02394028|579979981|FG003|Induction Phase|Physician Decision|4|||
160618415|NCT02394028|579979982|FG004|Induction Phase|Physician Decision|0|||
160618416|NCT02394028|579979983|FG005|Induction Phase|Physician Decision|2|||
160618417|NCT02394028|579979984|FG006|Induction Phase|Physician Decision|1|||
160618418|NCT02394028|579979985|FG007|Induction Phase|Physician Decision|0|||
160618419|NCT02394028|579979986|FG008|Induction Phase|Physician Decision|0|||
160618420|NCT02394028|579979987|FG009|Induction Phase|Physician Decision|0|||
160618421|NCT02394028|579979988|FG010|Induction Phase|Physician Decision|0|||
160618422|NCT02394028|579979978|FG000|Induction Phase|Protocol Violation|0|||
160618423|NCT02394028|579979979|FG001|Induction Phase|Protocol Violation|2|||
160618424|NCT02394028|579979980|FG002|Induction Phase|Protocol Violation|0|||
160618425|NCT02394028|579979981|FG003|Induction Phase|Protocol Violation|3|||
160661824|NCT03897088|580144159|FG001|Overall Study|Non-compliance with Study Drug|1|||
160618426|NCT02394028|579979982|FG004|Induction Phase|Protocol Violation|0|||
160618427|NCT02394028|579979983|FG005|Induction Phase|Protocol Violation|1|||
160618428|NCT02394028|579979984|FG006|Induction Phase|Protocol Violation|1|||
160618429|NCT02394028|579979985|FG007|Induction Phase|Protocol Violation|0|||
160618430|NCT02394028|579979986|FG008|Induction Phase|Protocol Violation|0|||
160618431|NCT02394028|579979987|FG009|Induction Phase|Protocol Violation|0|||
160618432|NCT02394028|579979988|FG010|Induction Phase|Protocol Violation|0|||
160618433|NCT02394028|579979978|FG000|Induction Phase|Withdrawal by Subject|1|||
160618434|NCT02394028|579979979|FG001|Induction Phase|Withdrawal by Subject|2|||
160661825|NCT03897088|580144158|FG000|Overall Study|Pregnancy|0|||
160661826|NCT03897088|580144159|FG001|Overall Study|Pregnancy|1|||
160661827|NCT04320849|580144162|FG000|Overall Study|Withdrawal by Subject|4|||
160618435|NCT02394028|579979980|FG002|Induction Phase|Withdrawal by Subject|4|||
160618436|NCT02394028|579979981|FG003|Induction Phase|Withdrawal by Subject|6|||
160618437|NCT02394028|579979982|FG004|Induction Phase|Withdrawal by Subject|7|||
160618438|NCT02394028|579979983|FG005|Induction Phase|Withdrawal by Subject|4|||
160618439|NCT02394028|579979984|FG006|Induction Phase|Withdrawal by Subject|3|||
160618440|NCT02394028|579979985|FG007|Induction Phase|Withdrawal by Subject|6|||
160618441|NCT02394028|579979986|FG008|Induction Phase|Withdrawal by Subject|0|||
160618442|NCT02394028|579979987|FG009|Induction Phase|Withdrawal by Subject|0|||
160618443|NCT02394028|579979988|FG010|Induction Phase|Withdrawal by Subject|0|||
160618444|NCT02394028|579979978|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
160496995|NCT00121667|579548546|FG002|Short Term (ST) Period|Pregnancy|0|||
160496996|NCT00121667|579548547|FG003|Short Term (ST) Period|Pregnancy|1|||
160496997|NCT00121667|579548544|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
160496998|NCT00121667|579548545|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
160496999|NCT00121667|579548546|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
160497000|NCT00121667|579548547|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
160497001|NCT00121667|579548544|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
160497002|NCT00121667|579548545|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
160618445|NCT02394028|579979979|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
160618446|NCT02394028|579979980|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
160618447|NCT02394028|579979981|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
160618448|NCT02394028|579979982|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
160618449|NCT02394028|579979983|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
160618450|NCT02394028|579979984|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
160618451|NCT02394028|579979985|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
160618452|NCT02394028|579979986|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
160618453|NCT02394028|579979987|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
160618454|NCT02394028|579979988|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
160618455|NCT02394028|579979978|FG000|Induction Phase|Sponsor decision|0|||
160618456|NCT02394028|579979979|FG001|Induction Phase|Sponsor decision|1|||
160618457|NCT02394028|579979980|FG002|Induction Phase|Sponsor decision|2|||
160618458|NCT02394028|579979981|FG003|Induction Phase|Sponsor decision|0|||
160618459|NCT02394028|579979982|FG004|Induction Phase|Sponsor decision|0|||
160618460|NCT02394028|579979983|FG005|Induction Phase|Sponsor decision|0|||
160618461|NCT02394028|579979984|FG006|Induction Phase|Sponsor decision|0|||
160618462|NCT02394028|579979985|FG007|Induction Phase|Sponsor decision|0|||
160618463|NCT02394028|579979986|FG008|Induction Phase|Sponsor decision|0|||
160618464|NCT02394028|579979987|FG009|Induction Phase|Sponsor decision|0|||
160618465|NCT02394028|579979988|FG010|Induction Phase|Sponsor decision|0|||
160618466|NCT02394028|579979978|FG000|Induction Phase|Technical reason|0|||
160618467|NCT02394028|579979979|FG001|Induction Phase|Technical reason|0|||
160618468|NCT02394028|579979980|FG002|Induction Phase|Technical reason|0|||
160618469|NCT02394028|579979981|FG003|Induction Phase|Technical reason|1|||
160618470|NCT02394028|579979982|FG004|Induction Phase|Technical reason|0|||
160618471|NCT02394028|579979983|FG005|Induction Phase|Technical reason|0|||
160618472|NCT02394028|579979984|FG006|Induction Phase|Technical reason|0|||
160618473|NCT02394028|579979985|FG007|Induction Phase|Technical reason|0|||
160618474|NCT02394028|579979986|FG008|Induction Phase|Technical reason|0|||
160618475|NCT02394028|579979987|FG009|Induction Phase|Technical reason|0|||
160618476|NCT02394028|579979988|FG010|Induction Phase|Technical reason|0|||
160618477|NCT02394028|579979978|FG000|Induction Phase|:ack of calculation|0|||
160618478|NCT02394028|579979979|FG001|Induction Phase|:ack of calculation|0|||
160618479|NCT02394028|579979980|FG002|Induction Phase|:ack of calculation|0|||
160618480|NCT02394028|579979981|FG003|Induction Phase|:ack of calculation|0|||
160618481|NCT02394028|579979982|FG004|Induction Phase|:ack of calculation|0|||
160618482|NCT02394028|579979983|FG005|Induction Phase|:ack of calculation|0|||
160618483|NCT02394028|579979984|FG006|Induction Phase|:ack of calculation|0|||
160618484|NCT02394028|579979985|FG007|Induction Phase|:ack of calculation|1|||
160618485|NCT02394028|579979986|FG008|Induction Phase|:ack of calculation|0|||
160618486|NCT02394028|579979987|FG009|Induction Phase|:ack of calculation|0|||
160618487|NCT02394028|579979988|FG010|Induction Phase|:ack of calculation|0|||
160618488|NCT02394028|579979978|FG000|Maintenance Phase|Protocol Violation|0|||
160618489|NCT02394028|579979979|FG001|Maintenance Phase|Protocol Violation|0|||
160618490|NCT02394028|579979980|FG002|Maintenance Phase|Protocol Violation|0|||
160618491|NCT02394028|579979981|FG003|Maintenance Phase|Protocol Violation|0|||
160618492|NCT02394028|579979982|FG004|Maintenance Phase|Protocol Violation|0|||
160618493|NCT02394028|579979983|FG005|Maintenance Phase|Protocol Violation|0|||
160618494|NCT02394028|579979984|FG006|Maintenance Phase|Protocol Violation|0|||
160618495|NCT02394028|579979985|FG007|Maintenance Phase|Protocol Violation|0|||
160618496|NCT02394028|579979986|FG008|Maintenance Phase|Protocol Violation|0|||
160618497|NCT02394028|579979987|FG009|Maintenance Phase|Protocol Violation|0|||
160618498|NCT02394028|579979988|FG010|Maintenance Phase|Protocol Violation|1|||
160618499|NCT02394028|579979978|FG000|Maintenance Phase|Physician Decision|0|||
160618500|NCT02394028|579979979|FG001|Maintenance Phase|Physician Decision|0|||
160497003|NCT00121667|579548546|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
160497004|NCT00121667|579548547|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
160618501|NCT02394028|579979980|FG002|Maintenance Phase|Physician Decision|0|||
160618502|NCT02394028|579979981|FG003|Maintenance Phase|Physician Decision|0|||
160618503|NCT02394028|579979982|FG004|Maintenance Phase|Physician Decision|0|||
160618504|NCT02394028|579979983|FG005|Maintenance Phase|Physician Decision|0|||
160618505|NCT02394028|579979984|FG006|Maintenance Phase|Physician Decision|0|||
160618506|NCT02394028|579979985|FG007|Maintenance Phase|Physician Decision|0|||
160618507|NCT02394028|579979986|FG008|Maintenance Phase|Physician Decision|1|||
160618508|NCT02394028|579979987|FG009|Maintenance Phase|Physician Decision|3|||
160618509|NCT02394028|579979988|FG010|Maintenance Phase|Physician Decision|2|||
160618510|NCT02394028|579979978|FG000|Maintenance Phase|Lack of Efficacy|0|||
160618511|NCT02394028|579979979|FG001|Maintenance Phase|Lack of Efficacy|0|||
160618512|NCT02394028|579979980|FG002|Maintenance Phase|Lack of Efficacy|0|||
160618513|NCT02394028|579979981|FG003|Maintenance Phase|Lack of Efficacy|0|||
160618514|NCT02394028|579979982|FG004|Maintenance Phase|Lack of Efficacy|0|||
160618515|NCT02394028|579979983|FG005|Maintenance Phase|Lack of Efficacy|0|||
160618516|NCT02394028|579979984|FG006|Maintenance Phase|Lack of Efficacy|0|||
160618517|NCT02394028|579979985|FG007|Maintenance Phase|Lack of Efficacy|0|||
160618518|NCT02394028|579979986|FG008|Maintenance Phase|Lack of Efficacy|7|||
160618519|NCT02394028|579979987|FG009|Maintenance Phase|Lack of Efficacy|25|||
160618520|NCT02394028|579979988|FG010|Maintenance Phase|Lack of Efficacy|33|||
160618521|NCT02394028|579979978|FG000|Maintenance Phase|Death|0|||
160618522|NCT02394028|579979979|FG001|Maintenance Phase|Death|0|||
160618523|NCT02394028|579979980|FG002|Maintenance Phase|Death|0|||
160618524|NCT02394028|579979981|FG003|Maintenance Phase|Death|0|||
160618525|NCT02394028|579979982|FG004|Maintenance Phase|Death|0|||
160618526|NCT02394028|579979983|FG005|Maintenance Phase|Death|0|||
160618527|NCT02394028|579979984|FG006|Maintenance Phase|Death|0|||
160618528|NCT02394028|579979985|FG007|Maintenance Phase|Death|0|||
160618529|NCT02394028|579979986|FG008|Maintenance Phase|Death|0|||
160618530|NCT02394028|579979987|FG009|Maintenance Phase|Death|0|||
160618531|NCT02394028|579979988|FG010|Maintenance Phase|Death|1|||
160618532|NCT02394028|579979978|FG000|Maintenance Phase|Adverse Event|0|||
160618533|NCT02394028|579979979|FG001|Maintenance Phase|Adverse Event|0|||
160618534|NCT02394028|579979980|FG002|Maintenance Phase|Adverse Event|0|||
160618535|NCT02394028|579979981|FG003|Maintenance Phase|Adverse Event|0|||
160618536|NCT02394028|579979982|FG004|Maintenance Phase|Adverse Event|0|||
160618537|NCT02394028|579979983|FG005|Maintenance Phase|Adverse Event|0|||
160618538|NCT02394028|579979984|FG006|Maintenance Phase|Adverse Event|0|||
160618539|NCT02394028|579979985|FG007|Maintenance Phase|Adverse Event|0|||
160618540|NCT02394028|579979986|FG008|Maintenance Phase|Adverse Event|1|||
160618541|NCT02394028|579979987|FG009|Maintenance Phase|Adverse Event|1|||
160618542|NCT02394028|579979988|FG010|Maintenance Phase|Adverse Event|3|||
160618543|NCT02394028|579979978|FG000|Maintenance Phase|Site closure|0|||
160618544|NCT02394028|579979979|FG001|Maintenance Phase|Site closure|0|||
160618545|NCT02394028|579979980|FG002|Maintenance Phase|Site closure|0|||
160618546|NCT02394028|579979981|FG003|Maintenance Phase|Site closure|0|||
160618547|NCT02394028|579979982|FG004|Maintenance Phase|Site closure|0|||
160618548|NCT02394028|579979983|FG005|Maintenance Phase|Site closure|0|||
160618549|NCT02394028|579979984|FG006|Maintenance Phase|Site closure|0|||
160618550|NCT02394028|579979985|FG007|Maintenance Phase|Site closure|0|||
160618551|NCT02394028|579979986|FG008|Maintenance Phase|Site closure|0|||
160618552|NCT02394028|579979987|FG009|Maintenance Phase|Site closure|1|||
160618553|NCT02394028|579979988|FG010|Maintenance Phase|Site closure|0|||
160618554|NCT02394028|579979978|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160618555|NCT02394028|579979979|FG001|Maintenance Phase|Withdrawal by Subject|0|||
160618556|NCT02394028|579979980|FG002|Maintenance Phase|Withdrawal by Subject|0|||
160618557|NCT02394028|579979981|FG003|Maintenance Phase|Withdrawal by Subject|0|||
160618558|NCT02394028|579979982|FG004|Maintenance Phase|Withdrawal by Subject|0|||
160618559|NCT02394028|579979983|FG005|Maintenance Phase|Withdrawal by Subject|0|||
160618560|NCT02394028|579979984|FG006|Maintenance Phase|Withdrawal by Subject|0|||
160618561|NCT02394028|579979985|FG007|Maintenance Phase|Withdrawal by Subject|0|||
160618562|NCT02394028|579979986|FG008|Maintenance Phase|Withdrawal by Subject|3|||
160618563|NCT02394028|579979987|FG009|Maintenance Phase|Withdrawal by Subject|12|||
160618564|NCT02394028|579979988|FG010|Maintenance Phase|Withdrawal by Subject|12|||
160618565|NCT00866606|579979989|FG000|Overall Study|Lost to Follow-up|3|||
160618566|NCT00866606|579979989|FG000|Overall Study|Adverse Event|1|||
160618567|NCT02993783|579979990|FG000|Overall Study|Reason not Specified|6|||
160618568|NCT02993783|579979991|FG001|Overall Study|Reason not Specified|9|||
160618569|NCT01277666|579979992|FG000|Overall Study|Adverse Event|26|||
160618570|NCT01277666|579979993|FG001|Overall Study|Adverse Event|25|||
160618571|NCT01277666|579979994|FG002|Overall Study|Adverse Event|20|||
160618572|NCT01277666|579979992|FG000|Overall Study|Lack of Efficacy|8|||
160618573|NCT01277666|579979993|FG001|Overall Study|Lack of Efficacy|20|||
160618574|NCT01277666|579979994|FG002|Overall Study|Lack of Efficacy|12|||
160618575|NCT01277666|579979992|FG000|Overall Study|Protocol Violation|2|||
160618576|NCT01277666|579979993|FG001|Overall Study|Protocol Violation|3|||
160618577|NCT01277666|579979994|FG002|Overall Study|Protocol Violation|2|||
160618578|NCT01277666|579979992|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
160618579|NCT01277666|579979993|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
160618580|NCT01277666|579979994|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
160618581|NCT01277666|579979992|FG000|Overall Study|Lost to Follow-up|1|||
160618582|NCT01277666|579979993|FG001|Overall Study|Lost to Follow-up|1|||
160618583|NCT01277666|579979994|FG002|Overall Study|Lost to Follow-up|2|||
160618584|NCT01277666|579979992|FG000|Overall Study|Withdrawal by Subject|7|||
160618585|NCT01277666|579979993|FG001|Overall Study|Withdrawal by Subject|8|||
160618586|NCT01277666|579979994|FG002|Overall Study|Withdrawal by Subject|6|||
160618587|NCT01277666|579979992|FG000|Overall Study|Death|0|||
160618588|NCT01277666|579979993|FG001|Overall Study|Death|0|||
160618589|NCT01277666|579979994|FG002|Overall Study|Death|1|||
160618590|NCT02312934|579979995|FG000|Overall Study|Lost to Follow-up|1|||
160618591|NCT02312934|579979996|FG001|Overall Study|Lost to Follow-up|0|||
160618592|NCT02312934|579979995|FG000|Overall Study|Physician Decision|1|||
160618593|NCT02312934|579979996|FG001|Overall Study|Physician Decision|0|||
160618594|NCT02886338|579979997|FG000|Overall Study|Withdrawal by Subject|1|||
160618595|NCT01156012|579979999|FG000|Overall Study|Adverse Event|3|||
160618596|NCT01156012|579980000|FG001|Overall Study|Adverse Event|1|||
160618597|NCT01156012|579979999|FG000|Overall Study|Lost to Follow-up|1|||
160618598|NCT01156012|579980000|FG001|Overall Study|Lost to Follow-up|0|||
160618599|NCT01156012|579979999|FG000|Overall Study|Withdrawal by Subject|1|||
160618600|NCT01156012|579980000|FG001|Overall Study|Withdrawal by Subject|0|||
160618601|NCT01156012|579979999|FG000|Overall Study|use of commercial drug instead of study|0|||
160618602|NCT01156012|579980000|FG001|Overall Study|use of commercial drug instead of study|1|||
160618603|NCT01156012|579979999|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
160618604|NCT01156012|579980000|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
160618605|NCT03395704|579980001|FG000|Overall Study|Adverse Event|2|||
160618606|NCT03395704|579980002|FG001|Overall Study|Adverse Event|1|||
160618607|NCT03395704|579980001|FG000|Overall Study|Withdrawal by Subject|2|||
160618608|NCT03395704|579980002|FG001|Overall Study|Withdrawal by Subject|1|||
160618609|NCT03395704|579980001|FG000|Overall Study|Physician Decision|0|||
160618610|NCT03395704|579980002|FG001|Overall Study|Physician Decision|1|||
160618611|NCT02927990|579981961|FG000|Overall Study|Protocol Violation|4|||
160618612|NCT02927990|579981961|FG000|Overall Study|Physician Decision|9|||
160618613|NCT02927990|579981961|FG000|Overall Study|Room switched and therefore no study device available|15|||
160618614|NCT02927990|579981961|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
160618615|NCT01524900|579981964|FG000|Overall Study|Lost to Follow-up|3|||
160618616|NCT01524900|579981965|FG001|Overall Study|Lost to Follow-up|12|||
160618617|NCT01524900|579981966|FG002|Overall Study|Lost to Follow-up|1|||
160618618|NCT01524900|579981967|FG003|Overall Study|Lost to Follow-up|0|||
160618619|NCT01524900|579981968|FG004|Overall Study|Lost to Follow-up|0|||
160618620|NCT01524900|579981964|FG000|Overall Study|Other reason than stated above|1|||
160618621|NCT01524900|579981965|FG001|Overall Study|Other reason than stated above|1|||
160618622|NCT01524900|579981966|FG002|Overall Study|Other reason than stated above|0|||
160618623|NCT01524900|579981967|FG003|Overall Study|Other reason than stated above|0|||
160618624|NCT01524900|579981968|FG004|Overall Study|Other reason than stated above|0|||
160618625|NCT01524900|579981964|FG000|Overall Study|No reason documented|2|||
160618626|NCT01524900|579981965|FG001|Overall Study|No reason documented|1|||
160618627|NCT01524900|579981966|FG002|Overall Study|No reason documented|0|||
160618628|NCT01524900|579981967|FG003|Overall Study|No reason documented|1|||
160618629|NCT01524900|579981968|FG004|Overall Study|No reason documented|0|||
160618630|NCT00772031|579981969|FG000|Overall Study|Early termination of trial|12|||
160618631|NCT00772031|579981970|FG001|Overall Study|Early termination of trial|10|||
160618632|NCT00772031|579981969|FG000|Overall Study|Lost to Follow-up|20|||
160618633|NCT00772031|579981970|FG001|Overall Study|Lost to Follow-up|33|||
160618634|NCT00532441|579981971|FG000|Overall Study|Death|1|||
160618635|NCT00532441|579981972|FG001|Overall Study|Death|0|||
160618636|NCT00303329|579981975|FG000|Overall Study|Adverse Event|7|||
160618637|NCT00303329|579981976|FG001|Overall Study|Adverse Event|14|||
160618638|NCT00303329|579981975|FG000|Overall Study|Abnormal Laboratory Values|0|||
160618639|NCT00303329|579981976|FG001|Overall Study|Abnormal Laboratory Values|1|||
160618640|NCT00303329|579981975|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
160618641|NCT00303329|579981976|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160618642|NCT00303329|579981975|FG000|Overall Study|Condition no longer requires study drug|0|||
160618643|NCT00303329|579981976|FG001|Overall Study|Condition no longer requires study drug|8|||
160618644|NCT00303329|579981975|FG000|Overall Study|Protocol Violation|3|||
160618645|NCT00303329|579981976|FG001|Overall Study|Protocol Violation|0|||
160618646|NCT00303329|579981975|FG000|Overall Study|Withdrawal by Subject|9|||
160618647|NCT00303329|579981976|FG001|Overall Study|Withdrawal by Subject|15|||
160618648|NCT00303329|579981975|FG000|Overall Study|Lost to Follow-up|0|||
160618649|NCT00303329|579981976|FG001|Overall Study|Lost to Follow-up|1|||
160618650|NCT00303329|579981975|FG000|Overall Study|Administrative problems|1|||
160618651|NCT00303329|579981976|FG001|Overall Study|Administrative problems|0|||
160618652|NCT00303329|579981975|FG000|Overall Study|Death|2|||
160618653|NCT00303329|579981976|FG001|Overall Study|Death|12|||
160618654|NCT00303329|579981975|FG000|Overall Study|Stopped at end of core|3|||
160618655|NCT00303329|579981976|FG001|Overall Study|Stopped at end of core|9|||
160618656|NCT00303329|579981975|FG000|Overall Study|Stopped at end of extension 1|1|||
160618657|NCT00303329|579981976|FG001|Overall Study|Stopped at end of extension 1|0|||
160618658|NCT01731951|579981977|FG000|Overall Study|Documented Disease Progression|1|||
160618659|NCT01731951|579981978|FG001|Overall Study|Documented Disease Progression|0|||
160618660|NCT01731951|579981979|FG002|Overall Study|Documented Disease Progression|0|||
160618661|NCT01731951|579981980|FG003|Overall Study|Documented Disease Progression|0|||
160497005|NCT00121667|579548544|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
160497006|NCT00121667|579548545|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
160497007|NCT00121667|579548546|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
160497008|NCT00121667|579548547|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
160497009|NCT00121667|579548544|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
160497010|NCT00121667|579548545|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
160497011|NCT00121667|579548546|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
160497012|NCT00121667|579548547|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
160497013|NCT00121667|579548544|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
160497014|NCT00121667|579548545|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
160497015|NCT00121667|579548546|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
160497016|NCT00121667|579548547|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
160497017|NCT00121667|579548544|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
160497018|NCT00121667|579548545|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
160497019|NCT00121667|579548546|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
160497020|NCT00121667|579548547|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
160497021|NCT00121667|579548544|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
160497022|NCT00121667|579548545|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
160497023|NCT00121667|579548546|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
160497024|NCT00121667|579548547|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
160497025|NCT00121667|579548544|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
160497026|NCT00121667|579548545|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
160497027|NCT00121667|579548546|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
160497028|NCT00121667|579548547|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
160497029|NCT00121667|579548544|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
160497030|NCT00121667|579548545|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
160497031|NCT00121667|579548546|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
160497032|NCT00121667|579548547|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
160497033|NCT04468230|579548549|FG000|Overall Study|Adverse Event|2|||
160497034|NCT03934099|579548550|FG000|Overall Study|Adverse Event|0|||
160497035|NCT03934099|579548551|FG001|Overall Study|Adverse Event|3|||
160497036|NCT03934099|579548552|FG002|Overall Study|Adverse Event|1|||
160497037|NCT03934099|579548553|FG003|Overall Study|Adverse Event|0|||
160497038|NCT03934099|579548550|FG000|Overall Study|Lost to Follow-up|1|||
160497039|NCT03934099|579548551|FG001|Overall Study|Lost to Follow-up|2|||
160497040|NCT03934099|579548552|FG002|Overall Study|Lost to Follow-up|1|||
160497041|NCT03934099|579548553|FG003|Overall Study|Lost to Follow-up|1|||
160497042|NCT03934099|579548550|FG000|Overall Study|Protocol Violation|1|||
160497043|NCT03934099|579548551|FG001|Overall Study|Protocol Violation|0|||
160497044|NCT03934099|579548552|FG002|Overall Study|Protocol Violation|0|||
160497045|NCT03934099|579548553|FG003|Overall Study|Protocol Violation|0|||
160497046|NCT03934099|579548550|FG000|Overall Study|Withdrawal by Subject|2|||
160497047|NCT03934099|579548551|FG001|Overall Study|Withdrawal by Subject|0|||
160497048|NCT03934099|579548552|FG002|Overall Study|Withdrawal by Subject|1|||
160497049|NCT03934099|579548553|FG003|Overall Study|Withdrawal by Subject|1|||
160497050|NCT03934099|579548550|FG000|Overall Study|Other reasons|0|||
160497051|NCT03934099|579548551|FG001|Overall Study|Other reasons|1|||
160497052|NCT03934099|579548552|FG002|Overall Study|Other reasons|0|||
160497053|NCT03934099|579548553|FG003|Overall Study|Other reasons|0|||
160497054|NCT02417441|579548554|FG000|Overall Study|Inconclusive due to missing data|52|||
160497055|NCT02417441|579548555|FG001|Overall Study|Inconclusive due to missing data|19|||
160497056|NCT03016598|579548559|FG000|Overall Study|Lost to Follow-up|0|||
160497057|NCT03016598|579548560|FG001|Overall Study|Lost to Follow-up|2|||
160497058|NCT02872012|579548572|FG000|Overall Study|Withdrawal by Subject|1|||
160497059|NCT02872012|579548573|FG001|Overall Study|Withdrawal by Subject|0|||
160497060|NCT02872012|579548574|FG002|Overall Study|Withdrawal by Subject|0|||
160497061|NCT02872012|579548575|FG003|Overall Study|Withdrawal by Subject|0|||
160497062|NCT02872012|579548576|FG004|Overall Study|Withdrawal by Subject|0|||
160497063|NCT01728623|579548577|FG000|Overall Study|Disease progression|26|||
160497064|NCT01728623|579548577|FG000|Overall Study|Adverse Event|1|||
160497065|NCT01728623|579548577|FG000|Overall Study|Withdrawal by Subject|1|||
160497066|NCT03000348|579548578|FG000|Overall Study|Adverse Event|1|||
160497067|NCT03000348|579548579|FG001|Overall Study|Adverse Event|1|||
160497068|NCT03000348|579548580|FG002|Overall Study|Adverse Event|1|||
160497069|NCT03000348|579548581|FG003|Overall Study|Adverse Event|1|||
160497070|NCT03000348|579548582|FG004|Overall Study|Adverse Event|1|||
160497071|NCT03000348|579548583|FG005|Overall Study|Adverse Event|1|||
160497072|NCT03000348|579548578|FG000|Overall Study|Lost to Follow-up|0|||
160661828|NCT04320849|580144162|FG000|Overall Study|Imaging data unavailable|2|||
160497073|NCT03000348|579548579|FG001|Overall Study|Lost to Follow-up|0|||
160497074|NCT03000348|579548580|FG002|Overall Study|Lost to Follow-up|1|||
160661829|NCT04320849|580144162|FG000|Overall Study|Incomplete imaging|2|||
160661830|NCT03135834|580144171|FG000|Stage 1|Adverse Event|1|||
160618662|NCT01731951|579981981|FG004|Overall Study|Documented Disease Progression|0|||
160618663|NCT01731951|579981982|FG005|Overall Study|Documented Disease Progression|0|||
160618664|NCT01731951|579981977|FG000|Overall Study|Lost to Follow-up|2|||
160618665|NCT01731951|579981978|FG001|Overall Study|Lost to Follow-up|0|||
160618666|NCT01731951|579981979|FG002|Overall Study|Lost to Follow-up|0|||
160618667|NCT01731951|579981980|FG003|Overall Study|Lost to Follow-up|1|||
160618668|NCT01731951|579981981|FG004|Overall Study|Lost to Follow-up|3|||
160618669|NCT01731951|579981982|FG005|Overall Study|Lost to Follow-up|1|||
160618670|NCT01731951|579981977|FG000|Overall Study|Withdrawal of Consent|1|||
160618671|NCT01731951|579981978|FG001|Overall Study|Withdrawal of Consent|0|||
160618672|NCT01731951|579981979|FG002|Overall Study|Withdrawal of Consent|0|||
160618673|NCT01731951|579981980|FG003|Overall Study|Withdrawal of Consent|0|||
160618674|NCT01731951|579981981|FG004|Overall Study|Withdrawal of Consent|0|||
160618675|NCT01731951|579981982|FG005|Overall Study|Withdrawal of Consent|2|||
160618676|NCT01731951|579981977|FG000|Overall Study|Death|13|||
160618677|NCT01731951|579981978|FG001|Overall Study|Death|15|||
160618678|NCT01731951|579981979|FG002|Overall Study|Death|9|||
160618679|NCT01731951|579981980|FG003|Overall Study|Death|8|||
160618680|NCT01731951|579981981|FG004|Overall Study|Death|9|||
160618681|NCT01731951|579981982|FG005|Overall Study|Death|6|||
160618682|NCT01977651|579981983|FG000|4 Month Treatment Period|Adverse Event|34|||
160618683|NCT01977651|579981983|FG000|4 Month Treatment Period|Death|3|||
160618684|NCT01977651|579981983|FG000|4 Month Treatment Period|Progressive Disease|43|||
160618685|NCT01977651|579981983|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
160618686|NCT01977651|579981983|FG000|4 Month Treatment Period|Physician Decision|4|||
160618687|NCT01977651|579981983|FG000|1 Year Extension Period|Adverse Event|14|||
160618688|NCT01977651|579981983|FG000|1 Year Extension Period|Death|10|||
160618689|NCT01977651|579981983|FG000|1 Year Extension Period|Lost to Follow-up|2|||
160618690|NCT01977651|579981983|FG000|1 Year Extension Period|Progressive Disease|86|||
160618691|NCT01977651|579981983|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
160618692|NCT01977651|579981983|FG000|1 Year Extension Period|Physician Decision|6|||
160618693|NCT01977651|579981983|FG000|1 Year Extension Period|Miscellaneous|1|||
160618694|NCT01977651|579981983|FG000|Post 1 Year Extension Period|Adverse Event|5|||
160618695|NCT01977651|579981983|FG000|Post 1 Year Extension Period|Death|13|||
160618696|NCT01977651|579981983|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
160618697|NCT01977651|579981983|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
160618698|NCT01977651|579981983|FG000|Post 1 Year Extension Period|Physician Decision|4|||
160618699|NCT01977651|579981983|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
160618700|NCT02906644|579981989|FG000|First 2 Weeks|Withdrawal by Subject|0|||
160618701|NCT02906644|579981990|FG001|First 2 Weeks|Withdrawal by Subject|2|||
160618702|NCT02906644|579981989|FG000|First 2 Weeks|Physician Decision|1|||
160618703|NCT02906644|579981990|FG001|First 2 Weeks|Physician Decision|1|||
160618704|NCT02906644|579981989|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
160618705|NCT02906644|579981990|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
160618706|NCT02906644|579981989|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
160618707|NCT02906644|579981990|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
160618708|NCT02452034|579981991|FG000|Overall Study|Adverse Event|0|||
160618709|NCT02452034|579981992|FG001|Overall Study|Adverse Event|0|||
160618710|NCT02452034|579981993|FG002|Overall Study|Adverse Event|0|||
160618711|NCT02452034|579981994|FG003|Overall Study|Adverse Event|0|||
160618712|NCT02452034|579981995|FG004|Overall Study|Adverse Event|0|||
160618713|NCT02452034|579981996|FG005|Overall Study|Adverse Event|1|||
160618714|NCT02452034|579981991|FG000|Overall Study|Death|0|||
160618715|NCT02452034|579981992|FG001|Overall Study|Death|0|||
160618716|NCT02452034|579981993|FG002|Overall Study|Death|0|||
160618717|NCT02452034|579981994|FG003|Overall Study|Death|0|||
160618718|NCT02452034|579981995|FG004|Overall Study|Death|1|||
160618719|NCT02452034|579981996|FG005|Overall Study|Death|1|||
160618720|NCT02452034|579981991|FG000|Overall Study|Physician Decision|0|||
160618721|NCT02452034|579981992|FG001|Overall Study|Physician Decision|1|||
160618722|NCT02452034|579981993|FG002|Overall Study|Physician Decision|1|||
160618723|NCT02452034|579981994|FG003|Overall Study|Physician Decision|0|||
160618724|NCT02452034|579981995|FG004|Overall Study|Physician Decision|0|||
160618725|NCT02452034|579981996|FG005|Overall Study|Physician Decision|0|||
160618726|NCT02452034|579981991|FG000|Overall Study|Protocol Violation|0|||
160661831|NCT03135834|580144172|FG001|Stage 1|Adverse Event|2|||
160661832|NCT03135834|580144173|FG002|Stage 1|Adverse Event|2|||
160661833|NCT03135834|580144174|FG003|Stage 1|Adverse Event|1|||
160661834|NCT03135834|580144171|FG000|Stage 1|Death|1|||
160661835|NCT03135834|580144172|FG001|Stage 1|Death|0|||
160661836|NCT03135834|580144173|FG002|Stage 1|Death|0|||
160661837|NCT03135834|580144174|FG003|Stage 1|Death|0|||
160661838|NCT03135834|580144171|FG000|Stage 1|Lost to Follow-up|17|||
160661839|NCT03135834|580144172|FG001|Stage 1|Lost to Follow-up|24|||
160661840|NCT03135834|580144173|FG002|Stage 1|Lost to Follow-up|21|||
160661841|NCT03135834|580144174|FG003|Stage 1|Lost to Follow-up|38|||
160661842|NCT03135834|580144171|FG000|Stage 1|No longer met eligibility criteria|1|||
160497075|NCT03000348|579548581|FG003|Overall Study|Lost to Follow-up|0|||
160618727|NCT02452034|579981992|FG001|Overall Study|Protocol Violation|0|||
160618728|NCT02452034|579981993|FG002|Overall Study|Protocol Violation|0|||
160618729|NCT02452034|579981994|FG003|Overall Study|Protocol Violation|0|||
160618730|NCT02452034|579981995|FG004|Overall Study|Protocol Violation|0|||
160618731|NCT02452034|579981996|FG005|Overall Study|Protocol Violation|1|||
160618732|NCT02452034|579981991|FG000|Overall Study|Screen Failure|1|||
160618733|NCT02452034|579981992|FG001|Overall Study|Screen Failure|0|||
160618734|NCT02452034|579981993|FG002|Overall Study|Screen Failure|0|||
160618735|NCT02452034|579981994|FG003|Overall Study|Screen Failure|1|||
160618736|NCT02452034|579981995|FG004|Overall Study|Screen Failure|0|||
160618737|NCT02452034|579981996|FG005|Overall Study|Screen Failure|0|||
160618738|NCT02452034|579981991|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
160618739|NCT02452034|579981992|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
160618740|NCT02452034|579981993|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
160618741|NCT02452034|579981994|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
160618742|NCT02452034|579981995|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
160618743|NCT02452034|579981996|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
160618744|NCT03288987|579982000|FG000|Overall Study|Protocol Violation|10|||
160618745|NCT03288987|579982001|FG001|Overall Study|Protocol Violation|4|||
160618746|NCT00672490|579982004|FG000|Overall Study|Withdrawal by Subject|8|||
160618747|NCT00672490|579982005|FG001|Overall Study|Withdrawal by Subject|8|||
160618748|NCT00672490|579982004|FG000|Overall Study|Lack of Compliance|2|||
160618749|NCT00672490|579982005|FG001|Overall Study|Lack of Compliance|7|||
160618750|NCT00672490|579982004|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
160618751|NCT00672490|579982005|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
160618752|NCT00672490|579982004|FG000|Overall Study|Adverse Event|5|||
160618753|NCT00672490|579982005|FG001|Overall Study|Adverse Event|8|||
160618754|NCT00672490|579982004|FG000|Overall Study|Violation of Concomitant Medicine|1|||
160618755|NCT00672490|579982005|FG001|Overall Study|Violation of Concomitant Medicine|0|||
160618756|NCT00672490|579982004|FG000|Overall Study|Intolerance|0|||
160618757|NCT00672490|579982005|FG001|Overall Study|Intolerance|2|||
160618758|NCT00672490|579982004|FG000|Overall Study|Lost to Follow-up|1|||
160618759|NCT00672490|579982005|FG001|Overall Study|Lost to Follow-up|5|||
160618760|NCT00672490|579982004|FG000|Overall Study|No reason was provided|6|||
160618761|NCT00672490|579982005|FG001|Overall Study|No reason was provided|2|||
160618762|NCT00545740|579982022|FG000|Overall Study|Lack of Efficacy|34|||
160618763|NCT00545740|579982023|FG001|Overall Study|Lack of Efficacy|35|||
160618764|NCT00545740|579982024|FG002|Overall Study|Lack of Efficacy|47|||
160618765|NCT00545740|579982025|FG003|Overall Study|Lack of Efficacy|36|||
160618766|NCT00545740|579982022|FG000|Overall Study|Withdrawal by Subject|17|||
160618767|NCT00545740|579982023|FG001|Overall Study|Withdrawal by Subject|15|||
160618768|NCT00545740|579982024|FG002|Overall Study|Withdrawal by Subject|16|||
160618769|NCT00545740|579982025|FG003|Overall Study|Withdrawal by Subject|18|||
160618770|NCT00545740|579982022|FG000|Overall Study|Adverse Event|10|||
160618771|NCT00545740|579982023|FG001|Overall Study|Adverse Event|18|||
160618772|NCT00545740|579982024|FG002|Overall Study|Adverse Event|19|||
160618773|NCT00545740|579982025|FG003|Overall Study|Adverse Event|9|||
160618774|NCT00545740|579982022|FG000|Overall Study|Lost to Follow-up|7|||
160618775|NCT00545740|579982023|FG001|Overall Study|Lost to Follow-up|5|||
160618776|NCT00545740|579982024|FG002|Overall Study|Lost to Follow-up|5|||
160618777|NCT00545740|579982025|FG003|Overall Study|Lost to Follow-up|6|||
160618778|NCT00545740|579982022|FG000|Overall Study|Protocol Violation|1|||
160618779|NCT00545740|579982023|FG001|Overall Study|Protocol Violation|3|||
160618780|NCT00545740|579982024|FG002|Overall Study|Protocol Violation|1|||
160618781|NCT00545740|579982025|FG003|Overall Study|Protocol Violation|0|||
160618782|NCT00545740|579982022|FG000|Overall Study|Non-compliance|0|||
160618783|NCT00545740|579982023|FG001|Overall Study|Non-compliance|2|||
160618784|NCT00545740|579982024|FG002|Overall Study|Non-compliance|1|||
160618785|NCT00545740|579982025|FG003|Overall Study|Non-compliance|0|||
160618786|NCT00545740|579982022|FG000|Overall Study|Moved|2|||
160661843|NCT03135834|580144172|FG001|Stage 1|No longer met eligibility criteria|6|||
160661844|NCT03135834|580144173|FG002|Stage 1|No longer met eligibility criteria|2|||
160618787|NCT00545740|579982023|FG001|Overall Study|Moved|0|||
160618788|NCT00545740|579982024|FG002|Overall Study|Moved|1|||
160618789|NCT00545740|579982025|FG003|Overall Study|Moved|0|||
160661845|NCT03135834|580144174|FG003|Stage 1|No longer met eligibility criteria|5|||
160661846|NCT03135834|580144171|FG000|Stage 1|Other|0|||
160661847|NCT03135834|580144172|FG001|Stage 1|Other|2|||
160661848|NCT03135834|580144173|FG002|Stage 1|Other|1|||
160661849|NCT03135834|580144174|FG003|Stage 1|Other|0|||
160661850|NCT03135834|580144171|FG000|Stage 1|Physician Decision|0|||
160661851|NCT03135834|580144172|FG001|Stage 1|Physician Decision|1|||
160661852|NCT03135834|580144173|FG002|Stage 1|Physician Decision|0|||
160661853|NCT03135834|580144174|FG003|Stage 1|Physician Decision|0|||
160661854|NCT03135834|580144171|FG000|Stage 1|Pregnancy|0|||
160661855|NCT03135834|580144172|FG001|Stage 1|Pregnancy|4|||
160661856|NCT03135834|580144173|FG002|Stage 1|Pregnancy|2|||
160661857|NCT03135834|580144174|FG003|Stage 1|Pregnancy|4|||
160661858|NCT03135834|580144171|FG000|Stage 1|Protocol Violation|1|||
160661859|NCT03135834|580144172|FG001|Stage 1|Protocol Violation|1|||
160661860|NCT03135834|580144173|FG002|Stage 1|Protocol Violation|2|||
160661861|NCT03135834|580144174|FG003|Stage 1|Protocol Violation|1|||
160661862|NCT03135834|580144171|FG000|Stage 1|Withdrawal by parent/guardian|2|||
160661863|NCT03135834|580144172|FG001|Stage 1|Withdrawal by parent/guardian|10|||
160661864|NCT03135834|580144173|FG002|Stage 1|Withdrawal by parent/guardian|2|||
160661865|NCT03135834|580144174|FG003|Stage 1|Withdrawal by parent/guardian|1|||
160661866|NCT03135834|580144171|FG000|Stage 1|Withdrawal by Subject|16|||
160661867|NCT03135834|580144172|FG001|Stage 1|Withdrawal by Subject|22|||
160661868|NCT03135834|580144173|FG002|Stage 1|Withdrawal by Subject|7|||
160661869|NCT03135834|580144174|FG003|Stage 1|Withdrawal by Subject|10|||
160661870|NCT03135834|580144171|FG000|Stage 1|Randomized but not Vaccinated|0|||
160661871|NCT03135834|580144172|FG001|Stage 1|Randomized but not Vaccinated|3|||
160661872|NCT03135834|580144173|FG002|Stage 1|Randomized but not Vaccinated|1|||
160661873|NCT03135834|580144174|FG003|Stage 1|Randomized but not Vaccinated|6|||
160661874|NCT03135834|580144171|FG000|Stage 2|Lost to Follow-up|0|||
160661875|NCT03135834|580144172|FG001|Stage 2|Lost to Follow-up|1|||
160661876|NCT03135834|580144173|FG002|Stage 2|Lost to Follow-up|0|||
160661877|NCT03135834|580144174|FG003|Stage 2|Lost to Follow-up|0|||
160661878|NCT03135834|580144171|FG000|Stage 2|Withdrawal by Subject|0|||
160661879|NCT03135834|580144172|FG001|Stage 2|Withdrawal by Subject|1|||
160661880|NCT03135834|580144173|FG002|Stage 2|Withdrawal by Subject|0|||
160661881|NCT03135834|580144174|FG003|Stage 2|Withdrawal by Subject|0|||
160661882|NCT03135834|580144171|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
160661883|NCT03135834|580144172|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
160661884|NCT03135834|580144173|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
160661885|NCT03135834|580144174|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
160661886|NCT03135834|580144171|FG000|Stage 2|Did not receive Booster Vaccination|1|||
160661887|NCT03135834|580144172|FG001|Stage 2|Did not receive Booster Vaccination|1|||
160661888|NCT03135834|580144173|FG002|Stage 2|Did not receive Booster Vaccination|0|||
160661889|NCT03135834|580144174|FG003|Stage 2|Did not receive Booster Vaccination|0|||
160661890|NCT00319735|580144175|FG000|Overall Study|Death|2|||
160661891|NCT03125200|580144178|FG000|Overall Study|Study Termination|0|||
160661892|NCT03125200|580144179|FG001|Overall Study|Study Termination|0|||
160661893|NCT03125200|580144180|FG002|Overall Study|Study Termination|0|||
160661894|NCT03125200|580144181|FG003|Overall Study|Study Termination|1|||
160661895|NCT03125200|580144182|FG004|Overall Study|Study Termination|1|||
160661896|NCT03125200|580144183|FG005|Overall Study|Study Termination|2|||
160661897|NCT03125200|580144184|FG006|Overall Study|Study Termination|1|||
160661898|NCT03125200|580144178|FG000|Overall Study|Clinical Progression|0|||
160661899|NCT03125200|580144179|FG001|Overall Study|Clinical Progression|0|||
160661900|NCT03125200|580144180|FG002|Overall Study|Clinical Progression|0|||
160661901|NCT03125200|580144181|FG003|Overall Study|Clinical Progression|1|||
160661902|NCT03125200|580144182|FG004|Overall Study|Clinical Progression|0|||
160661903|NCT03125200|580144183|FG005|Overall Study|Clinical Progression|1|||
160661904|NCT03125200|580144184|FG006|Overall Study|Clinical Progression|0|||
160661905|NCT03125200|580144178|FG000|Overall Study|Progressive Disease|2|||
160661906|NCT03125200|580144179|FG001|Overall Study|Progressive Disease|1|||
160661907|NCT03125200|580144180|FG002|Overall Study|Progressive Disease|2|||
160661908|NCT03125200|580144181|FG003|Overall Study|Progressive Disease|1|||
160661909|NCT03125200|580144182|FG004|Overall Study|Progressive Disease|2|||
160661910|NCT03125200|580144183|FG005|Overall Study|Progressive Disease|0|||
160661911|NCT03125200|580144184|FG006|Overall Study|Progressive Disease|1|||
160661912|NCT03125200|580144178|FG000|Overall Study|Lack of Efficacy|0|||
160661913|NCT03125200|580144179|FG001|Overall Study|Lack of Efficacy|0|||
160661914|NCT03125200|580144180|FG002|Overall Study|Lack of Efficacy|0|||
160661915|NCT03125200|580144181|FG003|Overall Study|Lack of Efficacy|1|||
160661916|NCT03125200|580144182|FG004|Overall Study|Lack of Efficacy|0|||
160661917|NCT03125200|580144183|FG005|Overall Study|Lack of Efficacy|0|||
160661918|NCT03125200|580144184|FG006|Overall Study|Lack of Efficacy|0|||
160661919|NCT03125200|580144178|FG000|Overall Study|Toxicity|0|||
160661920|NCT03125200|580144179|FG001|Overall Study|Toxicity|0|||
160661921|NCT03125200|580144180|FG002|Overall Study|Toxicity|0|||
160661922|NCT03125200|580144181|FG003|Overall Study|Toxicity|1|||
160661923|NCT03125200|580144182|FG004|Overall Study|Toxicity|0|||
160661924|NCT03125200|580144183|FG005|Overall Study|Toxicity|0|||
160661925|NCT03125200|580144184|FG006|Overall Study|Toxicity|0|||
160661926|NCT03125200|580144178|FG000|Overall Study|Consent Withdrawn by Subject|0|||
160618790|NCT00545740|579982022|FG000|Overall Study|Diverticulitis attack|0|||
160618791|NCT00545740|579982023|FG001|Overall Study|Diverticulitis attack|0|||
160618792|NCT00545740|579982024|FG002|Overall Study|Diverticulitis attack|1|||
160618793|NCT00545740|579982025|FG003|Overall Study|Diverticulitis attack|1|||
160618794|NCT00545740|579982022|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
160618795|NCT00545740|579982023|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
160618796|NCT00545740|579982024|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
160618797|NCT00545740|579982025|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
160618798|NCT00545740|579982022|FG000|Overall Study|Site closure|1|||
160618799|NCT00545740|579982023|FG001|Overall Study|Site closure|0|||
160618800|NCT00545740|579982024|FG002|Overall Study|Site closure|0|||
160618801|NCT00545740|579982025|FG003|Overall Study|Site closure|0|||
160618802|NCT00545740|579982022|FG000|Overall Study|Missed visit|1|||
160618803|NCT00545740|579982023|FG001|Overall Study|Missed visit|0|||
160618804|NCT00545740|579982024|FG002|Overall Study|Missed visit|0|||
160618805|NCT00545740|579982025|FG003|Overall Study|Missed visit|0|||
160618806|NCT00545740|579982022|FG000|Overall Study|Physician Decision|0|||
160618807|NCT00545740|579982023|FG001|Overall Study|Physician Decision|0|||
160618808|NCT00545740|579982024|FG002|Overall Study|Physician Decision|3|||
160618809|NCT00545740|579982025|FG003|Overall Study|Physician Decision|0|||
160618810|NCT00545740|579982022|FG000|Overall Study|Accepted only monthly telephone calls|1|||
160618811|NCT00545740|579982023|FG001|Overall Study|Accepted only monthly telephone calls|0|||
160618812|NCT00545740|579982024|FG002|Overall Study|Accepted only monthly telephone calls|0|||
160618813|NCT00545740|579982025|FG003|Overall Study|Accepted only monthly telephone calls|0|||
160618814|NCT00545740|579982022|FG000|Overall Study|Sponsor decision|0|||
160618815|NCT00545740|579982023|FG001|Overall Study|Sponsor decision|1|||
160618816|NCT00545740|579982024|FG002|Overall Study|Sponsor decision|0|||
160618817|NCT00545740|579982025|FG003|Overall Study|Sponsor decision|0|||
160618818|NCT00545740|579982022|FG000|Overall Study|Lack of time|0|||
160618819|NCT00545740|579982023|FG001|Overall Study|Lack of time|1|||
160618820|NCT00545740|579982024|FG002|Overall Study|Lack of time|0|||
160618821|NCT00545740|579982025|FG003|Overall Study|Lack of time|0|||
160618822|NCT00545740|579982022|FG000|Overall Study|Non-adherence to visits|0|||
160618823|NCT00545740|579982023|FG001|Overall Study|Non-adherence to visits|1|||
160618824|NCT00545740|579982024|FG002|Overall Study|Non-adherence to visits|0|||
160618825|NCT00545740|579982025|FG003|Overall Study|Non-adherence to visits|0|||
160618826|NCT00545740|579982022|FG000|Overall Study|Patient difficulties|0|||
160618827|NCT00545740|579982023|FG001|Overall Study|Patient difficulties|1|||
160618828|NCT00545740|579982024|FG002|Overall Study|Patient difficulties|0|||
160618829|NCT00545740|579982025|FG003|Overall Study|Patient difficulties|0|||
160618830|NCT00545740|579982022|FG000|Overall Study|Husband against study|0|||
160618831|NCT00545740|579982023|FG001|Overall Study|Husband against study|0|||
160618832|NCT00545740|579982024|FG002|Overall Study|Husband against study|1|||
160618833|NCT00545740|579982025|FG003|Overall Study|Husband against study|0|||
160618834|NCT02117024|579982026|FG000|Overall Study|Progressive Disease|26|||
160618835|NCT02117024|579982027|FG001|Overall Study|Progressive Disease|9|||
160618836|NCT02117024|579982026|FG000|Overall Study|Significant Clinical Progression|7|||
160618837|NCT02117024|579982027|FG001|Overall Study|Significant Clinical Progression|4|||
160618838|NCT02117024|579982026|FG000|Overall Study|Death|5|||
160618839|NCT02117024|579982027|FG001|Overall Study|Death|0|||
160618840|NCT02117024|579982026|FG000|Overall Study|Withdrawal by Subject|3|||
160618841|NCT02117024|579982027|FG001|Overall Study|Withdrawal by Subject|1|||
160618842|NCT02117024|579982026|FG000|Overall Study|Protocol Violation|1|||
160618843|NCT02117024|579982027|FG001|Overall Study|Protocol Violation|0|||
160618844|NCT02117024|579982026|FG000|Overall Study|Adverse Event|1|||
160618845|NCT02117024|579982027|FG001|Overall Study|Adverse Event|2|||
160618846|NCT02117024|579982026|FG000|Overall Study|Randomized in Error|1|||
160618847|NCT02117024|579982027|FG001|Overall Study|Randomized in Error|0|||
160618848|NCT02117024|579982026|FG000|Overall Study|Patient returned to primary oncologist|0|||
160618849|NCT02117024|579982027|FG001|Overall Study|Patient returned to primary oncologist|1|||
160618850|NCT02117024|579982026|FG000|Overall Study|Patient took treatment break|0|||
160618851|NCT02117024|579982027|FG001|Overall Study|Patient took treatment break|1|||
160618852|NCT02117024|579982026|FG000|Overall Study|Physician Decision|0|||
160618853|NCT02117024|579982027|FG001|Overall Study|Physician Decision|2|||
160618854|NCT03481634|579982032|FG000|Overall Study|Withdrawal by Subject|16|||
160618855|NCT03481634|579982033|FG001|Overall Study|Withdrawal by Subject|19|||
160618856|NCT03481634|579982034|FG002|Overall Study|Withdrawal by Subject|14|||
160618857|NCT03481634|579982032|FG000|Overall Study|Protocol Violation|1|||
160618858|NCT03481634|579982033|FG001|Overall Study|Protocol Violation|0|||
160618859|NCT03481634|579982034|FG002|Overall Study|Protocol Violation|1|||
160661927|NCT03125200|580144179|FG001|Overall Study|Consent Withdrawn by Subject|1|||
160618860|NCT03481634|579982032|FG000|Overall Study|Progressive disease|0|||
160618861|NCT03481634|579982033|FG001|Overall Study|Progressive disease|1|||
160618862|NCT03481634|579982034|FG002|Overall Study|Progressive disease|0|||
160618863|NCT03481634|579982032|FG000|Overall Study|Physician Decision|3|||
160618864|NCT03481634|579982033|FG001|Overall Study|Physician Decision|0|||
160618865|NCT03481634|579982034|FG002|Overall Study|Physician Decision|1|||
160497076|NCT03000348|579548582|FG004|Overall Study|Lost to Follow-up|0|||
160497077|NCT03000348|579548583|FG005|Overall Study|Lost to Follow-up|0|||
160497078|NCT03000348|579548578|FG000|Overall Study|Withdrawal by Subject|0|||
160497079|NCT03000348|579548579|FG001|Overall Study|Withdrawal by Subject|1|||
160497080|NCT03000348|579548580|FG002|Overall Study|Withdrawal by Subject|0|||
160497081|NCT03000348|579548581|FG003|Overall Study|Withdrawal by Subject|0|||
160497082|NCT03000348|579548582|FG004|Overall Study|Withdrawal by Subject|0|||
160497083|NCT03000348|579548583|FG005|Overall Study|Withdrawal by Subject|0|||
160497084|NCT03000348|579548578|FG000|Overall Study|Consent|0|||
160497085|NCT03000348|579548579|FG001|Overall Study|Consent|0|||
160497086|NCT03000348|579548580|FG002|Overall Study|Consent|0|||
160497087|NCT03000348|579548581|FG003|Overall Study|Consent|0|||
160497088|NCT03000348|579548582|FG004|Overall Study|Consent|1|||
160497089|NCT03000348|579548583|FG005|Overall Study|Consent|0|||
160497090|NCT03000348|579548578|FG000|Overall Study|Failure to expectorate sputum|1|||
160497091|NCT03000348|579548579|FG001|Overall Study|Failure to expectorate sputum|0|||
160497092|NCT03000348|579548580|FG002|Overall Study|Failure to expectorate sputum|1|||
160497093|NCT03000348|579548581|FG003|Overall Study|Failure to expectorate sputum|0|||
160497094|NCT03000348|579548582|FG004|Overall Study|Failure to expectorate sputum|1|||
160497095|NCT03000348|579548583|FG005|Overall Study|Failure to expectorate sputum|0|||
160497096|NCT03000348|579548578|FG000|Overall Study|No gram negative|1|||
160497097|NCT03000348|579548579|FG001|Overall Study|No gram negative|2|||
160497098|NCT03000348|579548580|FG002|Overall Study|No gram negative|1|||
160497099|NCT03000348|579548581|FG003|Overall Study|No gram negative|1|||
160497100|NCT03000348|579548582|FG004|Overall Study|No gram negative|1|||
160497101|NCT03000348|579548583|FG005|Overall Study|No gram negative|1|||
160497102|NCT03000348|579548578|FG000|Overall Study|Patient had no transport|0|||
160497103|NCT03000348|579548579|FG001|Overall Study|Patient had no transport|0|||
160497104|NCT03000348|579548580|FG002|Overall Study|Patient had no transport|0|||
160497105|NCT03000348|579548581|FG003|Overall Study|Patient had no transport|1|||
160497106|NCT03000348|579548582|FG004|Overall Study|Patient had no transport|0|||
160497107|NCT03000348|579548583|FG005|Overall Study|Patient had no transport|0|||
160497108|NCT03000348|579548578|FG000|Overall Study|Dosing|0|||
160497109|NCT03000348|579548579|FG001|Overall Study|Dosing|0|||
160497110|NCT03000348|579548580|FG002|Overall Study|Dosing|0|||
160497111|NCT03000348|579548581|FG003|Overall Study|Dosing|0|||
160497112|NCT03000348|579548582|FG004|Overall Study|Dosing|1|||
160497113|NCT03000348|579548583|FG005|Overall Study|Dosing|0|||
160497114|NCT00723125|579548584|FG000|Overall Study|Met Dx|1|||
160497115|NCT00723125|579548585|FG001|Overall Study|Met Dx|0|||
160497116|NCT00723125|579548584|FG000|Overall Study|Withdrawal by Subject|15|||
160497117|NCT00723125|579548585|FG001|Overall Study|Withdrawal by Subject|6|||
160497118|NCT00723125|579548584|FG000|Overall Study|Adverse Event|2|||
160497119|NCT00723125|579548585|FG001|Overall Study|Adverse Event|0|||
160497120|NCT01667549|579548586|FG000|Overall Study|Withdrawal by Subject|3|||
160497121|NCT01667549|579548587|FG001|Overall Study|Withdrawal by Subject|5|||
160497122|NCT01667549|579548588|FG002|Overall Study|Withdrawal by Subject|7|||
160497123|NCT01667549|579548589|FG003|Overall Study|Withdrawal by Subject|6|||
160497124|NCT01667549|579548590|FG004|Overall Study|Withdrawal by Subject|1|||
160497125|NCT01407276|579548592|FG000|Overall Study|Withdrawal by Subject|0|||
160497126|NCT01407276|579548593|FG001|Overall Study|Withdrawal by Subject|0|||
160497127|NCT01407276|579548594|FG002|Overall Study|Withdrawal by Subject|0|||
160497128|NCT01407276|579548595|FG003|Overall Study|Withdrawal by Subject|0|||
160497129|NCT01407276|579548596|FG004|Overall Study|Withdrawal by Subject|0|||
160497130|NCT01407276|579548597|FG005|Overall Study|Withdrawal by Subject|0|||
160497131|NCT01407276|579548598|FG006|Overall Study|Withdrawal by Subject|0|||
160497132|NCT01407276|579548599|FG007|Overall Study|Withdrawal by Subject|1|||
160497133|NCT01807182|579548601|FG000|Overall Study|Death|1|||
160497134|NCT01807182|579548601|FG000|Overall Study|New therapy|1|||
160497135|NCT01807182|579548601|FG000|Overall Study|Moved to hospice care|1|||
160497136|NCT04092452|579548603|FG000|Overall Study|Adverse Event|1|||
160497137|NCT04092452|579548604|FG001|Overall Study|Adverse Event|3|||
160497138|NCT04092452|579548605|FG002|Overall Study|Adverse Event|3|||
160497139|NCT04092452|579548606|FG003|Overall Study|Adverse Event|7|||
160497140|NCT04092452|579548603|FG000|Overall Study|Lack of Efficacy|1|||
160497141|NCT04092452|579548604|FG001|Overall Study|Lack of Efficacy|1|||
160497142|NCT04092452|579548605|FG002|Overall Study|Lack of Efficacy|1|||
160497143|NCT04092452|579548606|FG003|Overall Study|Lack of Efficacy|0|||
160497144|NCT04092452|579548603|FG000|Overall Study|Lost to Follow-up|4|||
160497145|NCT04092452|579548604|FG001|Overall Study|Lost to Follow-up|3|||
160497146|NCT04092452|579548605|FG002|Overall Study|Lost to Follow-up|5|||
160497147|NCT04092452|579548606|FG003|Overall Study|Lost to Follow-up|1|||
160497148|NCT04092452|579548603|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160497149|NCT04092452|579548604|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160497150|NCT04092452|579548605|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160497151|NCT04092452|579548606|FG003|Overall Study|Non-Compliance With Study Drug|1|||
160497152|NCT04092452|579548603|FG000|Overall Study|Physician Decision|1|||
160497153|NCT04092452|579548604|FG001|Overall Study|Physician Decision|0|||
160497154|NCT04092452|579548605|FG002|Overall Study|Physician Decision|1|||
160661928|NCT03125200|580144180|FG002|Overall Study|Consent Withdrawn by Subject|0|||
160661929|NCT03125200|580144181|FG003|Overall Study|Consent Withdrawn by Subject|0|||
160661930|NCT03125200|580144182|FG004|Overall Study|Consent Withdrawn by Subject|1|||
160661931|NCT03125200|580144183|FG005|Overall Study|Consent Withdrawn by Subject|0|||
160661932|NCT03125200|580144184|FG006|Overall Study|Consent Withdrawn by Subject|1|||
160661933|NCT00119379|580144185|FG000|Overall Study|Adverse Event|4|||
160661934|NCT00119379|580144186|FG001|Overall Study|Adverse Event|1|||
160661935|NCT02421952|580144193|FG000|Overall Study|Diary Not Returned|93|||
160661936|NCT02421952|580144193|FG000|Overall Study|Failed seriation task|13|||
160661937|NCT02421952|580144193|FG000|Overall Study|Subject uncooperative for baseline test|2|||
160661938|NCT02421952|580144193|FG000|Overall Study|Surgery cancelled|1|||
160661939|NCT01469546|580144195|FG000|Received 5 mg Dose|Adverse Event|13|||
160661940|NCT01469546|580144195|FG000|Received 5 mg Dose|Death|2|||
160661941|NCT01469546|580144195|FG000|Received 5 mg Dose|Protocol Violation|2|||
160661942|NCT01469546|580144195|FG000|Received 5 mg Dose|Progressive Disease|3|||
160661943|NCT01469546|580144195|FG000|Received 5 mg Dose|Physician Decision|3|||
160661944|NCT02801877|580144198|FG000|Overall Study|Lost to Follow-up|1|||
160661945|NCT02801877|580144199|FG001|Overall Study|Lost to Follow-up|1|||
160661946|NCT02801877|580144200|FG002|Overall Study|Lost to Follow-up|2|||
160661947|NCT02801877|580144201|FG003|Overall Study|Lost to Follow-up|0|||
160661948|NCT02801877|580144198|FG000|Overall Study|Never Started Treatment|2|||
160661949|NCT02801877|580144199|FG001|Overall Study|Never Started Treatment|0|||
160661950|NCT02801877|580144200|FG002|Overall Study|Never Started Treatment|4|||
160661951|NCT02801877|580144201|FG003|Overall Study|Never Started Treatment|0|||
160661952|NCT02865122|580144202|FG000|Overall Study|Adverse Event|1|||
160661953|NCT02865122|580144203|FG001|Overall Study|Adverse Event|0|||
160661954|NCT02865122|580144204|FG002|Overall Study|Adverse Event|0|||
160661955|NCT06358820|580145590|FG000|Overall Study|Adverse Event|11|||
160661956|NCT06358820|580145590|FG000|Overall Study|kidney transplantation|3|||
160661957|NCT06358820|580145590|FG000|Overall Study|patient voluntary withdrawal|6|||
160661958|NCT06358820|580145590|FG000|Overall Study|Physician Decision|1|||
160661959|NCT01294787|580145591|FG000|Period 1|Adverse Event|0|||
160661960|NCT01294787|580145592|FG001|Period 1|Adverse Event|0|||
160661961|NCT01294787|580145593|FG002|Period 1|Adverse Event|0|||
160661962|NCT01294787|580145594|FG003|Period 1|Adverse Event|0|||
160661963|NCT01294787|580145595|FG004|Period 1|Adverse Event|1|||
160661964|NCT01294787|580145596|FG005|Period 1|Adverse Event|0|||
160661965|NCT01294787|580145591|FG000|Period 1|Withdrawal by Subject|0|||
160661966|NCT01294787|580145592|FG001|Period 1|Withdrawal by Subject|0|||
160661967|NCT01294787|580145593|FG002|Period 1|Withdrawal by Subject|0|||
160661968|NCT01294787|580145594|FG003|Period 1|Withdrawal by Subject|1|||
160661969|NCT01294787|580145595|FG004|Period 1|Withdrawal by Subject|1|||
160661970|NCT01294787|580145596|FG005|Period 1|Withdrawal by Subject|1|||
160661971|NCT01294787|580145591|FG000|Period 1|Administrative problem|0|||
160661972|NCT01294787|580145592|FG001|Period 1|Administrative problem|0|||
160661973|NCT01294787|580145593|FG002|Period 1|Administrative problem|1|||
160661974|NCT01294787|580145594|FG003|Period 1|Administrative problem|0|||
160661975|NCT01294787|580145595|FG004|Period 1|Administrative problem|0|||
160661976|NCT01294787|580145596|FG005|Period 1|Administrative problem|1|||
160661977|NCT01294787|580145591|FG000|Period 2|Adverse Event|0|||
160661978|NCT01294787|580145592|FG001|Period 2|Adverse Event|3|||
160661979|NCT01294787|580145593|FG002|Period 2|Adverse Event|0|||
160661980|NCT01294787|580145594|FG003|Period 2|Adverse Event|1|||
160661981|NCT01294787|580145595|FG004|Period 2|Adverse Event|0|||
160661982|NCT01294787|580145596|FG005|Period 2|Adverse Event|0|||
160661983|NCT01294787|580145591|FG000|Period 2|No longer needs study drug|0|||
160661984|NCT01294787|580145592|FG001|Period 2|No longer needs study drug|0|||
160661985|NCT01294787|580145593|FG002|Period 2|No longer needs study drug|0|||
160661986|NCT01294787|580145594|FG003|Period 2|No longer needs study drug|1|||
160661987|NCT01294787|580145595|FG004|Period 2|No longer needs study drug|0|||
160661988|NCT01294787|580145596|FG005|Period 2|No longer needs study drug|0|||
160661989|NCT01294787|580145591|FG000|Period 3|Adverse Event|0|||
160661990|NCT01294787|580145592|FG001|Period 3|Adverse Event|0|||
160661991|NCT01294787|580145593|FG002|Period 3|Adverse Event|0|||
160661992|NCT01294787|580145594|FG003|Period 3|Adverse Event|0|||
160661993|NCT01294787|580145595|FG004|Period 3|Adverse Event|1|||
160661994|NCT01294787|580145596|FG005|Period 3|Adverse Event|0|||
160661995|NCT01948258|580145597|FG000|Overall Study|Pregnancy|41|||
160661996|NCT01948258|580145597|FG000|Overall Study|Did not complete by cut-off date|35|||
160661997|NCT01948258|580145597|FG000|Overall Study|Lost to Follow-up|27|||
160661998|NCT01948258|580145597|FG000|Overall Study|Withdrawal by SPD|8|||
160661999|NCT01948258|580145597|FG000|Overall Study|Withdrawal by Subject|6|||
160662000|NCT01948258|580145597|FG000|Overall Study|Health Care Professional|43|||
160662001|NCT01948258|580145597|FG000|Overall Study|Removed from statistical analysis|2|||
160662002|NCT01811953|580145604|FG000|Overall Study|Adverse Event|0|||
160662003|NCT01811953|580145605|FG001|Overall Study|Adverse Event|0|||
160662004|NCT01811953|580145606|FG002|Overall Study|Adverse Event|0|||
160662005|NCT01811953|580145607|FG003|Overall Study|Adverse Event|1|||
160662006|NCT01811953|580145608|FG004|Overall Study|Adverse Event|0|||
160662007|NCT01811953|580145609|FG005|Overall Study|Adverse Event|1|||
160497155|NCT04092452|579548606|FG003|Overall Study|Physician Decision|0|||
160497156|NCT04092452|579548603|FG000|Overall Study|Pregnancy|2|||
160497157|NCT04092452|579548604|FG001|Overall Study|Pregnancy|0|||
160497158|NCT04092452|579548605|FG002|Overall Study|Pregnancy|0|||
160497159|NCT04092452|579548606|FG003|Overall Study|Pregnancy|0|||
160497160|NCT04092452|579548603|FG000|Overall Study|Protocol Deviation|1|||
160497161|NCT04092452|579548604|FG001|Overall Study|Protocol Deviation|0|||
160497162|NCT04092452|579548605|FG002|Overall Study|Protocol Deviation|0|||
160497163|NCT04092452|579548606|FG003|Overall Study|Protocol Deviation|0|||
160497164|NCT04092452|579548603|FG000|Overall Study|Withdrawal by Subject|3|||
160497165|NCT04092452|579548604|FG001|Overall Study|Withdrawal by Subject|10|||
160497166|NCT04092452|579548605|FG002|Overall Study|Withdrawal by Subject|3|||
160497167|NCT04092452|579548606|FG003|Overall Study|Withdrawal by Subject|5|||
160497168|NCT04092452|579548603|FG000|Overall Study|Other|0|||
160497169|NCT04092452|579548604|FG001|Overall Study|Other|0|||
160497170|NCT04092452|579548605|FG002|Overall Study|Other|1|||
160497171|NCT04092452|579548606|FG003|Overall Study|Other|2|||
160497172|NCT01012947|579548614|FG000|Overall Study|Lost to Follow-up|131|||
160497173|NCT01012947|579548615|FG001|Overall Study|Lost to Follow-up|135|||
160497174|NCT01012947|579548616|FG002|Overall Study|Lost to Follow-up|130|||
160497175|NCT01012947|579548617|FG003|Overall Study|Lost to Follow-up|118|||
160497176|NCT01012947|579548618|FG004|Overall Study|Lost to Follow-up|142|||
160497177|NCT02127125|579548619|FG000|Overall Study|Lost to Follow-up|0|||
160497178|NCT02127125|579548620|FG001|Overall Study|Lost to Follow-up|0|||
160497179|NCT02127125|579548621|FG002|Overall Study|Lost to Follow-up|0|||
160497180|NCT02127125|579548622|FG003|Overall Study|Lost to Follow-up|0|||
160497181|NCT02127125|579548623|FG004|Overall Study|Lost to Follow-up|2|||
160497182|NCT02127125|579548624|FG005|Overall Study|Lost to Follow-up|1|||
160497183|NCT02127125|579548625|FG006|Overall Study|Lost to Follow-up|0|||
160497184|NCT02127125|579548626|FG007|Overall Study|Lost to Follow-up|0|||
160497185|NCT02127125|579548627|FG008|Overall Study|Lost to Follow-up|0|||
160497186|NCT02127125|579548619|FG000|Overall Study|Withdrawal by Subject|0|||
160497187|NCT02127125|579548620|FG001|Overall Study|Withdrawal by Subject|0|||
160497188|NCT02127125|579548621|FG002|Overall Study|Withdrawal by Subject|0|||
160497189|NCT02127125|579548622|FG003|Overall Study|Withdrawal by Subject|1|||
160497190|NCT02127125|579548623|FG004|Overall Study|Withdrawal by Subject|0|||
160497191|NCT02127125|579548624|FG005|Overall Study|Withdrawal by Subject|0|||
160497192|NCT02127125|579548625|FG006|Overall Study|Withdrawal by Subject|0|||
160497193|NCT02127125|579548626|FG007|Overall Study|Withdrawal by Subject|0|||
160497194|NCT02127125|579548627|FG008|Overall Study|Withdrawal by Subject|0|||
160497195|NCT02127125|579548619|FG000|Overall Study|Physician Decision|0|||
160497196|NCT02127125|579548620|FG001|Overall Study|Physician Decision|0|||
160497197|NCT02127125|579548621|FG002|Overall Study|Physician Decision|1|||
160497198|NCT02127125|579548622|FG003|Overall Study|Physician Decision|0|||
160497199|NCT02127125|579548623|FG004|Overall Study|Physician Decision|1|||
160497200|NCT02127125|579548624|FG005|Overall Study|Physician Decision|2|||
160497201|NCT02127125|579548625|FG006|Overall Study|Physician Decision|0|||
160497202|NCT02127125|579548626|FG007|Overall Study|Physician Decision|0|||
160497203|NCT02127125|579548627|FG008|Overall Study|Physician Decision|0|||
160497204|NCT01191008|579548628|FG000|Overall Study|Protocol Violation|7|||
160497205|NCT01191008|579548628|FG000|Overall Study|Lost to Follow-up|8|||
160497206|NCT03348631|579548631|FG000|Overall Study|Not Eligible, No treatment|0|||
160497207|NCT03348631|579548632|FG001|Overall Study|Not Eligible, No treatment|1|||
160497208|NCT03348631|579548631|FG000|Overall Study|Not Eligible, Treated|2|||
160497209|NCT03348631|579548632|FG001|Overall Study|Not Eligible, Treated|0|||
160497210|NCT03348631|579548631|FG000|Overall Study|Eligible, No Treatment|1|||
160662008|NCT01811953|580145604|FG000|Overall Study|Protocol Violation|0|||
160662009|NCT01811953|580145605|FG001|Overall Study|Protocol Violation|0|||
160662010|NCT01811953|580145606|FG002|Overall Study|Protocol Violation|0|||
160662011|NCT01811953|580145607|FG003|Overall Study|Protocol Violation|0|||
160497211|NCT03348631|579548632|FG001|Overall Study|Eligible, No Treatment|0|||
160497212|NCT01068210|579548633|FG000|Overall Study|Lost to Follow-up|1|||
160497213|NCT01068210|579548634|FG001|Overall Study|Lost to Follow-up|2|||
160497214|NCT01068210|579548635|FG002|Overall Study|Lost to Follow-up|2|||
160497215|NCT01068210|579548636|FG003|Overall Study|Lost to Follow-up|1|||
160497216|NCT01068210|579548633|FG000|Overall Study|Second cancer|0|||
160497217|NCT01068210|579548634|FG001|Overall Study|Second cancer|1|||
160497218|NCT01068210|579548635|FG002|Overall Study|Second cancer|0|||
160497219|NCT01068210|579548636|FG003|Overall Study|Second cancer|0|||
160497220|NCT01068210|579548633|FG000|Overall Study|Disease progression|0|||
160497221|NCT01068210|579548634|FG001|Overall Study|Disease progression|0|||
160497222|NCT01068210|579548635|FG002|Overall Study|Disease progression|0|||
160497223|NCT01068210|579548636|FG003|Overall Study|Disease progression|2|||
160497224|NCT03299959|579548641|FG000|Overall Study|Lost to Follow-up|7|||
160497225|NCT03299959|579548642|FG001|Overall Study|Lost to Follow-up|9|||
160497226|NCT03299959|579548641|FG000|Overall Study|Death|1|||
160497227|NCT03299959|579548642|FG001|Overall Study|Death|0|||
160497228|NCT03299959|579548641|FG000|Overall Study|Withdrawal by Subject|13|||
160497229|NCT03299959|579548642|FG001|Overall Study|Withdrawal by Subject|9|||
160497230|NCT03299959|579548641|FG000|Overall Study|Changes in study team and government regulations|1|||
160497231|NCT03299959|579548642|FG001|Overall Study|Changes in study team and government regulations|1|||
160497232|NCT03299959|579548641|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
160497233|NCT03299959|579548642|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
160497234|NCT02201901|579548644|FG000|Overall Study|Randomized but never treated|0|||
160497235|NCT02201901|579548645|FG001|Overall Study|Randomized but never treated|1|||
160497236|NCT02201901|579548646|FG002|Overall Study|Randomized but never treated|0|||
160497237|NCT02201901|579548644|FG000|Overall Study|Lack of Efficacy|7|||
160497238|NCT02201901|579548645|FG001|Overall Study|Lack of Efficacy|1|||
160497239|NCT02201901|579548646|FG002|Overall Study|Lack of Efficacy|6|||
160497240|NCT02201901|579548644|FG000|Overall Study|Death|3|||
160497241|NCT02201901|579548645|FG001|Overall Study|Death|3|||
160497242|NCT02201901|579548646|FG002|Overall Study|Death|3|||
160497243|NCT02201901|579548644|FG000|Overall Study|Lost to Follow-up|2|||
160497244|NCT02201901|579548645|FG001|Overall Study|Lost to Follow-up|3|||
160497245|NCT02201901|579548646|FG002|Overall Study|Lost to Follow-up|2|||
160497246|NCT02201901|579548644|FG000|Overall Study|Withdrew Consent|2|||
160497247|NCT02201901|579548645|FG001|Overall Study|Withdrew Consent|0|||
160497248|NCT02201901|579548646|FG002|Overall Study|Withdrew Consent|2|||
160497249|NCT02201901|579548644|FG000|Overall Study|Adverse Event|1|||
160497250|NCT02201901|579548645|FG001|Overall Study|Adverse Event|1|||
160497251|NCT02201901|579548646|FG002|Overall Study|Adverse Event|0|||
160497252|NCT01431950|579548649|FG000|Overall Study|Study Site Closed/Terminated|7|||
160497253|NCT01431950|579548650|FG001|Overall Study|Study Site Closed/Terminated|3|||
160497254|NCT01431950|579548649|FG000|Overall Study|Withdrawal by Subject|4|||
160497255|NCT01431950|579548650|FG001|Overall Study|Withdrawal by Subject|3|||
160497256|NCT01431950|579548649|FG000|Overall Study|Protocol Violation|2|||
160497257|NCT01431950|579548650|FG001|Overall Study|Protocol Violation|3|||
160497258|NCT01431950|579548649|FG000|Overall Study|Adverse Event|2|||
160497259|NCT01431950|579548650|FG001|Overall Study|Adverse Event|2|||
160497260|NCT01431950|579548649|FG000|Overall Study|Physician Decision|2|||
160497261|NCT01431950|579548650|FG001|Overall Study|Physician Decision|1|||
160497262|NCT01431950|579548649|FG000|Overall Study|Lack of Efficacy|2|||
160497263|NCT01431950|579548650|FG001|Overall Study|Lack of Efficacy|1|||
160497264|NCT01431950|579548649|FG000|Overall Study|Lost to Follow-up|0|||
160497265|NCT01431950|579548650|FG001|Overall Study|Lost to Follow-up|1|||
160497266|NCT01431950|579548649|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
160497267|NCT01431950|579548650|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
160497268|NCT00738283|579548653|FG000|Overall Study|Death|1|||
160497269|NCT00738283|579548653|FG000|Overall Study|Transfer to another facility|2|||
160497270|NCT00738283|579548653|FG000|Overall Study|Discharge home prior to end of study|1|||
160497271|NCT01210651|579548654|FG000|Overall Study|Lost to Follow-up|1|||
160497272|NCT01210651|579548655|FG001|Overall Study|Lost to Follow-up|1|||
160497273|NCT01210651|579548654|FG000|Overall Study|schedule conflicts|1|||
160497274|NCT01210651|579548655|FG001|Overall Study|schedule conflicts|5|||
160497275|NCT01210651|579548654|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
160497276|NCT01210651|579548655|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
160497277|NCT01210651|579548654|FG000|Overall Study|Withdrawal by Subject|1|||
160497278|NCT01210651|579548655|FG001|Overall Study|Withdrawal by Subject|1|||
160497279|NCT01210651|579548654|FG000|Overall Study|Injury outside study|2|||
160497280|NCT01210651|579548655|FG001|Overall Study|Injury outside study|0|||
160497281|NCT03494985|579548656|FG000|Overall Study|Adverse Event|3|||
160497282|NCT03494985|579548657|FG001|Overall Study|Adverse Event|2|||
160497283|NCT03494985|579548658|FG002|Overall Study|Adverse Event|3|||
160497284|NCT03494985|579548659|FG003|Overall Study|Adverse Event|0|||
160497285|NCT03494985|579548656|FG000|Overall Study|Other (Withdrawal of consent)|2|||
160497286|NCT03494985|579548657|FG001|Overall Study|Other (Withdrawal of consent)|3|||
160497287|NCT03494985|579548658|FG002|Overall Study|Other (Withdrawal of consent)|2|||
160497288|NCT03494985|579548659|FG003|Overall Study|Other (Withdrawal of consent)|5|||
160497289|NCT03494985|579548656|FG000|Overall Study|Other (Not specified)|0|||
160497290|NCT03494985|579548657|FG001|Overall Study|Other (Not specified)|1|||
160497291|NCT03494985|579548658|FG002|Overall Study|Other (Not specified)|1|||
160497292|NCT03494985|579548659|FG003|Overall Study|Other (Not specified)|0|||
160618866|NCT03481634|579982032|FG000|Overall Study|Lost to Follow-up|3|||
160497293|NCT03459846|579548660|FG000|Overall Study|Death|52|||
160497294|NCT03459846|579548661|FG001|Overall Study|Death|46|||
160497295|NCT03459846|579548660|FG000|Overall Study|Study terminated by sponsor|24|||
160497296|NCT03459846|579548661|FG001|Overall Study|Study terminated by sponsor|28|||
160497297|NCT03459846|579548660|FG000|Overall Study|Withdrawal by Subject|2|||
160497298|NCT03459846|579548661|FG001|Overall Study|Withdrawal by Subject|2|||
160497299|NCT04886518|579548668|FG000|Overall Study|Noncompliance with study drug|1|||
160618867|NCT03481634|579982033|FG001|Overall Study|Lost to Follow-up|4|||
160497300|NCT04886518|579548669|FG001|Overall Study|Noncompliance with study drug|0|||
160497301|NCT04886518|579548670|FG002|Overall Study|Noncompliance with study drug|0|||
160497302|NCT04886518|579548668|FG000|Overall Study|Adverse Event|0|||
160497303|NCT04886518|579548669|FG001|Overall Study|Adverse Event|1|||
160497304|NCT04886518|579548670|FG002|Overall Study|Adverse Event|0|||
160497305|NCT04886518|579548668|FG000|Overall Study|Withdrawal by Subject|1|||
160497306|NCT04886518|579548669|FG001|Overall Study|Withdrawal by Subject|0|||
160497307|NCT04886518|579548670|FG002|Overall Study|Withdrawal by Subject|0|||
160497308|NCT01090011|579550626|FG000|Overall Study|Progressive disease|128|||
160497309|NCT01090011|579550626|FG000|Overall Study|Adverse Event|32|||
160497310|NCT01090011|579550626|FG000|Overall Study|Protocol Violation|1|||
160497311|NCT01090011|579550626|FG000|Overall Study|Refusal to start/continue medication|5|||
160497312|NCT01090011|579550626|FG000|Overall Study|Other reason not defined above|5|||
160497313|NCT03778294|579550627|FG000|Overall Study|Death|1|||
160497314|NCT03778294|579550627|FG000|Overall Study|Issues with insurance|1|||
160497315|NCT03778294|579550627|FG000|Overall Study|disease progression before treatment|2|||
160497316|NCT01845805|579550628|FG000|Overall Study|Withdrawal by Subject|1|||
160497317|NCT01845805|579550629|FG001|Overall Study|Withdrawal by Subject|2|||
160497318|NCT01845805|579550628|FG000|Overall Study|Disease Progression|13|||
160497319|NCT01845805|579550629|FG001|Overall Study|Disease Progression|14|||
160497320|NCT01845805|579550628|FG000|Overall Study|Drug-related Toxicity|4|||
160497321|NCT01845805|579550629|FG001|Overall Study|Drug-related Toxicity|0|||
160497322|NCT03945773|579550630|FG000|Overall Study|Consent Withdrawn|1|||
160497323|NCT03945773|579550631|FG001|Overall Study|Consent Withdrawn|1|||
160497324|NCT03945773|579550630|FG000|Overall Study|Lost to Follow-up|1|||
160497325|NCT03945773|579550631|FG001|Overall Study|Lost to Follow-up|0|||
160497326|NCT03945773|579550630|FG000|Overall Study|Death|46|||
160497327|NCT03945773|579550631|FG001|Overall Study|Death|22|||
160497328|NCT03945773|579550630|FG000|Overall Study|Physician Decision|1|||
160497329|NCT03945773|579550631|FG001|Overall Study|Physician Decision|0|||
160497330|NCT03945773|579550630|FG000|Overall Study|Other|1|||
160497331|NCT03945773|579550631|FG001|Overall Study|Other|0|||
160497332|NCT03945773|579550630|FG000|Overall Study|Ongoing at the time of DCO|4|||
160497333|NCT03945773|579550631|FG001|Overall Study|Ongoing at the time of DCO|3|||
160618868|NCT03481634|579982034|FG002|Overall Study|Lost to Follow-up|4|||
160618869|NCT03481634|579982032|FG000|Overall Study|Death|4|||
160618870|NCT03481634|579982033|FG001|Overall Study|Death|8|||
160618871|NCT03481634|579982034|FG002|Overall Study|Death|7|||
160618872|NCT03481634|579982032|FG000|Overall Study|Adverse Event|6|||
160618873|NCT03481634|579982033|FG001|Overall Study|Adverse Event|3|||
160618874|NCT03481634|579982034|FG002|Overall Study|Adverse Event|7|||
160618875|NCT04491591|579982039|FG000|Overall Study|Accidently randomized|3|||
160618876|NCT04491591|579982040|FG001|Overall Study|Accidently randomized|1|||
160618877|NCT04491591|579982041|FG002|Overall Study|Accidently randomized|0|||
160618878|NCT04491591|579982039|FG000|Overall Study|Did not complete survey|28|||
160618879|NCT04491591|579982040|FG001|Overall Study|Did not complete survey|20|||
160618880|NCT04491591|579982041|FG002|Overall Study|Did not complete survey|3|||
160618881|NCT04212221|579982044|FG000|Overall Study|Remained on Treatment|0|||
160618882|NCT04212221|579982045|FG001|Overall Study|Remained on Treatment|0|||
160618883|NCT04212221|579982046|FG002|Overall Study|Remained on Treatment|0|||
160618884|NCT04212221|579982047|FG003|Overall Study|Remained on Treatment|1|||
160618885|NCT04212221|579982048|FG004|Overall Study|Remained on Treatment|0|||
160618886|NCT04212221|579982049|FG005|Overall Study|Remained on Treatment|0|||
160618887|NCT04212221|579982050|FG006|Overall Study|Remained on Treatment|3|||
160618888|NCT04212221|579982051|FG007|Overall Study|Remained on Treatment|9|||
160618889|NCT04212221|579982044|FG000|Overall Study|Adverse Event|0|||
160618890|NCT04212221|579982045|FG001|Overall Study|Adverse Event|0|||
160618891|NCT04212221|579982046|FG002|Overall Study|Adverse Event|0|||
160618892|NCT04212221|579982047|FG003|Overall Study|Adverse Event|0|||
160618893|NCT04212221|579982048|FG004|Overall Study|Adverse Event|0|||
160618894|NCT04212221|579982049|FG005|Overall Study|Adverse Event|0|||
160618895|NCT04212221|579982050|FG006|Overall Study|Adverse Event|2|||
160618896|NCT04212221|579982051|FG007|Overall Study|Adverse Event|3|||
160618897|NCT04212221|579982044|FG000|Overall Study|Death|0|||
160618898|NCT04212221|579982045|FG001|Overall Study|Death|0|||
160618899|NCT04212221|579982046|FG002|Overall Study|Death|0|||
160618900|NCT04212221|579982047|FG003|Overall Study|Death|0|||
160618901|NCT04212221|579982048|FG004|Overall Study|Death|0|||
160662012|NCT01811953|580145608|FG004|Overall Study|Protocol Violation|1|||
160662013|NCT01811953|580145609|FG005|Overall Study|Protocol Violation|0|||
160662014|NCT01900691|580145610|FG000|Overall Study|Death|7|||
160618902|NCT04212221|579982049|FG005|Overall Study|Death|0|||
160662015|NCT01900691|580145610|FG000|Overall Study|Lost to Follow-up|4|||
160662016|NCT01900691|580145610|FG000|Overall Study|Study Device Not Placed|3|||
160618903|NCT04212221|579982050|FG006|Overall Study|Death|0|||
160618904|NCT04212221|579982051|FG007|Overall Study|Death|2|||
160618905|NCT04212221|579982044|FG000|Overall Study|Disease progression according to irRECIST|1|||
160497334|NCT01200342|579550632|FG000|Overall Study|Disease Progression|1|||
160497335|NCT00725712|579550635|FG000|Overall Study|Withdrawal by Subject|2|||
160497336|NCT00725712|579550636|FG001|Overall Study|Withdrawal by Subject|1|||
160618906|NCT04212221|579982045|FG001|Overall Study|Disease progression according to irRECIST|2|||
160618907|NCT04212221|579982046|FG002|Overall Study|Disease progression according to irRECIST|3|||
160618908|NCT04212221|579982047|FG003|Overall Study|Disease progression according to irRECIST|3|||
160662017|NCT01900691|580145610|FG000|Overall Study|Non study stent placed|2|||
160497337|NCT00725712|579550635|FG000|Overall Study|Protocol Violation|1|||
160497338|NCT00725712|579550636|FG001|Overall Study|Protocol Violation|0|||
160497339|NCT00725712|579550635|FG000|Overall Study|Progressive disease|37|||
160497340|NCT00725712|579550636|FG001|Overall Study|Progressive disease|16|||
160497341|NCT00725712|579550635|FG000|Overall Study|Clinical progression not based on RECIST|0|||
160497342|NCT00725712|579550636|FG001|Overall Study|Clinical progression not based on RECIST|3|||
160497343|NCT00725712|579550635|FG000|Overall Study|Adverse Event|5|||
160497344|NCT00725712|579550636|FG001|Overall Study|Adverse Event|5|||
160497345|NCT00725712|579550635|FG000|Overall Study|Death|2|||
160497346|NCT00725712|579550636|FG001|Overall Study|Death|0|||
160497347|NCT00725712|579550635|FG000|Overall Study|Other: Death|1|||
160497348|NCT00725712|579550636|FG001|Overall Study|Other: Death|0|||
160497349|NCT00725712|579550635|FG000|Overall Study|Hospitalized, unable to continue|0|||
160497350|NCT00725712|579550636|FG001|Overall Study|Hospitalized, unable to continue|1|||
160497351|NCT01439867|579550642|FG000|Overall Study|Non-compliance|0|||
160497352|NCT01439867|579550643|FG001|Overall Study|Non-compliance|1|||
160497353|NCT01439867|579550642|FG000|Overall Study|Withdrawal by Subject|1|||
160497354|NCT01439867|579550643|FG001|Overall Study|Withdrawal by Subject|2|||
160497355|NCT01439867|579550642|FG000|Overall Study|Administrative Decision|4|||
160497356|NCT01439867|579550643|FG001|Overall Study|Administrative Decision|5|||
160497357|NCT01439867|579550642|FG000|Overall Study|Protocol-specified Criteria|1|||
160497358|NCT01439867|579550643|FG001|Overall Study|Protocol-specified Criteria|0|||
160497359|NCT03607422|579550644|FG000|Overall Study|Adverse Event|7|||
160497360|NCT03607422|579550645|FG001|Overall Study|Adverse Event|3|||
160497361|NCT03607422|579550646|FG002|Overall Study|Adverse Event|2|||
160497362|NCT03607422|579550647|FG003|Overall Study|Adverse Event|0|||
160497363|NCT03607422|579550648|FG004|Overall Study|Adverse Event|2|||
160497364|NCT03607422|579550649|FG005|Overall Study|Adverse Event|0|||
160497365|NCT03607422|579550644|FG000|Overall Study|Withdrawal by Subject|11|||
160497366|NCT03607422|579550645|FG001|Overall Study|Withdrawal by Subject|3|||
160497367|NCT03607422|579550646|FG002|Overall Study|Withdrawal by Subject|6|||
160497368|NCT03607422|579550647|FG003|Overall Study|Withdrawal by Subject|2|||
160497369|NCT03607422|579550648|FG004|Overall Study|Withdrawal by Subject|0|||
160497370|NCT03607422|579550649|FG005|Overall Study|Withdrawal by Subject|0|||
160497371|NCT03607422|579550644|FG000|Overall Study|Lost to Follow-up|0|||
160497372|NCT03607422|579550645|FG001|Overall Study|Lost to Follow-up|0|||
160497373|NCT03607422|579550646|FG002|Overall Study|Lost to Follow-up|1|||
160497374|NCT03607422|579550647|FG003|Overall Study|Lost to Follow-up|0|||
160497375|NCT03607422|579550648|FG004|Overall Study|Lost to Follow-up|0|||
160497376|NCT03607422|579550649|FG005|Overall Study|Lost to Follow-up|0|||
160497377|NCT03607422|579550644|FG000|Overall Study|Other|12|||
160497378|NCT03607422|579550645|FG001|Overall Study|Other|4|||
160497379|NCT03607422|579550646|FG002|Overall Study|Other|1|||
160497380|NCT03607422|579550647|FG003|Overall Study|Other|2|||
160497381|NCT03607422|579550648|FG004|Overall Study|Other|0|||
160497382|NCT03607422|579550649|FG005|Overall Study|Other|2|||
160497383|NCT03607422|579550644|FG000|Overall Study|Ongoing at Time of Analysis|8|||
160497384|NCT03607422|579550645|FG001|Overall Study|Ongoing at Time of Analysis|0|||
160497385|NCT03607422|579550646|FG002|Overall Study|Ongoing at Time of Analysis|2|||
160497386|NCT03607422|579550647|FG003|Overall Study|Ongoing at Time of Analysis|1|||
160497387|NCT03607422|579550648|FG004|Overall Study|Ongoing at Time of Analysis|1|||
160497388|NCT03607422|579550649|FG005|Overall Study|Ongoing at Time of Analysis|1|||
160497389|NCT03258723|579550652|FG000|Overall Study|COVID Interruption of study|54|||
160497390|NCT03258723|579550652|FG000|Overall Study|Lost to Follow-up|8|||
160497391|NCT01107899|579550653|FG000|Overall Study|Physician Decision|5|||
160497392|NCT01107899|579550654|FG001|Overall Study|Physician Decision|0|||
160497393|NCT01107899|579550655|FG002|Overall Study|Physician Decision|3|||
160497394|NCT01107899|579550653|FG000|Overall Study|Withdrawal by Subject|0|||
160497395|NCT01107899|579550654|FG001|Overall Study|Withdrawal by Subject|0|||
160497396|NCT01107899|579550655|FG002|Overall Study|Withdrawal by Subject|1|||
160497397|NCT03584152|579550656|FG000|Overall Study|Discontinued intervention|7|||
160497398|NCT03584152|579550657|FG001|Overall Study|Discontinued intervention|4|||
160497399|NCT04292470|579550658|FG000|Overall Study|Withdrawal by Subject|0|||
160497400|NCT04292470|579550659|FG001|Overall Study|Withdrawal by Subject|1|||
160497401|NCT01375673|579550676|FG000|Overall Study|Withdrawal by Subject|0|||
160497402|NCT01375673|579550677|FG001|Overall Study|Withdrawal by Subject|1|||
160497403|NCT04698915|579550682|FG000|Overall Study|Adverse Event|2|||
160497404|NCT04698915|579550683|FG001|Overall Study|Adverse Event|0|||
160497405|NCT04698915|579550682|FG000|Overall Study|Death|23|||
160497406|NCT04698915|579550683|FG001|Overall Study|Death|20|||
160497407|NCT04698915|579550682|FG000|Overall Study|Physician Decision|1|||
160497408|NCT04698915|579550683|FG001|Overall Study|Physician Decision|1|||
160497409|NCT04698915|579550682|FG000|Overall Study|Lost to Follow-up|1|||
160497410|NCT04698915|579550683|FG001|Overall Study|Lost to Follow-up|0|||
160497411|NCT04698915|579550682|FG000|Overall Study|Study Terminated by Sponsor|55|||
160497412|NCT04698915|579550683|FG001|Overall Study|Study Terminated by Sponsor|60|||
160497413|NCT04698915|579550682|FG000|Overall Study|Withdrawal by Subject|2|||
160497414|NCT04698915|579550683|FG001|Overall Study|Withdrawal by Subject|3|||
160497415|NCT01907906|579550684|FG000|Overall Study|Withdrawal by Subject|1|||
160497416|NCT01907906|579550685|FG001|Overall Study|Withdrawal by Subject|0|||
160497417|NCT01907906|579550684|FG000|Overall Study|Physician Decision|3|||
160662018|NCT01900691|580145610|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
160662019|NCT01900691|580145610|FG000|Overall Study|Complete stent migration through digestive tract|1|||
160662020|NCT01954394|580145611|FG000|Overall Study|Enrolled but not treated|1|||
160662021|NCT01954394|580145612|FG001|Overall Study|Enrolled but not treated|0|||
160662022|NCT01954394|580145611|FG000|Overall Study|Adverse Event|10|||
160662023|NCT01954394|580145612|FG001|Overall Study|Adverse Event|23|||
160662024|NCT01954394|580145611|FG000|Overall Study|Poor compliance to protocol|7|||
160662025|NCT01954394|580145612|FG001|Overall Study|Poor compliance to protocol|7|||
160662026|NCT01954394|580145611|FG000|Overall Study|Participant Moved|0|||
160662027|NCT01954394|580145612|FG001|Overall Study|Participant Moved|4|||
160662028|NCT01954394|580145611|FG000|Overall Study|Related to Study Drug administration|2|||
160662029|NCT01954394|580145612|FG001|Overall Study|Related to Study Drug administration|2|||
160662030|NCT01954394|580145611|FG000|Overall Study|Other than specified above|10|||
160662031|NCT01954394|580145612|FG001|Overall Study|Other than specified above|21|||
160662032|NCT00834249|580145615|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
160662033|NCT00834249|580145616|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
160662034|NCT00834249|580145615|FG000|Second Intervention|Adverse Event|1|||
160662035|NCT00834249|580145616|FG001|Second Intervention|Adverse Event|0|||
160662036|NCT00851877|580145617|FG000|Phase I-1|Death|1|||
160497418|NCT01907906|579550685|FG001|Overall Study|Physician Decision|1|||
160497419|NCT00979953|579550686|FG000|Overall Study|Adverse Event|5|||
160497420|NCT00979953|579550687|FG001|Overall Study|Adverse Event|2|||
160497421|NCT00979953|579550688|FG002|Overall Study|Adverse Event|17|||
160497422|NCT00979953|579550689|FG003|Overall Study|Adverse Event|4|||
160497423|NCT00979953|579550686|FG000|Overall Study|Lack of Efficacy|1|||
160497424|NCT00979953|579550687|FG001|Overall Study|Lack of Efficacy|2|||
160497425|NCT00979953|579550688|FG002|Overall Study|Lack of Efficacy|0|||
160497426|NCT00979953|579550689|FG003|Overall Study|Lack of Efficacy|0|||
160497427|NCT00979953|579550686|FG000|Overall Study|Lost to Follow-up|1|||
160497428|NCT00979953|579550687|FG001|Overall Study|Lost to Follow-up|1|||
160497429|NCT00979953|579550688|FG002|Overall Study|Lost to Follow-up|1|||
160497430|NCT00979953|579550689|FG003|Overall Study|Lost to Follow-up|0|||
160497431|NCT00979953|579550686|FG000|Overall Study|Withdrawal by Subject|0|||
160662037|NCT00851877|580145618|FG001|Phase I-1|Death|0|||
160662038|NCT00851877|580145619|FG002|Phase I-1|Death|0|||
160662039|NCT00851877|580145617|FG000|Phase II|Withdrawal by Subject|0|||
160662040|NCT00851877|580145618|FG001|Phase II|Withdrawal by Subject|0|||
160662041|NCT00851877|580145619|FG002|Phase II|Withdrawal by Subject|3|||
160662042|NCT00627016|580145620|FG000|Overall Study|Adverse Event|1|||
160662043|NCT00627016|580145621|FG001|Overall Study|Adverse Event|1|||
160662044|NCT00627016|580145620|FG000|Overall Study|Protocol Violation|0|||
160662045|NCT00627016|580145621|FG001|Overall Study|Protocol Violation|2|||
160662046|NCT00627016|580145620|FG000|Overall Study|Lost to Follow-up|0|||
160662047|NCT00627016|580145621|FG001|Overall Study|Lost to Follow-up|1|||
160662048|NCT00627016|580145620|FG000|Overall Study|Withdrawal by Subject|2|||
160662049|NCT00627016|580145621|FG001|Overall Study|Withdrawal by Subject|1|||
160662050|NCT00627016|580145620|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
160662051|NCT00627016|580145621|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
160662052|NCT00627016|580145620|FG000|Overall Study|Lack of Efficacy|1|||
160662053|NCT00627016|580145621|FG001|Overall Study|Lack of Efficacy|0|||
160662054|NCT00627016|580145620|FG000|Overall Study|Placed on Excluded Drugs|1|||
160497432|NCT00979953|579550687|FG001|Overall Study|Withdrawal by Subject|0|||
160497433|NCT00979953|579550688|FG002|Overall Study|Withdrawal by Subject|2|||
160497434|NCT00979953|579550689|FG003|Overall Study|Withdrawal by Subject|1|||
160497435|NCT00979953|579550686|FG000|Overall Study|Protocol Violation|1|||
160497436|NCT00979953|579550687|FG001|Overall Study|Protocol Violation|0|||
160497437|NCT00979953|579550688|FG002|Overall Study|Protocol Violation|2|||
160497438|NCT00979953|579550689|FG003|Overall Study|Protocol Violation|2|||
160497439|NCT01124097|579550690|FG000|Overall Study|Withdrawal by Subject|4|||
160497440|NCT01124097|579550691|FG001|Overall Study|Withdrawal by Subject|3|||
160497441|NCT01124097|579550692|FG002|Overall Study|Withdrawal by Subject|2|||
160497442|NCT01124097|579550693|FG003|Overall Study|Withdrawal by Subject|3|||
160497443|NCT01124097|579550690|FG000|Overall Study|Lack of Efficacy|2|||
160497444|NCT01124097|579550691|FG001|Overall Study|Lack of Efficacy|3|||
160497445|NCT01124097|579550692|FG002|Overall Study|Lack of Efficacy|1|||
160497446|NCT01124097|579550693|FG003|Overall Study|Lack of Efficacy|3|||
160497447|NCT01124097|579550690|FG000|Overall Study|Adverse Event|24|||
160497448|NCT01124097|579550691|FG001|Overall Study|Adverse Event|15|||
160497449|NCT01124097|579550692|FG002|Overall Study|Adverse Event|15|||
160497450|NCT01124097|579550693|FG003|Overall Study|Adverse Event|7|||
160497451|NCT01124097|579550690|FG000|Overall Study|Protocol Violation|2|||
160497452|NCT01124097|579550691|FG001|Overall Study|Protocol Violation|0|||
160497453|NCT01124097|579550692|FG002|Overall Study|Protocol Violation|2|||
160497454|NCT01124097|579550693|FG003|Overall Study|Protocol Violation|1|||
160497455|NCT01124097|579550690|FG000|Overall Study|Physician Decision|2|||
160497456|NCT01124097|579550691|FG001|Overall Study|Physician Decision|1|||
160497457|NCT01124097|579550692|FG002|Overall Study|Physician Decision|0|||
160497458|NCT01124097|579550693|FG003|Overall Study|Physician Decision|0|||
160497459|NCT05687032|579550694|FG000|Treatment Phase|Adverse Event|13|||
160497460|NCT05687032|579550694|FG000|Treatment Phase|Death|1|||
160497461|NCT05687032|579550694|FG000|Treatment Phase|Physician Decision|3|||
160497462|NCT05687032|579550694|FG000|Treatment Phase|Progressive disease|9|||
160497463|NCT05687032|579550694|FG000|Treatment Phase|Withdrawal by Subject|5|||
160497464|NCT05687032|579550694|FG000|Follow-Up Phase|Death|16|||
160497465|NCT05687032|579550694|FG000|Follow-Up Phase|Ongoing|26|||
160497466|NCT04829747|579550698|FG000|Overall Study|Protocol Violation|1|||
160497467|NCT02367352|579550701|FG000|Overall Study|Progressive disease|7|||
160497468|NCT02367352|579550702|FG001|Overall Study|Progressive disease|0|||
160497469|NCT02367352|579550703|FG002|Overall Study|Progressive disease|0|||
160497470|NCT02367352|579550701|FG000|Overall Study|Participant Received Alternative Therapy|1|||
160497471|NCT02367352|579550702|FG001|Overall Study|Participant Received Alternative Therapy|0|||
160497472|NCT02367352|579550703|FG002|Overall Study|Participant Received Alternative Therapy|0|||
160497473|NCT02367352|579550701|FG000|Overall Study|Adverse Event|1|||
160497474|NCT02367352|579550702|FG001|Overall Study|Adverse Event|0|||
160497475|NCT02367352|579550703|FG002|Overall Study|Adverse Event|0|||
160497476|NCT05878873|579550704|FG000|Overall Study|Lost to Follow-up|2|||
160497477|NCT05878873|579550705|FG001|Overall Study|Lost to Follow-up|0|||
160497478|NCT02375347|579550707|FG000|Overall Study|Protocol Violation|1|||
160497479|NCT00425607|579550708|FG000|Overall Study|Death|1|||
160497480|NCT00425607|579550708|FG000|Overall Study|Withdrawal by Subject|1|||
160497481|NCT00193479|579550709|FG000|Induction Chemotherapy|Adverse Event|2|||
160497482|NCT00193479|579550709|FG000|Induction Chemotherapy|Disease Progression|1|||
160497483|NCT00193479|579550709|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
160497484|NCT00193479|579550709|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
160497485|NCT00079339|579550710|FG000|Overall Study|Adverse Event|1|||
160497486|NCT00079339|579550711|FG001|Overall Study|Adverse Event|7|||
160497487|NCT00079339|579550712|FG002|Overall Study|Adverse Event|2|||
160497488|NCT00079339|579550710|FG000|Overall Study|Death|1|||
160497489|NCT00079339|579550711|FG001|Overall Study|Death|0|||
160497490|NCT00079339|579550712|FG002|Overall Study|Death|0|||
160497491|NCT00079339|579550710|FG000|Overall Study|Non-compliance|0|||
160497492|NCT00079339|579550711|FG001|Overall Study|Non-compliance|0|||
160497493|NCT00079339|579550712|FG002|Overall Study|Non-compliance|1|||
160497494|NCT00079339|579550710|FG000|Overall Study|Withdrawal by Subject|0|||
160497495|NCT00079339|579550711|FG001|Overall Study|Withdrawal by Subject|4|||
160497496|NCT00079339|579550712|FG002|Overall Study|Withdrawal by Subject|1|||
160497497|NCT00079339|579550710|FG000|Overall Study|Disease progression|3|||
160618909|NCT04212221|579982048|FG004|Overall Study|Disease progression according to irRECIST|2|||
160618910|NCT04212221|579982049|FG005|Overall Study|Disease progression according to irRECIST|2|||
160497498|NCT00079339|579550711|FG001|Overall Study|Disease progression|28|||
160497499|NCT00079339|579550712|FG002|Overall Study|Disease progression|2|||
160497500|NCT00559377|579550714|FG000|Overall Study|Withdrawal by Subject|9|||
160497501|NCT02563548|579550715|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
160497502|NCT02563548|579550716|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
160497503|NCT02563548|579550717|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
160497504|NCT02563548|579550718|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
160497505|NCT02563548|579550719|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
160662055|NCT00627016|580145621|FG001|Overall Study|Placed on Excluded Drugs|0|||
160662056|NCT00627016|580145620|FG000|Overall Study|Pregnancy|1|||
160662057|NCT00627016|580145621|FG001|Overall Study|Pregnancy|0|||
160662058|NCT01534663|580145622|FG000|Overall Study|Lost to Follow-up|0|||
160497506|NCT02563548|579550720|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
160497507|NCT02563548|579550715|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
160497508|NCT02563548|579550716|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
160497509|NCT02563548|579550717|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
160497510|NCT02563548|579550718|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
160497511|NCT02563548|579550719|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
160497512|NCT02563548|579550720|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
160497513|NCT02563548|579550715|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
160497514|NCT02563548|579550716|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
160497515|NCT02563548|579550717|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
160497516|NCT02563548|579550718|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
160497517|NCT02563548|579550719|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
160497518|NCT02563548|579550720|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
160497519|NCT02563548|579550715|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
160497520|NCT02563548|579550716|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
160497521|NCT02563548|579550717|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
160497522|NCT02563548|579550718|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
160497523|NCT02563548|579550719|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
160497524|NCT02563548|579550720|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
160497525|NCT02563548|579550715|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
160497526|NCT02563548|579550716|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
160497527|NCT02563548|579550717|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
160497528|NCT02563548|579550718|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
160497529|NCT02563548|579550719|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
160497530|NCT02563548|579550720|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
160497531|NCT02563548|579550715|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
160497532|NCT02563548|579550716|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
160497533|NCT02563548|579550717|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
160497534|NCT02563548|579550718|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
160497535|NCT02563548|579550719|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
160497536|NCT02563548|579550720|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
160497537|NCT02563548|579550715|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
160497538|NCT02563548|579550716|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
160497539|NCT02563548|579550717|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
160497540|NCT02563548|579550718|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
160497541|NCT02563548|579550719|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
160497542|NCT02563548|579550720|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
160497543|NCT02563548|579550715|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
160497544|NCT02563548|579550716|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
160497545|NCT02563548|579550717|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
160497546|NCT02563548|579550718|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
160497547|NCT02563548|579550719|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
160497548|NCT02563548|579550720|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
160497549|NCT02563548|579550715|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
160497550|NCT02563548|579550716|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
160497551|NCT02563548|579550717|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
160497552|NCT02563548|579550718|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
160497553|NCT02563548|579550719|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
160497554|NCT02563548|579550720|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
160497555|NCT02563548|579550715|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
160497556|NCT02563548|579550716|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
160497557|NCT02563548|579550717|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
160497558|NCT02563548|579550718|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
160497559|NCT02563548|579550719|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
160497560|NCT02563548|579550720|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
160497561|NCT02563548|579550715|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
160497562|NCT02563548|579550716|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
160497563|NCT02563548|579550717|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
160497564|NCT02563548|579550718|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
160662059|NCT01534663|580145623|FG001|Overall Study|Lost to Follow-up|2|||
160662060|NCT01534663|580145622|FG000|Overall Study|Adverse Event|2|||
160662061|NCT01534663|580145623|FG001|Overall Study|Adverse Event|1|||
160662062|NCT04088760|580145624|FG000|Overall Study|Physician Decision|1|||
160497565|NCT02563548|579550719|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
160497566|NCT02563548|579550720|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
160497567|NCT02563548|579550715|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
160497568|NCT02563548|579550716|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
160497569|NCT02563548|579550717|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
160497570|NCT02563548|579550718|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
160497571|NCT02563548|579550719|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
160497572|NCT02563548|579550720|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
160497573|NCT00203047|579550726|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
160497574|NCT00203047|579550727|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
160497575|NCT00203047|579550726|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
160497576|NCT00203047|579550727|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
160497577|NCT00203047|579550726|FG000|Overall Study|Withdrawal by Subject|13|||
160497578|NCT00203047|579550727|FG001|Overall Study|Withdrawal by Subject|47|||
160497579|NCT00203047|579550726|FG000|Overall Study|Teva requested participant withdrawal|1|||
160497580|NCT00203047|579550727|FG001|Overall Study|Teva requested participant withdrawal|1|||
160497581|NCT00203047|579550726|FG000|Overall Study|Physician Decision|8|||
160497582|NCT00203047|579550727|FG001|Overall Study|Physician Decision|7|||
160497583|NCT00203047|579550726|FG000|Overall Study|Non-compliance|4|||
160497584|NCT00203047|579550727|FG001|Overall Study|Non-compliance|8|||
160497585|NCT00203047|579550726|FG000|Overall Study|Protocol Violation|1|||
160497586|NCT00203047|579550727|FG001|Overall Study|Protocol Violation|0|||
160497587|NCT00203047|579550726|FG000|Overall Study|Lost to Follow-up|11|||
160497588|NCT00203047|579550727|FG001|Overall Study|Lost to Follow-up|5|||
160497589|NCT00203047|579550726|FG000|Overall Study|Adverse Event|8|||
160497590|NCT00203047|579550727|FG001|Overall Study|Adverse Event|18|||
160497591|NCT00203047|579550726|FG000|Overall Study|Death|1|||
160497592|NCT00203047|579550727|FG001|Overall Study|Death|2|||
160497593|NCT00203047|579550726|FG000|Overall Study|Pregnancy|3|||
160497594|NCT00203047|579550727|FG001|Overall Study|Pregnancy|0|||
160497595|NCT00203047|579550726|FG000|Overall Study|Other|5|||
160497596|NCT00203047|579550727|FG001|Overall Study|Other|5|||
160497597|NCT02229227|579550728|FG000|Overall Study|Adverse Event|14|||
160497598|NCT02229227|579550729|FG001|Overall Study|Adverse Event|9|||
160497599|NCT02229227|579550728|FG000|Overall Study|Lack of Efficacy|3|||
160497600|NCT02229227|579550729|FG001|Overall Study|Lack of Efficacy|3|||
160497601|NCT02229227|579550728|FG000|Overall Study|Protocol Violation|6|||
160497602|NCT02229227|579550729|FG001|Overall Study|Protocol Violation|8|||
160497603|NCT02229227|579550728|FG000|Overall Study|Protocol defined stopping criteria|1|||
160497604|NCT02229227|579550729|FG001|Overall Study|Protocol defined stopping criteria|3|||
160497605|NCT02229227|579550728|FG000|Overall Study|Lost to Follow-up|3|||
160497606|NCT02229227|579550729|FG001|Overall Study|Lost to Follow-up|3|||
160497607|NCT02229227|579550728|FG000|Overall Study|Study terminated by sponsor|11|||
160497608|NCT02229227|579550729|FG001|Overall Study|Study terminated by sponsor|11|||
160497609|NCT02229227|579550728|FG000|Overall Study|Withdrawal by Subject|8|||
160497610|NCT02229227|579550729|FG001|Overall Study|Withdrawal by Subject|12|||
160497611|NCT02229227|579550728|FG000|Overall Study|Other|0|||
160497612|NCT02229227|579550729|FG001|Overall Study|Other|1|||
160497613|NCT02229227|579550728|FG000|Overall Study|Physician Decision|5|||
160497614|NCT02229227|579550729|FG001|Overall Study|Physician Decision|12|||
160497615|NCT00340704|579550732|FG000|PK Study|Adverse Event|0|||
160497616|NCT00340704|579550733|FG001|PK Study|Adverse Event|1|||
160497617|NCT00340704|579550734|FG002|PK Study|Adverse Event|0|||
160497618|NCT00340704|579550735|FG003|PK Study|Adverse Event|0|||
160497619|NCT00340704|579550736|FG004|PK Study|Adverse Event|0|||
160497620|NCT00340704|579550737|FG005|PK Study|Adverse Event|0|||
160497621|NCT00340704|579550738|FG006|PK Study|Adverse Event|0|||
160497622|NCT00340704|579550739|FG007|PK Study|Adverse Event|0|||
160497623|NCT00340704|579550740|FG008|PK Study|Adverse Event|0|||
160497624|NCT00340704|579550732|FG000|PK Study|Not treated|0|||
160618911|NCT04212221|579982050|FG006|Overall Study|Disease progression according to irRECIST|21|||
160618912|NCT04212221|579982051|FG007|Overall Study|Disease progression according to irRECIST|17|||
160618913|NCT04212221|579982044|FG000|Overall Study|Global Deterioration of Health Status|0|||
160497625|NCT00340704|579550733|FG001|PK Study|Not treated|0|||
160618914|NCT04212221|579982045|FG001|Overall Study|Global Deterioration of Health Status|0|||
160618915|NCT04212221|579982046|FG002|Overall Study|Global Deterioration of Health Status|0|||
160618916|NCT04212221|579982047|FG003|Overall Study|Global Deterioration of Health Status|0|||
160618917|NCT04212221|579982048|FG004|Overall Study|Global Deterioration of Health Status|0|||
160497626|NCT00340704|579550734|FG002|PK Study|Not treated|1|||
160497627|NCT00340704|579550735|FG003|PK Study|Not treated|0|||
160497628|NCT00340704|579550736|FG004|PK Study|Not treated|0|||
160497629|NCT00340704|579550737|FG005|PK Study|Not treated|0|||
160497630|NCT00340704|579550738|FG006|PK Study|Not treated|0|||
160497631|NCT00340704|579550739|FG007|PK Study|Not treated|0|||
160497632|NCT00340704|579550740|FG008|PK Study|Not treated|0|||
160497633|NCT00340704|579550732|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
160497634|NCT00340704|579550733|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
160497635|NCT00340704|579550734|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
160497636|NCT00340704|579550735|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
160497637|NCT00340704|579550736|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
160497638|NCT00340704|579550737|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
160497639|NCT00340704|579550738|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
160497640|NCT00340704|579550739|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
160497641|NCT00340704|579550740|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
160497642|NCT00340704|579550732|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
160497643|NCT00340704|579550733|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
160497644|NCT00340704|579550734|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
160497645|NCT00340704|579550735|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
160497646|NCT00340704|579550736|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
160497647|NCT00340704|579550737|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
160497648|NCT00340704|579550738|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
160497649|NCT00340704|579550739|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
160497650|NCT00340704|579550740|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
160497651|NCT00340704|579550732|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
160497652|NCT00340704|579550733|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
160497653|NCT00340704|579550734|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
160497654|NCT00340704|579550735|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
160497655|NCT00340704|579550736|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
160497656|NCT00340704|579550737|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
160497657|NCT00340704|579550738|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
160497658|NCT00340704|579550739|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
160497659|NCT00340704|579550740|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
160497660|NCT00340704|579550732|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
160497661|NCT00340704|579550733|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
160497662|NCT00340704|579550734|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
160497663|NCT00340704|579550735|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
160497664|NCT00340704|579550736|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
160497665|NCT00340704|579550737|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
160497666|NCT00340704|579550738|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
160497667|NCT00340704|579550739|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
160497668|NCT00340704|579550740|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
160497669|NCT01453023|579550741|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
160497670|NCT01453023|579550742|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
160497671|NCT01453023|579550741|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
160497672|NCT01453023|579550742|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
160497673|NCT01453023|579550741|FG000|Treatment Period 2|Protocol Violation|0|||
160497674|NCT01453023|579550742|FG001|Treatment Period 2|Protocol Violation|1|||
160497675|NCT03721172|579550751|FG000|Placebo-controlled Phase|Adverse Event|7|||
160497676|NCT03721172|579550752|FG001|Placebo-controlled Phase|Adverse Event|7|||
160497677|NCT03721172|579550753|FG002|Placebo-controlled Phase|Adverse Event|0|||
160497678|NCT03721172|579550751|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
160497679|NCT03721172|579550752|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
160497680|NCT03721172|579550753|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
160497681|NCT03721172|579550751|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
160497682|NCT03721172|579550752|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
160497683|NCT03721172|579550753|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
160497684|NCT03721172|579550751|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
160497685|NCT03721172|579550752|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
160497686|NCT03721172|579550753|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
160497687|NCT03721172|579550751|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
160497688|NCT03721172|579550752|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
160497689|NCT03721172|579550753|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
160497690|NCT03721172|579550751|FG000|Placebo-controlled Phase|Other|3|||
160497691|NCT03721172|579550752|FG001|Placebo-controlled Phase|Other|0|||
160497692|NCT03721172|579550753|FG002|Placebo-controlled Phase|Other|0|||
160497693|NCT03721172|579550751|FG000|Apremilast Extension Phase|Adverse Event|0|||
160618918|NCT04212221|579982049|FG005|Overall Study|Global Deterioration of Health Status|0|||
160618919|NCT04212221|579982050|FG006|Overall Study|Global Deterioration of Health Status|0|||
160618920|NCT04212221|579982051|FG007|Overall Study|Global Deterioration of Health Status|2|||
160497694|NCT03721172|579550752|FG001|Apremilast Extension Phase|Adverse Event|0|||
160497695|NCT03721172|579550753|FG002|Apremilast Extension Phase|Adverse Event|10|||
160497696|NCT03721172|579550751|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
160618921|NCT04212221|579982044|FG000|Overall Study|Investigator's Decision|0|||
160662063|NCT01185548|580145625|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
160662064|NCT00086996|580145626|FG000|Overall Study|Adverse Event|29|||
160662065|NCT00086996|580145626|FG000|Overall Study|Death|4|||
160662066|NCT00086996|580145626|FG000|Overall Study|progression/relapse|7|||
160662067|NCT00086996|580145626|FG000|Overall Study|Withdrawal by Subject|13|||
160662068|NCT00086996|580145626|FG000|Overall Study|Other|6|||
160662069|NCT00086996|580145626|FG000|Overall Study|not eligible|5|||
160662070|NCT01422538|580145628|FG000|Overall Study|Lost to Follow-up|0|||
160662071|NCT01422538|580145629|FG001|Overall Study|Lost to Follow-up|1|||
160662072|NCT01422538|580145630|FG002|Overall Study|Lost to Follow-up|1|||
160662073|NCT01422538|580145628|FG000|Overall Study|Missed visit|0|||
160662074|NCT01422538|580145629|FG001|Overall Study|Missed visit|1|||
160662075|NCT01422538|580145630|FG002|Overall Study|Missed visit|1|||
160662076|NCT00312663|580145631|FG000|Immunization Phase|Adverse Event|0|||
160662077|NCT00312663|580145632|FG001|Immunization Phase|Adverse Event|1|||
160662078|NCT00312663|580145633|FG002|Immunization Phase|Adverse Event|0|||
160662079|NCT01536405|580145634|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
160662080|NCT01536405|580145635|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
160662081|NCT01536405|580145634|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
160662082|NCT01536405|580145635|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
160662083|NCT01536405|580145634|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
160662084|NCT01536405|580145635|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
160662085|NCT01536405|580145634|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
160662086|NCT01536405|580145635|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
160662087|NCT01536405|580145634|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
160662088|NCT01536405|580145635|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
160662089|NCT01536405|580145634|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
160662090|NCT01536405|580145635|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
160662091|NCT01536405|580145634|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
160662092|NCT01536405|580145635|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
160662093|NCT01536405|580145634|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
160662094|NCT01536405|580145635|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
160662095|NCT01536405|580145634|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
160662096|NCT01536405|580145635|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
160662097|NCT01536405|580145634|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
160662098|NCT01536405|580145635|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
160662099|NCT01536405|580145634|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
160662100|NCT01536405|580145635|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
160662101|NCT01536405|580145634|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
160662102|NCT01536405|580145635|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
160662103|NCT01536405|580145634|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
160662104|NCT01536405|580145635|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
160662105|NCT00301366|580145636|FG000|Overall Study|Adverse Event|1|||
160662106|NCT01313273|580145637|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
160662107|NCT01313273|580145638|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
160662108|NCT01313273|580145637|FG000|Overall Study|Withdrawal by Subject|1|||
160662109|NCT01313273|580145638|FG001|Overall Study|Withdrawal by Subject|0|||
160662110|NCT01313273|580145637|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
160662111|NCT01313273|580145638|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
160662112|NCT02726581|580145639|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
160497697|NCT03721172|579550752|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
160497698|NCT03721172|579550753|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
160497699|NCT03721172|579550751|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
160497700|NCT03721172|579550752|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
160497701|NCT03721172|579550753|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
160497702|NCT03721172|579550751|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
160497703|NCT03721172|579550752|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
160497704|NCT03721172|579550753|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
160497705|NCT03721172|579550751|FG000|Apremilast Extension Phase|Protocol Violation|0|||
160497706|NCT03721172|579550752|FG001|Apremilast Extension Phase|Protocol Violation|0|||
160497707|NCT03721172|579550753|FG002|Apremilast Extension Phase|Protocol Violation|1|||
160497708|NCT03721172|579550751|FG000|Apremilast Extension Phase|Physician Decision|0|||
160497709|NCT03721172|579550752|FG001|Apremilast Extension Phase|Physician Decision|0|||
160497710|NCT03721172|579550753|FG002|Apremilast Extension Phase|Physician Decision|1|||
160497711|NCT03721172|579550751|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
160497712|NCT03721172|579550752|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
160497713|NCT03721172|579550753|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
160497714|NCT03721172|579550751|FG000|Apremilast Extension Phase|Other|0|||
160497715|NCT03721172|579550752|FG001|Apremilast Extension Phase|Other|0|||
160497716|NCT03721172|579550753|FG002|Apremilast Extension Phase|Other|3|||
160497717|NCT03721172|579550751|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
160497718|NCT03721172|579550752|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
160497719|NCT03721172|579550753|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
160497720|NCT05628285|579550756|FG000|Overall Study|Lost to Follow-up|1|||
160497721|NCT02339506|579550757|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
160497722|NCT02339506|579550758|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
160497723|NCT02339506|579550757|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
160497724|NCT02339506|579550758|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
160497725|NCT02869867|579550761|FG000|Overall Study|Protocol Violation|1|||
160497726|NCT02869867|579550762|FG001|Overall Study|Protocol Violation|0|||
160497727|NCT02869867|579550761|FG000|Overall Study|Lost to Follow-up|5|||
160497728|NCT02869867|579550762|FG001|Overall Study|Lost to Follow-up|5|||
160497729|NCT05218499|579550763|FG000|Overall Study|Not treated|1|||
160497730|NCT05218499|579550764|FG001|Overall Study|Not treated|1|||
160497731|NCT05218499|579550765|FG002|Overall Study|Not treated|8|||
160497732|NCT05218499|579550763|FG000|Overall Study|Death|2|||
160497733|NCT05218499|579550764|FG001|Overall Study|Death|0|||
160497734|NCT05218499|579550765|FG002|Overall Study|Death|0|||
160497735|NCT05218499|579550763|FG000|Overall Study|Other than listed|3|||
160497736|NCT05218499|579550764|FG001|Overall Study|Other than listed|7|||
160497737|NCT05218499|579550765|FG002|Overall Study|Other than listed|10|||
160497738|NCT05218499|579550763|FG000|Overall Study|Protocol deviation|5|||
160497739|NCT05218499|579550764|FG001|Overall Study|Protocol deviation|6|||
160497740|NCT05218499|579550765|FG002|Overall Study|Protocol deviation|4|||
160497741|NCT05218499|579550763|FG000|Overall Study|Technical problems|0|||
160497742|NCT05218499|579550764|FG001|Overall Study|Technical problems|1|||
160497743|NCT05218499|579550765|FG002|Overall Study|Technical problems|0|||
160497744|NCT05218499|579550763|FG000|Overall Study|Burden of trial procedures|0|||
160497745|NCT05218499|579550764|FG001|Overall Study|Burden of trial procedures|1|||
160497746|NCT05218499|579550765|FG002|Overall Study|Burden of trial procedures|2|||
160497747|NCT05218499|579550763|FG000|Overall Study|Clinical disease progression|6|||
160497748|NCT05218499|579550764|FG001|Overall Study|Clinical disease progression|6|||
160497749|NCT05218499|579550765|FG002|Overall Study|Clinical disease progression|11|||
160497750|NCT05218499|579550763|FG000|Overall Study|Objective disease progression|44|||
160497751|NCT05218499|579550764|FG001|Overall Study|Objective disease progression|61|||
160497752|NCT05218499|579550765|FG002|Overall Study|Objective disease progression|42|||
160497753|NCT05218499|579550763|FG000|Overall Study|Adverse Event|11|||
160497754|NCT05218499|579550764|FG001|Overall Study|Adverse Event|36|||
160497755|NCT05218499|579550765|FG002|Overall Study|Adverse Event|9|||
160497756|NCT05218499|579550763|FG000|Overall Study|On treatment at time of snapshot|18|||
160618922|NCT04212221|579982045|FG001|Overall Study|Investigator's Decision|0|||
160618923|NCT04212221|579982046|FG002|Overall Study|Investigator's Decision|0|||
160618924|NCT04212221|579982047|FG003|Overall Study|Investigator's Decision|1|||
160497757|NCT05218499|579550764|FG001|Overall Study|On treatment at time of snapshot|29|||
160497758|NCT05218499|579550765|FG002|Overall Study|On treatment at time of snapshot|0|||
160497759|NCT05555615|579550770|FG000|Overall Study|Adverse Event|7|||
160497760|NCT05555615|579550770|FG000|Overall Study|Lack of Efficacy|12|||
160497761|NCT05555615|579550770|FG000|Overall Study|Lost to Follow-up|10|||
160497762|NCT05555615|579550770|FG000|Overall Study|Noncompliance with study drug|5|||
160497763|NCT05555615|579550770|FG000|Overall Study|Physician Decision|2|||
160497764|NCT05555615|579550770|FG000|Overall Study|Study terminated by sponsor|80|||
160497765|NCT05555615|579550770|FG000|Overall Study|Prohibited medication use|2|||
160497766|NCT05555615|579550770|FG000|Overall Study|Withdrawal by Subject|20|||
160497767|NCT05555615|579550770|FG000|Overall Study|Not further specified|4|||
160618925|NCT04212221|579982048|FG004|Overall Study|Investigator's Decision|0|||
160497768|NCT02498236|579550774|FG000|Overall Study|Did not show for testing|1|||
160497769|NCT02498236|579550775|FG001|Overall Study|Did not show for testing|0|||
160497770|NCT02498236|579550776|FG002|Overall Study|Did not show for testing|0|||
160497771|NCT02498236|579550777|FG003|Overall Study|Did not show for testing|0|||
160497772|NCT02498236|579550778|FG004|Overall Study|Did not show for testing|0|||
160497773|NCT02498236|579550779|FG005|Overall Study|Did not show for testing|0|||
160497774|NCT02498236|579550780|FG006|Overall Study|Did not show for testing|0|||
160497775|NCT02498236|579550781|FG007|Overall Study|Did not show for testing|1|||
160497776|NCT02498236|579550774|FG000|Overall Study|Equipment failure|0|||
160497777|NCT02498236|579550775|FG001|Overall Study|Equipment failure|0|||
160497778|NCT02498236|579550776|FG002|Overall Study|Equipment failure|0|||
160497779|NCT02498236|579550777|FG003|Overall Study|Equipment failure|0|||
160497780|NCT02498236|579550778|FG004|Overall Study|Equipment failure|0|||
160497781|NCT02498236|579550779|FG005|Overall Study|Equipment failure|0|||
160497782|NCT02498236|579550780|FG006|Overall Study|Equipment failure|1|||
160497783|NCT02498236|579550781|FG007|Overall Study|Equipment failure|0|||
160497784|NCT02498236|579550774|FG000|Overall Study|Withdrawal by Subject|0|||
160497785|NCT02498236|579550775|FG001|Overall Study|Withdrawal by Subject|0|||
160497786|NCT02498236|579550776|FG002|Overall Study|Withdrawal by Subject|0|||
160497787|NCT02498236|579550777|FG003|Overall Study|Withdrawal by Subject|0|||
160497788|NCT02498236|579550778|FG004|Overall Study|Withdrawal by Subject|1|||
160497789|NCT02498236|579550779|FG005|Overall Study|Withdrawal by Subject|0|||
160497790|NCT02498236|579550780|FG006|Overall Study|Withdrawal by Subject|0|||
160497791|NCT02498236|579550781|FG007|Overall Study|Withdrawal by Subject|0|||
160497792|NCT03566979|579550783|FG000|Overall Study|Withdrawal by Subject|2|||
160497793|NCT03566979|579550784|FG001|Overall Study|Withdrawal by Subject|0|||
160618926|NCT04212221|579982049|FG005|Overall Study|Investigator's Decision|0|||
160618927|NCT04212221|579982050|FG006|Overall Study|Investigator's Decision|3|||
160618928|NCT04212221|579982051|FG007|Overall Study|Investigator's Decision|0|||
160618929|NCT04212221|579982044|FG000|Overall Study|Participant refused to continue treatment|0|||
160618930|NCT04212221|579982045|FG001|Overall Study|Participant refused to continue treatment|1|||
160618931|NCT04212221|579982046|FG002|Overall Study|Participant refused to continue treatment|0|||
160618932|NCT04212221|579982047|FG003|Overall Study|Participant refused to continue treatment|1|||
160618933|NCT04212221|579982048|FG004|Overall Study|Participant refused to continue treatment|1|||
160618934|NCT04212221|579982049|FG005|Overall Study|Participant refused to continue treatment|2|||
160618935|NCT04212221|579982050|FG006|Overall Study|Participant refused to continue treatment|4|||
160618936|NCT04212221|579982051|FG007|Overall Study|Participant refused to continue treatment|2|||
160618937|NCT04212221|579982044|FG000|Overall Study|Protocol Violation|0|||
160618938|NCT04212221|579982045|FG001|Overall Study|Protocol Violation|0|||
160618939|NCT04212221|579982046|FG002|Overall Study|Protocol Violation|0|||
160618940|NCT04212221|579982047|FG003|Overall Study|Protocol Violation|0|||
160618941|NCT04212221|579982048|FG004|Overall Study|Protocol Violation|0|||
160618942|NCT04212221|579982049|FG005|Overall Study|Protocol Violation|0|||
160618943|NCT04212221|579982050|FG006|Overall Study|Protocol Violation|0|||
160618944|NCT04212221|579982051|FG007|Overall Study|Protocol Violation|1|||
160618945|NCT02692560|579982056|FG000|Overall Study|Withdrawal by Subject|0|||
160618946|NCT02692560|579982057|FG001|Overall Study|Withdrawal by Subject|6|||
160618947|NCT00715949|579982060|FG000|Overall Study|could not finish first test|4|||
160618948|NCT02274766|579982061|FG000|Overall Study|Withdrawal by Subject|3|||
160618949|NCT02274766|579982062|FG001|Overall Study|Withdrawal by Subject|6|||
160618950|NCT02274766|579982061|FG000|Overall Study|Did Not Receive Study Drug|1|||
160618951|NCT02274766|579982062|FG001|Overall Study|Did Not Receive Study Drug|1|||
160618952|NCT02274766|579982061|FG000|Overall Study|Subject Unwilling to Proceed|0|||
160618953|NCT02274766|579982062|FG001|Overall Study|Subject Unwilling to Proceed|1|||
160618954|NCT02274766|579982061|FG000|Overall Study|Adverse Event|0|||
160618955|NCT02274766|579982062|FG001|Overall Study|Adverse Event|1|||
160618956|NCT01681836|579982065|FG000|Second Intervention|Withdrawal by Subject|0|||
160618957|NCT01681836|579982066|FG001|Second Intervention|Withdrawal by Subject|1|||
160618958|NCT01058356|579982078|FG000|Overall Study|Adverse Event|5|||
160618959|NCT01058356|579982078|FG000|Overall Study|Administration of contraindicated drugs|12|||
160618960|NCT01058356|579982078|FG000|Overall Study|Withdrawal by Subject|21|||
160618961|NCT01058356|579982078|FG000|Overall Study|Lost to Follow-up|4|||
160497794|NCT03566979|579550785|FG002|Overall Study|Withdrawal by Subject|1|||
160497795|NCT03566979|579550786|FG003|Overall Study|Withdrawal by Subject|1|||
160497796|NCT03566979|579550783|FG000|Overall Study|Lost to Follow-up|2|||
160497797|NCT03566979|579550784|FG001|Overall Study|Lost to Follow-up|7|||
160497798|NCT03566979|579550785|FG002|Overall Study|Lost to Follow-up|9|||
160497799|NCT03566979|579550786|FG003|Overall Study|Lost to Follow-up|5|||
160497800|NCT03566979|579550783|FG000|Overall Study|Adverse Event|1|||
160497801|NCT03566979|579550784|FG001|Overall Study|Adverse Event|0|||
160618962|NCT03480841|579982079|FG000|Overall Study|Lost to Follow-up|2|||
160618963|NCT00606021|579982082|FG000|Induction Phase|Death|73|||
160618964|NCT00606021|579982083|FG001|Induction Phase|Death|0|||
160618965|NCT00606021|579982084|FG002|Induction Phase|Death|0|||
160618966|NCT00606021|579982082|FG000|Induction Phase|Physician Decision|2|||
160618967|NCT00606021|579982083|FG001|Induction Phase|Physician Decision|0|||
160497802|NCT03566979|579550785|FG002|Overall Study|Adverse Event|0|||
160497803|NCT03566979|579550786|FG003|Overall Study|Adverse Event|0|||
160497804|NCT01255761|579550787|FG000|Overall Study|Adverse Event|29|||
160497805|NCT01255761|579550788|FG001|Overall Study|Adverse Event|43|||
160497806|NCT01255761|579550787|FG000|Overall Study|Lack of Efficacy|86|||
160497807|NCT01255761|579550788|FG001|Overall Study|Lack of Efficacy|74|||
160497808|NCT01255761|579550787|FG000|Overall Study|Protocol Violation|9|||
160497809|NCT01255761|579550788|FG001|Overall Study|Protocol Violation|5|||
160497810|NCT01255761|579550787|FG000|Overall Study|Lost to Follow-up|10|||
160497811|NCT01255761|579550788|FG001|Overall Study|Lost to Follow-up|8|||
160497812|NCT01255761|579550787|FG000|Overall Study|Withdrawal by Subject|11|||
160497813|NCT01255761|579550788|FG001|Overall Study|Withdrawal by Subject|27|||
160497814|NCT01255761|579550787|FG000|Overall Study|Other Reasons|37|||
160497815|NCT01255761|579550788|FG001|Overall Study|Other Reasons|18|||
160497816|NCT00658606|579550789|FG000|Overall Study|Adverse Event|2|||
160497817|NCT00658606|579550790|FG001|Overall Study|Adverse Event|1|||
160497818|NCT00658606|579550789|FG000|Overall Study|Lack of Efficacy|6|||
160497819|NCT00658606|579550790|FG001|Overall Study|Lack of Efficacy|3|||
160497820|NCT00658606|579550789|FG000|Overall Study|Lost to Follow-up|1|||
160497821|NCT00658606|579550790|FG001|Overall Study|Lost to Follow-up|0|||
160497822|NCT00658606|579550789|FG000|Overall Study|Withdrawal by Subject|7|||
160497823|NCT00658606|579550790|FG001|Overall Study|Withdrawal by Subject|16|||
160497824|NCT00658606|579550789|FG000|Overall Study|Lack of Compliance|0|||
160497825|NCT00658606|579550790|FG001|Overall Study|Lack of Compliance|3|||
160497826|NCT00486252|579550795|FG000|Overall Study|Adverse Event|7|||
160497827|NCT00486252|579550795|FG000|Overall Study|Lack of Efficacy|9|||
160497828|NCT00486252|579550795|FG000|Overall Study|Lost to Follow-up|24|||
160497829|NCT00486252|579550795|FG000|Overall Study|Other|18|||
160497830|NCT02559310|579550796|FG000|Overall Study|Death|4|||
160497831|NCT02559310|579550797|FG001|Overall Study|Death|3|||
160497832|NCT02559310|579550796|FG000|Overall Study|Lost to Follow-up|5|||
160497833|NCT02559310|579550797|FG001|Overall Study|Lost to Follow-up|3|||
160497834|NCT02559310|579550796|FG000|Overall Study|Physician Decision|2|||
160497835|NCT02559310|579550797|FG001|Overall Study|Physician Decision|1|||
160497836|NCT02559310|579550796|FG000|Overall Study|Withdrawal by Subject|13|||
160497837|NCT02559310|579550797|FG001|Overall Study|Withdrawal by Subject|9|||
160497838|NCT02559310|579550796|FG000|Overall Study|Sponsor Decision|0|||
160497839|NCT02559310|579550797|FG001|Overall Study|Sponsor Decision|1|||
160497840|NCT02559310|579550796|FG000|Overall Study|Randomized but not treated|3|||
160497841|NCT02559310|579550797|FG001|Overall Study|Randomized but not treated|2|||
160497842|NCT02633397|579550798|FG000|Overall Study|Adverse Event|8|||
160497843|NCT02633397|579550799|FG001|Overall Study|Adverse Event|8|||
160497844|NCT02633397|579550798|FG000|Overall Study|Study Burden|4|||
160497845|NCT02633397|579550799|FG001|Overall Study|Study Burden|1|||
160497846|NCT02633397|579550798|FG000|Overall Study|Treatment interruption|2|||
160497847|NCT02633397|579550799|FG001|Overall Study|Treatment interruption|5|||
160497848|NCT02633397|579550798|FG000|Overall Study|Death|2|||
160497849|NCT02633397|579550799|FG001|Overall Study|Death|2|||
160497850|NCT02633397|579550798|FG000|Overall Study|Physician Decision|0|||
160497851|NCT02633397|579550799|FG001|Overall Study|Physician Decision|1|||
160497852|NCT03595878|579550800|FG000|Overall Study|Death|2|||
160497853|NCT03595878|579550801|FG001|Overall Study|Death|1|||
160497854|NCT03595878|579550802|FG002|Overall Study|Death|0|||
160497855|NCT03595878|579550800|FG000|Overall Study|Disease progression|2|||
160497856|NCT03595878|579550801|FG001|Overall Study|Disease progression|1|||
160497857|NCT03595878|579550802|FG002|Overall Study|Disease progression|2|||
160497858|NCT03036124|579550805|FG000|Overall Study|Lost to Follow-up|0|||
160497859|NCT03036124|579550806|FG001|Overall Study|Lost to Follow-up|2|||
160497860|NCT03036124|579550805|FG000|Overall Study|Withdrawal by Subject|5|||
160497861|NCT03036124|579550806|FG001|Overall Study|Withdrawal by Subject|4|||
160497862|NCT02282059|579550807|FG000|Overall Study|Other|15|||
160497863|NCT02282059|579550808|FG001|Overall Study|Other|3|||
160497864|NCT02282059|579550807|FG000|Overall Study|Participant refused further follow-up|8|||
160497865|NCT02282059|579550808|FG001|Overall Study|Participant refused further follow-up|4|||
160497866|NCT02282059|579550807|FG000|Overall Study|Lost to Follow-up|19|||
160497867|NCT02282059|579550808|FG001|Overall Study|Lost to Follow-up|3|||
160497868|NCT02282059|579550807|FG000|Overall Study|Death|40|||
160497869|NCT02282059|579550808|FG001|Overall Study|Death|8|||
160497870|NCT00127842|579552750|FG000|Overall Study|Adverse Event|15|||
160497871|NCT00127842|579552750|FG000|Overall Study|Withdrawal by Subject|3|||
160497872|NCT00127842|579552750|FG000|Overall Study|Lost to Follow-up|1|||
160497873|NCT00127842|579552750|FG000|Overall Study|Lack of Efficacy|12|||
160497874|NCT00127842|579552750|FG000|Overall Study|Noncompliance|2|||
160497875|NCT00127842|579552750|FG000|Overall Study|Protocol Violation|1|||
160497876|NCT00127842|579552750|FG000|Overall Study|Other|5|||
160497877|NCT01443403|579552751|FG000|Overall Study|Adverse Event|1|||
160497878|NCT01443403|579552752|FG001|Overall Study|Adverse Event|1|||
160497879|NCT01443403|579552753|FG002|Overall Study|Adverse Event|4|||
160497880|NCT01443403|579552754|FG003|Overall Study|Adverse Event|5|||
160497881|NCT01443403|579552751|FG000|Overall Study|Withdrawal by Subject|0|||
160497882|NCT01443403|579552752|FG001|Overall Study|Withdrawal by Subject|1|||
160497883|NCT01443403|579552753|FG002|Overall Study|Withdrawal by Subject|2|||
160497884|NCT01443403|579552754|FG003|Overall Study|Withdrawal by Subject|1|||
160497885|NCT01443403|579552751|FG000|Overall Study|Lost to Follow-up|0|||
160497886|NCT01443403|579552752|FG001|Overall Study|Lost to Follow-up|0|||
160497887|NCT01443403|579552753|FG002|Overall Study|Lost to Follow-up|0|||
160497888|NCT01443403|579552754|FG003|Overall Study|Lost to Follow-up|1|||
160497889|NCT01443403|579552751|FG000|Overall Study|Protocol Violation|2|||
160497890|NCT01443403|579552752|FG001|Overall Study|Protocol Violation|1|||
160497891|NCT01443403|579552753|FG002|Overall Study|Protocol Violation|1|||
160497892|NCT01443403|579552754|FG003|Overall Study|Protocol Violation|1|||
160497893|NCT01443403|579552751|FG000|Overall Study|Use of Prohibited Treatment|2|||
160497894|NCT01443403|579552752|FG001|Overall Study|Use of Prohibited Treatment|3|||
160497895|NCT01443403|579552753|FG002|Overall Study|Use of Prohibited Treatment|0|||
160497896|NCT01443403|579552754|FG003|Overall Study|Use of Prohibited Treatment|0|||
160618968|NCT00606021|579982084|FG002|Induction Phase|Physician Decision|0|||
160618969|NCT00606021|579982082|FG000|Induction Phase|Withdrawal by Subject|2|||
160618970|NCT00606021|579982083|FG001|Induction Phase|Withdrawal by Subject|0|||
160618971|NCT00606021|579982084|FG002|Induction Phase|Withdrawal by Subject|0|||
160618972|NCT00606021|579982082|FG000|Induction Phase|Lost to Follow-up|10|||
160618973|NCT00606021|579982083|FG001|Induction Phase|Lost to Follow-up|0|||
160618974|NCT00606021|579982084|FG002|Induction Phase|Lost to Follow-up|0|||
160618975|NCT00606021|579982082|FG000|Maintenance Phase|Death|0|||
160618976|NCT00606021|579982083|FG001|Maintenance Phase|Death|17|||
160618977|NCT00606021|579982084|FG002|Maintenance Phase|Death|15|||
160618978|NCT00606021|579982082|FG000|Maintenance Phase|Physician Decision|0|||
160618979|NCT00606021|579982083|FG001|Maintenance Phase|Physician Decision|1|||
160618980|NCT00606021|579982084|FG002|Maintenance Phase|Physician Decision|0|||
160618981|NCT00606021|579982082|FG000|Maintenance Phase|Lost to Follow-up|0|||
160618982|NCT00606021|579982083|FG001|Maintenance Phase|Lost to Follow-up|5|||
160618983|NCT00606021|579982084|FG002|Maintenance Phase|Lost to Follow-up|2|||
160618984|NCT01362049|579982085|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
160618985|NCT01362049|579982086|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
160618986|NCT01362049|579982087|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
160618987|NCT01362049|579982088|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
160618988|NCT01362049|579982085|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
160618989|NCT01362049|579982086|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
160618990|NCT01362049|579982087|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
160618991|NCT01362049|579982088|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
160618992|NCT00806494|579982092|FG000|Overall Study|Adverse Event|29|||
160618993|NCT00806494|579982092|FG000|Overall Study|Lack of Efficacy|6|||
160618994|NCT00806494|579982092|FG000|Overall Study|Lost to Follow-up|10|||
160618995|NCT00806494|579982092|FG000|Overall Study|Other|30|||
160618996|NCT00806494|579982092|FG000|Overall Study|Withdrawal by Subject|5|||
160618997|NCT02417935|579982093|FG000|Treatment Period|Adverse Event|12|||
160618998|NCT02417935|579982094|FG001|Treatment Period|Adverse Event|10|||
160618999|NCT02417935|579982093|FG000|Treatment Period|Lost to Follow-up|1|||
160619000|NCT02417935|579982094|FG001|Treatment Period|Lost to Follow-up|0|||
160619001|NCT02417935|579982093|FG000|Treatment Period|Entry Criteria not met|0|||
160619002|NCT02417935|579982094|FG001|Treatment Period|Entry Criteria not met|1|||
160619003|NCT02417935|579982093|FG000|Treatment Period|Protocol Violation|2|||
160619004|NCT02417935|579982094|FG001|Treatment Period|Protocol Violation|1|||
160619005|NCT02417935|579982093|FG000|Treatment Period|Withdrawal by Subject|3|||
160619006|NCT02417935|579982094|FG001|Treatment Period|Withdrawal by Subject|3|||
160619007|NCT02417935|579982093|FG000|Treatment Period|Physician Decision|3|||
160619008|NCT02417935|579982094|FG001|Treatment Period|Physician Decision|1|||
160619009|NCT02850276|579982097|FG000|Overall Study|screen failure|43|||
160619010|NCT02850276|579982097|FG000|Overall Study|Withdrawal by Subject|14|||
160619011|NCT02850276|579982097|FG000|Overall Study|Physician Decision|2|||
160619012|NCT02850276|579982097|FG000|Overall Study|Lost to Follow-up|2|||
160619013|NCT04815291|579982098|FG000|Overall Study|Lost to Follow-up|1|||
160619014|NCT04815291|579982098|FG000|Overall Study|Physician Decision|4|||
160619015|NCT04815291|579982098|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
160619016|NCT00095836|579982101|FG000|Overall Study|Lost to Follow-up|1|||
160619017|NCT00095836|579982101|FG000|Overall Study|Adverse Event|1|||
160497897|NCT01443403|579552751|FG000|Overall Study|Other - Miscellaneous|1|||
160497898|NCT01443403|579552752|FG001|Overall Study|Other - Miscellaneous|0|||
160619018|NCT00095836|579982101|FG000|Overall Study|Death|2|||
160497899|NCT01443403|579552753|FG002|Overall Study|Other - Miscellaneous|0|||
160497900|NCT01443403|579552754|FG003|Overall Study|Other - Miscellaneous|1|||
160497901|NCT03595124|579552755|FG000|Overall Study|Physician Decision|1|||
160619019|NCT00989664|579982102|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
160619020|NCT00989664|579982102|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
160619021|NCT00989664|579982102|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
160619022|NCT00989664|579982102|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
160619023|NCT00989664|579982102|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
160497902|NCT03595124|579552756|FG001|Overall Study|Physician Decision|1|||
160662113|NCT02726581|580145640|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
160662114|NCT02726581|580145641|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
160497903|NCT03595124|579552757|FG002|Overall Study|Physician Decision|1|||
160497904|NCT03595124|579552755|FG000|Overall Study|Ineligible|1|||
160497905|NCT03595124|579552756|FG001|Overall Study|Ineligible|1|||
160497906|NCT03595124|579552757|FG002|Overall Study|Ineligible|0|||
160497907|NCT03595124|579552755|FG000|Overall Study|Disease Progression|4|||
160497908|NCT03595124|579552756|FG001|Overall Study|Disease Progression|1|||
160497909|NCT03595124|579552757|FG002|Overall Study|Disease Progression|4|||
160497910|NCT04832971|579552758|FG000|Double-Blind (DB) Treatment Period|Death|1|||
160497911|NCT04832971|579552759|FG001|Double-Blind (DB) Treatment Period|Death|0|||
160497912|NCT04832971|579552760|FG002|Double-Blind (DB) Treatment Period|Death|0|||
160497913|NCT04832971|579552761|FG003|Double-Blind (DB) Treatment Period|Death|0|||
160497914|NCT04832971|579552762|FG004|Double-Blind (DB) Treatment Period|Death|0|||
160497915|NCT04832971|579552763|FG005|Double-Blind (DB) Treatment Period|Death|0|||
160497916|NCT04832971|579552764|FG006|Double-Blind (DB) Treatment Period|Death|0|||
160497917|NCT04832971|579552765|FG007|Double-Blind (DB) Treatment Period|Death|0|||
160497918|NCT04832971|579552766|FG008|Double-Blind (DB) Treatment Period|Death|0|||
160497919|NCT04832971|579552767|FG009|Double-Blind (DB) Treatment Period|Death|0|||
160497920|NCT04832971|579552758|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
160497921|NCT04832971|579552759|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
160497922|NCT04832971|579552760|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
160497923|NCT04832971|579552761|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160497924|NCT04832971|579552762|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160497925|NCT04832971|579552763|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160497926|NCT04832971|579552764|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160497927|NCT04832971|579552765|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160497928|NCT04832971|579552766|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160497929|NCT04832971|579552767|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160497930|NCT04832971|579552758|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
160497931|NCT04832971|579552759|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
160497932|NCT04832971|579552760|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
160497933|NCT04832971|579552761|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
160497934|NCT04832971|579552762|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160497935|NCT04832971|579552763|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160497936|NCT04832971|579552764|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160497937|NCT04832971|579552765|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160497938|NCT04832971|579552766|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160497939|NCT04832971|579552767|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160497940|NCT04832971|579552758|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
160497941|NCT04832971|579552759|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
160497942|NCT04832971|579552760|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
160497943|NCT04832971|579552761|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
160497944|NCT04832971|579552762|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
160662115|NCT02726581|580145639|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
160662116|NCT02726581|580145640|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
160662117|NCT02726581|580145641|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
160662118|NCT02726581|580145639|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
160662119|NCT02726581|580145640|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160662120|NCT02726581|580145641|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160662121|NCT02726581|580145639|FG000|Treatment Period|Disease progression|47|||
160662122|NCT02726581|580145640|FG001|Treatment Period|Disease progression|50|||
160662123|NCT02726581|580145641|FG002|Treatment Period|Disease progression|16|||
160662124|NCT02726581|580145639|FG000|Treatment Period|Other reasons|9|||
160662125|NCT02726581|580145640|FG001|Treatment Period|Other reasons|8|||
160497945|NCT04832971|579552763|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
160497946|NCT04832971|579552764|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
160497947|NCT04832971|579552765|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
160497948|NCT04832971|579552766|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
160662126|NCT02726581|580145641|FG002|Treatment Period|Other reasons|2|||
160662127|NCT02726581|580145639|FG000|Treatment Period|Study drug toxicity|6|||
160662128|NCT02726581|580145640|FG001|Treatment Period|Study drug toxicity|3|||
160662129|NCT02726581|580145641|FG002|Treatment Period|Study drug toxicity|2|||
160662130|NCT02726581|580145639|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
160662131|NCT02726581|580145640|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
160497949|NCT04832971|579552767|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
160497950|NCT04832971|579552758|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
160662132|NCT02726581|580145641|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
160497951|NCT04832971|579552759|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
160497952|NCT04832971|579552760|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
160497953|NCT04832971|579552761|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
160497954|NCT04832971|579552762|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
160497955|NCT04832971|579552763|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
160497956|NCT04832971|579552764|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
160497957|NCT04832971|579552765|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
160497958|NCT04832971|579552766|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
160497959|NCT04832971|579552767|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
160497960|NCT04832971|579552758|FG000|Open-Label Extension (OLE) Period|Death|0|||
160497961|NCT04832971|579552759|FG001|Open-Label Extension (OLE) Period|Death|0|||
160497962|NCT04832971|579552760|FG002|Open-Label Extension (OLE) Period|Death|0|||
160497963|NCT04832971|579552761|FG003|Open-Label Extension (OLE) Period|Death|0|||
160497964|NCT04832971|579552762|FG004|Open-Label Extension (OLE) Period|Death|0|||
160497965|NCT04832971|579552763|FG005|Open-Label Extension (OLE) Period|Death|0|||
160497966|NCT04832971|579552764|FG006|Open-Label Extension (OLE) Period|Death|0|||
160497967|NCT04832971|579552765|FG007|Open-Label Extension (OLE) Period|Death|1|||
160497968|NCT04832971|579552766|FG008|Open-Label Extension (OLE) Period|Death|0|||
160497969|NCT04832971|579552767|FG009|Open-Label Extension (OLE) Period|Death|0|||
160497970|NCT04832971|579552758|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160497971|NCT04832971|579552759|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160497972|NCT04832971|579552760|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160497973|NCT04832971|579552761|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160497974|NCT04832971|579552762|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160497975|NCT04832971|579552763|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160497976|NCT04832971|579552764|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
160497977|NCT04832971|579552765|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
160497978|NCT04832971|579552766|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160497979|NCT04832971|579552767|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160497980|NCT04832971|579552758|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
160497981|NCT04832971|579552759|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
160497982|NCT04832971|579552760|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
160497983|NCT04832971|579552761|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
160497984|NCT04832971|579552762|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
160497985|NCT04832971|579552763|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
160497986|NCT04832971|579552764|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
160497987|NCT04832971|579552765|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
160497988|NCT04832971|579552766|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
160497989|NCT04832971|579552767|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
160497990|NCT04832971|579552758|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160497991|NCT04832971|579552759|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160497992|NCT04832971|579552760|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160497993|NCT04832971|579552761|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160497994|NCT04832971|579552762|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
160497995|NCT04832971|579552763|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
160497996|NCT04832971|579552764|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160497997|NCT04832971|579552765|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
160497998|NCT04832971|579552766|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
160497999|NCT04832971|579552767|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
160498000|NCT04832971|579552758|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
160498001|NCT04832971|579552759|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
160498002|NCT04832971|579552760|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
160498003|NCT04832971|579552761|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
160498004|NCT04832971|579552762|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
160498005|NCT04832971|579552763|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
160498006|NCT04832971|579552764|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
160498007|NCT04832971|579552765|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
160498008|NCT04832971|579552766|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
160619024|NCT00989664|579982102|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
160619025|NCT00989664|579982102|FG000|Long-Term Follow-Up|Death|3|||
160619026|NCT00962780|579982106|FG000|Overall Study|Death|0|||
160619027|NCT00962780|579982107|FG001|Overall Study|Death|1|||
160619028|NCT00962780|579982106|FG000|Overall Study|Protocol Violation|9|||
160619029|NCT00962780|579982107|FG001|Overall Study|Protocol Violation|4|||
160619030|NCT00962780|579982106|FG000|Overall Study|Withdrawal by Subject|1|||
160498009|NCT04832971|579552767|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
160498010|NCT04024462|579552768|FG000|Overall Study|Withdrawal by Subject|6|||
160619031|NCT00962780|579982107|FG001|Overall Study|Withdrawal by Subject|8|||
160498011|NCT04024462|579552769|FG001|Overall Study|Withdrawal by Subject|7|||
160498012|NCT04024462|579552768|FG000|Overall Study|Progressive Disease|0|||
160498013|NCT04024462|579552769|FG001|Overall Study|Progressive Disease|1|||
160498014|NCT04024462|579552768|FG000|Overall Study|Adverse Event|0|||
160498015|NCT04024462|579552769|FG001|Overall Study|Adverse Event|1|||
160498016|NCT04024462|579552768|FG000|Overall Study|Death|0|||
160498017|NCT04024462|579552769|FG001|Overall Study|Death|1|||
160498018|NCT04024462|579552768|FG000|Overall Study|Lost to Follow-up|1|||
160498019|NCT04024462|579552769|FG001|Overall Study|Lost to Follow-up|0|||
160498020|NCT04024462|579552768|FG000|Overall Study|Ongoing in the Study|94|||
160498021|NCT04024462|579552769|FG001|Overall Study|Ongoing in the Study|89|||
160498022|NCT00983749|579552774|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
160498023|NCT00983749|579552775|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
160498024|NCT02906020|579552776|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
160498025|NCT02906020|579552777|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
160498026|NCT02906020|579552778|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
160498027|NCT02906020|579552779|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
160498028|NCT02906020|579552780|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
160498029|NCT02906020|579552781|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
160498030|NCT02906020|579552782|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
160498031|NCT02906020|579552783|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
160498032|NCT02906020|579552784|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
160498033|NCT02906020|579552785|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
160498034|NCT02906020|579552786|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
160498035|NCT02906020|579552787|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
160498036|NCT02906020|579552788|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
160498037|NCT02906020|579552789|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
160498038|NCT02906020|579552790|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
160498039|NCT02906020|579552791|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
160498040|NCT02906020|579552776|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498041|NCT02906020|579552777|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498042|NCT02906020|579552778|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498043|NCT02906020|579552779|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498044|NCT02906020|579552780|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498045|NCT02906020|579552781|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498046|NCT02906020|579552782|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498047|NCT02906020|579552783|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498048|NCT02906020|579552784|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
160498049|NCT02906020|579552785|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
160498050|NCT02906020|579552786|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498051|NCT02906020|579552787|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498052|NCT02906020|579552788|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498053|NCT02906020|579552789|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498054|NCT02906020|579552790|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498055|NCT02906020|579552791|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
160498056|NCT02906020|579552776|FG000|Part 2: Double-blind Treatment Period|Other|0|||
160498057|NCT02906020|579552777|FG001|Part 2: Double-blind Treatment Period|Other|0|||
160498058|NCT02906020|579552778|FG002|Part 2: Double-blind Treatment Period|Other|0|||
160498059|NCT02906020|579552779|FG003|Part 2: Double-blind Treatment Period|Other|0|||
160498060|NCT02906020|579552780|FG004|Part 2: Double-blind Treatment Period|Other|0|||
160498061|NCT02906020|579552781|FG005|Part 2: Double-blind Treatment Period|Other|0|||
160498062|NCT02906020|579552782|FG006|Part 2: Double-blind Treatment Period|Other|0|||
160498063|NCT02906020|579552783|FG007|Part 2: Double-blind Treatment Period|Other|0|||
160498064|NCT02906020|579552784|FG008|Part 2: Double-blind Treatment Period|Other|6|||
160498065|NCT02906020|579552785|FG009|Part 2: Double-blind Treatment Period|Other|10|||
160498066|NCT02906020|579552786|FG010|Part 2: Double-blind Treatment Period|Other|0|||
160498067|NCT02906020|579552787|FG011|Part 2: Double-blind Treatment Period|Other|0|||
160498068|NCT02906020|579552788|FG012|Part 2: Double-blind Treatment Period|Other|0|||
160498069|NCT02906020|579552789|FG013|Part 2: Double-blind Treatment Period|Other|0|||
160498070|NCT02906020|579552790|FG014|Part 2: Double-blind Treatment Period|Other|0|||
160498071|NCT02906020|579552791|FG015|Part 2: Double-blind Treatment Period|Other|0|||
160498072|NCT02906020|579552776|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498073|NCT02906020|579552777|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498074|NCT02906020|579552778|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498075|NCT02906020|579552779|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498076|NCT02906020|579552780|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498077|NCT02906020|579552781|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498078|NCT02906020|579552782|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498079|NCT02906020|579552783|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498080|NCT02906020|579552784|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498081|NCT02906020|579552785|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498082|NCT02906020|579552786|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498083|NCT02906020|579552787|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498084|NCT02906020|579552788|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
160498085|NCT02906020|579552789|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
160498086|NCT02906020|579552790|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498087|NCT02906020|579552791|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
160498088|NCT02906020|579552776|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498089|NCT02906020|579552777|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498090|NCT02906020|579552778|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498091|NCT02906020|579552779|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498092|NCT02906020|579552780|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498093|NCT02906020|579552781|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498094|NCT02906020|579552782|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498095|NCT02906020|579552783|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498096|NCT02906020|579552784|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498097|NCT02906020|579552785|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498098|NCT02906020|579552786|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498099|NCT02906020|579552787|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498100|NCT02906020|579552788|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
160498101|NCT02906020|579552789|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
160498102|NCT02906020|579552790|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
160498103|NCT02906020|579552791|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
160498104|NCT02906020|579552776|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498105|NCT02906020|579552777|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498106|NCT02906020|579552778|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498107|NCT02906020|579552779|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498108|NCT02906020|579552780|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498109|NCT02906020|579552781|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498110|NCT02906020|579552782|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498111|NCT02906020|579552783|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498112|NCT02906020|579552784|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498113|NCT02906020|579552785|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498114|NCT02906020|579552786|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498115|NCT02906020|579552787|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498116|NCT02906020|579552788|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
160498117|NCT02906020|579552789|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
160498118|NCT02906020|579552790|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498119|NCT02906020|579552791|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
160498120|NCT02906020|579552776|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498121|NCT02906020|579552777|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498122|NCT02906020|579552778|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160619032|NCT00962780|579982106|FG000|Overall Study|Other|0|||
160619033|NCT00962780|579982107|FG001|Overall Study|Other|1|||
160619034|NCT02646332|579982108|FG000|Overall Study|Lost to Follow-up|0|||
160619035|NCT02646332|579982109|FG001|Overall Study|Lost to Follow-up|3|||
160619036|NCT02363322|579982110|FG000|Overall Study|Lost to Follow-up|1|||
160619037|NCT02363322|579982111|FG001|Overall Study|Lost to Follow-up|0|||
160619038|NCT01775995|579982112|FG000|Overall Study|Lost to Follow-up|1|||
160619039|NCT01775995|579982113|FG001|Overall Study|Lost to Follow-up|1|||
160619040|NCT02909504|579982114|FG000|Overall Study|Adverse Event|2|||
160619041|NCT02909504|579982114|FG000|Overall Study|Lack of Efficacy|3|||
160619042|NCT02909504|579982114|FG000|Overall Study|Withdrawal by Subject|4|||
160619043|NCT02909504|579982114|FG000|Overall Study|Pregnancy|1|||
160619044|NCT02909504|579982114|FG000|Overall Study|Subject moved|1|||
160619045|NCT02909504|579982114|FG000|Overall Study|Lost to Follow-up|1|||
160619046|NCT02055976|579982115|FG000|Overall Study|Other|0|||
160619047|NCT02055976|579982116|FG001|Overall Study|Other|0|||
160619048|NCT02055976|579982117|FG002|Overall Study|Other|1|||
160619049|NCT02055976|579982118|FG003|Overall Study|Other|0|||
160619050|NCT02055976|579982119|FG004|Overall Study|Other|0|||
160619051|NCT02055976|579982120|FG005|Overall Study|Other|0|||
160619052|NCT02055976|579982121|FG006|Overall Study|Other|0|||
160619053|NCT02055976|579982122|FG007|Overall Study|Other|0|||
160619054|NCT02055976|579982123|FG008|Overall Study|Other|0|||
160619055|NCT02055976|579982115|FG000|Overall Study|Adverse Event|0|||
160619056|NCT02055976|579982116|FG001|Overall Study|Adverse Event|0|||
160619057|NCT02055976|579982117|FG002|Overall Study|Adverse Event|0|||
160619058|NCT02055976|579982118|FG003|Overall Study|Adverse Event|0|||
160619059|NCT02055976|579982119|FG004|Overall Study|Adverse Event|0|||
160619060|NCT02055976|579982120|FG005|Overall Study|Adverse Event|1|||
160619061|NCT02055976|579982121|FG006|Overall Study|Adverse Event|1|||
160498123|NCT02906020|579552779|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498124|NCT02906020|579552780|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498125|NCT02906020|579552781|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498126|NCT02906020|579552782|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498127|NCT02906020|579552783|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498128|NCT02906020|579552784|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498129|NCT02906020|579552785|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498130|NCT02906020|579552786|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498131|NCT02906020|579552787|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498132|NCT02906020|579552788|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
160498133|NCT02906020|579552789|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
160498134|NCT02906020|579552790|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498135|NCT02906020|579552791|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
160498136|NCT02906020|579552776|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498137|NCT02906020|579552777|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498138|NCT02906020|579552778|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498139|NCT02906020|579552779|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498140|NCT02906020|579552780|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498141|NCT02906020|579552781|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498142|NCT02906020|579552782|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498143|NCT02906020|579552783|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498144|NCT02906020|579552784|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498145|NCT02906020|579552785|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498146|NCT02906020|579552786|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498147|NCT02906020|579552787|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
160498148|NCT02906020|579552788|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
160498149|NCT02906020|579552789|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
160498150|NCT02906020|579552790|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
160498151|NCT02906020|579552791|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
160498152|NCT02906020|579552776|FG000|Part 2: Long-term Follow-up Period|Other|0|||
160498153|NCT02906020|579552777|FG001|Part 2: Long-term Follow-up Period|Other|0|||
160498154|NCT02906020|579552778|FG002|Part 2: Long-term Follow-up Period|Other|0|||
160498155|NCT02906020|579552779|FG003|Part 2: Long-term Follow-up Period|Other|0|||
160498156|NCT02906020|579552780|FG004|Part 2: Long-term Follow-up Period|Other|0|||
160498157|NCT02906020|579552781|FG005|Part 2: Long-term Follow-up Period|Other|0|||
160498158|NCT02906020|579552782|FG006|Part 2: Long-term Follow-up Period|Other|0|||
160498159|NCT02906020|579552783|FG007|Part 2: Long-term Follow-up Period|Other|0|||
160498160|NCT02906020|579552784|FG008|Part 2: Long-term Follow-up Period|Other|0|||
160498161|NCT02906020|579552785|FG009|Part 2: Long-term Follow-up Period|Other|0|||
160498162|NCT02906020|579552786|FG010|Part 2: Long-term Follow-up Period|Other|0|||
160498163|NCT02906020|579552787|FG011|Part 2: Long-term Follow-up Period|Other|0|||
160498164|NCT02906020|579552788|FG012|Part 2: Long-term Follow-up Period|Other|13|||
160498165|NCT02906020|579552789|FG013|Part 2: Long-term Follow-up Period|Other|8|||
160498166|NCT02906020|579552790|FG014|Part 2: Long-term Follow-up Period|Other|3|||
160498167|NCT02906020|579552791|FG015|Part 2: Long-term Follow-up Period|Other|2|||
160498168|NCT03377361|579552802|FG000|Pre-Treatment|Subject withdrew consent|0|||
160498169|NCT03377361|579552803|FG001|Pre-Treatment|Subject withdrew consent|0|||
160498170|NCT03377361|579552804|FG002|Pre-Treatment|Subject withdrew consent|0|||
160498171|NCT03377361|579552805|FG003|Pre-Treatment|Subject withdrew consent|0|||
160498172|NCT03377361|579552806|FG004|Pre-Treatment|Subject withdrew consent|0|||
160498173|NCT03377361|579552807|FG005|Pre-Treatment|Subject withdrew consent|0|||
160498174|NCT03377361|579552808|FG006|Pre-Treatment|Subject withdrew consent|0|||
160498175|NCT03377361|579552809|FG007|Pre-Treatment|Subject withdrew consent|3|||
160498176|NCT03377361|579552810|FG008|Pre-Treatment|Subject withdrew consent|1|||
160498177|NCT03377361|579552811|FG009|Pre-Treatment|Subject withdrew consent|0|||
160498178|NCT03377361|579552802|FG000|Pre-Treatment|Not Reported|0|||
160498179|NCT03377361|579552803|FG001|Pre-Treatment|Not Reported|0|||
160498180|NCT03377361|579552804|FG002|Pre-Treatment|Not Reported|0|||
160498181|NCT03377361|579552805|FG003|Pre-Treatment|Not Reported|0|||
160498182|NCT03377361|579552806|FG004|Pre-Treatment|Not Reported|0|||
160498183|NCT03377361|579552807|FG005|Pre-Treatment|Not Reported|0|||
160498184|NCT03377361|579552808|FG006|Pre-Treatment|Not Reported|0|||
160498185|NCT03377361|579552809|FG007|Pre-Treatment|Not Reported|0|||
160498186|NCT03377361|579552810|FG008|Pre-Treatment|Not Reported|3|||
160498187|NCT03377361|579552811|FG009|Pre-Treatment|Not Reported|0|||
160498188|NCT03377361|579552802|FG000|Treatment Period|Disease Progression|3|||
160498189|NCT03377361|579552803|FG001|Treatment Period|Disease Progression|2|||
160498190|NCT03377361|579552804|FG002|Treatment Period|Disease Progression|5|||
160498191|NCT03377361|579552805|FG003|Treatment Period|Disease Progression|3|||
160498192|NCT03377361|579552806|FG004|Treatment Period|Disease Progression|3|||
160498193|NCT03377361|579552807|FG005|Treatment Period|Disease Progression|3|||
160498194|NCT03377361|579552808|FG006|Treatment Period|Disease Progression|6|||
160498195|NCT03377361|579552809|FG007|Treatment Period|Disease Progression|106|||
160498196|NCT03377361|579552810|FG008|Treatment Period|Disease Progression|48|||
160498197|NCT03377361|579552811|FG009|Treatment Period|Disease Progression|59|||
160498198|NCT03377361|579552802|FG000|Treatment Period|Study Drug Toxicity|0|||
160498199|NCT03377361|579552803|FG001|Treatment Period|Study Drug Toxicity|0|||
160498200|NCT03377361|579552804|FG002|Treatment Period|Study Drug Toxicity|0|||
160498201|NCT03377361|579552805|FG003|Treatment Period|Study Drug Toxicity|1|||
160498202|NCT03377361|579552806|FG004|Treatment Period|Study Drug Toxicity|0|||
160498203|NCT03377361|579552807|FG005|Treatment Period|Study Drug Toxicity|0|||
160498204|NCT03377361|579552808|FG006|Treatment Period|Study Drug Toxicity|0|||
160498205|NCT03377361|579552809|FG007|Treatment Period|Study Drug Toxicity|7|||
160498206|NCT03377361|579552810|FG008|Treatment Period|Study Drug Toxicity|2|||
160498207|NCT03377361|579552811|FG009|Treatment Period|Study Drug Toxicity|16|||
160498208|NCT03377361|579552802|FG000|Treatment Period|Death|0|||
160498209|NCT03377361|579552803|FG001|Treatment Period|Death|0|||
160498210|NCT03377361|579552804|FG002|Treatment Period|Death|1|||
160498211|NCT03377361|579552805|FG003|Treatment Period|Death|0|||
160498212|NCT03377361|579552806|FG004|Treatment Period|Death|0|||
160498213|NCT03377361|579552807|FG005|Treatment Period|Death|0|||
160498214|NCT03377361|579552808|FG006|Treatment Period|Death|0|||
160498215|NCT03377361|579552809|FG007|Treatment Period|Death|2|||
160498216|NCT03377361|579552810|FG008|Treatment Period|Death|1|||
160498217|NCT03377361|579552811|FG009|Treatment Period|Death|3|||
160498218|NCT03377361|579552802|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
160498219|NCT03377361|579552803|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
160498220|NCT03377361|579552804|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
160498221|NCT03377361|579552805|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
160498222|NCT03377361|579552806|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
160498223|NCT03377361|579552807|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
160498224|NCT03377361|579552808|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
160498225|NCT03377361|579552809|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
160498226|NCT03377361|579552810|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
160498227|NCT03377361|579552811|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
160498228|NCT03377361|579552802|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
160498229|NCT03377361|579552803|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
160498230|NCT03377361|579552804|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
160498231|NCT03377361|579552805|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
160498232|NCT03377361|579552806|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
160498233|NCT03377361|579552807|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
160498234|NCT03377361|579552808|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
160498235|NCT03377361|579552809|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
160498236|NCT03377361|579552810|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
160498237|NCT03377361|579552811|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
160498238|NCT03377361|579552802|FG000|Treatment Period|Subject Withdrew Consent|0|||
160498239|NCT03377361|579552803|FG001|Treatment Period|Subject Withdrew Consent|0|||
160498240|NCT03377361|579552804|FG002|Treatment Period|Subject Withdrew Consent|0|||
160498241|NCT03377361|579552805|FG003|Treatment Period|Subject Withdrew Consent|0|||
160498242|NCT03377361|579552806|FG004|Treatment Period|Subject Withdrew Consent|0|||
160498243|NCT03377361|579552807|FG005|Treatment Period|Subject Withdrew Consent|0|||
160498244|NCT03377361|579552808|FG006|Treatment Period|Subject Withdrew Consent|0|||
160498245|NCT03377361|579552809|FG007|Treatment Period|Subject Withdrew Consent|0|||
160498246|NCT03377361|579552810|FG008|Treatment Period|Subject Withdrew Consent|2|||
160498247|NCT03377361|579552811|FG009|Treatment Period|Subject Withdrew Consent|1|||
160498248|NCT03377361|579552802|FG000|Treatment Period|No longer meets study criteria|0|||
160498249|NCT03377361|579552803|FG001|Treatment Period|No longer meets study criteria|1|||
160498250|NCT03377361|579552804|FG002|Treatment Period|No longer meets study criteria|0|||
160498251|NCT03377361|579552805|FG003|Treatment Period|No longer meets study criteria|0|||
160498252|NCT03377361|579552806|FG004|Treatment Period|No longer meets study criteria|0|||
160498253|NCT03377361|579552807|FG005|Treatment Period|No longer meets study criteria|0|||
160498254|NCT03377361|579552808|FG006|Treatment Period|No longer meets study criteria|0|||
160498255|NCT03377361|579552809|FG007|Treatment Period|No longer meets study criteria|1|||
160498256|NCT03377361|579552810|FG008|Treatment Period|No longer meets study criteria|0|||
160498257|NCT03377361|579552811|FG009|Treatment Period|No longer meets study criteria|0|||
160498258|NCT03377361|579552802|FG000|Treatment Period|Other Reasons|0|||
160498259|NCT03377361|579552803|FG001|Treatment Period|Other Reasons|0|||
160498260|NCT03377361|579552804|FG002|Treatment Period|Other Reasons|0|||
160498261|NCT03377361|579552805|FG003|Treatment Period|Other Reasons|3|||
160498262|NCT03377361|579552806|FG004|Treatment Period|Other Reasons|0|||
160498263|NCT03377361|579552807|FG005|Treatment Period|Other Reasons|0|||
160619062|NCT02055976|579982122|FG007|Overall Study|Adverse Event|0|||
160498264|NCT03377361|579552808|FG006|Treatment Period|Other Reasons|0|||
160498265|NCT03377361|579552809|FG007|Treatment Period|Other Reasons|2|||
160498266|NCT03377361|579552810|FG008|Treatment Period|Other Reasons|0|||
160498267|NCT03377361|579552811|FG009|Treatment Period|Other Reasons|1|||
160498268|NCT00742326|579552812|FG000|Overall Study|Physician Decision|0|||
160498269|NCT00742326|579552813|FG001|Overall Study|Physician Decision|1|||
160498270|NCT03698994|579552817|FG000|Overall Study|Adverse Event|2|||
160498271|NCT03698994|579552817|FG000|Overall Study|Death|1|||
160498272|NCT03698994|579552817|FG000|Overall Study|Physician Decision|1|||
160498273|NCT03698994|579552817|FG000|Overall Study|Withdrawal by Subject|3|||
160498274|NCT03698994|579552817|FG000|Overall Study|Progressive Disease|12|||
160498275|NCT03635086|579552820|FG000|Overall Study|Withdrawal of consent|0|||
160498276|NCT03635086|579552821|FG001|Overall Study|Withdrawal of consent|0|||
160498277|NCT03635086|579552822|FG002|Overall Study|Withdrawal of consent|1|||
160498278|NCT03635086|579552823|FG003|Overall Study|Withdrawal of consent|0|||
160498279|NCT03635086|579552824|FG004|Overall Study|Withdrawal of consent|0|||
160498280|NCT03635086|579552820|FG000|Overall Study|Adverse Event|0|||
160498281|NCT03635086|579552821|FG001|Overall Study|Adverse Event|1|||
160498282|NCT03635086|579552822|FG002|Overall Study|Adverse Event|0|||
160498283|NCT03635086|579552823|FG003|Overall Study|Adverse Event|0|||
160498284|NCT03635086|579552824|FG004|Overall Study|Adverse Event|0|||
160498285|NCT03635086|579552820|FG000|Overall Study|Lost to Follow-up|1|||
160498286|NCT03635086|579552821|FG001|Overall Study|Lost to Follow-up|0|||
160498287|NCT03635086|579552822|FG002|Overall Study|Lost to Follow-up|0|||
160498288|NCT03635086|579552823|FG003|Overall Study|Lost to Follow-up|0|||
160498289|NCT03635086|579552824|FG004|Overall Study|Lost to Follow-up|0|||
160498290|NCT02196077|579552825|FG000|Overall Study|Adverse Event|4|||
160498291|NCT02196077|579552825|FG000|Overall Study|Lack of Efficacy|1|||
160498292|NCT02196077|579552825|FG000|Overall Study|Withdrawal by Subject|14|||
160498293|NCT02196077|579552825|FG000|Overall Study|Physician Decision|1|||
160498294|NCT02196077|579552825|FG000|Overall Study|Lost to Follow-up|3|||
160498295|NCT02196077|579552825|FG000|Overall Study|Protocol Violation|24|||
160498296|NCT03482752|579552830|FG000|Overall Study|Withdrawal by Subject|2|||
160498297|NCT03482752|579552830|FG000|Overall Study|Lost to Follow-up|1|||
160498298|NCT03482752|579552830|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
160498299|NCT02844777|579552831|FG000|Overall Study|Withdrawal by Subject|2|||
160498300|NCT02844777|579552832|FG001|Overall Study|Withdrawal by Subject|0|||
160498301|NCT02844777|579552833|FG002|Overall Study|Withdrawal by Subject|0|||
160498302|NCT01776008|579552834|FG000|Overall Study|ineligible|2|||
160498303|NCT00150618|579552835|FG000|Overall Study|Adverse Event|2|||
160498304|NCT00150618|579552836|FG001|Overall Study|Adverse Event|2|||
160498305|NCT00150618|579552837|FG002|Overall Study|Adverse Event|6|||
160498306|NCT00150618|579552838|FG003|Overall Study|Adverse Event|9|||
160498307|NCT00150618|579552839|FG004|Overall Study|Adverse Event|5|||
160498308|NCT00150618|579552835|FG000|Overall Study|Withdrawal by Subject|6|||
160498309|NCT00150618|579552836|FG001|Overall Study|Withdrawal by Subject|8|||
160498310|NCT00150618|579552837|FG002|Overall Study|Withdrawal by Subject|8|||
160498311|NCT00150618|579552838|FG003|Overall Study|Withdrawal by Subject|4|||
160498312|NCT00150618|579552839|FG004|Overall Study|Withdrawal by Subject|5|||
160498313|NCT00150618|579552835|FG000|Overall Study|Lost to Follow-up|4|||
160498314|NCT00150618|579552836|FG001|Overall Study|Lost to Follow-up|1|||
160498315|NCT00150618|579552837|FG002|Overall Study|Lost to Follow-up|5|||
160498316|NCT00150618|579552838|FG003|Overall Study|Lost to Follow-up|8|||
160498317|NCT00150618|579552839|FG004|Overall Study|Lost to Follow-up|4|||
160498318|NCT00150618|579552835|FG000|Overall Study|Protocol Violation|1|||
160498319|NCT00150618|579552836|FG001|Overall Study|Protocol Violation|0|||
160498320|NCT00150618|579552837|FG002|Overall Study|Protocol Violation|0|||
160498321|NCT00150618|579552838|FG003|Overall Study|Protocol Violation|0|||
160498322|NCT00150618|579552839|FG004|Overall Study|Protocol Violation|1|||
160498323|NCT00150618|579552835|FG000|Overall Study|Lack of Efficacy|1|||
160498324|NCT00150618|579552836|FG001|Overall Study|Lack of Efficacy|4|||
160498325|NCT00150618|579552837|FG002|Overall Study|Lack of Efficacy|7|||
160662133|NCT02726581|580145639|FG000|Treatment Period|Participant withdrew consent|3|||
160662134|NCT02726581|580145640|FG001|Treatment Period|Participant withdrew consent|1|||
160498326|NCT00150618|579552838|FG003|Overall Study|Lack of Efficacy|4|||
160498327|NCT00150618|579552839|FG004|Overall Study|Lack of Efficacy|6|||
160498328|NCT00150618|579552835|FG000|Overall Study|No study meds|0|||
160498329|NCT00150618|579552836|FG001|Overall Study|No study meds|0|||
160498330|NCT00150618|579552837|FG002|Overall Study|No study meds|0|||
160498331|NCT00150618|579552838|FG003|Overall Study|No study meds|0|||
160498332|NCT00150618|579552839|FG004|Overall Study|No study meds|2|||
160498333|NCT00150618|579552835|FG000|Overall Study|Physician Decision|0|||
160662135|NCT02726581|580145641|FG002|Treatment Period|Participant withdrew consent|1|||
160498334|NCT00150618|579552836|FG001|Overall Study|Physician Decision|2|||
160498335|NCT00150618|579552837|FG002|Overall Study|Physician Decision|0|||
160498336|NCT00150618|579552838|FG003|Overall Study|Physician Decision|0|||
160498337|NCT00150618|579552839|FG004|Overall Study|Physician Decision|1|||
160498338|NCT00150618|579552835|FG000|Overall Study|Lack of compliance|2|||
160498339|NCT00150618|579552836|FG001|Overall Study|Lack of compliance|1|||
160498340|NCT00150618|579552837|FG002|Overall Study|Lack of compliance|1|||
160498341|NCT00150618|579552838|FG003|Overall Study|Lack of compliance|0|||
160498342|NCT00150618|579552839|FG004|Overall Study|Lack of compliance|1|||
160498343|NCT00150618|579552835|FG000|Overall Study|Abnormal ECG|1|||
160498344|NCT00150618|579552836|FG001|Overall Study|Abnormal ECG|0|||
160498345|NCT00150618|579552837|FG002|Overall Study|Abnormal ECG|0|||
160498346|NCT00150618|579552838|FG003|Overall Study|Abnormal ECG|0|||
160498347|NCT00150618|579552839|FG004|Overall Study|Abnormal ECG|0|||
160498348|NCT00150618|579552835|FG000|Overall Study|Sponsor's decision|0|||
160498349|NCT00150618|579552836|FG001|Overall Study|Sponsor's decision|0|||
160498350|NCT00150618|579552837|FG002|Overall Study|Sponsor's decision|0|||
160498351|NCT00150618|579552838|FG003|Overall Study|Sponsor's decision|1|||
160498352|NCT00150618|579552839|FG004|Overall Study|Sponsor's decision|0|||
160498353|NCT02493946|579552840|FG000|DB Period|Withdrawal by Subject|8|||
160498354|NCT02493946|579552841|FG001|DB Period|Withdrawal by Subject|5|||
160498355|NCT02493946|579552842|FG002|DB Period|Withdrawal by Subject|0|||
160498356|NCT02493946|579552840|FG000|Open Label Period|Withdrawal by Subject|0|||
160498357|NCT02493946|579552841|FG001|Open Label Period|Withdrawal by Subject|0|||
160498358|NCT02493946|579552842|FG002|Open Label Period|Withdrawal by Subject|74|||
160498359|NCT02493946|579552840|FG000|Open Label Period|Adverse Event|0|||
160498360|NCT02493946|579552841|FG001|Open Label Period|Adverse Event|0|||
160498361|NCT02493946|579552842|FG002|Open Label Period|Adverse Event|4|||
160498362|NCT02493946|579552840|FG000|Open Label Period|Lost to Follow-up|0|||
160498363|NCT02493946|579552841|FG001|Open Label Period|Lost to Follow-up|0|||
160498364|NCT02493946|579552842|FG002|Open Label Period|Lost to Follow-up|1|||
160498365|NCT02493946|579552840|FG000|Open Label Period|Investigator decision, non-compliance|0|||
160498366|NCT02493946|579552841|FG001|Open Label Period|Investigator decision, non-compliance|0|||
160498367|NCT02493946|579552842|FG002|Open Label Period|Investigator decision, non-compliance|2|||
160498368|NCT02493946|579552840|FG000|Open Label Period|Investigator decision, non-availability|0|||
160498369|NCT02493946|579552841|FG001|Open Label Period|Investigator decision, non-availability|0|||
160498370|NCT02493946|579552842|FG002|Open Label Period|Investigator decision, non-availability|1|||
160498371|NCT02493946|579552840|FG000|Open Label Period|Pregnancy|0|||
160498372|NCT02493946|579552841|FG001|Open Label Period|Pregnancy|0|||
160498373|NCT02493946|579552842|FG002|Open Label Period|Pregnancy|3|||
160498374|NCT02493946|579552840|FG000|Open Label Period|Site error|0|||
160498375|NCT02493946|579552841|FG001|Open Label Period|Site error|0|||
160498376|NCT02493946|579552842|FG002|Open Label Period|Site error|1|||
160498377|NCT00965497|579552843|FG000|Overall Study|Physician Decision|1|||
160498378|NCT02689453|579552844|FG000|Overall Study|Progressive disease|0|||
160498379|NCT02689453|579552845|FG001|Overall Study|Progressive disease|1|||
160498380|NCT02689453|579552846|FG002|Overall Study|Progressive disease|1|||
160498381|NCT01162486|579552847|FG000|Overall Study|low ANC|1|||
160498382|NCT01162486|579552848|FG001|Overall Study|low ANC|0|||
160498383|NCT01162486|579552849|FG002|Overall Study|low ANC|0|||
160498384|NCT01162486|579552850|FG003|Overall Study|low ANC|0|||
160498385|NCT01162486|579552851|FG004|Overall Study|low ANC|0|||
160498386|NCT01162486|579552847|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
160498387|NCT01162486|579552848|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
160498388|NCT01162486|579552849|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
160498389|NCT01162486|579552850|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
160498390|NCT01162486|579552851|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
160498391|NCT01162486|579552847|FG000|Overall Study|elevated LFTs|0|||
160498392|NCT01162486|579552848|FG001|Overall Study|elevated LFTs|0|||
160498393|NCT01162486|579552849|FG002|Overall Study|elevated LFTs|1|||
160619063|NCT02055976|579982123|FG008|Overall Study|Adverse Event|0|||
160619064|NCT02055976|579982115|FG000|Overall Study|Does not meet entrance criteria|0|||
160619065|NCT02055976|579982116|FG001|Overall Study|Does not meet entrance criteria|0|||
160619066|NCT02055976|579982117|FG002|Overall Study|Does not meet entrance criteria|0|||
160619067|NCT02055976|579982118|FG003|Overall Study|Does not meet entrance criteria|0|||
160619068|NCT02055976|579982119|FG004|Overall Study|Does not meet entrance criteria|0|||
160619069|NCT02055976|579982120|FG005|Overall Study|Does not meet entrance criteria|0|||
160619070|NCT02055976|579982121|FG006|Overall Study|Does not meet entrance criteria|1|||
160619071|NCT02055976|579982122|FG007|Overall Study|Does not meet entrance criteria|0|||
160662136|NCT02726581|580145639|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
160498394|NCT01162486|579552850|FG003|Overall Study|elevated LFTs|0|||
160498395|NCT01162486|579552851|FG004|Overall Study|elevated LFTs|0|||
160498396|NCT01162486|579552847|FG000|Overall Study|Pregnancy|0|||
160498397|NCT01162486|579552848|FG001|Overall Study|Pregnancy|0|||
160498398|NCT01162486|579552849|FG002|Overall Study|Pregnancy|0|||
160498399|NCT01162486|579552850|FG003|Overall Study|Pregnancy|1|||
160498400|NCT01162486|579552851|FG004|Overall Study|Pregnancy|0|||
160498401|NCT00794924|579552852|FG000|Overall Study|Lost to Follow-up|6|||
160498402|NCT00794924|579552853|FG001|Overall Study|Lost to Follow-up|8|||
160498403|NCT00794924|579552852|FG000|Overall Study|Withdrawal by Subject|48|||
160498404|NCT00794924|579552853|FG001|Overall Study|Withdrawal by Subject|60|||
160498405|NCT00794924|579552852|FG000|Overall Study|Adverse Event|6|||
160498406|NCT00794924|579552853|FG001|Overall Study|Adverse Event|2|||
160498407|NCT00953615|579552854|FG000|Overall Study|Adverse Event|1|||
160498408|NCT02296892|579552861|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
160498409|NCT02296892|579552862|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
160498410|NCT02296892|579552863|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
160498411|NCT02296892|579552861|FG000|Overall Study|Lost to Follow-up|5|||
160498412|NCT02296892|579552862|FG001|Overall Study|Lost to Follow-up|0|||
160498413|NCT02296892|579552863|FG002|Overall Study|Lost to Follow-up|1|||
160498414|NCT00383123|579552866|FG000|Overall Study|Adverse Event|1|||
160498415|NCT00383123|579552867|FG001|Overall Study|Adverse Event|0|||
160498416|NCT00383123|579552866|FG000|Overall Study|Lost to Follow-up|68|||
160498417|NCT00383123|579552867|FG001|Overall Study|Lost to Follow-up|61|||
160498418|NCT00383123|579552866|FG000|Overall Study|Protocol Violation|5|||
160498419|NCT00383123|579552867|FG001|Overall Study|Protocol Violation|1|||
160498420|NCT00383123|579552866|FG000|Overall Study|Withdrawal by Subject|27|||
160498421|NCT00383123|579552867|FG001|Overall Study|Withdrawal by Subject|18|||
160498422|NCT00383123|579552866|FG000|Overall Study|Other reason|10|||
160498423|NCT00383123|579552867|FG001|Overall Study|Other reason|6|||
160498424|NCT00250432|579552870|FG000|Overall Study|Adverse Event|25|||
160498425|NCT00250432|579552871|FG001|Overall Study|Adverse Event|29|||
160498426|NCT00250432|579552870|FG000|Overall Study|Lack of Efficacy|2|||
160498427|NCT00250432|579552871|FG001|Overall Study|Lack of Efficacy|1|||
160498428|NCT00250432|579552870|FG000|Overall Study|Lost to Follow-up|6|||
160498429|NCT00250432|579552871|FG001|Overall Study|Lost to Follow-up|5|||
160498430|NCT00250432|579552870|FG000|Overall Study|Patient Moved|0|||
160498431|NCT00250432|579552871|FG001|Overall Study|Patient Moved|1|||
160498432|NCT00250432|579552870|FG000|Overall Study|Protocol Violation|0|||
160498433|NCT00250432|579552871|FG001|Overall Study|Protocol Violation|3|||
160498434|NCT00250432|579552870|FG000|Overall Study|Withdrawal by Subject|6|||
160498435|NCT00250432|579552871|FG001|Overall Study|Withdrawal by Subject|2|||
160498436|NCT00250432|579552870|FG000|Overall Study|Pt died out of posttherapy report period|6|||
160498437|NCT00250432|579552871|FG001|Overall Study|Pt died out of posttherapy report period|5|||
160498438|NCT00250432|579552870|FG000|Overall Study|Pt was considered untreatable|0|||
160498439|NCT00250432|579552871|FG001|Overall Study|Pt was considered untreatable|1|||
160498440|NCT04147858|579552872|FG000|Overall Study|Adverse Event|6|||
160498441|NCT04147858|579552873|FG001|Overall Study|Adverse Event|6|||
160498442|NCT04147858|579552874|FG002|Overall Study|Adverse Event|6|||
160498443|NCT04147858|579552872|FG000|Overall Study|Lack of Efficacy|3|||
160498444|NCT04147858|579552873|FG001|Overall Study|Lack of Efficacy|3|||
160498445|NCT04147858|579552874|FG002|Overall Study|Lack of Efficacy|1|||
160498446|NCT04147858|579552872|FG000|Overall Study|Lost to Follow-up|1|||
160498447|NCT04147858|579552873|FG001|Overall Study|Lost to Follow-up|6|||
160498448|NCT04147858|579552874|FG002|Overall Study|Lost to Follow-up|2|||
160498449|NCT04147858|579552872|FG000|Overall Study|Withdrawal by Subject|3|||
160498450|NCT04147858|579552873|FG001|Overall Study|Withdrawal by Subject|4|||
160498451|NCT04147858|579552874|FG002|Overall Study|Withdrawal by Subject|10|||
160498452|NCT04147858|579552872|FG000|Overall Study|Subject Noncompliance, Other|4|||
160498453|NCT04147858|579552873|FG001|Overall Study|Subject Noncompliance, Other|3|||
160498454|NCT04147858|579552874|FG002|Overall Study|Subject Noncompliance, Other|1|||
160498455|NCT01056263|579552877|FG000|Overall Study|Adverse Event|12|||
160498456|NCT01056263|579552877|FG000|Overall Study|Death|1|||
160498457|NCT01056263|579552877|FG000|Overall Study|Withdrawal by Subject|1|||
160498458|NCT01056263|579552877|FG000|Overall Study|Lack of Efficacy|29|||
160498459|NCT01056263|579552877|FG000|Overall Study|Progressive disease|2|||
160498460|NCT01056263|579552877|FG000|Overall Study|Neoplasm progression|1|||
160498461|NCT01056263|579552877|FG000|Overall Study|Objective progression or relapse|1|||
160498462|NCT01056263|579552877|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
160498463|NCT03375320|579552882|FG000|Overall Study|Adverse Event|34|||
160498464|NCT03375320|579552883|FG001|Overall Study|Adverse Event|9|||
160498465|NCT03375320|579552884|FG002|Overall Study|Adverse Event|10|||
160498466|NCT03375320|579552885|FG003|Overall Study|Adverse Event|0|||
160498467|NCT03375320|579552882|FG000|Overall Study|Death|6|||
160498468|NCT03375320|579552883|FG001|Overall Study|Death|3|||
160498469|NCT03375320|579552884|FG002|Overall Study|Death|0|||
160498470|NCT03375320|579552885|FG003|Overall Study|Death|0|||
160498471|NCT03375320|579552882|FG000|Overall Study|Withdrawal by Subject|7|||
160498472|NCT03375320|579552883|FG001|Overall Study|Withdrawal by Subject|4|||
160498473|NCT03375320|579552884|FG002|Overall Study|Withdrawal by Subject|5|||
160498474|NCT03375320|579552885|FG003|Overall Study|Withdrawal by Subject|4|||
160498475|NCT03375320|579552882|FG000|Overall Study|Progressive disease|55|||
160498476|NCT03375320|579552883|FG001|Overall Study|Progressive disease|41|||
160498477|NCT03375320|579552884|FG002|Overall Study|Progressive disease|29|||
160498478|NCT03375320|579552885|FG003|Overall Study|Progressive disease|24|||
160498479|NCT03375320|579552882|FG000|Overall Study|Alternative treatment|6|||
160498480|NCT03375320|579552883|FG001|Overall Study|Alternative treatment|1|||
160498481|NCT03375320|579552884|FG002|Overall Study|Alternative treatment|1|||
160498482|NCT03375320|579552885|FG003|Overall Study|Alternative treatment|0|||
160498483|NCT03375320|579552882|FG000|Overall Study|Other disease|1|||
160498484|NCT03375320|579552883|FG001|Overall Study|Other disease|1|||
160498485|NCT03375320|579552884|FG002|Overall Study|Other disease|3|||
160498486|NCT03375320|579552885|FG003|Overall Study|Other disease|0|||
160498487|NCT03375320|579552882|FG000|Overall Study|Withdrawal prior to initiation|2|||
160498488|NCT03375320|579552883|FG001|Overall Study|Withdrawal prior to initiation|2|||
160498489|NCT03375320|579552884|FG002|Overall Study|Withdrawal prior to initiation|1|||
160498490|NCT03375320|579552885|FG003|Overall Study|Withdrawal prior to initiation|0|||
160498491|NCT03375320|579552882|FG000|Overall Study|Physician Decision|1|||
160498492|NCT03375320|579552883|FG001|Overall Study|Physician Decision|1|||
160498493|NCT03375320|579552884|FG002|Overall Study|Physician Decision|1|||
160498494|NCT03375320|579552885|FG003|Overall Study|Physician Decision|1|||
160498495|NCT03375320|579552882|FG000|Overall Study|Non-compliance|1|||
160498496|NCT03375320|579552883|FG001|Overall Study|Non-compliance|0|||
160498497|NCT03375320|579552884|FG002|Overall Study|Non-compliance|0|||
160498498|NCT03375320|579552885|FG003|Overall Study|Non-compliance|0|||
160498499|NCT00365547|579552888|FG000|Overall Study|Insurance did not cover Avastin|1|||
160498500|NCT00365547|579552888|FG000|Overall Study|Screen failure|1|||
160498501|NCT00365547|579552888|FG000|Overall Study|Withdrawal by Subject|1|||
160498502|NCT03692052|579552889|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
160498503|NCT03692052|579552889|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
160498504|NCT03692052|579552889|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
160498505|NCT03692052|579552889|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
160498506|NCT03170518|579552890|FG000|Overall Study|Lost to Follow-up|4|||
160498507|NCT03170518|579552891|FG001|Overall Study|Lost to Follow-up|1|||
160498508|NCT03170518|579552892|FG002|Overall Study|Lost to Follow-up|0|||
160498509|NCT03170518|579552890|FG000|Overall Study|Physician Decision|1|||
160498510|NCT03170518|579552891|FG001|Overall Study|Physician Decision|0|||
160498511|NCT03170518|579552892|FG002|Overall Study|Physician Decision|0|||
160498512|NCT03170518|579552890|FG000|Overall Study|Withdrawal by Subject|4|||
160498513|NCT03170518|579552891|FG001|Overall Study|Withdrawal by Subject|5|||
160498514|NCT03170518|579552892|FG002|Overall Study|Withdrawal by Subject|2|||
160498515|NCT03170518|579552890|FG000|Overall Study|Site terminated by sponsor|0|||
160498516|NCT03170518|579552891|FG001|Overall Study|Site terminated by sponsor|1|||
160498517|NCT03170518|579552892|FG002|Overall Study|Site terminated by sponsor|0|||
160498518|NCT03170518|579552890|FG000|Overall Study|Non-compliance with study drug|1|||
160498519|NCT03170518|579552891|FG001|Overall Study|Non-compliance with study drug|0|||
160498520|NCT03170518|579552892|FG002|Overall Study|Non-compliance with study drug|1|||
160498521|NCT03170518|579552890|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160498522|NCT03170518|579552891|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160498523|NCT03170518|579552892|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160498524|NCT00546078|579552893|FG000|Overall Study|Lost to Follow-up|1|||
160498525|NCT00546078|579552894|FG001|Overall Study|Lost to Follow-up|3|||
160498526|NCT00546078|579552893|FG000|Overall Study|Withdrawal by Subject|2|||
160498527|NCT00546078|579552894|FG001|Overall Study|Withdrawal by Subject|3|||
160498528|NCT00546078|579552893|FG000|Overall Study|Other reason|1|||
160498529|NCT00546078|579552894|FG001|Overall Study|Other reason|1|||
160619072|NCT02055976|579982123|FG008|Overall Study|Does not meet entrance criteria|0|||
160619073|NCT02055976|579982115|FG000|Overall Study|Lost to Follow-up|0|||
160619074|NCT02055976|579982116|FG001|Overall Study|Lost to Follow-up|0|||
160619075|NCT02055976|579982117|FG002|Overall Study|Lost to Follow-up|0|||
160619076|NCT02055976|579982118|FG003|Overall Study|Lost to Follow-up|1|||
160619077|NCT02055976|579982119|FG004|Overall Study|Lost to Follow-up|0|||
160619078|NCT02055976|579982120|FG005|Overall Study|Lost to Follow-up|0|||
160619079|NCT02055976|579982121|FG006|Overall Study|Lost to Follow-up|0|||
160619080|NCT02055976|579982122|FG007|Overall Study|Lost to Follow-up|0|||
160619081|NCT02055976|579982123|FG008|Overall Study|Lost to Follow-up|0|||
160619082|NCT02504424|579982127|FG000|Overall Study|Withdrawal by Subject|2|||
160619083|NCT00426842|579982128|FG000|Overall Study|Lost to Follow-up|1|||
160619084|NCT01657903|579982132|FG000|Overall Study|Lost to Follow-up|1|||
160619085|NCT01657903|579982132|FG000|Overall Study|Withdrawal by Subject|1|||
160619086|NCT00960323|579984861|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
160619087|NCT01101321|579984865|FG000|Period 1|Withdrawal by Subject|1|||
160619088|NCT01101321|579984866|FG001|Period 1|Withdrawal by Subject|1|||
160619089|NCT01101321|579984865|FG000|Period 1|Adverse Event|3|||
160619090|NCT01101321|579984866|FG001|Period 1|Adverse Event|3|||
160619091|NCT00561912|579984867|FG000|Overall Study|ineligible|1|||
160619092|NCT03938857|579984868|FG000|Overall Study|Physician Decision|1|||
160498530|NCT03512197|579552895|FG000|Overall Study|Guardian decision|1|||
160619093|NCT03938857|579984869|FG001|Overall Study|Physician Decision|0|||
160619094|NCT03938857|579984870|FG002|Overall Study|Physician Decision|0|||
160619095|NCT03938857|579984871|FG003|Overall Study|Physician Decision|0|||
160619096|NCT01345162|579984872|FG000|Overall Study|Protocol Violation|2|||
160498531|NCT03512197|579552896|FG001|Overall Study|Guardian decision|1|||
160498532|NCT03512197|579552895|FG000|Overall Study|Lack of Efficacy|19|||
160498533|NCT03512197|579552896|FG001|Overall Study|Lack of Efficacy|11|||
160498534|NCT03512197|579552895|FG000|Overall Study|New Therapy for Study Indication|16|||
160619097|NCT01345162|579984873|FG001|Overall Study|Protocol Violation|4|||
160619098|NCT03007472|579984874|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
160498535|NCT03512197|579552896|FG001|Overall Study|New Therapy for Study Indication|16|||
160498536|NCT03512197|579552895|FG000|Overall Study|Physician Decision|60|||
160498537|NCT03512197|579552896|FG001|Overall Study|Physician Decision|60|||
160498538|NCT03512197|579552895|FG000|Overall Study|Protocol Violation|0|||
160498539|NCT03512197|579552896|FG001|Overall Study|Protocol Violation|2|||
160498540|NCT03512197|579552895|FG000|Overall Study|Terminated by Sponsored|46|||
160498541|NCT03512197|579552896|FG001|Overall Study|Terminated by Sponsored|50|||
160498542|NCT03512197|579552895|FG000|Overall Study|Subject Decision|15|||
160498543|NCT03512197|579552896|FG001|Overall Study|Subject Decision|12|||
160498544|NCT03512197|579552895|FG000|Overall Study|Withdrawal of informed consent|20|||
160498545|NCT03512197|579552896|FG001|Overall Study|Withdrawal of informed consent|14|||
160498546|NCT03512197|579552895|FG000|Overall Study|Adverse Event|30|||
160498547|NCT03512197|579552896|FG001|Overall Study|Adverse Event|34|||
160498548|NCT03512197|579552895|FG000|Overall Study|Death|14|||
160498549|NCT03512197|579552896|FG001|Overall Study|Death|9|||
160498550|NCT03512197|579552895|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
160498551|NCT03512197|579552896|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
160498552|NCT03512197|579552895|FG000|Overall Study|Missing|3|||
160498553|NCT03512197|579552896|FG001|Overall Study|Missing|13|||
160498554|NCT01806389|579552897|FG000|Overall Study|Withdrawal by Subject|4|||
160498555|NCT03842436|579552898|FG000|Overall Study|Lost to Follow-up|1|||
160498556|NCT01948076|579552899|FG000|Overall Study|Withdrawal by Subject|0|||
160498557|NCT01948076|579552900|FG001|Overall Study|Withdrawal by Subject|1|||
160498558|NCT00936598|579552906|FG000|Overall Study|Withdrawal by Subject|1|||
160498559|NCT00936598|579552907|FG001|Overall Study|Withdrawal by Subject|0|||
160498560|NCT00936598|579552906|FG000|Overall Study|Ineligible after consent|1|||
160498561|NCT00936598|579552907|FG001|Overall Study|Ineligible after consent|0|||
160498562|NCT03358238|579552908|FG000|Overall Study|Withdrawal by Subject|0|||
160498563|NCT03358238|579552909|FG001|Overall Study|Withdrawal by Subject|1|||
160498564|NCT04596540|579552910|FG000|Overall Study|Withdrawal by Subject|9|||
160498565|NCT04596540|579552911|FG001|Overall Study|Withdrawal by Subject|8|||
160498566|NCT04596540|579552912|FG002|Overall Study|Withdrawal by Subject|5|||
160498567|NCT04596540|579552910|FG000|Overall Study|Lost to Follow-up|1|||
160498568|NCT04596540|579552911|FG001|Overall Study|Lost to Follow-up|2|||
160498569|NCT04596540|579552912|FG002|Overall Study|Lost to Follow-up|1|||
160498570|NCT04596540|579552910|FG000|Overall Study|Sponsor Decision|2|||
160498571|NCT04596540|579552911|FG001|Overall Study|Sponsor Decision|0|||
160498572|NCT04596540|579552912|FG002|Overall Study|Sponsor Decision|0|||
160498573|NCT04596540|579552910|FG000|Overall Study|Physician Decision|0|||
160498574|NCT04596540|579552911|FG001|Overall Study|Physician Decision|1|||
160498575|NCT04596540|579552912|FG002|Overall Study|Physician Decision|1|||
160498576|NCT04596540|579552910|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
160498577|NCT04596540|579552911|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
160498578|NCT04596540|579552912|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
160498579|NCT04596540|579552910|FG000|Overall Study|Other Than Specified|5|||
160498580|NCT04596540|579552911|FG001|Overall Study|Other Than Specified|5|||
160498581|NCT04596540|579552912|FG002|Overall Study|Other Than Specified|2|||
160498582|NCT04526665|579552913|FG000|Overall Study|Withdrawal by Subject|6|||
160498583|NCT04526665|579552914|FG001|Overall Study|Withdrawal by Subject|3|||
160498584|NCT04526665|579552913|FG000|Overall Study|Adverse Event|4|||
160498585|NCT04526665|579552914|FG001|Overall Study|Adverse Event|1|||
160498586|NCT04526665|579552913|FG000|Overall Study|Physician Decision|2|||
160498587|NCT04526665|579552914|FG001|Overall Study|Physician Decision|2|||
160498588|NCT04526665|579552913|FG000|Overall Study|Death|2|||
160498589|NCT04526665|579552914|FG001|Overall Study|Death|0|||
160498590|NCT04526665|579552913|FG000|Overall Study|Other|0|||
160498591|NCT04526665|579552914|FG001|Overall Study|Other|1|||
160498610|NCT04949802|579554394|FG000|Overall Study|Lost to Follow-up|3|||
160498611|NCT01020877|579554397|FG000|Second Intervention|Withdrawal by Subject|1|||
160498612|NCT01020877|579554398|FG001|Second Intervention|Withdrawal by Subject|0|||
160498613|NCT00433511|579554399|FG000|Step 1|Adverse Event|50|||
160498614|NCT00433511|579554400|FG001|Step 1|Adverse Event|157|||
160498615|NCT00433511|579554401|FG002|Step 1|Adverse Event|153|||
160498616|NCT00433511|579554399|FG000|Step 1|Withdrawal by Subject|45|||
160498617|NCT00433511|579554400|FG001|Step 1|Withdrawal by Subject|143|||
160498618|NCT00433511|579554401|FG002|Step 1|Withdrawal by Subject|154|||
160498619|NCT00433511|579554399|FG000|Step 1|Death|3|||
160498620|NCT00433511|579554400|FG001|Step 1|Death|1|||
160498621|NCT00433511|579554401|FG002|Step 1|Death|1|||
160498622|NCT00433511|579554399|FG000|Step 1|Physician Decision|1|||
160498623|NCT00433511|579554400|FG001|Step 1|Physician Decision|4|||
160498624|NCT00433511|579554401|FG002|Step 1|Physician Decision|3|||
160498625|NCT00433511|579554399|FG000|Step 1|Never started protocol therapy|28|||
160498626|NCT00433511|579554400|FG001|Step 1|Never started protocol therapy|64|||
160498627|NCT00433511|579554401|FG002|Step 1|Never started protocol therapy|66|||
160498628|NCT00433511|579554399|FG000|Step 1|Alternative therapy|2|||
160498629|NCT00433511|579554400|FG001|Step 1|Alternative therapy|1|||
160498630|NCT00433511|579554401|FG002|Step 1|Alternative therapy|3|||
160498631|NCT00433511|579554399|FG000|Step 1|Disease progression, relapse|5|||
160498632|NCT00433511|579554400|FG001|Step 1|Disease progression, relapse|3|||
160498633|NCT00433511|579554401|FG002|Step 1|Disease progression, relapse|3|||
160498634|NCT00433511|579554399|FG000|Step 1|Other complicating disease|2|||
160498635|NCT00433511|579554400|FG001|Step 1|Other complicating disease|6|||
160498636|NCT00433511|579554401|FG002|Step 1|Other complicating disease|3|||
160498637|NCT00433511|579554399|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
160498638|NCT00433511|579554400|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
160498639|NCT00433511|579554401|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
160498640|NCT00433511|579554399|FG000|Step 1|Suspected recurrence|0|||
160498641|NCT00433511|579554400|FG001|Step 1|Suspected recurrence|1|||
160498642|NCT00433511|579554401|FG002|Step 1|Suspected recurrence|0|||
160498643|NCT00433511|579554399|FG000|Step 1|Insurance/drug distribution issues|0|||
160498644|NCT00433511|579554400|FG001|Step 1|Insurance/drug distribution issues|1|||
160498645|NCT00433511|579554401|FG002|Step 1|Insurance/drug distribution issues|2|||
160498646|NCT00433511|579554399|FG000|Step 1|Patient moved|0|||
160498647|NCT00433511|579554400|FG001|Step 1|Patient moved|0|||
160498648|NCT00433511|579554401|FG002|Step 1|Patient moved|1|||
160498649|NCT00433511|579554399|FG000|Step 2 (Arm D)|Adverse Event|0|||
160498650|NCT00433511|579554400|FG001|Step 2 (Arm D)|Adverse Event|0|||
160498651|NCT00433511|579554401|FG002|Step 2 (Arm D)|Adverse Event|135|||
160498652|NCT00433511|579554399|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
160498653|NCT00433511|579554400|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
160498654|NCT00433511|579554401|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
160498655|NCT00433511|579554399|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
160498656|NCT00433511|579554400|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
160498657|NCT00433511|579554401|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
160498658|NCT00433511|579554399|FG000|Step 2 (Arm D)|Physician Decision|0|||
160498659|NCT00433511|579554400|FG001|Step 2 (Arm D)|Physician Decision|0|||
160498660|NCT00433511|579554401|FG002|Step 2 (Arm D)|Physician Decision|9|||
160498661|NCT00433511|579554399|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
160498662|NCT00433511|579554400|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
160498663|NCT00433511|579554401|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
160498664|NCT00433511|579554399|FG000|Step 2 (Arm D)|Other complicating disease|0|||
160498665|NCT00433511|579554400|FG001|Step 2 (Arm D)|Other complicating disease|0|||
160498666|NCT00433511|579554401|FG002|Step 2 (Arm D)|Other complicating disease|3|||
160498667|NCT00433511|579554399|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
160619099|NCT03007472|579984874|FG000|Overall Study|Death|2|||
160619100|NCT03007472|579984874|FG000|Overall Study|Loss to Follow Up|1|||
160619101|NCT02988115|579984875|FG000|Overall Study|Adverse Event|6|||
160619102|NCT02988115|579984876|FG001|Overall Study|Adverse Event|1|||
160619103|NCT02988115|579984875|FG000|Overall Study|Sponsor Decision|5|||
160619104|NCT02988115|579984876|FG001|Overall Study|Sponsor Decision|2|||
160498668|NCT00433511|579554400|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
160498669|NCT00433511|579554401|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
160619105|NCT02988115|579984875|FG000|Overall Study|Withdrawal by Subject|1|||
160619106|NCT02988115|579984876|FG001|Overall Study|Withdrawal by Subject|1|||
160498670|NCT00433511|579554399|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
160498671|NCT00433511|579554400|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
160498672|NCT00433511|579554401|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
160498673|NCT00433511|579554399|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
160498674|NCT00433511|579554400|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
160619107|NCT02988115|579984875|FG000|Overall Study|Withdrawn by Mistake|1|||
160498675|NCT00433511|579554401|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
160498676|NCT00433511|579554399|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
160498677|NCT00433511|579554400|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
160498678|NCT00433511|579554401|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
160619108|NCT02988115|579984876|FG001|Overall Study|Withdrawn by Mistake|0|||
160619109|NCT02988115|579984875|FG000|Overall Study|Lost to Follow-up|1|||
160619110|NCT02988115|579984876|FG001|Overall Study|Lost to Follow-up|0|||
160619111|NCT00649220|579984883|FG000|Overall Study|Adverse Event|2|||
160619112|NCT00649220|579984883|FG000|Overall Study|Withdrawal by Subject|1|||
160619113|NCT03339999|579984884|FG000|Overall Study|Adverse Event|1|||
160619114|NCT03339999|579984885|FG001|Overall Study|Adverse Event|2|||
160619115|NCT03339999|579984886|FG002|Overall Study|Adverse Event|2|||
160619116|NCT03339999|579984887|FG003|Overall Study|Adverse Event|1|||
160619117|NCT03339999|579984884|FG000|Overall Study|Lack of Efficacy|0|||
160619118|NCT03339999|579984885|FG001|Overall Study|Lack of Efficacy|1|||
160619119|NCT03339999|579984886|FG002|Overall Study|Lack of Efficacy|0|||
160619120|NCT03339999|579984887|FG003|Overall Study|Lack of Efficacy|0|||
160619121|NCT03339999|579984884|FG000|Overall Study|Lost to Follow-up|0|||
160619122|NCT03339999|579984885|FG001|Overall Study|Lost to Follow-up|0|||
160619123|NCT03339999|579984886|FG002|Overall Study|Lost to Follow-up|0|||
160619124|NCT03339999|579984887|FG003|Overall Study|Lost to Follow-up|1|||
160619125|NCT03339999|579984884|FG000|Overall Study|Study Terminated by Sponsor|6|||
160619126|NCT03339999|579984885|FG001|Overall Study|Study Terminated by Sponsor|3|||
160619127|NCT03339999|579984886|FG002|Overall Study|Study Terminated by Sponsor|4|||
160619128|NCT03339999|579984887|FG003|Overall Study|Study Terminated by Sponsor|3|||
160619129|NCT00525499|579984888|FG000|Overall Study|Lost to Follow-up|2|||
160619130|NCT00525499|579984889|FG001|Overall Study|Lost to Follow-up|4|||
160619131|NCT00525499|579984890|FG002|Overall Study|Lost to Follow-up|1|||
160498679|NCT01784523|579554402|FG000|Overall Study|Study closed early|7|||
160498680|NCT01784523|579554403|FG001|Overall Study|Study closed early|4|||
160498681|NCT00709228|579554404|FG000|Overall Study|Not treated|14|||
160498682|NCT00709228|579554404|FG000|Overall Study|Eligibility criteria not met|281|||
160498683|NCT00709228|579554404|FG000|Overall Study|Adverse events|2|||
160498684|NCT00709228|579554404|FG000|Overall Study|Discontinued treatment|14|||
160498685|NCT00709228|579554404|FG000|Overall Study|Did not enter follow-up|4|||
160498686|NCT00709228|579554404|FG000|Overall Study|Discontinued follow-up|5|||
160498687|NCT00709228|579554404|FG000|Overall Study|Disease progression|1|||
160498688|NCT00709228|579554404|FG000|Overall Study|Lost to Follow-up|6|||
160498689|NCT00709228|579554404|FG000|Overall Study|Non-compliance|5|||
160498690|NCT02179177|579554407|FG000|Overall Study|Lost to Follow-up|1|||
160498691|NCT02179177|579554408|FG001|Overall Study|Lost to Follow-up|1|||
160498692|NCT02179177|579554407|FG000|Overall Study|Withdrawal by Subject|1|||
160498693|NCT02179177|579554408|FG001|Overall Study|Withdrawal by Subject|1|||
160498694|NCT00022659|579554409|FG000|Overall Study|Ineligible: wrong primary|1|||
160498695|NCT00022659|579554409|FG000|Overall Study|Never treated|1|||
160498696|NCT00884650|579554410|FG000|Overall Study|Did not return complete pain diaries|7|||
160498697|NCT00884650|579554411|FG001|Overall Study|Did not return complete pain diaries|7|||
160498698|NCT00884650|579554410|FG000|Overall Study|Admitted Post-Op|1|||
160498699|NCT00884650|579554411|FG001|Overall Study|Admitted Post-Op|0|||
160498700|NCT00884650|579554410|FG000|Overall Study|Femoral Stress Fracture|1|||
160498701|NCT00884650|579554411|FG001|Overall Study|Femoral Stress Fracture|0|||
160498702|NCT00884650|579554410|FG000|Overall Study|Pain Pump Complication|0|||
160498703|NCT00884650|579554411|FG001|Overall Study|Pain Pump Complication|1|||
160498704|NCT04052425|579554412|FG000|24-Week Double-blind Period|Adverse Event|0|||
160498705|NCT04052425|579554413|FG001|24-Week Double-blind Period|Adverse Event|1|||
160498706|NCT04052425|579554414|FG002|24-Week Double-blind Period|Adverse Event|0|||
160498707|NCT04052425|579554415|FG003|24-Week Double-blind Period|Adverse Event|0|||
160498708|NCT04052425|579554412|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
160498709|NCT04052425|579554413|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
160498710|NCT04052425|579554414|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
160498711|NCT04052425|579554415|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
160498712|NCT04052425|579554412|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
160498713|NCT04052425|579554413|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
160498714|NCT04052425|579554414|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
160498715|NCT04052425|579554415|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
160498716|NCT04052425|579554412|FG000|24-Week Double-blind Period|Physician Decision|1|||
160498717|NCT04052425|579554413|FG001|24-Week Double-blind Period|Physician Decision|0|||
160498718|NCT04052425|579554414|FG002|24-Week Double-blind Period|Physician Decision|0|||
160498719|NCT04052425|579554415|FG003|24-Week Double-blind Period|Physician Decision|0|||
160498720|NCT04052425|579554412|FG000|24-Week Double-blind Period|Protocol Violation|1|||
160498721|NCT04052425|579554413|FG001|24-Week Double-blind Period|Protocol Violation|0|||
160498722|NCT04052425|579554414|FG002|24-Week Double-blind Period|Protocol Violation|0|||
160498723|NCT04052425|579554415|FG003|24-Week Double-blind Period|Protocol Violation|0|||
160498724|NCT04052425|579554412|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
160498725|NCT04052425|579554413|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
160498726|NCT04052425|579554414|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
160498727|NCT04052425|579554415|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
160498728|NCT04052425|579554412|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
160498729|NCT04052425|579554413|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
160498730|NCT04052425|579554414|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
160498731|NCT04052425|579554415|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
160498732|NCT04052425|579554412|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
160498733|NCT04052425|579554413|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
160498734|NCT04052425|579554414|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
160498735|NCT04052425|579554415|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
160498736|NCT04052425|579554412|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
160498737|NCT04052425|579554413|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
160498738|NCT04052425|579554414|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
160498739|NCT04052425|579554415|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
160498740|NCT04052425|579554412|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
160498741|NCT04052425|579554413|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
160498742|NCT04052425|579554414|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
160498743|NCT04052425|579554415|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
160498744|NCT04052425|579554412|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
160498745|NCT04052425|579554413|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
160498746|NCT04052425|579554414|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
160498747|NCT04052425|579554415|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
160619132|NCT00525499|579984891|FG003|Overall Study|Lost to Follow-up|4|||
160619133|NCT00525499|579984888|FG000|Overall Study|Adverse Event|0|||
160498748|NCT04052425|579554412|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
160498749|NCT04052425|579554413|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
160498750|NCT04052425|579554414|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
160498751|NCT04052425|579554415|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
160498752|NCT04052425|579554412|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
160498753|NCT04052425|579554413|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
160498754|NCT04052425|579554414|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
160498755|NCT04052425|579554415|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
160498756|NCT04052425|579554412|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
160498757|NCT04052425|579554413|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
160498758|NCT04052425|579554414|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
160498759|NCT04052425|579554415|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
160498760|NCT04334278|579554416|FG000|Overall Study|Lost to Follow-up|0|||
160498761|NCT04334278|579554417|FG001|Overall Study|Lost to Follow-up|3|||
160498762|NCT04334278|579554416|FG000|Overall Study|Withdrawal by Subject|4|||
160498763|NCT04334278|579554417|FG001|Overall Study|Withdrawal by Subject|2|||
160498764|NCT01516749|579554420|FG000|Active Therapy|Lost to Follow-up|1|||
160498765|NCT01516749|579554420|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
160498766|NCT01732549|579554421|FG000|Overall Study|Adverse Event|13|||
160498767|NCT01732549|579554422|FG001|Overall Study|Adverse Event|3|||
160498768|NCT01732549|579554421|FG000|Overall Study|Consent withdrawn|13|||
160498769|NCT01732549|579554422|FG001|Overall Study|Consent withdrawn|6|||
160498770|NCT01732549|579554421|FG000|Overall Study|Disease progression|37|||
160498771|NCT01732549|579554422|FG001|Overall Study|Disease progression|50|||
160498772|NCT01732549|579554421|FG000|Overall Study|Other|8|||
160498773|NCT01732549|579554422|FG001|Overall Study|Other|14|||
160498774|NCT03994731|579554424|FG000|Pegloticase + IMM Period|Death|2|||
160498775|NCT03994731|579554425|FG001|Pegloticase + IMM Period|Death|0|||
160498776|NCT03994731|579554424|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
160498777|NCT03994731|579554425|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
160498778|NCT03994731|579554424|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
160498779|NCT03994731|579554425|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
160498780|NCT00447590|579554428|FG000|Overall Study|Withdrawal by Subject|26|||
160498781|NCT00447590|579554428|FG000|Overall Study|Lost to Follow-up|24|||
160498782|NCT00447590|579554428|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
160498783|NCT03880019|579554429|FG000|Overall Study|Competing disease|1|||
160498784|NCT00732992|579554430|FG000|Overall Study|Adverse Event|1|||
160498785|NCT00732992|579554431|FG001|Overall Study|Adverse Event|1|||
160498786|NCT00732992|579554430|FG000|Overall Study|Objective Progression or Relapse|3|||
160498787|NCT00732992|579554431|FG001|Overall Study|Objective Progression or Relapse|5|||
160498788|NCT00732992|579554430|FG000|Overall Study|Global Deterioration of Health Status|1|||
160498789|NCT00732992|579554431|FG001|Overall Study|Global Deterioration of Health Status|0|||
160498790|NCT00732992|579554430|FG000|Overall Study|Withdrawal by Subject|1|||
160498791|NCT00732992|579554431|FG001|Overall Study|Withdrawal by Subject|0|||
160498792|NCT01163474|579554439|FG000|Overall Study|Withdrawal by Subject|1|||
160498793|NCT01163474|579554439|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
160498794|NCT01163474|579554439|FG000|Overall Study|Lost to Follow-up|3|||
160498795|NCT02878603|579554440|FG000|Overall Study|Lost to Follow-up|4|||
160498796|NCT02878603|579554441|FG001|Overall Study|Lost to Follow-up|1|||
160498797|NCT02878603|579554440|FG000|Overall Study|Withdrawal by Subject|1|||
160498798|NCT02878603|579554441|FG001|Overall Study|Withdrawal by Subject|1|||
160498799|NCT02878603|579554440|FG000|Overall Study|Death|1|||
160498800|NCT02878603|579554441|FG001|Overall Study|Death|0|||
160498801|NCT02878603|579554440|FG000|Overall Study|Physician Decision|0|||
160498802|NCT02878603|579554441|FG001|Overall Study|Physician Decision|3|||
160498803|NCT03274895|579554442|FG000|Overall Study|Lack of Efficacy|1|||
160498804|NCT03274895|579554443|FG001|Overall Study|Lack of Efficacy|0|||
160498805|NCT03274895|579554442|FG000|Overall Study|Adverse Event|8|||
160498806|NCT03274895|579554443|FG001|Overall Study|Adverse Event|7|||
160498807|NCT03274895|579554442|FG000|Overall Study|Lost to Follow-up|1|||
160498808|NCT03274895|579554443|FG001|Overall Study|Lost to Follow-up|0|||
160498809|NCT03274895|579554442|FG000|Overall Study|Diagnosis not confirmed|3|||
160498810|NCT03274895|579554443|FG001|Overall Study|Diagnosis not confirmed|4|||
160498811|NCT01969851|579554444|FG000|Overall Study|Adverse Event|0|||
160498812|NCT01969851|579554445|FG001|Overall Study|Adverse Event|0|||
160498813|NCT01969851|579554446|FG002|Overall Study|Adverse Event|3|||
160498814|NCT01969851|579554444|FG000|Overall Study|Lack of Efficacy|0|||
160498815|NCT01969851|579554445|FG001|Overall Study|Lack of Efficacy|3|||
160498816|NCT01969851|579554446|FG002|Overall Study|Lack of Efficacy|1|||
160498817|NCT01969851|579554444|FG000|Overall Study|Withdrawal by Subject|1|||
160498818|NCT01969851|579554445|FG001|Overall Study|Withdrawal by Subject|0|||
160498819|NCT01969851|579554446|FG002|Overall Study|Withdrawal by Subject|1|||
160498820|NCT01969851|579554444|FG000|Overall Study|No effective dose in Titration period|0|||
160498821|NCT01969851|579554445|FG001|Overall Study|No effective dose in Titration period|0|||
160619134|NCT00525499|579984889|FG001|Overall Study|Adverse Event|1|||
160619135|NCT00525499|579984890|FG002|Overall Study|Adverse Event|0|||
160619136|NCT00525499|579984891|FG003|Overall Study|Adverse Event|1|||
160619137|NCT00525499|579984888|FG000|Overall Study|Withdrawal by Subject|5|||
160619138|NCT00525499|579984889|FG001|Overall Study|Withdrawal by Subject|1|||
160619139|NCT00525499|579984890|FG002|Overall Study|Withdrawal by Subject|5|||
160498822|NCT01969851|579554446|FG002|Overall Study|No effective dose in Titration period|1|||
160498823|NCT01969851|579554444|FG000|Overall Study|Sponsor decision|0|||
160498824|NCT01969851|579554445|FG001|Overall Study|Sponsor decision|0|||
160498825|NCT01969851|579554446|FG002|Overall Study|Sponsor decision|1|||
160498826|NCT01294436|579554451|FG000|Overall Study|Adverse Event|10|||
160498827|NCT01294436|579554452|FG001|Overall Study|Adverse Event|17|||
160498828|NCT01294436|579554451|FG000|Overall Study|Withdrawal by Subject|11|||
160498829|NCT01294436|579554452|FG001|Overall Study|Withdrawal by Subject|28|||
160498830|NCT01294436|579554451|FG000|Overall Study|subject no longer meets study criteria|5|||
160498831|NCT01294436|579554452|FG001|Overall Study|subject no longer meets study criteria|20|||
160498832|NCT01294436|579554451|FG000|Overall Study|poor/non-compliance|2|||
160498833|NCT01294436|579554452|FG001|Overall Study|poor/non-compliance|5|||
160498834|NCT02389764|579554453|FG000|Overall Study|Lack of Efficacy|9|||
160498835|NCT00585078|579554456|FG000|Overall Study|Withdrawal by Subject|4|||
160498836|NCT00585078|579554456|FG000|Overall Study|Poor performance status|1|||
160498837|NCT00585078|579554456|FG000|Overall Study|Disease Progression|24|||
160498838|NCT00585078|579554456|FG000|Overall Study|Adverse Event|10|||
160498839|NCT00585078|579554456|FG000|Overall Study|Death|1|||
160498840|NCT01814072|579554459|FG000|Overall Study|Lost to Follow-up|2|||
160498841|NCT01814072|579554460|FG001|Overall Study|Lost to Follow-up|2|||
160498842|NCT01814072|579554461|FG002|Overall Study|Lost to Follow-up|2|||
160498843|NCT01814072|579554462|FG003|Overall Study|Lost to Follow-up|0|||
160498844|NCT01814072|579554463|FG004|Overall Study|Lost to Follow-up|2|||
160498845|NCT01814072|579554464|FG005|Overall Study|Lost to Follow-up|3|||
160498846|NCT01814072|579554465|FG006|Overall Study|Lost to Follow-up|3|||
160498847|NCT01814072|579554466|FG007|Overall Study|Lost to Follow-up|1|||
160498848|NCT01814072|579554467|FG008|Overall Study|Lost to Follow-up|2|||
160498849|NCT01814072|579554468|FG009|Overall Study|Lost to Follow-up|3|||
160498850|NCT01814072|579554469|FG010|Overall Study|Lost to Follow-up|1|||
160498851|NCT01814072|579554470|FG011|Overall Study|Lost to Follow-up|2|||
160498852|NCT01814072|579554471|FG012|Overall Study|Lost to Follow-up|2|||
160498853|NCT01814072|579554472|FG013|Overall Study|Lost to Follow-up|1|||
160498854|NCT01814072|579554473|FG014|Overall Study|Lost to Follow-up|2|||
160498855|NCT01814072|579554474|FG015|Overall Study|Lost to Follow-up|1|||
160498856|NCT01814072|579554475|FG016|Overall Study|Lost to Follow-up|3|||
160498857|NCT01814072|579554476|FG017|Overall Study|Lost to Follow-up|1|||
160498858|NCT01814072|579554477|FG018|Overall Study|Lost to Follow-up|3|||
160498859|NCT01814072|579554478|FG019|Overall Study|Lost to Follow-up|3|||
160498860|NCT01814072|579554479|FG020|Overall Study|Lost to Follow-up|2|||
160498861|NCT01814072|579554480|FG021|Overall Study|Lost to Follow-up|1|||
160498862|NCT01814072|579554481|FG022|Overall Study|Lost to Follow-up|3|||
160498863|NCT01814072|579554482|FG023|Overall Study|Lost to Follow-up|1|||
160498864|NCT01814072|579554483|FG024|Overall Study|Lost to Follow-up|4|||
160498865|NCT01814072|579554484|FG025|Overall Study|Lost to Follow-up|1|||
160498866|NCT01814072|579554485|FG026|Overall Study|Lost to Follow-up|1|||
160498867|NCT01814072|579554486|FG027|Overall Study|Lost to Follow-up|2|||
160498868|NCT01814072|579554487|FG028|Overall Study|Lost to Follow-up|3|||
160498869|NCT01814072|579554488|FG029|Overall Study|Lost to Follow-up|3|||
160498870|NCT01814072|579554489|FG030|Overall Study|Lost to Follow-up|2|||
160498871|NCT01814072|579554490|FG031|Overall Study|Lost to Follow-up|0|||
160498872|NCT01814072|579554459|FG000|Overall Study|Withdrawal by Subject|2|||
160498873|NCT01814072|579554460|FG001|Overall Study|Withdrawal by Subject|0|||
160498874|NCT01814072|579554461|FG002|Overall Study|Withdrawal by Subject|1|||
160498875|NCT01814072|579554462|FG003|Overall Study|Withdrawal by Subject|0|||
160498876|NCT01814072|579554463|FG004|Overall Study|Withdrawal by Subject|2|||
160498877|NCT01814072|579554464|FG005|Overall Study|Withdrawal by Subject|3|||
160498878|NCT01814072|579554465|FG006|Overall Study|Withdrawal by Subject|1|||
160498879|NCT01814072|579554466|FG007|Overall Study|Withdrawal by Subject|0|||
160498880|NCT01814072|579554467|FG008|Overall Study|Withdrawal by Subject|1|||
160619140|NCT00525499|579984891|FG003|Overall Study|Withdrawal by Subject|2|||
160498881|NCT01814072|579554468|FG009|Overall Study|Withdrawal by Subject|2|||
160498882|NCT01814072|579554469|FG010|Overall Study|Withdrawal by Subject|0|||
160498883|NCT01814072|579554470|FG011|Overall Study|Withdrawal by Subject|0|||
160498884|NCT01814072|579554471|FG012|Overall Study|Withdrawal by Subject|1|||
160498885|NCT01814072|579554472|FG013|Overall Study|Withdrawal by Subject|1|||
160498886|NCT01814072|579554473|FG014|Overall Study|Withdrawal by Subject|1|||
160498887|NCT01814072|579554474|FG015|Overall Study|Withdrawal by Subject|1|||
160498888|NCT01814072|579554475|FG016|Overall Study|Withdrawal by Subject|0|||
160498889|NCT01814072|579554476|FG017|Overall Study|Withdrawal by Subject|0|||
160498890|NCT01814072|579554477|FG018|Overall Study|Withdrawal by Subject|0|||
160498891|NCT01814072|579554478|FG019|Overall Study|Withdrawal by Subject|2|||
160498892|NCT01814072|579554479|FG020|Overall Study|Withdrawal by Subject|0|||
160498893|NCT01814072|579554480|FG021|Overall Study|Withdrawal by Subject|0|||
160498894|NCT01814072|579554481|FG022|Overall Study|Withdrawal by Subject|1|||
160498895|NCT01814072|579554482|FG023|Overall Study|Withdrawal by Subject|0|||
160498896|NCT01814072|579554483|FG024|Overall Study|Withdrawal by Subject|2|||
160498897|NCT01814072|579554484|FG025|Overall Study|Withdrawal by Subject|1|||
160498898|NCT01814072|579554485|FG026|Overall Study|Withdrawal by Subject|1|||
160498899|NCT01814072|579554486|FG027|Overall Study|Withdrawal by Subject|2|||
160498900|NCT01814072|579554487|FG028|Overall Study|Withdrawal by Subject|1|||
160498901|NCT01814072|579554488|FG029|Overall Study|Withdrawal by Subject|0|||
160498902|NCT01814072|579554489|FG030|Overall Study|Withdrawal by Subject|0|||
160498903|NCT01814072|579554490|FG031|Overall Study|Withdrawal by Subject|0|||
160498904|NCT02781311|579554491|FG000|Overall Study|Adverse Event|2|||
160498905|NCT02781311|579554492|FG001|Overall Study|Adverse Event|6|||
160498906|NCT02781311|579554493|FG002|Overall Study|Adverse Event|1|||
160498907|NCT02781311|579554491|FG000|Overall Study|Withdrawal of Consent|11|||
160498908|NCT02781311|579554492|FG001|Overall Study|Withdrawal of Consent|12|||
160498909|NCT02781311|579554493|FG002|Overall Study|Withdrawal of Consent|2|||
160498910|NCT02781311|579554491|FG000|Overall Study|Lost to Follow-up|11|||
160498911|NCT02781311|579554492|FG001|Overall Study|Lost to Follow-up|8|||
160498912|NCT02781311|579554493|FG002|Overall Study|Lost to Follow-up|1|||
160498913|NCT02781311|579554491|FG000|Overall Study|Non-Compliance with Study Drug|2|||
160498914|NCT02781311|579554492|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160498915|NCT02781311|579554493|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160498916|NCT01011868|579554498|FG000|After Week 18 Follow-up|Adverse Event|8|||
160498917|NCT01011868|579554499|FG001|After Week 18 Follow-up|Adverse Event|6|||
160498918|NCT01011868|579554500|FG002|After Week 18 Follow-up|Adverse Event|13|||
160498919|NCT01011868|579554498|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
160498920|NCT01011868|579554499|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
160498921|NCT01011868|579554500|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
160498922|NCT01011868|579554498|FG000|After Week 18 Follow-up|Protocol Violation|1|||
160498923|NCT01011868|579554499|FG001|After Week 18 Follow-up|Protocol Violation|1|||
160498924|NCT01011868|579554500|FG002|After Week 18 Follow-up|Protocol Violation|1|||
160498925|NCT01011868|579554498|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
160498926|NCT01011868|579554499|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
160498927|NCT01011868|579554500|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
160498928|NCT01011868|579554498|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
160498929|NCT01011868|579554499|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
160498930|NCT01011868|579554500|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
160498931|NCT01011868|579554498|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
160498932|NCT01011868|579554499|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
160498933|NCT01011868|579554500|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
160498934|NCT01011868|579554498|FG000|After Week 78 Follow-up|Adverse Event|14|||
160498935|NCT01011868|579554499|FG001|After Week 78 Follow-up|Adverse Event|18|||
160498936|NCT01011868|579554500|FG002|After Week 78 Follow-up|Adverse Event|21|||
160498937|NCT01011868|579554498|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
160498938|NCT01011868|579554499|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
160498939|NCT01011868|579554500|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
160498940|NCT01011868|579554498|FG000|After Week 78 Follow-up|Protocol Violation|9|||
160498941|NCT01011868|579554499|FG001|After Week 78 Follow-up|Protocol Violation|1|||
160498942|NCT01011868|579554500|FG002|After Week 78 Follow-up|Protocol Violation|2|||
160498943|NCT01011868|579554498|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
160498944|NCT01011868|579554499|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
160498945|NCT01011868|579554500|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
160498946|NCT01011868|579554498|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
160498947|NCT01011868|579554499|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
160498948|NCT01011868|579554500|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
160498949|NCT01011868|579554498|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
160498950|NCT01011868|579554499|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
160498951|NCT01011868|579554500|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
160498952|NCT02615938|579554501|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
160498953|NCT02615938|579554502|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
160498954|NCT02615938|579554503|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
160498955|NCT02615938|579554504|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
160498956|NCT02615938|579554501|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
160498957|NCT02615938|579554502|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
160498958|NCT02615938|579554503|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
160498959|NCT02615938|579554504|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
160498960|NCT02615938|579554501|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
160498961|NCT02615938|579554502|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
160498962|NCT02615938|579554503|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
160498963|NCT02615938|579554504|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
160619141|NCT00525499|579984888|FG000|Overall Study|Protocol Violation|0|||
160498964|NCT04905849|579554506|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
160498965|NCT04905849|579554507|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
160498966|NCT04199052|579554515|FG000|Overall Study|Lost to Follow-up|11|||
160498967|NCT04199052|579554516|FG001|Overall Study|Lost to Follow-up|18|||
160498968|NCT01358331|579554517|FG000|Overall Study|Lost to Follow-up|0|||
160498969|NCT01358331|579554518|FG001|Overall Study|Lost to Follow-up|0|||
160498970|NCT01358331|579554519|FG002|Overall Study|Lost to Follow-up|0|||
160498971|NCT01358331|579554520|FG003|Overall Study|Lost to Follow-up|1|||
160498972|NCT01358331|579554521|FG004|Overall Study|Lost to Follow-up|0|||
160498973|NCT01358331|579554522|FG005|Overall Study|Lost to Follow-up|0|||
160498974|NCT01358331|579554517|FG000|Overall Study|Withdrawal by Subject|0|||
160498975|NCT01358331|579554518|FG001|Overall Study|Withdrawal by Subject|0|||
160498976|NCT01358331|579554519|FG002|Overall Study|Withdrawal by Subject|0|||
160498977|NCT01358331|579554520|FG003|Overall Study|Withdrawal by Subject|1|||
160498978|NCT01358331|579554521|FG004|Overall Study|Withdrawal by Subject|1|||
160498979|NCT01358331|579554522|FG005|Overall Study|Withdrawal by Subject|1|||
160498980|NCT01358331|579554517|FG000|Overall Study|Adverse Events|1|||
160498981|NCT01358331|579554518|FG001|Overall Study|Adverse Events|1|||
160498982|NCT01358331|579554519|FG002|Overall Study|Adverse Events|1|||
160498983|NCT01358331|579554520|FG003|Overall Study|Adverse Events|0|||
160498984|NCT01358331|579554521|FG004|Overall Study|Adverse Events|1|||
160498985|NCT01358331|579554522|FG005|Overall Study|Adverse Events|5|||
160498986|NCT01358331|579554517|FG000|Overall Study|Symptomatic Deterioration|0|||
160498987|NCT01358331|579554518|FG001|Overall Study|Symptomatic Deterioration|0|||
160498988|NCT01358331|579554519|FG002|Overall Study|Symptomatic Deterioration|0|||
160498989|NCT01358331|579554520|FG003|Overall Study|Symptomatic Deterioration|0|||
160498990|NCT01358331|579554521|FG004|Overall Study|Symptomatic Deterioration|1|||
160498991|NCT01358331|579554522|FG005|Overall Study|Symptomatic Deterioration|0|||
160498992|NCT01358331|579554517|FG000|Overall Study|Participants did not wish to continue|0|||
160498993|NCT01358331|579554518|FG001|Overall Study|Participants did not wish to continue|0|||
160498994|NCT01358331|579554519|FG002|Overall Study|Participants did not wish to continue|0|||
160498995|NCT01358331|579554520|FG003|Overall Study|Participants did not wish to continue|0|||
160498996|NCT01358331|579554521|FG004|Overall Study|Participants did not wish to continue|1|||
160498997|NCT01358331|579554522|FG005|Overall Study|Participants did not wish to continue|0|||
160498998|NCT01358331|579554517|FG000|Overall Study|Progress of disease under investigation|1|||
160498999|NCT01358331|579554518|FG001|Overall Study|Progress of disease under investigation|2|||
160499000|NCT01358331|579554519|FG002|Overall Study|Progress of disease under investigation|3|||
160499001|NCT01358331|579554520|FG003|Overall Study|Progress of disease under investigation|1|||
160499002|NCT01358331|579554521|FG004|Overall Study|Progress of disease under investigation|3|||
160499003|NCT01358331|579554522|FG005|Overall Study|Progress of disease under investigation|0|||
160499004|NCT04946942|579554523|FG000|Overall Study|Lost to Follow-up|6|||
160499005|NCT04946942|579554524|FG001|Overall Study|Lost to Follow-up|2|||
160499006|NCT04946942|579554525|FG002|Overall Study|Lost to Follow-up|0|||
160499007|NCT04907357|579554526|FG000|Overall Study|Death|0|||
160499008|NCT04907357|579554527|FG001|Overall Study|Death|1|||
160499009|NCT04907357|579554526|FG000|Overall Study|Lost to Follow-up|9|||
160499010|NCT04907357|579554527|FG001|Overall Study|Lost to Follow-up|18|||
160499011|NCT04907357|579554526|FG000|Overall Study|Physician Decision|1|||
160499012|NCT04907357|579554527|FG001|Overall Study|Physician Decision|0|||
160499013|NCT04907357|579554526|FG000|Overall Study|Withdrawal by Subject|0|||
160499014|NCT04907357|579554527|FG001|Overall Study|Withdrawal by Subject|1|||
160499015|NCT04907357|579554526|FG000|Overall Study|Unable to attend visits|1|||
160499016|NCT04907357|579554527|FG001|Overall Study|Unable to attend visits|0|||
160499017|NCT04907357|579554526|FG000|Overall Study|Incarcerated|1|||
160499018|NCT04907357|579554527|FG001|Overall Study|Incarcerated|1|||
160499019|NCT02520310|579554530|FG000|At 6 Months Clinical Follow-up|Death|1|||
160499020|NCT02520310|579554530|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
160499021|NCT02520310|579554530|FG000|AT 3 Year Clinical Follow-up|Death|2|||
160499022|NCT02520310|579554530|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
160499023|NCT02520310|579554530|FG000|AT 4 Year Clinical Follow-up|Death|1|||
160499024|NCT02520310|579554530|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
160499025|NCT01340014|579554531|FG000|Period 1, First 7 Days|Adverse Event|1|||
160499026|NCT01340014|579554532|FG001|Period 1, First 7 Days|Adverse Event|0|||
160499027|NCT01340014|579554531|FG000|Period 1, First 7 Days|Personal Reasons|1|||
160499028|NCT01340014|579554532|FG001|Period 1, First 7 Days|Personal Reasons|0|||
160499029|NCT01340014|579554531|FG000|Period 2, Second 7 Days|Adverse Event|0|||
160499030|NCT01340014|579554532|FG001|Period 2, Second 7 Days|Adverse Event|1|||
160499031|NCT05101993|579554539|FG000|Overall Study|Withdrawal by Subject|1|||
160499032|NCT04577573|579554540|FG000|Overall Study|Technical - invalid protocol|0|||
160499033|NCT04577573|579554541|FG001|Overall Study|Technical - invalid protocol|2|||
160499034|NCT04577573|579554542|FG002|Overall Study|Technical - invalid protocol|0|||
160499035|NCT02065882|579554546|FG000|Part I: PK/PD|Screening failure|5|||
160499036|NCT02065882|579554546|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
160619142|NCT00525499|579984889|FG001|Overall Study|Protocol Violation|1|||
160499037|NCT02065882|579554546|FG000|Part I: PK/PD|Adverse Event|1|||
160499038|NCT02065882|579554546|FG000|Part II: Clinical Efficacy|Screening failure|7|||
160499039|NCT02065882|579554546|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
160499040|NCT02065882|579554546|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
160499041|NCT02065882|579554546|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
160499042|NCT02065882|579554546|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
160499043|NCT02065882|579554546|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
160499044|NCT02113124|579556100|FG000|Overall Study|Unable to retrieve blood sample|1|||
160499045|NCT02113124|579556101|FG001|Overall Study|Unable to retrieve blood sample|1|||
160499046|NCT01888874|579556102|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
160499047|NCT01888874|579556103|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
160499048|NCT01888874|579556104|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
160499049|NCT01888874|579556105|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
160499050|NCT01888874|579556106|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
160499051|NCT01888874|579556107|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
160499052|NCT01888874|579556108|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
160499053|NCT01888874|579556102|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
160499054|NCT01888874|579556103|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
160499055|NCT01888874|579556104|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
160499056|NCT01888874|579556105|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
160499057|NCT01888874|579556106|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
160499058|NCT01888874|579556107|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
160499059|NCT01888874|579556108|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
160499060|NCT01888874|579556102|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
160499061|NCT01888874|579556103|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
160499062|NCT01888874|579556104|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
160499063|NCT01888874|579556105|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
160499064|NCT01888874|579556106|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
160499065|NCT01888874|579556107|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
160499066|NCT01888874|579556108|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
160499067|NCT01888874|579556102|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
160499068|NCT01888874|579556103|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
160499069|NCT01888874|579556104|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
160499070|NCT01888874|579556105|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
160499071|NCT01888874|579556106|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
160499072|NCT01888874|579556107|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
160499073|NCT01888874|579556108|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
160499074|NCT01888874|579556102|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
160499075|NCT01888874|579556103|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
160499076|NCT01888874|579556104|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
160499077|NCT01888874|579556105|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
160499078|NCT01888874|579556106|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
160499079|NCT01888874|579556107|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
160499080|NCT01888874|579556108|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
160499081|NCT01888874|579556102|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
160499082|NCT01888874|579556103|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
160499083|NCT01888874|579556104|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
160499084|NCT01888874|579556105|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
160499085|NCT01888874|579556106|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
160499086|NCT01888874|579556107|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
160499087|NCT01888874|579556108|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
160499088|NCT01888874|579556102|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
160499089|NCT01888874|579556103|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
160499090|NCT01888874|579556104|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
160499091|NCT01888874|579556105|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
160499092|NCT01888874|579556106|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
160499093|NCT01888874|579556107|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
160499094|NCT01888874|579556108|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
160499095|NCT01888874|579556102|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
160499096|NCT01888874|579556103|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
160499097|NCT01888874|579556104|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
160619143|NCT00525499|579984890|FG002|Overall Study|Protocol Violation|1|||
160619144|NCT00525499|579984891|FG003|Overall Study|Protocol Violation|0|||
160619145|NCT01856920|579984894|FG000|Overall Study|Disease Progression On Study|3|||
160499098|NCT01888874|579556105|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
160619146|NCT01856920|579984895|FG001|Overall Study|Disease Progression On Study|4|||
160662137|NCT02726581|580145640|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
160662138|NCT02726581|580145641|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
160662139|NCT02726581|580145639|FG000|Treatment Period|Maximum clinical benefit|0|||
160662140|NCT02726581|580145640|FG001|Treatment Period|Maximum clinical benefit|2|||
160662141|NCT02726581|580145641|FG002|Treatment Period|Maximum clinical benefit|0|||
160662142|NCT02726581|580145639|FG000|Treatment Period|Death|1|||
160662143|NCT02726581|580145640|FG001|Treatment Period|Death|0|||
160662144|NCT02726581|580145641|FG002|Treatment Period|Death|0|||
160662145|NCT02726581|580145639|FG000|Treatment Period|Poor/non-compliance|1|||
160662146|NCT02726581|580145640|FG001|Treatment Period|Poor/non-compliance|0|||
160662147|NCT02726581|580145641|FG002|Treatment Period|Poor/non-compliance|0|||
160662148|NCT02726581|580145639|FG000|Treatment Period|Participant no longer meets study criteria|0|||
160662149|NCT02726581|580145640|FG001|Treatment Period|Participant no longer meets study criteria|1|||
160662150|NCT02726581|580145641|FG002|Treatment Period|Participant no longer meets study criteria|0|||
160662151|NCT03687736|580145645|FG000|Overall Study|Lost to Follow-up|7|||
160662152|NCT03687736|580145645|FG000|Overall Study|Withdrawal by Subject|3|||
160662153|NCT01844375|580145646|FG000|Overall Study|Protocol Violation|1|||
160662154|NCT01844375|580145647|FG001|Overall Study|Protocol Violation|1|||
160662155|NCT03496623|580145651|FG000|Run-In Period (2 Weeks)|Death|1|||
160662156|NCT03496623|580145652|FG001|Run-In Period (2 Weeks)|Death|0|||
160662157|NCT03496623|580145653|FG002|Run-In Period (2 Weeks)|Death|0|||
160662158|NCT03496623|580145654|FG003|Run-In Period (2 Weeks)|Death|0|||
160662159|NCT03496623|580145655|FG004|Run-In Period (2 Weeks)|Death|0|||
160662160|NCT03496623|580145651|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
160662161|NCT03496623|580145652|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
160662162|NCT03496623|580145653|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
160662163|NCT03496623|580145654|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
160662164|NCT03496623|580145655|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
160662165|NCT03496623|580145651|FG000|Period 1 (12 Weeks)|Death|0|||
160662166|NCT03496623|580145652|FG001|Period 1 (12 Weeks)|Death|3|||
160662167|NCT03496623|580145653|FG002|Period 1 (12 Weeks)|Death|0|||
160662168|NCT03496623|580145654|FG003|Period 1 (12 Weeks)|Death|0|||
160662169|NCT03496623|580145655|FG004|Period 1 (12 Weeks)|Death|0|||
160662170|NCT03496623|580145651|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
160662171|NCT03496623|580145652|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
160662172|NCT03496623|580145653|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
160662173|NCT03496623|580145654|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
160662174|NCT03496623|580145655|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
160662175|NCT03496623|580145651|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160662176|NCT03496623|580145652|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
160662177|NCT03496623|580145653|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
160662178|NCT03496623|580145654|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160662179|NCT03496623|580145655|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160662180|NCT03496623|580145651|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
160662181|NCT03496623|580145652|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
160662182|NCT03496623|580145653|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
160662183|NCT03496623|580145654|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
160662184|NCT03496623|580145655|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
160662185|NCT03496623|580145651|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160662186|NCT03496623|580145652|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160662187|NCT03496623|580145653|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
160662188|NCT03496623|580145654|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160662189|NCT03496623|580145655|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160662190|NCT03496623|580145651|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
160662191|NCT03496623|580145652|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
160662192|NCT03496623|580145653|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
160662193|NCT03496623|580145654|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
160662194|NCT03496623|580145655|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
160662195|NCT03496623|580145651|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160662196|NCT03496623|580145652|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
160662197|NCT03496623|580145653|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160662198|NCT03496623|580145654|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160662199|NCT03496623|580145655|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160662200|NCT01061866|580145656|FG000|Overall Study|Adverse Event|2|||
160662201|NCT02543203|580145657|FG000|Overall Study|Unpalatable Fragrance|2|||
160499099|NCT01888874|579556106|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
160499100|NCT01888874|579556107|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
160499101|NCT01888874|579556108|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
160499102|NCT01888874|579556102|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
160499103|NCT01888874|579556103|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
160499104|NCT01888874|579556104|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
160499105|NCT01888874|579556105|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
160499106|NCT01888874|579556106|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
160499107|NCT01888874|579556107|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
160499108|NCT01888874|579556108|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
160499109|NCT01888874|579556102|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
160499110|NCT01888874|579556103|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
160499111|NCT01888874|579556104|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
160499112|NCT01888874|579556105|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
160499113|NCT01888874|579556106|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
160499114|NCT01888874|579556107|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
160499115|NCT01888874|579556108|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
160499116|NCT01888874|579556102|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
160499117|NCT01888874|579556103|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
160499118|NCT01888874|579556104|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
160499119|NCT01888874|579556105|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
160499120|NCT01888874|579556106|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
160499121|NCT01888874|579556107|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
160499122|NCT01888874|579556108|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
160499123|NCT01888874|579556102|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
160499124|NCT01888874|579556103|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
160499125|NCT01888874|579556104|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
160499126|NCT01888874|579556105|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
160499127|NCT01888874|579556106|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
160499128|NCT01888874|579556107|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
160499129|NCT01888874|579556108|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
160499130|NCT01888874|579556102|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
160499131|NCT01888874|579556103|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
160499132|NCT01888874|579556104|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
160499133|NCT01888874|579556105|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
160499134|NCT01888874|579556106|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
160499135|NCT01888874|579556107|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
160499136|NCT01888874|579556108|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
160499137|NCT02763215|579556109|FG000|Overall Study|Participants withdrew from study|3|||
160499138|NCT02763215|579556109|FG000|Overall Study|Missed visit|1|||
160499139|NCT02763215|579556109|FG000|Overall Study|Visit outside visit-window|1|||
160499140|NCT02763215|579556109|FG000|Overall Study|Death|1|||
160499141|NCT02763215|579556109|FG000|Overall Study|Lost to Follow-up|1|||
160499142|NCT02963090|579556110|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
160499143|NCT02963090|579556111|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
160499144|NCT00945672|579556116|FG000|Overall Study|Withdrawal by Subject|0|||
160499145|NCT00945672|579556117|FG001|Overall Study|Withdrawal by Subject|0|||
160499146|NCT00945672|579556118|FG002|Overall Study|Withdrawal by Subject|0|||
160499147|NCT00945672|579556119|FG003|Overall Study|Withdrawal by Subject|1|||
160499148|NCT01681992|579556124|FG000|Overall Study|Adverse Event|3|||
160499149|NCT01681992|579556125|FG001|Overall Study|Adverse Event|2|||
160499150|NCT01681992|579556126|FG002|Overall Study|Adverse Event|3|||
160499151|NCT01681992|579556124|FG000|Overall Study|Lost to Follow-up|36|||
160499152|NCT01681992|579556125|FG001|Overall Study|Lost to Follow-up|38|||
160499153|NCT01681992|579556126|FG002|Overall Study|Lost to Follow-up|53|||
160499154|NCT01681992|579556124|FG000|Overall Study|As Per Sponsor Decision|0|||
160499155|NCT01681992|579556125|FG001|Overall Study|As Per Sponsor Decision|0|||
160499156|NCT01681992|579556126|FG002|Overall Study|As Per Sponsor Decision|1|||
160499157|NCT01681992|579556124|FG000|Overall Study|Protocol Violation|0|||
160499158|NCT01681992|579556125|FG001|Overall Study|Protocol Violation|0|||
160499159|NCT01681992|579556126|FG002|Overall Study|Protocol Violation|1|||
160499160|NCT01681992|579556124|FG000|Overall Study|Withdrawal by Subject|27|||
160499161|NCT01681992|579556125|FG001|Overall Study|Withdrawal by Subject|30|||
160499162|NCT01681992|579556126|FG002|Overall Study|Withdrawal by Subject|25|||
160499163|NCT04042077|579556127|FG000|Overall Study|Adverse Event|0|||
160619147|NCT01856920|579984894|FG000|Overall Study|Disease Progression before Treatment|1|||
160619148|NCT01856920|579984895|FG001|Overall Study|Disease Progression before Treatment|0|||
160619149|NCT01856920|579984894|FG000|Overall Study|Ineligible|0|||
160619150|NCT01856920|579984895|FG001|Overall Study|Ineligible|1|||
160632901|NCT02858076|580036100|FG000|Overall Study|Withdrawal by Subject|1|||
160662202|NCT02543203|580145658|FG001|Overall Study|Unpalatable Fragrance|2|||
160662203|NCT02543203|580145657|FG000|Overall Study|Lost to Follow-up|1|||
160662204|NCT02543203|580145658|FG001|Overall Study|Lost to Follow-up|0|||
160662205|NCT02543203|580145657|FG000|Overall Study|Increased Irritability|1|||
160662206|NCT02543203|580145658|FG001|Overall Study|Increased Irritability|0|||
160662207|NCT02543203|580145657|FG000|Overall Study|Family|1|||
160662208|NCT02543203|580145658|FG001|Overall Study|Family|2|||
160662209|NCT02543203|580145657|FG000|Overall Study|Negative Behavior|1|||
160662210|NCT02543203|580145658|FG001|Overall Study|Negative Behavior|0|||
160662211|NCT02543203|580145657|FG000|Overall Study|Withdrawal by Subject|0|||
160662212|NCT02543203|580145658|FG001|Overall Study|Withdrawal by Subject|1|||
160662213|NCT01270503|580145659|FG000|Overall Study|Lost to Follow-up|1|||
160662214|NCT02514122|580145660|FG000|Overall Study|Withdrawal by Subject|2|||
160662215|NCT02514122|580145661|FG001|Overall Study|Withdrawal by Subject|0|||
160662216|NCT01472341|580145665|FG000|Overall Study|Started insulin therapy|55|||
160662217|NCT01472341|580145665|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
160662218|NCT01472341|580145665|FG000|Overall Study|Withdrawal by Subject|39|||
160662219|NCT01472341|580145665|FG000|Overall Study|Lost to Follow-up|52|||
160662220|NCT01472341|580145665|FG000|Overall Study|Laboratory parameters unavailable|25|||
160662221|NCT01472341|580145665|FG000|Overall Study|Death|9|||
160662222|NCT00296647|580145669|FG000|Overall Study|Death|4|||
160662223|NCT00296647|580145670|FG001|Overall Study|Death|1|||
160662224|NCT00296647|580145671|FG002|Overall Study|Death|2|||
160662225|NCT00296647|580145672|FG003|Overall Study|Death|1|||
160662226|NCT00296647|580145673|FG004|Overall Study|Death|1|||
160662227|NCT00296647|580145669|FG000|Overall Study|Withdrawal by Subject|28|||
160662228|NCT00296647|580145670|FG001|Overall Study|Withdrawal by Subject|27|||
160662229|NCT00296647|580145671|FG002|Overall Study|Withdrawal by Subject|32|||
160662230|NCT00296647|580145672|FG003|Overall Study|Withdrawal by Subject|16|||
160662231|NCT00296647|580145673|FG004|Overall Study|Withdrawal by Subject|19|||
160662232|NCT05615935|580145676|FG000|Overall Study|Lost to Follow-up|1|||
160662233|NCT05615935|580145677|FG001|Overall Study|Lost to Follow-up|1|||
160662234|NCT00565448|580145678|FG000|Overall Study|Adverse Event|1|||
160662235|NCT00565448|580145679|FG001|Overall Study|Adverse Event|2|||
160662236|NCT00565448|580145678|FG000|Overall Study|Disease progression|1|||
160662237|NCT00565448|580145679|FG001|Overall Study|Disease progression|0|||
160662238|NCT00565448|580145678|FG000|Overall Study|Withdrawal by Subject|1|||
160499164|NCT04042077|579556128|FG001|Overall Study|Adverse Event|1|||
160499165|NCT04042077|579556127|FG000|Overall Study|Death|2|||
160499166|NCT04042077|579556128|FG001|Overall Study|Death|1|||
160499167|NCT04042077|579556127|FG000|Overall Study|Physician Decision|2|||
160499168|NCT04042077|579556128|FG001|Overall Study|Physician Decision|0|||
160499169|NCT04042077|579556127|FG000|Overall Study|Withdrawal by Subject|3|||
160499170|NCT04042077|579556128|FG001|Overall Study|Withdrawal by Subject|2|||
160499171|NCT04042077|579556127|FG000|Overall Study|Lack of Efficacy|0|||
160499172|NCT04042077|579556128|FG001|Overall Study|Lack of Efficacy|1|||
160499173|NCT01080300|579556129|FG000|Overall Study|Adverse Event|49|||
160499174|NCT01080300|579556130|FG001|Overall Study|Adverse Event|35|||
160499175|NCT01080300|579556129|FG000|Overall Study|Lack of Efficacy|12|||
160499176|NCT01080300|579556130|FG001|Overall Study|Lack of Efficacy|15|||
160499177|NCT01080300|579556129|FG000|Overall Study|Protocol Violation|7|||
160499178|NCT01080300|579556130|FG001|Overall Study|Protocol Violation|13|||
160499179|NCT01080300|579556129|FG000|Overall Study|Lost to Follow-up|10|||
160499180|NCT01080300|579556130|FG001|Overall Study|Lost to Follow-up|6|||
160499181|NCT01080300|579556129|FG000|Overall Study|Death|0|||
160499182|NCT01080300|579556130|FG001|Overall Study|Death|1|||
160499183|NCT01080300|579556129|FG000|Overall Study|Withdrawal by Subject|12|||
160499184|NCT01080300|579556130|FG001|Overall Study|Withdrawal by Subject|28|||
160499185|NCT01080300|579556129|FG000|Overall Study|Reasons not specified|4|||
160499186|NCT01080300|579556130|FG001|Overall Study|Reasons not specified|6|||
160499187|NCT01754753|579556137|FG000|Overall Study|Study close|43|||
160499188|NCT01754753|579556138|FG001|Overall Study|Study close|44|||
160499189|NCT01754753|579556137|FG000|Overall Study|Lost to Follow-up|9|||
160499190|NCT01754753|579556138|FG001|Overall Study|Lost to Follow-up|5|||
160662239|NCT00565448|580145679|FG001|Overall Study|Withdrawal by Subject|0|||
160662240|NCT01863745|580145680|FG000|Overall Study|Disease Progression|9|||
160662241|NCT01863745|580145680|FG000|Overall Study|Adverse Event|2|||
160662242|NCT01863745|580145680|FG000|Overall Study|Death|1|||
160662243|NCT01863745|580145680|FG000|Overall Study|Withdrawal by Subject|1|||
160662244|NCT00193609|580145681|FG000|Overall Study|Lack of Efficacy|2|||
160662245|NCT00193609|580145681|FG000|Overall Study|Adverse Event|2|||
160662246|NCT00735904|580145682|FG000|Overall Study|Adverse Event|3|||
160499191|NCT03229486|579556139|FG000|Overall Study|Protocol Violation|0|||
160662247|NCT00735904|580145682|FG000|Overall Study|Death|20|||
160499192|NCT03229486|579556140|FG001|Overall Study|Protocol Violation|1|||
160499193|NCT00856245|579556141|FG000|Overall Study|Was not transplanted|5|||
160499194|NCT04547023|579556144|FG000|Overall Study|Did Not Receive Intervention|3|||
160499195|NCT04547023|579556145|FG001|Overall Study|Did Not Receive Intervention|2|||
160499196|NCT04547023|579556144|FG000|Overall Study|Lost to Follow-up|1|||
160499197|NCT04547023|579556145|FG001|Overall Study|Lost to Follow-up|1|||
160499198|NCT01782690|579556146|FG000|Overall Study|Not reported|7|||
160499199|NCT01782690|579556146|FG000|Overall Study|Toxicity of gemcitabine|1|||
160499200|NCT01782690|579556146|FG000|Overall Study|Toxicity of erlotinib|1|||
160499201|NCT01782690|579556146|FG000|Overall Study|Lost to Follow-up|31|||
160499202|NCT01782690|579556146|FG000|Overall Study|Withdrawal of informed consent|2|||
160499203|NCT01782690|579556146|FG000|Overall Study|Absent rash|9|||
160499204|NCT01782690|579556146|FG000|Overall Study|Physician Decision|13|||
160499205|NCT01782690|579556146|FG000|Overall Study|Patient's wish|21|||
160499206|NCT01782690|579556146|FG000|Overall Study|Tumor progression|74|||
160499207|NCT01782690|579556146|FG000|Overall Study|Death|133|||
160499208|NCT01782690|579556146|FG000|Overall Study|Study completion unknown|7|||
160499209|NCT01637077|579556151|FG000|Overall Study|Cancel|1|||
160499210|NCT01637077|579556152|FG001|Overall Study|Cancel|1|||
160499211|NCT01637077|579556151|FG000|Overall Study|Withdrawal by Subject|1|||
160499212|NCT01637077|579556152|FG001|Overall Study|Withdrawal by Subject|0|||
160499213|NCT01637077|579556151|FG000|Overall Study|No cycle 1 questionnaire data|2|||
160499214|NCT01637077|579556152|FG001|Overall Study|No cycle 1 questionnaire data|0|||
160499215|NCT02638103|579556154|FG000|Overall Study|Adverse Event|13|||
160499216|NCT02638103|579556155|FG001|Overall Study|Adverse Event|12|||
160499217|NCT02638103|579556156|FG002|Overall Study|Adverse Event|19|||
160499218|NCT02638103|579556157|FG003|Overall Study|Adverse Event|12|||
160499219|NCT02638103|579556154|FG000|Overall Study|Withdrawal by Subject|43|||
160499220|NCT02638103|579556155|FG001|Overall Study|Withdrawal by Subject|53|||
160499221|NCT02638103|579556156|FG002|Overall Study|Withdrawal by Subject|30|||
160499222|NCT02638103|579556157|FG003|Overall Study|Withdrawal by Subject|61|||
160499223|NCT02638103|579556154|FG000|Overall Study|Protocol Violation|1|||
160499224|NCT02638103|579556155|FG001|Overall Study|Protocol Violation|2|||
160499225|NCT02638103|579556156|FG002|Overall Study|Protocol Violation|1|||
160499226|NCT02638103|579556157|FG003|Overall Study|Protocol Violation|4|||
160499227|NCT02638103|579556154|FG000|Overall Study|Pregnancy|2|||
160499228|NCT02638103|579556155|FG001|Overall Study|Pregnancy|3|||
160499229|NCT02638103|579556156|FG002|Overall Study|Pregnancy|0|||
160499230|NCT02638103|579556157|FG003|Overall Study|Pregnancy|1|||
160499231|NCT02638103|579556154|FG000|Overall Study|Non-compliance to Study Procedures|2|||
160499232|NCT02638103|579556155|FG001|Overall Study|Non-compliance to Study Procedures|1|||
160499233|NCT02638103|579556156|FG002|Overall Study|Non-compliance to Study Procedures|1|||
160499234|NCT02638103|579556157|FG003|Overall Study|Non-compliance to Study Procedures|1|||
160499235|NCT02638103|579556154|FG000|Overall Study|Lost to Follow-up|26|||
160499236|NCT02638103|579556155|FG001|Overall Study|Lost to Follow-up|33|||
160499237|NCT02638103|579556156|FG002|Overall Study|Lost to Follow-up|20|||
160499238|NCT02638103|579556157|FG003|Overall Study|Lost to Follow-up|37|||
160499239|NCT02638103|579556154|FG000|Overall Study|Lack of Efficacy|14|||
160499240|NCT02638103|579556155|FG001|Overall Study|Lack of Efficacy|10|||
160499241|NCT02638103|579556156|FG002|Overall Study|Lack of Efficacy|12|||
160499242|NCT02638103|579556157|FG003|Overall Study|Lack of Efficacy|22|||
160499243|NCT02638103|579556154|FG000|Overall Study|Other than specified|5|||
160499244|NCT02638103|579556155|FG001|Overall Study|Other than specified|4|||
160499245|NCT02638103|579556156|FG002|Overall Study|Other than specified|2|||
160499246|NCT02638103|579556157|FG003|Overall Study|Other than specified|4|||
160499247|NCT00838929|579556160|FG000|Overall Study|Protocol Violation|0|||
160499248|NCT00838929|579556161|FG001|Overall Study|Protocol Violation|1|||
160619151|NCT01856920|579984894|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
160619152|NCT01856920|579984895|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
160619153|NCT01856920|579984894|FG000|Overall Study|Refused further Treatment|5|||
160499249|NCT00838929|579556162|FG002|Overall Study|Protocol Violation|0|||
160499250|NCT00838929|579556160|FG000|Overall Study|Disease progression|0|||
160499251|NCT00838929|579556161|FG001|Overall Study|Disease progression|2|||
160499252|NCT00838929|579556162|FG002|Overall Study|Disease progression|1|||
160499253|NCT00699842|579556166|FG000|Overall Study|Death|0|||
160499254|NCT00699842|579556167|FG001|Overall Study|Death|1|||
160499255|NCT00699842|579556168|FG002|Overall Study|Death|0|||
160499256|NCT03342196|579556169|FG000|Overall Study|Physician Decision|1|||
160499257|NCT02257918|579556170|FG000|Overall Study|Lost to Follow-up|4|||
160499258|NCT02257918|579556171|FG001|Overall Study|Lost to Follow-up|1|||
160499259|NCT02257918|579556172|FG002|Overall Study|Lost to Follow-up|0|||
160499260|NCT02257918|579556170|FG000|Overall Study|Withdrawal by Subject|0|||
160499261|NCT02257918|579556171|FG001|Overall Study|Withdrawal by Subject|0|||
160499262|NCT02257918|579556172|FG002|Overall Study|Withdrawal by Subject|1|||
160499263|NCT02257918|579556170|FG000|Overall Study|Pregnancy|0|||
160499264|NCT02257918|579556171|FG001|Overall Study|Pregnancy|0|||
160619154|NCT01856920|579984895|FG001|Overall Study|Refused further Treatment|1|||
160499265|NCT02257918|579556172|FG002|Overall Study|Pregnancy|1|||
160499266|NCT03023423|579556175|FG000|Overall Study|Death|5|||
160499267|NCT03023423|579556176|FG001|Overall Study|Death|12|||
160499268|NCT03023423|579556177|FG002|Overall Study|Death|20|||
160499269|NCT03023423|579556175|FG000|Overall Study|Other|0|||
160499270|NCT03023423|579556176|FG001|Overall Study|Other|2|||
160499271|NCT03023423|579556177|FG002|Overall Study|Other|2|||
160499272|NCT03023423|579556175|FG000|Overall Study|Ongoing|2|||
160499273|NCT03023423|579556176|FG001|Overall Study|Ongoing|32|||
160499274|NCT03023423|579556177|FG002|Overall Study|Ongoing|24|||
160499275|NCT01151423|579556178|FG000|Overall Study|Study terminated by Sponsor|9|||
160499276|NCT01151423|579556179|FG001|Overall Study|Study terminated by Sponsor|10|||
160499277|NCT01151423|579556178|FG000|Overall Study|Protocol Violation|0|||
160499278|NCT01151423|579556179|FG001|Overall Study|Protocol Violation|1|||
160499279|NCT01151423|579556178|FG000|Overall Study|Physician Decision|1|||
160499280|NCT01151423|579556179|FG001|Overall Study|Physician Decision|1|||
160499281|NCT01151423|579556178|FG000|Overall Study|Pregnancy|0|||
160499282|NCT01151423|579556179|FG001|Overall Study|Pregnancy|1|||
160499283|NCT01151423|579556178|FG000|Overall Study|Death|0|||
160499284|NCT01151423|579556179|FG001|Overall Study|Death|1|||
160499285|NCT01151423|579556178|FG000|Overall Study|Adverse Event|3|||
160499286|NCT01151423|579556179|FG001|Overall Study|Adverse Event|0|||
160499287|NCT01151423|579556178|FG000|Overall Study|Withdrawal by Subject|1|||
160499288|NCT01151423|579556179|FG001|Overall Study|Withdrawal by Subject|3|||
160499289|NCT01151423|579556178|FG000|Overall Study|Lost to Follow-up|1|||
160499290|NCT01151423|579556179|FG001|Overall Study|Lost to Follow-up|0|||
160499291|NCT01151423|579556178|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
160499292|NCT01151423|579556179|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
160499293|NCT01151423|579556178|FG000|Overall Study|Participated in other clinical trial|1|||
160499294|NCT01151423|579556179|FG001|Overall Study|Participated in other clinical trial|0|||
160499295|NCT01263054|579556180|FG000|Overall Study|Death|1|||
160499296|NCT01263054|579556181|FG001|Overall Study|Death|0|||
160499297|NCT01263054|579556180|FG000|Overall Study|Lost to Follow-up|2|||
160499298|NCT01263054|579556181|FG001|Overall Study|Lost to Follow-up|2|||
160499299|NCT01263054|579556180|FG000|Overall Study|Withdrawal by Subject|1|||
160499300|NCT01263054|579556181|FG001|Overall Study|Withdrawal by Subject|3|||
160499301|NCT01263054|579556180|FG000|Overall Study|Qualification Violation|1|||
160499302|NCT01263054|579556181|FG001|Overall Study|Qualification Violation|0|||
160499303|NCT01263054|579556180|FG000|Overall Study|Other|0|||
160499304|NCT01263054|579556181|FG001|Overall Study|Other|1|||
160499305|NCT04277507|579556183|FG000|Overall Study|Lost to Follow-up|17|||
160499306|NCT04277507|579556183|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
160499307|NCT04277507|579556183|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
160499308|NCT04277507|579556183|FG000|Overall Study|Withdrawal by Subject|3|||
160499309|NCT04277507|579556183|FG000|Overall Study|Death due to COVID-19|1|||
160499310|NCT04277507|579556183|FG000|Overall Study|Data missing for full evaluation|5|||
160499311|NCT00583947|579556186|FG000|Cross-over Period|Adverse Event|2|||
160499312|NCT00583947|579556187|FG001|Cross-over Period|Adverse Event|0|||
160499313|NCT00583947|579556186|FG000|Cross-over Period|Withdrawal by Subject|2|||
160499314|NCT00583947|579556187|FG001|Cross-over Period|Withdrawal by Subject|0|||
160499315|NCT00583947|579556186|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
160499316|NCT00583947|579556187|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
160499317|NCT00583947|579556186|FG000|Cross-over Period|Other|1|||
160499318|NCT00583947|579556187|FG001|Cross-over Period|Other|1|||
160499319|NCT01261247|579556188|FG000|Overall Study|Ineligible|2|||
160499320|NCT01740154|579556189|FG000|Overall Study|Adverse Event|1|||
160499321|NCT05226130|579556193|FG000|Overall Study|Lost to Follow-up|0|||
160499322|NCT05226130|579556194|FG001|Overall Study|Lost to Follow-up|1|||
160499323|NCT05226130|579556193|FG000|Overall Study|Not treatment adherent|0|||
160499324|NCT05226130|579556194|FG001|Overall Study|Not treatment adherent|2|||
160499325|NCT03358472|579556195|FG000|Overall Study|Death|6|||
160499326|NCT03358472|579556196|FG001|Overall Study|Death|3|||
160499327|NCT03358472|579556197|FG002|Overall Study|Death|10|||
160499328|NCT03358472|579556195|FG000|Overall Study|Physician Decision|0|||
160499329|NCT03358472|579556196|FG001|Overall Study|Physician Decision|1|||
160499330|NCT03358472|579556197|FG002|Overall Study|Physician Decision|0|||
160499331|NCT03358472|579556195|FG000|Overall Study|Withdrawal by Subject|0|||
160499332|NCT03358472|579556196|FG001|Overall Study|Withdrawal by Subject|0|||
160499333|NCT03358472|579556197|FG002|Overall Study|Withdrawal by Subject|1|||
160499334|NCT03358472|579556195|FG000|Overall Study|On-going at clinical cut off date|9|||
160662248|NCT00735904|580145682|FG000|Overall Study|Protocol Violation|1|||
160499335|NCT03358472|579556196|FG001|Overall Study|On-going at clinical cut off date|6|||
160499336|NCT03358472|579556197|FG002|Overall Study|On-going at clinical cut off date|5|||
160499337|NCT03974022|579556198|FG000|Overall Study|Death|0|||
160499338|NCT03974022|579556199|FG001|Overall Study|Death|1|||
160499339|NCT03974022|579556200|FG002|Overall Study|Death|0|||
160499340|NCT03974022|579556201|FG003|Overall Study|Death|2|||
160499341|NCT03974022|579556202|FG004|Overall Study|Death|0|||
160499342|NCT03974022|579556203|FG005|Overall Study|Death|1|||
160499343|NCT03974022|579556204|FG006|Overall Study|Death|0|||
160499344|NCT03974022|579556205|FG007|Overall Study|Death|2|||
160499345|NCT03974022|579556206|FG008|Overall Study|Death|1|||
160499346|NCT03974022|579556207|FG009|Overall Study|Death|4|||
160499347|NCT03974022|579556208|FG010|Overall Study|Death|0|||
160499348|NCT03974022|579556209|FG011|Overall Study|Death|0|||
160499349|NCT03974022|579556210|FG012|Overall Study|Death|0|||
160499350|NCT03974022|579556211|FG013|Overall Study|Death|33|||
160499351|NCT03974022|579556212|FG014|Overall Study|Death|40|||
160499352|NCT03974022|579556198|FG000|Overall Study|Withdrawal by Subject|0|||
160499353|NCT03974022|579556199|FG001|Overall Study|Withdrawal by Subject|0|||
160499354|NCT03974022|579556200|FG002|Overall Study|Withdrawal by Subject|0|||
160499355|NCT03974022|579556201|FG003|Overall Study|Withdrawal by Subject|0|||
160499356|NCT03974022|579556202|FG004|Overall Study|Withdrawal by Subject|0|||
160499357|NCT03974022|579556203|FG005|Overall Study|Withdrawal by Subject|4|||
160499358|NCT03974022|579556204|FG006|Overall Study|Withdrawal by Subject|4|||
160499359|NCT03974022|579556205|FG007|Overall Study|Withdrawal by Subject|2|||
160499360|NCT03974022|579556206|FG008|Overall Study|Withdrawal by Subject|2|||
160499361|NCT03974022|579556207|FG009|Overall Study|Withdrawal by Subject|3|||
160499362|NCT03974022|579556208|FG010|Overall Study|Withdrawal by Subject|0|||
160499363|NCT03974022|579556209|FG011|Overall Study|Withdrawal by Subject|1|||
160499364|NCT03974022|579556210|FG012|Overall Study|Withdrawal by Subject|0|||
160499365|NCT03974022|579556211|FG013|Overall Study|Withdrawal by Subject|3|||
160499366|NCT03974022|579556212|FG014|Overall Study|Withdrawal by Subject|9|||
160499367|NCT03974022|579556198|FG000|Overall Study|Lost to Follow-up|0|||
160499368|NCT03974022|579556199|FG001|Overall Study|Lost to Follow-up|0|||
160499369|NCT03974022|579556200|FG002|Overall Study|Lost to Follow-up|0|||
160499370|NCT03974022|579556201|FG003|Overall Study|Lost to Follow-up|0|||
160499371|NCT03974022|579556202|FG004|Overall Study|Lost to Follow-up|0|||
160499372|NCT03974022|579556203|FG005|Overall Study|Lost to Follow-up|0|||
160499373|NCT03974022|579556204|FG006|Overall Study|Lost to Follow-up|1|||
160499374|NCT03974022|579556205|FG007|Overall Study|Lost to Follow-up|0|||
160499375|NCT03974022|579556206|FG008|Overall Study|Lost to Follow-up|0|||
160499376|NCT03974022|579556207|FG009|Overall Study|Lost to Follow-up|0|||
160499377|NCT03974022|579556208|FG010|Overall Study|Lost to Follow-up|0|||
160499378|NCT03974022|579556209|FG011|Overall Study|Lost to Follow-up|0|||
160499379|NCT03974022|579556210|FG012|Overall Study|Lost to Follow-up|0|||
160499380|NCT03974022|579556211|FG013|Overall Study|Lost to Follow-up|1|||
160499381|NCT03974022|579556212|FG014|Overall Study|Lost to Follow-up|1|||
160499382|NCT03974022|579556198|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
160499383|NCT03974022|579556199|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
160499384|NCT03974022|579556200|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
160499385|NCT03974022|579556201|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
160499386|NCT03974022|579556202|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
160499387|NCT03974022|579556203|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
160499388|NCT03974022|579556204|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
160499389|NCT03974022|579556205|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
160499390|NCT03974022|579556206|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
160499391|NCT03974022|579556207|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
160499392|NCT03974022|579556208|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
160499393|NCT03974022|579556209|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
160499394|NCT03974022|579556210|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
160499395|NCT03974022|579556211|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
160499396|NCT03974022|579556212|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
160499397|NCT04013971|579556215|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
160499398|NCT04013971|579556216|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
160499399|NCT04013971|579556215|FG000|Overall Study|Missing biomechanical data|0|||
160499400|NCT04013971|579556216|FG001|Overall Study|Missing biomechanical data|1|||
160499401|NCT05032066|579556219|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
160499402|NCT05032066|579556220|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
160499403|NCT05032066|579556221|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
160499404|NCT05032066|579556219|FG000|Part 1: Core Phase|Physician Decision|0|||
160499405|NCT05032066|579556220|FG001|Part 1: Core Phase|Physician Decision|1|||
160499406|NCT05032066|579556221|FG002|Part 1: Core Phase|Physician Decision|1|||
160499407|NCT05032066|579556219|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
160499408|NCT05032066|579556220|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
160499409|NCT05032066|579556221|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
160499410|NCT05032066|579556219|FG000|Part 1: Core Phase|Death|3|||
160499411|NCT05032066|579556220|FG001|Part 1: Core Phase|Death|4|||
160499412|NCT05032066|579556221|FG002|Part 1: Core Phase|Death|2|||
160499413|NCT05032066|579556219|FG000|Part 1: Core Phase|Adverse Event|2|||
160499414|NCT05032066|579556220|FG001|Part 1: Core Phase|Adverse Event|3|||
160499415|NCT05032066|579556221|FG002|Part 1: Core Phase|Adverse Event|0|||
160499416|NCT05032066|579556219|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
160499417|NCT05032066|579556220|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
160499418|NCT05032066|579556221|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
160499419|NCT05032066|579556219|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
160499420|NCT05032066|579556220|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
160499421|NCT05032066|579556221|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
160499422|NCT05032066|579556219|FG000|Part 2: Extension Phase|Physician Decision|1|||
160499423|NCT05032066|579556220|FG001|Part 2: Extension Phase|Physician Decision|2|||
160499424|NCT05032066|579556221|FG002|Part 2: Extension Phase|Physician Decision|0|||
160499425|NCT05032066|579556219|FG000|Part 2: Extension Phase|Death|2|||
160499426|NCT05032066|579556220|FG001|Part 2: Extension Phase|Death|4|||
160499427|NCT05032066|579556221|FG002|Part 2: Extension Phase|Death|5|||
160499428|NCT06719986|579556222|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
160499429|NCT06719986|579556223|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
160499430|NCT06719986|579556224|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
160499431|NCT06719986|579556222|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
160499432|NCT06719986|579556223|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
160499433|NCT06719986|579556224|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
160499434|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
160499435|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
160499436|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
160499437|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
160499438|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
160499439|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
160499440|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
160499441|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
160499442|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
160499443|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
160499444|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
160499445|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
160499446|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
160499447|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
160499448|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
160499449|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
160499450|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
160499451|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
160499452|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
160499453|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
160499454|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
160499455|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
160499456|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
160499457|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
160499458|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
160499459|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
160499460|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
160499461|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
160499462|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
160499463|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
160499464|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
160499465|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
160499466|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
160499467|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
160499468|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
160499469|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
160499470|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
160499471|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
160499472|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
160499473|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
160499474|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
160499475|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
160499476|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
160499477|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
160499478|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
160499479|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
160499480|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
160499481|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
160499482|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
160499483|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
160499484|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
160499485|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
160499486|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
160619155|NCT01856920|579984894|FG000|Overall Study|Other Reasons|0|||
160619156|NCT01856920|579984895|FG001|Overall Study|Other Reasons|1|||
160499487|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
160499488|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
160499489|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
160499490|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
160499491|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
160499492|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
160499493|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
160499494|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
160499495|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
160499496|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
160499497|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
160499498|NCT00217737|579556225|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
160499499|NCT00217737|579556226|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
160499500|NCT00217737|579556227|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
160499501|NCT00217737|579556228|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
160499502|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
160499503|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
160499504|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
160499505|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
160499506|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
160499507|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
160499508|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
160499509|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
160499510|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Study suspension|0|||
160499511|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Study suspension|45|||
160499512|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Study suspension|0|||
160499513|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Study suspension|0|||
160499514|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
160499515|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
160499516|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
160499517|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
160499518|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Death|2|||
160499519|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Death|3|||
160499520|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Death|0|||
160499521|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Death|0|||
160499522|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
160499523|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
160499524|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
160499525|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
160499526|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
160499527|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
160499528|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
160499529|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
160499530|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
160499531|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
160499532|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
160499533|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
160499534|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
160499535|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
160499536|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
160499537|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
160499538|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
160499539|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
160499540|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
160499541|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
160499542|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
160499543|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
160662249|NCT00735904|580145682|FG000|Overall Study|Withdrawal by Subject|1|||
160662250|NCT00735904|580145682|FG000|Overall Study|Study Terminated by Sponsor|5|||
160662251|NCT00735904|580145682|FG000|Overall Study|Other|8|||
160662252|NCT01171963|580145684|FG000|Overall Study|Adverse Event|10|||
160662253|NCT01171963|580145685|FG001|Overall Study|Adverse Event|15|||
160662254|NCT01171963|580145684|FG000|Overall Study|Lost to Follow-up|23|||
160499544|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
160499545|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
160662255|NCT01171963|580145685|FG001|Overall Study|Lost to Follow-up|24|||
160662256|NCT01171963|580145684|FG000|Overall Study|Other - diarrhoea|1|||
160499546|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
160499547|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
160499548|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
160499549|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
160499550|NCT00217737|579556225|FG000|Step 2 Randomization/Registration|Other|1|||
160499551|NCT00217737|579556226|FG001|Step 2 Randomization/Registration|Other|2|||
160499552|NCT00217737|579556227|FG002|Step 2 Randomization/Registration|Other|0|||
160499553|NCT00217737|579556228|FG003|Step 2 Randomization/Registration|Other|0|||
160499554|NCT01667926|579557536|FG000|Overall Study|Withdrawal by Subject|1|||
160499555|NCT01667926|579557537|FG001|Overall Study|Withdrawal by Subject|2|||
160499556|NCT01667926|579557538|FG002|Overall Study|Withdrawal by Subject|2|||
160499557|NCT01667926|579557536|FG000|Overall Study|Physician Decision|0|||
160499558|NCT01667926|579557537|FG001|Overall Study|Physician Decision|0|||
160499559|NCT01667926|579557538|FG002|Overall Study|Physician Decision|1|||
160499560|NCT01667926|579557536|FG000|Overall Study|Time committment|0|||
160499561|NCT01667926|579557537|FG001|Overall Study|Time committment|0|||
160499562|NCT01667926|579557538|FG002|Overall Study|Time committment|2|||
160499563|NCT01667926|579557536|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
160499564|NCT01667926|579557537|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
160499565|NCT01667926|579557538|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
160499566|NCT01667926|579557536|FG000|Overall Study|Lost to Follow-up|1|||
160499567|NCT01667926|579557537|FG001|Overall Study|Lost to Follow-up|2|||
160499568|NCT01667926|579557538|FG002|Overall Study|Lost to Follow-up|1|||
160499569|NCT01667926|579557536|FG000|Overall Study|Side effects|3|||
160499570|NCT01667926|579557537|FG001|Overall Study|Side effects|0|||
160499571|NCT01667926|579557538|FG002|Overall Study|Side effects|0|||
160499572|NCT01411241|579557542|FG000|Overall Study|Protocol Violation|0|||
160499573|NCT01411241|579557543|FG001|Overall Study|Protocol Violation|5|||
160499574|NCT01411241|579557542|FG000|Overall Study|Withdrawal by Subject|9|||
160499575|NCT01411241|579557543|FG001|Overall Study|Withdrawal by Subject|10|||
160499576|NCT01411241|579557542|FG000|Overall Study|Serious Adverse Event|0|||
160499577|NCT01411241|579557543|FG001|Overall Study|Serious Adverse Event|3|||
160499578|NCT01411241|579557542|FG000|Overall Study|Lost to Follow-up|2|||
160499579|NCT01411241|579557543|FG001|Overall Study|Lost to Follow-up|4|||
160499580|NCT02980042|579557546|FG000|Overall Study|Lost to Follow-up|5|||
160499581|NCT02980042|579557547|FG001|Overall Study|Lost to Follow-up|0|||
160499582|NCT02980042|579557546|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
160499583|NCT02980042|579557547|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
160499584|NCT00699153|579557549|FG000|Overall Study|Lost to Follow-up|1|||
160499585|NCT00699153|579557550|FG001|Overall Study|Lost to Follow-up|0|||
160499586|NCT00699153|579557549|FG000|Overall Study|Adverse Event|0|||
160499587|NCT00699153|579557550|FG001|Overall Study|Adverse Event|2|||
160499588|NCT00699153|579557549|FG000|Overall Study|Protocol Violation|1|||
160499589|NCT00699153|579557550|FG001|Overall Study|Protocol Violation|0|||
160499590|NCT00699153|579557549|FG000|Overall Study|Travel Problem|1|||
160499591|NCT00699153|579557550|FG001|Overall Study|Travel Problem|0|||
160499592|NCT02521363|579557552|FG000|Overall Study|Withdrawal by Subject|1|||
160499593|NCT02521363|579557553|FG001|Overall Study|Withdrawal by Subject|2|||
160499594|NCT00953771|579557557|FG000|Overall Study|Death|1|||
160499595|NCT00953771|579557558|FG001|Overall Study|Death|0|||
160499596|NCT00974259|579557559|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
160499597|NCT00974259|579557560|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
160619157|NCT01856920|579984894|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
160619158|NCT01856920|579984895|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
160619159|NCT03287089|579984901|FG000|Overall Study|Lost to Follow-up|0|||
160619160|NCT03287089|579984902|FG001|Overall Study|Lost to Follow-up|2|||
160619161|NCT03287089|579984901|FG000|Overall Study|Physician Decision|0|||
160619162|NCT03287089|579984902|FG001|Overall Study|Physician Decision|2|||
160619163|NCT03287089|579984901|FG000|Overall Study|Withdrawal by Subject|0|||
160619164|NCT03287089|579984902|FG001|Overall Study|Withdrawal by Subject|2|||
160619165|NCT01729559|579984903|FG000|Overall Study|Protocol Violation|31|||
160619166|NCT01729559|579984904|FG001|Overall Study|Protocol Violation|28|||
160619167|NCT03672006|579984909|FG000|Overall Study|exclusion criteria met|0|||
160662257|NCT01171963|580145685|FG001|Overall Study|Other - diarrhoea|0|||
160499598|NCT01606319|579557568|FG000|Overall Study|Lost to Follow-up|17|||
160499599|NCT01606319|579557569|FG001|Overall Study|Lost to Follow-up|14|||
160499600|NCT01606319|579557568|FG000|Overall Study|Withdrawal by Subject|9|||
160499601|NCT01606319|579557569|FG001|Overall Study|Withdrawal by Subject|12|||
160499602|NCT01606319|579557568|FG000|Overall Study|Physician Decision|1|||
160499603|NCT01606319|579557569|FG001|Overall Study|Physician Decision|2|||
160499604|NCT01606319|579557568|FG000|Overall Study|Lack of Efficacy|6|||
160499605|NCT01606319|579557569|FG001|Overall Study|Lack of Efficacy|8|||
160499606|NCT01606319|579557568|FG000|Overall Study|Adverse Event|1|||
160499607|NCT01606319|579557569|FG001|Overall Study|Adverse Event|4|||
160499608|NCT01821937|579557576|FG000|Overall Study|Adverse Event|0|||
160499609|NCT01821937|579557577|FG001|Overall Study|Adverse Event|3|||
160499610|NCT02030002|579557581|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
160499611|NCT02030002|579557581|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
160499612|NCT02030002|579557581|FG000|Follow-up|Lost to Follow-up|2|||
160499613|NCT00609947|579557582|FG000|Overall Study|Death|1|||
160499614|NCT00504075|579557583|FG000|Overall Study|Adverse Event|1|||
160499615|NCT00504075|579557583|FG000|Overall Study|Lost to Follow-up|5|||
160499616|NCT00504075|579557583|FG000|Overall Study|Withdrawal by Subject|1|||
160499617|NCT00504075|579557583|FG000|Overall Study|Required other therapeutic intervention|1|||
160499618|NCT02406248|579557584|FG000|Overall Study|Death|7|||
160499619|NCT02406248|579557584|FG000|Overall Study|Withdrawal by Subject|2|||
160499620|NCT01689857|579557586|FG000|Overall Study|Lost to Follow-up|5|||
160499621|NCT01689857|579557587|FG001|Overall Study|Lost to Follow-up|2|||
160499622|NCT02362503|579557594|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
160499623|NCT02362503|579557595|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
160499624|NCT02362503|579557596|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
160499625|NCT02362503|579557594|FG000|Double-blind Period-Up to 8 Days|Death|1|||
160499626|NCT02362503|579557595|FG001|Double-blind Period-Up to 8 Days|Death|0|||
160499627|NCT02362503|579557596|FG002|Double-blind Period-Up to 8 Days|Death|0|||
160499628|NCT02362503|579557594|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
160499629|NCT02362503|579557595|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
160499630|NCT02362503|579557596|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
160499631|NCT02362503|579557594|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
160499632|NCT02362503|579557595|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
160499633|NCT02362503|579557596|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
160499634|NCT02362503|579557594|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
160499635|NCT02362503|579557595|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
160499636|NCT02362503|579557596|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
160499637|NCT02362503|579557594|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
160499638|NCT02362503|579557595|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
160499639|NCT02362503|579557596|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
160499640|NCT02362503|579557594|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
160499641|NCT02362503|579557595|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
160499642|NCT02362503|579557596|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
160499643|NCT02362503|579557594|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
160499644|NCT02362503|579557595|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
160499645|NCT02362503|579557596|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
160499646|NCT02362503|579557594|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
160499647|NCT02362503|579557595|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
160499648|NCT02362503|579557596|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
160499649|NCT02362503|579557594|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
160499650|NCT02362503|579557595|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
160499651|NCT02362503|579557596|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
160499652|NCT02362503|579557594|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
160499653|NCT02362503|579557595|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
160499654|NCT02362503|579557596|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
160499655|NCT02362503|579557594|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
160499656|NCT02362503|579557595|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
160499657|NCT02362503|579557596|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
160499658|NCT02362503|579557594|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
160499659|NCT02362503|579557595|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
160499660|NCT02362503|579557596|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
160499661|NCT02362503|579557594|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
160499662|NCT02362503|579557595|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
160499663|NCT02362503|579557596|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
160499664|NCT00762476|579557597|FG000|Overall Study|Adverse Event|7|||
160499665|NCT00762476|579557598|FG001|Overall Study|Adverse Event|1|||
160499666|NCT00762476|579557597|FG000|Overall Study|Lost to Follow-up|2|||
160499667|NCT00762476|579557598|FG001|Overall Study|Lost to Follow-up|0|||
160499668|NCT00762476|579557597|FG000|Overall Study|Protocol Violation|5|||
160499669|NCT00762476|579557598|FG001|Overall Study|Protocol Violation|6|||
160499670|NCT00762476|579557597|FG000|Overall Study|Physician Decision|2|||
160619168|NCT03672006|579984910|FG001|Overall Study|exclusion criteria met|1|||
160619169|NCT00608426|579984911|FG000|Overall Study|Death|32|||
160619170|NCT00608426|579984912|FG001|Overall Study|Death|36|||
160619171|NCT00608426|579984911|FG000|Overall Study|Lost to Follow-up|485|||
160499671|NCT00762476|579557598|FG001|Overall Study|Physician Decision|14|||
160499672|NCT00762476|579557597|FG000|Overall Study|Withdrawal by Subject|6|||
160499673|NCT00762476|579557598|FG001|Overall Study|Withdrawal by Subject|12|||
160499674|NCT00762476|579557597|FG000|Overall Study|antibiotic use|0|||
160619172|NCT00608426|579984912|FG001|Overall Study|Lost to Follow-up|521|||
160619173|NCT00608426|579984911|FG000|Overall Study|refused, health issues, wrong address|319|||
160499675|NCT00762476|579557598|FG001|Overall Study|antibiotic use|1|||
160499676|NCT00762476|579557597|FG000|Overall Study|non-compliance with study visits|0|||
160499677|NCT00762476|579557598|FG001|Overall Study|non-compliance with study visits|2|||
160499678|NCT00762476|579557597|FG000|Overall Study|Seasonal allergies|1|||
160499679|NCT00762476|579557598|FG001|Overall Study|Seasonal allergies|0|||
160499680|NCT02838134|579557599|FG000|Overall Study|Lost to Follow-up|1|||
160499681|NCT02838134|579557600|FG001|Overall Study|Lost to Follow-up|2|||
160499682|NCT02838134|579557599|FG000|Overall Study|logistic problems|1|||
160499683|NCT02838134|579557600|FG001|Overall Study|logistic problems|1|||
160499684|NCT01912404|579557604|FG000|Overall Study|Due to personal reasons|1|||
160499685|NCT01912404|579557605|FG001|Overall Study|Due to personal reasons|0|||
160499686|NCT02269423|579557606|FG000|Overall Study|Discontinued due to change in residence|0|||
160499687|NCT02269423|579557607|FG001|Overall Study|Discontinued due to change in residence|1|||
160499688|NCT02269423|579557608|FG002|Overall Study|Discontinued due to change in residence|0|||
160499689|NCT02269423|579557609|FG003|Overall Study|Discontinued due to change in residence|1|||
160499690|NCT01430468|579557610|FG000|Overall Study|Physician Decision|2|||
160499691|NCT01430468|579557611|FG001|Overall Study|Physician Decision|1|||
160499692|NCT01430468|579557610|FG000|Overall Study|Withdrawal by Subject|5|||
160499693|NCT01430468|579557611|FG001|Overall Study|Withdrawal by Subject|5|||
160499694|NCT01281839|579557612|FG000|Overall Study|Lost to Follow-up|6|||
160499695|NCT01281839|579557613|FG001|Overall Study|Lost to Follow-up|3|||
160499696|NCT01281839|579557612|FG000|Overall Study|Withdrawal by Subject|4|||
160499697|NCT01281839|579557613|FG001|Overall Study|Withdrawal by Subject|10|||
160499698|NCT01281839|579557612|FG000|Overall Study|Reason not specified|0|||
160499699|NCT01281839|579557613|FG001|Overall Study|Reason not specified|1|||
160499700|NCT01305239|579557614|FG000|Overall Study|Adverse Event|22|||
160499701|NCT01305239|579557614|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
160499702|NCT01443923|579557615|FG000|Overall Study|Adverse Event|1|||
160499703|NCT01443923|579557616|FG001|Overall Study|Adverse Event|0|||
160499704|NCT01245374|579557620|FG000|Overall Study|Protocol Violation|1|||
160499705|NCT01245374|579557620|FG000|Overall Study|Withdrawal by Subject|3|||
160499706|NCT04674189|579557622|FG000|Overall Study|Adverse Event|0|||
160499707|NCT04674189|579557623|FG001|Overall Study|Adverse Event|0|||
160499708|NCT04674189|579557624|FG002|Overall Study|Adverse Event|1|||
160499709|NCT04674189|579557622|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
160499710|NCT04674189|579557623|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
160499711|NCT04674189|579557624|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
160499712|NCT04674189|579557622|FG000|Overall Study|Physician Decision|1|||
160499713|NCT04674189|579557623|FG001|Overall Study|Physician Decision|0|||
160499714|NCT04674189|579557624|FG002|Overall Study|Physician Decision|0|||
160499715|NCT04674189|579557622|FG000|Overall Study|Withdrawal by Participant|83|||
160499716|NCT04674189|579557623|FG001|Overall Study|Withdrawal by Participant|71|||
160499717|NCT04674189|579557624|FG002|Overall Study|Withdrawal by Participant|142|||
160499718|NCT04674189|579557622|FG000|Overall Study|Lost to Follow-up|55|||
160499719|NCT04674189|579557623|FG001|Overall Study|Lost to Follow-up|53|||
160499720|NCT04674189|579557624|FG002|Overall Study|Lost to Follow-up|44|||
160499721|NCT04674189|579557622|FG000|Overall Study|Miscellaneous|27|||
160499722|NCT04674189|579557623|FG001|Overall Study|Miscellaneous|23|||
160499723|NCT04674189|579557624|FG002|Overall Study|Miscellaneous|207|||
160499724|NCT04674189|579557622|FG000|Overall Study|Did Not Receive Treatment|3|||
160499725|NCT04674189|579557623|FG001|Overall Study|Did Not Receive Treatment|1|||
160499726|NCT04674189|579557624|FG002|Overall Study|Did Not Receive Treatment|2|||
160499727|NCT00681668|579557625|FG000|Overall Study|Protocol Violation|1|||
160619174|NCT00608426|579984912|FG001|Overall Study|refused, health issues, wrong address|348|||
160619175|NCT00761891|579984913|FG000|Overall Study|Withdrawal by Subject|10|||
160619176|NCT01453439|579984917|FG000|Treatment Phase|Withdrawal by Subject|13|||
160619177|NCT01453439|579984918|FG001|Treatment Phase|Withdrawal by Subject|10|||
160619178|NCT01453439|579984917|FG000|Treatment Phase|Suicidal Ideation|2|||
160619179|NCT01453439|579984918|FG001|Treatment Phase|Suicidal Ideation|0|||
160499728|NCT00681668|579557625|FG000|Overall Study|Withdrawal by Subject|1|||
160499729|NCT01124838|579557634|FG000|Overall Study|Miscellaneous|4|||
160499730|NCT01124838|579557635|FG001|Overall Study|Miscellaneous|2|||
160499731|NCT01124838|579557634|FG000|Overall Study|Adverse Event|7|||
160619180|NCT01453439|579984917|FG000|Treatment Phase|Need for higher level of care|1|||
160619181|NCT01453439|579984918|FG001|Treatment Phase|Need for higher level of care|1|||
160499732|NCT01124838|579557635|FG001|Overall Study|Adverse Event|11|||
160499733|NCT01124838|579557634|FG000|Overall Study|Lack of Efficacy|2|||
160499734|NCT01124838|579557635|FG001|Overall Study|Lack of Efficacy|0|||
160499735|NCT01124838|579557634|FG000|Overall Study|Withdrawal by Subject|3|||
160499736|NCT01124838|579557635|FG001|Overall Study|Withdrawal by Subject|2|||
160499737|NCT01124838|579557634|FG000|Overall Study|Lost to Follow-up|2|||
160499738|NCT01124838|579557635|FG001|Overall Study|Lost to Follow-up|0|||
160499739|NCT02600897|579557636|FG000|Overall Study|Death|1|||
160499740|NCT02600897|579557637|FG001|Overall Study|Death|2|||
160499741|NCT02600897|579557638|FG002|Overall Study|Death|1|||
160499742|NCT02600897|579557639|FG003|Overall Study|Death|2|||
160619182|NCT01453439|579984917|FG000|Treatment Phase|Therapist conflict of interest|1|||
160499743|NCT02600897|579557640|FG004|Overall Study|Death|3|||
160499744|NCT02600897|579557641|FG005|Overall Study|Death|2|||
160499745|NCT02600897|579557642|FG006|Overall Study|Death|10|||
160499746|NCT02600897|579557643|FG007|Overall Study|Death|7|||
160499747|NCT02600897|579557644|FG008|Overall Study|Death|20|||
160499748|NCT02600897|579557636|FG000|Overall Study|Lost to Follow-up|1|||
160499749|NCT02600897|579557637|FG001|Overall Study|Lost to Follow-up|0|||
160499750|NCT02600897|579557638|FG002|Overall Study|Lost to Follow-up|0|||
160499751|NCT02600897|579557639|FG003|Overall Study|Lost to Follow-up|0|||
160499752|NCT02600897|579557640|FG004|Overall Study|Lost to Follow-up|0|||
160499753|NCT02600897|579557641|FG005|Overall Study|Lost to Follow-up|0|||
160499754|NCT02600897|579557642|FG006|Overall Study|Lost to Follow-up|0|||
160499755|NCT02600897|579557643|FG007|Overall Study|Lost to Follow-up|1|||
160499756|NCT02600897|579557644|FG008|Overall Study|Lost to Follow-up|0|||
160499757|NCT02600897|579557636|FG000|Overall Study|Withdrawal by Subject|0|||
160499758|NCT02600897|579557637|FG001|Overall Study|Withdrawal by Subject|0|||
160499759|NCT02600897|579557638|FG002|Overall Study|Withdrawal by Subject|0|||
160499760|NCT02600897|579557639|FG003|Overall Study|Withdrawal by Subject|0|||
160499761|NCT02600897|579557640|FG004|Overall Study|Withdrawal by Subject|0|||
160499762|NCT02600897|579557641|FG005|Overall Study|Withdrawal by Subject|0|||
160499763|NCT02600897|579557642|FG006|Overall Study|Withdrawal by Subject|0|||
160499764|NCT02600897|579557643|FG007|Overall Study|Withdrawal by Subject|4|||
160499765|NCT02600897|579557644|FG008|Overall Study|Withdrawal by Subject|2|||
160499766|NCT02600897|579557636|FG000|Overall Study|Reason Not Specified|0|||
160499767|NCT02600897|579557637|FG001|Overall Study|Reason Not Specified|0|||
160499768|NCT02600897|579557638|FG002|Overall Study|Reason Not Specified|0|||
160499769|NCT02600897|579557639|FG003|Overall Study|Reason Not Specified|0|||
160499770|NCT02600897|579557640|FG004|Overall Study|Reason Not Specified|0|||
160499771|NCT02600897|579557641|FG005|Overall Study|Reason Not Specified|0|||
160499772|NCT02600897|579557642|FG006|Overall Study|Reason Not Specified|0|||
160499773|NCT02600897|579557643|FG007|Overall Study|Reason Not Specified|0|||
160499774|NCT02600897|579557644|FG008|Overall Study|Reason Not Specified|1|||
160499775|NCT02614183|579557645|FG000|Double Blind Treatment Phase|Adverse Event|10|||
160499776|NCT02614183|579557646|FG001|Double Blind Treatment Phase|Adverse Event|9|||
160499777|NCT02614183|579557647|FG002|Double Blind Treatment Phase|Adverse Event|7|||
160499778|NCT02614183|579557645|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
160499779|NCT02614183|579557646|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
160499780|NCT02614183|579557647|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
160499781|NCT02614183|579557645|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
160499782|NCT02614183|579557646|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
160499783|NCT02614183|579557647|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
160499784|NCT02614183|579557645|FG000|Double Blind Treatment Phase|Physician Decision|7|||
160499785|NCT02614183|579557646|FG001|Double Blind Treatment Phase|Physician Decision|3|||
160499786|NCT02614183|579557647|FG002|Double Blind Treatment Phase|Physician Decision|2|||
160499787|NCT02614183|579557645|FG000|Double Blind Treatment Phase|Pregnancy|2|||
160499788|NCT02614183|579557646|FG001|Double Blind Treatment Phase|Pregnancy|1|||
160499789|NCT02614183|579557647|FG002|Double Blind Treatment Phase|Pregnancy|3|||
160499790|NCT02614183|579557645|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
160499791|NCT02614183|579557646|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
160499792|NCT02614183|579557647|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
160499793|NCT02614183|579557645|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
160499794|NCT02614183|579557646|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
160499795|NCT02614183|579557647|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
160499796|NCT02614183|579557645|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
160499797|NCT02614183|579557646|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
160499798|NCT02614183|579557647|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
160499799|NCT02614183|579557645|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
160499800|NCT02614183|579557646|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
160499801|NCT02614183|579557647|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
160499802|NCT02614183|579557645|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
160662258|NCT01171963|580145684|FG000|Overall Study|Withdrawal by Subject|114|||
160499803|NCT02614183|579557646|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
160499804|NCT02614183|579557647|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
160499805|NCT02614183|579557645|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
160499806|NCT02614183|579557646|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
160499807|NCT02614183|579557647|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
160499808|NCT02614183|579557645|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
160499809|NCT02614183|579557646|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
160499810|NCT02614183|579557647|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
160499811|NCT03213704|579557649|FG000|Overall Study|Physician Decision|3|||
160499812|NCT03213704|579557649|FG000|Overall Study|Protocol Violation|1|||
160499813|NCT03213704|579557649|FG000|Overall Study|Progressive disease|4|||
160499814|NCT04680533|579557650|FG000|Overall Study|Screen failure|1|||
160499815|NCT01183390|579559881|FG000|First Intervention|Adverse Event|0|||
160499816|NCT01183390|579559882|FG001|First Intervention|Adverse Event|1|||
160499817|NCT00233480|579559887|FG000|Overall Study|Underwent status II heart transplant|0|||
160499818|NCT00233480|579559888|FG001|Overall Study|Underwent status II heart transplant|1|||
160499819|NCT00474526|579559891|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
160499820|NCT00474526|579559892|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
160499821|NCT00474526|579559893|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
160499822|NCT00474526|579559894|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
160499823|NCT00474526|579559895|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
160499824|NCT00474526|579559896|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
160499825|NCT00474526|579559897|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
160499826|NCT00474526|579559898|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
160499827|NCT00474526|579559899|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
160499828|NCT00474526|579559900|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
160499829|NCT00474526|579559901|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
160499830|NCT00474526|579559902|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
160499831|NCT00474526|579559903|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
160499832|NCT00474526|579559904|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
160499833|NCT00474526|579559905|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
160499834|NCT00474526|579559906|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
160499835|NCT00474526|579559907|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
160499836|NCT00474526|579559891|FG000|Overall Study|Adverse Event|2|||
160499837|NCT00474526|579559892|FG001|Overall Study|Adverse Event|0|||
160499838|NCT00474526|579559893|FG002|Overall Study|Adverse Event|2|||
160499839|NCT00474526|579559894|FG003|Overall Study|Adverse Event|4|||
160499840|NCT00474526|579559895|FG004|Overall Study|Adverse Event|2|||
160499841|NCT00474526|579559896|FG005|Overall Study|Adverse Event|1|||
160499842|NCT00474526|579559897|FG006|Overall Study|Adverse Event|1|||
160499843|NCT00474526|579559898|FG007|Overall Study|Adverse Event|0|||
160499844|NCT00474526|579559899|FG008|Overall Study|Adverse Event|0|||
160499845|NCT00474526|579559900|FG009|Overall Study|Adverse Event|0|||
160499846|NCT00474526|579559901|FG010|Overall Study|Adverse Event|0|||
160499847|NCT00474526|579559902|FG011|Overall Study|Adverse Event|0|||
160499848|NCT00474526|579559903|FG012|Overall Study|Adverse Event|0|||
160499849|NCT00474526|579559904|FG013|Overall Study|Adverse Event|0|||
160499850|NCT00474526|579559905|FG014|Overall Study|Adverse Event|1|||
160499851|NCT00474526|579559906|FG015|Overall Study|Adverse Event|1|||
160499852|NCT00474526|579559907|FG016|Overall Study|Adverse Event|0|||
160499853|NCT00474526|579559891|FG000|Overall Study|Death|0|||
160499854|NCT00474526|579559892|FG001|Overall Study|Death|0|||
160499855|NCT00474526|579559893|FG002|Overall Study|Death|0|||
160499856|NCT00474526|579559894|FG003|Overall Study|Death|0|||
160499857|NCT00474526|579559895|FG004|Overall Study|Death|0|||
160499858|NCT00474526|579559896|FG005|Overall Study|Death|0|||
160499859|NCT00474526|579559897|FG006|Overall Study|Death|0|||
160499860|NCT00474526|579559898|FG007|Overall Study|Death|0|||
160499861|NCT00474526|579559899|FG008|Overall Study|Death|0|||
160499862|NCT00474526|579559900|FG009|Overall Study|Death|0|||
160499863|NCT00474526|579559901|FG010|Overall Study|Death|0|||
160499864|NCT00474526|579559902|FG011|Overall Study|Death|0|||
160499865|NCT00474526|579559903|FG012|Overall Study|Death|0|||
160499866|NCT00474526|579559904|FG013|Overall Study|Death|3|||
160499867|NCT00474526|579559905|FG014|Overall Study|Death|0|||
160499868|NCT00474526|579559906|FG015|Overall Study|Death|0|||
160499869|NCT00474526|579559907|FG016|Overall Study|Death|0|||
160499870|NCT00474526|579559891|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499871|NCT00474526|579559892|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
160499872|NCT00474526|579559893|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499873|NCT00474526|579559894|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
160499874|NCT00474526|579559895|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
160499875|NCT00474526|579559896|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499876|NCT00474526|579559897|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499877|NCT00474526|579559898|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499878|NCT00474526|579559899|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499879|NCT00474526|579559900|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499880|NCT00474526|579559901|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160619183|NCT01453439|579984918|FG001|Treatment Phase|Therapist conflict of interest|0|||
160619184|NCT01453439|579984917|FG000|Follow-up|Withdrawal by Subject|0|||
160619185|NCT01453439|579984918|FG001|Follow-up|Withdrawal by Subject|1|||
160619186|NCT01453439|579984917|FG000|Follow-up|Lost to Follow-up|5|||
160619187|NCT01453439|579984918|FG001|Follow-up|Lost to Follow-up|10|||
160619188|NCT01014442|579984919|FG000|Overall Study|Adverse Event|0|||
160499881|NCT00474526|579559902|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499882|NCT00474526|579559903|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499883|NCT00474526|579559904|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
160499884|NCT00474526|579559905|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
160499885|NCT00474526|579559906|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499886|NCT00474526|579559907|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
160499887|NCT00474526|579559891|FG000|Overall Study|Lost to Follow-up|8|||
160499888|NCT00474526|579559892|FG001|Overall Study|Lost to Follow-up|6|||
160499889|NCT00474526|579559893|FG002|Overall Study|Lost to Follow-up|13|||
160499890|NCT00474526|579559894|FG003|Overall Study|Lost to Follow-up|29|||
160499891|NCT00474526|579559895|FG004|Overall Study|Lost to Follow-up|11|||
160499892|NCT00474526|579559896|FG005|Overall Study|Lost to Follow-up|5|||
160499893|NCT00474526|579559897|FG006|Overall Study|Lost to Follow-up|8|||
160499894|NCT00474526|579559898|FG007|Overall Study|Lost to Follow-up|1|||
160499895|NCT00474526|579559899|FG008|Overall Study|Lost to Follow-up|0|||
160499896|NCT00474526|579559900|FG009|Overall Study|Lost to Follow-up|6|||
160499897|NCT00474526|579559901|FG010|Overall Study|Lost to Follow-up|2|||
160499898|NCT00474526|579559902|FG011|Overall Study|Lost to Follow-up|4|||
160499899|NCT00474526|579559903|FG012|Overall Study|Lost to Follow-up|6|||
160499900|NCT00474526|579559904|FG013|Overall Study|Lost to Follow-up|74|||
160499901|NCT00474526|579559905|FG014|Overall Study|Lost to Follow-up|29|||
160499902|NCT00474526|579559906|FG015|Overall Study|Lost to Follow-up|4|||
160499903|NCT00474526|579559907|FG016|Overall Study|Lost to Follow-up|5|||
160499904|NCT00474526|579559891|FG000|Overall Study|Protocol Violation|2|||
160499905|NCT00474526|579559892|FG001|Overall Study|Protocol Violation|6|||
160499906|NCT00474526|579559893|FG002|Overall Study|Protocol Violation|4|||
160499907|NCT00474526|579559894|FG003|Overall Study|Protocol Violation|12|||
160499908|NCT00474526|579559895|FG004|Overall Study|Protocol Violation|3|||
160499909|NCT00474526|579559896|FG005|Overall Study|Protocol Violation|1|||
160499910|NCT00474526|579559897|FG006|Overall Study|Protocol Violation|3|||
160499911|NCT00474526|579559898|FG007|Overall Study|Protocol Violation|0|||
160499912|NCT00474526|579559899|FG008|Overall Study|Protocol Violation|0|||
160499913|NCT00474526|579559900|FG009|Overall Study|Protocol Violation|4|||
160499914|NCT00474526|579559901|FG010|Overall Study|Protocol Violation|2|||
160499915|NCT00474526|579559902|FG011|Overall Study|Protocol Violation|2|||
160499916|NCT00474526|579559903|FG012|Overall Study|Protocol Violation|4|||
160499917|NCT00474526|579559904|FG013|Overall Study|Protocol Violation|19|||
160499918|NCT00474526|579559905|FG014|Overall Study|Protocol Violation|9|||
160499919|NCT00474526|579559906|FG015|Overall Study|Protocol Violation|6|||
160499920|NCT00474526|579559907|FG016|Overall Study|Protocol Violation|2|||
160499921|NCT00474526|579559891|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
160499922|NCT00474526|579559892|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
160499923|NCT00474526|579559893|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
160499924|NCT00474526|579559894|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
160499925|NCT00474526|579559895|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
160499926|NCT00474526|579559896|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
160499927|NCT00474526|579559897|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
160499928|NCT00474526|579559898|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
160499929|NCT00474526|579559899|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
160499930|NCT00474526|579559900|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
160499931|NCT00474526|579559901|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
160499932|NCT00474526|579559902|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
160499933|NCT00474526|579559903|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
160499934|NCT00474526|579559904|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
160499935|NCT00474526|579559905|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
160499936|NCT00474526|579559906|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
160499937|NCT00474526|579559907|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
160499938|NCT00474526|579559891|FG000|Overall Study|Withdrawal by Subject|9|||
160499939|NCT00474526|579559892|FG001|Overall Study|Withdrawal by Subject|24|||
160499940|NCT00474526|579559893|FG002|Overall Study|Withdrawal by Subject|21|||
160499941|NCT00474526|579559894|FG003|Overall Study|Withdrawal by Subject|52|||
160499942|NCT00474526|579559895|FG004|Overall Study|Withdrawal by Subject|38|||
160499943|NCT00474526|579559896|FG005|Overall Study|Withdrawal by Subject|6|||
160499944|NCT00474526|579559897|FG006|Overall Study|Withdrawal by Subject|12|||
160499945|NCT00474526|579559898|FG007|Overall Study|Withdrawal by Subject|4|||
160499946|NCT00474526|579559899|FG008|Overall Study|Withdrawal by Subject|4|||
160499947|NCT00474526|579559900|FG009|Overall Study|Withdrawal by Subject|13|||
160499948|NCT00474526|579559901|FG010|Overall Study|Withdrawal by Subject|5|||
160499949|NCT00474526|579559902|FG011|Overall Study|Withdrawal by Subject|4|||
160499950|NCT00474526|579559903|FG012|Overall Study|Withdrawal by Subject|4|||
160499951|NCT00474526|579559904|FG013|Overall Study|Withdrawal by Subject|37|||
160499952|NCT00474526|579559905|FG014|Overall Study|Withdrawal by Subject|22|||
160499953|NCT00474526|579559906|FG015|Overall Study|Withdrawal by Subject|1|||
160619189|NCT01014442|579984920|FG001|Overall Study|Adverse Event|8|||
160619190|NCT01014442|579984919|FG000|Overall Study|Withdrawal by Subject|4|||
160619191|NCT01014442|579984920|FG001|Overall Study|Withdrawal by Subject|4|||
160499954|NCT00474526|579559907|FG016|Overall Study|Withdrawal by Subject|1|||
160499955|NCT00953147|579559910|FG000|Overall Study|Adverse Event|8|||
160499956|NCT00953147|579559911|FG001|Overall Study|Adverse Event|16|||
160499957|NCT00953147|579559912|FG002|Overall Study|Adverse Event|6|||
160499958|NCT00953147|579559910|FG000|Overall Study|Protocol Violation|2|||
160499959|NCT00953147|579559911|FG001|Overall Study|Protocol Violation|8|||
160499960|NCT00953147|579559912|FG002|Overall Study|Protocol Violation|4|||
160499961|NCT00953147|579559910|FG000|Overall Study|Withdrawal by Subject|13|||
160499962|NCT00953147|579559911|FG001|Overall Study|Withdrawal by Subject|15|||
160499963|NCT00953147|579559912|FG002|Overall Study|Withdrawal by Subject|12|||
160499964|NCT00953147|579559910|FG000|Overall Study|Lost to Follow-up|8|||
160499965|NCT00953147|579559911|FG001|Overall Study|Lost to Follow-up|9|||
160499966|NCT00953147|579559912|FG002|Overall Study|Lost to Follow-up|4|||
160499967|NCT00953147|579559910|FG000|Overall Study|Physician Decision|2|||
160499968|NCT00953147|579559911|FG001|Overall Study|Physician Decision|7|||
160499969|NCT00953147|579559912|FG002|Overall Study|Physician Decision|3|||
160499970|NCT00953147|579559910|FG000|Overall Study|Other|4|||
160499971|NCT00953147|579559911|FG001|Overall Study|Other|11|||
160499972|NCT00953147|579559912|FG002|Overall Study|Other|13|||
160499973|NCT01484431|579559913|FG000|Period 1: High Dose|Physician Decision|0|||
160499974|NCT01484431|579559914|FG001|Period 1: High Dose|Physician Decision|1|||
160499975|NCT01484431|579559915|FG002|Period 1: High Dose|Physician Decision|0|||
160499976|NCT01484431|579559913|FG000|Period 2|Death|0|||
160499977|NCT01484431|579559914|FG001|Period 2|Death|1|||
160499978|NCT01484431|579559915|FG002|Period 2|Death|1|||
160499979|NCT01484431|579559913|FG000|Period 2|Physician Decision|0|||
160499980|NCT01484431|579559914|FG001|Period 2|Physician Decision|0|||
160499981|NCT01484431|579559915|FG002|Period 2|Physician Decision|1|||
160499982|NCT01484431|579559913|FG000|Period 2|Non-Compliance with Study Drug|1|||
160499983|NCT01484431|579559914|FG001|Period 2|Non-Compliance with Study Drug|0|||
160499984|NCT01484431|579559915|FG002|Period 2|Non-Compliance with Study Drug|0|||
160499985|NCT01251770|579559916|FG000|Overall Study|Protocol Violation|13|||
160499986|NCT01251770|579559917|FG001|Overall Study|Protocol Violation|7|||
160499987|NCT02514239|579559918|FG000|Overall Study|Refused to continue trial medication|0|||
160499988|NCT02514239|579559919|FG001|Overall Study|Refused to continue trial medication|0|||
160499989|NCT02514239|579559920|FG002|Overall Study|Refused to continue trial medication|0|||
160499990|NCT02514239|579559921|FG003|Overall Study|Refused to continue trial medication|0|||
160499991|NCT02514239|579559922|FG004|Overall Study|Refused to continue trial medication|0|||
160499992|NCT02514239|579559923|FG005|Overall Study|Refused to continue trial medication|0|||
160499993|NCT02514239|579559924|FG006|Overall Study|Refused to continue trial medication|0|||
160499994|NCT02514239|579559925|FG007|Overall Study|Refused to continue trial medication|0|||
160499995|NCT02514239|579559926|FG008|Overall Study|Refused to continue trial medication|0|||
160499996|NCT02514239|579559927|FG009|Overall Study|Refused to continue trial medication|1|||
160499997|NCT02514239|579559918|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
160499998|NCT02514239|579559919|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
160499999|NCT02514239|579559920|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
160500000|NCT02514239|579559921|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
160500001|NCT02514239|579559922|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
160500002|NCT02514239|579559923|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
160500003|NCT02514239|579559924|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
160500004|NCT02514239|579559925|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
160500005|NCT02514239|579559926|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
160500006|NCT02514239|579559927|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
160500007|NCT02514239|579559918|FG000|Overall Study|Not treated|0|||
160500008|NCT02514239|579559919|FG001|Overall Study|Not treated|1|||
160662259|NCT01171963|580145685|FG001|Overall Study|Withdrawal by Subject|129|||
160662260|NCT00302952|580145690|FG000|Overall Study|Physician Decision|1|||
160662261|NCT00302952|580145691|FG001|Overall Study|Physician Decision|1|||
160662262|NCT00302952|580145690|FG000|Overall Study|Withdrawal by Subject|2|||
160662263|NCT00302952|580145691|FG001|Overall Study|Withdrawal by Subject|3|||
160662264|NCT00302952|580145690|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
160662265|NCT00302952|580145691|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
160662266|NCT04185909|580145693|FG000|Overall Study|Lost to Follow-up|1|||
160662267|NCT00857623|580145694|FG000|Overall Study|Adverse Event|5|||
160662268|NCT00857623|580145695|FG001|Overall Study|Adverse Event|2|||
160662269|NCT00857623|580145694|FG000|Overall Study|Study-specific discontinuation criteria|5|||
160662270|NCT00857623|580145695|FG001|Overall Study|Study-specific discontinuation criteria|3|||
160662271|NCT00857623|580145694|FG000|Overall Study|Withdrawal by Subject|2|||
160662272|NCT00857623|580145695|FG001|Overall Study|Withdrawal by Subject|1|||
160662273|NCT00857623|580145694|FG000|Overall Study|Lack of Efficacy|1|||
160662274|NCT00857623|580145695|FG001|Overall Study|Lack of Efficacy|1|||
160662275|NCT00857623|580145694|FG000|Overall Study|Severe non-compliance to protocol|1|||
160662276|NCT00857623|580145695|FG001|Overall Study|Severe non-compliance to protocol|1|||
160500009|NCT02514239|579559920|FG002|Overall Study|Not treated|0|||
160500010|NCT02514239|579559921|FG003|Overall Study|Not treated|0|||
160500011|NCT02514239|579559922|FG004|Overall Study|Not treated|0|||
160500012|NCT02514239|579559923|FG005|Overall Study|Not treated|0|||
160500013|NCT02514239|579559924|FG006|Overall Study|Not treated|0|||
160500014|NCT02514239|579559925|FG007|Overall Study|Not treated|0|||
160500015|NCT02514239|579559926|FG008|Overall Study|Not treated|0|||
160500016|NCT02514239|579559927|FG009|Overall Study|Not treated|0|||
160500017|NCT02514239|579559918|FG000|Overall Study|Other Adverse Events|2|||
160500018|NCT02514239|579559919|FG001|Overall Study|Other Adverse Events|0|||
160500019|NCT02514239|579559920|FG002|Overall Study|Other Adverse Events|0|||
160662277|NCT00857623|580145694|FG000|Overall Study|Intake of prohibited medication|0|||
160662278|NCT00857623|580145695|FG001|Overall Study|Intake of prohibited medication|1|||
160662279|NCT00857623|580145694|FG000|Overall Study|Positive for HEP C|0|||
160500020|NCT02514239|579559921|FG003|Overall Study|Other Adverse Events|1|||
160500021|NCT02514239|579559922|FG004|Overall Study|Other Adverse Events|0|||
160500022|NCT02514239|579559923|FG005|Overall Study|Other Adverse Events|1|||
160500023|NCT02514239|579559924|FG006|Overall Study|Other Adverse Events|0|||
160500024|NCT02514239|579559925|FG007|Overall Study|Other Adverse Events|1|||
160500025|NCT02514239|579559926|FG008|Overall Study|Other Adverse Events|2|||
160500026|NCT02514239|579559927|FG009|Overall Study|Other Adverse Events|0|||
160500027|NCT02514239|579559918|FG000|Overall Study|Progressive disease|3|||
160500028|NCT02514239|579559919|FG001|Overall Study|Progressive disease|3|||
160500029|NCT02514239|579559920|FG002|Overall Study|Progressive disease|2|||
160500030|NCT02514239|579559921|FG003|Overall Study|Progressive disease|2|||
160500031|NCT02514239|579559922|FG004|Overall Study|Progressive disease|3|||
160500032|NCT02514239|579559923|FG005|Overall Study|Progressive disease|3|||
160500033|NCT02514239|579559924|FG006|Overall Study|Progressive disease|4|||
160500034|NCT02514239|579559925|FG007|Overall Study|Progressive disease|2|||
160500035|NCT02514239|579559926|FG008|Overall Study|Progressive disease|5|||
160500036|NCT02514239|579559927|FG009|Overall Study|Progressive disease|0|||
160500037|NCT03299049|579559928|FG000|Overall Study|On-going|486|||
160500038|NCT03299049|579559929|FG001|Overall Study|On-going|481|||
160500039|NCT03299049|579559928|FG000|Overall Study|Withdrawal by Subject|6|||
160500040|NCT03299049|579559929|FG001|Overall Study|Withdrawal by Subject|21|||
160500041|NCT03299049|579559928|FG000|Overall Study|Physician Decision|5|||
160500042|NCT03299049|579559929|FG001|Overall Study|Physician Decision|1|||
160500043|NCT03299049|579559928|FG000|Overall Study|Lost to Follow-up|2|||
160500044|NCT03299049|579559929|FG001|Overall Study|Lost to Follow-up|0|||
160500045|NCT03299049|579559928|FG000|Overall Study|Pregnancy|1|||
160500046|NCT03299049|579559929|FG001|Overall Study|Pregnancy|3|||
160500047|NCT03299049|579559928|FG000|Overall Study|Protocol Violation|1|||
160500048|NCT03299049|579559929|FG001|Overall Study|Protocol Violation|1|||
160500049|NCT03299049|579559928|FG000|Overall Study|Lack of Efficacy|9|||
160500050|NCT03299049|579559929|FG001|Overall Study|Lack of Efficacy|3|||
160500051|NCT03299049|579559928|FG000|Overall Study|Adverse Event|12|||
160500052|NCT03299049|579559929|FG001|Overall Study|Adverse Event|13|||
160500053|NCT01901419|579559930|FG000|Overall Study|Protocol Violation|2|||
160500054|NCT01901419|579559931|FG001|Overall Study|Protocol Violation|6|||
160500055|NCT01901419|579559930|FG000|Overall Study|unavailable researchers|6|||
160500056|NCT01901419|579559931|FG001|Overall Study|unavailable researchers|3|||
160500057|NCT00475644|579559932|FG000|Overall Study|Protocol Violation|13|||
160500058|NCT00790400|579559939|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
160500059|NCT00790400|579559940|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
160500060|NCT00790400|579559939|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
160500061|NCT00790400|579559940|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
160500062|NCT00790400|579559939|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
160500063|NCT00790400|579559940|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
160500064|NCT00790400|579559939|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
160500065|NCT00790400|579559940|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
160500066|NCT00790400|579559939|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
160500067|NCT00790400|579559940|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
160500068|NCT00790400|579559939|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
160500069|NCT00790400|579559940|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
160500070|NCT00790400|579559939|FG000|Double-blind Period (Core Phase)|Death|1|||
160500071|NCT00790400|579559940|FG001|Double-blind Period (Core Phase)|Death|0|||
160500072|NCT00790400|579559939|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
160500073|NCT00790400|579559940|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
160500074|NCT00790400|579559939|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
160500075|NCT00790400|579559940|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
160500076|NCT00790400|579559939|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
160500077|NCT00790400|579559940|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
160500078|NCT00790400|579559939|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
160500079|NCT00790400|579559940|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
160500080|NCT00790400|579559939|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
160619192|NCT01014442|579984919|FG000|Overall Study|Protocol Violation|2|||
160500081|NCT00790400|579559940|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
160500082|NCT00790400|579559939|FG000|Everolimus Period (Core or Extension)|Death|1|||
160500083|NCT00790400|579559940|FG001|Everolimus Period (Core or Extension)|Death|0|||
160500084|NCT00790400|579559939|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
160500085|NCT00790400|579559940|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
160619193|NCT01014442|579984920|FG001|Overall Study|Protocol Violation|5|||
160500086|NCT00790400|579559939|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
160500087|NCT00790400|579559940|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
160500088|NCT00790400|579559939|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
160500089|NCT00790400|579559940|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
160500090|NCT02412735|579559943|FG000|Overall Study|Adverse Event|0|||
160500091|NCT02412735|579559944|FG001|Overall Study|Adverse Event|1|||
160500092|NCT02412735|579559945|FG002|Overall Study|Adverse Event|2|||
160500093|NCT02412735|579559943|FG000|Overall Study|Withdrawal by Subject|23|||
160500094|NCT02412735|579559944|FG001|Overall Study|Withdrawal by Subject|27|||
160500095|NCT02412735|579559945|FG002|Overall Study|Withdrawal by Subject|22|||
160500096|NCT02412735|579559943|FG000|Overall Study|Investigator Decision|3|||
160500097|NCT02412735|579559944|FG001|Overall Study|Investigator Decision|3|||
160500098|NCT02412735|579559945|FG002|Overall Study|Investigator Decision|2|||
160500099|NCT02412735|579559943|FG000|Overall Study|Lost to Follow-up|17|||
160500100|NCT02412735|579559944|FG001|Overall Study|Lost to Follow-up|11|||
160500101|NCT02412735|579559945|FG002|Overall Study|Lost to Follow-up|18|||
160500102|NCT02412735|579559943|FG000|Overall Study|Reason not Specified|3|||
160500103|NCT02412735|579559944|FG001|Overall Study|Reason not Specified|2|||
160500104|NCT02412735|579559945|FG002|Overall Study|Reason not Specified|2|||
160500105|NCT01006980|579559946|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
160500106|NCT01006980|579559947|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
160500107|NCT01006980|579559946|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
160500108|NCT01006980|579559947|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
160500109|NCT01006980|579559946|FG000|Vemurafenib and Dacarbazine|Death|13|||
160500110|NCT01006980|579559947|FG001|Vemurafenib and Dacarbazine|Death|12|||
160500111|NCT01006980|579559946|FG000|Vemurafenib and Dacarbazine|Progression|257|||
160500112|NCT01006980|579559947|FG001|Vemurafenib and Dacarbazine|Progression|218|||
160500113|NCT01006980|579559946|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
160500114|NCT01006980|579559947|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
160500115|NCT01006980|579559946|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
160500116|NCT01006980|579559947|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
160500117|NCT01006980|579559946|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
160500118|NCT01006980|579559947|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
160500119|NCT01006980|579559946|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
160500120|NCT01006980|579559947|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
160500121|NCT01006980|579559946|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
160500122|NCT01006980|579559947|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
160500123|NCT01006980|579559946|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
160500124|NCT01006980|579559947|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
160500125|NCT01006980|579559946|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
160500126|NCT01006980|579559947|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
160500127|NCT01006980|579559946|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
160500128|NCT01006980|579559947|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
160500129|NCT01006980|579559946|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
160500130|NCT01006980|579559947|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
160500131|NCT00078338|579559948|FG000|Overall Study|Adverse Event|31|||
160500132|NCT00078338|579559949|FG001|Overall Study|Adverse Event|24|||
160500133|NCT00078338|579559948|FG000|Overall Study|Lost to Follow-up|17|||
160500134|NCT00078338|579559949|FG001|Overall Study|Lost to Follow-up|2|||
160500135|NCT00078338|579559948|FG000|Overall Study|Protocol Violation|2|||
160500136|NCT00078338|579559949|FG001|Overall Study|Protocol Violation|2|||
160500137|NCT00078338|579559948|FG000|Overall Study|Disease Progression|4|||
160500138|NCT00078338|579559949|FG001|Overall Study|Disease Progression|7|||
160500139|NCT00078338|579559948|FG000|Overall Study|Other|28|||
160500140|NCT00078338|579559949|FG001|Overall Study|Other|16|||
160500141|NCT00078338|579559948|FG000|Overall Study|Subjects randomized, but not treated|3|||
160500142|NCT00078338|579559949|FG001|Overall Study|Subjects randomized, but not treated|3|||
160500143|NCT02124811|579559950|FG000|Overall Study|Early termination|2|||
160500144|NCT02124811|579559951|FG001|Overall Study|Early termination|2|||
160500145|NCT02124811|579559950|FG000|Overall Study|Withdrawal by Subject|1|||
160500146|NCT02124811|579559951|FG001|Overall Study|Withdrawal by Subject|0|||
160500147|NCT04201288|579559954|FG000|Overall Study|Death|1|||
160500148|NCT04201288|579559955|FG001|Overall Study|Death|1|||
160500149|NCT04201288|579559954|FG000|Overall Study|Lost to Follow-up|5|||
160500150|NCT04201288|579559955|FG001|Overall Study|Lost to Follow-up|3|||
160500151|NCT04201288|579559954|FG000|Overall Study|Withdrawal by Subject|1|||
160500152|NCT04201288|579559955|FG001|Overall Study|Withdrawal by Subject|0|||
160619194|NCT01014442|579984919|FG000|Overall Study|Lack of Compliance|0|||
160619195|NCT01014442|579984920|FG001|Overall Study|Lack of Compliance|1|||
160500153|NCT00592293|579559956|FG000|Overall Study|Withdrawal by Subject|1|||
160500154|NCT01270828|579559957|FG000|Pregabalin CR SB|Reason Unspecified|0|||
160500155|NCT01270828|579559958|FG001|Pregabalin CR SB|Reason Unspecified|0|||
160500156|NCT01270828|579559959|FG002|Pregabalin CR SB|Reason Unspecified|8|||
160500157|NCT01270828|579559957|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
160500158|NCT01270828|579559958|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
160500159|NCT01270828|579559959|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
160619196|NCT01014442|579984919|FG000|Overall Study|Unspecified Reason|1|||
160500160|NCT01270828|579559957|FG000|Pregabalin CR SB|Related adverse event|0|||
160500161|NCT01270828|579559958|FG001|Pregabalin CR SB|Related adverse event|0|||
160619197|NCT01014442|579984920|FG001|Overall Study|Unspecified Reason|1|||
160500162|NCT01270828|579559959|FG002|Pregabalin CR SB|Related adverse event|46|||
160500163|NCT01270828|579559957|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
160500164|NCT01270828|579559958|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
160500165|NCT01270828|579559959|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
160500166|NCT01270828|579559957|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
160500167|NCT01270828|579559958|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
160500168|NCT01270828|579559959|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
160500169|NCT01270828|579559957|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
160500170|NCT01270828|579559958|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
160500171|NCT01270828|579559959|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
160500172|NCT01270828|579559957|FG000|Pregabalin CR SB|Unrelated AE|0|||
160500173|NCT01270828|579559958|FG001|Pregabalin CR SB|Unrelated AE|0|||
160500174|NCT01270828|579559959|FG002|Pregabalin CR SB|Unrelated AE|8|||
160500175|NCT01270828|579559957|FG000|Pregabalin CR SB|Protocol Violation|0|||
160500176|NCT01270828|579559958|FG001|Pregabalin CR SB|Protocol Violation|0|||
160500177|NCT01270828|579559959|FG002|Pregabalin CR SB|Protocol Violation|8|||
160500178|NCT01270828|579559957|FG000|Double Blind Phase|Death|0|||
160500179|NCT01270828|579559958|FG001|Double Blind Phase|Death|1|||
160500180|NCT01270828|579559959|FG002|Double Blind Phase|Death|0|||
160500181|NCT01270828|579559957|FG000|Double Blind Phase|Protocol Violation|0|||
160500182|NCT01270828|579559958|FG001|Double Blind Phase|Protocol Violation|1|||
160500183|NCT01270828|579559959|FG002|Double Blind Phase|Protocol Violation|0|||
160500184|NCT01270828|579559957|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
160500185|NCT01270828|579559958|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
160500186|NCT01270828|579559959|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
160500187|NCT01270828|579559957|FG000|Double Blind Phase|Reason Unspecified|7|||
160500188|NCT01270828|579559958|FG001|Double Blind Phase|Reason Unspecified|4|||
160500189|NCT01270828|579559959|FG002|Double Blind Phase|Reason Unspecified|0|||
160500190|NCT01270828|579559957|FG000|Double Blind Phase|Withdrawal by Subject|6|||
160500191|NCT01270828|579559958|FG001|Double Blind Phase|Withdrawal by Subject|15|||
160500192|NCT01270828|579559959|FG002|Double Blind Phase|Withdrawal by Subject|0|||
160500193|NCT01270828|579559957|FG000|Double Blind Phase|Lost to Follow-up|1|||
160500194|NCT01270828|579559958|FG001|Double Blind Phase|Lost to Follow-up|2|||
160500195|NCT01270828|579559959|FG002|Double Blind Phase|Lost to Follow-up|0|||
160500196|NCT01270828|579559957|FG000|Double Blind Phase|Lack of Efficacy|2|||
160500197|NCT01270828|579559958|FG001|Double Blind Phase|Lack of Efficacy|11|||
160500198|NCT01270828|579559959|FG002|Double Blind Phase|Lack of Efficacy|0|||
160500199|NCT01270828|579559957|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
160500200|NCT01270828|579559958|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
160500201|NCT01270828|579559959|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
160500202|NCT01270828|579559957|FG000|Double Blind Phase|Adverse event related to study drug|5|||
160500203|NCT01270828|579559958|FG001|Double Blind Phase|Adverse event related to study drug|7|||
160500204|NCT01270828|579559959|FG002|Double Blind Phase|Adverse event related to study drug|0|||
160500205|NCT02870972|579559960|FG000|Overall Study|Adverse Event|1|||
160500206|NCT02870972|579559961|FG001|Overall Study|Adverse Event|0|||
160500207|NCT02870972|579559962|FG002|Overall Study|Adverse Event|0|||
160500208|NCT02870972|579559963|FG003|Overall Study|Adverse Event|0|||
160500209|NCT02870972|579559964|FG004|Overall Study|Adverse Event|0|||
160500210|NCT03445533|579559966|FG000|Overall Study|Progressive Disease|48|||
160500211|NCT03445533|579559967|FG001|Overall Study|Progressive Disease|81|||
160500212|NCT03445533|579559966|FG000|Overall Study|Adverse Event|60|||
160500213|NCT03445533|579559967|FG001|Overall Study|Adverse Event|64|||
160500214|NCT03445533|579559966|FG000|Overall Study|Death|9|||
160500215|NCT03445533|579559967|FG001|Overall Study|Death|19|||
160500216|NCT03445533|579559966|FG000|Overall Study|Miscellaneous|0|||
160500217|NCT03445533|579559967|FG001|Overall Study|Miscellaneous|16|||
160500218|NCT03445533|579559966|FG000|Overall Study|Withdrawal by Subject|3|||
160500219|NCT03445533|579559967|FG001|Overall Study|Withdrawal by Subject|4|||
160500220|NCT03445533|579559966|FG000|Overall Study|Physician Decision|1|||
160500221|NCT03445533|579559967|FG001|Overall Study|Physician Decision|3|||
160500222|NCT03445533|579559966|FG000|Overall Study|Sponsor Decision|0|||
160500223|NCT03445533|579559967|FG001|Overall Study|Sponsor Decision|1|||
160500224|NCT03445533|579559966|FG000|Overall Study|Lost to Follow-up|0|||
160500225|NCT03445533|579559967|FG001|Overall Study|Lost to Follow-up|1|||
160500226|NCT03445533|579559966|FG000|Overall Study|Never Received any Study Treatment|7|||
160500227|NCT03445533|579559967|FG001|Overall Study|Never Received any Study Treatment|4|||
160500228|NCT02615509|579559968|FG000|Overall Study|Lost to Follow-up|134|||
160500229|NCT02615509|579559968|FG000|Overall Study|Death|4|||
160500230|NCT02615509|579559968|FG000|Overall Study|Withdrawal by Subject|8|||
160500231|NCT03334253|579559969|FG000|Overall Study|Withdrawal by Subject|1|||
160500232|NCT03334253|579559970|FG001|Overall Study|Withdrawal by Subject|0|||
160500233|NCT03334253|579559969|FG000|Overall Study|Lost to Follow-up|4|||
160500234|NCT03334253|579559970|FG001|Overall Study|Lost to Follow-up|3|||
160500235|NCT03334253|579559969|FG000|Overall Study|Moved residence|2|||
160500236|NCT03334253|579559970|FG001|Overall Study|Moved residence|2|||
160500237|NCT03274453|579559971|FG000|Overall Study|Lost to Follow-up|2|||
160500238|NCT03274453|579559972|FG001|Overall Study|Lost to Follow-up|5|||
160500239|NCT03274453|579559973|FG002|Overall Study|Lost to Follow-up|4|||
160500240|NCT03274453|579559974|FG003|Overall Study|Lost to Follow-up|1|||
160500241|NCT03274453|579559971|FG000|Overall Study|Physician Decision|2|||
160500242|NCT03274453|579559972|FG001|Overall Study|Physician Decision|0|||
160500243|NCT03274453|579559973|FG002|Overall Study|Physician Decision|0|||
160500244|NCT03274453|579559974|FG003|Overall Study|Physician Decision|3|||
160500245|NCT03274453|579559971|FG000|Overall Study|Surgery Cancelled|0|||
160500246|NCT03274453|579559972|FG001|Overall Study|Surgery Cancelled|1|||
160500247|NCT03274453|579559973|FG002|Overall Study|Surgery Cancelled|0|||
160500248|NCT03274453|579559974|FG003|Overall Study|Surgery Cancelled|0|||
160500249|NCT00968526|579559975|FG000|Overall Study|Adverse Event|2|||
160500250|NCT00968526|579559976|FG001|Overall Study|Adverse Event|0|||
160500251|NCT00968526|579559975|FG000|Overall Study|Migrated/moved from study area|1|||
160500252|NCT00968526|579559976|FG001|Overall Study|Migrated/moved from study area|0|||
160500253|NCT01294397|579559977|FG000|Overall Study|Withdrawal by Subject|1|||
160500254|NCT01294397|579559977|FG000|Overall Study|Administrative Decision|1|||
160500255|NCT01967069|579559979|FG000|Overall Study|Adverse Event|2|||
160500256|NCT01967069|579559980|FG001|Overall Study|Adverse Event|2|||
160500257|NCT01967069|579559979|FG000|Overall Study|Lost to Follow-up|5|||
160500258|NCT01967069|579559980|FG001|Overall Study|Lost to Follow-up|2|||
160500259|NCT01967069|579559979|FG000|Overall Study|Withdrawal by Subject|1|||
160500260|NCT01967069|579559980|FG001|Overall Study|Withdrawal by Subject|3|||
160500261|NCT01967069|579559979|FG000|Overall Study|Lack of Efficacy|0|||
160500262|NCT01967069|579559980|FG001|Overall Study|Lack of Efficacy|1|||
160500263|NCT05569421|579559981|FG000|Overall Study|Withdrawal by Subject|1|||
160500264|NCT05569421|579559982|FG001|Overall Study|Withdrawal by Subject|0|||
160500265|NCT05569421|579559983|FG002|Overall Study|Withdrawal by Subject|0|||
160500266|NCT03812029|579559985|FG000|Overall Study|Protocol Violation|1|||
160662280|NCT00857623|580145695|FG001|Overall Study|Positive for HEP C|1|||
160662281|NCT02193178|580145696|FG000|Overall Study|Lost to Follow-up|1|||
160662282|NCT02193178|580145696|FG000|Overall Study|Dry eyes|1|||
160662283|NCT03435081|580145697|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
160662284|NCT03435081|580145698|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
160662285|NCT03435081|580145699|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
160662286|NCT03435081|580145697|FG000|Week 0 to Week 16|Adverse Event|2|||
160662287|NCT03435081|580145698|FG001|Week 0 to Week 16|Adverse Event|2|||
160662288|NCT03435081|580145699|FG002|Week 0 to Week 16|Adverse Event|2|||
160662289|NCT03435081|580145697|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
160662290|NCT03435081|580145698|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
160662291|NCT03435081|580145699|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
160662292|NCT03435081|580145697|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
160662293|NCT03435081|580145698|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
160662294|NCT03435081|580145699|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
160662295|NCT03435081|580145697|FG000|Week 0 to Week 16|Pregnancy|1|||
160662296|NCT03435081|580145698|FG001|Week 0 to Week 16|Pregnancy|0|||
160662297|NCT03435081|580145699|FG002|Week 0 to Week 16|Pregnancy|0|||
160662298|NCT03435081|580145697|FG000|Week 0 to Week 16|Non-compliance|1|||
160662299|NCT03435081|580145698|FG001|Week 0 to Week 16|Non-compliance|0|||
160662300|NCT03435081|580145699|FG002|Week 0 to Week 16|Non-compliance|2|||
160662301|NCT03435081|580145697|FG000|Week 0 to Week 16|Inadequate Response|0|||
160662302|NCT03435081|580145698|FG001|Week 0 to Week 16|Inadequate Response|1|||
160662303|NCT03435081|580145699|FG002|Week 0 to Week 16|Inadequate Response|0|||
160662304|NCT03435081|580145697|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
160662305|NCT03435081|580145698|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
160662306|NCT03435081|580145699|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
160662307|NCT03435081|580145697|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
160662308|NCT03435081|580145698|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
160662309|NCT03435081|580145699|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
160662310|NCT03435081|580145697|FG000|Week 16 to Week 104|Adverse Event|1|||
160662311|NCT03435081|580145698|FG001|Week 16 to Week 104|Adverse Event|0|||
160662312|NCT03435081|580145699|FG002|Week 16 to Week 104|Adverse Event|2|||
160662313|NCT03435081|580145697|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
160662314|NCT03435081|580145698|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
160662315|NCT03435081|580145699|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
160662316|NCT03435081|580145697|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
160662317|NCT03435081|580145698|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
160662318|NCT03435081|580145699|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
160500267|NCT03812029|579559986|FG001|Overall Study|Protocol Violation|0|||
160500268|NCT03812029|579559987|FG002|Overall Study|Protocol Violation|0|||
160500269|NCT03812029|579559988|FG003|Overall Study|Protocol Violation|1|||
160500270|NCT03812029|579559989|FG004|Overall Study|Protocol Violation|0|||
160500271|NCT03812029|579559985|FG000|Overall Study|Withdrawal by Subject|1|||
160500272|NCT03812029|579559986|FG001|Overall Study|Withdrawal by Subject|0|||
160500273|NCT03812029|579559987|FG002|Overall Study|Withdrawal by Subject|0|||
160500274|NCT03812029|579559988|FG003|Overall Study|Withdrawal by Subject|2|||
160500275|NCT03812029|579559989|FG004|Overall Study|Withdrawal by Subject|2|||
160662319|NCT03435081|580145697|FG000|Week 16 to Week 104|Non--Compliance|0|||
160619198|NCT02074059|579984921|FG000|Overall Study|Death|0|||
160619199|NCT02074059|579984922|FG001|Overall Study|Death|0|||
160619200|NCT02074059|579984923|FG002|Overall Study|Death|0|||
160500276|NCT03812029|579559985|FG000|Overall Study|Stopping rules|0|||
160500277|NCT03812029|579559986|FG001|Overall Study|Stopping rules|1|||
160500278|NCT03812029|579559987|FG002|Overall Study|Stopping rules|0|||
160500279|NCT03812029|579559988|FG003|Overall Study|Stopping rules|0|||
160500280|NCT03812029|579559989|FG004|Overall Study|Stopping rules|0|||
160500281|NCT03812029|579559985|FG000|Overall Study|Adverse Event|0|||
160500282|NCT03812029|579559986|FG001|Overall Study|Adverse Event|9|||
160500283|NCT03812029|579559987|FG002|Overall Study|Adverse Event|0|||
160500284|NCT03812029|579559988|FG003|Overall Study|Adverse Event|3|||
160500285|NCT03812029|579559989|FG004|Overall Study|Adverse Event|5|||
160500286|NCT03812029|579559985|FG000|Overall Study|Lost to Follow-up|0|||
160500287|NCT03812029|579559986|FG001|Overall Study|Lost to Follow-up|0|||
160500288|NCT03812029|579559987|FG002|Overall Study|Lost to Follow-up|0|||
160500289|NCT03812029|579559988|FG003|Overall Study|Lost to Follow-up|0|||
160500290|NCT03812029|579559989|FG004|Overall Study|Lost to Follow-up|3|||
160500291|NCT00479882|579559990|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
160500292|NCT00479882|579559991|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
160500293|NCT00479882|579559992|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
160500294|NCT00479882|579559993|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
160500295|NCT00479882|579559990|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
160500296|NCT00479882|579559991|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
160500297|NCT00479882|579559992|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
160500298|NCT00479882|579559993|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
160500299|NCT00479882|579559990|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
160500300|NCT00479882|579559991|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
160500301|NCT00479882|579559992|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
160500302|NCT00479882|579559993|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
160500303|NCT00479882|579559990|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
160500304|NCT00479882|579559991|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
160500305|NCT00479882|579559992|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
160500306|NCT00479882|579559993|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
160500307|NCT00479882|579559990|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
160500308|NCT00479882|579559991|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
160500309|NCT00479882|579559992|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
160500310|NCT00479882|579559993|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
160500311|NCT00479882|579559990|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
160500312|NCT00479882|579559991|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
160500313|NCT00479882|579559992|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
160500314|NCT00479882|579559993|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
160500315|NCT00479882|579559990|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
160500316|NCT00479882|579559991|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
160500317|NCT00479882|579559992|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
160500318|NCT00479882|579559993|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
160500319|NCT00479882|579559990|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
160500320|NCT00479882|579559991|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
160500321|NCT00479882|579559992|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
160500322|NCT00479882|579559993|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
160500323|NCT00479882|579559990|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
160500324|NCT00479882|579559991|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
160500325|NCT00479882|579559992|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
160500326|NCT00479882|579559993|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
160500327|NCT00479882|579559990|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
160500328|NCT00479882|579559991|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
160500329|NCT00479882|579559992|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
160500330|NCT00479882|579559993|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
160500331|NCT00479882|579559990|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
160500332|NCT00479882|579559991|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
160500333|NCT00479882|579559992|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
160619201|NCT02074059|579984924|FG003|Overall Study|Death|0|||
160500334|NCT00479882|579559993|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
160500335|NCT00479882|579559990|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
160500336|NCT00479882|579559991|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
160500337|NCT00479882|579559992|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
160500338|NCT00479882|579559993|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
160500339|NCT00479882|579559990|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
160619202|NCT02074059|579984925|FG004|Overall Study|Death|1|||
160500340|NCT00479882|579559991|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
160500341|NCT00479882|579559992|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
160500342|NCT00479882|579559993|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
160500343|NCT00479882|579559990|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
160500344|NCT00479882|579559991|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
160500345|NCT00479882|579559992|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
160500346|NCT00479882|579559993|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
160500347|NCT03106753|579559994|FG000|Overall Study|Withdrawal by Subject|0|||
160500348|NCT03106753|579559995|FG001|Overall Study|Withdrawal by Subject|1|||
160500349|NCT03149042|579559997|FG000|Overall Study|Invasive FFR not performed|21|||
160500350|NCT03149042|579559997|FG000|Overall Study|Poor CT Image Quality|1|||
160500351|NCT03149042|579559997|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
160500352|NCT01643044|579559998|FG000|Overall Study|Lost to Follow-up|1|||
160500353|NCT01643044|579559999|FG001|Overall Study|Lost to Follow-up|1|||
160500354|NCT01643044|579559998|FG000|Overall Study|Miscarried baby|2|||
160500355|NCT01643044|579559999|FG001|Overall Study|Miscarried baby|2|||
160500356|NCT01643044|579559998|FG000|Overall Study|Delivered outside of hospital|1|||
160500357|NCT01643044|579559999|FG001|Overall Study|Delivered outside of hospital|2|||
160500358|NCT01023958|579560006|FG000|Overall Study|Progressive disease|48|||
160500359|NCT01023958|579560006|FG000|Overall Study|Other adverse event|1|||
160500360|NCT01023958|579560006|FG000|Overall Study|Refused to continue medication|1|||
160500361|NCT02643628|579560010|FG000|Overall Study|Lost to Follow-up|1|||
160500362|NCT02643628|579560011|FG001|Overall Study|Lost to Follow-up|4|||
160500363|NCT02643628|579560010|FG000|Overall Study|Withdrawal by Subject|0|||
160500364|NCT02643628|579560011|FG001|Overall Study|Withdrawal by Subject|1|||
160500365|NCT02643628|579560010|FG000|Overall Study|Relocated out of state|0|||
160500366|NCT02643628|579560011|FG001|Overall Study|Relocated out of state|1|||
160500367|NCT04805073|579560015|FG000|Overall Study|study personnel not available|2|||
160500368|NCT04805073|579560016|FG001|Overall Study|study personnel not available|0|||
160500369|NCT04805073|579560015|FG000|Overall Study|spinal anesthesia failure|0|||
160500370|NCT04805073|579560016|FG001|Overall Study|spinal anesthesia failure|1|||
160500371|NCT04805073|579560015|FG000|Overall Study|Lost to Follow-up|0|||
160500372|NCT04805073|579560016|FG001|Overall Study|Lost to Follow-up|2|||
160500373|NCT00422734|579560020|FG000|Overall Study|Physician Decision|1|||
160500374|NCT00422734|579560021|FG001|Overall Study|Physician Decision|1|||
160500375|NCT00422734|579560020|FG000|Overall Study|Protocol Violation|1|||
160500376|NCT00422734|579560021|FG001|Overall Study|Protocol Violation|6|||
160500377|NCT00422734|579560020|FG000|Overall Study|Withdrawal by Subject|12|||
160500378|NCT00422734|579560021|FG001|Overall Study|Withdrawal by Subject|8|||
160500379|NCT00422734|579560020|FG000|Overall Study|Adverse Event|0|||
160500380|NCT00422734|579560021|FG001|Overall Study|Adverse Event|3|||
160500381|NCT00422734|579560020|FG000|Overall Study|Partner Decision|0|||
160500382|NCT00422734|579560021|FG001|Overall Study|Partner Decision|3|||
160500383|NCT02975102|579560024|FG000|Overall Study|Adverse Event|2|||
160500384|NCT02975102|579560025|FG001|Overall Study|Adverse Event|1|||
160500385|NCT04148651|579560026|FG000|Overall Study|Lost to Follow-up|2|||
160500386|NCT02609672|579560027|FG000|Overall Study|Lost to Follow-up|3|||
160500387|NCT02609672|579560028|FG001|Overall Study|Lost to Follow-up|1|||
160500388|NCT03392168|579560030|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
160500389|NCT03392168|579560031|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
160500390|NCT03392168|579560032|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
160500391|NCT03392168|579560033|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
160500392|NCT03392168|579560030|FG000|Period 2: Cohort 2|Other|0|||
160500393|NCT03392168|579560031|FG001|Period 2: Cohort 2|Other|1|||
160500394|NCT03392168|579560032|FG002|Period 2: Cohort 2|Other|0|||
160500395|NCT03392168|579560033|FG003|Period 2: Cohort 2|Other|0|||
160500396|NCT01441635|579560034|FG000|Overall Study|Adverse Event|4|||
160500397|NCT01441635|579560035|FG001|Overall Study|Adverse Event|3|||
160500398|NCT01441635|579560036|FG002|Overall Study|Adverse Event|1|||
160500399|NCT01441635|579560037|FG003|Overall Study|Adverse Event|5|||
160500400|NCT01441635|579560038|FG004|Overall Study|Adverse Event|1|||
160500401|NCT01441635|579560039|FG005|Overall Study|Adverse Event|2|||
160500402|NCT01441635|579560040|FG006|Overall Study|Adverse Event|2|||
160500403|NCT01441635|579560041|FG007|Overall Study|Adverse Event|2|||
160500404|NCT01441635|579560042|FG008|Overall Study|Adverse Event|1|||
160500405|NCT01441635|579560043|FG009|Overall Study|Adverse Event|0|||
160500406|NCT01441635|579560034|FG000|Overall Study|Withdrawal by Subject|1|||
160500407|NCT01441635|579560035|FG001|Overall Study|Withdrawal by Subject|1|||
160500408|NCT01441635|579560036|FG002|Overall Study|Withdrawal by Subject|0|||
160500409|NCT01441635|579560037|FG003|Overall Study|Withdrawal by Subject|1|||
160500410|NCT01441635|579560038|FG004|Overall Study|Withdrawal by Subject|0|||
160500411|NCT01441635|579560039|FG005|Overall Study|Withdrawal by Subject|0|||
160500412|NCT01441635|579560040|FG006|Overall Study|Withdrawal by Subject|2|||
160500413|NCT01441635|579560041|FG007|Overall Study|Withdrawal by Subject|0|||
160500414|NCT01441635|579560042|FG008|Overall Study|Withdrawal by Subject|1|||
160500415|NCT01441635|579560043|FG009|Overall Study|Withdrawal by Subject|1|||
160500416|NCT01441635|579560034|FG000|Overall Study|Lost to Follow-up|0|||
160619203|NCT02074059|579984926|FG005|Overall Study|Death|1|||
160619204|NCT02764229|579984930|FG000|Overall Study|Withdrawal by Subject|15|||
160619205|NCT02764229|579984930|FG000|Overall Study|Adverse Event|9|||
160619206|NCT02764229|579984930|FG000|Overall Study|Physician Decision|5|||
160619207|NCT02764229|579984930|FG000|Overall Study|Lost to Follow-up|3|||
160619208|NCT02764229|579984930|FG000|Overall Study|Lack of Efficacy|1|||
160619209|NCT02764229|579984930|FG000|Overall Study|Study Stopped by Sponsor|69|||
160619210|NCT02135848|579984933|FG000|Overall Study|Adverse Event|2|||
160619211|NCT02135848|579984934|FG001|Overall Study|Adverse Event|0|||
160619212|NCT02135848|579984933|FG000|Overall Study|Withdrawal by Subject|1|||
160619213|NCT02135848|579984934|FG001|Overall Study|Withdrawal by Subject|1|||
160619214|NCT02030067|579984935|FG000|Overall Study|Disease Progression|1|||
160619215|NCT02030067|579984936|FG001|Overall Study|Disease Progression|1|||
160619216|NCT02030067|579984937|FG002|Overall Study|Disease Progression|2|||
160619217|NCT02030067|579984938|FG003|Overall Study|Disease Progression|2|||
160619218|NCT02030067|579984939|FG004|Overall Study|Disease Progression|3|||
160619219|NCT02030067|579984940|FG005|Overall Study|Disease Progression|2|||
160619220|NCT02030067|579984941|FG006|Overall Study|Disease Progression|3|||
160619221|NCT02030067|579984942|FG007|Overall Study|Disease Progression|3|||
160619222|NCT02030067|579984943|FG008|Overall Study|Disease Progression|4|||
160500417|NCT01441635|579560035|FG001|Overall Study|Lost to Follow-up|1|||
160500418|NCT01441635|579560036|FG002|Overall Study|Lost to Follow-up|1|||
160500419|NCT01441635|579560037|FG003|Overall Study|Lost to Follow-up|1|||
160619223|NCT02030067|579984944|FG009|Overall Study|Disease Progression|3|||
160662320|NCT03435081|580145698|FG001|Week 16 to Week 104|Non--Compliance|0|||
160662321|NCT03435081|580145699|FG002|Week 16 to Week 104|Non--Compliance|1|||
160662322|NCT02601560|580145700|FG000|Overall Study|Other|0|||
160662323|NCT02601560|580145701|FG001|Overall Study|Other|0|||
160662324|NCT02601560|580145702|FG002|Overall Study|Other|0|||
160662325|NCT02601560|580145703|FG003|Overall Study|Other|0|||
160662326|NCT02601560|580145704|FG004|Overall Study|Other|0|||
160662327|NCT02601560|580145705|FG005|Overall Study|Other|0|||
160662328|NCT02601560|580145706|FG006|Overall Study|Other|1|||
160662329|NCT02601560|580145707|FG007|Overall Study|Other|0|||
160662330|NCT00420238|580145708|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
160662331|NCT00420238|580145709|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
160662332|NCT00420238|580145708|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
160662333|NCT00420238|580145709|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
160662334|NCT00420238|580145708|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
160662335|NCT00420238|580145709|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
160662336|NCT00420238|580145708|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
160662337|NCT00420238|580145709|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
160662338|NCT00420238|580145708|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
160662339|NCT00420238|580145709|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
160662340|NCT00420238|580145708|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
160662341|NCT00420238|580145709|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
160662342|NCT00626548|580145710|FG000|Overall Study|Adverse Event|164|||
160662343|NCT00626548|580145711|FG001|Overall Study|Adverse Event|44|||
160662344|NCT00626548|580145710|FG000|Overall Study|Withdrawal by Subject|42|||
160662345|NCT00626548|580145711|FG001|Overall Study|Withdrawal by Subject|46|||
160662346|NCT00626548|580145710|FG000|Overall Study|Protocol Violation|4|||
160662347|NCT00626548|580145711|FG001|Overall Study|Protocol Violation|11|||
160662348|NCT00626548|580145710|FG000|Overall Study|Lost to Follow-up|2|||
160662349|NCT00626548|580145711|FG001|Overall Study|Lost to Follow-up|2|||
160662350|NCT00626548|580145710|FG000|Overall Study|Other termination reason|493|||
160662351|NCT00626548|580145711|FG001|Overall Study|Other termination reason|613|||
160662352|NCT03555305|580145712|FG000|Period 1|Physician Decision|0|||
160662353|NCT03555305|580145713|FG001|Period 1|Physician Decision|1|||
160662354|NCT03555305|580145712|FG000|Period 1|Adverse Event|0|||
160662355|NCT03555305|580145713|FG001|Period 1|Adverse Event|1|||
160662356|NCT05369208|580147483|FG000|Core Phase|Prohibited Medication Required|2|||
160662357|NCT05369208|580147483|FG000|Core Phase|Adverse Event|1|||
160662358|NCT05369208|580147483|FG000|Core Phase|Lack of Efficacy|1|||
160662359|NCT04934722|580147484|FG000|Overall Study|Death|4|||
160662360|NCT04934722|580147485|FG001|Overall Study|Death|3|||
160662361|NCT04934722|580147484|FG000|Overall Study|Participants Ongoing|88|||
160662362|NCT04934722|580147485|FG001|Overall Study|Participants Ongoing|91|||
160662363|NCT01124175|580147486|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
160662364|NCT01124175|580147487|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
160662365|NCT00942968|580147488|FG000|Overall Study|Adverse Event|60|||
160662366|NCT00942968|580147488|FG000|Overall Study|Death|76|||
160619224|NCT02030067|579984945|FG010|Overall Study|Disease Progression|7|||
160619225|NCT02030067|579984946|FG011|Overall Study|Disease Progression|2|||
160619226|NCT02030067|579984947|FG012|Overall Study|Disease Progression|59|||
160619227|NCT02030067|579984935|FG000|Overall Study|Withdrawal by Subject|0|||
160619228|NCT02030067|579984936|FG001|Overall Study|Withdrawal by Subject|0|||
160619229|NCT02030067|579984937|FG002|Overall Study|Withdrawal by Subject|0|||
160619230|NCT02030067|579984938|FG003|Overall Study|Withdrawal by Subject|1|||
160619231|NCT02030067|579984939|FG004|Overall Study|Withdrawal by Subject|0|||
160619232|NCT02030067|579984940|FG005|Overall Study|Withdrawal by Subject|0|||
160619233|NCT02030067|579984941|FG006|Overall Study|Withdrawal by Subject|0|||
160619234|NCT02030067|579984942|FG007|Overall Study|Withdrawal by Subject|1|||
160619235|NCT02030067|579984943|FG008|Overall Study|Withdrawal by Subject|0|||
160619236|NCT02030067|579984944|FG009|Overall Study|Withdrawal by Subject|0|||
160619237|NCT02030067|579984945|FG010|Overall Study|Withdrawal by Subject|3|||
160619238|NCT02030067|579984946|FG011|Overall Study|Withdrawal by Subject|0|||
160619239|NCT02030067|579984947|FG012|Overall Study|Withdrawal by Subject|6|||
160619240|NCT02030067|579984935|FG000|Overall Study|Physician Decision|0|||
160619241|NCT02030067|579984936|FG001|Overall Study|Physician Decision|0|||
160619242|NCT02030067|579984937|FG002|Overall Study|Physician Decision|0|||
160619243|NCT02030067|579984938|FG003|Overall Study|Physician Decision|0|||
160619244|NCT02030067|579984939|FG004|Overall Study|Physician Decision|0|||
160619245|NCT02030067|579984940|FG005|Overall Study|Physician Decision|0|||
160619246|NCT02030067|579984941|FG006|Overall Study|Physician Decision|0|||
160619247|NCT02030067|579984942|FG007|Overall Study|Physician Decision|0|||
160619248|NCT02030067|579984943|FG008|Overall Study|Physician Decision|0|||
160662367|NCT00942968|580147488|FG000|Overall Study|Protocol Violation|9|||
160662368|NCT00942968|580147488|FG000|Overall Study|Lost to Follow-up|4|||
160500420|NCT01441635|579560038|FG004|Overall Study|Lost to Follow-up|1|||
160500421|NCT01441635|579560039|FG005|Overall Study|Lost to Follow-up|3|||
160500422|NCT01441635|579560040|FG006|Overall Study|Lost to Follow-up|1|||
160500423|NCT01441635|579560041|FG007|Overall Study|Lost to Follow-up|1|||
160500424|NCT01441635|579560042|FG008|Overall Study|Lost to Follow-up|0|||
160500425|NCT01441635|579560043|FG009|Overall Study|Lost to Follow-up|1|||
160500426|NCT01441635|579560034|FG000|Overall Study|Noncompliance|0|||
160500427|NCT01441635|579560035|FG001|Overall Study|Noncompliance|1|||
160500428|NCT01441635|579560036|FG002|Overall Study|Noncompliance|0|||
160500429|NCT01441635|579560037|FG003|Overall Study|Noncompliance|0|||
160500430|NCT01441635|579560038|FG004|Overall Study|Noncompliance|0|||
160500431|NCT01441635|579560039|FG005|Overall Study|Noncompliance|0|||
160500432|NCT01441635|579560040|FG006|Overall Study|Noncompliance|1|||
160500433|NCT01441635|579560041|FG007|Overall Study|Noncompliance|0|||
160500434|NCT01441635|579560042|FG008|Overall Study|Noncompliance|0|||
160500435|NCT01441635|579560043|FG009|Overall Study|Noncompliance|0|||
160500436|NCT01441635|579560034|FG000|Overall Study|Surgery or Invasive Intervention|0|||
160500437|NCT01441635|579560035|FG001|Overall Study|Surgery or Invasive Intervention|0|||
160500438|NCT01441635|579560036|FG002|Overall Study|Surgery or Invasive Intervention|1|||
160500439|NCT01441635|579560037|FG003|Overall Study|Surgery or Invasive Intervention|0|||
160500440|NCT01441635|579560038|FG004|Overall Study|Surgery or Invasive Intervention|0|||
160500441|NCT01441635|579560039|FG005|Overall Study|Surgery or Invasive Intervention|0|||
160500442|NCT01441635|579560040|FG006|Overall Study|Surgery or Invasive Intervention|0|||
160500443|NCT01441635|579560041|FG007|Overall Study|Surgery or Invasive Intervention|0|||
160500444|NCT01441635|579560042|FG008|Overall Study|Surgery or Invasive Intervention|0|||
160500445|NCT01441635|579560043|FG009|Overall Study|Surgery or Invasive Intervention|0|||
160500446|NCT01441635|579560034|FG000|Overall Study|Received Exclusionary Medication|1|||
160500447|NCT01441635|579560035|FG001|Overall Study|Received Exclusionary Medication|0|||
160500448|NCT01441635|579560036|FG002|Overall Study|Received Exclusionary Medication|0|||
160500449|NCT01441635|579560037|FG003|Overall Study|Received Exclusionary Medication|0|||
160500450|NCT01441635|579560038|FG004|Overall Study|Received Exclusionary Medication|0|||
160500451|NCT01441635|579560039|FG005|Overall Study|Received Exclusionary Medication|0|||
160500452|NCT01441635|579560040|FG006|Overall Study|Received Exclusionary Medication|0|||
160500453|NCT01441635|579560041|FG007|Overall Study|Received Exclusionary Medication|0|||
160500454|NCT01441635|579560042|FG008|Overall Study|Received Exclusionary Medication|0|||
160500455|NCT01441635|579560043|FG009|Overall Study|Received Exclusionary Medication|0|||
160500456|NCT01441635|579560034|FG000|Overall Study|Other|0|||
160500457|NCT01441635|579560035|FG001|Overall Study|Other|0|||
160500458|NCT01441635|579560036|FG002|Overall Study|Other|0|||
160500459|NCT01441635|579560037|FG003|Overall Study|Other|0|||
160500460|NCT01441635|579560038|FG004|Overall Study|Other|0|||
160500461|NCT01441635|579560039|FG005|Overall Study|Other|0|||
160500462|NCT01441635|579560040|FG006|Overall Study|Other|0|||
160500463|NCT01441635|579560041|FG007|Overall Study|Other|1|||
160500464|NCT01441635|579560042|FG008|Overall Study|Other|0|||
160500465|NCT01441635|579560043|FG009|Overall Study|Other|0|||
160500466|NCT02637323|579560045|FG000|Overall Study|Lost to Follow-up|2|||
160500467|NCT02637323|579560046|FG001|Overall Study|Lost to Follow-up|0|||
160500468|NCT02637323|579560045|FG000|Overall Study|Protocol Violation|0|||
160500469|NCT02637323|579560046|FG001|Overall Study|Protocol Violation|1|||
160500470|NCT01154140|579560047|FG000|Overall Study|Death|71|||
160500471|NCT01154140|579560048|FG001|Overall Study|Death|81|||
160500472|NCT01154140|579560047|FG000|Overall Study|Lost to Follow-up|4|||
160500473|NCT01154140|579560048|FG001|Overall Study|Lost to Follow-up|5|||
160500474|NCT01154140|579560047|FG000|Overall Study|Withdrawal by Subject|12|||
160500475|NCT01154140|579560048|FG001|Overall Study|Withdrawal by Subject|13|||
160500476|NCT01154140|579560047|FG000|Overall Study|Other|3|||
160500477|NCT01154140|579560048|FG001|Overall Study|Other|1|||
160500478|NCT01154140|579560047|FG000|Overall Study|Randomized but not treated|1|||
160500479|NCT01154140|579560048|FG001|Overall Study|Randomized but not treated|2|||
160500480|NCT00358644|579560049|FG000|Overall Study|Progressive Disease|21|||
160500481|NCT00358644|579560049|FG000|Overall Study|Adverse Event|7|||
160500482|NCT00358644|579560049|FG000|Overall Study|Death|11|||
160500483|NCT00358644|579560049|FG000|Overall Study|Withdrawal by Subject|4|||
160500484|NCT00358644|579560049|FG000|Overall Study|Physician Decision|6|||
160500485|NCT00358644|579560049|FG000|Overall Study|Patient not eligible for study|1|||
160500486|NCT00368875|579560050|FG000|Overall Study|Adverse Event|0|||
160500487|NCT00368875|579560051|FG001|Overall Study|Adverse Event|12|||
160500488|NCT00368875|579560050|FG000|Overall Study|Progressive disease|3|||
160500489|NCT00368875|579560051|FG001|Overall Study|Progressive disease|27|||
160500490|NCT00368875|579560050|FG000|Overall Study|Withdrawal by Subject|2|||
160500491|NCT00368875|579560051|FG001|Overall Study|Withdrawal by Subject|6|||
160619249|NCT02030067|579984944|FG009|Overall Study|Physician Decision|0|||
160500492|NCT00368875|579560050|FG000|Overall Study|Other Reason|0|||
160500493|NCT00368875|579560051|FG001|Overall Study|Other Reason|2|||
160500494|NCT00368875|579560050|FG000|Overall Study|Alternative Therapy|1|||
160500495|NCT00368875|579560051|FG001|Overall Study|Alternative Therapy|1|||
160500496|NCT03327831|579560052|FG000|Overall Study|Lost to Follow-up|2|||
160662369|NCT00942968|580147488|FG000|Overall Study|Withdrawal by Subject|44|||
160662370|NCT00942968|580147488|FG000|Overall Study|Sponsor request|5|||
160662371|NCT00942968|580147488|FG000|Overall Study|Physician Decision|11|||
160662372|NCT00942968|580147488|FG000|Overall Study|Progression of disease|12|||
160662373|NCT00942968|580147488|FG000|Overall Study|Inferior vena cava filter placement|4|||
160662374|NCT00942968|580147488|FG000|Overall Study|Pulmonary embolism (PE)|1|||
160662375|NCT00942968|580147488|FG000|Overall Study|Participant required pancreatic biopsy|1|||
160662376|NCT00942968|580147488|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
160500497|NCT02595372|579560053|FG000|Overall Study|Adverse Event|6|||
160500498|NCT02595372|579560053|FG000|Overall Study|Physician Decision|2|||
160500499|NCT02595372|579560053|FG000|Overall Study|Disease Progression|1|||
160500500|NCT00401258|579560056|FG000|Overall Study|Adverse Event|7|||
160500501|NCT04297618|579560066|FG000|Overall Study|Adverse Event|1|||
160500502|NCT04297618|579560066|FG000|Overall Study|Withdrawal by Subject|1|||
160500503|NCT04704219|579560067|FG000|Overall Study|Screen Failure|1|||
160500504|NCT04704219|579560067|FG000|Overall Study|Withdrawal by Subject|1|||
160500505|NCT04704219|579560067|FG000|Overall Study|Death|78|||
160500506|NCT04704219|579560067|FG000|Overall Study|Participants Ongoing|80|||
160500507|NCT04057573|579561652|FG000|24-Week Double-Blind Period|Adverse Event|2|||
160500508|NCT04057573|579561653|FG001|24-Week Double-Blind Period|Adverse Event|0|||
160500509|NCT04057573|579561654|FG002|24-Week Double-Blind Period|Adverse Event|0|||
160500510|NCT04057573|579561655|FG003|24-Week Double-Blind Period|Adverse Event|0|||
160500511|NCT04057573|579561652|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
160500512|NCT04057573|579561653|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
160500513|NCT04057573|579561654|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
160500514|NCT04057573|579561655|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
160500515|NCT04057573|579561652|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
160500516|NCT04057573|579561653|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
160500517|NCT04057573|579561654|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
160500518|NCT04057573|579561655|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
160500519|NCT04057573|579561652|FG000|24-Week Double-Blind Period|Physician Decision|1|||
160500520|NCT04057573|579561653|FG001|24-Week Double-Blind Period|Physician Decision|0|||
160500521|NCT04057573|579561654|FG002|24-Week Double-Blind Period|Physician Decision|0|||
160500522|NCT04057573|579561655|FG003|24-Week Double-Blind Period|Physician Decision|0|||
160500523|NCT04057573|579561652|FG000|24-Week Double-Blind Period|Pregnancy|1|||
160500524|NCT04057573|579561653|FG001|24-Week Double-Blind Period|Pregnancy|0|||
160500525|NCT04057573|579561654|FG002|24-Week Double-Blind Period|Pregnancy|0|||
160500526|NCT04057573|579561655|FG003|24-Week Double-Blind Period|Pregnancy|0|||
160500527|NCT04057573|579561652|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
160500528|NCT04057573|579561653|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
160500529|NCT04057573|579561654|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
160500530|NCT04057573|579561655|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
160500531|NCT04057573|579561652|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
160500532|NCT04057573|579561653|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
160500533|NCT04057573|579561654|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
160500534|NCT04057573|579561655|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
160500535|NCT04057573|579561652|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
160500536|NCT04057573|579561653|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
160500537|NCT04057573|579561654|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
160500538|NCT04057573|579561655|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
160500539|NCT04057573|579561652|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
160500540|NCT04057573|579561653|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
160500541|NCT04057573|579561654|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
160500542|NCT04057573|579561655|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
160500543|NCT04057573|579561652|FG000|24-Week Double-Blind Period|Not Treated|1|||
160500544|NCT04057573|579561653|FG001|24-Week Double-Blind Period|Not Treated|0|||
160500545|NCT04057573|579561654|FG002|24-Week Double-Blind Period|Not Treated|0|||
160500546|NCT04057573|579561655|FG003|24-Week Double-Blind Period|Not Treated|0|||
160500547|NCT04057573|579561652|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
160500548|NCT04057573|579561653|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
160500549|NCT04057573|579561654|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
160500550|NCT04057573|579561655|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
160500551|NCT04057573|579561652|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
160500552|NCT04057573|579561653|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
160500553|NCT04057573|579561654|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
160500554|NCT04057573|579561655|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
160662377|NCT00520130|580147489|FG000|Overall Study|Disease progression on study|4|||
160662378|NCT00520130|580147490|FG001|Overall Study|Disease progression on study|0|||
160500555|NCT04057573|579561652|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
160500556|NCT04057573|579561653|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
160500557|NCT04057573|579561654|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
160500558|NCT04057573|579561655|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
160500559|NCT04057573|579561652|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
160500560|NCT04057573|579561653|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
160500561|NCT04057573|579561654|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
160500562|NCT04057573|579561655|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
160500563|NCT04057573|579561652|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
160500564|NCT04057573|579561653|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
160500565|NCT04057573|579561654|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
160500566|NCT04057573|579561655|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
160500567|NCT04991753|579561656|FG000|Overall Study|Withdrawal by Subject|0|||
160500568|NCT04991753|579561657|FG001|Overall Study|Withdrawal by Subject|1|||
160500580|NCT00132678|579561671|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
160500581|NCT00132678|579561672|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
160500582|NCT00132678|579561673|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
160500583|NCT00132678|579561671|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
160500584|NCT00132678|579561672|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
160500585|NCT00132678|579561673|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
160500586|NCT00132678|579561671|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
160500587|NCT00132678|579561672|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
160500588|NCT00132678|579561673|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
160500589|NCT00132678|579561671|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
160500590|NCT00132678|579561672|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
160500591|NCT00132678|579561673|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
160500592|NCT00132678|579561671|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
160500593|NCT00132678|579561672|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
160500594|NCT00132678|579561673|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
160500595|NCT00132678|579561671|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
160500596|NCT00132678|579561672|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
160500597|NCT00132678|579561673|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
160500598|NCT00132678|579561671|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
160500599|NCT00132678|579561672|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
160500600|NCT00132678|579561673|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
160500601|NCT00132678|579561671|FG000|Period III (Open-Label Stabilization)|Death|2|||
160500602|NCT00132678|579561672|FG001|Period III (Open-Label Stabilization)|Death|0|||
160500603|NCT00132678|579561673|FG002|Period III (Open-Label Stabilization)|Death|0|||
160500604|NCT00132678|579561671|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
160500605|NCT00132678|579561672|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
160500606|NCT00132678|579561673|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
160500607|NCT00132678|579561671|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
160500608|NCT00132678|579561672|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
160500609|NCT00132678|579561673|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
160500610|NCT00132678|579561671|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
160500611|NCT00132678|579561672|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
160500612|NCT00132678|579561673|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
160500613|NCT00132678|579561671|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
160500614|NCT00132678|579561672|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
160500615|NCT00132678|579561673|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
160500616|NCT00132678|579561671|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
160500617|NCT00132678|579561672|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
160500618|NCT00132678|579561673|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
160500619|NCT00132678|579561671|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
160500620|NCT00132678|579561672|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
160500621|NCT00132678|579561673|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
160500622|NCT00132678|579561671|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
160500623|NCT00132678|579561672|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
160500624|NCT00132678|579561673|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
160500625|NCT00132678|579561671|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
160500626|NCT00132678|579561672|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
160500627|NCT00132678|579561673|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
160500628|NCT00132678|579561671|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
160500629|NCT00132678|579561672|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
160500630|NCT00132678|579561673|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
160500631|NCT00132678|579561671|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
160500632|NCT00132678|579561672|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
160500633|NCT00132678|579561673|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
160500634|NCT00132678|579561671|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
160500635|NCT00132678|579561672|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
160619250|NCT02030067|579984945|FG010|Overall Study|Physician Decision|1|||
160619251|NCT02030067|579984946|FG011|Overall Study|Physician Decision|0|||
160619252|NCT02030067|579984947|FG012|Overall Study|Physician Decision|3|||
160619253|NCT02030067|579984935|FG000|Overall Study|other reasons|0|||
160619254|NCT02030067|579984936|FG001|Overall Study|other reasons|0|||
160619255|NCT02030067|579984937|FG002|Overall Study|other reasons|0|||
160619256|NCT02030067|579984938|FG003|Overall Study|other reasons|0|||
160619257|NCT02030067|579984939|FG004|Overall Study|other reasons|0|||
160619258|NCT02030067|579984940|FG005|Overall Study|other reasons|1|||
160619259|NCT02030067|579984941|FG006|Overall Study|other reasons|0|||
160619260|NCT02030067|579984942|FG007|Overall Study|other reasons|0|||
160619261|NCT02030067|579984943|FG008|Overall Study|other reasons|2|||
160619262|NCT02030067|579984944|FG009|Overall Study|other reasons|0|||
160619263|NCT02030067|579984945|FG010|Overall Study|other reasons|0|||
160619264|NCT02030067|579984946|FG011|Overall Study|other reasons|0|||
160619265|NCT02030067|579984947|FG012|Overall Study|other reasons|4|||
160619266|NCT02030067|579984935|FG000|Overall Study|Adverse Event|0|||
160619267|NCT02030067|579984936|FG001|Overall Study|Adverse Event|0|||
160619268|NCT02030067|579984937|FG002|Overall Study|Adverse Event|0|||
160619269|NCT02030067|579984938|FG003|Overall Study|Adverse Event|0|||
160619270|NCT02030067|579984939|FG004|Overall Study|Adverse Event|0|||
160619271|NCT02030067|579984940|FG005|Overall Study|Adverse Event|0|||
160619272|NCT02030067|579984941|FG006|Overall Study|Adverse Event|0|||
160619273|NCT02030067|579984942|FG007|Overall Study|Adverse Event|0|||
160619274|NCT02030067|579984943|FG008|Overall Study|Adverse Event|0|||
160619275|NCT02030067|579984944|FG009|Overall Study|Adverse Event|0|||
160619276|NCT02030067|579984945|FG010|Overall Study|Adverse Event|0|||
160619277|NCT02030067|579984946|FG011|Overall Study|Adverse Event|1|||
160619278|NCT02030067|579984947|FG012|Overall Study|Adverse Event|8|||
160619279|NCT00265382|579984948|FG000|Overall Study|Adverse Event|21|||
160619280|NCT00265382|579984948|FG000|Overall Study|Laboratory Abnormality|1|||
160619281|NCT00265382|579984948|FG000|Overall Study|Lost to Follow-up|3|||
160619282|NCT00265382|579984948|FG000|Overall Study|Lack of Efficacy|6|||
160619283|NCT00265382|579984948|FG000|Overall Study|Miscellaneous|6|||
160619284|NCT00265382|579984948|FG000|Overall Study|Withdrawal by Subject|13|||
160619285|NCT00265382|579984948|FG000|Overall Study|Study terminated by sponsor|94|||
160619286|NCT00265382|579984948|FG000|Overall Study|Death|1|||
160619287|NCT00760994|579984955|FG000|Overall Study|Lost to Follow-up|4|||
160619288|NCT00760994|579984956|FG001|Overall Study|Lost to Follow-up|4|||
160619289|NCT00760994|579984957|FG002|Overall Study|Lost to Follow-up|3|||
160619290|NCT03258710|579984958|FG000|Overall Study|Adverse Event|1|||
160619291|NCT03258710|579984958|FG000|Overall Study|Protocol-defined stopping criteria|1|||
160619292|NCT03258710|579984958|FG000|Overall Study|Physician Decision|1|||
160619293|NCT00565721|579984959|FG000|Overall Study|Screen Failure|2|||
160619294|NCT00565721|579984959|FG000|Overall Study|Lost to Follow-up|6|||
160619295|NCT00565721|579984959|FG000|Overall Study|Technical Problems|1|||
160619296|NCT00565721|579984959|FG000|Overall Study|Physician Decision|2|||
160619297|NCT00565721|579984959|FG000|Overall Study|Other reasons|6|||
160619298|NCT02813681|579984960|FG000|Overall Study|Physician Decision|5|||
160619299|NCT02813681|579984961|FG001|Overall Study|Physician Decision|5|||
160619300|NCT02813681|579984962|FG002|Overall Study|Physician Decision|0|||
160619301|NCT02813681|579984960|FG000|Overall Study|Lost to Follow-up|0|||
160619302|NCT02813681|579984961|FG001|Overall Study|Lost to Follow-up|1|||
160619303|NCT02813681|579984962|FG002|Overall Study|Lost to Follow-up|0|||
160619304|NCT00352027|579984963|FG000|Overall Study|Progressive disease|3|||
160619305|NCT01874288|579984964|FG000|Overall Study|Withdrawal by Subject|1|||
160619306|NCT01874288|579984965|FG001|Overall Study|Withdrawal by Subject|0|||
160619307|NCT01874288|579984966|FG002|Overall Study|Withdrawal by Subject|2|||
160619308|NCT01874288|579984967|FG003|Overall Study|Withdrawal by Subject|1|||
160619309|NCT01874288|579984968|FG004|Overall Study|Withdrawal by Subject|1|||
160619310|NCT01874288|579984964|FG000|Overall Study|Physician Decision|0|||
160619311|NCT01874288|579984965|FG001|Overall Study|Physician Decision|0|||
160500636|NCT00132678|579561673|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
160500637|NCT00132678|579561671|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
160500638|NCT00132678|579561672|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
160500639|NCT00132678|579561673|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
160500640|NCT00132678|579561671|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
160500641|NCT00132678|579561672|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
160500642|NCT00132678|579561673|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
160500643|NCT00132678|579561671|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
160500644|NCT00132678|579561672|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
160500645|NCT00132678|579561673|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
160500646|NCT00132678|579561671|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
160500647|NCT00132678|579561672|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
160500648|NCT00132678|579561673|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
160500649|NCT00603525|579561674|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
160500650|NCT00603525|579561675|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
160500651|NCT00603525|579561676|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160500652|NCT00603525|579561674|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
160500653|NCT00603525|579561675|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
160500654|NCT00603525|579561676|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
160500655|NCT00603525|579561674|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
160500656|NCT00603525|579561675|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
160500657|NCT00603525|579561676|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
160500658|NCT00603525|579561674|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
160500659|NCT00603525|579561675|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
160500660|NCT00603525|579561676|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160500661|NCT00603525|579561674|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
160500662|NCT00603525|579561675|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
160500663|NCT00603525|579561676|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160500664|NCT00603525|579561674|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
160500665|NCT00603525|579561675|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
160500666|NCT00603525|579561676|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
160500667|NCT00603525|579561674|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
160500668|NCT00603525|579561675|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
160500669|NCT00603525|579561676|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
160500670|NCT00603525|579561674|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
160500671|NCT00603525|579561675|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
160619312|NCT01874288|579984966|FG002|Overall Study|Physician Decision|0|||
160619313|NCT01874288|579984967|FG003|Overall Study|Physician Decision|1|||
160619314|NCT01874288|579984968|FG004|Overall Study|Physician Decision|0|||
160619315|NCT01874288|579984964|FG000|Overall Study|Progressive disease|2|||
160619316|NCT01874288|579984965|FG001|Overall Study|Progressive disease|0|||
160619317|NCT01874288|579984966|FG002|Overall Study|Progressive disease|3|||
160619318|NCT01874288|579984967|FG003|Overall Study|Progressive disease|5|||
160619319|NCT01874288|579984968|FG004|Overall Study|Progressive disease|1|||
160619320|NCT03099304|579984969|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
160619321|NCT03099304|579984970|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
160619322|NCT03099304|579984971|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
160619323|NCT03099304|579984972|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
160619324|NCT03099304|579984973|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
160619325|NCT03099304|579984974|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
160619326|NCT03099304|579984969|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
160619327|NCT03099304|579984970|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
160619328|NCT03099304|579984971|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
160619329|NCT03099304|579984972|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
160619330|NCT03099304|579984973|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
160619331|NCT03099304|579984974|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
160619332|NCT03099304|579984969|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
160619333|NCT03099304|579984970|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
160619334|NCT03099304|579984971|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
160619335|NCT03099304|579984972|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
160619336|NCT03099304|579984973|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
160619337|NCT03099304|579984974|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
160619338|NCT03099304|579984969|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
160500672|NCT00603525|579561676|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
160500673|NCT00603525|579561674|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
160500674|NCT00603525|579561675|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
160500675|NCT00603525|579561676|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
160500676|NCT00603525|579561674|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
160500677|NCT00603525|579561675|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
160500678|NCT00603525|579561676|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
160500679|NCT00603525|579561674|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
160500680|NCT00603525|579561675|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
160500681|NCT00603525|579561676|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
160500682|NCT00603525|579561674|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
160500683|NCT00603525|579561675|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
160500684|NCT00603525|579561676|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
160500685|NCT00603525|579561674|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
160500686|NCT00603525|579561675|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
160500687|NCT00603525|579561676|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
160500688|NCT00603525|579561674|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
160500689|NCT00603525|579561675|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
160500690|NCT00603525|579561676|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
160500691|NCT00603525|579561674|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
160500692|NCT00603525|579561675|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
160500693|NCT00603525|579561676|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
160500694|NCT01483144|579561677|FG000|Overall Study|Adverse Event|9|||
160500695|NCT01483144|579561678|FG001|Overall Study|Adverse Event|4|||
160500696|NCT01483144|579561679|FG002|Overall Study|Adverse Event|6|||
160500697|NCT01483144|579561677|FG000|Overall Study|Withdrawal by Subject|0|||
160500698|NCT01483144|579561678|FG001|Overall Study|Withdrawal by Subject|2|||
160500699|NCT01483144|579561679|FG002|Overall Study|Withdrawal by Subject|5|||
160500700|NCT01483144|579561677|FG000|Overall Study|Physician Decision|1|||
160500701|NCT01483144|579561678|FG001|Overall Study|Physician Decision|0|||
160500702|NCT01483144|579561679|FG002|Overall Study|Physician Decision|0|||
160500703|NCT01483144|579561677|FG000|Overall Study|Lost to Follow-up|2|||
160500704|NCT01483144|579561678|FG001|Overall Study|Lost to Follow-up|4|||
160500705|NCT01483144|579561679|FG002|Overall Study|Lost to Follow-up|1|||
160500706|NCT01483144|579561677|FG000|Overall Study|Protocol Violation|3|||
160500707|NCT01483144|579561678|FG001|Overall Study|Protocol Violation|3|||
160500708|NCT01483144|579561679|FG002|Overall Study|Protocol Violation|3|||
160500709|NCT03374488|579561680|FG000|Overall Study|Death|13|||
160500710|NCT03374488|579561681|FG001|Overall Study|Death|13|||
160500711|NCT03374488|579561680|FG000|Overall Study|Withdrawal by Subject|3|||
160500712|NCT03374488|579561681|FG001|Overall Study|Withdrawal by Subject|1|||
160500713|NCT03374488|579561680|FG000|Overall Study|Physician Decision|3|||
160500714|NCT03374488|579561681|FG001|Overall Study|Physician Decision|0|||
160500715|NCT03104075|579561682|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
160500716|NCT03104075|579561683|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
160500717|NCT04896008|579561684|FG000|Overall Study|Ongoing|70|||
160500718|NCT04896008|579561685|FG001|Overall Study|Ongoing|38|||
160500719|NCT04896008|579561684|FG000|Overall Study|Adverse Event|0|||
160500720|NCT04896008|579561685|FG001|Overall Study|Adverse Event|2|||
160500721|NCT04896008|579561684|FG000|Overall Study|Death|5|||
160500722|NCT04896008|579561685|FG001|Overall Study|Death|10|||
160500723|NCT04896008|579561684|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
160500724|NCT04896008|579561685|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
160500725|NCT04896008|579561684|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
160500726|NCT04896008|579561685|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
160500727|NCT04896008|579561684|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
160500728|NCT04896008|579561685|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
160500729|NCT04896008|579561684|FG000|Overall Study|Withdrawal by Subject|1|||
160500730|NCT04896008|579561685|FG001|Overall Study|Withdrawal by Subject|4|||
160500731|NCT04896008|579561684|FG000|Overall Study|Investigator Decision|2|||
160500732|NCT04896008|579561685|FG001|Overall Study|Investigator Decision|0|||
160500733|NCT04896008|579561684|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
160500734|NCT04896008|579561685|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
160500735|NCT00944229|579561688|FG000|Overall Study|Withdrawal by Subject|11|||
160500736|NCT00944229|579561688|FG000|Overall Study|Physician Decision|14|||
160500737|NCT01810939|579561691|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
160500738|NCT01810939|579561692|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
160500739|NCT01810939|579561693|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
160500740|NCT01810939|579561691|FG000|Part A Treatment Period|Protocol Violation|2|||
160500741|NCT01810939|579561692|FG001|Part A Treatment Period|Protocol Violation|0|||
160500742|NCT01810939|579561693|FG002|Part A Treatment Period|Protocol Violation|0|||
160500743|NCT01810939|579561691|FG000|Part A Treatment Period|Adverse Event|10|||
160500744|NCT01810939|579561692|FG001|Part A Treatment Period|Adverse Event|0|||
160500745|NCT01810939|579561693|FG002|Part A Treatment Period|Adverse Event|0|||
160500746|NCT01810939|579561691|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
160500747|NCT01810939|579561692|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
160500748|NCT01810939|579561693|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
160500749|NCT01810939|579561691|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
160500750|NCT01810939|579561692|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
160500751|NCT01810939|579561693|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
160500752|NCT01810939|579561691|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
160500753|NCT01810939|579561692|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
160500754|NCT01810939|579561693|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
160500755|NCT01810939|579561691|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
160500756|NCT01810939|579561692|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
160500757|NCT01810939|579561693|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
160500758|NCT01810939|579561691|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
160500759|NCT01810939|579561692|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
160500760|NCT01810939|579561693|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
160500761|NCT01810939|579561691|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
160500762|NCT01810939|579561692|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
160500763|NCT01810939|579561693|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
160500764|NCT01810939|579561691|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
160500765|NCT01810939|579561692|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
160500766|NCT01810939|579561693|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
160500767|NCT01810939|579561691|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
160500768|NCT01810939|579561692|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
160500769|NCT01810939|579561693|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
160500770|NCT01810939|579561691|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
160500771|NCT01810939|579561692|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
160500772|NCT01810939|579561693|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
160500773|NCT01810939|579561691|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
160500774|NCT01810939|579561692|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
160500775|NCT01810939|579561693|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
160500776|NCT01810939|579561691|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
160500777|NCT01810939|579561692|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
160500778|NCT01810939|579561693|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
160500779|NCT01810939|579561691|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
160500780|NCT01810939|579561692|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
160500781|NCT01810939|579561693|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
160500782|NCT01810939|579561691|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
160500783|NCT01810939|579561692|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
160500784|NCT01810939|579561693|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
160500785|NCT01810939|579561691|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
160500786|NCT01810939|579561692|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
160500787|NCT01810939|579561693|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
160500788|NCT04400487|579561694|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
160500789|NCT04400487|579561694|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
160500790|NCT04400487|579561694|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
160500791|NCT03322540|579561700|FG000|Overall Study|Death|21|||
160500792|NCT03322540|579561701|FG001|Overall Study|Death|28|||
160500793|NCT03322540|579561700|FG000|Overall Study|Lost to Follow-up|0|||
160500794|NCT03322540|579561701|FG001|Overall Study|Lost to Follow-up|1|||
160500795|NCT03322540|579561700|FG000|Overall Study|Physician Decision|7|||
160500796|NCT03322540|579561701|FG001|Overall Study|Physician Decision|6|||
160500797|NCT03322540|579561700|FG000|Overall Study|Withdrawal by Subject|3|||
160500798|NCT03322540|579561701|FG001|Overall Study|Withdrawal by Subject|1|||
160500799|NCT03322540|579561700|FG000|Overall Study|Study terminated by sponsor|0|||
160500800|NCT03322540|579561701|FG001|Overall Study|Study terminated by sponsor|1|||
160500801|NCT01594827|579561704|FG000|Overall Study|Adverse Event|1|||
160500802|NCT01594827|579561705|FG001|Overall Study|Adverse Event|0|||
160500803|NCT01594827|579561704|FG000|Overall Study|Physician Decision|3|||
160500804|NCT01594827|579561705|FG001|Overall Study|Physician Decision|0|||
160500805|NCT01677299|579561706|FG000|Overall Study|Adverse Event|0|||
160500806|NCT01677299|579561707|FG001|Overall Study|Adverse Event|2|||
160500807|NCT01677299|579561708|FG002|Overall Study|Adverse Event|1|||
160500808|NCT01677299|579561709|FG003|Overall Study|Adverse Event|0|||
160500809|NCT01677299|579561706|FG000|Overall Study|Withdrawal by Subject|0|||
160500810|NCT01677299|579561707|FG001|Overall Study|Withdrawal by Subject|1|||
160500811|NCT01677299|579561708|FG002|Overall Study|Withdrawal by Subject|0|||
160500812|NCT01677299|579561709|FG003|Overall Study|Withdrawal by Subject|1|||
160500813|NCT02153905|579561710|FG000|Overall Study|Death|1|||
160662379|NCT00520130|580147489|FG000|Overall Study|Physician Decision|1|||
160662380|NCT00520130|580147490|FG001|Overall Study|Physician Decision|1|||
160662381|NCT01045096|580147493|FG000|Overall Study|Withdrawal by Subject|2|||
160662382|NCT01045096|580147494|FG001|Overall Study|Withdrawal by Subject|0|||
160500814|NCT02153905|579561711|FG001|Overall Study|Death|0|||
160500815|NCT00520845|579561712|FG000|Overall Study|Death|3|||
160500816|NCT00520845|579561712|FG000|Overall Study|Adverse Event|4|||
160500817|NCT00520845|579561712|FG000|Overall Study|Disease Progression, relapse|13|||
160500818|NCT00520845|579561712|FG000|Overall Study|Withdrawal by Subject|1|||
160500819|NCT00520845|579561712|FG000|Overall Study|Alternative Therapy|1|||
160500820|NCT00351377|579561713|FG000|Overall Study|Adverse Event|5|||
160500821|NCT00351377|579561713|FG000|Overall Study|Death|1|||
160500822|NCT00351377|579561713|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160500823|NCT02493062|579561715|FG000|Overall Study|Physician Decision|12|||
160500824|NCT01327612|579561716|FG000|Overall Study|Withdrawal by Subject|0|||
160500825|NCT01327612|579561717|FG001|Overall Study|Withdrawal by Subject|0|||
160500826|NCT01327612|579561718|FG002|Overall Study|Withdrawal by Subject|0|||
160500827|NCT01327612|579561719|FG003|Overall Study|Withdrawal by Subject|0|||
160500828|NCT01327612|579561720|FG004|Overall Study|Withdrawal by Subject|0|||
160500829|NCT01327612|579561721|FG005|Overall Study|Withdrawal by Subject|1|||
160500830|NCT01327612|579561722|FG006|Overall Study|Withdrawal by Subject|0|||
160500831|NCT01327612|579561716|FG000|Overall Study|Disease Progression|1|||
160500832|NCT01327612|579561717|FG001|Overall Study|Disease Progression|1|||
160500833|NCT01327612|579561718|FG002|Overall Study|Disease Progression|1|||
160500834|NCT01327612|579561719|FG003|Overall Study|Disease Progression|0|||
160500835|NCT01327612|579561720|FG004|Overall Study|Disease Progression|1|||
160500836|NCT01327612|579561721|FG005|Overall Study|Disease Progression|2|||
160500837|NCT01327612|579561722|FG006|Overall Study|Disease Progression|2|||
160500838|NCT01327612|579561716|FG000|Overall Study|Administrative Decision|0|||
160500839|NCT01327612|579561717|FG001|Overall Study|Administrative Decision|0|||
160500840|NCT01327612|579561718|FG002|Overall Study|Administrative Decision|0|||
160500841|NCT01327612|579561719|FG003|Overall Study|Administrative Decision|1|||
160500842|NCT01327612|579561720|FG004|Overall Study|Administrative Decision|0|||
160500843|NCT01327612|579561721|FG005|Overall Study|Administrative Decision|0|||
160500844|NCT01327612|579561722|FG006|Overall Study|Administrative Decision|0|||
160500845|NCT01327612|579561716|FG000|Overall Study|Death|0|||
160500846|NCT01327612|579561717|FG001|Overall Study|Death|0|||
160500847|NCT01327612|579561718|FG002|Overall Study|Death|0|||
160500848|NCT01327612|579561719|FG003|Overall Study|Death|0|||
160500849|NCT01327612|579561720|FG004|Overall Study|Death|1|||
160500850|NCT01327612|579561721|FG005|Overall Study|Death|0|||
160500851|NCT01327612|579561722|FG006|Overall Study|Death|0|||
160500852|NCT00874731|579561723|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
160500853|NCT00874731|579561724|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
160500854|NCT00874731|579561725|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
160500855|NCT00874731|579561723|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
160500856|NCT00874731|579561724|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
160500857|NCT00874731|579561725|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
160500858|NCT00874731|579561723|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
160500859|NCT00874731|579561724|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
160500860|NCT00874731|579561725|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
160500861|NCT00955708|579561726|FG000|Overall Study|Death|269|||
160500862|NCT00955708|579561726|FG000|Overall Study|Lost to Follow-up|72|||
160500863|NCT00955708|579561726|FG000|Overall Study|Physician Decision|36|||
160500864|NCT00955708|579561726|FG000|Overall Study|Protocol Violation|134|||
160500865|NCT00955708|579561726|FG000|Overall Study|Registry Conclusion|186|||
160500866|NCT00955708|579561726|FG000|Overall Study|Product removed from service|94|||
160500867|NCT00955708|579561726|FG000|Overall Study|Patient Refused to participate further|116|||
160500868|NCT00955708|579561726|FG000|Overall Study|Closure of study location|60|||
160500869|NCT00955708|579561726|FG000|Overall Study|Patient changed care provider/moved|91|||
160500870|NCT05105087|579561727|FG000|Overall Study|Withdrawal by Subject|2|||
160500871|NCT05105087|579561727|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
160500872|NCT01736540|579561730|FG000|Overall Study|Did not complete scan within 45 days|2|||
160500873|NCT01736540|579561730|FG000|Overall Study|Death|1|||
160500874|NCT01736540|579561730|FG000|Overall Study|Abnormal test procedure|1|||
160500875|NCT01736540|579561730|FG000|Overall Study|Withdrawal by Subject|5|||
160500876|NCT01736540|579561730|FG000|Overall Study|Protocol Violation|1|||
160500877|NCT01736540|579561730|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
160500878|NCT01736540|579561730|FG000|Overall Study|No show for MRI appointment|1|||
160500879|NCT01736540|579561730|FG000|Overall Study|Unable to make MRI appointment|3|||
160500880|NCT00581477|579561733|FG000|Overall Study|Physician Decision|2|||
160500881|NCT01735175|579561734|FG000|Overall Study|Withdrawal by Subject|9|||
160500882|NCT01735175|579561735|FG001|Overall Study|Withdrawal by Subject|2|||
160500883|NCT01735175|579561734|FG000|Overall Study|Lost to Follow-up|4|||
160500884|NCT01735175|579561735|FG001|Overall Study|Lost to Follow-up|2|||
160500885|NCT01735175|579561734|FG000|Overall Study|Death|3|||
160500886|NCT01735175|579561735|FG001|Overall Study|Death|2|||
160500887|NCT01735175|579561734|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
160500888|NCT01735175|579561735|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
160500889|NCT00790205|579561736|FG000|Overall Study|Lost to Follow-up|61|||
160500890|NCT00790205|579561737|FG001|Overall Study|Lost to Follow-up|71|||
160500891|NCT00790205|579561736|FG000|Overall Study|Withdrawal by Subject|299|||
160500892|NCT00790205|579561737|FG001|Overall Study|Withdrawal by Subject|363|||
160500893|NCT01031628|579561738|FG000|Overall Study|Study terminated early|0|||
160500894|NCT01031628|579561739|FG001|Overall Study|Study terminated early|1|||
160500895|NCT01031628|579561740|FG002|Overall Study|Study terminated early|3|||
160500896|NCT01031628|579561741|FG003|Overall Study|Study terminated early|0|||
160500897|NCT00755417|579561742|FG000|Overall Study|Adverse Event|28|||
160500898|NCT00755417|579561743|FG001|Overall Study|Adverse Event|20|||
160500899|NCT00755417|579561744|FG002|Overall Study|Adverse Event|7|||
160500900|NCT00755417|579561742|FG000|Overall Study|Lack of Efficacy|8|||
160500901|NCT00755417|579561743|FG001|Overall Study|Lack of Efficacy|4|||
160500902|NCT00755417|579561744|FG002|Overall Study|Lack of Efficacy|9|||
160500903|NCT00755417|579561742|FG000|Overall Study|Protocol Violation|2|||
160500904|NCT00755417|579561743|FG001|Overall Study|Protocol Violation|1|||
160500905|NCT00755417|579561744|FG002|Overall Study|Protocol Violation|1|||
160500906|NCT00755417|579561742|FG000|Overall Study|Lost to Follow-up|3|||
160500907|NCT00755417|579561743|FG001|Overall Study|Lost to Follow-up|0|||
160500908|NCT00755417|579561744|FG002|Overall Study|Lost to Follow-up|1|||
160500909|NCT00755417|579561742|FG000|Overall Study|Withdrawal by Subject|12|||
160500910|NCT00755417|579561743|FG001|Overall Study|Withdrawal by Subject|12|||
160500911|NCT00755417|579561744|FG002|Overall Study|Withdrawal by Subject|12|||
160500912|NCT00755417|579561742|FG000|Overall Study|Not specified or missing data|9|||
160500913|NCT00755417|579561743|FG001|Overall Study|Not specified or missing data|18|||
160500914|NCT00755417|579561744|FG002|Overall Study|Not specified or missing data|12|||
160500915|NCT02803593|579561747|FG000|Overall Study|Lost to Follow-up|17|||
160500916|NCT02803593|579561748|FG001|Overall Study|Lost to Follow-up|35|||
160500917|NCT05143138|579561749|FG000|Overall Study|Death|5|||
160500918|NCT05143138|579561750|FG001|Overall Study|Death|35|||
160500919|NCT05143138|579561751|FG002|Overall Study|Death|1|||
160500920|NCT05143138|579561749|FG000|Overall Study|Lost to Follow-up|2|||
160500921|NCT05143138|579561750|FG001|Overall Study|Lost to Follow-up|4|||
160500922|NCT05143138|579561751|FG002|Overall Study|Lost to Follow-up|0|||
160500923|NCT05143138|579561749|FG000|Overall Study|withdrawal|1|||
160500924|NCT05143138|579561750|FG001|Overall Study|withdrawal|1|||
160500925|NCT05143138|579561751|FG002|Overall Study|withdrawal|0|||
160500926|NCT04245345|579561754|FG000|Overall Study|Death|1|||
160500927|NCT04245345|579561754|FG000|Overall Study|Exited prior to implant|5|||
160500928|NCT04245345|579561754|FG000|Overall Study|Exited prior to 1-month|9|||
160500929|NCT04245345|579561754|FG000|Overall Study|Missed 1-month visit|3|||
160500930|NCT04245345|579561754|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
160500931|NCT04245345|579561754|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
160500932|NCT03933462|579561755|FG000|Overall Study|Adverse Event|2|||
160500933|NCT03933462|579561756|FG001|Overall Study|Adverse Event|0|||
160500934|NCT04210843|579561757|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
160500935|NCT04210843|579561758|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
160500936|NCT04210843|579561757|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
160500937|NCT04210843|579561758|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
160500938|NCT04210843|579561757|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
160500939|NCT04210843|579561758|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
160500940|NCT04210843|579561757|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
160500941|NCT04210843|579561758|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
160500942|NCT04210843|579561757|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
160500943|NCT04210843|579561758|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
160500944|NCT04210843|579561757|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
160500945|NCT04210843|579561758|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
160500946|NCT04210843|579561757|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
160500947|NCT04210843|579561758|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
160500948|NCT04210843|579561757|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
160500949|NCT04210843|579561758|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
160619339|NCT03099304|579984970|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
160619340|NCT03099304|579984971|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
160619341|NCT03099304|579984972|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
160619342|NCT03099304|579984973|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
160500950|NCT04210843|579561757|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
160500951|NCT04210843|579561758|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
160500952|NCT04210843|579561757|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
160500953|NCT04210843|579561758|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
160500954|NCT04210843|579561757|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
160500955|NCT04210843|579561758|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
160500956|NCT04210843|579561757|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
160500957|NCT04210843|579561758|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
160500958|NCT04210843|579561757|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
160619343|NCT03099304|579984974|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
160500959|NCT04210843|579561758|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
160500960|NCT04210843|579561757|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
160500961|NCT04210843|579561758|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
160500962|NCT04210843|579561757|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
160500963|NCT04210843|579561758|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
160500964|NCT04210843|579561757|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
160500965|NCT04210843|579561758|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
160500966|NCT04210843|579561757|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
160500967|NCT04210843|579561758|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
160500968|NCT04210843|579561757|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
160500969|NCT04210843|579561758|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
160500970|NCT04210843|579561757|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
160500971|NCT04210843|579561758|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
160500972|NCT04210843|579561757|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
160500973|NCT04210843|579561758|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
160500974|NCT04210843|579561757|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
160500975|NCT04210843|579561758|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
160500976|NCT04210843|579561757|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
160500977|NCT04210843|579561758|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
160500978|NCT04210843|579561757|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
160500979|NCT04210843|579561758|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
160500980|NCT04210843|579561757|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
160500981|NCT04210843|579561758|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
160500982|NCT01485120|579561767|FG000|Overall Study|Withdrawal by Subject|2|||
160500983|NCT00848484|579561768|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
160500984|NCT00848484|579561769|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
160500985|NCT00848484|579561768|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
160500986|NCT00848484|579561769|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
160500987|NCT00848484|579561768|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
160500988|NCT00848484|579561769|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
160500989|NCT00848484|579561768|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
160500990|NCT00848484|579561769|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
160500991|NCT00848484|579561768|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
160500992|NCT00848484|579561769|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
160500993|NCT01081886|579561770|FG000|Overall Study|Study termination|11|||
160500994|NCT01081886|579561771|FG001|Overall Study|Study termination|13|||
160500995|NCT03017742|579561773|FG000|Overall Study|Protocol Violation|36|||
160500996|NCT03017742|579561773|FG000|Overall Study|Withdrawal by Subject|37|||
160500997|NCT05262751|579561778|FG000|Washout Period 2|Adverse Event|1|||
160500998|NCT05262751|579561779|FG001|Washout Period 2|Adverse Event|0|||
160500999|NCT05262751|579561780|FG002|Washout Period 2|Adverse Event|0|||
160501000|NCT05262751|579561781|FG003|Washout Period 2|Adverse Event|0|||
160501001|NCT05262751|579561782|FG004|Washout Period 2|Adverse Event|0|||
160501002|NCT05262751|579561783|FG005|Washout Period 2|Adverse Event|0|||
160501003|NCT05262751|579561778|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
160501004|NCT05262751|579561779|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
160501005|NCT05262751|579561780|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
160501006|NCT05262751|579561781|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
160501007|NCT05262751|579561782|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
160501008|NCT05262751|579561783|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
160501009|NCT03690427|579561784|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
160501010|NCT03690427|579561785|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
160501011|NCT03519204|579561788|FG000|Overall Study|Lost to Follow-up|3|||
160501012|NCT03519204|579561789|FG001|Overall Study|Lost to Follow-up|8|||
160501013|NCT03519204|579561788|FG000|Overall Study|Withdrawal by Subject|9|||
160501014|NCT03519204|579561789|FG001|Overall Study|Withdrawal by Subject|7|||
160501015|NCT03519204|579561788|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160501016|NCT03519204|579561789|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160501017|NCT02956837|579561790|FG000|Overall Study|Serious Adverse Events|0|||
160501018|NCT02956837|579561791|FG001|Overall Study|Serious Adverse Events|1|||
160501019|NCT02956837|579561792|FG002|Overall Study|Serious Adverse Events|0|||
160619344|NCT03099304|579984969|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
160501020|NCT02956837|579561793|FG003|Overall Study|Serious Adverse Events|0|||
160501021|NCT02956837|579561790|FG000|Overall Study|Withdrawal by Subject|0|||
160501022|NCT02956837|579561791|FG001|Overall Study|Withdrawal by Subject|1|||
160619345|NCT03099304|579984970|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
160619346|NCT03099304|579984971|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
160501023|NCT02956837|579561792|FG002|Overall Study|Withdrawal by Subject|0|||
160501024|NCT02956837|579561793|FG003|Overall Study|Withdrawal by Subject|3|||
160501025|NCT02956837|579561790|FG000|Overall Study|Lost to Follow-up|0|||
160501026|NCT02956837|579561791|FG001|Overall Study|Lost to Follow-up|1|||
160501027|NCT02956837|579561792|FG002|Overall Study|Lost to Follow-up|2|||
160501028|NCT02956837|579561793|FG003|Overall Study|Lost to Follow-up|0|||
160501029|NCT02597712|579561798|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
160501030|NCT02597712|579561799|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
160501031|NCT02597712|579561798|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
160501032|NCT02597712|579561799|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
160501033|NCT02597712|579561798|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
160501034|NCT02597712|579561799|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
160501035|NCT01727505|579561803|FG000|First 24 Hours|Adverse Event|0|||
160501036|NCT01727505|579561804|FG001|First 24 Hours|Adverse Event|1|||
160501037|NCT01727505|579561803|FG000|Second 24 Hours|Missing data|0|||
160501038|NCT01727505|579561804|FG001|Second 24 Hours|Missing data|1|||
160501039|NCT00513708|579561805|FG000|Overall Study|Lost to Follow-up|4|||
160501040|NCT00513708|579561806|FG001|Overall Study|Lost to Follow-up|4|||
160501041|NCT00513708|579561807|FG002|Overall Study|Lost to Follow-up|4|||
160501042|NCT01564277|579561808|FG000|Overall Study|Protocol Violation|0|||
160501043|NCT01564277|579561809|FG001|Overall Study|Protocol Violation|1|||
160501044|NCT01564277|579561808|FG000|Overall Study|Physician Decision|1|||
160501045|NCT01564277|579561809|FG001|Overall Study|Physician Decision|0|||
160501046|NCT01594970|579561810|FG000|Overall Study|Non-Adverse Event Related|4|||
160501047|NCT01594970|579561811|FG001|Overall Study|Non-Adverse Event Related|5|||
160501048|NCT01594970|579561812|FG002|Overall Study|Non-Adverse Event Related|6|||
160501049|NCT01594970|579561810|FG000|Overall Study|Adverse Event|17|||
160501050|NCT01594970|579561811|FG001|Overall Study|Adverse Event|23|||
160501051|NCT01594970|579561812|FG002|Overall Study|Adverse Event|23|||
160501052|NCT01594970|579561810|FG000|Overall Study|Lost to Follow-up|54|||
160501053|NCT01594970|579561811|FG001|Overall Study|Lost to Follow-up|54|||
160501054|NCT01594970|579561812|FG002|Overall Study|Lost to Follow-up|37|||
160501055|NCT03816761|579564020|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
160501056|NCT03816761|579564021|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
160501057|NCT03816761|579564022|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
160501058|NCT03816761|579564023|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
160501059|NCT03816761|579564024|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
160501060|NCT03816761|579564025|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
160501061|NCT03816761|579564020|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
160501062|NCT03816761|579564021|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
160501063|NCT03816761|579564022|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
160501064|NCT03816761|579564023|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
160501065|NCT03816761|579564024|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
160501066|NCT03816761|579564025|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
160501067|NCT02460575|579564035|FG000|Overall Study|Lost to Follow-up|1|||
160501068|NCT02460575|579564036|FG001|Overall Study|Lost to Follow-up|0|||
160501069|NCT04043143|579564037|FG000|Overall Study|Lost to Follow-up|5|||
160501070|NCT04043143|579564038|FG001|Overall Study|Lost to Follow-up|5|||
160501071|NCT04043143|579564037|FG000|Overall Study|screen failure|1|||
160501072|NCT04043143|579564038|FG001|Overall Study|screen failure|0|||
160501073|NCT04307940|579564039|FG000|Overall Study|Adverse Event|1|||
160501074|NCT04307940|579564040|FG001|Overall Study|Adverse Event|0|||
160501075|NCT04307940|579564041|FG002|Overall Study|Adverse Event|0|||
160501076|NCT04307940|579564039|FG000|Overall Study|Withdrawal by Subject|2|||
160501077|NCT04307940|579564040|FG001|Overall Study|Withdrawal by Subject|3|||
160501078|NCT04307940|579564041|FG002|Overall Study|Withdrawal by Subject|1|||
160501079|NCT04307940|579564039|FG000|Overall Study|Lost to Follow-up|2|||
160501080|NCT04307940|579564040|FG001|Overall Study|Lost to Follow-up|0|||
160501081|NCT04307940|579564041|FG002|Overall Study|Lost to Follow-up|1|||
160501082|NCT04624243|579564045|FG000|Overall Study|Death|0|||
160501083|NCT04624243|579564046|FG001|Overall Study|Death|1|||
160501084|NCT04624243|579564047|FG002|Overall Study|Death|0|||
160501085|NCT04624243|579564048|FG003|Overall Study|Death|0|||
160501086|NCT04624243|579564049|FG004|Overall Study|Death|0|||
160501087|NCT04624243|579564045|FG000|Overall Study|Lost to Follow-up|2|||
160501088|NCT04624243|579564046|FG001|Overall Study|Lost to Follow-up|3|||
160619347|NCT03099304|579984972|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
160619348|NCT03099304|579984973|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
160501089|NCT04624243|579564047|FG002|Overall Study|Lost to Follow-up|7|||
160619349|NCT03099304|579984974|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
160619350|NCT03099304|579984969|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
160501090|NCT04624243|579564048|FG003|Overall Study|Lost to Follow-up|1|||
160501091|NCT04624243|579564049|FG004|Overall Study|Lost to Follow-up|3|||
160501092|NCT04624243|579564045|FG000|Overall Study|Physician Decision|3|||
160501093|NCT04624243|579564046|FG001|Overall Study|Physician Decision|8|||
160619351|NCT03099304|579984970|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
160619352|NCT03099304|579984971|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
160501094|NCT04624243|579564047|FG002|Overall Study|Physician Decision|15|||
160501095|NCT04624243|579564048|FG003|Overall Study|Physician Decision|2|||
160501096|NCT04624243|579564049|FG004|Overall Study|Physician Decision|11|||
160501097|NCT04624243|579564045|FG000|Overall Study|Withdrawal by Subject|19|||
160501098|NCT04624243|579564046|FG001|Overall Study|Withdrawal by Subject|44|||
160501099|NCT04624243|579564047|FG002|Overall Study|Withdrawal by Subject|40|||
160501100|NCT04624243|579564048|FG003|Overall Study|Withdrawal by Subject|21|||
160501101|NCT04624243|579564049|FG004|Overall Study|Withdrawal by Subject|39|||
160501102|NCT04624243|579564045|FG000|Overall Study|Miscellaneous|3|||
160501103|NCT04624243|579564046|FG001|Overall Study|Miscellaneous|12|||
160501104|NCT04624243|579564047|FG002|Overall Study|Miscellaneous|9|||
160501105|NCT04624243|579564048|FG003|Overall Study|Miscellaneous|4|||
160501106|NCT04624243|579564049|FG004|Overall Study|Miscellaneous|6|||
160501107|NCT04996004|579564050|FG000|Phase I|Death|1|||
160501108|NCT04996004|579564051|FG001|Phase I|Death|2|||
160501109|NCT04996004|579564052|FG002|Phase I|Death|1|||
160501110|NCT04996004|579564053|FG003|Phase I|Death|0|||
160501111|NCT04996004|579564054|FG004|Phase I|Death|0|||
160501112|NCT04996004|579564055|FG005|Phase I|Death|0|||
160501113|NCT04996004|579564050|FG000|Phase I|Study terminated by sponsor|2|||
160501114|NCT04996004|579564051|FG001|Phase I|Study terminated by sponsor|1|||
160501115|NCT04996004|579564052|FG002|Phase I|Study terminated by sponsor|2|||
160501116|NCT04996004|579564053|FG003|Phase I|Study terminated by sponsor|0|||
160501117|NCT04996004|579564054|FG004|Phase I|Study terminated by sponsor|0|||
160501118|NCT04996004|579564055|FG005|Phase I|Study terminated by sponsor|0|||
160501119|NCT04996004|579564050|FG000|Phase II|Study terminated by sponsor|0|||
160501120|NCT04996004|579564051|FG001|Phase II|Study terminated by sponsor|0|||
160501121|NCT04996004|579564052|FG002|Phase II|Study terminated by sponsor|0|||
160501122|NCT04996004|579564053|FG003|Phase II|Study terminated by sponsor|20|||
160501123|NCT04996004|579564054|FG004|Phase II|Study terminated by sponsor|10|||
160501124|NCT04996004|579564055|FG005|Phase II|Study terminated by sponsor|10|||
160501125|NCT04996004|579564050|FG000|Phase II|Withdrawal by Subject|0|||
160501126|NCT04996004|579564051|FG001|Phase II|Withdrawal by Subject|0|||
160501127|NCT04996004|579564052|FG002|Phase II|Withdrawal by Subject|0|||
160501128|NCT04996004|579564053|FG003|Phase II|Withdrawal by Subject|0|||
160501129|NCT04996004|579564054|FG004|Phase II|Withdrawal by Subject|1|||
160501130|NCT04996004|579564055|FG005|Phase II|Withdrawal by Subject|2|||
160501131|NCT04996004|579564050|FG000|Phase II|Death|0|||
160501132|NCT04996004|579564051|FG001|Phase II|Death|0|||
160501133|NCT04996004|579564052|FG002|Phase II|Death|0|||
160501134|NCT04996004|579564053|FG003|Phase II|Death|12|||
160501135|NCT04996004|579564054|FG004|Phase II|Death|2|||
160501136|NCT04996004|579564055|FG005|Phase II|Death|9|||
160501137|NCT04996004|579564050|FG000|Phase II|Other|0|||
160501138|NCT04996004|579564051|FG001|Phase II|Other|0|||
160501139|NCT04996004|579564052|FG002|Phase II|Other|0|||
160501140|NCT04996004|579564053|FG003|Phase II|Other|0|||
160501141|NCT04996004|579564054|FG004|Phase II|Other|0|||
160501142|NCT04996004|579564055|FG005|Phase II|Other|1|||
160501143|NCT05543174|579564056|FG000|Overall Study|Ongoing|7|||
160501144|NCT04497389|579564059|FG000|Overall Study|Withdrawal by Subject|1|||
160501145|NCT04497389|579564060|FG001|Overall Study|Withdrawal by Subject|0|||
160501146|NCT03926195|579564062|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
160501147|NCT03926195|579564063|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
160501148|NCT03926195|579564062|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
160501149|NCT03926195|579564063|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
160501150|NCT03926195|579564062|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
160501151|NCT03926195|579564063|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
160501152|NCT03926195|579564062|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
160501153|NCT03926195|579564063|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
160501154|NCT03926195|579564062|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
160501155|NCT03926195|579564063|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
160501156|NCT03926195|579564062|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
160501157|NCT03926195|579564063|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
160501158|NCT03054337|579564064|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
160501159|NCT03054337|579564065|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
160501160|NCT03054337|579564066|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
160501161|NCT03054337|579564067|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
160501162|NCT03054337|579564068|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
160501163|NCT03054337|579564069|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
160501164|NCT01661205|579564072|FG000|Overall Study|Physician Decision|2|||
160501165|NCT03443414|579564076|FG000|Overall Study|Adverse Event|6|||
160501166|NCT03443414|579564077|FG001|Overall Study|Adverse Event|0|||
160501167|NCT03443414|579564078|FG002|Overall Study|Adverse Event|4|||
160501168|NCT03443414|579564079|FG003|Overall Study|Adverse Event|2|||
160501169|NCT03443414|579564080|FG004|Overall Study|Adverse Event|3|||
160501170|NCT03443414|579564076|FG000|Overall Study|Withdrawal by Subject|3|||
160501171|NCT03443414|579564077|FG001|Overall Study|Withdrawal by Subject|2|||
160501172|NCT03443414|579564078|FG002|Overall Study|Withdrawal by Subject|2|||
160501173|NCT03443414|579564079|FG003|Overall Study|Withdrawal by Subject|2|||
160501174|NCT03443414|579564080|FG004|Overall Study|Withdrawal by Subject|1|||
160501175|NCT03443414|579564076|FG000|Overall Study|Death|0|||
160501176|NCT03443414|579564077|FG001|Overall Study|Death|1|||
160501177|NCT03443414|579564078|FG002|Overall Study|Death|0|||
160501178|NCT03443414|579564079|FG003|Overall Study|Death|1|||
160501179|NCT03443414|579564080|FG004|Overall Study|Death|0|||
160501180|NCT03443414|579564076|FG000|Overall Study|Reason not specified|2|||
160501181|NCT03443414|579564077|FG001|Overall Study|Reason not specified|0|||
160501182|NCT03443414|579564078|FG002|Overall Study|Reason not specified|0|||
160501183|NCT03443414|579564079|FG003|Overall Study|Reason not specified|0|||
160501184|NCT03443414|579564080|FG004|Overall Study|Reason not specified|1|||
160501185|NCT01266161|579564081|FG000|Overall Study|Ineligible|1|||
160501186|NCT01266161|579564082|FG001|Overall Study|Ineligible|0|||
160501187|NCT01266161|579564081|FG000|Overall Study|Lack of Efficacy|0|||
160501188|NCT01266161|579564082|FG001|Overall Study|Lack of Efficacy|1|||
160501189|NCT01266161|579564081|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
160501190|NCT01266161|579564082|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
160501191|NCT01436305|579564083|FG000|Overall Study|Death|1|||
160501192|NCT01436305|579564084|FG001|Overall Study|Death|0|||
160501193|NCT01436305|579564085|FG002|Overall Study|Death|0|||
160501194|NCT01436305|579564083|FG000|Overall Study|Lost to Follow-up|0|||
160501195|NCT01436305|579564084|FG001|Overall Study|Lost to Follow-up|1|||
160501196|NCT01436305|579564085|FG002|Overall Study|Lost to Follow-up|0|||
160501197|NCT01436305|579564083|FG000|Overall Study|Withdrawal by Subject|1|||
160501198|NCT01436305|579564084|FG001|Overall Study|Withdrawal by Subject|3|||
160501199|NCT01436305|579564085|FG002|Overall Study|Withdrawal by Subject|0|||
160501200|NCT03355209|579564086|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
160501201|NCT03355209|579564087|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
160501202|NCT03355209|579564088|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
160501203|NCT03355209|579564089|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
160501204|NCT03355209|579564090|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
160501205|NCT03355209|579564091|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
160501206|NCT03355209|579564086|FG000|Part 1: Double-Blind Period|Death|0|||
160501207|NCT03355209|579564087|FG001|Part 1: Double-Blind Period|Death|0|||
160501208|NCT03355209|579564088|FG002|Part 1: Double-Blind Period|Death|1|||
160501209|NCT03355209|579564089|FG003|Part 1: Double-Blind Period|Death|0|||
160501210|NCT03355209|579564090|FG004|Part 1: Double-Blind Period|Death|0|||
160501211|NCT03355209|579564091|FG005|Part 1: Double-Blind Period|Death|0|||
160501212|NCT03355209|579564086|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
160501213|NCT03355209|579564087|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
160501214|NCT03355209|579564088|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
160501215|NCT03355209|579564089|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
160501216|NCT03355209|579564090|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
160501217|NCT03355209|579564091|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
160501218|NCT03355209|579564086|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
160501219|NCT03355209|579564087|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
160501220|NCT03355209|579564088|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
160501221|NCT03355209|579564089|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
160501222|NCT03355209|579564090|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
160501223|NCT03355209|579564091|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
160501224|NCT03355209|579564086|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
160501225|NCT03355209|579564087|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
160501226|NCT03355209|579564088|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
160501227|NCT03355209|579564089|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
160501228|NCT03355209|579564090|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
160501229|NCT03355209|579564091|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
160501230|NCT03355209|579564086|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
160501231|NCT03355209|579564087|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
160501232|NCT03355209|579564088|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
160619353|NCT03099304|579984972|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
160619354|NCT03099304|579984973|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
160619355|NCT03099304|579984974|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
160619356|NCT03099304|579984969|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
160501233|NCT03355209|579564089|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
160501234|NCT03355209|579564090|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
160501235|NCT03355209|579564091|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
160501236|NCT03355209|579564086|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
160501237|NCT03355209|579564087|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
160501238|NCT03355209|579564088|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
160501239|NCT03355209|579564089|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
160501240|NCT03355209|579564090|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
160619357|NCT03099304|579984970|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
160501241|NCT03355209|579564091|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
160501242|NCT03355209|579564086|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
160501243|NCT03355209|579564087|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
160501244|NCT03355209|579564088|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
160501245|NCT03355209|579564089|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
160501246|NCT03355209|579564090|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
160501247|NCT03355209|579564091|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
160501248|NCT03355209|579564086|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
160501249|NCT03355209|579564087|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
160501250|NCT03355209|579564088|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
160501251|NCT03355209|579564089|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160501252|NCT03355209|579564090|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
160501253|NCT03355209|579564091|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160501254|NCT03355209|579564086|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
160501255|NCT03355209|579564087|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
160501256|NCT03355209|579564088|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
160501257|NCT03355209|579564089|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
160501258|NCT03355209|579564090|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
160501259|NCT03355209|579564091|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
160501260|NCT03355209|579564086|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
160501261|NCT03355209|579564087|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
160501262|NCT03355209|579564088|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
160501263|NCT03355209|579564089|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
160501264|NCT03355209|579564090|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
160501265|NCT03355209|579564091|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
160501266|NCT01277887|579564096|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
160501267|NCT01277887|579564097|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
160501268|NCT01277887|579564096|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
160501269|NCT01277887|579564097|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
160501270|NCT01277887|579564096|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
160501271|NCT01277887|579564097|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
160619358|NCT03099304|579984971|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
160619359|NCT03099304|579984972|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
160619360|NCT03099304|579984973|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
160619361|NCT03099304|579984974|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
160619362|NCT03099304|579984969|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
160619363|NCT03099304|579984970|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
160619364|NCT03099304|579984971|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
160619365|NCT03099304|579984972|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
160619366|NCT03099304|579984973|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
160619367|NCT03099304|579984974|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
160619368|NCT03099304|579984969|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
160619369|NCT03099304|579984970|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
160619370|NCT03099304|579984971|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
160619371|NCT03099304|579984972|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
160619372|NCT03099304|579984973|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
160619373|NCT03099304|579984974|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
160619374|NCT03099304|579984969|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
160619375|NCT03099304|579984970|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
160619376|NCT03099304|579984971|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
160619377|NCT03099304|579984972|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
160619378|NCT03099304|579984973|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
160619379|NCT03099304|579984974|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
160619380|NCT03099304|579984969|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
160619381|NCT03099304|579984970|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
160619382|NCT03099304|579984971|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
160619383|NCT03099304|579984972|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
160619384|NCT03099304|579984973|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
160619385|NCT03099304|579984974|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
160619386|NCT03099304|579984969|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
160619387|NCT03099304|579984970|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
160619388|NCT03099304|579984971|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
160619389|NCT03099304|579984972|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
160619390|NCT03099304|579984973|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
160619391|NCT03099304|579984974|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
160501272|NCT00415051|579564098|FG000|Overall Study|Protocol Violation|1|||
160501273|NCT04916730|579564100|FG000|Overall Study|Withdrawal by Subject|4|||
160501274|NCT04916730|579564101|FG001|Overall Study|Withdrawal by Subject|2|||
160501275|NCT04916730|579564100|FG000|Overall Study|Lost to Follow-up|0|||
160501276|NCT04916730|579564101|FG001|Overall Study|Lost to Follow-up|2|||
160501277|NCT04916730|579564100|FG000|Overall Study|Physician Decision|1|||
160501278|NCT04916730|579564101|FG001|Overall Study|Physician Decision|0|||
160501279|NCT00617929|579564104|FG000|Overall Study|Physician Decision|1|||
160501280|NCT00760747|579564114|FG000|Study Period II|Adverse Event|3|||
160501281|NCT00760747|579564115|FG001|Study Period II|Adverse Event|4|||
160501282|NCT00760747|579564114|FG000|Study Period II|Lack of Efficacy|0|||
160501283|NCT00760747|579564115|FG001|Study Period II|Lack of Efficacy|6|||
160501284|NCT00760747|579564114|FG000|Study Period II|Parent/Caregiver Decision|3|||
160501285|NCT00760747|579564115|FG001|Study Period II|Parent/Caregiver Decision|0|||
160501286|NCT00760747|579564114|FG000|Study Period II|Protocol Violation|6|||
160501287|NCT00760747|579564115|FG001|Study Period II|Protocol Violation|3|||
160501288|NCT00760747|579564114|FG000|Study Period II|Withdrawal by Subject|1|||
160501289|NCT00760747|579564115|FG001|Study Period II|Withdrawal by Subject|0|||
160501290|NCT00760747|579564114|FG000|Study Period II|No drug administered|0|||
160501291|NCT00760747|579564115|FG001|Study Period II|No drug administered|1|||
160501292|NCT00760747|579564114|FG000|Study Period III|Adverse Event|1|||
160501293|NCT00760747|579564115|FG001|Study Period III|Adverse Event|0|||
160501294|NCT00760747|579564114|FG000|Study Period III|Lack of Efficacy|1|||
160501295|NCT00760747|579564115|FG001|Study Period III|Lack of Efficacy|0|||
160501296|NCT00760747|579564114|FG000|Study Period III|Parent/Caregiver Decision|0|||
160501297|NCT00760747|579564115|FG001|Study Period III|Parent/Caregiver Decision|1|||
160501298|NCT00760747|579564114|FG000|Study Period III|Protocol Violation|1|||
160501299|NCT00760747|579564115|FG001|Study Period III|Protocol Violation|1|||
160501300|NCT00760747|579564114|FG000|Study Period III|Physician Decision|0|||
160501301|NCT00760747|579564115|FG001|Study Period III|Physician Decision|1|||
160501302|NCT00844597|579564116|FG000|Overall Study|Adverse Event|0|||
160501303|NCT00844597|579564117|FG001|Overall Study|Adverse Event|0|||
160501304|NCT00844597|579564118|FG002|Overall Study|Adverse Event|0|||
160501305|NCT00844597|579564119|FG003|Overall Study|Adverse Event|1|||
160501306|NCT00844597|579564120|FG004|Overall Study|Adverse Event|0|||
160501307|NCT00844597|579564121|FG005|Overall Study|Adverse Event|0|||
160501308|NCT04160988|579564122|FG000|Overall Study|poor image quality|28|||
160501309|NCT01250509|579564123|FG000|Overall Study|Lost to Follow-up|5|||
160501310|NCT01250509|579564124|FG001|Overall Study|Lost to Follow-up|2|||
160501311|NCT00108745|579564129|FG000|Overall Study|Withdrawal by Subject|19|||
160501312|NCT00108745|579564130|FG001|Overall Study|Withdrawal by Subject|12|||
160501313|NCT00108745|579564131|FG002|Overall Study|Withdrawal by Subject|12|||
160501314|NCT00108745|579564129|FG000|Overall Study|Never Treated|8|||
160501315|NCT00108745|579564130|FG001|Overall Study|Never Treated|10|||
160501316|NCT00108745|579564131|FG002|Overall Study|Never Treated|12|||
160501317|NCT00108745|579564129|FG000|Overall Study|Ineligible|7|||
160501318|NCT00108745|579564130|FG001|Overall Study|Ineligible|13|||
160501319|NCT00108745|579564131|FG002|Overall Study|Ineligible|13|||
160501320|NCT01228175|579564132|FG000|Overall Study|Lost to Follow-up|64|||
160501321|NCT01228175|579564133|FG001|Overall Study|Lost to Follow-up|50|||
160501322|NCT01228175|579564132|FG000|Overall Study|Withdrawal by Subject|1|||
160501323|NCT01228175|579564133|FG001|Overall Study|Withdrawal by Subject|2|||
160501324|NCT01228175|579564132|FG000|Overall Study|Physician Decision|1|||
160501325|NCT01228175|579564133|FG001|Overall Study|Physician Decision|1|||
160501326|NCT00243074|579564136|FG000|Overall Study|Ineligible|6|||
160501327|NCT00243074|579564136|FG000|Overall Study|Adverse Event|6|||
160501328|NCT00243074|579564136|FG000|Overall Study|Withdrawal by Subject|2|||
160501329|NCT00243074|579564136|FG000|Overall Study|Lack of Efficacy|36|||
160501330|NCT00243074|579564136|FG000|Overall Study|Death|2|||
160501331|NCT00243074|579564136|FG000|Overall Study|not protocol specified|1|||
160501332|NCT00243074|579564136|FG000|Overall Study|Did not receive any treatment|1|||
160501333|NCT00402051|579564139|FG000|Overall Study|Progressive Disease|13|||
160501334|NCT00402051|579564140|FG001|Overall Study|Progressive Disease|20|||
160501335|NCT00402051|579564139|FG000|Overall Study|Adverse Event|11|||
160501336|NCT00402051|579564140|FG001|Overall Study|Adverse Event|4|||
160501337|NCT00402051|579564139|FG000|Overall Study|Physician Decision|7|||
160501338|NCT00402051|579564140|FG001|Overall Study|Physician Decision|3|||
160619392|NCT03099304|579984969|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
160501339|NCT00402051|579564139|FG000|Overall Study|Withdrawal by Subject|3|||
160501340|NCT00402051|579564140|FG001|Overall Study|Withdrawal by Subject|3|||
160619393|NCT03099304|579984970|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
160619394|NCT03099304|579984971|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
160501341|NCT00402051|579564139|FG000|Overall Study|Death - Related to Study Drug|1|||
160501342|NCT00402051|579564140|FG001|Overall Study|Death - Related to Study Drug|2|||
160501343|NCT00402051|579564139|FG000|Overall Study|Death Due to Study Disease|2|||
160501344|NCT00402051|579564140|FG001|Overall Study|Death Due to Study Disease|1|||
160501345|NCT00402051|579564139|FG000|Overall Study|Death Due to Adverse Event|0|||
160501346|NCT00402051|579564140|FG001|Overall Study|Death Due to Adverse Event|2|||
160501347|NCT00402051|579564139|FG000|Overall Study|Lost to Follow-up|1|||
160501348|NCT00402051|579564140|FG001|Overall Study|Lost to Follow-up|0|||
160501349|NCT04463680|579564143|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
160501350|NCT04463680|579564143|FG000|Overall Study|Not eligible due to implant duration of use|1|||
160501351|NCT04463680|579564143|FG000|Overall Study|Withdrawal by Subject|3|||
160501352|NCT05239598|579564148|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
160501353|NCT05239598|579564149|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
160501354|NCT05239598|579564148|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
160501355|NCT05239598|579564149|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
160501356|NCT02592707|579564150|FG000|Overall Study|Consent Withdrawn|0|||
160501357|NCT02592707|579564151|FG001|Overall Study|Consent Withdrawn|1|||
160501358|NCT02592707|579564152|FG002|Overall Study|Consent Withdrawn|2|||
160501359|NCT02592707|579564153|FG003|Overall Study|Consent Withdrawn|0|||
160501360|NCT02592707|579564150|FG000|Overall Study|Death|1|||
160501361|NCT02592707|579564151|FG001|Overall Study|Death|0|||
160501362|NCT02592707|579564152|FG002|Overall Study|Death|0|||
160501363|NCT02592707|579564153|FG003|Overall Study|Death|0|||
160501364|NCT02592707|579564150|FG000|Overall Study|Progressive Disease|4|||
160501365|NCT02592707|579564151|FG001|Overall Study|Progressive Disease|4|||
160501366|NCT02592707|579564152|FG002|Overall Study|Progressive Disease|3|||
160501367|NCT02592707|579564153|FG003|Overall Study|Progressive Disease|3|||
160501368|NCT02592707|579564150|FG000|Overall Study|Other|0|||
160501369|NCT02592707|579564151|FG001|Overall Study|Other|0|||
160501370|NCT02592707|579564152|FG002|Overall Study|Other|1|||
160501371|NCT02592707|579564153|FG003|Overall Study|Other|2|||
160501372|NCT02592707|579564150|FG000|Overall Study|Never entered LTFU period|1|||
160501373|NCT02592707|579564151|FG001|Overall Study|Never entered LTFU period|0|||
160501374|NCT02592707|579564152|FG002|Overall Study|Never entered LTFU period|0|||
160501375|NCT02592707|579564153|FG003|Overall Study|Never entered LTFU period|2|||
160501376|NCT02998476|579564156|FG000|Overall Study|Lost to Follow-up|1|||
160501377|NCT02998476|579564157|FG001|Overall Study|Lost to Follow-up|0|||
160501378|NCT02998476|579564156|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
160501379|NCT02998476|579564157|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
160501380|NCT02998476|579564156|FG000|Overall Study|Withdrawal by Subject|1|||
160501381|NCT02998476|579564157|FG001|Overall Study|Withdrawal by Subject|2|||
160501382|NCT02998476|579564156|FG000|Overall Study|Death|45|||
160501383|NCT02998476|579564157|FG001|Overall Study|Death|2|||
160501384|NCT02998476|579564156|FG000|Overall Study|Other|6|||
160501385|NCT02998476|579564157|FG001|Overall Study|Other|1|||
160501386|NCT04855734|579564158|FG000|Overall Study|Lost to Follow-up|2|||
160501387|NCT04855734|579564159|FG001|Overall Study|Lost to Follow-up|2|||
160501388|NCT03832595|579564160|FG000|Overall Study|Death|142|||
160501389|NCT03832595|579564161|FG001|Overall Study|Death|130|||
160501390|NCT03832595|579564160|FG000|Overall Study|Medical management without dialysis|37|||
160501391|NCT03832595|579564161|FG001|Overall Study|Medical management without dialysis|1|||
160501392|NCT00344032|579564162|FG000|Overall Study|Adverse Event|0|||
160501393|NCT00344032|579564163|FG001|Overall Study|Adverse Event|1|||
160501394|NCT00344032|579564162|FG000|Overall Study|Withdrawal by Subject|6|||
160501395|NCT00344032|579564163|FG001|Overall Study|Withdrawal by Subject|2|||
160501396|NCT00344032|579564162|FG000|Overall Study|Lost to Follow-up|4|||
160501397|NCT00344032|579564163|FG001|Overall Study|Lost to Follow-up|6|||
160501398|NCT00344032|579564162|FG000|Overall Study|Physician Decision|4|||
160501399|NCT00344032|579564163|FG001|Overall Study|Physician Decision|1|||
160501400|NCT05131477|579564166|FG000|PART 1|Withdrawal by Subject|2|||
160501401|NCT05131477|579564167|FG001|PART 1|Withdrawal by Subject|9|||
160501402|NCT05131477|579564168|FG002|PART 1|Withdrawal by Subject|6|||
160501403|NCT05131477|579564169|FG003|PART 1|Withdrawal by Subject|2|||
160501404|NCT05131477|579564170|FG004|PART 1|Withdrawal by Subject|8|||
160501405|NCT05131477|579564171|FG005|PART 1|Withdrawal by Subject|0|||
160501406|NCT05131477|579564172|FG006|PART 1|Withdrawal by Subject|0|||
160501407|NCT05131477|579564173|FG007|PART 1|Withdrawal by Subject|0|||
160501408|NCT05131477|579564174|FG008|PART 1|Withdrawal by Subject|0|||
160501409|NCT05131477|579564175|FG009|PART 1|Withdrawal by Subject|0|||
160501410|NCT05131477|579564176|FG010|PART 1|Withdrawal by Subject|0|||
160501411|NCT05131477|579564177|FG011|PART 1|Withdrawal by Subject|0|||
160501412|NCT05131477|579564178|FG012|PART 1|Withdrawal by Subject|0|||
160501413|NCT05131477|579564179|FG013|PART 1|Withdrawal by Subject|0|||
160501414|NCT05131477|579564166|FG000|PART 1|Physician Decision|1|||
160501415|NCT05131477|579564167|FG001|PART 1|Physician Decision|0|||
160501416|NCT05131477|579564168|FG002|PART 1|Physician Decision|0|||
160501417|NCT05131477|579564169|FG003|PART 1|Physician Decision|0|||
160501418|NCT05131477|579564170|FG004|PART 1|Physician Decision|0|||
160501419|NCT05131477|579564171|FG005|PART 1|Physician Decision|0|||
160501420|NCT05131477|579564172|FG006|PART 1|Physician Decision|0|||
160501421|NCT05131477|579564173|FG007|PART 1|Physician Decision|0|||
160501422|NCT05131477|579564174|FG008|PART 1|Physician Decision|0|||
160501423|NCT05131477|579564175|FG009|PART 1|Physician Decision|0|||
160501424|NCT05131477|579564176|FG010|PART 1|Physician Decision|0|||
160501425|NCT05131477|579564177|FG011|PART 1|Physician Decision|0|||
160501426|NCT05131477|579564178|FG012|PART 1|Physician Decision|0|||
160501427|NCT05131477|579564179|FG013|PART 1|Physician Decision|0|||
160501428|NCT05131477|579564166|FG000|PART 1|Adverse Event|3|||
160501429|NCT05131477|579564167|FG001|PART 1|Adverse Event|5|||
160501430|NCT05131477|579564168|FG002|PART 1|Adverse Event|1|||
160501431|NCT05131477|579564169|FG003|PART 1|Adverse Event|6|||
160501432|NCT05131477|579564170|FG004|PART 1|Adverse Event|4|||
160501433|NCT05131477|579564171|FG005|PART 1|Adverse Event|0|||
160501434|NCT05131477|579564172|FG006|PART 1|Adverse Event|0|||
160501435|NCT05131477|579564173|FG007|PART 1|Adverse Event|0|||
160501436|NCT05131477|579564174|FG008|PART 1|Adverse Event|0|||
160501437|NCT05131477|579564175|FG009|PART 1|Adverse Event|0|||
160501438|NCT05131477|579564176|FG010|PART 1|Adverse Event|0|||
160501439|NCT05131477|579564177|FG011|PART 1|Adverse Event|0|||
160501440|NCT05131477|579564178|FG012|PART 1|Adverse Event|0|||
160501441|NCT05131477|579564179|FG013|PART 1|Adverse Event|0|||
160501442|NCT05131477|579564166|FG000|PART 1|unclassified|1|||
160501443|NCT05131477|579564167|FG001|PART 1|unclassified|1|||
160501444|NCT05131477|579564168|FG002|PART 1|unclassified|0|||
160501445|NCT05131477|579564169|FG003|PART 1|unclassified|0|||
160501446|NCT05131477|579564170|FG004|PART 1|unclassified|4|||
160501447|NCT05131477|579564171|FG005|PART 1|unclassified|0|||
160501448|NCT05131477|579564172|FG006|PART 1|unclassified|0|||
160501449|NCT05131477|579564173|FG007|PART 1|unclassified|0|||
160501450|NCT05131477|579564174|FG008|PART 1|unclassified|0|||
160501451|NCT05131477|579564175|FG009|PART 1|unclassified|0|||
160501452|NCT05131477|579564176|FG010|PART 1|unclassified|0|||
160501453|NCT05131477|579564177|FG011|PART 1|unclassified|0|||
160501454|NCT05131477|579564178|FG012|PART 1|unclassified|0|||
160501455|NCT05131477|579564179|FG013|PART 1|unclassified|0|||
160501456|NCT05131477|579564166|FG000|PART 1|Randomized and not treated|0|||
160501457|NCT05131477|579564167|FG001|PART 1|Randomized and not treated|0|||
160501458|NCT05131477|579564168|FG002|PART 1|Randomized and not treated|0|||
160501459|NCT05131477|579564169|FG003|PART 1|Randomized and not treated|1|||
160501460|NCT05131477|579564170|FG004|PART 1|Randomized and not treated|1|||
160501461|NCT05131477|579564171|FG005|PART 1|Randomized and not treated|0|||
160501462|NCT05131477|579564172|FG006|PART 1|Randomized and not treated|0|||
160501463|NCT05131477|579564173|FG007|PART 1|Randomized and not treated|0|||
160501464|NCT05131477|579564174|FG008|PART 1|Randomized and not treated|0|||
160501465|NCT05131477|579564175|FG009|PART 1|Randomized and not treated|0|||
160501466|NCT05131477|579564176|FG010|PART 1|Randomized and not treated|0|||
160501467|NCT05131477|579564177|FG011|PART 1|Randomized and not treated|0|||
160501468|NCT05131477|579564178|FG012|PART 1|Randomized and not treated|0|||
160501469|NCT05131477|579564179|FG013|PART 1|Randomized and not treated|0|||
160501470|NCT05131477|579564166|FG000|PART 1|Protocol Violation|2|||
160501471|NCT05131477|579564167|FG001|PART 1|Protocol Violation|0|||
160501472|NCT05131477|579564168|FG002|PART 1|Protocol Violation|0|||
160501473|NCT05131477|579564169|FG003|PART 1|Protocol Violation|1|||
160501474|NCT05131477|579564170|FG004|PART 1|Protocol Violation|0|||
160501475|NCT05131477|579564171|FG005|PART 1|Protocol Violation|0|||
160501476|NCT05131477|579564172|FG006|PART 1|Protocol Violation|0|||
160501477|NCT05131477|579564173|FG007|PART 1|Protocol Violation|0|||
160619395|NCT03099304|579984972|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
160619396|NCT03099304|579984973|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
160501478|NCT05131477|579564174|FG008|PART 1|Protocol Violation|0|||
160501479|NCT05131477|579564175|FG009|PART 1|Protocol Violation|0|||
160501480|NCT05131477|579564176|FG010|PART 1|Protocol Violation|0|||
160501481|NCT05131477|579564177|FG011|PART 1|Protocol Violation|0|||
160501482|NCT05131477|579564178|FG012|PART 1|Protocol Violation|0|||
160501483|NCT05131477|579564179|FG013|PART 1|Protocol Violation|0|||
160501484|NCT05131477|579564166|FG000|PART 1|Lack of Efficacy|0|||
160501485|NCT05131477|579564167|FG001|PART 1|Lack of Efficacy|1|||
160501486|NCT05131477|579564168|FG002|PART 1|Lack of Efficacy|1|||
160501487|NCT05131477|579564169|FG003|PART 1|Lack of Efficacy|2|||
160501488|NCT05131477|579564170|FG004|PART 1|Lack of Efficacy|5|||
160501489|NCT05131477|579564171|FG005|PART 1|Lack of Efficacy|0|||
160501490|NCT05131477|579564172|FG006|PART 1|Lack of Efficacy|0|||
160501491|NCT05131477|579564173|FG007|PART 1|Lack of Efficacy|0|||
160501492|NCT05131477|579564174|FG008|PART 1|Lack of Efficacy|0|||
160501493|NCT05131477|579564175|FG009|PART 1|Lack of Efficacy|0|||
160501494|NCT05131477|579564176|FG010|PART 1|Lack of Efficacy|0|||
160501495|NCT05131477|579564177|FG011|PART 1|Lack of Efficacy|0|||
160501496|NCT05131477|579564178|FG012|PART 1|Lack of Efficacy|0|||
160501497|NCT05131477|579564179|FG013|PART 1|Lack of Efficacy|0|||
160501498|NCT05131477|579564166|FG000|PART 2|Withdrawal by Subject|0|||
160501499|NCT05131477|579564167|FG001|PART 2|Withdrawal by Subject|0|||
160501500|NCT05131477|579564168|FG002|PART 2|Withdrawal by Subject|0|||
160501501|NCT05131477|579564169|FG003|PART 2|Withdrawal by Subject|0|||
160501502|NCT05131477|579564170|FG004|PART 2|Withdrawal by Subject|0|||
160501503|NCT05131477|579564171|FG005|PART 2|Withdrawal by Subject|0|||
160501504|NCT05131477|579564172|FG006|PART 2|Withdrawal by Subject|2|||
160501505|NCT05131477|579564173|FG007|PART 2|Withdrawal by Subject|0|||
160501506|NCT05131477|579564174|FG008|PART 2|Withdrawal by Subject|0|||
160501507|NCT05131477|579564175|FG009|PART 2|Withdrawal by Subject|0|||
160501508|NCT05131477|579564176|FG010|PART 2|Withdrawal by Subject|2|||
160501509|NCT05131477|579564177|FG011|PART 2|Withdrawal by Subject|0|||
160501510|NCT05131477|579564178|FG012|PART 2|Withdrawal by Subject|2|||
160501511|NCT05131477|579564179|FG013|PART 2|Withdrawal by Subject|2|||
160501512|NCT05131477|579564166|FG000|PART 2|Other|0|||
160501513|NCT05131477|579564167|FG001|PART 2|Other|0|||
160501514|NCT05131477|579564168|FG002|PART 2|Other|0|||
160501515|NCT05131477|579564169|FG003|PART 2|Other|0|||
160501516|NCT05131477|579564170|FG004|PART 2|Other|0|||
160501517|NCT05131477|579564171|FG005|PART 2|Other|0|||
160501518|NCT05131477|579564172|FG006|PART 2|Other|0|||
160501519|NCT05131477|579564173|FG007|PART 2|Other|0|||
160501520|NCT05131477|579564174|FG008|PART 2|Other|1|||
160501521|NCT05131477|579564175|FG009|PART 2|Other|1|||
160501522|NCT05131477|579564176|FG010|PART 2|Other|0|||
160501523|NCT05131477|579564177|FG011|PART 2|Other|0|||
160501524|NCT05131477|579564178|FG012|PART 2|Other|1|||
160501525|NCT05131477|579564179|FG013|PART 2|Other|0|||
160501526|NCT05131477|579564166|FG000|PART 2|Lack of Efficacy|0|||
160501527|NCT05131477|579564167|FG001|PART 2|Lack of Efficacy|0|||
160501528|NCT05131477|579564168|FG002|PART 2|Lack of Efficacy|0|||
160501529|NCT05131477|579564169|FG003|PART 2|Lack of Efficacy|0|||
160501530|NCT05131477|579564170|FG004|PART 2|Lack of Efficacy|0|||
160501531|NCT05131477|579564171|FG005|PART 2|Lack of Efficacy|1|||
160501532|NCT05131477|579564172|FG006|PART 2|Lack of Efficacy|1|||
160501533|NCT05131477|579564173|FG007|PART 2|Lack of Efficacy|0|||
160501534|NCT05131477|579564174|FG008|PART 2|Lack of Efficacy|3|||
160501535|NCT05131477|579564175|FG009|PART 2|Lack of Efficacy|0|||
160501536|NCT05131477|579564176|FG010|PART 2|Lack of Efficacy|1|||
160501537|NCT05131477|579564177|FG011|PART 2|Lack of Efficacy|0|||
160501538|NCT05131477|579564178|FG012|PART 2|Lack of Efficacy|2|||
160501539|NCT05131477|579564179|FG013|PART 2|Lack of Efficacy|0|||
160501540|NCT05131477|579564166|FG000|PART 2|Unclassified|0|||
160501541|NCT05131477|579564167|FG001|PART 2|Unclassified|0|||
160501542|NCT05131477|579564168|FG002|PART 2|Unclassified|0|||
160501543|NCT05131477|579564169|FG003|PART 2|Unclassified|0|||
160501544|NCT05131477|579564170|FG004|PART 2|Unclassified|0|||
160501545|NCT05131477|579564171|FG005|PART 2|Unclassified|0|||
160501546|NCT05131477|579564172|FG006|PART 2|Unclassified|0|||
160501547|NCT05131477|579564173|FG007|PART 2|Unclassified|0|||
160501548|NCT05131477|579564174|FG008|PART 2|Unclassified|0|||
160501549|NCT05131477|579564175|FG009|PART 2|Unclassified|0|||
160501550|NCT05131477|579564176|FG010|PART 2|Unclassified|1|||
160501551|NCT05131477|579564177|FG011|PART 2|Unclassified|0|||
160501552|NCT05131477|579564178|FG012|PART 2|Unclassified|0|||
160501553|NCT05131477|579564179|FG013|PART 2|Unclassified|0|||
160501554|NCT05131477|579564166|FG000|PART 2|Re-randomized and not treated|0|||
160501555|NCT05131477|579564167|FG001|PART 2|Re-randomized and not treated|0|||
160501556|NCT05131477|579564168|FG002|PART 2|Re-randomized and not treated|0|||
160501557|NCT05131477|579564169|FG003|PART 2|Re-randomized and not treated|0|||
160662383|NCT01045096|580147495|FG002|Overall Study|Withdrawal by Subject|0|||
160662384|NCT01045096|580147493|FG000|Overall Study|Other|1|||
160662385|NCT01045096|580147494|FG001|Overall Study|Other|0|||
160662386|NCT01045096|580147495|FG002|Overall Study|Other|0|||
160662387|NCT03785548|580147496|FG000|Overall Study|age > 80|1|||
160662388|NCT03785548|580147497|FG001|Overall Study|age > 80|0|||
160662389|NCT03785548|580147496|FG000|Overall Study|no Postop queries|1|||
160662390|NCT03785548|580147497|FG001|Overall Study|no Postop queries|0|||
160501558|NCT05131477|579564170|FG004|PART 2|Re-randomized and not treated|0|||
160501559|NCT05131477|579564171|FG005|PART 2|Re-randomized and not treated|0|||
160501560|NCT05131477|579564172|FG006|PART 2|Re-randomized and not treated|0|||
160501561|NCT05131477|579564173|FG007|PART 2|Re-randomized and not treated|1|||
160501562|NCT05131477|579564174|FG008|PART 2|Re-randomized and not treated|0|||
160501563|NCT05131477|579564175|FG009|PART 2|Re-randomized and not treated|0|||
160501564|NCT05131477|579564176|FG010|PART 2|Re-randomized and not treated|1|||
160501565|NCT05131477|579564177|FG011|PART 2|Re-randomized and not treated|0|||
160662391|NCT00396279|580147500|FG000|Overall Study|Ongoing in study|26|||
160662392|NCT00396279|580147500|FG000|Overall Study|Disease progression|2|||
160662393|NCT00396279|580147500|FG000|Overall Study|Withdrawal by Subject|1|||
160501566|NCT05131477|579564178|FG012|PART 2|Re-randomized and not treated|1|||
160501567|NCT05131477|579564179|FG013|PART 2|Re-randomized and not treated|1|||
160662394|NCT00396279|580147500|FG000|Overall Study|Physician Decision|1|||
160662395|NCT01882257|580147509|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
160662396|NCT01882257|580147510|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
160662397|NCT01882257|580147511|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
160501568|NCT02194829|579564180|FG000|Overall Study|Adverse Event|2|||
160501569|NCT02194829|579564181|FG001|Overall Study|Adverse Event|2|||
160501570|NCT02194829|579564180|FG000|Overall Study|Death|0|||
160501571|NCT02194829|579564181|FG001|Overall Study|Death|1|||
160501572|NCT02194829|579564180|FG000|Overall Study|Disease progression|0|||
160501573|NCT02194829|579564181|FG001|Overall Study|Disease progression|1|||
160501574|NCT02194829|579564180|FG000|Overall Study|Withdrawal by Subject|0|||
160501575|NCT02194829|579564181|FG001|Overall Study|Withdrawal by Subject|1|||
160501576|NCT02194829|579564180|FG000|Overall Study|Never started protocol therapy|0|||
160501577|NCT02194829|579564181|FG001|Overall Study|Never started protocol therapy|1|||
160501578|NCT05992922|579564183|FG000|Overall Study|Adverse Event|6|||
160501579|NCT05992922|579564184|FG001|Overall Study|Adverse Event|0|||
160501580|NCT05992922|579564183|FG000|Overall Study|Sponsor Termination of Study|14|||
160501581|NCT05992922|579564184|FG001|Overall Study|Sponsor Termination of Study|20|||
160501582|NCT03939689|579565624|FG000|Overall Study|Radiographic progression|14|||
160501583|NCT03939689|579565625|FG001|Overall Study|Radiographic progression|17|||
160501584|NCT03939689|579565624|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
160501585|NCT03939689|579565625|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
160501586|NCT03939689|579565624|FG000|Overall Study|Adverse Event|1|||
160501587|NCT03939689|579565625|FG001|Overall Study|Adverse Event|8|||
160501588|NCT03939689|579565624|FG000|Overall Study|Unequivocal clinical progression|2|||
160501589|NCT03939689|579565625|FG001|Overall Study|Unequivocal clinical progression|5|||
160501590|NCT03939689|579565624|FG000|Overall Study|Other|1|||
160501591|NCT03939689|579565625|FG001|Overall Study|Other|4|||
160501592|NCT03939689|579565624|FG000|Overall Study|Death|0|||
160501593|NCT03939689|579565625|FG001|Overall Study|Death|3|||
160501594|NCT03939689|579565624|FG000|Overall Study|Participant decision|0|||
160619397|NCT03099304|579984974|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
160619398|NCT03099304|579984969|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
160619399|NCT03099304|579984970|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
160619400|NCT03099304|579984971|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
160619401|NCT03099304|579984972|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
160619402|NCT03099304|579984973|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
160619403|NCT03099304|579984974|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
160619404|NCT03099304|579984969|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
160619405|NCT03099304|579984970|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
160619406|NCT03099304|579984971|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
160619407|NCT03099304|579984972|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
160619408|NCT03099304|579984973|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
160619409|NCT03099304|579984974|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
160619410|NCT03099304|579984969|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
160619411|NCT03099304|579984970|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
160619412|NCT03099304|579984971|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
160619413|NCT03099304|579984972|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
160619414|NCT03099304|579984973|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
160619415|NCT03099304|579984974|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
160619416|NCT03099304|579984969|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
160619417|NCT03099304|579984970|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
160619418|NCT03099304|579984971|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
160619419|NCT03099304|579984972|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
160619420|NCT03099304|579984973|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
160619421|NCT03099304|579984974|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
160619422|NCT00636506|579984975|FG000|Overall Study|Lost to Follow-up|8|||
160619423|NCT00636506|579984975|FG000|Overall Study|Explanted|1|||
160619424|NCT00636506|579984975|FG000|Overall Study|Withdrawal by Subject|6|||
160619425|NCT00636506|579984975|FG000|Overall Study|Procedure aborted|1|||
160619426|NCT01624974|579984976|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
160619427|NCT01624974|579984977|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
160619428|NCT01624974|579984976|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
160619429|NCT01624974|579984977|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
160619430|NCT01624974|579984976|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
160619431|NCT01624974|579984977|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
160619432|NCT01624974|579984976|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
160619433|NCT01624974|579984977|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
160619434|NCT01624974|579984976|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
160619435|NCT01624974|579984977|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
160619436|NCT01624974|579984976|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
160619437|NCT01624974|579984977|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
160619438|NCT01624974|579984976|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
160619439|NCT01624974|579984977|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
160619440|NCT01624974|579984976|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
160619441|NCT01624974|579984977|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
160619442|NCT01624974|579984976|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
160619443|NCT01624974|579984977|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
160501595|NCT03939689|579565625|FG001|Overall Study|Participant decision|3|||
160501596|NCT03939689|579565624|FG000|Overall Study|Withdrawal of consent|2|||
160619444|NCT01624974|579984976|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
160619445|NCT01624974|579984977|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
160501597|NCT03939689|579565625|FG001|Overall Study|Withdrawal of consent|1|||
160501598|NCT03939689|579565624|FG000|Overall Study|Investigator decision|1|||
160501599|NCT03939689|579565625|FG001|Overall Study|Investigator decision|0|||
160501600|NCT04427280|579565626|FG000|Overall Study|Withdrawal by Subject|0|||
160501601|NCT04427280|579565627|FG001|Overall Study|Withdrawal by Subject|2|||
160501602|NCT02473965|579565629|FG000|Overall Study|Adverse Event|6|||
160501603|NCT02473965|579565630|FG001|Overall Study|Adverse Event|4|||
160501604|NCT02473965|579565629|FG000|Overall Study|MG worsening|4|||
160501605|NCT02473965|579565630|FG001|Overall Study|MG worsening|1|||
160501606|NCT02473965|579565629|FG000|Overall Study|Withdrawal by Subject|2|||
160501607|NCT02473965|579565630|FG001|Overall Study|Withdrawal by Subject|3|||
160501608|NCT02473965|579565629|FG000|Overall Study|Physician Decision|0|||
160501609|NCT02473965|579565630|FG001|Overall Study|Physician Decision|2|||
160501610|NCT01920477|579565633|FG000|Overall Study|Adverse Event|0|||
160501611|NCT01920477|579565634|FG001|Overall Study|Adverse Event|1|||
160501612|NCT01920477|579565633|FG000|Overall Study|Lack of Efficacy|1|||
160501613|NCT01920477|579565634|FG001|Overall Study|Lack of Efficacy|0|||
160501614|NCT01920477|579565633|FG000|Overall Study|Study closed/terminated|14|||
160501615|NCT01920477|579565634|FG001|Overall Study|Study closed/terminated|15|||
160501616|NCT01920477|579565633|FG000|Overall Study|Withdrawal by Subject|0|||
160501617|NCT01920477|579565634|FG001|Overall Study|Withdrawal by Subject|1|||
160501618|NCT01681277|579565635|FG000|Overall Study|Adverse Event|1|||
160501619|NCT01681277|579565636|FG001|Overall Study|Adverse Event|0|||
160501620|NCT01681277|579565637|FG002|Overall Study|Adverse Event|0|||
160501621|NCT01681277|579565638|FG003|Overall Study|Adverse Event|0|||
160501622|NCT01681277|579565639|FG004|Overall Study|Adverse Event|0|||
160501623|NCT03838731|579565644|FG000|Overall Study|Pregnancy|0|||
160501624|NCT03838731|579565645|FG001|Overall Study|Pregnancy|1|||
160501625|NCT03838731|579565644|FG000|Overall Study|Withdrawal of consent|1|||
160501626|NCT03838731|579565645|FG001|Overall Study|Withdrawal of consent|0|||
160501627|NCT02038842|579565648|FG000|Overall Study|Withdrawal by Subject|2|||
160501628|NCT02038842|579565649|FG001|Overall Study|Withdrawal by Subject|2|||
160501629|NCT02038842|579565650|FG002|Overall Study|Withdrawal by Subject|0|||
160501630|NCT02038842|579565651|FG003|Overall Study|Withdrawal by Subject|0|||
160501631|NCT02038842|579565648|FG000|Overall Study|Participant decision|0|||
160501632|NCT02038842|579565649|FG001|Overall Study|Participant decision|0|||
160501633|NCT02038842|579565650|FG002|Overall Study|Participant decision|2|||
160501634|NCT02038842|579565651|FG003|Overall Study|Participant decision|1|||
160501635|NCT02038842|579565648|FG000|Overall Study|Adverse Event|0|||
160501636|NCT02038842|579565649|FG001|Overall Study|Adverse Event|0|||
160501637|NCT02038842|579565650|FG002|Overall Study|Adverse Event|3|||
160501638|NCT02038842|579565651|FG003|Overall Study|Adverse Event|1|||
160501639|NCT02038842|579565648|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
160501640|NCT02038842|579565649|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
160501641|NCT02038842|579565650|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
160501642|NCT02038842|579565651|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
160501643|NCT00789360|579565656|FG000|Overall Study|Protocol Violation|3|||
160501644|NCT00789360|579565657|FG001|Overall Study|Protocol Violation|1|||
160501645|NCT03559062|579565658|FG000|Overall Study|Other|0|||
160501646|NCT03559062|579565659|FG001|Overall Study|Other|1|||
160501647|NCT03559062|579565660|FG002|Overall Study|Other|0|||
160501648|NCT01757197|579565661|FG000|Overall Study|Death|2|||
160501649|NCT00847626|579565665|FG000|Overall Study|Adverse Event|10|||
160501650|NCT00847626|579565666|FG001|Overall Study|Adverse Event|10|||
160501651|NCT00847626|579565667|FG002|Overall Study|Adverse Event|6|||
160501652|NCT00847626|579565668|FG003|Overall Study|Adverse Event|19|||
160501653|NCT00847626|579565669|FG004|Overall Study|Adverse Event|11|||
160501654|NCT00847626|579565670|FG005|Overall Study|Adverse Event|22|||
160501655|NCT00847626|579565671|FG006|Overall Study|Adverse Event|4|||
160501656|NCT00847626|579565672|FG007|Overall Study|Adverse Event|6|||
160619446|NCT01624974|579984976|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
160619447|NCT01624974|579984977|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
160619448|NCT01624974|579984976|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
160501657|NCT00847626|579565673|FG008|Overall Study|Adverse Event|3|||
160501658|NCT00847626|579565674|FG009|Overall Study|Adverse Event|6|||
160619449|NCT01624974|579984977|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
160501659|NCT00847626|579565675|FG010|Overall Study|Adverse Event|6|||
160501660|NCT00847626|579565665|FG000|Overall Study|Protocol Violation|2|||
160501661|NCT00847626|579565666|FG001|Overall Study|Protocol Violation|1|||
160501662|NCT00847626|579565667|FG002|Overall Study|Protocol Violation|2|||
160501663|NCT00847626|579565668|FG003|Overall Study|Protocol Violation|1|||
160501664|NCT00847626|579565669|FG004|Overall Study|Protocol Violation|1|||
160501665|NCT00847626|579565670|FG005|Overall Study|Protocol Violation|1|||
160501666|NCT00847626|579565671|FG006|Overall Study|Protocol Violation|1|||
160501667|NCT00847626|579565672|FG007|Overall Study|Protocol Violation|1|||
160501668|NCT00847626|579565673|FG008|Overall Study|Protocol Violation|0|||
160501669|NCT00847626|579565674|FG009|Overall Study|Protocol Violation|1|||
160501670|NCT00847626|579565675|FG010|Overall Study|Protocol Violation|1|||
160501671|NCT00847626|579565665|FG000|Overall Study|Lost to Follow-up|0|||
160501672|NCT00847626|579565666|FG001|Overall Study|Lost to Follow-up|1|||
160501673|NCT00847626|579565667|FG002|Overall Study|Lost to Follow-up|1|||
160501674|NCT00847626|579565668|FG003|Overall Study|Lost to Follow-up|1|||
160501675|NCT00847626|579565669|FG004|Overall Study|Lost to Follow-up|0|||
160501676|NCT00847626|579565670|FG005|Overall Study|Lost to Follow-up|3|||
160501677|NCT00847626|579565671|FG006|Overall Study|Lost to Follow-up|1|||
160501678|NCT00847626|579565672|FG007|Overall Study|Lost to Follow-up|3|||
160501679|NCT00847626|579565673|FG008|Overall Study|Lost to Follow-up|1|||
160501680|NCT00847626|579565674|FG009|Overall Study|Lost to Follow-up|0|||
160501681|NCT00847626|579565675|FG010|Overall Study|Lost to Follow-up|1|||
160501682|NCT00847626|579565665|FG000|Overall Study|Withdrawal by Subject|5|||
160501683|NCT00847626|579565666|FG001|Overall Study|Withdrawal by Subject|5|||
160501684|NCT00847626|579565667|FG002|Overall Study|Withdrawal by Subject|3|||
160501685|NCT00847626|579565668|FG003|Overall Study|Withdrawal by Subject|8|||
160501686|NCT00847626|579565669|FG004|Overall Study|Withdrawal by Subject|12|||
160501687|NCT00847626|579565670|FG005|Overall Study|Withdrawal by Subject|9|||
160501688|NCT00847626|579565671|FG006|Overall Study|Withdrawal by Subject|8|||
160501689|NCT00847626|579565672|FG007|Overall Study|Withdrawal by Subject|4|||
160501690|NCT00847626|579565673|FG008|Overall Study|Withdrawal by Subject|4|||
160501691|NCT00847626|579565674|FG009|Overall Study|Withdrawal by Subject|5|||
160501692|NCT00847626|579565675|FG010|Overall Study|Withdrawal by Subject|2|||
160501693|NCT00847626|579565665|FG000|Overall Study|Lack of Efficacy|3|||
160501694|NCT00847626|579565666|FG001|Overall Study|Lack of Efficacy|1|||
160501695|NCT00847626|579565667|FG002|Overall Study|Lack of Efficacy|0|||
160501696|NCT00847626|579565668|FG003|Overall Study|Lack of Efficacy|1|||
160501697|NCT00847626|579565669|FG004|Overall Study|Lack of Efficacy|2|||
160501698|NCT00847626|579565670|FG005|Overall Study|Lack of Efficacy|0|||
160501699|NCT00847626|579565671|FG006|Overall Study|Lack of Efficacy|6|||
160501700|NCT00847626|579565672|FG007|Overall Study|Lack of Efficacy|2|||
160501701|NCT00847626|579565673|FG008|Overall Study|Lack of Efficacy|5|||
160501702|NCT00847626|579565674|FG009|Overall Study|Lack of Efficacy|1|||
160501703|NCT00847626|579565675|FG010|Overall Study|Lack of Efficacy|7|||
160501704|NCT00847626|579565665|FG000|Overall Study|Other|1|||
160501705|NCT00847626|579565666|FG001|Overall Study|Other|5|||
160501706|NCT00847626|579565667|FG002|Overall Study|Other|4|||
160501707|NCT00847626|579565668|FG003|Overall Study|Other|1|||
160501708|NCT00847626|579565669|FG004|Overall Study|Other|2|||
160501709|NCT00847626|579565670|FG005|Overall Study|Other|2|||
160501710|NCT00847626|579565671|FG006|Overall Study|Other|2|||
160501711|NCT00847626|579565672|FG007|Overall Study|Other|3|||
160501712|NCT00847626|579565673|FG008|Overall Study|Other|1|||
160501713|NCT00847626|579565674|FG009|Overall Study|Other|1|||
160501714|NCT00847626|579565675|FG010|Overall Study|Other|3|||
160501715|NCT02138786|579565681|FG000|Overall Study|Adverse Event|0|||
160501716|NCT02138786|579565682|FG001|Overall Study|Adverse Event|2|||
160501717|NCT02138786|579565683|FG002|Overall Study|Adverse Event|1|||
160501718|NCT02138786|579565681|FG000|Overall Study|Death|1|||
160501719|NCT02138786|579565682|FG001|Overall Study|Death|7|||
160501720|NCT02138786|579565683|FG002|Overall Study|Death|2|||
160501721|NCT02138786|579565681|FG000|Overall Study|Disease Progression|1|||
160501722|NCT02138786|579565682|FG001|Overall Study|Disease Progression|1|||
160501723|NCT02138786|579565683|FG002|Overall Study|Disease Progression|3|||
160501724|NCT02138786|579565681|FG000|Overall Study|Withdrawal by Subject|1|||
160501725|NCT02138786|579565682|FG001|Overall Study|Withdrawal by Subject|2|||
160501726|NCT02138786|579565683|FG002|Overall Study|Withdrawal by Subject|0|||
160501727|NCT02138786|579565681|FG000|Overall Study|Patient's Wish|0|||
160501728|NCT02138786|579565682|FG001|Overall Study|Patient's Wish|2|||
160501729|NCT02138786|579565683|FG002|Overall Study|Patient's Wish|0|||
160501730|NCT02138786|579565681|FG000|Overall Study|Sponsor Terminated Study|0|||
160501731|NCT02138786|579565682|FG001|Overall Study|Sponsor Terminated Study|1|||
160501732|NCT02138786|579565683|FG002|Overall Study|Sponsor Terminated Study|1|||
160501733|NCT02138786|579565681|FG000|Overall Study|Non-Compliance|0|||
160619450|NCT02607735|579984978|FG000|Primary Study|Randomized but Never Treated|1|||
160619451|NCT02607735|579984979|FG001|Primary Study|Randomized but Never Treated|0|||
160619452|NCT02607735|579984980|FG002|Primary Study|Randomized but Never Treated|0|||
160501734|NCT02138786|579565682|FG001|Overall Study|Non-Compliance|0|||
160501735|NCT02138786|579565683|FG002|Overall Study|Non-Compliance|1|||
160501736|NCT02088957|579565684|FG000|Overall Study|Lack of Efficacy|1|||
160501737|NCT02088957|579565685|FG001|Overall Study|Lack of Efficacy|0|||
160501738|NCT00426127|579565686|FG000|Overall Study|Adverse Event|1|||
160501739|NCT00426127|579565686|FG000|Overall Study|Removed due to disease progression|1|||
160501740|NCT03111095|579565687|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
160501741|NCT03111095|579565688|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
160501742|NCT03111095|579565687|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
160501743|NCT03111095|579565688|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
160501744|NCT04638660|579565692|FG000|Overall Study|Withdrawal by Subject|2|||
160501745|NCT04638660|579565693|FG001|Overall Study|Withdrawal by Subject|0|||
160501746|NCT04638660|579565692|FG000|Overall Study|Lost to Follow-up|1|||
160501747|NCT04638660|579565693|FG001|Overall Study|Lost to Follow-up|0|||
160619453|NCT02607735|579984978|FG000|Primary Study|Lost to Follow-up|4|||
160619454|NCT02607735|579984979|FG001|Primary Study|Lost to Follow-up|0|||
160619455|NCT02607735|579984980|FG002|Primary Study|Lost to Follow-up|0|||
160619456|NCT02607735|579984978|FG000|Primary Study|Withdrew Consent|2|||
160619457|NCT02607735|579984979|FG001|Primary Study|Withdrew Consent|0|||
160619458|NCT02607735|579984980|FG002|Primary Study|Withdrew Consent|0|||
160619459|NCT02607735|579984978|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
160619460|NCT02607735|579984979|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
160619461|NCT02607735|579984980|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
160619462|NCT02607735|579984978|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
160619463|NCT02607735|579984979|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
160619464|NCT02607735|579984980|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
160619465|NCT01376908|579984981|FG000|Overall Study|Protocol Violation|1|||
160619466|NCT01376908|579984982|FG001|Overall Study|Protocol Violation|1|||
160619467|NCT01376908|579984981|FG000|Overall Study|Withdrawal by Subject|1|||
160619468|NCT01376908|579984982|FG001|Overall Study|Withdrawal by Subject|2|||
160619469|NCT00742391|579984987|FG000|Overall Study|Adverse Event|2|||
160619470|NCT00742391|579984988|FG001|Overall Study|Adverse Event|1|||
160619471|NCT00742391|579984987|FG000|Overall Study|Lost to Follow-up|1|||
160619472|NCT00742391|579984988|FG001|Overall Study|Lost to Follow-up|0|||
160619473|NCT00742391|579984987|FG000|Overall Study|Protocol Violation|1|||
160619474|NCT00742391|579984988|FG001|Overall Study|Protocol Violation|0|||
160619475|NCT02142712|579984991|FG000|Overall Study|Lost to Follow-up|1|||
160619476|NCT02142712|579984992|FG001|Overall Study|Lost to Follow-up|1|||
160619477|NCT02142712|579984993|FG002|Overall Study|Lost to Follow-up|1|||
160619478|NCT02142712|579984994|FG003|Overall Study|Lost to Follow-up|0|||
160619479|NCT04490499|579985003|FG000|Overall Study|Withdrawal by Subject|2|||
160619480|NCT00620815|579985011|FG000|Overall Study|Adverse Event|1|||
160619481|NCT00620815|579985012|FG001|Overall Study|Adverse Event|1|||
160619482|NCT00620815|579985013|FG002|Overall Study|Adverse Event|2|||
160619483|NCT00620815|579985011|FG000|Overall Study|Withdrawal by Subject|1|||
160619484|NCT00620815|579985012|FG001|Overall Study|Withdrawal by Subject|2|||
160619485|NCT00620815|579985013|FG002|Overall Study|Withdrawal by Subject|0|||
160619486|NCT00620815|579985011|FG000|Overall Study|Lost to Follow-up|1|||
160619487|NCT00620815|579985012|FG001|Overall Study|Lost to Follow-up|6|||
160619488|NCT00620815|579985013|FG002|Overall Study|Lost to Follow-up|3|||
160619489|NCT00620815|579985011|FG000|Overall Study|Inappropriate enrolment|0|||
160619490|NCT00620815|579985012|FG001|Overall Study|Inappropriate enrolment|0|||
160619491|NCT00620815|579985013|FG002|Overall Study|Inappropriate enrolment|1|||
160619492|NCT00620815|579985011|FG000|Overall Study|Protocol Violation|1|||
160619493|NCT00620815|579985012|FG001|Overall Study|Protocol Violation|2|||
160619494|NCT00620815|579985013|FG002|Overall Study|Protocol Violation|1|||
160619495|NCT01230827|579985014|FG000|Overall Study|Lost to Follow-up|0|||
160619496|NCT01230827|579985015|FG001|Overall Study|Lost to Follow-up|0|||
160619497|NCT01230827|579985016|FG002|Overall Study|Lost to Follow-up|1|||
160619498|NCT01230827|579985017|FG003|Overall Study|Lost to Follow-up|3|||
160619499|NCT01230827|579985014|FG000|Overall Study|Withdrawal by Subject|1|||
160619500|NCT01230827|579985015|FG001|Overall Study|Withdrawal by Subject|0|||
160619501|NCT01230827|579985016|FG002|Overall Study|Withdrawal by Subject|3|||
160619502|NCT01230827|579985017|FG003|Overall Study|Withdrawal by Subject|2|||
160619503|NCT01230827|579985014|FG000|Overall Study|Lack of Efficacy|14|||
160619504|NCT01230827|579985015|FG001|Overall Study|Lack of Efficacy|1|||
160619505|NCT01230827|579985016|FG002|Overall Study|Lack of Efficacy|2|||
160619506|NCT01230827|579985017|FG003|Overall Study|Lack of Efficacy|3|||
160619507|NCT01230827|579985014|FG000|Overall Study|Adverse Event|4|||
160619508|NCT01230827|579985015|FG001|Overall Study|Adverse Event|2|||
160619509|NCT01230827|579985016|FG002|Overall Study|Adverse Event|3|||
160619510|NCT01230827|579985017|FG003|Overall Study|Adverse Event|7|||
160619511|NCT01230827|579985014|FG000|Overall Study|Recovery|0|||
160619512|NCT01230827|579985015|FG001|Overall Study|Recovery|6|||
160619513|NCT01230827|579985016|FG002|Overall Study|Recovery|0|||
160619514|NCT01230827|579985017|FG003|Overall Study|Recovery|0|||
160619515|NCT01230827|579985014|FG000|Overall Study|Study terminated by Sponsor|0|||
160619516|NCT01230827|579985015|FG001|Overall Study|Study terminated by Sponsor|2|||
160619517|NCT01230827|579985016|FG002|Overall Study|Study terminated by Sponsor|56|||
160619518|NCT01230827|579985017|FG003|Overall Study|Study terminated by Sponsor|63|||
160619519|NCT00983827|579985018|FG000|Overall Study|Withdrawal by Subject|1|||
160619520|NCT01888367|579985019|FG000|Overall Study|Physician Decision|3|||
160619521|NCT01888367|579985020|FG001|Overall Study|Physician Decision|4|||
160619522|NCT01888367|579985021|FG002|Overall Study|Physician Decision|2|||
160619523|NCT01888367|579985019|FG000|Overall Study|Death|2|||
160619524|NCT01888367|579985020|FG001|Overall Study|Death|0|||
160619525|NCT01888367|579985021|FG002|Overall Study|Death|1|||
160619526|NCT01888367|579985019|FG000|Overall Study|Withdrawal by Subject|1|||
160619527|NCT01888367|579985020|FG001|Overall Study|Withdrawal by Subject|0|||
160619528|NCT01888367|579985021|FG002|Overall Study|Withdrawal by Subject|1|||
160619529|NCT01888367|579985019|FG000|Overall Study|Lost to Follow-up|1|||
160619530|NCT01888367|579985020|FG001|Overall Study|Lost to Follow-up|1|||
160619531|NCT01888367|579985021|FG002|Overall Study|Lost to Follow-up|0|||
160501748|NCT04076943|579565698|FG000|Overall Study|Withdrawal by Subject|12|||
160501749|NCT04076943|579565698|FG000|Overall Study|Adverse Event|1|||
160501750|NCT04076943|579565698|FG000|Overall Study|Progressive Disease|2|||
160501751|NCT04076943|579565698|FG000|Overall Study|Death|13|||
160501752|NCT04076943|579565698|FG000|Overall Study|Other than specified|6|||
160501753|NCT03080493|579565699|FG000|Overall Study|Did not provide NRS pain results|1|||
160501754|NCT03080493|579565700|FG001|Overall Study|Did not provide NRS pain results|0|||
160501755|NCT03080493|579565699|FG000|Overall Study|Adverse Event|0|||
160501756|NCT03080493|579565700|FG001|Overall Study|Adverse Event|1|||
160501757|NCT03080493|579565699|FG000|Overall Study|Randomization error (parity group)|0|||
160501758|NCT03080493|579565700|FG001|Overall Study|Randomization error (parity group)|1|||
160501759|NCT02522728|579565704|FG000|Overall Study|Withdrawal by Subject|6|||
160501760|NCT02522728|579565705|FG001|Overall Study|Withdrawal by Subject|6|||
160501761|NCT02522728|579565704|FG000|Overall Study|Death|4|||
160501762|NCT02522728|579565705|FG001|Overall Study|Death|3|||
160501763|NCT02522728|579565704|FG000|Overall Study|Adverse Event|2|||
160501764|NCT02522728|579565705|FG001|Overall Study|Adverse Event|1|||
160501765|NCT02522728|579565704|FG000|Overall Study|Did not receive randomized study device|0|||
160501766|NCT02522728|579565705|FG001|Overall Study|Did not receive randomized study device|1|||
160501767|NCT01099917|579565706|FG000|Overall Study|Adverse Event|3|||
160501768|NCT01099917|579565706|FG000|Overall Study|Not Treated|24|||
160501769|NCT02344342|579565707|FG000|Overall Study|Industry partner dropped out|11|||
160501770|NCT02344342|579565708|FG001|Overall Study|Industry partner dropped out|9|||
160501771|NCT02344342|579565709|FG002|Overall Study|Industry partner dropped out|14|||
160501772|NCT02344342|579565710|FG003|Overall Study|Industry partner dropped out|10|||
160501773|NCT02567708|579565712|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
160501774|NCT02567708|579565713|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
160501775|NCT02567708|579565712|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
160501776|NCT02567708|579565713|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
160501777|NCT02567708|579565712|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
160501778|NCT02567708|579565713|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
160501779|NCT02567708|579565712|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
160501780|NCT02567708|579565713|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
160501781|NCT00706654|579565714|FG000|Conversion Phase|Lost to Follow-up|4|||
160501782|NCT00706654|579565715|FG001|Conversion Phase|Lost to Follow-up|0|||
160501783|NCT00706654|579565716|FG002|Conversion Phase|Lost to Follow-up|0|||
160501784|NCT00706654|579565717|FG003|Conversion Phase|Lost to Follow-up|0|||
160501785|NCT00706654|579565714|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
160501786|NCT00706654|579565715|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
160501787|NCT00706654|579565716|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
160501788|NCT00706654|579565717|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
160501789|NCT00706654|579565714|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
160501790|NCT00706654|579565715|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
160501791|NCT00706654|579565716|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
160501792|NCT00706654|579565717|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
160501793|NCT00706654|579565714|FG000|Conversion Phase|Withdrawn by Investigator|14|||
160501794|NCT00706654|579565715|FG001|Conversion Phase|Withdrawn by Investigator|0|||
160501795|NCT00706654|579565716|FG002|Conversion Phase|Withdrawn by Investigator|0|||
160501796|NCT00706654|579565717|FG003|Conversion Phase|Withdrawn by Investigator|0|||
160501797|NCT00706654|579565714|FG000|Conversion Phase|Withdrew Consent|38|||
160501798|NCT00706654|579565715|FG001|Conversion Phase|Withdrew Consent|0|||
160501799|NCT00706654|579565716|FG002|Conversion Phase|Withdrew Consent|0|||
160501800|NCT00706654|579565717|FG003|Conversion Phase|Withdrew Consent|0|||
160501801|NCT00706654|579565714|FG000|Conversion Phase|Adverse Event|18|||
160501802|NCT00706654|579565715|FG001|Conversion Phase|Adverse Event|0|||
160501803|NCT00706654|579565716|FG002|Conversion Phase|Adverse Event|0|||
160501804|NCT00706654|579565717|FG003|Conversion Phase|Adverse Event|0|||
160501805|NCT00706654|579565714|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
160501806|NCT00706654|579565715|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
160619532|NCT01888367|579985019|FG000|Overall Study|Protocol Violation|0|||
160619533|NCT01888367|579985020|FG001|Overall Study|Protocol Violation|0|||
160619534|NCT01888367|579985021|FG002|Overall Study|Protocol Violation|1|||
160501807|NCT00706654|579565716|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
160619535|NCT01888367|579985019|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
160619536|NCT01888367|579985020|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
160619537|NCT01888367|579985021|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
160501808|NCT00706654|579565717|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
160501809|NCT00706654|579565714|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
160501810|NCT00706654|579565715|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
160501811|NCT00706654|579565716|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
160501812|NCT00706654|579565717|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
160619538|NCT01920061|579985024|FG000|Overall Study|Death|1|||
160619539|NCT01920061|579985025|FG001|Overall Study|Death|1|||
160501813|NCT00706654|579565714|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
160501814|NCT00706654|579565715|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
160501815|NCT00706654|579565716|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
160501816|NCT00706654|579565717|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
160501817|NCT00706654|579565714|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
160501818|NCT00706654|579565715|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
160501819|NCT00706654|579565716|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
160501820|NCT00706654|579565717|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
160662398|NCT01882257|580147509|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
160662399|NCT01882257|580147510|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
160662400|NCT01882257|580147511|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
160662401|NCT00830206|580147512|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
160662402|NCT00830206|580147513|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
160662403|NCT00909610|580147517|FG000|Period: First Intervention|Adverse Event|0|||
160662404|NCT00909610|580147518|FG001|Period: First Intervention|Adverse Event|1|||
160662405|NCT00909610|580147517|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
160662406|NCT00909610|580147518|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
160662407|NCT00909610|580147517|FG000|Period: Second Intervention|Adverse Event|1|||
160662408|NCT00909610|580147518|FG001|Period: Second Intervention|Adverse Event|0|||
160662409|NCT02736721|580147530|FG000|Overall Study|Adverse Event|8|||
160662410|NCT02736721|580147530|FG000|Overall Study|Lost to Follow-up|3|||
160662411|NCT02736721|580147530|FG000|Overall Study|Other|5|||
160662412|NCT00328926|580147531|FG000|Overall Study|Pregnancy|2|||
160662413|NCT00328926|580147532|FG001|Overall Study|Pregnancy|1|||
160662414|NCT00328926|580147533|FG002|Overall Study|Pregnancy|0|||
160662415|NCT00328926|580147531|FG000|Overall Study|Lost to Follow-up|0|||
160662416|NCT00328926|580147532|FG001|Overall Study|Lost to Follow-up|1|||
160662417|NCT00328926|580147533|FG002|Overall Study|Lost to Follow-up|0|||
160662418|NCT00328926|580147531|FG000|Overall Study|Death|0|||
160662419|NCT00328926|580147532|FG001|Overall Study|Death|0|||
160662420|NCT00328926|580147533|FG002|Overall Study|Death|1|||
160662421|NCT00328926|580147531|FG000|Overall Study|In vitro fertilization treatment|0|||
160662422|NCT00328926|580147532|FG001|Overall Study|In vitro fertilization treatment|0|||
160662423|NCT00328926|580147533|FG002|Overall Study|In vitro fertilization treatment|1|||
160662424|NCT00328926|580147531|FG000|Overall Study|Lack of ovarian response|0|||
160662425|NCT00328926|580147532|FG001|Overall Study|Lack of ovarian response|1|||
160662426|NCT00328926|580147533|FG002|Overall Study|Lack of ovarian response|0|||
160662427|NCT02269657|580147534|FG000|Overall Study|Protocol Violation|3|||
160662428|NCT00834743|580147539|FG000|Second Intervention|Withdrawal by Subject|1|||
160662429|NCT00834743|580147540|FG001|Second Intervention|Withdrawal by Subject|0|||
160662430|NCT01693523|580147541|FG000|Overall Study|Adverse Event|2|||
160662431|NCT01693523|580147542|FG001|Overall Study|Adverse Event|1|||
160662432|NCT01693523|580147543|FG002|Overall Study|Adverse Event|0|||
160662433|NCT01693523|580147541|FG000|Overall Study|Death|0|||
160662434|NCT01693523|580147542|FG001|Overall Study|Death|1|||
160662435|NCT01693523|580147543|FG002|Overall Study|Death|1|||
160662436|NCT01693523|580147541|FG000|Overall Study|Lost to Follow-up|0|||
160662437|NCT01693523|580147542|FG001|Overall Study|Lost to Follow-up|0|||
160662438|NCT01693523|580147543|FG002|Overall Study|Lost to Follow-up|4|||
160662439|NCT01693523|580147541|FG000|Overall Study|Physician Decision|0|||
160662440|NCT01693523|580147542|FG001|Overall Study|Physician Decision|0|||
160662441|NCT01693523|580147543|FG002|Overall Study|Physician Decision|1|||
160662442|NCT01693523|580147541|FG000|Overall Study|Withdrawal by Subject|1|||
160662443|NCT01693523|580147542|FG001|Overall Study|Withdrawal by Subject|2|||
160662444|NCT01693523|580147543|FG002|Overall Study|Withdrawal by Subject|2|||
160662445|NCT01693523|580147541|FG000|Overall Study|Lack of compliance study medication|1|||
160662446|NCT01693523|580147542|FG001|Overall Study|Lack of compliance study medication|2|||
160662447|NCT01693523|580147543|FG002|Overall Study|Lack of compliance study medication|0|||
160662448|NCT01693523|580147541|FG000|Overall Study|Chemotherapy was held|1|||
160662449|NCT01693523|580147542|FG001|Overall Study|Chemotherapy was held|2|||
160662450|NCT01693523|580147543|FG002|Overall Study|Chemotherapy was held|0|||
160662451|NCT03025880|580147544|FG000|Overall Study|Adverse Event|1|||
160662452|NCT03025880|580147545|FG001|Overall Study|Adverse Event|0|||
160662453|NCT03025880|580147544|FG000|Overall Study|Death|1|||
160662454|NCT03025880|580147545|FG001|Overall Study|Death|1|||
160662455|NCT03025880|580147544|FG000|Overall Study|Withdrawal by Subject|0|||
160501821|NCT00706654|579565714|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
160662456|NCT03025880|580147545|FG001|Overall Study|Withdrawal by Subject|1|||
160662457|NCT03025880|580147544|FG000|Overall Study|Physician Decision|0|||
160662458|NCT03025880|580147545|FG001|Overall Study|Physician Decision|1|||
160662459|NCT03025880|580147544|FG000|Overall Study|Progressive Disease|12|||
160662460|NCT03025880|580147545|FG001|Overall Study|Progressive Disease|19|||
160662461|NCT02770820|580147547|FG000|Overall Study|Death|1|||
160662462|NCT02770820|580147547|FG000|Overall Study|Physician Decision|2|||
160662463|NCT00376623|580147549|FG000|Overall Study|Progressive disease|35|||
160662464|NCT00376623|580147550|FG001|Overall Study|Progressive disease|22|||
160662465|NCT00376623|580147551|FG002|Overall Study|Progressive disease|17|||
160501822|NCT00706654|579565715|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
160501823|NCT00706654|579565716|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
160501824|NCT00706654|579565717|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
160501825|NCT00706654|579565714|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
160501826|NCT00706654|579565715|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
160501827|NCT00706654|579565716|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
160501828|NCT00706654|579565717|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
160501829|NCT00706654|579565714|FG000|Oral Stabilization Phase|Withdrew consent|55|||
160501830|NCT00706654|579565715|FG001|Oral Stabilization Phase|Withdrew consent|0|||
160501831|NCT00706654|579565716|FG002|Oral Stabilization Phase|Withdrew consent|0|||
160501832|NCT00706654|579565717|FG003|Oral Stabilization Phase|Withdrew consent|0|||
160501833|NCT00706654|579565714|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
160501834|NCT00706654|579565715|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
160501835|NCT00706654|579565716|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
160501836|NCT00706654|579565717|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
160501837|NCT00706654|579565714|FG000|Oral Stabilization Phase|Adverse Event|21|||
160501838|NCT00706654|579565715|FG001|Oral Stabilization Phase|Adverse Event|0|||
160501839|NCT00706654|579565716|FG002|Oral Stabilization Phase|Adverse Event|0|||
160501840|NCT00706654|579565717|FG003|Oral Stabilization Phase|Adverse Event|0|||
160501841|NCT00706654|579565714|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
160501842|NCT00706654|579565715|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
160501843|NCT00706654|579565716|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
160501844|NCT00706654|579565717|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
160501845|NCT00706654|579565714|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
160501846|NCT00706654|579565715|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
160501847|NCT00706654|579565716|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
160501848|NCT00706654|579565717|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
160501849|NCT00706654|579565714|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
160501850|NCT00706654|579565715|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
160501851|NCT00706654|579565716|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
160501852|NCT00706654|579565717|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
160501853|NCT00706654|579565714|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
160501854|NCT00706654|579565715|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
160501855|NCT00706654|579565716|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
160501856|NCT00706654|579565717|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
160501857|NCT00706654|579565714|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
160501858|NCT00706654|579565715|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
160501859|NCT00706654|579565716|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
160501860|NCT00706654|579565717|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
160501861|NCT00706654|579565714|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
160501862|NCT00706654|579565715|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
160501863|NCT00706654|579565716|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
160501864|NCT00706654|579565717|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
160501865|NCT00706654|579565714|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
160501866|NCT00706654|579565715|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
160501867|NCT00706654|579565716|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
160501868|NCT00706654|579565717|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
160501869|NCT00706654|579565714|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
160501870|NCT00706654|579565715|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
160501871|NCT00706654|579565716|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
160501872|NCT00706654|579565717|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
160501873|NCT00706654|579565714|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
160501874|NCT00706654|579565715|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
160501875|NCT00706654|579565716|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
160501876|NCT00706654|579565717|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
160501877|NCT00706654|579565714|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
160501878|NCT00706654|579565715|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
160619540|NCT01920061|579985026|FG002|Overall Study|Death|0|||
160619541|NCT01920061|579985027|FG003|Overall Study|Death|1|||
160619542|NCT01920061|579985028|FG004|Overall Study|Death|1|||
160619543|NCT01920061|579985029|FG005|Overall Study|Death|0|||
160619544|NCT01920061|579985030|FG006|Overall Study|Death|0|||
160619545|NCT01920061|579985031|FG007|Overall Study|Death|1|||
160619546|NCT01920061|579985032|FG008|Overall Study|Death|0|||
160619547|NCT01920061|579985033|FG009|Overall Study|Death|1|||
160662466|NCT00376623|580147549|FG000|Overall Study|Lost to Follow-up|0|||
160662467|NCT00376623|580147550|FG001|Overall Study|Lost to Follow-up|1|||
160662468|NCT00376623|580147551|FG002|Overall Study|Lost to Follow-up|0|||
160619548|NCT01920061|579985034|FG010|Overall Study|Death|0|||
160619549|NCT01920061|579985035|FG011|Overall Study|Death|1|||
160619550|NCT01920061|579985036|FG012|Overall Study|Death|0|||
160501879|NCT00706654|579565716|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
160501880|NCT00706654|579565717|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
160501881|NCT01001390|579565718|FG000|Overall Study|Failure to wear AFO device|2|||
160501882|NCT01001390|579565719|FG001|Overall Study|Failure to wear AFO device|0|||
160501883|NCT01151215|579565720|FG000|Overall Study|Worsening of condition under study|1|||
160501884|NCT01151215|579565721|FG001|Overall Study|Worsening of condition under study|1|||
160501885|NCT01151215|579565722|FG002|Overall Study|Worsening of condition under study|1|||
160501886|NCT01151215|579565720|FG000|Overall Study|Death|16|||
160501887|NCT01151215|579565721|FG001|Overall Study|Death|20|||
160501888|NCT01151215|579565722|FG002|Overall Study|Death|11|||
160501889|NCT01151215|579565720|FG000|Overall Study|Lost to Follow-up|0|||
160501890|NCT01151215|579565721|FG001|Overall Study|Lost to Follow-up|0|||
160501891|NCT01151215|579565722|FG002|Overall Study|Lost to Follow-up|3|||
160501892|NCT01151215|579565720|FG000|Overall Study|Withdrawal by Subject|3|||
160501893|NCT01151215|579565721|FG001|Overall Study|Withdrawal by Subject|1|||
160501894|NCT01151215|579565722|FG002|Overall Study|Withdrawal by Subject|2|||
160501895|NCT01151215|579565720|FG000|Overall Study|Disease progression|0|||
160501896|NCT01151215|579565721|FG001|Overall Study|Disease progression|1|||
160501897|NCT01151215|579565722|FG002|Overall Study|Disease progression|1|||
160501898|NCT01151215|579565720|FG000|Overall Study|Safety as judged by the investigator|0|||
160501899|NCT01151215|579565721|FG001|Overall Study|Safety as judged by the investigator|0|||
160501900|NCT01151215|579565722|FG002|Overall Study|Safety as judged by the investigator|1|||
160501901|NCT01825577|579565726|FG000|Overall Study|Physician Decision|2|||
160501902|NCT01825577|579565726|FG000|Overall Study|Withdrawal by Subject|1|||
160501903|NCT01825577|579565726|FG000|Overall Study|Withdrawn by family members|2|||
160501904|NCT01825577|579565726|FG000|Overall Study|Lack of Efficacy|3|||
160501905|NCT01427725|579565733|FG000|Overall Study|Lost to Follow-up|17|||
160501906|NCT01427725|579565733|FG000|Overall Study|Protocol Violation|1|||
160501907|NCT01427725|579565733|FG000|Overall Study|Drug not administered|1|||
160501908|NCT01427725|579565733|FG000|Overall Study|Failure to visit|7|||
160501909|NCT01427725|579565733|FG000|Overall Study|Adverse Event|46|||
160501910|NCT01427725|579565733|FG000|Overall Study|Failure to visit after administration|40|||
160501911|NCT01427725|579565733|FG000|Overall Study|Patient's rejection|27|||
160501912|NCT01427725|579565733|FG000|Overall Study|Transfer to a different hospital|17|||
160501913|NCT01427725|579565733|FG000|Overall Study|Lack of Efficacy|8|||
160501914|NCT01427725|579565733|FG000|Overall Study|Death|7|||
160501915|NCT01427725|579565733|FG000|Overall Study|Symptom improvement|6|||
160501916|NCT01427725|579565733|FG000|Overall Study|AE and Patient's rejection|5|||
160619551|NCT01920061|579985037|FG013|Overall Study|Death|2|||
160619552|NCT01920061|579985038|FG014|Overall Study|Death|0|||
160619553|NCT01920061|579985039|FG015|Overall Study|Death|0|||
160619554|NCT01920061|579985040|FG016|Overall Study|Death|0|||
160619555|NCT01920061|579985041|FG017|Overall Study|Death|0|||
160619556|NCT01920061|579985042|FG018|Overall Study|Death|1|||
160619557|NCT01920061|579985043|FG019|Overall Study|Death|0|||
160619558|NCT01920061|579985024|FG000|Overall Study|Lost to Follow-up|0|||
160619559|NCT01920061|579985025|FG001|Overall Study|Lost to Follow-up|2|||
160619560|NCT01920061|579985026|FG002|Overall Study|Lost to Follow-up|0|||
160619561|NCT01920061|579985027|FG003|Overall Study|Lost to Follow-up|0|||
160619562|NCT01920061|579985028|FG004|Overall Study|Lost to Follow-up|0|||
160619563|NCT01920061|579985029|FG005|Overall Study|Lost to Follow-up|0|||
160619564|NCT01920061|579985030|FG006|Overall Study|Lost to Follow-up|1|||
160619565|NCT01920061|579985031|FG007|Overall Study|Lost to Follow-up|0|||
160619566|NCT01920061|579985032|FG008|Overall Study|Lost to Follow-up|0|||
160619567|NCT01920061|579985033|FG009|Overall Study|Lost to Follow-up|0|||
160619568|NCT01920061|579985034|FG010|Overall Study|Lost to Follow-up|3|||
160619569|NCT01920061|579985035|FG011|Overall Study|Lost to Follow-up|0|||
160619570|NCT01920061|579985036|FG012|Overall Study|Lost to Follow-up|0|||
160619571|NCT01920061|579985037|FG013|Overall Study|Lost to Follow-up|0|||
160619572|NCT01920061|579985038|FG014|Overall Study|Lost to Follow-up|0|||
160619573|NCT01920061|579985039|FG015|Overall Study|Lost to Follow-up|0|||
160619574|NCT01920061|579985040|FG016|Overall Study|Lost to Follow-up|0|||
160619575|NCT01920061|579985041|FG017|Overall Study|Lost to Follow-up|1|||
160619576|NCT01920061|579985042|FG018|Overall Study|Lost to Follow-up|4|||
160619577|NCT01920061|579985043|FG019|Overall Study|Lost to Follow-up|3|||
160619578|NCT01920061|579985024|FG000|Overall Study|Other|1|||
160619579|NCT01920061|579985025|FG001|Overall Study|Other|1|||
160619580|NCT01920061|579985026|FG002|Overall Study|Other|2|||
160619581|NCT01920061|579985027|FG003|Overall Study|Other|1|||
160501917|NCT01427725|579565733|FG000|Overall Study|Physician Decision|5|||
160501918|NCT01427725|579565733|FG000|Overall Study|Exacerbation of underlying disease|5|||
160501919|NCT01427725|579565733|FG000|Overall Study|Oral feeding difficulty|5|||
160501920|NCT01427725|579565733|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
160501921|NCT01427725|579565733|FG000|Overall Study|Forgetting prescription|1|||
160501922|NCT01427725|579565733|FG000|Overall Study|Other|2|||
160501923|NCT01299480|579565734|FG000|Overall Study|No longer willing to participate|19|||
160619582|NCT01920061|579985028|FG004|Overall Study|Other|0|||
160619583|NCT01920061|579985029|FG005|Overall Study|Other|1|||
160619584|NCT01920061|579985030|FG006|Overall Study|Other|0|||
160501924|NCT01299480|579565735|FG001|Overall Study|No longer willing to participate|17|||
160501925|NCT01299480|579565736|FG002|Overall Study|No longer willing to participate|14|||
160501926|NCT01299480|579565737|FG003|Overall Study|No longer willing to participate|13|||
160501927|NCT01299480|579565738|FG004|Overall Study|No longer willing to participate|10|||
160501928|NCT01299480|579565734|FG000|Overall Study|Protocol Violation|7|||
160501929|NCT01299480|579565735|FG001|Overall Study|Protocol Violation|5|||
160501930|NCT01299480|579565736|FG002|Overall Study|Protocol Violation|8|||
160501931|NCT01299480|579565737|FG003|Overall Study|Protocol Violation|1|||
160501932|NCT01299480|579565738|FG004|Overall Study|Protocol Violation|1|||
160501933|NCT01299480|579565734|FG000|Overall Study|Withdrawal by Subject|3|||
160501934|NCT01299480|579565735|FG001|Overall Study|Withdrawal by Subject|4|||
160501935|NCT01299480|579565736|FG002|Overall Study|Withdrawal by Subject|7|||
160501936|NCT01299480|579565737|FG003|Overall Study|Withdrawal by Subject|3|||
160501937|NCT01299480|579565738|FG004|Overall Study|Withdrawal by Subject|4|||
160501938|NCT01299480|579565734|FG000|Overall Study|Adverse Event|6|||
160501939|NCT01299480|579565735|FG001|Overall Study|Adverse Event|4|||
160501940|NCT01299480|579565736|FG002|Overall Study|Adverse Event|5|||
160501941|NCT01299480|579565737|FG003|Overall Study|Adverse Event|4|||
160501942|NCT01299480|579565738|FG004|Overall Study|Adverse Event|0|||
160501943|NCT01299480|579565734|FG000|Overall Study|Withdrawal due to pregnancy|0|||
160501944|NCT01299480|579565735|FG001|Overall Study|Withdrawal due to pregnancy|1|||
160501945|NCT01299480|579565736|FG002|Overall Study|Withdrawal due to pregnancy|1|||
160501946|NCT01299480|579565737|FG003|Overall Study|Withdrawal due to pregnancy|0|||
160501947|NCT01299480|579565738|FG004|Overall Study|Withdrawal due to pregnancy|0|||
160501948|NCT01299480|579565734|FG000|Overall Study|Physician Decision|1|||
160501949|NCT01299480|579565735|FG001|Overall Study|Physician Decision|1|||
160501950|NCT01299480|579565736|FG002|Overall Study|Physician Decision|0|||
160501951|NCT01299480|579565737|FG003|Overall Study|Physician Decision|2|||
160501952|NCT01299480|579565738|FG004|Overall Study|Physician Decision|0|||
160501953|NCT01299480|579565734|FG000|Overall Study|Lost to Follow-up|3|||
160501954|NCT01299480|579565735|FG001|Overall Study|Lost to Follow-up|1|||
160501955|NCT01299480|579565736|FG002|Overall Study|Lost to Follow-up|2|||
160501956|NCT01299480|579565737|FG003|Overall Study|Lost to Follow-up|1|||
160501957|NCT01299480|579565738|FG004|Overall Study|Lost to Follow-up|2|||
160501958|NCT01299480|579565734|FG000|Overall Study|Other|3|||
160501959|NCT01299480|579565735|FG001|Overall Study|Other|2|||
160501960|NCT01299480|579565736|FG002|Overall Study|Other|3|||
160501961|NCT01299480|579565737|FG003|Overall Study|Other|0|||
160501962|NCT01299480|579565738|FG004|Overall Study|Other|3|||
160501963|NCT01299480|579565734|FG000|Overall Study|Started, but not vaccinated|0|||
160501964|NCT01299480|579565735|FG001|Overall Study|Started, but not vaccinated|0|||
160501965|NCT01299480|579565736|FG002|Overall Study|Started, but not vaccinated|1|||
160501966|NCT01299480|579565737|FG003|Overall Study|Started, but not vaccinated|1|||
160501967|NCT01299480|579565738|FG004|Overall Study|Started, but not vaccinated|0|||
160501968|NCT01374568|579565739|FG000|Overall Study|Lab unable to analyze BTM|0|||
160501969|NCT01374568|579565740|FG001|Overall Study|Lab unable to analyze BTM|2|||
160501970|NCT04276051|579565741|FG000|Overall Study|Lost to Follow-up|0|||
160501971|NCT04276051|579565742|FG001|Overall Study|Lost to Follow-up|1|||
160501972|NCT04276051|579565741|FG000|Overall Study|Physician Decision|0|||
160501973|NCT04276051|579565742|FG001|Overall Study|Physician Decision|1|||
160501974|NCT04276051|579565741|FG000|Overall Study|Withdrawal by Subject|1|||
160501975|NCT04276051|579565742|FG001|Overall Study|Withdrawal by Subject|1|||
160501976|NCT04230122|579565743|FG000|Overall Study|Lost to Follow-up|1|||
160501977|NCT04230122|579565744|FG001|Overall Study|Lost to Follow-up|0|||
160501978|NCT00604708|579565748|FG000|Overall Study|Withdrawal by Subject|9|||
160501979|NCT00604708|579565749|FG001|Overall Study|Withdrawal by Subject|10|||
160501980|NCT00604708|579565748|FG000|Overall Study|Protocol Violation|2|||
160501981|NCT00604708|579565749|FG001|Overall Study|Protocol Violation|8|||
160501982|NCT00604708|579565748|FG000|Overall Study|Lost to Follow-up|5|||
160501983|NCT00604708|579565749|FG001|Overall Study|Lost to Follow-up|5|||
160619585|NCT01920061|579985031|FG007|Overall Study|Other|0|||
160501984|NCT00604708|579565748|FG000|Overall Study|administrative reasons|9|||
160501985|NCT00604708|579565749|FG001|Overall Study|administrative reasons|11|||
160501986|NCT00604708|579565748|FG000|Overall Study|Adverse Event|6|||
160501987|NCT00604708|579565749|FG001|Overall Study|Adverse Event|6|||
160619586|NCT01920061|579985032|FG008|Overall Study|Other|0|||
160501988|NCT00277095|579565752|FG000|Overall Study|Death|2|||
160501989|NCT00277095|579565752|FG000|Overall Study|Explanted|7|||
160501990|NCT00277095|579565752|FG000|Overall Study|Lost to Follow-up|2|||
160501991|NCT00277095|579565752|FG000|Overall Study|Missed Follow-up|9|||
160501992|NCT00277095|579565752|FG000|Overall Study|Physician Decision|1|||
160501993|NCT05415748|579565756|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
160501994|NCT05415748|579565757|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
160501995|NCT05415748|579565758|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
160501996|NCT05415748|579565759|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
160501997|NCT05415748|579565756|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
160501998|NCT05415748|579565757|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
160501999|NCT05415748|579565758|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
160502000|NCT05415748|579565759|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
160502001|NCT01447576|579565760|FG000|Overall Study|Lost to Follow-up|52|||
160502002|NCT01447576|579565760|FG000|Overall Study|Adverse Event|127|||
160502003|NCT01447576|579565760|FG000|Overall Study|Participant met withdrawal criteria|40|||
160502004|NCT01447576|579565760|FG000|Overall Study|Withdrawal by Subject|100|||
160502005|NCT01447576|579565760|FG000|Overall Study|Protocol deviation|83|||
160502006|NCT01447576|579565760|FG000|Overall Study|Lack of Efficacy|68|||
160502007|NCT01447576|579565760|FG000|Overall Study|Physician Decision|6|||
160502008|NCT03128671|579565761|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
160502009|NCT03128671|579565762|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
160502010|NCT03128671|579565761|FG000|Allocation|Death|1|||
160502011|NCT03128671|579565762|FG001|Allocation|Death|0|||
160502012|NCT03128671|579565761|FG000|Allocation|Withdrawal by Subject|4|||
160502013|NCT03128671|579565762|FG001|Allocation|Withdrawal by Subject|0|||
160502014|NCT03128671|579565761|FG000|Intervention|Withdrawal by Subject|11|||
160502015|NCT03128671|579565762|FG001|Intervention|Withdrawal by Subject|10|||
160502016|NCT03128671|579565761|FG000|Intervention|Palliative/hospice care initiated|9|||
160502017|NCT03128671|579565762|FG001|Intervention|Palliative/hospice care initiated|10|||
160502018|NCT03128671|579565761|FG000|Intervention|Death|13|||
160502019|NCT03128671|579565762|FG001|Intervention|Death|11|||
160502020|NCT03128671|579565761|FG000|Intervention|Interrupted by hurricane|1|||
160502021|NCT03128671|579565762|FG001|Intervention|Interrupted by hurricane|0|||
160502022|NCT03128671|579565761|FG000|Intervention|Physician Decision|2|||
160502023|NCT03128671|579565762|FG001|Intervention|Physician Decision|3|||
160502024|NCT04641962|579565763|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
160502025|NCT04641962|579565764|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
160502026|NCT04641962|579565765|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
160502027|NCT04641962|579565766|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
160502028|NCT04641962|579565767|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
160502029|NCT04641962|579565763|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
160502030|NCT04641962|579565764|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
160502031|NCT04641962|579565765|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
160502032|NCT04641962|579565766|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
160502033|NCT04641962|579565767|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
160502034|NCT04641962|579565763|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
160502035|NCT04641962|579565764|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
160502036|NCT04641962|579565765|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
160502037|NCT04641962|579565766|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
160502038|NCT04641962|579565767|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
160502039|NCT04641962|579565763|FG000|DBT Period: Up to 52 Weeks|Death|1|||
160502040|NCT04641962|579565764|FG001|DBT Period: Up to 52 Weeks|Death|0|||
160502041|NCT04641962|579565765|FG002|DBT Period: Up to 52 Weeks|Death|0|||
160502042|NCT04641962|579565766|FG003|DBT Period: Up to 52 Weeks|Death|0|||
160502043|NCT04641962|579565767|FG004|DBT Period: Up to 52 Weeks|Death|0|||
160502044|NCT04641962|579565763|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
160502045|NCT04641962|579565764|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
160502046|NCT04641962|579565765|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
160502047|NCT04641962|579565766|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
160502048|NCT04641962|579565767|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
160502049|NCT04641962|579565763|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
160502050|NCT04641962|579565764|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
160502051|NCT04641962|579565765|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
160502052|NCT04641962|579565766|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
160502053|NCT04641962|579565767|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
160502054|NCT04641962|579565763|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
160502055|NCT04641962|579565764|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
160502056|NCT04641962|579565765|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
160502057|NCT04641962|579565766|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
160502058|NCT04641962|579565767|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
160502059|NCT03277352|579565768|FG000|Overall Study|Study Terminated By Sponsor|2|||
160502060|NCT03277352|579565768|FG000|Overall Study|Withdrawal by Subject|4|||
160502061|NCT03277352|579565768|FG000|Overall Study|Death|4|||
160502062|NCT06840769|579565777|FG000|Overall Study|Withdrawal by Subject|1|||
160502063|NCT06840769|579565778|FG001|Overall Study|Withdrawal by Subject|0|||
160502064|NCT06840769|579565779|FG002|Overall Study|Withdrawal by Subject|0|||
160502065|NCT06840769|579565780|FG003|Overall Study|Withdrawal by Subject|0|||
160502066|NCT06840769|579565781|FG004|Overall Study|Withdrawal by Subject|0|||
160502067|NCT02726945|579565782|FG000|Overall Study|Withdrawal by Subject|0|||
160502068|NCT02726945|579565783|FG001|Overall Study|Withdrawal by Subject|0|||
160502069|NCT02726945|579565784|FG002|Overall Study|Withdrawal by Subject|1|||
160502070|NCT02726945|579565782|FG000|Overall Study|Elected to have total knee replacement|0|||
160502071|NCT02726945|579565783|FG001|Overall Study|Elected to have total knee replacement|1|||
160502072|NCT02726945|579565784|FG002|Overall Study|Elected to have total knee replacement|0|||
160502073|NCT02271984|579567436|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160502074|NCT02271984|579567437|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160502075|NCT02271984|579567438|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160502076|NCT02271984|579567439|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160502077|NCT02271984|579567440|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160502078|NCT02271984|579567441|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
160502079|NCT02271984|579567442|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160502080|NCT02271984|579567443|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
160502081|NCT02271984|579567444|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160502082|NCT02271984|579567445|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160502083|NCT02271984|579567446|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160502084|NCT02271984|579567447|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160502085|NCT01088984|579567448|FG000|Phase 1|Death|2|||
160502086|NCT01088984|579567449|FG001|Phase 1|Death|1|||
160502087|NCT01088984|579567448|FG000|Phase 1|Disease Progression|2|||
160502088|NCT01088984|579567449|FG001|Phase 1|Disease Progression|4|||
160502089|NCT01088984|579567448|FG000|Phase 1|Other|1|||
160502090|NCT01088984|579567449|FG001|Phase 1|Other|1|||
160502091|NCT01088984|579567448|FG000|Phase 2|Death|0|||
160502092|NCT01088984|579567449|FG001|Phase 2|Death|5|||
160502093|NCT01088984|579567448|FG000|Phase 2|Withdrawal by Subject|0|||
160502094|NCT01088984|579567449|FG001|Phase 2|Withdrawal by Subject|1|||
160502095|NCT01088984|579567448|FG000|Phase 2|DIsease Progression|0|||
160502096|NCT01088984|579567449|FG001|Phase 2|DIsease Progression|25|||
160502097|NCT01088984|579567448|FG000|Phase 2|Other|0|||
160502098|NCT01088984|579567449|FG001|Phase 2|Other|1|||
160502099|NCT02706405|579567456|FG000|Overall Study|Death|3|||
160502100|NCT02706405|579567457|FG001|Overall Study|Death|2|||
160502101|NCT02706405|579567458|FG002|Overall Study|Death|0|||
160502102|NCT02706405|579567459|FG003|Overall Study|Death|1|||
160502103|NCT02706405|579567460|FG004|Overall Study|Death|0|||
160502104|NCT02706405|579567461|FG005|Overall Study|Death|0|||
160502105|NCT02706405|579567462|FG006|Overall Study|Death|3|||
160502106|NCT02706405|579567463|FG007|Overall Study|Death|4|||
160502107|NCT02706405|579567456|FG000|Overall Study|Disease progression|0|||
160502108|NCT02706405|579567457|FG001|Overall Study|Disease progression|0|||
160502109|NCT02706405|579567458|FG002|Overall Study|Disease progression|0|||
160502110|NCT02706405|579567459|FG003|Overall Study|Disease progression|0|||
160502111|NCT02706405|579567460|FG004|Overall Study|Disease progression|0|||
160502112|NCT02706405|579567461|FG005|Overall Study|Disease progression|0|||
160502113|NCT02706405|579567462|FG006|Overall Study|Disease progression|0|||
160502114|NCT02706405|579567463|FG007|Overall Study|Disease progression|1|||
160502115|NCT02706405|579567456|FG000|Overall Study|Pt moved to new therapy|0|||
160502116|NCT02706405|579567457|FG001|Overall Study|Pt moved to new therapy|0|||
160502117|NCT02706405|579567458|FG002|Overall Study|Pt moved to new therapy|0|||
160502118|NCT02706405|579567459|FG003|Overall Study|Pt moved to new therapy|0|||
160502119|NCT02706405|579567460|FG004|Overall Study|Pt moved to new therapy|0|||
160502120|NCT02706405|579567461|FG005|Overall Study|Pt moved to new therapy|1|||
160502121|NCT02706405|579567462|FG006|Overall Study|Pt moved to new therapy|0|||
160502122|NCT02706405|579567463|FG007|Overall Study|Pt moved to new therapy|1|||
160502123|NCT02706405|579567456|FG000|Overall Study|Physician Decision|1|||
160502124|NCT02706405|579567457|FG001|Overall Study|Physician Decision|0|||
160502125|NCT02706405|579567458|FG002|Overall Study|Physician Decision|0|||
160502126|NCT02706405|579567459|FG003|Overall Study|Physician Decision|0|||
160502127|NCT02706405|579567460|FG004|Overall Study|Physician Decision|0|||
160502128|NCT02706405|579567461|FG005|Overall Study|Physician Decision|0|||
160502129|NCT02706405|579567462|FG006|Overall Study|Physician Decision|0|||
160502130|NCT02706405|579567463|FG007|Overall Study|Physician Decision|0|||
160619587|NCT01920061|579985033|FG009|Overall Study|Other|1|||
160619588|NCT01920061|579985034|FG010|Overall Study|Other|1|||
160619589|NCT01920061|579985035|FG011|Overall Study|Other|2|||
160619590|NCT01920061|579985036|FG012|Overall Study|Other|1|||
160619591|NCT01920061|579985037|FG013|Overall Study|Other|4|||
160619592|NCT01920061|579985038|FG014|Overall Study|Other|0|||
160502131|NCT02304705|579567468|FG000|Overall Study|Withdrawal by Subject|2|||
160502132|NCT02304705|579567469|FG001|Overall Study|Withdrawal by Subject|0|||
160502133|NCT02304705|579567468|FG000|Overall Study|Physician Decision|2|||
160502134|NCT02304705|579567469|FG001|Overall Study|Physician Decision|4|||
160502135|NCT02304705|579567468|FG000|Overall Study|Death|0|||
160502136|NCT02304705|579567469|FG001|Overall Study|Death|1|||
160502137|NCT02304705|579567468|FG000|Overall Study|Lost to Follow-up|0|||
160502138|NCT02304705|579567469|FG001|Overall Study|Lost to Follow-up|2|||
160502139|NCT05602727|579567480|FG000|Overall Study|Physician Decision|0|||
160502140|NCT05602727|579567481|FG001|Overall Study|Physician Decision|1|||
160502141|NCT05602727|579567482|FG002|Overall Study|Physician Decision|0|||
160502142|NCT05602727|579567480|FG000|Overall Study|Randomized by mistake without study medication|1|||
160619593|NCT01920061|579985039|FG015|Overall Study|Other|1|||
160502143|NCT05602727|579567481|FG001|Overall Study|Randomized by mistake without study medication|0|||
160502144|NCT05602727|579567482|FG002|Overall Study|Randomized by mistake without study medication|0|||
160619594|NCT01920061|579985040|FG016|Overall Study|Other|1|||
160619595|NCT01920061|579985041|FG017|Overall Study|Other|0|||
160619596|NCT01920061|579985042|FG018|Overall Study|Other|1|||
160502145|NCT05602727|579567480|FG000|Overall Study|Study termination by Sponsor|18|||
160502146|NCT05602727|579567481|FG001|Overall Study|Study termination by Sponsor|15|||
160502147|NCT05602727|579567482|FG002|Overall Study|Study termination by Sponsor|19|||
160502148|NCT05602727|579567480|FG000|Overall Study|Withdrawal by Subject|2|||
160502149|NCT05602727|579567481|FG001|Overall Study|Withdrawal by Subject|1|||
160502150|NCT05602727|579567482|FG002|Overall Study|Withdrawal by Subject|1|||
160502151|NCT05602727|579567480|FG000|Overall Study|Various reasons|1|||
160502152|NCT05602727|579567481|FG001|Overall Study|Various reasons|6|||
160502153|NCT05602727|579567482|FG002|Overall Study|Various reasons|1|||
160502154|NCT03412773|579567485|FG000|Overall Study|Lost to Follow-up|0|||
160502155|NCT03412773|579567486|FG001|Overall Study|Lost to Follow-up|7|||
160502156|NCT03412773|579567487|FG002|Overall Study|Lost to Follow-up|6|||
160502157|NCT03412773|579567485|FG000|Overall Study|Withdrawal by Subject|0|||
160502158|NCT03412773|579567486|FG001|Overall Study|Withdrawal by Subject|15|||
160502159|NCT03412773|579567487|FG002|Overall Study|Withdrawal by Subject|19|||
160502160|NCT03412773|579567485|FG000|Overall Study|Study Closed By Sponsor|3|||
160502161|NCT03412773|579567486|FG001|Overall Study|Study Closed By Sponsor|46|||
160502162|NCT03412773|579567487|FG002|Overall Study|Study Closed By Sponsor|33|||
160502163|NCT03412773|579567485|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
160502164|NCT03412773|579567486|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
160502165|NCT03412773|579567487|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
160502166|NCT03412773|579567485|FG000|Overall Study|Death|7|||
160502167|NCT03412773|579567486|FG001|Overall Study|Death|259|||
160502168|NCT03412773|579567487|FG002|Overall Study|Death|273|||
160502169|NCT03412773|579567485|FG000|Overall Study|Physician Decision|0|||
160502170|NCT03412773|579567486|FG001|Overall Study|Physician Decision|0|||
160502171|NCT03412773|579567487|FG002|Overall Study|Physician Decision|1|||
160502172|NCT02643303|579567490|FG000|Overall Study|Progressive Disease|4|||
160502173|NCT02643303|579567491|FG001|Overall Study|Progressive Disease|4|||
160502174|NCT02643303|579567492|FG002|Overall Study|Progressive Disease|1|||
160502175|NCT02643303|579567493|FG003|Overall Study|Progressive Disease|12|||
160502176|NCT02643303|579567494|FG004|Overall Study|Progressive Disease|6|||
160502177|NCT02643303|579567495|FG005|Overall Study|Progressive Disease|4|||
160502178|NCT02643303|579567496|FG006|Overall Study|Progressive Disease|8|||
160502179|NCT02643303|579567497|FG007|Overall Study|Progressive Disease|2|||
160502180|NCT02643303|579567498|FG008|Overall Study|Progressive Disease|6|||
160502181|NCT02643303|579567490|FG000|Overall Study|Adverse Event|0|||
160502182|NCT02643303|579567491|FG001|Overall Study|Adverse Event|1|||
160502183|NCT02643303|579567492|FG002|Overall Study|Adverse Event|0|||
160502184|NCT02643303|579567493|FG003|Overall Study|Adverse Event|0|||
160502185|NCT02643303|579567494|FG004|Overall Study|Adverse Event|1|||
160502186|NCT02643303|579567495|FG005|Overall Study|Adverse Event|0|||
160502187|NCT02643303|579567496|FG006|Overall Study|Adverse Event|0|||
160502188|NCT02643303|579567497|FG007|Overall Study|Adverse Event|0|||
160502189|NCT02643303|579567498|FG008|Overall Study|Adverse Event|0|||
160502190|NCT02643303|579567490|FG000|Overall Study|Withdrawal by Subject|0|||
160502191|NCT02643303|579567491|FG001|Overall Study|Withdrawal by Subject|0|||
160502192|NCT02643303|579567492|FG002|Overall Study|Withdrawal by Subject|0|||
160502193|NCT02643303|579567493|FG003|Overall Study|Withdrawal by Subject|1|||
160502194|NCT02643303|579567494|FG004|Overall Study|Withdrawal by Subject|0|||
160502195|NCT02643303|579567495|FG005|Overall Study|Withdrawal by Subject|0|||
160502196|NCT02643303|579567496|FG006|Overall Study|Withdrawal by Subject|1|||
160502197|NCT02643303|579567497|FG007|Overall Study|Withdrawal by Subject|1|||
160502198|NCT02643303|579567498|FG008|Overall Study|Withdrawal by Subject|1|||
160619597|NCT01920061|579985043|FG019|Overall Study|Other|1|||
160619598|NCT01920061|579985024|FG000|Overall Study|Participant refused further follow-up|0|||
160619599|NCT01920061|579985025|FG001|Overall Study|Participant refused further follow-up|0|||
160619600|NCT01920061|579985026|FG002|Overall Study|Participant refused further follow-up|0|||
160619601|NCT01920061|579985027|FG003|Overall Study|Participant refused further follow-up|0|||
160619602|NCT01920061|579985028|FG004|Overall Study|Participant refused further follow-up|1|||
160619603|NCT01920061|579985029|FG005|Overall Study|Participant refused further follow-up|1|||
160502199|NCT05332912|579567501|FG000|Overall Study|Withdrawal by Subject|0|||
160502200|NCT05332912|579567502|FG001|Overall Study|Withdrawal by Subject|1|||
160502201|NCT05332912|579567503|FG002|Overall Study|Withdrawal by Subject|2|||
160502202|NCT05332912|579567504|FG003|Overall Study|Withdrawal by Subject|0|||
160502203|NCT05332912|579567501|FG000|Overall Study|Lost to Follow-up|0|||
160502204|NCT05332912|579567502|FG001|Overall Study|Lost to Follow-up|0|||
160502205|NCT05332912|579567503|FG002|Overall Study|Lost to Follow-up|1|||
160502206|NCT05332912|579567504|FG003|Overall Study|Lost to Follow-up|0|||
160502207|NCT01174446|579567505|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
160502208|NCT01174446|579567506|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
160502209|NCT01174446|579567507|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
160502210|NCT01174446|579567508|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
160502211|NCT01174446|579567505|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
160502212|NCT01174446|579567506|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
160502213|NCT01174446|579567507|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
160502214|NCT01174446|579567508|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
160502215|NCT01174446|579567505|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
160502216|NCT01174446|579567506|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
160502217|NCT01174446|579567507|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
160502218|NCT01174446|579567508|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
160502219|NCT01174446|579567505|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
160502220|NCT01174446|579567506|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
160502221|NCT01174446|579567507|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
160502222|NCT01174446|579567508|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
160502223|NCT03057847|579567509|FG000|Overall Study|Lost to Follow-up|16|||
160502224|NCT04517669|579567510|FG000|Overall Study|Lost to Follow-up|2|||
160502225|NCT04517669|579567510|FG000|Overall Study|Withdrawal by Subject|3|||
160502226|NCT04517669|579567510|FG000|Overall Study|Drug withdrawn|44|||
160502227|NCT04517669|579567510|FG000|Overall Study|Other|1|||
160502228|NCT04517669|579567510|FG000|Overall Study|Eligibility criteria not met|4|||
160502229|NCT04517669|579567510|FG000|Overall Study|Did not receive treatment|3|||
160502230|NCT01923662|579567511|FG000|Overall Study|Withdrawal by Subject|1|||
160502231|NCT01199068|579567512|FG000|Overall Study|Unacceptable toxicity|0|||
160502232|NCT01199068|579567513|FG001|Overall Study|Unacceptable toxicity|0|||
160502233|NCT01199068|579567514|FG002|Overall Study|Unacceptable toxicity|2|||
160502234|NCT01199068|579567512|FG000|Overall Study|Progressive disease|3|||
160502235|NCT01199068|579567513|FG001|Overall Study|Progressive disease|3|||
160502236|NCT01199068|579567514|FG002|Overall Study|Progressive disease|6|||
160502237|NCT01199068|579567512|FG000|Overall Study|Withdrawal by Subject|0|||
160502238|NCT01199068|579567513|FG001|Overall Study|Withdrawal by Subject|0|||
160502239|NCT01199068|579567514|FG002|Overall Study|Withdrawal by Subject|1|||
160502240|NCT01250925|579567515|FG000|Overall Study|Lost to Follow-up|1|||
160662469|NCT00376623|580147549|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
160662470|NCT00376623|580147550|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
160662471|NCT00376623|580147551|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
160662472|NCT00376623|580147549|FG000|Overall Study|Not treated with BI 2536|1|||
160662473|NCT00376623|580147550|FG001|Overall Study|Not treated with BI 2536|0|||
160662474|NCT00376623|580147551|FG002|Overall Study|Not treated with BI 2536|0|||
160662475|NCT00376623|580147549|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
160662476|NCT00376623|580147550|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
160662477|NCT00376623|580147551|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
160662478|NCT00376623|580147549|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
160662479|NCT00376623|580147550|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
160662480|NCT00376623|580147551|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
160662481|NCT00376623|580147549|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
160662482|NCT00376623|580147550|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
160662483|NCT00376623|580147551|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
160662484|NCT00376623|580147549|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
160662485|NCT00376623|580147550|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
160662486|NCT00376623|580147551|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
160662487|NCT00376623|580147549|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
160662488|NCT00376623|580147550|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
160662489|NCT00376623|580147551|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
160662490|NCT00376623|580147549|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
160662491|NCT00376623|580147550|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
160662492|NCT00376623|580147551|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
160662493|NCT00376623|580147549|FG000|Overall Study|Increase of tumour markers|0|||
160662494|NCT00376623|580147550|FG001|Overall Study|Increase of tumour markers|1|||
160662495|NCT00376623|580147551|FG002|Overall Study|Increase of tumour markers|0|||
160502241|NCT01250925|579567516|FG001|Overall Study|Lost to Follow-up|1|||
160502242|NCT01250925|579567517|FG002|Overall Study|Lost to Follow-up|0|||
160502243|NCT01250925|579567515|FG000|Overall Study|Withdrawal by Subject|2|||
160502244|NCT01250925|579567516|FG001|Overall Study|Withdrawal by Subject|0|||
160502245|NCT01250925|579567517|FG002|Overall Study|Withdrawal by Subject|0|||
160502246|NCT01250925|579567515|FG000|Overall Study|Protocol Violation|2|||
160502247|NCT01250925|579567516|FG001|Overall Study|Protocol Violation|0|||
160502248|NCT01250925|579567517|FG002|Overall Study|Protocol Violation|0|||
160502249|NCT01250925|579567515|FG000|Overall Study|Physician Decision|0|||
160502250|NCT01250925|579567516|FG001|Overall Study|Physician Decision|2|||
160502251|NCT01250925|579567517|FG002|Overall Study|Physician Decision|1|||
160502252|NCT01250925|579567515|FG000|Overall Study|Adverse Event|0|||
160502253|NCT01250925|579567516|FG001|Overall Study|Adverse Event|0|||
160502254|NCT01250925|579567517|FG002|Overall Study|Adverse Event|1|||
160502255|NCT01016262|579567528|FG000|Double-blind Phase|Adverse Event|0|||
160502256|NCT01016262|579567529|FG001|Double-blind Phase|Adverse Event|0|||
160502257|NCT01016262|579567530|FG002|Double-blind Phase|Adverse Event|1|||
160502258|NCT01016262|579567531|FG003|Double-blind Phase|Adverse Event|0|||
160502259|NCT01016262|579567532|FG004|Double-blind Phase|Adverse Event|0|||
160502260|NCT01016262|579567533|FG005|Double-blind Phase|Adverse Event|0|||
160502261|NCT01016262|579567528|FG000|Double-blind Phase|Lack of Efficacy|1|||
160502262|NCT01016262|579567529|FG001|Double-blind Phase|Lack of Efficacy|0|||
160502263|NCT01016262|579567530|FG002|Double-blind Phase|Lack of Efficacy|5|||
160502264|NCT01016262|579567531|FG003|Double-blind Phase|Lack of Efficacy|0|||
160502265|NCT01016262|579567532|FG004|Double-blind Phase|Lack of Efficacy|0|||
160502266|NCT01016262|579567533|FG005|Double-blind Phase|Lack of Efficacy|0|||
160502267|NCT01016262|579567528|FG000|Double-blind Phase|Disease Progression|0|||
160502268|NCT01016262|579567529|FG001|Double-blind Phase|Disease Progression|1|||
160502269|NCT01016262|579567530|FG002|Double-blind Phase|Disease Progression|2|||
160502270|NCT01016262|579567531|FG003|Double-blind Phase|Disease Progression|0|||
160502271|NCT01016262|579567532|FG004|Double-blind Phase|Disease Progression|0|||
160502272|NCT01016262|579567533|FG005|Double-blind Phase|Disease Progression|0|||
160502273|NCT01016262|579567528|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
160502274|NCT01016262|579567529|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
160502275|NCT01016262|579567530|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
160502276|NCT01016262|579567531|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
160502277|NCT01016262|579567532|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
160502278|NCT01016262|579567533|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
160502279|NCT01016262|579567528|FG000|Open-Label Phase|Adverse Event|0|||
160502280|NCT01016262|579567529|FG001|Open-Label Phase|Adverse Event|0|||
160502281|NCT01016262|579567530|FG002|Open-Label Phase|Adverse Event|0|||
160502282|NCT01016262|579567531|FG003|Open-Label Phase|Adverse Event|1|||
160502283|NCT01016262|579567532|FG004|Open-Label Phase|Adverse Event|0|||
160502284|NCT01016262|579567533|FG005|Open-Label Phase|Adverse Event|0|||
160502285|NCT01016262|579567528|FG000|Open-Label Phase|Lost to Follow-up|0|||
160502286|NCT01016262|579567529|FG001|Open-Label Phase|Lost to Follow-up|0|||
160502287|NCT01016262|579567530|FG002|Open-Label Phase|Lost to Follow-up|0|||
160502288|NCT01016262|579567531|FG003|Open-Label Phase|Lost to Follow-up|0|||
160502289|NCT01016262|579567532|FG004|Open-Label Phase|Lost to Follow-up|1|||
160502290|NCT01016262|579567533|FG005|Open-Label Phase|Lost to Follow-up|0|||
160502291|NCT01016262|579567528|FG000|Open-Label Phase|Lack of Efficacy|0|||
160502292|NCT01016262|579567529|FG001|Open-Label Phase|Lack of Efficacy|0|||
160502293|NCT01016262|579567530|FG002|Open-Label Phase|Lack of Efficacy|0|||
160502294|NCT01016262|579567531|FG003|Open-Label Phase|Lack of Efficacy|1|||
160502295|NCT01016262|579567532|FG004|Open-Label Phase|Lack of Efficacy|0|||
160502296|NCT01016262|579567533|FG005|Open-Label Phase|Lack of Efficacy|0|||
160502297|NCT01016262|579567528|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
160502298|NCT01016262|579567529|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
160502299|NCT01016262|579567530|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
160502300|NCT01016262|579567531|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
160502301|NCT01016262|579567532|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
160502302|NCT01016262|579567533|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
160502303|NCT03738475|579567534|FG000|Overall Study|Participant Non-Compliance|1|||
160502304|NCT03738475|579567535|FG001|Overall Study|Participant Non-Compliance|0|||
160502305|NCT00677534|579567536|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
160662496|NCT00376623|580147549|FG000|Overall Study|Bone metastasis|1|||
160662497|NCT00376623|580147550|FG001|Overall Study|Bone metastasis|0|||
160662498|NCT00376623|580147551|FG002|Overall Study|Bone metastasis|0|||
160662499|NCT00286754|580147554|FG000|Overall Study|Adverse Event|2|||
160662500|NCT00286754|580147555|FG001|Overall Study|Adverse Event|2|||
160662501|NCT00286754|580147556|FG002|Overall Study|Adverse Event|3|||
160662502|NCT00286754|580147554|FG000|Overall Study|Withdrawal by Subject|6|||
160502306|NCT00677534|579567536|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
160502307|NCT00677534|579567536|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
160502308|NCT02224703|579567544|FG000|Overall Study|Adverse Event|0|||
160502309|NCT02224703|579567545|FG001|Overall Study|Adverse Event|5|||
160502310|NCT02224703|579567546|FG002|Overall Study|Adverse Event|0|||
160502311|NCT02224703|579567544|FG000|Overall Study|Withdrawn by investigator|1|||
160662503|NCT00286754|580147555|FG001|Overall Study|Withdrawal by Subject|2|||
160502312|NCT02224703|579567545|FG001|Overall Study|Withdrawn by investigator|0|||
160502313|NCT02224703|579567546|FG002|Overall Study|Withdrawn by investigator|0|||
160502314|NCT02224703|579567544|FG000|Overall Study|Advised by medical monitor|1|||
160502315|NCT02224703|579567545|FG001|Overall Study|Advised by medical monitor|0|||
160502316|NCT02224703|579567546|FG002|Overall Study|Advised by medical monitor|0|||
160502317|NCT02224703|579567544|FG000|Overall Study|Withdrawn by parent/guardian|0|||
160502318|NCT02224703|579567545|FG001|Overall Study|Withdrawn by parent/guardian|1|||
160662504|NCT00286754|580147556|FG002|Overall Study|Withdrawal by Subject|0|||
160662505|NCT00286754|580147554|FG000|Overall Study|Lost to Follow-up|12|||
160662506|NCT00286754|580147555|FG001|Overall Study|Lost to Follow-up|14|||
160662507|NCT00286754|580147556|FG002|Overall Study|Lost to Follow-up|6|||
160662508|NCT00286754|580147554|FG000|Overall Study|Moved out of state|0|||
160662509|NCT00286754|580147555|FG001|Overall Study|Moved out of state|0|||
160662510|NCT00286754|580147556|FG002|Overall Study|Moved out of state|1|||
160662511|NCT02331394|580147557|FG000|Overall Study|Disease progression|1|||
160662512|NCT00102440|580147564|FG000|Overall Study|Lost to Follow-up|25|||
160662513|NCT00102440|580147565|FG001|Overall Study|Lost to Follow-up|18|||
160662514|NCT00102440|580147566|FG002|Overall Study|Lost to Follow-up|21|||
160662515|NCT00102440|580147564|FG000|Overall Study|Adverse Event|16|||
160662516|NCT00102440|580147565|FG001|Overall Study|Adverse Event|23|||
160662517|NCT00102440|580147566|FG002|Overall Study|Adverse Event|8|||
160662518|NCT00102440|580147564|FG000|Overall Study|Gout Flare|10|||
160662519|NCT00102440|580147565|FG001|Overall Study|Gout Flare|28|||
160662520|NCT00102440|580147566|FG002|Overall Study|Gout Flare|9|||
160662521|NCT00102440|580147564|FG000|Overall Study|Personal Reason(s)|19|||
160662522|NCT00102440|580147565|FG001|Overall Study|Personal Reason(s)|13|||
160662523|NCT00102440|580147566|FG002|Overall Study|Personal Reason(s)|13|||
160662524|NCT00102440|580147564|FG000|Overall Study|Other|11|||
160662525|NCT00102440|580147565|FG001|Overall Study|Other|14|||
160662526|NCT00102440|580147566|FG002|Overall Study|Other|14|||
160662527|NCT00102440|580147564|FG000|Overall Study|Protocol Violation|7|||
160662528|NCT00102440|580147565|FG001|Overall Study|Protocol Violation|2|||
160662529|NCT00102440|580147566|FG002|Overall Study|Protocol Violation|1|||
160662530|NCT04786184|580147568|FG000|Overall Study|Adverse Event|4|||
160662531|NCT04786184|580147569|FG001|Overall Study|Adverse Event|0|||
160662532|NCT04786184|580147568|FG000|Overall Study|Withdrawal by Subject|3|||
160662533|NCT04786184|580147569|FG001|Overall Study|Withdrawal by Subject|1|||
160662534|NCT04786184|580147568|FG000|Overall Study|Lost to Follow-up|4|||
160662535|NCT04786184|580147569|FG001|Overall Study|Lost to Follow-up|2|||
160662536|NCT02255097|580147570|FG000|Overall Study|Death|151|||
160662537|NCT02255097|580147570|FG000|Overall Study|Lost to Follow-up|5|||
160662538|NCT02255097|580147570|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
160662539|NCT02255097|580147570|FG000|Overall Study|Withdrawal by Subject|7|||
160662540|NCT02255097|580147570|FG000|Overall Study|Allocated but not treated|1|||
160662541|NCT04239872|580147571|FG000|Overall Study|Lost to Follow-up|0|||
160662542|NCT04239872|580147572|FG001|Overall Study|Lost to Follow-up|1|||
160662543|NCT01792635|580147573|FG000|Part B|Adverse Event|0|||
160662544|NCT01792635|580147574|FG001|Part B|Adverse Event|0|||
160662545|NCT01792635|580147575|FG002|Part B|Adverse Event|1|||
160662546|NCT01792635|580147573|FG000|Part B|Study terminated|0|||
160662547|NCT01792635|580147574|FG001|Part B|Study terminated|4|||
160662548|NCT01792635|580147575|FG002|Part B|Study terminated|3|||
160662549|NCT01010542|580147576|FG000|Overall Study|Adverse Event|0|||
160662550|NCT01010542|580147577|FG001|Overall Study|Adverse Event|1|||
160662551|NCT01010542|580147578|FG002|Overall Study|Adverse Event|0|||
160662552|NCT01010542|580147576|FG000|Overall Study|Lost to Follow-up|0|||
160662553|NCT01010542|580147577|FG001|Overall Study|Lost to Follow-up|1|||
160662554|NCT01010542|580147578|FG002|Overall Study|Lost to Follow-up|0|||
160662555|NCT01010542|580147576|FG000|Overall Study|Withdrawal by Subject|0|||
160662556|NCT01010542|580147577|FG001|Overall Study|Withdrawal by Subject|3|||
160662557|NCT01010542|580147578|FG002|Overall Study|Withdrawal by Subject|2|||
160662558|NCT01498120|580147579|FG000|Overall Study|Lost to Follow-up|1|||
160662559|NCT01498120|580147579|FG000|Overall Study|Withdrawal by Subject|5|||
160662560|NCT01498120|580147579|FG000|Overall Study|AE, non-serious non-fatal|3|||
160662561|NCT01498120|580147579|FG000|Overall Study|Other|4|||
160662562|NCT01118312|580147580|FG000|Overall Study|Lost to Follow-up|33|||
160662563|NCT01118312|580147581|FG001|Overall Study|Lost to Follow-up|32|||
160662564|NCT01118312|580147580|FG000|Overall Study|Withdrawal by Subject|1|||
160662565|NCT01118312|580147581|FG001|Overall Study|Withdrawal by Subject|3|||
160662566|NCT03965091|580147582|FG000|Overall Study|Adverse Event|0|||
160662567|NCT03965091|580147583|FG001|Overall Study|Adverse Event|2|||
160662568|NCT03965091|580147584|FG002|Overall Study|Adverse Event|3|||
160662569|NCT03965091|580147582|FG000|Overall Study|Withdrawal by Subject|11|||
160502319|NCT02224703|579567546|FG002|Overall Study|Withdrawn by parent/guardian|0|||
160662570|NCT03965091|580147583|FG001|Overall Study|Withdrawal by Subject|3|||
160662571|NCT03965091|580147584|FG002|Overall Study|Withdrawal by Subject|5|||
160662572|NCT03965091|580147582|FG000|Overall Study|Non-compliance with study drug|0|||
160662573|NCT03965091|580147583|FG001|Overall Study|Non-compliance with study drug|0|||
160662574|NCT03965091|580147584|FG002|Overall Study|Non-compliance with study drug|1|||
160662575|NCT03965091|580147582|FG000|Overall Study|Lost to Follow-up|1|||
160662576|NCT03965091|580147583|FG001|Overall Study|Lost to Follow-up|1|||
160662577|NCT03965091|580147584|FG002|Overall Study|Lost to Follow-up|1|||
160662578|NCT03965091|580147582|FG000|Overall Study|Lack of Efficacy|2|||
160662579|NCT03965091|580147583|FG001|Overall Study|Lack of Efficacy|0|||
160662580|NCT03965091|580147584|FG002|Overall Study|Lack of Efficacy|0|||
160662581|NCT03965091|580147582|FG000|Overall Study|Other than specified|9|||
160662582|NCT03965091|580147583|FG001|Overall Study|Other than specified|11|||
160502320|NCT02224703|579567544|FG000|Overall Study|Lack of Efficacy|1|||
160502321|NCT02224703|579567545|FG001|Overall Study|Lack of Efficacy|0|||
160502322|NCT02224703|579567546|FG002|Overall Study|Lack of Efficacy|0|||
160502323|NCT00863681|579567549|FG000|Overall Study|Other|2|||
160502324|NCT00863681|579567550|FG001|Overall Study|Other|0|||
160502325|NCT00863681|579567551|FG002|Overall Study|Other|0|||
160502326|NCT00863681|579567549|FG000|Overall Study|Missing|1|||
160502327|NCT00863681|579567550|FG001|Overall Study|Missing|0|||
160502328|NCT00863681|579567551|FG002|Overall Study|Missing|0|||
160502329|NCT00863681|579567549|FG000|Overall Study|Death|40|||
160502330|NCT00863681|579567550|FG001|Overall Study|Death|23|||
160502331|NCT00863681|579567551|FG002|Overall Study|Death|6|||
160502332|NCT00863681|579567549|FG000|Overall Study|Withdrawal by Subject|12|||
160502333|NCT00863681|579567550|FG001|Overall Study|Withdrawal by Subject|5|||
160502334|NCT00863681|579567551|FG002|Overall Study|Withdrawal by Subject|2|||
160502335|NCT00863681|579567549|FG000|Overall Study|Protocol Violation|2|||
160502336|NCT00863681|579567550|FG001|Overall Study|Protocol Violation|0|||
160502337|NCT00863681|579567551|FG002|Overall Study|Protocol Violation|0|||
160502338|NCT00863681|579567549|FG000|Overall Study|Lost to Follow-up|3|||
160502339|NCT00863681|579567550|FG001|Overall Study|Lost to Follow-up|0|||
160502340|NCT00863681|579567551|FG002|Overall Study|Lost to Follow-up|3|||
160502341|NCT00863681|579567549|FG000|Overall Study|Adverse Event|28|||
160502342|NCT00863681|579567550|FG001|Overall Study|Adverse Event|10|||
160662583|NCT03965091|580147584|FG002|Overall Study|Other than specified|8|||
160662584|NCT04060147|580147586|FG000|Overall Study|Withdrew consent|1|||
160662585|NCT01534520|580147587|FG000|Overall Study|Adverse Event|0|||
160662586|NCT01534520|580147588|FG001|Overall Study|Adverse Event|1|||
160662587|NCT03204539|580147591|FG000|Overall Study|Loss of funding|0|||
160662588|NCT03204539|580147592|FG001|Overall Study|Loss of funding|1|||
160662589|NCT00550537|580147595|FG000|Overall Study|Death|18|||
160662590|NCT00550537|580147595|FG000|Overall Study|Adverse Event|20|||
160662591|NCT00550537|580147595|FG000|Overall Study|Disease progression before|46|||
160662592|NCT00550537|580147595|FG000|Overall Study|Withdrawal by Subject|7|||
160662593|NCT00550537|580147595|FG000|Overall Study|Change in treatment plan|4|||
160662594|NCT00550537|580147595|FG000|Overall Study|Other complicating ilness|3|||
160662595|NCT00550537|580147595|FG000|Overall Study|Declining performance status|2|||
160662596|NCT00550537|580147595|FG000|Overall Study|Treated closer to home|4|||
160662597|NCT02008565|580147596|FG000|Overall Study|Protocol Violation|1|||
160662598|NCT02008565|580147597|FG001|Overall Study|Protocol Violation|1|||
160662599|NCT02008565|580147598|FG002|Overall Study|Protocol Violation|2|||
160662600|NCT02008565|580147599|FG003|Overall Study|Protocol Violation|0|||
160662601|NCT00617305|580147600|FG000|Overall Study|Adverse Event|4|||
160662602|NCT00617305|580147601|FG001|Overall Study|Adverse Event|0|||
160662603|NCT00617305|580147602|FG002|Overall Study|Adverse Event|0|||
160662604|NCT00617305|580147600|FG000|Overall Study|Death|1|||
160662605|NCT00617305|580147601|FG001|Overall Study|Death|0|||
160662606|NCT00617305|580147602|FG002|Overall Study|Death|0|||
160662607|NCT00617305|580147600|FG000|Overall Study|Physician Decision|1|||
160662608|NCT00617305|580147601|FG001|Overall Study|Physician Decision|0|||
160662609|NCT00617305|580147602|FG002|Overall Study|Physician Decision|0|||
160662610|NCT00617305|580147600|FG000|Overall Study|Protocol Violation|1|||
160662611|NCT00617305|580147601|FG001|Overall Study|Protocol Violation|0|||
160662612|NCT00617305|580147602|FG002|Overall Study|Protocol Violation|1|||
160662613|NCT00617305|580147600|FG000|Overall Study|Withdrawal by Subject|1|||
160662614|NCT00617305|580147601|FG001|Overall Study|Withdrawal by Subject|0|||
160662615|NCT00617305|580147602|FG002|Overall Study|Withdrawal by Subject|0|||
160662616|NCT00537979|580147604|FG000|Overall Study|Adverse Event|2|||
160662617|NCT00537979|580147605|FG001|Overall Study|Adverse Event|2|||
160662618|NCT00537979|580147604|FG000|Overall Study|Withdrawal by Subject|1|||
160662619|NCT00537979|580147605|FG001|Overall Study|Withdrawal by Subject|4|||
160502343|NCT00863681|579567551|FG002|Overall Study|Adverse Event|6|||
160502344|NCT00863681|579567549|FG000|Overall Study|Lack of Efficacy|2|||
160502345|NCT00863681|579567550|FG001|Overall Study|Lack of Efficacy|2|||
160502346|NCT00863681|579567551|FG002|Overall Study|Lack of Efficacy|1|||
160502347|NCT00863681|579567549|FG000|Overall Study|Non-compliance with study drug|1|||
160502348|NCT00863681|579567550|FG001|Overall Study|Non-compliance with study drug|3|||
160502349|NCT00863681|579567551|FG002|Overall Study|Non-compliance with study drug|0|||
160502350|NCT02922023|579567552|FG000|Overall Study|Lost to Follow-up|2|||
160662620|NCT00537979|580147604|FG000|Overall Study|Lost to Follow-up|1|||
160662621|NCT00537979|580147605|FG001|Overall Study|Lost to Follow-up|4|||
160662622|NCT00537979|580147604|FG000|Overall Study|Lack of Efficacy|0|||
160662623|NCT00537979|580147605|FG001|Overall Study|Lack of Efficacy|1|||
160662624|NCT00537979|580147604|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
160662625|NCT00537979|580147605|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
160662626|NCT00537979|580147604|FG000|Overall Study|Death|0|||
160502351|NCT02922023|579567553|FG001|Overall Study|Lost to Follow-up|0|||
160502352|NCT03199469|579567555|FG000|Overall Study|Randomized, not treated|0|||
160502353|NCT03199469|579567556|FG001|Overall Study|Randomized, not treated|3|||
160502354|NCT03199469|579567555|FG000|Overall Study|Withdrawal by Subject|1|||
160662627|NCT00537979|580147605|FG001|Overall Study|Death|3|||
160662628|NCT00537979|580147604|FG000|Overall Study|Kidney transplant|0|||
160662629|NCT00537979|580147605|FG001|Overall Study|Kidney transplant|3|||
160662630|NCT00537979|580147604|FG000|Overall Study|Heart failure|0|||
160662631|NCT00537979|580147605|FG001|Overall Study|Heart failure|1|||
160662632|NCT04384978|580147609|FG000|Overall Study|Withdrawal by Subject|4|||
160662633|NCT04384978|580147610|FG001|Overall Study|Withdrawal by Subject|0|||
160662634|NCT00385593|580147611|FG000|Overall Study|Adverse Event|3|||
160662635|NCT00385593|580147612|FG001|Overall Study|Adverse Event|2|||
160662636|NCT00385593|580147611|FG000|Overall Study|Withdrawal by Subject|17|||
160662637|NCT00385593|580147612|FG001|Overall Study|Withdrawal by Subject|7|||
160662638|NCT00385593|580147611|FG000|Overall Study|Lost to Follow-up|12|||
160662639|NCT00385593|580147612|FG001|Overall Study|Lost to Follow-up|8|||
160662640|NCT00385593|580147611|FG000|Overall Study|Protocol Violation|7|||
160662641|NCT00385593|580147612|FG001|Overall Study|Protocol Violation|4|||
160662642|NCT00385593|580147611|FG000|Overall Study|Several reasons|17|||
160662643|NCT00385593|580147612|FG001|Overall Study|Several reasons|15|||
160662644|NCT00385593|580147611|FG000|Overall Study|Incorrect inclusion|2|||
160662645|NCT00385593|580147612|FG001|Overall Study|Incorrect inclusion|0|||
160662646|NCT00385593|580147611|FG000|Overall Study|Incorrect randomization|0|||
160662647|NCT00385593|580147612|FG001|Overall Study|Incorrect randomization|1|||
160662648|NCT01223365|580147633|FG000|Open-label Titration Period|Enrolled but not treated|1|||
160662649|NCT01223365|580147633|FG000|Open-label Titration Period|Adverse Event|23|||
160662650|NCT01223365|580147633|FG000|Open-label Titration Period|Lack of Efficacy|3|||
160662651|NCT01223365|580147633|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
160662652|NCT01223365|580147633|FG000|Open-label Titration Period|Protocol Violation|1|||
160662653|NCT01223365|580147633|FG000|Open-label Titration Period|Lost to Follow-up|2|||
160662654|NCT01223365|580147633|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
160662655|NCT01223365|580147633|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
160662656|NCT01223365|580147633|FG000|Open-label Titration Period|Starting physical therapy|1|||
160662657|NCT01223365|580147633|FG000|Open-label Treatment Period|Adverse Event|39|||
160662658|NCT01223365|580147633|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
160662659|NCT01223365|580147633|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
160662660|NCT01223365|580147633|FG000|Open-label Treatment Period|Protocol Violation|15|||
160662661|NCT01223365|580147633|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
160662662|NCT01223365|580147633|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
160662663|NCT01223365|580147633|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
160662664|NCT01223365|580147633|FG000|Open-label Treatment Period|Moved out of area|2|||
160662665|NCT01223365|580147633|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
160662666|NCT01223365|580147633|FG000|Open-label Treatment Period|"Out of window"|1|||
160662667|NCT01223365|580147633|FG000|Open-label Treatment Period|Starting physical therapy|1|||
160662668|NCT01223365|580147633|FG000|Open-label Treatment Period|Physician Decision|2|||
160662669|NCT03041025|580147634|FG000|Overall Study|Adverse Event|0|||
160662670|NCT03041025|580147635|FG001|Overall Study|Adverse Event|0|||
160662671|NCT03041025|580147636|FG002|Overall Study|Adverse Event|1|||
160662672|NCT03041025|580147634|FG000|Overall Study|Lost to Follow-up|1|||
160662673|NCT03041025|580147635|FG001|Overall Study|Lost to Follow-up|0|||
160662674|NCT03041025|580147636|FG002|Overall Study|Lost to Follow-up|0|||
160662675|NCT03041025|580147634|FG000|Overall Study|Withdrawal by Subject|0|||
160662676|NCT03041025|580147635|FG001|Overall Study|Withdrawal by Subject|0|||
160662677|NCT03041025|580147636|FG002|Overall Study|Withdrawal by Subject|1|||
160662678|NCT02963259|580147637|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
160662679|NCT02963259|580147637|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
160662680|NCT02963259|580147637|FG000|Overall Study|Death|1|||
160662681|NCT02963259|580147637|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
160662682|NCT03880266|580147638|FG000|Overall Study|Withdrawal by Subject|0|||
160662683|NCT03880266|580147639|FG001|Overall Study|Withdrawal by Subject|1|||
160662684|NCT03880266|580147640|FG002|Overall Study|Withdrawal by Subject|1|||
160662685|NCT03880266|580147641|FG003|Overall Study|Withdrawal by Subject|0|||
160662686|NCT03880266|580147642|FG004|Overall Study|Withdrawal by Subject|0|||
160662687|NCT03880266|580147643|FG005|Overall Study|Withdrawal by Subject|0|||
160662688|NCT03880266|580147644|FG006|Overall Study|Withdrawal by Subject|0|||
160662689|NCT03880266|580147645|FG007|Overall Study|Withdrawal by Subject|0|||
160662690|NCT03235739|580149118|FG000|Overall Study|Withdrawal by Subject|2|||
160662691|NCT03235739|580149119|FG001|Overall Study|Withdrawal by Subject|2|||
160662692|NCT03235739|580149118|FG000|Overall Study|Physician Decision|0|||
160662693|NCT03235739|580149119|FG001|Overall Study|Physician Decision|1|||
160662694|NCT01511939|580149124|FG000|Overall Study|Withdrawal by Subject|2|||
160662695|NCT01511939|580149125|FG001|Overall Study|Withdrawal by Subject|1|||
160662696|NCT01511939|580149126|FG002|Overall Study|Withdrawal by Subject|0|||
160662697|NCT01993030|580149132|FG000|Overall Study|Adverse Event|0|||
160662698|NCT01993030|580149133|FG001|Overall Study|Adverse Event|4|||
160662699|NCT02883452|580149134|FG000|Overall Study|Withdrawal by Subject|1|||
160662700|NCT02883452|580149135|FG001|Overall Study|Withdrawal by Subject|1|||
160662701|NCT02883452|580149136|FG002|Overall Study|Withdrawal by Subject|3|||
160619604|NCT01920061|579985030|FG006|Overall Study|Participant refused further follow-up|0|||
160619605|NCT01920061|579985031|FG007|Overall Study|Participant refused further follow-up|0|||
160619606|NCT01920061|579985032|FG008|Overall Study|Participant refused further follow-up|1|||
160619607|NCT01920061|579985033|FG009|Overall Study|Participant refused further follow-up|0|||
160619608|NCT01920061|579985034|FG010|Overall Study|Participant refused further follow-up|1|||
160619609|NCT01920061|579985035|FG011|Overall Study|Participant refused further follow-up|0|||
160619610|NCT01920061|579985036|FG012|Overall Study|Participant refused further follow-up|1|||
160619611|NCT01920061|579985037|FG013|Overall Study|Participant refused further follow-up|0|||
160619612|NCT01920061|579985038|FG014|Overall Study|Participant refused further follow-up|1|||
160619613|NCT01920061|579985039|FG015|Overall Study|Participant refused further follow-up|2|||
160619614|NCT01920061|579985040|FG016|Overall Study|Participant refused further follow-up|1|||
160619615|NCT01920061|579985041|FG017|Overall Study|Participant refused further follow-up|1|||
160619616|NCT01920061|579985042|FG018|Overall Study|Participant refused further follow-up|0|||
160619617|NCT01920061|579985043|FG019|Overall Study|Participant refused further follow-up|0|||
160619618|NCT00805142|579985046|FG000|Titration Period|Adverse Event|3|||
160619619|NCT00805142|579985047|FG001|Titration Period|Adverse Event|3|||
160619620|NCT00805142|579985046|FG000|Titration Period|Lack of Efficacy|1|||
160619621|NCT00805142|579985047|FG001|Titration Period|Lack of Efficacy|1|||
160619622|NCT00805142|579985046|FG000|Titration Period|Lost to Follow-up|0|||
160619623|NCT00805142|579985047|FG001|Titration Period|Lost to Follow-up|1|||
160619624|NCT00805142|579985046|FG000|Titration Period|Disease Progression|2|||
160619625|NCT00805142|579985047|FG001|Titration Period|Disease Progression|1|||
160619626|NCT00805142|579985046|FG000|Titration Period|Withdrawal of consent|0|||
160619627|NCT00805142|579985047|FG001|Titration Period|Withdrawal of consent|1|||
160619628|NCT00805142|579985046|FG000|Titration Period|Other|0|||
160619629|NCT00805142|579985047|FG001|Titration Period|Other|3|||
160619630|NCT00805142|579985046|FG000|Maintenance Period|Adverse Event|0|||
160619631|NCT00805142|579985047|FG001|Maintenance Period|Adverse Event|1|||
160619632|NCT00805142|579985046|FG000|Maintenance Period|Other|0|||
160619633|NCT00805142|579985047|FG001|Maintenance Period|Other|1|||
160619634|NCT00422942|579985048|FG000|Overall Study|Study terminated by Sponsor|3|||
160619635|NCT02828982|579985051|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
160619636|NCT02828982|579985052|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
160619637|NCT02475564|579985053|FG000|Overall Study|Withdrawal by Subject|1|||
160619638|NCT02475564|579985054|FG001|Overall Study|Withdrawal by Subject|0|||
160619639|NCT02475564|579985053|FG000|Overall Study|Lost to Follow-up|2|||
160619640|NCT02475564|579985054|FG001|Overall Study|Lost to Follow-up|1|||
160619641|NCT02475564|579985053|FG000|Overall Study|Intense Menstrual bleeding|1|||
160619642|NCT02475564|579985054|FG001|Overall Study|Intense Menstrual bleeding|0|||
160619643|NCT02705755|579985055|FG000|Part A (6 Days)|Adverse Event|1|||
160619644|NCT02705755|579985056|FG001|Part A (6 Days)|Adverse Event|0|||
160619645|NCT02705755|579985057|FG002|Part A (6 Days)|Adverse Event|0|||
160619646|NCT02705755|579985058|FG003|Part A (6 Days)|Adverse Event|0|||
160619647|NCT02705755|579985055|FG000|Part A (6 Days)|Physician Decision|3|||
160619648|NCT02705755|579985056|FG001|Part A (6 Days)|Physician Decision|0|||
160619649|NCT02705755|579985057|FG002|Part A (6 Days)|Physician Decision|0|||
160619650|NCT02705755|579985058|FG003|Part A (6 Days)|Physician Decision|0|||
160619651|NCT02705755|579985055|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
160619652|NCT02705755|579985056|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
160619653|NCT02705755|579985057|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
160619654|NCT02705755|579985058|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
160619655|NCT02705755|579985055|FG000|Part C (20 Weeks)|Physician Decision|0|||
160619656|NCT02705755|579985056|FG001|Part C (20 Weeks)|Physician Decision|0|||
160619657|NCT02705755|579985057|FG002|Part C (20 Weeks)|Physician Decision|0|||
160619658|NCT02705755|579985058|FG003|Part C (20 Weeks)|Physician Decision|2|||
160619659|NCT02705755|579985055|FG000|Part C (20 Weeks)|Adverse Event|0|||
160619660|NCT02705755|579985056|FG001|Part C (20 Weeks)|Adverse Event|0|||
160619661|NCT02705755|579985057|FG002|Part C (20 Weeks)|Adverse Event|0|||
160619662|NCT02705755|579985058|FG003|Part C (20 Weeks)|Adverse Event|6|||
160619663|NCT02705755|579985055|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
160619664|NCT02705755|579985056|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
160619665|NCT02705755|579985057|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
160619666|NCT02705755|579985058|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
160619667|NCT01906489|579985059|FG000|Overall Study|Adverse Event|10|||
160619668|NCT01906489|579985060|FG001|Overall Study|Adverse Event|3|||
160619669|NCT01906489|579985059|FG000|Overall Study|Worsening of CKD|6|||
160619670|NCT01906489|579985060|FG001|Overall Study|Worsening of CKD|4|||
160619671|NCT01906489|579985059|FG000|Overall Study|Withdrawal by Subject|5|||
160619672|NCT01906489|579985060|FG001|Overall Study|Withdrawal by Subject|0|||
160619673|NCT01906489|579985059|FG000|Overall Study|Worsening of Anemia|1|||
160619674|NCT01906489|579985060|FG001|Overall Study|Worsening of Anemia|0|||
160619675|NCT01906489|579985059|FG000|Overall Study|Protocol Violation|0|||
160619676|NCT01906489|579985060|FG001|Overall Study|Protocol Violation|1|||
160619677|NCT01906489|579985059|FG000|Overall Study|Non- Compliance|1|||
160619678|NCT01906489|579985060|FG001|Overall Study|Non- Compliance|0|||
160502355|NCT03199469|579567556|FG001|Overall Study|Withdrawal by Subject|0|||
160502356|NCT03199469|579567555|FG000|Overall Study|Death|1|||
160502357|NCT03199469|579567556|FG001|Overall Study|Death|3|||
160502358|NCT03199469|579567555|FG000|Overall Study|Ongoing|5|||
160502359|NCT03199469|579567556|FG001|Overall Study|Ongoing|14|||
160502360|NCT01304498|579567557|FG000|Overall Study|Adverse Event|1|||
160502361|NCT01304498|579567558|FG001|Overall Study|Adverse Event|1|||
160502362|NCT01304498|579567557|FG000|Overall Study|Withdrawal by Subject|2|||
160502363|NCT01304498|579567558|FG001|Overall Study|Withdrawal by Subject|3|||
160502364|NCT01304498|579567557|FG000|Overall Study|Protocol Violation|1|||
160502365|NCT01304498|579567558|FG001|Overall Study|Protocol Violation|0|||
160502366|NCT01304498|579567557|FG000|Overall Study|Lost to Follow-up|2|||
160502367|NCT01304498|579567558|FG001|Overall Study|Lost to Follow-up|1|||
160502368|NCT03004404|579567560|FG000|Period 2|Adverse Event|0|||
160502369|NCT03004404|579567561|FG001|Period 2|Adverse Event|0|||
160502370|NCT03004404|579567562|FG002|Period 2|Adverse Event|0|||
160502371|NCT03004404|579567563|FG003|Period 2|Adverse Event|0|||
160502372|NCT03004404|579567564|FG004|Period 2|Adverse Event|0|||
160502373|NCT03004404|579567565|FG005|Period 2|Adverse Event|0|||
160502374|NCT03004404|579567566|FG006|Period 2|Adverse Event|0|||
160502375|NCT03004404|579567567|FG007|Period 2|Adverse Event|0|||
160502376|NCT03004404|579567568|FG008|Period 2|Adverse Event|1|||
160502377|NCT03004404|579567569|FG009|Period 2|Adverse Event|0|||
160502378|NCT03004404|579567570|FG010|Period 2|Adverse Event|0|||
160502379|NCT03004404|579567571|FG011|Period 2|Adverse Event|0|||
160502380|NCT03004404|579567572|FG012|Period 2|Adverse Event|0|||
160502381|NCT03004404|579567573|FG013|Period 2|Adverse Event|0|||
160619679|NCT01906489|579985059|FG000|Overall Study|Sponsor Decision|1|||
160619680|NCT01906489|579985060|FG001|Overall Study|Sponsor Decision|0|||
160619681|NCT01906489|579985059|FG000|Overall Study|Lost to Follow-up|1|||
160619682|NCT01906489|579985060|FG001|Overall Study|Lost to Follow-up|1|||
160619683|NCT01906489|579985059|FG000|Overall Study|Other|1|||
160619684|NCT01906489|579985060|FG001|Overall Study|Other|0|||
160619685|NCT03458234|579985061|FG000|Overall Study|Withdrawal by Subject|1|||
160619686|NCT04524663|579986249|FG000|Overall Study|Withdrawal by Subject|0|||
160619687|NCT04524663|579986250|FG001|Overall Study|Withdrawal by Subject|2|||
160619688|NCT00911508|579986251|FG000|Overall Study|Lost to Follow-up|27|||
160619689|NCT00911508|579986252|FG001|Overall Study|Lost to Follow-up|18|||
160619690|NCT00911508|579986251|FG000|Overall Study|Withdrawal by Subject|79|||
160619691|NCT00911508|579986252|FG001|Overall Study|Withdrawal by Subject|112|||
160619692|NCT04308668|579986253|FG000|Overall Study|Lost to Follow-up|32|||
160619693|NCT04308668|579986254|FG001|Overall Study|Lost to Follow-up|38|||
160619694|NCT04308668|579986253|FG000|Overall Study|Withdrawal by Subject|4|||
160619695|NCT04308668|579986254|FG001|Overall Study|Withdrawal by Subject|4|||
160619696|NCT01266967|579986255|FG000|Overall Study|Death|69|||
160619697|NCT01266967|579986256|FG001|Overall Study|Death|61|||
160619698|NCT01266967|579986255|FG000|Overall Study|Study Closed/Terminated|15|||
160619699|NCT01266967|579986256|FG001|Overall Study|Study Closed/Terminated|17|||
160619700|NCT01266967|579986255|FG000|Overall Study|Lost to Follow-up|2|||
160619701|NCT01266967|579986256|FG001|Overall Study|Lost to Follow-up|1|||
160619702|NCT01266967|579986255|FG000|Overall Study|Physician Decision|0|||
160619703|NCT01266967|579986256|FG001|Overall Study|Physician Decision|1|||
160619704|NCT01266967|579986255|FG000|Overall Study|Withdrawal by Subject|3|||
160619705|NCT01266967|579986256|FG001|Overall Study|Withdrawal by Subject|3|||
160619706|NCT01519700|579986257|FG000|Overall Study|Death|1|||
160619707|NCT01519700|579986258|FG001|Overall Study|Death|0|||
160619708|NCT01519700|579986259|FG002|Overall Study|Death|0|||
160619709|NCT01519700|579986260|FG003|Overall Study|Death|0|||
160619710|NCT01519700|579986257|FG000|Overall Study|Lost to Follow-up|0|||
160619711|NCT01519700|579986258|FG001|Overall Study|Lost to Follow-up|0|||
160619712|NCT01519700|579986259|FG002|Overall Study|Lost to Follow-up|1|||
160619713|NCT01519700|579986260|FG003|Overall Study|Lost to Follow-up|1|||
160619714|NCT01519700|579986257|FG000|Overall Study|Physician Decision|1|||
160619715|NCT01519700|579986258|FG001|Overall Study|Physician Decision|1|||
160619716|NCT01519700|579986259|FG002|Overall Study|Physician Decision|3|||
160502382|NCT03004404|579567574|FG014|Period 2|Adverse Event|0|||
160502383|NCT03004404|579567575|FG015|Period 2|Adverse Event|1|||
160502384|NCT02990468|579567579|FG000|Phase 2: MTD|Change in treatment|0|||
160619717|NCT01519700|579986260|FG003|Overall Study|Physician Decision|0|||
160619718|NCT01519700|579986257|FG000|Overall Study|Withdrawal by Subject|5|||
160619719|NCT01519700|579986258|FG001|Overall Study|Withdrawal by Subject|3|||
160619720|NCT01519700|579986259|FG002|Overall Study|Withdrawal by Subject|3|||
160619721|NCT01519700|579986260|FG003|Overall Study|Withdrawal by Subject|2|||
160619722|NCT01519700|579986257|FG000|Overall Study|Other Reason|2|||
160619723|NCT01519700|579986258|FG001|Overall Study|Other Reason|2|||
160619724|NCT01519700|579986259|FG002|Overall Study|Other Reason|0|||
160502385|NCT02990468|579567580|FG001|Phase 2: MTD|Change in treatment|0|||
160502386|NCT02990468|579567581|FG002|Phase 2: MTD|Change in treatment|1|||
160502387|NCT01602510|579567584|FG000|Open Label Phase|Adverse Event|46|||
160502388|NCT01602510|579567585|FG001|Open Label Phase|Adverse Event|0|||
160502389|NCT01602510|579567586|FG002|Open Label Phase|Adverse Event|0|||
160502390|NCT01602510|579567584|FG000|Open Label Phase|Lack of Efficacy|22|||
160662702|NCT02883452|580149137|FG003|Overall Study|Withdrawal by Subject|0|||
160662703|NCT02883452|580149138|FG004|Overall Study|Withdrawal by Subject|2|||
160662704|NCT02883452|580149139|FG005|Overall Study|Withdrawal by Subject|5|||
160662705|NCT02883452|580149134|FG000|Overall Study|Disease progression|1|||
160662706|NCT02883452|580149135|FG001|Overall Study|Disease progression|0|||
160662707|NCT02883452|580149136|FG002|Overall Study|Disease progression|0|||
160662708|NCT02883452|580149137|FG003|Overall Study|Disease progression|1|||
160662709|NCT02883452|580149138|FG004|Overall Study|Disease progression|4|||
160662710|NCT02883452|580149139|FG005|Overall Study|Disease progression|5|||
160662711|NCT02883452|580149134|FG000|Overall Study|Adverse Event|2|||
160662712|NCT02883452|580149135|FG001|Overall Study|Adverse Event|1|||
160662713|NCT02883452|580149136|FG002|Overall Study|Adverse Event|1|||
160662714|NCT02883452|580149137|FG003|Overall Study|Adverse Event|1|||
160662715|NCT02883452|580149138|FG004|Overall Study|Adverse Event|1|||
160662716|NCT02883452|580149139|FG005|Overall Study|Adverse Event|3|||
160662717|NCT02883452|580149134|FG000|Overall Study|Physician Decision|0|||
160662718|NCT02883452|580149135|FG001|Overall Study|Physician Decision|0|||
160662719|NCT02883452|580149136|FG002|Overall Study|Physician Decision|0|||
160662720|NCT02883452|580149137|FG003|Overall Study|Physician Decision|0|||
160502391|NCT01602510|579567585|FG001|Open Label Phase|Lack of Efficacy|0|||
160502392|NCT01602510|579567586|FG002|Open Label Phase|Lack of Efficacy|0|||
160502393|NCT01602510|579567584|FG000|Open Label Phase|Protocol Violation|15|||
160502394|NCT01602510|579567585|FG001|Open Label Phase|Protocol Violation|0|||
160502395|NCT01602510|579567586|FG002|Open Label Phase|Protocol Violation|0|||
160502396|NCT01602510|579567584|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
160502397|NCT01602510|579567585|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
160502398|NCT01602510|579567586|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
160502399|NCT01602510|579567584|FG000|Open Label Phase|Lost to Follow-up|22|||
160502400|NCT01602510|579567585|FG001|Open Label Phase|Lost to Follow-up|0|||
160502401|NCT01602510|579567586|FG002|Open Label Phase|Lost to Follow-up|0|||
160502402|NCT01602510|579567584|FG000|Open Label Phase|Physician Decision|19|||
160502403|NCT01602510|579567585|FG001|Open Label Phase|Physician Decision|0|||
160502404|NCT01602510|579567586|FG002|Open Label Phase|Physician Decision|0|||
160502405|NCT01602510|579567584|FG000|Open Label Phase|Withdrawal by Subject|57|||
160502406|NCT01602510|579567585|FG001|Open Label Phase|Withdrawal by Subject|0|||
160662721|NCT02883452|580149138|FG004|Overall Study|Physician Decision|4|||
160662722|NCT02883452|580149139|FG005|Overall Study|Physician Decision|1|||
160662723|NCT02883452|580149134|FG000|Overall Study|Death|1|||
160662724|NCT02883452|580149135|FG001|Overall Study|Death|0|||
160662725|NCT02883452|580149136|FG002|Overall Study|Death|1|||
160662726|NCT02883452|580149137|FG003|Overall Study|Death|0|||
160502407|NCT01602510|579567586|FG002|Open Label Phase|Withdrawal by Subject|0|||
160502408|NCT01602510|579567584|FG000|Randomized Phase|Adverse Event|0|||
160502409|NCT01602510|579567585|FG001|Randomized Phase|Adverse Event|2|||
160502410|NCT01602510|579567586|FG002|Randomized Phase|Adverse Event|6|||
160502411|NCT01602510|579567584|FG000|Randomized Phase|Lack of Efficacy|0|||
160502412|NCT01602510|579567585|FG001|Randomized Phase|Lack of Efficacy|4|||
160502413|NCT01602510|579567586|FG002|Randomized Phase|Lack of Efficacy|4|||
160502414|NCT01602510|579567584|FG000|Randomized Phase|Protocol Violation|0|||
160502415|NCT01602510|579567585|FG001|Randomized Phase|Protocol Violation|3|||
160502416|NCT01602510|579567586|FG002|Randomized Phase|Protocol Violation|3|||
160502417|NCT01602510|579567584|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
160502418|NCT01602510|579567585|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
160502419|NCT01602510|579567586|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
160662727|NCT02883452|580149138|FG004|Overall Study|Death|0|||
160662728|NCT02883452|580149139|FG005|Overall Study|Death|0|||
160662729|NCT02883452|580149134|FG000|Overall Study|Other|0|||
160662730|NCT02883452|580149135|FG001|Overall Study|Other|0|||
160662731|NCT02883452|580149136|FG002|Overall Study|Other|0|||
160662732|NCT02883452|580149137|FG003|Overall Study|Other|0|||
160662733|NCT02883452|580149138|FG004|Overall Study|Other|0|||
160502420|NCT01602510|579567584|FG000|Randomized Phase|Lost to Follow-up|0|||
160502421|NCT01602510|579567585|FG001|Randomized Phase|Lost to Follow-up|1|||
160502422|NCT01602510|579567586|FG002|Randomized Phase|Lost to Follow-up|3|||
160502423|NCT01602510|579567584|FG000|Randomized Phase|Physician Decision|0|||
160662734|NCT02883452|580149139|FG005|Overall Study|Other|1|||
160662735|NCT00905346|580149140|FG000|Period 1|Withdrawal by Subject|1|||
160662736|NCT00905346|580149141|FG001|Period 1|Withdrawal by Subject|0|||
160662737|NCT03351335|580149142|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
160662738|NCT03351335|580149143|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
160662739|NCT03351335|580149144|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
160662740|NCT04089735|580149145|FG000|Overall Study|Adverse Event|1|||
160662741|NCT04089735|580149146|FG001|Overall Study|Adverse Event|0|||
160662742|NCT04089735|580149147|FG002|Overall Study|Adverse Event|1|||
160502424|NCT01602510|579567585|FG001|Randomized Phase|Physician Decision|0|||
160502425|NCT01602510|579567586|FG002|Randomized Phase|Physician Decision|2|||
160662743|NCT04089735|580149148|FG003|Overall Study|Adverse Event|1|||
160662744|NCT04089735|580149149|FG004|Overall Study|Adverse Event|0|||
160662745|NCT04089735|580149150|FG005|Overall Study|Adverse Event|0|||
160662746|NCT04089735|580149145|FG000|Overall Study|Physician Decision|0|||
160662747|NCT04089735|580149146|FG001|Overall Study|Physician Decision|3|||
160662748|NCT04089735|580149147|FG002|Overall Study|Physician Decision|0|||
160662749|NCT04089735|580149148|FG003|Overall Study|Physician Decision|0|||
160662750|NCT04089735|580149149|FG004|Overall Study|Physician Decision|0|||
160662751|NCT04089735|580149150|FG005|Overall Study|Physician Decision|0|||
160662752|NCT04089735|580149145|FG000|Overall Study|Withdrawal by Subject|0|||
160662753|NCT04089735|580149146|FG001|Overall Study|Withdrawal by Subject|0|||
160662754|NCT04089735|580149147|FG002|Overall Study|Withdrawal by Subject|1|||
160662755|NCT04089735|580149148|FG003|Overall Study|Withdrawal by Subject|0|||
160662756|NCT04089735|580149149|FG004|Overall Study|Withdrawal by Subject|0|||
160662757|NCT04089735|580149150|FG005|Overall Study|Withdrawal by Subject|0|||
160662758|NCT04089735|580149145|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
160502426|NCT01602510|579567584|FG000|Randomized Phase|Withdrawal by Subject|0|||
160502427|NCT01602510|579567585|FG001|Randomized Phase|Withdrawal by Subject|6|||
160502428|NCT01602510|579567586|FG002|Randomized Phase|Withdrawal by Subject|7|||
160502429|NCT01261000|579567587|FG000|Overall Study|Screen failure|1|||
160502430|NCT01721954|579567588|FG000|Overall Study|Death|58|||
160502431|NCT01721954|579567589|FG001|Overall Study|Death|64|||
160502432|NCT01721954|579567588|FG000|Overall Study|Withdrawal by Subject|8|||
160502433|NCT01721954|579567589|FG001|Overall Study|Withdrawal by Subject|4|||
160502434|NCT01721954|579567588|FG000|Overall Study|Adverse Event|2|||
160502435|NCT01721954|579567589|FG001|Overall Study|Adverse Event|0|||
160502436|NCT01721954|579567588|FG000|Overall Study|Lost to Follow-up|2|||
160662759|NCT04089735|580149146|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
160662760|NCT04089735|580149147|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
160662761|NCT04089735|580149148|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
160662762|NCT04089735|580149149|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
160662763|NCT04089735|580149150|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
160662764|NCT02956460|580149152|FG000|Lens 1|Lost to Follow-up|1|||
160662765|NCT02956460|580149153|FG001|Lens 1|Lost to Follow-up|0|||
160662766|NCT00829673|580149154|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
160662767|NCT00829673|580149155|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
160662768|NCT00272779|580149156|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
160502437|NCT01721954|579567589|FG001|Overall Study|Lost to Follow-up|1|||
160502438|NCT01195623|579567590|FG000|Overall Study|Lost to Follow-up|35|||
160502439|NCT01195623|579567591|FG001|Overall Study|Lost to Follow-up|37|||
160502440|NCT00534495|579567593|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
160502441|NCT00534495|579567594|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
160502442|NCT00534495|579567595|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
160502443|NCT00534495|579567593|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
160502444|NCT00534495|579567594|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
160502445|NCT00534495|579567595|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
160502446|NCT00534495|579567593|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
160502447|NCT00534495|579567594|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
160502448|NCT00534495|579567595|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
160502449|NCT00534495|579567593|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
160502450|NCT00534495|579567594|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
160502451|NCT00534495|579567595|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
160502452|NCT00534495|579567593|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
160502453|NCT00534495|579567594|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
160502454|NCT00534495|579567595|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
160502455|NCT00534495|579567593|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
160502456|NCT00534495|579567594|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
160502457|NCT00534495|579567595|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
160502458|NCT00534495|579567593|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
160502459|NCT00534495|579567594|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
160502460|NCT00534495|579567595|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
160502461|NCT00534495|579567593|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
160502462|NCT00534495|579567594|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
160502463|NCT00534495|579567595|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
160502464|NCT00534495|579567593|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
160502465|NCT00534495|579567594|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
160502466|NCT00534495|579567595|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
160662769|NCT00272779|580149157|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
160662770|NCT00272779|580149156|FG000|Baseline Through Week 48|Death before Week 48|4|||
160502467|NCT02920970|579567598|FG000|First Intervention|Protocol Violation|0|||
160502468|NCT02920970|579567599|FG001|First Intervention|Protocol Violation|1|||
160502469|NCT02920970|579567598|FG000|First Intervention|Adverse Event|0|||
160502470|NCT02920970|579567599|FG001|First Intervention|Adverse Event|1|||
160502471|NCT02920970|579567598|FG000|Second Intervention|Poor Lens Fit|1|||
160502472|NCT02920970|579567599|FG001|Second Intervention|Poor Lens Fit|0|||
160502473|NCT01711853|579567600|FG000|Overall Study|Not treated|3|||
160502474|NCT02670122|579567603|FG000|Overall Study|Lost to Follow-up|4|||
160502475|NCT04535544|579567607|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
160502476|NCT04535544|579567608|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
160502477|NCT04535544|579567609|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
160502478|NCT04535544|579567610|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
160502479|NCT04535544|579567607|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
160502480|NCT04535544|579567608|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
160502481|NCT04535544|579567609|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
160502482|NCT04535544|579567610|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
160502483|NCT04535544|579567607|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
160502484|NCT04535544|579567608|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
160502485|NCT04535544|579567609|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
160502486|NCT04535544|579567610|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
160502487|NCT04535544|579567607|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
160502488|NCT04535544|579567608|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
160502489|NCT04535544|579567609|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
160502490|NCT04535544|579567610|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
160502491|NCT04535544|579567607|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
160502492|NCT04535544|579567608|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
160619725|NCT01519700|579986260|FG003|Overall Study|Other Reason|4|||
160619726|NCT05111548|579986261|FG000|Overall Study|Withdrawal by Subject|2|||
160619727|NCT05111548|579986262|FG001|Overall Study|Withdrawal by Subject|1|||
160619728|NCT05111548|579986261|FG000|Overall Study|Adverse Event|1|||
160619729|NCT05111548|579986262|FG001|Overall Study|Adverse Event|0|||
160619730|NCT02577107|579986269|FG000|Overall Study|Protocol deviation|0|||
160619731|NCT02577107|579986270|FG001|Overall Study|Protocol deviation|1|||
160619732|NCT00577382|579986271|FG000|Overall Study|Adverse Event|0|||
160619733|NCT00577382|579986272|FG001|Overall Study|Adverse Event|6|||
160619734|NCT00577382|579986271|FG000|Overall Study|Withdrawal by Subject|0|||
160619735|NCT00577382|579986272|FG001|Overall Study|Withdrawal by Subject|1|||
160619736|NCT00577382|579986271|FG000|Overall Study|Progressive Disease|17|||
160619737|NCT00577382|579986272|FG001|Overall Study|Progressive Disease|19|||
160619738|NCT00577382|579986271|FG000|Overall Study|Intercurrent Illness|1|||
160619739|NCT00577382|579986272|FG001|Overall Study|Intercurrent Illness|2|||
160619740|NCT00577382|579986271|FG000|Overall Study|Death|1|||
160619741|NCT00577382|579986272|FG001|Overall Study|Death|1|||
160619742|NCT00577382|579986271|FG000|Overall Study|Lost to Follow-up|2|||
160619743|NCT00577382|579986272|FG001|Overall Study|Lost to Follow-up|2|||
160619744|NCT00104299|579986274|FG000|Overall Study|Adverse Event|3|||
160619745|NCT00104299|579986275|FG001|Overall Study|Adverse Event|1|||
160619746|NCT00104299|579986274|FG000|Overall Study|Death|2|||
160619747|NCT00104299|579986275|FG001|Overall Study|Death|2|||
160619748|NCT00104299|579986274|FG000|Overall Study|Withdrawal by Subject|2|||
160619749|NCT00104299|579986275|FG001|Overall Study|Withdrawal by Subject|6|||
160619750|NCT00104299|579986274|FG000|Overall Study|Physician Decision|1|||
160619751|NCT00104299|579986275|FG001|Overall Study|Physician Decision|1|||
160619752|NCT00104299|579986274|FG000|Overall Study|To have renal transplant|1|||
160619753|NCT00104299|579986275|FG001|Overall Study|To have renal transplant|0|||
160619754|NCT03802331|579986276|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
160619755|NCT03802331|579986277|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
160619756|NCT00368069|579986278|FG000|Overall Study|Adverse Event|5|||
160619757|NCT00368069|579986279|FG001|Overall Study|Adverse Event|2|||
160619758|NCT00368069|579986278|FG000|Overall Study|Lack of Efficacy|0|||
160619759|NCT00368069|579986279|FG001|Overall Study|Lack of Efficacy|1|||
160619760|NCT00368069|579986278|FG000|Overall Study|Lost to Follow-up|1|||
160619761|NCT00368069|579986279|FG001|Overall Study|Lost to Follow-up|0|||
160619762|NCT00368069|579986278|FG000|Overall Study|Protocol Violation|0|||
160619763|NCT00368069|579986279|FG001|Overall Study|Protocol Violation|2|||
160619764|NCT00368069|579986278|FG000|Overall Study|Withdrawal of Consent|2|||
160619765|NCT00368069|579986279|FG001|Overall Study|Withdrawal of Consent|1|||
160619766|NCT00368069|579986278|FG000|Overall Study|no blood sampling possible|0|||
160619767|NCT00368069|579986279|FG001|Overall Study|no blood sampling possible|1|||
160619768|NCT03432819|579986283|FG000|Overall Study|Lost to Follow-up|2|||
160619769|NCT03432819|579986284|FG001|Overall Study|Lost to Follow-up|2|||
160619770|NCT03432819|579986283|FG000|Overall Study|Withdrawal by Subject|5|||
160619771|NCT03432819|579986284|FG001|Overall Study|Withdrawal by Subject|3|||
160619772|NCT01474993|579986285|FG000|Overall Study|Lost to Follow-up|1|||
160619773|NCT01474993|579986286|FG001|Overall Study|Lost to Follow-up|2|||
160619774|NCT01474993|579986285|FG000|Overall Study|Adverse Event|0|||
160619775|NCT01474993|579986286|FG001|Overall Study|Adverse Event|1|||
160619776|NCT03451630|579986287|FG000|Overall Study|Death|15|||
160619777|NCT03451630|579986288|FG001|Overall Study|Death|16|||
160619778|NCT03451630|579986289|FG002|Overall Study|Death|11|||
160619779|NCT03451630|579986287|FG000|Overall Study|Lost to Follow-up|9|||
160619780|NCT03451630|579986288|FG001|Overall Study|Lost to Follow-up|0|||
160619781|NCT03451630|579986289|FG002|Overall Study|Lost to Follow-up|4|||
160619782|NCT03451630|579986287|FG000|Overall Study|Withdrawal by Subject|0|||
160619783|NCT03451630|579986288|FG001|Overall Study|Withdrawal by Subject|3|||
160619784|NCT03451630|579986289|FG002|Overall Study|Withdrawal by Subject|0|||
160619785|NCT03451630|579986287|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
160619786|NCT03451630|579986288|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
160619787|NCT03451630|579986289|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
160619788|NCT02500706|579986293|FG000|Overall Study|Adverse Event|0|||
160619789|NCT02500706|579986294|FG001|Overall Study|Adverse Event|0|||
160619790|NCT02500706|579986295|FG002|Overall Study|Adverse Event|1|||
160619791|NCT02500706|579986293|FG000|Overall Study|Lost to Follow-up|0|||
160619792|NCT02500706|579986294|FG001|Overall Study|Lost to Follow-up|1|||
160619793|NCT02500706|579986295|FG002|Overall Study|Lost to Follow-up|1|||
160619794|NCT02500706|579986293|FG000|Overall Study|Withdrawal by Subject|4|||
160619795|NCT02500706|579986294|FG001|Overall Study|Withdrawal by Subject|6|||
160619796|NCT02500706|579986295|FG002|Overall Study|Withdrawal by Subject|4|||
160619797|NCT02500706|579986293|FG000|Overall Study|Unclassified|0|||
160619798|NCT02500706|579986294|FG001|Overall Study|Unclassified|0|||
160619799|NCT02500706|579986295|FG002|Overall Study|Unclassified|1|||
160619800|NCT00529152|579986296|FG000|Overall Study|Adverse Event|2|||
160619801|NCT00529152|579986296|FG000|Overall Study|Withdrawal by Subject|2|||
160502493|NCT04535544|579567609|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
160502494|NCT04535544|579567610|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
160502495|NCT04535544|579567607|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
160502496|NCT04535544|579567608|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
160502497|NCT04535544|579567609|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
160502498|NCT04535544|579567610|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
160502499|NCT04535544|579567607|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
160619802|NCT00529152|579986296|FG000|Overall Study|Lost to Follow-up|1|||
160619803|NCT04062240|579986302|FG000|Overall Study|equipment malfunction|1|||
160619804|NCT01957111|579986303|FG000|Overall Study|Withdrawal by Subject|1|||
160619805|NCT01957111|579986304|FG001|Overall Study|Withdrawal by Subject|1|||
160619806|NCT03961529|579986305|FG000|Overall Study|Adverse Event|13|||
160619807|NCT03961529|579986306|FG001|Overall Study|Adverse Event|5|||
160619808|NCT03961529|579986307|FG002|Overall Study|Adverse Event|2|||
160619809|NCT03961529|579986305|FG000|Overall Study|Withdrawal by Subject|17|||
160619810|NCT03961529|579986306|FG001|Overall Study|Withdrawal by Subject|2|||
160619811|NCT03961529|579986307|FG002|Overall Study|Withdrawal by Subject|1|||
160619812|NCT03961529|579986305|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160619813|NCT03961529|579986306|FG001|Overall Study|Withdrawal by parent/guardian|7|||
160619814|NCT03961529|579986307|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160662771|NCT00272779|580149157|FG001|Baseline Through Week 48|Death before Week 48|4|||
160619815|NCT03961529|579986305|FG000|Overall Study|Physician Decision|2|||
160619816|NCT03961529|579986306|FG001|Overall Study|Physician Decision|1|||
160619817|NCT03961529|579986307|FG002|Overall Study|Physician Decision|1|||
160662772|NCT00272779|580149156|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
160662773|NCT00272779|580149157|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
160619818|NCT03961529|579986305|FG000|Overall Study|Lost to Follow-up|2|||
160502500|NCT04535544|579567608|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
160502501|NCT04535544|579567609|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
160502502|NCT04535544|579567610|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
160502503|NCT04535544|579567607|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
160502504|NCT04535544|579567608|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
160502505|NCT04535544|579567609|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
160502506|NCT04535544|579567610|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
160502507|NCT01228318|579570051|FG000|Overall Study|Clinic no show to receive intervention|1|||
160502508|NCT01228318|579570052|FG001|Overall Study|Clinic no show to receive intervention|0|||
160502509|NCT01228318|579570051|FG000|Overall Study|Unable to contact|2|||
160502510|NCT01228318|579570052|FG001|Overall Study|Unable to contact|5|||
160502511|NCT01228318|579570051|FG000|Overall Study|Moved|0|||
160502512|NCT01228318|579570052|FG001|Overall Study|Moved|2|||
160502513|NCT01228318|579570051|FG000|Overall Study|Incarcerated|1|||
160502514|NCT01228318|579570052|FG001|Overall Study|Incarcerated|0|||
160502515|NCT00770029|579570053|FG000|Overall Study|Lost to Follow-up|2|||
160502516|NCT00770029|579570054|FG001|Overall Study|Lost to Follow-up|0|||
160502517|NCT00770029|579570053|FG000|Overall Study|Withdrawal by Subject|3|||
160502518|NCT00770029|579570054|FG001|Overall Study|Withdrawal by Subject|3|||
160502519|NCT00770029|579570053|FG000|Overall Study|Adverse Event|1|||
160502520|NCT00770029|579570054|FG001|Overall Study|Adverse Event|0|||
160502521|NCT03140280|579570055|FG000|Overall Study|Physician Decision|5|||
160502522|NCT05620108|579570056|FG000|Overall Study|Physician Decision|1|||
160502523|NCT05620108|579570057|FG001|Overall Study|Physician Decision|2|||
160502524|NCT00626197|579570063|FG000|Overall Study|Did not cooperate|2|||
160502525|NCT00626197|579570064|FG001|Overall Study|Did not cooperate|6|||
160502526|NCT00626197|579570065|FG002|Overall Study|Did not cooperate|1|||
160502527|NCT00626197|579570063|FG000|Overall Study|Failure to return|6|||
160502528|NCT00626197|579570064|FG001|Overall Study|Failure to return|5|||
160502529|NCT00626197|579570065|FG002|Overall Study|Failure to return|6|||
160502530|NCT00626197|579570063|FG000|Overall Study|Adverse event, serious fatal|3|||
160502531|NCT00626197|579570064|FG001|Overall Study|Adverse event, serious fatal|6|||
160502532|NCT00626197|579570065|FG002|Overall Study|Adverse event, serious fatal|6|||
160502533|NCT00626197|579570063|FG000|Overall Study|Adverse Event|1|||
160502534|NCT00626197|579570064|FG001|Overall Study|Adverse Event|1|||
160502535|NCT00626197|579570065|FG002|Overall Study|Adverse Event|2|||
160502536|NCT00626197|579570063|FG000|Overall Study|Withdrawal by Subject|17|||
160502537|NCT00626197|579570064|FG001|Overall Study|Withdrawal by Subject|17|||
160502538|NCT00626197|579570065|FG002|Overall Study|Withdrawal by Subject|7|||
160502539|NCT00626197|579570063|FG000|Overall Study|Administrative reasons|15|||
160502540|NCT00626197|579570064|FG001|Overall Study|Administrative reasons|19|||
160502541|NCT00626197|579570065|FG002|Overall Study|Administrative reasons|55|||
160502542|NCT05282121|579570070|FG000|Overall Study|Adverse Event|1|||
160502543|NCT05282121|579570071|FG001|Overall Study|Adverse Event|1|||
160502544|NCT05282121|579570072|FG002|Overall Study|Adverse Event|4|||
160502545|NCT05282121|579570073|FG003|Overall Study|Adverse Event|1|||
160502546|NCT05282121|579570070|FG000|Overall Study|Study Terminated by Sponsor|1|||
160502547|NCT05282121|579570071|FG001|Overall Study|Study Terminated by Sponsor|2|||
160502548|NCT05282121|579570072|FG002|Overall Study|Study Terminated by Sponsor|2|||
160502549|NCT05282121|579570073|FG003|Overall Study|Study Terminated by Sponsor|2|||
160502550|NCT05282121|579570070|FG000|Overall Study|Other than listed|0|||
160502551|NCT05282121|579570071|FG001|Overall Study|Other than listed|0|||
160502552|NCT05282121|579570072|FG002|Overall Study|Other than listed|1|||
160502553|NCT05282121|579570073|FG003|Overall Study|Other than listed|0|||
160502554|NCT05282121|579570070|FG000|Overall Study|No reason available|0|||
160502555|NCT05282121|579570071|FG001|Overall Study|No reason available|0|||
160502556|NCT05282121|579570072|FG002|Overall Study|No reason available|1|||
160502557|NCT05282121|579570073|FG003|Overall Study|No reason available|0|||
160502558|NCT03301155|579570076|FG000|Overall Study|Сompliance with exclusion criteria|8|||
160502559|NCT03301155|579570077|FG001|Overall Study|Сompliance with exclusion criteria|7|||
160502560|NCT03510455|579570078|FG000|Overall Study|Physician Decision|1|||
160502561|NCT00384189|579570079|FG000|Overall Study|Reason Not Specified|50|||
160502562|NCT00384189|579570080|FG001|Overall Study|Reason Not Specified|57|||
160502563|NCT00384189|579570081|FG002|Overall Study|Reason Not Specified|58|||
160502564|NCT00384189|579570082|FG003|Overall Study|Reason Not Specified|40|||
160502565|NCT04958642|579570083|FG000|Overall Study|Transferred to OLEX program|3|||
160502566|NCT04958642|579570084|FG001|Overall Study|Transferred to OLEX program|0|||
160502567|NCT04958642|579570085|FG002|Overall Study|Transferred to OLEX program|5|||
160502568|NCT04958642|579570083|FG000|Overall Study|Death|0|||
160502569|NCT04958642|579570084|FG001|Overall Study|Death|0|||
160502570|NCT04958642|579570085|FG002|Overall Study|Death|1|||
160502571|NCT04958642|579570083|FG000|Overall Study|Withdrawal by Subject|4|||
160502572|NCT04958642|579570084|FG001|Overall Study|Withdrawal by Subject|9|||
160502573|NCT04958642|579570085|FG002|Overall Study|Withdrawal by Subject|13|||
160502574|NCT04958642|579570083|FG000|Overall Study|Investigator's Decision|0|||
160502575|NCT04958642|579570084|FG001|Overall Study|Investigator's Decision|0|||
160502576|NCT04958642|579570085|FG002|Overall Study|Investigator's Decision|1|||
160502577|NCT04958642|579570083|FG000|Overall Study|Adverse Event|1|||
160662774|NCT00272779|580149156|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
160662775|NCT00272779|580149157|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
160662776|NCT00272779|580149156|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
160662777|NCT00272779|580149157|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
160662778|NCT00272779|580149156|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
160662779|NCT00272779|580149157|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
160662780|NCT00272779|580149156|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
160662781|NCT00272779|580149157|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
160662782|NCT00272779|580149156|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
160662783|NCT00272779|580149157|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
160662784|NCT00272779|580149156|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
160662785|NCT00272779|580149157|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
160662786|NCT00272779|580149156|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
160662787|NCT00272779|580149157|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
160662788|NCT00272779|580149156|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
160662789|NCT00272779|580149157|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
160662790|NCT00272779|580149156|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
160662791|NCT00272779|580149157|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
160662792|NCT00272779|580149156|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
160662793|NCT00272779|580149157|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
160662794|NCT00272779|580149156|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
160662795|NCT00272779|580149157|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
160662796|NCT00272779|580149156|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
160662797|NCT00272779|580149157|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
160662798|NCT00272779|580149156|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
160662799|NCT00272779|580149157|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
160662800|NCT00272779|580149156|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
160662801|NCT00272779|580149157|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
160662802|NCT00272779|580149156|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
160662803|NCT00272779|580149157|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
160662804|NCT00272779|580149156|FG000|Baseline Through Week 48|Continuing treatment|385|||
160662805|NCT00272779|580149157|FG001|Baseline Through Week 48|Continuing treatment|368|||
160662806|NCT00272779|580149156|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
160662807|NCT00272779|580149157|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
160662808|NCT00272779|580149156|FG000|Baseline Through Week 48|Never treated|2|||
160662809|NCT00272779|580149157|FG001|Baseline Through Week 48|Never treated|3|||
160662810|NCT00272779|580149156|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
160662811|NCT00272779|580149157|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
160662812|NCT00272779|580149156|FG000|Baseline Through Week 96|Death before Week 96|6|||
160662813|NCT00272779|580149157|FG001|Baseline Through Week 96|Death before Week 96|5|||
160662814|NCT00272779|580149156|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
160662815|NCT00272779|580149157|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
160662816|NCT00272779|580149156|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
160662817|NCT00272779|580149157|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
160662818|NCT00272779|580149156|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
160662819|NCT00272779|580149157|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
160662820|NCT00272779|580149156|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
160662821|NCT00272779|580149157|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
160662822|NCT00272779|580149156|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
160662823|NCT00272779|580149157|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
160662824|NCT00272779|580149156|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
160662825|NCT00272779|580149157|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
160662826|NCT00272779|580149156|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
160662827|NCT00272779|580149157|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
160662828|NCT00272779|580149156|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
160662829|NCT00272779|580149157|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
160662830|NCT00272779|580149156|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
160662831|NCT00272779|580149157|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
160662832|NCT00272779|580149156|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
160662833|NCT00272779|580149157|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
160662834|NCT00272779|580149156|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
160502578|NCT04958642|579570084|FG001|Overall Study|Adverse Event|0|||
160502579|NCT04958642|579570085|FG002|Overall Study|Adverse Event|1|||
160662835|NCT00272779|580149157|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
160662836|NCT00272779|580149156|FG000|Baseline Through Week 96|Never treated|2|||
160619819|NCT03961529|579986306|FG001|Overall Study|Lost to Follow-up|1|||
160619820|NCT03961529|579986307|FG002|Overall Study|Lost to Follow-up|0|||
160619821|NCT03961529|579986305|FG000|Overall Study|Lack of Efficacy|2|||
160619822|NCT03961529|579986306|FG001|Overall Study|Lack of Efficacy|0|||
160619823|NCT03961529|579986307|FG002|Overall Study|Lack of Efficacy|1|||
160619824|NCT03961529|579986305|FG000|Overall Study|Other|6|||
160619825|NCT03961529|579986306|FG001|Overall Study|Other|1|||
160619826|NCT03961529|579986307|FG002|Overall Study|Other|0|||
160619827|NCT03644173|579986308|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
160619828|NCT03644173|579986308|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
160619829|NCT03644173|579986308|FG000|Participants at the 1-month Follow up|Death|2|||
160619830|NCT03644173|579986308|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
160619831|NCT03500419|579986309|FG000|Overall Study|Withdrawal by Subject|2|||
160619832|NCT03500419|579986310|FG001|Overall Study|Withdrawal by Subject|25|||
160619833|NCT01497899|579986311|FG000|Double-Blind Phase|Randomized but not Treated|1|||
160619834|NCT01497899|579986312|FG001|Double-Blind Phase|Randomized but not Treated|0|||
160619835|NCT01497899|579986313|FG002|Double-Blind Phase|Randomized but not Treated|0|||
160619836|NCT01497899|579986314|FG003|Double-Blind Phase|Randomized but not Treated|0|||
160619837|NCT01497899|579986311|FG000|Double-Blind Phase|Adverse Event|1|||
160619838|NCT01497899|579986312|FG001|Double-Blind Phase|Adverse Event|0|||
160619839|NCT01497899|579986313|FG002|Double-Blind Phase|Adverse Event|0|||
160619840|NCT01497899|579986314|FG003|Double-Blind Phase|Adverse Event|0|||
160619841|NCT01497899|579986311|FG000|Double-Blind Phase|Lack of Efficacy|0|||
160619842|NCT01497899|579986312|FG001|Double-Blind Phase|Lack of Efficacy|1|||
160619843|NCT01497899|579986313|FG002|Double-Blind Phase|Lack of Efficacy|0|||
160619844|NCT01497899|579986314|FG003|Double-Blind Phase|Lack of Efficacy|0|||
160619845|NCT01497899|579986311|FG000|Double-Blind Phase|Investigator's Discretion|1|||
160619846|NCT01497899|579986312|FG001|Double-Blind Phase|Investigator's Discretion|0|||
160619847|NCT01497899|579986313|FG002|Double-Blind Phase|Investigator's Discretion|0|||
160619848|NCT01497899|579986314|FG003|Double-Blind Phase|Investigator's Discretion|0|||
160619849|NCT01497899|579986311|FG000|Double-Blind Phase|Withdrew Consent|0|||
160619850|NCT01497899|579986312|FG001|Double-Blind Phase|Withdrew Consent|1|||
160619851|NCT01497899|579986313|FG002|Double-Blind Phase|Withdrew Consent|0|||
160619852|NCT01497899|579986314|FG003|Double-Blind Phase|Withdrew Consent|0|||
160619853|NCT01497899|579986311|FG000|Double-Blind Phase|Lost to Follow-up|3|||
160619854|NCT01497899|579986312|FG001|Double-Blind Phase|Lost to Follow-up|2|||
160619855|NCT01497899|579986313|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160619856|NCT01497899|579986314|FG003|Double-Blind Phase|Lost to Follow-up|0|||
160619857|NCT01497899|579986311|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
160619858|NCT01497899|579986312|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
160619859|NCT01497899|579986313|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
160619860|NCT01497899|579986314|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
160619861|NCT01497899|579986311|FG000|Open-Label Extension Phase|Adverse Event|1|||
160619862|NCT01497899|579986312|FG001|Open-Label Extension Phase|Adverse Event|0|||
160619863|NCT01497899|579986313|FG002|Open-Label Extension Phase|Adverse Event|0|||
160619864|NCT01497899|579986314|FG003|Open-Label Extension Phase|Adverse Event|0|||
160619865|NCT01497899|579986311|FG000|Open-Label Extension Phase|Death|1|||
160619866|NCT01497899|579986312|FG001|Open-Label Extension Phase|Death|0|||
160619867|NCT01497899|579986313|FG002|Open-Label Extension Phase|Death|0|||
160619868|NCT01497899|579986314|FG003|Open-Label Extension Phase|Death|0|||
160619869|NCT01497899|579986311|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
160619870|NCT01497899|579986312|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
160619871|NCT01497899|579986313|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
160619872|NCT01497899|579986314|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
160619873|NCT01497899|579986311|FG000|Open-Label Extension Phase|Pregnancy|0|||
160619874|NCT01497899|579986312|FG001|Open-Label Extension Phase|Pregnancy|1|||
160619875|NCT01497899|579986313|FG002|Open-Label Extension Phase|Pregnancy|1|||
160619876|NCT01497899|579986314|FG003|Open-Label Extension Phase|Pregnancy|0|||
160619877|NCT01497899|579986311|FG000|Open-Label Extension Phase|Protocol Violation|0|||
160619878|NCT01497899|579986312|FG001|Open-Label Extension Phase|Protocol Violation|0|||
160619879|NCT01497899|579986313|FG002|Open-Label Extension Phase|Protocol Violation|1|||
160619880|NCT01497899|579986314|FG003|Open-Label Extension Phase|Protocol Violation|0|||
160619881|NCT01497899|579986311|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
160619882|NCT01497899|579986312|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
160619883|NCT01497899|579986313|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
160619884|NCT01497899|579986314|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
160619885|NCT03323385|579986317|FG000|Overall Study|Withdrawal by Subject|1|||
160619886|NCT03323385|579986318|FG001|Overall Study|Withdrawal by Subject|2|||
160619887|NCT03323385|579986317|FG000|Overall Study|Noncompliance|0|||
160619888|NCT03323385|579986318|FG001|Overall Study|Noncompliance|1|||
160619889|NCT01000311|579986323|FG000|Overall Study|Adverse Event|2|||
160619890|NCT01000311|579986324|FG001|Overall Study|Adverse Event|5|||
160619891|NCT01000311|579986323|FG000|Overall Study|Withdrawal by Subject|16|||
160619892|NCT01000311|579986324|FG001|Overall Study|Withdrawal by Subject|24|||
160619893|NCT01000311|579986323|FG000|Overall Study|Lost to Follow-up|15|||
160662837|NCT00272779|580149157|FG001|Baseline Through Week 96|Never treated|3|||
160662838|NCT00272779|580149156|FG000|Baseline Through Week 96|Continuing on treatment|61|||
160662839|NCT00272779|580149157|FG001|Baseline Through Week 96|Continuing on treatment|38|||
160662840|NCT02440711|580149158|FG000|Second Intervention|Lost to Follow-up|1|||
160662841|NCT02440711|580149159|FG001|Second Intervention|Lost to Follow-up|0|||
160662842|NCT04129346|580149160|FG000|Overall Study|Death|1|||
160662843|NCT04129346|580149161|FG001|Overall Study|Death|0|||
160662844|NCT00573066|580149162|FG000|Overall Study|Exclusion criteria|18|||
160662845|NCT00573066|580149162|FG000|Overall Study|IV malfunction|1|||
160662846|NCT00573066|580149162|FG000|Overall Study|Postoperative bleeding|1|||
160662847|NCT05755282|580149163|FG000|Overall Study|Protocol Violation|0|||
160662848|NCT05755282|580149164|FG001|Overall Study|Protocol Violation|1|||
160662849|NCT00829790|580149168|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
160662850|NCT00829790|580149169|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
160662851|NCT04247282|580149172|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
160662852|NCT04247282|580149173|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
160662853|NCT04247282|580149174|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
160662854|NCT04247282|580149175|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
160662855|NCT04247282|580149172|FG000|Overall Study|Refused further treatment|0|||
160662856|NCT04247282|580149173|FG001|Overall Study|Refused further treatment|1|||
160662857|NCT04247282|580149174|FG002|Overall Study|Refused further treatment|0|||
160662858|NCT04247282|580149175|FG003|Overall Study|Refused further treatment|0|||
160662859|NCT02098876|580149177|FG000|Overall Study|Withdrawal by Subject|5|||
160662860|NCT02098876|580149178|FG001|Overall Study|Withdrawal by Subject|5|||
160662861|NCT03195491|580149179|FG000|Overall Study|Study drug toxicity|25|||
160662862|NCT03195491|580149180|FG001|Overall Study|Study drug toxicity|3|||
160662863|NCT03195491|580149179|FG000|Overall Study|Maximum clinical benefit|5|||
160662864|NCT03195491|580149180|FG001|Overall Study|Maximum clinical benefit|0|||
160662865|NCT03195491|580149179|FG000|Overall Study|Lost to Follow-up|1|||
160662866|NCT03195491|580149180|FG001|Overall Study|Lost to Follow-up|0|||
160662867|NCT03195491|580149179|FG000|Overall Study|Death|3|||
160662868|NCT03195491|580149180|FG001|Overall Study|Death|0|||
160662869|NCT03195491|580149179|FG000|Overall Study|Adverse event unrelated to study drug|19|||
160662870|NCT03195491|580149180|FG001|Overall Study|Adverse event unrelated to study drug|2|||
160662871|NCT03195491|580149179|FG000|Overall Study|Disease progression|266|||
160662872|NCT03195491|580149180|FG001|Overall Study|Disease progression|8|||
160662873|NCT03195491|580149179|FG000|Overall Study|Other reasons|10|||
160662874|NCT03195491|580149180|FG001|Overall Study|Other reasons|0|||
160662875|NCT03195491|580149179|FG000|Overall Study|Participant withdrew consent|8|||
160662876|NCT03195491|580149180|FG001|Overall Study|Participant withdrew consent|1|||
160662877|NCT03195491|580149179|FG000|Overall Study|Participant no longer meets study criteria|0|||
160662878|NCT03195491|580149180|FG001|Overall Study|Participant no longer meets study criteria|1|||
160662879|NCT03195491|580149179|FG000|Overall Study|Participant request to discontinue study treatment|10|||
160662880|NCT03195491|580149180|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160662881|NCT01263704|580149181|FG000|Overall Study|Progressive disease|18|||
160662882|NCT01263704|580149181|FG000|Overall Study|Adverse Event|3|||
160662883|NCT01263704|580149181|FG000|Overall Study|Death|2|||
160662884|NCT01263704|580149181|FG000|Overall Study|Patient withdrew consent|2|||
160662885|NCT01263704|580149181|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
160662886|NCT01263704|580149181|FG000|Overall Study|Lost to Follow-up|1|||
160662887|NCT01263704|580149181|FG000|Overall Study|Colon metastases|1|||
160662888|NCT01263704|580149181|FG000|Overall Study|Principal Investigator (PI) decision|1|||
160662889|NCT02459951|580149182|FG000|Overall Study|Unable to meet holding requirement|1|||
160662890|NCT03956862|580149187|FG000|Overall Study|Lost to Follow-up|1|||
160502580|NCT04958642|579570083|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
160502581|NCT04958642|579570084|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
160619894|NCT01000311|579986324|FG001|Overall Study|Lost to Follow-up|24|||
160619895|NCT01000311|579986323|FG000|Overall Study|Protocol Violation|1|||
160619896|NCT01000311|579986324|FG001|Overall Study|Protocol Violation|2|||
160619897|NCT01000311|579986323|FG000|Overall Study|Inappropriate enrollment|2|||
160619898|NCT01000311|579986324|FG001|Overall Study|Inappropriate enrollment|0|||
160619899|NCT01000311|579986323|FG000|Overall Study|Administrative reason|9|||
160619900|NCT01000311|579986324|FG001|Overall Study|Administrative reason|15|||
160619901|NCT01646255|579986325|FG000|Overall Study|Adverse Event|7|||
160619902|NCT01646255|579986326|FG001|Overall Study|Adverse Event|8|||
160619903|NCT01646255|579986325|FG000|Overall Study|Lack of Efficacy|2|||
160619904|NCT01646255|579986326|FG001|Overall Study|Lack of Efficacy|0|||
160619905|NCT01646255|579986325|FG000|Overall Study|Withdrawal by Subject|10|||
160619906|NCT01646255|579986326|FG001|Overall Study|Withdrawal by Subject|6|||
160619907|NCT01646255|579986325|FG000|Overall Study|Compliance is not well|1|||
160619908|NCT01646255|579986326|FG001|Overall Study|Compliance is not well|0|||
160619909|NCT01646255|579986325|FG000|Overall Study|Inclusion Criteria Deviation|1|||
160619910|NCT01646255|579986326|FG001|Overall Study|Inclusion Criteria Deviation|0|||
160619911|NCT01241318|579986327|FG000|Overall Study|Woman: false pregnancies|27|||
160662891|NCT03956862|580149188|FG001|Overall Study|Lost to Follow-up|1|||
160662892|NCT03956862|580149187|FG000|Overall Study|Withdrawal by Subject|1|||
160662893|NCT03956862|580149188|FG001|Overall Study|Withdrawal by Subject|1|||
160662894|NCT02294604|580149189|FG000|Overall Study|Did not provide samples for culture|0|||
160662895|NCT02294604|580149190|FG001|Overall Study|Did not provide samples for culture|1|||
160662896|NCT02294604|580149191|FG002|Overall Study|Did not provide samples for culture|0|||
160662897|NCT02294604|580149189|FG000|Overall Study|Culture contamination|1|||
160662898|NCT02294604|580149190|FG001|Overall Study|Culture contamination|2|||
160662899|NCT02294604|580149191|FG002|Overall Study|Culture contamination|0|||
160662900|NCT01401647|580149202|FG000|Overall Study|Withdrawal by Subject|1|||
160662901|NCT01401647|580149203|FG001|Overall Study|Withdrawal by Subject|5|||
160662902|NCT01401647|580149204|FG002|Overall Study|Withdrawal by Subject|2|||
160662903|NCT01401647|580149202|FG000|Overall Study|Lost to Follow-up|3|||
160662904|NCT01401647|580149203|FG001|Overall Study|Lost to Follow-up|3|||
160662905|NCT01401647|580149204|FG002|Overall Study|Lost to Follow-up|1|||
160662906|NCT00336479|580149206|FG000|Overall Study|Adverse Event|8|||
160662907|NCT00336479|580149207|FG001|Overall Study|Adverse Event|11|||
160662908|NCT00336479|580149208|FG002|Overall Study|Adverse Event|18|||
160662909|NCT00336479|580149209|FG003|Overall Study|Adverse Event|4|||
160662910|NCT00336479|580149206|FG000|Overall Study|Noncompliant|1|||
160662911|NCT00336479|580149207|FG001|Overall Study|Noncompliant|7|||
160662912|NCT00336479|580149208|FG002|Overall Study|Noncompliant|3|||
160662913|NCT00336479|580149209|FG003|Overall Study|Noncompliant|0|||
160662914|NCT00336479|580149206|FG000|Overall Study|Physician Decision|2|||
160662915|NCT00336479|580149207|FG001|Overall Study|Physician Decision|3|||
160662916|NCT00336479|580149208|FG002|Overall Study|Physician Decision|1|||
160662917|NCT00336479|580149209|FG003|Overall Study|Physician Decision|0|||
160662918|NCT00336479|580149206|FG000|Overall Study|Lost to Follow-up|3|||
160662919|NCT00336479|580149207|FG001|Overall Study|Lost to Follow-up|2|||
160662920|NCT00336479|580149208|FG002|Overall Study|Lost to Follow-up|0|||
160662921|NCT00336479|580149209|FG003|Overall Study|Lost to Follow-up|0|||
160662922|NCT00336479|580149206|FG000|Overall Study|Withdrawal by Subject|3|||
160662923|NCT00336479|580149207|FG001|Overall Study|Withdrawal by Subject|2|||
160662924|NCT00336479|580149208|FG002|Overall Study|Withdrawal by Subject|3|||
160662925|NCT00336479|580149209|FG003|Overall Study|Withdrawal by Subject|0|||
160662926|NCT00336479|580149206|FG000|Overall Study|Other|0|||
160662927|NCT00336479|580149207|FG001|Overall Study|Other|0|||
160662928|NCT00336479|580149208|FG002|Overall Study|Other|1|||
160662929|NCT00336479|580149209|FG003|Overall Study|Other|0|||
160662930|NCT00336479|580149206|FG000|Overall Study|Virologic Stopping Rule|20|||
160662931|NCT00336479|580149207|FG001|Overall Study|Virologic Stopping Rule|0|||
160662932|NCT00336479|580149208|FG002|Overall Study|Virologic Stopping Rule|0|||
160662933|NCT00336479|580149209|FG003|Overall Study|Virologic Stopping Rule|0|||
160662934|NCT01059903|580149213|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
160502582|NCT04958642|579570085|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
160502583|NCT04958642|579570083|FG000|Overall Study|Lost to Follow-up|1|||
160502584|NCT04958642|579570084|FG001|Overall Study|Lost to Follow-up|0|||
160502585|NCT04958642|579570085|FG002|Overall Study|Lost to Follow-up|0|||
160502586|NCT04958642|579570083|FG000|Overall Study|Transferred to EAP following study termination|0|||
160502587|NCT04958642|579570084|FG001|Overall Study|Transferred to EAP following study termination|0|||
160502588|NCT04958642|579570085|FG002|Overall Study|Transferred to EAP following study termination|1|||
160502589|NCT04958642|579570083|FG000|Overall Study|Transferred to Expanded Access Program|1|||
160502590|NCT04958642|579570084|FG001|Overall Study|Transferred to Expanded Access Program|0|||
160502591|NCT04958642|579570085|FG002|Overall Study|Transferred to Expanded Access Program|0|||
160502592|NCT02942004|579570086|FG000|Overall Study|Withdrawal by Subject|0|||
160502593|NCT02942004|579570087|FG001|Overall Study|Withdrawal by Subject|2|||
160502594|NCT02942004|579570088|FG002|Overall Study|Withdrawal by Subject|3|||
160502595|NCT02942004|579570086|FG000|Overall Study|Lost to Follow-up|1|||
160502596|NCT02942004|579570087|FG001|Overall Study|Lost to Follow-up|1|||
160502597|NCT02942004|579570088|FG002|Overall Study|Lost to Follow-up|2|||
160502598|NCT02942004|579570086|FG000|Overall Study|Randomized but not dosed|3|||
160502599|NCT02942004|579570087|FG001|Overall Study|Randomized but not dosed|9|||
160502600|NCT02942004|579570088|FG002|Overall Study|Randomized but not dosed|4|||
160502601|NCT05627258|579570089|FG000|Overall Study|Lost to Follow-up|1|||
160502602|NCT05627258|579570090|FG001|Overall Study|Lost to Follow-up|0|||
160502603|NCT05627258|579570091|FG002|Overall Study|Lost to Follow-up|0|||
160502604|NCT05627258|579570092|FG003|Overall Study|Lost to Follow-up|0|||
160502605|NCT05627258|579570093|FG004|Overall Study|Lost to Follow-up|0|||
160502606|NCT05627258|579570094|FG005|Overall Study|Lost to Follow-up|0|||
160502607|NCT05627258|579570089|FG000|Overall Study|Withdrawal by Subject|0|||
160662935|NCT01059903|580149214|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
160662936|NCT00858845|580149215|FG000|Overall Study|Patient underwent heart transplant.|0|||
160502608|NCT05627258|579570090|FG001|Overall Study|Withdrawal by Subject|0|||
160662937|NCT00858845|580149216|FG001|Overall Study|Patient underwent heart transplant.|1|||
160662938|NCT02100228|580149217|FG000|Overall Study|Other|19|||
160662939|NCT02100228|580149218|FG001|Overall Study|Other|19|||
160619912|NCT01241318|579986328|FG001|Overall Study|Woman: false pregnancies|15|||
160619913|NCT01241318|579986327|FG000|Overall Study|Woman: miscarriage/abortion|46|||
160619914|NCT01241318|579986328|FG001|Overall Study|Woman: miscarriage/abortion|38|||
160619915|NCT01241318|579986327|FG000|Overall Study|Withdrawal by Subject|175|||
160619916|NCT01241318|579986328|FG001|Overall Study|Withdrawal by Subject|46|||
160619917|NCT01241318|579986327|FG000|Overall Study|Lost to Follow-up|740|||
160619918|NCT01241318|579986328|FG001|Overall Study|Lost to Follow-up|455|||
160619919|NCT01241318|579986327|FG000|Overall Study|Death|2|||
160619920|NCT01241318|579986328|FG001|Overall Study|Death|4|||
160619921|NCT01241318|579986327|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
160619922|NCT01241318|579986328|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
160619923|NCT01241318|579986327|FG000|Overall Study|Woman: Stillborn infant|129|||
160619924|NCT01241318|579986328|FG001|Overall Study|Woman: Stillborn infant|146|||
160619925|NCT03607994|579986329|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
160619926|NCT03607994|579986330|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
160619927|NCT01997333|579986335|FG000|Randomization and Treatment|Disease Progression|70|||
160619928|NCT01997333|579986336|FG001|Randomization and Treatment|Disease Progression|159|||
160619929|NCT01997333|579986335|FG000|Randomization and Treatment|Adverse Event|10|||
160619930|NCT01997333|579986336|FG001|Randomization and Treatment|Adverse Event|32|||
160619931|NCT01997333|579986335|FG000|Randomization and Treatment|Physician Decision|0|||
160619932|NCT01997333|579986336|FG001|Randomization and Treatment|Physician Decision|4|||
160619933|NCT01997333|579986335|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
160619934|NCT01997333|579986336|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
160619935|NCT01997333|579986335|FG000|Randomization and Treatment|Did not receive treatment|17|||
160619936|NCT01997333|579986336|FG001|Randomization and Treatment|Did not receive treatment|5|||
160619937|NCT01997333|579986335|FG000|Survival Follow up|Withdrawal by Subject|15|||
160619938|NCT01997333|579986336|FG001|Survival Follow up|Withdrawal by Subject|6|||
160619939|NCT01997333|579986335|FG000|Survival Follow up|Lost to Follow-up|0|||
160619940|NCT01997333|579986336|FG001|Survival Follow up|Lost to Follow-up|6|||
160619941|NCT01997333|579986335|FG000|Survival Follow up|Various|1|||
160619942|NCT01997333|579986336|FG001|Survival Follow up|Various|2|||
160619943|NCT02269709|579986337|FG000|Time of Enrollment|Withdrawal by Subject|3|||
160619944|NCT02269709|579986337|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
160619945|NCT02269709|579986337|FG000|Six Month Follow-up|Lost to Follow-up|12|||
160619946|NCT04411472|579986338|FG000|Overall Study|Adverse Event|5|||
160619947|NCT04411472|579986339|FG001|Overall Study|Adverse Event|10|||
160619948|NCT04411472|579986340|FG002|Overall Study|Adverse Event|1|||
160619949|NCT04411472|579986341|FG003|Overall Study|Adverse Event|0|||
160619950|NCT04411472|579986342|FG004|Overall Study|Adverse Event|0|||
160619951|NCT04411472|579986343|FG005|Overall Study|Adverse Event|0|||
160619952|NCT04411472|579986338|FG000|Overall Study|Protocol Violation|1|||
160619953|NCT04411472|579986339|FG001|Overall Study|Protocol Violation|0|||
160619954|NCT04411472|579986340|FG002|Overall Study|Protocol Violation|0|||
160619955|NCT04411472|579986341|FG003|Overall Study|Protocol Violation|0|||
160619956|NCT04411472|579986342|FG004|Overall Study|Protocol Violation|0|||
160619957|NCT04411472|579986343|FG005|Overall Study|Protocol Violation|0|||
160619958|NCT04411472|579986338|FG000|Overall Study|Withdrawal by Subject|0|||
160619959|NCT04411472|579986339|FG001|Overall Study|Withdrawal by Subject|1|||
160619960|NCT04411472|579986340|FG002|Overall Study|Withdrawal by Subject|0|||
160619961|NCT04411472|579986341|FG003|Overall Study|Withdrawal by Subject|1|||
160619962|NCT04411472|579986342|FG004|Overall Study|Withdrawal by Subject|0|||
160619963|NCT04411472|579986343|FG005|Overall Study|Withdrawal by Subject|0|||
160619964|NCT04411472|579986338|FG000|Overall Study|Physician Decision|1|||
160619965|NCT04411472|579986339|FG001|Overall Study|Physician Decision|0|||
160619966|NCT04411472|579986340|FG002|Overall Study|Physician Decision|0|||
160619967|NCT04411472|579986341|FG003|Overall Study|Physician Decision|0|||
160619968|NCT04411472|579986342|FG004|Overall Study|Physician Decision|0|||
160619969|NCT04411472|579986343|FG005|Overall Study|Physician Decision|0|||
160619970|NCT04411472|579986338|FG000|Overall Study|Study terminated by sponsor|17|||
160619971|NCT04411472|579986339|FG001|Overall Study|Study terminated by sponsor|20|||
160619972|NCT04411472|579986340|FG002|Overall Study|Study terminated by sponsor|3|||
160619973|NCT04411472|579986341|FG003|Overall Study|Study terminated by sponsor|0|||
160619974|NCT04411472|579986342|FG004|Overall Study|Study terminated by sponsor|0|||
160619975|NCT04411472|579986343|FG005|Overall Study|Study terminated by sponsor|0|||
160619976|NCT01747655|579986346|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
160619977|NCT01747655|579986347|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
160619978|NCT01747655|579986346|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
160619979|NCT01747655|579986347|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
160619980|NCT01747655|579986346|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
160619981|NCT01747655|579986347|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
160619982|NCT00982111|579986348|FG000|Overall Study|Adverse Event|1|||
160619983|NCT00982111|579986349|FG001|Overall Study|Adverse Event|1|||
160619984|NCT00982111|579986348|FG000|Overall Study|Progressive Disease|46|||
160619985|NCT00982111|579986349|FG001|Overall Study|Progressive Disease|39|||
160502609|NCT05627258|579570091|FG002|Overall Study|Withdrawal by Subject|0|||
160502610|NCT05627258|579570092|FG003|Overall Study|Withdrawal by Subject|0|||
160502611|NCT05627258|579570093|FG004|Overall Study|Withdrawal by Subject|2|||
160502612|NCT05627258|579570094|FG005|Overall Study|Withdrawal by Subject|0|||
160502613|NCT05627258|579570089|FG000|Overall Study|Enrolled, but product not administered|1|||
160502614|NCT05627258|579570090|FG001|Overall Study|Enrolled, but product not administered|0|||
160502615|NCT05627258|579570091|FG002|Overall Study|Enrolled, but product not administered|0|||
160502616|NCT05627258|579570092|FG003|Overall Study|Enrolled, but product not administered|0|||
160502617|NCT05627258|579570093|FG004|Overall Study|Enrolled, but product not administered|0|||
160502618|NCT05627258|579570094|FG005|Overall Study|Enrolled, but product not administered|0|||
160502619|NCT05627258|579570089|FG000|Overall Study|Other subject illness/injury|1|||
160502620|NCT05627258|579570090|FG001|Overall Study|Other subject illness/injury|0|||
160502621|NCT05627258|579570091|FG002|Overall Study|Other subject illness/injury|0|||
160502622|NCT05627258|579570092|FG003|Overall Study|Other subject illness/injury|0|||
160502623|NCT05627258|579570093|FG004|Overall Study|Other subject illness/injury|0|||
160502624|NCT05627258|579570094|FG005|Overall Study|Other subject illness/injury|0|||
160502625|NCT05627258|579570089|FG000|Overall Study|Subject moved from area|0|||
160502626|NCT05627258|579570090|FG001|Overall Study|Subject moved from area|0|||
160502627|NCT05627258|579570091|FG002|Overall Study|Subject moved from area|1|||
160502628|NCT05627258|579570092|FG003|Overall Study|Subject moved from area|0|||
160502629|NCT05627258|579570093|FG004|Overall Study|Subject moved from area|0|||
160502630|NCT05627258|579570094|FG005|Overall Study|Subject moved from area|0|||
160502631|NCT00678301|579570095|FG000|Overall Study|Non-compliance with study procedures|0|||
160502632|NCT00678301|579570096|FG001|Overall Study|Non-compliance with study procedures|1|||
160502633|NCT00678301|579570095|FG000|Overall Study|Adverse Event|1|||
160502634|NCT00678301|579570096|FG001|Overall Study|Adverse Event|0|||
160502635|NCT00678301|579570095|FG000|Overall Study|Withdrawal by Subject|4|||
160502636|NCT00678301|579570096|FG001|Overall Study|Withdrawal by Subject|0|||
160502637|NCT00678301|579570095|FG000|Overall Study|Lost to Follow-up|3|||
160502638|NCT00678301|579570096|FG001|Overall Study|Lost to Follow-up|1|||
160502639|NCT05048238|579570097|FG000|Overall Study|Withdrawal by Subject|1|||
160502640|NCT00335140|579570101|FG000|Overall Study|Ineligible|1|||
160502641|NCT00737477|579570102|FG000|Overall Study|Adverse Event|9|||
160502642|NCT00737477|579570102|FG000|Overall Study|Death|9|||
160502643|NCT00737477|579570102|FG000|Overall Study|Treatment Refusal|1|||
160502644|NCT00737477|579570102|FG000|Overall Study|Withdrawal by Subject|1|||
160502645|NCT00737477|579570102|FG000|Overall Study|Renal Transplantation|10|||
160502646|NCT00737477|579570102|FG000|Overall Study|Other|4|||
160502647|NCT01132820|579570103|FG000|Overall Study|Ineligible: wrong cell type|1|||
160502648|NCT01132820|579570103|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
160502649|NCT01132820|579570103|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
160502650|NCT01132820|579570103|FG000|Overall Study|Never treated|1|||
160502651|NCT01132820|579570103|FG000|Overall Study|Inadequate data|1|||
160502652|NCT01370655|579570104|FG000|Period 1|Adverse Event|2|||
160502653|NCT01370655|579570105|FG001|Period 1|Adverse Event|0|||
160502654|NCT01370655|579570106|FG002|Period 1|Adverse Event|0|||
160502655|NCT01370655|579570107|FG003|Period 1|Adverse Event|0|||
160502656|NCT01370655|579570108|FG004|Period 1|Adverse Event|0|||
160502657|NCT01370655|579570109|FG005|Period 1|Adverse Event|0|||
160502658|NCT01370655|579570110|FG006|Period 1|Adverse Event|1|||
160502659|NCT01370655|579570111|FG007|Period 1|Adverse Event|0|||
160502660|NCT01370655|579570112|FG008|Period 1|Adverse Event|0|||
160502661|NCT01370655|579570113|FG009|Period 1|Adverse Event|0|||
160502662|NCT01370655|579570114|FG010|Period 1|Adverse Event|0|||
160502663|NCT01370655|579570115|FG011|Period 1|Adverse Event|0|||
160502664|NCT01370655|579570104|FG000|Period 2|Adverse Event|0|||
160502665|NCT01370655|579570105|FG001|Period 2|Adverse Event|0|||
160502666|NCT01370655|579570106|FG002|Period 2|Adverse Event|1|||
160502667|NCT01370655|579570107|FG003|Period 2|Adverse Event|0|||
160502668|NCT01370655|579570108|FG004|Period 2|Adverse Event|1|||
160502669|NCT01370655|579570109|FG005|Period 2|Adverse Event|0|||
160619986|NCT00982111|579986348|FG000|Overall Study|Lost to Follow-up|9|||
160619987|NCT00982111|579986349|FG001|Overall Study|Lost to Follow-up|6|||
160619988|NCT00982111|579986348|FG000|Overall Study|New Anti-Cancer Therapy|5|||
160502670|NCT01370655|579570110|FG006|Period 2|Adverse Event|0|||
160502671|NCT01370655|579570111|FG007|Period 2|Adverse Event|1|||
160502672|NCT01370655|579570112|FG008|Period 2|Adverse Event|0|||
160502673|NCT01370655|579570113|FG009|Period 2|Adverse Event|0|||
160502674|NCT01370655|579570114|FG010|Period 2|Adverse Event|0|||
160502675|NCT01370655|579570115|FG011|Period 2|Adverse Event|0|||
160502676|NCT01370655|579570104|FG000|Period 2|met protocol specified stopping criteria|0|||
160502677|NCT01370655|579570105|FG001|Period 2|met protocol specified stopping criteria|0|||
160502678|NCT01370655|579570106|FG002|Period 2|met protocol specified stopping criteria|1|||
160502679|NCT01370655|579570107|FG003|Period 2|met protocol specified stopping criteria|0|||
160502680|NCT01370655|579570108|FG004|Period 2|met protocol specified stopping criteria|0|||
160502681|NCT01370655|579570109|FG005|Period 2|met protocol specified stopping criteria|0|||
160502682|NCT01370655|579570110|FG006|Period 2|met protocol specified stopping criteria|1|||
160619989|NCT00982111|579986349|FG001|Overall Study|New Anti-Cancer Therapy|5|||
160502683|NCT01370655|579570111|FG007|Period 2|met protocol specified stopping criteria|0|||
160502684|NCT01370655|579570112|FG008|Period 2|met protocol specified stopping criteria|1|||
160502685|NCT01370655|579570113|FG009|Period 2|met protocol specified stopping criteria|0|||
160502686|NCT01370655|579570114|FG010|Period 2|met protocol specified stopping criteria|1|||
160502687|NCT01370655|579570115|FG011|Period 2|met protocol specified stopping criteria|0|||
160502688|NCT01370655|579570104|FG000|Period 2|Withdrawal by Subject|0|||
160502689|NCT01370655|579570105|FG001|Period 2|Withdrawal by Subject|0|||
160502690|NCT01370655|579570106|FG002|Period 2|Withdrawal by Subject|0|||
160502691|NCT01370655|579570107|FG003|Period 2|Withdrawal by Subject|0|||
160502692|NCT01370655|579570108|FG004|Period 2|Withdrawal by Subject|0|||
160502693|NCT01370655|579570109|FG005|Period 2|Withdrawal by Subject|0|||
160502694|NCT01370655|579570110|FG006|Period 2|Withdrawal by Subject|0|||
160502695|NCT01370655|579570111|FG007|Period 2|Withdrawal by Subject|0|||
160502696|NCT01370655|579570112|FG008|Period 2|Withdrawal by Subject|1|||
160502697|NCT01370655|579570113|FG009|Period 2|Withdrawal by Subject|0|||
160502698|NCT01370655|579570114|FG010|Period 2|Withdrawal by Subject|0|||
160502699|NCT01370655|579570115|FG011|Period 2|Withdrawal by Subject|0|||
160502700|NCT01730378|579570116|FG000|Overall Study|Lost to Follow-up|1|||
160502701|NCT01730378|579570117|FG001|Overall Study|Lost to Follow-up|0|||
160502702|NCT02687035|579570118|FG000|Overall Study|Withdrawal by Subject|1|||
160502703|NCT02687035|579570118|FG000|Overall Study|Death|87|||
160502704|NCT02687035|579570118|FG000|Overall Study|Lost to Follow-up|1|||
160502705|NCT02687035|579570118|FG000|Overall Study|Missed Visit|87|||
160502706|NCT02687035|579570118|FG000|Overall Study|Did not receive Study Device|8|||
160502707|NCT00667394|579570122|FG000|Overall Study|Adverse Event|3|||
160502708|NCT00667394|579570123|FG001|Overall Study|Adverse Event|0|||
160502709|NCT00667394|579570122|FG000|Overall Study|Progressive disease|1|||
160502710|NCT00667394|579570123|FG001|Overall Study|Progressive disease|0|||
160502711|NCT05000216|579570124|FG000|Stage 1|Lost to Follow-up|0|||
160502712|NCT05000216|579570125|FG001|Stage 1|Lost to Follow-up|0|||
160502713|NCT05000216|579570126|FG002|Stage 1|Lost to Follow-up|0|||
160502714|NCT05000216|579570127|FG003|Stage 1|Lost to Follow-up|0|||
160502715|NCT05000216|579570128|FG004|Stage 1|Lost to Follow-up|0|||
160502716|NCT05000216|579570129|FG005|Stage 1|Lost to Follow-up|0|||
160502717|NCT05000216|579570130|FG006|Stage 1|Lost to Follow-up|1|||
160502718|NCT05000216|579570131|FG007|Stage 1|Lost to Follow-up|1|||
160502719|NCT05000216|579570132|FG008|Stage 1|Lost to Follow-up|0|||
160502720|NCT05000216|579570133|FG009|Stage 1|Lost to Follow-up|2|||
160502721|NCT05000216|579570134|FG010|Stage 1|Lost to Follow-up|3|||
160502722|NCT05000216|579570135|FG011|Stage 1|Lost to Follow-up|0|||
160502723|NCT05000216|579570136|FG012|Stage 1|Lost to Follow-up|0|||
160502724|NCT05000216|579570137|FG013|Stage 1|Lost to Follow-up|0|||
160502725|NCT05000216|579570138|FG014|Stage 1|Lost to Follow-up|0|||
160502726|NCT05000216|579570139|FG015|Stage 1|Lost to Follow-up|0|||
160502727|NCT05000216|579570140|FG016|Stage 1|Lost to Follow-up|0|||
160502728|NCT05000216|579570141|FG017|Stage 1|Lost to Follow-up|0|||
160502729|NCT05000216|579570142|FG018|Stage 1|Lost to Follow-up|0|||
160502730|NCT05000216|579570143|FG019|Stage 1|Lost to Follow-up|0|||
160502731|NCT05000216|579570144|FG020|Stage 1|Lost to Follow-up|0|||
160502732|NCT05000216|579570145|FG021|Stage 1|Lost to Follow-up|0|||
160502733|NCT05000216|579570124|FG000|Stage 1|Physician Decision|0|||
160502734|NCT05000216|579570125|FG001|Stage 1|Physician Decision|0|||
160502735|NCT05000216|579570126|FG002|Stage 1|Physician Decision|0|||
160502736|NCT05000216|579570127|FG003|Stage 1|Physician Decision|0|||
160502737|NCT05000216|579570128|FG004|Stage 1|Physician Decision|0|||
160502738|NCT05000216|579570129|FG005|Stage 1|Physician Decision|0|||
160502739|NCT05000216|579570130|FG006|Stage 1|Physician Decision|0|||
160502740|NCT05000216|579570131|FG007|Stage 1|Physician Decision|1|||
160502741|NCT05000216|579570132|FG008|Stage 1|Physician Decision|1|||
160502742|NCT05000216|579570133|FG009|Stage 1|Physician Decision|0|||
160502743|NCT05000216|579570134|FG010|Stage 1|Physician Decision|0|||
160502744|NCT05000216|579570135|FG011|Stage 1|Physician Decision|0|||
160502745|NCT05000216|579570136|FG012|Stage 1|Physician Decision|0|||
160502746|NCT05000216|579570137|FG013|Stage 1|Physician Decision|0|||
160502747|NCT05000216|579570138|FG014|Stage 1|Physician Decision|0|||
160502748|NCT05000216|579570139|FG015|Stage 1|Physician Decision|0|||
160502749|NCT05000216|579570140|FG016|Stage 1|Physician Decision|0|||
160502750|NCT05000216|579570141|FG017|Stage 1|Physician Decision|0|||
160502751|NCT05000216|579570142|FG018|Stage 1|Physician Decision|0|||
160502752|NCT05000216|579570143|FG019|Stage 1|Physician Decision|0|||
160502753|NCT05000216|579570144|FG020|Stage 1|Physician Decision|0|||
160502754|NCT05000216|579570145|FG021|Stage 1|Physician Decision|0|||
160502755|NCT05000216|579570124|FG000|Stage 1|Withdrawal by Subject|0|||
160502756|NCT05000216|579570125|FG001|Stage 1|Withdrawal by Subject|1|||
160502757|NCT05000216|579570126|FG002|Stage 1|Withdrawal by Subject|0|||
160502758|NCT05000216|579570127|FG003|Stage 1|Withdrawal by Subject|0|||
160502759|NCT05000216|579570128|FG004|Stage 1|Withdrawal by Subject|0|||
160502760|NCT05000216|579570129|FG005|Stage 1|Withdrawal by Subject|0|||
160502761|NCT05000216|579570130|FG006|Stage 1|Withdrawal by Subject|0|||
160502762|NCT05000216|579570131|FG007|Stage 1|Withdrawal by Subject|0|||
160502763|NCT05000216|579570132|FG008|Stage 1|Withdrawal by Subject|0|||
160502764|NCT05000216|579570133|FG009|Stage 1|Withdrawal by Subject|3|||
160502765|NCT05000216|579570134|FG010|Stage 1|Withdrawal by Subject|10|||
160502766|NCT05000216|579570135|FG011|Stage 1|Withdrawal by Subject|0|||
160502767|NCT05000216|579570136|FG012|Stage 1|Withdrawal by Subject|0|||
160502768|NCT05000216|579570137|FG013|Stage 1|Withdrawal by Subject|0|||
160502769|NCT05000216|579570138|FG014|Stage 1|Withdrawal by Subject|0|||
160502770|NCT05000216|579570139|FG015|Stage 1|Withdrawal by Subject|0|||
160502771|NCT05000216|579570140|FG016|Stage 1|Withdrawal by Subject|0|||
160502772|NCT05000216|579570141|FG017|Stage 1|Withdrawal by Subject|0|||
160502773|NCT05000216|579570142|FG018|Stage 1|Withdrawal by Subject|0|||
160502774|NCT05000216|579570143|FG019|Stage 1|Withdrawal by Subject|0|||
160502775|NCT05000216|579570144|FG020|Stage 1|Withdrawal by Subject|0|||
160502776|NCT05000216|579570145|FG021|Stage 1|Withdrawal by Subject|0|||
160502777|NCT05000216|579570124|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
160502778|NCT05000216|579570125|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
160502779|NCT05000216|579570126|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
160502780|NCT05000216|579570127|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
160502781|NCT05000216|579570128|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
160502782|NCT05000216|579570129|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
160502783|NCT05000216|579570130|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
160502784|NCT05000216|579570131|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
160502785|NCT05000216|579570132|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
160502786|NCT05000216|579570133|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
160502787|NCT05000216|579570134|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
160502788|NCT05000216|579570135|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
160502789|NCT05000216|579570136|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
160502790|NCT05000216|579570137|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
160502791|NCT05000216|579570138|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
160502792|NCT05000216|579570139|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
160502793|NCT05000216|579570140|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
160502794|NCT05000216|579570141|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
160502795|NCT05000216|579570142|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
160502796|NCT05000216|579570143|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
160502797|NCT05000216|579570144|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
160502798|NCT05000216|579570145|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
160502799|NCT05000216|579570124|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502800|NCT05000216|579570125|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502801|NCT05000216|579570126|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502802|NCT05000216|579570127|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502803|NCT05000216|579570128|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502804|NCT05000216|579570129|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502805|NCT05000216|579570130|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502806|NCT05000216|579570131|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502807|NCT05000216|579570132|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
160502808|NCT05000216|579570133|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502809|NCT05000216|579570134|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502810|NCT05000216|579570135|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502811|NCT05000216|579570136|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502812|NCT05000216|579570137|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502813|NCT05000216|579570138|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502814|NCT05000216|579570139|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502815|NCT05000216|579570140|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502816|NCT05000216|579570141|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502817|NCT05000216|579570142|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502818|NCT05000216|579570143|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502819|NCT05000216|579570144|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502820|NCT05000216|579570145|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
160502821|NCT05000216|579570124|FG000|Stage 1|Other|0|||
160502822|NCT05000216|579570125|FG001|Stage 1|Other|0|||
160502823|NCT05000216|579570126|FG002|Stage 1|Other|0|||
160502824|NCT05000216|579570127|FG003|Stage 1|Other|0|||
160502825|NCT05000216|579570128|FG004|Stage 1|Other|1|||
160502826|NCT05000216|579570129|FG005|Stage 1|Other|0|||
160502827|NCT05000216|579570130|FG006|Stage 1|Other|0|||
160502828|NCT05000216|579570131|FG007|Stage 1|Other|2|||
160502829|NCT05000216|579570132|FG008|Stage 1|Other|0|||
160502830|NCT05000216|579570133|FG009|Stage 1|Other|0|||
160502831|NCT05000216|579570134|FG010|Stage 1|Other|1|||
160502832|NCT05000216|579570135|FG011|Stage 1|Other|1|||
160502833|NCT05000216|579570136|FG012|Stage 1|Other|0|||
160502834|NCT05000216|579570137|FG013|Stage 1|Other|0|||
160502835|NCT05000216|579570138|FG014|Stage 1|Other|0|||
160502836|NCT05000216|579570139|FG015|Stage 1|Other|0|||
160502837|NCT05000216|579570140|FG016|Stage 1|Other|0|||
160502838|NCT05000216|579570141|FG017|Stage 1|Other|0|||
160502839|NCT05000216|579570142|FG018|Stage 1|Other|0|||
160502840|NCT05000216|579570143|FG019|Stage 1|Other|0|||
160502841|NCT05000216|579570144|FG020|Stage 1|Other|0|||
160502842|NCT05000216|579570145|FG021|Stage 1|Other|0|||
160502843|NCT05000216|579570124|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
160502844|NCT05000216|579570125|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
160502845|NCT05000216|579570126|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
160502846|NCT05000216|579570127|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
160502847|NCT05000216|579570128|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
160502848|NCT05000216|579570129|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
160502849|NCT05000216|579570130|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
160502850|NCT05000216|579570131|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
160502851|NCT05000216|579570132|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
160502852|NCT05000216|579570133|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
160502853|NCT05000216|579570134|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
160502854|NCT05000216|579570135|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
160502855|NCT05000216|579570136|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
160502856|NCT05000216|579570137|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
160502857|NCT05000216|579570138|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
160502858|NCT05000216|579570139|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
160502859|NCT05000216|579570140|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
160502860|NCT05000216|579570141|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
160502861|NCT05000216|579570142|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
160502862|NCT05000216|579570143|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
160502863|NCT05000216|579570144|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
160502864|NCT05000216|579570145|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
160502865|NCT05000216|579570124|FG000|Stage 2|Lost to Follow-up|0|||
160502866|NCT05000216|579570125|FG001|Stage 2|Lost to Follow-up|0|||
160502867|NCT05000216|579570126|FG002|Stage 2|Lost to Follow-up|0|||
160502868|NCT05000216|579570127|FG003|Stage 2|Lost to Follow-up|0|||
160502869|NCT05000216|579570128|FG004|Stage 2|Lost to Follow-up|0|||
160502870|NCT05000216|579570129|FG005|Stage 2|Lost to Follow-up|0|||
160502871|NCT05000216|579570130|FG006|Stage 2|Lost to Follow-up|0|||
160502872|NCT05000216|579570131|FG007|Stage 2|Lost to Follow-up|0|||
160502873|NCT05000216|579570132|FG008|Stage 2|Lost to Follow-up|0|||
160502874|NCT05000216|579570133|FG009|Stage 2|Lost to Follow-up|0|||
160502875|NCT05000216|579570134|FG010|Stage 2|Lost to Follow-up|0|||
160502876|NCT05000216|579570135|FG011|Stage 2|Lost to Follow-up|0|||
160502877|NCT05000216|579570136|FG012|Stage 2|Lost to Follow-up|0|||
160502878|NCT05000216|579570137|FG013|Stage 2|Lost to Follow-up|0|||
160502879|NCT05000216|579570138|FG014|Stage 2|Lost to Follow-up|0|||
160502880|NCT05000216|579570139|FG015|Stage 2|Lost to Follow-up|0|||
160502881|NCT05000216|579570140|FG016|Stage 2|Lost to Follow-up|4|||
160502882|NCT05000216|579570141|FG017|Stage 2|Lost to Follow-up|0|||
160502883|NCT05000216|579570142|FG018|Stage 2|Lost to Follow-up|0|||
160502884|NCT05000216|579570143|FG019|Stage 2|Lost to Follow-up|0|||
160502885|NCT05000216|579570144|FG020|Stage 2|Lost to Follow-up|0|||
160502886|NCT05000216|579570145|FG021|Stage 2|Lost to Follow-up|0|||
160502887|NCT05000216|579570124|FG000|Stage 2|Physician Decision|0|||
160502888|NCT05000216|579570125|FG001|Stage 2|Physician Decision|0|||
160502889|NCT05000216|579570126|FG002|Stage 2|Physician Decision|0|||
160502890|NCT05000216|579570127|FG003|Stage 2|Physician Decision|0|||
160502891|NCT05000216|579570128|FG004|Stage 2|Physician Decision|0|||
160502892|NCT05000216|579570129|FG005|Stage 2|Physician Decision|0|||
160502893|NCT05000216|579570130|FG006|Stage 2|Physician Decision|0|||
160502894|NCT05000216|579570131|FG007|Stage 2|Physician Decision|0|||
160502895|NCT05000216|579570132|FG008|Stage 2|Physician Decision|0|||
160502896|NCT05000216|579570133|FG009|Stage 2|Physician Decision|0|||
160502897|NCT05000216|579570134|FG010|Stage 2|Physician Decision|0|||
160502898|NCT05000216|579570135|FG011|Stage 2|Physician Decision|0|||
160502899|NCT05000216|579570136|FG012|Stage 2|Physician Decision|1|||
160502900|NCT05000216|579570137|FG013|Stage 2|Physician Decision|0|||
160502901|NCT05000216|579570138|FG014|Stage 2|Physician Decision|0|||
160502902|NCT05000216|579570139|FG015|Stage 2|Physician Decision|0|||
160502903|NCT05000216|579570140|FG016|Stage 2|Physician Decision|0|||
160502904|NCT05000216|579570141|FG017|Stage 2|Physician Decision|0|||
160502905|NCT05000216|579570142|FG018|Stage 2|Physician Decision|0|||
160502906|NCT05000216|579570143|FG019|Stage 2|Physician Decision|0|||
160502907|NCT05000216|579570144|FG020|Stage 2|Physician Decision|0|||
160502908|NCT05000216|579570145|FG021|Stage 2|Physician Decision|0|||
160502909|NCT05000216|579570124|FG000|Stage 2|Withdrawal by Subject|0|||
160502910|NCT05000216|579570125|FG001|Stage 2|Withdrawal by Subject|0|||
160502911|NCT05000216|579570126|FG002|Stage 2|Withdrawal by Subject|0|||
160502912|NCT05000216|579570127|FG003|Stage 2|Withdrawal by Subject|0|||
160502913|NCT05000216|579570128|FG004|Stage 2|Withdrawal by Subject|0|||
160502914|NCT05000216|579570129|FG005|Stage 2|Withdrawal by Subject|0|||
160502915|NCT05000216|579570130|FG006|Stage 2|Withdrawal by Subject|0|||
160502916|NCT05000216|579570131|FG007|Stage 2|Withdrawal by Subject|0|||
160502917|NCT05000216|579570132|FG008|Stage 2|Withdrawal by Subject|0|||
160502918|NCT05000216|579570133|FG009|Stage 2|Withdrawal by Subject|0|||
160502919|NCT05000216|579570134|FG010|Stage 2|Withdrawal by Subject|0|||
160502920|NCT05000216|579570135|FG011|Stage 2|Withdrawal by Subject|0|||
160502921|NCT05000216|579570136|FG012|Stage 2|Withdrawal by Subject|0|||
160502922|NCT05000216|579570137|FG013|Stage 2|Withdrawal by Subject|0|||
160502923|NCT05000216|579570138|FG014|Stage 2|Withdrawal by Subject|2|||
160502924|NCT05000216|579570139|FG015|Stage 2|Withdrawal by Subject|0|||
160502925|NCT05000216|579570140|FG016|Stage 2|Withdrawal by Subject|9|||
160502926|NCT05000216|579570141|FG017|Stage 2|Withdrawal by Subject|0|||
160502927|NCT05000216|579570142|FG018|Stage 2|Withdrawal by Subject|0|||
160502928|NCT05000216|579570143|FG019|Stage 2|Withdrawal by Subject|0|||
160502929|NCT05000216|579570144|FG020|Stage 2|Withdrawal by Subject|0|||
160502930|NCT05000216|579570145|FG021|Stage 2|Withdrawal by Subject|0|||
160502931|NCT05000216|579570124|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
160502932|NCT05000216|579570125|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
160502933|NCT05000216|579570126|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
160502934|NCT05000216|579570127|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
160502935|NCT05000216|579570128|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
160502936|NCT05000216|579570129|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
160502937|NCT05000216|579570130|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
160502938|NCT05000216|579570131|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
160502939|NCT05000216|579570132|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
160502940|NCT05000216|579570133|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
160502941|NCT05000216|579570134|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
160502942|NCT05000216|579570135|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
160502943|NCT05000216|579570136|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
160502944|NCT05000216|579570137|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
160502945|NCT05000216|579570138|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
160502946|NCT05000216|579570139|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
160502947|NCT05000216|579570140|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
160502948|NCT05000216|579570141|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
160502949|NCT05000216|579570142|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
160502950|NCT05000216|579570143|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
160502951|NCT05000216|579570144|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
160502952|NCT05000216|579570145|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
160502953|NCT05000216|579570124|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502954|NCT05000216|579570125|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502955|NCT05000216|579570126|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502956|NCT05000216|579570127|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502957|NCT05000216|579570128|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502958|NCT05000216|579570129|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502959|NCT05000216|579570130|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502960|NCT05000216|579570131|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502961|NCT05000216|579570132|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502962|NCT05000216|579570133|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502963|NCT05000216|579570134|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502964|NCT05000216|579570135|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502965|NCT05000216|579570136|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502966|NCT05000216|579570137|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502967|NCT05000216|579570138|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
160502968|NCT05000216|579570139|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502969|NCT05000216|579570140|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
160502970|NCT05000216|579570141|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502971|NCT05000216|579570142|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502972|NCT05000216|579570143|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502973|NCT05000216|579570144|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502974|NCT05000216|579570145|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
160502975|NCT05000216|579570124|FG000|Stage 2|Other reason|0|||
160502976|NCT05000216|579570125|FG001|Stage 2|Other reason|0|||
160502977|NCT05000216|579570126|FG002|Stage 2|Other reason|0|||
160502978|NCT05000216|579570127|FG003|Stage 2|Other reason|0|||
160502979|NCT05000216|579570128|FG004|Stage 2|Other reason|0|||
160502980|NCT05000216|579570129|FG005|Stage 2|Other reason|0|||
160502981|NCT05000216|579570130|FG006|Stage 2|Other reason|0|||
160502982|NCT05000216|579570131|FG007|Stage 2|Other reason|0|||
160502983|NCT05000216|579570132|FG008|Stage 2|Other reason|0|||
160502984|NCT05000216|579570133|FG009|Stage 2|Other reason|0|||
160502985|NCT05000216|579570134|FG010|Stage 2|Other reason|0|||
160502986|NCT05000216|579570135|FG011|Stage 2|Other reason|0|||
160502987|NCT05000216|579570136|FG012|Stage 2|Other reason|0|||
160502988|NCT05000216|579570137|FG013|Stage 2|Other reason|0|||
160502989|NCT05000216|579570138|FG014|Stage 2|Other reason|0|||
160502990|NCT05000216|579570139|FG015|Stage 2|Other reason|0|||
160502991|NCT05000216|579570140|FG016|Stage 2|Other reason|1|||
160502992|NCT05000216|579570141|FG017|Stage 2|Other reason|0|||
160502993|NCT05000216|579570142|FG018|Stage 2|Other reason|0|||
160502994|NCT05000216|579570143|FG019|Stage 2|Other reason|0|||
160502995|NCT05000216|579570144|FG020|Stage 2|Other reason|0|||
160502996|NCT05000216|579570145|FG021|Stage 2|Other reason|0|||
160502997|NCT05000216|579570124|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
160502998|NCT05000216|579570125|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
160502999|NCT05000216|579570126|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
160503000|NCT05000216|579570127|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
160503001|NCT05000216|579570128|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
160503002|NCT05000216|579570129|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
160503003|NCT05000216|579570130|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
160503004|NCT05000216|579570131|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
160503005|NCT05000216|579570132|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
160503006|NCT05000216|579570133|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
160503007|NCT05000216|579570134|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
160503008|NCT05000216|579570135|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
160503009|NCT05000216|579570136|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
160503010|NCT05000216|579570137|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
160503011|NCT05000216|579570138|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
160503012|NCT05000216|579570139|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
160503013|NCT05000216|579570140|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
160503014|NCT05000216|579570141|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
160503015|NCT05000216|579570142|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
160503016|NCT05000216|579570143|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
160503017|NCT05000216|579570144|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
160503018|NCT05000216|579570145|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
160503019|NCT05000216|579570124|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503020|NCT05000216|579570125|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503021|NCT05000216|579570126|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503022|NCT05000216|579570127|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503023|NCT05000216|579570128|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503024|NCT05000216|579570129|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503025|NCT05000216|579570130|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503026|NCT05000216|579570131|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503027|NCT05000216|579570132|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503028|NCT05000216|579570133|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503029|NCT05000216|579570134|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503030|NCT05000216|579570135|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503031|NCT05000216|579570136|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503032|NCT05000216|579570137|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503033|NCT05000216|579570138|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503034|NCT05000216|579570139|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
160503035|NCT05000216|579570140|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503036|NCT05000216|579570141|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503037|NCT05000216|579570142|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503038|NCT05000216|579570143|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503039|NCT05000216|579570144|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503040|NCT05000216|579570145|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
160503041|NCT05000216|579570124|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503042|NCT05000216|579570125|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503043|NCT05000216|579570126|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503044|NCT05000216|579570127|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503045|NCT05000216|579570128|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503046|NCT05000216|579570129|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503047|NCT05000216|579570130|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503048|NCT05000216|579570131|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503049|NCT05000216|579570132|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503050|NCT05000216|579570133|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503051|NCT05000216|579570134|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503052|NCT05000216|579570135|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503053|NCT05000216|579570136|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503054|NCT05000216|579570137|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
160503055|NCT05000216|579570138|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503056|NCT05000216|579570139|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
160503057|NCT05000216|579570140|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503058|NCT05000216|579570141|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503059|NCT05000216|579570142|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
160503060|NCT05000216|579570143|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503061|NCT05000216|579570144|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503062|NCT05000216|579570145|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
160503063|NCT04481373|579570146|FG000|Overall Study|Protocol Violation|1|||
160503064|NCT04481373|579570147|FG001|Overall Study|Protocol Violation|0|||
160503065|NCT04481373|579570146|FG000|Overall Study|Viral load in hospital not over 1000|2|||
160503066|NCT04481373|579570147|FG001|Overall Study|Viral load in hospital not over 1000|1|||
160619990|NCT00982111|579986348|FG000|Overall Study|Medical Decision|1|||
160503067|NCT04481373|579570146|FG000|Overall Study|Death before hospital discharge|1|||
160503068|NCT04481373|579570147|FG001|Overall Study|Death before hospital discharge|0|||
160503069|NCT00332462|579570149|FG000|Overall Study|Adverse Event|5|||
160503070|NCT00332462|579570149|FG000|Overall Study|Abnormal Lab Value|1|||
160503071|NCT00332462|579570149|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160503072|NCT00332462|579570149|FG000|Overall Study|no longer requires study drug|1|||
160503073|NCT00332462|579570149|FG000|Overall Study|Death|3|||
160503074|NCT00332462|579570149|FG000|Overall Study|Graft Loss|2|||
160503075|NCT01685229|579570152|FG000|Overall Study|Subjects missing Study Exit form|3|||
160503076|NCT01685229|579570153|FG001|Overall Study|Subjects missing Study Exit form|1|||
160503077|NCT01685229|579570152|FG000|Overall Study|Lost to Follow-up|16|||
160503078|NCT01685229|579570153|FG001|Overall Study|Lost to Follow-up|10|||
160503079|NCT01685229|579570152|FG000|Overall Study|Withdrawal by Subject|6|||
160503080|NCT01685229|579570153|FG001|Overall Study|Withdrawal by Subject|5|||
160503081|NCT01685229|579570152|FG000|Overall Study|Death|1|||
160503082|NCT01685229|579570153|FG001|Overall Study|Death|0|||
160503083|NCT03325777|579570171|FG000|Overall Study|Lost to Follow-up|9|||
160503084|NCT03325777|579570172|FG001|Overall Study|Lost to Follow-up|12|||
160503085|NCT04191616|579570175|FG000|Pre-assignment Period|Did not receive study treatment|2|||
160503086|NCT04191616|579570175|FG000|Treatment Period|Death|37|||
160503087|NCT04191616|579570175|FG000|Treatment Period|Sponsor decision|11|||
160503088|NCT04191616|579570175|FG000|Treatment Period|Withdrawal by Subject|4|||
160503089|NCT01361594|579570176|FG000|Overall Study|Withdrawal by Subject|1|||
160503090|NCT01361594|579570177|FG001|Overall Study|Withdrawal by Subject|2|||
160503091|NCT02762903|579570181|FG000|Overall Study|Lost to Follow-up|0|||
160503092|NCT02762903|579570182|FG001|Overall Study|Lost to Follow-up|1|||
160503093|NCT01889069|579570183|FG000|Overall Study|Death|18|||
160503094|NCT01889069|579570183|FG000|Overall Study|Progression of Disease|14|||
160503095|NCT01889069|579570183|FG000|Overall Study|Lost to Follow-up|6|||
160503096|NCT01889069|579570183|FG000|Overall Study|Other|4|||
160503097|NCT01889069|579570183|FG000|Overall Study|Consent Withdrawal|3|||
160503098|NCT01426347|579570187|FG000|Overall Study|Lost to Follow-up|0|||
160503099|NCT01426347|579570188|FG001|Overall Study|Lost to Follow-up|3|||
160503100|NCT01426347|579570187|FG000|Overall Study|Protocol Violation|2|||
160503101|NCT01426347|579570188|FG001|Overall Study|Protocol Violation|0|||
160503102|NCT01426347|579570187|FG000|Overall Study|Withdrawal by Subject|5|||
160503103|NCT01426347|579570188|FG001|Overall Study|Withdrawal by Subject|0|||
160503104|NCT00455741|579570189|FG000|Overall Study|Physician Decision|0|||
160503105|NCT00455741|579570190|FG001|Overall Study|Physician Decision|1|||
160503106|NCT03041792|579570191|FG000|Overall Study|Adverse Event|4|||
160503107|NCT03041792|579570192|FG001|Overall Study|Adverse Event|0|||
160503108|NCT03041792|579570191|FG000|Overall Study|Death in the family|0|||
160503109|NCT03041792|579570192|FG001|Overall Study|Death in the family|2|||
160503110|NCT03041792|579570191|FG000|Overall Study|Randomized but not treated|0|||
160503111|NCT03041792|579570192|FG001|Overall Study|Randomized but not treated|1|||
160503112|NCT04978090|579570193|FG000|Overall Study|unable to adequately fit device|2|||
160503113|NCT01509547|579570196|FG000|Overall Study|Lost to Follow-up|24|||
160503114|NCT01509547|579570197|FG001|Overall Study|Lost to Follow-up|14|||
160503115|NCT01509547|579570196|FG000|Overall Study|Withdrawal by Subject|11|||
160503116|NCT01509547|579570197|FG001|Overall Study|Withdrawal by Subject|24|||
160503117|NCT01509547|579570196|FG000|Overall Study|Physician Decision|0|||
160503118|NCT01509547|579570197|FG001|Overall Study|Physician Decision|1|||
160503119|NCT02227992|579570198|FG000|Overall Study|Lost to Follow-up|1|||
160503120|NCT02227992|579570199|FG001|Overall Study|Lost to Follow-up|1|||
160503121|NCT01371708|579570204|FG000|Overall Study|Insufficient clinical response|3|||
160503122|NCT01371708|579570205|FG001|Overall Study|Insufficient clinical response|2|||
160503123|NCT01371708|579570206|FG002|Overall Study|Insufficient clinical response|0|||
160503124|NCT01371708|579570204|FG000|Overall Study|Lost to Follow-up|5|||
160503125|NCT01371708|579570205|FG001|Overall Study|Lost to Follow-up|9|||
160503126|NCT01371708|579570206|FG002|Overall Study|Lost to Follow-up|7|||
160503127|NCT01371708|579570204|FG000|Overall Study|Protocol Violation|2|||
160503128|NCT01371708|579570205|FG001|Overall Study|Protocol Violation|1|||
160503129|NCT01371708|579570206|FG002|Overall Study|Protocol Violation|2|||
160503130|NCT01371708|579570204|FG000|Overall Study|No longer willing to participate|7|||
160503131|NCT01371708|579570205|FG001|Overall Study|No longer willing to participate|7|||
160503132|NCT01371708|579570206|FG002|Overall Study|No longer willing to participate|13|||
160503133|NCT01371708|579570204|FG000|Overall Study|Medication error/not related to AE|0|||
160503134|NCT01371708|579570205|FG001|Overall Study|Medication error/not related to AE|1|||
160503135|NCT01371708|579570206|FG002|Overall Study|Medication error/not related to AE|0|||
160503136|NCT01371708|579570204|FG000|Overall Study|Other|3|||
160503137|NCT01371708|579570205|FG001|Overall Study|Other|2|||
160619991|NCT00982111|579986349|FG001|Overall Study|Medical Decision|0|||
160619992|NCT00982111|579986348|FG000|Overall Study|Withdrawal by Subject|17|||
160619993|NCT00982111|579986349|FG001|Overall Study|Withdrawal by Subject|19|||
160619994|NCT00982111|579986348|FG000|Overall Study|Global Study End|0|||
160503138|NCT01371708|579570206|FG002|Overall Study|Other|4|||
160503139|NCT01371708|579570204|FG000|Overall Study|Adverse Event|5|||
160503140|NCT01371708|579570205|FG001|Overall Study|Adverse Event|8|||
160503141|NCT01371708|579570206|FG002|Overall Study|Adverse Event|12|||
160503142|NCT01371708|579570204|FG000|Overall Study|Started but did not receive treatment|1|||
160503143|NCT01371708|579570205|FG001|Overall Study|Started but did not receive treatment|0|||
160503144|NCT01371708|579570206|FG002|Overall Study|Started but did not receive treatment|1|||
160503145|NCT02514551|579570207|FG000|Overall Study|Lost to Follow-up|0|||
160503146|NCT02514551|579570208|FG001|Overall Study|Lost to Follow-up|1|||
160503147|NCT02514551|579570207|FG000|Overall Study|Participant Never Treated|0|||
160503148|NCT02514551|579570208|FG001|Overall Study|Participant Never Treated|2|||
160503149|NCT03197766|579570219|FG000|Overall Study|Withdrawal by Subject|2|||
160503150|NCT03197766|579570220|FG001|Overall Study|Withdrawal by Subject|0|||
160503151|NCT00996606|579570221|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
160503152|NCT00996606|579570221|FG000|Overall Study|Insufficient Therapeutic Response|2|||
160503153|NCT00996606|579570221|FG000|Overall Study|Protocol Violation|1|||
160503154|NCT00996606|579570221|FG000|Overall Study|Withdrawal by Subject|3|||
160503155|NCT00570908|579570223|FG000|Overall Study|Adverse Event|5|||
160503156|NCT00570908|579570223|FG000|Overall Study|Withdrawal by Subject|2|||
160503157|NCT00632502|579570224|FG000|Overall Study|Adverse Event|0|||
160503158|NCT00632502|579570225|FG001|Overall Study|Adverse Event|1|||
160503159|NCT00632502|579570224|FG000|Overall Study|Randomized not treated|3|||
160503160|NCT00632502|579570225|FG001|Overall Study|Randomized not treated|0|||
160503161|NCT01213524|579570226|FG000|Baseline|Withdrawal by Subject|5|||
160503162|NCT01213524|579570226|FG000|Baseline|high breath alcohol levels|1|||
160503163|NCT01213524|579570226|FG000|Baseline|Physician Decision|1|||
160503164|NCT01213524|579570226|FG000|Session 2|Withdrawal by Subject|5|||
160503165|NCT01213524|579570226|FG000|Session 3|Withdrawal by Subject|4|||
160503166|NCT01213524|579570226|FG000|Session 4|Physician Decision|1|||
160503167|NCT01213524|579570226|FG000|Session 4|Withdrawal by Subject|2|||
160503168|NCT00975676|579570230|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
160503169|NCT00975676|579570231|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
160503170|NCT02209181|579570232|FG000|Overall Study|Adverse Event|1|||
160503171|NCT02209181|579570233|FG001|Overall Study|Adverse Event|0|||
160503172|NCT02209181|579570234|FG002|Overall Study|Adverse Event|1|||
160503173|NCT02209181|579570235|FG003|Overall Study|Adverse Event|0|||
160503174|NCT02209181|579570232|FG000|Overall Study|Withdrawal by Subject|0|||
160503175|NCT02209181|579570233|FG001|Overall Study|Withdrawal by Subject|1|||
160503176|NCT02209181|579570234|FG002|Overall Study|Withdrawal by Subject|0|||
160503177|NCT02209181|579570235|FG003|Overall Study|Withdrawal by Subject|0|||
160503178|NCT02548078|579570236|FG000|Overall Study|Serious adverse event/Adverse event|1|||
160503179|NCT02548078|579570237|FG001|Overall Study|Serious adverse event/Adverse event|0|||
160503180|NCT02548078|579570236|FG000|Overall Study|Moved from study area|3|||
160503181|NCT02548078|579570237|FG001|Overall Study|Moved from study area|3|||
160503182|NCT02548078|579570236|FG000|Overall Study|Lost to Follow-up|1|||
160503183|NCT02548078|579570237|FG001|Overall Study|Lost to Follow-up|3|||
160503184|NCT02579772|579570238|FG000|Overall Study|Withdrawal by Subject|0|||
160503185|NCT02579772|579570239|FG001|Overall Study|Withdrawal by Subject|1|||
160503186|NCT02579772|579570238|FG000|Overall Study|Usage of additional antioxidants|1|||
160503187|NCT02579772|579570239|FG001|Overall Study|Usage of additional antioxidants|0|||
160503188|NCT02579772|579570238|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
160503189|NCT02579772|579570239|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
160503190|NCT01040169|579570240|FG000|Overall Study|Lost to Follow-up|3|||
160503191|NCT01040169|579570241|FG001|Overall Study|Lost to Follow-up|8|||
160503192|NCT00350727|579570242|FG000|Phase I: Dose Escalation|Adverse Event|4|||
160503193|NCT00350727|579570243|FG001|Phase I: Dose Escalation|Adverse Event|0|||
160503194|NCT00350727|579570244|FG002|Phase I: Dose Escalation|Adverse Event|0|||
160503195|NCT00350727|579570242|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
160503196|NCT00350727|579570243|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
160503197|NCT00350727|579570244|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
160503198|NCT00350727|579570242|FG000|Phase I: Dose Escalation|Death|1|||
160503199|NCT00350727|579570243|FG001|Phase I: Dose Escalation|Death|0|||
160503200|NCT00350727|579570244|FG002|Phase I: Dose Escalation|Death|0|||
160503201|NCT00350727|579570242|FG000|Phase I: Dose Escalation|Physician Decision|1|||
160503202|NCT00350727|579570243|FG001|Phase I: Dose Escalation|Physician Decision|0|||
160503203|NCT00350727|579570244|FG002|Phase I: Dose Escalation|Physician Decision|0|||
160503204|NCT00350727|579570242|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
160503205|NCT00350727|579570243|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
160503206|NCT00350727|579570244|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
160503207|NCT00350727|579570242|FG000|Phase II|Disease Progression|0|||
160503208|NCT00350727|579570243|FG001|Phase II|Disease Progression|15|||
160503209|NCT00350727|579570244|FG002|Phase II|Disease Progression|16|||
160503210|NCT00350727|579570242|FG000|Phase II|Clinical Deterioration|0|||
160619995|NCT00982111|579986349|FG001|Overall Study|Global Study End|1|||
160619996|NCT00982111|579986348|FG000|Overall Study|Sponsor's Decision|0|||
160503211|NCT00350727|579570243|FG001|Phase II|Clinical Deterioration|1|||
160503212|NCT00350727|579570244|FG002|Phase II|Clinical Deterioration|0|||
160503213|NCT00350727|579570242|FG000|Phase II|Withdrawal by Subject|0|||
160503214|NCT00350727|579570243|FG001|Phase II|Withdrawal by Subject|2|||
160503215|NCT00350727|579570244|FG002|Phase II|Withdrawal by Subject|1|||
160503216|NCT00350727|579570242|FG000|Phase II|Adverse Event|0|||
160503217|NCT00350727|579570243|FG001|Phase II|Adverse Event|1|||
160503218|NCT00350727|579570244|FG002|Phase II|Adverse Event|1|||
160503219|NCT00350727|579570242|FG000|Phase II|Death|0|||
160503220|NCT00350727|579570243|FG001|Phase II|Death|0|||
160503221|NCT00350727|579570244|FG002|Phase II|Death|2|||
160503222|NCT00350727|579570242|FG000|Phase II|Sponsor Terminated Study|0|||
160503223|NCT00350727|579570243|FG001|Phase II|Sponsor Terminated Study|0|||
160503224|NCT00350727|579570244|FG002|Phase II|Sponsor Terminated Study|1|||
160503225|NCT00350727|579570242|FG000|Phase II|Enrolled in Rollover Study|0|||
160503226|NCT00350727|579570243|FG001|Phase II|Enrolled in Rollover Study|0|||
160503227|NCT00350727|579570244|FG002|Phase II|Enrolled in Rollover Study|1|||
160503228|NCT00862836|579570245|FG000|Overall Study|Withdrawal by Subject|1|||
160503229|NCT03554629|579572472|FG000|Overall Study|Inadequate data|6|||
160503230|NCT01182441|579572475|FG000|Overall Study|Patient Still in Follow-up|152|||
160503231|NCT01182441|579572476|FG001|Overall Study|Patient Still in Follow-up|72|||
160503232|NCT01182441|579572475|FG000|Overall Study|Death|37|||
160503233|NCT01182441|579572476|FG001|Overall Study|Death|25|||
160503234|NCT01182441|579572475|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
160503235|NCT01182441|579572476|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
160503236|NCT01182441|579572475|FG000|Overall Study|Lost to Follow-up|5|||
160503237|NCT01182441|579572476|FG001|Overall Study|Lost to Follow-up|8|||
160503238|NCT01182441|579572475|FG000|Overall Study|Withdrawal by Subject|6|||
160503239|NCT01182441|579572476|FG001|Overall Study|Withdrawal by Subject|13|||
160503240|NCT01182441|579572475|FG000|Overall Study|Implant Not Attempted|4|||
160503241|NCT01182441|579572476|FG001|Overall Study|Implant Not Attempted|0|||
160503242|NCT01182441|579572475|FG000|Overall Study|Adverse Event|2|||
160503243|NCT01182441|579572476|FG001|Overall Study|Adverse Event|0|||
160503244|NCT01182441|579572475|FG000|Overall Study|Physician Decision|1|||
160503245|NCT01182441|579572476|FG001|Overall Study|Physician Decision|1|||
160503246|NCT03480932|579572477|FG000|Overall Study|Death|1|||
160503247|NCT03480932|579572478|FG001|Overall Study|Death|1|||
160503248|NCT03480932|579572479|FG002|Overall Study|Death|0|||
160503249|NCT03480932|579572477|FG000|Overall Study|Lost to Follow-up|0|||
160503250|NCT03480932|579572478|FG001|Overall Study|Lost to Follow-up|2|||
160503251|NCT03480932|579572479|FG002|Overall Study|Lost to Follow-up|3|||
160503252|NCT03480932|579572477|FG000|Overall Study|Incarcerated|2|||
160503253|NCT03480932|579572478|FG001|Overall Study|Incarcerated|2|||
160619997|NCT00982111|579986349|FG001|Overall Study|Sponsor's Decision|1|||
160619998|NCT03769753|579986350|FG000|Overall Study|Not Treated|6|||
160619999|NCT03769753|579986350|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
160620000|NCT01070381|579986351|FG000|Period 2, 1 Week of Wear|Handling|0|||
160620001|NCT01070381|579986352|FG001|Period 2, 1 Week of Wear|Handling|1|||
160620002|NCT01070381|579986351|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
160620003|NCT01070381|579986352|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
160620004|NCT00684073|579986353|FG000|Selection|Selection/non-selection criteria|3|||
160620005|NCT00684073|579986353|FG000|Selection|Death|1|||
160620006|NCT00684073|579986353|FG000|Selection|noncompliance|1|||
160620007|NCT00684073|579986353|FG000|Selection|Lost to Follow-up|1|||
160620008|NCT00684073|579986353|FG000|Selection|request of the sponsor|1|||
160620009|NCT00684073|579986353|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
160620010|NCT01259388|579986355|FG000|Overall Study|Adverse Event|3|||
160620011|NCT01259388|579986356|FG001|Overall Study|Adverse Event|0|||
160620012|NCT01259388|579986355|FG000|Overall Study|Withdrawal by Subject|1|||
160620013|NCT01259388|579986356|FG001|Overall Study|Withdrawal by Subject|1|||
160620014|NCT01259388|579986355|FG000|Overall Study|Physician Decision|1|||
160620015|NCT01259388|579986356|FG001|Overall Study|Physician Decision|0|||
160620016|NCT02728804|579986359|FG000|Overall Study|Ineligible|3|||
160620017|NCT02728804|579986359|FG000|Overall Study|Did not complete baseline questionnaire|9|||
160620018|NCT02728804|579986359|FG000|Overall Study|Death|99|||
160620019|NCT00591786|579986360|FG000|Overall Study|Withdrawal of Informed Consent|0|||
160620020|NCT00591786|579986361|FG001|Overall Study|Withdrawal of Informed Consent|0|||
160620021|NCT00591786|579986362|FG002|Overall Study|Withdrawal of Informed Consent|1|||
160620022|NCT00591786|579986363|FG003|Overall Study|Withdrawal of Informed Consent|0|||
160620023|NCT00591786|579986364|FG004|Overall Study|Withdrawal of Informed Consent|0|||
160620024|NCT00591786|579986365|FG005|Overall Study|Withdrawal of Informed Consent|0|||
160662940|NCT02100228|580149217|FG000|Overall Study|Administrative reason|0|||
160662941|NCT02100228|580149218|FG001|Overall Study|Administrative reason|1|||
160662942|NCT02100228|580149217|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
160503254|NCT03480932|579572479|FG002|Overall Study|Incarcerated|2|||
160620025|NCT00591786|579986366|FG006|Overall Study|Withdrawal of Informed Consent|0|||
160620026|NCT00591786|579986367|FG007|Overall Study|Withdrawal of Informed Consent|0|||
160620027|NCT00591786|579986368|FG008|Overall Study|Withdrawal of Informed Consent|0|||
160662943|NCT02100228|580149218|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
160503255|NCT00663702|579572480|FG000|Overall Study|Adverse Event|8|||
160503256|NCT00663702|579572481|FG001|Overall Study|Adverse Event|4|||
160503257|NCT00663702|579572480|FG000|Overall Study|Withdrawal by Subject|3|||
160503258|NCT00663702|579572481|FG001|Overall Study|Withdrawal by Subject|1|||
160503259|NCT00663702|579572480|FG000|Overall Study|Pregnancy|0|||
160503260|NCT00663702|579572481|FG001|Overall Study|Pregnancy|1|||
160503261|NCT00663702|579572480|FG000|Overall Study|Lost to Follow-up|3|||
160503262|NCT00663702|579572481|FG001|Overall Study|Lost to Follow-up|0|||
160503263|NCT00663702|579572480|FG000|Overall Study|Death|1|||
160503264|NCT00663702|579572481|FG001|Overall Study|Death|1|||
160503265|NCT00663702|579572480|FG000|Overall Study|Lack of Efficacy|3|||
160503266|NCT00663702|579572481|FG001|Overall Study|Lack of Efficacy|3|||
160503267|NCT03056300|579572482|FG000|Overall Study|Surgical reason per study protocol|3|||
160503268|NCT05262517|579572489|FG000|Overall Study|Randomized but not treated|5|||
160503269|NCT05262517|579572490|FG001|Overall Study|Randomized but not treated|11|||
160503270|NCT05577715|579572491|FG000|Overall Study|Withdrawal by Subject|1|||
160503271|NCT05577715|579572491|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
160503272|NCT05577715|579572491|FG000|Overall Study|Lost to Follow-up|1|||
160503273|NCT05577715|579572491|FG000|Overall Study|Death|6|||
160503274|NCT02476175|579572492|FG000|Overall Study|Adverse Event|2|||
160503275|NCT02057575|579572498|FG000|Overall Study|Adverse Event|0|||
160503276|NCT02057575|579572499|FG001|Overall Study|Adverse Event|2|||
160503277|NCT02057575|579572500|FG002|Overall Study|Adverse Event|0|||
160503278|NCT02057575|579572501|FG003|Overall Study|Adverse Event|1|||
160503279|NCT02057575|579572498|FG000|Overall Study|Withdrawal by Subject|1|||
160503280|NCT02057575|579572499|FG001|Overall Study|Withdrawal by Subject|0|||
160503281|NCT02057575|579572500|FG002|Overall Study|Withdrawal by Subject|0|||
160503282|NCT02057575|579572501|FG003|Overall Study|Withdrawal by Subject|0|||
160503283|NCT02057575|579572498|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
160503284|NCT02057575|579572499|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
160503285|NCT02057575|579572500|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
160503286|NCT02057575|579572501|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
160503287|NCT02057575|579572498|FG000|Overall Study|Protocol Violation|0|||
160503288|NCT02057575|579572499|FG001|Overall Study|Protocol Violation|1|||
160503289|NCT02057575|579572500|FG002|Overall Study|Protocol Violation|0|||
160503290|NCT02057575|579572501|FG003|Overall Study|Protocol Violation|0|||
160503291|NCT02979249|579572503|FG000|Overall Study|Lost to Follow-up|2|||
160503292|NCT02979249|579572503|FG000|Overall Study|Withdrawal by Subject|4|||
160503293|NCT01125046|579572504|FG000|First 6 Months of Treatment|Death|1|||
160503294|NCT01125046|579572504|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
160503295|NCT01125046|579572504|FG000|First 6 Months of Treatment|Non-compliance|1|||
160503296|NCT01125046|579572504|FG000|First 6 Months of Treatment|Surgery|1|||
160503297|NCT01125046|579572504|FG000|First 6 Months of Treatment|Progressive Disease|7|||
160503298|NCT01125046|579572504|FG000|First 6 Months of Treatment|Adverse Event|2|||
160503299|NCT01125046|579572504|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
160503300|NCT01125046|579572504|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
160503301|NCT01125046|579572504|FG000|Follow-up/Data Cut Off Point|Death|29|||
160503302|NCT01125046|579572504|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
160503303|NCT00659880|579572512|FG000|Overall Study|Lost to Follow-up|5|||
160503304|NCT01853475|579572513|FG000|Overall Study|Withdrawal by Subject|0|||
160503305|NCT01853475|579572514|FG001|Overall Study|Withdrawal by Subject|1|||
160503306|NCT01853475|579572515|FG002|Overall Study|Withdrawal by Subject|0|||
160503307|NCT02159040|579572516|FG000|Overall Study|Death|1|||
160503308|NCT02766777|579572520|FG000|Overall Study|Adverse Event|12|||
160503309|NCT02766777|579572520|FG000|Overall Study|Lost to Follow-up|16|||
160503310|NCT02766777|579572520|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160503311|NCT02766777|579572520|FG000|Overall Study|Protocol Violation|1|||
160503312|NCT02766777|579572520|FG000|Overall Study|Withdrawal by Subject|4|||
160503313|NCT01886287|579572521|FG000|Overall Study|Radiographic disease progression|1|||
160503314|NCT01886287|579572521|FG000|Overall Study|Clinical progression due to disease|1|||
160503315|NCT02964325|579572522|FG000|Overall Study|Lost to Follow-up|3|||
160503316|NCT02964325|579572523|FG001|Overall Study|Lost to Follow-up|3|||
160503317|NCT02964325|579572522|FG000|Overall Study|Physician Decision|5|||
160503318|NCT02964325|579572523|FG001|Overall Study|Physician Decision|4|||
160503319|NCT02964325|579572522|FG000|Overall Study|Death|1|||
160620028|NCT00591786|579986369|FG009|Overall Study|Withdrawal of Informed Consent|0|||
160620029|NCT01854918|579986370|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
160620030|NCT01854918|579986371|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
160620031|NCT01854918|579986370|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
160620032|NCT01854918|579986371|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
160620033|NCT01854918|579986370|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
160620034|NCT01854918|579986371|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
160620035|NCT01854918|579986370|FG000|SOC-controlled Period (Year 1)|Death|5|||
160620036|NCT01854918|579986371|FG001|SOC-controlled Period (Year 1)|Death|5|||
160503320|NCT02964325|579572523|FG001|Overall Study|Death|3|||
160503321|NCT02964325|579572522|FG000|Overall Study|Withdrawal by Subject|2|||
160503322|NCT02964325|579572523|FG001|Overall Study|Withdrawal by Subject|1|||
160503323|NCT02964325|579572522|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
160503324|NCT02964325|579572523|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
160503325|NCT03596762|579572524|FG000|Overall Study|Protocol Violation|0|||
160503326|NCT03596762|579572525|FG001|Overall Study|Protocol Violation|0|||
160503327|NCT03596762|579572526|FG002|Overall Study|Protocol Violation|0|||
160503328|NCT03596762|579572527|FG003|Overall Study|Protocol Violation|0|||
160503329|NCT03596762|579572528|FG004|Overall Study|Protocol Violation|1|||
160503330|NCT03596762|579572524|FG000|Overall Study|Adverse Event|2|||
160503331|NCT03596762|579572525|FG001|Overall Study|Adverse Event|0|||
160503332|NCT03596762|579572526|FG002|Overall Study|Adverse Event|1|||
160503333|NCT03596762|579572527|FG003|Overall Study|Adverse Event|0|||
160503334|NCT03596762|579572528|FG004|Overall Study|Adverse Event|5|||
160503335|NCT03596762|579572524|FG000|Overall Study|Withdrawal by Subject|2|||
160503336|NCT03596762|579572525|FG001|Overall Study|Withdrawal by Subject|1|||
160503337|NCT03596762|579572526|FG002|Overall Study|Withdrawal by Subject|0|||
160503338|NCT03596762|579572527|FG003|Overall Study|Withdrawal by Subject|1|||
160503339|NCT03596762|579572528|FG004|Overall Study|Withdrawal by Subject|1|||
160503340|NCT02510040|579572529|FG000|Overall Study|Deemed no longer eligible|18|||
160503341|NCT02510040|579572530|FG001|Overall Study|Deemed no longer eligible|3|||
160503342|NCT02510040|579572531|FG002|Overall Study|Deemed no longer eligible|1|||
160503343|NCT03842228|579572532|FG000|Overall Study|Adverse Event|1|||
160503344|NCT03842228|579572533|FG001|Overall Study|Adverse Event|1|||
160503345|NCT03842228|579572534|FG002|Overall Study|Adverse Event|1|||
160503346|NCT03842228|579572535|FG003|Overall Study|Adverse Event|0|||
160503347|NCT03842228|579572536|FG004|Overall Study|Adverse Event|0|||
160503348|NCT03842228|579572537|FG005|Overall Study|Adverse Event|0|||
160503349|NCT03842228|579572538|FG006|Overall Study|Adverse Event|0|||
160503350|NCT03842228|579572532|FG000|Overall Study|Death|0|||
160503351|NCT03842228|579572533|FG001|Overall Study|Death|1|||
160503352|NCT03842228|579572534|FG002|Overall Study|Death|0|||
160503353|NCT03842228|579572535|FG003|Overall Study|Death|0|||
160503354|NCT03842228|579572536|FG004|Overall Study|Death|0|||
160503355|NCT03842228|579572537|FG005|Overall Study|Death|0|||
160503356|NCT03842228|579572538|FG006|Overall Study|Death|0|||
160503357|NCT03842228|579572532|FG000|Overall Study|Withdrawal by Subject|0|||
160503358|NCT03842228|579572533|FG001|Overall Study|Withdrawal by Subject|0|||
160503359|NCT03842228|579572534|FG002|Overall Study|Withdrawal by Subject|2|||
160503360|NCT03842228|579572535|FG003|Overall Study|Withdrawal by Subject|1|||
160503361|NCT03842228|579572536|FG004|Overall Study|Withdrawal by Subject|0|||
160503362|NCT03842228|579572537|FG005|Overall Study|Withdrawal by Subject|0|||
160503363|NCT03842228|579572538|FG006|Overall Study|Withdrawal by Subject|2|||
160503364|NCT03842228|579572532|FG000|Overall Study|Progression|8|||
160503365|NCT03842228|579572533|FG001|Overall Study|Progression|1|||
160503366|NCT03842228|579572534|FG002|Overall Study|Progression|7|||
160503367|NCT03842228|579572535|FG003|Overall Study|Progression|5|||
160503368|NCT03842228|579572536|FG004|Overall Study|Progression|4|||
160503369|NCT03842228|579572537|FG005|Overall Study|Progression|2|||
160503370|NCT03842228|579572538|FG006|Overall Study|Progression|3|||
160503371|NCT02195479|579572543|FG000|Overall Study|Lost to Follow-up|18|||
160503372|NCT02195479|579572544|FG001|Overall Study|Lost to Follow-up|15|||
160503373|NCT02195479|579572543|FG000|Overall Study|Death|217|||
160503374|NCT02195479|579572544|FG001|Overall Study|Death|171|||
160503375|NCT02195479|579572543|FG000|Overall Study|Physician Decision|1|||
160503376|NCT02195479|579572544|FG001|Overall Study|Physician Decision|0|||
160503377|NCT02195479|579572543|FG000|Overall Study|Withdrawal by Subject|30|||
160503378|NCT02195479|579572544|FG001|Overall Study|Withdrawal by Subject|30|||
160503379|NCT02195479|579572543|FG000|Overall Study|Other|3|||
160503380|NCT02195479|579572544|FG001|Overall Study|Other|4|||
160503381|NCT02195479|579572543|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
160503382|NCT02195479|579572544|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
160503383|NCT01834586|579572545|FG000|Overall Study|Adverse Event|1|||
160620037|NCT01854918|579986370|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
160620038|NCT01854918|579986371|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
160620039|NCT01854918|579986370|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
160620040|NCT01854918|579986371|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
160620041|NCT01854918|579986370|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
160620042|NCT01854918|579986371|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
160620043|NCT01854918|579986370|FG000|All-IP Period (Years 2 and 3)|Death|5|||
160620044|NCT01854918|579986371|FG001|All-IP Period (Years 2 and 3)|Death|16|||
160620045|NCT04823494|579988371|FG000|Overall Study|Programming software malfunction.|1|||
160620046|NCT04823494|579988372|FG001|Overall Study|Programming software malfunction.|0|||
160620047|NCT04823494|579988371|FG000|Overall Study|Withdrawal by Subject|1|||
160620048|NCT04823494|579988372|FG001|Overall Study|Withdrawal by Subject|0|||
160620049|NCT04823494|579988371|FG000|Overall Study|Devices lost|0|||
160503384|NCT01263509|579572546|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
160503385|NCT01263509|579572547|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
160503386|NCT01263509|579572548|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
160503387|NCT01263509|579572549|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
160503388|NCT01263509|579572546|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
160503389|NCT01263509|579572547|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
160503390|NCT01263509|579572548|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
160503391|NCT01263509|579572549|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
160503392|NCT01263509|579572546|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
160620050|NCT04823494|579988372|FG001|Overall Study|Devices lost|1|||
160620051|NCT03691831|579988373|FG000|Overall Study|Lost to Follow-up|16|||
160503393|NCT01263509|579572547|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160503394|NCT01263509|579572548|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
160503395|NCT01263509|579572549|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
160503396|NCT01263509|579572546|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
160503397|NCT01263509|579572547|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
160503398|NCT01263509|579572548|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
160503399|NCT01263509|579572549|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
160503400|NCT01263509|579572546|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
160503401|NCT01263509|579572547|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
160503402|NCT01263509|579572548|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
160503403|NCT01263509|579572549|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
160503404|NCT01371825|579572550|FG000|Overall Study|Death|4|||
160503405|NCT01818531|579572556|FG000|Overall Study|Withdrawn for case delay after block|1|||
160503406|NCT01818531|579572557|FG001|Overall Study|Withdrawn for case delay after block|0|||
160503407|NCT01818531|579572556|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
160503408|NCT01818531|579572557|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
160503409|NCT01818531|579572556|FG000|Overall Study|Withdrawn for failure to place block|0|||
160503410|NCT01818531|579572557|FG001|Overall Study|Withdrawn for failure to place block|1|||
160503411|NCT00214019|579572558|FG000|Overall Study|Lost to Follow-up|11|||
160503412|NCT00214019|579572558|FG000|Overall Study|Withdrawal by Subject|2|||
160503413|NCT00214019|579572558|FG000|Overall Study|Screen Failed prior to randomization|17|||
160503414|NCT00477490|579572559|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
160503415|NCT00477490|579572560|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
160503416|NCT00477490|579572561|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
160503417|NCT00477490|579572562|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
160503418|NCT00477490|579572563|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
160503419|NCT00477490|579572564|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
160503420|NCT00477490|579572565|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
160503421|NCT00477490|579572566|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
160503422|NCT00477490|579572567|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
160503423|NCT00477490|579572559|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
160503424|NCT00477490|579572560|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
160503425|NCT00477490|579572561|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
160503426|NCT00477490|579572562|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
160503427|NCT00477490|579572563|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
160503428|NCT00477490|579572564|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
160503429|NCT00477490|579572565|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
160503430|NCT00477490|579572566|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
160503431|NCT00477490|579572567|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
160503432|NCT00477490|579572559|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
160503433|NCT00477490|579572560|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
160503434|NCT00477490|579572561|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
160503435|NCT00477490|579572562|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
160503436|NCT00477490|579572563|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
160503437|NCT00477490|579572564|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
160503438|NCT00477490|579572565|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
160503439|NCT00477490|579572566|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
160503440|NCT00477490|579572567|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
160503441|NCT00477490|579572559|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
160503442|NCT00477490|579572560|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
160503443|NCT00477490|579572561|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
160503444|NCT00477490|579572562|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
160503445|NCT00477490|579572563|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
160503446|NCT00477490|579572564|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
160503447|NCT00477490|579572565|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
160503448|NCT00477490|579572566|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
160503449|NCT00477490|579572567|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
160503450|NCT00477490|579572559|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
160503451|NCT00477490|579572560|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
160503452|NCT00477490|579572561|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
160503453|NCT00477490|579572562|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
160503454|NCT00477490|579572563|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
160503455|NCT00477490|579572564|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
160503456|NCT00477490|579572565|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
160503457|NCT00477490|579572566|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
160503458|NCT00477490|579572567|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
160620052|NCT03691831|579988374|FG001|Overall Study|Lost to Follow-up|12|||
160620053|NCT03691831|579988373|FG000|Overall Study|Withdrawal by Subject|9|||
160620054|NCT03691831|579988374|FG001|Overall Study|Withdrawal by Subject|17|||
160503459|NCT00477490|579572559|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
160503460|NCT00477490|579572560|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
160503461|NCT00477490|579572561|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
160503462|NCT00477490|579572562|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
160503463|NCT00477490|579572563|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
160503464|NCT00477490|579572564|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
160503465|NCT00477490|579572565|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
160503466|NCT00477490|579572566|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
160503467|NCT00477490|579572567|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
160503468|NCT00477490|579572559|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
160503469|NCT00477490|579572560|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
160503470|NCT00477490|579572561|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
160503471|NCT00477490|579572562|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
160503472|NCT00477490|579572563|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
160503473|NCT00477490|579572564|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
160503474|NCT00477490|579572565|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
160503475|NCT00477490|579572566|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
160503476|NCT00477490|579572567|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
160503477|NCT00477490|579572559|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
160503478|NCT00477490|579572560|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
160503479|NCT00477490|579572561|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
160503480|NCT00477490|579572562|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
160503481|NCT00477490|579572563|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
160503482|NCT00477490|579572564|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
160503483|NCT00477490|579572565|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
160503484|NCT00477490|579572566|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
160503485|NCT00477490|579572567|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
160503486|NCT00477490|579572559|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
160503487|NCT00477490|579572560|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
160503488|NCT00477490|579572561|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
160503489|NCT00477490|579572562|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
160503490|NCT00477490|579572563|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
160503491|NCT00477490|579572564|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
160503492|NCT00477490|579572565|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
160503493|NCT00477490|579572566|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
160503494|NCT00477490|579572567|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
160503495|NCT00477490|579572559|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
160503496|NCT00477490|579572560|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
160503497|NCT00477490|579572561|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
160503498|NCT00477490|579572562|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
160503499|NCT00477490|579572563|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
160503500|NCT00477490|579572564|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
160503501|NCT00477490|579572565|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
160503502|NCT00477490|579572566|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
160503503|NCT00477490|579572567|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
160503504|NCT00477490|579572559|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
160503505|NCT00477490|579572560|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
160503506|NCT00477490|579572561|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
160503507|NCT00477490|579572562|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
160503508|NCT00477490|579572563|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
160503509|NCT00477490|579572564|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
160503510|NCT00477490|579572565|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
160503511|NCT00477490|579572566|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
160503512|NCT00477490|579572567|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
160503513|NCT00477490|579572559|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
160503514|NCT00477490|579572560|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
160503515|NCT00477490|579572561|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
160503516|NCT00477490|579572562|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
160503517|NCT00477490|579572563|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
160503518|NCT00477490|579572564|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
160503519|NCT00477490|579572565|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
160503520|NCT00477490|579572566|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
160503521|NCT00477490|579572567|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
160662944|NCT02100228|580149217|FG000|Overall Study|Non-compliance|0|||
160662945|NCT02100228|580149218|FG001|Overall Study|Non-compliance|3|||
160662946|NCT02100228|580149217|FG000|Overall Study|Lost to Follow-up|0|||
160662947|NCT02100228|580149218|FG001|Overall Study|Lost to Follow-up|1|||
160503522|NCT00477490|579572559|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
160503523|NCT00477490|579572560|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
160503524|NCT00477490|579572561|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
160503525|NCT00477490|579572562|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
160503526|NCT00477490|579572563|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
160503527|NCT00477490|579572564|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
160503528|NCT00477490|579572565|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
160503529|NCT00477490|579572566|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
160503530|NCT00477490|579572567|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
160503531|NCT00477490|579572559|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
160503532|NCT00477490|579572560|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
160503533|NCT00477490|579572561|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
160503534|NCT00477490|579572562|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
160503535|NCT00477490|579572563|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
160503536|NCT00477490|579572564|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
160503537|NCT00477490|579572565|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
160503538|NCT00477490|579572566|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
160503539|NCT00477490|579572567|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
160503540|NCT01465763|579572570|FG000|Overall Study|Withdrawal by Subject|4|||
160503541|NCT01465763|579572571|FG001|Overall Study|Withdrawal by Subject|0|||
160503542|NCT01465763|579572572|FG002|Overall Study|Withdrawal by Subject|1|||
160503543|NCT01465763|579572570|FG000|Overall Study|Insufficient Clinical Response|11|||
160503544|NCT01465763|579572571|FG001|Overall Study|Insufficient Clinical Response|0|||
160503545|NCT01465763|579572572|FG002|Overall Study|Insufficient Clinical Response|1|||
160503546|NCT01465763|579572570|FG000|Overall Study|Adverse Event|9|||
160503547|NCT01465763|579572571|FG001|Overall Study|Adverse Event|0|||
160503548|NCT01465763|579572572|FG002|Overall Study|Adverse Event|1|||
160503549|NCT01465763|579572570|FG000|Overall Study|Other|2|||
160503550|NCT01465763|579572571|FG001|Overall Study|Other|0|||
160503551|NCT01465763|579572572|FG002|Overall Study|Other|0|||
160503552|NCT01465763|579572570|FG000|Overall Study|Protocol Violation|4|||
160503553|NCT01465763|579572571|FG001|Overall Study|Protocol Violation|1|||
160503554|NCT01465763|579572572|FG002|Overall Study|Protocol Violation|1|||
160503555|NCT01465763|579572570|FG000|Overall Study|Death|1|||
160503556|NCT01465763|579572571|FG001|Overall Study|Death|0|||
160503557|NCT01465763|579572572|FG002|Overall Study|Death|0|||
160503558|NCT01646177|579572573|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
160503559|NCT01646177|579572574|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
160503560|NCT01646177|579572575|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
160503561|NCT01646177|579572576|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
160503562|NCT01646177|579572577|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
160503563|NCT01646177|579572578|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
160503564|NCT01646177|579572579|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
160503565|NCT01646177|579572580|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
160503566|NCT01646177|579572581|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
160503567|NCT01646177|579572582|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
160503568|NCT01646177|579572583|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
160503569|NCT01646177|579572584|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
160503570|NCT01646177|579572573|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
160503571|NCT01646177|579572574|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
160503572|NCT01646177|579572575|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
160503573|NCT01646177|579572576|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
160503574|NCT01646177|579572577|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
160503575|NCT01646177|579572578|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
160503576|NCT01646177|579572579|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
160503577|NCT01646177|579572580|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
160503578|NCT01646177|579572581|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
160503579|NCT01646177|579572582|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
160503580|NCT01646177|579572583|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
160503581|NCT01646177|579572584|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
160503582|NCT01646177|579572573|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
160503583|NCT01646177|579572574|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
160503584|NCT01646177|579572575|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
160503585|NCT01646177|579572576|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
160503586|NCT01646177|579572577|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
160503587|NCT01646177|579572578|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
160503588|NCT01646177|579572579|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
160503589|NCT01646177|579572580|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
160503590|NCT01646177|579572581|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
160503591|NCT01646177|579572582|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
160503592|NCT01646177|579572583|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
160503593|NCT01646177|579572584|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
160503594|NCT01646177|579572573|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
160503595|NCT01646177|579572574|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
160503596|NCT01646177|579572575|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
160503597|NCT01646177|579572576|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
160503598|NCT01646177|579572577|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
160503599|NCT01646177|579572578|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
160503600|NCT01646177|579572579|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
160503601|NCT01646177|579572580|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
160503602|NCT01646177|579572581|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
160503603|NCT01646177|579572582|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
160503604|NCT01646177|579572583|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
160503605|NCT01646177|579572584|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
160503606|NCT01646177|579572573|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
160503607|NCT01646177|579572574|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
160503608|NCT01646177|579572575|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
160503609|NCT01646177|579572576|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
160503610|NCT01646177|579572577|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
160503611|NCT01646177|579572578|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
160503612|NCT01646177|579572579|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
160503613|NCT01646177|579572580|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
160503614|NCT01646177|579572581|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
160503615|NCT01646177|579572582|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
160503616|NCT01646177|579572583|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
160503617|NCT01646177|579572584|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
160503618|NCT01646177|579572573|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
160503619|NCT01646177|579572574|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
160503620|NCT01646177|579572575|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
160503621|NCT01646177|579572576|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
160503622|NCT01646177|579572577|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
160503623|NCT01646177|579572578|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
160503624|NCT01646177|579572579|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
160503625|NCT01646177|579572580|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
160503626|NCT01646177|579572581|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
160503627|NCT01646177|579572582|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
160503628|NCT01646177|579572583|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
160503629|NCT01646177|579572584|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
160503630|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
160503631|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
160503632|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
160503633|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
160503634|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
160503635|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
160503636|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
160503637|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
160503638|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
160503639|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
160503640|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
160503641|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
160503642|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
160503643|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
160503644|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
160503645|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
160503646|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
160503647|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
160503648|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
160503649|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
160503650|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
160503651|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
160503652|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
160620055|NCT03691831|579988373|FG000|Overall Study|Investigator Decision|2|||
160620056|NCT03691831|579988374|FG001|Overall Study|Investigator Decision|2|||
160620057|NCT02198040|579988375|FG000|Overall Study|Work reasons|0|||
160503653|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
160503654|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
160503655|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
160503656|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
160503657|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
160503658|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
160503659|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
160503660|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
160503661|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
160503662|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
160503663|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
160503664|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
160503665|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
160503666|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
160503667|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
160503668|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
160503669|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
160503670|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
160503671|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
160503672|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
160503673|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
160503674|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
160503675|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
160503676|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
160503677|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
160503678|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
160503679|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
160503680|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
160503681|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
160503682|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
160503683|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
160503684|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
160503685|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
160503686|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
160503687|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
160503688|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
160503689|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
160503690|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
160503691|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
160503692|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
160503693|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
160503694|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
160503695|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
160503696|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
160503697|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
160503698|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
160503699|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
160503700|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
160503701|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
160503702|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
160503703|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
160503704|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
160503705|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
160503706|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
160503707|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
160503708|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
160503709|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
160503710|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
160503711|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
160503712|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
160503713|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
160503714|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
160620058|NCT02198040|579988376|FG001|Overall Study|Work reasons|1|||
160662948|NCT02100228|580149217|FG000|Overall Study|Withdrawal by Subject|27|||
160662949|NCT02100228|580149218|FG001|Overall Study|Withdrawal by Subject|37|||
160662950|NCT02100228|580149217|FG000|Overall Study|Adverse Event|16|||
160662951|NCT02100228|580149218|FG001|Overall Study|Adverse Event|12|||
160662952|NCT02100228|580149217|FG000|Overall Study|Death|1|||
160503715|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
160503716|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
160503717|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
160503718|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
160503719|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
160503720|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
160662953|NCT02100228|580149218|FG001|Overall Study|Death|1|||
160662954|NCT00214422|580149219|FG000|Overall Study|Physician Decision|2|||
160662955|NCT00214422|580149220|FG001|Overall Study|Physician Decision|0|||
160662956|NCT00214422|580149221|FG002|Overall Study|Physician Decision|0|||
160662957|NCT00214422|580149219|FG000|Overall Study|Developed esophageal ca|1|||
160662958|NCT00214422|580149220|FG001|Overall Study|Developed esophageal ca|0|||
160503721|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
160503722|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
160503723|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
160503724|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
160503725|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
160503726|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
160503727|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
160503728|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
160503729|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
160503730|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
160503731|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
160503732|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
160503733|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
160503734|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
160503735|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
160503736|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
160503737|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
160503738|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503739|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503740|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503741|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503742|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503743|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503744|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503745|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
160503746|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503747|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503748|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503749|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
160503750|NCT01646177|579572573|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
160503751|NCT01646177|579572574|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
160503752|NCT01646177|579572575|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
160503753|NCT01646177|579572576|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
160503754|NCT01646177|579572577|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
160503755|NCT01646177|579572578|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
160503756|NCT01646177|579572579|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
160503757|NCT01646177|579572580|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
160503758|NCT01646177|579572581|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
160503759|NCT01646177|579572582|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
160503760|NCT01646177|579572583|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
160503761|NCT01646177|579572584|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
160503762|NCT01646177|579572573|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
160503763|NCT01646177|579572574|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
160503764|NCT01646177|579572575|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
160503765|NCT01646177|579572576|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
160503766|NCT01646177|579572577|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
160503767|NCT01646177|579572578|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
160503768|NCT01646177|579572579|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
160662959|NCT00214422|580149221|FG002|Overall Study|Developed esophageal ca|0|||
160503769|NCT01646177|579572580|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
160503770|NCT01646177|579572581|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
160503771|NCT01646177|579572582|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
160503772|NCT01646177|579572583|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
160503773|NCT01646177|579572584|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
160503774|NCT01646177|579572573|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
160503775|NCT01646177|579572574|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
160503776|NCT01646177|579572575|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
160503777|NCT01646177|579572576|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
160503778|NCT01646177|579572577|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
160503779|NCT01646177|579572578|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
160503780|NCT01646177|579572579|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
160503781|NCT01646177|579572580|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
160503782|NCT01646177|579572581|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
160503783|NCT01646177|579572582|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
160503784|NCT01646177|579572583|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
160503785|NCT01646177|579572584|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
160503786|NCT01646177|579572573|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
160503787|NCT01646177|579572574|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
160503788|NCT01646177|579572575|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
160503789|NCT01646177|579572576|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
160503790|NCT01646177|579572577|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
160503791|NCT01646177|579572578|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
160503792|NCT01646177|579572579|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
160503793|NCT01646177|579572580|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
160503794|NCT01646177|579572581|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
160503795|NCT01646177|579572582|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
160503796|NCT01646177|579572583|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
160503797|NCT01646177|579572584|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
160503798|NCT01646177|579572573|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
160503799|NCT01646177|579572574|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
160503800|NCT01646177|579572575|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
160503801|NCT01646177|579572576|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
160503802|NCT01646177|579572577|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
160503803|NCT01646177|579572578|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
160620059|NCT02198040|579988377|FG002|Overall Study|Work reasons|0|||
160620060|NCT02198040|579988375|FG000|Overall Study|Withdrawal by Subject|0|||
160620061|NCT02198040|579988376|FG001|Overall Study|Withdrawal by Subject|0|||
160620062|NCT02198040|579988377|FG002|Overall Study|Withdrawal by Subject|1|||
160620063|NCT00337935|579988378|FG000|Overall Study|Adverse Event|2|||
160620064|NCT00337935|579988379|FG001|Overall Study|Adverse Event|5|||
160620065|NCT00337935|579988378|FG000|Overall Study|Death|2|||
160620066|NCT00337935|579988379|FG001|Overall Study|Death|8|||
160620067|NCT00337935|579988378|FG000|Overall Study|Physician Decision|1|||
160620068|NCT00337935|579988379|FG001|Overall Study|Physician Decision|1|||
160503804|NCT01646177|579572579|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
160503805|NCT01646177|579572580|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
160503806|NCT01646177|579572581|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
160503807|NCT01646177|579572582|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
160503808|NCT01646177|579572583|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
160503809|NCT01646177|579572584|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
160503810|NCT01646177|579572573|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
160503811|NCT01646177|579572574|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
160503812|NCT01646177|579572575|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
160503813|NCT01646177|579572576|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
160503814|NCT01646177|579572577|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
160503815|NCT01646177|579572578|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
160503816|NCT01646177|579572579|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
160503817|NCT01646177|579572580|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
160503818|NCT01646177|579572581|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
160503819|NCT01646177|579572582|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
160503820|NCT01646177|579572583|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
160503821|NCT01646177|579572584|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
160503822|NCT01646177|579572573|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
160503823|NCT01646177|579572574|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
160503824|NCT01646177|579572575|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
160503825|NCT01646177|579572576|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
160503826|NCT01646177|579572577|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
160503827|NCT01646177|579572578|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
160503828|NCT01646177|579572579|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
160503829|NCT01646177|579572580|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
160503830|NCT01646177|579572581|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
160503831|NCT01646177|579572582|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
160503832|NCT01646177|579572583|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
160503833|NCT01646177|579572584|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
160503834|NCT01646177|579572573|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
160503835|NCT01646177|579572574|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
160503836|NCT01646177|579572575|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
160503837|NCT01646177|579572576|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
160503838|NCT01646177|579572577|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
160503839|NCT01646177|579572578|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
160503840|NCT01646177|579572579|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
160503841|NCT01646177|579572580|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
160503842|NCT01646177|579572581|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
160503843|NCT01646177|579572582|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
160503844|NCT01646177|579572583|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
160503845|NCT01646177|579572584|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
160503846|NCT01646177|579572573|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
160503847|NCT01646177|579572574|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
160503848|NCT01646177|579572575|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
160503849|NCT01646177|579572576|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
160503850|NCT01646177|579572577|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
160503851|NCT01646177|579572578|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
160503852|NCT01646177|579572579|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
160503853|NCT01646177|579572580|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
160503854|NCT01646177|579572581|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
160503855|NCT01646177|579572582|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
160503856|NCT01646177|579572583|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
160503857|NCT01646177|579572584|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
160503858|NCT01646177|579572573|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
160503859|NCT01646177|579572574|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
160503860|NCT01646177|579572575|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
160503861|NCT01646177|579572576|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
160503862|NCT01646177|579572577|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
160503863|NCT01646177|579572578|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
160503864|NCT01646177|579572579|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
160503865|NCT01646177|579572580|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
160503866|NCT01646177|579572581|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
160503867|NCT01646177|579572582|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
160620069|NCT00337935|579988378|FG000|Overall Study|Lost to Follow-up|0|||
160620070|NCT00337935|579988379|FG001|Overall Study|Lost to Follow-up|1|||
160620071|NCT00337935|579988378|FG000|Overall Study|Protocol Violation|4|||
160662960|NCT00214422|580149219|FG000|Overall Study|Pt taken off study|1|||
160662961|NCT00214422|580149220|FG001|Overall Study|Pt taken off study|1|||
160662962|NCT00214422|580149221|FG002|Overall Study|Pt taken off study|0|||
160503868|NCT01646177|579572583|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
160503869|NCT01646177|579572584|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
160503870|NCT01646177|579572573|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
160503871|NCT01646177|579572574|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
160503872|NCT01646177|579572575|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
160662963|NCT00214422|580149219|FG000|Overall Study|Disease progression on study|1|||
160662964|NCT00214422|580149220|FG001|Overall Study|Disease progression on study|0|||
160662965|NCT00214422|580149221|FG002|Overall Study|Disease progression on study|0|||
160662966|NCT00214422|580149219|FG000|Overall Study|Unable to make a radiation treatment|0|||
160662967|NCT00214422|580149220|FG001|Overall Study|Unable to make a radiation treatment|0|||
160662968|NCT00214422|580149221|FG002|Overall Study|Unable to make a radiation treatment|1|||
160662969|NCT00854100|580149230|FG000|Overall Study|Inability to complete the study visits|0|||
160662970|NCT00854100|580149231|FG001|Overall Study|Inability to complete the study visits|0|||
160662971|NCT00854100|580149232|FG002|Overall Study|Inability to complete the study visits|1|||
160662972|NCT00854100|580149230|FG000|Overall Study|Lost to Follow-up|2|||
160662973|NCT00854100|580149231|FG001|Overall Study|Lost to Follow-up|0|||
160662974|NCT00854100|580149232|FG002|Overall Study|Lost to Follow-up|3|||
160662975|NCT00854100|580149230|FG000|Overall Study|Withdrawal by Subject|3|||
160662976|NCT00854100|580149231|FG001|Overall Study|Withdrawal by Subject|1|||
160503873|NCT01646177|579572576|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
160503874|NCT01646177|579572577|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
160503875|NCT01646177|579572578|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
160503876|NCT01646177|579572579|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
160503877|NCT01646177|579572580|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
160503878|NCT01646177|579572581|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
160503879|NCT01646177|579572582|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
160503880|NCT01646177|579572583|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
160503881|NCT01646177|579572584|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
160503882|NCT01038427|579572587|FG000|Overall Study|Lost to follow up|1|||
160503883|NCT01038427|579572588|FG001|Overall Study|Lost to follow up|1|||
160503884|NCT01038427|579572589|FG002|Overall Study|Lost to follow up|0|||
160503885|NCT01038427|579572587|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
160503886|NCT01038427|579572588|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
160503887|NCT01038427|579572589|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
160503888|NCT01038427|579572587|FG000|Overall Study|Withdrew consent|0|||
160503889|NCT01038427|579572588|FG001|Overall Study|Withdrew consent|0|||
160503890|NCT01038427|579572589|FG002|Overall Study|Withdrew consent|1|||
160503891|NCT01038427|579572587|FG000|Overall Study|Adverse Event|2|||
160503892|NCT01038427|579572588|FG001|Overall Study|Adverse Event|2|||
160503893|NCT01038427|579572589|FG002|Overall Study|Adverse Event|1|||
160503894|NCT01038427|579572587|FG000|Overall Study|Enrolled in error|0|||
160503895|NCT01038427|579572588|FG001|Overall Study|Enrolled in error|1|||
160503896|NCT01038427|579572589|FG002|Overall Study|Enrolled in error|1|||
160503897|NCT01038427|579572587|FG000|Overall Study|Other|0|||
160503898|NCT01038427|579572588|FG001|Overall Study|Other|2|||
160503899|NCT01038427|579572589|FG002|Overall Study|Other|0|||
160503900|NCT00820170|579572590|FG000|Overall Study|Adverse Event|0|||
160503901|NCT00820170|579572591|FG001|Overall Study|Adverse Event|0|||
160503902|NCT00820170|579572592|FG002|Overall Study|Adverse Event|0|||
160503903|NCT00820170|579572593|FG003|Overall Study|Adverse Event|0|||
160503904|NCT00820170|579572594|FG004|Overall Study|Adverse Event|2|||
160503905|NCT00820170|579572590|FG000|Overall Study|Progressive Disease|0|||
160503906|NCT00820170|579572591|FG001|Overall Study|Progressive Disease|0|||
160503907|NCT00820170|579572592|FG002|Overall Study|Progressive Disease|0|||
160503908|NCT00820170|579572593|FG003|Overall Study|Progressive Disease|0|||
160503909|NCT00820170|579572594|FG004|Overall Study|Progressive Disease|2|||
160503910|NCT03651700|579572595|FG000|Overall Study|Withdrawal by Subject|1|||
160503911|NCT03651700|579572596|FG001|Overall Study|Withdrawal by Subject|0|||
160503912|NCT05479734|579572597|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
160503913|NCT05479734|579572598|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
160503914|NCT05479734|579572597|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
160503915|NCT05479734|579572598|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
160503916|NCT05479734|579572597|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
160503917|NCT05479734|579572598|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
160503918|NCT05479734|579572597|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
160503919|NCT05479734|579572598|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
160503920|NCT00664534|579572601|FG000|Overall Study|Adverse Event|2|||
160662977|NCT00854100|580149232|FG002|Overall Study|Withdrawal by Subject|2|||
160662978|NCT00854100|580149230|FG000|Overall Study|Protocol Violation|2|||
160662979|NCT00854100|580149231|FG001|Overall Study|Protocol Violation|4|||
160662980|NCT00854100|580149232|FG002|Overall Study|Protocol Violation|3|||
160662981|NCT00854100|580149230|FG000|Overall Study|Adverse Event|2|||
160662982|NCT00854100|580149231|FG001|Overall Study|Adverse Event|1|||
160662983|NCT00854100|580149232|FG002|Overall Study|Adverse Event|2|||
160662984|NCT02242201|580149234|FG000|Overall Study|preoperative identified neuropathy|2|||
160662985|NCT02242201|580149235|FG001|Overall Study|preoperative identified neuropathy|0|||
160662986|NCT02242201|580149236|FG002|Overall Study|preoperative identified neuropathy|0|||
160662987|NCT02242201|580149234|FG000|Overall Study|planned post-op anticoagulation|1|||
160662988|NCT02242201|580149235|FG001|Overall Study|planned post-op anticoagulation|0|||
160662989|NCT02242201|580149236|FG002|Overall Study|planned post-op anticoagulation|0|||
160662990|NCT02242201|580149234|FG000|Overall Study|changed surgical procedure|1|||
160662991|NCT02242201|580149235|FG001|Overall Study|changed surgical procedure|0|||
160662992|NCT02242201|580149236|FG002|Overall Study|changed surgical procedure|0|||
160662993|NCT02242201|580149234|FG000|Overall Study|postponed surgery|0|||
160503921|NCT00664534|579572602|FG001|Overall Study|Adverse Event|3|||
160503922|NCT00664534|579572601|FG000|Overall Study|Lost to Follow-up|6|||
160662994|NCT02242201|580149235|FG001|Overall Study|postponed surgery|0|||
160662995|NCT02242201|580149236|FG002|Overall Study|postponed surgery|1|||
160662996|NCT02242201|580149234|FG000|Overall Study|preoperative opioid consumption|0|||
160503923|NCT00664534|579572602|FG001|Overall Study|Lost to Follow-up|10|||
160503924|NCT00664534|579572601|FG000|Overall Study|Protocol Violation|10|||
160503925|NCT00664534|579572602|FG001|Overall Study|Protocol Violation|8|||
160503926|NCT00664534|579572601|FG000|Overall Study|Withdrawal by Subject|7|||
160662997|NCT02242201|580149235|FG001|Overall Study|preoperative opioid consumption|1|||
160662998|NCT02242201|580149236|FG002|Overall Study|preoperative opioid consumption|0|||
160662999|NCT00389064|580149237|FG000|Overall Study|Adverse Event|11|||
160663000|NCT00389064|580149238|FG001|Overall Study|Adverse Event|3|||
160663001|NCT00389064|580149237|FG000|Overall Study|Lack of Efficacy|3|||
160663002|NCT00389064|580149238|FG001|Overall Study|Lack of Efficacy|14|||
160663003|NCT00389064|580149237|FG000|Overall Study|Withdrawal by Subject|17|||
160663004|NCT00389064|580149238|FG001|Overall Study|Withdrawal by Subject|27|||
160503927|NCT00664534|579572602|FG001|Overall Study|Withdrawal by Subject|6|||
160503928|NCT00664534|579572601|FG000|Overall Study|Physician Decision|8|||
160503929|NCT00664534|579572602|FG001|Overall Study|Physician Decision|0|||
160503930|NCT00664534|579572601|FG000|Overall Study|Sponsor decision|8|||
160503931|NCT00664534|579572602|FG001|Overall Study|Sponsor decision|6|||
160503932|NCT00935532|579572605|FG000|Overall Study|Adverse Event|11|||
160503933|NCT00935532|579572606|FG001|Overall Study|Adverse Event|6|||
160503934|NCT00935532|579572605|FG000|Overall Study|Death|1|||
160503935|NCT00935532|579572606|FG001|Overall Study|Death|0|||
160503936|NCT00935532|579572605|FG000|Overall Study|Lost to Follow-up|1|||
160503937|NCT00935532|579572606|FG001|Overall Study|Lost to Follow-up|0|||
160503938|NCT00935532|579572605|FG000|Overall Study|Physician Decision|1|||
160503939|NCT00935532|579572606|FG001|Overall Study|Physician Decision|2|||
160503940|NCT00935532|579572605|FG000|Overall Study|Protocol Violation|2|||
160503941|NCT00935532|579572606|FG001|Overall Study|Protocol Violation|1|||
160503942|NCT00935532|579572605|FG000|Overall Study|Subject Decision|2|||
160503943|NCT00935532|579572606|FG001|Overall Study|Subject Decision|1|||
160503944|NCT00935532|579572605|FG000|Overall Study|Sponsor Decision|0|||
160503945|NCT00935532|579572606|FG001|Overall Study|Sponsor Decision|1|||
160503946|NCT00935532|579572605|FG000|Overall Study|Loss Glucose Control|4|||
160503947|NCT00935532|579572606|FG001|Overall Study|Loss Glucose Control|0|||
160503948|NCT01399918|579572607|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
160503949|NCT01436253|579572609|FG000|Overall Study|Lost to Follow-up|182|||
160503950|NCT01436253|579572609|FG000|Overall Study|Not meeting all eligibility criteria|117|||
160503951|NCT03083665|579572611|FG000|Double-Blind Period|Adverse Event|5|||
160503952|NCT03083665|579572612|FG001|Double-Blind Period|Adverse Event|4|||
160503953|NCT03083665|579572613|FG002|Double-Blind Period|Adverse Event|5|||
160503954|NCT03083665|579572614|FG003|Double-Blind Period|Adverse Event|0|||
160503955|NCT03083665|579572615|FG004|Double-Blind Period|Adverse Event|0|||
160503956|NCT03083665|579572616|FG005|Double-Blind Period|Adverse Event|0|||
160503957|NCT03083665|579572611|FG000|Double-Blind Period|Lack of Efficacy|0|||
160503958|NCT03083665|579572612|FG001|Double-Blind Period|Lack of Efficacy|0|||
160503959|NCT03083665|579572613|FG002|Double-Blind Period|Lack of Efficacy|1|||
160663005|NCT00389064|580149237|FG000|Overall Study|Physician Decision|2|||
160663006|NCT00389064|580149238|FG001|Overall Study|Physician Decision|2|||
160663007|NCT00389064|580149237|FG000|Overall Study|Lost to Follow-up|1|||
160663008|NCT00389064|580149238|FG001|Overall Study|Lost to Follow-up|2|||
160663009|NCT00389064|580149237|FG000|Overall Study|Protocol Violation|2|||
160663010|NCT00389064|580149238|FG001|Overall Study|Protocol Violation|0|||
160663011|NCT00389064|580149237|FG000|Overall Study|Multiple Reasons|9|||
160503960|NCT03083665|579572614|FG003|Double-Blind Period|Lack of Efficacy|0|||
160503961|NCT03083665|579572615|FG004|Double-Blind Period|Lack of Efficacy|0|||
160503962|NCT03083665|579572616|FG005|Double-Blind Period|Lack of Efficacy|0|||
160503963|NCT03083665|579572611|FG000|Double-Blind Period|Protocol Violation|1|||
160503964|NCT03083665|579572612|FG001|Double-Blind Period|Protocol Violation|0|||
160503965|NCT03083665|579572613|FG002|Double-Blind Period|Protocol Violation|1|||
160503966|NCT03083665|579572614|FG003|Double-Blind Period|Protocol Violation|0|||
160503967|NCT03083665|579572615|FG004|Double-Blind Period|Protocol Violation|0|||
160503968|NCT03083665|579572616|FG005|Double-Blind Period|Protocol Violation|0|||
160503969|NCT03083665|579572611|FG000|Double-Blind Period|Lost to Follow-up|1|||
160503970|NCT03083665|579572612|FG001|Double-Blind Period|Lost to Follow-up|0|||
160503971|NCT03083665|579572613|FG002|Double-Blind Period|Lost to Follow-up|1|||
160503972|NCT03083665|579572614|FG003|Double-Blind Period|Lost to Follow-up|0|||
160503973|NCT03083665|579572615|FG004|Double-Blind Period|Lost to Follow-up|0|||
160503974|NCT03083665|579572616|FG005|Double-Blind Period|Lost to Follow-up|0|||
160503975|NCT03083665|579572611|FG000|Double-Blind Period|Withdrawal by Subject|3|||
160503976|NCT03083665|579572612|FG001|Double-Blind Period|Withdrawal by Subject|0|||
160503977|NCT03083665|579572613|FG002|Double-Blind Period|Withdrawal by Subject|0|||
160503978|NCT03083665|579572614|FG003|Double-Blind Period|Withdrawal by Subject|0|||
160503979|NCT03083665|579572615|FG004|Double-Blind Period|Withdrawal by Subject|0|||
160503980|NCT03083665|579572616|FG005|Double-Blind Period|Withdrawal by Subject|0|||
160503981|NCT03083665|579572611|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
160503982|NCT03083665|579572612|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
160503983|NCT03083665|579572613|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
160503984|NCT03083665|579572614|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
160503985|NCT03083665|579572615|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
160503986|NCT03083665|579572616|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
160503987|NCT03083665|579572611|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
160503988|NCT03083665|579572612|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
160503989|NCT03083665|579572613|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
160503990|NCT03083665|579572614|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
160503991|NCT03083665|579572615|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
160503992|NCT03083665|579572616|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
160503993|NCT03083665|579572611|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
160503994|NCT03083665|579572612|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
160503995|NCT03083665|579572613|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
160503996|NCT03083665|579572614|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
160503997|NCT03083665|579572615|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
160503998|NCT03083665|579572616|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
160503999|NCT03083665|579572611|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
160504000|NCT03083665|579572612|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
160504001|NCT03083665|579572613|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
160504002|NCT03083665|579572614|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
160504003|NCT03083665|579572615|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
160504004|NCT03083665|579572616|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
160504005|NCT03083665|579572611|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
160504006|NCT03083665|579572612|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
160504007|NCT03083665|579572613|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
160504008|NCT03083665|579572614|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
160504009|NCT03083665|579572615|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
160504010|NCT03083665|579572616|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
160504011|NCT03083665|579572611|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
160504012|NCT03083665|579572612|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
160504013|NCT03083665|579572613|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
160504014|NCT03083665|579572614|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
160504015|NCT03083665|579572615|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
160504016|NCT03083665|579572616|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
160504017|NCT03083665|579572611|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
160504018|NCT03083665|579572612|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
160504019|NCT03083665|579572613|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
160504020|NCT03083665|579572614|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
160504021|NCT03083665|579572615|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
160504022|NCT03083665|579572616|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
160504023|NCT03083665|579572611|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
160504024|NCT03083665|579572612|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
160504025|NCT03083665|579572613|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
160504026|NCT03083665|579572614|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
160504027|NCT03083665|579572615|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
160504028|NCT03083665|579572616|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
160504029|NCT03083665|579572611|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
160504030|NCT03083665|579572612|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
160504031|NCT03083665|579572613|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
160504032|NCT03083665|579572614|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
160504033|NCT03083665|579572615|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
160504034|NCT03083665|579572616|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
160504035|NCT02519348|579572617|FG000|Overall Study|Death|31|||
160504036|NCT02519348|579572618|FG001|Overall Study|Death|74|||
160504037|NCT02519348|579572619|FG002|Overall Study|Death|47|||
160504038|NCT02519348|579572620|FG003|Overall Study|Death|54|||
160504039|NCT02519348|579572621|FG004|Overall Study|Death|63|||
160504040|NCT02519348|579572622|FG005|Overall Study|Death|18|||
160504041|NCT02519348|579572623|FG006|Overall Study|Death|2|||
160504042|NCT02519348|579572624|FG007|Overall Study|Death|5|||
160504043|NCT02519348|579572625|FG008|Overall Study|Death|5|||
160504044|NCT02519348|579572617|FG000|Overall Study|Withdrawal by Subject|4|||
160504045|NCT02519348|579572618|FG001|Overall Study|Withdrawal by Subject|7|||
160504046|NCT02519348|579572619|FG002|Overall Study|Withdrawal by Subject|4|||
160504047|NCT02519348|579572620|FG003|Overall Study|Withdrawal by Subject|3|||
160504048|NCT02519348|579572621|FG004|Overall Study|Withdrawal by Subject|3|||
160504049|NCT02519348|579572622|FG005|Overall Study|Withdrawal by Subject|2|||
160504050|NCT02519348|579572623|FG006|Overall Study|Withdrawal by Subject|0|||
160504051|NCT02519348|579572624|FG007|Overall Study|Withdrawal by Subject|0|||
160504052|NCT02519348|579572625|FG008|Overall Study|Withdrawal by Subject|1|||
160504053|NCT02519348|579572617|FG000|Overall Study|Lost to Follow-up|0|||
160504054|NCT02519348|579572618|FG001|Overall Study|Lost to Follow-up|0|||
160504055|NCT02519348|579572619|FG002|Overall Study|Lost to Follow-up|1|||
160504056|NCT02519348|579572620|FG003|Overall Study|Lost to Follow-up|0|||
160504057|NCT02519348|579572621|FG004|Overall Study|Lost to Follow-up|2|||
160504058|NCT02519348|579572622|FG005|Overall Study|Lost to Follow-up|1|||
160504059|NCT02519348|579572623|FG006|Overall Study|Lost to Follow-up|1|||
160504060|NCT02519348|579572624|FG007|Overall Study|Lost to Follow-up|0|||
160504061|NCT02519348|579572625|FG008|Overall Study|Lost to Follow-up|0|||
160504062|NCT02519348|579572617|FG000|Overall Study|Other|0|||
160504063|NCT02519348|579572618|FG001|Overall Study|Other|3|||
160504064|NCT02519348|579572619|FG002|Overall Study|Other|0|||
160504065|NCT02519348|579572620|FG003|Overall Study|Other|0|||
160504066|NCT02519348|579572621|FG004|Overall Study|Other|1|||
160504067|NCT02519348|579572622|FG005|Overall Study|Other|0|||
160504068|NCT02519348|579572623|FG006|Overall Study|Other|0|||
160504069|NCT02519348|579572624|FG007|Overall Study|Other|0|||
160504070|NCT02519348|579572625|FG008|Overall Study|Other|0|||
160504071|NCT02519348|579572617|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
160504072|NCT02519348|579572618|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
160504073|NCT02519348|579572619|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
160504074|NCT02519348|579572620|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
160504075|NCT02519348|579572621|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
160504076|NCT02519348|579572622|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
160504077|NCT02519348|579572623|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
160504078|NCT02519348|579572624|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
160504079|NCT02519348|579572625|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
160504080|NCT04103892|579572631|FG000|Overall Study|Adverse Event|0|||
160504081|NCT04103892|579572632|FG001|Overall Study|Adverse Event|0|||
160504082|NCT04103892|579572633|FG002|Overall Study|Adverse Event|0|||
160504083|NCT04103892|579572634|FG003|Overall Study|Adverse Event|3|||
160504084|NCT04103892|579572631|FG000|Overall Study|Lost to Follow-up|0|||
160504085|NCT04103892|579572632|FG001|Overall Study|Lost to Follow-up|0|||
160504086|NCT04103892|579572633|FG002|Overall Study|Lost to Follow-up|2|||
160504087|NCT04103892|579572634|FG003|Overall Study|Lost to Follow-up|0|||
160504088|NCT04103892|579572631|FG000|Overall Study|Protocol Violation|0|||
160504089|NCT04103892|579572632|FG001|Overall Study|Protocol Violation|0|||
160504090|NCT04103892|579572633|FG002|Overall Study|Protocol Violation|1|||
160504091|NCT04103892|579572634|FG003|Overall Study|Protocol Violation|1|||
160504092|NCT04103892|579572631|FG000|Overall Study|Withdrawal by Subject|1|||
160504093|NCT04103892|579572632|FG001|Overall Study|Withdrawal by Subject|0|||
160504094|NCT04103892|579572633|FG002|Overall Study|Withdrawal by Subject|2|||
160504095|NCT04103892|579572634|FG003|Overall Study|Withdrawal by Subject|5|||
160504096|NCT04103892|579572631|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
160504097|NCT04103892|579572632|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
160504098|NCT04103892|579572633|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
160504099|NCT04103892|579572634|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
160504100|NCT05576662|579572635|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
160504101|NCT05576662|579572636|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
160504102|NCT05576662|579572635|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
160504103|NCT05576662|579572636|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
160504104|NCT05576662|579572635|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
160504105|NCT05576662|579572636|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
160504106|NCT05576662|579572635|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
160504107|NCT05576662|579572636|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
160504108|NCT00281320|579572637|FG000|Overall Study|Adverse Event|12|||
160504109|NCT00281320|579572638|FG001|Overall Study|Adverse Event|9|||
160504110|NCT00281320|579572637|FG000|Overall Study|Lack of Efficacy|4|||
160504111|NCT00281320|579572638|FG001|Overall Study|Lack of Efficacy|3|||
160504112|NCT00281320|579572637|FG000|Overall Study|Withdrawal by Subject|5|||
160504113|NCT00281320|579572638|FG001|Overall Study|Withdrawal by Subject|6|||
160504114|NCT00281320|579572637|FG000|Overall Study|Lost to Follow-up|1|||
160504115|NCT00281320|579572638|FG001|Overall Study|Lost to Follow-up|2|||
160504116|NCT00281320|579572637|FG000|Overall Study|Other|3|||
160504117|NCT00281320|579572638|FG001|Overall Study|Other|1|||
160504118|NCT03008005|579572641|FG000|Overall Study|Physician Decision|1|||
160504119|NCT03008005|579572642|FG001|Overall Study|Physician Decision|0|||
160504120|NCT03008005|579572643|FG002|Overall Study|Physician Decision|0|||
160504121|NCT03008005|579572641|FG000|Overall Study|Withdrawal by Subject|1|||
160504122|NCT03008005|579572642|FG001|Overall Study|Withdrawal by Subject|0|||
160504123|NCT03008005|579572643|FG002|Overall Study|Withdrawal by Subject|0|||
160504124|NCT03008005|579572641|FG000|Overall Study|Ineligible|0|||
160504125|NCT03008005|579572642|FG001|Overall Study|Ineligible|1|||
160504126|NCT03008005|579572643|FG002|Overall Study|Ineligible|0|||
160504127|NCT00475228|579572645|FG000|Overall Study|Lost to Follow-up|17|||
160504128|NCT00475228|579572646|FG001|Overall Study|Lost to Follow-up|17|||
160504129|NCT03633799|579572654|FG000|Overall Study|Adverse Event|349|||
160504130|NCT03633799|579572654|FG000|Overall Study|Withdrawal by Subject|288|||
160504131|NCT03633799|579572654|FG000|Overall Study|Lost to Follow-up|97|||
160504132|NCT03633799|579572654|FG000|Overall Study|Physician Decision|9|||
160504133|NCT03633799|579572654|FG000|Overall Study|Protocol Violation|4|||
160504134|NCT03633799|579572654|FG000|Overall Study|Pregnancy|20|||
160504135|NCT03633799|579572654|FG000|Overall Study|other|39|||
160504136|NCT03633799|579572654|FG000|Overall Study|ongoing within third year of study|106|||
160504137|NCT03633799|579572654|FG000|Overall Study|unsuccessful study drug placement|19|||
160504138|NCT05855967|579572655|FG000|Overall Study|Withdrawal by Subject|7|||
160504139|NCT05855967|579572656|FG001|Overall Study|Withdrawal by Subject|5|||
160504140|NCT05855967|579572655|FG000|Overall Study|Lost to Follow-up|2|||
160504141|NCT05855967|579572656|FG001|Overall Study|Lost to Follow-up|1|||
160504142|NCT02446821|579572657|FG000|Overall Study|Adverse Event|28|||
160504143|NCT02446821|579572657|FG000|Overall Study|Withdrawal by Subject|6|||
160504144|NCT02446821|579572657|FG000|Overall Study|Lost to Follow-up|22|||
160504145|NCT02446821|579572657|FG000|Overall Study|other|9|||
160504146|NCT02446821|579572657|FG000|Overall Study|insertion failure|3|||
160504147|NCT02284009|579572661|FG000|Overall Study|Adverse Event|3|||
160504148|NCT02284009|579572662|FG001|Overall Study|Adverse Event|0|||
160504149|NCT02284009|579572661|FG000|Overall Study|Lost to Follow-up|1|||
160504150|NCT02284009|579572662|FG001|Overall Study|Lost to Follow-up|3|||
160504151|NCT02284009|579572661|FG000|Overall Study|Physician Decision|0|||
160504152|NCT02284009|579572662|FG001|Overall Study|Physician Decision|2|||
160504153|NCT02284009|579572661|FG000|Overall Study|Withdrawal by Subject|2|||
160504154|NCT02284009|579572662|FG001|Overall Study|Withdrawal by Subject|5|||
160504155|NCT04147195|579572663|FG000|Overall Study|Adverse Event|0|||
160504156|NCT04147195|579572664|FG001|Overall Study|Adverse Event|3|||
160504157|NCT04147195|579572663|FG000|Overall Study|Study Terminated by Sponsor|4|||
160504158|NCT04147195|579572664|FG001|Overall Study|Study Terminated by Sponsor|2|||
160504159|NCT04147195|579572663|FG000|Overall Study|Withdrawal by Subject|0|||
160504160|NCT04147195|579572664|FG001|Overall Study|Withdrawal by Subject|1|||
160504161|NCT03841526|579572665|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
160504162|NCT03841526|579572666|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
160504163|NCT03841526|579572667|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
160504164|NCT03841526|579572668|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
160504165|NCT03841526|579572669|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
160504166|NCT03841526|579572670|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
160504167|NCT03841526|579572665|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
160504168|NCT03841526|579572666|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
160504169|NCT03841526|579572667|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
160504170|NCT03841526|579572668|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
160504171|NCT03841526|579572669|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
160504172|NCT03841526|579572670|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
160504173|NCT03841526|579572665|FG000|Outpatient Phase Treatment|Physician Decision|0|||
160504174|NCT03841526|579572666|FG001|Outpatient Phase Treatment|Physician Decision|1|||
160504175|NCT03841526|579572667|FG002|Outpatient Phase Treatment|Physician Decision|0|||
160504176|NCT03841526|579572668|FG003|Outpatient Phase Treatment|Physician Decision|0|||
160504177|NCT03841526|579572669|FG004|Outpatient Phase Treatment|Physician Decision|0|||
160504178|NCT03841526|579572670|FG005|Outpatient Phase Treatment|Physician Decision|0|||
160504179|NCT03841526|579572665|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
160504180|NCT03841526|579572666|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
160504181|NCT03841526|579572667|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
160504182|NCT03841526|579572668|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
160504183|NCT03841526|579572669|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
160504184|NCT03841526|579572670|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
160504185|NCT04707664|579574551|FG000|Overall Study|Adverse Event|2|||
160663012|NCT00389064|580149238|FG001|Overall Study|Multiple Reasons|11|||
160663013|NCT01697696|580149241|FG000|Overall Study|Study terminated by sponsor|0|||
160663014|NCT01697696|580149242|FG001|Overall Study|Study terminated by sponsor|3|||
160663015|NCT01697696|580149241|FG000|Overall Study|Protocol deviation|1|||
160663016|NCT01697696|580149242|FG001|Overall Study|Protocol deviation|0|||
160663017|NCT01697696|580149241|FG000|Overall Study|Physician Decision|1|||
160663018|NCT01697696|580149242|FG001|Overall Study|Physician Decision|0|||
160663019|NCT01697696|580149241|FG000|Overall Study|Death|4|||
160663020|NCT01697696|580149242|FG001|Overall Study|Death|2|||
160663021|NCT01697696|580149241|FG000|Overall Study|Lost to Follow-up|10|||
160663022|NCT01697696|580149242|FG001|Overall Study|Lost to Follow-up|7|||
160504186|NCT04707664|579574552|FG001|Overall Study|Adverse Event|0|||
160504187|NCT04707664|579574551|FG000|Overall Study|Death|1|||
160504188|NCT04707664|579574552|FG001|Overall Study|Death|2|||
160504189|NCT04707664|579574551|FG000|Overall Study|Withdrawal by Subject|13|||
160504190|NCT04707664|579574552|FG001|Overall Study|Withdrawal by Subject|21|||
160504191|NCT04707664|579574551|FG000|Overall Study|Lost to Follow-up|11|||
160504192|NCT04707664|579574552|FG001|Overall Study|Lost to Follow-up|13|||
160504193|NCT04707664|579574551|FG000|Overall Study|Not treated|2|||
160504194|NCT04707664|579574552|FG001|Overall Study|Not treated|0|||
160504195|NCT00288639|579574561|FG000|Overall Study|Adverse Event|5|||
160504196|NCT00288639|579574561|FG000|Overall Study|Lack of Efficacy|4|||
160504197|NCT00288639|579574561|FG000|Overall Study|Withdrawal by Subject|2|||
160504198|NCT00288639|579574561|FG000|Overall Study|Other|1|||
160663023|NCT01697696|580149241|FG000|Overall Study|Subject/guardian decision|31|||
160504199|NCT01195948|579574562|FG000|Overall Study|Lost to Follow-up|0|||
160504200|NCT01195948|579574563|FG001|Overall Study|Lost to Follow-up|1|||
160504201|NCT01195948|579574564|FG002|Overall Study|Lost to Follow-up|2|||
160504202|NCT01498887|579574565|FG000|Overall Study|Administrative problems|1|||
160663024|NCT01697696|580149242|FG001|Overall Study|Subject/guardian decision|35|||
160663025|NCT03616106|580149243|FG000|Overall Study|Removed by PI|6|||
160504203|NCT01498887|579574566|FG001|Overall Study|Administrative problems|0|||
160504204|NCT01498887|579574565|FG000|Overall Study|Lost to Follow-up|1|||
160504205|NCT01498887|579574566|FG001|Overall Study|Lost to Follow-up|1|||
160504206|NCT01498887|579574565|FG000|Overall Study|Withdrawal by Subject|1|||
160504207|NCT01498887|579574566|FG001|Overall Study|Withdrawal by Subject|0|||
160504208|NCT01498887|579574565|FG000|Overall Study|Protocol Violation|1|||
160504209|NCT01498887|579574566|FG001|Overall Study|Protocol Violation|3|||
160504210|NCT01498887|579574565|FG000|Overall Study|Lack of Efficacy|5|||
160504211|NCT01498887|579574566|FG001|Overall Study|Lack of Efficacy|3|||
160504212|NCT01498887|579574565|FG000|Overall Study|Abnormal result from test procedure|1|||
160504213|NCT01498887|579574566|FG001|Overall Study|Abnormal result from test procedure|1|||
160504214|NCT01498887|579574565|FG000|Overall Study|Abnormal laboratory value|2|||
160504215|NCT01498887|579574566|FG001|Overall Study|Abnormal laboratory value|2|||
160504216|NCT01498887|579574565|FG000|Overall Study|Adverse Event|4|||
160504217|NCT01498887|579574566|FG001|Overall Study|Adverse Event|1|||
160504218|NCT04079868|579574567|FG000|Overall Study|Lost to Follow-up|100|||
160504219|NCT04079868|579574568|FG001|Overall Study|Lost to Follow-up|200|||
160504220|NCT04079868|579574567|FG000|Overall Study|Physician Decision|100|||
160504221|NCT04079868|579574568|FG001|Overall Study|Physician Decision|0|||
160504222|NCT04335591|579574569|FG000|Overall Study|Adverse Event|5|||
160504223|NCT04335591|579574570|FG001|Overall Study|Adverse Event|2|||
160504224|NCT04335591|579574571|FG002|Overall Study|Adverse Event|3|||
160504225|NCT04335591|579574572|FG003|Overall Study|Adverse Event|2|||
160504226|NCT04335591|579574569|FG000|Overall Study|Protocol Violation|1|||
160504227|NCT04335591|579574570|FG001|Overall Study|Protocol Violation|0|||
160663026|NCT03616106|580149244|FG001|Overall Study|Removed by PI|0|||
160663027|NCT03616106|580149243|FG000|Overall Study|Withdrawal by Subject|1|||
160663028|NCT03616106|580149244|FG001|Overall Study|Withdrawal by Subject|1|||
160663029|NCT03616106|580149243|FG000|Overall Study|Lost to Follow-up|7|||
160663030|NCT03616106|580149244|FG001|Overall Study|Lost to Follow-up|0|||
160663031|NCT01880593|580149245|FG000|Overall Study|Adverse Event|1|||
160663032|NCT01880593|580149246|FG001|Overall Study|Adverse Event|0|||
160504228|NCT04335591|579574571|FG002|Overall Study|Protocol Violation|0|||
160504229|NCT04335591|579574572|FG003|Overall Study|Protocol Violation|0|||
160504230|NCT04335591|579574569|FG000|Overall Study|Withdrawal by Subject|8|||
160504231|NCT04335591|579574570|FG001|Overall Study|Withdrawal by Subject|4|||
160504232|NCT04335591|579574571|FG002|Overall Study|Withdrawal by Subject|4|||
160504233|NCT04335591|579574572|FG003|Overall Study|Withdrawal by Subject|5|||
160504234|NCT04335591|579574569|FG000|Overall Study|Subject planning pregnancy|0|||
160663033|NCT01880593|580149245|FG000|Overall Study|Lack of Efficacy|1|||
160663034|NCT01880593|580149246|FG001|Overall Study|Lack of Efficacy|5|||
160504235|NCT04335591|579574570|FG001|Overall Study|Subject planning pregnancy|1|||
160504236|NCT04335591|579574571|FG002|Overall Study|Subject planning pregnancy|0|||
160663035|NCT01880593|580149245|FG000|Overall Study|Withdrawal by Subject|6|||
160663036|NCT01880593|580149246|FG001|Overall Study|Withdrawal by Subject|1|||
160663037|NCT05275205|580149251|FG000|Overall Study|Adverse Event|1|||
160663038|NCT05275205|580149252|FG001|Overall Study|Adverse Event|2|||
160663039|NCT05275205|580149251|FG000|Overall Study|Physician Decision|1|||
160663040|NCT05275205|580149252|FG001|Overall Study|Physician Decision|1|||
160504237|NCT04335591|579574572|FG003|Overall Study|Subject planning pregnancy|0|||
160504238|NCT04335591|579574569|FG000|Overall Study|Ukrainian Russian war conflict|4|||
160504239|NCT04335591|579574570|FG001|Overall Study|Ukrainian Russian war conflict|5|||
160504240|NCT04335591|579574571|FG002|Overall Study|Ukrainian Russian war conflict|2|||
160504241|NCT04335591|579574572|FG003|Overall Study|Ukrainian Russian war conflict|0|||
160663041|NCT05275205|580149251|FG000|Overall Study|Withdrawal by Subject|2|||
160663042|NCT05275205|580149252|FG001|Overall Study|Withdrawal by Subject|3|||
160663043|NCT05275205|580149251|FG000|Overall Study|Death|1|||
160663044|NCT05275205|580149252|FG001|Overall Study|Death|0|||
160663045|NCT05275205|580149251|FG000|Overall Study|Patient unable to attend visits|1|||
160663046|NCT05275205|580149252|FG001|Overall Study|Patient unable to attend visits|0|||
160663047|NCT03243630|580149254|FG000|Overall Study|Protocol Violation|1|||
160663048|NCT03243630|580149254|FG000|Overall Study|Physician Decision|1|||
160663049|NCT00939003|580149256|FG000|Double-blind Treatment Period|Adverse Event|1|||
160663050|NCT00939003|580149257|FG001|Double-blind Treatment Period|Adverse Event|1|||
160663051|NCT00939003|580149256|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
160663052|NCT00939003|580149257|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
160663053|NCT00939003|580149256|FG000|Double-blind Treatment Period|Pregnancy|0|||
160663054|NCT00939003|580149257|FG001|Double-blind Treatment Period|Pregnancy|1|||
160663055|NCT00939003|580149256|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
160504242|NCT01077128|579574577|FG000|Overall Study|Adverse Event|8|||
160504243|NCT01077128|579574577|FG000|Overall Study|Lack of Efficacy|1|||
160504244|NCT01077128|579574577|FG000|Overall Study|Disease exacerbation|1|||
160504245|NCT01077128|579574577|FG000|Overall Study|Adverse event and consent withdrawal|1|||
160504246|NCT01077128|579574577|FG000|Overall Study|Adverse event and disease exacerbation|1|||
160663056|NCT00939003|580149257|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
160663057|NCT00939003|580149256|FG000|Open-label Treatment Period|Adverse Event|4|||
160663058|NCT00939003|580149257|FG001|Open-label Treatment Period|Adverse Event|8|||
160663059|NCT00939003|580149256|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
160663060|NCT00939003|580149257|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
160663061|NCT00939003|580149256|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
160663062|NCT00939003|580149257|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
160663063|NCT00939003|580149256|FG000|Open-label Treatment Period|Pregnancy|1|||
160663064|NCT00939003|580149257|FG001|Open-label Treatment Period|Pregnancy|1|||
160663065|NCT00939003|580149256|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
160663066|NCT00939003|580149257|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
160663067|NCT00939003|580149256|FG000|Open-label Treatment Period|Site Closure|3|||
160663068|NCT00939003|580149257|FG001|Open-label Treatment Period|Site Closure|4|||
160663069|NCT02131129|580149258|FG000|Overall Study|Withdrawal by Subject|1|||
160663070|NCT02131129|580149259|FG001|Overall Study|Withdrawal by Subject|0|||
160663071|NCT03707912|580149260|FG000|Overall Study|Violation of inclusion criteria|1|||
160663072|NCT03707912|580149261|FG001|Overall Study|Violation of inclusion criteria|0|||
160663073|NCT02186821|580149262|FG000|Overall Study|Adverse Event|9|||
160663074|NCT02186821|580149262|FG000|Overall Study|Death|2|||
160663075|NCT02186821|580149262|FG000|Overall Study|Disease progression|32|||
160663076|NCT02186821|580149262|FG000|Overall Study|Protocol Violation|1|||
160663077|NCT02186821|580149262|FG000|Overall Study|Physician Decision|1|||
160663078|NCT02186821|580149262|FG000|Overall Study|Study terminated by sponsor|2|||
160663079|NCT00467896|580150564|FG000|Overall Study|Consent Withdrawal|18|||
160663080|NCT00467896|580150564|FG000|Overall Study|Adverse Event|7|||
160663081|NCT00467896|580150564|FG000|Overall Study|Serious Adverse Event|13|||
160663082|NCT00467896|580150564|FG000|Overall Study|Non-compliance|3|||
160663083|NCT00467896|580150564|FG000|Overall Study|Changed therapy|2|||
160663084|NCT00467896|580150564|FG000|Overall Study|Patient received transplant|2|||
160663085|NCT00467896|580150564|FG000|Overall Study|Patient had atrial septostomy|1|||
160663086|NCT00467896|580150564|FG000|Overall Study|Patient weaned off iloprost|1|||
160663087|NCT00467896|580150564|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
160663088|NCT00467896|580150564|FG000|Overall Study|Started intravenous prostacyclin|1|||
160663089|NCT00467896|580150564|FG000|Overall Study|Started inhaled Remodulin|1|||
160663090|NCT00467896|580150564|FG000|Overall Study|Patient had no improvement|1|||
160663091|NCT03818581|580150567|FG000|Overall Study|Adverse Event|1|||
160663092|NCT03818581|580150568|FG001|Overall Study|Adverse Event|0|||
160663093|NCT03818581|580150569|FG002|Overall Study|Adverse Event|0|||
160663094|NCT03818581|580150570|FG003|Overall Study|Adverse Event|0|||
160663095|NCT03818581|580150571|FG004|Overall Study|Adverse Event|0|||
160663096|NCT03818581|580150567|FG000|Overall Study|Covid-19|2|||
160663097|NCT03818581|580150568|FG001|Overall Study|Covid-19|0|||
160663098|NCT03818581|580150569|FG002|Overall Study|Covid-19|0|||
160663099|NCT03818581|580150570|FG003|Overall Study|Covid-19|0|||
160663100|NCT03818581|580150571|FG004|Overall Study|Covid-19|1|||
160663101|NCT03818581|580150567|FG000|Overall Study|Withdrawal by Subject|0|||
160663102|NCT03818581|580150568|FG001|Overall Study|Withdrawal by Subject|0|||
160663103|NCT03818581|580150569|FG002|Overall Study|Withdrawal by Subject|0|||
160663104|NCT03818581|580150570|FG003|Overall Study|Withdrawal by Subject|0|||
160663105|NCT03818581|580150571|FG004|Overall Study|Withdrawal by Subject|1|||
160663106|NCT03818581|580150567|FG000|Overall Study|No longer met study criteria|0|||
160663107|NCT03818581|580150568|FG001|Overall Study|No longer met study criteria|0|||
160663108|NCT03818581|580150569|FG002|Overall Study|No longer met study criteria|0|||
160663109|NCT03818581|580150570|FG003|Overall Study|No longer met study criteria|0|||
160504247|NCT01077128|579574577|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
160504248|NCT01077128|579574577|FG000|Overall Study|Other|54|||
160504249|NCT03338296|579574585|FG000|Overall Study|Adverse Event|0|||
160663110|NCT03818581|580150571|FG004|Overall Study|No longer met study criteria|1|||
160663111|NCT01466166|580150577|FG000|Overall Study|Death|1|||
160663112|NCT01466166|580150577|FG000|Overall Study|Lost to Follow-up|7|||
160663113|NCT01466166|580150577|FG000|Overall Study|Infusion Reaction (IR)|27|||
160663114|NCT01466166|580150577|FG000|Overall Study|Adverse Event (Other than IR)|11|||
160663115|NCT01466166|580150577|FG000|Overall Study|Elevated Serum Uric Acid|78|||
160663116|NCT01466166|580150577|FG000|Overall Study|Withdrawal by Subject|13|||
160663117|NCT01466166|580150577|FG000|Overall Study|Sponsor Decision|4|||
160663118|NCT01466166|580150577|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
160663119|NCT01466166|580150577|FG000|Overall Study|Other|20|||
160663120|NCT00070291|580150578|FG000|Step 1|Withdrawal by Subject|1|||
160663121|NCT00070291|580150578|FG000|Step 1|Adverse Event|1|||
160663122|NCT00070291|580150578|FG000|Step 2|Adverse Event|1|||
160663123|NCT02262377|580150579|FG000|Overall Study|Lost to Follow-up|5|||
160663124|NCT02262377|580150580|FG001|Overall Study|Lost to Follow-up|6|||
160504250|NCT03338296|579574586|FG001|Overall Study|Adverse Event|1|||
160504251|NCT03338296|579574585|FG000|Overall Study|Withdrawal by Subject|14|||
160663125|NCT02262377|580150579|FG000|Overall Study|Found ineligible after enrollment|3|||
160663126|NCT02262377|580150580|FG001|Overall Study|Found ineligible after enrollment|0|||
160663127|NCT02262377|580150579|FG000|Overall Study|Withdrawal by Subject|4|||
160663128|NCT02262377|580150580|FG001|Overall Study|Withdrawal by Subject|0|||
160663129|NCT00371839|580150581|FG000|Overall Study|Death|4|||
160663130|NCT00371839|580150582|FG001|Overall Study|Death|0|||
160663131|NCT00371839|580150583|FG002|Overall Study|Death|0|||
160663132|NCT00371839|580150581|FG000|Overall Study|Withdrawal by Subject|7|||
160663133|NCT00371839|580150582|FG001|Overall Study|Withdrawal by Subject|4|||
160663134|NCT00371839|580150583|FG002|Overall Study|Withdrawal by Subject|0|||
160663135|NCT00371839|580150581|FG000|Overall Study|Lost to Follow-up|6|||
160663136|NCT00371839|580150582|FG001|Overall Study|Lost to Follow-up|3|||
160663137|NCT00371839|580150583|FG002|Overall Study|Lost to Follow-up|2|||
160663138|NCT02533258|580150585|FG000|Overall Study|Adverse Event|1|||
160663139|NCT02533258|580150585|FG000|Overall Study|Death|2|||
160663140|NCT02533258|580150585|FG000|Overall Study|Other|1|||
160663141|NCT02533258|580150585|FG000|Overall Study|Economic factor|1|||
160663142|NCT02533258|580150585|FG000|Overall Study|Progression of pleural effusion|1|||
160663143|NCT02533258|580150585|FG000|Overall Study|Lack of Efficacy|2|||
160663144|NCT02096211|580150586|FG000|Overall Study|Death|2|||
160663145|NCT02096211|580150586|FG000|Overall Study|Withdrawal by Subject|8|||
160663146|NCT02096211|580150586|FG000|Overall Study|Revision of implant|7|||
160663147|NCT02096211|580150586|FG000|Overall Study|Lost to Follow-up|43|||
160663148|NCT01049334|580150587|FG000|Overall Study|Withdrawal by Subject|5|||
160663149|NCT01049334|580150588|FG001|Overall Study|Withdrawal by Subject|3|||
160663150|NCT01049334|580150587|FG000|Overall Study|Adverse Event|2|||
160663151|NCT01049334|580150588|FG001|Overall Study|Adverse Event|3|||
160663152|NCT01049334|580150587|FG000|Overall Study|Physician Decision|2|||
160663153|NCT01049334|580150588|FG001|Overall Study|Physician Decision|0|||
160663154|NCT01049334|580150587|FG000|Overall Study|Protocol Violation|0|||
160663155|NCT01049334|580150588|FG001|Overall Study|Protocol Violation|1|||
160663156|NCT02378935|580150595|FG000|Overall Study|Lack of Efficacy|10|||
160663157|NCT02378935|580150596|FG001|Overall Study|Lack of Efficacy|0|||
160663158|NCT02378935|580150597|FG002|Overall Study|Lack of Efficacy|2|||
160663159|NCT02378935|580150598|FG003|Overall Study|Lack of Efficacy|6|||
160663160|NCT02378935|580150599|FG004|Overall Study|Lack of Efficacy|0|||
160663161|NCT02378935|580150600|FG005|Overall Study|Lack of Efficacy|0|||
160663162|NCT02378935|580150601|FG006|Overall Study|Lack of Efficacy|0|||
160663163|NCT02378935|580150595|FG000|Overall Study|Death|0|||
160663164|NCT02378935|580150596|FG001|Overall Study|Death|0|||
160663165|NCT02378935|580150597|FG002|Overall Study|Death|1|||
160663166|NCT02378935|580150598|FG003|Overall Study|Death|0|||
160663167|NCT02378935|580150599|FG004|Overall Study|Death|0|||
160663168|NCT02378935|580150600|FG005|Overall Study|Death|0|||
160663169|NCT02378935|580150601|FG006|Overall Study|Death|0|||
160663170|NCT02476994|580150602|FG000|Overall Study|Based on feedback from FDA|1|||
160663171|NCT02476994|580150603|FG001|Overall Study|Based on feedback from FDA|0|||
160663172|NCT02246166|580150604|FG000|Overall Study|Protocol Violation|1|||
160663173|NCT02246166|580150605|FG001|Overall Study|Protocol Violation|0|||
160663174|NCT02924883|580150610|FG000|Overall Study|Death|39|||
160663175|NCT02924883|580150611|FG001|Overall Study|Death|20|||
160663176|NCT02924883|580150610|FG000|Overall Study|Lost to Follow-up|1|||
160663177|NCT02924883|580150611|FG001|Overall Study|Lost to Follow-up|0|||
160663178|NCT02924883|580150610|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
160663179|NCT02924883|580150611|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
160663180|NCT02924883|580150610|FG000|Overall Study|Protocol Violation|1|||
160663181|NCT02924883|580150611|FG001|Overall Study|Protocol Violation|0|||
160663182|NCT02924883|580150610|FG000|Overall Study|Withdrawal by Subject|22|||
160663183|NCT02924883|580150611|FG001|Overall Study|Withdrawal by Subject|16|||
160663184|NCT02924883|580150610|FG000|Overall Study|Progressive Disease|1|||
160663185|NCT02924883|580150611|FG001|Overall Study|Progressive Disease|0|||
160663186|NCT02924883|580150610|FG000|Overall Study|Study Terminated by Sponsor|69|||
160663187|NCT02924883|580150611|FG001|Overall Study|Study Terminated by Sponsor|32|||
160663188|NCT00004562|580150612|FG000|Overall Study|Lost to Follow-up|102|||
160663189|NCT00004562|580150613|FG001|Overall Study|Lost to Follow-up|91|||
160663190|NCT02865850|580150614|FG000|Overall Study|Death|15|||
160663191|NCT02865850|580150615|FG001|Overall Study|Death|19|||
160663192|NCT02865850|580150614|FG000|Overall Study|Withdrawal by Subject|3|||
160663193|NCT02865850|580150615|FG001|Overall Study|Withdrawal by Subject|2|||
160663194|NCT02865850|580150614|FG000|Overall Study|Lost to Follow-up|3|||
160663195|NCT02865850|580150615|FG001|Overall Study|Lost to Follow-up|2|||
160663196|NCT00552669|580150616|FG000|Overall Study|Death|3|||
160663197|NCT00552669|580150617|FG001|Overall Study|Death|7|||
160663198|NCT00252720|580150621|FG000|Overall Study|Withdrawal by Subject|95|||
160663199|NCT00252720|580150622|FG001|Overall Study|Withdrawal by Subject|97|||
160663200|NCT00252720|580150621|FG000|Overall Study|Death|7|||
160663201|NCT00252720|580150622|FG001|Overall Study|Death|8|||
160663202|NCT00252720|580150621|FG000|Overall Study|Moving|23|||
160663203|NCT00252720|580150622|FG001|Overall Study|Moving|42|||
160663204|NCT00252720|580150621|FG000|Overall Study|Mainly patients lost to follow-up|7|||
160663205|NCT00252720|580150622|FG001|Overall Study|Mainly patients lost to follow-up|18|||
160663206|NCT02481830|580150625|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
160504252|NCT03338296|579574586|FG001|Overall Study|Withdrawal by Subject|13|||
160504253|NCT03338296|579574585|FG000|Overall Study|Lost to Follow-up|10|||
160504254|NCT03338296|579574586|FG001|Overall Study|Lost to Follow-up|10|||
160504255|NCT03338296|579574585|FG000|Overall Study|Study Terminated by Sponsor|77|||
160504256|NCT03338296|579574586|FG001|Overall Study|Study Terminated by Sponsor|76|||
160504257|NCT03338296|579574585|FG000|Overall Study|Other|2|||
160504258|NCT03338296|579574586|FG001|Overall Study|Other|7|||
160504259|NCT03338296|579574585|FG000|Overall Study|Missing|0|||
160504260|NCT03338296|579574586|FG001|Overall Study|Missing|1|||
160504261|NCT01939353|579574587|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
160504262|NCT01939353|579574587|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
160504263|NCT01939353|579574587|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
160504264|NCT01939353|579574587|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
160504265|NCT01939353|579574587|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
160504266|NCT04421950|579574591|FG000|Overall Study|Dropped or lost to follow up|4|||
160504267|NCT04421950|579574592|FG001|Overall Study|Dropped or lost to follow up|2|||
160504268|NCT04546425|579574593|FG000|Overall Study|Protocol Violation|1|||
160504269|NCT04546425|579574594|FG001|Overall Study|Protocol Violation|1|||
160504270|NCT04546425|579574595|FG002|Overall Study|Protocol Violation|0|||
160504271|NCT04546425|579574596|FG003|Overall Study|Protocol Violation|0|||
160504272|NCT04546425|579574593|FG000|Overall Study|Adverse Event|3|||
160504273|NCT04546425|579574594|FG001|Overall Study|Adverse Event|0|||
160504274|NCT04546425|579574595|FG002|Overall Study|Adverse Event|0|||
160504275|NCT04546425|579574596|FG003|Overall Study|Adverse Event|0|||
160504276|NCT04546425|579574593|FG000|Overall Study|Lost to Follow-up|5|||
160504277|NCT04546425|579574594|FG001|Overall Study|Lost to Follow-up|4|||
160504278|NCT04546425|579574595|FG002|Overall Study|Lost to Follow-up|0|||
160504279|NCT04546425|579574596|FG003|Overall Study|Lost to Follow-up|0|||
160504280|NCT04546425|579574593|FG000|Overall Study|No Longer met eligibility criteria|3|||
160504281|NCT04546425|579574594|FG001|Overall Study|No Longer met eligibility criteria|3|||
160504282|NCT04546425|579574595|FG002|Overall Study|No Longer met eligibility criteria|1|||
160620072|NCT00337935|579988379|FG001|Overall Study|Protocol Violation|3|||
160620073|NCT00337935|579988378|FG000|Overall Study|Withdrawal by Subject|1|||
160620074|NCT00337935|579988379|FG001|Overall Study|Withdrawal by Subject|7|||
160620075|NCT00337935|579988378|FG000|Overall Study|Other|0|||
160620076|NCT00337935|579988379|FG001|Overall Study|Other|1|||
160620077|NCT00337935|579988378|FG000|Overall Study|Lack of Efficacy|0|||
160620078|NCT00337935|579988379|FG001|Overall Study|Lack of Efficacy|1|||
160620079|NCT01884675|579988380|FG000|Overall Study|Study closed/terminated|3|||
160620080|NCT01884675|579988381|FG001|Overall Study|Study closed/terminated|2|||
160620081|NCT03359811|579988382|FG000|Overall Study|Protocol Violation|2|||
160620082|NCT03359811|579988383|FG001|Overall Study|Protocol Violation|0|||
160620083|NCT01682876|579988386|FG000|Overall Study|Administrative reason|4|||
160620084|NCT01682876|579988387|FG001|Overall Study|Administrative reason|4|||
160620085|NCT01682876|579988388|FG002|Overall Study|Administrative reason|0|||
160620086|NCT01682876|579988389|FG003|Overall Study|Administrative reason|3|||
160620087|NCT01682876|579988386|FG000|Overall Study|Adverse Event|0|||
160620088|NCT01682876|579988387|FG001|Overall Study|Adverse Event|0|||
160620089|NCT01682876|579988388|FG002|Overall Study|Adverse Event|0|||
160620090|NCT01682876|579988389|FG003|Overall Study|Adverse Event|1|||
160620091|NCT01682876|579988386|FG000|Overall Study|Lost to Follow-up|11|||
160620092|NCT01682876|579988387|FG001|Overall Study|Lost to Follow-up|15|||
160620093|NCT01682876|579988388|FG002|Overall Study|Lost to Follow-up|9|||
160620094|NCT01682876|579988389|FG003|Overall Study|Lost to Follow-up|11|||
160620095|NCT01682876|579988386|FG000|Overall Study|Protocol Violation|1|||
160620096|NCT01682876|579988387|FG001|Overall Study|Protocol Violation|1|||
160620097|NCT01682876|579988388|FG002|Overall Study|Protocol Violation|1|||
160620098|NCT01682876|579988389|FG003|Overall Study|Protocol Violation|1|||
160620099|NCT01682876|579988386|FG000|Overall Study|Withdrawal by Subject|4|||
160620100|NCT01682876|579988387|FG001|Overall Study|Withdrawal by Subject|0|||
160620101|NCT01682876|579988388|FG002|Overall Study|Withdrawal by Subject|0|||
160620102|NCT01682876|579988389|FG003|Overall Study|Withdrawal by Subject|2|||
160620103|NCT01682876|579988386|FG000|Overall Study|Other|1|||
160620104|NCT01682876|579988387|FG001|Overall Study|Other|0|||
160620105|NCT01682876|579988388|FG002|Overall Study|Other|1|||
160620106|NCT01682876|579988389|FG003|Overall Study|Other|1|||
160620107|NCT01409382|579988390|FG000|Overall Study|Lost to Follow-up|1|||
160663207|NCT02481830|580150626|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
160663208|NCT02481830|580150625|FG000|Pre-treatment|Withdrawal by Subject|0|||
160504283|NCT04546425|579574596|FG003|Overall Study|No Longer met eligibility criteria|1|||
160504284|NCT04546425|579574593|FG000|Overall Study|Withdrawal by parent/guardian|6|||
160620108|NCT01409382|579988391|FG001|Overall Study|Lost to Follow-up|1|||
160620109|NCT01409382|579988390|FG000|Overall Study|Protocol Violation|0|||
160663209|NCT02481830|580150626|FG001|Pre-treatment|Withdrawal by Subject|10|||
160504285|NCT04546425|579574594|FG001|Overall Study|Withdrawal by parent/guardian|5|||
160504286|NCT04546425|579574595|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160620110|NCT01409382|579988391|FG001|Overall Study|Protocol Violation|3|||
160620111|NCT01409382|579988390|FG000|Overall Study|Multiple pregnancy|2|||
160504287|NCT04546425|579574596|FG003|Overall Study|Withdrawal by parent/guardian|1|||
160504288|NCT03435692|579574597|FG000|Overall Study|Lack of Efficacy|2|||
160504289|NCT03435692|579574598|FG001|Overall Study|Lack of Efficacy|2|||
160504290|NCT03435692|579574599|FG002|Overall Study|Lack of Efficacy|0|||
160504291|NCT00967005|579574600|FG000|Overall Study|Lost to Follow-up|7|||
160504292|NCT00967005|579574601|FG001|Overall Study|Lost to Follow-up|10|||
160504293|NCT05071053|579574602|FG000|Overall Study|Progressive disease|30|||
160504294|NCT05071053|579574602|FG000|Overall Study|Adverse Event|5|||
160504295|NCT02593123|579574603|FG000|Overall Study|Physician Decision|2|||
160504296|NCT02593123|579574604|FG001|Overall Study|Physician Decision|1|||
160504297|NCT02593123|579574603|FG000|Overall Study|Relapse|1|||
160504298|NCT02593123|579574604|FG001|Overall Study|Relapse|1|||
160504299|NCT00895895|579574612|FG000|Period 1|Adverse Event|7|||
160504300|NCT00895895|579574613|FG001|Period 1|Adverse Event|6|||
160504301|NCT00895895|579574614|FG002|Period 1|Adverse Event|4|||
160504302|NCT00895895|579574615|FG003|Period 1|Adverse Event|6|||
160504303|NCT00895895|579574616|FG004|Period 1|Adverse Event|7|||
160504304|NCT00895895|579574612|FG000|Period 1|Death|0|||
160504305|NCT00895895|579574613|FG001|Period 1|Death|0|||
160504306|NCT00895895|579574614|FG002|Period 1|Death|0|||
160504307|NCT00895895|579574615|FG003|Period 1|Death|0|||
160504308|NCT00895895|579574616|FG004|Period 1|Death|1|||
160504309|NCT00895895|579574612|FG000|Period 1|discontinued by sponsor|2|||
160504310|NCT00895895|579574613|FG001|Period 1|discontinued by sponsor|1|||
160504311|NCT00895895|579574614|FG002|Period 1|discontinued by sponsor|2|||
160504312|NCT00895895|579574615|FG003|Period 1|discontinued by sponsor|1|||
160504313|NCT00895895|579574616|FG004|Period 1|discontinued by sponsor|1|||
160504314|NCT00895895|579574612|FG000|Period 1|failed to return|0|||
160504315|NCT00895895|579574613|FG001|Period 1|failed to return|0|||
160504316|NCT00895895|579574614|FG002|Period 1|failed to return|1|||
160504317|NCT00895895|579574615|FG003|Period 1|failed to return|0|||
160504318|NCT00895895|579574616|FG004|Period 1|failed to return|1|||
160504319|NCT00895895|579574612|FG000|Period 1|investigator request|0|||
160504320|NCT00895895|579574613|FG001|Period 1|investigator request|1|||
160504321|NCT00895895|579574614|FG002|Period 1|investigator request|0|||
160504322|NCT00895895|579574615|FG003|Period 1|investigator request|0|||
160504323|NCT00895895|579574616|FG004|Period 1|investigator request|0|||
160504324|NCT00895895|579574612|FG000|Period 1|Lost to Follow-up|2|||
160504325|NCT00895895|579574613|FG001|Period 1|Lost to Follow-up|1|||
160504326|NCT00895895|579574614|FG002|Period 1|Lost to Follow-up|3|||
160504327|NCT00895895|579574615|FG003|Period 1|Lost to Follow-up|2|||
160504328|NCT00895895|579574616|FG004|Period 1|Lost to Follow-up|3|||
160504329|NCT00895895|579574612|FG000|Period 1|Other|1|||
160504330|NCT00895895|579574613|FG001|Period 1|Other|2|||
160504331|NCT00895895|579574614|FG002|Period 1|Other|1|||
160504332|NCT00895895|579574615|FG003|Period 1|Other|1|||
160504333|NCT00895895|579574616|FG004|Period 1|Other|1|||
160504334|NCT00895895|579574612|FG000|Period 1|Protocol Violation|0|||
160504335|NCT00895895|579574613|FG001|Period 1|Protocol Violation|1|||
160504336|NCT00895895|579574614|FG002|Period 1|Protocol Violation|0|||
160504337|NCT00895895|579574615|FG003|Period 1|Protocol Violation|0|||
160504338|NCT00895895|579574616|FG004|Period 1|Protocol Violation|0|||
160504339|NCT00895895|579574612|FG000|Period 1|Withdrawal by Subject|6|||
160504340|NCT00895895|579574613|FG001|Period 1|Withdrawal by Subject|6|||
160504341|NCT00895895|579574614|FG002|Period 1|Withdrawal by Subject|8|||
160504342|NCT00895895|579574615|FG003|Period 1|Withdrawal by Subject|2|||
160504343|NCT00895895|579574616|FG004|Period 1|Withdrawal by Subject|4|||
160504344|NCT00895895|579574612|FG000|Period 1|unsatisfactory response-efficacy|2|||
160663210|NCT02481830|580150625|FG000|Pre-treatment|Disease Progression|1|||
160663211|NCT02481830|580150626|FG001|Pre-treatment|Disease Progression|1|||
160663212|NCT02481830|580150625|FG000|Pre-treatment|Other reasons|0|||
160663213|NCT02481830|580150626|FG001|Pre-treatment|Other reasons|1|||
160663214|NCT02481830|580150625|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
160663215|NCT02481830|580150626|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
160663216|NCT02481830|580150625|FG000|Treatment|Disease Progression|233|||
160504345|NCT00895895|579574613|FG001|Period 1|unsatisfactory response-efficacy|0|||
160504346|NCT00895895|579574614|FG002|Period 1|unsatisfactory response-efficacy|0|||
160504347|NCT00895895|579574615|FG003|Period 1|unsatisfactory response-efficacy|0|||
160504348|NCT00895895|579574616|FG004|Period 1|unsatisfactory response-efficacy|0|||
160504349|NCT00895895|579574612|FG000|Period 1|randomized and not treated|1|||
160663217|NCT02481830|580150626|FG001|Treatment|Disease Progression|171|||
160504350|NCT00895895|579574613|FG001|Period 1|randomized and not treated|3|||
160663218|NCT02481830|580150625|FG000|Treatment|Study drug toxicity|18|||
160663219|NCT02481830|580150626|FG001|Treatment|Study drug toxicity|38|||
160504351|NCT00895895|579574614|FG002|Period 1|randomized and not treated|1|||
160663220|NCT02481830|580150625|FG000|Treatment|Death|1|||
160663221|NCT02481830|580150626|FG001|Treatment|Death|1|||
160663222|NCT02481830|580150625|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
160504352|NCT00895895|579574615|FG003|Period 1|randomized and not treated|1|||
160504353|NCT00895895|579574616|FG004|Period 1|randomized and not treated|2|||
160504354|NCT00895895|579574612|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
160504355|NCT00895895|579574613|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
160504356|NCT00895895|579574614|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
160504357|NCT00895895|579574615|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
160504358|NCT00895895|579574616|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
160504359|NCT00895895|579574612|FG000|After Period 1, Prior to Period 2|Other|0|||
160504360|NCT00895895|579574613|FG001|After Period 1, Prior to Period 2|Other|0|||
160504361|NCT00895895|579574614|FG002|After Period 1, Prior to Period 2|Other|1|||
160504362|NCT00895895|579574615|FG003|After Period 1, Prior to Period 2|Other|0|||
160504363|NCT00895895|579574616|FG004|After Period 1, Prior to Period 2|Other|0|||
160504364|NCT00895895|579574612|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
160504365|NCT00895895|579574613|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
160504366|NCT00895895|579574614|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
160504367|NCT00895895|579574615|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
160504368|NCT00895895|579574616|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
160504369|NCT00895895|579574612|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
160504370|NCT00895895|579574613|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
160504371|NCT00895895|579574614|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
160504372|NCT00895895|579574615|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
160504373|NCT00895895|579574616|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
160504374|NCT00895895|579574612|FG000|Period 2|Adverse Event|3|||
160504375|NCT00895895|579574613|FG001|Period 2|Adverse Event|3|||
160504376|NCT00895895|579574614|FG002|Period 2|Adverse Event|5|||
160504377|NCT00895895|579574615|FG003|Period 2|Adverse Event|2|||
160504378|NCT00895895|579574616|FG004|Period 2|Adverse Event|5|||
160504379|NCT00895895|579574612|FG000|Period 2|Death|0|||
160504380|NCT00895895|579574613|FG001|Period 2|Death|0|||
160504381|NCT00895895|579574614|FG002|Period 2|Death|1|||
160504382|NCT00895895|579574615|FG003|Period 2|Death|0|||
160504383|NCT00895895|579574616|FG004|Period 2|Death|0|||
160504384|NCT00895895|579574612|FG000|Period 2|discontinued by sponsor|44|||
160504385|NCT00895895|579574613|FG001|Period 2|discontinued by sponsor|44|||
160504386|NCT00895895|579574614|FG002|Period 2|discontinued by sponsor|38|||
160504387|NCT00895895|579574615|FG003|Period 2|discontinued by sponsor|46|||
160504388|NCT00895895|579574616|FG004|Period 2|discontinued by sponsor|37|||
160504389|NCT00895895|579574612|FG000|Period 2|failed to return|2|||
160504390|NCT00895895|579574613|FG001|Period 2|failed to return|0|||
160504391|NCT00895895|579574614|FG002|Period 2|failed to return|0|||
160504392|NCT00895895|579574615|FG003|Period 2|failed to return|0|||
160504393|NCT00895895|579574616|FG004|Period 2|failed to return|0|||
160504394|NCT00895895|579574612|FG000|Period 2|investigator request|2|||
160504395|NCT00895895|579574613|FG001|Period 2|investigator request|0|||
160504396|NCT00895895|579574614|FG002|Period 2|investigator request|0|||
160504397|NCT00895895|579574615|FG003|Period 2|investigator request|0|||
160504398|NCT00895895|579574616|FG004|Period 2|investigator request|0|||
160504399|NCT00895895|579574612|FG000|Period 2|Lost to Follow-up|1|||
160504400|NCT00895895|579574613|FG001|Period 2|Lost to Follow-up|2|||
160504401|NCT00895895|579574614|FG002|Period 2|Lost to Follow-up|1|||
160504402|NCT00895895|579574615|FG003|Period 2|Lost to Follow-up|1|||
160504403|NCT00895895|579574616|FG004|Period 2|Lost to Follow-up|0|||
160504404|NCT00895895|579574612|FG000|Period 2|Other|1|||
160504405|NCT00895895|579574613|FG001|Period 2|Other|1|||
160504406|NCT00895895|579574614|FG002|Period 2|Other|3|||
160504407|NCT00895895|579574615|FG003|Period 2|Other|1|||
160504408|NCT00895895|579574616|FG004|Period 2|Other|1|||
160504409|NCT00895895|579574612|FG000|Period 2|Protocol Violation|1|||
160504410|NCT00895895|579574613|FG001|Period 2|Protocol Violation|0|||
160504411|NCT00895895|579574614|FG002|Period 2|Protocol Violation|1|||
160504412|NCT00895895|579574615|FG003|Period 2|Protocol Violation|1|||
160504413|NCT00895895|579574616|FG004|Period 2|Protocol Violation|1|||
160504414|NCT00895895|579574612|FG000|Period 2|Withdrawal by Subject|0|||
160504415|NCT00895895|579574613|FG001|Period 2|Withdrawal by Subject|2|||
160504416|NCT00895895|579574614|FG002|Period 2|Withdrawal by Subject|0|||
160504417|NCT00895895|579574615|FG003|Period 2|Withdrawal by Subject|3|||
160504418|NCT00895895|579574616|FG004|Period 2|Withdrawal by Subject|5|||
160504419|NCT00895895|579574612|FG000|Period 2|unsatisfactory response-efficacy|2|||
160504420|NCT00895895|579574613|FG001|Period 2|unsatisfactory response-efficacy|1|||
160504421|NCT00895895|579574614|FG002|Period 2|unsatisfactory response-efficacy|0|||
160504422|NCT00895895|579574615|FG003|Period 2|unsatisfactory response-efficacy|0|||
160504423|NCT00895895|579574616|FG004|Period 2|unsatisfactory response-efficacy|0|||
160504424|NCT03019640|579574617|FG000|Overall Study|Screen Failures|4|||
160504425|NCT03019640|579574617|FG000|Overall Study|Adverse Event|3|||
160504426|NCT03019640|579574617|FG000|Overall Study|Participant Relapsed|1|||
160504427|NCT02992691|579574618|FG000|Overall Study|Adverse Event|2|||
160504428|NCT02992691|579574618|FG000|Overall Study|Withdrawal by Subject|1|||
160504429|NCT00588692|579574619|FG000|Overall Study|Withdrawal by Subject|4|||
160504430|NCT00588692|579574620|FG001|Overall Study|Withdrawal by Subject|2|||
160504431|NCT00588692|579574619|FG000|Overall Study|Hip Surgery|0|||
160504432|NCT00588692|579574620|FG001|Overall Study|Hip Surgery|1|||
160504433|NCT00588692|579574619|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
160504434|NCT00588692|579574620|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
160504435|NCT00588692|579574619|FG000|Overall Study|Cancer|1|||
160504436|NCT00588692|579574620|FG001|Overall Study|Cancer|0|||
160504437|NCT00588692|579574619|FG000|Overall Study|Death|1|||
160504438|NCT00588692|579574620|FG001|Overall Study|Death|0|||
160504439|NCT03538938|579574622|FG000|Overall Study|Death|0|||
160504440|NCT03538938|579574623|FG001|Overall Study|Death|0|||
160504441|NCT03538938|579574624|FG002|Overall Study|Death|2|||
160504442|NCT03538938|579574625|FG003|Overall Study|Death|0|||
160504443|NCT03538938|579574626|FG004|Overall Study|Death|0|||
160504444|NCT03538938|579574627|FG005|Overall Study|Death|1|||
160504445|NCT03538938|579574628|FG006|Overall Study|Death|0|||
160504446|NCT03538938|579574629|FG007|Overall Study|Death|1|||
160504447|NCT03538938|579574630|FG008|Overall Study|Death|1|||
160504448|NCT03538938|579574631|FG009|Overall Study|Death|1|||
160504449|NCT03538938|579574632|FG010|Overall Study|Death|0|||
160504450|NCT03538938|579574633|FG011|Overall Study|Death|0|||
160504451|NCT03538938|579574634|FG012|Overall Study|Death|1|||
160504452|NCT03538938|579574635|FG013|Overall Study|Death|1|||
160504453|NCT03538938|579574636|FG014|Overall Study|Death|0|||
160504454|NCT03538938|579574637|FG015|Overall Study|Death|1|||
160504455|NCT03538938|579574622|FG000|Overall Study|Withdrawal by Subject|4|||
160504456|NCT03538938|579574623|FG001|Overall Study|Withdrawal by Subject|6|||
160504457|NCT03538938|579574624|FG002|Overall Study|Withdrawal by Subject|5|||
160504458|NCT03538938|579574625|FG003|Overall Study|Withdrawal by Subject|3|||
160504459|NCT03538938|579574626|FG004|Overall Study|Withdrawal by Subject|0|||
160504460|NCT03538938|579574627|FG005|Overall Study|Withdrawal by Subject|0|||
160504461|NCT03538938|579574628|FG006|Overall Study|Withdrawal by Subject|3|||
160504462|NCT03538938|579574629|FG007|Overall Study|Withdrawal by Subject|1|||
160504463|NCT03538938|579574630|FG008|Overall Study|Withdrawal by Subject|5|||
160504464|NCT03538938|579574631|FG009|Overall Study|Withdrawal by Subject|1|||
160504465|NCT03538938|579574632|FG010|Overall Study|Withdrawal by Subject|2|||
160504466|NCT03538938|579574633|FG011|Overall Study|Withdrawal by Subject|1|||
160504467|NCT03538938|579574634|FG012|Overall Study|Withdrawal by Subject|3|||
160504468|NCT03538938|579574635|FG013|Overall Study|Withdrawal by Subject|0|||
160504469|NCT03538938|579574636|FG014|Overall Study|Withdrawal by Subject|2|||
160504470|NCT03538938|579574637|FG015|Overall Study|Withdrawal by Subject|4|||
160504471|NCT03538938|579574622|FG000|Overall Study|Incarcerated|0|||
160504472|NCT03538938|579574623|FG001|Overall Study|Incarcerated|0|||
160504473|NCT03538938|579574624|FG002|Overall Study|Incarcerated|0|||
160504474|NCT03538938|579574625|FG003|Overall Study|Incarcerated|0|||
160504475|NCT03538938|579574626|FG004|Overall Study|Incarcerated|0|||
160504476|NCT03538938|579574627|FG005|Overall Study|Incarcerated|0|||
160504477|NCT03538938|579574628|FG006|Overall Study|Incarcerated|0|||
160504478|NCT03538938|579574629|FG007|Overall Study|Incarcerated|0|||
160504479|NCT03538938|579574630|FG008|Overall Study|Incarcerated|0|||
160504480|NCT03538938|579574631|FG009|Overall Study|Incarcerated|0|||
160504481|NCT03538938|579574632|FG010|Overall Study|Incarcerated|0|||
160504482|NCT03538938|579574633|FG011|Overall Study|Incarcerated|1|||
160504483|NCT03538938|579574634|FG012|Overall Study|Incarcerated|0|||
160504484|NCT03538938|579574635|FG013|Overall Study|Incarcerated|0|||
160504485|NCT03538938|579574636|FG014|Overall Study|Incarcerated|0|||
160504486|NCT03538938|579574637|FG015|Overall Study|Incarcerated|0|||
160504487|NCT00755105|579574638|FG000|Overall Study|Withdrawal by Subject|9|||
160504488|NCT00755105|579574639|FG001|Overall Study|Withdrawal by Subject|11|||
160504489|NCT00755105|579574640|FG002|Overall Study|Withdrawal by Subject|4|||
160504490|NCT03995316|579574641|FG000|Overall Study|Lost to Follow-up|10|||
160504491|NCT03995316|579574642|FG001|Overall Study|Lost to Follow-up|3|||
160504492|NCT02180243|579574643|FG000|Overall Study|Withdrawal by Subject|12|||
160504493|NCT02180243|579574644|FG001|Overall Study|Withdrawal by Subject|12|||
160504494|NCT02180243|579574643|FG000|Overall Study|Lost to Follow-up|12|||
160504495|NCT02180243|579574644|FG001|Overall Study|Lost to Follow-up|2|||
160504496|NCT02202785|579574645|FG000|Overall Study|Study Terminated by Sponsor|1|||
160504497|NCT02202785|579574646|FG001|Overall Study|Study Terminated by Sponsor|6|||
160504498|NCT02202785|579574647|FG002|Overall Study|Study Terminated by Sponsor|4|||
160504499|NCT02202785|579574645|FG000|Overall Study|Withdrawal by Subject|0|||
160504500|NCT02202785|579574646|FG001|Overall Study|Withdrawal by Subject|1|||
160504501|NCT02202785|579574647|FG002|Overall Study|Withdrawal by Subject|0|||
160504502|NCT02202785|579574645|FG000|Overall Study|Lost to Follow-up|0|||
160504503|NCT02202785|579574646|FG001|Overall Study|Lost to Follow-up|1|||
160504504|NCT02202785|579574647|FG002|Overall Study|Lost to Follow-up|0|||
160504505|NCT02202785|579574645|FG000|Overall Study|Reason not Specified|10|||
160504506|NCT02202785|579574646|FG001|Overall Study|Reason not Specified|7|||
160620112|NCT01409382|579988391|FG001|Overall Study|Multiple pregnancy|4|||
160504507|NCT02202785|579574647|FG002|Overall Study|Reason not Specified|13|||
160504508|NCT01137578|579574648|FG000|Overall Study|Participant requested to Discontinue|3|||
160504509|NCT01137578|579574649|FG001|Overall Study|Participant requested to Discontinue|0|||
160504510|NCT01137578|579574650|FG002|Overall Study|Participant requested to Discontinue|0|||
160504511|NCT01137578|579574648|FG000|Overall Study|Withdrawal by Subject|1|||
160504512|NCT01137578|579574649|FG001|Overall Study|Withdrawal by Subject|0|||
160504513|NCT01137578|579574650|FG002|Overall Study|Withdrawal by Subject|0|||
160504514|NCT01137578|579574648|FG000|Overall Study|Other|12|||
160504515|NCT01137578|579574649|FG001|Overall Study|Other|2|||
160504516|NCT01137578|579574650|FG002|Overall Study|Other|6|||
160504517|NCT03945825|579574658|FG000|Overall Study|Enrolled but treatment not administered|0|||
160504518|NCT03945825|579574659|FG001|Overall Study|Enrolled but treatment not administered|0|||
160504519|NCT03945825|579574660|FG002|Overall Study|Enrolled but treatment not administered|0|||
160504520|NCT03945825|579574661|FG003|Overall Study|Enrolled but treatment not administered|0|||
160504521|NCT03945825|579574662|FG004|Overall Study|Enrolled but treatment not administered|1|||
160504522|NCT03945825|579574663|FG005|Overall Study|Enrolled but treatment not administered|0|||
160504523|NCT03945825|579574658|FG000|Overall Study|Lost to Follow-up|1|||
160504524|NCT03945825|579574659|FG001|Overall Study|Lost to Follow-up|5|||
160504525|NCT03945825|579574660|FG002|Overall Study|Lost to Follow-up|0|||
160504526|NCT03945825|579574661|FG003|Overall Study|Lost to Follow-up|1|||
160504527|NCT03945825|579574662|FG004|Overall Study|Lost to Follow-up|2|||
160504528|NCT03945825|579574663|FG005|Overall Study|Lost to Follow-up|2|||
160504529|NCT03945825|579574658|FG000|Overall Study|Withdrawal by Subject|1|||
160504530|NCT03945825|579574659|FG001|Overall Study|Withdrawal by Subject|0|||
160504531|NCT03945825|579574660|FG002|Overall Study|Withdrawal by Subject|1|||
160504532|NCT03945825|579574661|FG003|Overall Study|Withdrawal by Subject|1|||
160504533|NCT03945825|579574662|FG004|Overall Study|Withdrawal by Subject|0|||
160504534|NCT03945825|579574663|FG005|Overall Study|Withdrawal by Subject|1|||
160504535|NCT01461005|579574664|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
160504536|NCT00203268|579574665|FG000|Early Treatment|only treated one headache|2|||
160504537|NCT00203268|579574665|FG000|Early Treatment|Lost to Follow-up|1|||
160504538|NCT00203268|579574665|FG000|Early Treatment|Withdrawal by Subject|1|||
160504539|NCT00600613|579574666|FG000|Overall Study|Protocol Deviation|1|||
160504540|NCT00846807|579574670|FG000|Overall Study|Adverse Event|270|||
160504541|NCT00846807|579574670|FG000|Overall Study|Lost to Follow-up|94|||
160504542|NCT00846807|579574670|FG000|Overall Study|Withdrawal by Subject|56|||
160504543|NCT00846807|579574670|FG000|Overall Study|Non compliant with European label|7|||
160504544|NCT00846807|579574670|FG000|Overall Study|Switch to other anticoagulants|89|||
160504545|NCT00846807|579574670|FG000|Overall Study|No prescription after hospital discharge|56|||
160504546|NCT00846807|579574670|FG000|Overall Study|Other|60|||
160504547|NCT00245960|579574671|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
160504548|NCT00245960|579574672|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
160504549|NCT00245960|579574671|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
160504550|NCT00245960|579574672|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
160504551|NCT00245960|579574671|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
160504552|NCT00245960|579574672|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
160504553|NCT00245960|579574671|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
160504554|NCT00245960|579574672|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
160504555|NCT00245960|579574671|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
160504556|NCT00245960|579574672|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
160504557|NCT00245960|579574671|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
160504558|NCT00245960|579574672|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
160504559|NCT00245960|579574671|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
160504560|NCT00245960|579574672|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
160504561|NCT00245960|579574671|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
160504562|NCT00245960|579574672|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
160504563|NCT00245960|579574671|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
160504564|NCT00245960|579574672|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
160504565|NCT00245960|579574671|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
160504566|NCT00245960|579574672|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
160504567|NCT00245960|579574671|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
160504568|NCT00245960|579574672|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
160504569|NCT00245960|579574671|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
160504570|NCT00245960|579574672|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
160504571|NCT00737698|579574673|FG000|Overall Study|Withdrawal by Subject|6|||
160504572|NCT00737698|579574674|FG001|Overall Study|Withdrawal by Subject|5|||
160504573|NCT00737698|579574675|FG002|Overall Study|Withdrawal by Subject|3|||
160504574|NCT00737698|579574673|FG000|Overall Study|Death|0|||
160504575|NCT00737698|579574674|FG001|Overall Study|Death|0|||
160504576|NCT00737698|579574675|FG002|Overall Study|Death|1|||
160504577|NCT00669877|579574678|FG000|Overall Study|Disease Progression/Death|4|||
160504578|NCT01110408|579574679|FG000|Overall Study|Protocol Violation|1|||
160504579|NCT01110408|579574680|FG001|Overall Study|Protocol Violation|0|||
160504580|NCT04844879|579574681|FG000|Overall Study|Death|1|||
160620113|NCT01409382|579988390|FG000|Overall Study|Still pregnant when study ended|13|||
160620114|NCT01409382|579988391|FG001|Overall Study|Still pregnant when study ended|2|||
160620115|NCT01409382|579988390|FG000|Overall Study|Did not manage to get pregnant|64|||
160620116|NCT01409382|579988391|FG001|Overall Study|Did not manage to get pregnant|70|||
160620117|NCT01409382|579988390|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
160504581|NCT04844879|579574681|FG000|Overall Study|Withdrawal by Subject|1|||
160504582|NCT04844879|579574681|FG000|Overall Study|Adverse Event|1|||
160504583|NCT03551691|579574701|FG000|Overall Study|Withdrawal by Subject|3|||
160504584|NCT03551691|579574702|FG001|Overall Study|Withdrawal by Subject|3|||
160504585|NCT02367040|579574703|FG000|Overall Study|Lost to Follow-up|1|||
160504586|NCT02367040|579574704|FG001|Overall Study|Lost to Follow-up|1|||
160504587|NCT02367040|579574703|FG000|Overall Study|Lack of Efficacy|1|||
160504588|NCT02367040|579574704|FG001|Overall Study|Lack of Efficacy|0|||
160504589|NCT02367040|579574703|FG000|Overall Study|Additional primary malignancy|1|||
160504590|NCT02367040|579574704|FG001|Overall Study|Additional primary malignancy|1|||
160504591|NCT02367040|579574703|FG000|Overall Study|AE not associated with clinical disease progression|117|||
160504592|NCT02367040|579574704|FG001|Overall Study|AE not associated with clinical disease progression|12|||
160504593|NCT02367040|579574703|FG000|Overall Study|AE associated with clinical disease progression|1|||
160504594|NCT02367040|579574704|FG001|Overall Study|AE associated with clinical disease progression|4|||
160504595|NCT02367040|579574703|FG000|Overall Study|Physician Decision|2|||
160504596|NCT02367040|579574704|FG001|Overall Study|Physician Decision|8|||
160504597|NCT02367040|579574703|FG000|Overall Study|Non-compliance to study drug|1|||
160504598|NCT02367040|579574704|FG001|Overall Study|Non-compliance to study drug|0|||
160504599|NCT02367040|579574703|FG000|Overall Study|Failure to meet continuation criteria|1|||
160504600|NCT02367040|579574704|FG001|Overall Study|Failure to meet continuation criteria|0|||
160504601|NCT02367040|579574703|FG000|Overall Study|Switching to other therapy|2|||
160504602|NCT02367040|579574704|FG001|Overall Study|Switching to other therapy|0|||
160504603|NCT02367040|579574703|FG000|Overall Study|Withdrawal by Subject|51|||
160504604|NCT02367040|579574704|FG001|Overall Study|Withdrawal by Subject|16|||
160504605|NCT02367040|579574703|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
160504606|NCT02367040|579574704|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
160504607|NCT02367040|579574703|FG000|Overall Study|Patient decision|40|||
160504608|NCT02367040|579574704|FG001|Overall Study|Patient decision|14|||
160504609|NCT02367040|579574703|FG000|Overall Study|Required procedure failed|1|||
160504610|NCT02367040|579574704|FG001|Overall Study|Required procedure failed|0|||
160504611|NCT02367040|579574703|FG000|Overall Study|Randomized by mistake with study treatment|1|||
160504612|NCT02367040|579574704|FG001|Overall Study|Randomized by mistake with study treatment|0|||
160504613|NCT02367040|579574703|FG000|Overall Study|Protocol Violation|1|||
160504614|NCT02367040|579574704|FG001|Overall Study|Protocol Violation|0|||
160504615|NCT02367040|579574703|FG000|Overall Study|Progressive disease - radiological progression|54|||
160504616|NCT02367040|579574704|FG001|Overall Study|Progressive disease - radiological progression|80|||
160504617|NCT02367040|579574703|FG000|Overall Study|Progressive disease - clinical progression|6|||
160504618|NCT02367040|579574704|FG001|Overall Study|Progressive disease - clinical progression|6|||
160504619|NCT02367040|579574703|FG000|Overall Study|Drug not administered|3|||
160504620|NCT02367040|579574704|FG001|Overall Study|Drug not administered|2|||
160504621|NCT02367040|579574703|FG000|Overall Study|Progressive disease|0|||
160504622|NCT02367040|579574704|FG001|Overall Study|Progressive disease|1|||
160504623|NCT02367040|579574703|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
160504624|NCT02367040|579574704|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
160504625|NCT02367040|579574703|FG000|Overall Study|Death|2|||
160504626|NCT02367040|579574704|FG001|Overall Study|Death|0|||
160504627|NCT02367040|579574703|FG000|Overall Study|Study terminated by sponsor|19|||
160504628|NCT02367040|579574704|FG001|Overall Study|Study terminated by sponsor|2|||
160504629|NCT02477618|579574705|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
160504630|NCT02477618|579574706|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
160504631|NCT02477618|579574705|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
160504632|NCT02477618|579574706|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
160504633|NCT02477618|579574705|FG000|Overall Study|Adverse Event|1|||
160504634|NCT02477618|579574706|FG001|Overall Study|Adverse Event|1|||
160504635|NCT02477618|579574705|FG000|Overall Study|Transferred Away from Study Site|1|||
160504636|NCT02477618|579574706|FG001|Overall Study|Transferred Away from Study Site|0|||
160504637|NCT02477618|579574705|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
160504638|NCT02477618|579574706|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
160504639|NCT03007420|579574707|FG000|Overall Study|Withdrawal by Subject|0|||
160504640|NCT03007420|579574708|FG001|Overall Study|Withdrawal by Subject|2|||
160504641|NCT03007420|579574707|FG000|Overall Study|Physician Decision|0|||
160504642|NCT03007420|579574708|FG001|Overall Study|Physician Decision|1|||
160504643|NCT01435772|579574711|FG000|Overall Study|Adverse Event|1|||
160504644|NCT01435772|579574712|FG001|Overall Study|Adverse Event|0|||
160504645|NCT01435772|579574713|FG002|Overall Study|Adverse Event|2|||
160504646|NCT01435772|579574711|FG000|Overall Study|Withdrawal by Subject|0|||
160504647|NCT01435772|579574712|FG001|Overall Study|Withdrawal by Subject|1|||
160504648|NCT01435772|579574713|FG002|Overall Study|Withdrawal by Subject|3|||
160504649|NCT01435772|579574711|FG000|Overall Study|Other - study termination|2|||
160504650|NCT01435772|579574712|FG001|Overall Study|Other - study termination|2|||
160504651|NCT01435772|579574713|FG002|Overall Study|Other - study termination|10|||
160504652|NCT03238963|579574714|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
160663223|NCT02481830|580150626|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
160663224|NCT02481830|580150625|FG000|Treatment|Participants request to discontinue Study treatment|6|||
160663225|NCT02481830|580150626|FG001|Treatment|Participants request to discontinue Study treatment|34|||
160663226|NCT02481830|580150625|FG000|Treatment|Withdrawal by Subject|2|||
160663227|NCT02481830|580150626|FG001|Treatment|Withdrawal by Subject|3|||
160663228|NCT02481830|580150625|FG000|Treatment|Lost to Follow-up|1|||
160663229|NCT02481830|580150626|FG001|Treatment|Lost to Follow-up|0|||
160663230|NCT02481830|580150625|FG000|Treatment|Maximum Clinical Benefit|0|||
160663231|NCT02481830|580150626|FG001|Treatment|Maximum Clinical Benefit|5|||
160663232|NCT02481830|580150625|FG000|Treatment|Administrative reason by sponsor|1|||
160663233|NCT02481830|580150626|FG001|Treatment|Administrative reason by sponsor|1|||
160663234|NCT02481830|580150625|FG000|Treatment|Other reasons|6|||
160663235|NCT02481830|580150626|FG001|Treatment|Other reasons|1|||
160663236|NCT00772941|580150627|FG000|Overall Study|CRFs not available|195|||
160663237|NCT00772941|580150627|FG000|Overall Study|Study not completed|16|||
160663238|NCT00772941|580150627|FG000|Overall Study|Missed Visits|374|||
160663239|NCT00772941|580150627|FG000|Overall Study|Poor Compliance|7|||
160663240|NCT00772941|580150627|FG000|Overall Study|GPSP Violation|90|||
160663241|NCT04627038|580150628|FG000|Overall Study|Adverse Event|36|||
160663242|NCT04627038|580150629|FG001|Overall Study|Adverse Event|8|||
160663243|NCT04627038|580150628|FG000|Overall Study|Lost to Follow-up|1|||
160663244|NCT04627038|580150629|FG001|Overall Study|Lost to Follow-up|0|||
160663245|NCT04627038|580150628|FG000|Overall Study|Physician Decision|0|||
160504653|NCT03238963|579574715|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
160504654|NCT03238963|579574714|FG000|Overall Study|Withdrawal by Subject|1|||
160504655|NCT03238963|579574715|FG001|Overall Study|Withdrawal by Subject|1|||
160504656|NCT03238963|579574714|FG000|Overall Study|Lost to Follow-up|1|||
160504657|NCT03238963|579574715|FG001|Overall Study|Lost to Follow-up|0|||
160504658|NCT03238963|579574714|FG000|Overall Study|Protocol Violation|1|||
160504659|NCT03238963|579574715|FG001|Overall Study|Protocol Violation|1|||
160504660|NCT03238963|579574714|FG000|Overall Study|Adverse Event|1|||
160504661|NCT03238963|579574715|FG001|Overall Study|Adverse Event|0|||
160663246|NCT04627038|580150629|FG001|Overall Study|Physician Decision|1|||
160663247|NCT04627038|580150628|FG000|Overall Study|Protocol Violation|3|||
160663248|NCT04627038|580150629|FG001|Overall Study|Protocol Violation|1|||
160663249|NCT04627038|580150628|FG000|Overall Study|Withdrawal by Subject|13|||
160663250|NCT04627038|580150629|FG001|Overall Study|Withdrawal by Subject|3|||
160663251|NCT04627038|580150628|FG000|Overall Study|Non-compliance with study drug|0|||
160663252|NCT04627038|580150629|FG001|Overall Study|Non-compliance with study drug|1|||
160663253|NCT04627038|580150628|FG000|Overall Study|Prohibited Concomitant Medication|1|||
160663254|NCT04627038|580150629|FG001|Overall Study|Prohibited Concomitant Medication|0|||
160663255|NCT02714062|580150635|FG000|Overall Study|Adverse Event|0|||
160504662|NCT05823012|579574716|FG000|Titration Period|Adverse Event|1|||
160504663|NCT05823012|579574716|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
160504664|NCT05823012|579574716|FG000|Maintenance Period|Adverse Event|1|||
160504665|NCT05823012|579574716|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
160504666|NCT05823012|579574716|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
160504667|NCT01424813|579574717|FG000|Overall Study|Withdrawal by Subject|3|||
160663256|NCT02714062|580150636|FG001|Overall Study|Adverse Event|0|||
160663257|NCT02714062|580150637|FG002|Overall Study|Adverse Event|2|||
160663258|NCT02714062|580150635|FG000|Overall Study|Withdrawal by Subject|1|||
160663259|NCT02714062|580150636|FG001|Overall Study|Withdrawal by Subject|0|||
160663260|NCT02714062|580150637|FG002|Overall Study|Withdrawal by Subject|1|||
160663261|NCT02714062|580150635|FG000|Overall Study|Protocol Violation|0|||
160663262|NCT02714062|580150636|FG001|Overall Study|Protocol Violation|1|||
160663263|NCT02714062|580150637|FG002|Overall Study|Protocol Violation|0|||
160663264|NCT02682784|580150638|FG000|Overall Study|Withdrawal by Subject|0|||
160663265|NCT02682784|580150639|FG001|Overall Study|Withdrawal by Subject|2|||
160663266|NCT02682784|580150640|FG002|Overall Study|Withdrawal by Subject|1|||
160663267|NCT02682784|580150641|FG003|Overall Study|Withdrawal by Subject|2|||
160663268|NCT02682784|580150638|FG000|Overall Study|Physician Decision|1|||
160663269|NCT02682784|580150639|FG001|Overall Study|Physician Decision|0|||
160663270|NCT02682784|580150640|FG002|Overall Study|Physician Decision|1|||
160504668|NCT01424813|579574718|FG001|Overall Study|Withdrawal by Subject|0|||
160504669|NCT01424813|579574717|FG000|Overall Study|Protocol Violation|1|||
160504670|NCT01424813|579574718|FG001|Overall Study|Protocol Violation|0|||
160504671|NCT01424813|579574717|FG000|Overall Study|Other|1|||
160504672|NCT01424813|579574718|FG001|Overall Study|Other|2|||
160504673|NCT07149155|579574719|FG000|Overall Study|Lost to Follow-up|10|||
160663271|NCT02682784|580150641|FG003|Overall Study|Physician Decision|1|||
160663272|NCT00467363|580150642|FG000|Overall Study|Lost to Follow-up|80|||
160663273|NCT00467363|580150643|FG001|Overall Study|Lost to Follow-up|70|||
160663274|NCT03181594|580150644|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
160663275|NCT03181594|580150644|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
160663276|NCT03181594|580150644|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
160663277|NCT03181594|580150644|FG000|Initial Study Protocol (12-month FU)|Death|1|||
160663278|NCT03181594|580150644|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
160663279|NCT03181594|580150644|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
160663280|NCT02017223|580150645|FG000|Overall Study|Algorithm problems|2|||
160504674|NCT01876082|579576896|FG000|Overall Study|Withdrawal by Subject|0|||
160504675|NCT01876082|579576897|FG001|Overall Study|Withdrawal by Subject|2|||
160504676|NCT01876082|579576896|FG000|Overall Study|Protocol Violation|1|||
160504677|NCT01876082|579576897|FG001|Overall Study|Protocol Violation|0|||
160504678|NCT01876082|579576896|FG000|Overall Study|Adverse Event|1|||
160504679|NCT01876082|579576897|FG001|Overall Study|Adverse Event|1|||
160504680|NCT01876082|579576896|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
160504681|NCT01876082|579576897|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
160504682|NCT03829501|579576908|FG000|Overall Study|Withdrawal of Consent|2|||
160504683|NCT03829501|579576909|FG001|Overall Study|Withdrawal of Consent|0|||
160663281|NCT00473330|580150651|FG000|Core Study|Adverse Event|4|||
160663282|NCT00473330|580150652|FG001|Core Study|Adverse Event|4|||
160663283|NCT00473330|580150653|FG002|Core Study|Adverse Event|1|||
160663284|NCT00473330|580150651|FG000|Core Study|Death|6|||
160663285|NCT00473330|580150652|FG001|Core Study|Death|4|||
160663286|NCT00473330|580150653|FG002|Core Study|Death|4|||
160663287|NCT00473330|580150651|FG000|Core Study|Lost to Follow-up|5|||
160663288|NCT00473330|580150652|FG001|Core Study|Lost to Follow-up|5|||
160663289|NCT00473330|580150653|FG002|Core Study|Lost to Follow-up|10|||
160663290|NCT00473330|580150651|FG000|Core Study|Physician Decision|2|||
160504684|NCT03829501|579576910|FG002|Overall Study|Withdrawal of Consent|3|||
160504685|NCT03829501|579576911|FG003|Overall Study|Withdrawal of Consent|0|||
160504686|NCT03829501|579576912|FG004|Overall Study|Withdrawal of Consent|1|||
160504687|NCT03829501|579576913|FG005|Overall Study|Withdrawal of Consent|1|||
160504688|NCT03829501|579576914|FG006|Overall Study|Withdrawal of Consent|0|||
160504689|NCT03829501|579576915|FG007|Overall Study|Withdrawal of Consent|10|||
160504690|NCT03829501|579576916|FG008|Overall Study|Withdrawal of Consent|10|||
160504691|NCT03829501|579576917|FG009|Overall Study|Withdrawal of Consent|3|||
160504692|NCT03829501|579576918|FG010|Overall Study|Withdrawal of Consent|4|||
160504693|NCT03829501|579576919|FG011|Overall Study|Withdrawal of Consent|4|||
160504694|NCT03829501|579576920|FG012|Overall Study|Withdrawal of Consent|4|||
160504695|NCT03829501|579576921|FG013|Overall Study|Withdrawal of Consent|0|||
160504696|NCT03829501|579576922|FG014|Overall Study|Withdrawal of Consent|3|||
160504697|NCT03829501|579576923|FG015|Overall Study|Withdrawal of Consent|0|||
160504698|NCT03829501|579576924|FG016|Overall Study|Withdrawal of Consent|1|||
160504699|NCT03829501|579576925|FG017|Overall Study|Withdrawal of Consent|1|||
160504700|NCT03829501|579576926|FG018|Overall Study|Withdrawal of Consent|0|||
160504701|NCT03829501|579576927|FG019|Overall Study|Withdrawal of Consent|0|||
160504702|NCT03829501|579576928|FG020|Overall Study|Withdrawal of Consent|3|||
160504703|NCT03829501|579576929|FG021|Overall Study|Withdrawal of Consent|0|||
160504704|NCT03829501|579576930|FG022|Overall Study|Withdrawal of Consent|1|||
160504705|NCT03829501|579576908|FG000|Overall Study|PD|0|||
160504706|NCT03829501|579576909|FG001|Overall Study|PD|0|||
160504707|NCT03829501|579576910|FG002|Overall Study|PD|0|||
160504708|NCT03829501|579576911|FG003|Overall Study|PD|2|||
160504709|NCT03829501|579576912|FG004|Overall Study|PD|0|||
160504710|NCT03829501|579576913|FG005|Overall Study|PD|0|||
160504711|NCT03829501|579576914|FG006|Overall Study|PD|0|||
160504712|NCT03829501|579576915|FG007|Overall Study|PD|0|||
160504713|NCT03829501|579576916|FG008|Overall Study|PD|0|||
160504714|NCT03829501|579576917|FG009|Overall Study|PD|0|||
160504715|NCT03829501|579576918|FG010|Overall Study|PD|0|||
160504716|NCT03829501|579576919|FG011|Overall Study|PD|0|||
160504717|NCT03829501|579576920|FG012|Overall Study|PD|0|||
160504718|NCT03829501|579576921|FG013|Overall Study|PD|0|||
160504719|NCT03829501|579576922|FG014|Overall Study|PD|0|||
160504720|NCT03829501|579576923|FG015|Overall Study|PD|1|||
160504721|NCT03829501|579576924|FG016|Overall Study|PD|0|||
160504722|NCT03829501|579576925|FG017|Overall Study|PD|0|||
160504723|NCT03829501|579576926|FG018|Overall Study|PD|0|||
160504724|NCT03829501|579576927|FG019|Overall Study|PD|0|||
160504725|NCT03829501|579576928|FG020|Overall Study|PD|1|||
160504726|NCT03829501|579576929|FG021|Overall Study|PD|0|||
160504727|NCT03829501|579576930|FG022|Overall Study|PD|0|||
160504728|NCT03829501|579576908|FG000|Overall Study|Study Terminated by Sponsor|0|||
160504729|NCT03829501|579576909|FG001|Overall Study|Study Terminated by Sponsor|0|||
160504730|NCT03829501|579576910|FG002|Overall Study|Study Terminated by Sponsor|0|||
160504731|NCT03829501|579576911|FG003|Overall Study|Study Terminated by Sponsor|0|||
160504732|NCT03829501|579576912|FG004|Overall Study|Study Terminated by Sponsor|0|||
160504733|NCT03829501|579576913|FG005|Overall Study|Study Terminated by Sponsor|0|||
160504734|NCT03829501|579576914|FG006|Overall Study|Study Terminated by Sponsor|0|||
160504735|NCT03829501|579576915|FG007|Overall Study|Study Terminated by Sponsor|3|||
160504736|NCT03829501|579576916|FG008|Overall Study|Study Terminated by Sponsor|1|||
160504737|NCT03829501|579576917|FG009|Overall Study|Study Terminated by Sponsor|0|||
160504738|NCT03829501|579576918|FG010|Overall Study|Study Terminated by Sponsor|0|||
160504739|NCT03829501|579576919|FG011|Overall Study|Study Terminated by Sponsor|0|||
160504740|NCT03829501|579576920|FG012|Overall Study|Study Terminated by Sponsor|0|||
160504741|NCT03829501|579576921|FG013|Overall Study|Study Terminated by Sponsor|0|||
160504742|NCT03829501|579576922|FG014|Overall Study|Study Terminated by Sponsor|3|||
160663291|NCT00473330|580150652|FG001|Core Study|Physician Decision|1|||
160663292|NCT00473330|580150653|FG002|Core Study|Physician Decision|3|||
160663293|NCT00473330|580150651|FG000|Core Study|Subject Non-compliance|1|||
160663294|NCT00473330|580150652|FG001|Core Study|Subject Non-compliance|2|||
160504743|NCT03829501|579576923|FG015|Overall Study|Study Terminated by Sponsor|2|||
160504744|NCT03829501|579576924|FG016|Overall Study|Study Terminated by Sponsor|2|||
160504745|NCT03829501|579576925|FG017|Overall Study|Study Terminated by Sponsor|0|||
160504746|NCT03829501|579576926|FG018|Overall Study|Study Terminated by Sponsor|0|||
160504747|NCT03829501|579576927|FG019|Overall Study|Study Terminated by Sponsor|0|||
160504748|NCT03829501|579576928|FG020|Overall Study|Study Terminated by Sponsor|1|||
160504749|NCT03829501|579576929|FG021|Overall Study|Study Terminated by Sponsor|0|||
160504750|NCT03829501|579576930|FG022|Overall Study|Study Terminated by Sponsor|3|||
160504751|NCT03829501|579576908|FG000|Overall Study|Lost to Follow Up|0|||
160504752|NCT03829501|579576909|FG001|Overall Study|Lost to Follow Up|0|||
160504753|NCT03829501|579576910|FG002|Overall Study|Lost to Follow Up|0|||
160504754|NCT03829501|579576911|FG003|Overall Study|Lost to Follow Up|0|||
160504755|NCT03829501|579576912|FG004|Overall Study|Lost to Follow Up|1|||
160504756|NCT03829501|579576913|FG005|Overall Study|Lost to Follow Up|0|||
160504757|NCT03829501|579576914|FG006|Overall Study|Lost to Follow Up|0|||
160663295|NCT00473330|580150653|FG002|Core Study|Subject Non-compliance|1|||
160504758|NCT03829501|579576915|FG007|Overall Study|Lost to Follow Up|2|||
160504759|NCT03829501|579576916|FG008|Overall Study|Lost to Follow Up|2|||
160663296|NCT00473330|580150651|FG000|Core Study|Subject Required Other Therapy|0|||
160663297|NCT00473330|580150652|FG001|Core Study|Subject Required Other Therapy|1|||
160663298|NCT00473330|580150653|FG002|Core Study|Subject Required Other Therapy|3|||
160663299|NCT00473330|580150651|FG000|Core Study|Subject's Decision|9|||
160663300|NCT00473330|580150652|FG001|Core Study|Subject's Decision|8|||
160663301|NCT00473330|580150653|FG002|Core Study|Subject's Decision|19|||
160504760|NCT03829501|579576917|FG009|Overall Study|Lost to Follow Up|0|||
160504761|NCT03829501|579576918|FG010|Overall Study|Lost to Follow Up|2|||
160663302|NCT00473330|580150651|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
160663303|NCT00473330|580150652|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
160663304|NCT00473330|580150653|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
160663305|NCT00473330|580150651|FG000|Open-label Extension Through Month 48|Death|2|||
160504762|NCT03829501|579576919|FG011|Overall Study|Lost to Follow Up|1|||
160504763|NCT03829501|579576920|FG012|Overall Study|Lost to Follow Up|0|||
160504764|NCT03829501|579576921|FG013|Overall Study|Lost to Follow Up|1|||
160504765|NCT03829501|579576922|FG014|Overall Study|Lost to Follow Up|1|||
160504766|NCT03829501|579576923|FG015|Overall Study|Lost to Follow Up|0|||
160504767|NCT03829501|579576924|FG016|Overall Study|Lost to Follow Up|0|||
160504768|NCT03829501|579576925|FG017|Overall Study|Lost to Follow Up|0|||
160504769|NCT03829501|579576926|FG018|Overall Study|Lost to Follow Up|0|||
160504770|NCT03829501|579576927|FG019|Overall Study|Lost to Follow Up|0|||
160504771|NCT03829501|579576928|FG020|Overall Study|Lost to Follow Up|0|||
160504772|NCT03829501|579576929|FG021|Overall Study|Lost to Follow Up|0|||
160504773|NCT03829501|579576930|FG022|Overall Study|Lost to Follow Up|1|||
160504774|NCT03829501|579576908|FG000|Overall Study|Death|2|||
160504775|NCT03829501|579576909|FG001|Overall Study|Death|4|||
160504776|NCT03829501|579576910|FG002|Overall Study|Death|5|||
160504777|NCT03829501|579576911|FG003|Overall Study|Death|6|||
160504778|NCT03829501|579576912|FG004|Overall Study|Death|5|||
160504779|NCT03829501|579576913|FG005|Overall Study|Death|4|||
160504780|NCT03829501|579576914|FG006|Overall Study|Death|5|||
160504781|NCT03829501|579576915|FG007|Overall Study|Death|24|||
160504782|NCT03829501|579576916|FG008|Overall Study|Death|22|||
160504783|NCT03829501|579576917|FG009|Overall Study|Death|6|||
160504784|NCT03829501|579576918|FG010|Overall Study|Death|3|||
160504785|NCT03829501|579576919|FG011|Overall Study|Death|10|||
160504786|NCT03829501|579576920|FG012|Overall Study|Death|10|||
160504787|NCT03829501|579576921|FG013|Overall Study|Death|5|||
160504788|NCT03829501|579576922|FG014|Overall Study|Death|7|||
160504789|NCT03829501|579576923|FG015|Overall Study|Death|2|||
160504790|NCT03829501|579576924|FG016|Overall Study|Death|2|||
160504791|NCT03829501|579576925|FG017|Overall Study|Death|1|||
160504792|NCT03829501|579576926|FG018|Overall Study|Death|1|||
160663306|NCT00473330|580150652|FG001|Open-label Extension Through Month 48|Death|0|||
160663307|NCT00473330|580150653|FG002|Open-label Extension Through Month 48|Death|0|||
160663308|NCT00473330|580150651|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
160663309|NCT00473330|580150652|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
160504793|NCT03829501|579576927|FG019|Overall Study|Death|1|||
160504794|NCT03829501|579576928|FG020|Overall Study|Death|1|||
160504795|NCT03829501|579576929|FG021|Overall Study|Death|2|||
160504796|NCT03829501|579576930|FG022|Overall Study|Death|3|||
160504797|NCT03829501|579576908|FG000|Overall Study|Miscellaneous|0|||
160504798|NCT03829501|579576909|FG001|Overall Study|Miscellaneous|0|||
160504799|NCT03829501|579576910|FG002|Overall Study|Miscellaneous|1|||
160504800|NCT03829501|579576911|FG003|Overall Study|Miscellaneous|0|||
160504801|NCT03829501|579576912|FG004|Overall Study|Miscellaneous|0|||
160504802|NCT03829501|579576913|FG005|Overall Study|Miscellaneous|0|||
160663310|NCT00473330|580150653|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
160663311|NCT00473330|580150651|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
160504803|NCT03829501|579576914|FG006|Overall Study|Miscellaneous|0|||
160504804|NCT03829501|579576915|FG007|Overall Study|Miscellaneous|1|||
160504805|NCT03829501|579576916|FG008|Overall Study|Miscellaneous|0|||
160504806|NCT03829501|579576917|FG009|Overall Study|Miscellaneous|0|||
160504807|NCT03829501|579576918|FG010|Overall Study|Miscellaneous|0|||
160504808|NCT03829501|579576919|FG011|Overall Study|Miscellaneous|0|||
160504809|NCT03829501|579576920|FG012|Overall Study|Miscellaneous|0|||
160504810|NCT03829501|579576921|FG013|Overall Study|Miscellaneous|0|||
160663312|NCT00473330|580150652|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
160504811|NCT03829501|579576922|FG014|Overall Study|Miscellaneous|0|||
160504812|NCT03829501|579576923|FG015|Overall Study|Miscellaneous|0|||
160504813|NCT03829501|579576924|FG016|Overall Study|Miscellaneous|0|||
160504814|NCT03829501|579576925|FG017|Overall Study|Miscellaneous|0|||
160504815|NCT03829501|579576926|FG018|Overall Study|Miscellaneous|0|||
160504816|NCT03829501|579576927|FG019|Overall Study|Miscellaneous|0|||
160504817|NCT03829501|579576928|FG020|Overall Study|Miscellaneous|0|||
160504818|NCT03829501|579576929|FG021|Overall Study|Miscellaneous|0|||
160504819|NCT03829501|579576930|FG022|Overall Study|Miscellaneous|1|||
160504820|NCT02964013|579576931|FG000|Overall Study|Death|58|||
160504821|NCT02964013|579576932|FG001|Overall Study|Death|239|||
160504822|NCT02964013|579576933|FG002|Overall Study|Death|38|||
160504823|NCT02964013|579576934|FG003|Overall Study|Death|10|||
160504824|NCT02964013|579576935|FG004|Overall Study|Death|33|||
160504825|NCT02964013|579576931|FG000|Overall Study|Lost to Follow-up|1|||
160504826|NCT02964013|579576932|FG001|Overall Study|Lost to Follow-up|4|||
160504827|NCT02964013|579576933|FG002|Overall Study|Lost to Follow-up|2|||
160504828|NCT02964013|579576934|FG003|Overall Study|Lost to Follow-up|0|||
160504829|NCT02964013|579576935|FG004|Overall Study|Lost to Follow-up|0|||
160504830|NCT02964013|579576931|FG000|Overall Study|Physician Decision|0|||
160504831|NCT02964013|579576932|FG001|Overall Study|Physician Decision|1|||
160504832|NCT02964013|579576933|FG002|Overall Study|Physician Decision|0|||
160504833|NCT02964013|579576934|FG003|Overall Study|Physician Decision|0|||
160504834|NCT02964013|579576935|FG004|Overall Study|Physician Decision|0|||
160504835|NCT02964013|579576931|FG000|Overall Study|Sponsor Decision|3|||
160504836|NCT02964013|579576932|FG001|Overall Study|Sponsor Decision|22|||
160504837|NCT02964013|579576933|FG002|Overall Study|Sponsor Decision|11|||
160504838|NCT02964013|579576934|FG003|Overall Study|Sponsor Decision|0|||
160504839|NCT02964013|579576935|FG004|Overall Study|Sponsor Decision|7|||
160504840|NCT02964013|579576931|FG000|Overall Study|Withdrawal by Subject|6|||
160504841|NCT02964013|579576932|FG001|Overall Study|Withdrawal by Subject|27|||
160504842|NCT02964013|579576933|FG002|Overall Study|Withdrawal by Subject|9|||
160504843|NCT02964013|579576934|FG003|Overall Study|Withdrawal by Subject|0|||
160504844|NCT02964013|579576935|FG004|Overall Study|Withdrawal by Subject|0|||
160504845|NCT02964013|579576931|FG000|Overall Study|Not Treated|0|||
160504846|NCT02964013|579576932|FG001|Overall Study|Not Treated|2|||
160504847|NCT02964013|579576933|FG002|Overall Study|Not Treated|0|||
160504848|NCT02964013|579576934|FG003|Overall Study|Not Treated|1|||
160504849|NCT02964013|579576935|FG004|Overall Study|Not Treated|0|||
160504850|NCT01123070|579576936|FG000|Part B Double Blind Period|Protocol Violation|0|||
160504851|NCT01123070|579576937|FG001|Part B Double Blind Period|Protocol Violation|0|||
160504852|NCT01123070|579576938|FG002|Part B Double Blind Period|Protocol Violation|0|||
160504853|NCT01123070|579576939|FG003|Part B Double Blind Period|Protocol Violation|1|||
160504854|NCT01123070|579576936|FG000|Part B Double Blind Period|Adverse Event|0|||
160504855|NCT01123070|579576937|FG001|Part B Double Blind Period|Adverse Event|0|||
160504856|NCT01123070|579576938|FG002|Part B Double Blind Period|Adverse Event|2|||
160504857|NCT01123070|579576939|FG003|Part B Double Blind Period|Adverse Event|0|||
160504858|NCT01123070|579576936|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
160504859|NCT01123070|579576937|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
160504860|NCT01123070|579576938|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
160504861|NCT01123070|579576939|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
160504862|NCT04942366|579576940|FG000|Overall Study|Withdrawal by Subject|5|||
160504863|NCT04942366|579576941|FG001|Overall Study|Withdrawal by Subject|5|||
160504864|NCT00747227|579576948|FG000|Overall Study|Death|3|||
160504865|NCT00747227|579576949|FG001|Overall Study|Death|1|||
160504866|NCT00747227|579576948|FG000|Overall Study|Withdrawal by Subject|1|||
160504867|NCT00747227|579576949|FG001|Overall Study|Withdrawal by Subject|0|||
160504868|NCT00747227|579576948|FG000|Overall Study|Lost to Follow-up|1|||
160504869|NCT00747227|579576949|FG001|Overall Study|Lost to Follow-up|2|||
160504870|NCT00747227|579576948|FG000|Overall Study|Illness|1|||
160504871|NCT00747227|579576949|FG001|Overall Study|Illness|1|||
160504872|NCT03284229|579576950|FG000|Overall Study|Lost to Follow-up|3|||
160504873|NCT00918879|579576952|FG000|Overall Study|Withdrawal by Subject|4|||
160504874|NCT00918879|579576953|FG001|Overall Study|Withdrawal by Subject|4|||
160504875|NCT00918879|579576952|FG000|Overall Study|Lost to Follow-up|1|||
160504876|NCT00918879|579576953|FG001|Overall Study|Lost to Follow-up|1|||
160504877|NCT00918879|579576952|FG000|Overall Study|Severe non-compliance to protocol|1|||
160504878|NCT00918879|579576953|FG001|Overall Study|Severe non-compliance to protocol|1|||
160504879|NCT00357110|579576954|FG000|Overall Study|Early study termination|5|||
160504880|NCT00357110|579576955|FG001|Overall Study|Early study termination|5|||
160504881|NCT03339245|579576962|FG000|Overall Study|Adverse Event|1|||
160504882|NCT03339245|579576963|FG001|Overall Study|Adverse Event|1|||
160504883|NCT03339245|579576962|FG000|Overall Study|Withdrawal by Subject|1|||
160504884|NCT03339245|579576963|FG001|Overall Study|Withdrawal by Subject|0|||
160504885|NCT01706705|579576971|FG000|Overall Study|Death|1|||
160504886|NCT01706705|579576971|FG000|Overall Study|Lack of Efficacy|13|||
160504887|NCT01706705|579576971|FG000|Overall Study|Non-clinical|6|||
160504888|NCT02175641|579576974|FG000|Overall Study|Death|3|||
160504889|NCT02175641|579576975|FG001|Overall Study|Death|4|||
160504890|NCT02175641|579576974|FG000|Overall Study|Lost to Follow-up|4|||
160620118|NCT01409382|579988391|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
160620119|NCT04120116|579988396|FG000|Overall Study|Lost to Follow-up|0|||
160620120|NCT04120116|579988397|FG001|Overall Study|Lost to Follow-up|1|||
160620121|NCT04120116|579988398|FG002|Overall Study|Lost to Follow-up|0|||
160620122|NCT04120116|579988399|FG003|Overall Study|Lost to Follow-up|2|||
160620123|NCT04120116|579988396|FG000|Overall Study|Withdrawal by Subject|1|||
160620124|NCT04120116|579988397|FG001|Overall Study|Withdrawal by Subject|0|||
160504891|NCT02175641|579576975|FG001|Overall Study|Lost to Follow-up|4|||
160504892|NCT02175641|579576974|FG000|Overall Study|Withdrawal by Subject|7|||
160504893|NCT02175641|579576975|FG001|Overall Study|Withdrawal by Subject|4|||
160620125|NCT04120116|579988398|FG002|Overall Study|Withdrawal by Subject|1|||
160504894|NCT02175641|579576974|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
160504895|NCT02175641|579576975|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
160504896|NCT02175641|579576974|FG000|Overall Study|Developed Contraindicated Condition|8|||
160504897|NCT02175641|579576975|FG001|Overall Study|Developed Contraindicated Condition|0|||
160504898|NCT02242097|579576976|FG000|Ibrutinib Treatment|Adverse Event|16|||
160504899|NCT02242097|579576976|FG000|Ibrutinib Treatment|Physician Decision|1|||
160504900|NCT02242097|579576976|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
160504901|NCT02242097|579576976|FG000|Ibrutinib Treatment|Death|1|||
160504902|NCT02242097|579576976|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
160504903|NCT02242097|579576976|FG000|Post Therapy Follow Up|Death|3|||
160504904|NCT02242097|579576976|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
160504905|NCT03031496|579576978|FG000|Period 1|Adverse Event|2|||
160504906|NCT03031496|579576979|FG001|Period 1|Adverse Event|0|||
160504907|NCT03031496|579576978|FG000|Period 1|Withdrawal by Subject|0|||
160504908|NCT03031496|579576979|FG001|Period 1|Withdrawal by Subject|2|||
160504909|NCT03868787|579576981|FG000|Overall Study|Withdrawal by Subject|2|||
160504910|NCT03868787|579576982|FG001|Overall Study|Withdrawal by Subject|1|||
160504911|NCT01712061|579576983|FG000|Overall Study|Adverse Event|4|||
160504912|NCT01712061|579576984|FG001|Overall Study|Adverse Event|9|||
160504913|NCT01712061|579576985|FG002|Overall Study|Adverse Event|5|||
160504914|NCT01712061|579576983|FG000|Overall Study|Death|0|||
160504915|NCT01712061|579576984|FG001|Overall Study|Death|0|||
160504916|NCT01712061|579576985|FG002|Overall Study|Death|1|||
160504917|NCT01712061|579576983|FG000|Overall Study|Lost to Follow-up|1|||
160504918|NCT01712061|579576984|FG001|Overall Study|Lost to Follow-up|0|||
160504919|NCT01712061|579576985|FG002|Overall Study|Lost to Follow-up|1|||
160504920|NCT01712061|579576983|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
160504921|NCT01712061|579576984|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
160504922|NCT01712061|579576985|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
160504923|NCT01712061|579576983|FG000|Overall Study|Medication Error Without Associated AE|0|||
160504924|NCT01712061|579576984|FG001|Overall Study|Medication Error Without Associated AE|1|||
160504925|NCT01712061|579576985|FG002|Overall Study|Medication Error Without Associated AE|0|||
160504926|NCT01712061|579576983|FG000|Overall Study|Withdrawal by Subject|1|||
160504927|NCT01712061|579576984|FG001|Overall Study|Withdrawal by Subject|7|||
160504928|NCT01712061|579576985|FG002|Overall Study|Withdrawal by Subject|1|||
160504929|NCT01712061|579576983|FG000|Overall Study|Other|0|||
160504930|NCT01712061|579576984|FG001|Overall Study|Other|3|||
160504931|NCT01712061|579576985|FG002|Overall Study|Other|0|||
160504932|NCT00504777|579576988|FG000|Overall Study|Adverse Event|1|||
160504933|NCT04868539|579576992|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
160504934|NCT04868539|579576993|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
160504935|NCT01572740|579576994|FG000|Overall Study|Adverse Event|1|||
160504936|NCT01572740|579576995|FG001|Overall Study|Adverse Event|1|||
160504937|NCT01572740|579576994|FG000|Overall Study|Withdrawal by Subject|1|||
160504938|NCT01572740|579576995|FG001|Overall Study|Withdrawal by Subject|1|||
160504939|NCT01572740|579576994|FG000|Overall Study|unclassified|4|||
160504940|NCT01572740|579576995|FG001|Overall Study|unclassified|3|||
160504941|NCT01401153|579576996|FG000|First Test Day|Learning disabilities; illness|1|||
160504942|NCT01401153|579576997|FG001|First Test Day|Learning disabilities; illness|10|||
160504943|NCT01401153|579576996|FG000|Second Test Day|illness|0|||
160504944|NCT01401153|579576997|FG001|Second Test Day|illness|5|||
160504945|NCT01677767|579577000|FG000|Overall Study|Adverse Event|1|||
160504946|NCT01677767|579577000|FG000|Overall Study|Death|4|||
160504947|NCT01677767|579577000|FG000|Overall Study|Protocol Violation|4|||
160504948|NCT01677767|579577000|FG000|Overall Study|Withdrawal by Subject|10|||
160504949|NCT01677767|579577000|FG000|Overall Study|Non-compliance by the participants|3|||
160504950|NCT00842244|579577001|FG000|Overall Study|Death|3|||
160504951|NCT00842244|579577001|FG000|Overall Study|Withdrawal by Subject|1|||
160504952|NCT00842244|579577001|FG000|Overall Study|Other|17|||
160504953|NCT01068665|579577002|FG000|Overall Study|Adverse Event|5|||
160504954|NCT01068665|579577003|FG001|Overall Study|Adverse Event|4|||
160504955|NCT01068665|579577002|FG000|Overall Study|Lack of Efficacy|0|||
160504956|NCT01068665|579577003|FG001|Overall Study|Lack of Efficacy|2|||
160504957|NCT01068665|579577002|FG000|Overall Study|Protocol Violation|5|||
160504958|NCT01068665|579577003|FG001|Overall Study|Protocol Violation|2|||
160504959|NCT01068665|579577002|FG000|Overall Study|Withdrawal Criteria|3|||
160504960|NCT01068665|579577003|FG001|Overall Study|Withdrawal Criteria|9|||
160504961|NCT01068665|579577002|FG000|Overall Study|Other|17|||
160504962|NCT01068665|579577003|FG001|Overall Study|Other|12|||
160504963|NCT02807272|579577004|FG000|Overall Study|Death|9|||
160504964|NCT02807272|579577005|FG001|Overall Study|Death|5|||
160504965|NCT02807272|579577006|FG002|Overall Study|Death|2|||
160504966|NCT02807272|579577007|FG003|Overall Study|Death|0|||
160504967|NCT02807272|579577008|FG004|Overall Study|Death|1|||
160504968|NCT02807272|579577004|FG000|Overall Study|Lost to Follow-up|1|||
160504969|NCT02807272|579577005|FG001|Overall Study|Lost to Follow-up|0|||
160504970|NCT02807272|579577006|FG002|Overall Study|Lost to Follow-up|0|||
160504971|NCT02807272|579577007|FG003|Overall Study|Lost to Follow-up|0|||
160504972|NCT02807272|579577008|FG004|Overall Study|Lost to Follow-up|0|||
160504973|NCT02807272|579577004|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
160504974|NCT02807272|579577005|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
160504975|NCT02807272|579577006|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
160504976|NCT02807272|579577007|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
160504977|NCT02807272|579577008|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
160663313|NCT00473330|580150653|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
160663314|NCT00473330|580150651|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
160663315|NCT00473330|580150652|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
160663316|NCT00473330|580150653|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
160663317|NCT00473330|580150651|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
160663318|NCT00473330|580150652|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
160663319|NCT00473330|580150653|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
160663320|NCT00473330|580150651|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
160663321|NCT00473330|580150652|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
160663322|NCT00473330|580150653|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
160663323|NCT00473330|580150651|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
160663324|NCT00473330|580150652|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
160663325|NCT00473330|580150653|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
160663326|NCT00473330|580150651|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
160663327|NCT00473330|580150652|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
160663328|NCT00473330|580150653|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
160663329|NCT00473330|580150651|FG000|Open-label Extension Through Month 60|Death|2|||
160663330|NCT00473330|580150652|FG001|Open-label Extension Through Month 60|Death|2|||
160663331|NCT00473330|580150653|FG002|Open-label Extension Through Month 60|Death|1|||
160663332|NCT00473330|580150651|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
160663333|NCT00473330|580150652|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
160663334|NCT00473330|580150653|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
160663335|NCT00473330|580150651|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
160663336|NCT00473330|580150652|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
160663337|NCT00473330|580150653|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
160663338|NCT00473330|580150651|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
160663339|NCT00473330|580150652|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
160663340|NCT00473330|580150653|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
160663341|NCT00473330|580150651|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
160663342|NCT00473330|580150652|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
160663343|NCT00473330|580150653|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
160663344|NCT00473330|580150651|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
160663345|NCT00473330|580150652|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
160663346|NCT00473330|580150653|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
160663347|NCT00473330|580150651|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
160663348|NCT00473330|580150652|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
160663349|NCT00473330|580150653|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
160663350|NCT01975948|580150654|FG000|Overall Study|Withdrawal by Subject|17|||
160663351|NCT01975948|580150655|FG001|Overall Study|Withdrawal by Subject|21|||
160663352|NCT01975948|580150656|FG002|Overall Study|Withdrawal by Subject|7|||
160663353|NCT01975948|580150657|FG003|Overall Study|Withdrawal by Subject|6|||
160663354|NCT01675765|580150658|FG000|Overall Study|Progressive disease|4|||
160663355|NCT01675765|580150659|FG001|Overall Study|Progressive disease|4|||
160663356|NCT01675765|580150658|FG000|Overall Study|Adverse Event|1|||
160663357|NCT01675765|580150659|FG001|Overall Study|Adverse Event|2|||
160663358|NCT01675765|580150658|FG000|Overall Study|Withdrawal by Subject|2|||
160663359|NCT01675765|580150659|FG001|Overall Study|Withdrawal by Subject|0|||
160663360|NCT01675765|580150658|FG000|Overall Study|Death|1|||
160663361|NCT01675765|580150659|FG001|Overall Study|Death|0|||
160663362|NCT01675765|580150658|FG000|Overall Study|Clinical progression|3|||
160663363|NCT01675765|580150659|FG001|Overall Study|Clinical progression|2|||
160663364|NCT00365846|580150660|FG000|Overall Study|Lost to Follow-up|1|||
160663365|NCT00904215|580150661|FG000|Overall Study|Adverse Event|25|||
160663366|NCT00904215|580150661|FG000|Overall Study|Protocol Violation|10|||
160663367|NCT00904215|580150661|FG000|Overall Study|Lost to Follow-up|63|||
160663368|NCT00904215|580150661|FG000|Overall Study|Withdrawal by Subject|9|||
160663369|NCT00904215|580150661|FG000|Overall Study|Other|28|||
160663370|NCT01185821|580150667|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160504978|NCT02807272|579577004|FG000|Overall Study|Protocol-defined Disease Progression|0|||
160504979|NCT02807272|579577005|FG001|Overall Study|Protocol-defined Disease Progression|1|||
160504980|NCT02807272|579577006|FG002|Overall Study|Protocol-defined Disease Progression|0|||
160504981|NCT02807272|579577007|FG003|Overall Study|Protocol-defined Disease Progression|0|||
160663371|NCT01185821|580150668|FG001|Overall Study|Abnormal laboratory value(s)|2|||
160663372|NCT01185821|580150669|FG002|Overall Study|Abnormal laboratory value(s)|1|||
160663373|NCT01185821|580150670|FG003|Overall Study|Abnormal laboratory value(s)|0|||
160504982|NCT02807272|579577008|FG004|Overall Study|Protocol-defined Disease Progression|1|||
160504983|NCT02807272|579577004|FG000|Overall Study|Study Terminated by Sponsor|1|||
160504984|NCT02807272|579577005|FG001|Overall Study|Study Terminated by Sponsor|0|||
160504985|NCT02807272|579577006|FG002|Overall Study|Study Terminated by Sponsor|0|||
160504986|NCT02807272|579577007|FG003|Overall Study|Study Terminated by Sponsor|1|||
160504987|NCT02807272|579577008|FG004|Overall Study|Study Terminated by Sponsor|0|||
160504988|NCT02807272|579577004|FG000|Overall Study|Other|1|||
160504989|NCT02807272|579577005|FG001|Overall Study|Other|0|||
160620126|NCT04120116|579988399|FG003|Overall Study|Withdrawal by Subject|1|||
160620127|NCT04120116|579988396|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
160620128|NCT04120116|579988397|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
160620129|NCT04120116|579988398|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
160620130|NCT04120116|579988399|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
160620131|NCT00965458|579988400|FG000|Overall Study|Adverse Event|1|||
160620132|NCT00965458|579988401|FG001|Overall Study|Adverse Event|0|||
160620133|NCT00965458|579988400|FG000|Overall Study|Lost to Follow-up|1|||
160620134|NCT00965458|579988401|FG001|Overall Study|Lost to Follow-up|3|||
160620135|NCT00965458|579988400|FG000|Overall Study|Withdrawal by Subject|0|||
160620136|NCT00965458|579988401|FG001|Overall Study|Withdrawal by Subject|1|||
160620137|NCT01846039|579988404|FG000|Overall Study|Protocol Violation|1|||
160620138|NCT01846039|579988404|FG000|Overall Study|Subject Withdrew Consent|1|||
160620139|NCT02528331|579988415|FG000|Overall Study|Withdrawal by Subject|2|||
160504990|NCT02807272|579577006|FG002|Overall Study|Other|0|||
160504991|NCT02807272|579577007|FG003|Overall Study|Other|0|||
160504992|NCT02807272|579577008|FG004|Overall Study|Other|1|||
160504993|NCT01162863|579577012|FG000|Overall Study|Lack of Efficacy|1|||
160504994|NCT01162863|579577013|FG001|Overall Study|Lack of Efficacy|0|||
160504995|NCT01162863|579577014|FG002|Overall Study|Lack of Efficacy|0|||
160504996|NCT01162863|579577012|FG000|Overall Study|Adverse Event|0|||
160504997|NCT01162863|579577013|FG001|Overall Study|Adverse Event|1|||
160504998|NCT01162863|579577014|FG002|Overall Study|Adverse Event|0|||
160504999|NCT00392925|579577015|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
160505000|NCT00392925|579577016|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
160505001|NCT00392925|579577017|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
160620140|NCT00386152|579988420|FG000|Overall Study|Adverse Event|6|||
160620141|NCT00386152|579988421|FG001|Overall Study|Adverse Event|5|||
160620142|NCT00386152|579988422|FG002|Overall Study|Adverse Event|4|||
160620143|NCT00386152|579988420|FG000|Overall Study|Chang from original chemo stratification|4|||
160620144|NCT00386152|579988421|FG001|Overall Study|Chang from original chemo stratification|5|||
160620145|NCT00386152|579988422|FG002|Overall Study|Chang from original chemo stratification|6|||
160620146|NCT00386152|579988420|FG000|Overall Study|Death|3|||
160620147|NCT00386152|579988421|FG001|Overall Study|Death|0|||
160620148|NCT00386152|579988422|FG002|Overall Study|Death|1|||
160620149|NCT00386152|579988420|FG000|Overall Study|Disease progression|7|||
160620150|NCT00386152|579988421|FG001|Overall Study|Disease progression|4|||
160620151|NCT00386152|579988422|FG002|Overall Study|Disease progression|5|||
160620152|NCT00386152|579988420|FG000|Overall Study|Physician Decision|13|||
160620153|NCT00386152|579988421|FG001|Overall Study|Physician Decision|10|||
160620154|NCT00386152|579988422|FG002|Overall Study|Physician Decision|4|||
160620155|NCT00386152|579988420|FG000|Overall Study|Lost to Follow-up|1|||
160620156|NCT00386152|579988421|FG001|Overall Study|Lost to Follow-up|0|||
160620157|NCT00386152|579988422|FG002|Overall Study|Lost to Follow-up|0|||
160620158|NCT00386152|579988420|FG000|Overall Study|Completed chemotherapy|4|||
160620159|NCT00386152|579988421|FG001|Overall Study|Completed chemotherapy|5|||
160620160|NCT00386152|579988422|FG002|Overall Study|Completed chemotherapy|1|||
160620161|NCT00386152|579988420|FG000|Overall Study|Protocol Violation|3|||
160620162|NCT00386152|579988421|FG001|Overall Study|Protocol Violation|5|||
160620163|NCT00386152|579988422|FG002|Overall Study|Protocol Violation|2|||
160620164|NCT00386152|579988420|FG000|Overall Study|Withdrawal by Subject|3|||
160620165|NCT00386152|579988421|FG001|Overall Study|Withdrawal by Subject|6|||
160620166|NCT00386152|579988422|FG002|Overall Study|Withdrawal by Subject|10|||
160663374|NCT01185821|580150671|FG004|Overall Study|Abnormal laboratory value(s)|0|||
160505002|NCT00392925|579577018|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
160505003|NCT00392925|579577015|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
160663375|NCT01185821|580150667|FG000|Overall Study|Protocol Violation|0|||
160620167|NCT03380091|579988424|FG000|Overall Study|Withdrawal by Subject|2|||
160620168|NCT03380091|579988425|FG001|Overall Study|Withdrawal by Subject|1|||
160620169|NCT00727246|579988426|FG000|Overall Study|could not complete MRI|0|||
160620170|NCT00727246|579988427|FG001|Overall Study|could not complete MRI|1|||
160620171|NCT00727246|579988428|FG002|Overall Study|could not complete MRI|0|||
160620172|NCT00727246|579988429|FG003|Overall Study|could not complete MRI|1|||
160505004|NCT00392925|579577016|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
160505005|NCT00392925|579577017|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
160505006|NCT00392925|579577018|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
160505007|NCT00392925|579577015|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
160505008|NCT00392925|579577016|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
160505009|NCT00392925|579577017|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
160505010|NCT00392925|579577018|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
160505011|NCT00392925|579577015|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
160505012|NCT00392925|579577016|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
160505013|NCT00392925|579577017|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
160505014|NCT00392925|579577018|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
160505015|NCT00392925|579577015|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
160505016|NCT00392925|579577016|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
160505017|NCT00392925|579577017|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
160505018|NCT00392925|579577018|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
160505019|NCT00392925|579577015|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
160505020|NCT00392925|579577016|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
160505021|NCT00392925|579577017|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
160505022|NCT00392925|579577018|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
160505023|NCT00392925|579577015|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
160505024|NCT00392925|579577016|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
160505025|NCT00392925|579577017|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
160505026|NCT00392925|579577018|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
160505027|NCT00392925|579577015|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
160505028|NCT00392925|579577016|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
160505029|NCT00392925|579577017|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
160505030|NCT00392925|579577018|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
160505031|NCT00392925|579577015|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
160505032|NCT00392925|579577016|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
160505033|NCT00392925|579577017|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
160505034|NCT00392925|579577018|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
160505035|NCT01840410|579577020|FG000|Overall Study|Physician Decision|1|||
160505036|NCT01840410|579577021|FG001|Overall Study|Physician Decision|2|||
160505037|NCT01840410|579577020|FG000|Overall Study|Pregnancy|1|||
160505038|NCT01840410|579577021|FG001|Overall Study|Pregnancy|0|||
160505039|NCT01840410|579577020|FG000|Overall Study|Protocol deviation|1|||
160505040|NCT01840410|579577021|FG001|Overall Study|Protocol deviation|0|||
160505041|NCT01840410|579577020|FG000|Overall Study|Lost to Follow-up|1|||
160505042|NCT01840410|579577021|FG001|Overall Study|Lost to Follow-up|0|||
160505043|NCT01840410|579577020|FG000|Overall Study|Withdrawal by Subject|2|||
160505044|NCT01840410|579577021|FG001|Overall Study|Withdrawal by Subject|1|||
160505045|NCT01840410|579577020|FG000|Overall Study|Adverse Event|1|||
160505046|NCT01840410|579577021|FG001|Overall Study|Adverse Event|1|||
160505047|NCT00839956|579577022|FG000|Overall Study|Adverse Event|2|||
160505048|NCT00839956|579577022|FG000|Overall Study|Lack of Efficacy|6|||
160505049|NCT00839956|579577022|FG000|Overall Study|Physician Decision|1|||
160505050|NCT00839956|579577022|FG000|Overall Study|Withdrawal by Subject|3|||
160505051|NCT00594880|579577023|FG000|Overall Study|Withdrawal by Subject|1|||
160505052|NCT00594880|579577024|FG001|Overall Study|Withdrawal by Subject|1|||
160505053|NCT00594880|579577023|FG000|Overall Study|Lost to Follow-up|1|||
160505054|NCT00594880|579577024|FG001|Overall Study|Lost to Follow-up|0|||
160505055|NCT02206061|579577025|FG000|Overall Study|Withdrawal by Subject|4|||
160505056|NCT02206061|579577026|FG001|Overall Study|Withdrawal by Subject|7|||
160505057|NCT02206061|579577027|FG002|Overall Study|Withdrawal by Subject|1|||
160505058|NCT02206061|579577025|FG000|Overall Study|Lost to Follow-up|14|||
160505059|NCT02206061|579577026|FG001|Overall Study|Lost to Follow-up|7|||
160505060|NCT02206061|579577027|FG002|Overall Study|Lost to Follow-up|20|||
160505061|NCT00694109|579577028|FG000|Overall Study|Physician Decision|3|||
160505062|NCT00694109|579577028|FG000|Overall Study|Adverse Event|74|||
160505063|NCT00694109|579577028|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
160505064|NCT00694109|579577028|FG000|Overall Study|Lack of Efficacy|2|||
160505065|NCT00694109|579577028|FG000|Overall Study|Withdrawal by Subject|13|||
160505066|NCT00694109|579577028|FG000|Overall Study|Pregnancy|1|||
160505067|NCT00694109|579577028|FG000|Overall Study|Enrolled but not treated|1|||
160505068|NCT00694109|579577028|FG000|Overall Study|Other|2|||
160505069|NCT00694109|579577028|FG000|Overall Study|Consented but no additional treatment|3|||
160505070|NCT01067846|579577029|FG000|Overall Study|Lost to Follow-up|17|||
160505071|NCT01067846|579577030|FG001|Overall Study|Lost to Follow-up|19|||
160505072|NCT01067846|579577029|FG000|Overall Study|Withdrawal by Subject|1|||
160505073|NCT01067846|579577030|FG001|Overall Study|Withdrawal by Subject|0|||
160505074|NCT01067846|579577029|FG000|Overall Study|participation in other tx study|1|||
160505075|NCT01067846|579577030|FG001|Overall Study|participation in other tx study|0|||
160505076|NCT02817906|579577031|FG000|Overall Study|Adverse Event|3|||
160505077|NCT02817906|579577032|FG001|Overall Study|Adverse Event|0|||
160505078|NCT02817906|579577031|FG000|Overall Study|Lack of Efficacy|1|||
160505079|NCT02817906|579577032|FG001|Overall Study|Lack of Efficacy|0|||
160505080|NCT02817906|579577031|FG000|Overall Study|Protocol Violation|1|||
160505081|NCT02817906|579577032|FG001|Overall Study|Protocol Violation|1|||
160505082|NCT02817906|579577031|FG000|Overall Study|Study Terminated by Sponsor|2|||
160505083|NCT02817906|579577032|FG001|Overall Study|Study Terminated by Sponsor|2|||
160505084|NCT02817906|579577031|FG000|Overall Study|Withdrawal by Subject|7|||
160505085|NCT02817906|579577032|FG001|Overall Study|Withdrawal by Subject|0|||
160505086|NCT02817906|579577031|FG000|Overall Study|Other|2|||
160505087|NCT02817906|579577032|FG001|Overall Study|Other|2|||
160505088|NCT03686423|579577040|FG000|Overall Study|Withdrawal by Subject|9|||
160505089|NCT03686423|579577040|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
160505090|NCT04954326|579577041|FG000|Overall Study|Protocol Violation|0|||
160505091|NCT04954326|579577042|FG001|Overall Study|Protocol Violation|1|||
160505092|NCT04954326|579577041|FG000|Overall Study|Death|0|||
160505093|NCT04954326|579577042|FG001|Overall Study|Death|2|||
160505094|NCT04954326|579577041|FG000|Overall Study|Physician Decision|0|||
160505095|NCT04954326|579577042|FG001|Overall Study|Physician Decision|1|||
160505096|NCT01495598|579577047|FG000|Overall Study|Death during follow up period|2|||
160505097|NCT01495598|579577047|FG000|Overall Study|Death on study|1|||
160505098|NCT01495598|579577047|FG000|Overall Study|Lost to Follow-up|3|||
160505099|NCT01495598|579577047|FG000|Overall Study|Physician Decision|8|||
160505100|NCT03635099|579577048|FG000|Period 1|Adverse Event|1|||
160505101|NCT03635099|579577049|FG001|Period 1|Adverse Event|0|||
160505102|NCT03635099|579577050|FG002|Period 1|Adverse Event|0|||
160505103|NCT03635099|579577051|FG003|Period 1|Adverse Event|1|||
160505104|NCT03635099|579577052|FG004|Period 1|Adverse Event|0|||
160505105|NCT03635099|579577053|FG005|Period 1|Adverse Event|0|||
160505106|NCT03635099|579577054|FG006|Period 1|Adverse Event|0|||
160505107|NCT03635099|579577055|FG007|Period 1|Adverse Event|0|||
160505108|NCT03635099|579577048|FG000|Period 1|Protocol Violation|0|||
160505109|NCT03635099|579577049|FG001|Period 1|Protocol Violation|0|||
160505110|NCT03635099|579577050|FG002|Period 1|Protocol Violation|1|||
160505111|NCT03635099|579577051|FG003|Period 1|Protocol Violation|0|||
160505112|NCT03635099|579577052|FG004|Period 1|Protocol Violation|0|||
160505113|NCT03635099|579577053|FG005|Period 1|Protocol Violation|0|||
160505114|NCT03635099|579577054|FG006|Period 1|Protocol Violation|0|||
160505115|NCT03635099|579577055|FG007|Period 1|Protocol Violation|0|||
160505116|NCT03635099|579577048|FG000|Period 1|Lost to Follow-up|0|||
160505117|NCT03635099|579577049|FG001|Period 1|Lost to Follow-up|0|||
160505118|NCT03635099|579577050|FG002|Period 1|Lost to Follow-up|1|||
160505119|NCT03635099|579577051|FG003|Period 1|Lost to Follow-up|2|||
160505120|NCT03635099|579577052|FG004|Period 1|Lost to Follow-up|1|||
160505121|NCT03635099|579577053|FG005|Period 1|Lost to Follow-up|0|||
160505122|NCT03635099|579577054|FG006|Period 1|Lost to Follow-up|1|||
160505123|NCT03635099|579577055|FG007|Period 1|Lost to Follow-up|2|||
160505124|NCT03635099|579577048|FG000|Period 1|Withdrawal by Subject|3|||
160505125|NCT03635099|579577049|FG001|Period 1|Withdrawal by Subject|3|||
160505126|NCT03635099|579577050|FG002|Period 1|Withdrawal by Subject|5|||
160505127|NCT03635099|579577051|FG003|Period 1|Withdrawal by Subject|2|||
160505128|NCT03635099|579577052|FG004|Period 1|Withdrawal by Subject|2|||
160505129|NCT03635099|579577053|FG005|Period 1|Withdrawal by Subject|0|||
160505130|NCT03635099|579577054|FG006|Period 1|Withdrawal by Subject|3|||
160505131|NCT03635099|579577055|FG007|Period 1|Withdrawal by Subject|0|||
160505132|NCT03635099|579577048|FG000|Period 1|History of suicidal ideation|0|||
160505133|NCT03635099|579577049|FG001|Period 1|History of suicidal ideation|0|||
160505134|NCT03635099|579577050|FG002|Period 1|History of suicidal ideation|1|||
160505135|NCT03635099|579577051|FG003|Period 1|History of suicidal ideation|0|||
160505136|NCT03635099|579577052|FG004|Period 1|History of suicidal ideation|0|||
160505137|NCT03635099|579577053|FG005|Period 1|History of suicidal ideation|0|||
160505138|NCT03635099|579577054|FG006|Period 1|History of suicidal ideation|0|||
160505139|NCT03635099|579577055|FG007|Period 1|History of suicidal ideation|0|||
160505140|NCT03635099|579577048|FG000|Period 1|pursue other treatment options|0|||
160505141|NCT03635099|579577049|FG001|Period 1|pursue other treatment options|0|||
160505142|NCT03635099|579577050|FG002|Period 1|pursue other treatment options|0|||
160505143|NCT03635099|579577051|FG003|Period 1|pursue other treatment options|0|||
160505144|NCT03635099|579577052|FG004|Period 1|pursue other treatment options|0|||
160505145|NCT03635099|579577053|FG005|Period 1|pursue other treatment options|1|||
160505146|NCT03635099|579577054|FG006|Period 1|pursue other treatment options|0|||
160505147|NCT03635099|579577055|FG007|Period 1|pursue other treatment options|0|||
160505148|NCT03635099|579577048|FG000|Not Eligible for Period 2|Pregnancy|0|||
160505149|NCT03635099|579577049|FG001|Not Eligible for Period 2|Pregnancy|0|||
160505150|NCT03635099|579577050|FG002|Not Eligible for Period 2|Pregnancy|0|||
160505151|NCT03635099|579577051|FG003|Not Eligible for Period 2|Pregnancy|1|||
160505152|NCT03635099|579577052|FG004|Not Eligible for Period 2|Pregnancy|0|||
160505153|NCT03635099|579577053|FG005|Not Eligible for Period 2|Pregnancy|0|||
160505154|NCT03635099|579577054|FG006|Not Eligible for Period 2|Pregnancy|0|||
160505155|NCT03635099|579577055|FG007|Not Eligible for Period 2|Pregnancy|0|||
160505156|NCT03635099|579577048|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
160505157|NCT03635099|579577049|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
160505158|NCT03635099|579577050|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
160505159|NCT03635099|579577051|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
160505160|NCT03635099|579577052|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
160505161|NCT03635099|579577053|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
160505162|NCT03635099|579577054|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
160505163|NCT03635099|579577055|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
160663376|NCT01185821|580150668|FG001|Overall Study|Protocol Violation|0|||
160663377|NCT01185821|580150669|FG002|Overall Study|Protocol Violation|0|||
160505164|NCT03635099|579577048|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
160663378|NCT01185821|580150670|FG003|Overall Study|Protocol Violation|1|||
160663379|NCT01185821|580150671|FG004|Overall Study|Protocol Violation|1|||
160663380|NCT01185821|580150667|FG000|Overall Study|Abnormal test procedure result|0|||
160663381|NCT01185821|580150668|FG001|Overall Study|Abnormal test procedure result|0|||
160663382|NCT01185821|580150669|FG002|Overall Study|Abnormal test procedure result|0|||
160663383|NCT01185821|580150670|FG003|Overall Study|Abnormal test procedure result|0|||
160663384|NCT01185821|580150671|FG004|Overall Study|Abnormal test procedure result|1|||
160663385|NCT01185821|580150667|FG000|Overall Study|Death|0|||
160663386|NCT01185821|580150668|FG001|Overall Study|Death|1|||
160663387|NCT01185821|580150669|FG002|Overall Study|Death|0|||
160663388|NCT01185821|580150670|FG003|Overall Study|Death|0|||
160663389|NCT01185821|580150671|FG004|Overall Study|Death|0|||
160663390|NCT01185821|580150667|FG000|Overall Study|Condition no longer required study drug|0|||
160663391|NCT01185821|580150668|FG001|Overall Study|Condition no longer required study drug|0|||
160663392|NCT01185821|580150669|FG002|Overall Study|Condition no longer required study drug|0|||
160663393|NCT01185821|580150670|FG003|Overall Study|Condition no longer required study drug|0|||
160663394|NCT01185821|580150671|FG004|Overall Study|Condition no longer required study drug|1|||
160663395|NCT01185821|580150667|FG000|Overall Study|Adverse Event|2|||
160663396|NCT01185821|580150668|FG001|Overall Study|Adverse Event|3|||
160663397|NCT01185821|580150669|FG002|Overall Study|Adverse Event|1|||
160663398|NCT01185821|580150670|FG003|Overall Study|Adverse Event|2|||
160663399|NCT01185821|580150671|FG004|Overall Study|Adverse Event|5|||
160663400|NCT01185821|580150667|FG000|Overall Study|Lack of Efficacy|0|||
160663401|NCT01185821|580150668|FG001|Overall Study|Lack of Efficacy|0|||
160663402|NCT01185821|580150669|FG002|Overall Study|Lack of Efficacy|3|||
160663403|NCT01185821|580150670|FG003|Overall Study|Lack of Efficacy|0|||
160663404|NCT01185821|580150671|FG004|Overall Study|Lack of Efficacy|9|||
160663405|NCT01185821|580150667|FG000|Overall Study|Withdrawal by Subject|3|||
160663406|NCT01185821|580150668|FG001|Overall Study|Withdrawal by Subject|2|||
160505165|NCT03635099|579577049|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
160505166|NCT03635099|579577050|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
160505167|NCT03635099|579577051|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
160505168|NCT03635099|579577052|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
160505169|NCT03635099|579577053|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
160505170|NCT03635099|579577054|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
160505171|NCT03635099|579577055|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
160505172|NCT03635099|579577048|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
160505173|NCT03635099|579577049|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
160505174|NCT03635099|579577050|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
160505175|NCT03635099|579577051|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
160505176|NCT03635099|579577052|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
160505177|NCT03635099|579577053|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
160505178|NCT03635099|579577054|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
160505179|NCT03635099|579577055|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
160505180|NCT03635099|579577048|FG000|Period 2|Adverse Event|0|||
160505181|NCT03635099|579577049|FG001|Period 2|Adverse Event|0|||
160505182|NCT03635099|579577050|FG002|Period 2|Adverse Event|1|||
160505183|NCT03635099|579577051|FG003|Period 2|Adverse Event|0|||
160505184|NCT03635099|579577052|FG004|Period 2|Adverse Event|1|||
160505185|NCT03635099|579577053|FG005|Period 2|Adverse Event|0|||
160505186|NCT03635099|579577054|FG006|Period 2|Adverse Event|0|||
160505187|NCT03635099|579577055|FG007|Period 2|Adverse Event|0|||
160663407|NCT01185821|580150669|FG002|Overall Study|Withdrawal by Subject|2|||
160663408|NCT01185821|580150670|FG003|Overall Study|Withdrawal by Subject|1|||
160663409|NCT01185821|580150671|FG004|Overall Study|Withdrawal by Subject|3|||
160663410|NCT01185821|580150667|FG000|Overall Study|Lost to Follow-up|1|||
160505188|NCT03635099|579577048|FG000|Period 2|Lost to Follow-up|0|||
160505189|NCT03635099|579577049|FG001|Period 2|Lost to Follow-up|0|||
160505190|NCT03635099|579577050|FG002|Period 2|Lost to Follow-up|1|||
160505191|NCT03635099|579577051|FG003|Period 2|Lost to Follow-up|0|||
160505192|NCT03635099|579577052|FG004|Period 2|Lost to Follow-up|4|||
160505193|NCT03635099|579577053|FG005|Period 2|Lost to Follow-up|0|||
160505194|NCT03635099|579577054|FG006|Period 2|Lost to Follow-up|0|||
160505195|NCT03635099|579577055|FG007|Period 2|Lost to Follow-up|0|||
160505196|NCT03635099|579577048|FG000|Period 2|Withdrawal by Subject|0|||
160505197|NCT03635099|579577049|FG001|Period 2|Withdrawal by Subject|0|||
160505198|NCT03635099|579577050|FG002|Period 2|Withdrawal by Subject|7|||
160505199|NCT03635099|579577051|FG003|Period 2|Withdrawal by Subject|4|||
160505200|NCT03635099|579577052|FG004|Period 2|Withdrawal by Subject|7|||
160505201|NCT03635099|579577053|FG005|Period 2|Withdrawal by Subject|0|||
160505202|NCT03635099|579577054|FG006|Period 2|Withdrawal by Subject|0|||
160505203|NCT03635099|579577055|FG007|Period 2|Withdrawal by Subject|0|||
160505204|NCT01289210|579577056|FG000|Overall Study|Adverse Event|1|||
160505205|NCT06285240|579577057|FG000|Overall Study|Withdrawal by Subject|2|||
160505206|NCT06285240|579577058|FG001|Overall Study|Withdrawal by Subject|0|||
160505207|NCT06285240|579577059|FG002|Overall Study|Withdrawal by Subject|0|||
160505208|NCT06285240|579577060|FG003|Overall Study|Withdrawal by Subject|0|||
160505209|NCT06285240|579577057|FG000|Overall Study|Serious Adverse Event|0|||
160505210|NCT06285240|579577058|FG001|Overall Study|Serious Adverse Event|0|||
160505211|NCT06285240|579577059|FG002|Overall Study|Serious Adverse Event|1|||
160505212|NCT06285240|579577060|FG003|Overall Study|Serious Adverse Event|0|||
160505213|NCT05140915|579577063|FG000|Overall Study|Lost to Follow-up|2|||
160505214|NCT05140915|579577064|FG001|Overall Study|Lost to Follow-up|1|||
160505215|NCT04520659|579577065|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
160505216|NCT04520659|579577066|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
160505217|NCT04520659|579577067|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
160505218|NCT04520659|579577068|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
160505219|NCT04485611|579577073|FG000|Prehabilitation|Physician Decision|1|||
160505220|NCT04879849|579577074|FG000|Overall Study|Lost to Follow-up|0|||
160505221|NCT04879849|579577075|FG001|Overall Study|Lost to Follow-up|0|||
160505222|NCT04879849|579577076|FG002|Overall Study|Lost to Follow-up|0|||
160505223|NCT04879849|579577077|FG003|Overall Study|Lost to Follow-up|1|||
160505224|NCT04879849|579577078|FG004|Overall Study|Lost to Follow-up|0|||
160505225|NCT04879849|579577079|FG005|Overall Study|Lost to Follow-up|0|||
160505226|NCT04879849|579577080|FG006|Overall Study|Lost to Follow-up|0|||
160505227|NCT04879849|579577081|FG007|Overall Study|Lost to Follow-up|0|||
160505228|NCT04879849|579577074|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
160505229|NCT04879849|579577075|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
160505230|NCT04879849|579577076|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
160505231|NCT04879849|579577077|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
160505232|NCT04879849|579577078|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
160505233|NCT04879849|579577079|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
160505234|NCT04879849|579577080|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
160505235|NCT04879849|579577081|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
160505236|NCT04879849|579577074|FG000|Overall Study|Withdrawal by Subject|0|||
160505237|NCT04879849|579577075|FG001|Overall Study|Withdrawal by Subject|0|||
160505238|NCT04879849|579577076|FG002|Overall Study|Withdrawal by Subject|0|||
160505239|NCT04879849|579577077|FG003|Overall Study|Withdrawal by Subject|0|||
160505240|NCT04879849|579577078|FG004|Overall Study|Withdrawal by Subject|2|||
160505241|NCT04879849|579577079|FG005|Overall Study|Withdrawal by Subject|0|||
160505242|NCT04879849|579577080|FG006|Overall Study|Withdrawal by Subject|1|||
160505243|NCT04879849|579577081|FG007|Overall Study|Withdrawal by Subject|0|||
160505244|NCT04879849|579577074|FG000|Overall Study|Progressive Disease|0|||
160505245|NCT04879849|579577075|FG001|Overall Study|Progressive Disease|0|||
160505246|NCT04879849|579577076|FG002|Overall Study|Progressive Disease|1|||
160505247|NCT04879849|579577077|FG003|Overall Study|Progressive Disease|0|||
160505248|NCT04879849|579577078|FG004|Overall Study|Progressive Disease|0|||
160505249|NCT04879849|579577079|FG005|Overall Study|Progressive Disease|0|||
160505250|NCT04879849|579577080|FG006|Overall Study|Progressive Disease|0|||
160505251|NCT04879849|579577081|FG007|Overall Study|Progressive Disease|0|||
160505252|NCT04879849|579577074|FG000|Overall Study|Death|0|||
160620173|NCT00727246|579988426|FG000|Overall Study|incidental finding|0|||
160620174|NCT00727246|579988427|FG001|Overall Study|incidental finding|0|||
160505253|NCT04879849|579577075|FG001|Overall Study|Death|0|||
160505254|NCT04879849|579577076|FG002|Overall Study|Death|1|||
160505255|NCT04879849|579577077|FG003|Overall Study|Death|1|||
160505256|NCT04879849|579577078|FG004|Overall Study|Death|1|||
160505257|NCT04879849|579577079|FG005|Overall Study|Death|2|||
160505258|NCT04879849|579577080|FG006|Overall Study|Death|1|||
160505259|NCT04879849|579577081|FG007|Overall Study|Death|2|||
160505260|NCT04879849|579577074|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
160505261|NCT04879849|579577075|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
160505262|NCT04879849|579577076|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
160505263|NCT04879849|579577077|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
160505264|NCT04879849|579577078|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
160505265|NCT04879849|579577079|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
160505266|NCT04879849|579577080|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
160505267|NCT04879849|579577081|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
160505268|NCT04879849|579577074|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
160505269|NCT04879849|579577075|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
160505270|NCT04879849|579577076|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
160505271|NCT04879849|579577077|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
160505272|NCT04879849|579577078|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
160505273|NCT04879849|579577079|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
160505274|NCT04879849|579577080|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
160505275|NCT04879849|579577081|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
160505276|NCT04879849|579577074|FG000|Overall Study|Reason Not Specified|1|||
160505277|NCT04879849|579577075|FG001|Overall Study|Reason Not Specified|0|||
160505278|NCT04879849|579577076|FG002|Overall Study|Reason Not Specified|0|||
160505279|NCT04879849|579577077|FG003|Overall Study|Reason Not Specified|0|||
160505280|NCT04879849|579577078|FG004|Overall Study|Reason Not Specified|0|||
160505281|NCT04879849|579577079|FG005|Overall Study|Reason Not Specified|0|||
160505282|NCT04879849|579577080|FG006|Overall Study|Reason Not Specified|0|||
160505283|NCT04879849|579577081|FG007|Overall Study|Reason Not Specified|0|||
160505284|NCT05292586|579577082|FG000|Overall Study|Withdrawal by Subject|3|||
160505285|NCT05292586|579577083|FG001|Overall Study|Withdrawal by Subject|10|||
160505286|NCT05292586|579577082|FG000|Overall Study|Randomization error|3|||
160505287|NCT05292586|579577083|FG001|Overall Study|Randomization error|7|||
160505288|NCT05292586|579577082|FG000|Overall Study|Adverse Event|3|||
160505289|NCT05292586|579577083|FG001|Overall Study|Adverse Event|0|||
160505290|NCT05292586|579577082|FG000|Overall Study|Lost to Follow-up|0|||
160505291|NCT05292586|579577083|FG001|Overall Study|Lost to Follow-up|1|||
160505292|NCT05292586|579577082|FG000|Overall Study|Patient refused treatment|1|||
160505293|NCT05292586|579577083|FG001|Overall Study|Patient refused treatment|0|||
160505294|NCT05292586|579577082|FG000|Overall Study|Patient could not travel to the study site|1|||
160505295|NCT05292586|579577083|FG001|Overall Study|Patient could not travel to the study site|0|||
160505296|NCT05292586|579577082|FG000|Overall Study|Technical issues with the masterscope|0|||
160505297|NCT05292586|579577083|FG001|Overall Study|Technical issues with the masterscope|3|||
160505298|NCT05292586|579577082|FG000|Overall Study|Patient moved to a different state|0|||
160505299|NCT05292586|579577083|FG001|Overall Study|Patient moved to a different state|1|||
160505300|NCT03345576|579577085|FG000|Overall Study|Withdrawal by Subject|2|||
160505301|NCT03345576|579577086|FG001|Overall Study|Withdrawal by Subject|2|||
160505302|NCT03345576|579577085|FG000|Overall Study|Adverse Event|1|||
160505303|NCT03345576|579577086|FG001|Overall Study|Adverse Event|0|||
160505304|NCT05718466|579578306|FG000|Overall Study|Withdrawal by Subject|1|||
160505305|NCT05718466|579578307|FG001|Overall Study|Withdrawal by Subject|2|||
160505306|NCT05718466|579578306|FG000|Overall Study|Death|0|||
160505307|NCT05718466|579578307|FG001|Overall Study|Death|1|||
160505308|NCT01253135|579578308|FG000|Original Protocol|Protocol Amendment|15|||
160505309|NCT01253135|579578308|FG000|Amended Protocol|Non-compliance|1|||
160505310|NCT00833261|579578315|FG000|Overall Study|Withdrawal by Subject|4|||
160505311|NCT00515671|579578318|FG000|Overall Study|Lost to Follow-up|13|||
160505312|NCT00515671|579578319|FG001|Overall Study|Lost to Follow-up|10|||
160505313|NCT00515671|579578318|FG000|Overall Study|Withdrawal by Subject|3|||
160505314|NCT00515671|579578319|FG001|Overall Study|Withdrawal by Subject|5|||
160505315|NCT00515671|579578318|FG000|Overall Study|incarcerated|1|||
160505316|NCT00515671|579578319|FG001|Overall Study|incarcerated|2|||
160505317|NCT02815579|579578324|FG000|Overall Study|Non-payment of loan down-payment|16|||
160505318|NCT02815579|579578325|FG001|Overall Study|Non-payment of loan down-payment|0|||
160505319|NCT02815579|579578324|FG000|Overall Study|Withdrawal by Subject|7|||
160505320|NCT02815579|579578325|FG001|Overall Study|Withdrawal by Subject|1|||
160505321|NCT02815579|579578324|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
160620175|NCT00727246|579988428|FG002|Overall Study|incidental finding|0|||
160620176|NCT00727246|579988429|FG003|Overall Study|incidental finding|1|||
160620177|NCT00727246|579988426|FG000|Overall Study|withdrawn|0|||
160620178|NCT00727246|579988427|FG001|Overall Study|withdrawn|0|||
160620179|NCT00727246|579988428|FG002|Overall Study|withdrawn|1|||
160620180|NCT00727246|579988429|FG003|Overall Study|withdrawn|0|||
160620181|NCT04594213|579988430|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
160505322|NCT02815579|579578325|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
160505323|NCT02815579|579578324|FG000|Overall Study|Lost to Follow-up|7|||
160620182|NCT04594213|579988431|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
160620183|NCT04594213|579988432|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
160620184|NCT04594213|579988433|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
160505324|NCT02815579|579578325|FG001|Overall Study|Lost to Follow-up|4|||
160505325|NCT02815579|579578324|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
160505326|NCT02815579|579578325|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
160505327|NCT02815579|579578324|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
160505328|NCT02815579|579578325|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
160505329|NCT02815579|579578324|FG000|Overall Study|Death|5|||
160505330|NCT02815579|579578325|FG001|Overall Study|Death|4|||
160505331|NCT02815579|579578324|FG000|Overall Study|Imprisoned|0|||
160505332|NCT02815579|579578325|FG001|Overall Study|Imprisoned|2|||
160505333|NCT02815579|579578324|FG000|Overall Study|Did not meet enrollment criteria|0|||
160505334|NCT02815579|579578325|FG001|Overall Study|Did not meet enrollment criteria|1|||
160505335|NCT00264303|579578326|FG000|Overall Study|Adverse Event|4|||
160505336|NCT00264303|579578327|FG001|Overall Study|Adverse Event|3|||
160505337|NCT00264303|579578326|FG000|Overall Study|Lack of Efficacy|10|||
160505338|NCT00264303|579578327|FG001|Overall Study|Lack of Efficacy|13|||
160505339|NCT00264303|579578326|FG000|Overall Study|Lost to Follow-up|3|||
160505340|NCT00264303|579578327|FG001|Overall Study|Lost to Follow-up|3|||
160505341|NCT00264303|579578326|FG000|Overall Study|Withdrawal by Subject|2|||
160505342|NCT00264303|579578327|FG001|Overall Study|Withdrawal by Subject|3|||
160505343|NCT00264303|579578326|FG000|Overall Study|Various reasons listed in study report|6|||
160505344|NCT00264303|579578327|FG001|Overall Study|Various reasons listed in study report|7|||
160505345|NCT00818168|579578335|FG000|Overall Study|Lack of Efficacy|18|||
160505346|NCT00818168|579578335|FG000|Overall Study|Pregnancy|2|||
160505347|NCT00818168|579578335|FG000|Overall Study|Withdrawal by Subject|16|||
160505348|NCT00818168|579578335|FG000|Overall Study|Lost to Follow-up|7|||
160505349|NCT00818168|579578335|FG000|Overall Study|Adverse Event|19|||
160505350|NCT00818168|579578335|FG000|Overall Study|Reason for Non-completion Not reported|6|||
160505351|NCT00818168|579578335|FG000|Overall Study|Participant Moved|2|||
160505352|NCT02993406|579578340|FG000|Overall Study|Withdrawal by Subject|170|||
160505353|NCT02993406|579578341|FG001|Overall Study|Withdrawal by Subject|196|||
160505354|NCT02993406|579578340|FG000|Overall Study|Physician Decision|3|||
160505355|NCT02993406|579578341|FG001|Overall Study|Physician Decision|5|||
160505356|NCT02993406|579578340|FG000|Overall Study|Lost to Follow-up|12|||
160505357|NCT02993406|579578341|FG001|Overall Study|Lost to Follow-up|13|||
160505358|NCT02993406|579578340|FG000|Overall Study|Unclassifiable Response|105|||
160505359|NCT02993406|579578341|FG001|Overall Study|Unclassifiable Response|139|||
160505360|NCT02993406|579578340|FG000|Overall Study|Administrative decision|1|||
160505361|NCT02993406|579578341|FG001|Overall Study|Administrative decision|0|||
160505362|NCT02993406|579578340|FG000|Overall Study|Sponsor decision|4|||
160505363|NCT02993406|579578341|FG001|Overall Study|Sponsor decision|5|||
160505364|NCT02942277|579578342|FG000|Year 1|Withdrawal by Subject|0|||
160505365|NCT02942277|579578343|FG001|Year 1|Withdrawal by Subject|0|||
160505366|NCT02942277|579578344|FG002|Year 1|Withdrawal by Subject|0|||
160505367|NCT02942277|579578345|FG003|Year 1|Withdrawal by Subject|0|||
160505368|NCT02942277|579578346|FG004|Year 1|Withdrawal by Subject|1|||
160505369|NCT02942277|579578347|FG005|Year 1|Withdrawal by Subject|3|||
160505370|NCT02942277|579578348|FG006|Year 1|Withdrawal by Subject|0|||
160505371|NCT02942277|579578349|FG007|Year 1|Withdrawal by Subject|1|||
160505372|NCT02942277|579578350|FG008|Year 1|Withdrawal by Subject|0|||
160505373|NCT02942277|579578351|FG009|Year 1|Withdrawal by Subject|0|||
160505374|NCT02942277|579578352|FG010|Year 1|Withdrawal by Subject|3|||
160505375|NCT02942277|579578342|FG000|Year 1|Travel|0|||
160505376|NCT02942277|579578343|FG001|Year 1|Travel|1|||
160505377|NCT02942277|579578344|FG002|Year 1|Travel|0|||
160505378|NCT02942277|579578345|FG003|Year 1|Travel|0|||
160505379|NCT02942277|579578346|FG004|Year 1|Travel|4|||
160505380|NCT02942277|579578347|FG005|Year 1|Travel|5|||
160505381|NCT02942277|579578348|FG006|Year 1|Travel|0|||
160505382|NCT02942277|579578349|FG007|Year 1|Travel|0|||
160505383|NCT02942277|579578350|FG008|Year 1|Travel|0|||
160505384|NCT02942277|579578351|FG009|Year 1|Travel|0|||
160505385|NCT02942277|579578352|FG010|Year 1|Travel|8|||
160505386|NCT02942277|579578342|FG000|Year 1|Joined Army|0|||
160505387|NCT02942277|579578343|FG001|Year 1|Joined Army|1|||
160505388|NCT02942277|579578344|FG002|Year 1|Joined Army|0|||
160505389|NCT02942277|579578345|FG003|Year 1|Joined Army|0|||
160505390|NCT02942277|579578346|FG004|Year 1|Joined Army|0|||
160505391|NCT02942277|579578347|FG005|Year 1|Joined Army|0|||
160505392|NCT02942277|579578348|FG006|Year 1|Joined Army|0|||
160505393|NCT02942277|579578349|FG007|Year 1|Joined Army|0|||
160505394|NCT02942277|579578350|FG008|Year 1|Joined Army|0|||
160505395|NCT02942277|579578351|FG009|Year 1|Joined Army|0|||
160505396|NCT02942277|579578352|FG010|Year 1|Joined Army|0|||
160505397|NCT02942277|579578342|FG000|Year 1|Subject met withdrawal criteria|0|||
160505398|NCT02942277|579578343|FG001|Year 1|Subject met withdrawal criteria|0|||
160505399|NCT02942277|579578344|FG002|Year 1|Subject met withdrawal criteria|0|||
160505400|NCT02942277|579578345|FG003|Year 1|Subject met withdrawal criteria|1|||
160505401|NCT02942277|579578346|FG004|Year 1|Subject met withdrawal criteria|0|||
160505402|NCT02942277|579578347|FG005|Year 1|Subject met withdrawal criteria|0|||
160505403|NCT02942277|579578348|FG006|Year 1|Subject met withdrawal criteria|0|||
160505404|NCT02942277|579578349|FG007|Year 1|Subject met withdrawal criteria|0|||
160505405|NCT02942277|579578350|FG008|Year 1|Subject met withdrawal criteria|0|||
160505406|NCT02942277|579578351|FG009|Year 1|Subject met withdrawal criteria|0|||
160505407|NCT02942277|579578352|FG010|Year 1|Subject met withdrawal criteria|0|||
160505408|NCT02942277|579578342|FG000|Year 1|Lost to Follow-up|0|||
160505409|NCT02942277|579578343|FG001|Year 1|Lost to Follow-up|0|||
160505410|NCT02942277|579578344|FG002|Year 1|Lost to Follow-up|0|||
160505411|NCT02942277|579578345|FG003|Year 1|Lost to Follow-up|0|||
160505412|NCT02942277|579578346|FG004|Year 1|Lost to Follow-up|1|||
160505413|NCT02942277|579578347|FG005|Year 1|Lost to Follow-up|0|||
160505414|NCT02942277|579578348|FG006|Year 1|Lost to Follow-up|0|||
160505415|NCT02942277|579578349|FG007|Year 1|Lost to Follow-up|0|||
160505416|NCT02942277|579578350|FG008|Year 1|Lost to Follow-up|0|||
160505417|NCT02942277|579578351|FG009|Year 1|Lost to Follow-up|0|||
160505418|NCT02942277|579578352|FG010|Year 1|Lost to Follow-up|2|||
160505419|NCT02942277|579578342|FG000|Year 1|Protocol Violation|0|||
160505420|NCT02942277|579578343|FG001|Year 1|Protocol Violation|0|||
160505421|NCT02942277|579578344|FG002|Year 1|Protocol Violation|0|||
160505422|NCT02942277|579578345|FG003|Year 1|Protocol Violation|0|||
160505423|NCT02942277|579578346|FG004|Year 1|Protocol Violation|1|||
160505424|NCT02942277|579578347|FG005|Year 1|Protocol Violation|1|||
160505425|NCT02942277|579578348|FG006|Year 1|Protocol Violation|0|||
160505426|NCT02942277|579578349|FG007|Year 1|Protocol Violation|0|||
160505427|NCT02942277|579578350|FG008|Year 1|Protocol Violation|0|||
160505428|NCT02942277|579578351|FG009|Year 1|Protocol Violation|0|||
160505429|NCT02942277|579578352|FG010|Year 1|Protocol Violation|2|||
160505430|NCT02942277|579578342|FG000|Year 1|Pregnancy|0|||
160505431|NCT02942277|579578343|FG001|Year 1|Pregnancy|0|||
160505432|NCT02942277|579578344|FG002|Year 1|Pregnancy|0|||
160505433|NCT02942277|579578345|FG003|Year 1|Pregnancy|0|||
160505434|NCT02942277|579578346|FG004|Year 1|Pregnancy|0|||
160505435|NCT02942277|579578347|FG005|Year 1|Pregnancy|1|||
160505436|NCT02942277|579578348|FG006|Year 1|Pregnancy|0|||
160505437|NCT02942277|579578349|FG007|Year 1|Pregnancy|0|||
160505438|NCT02942277|579578350|FG008|Year 1|Pregnancy|0|||
160505439|NCT02942277|579578351|FG009|Year 1|Pregnancy|0|||
160505440|NCT02942277|579578352|FG010|Year 1|Pregnancy|0|||
160505441|NCT02942277|579578342|FG000|Year 2|Lost to Follow-up|0|||
160505442|NCT02942277|579578343|FG001|Year 2|Lost to Follow-up|0|||
160505443|NCT02942277|579578344|FG002|Year 2|Lost to Follow-up|0|||
160505444|NCT02942277|579578345|FG003|Year 2|Lost to Follow-up|0|||
160505445|NCT02942277|579578346|FG004|Year 2|Lost to Follow-up|2|||
160505446|NCT02942277|579578347|FG005|Year 2|Lost to Follow-up|1|||
160505447|NCT02942277|579578348|FG006|Year 2|Lost to Follow-up|0|||
160505448|NCT02942277|579578349|FG007|Year 2|Lost to Follow-up|0|||
160505449|NCT02942277|579578350|FG008|Year 2|Lost to Follow-up|0|||
160505450|NCT02942277|579578351|FG009|Year 2|Lost to Follow-up|0|||
160505451|NCT02942277|579578352|FG010|Year 2|Lost to Follow-up|0|||
160505452|NCT02942277|579578342|FG000|Year 2|Did not rescreen|0|||
160505453|NCT02942277|579578343|FG001|Year 2|Did not rescreen|0|||
160505454|NCT02942277|579578344|FG002|Year 2|Did not rescreen|1|||
160505455|NCT02942277|579578345|FG003|Year 2|Did not rescreen|1|||
160505456|NCT02942277|579578346|FG004|Year 2|Did not rescreen|9|||
160505457|NCT02942277|579578347|FG005|Year 2|Did not rescreen|6|||
160505458|NCT02942277|579578348|FG006|Year 2|Did not rescreen|0|||
160505459|NCT02942277|579578349|FG007|Year 2|Did not rescreen|1|||
160505460|NCT02942277|579578350|FG008|Year 2|Did not rescreen|0|||
160505461|NCT02942277|579578351|FG009|Year 2|Did not rescreen|0|||
160505462|NCT02942277|579578352|FG010|Year 2|Did not rescreen|21|||
160505463|NCT02942277|579578342|FG000|Year 2|Met withdrawal criteria|0|||
160505464|NCT02942277|579578343|FG001|Year 2|Met withdrawal criteria|0|||
160505465|NCT02942277|579578344|FG002|Year 2|Met withdrawal criteria|0|||
160505466|NCT02942277|579578345|FG003|Year 2|Met withdrawal criteria|0|||
160505467|NCT02942277|579578346|FG004|Year 2|Met withdrawal criteria|1|||
160505468|NCT02942277|579578347|FG005|Year 2|Met withdrawal criteria|2|||
160505469|NCT02942277|579578348|FG006|Year 2|Met withdrawal criteria|0|||
160505470|NCT02942277|579578349|FG007|Year 2|Met withdrawal criteria|0|||
160505471|NCT02942277|579578350|FG008|Year 2|Met withdrawal criteria|0|||
160505472|NCT02942277|579578351|FG009|Year 2|Met withdrawal criteria|0|||
160505473|NCT02942277|579578352|FG010|Year 2|Met withdrawal criteria|1|||
160505474|NCT02942277|579578342|FG000|Year 2|Travel|0|||
160505475|NCT02942277|579578343|FG001|Year 2|Travel|1|||
160505476|NCT02942277|579578344|FG002|Year 2|Travel|0|||
160505477|NCT02942277|579578345|FG003|Year 2|Travel|0|||
160505478|NCT02942277|579578346|FG004|Year 2|Travel|0|||
160505479|NCT02942277|579578347|FG005|Year 2|Travel|1|||
160505480|NCT02942277|579578348|FG006|Year 2|Travel|0|||
160505481|NCT02942277|579578349|FG007|Year 2|Travel|0|||
160505482|NCT02942277|579578350|FG008|Year 2|Travel|0|||
160505483|NCT02942277|579578351|FG009|Year 2|Travel|1|||
160505484|NCT02942277|579578352|FG010|Year 2|Travel|3|||
160505485|NCT02942277|579578342|FG000|Year 2|Non-compliant|0|||
160505486|NCT02942277|579578343|FG001|Year 2|Non-compliant|0|||
160505487|NCT02942277|579578344|FG002|Year 2|Non-compliant|0|||
160505488|NCT02942277|579578345|FG003|Year 2|Non-compliant|0|||
160505489|NCT02942277|579578346|FG004|Year 2|Non-compliant|1|||
160505490|NCT02942277|579578347|FG005|Year 2|Non-compliant|1|||
160505491|NCT02942277|579578348|FG006|Year 2|Non-compliant|0|||
160505492|NCT02942277|579578349|FG007|Year 2|Non-compliant|0|||
160505493|NCT02942277|579578350|FG008|Year 2|Non-compliant|0|||
160505494|NCT02942277|579578351|FG009|Year 2|Non-compliant|0|||
160505495|NCT02942277|579578352|FG010|Year 2|Non-compliant|0|||
160505496|NCT02942277|579578342|FG000|Year 2|Withdrawal by Subject|0|||
160505497|NCT02942277|579578343|FG001|Year 2|Withdrawal by Subject|0|||
160505498|NCT02942277|579578344|FG002|Year 2|Withdrawal by Subject|0|||
160505499|NCT02942277|579578345|FG003|Year 2|Withdrawal by Subject|0|||
160505500|NCT02942277|579578346|FG004|Year 2|Withdrawal by Subject|0|||
160505501|NCT02942277|579578347|FG005|Year 2|Withdrawal by Subject|0|||
160505502|NCT02942277|579578348|FG006|Year 2|Withdrawal by Subject|1|||
160505503|NCT02942277|579578349|FG007|Year 2|Withdrawal by Subject|0|||
160505504|NCT02942277|579578350|FG008|Year 2|Withdrawal by Subject|0|||
160505505|NCT02942277|579578351|FG009|Year 2|Withdrawal by Subject|0|||
160505506|NCT02942277|579578352|FG010|Year 2|Withdrawal by Subject|0|||
160505507|NCT04325282|579578353|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
160505508|NCT04325282|579578354|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
160505509|NCT04325282|579578353|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
160505510|NCT04325282|579578354|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
160505511|NCT04020185|579578359|FG000|Overall Study|Death|0|||
160505512|NCT04020185|579578360|FG001|Overall Study|Death|0|||
160505513|NCT04020185|579578361|FG002|Overall Study|Death|1|||
160505514|NCT04020185|579578362|FG003|Overall Study|Death|2|||
160505515|NCT04020185|579578363|FG004|Overall Study|Death|1|||
160505516|NCT04020185|579578364|FG005|Overall Study|Death|0|||
160505517|NCT04020185|579578365|FG006|Overall Study|Death|1|||
160505518|NCT04020185|579578366|FG007|Overall Study|Death|0|||
160505519|NCT04020185|579578359|FG000|Overall Study|Consent withdrawn|1|||
160505520|NCT04020185|579578360|FG001|Overall Study|Consent withdrawn|0|||
160505521|NCT04020185|579578361|FG002|Overall Study|Consent withdrawn|0|||
160505522|NCT04020185|579578362|FG003|Overall Study|Consent withdrawn|0|||
160505523|NCT04020185|579578363|FG004|Overall Study|Consent withdrawn|2|||
160505524|NCT04020185|579578364|FG005|Overall Study|Consent withdrawn|0|||
160505525|NCT04020185|579578365|FG006|Overall Study|Consent withdrawn|1|||
160505526|NCT04020185|579578366|FG007|Overall Study|Consent withdrawn|1|||
160505527|NCT04020185|579578359|FG000|Overall Study|Patient in hospice|0|||
160505528|NCT04020185|579578360|FG001|Overall Study|Patient in hospice|1|||
160505529|NCT04020185|579578361|FG002|Overall Study|Patient in hospice|0|||
160505530|NCT04020185|579578362|FG003|Overall Study|Patient in hospice|0|||
160505531|NCT04020185|579578363|FG004|Overall Study|Patient in hospice|0|||
160505532|NCT04020185|579578364|FG005|Overall Study|Patient in hospice|0|||
160505533|NCT04020185|579578365|FG006|Overall Study|Patient in hospice|0|||
160505534|NCT04020185|579578366|FG007|Overall Study|Patient in hospice|0|||
160505535|NCT04020185|579578359|FG000|Overall Study|Continuing on expanded access|0|||
160505536|NCT04020185|579578360|FG001|Overall Study|Continuing on expanded access|0|||
160505537|NCT04020185|579578361|FG002|Overall Study|Continuing on expanded access|0|||
160505538|NCT04020185|579578362|FG003|Overall Study|Continuing on expanded access|0|||
160505539|NCT04020185|579578363|FG004|Overall Study|Continuing on expanded access|0|||
160505540|NCT04020185|579578364|FG005|Overall Study|Continuing on expanded access|0|||
160505541|NCT04020185|579578365|FG006|Overall Study|Continuing on expanded access|1|||
160505542|NCT04020185|579578366|FG007|Overall Study|Continuing on expanded access|1|||
160505543|NCT00527787|579578368|FG000|Overall Study|Adverse Event|14|||
160505544|NCT00527787|579578369|FG001|Overall Study|Adverse Event|24|||
160505545|NCT00527787|579578368|FG000|Overall Study|Withdrawal by Subject|13|||
160505546|NCT00527787|579578369|FG001|Overall Study|Withdrawal by Subject|25|||
160505547|NCT00527787|579578368|FG000|Overall Study|Lost to Follow-up|5|||
160505548|NCT00527787|579578369|FG001|Overall Study|Lost to Follow-up|2|||
160505549|NCT00527787|579578368|FG000|Overall Study|Duodenal Ulcer|1|||
160505550|NCT00527787|579578369|FG001|Overall Study|Duodenal Ulcer|10|||
160505551|NCT00527787|579578368|FG000|Overall Study|misc|5|||
160505552|NCT00527787|579578369|FG001|Overall Study|misc|2|||
160505553|NCT00608868|579578374|FG000|Overall Study|Withdrawal by Subject|7|||
160620185|NCT04594213|579988434|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
160620186|NCT04594213|579988435|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
160620187|NCT04594213|579988430|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
160620188|NCT04594213|579988431|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
160505554|NCT00608868|579578374|FG000|Overall Study|Protocol Violation|3|||
160505555|NCT00608868|579578374|FG000|Overall Study|Lost to Follow-up|2|||
160505556|NCT00608868|579578374|FG000|Overall Study|Adverse Event|1|||
160505557|NCT00608868|579578374|FG000|Overall Study|Physician Decision|2|||
160505558|NCT00702962|579578375|FG000|Overall Study|Progressive disease|0|||
160505559|NCT00702962|579578376|FG001|Overall Study|Progressive disease|1|||
160505560|NCT00702962|579578375|FG000|Overall Study|Hospitalized for other health disorder|1|||
160505561|NCT00702962|579578376|FG001|Overall Study|Hospitalized for other health disorder|0|||
160505562|NCT01252355|579578377|FG000|Overall Study|Adverse Event|9|||
160505563|NCT01252355|579578378|FG001|Overall Study|Adverse Event|17|||
160505564|NCT01252355|579578379|FG002|Overall Study|Adverse Event|22|||
160620189|NCT04594213|579988432|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
160663411|NCT01185821|580150668|FG001|Overall Study|Lost to Follow-up|1|||
160505565|NCT01252355|579578377|FG000|Overall Study|Lack of Efficacy|6|||
160505566|NCT01252355|579578378|FG001|Overall Study|Lack of Efficacy|4|||
160505567|NCT01252355|579578379|FG002|Overall Study|Lack of Efficacy|2|||
160505568|NCT01252355|579578377|FG000|Overall Study|Lost to Follow-up|0|||
160505569|NCT01252355|579578378|FG001|Overall Study|Lost to Follow-up|0|||
160505570|NCT01252355|579578379|FG002|Overall Study|Lost to Follow-up|1|||
160505571|NCT01252355|579578377|FG000|Overall Study|Poor Compliance to Protocol|1|||
160505572|NCT01252355|579578378|FG001|Overall Study|Poor Compliance to Protocol|1|||
160505573|NCT01252355|579578379|FG002|Overall Study|Poor Compliance to Protocol|1|||
160505574|NCT01252355|579578377|FG000|Overall Study|Progressive Disease|2|||
160505575|NCT01252355|579578378|FG001|Overall Study|Progressive Disease|0|||
160505576|NCT01252355|579578379|FG002|Overall Study|Progressive Disease|0|||
160505577|NCT01252355|579578377|FG000|Overall Study|Sponsor Early Termination of Study|149|||
160505578|NCT01252355|579578378|FG001|Overall Study|Sponsor Early Termination of Study|149|||
160505579|NCT01252355|579578379|FG002|Overall Study|Sponsor Early Termination of Study|146|||
160505580|NCT01252355|579578377|FG000|Overall Study|Randomized but not Treated|2|||
160505581|NCT01252355|579578378|FG001|Overall Study|Randomized but not Treated|0|||
160505582|NCT01252355|579578379|FG002|Overall Study|Randomized but not Treated|0|||
160505583|NCT01252355|579578377|FG000|Overall Study|Other Than Above|8|||
160505584|NCT01252355|579578378|FG001|Overall Study|Other Than Above|7|||
160505585|NCT01252355|579578379|FG002|Overall Study|Other Than Above|7|||
160505586|NCT01876901|579578383|FG000|Overall Study|Protocol Violation|10|||
160505587|NCT01876901|579578384|FG001|Overall Study|Protocol Violation|2|||
160505588|NCT01876901|579578383|FG000|Overall Study|No or other surgical intervention|7|||
160505589|NCT01876901|579578384|FG001|Overall Study|No or other surgical intervention|5|||
160505590|NCT01399697|579578387|FG000|Overall Study|Adverse Event|13|||
160505591|NCT01399697|579578388|FG001|Overall Study|Adverse Event|3|||
160505592|NCT01399697|579578389|FG002|Overall Study|Adverse Event|1|||
160505593|NCT01399697|579578387|FG000|Overall Study|Lost to Follow-up|2|||
160505594|NCT01399697|579578388|FG001|Overall Study|Lost to Follow-up|0|||
160505595|NCT01399697|579578389|FG002|Overall Study|Lost to Follow-up|0|||
160505596|NCT01399697|579578387|FG000|Overall Study|Withdrawal by Subject|8|||
160505597|NCT01399697|579578388|FG001|Overall Study|Withdrawal by Subject|0|||
160505598|NCT01399697|579578389|FG002|Overall Study|Withdrawal by Subject|0|||
160505599|NCT01399697|579578387|FG000|Overall Study|Investigator Decisión|1|||
160505600|NCT01399697|579578388|FG001|Overall Study|Investigator Decisión|0|||
160505601|NCT01399697|579578389|FG002|Overall Study|Investigator Decisión|2|||
160505602|NCT01399697|579578387|FG000|Overall Study|Lack of Efficacy|9|||
160505603|NCT01399697|579578388|FG001|Overall Study|Lack of Efficacy|0|||
160505604|NCT01399697|579578389|FG002|Overall Study|Lack of Efficacy|1|||
160505605|NCT01399697|579578387|FG000|Overall Study|Protocol Violation|2|||
160505606|NCT01399697|579578388|FG001|Overall Study|Protocol Violation|0|||
160505607|NCT01399697|579578389|FG002|Overall Study|Protocol Violation|0|||
160505608|NCT01399697|579578387|FG000|Overall Study|Non-Compliant|1|||
160505609|NCT01399697|579578388|FG001|Overall Study|Non-Compliant|0|||
160505610|NCT01399697|579578389|FG002|Overall Study|Non-Compliant|0|||
160505611|NCT01399697|579578387|FG000|Overall Study|Inclusion Error|2|||
160505612|NCT01399697|579578388|FG001|Overall Study|Inclusion Error|0|||
160505613|NCT01399697|579578389|FG002|Overall Study|Inclusion Error|0|||
160505614|NCT01399697|579578387|FG000|Overall Study|Positive result for hepatitis B|1|||
160505615|NCT01399697|579578388|FG001|Overall Study|Positive result for hepatitis B|0|||
160505616|NCT01399697|579578389|FG002|Overall Study|Positive result for hepatitis B|0|||
160505617|NCT01399697|579578387|FG000|Overall Study|Clinical RA remission|1|||
160505618|NCT01399697|579578388|FG001|Overall Study|Clinical RA remission|0|||
160505619|NCT01399697|579578389|FG002|Overall Study|Clinical RA remission|0|||
160505620|NCT01399697|579578387|FG000|Overall Study|Sponsor Decision|1|||
160505621|NCT01399697|579578388|FG001|Overall Study|Sponsor Decision|0|||
160505622|NCT01399697|579578389|FG002|Overall Study|Sponsor Decision|0|||
160505623|NCT04313608|579578390|FG000|Overall Study|Death|12|||
160505624|NCT04313608|579578391|FG001|Overall Study|Death|3|||
160505625|NCT03552523|579578400|FG000|Overall Study|Withdrawal by Subject|1|||
160505626|NCT03552523|579578401|FG001|Overall Study|Withdrawal by Subject|1|||
160505627|NCT04145700|579578402|FG000|Overall Study|Withdrawal by Subject|8|||
160663412|NCT01185821|580150669|FG002|Overall Study|Lost to Follow-up|2|||
160663413|NCT01185821|580150670|FG003|Overall Study|Lost to Follow-up|1|||
160505628|NCT04145700|579578403|FG001|Overall Study|Withdrawal by Subject|3|||
160505629|NCT00780559|579578406|FG000|Overall Study|Lost to Follow-up|2|||
160505630|NCT00780559|579578407|FG001|Overall Study|Lost to Follow-up|7|||
160505631|NCT00780559|579578406|FG000|Overall Study|Death|1|||
160505632|NCT00780559|579578407|FG001|Overall Study|Death|0|||
160505633|NCT04958200|579578409|FG000|Overall Study|Withdrawal by Subject|0|||
160505634|NCT04958200|579578410|FG001|Overall Study|Withdrawal by Subject|2|||
160505635|NCT04958200|579578409|FG000|Overall Study|Lost to Follow-up|3|||
160505636|NCT04958200|579578410|FG001|Overall Study|Lost to Follow-up|2|||
160505637|NCT00316017|579578411|FG000|Overall Study|Protocol Violation|11|||
160505638|NCT00316017|579578412|FG001|Overall Study|Protocol Violation|13|||
160505639|NCT00316017|579578413|FG002|Overall Study|Protocol Violation|19|||
160505640|NCT03361865|579578415|FG000|Overall Study|Death|17|||
160505641|NCT03361865|579578416|FG001|Overall Study|Death|18|||
160505642|NCT03361865|579578415|FG000|Overall Study|Physician Decision|1|||
160663414|NCT01185821|580150671|FG004|Overall Study|Lost to Follow-up|2|||
160505643|NCT03361865|579578416|FG001|Overall Study|Physician Decision|9|||
160505644|NCT03361865|579578415|FG000|Overall Study|Withdrawal by Subject|1|||
160505645|NCT03361865|579578416|FG001|Overall Study|Withdrawal by Subject|0|||
160505646|NCT03852719|579578418|FG000|Overall Study|Withdrawal of consent|8|||
160505647|NCT03852719|579578419|FG001|Overall Study|Withdrawal of consent|8|||
160505648|NCT03852719|579578420|FG002|Overall Study|Withdrawal of consent|9|||
160505649|NCT03852719|579578418|FG000|Overall Study|Physician Decision|5|||
160505650|NCT03852719|579578419|FG001|Overall Study|Physician Decision|4|||
160505651|NCT03852719|579578420|FG002|Overall Study|Physician Decision|1|||
160505652|NCT03852719|579578418|FG000|Overall Study|Pregnancy|2|||
160505653|NCT03852719|579578419|FG001|Overall Study|Pregnancy|1|||
160505654|NCT03852719|579578420|FG002|Overall Study|Pregnancy|0|||
160505655|NCT03852719|579578418|FG000|Overall Study|Death|1|||
160505656|NCT03852719|579578419|FG001|Overall Study|Death|0|||
160505657|NCT03852719|579578420|FG002|Overall Study|Death|0|||
160505658|NCT03852719|579578418|FG000|Overall Study|Reason not Specified|3|||
160505659|NCT03852719|579578419|FG001|Overall Study|Reason not Specified|3|||
160505660|NCT03852719|579578420|FG002|Overall Study|Reason not Specified|5|||
160505661|NCT03852719|579578418|FG000|Overall Study|Adverse Event|2|||
160505662|NCT03852719|579578419|FG001|Overall Study|Adverse Event|1|||
160505663|NCT03852719|579578420|FG002|Overall Study|Adverse Event|4|||
160505664|NCT03852719|579578418|FG000|Overall Study|Progressive disease|1|||
160505665|NCT03852719|579578419|FG001|Overall Study|Progressive disease|4|||
160505666|NCT03852719|579578420|FG002|Overall Study|Progressive disease|1|||
160505667|NCT03852719|579578418|FG000|Overall Study|Lost to Follow-up|1|||
160505668|NCT03852719|579578419|FG001|Overall Study|Lost to Follow-up|0|||
160505669|NCT03852719|579578420|FG002|Overall Study|Lost to Follow-up|0|||
160505670|NCT01647542|579578422|FG000|Overall Study|Major Protocol Deviation|1|||
160505671|NCT01647542|579578423|FG001|Overall Study|Major Protocol Deviation|0|||
160505672|NCT01647542|579578424|FG002|Overall Study|Major Protocol Deviation|0|||
160505673|NCT01647542|579578422|FG000|Overall Study|Adverse Event|4|||
160505674|NCT01647542|579578423|FG001|Overall Study|Adverse Event|5|||
160505675|NCT01647542|579578424|FG002|Overall Study|Adverse Event|4|||
160505676|NCT01647542|579578422|FG000|Overall Study|Lost to Follow-up|0|||
160505677|NCT01647542|579578423|FG001|Overall Study|Lost to Follow-up|2|||
160505678|NCT01647542|579578424|FG002|Overall Study|Lost to Follow-up|2|||
160505679|NCT01647542|579578422|FG000|Overall Study|Withdrawal by Subject|6|||
160505680|NCT01647542|579578423|FG001|Overall Study|Withdrawal by Subject|4|||
160505681|NCT01647542|579578424|FG002|Overall Study|Withdrawal by Subject|0|||
160505682|NCT01647542|579578422|FG000|Overall Study|Study Termination|64|||
160505683|NCT01647542|579578423|FG001|Overall Study|Study Termination|61|||
160505684|NCT01647542|579578424|FG002|Overall Study|Study Termination|65|||
160505685|NCT01647542|579578422|FG000|Overall Study|Lack of Efficacy|1|||
160505686|NCT01647542|579578423|FG001|Overall Study|Lack of Efficacy|1|||
160505687|NCT01647542|579578424|FG002|Overall Study|Lack of Efficacy|0|||
160505688|NCT01647542|579578422|FG000|Overall Study|Death|0|||
160505689|NCT01647542|579578423|FG001|Overall Study|Death|0|||
160505690|NCT01647542|579578424|FG002|Overall Study|Death|1|||
160505691|NCT02819024|579578425|FG000|Overall Study|Withdrawal by Subject|1|||
160505692|NCT05217641|579578429|FG000|Overall Study|Lost to Follow-up|1|||
160505693|NCT05217641|579578430|FG001|Overall Study|Lost to Follow-up|1|||
160505694|NCT05217641|579578431|FG002|Overall Study|Lost to Follow-up|0|||
160505695|NCT05217641|579578432|FG003|Overall Study|Lost to Follow-up|1|||
160505696|NCT05217641|579578433|FG004|Overall Study|Lost to Follow-up|1|||
160505697|NCT05217641|579578434|FG005|Overall Study|Lost to Follow-up|0|||
160505698|NCT05217641|579578429|FG000|Overall Study|Withdrawal by Subject|0|||
160505699|NCT05217641|579578430|FG001|Overall Study|Withdrawal by Subject|0|||
160505700|NCT05217641|579578431|FG002|Overall Study|Withdrawal by Subject|0|||
160505701|NCT05217641|579578432|FG003|Overall Study|Withdrawal by Subject|3|||
160505702|NCT05217641|579578433|FG004|Overall Study|Withdrawal by Subject|1|||
160505703|NCT05217641|579578434|FG005|Overall Study|Withdrawal by Subject|0|||
160505704|NCT05217641|579578429|FG000|Overall Study|Other: participant did not specify reason|0|||
160505705|NCT05217641|579578430|FG001|Overall Study|Other: participant did not specify reason|0|||
160505706|NCT05217641|579578431|FG002|Overall Study|Other: participant did not specify reason|0|||
160620190|NCT04594213|579988433|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
160505707|NCT05217641|579578432|FG003|Overall Study|Other: participant did not specify reason|0|||
160505708|NCT05217641|579578433|FG004|Overall Study|Other: participant did not specify reason|1|||
160505709|NCT05217641|579578434|FG005|Overall Study|Other: participant did not specify reason|0|||
160505710|NCT05217641|579578429|FG000|Overall Study|Extended Follow up|1|||
160505711|NCT05217641|579578430|FG001|Overall Study|Extended Follow up|1|||
160505712|NCT05217641|579578431|FG002|Overall Study|Extended Follow up|0|||
160505713|NCT05217641|579578432|FG003|Overall Study|Extended Follow up|0|||
160505714|NCT05217641|579578433|FG004|Overall Study|Extended Follow up|1|||
160505715|NCT05217641|579578434|FG005|Overall Study|Extended Follow up|0|||
160505716|NCT02994069|579578435|FG000|Overall Study|Death|7|||
160620191|NCT04594213|579988434|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
160505717|NCT02994069|579578436|FG001|Overall Study|Death|13|||
160505718|NCT02994069|579578435|FG000|Overall Study|Adverse Event|1|||
160505719|NCT02994069|579578436|FG001|Overall Study|Adverse Event|0|||
160505720|NCT02994069|579578435|FG000|Overall Study|Other|2|||
160505721|NCT02994069|579578436|FG001|Overall Study|Other|0|||
160505722|NCT02994069|579578435|FG000|Overall Study|still on follow up/treatment|5|||
160505723|NCT02994069|579578436|FG001|Overall Study|still on follow up/treatment|6|||
160505724|NCT01255631|579580188|FG000|Overall Study|poor enrollment, no data analyzed|9|||
160505725|NCT01255631|579580189|FG001|Overall Study|poor enrollment, no data analyzed|6|||
160505726|NCT02311673|579580195|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
160505727|NCT02311673|579580196|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
160505728|NCT02311673|579580197|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
160505729|NCT02311673|579580198|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
160505730|NCT00414908|579580199|FG000|Overall Study|Protocol Violation|1|||
160505731|NCT00414908|579580200|FG001|Overall Study|Protocol Violation|1|||
160505732|NCT01076153|579580201|FG000|Overall Study|Symptoms improved/resolved|10|||
160505733|NCT01076153|579580201|FG000|Overall Study|Adverse Event|1|||
160505734|NCT04165031|579580202|FG000|Overall Study|Adverse Event|1|||
160505735|NCT04165031|579580203|FG001|Overall Study|Adverse Event|1|||
160505736|NCT04165031|579580204|FG002|Overall Study|Adverse Event|0|||
160505737|NCT04165031|579580205|FG003|Overall Study|Adverse Event|0|||
160505738|NCT04165031|579580206|FG004|Overall Study|Adverse Event|0|||
160505739|NCT04165031|579580207|FG005|Overall Study|Adverse Event|0|||
160505740|NCT04165031|579580202|FG000|Overall Study|Withdrawal by Subject|0|||
160505741|NCT04165031|579580203|FG001|Overall Study|Withdrawal by Subject|0|||
160505742|NCT04165031|579580204|FG002|Overall Study|Withdrawal by Subject|1|||
160505743|NCT04165031|579580205|FG003|Overall Study|Withdrawal by Subject|0|||
160505744|NCT04165031|579580206|FG004|Overall Study|Withdrawal by Subject|0|||
160505745|NCT04165031|579580207|FG005|Overall Study|Withdrawal by Subject|0|||
160505746|NCT01977677|579580208|FG000|Overall Study|Unrelated Adverse Event|0|||
160505747|NCT01977677|579580209|FG001|Overall Study|Unrelated Adverse Event|0|||
160505748|NCT01977677|579580210|FG002|Overall Study|Unrelated Adverse Event|1|||
160505749|NCT00667225|579580211|FG000|Overall Study|Subject had no more lesions to treat.|1|||
160505750|NCT00667225|579580212|FG001|Overall Study|Subject had no more lesions to treat.|0|||
160505751|NCT00667225|579580211|FG000|Overall Study|Lost to Follow-up|0|||
160505752|NCT00667225|579580212|FG001|Overall Study|Lost to Follow-up|1|||
160505753|NCT02248818|579580217|FG000|Screening|Protocol Violation|0|||
160505754|NCT02248818|579580218|FG001|Screening|Protocol Violation|0|||
160505755|NCT02248818|579580219|FG002|Screening|Protocol Violation|0|||
160505756|NCT02248818|579580220|FG003|Screening|Protocol Violation|0|||
160505757|NCT02248818|579580221|FG004|Screening|Protocol Violation|0|||
160505758|NCT02248818|579580222|FG005|Screening|Protocol Violation|0|||
160505759|NCT02248818|579580223|FG006|Screening|Protocol Violation|0|||
160505760|NCT02248818|579580224|FG007|Screening|Protocol Violation|0|||
160505761|NCT02248818|579580225|FG008|Screening|Protocol Violation|7|||
160505762|NCT02248818|579580217|FG000|Screening|Study fully enrolled|0|||
160505763|NCT02248818|579580218|FG001|Screening|Study fully enrolled|0|||
160505764|NCT02248818|579580219|FG002|Screening|Study fully enrolled|0|||
160505765|NCT02248818|579580220|FG003|Screening|Study fully enrolled|0|||
160505766|NCT02248818|579580221|FG004|Screening|Study fully enrolled|0|||
160505767|NCT02248818|579580222|FG005|Screening|Study fully enrolled|0|||
160505768|NCT02248818|579580223|FG006|Screening|Study fully enrolled|0|||
160505769|NCT02248818|579580224|FG007|Screening|Study fully enrolled|0|||
160505770|NCT02248818|579580225|FG008|Screening|Study fully enrolled|14|||
160505771|NCT02248818|579580217|FG000|Screening|Physician Decision|0|||
160505772|NCT02248818|579580218|FG001|Screening|Physician Decision|0|||
160505773|NCT02248818|579580219|FG002|Screening|Physician Decision|0|||
160505774|NCT02248818|579580220|FG003|Screening|Physician Decision|0|||
160505775|NCT02248818|579580221|FG004|Screening|Physician Decision|0|||
160505776|NCT02248818|579580222|FG005|Screening|Physician Decision|0|||
160505777|NCT02248818|579580223|FG006|Screening|Physician Decision|0|||
160505778|NCT02248818|579580224|FG007|Screening|Physician Decision|0|||
160505779|NCT02248818|579580225|FG008|Screening|Physician Decision|73|||
160505780|NCT02248818|579580217|FG000|Screening|Withdrawal by Subject|0|||
160505781|NCT02248818|579580218|FG001|Screening|Withdrawal by Subject|0|||
160505782|NCT02248818|579580219|FG002|Screening|Withdrawal by Subject|0|||
160505783|NCT02248818|579580220|FG003|Screening|Withdrawal by Subject|0|||
160505784|NCT02248818|579580221|FG004|Screening|Withdrawal by Subject|0|||
160505785|NCT02248818|579580222|FG005|Screening|Withdrawal by Subject|0|||
160505786|NCT02248818|579580223|FG006|Screening|Withdrawal by Subject|0|||
160505787|NCT02248818|579580224|FG007|Screening|Withdrawal by Subject|0|||
160505788|NCT02248818|579580225|FG008|Screening|Withdrawal by Subject|6|||
160505789|NCT02248818|579580217|FG000|Screening|Lost to Follow-up|0|||
160505790|NCT02248818|579580218|FG001|Screening|Lost to Follow-up|0|||
160505791|NCT02248818|579580219|FG002|Screening|Lost to Follow-up|0|||
160505792|NCT02248818|579580220|FG003|Screening|Lost to Follow-up|0|||
160505793|NCT02248818|579580221|FG004|Screening|Lost to Follow-up|0|||
160505794|NCT02248818|579580222|FG005|Screening|Lost to Follow-up|0|||
160505795|NCT02248818|579580223|FG006|Screening|Lost to Follow-up|0|||
160505796|NCT02248818|579580224|FG007|Screening|Lost to Follow-up|0|||
160505797|NCT02248818|579580225|FG008|Screening|Lost to Follow-up|7|||
160505798|NCT02248818|579580217|FG000|Randomised Study|Administrative - randomization error|0|||
160505799|NCT02248818|579580218|FG001|Randomised Study|Administrative - randomization error|0|||
160505800|NCT02248818|579580219|FG002|Randomised Study|Administrative - randomization error|0|||
160505801|NCT02248818|579580220|FG003|Randomised Study|Administrative - randomization error|0|||
160505802|NCT02248818|579580221|FG004|Randomised Study|Administrative - randomization error|0|||
160505803|NCT02248818|579580222|FG005|Randomised Study|Administrative - randomization error|8|||
160505804|NCT02248818|579580223|FG006|Randomised Study|Administrative - randomization error|0|||
160505805|NCT02248818|579580224|FG007|Randomised Study|Administrative - randomization error|0|||
160505806|NCT02248818|579580225|FG008|Randomised Study|Administrative - randomization error|0|||
160505807|NCT02187159|579580226|FG000|Overall Study|Protocol Violation|4|||
160505808|NCT02187159|579580227|FG001|Overall Study|Protocol Violation|6|||
160505809|NCT02187159|579580228|FG002|Overall Study|Protocol Violation|3|||
160505810|NCT02187159|579580229|FG003|Overall Study|Protocol Violation|4|||
160505811|NCT02187159|579580226|FG000|Overall Study|Lack of Efficacy|10|||
160505812|NCT02187159|579580227|FG001|Overall Study|Lack of Efficacy|5|||
160505813|NCT02187159|579580228|FG002|Overall Study|Lack of Efficacy|4|||
160505814|NCT02187159|579580229|FG003|Overall Study|Lack of Efficacy|7|||
160505815|NCT02187159|579580226|FG000|Overall Study|Adverse Event|28|||
160505816|NCT02187159|579580227|FG001|Overall Study|Adverse Event|33|||
160505817|NCT02187159|579580228|FG002|Overall Study|Adverse Event|42|||
160505818|NCT02187159|579580229|FG003|Overall Study|Adverse Event|50|||
160505819|NCT02187159|579580226|FG000|Overall Study|Withdrawal by Subject|24|||
160505820|NCT02187159|579580227|FG001|Overall Study|Withdrawal by Subject|28|||
160505821|NCT02187159|579580228|FG002|Overall Study|Withdrawal by Subject|25|||
160505822|NCT02187159|579580229|FG003|Overall Study|Withdrawal by Subject|26|||
160505823|NCT02187159|579580226|FG000|Overall Study|Other|3|||
160505824|NCT02187159|579580227|FG001|Overall Study|Other|7|||
160505825|NCT02187159|579580228|FG002|Overall Study|Other|3|||
160505826|NCT02187159|579580229|FG003|Overall Study|Other|9|||
160505827|NCT01283152|579580230|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
160505828|NCT01283152|579580231|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
160505829|NCT01283152|579580230|FG000|Overall Study|Refused HESA|1|||
160505830|NCT01283152|579580231|FG001|Overall Study|Refused HESA|0|||
160505831|NCT03482466|579580232|FG000|Overall Study|Protocol Violation|2|||
160505832|NCT04833127|579580233|FG000|Overall Study|Lost to Follow-up|1|||
160505833|NCT04833127|579580234|FG001|Overall Study|Lost to Follow-up|1|||
160505834|NCT01736189|579580235|FG000|Overall Study|Violation of registration criteria|41|||
160505835|NCT01736189|579580235|FG000|Overall Study|Protocol Violation|4|||
160505836|NCT01736189|579580235|FG000|Overall Study|Criteria and protocol violations|1|||
160505837|NCT01499303|579580236|FG000|Overall Study|Ongoing|2|||
160505838|NCT01499303|579580237|FG001|Overall Study|Ongoing|1|||
160505839|NCT01499303|579580236|FG000|Overall Study|Withdrawal by Subject|0|||
160505840|NCT01499303|579580237|FG001|Overall Study|Withdrawal by Subject|1|||
160505841|NCT01499303|579580236|FG000|Overall Study|Adverse Event|1|||
160505842|NCT01499303|579580237|FG001|Overall Study|Adverse Event|4|||
160505843|NCT01499303|579580236|FG000|Overall Study|Other|0|||
160505844|NCT01499303|579580237|FG001|Overall Study|Other|1|||
160505845|NCT00461981|579580238|FG000|Overall Study|Lost to Follow-up|9|||
160505846|NCT00461981|579580239|FG001|Overall Study|Lost to Follow-up|6|||
160505847|NCT00461981|579580238|FG000|Overall Study|Withdrawal by Subject|2|||
160505848|NCT00461981|579580239|FG001|Overall Study|Withdrawal by Subject|3|||
160505849|NCT01240915|579580244|FG000|Overall Study|Adverse Event|0|||
160505850|NCT01240915|579580245|FG001|Overall Study|Adverse Event|0|||
160505851|NCT01240915|579580246|FG002|Overall Study|Adverse Event|0|||
160505852|NCT01240915|579580247|FG003|Overall Study|Adverse Event|1|||
160505853|NCT01240915|579580248|FG004|Overall Study|Adverse Event|0|||
160505854|NCT01240915|579580249|FG005|Overall Study|Adverse Event|2|||
160505855|NCT01240915|579580250|FG006|Overall Study|Adverse Event|0|||
160505856|NCT01240915|579580251|FG007|Overall Study|Adverse Event|0|||
160505857|NCT01240915|579580252|FG008|Overall Study|Adverse Event|1|||
160505858|NCT01240915|579580244|FG000|Overall Study|Lost to Follow-up|0|||
160505859|NCT01240915|579580245|FG001|Overall Study|Lost to Follow-up|0|||
160620192|NCT04594213|579988435|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
160505860|NCT01240915|579580246|FG002|Overall Study|Lost to Follow-up|0|||
160505861|NCT01240915|579580247|FG003|Overall Study|Lost to Follow-up|0|||
160505862|NCT01240915|579580248|FG004|Overall Study|Lost to Follow-up|1|||
160505863|NCT01240915|579580249|FG005|Overall Study|Lost to Follow-up|1|||
160505864|NCT01240915|579580250|FG006|Overall Study|Lost to Follow-up|0|||
160505865|NCT01240915|579580251|FG007|Overall Study|Lost to Follow-up|1|||
160505866|NCT01240915|579580252|FG008|Overall Study|Lost to Follow-up|1|||
160505867|NCT01240915|579580244|FG000|Overall Study|Withdrawal by Subject|2|||
160505868|NCT01240915|579580245|FG001|Overall Study|Withdrawal by Subject|1|||
160505869|NCT01240915|579580246|FG002|Overall Study|Withdrawal by Subject|0|||
160505870|NCT01240915|579580247|FG003|Overall Study|Withdrawal by Subject|2|||
160505871|NCT01240915|579580248|FG004|Overall Study|Withdrawal by Subject|0|||
160505872|NCT01240915|579580249|FG005|Overall Study|Withdrawal by Subject|4|||
160505873|NCT01240915|579580250|FG006|Overall Study|Withdrawal by Subject|2|||
160505874|NCT01240915|579580251|FG007|Overall Study|Withdrawal by Subject|3|||
160505875|NCT01240915|579580252|FG008|Overall Study|Withdrawal by Subject|3|||
160505876|NCT01240915|579580244|FG000|Overall Study|Other|0|||
160505877|NCT01240915|579580245|FG001|Overall Study|Other|0|||
160505878|NCT01240915|579580246|FG002|Overall Study|Other|0|||
160505879|NCT01240915|579580247|FG003|Overall Study|Other|0|||
160505880|NCT01240915|579580248|FG004|Overall Study|Other|2|||
160505881|NCT01240915|579580249|FG005|Overall Study|Other|0|||
160505882|NCT01240915|579580250|FG006|Overall Study|Other|0|||
160505883|NCT01240915|579580251|FG007|Overall Study|Other|0|||
160505884|NCT01240915|579580252|FG008|Overall Study|Other|0|||
160505885|NCT01240915|579580244|FG000|Overall Study|Insufficient Clinical Response|0|||
160663415|NCT01185821|580150667|FG000|Overall Study|Administrative problems|0|||
160663416|NCT01185821|580150668|FG001|Overall Study|Administrative problems|0|||
160663417|NCT01185821|580150669|FG002|Overall Study|Administrative problems|1|||
160663418|NCT01185821|580150670|FG003|Overall Study|Administrative problems|1|||
160663419|NCT01185821|580150671|FG004|Overall Study|Administrative problems|2|||
160663420|NCT00846495|580150673|FG000|Overall Study|Lost to Follow-up|1|||
160505886|NCT01240915|579580245|FG001|Overall Study|Insufficient Clinical Response|0|||
160505887|NCT01240915|579580246|FG002|Overall Study|Insufficient Clinical Response|0|||
160505888|NCT01240915|579580247|FG003|Overall Study|Insufficient Clinical Response|0|||
160505889|NCT01240915|579580248|FG004|Overall Study|Insufficient Clinical Response|1|||
160505890|NCT01240915|579580249|FG005|Overall Study|Insufficient Clinical Response|3|||
160505891|NCT01240915|579580250|FG006|Overall Study|Insufficient Clinical Response|6|||
160505892|NCT01240915|579580251|FG007|Overall Study|Insufficient Clinical Response|0|||
160505893|NCT01240915|579580252|FG008|Overall Study|Insufficient Clinical Response|3|||
160505894|NCT02574845|579580254|FG000|Overall Study|Consent withdrawn further participation|0|||
160505895|NCT02574845|579580255|FG001|Overall Study|Consent withdrawn further participation|0|||
160505896|NCT02574845|579580256|FG002|Overall Study|Consent withdrawn further participation|0|||
160505897|NCT02574845|579580257|FG003|Overall Study|Consent withdrawn further participation|0|||
160505898|NCT02574845|579580258|FG004|Overall Study|Consent withdrawn further participation|1|||
160505899|NCT02574845|579580259|FG005|Overall Study|Consent withdrawn further participation|0|||
160505900|NCT02574845|579580254|FG000|Overall Study|Adverse Event|0|||
160505901|NCT02574845|579580255|FG001|Overall Study|Adverse Event|1|||
160505902|NCT02574845|579580256|FG002|Overall Study|Adverse Event|0|||
160505903|NCT02574845|579580257|FG003|Overall Study|Adverse Event|0|||
160505904|NCT02574845|579580258|FG004|Overall Study|Adverse Event|0|||
160505905|NCT02574845|579580259|FG005|Overall Study|Adverse Event|1|||
160505906|NCT01867333|579580262|FG000|Overall Study|Withdrawal by Subject|1|||
160505907|NCT01867333|579580263|FG001|Overall Study|Withdrawal by Subject|0|||
160505908|NCT01867333|579580262|FG000|Overall Study|Adverse Event|1|||
160505909|NCT01867333|579580263|FG001|Overall Study|Adverse Event|0|||
160505910|NCT01867333|579580262|FG000|Overall Study|Participant choice|1|||
160505911|NCT01867333|579580263|FG001|Overall Study|Participant choice|2|||
160505912|NCT01867333|579580262|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
160505913|NCT01867333|579580263|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
160505914|NCT01867333|579580262|FG000|Overall Study|Death|0|||
160505915|NCT01867333|579580263|FG001|Overall Study|Death|1|||
160505916|NCT01867333|579580262|FG000|Overall Study|Physician Decision|3|||
160505917|NCT01867333|579580263|FG001|Overall Study|Physician Decision|2|||
160505918|NCT01867333|579580262|FG000|Overall Study|Switched to alternative treatment|1|||
160505919|NCT01867333|579580263|FG001|Overall Study|Switched to alternative treatment|0|||
160505920|NCT01145898|579580264|FG000|3-year Treatment|medication change by treating physician|3|||
160505921|NCT01145898|579580265|FG001|3-year Treatment|medication change by treating physician|16|||
160505922|NCT00879775|579580266|FG000|Overall Study|Lost to Follow-up|2|||
160505923|NCT00879775|579580267|FG001|Overall Study|Lost to Follow-up|1|||
160505924|NCT02440425|579580268|FG000|Overall Study|Death likely due to disease progression|1|||
160505925|NCT02440425|579580268|FG000|Overall Study|Withdrawal by Subject|2|||
160505926|NCT02440425|579580268|FG000|Overall Study|Adverse Event|1|||
160505927|NCT02440425|579580268|FG000|Overall Study|Adverse Event/Ineligible|1|||
160505928|NCT03101462|579580269|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
160505929|NCT03101462|579580270|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
160505930|NCT01669577|579580273|FG000|Overall Study|Death|22|||
160505931|NCT01669577|579580273|FG000|Overall Study|Lost to Follow-up|78|||
160505932|NCT01669577|579580273|FG000|Overall Study|Physician Decision|34|||
160505933|NCT02833077|579580276|FG000|Overall Study|Adverse Event|1|||
160505934|NCT02833077|579580277|FG001|Overall Study|Adverse Event|2|||
160505935|NCT02833077|579580276|FG000|Overall Study|Lost to Follow-up|10|||
160505936|NCT02833077|579580277|FG001|Overall Study|Lost to Follow-up|1|||
160505937|NCT02833077|579580276|FG000|Overall Study|Personal Reasons|6|||
160505938|NCT02833077|579580277|FG001|Overall Study|Personal Reasons|4|||
160505939|NCT02833077|579580276|FG000|Overall Study|Protocol Deviation|0|||
160505940|NCT02833077|579580277|FG001|Overall Study|Protocol Deviation|1|||
160505941|NCT04608773|579580278|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
160505942|NCT04608773|579580279|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
160505943|NCT04608773|579580278|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
160505944|NCT04608773|579580279|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
160505945|NCT04608773|579580278|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
160505946|NCT04608773|579580279|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
160505947|NCT04608773|579580278|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
160505948|NCT04608773|579580279|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
160505949|NCT04608773|579580278|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
160620193|NCT04594213|579988430|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
160505950|NCT04608773|579580279|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
160505951|NCT01077518|579580282|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
160505952|NCT01077518|579580283|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
160505953|NCT01077518|579580284|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
160505954|NCT01077518|579580282|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
160505955|NCT01077518|579580283|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
160505956|NCT01077518|579580284|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
160505957|NCT01077518|579580282|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
160505958|NCT01077518|579580283|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
160505959|NCT01077518|579580284|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
160505960|NCT01077518|579580282|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
160505961|NCT01077518|579580283|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
160505962|NCT01077518|579580284|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
160505963|NCT01077518|579580282|FG000|Optional Ofa Phase|Physician Decision|0|||
160505964|NCT01077518|579580283|FG001|Optional Ofa Phase|Physician Decision|0|||
160505965|NCT01077518|579580284|FG002|Optional Ofa Phase|Physician Decision|1|||
160505966|NCT01077518|579580282|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
160505967|NCT01077518|579580283|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
160505968|NCT01077518|579580284|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
160505969|NCT01077518|579580282|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
160505970|NCT01077518|579580283|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
160505971|NCT01077518|579580284|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
160505972|NCT00972322|579580285|FG000|Overall Study|Adverse Event|2|||
160505973|NCT00972322|579580286|FG001|Overall Study|Adverse Event|1|||
160505974|NCT00972322|579580285|FG000|Overall Study|Positive drug screen|0|||
160505975|NCT00972322|579580286|FG001|Overall Study|Positive drug screen|1|||
160505976|NCT00972322|579580285|FG000|Overall Study|Lost to Follow-up|0|||
160505977|NCT00972322|579580286|FG001|Overall Study|Lost to Follow-up|1|||
160505978|NCT00972322|579580285|FG000|Overall Study|Consistently high glucose values|1|||
160505979|NCT00972322|579580286|FG001|Overall Study|Consistently high glucose values|0|||
160505980|NCT04157400|579580289|FG000|Overall Study|Withdrawal by Subject|1|||
160505981|NCT04157400|579580289|FG000|Overall Study|Lost to Follow-up|3|||
160505982|NCT00623805|579580290|FG000|Overall Study|Adverse Event|9|||
160505983|NCT00623805|579580291|FG001|Overall Study|Adverse Event|6|||
160505984|NCT00623805|579580290|FG000|Overall Study|Death|2|||
160505985|NCT00623805|579580291|FG001|Overall Study|Death|0|||
160505986|NCT00623805|579580290|FG000|Overall Study|Lack of Efficacy|3|||
160505987|NCT00623805|579580291|FG001|Overall Study|Lack of Efficacy|7|||
160505988|NCT00623805|579580290|FG000|Overall Study|Lost to Follow-up|2|||
160505989|NCT00623805|579580291|FG001|Overall Study|Lost to Follow-up|2|||
160505990|NCT00623805|579580290|FG000|Overall Study|Protocol Violation|1|||
160505991|NCT00623805|579580291|FG001|Overall Study|Protocol Violation|1|||
160505992|NCT00623805|579580290|FG000|Overall Study|Reason not Specified|3|||
160505993|NCT00623805|579580291|FG001|Overall Study|Reason not Specified|6|||
160505994|NCT02671500|579580299|FG000|Overall Study|Lack of Efficacy|12|||
160505995|NCT02671500|579580299|FG000|Overall Study|Lost to Follow-up|2|||
160505996|NCT05235269|579580301|FG000|Overall Study|Adverse Event|1|||
160505997|NCT05235269|579580301|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
160505998|NCT05235269|579580301|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
160505999|NCT03810235|579580304|FG000|Overall Study|Withdrawal by Subject|2|||
160506000|NCT03810235|579580305|FG001|Overall Study|Withdrawal by Subject|0|||
160506001|NCT04201262|579580306|FG000|Primary Treatment Period|Adverse Event|1|||
160506002|NCT04201262|579580307|FG001|Primary Treatment Period|Adverse Event|2|||
160506003|NCT04201262|579580306|FG000|Primary Treatment Period|Physician Decision|1|||
160506004|NCT04201262|579580307|FG001|Primary Treatment Period|Physician Decision|1|||
160506005|NCT04201262|579580306|FG000|Long-term Extension Period|Death|1|||
160506006|NCT04201262|579580307|FG001|Long-term Extension Period|Death|0|||
160506007|NCT03682185|579580308|FG000|Overall Study|Lost to Follow-up|4|||
160506008|NCT03682185|579580309|FG001|Overall Study|Lost to Follow-up|7|||
160506009|NCT03682185|579580310|FG002|Overall Study|Lost to Follow-up|4|||
160506010|NCT03682185|579580311|FG003|Overall Study|Lost to Follow-up|7|||
160506011|NCT03682185|579580312|FG004|Overall Study|Lost to Follow-up|1|||
160506012|NCT03682185|579580308|FG000|Overall Study|Withdrawal by Subject|7|||
160506013|NCT03682185|579580309|FG001|Overall Study|Withdrawal by Subject|3|||
160506014|NCT03682185|579580310|FG002|Overall Study|Withdrawal by Subject|7|||
160506015|NCT03682185|579580311|FG003|Overall Study|Withdrawal by Subject|3|||
160506016|NCT03682185|579580312|FG004|Overall Study|Withdrawal by Subject|0|||
160506017|NCT03548220|579580314|FG000|Overall Study|Lost to Follow-up|1|||
160506018|NCT03548220|579580315|FG001|Overall Study|Lost to Follow-up|0|||
160506019|NCT03548220|579580316|FG002|Overall Study|Lost to Follow-up|0|||
160506020|NCT03548220|579580317|FG003|Overall Study|Lost to Follow-up|0|||
160506021|NCT02397447|579580318|FG000|Overall Study|Lost to Follow-up|2|||
160506022|NCT02397447|579580319|FG001|Overall Study|Lost to Follow-up|2|||
160506023|NCT06926673|579580322|FG000|Overall Study|Lost to Follow-up|0|||
160506024|NCT06926673|579580323|FG001|Overall Study|Lost to Follow-up|0|||
160506025|NCT06926673|579580324|FG002|Overall Study|Lost to Follow-up|0|||
160506026|NCT06926673|579580325|FG003|Overall Study|Lost to Follow-up|1|||
160506027|NCT06926673|579580326|FG004|Overall Study|Lost to Follow-up|0|||
160506028|NCT06926673|579580327|FG005|Overall Study|Lost to Follow-up|0|||
160506029|NCT06926673|579580328|FG006|Overall Study|Lost to Follow-up|0|||
160506030|NCT06926673|579580322|FG000|Overall Study|Physician Decision|0|||
160506031|NCT06926673|579580323|FG001|Overall Study|Physician Decision|0|||
160506032|NCT06926673|579580324|FG002|Overall Study|Physician Decision|0|||
160506033|NCT06926673|579580325|FG003|Overall Study|Physician Decision|0|||
160506034|NCT06926673|579580326|FG004|Overall Study|Physician Decision|0|||
160506035|NCT06926673|579580327|FG005|Overall Study|Physician Decision|0|||
160506036|NCT06926673|579580328|FG006|Overall Study|Physician Decision|1|||
160506037|NCT06926673|579580322|FG000|Overall Study|Withdrawal by Subject|0|||
160506038|NCT06926673|579580323|FG001|Overall Study|Withdrawal by Subject|3|||
160506039|NCT06926673|579580324|FG002|Overall Study|Withdrawal by Subject|2|||
160506040|NCT06926673|579580325|FG003|Overall Study|Withdrawal by Subject|1|||
160506041|NCT06926673|579580326|FG004|Overall Study|Withdrawal by Subject|0|||
160506042|NCT06926673|579580327|FG005|Overall Study|Withdrawal by Subject|2|||
160506043|NCT06926673|579580328|FG006|Overall Study|Withdrawal by Subject|0|||
160506044|NCT00387426|579581936|FG000|Overall Study|Lack of Response|7|||
160506045|NCT00387426|579581936|FG000|Overall Study|Toxicities|4|||
160506046|NCT00387426|579581936|FG000|Overall Study|Disease Progression|3|||
160506047|NCT04396366|579581939|FG000|Overall Study|Adverse Event|1|||
160506048|NCT04396366|579581940|FG001|Overall Study|Adverse Event|0|||
160506049|NCT01531673|579581941|FG000|Overall Study|Non-Compliance|0|||
160506050|NCT01531673|579581942|FG001|Overall Study|Non-Compliance|0|||
160506051|NCT01531673|579581943|FG002|Overall Study|Non-Compliance|0|||
160506052|NCT01531673|579581944|FG003|Overall Study|Non-Compliance|0|||
160506053|NCT01531673|579581945|FG004|Overall Study|Non-Compliance|0|||
160506054|NCT01531673|579581946|FG005|Overall Study|Non-Compliance|1|||
160506055|NCT01531673|579581947|FG006|Overall Study|Non-Compliance|0|||
160506056|NCT01531673|579581948|FG007|Overall Study|Non-Compliance|0|||
160506057|NCT01531673|579581949|FG008|Overall Study|Non-Compliance|0|||
160506058|NCT01531673|579581950|FG009|Overall Study|Non-Compliance|0|||
160506059|NCT01531673|579581951|FG010|Overall Study|Non-Compliance|0|||
160506060|NCT01531673|579581952|FG011|Overall Study|Non-Compliance|0|||
160506061|NCT01531673|579581953|FG012|Overall Study|Non-Compliance|0|||
160506062|NCT01531673|579581941|FG000|Overall Study|Adverse Event|0|||
160506063|NCT01531673|579581942|FG001|Overall Study|Adverse Event|1|||
160506064|NCT01531673|579581943|FG002|Overall Study|Adverse Event|0|||
160506065|NCT01531673|579581944|FG003|Overall Study|Adverse Event|0|||
160506066|NCT01531673|579581945|FG004|Overall Study|Adverse Event|0|||
160506067|NCT01531673|579581946|FG005|Overall Study|Adverse Event|0|||
160506068|NCT01531673|579581947|FG006|Overall Study|Adverse Event|0|||
160506069|NCT01531673|579581948|FG007|Overall Study|Adverse Event|0|||
160506070|NCT01531673|579581949|FG008|Overall Study|Adverse Event|0|||
160506071|NCT01531673|579581950|FG009|Overall Study|Adverse Event|0|||
160506072|NCT01531673|579581951|FG010|Overall Study|Adverse Event|0|||
160506073|NCT01531673|579581952|FG011|Overall Study|Adverse Event|0|||
160506074|NCT01531673|579581953|FG012|Overall Study|Adverse Event|0|||
160506075|NCT01531673|579581941|FG000|Overall Study|Lost to Follow-up|0|||
160506076|NCT01531673|579581942|FG001|Overall Study|Lost to Follow-up|0|||
160506077|NCT01531673|579581943|FG002|Overall Study|Lost to Follow-up|0|||
160506078|NCT01531673|579581944|FG003|Overall Study|Lost to Follow-up|0|||
160506079|NCT01531673|579581945|FG004|Overall Study|Lost to Follow-up|1|||
160506080|NCT01531673|579581946|FG005|Overall Study|Lost to Follow-up|0|||
160506081|NCT01531673|579581947|FG006|Overall Study|Lost to Follow-up|0|||
160506082|NCT01531673|579581948|FG007|Overall Study|Lost to Follow-up|0|||
160506083|NCT01531673|579581949|FG008|Overall Study|Lost to Follow-up|0|||
160506084|NCT01531673|579581950|FG009|Overall Study|Lost to Follow-up|0|||
160506085|NCT01531673|579581951|FG010|Overall Study|Lost to Follow-up|0|||
160506086|NCT01531673|579581952|FG011|Overall Study|Lost to Follow-up|0|||
160506087|NCT01531673|579581953|FG012|Overall Study|Lost to Follow-up|0|||
160506088|NCT01531673|579581941|FG000|Overall Study|Other|0|||
160506089|NCT01531673|579581942|FG001|Overall Study|Other|0|||
160506090|NCT01531673|579581943|FG002|Overall Study|Other|0|||
160506091|NCT01531673|579581944|FG003|Overall Study|Other|1|||
160506092|NCT01531673|579581945|FG004|Overall Study|Other|0|||
160506093|NCT01531673|579581946|FG005|Overall Study|Other|0|||
160506094|NCT01531673|579581947|FG006|Overall Study|Other|0|||
160506095|NCT01531673|579581948|FG007|Overall Study|Other|0|||
160506096|NCT01531673|579581949|FG008|Overall Study|Other|0|||
160506097|NCT01531673|579581950|FG009|Overall Study|Other|1|||
160506098|NCT01531673|579581951|FG010|Overall Study|Other|0|||
160506099|NCT01531673|579581952|FG011|Overall Study|Other|0|||
160506100|NCT01531673|579581953|FG012|Overall Study|Other|0|||
160506101|NCT02389452|579581954|FG000|Overall Study|Lost to Follow-up|13|||
160506102|NCT02389452|579581954|FG000|Overall Study|Adverse Event|1|||
160506103|NCT02389452|579581954|FG000|Overall Study|Withdrawal by Subject|5|||
160506104|NCT02389452|579581954|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
160506105|NCT01014208|579581960|FG000|Overall Study|Lost to Follow-up|2|||
160506106|NCT01014208|579581961|FG001|Overall Study|Lost to Follow-up|5|||
160506107|NCT01014208|579581960|FG000|Overall Study|Participant Withdrew Consent|12|||
160506108|NCT01014208|579581961|FG001|Overall Study|Participant Withdrew Consent|12|||
160506109|NCT01014208|579581960|FG000|Overall Study|Did Not Receive Study Drug|2|||
160506110|NCT01014208|579581961|FG001|Overall Study|Did Not Receive Study Drug|0|||
160506111|NCT01014208|579581960|FG000|Overall Study|Study Closed/terminated|78|||
160506112|NCT01014208|579581961|FG001|Overall Study|Study Closed/terminated|83|||
160506113|NCT03563157|579581962|FG000|Overall Study|Progressive Disease|2|||
160506114|NCT02787044|579581965|FG000|Overall Study|Lost to Follow-up|15|||
160506115|NCT02787044|579581966|FG001|Overall Study|Lost to Follow-up|19|||
160506116|NCT00567567|579581967|FG000|Overall Study|Adverse Event|0|||
160506117|NCT00567567|579581968|FG001|Overall Study|Adverse Event|2|||
160506118|NCT00567567|579581969|FG002|Overall Study|Adverse Event|5|||
160506119|NCT00567567|579581967|FG000|Overall Study|Death|8|||
160506120|NCT00567567|579581968|FG001|Overall Study|Death|1|||
160506121|NCT00567567|579581969|FG002|Overall Study|Death|5|||
160506122|NCT00567567|579581967|FG000|Overall Study|Lack of Efficacy|16|||
160506123|NCT00567567|579581968|FG001|Overall Study|Lack of Efficacy|17|||
160506124|NCT00567567|579581969|FG002|Overall Study|Lack of Efficacy|48|||
160506125|NCT00567567|579581967|FG000|Overall Study|Lost to Follow-up|0|||
160506126|NCT00567567|579581968|FG001|Overall Study|Lost to Follow-up|0|||
160506127|NCT00567567|579581969|FG002|Overall Study|Lost to Follow-up|1|||
160506128|NCT00567567|579581967|FG000|Overall Study|Physician Decision|16|||
160506129|NCT00567567|579581968|FG001|Overall Study|Physician Decision|18|||
160506130|NCT00567567|579581969|FG002|Overall Study|Physician Decision|84|||
160506131|NCT00567567|579581967|FG000|Overall Study|Withdrawal by Subject|0|||
160506132|NCT00567567|579581968|FG001|Overall Study|Withdrawal by Subject|0|||
160506133|NCT00567567|579581969|FG002|Overall Study|Withdrawal by Subject|2|||
160506134|NCT00567567|579581967|FG000|Overall Study|Ineligible|4|||
160506135|NCT00567567|579581968|FG001|Overall Study|Ineligible|0|||
160506136|NCT00567567|579581969|FG002|Overall Study|Ineligible|9|||
160506137|NCT00567567|579581967|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
160506138|NCT00567567|579581968|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
160506139|NCT00567567|579581969|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
160506140|NCT00567567|579581967|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
160506141|NCT00567567|579581968|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
160506142|NCT00567567|579581969|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
160506143|NCT00567567|579581967|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
160506144|NCT00567567|579581968|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
160506145|NCT00567567|579581969|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
160506146|NCT03433677|579581970|FG000|Period 1|Protocol Violation|1|||
160506147|NCT03433677|579581971|FG001|Period 1|Protocol Violation|0|||
160506148|NCT03433677|579581970|FG000|Period 2|Withdrawal by Subject|1|||
160506149|NCT03433677|579581971|FG001|Period 2|Withdrawal by Subject|1|||
160506150|NCT03330405|579581972|FG000|Overall Study|Other|1|||
160506151|NCT03330405|579581973|FG001|Overall Study|Other|3|||
160506152|NCT03330405|579581974|FG002|Overall Study|Other|1|||
160506153|NCT03330405|579581975|FG003|Overall Study|Other|0|||
160506154|NCT03330405|579581976|FG004|Overall Study|Other|2|||
160506155|NCT03330405|579581977|FG005|Overall Study|Other|0|||
160506156|NCT03330405|579581978|FG006|Overall Study|Other|1|||
160506157|NCT03330405|579581979|FG007|Overall Study|Other|0|||
160506158|NCT03330405|579581980|FG008|Overall Study|Other|0|||
160506159|NCT03330405|579581981|FG009|Overall Study|Other|0|||
160506160|NCT03330405|579581982|FG010|Overall Study|Other|0|||
160506161|NCT03330405|579581972|FG000|Overall Study|Progressive disease|8|||
160506162|NCT03330405|579581973|FG001|Overall Study|Progressive disease|27|||
160506163|NCT03330405|579581974|FG002|Overall Study|Progressive disease|4|||
160506164|NCT03330405|579581975|FG003|Overall Study|Progressive disease|18|||
160506165|NCT03330405|579581976|FG004|Overall Study|Progressive disease|16|||
160506166|NCT03330405|579581977|FG005|Overall Study|Progressive disease|14|||
160506167|NCT03330405|579581978|FG006|Overall Study|Progressive disease|7|||
160506168|NCT03330405|579581979|FG007|Overall Study|Progressive disease|29|||
160506169|NCT03330405|579581980|FG008|Overall Study|Progressive disease|9|||
160506170|NCT03330405|579581981|FG009|Overall Study|Progressive disease|11|||
160506171|NCT03330405|579581982|FG010|Overall Study|Progressive disease|5|||
160506172|NCT03330405|579581972|FG000|Overall Study|Withdrawal by Subject|1|||
160620194|NCT04594213|579988431|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160620195|NCT04594213|579988432|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
160620196|NCT04594213|579988433|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160620197|NCT04594213|579988434|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160620198|NCT04594213|579988435|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160620199|NCT04594213|579988430|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160620200|NCT04594213|579988431|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160506173|NCT03330405|579581973|FG001|Overall Study|Withdrawal by Subject|4|||
160506174|NCT03330405|579581974|FG002|Overall Study|Withdrawal by Subject|0|||
160506175|NCT03330405|579581975|FG003|Overall Study|Withdrawal by Subject|1|||
160506176|NCT03330405|579581976|FG004|Overall Study|Withdrawal by Subject|1|||
160506177|NCT03330405|579581977|FG005|Overall Study|Withdrawal by Subject|1|||
160506178|NCT03330405|579581978|FG006|Overall Study|Withdrawal by Subject|0|||
160506179|NCT03330405|579581979|FG007|Overall Study|Withdrawal by Subject|2|||
160506180|NCT03330405|579581980|FG008|Overall Study|Withdrawal by Subject|2|||
160506181|NCT03330405|579581981|FG009|Overall Study|Withdrawal by Subject|1|||
160506182|NCT03330405|579581982|FG010|Overall Study|Withdrawal by Subject|1|||
160506183|NCT03330405|579581972|FG000|Overall Study|Global deterioration of health status|2|||
160506184|NCT03330405|579581973|FG001|Overall Study|Global deterioration of health status|3|||
160506185|NCT03330405|579581974|FG002|Overall Study|Global deterioration of health status|0|||
160506186|NCT03330405|579581975|FG003|Overall Study|Global deterioration of health status|2|||
160506187|NCT03330405|579581976|FG004|Overall Study|Global deterioration of health status|3|||
160663421|NCT00846495|580150674|FG001|Overall Study|Lost to Follow-up|0|||
160663422|NCT00846495|580150673|FG000|Overall Study|Adverse Event|5|||
160663423|NCT00846495|580150674|FG001|Overall Study|Adverse Event|1|||
160663424|NCT00846495|580150673|FG000|Overall Study|Lack of Efficacy|1|||
160663425|NCT00846495|580150674|FG001|Overall Study|Lack of Efficacy|2|||
160663426|NCT00846495|580150673|FG000|Overall Study|Physician Decision|1|||
160663427|NCT00846495|580150674|FG001|Overall Study|Physician Decision|0|||
160663428|NCT01079988|580150675|FG000|Overall Study|Lost to Follow-up|0|||
160663429|NCT01079988|580150676|FG001|Overall Study|Lost to Follow-up|0|||
160663430|NCT01079988|580150677|FG002|Overall Study|Lost to Follow-up|0|||
160663431|NCT01079988|580150678|FG003|Overall Study|Lost to Follow-up|1|||
160663432|NCT01079988|580150679|FG004|Overall Study|Lost to Follow-up|0|||
160663433|NCT01079988|580150675|FG000|Overall Study|Lack of Efficacy|1|||
160663434|NCT01079988|580150676|FG001|Overall Study|Lack of Efficacy|0|||
160663435|NCT01079988|580150677|FG002|Overall Study|Lack of Efficacy|0|||
160663436|NCT01079988|580150678|FG003|Overall Study|Lack of Efficacy|0|||
160663437|NCT01079988|580150679|FG004|Overall Study|Lack of Efficacy|0|||
160663438|NCT01079988|580150675|FG000|Overall Study|Other|0|||
160663439|NCT01079988|580150676|FG001|Overall Study|Other|0|||
160663440|NCT01079988|580150677|FG002|Overall Study|Other|0|||
160663441|NCT01079988|580150678|FG003|Overall Study|Other|2|||
160663442|NCT01079988|580150679|FG004|Overall Study|Other|1|||
160663443|NCT01265056|580150680|FG000|Initial Study Period|Withdrawal by Subject|1|||
160506188|NCT03330405|579581977|FG005|Overall Study|Global deterioration of health status|3|||
160506189|NCT03330405|579581978|FG006|Overall Study|Global deterioration of health status|0|||
160506190|NCT03330405|579581979|FG007|Overall Study|Global deterioration of health status|2|||
160506191|NCT03330405|579581980|FG008|Overall Study|Global deterioration of health status|8|||
160506192|NCT03330405|579581981|FG009|Overall Study|Global deterioration of health status|4|||
160506193|NCT03330405|579581982|FG010|Overall Study|Global deterioration of health status|1|||
160506194|NCT03330405|579581972|FG000|Overall Study|Adverse Event|0|||
160506195|NCT03330405|579581973|FG001|Overall Study|Adverse Event|1|||
160506196|NCT03330405|579581974|FG002|Overall Study|Adverse Event|0|||
160506197|NCT03330405|579581975|FG003|Overall Study|Adverse Event|1|||
160506198|NCT03330405|579581976|FG004|Overall Study|Adverse Event|1|||
160506199|NCT03330405|579581977|FG005|Overall Study|Adverse Event|1|||
160506200|NCT03330405|579581978|FG006|Overall Study|Adverse Event|3|||
160663444|NCT01265056|580150681|FG001|Initial Study Period|Withdrawal by Subject|1|||
160663445|NCT01265056|580150680|FG000|Initial Study Period|Withdrawal by Subject|1|||
160663446|NCT01265056|580150681|FG001|Initial Study Period|Withdrawal by Subject|1|||
160663447|NCT01265056|580150680|FG000|Follow up|Lost to Follow-up|7|||
160663448|NCT01265056|580150681|FG001|Follow up|Lost to Follow-up|3|||
160663449|NCT02711852|580150683|FG000|Overall Study|Death|5|||
160663450|NCT02711852|580150683|FG000|Overall Study|Lost to Follow-up|1|||
160663451|NCT02711852|580150683|FG000|Overall Study|Completed follow-up|3|||
160663452|NCT02711852|580150683|FG000|Overall Study|Withdrawal by Subject|1|||
160663453|NCT01417078|580150687|FG000|Overall Study|Withdrawal by Subject|1|||
160506201|NCT03330405|579581979|FG007|Overall Study|Adverse Event|4|||
160506202|NCT03330405|579581980|FG008|Overall Study|Adverse Event|2|||
160506203|NCT03330405|579581981|FG009|Overall Study|Adverse Event|2|||
160506204|NCT03330405|579581982|FG010|Overall Study|Adverse Event|2|||
160506205|NCT03330405|579581972|FG000|Overall Study|Death|0|||
160506206|NCT03330405|579581973|FG001|Overall Study|Death|4|||
160506207|NCT03330405|579581974|FG002|Overall Study|Death|0|||
160506208|NCT03330405|579581975|FG003|Overall Study|Death|0|||
160506209|NCT03330405|579581976|FG004|Overall Study|Death|0|||
160506210|NCT03330405|579581977|FG005|Overall Study|Death|1|||
160506211|NCT03330405|579581978|FG006|Overall Study|Death|0|||
160506212|NCT03330405|579581979|FG007|Overall Study|Death|2|||
160506213|NCT03330405|579581980|FG008|Overall Study|Death|0|||
160506214|NCT03330405|579581981|FG009|Overall Study|Death|0|||
160506215|NCT03330405|579581982|FG010|Overall Study|Death|0|||
160506216|NCT03330405|579581972|FG000|Overall Study|Physician Decision|0|||
160506217|NCT03330405|579581973|FG001|Overall Study|Physician Decision|0|||
160506218|NCT03330405|579581974|FG002|Overall Study|Physician Decision|0|||
160663454|NCT03031847|580150688|FG000|Overall Study|Death|1|||
160663455|NCT03031847|580150689|FG001|Overall Study|Death|1|||
160663456|NCT03031847|580150690|FG002|Overall Study|Death|2|||
160663457|NCT03031847|580150691|FG003|Overall Study|Death|3|||
160663458|NCT03031847|580150688|FG000|Overall Study|Lost to Follow-up|1|||
160663459|NCT03031847|580150689|FG001|Overall Study|Lost to Follow-up|1|||
160663460|NCT03031847|580150690|FG002|Overall Study|Lost to Follow-up|2|||
160506219|NCT03330405|579581975|FG003|Overall Study|Physician Decision|0|||
160506220|NCT03330405|579581976|FG004|Overall Study|Physician Decision|0|||
160506221|NCT03330405|579581977|FG005|Overall Study|Physician Decision|0|||
160663461|NCT03031847|580150691|FG003|Overall Study|Lost to Follow-up|3|||
160506222|NCT03330405|579581978|FG006|Overall Study|Physician Decision|0|||
160663462|NCT02612337|580150694|FG000|Overall Study|Lack of Efficacy|1|||
160663463|NCT02612337|580150695|FG001|Overall Study|Lack of Efficacy|0|||
160506223|NCT03330405|579581979|FG007|Overall Study|Physician Decision|1|||
160506224|NCT03330405|579581980|FG008|Overall Study|Physician Decision|0|||
160506225|NCT03330405|579581981|FG009|Overall Study|Physician Decision|0|||
160506226|NCT03330405|579581982|FG010|Overall Study|Physician Decision|0|||
160506227|NCT03889704|579581984|FG000|Overall Study|Study terminated due to pandemic|1|||
160506228|NCT01896557|579581991|FG000|Clopidogrel Alone|Adverse Event|1|||
160506229|NCT01896557|579581992|FG001|Clopidogrel Alone|Adverse Event|0|||
160506230|NCT01896557|579581991|FG000|Clopidogrel + GI Protector|low adherence|1|||
160506231|NCT01896557|579581992|FG001|Clopidogrel + GI Protector|low adherence|1|||
160506232|NCT01896557|579581991|FG000|Clopidogrel + GI Protector|Reading error|1|||
160506233|NCT01896557|579581992|FG001|Clopidogrel + GI Protector|Reading error|3|||
160506234|NCT02383940|579581993|FG000|Overall Study|Adverse Event|1|||
160506235|NCT02383940|579581994|FG001|Overall Study|Adverse Event|0|||
160506236|NCT02383940|579581993|FG000|Overall Study|Lost to Follow-up|2|||
160506237|NCT02383940|579581994|FG001|Overall Study|Lost to Follow-up|2|||
160506238|NCT02383940|579581993|FG000|Overall Study|Physician Decision|2|||
160506239|NCT02383940|579581994|FG001|Overall Study|Physician Decision|0|||
160506240|NCT02383940|579581993|FG000|Overall Study|Withdrawal by Subject|1|||
160506241|NCT02383940|579581994|FG001|Overall Study|Withdrawal by Subject|1|||
160506242|NCT02383940|579581993|FG000|Overall Study|Randomized but not treated|2|||
160506243|NCT02383940|579581994|FG001|Overall Study|Randomized but not treated|0|||
160506244|NCT02383940|579581993|FG000|Overall Study|Other than specified above|1|||
160506245|NCT02383940|579581994|FG001|Overall Study|Other than specified above|0|||
160506246|NCT01517295|579581995|FG000|Overall Study|Physician Decision|1|||
160506247|NCT01517295|579581996|FG001|Overall Study|Physician Decision|0|||
160506248|NCT00565773|579581997|FG000|Overall Study|Withdrawal by Subject|1|||
160506249|NCT00565773|579581997|FG000|Overall Study|Physician Decision|1|||
160506250|NCT03853551|579581998|FG000|Overall Study|Death|2|||
160506251|NCT03853551|579581998|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
160506252|NCT01923467|579581999|FG000|Overall Study|Lost to Follow-up|62|||
160506253|NCT01923467|579581999|FG000|Overall Study|Subject non-interest|479|||
160506254|NCT01075958|579582000|FG000|Overall Study|Blood sample could not be obtained|44|||
160506255|NCT01696045|579582005|FG000|Overall Study|Study drug toxicity|1|||
160506256|NCT01696045|579582006|FG001|Overall Study|Study drug toxicity|5|||
160506257|NCT01696045|579582005|FG000|Overall Study|Disease progression|2|||
160506258|NCT01696045|579582006|FG001|Overall Study|Disease progression|2|||
160506259|NCT01559129|579582007|FG000|Treatment Phase|Adverse Event|0|||
160506260|NCT01559129|579582008|FG001|Treatment Phase|Adverse Event|2|||
160506261|NCT01559129|579582007|FG000|Treatment Phase|Progressive Disease|1|||
160506262|NCT01559129|579582008|FG001|Treatment Phase|Progressive Disease|1|||
160506263|NCT01559129|579582007|FG000|Treatment Phase|Lack of Efficacy|0|||
160506264|NCT01559129|579582008|FG001|Treatment Phase|Lack of Efficacy|1|||
160506265|NCT01559129|579582007|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
160506266|NCT01559129|579582008|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
160506267|NCT01559129|579582007|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
160506268|NCT01559129|579582008|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
160506269|NCT01559129|579582007|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
160506270|NCT01559129|579582008|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
160506271|NCT01559129|579582007|FG000|Open-label Extension Period|Adverse Event|1|||
160506272|NCT01559129|579582008|FG001|Open-label Extension Period|Adverse Event|0|||
160506273|NCT01559129|579582007|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
160506274|NCT01559129|579582008|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
160506275|NCT03525392|579582009|FG000|Overall Study|Adverse Event|1|||
160506276|NCT03525392|579582010|FG001|Overall Study|Adverse Event|0|||
160506277|NCT03525392|579582011|FG002|Overall Study|Adverse Event|2|||
160506278|NCT03525392|579582012|FG003|Overall Study|Adverse Event|0|||
160506279|NCT03525392|579582013|FG004|Overall Study|Adverse Event|0|||
160506280|NCT03525392|579582009|FG000|Overall Study|Progressive disease|0|||
160506281|NCT03525392|579582010|FG001|Overall Study|Progressive disease|1|||
160506282|NCT03525392|579582011|FG002|Overall Study|Progressive disease|1|||
160506283|NCT03525392|579582012|FG003|Overall Study|Progressive disease|3|||
160506284|NCT03525392|579582013|FG004|Overall Study|Progressive disease|1|||
160506285|NCT00831129|579582016|FG000|Overall Study|Adverse Event|0|||
160506286|NCT00831129|579582017|FG001|Overall Study|Adverse Event|1|||
160506287|NCT00831129|579582016|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
160620201|NCT04594213|579988432|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160620202|NCT04594213|579988433|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160620203|NCT04594213|579988434|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
160506288|NCT00831129|579582017|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
160506289|NCT04462289|579582020|FG000|Overall Study|Lost to Follow-up|4|||
160506290|NCT04462289|579582021|FG001|Overall Study|Lost to Follow-up|5|||
160506291|NCT04462289|579582020|FG000|Overall Study|Death|0|||
160506292|NCT04462289|579582021|FG001|Overall Study|Death|3|||
160506293|NCT04462289|579582020|FG000|Overall Study|Withdrawal by Subject|1|||
160506294|NCT04462289|579582021|FG001|Overall Study|Withdrawal by Subject|3|||
160506295|NCT00818779|579582022|FG000|Overall Study|Protocol Violation|1|||
160620204|NCT04594213|579988435|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160506296|NCT00818779|579582023|FG001|Overall Study|Protocol Violation|0|||
160506297|NCT00818779|579582022|FG000|Overall Study|Lost to Follow-up|1|||
160506298|NCT00818779|579582023|FG001|Overall Study|Lost to Follow-up|0|||
160506299|NCT00818779|579582022|FG000|Overall Study|Adverse Event|4|||
160506300|NCT00818779|579582023|FG001|Overall Study|Adverse Event|1|||
160506301|NCT01518153|579582024|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
160506302|NCT01518153|579582025|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
160506303|NCT01518153|579582026|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
160506304|NCT01518153|579582024|FG000|Stem Cell Transplant|Death|2|||
160506305|NCT01518153|579582025|FG001|Stem Cell Transplant|Death|0|||
160506306|NCT01518153|579582026|FG002|Stem Cell Transplant|Death|0|||
160506307|NCT01518153|579582024|FG000|Stem Cell Transplant|Secondary graft failure|1|||
160506308|NCT01518153|579582025|FG001|Stem Cell Transplant|Secondary graft failure|0|||
160506309|NCT01518153|579582026|FG002|Stem Cell Transplant|Secondary graft failure|0|||
160506310|NCT01518153|579582024|FG000|Stem Cell Transplant|Adverse Event|1|||
160506311|NCT01518153|579582025|FG001|Stem Cell Transplant|Adverse Event|0|||
160506312|NCT01518153|579582026|FG002|Stem Cell Transplant|Adverse Event|0|||
160506313|NCT01518153|579582024|FG000|Donor Lymphocyte Infusion|Death|0|||
160506314|NCT01518153|579582025|FG001|Donor Lymphocyte Infusion|Death|2|||
160506315|NCT01518153|579582026|FG002|Donor Lymphocyte Infusion|Death|1|||
160506316|NCT00132873|579582027|FG000|Overall Study|Adverse Event|3|||
160506317|NCT00132873|579582027|FG000|Overall Study|Lost to Follow-up|1|||
160506318|NCT00132873|579582027|FG000|Overall Study|Lack of Efficacy|1|||
160506319|NCT00132873|579582027|FG000|Overall Study|Withdrawal by Subject|3|||
160506320|NCT00132873|579582027|FG000|Overall Study|Planned Pregnancy|1|||
160506321|NCT04276415|579582028|FG000|Overall Study|Adverse Event|0|||
160506322|NCT04276415|579582029|FG001|Overall Study|Adverse Event|0|||
160506323|NCT04276415|579582030|FG002|Overall Study|Adverse Event|0|||
160506324|NCT04276415|579582031|FG003|Overall Study|Adverse Event|3|||
160506325|NCT04276415|579582032|FG004|Overall Study|Adverse Event|0|||
160506326|NCT04276415|579582033|FG005|Overall Study|Adverse Event|0|||
160506327|NCT04276415|579582028|FG000|Overall Study|Clinical progression|1|||
160506328|NCT04276415|579582029|FG001|Overall Study|Clinical progression|1|||
160506329|NCT04276415|579582030|FG002|Overall Study|Clinical progression|0|||
160506330|NCT04276415|579582031|FG003|Overall Study|Clinical progression|0|||
160506331|NCT04276415|579582032|FG004|Overall Study|Clinical progression|1|||
160506332|NCT04276415|579582033|FG005|Overall Study|Clinical progression|0|||
160506333|NCT04276415|579582028|FG000|Overall Study|Other|0|||
160506334|NCT04276415|579582029|FG001|Overall Study|Other|0|||
160506335|NCT04276415|579582030|FG002|Overall Study|Other|0|||
160506336|NCT04276415|579582031|FG003|Overall Study|Other|1|||
160506337|NCT04276415|579582032|FG004|Overall Study|Other|0|||
160506338|NCT04276415|579582033|FG005|Overall Study|Other|0|||
160506339|NCT04276415|579582028|FG000|Overall Study|Physician Decision|0|||
160506340|NCT04276415|579582029|FG001|Overall Study|Physician Decision|0|||
160506341|NCT04276415|579582030|FG002|Overall Study|Physician Decision|1|||
160506342|NCT04276415|579582031|FG003|Overall Study|Physician Decision|3|||
160506343|NCT04276415|579582032|FG004|Overall Study|Physician Decision|2|||
160506344|NCT04276415|579582033|FG005|Overall Study|Physician Decision|0|||
160506345|NCT04276415|579582028|FG000|Overall Study|Progressive disease|3|||
160506346|NCT04276415|579582029|FG001|Overall Study|Progressive disease|3|||
160506347|NCT04276415|579582030|FG002|Overall Study|Progressive disease|4|||
160506348|NCT04276415|579582031|FG003|Overall Study|Progressive disease|5|||
160506349|NCT04276415|579582032|FG004|Overall Study|Progressive disease|1|||
160506350|NCT04276415|579582033|FG005|Overall Study|Progressive disease|2|||
160506351|NCT04276415|579582028|FG000|Overall Study|Withdrawal by patient|0|||
160506352|NCT04276415|579582029|FG001|Overall Study|Withdrawal by patient|0|||
160506353|NCT04276415|579582030|FG002|Overall Study|Withdrawal by patient|0|||
160506354|NCT04276415|579582031|FG003|Overall Study|Withdrawal by patient|1|||
160506355|NCT04276415|579582032|FG004|Overall Study|Withdrawal by patient|2|||
160506356|NCT04276415|579582033|FG005|Overall Study|Withdrawal by patient|0|||
160506357|NCT03309813|579582034|FG000|Main Randomized Study|Withdrawal by Subject|1|||
160506358|NCT03309813|579582035|FG001|Main Randomized Study|Withdrawal by Subject|0|||
160506359|NCT01327846|579582036|FG000|Core Phase|Subject decision (vital status: missing)|1|||
160506360|NCT01327846|579582037|FG001|Core Phase|Subject decision (vital status: missing)|2|||
160506361|NCT01327846|579582038|FG002|Core Phase|Subject decision (vital status: missing)|2|||
160506362|NCT01327846|579582039|FG003|Core Phase|Subject decision (vital status: missing)|1|||
160506363|NCT01327846|579582036|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
160620205|NCT04594213|579988430|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160620206|NCT04594213|579988431|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160506364|NCT01327846|579582037|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
160506365|NCT01327846|579582038|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
160506366|NCT01327846|579582039|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
160506367|NCT01327846|579582036|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
160506368|NCT01327846|579582037|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
160506369|NCT01327846|579582038|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
160506370|NCT01327846|579582039|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
160506371|NCT01327846|579582036|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
160506372|NCT01327846|579582037|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
160506373|NCT01327846|579582038|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
160506374|NCT01327846|579582039|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
160506375|NCT01327846|579582036|FG000|Core Phase|Lost to Follow-up|3|||
160506376|NCT01327846|579582037|FG001|Core Phase|Lost to Follow-up|3|||
160506377|NCT01327846|579582038|FG002|Core Phase|Lost to Follow-up|4|||
160506378|NCT01327846|579582039|FG003|Core Phase|Lost to Follow-up|5|||
160506379|NCT01327846|579582036|FG000|Extension Phase|Study terminated by sponsor|1073|||
160506380|NCT01327846|579582037|FG001|Extension Phase|Study terminated by sponsor|1124|||
160506381|NCT01327846|579582038|FG002|Extension Phase|Study terminated by sponsor|1067|||
160506382|NCT01327846|579582039|FG003|Extension Phase|Study terminated by sponsor|1660|||
160506383|NCT01327846|579582036|FG000|Extension Phase|Withdrawal by Subject|20|||
160506384|NCT01327846|579582037|FG001|Extension Phase|Withdrawal by Subject|13|||
160506385|NCT01327846|579582038|FG002|Extension Phase|Withdrawal by Subject|19|||
160506386|NCT01327846|579582039|FG003|Extension Phase|Withdrawal by Subject|37|||
160506387|NCT01327846|579582036|FG000|Extension Phase|Lost to Follow-up|4|||
160506388|NCT01327846|579582037|FG001|Extension Phase|Lost to Follow-up|3|||
160506389|NCT01327846|579582038|FG002|Extension Phase|Lost to Follow-up|4|||
160506390|NCT01327846|579582039|FG003|Extension Phase|Lost to Follow-up|7|||
160506391|NCT01327846|579582036|FG000|Extension Phase|Technical Problems|2|||
160506392|NCT01327846|579582037|FG001|Extension Phase|Technical Problems|4|||
160506393|NCT01327846|579582038|FG002|Extension Phase|Technical Problems|2|||
160506394|NCT01327846|579582039|FG003|Extension Phase|Technical Problems|2|||
160506395|NCT04662931|579582040|FG000|Overall Study|Withdrawal by Subject|17|||
160506396|NCT04662931|579582040|FG000|Overall Study|Death|3|||
160506397|NCT04662931|579582040|FG000|Overall Study|Lost to Follow-up|3|||
160506398|NCT04662931|579582040|FG000|Overall Study|Guardian Decision|1|||
160506399|NCT04343976|579582044|FG000|Overall Study|Withdrawal by Subject|0|||
160506400|NCT04343976|579582045|FG001|Overall Study|Withdrawal by Subject|1|||
160506401|NCT02807883|579582046|FG000|Overall Study|Withdrawal by Subject|2|||
160506402|NCT02406677|579582047|FG000|Overall Study|Death|16|||
160506403|NCT02406677|579582048|FG001|Overall Study|Death|8|||
160506404|NCT02406677|579582047|FG000|Overall Study|Discharged without P2Y12|1|||
160506405|NCT02406677|579582048|FG001|Overall Study|Discharged without P2Y12|3|||
160506406|NCT02406677|579582047|FG000|Overall Study|Discharged on prasugrel|283|||
160506407|NCT02406677|579582048|FG001|Overall Study|Discharged on prasugrel|587|||
160506408|NCT02406677|579582047|FG000|Overall Study|Withdrawal by Subject|1|||
160506409|NCT02406677|579582048|FG001|Overall Study|Withdrawal by Subject|0|||
160506410|NCT02145468|579582051|FG000|Overall Study|Withdrawal by Subject|5|||
160506411|NCT02145468|579582052|FG001|Overall Study|Withdrawal by Subject|8|||
160506412|NCT01803282|579582055|FG000|Overall Study|Progressive Disease|4|||
160506413|NCT01803282|579582056|FG001|Overall Study|Progressive Disease|3|||
160506414|NCT01803282|579582057|FG002|Overall Study|Progressive Disease|6|||
160506415|NCT01803282|579582058|FG003|Overall Study|Progressive Disease|22|||
160506416|NCT01803282|579582059|FG004|Overall Study|Progressive Disease|5|||
160506417|NCT01803282|579582060|FG005|Overall Study|Progressive Disease|8|||
160506418|NCT01803282|579582061|FG006|Overall Study|Progressive Disease|23|||
160506419|NCT01803282|579582062|FG007|Overall Study|Progressive Disease|24|||
160506420|NCT01803282|579582063|FG008|Overall Study|Progressive Disease|3|||
160506421|NCT01803282|579582064|FG009|Overall Study|Progressive Disease|29|||
160506422|NCT01803282|579582065|FG010|Overall Study|Progressive Disease|6|||
160506423|NCT01803282|579582066|FG011|Overall Study|Progressive Disease|11|||
160506424|NCT01803282|579582055|FG000|Overall Study|Death|0|||
160506425|NCT01803282|579582056|FG001|Overall Study|Death|0|||
160506426|NCT01803282|579582057|FG002|Overall Study|Death|0|||
160506427|NCT01803282|579582058|FG003|Overall Study|Death|0|||
160506428|NCT01803282|579582059|FG004|Overall Study|Death|2|||
160506429|NCT01803282|579582060|FG005|Overall Study|Death|1|||
160506430|NCT01803282|579582061|FG006|Overall Study|Death|1|||
160506431|NCT01803282|579582062|FG007|Overall Study|Death|5|||
160506432|NCT01803282|579582063|FG008|Overall Study|Death|1|||
160506433|NCT01803282|579582064|FG009|Overall Study|Death|1|||
160506434|NCT01803282|579582065|FG010|Overall Study|Death|0|||
160506435|NCT01803282|579582066|FG011|Overall Study|Death|0|||
160506436|NCT01803282|579582055|FG000|Overall Study|Withdrew Consent|0|||
160506437|NCT01803282|579582056|FG001|Overall Study|Withdrew Consent|0|||
160506438|NCT01803282|579582057|FG002|Overall Study|Withdrew Consent|0|||
160506439|NCT01803282|579582058|FG003|Overall Study|Withdrew Consent|6|||
160506440|NCT01803282|579582059|FG004|Overall Study|Withdrew Consent|1|||
160506441|NCT01803282|579582060|FG005|Overall Study|Withdrew Consent|0|||
160506442|NCT01803282|579582061|FG006|Overall Study|Withdrew Consent|8|||
160506443|NCT01803282|579582062|FG007|Overall Study|Withdrew Consent|3|||
160506444|NCT01803282|579582063|FG008|Overall Study|Withdrew Consent|1|||
160506445|NCT01803282|579582064|FG009|Overall Study|Withdrew Consent|5|||
160506446|NCT01803282|579582065|FG010|Overall Study|Withdrew Consent|0|||
160506447|NCT01803282|579582066|FG011|Overall Study|Withdrew Consent|1|||
160506448|NCT01803282|579582055|FG000|Overall Study|Investigator's Discretion|0|||
160506449|NCT01803282|579582056|FG001|Overall Study|Investigator's Discretion|0|||
160506450|NCT01803282|579582057|FG002|Overall Study|Investigator's Discretion|0|||
160506451|NCT01803282|579582058|FG003|Overall Study|Investigator's Discretion|7|||
160506452|NCT01803282|579582059|FG004|Overall Study|Investigator's Discretion|2|||
160506453|NCT01803282|579582060|FG005|Overall Study|Investigator's Discretion|1|||
160506454|NCT01803282|579582061|FG006|Overall Study|Investigator's Discretion|7|||
160506455|NCT01803282|579582062|FG007|Overall Study|Investigator's Discretion|10|||
160506456|NCT01803282|579582063|FG008|Overall Study|Investigator's Discretion|6|||
160506457|NCT01803282|579582064|FG009|Overall Study|Investigator's Discretion|7|||
160506458|NCT01803282|579582065|FG010|Overall Study|Investigator's Discretion|1|||
160506459|NCT01803282|579582066|FG011|Overall Study|Investigator's Discretion|0|||
160506460|NCT01803282|579582055|FG000|Overall Study|Adverse Event|0|||
160506461|NCT01803282|579582056|FG001|Overall Study|Adverse Event|0|||
160506462|NCT01803282|579582057|FG002|Overall Study|Adverse Event|0|||
160506463|NCT01803282|579582058|FG003|Overall Study|Adverse Event|0|||
160506464|NCT01803282|579582059|FG004|Overall Study|Adverse Event|0|||
160506465|NCT01803282|579582060|FG005|Overall Study|Adverse Event|0|||
160506466|NCT01803282|579582061|FG006|Overall Study|Adverse Event|1|||
160506467|NCT01803282|579582062|FG007|Overall Study|Adverse Event|2|||
160506468|NCT01803282|579582063|FG008|Overall Study|Adverse Event|0|||
160506469|NCT01803282|579582064|FG009|Overall Study|Adverse Event|1|||
160506470|NCT01803282|579582065|FG010|Overall Study|Adverse Event|0|||
160506471|NCT01803282|579582066|FG011|Overall Study|Adverse Event|3|||
160506472|NCT01803282|579582055|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160506473|NCT01803282|579582056|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160506474|NCT01803282|579582057|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160506475|NCT01803282|579582058|FG003|Overall Study|Non-Compliance with Study Drug|1|||
160506476|NCT01803282|579582059|FG004|Overall Study|Non-Compliance with Study Drug|0|||
160506477|NCT01803282|579582060|FG005|Overall Study|Non-Compliance with Study Drug|0|||
160506478|NCT01803282|579582061|FG006|Overall Study|Non-Compliance with Study Drug|0|||
160506479|NCT01803282|579582062|FG007|Overall Study|Non-Compliance with Study Drug|0|||
160506480|NCT01803282|579582063|FG008|Overall Study|Non-Compliance with Study Drug|0|||
160506481|NCT01803282|579582064|FG009|Overall Study|Non-Compliance with Study Drug|0|||
160506482|NCT01803282|579582065|FG010|Overall Study|Non-Compliance with Study Drug|0|||
160506483|NCT01803282|579582066|FG011|Overall Study|Non-Compliance with Study Drug|0|||
160506484|NCT01803282|579582055|FG000|Overall Study|Unknown Reason|0|||
160506485|NCT01803282|579582056|FG001|Overall Study|Unknown Reason|0|||
160506486|NCT01803282|579582057|FG002|Overall Study|Unknown Reason|0|||
160506487|NCT01803282|579582058|FG003|Overall Study|Unknown Reason|0|||
160506488|NCT01803282|579582059|FG004|Overall Study|Unknown Reason|0|||
160506489|NCT01803282|579582060|FG005|Overall Study|Unknown Reason|0|||
160506490|NCT01803282|579582061|FG006|Overall Study|Unknown Reason|0|||
160506491|NCT01803282|579582062|FG007|Overall Study|Unknown Reason|1|||
160506492|NCT01803282|579582063|FG008|Overall Study|Unknown Reason|0|||
160506493|NCT01803282|579582064|FG009|Overall Study|Unknown Reason|0|||
160506494|NCT01803282|579582065|FG010|Overall Study|Unknown Reason|0|||
160506495|NCT01803282|579582066|FG011|Overall Study|Unknown Reason|0|||
160506496|NCT01803282|579582055|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
160506497|NCT01803282|579582056|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
160506498|NCT01803282|579582057|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
160506499|NCT01803282|579582058|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
160506500|NCT01803282|579582059|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
160506501|NCT01803282|579582060|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
160506502|NCT01803282|579582061|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
160506503|NCT01803282|579582062|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
160506504|NCT01803282|579582063|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
160506505|NCT01803282|579582064|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
160506506|NCT01803282|579582065|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
160620207|NCT04594213|579988432|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160620208|NCT04594213|579988433|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
160620209|NCT04594213|579988434|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
160620210|NCT04594213|579988435|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
160620211|NCT04594213|579988430|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160506507|NCT01803282|579582066|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
160506508|NCT01803282|579582055|FG000|Overall Study|Enrolled but Never Treated|0|||
160506509|NCT01803282|579582056|FG001|Overall Study|Enrolled but Never Treated|0|||
160506510|NCT01803282|579582057|FG002|Overall Study|Enrolled but Never Treated|0|||
160506511|NCT01803282|579582058|FG003|Overall Study|Enrolled but Never Treated|0|||
160506512|NCT01803282|579582059|FG004|Overall Study|Enrolled but Never Treated|1|||
160506513|NCT01803282|579582060|FG005|Overall Study|Enrolled but Never Treated|0|||
160506514|NCT01803282|579582061|FG006|Overall Study|Enrolled but Never Treated|1|||
160506515|NCT01803282|579582062|FG007|Overall Study|Enrolled but Never Treated|1|||
160506516|NCT01803282|579582063|FG008|Overall Study|Enrolled but Never Treated|0|||
160506517|NCT01803282|579582064|FG009|Overall Study|Enrolled but Never Treated|1|||
160620212|NCT04594213|579988431|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160506518|NCT01803282|579582065|FG010|Overall Study|Enrolled but Never Treated|0|||
160506519|NCT01803282|579582066|FG011|Overall Study|Enrolled but Never Treated|0|||
160506520|NCT00798434|579582067|FG000|Double-Blind|Adverse Event|22|||
160506521|NCT00798434|579582068|FG001|Double-Blind|Adverse Event|46|||
160506522|NCT00798434|579582067|FG000|Double-Blind|Death|0|||
160506523|NCT00798434|579582068|FG001|Double-Blind|Death|1|||
160506524|NCT00798434|579582067|FG000|Double-Blind|Lost to Follow-up|1|||
160506525|NCT00798434|579582068|FG001|Double-Blind|Lost to Follow-up|0|||
160506526|NCT00798434|579582067|FG000|Double-Blind|Lack of Efficacy|8|||
160506527|NCT00798434|579582068|FG001|Double-Blind|Lack of Efficacy|12|||
160506528|NCT00798434|579582067|FG000|Double-Blind|Withdrawal by Subject|17|||
160506529|NCT00798434|579582068|FG001|Double-Blind|Withdrawal by Subject|14|||
160506530|NCT00798434|579582067|FG000|Double-Blind|Protocol Violation|1|||
160506531|NCT00798434|579582068|FG001|Double-Blind|Protocol Violation|4|||
160506532|NCT00798434|579582067|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
160506533|NCT00798434|579582068|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
160506534|NCT00798434|579582067|FG000|Double-Blind|Other|1|||
160506535|NCT00798434|579582068|FG001|Double-Blind|Other|0|||
160506536|NCT00798434|579582067|FG000|Double-Blind|Not Treated|3|||
160506537|NCT00798434|579582068|FG001|Double-Blind|Not Treated|6|||
160506538|NCT00798434|579582067|FG000|Open-Label|Adverse Event|33|||
160506539|NCT00798434|579582068|FG001|Open-Label|Adverse Event|11|||
160506540|NCT00798434|579582067|FG000|Open-Label|Lack of Efficacy|5|||
160506541|NCT00798434|579582068|FG001|Open-Label|Lack of Efficacy|11|||
160506542|NCT00798434|579582067|FG000|Open-Label|Withdrawal by Subject|2|||
160506543|NCT00798434|579582068|FG001|Open-Label|Withdrawal by Subject|7|||
160506544|NCT00798434|579582067|FG000|Open-Label|Protocol Violation|1|||
160506545|NCT00798434|579582068|FG001|Open-Label|Protocol Violation|0|||
160506546|NCT00798434|579582067|FG000|Open-Label|Other|1|||
160506547|NCT00798434|579582068|FG001|Open-Label|Other|2|||
160506548|NCT00798434|579582067|FG000|Open-Label|Not Treated|0|||
160506549|NCT00798434|579582068|FG001|Open-Label|Not Treated|1|||
160506550|NCT01217437|579582072|FG000|Overall Study|Adverse Event|0|||
160506551|NCT01217437|579582073|FG001|Overall Study|Adverse Event|8|||
160506552|NCT01217437|579582072|FG000|Overall Study|Death|5|||
160506553|NCT01217437|579582073|FG001|Overall Study|Death|0|||
160506554|NCT01217437|579582072|FG000|Overall Study|Lack of Efficacy|29|||
160506555|NCT01217437|579582073|FG001|Overall Study|Lack of Efficacy|25|||
160506556|NCT01217437|579582072|FG000|Overall Study|Physician Decision|8|||
160506557|NCT01217437|579582073|FG001|Overall Study|Physician Decision|5|||
160506558|NCT01217437|579582072|FG000|Overall Study|Withdrawal by Subject|0|||
160506559|NCT01217437|579582073|FG001|Overall Study|Withdrawal by Subject|2|||
160506560|NCT01217437|579582072|FG000|Overall Study|Ineligible|1|||
160506561|NCT01217437|579582073|FG001|Overall Study|Ineligible|1|||
160506562|NCT04908631|579582076|FG000|Overall Study|Lost to Follow-up|1|||
160506563|NCT04908631|579582076|FG000|Overall Study|Physician Decision|1|||
160506564|NCT04908631|579582076|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
160506565|NCT04500769|579583308|FG000|Overall Study|Withdrawal by Subject|5|||
160506566|NCT01967147|579583309|FG000|Overall Study|Adverse Event|5|||
160506567|NCT01967147|579583310|FG001|Overall Study|Adverse Event|2|||
160506568|NCT01967147|579583309|FG000|Overall Study|Lack of Efficacy|1|||
160506569|NCT01967147|579583310|FG001|Overall Study|Lack of Efficacy|4|||
160506570|NCT01967147|579583309|FG000|Overall Study|Lost to Follow-up|1|||
160506571|NCT01967147|579583310|FG001|Overall Study|Lost to Follow-up|2|||
160506572|NCT01967147|579583309|FG000|Overall Study|Withdrawal by Subject|2|||
160506573|NCT01967147|579583310|FG001|Overall Study|Withdrawal by Subject|4|||
160506574|NCT01967147|579583309|FG000|Overall Study|Non-compliance with Study Drug|0|||
160506575|NCT01967147|579583310|FG001|Overall Study|Non-compliance with Study Drug|3|||
160506576|NCT01967147|579583309|FG000|Overall Study|Other|4|||
160506577|NCT01967147|579583310|FG001|Overall Study|Other|5|||
160506578|NCT03843554|579583311|FG000|Overall Study|Physician Decision|0|||
160506579|NCT03843554|579583312|FG001|Overall Study|Physician Decision|2|||
160506580|NCT02218606|579583314|FG000|Overall Study|Adverse Event|1|||
160506581|NCT02218606|579583315|FG001|Overall Study|Adverse Event|1|||
160506582|NCT02218606|579583314|FG000|Overall Study|Death|15|||
160506583|NCT02218606|579583315|FG001|Overall Study|Death|28|||
160506584|NCT02218606|579583314|FG000|Overall Study|Physician Decision|0|||
160506585|NCT02218606|579583315|FG001|Overall Study|Physician Decision|1|||
160506586|NCT02218606|579583314|FG000|Overall Study|Withdrawal by Subject|4|||
160506587|NCT02218606|579583315|FG001|Overall Study|Withdrawal by Subject|0|||
160506588|NCT02218606|579583314|FG000|Overall Study|Noncompliance|1|||
160620213|NCT04594213|579988432|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160506589|NCT02218606|579583315|FG001|Overall Study|Noncompliance|0|||
160506590|NCT02218606|579583314|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
160506591|NCT02218606|579583315|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
160506592|NCT02218606|579583314|FG000|Overall Study|Other|2|||
160506593|NCT02218606|579583315|FG001|Overall Study|Other|1|||
160506594|NCT02218606|579583314|FG000|Overall Study|Never started treatment|0|||
160506595|NCT02218606|579583315|FG001|Overall Study|Never started treatment|1|||
160506596|NCT03203473|579583316|FG000|Induction Phase|Never started primary treatment|2|||
160506597|NCT03203473|579583317|FG001|Induction Phase|Never started primary treatment|0|||
160506598|NCT03203473|579583318|FG002|Induction Phase|Never started primary treatment|0|||
160506599|NCT03203473|579583316|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
160506600|NCT03203473|579583317|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
160506601|NCT03203473|579583318|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
160506602|NCT03203473|579583316|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
160506603|NCT03203473|579583317|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
160506604|NCT03203473|579583318|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
160506605|NCT03203473|579583316|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
160506606|NCT03203473|579583317|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
160506607|NCT03203473|579583318|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
160506608|NCT03203473|579583316|FG000|Arm Allocation Phase|started salvage therapy|0|||
160506609|NCT03203473|579583317|FG001|Arm Allocation Phase|started salvage therapy|5|||
160506610|NCT03203473|579583318|FG002|Arm Allocation Phase|started salvage therapy|0|||
160506611|NCT03203473|579583316|FG000|Arm Allocation Phase|Disease progression|0|||
160506612|NCT03203473|579583317|FG001|Arm Allocation Phase|Disease progression|0|||
160506613|NCT03203473|579583318|FG002|Arm Allocation Phase|Disease progression|37|||
160506614|NCT03203473|579583316|FG000|Arm Allocation Phase|Adverse Event|0|||
160506615|NCT03203473|579583317|FG001|Arm Allocation Phase|Adverse Event|0|||
160506616|NCT03203473|579583318|FG002|Arm Allocation Phase|Adverse Event|11|||
160506617|NCT03203473|579583316|FG000|Arm Allocation Phase|Physician Decision|0|||
160506618|NCT03203473|579583317|FG001|Arm Allocation Phase|Physician Decision|0|||
160506619|NCT03203473|579583318|FG002|Arm Allocation Phase|Physician Decision|3|||
160506620|NCT03203473|579583316|FG000|Arm Allocation Phase|Death|0|||
160506621|NCT03203473|579583317|FG001|Arm Allocation Phase|Death|0|||
160506622|NCT03203473|579583318|FG002|Arm Allocation Phase|Death|1|||
160506623|NCT03203473|579583316|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
160506624|NCT03203473|579583317|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
160506625|NCT03203473|579583318|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
160506626|NCT03203473|579583316|FG000|Arm Allocation Phase|Intercurrent illness|0|||
160506627|NCT03203473|579583317|FG001|Arm Allocation Phase|Intercurrent illness|0|||
160506628|NCT03203473|579583318|FG002|Arm Allocation Phase|Intercurrent illness|1|||
160506629|NCT03203473|579583316|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
160506630|NCT03203473|579583317|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
160506631|NCT03203473|579583318|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
160506632|NCT00890695|579583319|FG000|Overall Study|Protocol Violation|1|||
160506633|NCT00890695|579583320|FG001|Overall Study|Protocol Violation|0|||
160506634|NCT01008410|579583325|FG000|Overall Study|Adverse Event|13|||
160506635|NCT01008410|579583326|FG001|Overall Study|Adverse Event|7|||
160506636|NCT01008410|579583325|FG000|Overall Study|Withdrawal by Subject|6|||
160506637|NCT01008410|579583326|FG001|Overall Study|Withdrawal by Subject|2|||
160506638|NCT01008410|579583325|FG000|Overall Study|Lost to Follow-up|1|||
160506639|NCT01008410|579583326|FG001|Overall Study|Lost to Follow-up|0|||
160506640|NCT01008410|579583325|FG000|Overall Study|Noncompliance|1|||
160506641|NCT01008410|579583326|FG001|Overall Study|Noncompliance|0|||
160506642|NCT01008410|579583325|FG000|Overall Study|Low Cortisol|2|||
160506643|NCT01008410|579583326|FG001|Overall Study|Low Cortisol|0|||
160506644|NCT01008410|579583325|FG000|Overall Study|Lack of Efficacy|2|||
160506645|NCT01008410|579583326|FG001|Overall Study|Lack of Efficacy|6|||
160506646|NCT01008410|579583325|FG000|Overall Study|Met Exclusion Criterion|0|||
160506647|NCT01008410|579583326|FG001|Overall Study|Met Exclusion Criterion|1|||
160506648|NCT00297427|579583329|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
160506649|NCT00297427|579583330|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
160506650|NCT00297427|579583329|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
160506651|NCT00297427|579583330|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
160506652|NCT00297427|579583329|FG000|Phase 1: Initial Intervention|Death|0|||
160506653|NCT00297427|579583330|FG001|Phase 1: Initial Intervention|Death|1|||
160506654|NCT00297427|579583329|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
160506655|NCT00297427|579583330|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
160506656|NCT00297427|579583329|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
160506657|NCT00297427|579583330|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
160506658|NCT00297427|579583329|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
160506659|NCT00297427|579583330|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
160506660|NCT00297427|579583329|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
160506661|NCT00297427|579583330|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
160506662|NCT00297427|579583329|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
160506663|NCT00297427|579583330|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
160506664|NCT01127893|579583331|FG000|Overall Study|Study Termination by the Sponsor|1|||
160506665|NCT01262677|579583332|FG000|Overall Study|Does not meet entrance criteria|0|||
160506666|NCT01262677|579583333|FG001|Overall Study|Does not meet entrance criteria|2|||
160506667|NCT01262677|579583334|FG002|Overall Study|Does not meet entrance criteria|0|||
160506668|NCT01262677|579583332|FG000|Overall Study|Insufficient clinical response|0|||
160506669|NCT01262677|579583333|FG001|Overall Study|Insufficient clinical response|0|||
160506670|NCT01262677|579583334|FG002|Overall Study|Insufficient clinical response|1|||
160506671|NCT01262677|579583332|FG000|Overall Study|Lost to Follow-up|1|||
160506672|NCT01262677|579583333|FG001|Overall Study|Lost to Follow-up|0|||
160506673|NCT01262677|579583334|FG002|Overall Study|Lost to Follow-up|2|||
160506674|NCT01262677|579583332|FG000|Overall Study|No longer willing to participate|3|||
160506675|NCT01262677|579583333|FG001|Overall Study|No longer willing to participate|3|||
160506676|NCT01262677|579583334|FG002|Overall Study|No longer willing to participate|2|||
160506677|NCT01262677|579583332|FG000|Overall Study|Reason not provided|2|||
160506678|NCT01262677|579583333|FG001|Overall Study|Reason not provided|1|||
160506679|NCT01262677|579583334|FG002|Overall Study|Reason not provided|3|||
160506680|NCT01262677|579583332|FG000|Overall Study|Protocol Violation|0|||
160506681|NCT01262677|579583333|FG001|Overall Study|Protocol Violation|1|||
160506682|NCT01262677|579583334|FG002|Overall Study|Protocol Violation|1|||
160506683|NCT01262677|579583332|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
160506684|NCT01262677|579583333|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
160506685|NCT01262677|579583334|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
160506686|NCT01638429|579583337|FG000|Overall Study|Withdrawal by Subject|1|||
160506687|NCT04552899|579583338|FG000|Overall Study|Adverse Event|4|||
160506688|NCT04552899|579583339|FG001|Overall Study|Adverse Event|3|||
160506689|NCT04552899|579583338|FG000|Overall Study|Death|4|||
160506690|NCT04552899|579583339|FG001|Overall Study|Death|4|||
160506691|NCT04552899|579583338|FG000|Overall Study|Lost to Follow-up|8|||
160506692|NCT04552899|579583339|FG001|Overall Study|Lost to Follow-up|13|||
160506693|NCT04552899|579583338|FG000|Overall Study|Lung Transplant|4|||
160506694|NCT04552899|579583339|FG001|Overall Study|Lung Transplant|3|||
160506695|NCT04552899|579583338|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
160506696|NCT04552899|579583339|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
160506697|NCT04552899|579583338|FG000|Overall Study|Physician Decision|3|||
160506698|NCT04552899|579583339|FG001|Overall Study|Physician Decision|4|||
160506699|NCT04552899|579583338|FG000|Overall Study|Study Terminated By Sponsor|237|||
160506700|NCT04552899|579583339|FG001|Overall Study|Study Terminated By Sponsor|239|||
160506701|NCT04552899|579583338|FG000|Overall Study|Withdrawal by Subject|15|||
160506702|NCT04552899|579583339|FG001|Overall Study|Withdrawal by Subject|17|||
160506703|NCT02591953|579583340|FG000|Overall Study|Lost to Follow-up|6|||
160506704|NCT02591953|579583341|FG001|Overall Study|Lost to Follow-up|6|||
160506705|NCT02060370|579583342|FG000|Overall Study|Physician Decision|1|||
160506706|NCT00743431|579583352|FG000|Overall Study|Toxicity|6|||
160506707|NCT00743431|579583352|FG000|Overall Study|Tumor progression|56|||
160506708|NCT00743431|579583352|FG000|Overall Study|Withdrawal by Subject|13|||
160506709|NCT00743431|579583352|FG000|Overall Study|Death|9|||
160506710|NCT00743431|579583352|FG000|Overall Study|Reason for discontinuation not specified|29|||
160506711|NCT00743431|579583352|FG000|Overall Study|No documentation available|13|||
160506712|NCT03291288|579583353|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
160506713|NCT03291288|579583354|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
160506714|NCT03291288|579583353|FG000|Drug-drug Interaction Phase|Disease progression|1|||
160506715|NCT03291288|579583354|FG001|Drug-drug Interaction Phase|Disease progression|0|||
160506716|NCT03291288|579583353|FG000|Drug-drug Interaction Phase|Other|3|||
160506717|NCT03291288|579583354|FG001|Drug-drug Interaction Phase|Other|0|||
160506718|NCT03291288|579583353|FG000|Pexidartinib Only|Ongoing|0|||
160506719|NCT03291288|579583354|FG001|Pexidartinib Only|Ongoing|2|||
160506720|NCT04978493|579583355|FG000|Overall Study|No reason available|0|||
160506721|NCT04978493|579583356|FG001|Overall Study|No reason available|1|||
160506722|NCT04978493|579583355|FG000|Overall Study|Adverse Event|1|||
160506723|NCT04978493|579583356|FG001|Overall Study|Adverse Event|0|||
160506724|NCT01896726|579583357|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
160506725|NCT01896726|579583357|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
160506726|NCT01128114|579583358|FG000|Overall Study|Treatment Withdrawn|6|||
160506727|NCT01128114|579583358|FG000|Overall Study|Screening Failed|2|||
160506728|NCT00208325|579583359|FG000|Overall Study|Death|18|||
160506729|NCT00208325|579583360|FG001|Overall Study|Death|19|||
160506730|NCT00208325|579583361|FG002|Overall Study|Death|7|||
160506731|NCT00208325|579583362|FG003|Overall Study|Death|5|||
160506732|NCT00208325|579583359|FG000|Overall Study|Withdrawal by Subject|0|||
160506733|NCT00208325|579583360|FG001|Overall Study|Withdrawal by Subject|1|||
160506734|NCT00208325|579583361|FG002|Overall Study|Withdrawal by Subject|0|||
160506735|NCT00208325|579583362|FG003|Overall Study|Withdrawal by Subject|0|||
160506736|NCT00208325|579583359|FG000|Overall Study|Revision|4|||
160506737|NCT00208325|579583360|FG001|Overall Study|Revision|1|||
160506738|NCT00208325|579583361|FG002|Overall Study|Revision|0|||
160506739|NCT00208325|579583362|FG003|Overall Study|Revision|4|||
160506740|NCT00208325|579583359|FG000|Overall Study|Lost to Follow-up|1|||
160506741|NCT00208325|579583360|FG001|Overall Study|Lost to Follow-up|0|||
160506742|NCT00208325|579583361|FG002|Overall Study|Lost to Follow-up|2|||
160506743|NCT00208325|579583362|FG003|Overall Study|Lost to Follow-up|0|||
160506744|NCT00208325|579583359|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
160506745|NCT00208325|579583360|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
160506746|NCT00208325|579583361|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
160506747|NCT00208325|579583362|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
160506748|NCT00208325|579583359|FG000|Overall Study|Does not wish to Continue in Study|5|||
160506749|NCT00208325|579583360|FG001|Overall Study|Does not wish to Continue in Study|8|||
160506750|NCT00208325|579583361|FG002|Overall Study|Does not wish to Continue in Study|3|||
160506751|NCT00208325|579583362|FG003|Overall Study|Does not wish to Continue in Study|2|||
160506752|NCT00208325|579583359|FG000|Overall Study|Other|2|||
160506753|NCT00208325|579583360|FG001|Overall Study|Other|1|||
160506754|NCT00208325|579583361|FG002|Overall Study|Other|1|||
160506755|NCT00208325|579583362|FG003|Overall Study|Other|0|||
160506756|NCT00208325|579583359|FG000|Overall Study|Mis-Randomized|17|||
160506757|NCT00208325|579583360|FG001|Overall Study|Mis-Randomized|20|||
160506758|NCT00208325|579583361|FG002|Overall Study|Mis-Randomized|0|||
160506759|NCT00208325|579583362|FG003|Overall Study|Mis-Randomized|0|||
160506760|NCT01254747|579583363|FG000|Overall Study|Unacceptable subjective vision|0|||
160506761|NCT01254747|579583364|FG001|Overall Study|Unacceptable subjective vision|0|||
160506762|NCT01254747|579583365|FG002|Overall Study|Unacceptable subjective vision|0|||
160506763|NCT01254747|579583366|FG003|Overall Study|Unacceptable subjective vision|2|||
160506764|NCT01254747|579583363|FG000|Overall Study|Difficult removal handling|0|||
160506765|NCT01254747|579583364|FG001|Overall Study|Difficult removal handling|0|||
160506766|NCT01254747|579583365|FG002|Overall Study|Difficult removal handling|1|||
160506767|NCT01254747|579583366|FG003|Overall Study|Difficult removal handling|0|||
160506768|NCT01254747|579583363|FG000|Overall Study|Symptoms and problems|0|||
160506769|NCT01254747|579583364|FG001|Overall Study|Symptoms and problems|2|||
160506770|NCT01254747|579583365|FG002|Overall Study|Symptoms and problems|1|||
160506771|NCT01254747|579583366|FG003|Overall Study|Symptoms and problems|0|||
160506772|NCT01254747|579583363|FG000|Overall Study|Lost to Follow-up|0|||
160506773|NCT01254747|579583364|FG001|Overall Study|Lost to Follow-up|0|||
160506774|NCT01254747|579583365|FG002|Overall Study|Lost to Follow-up|1|||
160506775|NCT01254747|579583366|FG003|Overall Study|Lost to Follow-up|0|||
160506776|NCT01254747|579583363|FG000|Overall Study|Biomicroscopy|0|||
160506777|NCT01254747|579583364|FG001|Overall Study|Biomicroscopy|0|||
160506778|NCT01254747|579583365|FG002|Overall Study|Biomicroscopy|1|||
160506779|NCT01254747|579583366|FG003|Overall Study|Biomicroscopy|0|||
160506780|NCT01254747|579583363|FG000|Overall Study|Discomfort|0|||
160506781|NCT01254747|579583364|FG001|Overall Study|Discomfort|4|||
160506782|NCT01254747|579583365|FG002|Overall Study|Discomfort|0|||
160506783|NCT01254747|579583366|FG003|Overall Study|Discomfort|0|||
160506784|NCT04531098|579583369|FG000|Stage I|Adverse Event|0|||
160506785|NCT04531098|579583370|FG001|Stage I|Adverse Event|0|||
160506786|NCT04531098|579583371|FG002|Stage I|Adverse Event|3|||
160506787|NCT04531098|579583369|FG000|Stage I|Protocol Violation|0|||
160506788|NCT04531098|579583370|FG001|Stage I|Protocol Violation|0|||
160506789|NCT04531098|579583371|FG002|Stage I|Protocol Violation|5|||
160506790|NCT04531098|579583369|FG000|Stage I|Withdrawal by Subject|0|||
160506791|NCT04531098|579583370|FG001|Stage I|Withdrawal by Subject|5|||
160506792|NCT04531098|579583371|FG002|Stage I|Withdrawal by Subject|10|||
160506793|NCT04531098|579583369|FG000|Stage II|Adverse Event|1|||
160506794|NCT04531098|579583370|FG001|Stage II|Adverse Event|2|||
160506795|NCT04531098|579583371|FG002|Stage II|Adverse Event|0|||
160506796|NCT04531098|579583369|FG000|Stage II|Protocol Violation|1|||
160506797|NCT04531098|579583370|FG001|Stage II|Protocol Violation|2|||
160506798|NCT04531098|579583371|FG002|Stage II|Protocol Violation|0|||
160506799|NCT04531098|579583369|FG000|Stage II|Withdrawal by Subject|3|||
160506800|NCT04531098|579583370|FG001|Stage II|Withdrawal by Subject|1|||
160506801|NCT04531098|579583371|FG002|Stage II|Withdrawal by Subject|0|||
160506802|NCT04531098|579583369|FG000|Stage II|Moved from study area|8|||
160506803|NCT04531098|579583370|FG001|Stage II|Moved from study area|5|||
160506804|NCT04531098|579583371|FG002|Stage II|Moved from study area|0|||
160506805|NCT05543707|579583381|FG000|Overall Study|Study drug non-compliance/|5|||
160506806|NCT05543707|579583382|FG001|Overall Study|Study drug non-compliance/|0|||
160506807|NCT05543707|579583381|FG000|Overall Study|Withdrawal by Subject|1|||
160506808|NCT05543707|579583382|FG001|Overall Study|Withdrawal by Subject|1|||
160506809|NCT05543707|579583381|FG000|Overall Study|Adverse Event|1|||
160506810|NCT05543707|579583382|FG001|Overall Study|Adverse Event|0|||
160620214|NCT04594213|579988433|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160506811|NCT05543707|579583381|FG000|Overall Study|concurrent illness|0|||
160506812|NCT05543707|579583382|FG001|Overall Study|concurrent illness|1|||
160506813|NCT05543707|579583381|FG000|Overall Study|Pregnancy|1|||
160506814|NCT05543707|579583382|FG001|Overall Study|Pregnancy|1|||
160506815|NCT05511038|579583383|FG000|Overall|Withdrawal by Subject|5|||
160506816|NCT05511038|579583384|FG001|Overall|Withdrawal by Subject|3|||
160506817|NCT05511038|579583383|FG000|Overall|Screen Failure|20|||
160506818|NCT05511038|579583384|FG001|Overall|Screen Failure|1|||
160506819|NCT05511038|579583383|FG000|Overall|Physician Decision|3|||
160506820|NCT05511038|579583384|FG001|Overall|Physician Decision|0|||
160506821|NCT05511038|579583383|FG000|Overall|Lost to Follow-up|3|||
160506822|NCT05511038|579583384|FG001|Overall|Lost to Follow-up|0|||
160506823|NCT05511038|579583383|FG000|Overall|Death|1|||
160506824|NCT05511038|579583384|FG001|Overall|Death|0|||
160506825|NCT05511038|579583383|FG000|Screening|Withdrawal by Subject|1|||
160506826|NCT05511038|579583384|FG001|Screening|Withdrawal by Subject|0|||
160506827|NCT05511038|579583383|FG000|Screening|Lost to Follow Up (1 participant)|1|||
160506828|NCT05511038|579583384|FG001|Screening|Lost to Follow Up (1 participant)|0|||
160506829|NCT05511038|579583383|FG000|Screening|Screen Failure|3|||
160506830|NCT05511038|579583384|FG001|Screening|Screen Failure|0|||
160506831|NCT05511038|579583383|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
160506832|NCT05511038|579583384|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
160506833|NCT05511038|579583383|FG000|Treatment|Withdrawal by Subject|5|||
160506834|NCT05511038|579583384|FG001|Treatment|Withdrawal by Subject|3|||
160506835|NCT05511038|579583383|FG000|Treatment|Physician Decision|4|||
160506836|NCT05511038|579583384|FG001|Treatment|Physician Decision|0|||
160506837|NCT05511038|579583383|FG000|Treatment|Lost to Follow-up|2|||
160506838|NCT05511038|579583384|FG001|Treatment|Lost to Follow-up|0|||
160506839|NCT05511038|579583383|FG000|Treatment|Death|1|||
160506840|NCT05511038|579583384|FG001|Treatment|Death|0|||
160506841|NCT05511038|579583383|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
160506842|NCT05511038|579583384|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
160506843|NCT05511038|579583383|FG000|Treatment|Refuse by subject|1|||
160506844|NCT05511038|579583384|FG001|Treatment|Refuse by subject|0|||
160506845|NCT05511038|579583383|FG000|Treatment|Subject did not go to the site for visit|1|||
160506846|NCT05511038|579583384|FG001|Treatment|Subject did not go to the site for visit|0|||
160506847|NCT02108964|579583385|FG000|Overall Study|Progressive disease|15|||
160506848|NCT02108964|579583386|FG001|Overall Study|Progressive disease|31|||
160506849|NCT02108964|579583387|FG002|Overall Study|Progressive disease|54|||
160506850|NCT02108964|579583388|FG003|Overall Study|Progressive disease|7|||
160506851|NCT02108964|579583389|FG004|Overall Study|Progressive disease|20|||
160506852|NCT02108964|579583390|FG005|Overall Study|Progressive disease|4|||
160506853|NCT02108964|579583391|FG006|Overall Study|Progressive disease|6|||
160506854|NCT02108964|579583392|FG007|Overall Study|Progressive disease|33|||
160506855|NCT02108964|579583385|FG000|Overall Study|Physician Decision|1|||
160506856|NCT02108964|579583386|FG001|Overall Study|Physician Decision|5|||
160506857|NCT02108964|579583387|FG002|Overall Study|Physician Decision|7|||
160506858|NCT02108964|579583388|FG003|Overall Study|Physician Decision|1|||
160506859|NCT02108964|579583389|FG004|Overall Study|Physician Decision|2|||
160506860|NCT02108964|579583390|FG005|Overall Study|Physician Decision|1|||
160506861|NCT02108964|579583391|FG006|Overall Study|Physician Decision|1|||
160506862|NCT02108964|579583392|FG007|Overall Study|Physician Decision|3|||
160506863|NCT02108964|579583385|FG000|Overall Study|Adverse Event|0|||
160506864|NCT02108964|579583386|FG001|Overall Study|Adverse Event|0|||
160506865|NCT02108964|579583387|FG002|Overall Study|Adverse Event|4|||
160506866|NCT02108964|579583388|FG003|Overall Study|Adverse Event|0|||
160506867|NCT02108964|579583389|FG004|Overall Study|Adverse Event|1|||
160506868|NCT02108964|579583390|FG005|Overall Study|Adverse Event|0|||
160506869|NCT02108964|579583391|FG006|Overall Study|Adverse Event|3|||
160506870|NCT02108964|579583392|FG007|Overall Study|Adverse Event|2|||
160506871|NCT02108964|579583385|FG000|Overall Study|Death|1|||
160506872|NCT02108964|579583386|FG001|Overall Study|Death|1|||
160506873|NCT02108964|579583387|FG002|Overall Study|Death|4|||
160506874|NCT02108964|579583388|FG003|Overall Study|Death|0|||
160506875|NCT02108964|579583389|FG004|Overall Study|Death|3|||
160506876|NCT02108964|579583390|FG005|Overall Study|Death|0|||
160506877|NCT02108964|579583391|FG006|Overall Study|Death|0|||
160506878|NCT02108964|579583392|FG007|Overall Study|Death|2|||
160506879|NCT02108964|579583385|FG000|Overall Study|Subject/Guardian decision|0|||
160506880|NCT02108964|579583386|FG001|Overall Study|Subject/Guardian decision|1|||
160506881|NCT02108964|579583387|FG002|Overall Study|Subject/Guardian decision|4|||
160506882|NCT02108964|579583388|FG003|Overall Study|Subject/Guardian decision|0|||
160506883|NCT02108964|579583389|FG004|Overall Study|Subject/Guardian decision|2|||
160506884|NCT02108964|579583390|FG005|Overall Study|Subject/Guardian decision|0|||
160506885|NCT02108964|579583391|FG006|Overall Study|Subject/Guardian decision|1|||
160506886|NCT02108964|579583392|FG007|Overall Study|Subject/Guardian decision|2|||
160506887|NCT02108964|579583385|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
160506888|NCT02108964|579583386|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
160506889|NCT02108964|579583387|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
160506890|NCT02108964|579583388|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
160506891|NCT02108964|579583389|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
160506892|NCT02108964|579583390|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
160506893|NCT02108964|579583391|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
160506894|NCT02108964|579583392|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
160506895|NCT06655558|579583395|FG000|Overall Study|Protocol Violation|1|||
160620215|NCT04594213|579988434|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160506896|NCT04998812|579583399|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
160506897|NCT04998812|579583400|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
160506898|NCT04998812|579583399|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
160506899|NCT04998812|579583400|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
160506900|NCT04998812|579583399|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
160506901|NCT04998812|579583400|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
160506902|NCT04998812|579583399|FG000|Vaccination Period|Ongoing in study|23|||
160506903|NCT04998812|579583400|FG001|Vaccination Period|Ongoing in study|23|||
160506904|NCT03524092|579583406|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
160506905|NCT03524092|579583407|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
160506906|NCT03524092|579583408|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
160506907|NCT03524092|579583409|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
160506908|NCT03524092|579583410|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
160506909|NCT03524092|579583411|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
160506910|NCT03524092|579583406|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
160506911|NCT03524092|579583407|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
160506912|NCT03524092|579583408|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
160506913|NCT03524092|579583409|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
160506914|NCT03524092|579583410|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
160506915|NCT03524092|579583411|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
160506916|NCT03524092|579583406|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
160506917|NCT03524092|579583407|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
160506918|NCT03524092|579583408|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
160506919|NCT03524092|579583409|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
160506920|NCT03524092|579583410|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
160506921|NCT03524092|579583411|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
160506922|NCT03524092|579583406|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
160506923|NCT03524092|579583407|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
160506924|NCT03524092|579583408|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
160506925|NCT03524092|579583409|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
160506926|NCT03524092|579583410|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
160620216|NCT04594213|579988435|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
160620217|NCT04594213|579988430|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160620218|NCT04594213|579988431|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160620219|NCT04594213|579988432|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160620220|NCT04594213|579988433|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
160620221|NCT04594213|579988434|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160620222|NCT04594213|579988435|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160620223|NCT04594213|579988430|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
160620224|NCT04594213|579988431|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
160620225|NCT04594213|579988432|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
160620226|NCT04594213|579988433|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
160620227|NCT04594213|579988434|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
160620228|NCT04594213|579988435|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
160620229|NCT04594213|579988430|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
160620230|NCT04594213|579988431|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
160620231|NCT04594213|579988432|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
160620232|NCT04594213|579988433|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
160620233|NCT04594213|579988434|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
160620234|NCT04594213|579988435|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
160620235|NCT04594213|579988430|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
160620236|NCT04594213|579988431|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
160620237|NCT04594213|579988432|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
160620238|NCT04594213|579988433|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
160620239|NCT04594213|579988434|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
160620240|NCT04594213|579988435|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
160620241|NCT04594213|579988430|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
160620242|NCT04594213|579988431|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
160620243|NCT04594213|579988432|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
160620244|NCT04594213|579988433|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
160620245|NCT04594213|579988434|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
160620246|NCT04594213|579988435|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
160620247|NCT01980056|579988437|FG000|Overall Study|Death|1|||
160620248|NCT01980056|579988438|FG001|Overall Study|Death|1|||
160620249|NCT01980056|579988439|FG002|Overall Study|Death|0|||
160620250|NCT01707667|579988440|FG000|Period 1|expulsion of colonic sensor catheter|1|||
160506927|NCT03524092|579583411|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
160506928|NCT03524092|579583406|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
160506929|NCT03524092|579583407|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
160506930|NCT03524092|579583408|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
160506931|NCT03524092|579583409|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
160506932|NCT03524092|579583410|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
160506933|NCT03524092|579583411|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
160506934|NCT03524092|579583406|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
160506935|NCT03524092|579583407|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
160506936|NCT03524092|579583408|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
160506937|NCT03524092|579583409|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
160506938|NCT03524092|579583410|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
160506939|NCT03524092|579583411|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
160506940|NCT03524092|579583406|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
160506941|NCT03524092|579583407|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
160506942|NCT03524092|579583408|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
160506943|NCT03524092|579583409|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
160506944|NCT03524092|579583410|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
160506945|NCT03524092|579583411|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
160506946|NCT03524092|579583406|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
160506947|NCT03524092|579583407|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
160506948|NCT03524092|579583408|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
160506949|NCT03524092|579583409|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
160506950|NCT03524092|579583410|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
160506951|NCT03524092|579583411|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
160506952|NCT03524092|579583406|FG000|Loss of Response Rescue Period|Adverse Event|0|||
160506953|NCT03524092|579583407|FG001|Loss of Response Rescue Period|Adverse Event|0|||
160663464|NCT02612337|580150694|FG000|Overall Study|Withdrawal by Subject|2|||
160663465|NCT02612337|580150695|FG001|Overall Study|Withdrawal by Subject|2|||
160663466|NCT02612337|580150694|FG000|Overall Study|Did not receive study drug|0|||
160663467|NCT02612337|580150695|FG001|Overall Study|Did not receive study drug|1|||
160663468|NCT01313780|580150702|FG000|Overall Study|Lack of Efficacy|4|||
160663469|NCT01313780|580150703|FG001|Overall Study|Lack of Efficacy|2|||
160663470|NCT01313780|580150702|FG000|Overall Study|Adverse Event|6|||
160663471|NCT01313780|580150703|FG001|Overall Study|Adverse Event|11|||
160663472|NCT01313780|580150702|FG000|Overall Study|Withdrawal by Subject|2|||
160663473|NCT01313780|580150703|FG001|Overall Study|Withdrawal by Subject|8|||
160663474|NCT01313780|580150702|FG000|Overall Study|Protocol Violation|10|||
160663475|NCT01313780|580150703|FG001|Overall Study|Protocol Violation|4|||
160663476|NCT01313780|580150702|FG000|Overall Study|missing data|3|||
160506954|NCT03524092|579583408|FG002|Loss of Response Rescue Period|Adverse Event|0|||
160506955|NCT03524092|579583409|FG003|Loss of Response Rescue Period|Adverse Event|2|||
160506956|NCT03524092|579583410|FG004|Loss of Response Rescue Period|Adverse Event|0|||
160506957|NCT03524092|579583411|FG005|Loss of Response Rescue Period|Adverse Event|0|||
160506958|NCT03524092|579583406|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
160506959|NCT03524092|579583407|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
160506960|NCT03524092|579583408|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
160506961|NCT03524092|579583409|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
160506962|NCT03524092|579583410|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
160506963|NCT03524092|579583411|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
160506964|NCT03524092|579583406|FG000|Loss of Response Rescue Period|Pregnancy|0|||
160506965|NCT03524092|579583407|FG001|Loss of Response Rescue Period|Pregnancy|0|||
160506966|NCT03524092|579583408|FG002|Loss of Response Rescue Period|Pregnancy|0|||
160506967|NCT03524092|579583409|FG003|Loss of Response Rescue Period|Pregnancy|1|||
160506968|NCT03524092|579583410|FG004|Loss of Response Rescue Period|Pregnancy|0|||
160506969|NCT03524092|579583411|FG005|Loss of Response Rescue Period|Pregnancy|0|||
160506970|NCT03524092|579583406|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
160506971|NCT03524092|579583407|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
160663477|NCT01313780|580150703|FG001|Overall Study|missing data|3|||
160506972|NCT03524092|579583408|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
160506973|NCT03524092|579583409|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
160677540|NCT01567527|580198880|FG001|Conversion Phase.|Withdrawal by Subject|0|||
160677541|NCT01567527|580198881|FG002|Conversion Phase.|Withdrawal by Subject|0|||
160506974|NCT03524092|579583410|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
160506975|NCT03524092|579583411|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
160506976|NCT03524092|579583406|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
160677542|NCT01567527|580198882|FG003|Conversion Phase.|Withdrawal by Subject|0|||
160677543|NCT01567527|580198883|FG004|Conversion Phase.|Withdrawal by Subject|0|||
160677544|NCT01567527|580198879|FG000|Conversion Phase.|Lost to Follow-up|16|||
160506977|NCT03524092|579583407|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
160506978|NCT03524092|579583408|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
160506979|NCT03524092|579583409|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
160506980|NCT03524092|579583410|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
160506981|NCT03524092|579583411|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
160506982|NCT03524092|579583406|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
160506983|NCT03524092|579583407|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
160506984|NCT03524092|579583408|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
160506985|NCT03524092|579583409|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
160506986|NCT03524092|579583410|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
160506987|NCT03524092|579583411|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
160506988|NCT03524092|579583406|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
160506989|NCT03524092|579583407|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
160506990|NCT03524092|579583408|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
160506991|NCT03524092|579583409|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
160506992|NCT03524092|579583410|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
160506993|NCT03524092|579583411|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
160506994|NCT03524092|579583406|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
160506995|NCT03524092|579583407|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
160506996|NCT03524092|579583408|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
160506997|NCT03524092|579583409|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
160506998|NCT03524092|579583410|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
160506999|NCT03524092|579583411|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
160507000|NCT03524092|579583406|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
160507001|NCT03524092|579583407|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
160507002|NCT03524092|579583408|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
160507003|NCT03524092|579583409|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
160507004|NCT03524092|579583410|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
160507005|NCT03524092|579583411|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
160507006|NCT03524092|579583406|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
160507007|NCT03524092|579583407|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
160507008|NCT03524092|579583408|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
160507009|NCT03524092|579583409|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
160507010|NCT03524092|579583410|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
160507011|NCT03524092|579583411|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
160507012|NCT03524092|579583406|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
160507013|NCT03524092|579583407|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
160507014|NCT03524092|579583408|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
160507015|NCT03524092|579583409|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
160507016|NCT03524092|579583410|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
160507017|NCT03524092|579583411|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
160507018|NCT03524092|579583406|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
160507019|NCT03524092|579583407|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
160507020|NCT03524092|579583408|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
160507021|NCT03524092|579583409|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
160507022|NCT03524092|579583410|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
160507023|NCT03524092|579583411|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
160507024|NCT03524092|579583406|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
160507025|NCT03524092|579583407|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
160507026|NCT03524092|579583408|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
160507027|NCT03524092|579583409|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
160507028|NCT03524092|579583410|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
160507029|NCT03524092|579583411|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
160507030|NCT03524092|579583406|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
160507031|NCT03524092|579583407|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
160507032|NCT03524092|579583408|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
160507033|NCT03524092|579583409|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
160507034|NCT03524092|579583410|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
160507035|NCT03524092|579583411|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
160663478|NCT05472038|580152281|FG000|Overall Study|Adverse Event|0|||
160663479|NCT05472038|580152282|FG001|Overall Study|Adverse Event|0|||
160663480|NCT05472038|580152283|FG002|Overall Study|Adverse Event|1|||
160507036|NCT03524092|579583406|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
160507037|NCT03524092|579583407|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
160507038|NCT03524092|579583408|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
160507039|NCT03524092|579583409|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
160507040|NCT03524092|579583410|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
160507041|NCT03524092|579583411|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
160507042|NCT04303780|579583412|FG000|Overall Study|Death|104|||
160507043|NCT04303780|579583413|FG001|Overall Study|Death|85|||
160507044|NCT04303780|579583412|FG000|Overall Study|Lost to Follow-up|5|||
160507045|NCT04303780|579583413|FG001|Overall Study|Lost to Follow-up|2|||
160507046|NCT04303780|579583412|FG000|Overall Study|Withdrawal by Subject|12|||
160507047|NCT04303780|579583413|FG001|Overall Study|Withdrawal by Subject|39|||
160507048|NCT04303780|579583412|FG000|Overall Study|Ongoing in study|50|||
160507049|NCT04303780|579583413|FG001|Overall Study|Ongoing in study|45|||
160507050|NCT03826030|579583414|FG000|Overall Study|Withdrawal by Subject|2|||
160507051|NCT03826030|579583415|FG001|Overall Study|Withdrawal by Subject|0|||
160507052|NCT03826030|579583416|FG002|Overall Study|Withdrawal by Subject|1|||
160507053|NCT03826030|579583414|FG000|Overall Study|Lost to Follow-up|1|||
160507054|NCT03826030|579583415|FG001|Overall Study|Lost to Follow-up|1|||
160507055|NCT03826030|579583416|FG002|Overall Study|Lost to Follow-up|1|||
160507056|NCT03826030|579583414|FG000|Overall Study|Too busy to return for visits|1|||
160507057|NCT03826030|579583415|FG001|Overall Study|Too busy to return for visits|0|||
160507058|NCT03826030|579583416|FG002|Overall Study|Too busy to return for visits|0|||
160507059|NCT03578887|579583417|FG000|Overall Study|Withdrawal by Subject|7|||
160507060|NCT03578887|579583418|FG001|Overall Study|Withdrawal by Subject|2|||
160507061|NCT03578887|579583419|FG002|Overall Study|Withdrawal by Subject|1|||
160507062|NCT03578887|579583417|FG000|Overall Study|Lost to Follow-up|13|||
160507063|NCT03578887|579583418|FG001|Overall Study|Lost to Follow-up|1|||
160507064|NCT03578887|579583419|FG002|Overall Study|Lost to Follow-up|4|||
160507065|NCT03578887|579583417|FG000|Overall Study|Physician Decision|0|||
160507066|NCT03578887|579583418|FG001|Overall Study|Physician Decision|1|||
160507067|NCT03578887|579583419|FG002|Overall Study|Physician Decision|1|||
160507068|NCT00095498|579585459|FG000|Overall Study|Physician Decision|9|||
160507069|NCT00095498|579585460|FG001|Overall Study|Physician Decision|10|||
160507070|NCT00095498|579585461|FG002|Overall Study|Physician Decision|8|||
160507071|NCT00095498|579585459|FG000|Overall Study|Adverse Event|1|||
160507072|NCT00095498|579585460|FG001|Overall Study|Adverse Event|0|||
160507073|NCT00095498|579585461|FG002|Overall Study|Adverse Event|1|||
160507074|NCT00095498|579585459|FG000|Overall Study|Withdrawal by Subject|15|||
160507075|NCT00095498|579585460|FG001|Overall Study|Withdrawal by Subject|16|||
160507076|NCT00095498|579585461|FG002|Overall Study|Withdrawal by Subject|15|||
160507077|NCT00095498|579585459|FG000|Overall Study|Disease progression|0|||
160507078|NCT00095498|579585460|FG001|Overall Study|Disease progression|1|||
160507079|NCT00095498|579585461|FG002|Overall Study|Disease progression|1|||
160507080|NCT00095498|579585459|FG000|Overall Study|Ineligibility determined|3|||
160507081|NCT00095498|579585460|FG001|Overall Study|Ineligibility determined|0|||
160507082|NCT00095498|579585461|FG002|Overall Study|Ineligibility determined|2|||
160507083|NCT00095498|579585459|FG000|Overall Study|Lost to Follow-up|1|||
160507084|NCT00095498|579585460|FG001|Overall Study|Lost to Follow-up|1|||
160507085|NCT00095498|579585461|FG002|Overall Study|Lost to Follow-up|2|||
160507086|NCT00095498|579585459|FG000|Overall Study|Noncompliance|1|||
160507087|NCT00095498|579585460|FG001|Overall Study|Noncompliance|0|||
160507088|NCT00095498|579585461|FG002|Overall Study|Noncompliance|1|||
160507089|NCT00095498|579585459|FG000|Overall Study|Other|6|||
160507090|NCT00095498|579585460|FG001|Overall Study|Other|7|||
160507091|NCT00095498|579585461|FG002|Overall Study|Other|6|||
160507092|NCT00095498|579585459|FG000|Overall Study|Protocol Violation|0|||
160507093|NCT00095498|579585460|FG001|Overall Study|Protocol Violation|0|||
160507094|NCT00095498|579585461|FG002|Overall Study|Protocol Violation|1|||
160507095|NCT00095498|579585459|FG000|Overall Study|Requirement for alternative therapy|1|||
160507096|NCT00095498|579585460|FG001|Overall Study|Requirement for alternative therapy|0|||
160507097|NCT00095498|579585461|FG002|Overall Study|Requirement for alternative therapy|2|||
160507098|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
160507099|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
160507100|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
160507101|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
160507102|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
160507103|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
160507104|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
160620251|NCT01707667|579988441|FG001|Period 1|expulsion of colonic sensor catheter|0|||
160620252|NCT04225026|579988444|FG000|Overall Study|Withdrawal by Subject|4|||
160620253|NCT04225026|579988444|FG000|Overall Study|Adverse Event|1|||
160620254|NCT04225026|579988444|FG000|Overall Study|Other|1|||
160620255|NCT04225026|579988444|FG000|Overall Study|Death|11|||
160663481|NCT05472038|580152284|FG003|Overall Study|Adverse Event|0|||
160507105|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
160507106|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
160507107|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
160507108|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
160507109|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
160507110|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Death|1|||
160507111|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Death|2|||
160507112|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Death|2|||
160507113|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Death|0|||
160507114|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Death|0|||
160507115|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Death|0|||
160507116|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
160507117|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
160507118|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
160507119|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
160507120|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
160507121|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
160507122|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
160507123|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
160507124|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
160507125|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
160507126|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
160507127|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
160507128|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
160507129|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
160507130|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
160507131|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
160507132|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
160507133|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
160507134|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
160507135|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
160507136|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
160507137|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
160507138|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
160507139|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
160507140|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
160507141|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
160507142|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
160507143|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
160507144|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
160507145|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
160507146|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
160507147|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
160507148|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
160507149|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
160507150|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
160507151|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
160507152|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
160507153|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
160507154|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
160507155|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
160507156|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
160507157|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
160507158|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Site closure|0|||
160507159|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Site closure|0|||
160507160|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Site closure|1|||
160507161|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Site closure|0|||
160507162|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Site closure|0|||
160507163|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Site closure|0|||
160507164|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
160507165|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
160507166|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
160507167|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
160507168|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
160507169|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
160507170|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
160507171|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
160507172|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
160663482|NCT05472038|580152285|FG004|Overall Study|Adverse Event|0|||
160663483|NCT05472038|580152286|FG005|Overall Study|Adverse Event|0|||
160663484|NCT05472038|580152287|FG006|Overall Study|Adverse Event|0|||
160663485|NCT05472038|580152288|FG007|Overall Study|Adverse Event|0|||
160663486|NCT05472038|580152289|FG008|Overall Study|Adverse Event|0|||
160663487|NCT05472038|580152290|FG009|Overall Study|Adverse Event|0|||
160663488|NCT05472038|580152291|FG010|Overall Study|Adverse Event|0|||
160507173|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
160507174|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
160507175|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
160507176|NCT03439254|579585465|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
160507177|NCT03439254|579585466|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
160507178|NCT03439254|579585467|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
160507179|NCT03439254|579585468|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
160507180|NCT03439254|579585469|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
160507181|NCT03439254|579585470|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
160507182|NCT03439254|579585465|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
160507183|NCT03439254|579585466|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
160507184|NCT03439254|579585467|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
160507185|NCT03439254|579585468|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
160507186|NCT03439254|579585469|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
160507187|NCT03439254|579585470|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
160507188|NCT03439254|579585465|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
160507189|NCT03439254|579585466|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
160507190|NCT03439254|579585467|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
160507191|NCT03439254|579585468|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
160507192|NCT03439254|579585469|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
160507193|NCT03439254|579585470|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
160507194|NCT03439254|579585465|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
160507195|NCT03439254|579585466|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
160507196|NCT03439254|579585467|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
160507197|NCT03439254|579585468|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
160507198|NCT03439254|579585469|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
160507199|NCT03439254|579585470|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
160507200|NCT03439254|579585465|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
160507201|NCT03439254|579585466|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
160507202|NCT03439254|579585467|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
160507203|NCT03439254|579585468|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
160507204|NCT03439254|579585469|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
160507205|NCT03439254|579585470|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
160507206|NCT03439254|579585465|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
160507207|NCT03439254|579585466|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
160507208|NCT03439254|579585467|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
160507209|NCT03439254|579585468|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
160507210|NCT03439254|579585469|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
160507211|NCT03439254|579585470|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
160507212|NCT03439254|579585465|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
160507213|NCT03439254|579585466|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
160507214|NCT03439254|579585467|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
160507215|NCT03439254|579585468|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
160507216|NCT03439254|579585469|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
160507217|NCT03439254|579585470|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
160507218|NCT03439254|579585465|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
160507219|NCT03439254|579585466|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
160507220|NCT03439254|579585467|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
160507221|NCT03439254|579585468|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
160663489|NCT05472038|580152292|FG011|Overall Study|Adverse Event|0|||
160663490|NCT05472038|580152281|FG000|Overall Study|Death|0|||
160663491|NCT05472038|580152282|FG001|Overall Study|Death|0|||
160507222|NCT03439254|579585469|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
160507223|NCT03439254|579585470|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
160507224|NCT03439254|579585465|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
160507225|NCT03439254|579585466|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
160507226|NCT03439254|579585467|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
160507227|NCT03439254|579585468|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
160507228|NCT03439254|579585469|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
160507229|NCT03439254|579585470|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
160507230|NCT03439254|579585465|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
160507231|NCT03439254|579585466|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
160507232|NCT03439254|579585467|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
160507233|NCT03439254|579585468|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
160507234|NCT03439254|579585469|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
160507235|NCT03439254|579585470|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
160507236|NCT00128102|579585471|FG000|Overall Study|Site Discontinued|3|||
160507237|NCT00128102|579585472|FG001|Overall Study|Site Discontinued|6|||
160507238|NCT00128102|579585471|FG000|Overall Study|Other|0|||
160507239|NCT00128102|579585472|FG001|Overall Study|Other|1|||
160507240|NCT00128102|579585471|FG000|Overall Study|Progressive Disease|255|||
160507241|NCT00128102|579585472|FG001|Overall Study|Progressive Disease|285|||
160507242|NCT00128102|579585471|FG000|Overall Study|Adverse Event|34|||
160507243|NCT00128102|579585472|FG001|Overall Study|Adverse Event|11|||
160507244|NCT00128102|579585471|FG000|Overall Study|Death|12|||
160507245|NCT00128102|579585472|FG001|Overall Study|Death|13|||
160507246|NCT00128102|579585471|FG000|Overall Study|Physician Decision|3|||
160507247|NCT00128102|579585472|FG001|Overall Study|Physician Decision|3|||
160507248|NCT00128102|579585471|FG000|Overall Study|Withdrawal by Subject|19|||
160507249|NCT00128102|579585472|FG001|Overall Study|Withdrawal by Subject|11|||
160507250|NCT00128102|579585471|FG000|Overall Study|Protocol Violation|2|||
160507251|NCT00128102|579585472|FG001|Overall Study|Protocol Violation|2|||
160507252|NCT00568178|579585473|FG000|Double Blind Base Study|Adverse Event|0|||
160507253|NCT00568178|579585474|FG001|Double Blind Base Study|Adverse Event|2|||
160507254|NCT00568178|579585475|FG002|Double Blind Base Study|Adverse Event|1|||
160507255|NCT00568178|579585476|FG003|Double Blind Base Study|Adverse Event|2|||
160507256|NCT00568178|579585477|FG004|Double Blind Base Study|Adverse Event|0|||
160507257|NCT00568178|579585478|FG005|Double Blind Base Study|Adverse Event|0|||
160507258|NCT00568178|579585473|FG000|Double Blind Base Study|Lost to Follow-up|1|||
160507259|NCT00568178|579585474|FG001|Double Blind Base Study|Lost to Follow-up|0|||
160507260|NCT00568178|579585475|FG002|Double Blind Base Study|Lost to Follow-up|0|||
160507261|NCT00568178|579585476|FG003|Double Blind Base Study|Lost to Follow-up|1|||
160507262|NCT00568178|579585477|FG004|Double Blind Base Study|Lost to Follow-up|0|||
160507263|NCT00568178|579585478|FG005|Double Blind Base Study|Lost to Follow-up|0|||
160507264|NCT00568178|579585473|FG000|Double Blind Base Study|Physician Decision|1|||
160507265|NCT00568178|579585474|FG001|Double Blind Base Study|Physician Decision|1|||
160507266|NCT00568178|579585475|FG002|Double Blind Base Study|Physician Decision|0|||
160507267|NCT00568178|579585476|FG003|Double Blind Base Study|Physician Decision|1|||
160507268|NCT00568178|579585477|FG004|Double Blind Base Study|Physician Decision|0|||
160507269|NCT00568178|579585478|FG005|Double Blind Base Study|Physician Decision|0|||
160507270|NCT00568178|579585473|FG000|Double Blind Base Study|Protocol Violation|3|||
160663492|NCT05472038|580152283|FG002|Overall Study|Death|0|||
160663493|NCT05472038|580152284|FG003|Overall Study|Death|0|||
160663494|NCT05472038|580152285|FG004|Overall Study|Death|0|||
160507271|NCT00568178|579585474|FG001|Double Blind Base Study|Protocol Violation|2|||
160507272|NCT00568178|579585475|FG002|Double Blind Base Study|Protocol Violation|0|||
160507273|NCT00568178|579585476|FG003|Double Blind Base Study|Protocol Violation|0|||
160507274|NCT00568178|579585477|FG004|Double Blind Base Study|Protocol Violation|0|||
160507275|NCT00568178|579585478|FG005|Double Blind Base Study|Protocol Violation|0|||
160507276|NCT00568178|579585473|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
160507277|NCT00568178|579585474|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
160507278|NCT00568178|579585475|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
160507279|NCT00568178|579585476|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
160663495|NCT05472038|580152286|FG005|Overall Study|Death|1|||
160507280|NCT00568178|579585477|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
160507281|NCT00568178|579585478|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
160507282|NCT00568178|579585473|FG000|Double Blind Base Study|Progressive Disease|0|||
160507283|NCT00568178|579585474|FG001|Double Blind Base Study|Progressive Disease|0|||
160507284|NCT00568178|579585475|FG002|Double Blind Base Study|Progressive Disease|0|||
160507285|NCT00568178|579585476|FG003|Double Blind Base Study|Progressive Disease|1|||
160507286|NCT00568178|579585477|FG004|Double Blind Base Study|Progressive Disease|0|||
160507287|NCT00568178|579585478|FG005|Double Blind Base Study|Progressive Disease|0|||
160507288|NCT00568178|579585473|FG000|Open Label Extension|Adverse Event|0|||
160663496|NCT05472038|580152287|FG006|Overall Study|Death|0|||
160663497|NCT05472038|580152288|FG007|Overall Study|Death|0|||
160507289|NCT00568178|579585474|FG001|Open Label Extension|Adverse Event|0|||
160507290|NCT00568178|579585475|FG002|Open Label Extension|Adverse Event|0|||
160507291|NCT00568178|579585476|FG003|Open Label Extension|Adverse Event|0|||
160507292|NCT00568178|579585477|FG004|Open Label Extension|Adverse Event|11|||
160507293|NCT00568178|579585478|FG005|Open Label Extension|Adverse Event|8|||
160507294|NCT00568178|579585473|FG000|Open Label Extension|Protocol Violation|0|||
160507295|NCT00568178|579585474|FG001|Open Label Extension|Protocol Violation|0|||
160507296|NCT00568178|579585475|FG002|Open Label Extension|Protocol Violation|0|||
160507297|NCT00568178|579585476|FG003|Open Label Extension|Protocol Violation|0|||
160663498|NCT05472038|580152289|FG008|Overall Study|Death|0|||
160663499|NCT05472038|580152290|FG009|Overall Study|Death|0|||
160663500|NCT05472038|580152291|FG010|Overall Study|Death|0|||
160663501|NCT05472038|580152292|FG011|Overall Study|Death|0|||
160663502|NCT05472038|580152281|FG000|Overall Study|Lost to Follow-up|1|||
160663503|NCT05472038|580152282|FG001|Overall Study|Lost to Follow-up|3|||
160663504|NCT05472038|580152283|FG002|Overall Study|Lost to Follow-up|3|||
160663505|NCT05472038|580152284|FG003|Overall Study|Lost to Follow-up|9|||
160663506|NCT05472038|580152285|FG004|Overall Study|Lost to Follow-up|2|||
160663507|NCT05472038|580152286|FG005|Overall Study|Lost to Follow-up|2|||
160663508|NCT05472038|580152287|FG006|Overall Study|Lost to Follow-up|1|||
160663509|NCT05472038|580152288|FG007|Overall Study|Lost to Follow-up|0|||
160663510|NCT05472038|580152289|FG008|Overall Study|Lost to Follow-up|1|||
160663511|NCT05472038|580152290|FG009|Overall Study|Lost to Follow-up|0|||
160663512|NCT05472038|580152291|FG010|Overall Study|Lost to Follow-up|2|||
160663513|NCT05472038|580152292|FG011|Overall Study|Lost to Follow-up|1|||
160663514|NCT05472038|580152281|FG000|Overall Study|Physician Decision|0|||
160663515|NCT05472038|580152282|FG001|Overall Study|Physician Decision|0|||
160663516|NCT05472038|580152283|FG002|Overall Study|Physician Decision|0|||
160663517|NCT05472038|580152284|FG003|Overall Study|Physician Decision|0|||
160663518|NCT05472038|580152285|FG004|Overall Study|Physician Decision|1|||
160663519|NCT05472038|580152286|FG005|Overall Study|Physician Decision|0|||
160663520|NCT05472038|580152287|FG006|Overall Study|Physician Decision|0|||
160663521|NCT05472038|580152288|FG007|Overall Study|Physician Decision|0|||
160663522|NCT05472038|580152289|FG008|Overall Study|Physician Decision|0|||
160663523|NCT05472038|580152290|FG009|Overall Study|Physician Decision|0|||
160663524|NCT05472038|580152291|FG010|Overall Study|Physician Decision|0|||
160663525|NCT05472038|580152292|FG011|Overall Study|Physician Decision|0|||
160663526|NCT05472038|580152281|FG000|Overall Study|Withdrawal by Subject|1|||
160663527|NCT05472038|580152282|FG001|Overall Study|Withdrawal by Subject|3|||
160663528|NCT05472038|580152283|FG002|Overall Study|Withdrawal by Subject|1|||
160507298|NCT00568178|579585477|FG004|Open Label Extension|Protocol Violation|1|||
160620256|NCT04225026|579988444|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
160620257|NCT04738123|579988445|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
160620258|NCT04738123|579988446|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
160620259|NCT04738123|579988445|FG000|Overall Study|Progressive Disease|0|||
160620260|NCT04738123|579988446|FG001|Overall Study|Progressive Disease|4|||
160620261|NCT04738123|579988445|FG000|Overall Study|Adverse Event|8|||
160620262|NCT04738123|579988446|FG001|Overall Study|Adverse Event|7|||
160620263|NCT04738123|579988445|FG000|Overall Study|Other Reasons|0|||
160620264|NCT04738123|579988446|FG001|Overall Study|Other Reasons|1|||
160620265|NCT04738123|579988445|FG000|Overall Study|Suicidal or assaultive behavior|0|||
160620266|NCT04738123|579988446|FG001|Overall Study|Suicidal or assaultive behavior|2|||
160620267|NCT04738123|579988445|FG000|Overall Study|Protocol Violation|2|||
160620268|NCT04738123|579988446|FG001|Overall Study|Protocol Violation|2|||
160620269|NCT04738123|579988445|FG000|Overall Study|Consent Withdrawn|35|||
160620270|NCT04738123|579988446|FG001|Overall Study|Consent Withdrawn|22|||
160620271|NCT03982069|579988447|FG000|Overall Study|Lost to Follow-up|5|||
160620272|NCT03982069|579988448|FG001|Overall Study|Lost to Follow-up|5|||
160620273|NCT03982069|579988449|FG002|Overall Study|Lost to Follow-up|3|||
160620274|NCT03982069|579988450|FG003|Overall Study|Lost to Follow-up|5|||
160620275|NCT03982069|579988447|FG000|Overall Study|Physician Decision|0|||
160620276|NCT03982069|579988448|FG001|Overall Study|Physician Decision|1|||
160620277|NCT03982069|579988449|FG002|Overall Study|Physician Decision|0|||
160620278|NCT03982069|579988450|FG003|Overall Study|Physician Decision|0|||
160663529|NCT05472038|580152284|FG003|Overall Study|Withdrawal by Subject|6|||
160663530|NCT05472038|580152285|FG004|Overall Study|Withdrawal by Subject|1|||
160663531|NCT05472038|580152286|FG005|Overall Study|Withdrawal by Subject|3|||
160663532|NCT05472038|580152287|FG006|Overall Study|Withdrawal by Subject|0|||
160663533|NCT05472038|580152288|FG007|Overall Study|Withdrawal by Subject|2|||
160663534|NCT05472038|580152289|FG008|Overall Study|Withdrawal by Subject|3|||
160663535|NCT05472038|580152290|FG009|Overall Study|Withdrawal by Subject|1|||
160620279|NCT03982069|579988447|FG000|Overall Study|Withdrawal by Subject|2|||
160663536|NCT05472038|580152291|FG010|Overall Study|Withdrawal by Subject|2|||
160663537|NCT05472038|580152292|FG011|Overall Study|Withdrawal by Subject|2|||
160507299|NCT00568178|579585478|FG005|Open Label Extension|Protocol Violation|0|||
160620280|NCT03982069|579988448|FG001|Overall Study|Withdrawal by Subject|1|||
160620281|NCT03982069|579988449|FG002|Overall Study|Withdrawal by Subject|5|||
160620282|NCT03982069|579988450|FG003|Overall Study|Withdrawal by Subject|2|||
160663538|NCT05472038|580152281|FG000|Overall Study|Protocol Violation|0|||
160663539|NCT05472038|580152282|FG001|Overall Study|Protocol Violation|0|||
160663540|NCT05472038|580152283|FG002|Overall Study|Protocol Violation|0|||
160663541|NCT05472038|580152284|FG003|Overall Study|Protocol Violation|0|||
160663542|NCT05472038|580152285|FG004|Overall Study|Protocol Violation|0|||
160663543|NCT05472038|580152286|FG005|Overall Study|Protocol Violation|0|||
160663544|NCT05472038|580152287|FG006|Overall Study|Protocol Violation|0|||
160663545|NCT05472038|580152288|FG007|Overall Study|Protocol Violation|1|||
160663546|NCT05472038|580152289|FG008|Overall Study|Protocol Violation|1|||
160663547|NCT05472038|580152290|FG009|Overall Study|Protocol Violation|1|||
160663548|NCT05472038|580152291|FG010|Overall Study|Protocol Violation|1|||
160663549|NCT05472038|580152292|FG011|Overall Study|Protocol Violation|1|||
160663550|NCT05472038|580152281|FG000|Overall Study|Not vaccinated|0|||
160663551|NCT05472038|580152282|FG001|Overall Study|Not vaccinated|0|||
160663552|NCT05472038|580152283|FG002|Overall Study|Not vaccinated|0|||
160663553|NCT05472038|580152284|FG003|Overall Study|Not vaccinated|1|||
160663554|NCT05472038|580152285|FG004|Overall Study|Not vaccinated|0|||
160663555|NCT05472038|580152286|FG005|Overall Study|Not vaccinated|0|||
160663556|NCT05472038|580152287|FG006|Overall Study|Not vaccinated|0|||
160663557|NCT05472038|580152288|FG007|Overall Study|Not vaccinated|0|||
160663558|NCT05472038|580152289|FG008|Overall Study|Not vaccinated|0|||
160663559|NCT05472038|580152290|FG009|Overall Study|Not vaccinated|0|||
160663560|NCT05472038|580152291|FG010|Overall Study|Not vaccinated|0|||
160663561|NCT05472038|580152292|FG011|Overall Study|Not vaccinated|0|||
160663562|NCT02847650|580152293|FG000|Overall Study|Adverse Event|2|||
160663563|NCT02847650|580152294|FG001|Overall Study|Adverse Event|4|||
160663564|NCT02847650|580152293|FG000|Overall Study|Lost to Follow-up|1|||
160663565|NCT02847650|580152294|FG001|Overall Study|Lost to Follow-up|0|||
160663566|NCT02847650|580152293|FG000|Overall Study|Protocol Violation|0|||
160663567|NCT02847650|580152294|FG001|Overall Study|Protocol Violation|1|||
160663568|NCT02847650|580152293|FG000|Overall Study|Withdrawal by Subject|1|||
160663569|NCT02847650|580152294|FG001|Overall Study|Withdrawal by Subject|1|||
160663570|NCT01591785|580152295|FG000|Overall Study|worsening condition|1|||
160663571|NCT01591785|580152296|FG001|Overall Study|worsening condition|2|||
160663572|NCT01591785|580152295|FG000|Overall Study|Protocol Violation|2|||
160663573|NCT01591785|580152296|FG001|Overall Study|Protocol Violation|0|||
160663574|NCT01591785|580152295|FG000|Overall Study|Lost to Follow-up|1|||
160663575|NCT01591785|580152296|FG001|Overall Study|Lost to Follow-up|0|||
160663576|NCT01439880|580152300|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
160663577|NCT01439880|580152301|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
160663578|NCT01439880|580152300|FG000|SOC-controlled Period (Year 1)|Death|2|||
160663579|NCT01439880|580152301|FG001|SOC-controlled Period (Year 1)|Death|1|||
160663580|NCT01439880|580152300|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
160663581|NCT01439880|580152301|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
160663582|NCT01439880|580152300|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
160663583|NCT01439880|580152301|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
160663584|NCT01439880|580152300|FG000|SOC-controlled Period (Year 1)|Other|8|||
160663585|NCT01439880|580152301|FG001|SOC-controlled Period (Year 1)|Other|13|||
160663586|NCT01439880|580152300|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
160663587|NCT01439880|580152301|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
160663588|NCT01439880|580152300|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
160663589|NCT01439880|580152301|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
160663590|NCT01439880|580152300|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
160663591|NCT01439880|580152301|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
160663592|NCT01439880|580152300|FG000|All-IP Period (Years 2 to 5)|Death|3|||
160663593|NCT01439880|580152301|FG001|All-IP Period (Years 2 to 5)|Death|13|||
160663594|NCT01439880|580152300|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
160663595|NCT01439880|580152301|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
160663596|NCT01439880|580152300|FG000|All-IP Period (Years 2 to 5)|Other|14|||
160663597|NCT01439880|580152301|FG001|All-IP Period (Years 2 to 5)|Other|31|||
160663598|NCT01439880|580152300|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
160663599|NCT01439880|580152301|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
160663600|NCT03450057|580152308|FG000|Overall Study|Death|17|||
160663601|NCT03450057|580152308|FG000|Overall Study|ICF withdrawal|4|||
160663602|NCT03450057|580152308|FG000|Overall Study|Lost to Follow-up|2|||
160663603|NCT03214952|580152311|FG000|Overall Study|Protocol Deviation|45|||
160663604|NCT03214952|580152311|FG000|Overall Study|Case Report Forms Uncollected|13|||
160663605|NCT03935880|580152312|FG000|Overall Study|Lost to Follow-up|0|||
160663606|NCT03935880|580152313|FG001|Overall Study|Lost to Follow-up|1|||
160663607|NCT03769896|580152314|FG000|Open-label Phase|Lack of Efficacy|5|||
160663608|NCT03769896|580152315|FG001|Open-label Phase|Lack of Efficacy|0|||
160663609|NCT03769896|580152314|FG000|Open-label Phase|Adverse Event|3|||
160663610|NCT03769896|580152315|FG001|Open-label Phase|Adverse Event|0|||
160663611|NCT03769896|580152314|FG000|Open-label Phase|Withdrawal by Subject|1|||
160663612|NCT03769896|580152315|FG001|Open-label Phase|Withdrawal by Subject|0|||
160663613|NCT01015703|580152316|FG000|Overall Study|Withdrawal by Subject|0|||
160663614|NCT01015703|580152317|FG001|Overall Study|Withdrawal by Subject|1|||
160620283|NCT03982069|579988447|FG000|Overall Study|Specimen loss|3|||
160620284|NCT03982069|579988448|FG001|Overall Study|Specimen loss|3|||
160620285|NCT03982069|579988449|FG002|Overall Study|Specimen loss|1|||
160620286|NCT03982069|579988450|FG003|Overall Study|Specimen loss|1|||
160620287|NCT00083616|579988451|FG000|Overall Study|Disease Progression|16|||
160620288|NCT00083616|579988451|FG000|Overall Study|Lost to Follow-up|1|||
160620289|NCT00083616|579988451|FG000|Overall Study|Physician Decision|2|||
160620290|NCT00083616|579988451|FG000|Overall Study|Withdrawal by Subject|3|||
160620291|NCT00083616|579988451|FG000|Overall Study|Ineligibility determined|2|||
160620292|NCT00083616|579988451|FG000|Overall Study|Non-compliance|1|||
160620293|NCT00083616|579988451|FG000|Overall Study|Other|6|||
160620294|NCT02041533|579988452|FG000|Pre-Treatment Period|Disease Progression|1|||
160620295|NCT02041533|579988453|FG001|Pre-Treatment Period|Disease Progression|1|||
160620296|NCT02041533|579988452|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
160620297|NCT02041533|579988453|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
160620298|NCT02041533|579988452|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
160620299|NCT02041533|579988453|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
160620300|NCT02041533|579988452|FG000|Treatment Period|Disease progression|189|||
160620301|NCT02041533|579988453|FG001|Treatment Period|Disease progression|146|||
160620302|NCT02041533|579988452|FG000|Treatment Period|Study drug toxicity|30|||
160620303|NCT02041533|579988453|FG001|Treatment Period|Study drug toxicity|34|||
160620304|NCT02041533|579988452|FG000|Treatment Period|Death|1|||
160620305|NCT02041533|579988453|FG001|Treatment Period|Death|0|||
160620306|NCT02041533|579988452|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
160620307|NCT02041533|579988453|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
160620308|NCT02041533|579988452|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
160620309|NCT02041533|579988453|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
160620310|NCT02041533|579988452|FG000|Treatment Period|Participant withdrew consent|2|||
160620311|NCT02041533|579988453|FG001|Treatment Period|Participant withdrew consent|2|||
160620312|NCT02041533|579988452|FG000|Treatment Period|Maximum clinical benefit|0|||
160620313|NCT02041533|579988453|FG001|Treatment Period|Maximum clinical benefit|18|||
160620314|NCT02041533|579988452|FG000|Treatment Period|Poor/Non-compliance|1|||
160620315|NCT02041533|579988453|FG001|Treatment Period|Poor/Non-compliance|0|||
160620316|NCT02041533|579988452|FG000|Treatment Period|Administrative reason by sponsor|1|||
160620317|NCT02041533|579988453|FG001|Treatment Period|Administrative reason by sponsor|0|||
160620318|NCT02041533|579988452|FG000|Treatment Period|Other reasons|9|||
160620319|NCT02041533|579988453|FG001|Treatment Period|Other reasons|2|||
160620320|NCT02041533|579988452|FG000|Treatment Period|Not Reported|0|||
160620321|NCT02041533|579988453|FG001|Treatment Period|Not Reported|1|||
160620322|NCT01468844|579988454|FG000|Overall Study|Adverse Event|1|||
160620323|NCT01468844|579988455|FG001|Overall Study|Adverse Event|0|||
160620324|NCT01468844|579988454|FG000|Overall Study|Withdrawal by Subject|1|||
160620325|NCT01468844|579988455|FG001|Overall Study|Withdrawal by Subject|0|||
160620326|NCT02355665|579988456|FG000|Overall Study|Adverse Event|16|||
160620327|NCT02355665|579988457|FG001|Overall Study|Adverse Event|24|||
160620328|NCT02355665|579988456|FG000|Overall Study|Protocol Violation|2|||
160620329|NCT02355665|579988457|FG001|Overall Study|Protocol Violation|0|||
160620330|NCT02355665|579988456|FG000|Overall Study|Withdrawal by Subject|90|||
160620331|NCT02355665|579988457|FG001|Overall Study|Withdrawal by Subject|100|||
160620332|NCT02355665|579988456|FG000|Overall Study|Lost to Follow-up|131|||
160620333|NCT02355665|579988457|FG001|Overall Study|Lost to Follow-up|103|||
160620334|NCT02355665|579988456|FG000|Overall Study|Death|4|||
160620335|NCT02355665|579988457|FG001|Overall Study|Death|2|||
160620336|NCT02355665|579988456|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
160620337|NCT02355665|579988457|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
160620338|NCT00266695|579988460|FG000|Overall Study|Adverse Event|1|||
160620339|NCT00266695|579988460|FG000|Overall Study|Death|9|||
160620340|NCT00266695|579988460|FG000|Overall Study|Physician Decision|1|||
160620341|NCT00266695|579988460|FG000|Overall Study|Lost to Follow-up|3|||
160620342|NCT00266695|579988460|FG000|Overall Study|Withdrawal by Subject|15|||
160620343|NCT02380703|579988461|FG000|Overall Study|Withdrawal by Subject|12|||
160620344|NCT02380703|579988462|FG001|Overall Study|Withdrawal by Subject|9|||
160620345|NCT02380703|579988461|FG000|Overall Study|Lost to Follow-up|12|||
160620346|NCT02380703|579988462|FG001|Overall Study|Lost to Follow-up|12|||
160620347|NCT02380703|579988461|FG000|Overall Study|Caregiver death|1|||
160620348|NCT02380703|579988462|FG001|Overall Study|Caregiver death|0|||
160620349|NCT02380703|579988461|FG000|Overall Study|Person with dementia (PWD) death|7|||
160620350|NCT02380703|579988462|FG001|Overall Study|Person with dementia (PWD) death|8|||
160620351|NCT02380703|579988461|FG000|Overall Study|Entered Long-term Care|4|||
160620352|NCT02380703|579988462|FG001|Overall Study|Entered Long-term Care|7|||
160620353|NCT02853318|579988467|FG000|Overall Study|Withdrawal by Subject|1|||
160620354|NCT01882439|579988468|FG000|Overall Study|Adverse event related to study drug|3|||
160620355|NCT01882439|579988469|FG001|Overall Study|Adverse event related to study drug|8|||
160620356|NCT01882439|579988470|FG002|Overall Study|Adverse event related to study drug|1|||
160620357|NCT01882439|579988471|FG003|Overall Study|Adverse event related to study drug|2|||
160620358|NCT01882439|579988468|FG000|Overall Study|Pregnancy|0|||
160663615|NCT01015703|580152318|FG002|Overall Study|Withdrawal by Subject|0|||
160663616|NCT01015703|580152319|FG003|Overall Study|Withdrawal by Subject|0|||
160663617|NCT01015703|580152320|FG004|Overall Study|Withdrawal by Subject|0|||
160663618|NCT01015703|580152316|FG000|Overall Study|Adverse Event|1|||
160663619|NCT01015703|580152317|FG001|Overall Study|Adverse Event|0|||
160663620|NCT01015703|580152318|FG002|Overall Study|Adverse Event|0|||
160663621|NCT01015703|580152319|FG003|Overall Study|Adverse Event|0|||
160663622|NCT01015703|580152320|FG004|Overall Study|Adverse Event|0|||
160663623|NCT01015703|580152316|FG000|Overall Study|Protocol Violation|1|||
160663624|NCT01015703|580152317|FG001|Overall Study|Protocol Violation|0|||
160663625|NCT01015703|580152318|FG002|Overall Study|Protocol Violation|0|||
160663626|NCT01015703|580152319|FG003|Overall Study|Protocol Violation|0|||
160663627|NCT01015703|580152320|FG004|Overall Study|Protocol Violation|0|||
160663628|NCT03122535|580152321|FG000|Overall Study|Lost to Follow-up|68|||
160663629|NCT03122535|580152322|FG001|Overall Study|Lost to Follow-up|68|||
160663630|NCT03122535|580152321|FG000|Overall Study|Physician Decision|3|||
160663631|NCT03122535|580152322|FG001|Overall Study|Physician Decision|3|||
160663632|NCT03122535|580152321|FG000|Overall Study|Withdrawal by Subject|2|||
160663633|NCT03122535|580152322|FG001|Overall Study|Withdrawal by Subject|2|||
160663634|NCT00857454|580152323|FG000|Overall Study|Withdrawal by Subject|2|||
160663635|NCT00857454|580152323|FG000|Overall Study|Lost to Follow-up|1|||
160663636|NCT00857454|580152323|FG000|Overall Study|Adverse Event|2|||
160663637|NCT00857454|580152323|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
160663638|NCT00857454|580152323|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
160663639|NCT00857454|580152323|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
160663640|NCT00984022|580152324|FG000|Overall Study|Lost to Follow-up|10|||
160663641|NCT00984022|580152325|FG001|Overall Study|Lost to Follow-up|14|||
160663642|NCT00573443|580152326|FG000|Double-Blind Phase|Lost to Follow-up|1|||
160663643|NCT00573443|580152327|FG001|Double-Blind Phase|Lost to Follow-up|3|||
160663644|NCT00573443|580152328|FG002|Double-Blind Phase|Lost to Follow-up|2|||
160663645|NCT00573443|580152326|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
160663646|NCT00573443|580152327|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
160663647|NCT00573443|580152328|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
160663648|NCT00573443|580152326|FG000|Double-Blind Phase|Adverse Event|1|||
160663649|NCT00573443|580152327|FG001|Double-Blind Phase|Adverse Event|5|||
160663650|NCT00573443|580152328|FG002|Double-Blind Phase|Adverse Event|0|||
160663651|NCT00573443|580152326|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
160663652|NCT00573443|580152327|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
160663653|NCT00573443|580152328|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
160663654|NCT00573443|580152326|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
160663655|NCT00573443|580152327|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
160663656|NCT00573443|580152328|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
160663657|NCT00573443|580152326|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
160663658|NCT00573443|580152327|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
160663659|NCT00573443|580152328|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
160663660|NCT00573443|580152326|FG000|Double-Blind Phase|Protocol Violation|0|||
160663661|NCT00573443|580152327|FG001|Double-Blind Phase|Protocol Violation|2|||
160663662|NCT00573443|580152328|FG002|Double-Blind Phase|Protocol Violation|1|||
160663663|NCT00573443|580152326|FG000|Double-Blind Phase|Other|0|||
160663664|NCT00573443|580152327|FG001|Double-Blind Phase|Other|2|||
160663665|NCT00573443|580152328|FG002|Double-Blind Phase|Other|3|||
160663666|NCT00573443|580152326|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
160663667|NCT00573443|580152327|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
160663668|NCT00573443|580152328|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
160663669|NCT00573443|580152326|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
160663670|NCT00573443|580152327|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
160663671|NCT00573443|580152328|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
160663672|NCT00573443|580152326|FG000|Open-Label Extension Phase|Adverse Event|3|||
160663673|NCT00573443|580152327|FG001|Open-Label Extension Phase|Adverse Event|0|||
160663674|NCT00573443|580152328|FG002|Open-Label Extension Phase|Adverse Event|0|||
160663675|NCT00573443|580152326|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
160663676|NCT00573443|580152327|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
160663677|NCT00573443|580152328|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
160663678|NCT00573443|580152326|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
160663679|NCT00573443|580152327|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
160663680|NCT00573443|580152328|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
160663681|NCT00573443|580152326|FG000|Open-Label Extension Phase|Protocol Violation|2|||
160663682|NCT00573443|580152327|FG001|Open-Label Extension Phase|Protocol Violation|0|||
160663683|NCT00573443|580152328|FG002|Open-Label Extension Phase|Protocol Violation|0|||
160663684|NCT00573443|580152326|FG000|Open-Label Extension Phase|Other|2|||
160663685|NCT00573443|580152327|FG001|Open-Label Extension Phase|Other|0|||
160663686|NCT00573443|580152328|FG002|Open-Label Extension Phase|Other|0|||
160663687|NCT04567186|580152330|FG000|Period 1|COVID-19 related|1|||
160663688|NCT04567186|580152331|FG001|Period 1|COVID-19 related|0|||
160663689|NCT04567186|580152330|FG000|Period 1|Protocol Violation|0|||
160663690|NCT04567186|580152331|FG001|Period 1|Protocol Violation|1|||
160663691|NCT04567186|580152330|FG000|Period 1|Adverse Event|0|||
160663692|NCT04567186|580152331|FG001|Period 1|Adverse Event|2|||
160663693|NCT04567186|580152330|FG000|Period 2|COVID-19 Related|0|||
160663694|NCT04567186|580152331|FG001|Period 2|COVID-19 Related|1|||
160663695|NCT04567186|580152330|FG000|Period 2|Protocol Violation|0|||
160663696|NCT04567186|580152331|FG001|Period 2|Protocol Violation|1|||
160663697|NCT04567186|580152330|FG000|Period 2|Lost to Follow-up|0|||
160663698|NCT04567186|580152331|FG001|Period 2|Lost to Follow-up|1|||
160663699|NCT04567186|580152330|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
160663700|NCT04567186|580152331|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
160663701|NCT01702987|580152332|FG000|Overall Study|Withdrawal by Subject|1|||
160663702|NCT01702987|580152333|FG001|Overall Study|Withdrawal by Subject|0|||
160663703|NCT00838630|580152334|FG000|First Intervention|Adverse Event|1|||
160663704|NCT00838630|580152335|FG001|First Intervention|Adverse Event|0|||
160663705|NCT00838630|580152334|FG000|Washout: 7 Days|Protocol Violation|1|||
160663706|NCT00838630|580152335|FG001|Washout: 7 Days|Protocol Violation|0|||
160663707|NCT02057458|580152342|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
160663708|NCT02057458|580152343|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
160663709|NCT02057458|580152344|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
160663710|NCT02057458|580152342|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
160663711|NCT02057458|580152343|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
160663712|NCT02057458|580152344|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
160663713|NCT02057458|580152342|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
160663714|NCT02057458|580152343|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
160663715|NCT02057458|580152344|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
160663716|NCT04263649|580152345|FG000|Overall Study|Adverse Event|53|||
160663717|NCT04263649|580152345|FG000|Overall Study|Lost to Follow-up|3|||
160663718|NCT04263649|580152345|FG000|Overall Study|Death|29|||
160663719|NCT04263649|580152345|FG000|Overall Study|Device deficiency|19|||
160663720|NCT04263649|580152345|FG000|Overall Study|other reasons|11|||
160663721|NCT05169710|580152346|FG000|Overall Study|Adverse Event|1|||
160663722|NCT05169710|580152347|FG001|Overall Study|Adverse Event|2|||
160663723|NCT05169710|580152348|FG002|Overall Study|Adverse Event|2|||
160620359|NCT01882439|579988469|FG001|Overall Study|Pregnancy|1|||
160620360|NCT01882439|579988470|FG002|Overall Study|Pregnancy|0|||
160620361|NCT01882439|579988471|FG003|Overall Study|Pregnancy|0|||
160620362|NCT01882439|579988468|FG000|Overall Study|Protocol Violation|2|||
160620363|NCT01882439|579988469|FG001|Overall Study|Protocol Violation|2|||
160620364|NCT01882439|579988470|FG002|Overall Study|Protocol Violation|0|||
160620365|NCT01882439|579988471|FG003|Overall Study|Protocol Violation|1|||
160620366|NCT01882439|579988468|FG000|Overall Study|No longer willing to participate|1|||
160620367|NCT01882439|579988469|FG001|Overall Study|No longer willing to participate|4|||
160620368|NCT01882439|579988470|FG002|Overall Study|No longer willing to participate|2|||
160620369|NCT01882439|579988471|FG003|Overall Study|No longer willing to participate|3|||
160620370|NCT01882439|579988468|FG000|Overall Study|Medication error with no associated AE|0|||
160620371|NCT01882439|579988469|FG001|Overall Study|Medication error with no associated AE|0|||
160620372|NCT01882439|579988470|FG002|Overall Study|Medication error with no associated AE|2|||
160620373|NCT01882439|579988471|FG003|Overall Study|Medication error with no associated AE|0|||
160620374|NCT01882439|579988468|FG000|Overall Study|Insufficient clinical response|1|||
160620375|NCT01882439|579988469|FG001|Overall Study|Insufficient clinical response|4|||
160620376|NCT01882439|579988470|FG002|Overall Study|Insufficient clinical response|4|||
160620377|NCT01882439|579988471|FG003|Overall Study|Insufficient clinical response|2|||
160620378|NCT01882439|579988468|FG000|Overall Study|Adverse event unrelated to study drug|2|||
160620379|NCT01882439|579988469|FG001|Overall Study|Adverse event unrelated to study drug|2|||
160620380|NCT01882439|579988470|FG002|Overall Study|Adverse event unrelated to study drug|1|||
160620381|NCT01882439|579988471|FG003|Overall Study|Adverse event unrelated to study drug|1|||
160620382|NCT03125902|579988472|FG000|Overall Study|Adverse Event|0|||
160620383|NCT03125902|579988473|FG001|Overall Study|Adverse Event|1|||
160620384|NCT03125902|579988472|FG000|Overall Study|Death|119|||
160620385|NCT03125902|579988473|FG001|Overall Study|Death|229|||
160620386|NCT03125902|579988472|FG000|Overall Study|Lost to Follow-up|4|||
160620387|NCT03125902|579988473|FG001|Overall Study|Lost to Follow-up|13|||
160620388|NCT03125902|579988472|FG000|Overall Study|Other|0|||
160620389|NCT03125902|579988473|FG001|Overall Study|Other|4|||
160620390|NCT03125902|579988472|FG000|Overall Study|Physician Decision|2|||
160620391|NCT03125902|579988473|FG001|Overall Study|Physician Decision|1|||
160620392|NCT03125902|579988472|FG000|Overall Study|Progressive Disease|0|||
160620393|NCT03125902|579988473|FG001|Overall Study|Progressive Disease|3|||
160620394|NCT03125902|579988472|FG000|Overall Study|Study Terminated By Sponsor|74|||
160620395|NCT03125902|579988473|FG001|Overall Study|Study Terminated By Sponsor|143|||
160663724|NCT05169710|580152346|FG000|Overall Study|Lost to Follow-up|0|||
160663725|NCT05169710|580152347|FG001|Overall Study|Lost to Follow-up|0|||
160663726|NCT05169710|580152348|FG002|Overall Study|Lost to Follow-up|1|||
160663727|NCT05169710|580152346|FG000|Overall Study|Withdrawal by Subject|2|||
160663728|NCT05169710|580152347|FG001|Overall Study|Withdrawal by Subject|1|||
160663729|NCT05169710|580152348|FG002|Overall Study|Withdrawal by Subject|0|||
160663730|NCT05169710|580152346|FG000|Overall Study|Other Study Discontinuation Reason|0|||
160663731|NCT05169710|580152347|FG001|Overall Study|Other Study Discontinuation Reason|2|||
160663732|NCT05169710|580152348|FG002|Overall Study|Other Study Discontinuation Reason|0|||
160663733|NCT00723710|580152360|FG000|Overall Study|Disease progression|48|||
160507300|NCT00568178|579585473|FG000|Open Label Extension|Lost to Follow-up|0|||
160663734|NCT00723710|580152360|FG000|Overall Study|Adverse Event|88|||
160663735|NCT00723710|580152360|FG000|Overall Study|Withdrawal by Subject|36|||
160663736|NCT00723710|580152360|FG000|Overall Study|Physician Decision|2|||
160663737|NCT02158663|580152362|FG000|Overall Study|Withdrawal by Subject|5|||
160663738|NCT02158663|580152363|FG001|Overall Study|Withdrawal by Subject|4|||
160663739|NCT03459807|580152364|FG000|Overall Study|Withdrawal due to transplant|0|||
160663740|NCT03459807|580152365|FG001|Overall Study|Withdrawal due to transplant|1|||
160663741|NCT00833937|580152370|FG000|Washout|Withdrawal by Subject|1|||
160663742|NCT00833937|580152371|FG001|Washout|Withdrawal by Subject|0|||
160663743|NCT02392000|580152372|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
160663744|NCT02392000|580152372|FG000|Overall Study|Withdrawal by Subject|1|||
160663745|NCT02392000|580152372|FG000|Overall Study|Lost to Follow-up|8|||
160663746|NCT00576056|580152375|FG000|Overall Study|Adverse Event|1|||
160663747|NCT00576056|580152375|FG000|Overall Study|Death|1|||
160663748|NCT00576056|580152375|FG000|Overall Study|Lack of Efficacy|1|||
160663749|NCT00576056|580152375|FG000|Overall Study|Withdrawal by Subject|2|||
160663750|NCT00576056|580152375|FG000|Overall Study|did not meet eligibility criteria|8|||
160663751|NCT00576056|580152375|FG000|Overall Study|Physician Decision|1|||
160663752|NCT03197883|580152376|FG000|Overall Study|Adverse Event|1|||
160663753|NCT03197883|580152377|FG001|Overall Study|Adverse Event|1|||
160663754|NCT03197883|580152376|FG000|Overall Study|Lost to Follow-up|1|||
160663755|NCT03197883|580152377|FG001|Overall Study|Lost to Follow-up|0|||
160663756|NCT03197883|580152376|FG000|Overall Study|Protocol Violation|1|||
160663757|NCT03197883|580152377|FG001|Overall Study|Protocol Violation|0|||
160663758|NCT03197883|580152376|FG000|Overall Study|Other (Not Specified)|0|||
160663759|NCT03197883|580152377|FG001|Overall Study|Other (Not Specified)|5|||
160663760|NCT01353664|580152378|FG000|Overall Study|Other|3|||
160663761|NCT01353664|580152378|FG000|Overall Study|Disease Progression|16|||
160663762|NCT03273153|580152379|FG000|Overall Study|Adverse Event|1|||
160663763|NCT03273153|580152380|FG001|Overall Study|Adverse Event|2|||
160663764|NCT03273153|580152379|FG000|Overall Study|Missing|0|||
160663765|NCT03273153|580152380|FG001|Overall Study|Missing|2|||
160663766|NCT03273153|580152379|FG000|Overall Study|Other|3|||
160663767|NCT03273153|580152380|FG001|Overall Study|Other|2|||
160663768|NCT03273153|580152379|FG000|Overall Study|Symptomatic Deterioration|0|||
160663769|NCT03273153|580152380|FG001|Overall Study|Symptomatic Deterioration|1|||
160663770|NCT03273153|580152379|FG000|Overall Study|Progressive Disease|6|||
160663771|NCT03273153|580152380|FG001|Overall Study|Progressive Disease|5|||
160663772|NCT03273153|580152379|FG000|Overall Study|Physician Decision|1|||
160663773|NCT03273153|580152380|FG001|Overall Study|Physician Decision|3|||
160663774|NCT03273153|580152379|FG000|Overall Study|Study Terminated by Sponsor|112|||
160663775|NCT03273153|580152380|FG001|Overall Study|Study Terminated by Sponsor|102|||
160663776|NCT03273153|580152379|FG000|Overall Study|Withdrawal by Subject|26|||
160663777|NCT03273153|580152380|FG001|Overall Study|Withdrawal by Subject|25|||
160663778|NCT03273153|580152379|FG000|Overall Study|Protocol Deviation|3|||
160663779|NCT03273153|580152380|FG001|Overall Study|Protocol Deviation|0|||
160663780|NCT03273153|580152379|FG000|Overall Study|Lost to Follow-up|6|||
160663781|NCT03273153|580152380|FG001|Overall Study|Lost to Follow-up|11|||
160663782|NCT03273153|580152379|FG000|Overall Study|Death|66|||
160663783|NCT03273153|580152380|FG001|Overall Study|Death|69|||
160663784|NCT00838539|580152381|FG000|Overall Study|Disease Progression|2|||
160663785|NCT00838539|580152382|FG001|Overall Study|Disease Progression|4|||
160663786|NCT00838539|580152383|FG002|Overall Study|Disease Progression|3|||
160663787|NCT00838539|580152384|FG003|Overall Study|Disease Progression|2|||
160663788|NCT00838539|580152385|FG004|Overall Study|Disease Progression|4|||
160507301|NCT00568178|579585474|FG001|Open Label Extension|Lost to Follow-up|0|||
160507302|NCT00568178|579585475|FG002|Open Label Extension|Lost to Follow-up|0|||
160507303|NCT00568178|579585476|FG003|Open Label Extension|Lost to Follow-up|0|||
160507304|NCT00568178|579585477|FG004|Open Label Extension|Lost to Follow-up|6|||
160507305|NCT00568178|579585478|FG005|Open Label Extension|Lost to Follow-up|11|||
160507306|NCT00568178|579585473|FG000|Open Label Extension|Physician Decision|0|||
160663789|NCT00838539|580152386|FG005|Overall Study|Disease Progression|2|||
160663790|NCT00838539|580152387|FG006|Overall Study|Disease Progression|3|||
160663791|NCT00838539|580152388|FG007|Overall Study|Disease Progression|4|||
160663792|NCT00838539|580152389|FG008|Overall Study|Disease Progression|4|||
160663793|NCT00838539|580152390|FG009|Overall Study|Disease Progression|5|||
160663794|NCT00838539|580152391|FG010|Overall Study|Disease Progression|1|||
160663795|NCT00838539|580152392|FG011|Overall Study|Disease Progression|4|||
160663796|NCT00838539|580152381|FG000|Overall Study|Adverse Event|1|||
160663797|NCT00838539|580152382|FG001|Overall Study|Adverse Event|1|||
160663798|NCT00838539|580152383|FG002|Overall Study|Adverse Event|1|||
160663799|NCT00838539|580152384|FG003|Overall Study|Adverse Event|1|||
160663800|NCT00838539|580152385|FG004|Overall Study|Adverse Event|2|||
160507307|NCT00568178|579585474|FG001|Open Label Extension|Physician Decision|0|||
160507308|NCT00568178|579585475|FG002|Open Label Extension|Physician Decision|0|||
160507309|NCT00568178|579585476|FG003|Open Label Extension|Physician Decision|0|||
160507310|NCT00568178|579585477|FG004|Open Label Extension|Physician Decision|9|||
160507311|NCT00568178|579585478|FG005|Open Label Extension|Physician Decision|8|||
160507312|NCT00568178|579585473|FG000|Open Label Extension|Pregnancy|0|||
160507313|NCT00568178|579585474|FG001|Open Label Extension|Pregnancy|0|||
160507314|NCT00568178|579585475|FG002|Open Label Extension|Pregnancy|0|||
160507315|NCT00568178|579585476|FG003|Open Label Extension|Pregnancy|0|||
160507316|NCT00568178|579585477|FG004|Open Label Extension|Pregnancy|0|||
160507317|NCT00568178|579585478|FG005|Open Label Extension|Pregnancy|1|||
160507318|NCT00568178|579585473|FG000|Open Label Extension|Progressive Disease|0|||
160507319|NCT00568178|579585474|FG001|Open Label Extension|Progressive Disease|0|||
160507320|NCT00568178|579585475|FG002|Open Label Extension|Progressive Disease|0|||
160507321|NCT00568178|579585476|FG003|Open Label Extension|Progressive Disease|0|||
160507322|NCT00568178|579585477|FG004|Open Label Extension|Progressive Disease|3|||
160507323|NCT00568178|579585478|FG005|Open Label Extension|Progressive Disease|1|||
160507324|NCT00568178|579585473|FG000|Open Label Extension|Termination of Trial|0|||
160507325|NCT00568178|579585474|FG001|Open Label Extension|Termination of Trial|0|||
160507326|NCT00568178|579585475|FG002|Open Label Extension|Termination of Trial|0|||
160507327|NCT00568178|579585476|FG003|Open Label Extension|Termination of Trial|0|||
160507328|NCT00568178|579585477|FG004|Open Label Extension|Termination of Trial|45|||
160507329|NCT00568178|579585478|FG005|Open Label Extension|Termination of Trial|47|||
160507330|NCT00568178|579585473|FG000|Open Label Extension|Withdrawal by Subject|0|||
160507331|NCT00568178|579585474|FG001|Open Label Extension|Withdrawal by Subject|0|||
160507332|NCT00568178|579585475|FG002|Open Label Extension|Withdrawal by Subject|0|||
160507333|NCT00568178|579585476|FG003|Open Label Extension|Withdrawal by Subject|0|||
160507334|NCT00568178|579585477|FG004|Open Label Extension|Withdrawal by Subject|4|||
160507335|NCT00568178|579585478|FG005|Open Label Extension|Withdrawal by Subject|4|||
160507336|NCT01332630|579585479|FG000|Overall Study|Withdrawal by Subject|3|||
160507337|NCT04476251|579585482|FG000|Overall Study|Not treated|1|||
160507338|NCT01008553|579585483|FG000|Period 1 (Titration Period)|Physician Decision|2|||
160507339|NCT01008553|579585484|FG001|Period 1 (Titration Period)|Physician Decision|0|||
160507340|NCT01008553|579585485|FG002|Period 1 (Titration Period)|Physician Decision|0|||
160507341|NCT01008553|579585483|FG000|Period 1 (Titration Period)|Adverse Event|33|||
160507342|NCT01008553|579585484|FG001|Period 1 (Titration Period)|Adverse Event|0|||
160507343|NCT01008553|579585485|FG002|Period 1 (Titration Period)|Adverse Event|0|||
160507344|NCT01008553|579585483|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
160507345|NCT01008553|579585484|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
160507346|NCT01008553|579585485|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
160507347|NCT01008553|579585483|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
160507348|NCT01008553|579585484|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
160507349|NCT01008553|579585485|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
160507350|NCT01008553|579585483|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
160507351|NCT01008553|579585484|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
160507352|NCT01008553|579585485|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
160507353|NCT01008553|579585483|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
160507354|NCT01008553|579585484|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
160507355|NCT01008553|579585485|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
160507356|NCT01008553|579585483|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
160507357|NCT01008553|579585484|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
160507358|NCT01008553|579585485|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
160507359|NCT01008553|579585483|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
160507360|NCT01008553|579585484|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
160507361|NCT01008553|579585485|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
160507362|NCT01008553|579585483|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
160507363|NCT01008553|579585484|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
160507364|NCT01008553|579585485|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
160507365|NCT01008553|579585483|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
160507366|NCT01008553|579585484|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
160507367|NCT01008553|579585485|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
160507368|NCT01008553|579585483|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
160507369|NCT01008553|579585484|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
160507370|NCT01008553|579585485|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
160507371|NCT01008553|579585483|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
160507372|NCT01008553|579585484|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
160507373|NCT01008553|579585485|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
160620396|NCT03125902|579988472|FG000|Overall Study|Withdrawal by Subject|21|||
160620397|NCT03125902|579988473|FG001|Overall Study|Withdrawal by Subject|37|||
160620398|NCT00440232|579988476|FG000|Overall Study|Lost to Follow-up|1|||
160507374|NCT01008553|579585483|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
160507375|NCT01008553|579585484|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
160507376|NCT01008553|579585485|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
160507377|NCT01008553|579585483|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
160507378|NCT01008553|579585484|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
160507379|NCT01008553|579585485|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
160507380|NCT00574873|579585488|FG000|Overall Study|Withdrawal by Subject|18|||
160507381|NCT00574873|579585489|FG001|Overall Study|Withdrawal by Subject|19|||
160507382|NCT00574873|579585488|FG000|Overall Study|Investigator request|18|||
160507383|NCT00574873|579585489|FG001|Overall Study|Investigator request|8|||
160507384|NCT00574873|579585488|FG000|Overall Study|Death|15|||
160507385|NCT00574873|579585489|FG001|Overall Study|Death|14|||
160507386|NCT00574873|579585488|FG000|Overall Study|Lost to Follow-up|14|||
160507387|NCT00574873|579585489|FG001|Overall Study|Lost to Follow-up|5|||
160507388|NCT00574873|579585488|FG000|Overall Study|Other|40|||
160507389|NCT00574873|579585489|FG001|Overall Study|Other|4|||
160507390|NCT00574873|579585488|FG000|Overall Study|Discontinuation of study by sponsor|5|||
160507391|NCT00574873|579585489|FG001|Overall Study|Discontinuation of study by sponsor|199|||
160507392|NCT00574873|579585488|FG000|Overall Study|Blank, site closed per local regulations|2|||
160507393|NCT00574873|579585489|FG001|Overall Study|Blank, site closed per local regulations|2|||
160507394|NCT00574873|579585488|FG000|Overall Study|Extension Study|126|||
160507395|NCT00574873|579585489|FG001|Overall Study|Extension Study|0|||
160507396|NCT02898077|579585496|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
160507397|NCT02898077|579585497|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
160507398|NCT02898077|579585496|FG000|Overall Study|Lost to Follow-up|4|||
160507399|NCT02898077|579585497|FG001|Overall Study|Lost to Follow-up|3|||
160507400|NCT02898077|579585496|FG000|Overall Study|Physician Decision|0|||
160507401|NCT02898077|579585497|FG001|Overall Study|Physician Decision|2|||
160507402|NCT02898077|579585496|FG000|Overall Study|Sponsor Decision|32|||
160507403|NCT02898077|579585497|FG001|Overall Study|Sponsor Decision|13|||
160507404|NCT02898077|579585496|FG000|Overall Study|Withdrawal by Subject|6|||
160507405|NCT02898077|579585497|FG001|Overall Study|Withdrawal by Subject|3|||
160507406|NCT02898077|579585496|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
160507407|NCT02898077|579585497|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
160507408|NCT02898077|579585496|FG000|Overall Study|Ended extension period|3|||
160507409|NCT02898077|579585497|FG001|Overall Study|Ended extension period|0|||
160507410|NCT02040584|579585498|FG000|Overall Study|Adverse Event|13|||
160507411|NCT02040584|579585499|FG001|Overall Study|Adverse Event|6|||
160507412|NCT02040584|579585498|FG000|Overall Study|Protocol Violation|9|||
160507413|NCT02040584|579585499|FG001|Overall Study|Protocol Violation|11|||
160507414|NCT02040584|579585498|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160507415|NCT02040584|579585499|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160507416|NCT02040584|579585498|FG000|Overall Study|Death|6|||
160507417|NCT02040584|579585499|FG001|Overall Study|Death|3|||
160507418|NCT02040584|579585498|FG000|Overall Study|Transplant rejection/retransplant|0|||
160507419|NCT02040584|579585499|FG001|Overall Study|Transplant rejection/retransplant|1|||
160507420|NCT02040584|579585498|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
160507421|NCT02040584|579585499|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
160507422|NCT00996476|579585500|FG000|Overall Study|Withdrawal by Subject|1|||
160507423|NCT00996476|579585501|FG001|Overall Study|Withdrawal by Subject|2|||
160507424|NCT00996476|579585502|FG002|Overall Study|Withdrawal by Subject|1|||
160507425|NCT00996476|579585503|FG003|Overall Study|Withdrawal by Subject|0|||
160507426|NCT00996476|579585504|FG004|Overall Study|Withdrawal by Subject|1|||
160507427|NCT00996476|579585500|FG000|Overall Study|Adverse Event|0|||
160507428|NCT00996476|579585501|FG001|Overall Study|Adverse Event|1|||
160620399|NCT00440232|579988477|FG001|Overall Study|Lost to Follow-up|1|||
160620400|NCT00440232|579988476|FG000|Overall Study|Unable to treat within allowed time|0|||
160620401|NCT00440232|579988477|FG001|Overall Study|Unable to treat within allowed time|1|||
160620402|NCT00440232|579988476|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
160620403|NCT00440232|579988477|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
160620404|NCT00362297|579988478|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
160620405|NCT00362297|579988479|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
160620406|NCT00819052|579988480|FG000|Overall Study|Adverse Event|0|||
160620407|NCT00819052|579988481|FG001|Overall Study|Adverse Event|5|||
160507429|NCT00996476|579585502|FG002|Overall Study|Adverse Event|0|||
160507430|NCT00996476|579585503|FG003|Overall Study|Adverse Event|0|||
160507431|NCT00996476|579585504|FG004|Overall Study|Adverse Event|1|||
160507432|NCT01940939|579585505|FG000|Overall Study|Withdrawal by Subject|2|||
160507433|NCT01940939|579585506|FG001|Overall Study|Withdrawal by Subject|8|||
160507434|NCT01470001|579585507|FG000|Overall Study|Lost to Follow-up|1|||
160507435|NCT01470001|579585508|FG001|Overall Study|Lost to Follow-up|1|||
160507436|NCT01470001|579585507|FG000|Overall Study|Physician Decision|2|||
160507437|NCT01470001|579585508|FG001|Overall Study|Physician Decision|0|||
160620408|NCT00819052|579988480|FG000|Overall Study|Protocol Violation|1|||
160507438|NCT01470001|579585507|FG000|Overall Study|Withdrawal by Subject|2|||
160507439|NCT01470001|579585508|FG001|Overall Study|Withdrawal by Subject|1|||
160507440|NCT00731133|579585512|FG000|Overall Study|Withdrawal by Subject|10|||
160507441|NCT00943852|579585513|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
160507442|NCT00943852|579585514|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
160507443|NCT00943852|579585515|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
160507444|NCT00943852|579585516|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
160507445|NCT00943852|579585517|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
160507446|NCT00943852|579585518|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
160507447|NCT00943852|579585519|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
160507448|NCT00943852|579585520|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
160507449|NCT00943852|579585521|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
160507450|NCT00943852|579585522|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
160507451|NCT00943852|579585513|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
160507452|NCT00943852|579585514|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
160507453|NCT00943852|579585515|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
160507454|NCT00943852|579585516|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
160507455|NCT00943852|579585517|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
160507456|NCT00943852|579585518|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
160507457|NCT00943852|579585519|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
160507458|NCT00943852|579585520|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
160507459|NCT00943852|579585521|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
160507460|NCT00943852|579585522|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
160507461|NCT00943852|579585513|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
160507462|NCT00943852|579585514|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
160507463|NCT00943852|579585515|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
160507464|NCT00943852|579585516|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
160507465|NCT00943852|579585517|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
160507466|NCT00943852|579585518|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
160507467|NCT00943852|579585519|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
160507468|NCT00943852|579585520|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
160507469|NCT00943852|579585521|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
160507470|NCT00943852|579585522|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
160507471|NCT00943852|579585513|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
160507472|NCT00943852|579585514|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
160507473|NCT00943852|579585515|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
160507474|NCT00943852|579585516|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
160507475|NCT00943852|579585517|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
160507476|NCT00943852|579585518|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
160507477|NCT00943852|579585519|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
160507478|NCT00943852|579585520|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
160507479|NCT00943852|579585521|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
160507480|NCT00943852|579585522|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
160507481|NCT00943852|579585513|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
160507482|NCT00943852|579585514|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
160507483|NCT00943852|579585515|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
160507484|NCT00943852|579585516|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
160507485|NCT00943852|579585517|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
160507486|NCT00943852|579585518|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
160507487|NCT00943852|579585519|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
160507488|NCT00943852|579585520|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
160507489|NCT00943852|579585521|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
160507490|NCT00943852|579585522|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
160507491|NCT04939701|579585523|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
160507492|NCT04939701|579585524|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
160507493|NCT04939701|579585525|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
160507494|NCT04939701|579585523|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
160620409|NCT00819052|579988481|FG001|Overall Study|Protocol Violation|2|||
160620410|NCT00819052|579988480|FG000|Overall Study|Lost to Follow-up|1|||
160663801|NCT00838539|580152386|FG005|Overall Study|Adverse Event|1|||
160663802|NCT00838539|580152387|FG006|Overall Study|Adverse Event|0|||
160663803|NCT00838539|580152388|FG007|Overall Study|Adverse Event|2|||
160663804|NCT00838539|580152389|FG008|Overall Study|Adverse Event|0|||
160663805|NCT00838539|580152390|FG009|Overall Study|Adverse Event|1|||
160663806|NCT00838539|580152391|FG010|Overall Study|Adverse Event|2|||
160663807|NCT00838539|580152392|FG011|Overall Study|Adverse Event|0|||
160663808|NCT00838539|580152381|FG000|Overall Study|Withdrawal by Subject|0|||
160663809|NCT00838539|580152382|FG001|Overall Study|Withdrawal by Subject|1|||
160663810|NCT00838539|580152383|FG002|Overall Study|Withdrawal by Subject|0|||
160663811|NCT00838539|580152384|FG003|Overall Study|Withdrawal by Subject|0|||
160663812|NCT00838539|580152385|FG004|Overall Study|Withdrawal by Subject|0|||
160663813|NCT00838539|580152386|FG005|Overall Study|Withdrawal by Subject|0|||
160663814|NCT00838539|580152387|FG006|Overall Study|Withdrawal by Subject|0|||
160663815|NCT00838539|580152388|FG007|Overall Study|Withdrawal by Subject|0|||
160663816|NCT00838539|580152389|FG008|Overall Study|Withdrawal by Subject|0|||
160663817|NCT00838539|580152390|FG009|Overall Study|Withdrawal by Subject|1|||
160663818|NCT00838539|580152391|FG010|Overall Study|Withdrawal by Subject|2|||
160663819|NCT00838539|580152392|FG011|Overall Study|Withdrawal by Subject|0|||
160663820|NCT00838539|580152381|FG000|Overall Study|Death|0|||
160663821|NCT00838539|580152382|FG001|Overall Study|Death|0|||
160663822|NCT00838539|580152383|FG002|Overall Study|Death|0|||
160663823|NCT00838539|580152384|FG003|Overall Study|Death|0|||
160663824|NCT00838539|580152385|FG004|Overall Study|Death|0|||
160663825|NCT00838539|580152386|FG005|Overall Study|Death|0|||
160663826|NCT00838539|580152387|FG006|Overall Study|Death|1|||
160663827|NCT00838539|580152388|FG007|Overall Study|Death|0|||
160663828|NCT00838539|580152389|FG008|Overall Study|Death|0|||
160663829|NCT00838539|580152390|FG009|Overall Study|Death|0|||
160663830|NCT00838539|580152391|FG010|Overall Study|Death|0|||
160663831|NCT00838539|580152392|FG011|Overall Study|Death|0|||
160663832|NCT00838539|580152381|FG000|Overall Study|Physician Decision|0|||
160663833|NCT00838539|580152382|FG001|Overall Study|Physician Decision|0|||
160663834|NCT00838539|580152383|FG002|Overall Study|Physician Decision|0|||
160663835|NCT00838539|580152384|FG003|Overall Study|Physician Decision|0|||
160663836|NCT00838539|580152385|FG004|Overall Study|Physician Decision|0|||
160663837|NCT00838539|580152386|FG005|Overall Study|Physician Decision|0|||
160663838|NCT00838539|580152387|FG006|Overall Study|Physician Decision|0|||
160663839|NCT00838539|580152388|FG007|Overall Study|Physician Decision|0|||
160663840|NCT00838539|580152389|FG008|Overall Study|Physician Decision|1|||
160663841|NCT00838539|580152390|FG009|Overall Study|Physician Decision|0|||
160663842|NCT00838539|580152391|FG010|Overall Study|Physician Decision|0|||
160663843|NCT00838539|580152392|FG011|Overall Study|Physician Decision|0|||
160663844|NCT00838539|580152381|FG000|Overall Study|Clinical Progression|0|||
160663845|NCT00838539|580152382|FG001|Overall Study|Clinical Progression|0|||
160663846|NCT00838539|580152383|FG002|Overall Study|Clinical Progression|0|||
160663847|NCT00838539|580152384|FG003|Overall Study|Clinical Progression|0|||
160663848|NCT00838539|580152385|FG004|Overall Study|Clinical Progression|0|||
160663849|NCT00838539|580152386|FG005|Overall Study|Clinical Progression|0|||
160663850|NCT00838539|580152387|FG006|Overall Study|Clinical Progression|1|||
160663851|NCT00838539|580152388|FG007|Overall Study|Clinical Progression|0|||
160663852|NCT00838539|580152389|FG008|Overall Study|Clinical Progression|0|||
160663853|NCT00838539|580152390|FG009|Overall Study|Clinical Progression|0|||
160663854|NCT00838539|580152391|FG010|Overall Study|Clinical Progression|0|||
160663855|NCT00838539|580152392|FG011|Overall Study|Clinical Progression|0|||
160663856|NCT00838539|580152381|FG000|Overall Study|Symptomatic Deterioration|0|||
160663857|NCT00838539|580152382|FG001|Overall Study|Symptomatic Deterioration|0|||
160663858|NCT00838539|580152383|FG002|Overall Study|Symptomatic Deterioration|1|||
160663859|NCT00838539|580152384|FG003|Overall Study|Symptomatic Deterioration|1|||
160663860|NCT00838539|580152385|FG004|Overall Study|Symptomatic Deterioration|0|||
160663861|NCT00838539|580152386|FG005|Overall Study|Symptomatic Deterioration|1|||
160663862|NCT00838539|580152387|FG006|Overall Study|Symptomatic Deterioration|0|||
160663863|NCT00838539|580152388|FG007|Overall Study|Symptomatic Deterioration|0|||
160663864|NCT00838539|580152389|FG008|Overall Study|Symptomatic Deterioration|0|||
160663865|NCT00838539|580152390|FG009|Overall Study|Symptomatic Deterioration|1|||
160663866|NCT00838539|580152391|FG010|Overall Study|Symptomatic Deterioration|0|||
160663867|NCT00838539|580152392|FG011|Overall Study|Symptomatic Deterioration|0|||
160663868|NCT01908205|580152393|FG000|Overall Study|Lost to Follow-up|2|||
160663869|NCT01908205|580152394|FG001|Overall Study|Lost to Follow-up|0|||
160663870|NCT01908205|580152393|FG000|Overall Study|Withdrawal by Subject|3|||
160663871|NCT01908205|580152394|FG001|Overall Study|Withdrawal by Subject|1|||
160663872|NCT05323396|580152395|FG000|Overall Study|Lost to Follow-up|1|||
160663873|NCT05323396|580152396|FG001|Overall Study|Lost to Follow-up|35|||
160663874|NCT05323396|580152395|FG000|Overall Study|Pregnancy|1|||
160663875|NCT05323396|580152396|FG001|Overall Study|Pregnancy|0|||
160663876|NCT03420300|580152398|FG000|Overall Study|Death|2|||
160663877|NCT03681470|580152406|FG000|Overall Study|Lack of Efficacy|3|||
160663878|NCT03681470|580152406|FG000|Overall Study|Lost to Follow-up|1|||
160663879|NCT03681470|580152406|FG000|Overall Study|Protocol Violation|3|||
160620411|NCT00819052|579988481|FG001|Overall Study|Lost to Follow-up|2|||
160620412|NCT00819052|579988480|FG000|Overall Study|Withdrawal by Subject|1|||
160620413|NCT00819052|579988481|FG001|Overall Study|Withdrawal by Subject|2|||
160620414|NCT00819052|579988480|FG000|Overall Study|Lack of Efficacy|1|||
160620415|NCT00819052|579988481|FG001|Overall Study|Lack of Efficacy|1|||
160620416|NCT00819052|579988480|FG000|Overall Study|Pregnancy|1|||
160620417|NCT00819052|579988481|FG001|Overall Study|Pregnancy|2|||
160620418|NCT00819052|579988480|FG000|Overall Study|Death or events leading to death|1|||
160620419|NCT00819052|579988481|FG001|Overall Study|Death or events leading to death|0|||
160620420|NCT02146352|579988489|FG000|Overall Study|Death|1|||
160620421|NCT02146352|579988489|FG000|Overall Study|Patient entered hospice care|1|||
160620422|NCT02918006|579988491|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
160620423|NCT02918006|579988492|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
160620424|NCT02918006|579988493|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
160620425|NCT02918006|579988491|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
160620426|NCT02918006|579988492|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
160620427|NCT02918006|579988493|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
160620428|NCT02918006|579988491|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
160620429|NCT02918006|579988492|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
160620430|NCT02918006|579988493|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
160620431|NCT02918006|579988491|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
160620432|NCT02918006|579988492|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
160620433|NCT02918006|579988493|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
160620434|NCT02918006|579988491|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
160620435|NCT02918006|579988492|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
160620436|NCT02918006|579988493|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
160620437|NCT02918006|579988491|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
160620438|NCT02918006|579988492|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
160620439|NCT02918006|579988493|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
160620440|NCT02918006|579988491|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
160620441|NCT02918006|579988492|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
160620442|NCT02918006|579988493|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
160620443|NCT02918006|579988491|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
160620444|NCT02918006|579988492|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
160620445|NCT02918006|579988493|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
160620446|NCT02918006|579988491|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
160620447|NCT02918006|579988492|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
160620448|NCT02918006|579988493|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
160620449|NCT03969589|579988494|FG000|Overall Study|Lost to Follow-up|3|||
160620450|NCT03969589|579988495|FG001|Overall Study|Lost to Follow-up|2|||
160620451|NCT03969589|579988494|FG000|Overall Study|Declined Follow-Up|0|||
160620452|NCT03969589|579988495|FG001|Overall Study|Declined Follow-Up|1|||
160620453|NCT03091920|579988499|FG000|Overall Study|Adverse Event|0|||
160620454|NCT03091920|579988500|FG001|Overall Study|Adverse Event|1|||
160620455|NCT03091920|579988501|FG002|Overall Study|Adverse Event|0|||
160620456|NCT00453349|579988502|FG000|Randomized|Adverse Event|12|||
160620457|NCT00453349|579988503|FG001|Randomized|Adverse Event|11|||
160620458|NCT00453349|579988502|FG000|Randomized|Lack of Efficacy|2|||
160620459|NCT00453349|579988503|FG001|Randomized|Lack of Efficacy|1|||
160620460|NCT00453349|579988502|FG000|Randomized|Lost to Follow-up|7|||
160620461|NCT00453349|579988503|FG001|Randomized|Lost to Follow-up|5|||
160620462|NCT00453349|579988502|FG000|Randomized|Protocol Violation|1|||
160620463|NCT00453349|579988503|FG001|Randomized|Protocol Violation|1|||
160620464|NCT00453349|579988502|FG000|Randomized|Withdrawal by Subject|3|||
160620465|NCT00453349|579988503|FG001|Randomized|Withdrawal by Subject|5|||
160620466|NCT00453349|579988502|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
160620467|NCT00453349|579988503|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
160620468|NCT00453349|579988502|FG000|Completed Study|Adverse Event|12|||
160620469|NCT00453349|579988503|FG001|Completed Study|Adverse Event|11|||
160620470|NCT00453349|579988502|FG000|Completed Study|Lack of Efficacy|2|||
160620471|NCT00453349|579988503|FG001|Completed Study|Lack of Efficacy|1|||
160620472|NCT00453349|579988502|FG000|Completed Study|Lost to Follow-up|7|||
160620473|NCT00453349|579988503|FG001|Completed Study|Lost to Follow-up|5|||
160620474|NCT00453349|579988502|FG000|Completed Study|Protocol Violation|1|||
160620475|NCT00453349|579988503|FG001|Completed Study|Protocol Violation|1|||
160620476|NCT00453349|579988502|FG000|Completed Study|Withdrawal by Subject|3|||
160620477|NCT00453349|579988503|FG001|Completed Study|Withdrawal by Subject|5|||
160620478|NCT00453349|579988502|FG000|Completed Study|Lost to follow up after study treatment|2|||
160620479|NCT00453349|579988503|FG001|Completed Study|Lost to follow up after study treatment|11|||
160620480|NCT01513460|579988505|FG000|Overall Study|Death|0|||
160620481|NCT01513460|579988506|FG001|Overall Study|Death|0|||
160620482|NCT01513460|579988507|FG002|Overall Study|Death|1|||
160620483|NCT01513460|579988505|FG000|Overall Study|Lost to Follow-up|0|||
160620484|NCT01513460|579988506|FG001|Overall Study|Lost to Follow-up|0|||
160620485|NCT01513460|579988507|FG002|Overall Study|Lost to Follow-up|2|||
160663880|NCT03681470|580152406|FG000|Overall Study|Withdrawal by Subject|1|||
160663881|NCT03500692|580152411|FG000|Overall Study|Death|163|||
160663882|NCT03500692|580152411|FG000|Overall Study|Lost to Follow-up|75|||
160663883|NCT03500692|580152411|FG000|Overall Study|Termination Reasons|3|||
160663884|NCT02305758|580152412|FG000|Overall Study|Death|27|||
160663885|NCT02305758|580152413|FG001|Overall Study|Death|27|||
160507495|NCT04939701|579585524|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
160507496|NCT04939701|579585525|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
160507497|NCT04939701|579585523|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
160507498|NCT04939701|579585524|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
160507499|NCT04939701|579585525|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
160507500|NCT04939701|579585523|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
160507501|NCT04939701|579585524|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
160507502|NCT04939701|579585525|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
160507503|NCT04939701|579585523|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
160507504|NCT04939701|579585524|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
160507505|NCT04939701|579585525|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
160507506|NCT04939701|579585523|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
160507507|NCT04939701|579585524|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
160507508|NCT04939701|579585525|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
160507509|NCT04939701|579585523|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
160507510|NCT04939701|579585524|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
160507511|NCT04939701|579585525|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
160507512|NCT02672852|579585531|FG000|Part A1|Disease Worsening|1|||
160507513|NCT02672852|579585532|FG001|Part A1|Disease Worsening|0|||
160507514|NCT02672852|579585533|FG002|Part A1|Disease Worsening|0|||
160507515|NCT02672852|579585534|FG003|Part A1|Disease Worsening|0|||
160507516|NCT02672852|579585535|FG004|Part A1|Disease Worsening|0|||
160507517|NCT02672852|579585536|FG005|Part A1|Disease Worsening|0|||
160507518|NCT02672852|579585537|FG006|Part A1|Disease Worsening|0|||
160507519|NCT02672852|579585531|FG000|Part A1|Adverse Event|0|||
160507520|NCT02672852|579585532|FG001|Part A1|Adverse Event|1|||
160507521|NCT02672852|579585533|FG002|Part A1|Adverse Event|0|||
160507522|NCT02672852|579585534|FG003|Part A1|Adverse Event|0|||
160507523|NCT02672852|579585535|FG004|Part A1|Adverse Event|0|||
160507524|NCT02672852|579585536|FG005|Part A1|Adverse Event|0|||
160507525|NCT02672852|579585537|FG006|Part A1|Adverse Event|0|||
160507526|NCT02672852|579585531|FG000|Part A1|Lost to Follow-up|1|||
160507527|NCT02672852|579585532|FG001|Part A1|Lost to Follow-up|2|||
160507528|NCT02672852|579585533|FG002|Part A1|Lost to Follow-up|0|||
160507529|NCT02672852|579585534|FG003|Part A1|Lost to Follow-up|0|||
160507530|NCT02672852|579585535|FG004|Part A1|Lost to Follow-up|0|||
160507531|NCT02672852|579585536|FG005|Part A1|Lost to Follow-up|0|||
160507532|NCT02672852|579585537|FG006|Part A1|Lost to Follow-up|0|||
160507533|NCT02672852|579585531|FG000|Part A1|Withdrawal by Subject|1|||
160507534|NCT02672852|579585532|FG001|Part A1|Withdrawal by Subject|1|||
160507535|NCT02672852|579585533|FG002|Part A1|Withdrawal by Subject|0|||
160507536|NCT02672852|579585534|FG003|Part A1|Withdrawal by Subject|0|||
160507537|NCT02672852|579585535|FG004|Part A1|Withdrawal by Subject|0|||
160507538|NCT02672852|579585536|FG005|Part A1|Withdrawal by Subject|0|||
160507539|NCT02672852|579585537|FG006|Part A1|Withdrawal by Subject|0|||
160507540|NCT02672852|579585531|FG000|Part A2|Disease worsening|0|||
160507541|NCT02672852|579585532|FG001|Part A2|Disease worsening|0|||
160507542|NCT02672852|579585533|FG002|Part A2|Disease worsening|1|||
160507543|NCT02672852|579585534|FG003|Part A2|Disease worsening|0|||
160507544|NCT02672852|579585535|FG004|Part A2|Disease worsening|0|||
160507545|NCT02672852|579585536|FG005|Part A2|Disease worsening|0|||
160507546|NCT02672852|579585537|FG006|Part A2|Disease worsening|0|||
160507547|NCT02672852|579585531|FG000|Part A2|Adverse Event|0|||
160507548|NCT02672852|579585532|FG001|Part A2|Adverse Event|0|||
160507549|NCT02672852|579585533|FG002|Part A2|Adverse Event|3|||
160507550|NCT02672852|579585534|FG003|Part A2|Adverse Event|0|||
160507551|NCT02672852|579585535|FG004|Part A2|Adverse Event|0|||
160507552|NCT02672852|579585536|FG005|Part A2|Adverse Event|0|||
160507553|NCT02672852|579585537|FG006|Part A2|Adverse Event|0|||
160507554|NCT02672852|579585531|FG000|Part A2|Lost to Follow-up|0|||
160507555|NCT02672852|579585532|FG001|Part A2|Lost to Follow-up|0|||
160507556|NCT02672852|579585533|FG002|Part A2|Lost to Follow-up|2|||
160507557|NCT02672852|579585534|FG003|Part A2|Lost to Follow-up|0|||
160507558|NCT02672852|579585535|FG004|Part A2|Lost to Follow-up|0|||
160663886|NCT02305758|580152412|FG000|Overall Study|Withdrew consent|9|||
160507559|NCT02672852|579585536|FG005|Part A2|Lost to Follow-up|0|||
160507560|NCT02672852|579585537|FG006|Part A2|Lost to Follow-up|0|||
160507561|NCT02672852|579585531|FG000|Part A2|Withdrawal by Subject|0|||
160507562|NCT02672852|579585532|FG001|Part A2|Withdrawal by Subject|0|||
160507563|NCT02672852|579585533|FG002|Part A2|Withdrawal by Subject|1|||
160663887|NCT02305758|580152413|FG001|Overall Study|Withdrew consent|2|||
160663888|NCT02305758|580152412|FG000|Overall Study|Lost to Follow-up|6|||
160507564|NCT02672852|579585534|FG003|Part A2|Withdrawal by Subject|0|||
160507565|NCT02672852|579585535|FG004|Part A2|Withdrawal by Subject|0|||
160507566|NCT02672852|579585536|FG005|Part A2|Withdrawal by Subject|0|||
160507567|NCT02672852|579585537|FG006|Part A2|Withdrawal by Subject|0|||
160507568|NCT02672852|579585531|FG000|Part A2|Other|0|||
160507569|NCT02672852|579585532|FG001|Part A2|Other|0|||
160507570|NCT02672852|579585533|FG002|Part A2|Other|3|||
160507571|NCT02672852|579585534|FG003|Part A2|Other|0|||
160507572|NCT02672852|579585535|FG004|Part A2|Other|0|||
160507573|NCT02672852|579585536|FG005|Part A2|Other|0|||
160507574|NCT02672852|579585537|FG006|Part A2|Other|0|||
160507575|NCT02672852|579585531|FG000|Part A2|Not entered in Part B|0|||
160507576|NCT02672852|579585532|FG001|Part A2|Not entered in Part B|0|||
160507577|NCT02672852|579585533|FG002|Part A2|Not entered in Part B|0|||
160507578|NCT02672852|579585534|FG003|Part A2|Not entered in Part B|4|||
160507579|NCT02672852|579585535|FG004|Part A2|Not entered in Part B|0|||
160507580|NCT02672852|579585536|FG005|Part A2|Not entered in Part B|0|||
160507581|NCT02672852|579585537|FG006|Part A2|Not entered in Part B|0|||
160507582|NCT02672852|579585531|FG000|Part B|Disease worsening|0|||
160507583|NCT02672852|579585532|FG001|Part B|Disease worsening|0|||
160507584|NCT02672852|579585533|FG002|Part B|Disease worsening|0|||
160507585|NCT02672852|579585534|FG003|Part B|Disease worsening|0|||
160507586|NCT02672852|579585535|FG004|Part B|Disease worsening|1|||
160507587|NCT02672852|579585536|FG005|Part B|Disease worsening|0|||
160507588|NCT02672852|579585537|FG006|Part B|Disease worsening|1|||
160507589|NCT02672852|579585531|FG000|Part B|Worsening pre-existing condition|0|||
160507590|NCT02672852|579585532|FG001|Part B|Worsening pre-existing condition|0|||
160507591|NCT02672852|579585533|FG002|Part B|Worsening pre-existing condition|0|||
160507592|NCT02672852|579585534|FG003|Part B|Worsening pre-existing condition|0|||
160507593|NCT02672852|579585535|FG004|Part B|Worsening pre-existing condition|0|||
160507594|NCT02672852|579585536|FG005|Part B|Worsening pre-existing condition|1|||
160507595|NCT02672852|579585537|FG006|Part B|Worsening pre-existing condition|0|||
160507596|NCT02672852|579585531|FG000|Part B|Other adverse event|0|||
160507597|NCT02672852|579585532|FG001|Part B|Other adverse event|0|||
160507598|NCT02672852|579585533|FG002|Part B|Other adverse event|0|||
160507599|NCT02672852|579585534|FG003|Part B|Other adverse event|0|||
160507600|NCT02672852|579585535|FG004|Part B|Other adverse event|3|||
160507601|NCT02672852|579585536|FG005|Part B|Other adverse event|5|||
160507602|NCT02672852|579585537|FG006|Part B|Other adverse event|1|||
160507603|NCT02672852|579585531|FG000|Part B|Lost to Follow-up|0|||
160507604|NCT02672852|579585532|FG001|Part B|Lost to Follow-up|0|||
160507605|NCT02672852|579585533|FG002|Part B|Lost to Follow-up|0|||
160507606|NCT02672852|579585534|FG003|Part B|Lost to Follow-up|0|||
160507607|NCT02672852|579585535|FG004|Part B|Lost to Follow-up|3|||
160507608|NCT02672852|579585536|FG005|Part B|Lost to Follow-up|4|||
160507609|NCT02672852|579585537|FG006|Part B|Lost to Follow-up|1|||
160507610|NCT02672852|579585531|FG000|Part B|Withdrawal by Subject|0|||
160507611|NCT02672852|579585532|FG001|Part B|Withdrawal by Subject|0|||
160507612|NCT02672852|579585533|FG002|Part B|Withdrawal by Subject|0|||
160507613|NCT02672852|579585534|FG003|Part B|Withdrawal by Subject|0|||
160507614|NCT02672852|579585535|FG004|Part B|Withdrawal by Subject|5|||
160507615|NCT02672852|579585536|FG005|Part B|Withdrawal by Subject|0|||
160507616|NCT02672852|579585537|FG006|Part B|Withdrawal by Subject|7|||
160507617|NCT02672852|579585531|FG000|Part B|Other|0|||
160507618|NCT02672852|579585532|FG001|Part B|Other|0|||
160507619|NCT02672852|579585533|FG002|Part B|Other|0|||
160507620|NCT02672852|579585534|FG003|Part B|Other|0|||
160507621|NCT02672852|579585535|FG004|Part B|Other|4|||
160507622|NCT02672852|579585536|FG005|Part B|Other|1|||
160507623|NCT02672852|579585537|FG006|Part B|Other|2|||
160507624|NCT01353859|579585538|FG000|Overall Study|Adverse Event|3|||
160507625|NCT01353859|579585538|FG000|Overall Study|Lack of Efficacy|1|||
160507626|NCT01725126|579585539|FG000|Overall Study|Protocol Violation|0|||
160507627|NCT01725126|579585540|FG001|Overall Study|Protocol Violation|1|||
160507628|NCT01725126|579585541|FG002|Overall Study|Protocol Violation|0|||
160507629|NCT01725126|579585542|FG003|Overall Study|Protocol Violation|0|||
160507630|NCT01725126|579585543|FG004|Overall Study|Protocol Violation|0|||
160507631|NCT01725126|579585544|FG005|Overall Study|Protocol Violation|0|||
160507632|NCT01725126|579585539|FG000|Overall Study|Withdrawal by Subject|0|||
160507633|NCT01725126|579585540|FG001|Overall Study|Withdrawal by Subject|0|||
160507634|NCT01725126|579585541|FG002|Overall Study|Withdrawal by Subject|0|||
160507635|NCT01725126|579585542|FG003|Overall Study|Withdrawal by Subject|1|||
160507636|NCT01725126|579585543|FG004|Overall Study|Withdrawal by Subject|0|||
160507637|NCT01725126|579585544|FG005|Overall Study|Withdrawal by Subject|0|||
160507638|NCT02530970|579585560|FG000|Overall Study|Adverse Event|8|||
160507639|NCT02530970|579585560|FG000|Overall Study|Lost to Follow-up|88|||
160507640|NCT02530970|579585560|FG000|Overall Study|Physician Decision|5|||
160507641|NCT02530970|579585560|FG000|Overall Study|Withdrawal by Subject|14|||
160507642|NCT02530970|579585560|FG000|Overall Study|Death|6|||
160507643|NCT02530970|579585560|FG000|Overall Study|Hospitalization|1|||
160507644|NCT02530970|579585560|FG000|Overall Study|Insurance|2|||
160507645|NCT02530970|579585560|FG000|Overall Study|Explant|2|||
160507646|NCT02530970|579585560|FG000|Overall Study|Change in Provider|5|||
160507647|NCT02530970|579585560|FG000|Overall Study|Relocation|3|||
160507648|NCT02636725|579585564|FG000|Overall Study|Adverse Event|1|||
160507649|NCT00444275|579585568|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
160507650|NCT00444275|579585569|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
160507651|NCT00444275|579585570|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
160507652|NCT00444275|579585571|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
160507653|NCT00444275|579585572|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
160507654|NCT00444275|579585568|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
160507655|NCT00444275|579585569|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
160507656|NCT00444275|579585570|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
160507657|NCT00444275|579585571|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
160507658|NCT00444275|579585572|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
160507659|NCT00444275|579585568|FG000|Maintenance Treatment Phase|Adverse Event|0|||
160507660|NCT00444275|579585569|FG001|Maintenance Treatment Phase|Adverse Event|0|||
160507661|NCT00444275|579585570|FG002|Maintenance Treatment Phase|Adverse Event|3|||
160507662|NCT00444275|579585571|FG003|Maintenance Treatment Phase|Adverse Event|2|||
160507663|NCT00444275|579585572|FG004|Maintenance Treatment Phase|Adverse Event|13|||
160507664|NCT00444275|579585568|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
160507665|NCT00444275|579585569|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
160507666|NCT00444275|579585570|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
160507667|NCT00444275|579585571|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
160507668|NCT00444275|579585572|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
160507669|NCT00444275|579585568|FG000|Maintenance Treatment Phase|Patient's wish|0|||
160507670|NCT00444275|579585569|FG001|Maintenance Treatment Phase|Patient's wish|0|||
160507671|NCT00444275|579585570|FG002|Maintenance Treatment Phase|Patient's wish|19|||
160507672|NCT00444275|579585571|FG003|Maintenance Treatment Phase|Patient's wish|9|||
160507673|NCT00444275|579585572|FG004|Maintenance Treatment Phase|Patient's wish|20|||
160507674|NCT00444275|579585568|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
160507675|NCT00444275|579585569|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
160507676|NCT00444275|579585570|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
160507677|NCT00444275|579585571|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
160507678|NCT00444275|579585572|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
160507679|NCT00444275|579585568|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
160507680|NCT00444275|579585569|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
160507681|NCT00444275|579585570|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
160507682|NCT00444275|579585571|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
160507683|NCT00444275|579585572|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
160507684|NCT04187326|579585573|FG000|Overall Study|Lost to Follow-up|2|||
160507685|NCT04187326|579585574|FG001|Overall Study|Lost to Follow-up|1|||
160507686|NCT04187326|579585573|FG000|Overall Study|Computer error- task was only partially completed.|0|||
160507687|NCT04187326|579585574|FG001|Overall Study|Computer error- task was only partially completed.|1|||
160507688|NCT02387970|579585575|FG000|Overall Study|Did not complete 1-year follow up|1|||
160507689|NCT02387970|579585576|FG001|Overall Study|Did not complete 1-year follow up|2|||
160507690|NCT02628028|579585577|FG000|Dosing Period|Withdrawal by Subject|0|||
160507691|NCT02628028|579585578|FG001|Dosing Period|Withdrawal by Subject|0|||
160507692|NCT02628028|579585579|FG002|Dosing Period|Withdrawal by Subject|1|||
160507693|NCT02628028|579585580|FG003|Dosing Period|Withdrawal by Subject|0|||
160507694|NCT02628028|579585581|FG004|Dosing Period|Withdrawal by Subject|2|||
160507695|NCT02628028|579585582|FG005|Dosing Period|Withdrawal by Subject|4|||
160507696|NCT02628028|579585583|FG006|Dosing Period|Withdrawal by Subject|1|||
160507697|NCT02628028|579585584|FG007|Dosing Period|Withdrawal by Subject|1|||
160507698|NCT02628028|579585577|FG000|Dosing Period|Adverse Event|0|||
160507699|NCT02628028|579585578|FG001|Dosing Period|Adverse Event|0|||
160507700|NCT02628028|579585579|FG002|Dosing Period|Adverse Event|0|||
160507701|NCT02628028|579585580|FG003|Dosing Period|Adverse Event|0|||
160507702|NCT02628028|579585581|FG004|Dosing Period|Adverse Event|2|||
160507703|NCT02628028|579585582|FG005|Dosing Period|Adverse Event|1|||
160507704|NCT02628028|579585583|FG006|Dosing Period|Adverse Event|3|||
160507705|NCT02628028|579585584|FG007|Dosing Period|Adverse Event|2|||
160507706|NCT02628028|579585577|FG000|Dosing Period|Death|0|||
160507707|NCT02628028|579585578|FG001|Dosing Period|Death|0|||
160507708|NCT02628028|579585579|FG002|Dosing Period|Death|0|||
160507709|NCT02628028|579585580|FG003|Dosing Period|Death|0|||
160507710|NCT02628028|579585581|FG004|Dosing Period|Death|0|||
160507711|NCT02628028|579585582|FG005|Dosing Period|Death|0|||
160507712|NCT02628028|579585583|FG006|Dosing Period|Death|0|||
160507713|NCT02628028|579585584|FG007|Dosing Period|Death|1|||
160507714|NCT02628028|579585577|FG000|Dosing Period|Lack of Efficacy|0|||
160507715|NCT02628028|579585578|FG001|Dosing Period|Lack of Efficacy|0|||
160507716|NCT02628028|579585579|FG002|Dosing Period|Lack of Efficacy|0|||
160507717|NCT02628028|579585580|FG003|Dosing Period|Lack of Efficacy|0|||
160507718|NCT02628028|579585581|FG004|Dosing Period|Lack of Efficacy|3|||
160507719|NCT02628028|579585582|FG005|Dosing Period|Lack of Efficacy|0|||
160507720|NCT02628028|579585583|FG006|Dosing Period|Lack of Efficacy|1|||
160507721|NCT02628028|579585584|FG007|Dosing Period|Lack of Efficacy|0|||
160507722|NCT02628028|579585577|FG000|Dosing Period|Study Terminated by Sponsor|0|||
160507723|NCT02628028|579585578|FG001|Dosing Period|Study Terminated by Sponsor|0|||
160663889|NCT02305758|580152413|FG001|Overall Study|Lost to Follow-up|1|||
160507724|NCT02628028|579585579|FG002|Dosing Period|Study Terminated by Sponsor|0|||
160507725|NCT02628028|579585580|FG003|Dosing Period|Study Terminated by Sponsor|0|||
160507726|NCT02628028|579585581|FG004|Dosing Period|Study Terminated by Sponsor|7|||
160507727|NCT02628028|579585582|FG005|Dosing Period|Study Terminated by Sponsor|6|||
160507728|NCT02628028|579585583|FG006|Dosing Period|Study Terminated by Sponsor|7|||
160507729|NCT02628028|579585584|FG007|Dosing Period|Study Terminated by Sponsor|7|||
160507730|NCT02628028|579585577|FG000|Dosing Period|Physician Decision|0|||
160507731|NCT02628028|579585578|FG001|Dosing Period|Physician Decision|0|||
160507732|NCT02628028|579585579|FG002|Dosing Period|Physician Decision|0|||
160507733|NCT02628028|579585580|FG003|Dosing Period|Physician Decision|0|||
160507734|NCT02628028|579585581|FG004|Dosing Period|Physician Decision|0|||
160507735|NCT02628028|579585582|FG005|Dosing Period|Physician Decision|1|||
160507736|NCT02628028|579585583|FG006|Dosing Period|Physician Decision|0|||
160507737|NCT02628028|579585584|FG007|Dosing Period|Physician Decision|0|||
160507738|NCT02628028|579585577|FG000|Dosing Period|Site Terminated by Sponsor|0|||
160507739|NCT02628028|579585578|FG001|Dosing Period|Site Terminated by Sponsor|0|||
160507740|NCT02628028|579585579|FG002|Dosing Period|Site Terminated by Sponsor|0|||
160507741|NCT02628028|579585580|FG003|Dosing Period|Site Terminated by Sponsor|0|||
160507742|NCT02628028|579585581|FG004|Dosing Period|Site Terminated by Sponsor|0|||
160507743|NCT02628028|579585582|FG005|Dosing Period|Site Terminated by Sponsor|1|||
160507744|NCT02628028|579585583|FG006|Dosing Period|Site Terminated by Sponsor|1|||
160507745|NCT02628028|579585584|FG007|Dosing Period|Site Terminated by Sponsor|0|||
160507746|NCT02628028|579585577|FG000|Dosing Period|Lost to Follow-up|0|||
160507747|NCT02628028|579585578|FG001|Dosing Period|Lost to Follow-up|0|||
160507748|NCT02628028|579585579|FG002|Dosing Period|Lost to Follow-up|0|||
160507749|NCT02628028|579585580|FG003|Dosing Period|Lost to Follow-up|0|||
160507750|NCT02628028|579585581|FG004|Dosing Period|Lost to Follow-up|0|||
160507751|NCT02628028|579585582|FG005|Dosing Period|Lost to Follow-up|0|||
160507752|NCT02628028|579585583|FG006|Dosing Period|Lost to Follow-up|1|||
160507753|NCT02628028|579585584|FG007|Dosing Period|Lost to Follow-up|0|||
160507754|NCT02628028|579585577|FG000|Dosing Period|Other|0|||
160507755|NCT02628028|579585578|FG001|Dosing Period|Other|0|||
160507756|NCT02628028|579585579|FG002|Dosing Period|Other|0|||
160507757|NCT02628028|579585580|FG003|Dosing Period|Other|0|||
160507758|NCT02628028|579585581|FG004|Dosing Period|Other|2|||
160507759|NCT02628028|579585582|FG005|Dosing Period|Other|1|||
160507760|NCT02628028|579585583|FG006|Dosing Period|Other|2|||
160507761|NCT02628028|579585584|FG007|Dosing Period|Other|4|||
160507762|NCT02628028|579585577|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
160507763|NCT02628028|579585578|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
160507764|NCT02628028|579585579|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
160507765|NCT02628028|579585580|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
160507766|NCT02628028|579585581|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
160507767|NCT02628028|579585582|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
160507768|NCT02628028|579585583|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
160507769|NCT02628028|579585584|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
160507770|NCT02628028|579585577|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
160507771|NCT02628028|579585578|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
160507772|NCT02628028|579585579|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
160507773|NCT02628028|579585580|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
160507774|NCT02628028|579585581|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
160507775|NCT02628028|579585582|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
160507776|NCT02628028|579585583|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
160507777|NCT02628028|579585584|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
160507778|NCT02628028|579585577|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
160507779|NCT02628028|579585578|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
160507780|NCT02628028|579585579|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
160507781|NCT02628028|579585580|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
160507782|NCT02628028|579585581|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
160507783|NCT02628028|579585582|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
160507784|NCT02628028|579585583|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
160507785|NCT02628028|579585584|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
160507786|NCT02628028|579585577|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
160663890|NCT02305758|580152412|FG000|Overall Study|Study Terminated by Sponsor|21|||
160663891|NCT02305758|580152413|FG001|Overall Study|Study Terminated by Sponsor|34|||
160663892|NCT02305758|580152412|FG000|Overall Study|Other, not specified|2|||
160507787|NCT02628028|579585578|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
160507788|NCT02628028|579585579|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
160663893|NCT02305758|580152413|FG001|Overall Study|Other, not specified|1|||
160507789|NCT02628028|579585580|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
160507790|NCT02628028|579585581|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
160507791|NCT02628028|579585582|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
160507792|NCT02628028|579585583|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
160663894|NCT04149964|580152414|FG000|Overall Study|Lost to Follow-up|19|||
160507793|NCT02628028|579585584|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
160507794|NCT02628028|579585577|FG000|Long-term Extension (LTE) Period|Other|0|||
160507795|NCT02628028|579585578|FG001|Long-term Extension (LTE) Period|Other|0|||
160507796|NCT02628028|579585579|FG002|Long-term Extension (LTE) Period|Other|0|||
160507797|NCT02628028|579585580|FG003|Long-term Extension (LTE) Period|Other|0|||
160507798|NCT02628028|579585581|FG004|Long-term Extension (LTE) Period|Other|0|||
160507799|NCT02628028|579585582|FG005|Long-term Extension (LTE) Period|Other|3|||
160507800|NCT02628028|579585583|FG006|Long-term Extension (LTE) Period|Other|4|||
160507801|NCT02628028|579585584|FG007|Long-term Extension (LTE) Period|Other|3|||
160507802|NCT00586612|579585585|FG000|Primary Phase|Protocol Violation|1|||
160507803|NCT00586612|579585586|FG001|Primary Phase|Protocol Violation|0|||
160507804|NCT00586612|579585585|FG000|Primary Phase|Lost to Follow-up|0|||
160507805|NCT00586612|579585586|FG001|Primary Phase|Lost to Follow-up|1|||
160507806|NCT00586612|579585585|FG000|Primary Phase|Withdrawal by Subject|0|||
160507807|NCT00586612|579585586|FG001|Primary Phase|Withdrawal by Subject|2|||
160507808|NCT00586612|579585585|FG000|Booster Phase|Lost to Follow-up|3|||
160507809|NCT00586612|579585586|FG001|Booster Phase|Lost to Follow-up|1|||
160507810|NCT00186888|579585587|FG000|Overall Study|Toxicity|0|||
160507811|NCT00186888|579585588|FG001|Overall Study|Toxicity|1|||
160507812|NCT00186888|579585589|FG002|Overall Study|Toxicity|0|||
160507813|NCT00186888|579585587|FG000|Overall Study|Relapse or progression of disease|4|||
160507814|NCT00186888|579585588|FG001|Overall Study|Relapse or progression of disease|2|||
160507815|NCT00186888|579585589|FG002|Overall Study|Relapse or progression of disease|0|||
160507816|NCT04777864|579585590|FG000|Overall Study|Lost to Follow-up|8|||
160507817|NCT04777864|579585591|FG001|Overall Study|Lost to Follow-up|19|||
160507818|NCT03086655|579585592|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
160507819|NCT03086655|579585593|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
160507820|NCT03086655|579585592|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
160507821|NCT03086655|579585593|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
160507822|NCT03086655|579585592|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
160507823|NCT03086655|579585593|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
160507824|NCT03086655|579585592|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
160507825|NCT03086655|579585593|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
160507826|NCT03086655|579585592|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
160507827|NCT03086655|579585593|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
160507828|NCT03086655|579585592|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
160507829|NCT03086655|579585593|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
160507830|NCT03086655|579585592|FG000|12 Month Follow-up = Final Assessment|Death|0|||
160507831|NCT03086655|579585593|FG001|12 Month Follow-up = Final Assessment|Death|1|||
160507832|NCT00384397|579585594|FG000|Overall Study|Adverse Event|0|||
160507833|NCT00384397|579585595|FG001|Overall Study|Adverse Event|1|||
160507834|NCT00384397|579585596|FG002|Overall Study|Adverse Event|2|||
160507835|NCT00384397|579585594|FG000|Overall Study|Protocol Violation|7|||
160507836|NCT00384397|579585595|FG001|Overall Study|Protocol Violation|15|||
160507837|NCT00384397|579585596|FG002|Overall Study|Protocol Violation|13|||
160507838|NCT00384397|579585594|FG000|Overall Study|Lost to Follow-up|11|||
160507839|NCT00384397|579585595|FG001|Overall Study|Lost to Follow-up|13|||
160507840|NCT00384397|579585596|FG002|Overall Study|Lost to Follow-up|3|||
160507841|NCT00384397|579585594|FG000|Overall Study|Withdrawal by Subject|14|||
160507842|NCT00384397|579585595|FG001|Overall Study|Withdrawal by Subject|17|||
160507843|NCT00384397|579585596|FG002|Overall Study|Withdrawal by Subject|15|||
160507844|NCT02336451|579585597|FG000|Overall Study|Adverse Event|1|||
160507845|NCT02336451|579585598|FG001|Overall Study|Adverse Event|2|||
160507846|NCT02336451|579585599|FG002|Overall Study|Adverse Event|0|||
160507847|NCT02336451|579585600|FG003|Overall Study|Adverse Event|6|||
160507848|NCT02336451|579585601|FG004|Overall Study|Adverse Event|4|||
160507849|NCT02336451|579585597|FG000|Overall Study|Death|6|||
160507850|NCT02336451|579585598|FG001|Overall Study|Death|2|||
160507851|NCT02336451|579585599|FG002|Overall Study|Death|3|||
160507852|NCT02336451|579585600|FG003|Overall Study|Death|6|||
160507853|NCT02336451|579585601|FG004|Overall Study|Death|6|||
160507854|NCT02336451|579585597|FG000|Overall Study|Physician Decision|9|||
160507855|NCT02336451|579585598|FG001|Overall Study|Physician Decision|6|||
160507856|NCT02336451|579585599|FG002|Overall Study|Physician Decision|7|||
160507857|NCT02336451|579585600|FG003|Overall Study|Physician Decision|16|||
160507858|NCT02336451|579585601|FG004|Overall Study|Physician Decision|3|||
160507859|NCT02336451|579585597|FG000|Overall Study|Progressive disease|23|||
160507860|NCT02336451|579585598|FG001|Overall Study|Progressive disease|26|||
160507861|NCT02336451|579585599|FG002|Overall Study|Progressive disease|2|||
160507862|NCT02336451|579585600|FG003|Overall Study|Progressive disease|14|||
160507863|NCT02336451|579585601|FG004|Overall Study|Progressive disease|4|||
160507864|NCT02336451|579585597|FG000|Overall Study|Protocol Violation|1|||
160507865|NCT02336451|579585598|FG001|Overall Study|Protocol Violation|0|||
160507866|NCT02336451|579585599|FG002|Overall Study|Protocol Violation|0|||
160507867|NCT02336451|579585600|FG003|Overall Study|Protocol Violation|0|||
160507868|NCT02336451|579585601|FG004|Overall Study|Protocol Violation|0|||
160507869|NCT02336451|579585597|FG000|Overall Study|Patient/guardian decision|2|||
160507870|NCT02336451|579585598|FG001|Overall Study|Patient/guardian decision|4|||
160507871|NCT02336451|579585599|FG002|Overall Study|Patient/guardian decision|0|||
160507872|NCT02336451|579585600|FG003|Overall Study|Patient/guardian decision|2|||
160507873|NCT02336451|579585601|FG004|Overall Study|Patient/guardian decision|1|||
160507874|NCT04893460|579585607|FG000|Overall Study|Lost to Follow-up|18|||
160507875|NCT06748729|579585609|FG000|Overall Study|Withdrawal by Subject|1|||
160507876|NCT01099215|579587338|FG000|Overall Study|Withdrawal by Subject|1|||
160507877|NCT01099215|579587339|FG001|Overall Study|Withdrawal by Subject|0|||
160507878|NCT01099215|579587338|FG000|Overall Study|Adverse Event|0|||
160507879|NCT01099215|579587339|FG001|Overall Study|Adverse Event|1|||
160507880|NCT01732822|579587341|FG000|Overall Study|Withdrawal by Subject|123|||
160507881|NCT01732822|579587342|FG001|Overall Study|Withdrawal by Subject|113|||
160507882|NCT02314780|579587343|FG000|Overall Study|organizational reasons|0|||
160507883|NCT02314780|579587344|FG001|Overall Study|organizational reasons|2|||
160507884|NCT02314780|579587345|FG002|Overall Study|organizational reasons|0|||
160507885|NCT02314780|579587343|FG000|Overall Study|Adverse Event|0|||
160507886|NCT02314780|579587344|FG001|Overall Study|Adverse Event|1|||
160507887|NCT02314780|579587345|FG002|Overall Study|Adverse Event|0|||
160507888|NCT01901432|579587346|FG000|Overall Study|Adverse Event|0|||
160507889|NCT01901432|579587347|FG001|Overall Study|Adverse Event|1|||
160507890|NCT01901432|579587348|FG002|Overall Study|Adverse Event|1|||
160507891|NCT01901432|579587349|FG003|Overall Study|Adverse Event|0|||
160507892|NCT01901432|579587350|FG004|Overall Study|Adverse Event|1|||
160507893|NCT01901432|579587346|FG000|Overall Study|Withdrawal by Subject|0|||
160507894|NCT01901432|579587347|FG001|Overall Study|Withdrawal by Subject|0|||
160507895|NCT01901432|579587348|FG002|Overall Study|Withdrawal by Subject|1|||
160507896|NCT01901432|579587349|FG003|Overall Study|Withdrawal by Subject|0|||
160507897|NCT01901432|579587350|FG004|Overall Study|Withdrawal by Subject|5|||
160507898|NCT01901432|579587346|FG000|Overall Study|Physician Decision|0|||
160507899|NCT01901432|579587347|FG001|Overall Study|Physician Decision|0|||
160507900|NCT01901432|579587348|FG002|Overall Study|Physician Decision|0|||
160507901|NCT01901432|579587349|FG003|Overall Study|Physician Decision|0|||
160507902|NCT01901432|579587350|FG004|Overall Study|Physician Decision|2|||
160507903|NCT01901432|579587346|FG000|Overall Study|Patient decision to stop study drug|0|||
160507904|NCT01901432|579587347|FG001|Overall Study|Patient decision to stop study drug|0|||
160507905|NCT01901432|579587348|FG002|Overall Study|Patient decision to stop study drug|0|||
160507906|NCT01901432|579587349|FG003|Overall Study|Patient decision to stop study drug|0|||
160507907|NCT01901432|579587350|FG004|Overall Study|Patient decision to stop study drug|1|||
160507908|NCT01077271|579587356|FG000|Overall Study|Parental desire|8|||
160507909|NCT01077271|579587356|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
160507910|NCT01077271|579587356|FG000|Overall Study|Noncompliance|2|||
160507911|NCT01077271|579587356|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
160507912|NCT01077271|579587356|FG000|Overall Study|Changed doctors|2|||
160507913|NCT01077271|579587356|FG000|Overall Study|Parents thought too many injections|2|||
160507914|NCT01077271|579587356|FG000|Overall Study|End of RSV season nearly reached|1|||
160507915|NCT01077271|579587356|FG000|Overall Study|Mother unconvinced of the necessity|1|||
160507916|NCT00379288|579587357|FG000|Overall Study|Adverse Event|5|||
160507917|NCT00379288|579587358|FG001|Overall Study|Adverse Event|6|||
160507918|NCT00379288|579587359|FG002|Overall Study|Adverse Event|2|||
160507919|NCT00379288|579587360|FG003|Overall Study|Adverse Event|0|||
160507920|NCT00379288|579587357|FG000|Overall Study|Treatment Failure|0|||
160507921|NCT00379288|579587358|FG001|Overall Study|Treatment Failure|1|||
160507922|NCT00379288|579587359|FG002|Overall Study|Treatment Failure|0|||
160507923|NCT00379288|579587360|FG003|Overall Study|Treatment Failure|1|||
160507924|NCT00379288|579587357|FG000|Overall Study|Lost to Follow-up|3|||
160507925|NCT00379288|579587358|FG001|Overall Study|Lost to Follow-up|3|||
160507926|NCT00379288|579587359|FG002|Overall Study|Lost to Follow-up|2|||
160507927|NCT00379288|579587360|FG003|Overall Study|Lost to Follow-up|0|||
160507928|NCT00379288|579587357|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
160507929|NCT00379288|579587358|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
160507930|NCT00379288|579587359|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
160507931|NCT00379288|579587360|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
160507932|NCT00379288|579587357|FG000|Overall Study|Subject withdrew-related to study drug|1|||
160507933|NCT00379288|579587358|FG001|Overall Study|Subject withdrew-related to study drug|0|||
160507934|NCT00379288|579587359|FG002|Overall Study|Subject withdrew-related to study drug|0|||
160507935|NCT00379288|579587360|FG003|Overall Study|Subject withdrew-related to study drug|1|||
160507936|NCT00379288|579587357|FG000|Overall Study|Noncompliance with protocol|8|||
160507937|NCT00379288|579587358|FG001|Overall Study|Noncompliance with protocol|6|||
160507938|NCT00379288|579587359|FG002|Overall Study|Noncompliance with protocol|2|||
160507939|NCT00379288|579587360|FG003|Overall Study|Noncompliance with protocol|1|||
160507940|NCT00379288|579587357|FG000|Overall Study|Did not meet protocol eligibility|0|||
160507941|NCT00379288|579587358|FG001|Overall Study|Did not meet protocol eligibility|1|||
160507942|NCT00379288|579587359|FG002|Overall Study|Did not meet protocol eligibility|0|||
160507943|NCT00379288|579587360|FG003|Overall Study|Did not meet protocol eligibility|2|||
160507944|NCT00379288|579587357|FG000|Overall Study|Administrative|2|||
160507945|NCT00379288|579587358|FG001|Overall Study|Administrative|2|||
160507946|NCT00379288|579587359|FG002|Overall Study|Administrative|0|||
160507947|NCT00379288|579587360|FG003|Overall Study|Administrative|1|||
160507948|NCT00215137|579587361|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
160507949|NCT00215137|579587362|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
160507950|NCT00215137|579587363|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
160507951|NCT00215137|579587361|FG000|Randomization Period|Lost to Follow-up|0|||
160507952|NCT00215137|579587362|FG001|Randomization Period|Lost to Follow-up|1|||
160507953|NCT00215137|579587363|FG002|Randomization Period|Lost to Follow-up|0|||
160507954|NCT00215137|579587361|FG000|Randomization Period|Withdrawal by Subject|0|||
160507955|NCT00215137|579587362|FG001|Randomization Period|Withdrawal by Subject|1|||
160507956|NCT00215137|579587363|FG002|Randomization Period|Withdrawal by Subject|0|||
160507957|NCT03333876|579587364|FG000|Screening Period|Screen Failure|4|||
160507958|NCT03333876|579587364|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
160507959|NCT03333876|579587364|FG000|Mandibular Advancement|Adverse Event|2|||
160507960|NCT03333876|579587364|FG000|Mandibular Advancement|Product Damage|2|||
160507961|NCT05020327|579587366|FG000|Overall Study|Physician Decision|3|||
160507962|NCT05020327|579587367|FG001|Overall Study|Physician Decision|0|||
160507963|NCT05020327|579587368|FG002|Overall Study|Physician Decision|0|||
160507964|NCT05020327|579587366|FG000|Overall Study|Withdrawal by Subject|1|||
160507965|NCT05020327|579587367|FG001|Overall Study|Withdrawal by Subject|1|||
160507966|NCT05020327|579587368|FG002|Overall Study|Withdrawal by Subject|0|||
160507967|NCT05020327|579587366|FG000|Overall Study|personal/cultural, ineligible|12|||
160507968|NCT05020327|579587367|FG001|Overall Study|personal/cultural, ineligible|0|||
160507969|NCT05020327|579587368|FG002|Overall Study|personal/cultural, ineligible|0|||
160507970|NCT00166712|579587369|FG000|Overall Study|Death|0|||
160507971|NCT00166712|579587370|FG001|Overall Study|Death|1|||
160620486|NCT01513460|579988505|FG000|Overall Study|Abnormal laboratory value|1|||
160620487|NCT01513460|579988506|FG001|Overall Study|Abnormal laboratory value|0|||
160620488|NCT01513460|579988507|FG002|Overall Study|Abnormal laboratory value|1|||
160507972|NCT00166712|579587369|FG000|Overall Study|Adverse Event|1|||
160507973|NCT00166712|579587370|FG001|Overall Study|Adverse Event|0|||
160507974|NCT00166712|579587369|FG000|Overall Study|Withdrawal by Subject|1|||
160507975|NCT00166712|579587370|FG001|Overall Study|Withdrawal by Subject|2|||
160507976|NCT00166712|579587369|FG000|Overall Study|Physician Decision|0|||
160507977|NCT00166712|579587370|FG001|Overall Study|Physician Decision|2|||
160507978|NCT04684394|579587371|FG000|Overall Study|Death|1|||
160507979|NCT04684394|579587372|FG001|Overall Study|Death|2|||
160507980|NCT04684394|579587371|FG000|Overall Study|Lost to Follow-up|1|||
160507981|NCT04684394|579587372|FG001|Overall Study|Lost to Follow-up|0|||
160620489|NCT01513460|579988505|FG000|Overall Study|Lack of Efficacy|1|||
160620490|NCT01513460|579988506|FG001|Overall Study|Lack of Efficacy|2|||
160507982|NCT04684394|579587371|FG000|Overall Study|Withdrawal by Subject|2|||
160507983|NCT04684394|579587372|FG001|Overall Study|Withdrawal by Subject|0|||
160507984|NCT04684394|579587371|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
160507985|NCT04684394|579587372|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
160507986|NCT03986944|579587373|FG000|Overall Study|Adverse Event|1|||
160507987|NCT03986944|579587374|FG001|Overall Study|Adverse Event|2|||
160507988|NCT03986944|579587375|FG002|Overall Study|Adverse Event|3|||
160507989|NCT03986944|579587373|FG000|Overall Study|Protocol Violation|0|||
160507990|NCT03986944|579587374|FG001|Overall Study|Protocol Violation|1|||
160507991|NCT03986944|579587375|FG002|Overall Study|Protocol Violation|1|||
160507992|NCT03986944|579587373|FG000|Overall Study|Withdrawal by Subject|3|||
160507993|NCT03986944|579587374|FG001|Overall Study|Withdrawal by Subject|5|||
160507994|NCT03986944|579587375|FG002|Overall Study|Withdrawal by Subject|5|||
160507995|NCT03986944|579587373|FG000|Overall Study|Study termination|10|||
160507996|NCT03986944|579587374|FG001|Overall Study|Study termination|10|||
160507997|NCT03986944|579587375|FG002|Overall Study|Study termination|10|||
160507998|NCT03986944|579587373|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
160507999|NCT03986944|579587374|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
160508000|NCT03986944|579587375|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
160508001|NCT03986944|579587373|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
160508002|NCT03986944|579587374|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
160508003|NCT03986944|579587375|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
160508004|NCT03002220|579587377|FG000|Overall Study|Lack of Efficacy|2|||
160508005|NCT03002220|579587377|FG000|Overall Study|Withdrawal by Subject|3|||
160508006|NCT03002220|579587377|FG000|Overall Study|Adverse Event|2|||
160508007|NCT03002220|579587377|FG000|Overall Study|Disease progression|13|||
160508008|NCT03002220|579587377|FG000|Overall Study|Physician Decision|1|||
160508009|NCT01015560|579587378|FG000|Overall Study|Adverse Event|1|||
160508010|NCT01015560|579587378|FG000|Overall Study|Not protocol specified|1|||
160508011|NCT01015560|579587378|FG000|Overall Study|Withdrawal by Subject|1|||
160508012|NCT00581555|579587390|FG000|Overall Study|Adverse Event|4|||
160508013|NCT00581555|579587391|FG001|Overall Study|Adverse Event|3|||
160508014|NCT00581555|579587390|FG000|Overall Study|Physician Decision|3|||
160508015|NCT00581555|579587391|FG001|Overall Study|Physician Decision|2|||
160508016|NCT00581555|579587390|FG000|Overall Study|Withdrawal by Subject|18|||
160508017|NCT00581555|579587391|FG001|Overall Study|Withdrawal by Subject|9|||
160508018|NCT00581555|579587390|FG000|Overall Study|Lost to Follow-up|2|||
160508019|NCT00581555|579587391|FG001|Overall Study|Lost to Follow-up|2|||
160508020|NCT00581555|579587390|FG000|Overall Study|Other reasons|16|||
160508021|NCT00581555|579587391|FG001|Overall Study|Other reasons|4|||
160508022|NCT05816330|579587397|FG000|Overall Study|Withdrawal by Subject|4|||
160508023|NCT05816330|579587398|FG001|Overall Study|Withdrawal by Subject|1|||
160508024|NCT00201643|579587399|FG000|Overall Study|Withdrawal by Subject|5|||
160508025|NCT00201643|579587400|FG001|Overall Study|Withdrawal by Subject|4|||
160508026|NCT03446781|579587401|FG000|Overall Study|Lost to Follow-up|11|||
160508027|NCT03446781|579587402|FG001|Overall Study|Lost to Follow-up|5|||
160508028|NCT03446781|579587401|FG000|Overall Study|Withdrawal by Subject|9|||
160508029|NCT03446781|579587402|FG001|Overall Study|Withdrawal by Subject|7|||
160620491|NCT01513460|579988507|FG002|Overall Study|Lack of Efficacy|5|||
160620492|NCT01513460|579988505|FG000|Overall Study|Protocol deviations|3|||
160620493|NCT01513460|579988506|FG001|Overall Study|Protocol deviations|4|||
160620494|NCT01513460|579988507|FG002|Overall Study|Protocol deviations|3|||
160620495|NCT01513460|579988505|FG000|Overall Study|Withdrawal by Subject|7|||
160508030|NCT03446781|579587401|FG000|Overall Study|Adverse Event|8|||
160508031|NCT03446781|579587402|FG001|Overall Study|Adverse Event|2|||
160508032|NCT03446781|579587401|FG000|Overall Study|Protocol Violation|0|||
160508033|NCT03446781|579587402|FG001|Overall Study|Protocol Violation|3|||
160508034|NCT01802567|579587404|FG000|Overall Study|Withdrawal by Subject|2|||
160508035|NCT01802567|579587404|FG000|Overall Study|Physician Decision|1|||
160508036|NCT01802567|579587404|FG000|Overall Study|Lack of Efficacy|7|||
160508037|NCT01802567|579587404|FG000|Overall Study|Consented but did not start therapy|7|||
160508038|NCT01802567|579587404|FG000|Overall Study|Protocol Violation|1|||
160508039|NCT01895101|579587405|FG000|Overall Study|OPCAB procedure|1|||
160508040|NCT01895101|579587406|FG001|Overall Study|OPCAB procedure|1|||
160508041|NCT01895101|579587407|FG002|Overall Study|OPCAB procedure|3|||
160508042|NCT01895101|579587405|FG000|Overall Study|Withdrawal by Subject|0|||
160508043|NCT01895101|579587406|FG001|Overall Study|Withdrawal by Subject|1|||
160508044|NCT01895101|579587407|FG002|Overall Study|Withdrawal by Subject|2|||
160508045|NCT01895101|579587405|FG000|Overall Study|another study, enrolled in other study|0|||
160508046|NCT01895101|579587406|FG001|Overall Study|another study, enrolled in other study|1|||
160508047|NCT01895101|579587407|FG002|Overall Study|another study, enrolled in other study|0|||
160508048|NCT01895101|579587405|FG000|Overall Study|Death|0|||
160508049|NCT01895101|579587406|FG001|Overall Study|Death|1|||
160508050|NCT01895101|579587407|FG002|Overall Study|Death|0|||
160508051|NCT01895101|579587405|FG000|Overall Study|coagulation disorder|0|||
160508052|NCT01895101|579587406|FG001|Overall Study|coagulation disorder|1|||
160508053|NCT01895101|579587407|FG002|Overall Study|coagulation disorder|0|||
160508054|NCT03268603|579587408|FG000|Overall Study|Withdrawal by Subject|6|||
160508055|NCT03268603|579587408|FG000|Overall Study|Physician Decision|1|||
160508056|NCT03268603|579587408|FG000|Overall Study|Withdrawn due to disease progression|2|||
160508057|NCT03248882|579587409|FG000|Overall Study|Adverse Event|3|||
160508058|NCT03248882|579587410|FG001|Overall Study|Adverse Event|3|||
160508059|NCT03248882|579587411|FG002|Overall Study|Adverse Event|2|||
160508060|NCT03248882|579587412|FG003|Overall Study|Adverse Event|6|||
160508061|NCT03248882|579587413|FG004|Overall Study|Adverse Event|9|||
160508062|NCT03248882|579587409|FG000|Overall Study|Lost to Follow-up|0|||
160508063|NCT03248882|579587410|FG001|Overall Study|Lost to Follow-up|0|||
160508064|NCT03248882|579587411|FG002|Overall Study|Lost to Follow-up|0|||
160508065|NCT03248882|579587412|FG003|Overall Study|Lost to Follow-up|0|||
160508066|NCT03248882|579587413|FG004|Overall Study|Lost to Follow-up|1|||
160508067|NCT03248882|579587409|FG000|Overall Study|Protocol Violation|2|||
160508068|NCT03248882|579587410|FG001|Overall Study|Protocol Violation|0|||
160508069|NCT03248882|579587411|FG002|Overall Study|Protocol Violation|2|||
160508070|NCT03248882|579587412|FG003|Overall Study|Protocol Violation|0|||
160508071|NCT03248882|579587413|FG004|Overall Study|Protocol Violation|1|||
160508072|NCT03248882|579587409|FG000|Overall Study|Withdrawal by Subject|2|||
160508073|NCT03248882|579587410|FG001|Overall Study|Withdrawal by Subject|2|||
160508074|NCT03248882|579587411|FG002|Overall Study|Withdrawal by Subject|3|||
160508075|NCT03248882|579587412|FG003|Overall Study|Withdrawal by Subject|4|||
160508076|NCT03248882|579587413|FG004|Overall Study|Withdrawal by Subject|2|||
160508077|NCT02182947|579587414|FG000|Overall Study|Withdrawal by Subject|7|||
160508078|NCT02182947|579587414|FG000|Overall Study|Lost to Follow-up|3|||
160508079|NCT02182947|579587414|FG000|Overall Study|Failed screening activities|8|||
160508080|NCT04308590|579587415|FG000|Overall Study|Adverse Event|12|||
160508081|NCT04308590|579587416|FG001|Overall Study|Adverse Event|2|||
160508082|NCT04308590|579587415|FG000|Overall Study|Withdrawal by Subject|10|||
160508083|NCT04308590|579587416|FG001|Overall Study|Withdrawal by Subject|4|||
160508084|NCT04308590|579587415|FG000|Overall Study|Death|1|||
160508085|NCT04308590|579587416|FG001|Overall Study|Death|0|||
160508086|NCT04308590|579587415|FG000|Overall Study|Lost to Follow-up|1|||
160508087|NCT04308590|579587416|FG001|Overall Study|Lost to Follow-up|1|||
160508088|NCT04308590|579587415|FG000|Overall Study|Physician Decision|1|||
160508089|NCT04308590|579587416|FG001|Overall Study|Physician Decision|0|||
160508090|NCT04308590|579587415|FG000|Overall Study|Subject does not want to continue with Pi|0|||
160508091|NCT04308590|579587416|FG001|Overall Study|Subject does not want to continue with Pi|1|||
160508092|NCT01156376|579587418|FG000|Overall Study|Adverse Event|1|||
160508093|NCT01156376|579587419|FG001|Overall Study|Adverse Event|0|||
160508094|NCT01156376|579587420|FG002|Overall Study|Adverse Event|1|||
160508095|NCT01156376|579587418|FG000|Overall Study|Withdrawal by Subject|0|||
160508096|NCT01156376|579587419|FG001|Overall Study|Withdrawal by Subject|0|||
160508097|NCT01156376|579587420|FG002|Overall Study|Withdrawal by Subject|3|||
160508098|NCT01493427|579587421|FG000|Overall Study|Adverse Event|10|||
160508099|NCT01493427|579587421|FG000|Overall Study|Personal Reasons|4|||
160508100|NCT01493427|579587421|FG000|Overall Study|Lost to Follow-up|2|||
160508101|NCT01493427|579587421|FG000|Overall Study|Inability to Follow Instructions|2|||
160508102|NCT01493427|579587421|FG000|Overall Study|Other|2|||
160508103|NCT03733314|579587422|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
160508104|NCT03733314|579587423|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
160508105|NCT03733314|579587422|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
160508106|NCT03733314|579587423|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
160508107|NCT03733314|579587422|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
160508108|NCT03733314|579587423|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
160508109|NCT03733314|579587422|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
160508110|NCT03733314|579587423|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
160508111|NCT03733314|579587422|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
160508112|NCT03733314|579587423|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
160508113|NCT03733314|579587422|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
160508114|NCT03733314|579587423|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
160508115|NCT01598662|579587424|FG000|Overall Study|Lost to Follow-up|10|||
160508116|NCT01598662|579587425|FG001|Overall Study|Lost to Follow-up|17|||
160508117|NCT01598662|579587424|FG000|Overall Study|Physician Decision|1|||
160508118|NCT01598662|579587425|FG001|Overall Study|Physician Decision|2|||
160508119|NCT01598662|579587424|FG000|Overall Study|IUD expelled before month 6|0|||
160508120|NCT01598662|579587425|FG001|Overall Study|IUD expelled before month 6|2|||
160508121|NCT02075073|579587426|FG000|Overall Study|Withdrawal by Subject|0|||
160508122|NCT02075073|579587427|FG001|Overall Study|Withdrawal by Subject|1|||
160508123|NCT02075073|579587428|FG002|Overall Study|Withdrawal by Subject|0|||
160508124|NCT02683785|579587429|FG000|Overall Study|Withdrawal by Subject|1|||
160508125|NCT02683785|579587430|FG001|Overall Study|Withdrawal by Subject|1|||
160508126|NCT02683785|579587429|FG000|Overall Study|Lost to Follow-up|0|||
160508127|NCT02683785|579587430|FG001|Overall Study|Lost to Follow-up|1|||
160508128|NCT02683785|579587429|FG000|Overall Study|Adverse Event|0|||
160508129|NCT02683785|579587430|FG001|Overall Study|Adverse Event|2|||
160508130|NCT01305408|579587433|FG000|Overall Study|Adverse Event|10|||
160508131|NCT01305408|579587434|FG001|Overall Study|Adverse Event|7|||
160508132|NCT01305408|579587433|FG000|Overall Study|Lack of Efficacy|3|||
160508133|NCT01305408|579587434|FG001|Overall Study|Lack of Efficacy|4|||
160508134|NCT01305408|579587433|FG000|Overall Study|Withdrawal by Subject|9|||
160508135|NCT01305408|579587434|FG001|Overall Study|Withdrawal by Subject|9|||
160508136|NCT01305408|579587433|FG000|Overall Study|Protocol Violation|4|||
160508137|NCT01305408|579587434|FG001|Overall Study|Protocol Violation|6|||
160508138|NCT01305408|579587433|FG000|Overall Study|Lost to Follow-up|5|||
160508139|NCT01305408|579587434|FG001|Overall Study|Lost to Follow-up|3|||
160508140|NCT01305408|579587433|FG000|Overall Study|Noncompliance with study medication|0|||
160508141|NCT01305408|579587434|FG001|Overall Study|Noncompliance with study medication|1|||
160508142|NCT01305408|579587433|FG000|Overall Study|Noncompliance with study procedures|0|||
160508143|NCT01305408|579587434|FG001|Overall Study|Noncompliance with study procedures|1|||
160508144|NCT01305408|579587433|FG000|Overall Study|Other|1|||
160508145|NCT01305408|579587434|FG001|Overall Study|Other|0|||
160508146|NCT02770612|579587435|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
160508147|NCT02233803|579587436|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
160508148|NCT02233803|579587437|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
160508149|NCT02233803|579587436|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
160508150|NCT02233803|579587437|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
160508151|NCT02233803|579587436|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
160508152|NCT02233803|579587437|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
160508153|NCT02233803|579587436|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
160508154|NCT02233803|579587437|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
160508155|NCT02233803|579587436|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
160508156|NCT02233803|579587437|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
160508157|NCT02233803|579587436|FG000|Washout Period (4-Wks)|Physician Decision|1|||
160508158|NCT02233803|579587437|FG001|Washout Period (4-Wks)|Physician Decision|0|||
160508159|NCT02233803|579587436|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
160508160|NCT02233803|579587437|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
160508161|NCT02233803|579587436|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
160508162|NCT02233803|579587437|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
160508163|NCT02233803|579587436|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
160508164|NCT02233803|579587437|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
160663895|NCT04149964|580152415|FG001|Overall Study|Lost to Follow-up|18|||
160663896|NCT05593965|580152416|FG000|1st Intervention (1 Day)|Technical error|1|||
160663897|NCT05593965|580152417|FG001|1st Intervention (1 Day)|Technical error|0|||
160663898|NCT02272777|580152418|FG000|Overall Study|Adverse Event|0|||
160663899|NCT02272777|580152419|FG001|Overall Study|Adverse Event|1|||
160663900|NCT02272777|580152418|FG000|Overall Study|Withdrawal by Subject|0|||
160508165|NCT03846453|579587438|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
160508166|NCT03846453|579587439|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
160508167|NCT03846453|579587440|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
160508168|NCT03846453|579587438|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
160508169|NCT03846453|579587439|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
160508170|NCT03846453|579587440|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
160508171|NCT03846453|579587438|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
160508172|NCT03846453|579587439|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
160663901|NCT02272777|580152419|FG001|Overall Study|Withdrawal by Subject|3|||
160508173|NCT03846453|579587440|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
160508174|NCT03846453|579587438|FG000|Placebo Run-in (14 Days)|Other|2|||
160508175|NCT03846453|579587439|FG001|Placebo Run-in (14 Days)|Other|0|||
160508176|NCT03846453|579587440|FG002|Placebo Run-in (14 Days)|Other|0|||
160508177|NCT03846453|579587438|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
160508178|NCT03846453|579587439|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
160508179|NCT03846453|579587440|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
160508180|NCT03846453|579587438|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
160508181|NCT03846453|579587439|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
160508182|NCT03846453|579587440|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
160508183|NCT03846453|579587438|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
160508184|NCT03846453|579587439|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
160508185|NCT03846453|579587440|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
160508186|NCT03846453|579587438|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
160508187|NCT03846453|579587439|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
160508188|NCT03846453|579587440|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
160508189|NCT03846453|579587438|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
160508190|NCT03846453|579587439|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
160508191|NCT03846453|579587440|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
160508192|NCT00886795|579587441|FG000|Overall Study|Lack of Efficacy|1|||
160508193|NCT01877239|579587444|FG000|Overall Study|Adverse Event|4|||
160508194|NCT01877239|579587444|FG000|Overall Study|Disease Remission|1|||
160508195|NCT01877239|579587444|FG000|Overall Study|Withdrawal by Subject|4|||
160508196|NCT01877239|579587444|FG000|Overall Study|Other|2|||
160508197|NCT01877239|579587444|FG000|Overall Study|Lack of Efficacy|4|||
160508198|NCT01877239|579587444|FG000|Overall Study|Data not available|35|||
160508199|NCT01283516|579587448|FG000|Overall Study|Adverse Event|0|||
160508200|NCT01283516|579587449|FG001|Overall Study|Adverse Event|0|||
160508201|NCT01283516|579587450|FG002|Overall Study|Adverse Event|0|||
160508202|NCT01283516|579587451|FG003|Overall Study|Adverse Event|0|||
160508203|NCT01283516|579587452|FG004|Overall Study|Adverse Event|0|||
160508204|NCT01283516|579587453|FG005|Overall Study|Adverse Event|0|||
160508205|NCT01283516|579587454|FG006|Overall Study|Adverse Event|2|||
160508206|NCT01283516|579587455|FG007|Overall Study|Adverse Event|0|||
160508207|NCT01283516|579587456|FG008|Overall Study|Adverse Event|28|||
160508208|NCT01283516|579587448|FG000|Overall Study|Death|0|||
160508209|NCT01283516|579587449|FG001|Overall Study|Death|0|||
160508210|NCT01283516|579587450|FG002|Overall Study|Death|0|||
160508211|NCT01283516|579587451|FG003|Overall Study|Death|0|||
160508212|NCT01283516|579587452|FG004|Overall Study|Death|0|||
160508213|NCT01283516|579587453|FG005|Overall Study|Death|1|||
160508214|NCT01283516|579587454|FG006|Overall Study|Death|0|||
160508215|NCT01283516|579587455|FG007|Overall Study|Death|1|||
160508216|NCT01283516|579587456|FG008|Overall Study|Death|12|||
160508217|NCT01283516|579587448|FG000|Overall Study|Disease Progression|2|||
160508218|NCT01283516|579587449|FG001|Overall Study|Disease Progression|2|||
160508219|NCT01283516|579587450|FG002|Overall Study|Disease Progression|3|||
160508220|NCT01283516|579587451|FG003|Overall Study|Disease Progression|3|||
160508221|NCT01283516|579587452|FG004|Overall Study|Disease Progression|13|||
160508222|NCT01283516|579587453|FG005|Overall Study|Disease Progression|8|||
160508223|NCT01283516|579587454|FG006|Overall Study|Disease Progression|6|||
160508224|NCT01283516|579587455|FG007|Overall Study|Disease Progression|3|||
160508225|NCT01283516|579587456|FG008|Overall Study|Disease Progression|139|||
160508226|NCT01283516|579587448|FG000|Overall Study|Withdrawal by Subject|0|||
160508227|NCT01283516|579587449|FG001|Overall Study|Withdrawal by Subject|0|||
160508228|NCT01283516|579587450|FG002|Overall Study|Withdrawal by Subject|0|||
160508229|NCT01283516|579587451|FG003|Overall Study|Withdrawal by Subject|0|||
160508230|NCT01283516|579587452|FG004|Overall Study|Withdrawal by Subject|1|||
160508231|NCT01283516|579587453|FG005|Overall Study|Withdrawal by Subject|0|||
160508232|NCT01283516|579587454|FG006|Overall Study|Withdrawal by Subject|1|||
160508233|NCT01283516|579587455|FG007|Overall Study|Withdrawal by Subject|0|||
160508234|NCT01283516|579587456|FG008|Overall Study|Withdrawal by Subject|36|||
160508235|NCT01283516|579587448|FG000|Overall Study|Administrative problems|0|||
160508236|NCT01283516|579587449|FG001|Overall Study|Administrative problems|0|||
160508237|NCT01283516|579587450|FG002|Overall Study|Administrative problems|0|||
160508238|NCT01283516|579587451|FG003|Overall Study|Administrative problems|0|||
160508239|NCT01283516|579587452|FG004|Overall Study|Administrative problems|0|||
160508240|NCT01283516|579587453|FG005|Overall Study|Administrative problems|1|||
160508241|NCT01283516|579587454|FG006|Overall Study|Administrative problems|1|||
160508242|NCT01283516|579587455|FG007|Overall Study|Administrative problems|1|||
160508243|NCT01283516|579587456|FG008|Overall Study|Administrative problems|39|||
160508244|NCT01283516|579587448|FG000|Overall Study|Lost to Follow-up|0|||
160508245|NCT01283516|579587449|FG001|Overall Study|Lost to Follow-up|0|||
160508246|NCT01283516|579587450|FG002|Overall Study|Lost to Follow-up|0|||
160508247|NCT01283516|579587451|FG003|Overall Study|Lost to Follow-up|0|||
160508248|NCT01283516|579587452|FG004|Overall Study|Lost to Follow-up|0|||
160508249|NCT01283516|579587453|FG005|Overall Study|Lost to Follow-up|0|||
160508250|NCT01283516|579587454|FG006|Overall Study|Lost to Follow-up|0|||
160508251|NCT01283516|579587455|FG007|Overall Study|Lost to Follow-up|0|||
160508252|NCT01283516|579587456|FG008|Overall Study|Lost to Follow-up|1|||
160508253|NCT01989169|579587459|FG000|Period 2|Adverse Event|0|||
160508254|NCT01989169|579587460|FG001|Period 2|Adverse Event|1|||
160508255|NCT01114880|579587461|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
160508256|NCT01114880|579587462|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
160508257|NCT01114880|579587461|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
160508258|NCT01114880|579587462|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
160508259|NCT01114880|579587461|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
160508260|NCT01114880|579587462|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
160508261|NCT01114880|579587461|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
160508262|NCT01114880|579587462|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
160508263|NCT01114880|579587461|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
160508264|NCT01114880|579587462|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
160508265|NCT01114880|579587461|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
160508266|NCT01114880|579587462|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
160508267|NCT02738853|579587465|FG000|Enrollment|Inclusion/Exclusion not met|21|||
160508268|NCT02738853|579587465|FG000|Enrollment|Withdrawal by Subject|3|||
160508269|NCT02738853|579587465|FG000|Enrollment|Subject treated with commercially available device|6|||
160508270|NCT02738853|579587465|FG000|Enrollment|Study Enrollment Closed|3|||
160508271|NCT02738853|579587465|FG000|Procedure|Death|1|||
160508272|NCT02738853|579587465|FG000|1 Month|Death|2|||
160508273|NCT02738853|579587465|FG000|6 Month|Death|4|||
160508274|NCT02738853|579587465|FG000|6 Month|Withdrawal by Subject|2|||
160508275|NCT02738853|579587465|FG000|1 Year|Death|6|||
160508276|NCT02738853|579587465|FG000|1 Year|Withdrawal by Subject|1|||
160508277|NCT02738853|579587465|FG000|2 Year|Death|2|||
160508278|NCT02738853|579587465|FG000|2 Year|Lost to Follow-up|1|||
160508279|NCT02738853|579587465|FG000|3 Year|Death|2|||
160508280|NCT02738853|579587465|FG000|3 Year|Withdrawal by Subject|1|||
160508281|NCT02738853|579587465|FG000|4 Year|Death|9|||
160508282|NCT02738853|579587465|FG000|5 Year|Lost to Follow-up|4|||
160508283|NCT04655027|579587468|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
160508284|NCT04655027|579587469|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
160508285|NCT03006848|579587472|FG000|Overall Study|Adverse Event|1|||
160508286|NCT03006848|579587472|FG000|Overall Study|Physician Decision|1|||
160508287|NCT03006848|579587472|FG000|Overall Study|Lack of Efficacy|16|||
160508288|NCT03520712|579587473|FG000|Overall Study|Early termination of the study by Sponsor|2|||
160508289|NCT04531982|579587474|FG000|Overall Study|Withdrawal by Subject|10|||
160508290|NCT04531982|579587475|FG001|Overall Study|Withdrawal by Subject|11|||
160508291|NCT04531982|579587474|FG000|Overall Study|Adverse Event|6|||
160508292|NCT04531982|579587475|FG001|Overall Study|Adverse Event|14|||
160508293|NCT04531982|579587474|FG000|Overall Study|Protocol Violation|6|||
160508294|NCT04531982|579587475|FG001|Overall Study|Protocol Violation|9|||
160508295|NCT04531982|579587474|FG000|Overall Study|Non-compliance with study drug|3|||
160508296|NCT04531982|579587475|FG001|Overall Study|Non-compliance with study drug|2|||
160508297|NCT04531982|579587474|FG000|Overall Study|Use of prohibited medication|2|||
160508298|NCT04531982|579587475|FG001|Overall Study|Use of prohibited medication|0|||
160508299|NCT04531982|579587474|FG000|Overall Study|Lost to Follow-up|0|||
160508300|NCT04531982|579587475|FG001|Overall Study|Lost to Follow-up|1|||
160508301|NCT04531982|579587474|FG000|Overall Study|Geopolitical conflict|2|||
160508302|NCT04531982|579587475|FG001|Overall Study|Geopolitical conflict|0|||
160508303|NCT04531982|579587474|FG000|Overall Study|Lack of Efficacy|3|||
160508304|NCT04531982|579587475|FG001|Overall Study|Lack of Efficacy|1|||
160508305|NCT00591370|579589475|FG000|Overall Study|Not Treated|2|||
160508306|NCT01183260|579589476|FG000|Overall Study|Intraop screen failure|2|||
160663902|NCT02272777|580152418|FG000|Overall Study|Lost to Follow-up|2|||
160508307|NCT01183260|579589477|FG001|Overall Study|Intraop screen failure|0|||
160508308|NCT01183260|579589476|FG000|Overall Study|Withdrawal by Subject|1|||
160508309|NCT01183260|579589477|FG001|Overall Study|Withdrawal by Subject|1|||
160508310|NCT01183260|579589476|FG000|Overall Study|Revised within 30 days|0|||
160508311|NCT01183260|579589477|FG001|Overall Study|Revised within 30 days|1|||
160508312|NCT01183260|579589476|FG000|Overall Study|Death|1|||
160508313|NCT01183260|579589477|FG001|Overall Study|Death|0|||
160508314|NCT01202903|579589479|FG000|Overall Study|Administrative Probelms|1|||
160508315|NCT01202903|579589480|FG001|Overall Study|Administrative Probelms|4|||
160508316|NCT01202903|579589479|FG000|Overall Study|Protocol Violation|0|||
160508317|NCT01202903|579589480|FG001|Overall Study|Protocol Violation|1|||
160508318|NCT01202903|579589479|FG000|Overall Study|Death|1|||
160508319|NCT01202903|579589480|FG001|Overall Study|Death|0|||
160508320|NCT01202903|579589479|FG000|Overall Study|Lost to Follow-up|1|||
160508321|NCT01202903|579589480|FG001|Overall Study|Lost to Follow-up|1|||
160508322|NCT01202903|579589479|FG000|Overall Study|Lack of Efficacy|1|||
160508323|NCT01202903|579589480|FG001|Overall Study|Lack of Efficacy|3|||
160508324|NCT01202903|579589479|FG000|Overall Study|Adverse Event|3|||
160508325|NCT01202903|579589480|FG001|Overall Study|Adverse Event|3|||
160508326|NCT01202903|579589479|FG000|Overall Study|Withdrawal by Subject|4|||
160508327|NCT01202903|579589480|FG001|Overall Study|Withdrawal by Subject|4|||
160508328|NCT01302080|579589481|FG000|Overall Study|Withdrew Consent|92|||
160508329|NCT01302080|579589482|FG001|Overall Study|Withdrew Consent|39|||
160508330|NCT01302080|579589481|FG000|Overall Study|Patient/Family Moved|28|||
160508331|NCT01302080|579589482|FG001|Overall Study|Patient/Family Moved|3|||
160508332|NCT01302080|579589481|FG000|Overall Study|Lost to Follow-up|192|||
160508333|NCT01302080|579589482|FG001|Overall Study|Lost to Follow-up|93|||
160508334|NCT01302080|579589481|FG000|Overall Study|Death|1|||
160508335|NCT01302080|579589482|FG001|Overall Study|Death|0|||
160508336|NCT01302080|579589481|FG000|Overall Study|Other|52|||
160508337|NCT01302080|579589482|FG001|Overall Study|Other|8|||
160508338|NCT01302080|579589481|FG000|Overall Study|Reason Missing For Discontinuation|1|||
160508339|NCT01302080|579589482|FG001|Overall Study|Reason Missing For Discontinuation|0|||
160508340|NCT00837694|579589483|FG000|Overall Study|Lost to Follow-up|2|||
160508341|NCT00837694|579589484|FG001|Overall Study|Lost to Follow-up|0|||
160508342|NCT00837694|579589485|FG002|Overall Study|Lost to Follow-up|2|||
160508343|NCT00837694|579589486|FG003|Overall Study|Lost to Follow-up|1|||
160508344|NCT00837694|579589487|FG004|Overall Study|Lost to Follow-up|1|||
160508345|NCT00837694|579589488|FG005|Overall Study|Lost to Follow-up|1|||
160508346|NCT00095056|579589489|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
160508347|NCT00095056|579589490|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
160508348|NCT00095056|579589489|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
160508349|NCT00095056|579589490|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
160508350|NCT00095056|579589489|FG000|Phase A (Weeks 0-12)|Death|1|||
160508351|NCT00095056|579589490|FG001|Phase A (Weeks 0-12)|Death|0|||
160508352|NCT00095056|579589489|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
160508353|NCT00095056|579589490|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
160508354|NCT00095056|579589489|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
160508355|NCT00095056|579589490|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
160508356|NCT00095056|579589489|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
160508357|NCT00095056|579589490|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
160508358|NCT00095056|579589489|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
160508359|NCT00095056|579589490|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
160508360|NCT00095056|579589489|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
160508361|NCT00095056|579589490|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
160508362|NCT00095056|579589489|FG000|Phase B (Weeks 12-54)|Death|3|||
160508363|NCT00095056|579589490|FG001|Phase B (Weeks 12-54)|Death|1|||
160508364|NCT00095056|579589489|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
160508365|NCT00095056|579589490|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
160508366|NCT00095056|579589489|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
160508367|NCT00095056|579589490|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
160508368|NCT00306670|579589491|FG000|Overall Study|patients recruited; Genentech, the st|0|||
160508369|NCT00306670|579589492|FG001|Overall Study|patients recruited; Genentech, the st|2|||
160508370|NCT00503139|579589493|FG000|Overall Study|Case Report Forms were not collected|4|||
160508371|NCT00503139|579589493|FG000|Overall Study|Protocol Violation|4|||
160508372|NCT00091169|579589497|FG000|Overall Study|Disease progression|3|||
160508373|NCT00091169|579589498|FG001|Overall Study|Disease progression|1|||
160508374|NCT00091169|579589497|FG000|Overall Study|Adverse Event|11|||
160508375|NCT00091169|579589498|FG001|Overall Study|Adverse Event|17|||
160508376|NCT00091169|579589497|FG000|Overall Study|Death|4|||
160508377|NCT00091169|579589498|FG001|Overall Study|Death|1|||
160508378|NCT00091169|579589497|FG000|Overall Study|Withdrawal by Subject|10|||
160508379|NCT00091169|579589498|FG001|Overall Study|Withdrawal by Subject|13|||
160508380|NCT00091169|579589497|FG000|Overall Study|Other|3|||
160508381|NCT00091169|579589498|FG001|Overall Study|Other|4|||
160508382|NCT00091169|579589497|FG000|Overall Study|Not start protocol therapy|26|||
160508383|NCT00091169|579589498|FG001|Overall Study|Not start protocol therapy|17|||
160508384|NCT02735577|579589499|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
160508385|NCT02735577|579589499|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
160663903|NCT02272777|580152419|FG001|Overall Study|Lost to Follow-up|0|||
160663904|NCT02272777|580152418|FG000|Overall Study|Other|2|||
160663905|NCT02272777|580152419|FG001|Overall Study|Other|0|||
160663906|NCT02066922|580152422|FG000|Overall Study|Adverse Event|1|||
160663907|NCT00440297|580152423|FG000|Overall Study|Adverse Event|8|||
160508386|NCT00833833|579589500|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
160508387|NCT00833833|579589501|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
160508388|NCT00833833|579589502|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
160508389|NCT00833833|579589503|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
160508390|NCT00833833|579589504|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
160508391|NCT00833833|579589505|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
160508392|NCT00833833|579589500|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
160508393|NCT00833833|579589501|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
160508394|NCT00833833|579589502|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
160663908|NCT00440297|580152424|FG001|Overall Study|Adverse Event|5|||
160508395|NCT00833833|579589503|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
160508396|NCT00833833|579589504|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
160508397|NCT00833833|579589505|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
160508398|NCT00833833|579589500|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
160508399|NCT00833833|579589501|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
160508400|NCT00833833|579589502|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
160508401|NCT00833833|579589503|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
160508402|NCT00833833|579589504|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
160508403|NCT00833833|579589505|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
160508404|NCT00833833|579589500|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
160508405|NCT00833833|579589501|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
160508406|NCT00833833|579589502|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
160508407|NCT00833833|579589503|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
160508408|NCT00833833|579589504|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
160508409|NCT00833833|579589505|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
160508410|NCT00833833|579589500|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
160508411|NCT00833833|579589501|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
160508412|NCT00833833|579589502|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
160508413|NCT00833833|579589503|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
160508414|NCT00833833|579589504|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
160508415|NCT00833833|579589505|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
160508416|NCT00833833|579589500|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
160508417|NCT00833833|579589501|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
160508418|NCT00833833|579589502|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
160508419|NCT00833833|579589503|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
160508420|NCT00833833|579589504|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
160508421|NCT00833833|579589505|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
160508422|NCT00833833|579589500|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
160508423|NCT00833833|579589501|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
160508424|NCT00833833|579589502|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
160508425|NCT00833833|579589503|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
160508426|NCT00833833|579589504|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
160508427|NCT00833833|579589505|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
160508428|NCT00833833|579589500|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
160508429|NCT00833833|579589501|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
160508430|NCT00833833|579589502|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
160508431|NCT00833833|579589503|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
160508432|NCT00833833|579589504|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
160508433|NCT00833833|579589505|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
160508434|NCT00833833|579589500|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
160508435|NCT00833833|579589501|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
160508436|NCT00833833|579589502|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
160508437|NCT00833833|579589503|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
160508438|NCT00833833|579589504|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
160508439|NCT00833833|579589505|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
160508440|NCT00833833|579589500|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
160508441|NCT00833833|579589501|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
160508442|NCT00833833|579589502|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
160508443|NCT00833833|579589503|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
160663909|NCT00440297|580152423|FG000|Overall Study|Lost to Follow-up|1|||
160508444|NCT00833833|579589504|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
160508445|NCT00833833|579589505|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
160508446|NCT00833833|579589500|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
160508447|NCT00833833|579589501|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
160508448|NCT00833833|579589502|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
160508449|NCT00833833|579589503|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
160508450|NCT00833833|579589504|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
160508451|NCT00833833|579589505|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
160508452|NCT00833833|579589500|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
160508453|NCT00833833|579589501|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
160508454|NCT00833833|579589502|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
160508455|NCT00833833|579589503|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
160508456|NCT00833833|579589504|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
160508457|NCT00833833|579589505|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
160508458|NCT00833833|579589500|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
160508459|NCT00833833|579589501|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
160508460|NCT00833833|579589502|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
160508461|NCT00833833|579589503|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
160663910|NCT00440297|580152424|FG001|Overall Study|Lost to Follow-up|0|||
160508462|NCT00833833|579589504|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
160508463|NCT00833833|579589505|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
160508464|NCT02040259|579589506|FG000|Overall Study|Death|280|||
160508465|NCT02040259|579589506|FG000|Overall Study|Lost to Follow-up|76|||
160508466|NCT02040259|579589506|FG000|Overall Study|Assessment not completed|3|||
160508467|NCT02040259|579589506|FG000|Overall Study|Withdrawal by Subject|4|||
160508468|NCT00316602|579589514|FG000|Overall Study|Withdrawal by Subject|3|||
160508469|NCT00316602|579589515|FG001|Overall Study|Withdrawal by Subject|2|||
160508470|NCT00316602|579589514|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
160508471|NCT00316602|579589515|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
160508472|NCT00316602|579589514|FG000|Overall Study|Adverse Event|1|||
160508473|NCT00316602|579589515|FG001|Overall Study|Adverse Event|0|||
160508474|NCT00316602|579589514|FG000|Overall Study|Other|3|||
160508475|NCT00316602|579589515|FG001|Overall Study|Other|6|||
160508476|NCT01142232|579589516|FG000|Overall Study|Adverse Event|1|||
160508477|NCT01142232|579589517|FG001|Overall Study|Adverse Event|2|||
160508478|NCT01142232|579589518|FG002|Overall Study|Adverse Event|1|||
160508479|NCT01142232|579589519|FG003|Overall Study|Adverse Event|0|||
160508480|NCT01142232|579589520|FG004|Overall Study|Adverse Event|4|||
160508481|NCT01142232|579589516|FG000|Overall Study|Death|0|||
160508482|NCT01142232|579589517|FG001|Overall Study|Death|0|||
160508483|NCT01142232|579589518|FG002|Overall Study|Death|0|||
160508484|NCT01142232|579589519|FG003|Overall Study|Death|0|||
160508485|NCT01142232|579589520|FG004|Overall Study|Death|1|||
160508486|NCT01142232|579589516|FG000|Overall Study|Disease Progression|2|||
160508487|NCT01142232|579589517|FG001|Overall Study|Disease Progression|0|||
160508488|NCT01142232|579589518|FG002|Overall Study|Disease Progression|1|||
160508489|NCT01142232|579589519|FG003|Overall Study|Disease Progression|2|||
160508490|NCT01142232|579589520|FG004|Overall Study|Disease Progression|12|||
160508491|NCT01142232|579589516|FG000|Overall Study|Withdrawal by Subject|0|||
160508492|NCT01142232|579589517|FG001|Overall Study|Withdrawal by Subject|0|||
160508493|NCT01142232|579589518|FG002|Overall Study|Withdrawal by Subject|0|||
160508494|NCT01142232|579589519|FG003|Overall Study|Withdrawal by Subject|1|||
160508495|NCT01142232|579589520|FG004|Overall Study|Withdrawal by Subject|3|||
160508496|NCT01142232|579589516|FG000|Overall Study|Physician Decision|0|||
160508497|NCT01142232|579589517|FG001|Overall Study|Physician Decision|1|||
160508498|NCT01142232|579589518|FG002|Overall Study|Physician Decision|0|||
160508499|NCT01142232|579589519|FG003|Overall Study|Physician Decision|2|||
160508500|NCT01142232|579589520|FG004|Overall Study|Physician Decision|10|||
160508501|NCT01142232|579589516|FG000|Overall Study|Alternative Therapy|0|||
160508502|NCT01142232|579589517|FG001|Overall Study|Alternative Therapy|1|||
160508503|NCT01142232|579589518|FG002|Overall Study|Alternative Therapy|1|||
160508504|NCT01142232|579589519|FG003|Overall Study|Alternative Therapy|0|||
160508505|NCT01142232|579589520|FG004|Overall Study|Alternative Therapy|1|||
160508506|NCT01142232|579589516|FG000|Overall Study|Off Trt for other complicating disease|0|||
160508507|NCT01142232|579589517|FG001|Overall Study|Off Trt for other complicating disease|0|||
160508508|NCT01142232|579589518|FG002|Overall Study|Off Trt for other complicating disease|0|||
160508509|NCT01142232|579589519|FG003|Overall Study|Off Trt for other complicating disease|0|||
160508510|NCT01142232|579589520|FG004|Overall Study|Off Trt for other complicating disease|1|||
160508511|NCT01142232|579589516|FG000|Overall Study|Noncompliance|0|||
160508512|NCT01142232|579589517|FG001|Overall Study|Noncompliance|0|||
160508513|NCT01142232|579589518|FG002|Overall Study|Noncompliance|0|||
160508514|NCT01142232|579589519|FG003|Overall Study|Noncompliance|0|||
160508515|NCT01142232|579589520|FG004|Overall Study|Noncompliance|2|||
160508516|NCT00626990|579589521|FG000|Overall Study|Lack of Efficacy|6|||
160508517|NCT00626990|579589522|FG001|Overall Study|Lack of Efficacy|7|||
160663911|NCT00440297|580152423|FG000|Overall Study|Physician Decision|1|||
160663912|NCT00440297|580152424|FG001|Overall Study|Physician Decision|0|||
160663913|NCT00440297|580152423|FG000|Overall Study|Protocol Violation|11|||
160663914|NCT00440297|580152424|FG001|Overall Study|Protocol Violation|7|||
160663915|NCT00440297|580152423|FG000|Overall Study|Withdrawal by Subject|1|||
160663916|NCT00440297|580152424|FG001|Overall Study|Withdrawal by Subject|6|||
160508518|NCT00626990|579589523|FG002|Overall Study|Lack of Efficacy|49|||
160508519|NCT00626990|579589524|FG003|Overall Study|Lack of Efficacy|40|||
160663917|NCT00440297|580152423|FG000|Overall Study|Randomized by mistake|1|||
160508520|NCT00626990|579589521|FG000|Overall Study|Adverse Event|1|||
160508521|NCT00626990|579589522|FG001|Overall Study|Adverse Event|7|||
160508522|NCT00626990|579589523|FG002|Overall Study|Adverse Event|14|||
160508523|NCT00626990|579589524|FG003|Overall Study|Adverse Event|28|||
160508524|NCT00626990|579589521|FG000|Overall Study|Death|0|||
160508525|NCT00626990|579589522|FG001|Overall Study|Death|1|||
160508526|NCT00626990|579589523|FG002|Overall Study|Death|0|||
160508527|NCT00626990|579589524|FG003|Overall Study|Death|0|||
160508528|NCT00626990|579589521|FG000|Overall Study|Withdrawal by Subject|3|||
160508529|NCT00626990|579589522|FG001|Overall Study|Withdrawal by Subject|1|||
160508530|NCT00626990|579589523|FG002|Overall Study|Withdrawal by Subject|5|||
160508531|NCT00626990|579589524|FG003|Overall Study|Withdrawal by Subject|11|||
160508532|NCT00626990|579589521|FG000|Overall Study|Protocol Violation|0|||
160508533|NCT00626990|579589522|FG001|Overall Study|Protocol Violation|1|||
160508534|NCT00626990|579589523|FG002|Overall Study|Protocol Violation|1|||
160508535|NCT00626990|579589524|FG003|Overall Study|Protocol Violation|0|||
160508536|NCT00626990|579589521|FG000|Overall Study|Various different reasons/missing|4|||
160508537|NCT00626990|579589522|FG001|Overall Study|Various different reasons/missing|8|||
160508538|NCT00626990|579589523|FG002|Overall Study|Various different reasons/missing|8|||
160508539|NCT00626990|579589524|FG003|Overall Study|Various different reasons/missing|16|||
160508540|NCT04138576|579589529|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
160508541|NCT04410523|579589533|FG000|Overall Study|Study terminated by sponsor|1|||
160508542|NCT04410523|579589534|FG001|Overall Study|Study terminated by sponsor|3|||
160508543|NCT04410523|579589535|FG002|Overall Study|Study terminated by sponsor|2|||
160508544|NCT04410523|579589536|FG003|Overall Study|Study terminated by sponsor|6|||
160508545|NCT04410523|579589537|FG004|Overall Study|Study terminated by sponsor|3|||
160508546|NCT04410523|579589538|FG005|Overall Study|Study terminated by sponsor|4|||
160508547|NCT04410523|579589533|FG000|Overall Study|Adverse Event|1|||
160508548|NCT04410523|579589534|FG001|Overall Study|Adverse Event|0|||
160508549|NCT04410523|579589535|FG002|Overall Study|Adverse Event|0|||
160508550|NCT04410523|579589536|FG003|Overall Study|Adverse Event|0|||
160508551|NCT04410523|579589537|FG004|Overall Study|Adverse Event|0|||
160508552|NCT04410523|579589538|FG005|Overall Study|Adverse Event|2|||
160508553|NCT04410523|579589533|FG000|Overall Study|Lost to Follow-up|0|||
160508554|NCT04410523|579589534|FG001|Overall Study|Lost to Follow-up|1|||
160508555|NCT04410523|579589535|FG002|Overall Study|Lost to Follow-up|0|||
160508556|NCT04410523|579589536|FG003|Overall Study|Lost to Follow-up|0|||
160508557|NCT04410523|579589537|FG004|Overall Study|Lost to Follow-up|0|||
160508558|NCT04410523|579589538|FG005|Overall Study|Lost to Follow-up|0|||
160508559|NCT04410523|579589533|FG000|Overall Study|Physician Decision|0|||
160508560|NCT04410523|579589534|FG001|Overall Study|Physician Decision|1|||
160508561|NCT04410523|579589535|FG002|Overall Study|Physician Decision|0|||
160508562|NCT04410523|579589536|FG003|Overall Study|Physician Decision|0|||
160508563|NCT04410523|579589537|FG004|Overall Study|Physician Decision|0|||
160508564|NCT04410523|579589538|FG005|Overall Study|Physician Decision|0|||
160508565|NCT04410523|579589533|FG000|Overall Study|Pregnancy|0|||
160508566|NCT04410523|579589534|FG001|Overall Study|Pregnancy|0|||
160508567|NCT04410523|579589535|FG002|Overall Study|Pregnancy|0|||
160508568|NCT04410523|579589536|FG003|Overall Study|Pregnancy|0|||
160508569|NCT04410523|579589537|FG004|Overall Study|Pregnancy|0|||
160508570|NCT04410523|579589538|FG005|Overall Study|Pregnancy|1|||
160508571|NCT04410523|579589533|FG000|Overall Study|Protocol deviation|0|||
160508572|NCT04410523|579589534|FG001|Overall Study|Protocol deviation|0|||
160508573|NCT04410523|579589535|FG002|Overall Study|Protocol deviation|0|||
160508574|NCT04410523|579589536|FG003|Overall Study|Protocol deviation|0|||
160508575|NCT04410523|579589537|FG004|Overall Study|Protocol deviation|0|||
160508576|NCT04410523|579589538|FG005|Overall Study|Protocol deviation|2|||
160508577|NCT04410523|579589533|FG000|Overall Study|Subject decision|2|||
160508578|NCT04410523|579589534|FG001|Overall Study|Subject decision|0|||
160508579|NCT04410523|579589535|FG002|Overall Study|Subject decision|0|||
160508580|NCT04410523|579589536|FG003|Overall Study|Subject decision|1|||
160508581|NCT04410523|579589537|FG004|Overall Study|Subject decision|0|||
160508582|NCT04410523|579589538|FG005|Overall Study|Subject decision|1|||
160508583|NCT00490490|579589539|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
160508584|NCT00490490|579589539|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
160508585|NCT00772330|579589540|FG000|Overall Study|Lost to Follow-up|3|||
160508586|NCT00734591|579589541|FG000|Screening for Prospective Period|Site did not participate|1604|||
160508587|NCT00734591|579589542|FG001|Screening for Prospective Period|Site did not participate|1488|||
160508588|NCT00734591|579589541|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
160508589|NCT00734591|579589542|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
160508590|NCT00734591|579589541|FG000|Prospective Period|Withdrawal by Subject|11|||
160508591|NCT00734591|579589542|FG001|Prospective Period|Withdrawal by Subject|9|||
160508592|NCT00734591|579589541|FG000|Prospective Period|Lost to Follow-up|37|||
160508593|NCT00734591|579589542|FG001|Prospective Period|Lost to Follow-up|33|||
160508594|NCT00734591|579589541|FG000|Prospective Period|Study Terminated|1|||
160508595|NCT00734591|579589542|FG001|Prospective Period|Study Terminated|0|||
160508596|NCT00734591|579589541|FG000|Prospective Period|Other|2|||
160508597|NCT00734591|579589542|FG001|Prospective Period|Other|2|||
160508598|NCT01656200|579589545|FG000|Overall Study|Withdrawal by Subject|1|||
160508599|NCT02236988|579589546|FG000|Overall Study|Lost to Follow-up|0|||
160508600|NCT02236988|579589547|FG001|Overall Study|Lost to Follow-up|0|||
160508601|NCT02236988|579589548|FG002|Overall Study|Lost to Follow-up|0|||
160508602|NCT02236988|579589549|FG003|Overall Study|Lost to Follow-up|1|||
160508603|NCT02236988|579589546|FG000|Overall Study|Unable to Comply with Study Visits|0|||
160508604|NCT02236988|579589547|FG001|Overall Study|Unable to Comply with Study Visits|0|||
160508605|NCT02236988|579589548|FG002|Overall Study|Unable to Comply with Study Visits|0|||
160508606|NCT02236988|579589549|FG003|Overall Study|Unable to Comply with Study Visits|2|||
160508607|NCT05775991|579589550|FG000|Overall Study|Withdrawal by Subject|0|||
160508608|NCT05775991|579589551|FG001|Overall Study|Withdrawal by Subject|0|||
160508609|NCT05775991|579589552|FG002|Overall Study|Withdrawal by Subject|2|||
160508610|NCT01461811|579589555|FG000|Overall Study|Adverse Event|2|||
160508611|NCT01461811|579589556|FG001|Overall Study|Adverse Event|1|||
160508612|NCT01461811|579589555|FG000|Overall Study|Subject decision unrelated to an AE|1|||
160508613|NCT01461811|579589556|FG001|Overall Study|Subject decision unrelated to an AE|1|||
160508614|NCT01461811|579589555|FG000|Overall Study|Noncompliance|1|||
160508615|NCT01461811|579589556|FG001|Overall Study|Noncompliance|1|||
160508616|NCT03015129|579589557|FG000|Overall Study|Death|2|||
160508617|NCT03015129|579589558|FG001|Overall Study|Death|2|||
160508618|NCT03015129|579589557|FG000|Overall Study|Lost to Follow-up|0|||
160508619|NCT03015129|579589558|FG001|Overall Study|Lost to Follow-up|1|||
160508620|NCT03015129|579589557|FG000|Overall Study|Progression of disease|38|||
160508621|NCT03015129|579589558|FG001|Overall Study|Progression of disease|33|||
160508622|NCT03015129|579589557|FG000|Overall Study|Adverse Event|0|||
160508623|NCT03015129|579589558|FG001|Overall Study|Adverse Event|4|||
160508624|NCT00939822|579589559|FG000|Overall Study|Lost to Follow-up|1|||
160508625|NCT00939822|579589560|FG001|Overall Study|Lost to Follow-up|0|||
160508626|NCT00939822|579589559|FG000|Overall Study|withdrew from study due to busy schedule|1|||
160508627|NCT00939822|579589560|FG001|Overall Study|withdrew from study due to busy schedule|1|||
160508628|NCT00939822|579589559|FG000|Overall Study|Mental health issues|0|||
160508629|NCT00939822|579589560|FG001|Overall Study|Mental health issues|2|||
160508630|NCT00338962|579589565|FG000|Overall Study|Lost to Follow-up|3|||
160508631|NCT00338962|579589566|FG001|Overall Study|Lost to Follow-up|3|||
160508632|NCT00338962|579589567|FG002|Overall Study|Lost to Follow-up|2|||
160508633|NCT00338962|579589568|FG003|Overall Study|Lost to Follow-up|3|||
160508634|NCT00338962|579589565|FG000|Overall Study|Withdrawal by Subject|1|||
160508635|NCT00338962|579589566|FG001|Overall Study|Withdrawal by Subject|0|||
160508636|NCT00338962|579589567|FG002|Overall Study|Withdrawal by Subject|0|||
160508637|NCT00338962|579589568|FG003|Overall Study|Withdrawal by Subject|0|||
160508638|NCT00338962|579589565|FG000|Overall Study|No Transportation|2|||
160508639|NCT00338962|579589566|FG001|Overall Study|No Transportation|0|||
160508640|NCT00338962|579589567|FG002|Overall Study|No Transportation|0|||
160508641|NCT00338962|579589568|FG003|Overall Study|No Transportation|0|||
160508642|NCT00338962|579589565|FG000|Overall Study|Time Constraint|2|||
160508643|NCT00338962|579589566|FG001|Overall Study|Time Constraint|0|||
160508644|NCT00338962|579589567|FG002|Overall Study|Time Constraint|0|||
160508645|NCT00338962|579589568|FG003|Overall Study|Time Constraint|0|||
160508646|NCT00338962|579589565|FG000|Overall Study|Moved|0|||
160508647|NCT00338962|579589566|FG001|Overall Study|Moved|1|||
160508648|NCT00338962|579589567|FG002|Overall Study|Moved|0|||
160508649|NCT00338962|579589568|FG003|Overall Study|Moved|0|||
160508650|NCT00338962|579589565|FG000|Overall Study|Adverse Event|0|||
160508651|NCT00338962|579589566|FG001|Overall Study|Adverse Event|0|||
160508652|NCT00338962|579589567|FG002|Overall Study|Adverse Event|2|||
160508653|NCT00338962|579589568|FG003|Overall Study|Adverse Event|0|||
160508654|NCT00338962|579589565|FG000|Overall Study|Poor Compliance|0|||
160508655|NCT00338962|579589566|FG001|Overall Study|Poor Compliance|0|||
160508656|NCT00338962|579589567|FG002|Overall Study|Poor Compliance|2|||
160508657|NCT00338962|579589568|FG003|Overall Study|Poor Compliance|0|||
160508658|NCT00910039|579589569|FG000|Overall Study|Physician Decision|1|||
160508659|NCT04155047|579589573|FG000|Overall Study|Adverse Event|1|||
160508660|NCT04155047|579589574|FG001|Overall Study|Adverse Event|0|||
160508661|NCT04155047|579589573|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
160508662|NCT04155047|579589574|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
160508663|NCT04514510|579589575|FG000|Overall Study|Lost to Follow-up|0|||
160508664|NCT04514510|579589576|FG001|Overall Study|Lost to Follow-up|1|||
160508665|NCT04514510|579589575|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
160508666|NCT04514510|579589576|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
160508667|NCT02781090|579589579|FG000|3-Month Follow-Up|Missed Visit|20|||
160508668|NCT02781090|579589580|FG001|3-Month Follow-Up|Missed Visit|20|||
160508669|NCT02781090|579589579|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
160508670|NCT02781090|579589580|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
160508671|NCT02781090|579589579|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
160508672|NCT02781090|579589580|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
160508673|NCT02781090|579589579|FG000|3-Month Follow-Up|Death|1|||
160508674|NCT02781090|579589580|FG001|3-Month Follow-Up|Death|0|||
160508675|NCT02781090|579589579|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
160508676|NCT02781090|579589580|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
160508677|NCT02781090|579589579|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
160508678|NCT02781090|579589580|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
160508679|NCT02781090|579589579|FG000|6-Month Follow-Up|Death|0|||
160508680|NCT02781090|579589580|FG001|6-Month Follow-Up|Death|1|||
160508681|NCT00643617|579589581|FG000|Overall Study|Death|6|||
160508682|NCT00643617|579589582|FG001|Overall Study|Death|9|||
160508683|NCT00643617|579589581|FG000|Overall Study|Lost to Follow-up|42|||
160508684|NCT00643617|579589582|FG001|Overall Study|Lost to Follow-up|51|||
160508685|NCT01208103|579589585|FG000|Overall Study|Adverse Event|1|||
160508686|NCT01208103|579589585|FG000|Overall Study|Withdrawal by Subject|1|||
160508687|NCT00416195|579589588|FG000|Overall Study|Adverse Event|1|||
160508688|NCT00416195|579589589|FG001|Overall Study|Adverse Event|2|||
160508689|NCT00416195|579589588|FG000|Overall Study|Protocol Violation|1|||
160508690|NCT00416195|579589589|FG001|Overall Study|Protocol Violation|1|||
160508691|NCT00416195|579589588|FG000|Overall Study|Other|0|||
160508692|NCT00416195|579589589|FG001|Overall Study|Other|1|||
160508693|NCT00468143|579589592|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
160508694|NCT00468143|579589593|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
160508695|NCT00468143|579589592|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
160508696|NCT00468143|579589593|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
160508697|NCT01606670|579589596|FG000|Overall Study|Adverse Event|6|||
160508698|NCT01606670|579589596|FG000|Overall Study|Lack of Efficacy|2|||
160508699|NCT01606670|579589596|FG000|Overall Study|Lost to Follow-up|3|||
160508700|NCT01606670|579589596|FG000|Overall Study|Withdrawal by Subject|3|||
160508701|NCT01606670|579589596|FG000|Overall Study|Other Reason|2|||
160508702|NCT03653208|579589603|FG000|Overall Study|Withdrawal by Subject|0|||
160508703|NCT03653208|579589604|FG001|Overall Study|Withdrawal by Subject|0|||
160508704|NCT03653208|579589605|FG002|Overall Study|Withdrawal by Subject|0|||
160508705|NCT03653208|579589606|FG003|Overall Study|Withdrawal by Subject|0|||
160508706|NCT03653208|579589607|FG004|Overall Study|Withdrawal by Subject|1|||
160508707|NCT03653208|579589608|FG005|Overall Study|Withdrawal by Subject|0|||
160508708|NCT03653208|579589609|FG006|Overall Study|Withdrawal by Subject|0|||
160508709|NCT03653208|579589610|FG007|Overall Study|Withdrawal by Subject|1|||
160508710|NCT03653208|579589611|FG008|Overall Study|Withdrawal by Subject|1|||
160508711|NCT00368927|579589612|FG000|Overall Study|Lost to Follow-up|2|||
160508712|NCT00368927|579589613|FG001|Overall Study|Lost to Follow-up|0|||
160508713|NCT00368927|579589612|FG000|Overall Study|Adverse Event|1|||
160508714|NCT00368927|579589613|FG001|Overall Study|Adverse Event|1|||
160508715|NCT00368927|579589612|FG000|Overall Study|Withdrawal by Subject|1|||
160508716|NCT00368927|579589613|FG001|Overall Study|Withdrawal by Subject|2|||
160508717|NCT00368927|579589612|FG000|Overall Study|Physician Decision|1|||
160508718|NCT00368927|579589613|FG001|Overall Study|Physician Decision|0|||
160508719|NCT01204710|579589614|FG000|Randomization Treatment|Lost to Follow-up|1|||
160508720|NCT01204710|579589615|FG001|Randomization Treatment|Lost to Follow-up|0|||
160508721|NCT01204710|579589614|FG000|Randomization Treatment|Withdrawal by Subject|6|||
160508722|NCT01204710|579589615|FG001|Randomization Treatment|Withdrawal by Subject|5|||
160508723|NCT01204710|579589614|FG000|Randomization Treatment|Physician Decision|3|||
160508724|NCT01204710|579589615|FG001|Randomization Treatment|Physician Decision|2|||
160508725|NCT01204710|579589614|FG000|Randomization Treatment|Entry criteria not met|0|||
160508726|NCT01204710|579589615|FG001|Randomization Treatment|Entry criteria not met|1|||
160508727|NCT01204710|579589614|FG000|Randomization Treatment|Adverse Event|4|||
160508728|NCT01204710|579589615|FG001|Randomization Treatment|Adverse Event|2|||
160508729|NCT01204710|579589614|FG000|Randomization Treatment|Sponsor Decision|0|||
160508730|NCT01204710|579589615|FG001|Randomization Treatment|Sponsor Decision|1|||
160508731|NCT01204710|579589614|FG000|Randomization Treatment|Worsening of General condition|0|||
160508732|NCT01204710|579589615|FG001|Randomization Treatment|Worsening of General condition|1|||
160508733|NCT01204710|579589614|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
160508734|NCT01204710|579589615|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
160508735|NCT01204710|579589614|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
160508736|NCT01204710|579589615|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
160508737|NCT01204710|579589614|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
160508738|NCT01204710|579589615|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
160508739|NCT01204710|579589614|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
160508740|NCT01204710|579589615|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
160508741|NCT04531904|579589617|FG000|Overall Study|Lost to Follow-up|1|||
160508742|NCT04531904|579589617|FG000|Overall Study|Death|14|||
160508743|NCT00283244|579589618|FG000|Overall Study|Adverse Event|0|||
160508744|NCT00283244|579589619|FG001|Overall Study|Adverse Event|8|||
160508745|NCT00283244|579589620|FG002|Overall Study|Adverse Event|11|||
160508746|NCT00283244|579589618|FG000|Overall Study|Death|4|||
160508747|NCT00283244|579589619|FG001|Overall Study|Death|3|||
160508748|NCT00283244|579589620|FG002|Overall Study|Death|2|||
160508749|NCT00283244|579589618|FG000|Overall Study|Lack of Efficacy|8|||
160508750|NCT00283244|579589619|FG001|Overall Study|Lack of Efficacy|32|||
160508751|NCT00283244|579589620|FG002|Overall Study|Lack of Efficacy|26|||
160508752|NCT00283244|579589618|FG000|Overall Study|Withdrawal by Subject|1|||
160508753|NCT00283244|579589619|FG001|Overall Study|Withdrawal by Subject|2|||
160508754|NCT00283244|579589620|FG002|Overall Study|Withdrawal by Subject|2|||
160508755|NCT00283244|579589618|FG000|Overall Study|Physician Decision|0|||
160508756|NCT00283244|579589619|FG001|Overall Study|Physician Decision|0|||
160508757|NCT00283244|579589620|FG002|Overall Study|Physician Decision|1|||
160508758|NCT00283244|579589618|FG000|Overall Study|Medical illness (other complicating dz)|4|||
160508759|NCT00283244|579589619|FG001|Overall Study|Medical illness (other complicating dz)|3|||
160508760|NCT00283244|579589620|FG002|Overall Study|Medical illness (other complicating dz)|6|||
160508761|NCT00283244|579589618|FG000|Overall Study|Clinical deterioration|1|||
160508762|NCT00283244|579589619|FG001|Overall Study|Clinical deterioration|3|||
160508763|NCT00283244|579589620|FG002|Overall Study|Clinical deterioration|3|||
160508764|NCT01743989|579589621|FG000|Treatment Phase|Unstable MR4.0|0|||
160508765|NCT01743989|579589622|FG001|Treatment Phase|Unstable MR4.0|6|||
160508766|NCT01743989|579589623|FG002|Treatment Phase|Unstable MR4.0|263|||
160508767|NCT01743989|579589621|FG000|Treatment Phase|Adverse Event|0|||
160508768|NCT01743989|579589622|FG001|Treatment Phase|Adverse Event|4|||
160508769|NCT01743989|579589623|FG002|Treatment Phase|Adverse Event|67|||
160508770|NCT01743989|579589621|FG000|Treatment Phase|Withdrawal by Subject|1|||
160508771|NCT01743989|579589622|FG001|Treatment Phase|Withdrawal by Subject|3|||
160508772|NCT01743989|579589623|FG002|Treatment Phase|Withdrawal by Subject|28|||
160508773|NCT01743989|579589621|FG000|Treatment Phase|Death|0|||
160508774|NCT01743989|579589622|FG001|Treatment Phase|Death|1|||
160508775|NCT01743989|579589623|FG002|Treatment Phase|Death|3|||
160508776|NCT01743989|579589621|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
160508777|NCT01743989|579589622|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
160508778|NCT01743989|579589623|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
160508779|NCT01743989|579589621|FG000|Treatment Phase|Protocol deviation|0|||
160508780|NCT01743989|579589622|FG001|Treatment Phase|Protocol deviation|0|||
160508781|NCT01743989|579589623|FG002|Treatment Phase|Protocol deviation|3|||
160508782|NCT01743989|579589621|FG000|Treatment Phase|Pregnancy|0|||
160508783|NCT01743989|579589622|FG001|Treatment Phase|Pregnancy|0|||
160508784|NCT01743989|579589623|FG002|Treatment Phase|Pregnancy|2|||
160508785|NCT01743989|579589621|FG000|Treatment Phase|Lost to Follow-up|0|||
160508786|NCT01743989|579589622|FG001|Treatment Phase|Lost to Follow-up|0|||
160508787|NCT01743989|579589623|FG002|Treatment Phase|Lost to Follow-up|2|||
160508788|NCT01743989|579589621|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
160508789|NCT01743989|579589622|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
160508790|NCT01743989|579589623|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
160508791|NCT01743989|579589621|FG000|Treatment Phase|Administrative problems|0|||
160508792|NCT01743989|579589622|FG001|Treatment Phase|Administrative problems|0|||
160508793|NCT01743989|579589623|FG002|Treatment Phase|Administrative problems|1|||
160508794|NCT01743989|579589621|FG000|Treatment Phase|New cancer (CML) therapy|0|||
160508795|NCT01743989|579589622|FG001|Treatment Phase|New cancer (CML) therapy|1|||
160508796|NCT01743989|579589623|FG002|Treatment Phase|New cancer (CML) therapy|0|||
160508797|NCT01743989|579589621|FG000|Treatment Phase|Physician Decision|0|||
160508798|NCT01743989|579589622|FG001|Treatment Phase|Physician Decision|0|||
160508799|NCT01743989|579589623|FG002|Treatment Phase|Physician Decision|3|||
160508800|NCT01743989|579589621|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
160508801|NCT01743989|579589622|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
160508802|NCT01743989|579589623|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
160508803|NCT01743989|579589621|FG000|Treatment Phase|Not randomized by mistake|0|||
160508804|NCT01743989|579589622|FG001|Treatment Phase|Not randomized by mistake|0|||
160508805|NCT01743989|579589623|FG002|Treatment Phase|Not randomized by mistake|1|||
160508806|NCT01743989|579589621|FG000|Treatment Phase|Included by mistake|0|||
160508807|NCT01743989|579589622|FG001|Treatment Phase|Included by mistake|0|||
160508808|NCT01743989|579589623|FG002|Treatment Phase|Included by mistake|1|||
160508809|NCT01743989|579589621|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
160508810|NCT01743989|579589622|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
160508811|NCT01743989|579589623|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
160508812|NCT01743989|579589621|FG000|TFR Phase|Adverse Event|0|||
160508813|NCT01743989|579589622|FG001|TFR Phase|Adverse Event|1|||
160508814|NCT01743989|579589623|FG002|TFR Phase|Adverse Event|0|||
160508815|NCT01743989|579589621|FG000|TFR Phase|Lost to Follow-up|0|||
160508816|NCT01743989|579589622|FG001|TFR Phase|Lost to Follow-up|2|||
160508817|NCT01743989|579589623|FG002|TFR Phase|Lost to Follow-up|0|||
160508818|NCT01743989|579589621|FG000|TFR Phase|Physician Decision|0|||
160508819|NCT01743989|579589622|FG001|TFR Phase|Physician Decision|1|||
160508820|NCT01743989|579589623|FG002|TFR Phase|Physician Decision|0|||
160663918|NCT00440297|580152424|FG001|Overall Study|Randomized by mistake|0|||
160663919|NCT02445339|580152425|FG000|Overall Study|Physician Decision|1|||
160508821|NCT01743989|579589621|FG000|TFR Phase|Logistical problems|0|||
160508822|NCT01743989|579589622|FG001|TFR Phase|Logistical problems|2|||
160508823|NCT01743989|579589623|FG002|TFR Phase|Logistical problems|0|||
160508824|NCT01743989|579589621|FG000|TFR Phase|Protocol deviation|0|||
160508825|NCT01743989|579589622|FG001|TFR Phase|Protocol deviation|1|||
160508826|NCT01743989|579589623|FG002|TFR Phase|Protocol deviation|0|||
160508827|NCT01743989|579589621|FG000|TFR Phase|Withdrawal by Subject|0|||
160508828|NCT01743989|579589622|FG001|TFR Phase|Withdrawal by Subject|2|||
160508829|NCT01743989|579589623|FG002|TFR Phase|Withdrawal by Subject|0|||
160508830|NCT01743989|579589621|FG000|Re-treatment Phase|Adverse Event|8|||
160508831|NCT01743989|579589622|FG001|Re-treatment Phase|Adverse Event|4|||
160508832|NCT01743989|579589623|FG002|Re-treatment Phase|Adverse Event|0|||
160508833|NCT01743989|579589621|FG000|Re-treatment Phase|Death|1|||
160508834|NCT01743989|579589622|FG001|Re-treatment Phase|Death|1|||
160508835|NCT01743989|579589623|FG002|Re-treatment Phase|Death|0|||
160508836|NCT01743989|579589621|FG000|Re-treatment Phase|Administrative problems|1|||
160508837|NCT01743989|579589622|FG001|Re-treatment Phase|Administrative problems|1|||
160508838|NCT01743989|579589623|FG002|Re-treatment Phase|Administrative problems|0|||
160508839|NCT01743989|579589621|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
160508840|NCT01743989|579589622|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
160508841|NCT01743989|579589623|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
160508842|NCT01743989|579589621|FG000|Re-treatment Phase|Unstable MR|1|||
160508843|NCT01743989|579589622|FG001|Re-treatment Phase|Unstable MR|0|||
160508844|NCT01743989|579589623|FG002|Re-treatment Phase|Unstable MR|0|||
160508845|NCT01743989|579589621|FG000|Re-treatment Phase|Physician Decision|0|||
160508846|NCT01743989|579589622|FG001|Re-treatment Phase|Physician Decision|1|||
160508847|NCT01743989|579589623|FG002|Re-treatment Phase|Physician Decision|0|||
160508848|NCT01743989|579589621|FG000|Re-treatment Phase|Lost to Follow-up|0|||
160508849|NCT01743989|579589622|FG001|Re-treatment Phase|Lost to Follow-up|1|||
160508850|NCT01743989|579589623|FG002|Re-treatment Phase|Lost to Follow-up|0|||
160508851|NCT02235311|579589624|FG000|Overall Study|Lost to Follow-up|0|||
160508852|NCT02235311|579589625|FG001|Overall Study|Lost to Follow-up|1|||
160508853|NCT02235311|579589624|FG000|Overall Study|Protocol Violation|0|||
160508854|NCT02235311|579589625|FG001|Overall Study|Protocol Violation|1|||
160508855|NCT00658788|579589626|FG000|Overall Study|Adverse Event|11|||
160508856|NCT00658788|579589626|FG000|Overall Study|Withdrawal by Subject|13|||
160508857|NCT00658788|579589626|FG000|Overall Study|Lost to Follow-up|18|||
160508858|NCT00658788|579589626|FG000|Overall Study|Treatment Discontinuation|32|||
160508859|NCT00653523|579589627|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
160508860|NCT00653523|579589627|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
160508861|NCT00653523|579589627|FG000|Overall Study|Adverse Event|7|||
160508862|NCT00653523|579589627|FG000|Overall Study|Withdrawal by Subject|6|||
160508863|NCT00653523|579589627|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
160508864|NCT00653523|579589627|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
160508865|NCT03519997|579589628|FG000|Overall Study|Adverse Event|4|||
160508866|NCT03519997|579589628|FG000|Overall Study|Withdrawal by Subject|2|||
160508867|NCT03519997|579589628|FG000|Overall Study|Protocol Violation|1|||
160508868|NCT03361605|579589629|FG000|Overall Study|Analyzable data not available|3|||
160508869|NCT05543187|579589630|FG000|Overall Study|Ongoing|3|||
160508870|NCT05543187|579589631|FG001|Overall Study|Ongoing|2|||
160508871|NCT04372121|579589632|FG000|Overall Study|Lost to Follow-up|0|||
160508872|NCT04372121|579589633|FG001|Overall Study|Lost to Follow-up|0|||
160508873|NCT04372121|579589634|FG002|Overall Study|Lost to Follow-up|0|||
160508874|NCT04372121|579589635|FG003|Overall Study|Lost to Follow-up|1|||
160508875|NCT04372121|579589632|FG000|Overall Study|Protocol Violation|0|||
160508876|NCT04372121|579589633|FG001|Overall Study|Protocol Violation|0|||
160508877|NCT04372121|579589634|FG002|Overall Study|Protocol Violation|1|||
160508878|NCT04372121|579589635|FG003|Overall Study|Protocol Violation|0|||
160508879|NCT04372121|579589632|FG000|Overall Study|Withdrawal by Subject|3|||
160508880|NCT04372121|579589633|FG001|Overall Study|Withdrawal by Subject|1|||
160508881|NCT04372121|579589634|FG002|Overall Study|Withdrawal by Subject|0|||
160508882|NCT04372121|579589635|FG003|Overall Study|Withdrawal by Subject|0|||
160508883|NCT04372121|579589632|FG000|Overall Study|Study termination|6|||
160508884|NCT04372121|579589633|FG001|Overall Study|Study termination|5|||
160508885|NCT04372121|579589634|FG002|Overall Study|Study termination|1|||
160508886|NCT04372121|579589635|FG003|Overall Study|Study termination|1|||
160508887|NCT04372121|579589632|FG000|Overall Study|Hysterectomy planned|1|||
160508888|NCT04372121|579589633|FG001|Overall Study|Hysterectomy planned|0|||
160508889|NCT04372121|579589634|FG002|Overall Study|Hysterectomy planned|0|||
160508890|NCT04372121|579589635|FG003|Overall Study|Hysterectomy planned|0|||
160508891|NCT02344290|579589639|FG000|Overall Study|Withdrawal by Subject|315|||
160508892|NCT02344290|579589640|FG001|Overall Study|Withdrawal by Subject|324|||
160508893|NCT02344290|579589639|FG000|Overall Study|Lost to Follow-up|258|||
160508894|NCT02344290|579589640|FG001|Overall Study|Lost to Follow-up|249|||
160508895|NCT02344290|579589639|FG000|Overall Study|Unable to get to clinic|69|||
160508896|NCT02344290|579589640|FG001|Overall Study|Unable to get to clinic|60|||
160508897|NCT02344290|579589639|FG000|Overall Study|Physician Decision|25|||
160508898|NCT02344290|579589640|FG001|Overall Study|Physician Decision|25|||
160508899|NCT02344290|579589639|FG000|Overall Study|Site Closure|15|||
160508900|NCT02344290|579589640|FG001|Overall Study|Site Closure|19|||
160508901|NCT02344290|579589639|FG000|Overall Study|Other|5|||
160508902|NCT02344290|579589640|FG001|Overall Study|Other|3|||
160508903|NCT04047862|579589646|FG000|Overall Study|Death|0|||
160508904|NCT04047862|579589647|FG001|Overall Study|Death|0|||
160620496|NCT01513460|579988506|FG001|Overall Study|Withdrawal by Subject|8|||
160620497|NCT01513460|579988507|FG002|Overall Study|Withdrawal by Subject|21|||
160508905|NCT04047862|579589648|FG002|Overall Study|Death|4|||
160508906|NCT04047862|579589649|FG003|Overall Study|Death|7|||
160508907|NCT04047862|579589650|FG004|Overall Study|Death|2|||
160508908|NCT04047862|579589651|FG005|Overall Study|Death|4|||
160508909|NCT04047862|579589652|FG006|Overall Study|Death|3|||
160508910|NCT04047862|579589653|FG007|Overall Study|Death|24|||
160508911|NCT04047862|579589654|FG008|Overall Study|Death|24|||
160508912|NCT04047862|579589655|FG009|Overall Study|Death|22|||
160508913|NCT04047862|579589656|FG010|Overall Study|Death|35|||
160508914|NCT04047862|579589657|FG011|Overall Study|Death|18|||
160508915|NCT04047862|579589658|FG012|Overall Study|Death|14|||
160620498|NCT01513460|579988505|FG000|Overall Study|Adverse Event|16|||
160620499|NCT01513460|579988506|FG001|Overall Study|Adverse Event|18|||
160508916|NCT04047862|579589659|FG013|Overall Study|Death|6|||
160508917|NCT04047862|579589660|FG014|Overall Study|Death|19|||
160508918|NCT04047862|579589661|FG015|Overall Study|Death|42|||
160508919|NCT04047862|579589662|FG016|Overall Study|Death|9|||
160508920|NCT04047862|579589663|FG017|Overall Study|Death|8|||
160508921|NCT04047862|579589664|FG018|Overall Study|Death|10|||
160508922|NCT04047862|579589646|FG000|Overall Study|Withdrawal by Subject|0|||
160508923|NCT04047862|579589647|FG001|Overall Study|Withdrawal by Subject|0|||
160508924|NCT04047862|579589648|FG002|Overall Study|Withdrawal by Subject|0|||
160508925|NCT04047862|579589649|FG003|Overall Study|Withdrawal by Subject|5|||
160508926|NCT04047862|579589650|FG004|Overall Study|Withdrawal by Subject|2|||
160508927|NCT04047862|579589651|FG005|Overall Study|Withdrawal by Subject|0|||
160508928|NCT04047862|579589652|FG006|Overall Study|Withdrawal by Subject|1|||
160508929|NCT04047862|579589653|FG007|Overall Study|Withdrawal by Subject|0|||
160508930|NCT04047862|579589654|FG008|Overall Study|Withdrawal by Subject|4|||
160508931|NCT04047862|579589655|FG009|Overall Study|Withdrawal by Subject|4|||
160508932|NCT04047862|579589656|FG010|Overall Study|Withdrawal by Subject|4|||
160508933|NCT04047862|579589657|FG011|Overall Study|Withdrawal by Subject|2|||
160508934|NCT04047862|579589658|FG012|Overall Study|Withdrawal by Subject|3|||
160508935|NCT04047862|579589659|FG013|Overall Study|Withdrawal by Subject|0|||
160508936|NCT04047862|579589660|FG014|Overall Study|Withdrawal by Subject|9|||
160508937|NCT04047862|579589661|FG015|Overall Study|Withdrawal by Subject|5|||
160508938|NCT04047862|579589662|FG016|Overall Study|Withdrawal by Subject|1|||
160508939|NCT04047862|579589663|FG017|Overall Study|Withdrawal by Subject|3|||
160508940|NCT04047862|579589664|FG018|Overall Study|Withdrawal by Subject|1|||
160508941|NCT04047862|579589646|FG000|Overall Study|Lost to Follow-up|0|||
160508942|NCT04047862|579589647|FG001|Overall Study|Lost to Follow-up|0|||
160508943|NCT04047862|579589648|FG002|Overall Study|Lost to Follow-up|1|||
160508944|NCT04047862|579589649|FG003|Overall Study|Lost to Follow-up|0|||
160508945|NCT04047862|579589650|FG004|Overall Study|Lost to Follow-up|0|||
160508946|NCT04047862|579589651|FG005|Overall Study|Lost to Follow-up|0|||
160508947|NCT04047862|579589652|FG006|Overall Study|Lost to Follow-up|0|||
160508948|NCT04047862|579589653|FG007|Overall Study|Lost to Follow-up|1|||
160508949|NCT04047862|579589654|FG008|Overall Study|Lost to Follow-up|0|||
160508950|NCT04047862|579589655|FG009|Overall Study|Lost to Follow-up|1|||
160508951|NCT04047862|579589656|FG010|Overall Study|Lost to Follow-up|0|||
160508952|NCT04047862|579589657|FG011|Overall Study|Lost to Follow-up|3|||
160508953|NCT04047862|579589658|FG012|Overall Study|Lost to Follow-up|0|||
160508954|NCT04047862|579589659|FG013|Overall Study|Lost to Follow-up|0|||
160508955|NCT04047862|579589660|FG014|Overall Study|Lost to Follow-up|2|||
160508956|NCT04047862|579589661|FG015|Overall Study|Lost to Follow-up|2|||
160508957|NCT04047862|579589662|FG016|Overall Study|Lost to Follow-up|1|||
160508958|NCT04047862|579589663|FG017|Overall Study|Lost to Follow-up|0|||
160508959|NCT04047862|579589664|FG018|Overall Study|Lost to Follow-up|0|||
160508960|NCT04047862|579589646|FG000|Overall Study|Physician Decision|0|||
160508961|NCT04047862|579589647|FG001|Overall Study|Physician Decision|0|||
160508962|NCT04047862|579589648|FG002|Overall Study|Physician Decision|0|||
160508963|NCT04047862|579589649|FG003|Overall Study|Physician Decision|1|||
160508964|NCT04047862|579589650|FG004|Overall Study|Physician Decision|0|||
160508965|NCT04047862|579589651|FG005|Overall Study|Physician Decision|0|||
160508966|NCT04047862|579589652|FG006|Overall Study|Physician Decision|0|||
160508967|NCT04047862|579589653|FG007|Overall Study|Physician Decision|0|||
160508968|NCT04047862|579589654|FG008|Overall Study|Physician Decision|0|||
160508969|NCT04047862|579589655|FG009|Overall Study|Physician Decision|0|||
160508970|NCT04047862|579589656|FG010|Overall Study|Physician Decision|0|||
160508971|NCT04047862|579589657|FG011|Overall Study|Physician Decision|0|||
160508972|NCT04047862|579589658|FG012|Overall Study|Physician Decision|0|||
160508973|NCT04047862|579589659|FG013|Overall Study|Physician Decision|0|||
160508974|NCT04047862|579589660|FG014|Overall Study|Physician Decision|1|||
160508975|NCT04047862|579589661|FG015|Overall Study|Physician Decision|0|||
160508976|NCT04047862|579589662|FG016|Overall Study|Physician Decision|1|||
160508977|NCT04047862|579589663|FG017|Overall Study|Physician Decision|0|||
160508978|NCT04047862|579589664|FG018|Overall Study|Physician Decision|0|||
160508979|NCT04047862|579589646|FG000|Overall Study|Completed all Assessments|1|||
160508980|NCT04047862|579589647|FG001|Overall Study|Completed all Assessments|3|||
160508981|NCT04047862|579589648|FG002|Overall Study|Completed all Assessments|1|||
160508982|NCT04047862|579589649|FG003|Overall Study|Completed all Assessments|3|||
160508983|NCT04047862|579589650|FG004|Overall Study|Completed all Assessments|2|||
160508984|NCT04047862|579589651|FG005|Overall Study|Completed all Assessments|5|||
160508985|NCT04047862|579589652|FG006|Overall Study|Completed all Assessments|7|||
160508986|NCT04047862|579589653|FG007|Overall Study|Completed all Assessments|0|||
160508987|NCT04047862|579589654|FG008|Overall Study|Completed all Assessments|0|||
160508988|NCT04047862|579589655|FG009|Overall Study|Completed all Assessments|0|||
160508989|NCT04047862|579589656|FG010|Overall Study|Completed all Assessments|0|||
160508990|NCT04047862|579589657|FG011|Overall Study|Completed all Assessments|0|||
160508991|NCT04047862|579589658|FG012|Overall Study|Completed all Assessments|0|||
160508992|NCT04047862|579589659|FG013|Overall Study|Completed all Assessments|0|||
160508993|NCT04047862|579589660|FG014|Overall Study|Completed all Assessments|0|||
160508994|NCT04047862|579589661|FG015|Overall Study|Completed all Assessments|0|||
160508995|NCT04047862|579589662|FG016|Overall Study|Completed all Assessments|0|||
160508996|NCT04047862|579589663|FG017|Overall Study|Completed all Assessments|0|||
160508997|NCT04047862|579589664|FG018|Overall Study|Completed all Assessments|0|||
160508998|NCT04047862|579589646|FG000|Overall Study|Sponsor Decision|0|||
160508999|NCT04047862|579589647|FG001|Overall Study|Sponsor Decision|0|||
160509000|NCT04047862|579589648|FG002|Overall Study|Sponsor Decision|0|||
160509001|NCT04047862|579589649|FG003|Overall Study|Sponsor Decision|0|||
160509002|NCT04047862|579589650|FG004|Overall Study|Sponsor Decision|0|||
160509003|NCT04047862|579589651|FG005|Overall Study|Sponsor Decision|0|||
160509004|NCT04047862|579589652|FG006|Overall Study|Sponsor Decision|0|||
160509005|NCT04047862|579589653|FG007|Overall Study|Sponsor Decision|13|||
160509006|NCT04047862|579589654|FG008|Overall Study|Sponsor Decision|10|||
160509007|NCT04047862|579589655|FG009|Overall Study|Sponsor Decision|18|||
160509008|NCT04047862|579589656|FG010|Overall Study|Sponsor Decision|3|||
160509009|NCT04047862|579589657|FG011|Overall Study|Sponsor Decision|3|||
160509010|NCT04047862|579589658|FG012|Overall Study|Sponsor Decision|4|||
160509011|NCT04047862|579589659|FG013|Overall Study|Sponsor Decision|0|||
160509012|NCT04047862|579589660|FG014|Overall Study|Sponsor Decision|7|||
160509013|NCT04047862|579589661|FG015|Overall Study|Sponsor Decision|8|||
160509014|NCT04047862|579589662|FG016|Overall Study|Sponsor Decision|9|||
160509015|NCT04047862|579589663|FG017|Overall Study|Sponsor Decision|7|||
160509016|NCT04047862|579589664|FG018|Overall Study|Sponsor Decision|8|||
160509017|NCT04047862|579589646|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509018|NCT04047862|579589647|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509019|NCT04047862|579589648|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509020|NCT04047862|579589649|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509021|NCT04047862|579589650|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509022|NCT04047862|579589651|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509023|NCT04047862|579589652|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509024|NCT04047862|579589653|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
160509025|NCT04047862|579589654|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
160509026|NCT04047862|579589655|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509027|NCT04047862|579589656|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
160509028|NCT04047862|579589657|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509029|NCT04047862|579589658|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509030|NCT04047862|579589659|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
160509031|NCT04047862|579589660|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
160509032|NCT04047862|579589661|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
160509033|NCT04047862|579589662|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
160509034|NCT04047862|579589663|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
160509035|NCT04047862|579589664|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
160509036|NCT04047862|579589646|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509037|NCT04047862|579589647|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509038|NCT04047862|579589648|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509039|NCT04047862|579589649|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509040|NCT04047862|579589650|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509041|NCT04047862|579589651|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509042|NCT04047862|579589652|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509043|NCT04047862|579589653|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509044|NCT04047862|579589654|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509045|NCT04047862|579589655|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509046|NCT04047862|579589656|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509047|NCT04047862|579589657|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509048|NCT04047862|579589658|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509049|NCT04047862|579589659|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509050|NCT04047862|579589660|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509051|NCT04047862|579589661|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
160509052|NCT04047862|579589662|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509053|NCT04047862|579589663|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
160509054|NCT04047862|579589664|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
160509055|NCT04047862|579589646|FG000|Overall Study|Other|0|||
160663920|NCT02445339|580152426|FG001|Overall Study|Physician Decision|0|||
160509056|NCT04047862|579589647|FG001|Overall Study|Other|0|||
160509057|NCT04047862|579589648|FG002|Overall Study|Other|0|||
160509058|NCT04047862|579589649|FG003|Overall Study|Other|0|||
160509059|NCT04047862|579589650|FG004|Overall Study|Other|0|||
160509060|NCT04047862|579589651|FG005|Overall Study|Other|0|||
160663921|NCT02445339|580152425|FG000|Overall Study|Lost to Follow-up|11|||
160663922|NCT02445339|580152426|FG001|Overall Study|Lost to Follow-up|15|||
160509061|NCT04047862|579589652|FG006|Overall Study|Other|0|||
160509062|NCT04047862|579589653|FG007|Overall Study|Other|0|||
160509063|NCT04047862|579589654|FG008|Overall Study|Other|0|||
160509064|NCT04047862|579589655|FG009|Overall Study|Other|0|||
160509065|NCT04047862|579589656|FG010|Overall Study|Other|0|||
160509066|NCT04047862|579589657|FG011|Overall Study|Other|0|||
160509067|NCT04047862|579589658|FG012|Overall Study|Other|0|||
160509068|NCT04047862|579589659|FG013|Overall Study|Other|0|||
160509069|NCT04047862|579589660|FG014|Overall Study|Other|2|||
160509070|NCT04047862|579589661|FG015|Overall Study|Other|1|||
160509071|NCT04047862|579589662|FG016|Overall Study|Other|1|||
160509072|NCT04047862|579589663|FG017|Overall Study|Other|1|||
160509073|NCT04047862|579589664|FG018|Overall Study|Other|0|||
160509074|NCT00640133|579591334|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
160509075|NCT00640133|579591335|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
160509076|NCT00640133|579591334|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
160509077|NCT00640133|579591335|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
160509078|NCT00640133|579591334|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
160509079|NCT00640133|579591335|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
160509080|NCT01994837|579591337|FG000|Overall Study|Progressive disease per protocol|23|||
160509081|NCT01994837|579591337|FG000|Overall Study|Adv event related to progressive disease|3|||
160509082|NCT01994837|579591337|FG000|Overall Study|Fatal progressive disease|2|||
160509083|NCT01994837|579591337|FG000|Overall Study|Adverse event not related to progression|1|||
160509084|NCT01994837|579591337|FG000|Overall Study|Chose palliative care|1|||
160509085|NCT01994837|579591337|FG000|Overall Study|Proceeded to transplant|1|||
160509086|NCT01994837|579591337|FG000|Overall Study|Removed from study due to no response|1|||
160509087|NCT03900416|579591339|FG000|Six Week Follow-up|Lost to Follow-up|1|||
160509088|NCT03900416|579591340|FG001|Six Week Follow-up|Lost to Follow-up|0|||
160509089|NCT03900416|579591339|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
160509090|NCT03900416|579591340|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
160509091|NCT03900416|579591339|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
160509092|NCT03900416|579591340|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
160509093|NCT03900416|579591339|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
160509094|NCT03900416|579591340|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
160509095|NCT03900416|579591339|FG000|Twelve Week Follow-up|Adverse Event|1|||
160509096|NCT03900416|579591340|FG001|Twelve Week Follow-up|Adverse Event|1|||
160509097|NCT03900416|579591339|FG000|Six Month Follow-up|Lost to Follow-up|4|||
160509098|NCT03900416|579591340|FG001|Six Month Follow-up|Lost to Follow-up|3|||
160509099|NCT03900416|579591339|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
160509100|NCT03900416|579591340|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
160509101|NCT03207451|579591343|FG000|Overall Study|scheduling conflict|1|||
160509102|NCT03207451|579591344|FG001|Overall Study|scheduling conflict|0|||
160509103|NCT03207451|579591345|FG002|Overall Study|scheduling conflict|2|||
160509104|NCT03207451|579591346|FG003|Overall Study|scheduling conflict|2|||
160509105|NCT03207451|579591343|FG000|Overall Study|Adverse Event|0|||
160509106|NCT03207451|579591344|FG001|Overall Study|Adverse Event|0|||
160509107|NCT03207451|579591345|FG002|Overall Study|Adverse Event|0|||
160509108|NCT03207451|579591346|FG003|Overall Study|Adverse Event|1|||
160509109|NCT03896152|579591347|FG000|Overall Study|Patient/guardian decision|1|||
160509110|NCT03896152|579591348|FG001|Overall Study|Patient/guardian decision|1|||
160509111|NCT03896152|579591347|FG000|Overall Study|Adverse Event|0|||
160509112|NCT03896152|579591348|FG001|Overall Study|Adverse Event|1|||
160509113|NCT03896152|579591347|FG000|Overall Study|Physician Decision|1|||
160509114|NCT03896152|579591348|FG001|Overall Study|Physician Decision|0|||
160509115|NCT03896152|579591347|FG000|Overall Study|Technical problems|1|||
160509116|NCT03896152|579591348|FG001|Overall Study|Technical problems|0|||
160509117|NCT00436852|579591349|FG000|Overall Study|Death|23|||
160509118|NCT00436852|579591350|FG001|Overall Study|Death|34|||
160509119|NCT00436852|579591349|FG000|Overall Study|Lack of Efficacy|9|||
160509120|NCT00436852|579591350|FG001|Overall Study|Lack of Efficacy|7|||
160509121|NCT00436852|579591349|FG000|Overall Study|Withdrawal by Subject|2|||
160509122|NCT00436852|579591350|FG001|Overall Study|Withdrawal by Subject|4|||
160509123|NCT00436852|579591349|FG000|Overall Study|Ineligible|1|||
160509124|NCT00436852|579591350|FG001|Overall Study|Ineligible|0|||
160509125|NCT00370682|579591351|FG000|Overall Study|Moved from area|0|||
160509126|NCT00370682|579591352|FG001|Overall Study|Moved from area|2|||
160509127|NCT00370682|579591353|FG002|Overall Study|Moved from area|0|||
160509128|NCT00370682|579591351|FG000|Overall Study|Lost to Follow-up|0|||
160509129|NCT00370682|579591352|FG001|Overall Study|Lost to Follow-up|1|||
160509130|NCT00370682|579591353|FG002|Overall Study|Lost to Follow-up|1|||
160509131|NCT03167359|579591354|FG000|Overall Study|Physician Decision|1|||
160509132|NCT03167359|579591354|FG000|Overall Study|Lost to Follow-up|1|||
160509133|NCT03339583|579591355|FG000|First Intervention (14 Days)|Adverse Event|1|||
160663923|NCT02024932|580152427|FG000|Overall Study|Adverse Event|2|||
160509134|NCT03339583|579591356|FG001|First Intervention (14 Days)|Adverse Event|0|||
160663924|NCT02024932|580152428|FG001|Overall Study|Adverse Event|3|||
160509135|NCT03339583|579591355|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
160509136|NCT03339583|579591356|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
160509137|NCT03339583|579591355|FG000|Second Intervention (14 Days)|Adverse Event|0|||
160509138|NCT03339583|579591356|FG001|Second Intervention (14 Days)|Adverse Event|1|||
160509139|NCT03339583|579591355|FG000|Follow-up (14 Days)|Physician Decision|6|||
160509140|NCT03339583|579591356|FG001|Follow-up (14 Days)|Physician Decision|3|||
160509141|NCT02141620|579591357|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
160509142|NCT02141620|579591358|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
160509143|NCT00224887|579591359|FG000|Overall Study|Pregnancy|6|||
160509144|NCT00224887|579591360|FG001|Overall Study|Pregnancy|6|||
160509145|NCT00730275|579591361|FG000|Overall Study|Withdrawal by Subject|0|||
160509146|NCT00730275|579591362|FG001|Overall Study|Withdrawal by Subject|0|||
160509147|NCT00730275|579591363|FG002|Overall Study|Withdrawal by Subject|0|||
160509148|NCT00730275|579591364|FG003|Overall Study|Withdrawal by Subject|1|||
160509149|NCT00356408|579591365|FG000|Overall Study|Adverse Event|9|||
160509150|NCT00356408|579591365|FG000|Overall Study|Lack of Efficacy|36|||
160509151|NCT00356408|579591365|FG000|Overall Study|Lost to Follow-up|2|||
160509152|NCT00356408|579591365|FG000|Overall Study|Withdrawal by Subject|6|||
160509153|NCT00356408|579591365|FG000|Overall Study|Other: Principal investigator discretion|3|||
160509154|NCT00356408|579591365|FG000|Overall Study|Other: Sponsor request|1|||
160509155|NCT00356408|579591365|FG000|Overall Study|Other: Azathioprine stopped|1|||
160509156|NCT00356408|579591365|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
160509157|NCT00356408|579591365|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
160509158|NCT05487586|579591368|FG000|Overall Study|Death|22|||
160509159|NCT05487586|579591368|FG000|Overall Study|Physician Decision|1|||
160509160|NCT05487586|579591368|FG000|Overall Study|Transfer to another hospital|4|||
160509161|NCT05487586|579591368|FG000|Overall Study|Other|1|||
160509162|NCT03921723|579591369|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
160509163|NCT03921723|579591369|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
160509164|NCT01072630|579591371|FG000|Overall Study|Adverse Event|11|||
160509165|NCT01072630|579591372|FG001|Overall Study|Adverse Event|19|||
160509166|NCT01072630|579591373|FG002|Overall Study|Adverse Event|2|||
160509167|NCT01072630|579591371|FG000|Overall Study|Lack of Efficacy|10|||
160509168|NCT01072630|579591372|FG001|Overall Study|Lack of Efficacy|10|||
160509169|NCT01072630|579591373|FG002|Overall Study|Lack of Efficacy|1|||
160509170|NCT01072630|579591371|FG000|Overall Study|Withdrawal by Subject|8|||
160509171|NCT01072630|579591372|FG001|Overall Study|Withdrawal by Subject|7|||
160509172|NCT01072630|579591373|FG002|Overall Study|Withdrawal by Subject|2|||
160509173|NCT01072630|579591371|FG000|Overall Study|Protocol Violation|10|||
160509174|NCT01072630|579591372|FG001|Overall Study|Protocol Violation|8|||
160509175|NCT01072630|579591373|FG002|Overall Study|Protocol Violation|4|||
160509176|NCT01072630|579591371|FG000|Overall Study|Lost to Follow-up|11|||
160509177|NCT01072630|579591372|FG001|Overall Study|Lost to Follow-up|11|||
160509178|NCT01072630|579591373|FG002|Overall Study|Lost to Follow-up|1|||
160509179|NCT01072630|579591371|FG000|Overall Study|Noncompliance with study medication|1|||
160509180|NCT01072630|579591372|FG001|Overall Study|Noncompliance with study medication|1|||
160509181|NCT01072630|579591373|FG002|Overall Study|Noncompliance with study medication|1|||
160509182|NCT01072630|579591371|FG000|Overall Study|Noncompliance with study procedures|1|||
160509183|NCT01072630|579591372|FG001|Overall Study|Noncompliance with study procedures|2|||
160509184|NCT01072630|579591373|FG002|Overall Study|Noncompliance with study procedures|1|||
160509185|NCT01072630|579591371|FG000|Overall Study|Other|3|||
160509186|NCT01072630|579591372|FG001|Overall Study|Other|2|||
160509187|NCT01072630|579591373|FG002|Overall Study|Other|1|||
160509188|NCT05032872|579591374|FG000|Overall Study|Adverse Event|1|||
160509189|NCT05032872|579591375|FG001|Overall Study|Adverse Event|0|||
160509190|NCT05032872|579591374|FG000|Overall Study|Lost to Follow-up|2|||
160509191|NCT05032872|579591375|FG001|Overall Study|Lost to Follow-up|4|||
160509192|NCT05032872|579591374|FG000|Overall Study|Withdrawal by Subject|4|||
160509193|NCT05032872|579591375|FG001|Overall Study|Withdrawal by Subject|3|||
160509194|NCT03214640|579591376|FG000|Overall Study|Protocol Violation|1|||
160509195|NCT03214640|579591377|FG001|Overall Study|Protocol Violation|2|||
160509196|NCT03214640|579591378|FG002|Overall Study|Protocol Violation|1|||
160509197|NCT03214640|579591379|FG003|Overall Study|Protocol Violation|4|||
160509198|NCT00821587|579591384|FG000|Overall Study|Physician Decision|0|||
160509199|NCT00821587|579591385|FG001|Overall Study|Physician Decision|1|||
160509200|NCT04488770|579591386|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509201|NCT04488770|579591387|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509202|NCT04488770|579591388|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509203|NCT04488770|579591389|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
160509204|NCT04488770|579591390|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509205|NCT04488770|579591391|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509206|NCT04488770|579591392|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509207|NCT04488770|579591393|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509208|NCT04488770|579591394|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509209|NCT04488770|579591395|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509210|NCT04488770|579591396|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509211|NCT04488770|579591397|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509212|NCT04488770|579591398|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
160509213|NCT04488770|579591386|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
160509214|NCT04488770|579591387|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509215|NCT04488770|579591388|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509216|NCT04488770|579591389|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509217|NCT04488770|579591390|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509218|NCT04488770|579591391|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509219|NCT04488770|579591392|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509220|NCT04488770|579591393|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509221|NCT04488770|579591394|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509222|NCT04488770|579591395|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509223|NCT04488770|579591396|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509224|NCT04488770|579591397|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509225|NCT04488770|579591398|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
160509226|NCT04488770|579591386|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509227|NCT04488770|579591387|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509228|NCT04488770|579591388|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509229|NCT04488770|579591389|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509230|NCT04488770|579591390|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509231|NCT04488770|579591391|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
160509232|NCT04488770|579591392|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
160663925|NCT02024932|580152429|FG002|Overall Study|Adverse Event|0|||
160663926|NCT02024932|580152430|FG003|Overall Study|Adverse Event|0|||
160663927|NCT02024932|580152431|FG004|Overall Study|Adverse Event|2|||
160663928|NCT02024932|580152432|FG005|Overall Study|Adverse Event|0|||
160509233|NCT04488770|579591393|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509234|NCT04488770|579591394|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509235|NCT04488770|579591395|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509236|NCT04488770|579591396|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509237|NCT04488770|579591397|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509238|NCT04488770|579591398|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160509239|NCT04488770|579591386|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509240|NCT04488770|579591387|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509241|NCT04488770|579591388|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509242|NCT04488770|579591389|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509243|NCT04488770|579591390|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
160509244|NCT04488770|579591391|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509245|NCT04488770|579591392|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509246|NCT04488770|579591393|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509247|NCT04488770|579591394|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509248|NCT04488770|579591395|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509249|NCT04488770|579591396|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509250|NCT04488770|579591397|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509251|NCT04488770|579591398|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
160509252|NCT03192475|579591409|FG000|Overall Study|Death|0|||
160509253|NCT03192475|579591410|FG001|Overall Study|Death|1|||
160509254|NCT03192475|579591409|FG000|Overall Study|Lost to Follow-up|13|||
160509255|NCT03192475|579591410|FG001|Overall Study|Lost to Follow-up|8|||
160509256|NCT03980808|579591411|FG000|Overall Study|Lost to Follow-up|2|||
160509257|NCT03980808|579591412|FG001|Overall Study|Lost to Follow-up|2|||
160509258|NCT00798590|579591413|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
160509259|NCT00798590|579591414|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
160509260|NCT03898167|579591417|FG000|Overall Study|Terminated phone call early|7|||
160509261|NCT03898167|579591418|FG001|Overall Study|Terminated phone call early|0|||
160509262|NCT03898167|579591419|FG002|Overall Study|Terminated phone call early|0|||
160509263|NCT03898167|579591417|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
160509264|NCT03898167|579591418|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
160509265|NCT03898167|579591419|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
160509266|NCT00151281|579591421|FG000|Overall Study|Not evaluable|3|||
160509267|NCT02906007|579591424|FG000|Overall Study|Physician Decision|0|||
160509268|NCT02906007|579591425|FG001|Overall Study|Physician Decision|0|||
160509269|NCT02906007|579591426|FG002|Overall Study|Physician Decision|1|||
160663929|NCT02024932|580152427|FG000|Overall Study|Abnormal laboratory value|0|||
160663930|NCT02024932|580152428|FG001|Overall Study|Abnormal laboratory value|0|||
160663931|NCT02024932|580152429|FG002|Overall Study|Abnormal laboratory value|0|||
160663932|NCT02024932|580152430|FG003|Overall Study|Abnormal laboratory value|2|||
160663933|NCT02024932|580152431|FG004|Overall Study|Abnormal laboratory value|0|||
160509270|NCT02906007|579591424|FG000|Overall Study|Died|1|||
160509271|NCT02906007|579591425|FG001|Overall Study|Died|0|||
160509272|NCT02906007|579591426|FG002|Overall Study|Died|0|||
160509273|NCT04696653|579591427|FG000|Overall Study|left organization|18|||
160509274|NCT04696653|579591427|FG000|Overall Study|Lost to Follow-up|3|||
160509275|NCT03651622|579592923|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
160509276|NCT03651622|579592924|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
160509277|NCT03651622|579592925|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
160509278|NCT03651622|579592923|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
160509279|NCT03651622|579592924|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
160509280|NCT03651622|579592925|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
160509281|NCT03651622|579592923|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
160509282|NCT03651622|579592924|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
160509283|NCT03651622|579592925|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
160509284|NCT03651622|579592923|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
160509285|NCT03651622|579592924|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
160509286|NCT03651622|579592925|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
160509287|NCT03651622|579592923|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
160509288|NCT03651622|579592924|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
160509289|NCT03651622|579592925|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
160509290|NCT01519089|579592926|FG000|Overall Study|Adverse Event|4|||
160509291|NCT01519089|579592927|FG001|Overall Study|Adverse Event|4|||
160509292|NCT01519089|579592926|FG000|Overall Study|Lack of Efficacy|0|||
160509293|NCT01519089|579592927|FG001|Overall Study|Lack of Efficacy|2|||
160509294|NCT01519089|579592926|FG000|Overall Study|Lost to Follow-up|1|||
160509295|NCT01519089|579592927|FG001|Overall Study|Lost to Follow-up|0|||
160509296|NCT01519089|579592926|FG000|Overall Study|Withdrawal by Subject|0|||
160509297|NCT01519089|579592927|FG001|Overall Study|Withdrawal by Subject|2|||
160509298|NCT01519089|579592926|FG000|Overall Study|Other|2|||
160509299|NCT01519089|579592927|FG001|Overall Study|Other|6|||
160509300|NCT01519089|579592926|FG000|Overall Study|Not received study drug|0|||
160509301|NCT01519089|579592927|FG001|Overall Study|Not received study drug|1|||
160509302|NCT00307684|579592928|FG000|Open Label Phase|Lack of Efficacy|0|||
160509303|NCT00307684|579592929|FG001|Open Label Phase|Lack of Efficacy|0|||
160509304|NCT00307684|579592930|FG002|Open Label Phase|Lack of Efficacy|3|||
160509305|NCT00307684|579592928|FG000|Open Label Phase|Adverse Event|0|||
160509306|NCT00307684|579592929|FG001|Open Label Phase|Adverse Event|0|||
160509307|NCT00307684|579592930|FG002|Open Label Phase|Adverse Event|16|||
160509308|NCT00307684|579592928|FG000|Open Label Phase|Withdrawal by Subject|0|||
160509309|NCT00307684|579592929|FG001|Open Label Phase|Withdrawal by Subject|0|||
160509310|NCT00307684|579592930|FG002|Open Label Phase|Withdrawal by Subject|15|||
160509311|NCT00307684|579592928|FG000|Open Label Phase|Lost to Follow-up|0|||
160509312|NCT00307684|579592929|FG001|Open Label Phase|Lost to Follow-up|0|||
160509313|NCT00307684|579592930|FG002|Open Label Phase|Lost to Follow-up|11|||
160509314|NCT00307684|579592928|FG000|Open Label Phase|non compliance|0|||
160509315|NCT00307684|579592929|FG001|Open Label Phase|non compliance|0|||
160509316|NCT00307684|579592930|FG002|Open Label Phase|non compliance|5|||
160509317|NCT00307684|579592928|FG000|Open Label Phase|other|0|||
160509318|NCT00307684|579592929|FG001|Open Label Phase|other|0|||
160509319|NCT00307684|579592930|FG002|Open Label Phase|other|6|||
160509320|NCT00307684|579592928|FG000|Double Blind Phase|Lack of Efficacy|2|||
160509321|NCT00307684|579592929|FG001|Double Blind Phase|Lack of Efficacy|5|||
160509322|NCT00307684|579592930|FG002|Double Blind Phase|Lack of Efficacy|0|||
160509323|NCT03046121|579592933|FG000|Overall Study|Death|32|||
160509324|NCT03046121|579592934|FG001|Overall Study|Death|60|||
160509325|NCT03046121|579592933|FG000|Overall Study|Withdrawal by Subject|14|||
160509326|NCT03046121|579592934|FG001|Overall Study|Withdrawal by Subject|12|||
160509327|NCT00406692|579592939|FG000|Overall Study|Withdrawal by Subject|4|||
160509328|NCT00406692|579592939|FG000|Overall Study|Physician Decision|1|||
160509329|NCT00406692|579592939|FG000|Overall Study|Adverse Event|1|||
160509330|NCT00406692|579592939|FG000|Overall Study|Lack of Efficacy|1|||
160509331|NCT03547739|579592940|FG000|Overall Study|Death|0|||
160509332|NCT03547739|579592941|FG001|Overall Study|Death|1|||
160509333|NCT03547739|579592942|FG002|Overall Study|Death|5|||
160509334|NCT03547739|579592940|FG000|Overall Study|Adverse Event|24|||
160509335|NCT03547739|579592941|FG001|Overall Study|Adverse Event|11|||
160509336|NCT03547739|579592942|FG002|Overall Study|Adverse Event|13|||
160509337|NCT03547739|579592940|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
160509338|NCT03547739|579592941|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
160509339|NCT03547739|579592942|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
160509340|NCT03547739|579592940|FG000|Overall Study|Lost to Follow-up|80|||
160509341|NCT03547739|579592941|FG001|Overall Study|Lost to Follow-up|84|||
160509342|NCT03547739|579592942|FG002|Overall Study|Lost to Follow-up|116|||
160509343|NCT01744392|579592946|FG000|Overall Study|Physician Decision|1|||
160509344|NCT00299494|579592947|FG000|Overall Study|Withdrawal by Subject|0|||
160509345|NCT00299494|579592948|FG001|Overall Study|Withdrawal by Subject|0|||
160509346|NCT00299494|579592949|FG002|Overall Study|Withdrawal by Subject|0|||
160509347|NCT00299494|579592950|FG003|Overall Study|Withdrawal by Subject|3|||
160509348|NCT00299494|579592951|FG004|Overall Study|Withdrawal by Subject|1|||
160509349|NCT00299494|579592952|FG005|Overall Study|Withdrawal by Subject|4|||
160509350|NCT00299494|579592947|FG000|Overall Study|Physician Decision|0|||
160509351|NCT00299494|579592948|FG001|Overall Study|Physician Decision|0|||
160509352|NCT00299494|579592949|FG002|Overall Study|Physician Decision|0|||
160509353|NCT00299494|579592950|FG003|Overall Study|Physician Decision|0|||
160509354|NCT00299494|579592951|FG004|Overall Study|Physician Decision|1|||
160509355|NCT00299494|579592952|FG005|Overall Study|Physician Decision|0|||
160509356|NCT00299494|579592947|FG000|Overall Study|Death|3|||
160509357|NCT00299494|579592948|FG001|Overall Study|Death|1|||
160509358|NCT00299494|579592949|FG002|Overall Study|Death|4|||
160509359|NCT00299494|579592950|FG003|Overall Study|Death|6|||
160509360|NCT00299494|579592951|FG004|Overall Study|Death|18|||
160509361|NCT00299494|579592952|FG005|Overall Study|Death|19|||
160509362|NCT00299494|579592947|FG000|Overall Study|Lost to Follow-up|0|||
160509363|NCT00299494|579592948|FG001|Overall Study|Lost to Follow-up|0|||
160509364|NCT00299494|579592949|FG002|Overall Study|Lost to Follow-up|0|||
160509365|NCT00299494|579592950|FG003|Overall Study|Lost to Follow-up|0|||
160509366|NCT00299494|579592951|FG004|Overall Study|Lost to Follow-up|3|||
160509367|NCT00299494|579592952|FG005|Overall Study|Lost to Follow-up|1|||
160509368|NCT00299494|579592947|FG000|Overall Study|Other - Unspecified|0|||
160509369|NCT00299494|579592948|FG001|Overall Study|Other - Unspecified|0|||
160509370|NCT00299494|579592949|FG002|Overall Study|Other - Unspecified|0|||
160509371|NCT00299494|579592950|FG003|Overall Study|Other - Unspecified|0|||
160509372|NCT00299494|579592951|FG004|Overall Study|Other - Unspecified|3|||
160509373|NCT00299494|579592952|FG005|Overall Study|Other - Unspecified|1|||
160509374|NCT00299494|579592947|FG000|Overall Study|Other - site closure|0|||
160509375|NCT00299494|579592948|FG001|Overall Study|Other - site closure|0|||
160509376|NCT00299494|579592949|FG002|Overall Study|Other - site closure|0|||
160509377|NCT00299494|579592950|FG003|Overall Study|Other - site closure|1|||
160509378|NCT00299494|579592951|FG004|Overall Study|Other - site closure|1|||
160509379|NCT00299494|579592952|FG005|Overall Study|Other - site closure|1|||
160509380|NCT00635661|579592958|FG000|Overall Study|Withdrawal by Subject|4|||
160509381|NCT00403767|579592964|FG000|Overall Study|Adverse Event|993|||
160509382|NCT00403767|579592965|FG001|Overall Study|Adverse Event|919|||
160509383|NCT00403767|579592964|FG000|Overall Study|Non-compliant with study medication|134|||
160509384|NCT00403767|579592965|FG001|Overall Study|Non-compliant with study medication|164|||
160509385|NCT00403767|579592964|FG000|Overall Study|Consent withdrawn|671|||
160509386|NCT00403767|579592965|FG001|Overall Study|Consent withdrawn|673|||
160509387|NCT00403767|579592964|FG000|Overall Study|Investigator dec./not protocol-related|191|||
160509388|NCT00403767|579592965|FG001|Overall Study|Investigator dec./not protocol-related|178|||
160509389|NCT00403767|579592964|FG000|Overall Study|Lost to Follow-up|6|||
160509390|NCT00403767|579592965|FG001|Overall Study|Lost to Follow-up|8|||
160509391|NCT00403767|579592964|FG000|Overall Study|Protocol Violation|142|||
160509392|NCT00403767|579592965|FG001|Overall Study|Protocol Violation|124|||
160509393|NCT00403767|579592964|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
160509394|NCT00403767|579592965|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
160509395|NCT00403767|579592964|FG000|Overall Study|Study terminated by sponsor|82|||
160509396|NCT00403767|579592965|FG001|Overall Study|Study terminated by sponsor|69|||
160509397|NCT00403767|579592964|FG000|Overall Study|Missing/incomplete data|1|||
160509398|NCT00403767|579592965|FG001|Overall Study|Missing/incomplete data|1|||
160509399|NCT01696955|579592966|FG000|Main Study|Protocol Violation|1|||
160509400|NCT01696955|579592967|FG001|Main Study|Protocol Violation|0|||
160509401|NCT01696955|579592966|FG000|Main Study|Withdrawal by Subject|1|||
160509402|NCT01696955|579592967|FG001|Main Study|Withdrawal by Subject|1|||
160509403|NCT01641159|579592968|FG000|Overall Study|Lost to Follow-up|2|||
160509404|NCT01641159|579592969|FG001|Overall Study|Lost to Follow-up|1|||
160509405|NCT01641159|579592968|FG000|Overall Study|Withdrawal by Subject|0|||
160509406|NCT01641159|579592969|FG001|Overall Study|Withdrawal by Subject|1|||
160509407|NCT05330676|579592970|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
160509408|NCT05330676|579592971|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
160509409|NCT00436605|579592972|FG000|Overall Study|Protocol Violation|3|||
160509410|NCT00573859|579592977|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
160509411|NCT00573859|579592977|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
160509412|NCT02416453|579592978|FG000|Overall Study|Adverse Event|0|||
160620500|NCT01513460|579988507|FG002|Overall Study|Adverse Event|23|||
160509413|NCT02416453|579592979|FG001|Overall Study|Adverse Event|0|||
160509414|NCT02416453|579592980|FG002|Overall Study|Adverse Event|0|||
160509415|NCT02416453|579592981|FG003|Overall Study|Adverse Event|2|||
160509416|NCT02416453|579592982|FG004|Overall Study|Adverse Event|0|||
160509417|NCT02416453|579592983|FG005|Overall Study|Adverse Event|1|||
160509418|NCT02416453|579592984|FG006|Overall Study|Adverse Event|0|||
160509419|NCT02416453|579592985|FG007|Overall Study|Adverse Event|0|||
160509420|NCT02416453|579592986|FG008|Overall Study|Adverse Event|0|||
160509421|NCT02416453|579592987|FG009|Overall Study|Adverse Event|0|||
160509422|NCT02416453|579592988|FG010|Overall Study|Adverse Event|0|||
160509423|NCT02416453|579592978|FG000|Overall Study|Lost to Follow-up|1|||
160509424|NCT02416453|579592979|FG001|Overall Study|Lost to Follow-up|3|||
160509425|NCT02416453|579592980|FG002|Overall Study|Lost to Follow-up|0|||
160509426|NCT02416453|579592981|FG003|Overall Study|Lost to Follow-up|8|||
160509427|NCT02416453|579592982|FG004|Overall Study|Lost to Follow-up|0|||
160509428|NCT02416453|579592983|FG005|Overall Study|Lost to Follow-up|5|||
160509429|NCT02416453|579592984|FG006|Overall Study|Lost to Follow-up|1|||
160509430|NCT02416453|579592985|FG007|Overall Study|Lost to Follow-up|3|||
160509431|NCT02416453|579592986|FG008|Overall Study|Lost to Follow-up|1|||
160509432|NCT02416453|579592987|FG009|Overall Study|Lost to Follow-up|0|||
160509433|NCT02416453|579592988|FG010|Overall Study|Lost to Follow-up|0|||
160509434|NCT02416453|579592978|FG000|Overall Study|Physician Decision|0|||
160509435|NCT02416453|579592979|FG001|Overall Study|Physician Decision|0|||
160509436|NCT02416453|579592980|FG002|Overall Study|Physician Decision|0|||
160509437|NCT02416453|579592981|FG003|Overall Study|Physician Decision|0|||
160509438|NCT02416453|579592982|FG004|Overall Study|Physician Decision|0|||
160509439|NCT02416453|579592983|FG005|Overall Study|Physician Decision|1|||
160509440|NCT02416453|579592984|FG006|Overall Study|Physician Decision|1|||
160509441|NCT02416453|579592985|FG007|Overall Study|Physician Decision|1|||
160509442|NCT02416453|579592986|FG008|Overall Study|Physician Decision|0|||
160509443|NCT02416453|579592987|FG009|Overall Study|Physician Decision|0|||
160509444|NCT02416453|579592988|FG010|Overall Study|Physician Decision|0|||
160509445|NCT02416453|579592978|FG000|Overall Study|Withdrawal by Subject|2|||
160509446|NCT02416453|579592979|FG001|Overall Study|Withdrawal by Subject|0|||
160509447|NCT02416453|579592980|FG002|Overall Study|Withdrawal by Subject|0|||
160509448|NCT02416453|579592981|FG003|Overall Study|Withdrawal by Subject|5|||
160509449|NCT02416453|579592982|FG004|Overall Study|Withdrawal by Subject|1|||
160509450|NCT02416453|579592983|FG005|Overall Study|Withdrawal by Subject|8|||
160509451|NCT02416453|579592984|FG006|Overall Study|Withdrawal by Subject|0|||
160509452|NCT02416453|579592985|FG007|Overall Study|Withdrawal by Subject|8|||
160509453|NCT02416453|579592986|FG008|Overall Study|Withdrawal by Subject|4|||
160509454|NCT02416453|579592987|FG009|Overall Study|Withdrawal by Subject|0|||
160509455|NCT02416453|579592988|FG010|Overall Study|Withdrawal by Subject|0|||
160509456|NCT02416453|579592978|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
160509457|NCT02416453|579592979|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
160509458|NCT02416453|579592980|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
160509459|NCT02416453|579592981|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
160509460|NCT02416453|579592982|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
160509461|NCT02416453|579592983|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
160509462|NCT02416453|579592984|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
160509463|NCT02416453|579592985|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
160509464|NCT02416453|579592986|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
160509465|NCT02416453|579592987|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
160509466|NCT02416453|579592988|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
160509467|NCT02416453|579592978|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
160509468|NCT02416453|579592979|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
160509469|NCT02416453|579592980|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
160509470|NCT02416453|579592981|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
160509471|NCT02416453|579592982|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
160509472|NCT02416453|579592983|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
160509473|NCT02416453|579592984|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
160509474|NCT02416453|579592985|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
160509475|NCT02416453|579592986|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
160509476|NCT02416453|579592987|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
160509477|NCT02416453|579592988|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
160509478|NCT01152814|579592989|FG000|Overall Study|Lost to Follow-up|2|||
160509479|NCT00992225|579592994|FG000|Overall Study|Entry Criteria Not Met|8|||
160509480|NCT00992225|579592994|FG000|Overall Study|Adverse Event|2|||
160509481|NCT03466073|579592995|FG000|Overall Study|Death|1|||
160509482|NCT03466073|579592996|FG001|Overall Study|Death|0|||
160509483|NCT03466073|579592997|FG002|Overall Study|Death|0|||
160509484|NCT03466073|579592998|FG003|Overall Study|Death|0|||
160509485|NCT03466073|579592999|FG004|Overall Study|Death|0|||
160509486|NCT03466073|579593000|FG005|Overall Study|Death|1|||
160509487|NCT00532493|579593001|FG000|Overall Study|Death|1|||
160509488|NCT00532493|579593002|FG001|Overall Study|Death|1|||
160509489|NCT00532493|579593001|FG000|Overall Study|Lost to Follow-up|10|||
160509490|NCT00532493|579593002|FG001|Overall Study|Lost to Follow-up|7|||
160509491|NCT00532493|579593001|FG000|Overall Study|Withdrawal by Subject|7|||
160509492|NCT00532493|579593002|FG001|Overall Study|Withdrawal by Subject|9|||
160509493|NCT00532493|579593001|FG000|Overall Study|Physician Decision|1|||
160509494|NCT00532493|579593002|FG001|Overall Study|Physician Decision|6|||
160509495|NCT00532493|579593001|FG000|Overall Study|Adverse Event|6|||
160509496|NCT00532493|579593002|FG001|Overall Study|Adverse Event|5|||
160509497|NCT00532493|579593001|FG000|Overall Study|Protocol Deviation|1|||
160509498|NCT00532493|579593002|FG001|Overall Study|Protocol Deviation|0|||
160509499|NCT00532493|579593001|FG000|Overall Study|Subject Moved Away|3|||
160509500|NCT00532493|579593002|FG001|Overall Study|Subject Moved Away|1|||
160509501|NCT00532493|579593001|FG000|Overall Study|Contraindicative Medication|1|||
160509502|NCT00532493|579593002|FG001|Overall Study|Contraindicative Medication|0|||
160509503|NCT01276379|579593003|FG000|Overall Study|Screening failure|40|||
160509504|NCT01278173|579593004|FG000|Overall Study|Lack of Efficacy|13|||
160509505|NCT01278173|579593004|FG000|Overall Study|Adverse Event|8|||
160509506|NCT01278173|579593004|FG000|Overall Study|Administrative or other reason|4|||
160509507|NCT01278173|579593004|FG000|Overall Study|Protocol Violation|1|||
160509508|NCT01278173|579593004|FG000|Overall Study|Withdrawal by Subject|1|||
160509509|NCT02729831|579593005|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
160509510|NCT02729831|579593006|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
160509511|NCT02729831|579593007|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
160509512|NCT02729831|579593008|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
160509513|NCT02729831|579593005|FG000|1 Week Post-visit|Lost to Follow-up|43|||
160509514|NCT02729831|579593006|FG001|1 Week Post-visit|Lost to Follow-up|40|||
160509515|NCT02729831|579593007|FG002|1 Week Post-visit|Lost to Follow-up|38|||
160509516|NCT02729831|579593008|FG003|1 Week Post-visit|Lost to Follow-up|36|||
160509517|NCT02729831|579593005|FG000|6 Month Follow-up|Lost to Follow-up|54|||
160509518|NCT02729831|579593006|FG001|6 Month Follow-up|Lost to Follow-up|51|||
160509519|NCT02729831|579593007|FG002|6 Month Follow-up|Lost to Follow-up|48|||
160509520|NCT02729831|579593008|FG003|6 Month Follow-up|Lost to Follow-up|42|||
160509521|NCT02729831|579593005|FG000|6 Month Follow-up|Death|1|||
160509522|NCT02729831|579593006|FG001|6 Month Follow-up|Death|3|||
160509523|NCT02729831|579593007|FG002|6 Month Follow-up|Death|0|||
160509524|NCT02729831|579593008|FG003|6 Month Follow-up|Death|1|||
160509525|NCT00864253|579593009|FG000|Overall Study|Adverse Event|56|||
160509526|NCT00864253|579593010|FG001|Overall Study|Adverse Event|11|||
160509527|NCT00864253|579593009|FG000|Overall Study|Unrelated Adverse Event|3|||
160509528|NCT00864253|579593010|FG001|Overall Study|Unrelated Adverse Event|1|||
160509529|NCT00864253|579593009|FG000|Overall Study|Physician Decision|11|||
160509530|NCT00864253|579593010|FG001|Overall Study|Physician Decision|15|||
160509531|NCT00864253|579593009|FG000|Overall Study|Protocol Violation|0|||
160509532|NCT00864253|579593010|FG001|Overall Study|Protocol Violation|2|||
160509533|NCT00864253|579593009|FG000|Overall Study|Lost to Follow-up|1|||
160509534|NCT00864253|579593010|FG001|Overall Study|Lost to Follow-up|1|||
160509535|NCT00864253|579593009|FG000|Overall Study|Withdrawal by Subject|18|||
160509536|NCT00864253|579593010|FG001|Overall Study|Withdrawal by Subject|18|||
160509537|NCT00864253|579593009|FG000|Overall Study|Death|1|||
160509538|NCT00864253|579593010|FG001|Overall Study|Death|0|||
160509539|NCT00864253|579593009|FG000|Overall Study|Ongoing|2|||
160509540|NCT00864253|579593010|FG001|Overall Study|Ongoing|3|||
160509541|NCT00864253|579593009|FG000|Overall Study|Untreated|7|||
160509542|NCT00864253|579593010|FG001|Overall Study|Untreated|7|||
160509543|NCT01747551|579593011|FG000|Overall Study|Progressive Disease|24|||
160509544|NCT01747551|579593012|FG001|Overall Study|Progressive Disease|17|||
160509545|NCT01747551|579593011|FG000|Overall Study|Death|3|||
160509546|NCT01747551|579593012|FG001|Overall Study|Death|1|||
160509547|NCT01747551|579593011|FG000|Overall Study|Adverse Event|7|||
160509548|NCT01747551|579593012|FG001|Overall Study|Adverse Event|1|||
160509549|NCT01747551|579593011|FG000|Overall Study|Prolonged Treatment Delay|2|||
160509550|NCT01747551|579593012|FG001|Overall Study|Prolonged Treatment Delay|0|||
160509551|NCT01747551|579593011|FG000|Overall Study|Withdrawal by Subject|3|||
160509552|NCT01747551|579593012|FG001|Overall Study|Withdrawal by Subject|1|||
160509553|NCT01747551|579593011|FG000|Overall Study|Physician Decision|2|||
160509554|NCT01747551|579593012|FG001|Overall Study|Physician Decision|1|||
160509555|NCT01747551|579593011|FG000|Overall Study|Other|2|||
160509556|NCT01747551|579593012|FG001|Overall Study|Other|0|||
160509557|NCT01609062|579593013|FG000|Extension Phase|Terminated by Sponsor|14|||
160509558|NCT01609062|579593014|FG001|Extension Phase|Terminated by Sponsor|9|||
160509559|NCT01609062|579593013|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
160509560|NCT01609062|579593014|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
160509561|NCT01609062|579593013|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
160509562|NCT01609062|579593014|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
160509563|NCT00680992|579593015|FG000|Overall Study|Complete Resection (as per protocol)|25|||
160509564|NCT00680992|579593016|FG001|Overall Study|Complete Resection (as per protocol)|121|||
160509565|NCT00680992|579593017|FG002|Overall Study|Complete Resection (as per protocol)|0|||
160509566|NCT00680992|579593015|FG000|Overall Study|Administrative Decision|83|||
160509567|NCT00680992|579593016|FG001|Overall Study|Administrative Decision|42|||
160509568|NCT00680992|579593017|FG002|Overall Study|Administrative Decision|5|||
160509569|NCT00680992|579593015|FG000|Overall Study|End of Trial|32|||
160509570|NCT00680992|579593016|FG001|Overall Study|End of Trial|12|||
160509571|NCT00680992|579593017|FG002|Overall Study|End of Trial|3|||
160509572|NCT00680992|579593015|FG000|Overall Study|Withdrawal by Subject|33|||
160509573|NCT00680992|579593016|FG001|Overall Study|Withdrawal by Subject|11|||
160509574|NCT00680992|579593017|FG002|Overall Study|Withdrawal by Subject|1|||
160509575|NCT00680992|579593015|FG000|Overall Study|Adverse Event|21|||
160509576|NCT00680992|579593016|FG001|Overall Study|Adverse Event|19|||
160509577|NCT00680992|579593017|FG002|Overall Study|Adverse Event|1|||
160509578|NCT00680992|579593015|FG000|Overall Study|Other|19|||
160509579|NCT00680992|579593016|FG001|Overall Study|Other|14|||
160509580|NCT00680992|579593017|FG002|Overall Study|Other|1|||
160509581|NCT00680992|579593015|FG000|Overall Study|Disease Progression|21|||
160509582|NCT00680992|579593016|FG001|Overall Study|Disease Progression|9|||
160509583|NCT00680992|579593017|FG002|Overall Study|Disease Progression|0|||
160509584|NCT00680992|579593015|FG000|Overall Study|Lost to Follow-up|12|||
160509585|NCT00680992|579593016|FG001|Overall Study|Lost to Follow-up|14|||
160509586|NCT00680992|579593017|FG002|Overall Study|Lost to Follow-up|0|||
160509587|NCT00680992|579593015|FG000|Overall Study|Noncompliance|4|||
160509588|NCT00680992|579593016|FG001|Overall Study|Noncompliance|6|||
160509589|NCT00680992|579593017|FG002|Overall Study|Noncompliance|0|||
160509590|NCT00680992|579593015|FG000|Overall Study|Requirement for Alternative Therapy|8|||
160509591|NCT00680992|579593016|FG001|Overall Study|Requirement for Alternative Therapy|2|||
160509592|NCT00680992|579593017|FG002|Overall Study|Requirement for Alternative Therapy|0|||
160509593|NCT00680992|579593015|FG000|Overall Study|Pregnancy|5|||
160509594|NCT00680992|579593016|FG001|Overall Study|Pregnancy|0|||
160509595|NCT00680992|579593017|FG002|Overall Study|Pregnancy|1|||
160509596|NCT00680992|579593015|FG000|Overall Study|Death|5|||
160509597|NCT00680992|579593016|FG001|Overall Study|Death|1|||
160509598|NCT00680992|579593017|FG002|Overall Study|Death|0|||
160509599|NCT00680992|579593015|FG000|Overall Study|Ineligibility Determined|0|||
160509600|NCT00680992|579593016|FG001|Overall Study|Ineligibility Determined|1|||
160509601|NCT00680992|579593017|FG002|Overall Study|Ineligibility Determined|0|||
160509602|NCT03842358|579593022|FG000|Overall Study|Poor DOT probe contact with breast|2|||
160509603|NCT03842358|579593022|FG000|Overall Study|DOT system problem|1|||
160509604|NCT03842358|579593022|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
160509605|NCT03842358|579593022|FG000|Overall Study|No biopsy after physician review|4|||
160509606|NCT03842358|579593022|FG000|Overall Study|Patient withdrew|2|||
160509607|NCT05384938|579593023|FG000|Overall Study|Withdrawal by Subject|8|||
160509608|NCT05384938|579593023|FG000|Overall Study|Lost to Follow-up|6|||
160509609|NCT05384938|579593023|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
160509610|NCT02626455|579593024|FG000|Overall Study|Other|1|||
160509611|NCT02626455|579593025|FG001|Overall Study|Other|1|||
160509612|NCT02626455|579593026|FG002|Overall Study|Other|0|||
160509613|NCT02626455|579593027|FG003|Overall Study|Other|0|||
160509614|NCT02626455|579593028|FG004|Overall Study|Other|0|||
160509615|NCT02626455|579593029|FG005|Overall Study|Other|17|||
160509616|NCT02626455|579593030|FG006|Overall Study|Other|23|||
160509617|NCT02626455|579593024|FG000|Overall Study|Withdrawal by Subject|1|||
160509618|NCT02626455|579593025|FG001|Overall Study|Withdrawal by Subject|0|||
160509619|NCT02626455|579593026|FG002|Overall Study|Withdrawal by Subject|0|||
160509620|NCT02626455|579593027|FG003|Overall Study|Withdrawal by Subject|0|||
160509621|NCT02626455|579593028|FG004|Overall Study|Withdrawal by Subject|0|||
160509622|NCT02626455|579593029|FG005|Overall Study|Withdrawal by Subject|10|||
160509623|NCT02626455|579593030|FG006|Overall Study|Withdrawal by Subject|6|||
160509624|NCT02626455|579593024|FG000|Overall Study|Physician Decision|0|||
160509625|NCT02626455|579593025|FG001|Overall Study|Physician Decision|2|||
160509626|NCT02626455|579593026|FG002|Overall Study|Physician Decision|2|||
160509627|NCT02626455|579593027|FG003|Overall Study|Physician Decision|2|||
160509628|NCT02626455|579593028|FG004|Overall Study|Physician Decision|1|||
160509629|NCT02626455|579593029|FG005|Overall Study|Physician Decision|10|||
160509630|NCT02626455|579593030|FG006|Overall Study|Physician Decision|3|||
160509631|NCT02626455|579593024|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
160509632|NCT02626455|579593025|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
160509633|NCT02626455|579593026|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
160509634|NCT02626455|579593027|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
160509635|NCT02626455|579593028|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
160509636|NCT02626455|579593029|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
160509637|NCT02626455|579593030|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
160509638|NCT02626455|579593024|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
160509639|NCT02626455|579593025|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
160509640|NCT02626455|579593026|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
160509641|NCT02626455|579593027|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
160509642|NCT02626455|579593028|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
160509643|NCT02626455|579593029|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
160509644|NCT02626455|579593030|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
160509645|NCT02626455|579593024|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
160509646|NCT02626455|579593025|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
160509647|NCT02626455|579593026|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
160509648|NCT02626455|579593027|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
160620501|NCT01513460|579988505|FG000|Overall Study|Abnormal test procedure|1|||
160509649|NCT02626455|579593028|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
160509650|NCT02626455|579593029|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
160509651|NCT02626455|579593030|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
160509652|NCT02626455|579593024|FG000|Overall Study|Patient decision|0|||
160509653|NCT02626455|579593025|FG001|Overall Study|Patient decision|1|||
160509654|NCT02626455|579593026|FG002|Overall Study|Patient decision|0|||
160509655|NCT02626455|579593027|FG003|Overall Study|Patient decision|0|||
160509656|NCT02626455|579593028|FG004|Overall Study|Patient decision|1|||
160509657|NCT02626455|579593029|FG005|Overall Study|Patient decision|36|||
160509658|NCT02626455|579593030|FG006|Overall Study|Patient decision|22|||
160509659|NCT02626455|579593024|FG000|Overall Study|Protocol Violation|0|||
160509660|NCT02626455|579593025|FG001|Overall Study|Protocol Violation|0|||
160509661|NCT02626455|579593026|FG002|Overall Study|Protocol Violation|0|||
160509662|NCT02626455|579593027|FG003|Overall Study|Protocol Violation|0|||
160509663|NCT02626455|579593028|FG004|Overall Study|Protocol Violation|0|||
160509664|NCT02626455|579593029|FG005|Overall Study|Protocol Violation|0|||
160509665|NCT02626455|579593030|FG006|Overall Study|Protocol Violation|1|||
160509666|NCT02626455|579593024|FG000|Overall Study|Progressive disease - radiological progression|0|||
160509667|NCT02626455|579593025|FG001|Overall Study|Progressive disease - radiological progression|0|||
160509668|NCT02626455|579593026|FG002|Overall Study|Progressive disease - radiological progression|0|||
160509669|NCT02626455|579593027|FG003|Overall Study|Progressive disease - radiological progression|0|||
160509670|NCT02626455|579593028|FG004|Overall Study|Progressive disease - radiological progression|0|||
160509671|NCT02626455|579593029|FG005|Overall Study|Progressive disease - radiological progression|11|||
160509672|NCT02626455|579593030|FG006|Overall Study|Progressive disease - radiological progression|22|||
160509673|NCT02626455|579593024|FG000|Overall Study|Progressive disease - clinical progression|0|||
160509674|NCT02626455|579593025|FG001|Overall Study|Progressive disease - clinical progression|0|||
160509675|NCT02626455|579593026|FG002|Overall Study|Progressive disease - clinical progression|0|||
160509676|NCT02626455|579593027|FG003|Overall Study|Progressive disease - clinical progression|0|||
160509677|NCT02626455|579593028|FG004|Overall Study|Progressive disease - clinical progression|0|||
160509678|NCT02626455|579593029|FG005|Overall Study|Progressive disease - clinical progression|1|||
160509679|NCT02626455|579593030|FG006|Overall Study|Progressive disease - clinical progression|2|||
160509680|NCT02626455|579593024|FG000|Overall Study|Lost to Follow-up|0|||
160509681|NCT02626455|579593025|FG001|Overall Study|Lost to Follow-up|0|||
160509682|NCT02626455|579593026|FG002|Overall Study|Lost to Follow-up|0|||
160509683|NCT02626455|579593027|FG003|Overall Study|Lost to Follow-up|0|||
160509684|NCT02626455|579593028|FG004|Overall Study|Lost to Follow-up|0|||
160509685|NCT02626455|579593029|FG005|Overall Study|Lost to Follow-up|1|||
160509686|NCT02626455|579593030|FG006|Overall Study|Lost to Follow-up|0|||
160509687|NCT02626455|579593024|FG000|Overall Study|AE not associated with clinical disease progression|1|||
160509688|NCT02626455|579593025|FG001|Overall Study|AE not associated with clinical disease progression|1|||
160509689|NCT02626455|579593026|FG002|Overall Study|AE not associated with clinical disease progression|0|||
160509690|NCT02626455|579593027|FG003|Overall Study|AE not associated with clinical disease progression|2|||
160509691|NCT02626455|579593028|FG004|Overall Study|AE not associated with clinical disease progression|1|||
160509692|NCT02626455|579593029|FG005|Overall Study|AE not associated with clinical disease progression|65|||
160509693|NCT02626455|579593030|FG006|Overall Study|AE not associated with clinical disease progression|21|||
160509694|NCT02626455|579593024|FG000|Overall Study|AE associated with clinical disease progression|0|||
160509695|NCT02626455|579593025|FG001|Overall Study|AE associated with clinical disease progression|0|||
160509696|NCT02626455|579593026|FG002|Overall Study|AE associated with clinical disease progression|0|||
160509697|NCT02626455|579593027|FG003|Overall Study|AE associated with clinical disease progression|0|||
160509698|NCT02626455|579593028|FG004|Overall Study|AE associated with clinical disease progression|0|||
160509699|NCT02626455|579593029|FG005|Overall Study|AE associated with clinical disease progression|1|||
160509700|NCT02626455|579593030|FG006|Overall Study|AE associated with clinical disease progression|2|||
160509701|NCT02626455|579593024|FG000|Overall Study|Study intervention never administered|0|||
160509702|NCT02626455|579593025|FG001|Overall Study|Study intervention never administered|0|||
160509703|NCT02626455|579593026|FG002|Overall Study|Study intervention never administered|0|||
160509704|NCT02626455|579593027|FG003|Overall Study|Study intervention never administered|0|||
160509705|NCT02626455|579593028|FG004|Overall Study|Study intervention never administered|0|||
160509706|NCT02626455|579593029|FG005|Overall Study|Study intervention never administered|1|||
160509707|NCT02626455|579593030|FG006|Overall Study|Study intervention never administered|3|||
160509708|NCT01525238|579593031|FG000|Overall Study|Withdrawal by Subject|1|||
160509709|NCT01525238|579593032|FG001|Overall Study|Withdrawal by Subject|0|||
160509710|NCT01525238|579593033|FG002|Overall Study|Withdrawal by Subject|0|||
160509711|NCT00607724|579593034|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
160509712|NCT00607724|579593035|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
160620502|NCT01513460|579988506|FG001|Overall Study|Abnormal test procedure|0|||
160509713|NCT00607724|579593036|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
160509714|NCT00607724|579593037|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
160509715|NCT00607724|579593038|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
160509716|NCT00607724|579593039|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
160509717|NCT00607724|579593040|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
160509718|NCT00607724|579593034|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
160509719|NCT00607724|579593035|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
160509720|NCT00607724|579593036|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
160509721|NCT00607724|579593037|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
160509722|NCT00607724|579593038|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
160509723|NCT00607724|579593039|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
160509724|NCT00607724|579593040|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
160509725|NCT00607724|579593034|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
160509726|NCT00607724|579593035|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
160509727|NCT00607724|579593036|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
160509728|NCT00607724|579593037|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
160509729|NCT00607724|579593038|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
160509730|NCT00607724|579593039|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
160509731|NCT00607724|579593040|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
160509732|NCT00607724|579593034|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
160509733|NCT00607724|579593035|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
160509734|NCT00607724|579593036|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
160509735|NCT00607724|579593037|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
160509736|NCT00607724|579593038|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
160509737|NCT00607724|579593039|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
160509738|NCT00607724|579593040|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
160509739|NCT00607724|579593034|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
160509740|NCT00607724|579593035|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
160509741|NCT00607724|579593036|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
160509742|NCT00607724|579593037|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
160509743|NCT00607724|579593038|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
160509744|NCT00607724|579593039|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
160509745|NCT00607724|579593040|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
160509746|NCT01133418|579593041|FG000|Overall Study|Lost to Follow-up|5|||
160509747|NCT01133418|579593042|FG001|Overall Study|Lost to Follow-up|6|||
160509748|NCT04150068|579593048|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
160509749|NCT04150068|579593049|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
160509750|NCT04150068|579593050|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
160509751|NCT04150068|579593048|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
160509752|NCT04150068|579593049|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
160509753|NCT04150068|579593050|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
160509754|NCT05316701|579593051|FG000|Overall Study|Adverse Event|0|||
160509755|NCT05316701|579593052|FG001|Overall Study|Adverse Event|1|||
160509756|NCT05316701|579593051|FG000|Overall Study|Death|3|||
160509757|NCT05316701|579593052|FG001|Overall Study|Death|9|||
160509758|NCT05316701|579593051|FG000|Overall Study|Lost to Follow-up|1|||
160509759|NCT05316701|579593052|FG001|Overall Study|Lost to Follow-up|0|||
160509760|NCT05316701|579593051|FG000|Overall Study|Physician Decision|1|||
160509761|NCT05316701|579593052|FG001|Overall Study|Physician Decision|4|||
160509762|NCT05316701|579593051|FG000|Overall Study|Withdrawal by Subject|3|||
160509763|NCT05316701|579593052|FG001|Overall Study|Withdrawal by Subject|5|||
160509764|NCT05316701|579593051|FG000|Overall Study|Progression/Relapse|14|||
160509765|NCT05316701|579593052|FG001|Overall Study|Progression/Relapse|9|||
160509766|NCT05316701|579593051|FG000|Overall Study|Received Standard of Care|1|||
160509767|NCT05316701|579593052|FG001|Overall Study|Received Standard of Care|0|||
160509768|NCT05316701|579593051|FG000|Overall Study|Ongoing|70|||
160509769|NCT05316701|579593052|FG001|Overall Study|Ongoing|64|||
160509770|NCT04679935|579593053|FG000|Overall Study|Death|0|||
160509771|NCT04679935|579593054|FG001|Overall Study|Death|1|||
160509772|NCT04349631|579593057|FG000|Overall Study|Lost to Follow-up|3|||
160509773|NCT04349631|579593057|FG000|Overall Study|Withdrawal by Subject|7|||
160509774|NCT00775463|579594855|FG000|Overall Study|Withdrawal by Subject|0|||
160509775|NCT00775463|579594856|FG001|Overall Study|Withdrawal by Subject|1|||
160509776|NCT00775463|579594855|FG000|Overall Study|Adverse Event|7|||
160509777|NCT00775463|579594856|FG001|Overall Study|Adverse Event|9|||
160509778|NCT00775463|579594855|FG000|Overall Study|Protocol Violation|2|||
160509779|NCT00775463|579594856|FG001|Overall Study|Protocol Violation|2|||
160509780|NCT00775463|579594855|FG000|Overall Study|Lost to Follow-up|1|||
160509781|NCT00775463|579594856|FG001|Overall Study|Lost to Follow-up|0|||
160509782|NCT00775463|579594855|FG000|Overall Study|Lack of Efficacy|1|||
160509783|NCT00775463|579594856|FG001|Overall Study|Lack of Efficacy|1|||
160509784|NCT03037931|579594857|FG000|Overall Study|Death|354|||
160509785|NCT03037931|579594858|FG001|Overall Study|Death|367|||
160509786|NCT03037931|579594857|FG000|Overall Study|Lost to Follow-up|7|||
160509787|NCT03037931|579594858|FG001|Overall Study|Lost to Follow-up|4|||
160509788|NCT03037931|579594857|FG000|Overall Study|Withdrawal by Subject|48|||
160509789|NCT03037931|579594858|FG001|Overall Study|Withdrawal by Subject|41|||
160509790|NCT01789567|579594859|FG000|Overall Study|Death|6|||
160509791|NCT01850446|579594860|FG000|Overall Study|Lack of Efficacy|1|||
160509792|NCT01850446|579594861|FG001|Overall Study|Lack of Efficacy|0|||
160509793|NCT01850446|579594860|FG000|Overall Study|Withdrawal by Subject|4|||
160509794|NCT01850446|579594861|FG001|Overall Study|Withdrawal by Subject|0|||
160509795|NCT01850446|579594860|FG000|Overall Study|Protocol Violation|0|||
160509796|NCT01850446|579594861|FG001|Overall Study|Protocol Violation|2|||
160509797|NCT00591721|579594862|FG000|Overall Study|Withdrawal by Subject|10|||
160509798|NCT00591721|579594863|FG001|Overall Study|Withdrawal by Subject|10|||
160509799|NCT00591721|579594862|FG000|Overall Study|Lost to Follow-up|1|||
160509800|NCT00591721|579594863|FG001|Overall Study|Lost to Follow-up|4|||
160509801|NCT00591721|579594862|FG000|Overall Study|Intervention not received|10|||
160509802|NCT00591721|579594863|FG001|Overall Study|Intervention not received|8|||
160509803|NCT04032613|579594868|FG000|Overall Study|Did not complete post-program assessment|5|||
160509804|NCT04032613|579594869|FG001|Overall Study|Did not complete post-program assessment|2|||
160509805|NCT01659853|579594870|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
160509806|NCT01659853|579594871|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
160509807|NCT01659853|579594870|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
160509808|NCT01659853|579594871|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
160509809|NCT02683876|579594872|FG000|Overall Study|samples damaged during shipping|2|||
160509810|NCT02683876|579594873|FG001|Overall Study|samples damaged during shipping|0|||
160509811|NCT01232738|579594874|FG000|Overall Study|Death|3|||
160509812|NCT01232738|579594874|FG000|Overall Study|Physician Decision|2|||
160509813|NCT01232738|579594874|FG000|Overall Study|Lost to Follow-up|1|||
160509814|NCT01232738|579594874|FG000|Overall Study|Withdrawal by Subject|2|||
160509815|NCT01232738|579594874|FG000|Overall Study|Adverse Event|5|||
160509816|NCT00859222|579594879|FG000|Overall Study|Adverse Event|2|||
160509817|NCT00859222|579594880|FG001|Overall Study|Adverse Event|3|||
160509818|NCT00859222|579594881|FG002|Overall Study|Adverse Event|6|||
160509819|NCT00859222|579594882|FG003|Overall Study|Adverse Event|24|||
160509820|NCT00859222|579594883|FG004|Overall Study|Adverse Event|15|||
160509821|NCT00859222|579594879|FG000|Overall Study|DLT|1|||
160509822|NCT00859222|579594880|FG001|Overall Study|DLT|0|||
160509823|NCT00859222|579594881|FG002|Overall Study|DLT|0|||
160509824|NCT00859222|579594882|FG003|Overall Study|DLT|0|||
160509825|NCT00859222|579594883|FG004|Overall Study|DLT|0|||
160509826|NCT01417104|579594885|FG000|Overall Study|Withdrawal by Subject|5|||
160509827|NCT01417104|579594886|FG001|Overall Study|Withdrawal by Subject|1|||
160509828|NCT01417104|579594885|FG000|Overall Study|Failure to make contact|0|||
160509829|NCT01417104|579594886|FG001|Overall Study|Failure to make contact|1|||
160509830|NCT01417104|579594885|FG000|Overall Study|Adverse Event|1|||
160509831|NCT01417104|579594886|FG001|Overall Study|Adverse Event|0|||
160509832|NCT01365481|579594892|FG000|Overall Study|Adverse Event|6|||
160509833|NCT01365481|579594893|FG001|Overall Study|Adverse Event|9|||
160509834|NCT01365481|579594894|FG002|Overall Study|Adverse Event|0|||
160509835|NCT01365481|579594895|FG003|Overall Study|Adverse Event|2|||
160509836|NCT01365481|579594892|FG000|Overall Study|Withdrawal by Subject|0|||
160509837|NCT01365481|579594893|FG001|Overall Study|Withdrawal by Subject|2|||
160509838|NCT01365481|579594894|FG002|Overall Study|Withdrawal by Subject|1|||
160509839|NCT01365481|579594895|FG003|Overall Study|Withdrawal by Subject|1|||
160509840|NCT01365481|579594892|FG000|Overall Study|Lost to Follow-up|1|||
160509841|NCT01365481|579594893|FG001|Overall Study|Lost to Follow-up|1|||
160509842|NCT01365481|579594894|FG002|Overall Study|Lost to Follow-up|2|||
160509843|NCT01365481|579594895|FG003|Overall Study|Lost to Follow-up|3|||
160509844|NCT01365481|579594892|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160509845|NCT01365481|579594893|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160509846|NCT01365481|579594894|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160509847|NCT01365481|579594895|FG003|Overall Study|Abnormal laboratory value(s)|0|||
160509848|NCT01365481|579594892|FG000|Overall Study|Administrative problems|0|||
160509849|NCT01365481|579594893|FG001|Overall Study|Administrative problems|1|||
160509850|NCT01365481|579594894|FG002|Overall Study|Administrative problems|0|||
160509851|NCT01365481|579594895|FG003|Overall Study|Administrative problems|0|||
160509852|NCT01365481|579594892|FG000|Overall Study|Protocol deviation|0|||
160509853|NCT01365481|579594893|FG001|Overall Study|Protocol deviation|1|||
160509854|NCT01365481|579594894|FG002|Overall Study|Protocol deviation|0|||
160509855|NCT01365481|579594895|FG003|Overall Study|Protocol deviation|1|||
160509856|NCT01365481|579594892|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160509857|NCT01365481|579594893|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160509858|NCT01365481|579594894|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
160509859|NCT01365481|579594895|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
160509860|NCT00757627|579594896|FG000|Overall Study|Adverse Event|15|||
160620503|NCT01513460|579988507|FG002|Overall Study|Abnormal test procedure|0|||
160509861|NCT00757627|579594896|FG000|Overall Study|Lack of Efficacy|10|||
160509862|NCT00757627|579594896|FG000|Overall Study|Lost to Follow-up|28|||
160509863|NCT00757627|579594896|FG000|Overall Study|Withdrawal by Subject|27|||
160509864|NCT00757627|579594896|FG000|Overall Study|Other|1|||
160509865|NCT02755818|579594899|FG000|Overall Study|Withdrawal by Subject|0|||
160620504|NCT00489216|579988511|FG000|Overall Study|Adverse Event|1|||
160509866|NCT02755818|579594900|FG001|Overall Study|Withdrawal by Subject|0|||
160509867|NCT02755818|579594901|FG002|Overall Study|Withdrawal by Subject|0|||
160509868|NCT02755818|579594902|FG003|Overall Study|Withdrawal by Subject|2|||
160509869|NCT02755818|579594899|FG000|Overall Study|withdrawal by PI|0|||
160509870|NCT02755818|579594900|FG001|Overall Study|withdrawal by PI|0|||
160509871|NCT02755818|579594901|FG002|Overall Study|withdrawal by PI|1|||
160509872|NCT02755818|579594902|FG003|Overall Study|withdrawal by PI|1|||
160509873|NCT03014011|579594903|FG000|First Intervention|Withdrawal by Subject|1|||
160509874|NCT03014011|579594904|FG001|First Intervention|Withdrawal by Subject|0|||
160509875|NCT03014011|579594903|FG000|Washout|Withdrawal by Subject|1|||
160509876|NCT03014011|579594904|FG001|Washout|Withdrawal by Subject|0|||
160509877|NCT01280357|579594905|FG000|Overall Study|Excluded no internal monitoring|14|||
160509878|NCT01280357|579594905|FG000|Overall Study|IInsufficient data/No data supplied|12|||
160509879|NCT02229851|579594906|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
160509880|NCT02229851|579594907|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
160509881|NCT02229851|579594908|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
160509882|NCT02229851|579594909|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
160509883|NCT02229851|579594910|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
160509884|NCT02229851|579594911|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
160509885|NCT02229851|579594912|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
160509886|NCT02229851|579594906|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
160509887|NCT02229851|579594907|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
160509888|NCT02229851|579594908|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
160509889|NCT02229851|579594909|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
160509890|NCT02229851|579594910|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
160509891|NCT02229851|579594911|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
160509892|NCT02229851|579594912|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
160509893|NCT02229851|579594906|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
160509894|NCT02229851|579594907|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
160509895|NCT02229851|579594908|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
160509896|NCT02229851|579594909|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
160509897|NCT02229851|579594910|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
160509898|NCT02229851|579594911|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
160509899|NCT02229851|579594912|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
160509900|NCT02229851|579594906|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
160509901|NCT02229851|579594907|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
160509902|NCT02229851|579594908|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
160509903|NCT02229851|579594909|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
160509904|NCT02229851|579594910|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
160509905|NCT02229851|579594911|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
160509906|NCT02229851|579594912|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
160509907|NCT02229851|579594906|FG000|Main Phase (Double-blind Phase)|Death|1|||
160509908|NCT02229851|579594907|FG001|Main Phase (Double-blind Phase)|Death|1|||
160509909|NCT02229851|579594908|FG002|Main Phase (Double-blind Phase)|Death|0|||
160509910|NCT02229851|579594909|FG003|Main Phase (Double-blind Phase)|Death|0|||
160509911|NCT02229851|579594910|FG004|Main Phase (Double-blind Phase)|Death|0|||
160509912|NCT02229851|579594911|FG005|Main Phase (Double-blind Phase)|Death|0|||
160509913|NCT02229851|579594912|FG006|Main Phase (Double-blind Phase)|Death|0|||
160509914|NCT02229851|579594906|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
160509915|NCT02229851|579594907|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
160509916|NCT02229851|579594908|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
160509917|NCT02229851|579594909|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
160509918|NCT02229851|579594910|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
160509919|NCT02229851|579594911|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
160509920|NCT02229851|579594912|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
160509921|NCT02229851|579594906|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
160509922|NCT02229851|579594907|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
160509923|NCT02229851|579594908|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
160509924|NCT02229851|579594909|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
160509925|NCT02229851|579594910|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
160509926|NCT02229851|579594911|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
160509927|NCT02229851|579594912|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
160509928|NCT02229851|579594906|FG000|Extension Phase (Open-label Phase)|Death|0|||
160509929|NCT02229851|579594907|FG001|Extension Phase (Open-label Phase)|Death|0|||
160509930|NCT02229851|579594908|FG002|Extension Phase (Open-label Phase)|Death|0|||
160509931|NCT02229851|579594909|FG003|Extension Phase (Open-label Phase)|Death|1|||
160509932|NCT02229851|579594910|FG004|Extension Phase (Open-label Phase)|Death|0|||
160509933|NCT02229851|579594911|FG005|Extension Phase (Open-label Phase)|Death|1|||
160509934|NCT02229851|579594912|FG006|Extension Phase (Open-label Phase)|Death|1|||
160509935|NCT03284203|579594913|FG000|Overall Study|Lost to Follow-up|3|||
160509936|NCT03682302|579594916|FG000|Overall Study|Lost to Follow-up|1|||
160509937|NCT03682302|579594917|FG001|Overall Study|Lost to Follow-up|2|||
160509938|NCT03682302|579594918|FG002|Overall Study|Lost to Follow-up|0|||
160509939|NCT03682302|579594919|FG003|Overall Study|Lost to Follow-up|1|||
160509940|NCT03682302|579594916|FG000|Overall Study|Study drug was not administered|0|||
160509941|NCT03682302|579594917|FG001|Overall Study|Study drug was not administered|0|||
160509942|NCT03682302|579594918|FG002|Overall Study|Study drug was not administered|1|||
160509943|NCT03682302|579594919|FG003|Overall Study|Study drug was not administered|1|||
160509944|NCT01489891|579594922|FG000|Overall Study|Endoscopy failure|1|||
160509945|NCT01489891|579594923|FG001|Overall Study|Endoscopy failure|0|||
160509946|NCT02045875|579594927|FG000|Overall Study|Lost to Follow-up|3|||
160509947|NCT02045875|579594928|FG001|Overall Study|Lost to Follow-up|0|||
160509948|NCT02045875|579594927|FG000|Overall Study|Withdrawal by Subject|4|||
160509949|NCT02045875|579594928|FG001|Overall Study|Withdrawal by Subject|3|||
160509950|NCT01769326|579594934|FG000|Overall Study|Lost to Follow-up|1|||
160509951|NCT01769326|579594935|FG001|Overall Study|Lost to Follow-up|2|||
160509952|NCT01769326|579594936|FG002|Overall Study|Lost to Follow-up|0|||
160509953|NCT01769326|579594937|FG003|Overall Study|Lost to Follow-up|0|||
160509954|NCT01769326|579594934|FG000|Overall Study|unrelated injry|1|||
160509955|NCT01769326|579594935|FG001|Overall Study|unrelated injry|1|||
160509956|NCT01769326|579594936|FG002|Overall Study|unrelated injry|0|||
160509957|NCT01769326|579594937|FG003|Overall Study|unrelated injry|0|||
160509958|NCT01769326|579594934|FG000|Overall Study|got a job|0|||
160509959|NCT01769326|579594935|FG001|Overall Study|got a job|1|||
160509960|NCT01769326|579594936|FG002|Overall Study|got a job|0|||
160509961|NCT01769326|579594937|FG003|Overall Study|got a job|0|||
160509962|NCT01769326|579594934|FG000|Overall Study|Got sick and could not complete study|0|||
160509963|NCT01769326|579594935|FG001|Overall Study|Got sick and could not complete study|0|||
160509964|NCT01769326|579594936|FG002|Overall Study|Got sick and could not complete study|1|||
160509965|NCT01769326|579594937|FG003|Overall Study|Got sick and could not complete study|0|||
160509966|NCT01036438|579594938|FG000|Overall Study|Adverse Event|7|||
160509967|NCT01036438|579594939|FG001|Overall Study|Adverse Event|8|||
160509968|NCT01036438|579594938|FG000|Overall Study|Death|0|||
160509969|NCT01036438|579594939|FG001|Overall Study|Death|1|||
160509970|NCT01036438|579594938|FG000|Overall Study|No effect of study treatment|3|||
160509971|NCT01036438|579594939|FG001|Overall Study|No effect of study treatment|1|||
160509972|NCT00888927|579594940|FG000|Overall Study|Adverse Event|0|||
160509973|NCT00888927|579594941|FG001|Overall Study|Adverse Event|0|||
160509974|NCT00888927|579594942|FG002|Overall Study|Adverse Event|0|||
160509975|NCT00888927|579594943|FG003|Overall Study|Adverse Event|1|||
160509976|NCT00888927|579594940|FG000|Overall Study|Withdrawal of consent|0|||
160509977|NCT00888927|579594941|FG001|Overall Study|Withdrawal of consent|0|||
160509978|NCT00888927|579594942|FG002|Overall Study|Withdrawal of consent|0|||
160509979|NCT00888927|579594943|FG003|Overall Study|Withdrawal of consent|1|||
160509980|NCT03459443|579594944|FG000|Overall Study|Lack of Efficacy|3|||
160509981|NCT03459443|579594944|FG000|Overall Study|Adverse Event|1|||
160509982|NCT03459443|579594944|FG000|Overall Study|Sponsor's decision to close the study|18|||
160509983|NCT02153073|579594945|FG000|Overall Study|Case Report Forms Uncollected|230|||
160509984|NCT02153073|579594945|FG000|Overall Study|Protocol Deviation|68|||
160509985|NCT03189745|579594946|FG000|Overall Study|Conflict in work schedule of participant|1|||
160509986|NCT03189745|579594947|FG001|Overall Study|Conflict in work schedule of participant|1|||
160509987|NCT03702231|579594948|FG000|Overall Study|Withdrawal by Subject|1|||
160509988|NCT03702231|579594949|FG001|Overall Study|Withdrawal by Subject|0|||
160509989|NCT03702231|579594950|FG002|Overall Study|Withdrawal by Subject|0|||
160509990|NCT03702231|579594948|FG000|Overall Study|Protocol Violation|0|||
160509991|NCT03702231|579594949|FG001|Overall Study|Protocol Violation|0|||
160509992|NCT03702231|579594950|FG002|Overall Study|Protocol Violation|1|||
160509993|NCT03702231|579594948|FG000|Overall Study|Change in CLL Treatment|0|||
160509994|NCT03702231|579594949|FG001|Overall Study|Change in CLL Treatment|0|||
160509995|NCT03702231|579594950|FG002|Overall Study|Change in CLL Treatment|1|||
160509996|NCT03702231|579594948|FG000|Overall Study|COVID Pandemic|1|||
160509997|NCT03702231|579594949|FG001|Overall Study|COVID Pandemic|4|||
160509998|NCT03702231|579594950|FG002|Overall Study|COVID Pandemic|1|||
160509999|NCT03702231|579594948|FG000|Overall Study|Non-compliance|0|||
160620505|NCT01189201|579990283|FG000|Overall Study|Adverse Event|1|||
160510000|NCT03702231|579594949|FG001|Overall Study|Non-compliance|0|||
160510001|NCT03702231|579594950|FG002|Overall Study|Non-compliance|1|||
160510002|NCT01111240|579594953|FG000|Overall Study|Adverse Event|190|||
160510003|NCT01111240|579594953|FG000|Overall Study|Lack of Efficacy|545|||
160510004|NCT01111240|579594953|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
160510005|NCT01111240|579594953|FG000|Overall Study|Other|312|||
160510006|NCT01607476|579594955|FG000|Overall Study|Withdrawal by Subject|1|||
160510007|NCT01607476|579594956|FG001|Overall Study|Withdrawal by Subject|0|||
160620506|NCT01277757|579990284|FG000|Overall Study|Disease Progression|1|||
160510008|NCT01607476|579594957|FG002|Overall Study|Withdrawal by Subject|1|||
160620507|NCT01277757|579990284|FG000|Overall Study|Withdrawal by Subject|1|||
160620508|NCT00240331|579990290|FG000|Overall Study|Withdrawal by Subject|125|||
160510009|NCT01607476|579594955|FG000|Overall Study|Lost to Follow-up|0|||
160510010|NCT01607476|579594956|FG001|Overall Study|Lost to Follow-up|0|||
160510011|NCT01607476|579594957|FG002|Overall Study|Lost to Follow-up|2|||
160510012|NCT04445987|579594958|FG000|Overall Study|Adverse Event|0|||
160510013|NCT04445987|579594959|FG001|Overall Study|Adverse Event|0|||
160510014|NCT04445987|579594960|FG002|Overall Study|Adverse Event|1|||
160510015|NCT04445987|579594961|FG003|Overall Study|Adverse Event|0|||
160510016|NCT04445987|579594962|FG004|Overall Study|Adverse Event|4|||
160510017|NCT04445987|579594963|FG005|Overall Study|Adverse Event|0|||
160510018|NCT04445987|579594958|FG000|Overall Study|Lost to Follow-up|4|||
160510019|NCT04445987|579594959|FG001|Overall Study|Lost to Follow-up|3|||
160510020|NCT04445987|579594960|FG002|Overall Study|Lost to Follow-up|1|||
160510021|NCT04445987|579594961|FG003|Overall Study|Lost to Follow-up|1|||
160510022|NCT04445987|579594962|FG004|Overall Study|Lost to Follow-up|29|||
160510023|NCT04445987|579594963|FG005|Overall Study|Lost to Follow-up|0|||
160510024|NCT04445987|579594958|FG000|Overall Study|Physician Decision|0|||
160510025|NCT04445987|579594959|FG001|Overall Study|Physician Decision|0|||
160510026|NCT04445987|579594960|FG002|Overall Study|Physician Decision|0|||
160510027|NCT04445987|579594961|FG003|Overall Study|Physician Decision|0|||
160510028|NCT04445987|579594962|FG004|Overall Study|Physician Decision|1|||
160510029|NCT04445987|579594963|FG005|Overall Study|Physician Decision|0|||
160510030|NCT04445987|579594958|FG000|Overall Study|Protocol Violation|1|||
160510031|NCT04445987|579594959|FG001|Overall Study|Protocol Violation|0|||
160510032|NCT04445987|579594960|FG002|Overall Study|Protocol Violation|0|||
160510033|NCT04445987|579594961|FG003|Overall Study|Protocol Violation|0|||
160510034|NCT04445987|579594962|FG004|Overall Study|Protocol Violation|2|||
160510035|NCT04445987|579594963|FG005|Overall Study|Protocol Violation|0|||
160510036|NCT04445987|579594958|FG000|Overall Study|Withdrawal by Subject|4|||
160510037|NCT04445987|579594959|FG001|Overall Study|Withdrawal by Subject|0|||
160510038|NCT04445987|579594960|FG002|Overall Study|Withdrawal by Subject|1|||
160510039|NCT04445987|579594961|FG003|Overall Study|Withdrawal by Subject|0|||
160510040|NCT04445987|579594962|FG004|Overall Study|Withdrawal by Subject|18|||
160510041|NCT04445987|579594963|FG005|Overall Study|Withdrawal by Subject|1|||
160510042|NCT04445987|579594958|FG000|Overall Study|Other reason|0|||
160510043|NCT04445987|579594959|FG001|Overall Study|Other reason|0|||
160510044|NCT04445987|579594960|FG002|Overall Study|Other reason|1|||
160510045|NCT04445987|579594961|FG003|Overall Study|Other reason|0|||
160510046|NCT04445987|579594962|FG004|Overall Study|Other reason|2|||
160510047|NCT04445987|579594963|FG005|Overall Study|Other reason|0|||
160510048|NCT03772587|579594969|FG000|Overall Study|COVID-19|0|||
160510049|NCT03772587|579594970|FG001|Overall Study|COVID-19|0|||
160510050|NCT03772587|579594971|FG002|Overall Study|COVID-19|1|||
160510051|NCT03772587|579594972|FG003|Overall Study|COVID-19|1|||
160510052|NCT03772587|579594973|FG004|Overall Study|COVID-19|0|||
160510053|NCT03772587|579594969|FG000|Overall Study|Withdrawal by Subject|1|||
160510054|NCT03772587|579594970|FG001|Overall Study|Withdrawal by Subject|0|||
160510055|NCT03772587|579594971|FG002|Overall Study|Withdrawal by Subject|0|||
160510056|NCT03772587|579594972|FG003|Overall Study|Withdrawal by Subject|0|||
160510057|NCT03772587|579594973|FG004|Overall Study|Withdrawal by Subject|0|||
160510058|NCT02297139|579594974|FG000|Overall Study|Disease progression|0|||
160510059|NCT02297139|579594975|FG001|Overall Study|Disease progression|1|||
160510060|NCT02297139|579594974|FG000|Overall Study|Study drug toxicity|0|||
160510061|NCT02297139|579594975|FG001|Overall Study|Study drug toxicity|4|||
160510062|NCT02297139|579594974|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160510063|NCT02297139|579594975|FG001|Overall Study|Participant request to discontinue study treatment|1|||
160510064|NCT02297139|579594974|FG000|Overall Study|Maximum clinical benefit|1|||
160510065|NCT02297139|579594975|FG001|Overall Study|Maximum clinical benefit|0|||
160510066|NCT02297139|579594974|FG000|Overall Study|Administrative reason by sponsor|0|||
160510067|NCT02297139|579594975|FG001|Overall Study|Administrative reason by sponsor|2|||
160510068|NCT02297139|579594974|FG000|Overall Study|Other reasons|0|||
160510069|NCT02297139|579594975|FG001|Overall Study|Other reasons|8|||
160510070|NCT05051462|579594981|FG000|Overall Study|Lost to Follow-up|1|||
160510071|NCT05051462|579594982|FG001|Overall Study|Lost to Follow-up|8|||
160620509|NCT00240331|579990291|FG001|Overall Study|Withdrawal by Subject|132|||
160510072|NCT05051462|579594981|FG000|Overall Study|Withdrawal by Subject|1|||
160510073|NCT05051462|579594982|FG001|Overall Study|Withdrawal by Subject|0|||
160510074|NCT05051462|579594981|FG000|Overall Study|Protocol Violation|0|||
160510075|NCT05051462|579594982|FG001|Overall Study|Protocol Violation|2|||
160510076|NCT02425904|579594983|FG000|Overall Study|Lost to Follow-up|1|||
160510077|NCT02425904|579594984|FG001|Overall Study|Lost to Follow-up|0|||
160510078|NCT02425904|579594983|FG000|Overall Study|Withdrawal by Subject|2|||
160510079|NCT02425904|579594984|FG001|Overall Study|Withdrawal by Subject|0|||
160510080|NCT02425904|579594983|FG000|Overall Study|Death|0|||
160510081|NCT02425904|579594984|FG001|Overall Study|Death|3|||
160510082|NCT05260021|579594985|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
160510083|NCT05260021|579594986|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
160510084|NCT05260021|579594987|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
160510085|NCT05260021|579594985|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
160510086|NCT05260021|579594986|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
160510087|NCT05260021|579594987|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
160510088|NCT05260021|579594985|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
160510089|NCT05260021|579594986|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
160510090|NCT05260021|579594987|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
160510091|NCT05260021|579594985|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
160510092|NCT05260021|579594986|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
160510093|NCT05260021|579594987|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
160510094|NCT05260021|579594985|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
160510095|NCT05260021|579594986|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
160510096|NCT05260021|579594987|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
160510097|NCT05597787|579594988|FG000|Overall Study|Withdrawal by Subject|0|||
160510098|NCT05597787|579594989|FG001|Overall Study|Withdrawal by Subject|0|||
160510099|NCT05597787|579594990|FG002|Overall Study|Withdrawal by Subject|1|||
160510100|NCT05148962|579594991|FG000|Overall Study|Withdrawal by Subject|1|||
160510101|NCT05148962|579594992|FG001|Overall Study|Withdrawal by Subject|1|||
160510102|NCT05148962|579594993|FG002|Overall Study|Withdrawal by Subject|0|||
160510103|NCT05148962|579594994|FG003|Overall Study|Withdrawal by Subject|1|||
160510104|NCT05148962|579594995|FG004|Overall Study|Withdrawal by Subject|0|||
160510105|NCT05148962|579594991|FG000|Overall Study|Participant was early terminated per protocol|0|||
160510106|NCT05148962|579594992|FG001|Overall Study|Participant was early terminated per protocol|0|||
160510107|NCT05148962|579594993|FG002|Overall Study|Participant was early terminated per protocol|3|||
160510108|NCT05148962|579594994|FG003|Overall Study|Participant was early terminated per protocol|5|||
160510109|NCT05148962|579594995|FG004|Overall Study|Participant was early terminated per protocol|2|||
160510110|NCT05148962|579594991|FG000|Overall Study|Miscellaneous|0|||
160510111|NCT05148962|579594992|FG001|Overall Study|Miscellaneous|0|||
160510112|NCT05148962|579594993|FG002|Overall Study|Miscellaneous|0|||
160510113|NCT05148962|579594994|FG003|Overall Study|Miscellaneous|1|||
160510114|NCT05148962|579594995|FG004|Overall Study|Miscellaneous|0|||
160510115|NCT06665919|579594996|FG000|Overall Study|Withdrawal by Subject|4|||
160510116|NCT06665919|579594997|FG001|Overall Study|Withdrawal by Subject|4|||
160510117|NCT06665919|579594998|FG002|Overall Study|Withdrawal by Subject|4|||
160510118|NCT06665919|579594996|FG000|Overall Study|Non-compliance to Treatment|4|||
160510119|NCT06665919|579594997|FG001|Overall Study|Non-compliance to Treatment|1|||
160510120|NCT06665919|579594998|FG002|Overall Study|Non-compliance to Treatment|6|||
160510121|NCT06665919|579594996|FG000|Overall Study|Lost to Follow-up|3|||
160510122|NCT06665919|579594997|FG001|Overall Study|Lost to Follow-up|0|||
160510123|NCT06665919|579594998|FG002|Overall Study|Lost to Follow-up|2|||
160510124|NCT06665919|579594996|FG000|Overall Study|Physician Decision|4|||
160510125|NCT06665919|579594997|FG001|Overall Study|Physician Decision|0|||
160510126|NCT06665919|579594998|FG002|Overall Study|Physician Decision|1|||
160510127|NCT01200290|579594999|FG000|Treatment Period|Adverse Event|1|||
160510128|NCT01200290|579594999|FG000|Post-Treatment Follow-Up Period|Death|2|||
160510129|NCT01144377|579595000|FG000|52 Week Treatment Period|Adverse Event|0|||
160510130|NCT01144377|579595001|FG001|52 Week Treatment Period|Adverse Event|0|||
160510131|NCT01144377|579595002|FG002|52 Week Treatment Period|Adverse Event|3|||
160510132|NCT01144377|579595003|FG003|52 Week Treatment Period|Adverse Event|2|||
160510133|NCT01144377|579595004|FG004|52 Week Treatment Period|Adverse Event|1|||
160510134|NCT01144377|579595000|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
160510135|NCT01144377|579595001|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
160510136|NCT01144377|579595002|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
160510137|NCT01144377|579595003|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
160510138|NCT01144377|579595004|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
160510139|NCT01144377|579595000|FG000|52 Week Treatment Period|Protocol Violation|0|||
160510140|NCT01144377|579595001|FG001|52 Week Treatment Period|Protocol Violation|0|||
160510141|NCT01144377|579595002|FG002|52 Week Treatment Period|Protocol Violation|0|||
160510142|NCT01144377|579595003|FG003|52 Week Treatment Period|Protocol Violation|0|||
160510143|NCT01144377|579595004|FG004|52 Week Treatment Period|Protocol Violation|1|||
160510144|NCT01144377|579595000|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
160510145|NCT01144377|579595001|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
160510146|NCT01144377|579595002|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
160510147|NCT01144377|579595003|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
160510148|NCT01144377|579595004|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
160510149|NCT01144377|579595000|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
160510150|NCT01144377|579595001|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
160510151|NCT01144377|579595002|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
160510152|NCT01144377|579595003|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
160510153|NCT01144377|579595004|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
160620510|NCT00240331|579990290|FG000|Overall Study|Option selected by investigator|1|||
160510154|NCT01144377|579595000|FG000|52 Week Treatment Period|Sponsor Decision|0|||
160620511|NCT00240331|579990291|FG001|Overall Study|Option selected by investigator|2|||
160510155|NCT01144377|579595001|FG001|52 Week Treatment Period|Sponsor Decision|0|||
160510156|NCT01144377|579595002|FG002|52 Week Treatment Period|Sponsor Decision|0|||
160510157|NCT01144377|579595003|FG003|52 Week Treatment Period|Sponsor Decision|0|||
160510158|NCT01144377|579595004|FG004|52 Week Treatment Period|Sponsor Decision|1|||
160510159|NCT01144377|579595000|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
160510160|NCT01144377|579595001|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
160510161|NCT01144377|579595002|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
160510162|NCT01144377|579595003|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
160510163|NCT01144377|579595004|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
160510164|NCT01144377|579595000|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
160510165|NCT01144377|579595001|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
160510166|NCT01144377|579595002|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
160510167|NCT01144377|579595003|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
160510168|NCT01144377|579595004|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
160510169|NCT01144377|579595000|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
160510170|NCT01144377|579595001|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
160510171|NCT01144377|579595002|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
160510172|NCT01144377|579595003|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
160510173|NCT01144377|579595004|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
160510174|NCT01241604|579595006|FG000|Screening Period|Screen Failure|3|||
160510175|NCT01241604|579595007|FG001|Screening Period|Screen Failure|0|||
160510176|NCT01241604|579595008|FG002|Screening Period|Screen Failure|0|||
160510177|NCT01593787|579595009|FG000|Overall Study|Adverse Event|1|||
160510178|NCT01593787|579595010|FG001|Overall Study|Adverse Event|0|||
160510179|NCT01593787|579595011|FG002|Overall Study|Adverse Event|0|||
160510180|NCT01946529|579595014|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
160510181|NCT01946529|579595015|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
160510182|NCT01946529|579595016|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
160510183|NCT01946529|579595014|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
160510184|NCT01946529|579595015|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
160510185|NCT01946529|579595016|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
160510186|NCT02980731|579596762|FG000|Overall Study|Death|63|||
160510187|NCT02980731|579596762|FG000|Overall Study|Withdrawal by Subject|6|||
160510188|NCT02980731|579596762|FG000|Overall Study|Lost to Follow-up|5|||
160510189|NCT02980731|579596762|FG000|Overall Study|Study terminated by Sponsor|4|||
160510190|NCT02980731|579596762|FG000|Overall Study|Completed survival follow-up period|65|||
160510191|NCT02980731|579596762|FG000|Overall Study|COVID-19 infection|1|||
160510192|NCT02980731|579596762|FG000|Overall Study|Other, not specified|66|||
160510193|NCT02075476|579596763|FG000|Overall Study|Death|2|||
160510194|NCT02075476|579596764|FG001|Overall Study|Death|2|||
160510195|NCT02075476|579596763|FG000|Overall Study|Lost to Follow-up|1|||
160510196|NCT02075476|579596764|FG001|Overall Study|Lost to Follow-up|3|||
160510197|NCT02914275|579596770|FG000|Overall Study|Lost to Follow-up|84|||
160510198|NCT02914275|579596771|FG001|Overall Study|Lost to Follow-up|29|||
160510199|NCT02914275|579596770|FG000|Overall Study|Withdrawal by Subject|26|||
160510200|NCT02914275|579596771|FG001|Overall Study|Withdrawal by Subject|10|||
160510201|NCT02914275|579596770|FG000|Overall Study|Protocol Violation|1|||
160510202|NCT02914275|579596771|FG001|Overall Study|Protocol Violation|1|||
160510203|NCT02914275|579596770|FG000|Overall Study|Physician Decision|3|||
160510204|NCT02914275|579596771|FG001|Overall Study|Physician Decision|1|||
160510205|NCT02914275|579596770|FG000|Overall Study|Other|4|||
160510206|NCT02914275|579596771|FG001|Overall Study|Other|1|||
160510207|NCT02914275|579596770|FG000|Overall Study|Excluded due to invalid informed consent|3|||
160510208|NCT02914275|579596771|FG001|Overall Study|Excluded due to invalid informed consent|0|||
160510209|NCT02731690|579596772|FG000|Overall Study|Adverse Event|1|||
160510210|NCT02731690|579596772|FG000|Overall Study|Withdrawal by Subject|3|||
160510211|NCT02731690|579596772|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
160510212|NCT00872989|579596773|FG000|Overall Study|Adverse Event|7|||
160510213|NCT00872989|579596774|FG001|Overall Study|Adverse Event|15|||
160510214|NCT00872989|579596773|FG000|Overall Study|Withdrawal by Subject|8|||
160510215|NCT00872989|579596774|FG001|Overall Study|Withdrawal by Subject|5|||
160510216|NCT00872989|579596773|FG000|Overall Study|Progression/relapse|47|||
160510217|NCT00872989|579596774|FG001|Overall Study|Progression/relapse|35|||
160510218|NCT00872989|579596773|FG000|Overall Study|Not protocol specified|3|||
160510219|NCT00872989|579596774|FG001|Overall Study|Not protocol specified|8|||
160510220|NCT02407990|579596775|FG000|Overall Study|Death|2|||
160510221|NCT02407990|579596776|FG001|Overall Study|Death|22|||
160510222|NCT02407990|579596777|FG002|Overall Study|Death|23|||
160510223|NCT02407990|579596778|FG003|Overall Study|Death|7|||
160510224|NCT02407990|579596779|FG004|Overall Study|Death|17|||
160620512|NCT01233076|579990292|FG000|Period 2, One Week|Lost to Follow-up|1|||
160620513|NCT01233076|579990293|FG001|Period 2, One Week|Lost to Follow-up|0|||
160510225|NCT02407990|579596780|FG005|Overall Study|Death|16|||
160620514|NCT04563845|579990294|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160510226|NCT02407990|579596781|FG006|Overall Study|Death|10|||
160510227|NCT02407990|579596782|FG007|Overall Study|Death|248|||
160510228|NCT02407990|579596775|FG000|Overall Study|Lost to Follow-up|0|||
160510229|NCT02407990|579596776|FG001|Overall Study|Lost to Follow-up|1|||
160510230|NCT02407990|579596777|FG002|Overall Study|Lost to Follow-up|0|||
160510231|NCT02407990|579596778|FG003|Overall Study|Lost to Follow-up|0|||
160510232|NCT02407990|579596779|FG004|Overall Study|Lost to Follow-up|0|||
160510233|NCT02407990|579596780|FG005|Overall Study|Lost to Follow-up|0|||
160510234|NCT02407990|579596781|FG006|Overall Study|Lost to Follow-up|0|||
160510235|NCT02407990|579596782|FG007|Overall Study|Lost to Follow-up|17|||
160510236|NCT02407990|579596775|FG000|Overall Study|Progressive Disease|0|||
160510237|NCT02407990|579596776|FG001|Overall Study|Progressive Disease|0|||
160510238|NCT02407990|579596777|FG002|Overall Study|Progressive Disease|0|||
160510239|NCT02407990|579596778|FG003|Overall Study|Progressive Disease|0|||
160510240|NCT02407990|579596779|FG004|Overall Study|Progressive Disease|0|||
160510241|NCT02407990|579596780|FG005|Overall Study|Progressive Disease|0|||
160510242|NCT02407990|579596781|FG006|Overall Study|Progressive Disease|0|||
160510243|NCT02407990|579596782|FG007|Overall Study|Progressive Disease|1|||
160510244|NCT02407990|579596775|FG000|Overall Study|Withdrawal by Subject|0|||
160510245|NCT02407990|579596776|FG001|Overall Study|Withdrawal by Subject|0|||
160510246|NCT02407990|579596777|FG002|Overall Study|Withdrawal by Subject|0|||
160510247|NCT02407990|579596778|FG003|Overall Study|Withdrawal by Subject|0|||
160510248|NCT02407990|579596779|FG004|Overall Study|Withdrawal by Subject|1|||
160510249|NCT02407990|579596780|FG005|Overall Study|Withdrawal by Subject|0|||
160510250|NCT02407990|579596781|FG006|Overall Study|Withdrawal by Subject|0|||
160510251|NCT02407990|579596782|FG007|Overall Study|Withdrawal by Subject|30|||
160510252|NCT02407990|579596775|FG000|Overall Study|Study Terminated by Sponsor|1|||
160510253|NCT02407990|579596776|FG001|Overall Study|Study Terminated by Sponsor|3|||
160510254|NCT02407990|579596777|FG002|Overall Study|Study Terminated by Sponsor|3|||
160510255|NCT02407990|579596778|FG003|Overall Study|Study Terminated by Sponsor|0|||
160510256|NCT02407990|579596779|FG004|Overall Study|Study Terminated by Sponsor|3|||
160510257|NCT02407990|579596780|FG005|Overall Study|Study Terminated by Sponsor|4|||
160510258|NCT02407990|579596781|FG006|Overall Study|Study Terminated by Sponsor|3|||
160510259|NCT02407990|579596782|FG007|Overall Study|Study Terminated by Sponsor|37|||
160510260|NCT02407990|579596775|FG000|Overall Study|Logistics|0|||
160510261|NCT02407990|579596776|FG001|Overall Study|Logistics|0|||
160510262|NCT02407990|579596777|FG002|Overall Study|Logistics|0|||
160510263|NCT02407990|579596778|FG003|Overall Study|Logistics|0|||
160510264|NCT02407990|579596779|FG004|Overall Study|Logistics|0|||
160510265|NCT02407990|579596780|FG005|Overall Study|Logistics|0|||
160510266|NCT02407990|579596781|FG006|Overall Study|Logistics|0|||
160510267|NCT02407990|579596782|FG007|Overall Study|Logistics|1|||
160510268|NCT02407990|579596775|FG000|Overall Study|Rolled into long-term extension study|0|||
160510269|NCT02407990|579596776|FG001|Overall Study|Rolled into long-term extension study|0|||
160510270|NCT02407990|579596777|FG002|Overall Study|Rolled into long-term extension study|0|||
160510271|NCT02407990|579596778|FG003|Overall Study|Rolled into long-term extension study|0|||
160510272|NCT02407990|579596779|FG004|Overall Study|Rolled into long-term extension study|0|||
160510273|NCT02407990|579596780|FG005|Overall Study|Rolled into long-term extension study|0|||
160510274|NCT02407990|579596781|FG006|Overall Study|Rolled into long-term extension study|0|||
160510275|NCT02407990|579596782|FG007|Overall Study|Rolled into long-term extension study|1|||
160510276|NCT00923260|579596783|FG000|Overall Study|Lost to Follow-up|1|||
160510277|NCT00923260|579596784|FG001|Overall Study|Lost to Follow-up|1|||
160510278|NCT01238900|579596785|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
160510279|NCT01238900|579596785|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
160510280|NCT03241927|579596790|FG000|Overall Study|study terminated|1|||
160510281|NCT03241927|579596791|FG001|Overall Study|study terminated|0|||
160510282|NCT01198756|579596792|FG000|Overall Study|Adverse Event|0|||
160510283|NCT01198756|579596793|FG001|Overall Study|Adverse Event|0|||
160510284|NCT01198756|579596794|FG002|Overall Study|Adverse Event|0|||
160510285|NCT01198756|579596795|FG003|Overall Study|Adverse Event|1|||
160510286|NCT01198756|579596792|FG000|Overall Study|Protocol Violation|0|||
160510287|NCT01198756|579596793|FG001|Overall Study|Protocol Violation|0|||
160510288|NCT01198756|579596794|FG002|Overall Study|Protocol Violation|0|||
160510289|NCT01198756|579596795|FG003|Overall Study|Protocol Violation|2|||
160510290|NCT01198756|579596792|FG000|Overall Study|Withdrawal by Subject|9|||
160510291|NCT01198756|579596793|FG001|Overall Study|Withdrawal by Subject|4|||
160510292|NCT01198756|579596794|FG002|Overall Study|Withdrawal by Subject|7|||
160510293|NCT01198756|579596795|FG003|Overall Study|Withdrawal by Subject|5|||
160510294|NCT01198756|579596792|FG000|Overall Study|Lost to Follow-up|29|||
160510295|NCT01198756|579596793|FG001|Overall Study|Lost to Follow-up|36|||
160510296|NCT01198756|579596794|FG002|Overall Study|Lost to Follow-up|23|||
160510297|NCT01198756|579596795|FG003|Overall Study|Lost to Follow-up|18|||
160510298|NCT02915302|579596796|FG000|Overall Study|Adverse Event|3|||
160510299|NCT02915302|579596797|FG001|Overall Study|Adverse Event|0|||
160510300|NCT02915302|579596796|FG000|Overall Study|Protocol Violation|20|||
160510301|NCT02915302|579596797|FG001|Overall Study|Protocol Violation|27|||
160510302|NCT02915302|579596796|FG000|Overall Study|Lost to Follow-up|19|||
160510303|NCT02915302|579596797|FG001|Overall Study|Lost to Follow-up|22|||
160510304|NCT02915302|579596796|FG000|Overall Study|Withdrawal by Subject|22|||
160510305|NCT02915302|579596797|FG001|Overall Study|Withdrawal by Subject|29|||
160510306|NCT02915302|579596796|FG000|Overall Study|Other|1|||
160510307|NCT02915302|579596797|FG001|Overall Study|Other|0|||
160510308|NCT04343872|579596800|FG000|Overall Study|Lost to Follow-up|6|||
160510309|NCT04343872|579596801|FG001|Overall Study|Lost to Follow-up|3|||
160510310|NCT02134977|579596802|FG000|Overall Study|Protocol Deviation|102|||
160510311|NCT03507777|579596803|FG000|Overall Study|Lost to Follow-up|5|||
160510312|NCT03507777|579596804|FG001|Overall Study|Lost to Follow-up|7|||
160510313|NCT03507777|579596803|FG000|Overall Study|Withdrawal by Subject|6|||
160510314|NCT03507777|579596804|FG001|Overall Study|Withdrawal by Subject|11|||
160510315|NCT03507777|579596803|FG000|Overall Study|Death|30|||
160510316|NCT03507777|579596804|FG001|Overall Study|Death|44|||
160510317|NCT03507777|579596803|FG000|Overall Study|Other Reasons|3|||
160510318|NCT03507777|579596804|FG001|Overall Study|Other Reasons|8|||
160510319|NCT01879722|579596806|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160510320|NCT01879722|579596807|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
160510321|NCT01879722|579596808|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
160510322|NCT01879722|579596809|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
160510323|NCT01879722|579596810|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
160510324|NCT01879722|579596811|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
160510325|NCT01879722|579596812|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
160510326|NCT01879722|579596813|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
160510327|NCT01879722|579596814|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
160510328|NCT01879722|579596815|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
160510329|NCT01879722|579596806|FG000|Overall Study|Voluntary Withdrawal|0|||
160510330|NCT01879722|579596807|FG001|Overall Study|Voluntary Withdrawal|0|||
160510331|NCT01879722|579596808|FG002|Overall Study|Voluntary Withdrawal|0|||
160510332|NCT01879722|579596809|FG003|Overall Study|Voluntary Withdrawal|0|||
160510333|NCT01879722|579596810|FG004|Overall Study|Voluntary Withdrawal|0|||
160510334|NCT01879722|579596811|FG005|Overall Study|Voluntary Withdrawal|0|||
160510335|NCT01879722|579596812|FG006|Overall Study|Voluntary Withdrawal|0|||
160510336|NCT01879722|579596813|FG007|Overall Study|Voluntary Withdrawal|0|||
160510337|NCT01879722|579596814|FG008|Overall Study|Voluntary Withdrawal|1|||
160510338|NCT01879722|579596815|FG009|Overall Study|Voluntary Withdrawal|0|||
160510339|NCT00037830|579596818|FG000|Overall Study|Adverse Event|2|||
160510340|NCT00037830|579596819|FG001|Overall Study|Adverse Event|0|||
160510341|NCT00037830|579596820|FG002|Overall Study|Adverse Event|0|||
160510342|NCT00037830|579596818|FG000|Overall Study|Withdrawal by Subject|4|||
160510343|NCT00037830|579596819|FG001|Overall Study|Withdrawal by Subject|5|||
160510344|NCT00037830|579596820|FG002|Overall Study|Withdrawal by Subject|1|||
160510345|NCT00037830|579596818|FG000|Overall Study|Protocol Violation|2|||
160510346|NCT00037830|579596819|FG001|Overall Study|Protocol Violation|2|||
160510347|NCT00037830|579596820|FG002|Overall Study|Protocol Violation|0|||
160510348|NCT00037830|579596818|FG000|Overall Study|Unrelated Medical Problem|2|||
160510349|NCT00037830|579596819|FG001|Overall Study|Unrelated Medical Problem|0|||
160510350|NCT00037830|579596820|FG002|Overall Study|Unrelated Medical Problem|0|||
160510351|NCT00127205|579596821|FG000|Overall Study|Adverse Event|228|||
160510352|NCT00127205|579596822|FG001|Overall Study|Adverse Event|387|||
160510353|NCT00127205|579596823|FG002|Overall Study|Adverse Event|273|||
160510354|NCT00127205|579596821|FG000|Overall Study|Death|8|||
160510355|NCT00127205|579596822|FG001|Overall Study|Death|6|||
160510356|NCT00127205|579596823|FG002|Overall Study|Death|5|||
160510357|NCT00127205|579596821|FG000|Overall Study|Withdrawal by Subject|318|||
160510358|NCT00127205|579596822|FG001|Overall Study|Withdrawal by Subject|310|||
160510359|NCT00127205|579596823|FG002|Overall Study|Withdrawal by Subject|172|||
160510360|NCT00127205|579596821|FG000|Overall Study|Other-non protocol specified|142|||
160510361|NCT00127205|579596822|FG001|Overall Study|Other-non protocol specified|129|||
160510362|NCT00127205|579596823|FG002|Overall Study|Other-non protocol specified|77|||
160510363|NCT00127205|579596821|FG000|Overall Study|Data not reported|6|||
160510364|NCT00127205|579596822|FG001|Overall Study|Data not reported|10|||
160510365|NCT00127205|579596823|FG002|Overall Study|Data not reported|1|||
160510366|NCT00127205|579596821|FG000|Overall Study|Progression|127|||
160510367|NCT00127205|579596822|FG001|Overall Study|Progression|131|||
160510368|NCT00127205|579596823|FG002|Overall Study|Progression|84|||
160620515|NCT04563845|579990295|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160620516|NCT04563845|579990296|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160620517|NCT04563845|579990297|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160620518|NCT04563845|579990298|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160620519|NCT04563845|579990299|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160620520|NCT04563845|579990300|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160620521|NCT04563845|579990301|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
160510369|NCT01327495|579596824|FG000|Overall Study|Adverse Event|2|||
160510370|NCT01327495|579596825|FG001|Overall Study|Adverse Event|1|||
160510371|NCT01327495|579596826|FG002|Overall Study|Adverse Event|1|||
160510372|NCT01327495|579596827|FG003|Overall Study|Adverse Event|0|||
160510373|NCT01327495|579596828|FG004|Overall Study|Adverse Event|0|||
160510374|NCT01327495|579596829|FG005|Overall Study|Adverse Event|2|||
160510375|NCT01327495|579596824|FG000|Overall Study|Withdrawal by Subject|0|||
160510376|NCT01327495|579596825|FG001|Overall Study|Withdrawal by Subject|1|||
160510377|NCT01327495|579596826|FG002|Overall Study|Withdrawal by Subject|1|||
160510378|NCT01327495|579596827|FG003|Overall Study|Withdrawal by Subject|0|||
160510379|NCT01327495|579596828|FG004|Overall Study|Withdrawal by Subject|1|||
160510380|NCT01327495|579596829|FG005|Overall Study|Withdrawal by Subject|0|||
160510381|NCT01327495|579596824|FG000|Overall Study|Physician Decision|0|||
160510382|NCT01327495|579596825|FG001|Overall Study|Physician Decision|0|||
160510383|NCT01327495|579596826|FG002|Overall Study|Physician Decision|0|||
160510384|NCT01327495|579596827|FG003|Overall Study|Physician Decision|0|||
160510385|NCT01327495|579596828|FG004|Overall Study|Physician Decision|2|||
160510386|NCT01327495|579596829|FG005|Overall Study|Physician Decision|0|||
160510387|NCT03377699|579596830|FG000|Overall Study|Withdrawal by Subject|2|||
160510388|NCT03377699|579596831|FG001|Overall Study|Withdrawal by Subject|9|||
160510389|NCT03377699|579596830|FG000|Overall Study|Lost to Follow-up|1|||
160510390|NCT03377699|579596831|FG001|Overall Study|Lost to Follow-up|1|||
160510391|NCT03377699|579596830|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
160510392|NCT03377699|579596831|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
160510393|NCT03377699|579596830|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
160510394|NCT03377699|579596831|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
160510395|NCT03377699|579596830|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
160510396|NCT03377699|579596831|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
160510397|NCT03377699|579596830|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
160510398|NCT03377699|579596831|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
160510399|NCT02580305|579596835|FG000|Overall Study|Adverse Event|15|||
160510400|NCT02580305|579596836|FG001|Overall Study|Adverse Event|19|||
160510401|NCT02580305|579596837|FG002|Overall Study|Adverse Event|10|||
160510402|NCT02580305|579596835|FG000|Overall Study|Lack of Efficacy|5|||
160510403|NCT02580305|579596836|FG001|Overall Study|Lack of Efficacy|0|||
160510404|NCT02580305|579596837|FG002|Overall Study|Lack of Efficacy|2|||
160510405|NCT02580305|579596835|FG000|Overall Study|Protocol Violation|4|||
160510406|NCT02580305|579596836|FG001|Overall Study|Protocol Violation|9|||
160510407|NCT02580305|579596837|FG002|Overall Study|Protocol Violation|6|||
160510408|NCT02580305|579596835|FG000|Overall Study|Lost to Follow-up|4|||
160510409|NCT02580305|579596836|FG001|Overall Study|Lost to Follow-up|4|||
160510410|NCT02580305|579596837|FG002|Overall Study|Lost to Follow-up|2|||
160510411|NCT02580305|579596835|FG000|Overall Study|Withdrawal by Subject|11|||
160510412|NCT02580305|579596836|FG001|Overall Study|Withdrawal by Subject|9|||
160510413|NCT02580305|579596837|FG002|Overall Study|Withdrawal by Subject|7|||
160510414|NCT02580305|579596835|FG000|Overall Study|Randomized in error and never treated|4|||
160510415|NCT02580305|579596836|FG001|Overall Study|Randomized in error and never treated|8|||
160510416|NCT02580305|579596837|FG002|Overall Study|Randomized in error and never treated|5|||
160510417|NCT03582943|579596838|FG000|Allocated to Groups|Withdrawal by Subject|1|||
160510418|NCT03582943|579596839|FG001|Allocated to Groups|Withdrawal by Subject|1|||
160510419|NCT03582943|579596838|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
160510420|NCT03582943|579596839|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
160510421|NCT03582943|579596838|FG000|Analyzed|Protocol Violation|4|||
160510422|NCT03582943|579596839|FG001|Analyzed|Protocol Violation|1|||
160510423|NCT03527550|579596842|FG000|Overall Study|Lost to Follow-up|4|||
160510424|NCT03527550|579596843|FG001|Overall Study|Lost to Follow-up|2|||
160510425|NCT03527550|579596842|FG000|Overall Study|Withdrawal by Subject|4|||
160510426|NCT03527550|579596843|FG001|Overall Study|Withdrawal by Subject|1|||
160510427|NCT03527550|579596842|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
160510428|NCT03527550|579596843|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
160510429|NCT03053518|579596848|FG000|Overall Study|Withdrawal by Subject|3|||
160510430|NCT03053518|579596848|FG000|Overall Study|Lost to Follow-up|2|||
160510431|NCT03053518|579596848|FG000|Overall Study|Ineligible|5|||
160510432|NCT03231800|579596849|FG000|Overall Study|Lost to Follow-up|0|||
160510433|NCT03231800|579596850|FG001|Overall Study|Lost to Follow-up|2|||
160510434|NCT03231800|579596849|FG000|Overall Study|Protocol Violation|1|||
160510435|NCT03231800|579596850|FG001|Overall Study|Protocol Violation|1|||
160510436|NCT03231800|579596849|FG000|Overall Study|reason not provided|2|||
160510437|NCT03231800|579596850|FG001|Overall Study|reason not provided|0|||
160510438|NCT00488475|579596851|FG000|Overall Study|Other|1754|||
160510439|NCT00400725|579596866|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
160510440|NCT00400725|579596867|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
160510441|NCT00400725|579596868|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
160510442|NCT00400725|579596866|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
160510443|NCT00400725|579596867|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
160510444|NCT00400725|579596868|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
160510445|NCT00400725|579596866|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
160510446|NCT00400725|579596867|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
160510447|NCT00400725|579596868|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
160510448|NCT00400725|579596866|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
160510449|NCT00400725|579596867|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
160510450|NCT00400725|579596868|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
160510451|NCT00400725|579596866|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
160510452|NCT00400725|579596867|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
160510453|NCT00400725|579596868|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
160510454|NCT00400725|579596866|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
160510455|NCT00400725|579596867|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
160510456|NCT00400725|579596868|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
160510457|NCT00400725|579596866|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
160510458|NCT00400725|579596867|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
160510459|NCT00400725|579596868|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
160510460|NCT00400725|579596866|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
160510461|NCT00400725|579596867|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
160510462|NCT00400725|579596868|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
160510463|NCT00400725|579596866|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
160510464|NCT00400725|579596867|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
160510465|NCT00400725|579596868|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
160510466|NCT02797080|579596873|FG000|Overall Study|Lost to Follow-up|1|||
160510467|NCT02797080|579596873|FG000|Overall Study|Withdrawal by Subject|1|||
160510468|NCT04035499|579596876|FG000|Overall Study|Death|2|||
160510469|NCT04035499|579596876|FG000|Overall Study|Withdrawal by Subject|1|||
160510470|NCT00951015|579596877|FG000|Randomization Phase 96 Week|Adverse Event|1|||
160510471|NCT00951015|579596878|FG001|Randomization Phase 96 Week|Adverse Event|1|||
160510472|NCT00951015|579596879|FG002|Randomization Phase 96 Week|Adverse Event|2|||
160510473|NCT00951015|579596880|FG003|Randomization Phase 96 Week|Adverse Event|5|||
160510474|NCT00951015|579596881|FG004|Randomization Phase 96 Week|Adverse Event|0|||
160510475|NCT00951015|579596877|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
160510476|NCT00951015|579596878|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
160510477|NCT00951015|579596879|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
160510478|NCT00951015|579596880|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
160510479|NCT00951015|579596881|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
160510480|NCT00951015|579596877|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
160510481|NCT00951015|579596878|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
160510482|NCT00951015|579596879|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
160510483|NCT00951015|579596880|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
160510484|NCT00951015|579596881|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
160510485|NCT00951015|579596877|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
160510486|NCT00951015|579596878|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
160510487|NCT00951015|579596879|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
160510488|NCT00951015|579596880|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
160510489|NCT00951015|579596881|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
160510490|NCT00951015|579596877|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
160510491|NCT00951015|579596878|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
160510492|NCT00951015|579596879|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
160510493|NCT00951015|579596880|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
160510494|NCT00951015|579596881|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
160510495|NCT00951015|579596877|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
160510496|NCT00951015|579596878|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
160510497|NCT00951015|579596879|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
160510498|NCT00951015|579596880|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
160510499|NCT00951015|579596881|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
160510500|NCT00951015|579596877|FG000|Open-label Phase|Adverse Event|0|||
160510501|NCT00951015|579596878|FG001|Open-label Phase|Adverse Event|0|||
160510502|NCT00951015|579596879|FG002|Open-label Phase|Adverse Event|0|||
160510503|NCT00951015|579596880|FG003|Open-label Phase|Adverse Event|0|||
160510504|NCT00951015|579596881|FG004|Open-label Phase|Adverse Event|3|||
160510505|NCT00951015|579596877|FG000|Open-label Phase|Lack of Efficacy|0|||
160510506|NCT00951015|579596878|FG001|Open-label Phase|Lack of Efficacy|0|||
160510507|NCT00951015|579596879|FG002|Open-label Phase|Lack of Efficacy|0|||
160510508|NCT00951015|579596880|FG003|Open-label Phase|Lack of Efficacy|0|||
160510509|NCT00951015|579596881|FG004|Open-label Phase|Lack of Efficacy|1|||
160510510|NCT00951015|579596877|FG000|Open-label Phase|Protocol Violation|0|||
160663934|NCT02024932|580152432|FG005|Overall Study|Abnormal laboratory value|0|||
160663935|NCT03206177|580152433|FG000|Overall Study|Withdrawal by Subject|1|||
160663936|NCT03020641|580152434|FG000|Overall Study|Lost to Follow-up|0|||
160510511|NCT00951015|579596878|FG001|Open-label Phase|Protocol Violation|0|||
160510512|NCT00951015|579596879|FG002|Open-label Phase|Protocol Violation|0|||
160510513|NCT00951015|579596880|FG003|Open-label Phase|Protocol Violation|0|||
160510514|NCT00951015|579596881|FG004|Open-label Phase|Protocol Violation|12|||
160663937|NCT03020641|580152435|FG001|Overall Study|Lost to Follow-up|1|||
160510515|NCT00951015|579596877|FG000|Open-label Phase|Lost to Follow-up|0|||
160510516|NCT00951015|579596878|FG001|Open-label Phase|Lost to Follow-up|0|||
160510517|NCT00951015|579596879|FG002|Open-label Phase|Lost to Follow-up|0|||
160510518|NCT00951015|579596880|FG003|Open-label Phase|Lost to Follow-up|0|||
160510519|NCT00951015|579596881|FG004|Open-label Phase|Lost to Follow-up|12|||
160510520|NCT00951015|579596877|FG000|Open-label Phase|Withdrawal by Subject|0|||
160510521|NCT00951015|579596878|FG001|Open-label Phase|Withdrawal by Subject|0|||
160510522|NCT00951015|579596879|FG002|Open-label Phase|Withdrawal by Subject|0|||
160510523|NCT00951015|579596880|FG003|Open-label Phase|Withdrawal by Subject|0|||
160510524|NCT00951015|579596881|FG004|Open-label Phase|Withdrawal by Subject|14|||
160510525|NCT00951015|579596877|FG000|Open-label Phase|Physician Decision|0|||
160510526|NCT00951015|579596878|FG001|Open-label Phase|Physician Decision|0|||
160510527|NCT00951015|579596879|FG002|Open-label Phase|Physician Decision|0|||
160510528|NCT00951015|579596880|FG003|Open-label Phase|Physician Decision|0|||
160510529|NCT00951015|579596881|FG004|Open-label Phase|Physician Decision|8|||
160510530|NCT01416389|579596882|FG000|Overall Study|Lost to Follow-up|1|||
160510531|NCT01416389|579596883|FG001|Overall Study|Lost to Follow-up|0|||
160510532|NCT01416389|579596882|FG000|Overall Study|Started New Therapy|2|||
160510533|NCT01416389|579596883|FG001|Overall Study|Started New Therapy|0|||
160510534|NCT02535091|579596884|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
160510535|NCT02535091|579596885|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
160510536|NCT02535091|579596886|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
160510537|NCT02535091|579596884|FG000|Overall Study|Withdrawal by Subject|14|||
160510538|NCT02535091|579596885|FG001|Overall Study|Withdrawal by Subject|5|||
160510539|NCT02535091|579596886|FG002|Overall Study|Withdrawal by Subject|121|||
160510540|NCT02535091|579596884|FG000|Overall Study|Adverse Event|9|||
160510541|NCT02535091|579596885|FG001|Overall Study|Adverse Event|4|||
160510542|NCT02535091|579596886|FG002|Overall Study|Adverse Event|170|||
160510543|NCT02535091|579596884|FG000|Overall Study|Other|4|||
160510544|NCT02535091|579596885|FG001|Overall Study|Other|3|||
160510545|NCT02535091|579596886|FG002|Overall Study|Other|81|||
160510546|NCT02535091|579596884|FG000|Overall Study|Lost to Follow-up|0|||
160510547|NCT02535091|579596885|FG001|Overall Study|Lost to Follow-up|1|||
160510548|NCT02535091|579596886|FG002|Overall Study|Lost to Follow-up|19|||
160510549|NCT02535091|579596884|FG000|Overall Study|Protocol Violation|0|||
160510550|NCT02535091|579596885|FG001|Overall Study|Protocol Violation|1|||
160510551|NCT02535091|579596886|FG002|Overall Study|Protocol Violation|11|||
160510552|NCT02535091|579596884|FG000|Overall Study|Pregnancy|0|||
160510553|NCT02535091|579596885|FG001|Overall Study|Pregnancy|0|||
160510554|NCT02535091|579596886|FG002|Overall Study|Pregnancy|7|||
160510555|NCT03223662|579596893|FG000|Overall Study|Physician Decision|1|||
160510556|NCT03223662|579596893|FG000|Overall Study|Study closure|1|||
160510557|NCT01259089|579596894|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
160510558|NCT01259089|579596895|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
160510559|NCT01259089|579596896|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
160510560|NCT01259089|579596897|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
160510561|NCT01259089|579596898|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
160510562|NCT01259089|579596899|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
160510563|NCT01259089|579596894|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
160510564|NCT01259089|579596895|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
160510565|NCT01259089|579596896|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
160510566|NCT01259089|579596897|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
160510567|NCT01259089|579596898|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
160510568|NCT01259089|579596899|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
160510569|NCT01259089|579596894|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
160510570|NCT01259089|579596895|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
160510571|NCT01259089|579596896|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
160510572|NCT01259089|579596897|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
160510573|NCT01259089|579596898|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
160510574|NCT01259089|579596899|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
160510575|NCT01259089|579596894|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
160510576|NCT01259089|579596895|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
160510577|NCT01259089|579596896|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
160510578|NCT01259089|579596897|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
160510579|NCT01259089|579596898|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
160510580|NCT01259089|579596899|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
160510581|NCT01259089|579596894|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
160510582|NCT01259089|579596895|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
160510583|NCT01259089|579596896|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
160510584|NCT01259089|579596897|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
160510585|NCT01259089|579596898|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
160510586|NCT01259089|579596899|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
160510587|NCT01259089|579596894|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
160510588|NCT01259089|579596895|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
160510589|NCT01259089|579596896|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
160510590|NCT01259089|579596897|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
160510591|NCT01259089|579596898|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
160510592|NCT01259089|579596899|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
160510593|NCT01259089|579596894|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
160510594|NCT01259089|579596895|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
160510595|NCT01259089|579596896|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
160510596|NCT01259089|579596897|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
160510597|NCT01259089|579596898|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
160510598|NCT01259089|579596899|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
160510599|NCT01259089|579596894|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
160510600|NCT01259089|579596895|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
160510601|NCT01259089|579596896|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
160510602|NCT01259089|579596897|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
160510603|NCT01259089|579596898|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
160510604|NCT01259089|579596899|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
160510605|NCT01259089|579596894|FG000|Survival Follow up for Two Years|Death|3|||
160510606|NCT01259089|579596895|FG001|Survival Follow up for Two Years|Death|2|||
160510607|NCT01259089|579596896|FG002|Survival Follow up for Two Years|Death|2|||
160510608|NCT01259089|579596897|FG003|Survival Follow up for Two Years|Death|3|||
160510609|NCT01259089|579596898|FG004|Survival Follow up for Two Years|Death|6|||
160510610|NCT01259089|579596899|FG005|Survival Follow up for Two Years|Death|13|||
160510611|NCT01259089|579596894|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
160510612|NCT01259089|579596895|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
160510613|NCT01259089|579596896|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
160510614|NCT01259089|579596897|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
160510615|NCT01259089|579596898|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
160510616|NCT01259089|579596899|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
160510617|NCT01259089|579596894|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
160510618|NCT01259089|579596895|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
160510619|NCT01259089|579596896|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
160510620|NCT01259089|579596897|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
160510621|NCT01259089|579596898|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
160510622|NCT01259089|579596899|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
160510623|NCT00688870|579596904|FG000|Infant Series|Parent or legal guardian request|4|||
160510624|NCT00688870|579596905|FG001|Infant Series|Parent or legal guardian request|0|||
160510625|NCT00528931|579596906|FG000|Overall Study|Lost to Follow-up|1|||
160510626|NCT03122223|579596907|FG000|Overall Study|Withdrawal by Subject|2|||
160510627|NCT03122223|579596908|FG001|Overall Study|Withdrawal by Subject|2|||
160510628|NCT03122223|579596909|FG002|Overall Study|Withdrawal by Subject|1|||
160510629|NCT03122223|579596910|FG003|Overall Study|Withdrawal by Subject|0|||
160510630|NCT03122223|579596907|FG000|Overall Study|Lost to Follow-up|0|||
160510631|NCT03122223|579596908|FG001|Overall Study|Lost to Follow-up|2|||
160510632|NCT03122223|579596909|FG002|Overall Study|Lost to Follow-up|2|||
160510633|NCT03122223|579596910|FG003|Overall Study|Lost to Follow-up|0|||
160510634|NCT03122223|579596907|FG000|Overall Study|Participant unable to adhere|1|||
160510635|NCT03122223|579596908|FG001|Overall Study|Participant unable to adhere|1|||
160510636|NCT03122223|579596909|FG002|Overall Study|Participant unable to adhere|1|||
160510637|NCT03122223|579596910|FG003|Overall Study|Participant unable to adhere|0|||
160510638|NCT01151410|579596911|FG000|Overall Study|Withdrawal by Subject|3|||
160510639|NCT01151410|579596912|FG001|Overall Study|Withdrawal by Subject|5|||
160510640|NCT01151410|579596911|FG000|Overall Study|Lost to Follow-up|3|||
160510641|NCT01151410|579596912|FG001|Overall Study|Lost to Follow-up|4|||
160510642|NCT01151410|579596911|FG000|Overall Study|Adverse Event|1|||
160510643|NCT01151410|579596912|FG001|Overall Study|Adverse Event|2|||
160510644|NCT01151410|579596911|FG000|Overall Study|Protocol deviation|2|||
160510645|NCT01151410|579596912|FG001|Overall Study|Protocol deviation|1|||
160510646|NCT01151410|579596911|FG000|Overall Study|Administrative problems|1|||
160510647|NCT01151410|579596912|FG001|Overall Study|Administrative problems|1|||
160663938|NCT03020641|580152434|FG000|Overall Study|Converted to open surgery|2|||
160663939|NCT03020641|580152435|FG001|Overall Study|Converted to open surgery|1|||
160663940|NCT03020641|580152434|FG000|Overall Study|for surgery not performed|0|||
160663941|NCT03020641|580152435|FG001|Overall Study|for surgery not performed|1|||
160663942|NCT00727961|580152436|FG000|Overall Study|Lost to Follow-up|1|||
160510648|NCT01151410|579596911|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160510649|NCT01151410|579596912|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160510650|NCT01151410|579596911|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160510651|NCT01151410|579596912|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160510652|NCT01253018|579596913|FG000|Overall Study|Lost to Follow-up|1|||
160663943|NCT00727961|580152436|FG000|Overall Study|Adverse Event|4|||
160510653|NCT01253018|579596914|FG001|Overall Study|Lost to Follow-up|1|||
160510654|NCT01253018|579596913|FG000|Overall Study|Robot Repair Issues|2|||
160510655|NCT01253018|579596914|FG001|Overall Study|Robot Repair Issues|0|||
160510656|NCT01253018|579596913|FG000|Overall Study|Withdrawal by Subject|1|||
160510657|NCT01253018|579596914|FG001|Overall Study|Withdrawal by Subject|1|||
160510658|NCT00744757|579596915|FG000|Overall Study|Objective disease progression|7|||
160510659|NCT00744757|579596915|FG000|Overall Study|Physician Decision|5|||
160510660|NCT00744757|579596915|FG000|Overall Study|Withdrawal by Subject|1|||
160510661|NCT00744757|579596915|FG000|Overall Study|Death|6|||
160510662|NCT00744757|579596915|FG000|Overall Study|Adverse Event|2|||
160510663|NCT00548262|579596916|FG000|Overall Study|Death|21|||
160510664|NCT00548262|579596916|FG000|Overall Study|Adverse Event|2|||
160510665|NCT00548262|579596916|FG000|Overall Study|Lack of Efficacy|4|||
160510666|NCT00548262|579596916|FG000|Overall Study|Lost to Follow-up|1|||
160510667|NCT00548262|579596916|FG000|Overall Study|Other|3|||
160510668|NCT00548262|579596916|FG000|Overall Study|Withdrawal by Subject|1|||
160510669|NCT02285153|579596917|FG000|Overall Study|Adverse Event|1|||
160510670|NCT02285153|579596918|FG001|Overall Study|Adverse Event|0|||
160510671|NCT01712659|579596919|FG000|Dose Escalation|Physician Decision|0|||
160510672|NCT01712659|579596920|FG001|Dose Escalation|Physician Decision|1|||
160510673|NCT01712659|579596921|FG002|Dose Escalation|Physician Decision|0|||
160510674|NCT01712659|579596922|FG003|Dose Escalation|Physician Decision|0|||
160510675|NCT01712659|579596923|FG004|Dose Escalation|Physician Decision|0|||
160510676|NCT01712659|579596919|FG000|Dose Escalation|Unable to take study drug|0|||
160510677|NCT01712659|579596920|FG001|Dose Escalation|Unable to take study drug|1|||
160510678|NCT01712659|579596921|FG002|Dose Escalation|Unable to take study drug|0|||
160510679|NCT01712659|579596922|FG003|Dose Escalation|Unable to take study drug|0|||
160510680|NCT01712659|579596923|FG004|Dose Escalation|Unable to take study drug|0|||
160510681|NCT01712659|579596919|FG000|Dose Expansion|Early disease progression|1|||
160510682|NCT01712659|579596920|FG001|Dose Expansion|Early disease progression|0|||
160510683|NCT01712659|579596921|FG002|Dose Expansion|Early disease progression|0|||
160510684|NCT01712659|579596922|FG003|Dose Expansion|Early disease progression|0|||
160510685|NCT01712659|579596923|FG004|Dose Expansion|Early disease progression|0|||
160510686|NCT01712659|579596919|FG000|Dose Expansion|Physician Decision|1|||
160510687|NCT01712659|579596920|FG001|Dose Expansion|Physician Decision|0|||
160510688|NCT01712659|579596921|FG002|Dose Expansion|Physician Decision|0|||
160510689|NCT01712659|579596922|FG003|Dose Expansion|Physician Decision|0|||
160510690|NCT01712659|579596923|FG004|Dose Expansion|Physician Decision|0|||
160510691|NCT00948766|579596924|FG000|Core Study|Adverse Event|73|||
160510692|NCT00948766|579596925|FG001|Core Study|Adverse Event|51|||
160510693|NCT00948766|579596924|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
160510694|NCT00948766|579596925|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
160510695|NCT00948766|579596924|FG000|Core Study|Patient Withdrew Consent|27|||
160510696|NCT00948766|579596925|FG001|Core Study|Patient Withdrew Consent|46|||
160510697|NCT00948766|579596924|FG000|Core Study|Lost to Follow-up|3|||
160510698|NCT00948766|579596925|FG001|Core Study|Lost to Follow-up|2|||
160510699|NCT00948766|579596924|FG000|Core Study|Administrative Problems|2|||
160510700|NCT00948766|579596925|FG001|Core Study|Administrative Problems|2|||
160510701|NCT00948766|579596924|FG000|Core Study|Death|1|||
160510702|NCT00948766|579596925|FG001|Core Study|Death|1|||
160510703|NCT00948766|579596924|FG000|Core Study|Protocol Deviation|8|||
160510704|NCT00948766|579596925|FG001|Core Study|Protocol Deviation|10|||
160510705|NCT00948766|579596924|FG000|Extension Study|Adverse Event|43|||
160510706|NCT00948766|579596925|FG001|Extension Study|Adverse Event|0|||
160510707|NCT00948766|579596924|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
160510708|NCT00948766|579596925|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
160510709|NCT00948766|579596924|FG000|Extension Study|Study Drug No Longer Required|1|||
160510710|NCT00948766|579596925|FG001|Extension Study|Study Drug No Longer Required|0|||
160510711|NCT00948766|579596924|FG000|Extension Study|Patient Withdrew Consent|32|||
160510712|NCT00948766|579596925|FG001|Extension Study|Patient Withdrew Consent|0|||
160510713|NCT00948766|579596924|FG000|Extension Study|Lost to Follow-up|8|||
160510714|NCT00948766|579596925|FG001|Extension Study|Lost to Follow-up|0|||
160510715|NCT00948766|579596924|FG000|Extension Study|Administrative Problems|1|||
160510716|NCT00948766|579596925|FG001|Extension Study|Administrative Problems|0|||
160510717|NCT00948766|579596924|FG000|Extension Study|Death|4|||
160510718|NCT00948766|579596925|FG001|Extension Study|Death|0|||
160510719|NCT02091206|579596927|FG000|Treatment Period|Adverse Event|0|||
160510720|NCT02091206|579596928|FG001|Treatment Period|Adverse Event|1|||
160510721|NCT02091206|579596929|FG002|Treatment Period|Adverse Event|0|||
160510722|NCT02091206|579596930|FG003|Treatment Period|Adverse Event|0|||
160510723|NCT02091206|579596927|FG000|Treatment Period|Met withdrawal criteria|0|||
160510724|NCT02091206|579596928|FG001|Treatment Period|Met withdrawal criteria|0|||
160510725|NCT02091206|579596929|FG002|Treatment Period|Met withdrawal criteria|1|||
160510726|NCT02091206|579596930|FG003|Treatment Period|Met withdrawal criteria|0|||
160510727|NCT02091206|579596927|FG000|Taper Period|Participant refused study drug|1|||
160510728|NCT02091206|579596928|FG001|Taper Period|Participant refused study drug|0|||
160510729|NCT02091206|579596929|FG002|Taper Period|Participant refused study drug|0|||
160510730|NCT02091206|579596930|FG003|Taper Period|Participant refused study drug|1|||
160510731|NCT02091206|579596927|FG000|Taper Period|Lost to Follow-up|0|||
160510732|NCT02091206|579596928|FG001|Taper Period|Lost to Follow-up|0|||
160510733|NCT02091206|579596929|FG002|Taper Period|Lost to Follow-up|0|||
160510734|NCT02091206|579596930|FG003|Taper Period|Lost to Follow-up|1|||
160510735|NCT01214642|579596931|FG000|Overall Study|Progressive Disease|3|||
160510736|NCT01214642|579596932|FG001|Overall Study|Progressive Disease|2|||
160510737|NCT01214642|579596933|FG002|Overall Study|Progressive Disease|3|||
160510738|NCT01214642|579596934|FG003|Overall Study|Progressive Disease|5|||
160510739|NCT01214642|579596935|FG004|Overall Study|Progressive Disease|5|||
160510740|NCT01214642|579596936|FG005|Overall Study|Progressive Disease|3|||
160510741|NCT01214642|579596937|FG006|Overall Study|Progressive Disease|5|||
160510742|NCT01214642|579596938|FG007|Overall Study|Progressive Disease|3|||
160510743|NCT01214642|579596939|FG008|Overall Study|Progressive Disease|10|||
160510744|NCT01214642|579596940|FG009|Overall Study|Progressive Disease|2|||
160510745|NCT01214642|579596941|FG010|Overall Study|Progressive Disease|1|||
160510746|NCT01214642|579596942|FG011|Overall Study|Progressive Disease|4|||
160510747|NCT01214642|579596931|FG000|Overall Study|Adverse Event|0|||
160510748|NCT01214642|579596932|FG001|Overall Study|Adverse Event|1|||
160510749|NCT01214642|579596933|FG002|Overall Study|Adverse Event|0|||
160510750|NCT01214642|579596934|FG003|Overall Study|Adverse Event|0|||
160510751|NCT01214642|579596935|FG004|Overall Study|Adverse Event|0|||
160510752|NCT01214642|579596936|FG005|Overall Study|Adverse Event|0|||
160510753|NCT01214642|579596937|FG006|Overall Study|Adverse Event|1|||
160510754|NCT01214642|579596938|FG007|Overall Study|Adverse Event|0|||
160510755|NCT01214642|579596939|FG008|Overall Study|Adverse Event|0|||
160510756|NCT01214642|579596940|FG009|Overall Study|Adverse Event|1|||
160510757|NCT01214642|579596941|FG010|Overall Study|Adverse Event|1|||
160510758|NCT01214642|579596942|FG011|Overall Study|Adverse Event|0|||
160510759|NCT01214642|579596931|FG000|Overall Study|Death|0|||
160510760|NCT01214642|579596932|FG001|Overall Study|Death|0|||
160510761|NCT01214642|579596933|FG002|Overall Study|Death|1|||
160510762|NCT01214642|579596934|FG003|Overall Study|Death|0|||
160510763|NCT01214642|579596935|FG004|Overall Study|Death|0|||
160510764|NCT01214642|579596936|FG005|Overall Study|Death|0|||
160510765|NCT01214642|579596937|FG006|Overall Study|Death|0|||
160510766|NCT01214642|579596938|FG007|Overall Study|Death|0|||
160510767|NCT01214642|579596939|FG008|Overall Study|Death|0|||
160510768|NCT01214642|579596940|FG009|Overall Study|Death|0|||
160510769|NCT01214642|579596941|FG010|Overall Study|Death|1|||
160510770|NCT01214642|579596942|FG011|Overall Study|Death|0|||
160510771|NCT01214642|579596931|FG000|Overall Study|Withdrawal by Subject|0|||
160510772|NCT01214642|579596932|FG001|Overall Study|Withdrawal by Subject|0|||
160510773|NCT01214642|579596933|FG002|Overall Study|Withdrawal by Subject|1|||
160510774|NCT01214642|579596934|FG003|Overall Study|Withdrawal by Subject|0|||
160510775|NCT01214642|579596935|FG004|Overall Study|Withdrawal by Subject|0|||
160510776|NCT01214642|579596936|FG005|Overall Study|Withdrawal by Subject|0|||
160510777|NCT01214642|579596937|FG006|Overall Study|Withdrawal by Subject|0|||
160510778|NCT01214642|579596938|FG007|Overall Study|Withdrawal by Subject|0|||
160510779|NCT01214642|579596939|FG008|Overall Study|Withdrawal by Subject|3|||
160510780|NCT01214642|579596940|FG009|Overall Study|Withdrawal by Subject|1|||
160510781|NCT01214642|579596941|FG010|Overall Study|Withdrawal by Subject|1|||
160510782|NCT01214642|579596942|FG011|Overall Study|Withdrawal by Subject|0|||
160510783|NCT01214642|579596931|FG000|Overall Study|Physician Decision|0|||
160510784|NCT01214642|579596932|FG001|Overall Study|Physician Decision|0|||
160510785|NCT01214642|579596933|FG002|Overall Study|Physician Decision|1|||
160510786|NCT01214642|579596934|FG003|Overall Study|Physician Decision|1|||
160510787|NCT01214642|579596935|FG004|Overall Study|Physician Decision|1|||
160510788|NCT01214642|579596936|FG005|Overall Study|Physician Decision|0|||
160510789|NCT01214642|579596937|FG006|Overall Study|Physician Decision|0|||
160510790|NCT01214642|579596938|FG007|Overall Study|Physician Decision|0|||
160510791|NCT01214642|579596939|FG008|Overall Study|Physician Decision|0|||
160510792|NCT01214642|579596940|FG009|Overall Study|Physician Decision|0|||
160510793|NCT01214642|579596941|FG010|Overall Study|Physician Decision|0|||
160510794|NCT01214642|579596942|FG011|Overall Study|Physician Decision|2|||
160510795|NCT00969709|579598551|FG000|Overall Study|Adverse Event|3|||
160510796|NCT00969709|579598552|FG001|Overall Study|Adverse Event|13|||
160510797|NCT00969709|579598553|FG002|Overall Study|Adverse Event|26|||
160510798|NCT00969709|579598554|FG003|Overall Study|Adverse Event|12|||
160510799|NCT00969709|579598551|FG000|Overall Study|Lack of Efficacy|7|||
160510800|NCT00969709|579598552|FG001|Overall Study|Lack of Efficacy|4|||
160510801|NCT00969709|579598553|FG002|Overall Study|Lack of Efficacy|1|||
160510802|NCT00969709|579598554|FG003|Overall Study|Lack of Efficacy|3|||
160510803|NCT00969709|579598551|FG000|Overall Study|Protocol Violation|9|||
160510804|NCT00969709|579598552|FG001|Overall Study|Protocol Violation|5|||
160510805|NCT00969709|579598553|FG002|Overall Study|Protocol Violation|9|||
160510806|NCT00969709|579598554|FG003|Overall Study|Protocol Violation|10|||
160510807|NCT00969709|579598551|FG000|Overall Study|Withdrawal by Subject|9|||
160510808|NCT00969709|579598552|FG001|Overall Study|Withdrawal by Subject|12|||
160510809|NCT00969709|579598553|FG002|Overall Study|Withdrawal by Subject|11|||
160510810|NCT00969709|579598554|FG003|Overall Study|Withdrawal by Subject|23|||
160510811|NCT00969709|579598551|FG000|Overall Study|Lost to Follow-up|10|||
160510812|NCT00969709|579598552|FG001|Overall Study|Lost to Follow-up|14|||
160510813|NCT00969709|579598553|FG002|Overall Study|Lost to Follow-up|8|||
160510814|NCT00969709|579598554|FG003|Overall Study|Lost to Follow-up|15|||
160510815|NCT00969709|579598551|FG000|Overall Study|Other reasons|0|||
160510816|NCT00969709|579598552|FG001|Overall Study|Other reasons|0|||
160510817|NCT00969709|579598553|FG002|Overall Study|Other reasons|3|||
160510818|NCT00969709|579598554|FG003|Overall Study|Other reasons|0|||
160510819|NCT02516332|579598555|FG000|Overall Study|Withdrawal by Subject|2|||
160510820|NCT02516332|579598556|FG001|Overall Study|Withdrawal by Subject|1|||
160510821|NCT02516332|579598557|FG002|Overall Study|Withdrawal by Subject|2|||
160510822|NCT00055601|579598558|FG000|Overall Study|Protocol Violation|1|||
160510823|NCT00055601|579598559|FG001|Overall Study|Protocol Violation|1|||
160510824|NCT00055601|579598558|FG000|Overall Study|No protocol treatment received|1|||
160510825|NCT00055601|579598559|FG001|Overall Study|No protocol treatment received|1|||
160510826|NCT03573583|579598563|FG000|Overall Study|Lost to Follow-up|1|||
160510827|NCT03573583|579598564|FG001|Overall Study|Lost to Follow-up|0|||
160510828|NCT03573583|579598563|FG000|Overall Study|Withdrawal by Subject|1|||
160510829|NCT03573583|579598564|FG001|Overall Study|Withdrawal by Subject|1|||
160510830|NCT01119105|579598568|FG000|Overall Study|Withdrawal by Subject|1|||
160510831|NCT01119105|579598569|FG001|Overall Study|Withdrawal by Subject|1|||
160510832|NCT01119105|579598570|FG002|Overall Study|Withdrawal by Subject|1|||
160510833|NCT01119105|579598568|FG000|Overall Study|Lost to Follow-up|0|||
160510834|NCT01119105|579598569|FG001|Overall Study|Lost to Follow-up|2|||
160510835|NCT01119105|579598570|FG002|Overall Study|Lost to Follow-up|5|||
160510836|NCT01119105|579598568|FG000|Overall Study|Adverse Event|1|||
160510837|NCT01119105|579598569|FG001|Overall Study|Adverse Event|0|||
160510838|NCT01119105|579598570|FG002|Overall Study|Adverse Event|1|||
160510839|NCT01119105|579598568|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
160510840|NCT01119105|579598569|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
160510841|NCT01119105|579598570|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
160510842|NCT01119105|579598568|FG000|Overall Study|Other|1|||
160510843|NCT01119105|579598569|FG001|Overall Study|Other|1|||
160510844|NCT01119105|579598570|FG002|Overall Study|Other|0|||
160510845|NCT01639495|579598571|FG000|Overall Study|Lost to Follow-up|6|||
160510846|NCT01639495|579598571|FG000|Overall Study|Consented but didn't have study catheter|4|||
160510847|NCT01639495|579598571|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
160510848|NCT01639495|579598571|FG000|Overall Study|No radiofrequency energy applied|2|||
160510849|NCT01631227|579598574|FG000|Overall Study|withdrawn consent|27|||
160510850|NCT01631227|579598575|FG001|Overall Study|withdrawn consent|21|||
160510851|NCT01631227|579598574|FG000|Overall Study|Adverse Event|1|||
160510852|NCT01631227|579598575|FG001|Overall Study|Adverse Event|0|||
160510853|NCT01631227|579598574|FG000|Overall Study|administrative|2|||
160510854|NCT01631227|579598575|FG001|Overall Study|administrative|1|||
160510855|NCT01153321|579598576|FG000|Overall Study|Development of study withdrawal criteria|0|||
160510856|NCT01153321|579598577|FG001|Overall Study|Development of study withdrawal criteria|1|||
160510857|NCT01153321|579598576|FG000|Overall Study|Withdrawal by Subject|0|||
160510858|NCT01153321|579598577|FG001|Overall Study|Withdrawal by Subject|1|||
160510859|NCT01153321|579598576|FG000|Overall Study|Adverse Event|1|||
160510860|NCT01153321|579598577|FG001|Overall Study|Adverse Event|1|||
160510861|NCT01177800|579598579|FG000|Overall Study|Adverse Event|9|||
160510862|NCT01177800|579598580|FG001|Overall Study|Adverse Event|3|||
160510863|NCT01177800|579598579|FG000|Overall Study|Protocol Violation|0|||
160510864|NCT01177800|579598580|FG001|Overall Study|Protocol Violation|1|||
160510865|NCT01177800|579598579|FG000|Overall Study|Physician Decision|1|||
160510866|NCT01177800|579598580|FG001|Overall Study|Physician Decision|0|||
160510867|NCT01177800|579598579|FG000|Overall Study|Withdrawal of informed consent|0|||
160510868|NCT01177800|579598580|FG001|Overall Study|Withdrawal of informed consent|1|||
160510869|NCT02071290|579598583|FG000|Overall Study|Death|1|||
160510870|NCT02071290|579598584|FG001|Overall Study|Death|0|||
160510871|NCT02071290|579598583|FG000|Overall Study|Withdrawal by Subject|0|||
160510872|NCT02071290|579598584|FG001|Overall Study|Withdrawal by Subject|1|||
160510873|NCT02071290|579598583|FG000|Overall Study|Protocol Violation|3|||
160510874|NCT02071290|579598584|FG001|Overall Study|Protocol Violation|5|||
160510875|NCT02071290|579598583|FG000|Overall Study|Physician Decision|0|||
160510876|NCT02071290|579598584|FG001|Overall Study|Physician Decision|1|||
160510877|NCT05560243|579598589|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
160510878|NCT05870228|579598591|FG000|Overall Study|Lost to Follow-up|2|||
160510879|NCT05870228|579598592|FG001|Overall Study|Lost to Follow-up|0|||
160510880|NCT05870228|579598591|FG000|Overall Study|Withdrawal by Subject|1|||
160510881|NCT05870228|579598592|FG001|Overall Study|Withdrawal by Subject|0|||
160510882|NCT03500159|579598594|FG000|Overall Study|Study Terminated|2|||
160510883|NCT03500159|579598595|FG001|Overall Study|Study Terminated|1|||
160510884|NCT04075994|579598596|FG000|Overall Study|Withdrawal by Subject|8|||
160510885|NCT04075994|579598597|FG001|Overall Study|Withdrawal by Subject|9|||
160510886|NCT04075994|579598596|FG000|Overall Study|Adverse Event|2|||
160620522|NCT04563845|579990302|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160510887|NCT04075994|579598597|FG001|Overall Study|Adverse Event|2|||
160510888|NCT04075994|579598596|FG000|Overall Study|Investigator withdrew|3|||
160510889|NCT04075994|579598597|FG001|Overall Study|Investigator withdrew|1|||
160510890|NCT01941719|579598604|FG000|Overall Study|Lost to Follow-up|20|||
160510891|NCT01941719|579598605|FG001|Overall Study|Lost to Follow-up|19|||
160510892|NCT00252577|579598606|FG000|Overall Study|Lost to Follow-up|20|||
160510893|NCT00560066|579598607|FG000|Overall Study|Death|2|||
160510894|NCT00560066|579598608|FG001|Overall Study|Death|1|||
160510895|NCT00560066|579598607|FG000|Overall Study|Withdrawal by Subject|0|||
160510896|NCT00560066|579598608|FG001|Overall Study|Withdrawal by Subject|3|||
160510897|NCT00560066|579598607|FG000|Overall Study|Lost to Follow-up|4|||
160510898|NCT00560066|579598608|FG001|Overall Study|Lost to Follow-up|10|||
160510899|NCT00560066|579598607|FG000|Overall Study|Protocol Violation|0|||
160510900|NCT00560066|579598608|FG001|Overall Study|Protocol Violation|1|||
160510901|NCT00560066|579598607|FG000|Overall Study|Administrative reason|0|||
160510902|NCT00560066|579598608|FG001|Overall Study|Administrative reason|5|||
160510903|NCT00560066|579598607|FG000|Overall Study|Missing primary reason|0|||
160510904|NCT00560066|579598608|FG001|Overall Study|Missing primary reason|2|||
160510905|NCT03819634|579598610|FG000|Overall Study|Physician Decision|2|||
160510906|NCT00958841|579598611|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160510907|NCT00958841|579598611|FG000|Overall Study|Abnormal test procedure result(s)|3|||
160510908|NCT00958841|579598611|FG000|Overall Study|Administrative problems|1|||
160510909|NCT00958841|579598611|FG000|Overall Study|Adverse Event|8|||
160510910|NCT00958841|579598611|FG000|Overall Study|New cancer therapy|5|||
160510911|NCT00958841|579598611|FG000|Overall Study|Withdrawal by Subject|1|||
160510912|NCT00958841|579598611|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
160510913|NCT00958841|579598611|FG000|Overall Study|Completed M6/did not enter extension|27|||
160510914|NCT00958841|579598611|FG000|Overall Study|Discontinued prior to M*|28|||
160510915|NCT01125514|579598619|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
160510916|NCT01125514|579598619|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
160510917|NCT01125514|579598619|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
160510918|NCT01125514|579598619|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
160510919|NCT01125514|579598619|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
160510920|NCT01125514|579598619|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
160510921|NCT00858364|579598620|FG000|Overall Study|Administrative Decision|3|||
160510922|NCT00858364|579598621|FG001|Overall Study|Administrative Decision|2|||
160510923|NCT00858364|579598620|FG000|Overall Study|Adverse Event|5|||
160510924|NCT00858364|579598621|FG001|Overall Study|Adverse Event|2|||
160510925|NCT00858364|579598620|FG000|Overall Study|Withdrawal by Subject|44|||
160510926|NCT00858364|579598621|FG001|Overall Study|Withdrawal by Subject|118|||
160510927|NCT00858364|579598620|FG000|Overall Study|Ineligibility Determined|1|||
160510928|NCT00858364|579598621|FG001|Overall Study|Ineligibility Determined|10|||
160510929|NCT00858364|579598620|FG000|Overall Study|Lost to Follow-up|24|||
160510930|NCT00858364|579598621|FG001|Overall Study|Lost to Follow-up|54|||
160510931|NCT00858364|579598620|FG000|Overall Study|Noncompliance|3|||
160510932|NCT00858364|579598621|FG001|Overall Study|Noncompliance|4|||
160510933|NCT00858364|579598620|FG000|Overall Study|Protocol Deviation|0|||
160510934|NCT00858364|579598621|FG001|Overall Study|Protocol Deviation|2|||
160510935|NCT00858364|579598620|FG000|Overall Study|Other|9|||
160510936|NCT00858364|579598621|FG001|Overall Study|Other|17|||
160510937|NCT00858364|579598620|FG000|Overall Study|Missing|1|||
160510938|NCT00858364|579598621|FG001|Overall Study|Missing|1|||
160510939|NCT00858364|579598620|FG000|Overall Study|Still on-study|114|||
160510940|NCT00858364|579598621|FG001|Overall Study|Still on-study|247|||
160510941|NCT01655693|579598625|FG000|Overall Study|Progression of Disease|92|||
160510942|NCT01655693|579598626|FG001|Overall Study|Progression of Disease|76|||
160510943|NCT01655693|579598627|FG002|Overall Study|Progression of Disease|58|||
160510944|NCT01655693|579598625|FG000|Overall Study|Death|8|||
160510945|NCT01655693|579598626|FG001|Overall Study|Death|9|||
160510946|NCT01655693|579598627|FG002|Overall Study|Death|12|||
160510947|NCT01655693|579598625|FG000|Overall Study|Serious Adverse Event|3|||
160510948|NCT01655693|579598626|FG001|Overall Study|Serious Adverse Event|15|||
160510949|NCT01655693|579598627|FG002|Overall Study|Serious Adverse Event|11|||
160510950|NCT01655693|579598625|FG000|Overall Study|Withdrawal by Subject|3|||
160510951|NCT01655693|579598626|FG001|Overall Study|Withdrawal by Subject|2|||
160510952|NCT01655693|579598627|FG002|Overall Study|Withdrawal by Subject|20|||
160510953|NCT01655693|579598625|FG000|Overall Study|Adverse Event|3|||
160510954|NCT01655693|579598626|FG001|Overall Study|Adverse Event|11|||
160510955|NCT01655693|579598627|FG002|Overall Study|Adverse Event|3|||
160620523|NCT04563845|579990303|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160510956|NCT01655693|579598625|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
160510957|NCT01655693|579598626|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
160510958|NCT01655693|579598627|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
160510959|NCT01655693|579598625|FG000|Overall Study|Non-Compliance|0|||
160510960|NCT01655693|579598626|FG001|Overall Study|Non-Compliance|0|||
160510961|NCT01655693|579598627|FG002|Overall Study|Non-Compliance|7|||
160620524|NCT04563845|579990304|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160663944|NCT00727961|580152436|FG000|Overall Study|Patient's refusal|2|||
160620525|NCT04563845|579990305|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160620526|NCT04563845|579990306|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160620527|NCT04563845|579990307|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
160620528|NCT04563845|579990294|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620529|NCT04563845|579990295|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620530|NCT04563845|579990296|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620531|NCT04563845|579990297|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620532|NCT04563845|579990298|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
160620533|NCT04563845|579990299|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620534|NCT04563845|579990300|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620535|NCT04563845|579990301|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620536|NCT04563845|579990302|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620537|NCT04563845|579990303|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620538|NCT04563845|579990304|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620539|NCT04563845|579990305|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620540|NCT04563845|579990306|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620541|NCT04563845|579990307|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
160620542|NCT01020812|579990308|FG000|Overall Study|Physician Decision|1|||
160620543|NCT01020812|579990308|FG000|Overall Study|Withdrawal by Subject|1|||
160620544|NCT01020812|579990308|FG000|Overall Study|Protocol Violation|1|||
160620545|NCT02155660|579990321|FG000|Overall Study|Other Reason|8|||
160620546|NCT02155660|579990322|FG001|Overall Study|Other Reason|6|||
160620547|NCT02155660|579990323|FG002|Overall Study|Other Reason|10|||
160620548|NCT02155660|579990324|FG003|Overall Study|Other Reason|10|||
160620549|NCT02155660|579990321|FG000|Overall Study|Study-specific withdrawal criteria|0|||
160620550|NCT02155660|579990322|FG001|Overall Study|Study-specific withdrawal criteria|1|||
160620551|NCT02155660|579990323|FG002|Overall Study|Study-specific withdrawal criteria|1|||
160620552|NCT02155660|579990324|FG003|Overall Study|Study-specific withdrawal criteria|1|||
160620553|NCT02155660|579990321|FG000|Overall Study|Severe non-compliance|0|||
160620554|NCT02155660|579990322|FG001|Overall Study|Severe non-compliance|4|||
160620555|NCT02155660|579990323|FG002|Overall Study|Severe non-compliance|0|||
160620556|NCT02155660|579990324|FG003|Overall Study|Severe non-compliance|1|||
160620557|NCT02155660|579990321|FG000|Overall Study|Adverse Event|2|||
160620558|NCT02155660|579990322|FG001|Overall Study|Adverse Event|6|||
160620559|NCT02155660|579990323|FG002|Overall Study|Adverse Event|3|||
160620560|NCT02155660|579990324|FG003|Overall Study|Adverse Event|1|||
160620561|NCT02155660|579990321|FG000|Overall Study|Lost to Follow-up|3|||
160620562|NCT02155660|579990322|FG001|Overall Study|Lost to Follow-up|6|||
160620563|NCT02155660|579990323|FG002|Overall Study|Lost to Follow-up|5|||
160620564|NCT02155660|579990324|FG003|Overall Study|Lost to Follow-up|8|||
160620565|NCT02155660|579990321|FG000|Overall Study|Death|17|||
160620566|NCT02155660|579990322|FG001|Overall Study|Death|19|||
160620567|NCT02155660|579990323|FG002|Overall Study|Death|17|||
160620568|NCT02155660|579990324|FG003|Overall Study|Death|19|||
160620569|NCT02155660|579990321|FG000|Overall Study|Withdrawal by Subject|28|||
160620570|NCT02155660|579990322|FG001|Overall Study|Withdrawal by Subject|31|||
160620571|NCT02155660|579990323|FG002|Overall Study|Withdrawal by Subject|24|||
160620572|NCT02155660|579990324|FG003|Overall Study|Withdrawal by Subject|21|||
160620573|NCT03730987|579990325|FG000|Overall Study|Lost to Follow-up|2|||
160620574|NCT03730987|579990326|FG001|Overall Study|Lost to Follow-up|0|||
160620575|NCT03730987|579990327|FG002|Overall Study|Lost to Follow-up|2|||
160620576|NCT03730987|579990328|FG003|Overall Study|Lost to Follow-up|0|||
160620577|NCT02505945|579990329|FG000|Overall Study|Withdrawal by Subject|13|||
160620578|NCT02505945|579990330|FG001|Overall Study|Withdrawal by Subject|2|||
160620579|NCT02505945|579990329|FG000|Overall Study|Adverse Event|1|||
160620580|NCT02505945|579990330|FG001|Overall Study|Adverse Event|0|||
160620581|NCT02505945|579990329|FG000|Overall Study|Physician Decision|2|||
160620582|NCT02505945|579990330|FG001|Overall Study|Physician Decision|1|||
160620583|NCT02505945|579990329|FG000|Overall Study|Lost to Follow-up|6|||
160620584|NCT02505945|579990330|FG001|Overall Study|Lost to Follow-up|1|||
160620585|NCT00719706|579990337|FG000|Overall Study|Adverse Event|5|||
160620586|NCT00719706|579990338|FG001|Overall Study|Adverse Event|4|||
160620587|NCT00719706|579990337|FG000|Overall Study|Withdrawal by Subject|1|||
160620588|NCT00719706|579990338|FG001|Overall Study|Withdrawal by Subject|2|||
160620589|NCT00719706|579990337|FG000|Overall Study|Protocol Violation|3|||
160620590|NCT00719706|579990338|FG001|Overall Study|Protocol Violation|0|||
160620591|NCT02681094|579990339|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
160620592|NCT02681094|579990340|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
160620593|NCT02681094|579990341|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
160620594|NCT02681094|579990339|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
160620595|NCT02681094|579990340|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
160620596|NCT02681094|579990341|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
160620597|NCT02681094|579990339|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
160620598|NCT02681094|579990340|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
160620599|NCT02681094|579990341|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
160620600|NCT02681094|579990339|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
160620601|NCT02681094|579990340|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
160620602|NCT02681094|579990341|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
160620603|NCT02681094|579990339|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
160620604|NCT02681094|579990340|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
160620605|NCT02681094|579990341|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
160620606|NCT02681094|579990339|FG000|1 -Modified Enrolled Participants Set|Other|6|||
160620607|NCT02681094|579990340|FG001|1 -Modified Enrolled Participants Set|Other|6|||
160620608|NCT02681094|579990341|FG002|1 -Modified Enrolled Participants Set|Other|7|||
160620609|NCT02681094|579990339|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
160620610|NCT02681094|579990340|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
160620611|NCT02681094|579990341|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
160620612|NCT02681094|579990339|FG000|2 - Enrolled Participants Set|Participant decision|7|||
160620613|NCT02681094|579990340|FG001|2 - Enrolled Participants Set|Participant decision|10|||
160620614|NCT02681094|579990341|FG002|2 - Enrolled Participants Set|Participant decision|9|||
160620615|NCT02681094|579990339|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
160663945|NCT00727961|580152436|FG000|Overall Study|Progression|30|||
160663946|NCT03238781|580152437|FG000|Overall Study|Adverse Event|1|||
160510962|NCT01655693|579598625|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
160510963|NCT01655693|579598626|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
160510964|NCT01655693|579598627|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
160510965|NCT01655693|579598625|FG000|Overall Study|Protocol Violation|1|||
160510966|NCT01655693|579598626|FG001|Overall Study|Protocol Violation|0|||
160510967|NCT01655693|579598627|FG002|Overall Study|Protocol Violation|3|||
160510968|NCT01655693|579598625|FG000|Overall Study|Lost to Follow-up|1|||
160510969|NCT01655693|579598626|FG001|Overall Study|Lost to Follow-up|0|||
160510970|NCT01655693|579598627|FG002|Overall Study|Lost to Follow-up|1|||
160510971|NCT01655693|579598625|FG000|Overall Study|Screening Failure|1|||
160510972|NCT01655693|579598626|FG001|Overall Study|Screening Failure|0|||
160510973|NCT01655693|579598627|FG002|Overall Study|Screening Failure|0|||
160510974|NCT01655693|579598625|FG000|Overall Study|Other|8|||
160510975|NCT01655693|579598626|FG001|Overall Study|Other|6|||
160510976|NCT01655693|579598627|FG002|Overall Study|Other|15|||
160510977|NCT01163292|579598633|FG000|Overall Study|Lack of Efficacy|9|||
160510978|NCT01163292|579598634|FG001|Overall Study|Lack of Efficacy|0|||
160510979|NCT01163292|579598633|FG000|Overall Study|Adverse Event|6|||
160510980|NCT01163292|579598634|FG001|Overall Study|Adverse Event|0|||
160510981|NCT01163292|579598633|FG000|Overall Study|Initiation of biological therapy|0|||
160510982|NCT01163292|579598634|FG001|Overall Study|Initiation of biological therapy|15|||
160510983|NCT01163292|579598633|FG000|Overall Study|Sufficient response to adalimumab|8|||
160510984|NCT01163292|579598634|FG001|Overall Study|Sufficient response to adalimumab|0|||
160510985|NCT01163292|579598633|FG000|Overall Study|Refusal to receive adalimumab|7|||
160510986|NCT01163292|579598634|FG001|Overall Study|Refusal to receive adalimumab|0|||
160510987|NCT01163292|579598633|FG000|Overall Study|Economic reasons|6|||
160510988|NCT01163292|579598634|FG001|Overall Study|Economic reasons|0|||
160510989|NCT01163292|579598633|FG000|Overall Study|No further visits|5|||
160510990|NCT01163292|579598634|FG001|Overall Study|No further visits|7|||
160510991|NCT02643472|579598638|FG000|Overall Study|Death|2|||
160510992|NCT02643472|579598639|FG001|Overall Study|Death|5|||
160510993|NCT02643472|579598638|FG000|Overall Study|Withdrawal by Subject|3|||
160510994|NCT02643472|579598639|FG001|Overall Study|Withdrawal by Subject|2|||
160510995|NCT02643472|579598638|FG000|Overall Study|Protocol Violation|0|||
160510996|NCT02643472|579598639|FG001|Overall Study|Protocol Violation|1|||
160510997|NCT02643472|579598638|FG000|Overall Study|Lost to Follow-up|22|||
160510998|NCT02643472|579598639|FG001|Overall Study|Lost to Follow-up|26|||
160510999|NCT01258595|579598640|FG000|Overall Study|Lost to Follow-up|1|||
160511000|NCT01258595|579598641|FG001|Overall Study|Lost to Follow-up|0|||
160511001|NCT01258595|579598640|FG000|Overall Study|Withdrawal by Subject|0|||
160511002|NCT01258595|579598641|FG001|Overall Study|Withdrawal by Subject|1|||
160511003|NCT01215188|579598642|FG000|Overall Study|Lost to Follow-up|22|||
160511004|NCT01215188|579598643|FG001|Overall Study|Lost to Follow-up|22|||
160511005|NCT01215188|579598644|FG002|Overall Study|Lost to Follow-up|16|||
160511006|NCT01215188|579598642|FG000|Overall Study|Adverse Event|1|||
160511007|NCT01215188|579598643|FG001|Overall Study|Adverse Event|1|||
160511008|NCT01215188|579598644|FG002|Overall Study|Adverse Event|3|||
160511009|NCT01215188|579598642|FG000|Overall Study|Physician Decision|2|||
160511010|NCT01215188|579598643|FG001|Overall Study|Physician Decision|1|||
160511011|NCT01215188|579598644|FG002|Overall Study|Physician Decision|0|||
160511012|NCT01215188|579598642|FG000|Overall Study|Lack of Efficacy|0|||
160511013|NCT01215188|579598643|FG001|Overall Study|Lack of Efficacy|0|||
160511014|NCT01215188|579598644|FG002|Overall Study|Lack of Efficacy|1|||
160511015|NCT01215188|579598642|FG000|Overall Study|Protocol Violation|1|||
160511016|NCT01215188|579598643|FG001|Overall Study|Protocol Violation|1|||
160511017|NCT01215188|579598644|FG002|Overall Study|Protocol Violation|1|||
160511018|NCT01215188|579598642|FG000|Overall Study|Withdrawal by Subject|32|||
160511019|NCT01215188|579598643|FG001|Overall Study|Withdrawal by Subject|34|||
160511020|NCT01215188|579598644|FG002|Overall Study|Withdrawal by Subject|31|||
160511021|NCT02310100|579598645|FG000|Overall Study|Physician Decision|3|||
160511022|NCT02310100|579598645|FG000|Overall Study|Withdrawal by Subject|10|||
160511023|NCT02310100|579598645|FG000|Overall Study|Enrollment closure|1|||
160511024|NCT02310100|579598645|FG000|Overall Study|Unapproved ablation operator|1|||
160511025|NCT02310100|579598645|FG000|Overall Study|Visit compliance|1|||
160511026|NCT02310100|579598645|FG000|Overall Study|Lost to Follow-up|2|||
160511027|NCT01820585|579598652|FG000|Overall Study|Adverse Event|9|||
160511028|NCT01820585|579598653|FG001|Overall Study|Adverse Event|13|||
160511029|NCT01820585|579598654|FG002|Overall Study|Adverse Event|23|||
160511030|NCT01820585|579598655|FG003|Overall Study|Adverse Event|34|||
160511031|NCT01820585|579598652|FG000|Overall Study|Lack of Efficacy|9|||
160511032|NCT01820585|579598653|FG001|Overall Study|Lack of Efficacy|7|||
160511033|NCT01820585|579598654|FG002|Overall Study|Lack of Efficacy|5|||
160511034|NCT01820585|579598655|FG003|Overall Study|Lack of Efficacy|1|||
160511035|NCT01820585|579598652|FG000|Overall Study|Withdrawal by Subject|3|||
160511036|NCT01820585|579598653|FG001|Overall Study|Withdrawal by Subject|7|||
160511037|NCT01820585|579598654|FG002|Overall Study|Withdrawal by Subject|3|||
160511038|NCT01820585|579598655|FG003|Overall Study|Withdrawal by Subject|8|||
160511039|NCT01820585|579598652|FG000|Overall Study|Lost to Follow-up|3|||
160511040|NCT01820585|579598653|FG001|Overall Study|Lost to Follow-up|3|||
160511041|NCT01820585|579598654|FG002|Overall Study|Lost to Follow-up|0|||
160511042|NCT01820585|579598655|FG003|Overall Study|Lost to Follow-up|3|||
160511043|NCT01820585|579598652|FG000|Overall Study|Protocol Violation|3|||
160511044|NCT01820585|579598653|FG001|Overall Study|Protocol Violation|1|||
160511045|NCT01820585|579598654|FG002|Overall Study|Protocol Violation|1|||
160511046|NCT01820585|579598655|FG003|Overall Study|Protocol Violation|1|||
160620616|NCT02681094|579990340|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
160620617|NCT02681094|579990341|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
160620618|NCT02681094|579990339|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
160620619|NCT02681094|579990340|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
160620620|NCT02681094|579990341|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
160620621|NCT02681094|579990339|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
160620622|NCT02681094|579990340|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
160620623|NCT02681094|579990341|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
160620624|NCT02681094|579990339|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
160620625|NCT02681094|579990340|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
160620626|NCT02681094|579990341|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
160620627|NCT02681094|579990339|FG000|2 - Enrolled Participants Set|Other|6|||
160620628|NCT02681094|579990340|FG001|2 - Enrolled Participants Set|Other|6|||
160620629|NCT02681094|579990341|FG002|2 - Enrolled Participants Set|Other|7|||
160620630|NCT02681094|579990339|FG000|2 - Enrolled Participants Set|No treatment given|0|||
160620631|NCT02681094|579990340|FG001|2 - Enrolled Participants Set|No treatment given|1|||
160620632|NCT02681094|579990341|FG002|2 - Enrolled Participants Set|No treatment given|1|||
160620633|NCT01072175|579990342|FG000|Part A (Drug-Drug Interaction)|Death|1|||
160620634|NCT01072175|579990343|FG001|Part A (Drug-Drug Interaction)|Death|0|||
160620635|NCT01072175|579990344|FG002|Part A (Drug-Drug Interaction)|Death|0|||
160620636|NCT01072175|579990345|FG003|Part A (Drug-Drug Interaction)|Death|0|||
160620637|NCT01072175|579990346|FG004|Part A (Drug-Drug Interaction)|Death|0|||
160620638|NCT01072175|579990347|FG005|Part A (Drug-Drug Interaction)|Death|0|||
160620639|NCT01072175|579990348|FG006|Part A (Drug-Drug Interaction)|Death|0|||
160620640|NCT01072175|579990349|FG007|Part A (Drug-Drug Interaction)|Death|0|||
160620641|NCT01072175|579990350|FG008|Part A (Drug-Drug Interaction)|Death|0|||
160620642|NCT01072175|579990351|FG009|Part A (Drug-Drug Interaction)|Death|0|||
160620643|NCT01072175|579990352|FG010|Part A (Drug-Drug Interaction)|Death|0|||
160620644|NCT01072175|579990353|FG011|Part A (Drug-Drug Interaction)|Death|0|||
160620645|NCT01072175|579990354|FG012|Part A (Drug-Drug Interaction)|Death|0|||
160620646|NCT01072175|579990342|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
160620647|NCT01072175|579990343|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620648|NCT01072175|579990344|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620649|NCT01072175|579990345|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620650|NCT01072175|579990346|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620651|NCT01072175|579990347|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620652|NCT01072175|579990348|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620653|NCT01072175|579990349|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620654|NCT01072175|579990350|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620655|NCT01072175|579990351|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620656|NCT01072175|579990352|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620657|NCT01072175|579990353|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620658|NCT01072175|579990354|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
160620659|NCT01072175|579990342|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
160620660|NCT01072175|579990343|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620661|NCT01072175|579990344|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620662|NCT01072175|579990345|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620663|NCT01072175|579990346|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620664|NCT01072175|579990347|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620665|NCT01072175|579990348|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620666|NCT01072175|579990349|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620667|NCT01072175|579990350|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620668|NCT01072175|579990351|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160663947|NCT03238781|580152438|FG001|Overall Study|Adverse Event|1|||
160663948|NCT03238781|580152439|FG002|Overall Study|Adverse Event|2|||
160511047|NCT01820585|579598652|FG000|Overall Study|Subject non-compliance|0|||
160511048|NCT01820585|579598653|FG001|Overall Study|Subject non-compliance|0|||
160511049|NCT01820585|579598654|FG002|Overall Study|Subject non-compliance|1|||
160620669|NCT01072175|579990352|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620670|NCT01072175|579990353|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620671|NCT01072175|579990354|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
160620672|NCT01072175|579990342|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
160511050|NCT01820585|579598655|FG003|Overall Study|Subject non-compliance|2|||
160511051|NCT01820585|579598652|FG000|Overall Study|at sponsor request|0|||
160511052|NCT01820585|579598653|FG001|Overall Study|at sponsor request|0|||
160511053|NCT01820585|579598654|FG002|Overall Study|at sponsor request|1|||
160511054|NCT01820585|579598655|FG003|Overall Study|at sponsor request|0|||
160511055|NCT01820585|579598652|FG000|Overall Study|Pregnancy|0|||
160511056|NCT01820585|579598653|FG001|Overall Study|Pregnancy|1|||
160511057|NCT01820585|579598654|FG002|Overall Study|Pregnancy|0|||
160511058|NCT01820585|579598655|FG003|Overall Study|Pregnancy|0|||
160511059|NCT03592745|579598658|FG000|Overall Study|Adverse Event|0|||
160511060|NCT03592745|579598659|FG001|Overall Study|Adverse Event|2|||
160511061|NCT03592745|579598658|FG000|Overall Study|Lost to Follow-up|2|||
160511062|NCT03592745|579598659|FG001|Overall Study|Lost to Follow-up|0|||
160511063|NCT03592745|579598658|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
160511064|NCT03592745|579598659|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
160663949|NCT03238781|580152437|FG000|Overall Study|Lost to Follow-up|2|||
160663950|NCT03238781|580152438|FG001|Overall Study|Lost to Follow-up|1|||
160663951|NCT03238781|580152439|FG002|Overall Study|Lost to Follow-up|2|||
160663952|NCT03238781|580152437|FG000|Overall Study|Withdrawal by Subject|23|||
160663953|NCT03238781|580152438|FG001|Overall Study|Withdrawal by Subject|14|||
160663954|NCT03238781|580152439|FG002|Overall Study|Withdrawal by Subject|16|||
160663955|NCT03238781|580152437|FG000|Overall Study|Decision by sponsor|0|||
160663956|NCT03238781|580152438|FG001|Overall Study|Decision by sponsor|1|||
160663957|NCT03238781|580152439|FG002|Overall Study|Decision by sponsor|0|||
160663958|NCT03161405|580152440|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
160663959|NCT01577381|580152441|FG000|Overall Study|Discontinued|2|||
160663960|NCT01577381|580152442|FG001|Overall Study|Discontinued|1|||
160663961|NCT01577381|580152443|FG002|Overall Study|Discontinued|2|||
160663962|NCT01577381|580152444|FG003|Overall Study|Discontinued|2|||
160663963|NCT01577381|580152441|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
160663964|NCT01577381|580152442|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
160663965|NCT01577381|580152443|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
160663966|NCT01577381|580152444|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
160663967|NCT01597245|580152445|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
160663968|NCT01597245|580152446|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
160663969|NCT01597245|580152447|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
160663970|NCT01597245|580152448|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
160663971|NCT01597245|580152449|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663972|NCT01597245|580152450|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663973|NCT01597245|580152451|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663974|NCT01597245|580152452|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663975|NCT01597245|580152453|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663976|NCT01597245|580152454|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663977|NCT01597245|580152455|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663978|NCT01597245|580152456|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663979|NCT01597245|580152457|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663980|NCT01597245|580152458|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663981|NCT01597245|580152459|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663982|NCT01597245|580152460|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663983|NCT01597245|580152461|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663984|NCT01597245|580152462|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663985|NCT01597245|580152463|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663986|NCT01597245|580152464|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663987|NCT01597245|580152465|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160663988|NCT01597245|580152445|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
160663989|NCT01597245|580152446|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
160511065|NCT02270515|579598660|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
160511066|NCT02270515|579598660|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
160511067|NCT02270515|579598660|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
160663990|NCT01597245|580152447|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
160663991|NCT01597245|580152448|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
160663992|NCT01597245|580152449|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160663993|NCT01597245|580152450|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160663994|NCT01597245|580152451|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160663995|NCT01597245|580152452|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160663996|NCT01597245|580152453|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160663997|NCT01597245|580152454|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160663998|NCT01597245|580152455|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160663999|NCT01597245|580152456|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160664000|NCT01597245|580152457|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160511068|NCT02270515|579598660|FG000|Intervention Period 1: 0-6 Months|Death|7|||
160511069|NCT02270515|579598660|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
160664001|NCT01597245|580152458|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160664002|NCT01597245|580152459|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160664003|NCT01597245|580152460|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160664004|NCT01597245|580152461|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160664005|NCT01597245|580152462|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160664006|NCT01597245|580152463|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160664007|NCT01597245|580152464|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160664008|NCT01597245|580152465|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160664009|NCT01597245|580152445|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
160664010|NCT01597245|580152446|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
160664011|NCT01597245|580152447|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
160664012|NCT01597245|580152448|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
160664013|NCT01597245|580152449|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664014|NCT01597245|580152450|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664015|NCT01597245|580152451|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664016|NCT01597245|580152452|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664017|NCT01597245|580152453|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664018|NCT01597245|580152454|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664019|NCT01597245|580152455|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664020|NCT01597245|580152456|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664021|NCT01597245|580152457|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664022|NCT01597245|580152458|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664023|NCT01597245|580152459|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664024|NCT01597245|580152460|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664025|NCT01597245|580152461|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664026|NCT01597245|580152462|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664027|NCT01597245|580152463|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664028|NCT01597245|580152464|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664029|NCT01597245|580152465|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160664030|NCT01597245|580152445|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
160664031|NCT01597245|580152446|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
160664032|NCT01597245|580152447|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
160664033|NCT01597245|580152448|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664034|NCT01597245|580152449|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664035|NCT01597245|580152450|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664036|NCT01597245|580152451|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664037|NCT01597245|580152452|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664038|NCT01597245|580152453|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664039|NCT01597245|580152454|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664040|NCT01597245|580152455|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664041|NCT01597245|580152456|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664042|NCT01597245|580152457|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664043|NCT01597245|580152458|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664044|NCT01597245|580152459|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664045|NCT01597245|580152460|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664046|NCT01597245|580152461|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664047|NCT01597245|580152462|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664048|NCT01597245|580152463|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664049|NCT01597245|580152464|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664050|NCT01597245|580152465|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
160664051|NCT01597245|580152445|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
160664052|NCT01597245|580152446|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664053|NCT01597245|580152447|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664054|NCT01597245|580152448|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
160664055|NCT01597245|580152449|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664056|NCT01597245|580152450|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664057|NCT01597245|580152451|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664058|NCT01597245|580152452|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664059|NCT01597245|580152453|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664060|NCT01597245|580152454|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664061|NCT01597245|580152455|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664062|NCT01597245|580152456|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664063|NCT01597245|580152457|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664064|NCT01597245|580152458|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160511070|NCT02270515|579598660|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
160511071|NCT02270515|579598660|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
160511072|NCT02270515|579598660|FG000|Intervention Period 2: 6-12 Months|Death|5|||
160511073|NCT02270515|579598660|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
160511074|NCT02270515|579598660|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
160511075|NCT02270515|579598660|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
160511076|NCT02270515|579598660|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
160511077|NCT02270515|579598660|FG000|Intervention Period 3: 12-18 Months|Death|3|||
160511078|NCT02270515|579598660|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
160511079|NCT00293059|579598661|FG000|Overall Study|Adverse Event|12|||
160511080|NCT00293059|579598662|FG001|Overall Study|Adverse Event|4|||
160511081|NCT00293059|579598661|FG000|Overall Study|Lack of Efficacy|2|||
160511082|NCT00293059|579598662|FG001|Overall Study|Lack of Efficacy|0|||
160511083|NCT00293059|579598661|FG000|Overall Study|Lost to Follow-up|2|||
160511084|NCT00293059|579598662|FG001|Overall Study|Lost to Follow-up|3|||
160511085|NCT00293059|579598661|FG000|Overall Study|Pregnancy|1|||
160511086|NCT00293059|579598662|FG001|Overall Study|Pregnancy|1|||
160511087|NCT00293059|579598661|FG000|Overall Study|Protocol Violation|2|||
160511088|NCT00293059|579598662|FG001|Overall Study|Protocol Violation|0|||
160511089|NCT00293059|579598661|FG000|Overall Study|Withdrawal by Subject|11|||
160511090|NCT00293059|579598662|FG001|Overall Study|Withdrawal by Subject|5|||
160511091|NCT00293059|579598661|FG000|Overall Study|Participant moved out of state|1|||
160511092|NCT00293059|579598662|FG001|Overall Study|Participant moved out of state|0|||
160511093|NCT00293059|579598661|FG000|Overall Study|Participant stopped study drug|1|||
160511094|NCT00293059|579598662|FG001|Overall Study|Participant stopped study drug|0|||
160511095|NCT00293059|579598661|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
160511096|NCT00293059|579598662|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
160511097|NCT00293059|579598661|FG000|Overall Study|missing|3|||
160511098|NCT00293059|579598662|FG001|Overall Study|missing|5|||
160511099|NCT04362189|579598665|FG000|Overall Study|Lost to Follow-up|0|||
160511100|NCT04362189|579598666|FG001|Overall Study|Lost to Follow-up|1|||
160511101|NCT04362189|579598665|FG000|Overall Study|Withdrawal by Subject|1|||
160511102|NCT04362189|579598666|FG001|Overall Study|Withdrawal by Subject|0|||
160511103|NCT04362189|579598665|FG000|Overall Study|FDA Clinical Hold|7|||
160511104|NCT04362189|579598666|FG001|Overall Study|FDA Clinical Hold|2|||
160511105|NCT04362189|579598665|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
160511106|NCT04362189|579598666|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
160511107|NCT04362189|579598665|FG000|Overall Study|Adverse Event|0|||
160511108|NCT04362189|579598666|FG001|Overall Study|Adverse Event|2|||
160511109|NCT04362189|579598665|FG000|Overall Study|Death|4|||
160511110|NCT04362189|579598666|FG001|Overall Study|Death|1|||
160511111|NCT02111681|579598667|FG000|Overall Study|Death|5|||
160511112|NCT02111681|579598667|FG000|Overall Study|Lack of Efficacy|2|||
160511113|NCT02111681|579598667|FG000|Overall Study|Progression of disease|4|||
160511114|NCT03695237|579600357|FG000|Overall Study|Withdrawal by Subject|1|||
160511115|NCT03695237|579600358|FG001|Overall Study|Withdrawal by Subject|3|||
160511116|NCT03695237|579600357|FG000|Overall Study|Lost to Follow-up|1|||
160511117|NCT03695237|579600358|FG001|Overall Study|Lost to Follow-up|2|||
160511118|NCT03695237|579600357|FG000|Overall Study|Other, Not Specified|8|||
160511119|NCT03695237|579600358|FG001|Overall Study|Other, Not Specified|2|||
160511120|NCT02217332|579600359|FG000|Overall Study|Adverse Event|3|||
160511121|NCT02217332|579600359|FG000|Overall Study|Dose interruption >1 month|1|||
160511122|NCT02217332|579600359|FG000|Overall Study|Protocol Violation (eligibility)|1|||
160620673|NCT01072175|579990343|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
160620674|NCT01072175|579990344|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
160620675|NCT01072175|579990345|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
160620676|NCT01072175|579990346|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
160620677|NCT01072175|579990347|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
160620678|NCT01072175|579990348|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
160620679|NCT01072175|579990349|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
160620680|NCT01072175|579990350|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
160620681|NCT01072175|579990351|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
160620682|NCT01072175|579990352|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
160620683|NCT01072175|579990353|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
160620684|NCT01072175|579990354|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
160620685|NCT01072175|579990342|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620686|NCT01072175|579990343|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620687|NCT01072175|579990344|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
160511123|NCT02217332|579600359|FG000|Overall Study|Withdrawal by Subject|1|||
160511124|NCT02217332|579600359|FG000|Overall Study|Lost to Follow-up|1|||
160511125|NCT01227577|579600366|FG000|Overall Study|Protocol deviation|3|||
160511126|NCT01227577|579600366|FG000|Overall Study|Death|3|||
160511127|NCT01227577|579600366|FG000|Overall Study|Administrative problems|2|||
160511128|NCT01227577|579600366|FG000|Overall Study|Lost to Follow-up|1|||
160511129|NCT01227577|579600366|FG000|Overall Study|Withdrawal by Subject|4|||
160664065|NCT01597245|580152459|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664066|NCT01597245|580152460|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664067|NCT01597245|580152461|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664068|NCT01597245|580152462|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664069|NCT01597245|580152463|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664070|NCT01597245|580152464|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664071|NCT01597245|580152465|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160664072|NCT01597245|580152445|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
160664073|NCT01597245|580152446|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
160664074|NCT01597245|580152447|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
160664075|NCT01597245|580152448|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664076|NCT01597245|580152449|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664077|NCT01597245|580152450|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664078|NCT01597245|580152451|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664079|NCT01597245|580152452|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664080|NCT01597245|580152453|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664081|NCT01597245|580152454|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664082|NCT01597245|580152455|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664083|NCT01597245|580152456|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664084|NCT01597245|580152457|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664085|NCT01597245|580152458|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664086|NCT01597245|580152459|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664087|NCT01597245|580152460|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664088|NCT01597245|580152461|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664089|NCT01597245|580152462|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664090|NCT01597245|580152463|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664091|NCT01597245|580152464|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664092|NCT01597245|580152465|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160664093|NCT01597245|580152445|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664094|NCT01597245|580152446|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664095|NCT01597245|580152447|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664096|NCT01597245|580152448|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664097|NCT01597245|580152449|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664098|NCT01597245|580152450|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
160664099|NCT01597245|580152451|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
160664100|NCT01597245|580152452|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664101|NCT01597245|580152453|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664102|NCT01597245|580152454|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664103|NCT01597245|580152455|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664104|NCT01597245|580152456|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664105|NCT01597245|580152457|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664106|NCT01597245|580152458|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664107|NCT01597245|580152459|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664108|NCT01597245|580152460|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664109|NCT01597245|580152461|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664110|NCT01597245|580152462|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664111|NCT01597245|580152463|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664112|NCT01597245|580152464|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664113|NCT01597245|580152465|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
160664114|NCT01597245|580152445|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664115|NCT01597245|580152446|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664116|NCT01597245|580152447|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160511130|NCT01227577|579600366|FG000|Overall Study|Lack of Efficacy|5|||
160511131|NCT01227577|579600366|FG000|Overall Study|Adverse Event|17|||
160511132|NCT03809429|579600367|FG000|Overall Study|Withdrawal by Subject|7|||
160664117|NCT01597245|580152448|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664118|NCT01597245|580152449|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
160664119|NCT01597245|580152450|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
160664120|NCT01597245|580152451|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
160664121|NCT01597245|580152452|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
160664122|NCT01597245|580152453|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664123|NCT01597245|580152454|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
160511133|NCT03809429|579600368|FG001|Overall Study|Withdrawal by Subject|3|||
160511134|NCT03809429|579600367|FG000|Overall Study|Adverse Event|6|||
160511135|NCT03809429|579600368|FG001|Overall Study|Adverse Event|9|||
160511136|NCT03809429|579600367|FG000|Overall Study|COVID-19|3|||
160664124|NCT01597245|580152455|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664125|NCT01597245|580152456|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664126|NCT01597245|580152457|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664127|NCT01597245|580152458|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664128|NCT01597245|580152459|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664129|NCT01597245|580152460|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664130|NCT01597245|580152461|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664131|NCT01597245|580152462|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664132|NCT01597245|580152463|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664133|NCT01597245|580152464|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664134|NCT01597245|580152465|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
160664135|NCT01597245|580152445|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664136|NCT01597245|580152446|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664137|NCT01597245|580152447|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664138|NCT01597245|580152448|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664139|NCT01597245|580152449|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664140|NCT01597245|580152450|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
160664141|NCT01597245|580152451|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664142|NCT01597245|580152452|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664143|NCT01597245|580152453|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
160664144|NCT01597245|580152454|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664145|NCT01597245|580152455|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
160664146|NCT01597245|580152456|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
160664147|NCT01597245|580152457|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
160664148|NCT01597245|580152458|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664149|NCT01597245|580152459|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664150|NCT01597245|580152460|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664151|NCT01597245|580152461|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664152|NCT01597245|580152462|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664153|NCT01597245|580152463|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664154|NCT01597245|580152464|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664155|NCT01597245|580152465|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160664156|NCT01597245|580152445|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664157|NCT01597245|580152446|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664158|NCT01597245|580152447|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664159|NCT01597245|580152448|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664160|NCT01597245|580152449|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
160664161|NCT01597245|580152450|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
160664162|NCT01597245|580152451|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
160664163|NCT01597245|580152452|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
160664164|NCT01597245|580152453|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
160664165|NCT01597245|580152454|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
160664166|NCT01597245|580152455|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
160664167|NCT01597245|580152456|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
160664168|NCT01597245|580152457|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
160664169|NCT01597245|580152458|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664170|NCT01597245|580152459|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664171|NCT01597245|580152460|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664172|NCT01597245|580152461|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664173|NCT01597245|580152462|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664174|NCT01597245|580152463|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664175|NCT01597245|580152464|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664176|NCT01597245|580152465|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160664177|NCT01597245|580152445|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664178|NCT01597245|580152446|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664179|NCT01597245|580152447|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664180|NCT01597245|580152448|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664181|NCT01597245|580152449|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
160664182|NCT01597245|580152450|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
160664183|NCT01597245|580152451|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
160664184|NCT01597245|580152452|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664185|NCT01597245|580152453|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
160664186|NCT01597245|580152454|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
160664187|NCT01597245|580152455|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
160664188|NCT01597245|580152456|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
160664189|NCT01597245|580152457|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
160664190|NCT01597245|580152458|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664191|NCT01597245|580152459|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664192|NCT01597245|580152460|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664193|NCT01597245|580152461|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664194|NCT01597245|580152462|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664195|NCT01597245|580152463|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664196|NCT01597245|580152464|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664197|NCT01597245|580152465|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160664198|NCT01597245|580152445|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664199|NCT01597245|580152446|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664200|NCT01597245|580152447|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664201|NCT01597245|580152448|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664202|NCT01597245|580152449|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
160664203|NCT01597245|580152450|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664204|NCT01597245|580152451|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664205|NCT01597245|580152452|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664206|NCT01597245|580152453|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
160664207|NCT01597245|580152454|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
160664208|NCT01597245|580152455|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
160664209|NCT01597245|580152456|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664210|NCT01597245|580152457|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
160664211|NCT01597245|580152458|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664212|NCT01597245|580152459|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664213|NCT01597245|580152460|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664214|NCT01597245|580152461|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664215|NCT01597245|580152462|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664216|NCT01597245|580152463|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664217|NCT01597245|580152464|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664218|NCT01597245|580152465|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160664219|NCT01597245|580152445|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664220|NCT01597245|580152446|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664221|NCT01597245|580152447|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664222|NCT01597245|580152448|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664223|NCT01597245|580152449|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
160664224|NCT01597245|580152450|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
160664225|NCT01597245|580152451|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
160664226|NCT01597245|580152452|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664227|NCT01597245|580152453|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
160664228|NCT01597245|580152454|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
160664229|NCT01597245|580152455|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
160664230|NCT01597245|580152456|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
160664231|NCT01597245|580152457|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
160664232|NCT01597245|580152458|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664233|NCT01597245|580152459|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664234|NCT01597245|580152460|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664235|NCT01597245|580152461|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664236|NCT01597245|580152462|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664237|NCT01597245|580152463|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664238|NCT01597245|580152464|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664239|NCT01597245|580152465|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160664240|NCT01597245|580152445|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664241|NCT01597245|580152446|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664242|NCT01597245|580152447|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664243|NCT01597245|580152448|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664244|NCT01597245|580152449|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160511137|NCT03809429|579600368|FG001|Overall Study|COVID-19|1|||
160511138|NCT03809429|579600367|FG000|Overall Study|Participant was discontinued by investigator|12|||
160664245|NCT01597245|580152450|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
160664246|NCT01597245|580152451|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160511139|NCT03809429|579600368|FG001|Overall Study|Participant was discontinued by investigator|7|||
160511140|NCT03828747|579600369|FG000|Double-Blind Treatment Period|Adverse Event|6|||
160511141|NCT03828747|579600370|FG001|Double-Blind Treatment Period|Adverse Event|6|||
160620688|NCT01072175|579990345|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620689|NCT01072175|579990346|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
160620690|NCT01072175|579990347|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620691|NCT01072175|579990348|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620692|NCT01072175|579990349|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620693|NCT01072175|579990350|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620694|NCT01072175|579990351|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620695|NCT01072175|579990352|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620696|NCT01072175|579990353|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620697|NCT01072175|579990354|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
160620698|NCT01072175|579990342|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
160620699|NCT01072175|579990343|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
160620700|NCT01072175|579990344|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
160620701|NCT01072175|579990345|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
160620702|NCT01072175|579990346|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
160620703|NCT01072175|579990347|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
160620704|NCT01072175|579990348|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
160620705|NCT01072175|579990349|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
160620706|NCT01072175|579990350|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
160620707|NCT01072175|579990351|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
160620708|NCT01072175|579990352|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
160620709|NCT01072175|579990353|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
160620710|NCT01072175|579990354|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
160620711|NCT01072175|579990342|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
160620712|NCT01072175|579990343|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
160620713|NCT01072175|579990344|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
160620714|NCT01072175|579990345|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
160620715|NCT01072175|579990346|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
160620716|NCT01072175|579990347|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
160620717|NCT01072175|579990348|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
160620718|NCT01072175|579990349|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
160620719|NCT01072175|579990350|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
160620720|NCT01072175|579990351|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
160620721|NCT01072175|579990352|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
160620722|NCT01072175|579990353|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
160620723|NCT01072175|579990354|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
160620724|NCT01072175|579990342|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
160620725|NCT01072175|579990343|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
160620726|NCT01072175|579990344|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
160620727|NCT01072175|579990345|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
160620728|NCT01072175|579990346|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
160620729|NCT01072175|579990347|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
160620730|NCT01072175|579990348|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
160620731|NCT01072175|579990349|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
160620732|NCT01072175|579990350|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
160620733|NCT01072175|579990351|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
160620734|NCT01072175|579990352|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
160620735|NCT01072175|579990353|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
160620736|NCT01072175|579990354|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
160620737|NCT01072175|579990342|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
160620738|NCT01072175|579990343|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
160620739|NCT01072175|579990344|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
160620740|NCT01072175|579990345|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
160620741|NCT01072175|579990346|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
160620742|NCT01072175|579990347|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
160664247|NCT01597245|580152452|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160511142|NCT03828747|579600369|FG000|Double-Blind Treatment Period|Death|1|||
160511143|NCT03828747|579600370|FG001|Double-Blind Treatment Period|Death|1|||
160511144|NCT03828747|579600369|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160511145|NCT03828747|579600370|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
160511146|NCT03828747|579600369|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
160511147|NCT03828747|579600370|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
160511148|NCT03828747|579600369|FG000|Double-Blind Treatment Period|Physician Decision|1|||
160511149|NCT03828747|579600370|FG001|Double-Blind Treatment Period|Physician Decision|4|||
160511150|NCT03828747|579600369|FG000|Double-Blind Treatment Period|Various reasons|5|||
160664248|NCT01597245|580152453|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
160664249|NCT01597245|580152454|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
160664250|NCT01597245|580152455|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
160664251|NCT01597245|580152456|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
160664252|NCT01597245|580152457|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664253|NCT01597245|580152458|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664254|NCT01597245|580152459|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664255|NCT01597245|580152460|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664256|NCT01597245|580152461|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664257|NCT01597245|580152462|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664258|NCT01597245|580152463|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664259|NCT01597245|580152464|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664260|NCT01597245|580152465|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
160664261|NCT01597245|580152445|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664262|NCT01597245|580152446|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664263|NCT01597245|580152447|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664264|NCT01597245|580152448|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664265|NCT01597245|580152449|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664266|NCT01597245|580152450|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664267|NCT01597245|580152451|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664268|NCT01597245|580152452|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664269|NCT01597245|580152453|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664270|NCT01597245|580152454|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664271|NCT01597245|580152455|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
160664272|NCT01597245|580152456|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664273|NCT01597245|580152457|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664274|NCT01597245|580152458|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664275|NCT01597245|580152459|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664276|NCT01597245|580152460|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664277|NCT01597245|580152461|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664278|NCT01597245|580152462|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664279|NCT01597245|580152463|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664280|NCT01597245|580152464|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664281|NCT01597245|580152465|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160664282|NCT01597245|580152445|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664283|NCT01597245|580152446|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664284|NCT01597245|580152447|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664285|NCT01597245|580152448|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664286|NCT01597245|580152449|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664287|NCT01597245|580152450|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664288|NCT01597245|580152451|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664289|NCT01597245|580152452|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664290|NCT01597245|580152453|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664291|NCT01597245|580152454|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664292|NCT01597245|580152455|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664293|NCT01597245|580152456|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664294|NCT01597245|580152457|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664295|NCT01597245|580152458|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
160664296|NCT01597245|580152459|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
160664297|NCT01597245|580152460|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
160664298|NCT01597245|580152461|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664299|NCT01597245|580152462|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664300|NCT01597245|580152463|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664301|NCT01597245|580152464|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664302|NCT01597245|580152465|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160664303|NCT01597245|580152445|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664304|NCT01597245|580152446|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664305|NCT01597245|580152447|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664306|NCT01597245|580152448|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664307|NCT01597245|580152449|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664308|NCT01597245|580152450|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664309|NCT01597245|580152451|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664310|NCT01597245|580152452|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664311|NCT01597245|580152453|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160511151|NCT03828747|579600370|FG001|Double-Blind Treatment Period|Various reasons|3|||
160511152|NCT03828747|579600369|FG000|Open-Label Extension|Adverse Event|9|||
160511153|NCT03828747|579600370|FG001|Open-Label Extension|Adverse Event|7|||
160511154|NCT03828747|579600369|FG000|Open-Label Extension|Death|0|||
160511155|NCT03828747|579600370|FG001|Open-Label Extension|Death|2|||
160511156|NCT03828747|579600369|FG000|Open-Label Extension|Lost to Follow-up|4|||
160511157|NCT03828747|579600370|FG001|Open-Label Extension|Lost to Follow-up|0|||
160511158|NCT03828747|579600369|FG000|Open-Label Extension|Withdrawal by Subject|31|||
160511159|NCT03828747|579600370|FG001|Open-Label Extension|Withdrawal by Subject|30|||
160511160|NCT03828747|579600369|FG000|Open-Label Extension|Various reasons|4|||
160511161|NCT03828747|579600370|FG001|Open-Label Extension|Various reasons|4|||
160511162|NCT03828747|579600369|FG000|Open-Label Extension|Physician Decision|6|||
160511163|NCT03828747|579600370|FG001|Open-Label Extension|Physician Decision|2|||
160511164|NCT01658150|579600371|FG000|Overall Study|Withdrawal by Subject|1|||
160511165|NCT04187989|579600372|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
160511166|NCT04187989|579600373|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
160511167|NCT04187989|579600372|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
160511168|NCT04187989|579600373|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
160511169|NCT03646656|579600374|FG000|Overall Study|Lost to Follow-up|1|||
160511170|NCT03646656|579600375|FG001|Overall Study|Lost to Follow-up|0|||
160511171|NCT03646656|579600374|FG000|Overall Study|Withdrawal by Subject|2|||
160511172|NCT03646656|579600375|FG001|Overall Study|Withdrawal by Subject|0|||
160511173|NCT02366468|579600379|FG000|Overall Study|Adverse Event|2|||
160511174|NCT02366468|579600380|FG001|Overall Study|Adverse Event|0|||
160511175|NCT02366468|579600379|FG000|Overall Study|Withdrawal by Subject|1|||
160511176|NCT02366468|579600380|FG001|Overall Study|Withdrawal by Subject|5|||
160511177|NCT02366468|579600379|FG000|Overall Study|Lost to Follow-up|2|||
160511178|NCT02366468|579600380|FG001|Overall Study|Lost to Follow-up|0|||
160511179|NCT02366468|579600379|FG000|Overall Study|Death|1|||
160511180|NCT02366468|579600380|FG001|Overall Study|Death|2|||
160511181|NCT02366468|579600379|FG000|Overall Study|Other|0|||
160511182|NCT02366468|579600380|FG001|Overall Study|Other|2|||
160511183|NCT00446043|579600381|FG000|Overall Study|Adverse Event|9|||
160511184|NCT00446043|579600381|FG000|Overall Study|Withdrawal by Subject|70|||
160511185|NCT00446043|579600381|FG000|Overall Study|Protocol Violation|2|||
160511186|NCT00446043|579600381|FG000|Overall Study|Lost to Follow-up|42|||
160511187|NCT00446043|579600381|FG000|Overall Study|Pregnancy|2|||
160511188|NCT05540717|579600382|FG000|Overall Study|Lost to Follow-up|2|||
160511189|NCT05540717|579600383|FG001|Overall Study|Lost to Follow-up|5|||
160511190|NCT05540717|579600382|FG000|Overall Study|Withdrawal by Subject|6|||
160511191|NCT05540717|579600383|FG001|Overall Study|Withdrawal by Subject|6|||
160511192|NCT05540717|579600382|FG000|Overall Study|Sponsor request|1|||
160511193|NCT05540717|579600383|FG001|Overall Study|Sponsor request|0|||
160511194|NCT05540717|579600382|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
160511195|NCT05540717|579600383|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
160511196|NCT05540717|579600382|FG000|Overall Study|Other|0|||
160511197|NCT05540717|579600383|FG001|Overall Study|Other|1|||
160511198|NCT01144052|579600384|FG000|Overall Study|Withdrawal by Subject|1|||
160511199|NCT01144052|579600385|FG001|Overall Study|Withdrawal by Subject|1|||
160511200|NCT03836716|579600389|FG000|Overall Study|Adverse Event|3|||
160511201|NCT03836716|579600389|FG000|Overall Study|Death|22|||
160511202|NCT03836716|579600389|FG000|Overall Study|Withdrawal by Subject|8|||
160511203|NCT03836716|579600389|FG000|Overall Study|Study terminated by sponsor|87|||
160511204|NCT01983254|579600390|FG000|Overall Study|Death|6|||
160511205|NCT01983254|579600391|FG001|Overall Study|Death|6|||
160511206|NCT01983254|579600390|FG000|Overall Study|Lost to Follow-up|17|||
160511207|NCT01983254|579600391|FG001|Overall Study|Lost to Follow-up|16|||
160511208|NCT01983254|579600390|FG000|Overall Study|too ill|11|||
160511209|NCT01983254|579600391|FG001|Overall Study|too ill|8|||
160511210|NCT01639560|579600392|FG000|Overall Study|Withdrawal by Subject|9|||
160511211|NCT01639560|579600393|FG001|Overall Study|Withdrawal by Subject|14|||
160511212|NCT01639560|579600392|FG000|Overall Study|Lack of Efficacy|1|||
160511213|NCT01639560|579600393|FG001|Overall Study|Lack of Efficacy|2|||
160511214|NCT01639560|579600392|FG000|Overall Study|Lost to Follow-up|9|||
160511215|NCT01639560|579600393|FG001|Overall Study|Lost to Follow-up|11|||
160620743|NCT01072175|579990348|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
160620744|NCT01072175|579990349|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
160511216|NCT01639560|579600392|FG000|Overall Study|Adverse Event|0|||
160511217|NCT01639560|579600393|FG001|Overall Study|Adverse Event|2|||
160511218|NCT00774930|579600395|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
160511219|NCT00774930|579600396|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
160511220|NCT00774930|579600395|FG000|DB Phase|Adverse Event|1|||
160511221|NCT00774930|579600396|FG001|DB Phase|Adverse Event|2|||
160511222|NCT00774930|579600395|FG000|DB Phase|Subject Decision|1|||
160511223|NCT00774930|579600396|FG001|DB Phase|Subject Decision|5|||
160511224|NCT00774930|579600395|FG000|DB Phase|Sponsor Decision|0|||
160511225|NCT00774930|579600396|FG001|DB Phase|Sponsor Decision|1|||
160620745|NCT01072175|579990350|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
160664312|NCT01597245|580152454|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664313|NCT01597245|580152455|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664314|NCT01597245|580152456|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664315|NCT01597245|580152457|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664316|NCT01597245|580152458|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
160664317|NCT01597245|580152459|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
160664318|NCT01597245|580152460|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
160664319|NCT01597245|580152461|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664320|NCT01597245|580152462|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664321|NCT01597245|580152463|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664322|NCT01597245|580152464|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664323|NCT01597245|580152465|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160664324|NCT01597245|580152445|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664325|NCT01597245|580152446|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664326|NCT01597245|580152447|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664327|NCT01597245|580152448|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664328|NCT01597245|580152449|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664329|NCT01597245|580152450|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664330|NCT01597245|580152451|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664331|NCT01597245|580152452|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664332|NCT01597245|580152453|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664333|NCT01597245|580152454|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664334|NCT01597245|580152455|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664335|NCT01597245|580152456|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664336|NCT01597245|580152457|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664337|NCT01597245|580152458|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664338|NCT01597245|580152459|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
160664339|NCT01597245|580152460|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
160664340|NCT01597245|580152461|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664341|NCT01597245|580152462|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664342|NCT01597245|580152463|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664343|NCT01597245|580152464|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664344|NCT01597245|580152465|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160664345|NCT01597245|580152445|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664346|NCT01597245|580152446|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664347|NCT01597245|580152447|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664348|NCT01597245|580152448|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664349|NCT01597245|580152449|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664350|NCT01597245|580152450|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664351|NCT01597245|580152451|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664352|NCT01597245|580152452|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664353|NCT01597245|580152453|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664354|NCT01597245|580152454|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664355|NCT01597245|580152455|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664356|NCT01597245|580152456|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664357|NCT01597245|580152457|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664358|NCT01597245|580152458|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664359|NCT01597245|580152459|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
160664360|NCT01597245|580152460|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
160664361|NCT01597245|580152461|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664362|NCT01597245|580152462|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664363|NCT01597245|580152463|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664364|NCT01597245|580152464|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664365|NCT01597245|580152465|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
160664366|NCT01597245|580152445|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664367|NCT01597245|580152446|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664368|NCT01597245|580152447|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664369|NCT01597245|580152448|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664370|NCT01597245|580152449|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664371|NCT01597245|580152450|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664372|NCT01597245|580152451|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664373|NCT01597245|580152452|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664374|NCT01597245|580152453|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160511226|NCT00774930|579600395|FG000|DB Phase|Disease Progression|1|||
160511227|NCT00774930|579600396|FG001|DB Phase|Disease Progression|1|||
160511228|NCT00774930|579600395|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
160511229|NCT00774930|579600396|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
160511230|NCT00774930|579600395|FG000|IOL Phase|Adverse Event|1|||
160511231|NCT00774930|579600396|FG001|IOL Phase|Adverse Event|1|||
160511232|NCT00774930|579600395|FG000|IOL Phase|Subject Decision|4|||
160511233|NCT00774930|579600396|FG001|IOL Phase|Subject Decision|3|||
160511234|NCT00774930|579600395|FG000|IOL Phase|Physician Decision|3|||
160511235|NCT00774930|579600396|FG001|IOL Phase|Physician Decision|2|||
160511236|NCT00774930|579600395|FG000|IOL Phase|Sponsor Decision|1|||
160511237|NCT00774930|579600396|FG001|IOL Phase|Sponsor Decision|0|||
160511238|NCT00774930|579600395|FG000|IOL Phase|Disease Progression|2|||
160511239|NCT00774930|579600396|FG001|IOL Phase|Disease Progression|1|||
160511240|NCT00774930|579600395|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
160511241|NCT00774930|579600396|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
160511242|NCT00774930|579600395|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
160511243|NCT00774930|579600396|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
160511244|NCT00774930|579600395|FG000|IOL Phase|Other|1|||
160511245|NCT00774930|579600396|FG001|IOL Phase|Other|0|||
160511246|NCT00774930|579600395|FG000|IOL Phase|Brain radiation|0|||
160511247|NCT00774930|579600396|FG001|IOL Phase|Brain radiation|1|||
160511248|NCT00774930|579600395|FG000|LTOLE Phase|Adverse Event|7|||
160511249|NCT00774930|579600396|FG001|LTOLE Phase|Adverse Event|3|||
160511250|NCT00774930|579600395|FG000|LTOLE Phase|Subject decision|0|||
160511251|NCT00774930|579600396|FG001|LTOLE Phase|Subject decision|5|||
160511252|NCT00774930|579600395|FG000|LTOLE Phase|Physician Decision|4|||
160511253|NCT00774930|579600396|FG001|LTOLE Phase|Physician Decision|1|||
160511254|NCT00774930|579600395|FG000|LTOLE Phase|Sponsor decision|2|||
160511255|NCT00774930|579600396|FG001|LTOLE Phase|Sponsor decision|1|||
160511256|NCT00774930|579600395|FG000|LTOLE Phase|Disease Progression|2|||
160511257|NCT00774930|579600396|FG001|LTOLE Phase|Disease Progression|5|||
160511258|NCT00774930|579600395|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
160511259|NCT00774930|579600396|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
160511260|NCT00774930|579600395|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
160511261|NCT00774930|579600396|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
160511262|NCT00766363|579600401|FG000|Overall Study|Withdrawal by Subject|1|||
160511263|NCT00766363|579600402|FG001|Overall Study|Withdrawal by Subject|0|||
160511264|NCT00766363|579600403|FG002|Overall Study|Withdrawal by Subject|0|||
160511265|NCT00766363|579600404|FG003|Overall Study|Withdrawal by Subject|0|||
160511266|NCT00766363|579600401|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
160511267|NCT00766363|579600402|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
160511268|NCT00766363|579600403|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
160511269|NCT00766363|579600404|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
160511270|NCT03020576|579600405|FG000|Overall Study|Withdrawal by Subject|1|||
160511271|NCT03020576|579600406|FG001|Overall Study|Withdrawal by Subject|2|||
160511272|NCT03292432|579600407|FG000|Overall Study|Lost to Follow-up|11|||
160511273|NCT03292432|579600408|FG001|Overall Study|Lost to Follow-up|8|||
160511274|NCT03292432|579600407|FG000|Overall Study|Death|2|||
160511275|NCT03292432|579600408|FG001|Overall Study|Death|1|||
160511276|NCT03292432|579600407|FG000|Overall Study|Withdrawal by Subject|1|||
160511277|NCT03292432|579600408|FG001|Overall Study|Withdrawal by Subject|2|||
160511278|NCT03292432|579600407|FG000|Overall Study|Site closed before any data collected|1|||
160511279|NCT03292432|579600408|FG001|Overall Study|Site closed before any data collected|0|||
160511280|NCT00911937|579600409|FG000|Overall Study|Death|1|||
160620746|NCT01072175|579990351|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
160620747|NCT01072175|579990352|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
160620748|NCT01072175|579990353|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
160620749|NCT01072175|579990354|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
160620750|NCT01072175|579990342|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
160620751|NCT01072175|579990343|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
160620752|NCT01072175|579990344|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
160620753|NCT01072175|579990345|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
160620754|NCT01072175|579990346|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
160620755|NCT01072175|579990347|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
160620756|NCT01072175|579990348|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
160620757|NCT01072175|579990349|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
160620758|NCT01072175|579990350|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
160620759|NCT01072175|579990351|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
160620760|NCT01072175|579990352|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
160620761|NCT01072175|579990353|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
160620762|NCT01072175|579990354|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
160620763|NCT01072175|579990342|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160620764|NCT01072175|579990343|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160511281|NCT00911937|579600410|FG001|Overall Study|Death|0|||
160511282|NCT00911937|579600409|FG000|Overall Study|Lost to Follow-up|8|||
160511283|NCT00911937|579600410|FG001|Overall Study|Lost to Follow-up|5|||
160511284|NCT00911937|579600409|FG000|Overall Study|Withdrawal by Subject|10|||
160511285|NCT00911937|579600410|FG001|Overall Study|Withdrawal by Subject|7|||
160511286|NCT00911937|579600409|FG000|Overall Study|Withdrawn due to pregnancy|1|||
160511287|NCT00911937|579600410|FG001|Overall Study|Withdrawn due to pregnancy|0|||
160511288|NCT00911937|579600409|FG000|Overall Study|Adverse Event|11|||
160511289|NCT00911937|579600410|FG001|Overall Study|Adverse Event|25|||
160511290|NCT00911937|579600409|FG000|Overall Study|Lack of Efficacy|11|||
160511291|NCT00911937|579600410|FG001|Overall Study|Lack of Efficacy|6|||
160511292|NCT00911937|579600409|FG000|Overall Study|Did not meet inclusion criteria|9|||
160511293|NCT00911937|579600410|FG001|Overall Study|Did not meet inclusion criteria|11|||
160511294|NCT00911937|579600409|FG000|Overall Study|Protocol Violation|14|||
160511295|NCT00911937|579600410|FG001|Overall Study|Protocol Violation|23|||
160511296|NCT00911937|579600409|FG000|Overall Study|Randomized but not treated|13|||
160511297|NCT00911937|579600410|FG001|Overall Study|Randomized but not treated|13|||
160511298|NCT00911937|579600409|FG000|Overall Study|Other|9|||
160511299|NCT00911937|579600410|FG001|Overall Study|Other|5|||
160511300|NCT01498679|579600411|FG000|Overall Study|Adverse Event|1|||
160511301|NCT01498679|579600412|FG001|Overall Study|Adverse Event|4|||
160511302|NCT01498679|579600411|FG000|Overall Study|Lack of Efficacy|72|||
160511303|NCT01498679|579600412|FG001|Overall Study|Lack of Efficacy|12|||
160511304|NCT01498679|579600411|FG000|Overall Study|Protocol Violation|4|||
160511305|NCT01498679|579600412|FG001|Overall Study|Protocol Violation|0|||
160511306|NCT01498679|579600411|FG000|Overall Study|Physician Decision|0|||
160511307|NCT01498679|579600412|FG001|Overall Study|Physician Decision|2|||
160511308|NCT01498679|579600411|FG000|Overall Study|Withdrawal by Subject|12|||
160511309|NCT01498679|579600412|FG001|Overall Study|Withdrawal by Subject|4|||
160511310|NCT00700427|579600413|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
160511311|NCT00700427|579600414|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
160511312|NCT00700427|579600415|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
160511313|NCT00700427|579600416|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
160511314|NCT00700427|579600417|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
160511315|NCT00700427|579600413|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
160511316|NCT00700427|579600414|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
160511317|NCT00700427|579600415|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
160511318|NCT00700427|579600416|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
160511319|NCT00700427|579600417|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
160511320|NCT00700427|579600413|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
160511321|NCT00700427|579600414|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
160511322|NCT00700427|579600415|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
160511323|NCT00700427|579600416|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
160511324|NCT00700427|579600417|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
160511325|NCT00700427|579600413|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
160511326|NCT00700427|579600414|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
160511327|NCT00700427|579600415|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
160511328|NCT00700427|579600416|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
160511329|NCT00700427|579600417|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
160511330|NCT00700427|579600413|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
160511331|NCT00700427|579600414|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
160511332|NCT00700427|579600415|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
160511333|NCT00700427|579600416|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
160511334|NCT00700427|579600417|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
160511335|NCT00700427|579600413|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
160511336|NCT00700427|579600414|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
160511337|NCT00700427|579600415|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
160511338|NCT00700427|579600416|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
160511339|NCT00700427|579600417|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
160511340|NCT00700427|579600413|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
160511341|NCT00700427|579600414|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
160511342|NCT00700427|579600415|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
160511343|NCT00700427|579600416|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
160511344|NCT00700427|579600417|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
160511345|NCT00700427|579600413|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
160511346|NCT00700427|579600414|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
160511347|NCT00700427|579600415|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
160511348|NCT00700427|579600416|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
160511349|NCT00700427|579600417|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
160664375|NCT01597245|580152454|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664376|NCT01597245|580152455|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664377|NCT01597245|580152456|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664378|NCT01597245|580152457|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664379|NCT01597245|580152458|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
160664380|NCT01597245|580152459|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
160664381|NCT01597245|580152460|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
160664382|NCT01597245|580152461|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664383|NCT01597245|580152462|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664384|NCT01597245|580152463|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664385|NCT01597245|580152464|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664386|NCT01597245|580152465|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160664387|NCT01597245|580152445|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664388|NCT01597245|580152446|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664389|NCT01597245|580152447|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664390|NCT01597245|580152448|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664391|NCT01597245|580152449|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664392|NCT01597245|580152450|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664393|NCT01597245|580152451|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664394|NCT01597245|580152452|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664395|NCT01597245|580152453|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664396|NCT01597245|580152454|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664397|NCT01597245|580152455|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664398|NCT01597245|580152456|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664399|NCT01597245|580152457|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664400|NCT01597245|580152458|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664401|NCT01597245|580152459|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
160664402|NCT01597245|580152460|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
160664403|NCT01597245|580152461|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664404|NCT01597245|580152462|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664405|NCT01597245|580152463|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
160511350|NCT00700427|579600413|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
160511351|NCT00700427|579600414|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
160511352|NCT00700427|579600415|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
160511353|NCT00700427|579600416|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
160511354|NCT00700427|579600417|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
160511355|NCT00700427|579600413|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
160511356|NCT00700427|579600414|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
160511357|NCT00700427|579600415|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
160511358|NCT00700427|579600416|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
160511359|NCT00700427|579600417|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
160511360|NCT00700427|579600413|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
160511361|NCT00700427|579600414|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
160511362|NCT00700427|579600415|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
160511363|NCT00700427|579600416|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
160511364|NCT00700427|579600417|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
160511365|NCT00700427|579600413|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
160511366|NCT00700427|579600414|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
160511367|NCT00700427|579600415|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
160511368|NCT00700427|579600416|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
160511369|NCT00700427|579600417|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
160511370|NCT00700427|579600413|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
160511371|NCT00700427|579600414|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
160511372|NCT00700427|579600415|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
160511373|NCT00700427|579600416|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
160511374|NCT00700427|579600417|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
160511375|NCT00700427|579600413|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
160511376|NCT00700427|579600414|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
160664406|NCT01597245|580152464|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664407|NCT01597245|580152465|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
160664408|NCT01597245|580152445|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664409|NCT01597245|580152446|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664410|NCT01597245|580152447|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664411|NCT01597245|580152448|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160511377|NCT00700427|579600415|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
160511378|NCT00700427|579600416|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
160511379|NCT00700427|579600417|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
160511380|NCT00700427|579600413|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
160511381|NCT00700427|579600414|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
160511382|NCT00700427|579600415|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
160511383|NCT00700427|579600416|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
160511384|NCT00700427|579600417|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
160511385|NCT00700427|579600413|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
160511386|NCT00700427|579600414|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
160511387|NCT00700427|579600415|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
160511388|NCT00700427|579600416|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
160511389|NCT00700427|579600417|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
160511390|NCT00700427|579600413|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
160511391|NCT00700427|579600414|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
160511392|NCT00700427|579600415|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
160511393|NCT00700427|579600416|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
160511394|NCT00700427|579600417|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
160511395|NCT00700427|579600413|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
160511396|NCT00700427|579600414|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
160511397|NCT00700427|579600415|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
160511398|NCT00700427|579600416|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
160511399|NCT00700427|579600417|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
160511400|NCT00700427|579600413|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
160511401|NCT00700427|579600414|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
160511402|NCT00700427|579600415|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
160511403|NCT00700427|579600416|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
160511404|NCT00700427|579600417|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
160511405|NCT00700427|579600413|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
160511406|NCT00700427|579600414|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
160511407|NCT00700427|579600415|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
160511408|NCT00700427|579600416|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
160511409|NCT00700427|579600417|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
160511410|NCT00700427|579600413|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
160511411|NCT00700427|579600414|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
160511412|NCT00700427|579600415|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
160511413|NCT00700427|579600416|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
160511414|NCT00700427|579600417|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
160511415|NCT00700427|579600413|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
160511416|NCT00700427|579600414|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
160620765|NCT01072175|579990344|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160620766|NCT01072175|579990345|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160620767|NCT01072175|579990346|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160620768|NCT01072175|579990347|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160620769|NCT01072175|579990348|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
160620770|NCT01072175|579990349|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
160620771|NCT01072175|579990350|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160620772|NCT01072175|579990351|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160620773|NCT01072175|579990352|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160620774|NCT01072175|579990353|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160620775|NCT01072175|579990354|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
160620776|NCT01072175|579990342|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
160620777|NCT01072175|579990343|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
160620778|NCT01072175|579990344|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
160620779|NCT01072175|579990345|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
160620780|NCT01072175|579990346|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
160620781|NCT01072175|579990347|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
160620782|NCT01072175|579990348|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
160620783|NCT01072175|579990349|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
160511417|NCT00700427|579600415|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
160511418|NCT00700427|579600416|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
160511419|NCT00700427|579600417|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
160511420|NCT00700427|579600413|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
160620784|NCT01072175|579990350|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
160511421|NCT00700427|579600414|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
160511422|NCT00700427|579600415|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
160511423|NCT00700427|579600416|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
160511424|NCT00700427|579600417|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
160511425|NCT00700427|579600413|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
160511426|NCT00700427|579600414|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
160511427|NCT00700427|579600415|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
160511428|NCT00700427|579600416|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
160511429|NCT00700427|579600417|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
160620785|NCT01072175|579990351|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
160620786|NCT01072175|579990352|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
160620787|NCT01072175|579990353|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
160620788|NCT01072175|579990354|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
160620789|NCT01072175|579990342|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620790|NCT01072175|579990343|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620791|NCT01072175|579990344|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620792|NCT01072175|579990345|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620793|NCT01072175|579990346|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620794|NCT01072175|579990347|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
160620795|NCT01072175|579990348|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
160620796|NCT01072175|579990349|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620797|NCT01072175|579990350|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620798|NCT01072175|579990351|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620799|NCT01072175|579990352|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620800|NCT01072175|579990353|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620801|NCT01072175|579990354|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
160620802|NCT01072175|579990342|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620803|NCT01072175|579990343|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620804|NCT01072175|579990344|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620805|NCT01072175|579990345|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620806|NCT01072175|579990346|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620807|NCT01072175|579990347|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620808|NCT01072175|579990348|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620809|NCT01072175|579990349|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620810|NCT01072175|579990350|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
160620811|NCT01072175|579990351|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620812|NCT01072175|579990352|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620813|NCT01072175|579990353|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620814|NCT01072175|579990354|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
160620815|NCT01072175|579990342|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620816|NCT01072175|579990343|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620817|NCT01072175|579990344|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620818|NCT01072175|579990345|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620819|NCT01072175|579990346|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620820|NCT01072175|579990347|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620821|NCT01072175|579990348|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620822|NCT01072175|579990349|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620823|NCT01072175|579990350|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
160620824|NCT01072175|579990351|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620825|NCT01072175|579990352|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620826|NCT01072175|579990353|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620827|NCT01072175|579990354|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
160620828|NCT01072175|579990342|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620829|NCT01072175|579990343|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620830|NCT01072175|579990344|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620831|NCT01072175|579990345|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620832|NCT01072175|579990346|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620833|NCT01072175|579990347|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620834|NCT01072175|579990348|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620835|NCT01072175|579990349|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620836|NCT01072175|579990350|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
160620837|NCT01072175|579990351|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160664412|NCT01597245|580152449|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160511430|NCT00700427|579600413|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
160511431|NCT00700427|579600414|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
160511432|NCT00700427|579600415|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
160511433|NCT00700427|579600416|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
160511434|NCT00700427|579600417|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
160511435|NCT00700427|579600413|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
160511436|NCT00700427|579600414|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
160511437|NCT00700427|579600415|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
160511438|NCT00700427|579600416|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
160511439|NCT00700427|579600417|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
160511440|NCT00700427|579600413|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
160511441|NCT00700427|579600414|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
160511442|NCT00700427|579600415|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
160511443|NCT00700427|579600416|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
160511444|NCT00700427|579600417|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
160511445|NCT00700427|579600413|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
160511446|NCT00700427|579600414|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
160511447|NCT00700427|579600415|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
160511448|NCT00700427|579600416|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
160511449|NCT00700427|579600417|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
160511450|NCT00700427|579600413|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
160511451|NCT00700427|579600414|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
160511452|NCT00700427|579600415|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
160511453|NCT00700427|579600416|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
160511454|NCT00700427|579600417|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
160511455|NCT00700427|579600413|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
160511456|NCT00700427|579600414|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
160511457|NCT00700427|579600415|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
160511458|NCT00700427|579600416|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
160511459|NCT00700427|579600417|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
160511460|NCT00700427|579600413|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
160511461|NCT00700427|579600414|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
160511462|NCT00700427|579600415|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
160511463|NCT00700427|579600416|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
160511464|NCT00700427|579600417|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
160511465|NCT00700427|579600413|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
160511466|NCT00700427|579600414|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
160511467|NCT00700427|579600415|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
160511468|NCT00700427|579600416|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
160511469|NCT00700427|579600417|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
160511470|NCT00700427|579600413|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
160511471|NCT00700427|579600414|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
160511472|NCT00700427|579600415|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
160511473|NCT00700427|579600416|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
160511474|NCT00700427|579600417|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
160511475|NCT00700427|579600413|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
160511476|NCT00700427|579600414|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
160511477|NCT00700427|579600415|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
160511478|NCT00700427|579600416|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
160511479|NCT00700427|579600417|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
160511480|NCT00700427|579600413|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
160511481|NCT00700427|579600414|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
160511482|NCT00700427|579600415|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
160511483|NCT00700427|579600416|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
160511484|NCT00700427|579600417|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
160511485|NCT00700427|579600413|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
160511486|NCT00700427|579600414|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
160511487|NCT00700427|579600415|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
160511488|NCT00700427|579600416|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
160511489|NCT00700427|579600417|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
160511490|NCT00700427|579600413|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
160511491|NCT00700427|579600414|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
160511492|NCT00700427|579600415|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
160511493|NCT00700427|579600416|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
160511494|NCT00700427|579600417|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
160511495|NCT00700427|579600413|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
160664413|NCT01597245|580152450|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664414|NCT01597245|580152451|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664415|NCT01597245|580152452|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664416|NCT01597245|580152453|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664417|NCT01597245|580152454|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664418|NCT01597245|580152455|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664419|NCT01597245|580152456|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664420|NCT01597245|580152457|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664421|NCT01597245|580152458|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664422|NCT01597245|580152459|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
160664423|NCT01597245|580152460|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
160664424|NCT01597245|580152461|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664425|NCT01597245|580152462|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664426|NCT01597245|580152463|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664427|NCT01597245|580152464|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664428|NCT01597245|580152465|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
160664429|NCT01597245|580152445|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664430|NCT01597245|580152446|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664431|NCT01597245|580152447|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664432|NCT01597245|580152448|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664433|NCT01597245|580152449|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664434|NCT01597245|580152450|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664435|NCT01597245|580152451|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664436|NCT01597245|580152452|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664437|NCT01597245|580152453|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664438|NCT01597245|580152454|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664439|NCT01597245|580152455|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664440|NCT01597245|580152456|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664441|NCT01597245|580152457|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664442|NCT01597245|580152458|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664443|NCT01597245|580152459|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
160664444|NCT01597245|580152460|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
160664445|NCT01597245|580152461|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664446|NCT01597245|580152462|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664447|NCT01597245|580152463|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664448|NCT01597245|580152464|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664449|NCT01597245|580152465|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160664450|NCT01597245|580152445|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664451|NCT01597245|580152446|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664452|NCT01597245|580152447|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664453|NCT01597245|580152448|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664454|NCT01597245|580152449|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664455|NCT01597245|580152450|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664456|NCT01597245|580152451|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664457|NCT01597245|580152452|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664458|NCT01597245|580152453|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664459|NCT01597245|580152454|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664460|NCT01597245|580152455|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664461|NCT01597245|580152456|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664462|NCT01597245|580152457|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664463|NCT01597245|580152458|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664464|NCT01597245|580152459|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
160664465|NCT01597245|580152460|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
160664466|NCT01597245|580152461|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664467|NCT01597245|580152462|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664468|NCT01597245|580152463|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664469|NCT01597245|580152464|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664470|NCT01597245|580152465|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160664471|NCT01597245|580152445|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664472|NCT01597245|580152446|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664473|NCT01597245|580152447|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664474|NCT01597245|580152448|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664475|NCT01597245|580152449|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664476|NCT01597245|580152450|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664477|NCT01597245|580152451|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664478|NCT01597245|580152452|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664479|NCT01597245|580152453|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664480|NCT01597245|580152454|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664481|NCT01597245|580152455|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664482|NCT01597245|580152456|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664483|NCT01597245|580152457|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664484|NCT01597245|580152458|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
160664485|NCT01597245|580152459|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664486|NCT01597245|580152460|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664487|NCT01597245|580152461|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664488|NCT01597245|580152462|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664489|NCT01597245|580152463|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664490|NCT01597245|580152464|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664491|NCT01597245|580152465|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
160664492|NCT01597245|580152445|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664493|NCT01597245|580152446|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664494|NCT01597245|580152447|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664495|NCT01597245|580152448|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664496|NCT01597245|580152449|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664497|NCT01597245|580152450|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664498|NCT01597245|580152451|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664499|NCT01597245|580152452|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664500|NCT01597245|580152453|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160511496|NCT00700427|579600414|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
160511497|NCT00700427|579600415|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
160511498|NCT00700427|579600416|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
160664501|NCT01597245|580152454|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664502|NCT01597245|580152455|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664503|NCT01597245|580152456|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664504|NCT01597245|580152457|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664505|NCT01597245|580152458|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664506|NCT01597245|580152459|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664507|NCT01597245|580152460|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
160664508|NCT01597245|580152461|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
160664509|NCT01597245|580152462|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
160664510|NCT01597245|580152463|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
160664511|NCT01597245|580152464|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
160664512|NCT01597245|580152465|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
160664513|NCT01597245|580152445|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664514|NCT01597245|580152446|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664515|NCT01597245|580152447|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664516|NCT01597245|580152448|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664517|NCT01597245|580152449|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664518|NCT01597245|580152450|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664519|NCT01597245|580152451|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664520|NCT01597245|580152452|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664521|NCT01597245|580152453|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664522|NCT01597245|580152454|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664523|NCT01597245|580152455|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664524|NCT01597245|580152456|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664525|NCT01597245|580152457|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664526|NCT01597245|580152458|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664527|NCT01597245|580152459|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664528|NCT01597245|580152460|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160664529|NCT01597245|580152461|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160511499|NCT00700427|579600417|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
160664530|NCT01597245|580152462|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
160664531|NCT01597245|580152463|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
160664532|NCT01597245|580152464|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
160511500|NCT00424385|579600421|FG000|Cohort 0|Withdrawal by Subject|5|||
160511501|NCT00424385|579600421|FG000|Cohort 0|Physician Decision|1|||
160511502|NCT00424385|579600421|FG000|Cohort 1|Withdrawal by Subject|1|||
160511503|NCT02057523|579600422|FG000|Overall Study|Withdrawal by Subject|1|||
160511504|NCT02057523|579600422|FG000|Overall Study|Lack of Efficacy|1|||
160511505|NCT00964886|579600423|FG000|Overall Study|Lost to Follow-up|2|||
160511506|NCT00964886|579600424|FG001|Overall Study|Lost to Follow-up|2|||
160511507|NCT00964886|579600425|FG002|Overall Study|Lost to Follow-up|6|||
160511508|NCT00964886|579600426|FG003|Overall Study|Lost to Follow-up|4|||
160511509|NCT00964886|579600423|FG000|Overall Study|Withdrawal by Subject|6|||
160511510|NCT00964886|579600424|FG001|Overall Study|Withdrawal by Subject|2|||
160511511|NCT00964886|579600425|FG002|Overall Study|Withdrawal by Subject|5|||
160511512|NCT00964886|579600426|FG003|Overall Study|Withdrawal by Subject|3|||
160511513|NCT00964886|579600423|FG000|Overall Study|Adverse Event|3|||
160511514|NCT00964886|579600424|FG001|Overall Study|Adverse Event|1|||
160511515|NCT00964886|579600425|FG002|Overall Study|Adverse Event|5|||
160511516|NCT00964886|579600426|FG003|Overall Study|Adverse Event|2|||
160511517|NCT00964886|579600423|FG000|Overall Study|Protocol Violation|0|||
160511518|NCT00964886|579600424|FG001|Overall Study|Protocol Violation|2|||
160511519|NCT00964886|579600425|FG002|Overall Study|Protocol Violation|0|||
160511520|NCT00964886|579600426|FG003|Overall Study|Protocol Violation|0|||
160511521|NCT00929110|579600427|FG000|Overall Study|Adverse Event|40|||
160511522|NCT00929110|579600428|FG001|Overall Study|Adverse Event|29|||
160511523|NCT00929110|579600429|FG002|Overall Study|Adverse Event|18|||
160511524|NCT00929110|579600427|FG000|Overall Study|Subject withdrew consent|40|||
160511525|NCT00929110|579600428|FG001|Overall Study|Subject withdrew consent|23|||
160511526|NCT00929110|579600429|FG002|Overall Study|Subject withdrew consent|26|||
160511527|NCT00929110|579600427|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
160511528|NCT00929110|579600428|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
160511529|NCT00929110|579600429|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
160511530|NCT00929110|579600427|FG000|Overall Study|Lost to Follow-up|7|||
160511531|NCT00929110|579600428|FG001|Overall Study|Lost to Follow-up|7|||
160511532|NCT00929110|579600429|FG002|Overall Study|Lost to Follow-up|3|||
160511533|NCT00929110|579600427|FG000|Overall Study|Protocol deviation|5|||
160511534|NCT00929110|579600428|FG001|Overall Study|Protocol deviation|2|||
160511535|NCT00929110|579600429|FG002|Overall Study|Protocol deviation|4|||
160511536|NCT00929110|579600427|FG000|Overall Study|Administrative problems|4|||
160511537|NCT00929110|579600428|FG001|Overall Study|Administrative problems|1|||
160511538|NCT00929110|579600429|FG002|Overall Study|Administrative problems|2|||
160511539|NCT00929110|579600427|FG000|Overall Study|Death|2|||
160511540|NCT00929110|579600428|FG001|Overall Study|Death|2|||
160511541|NCT00929110|579600429|FG002|Overall Study|Death|2|||
160511542|NCT00929110|579600427|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160511543|NCT00929110|579600428|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160511544|NCT00929110|579600429|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160511545|NCT00929110|579600427|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160511546|NCT00929110|579600428|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160511547|NCT00929110|579600429|FG002|Overall Study|Abnormal test procedure result(s)|1|||
160511548|NCT00929110|579600427|FG000|Overall Study|Patient inability to use the device|0|||
160511549|NCT00929110|579600428|FG001|Overall Study|Patient inability to use the device|1|||
160511550|NCT00929110|579600429|FG002|Overall Study|Patient inability to use the device|0|||
160511551|NCT01012414|579600430|FG000|Overall Study|Withdrawal by Subject|2|||
160511552|NCT01012414|579600430|FG000|Overall Study|Lost to Follow-up|1|||
160511553|NCT01012414|579600430|FG000|Overall Study|Trial was stopped before completed|7|||
160511554|NCT00291642|579600435|FG000|Overall Study|Adverse Event|1|||
160511555|NCT00291642|579600436|FG001|Overall Study|Adverse Event|0|||
160511556|NCT00291642|579600437|FG002|Overall Study|Adverse Event|1|||
160511557|NCT00291642|579600438|FG003|Overall Study|Adverse Event|0|||
160511558|NCT00291642|579600439|FG004|Overall Study|Adverse Event|1|||
160511559|NCT00291642|579600435|FG000|Overall Study|Patient missed visit|0|||
160511560|NCT00291642|579600436|FG001|Overall Study|Patient missed visit|0|||
160511561|NCT00291642|579600437|FG002|Overall Study|Patient missed visit|1|||
160511562|NCT00291642|579600438|FG003|Overall Study|Patient missed visit|0|||
160511563|NCT00291642|579600439|FG004|Overall Study|Patient missed visit|0|||
160511564|NCT00291642|579600435|FG000|Overall Study|Intake of prohibited medication|1|||
160511565|NCT00291642|579600436|FG001|Overall Study|Intake of prohibited medication|0|||
160511566|NCT00291642|579600437|FG002|Overall Study|Intake of prohibited medication|0|||
160511567|NCT00291642|579600438|FG003|Overall Study|Intake of prohibited medication|0|||
160511568|NCT00291642|579600439|FG004|Overall Study|Intake of prohibited medication|0|||
160511569|NCT03590366|579600445|FG000|Overall Study|Adverse Event|0|||
160511570|NCT03590366|579600446|FG001|Overall Study|Adverse Event|3|||
160511571|NCT03590366|579600445|FG000|Overall Study|Lost to Follow-up|3|||
160511572|NCT03590366|579600446|FG001|Overall Study|Lost to Follow-up|3|||
160511573|NCT03590366|579600445|FG000|Overall Study|Withdrawal by Subject|0|||
160511574|NCT03590366|579600446|FG001|Overall Study|Withdrawal by Subject|2|||
160511575|NCT00738894|579600447|FG000|Overall Study|Lost to Follow-up|23|||
160511576|NCT00738894|579600448|FG001|Overall Study|Lost to Follow-up|13|||
160511577|NCT00738894|579600447|FG000|Overall Study|Withdrawal by Subject|10|||
160511578|NCT00738894|579600448|FG001|Overall Study|Withdrawal by Subject|15|||
160511579|NCT00738894|579600447|FG000|Overall Study|Physician Decision|4|||
160664533|NCT01597245|580152465|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
160664534|NCT01597245|580152445|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664535|NCT01597245|580152446|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664536|NCT01597245|580152447|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664537|NCT01597245|580152448|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664538|NCT01597245|580152449|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664539|NCT01597245|580152450|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664540|NCT01597245|580152451|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664541|NCT01597245|580152452|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664542|NCT01597245|580152453|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664543|NCT01597245|580152454|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664544|NCT01597245|580152455|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664545|NCT01597245|580152456|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664546|NCT01597245|580152457|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664547|NCT01597245|580152458|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664548|NCT01597245|580152459|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664549|NCT01597245|580152460|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664550|NCT01597245|580152461|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
160511580|NCT00738894|579600448|FG001|Overall Study|Physician Decision|5|||
160511581|NCT00738894|579600447|FG000|Overall Study|Death|2|||
160511582|NCT00738894|579600448|FG001|Overall Study|Death|0|||
160511583|NCT05017103|579600449|FG000|Overall Study|Death|2|||
160511584|NCT02656329|579600450|FG000|Overall Study|Lost to Follow-up|2|||
160511585|NCT02656329|579600451|FG001|Overall Study|Lost to Follow-up|3|||
160511586|NCT02656329|579600450|FG000|Overall Study|Withdrawal by Subject|7|||
160511587|NCT02656329|579600451|FG001|Overall Study|Withdrawal by Subject|6|||
160511588|NCT02656329|579600450|FG000|Overall Study|Study termination by Sponsor|150|||
160511589|NCT02656329|579600451|FG001|Overall Study|Study termination by Sponsor|142|||
160511590|NCT02656329|579600450|FG000|Overall Study|Other than specified above|5|||
160511591|NCT02656329|579600451|FG001|Overall Study|Other than specified above|6|||
160511592|NCT01081665|579600453|FG000|Overall Study|Death|41|||
160511593|NCT01081665|579600453|FG000|Overall Study|Lost to Follow-up|18|||
160511594|NCT01081665|579600453|FG000|Overall Study|Withdrawal by Subject|17|||
160511595|NCT01081665|579600453|FG000|Overall Study|Change of dialysis unit|10|||
160511596|NCT01081665|579600453|FG000|Overall Study|Regulation of iPTH|5|||
160511597|NCT01081665|579600453|FG000|Overall Study|Change in renal replacement therapy|2|||
160511598|NCT01081665|579600453|FG000|Overall Study|Adverse Event|1|||
160511599|NCT01081665|579600453|FG000|Overall Study|Lack of Efficacy|1|||
160511600|NCT01413503|579600466|FG000|Overall Study|Lost to Follow-up|1|||
160511601|NCT02546921|579600467|FG000|Overall Study|Adverse Event|0|||
160511602|NCT02546921|579600468|FG001|Overall Study|Adverse Event|5|||
160620838|NCT01072175|579990352|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620839|NCT01072175|579990353|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620840|NCT01072175|579990354|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
160620841|NCT01072175|579990342|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620842|NCT01072175|579990343|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620843|NCT01072175|579990344|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620844|NCT01072175|579990345|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620845|NCT01072175|579990346|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620846|NCT01072175|579990347|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620847|NCT01072175|579990348|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620848|NCT01072175|579990349|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620849|NCT01072175|579990350|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
160620850|NCT01072175|579990351|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620851|NCT01072175|579990352|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620852|NCT01072175|579990353|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620853|NCT01072175|579990354|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
160620854|NCT01072175|579990342|FG000|Part D (HPMC Capsules)|Death|0|||
160620855|NCT01072175|579990343|FG001|Part D (HPMC Capsules)|Death|0|||
160620856|NCT01072175|579990344|FG002|Part D (HPMC Capsules)|Death|0|||
160620857|NCT01072175|579990345|FG003|Part D (HPMC Capsules)|Death|0|||
160664551|NCT01597245|580152462|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160664552|NCT01597245|580152463|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160511603|NCT02546921|579600469|FG002|Overall Study|Adverse Event|2|||
160511604|NCT02546921|579600470|FG003|Overall Study|Adverse Event|0|||
160511605|NCT02546921|579600471|FG004|Overall Study|Adverse Event|0|||
160511606|NCT02546921|579600472|FG005|Overall Study|Adverse Event|0|||
160511607|NCT02546921|579600473|FG006|Overall Study|Adverse Event|0|||
160511608|NCT02546921|579600467|FG000|Overall Study|Evidence of Disease Progression|1|||
160620858|NCT01072175|579990346|FG004|Part D (HPMC Capsules)|Death|0|||
160664553|NCT01597245|580152464|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
160664554|NCT01597245|580152465|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
160664555|NCT01597245|580152445|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664556|NCT01597245|580152446|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664557|NCT01597245|580152447|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664558|NCT01597245|580152448|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664559|NCT01597245|580152449|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664560|NCT01597245|580152450|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664561|NCT01597245|580152451|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664562|NCT01597245|580152452|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664563|NCT01597245|580152453|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664564|NCT01597245|580152454|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664565|NCT01597245|580152455|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664566|NCT01597245|580152456|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664567|NCT01597245|580152457|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664568|NCT01597245|580152458|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664569|NCT01597245|580152459|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664570|NCT01597245|580152460|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664571|NCT01597245|580152461|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664572|NCT01597245|580152462|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
160664573|NCT01597245|580152463|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
160664574|NCT01597245|580152464|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
160664575|NCT01597245|580152465|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
160664576|NCT01597245|580152445|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664577|NCT01597245|580152446|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664578|NCT01597245|580152447|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160511609|NCT02546921|579600468|FG001|Overall Study|Evidence of Disease Progression|0|||
160511610|NCT02546921|579600469|FG002|Overall Study|Evidence of Disease Progression|0|||
160511611|NCT02546921|579600470|FG003|Overall Study|Evidence of Disease Progression|0|||
160511612|NCT02546921|579600471|FG004|Overall Study|Evidence of Disease Progression|1|||
160511613|NCT02546921|579600472|FG005|Overall Study|Evidence of Disease Progression|0|||
160511614|NCT02546921|579600473|FG006|Overall Study|Evidence of Disease Progression|0|||
160511615|NCT02546921|579600467|FG000|Overall Study|Patient Choice|0|||
160511616|NCT02546921|579600468|FG001|Overall Study|Patient Choice|1|||
160511617|NCT02546921|579600469|FG002|Overall Study|Patient Choice|0|||
160511618|NCT02546921|579600470|FG003|Overall Study|Patient Choice|0|||
160511619|NCT02546921|579600471|FG004|Overall Study|Patient Choice|0|||
160511620|NCT02546921|579600472|FG005|Overall Study|Patient Choice|1|||
160511621|NCT02546921|579600473|FG006|Overall Study|Patient Choice|0|||
160511622|NCT01373151|579600474|FG000|Period 1|Lack of Efficacy|3|||
160511623|NCT01373151|579600475|FG001|Period 1|Lack of Efficacy|0|||
160511624|NCT01373151|579600476|FG002|Period 1|Lack of Efficacy|0|||
160511625|NCT01373151|579600477|FG003|Period 1|Lack of Efficacy|0|||
160511626|NCT01373151|579600478|FG004|Period 1|Lack of Efficacy|1|||
160511627|NCT01373151|579600479|FG005|Period 1|Lack of Efficacy|0|||
160511628|NCT01373151|579600480|FG006|Period 1|Lack of Efficacy|0|||
160511629|NCT01373151|579600474|FG000|Period 1|Adverse Event|0|||
160511630|NCT01373151|579600475|FG001|Period 1|Adverse Event|0|||
160511631|NCT01373151|579600476|FG002|Period 1|Adverse Event|1|||
160511632|NCT01373151|579600477|FG003|Period 1|Adverse Event|0|||
160511633|NCT01373151|579600478|FG004|Period 1|Adverse Event|4|||
160511634|NCT01373151|579600479|FG005|Period 1|Adverse Event|3|||
160511635|NCT01373151|579600480|FG006|Period 1|Adverse Event|0|||
160511636|NCT01373151|579600474|FG000|Period 1|Withdrawal by Subject|2|||
160511637|NCT01373151|579600475|FG001|Period 1|Withdrawal by Subject|0|||
160511638|NCT01373151|579600476|FG002|Period 1|Withdrawal by Subject|3|||
160511639|NCT01373151|579600477|FG003|Period 1|Withdrawal by Subject|1|||
160511640|NCT01373151|579600478|FG004|Period 1|Withdrawal by Subject|0|||
160511641|NCT01373151|579600479|FG005|Period 1|Withdrawal by Subject|1|||
160511642|NCT01373151|579600480|FG006|Period 1|Withdrawal by Subject|0|||
160511643|NCT01373151|579600474|FG000|Period 2|Lack of Efficacy|9|||
160511644|NCT01373151|579600475|FG001|Period 2|Lack of Efficacy|0|||
160511645|NCT01373151|579600476|FG002|Period 2|Lack of Efficacy|0|||
160511646|NCT01373151|579600477|FG003|Period 2|Lack of Efficacy|1|||
160620859|NCT01072175|579990347|FG005|Part D (HPMC Capsules)|Death|0|||
160620860|NCT01072175|579990348|FG006|Part D (HPMC Capsules)|Death|0|||
160620861|NCT01072175|579990349|FG007|Part D (HPMC Capsules)|Death|0|||
160620862|NCT01072175|579990350|FG008|Part D (HPMC Capsules)|Death|0|||
160620863|NCT01072175|579990351|FG009|Part D (HPMC Capsules)|Death|10|||
160620864|NCT01072175|579990352|FG010|Part D (HPMC Capsules)|Death|12|||
160620865|NCT01072175|579990353|FG011|Part D (HPMC Capsules)|Death|28|||
160620866|NCT01072175|579990354|FG012|Part D (HPMC Capsules)|Death|26|||
160620867|NCT01072175|579990342|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
160620868|NCT01072175|579990343|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
160620869|NCT01072175|579990344|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
160620870|NCT01072175|579990345|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
160620871|NCT01072175|579990346|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
160620872|NCT01072175|579990347|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
160620873|NCT01072175|579990348|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
160620874|NCT01072175|579990349|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
160620875|NCT01072175|579990350|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
160620876|NCT01072175|579990351|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
160620877|NCT01072175|579990352|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
160620878|NCT01072175|579990353|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
160620879|NCT01072175|579990354|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
160620880|NCT01072175|579990342|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
160620881|NCT01072175|579990343|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
160620882|NCT01072175|579990344|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
160620883|NCT01072175|579990345|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
160620884|NCT01072175|579990346|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
160620885|NCT01072175|579990347|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
160511647|NCT01373151|579600478|FG004|Period 2|Lack of Efficacy|2|||
160511648|NCT01373151|579600479|FG005|Period 2|Lack of Efficacy|0|||
160511649|NCT01373151|579600480|FG006|Period 2|Lack of Efficacy|3|||
160511650|NCT01373151|579600474|FG000|Period 2|Adverse Event|0|||
160511651|NCT01373151|579600475|FG001|Period 2|Adverse Event|0|||
160511652|NCT01373151|579600476|FG002|Period 2|Adverse Event|3|||
160511653|NCT01373151|579600477|FG003|Period 2|Adverse Event|3|||
160511654|NCT01373151|579600478|FG004|Period 2|Adverse Event|0|||
160511655|NCT01373151|579600479|FG005|Period 2|Adverse Event|0|||
160620886|NCT01072175|579990348|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
160620887|NCT01072175|579990349|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
160620888|NCT01072175|579990350|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
160620889|NCT01072175|579990351|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
160511656|NCT01373151|579600480|FG006|Period 2|Adverse Event|1|||
160511657|NCT01373151|579600474|FG000|Period 2|subject request to discontinue|0|||
160664579|NCT01597245|580152448|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664580|NCT01597245|580152449|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664581|NCT01597245|580152450|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664582|NCT01597245|580152451|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664583|NCT01597245|580152452|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664584|NCT01597245|580152453|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664585|NCT01597245|580152454|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664586|NCT01597245|580152455|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664587|NCT01597245|580152456|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664588|NCT01597245|580152457|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664589|NCT01597245|580152458|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664590|NCT01597245|580152459|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664591|NCT01597245|580152460|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664592|NCT01597245|580152461|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
160664593|NCT01597245|580152462|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664594|NCT01597245|580152463|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160664595|NCT01597245|580152464|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
160664596|NCT01597245|580152465|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
160664597|NCT01597245|580152445|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664598|NCT01597245|580152446|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664599|NCT01597245|580152447|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664600|NCT01597245|580152448|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664601|NCT01597245|580152449|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664602|NCT01597245|580152450|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664603|NCT01597245|580152451|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664604|NCT01597245|580152452|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664605|NCT01597245|580152453|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664606|NCT01597245|580152454|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664607|NCT01597245|580152455|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664608|NCT01597245|580152456|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664609|NCT01597245|580152457|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664610|NCT01597245|580152458|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664611|NCT01597245|580152459|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664612|NCT01597245|580152460|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664613|NCT01597245|580152461|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
160664614|NCT01597245|580152462|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664615|NCT01597245|580152463|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160664616|NCT01597245|580152464|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
160664617|NCT01597245|580152465|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
160664618|NCT01597245|580152445|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664619|NCT01597245|580152446|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664620|NCT01597245|580152447|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664621|NCT01597245|580152448|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664622|NCT01597245|580152449|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664623|NCT01597245|580152450|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664624|NCT01597245|580152451|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664625|NCT01597245|580152452|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664626|NCT01597245|580152453|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664627|NCT01597245|580152454|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664628|NCT01597245|580152455|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664629|NCT01597245|580152456|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664630|NCT01597245|580152457|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664631|NCT01597245|580152458|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664632|NCT01597245|580152459|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664633|NCT01597245|580152460|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664634|NCT01597245|580152461|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
160664635|NCT01597245|580152462|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664636|NCT01597245|580152463|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160664637|NCT01597245|580152464|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
160664638|NCT01597245|580152465|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
160511658|NCT01373151|579600475|FG001|Period 2|subject request to discontinue|1|||
160511659|NCT01373151|579600476|FG002|Period 2|subject request to discontinue|0|||
160511660|NCT01373151|579600477|FG003|Period 2|subject request to discontinue|0|||
160511661|NCT01373151|579600478|FG004|Period 2|subject request to discontinue|0|||
160620890|NCT01072175|579990352|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
160620891|NCT01072175|579990353|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
160620892|NCT01072175|579990354|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
160620893|NCT01072175|579990342|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
160620894|NCT01072175|579990343|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
160620895|NCT01072175|579990344|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
160620896|NCT01072175|579990345|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
160620897|NCT01072175|579990346|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
160620898|NCT01072175|579990347|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
160620899|NCT01072175|579990348|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
160620900|NCT01072175|579990349|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
160620901|NCT01072175|579990350|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
160620902|NCT01072175|579990351|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
160620903|NCT01072175|579990352|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
160620904|NCT01072175|579990353|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
160620905|NCT01072175|579990354|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
160620906|NCT01072175|579990342|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160620907|NCT01072175|579990343|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160620908|NCT01072175|579990344|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160620909|NCT01072175|579990345|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160620910|NCT01072175|579990346|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160620911|NCT01072175|579990347|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160620912|NCT01072175|579990348|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160620913|NCT01072175|579990349|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160620914|NCT01072175|579990350|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160620915|NCT01072175|579990351|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160620916|NCT01072175|579990352|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
160620917|NCT01072175|579990353|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
160620918|NCT01072175|579990354|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
160511662|NCT01373151|579600479|FG005|Period 2|subject request to discontinue|0|||
160511663|NCT01373151|579600480|FG006|Period 2|subject request to discontinue|0|||
160511664|NCT01373151|579600474|FG000|Period 2|Withdrawal by Subject|0|||
160511665|NCT01373151|579600475|FG001|Period 2|Withdrawal by Subject|0|||
160511666|NCT01373151|579600476|FG002|Period 2|Withdrawal by Subject|0|||
160511667|NCT01373151|579600477|FG003|Period 2|Withdrawal by Subject|1|||
160511668|NCT01373151|579600478|FG004|Period 2|Withdrawal by Subject|0|||
160511669|NCT01373151|579600479|FG005|Period 2|Withdrawal by Subject|0|||
160511670|NCT01373151|579600480|FG006|Period 2|Withdrawal by Subject|0|||
160511671|NCT01373151|579600474|FG000|Period 2|Other|0|||
160511672|NCT01373151|579600475|FG001|Period 2|Other|0|||
160511673|NCT01373151|579600476|FG002|Period 2|Other|1|||
160511674|NCT01373151|579600477|FG003|Period 2|Other|0|||
160511675|NCT01373151|579600478|FG004|Period 2|Other|0|||
160511676|NCT01373151|579600479|FG005|Period 2|Other|0|||
160511677|NCT01373151|579600480|FG006|Period 2|Other|1|||
160511678|NCT03026075|579600484|FG000|Overall Study|Physician Decision|1|||
160511679|NCT03381339|579600485|FG000|Overall Study|Protocol Violation|4|||
160511680|NCT03381339|579600486|FG001|Overall Study|Protocol Violation|3|||
160511681|NCT03381339|579600485|FG000|Overall Study|Lost to Follow-up|0|||
160511682|NCT03381339|579600486|FG001|Overall Study|Lost to Follow-up|1|||
160511683|NCT02001064|579600488|FG000|Overall Study|Withdrawal by Subject|2|||
160511684|NCT02001064|579600489|FG001|Overall Study|Withdrawal by Subject|1|||
160511685|NCT00545753|579600490|FG000|Overall Study|Withdrawal by Subject|0|||
160511686|NCT00545753|579600491|FG001|Overall Study|Withdrawal by Subject|1|||
160511687|NCT00545753|579600492|FG002|Overall Study|Withdrawal by Subject|10|||
160511688|NCT00545753|579600490|FG000|Overall Study|Lost to Follow-up|13|||
160511689|NCT00545753|579600491|FG001|Overall Study|Lost to Follow-up|3|||
160511690|NCT00545753|579600492|FG002|Overall Study|Lost to Follow-up|12|||
160511691|NCT00545753|579600490|FG000|Overall Study|Protocol Violation|3|||
160620919|NCT00682539|579990355|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
160620920|NCT00682539|579990356|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
160511692|NCT00545753|579600491|FG001|Overall Study|Protocol Violation|1|||
160511693|NCT00545753|579600492|FG002|Overall Study|Protocol Violation|4|||
160511694|NCT03981861|579600494|FG000|Overall Study|Withdrawal by Subject|3|||
160511695|NCT03973931|579600495|FG000|Overall Study|Lost to Follow-up|47|||
160511696|NCT03973931|579600496|FG001|Overall Study|Lost to Follow-up|63|||
160511697|NCT03973931|579600497|FG002|Overall Study|Lost to Follow-up|51|||
160511698|NCT03973931|579600498|FG003|Overall Study|Lost to Follow-up|54|||
160511699|NCT03973931|579600495|FG000|Overall Study|opted out|6|||
160620921|NCT00682539|579990357|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
160620922|NCT00682539|579990355|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
160511700|NCT03973931|579600496|FG001|Overall Study|opted out|5|||
160511701|NCT03973931|579600497|FG002|Overall Study|opted out|5|||
160511702|NCT03973931|579600498|FG003|Overall Study|opted out|1|||
160511703|NCT02245737|579602018|FG000|Overall Study|Adverse Event|23|||
160511704|NCT02245737|579602019|FG001|Overall Study|Adverse Event|26|||
160511705|NCT02245737|579602020|FG002|Overall Study|Adverse Event|33|||
160511706|NCT02245737|579602018|FG000|Overall Study|Condition Worsened|9|||
160511707|NCT02245737|579602019|FG001|Overall Study|Condition Worsened|10|||
160511708|NCT02245737|579602020|FG002|Overall Study|Condition Worsened|9|||
160511709|NCT02245737|579602018|FG000|Overall Study|Death|2|||
160511710|NCT02245737|579602019|FG001|Overall Study|Death|4|||
160511711|NCT02245737|579602020|FG002|Overall Study|Death|4|||
160511712|NCT02245737|579602018|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
160511713|NCT02245737|579602019|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
160511714|NCT02245737|579602020|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
160511715|NCT02245737|579602018|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
160511716|NCT02245737|579602019|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
160511717|NCT02245737|579602020|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
160511718|NCT02245737|579602018|FG000|Overall Study|Lost to Follow-up|2|||
160511719|NCT02245737|579602019|FG001|Overall Study|Lost to Follow-up|5|||
160511720|NCT02245737|579602020|FG002|Overall Study|Lost to Follow-up|4|||
160511721|NCT02245737|579602018|FG000|Overall Study|Other-determined by Investigator|9|||
160511722|NCT02245737|579602019|FG001|Overall Study|Other-determined by Investigator|10|||
160511723|NCT02245737|579602020|FG002|Overall Study|Other-determined by Investigator|10|||
160511724|NCT02245737|579602018|FG000|Overall Study|Physician Decision|6|||
160511725|NCT02245737|579602019|FG001|Overall Study|Physician Decision|3|||
160511726|NCT02245737|579602020|FG002|Overall Study|Physician Decision|6|||
160511727|NCT02245737|579602018|FG000|Overall Study|Protocol Violation|3|||
160511728|NCT02245737|579602019|FG001|Overall Study|Protocol Violation|2|||
160511729|NCT02245737|579602020|FG002|Overall Study|Protocol Violation|3|||
160511730|NCT02245737|579602018|FG000|Overall Study|Withdrawal by Subject|40|||
160511731|NCT02245737|579602019|FG001|Overall Study|Withdrawal by Subject|41|||
160511732|NCT02245737|579602020|FG002|Overall Study|Withdrawal by Subject|44|||
160511733|NCT02245737|579602018|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
160511734|NCT02245737|579602019|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
160511735|NCT02245737|579602020|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
160511736|NCT02245737|579602018|FG000|Overall Study|Sponsor Decision|445|||
160511737|NCT02245737|579602019|FG001|Overall Study|Sponsor Decision|430|||
160511738|NCT02245737|579602020|FG002|Overall Study|Sponsor Decision|432|||
160511739|NCT00836745|579602021|FG000|Overall Study|Death|2|||
160511740|NCT00836745|579602021|FG000|Overall Study|Lost to Follow-up|10|||
160511741|NCT00836745|579602021|FG000|Overall Study|Adverse Event|3|||
160511742|NCT00836745|579602021|FG000|Overall Study|Objective progression or relapse|4|||
160511743|NCT00836745|579602021|FG000|Overall Study|Other|2|||
160511744|NCT01239043|579602024|FG000|Overall Study|Protocol Violation|2|||
160511745|NCT01239043|579602025|FG001|Overall Study|Protocol Violation|1|||
160511746|NCT02121301|579602026|FG000|Overall Study|Protocol Violation|1|||
160511747|NCT02121301|579602027|FG001|Overall Study|Protocol Violation|4|||
160511748|NCT02121301|579602028|FG002|Overall Study|Protocol Violation|1|||
160511749|NCT00434213|579602034|FG000|Overall Study|Adverse Event|12|||
160511750|NCT00434213|579602034|FG000|Overall Study|Lack of Efficacy|9|||
160511751|NCT00434213|579602034|FG000|Overall Study|Lost to Follow-up|14|||
160511752|NCT00434213|579602034|FG000|Overall Study|Withdrawal by Subject|7|||
160511753|NCT00434213|579602034|FG000|Overall Study|Protocol Violation|3|||
160511754|NCT00434213|579602034|FG000|Overall Study|Unable to comply with study visit window|2|||
160511755|NCT00434213|579602034|FG000|Overall Study|Application site reaction|1|||
160511756|NCT00434213|579602034|FG000|Overall Study|Non-compliant to study schedule|1|||
160511757|NCT01699503|579602035|FG000|Overall Study|Death|31|||
160511758|NCT01699503|579602036|FG001|Overall Study|Death|40|||
160511759|NCT01699503|579602035|FG000|Overall Study|Withdrawal by Subject|65|||
160511760|NCT01699503|579602036|FG001|Overall Study|Withdrawal by Subject|57|||
160511761|NCT01699503|579602035|FG000|Overall Study|Lost to Follow-up|121|||
160511762|NCT01699503|579602036|FG001|Overall Study|Lost to Follow-up|117|||
160511763|NCT01699503|579602035|FG000|Overall Study|Excluded due to quality|783|||
160511764|NCT01699503|579602036|FG001|Overall Study|Excluded due to quality|791|||
160511765|NCT01871805|579602046|FG000|Phase I|Death|7|||
160511766|NCT01871805|579602047|FG001|Phase I|Death|4|||
160511767|NCT01871805|579602048|FG002|Phase I|Death|6|||
160511768|NCT01871805|579602049|FG003|Phase I|Death|2|||
160511769|NCT01871805|579602050|FG004|Phase I|Death|9|||
160664639|NCT01597245|580152445|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160511770|NCT01871805|579602051|FG005|Phase I|Death|0|||
160511771|NCT01871805|579602046|FG000|Phase I|Alive in Survival Follow-up|0|||
160511772|NCT01871805|579602047|FG001|Phase I|Alive in Survival Follow-up|2|||
160511773|NCT01871805|579602048|FG002|Phase I|Alive in Survival Follow-up|4|||
160511774|NCT01871805|579602049|FG003|Phase I|Alive in Survival Follow-up|5|||
160511775|NCT01871805|579602050|FG004|Phase I|Alive in Survival Follow-up|4|||
160511776|NCT01871805|579602051|FG005|Phase I|Alive in Survival Follow-up|0|||
160511777|NCT01871805|579602046|FG000|Phase I|Lost to Follow-up|0|||
160511778|NCT01871805|579602047|FG001|Phase I|Lost to Follow-up|1|||
160664640|NCT01597245|580152446|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664641|NCT01597245|580152447|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664642|NCT01597245|580152448|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664643|NCT01597245|580152449|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664644|NCT01597245|580152450|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664645|NCT01597245|580152451|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664646|NCT01597245|580152452|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664647|NCT01597245|580152453|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664648|NCT01597245|580152454|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664649|NCT01597245|580152455|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664650|NCT01597245|580152456|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664651|NCT01597245|580152457|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664652|NCT01597245|580152458|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664653|NCT01597245|580152459|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664654|NCT01597245|580152460|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664655|NCT01597245|580152461|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
160664656|NCT01597245|580152462|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664657|NCT01597245|580152463|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664658|NCT01597245|580152464|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
160664659|NCT01597245|580152465|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
160664660|NCT01597245|580152445|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664661|NCT01597245|580152446|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664662|NCT01597245|580152447|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664663|NCT01597245|580152448|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664664|NCT01597245|580152449|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664665|NCT01597245|580152450|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664666|NCT01597245|580152451|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664667|NCT01597245|580152452|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664668|NCT01597245|580152453|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664669|NCT01597245|580152454|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664670|NCT01597245|580152455|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664671|NCT01597245|580152456|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664672|NCT01597245|580152457|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664673|NCT01597245|580152458|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664674|NCT01597245|580152459|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664675|NCT01597245|580152460|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664676|NCT01597245|580152461|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664677|NCT01597245|580152462|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664678|NCT01597245|580152463|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664679|NCT01597245|580152464|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
160664680|NCT01597245|580152465|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
160664681|NCT03255733|580153500|FG000|Overall Study|Lost to Follow-up|4|||
160664682|NCT02563561|580153501|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
160664683|NCT02563561|580153502|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
160664684|NCT02563561|580153503|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
160664685|NCT02563561|580153501|FG000|Overall Study|Withdrew of Consent|1|||
160664686|NCT02563561|580153502|FG001|Overall Study|Withdrew of Consent|1|||
160664687|NCT02563561|580153503|FG002|Overall Study|Withdrew of Consent|2|||
160664688|NCT02563561|580153501|FG000|Overall Study|Lost to Follow-up|1|||
160664689|NCT02563561|580153502|FG001|Overall Study|Lost to Follow-up|1|||
160664690|NCT02563561|580153503|FG002|Overall Study|Lost to Follow-up|0|||
160664691|NCT02563561|580153501|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
160664692|NCT02563561|580153502|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
160664693|NCT02563561|580153503|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
160664694|NCT02563561|580153501|FG000|Overall Study|Investigator Decision|3|||
160664695|NCT02563561|580153502|FG001|Overall Study|Investigator Decision|4|||
160664696|NCT02563561|580153503|FG002|Overall Study|Investigator Decision|2|||
160664697|NCT02563561|580153501|FG000|Overall Study|Sponsor Decision|5|||
160664698|NCT02563561|580153502|FG001|Overall Study|Sponsor Decision|2|||
160664699|NCT02563561|580153503|FG002|Overall Study|Sponsor Decision|4|||
160664700|NCT02563561|580153501|FG000|Overall Study|Other|1|||
160664701|NCT02563561|580153502|FG001|Overall Study|Other|5|||
160664702|NCT02563561|580153503|FG002|Overall Study|Other|2|||
160664703|NCT02646124|580153504|FG000|Overall Study|Lost to Follow-up|0|||
160664704|NCT02646124|580153505|FG001|Overall Study|Lost to Follow-up|2|||
160664705|NCT03154047|580153506|FG000|Overall Study|Death|1|||
160664706|NCT03154047|580153506|FG000|Overall Study|Study terminated by sponsor|76|||
160664707|NCT03154047|580153506|FG000|Overall Study|Withdrawal by Subject|3|||
160664708|NCT00365365|580153507|FG000|Overall Study|Randomized but not treated|0|||
160664709|NCT00365365|580153508|FG001|Overall Study|Randomized but not treated|2|||
160511779|NCT01871805|579602048|FG002|Phase I|Lost to Follow-up|3|||
160511780|NCT01871805|579602049|FG003|Phase I|Lost to Follow-up|0|||
160511781|NCT01871805|579602050|FG004|Phase I|Lost to Follow-up|0|||
160511782|NCT01871805|579602051|FG005|Phase I|Lost to Follow-up|0|||
160511783|NCT01871805|579602046|FG000|Phase II|Death|0|||
160511784|NCT01871805|579602047|FG001|Phase II|Death|0|||
160620923|NCT00682539|579990356|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
160620924|NCT00682539|579990357|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
160620925|NCT02477215|579990367|FG000|Dose Escalation Phase|Physician Decision|1|||
160620926|NCT02477215|579990368|FG001|Dose Escalation Phase|Physician Decision|2|||
160620927|NCT02477215|579990369|FG002|Dose Escalation Phase|Physician Decision|0|||
160620928|NCT02477215|579990367|FG000|Fixed Dose Phase|Physician Decision|0|||
160620929|NCT02477215|579990368|FG001|Fixed Dose Phase|Physician Decision|7|||
160620930|NCT02477215|579990369|FG002|Fixed Dose Phase|Physician Decision|0|||
160620931|NCT00508872|579990370|FG000|Overall Study|Lost to Follow-up|1|||
160620932|NCT00508872|579990370|FG000|Overall Study|Physician Decision|1|||
160620933|NCT00883896|579990371|FG000|Overall Study|Lost to Follow-up|0|||
160620934|NCT00883896|579990372|FG001|Overall Study|Lost to Follow-up|0|||
160620935|NCT00883896|579990373|FG002|Overall Study|Lost to Follow-up|0|||
160620936|NCT00883896|579990374|FG003|Overall Study|Lost to Follow-up|2|||
160620937|NCT00883896|579990371|FG000|Overall Study|Withdrawal by Subject|5|||
160620938|NCT00883896|579990372|FG001|Overall Study|Withdrawal by Subject|0|||
160620939|NCT00883896|579990373|FG002|Overall Study|Withdrawal by Subject|1|||
160620940|NCT00883896|579990374|FG003|Overall Study|Withdrawal by Subject|3|||
160620941|NCT00883896|579990371|FG000|Overall Study|Lack of Efficacy|0|||
160620942|NCT00883896|579990372|FG001|Overall Study|Lack of Efficacy|0|||
160620943|NCT00883896|579990373|FG002|Overall Study|Lack of Efficacy|0|||
160620944|NCT00883896|579990374|FG003|Overall Study|Lack of Efficacy|2|||
160620945|NCT00883896|579990371|FG000|Overall Study|Other|1|||
160620946|NCT00883896|579990372|FG001|Overall Study|Other|0|||
160620947|NCT00883896|579990373|FG002|Overall Study|Other|0|||
160620948|NCT00883896|579990374|FG003|Overall Study|Other|0|||
160620949|NCT02210559|579990375|FG000|Overall Study|Progressive Disease|3|||
160620950|NCT02210559|579990376|FG001|Overall Study|Progressive Disease|2|||
160620951|NCT02210559|579990375|FG000|Overall Study|Adverse Event|2|||
160620952|NCT02210559|579990376|FG001|Overall Study|Adverse Event|2|||
160620953|NCT02210559|579990375|FG000|Overall Study|Physician Decision|1|||
160620954|NCT02210559|579990376|FG001|Overall Study|Physician Decision|0|||
160620955|NCT02210559|579990375|FG000|Overall Study|Withdrawal by Subject|0|||
160620956|NCT02210559|579990376|FG001|Overall Study|Withdrawal by Subject|1|||
160620957|NCT02210559|579990375|FG000|Overall Study|Other than specified|0|||
160620958|NCT02210559|579990376|FG001|Overall Study|Other than specified|1|||
160620959|NCT02546193|579990377|FG000|Overall Study|Withdrawal by Subject|2|||
160620960|NCT02546193|579990378|FG001|Overall Study|Withdrawal by Subject|0|||
160620961|NCT02546193|579990379|FG002|Overall Study|Withdrawal by Subject|1|||
160620962|NCT02546193|579990380|FG003|Overall Study|Withdrawal by Subject|0|||
160620963|NCT02546193|579990377|FG000|Overall Study|Not eligible at time of induction|4|||
160620964|NCT02546193|579990378|FG001|Overall Study|Not eligible at time of induction|6|||
160620965|NCT02546193|579990379|FG002|Overall Study|Not eligible at time of induction|1|||
160620966|NCT02546193|579990380|FG003|Overall Study|Not eligible at time of induction|0|||
160620967|NCT00792467|579990381|FG000|Overall Study|progression of disease|17|||
160620968|NCT00792467|579990381|FG000|Overall Study|Adverse Event|1|||
160620969|NCT00792467|579990381|FG000|Overall Study|patient request|1|||
160620970|NCT00792467|579990381|FG000|Overall Study|Lost to Follow-up|1|||
160620971|NCT00792467|579990381|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
160620972|NCT00792467|579990381|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
160620973|NCT01287403|579990385|FG000|1st Intervention (1 Day)|Adverse Event|1|||
160620974|NCT01098266|579990386|FG000|Overall Study|Physician Decision|1|||
160620975|NCT01098266|579990387|FG001|Overall Study|Physician Decision|0|||
160511785|NCT01871805|579602048|FG002|Phase II|Death|0|||
160620976|NCT01098266|579990386|FG000|Overall Study|Death|3|||
160620977|NCT01098266|579990387|FG001|Overall Study|Death|2|||
160620978|NCT01098266|579990386|FG000|Overall Study|Withdrawal by Subject|3|||
160620979|NCT01098266|579990387|FG001|Overall Study|Withdrawal by Subject|5|||
160620980|NCT00438815|579990388|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
160620981|NCT00438815|579990388|FG000|Overall Study|3-month follow-up no longer required|12|||
160620982|NCT00438815|579990388|FG000|Overall Study|Noncompliance with protocol requirements|9|||
160620983|NCT00438815|579990388|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
160620984|NCT00438815|579990388|FG000|Overall Study|Lost to Follow-up|6|||
160620985|NCT00438815|579990388|FG000|Overall Study|Withdrawal by Subject|6|||
160511786|NCT01871805|579602049|FG003|Phase II|Death|0|||
160511787|NCT01871805|579602050|FG004|Phase II|Death|0|||
160511788|NCT01871805|579602051|FG005|Phase II|Death|45|||
160511789|NCT01871805|579602046|FG000|Phase II|Alive in Survival Follow-up|0|||
160620986|NCT00438815|579990388|FG000|Overall Study|Death|1|||
160620987|NCT01733758|579990389|FG000|Overall Study|Adverse Event|5|||
160620988|NCT01733758|579990390|FG001|Overall Study|Adverse Event|7|||
160620989|NCT01733758|579990391|FG002|Overall Study|Adverse Event|8|||
160511790|NCT01871805|579602047|FG001|Phase II|Alive in Survival Follow-up|0|||
160511791|NCT01871805|579602048|FG002|Phase II|Alive in Survival Follow-up|0|||
160511792|NCT01871805|579602049|FG003|Phase II|Alive in Survival Follow-up|0|||
160511793|NCT01871805|579602050|FG004|Phase II|Alive in Survival Follow-up|0|||
160511794|NCT01871805|579602051|FG005|Phase II|Alive in Survival Follow-up|29|||
160511795|NCT01871805|579602046|FG000|Phase II|Lost to Follow-up|0|||
160620990|NCT01733758|579990392|FG003|Overall Study|Adverse Event|1|||
160620991|NCT01733758|579990389|FG000|Overall Study|Withdrawal by Subject|1|||
160620992|NCT01733758|579990390|FG001|Overall Study|Withdrawal by Subject|1|||
160620993|NCT01733758|579990391|FG002|Overall Study|Withdrawal by Subject|5|||
160620994|NCT01733758|579990392|FG003|Overall Study|Withdrawal by Subject|3|||
160620995|NCT01733758|579990389|FG000|Overall Study|Persistent Hyperglycemia|3|||
160620996|NCT01733758|579990390|FG001|Overall Study|Persistent Hyperglycemia|2|||
160620997|NCT01733758|579990391|FG002|Overall Study|Persistent Hyperglycemia|0|||
160620998|NCT01733758|579990392|FG003|Overall Study|Persistent Hyperglycemia|0|||
160620999|NCT01733758|579990389|FG000|Overall Study|Protocol Violation|0|||
160621000|NCT01733758|579990390|FG001|Overall Study|Protocol Violation|1|||
160621001|NCT01733758|579990391|FG002|Overall Study|Protocol Violation|2|||
160621002|NCT01733758|579990392|FG003|Overall Study|Protocol Violation|2|||
160621003|NCT01733758|579990389|FG000|Overall Study|Non-compliance|1|||
160621004|NCT01733758|579990390|FG001|Overall Study|Non-compliance|0|||
160621005|NCT01733758|579990391|FG002|Overall Study|Non-compliance|0|||
160621006|NCT01733758|579990392|FG003|Overall Study|Non-compliance|0|||
160621007|NCT01733758|579990389|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
160621008|NCT01733758|579990390|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
160621009|NCT01733758|579990391|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
160621010|NCT01733758|579990392|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
160621011|NCT01733758|579990389|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
160621012|NCT01733758|579990390|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
160621013|NCT01733758|579990391|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
160621014|NCT01733758|579990392|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
160621015|NCT02545270|579990397|FG000|Overall Study|technical difficulties|0|||
160621016|NCT02545270|579990398|FG001|Overall Study|technical difficulties|1|||
160621017|NCT02545270|579990399|FG002|Overall Study|technical difficulties|0|||
160621018|NCT02545270|579990397|FG000|Overall Study|Videos being too similar to other|0|||
160621019|NCT02545270|579990398|FG001|Overall Study|Videos being too similar to other|0|||
160621020|NCT02545270|579990399|FG002|Overall Study|Videos being too similar to other|2|||
160621021|NCT00661362|579990400|FG000|Overall Study|Adverse Event|5|||
160621022|NCT00661362|579990401|FG001|Overall Study|Adverse Event|4|||
160621023|NCT00661362|579990400|FG000|Overall Study|Incorrect enrollment|2|||
160621024|NCT00661362|579990401|FG001|Overall Study|Incorrect enrollment|0|||
160621025|NCT00661362|579990400|FG000|Overall Study|Study specific discontinuation criteria|4|||
160621026|NCT00661362|579990401|FG001|Overall Study|Study specific discontinuation criteria|11|||
160621027|NCT00661362|579990400|FG000|Overall Study|Withdrawal by Subject|13|||
160621028|NCT00661362|579990401|FG001|Overall Study|Withdrawal by Subject|23|||
160621029|NCT00661362|579990400|FG000|Overall Study|Lost to Follow-up|3|||
160621030|NCT00661362|579990401|FG001|Overall Study|Lost to Follow-up|1|||
160621031|NCT00661362|579990400|FG000|Overall Study|Severe non-compliance to protocol|0|||
160621032|NCT00661362|579990401|FG001|Overall Study|Severe non-compliance to protocol|1|||
160621033|NCT00661362|579990400|FG000|Overall Study|Safety reasons|1|||
160621034|NCT00661362|579990401|FG001|Overall Study|Safety reasons|0|||
160621035|NCT00661362|579990400|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
160511796|NCT01871805|579602047|FG001|Phase II|Lost to Follow-up|0|||
160511797|NCT01871805|579602048|FG002|Phase II|Lost to Follow-up|0|||
160511798|NCT01871805|579602049|FG003|Phase II|Lost to Follow-up|0|||
160511799|NCT01871805|579602050|FG004|Phase II|Lost to Follow-up|0|||
160511800|NCT01871805|579602051|FG005|Phase II|Lost to Follow-up|13|||
160511801|NCT00941070|579602056|FG000|Overall Study|Patient non-compliant|1|||
160511802|NCT03174431|579602057|FG000|Overall Study|Withdrawal by Subject|14|||
160511803|NCT03174431|579602058|FG001|Overall Study|Withdrawal by Subject|11|||
160511804|NCT03174431|579602057|FG000|Overall Study|alternative treatment|2|||
160511805|NCT03174431|579602058|FG001|Overall Study|alternative treatment|0|||
160511806|NCT03174431|579602057|FG000|Overall Study|Lost to Follow-up|1|||
160511807|NCT03174431|579602058|FG001|Overall Study|Lost to Follow-up|5|||
160511808|NCT03484273|579602063|FG000|Overall Study|Equipment Malfunction|1|||
160511809|NCT03484273|579602063|FG000|Overall Study|Data excluded from analysis|1|||
160621036|NCT00661362|579990401|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
160621037|NCT00535262|579990404|FG000|Overall Study|No funding|3|||
160621038|NCT04382066|579990406|FG000|Overall Study|Adverse Event|1|||
160511810|NCT00468104|579602069|FG000|First Intervention|Protocol Violation|2|||
160511811|NCT00468104|579602070|FG001|First Intervention|Protocol Violation|1|||
160511812|NCT00468104|579602069|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
160621039|NCT04382066|579990407|FG001|Overall Study|Adverse Event|0|||
160621040|NCT04382066|579990408|FG002|Overall Study|Adverse Event|0|||
160621041|NCT04382066|579990406|FG000|Overall Study|Death|1|||
160511813|NCT00468104|579602070|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
160511814|NCT00468104|579602069|FG000|First Intervention|died within 3 weeks|1|||
160511815|NCT00468104|579602070|FG001|First Intervention|died within 3 weeks|0|||
160511816|NCT00468104|579602069|FG000|First Intervention|malposition/blocked chest tube tube|2|||
160511817|NCT00468104|579602070|FG001|First Intervention|malposition/blocked chest tube tube|0|||
160511818|NCT00468104|579602069|FG000|First Intervention|large lung mass with minimal effusion|1|||
160511819|NCT00468104|579602070|FG001|First Intervention|large lung mass with minimal effusion|0|||
160511820|NCT00468104|579602069|FG000|First Intervention|associated prolonged pneumothorax|1|||
160511821|NCT00468104|579602070|FG001|First Intervention|associated prolonged pneumothorax|0|||
160511822|NCT00468104|579602069|FG000|First Intervention|trapped lung|1|||
160511823|NCT00468104|579602070|FG001|First Intervention|trapped lung|0|||
160511824|NCT00468104|579602069|FG000|Second Intervention|Withdrawal by Subject|5|||
160511825|NCT00468104|579602070|FG001|Second Intervention|Withdrawal by Subject|2|||
160511826|NCT00468104|579602069|FG000|Second Intervention|discarded for malposition of chest tube|0|||
160511827|NCT00468104|579602070|FG001|Second Intervention|discarded for malposition of chest tube|2|||
160511828|NCT01263665|579602071|FG000|Overall Study|Withdrew Consent|1|||
160511829|NCT01263665|579602071|FG000|Overall Study|Lost to Follow-up|3|||
160511830|NCT01263665|579602071|FG000|Overall Study|Death|2|||
160511831|NCT01263665|579602071|FG000|Overall Study|Amputation above the ankle|1|||
160511832|NCT01263665|579602071|FG000|Overall Study|Surgical Bypass|2|||
160511833|NCT02706899|579602076|FG000|Overall Study|Withdrawal by Subject|1|||
160511834|NCT02706899|579602077|FG001|Overall Study|Withdrawal by Subject|0|||
160511835|NCT02706899|579602076|FG000|Overall Study|Death|8|||
160511836|NCT02706899|579602077|FG001|Overall Study|Death|0|||
160511837|NCT02706899|579602076|FG000|Overall Study|Study Termination by Sponsor|4|||
160511838|NCT02706899|579602077|FG001|Overall Study|Study Termination by Sponsor|6|||
160621042|NCT04382066|579990407|FG001|Overall Study|Death|0|||
160621043|NCT04382066|579990408|FG002|Overall Study|Death|1|||
160621044|NCT00779506|579990416|FG000|Overall Study|Screening Failed|2|||
160621045|NCT00779506|579990416|FG000|Overall Study|Adverse Event|4|||
160621046|NCT00779506|579990416|FG000|Overall Study|Lack of Efficacy|11|||
160621047|NCT00779506|579990416|FG000|Overall Study|Protocol Violation|5|||
160621048|NCT00779506|579990416|FG000|Overall Study|Withdrawal by Subject|6|||
160621049|NCT00779506|579990416|FG000|Overall Study|Lost to Follow-up|1|||
160621050|NCT00787527|579990419|FG000|Overall Study|Toxicity|3|||
160621051|NCT00914940|579990420|FG000|D0 to D100 Post-transplant|Death|2|||
160621052|NCT00914940|579990420|FG000|D101 to 2 Years Post-transplant|Death|8|||
160621053|NCT00914940|579990420|FG000|2 Years to 5 Years Post-transplant|Death|3|||
160621054|NCT01724021|579990421|FG000|Overall Study|Adverse Event|11|||
160621055|NCT01724021|579990422|FG001|Overall Study|Adverse Event|6|||
160621056|NCT01724021|579990421|FG000|Overall Study|Death|46|||
160621057|NCT01724021|579990422|FG001|Overall Study|Death|58|||
160621058|NCT01724021|579990421|FG000|Overall Study|Participant request/ Withdrew consent|18|||
160621059|NCT01724021|579990422|FG001|Overall Study|Participant request/ Withdrew consent|14|||
160621060|NCT01724021|579990421|FG000|Overall Study|Lost to Follow-up|15|||
160621061|NCT01724021|579990422|FG001|Overall Study|Lost to Follow-up|15|||
160621062|NCT01724021|579990421|FG000|Overall Study|Reason Not Specified|36|||
160621063|NCT01724021|579990422|FG001|Overall Study|Reason Not Specified|39|||
160621064|NCT01724021|579990421|FG000|Overall Study|Missing|1|||
160621065|NCT01724021|579990422|FG001|Overall Study|Missing|1|||
160621066|NCT03742271|579990435|FG000|Overall Study|Unsatisfactory Visual Response|1|||
160621067|NCT03742271|579990435|FG000|Overall Study|Withdrawal by Subject|3|||
160621068|NCT03742271|579990435|FG000|Overall Study|Lost to Follow-up|4|||
160621069|NCT03742271|579990435|FG000|Overall Study|Failed Insertion & removal|3|||
160621070|NCT03742271|579990435|FG000|Overall Study|Protocol Violation|1|||
160621071|NCT01843933|579990436|FG000|Overall Study|Data lost|6|||
160621072|NCT01843933|579990437|FG001|Overall Study|Data lost|4|||
160621073|NCT00554229|579990438|FG000|Overall Study|Lost to Follow-up|3|||
160621074|NCT00554229|579990439|FG001|Overall Study|Lost to Follow-up|6|||
160621075|NCT00554229|579990438|FG000|Overall Study|Withdrawal by Subject|29|||
160621076|NCT00554229|579990439|FG001|Overall Study|Withdrawal by Subject|37|||
160621077|NCT00554229|579990438|FG000|Overall Study|Adverse Event|71|||
160621078|NCT00554229|579990439|FG001|Overall Study|Adverse Event|39|||
160621079|NCT00554229|579990438|FG000|Overall Study|Protocol Violation|3|||
160621080|NCT00554229|579990439|FG001|Overall Study|Protocol Violation|3|||
160621081|NCT00554229|579990438|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
160621082|NCT00554229|579990439|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
160621083|NCT00554229|579990438|FG000|Overall Study|Randomised but no treatment received|1|||
160621084|NCT00554229|579990439|FG001|Overall Study|Randomised but no treatment received|0|||
160621085|NCT00939094|579990442|FG000|Overall Study|Adverse Event|9|||
160621086|NCT00939094|579990443|FG001|Overall Study|Adverse Event|0|||
160621087|NCT00939094|579990442|FG000|Overall Study|Withdrawal by Subject|1|||
160621088|NCT00939094|579990443|FG001|Overall Study|Withdrawal by Subject|6|||
160621089|NCT00939094|579990442|FG000|Overall Study|Lost to Follow-up|1|||
160621090|NCT00939094|579990443|FG001|Overall Study|Lost to Follow-up|1|||
160621091|NCT00939094|579990442|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
160511839|NCT00324675|579602078|FG000|Overall Study|Adverse Event|1|||
160511840|NCT00324675|579602079|FG001|Overall Study|Adverse Event|0|||
160511841|NCT00381615|579602080|FG000|Overall Study|Withdrawal by Subject|1|||
160511842|NCT00381615|579602081|FG001|Overall Study|Withdrawal by Subject|3|||
160511843|NCT00381615|579602082|FG002|Overall Study|Withdrawal by Subject|0|||
160511844|NCT00381615|579602083|FG003|Overall Study|Withdrawal by Subject|1|||
160511845|NCT00381615|579602080|FG000|Overall Study|Lost to Follow-up|3|||
160511846|NCT00381615|579602081|FG001|Overall Study|Lost to Follow-up|2|||
160511847|NCT00381615|579602082|FG002|Overall Study|Lost to Follow-up|0|||
160511848|NCT00381615|579602083|FG003|Overall Study|Lost to Follow-up|1|||
160511849|NCT00381615|579602080|FG000|Overall Study|Protocol Violation|0|||
160511850|NCT00381615|579602081|FG001|Overall Study|Protocol Violation|0|||
160511851|NCT00381615|579602082|FG002|Overall Study|Protocol Violation|1|||
160511852|NCT00381615|579602083|FG003|Overall Study|Protocol Violation|0|||
160511853|NCT04811131|579602089|FG000|Overall Study|Adverse Event|0|||
160511854|NCT04811131|579602090|FG001|Overall Study|Adverse Event|0|||
160511855|NCT04811131|579602091|FG002|Overall Study|Adverse Event|1|||
160511856|NCT04811131|579602092|FG003|Overall Study|Adverse Event|0|||
160511857|NCT04811131|579602089|FG000|Overall Study|Lack of Efficacy|0|||
160511858|NCT04811131|579602090|FG001|Overall Study|Lack of Efficacy|0|||
160511859|NCT04811131|579602091|FG002|Overall Study|Lack of Efficacy|0|||
160511860|NCT04811131|579602092|FG003|Overall Study|Lack of Efficacy|1|||
160511861|NCT04811131|579602089|FG000|Overall Study|Lost to Follow-up|0|||
160511862|NCT04811131|579602090|FG001|Overall Study|Lost to Follow-up|1|||
160511863|NCT04811131|579602091|FG002|Overall Study|Lost to Follow-up|0|||
160511864|NCT04811131|579602092|FG003|Overall Study|Lost to Follow-up|0|||
160511865|NCT04811131|579602089|FG000|Overall Study|Sponsor request|31|||
160511866|NCT04811131|579602090|FG001|Overall Study|Sponsor request|35|||
160511867|NCT04811131|579602091|FG002|Overall Study|Sponsor request|27|||
160511868|NCT04811131|579602092|FG003|Overall Study|Sponsor request|10|||
160511869|NCT04811131|579602089|FG000|Overall Study|Withdrawal by Subject|3|||
160511870|NCT04811131|579602090|FG001|Overall Study|Withdrawal by Subject|1|||
160511871|NCT04811131|579602091|FG002|Overall Study|Withdrawal by Subject|3|||
160511872|NCT04811131|579602092|FG003|Overall Study|Withdrawal by Subject|1|||
160511873|NCT02601300|579602095|FG000|Induction Phase|Lack of Efficacy|2|||
160664710|NCT00365365|580153509|FG002|Overall Study|Randomized but not treated|0|||
160511874|NCT02601300|579602095|FG000|Induction Phase|Protocol Violation|1|||
160511875|NCT02601300|579602095|FG000|Extension Phase|Withdrawal by Subject|3|||
160511876|NCT02601300|579602095|FG000|Extension Phase|Adverse Event|4|||
160511877|NCT02601300|579602095|FG000|Extension Phase|Lack of Efficacy|10|||
160511878|NCT01127763|579602096|FG000|Overall Study|Adverse Event|2|||
160511879|NCT01127763|579602096|FG000|Overall Study|Withdrawal by Subject|1|||
160511880|NCT01127763|579602096|FG000|Overall Study|Physician Decision|2|||
160511881|NCT03181789|579602098|FG000|Overall Study|Withdrawal by Subject|0|||
160511882|NCT03181789|579602099|FG001|Overall Study|Withdrawal by Subject|1|||
160511883|NCT03181789|579602100|FG002|Overall Study|Withdrawal by Subject|1|||
160511884|NCT03181789|579602101|FG003|Overall Study|Withdrawal by Subject|0|||
160511885|NCT03181789|579602098|FG000|Overall Study|Lost to Follow-up|7|||
160511886|NCT03181789|579602099|FG001|Overall Study|Lost to Follow-up|1|||
160511887|NCT03181789|579602100|FG002|Overall Study|Lost to Follow-up|0|||
160511888|NCT03181789|579602101|FG003|Overall Study|Lost to Follow-up|0|||
160511889|NCT03181789|579602098|FG000|Overall Study|Participant unable to adhere to visit|0|||
160511890|NCT03181789|579602099|FG001|Overall Study|Participant unable to adhere to visit|1|||
160511891|NCT03181789|579602100|FG002|Overall Study|Participant unable to adhere to visit|0|||
160511892|NCT03181789|579602101|FG003|Overall Study|Participant unable to adhere to visit|0|||
160511893|NCT01131182|579602102|FG000|Overall Study|Withdrawal by Subject|1|||
160511894|NCT01131182|579602103|FG001|Overall Study|Withdrawal by Subject|1|||
160511895|NCT01131182|579602102|FG000|Overall Study|Lost to Follow-up|14|||
160511896|NCT01131182|579602103|FG001|Overall Study|Lost to Follow-up|15|||
160511897|NCT01131182|579602102|FG000|Overall Study|Other Reason|1|||
160511898|NCT01131182|579602103|FG001|Overall Study|Other Reason|0|||
160511899|NCT00735475|579602104|FG000|Overall Study|Adverse Event|0|||
160511900|NCT00735475|579602105|FG001|Overall Study|Adverse Event|1|||
160511901|NCT00735475|579602104|FG000|Overall Study|Death|1|||
160511902|NCT00735475|579602105|FG001|Overall Study|Death|1|||
160511903|NCT00735475|579602104|FG000|Overall Study|Lost to Follow-up|3|||
160511904|NCT00735475|579602105|FG001|Overall Study|Lost to Follow-up|3|||
160511905|NCT00735475|579602104|FG000|Overall Study|Physician Decision|0|||
160511906|NCT00735475|579602105|FG001|Overall Study|Physician Decision|1|||
160511907|NCT00735475|579602104|FG000|Overall Study|Withdrawal by Subject|4|||
160511908|NCT00735475|579602105|FG001|Overall Study|Withdrawal by Subject|5|||
160511909|NCT02544451|579602108|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
160511910|NCT02544451|579602109|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
160511911|NCT02544451|579602110|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
160511912|NCT02544451|579602111|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
160511913|NCT02544451|579602108|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
160511914|NCT02544451|579602109|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
160664711|NCT00365365|580153507|FG000|Overall Study|Poor compliance to protocol|0|||
160664712|NCT00365365|580153508|FG001|Overall Study|Poor compliance to protocol|1|||
160664713|NCT00365365|580153509|FG002|Overall Study|Poor compliance to protocol|0|||
160664714|NCT00365365|580153507|FG000|Overall Study|Lost to Follow-up|3|||
160664715|NCT00365365|580153508|FG001|Overall Study|Lost to Follow-up|3|||
160664716|NCT00365365|580153509|FG002|Overall Study|Lost to Follow-up|3|||
160664717|NCT00365365|580153507|FG000|Overall Study|Death|1|||
160664718|NCT00365365|580153508|FG001|Overall Study|Death|3|||
160664719|NCT00365365|580153509|FG002|Overall Study|Death|0|||
160664720|NCT00365365|580153507|FG000|Overall Study|Subject's request|11|||
160664721|NCT00365365|580153508|FG001|Overall Study|Subject's request|13|||
160664722|NCT00365365|580153509|FG002|Overall Study|Subject's request|1|||
160664723|NCT00365365|580153507|FG000|Overall Study|Disease progression/relapse|9|||
160664724|NCT00365365|580153508|FG001|Overall Study|Disease progression/relapse|6|||
160664725|NCT00365365|580153509|FG002|Overall Study|Disease progression/relapse|7|||
160664726|NCT00365365|580153507|FG000|Overall Study|Adverse Event|6|||
160664727|NCT00365365|580153508|FG001|Overall Study|Adverse Event|6|||
160664728|NCT00365365|580153509|FG002|Overall Study|Adverse Event|3|||
160664729|NCT00365365|580153507|FG000|Overall Study|Moved|2|||
160664730|NCT00365365|580153508|FG001|Overall Study|Moved|0|||
160664731|NCT00365365|580153509|FG002|Overall Study|Moved|0|||
160664732|NCT00365365|580153507|FG000|Overall Study|New cancer|1|||
160664733|NCT00365365|580153508|FG001|Overall Study|New cancer|0|||
160664734|NCT00365365|580153509|FG002|Overall Study|New cancer|0|||
160664735|NCT00365365|580153507|FG000|Overall Study|Withdrew consent|1|||
160664736|NCT00365365|580153508|FG001|Overall Study|Withdrew consent|1|||
160664737|NCT00365365|580153509|FG002|Overall Study|Withdrew consent|0|||
160664738|NCT00365365|580153507|FG000|Overall Study|Second malignancy|0|||
160664739|NCT00365365|580153508|FG001|Overall Study|Second malignancy|1|||
160664740|NCT00365365|580153509|FG002|Overall Study|Second malignancy|0|||
160664741|NCT00365365|580153507|FG000|Overall Study|Patient/physician decision|0|||
160664742|NCT00365365|580153508|FG001|Overall Study|Patient/physician decision|0|||
160664743|NCT00365365|580153509|FG002|Overall Study|Patient/physician decision|1|||
160664744|NCT02472366|580153513|FG000|Overall Study|Lost to Follow-up|1|||
160664745|NCT02472366|580153514|FG001|Overall Study|Lost to Follow-up|0|||
160664746|NCT03699020|580153517|FG000|Overall Study|Withdrawal by Subject|3|||
160664747|NCT03699020|580153518|FG001|Overall Study|Withdrawal by Subject|2|||
160664748|NCT04274686|580153522|FG000|Overall Study|Physician Decision|1|||
160664749|NCT04274686|580153523|FG001|Overall Study|Physician Decision|0|||
160664750|NCT01037114|580153524|FG000|Year 20|Others|1|||
160664751|NCT01602419|580153525|FG000|Overall Study|Not treated with Wilate|9|||
160664752|NCT01602419|580153525|FG000|Overall Study|Adverse Drug Reaction|4|||
160664753|NCT01602419|580153525|FG000|Overall Study|Insurance issues|3|||
160664754|NCT01602419|580153525|FG000|Overall Study|Changed treatment centre|1|||
160664755|NCT01602419|580153525|FG000|Overall Study|Treatment centre closed|1|||
160664756|NCT01602419|580153525|FG000|Overall Study|Withdrawal by Subject|5|||
160664757|NCT01602419|580153525|FG000|Overall Study|Lost to Follow-up|6|||
160664758|NCT03620747|580153532|FG000|Overall Study|Participant decision|7|||
160664759|NCT03620747|580153532|FG000|Overall Study|Adverse Event|6|||
160664760|NCT03620747|580153532|FG000|Overall Study|Lack of Efficacy|1|||
160664761|NCT03620747|580153532|FG000|Overall Study|Poor compliance to protocol|2|||
160664762|NCT03620747|580153532|FG000|Overall Study|Other-unspecified|3|||
160664763|NCT01745120|580153535|FG000|Overall Study|Investigator decision|1|||
160664764|NCT01745120|580153536|FG001|Overall Study|Investigator decision|0|||
160664765|NCT00850174|580153544|FG000|Washout: One Week|Withdrawal by Subject|0|||
160664766|NCT00850174|580153545|FG001|Washout: One Week|Withdrawal by Subject|2|||
160664767|NCT00850174|580153544|FG000|Second Intervention|Withdrawal by Subject|1|||
160664768|NCT00850174|580153545|FG001|Second Intervention|Withdrawal by Subject|0|||
160664769|NCT00635492|580153546|FG000|Overall Study|Death|12|||
160664770|NCT00635492|580153547|FG001|Overall Study|Death|40|||
160664771|NCT00635492|580153546|FG000|Overall Study|Lost to Follow-up|151|||
160664772|NCT00635492|580153547|FG001|Overall Study|Lost to Follow-up|172|||
160664773|NCT00635492|580153546|FG000|Overall Study|Physician Decision|32|||
160664774|NCT00635492|580153547|FG001|Overall Study|Physician Decision|22|||
160664775|NCT00635492|580153546|FG000|Overall Study|Sponsor decision|2|||
160664776|NCT00635492|580153547|FG001|Overall Study|Sponsor decision|3|||
160664777|NCT00635492|580153546|FG000|Overall Study|Withdrawal by Subject|82|||
160664778|NCT00635492|580153547|FG001|Overall Study|Withdrawal by Subject|45|||
160664779|NCT04533594|580153552|FG000|Overall Study|Death|26|||
160664780|NCT01200810|580153555|FG000|Overall Study|Physician Decision|1|||
160664781|NCT01200810|580153556|FG001|Overall Study|Physician Decision|0|||
160664782|NCT01200810|580153555|FG000|Overall Study|Withdrawal by Subject|1|||
160664783|NCT01200810|580153556|FG001|Overall Study|Withdrawal by Subject|2|||
160664784|NCT01200810|580153555|FG000|Overall Study|Sponsor stopped making study drug|3|||
160664785|NCT01200810|580153556|FG001|Overall Study|Sponsor stopped making study drug|3|||
160664786|NCT03500341|580153560|FG000|Overall Study|Withdrawn prior to Completion|2|||
160664787|NCT00640562|580153563|FG000|Overall Study|Adverse Event|8|||
160664788|NCT00640562|580153564|FG001|Overall Study|Adverse Event|5|||
160664789|NCT00640562|580153563|FG000|Overall Study|Lack of Efficacy|1|||
160664790|NCT00640562|580153564|FG001|Overall Study|Lack of Efficacy|4|||
160664791|NCT00640562|580153563|FG000|Overall Study|Protocol Violation|2|||
160664792|NCT00640562|580153564|FG001|Overall Study|Protocol Violation|4|||
160664793|NCT00640562|580153563|FG000|Overall Study|Withdrawal by Subject|6|||
160664794|NCT00640562|580153564|FG001|Overall Study|Withdrawal by Subject|10|||
160664795|NCT00640562|580153563|FG000|Overall Study|Known risperidone intolerance|0|||
160664796|NCT00640562|580153564|FG001|Overall Study|Known risperidone intolerance|1|||
160664797|NCT00640562|580153563|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
160664798|NCT00640562|580153564|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
160664799|NCT00640562|580153563|FG000|Overall Study|Low study drug dose|0|||
160664800|NCT00640562|580153564|FG001|Overall Study|Low study drug dose|1|||
160664801|NCT00640562|580153563|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
160664802|NCT00640562|580153564|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
160664803|NCT02699866|580153565|FG000|Overall Study|Withdrawal by Subject|3|||
160664804|NCT02699866|580153565|FG000|Overall Study|Physician Decision|2|||
160664805|NCT02699866|580153565|FG000|Overall Study|Adverse Event|3|||
160664806|NCT02937870|580153566|FG000|Overall Study|Adverse Event|1|||
160664807|NCT02937870|580153566|FG000|Overall Study|Protocol Deviation|2|||
160664808|NCT00244764|580153567|FG000|Overall Study|Adverse Event|37|||
160664809|NCT00244764|580153567|FG000|Overall Study|Lost to Follow-up|23|||
160664810|NCT00244764|580153567|FG000|Overall Study|Withdrawal by Subject|12|||
160664811|NCT00244764|580153567|FG000|Overall Study|Disease Progression|13|||
160664812|NCT00244764|580153567|FG000|Overall Study|Protocol Violation|2|||
160664813|NCT00244764|580153567|FG000|Overall Study|Death|1|||
160664814|NCT00244764|580153567|FG000|Overall Study|Off Study Medication for >21 Days|1|||
160664815|NCT00244764|580153567|FG000|Overall Study|Declining Performance Status|1|||
160664816|NCT00244764|580153567|FG000|Overall Study|Participant was Hospitalized until Death|1|||
160664817|NCT00244764|580153567|FG000|Overall Study|Primary Investigator Discretion|2|||
160664818|NCT00244764|580153567|FG000|Overall Study|Sponsor Terminated Study|2|||
160664819|NCT00244764|580153567|FG000|Overall Study|Developed Secondary Malignancy|1|||
160664820|NCT01294917|580153568|FG000|Overall Study|Relocation|5|||
160664821|NCT01294917|580153568|FG000|Overall Study|Inconvenience|1|||
160664822|NCT03017885|580153569|FG000|Overall Study|Adverse Event|2|||
160664823|NCT03017885|580153570|FG001|Overall Study|Adverse Event|0|||
160664824|NCT03017885|580153571|FG002|Overall Study|Adverse Event|0|||
160664825|NCT03017885|580153572|FG003|Overall Study|Adverse Event|0|||
160664826|NCT03017885|580153573|FG004|Overall Study|Adverse Event|0|||
160664827|NCT03017885|580153574|FG005|Overall Study|Adverse Event|0|||
160664828|NCT03017885|580153569|FG000|Overall Study|Progression of disease|4|||
160664829|NCT03017885|580153570|FG001|Overall Study|Progression of disease|3|||
160664830|NCT03017885|580153571|FG002|Overall Study|Progression of disease|4|||
160664831|NCT03017885|580153572|FG003|Overall Study|Progression of disease|0|||
160664832|NCT03017885|580153573|FG004|Overall Study|Progression of disease|0|||
160664833|NCT03017885|580153574|FG005|Overall Study|Progression of disease|0|||
160664834|NCT03017885|580153569|FG000|Overall Study|Other than listed|1|||
160664835|NCT03017885|580153570|FG001|Overall Study|Other than listed|2|||
160664836|NCT03017885|580153571|FG002|Overall Study|Other than listed|1|||
160664837|NCT03017885|580153572|FG003|Overall Study|Other than listed|0|||
160664838|NCT03017885|580153573|FG004|Overall Study|Other than listed|0|||
160664839|NCT03017885|580153574|FG005|Overall Study|Other than listed|0|||
160664840|NCT03017885|580153569|FG000|Overall Study|Lost to Follow-up|2|||
160664841|NCT03017885|580153570|FG001|Overall Study|Lost to Follow-up|0|||
160664842|NCT03017885|580153571|FG002|Overall Study|Lost to Follow-up|3|||
160664843|NCT03017885|580153572|FG003|Overall Study|Lost to Follow-up|0|||
160664844|NCT03017885|580153573|FG004|Overall Study|Lost to Follow-up|0|||
160664845|NCT03017885|580153574|FG005|Overall Study|Lost to Follow-up|0|||
160664846|NCT03017885|580153569|FG000|Overall Study|Change to other anti-cancer therapy|0|||
160664847|NCT03017885|580153570|FG001|Overall Study|Change to other anti-cancer therapy|0|||
160664848|NCT03017885|580153571|FG002|Overall Study|Change to other anti-cancer therapy|1|||
160664849|NCT03017885|580153572|FG003|Overall Study|Change to other anti-cancer therapy|0|||
160664850|NCT03017885|580153573|FG004|Overall Study|Change to other anti-cancer therapy|0|||
160664851|NCT03017885|580153574|FG005|Overall Study|Change to other anti-cancer therapy|0|||
160664852|NCT01208337|580153581|FG000|Overall Study|Death|3|||
160664853|NCT00836056|580153584|FG000|First Intervention|Adverse Event|1|||
160664854|NCT00836056|580153585|FG001|First Intervention|Adverse Event|0|||
160664855|NCT01001208|580153589|FG000|Overall Study|Adverse Event|10|||
160664856|NCT01001208|580153590|FG001|Overall Study|Adverse Event|5|||
160664857|NCT01001208|580153589|FG000|Overall Study|Lost to Follow-up|5|||
160664858|NCT01001208|580153590|FG001|Overall Study|Lost to Follow-up|9|||
160664859|NCT01001208|580153589|FG000|Overall Study|Physician Decision|1|||
160664860|NCT01001208|580153590|FG001|Overall Study|Physician Decision|0|||
160664861|NCT01001208|580153589|FG000|Overall Study|Withdrawal by Subject|4|||
160664862|NCT01001208|580153590|FG001|Overall Study|Withdrawal by Subject|5|||
160664863|NCT01001208|580153589|FG000|Overall Study|Ineligibility Determined|4|||
160664864|NCT01001208|580153590|FG001|Overall Study|Ineligibility Determined|2|||
160664865|NCT01001208|580153589|FG000|Overall Study|Noncompliance|4|||
160664866|NCT01001208|580153590|FG001|Overall Study|Noncompliance|7|||
160664867|NCT01001208|580153589|FG000|Overall Study|Disease Progression|0|||
160664868|NCT01001208|580153590|FG001|Overall Study|Disease Progression|3|||
160664869|NCT01001208|580153589|FG000|Overall Study|Other|0|||
160664870|NCT01001208|580153590|FG001|Overall Study|Other|2|||
160664871|NCT01864174|580153591|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
160664872|NCT01864174|580153592|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
160664873|NCT01864174|580153591|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
160664874|NCT01864174|580153592|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
160664875|NCT01864174|580153591|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
160664876|NCT01864174|580153592|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
160664877|NCT01864174|580153591|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
160664878|NCT01864174|580153592|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
160664879|NCT01864174|580153591|FG000|Double Blind - Compliant Randomized|Death|1|||
160664880|NCT01864174|580153592|FG001|Double Blind - Compliant Randomized|Death|0|||
160664881|NCT01864174|580153591|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
160664882|NCT01864174|580153592|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
160664883|NCT01864174|580153591|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
160664884|NCT01864174|580153592|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
160664885|NCT01864174|580153591|FG000|Double Blind - Compliant Randomized|Other|6|||
160664886|NCT01864174|580153592|FG001|Double Blind - Compliant Randomized|Other|10|||
160664887|NCT01864174|580153591|FG000|Off Treatment Follow-Up|Other|2|||
160664888|NCT01864174|580153592|FG001|Off Treatment Follow-Up|Other|0|||
160664889|NCT01864174|580153591|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
160664890|NCT01864174|580153592|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
160664891|NCT02648347|580153593|FG000|Overall Study|Death|174|||
160664892|NCT02648347|580153594|FG001|Overall Study|Death|167|||
160664893|NCT02648347|580153593|FG000|Overall Study|Withdrawal by Subject|16|||
160664894|NCT02648347|580153594|FG001|Overall Study|Withdrawal by Subject|9|||
160664895|NCT02648347|580153593|FG000|Overall Study|Lost to Follow-up|18|||
160664896|NCT02648347|580153594|FG001|Overall Study|Lost to Follow-up|21|||
160664897|NCT02648347|580153593|FG000|Overall Study|Missing|1|||
160664898|NCT02648347|580153594|FG001|Overall Study|Missing|0|||
160664899|NCT03546842|580153596|FG000|Overall Study|Protocol Violation|1|||
160664900|NCT03546842|580153596|FG000|Overall Study|Withdrawal by Subject|2|||
160664901|NCT01723397|580153597|FG000|Study Period 1|Protocol Violation|0|||
160664902|NCT01723397|580153598|FG001|Study Period 1|Protocol Violation|1|||
160664903|NCT01723397|580153597|FG000|Study Period 2|Protocol Violation|0|||
160664904|NCT01723397|580153598|FG001|Study Period 2|Protocol Violation|1|||
160664905|NCT02739997|580153599|FG000|Overall Study|Death|1|||
160664906|NCT02739997|580153599|FG000|Overall Study|Withdrawal by Subject|1|||
160664907|NCT00468286|580153602|FG000|Overall Study|Adverse Event|1|||
160664908|NCT00468286|580153603|FG001|Overall Study|Adverse Event|6|||
160664909|NCT00468286|580153602|FG000|Overall Study|Protocol Violation|2|||
160664910|NCT00468286|580153603|FG001|Overall Study|Protocol Violation|2|||
160664911|NCT00468286|580153602|FG000|Overall Study|Withdrawal by Subject|4|||
160664912|NCT00468286|580153603|FG001|Overall Study|Withdrawal by Subject|3|||
160664913|NCT00468286|580153602|FG000|Overall Study|Physician Decision|0|||
160664914|NCT00468286|580153603|FG001|Overall Study|Physician Decision|1|||
160664915|NCT02196675|580153606|FG000|Overall Study|Withdrawal by Subject|1|||
160664916|NCT02196675|580153607|FG001|Overall Study|Withdrawal by Subject|0|||
160664917|NCT02196675|580153608|FG002|Overall Study|Withdrawal by Subject|0|||
160664918|NCT02196675|580153606|FG000|Overall Study|Intra-operative surgical exclusion|1|||
160664919|NCT02196675|580153607|FG001|Overall Study|Intra-operative surgical exclusion|1|||
160664920|NCT02196675|580153608|FG002|Overall Study|Intra-operative surgical exclusion|0|||
160664921|NCT02196675|580153606|FG000|Overall Study|Protocol Violation|0|||
160664922|NCT02196675|580153607|FG001|Overall Study|Protocol Violation|1|||
160664923|NCT02196675|580153608|FG002|Overall Study|Protocol Violation|0|||
160664924|NCT02196675|580153606|FG000|Overall Study|Death|0|||
160664925|NCT02196675|580153607|FG001|Overall Study|Death|0|||
160664926|NCT02196675|580153608|FG002|Overall Study|Death|1|||
160664927|NCT01424644|580153609|FG000|Overall Study|Adverse Event|2|||
160664928|NCT01424644|580153610|FG001|Overall Study|Adverse Event|0|||
160664929|NCT01424644|580153609|FG000|Overall Study|Withdrawal by Subject|9|||
160664930|NCT01424644|580153610|FG001|Overall Study|Withdrawal by Subject|12|||
160664931|NCT01424644|580153609|FG000|Overall Study|Lost to Follow-up|16|||
160664932|NCT01424644|580153610|FG001|Overall Study|Lost to Follow-up|12|||
160664933|NCT01424644|580153609|FG000|Overall Study|Protocol Violation|4|||
160664934|NCT01424644|580153610|FG001|Overall Study|Protocol Violation|3|||
160664935|NCT01424644|580153609|FG000|Overall Study|Administrative Reason|1|||
160664936|NCT01424644|580153610|FG001|Overall Study|Administrative Reason|0|||
160664937|NCT01424644|580153609|FG000|Overall Study|Unable to Classify|1|||
160664938|NCT01424644|580153610|FG001|Overall Study|Unable to Classify|0|||
160664939|NCT00837486|580153611|FG000|Blinded-treatment Phase|Physician Decision|1|||
160664940|NCT00837486|580153612|FG001|Blinded-treatment Phase|Physician Decision|0|||
160664941|NCT00837486|580153611|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
160621092|NCT00939094|579990443|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160621093|NCT00939094|579990442|FG000|Overall Study|Severe non-compliance to protocol|0|||
160621094|NCT00939094|579990443|FG001|Overall Study|Severe non-compliance to protocol|1|||
160621095|NCT00939094|579990442|FG000|Overall Study|Study stopped by sponsor|0|||
160621096|NCT00939094|579990443|FG001|Overall Study|Study stopped by sponsor|2|||
160621097|NCT00939094|579990442|FG000|Overall Study|Abnormal ECG findings|1|||
160621098|NCT00939094|579990443|FG001|Overall Study|Abnormal ECG findings|0|||
160621099|NCT01078389|579992458|FG000|Overall Study|Adverse Event|10|||
160621100|NCT01078389|579992459|FG001|Overall Study|Adverse Event|6|||
160621101|NCT01078389|579992458|FG000|Overall Study|Major Protocol Deviation|2|||
160621102|NCT01078389|579992459|FG001|Overall Study|Major Protocol Deviation|0|||
160621103|NCT01078389|579992458|FG000|Overall Study|Lost to Follow-up|23|||
160621104|NCT01078389|579992459|FG001|Overall Study|Lost to Follow-up|23|||
160621105|NCT01078389|579992458|FG000|Overall Study|Voluntary Withdrawal|20|||
160621106|NCT01078389|579992459|FG001|Overall Study|Voluntary Withdrawal|36|||
160621107|NCT01078389|579992458|FG000|Overall Study|Other|9|||
160621108|NCT01078389|579992459|FG001|Overall Study|Other|2|||
160621109|NCT03726320|579992460|FG000|Overall Study|Lost to Follow-up|2|||
160621110|NCT03726320|579992461|FG001|Overall Study|Lost to Follow-up|4|||
160621111|NCT03726320|579992462|FG002|Overall Study|Lost to Follow-up|0|||
160621112|NCT03726320|579992460|FG000|Overall Study|Time Constraints|4|||
160621113|NCT03726320|579992461|FG001|Overall Study|Time Constraints|1|||
160621114|NCT03726320|579992462|FG002|Overall Study|Time Constraints|0|||
160621115|NCT03726320|579992460|FG000|Overall Study|Ineligible after enrollment|3|||
160621116|NCT03726320|579992461|FG001|Overall Study|Ineligible after enrollment|3|||
160621117|NCT03726320|579992462|FG002|Overall Study|Ineligible after enrollment|0|||
160621118|NCT03726320|579992460|FG000|Overall Study|Clinic / insurance issue|2|||
160621119|NCT03726320|579992461|FG001|Overall Study|Clinic / insurance issue|0|||
160621120|NCT03726320|579992462|FG002|Overall Study|Clinic / insurance issue|0|||
160621121|NCT03726320|579992460|FG000|Overall Study|Language barrier|1|||
160621122|NCT03726320|579992461|FG001|Overall Study|Language barrier|0|||
160621123|NCT03726320|579992462|FG002|Overall Study|Language barrier|0|||
160621124|NCT03726320|579992460|FG000|Overall Study|Provider left the clinic|0|||
160621125|NCT03726320|579992461|FG001|Overall Study|Provider left the clinic|0|||
160621126|NCT03726320|579992462|FG002|Overall Study|Provider left the clinic|1|||
160621127|NCT02361307|579992465|FG000|Overall Study|Unstable medical condition.|0|||
160621128|NCT02361307|579992466|FG001|Overall Study|Unstable medical condition.|1|||
160621129|NCT00421928|579992467|FG000|Overall Study|Adverse Event|61|||
160621130|NCT00421928|579992468|FG001|Overall Study|Adverse Event|140|||
160621131|NCT00421928|579992469|FG002|Overall Study|Adverse Event|22|||
160621132|NCT00421928|579992467|FG000|Overall Study|Lost to Follow-up|5|||
160621133|NCT00421928|579992468|FG001|Overall Study|Lost to Follow-up|0|||
160621134|NCT00421928|579992469|FG002|Overall Study|Lost to Follow-up|3|||
160621135|NCT00421928|579992467|FG000|Overall Study|Withdrawal by Subject|50|||
160621136|NCT00421928|579992468|FG001|Overall Study|Withdrawal by Subject|48|||
160621137|NCT00421928|579992469|FG002|Overall Study|Withdrawal by Subject|43|||
160621138|NCT00421928|579992467|FG000|Overall Study|Lack of Efficacy|15|||
160621139|NCT00421928|579992468|FG001|Overall Study|Lack of Efficacy|7|||
160621140|NCT00421928|579992469|FG002|Overall Study|Lack of Efficacy|35|||
160621141|NCT00421928|579992467|FG000|Overall Study|Study drug non-compliant|6|||
160621142|NCT00421928|579992468|FG001|Overall Study|Study drug non-compliant|7|||
160621143|NCT00421928|579992469|FG002|Overall Study|Study drug non-compliant|4|||
160621144|NCT00421928|579992467|FG000|Overall Study|All other|26|||
160621145|NCT00421928|579992468|FG001|Overall Study|All other|21|||
160621146|NCT00421928|579992469|FG002|Overall Study|All other|27|||
160621147|NCT00421928|579992467|FG000|Overall Study|Death|0|||
160621148|NCT00421928|579992468|FG001|Overall Study|Death|1|||
160621149|NCT00421928|579992469|FG002|Overall Study|Death|0|||
160621150|NCT00346775|579992470|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
160621151|NCT00346775|579992471|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
160621152|NCT00346775|579992470|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
160621153|NCT00346775|579992471|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
160621154|NCT00346775|579992470|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
160621155|NCT00346775|579992471|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
160621156|NCT02946515|579992472|FG000|Overall Study|Lost to Follow-up|2|||
160621157|NCT02946515|579992473|FG001|Overall Study|Lost to Follow-up|1|||
160621158|NCT01096017|579992478|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
160621159|NCT01096017|579992479|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
160621160|NCT04177862|579992483|FG000|Overall Study|Protocol Violation|2|||
160621161|NCT04177862|579992484|FG001|Overall Study|Protocol Violation|7|||
160621162|NCT05637515|579992485|FG000|Overall Study|Withdrawal by Subject|17|||
160621163|NCT05637515|579992486|FG001|Overall Study|Withdrawal by Subject|17|||
160621164|NCT04516291|579992488|FG000|Treatment Period (24 Weeks)|Other|1|||
160621165|NCT04516291|579992489|FG001|Treatment Period (24 Weeks)|Other|0|||
160621166|NCT04516291|579992490|FG002|Treatment Period (24 Weeks)|Other|0|||
160621167|NCT04516291|579992491|FG003|Treatment Period (24 Weeks)|Other|2|||
160621168|NCT04516291|579992492|FG004|Treatment Period (24 Weeks)|Other|2|||
160621169|NCT04516291|579992493|FG005|Treatment Period (24 Weeks)|Other|4|||
160621170|NCT04516291|579992494|FG006|Treatment Period (24 Weeks)|Other|2|||
160621171|NCT04516291|579992495|FG007|Treatment Period (24 Weeks)|Other|0|||
160621172|NCT04516291|579992488|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160621173|NCT04516291|579992489|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
160621174|NCT04516291|579992490|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
160621175|NCT04516291|579992491|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160621176|NCT04516291|579992492|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
160621177|NCT04516291|579992493|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160621178|NCT04516291|579992494|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160621179|NCT04516291|579992495|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160621180|NCT04516291|579992488|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
160621181|NCT04516291|579992489|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
160621182|NCT04516291|579992490|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
160621183|NCT04516291|579992491|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
160621184|NCT04516291|579992492|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
160621185|NCT04516291|579992493|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
160621186|NCT04516291|579992494|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
160621187|NCT04516291|579992495|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
160621188|NCT04516291|579992488|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160621189|NCT04516291|579992489|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
160621190|NCT04516291|579992490|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160621191|NCT04516291|579992491|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160621192|NCT04516291|579992492|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160621193|NCT04516291|579992493|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160621194|NCT04516291|579992494|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160621195|NCT04516291|579992495|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160621196|NCT04516291|579992488|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
160621197|NCT04516291|579992489|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
160621198|NCT04516291|579992490|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
160621199|NCT04516291|579992491|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
160621200|NCT04516291|579992492|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
160621201|NCT04516291|579992493|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
160621202|NCT04516291|579992494|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
160621203|NCT04516291|579992495|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
160621204|NCT04516291|579992488|FG000|Follow-up Period (12 Weeks)|Other|0|||
160621205|NCT04516291|579992489|FG001|Follow-up Period (12 Weeks)|Other|1|||
160621206|NCT04516291|579992490|FG002|Follow-up Period (12 Weeks)|Other|0|||
160621207|NCT04516291|579992491|FG003|Follow-up Period (12 Weeks)|Other|2|||
160621208|NCT04516291|579992492|FG004|Follow-up Period (12 Weeks)|Other|0|||
160621209|NCT04516291|579992493|FG005|Follow-up Period (12 Weeks)|Other|0|||
160621210|NCT04516291|579992494|FG006|Follow-up Period (12 Weeks)|Other|0|||
160621211|NCT04516291|579992495|FG007|Follow-up Period (12 Weeks)|Other|0|||
160621212|NCT04516291|579992488|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
160621213|NCT04516291|579992489|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
160621214|NCT04516291|579992490|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
160621215|NCT04516291|579992491|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
160621216|NCT04516291|579992492|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
160621217|NCT04516291|579992493|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
160621218|NCT04516291|579992494|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
160621219|NCT04516291|579992495|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
160621220|NCT04516291|579992488|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
160621221|NCT04516291|579992489|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
160621222|NCT04516291|579992490|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
160621223|NCT04516291|579992491|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
160621224|NCT04516291|579992492|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
160621225|NCT04516291|579992493|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
160621226|NCT04516291|579992494|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
160621227|NCT04516291|579992495|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
160621228|NCT01855607|579992496|FG000|Overall Study|Withdrawal by Subject|1|||
160621229|NCT01855607|579992496|FG000|Overall Study|Study was terminated|11|||
160621230|NCT02181634|579992497|FG000|Overall Study|Lack of Efficacy|33|||
160621231|NCT02181634|579992497|FG000|Overall Study|Adverse Event|17|||
160621232|NCT02181634|579992497|FG000|Overall Study|Physician Decision|8|||
160621233|NCT02181634|579992497|FG000|Overall Study|Withdrawal by Subject|5|||
160621234|NCT02181634|579992497|FG000|Overall Study|Death|2|||
160621235|NCT02181634|579992497|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
160621236|NCT02181634|579992497|FG000|Overall Study|Ineligible|1|||
160664942|NCT00837486|580153612|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
160621237|NCT02181634|579992497|FG000|Overall Study|Max number of dose reduction|1|||
160621238|NCT02181634|579992497|FG000|Overall Study|Symptomatic progression|1|||
160621239|NCT02181634|579992497|FG000|Overall Study|Patient opted to proceed to surgery|1|||
160621240|NCT03824704|579992503|FG000|Overall Study|Study Terminated by Sponsor|1|||
160621241|NCT02087085|579992504|FG000|Overall Study|Adverse Event|10|||
160511915|NCT02544451|579602110|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
160511916|NCT02544451|579602111|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
160511917|NCT02544451|579602108|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
160511918|NCT02544451|579602109|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
160511919|NCT02544451|579602110|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
160511920|NCT02544451|579602111|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
160511921|NCT02544451|579602108|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
160511922|NCT02544451|579602109|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
160511923|NCT02544451|579602110|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
160511924|NCT02544451|579602111|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
160511925|NCT02544451|579602108|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
160511926|NCT02544451|579602109|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
160511927|NCT02544451|579602110|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
160511928|NCT02544451|579602111|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
160511929|NCT02544451|579602108|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
160511930|NCT02544451|579602109|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
160511931|NCT02544451|579602110|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
160511932|NCT02544451|579602111|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
160511933|NCT04602221|579602112|FG000|Overall Study|Discontinuation of trial treatment|0|||
160511934|NCT04602221|579602113|FG001|Overall Study|Discontinuation of trial treatment|0|||
160511935|NCT04602221|579602114|FG002|Overall Study|Discontinuation of trial treatment|1|||
160511936|NCT04602221|579602115|FG003|Overall Study|Discontinuation of trial treatment|0|||
160511937|NCT04602221|579602116|FG004|Overall Study|Discontinuation of trial treatment|0|||
160511938|NCT04602221|579602117|FG005|Overall Study|Discontinuation of trial treatment|0|||
160511939|NCT04602221|579602118|FG006|Overall Study|Discontinuation of trial treatment|0|||
160511940|NCT04602221|579602119|FG007|Overall Study|Discontinuation of trial treatment|0|||
160511941|NCT04602221|579602120|FG008|Overall Study|Discontinuation of trial treatment|0|||
160511942|NCT04602221|579602121|FG009|Overall Study|Discontinuation of trial treatment|0|||
160511943|NCT04602221|579602122|FG010|Overall Study|Discontinuation of trial treatment|0|||
160511944|NCT04602221|579602123|FG011|Overall Study|Discontinuation of trial treatment|0|||
160511945|NCT04602221|579602124|FG012|Overall Study|Discontinuation of trial treatment|0|||
160511946|NCT04602221|579602125|FG013|Overall Study|Discontinuation of trial treatment|0|||
160511947|NCT04602221|579602126|FG014|Overall Study|Discontinuation of trial treatment|0|||
160511948|NCT04602221|579602127|FG015|Overall Study|Discontinuation of trial treatment|0|||
160511949|NCT04602221|579602128|FG016|Overall Study|Discontinuation of trial treatment|0|||
160621242|NCT02087085|579992505|FG001|Overall Study|Adverse Event|14|||
160621243|NCT02087085|579992504|FG000|Overall Study|Lack of Efficacy|4|||
160621244|NCT02087085|579992505|FG001|Overall Study|Lack of Efficacy|3|||
160621245|NCT02087085|579992504|FG000|Overall Study|Lost to Follow-up|6|||
160621246|NCT02087085|579992505|FG001|Overall Study|Lost to Follow-up|4|||
160621247|NCT02087085|579992504|FG000|Overall Study|Withdrawal by Subject|9|||
160621248|NCT02087085|579992505|FG001|Overall Study|Withdrawal by Subject|11|||
160621249|NCT02087085|579992504|FG000|Overall Study|Protocol Violation|1|||
160621250|NCT02087085|579992505|FG001|Overall Study|Protocol Violation|0|||
160621251|NCT02087085|579992504|FG000|Overall Study|Study Terminated by Sponsor|87|||
160621252|NCT02087085|579992505|FG001|Overall Study|Study Terminated by Sponsor|80|||
160621253|NCT02087085|579992504|FG000|Overall Study|Other Miscellaneous Reasons|3|||
160621254|NCT02087085|579992505|FG001|Overall Study|Other Miscellaneous Reasons|4|||
160621255|NCT00635804|579992506|FG000|Overall Study|Adverse Event|0|||
160621256|NCT00635804|579992507|FG001|Overall Study|Adverse Event|0|||
160621257|NCT00635804|579992508|FG002|Overall Study|Adverse Event|0|||
160621258|NCT00635804|579992509|FG003|Overall Study|Adverse Event|0|||
160621259|NCT00635804|579992510|FG004|Overall Study|Adverse Event|0|||
160621260|NCT00635804|579992511|FG005|Overall Study|Adverse Event|1|||
160621261|NCT00635804|579992512|FG006|Overall Study|Adverse Event|0|||
160621262|NCT00635804|579992513|FG007|Overall Study|Adverse Event|0|||
160621263|NCT00635804|579992506|FG000|Overall Study|Withdrawal by Subject|1|||
160621264|NCT00635804|579992507|FG001|Overall Study|Withdrawal by Subject|0|||
160621265|NCT00635804|579992508|FG002|Overall Study|Withdrawal by Subject|0|||
160621266|NCT00635804|579992509|FG003|Overall Study|Withdrawal by Subject|0|||
160621267|NCT00635804|579992510|FG004|Overall Study|Withdrawal by Subject|0|||
160621268|NCT00635804|579992511|FG005|Overall Study|Withdrawal by Subject|0|||
160621269|NCT00635804|579992512|FG006|Overall Study|Withdrawal by Subject|0|||
160621270|NCT00635804|579992513|FG007|Overall Study|Withdrawal by Subject|0|||
160621271|NCT01425268|579992515|FG000|Overall Study|Withdrawal by Subject|2|||
160621272|NCT01425268|579992516|FG001|Overall Study|Withdrawal by Subject|0|||
160621273|NCT01425268|579992515|FG000|Overall Study|Sponsor Decision|5|||
160621274|NCT01425268|579992516|FG001|Overall Study|Sponsor Decision|0|||
160621275|NCT01425268|579992515|FG000|Overall Study|Physician Decision|1|||
160621276|NCT01425268|579992516|FG001|Overall Study|Physician Decision|0|||
160621277|NCT02839330|579992517|FG000|Overall Study|Adverse Event|0|||
160621278|NCT02839330|579992518|FG001|Overall Study|Adverse Event|1|||
160621279|NCT02839330|579992519|FG002|Overall Study|Adverse Event|2|||
160664943|NCT00837486|580153611|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
160664944|NCT00837486|580153612|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
160664945|NCT00837486|580153611|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
160664946|NCT00837486|580153612|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
160664947|NCT01421277|580153613|FG000|Overall Study|Lack of qualifying event|0|||
160664948|NCT01421277|580153614|FG001|Overall Study|Lack of qualifying event|61|||
160664949|NCT01421277|580153613|FG000|Overall Study|Incomplete baseline data|0|||
160664950|NCT01421277|580153614|FG001|Overall Study|Incomplete baseline data|31|||
160664951|NCT02039908|580153615|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
160664952|NCT02039908|580153616|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
160664953|NCT02039908|580153617|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
160664954|NCT02039908|580153618|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
160664955|NCT02039908|580153615|FG000|Phase 1-Summer|Protocol Violation|6|||
160664956|NCT02039908|580153616|FG001|Phase 1-Summer|Protocol Violation|0|||
160664957|NCT02039908|580153617|FG002|Phase 1-Summer|Protocol Violation|0|||
160664958|NCT02039908|580153618|FG003|Phase 1-Summer|Protocol Violation|0|||
160664959|NCT02039908|580153615|FG000|Phase 2-School Year|Lost to Follow-up|0|||
160664960|NCT02039908|580153616|FG001|Phase 2-School Year|Lost to Follow-up|0|||
160664961|NCT02039908|580153617|FG002|Phase 2-School Year|Lost to Follow-up|1|||
160664962|NCT02039908|580153618|FG003|Phase 2-School Year|Lost to Follow-up|3|||
160664963|NCT02039908|580153615|FG000|Phase 2-School Year|Protocol Violation|0|||
160664964|NCT02039908|580153616|FG001|Phase 2-School Year|Protocol Violation|0|||
160664965|NCT02039908|580153617|FG002|Phase 2-School Year|Protocol Violation|3|||
160664966|NCT02039908|580153618|FG003|Phase 2-School Year|Protocol Violation|0|||
160664967|NCT02039908|580153615|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
160664968|NCT02039908|580153616|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
160664969|NCT02039908|580153617|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
160664970|NCT02039908|580153618|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
160664971|NCT00731783|580153619|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
160664972|NCT00731783|580153620|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
160664973|NCT00731783|580153619|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
160664974|NCT00731783|580153620|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
160664975|NCT00731783|580153619|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
160664976|NCT00731783|580153620|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
160664977|NCT00731783|580153619|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
160664978|NCT00731783|580153620|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
160664979|NCT04115293|580155365|FG000|Overall Study|Adverse Event|0|||
160664980|NCT04115293|580155366|FG001|Overall Study|Adverse Event|2|||
160664981|NCT04115293|580155365|FG000|Overall Study|Withdrawal by Subject|2|||
160664982|NCT04115293|580155366|FG001|Overall Study|Withdrawal by Subject|1|||
160664983|NCT04115293|580155365|FG000|Overall Study|Physician Decision|1|||
160664984|NCT04115293|580155366|FG001|Overall Study|Physician Decision|0|||
160664985|NCT04115293|580155365|FG000|Overall Study|Death|1|||
160664986|NCT04115293|580155366|FG001|Overall Study|Death|1|||
160664987|NCT02674152|580155367|FG000|Overall Study|Personal Reasons|1|||
160664988|NCT02674152|580155368|FG001|Overall Study|Personal Reasons|0|||
160664989|NCT02674152|580155369|FG002|Overall Study|Personal Reasons|0|||
160664990|NCT02674152|580155370|FG003|Overall Study|Personal Reasons|1|||
160664991|NCT02674152|580155371|FG004|Overall Study|Personal Reasons|1|||
160664992|NCT02674152|580155367|FG000|Overall Study|Other adverse event or clinical progression|0|||
160664993|NCT02674152|580155368|FG001|Overall Study|Other adverse event or clinical progression|1|||
160664994|NCT02674152|580155369|FG002|Overall Study|Other adverse event or clinical progression|0|||
160664995|NCT02674152|580155370|FG003|Overall Study|Other adverse event or clinical progression|3|||
160664996|NCT02674152|580155371|FG004|Overall Study|Other adverse event or clinical progression|0|||
160664997|NCT02674152|580155367|FG000|Overall Study|Dose-limiting toxicity|0|||
160664998|NCT02674152|580155368|FG001|Overall Study|Dose-limiting toxicity|0|||
160664999|NCT02674152|580155369|FG002|Overall Study|Dose-limiting toxicity|0|||
160665000|NCT02674152|580155370|FG003|Overall Study|Dose-limiting toxicity|0|||
160665001|NCT02674152|580155371|FG004|Overall Study|Dose-limiting toxicity|1|||
160665002|NCT02674152|580155367|FG000|Overall Study|Progressive Disease|2|||
160665003|NCT02674152|580155368|FG001|Overall Study|Progressive Disease|1|||
160665004|NCT02674152|580155369|FG002|Overall Study|Progressive Disease|1|||
160665005|NCT02674152|580155370|FG003|Overall Study|Progressive Disease|13|||
160665006|NCT02674152|580155371|FG004|Overall Study|Progressive Disease|2|||
160665007|NCT02674152|580155367|FG000|Overall Study|Adverse Event|0|||
160665008|NCT02674152|580155368|FG001|Overall Study|Adverse Event|0|||
160665009|NCT02674152|580155369|FG002|Overall Study|Adverse Event|1|||
160665010|NCT02674152|580155370|FG003|Overall Study|Adverse Event|0|||
160665011|NCT02674152|580155371|FG004|Overall Study|Adverse Event|1|||
160665012|NCT02571907|580155372|FG000|Overall Study|Death|4|||
160665013|NCT02571907|580155372|FG000|Overall Study|Lost to Follow-up|3|||
160665014|NCT02571907|580155372|FG000|Overall Study|Withdrawal by Subject|3|||
160665015|NCT03772522|580155373|FG000|Pre-intervention|Withdrawal by Subject|3|||
160665016|NCT03772522|580155374|FG001|Pre-intervention|Withdrawal by Subject|4|||
160665017|NCT03772522|580155373|FG000|Intervention|Withdrawal by Subject|1|||
160511950|NCT04602221|579602129|FG017|Overall Study|Discontinuation of trial treatment|0|||
160511951|NCT04602221|579602112|FG000|Overall Study|Other than listed|0|||
160511952|NCT04602221|579602113|FG001|Overall Study|Other than listed|0|||
160511953|NCT04602221|579602114|FG002|Overall Study|Other than listed|0|||
160511954|NCT04602221|579602115|FG003|Overall Study|Other than listed|0|||
160511955|NCT04602221|579602116|FG004|Overall Study|Other than listed|0|||
160511956|NCT04602221|579602117|FG005|Overall Study|Other than listed|0|||
160511957|NCT04602221|579602118|FG006|Overall Study|Other than listed|0|||
160511958|NCT04602221|579602119|FG007|Overall Study|Other than listed|0|||
160511959|NCT04602221|579602120|FG008|Overall Study|Other than listed|0|||
160511960|NCT04602221|579602121|FG009|Overall Study|Other than listed|0|||
160621280|NCT02839330|579992520|FG003|Overall Study|Adverse Event|2|||
160621281|NCT02839330|579992517|FG000|Overall Study|Death|4|||
160621282|NCT02839330|579992518|FG001|Overall Study|Death|6|||
160621283|NCT02839330|579992519|FG002|Overall Study|Death|1|||
160621284|NCT02839330|579992520|FG003|Overall Study|Death|1|||
160621285|NCT02839330|579992517|FG000|Overall Study|Withdrawal by Subject|27|||
160621286|NCT02839330|579992518|FG001|Overall Study|Withdrawal by Subject|19|||
160621287|NCT02839330|579992519|FG002|Overall Study|Withdrawal by Subject|11|||
160621288|NCT02839330|579992520|FG003|Overall Study|Withdrawal by Subject|13|||
160621289|NCT02839330|579992517|FG000|Overall Study|Lost to Follow-up|22|||
160621290|NCT02839330|579992518|FG001|Overall Study|Lost to Follow-up|27|||
160621291|NCT02839330|579992519|FG002|Overall Study|Lost to Follow-up|29|||
160621292|NCT02839330|579992520|FG003|Overall Study|Lost to Follow-up|25|||
160621293|NCT02839330|579992517|FG000|Overall Study|Administrative Reason|0|||
160621294|NCT02839330|579992518|FG001|Overall Study|Administrative Reason|0|||
160621295|NCT02839330|579992519|FG002|Overall Study|Administrative Reason|0|||
160621296|NCT02839330|579992520|FG003|Overall Study|Administrative Reason|1|||
160621297|NCT02839330|579992517|FG000|Overall Study|Protocol Violation|1|||
160621298|NCT02839330|579992518|FG001|Overall Study|Protocol Violation|2|||
160621299|NCT02839330|579992519|FG002|Overall Study|Protocol Violation|2|||
160621300|NCT02839330|579992520|FG003|Overall Study|Protocol Violation|3|||
160621301|NCT02839330|579992517|FG000|Overall Study|Other reason, not specified|4|||
160621302|NCT02839330|579992518|FG001|Overall Study|Other reason, not specified|3|||
160621303|NCT02839330|579992519|FG002|Overall Study|Other reason, not specified|3|||
160621304|NCT02839330|579992520|FG003|Overall Study|Other reason, not specified|6|||
160621305|NCT00310440|579992521|FG000|Overall Study|Lost to Follow-up|17|||
160621306|NCT00310440|579992522|FG001|Overall Study|Lost to Follow-up|8|||
160621307|NCT00310440|579992521|FG000|Overall Study|Withdrawal by Subject|2|||
160621308|NCT00310440|579992522|FG001|Overall Study|Withdrawal by Subject|1|||
160621309|NCT00310440|579992521|FG000|Overall Study|Missed 12 Month Visit|7|||
160621310|NCT00310440|579992522|FG001|Overall Study|Missed 12 Month Visit|4|||
160621311|NCT01654666|579992532|FG000|Overall Study|Protocol Violation|7|||
160621312|NCT01654666|579992533|FG001|Overall Study|Protocol Violation|4|||
160621313|NCT01654666|579992534|FG002|Overall Study|Protocol Violation|8|||
160621314|NCT01654666|579992532|FG000|Overall Study|Lost to Follow-up|4|||
160621315|NCT01654666|579992533|FG001|Overall Study|Lost to Follow-up|5|||
160621316|NCT01654666|579992534|FG002|Overall Study|Lost to Follow-up|5|||
160621317|NCT01654666|579992532|FG000|Overall Study|Withdrawal by Subject|4|||
160621318|NCT01654666|579992533|FG001|Overall Study|Withdrawal by Subject|4|||
160621319|NCT01654666|579992534|FG002|Overall Study|Withdrawal by Subject|1|||
160621320|NCT01616173|579992535|FG000|Overall Study|Lost to Follow-up|0|||
160621321|NCT01616173|579992536|FG001|Overall Study|Lost to Follow-up|2|||
160621322|NCT01616173|579992537|FG002|Overall Study|Lost to Follow-up|0|||
160621323|NCT01430559|579992544|FG000|Overall Study|Adverse Event|7|||
160621324|NCT01430559|579992545|FG001|Overall Study|Adverse Event|3|||
160621325|NCT01430559|579992544|FG000|Overall Study|Entry criteria not met|1|||
160621326|NCT01430559|579992545|FG001|Overall Study|Entry criteria not met|1|||
160621327|NCT01430559|579992544|FG000|Overall Study|Lost to Follow-up|1|||
160621328|NCT01430559|579992545|FG001|Overall Study|Lost to Follow-up|0|||
160621329|NCT01430559|579992544|FG000|Overall Study|Medication error|1|||
160621330|NCT01430559|579992545|FG001|Overall Study|Medication error|0|||
160621331|NCT01430559|579992544|FG000|Overall Study|Withdrawal by Subject|3|||
160621332|NCT01430559|579992545|FG001|Overall Study|Withdrawal by Subject|2|||
160621333|NCT01430559|579992544|FG000|Overall Study|Protocol Violation|1|||
160621334|NCT01430559|579992545|FG001|Overall Study|Protocol Violation|0|||
160621335|NCT01430559|579992544|FG000|Overall Study|Other|3|||
160621336|NCT01430559|579992545|FG001|Overall Study|Other|3|||
160621337|NCT01430559|579992544|FG000|Overall Study|Randomized, Not Treated|3|||
160621338|NCT01430559|579992545|FG001|Overall Study|Randomized, Not Treated|3|||
160621339|NCT01177943|579992546|FG000|First Intervention|Withdrawal by Subject|2|||
160621340|NCT01177943|579992547|FG001|First Intervention|Withdrawal by Subject|0|||
160511961|NCT04602221|579602122|FG010|Overall Study|Other than listed|0|||
160511962|NCT04602221|579602123|FG011|Overall Study|Other than listed|0|||
160621341|NCT01220024|579992548|FG000|Overall Study|Lost to Follow-up|1|||
160621342|NCT01220024|579992549|FG001|Overall Study|Lost to Follow-up|1|||
160621343|NCT00779142|579992550|FG000|Overall Study|Screen Failures|3|||
160621344|NCT03137433|579992552|FG000|Overall Study|Withdrawal by Subject|11|||
160621345|NCT03137433|579992553|FG001|Overall Study|Withdrawal by Subject|11|||
160621346|NCT03137433|579992552|FG000|Overall Study|Lost to Follow-up|5|||
160621347|NCT03137433|579992553|FG001|Overall Study|Lost to Follow-up|6|||
160621348|NCT03137433|579992552|FG000|Overall Study|Physician Decision|2|||
160621349|NCT03137433|579992553|FG001|Overall Study|Physician Decision|0|||
160621350|NCT03137433|579992552|FG000|Overall Study|Moved out of study area|1|||
160621351|NCT03137433|579992553|FG001|Overall Study|Moved out of study area|0|||
160621352|NCT03137433|579992552|FG000|Overall Study|Too far out of window due to COVID|0|||
160621353|NCT03137433|579992553|FG001|Overall Study|Too far out of window due to COVID|1|||
160621354|NCT01288911|579992554|FG000|Double-blind Period|Death|11|||
160621355|NCT01288911|579992555|FG001|Double-blind Period|Death|7|||
160621356|NCT01288911|579992554|FG000|Double-blind Period|Lost to Follow-up|0|||
160621357|NCT01288911|579992555|FG001|Double-blind Period|Lost to Follow-up|2|||
160621358|NCT01288911|579992554|FG000|Double-blind Period|Progressive Disease|75|||
160621359|NCT01288911|579992555|FG001|Double-blind Period|Progressive Disease|103|||
160621360|NCT01288911|579992554|FG000|Double-blind Period|Protocol Violation|1|||
160621361|NCT01288911|579992555|FG001|Double-blind Period|Protocol Violation|0|||
160621362|NCT01288911|579992554|FG000|Double-blind Period|Withdrawal by Subject|25|||
160621363|NCT01288911|579992555|FG001|Double-blind Period|Withdrawal by Subject|26|||
160621364|NCT01288911|579992554|FG000|Double-blind Period|Miscellaneous Reason|29|||
160621365|NCT01288911|579992555|FG001|Double-blind Period|Miscellaneous Reason|42|||
160621366|NCT01288911|579992554|FG000|Double-blind Period|Randomized but never received study drug|1|||
160621367|NCT01288911|579992555|FG001|Double-blind Period|Randomized but never received study drug|2|||
160621368|NCT01288911|579992554|FG000|Open-label Period (All Enzalutamide)|Death|0|||
160621369|NCT01288911|579992555|FG001|Open-label Period (All Enzalutamide)|Death|1|||
160621370|NCT01288911|579992554|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
160621371|NCT01288911|579992555|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
160621372|NCT01288911|579992554|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
160621373|NCT01288911|579992555|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
160621374|NCT01288911|579992554|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
160621375|NCT01288911|579992555|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
160621376|NCT01288911|579992554|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
160621377|NCT01288911|579992555|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
160621378|NCT01288911|579992554|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
160621379|NCT01288911|579992555|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
160621380|NCT02543918|579992556|FG000|Overall Study|Never treated|0|||
160621381|NCT02543918|579992557|FG001|Overall Study|Never treated|1|||
160621382|NCT02543918|579992556|FG000|Overall Study|Lost to Follow-up|1|||
160621383|NCT02543918|579992557|FG001|Overall Study|Lost to Follow-up|1|||
160621384|NCT02543918|579992556|FG000|Overall Study|Withdrawal by Subject|1|||
160621385|NCT02543918|579992557|FG001|Overall Study|Withdrawal by Subject|1|||
160621386|NCT02543918|579992556|FG000|Overall Study|Adverse Event|1|||
160621387|NCT02543918|579992557|FG001|Overall Study|Adverse Event|1|||
160621388|NCT02452892|579992560|FG000|Week 1 Initial Randommization|Adverse Event|1|||
160621389|NCT02452892|579992561|FG001|Week 1 Initial Randommization|Adverse Event|0|||
160621390|NCT02452892|579992562|FG002|Week 1 Initial Randommization|Adverse Event|0|||
160621391|NCT02452892|579992563|FG003|Week 1 Initial Randommization|Adverse Event|0|||
160621392|NCT02452892|579992560|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
160621393|NCT02452892|579992561|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
160621394|NCT02452892|579992562|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
160621395|NCT02452892|579992563|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
160621396|NCT02452892|579992560|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
160621397|NCT02452892|579992561|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
160621398|NCT02452892|579992562|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
160621399|NCT02452892|579992563|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
160621400|NCT02452892|579992560|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
160621401|NCT02452892|579992561|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
160621402|NCT02452892|579992562|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
160621403|NCT02452892|579992563|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
160621404|NCT02452892|579992560|FG000|Follow-up|Withdrawal by Subject|0|||
160621405|NCT02452892|579992561|FG001|Follow-up|Withdrawal by Subject|0|||
160621406|NCT02452892|579992562|FG002|Follow-up|Withdrawal by Subject|0|||
160621407|NCT02452892|579992563|FG003|Follow-up|Withdrawal by Subject|1|||
160621408|NCT02452892|579992560|FG000|Follow-up|Subject left town on Day 42|1|||
160621409|NCT02452892|579992561|FG001|Follow-up|Subject left town on Day 42|0|||
160621410|NCT02452892|579992562|FG002|Follow-up|Subject left town on Day 42|0|||
160621411|NCT02452892|579992563|FG003|Follow-up|Subject left town on Day 42|0|||
160621412|NCT00486720|579992564|FG000|Overall Study|Adverse Event|1|||
160621413|NCT00486720|579992565|FG001|Overall Study|Adverse Event|2|||
160621414|NCT00486720|579992564|FG000|Overall Study|Lack of Efficacy|4|||
160621415|NCT00486720|579992565|FG001|Overall Study|Lack of Efficacy|6|||
160621416|NCT00486720|579992564|FG000|Overall Study|Physician Decision|1|||
160621417|NCT00486720|579992565|FG001|Overall Study|Physician Decision|2|||
160621418|NCT00486720|579992564|FG000|Overall Study|Protocol Violation|1|||
160621419|NCT00486720|579992565|FG001|Overall Study|Protocol Violation|0|||
160621420|NCT00486720|579992564|FG000|Overall Study|Withdrawal by Subject|3|||
160621421|NCT00486720|579992565|FG001|Overall Study|Withdrawal by Subject|1|||
160621422|NCT00486720|579992564|FG000|Overall Study|Progressive Disease|0|||
160621423|NCT00486720|579992565|FG001|Overall Study|Progressive Disease|1|||
160621424|NCT01005875|579992573|FG000|Overall Study|Death|3|||
160621425|NCT00606931|579992574|FG000|Overall Study|Withdrawal by Subject|3|||
160621426|NCT05047601|579992575|FG000|Overall Study|Lost to Follow-up|9|||
160621427|NCT05047601|579992576|FG001|Overall Study|Lost to Follow-up|11|||
160621428|NCT05047601|579992577|FG002|Overall Study|Lost to Follow-up|7|||
160621429|NCT05047601|579992575|FG000|Overall Study|Withdrawal by Subject|25|||
160621430|NCT05047601|579992576|FG001|Overall Study|Withdrawal by Subject|36|||
160621431|NCT05047601|579992577|FG002|Overall Study|Withdrawal by Subject|23|||
160621432|NCT05047601|579992575|FG000|Overall Study|Other|10|||
160621433|NCT05047601|579992576|FG001|Overall Study|Other|6|||
160621434|NCT05047601|579992577|FG002|Overall Study|Other|5|||
160621435|NCT00286234|579992578|FG000|Overall Study|Protocol Violation|1|||
160621436|NCT00286234|579992579|FG001|Overall Study|Protocol Violation|2|||
160621437|NCT00286234|579992580|FG002|Overall Study|Protocol Violation|0|||
160621438|NCT00286234|579992581|FG003|Overall Study|Protocol Violation|1|||
160621439|NCT00286234|579992578|FG000|Overall Study|Physician Decision|1|||
160621440|NCT00286234|579992579|FG001|Overall Study|Physician Decision|0|||
160621441|NCT00286234|579992580|FG002|Overall Study|Physician Decision|0|||
160621442|NCT00286234|579992581|FG003|Overall Study|Physician Decision|1|||
160621443|NCT00286234|579992578|FG000|Overall Study|Adverse Event|0|||
160621444|NCT00286234|579992579|FG001|Overall Study|Adverse Event|0|||
160621445|NCT00286234|579992580|FG002|Overall Study|Adverse Event|0|||
160621446|NCT00286234|579992581|FG003|Overall Study|Adverse Event|1|||
160621447|NCT00286234|579992578|FG000|Overall Study|Adverse Event|0|||
160621448|NCT00286234|579992579|FG001|Overall Study|Adverse Event|0|||
160621449|NCT00286234|579992580|FG002|Overall Study|Adverse Event|0|||
160621450|NCT00286234|579992581|FG003|Overall Study|Adverse Event|1|||
160621451|NCT02924129|579992590|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
160621452|NCT02924129|579992591|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
160621453|NCT02924129|579992590|FG000|Overall Study|Withdrawal by Subject|2|||
160621454|NCT02924129|579992591|FG001|Overall Study|Withdrawal by Subject|2|||
160621455|NCT02924129|579992590|FG000|Overall Study|Physician Decision|1|||
160621456|NCT02924129|579992591|FG001|Overall Study|Physician Decision|0|||
160621457|NCT02924129|579992590|FG000|Overall Study|Missed Visit|0|||
160621458|NCT02924129|579992591|FG001|Overall Study|Missed Visit|1|||
160621459|NCT03137173|579992599|FG000|Overall Study|Withdrawal by Subject|8|||
160621460|NCT03137173|579992600|FG001|Overall Study|Withdrawal by Subject|13|||
160621461|NCT03137173|579992599|FG000|Overall Study|Death|1|||
160621462|NCT03137173|579992600|FG001|Overall Study|Death|3|||
160621463|NCT03137173|579992599|FG000|Overall Study|Physician Decision|1|||
160621464|NCT03137173|579992600|FG001|Overall Study|Physician Decision|0|||
160621465|NCT03137173|579992599|FG000|Overall Study|Lost to Follow-up|13|||
160621466|NCT03137173|579992600|FG001|Overall Study|Lost to Follow-up|18|||
160621467|NCT03137173|579992599|FG000|Overall Study|Other reasons|3|||
160621468|NCT03137173|579992600|FG001|Overall Study|Other reasons|2|||
160621469|NCT05060003|579992601|FG000|Overall Study|ctDNA negative|7|||
160621470|NCT03524664|579992602|FG000|Overall Study|Withdrawal by Subject|1|||
160621471|NCT03524664|579992603|FG001|Overall Study|Withdrawal by Subject|2|||
160621472|NCT03524664|579992602|FG000|Overall Study|Lost to Follow-up|4|||
160621473|NCT03524664|579992603|FG001|Overall Study|Lost to Follow-up|13|||
160621474|NCT01482598|579992604|FG000|Overall Study|Death|7|||
160621475|NCT01482598|579992605|FG001|Overall Study|Death|10|||
160621476|NCT01482598|579992604|FG000|Overall Study|Physician Decision|0|||
160621477|NCT01482598|579992605|FG001|Overall Study|Physician Decision|3|||
160621478|NCT01482598|579992604|FG000|Overall Study|Withdrawal by Subject|4|||
160621479|NCT01482598|579992605|FG001|Overall Study|Withdrawal by Subject|5|||
160621480|NCT01482598|579992604|FG000|Overall Study|Lost to Follow-up|5|||
160621481|NCT01482598|579992605|FG001|Overall Study|Lost to Follow-up|4|||
160621482|NCT02694562|579992606|FG000|Overall Study|Death|8|||
160621483|NCT02694562|579992606|FG000|Overall Study|Protocol Violation|4|||
160621484|NCT02694562|579992606|FG000|Overall Study|Lost to Follow-up|3|||
160621485|NCT02694562|579992606|FG000|Overall Study|Screen Failure|2|||
160621486|NCT02694562|579992606|FG000|Overall Study|Physician Decision|1|||
160621487|NCT01373294|579992607|FG000|Overall Study|Adverse Event|1|||
160621488|NCT01373294|579992608|FG001|Overall Study|Adverse Event|0|||
160621489|NCT00423267|579992609|FG000|Period A|Withdrawal by Subject|0|||
160621490|NCT00423267|579992610|FG001|Period A|Withdrawal by Subject|1|||
160621491|NCT00423267|579992609|FG000|Period A|Non-compliance with protocol|1|||
160621492|NCT00423267|579992610|FG001|Period A|Non-compliance with protocol|0|||
160621493|NCT00423267|579992609|FG000|Period A|Administrative|1|||
160621494|NCT00423267|579992610|FG001|Period A|Administrative|0|||
160621495|NCT03702166|579992611|FG000|Overall Study|Lost to Follow-up|1|||
160621496|NCT03702166|579992611|FG000|Overall Study|Withdrawal by Subject|1|||
160621497|NCT01333865|579992612|FG000|Overall Study|Adverse Event|2|||
160665018|NCT03772522|580155374|FG001|Intervention|Withdrawal by Subject|0|||
160665019|NCT03772522|580155373|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
160665020|NCT03772522|580155374|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
160665021|NCT03071575|580155375|FG000|Overall Study|Death|0|||
160665022|NCT03071575|580155376|FG001|Overall Study|Death|1|||
160665023|NCT03071575|580155375|FG000|Overall Study|Lost to Follow-up|5|||
160665024|NCT03071575|580155376|FG001|Overall Study|Lost to Follow-up|11|||
160665025|NCT03071575|580155375|FG000|Overall Study|Withdrawal by Subject|4|||
160665026|NCT03071575|580155376|FG001|Overall Study|Withdrawal by Subject|2|||
160665027|NCT00218257|580155377|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
160665028|NCT00218257|580155378|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
160665029|NCT00579345|580155379|FG000|Overall Study|Withdrawal by Subject|2|||
160665030|NCT00579345|580155380|FG001|Overall Study|Withdrawal by Subject|0|||
160665031|NCT00579345|580155381|FG002|Overall Study|Withdrawal by Subject|0|||
160665032|NCT00579345|580155382|FG003|Overall Study|Withdrawal by Subject|0|||
160665033|NCT00579345|580155383|FG004|Overall Study|Withdrawal by Subject|0|||
160665034|NCT00579345|580155384|FG005|Overall Study|Withdrawal by Subject|0|||
160665035|NCT00579345|580155385|FG006|Overall Study|Withdrawal by Subject|0|||
160665036|NCT00579345|580155386|FG007|Overall Study|Withdrawal by Subject|1|||
160665037|NCT00579345|580155379|FG000|Overall Study|Lost to Follow-up|1|||
160511963|NCT04602221|579602124|FG012|Overall Study|Other than listed|0|||
160511964|NCT04602221|579602125|FG013|Overall Study|Other than listed|0|||
160511965|NCT04602221|579602126|FG014|Overall Study|Other than listed|0|||
160511966|NCT04602221|579602127|FG015|Overall Study|Other than listed|1|||
160511967|NCT04602221|579602128|FG016|Overall Study|Other than listed|0|||
160511968|NCT04602221|579602129|FG017|Overall Study|Other than listed|1|||
160511969|NCT04602221|579602112|FG000|Overall Study|Withdrawal by Subject|0|||
160621498|NCT03512028|579992615|FG000|Overall Study|Withdrawal by Subject|2|||
160621499|NCT03512028|579992616|FG001|Overall Study|Withdrawal by Subject|0|||
160621500|NCT03512028|579992615|FG000|Overall Study|Protocol Violation|2|||
160621501|NCT03512028|579992616|FG001|Overall Study|Protocol Violation|0|||
160621502|NCT00517634|579992621|FG000|Second Treatment Period|Withdrawal by Subject|0|||
160621503|NCT00517634|579992622|FG001|Second Treatment Period|Withdrawal by Subject|0|||
160621504|NCT00517634|579992623|FG002|Second Treatment Period|Withdrawal by Subject|0|||
160621505|NCT00517634|579992624|FG003|Second Treatment Period|Withdrawal by Subject|0|||
160621506|NCT00517634|579992625|FG004|Second Treatment Period|Withdrawal by Subject|1|||
160621507|NCT00517634|579992626|FG005|Second Treatment Period|Withdrawal by Subject|0|||
160621508|NCT03143855|579992627|FG000|Overall Study|Withdrawal by Subject|4|||
160621509|NCT03143855|579992628|FG001|Overall Study|Withdrawal by Subject|3|||
160621510|NCT03143855|579992627|FG000|Overall Study|Protocol Violation|1|||
160621511|NCT03143855|579992628|FG001|Overall Study|Protocol Violation|0|||
160621512|NCT03143855|579992627|FG000|Overall Study|Participant experienced withdrawal|0|||
160621513|NCT03143855|579992628|FG001|Overall Study|Participant experienced withdrawal|1|||
160621514|NCT00701064|579992629|FG000|Overall Study|Protocol Violation|1|||
160621515|NCT00701064|579992630|FG001|Overall Study|Protocol Violation|1|||
160621516|NCT00701064|579992629|FG000|Overall Study|Withdrawal by Subject|1|||
160621517|NCT00701064|579992630|FG001|Overall Study|Withdrawal by Subject|1|||
160621518|NCT00701064|579992629|FG000|Overall Study|initiated other PTSD treatment|2|||
160621519|NCT00701064|579992630|FG001|Overall Study|initiated other PTSD treatment|2|||
160621520|NCT02098733|579992631|FG000|Overall Study|Data Not Available|5|||
160621521|NCT02098733|579992631|FG000|Overall Study|Lost to Follow-up|5|||
160621522|NCT00690612|579994228|FG000|Overall Study|Adverse Event|1|||
160621523|NCT00690612|579994228|FG000|Overall Study|Withdrawal by Subject|2|||
160621524|NCT03808298|579994229|FG000|Overall Study|Adverse Event|3|||
160621525|NCT03808298|579994229|FG000|Overall Study|Physician Decision|1|||
160621526|NCT03808298|579994229|FG000|Overall Study|Withdrawal by Subject|1|||
160621527|NCT03808298|579994229|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
160621528|NCT01858701|579994232|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
160621529|NCT01858701|579994233|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
160621530|NCT01858701|579994232|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
160621531|NCT01858701|579994233|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
160621532|NCT01858701|579994232|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
160621533|NCT01858701|579994233|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
160621534|NCT01858701|579994232|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
160621535|NCT01858701|579994233|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
160511970|NCT04602221|579602113|FG001|Overall Study|Withdrawal by Subject|0|||
160511971|NCT04602221|579602114|FG002|Overall Study|Withdrawal by Subject|0|||
160511972|NCT04602221|579602115|FG003|Overall Study|Withdrawal by Subject|0|||
160621536|NCT01674010|579994234|FG000|Open Treatment Phase 1|Adverse Event|10|||
160621537|NCT01674010|579994235|FG001|Open Treatment Phase 1|Adverse Event|0|||
160665038|NCT00579345|580155380|FG001|Overall Study|Lost to Follow-up|0|||
160665039|NCT00579345|580155381|FG002|Overall Study|Lost to Follow-up|0|||
160665040|NCT00579345|580155382|FG003|Overall Study|Lost to Follow-up|0|||
160665041|NCT00579345|580155383|FG004|Overall Study|Lost to Follow-up|0|||
160511973|NCT04602221|579602116|FG004|Overall Study|Withdrawal by Subject|0|||
160621538|NCT01674010|579994236|FG002|Open Treatment Phase 1|Adverse Event|0|||
160621539|NCT01674010|579994234|FG000|Open Treatment Phase 1|Death|1|||
160621540|NCT01674010|579994235|FG001|Open Treatment Phase 1|Death|0|||
160621541|NCT01674010|579994236|FG002|Open Treatment Phase 1|Death|0|||
160621542|NCT01674010|579994234|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
160621543|NCT01674010|579994235|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
160621544|NCT01674010|579994236|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
160621545|NCT01674010|579994234|FG000|Open Treatment Phase 1|Physician Decision|9|||
160621546|NCT01674010|579994235|FG001|Open Treatment Phase 1|Physician Decision|0|||
160621547|NCT01674010|579994236|FG002|Open Treatment Phase 1|Physician Decision|0|||
160621548|NCT01674010|579994234|FG000|Open Treatment Phase 1|Protocol Violation|7|||
160621549|NCT01674010|579994235|FG001|Open Treatment Phase 1|Protocol Violation|0|||
160621550|NCT01674010|579994236|FG002|Open Treatment Phase 1|Protocol Violation|0|||
160621551|NCT01674010|579994234|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
160621552|NCT01674010|579994235|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
160621553|NCT01674010|579994236|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
160621554|NCT01674010|579994234|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
160621555|NCT01674010|579994235|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
160621556|NCT01674010|579994236|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
160621557|NCT01674010|579994234|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
160621558|NCT01674010|579994235|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
160621559|NCT01674010|579994236|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
160621560|NCT01674010|579994234|FG000|Randomization Phase 2|Adverse Event|0|||
160621561|NCT01674010|579994235|FG001|Randomization Phase 2|Adverse Event|1|||
160621562|NCT01674010|579994236|FG002|Randomization Phase 2|Adverse Event|1|||
160621563|NCT01674010|579994234|FG000|Randomization Phase 2|Lost to Follow-up|0|||
160621564|NCT01674010|579994235|FG001|Randomization Phase 2|Lost to Follow-up|1|||
160621565|NCT01674010|579994236|FG002|Randomization Phase 2|Lost to Follow-up|2|||
160621566|NCT01674010|579994234|FG000|Randomization Phase 2|Mood episode recurrence|0|||
160621567|NCT01674010|579994235|FG001|Randomization Phase 2|Mood episode recurrence|8|||
160621568|NCT01674010|579994236|FG002|Randomization Phase 2|Mood episode recurrence|2|||
160621569|NCT01674010|579994234|FG000|Randomization Phase 2|Physician Decision|0|||
160621570|NCT01674010|579994235|FG001|Randomization Phase 2|Physician Decision|0|||
160621571|NCT01674010|579994236|FG002|Randomization Phase 2|Physician Decision|2|||
160621572|NCT01674010|579994234|FG000|Randomization Phase 2|Pregnancy|0|||
160621573|NCT01674010|579994235|FG001|Randomization Phase 2|Pregnancy|1|||
160621574|NCT01674010|579994236|FG002|Randomization Phase 2|Pregnancy|1|||
160621575|NCT01674010|579994234|FG000|Randomization Phase 2|Protocol Violation|0|||
160621576|NCT01674010|579994235|FG001|Randomization Phase 2|Protocol Violation|1|||
160621577|NCT01674010|579994236|FG002|Randomization Phase 2|Protocol Violation|1|||
160621578|NCT01674010|579994234|FG000|Randomization Phase 2|Sponsor Decision|0|||
160621579|NCT01674010|579994235|FG001|Randomization Phase 2|Sponsor Decision|42|||
160621580|NCT01674010|579994236|FG002|Randomization Phase 2|Sponsor Decision|45|||
160621581|NCT01674010|579994234|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
160621582|NCT01674010|579994235|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
160621583|NCT01674010|579994236|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
160621584|NCT01801475|579994243|FG000|Overall Study|Withdrawal by Subject|0|||
160621585|NCT01801475|579994244|FG001|Overall Study|Withdrawal by Subject|0|||
160621586|NCT01801475|579994245|FG002|Overall Study|Withdrawal by Subject|0|||
160621587|NCT01801475|579994246|FG003|Overall Study|Withdrawal by Subject|0|||
160621588|NCT01801475|579994247|FG004|Overall Study|Withdrawal by Subject|1|||
160621589|NCT01786707|579994250|FG000|Overall Study|Lost to Follow-up|1|||
160621590|NCT01786707|579994251|FG001|Overall Study|Lost to Follow-up|1|||
160621591|NCT01545375|579994260|FG000|Overall Study|Adverse Event|2|||
160621592|NCT01545375|579994261|FG001|Overall Study|Adverse Event|1|||
160621593|NCT01545375|579994260|FG000|Overall Study|Lost to Follow-up|34|||
160621594|NCT01545375|579994261|FG001|Overall Study|Lost to Follow-up|31|||
160621595|NCT01545375|579994260|FG000|Overall Study|Protocol Violation|3|||
160621596|NCT01545375|579994261|FG001|Overall Study|Protocol Violation|3|||
160621597|NCT01545375|579994260|FG000|Overall Study|Withdrawal by Subject|58|||
160621598|NCT01545375|579994261|FG001|Overall Study|Withdrawal by Subject|55|||
160621599|NCT00594958|579994263|FG000|Overall Study|Withdrawal by Subject|1|||
160621600|NCT00594958|579994264|FG001|Overall Study|Withdrawal by Subject|0|||
160621601|NCT00594958|579994265|FG002|Overall Study|Withdrawal by Subject|1|||
160621602|NCT00594958|579994263|FG000|Overall Study|Adverse Event|4|||
160621603|NCT00594958|579994264|FG001|Overall Study|Adverse Event|1|||
160621604|NCT00594958|579994265|FG002|Overall Study|Adverse Event|2|||
160621605|NCT00594958|579994263|FG000|Overall Study|Pregnancy|0|||
160621606|NCT00594958|579994264|FG001|Overall Study|Pregnancy|2|||
160621607|NCT00594958|579994265|FG002|Overall Study|Pregnancy|0|||
160621608|NCT00594958|579994263|FG000|Overall Study|Protocol Violation|1|||
160621609|NCT00594958|579994264|FG001|Overall Study|Protocol Violation|0|||
160621610|NCT00594958|579994265|FG002|Overall Study|Protocol Violation|2|||
160621611|NCT00594958|579994263|FG000|Overall Study|Lost to Follow-up|5|||
160621612|NCT00594958|579994264|FG001|Overall Study|Lost to Follow-up|0|||
160621613|NCT00594958|579994265|FG002|Overall Study|Lost to Follow-up|3|||
160621614|NCT00594958|579994263|FG000|Overall Study|administrative|3|||
160621615|NCT00594958|579994264|FG001|Overall Study|administrative|0|||
160621616|NCT00594958|579994265|FG002|Overall Study|administrative|2|||
160621617|NCT03233009|579994266|FG000|Overall Study|Lost to Follow-up|1|||
160621618|NCT03039686|579994267|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
160621619|NCT03039686|579994268|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
160621620|NCT03039686|579994269|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
160621621|NCT03039686|579994267|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
160621622|NCT03039686|579994268|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
160621623|NCT03039686|579994269|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
160621624|NCT03039686|579994267|FG000|Double-blind Period|Withdrawal by Subject|2|||
160621625|NCT03039686|579994268|FG001|Double-blind Period|Withdrawal by Subject|2|||
160621626|NCT03039686|579994269|FG002|Double-blind Period|Withdrawal by Subject|1|||
160621627|NCT03039686|579994267|FG000|Double-blind Period|Death|0|||
160621628|NCT03039686|579994268|FG001|Double-blind Period|Death|0|||
160621629|NCT03039686|579994269|FG002|Double-blind Period|Death|1|||
160621630|NCT03039686|579994267|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
160621631|NCT03039686|579994268|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
160621632|NCT03039686|579994269|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
160621633|NCT03039686|579994267|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
160621634|NCT03039686|579994268|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
160621635|NCT03039686|579994269|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
160621636|NCT03039686|579994267|FG000|Open Label Period|Withdrawal by Subject|0|||
160621637|NCT03039686|579994268|FG001|Open Label Period|Withdrawal by Subject|3|||
160621638|NCT03039686|579994269|FG002|Open Label Period|Withdrawal by Subject|1|||
160621639|NCT02158949|579994270|FG000|Overall Study|Withdrawal by Subject|1|||
160621640|NCT02158949|579994271|FG001|Overall Study|Withdrawal by Subject|0|||
160621641|NCT02158949|579994270|FG000|Overall Study|Lost to Follow-up|5|||
160621642|NCT02158949|579994271|FG001|Overall Study|Lost to Follow-up|11|||
160621643|NCT00134563|579994272|FG000|Overall Study|Not treated due to protocol violation|0|||
160621644|NCT00134563|579994273|FG001|Overall Study|Not treated due to protocol violation|1|||
160621645|NCT00134563|579994274|FG002|Overall Study|Not treated due to protocol violation|1|||
160621646|NCT00134563|579994272|FG000|Overall Study|Adverse Event|29|||
160621647|NCT00134563|579994273|FG001|Overall Study|Adverse Event|37|||
160621648|NCT00134563|579994274|FG002|Overall Study|Adverse Event|38|||
160621649|NCT00134563|579994272|FG000|Overall Study|Lack of Efficacy|24|||
160621650|NCT00134563|579994273|FG001|Overall Study|Lack of Efficacy|14|||
160621651|NCT00134563|579994274|FG002|Overall Study|Lack of Efficacy|17|||
160621652|NCT00134563|579994272|FG000|Overall Study|Protocol Violation|3|||
160621653|NCT00134563|579994273|FG001|Overall Study|Protocol Violation|2|||
160621654|NCT00134563|579994274|FG002|Overall Study|Protocol Violation|5|||
160621655|NCT00134563|579994272|FG000|Overall Study|Lost to Follow-up|4|||
160621656|NCT00134563|579994273|FG001|Overall Study|Lost to Follow-up|0|||
160621657|NCT00134563|579994274|FG002|Overall Study|Lost to Follow-up|2|||
160621658|NCT00134563|579994272|FG000|Overall Study|progressive disease|11|||
160621659|NCT00134563|579994273|FG001|Overall Study|progressive disease|4|||
160621660|NCT00134563|579994274|FG002|Overall Study|progressive disease|2|||
160621661|NCT00134563|579994272|FG000|Overall Study|did not wish to continue|33|||
160621662|NCT00134563|579994273|FG001|Overall Study|did not wish to continue|32|||
160621663|NCT00134563|579994274|FG002|Overall Study|did not wish to continue|26|||
160621664|NCT00134563|579994272|FG000|Overall Study|Reason other than above|0|||
160621665|NCT00134563|579994273|FG001|Overall Study|Reason other than above|2|||
160621666|NCT00134563|579994274|FG002|Overall Study|Reason other than above|5|||
160621667|NCT02406586|579994275|FG000|Overall Study|Lost to Follow-up|0|||
160621668|NCT02406586|579994276|FG001|Overall Study|Lost to Follow-up|4|||
160621669|NCT02406586|579994277|FG002|Overall Study|Lost to Follow-up|2|||
160621670|NCT02406586|579994275|FG000|Overall Study|Withdrawal by Subject|1|||
160621671|NCT02406586|579994276|FG001|Overall Study|Withdrawal by Subject|0|||
160621672|NCT02406586|579994277|FG002|Overall Study|Withdrawal by Subject|0|||
160621673|NCT03382639|579994278|FG000|Overall Study|Adverse Event|2|||
160621674|NCT03382639|579994279|FG001|Overall Study|Adverse Event|0|||
160621675|NCT03382639|579994280|FG002|Overall Study|Adverse Event|1|||
160665042|NCT00579345|580155384|FG005|Overall Study|Lost to Follow-up|0|||
160621676|NCT03382639|579994281|FG003|Overall Study|Adverse Event|1|||
160621677|NCT03382639|579994278|FG000|Overall Study|Lost to Follow-up|1|||
160621678|NCT03382639|579994279|FG001|Overall Study|Lost to Follow-up|0|||
160621679|NCT03382639|579994280|FG002|Overall Study|Lost to Follow-up|0|||
160621680|NCT03382639|579994281|FG003|Overall Study|Lost to Follow-up|0|||
160621681|NCT03382639|579994278|FG000|Overall Study|Withdrawal by Subject|4|||
160621682|NCT03382639|579994279|FG001|Overall Study|Withdrawal by Subject|3|||
160621683|NCT03382639|579994280|FG002|Overall Study|Withdrawal by Subject|2|||
160621684|NCT03382639|579994281|FG003|Overall Study|Withdrawal by Subject|3|||
160621685|NCT03382639|579994278|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
160665043|NCT00579345|580155385|FG006|Overall Study|Lost to Follow-up|0|||
160621686|NCT03382639|579994279|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
160665044|NCT00579345|580155386|FG007|Overall Study|Lost to Follow-up|0|||
160665045|NCT00579345|580155379|FG000|Overall Study|Adverse Event|0|||
160665046|NCT00579345|580155380|FG001|Overall Study|Adverse Event|0|||
160665047|NCT00579345|580155381|FG002|Overall Study|Adverse Event|1|||
160665048|NCT00579345|580155382|FG003|Overall Study|Adverse Event|0|||
160665049|NCT00579345|580155383|FG004|Overall Study|Adverse Event|0|||
160665050|NCT00579345|580155384|FG005|Overall Study|Adverse Event|0|||
160665051|NCT00579345|580155385|FG006|Overall Study|Adverse Event|0|||
160665052|NCT00579345|580155386|FG007|Overall Study|Adverse Event|0|||
160665053|NCT00579345|580155379|FG000|Overall Study|Protocol Violation|1|||
160665054|NCT00579345|580155380|FG001|Overall Study|Protocol Violation|0|||
160665055|NCT00579345|580155381|FG002|Overall Study|Protocol Violation|0|||
160665056|NCT00579345|580155382|FG003|Overall Study|Protocol Violation|0|||
160511974|NCT04602221|579602117|FG005|Overall Study|Withdrawal by Subject|0|||
160511975|NCT04602221|579602118|FG006|Overall Study|Withdrawal by Subject|0|||
160511976|NCT04602221|579602119|FG007|Overall Study|Withdrawal by Subject|0|||
160511977|NCT04602221|579602120|FG008|Overall Study|Withdrawal by Subject|0|||
160511978|NCT04602221|579602121|FG009|Overall Study|Withdrawal by Subject|0|||
160511979|NCT04602221|579602122|FG010|Overall Study|Withdrawal by Subject|0|||
160511980|NCT04602221|579602123|FG011|Overall Study|Withdrawal by Subject|0|||
160511981|NCT04602221|579602124|FG012|Overall Study|Withdrawal by Subject|1|||
160511982|NCT04602221|579602125|FG013|Overall Study|Withdrawal by Subject|0|||
160511983|NCT04602221|579602126|FG014|Overall Study|Withdrawal by Subject|0|||
160511984|NCT04602221|579602127|FG015|Overall Study|Withdrawal by Subject|0|||
160511985|NCT04602221|579602128|FG016|Overall Study|Withdrawal by Subject|0|||
160511986|NCT04602221|579602129|FG017|Overall Study|Withdrawal by Subject|0|||
160511987|NCT04602221|579602112|FG000|Overall Study|Lost to Follow-up|0|||
160511988|NCT04602221|579602113|FG001|Overall Study|Lost to Follow-up|0|||
160511989|NCT04602221|579602114|FG002|Overall Study|Lost to Follow-up|0|||
160511990|NCT04602221|579602115|FG003|Overall Study|Lost to Follow-up|0|||
160511991|NCT04602221|579602116|FG004|Overall Study|Lost to Follow-up|0|||
160511992|NCT04602221|579602117|FG005|Overall Study|Lost to Follow-up|1|||
160511993|NCT04602221|579602118|FG006|Overall Study|Lost to Follow-up|0|||
160511994|NCT04602221|579602119|FG007|Overall Study|Lost to Follow-up|0|||
160511995|NCT04602221|579602120|FG008|Overall Study|Lost to Follow-up|0|||
160511996|NCT04602221|579602121|FG009|Overall Study|Lost to Follow-up|0|||
160511997|NCT04602221|579602122|FG010|Overall Study|Lost to Follow-up|0|||
160511998|NCT04602221|579602123|FG011|Overall Study|Lost to Follow-up|0|||
160511999|NCT04602221|579602124|FG012|Overall Study|Lost to Follow-up|0|||
160512000|NCT04602221|579602125|FG013|Overall Study|Lost to Follow-up|0|||
160512001|NCT04602221|579602126|FG014|Overall Study|Lost to Follow-up|0|||
160512002|NCT04602221|579602127|FG015|Overall Study|Lost to Follow-up|0|||
160512003|NCT04602221|579602128|FG016|Overall Study|Lost to Follow-up|0|||
160512004|NCT04602221|579602129|FG017|Overall Study|Lost to Follow-up|0|||
160512005|NCT03001076|579602130|FG000|Overall Study|Withdrawal by patient|2|||
160512006|NCT03001076|579602131|FG001|Overall Study|Withdrawal by patient|0|||
160512007|NCT03001076|579602130|FG000|Overall Study|Other|1|||
160512008|NCT03001076|579602131|FG001|Overall Study|Other|0|||
160512009|NCT03001076|579602130|FG000|Overall Study|Adverse Event|3|||
160512010|NCT03001076|579602131|FG001|Overall Study|Adverse Event|3|||
160512011|NCT03001076|579602130|FG000|Overall Study|Sponsor decision|1|||
160512012|NCT03001076|579602131|FG001|Overall Study|Sponsor decision|0|||
160512013|NCT03001076|579602130|FG000|Overall Study|Lost to Follow-up|0|||
160512014|NCT03001076|579602131|FG001|Overall Study|Lost to Follow-up|2|||
160512015|NCT02576587|579602132|FG000|Baseline|Equipment failure|0|||
160512016|NCT02576587|579602133|FG001|Baseline|Equipment failure|1|||
160512017|NCT02576587|579602132|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
160512018|NCT02576587|579602133|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
160512019|NCT02576587|579602132|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
160512020|NCT02576587|579602133|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
160512021|NCT02576587|579602132|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
160512022|NCT02576587|579602133|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
160512023|NCT00844532|579602134|FG000|Overall Study|Death|16|||
160512024|NCT00844532|579602134|FG000|Overall Study|Withdrawal by Subject|16|||
160512025|NCT00844532|579602134|FG000|Overall Study|Lost to Follow-up|7|||
160512026|NCT01080716|579602135|FG000|Part 1|Physician Decision|1|||
160512027|NCT01080716|579602136|FG001|Part 1|Physician Decision|0|||
160512028|NCT01080716|579602137|FG002|Part 1|Physician Decision|0|||
160512029|NCT01080716|579602138|FG003|Part 1|Physician Decision|0|||
160512030|NCT01056718|579602139|FG000|Overall Study|Withdrawal by Subject|2|||
160512031|NCT01056718|579602139|FG000|Overall Study|Ischemia on baseline stress test|1|||
160512032|NCT05086276|579602140|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
160512033|NCT05086276|579602141|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
160512034|NCT00777088|579602142|FG000|Overall Study|PED Treatment not attempted|1|||
160512035|NCT00633880|579602143|FG000|Open Label Titration|Lack of Efficacy|1|||
160512036|NCT00633880|579602144|FG001|Open Label Titration|Lack of Efficacy|0|||
160665057|NCT00579345|580155383|FG004|Overall Study|Protocol Violation|0|||
160665058|NCT00579345|580155384|FG005|Overall Study|Protocol Violation|0|||
160665059|NCT00579345|580155385|FG006|Overall Study|Protocol Violation|0|||
160665060|NCT00579345|580155386|FG007|Overall Study|Protocol Violation|1|||
160665061|NCT00579345|580155379|FG000|Overall Study|Death|1|||
160665062|NCT00579345|580155380|FG001|Overall Study|Death|1|||
160665063|NCT00579345|580155381|FG002|Overall Study|Death|1|||
160665064|NCT00579345|580155382|FG003|Overall Study|Death|1|||
160665065|NCT00579345|580155383|FG004|Overall Study|Death|0|||
160665066|NCT00579345|580155384|FG005|Overall Study|Death|0|||
160665067|NCT00579345|580155385|FG006|Overall Study|Death|0|||
160665068|NCT00579345|580155386|FG007|Overall Study|Death|0|||
160665069|NCT02267187|580155395|FG000|Overall Study|Physician Decision|2|||
160665070|NCT02267187|580155395|FG000|Overall Study|Screen fail|3|||
160665071|NCT00934050|580155399|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
160665072|NCT00934050|580155400|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
160665073|NCT00934050|580155401|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
160665074|NCT00934050|580155402|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
160665075|NCT00934050|580155403|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
160665076|NCT00934050|580155404|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
160665077|NCT00934050|580155399|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
160665078|NCT00934050|580155400|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
160665079|NCT00934050|580155401|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
160665080|NCT00934050|580155402|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
160665081|NCT00934050|580155403|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
160665082|NCT00934050|580155404|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
160665083|NCT00934050|580155399|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
160665084|NCT00934050|580155400|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
160665085|NCT00934050|580155401|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
160665086|NCT00934050|580155402|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
160665087|NCT00934050|580155403|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
160621687|NCT03382639|579994280|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
160621688|NCT03382639|579994281|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
160621689|NCT03382639|579994278|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
160621690|NCT03382639|579994279|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
160621691|NCT03382639|579994280|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
160621692|NCT03382639|579994281|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
160621693|NCT03382639|579994278|FG000|Overall Study|Other|2|||
160621694|NCT03382639|579994279|FG001|Overall Study|Other|0|||
160621695|NCT03382639|579994280|FG002|Overall Study|Other|0|||
160621696|NCT03382639|579994281|FG003|Overall Study|Other|3|||
160621697|NCT00285857|579994284|FG000|Overall Study|Withdrawal by Subject|2|||
160621698|NCT00285857|579994284|FG000|Overall Study|Inadequate initial breast cytology|1|||
160621699|NCT00285857|579994284|FG000|Overall Study|Adverse Event|1|||
160621700|NCT00475657|579994290|FG000|Overall Study|Death|1|||
160621701|NCT00475657|579994290|FG000|Overall Study|Sponsor's Decision|3|||
160621702|NCT00408408|579994291|FG000|Overall Study|No follow up data|2|||
160621703|NCT00408408|579994292|FG001|Overall Study|No follow up data|3|||
160621704|NCT00408408|579994293|FG002|Overall Study|No follow up data|0|||
160621705|NCT00408408|579994294|FG003|Overall Study|No follow up data|7|||
160621706|NCT00408408|579994295|FG004|Overall Study|No follow up data|5|||
160621707|NCT00408408|579994296|FG005|Overall Study|No follow up data|3|||
160621708|NCT02898662|579994301|FG000|Overall Study|Adverse Event|1|||
160621709|NCT02898662|579994302|FG001|Overall Study|Adverse Event|0|||
160621710|NCT02898662|579994301|FG000|Overall Study|Loss of asthma control|23|||
160621711|NCT02898662|579994302|FG001|Overall Study|Loss of asthma control|24|||
160621712|NCT02898662|579994301|FG000|Overall Study|Withdrawal by Subject|4|||
160621713|NCT02898662|579994302|FG001|Overall Study|Withdrawal by Subject|1|||
160621714|NCT02898662|579994301|FG000|Overall Study|Technical issue|0|||
160621715|NCT02898662|579994302|FG001|Overall Study|Technical issue|1|||
160621716|NCT02898662|579994301|FG000|Overall Study|Randomized in error|0|||
160621717|NCT02898662|579994302|FG001|Overall Study|Randomized in error|1|||
160621718|NCT02898662|579994301|FG000|Overall Study|Subject decision|1|||
160621719|NCT02898662|579994302|FG001|Overall Study|Subject decision|0|||
160621720|NCT02898662|579994301|FG000|Overall Study|Other|0|||
160621721|NCT02898662|579994302|FG001|Overall Study|Other|1|||
160621722|NCT00399542|579994303|FG000|Overall Study|Adverse Event|18|||
160621723|NCT00399542|579994304|FG001|Overall Study|Adverse Event|15|||
160621724|NCT00399542|579994303|FG000|Overall Study|Protocol Violation|13|||
160621725|NCT00399542|579994304|FG001|Overall Study|Protocol Violation|3|||
160665088|NCT00934050|580155404|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
160621726|NCT00399542|579994303|FG000|Overall Study|Withdrawal by Subject|28|||
160621727|NCT00399542|579994304|FG001|Overall Study|Withdrawal by Subject|10|||
160621728|NCT00399542|579994303|FG000|Overall Study|Lack of Efficacy|18|||
160621729|NCT00399542|579994304|FG001|Overall Study|Lack of Efficacy|8|||
160621730|NCT00399542|579994303|FG000|Overall Study|Lost to Follow-up|6|||
160621731|NCT00399542|579994304|FG001|Overall Study|Lost to Follow-up|6|||
160665089|NCT00934050|580155399|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
160665090|NCT00934050|580155400|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
160512037|NCT00633880|579602145|FG002|Open Label Titration|Lack of Efficacy|0|||
160512038|NCT00633880|579602143|FG000|Open Label Titration|Adverse Event|13|||
160512039|NCT00633880|579602144|FG001|Open Label Titration|Adverse Event|0|||
160512040|NCT00633880|579602145|FG002|Open Label Titration|Adverse Event|0|||
160512041|NCT00633880|579602143|FG000|Open Label Titration|Treatment Failure|55|||
160512042|NCT00633880|579602144|FG001|Open Label Titration|Treatment Failure|0|||
160512043|NCT00633880|579602145|FG002|Open Label Titration|Treatment Failure|0|||
160512044|NCT00633880|579602143|FG000|Open Label Titration|Protocol Violation|6|||
160512045|NCT00633880|579602144|FG001|Open Label Titration|Protocol Violation|0|||
160512046|NCT00633880|579602145|FG002|Open Label Titration|Protocol Violation|0|||
160512047|NCT00633880|579602143|FG000|Open Label Titration|Physician Decision|1|||
160512048|NCT00633880|579602144|FG001|Open Label Titration|Physician Decision|0|||
160512049|NCT00633880|579602145|FG002|Open Label Titration|Physician Decision|0|||
160512050|NCT00633880|579602143|FG000|Open Label Titration|Withdrawal by Subject|4|||
160512051|NCT00633880|579602144|FG001|Open Label Titration|Withdrawal by Subject|0|||
160621732|NCT00399542|579994303|FG000|Overall Study|Other|1|||
160621733|NCT00399542|579994304|FG001|Overall Study|Other|0|||
160621734|NCT00399542|579994303|FG000|Overall Study|Physician Decision|0|||
160621735|NCT00399542|579994304|FG001|Overall Study|Physician Decision|1|||
160621736|NCT00917553|579994305|FG000|Overall Study|Lost to Follow-up|2|||
160621737|NCT00917553|579994306|FG001|Overall Study|Lost to Follow-up|1|||
160621738|NCT03172026|579994307|FG000|Overall Study|Withdrawal by Subject|1|||
160621739|NCT03172026|579994308|FG001|Overall Study|Withdrawal by Subject|0|||
160621740|NCT03172026|579994307|FG000|Overall Study|COVID restrictions|1|||
160621741|NCT03172026|579994308|FG001|Overall Study|COVID restrictions|0|||
160621742|NCT00504595|579994309|FG000|Overall Study|Lack of Efficacy|1|||
160621743|NCT00504595|579994310|FG001|Overall Study|Lack of Efficacy|0|||
160621744|NCT00504595|579994311|FG002|Overall Study|Lack of Efficacy|0|||
160621745|NCT00504595|579994312|FG003|Overall Study|Lack of Efficacy|0|||
160621746|NCT00504595|579994309|FG000|Overall Study|Other|0|||
160621747|NCT00504595|579994310|FG001|Overall Study|Other|0|||
160621748|NCT00504595|579994311|FG002|Overall Study|Other|2|||
160621749|NCT00504595|579994312|FG003|Overall Study|Other|0|||
160621750|NCT00174460|579994314|FG000|Overall Study|Withdrawal by Subject|0|||
160621751|NCT00174460|579994315|FG001|Overall Study|Withdrawal by Subject|1|||
160621752|NCT00579059|579994316|FG000|Overall Study|Study Canceled at 1 Year|21|||
160621753|NCT00579059|579994317|FG001|Overall Study|Study Canceled at 1 Year|10|||
160621754|NCT04652245|579994318|FG000|Wash-Out Period|Adverse Event|0|||
160621755|NCT04652245|579994319|FG001|Wash-Out Period|Adverse Event|2|||
160621756|NCT04652245|579994318|FG000|Wash-Out Period|Withdrawal by Subject|0|||
160621757|NCT04652245|579994319|FG001|Wash-Out Period|Withdrawal by Subject|2|||
160621758|NCT01218477|579994325|FG000|Overall Study|Disease progression|2|||
160621759|NCT01218477|579994326|FG001|Overall Study|Disease progression|3|||
160621760|NCT01218477|579994327|FG002|Overall Study|Disease progression|6|||
160621761|NCT01218477|579994328|FG003|Overall Study|Disease progression|2|||
160621762|NCT01218477|579994325|FG000|Overall Study|Study drug toxicity|0|||
160621763|NCT01218477|579994326|FG001|Overall Study|Study drug toxicity|2|||
160621764|NCT01218477|579994327|FG002|Overall Study|Study drug toxicity|5|||
160621765|NCT01218477|579994328|FG003|Overall Study|Study drug toxicity|0|||
160621766|NCT01218477|579994325|FG000|Overall Study|No longer meets study criteria|1|||
160621767|NCT01218477|579994326|FG001|Overall Study|No longer meets study criteria|0|||
160621768|NCT01218477|579994327|FG002|Overall Study|No longer meets study criteria|0|||
160621769|NCT01218477|579994328|FG003|Overall Study|No longer meets study criteria|0|||
160621770|NCT01218477|579994325|FG000|Overall Study|Withdrawal by Subject|0|||
160621771|NCT01218477|579994326|FG001|Overall Study|Withdrawal by Subject|0|||
160621772|NCT01218477|579994327|FG002|Overall Study|Withdrawal by Subject|1|||
160621773|NCT01218477|579994328|FG003|Overall Study|Withdrawal by Subject|0|||
160621774|NCT01218477|579994325|FG000|Overall Study|Prepared for cell transplantation|0|||
160621775|NCT01218477|579994326|FG001|Overall Study|Prepared for cell transplantation|1|||
160621776|NCT01218477|579994327|FG002|Overall Study|Prepared for cell transplantation|1|||
160621777|NCT01218477|579994328|FG003|Overall Study|Prepared for cell transplantation|0|||
160621778|NCT01218477|579994325|FG000|Overall Study|Administrative reason by sponsor|0|||
160665091|NCT00934050|580155401|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
160665092|NCT00934050|580155402|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
160512052|NCT00633880|579602145|FG002|Open Label Titration|Withdrawal by Subject|0|||
160512053|NCT01468181|579602148|FG000|Overall Study|Adverse Event|8|||
160512054|NCT01468181|579602149|FG001|Overall Study|Adverse Event|1|||
160512055|NCT01468181|579602150|FG002|Overall Study|Adverse Event|6|||
160512056|NCT01468181|579602151|FG003|Overall Study|Adverse Event|2|||
160621779|NCT01218477|579994326|FG001|Overall Study|Administrative reason by sponsor|0|||
160621780|NCT01218477|579994327|FG002|Overall Study|Administrative reason by sponsor|1|||
160665093|NCT00934050|580155403|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
160512057|NCT01468181|579602152|FG004|Overall Study|Adverse Event|2|||
160621781|NCT01218477|579994328|FG003|Overall Study|Administrative reason by sponsor|0|||
160621782|NCT01218477|579994325|FG000|Overall Study|Maximum clinical benefit|0|||
160512058|NCT01468181|579602148|FG000|Overall Study|Protocol Violation|2|||
160512059|NCT01468181|579602149|FG001|Overall Study|Protocol Violation|0|||
160665094|NCT00934050|580155404|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
160665095|NCT00934050|580155399|FG000|Enrolled After 15 Dec 2009|Death|0|||
160665096|NCT00934050|580155400|FG001|Enrolled After 15 Dec 2009|Death|0|||
160665097|NCT00934050|580155401|FG002|Enrolled After 15 Dec 2009|Death|0|||
160665098|NCT00934050|580155402|FG003|Enrolled After 15 Dec 2009|Death|0|||
160665099|NCT00934050|580155403|FG004|Enrolled After 15 Dec 2009|Death|0|||
160665100|NCT00934050|580155404|FG005|Enrolled After 15 Dec 2009|Death|1|||
160665101|NCT00934050|580155399|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
160665102|NCT00934050|580155400|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
160665103|NCT00934050|580155401|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
160665104|NCT00934050|580155402|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
160512060|NCT01468181|579602150|FG002|Overall Study|Protocol Violation|1|||
160512061|NCT01468181|579602151|FG003|Overall Study|Protocol Violation|0|||
160512062|NCT01468181|579602152|FG004|Overall Study|Protocol Violation|1|||
160512063|NCT01468181|579602148|FG000|Overall Study|Physician Decision|0|||
160512064|NCT01468181|579602149|FG001|Overall Study|Physician Decision|0|||
160512065|NCT01468181|579602150|FG002|Overall Study|Physician Decision|0|||
160512066|NCT01468181|579602151|FG003|Overall Study|Physician Decision|1|||
160512067|NCT01468181|579602152|FG004|Overall Study|Physician Decision|1|||
160512068|NCT01468181|579602148|FG000|Overall Study|Lost to Follow-up|0|||
160512069|NCT01468181|579602149|FG001|Overall Study|Lost to Follow-up|0|||
160512070|NCT01468181|579602150|FG002|Overall Study|Lost to Follow-up|1|||
160512071|NCT01468181|579602151|FG003|Overall Study|Lost to Follow-up|0|||
160512072|NCT01468181|579602152|FG004|Overall Study|Lost to Follow-up|1|||
160512073|NCT01468181|579602148|FG000|Overall Study|Withdrawal by Subject|0|||
160512074|NCT01468181|579602149|FG001|Overall Study|Withdrawal by Subject|1|||
160512075|NCT01468181|579602150|FG002|Overall Study|Withdrawal by Subject|0|||
160512076|NCT01468181|579602151|FG003|Overall Study|Withdrawal by Subject|0|||
160512077|NCT01468181|579602152|FG004|Overall Study|Withdrawal by Subject|0|||
160621783|NCT01218477|579994326|FG001|Overall Study|Maximum clinical benefit|2|||
160621784|NCT01218477|579994327|FG002|Overall Study|Maximum clinical benefit|0|||
160621785|NCT01218477|579994328|FG003|Overall Study|Maximum clinical benefit|0|||
160621786|NCT01303159|579994329|FG000|Overall Study|Death|16|||
160621787|NCT01303159|579994329|FG000|Overall Study|Study Termination|7|||
160621788|NCT00496782|579994335|FG000|Overall Study|Protocol Violation|1|||
160621789|NCT00496782|579994336|FG001|Overall Study|Protocol Violation|2|||
160621790|NCT01853397|579994340|FG000|Overall Study|Withdrawal by Subject|0|||
160621791|NCT01853397|579994341|FG001|Overall Study|Withdrawal by Subject|0|||
160621792|NCT01853397|579994342|FG002|Overall Study|Withdrawal by Subject|0|||
160621793|NCT01853397|579994343|FG003|Overall Study|Withdrawal by Subject|1|||
160621794|NCT01853397|579994340|FG000|Overall Study|Subject Noncompliance|0|||
160621795|NCT01853397|579994341|FG001|Overall Study|Subject Noncompliance|0|||
160621796|NCT01853397|579994342|FG002|Overall Study|Subject Noncompliance|0|||
160621797|NCT01853397|579994343|FG003|Overall Study|Subject Noncompliance|1|||
160621798|NCT02132312|579994344|FG000|Overall Study|Adverse Event|2|||
160621799|NCT02132312|579994345|FG001|Overall Study|Adverse Event|0|||
160621800|NCT02132312|579994344|FG000|Overall Study|Physician Decision|1|||
160621801|NCT02132312|579994345|FG001|Overall Study|Physician Decision|1|||
160621802|NCT02132312|579994344|FG000|Overall Study|Protocol Violation|0|||
160621803|NCT02132312|579994345|FG001|Overall Study|Protocol Violation|1|||
160621804|NCT02132312|579994344|FG000|Overall Study|Withdrawal by Subject|1|||
160621805|NCT02132312|579994345|FG001|Overall Study|Withdrawal by Subject|0|||
160621806|NCT02132312|579994344|FG000|Overall Study|Lost to Follow-up|2|||
160621807|NCT02132312|579994345|FG001|Overall Study|Lost to Follow-up|1|||
160621808|NCT01632345|579994346|FG000|Treatment: Part I|Adverse Event|1|||
160621809|NCT01632345|579994347|FG001|Treatment: Part I|Adverse Event|4|||
160621810|NCT01632345|579994348|FG002|Treatment: Part I|Adverse Event|2|||
160621811|NCT01632345|579994349|FG003|Treatment: Part I|Adverse Event|1|||
160621812|NCT01632345|579994350|FG004|Treatment: Part I|Adverse Event|3|||
160621813|NCT01632345|579994351|FG005|Treatment: Part I|Adverse Event|0|||
160621814|NCT01632345|579994352|FG006|Treatment: Part I|Adverse Event|0|||
160621815|NCT01632345|579994346|FG000|Treatment: Part I|Lack of Efficacy|0|||
160621816|NCT01632345|579994347|FG001|Treatment: Part I|Lack of Efficacy|1|||
160621817|NCT01632345|579994348|FG002|Treatment: Part I|Lack of Efficacy|0|||
160621818|NCT01632345|579994349|FG003|Treatment: Part I|Lack of Efficacy|1|||
160621819|NCT01632345|579994350|FG004|Treatment: Part I|Lack of Efficacy|1|||
160621820|NCT01632345|579994351|FG005|Treatment: Part I|Lack of Efficacy|0|||
160621821|NCT01632345|579994352|FG006|Treatment: Part I|Lack of Efficacy|0|||
160621822|NCT01632345|579994346|FG000|Treatment: Part I|Lost to Follow-up|3|||
160621823|NCT01632345|579994347|FG001|Treatment: Part I|Lost to Follow-up|2|||
160621824|NCT01632345|579994348|FG002|Treatment: Part I|Lost to Follow-up|1|||
160621825|NCT01632345|579994349|FG003|Treatment: Part I|Lost to Follow-up|3|||
160621826|NCT01632345|579994350|FG004|Treatment: Part I|Lost to Follow-up|4|||
160512078|NCT00513305|579602153|FG000|Overall Study|Adverse Event|6|||
160512079|NCT00513305|579602154|FG001|Overall Study|Adverse Event|2|||
160512080|NCT00513305|579602153|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
160512081|NCT00513305|579602154|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
160512082|NCT00513305|579602153|FG000|Overall Study|Lack of Efficacy|8|||
160665105|NCT00934050|580155403|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
160665106|NCT00934050|580155404|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
160665107|NCT00934050|580155399|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
160665108|NCT00934050|580155400|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
160665109|NCT00934050|580155401|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
160665110|NCT00934050|580155402|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
160665111|NCT00934050|580155403|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
160665112|NCT00934050|580155404|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
160665113|NCT00829309|580155407|FG000|Washout: 7 Days|Protocol Violation|1|||
160665114|NCT00829309|580155408|FG001|Washout: 7 Days|Protocol Violation|0|||
160665115|NCT01083693|580155409|FG000|Overall Study|Adverse Event|1|||
160665116|NCT01083693|580155410|FG001|Overall Study|Adverse Event|1|||
160665117|NCT01083693|580155411|FG002|Overall Study|Adverse Event|0|||
160665118|NCT01083693|580155409|FG000|Overall Study|Lost to Follow-up|2|||
160665119|NCT01083693|580155410|FG001|Overall Study|Lost to Follow-up|0|||
160665120|NCT01083693|580155411|FG002|Overall Study|Lost to Follow-up|2|||
160665121|NCT01083693|580155409|FG000|Overall Study|Lack of effectiveness|13|||
160665122|NCT01083693|580155410|FG001|Overall Study|Lack of effectiveness|2|||
160665123|NCT01083693|580155411|FG002|Overall Study|Lack of effectiveness|2|||
160665124|NCT01083693|580155409|FG000|Overall Study|Patient Moved|0|||
160665125|NCT01083693|580155410|FG001|Overall Study|Patient Moved|1|||
160665126|NCT01083693|580155411|FG002|Overall Study|Patient Moved|0|||
160665127|NCT01083693|580155409|FG000|Overall Study|Complete remission|0|||
160665128|NCT01083693|580155410|FG001|Overall Study|Complete remission|1|||
160665129|NCT01083693|580155411|FG002|Overall Study|Complete remission|0|||
160665130|NCT01083693|580155409|FG000|Overall Study|Other medical condition/surgery|1|||
160665131|NCT01083693|580155410|FG001|Overall Study|Other medical condition/surgery|1|||
160665132|NCT01083693|580155411|FG002|Overall Study|Other medical condition/surgery|0|||
160665133|NCT01083693|580155409|FG000|Overall Study|Withdrawal by Subject|3|||
160665134|NCT01083693|580155410|FG001|Overall Study|Withdrawal by Subject|0|||
160665135|NCT01083693|580155411|FG002|Overall Study|Withdrawal by Subject|2|||
160665136|NCT01083693|580155409|FG000|Overall Study|Reason unknown|0|||
160665137|NCT01083693|580155410|FG001|Overall Study|Reason unknown|0|||
160665138|NCT01083693|580155411|FG002|Overall Study|Reason unknown|1|||
160665139|NCT00777023|580155413|FG000|Overall Study|Adverse Event|15|||
160665140|NCT00777023|580155414|FG001|Overall Study|Adverse Event|21|||
160665141|NCT00777023|580155415|FG002|Overall Study|Adverse Event|8|||
160665142|NCT00777023|580155413|FG000|Overall Study|Lack of Efficacy|1|||
160665143|NCT00777023|580155414|FG001|Overall Study|Lack of Efficacy|0|||
160665144|NCT00777023|580155415|FG002|Overall Study|Lack of Efficacy|14|||
160665145|NCT00777023|580155413|FG000|Overall Study|Protocol Violation|2|||
160665146|NCT00777023|580155414|FG001|Overall Study|Protocol Violation|1|||
160665147|NCT00777023|580155415|FG002|Overall Study|Protocol Violation|1|||
160665148|NCT00777023|580155413|FG000|Overall Study|Lost to Follow-up|2|||
160665149|NCT00777023|580155414|FG001|Overall Study|Lost to Follow-up|3|||
160665150|NCT00777023|580155415|FG002|Overall Study|Lost to Follow-up|3|||
160665151|NCT00777023|580155413|FG000|Overall Study|Death|0|||
160665152|NCT00777023|580155414|FG001|Overall Study|Death|1|||
160665153|NCT00777023|580155415|FG002|Overall Study|Death|0|||
160665154|NCT00777023|580155413|FG000|Overall Study|Withdrawal by Subject|7|||
160665155|NCT00777023|580155414|FG001|Overall Study|Withdrawal by Subject|7|||
160665156|NCT00777023|580155415|FG002|Overall Study|Withdrawal by Subject|8|||
160665157|NCT00777023|580155413|FG000|Overall Study|Missing data|1|||
160665158|NCT00777023|580155414|FG001|Overall Study|Missing data|1|||
160665159|NCT00777023|580155415|FG002|Overall Study|Missing data|0|||
160665160|NCT00777023|580155413|FG000|Overall Study|Reasons not specified|4|||
160665161|NCT00777023|580155414|FG001|Overall Study|Reasons not specified|4|||
160665162|NCT00777023|580155415|FG002|Overall Study|Reasons not specified|2|||
160665163|NCT00777023|580155413|FG000|Overall Study|Last dose date unknown|3|||
160512083|NCT00513305|579602154|FG001|Overall Study|Lack of Efficacy|13|||
160512084|NCT00513305|579602153|FG000|Overall Study|Withdrawal by Subject|1|||
160512085|NCT00513305|579602154|FG001|Overall Study|Withdrawal by Subject|2|||
160512086|NCT00513305|579602153|FG000|Overall Study|Disease progression|8|||
160665164|NCT00777023|580155414|FG001|Overall Study|Last dose date unknown|3|||
160512087|NCT00513305|579602154|FG001|Overall Study|Disease progression|5|||
160665165|NCT00777023|580155415|FG002|Overall Study|Last dose date unknown|1|||
160665166|NCT00905840|580155418|FG000|Overall Study|Lost to Follow-up|11|||
160665167|NCT00905840|580155418|FG000|Overall Study|Death|3|||
160665168|NCT00905840|580155418|FG000|Overall Study|Withdrawal by Subject|1|||
160665169|NCT00905840|580155418|FG000|Overall Study|Adverse Event|1|||
160665170|NCT00448019|580155419|FG000|Overall Study|Withdrawal by Subject|3|||
160665171|NCT00448019|580155419|FG000|Overall Study|Disease progression|1|||
160665172|NCT00448019|580155419|FG000|Overall Study|Death|2|||
160665173|NCT00448019|580155419|FG000|Overall Study|Insurance Issues|1|||
160512088|NCT00513305|579602153|FG000|Overall Study|Eligible for stem cell transplant|1|||
160512089|NCT00513305|579602154|FG001|Overall Study|Eligible for stem cell transplant|0|||
160665174|NCT03020615|580155420|FG000|Overall Study|Physician Decision|3|||
160665175|NCT03020615|580155421|FG001|Overall Study|Physician Decision|1|||
160665176|NCT03020615|580155422|FG002|Overall Study|Physician Decision|2|||
160665177|NCT03020615|580155420|FG000|Overall Study|Parent/guardian/patient choice|3|||
160665178|NCT03020615|580155421|FG001|Overall Study|Parent/guardian/patient choice|0|||
160665179|NCT03020615|580155422|FG002|Overall Study|Parent/guardian/patient choice|4|||
160665180|NCT03020615|580155420|FG000|Overall Study|Screen failure|0|||
160665181|NCT03020615|580155421|FG001|Overall Study|Screen failure|0|||
160665182|NCT03020615|580155422|FG002|Overall Study|Screen failure|1|||
160665183|NCT03020615|580155420|FG000|Overall Study|Death|1|||
160665184|NCT03020615|580155421|FG001|Overall Study|Death|0|||
160665185|NCT03020615|580155422|FG002|Overall Study|Death|0|||
160665186|NCT03020615|580155420|FG000|Overall Study|Lost to Follow-up|0|||
160665187|NCT03020615|580155421|FG001|Overall Study|Lost to Follow-up|1|||
160665188|NCT03020615|580155422|FG002|Overall Study|Lost to Follow-up|0|||
160665189|NCT00089661|580155423|FG000|Overall Study|Adverse Event|0|||
160665190|NCT00089661|580155424|FG001|Overall Study|Adverse Event|2|||
160665191|NCT00089661|580155423|FG000|Overall Study|Death|1|||
160665192|NCT00089661|580155424|FG001|Overall Study|Death|0|||
160665193|NCT00089661|580155423|FG000|Overall Study|Lost to Follow-up|0|||
160665194|NCT00089661|580155424|FG001|Overall Study|Lost to Follow-up|3|||
160665195|NCT00089661|580155423|FG000|Overall Study|Withdrawal by Subject|11|||
160665196|NCT00089661|580155424|FG001|Overall Study|Withdrawal by Subject|9|||
160665197|NCT00089661|580155423|FG000|Overall Study|Disease progression|1|||
160665198|NCT00089661|580155424|FG001|Overall Study|Disease progression|3|||
160665199|NCT00089661|580155423|FG000|Overall Study|Ineligibility determined|4|||
160665200|NCT00089661|580155424|FG001|Overall Study|Ineligibility determined|4|||
160665201|NCT00089661|580155423|FG000|Overall Study|Noncompliance|2|||
160665202|NCT00089661|580155424|FG001|Overall Study|Noncompliance|4|||
160665203|NCT00089661|580155423|FG000|Overall Study|Other|2|||
160665204|NCT00089661|580155424|FG001|Overall Study|Other|1|||
160621827|NCT01632345|579994351|FG005|Treatment: Part I|Lost to Follow-up|0|||
160621828|NCT01632345|579994352|FG006|Treatment: Part I|Lost to Follow-up|0|||
160621829|NCT01632345|579994346|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
160621830|NCT01632345|579994347|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
160621831|NCT01632345|579994348|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
160621832|NCT01632345|579994349|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
160621833|NCT01632345|579994350|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
160621834|NCT01632345|579994351|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
160621835|NCT01632345|579994352|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
160621836|NCT01632345|579994346|FG000|Treatment: Part I|Physician Decision|2|||
160621837|NCT01632345|579994347|FG001|Treatment: Part I|Physician Decision|1|||
160621838|NCT01632345|579994348|FG002|Treatment: Part I|Physician Decision|0|||
160621839|NCT01632345|579994349|FG003|Treatment: Part I|Physician Decision|0|||
160621840|NCT01632345|579994350|FG004|Treatment: Part I|Physician Decision|1|||
160621841|NCT01632345|579994351|FG005|Treatment: Part I|Physician Decision|0|||
160621842|NCT01632345|579994352|FG006|Treatment: Part I|Physician Decision|0|||
160621843|NCT01632345|579994346|FG000|Treatment: Part I|Pregnancy|0|||
160621844|NCT01632345|579994347|FG001|Treatment: Part I|Pregnancy|1|||
160621845|NCT01632345|579994348|FG002|Treatment: Part I|Pregnancy|0|||
160621846|NCT01632345|579994349|FG003|Treatment: Part I|Pregnancy|0|||
160621847|NCT01632345|579994350|FG004|Treatment: Part I|Pregnancy|0|||
160621848|NCT01632345|579994351|FG005|Treatment: Part I|Pregnancy|0|||
160621849|NCT01632345|579994352|FG006|Treatment: Part I|Pregnancy|0|||
160621850|NCT01632345|579994346|FG000|Treatment: Part I|Protocol Deviation|0|||
160621851|NCT01632345|579994347|FG001|Treatment: Part I|Protocol Deviation|0|||
160621852|NCT01632345|579994348|FG002|Treatment: Part I|Protocol Deviation|1|||
160621853|NCT01632345|579994349|FG003|Treatment: Part I|Protocol Deviation|1|||
160621854|NCT01632345|579994350|FG004|Treatment: Part I|Protocol Deviation|0|||
160621855|NCT01632345|579994351|FG005|Treatment: Part I|Protocol Deviation|0|||
160621856|NCT01632345|579994352|FG006|Treatment: Part I|Protocol Deviation|0|||
160621857|NCT01632345|579994346|FG000|Treatment: Part I|Withdrawal by Subject|3|||
160621858|NCT01632345|579994347|FG001|Treatment: Part I|Withdrawal by Subject|4|||
160665205|NCT01273805|580155425|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
160665206|NCT01273805|580155426|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
160665207|NCT02647944|580155427|FG000|Overall Study|Withdrawal by Subject|0|||
160665208|NCT02647944|580155428|FG001|Overall Study|Withdrawal by Subject|3|||
160621859|NCT01632345|579994348|FG002|Treatment: Part I|Withdrawal by Subject|4|||
160621860|NCT01632345|579994349|FG003|Treatment: Part I|Withdrawal by Subject|1|||
160621861|NCT01632345|579994350|FG004|Treatment: Part I|Withdrawal by Subject|4|||
160621862|NCT01632345|579994351|FG005|Treatment: Part I|Withdrawal by Subject|0|||
160621863|NCT01632345|579994352|FG006|Treatment: Part I|Withdrawal by Subject|0|||
160621864|NCT01632345|579994346|FG000|Treatment: Part II|Adverse Event|0|||
160665209|NCT02647944|580155427|FG000|Overall Study|Adverse Event|2|||
160665210|NCT02647944|580155428|FG001|Overall Study|Adverse Event|0|||
160665211|NCT02077465|580155430|FG000|Overall Study|Withdrew Consent|0|||
160665212|NCT02077465|580155431|FG001|Overall Study|Withdrew Consent|1|||
160665213|NCT02077465|580155430|FG000|Overall Study|Lost to Follow-up|1|||
160621865|NCT01632345|579994347|FG001|Treatment: Part II|Adverse Event|0|||
160621866|NCT01632345|579994348|FG002|Treatment: Part II|Adverse Event|0|||
160621867|NCT01632345|579994349|FG003|Treatment: Part II|Adverse Event|0|||
160621868|NCT01632345|579994350|FG004|Treatment: Part II|Adverse Event|0|||
160621869|NCT01632345|579994351|FG005|Treatment: Part II|Adverse Event|3|||
160621870|NCT01632345|579994352|FG006|Treatment: Part II|Adverse Event|8|||
160621871|NCT01632345|579994346|FG000|Treatment: Part II|Lost to Follow-up|0|||
160621872|NCT01632345|579994347|FG001|Treatment: Part II|Lost to Follow-up|0|||
160621873|NCT01632345|579994348|FG002|Treatment: Part II|Lost to Follow-up|0|||
160621874|NCT01632345|579994349|FG003|Treatment: Part II|Lost to Follow-up|0|||
160621875|NCT01632345|579994350|FG004|Treatment: Part II|Lost to Follow-up|0|||
160621876|NCT01632345|579994351|FG005|Treatment: Part II|Lost to Follow-up|3|||
160621877|NCT01632345|579994352|FG006|Treatment: Part II|Lost to Follow-up|1|||
160621878|NCT01632345|579994346|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
160621879|NCT01632345|579994347|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
160621880|NCT01632345|579994348|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
160621881|NCT01632345|579994349|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
160621882|NCT01632345|579994350|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
160621883|NCT01632345|579994351|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
160621884|NCT01632345|579994352|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
160621885|NCT01632345|579994346|FG000|Treatment: Part II|Withdrawal by Subject|0|||
160621886|NCT01632345|579994347|FG001|Treatment: Part II|Withdrawal by Subject|0|||
160621887|NCT01632345|579994348|FG002|Treatment: Part II|Withdrawal by Subject|0|||
160621888|NCT01632345|579994349|FG003|Treatment: Part II|Withdrawal by Subject|0|||
160621889|NCT01632345|579994350|FG004|Treatment: Part II|Withdrawal by Subject|0|||
160621890|NCT01632345|579994351|FG005|Treatment: Part II|Withdrawal by Subject|2|||
160621891|NCT01632345|579994352|FG006|Treatment: Part II|Withdrawal by Subject|2|||
160621892|NCT00089505|579994353|FG000|Overall Study|Death|4|||
160621893|NCT00089505|579994354|FG001|Overall Study|Death|1|||
160621894|NCT00089505|579994355|FG002|Overall Study|Death|5|||
160621895|NCT00089505|579994356|FG003|Overall Study|Death|8|||
160621896|NCT00089505|579994353|FG000|Overall Study|Withdrawal by Subject|3|||
160621897|NCT00089505|579994354|FG001|Overall Study|Withdrawal by Subject|0|||
160621898|NCT00089505|579994355|FG002|Overall Study|Withdrawal by Subject|6|||
160621899|NCT00089505|579994356|FG003|Overall Study|Withdrawal by Subject|6|||
160621900|NCT00089505|579994353|FG000|Overall Study|Lost to Follow-up|1|||
160621901|NCT00089505|579994354|FG001|Overall Study|Lost to Follow-up|1|||
160621902|NCT00089505|579994355|FG002|Overall Study|Lost to Follow-up|9|||
160621903|NCT00089505|579994356|FG003|Overall Study|Lost to Follow-up|7|||
160621904|NCT00089505|579994353|FG000|Overall Study|Physician Decision|1|||
160621905|NCT00089505|579994354|FG001|Overall Study|Physician Decision|0|||
160621906|NCT00089505|579994355|FG002|Overall Study|Physician Decision|0|||
160621907|NCT00089505|579994356|FG003|Overall Study|Physician Decision|0|||
160621908|NCT00089505|579994353|FG000|Overall Study|Protocol Violation|0|||
160621909|NCT00089505|579994354|FG001|Overall Study|Protocol Violation|0|||
160621910|NCT00089505|579994355|FG002|Overall Study|Protocol Violation|1|||
160621911|NCT00089505|579994356|FG003|Overall Study|Protocol Violation|0|||
160621912|NCT02431559|579994357|FG000|Overall Study|Adverse Event|0|||
160621913|NCT02431559|579994358|FG001|Overall Study|Adverse Event|1|||
160621914|NCT02431559|579994359|FG002|Overall Study|Adverse Event|0|||
160621915|NCT02431559|579994360|FG003|Overall Study|Adverse Event|4|||
160621916|NCT02431559|579994357|FG000|Overall Study|Progressive disease|2|||
160621917|NCT02431559|579994358|FG001|Overall Study|Progressive disease|1|||
160621918|NCT02431559|579994359|FG002|Overall Study|Progressive disease|4|||
160621919|NCT02431559|579994360|FG003|Overall Study|Progressive disease|22|||
160621920|NCT02431559|579994357|FG000|Overall Study|Withdrawal by Subject|0|||
160621921|NCT02431559|579994358|FG001|Overall Study|Withdrawal by Subject|1|||
160621922|NCT02431559|579994359|FG002|Overall Study|Withdrawal by Subject|0|||
160621923|NCT02431559|579994360|FG003|Overall Study|Withdrawal by Subject|4|||
160621924|NCT02431559|579994357|FG000|Overall Study|Physician Decision|0|||
160621925|NCT02431559|579994358|FG001|Overall Study|Physician Decision|0|||
160621926|NCT02431559|579994359|FG002|Overall Study|Physician Decision|0|||
160621927|NCT02431559|579994360|FG003|Overall Study|Physician Decision|1|||
160621928|NCT00283062|579994363|FG000|Overall Study|Did not receive any study medication|5|||
160621929|NCT00283062|579994364|FG001|Overall Study|Did not receive any study medication|4|||
160621930|NCT00283062|579994365|FG002|Overall Study|Did not receive any study medication|36|||
160621931|NCT00283062|579994366|FG003|Overall Study|Did not receive any study medication|45|||
160665214|NCT02077465|580155431|FG001|Overall Study|Lost to Follow-up|0|||
160621932|NCT00283062|579994363|FG000|Overall Study|Adverse Event|2|||
160665215|NCT02760368|580155432|FG000|Overall Study|Withdrawal by Subject|8|||
160665216|NCT02760368|580155433|FG001|Overall Study|Withdrawal by Subject|12|||
160665217|NCT02760368|580155434|FG002|Overall Study|Withdrawal by Subject|9|||
160621933|NCT00283062|579994364|FG001|Overall Study|Adverse Event|0|||
160621934|NCT00283062|579994365|FG002|Overall Study|Adverse Event|1|||
160621935|NCT00283062|579994366|FG003|Overall Study|Adverse Event|0|||
160621936|NCT00283062|579994363|FG000|Overall Study|Lost to Follow-up|1|||
160621937|NCT00283062|579994364|FG001|Overall Study|Lost to Follow-up|0|||
160621938|NCT00283062|579994365|FG002|Overall Study|Lost to Follow-up|1|||
160621939|NCT00283062|579994366|FG003|Overall Study|Lost to Follow-up|0|||
160621940|NCT00283062|579994363|FG000|Overall Study|Progressive disease|0|||
160621941|NCT00283062|579994364|FG001|Overall Study|Progressive disease|0|||
160621942|NCT00283062|579994365|FG002|Overall Study|Progressive disease|1|||
160621943|NCT00283062|579994366|FG003|Overall Study|Progressive disease|0|||
160621944|NCT00283062|579994363|FG000|Overall Study|Participant did not wish to continue|3|||
160621945|NCT00283062|579994364|FG001|Overall Study|Participant did not wish to continue|2|||
160621946|NCT00283062|579994365|FG002|Overall Study|Participant did not wish to continue|1|||
160621947|NCT00283062|579994366|FG003|Overall Study|Participant did not wish to continue|0|||
160621948|NCT00283062|579994363|FG000|Overall Study|Undefined|0|||
160621949|NCT00283062|579994364|FG001|Overall Study|Undefined|1|||
160621950|NCT00283062|579994365|FG002|Overall Study|Undefined|1|||
160621951|NCT00283062|579994366|FG003|Overall Study|Undefined|4|||
160621952|NCT00283062|579994363|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
160621953|NCT00283062|579994364|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
160621954|NCT00283062|579994365|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
160621955|NCT00283062|579994366|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
160621956|NCT03529162|579994367|FG000|Overall Study|Lost to Follow-up|2|||
160621957|NCT03529162|579994368|FG001|Overall Study|Lost to Follow-up|2|||
160621958|NCT00784836|579994369|FG000|Overall Study|Early Study Termination|3|||
160621959|NCT02613910|579994370|FG000|Overall Study|Termination of study|1|||
160621960|NCT03077646|579994371|FG000|Overall Study|Lost to Follow-up|29|||
160621961|NCT03077646|579994372|FG001|Overall Study|Lost to Follow-up|30|||
160621962|NCT03077646|579994373|FG002|Overall Study|Lost to Follow-up|31|||
160621963|NCT00765726|579994374|FG000|Overall Study|Withdrawal by Subject|1|||
160621964|NCT00765726|579994374|FG000|Overall Study|Discontinuation of study by sponsor|8|||
160621965|NCT02993731|579994375|FG000|Overall Study|Study Termination|101|||
160621966|NCT02993731|579994376|FG001|Overall Study|Study Termination|105|||
160621967|NCT02545504|579994382|FG000|Overall Study|Death|174|||
160621968|NCT02545504|579994383|FG001|Overall Study|Death|168|||
160621969|NCT02545504|579994382|FG000|Overall Study|Unknown reason|30|||
160621970|NCT02545504|579994383|FG001|Overall Study|Unknown reason|32|||
160621971|NCT02545504|579994382|FG000|Overall Study|Withdrew consent|9|||
160621972|NCT02545504|579994383|FG001|Overall Study|Withdrew consent|11|||
160621973|NCT02545504|579994382|FG000|Overall Study|Investigator's discretion|3|||
160621974|NCT02545504|579994383|FG001|Overall Study|Investigator's discretion|1|||
160621975|NCT02545504|579994382|FG000|Overall Study|Lost to Follow-up|2|||
160621976|NCT02545504|579994383|FG001|Overall Study|Lost to Follow-up|2|||
160621977|NCT01002573|579996107|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
160621978|NCT01002573|579996108|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
160621979|NCT02028182|579996109|FG000|Overall Study|Protocol Violation|2|||
160621980|NCT01684930|579996112|FG000|Overall Study|Withdrawal by Subject|3|||
160621981|NCT01684930|579996113|FG001|Overall Study|Withdrawal by Subject|1|||
160621982|NCT01336647|579996115|FG000|Overall Study|Lost to Follow-up|4|||
160621983|NCT01336647|579996116|FG001|Overall Study|Lost to Follow-up|1|||
160621984|NCT01336647|579996117|FG002|Overall Study|Lost to Follow-up|3|||
160621985|NCT02713490|579996118|FG000|Overall Study|Withdrawal by Subject|2|||
160621986|NCT02713490|579996119|FG001|Overall Study|Withdrawal by Subject|1|||
160621987|NCT02713490|579996118|FG000|Overall Study|Did not receive study drug|1|||
160621988|NCT02713490|579996119|FG001|Overall Study|Did not receive study drug|0|||
160621989|NCT02713490|579996118|FG000|Overall Study|Met exclusion criteria|0|||
160621990|NCT02713490|579996119|FG001|Overall Study|Met exclusion criteria|1|||
160621991|NCT01714726|579996120|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
160621992|NCT01714726|579996121|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
160621993|NCT01714726|579996122|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
160621994|NCT01714726|579996123|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
160621995|NCT01714726|579996120|FG000|Double-Blinded Induction Period|Adverse Event|0|||
160621996|NCT01714726|579996121|FG001|Double-Blinded Induction Period|Adverse Event|1|||
160621997|NCT01714726|579996122|FG002|Double-Blinded Induction Period|Adverse Event|0|||
160621998|NCT01714726|579996123|FG003|Double-Blinded Induction Period|Adverse Event|0|||
160621999|NCT01714726|579996120|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
160622000|NCT01714726|579996121|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
160622001|NCT01714726|579996122|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
160622002|NCT01714726|579996123|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
160622003|NCT01714726|579996120|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
160622004|NCT01714726|579996121|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
160622005|NCT01714726|579996122|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
160622006|NCT01714726|579996123|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
160622007|NCT01714726|579996120|FG000|Open-Label Period|Other|0|||
160622008|NCT01714726|579996121|FG001|Open-Label Period|Other|0|||
160622009|NCT01714726|579996122|FG002|Open-Label Period|Other|1|||
160622010|NCT01714726|579996123|FG003|Open-Label Period|Other|3|||
160622011|NCT01714726|579996120|FG000|Open-Label Period|Adverse Event|0|||
160622012|NCT01714726|579996121|FG001|Open-Label Period|Adverse Event|0|||
160622013|NCT01714726|579996122|FG002|Open-Label Period|Adverse Event|1|||
160512090|NCT00513305|579602153|FG000|Overall Study|Hematologic counts did not recover|1|||
160512091|NCT00513305|579602154|FG001|Overall Study|Hematologic counts did not recover|0|||
160512092|NCT00513305|579602153|FG000|Overall Study|Physician Decision|1|||
160512093|NCT00513305|579602154|FG001|Overall Study|Physician Decision|0|||
160512094|NCT00513305|579602153|FG000|Overall Study|Persistent hypocellularity|0|||
160512095|NCT00513305|579602154|FG001|Overall Study|Persistent hypocellularity|1|||
160512096|NCT00513305|579602153|FG000|Overall Study|Sponsor Decision|0|||
160512097|NCT00513305|579602154|FG001|Overall Study|Sponsor Decision|2|||
160512098|NCT01262027|579602156|FG000|Overall Study|Adverse Event|1|||
160622014|NCT01714726|579996123|FG003|Open-Label Period|Adverse Event|0|||
160622015|NCT01714726|579996120|FG000|Open-Label Period|Withdrawal by Subject|0|||
160622016|NCT01714726|579996121|FG001|Open-Label Period|Withdrawal by Subject|0|||
160622017|NCT01714726|579996122|FG002|Open-Label Period|Withdrawal by Subject|9|||
160622018|NCT01714726|579996123|FG003|Open-Label Period|Withdrawal by Subject|19|||
160622019|NCT01714726|579996120|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
160622020|NCT01714726|579996121|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
160622021|NCT01714726|579996122|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
160622022|NCT01714726|579996123|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
160622023|NCT01714726|579996120|FG000|Open-Label Period|Lost to Follow-up|0|||
160622024|NCT01714726|579996121|FG001|Open-Label Period|Lost to Follow-up|0|||
160622025|NCT01714726|579996122|FG002|Open-Label Period|Lost to Follow-up|3|||
160622026|NCT01714726|579996123|FG003|Open-Label Period|Lost to Follow-up|4|||
160622027|NCT00548340|579996125|FG000|Overall Study|Protocol Violation|2|||
160622028|NCT00548340|579996126|FG001|Overall Study|Protocol Violation|3|||
160622029|NCT00548340|579996127|FG002|Overall Study|Protocol Violation|3|||
160622030|NCT00548340|579996125|FG000|Overall Study|Adverse Event|2|||
160622031|NCT00548340|579996126|FG001|Overall Study|Adverse Event|2|||
160622032|NCT00548340|579996127|FG002|Overall Study|Adverse Event|2|||
160622033|NCT00548340|579996125|FG000|Overall Study|Lost to Follow-up|1|||
160622034|NCT00548340|579996126|FG001|Overall Study|Lost to Follow-up|1|||
160622035|NCT00548340|579996127|FG002|Overall Study|Lost to Follow-up|0|||
160622036|NCT00548340|579996125|FG000|Overall Study|Withdrawal by Subject|2|||
160622037|NCT00548340|579996126|FG001|Overall Study|Withdrawal by Subject|4|||
160622038|NCT00548340|579996127|FG002|Overall Study|Withdrawal by Subject|3|||
160622039|NCT00548340|579996125|FG000|Overall Study|Other|1|||
160622040|NCT00548340|579996126|FG001|Overall Study|Other|1|||
160622041|NCT00548340|579996127|FG002|Overall Study|Other|1|||
160622042|NCT02600559|579996128|FG000|Overall Study|Withdrawal by Subject|3|||
160622043|NCT02600559|579996128|FG000|Overall Study|Lost to Follow-up|20|||
160622044|NCT02392078|579996133|FG000|Overall Study|Did not have procedure|32|||
160622045|NCT02392078|579996134|FG001|Overall Study|Did not have procedure|43|||
160622046|NCT02392078|579996135|FG002|Overall Study|Did not have procedure|20|||
160622047|NCT02392078|579996136|FG003|Overall Study|Did not have procedure|1|||
160622048|NCT02079077|579996137|FG000|Overall Study|Lost to Follow-up|5|||
160622049|NCT02079077|579996138|FG001|Overall Study|Lost to Follow-up|7|||
160622050|NCT02079077|579996137|FG000|Overall Study|Became STIs Positive|1|||
160622051|NCT02079077|579996138|FG001|Overall Study|Became STIs Positive|2|||
160622052|NCT03868410|579996141|FG000|Overall Study|Physician Decision|0|||
160622053|NCT03868410|579996142|FG001|Overall Study|Physician Decision|1|||
160622054|NCT02624713|579996149|FG000|Overall Study|Lost to Follow-up|14|||
160622055|NCT02624713|579996150|FG001|Overall Study|Lost to Follow-up|0|||
160622056|NCT00148109|579996151|FG000|Overall Study|Lack of Efficacy|10|||
160622057|NCT00148109|579996152|FG001|Overall Study|Lack of Efficacy|18|||
160622058|NCT00148109|579996151|FG000|Overall Study|Adverse Event|0|||
160622059|NCT00148109|579996152|FG001|Overall Study|Adverse Event|2|||
160622060|NCT00148109|579996151|FG000|Overall Study|Withdrawal by Subject|2|||
160622061|NCT00148109|579996152|FG001|Overall Study|Withdrawal by Subject|0|||
160622062|NCT06104423|579996153|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
160622063|NCT06104423|579996154|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
160622064|NCT06104423|579996155|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
160622065|NCT06104423|579996153|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
160622066|NCT06104423|579996154|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
160622067|NCT06104423|579996155|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
160622068|NCT00351611|579996160|FG000|Overall Study|Adverse Event|11|||
160622069|NCT00351611|579996161|FG001|Overall Study|Adverse Event|3|||
160622070|NCT00351611|579996160|FG000|Overall Study|Death|1|||
160622071|NCT00351611|579996161|FG001|Overall Study|Death|0|||
160622072|NCT00351611|579996160|FG000|Overall Study|Lost to Follow-up|1|||
160622073|NCT00351611|579996161|FG001|Overall Study|Lost to Follow-up|0|||
160622074|NCT00351611|579996160|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
160622075|NCT00351611|579996161|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
160622076|NCT00351611|579996160|FG000|Overall Study|Other|1|||
160622077|NCT00351611|579996161|FG001|Overall Study|Other|0|||
160622078|NCT00351611|579996160|FG000|Overall Study|Protocol Violation|0|||
160622079|NCT00351611|579996161|FG001|Overall Study|Protocol Violation|2|||
160622080|NCT01589185|579996162|FG000|Overall Study|Death|1|||
160512099|NCT01262027|579602156|FG000|Overall Study|Withdrawal by Subject|3|||
160512100|NCT01262027|579602156|FG000|Overall Study|Protocol Violation|1|||
160512101|NCT01011153|579602160|FG000|Overall Study|Less than 78 cases completed|8|||
160512102|NCT01011153|579602161|FG001|Overall Study|Less than 78 cases completed|11|||
160622081|NCT01589185|579996163|FG001|Overall Study|Death|2|||
160622082|NCT01589185|579996164|FG002|Overall Study|Death|2|||
160622083|NCT01589185|579996165|FG003|Overall Study|Death|0|||
160622084|NCT01589185|579996166|FG004|Overall Study|Death|1|||
160622085|NCT01589185|579996162|FG000|Overall Study|Lost to Follow-up|1|||
160622086|NCT01589185|579996163|FG001|Overall Study|Lost to Follow-up|0|||
160622087|NCT01589185|579996164|FG002|Overall Study|Lost to Follow-up|2|||
160622088|NCT01589185|579996165|FG003|Overall Study|Lost to Follow-up|3|||
160622089|NCT01589185|579996166|FG004|Overall Study|Lost to Follow-up|0|||
160622090|NCT02708524|579996167|FG000|Overall Study|Adverse Event|0|||
160622091|NCT02708524|579996168|FG001|Overall Study|Adverse Event|1|||
160622092|NCT02708524|579996169|FG002|Overall Study|Adverse Event|0|||
160622093|NCT02708524|579996170|FG003|Overall Study|Adverse Event|0|||
160622094|NCT02708524|579996167|FG000|Overall Study|Lens Discomfort|1|||
160622095|NCT02708524|579996168|FG001|Overall Study|Lens Discomfort|0|||
160622096|NCT02708524|579996169|FG002|Overall Study|Lens Discomfort|1|||
160512103|NCT01011153|579602162|FG002|Overall Study|Less than 78 cases completed|9|||
160512104|NCT03014479|579602168|FG000|Overall Study|Adverse Event|0|||
160512105|NCT03014479|579602169|FG001|Overall Study|Adverse Event|1|||
160512106|NCT03014479|579602168|FG000|Overall Study|Voluntary Withdrawal|0|||
160512107|NCT03014479|579602169|FG001|Overall Study|Voluntary Withdrawal|2|||
160512108|NCT03014479|579602168|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
160512109|NCT03014479|579602169|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
160512110|NCT01081132|579602174|FG000|Overall Study|Lack of Efficacy|25|||
160512111|NCT01081132|579602175|FG001|Overall Study|Lack of Efficacy|9|||
160512112|NCT01081132|579602174|FG000|Overall Study|Withdrawal by Subject|13|||
160512113|NCT01081132|579602175|FG001|Overall Study|Withdrawal by Subject|16|||
160512114|NCT01081132|579602174|FG000|Overall Study|Lost to Follow-up|4|||
160512115|NCT01081132|579602175|FG001|Overall Study|Lost to Follow-up|11|||
160512116|NCT01081132|579602174|FG000|Overall Study|Adverse Event|3|||
160512117|NCT01081132|579602175|FG001|Overall Study|Adverse Event|9|||
160512118|NCT01081132|579602174|FG000|Overall Study|Non Compliance|4|||
160512119|NCT01081132|579602175|FG001|Overall Study|Non Compliance|2|||
160512120|NCT01081132|579602174|FG000|Overall Study|Lack Of Compliance|0|||
160512121|NCT01081132|579602175|FG001|Overall Study|Lack Of Compliance|1|||
160512122|NCT01081132|579602174|FG000|Overall Study|Missed Visits|1|||
160512123|NCT01081132|579602175|FG001|Overall Study|Missed Visits|1|||
160512124|NCT01081132|579602174|FG000|Overall Study|Stopped Taking Meds|2|||
160512125|NCT01081132|579602175|FG001|Overall Study|Stopped Taking Meds|0|||
160512126|NCT01081132|579602174|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
160512127|NCT01081132|579602175|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
160512128|NCT01081132|579602174|FG000|Overall Study|Declined Taper Phase|0|||
160512129|NCT01081132|579602175|FG001|Overall Study|Declined Taper Phase|1|||
160512130|NCT01081132|579602174|FG000|Overall Study|Protocol Violation|3|||
160622097|NCT02708524|579996170|FG003|Overall Study|Lens Discomfort|0|||
160622098|NCT02708524|579996167|FG000|Overall Study|Lost to Follow-up|1|||
160622099|NCT02708524|579996168|FG001|Overall Study|Lost to Follow-up|1|||
160622100|NCT02708524|579996169|FG002|Overall Study|Lost to Follow-up|1|||
160622101|NCT02708524|579996170|FG003|Overall Study|Lost to Follow-up|0|||
160622102|NCT02708524|579996167|FG000|Overall Study|Protocol Violation|0|||
160622103|NCT02708524|579996168|FG001|Overall Study|Protocol Violation|1|||
160622104|NCT02708524|579996169|FG002|Overall Study|Protocol Violation|0|||
160622105|NCT02708524|579996170|FG003|Overall Study|Protocol Violation|0|||
160622106|NCT02708524|579996167|FG000|Overall Study|Withdrawal by Subject|1|||
160622107|NCT02708524|579996168|FG001|Overall Study|Withdrawal by Subject|1|||
160622108|NCT02708524|579996169|FG002|Overall Study|Withdrawal by Subject|0|||
160622109|NCT02708524|579996170|FG003|Overall Study|Withdrawal by Subject|0|||
160622110|NCT02708524|579996167|FG000|Overall Study|Dispensed incorrect study lens|0|||
160622111|NCT02708524|579996168|FG001|Overall Study|Dispensed incorrect study lens|1|||
160622112|NCT02708524|579996169|FG002|Overall Study|Dispensed incorrect study lens|1|||
160622113|NCT02708524|579996170|FG003|Overall Study|Dispensed incorrect study lens|0|||
160622114|NCT02708524|579996167|FG000|Overall Study|Did not wear lens at final visit|0|||
160622115|NCT02708524|579996168|FG001|Overall Study|Did not wear lens at final visit|1|||
160622116|NCT02708524|579996169|FG002|Overall Study|Did not wear lens at final visit|0|||
160622117|NCT02708524|579996170|FG003|Overall Study|Did not wear lens at final visit|0|||
160622118|NCT02708524|579996167|FG000|Overall Study|Subject lost study lens|1|||
160512131|NCT01081132|579602175|FG001|Overall Study|Protocol Violation|1|||
160622119|NCT02708524|579996168|FG001|Overall Study|Subject lost study lens|0|||
160512132|NCT02101385|579602176|FG000|Study Treatment|Disease Progression|9|||
160622120|NCT02708524|579996169|FG002|Overall Study|Subject lost study lens|0|||
160622121|NCT02708524|579996170|FG003|Overall Study|Subject lost study lens|0|||
160622122|NCT03781167|579996176|FG000|Overall Study|Adverse Event|23|||
160622123|NCT03781167|579996177|FG001|Overall Study|Adverse Event|25|||
160622124|NCT03781167|579996176|FG000|Overall Study|Withdrew consent|16|||
160665218|NCT02760368|580155432|FG000|Overall Study|Screen Failure|0|||
160665219|NCT02760368|580155433|FG001|Overall Study|Screen Failure|0|||
160665220|NCT02760368|580155434|FG002|Overall Study|Screen Failure|1|||
160665221|NCT02760368|580155432|FG000|Overall Study|Death|0|||
160665222|NCT02760368|580155433|FG001|Overall Study|Death|1|||
160665223|NCT02760368|580155434|FG002|Overall Study|Death|0|||
160665224|NCT02760368|580155432|FG000|Overall Study|Withdrawal by Sponsor|0|||
160665225|NCT02760368|580155433|FG001|Overall Study|Withdrawal by Sponsor|0|||
160665226|NCT02760368|580155434|FG002|Overall Study|Withdrawal by Sponsor|1|||
160665227|NCT00794963|580155435|FG000|Overall Study|Withdrawal by Subject|1|||
160665228|NCT00794963|580155436|FG001|Overall Study|Withdrawal by Subject|4|||
160665229|NCT01513174|580155439|FG000|Overall Study|Inclusion Error|1|||
160665230|NCT01513174|580155440|FG001|Overall Study|Inclusion Error|7|||
160665231|NCT01513174|580155439|FG000|Overall Study|Not receive study treatment|3|||
160665232|NCT01513174|580155440|FG001|Overall Study|Not receive study treatment|1|||
160665233|NCT01900626|580155443|FG000|Overall Study|study was closed due to low enrollment|1|||
160665234|NCT01900626|580155444|FG001|Overall Study|study was closed due to low enrollment|1|||
160665235|NCT00448591|580155447|FG000|Overall Study|Withdrawal by Subject|178|||
160665236|NCT00448591|580155447|FG000|Overall Study|Progressive Disease|1382|||
160665237|NCT00448591|580155447|FG000|Overall Study|Adverse Event|382|||
160665238|NCT00448591|580155447|FG000|Overall Study|Protocol Violation|41|||
160665239|NCT00448591|580155447|FG000|Overall Study|Lost to Follow-up|19|||
160665240|NCT00448591|580155447|FG000|Overall Study|Treatment Regimen Completed|70|||
160665241|NCT00448591|580155447|FG000|Overall Study|Other|154|||
160665242|NCT00448591|580155447|FG000|Overall Study|Termination of Study|70|||
160665243|NCT03138967|580155448|FG000|Overall Study|Death|0|||
160665244|NCT03138967|580155449|FG001|Overall Study|Death|1|||
160665245|NCT03138967|580155448|FG000|Overall Study|Physician Decision|1|||
160665246|NCT03138967|580155449|FG001|Overall Study|Physician Decision|3|||
160665247|NCT04604275|580155452|FG000|Washout-1 Week|Withdrawal by Subject|1|||
160665248|NCT04604275|580155453|FG001|Washout-1 Week|Withdrawal by Subject|0|||
160665249|NCT04405570|580155454|FG000|Overall Study|Adverse Event|0|||
160665250|NCT04405570|580155455|FG001|Overall Study|Adverse Event|1|||
160665251|NCT04405570|580155456|FG002|Overall Study|Adverse Event|1|||
160665252|NCT04405570|580155457|FG003|Overall Study|Adverse Event|1|||
160665253|NCT04405570|580155454|FG000|Overall Study|Lost to Follow-up|0|||
160665254|NCT04405570|580155455|FG001|Overall Study|Lost to Follow-up|1|||
160665255|NCT04405570|580155456|FG002|Overall Study|Lost to Follow-up|0|||
160665256|NCT04405570|580155457|FG003|Overall Study|Lost to Follow-up|0|||
160665257|NCT04405570|580155454|FG000|Overall Study|Physician Decision|0|||
160665258|NCT04405570|580155455|FG001|Overall Study|Physician Decision|0|||
160665259|NCT04405570|580155456|FG002|Overall Study|Physician Decision|1|||
160665260|NCT04405570|580155457|FG003|Overall Study|Physician Decision|0|||
160665261|NCT04405570|580155454|FG000|Overall Study|Withdrawal by Subject|0|||
160665262|NCT04405570|580155455|FG001|Overall Study|Withdrawal by Subject|1|||
160665263|NCT04405570|580155456|FG002|Overall Study|Withdrawal by Subject|1|||
160665264|NCT04405570|580155457|FG003|Overall Study|Withdrawal by Subject|0|||
160665265|NCT04405570|580155454|FG000|Overall Study|Randomized not dosed|0|||
160665266|NCT04405570|580155455|FG001|Overall Study|Randomized not dosed|2|||
160665267|NCT04405570|580155456|FG002|Overall Study|Randomized not dosed|0|||
160665268|NCT04405570|580155457|FG003|Overall Study|Randomized not dosed|0|||
160665269|NCT04499963|580155458|FG000|Overall Study|Adverse Event|3|||
160665270|NCT04499963|580155459|FG001|Overall Study|Adverse Event|0|||
160665271|NCT04499963|580155458|FG000|Overall Study|Death|3|||
160665272|NCT04499963|580155459|FG001|Overall Study|Death|0|||
160665273|NCT04499963|580155458|FG000|Overall Study|Lack of Efficacy|7|||
160665274|NCT04499963|580155459|FG001|Overall Study|Lack of Efficacy|0|||
160665275|NCT04499963|580155458|FG000|Overall Study|Lost to Follow-up|2|||
160665276|NCT04499963|580155459|FG001|Overall Study|Lost to Follow-up|0|||
160665277|NCT02601625|580155463|FG000|Overall Study|Lost to Follow-up|0|||
160665278|NCT02601625|580155464|FG001|Overall Study|Lost to Follow-up|0|||
160665279|NCT02601625|580155465|FG002|Overall Study|Lost to Follow-up|1|||
160665280|NCT02601625|580155466|FG003|Overall Study|Lost to Follow-up|1|||
160665281|NCT00838279|580155467|FG000|Washout|Protocol Violation|1|||
160665282|NCT00838279|580155468|FG001|Washout|Protocol Violation|0|||
160665283|NCT00838279|580155467|FG000|Washout|Withdrawal by Subject|0|||
160665284|NCT00838279|580155468|FG001|Washout|Withdrawal by Subject|1|||
160665285|NCT04608188|580155469|FG000|Overall Study|Withdrawal by Subject|4|||
160665286|NCT04608188|580155470|FG001|Overall Study|Withdrawal by Subject|8|||
160665287|NCT04419311|580155472|FG000|Overall Study|Lost to Follow-up|1|||
160665288|NCT04419311|580155473|FG001|Overall Study|Lost to Follow-up|0|||
160665289|NCT03586726|580155476|FG000|Overall Study|Withdrawal by Subject|1|||
160665290|NCT01921062|580155477|FG000|Overall Study|Withdrawal by Subject|0|||
160665291|NCT01921062|580155478|FG001|Overall Study|Withdrawal by Subject|7|||
160665292|NCT01921062|580155477|FG000|Overall Study|Adverse Event|5|||
160665293|NCT01921062|580155478|FG001|Overall Study|Adverse Event|6|||
160665294|NCT01921062|580155477|FG000|Overall Study|Protocol Violation|0|||
160665295|NCT01921062|580155478|FG001|Overall Study|Protocol Violation|1|||
160665296|NCT01921062|580155477|FG000|Overall Study|VMIQ score > 72|4|||
160622125|NCT03781167|579996177|FG001|Overall Study|Withdrew consent|12|||
160622126|NCT03781167|579996176|FG000|Overall Study|Lost to Follow-up|0|||
160622127|NCT03781167|579996177|FG001|Overall Study|Lost to Follow-up|1|||
160622128|NCT03781167|579996176|FG000|Overall Study|Lack of Efficacy|4|||
160622129|NCT03781167|579996177|FG001|Overall Study|Lack of Efficacy|5|||
160622130|NCT03781167|579996176|FG000|Overall Study|Difficulty with drug delivery system|2|||
160622131|NCT03781167|579996177|FG001|Overall Study|Difficulty with drug delivery system|3|||
160622132|NCT03781167|579996176|FG000|Overall Study|Other, not specified|2|||
160622133|NCT03781167|579996177|FG001|Overall Study|Other, not specified|2|||
160622134|NCT00462501|579996178|FG000|Overall Study|Not treated|3|||
160622135|NCT00462501|579996178|FG000|Overall Study|Adverse Event|2|||
160622136|NCT00679354|579996183|FG000|Overall Study|Death|3|||
160622137|NCT00679354|579996183|FG000|Overall Study|Lack of Efficacy|22|||
160622138|NCT00679354|579996183|FG000|Overall Study|Physician Decision|4|||
160622139|NCT00679354|579996183|FG000|Overall Study|Ineligible|1|||
160622140|NCT01258803|579996184|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
160622141|NCT01258803|579996185|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
160622142|NCT01258803|579996186|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
160622143|NCT01258803|579996187|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
160622144|NCT01258803|579996188|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
160622145|NCT01258803|579996189|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
160622146|NCT01258803|579996184|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
160622147|NCT01258803|579996185|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
160622148|NCT01258803|579996186|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
160622149|NCT01258803|579996187|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
160622150|NCT01258803|579996188|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
160622151|NCT01258803|579996189|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
160622152|NCT01258803|579996184|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
160622153|NCT01258803|579996185|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
160622154|NCT01258803|579996186|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
160622155|NCT01258803|579996187|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
160622156|NCT01258803|579996188|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
160622157|NCT01258803|579996189|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
160622158|NCT01552408|579996190|FG000|Overall Study|Lost to Follow-up|2|||
160622159|NCT01552408|579996191|FG001|Overall Study|Lost to Follow-up|0|||
160622160|NCT01552408|579996190|FG000|Overall Study|Relocation|0|||
160622161|NCT01552408|579996191|FG001|Overall Study|Relocation|1|||
160622162|NCT01552408|579996190|FG000|Overall Study|Withdrawal by Subject|2|||
160622163|NCT01552408|579996191|FG001|Overall Study|Withdrawal by Subject|1|||
160622164|NCT04047472|579996195|FG000|Overall Study|Adverse Event|3|||
160622165|NCT04047472|579996196|FG001|Overall Study|Adverse Event|3|||
160622166|NCT04047472|579996195|FG000|Overall Study|Death|0|||
160622167|NCT04047472|579996196|FG001|Overall Study|Death|1|||
160622168|NCT04047472|579996195|FG000|Overall Study|Lost to Follow-up|1|||
160622169|NCT04047472|579996196|FG001|Overall Study|Lost to Follow-up|0|||
160622170|NCT04047472|579996195|FG000|Overall Study|Physician Decision|1|||
160622171|NCT04047472|579996196|FG001|Overall Study|Physician Decision|2|||
160622172|NCT04047472|579996195|FG000|Overall Study|Protocol Violation|1|||
160622173|NCT04047472|579996196|FG001|Overall Study|Protocol Violation|0|||
160622174|NCT04047472|579996195|FG000|Overall Study|Withdrawal by Subject|10|||
160622175|NCT04047472|579996196|FG001|Overall Study|Withdrawal by Subject|10|||
160622176|NCT01016912|579996200|FG000|End of Treatment Period|Lack of Efficacy|0|||
160622177|NCT01016912|579996201|FG001|End of Treatment Period|Lack of Efficacy|1|||
160622178|NCT01016912|579996202|FG002|End of Treatment Period|Lack of Efficacy|0|||
160622179|NCT01016912|579996203|FG003|End of Treatment Period|Lack of Efficacy|4|||
160622180|NCT01016912|579996204|FG004|End of Treatment Period|Lack of Efficacy|4|||
160622181|NCT01016912|579996200|FG000|End of Treatment Period|Adverse Event|0|||
160622182|NCT01016912|579996201|FG001|End of Treatment Period|Adverse Event|1|||
160622183|NCT01016912|579996202|FG002|End of Treatment Period|Adverse Event|1|||
160622184|NCT01016912|579996203|FG003|End of Treatment Period|Adverse Event|0|||
160622185|NCT01016912|579996204|FG004|End of Treatment Period|Adverse Event|0|||
160622186|NCT01016912|579996200|FG000|End of Treatment Period|Completed double-blind period only|0|||
160622187|NCT01016912|579996201|FG001|End of Treatment Period|Completed double-blind period only|1|||
160622188|NCT01016912|579996202|FG002|End of Treatment Period|Completed double-blind period only|0|||
160622189|NCT01016912|579996203|FG003|End of Treatment Period|Completed double-blind period only|0|||
160622190|NCT01016912|579996204|FG004|End of Treatment Period|Completed double-blind period only|0|||
160622191|NCT01016912|579996200|FG000|Follow-up Period|Other reason|0|||
160622192|NCT01016912|579996201|FG001|Follow-up Period|Other reason|0|||
160622193|NCT01016912|579996202|FG002|Follow-up Period|Other reason|1|||
160622194|NCT01016912|579996203|FG003|Follow-up Period|Other reason|1|||
160622195|NCT01016912|579996204|FG004|Follow-up Period|Other reason|0|||
160622196|NCT00302731|579996205|FG000|Overall Study|Lost to Follow-up|1|||
160622197|NCT00302731|579996206|FG001|Overall Study|Lost to Follow-up|2|||
160622198|NCT00302731|579996207|FG002|Overall Study|Lost to Follow-up|0|||
160622199|NCT00302731|579996208|FG003|Overall Study|Lost to Follow-up|0|||
160622200|NCT00302731|579996205|FG000|Overall Study|Adverse Event|0|||
160665297|NCT01921062|580155478|FG001|Overall Study|VMIQ score > 72|1|||
160665298|NCT01921062|580155477|FG000|Overall Study|Logistic error|0|||
160665299|NCT01921062|580155478|FG001|Overall Study|Logistic error|1|||
160665300|NCT00965185|580155479|FG000|Overall Study|Lost to Follow-up|2|||
160665301|NCT00965185|580155480|FG001|Overall Study|Lost to Follow-up|0|||
160665302|NCT00965185|580155479|FG000|Overall Study|Withdrawal by Subject|0|||
160665303|NCT00965185|580155480|FG001|Overall Study|Withdrawal by Subject|1|||
160665304|NCT03686033|580155481|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
160665305|NCT03686033|580155482|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
160665306|NCT03686033|580155483|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
160665307|NCT03686033|580155484|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
160665308|NCT03686033|580155485|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
160665309|NCT03686033|580155486|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
160665310|NCT01045161|580155487|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
160665311|NCT01045161|580155488|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
160665312|NCT01045161|580155489|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
160665313|NCT01045161|580155487|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
160665314|NCT01045161|580155488|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
160665315|NCT01045161|580155489|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
160665316|NCT01045161|580155487|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
160665317|NCT01045161|580155488|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
160665318|NCT01045161|580155489|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
160665319|NCT01045161|580155487|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
160665320|NCT01045161|580155488|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
160665321|NCT01045161|580155489|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
160665322|NCT01045161|580155487|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
160665323|NCT01045161|580155488|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
160665324|NCT01045161|580155489|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
160665325|NCT01045161|580155487|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
160665326|NCT01045161|580155488|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
160665327|NCT01045161|580155489|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
160665328|NCT01045161|580155487|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
160665329|NCT01045161|580155488|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
160665330|NCT01045161|580155489|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
160665331|NCT01045161|580155487|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
160665332|NCT01045161|580155488|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
160665333|NCT01045161|580155489|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
160665334|NCT01045161|580155487|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
160665335|NCT01045161|580155488|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
160665336|NCT01045161|580155489|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
160665337|NCT01045161|580155487|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
160665338|NCT01045161|580155488|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
160665339|NCT01045161|580155489|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
160665340|NCT01045161|580155487|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
160665341|NCT01045161|580155488|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
160665342|NCT01045161|580155489|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
160665343|NCT01045161|580155487|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
160665344|NCT01045161|580155488|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
160665345|NCT01045161|580155489|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
160665346|NCT01045161|580155487|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
160665347|NCT01045161|580155488|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
160665348|NCT01045161|580155489|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
160665349|NCT01045161|580155487|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
160665350|NCT01045161|580155488|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
160665351|NCT01045161|580155489|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
160665352|NCT01854047|580155490|FG000|Overall Study|Lack of Efficacy|1|||
160665353|NCT01854047|580155491|FG001|Overall Study|Lack of Efficacy|0|||
160665354|NCT01854047|580155492|FG002|Overall Study|Lack of Efficacy|0|||
160665355|NCT01854047|580155493|FG003|Overall Study|Lack of Efficacy|0|||
160665356|NCT01854047|580155494|FG004|Overall Study|Lack of Efficacy|0|||
160665357|NCT01854047|580155490|FG000|Overall Study|Poor compliance to protocol|3|||
160665358|NCT01854047|580155491|FG001|Overall Study|Poor compliance to protocol|0|||
160665359|NCT01854047|580155492|FG002|Overall Study|Poor compliance to protocol|2|||
160665360|NCT01854047|580155493|FG003|Overall Study|Poor compliance to protocol|0|||
160665361|NCT01854047|580155494|FG004|Overall Study|Poor compliance to protocol|0|||
160665362|NCT01854047|580155490|FG000|Overall Study|Adverse Event|5|||
160665363|NCT01854047|580155491|FG001|Overall Study|Adverse Event|4|||
160665364|NCT01854047|580155492|FG002|Overall Study|Adverse Event|6|||
160665365|NCT01854047|580155493|FG003|Overall Study|Adverse Event|10|||
160665366|NCT01854047|580155494|FG004|Overall Study|Adverse Event|7|||
160665367|NCT01854047|580155490|FG000|Overall Study|Randomized but not treated|0|||
160665368|NCT01854047|580155491|FG001|Overall Study|Randomized but not treated|1|||
160665369|NCT01854047|580155492|FG002|Overall Study|Randomized but not treated|2|||
160665370|NCT01854047|580155493|FG003|Overall Study|Randomized but not treated|0|||
160665371|NCT01854047|580155494|FG004|Overall Study|Randomized but not treated|4|||
160665372|NCT01854047|580155490|FG000|Overall Study|Other than specified above|3|||
160665373|NCT01854047|580155491|FG001|Overall Study|Other than specified above|3|||
160665374|NCT01854047|580155492|FG002|Overall Study|Other than specified above|3|||
160665375|NCT01854047|580155493|FG003|Overall Study|Other than specified above|5|||
160665376|NCT01854047|580155494|FG004|Overall Study|Other than specified above|8|||
160665377|NCT01302548|580155496|FG000|Overall Study|Lost to Follow-up|2|||
160665378|NCT01302548|580155497|FG001|Overall Study|Lost to Follow-up|1|||
160665379|NCT02409355|580155498|FG000|Overall Study|Withdrawal by Subject|1|||
160665380|NCT02409355|580155499|FG001|Overall Study|Withdrawal by Subject|0|||
160665381|NCT02409355|580155498|FG000|Overall Study|Death|1|||
160665382|NCT02409355|580155499|FG001|Overall Study|Death|1|||
160665383|NCT02409355|580155498|FG000|Overall Study|Study terminated by Sponsor|2|||
160665384|NCT02409355|580155499|FG001|Overall Study|Study terminated by Sponsor|3|||
160665385|NCT01237054|580155500|FG000|Overall Study|imaging 10C0096|1|||
160665386|NCT02089997|580155514|FG000|Overall Study|Case report forms uncollected|99|||
160665387|NCT02089997|580155514|FG000|Overall Study|Protocol Violation|147|||
160665388|NCT00095212|580155517|FG000|Overall Study|Withdrawal by Subject|1|||
160665389|NCT00095212|580155518|FG001|Overall Study|Withdrawal by Subject|3|||
160665390|NCT02374853|580155522|FG000|Overall Study|Surgery Cancelled|5|||
160665391|NCT02374853|580155523|FG001|Overall Study|Surgery Cancelled|11|||
160665392|NCT02281084|580155525|FG000|Overall Study|Death|21|||
160665393|NCT02281084|580155526|FG001|Overall Study|Death|18|||
160665394|NCT02281084|580155527|FG002|Overall Study|Death|3|||
160512133|NCT02101385|579602177|FG001|Study Treatment|Disease Progression|3|||
160665395|NCT02281084|580155528|FG003|Overall Study|Death|5|||
160665396|NCT02281084|580155525|FG000|Overall Study|Adverse Event|1|||
160512134|NCT02101385|579602176|FG000|Study Treatment|Alternative therapy|0|||
160512135|NCT02101385|579602177|FG001|Study Treatment|Alternative therapy|1|||
160512136|NCT02101385|579602176|FG000|Study Treatment|No treatment, per protocol criteria|0|||
160512137|NCT02101385|579602177|FG001|Study Treatment|No treatment, per protocol criteria|4|||
160512138|NCT02101385|579602176|FG000|Study Treatment|Patient Non compliance|0|||
160512139|NCT02101385|579602177|FG001|Study Treatment|Patient Non compliance|2|||
160512140|NCT02101385|579602176|FG000|Study Treatment|Withdrawal by Subject|5|||
160512141|NCT02101385|579602177|FG001|Study Treatment|Withdrawal by Subject|2|||
160512142|NCT02101385|579602176|FG000|Study Treatment|screen failure|1|||
160512143|NCT02101385|579602177|FG001|Study Treatment|screen failure|0|||
160512144|NCT02101385|579602176|FG000|Study Treatment|AE/Side Effects/Complications|8|||
160512145|NCT02101385|579602177|FG001|Study Treatment|AE/Side Effects/Complications|0|||
160512146|NCT02101385|579602176|FG000|Study Treatment|Lost to Follow-up|1|||
160512147|NCT02101385|579602177|FG001|Study Treatment|Lost to Follow-up|0|||
160512148|NCT02101385|579602176|FG000|Study Treatment|Disease Progression before treatment|1|||
160512149|NCT02101385|579602177|FG001|Study Treatment|Disease Progression before treatment|0|||
160512150|NCT02101385|579602176|FG000|Study Treatment|Death|1|||
160512151|NCT02101385|579602177|FG001|Study Treatment|Death|0|||
160512152|NCT02101385|579602176|FG000|Follow up|Lost to Follow-up|4|||
160512153|NCT02101385|579602177|FG001|Follow up|Lost to Follow-up|9|||
160512154|NCT02101385|579602176|FG000|Follow up|Refused to follow up|5|||
160512155|NCT02101385|579602177|FG001|Follow up|Refused to follow up|4|||
160512156|NCT02101385|579602176|FG000|Follow up|Death|21|||
160512157|NCT02101385|579602177|FG001|Follow up|Death|39|||
160512158|NCT02101385|579602176|FG000|Follow up|study completed|33|||
160512159|NCT02101385|579602177|FG001|Follow up|study completed|52|||
160512160|NCT02101385|579602176|FG000|Follow up|screen failure|2|||
160512161|NCT02101385|579602177|FG001|Follow up|screen failure|0|||
160512162|NCT02101385|579602176|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
160512163|NCT02101385|579602177|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
160512164|NCT02101385|579602176|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
160512165|NCT02101385|579602177|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
160512166|NCT02101385|579602176|FG000|Follow up|Withdrawal by Subject|2|||
160512167|NCT02101385|579602177|FG001|Follow up|Withdrawal by Subject|2|||
160512168|NCT02101385|579602176|FG000|Follow up|PI requested closure of site|0|||
160512169|NCT02101385|579602177|FG001|Follow up|PI requested closure of site|5|||
160512170|NCT01982448|579602187|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
160665397|NCT02281084|580155526|FG001|Overall Study|Adverse Event|0|||
160665398|NCT02281084|580155527|FG002|Overall Study|Adverse Event|0|||
160512171|NCT01982448|579602188|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
160512172|NCT01982448|579602187|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
160665399|NCT02281084|580155528|FG003|Overall Study|Adverse Event|0|||
160665400|NCT02281084|580155525|FG000|Overall Study|Withdrawal by Subject|2|||
160622201|NCT00302731|579996206|FG001|Overall Study|Adverse Event|2|||
160622202|NCT00302731|579996207|FG002|Overall Study|Adverse Event|2|||
160622203|NCT00302731|579996208|FG003|Overall Study|Adverse Event|0|||
160622204|NCT00302731|579996205|FG000|Overall Study|Withdrawal by Subject|1|||
160622205|NCT00302731|579996206|FG001|Overall Study|Withdrawal by Subject|1|||
160622206|NCT00302731|579996207|FG002|Overall Study|Withdrawal by Subject|0|||
160622207|NCT00302731|579996208|FG003|Overall Study|Withdrawal by Subject|0|||
160622208|NCT00302731|579996205|FG000|Overall Study|Protocol Violation|1|||
160622209|NCT00302731|579996206|FG001|Overall Study|Protocol Violation|0|||
160622210|NCT00302731|579996207|FG002|Overall Study|Protocol Violation|0|||
160622211|NCT00302731|579996208|FG003|Overall Study|Protocol Violation|0|||
160622212|NCT00302731|579996205|FG000|Overall Study|cancer unrelated to study discovered|1|||
160622213|NCT00302731|579996206|FG001|Overall Study|cancer unrelated to study discovered|0|||
160622214|NCT00302731|579996207|FG002|Overall Study|cancer unrelated to study discovered|1|||
160622215|NCT00302731|579996208|FG003|Overall Study|cancer unrelated to study discovered|0|||
160622216|NCT01610752|579996209|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
160622217|NCT01610752|579996210|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
160622218|NCT01610752|579996211|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
160622219|NCT00252499|579996212|FG000|Overall Study|Lost to Follow-up|1|||
160622220|NCT00252499|579996213|FG001|Overall Study|Lost to Follow-up|0|||
160622221|NCT00252499|579996214|FG002|Overall Study|Lost to Follow-up|0|||
160622222|NCT01535638|579996215|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
160622223|NCT01535638|579996216|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
160622224|NCT01535638|579996217|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
160622225|NCT01535638|579996218|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
160622226|NCT01535638|579996219|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
160622227|NCT01535638|579996220|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
160622228|NCT01535638|579996215|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
160622229|NCT01535638|579996216|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
160622230|NCT01535638|579996217|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
160622231|NCT01535638|579996218|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
160622232|NCT01535638|579996219|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
160622233|NCT01535638|579996220|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
160622234|NCT00827112|579996221|FG000|Overall Study|Adverse Event|2|||
160622235|NCT00827112|579996222|FG001|Overall Study|Adverse Event|0|||
160622236|NCT00827112|579996221|FG000|Overall Study|Lack of Efficacy|2|||
160622237|NCT00827112|579996222|FG001|Overall Study|Lack of Efficacy|0|||
160622238|NCT00827112|579996221|FG000|Overall Study|Lost to Follow-up|3|||
160622239|NCT00827112|579996222|FG001|Overall Study|Lost to Follow-up|2|||
160622240|NCT00827112|579996221|FG000|Overall Study|Pregnancy|0|||
160622241|NCT00827112|579996222|FG001|Overall Study|Pregnancy|1|||
160622242|NCT00827112|579996221|FG000|Overall Study|Protocol Violation|0|||
160622243|NCT00827112|579996222|FG001|Overall Study|Protocol Violation|2|||
160622244|NCT00827112|579996221|FG000|Overall Study|Withdrawal by Subject|2|||
160622245|NCT00827112|579996222|FG001|Overall Study|Withdrawal by Subject|1|||
160622246|NCT00827112|579996221|FG000|Overall Study|Randomized but not treated|5|||
160622247|NCT00827112|579996222|FG001|Overall Study|Randomized but not treated|3|||
160622248|NCT00827112|579996221|FG000|Overall Study|Other|1|||
160622249|NCT00827112|579996222|FG001|Overall Study|Other|3|||
160622250|NCT01521494|579996227|FG000|Overall Study|Adverse Event|1|||
160622251|NCT01521494|579996228|FG001|Overall Study|Adverse Event|2|||
160622252|NCT01521494|579996229|FG002|Overall Study|Adverse Event|9|||
160622253|NCT01521494|579996230|FG003|Overall Study|Adverse Event|6|||
160622254|NCT01521494|579996231|FG004|Overall Study|Adverse Event|2|||
160622255|NCT01521494|579996227|FG000|Overall Study|Lack of Efficacy|0|||
160622256|NCT01521494|579996228|FG001|Overall Study|Lack of Efficacy|0|||
160622257|NCT01521494|579996229|FG002|Overall Study|Lack of Efficacy|0|||
160622258|NCT01521494|579996230|FG003|Overall Study|Lack of Efficacy|0|||
160622259|NCT01521494|579996231|FG004|Overall Study|Lack of Efficacy|2|||
160622260|NCT01521494|579996227|FG000|Overall Study|Withdrawal by Subject|1|||
160622261|NCT01521494|579996228|FG001|Overall Study|Withdrawal by Subject|1|||
160622262|NCT01521494|579996229|FG002|Overall Study|Withdrawal by Subject|0|||
160622263|NCT01521494|579996230|FG003|Overall Study|Withdrawal by Subject|2|||
160622264|NCT01521494|579996231|FG004|Overall Study|Withdrawal by Subject|0|||
160622265|NCT01521494|579996227|FG000|Overall Study|Decrease in serum phosphate|0|||
160622266|NCT01521494|579996228|FG001|Overall Study|Decrease in serum phosphate|2|||
160622267|NCT01521494|579996229|FG002|Overall Study|Decrease in serum phosphate|3|||
160622268|NCT01521494|579996230|FG003|Overall Study|Decrease in serum phosphate|12|||
160622269|NCT01521494|579996231|FG004|Overall Study|Decrease in serum phosphate|0|||
160622270|NCT01521494|579996227|FG000|Overall Study|Decrease in serum calcium|0|||
160622271|NCT01521494|579996228|FG001|Overall Study|Decrease in serum calcium|0|||
160622272|NCT01521494|579996229|FG002|Overall Study|Decrease in serum calcium|0|||
160622273|NCT01521494|579996230|FG003|Overall Study|Decrease in serum calcium|1|||
160622274|NCT01521494|579996231|FG004|Overall Study|Decrease in serum calcium|1|||
160622275|NCT01521494|579996227|FG000|Overall Study|Physician Decision|0|||
160622276|NCT01521494|579996228|FG001|Overall Study|Physician Decision|0|||
160622277|NCT01521494|579996229|FG002|Overall Study|Physician Decision|0|||
160512173|NCT01982448|579602188|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
160512174|NCT01982448|579602187|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
160512175|NCT01982448|579602188|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
160512176|NCT01982448|579602187|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
160512177|NCT01982448|579602188|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
160512178|NCT00978627|579603329|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
160512179|NCT00978627|579603330|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
160512180|NCT00978627|579603329|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
160512181|NCT00978627|579603330|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
160512182|NCT00978627|579603329|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
160512183|NCT00978627|579603330|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
160512184|NCT00978627|579603329|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
160512185|NCT00978627|579603330|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
160512186|NCT00978627|579603329|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
160512187|NCT00978627|579603330|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
160512188|NCT00978627|579603329|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
160512189|NCT00978627|579603330|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
160512190|NCT00978627|579603329|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
160512191|NCT00978627|579603330|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
160512192|NCT00978627|579603329|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
160512193|NCT00978627|579603330|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
160512194|NCT00978627|579603329|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
160512195|NCT00978627|579603330|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
160512196|NCT03541174|579603333|FG000|Part 1 Double-Blind|Adverse Event|6|||
160512197|NCT03541174|579603334|FG001|Part 1 Double-Blind|Adverse Event|5|||
160512198|NCT03541174|579603335|FG002|Part 1 Double-Blind|Adverse Event|2|||
160512199|NCT03541174|579603336|FG003|Part 1 Double-Blind|Adverse Event|0|||
160512200|NCT03541174|579603337|FG004|Part 1 Double-Blind|Adverse Event|0|||
160512201|NCT03541174|579603338|FG005|Part 1 Double-Blind|Adverse Event|0|||
160512202|NCT03541174|579603333|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
160512203|NCT03541174|579603334|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
160512204|NCT03541174|579603335|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
160512205|NCT03541174|579603336|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
160512206|NCT03541174|579603337|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
160512207|NCT03541174|579603338|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
160512208|NCT03541174|579603333|FG000|Part 1 Double-Blind|Other reasons|3|||
160512209|NCT03541174|579603334|FG001|Part 1 Double-Blind|Other reasons|2|||
160512210|NCT03541174|579603335|FG002|Part 1 Double-Blind|Other reasons|3|||
160512211|NCT03541174|579603336|FG003|Part 1 Double-Blind|Other reasons|0|||
160512212|NCT03541174|579603337|FG004|Part 1 Double-Blind|Other reasons|0|||
160512213|NCT03541174|579603338|FG005|Part 1 Double-Blind|Other reasons|0|||
160512214|NCT03541174|579603333|FG000|Part 2 Single-Blind|Adverse Event|0|||
160512215|NCT03541174|579603334|FG001|Part 2 Single-Blind|Adverse Event|0|||
160512216|NCT03541174|579603335|FG002|Part 2 Single-Blind|Adverse Event|0|||
160512217|NCT03541174|579603336|FG003|Part 2 Single-Blind|Adverse Event|25|||
160512218|NCT03541174|579603337|FG004|Part 2 Single-Blind|Adverse Event|0|||
160512219|NCT03541174|579603338|FG005|Part 2 Single-Blind|Adverse Event|0|||
160512220|NCT03541174|579603333|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
160512221|NCT03541174|579603334|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
160512222|NCT03541174|579603335|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
160512223|NCT03541174|579603336|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
160512224|NCT03541174|579603337|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
160512225|NCT03541174|579603338|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
160512226|NCT03541174|579603333|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
160512227|NCT03541174|579603334|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
160512228|NCT03541174|579603335|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
160512229|NCT03541174|579603336|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
160512230|NCT03541174|579603337|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
160512231|NCT03541174|579603338|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
160512232|NCT03541174|579603333|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
160512233|NCT03541174|579603334|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
160512234|NCT03541174|579603335|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
160512235|NCT03541174|579603336|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
160512236|NCT03541174|579603337|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
160512237|NCT03541174|579603338|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
160512238|NCT03541174|579603333|FG000|Part 2 Single-Blind|Death|0|||
160512239|NCT03541174|579603334|FG001|Part 2 Single-Blind|Death|0|||
160512240|NCT03541174|579603335|FG002|Part 2 Single-Blind|Death|0|||
160665401|NCT02281084|580155526|FG001|Overall Study|Withdrawal by Subject|2|||
160512241|NCT03541174|579603336|FG003|Part 2 Single-Blind|Death|5|||
160512242|NCT03541174|579603337|FG004|Part 2 Single-Blind|Death|0|||
160512243|NCT03541174|579603338|FG005|Part 2 Single-Blind|Death|0|||
160512244|NCT03541174|579603333|FG000|Part 2 Single-Blind|Pregnancy|0|||
160512245|NCT03541174|579603334|FG001|Part 2 Single-Blind|Pregnancy|0|||
160665402|NCT02281084|580155527|FG002|Overall Study|Withdrawal by Subject|0|||
160665403|NCT02281084|580155528|FG003|Overall Study|Withdrawal by Subject|0|||
160665404|NCT02281084|580155525|FG000|Overall Study|Site Closure by Sponsor|5|||
160665405|NCT02281084|580155526|FG001|Overall Study|Site Closure by Sponsor|1|||
160665406|NCT02281084|580155527|FG002|Overall Study|Site Closure by Sponsor|2|||
160665407|NCT02281084|580155528|FG003|Overall Study|Site Closure by Sponsor|0|||
160665408|NCT02335658|580155529|FG000|Overall Study|Adverse Event|18|||
160665409|NCT02335658|580155530|FG001|Overall Study|Adverse Event|12|||
160665410|NCT02335658|580155529|FG000|Overall Study|Lack of Efficacy|4|||
160665411|NCT02335658|580155530|FG001|Overall Study|Lack of Efficacy|5|||
160665412|NCT02335658|580155529|FG000|Overall Study|Pregnancy|1|||
160665413|NCT02335658|580155530|FG001|Overall Study|Pregnancy|0|||
160665414|NCT02335658|580155529|FG000|Overall Study|Withdrawal by Subject|13|||
160665415|NCT02335658|580155530|FG001|Overall Study|Withdrawal by Subject|21|||
160665416|NCT02335658|580155529|FG000|Overall Study|non-compliance|2|||
160665417|NCT02335658|580155530|FG001|Overall Study|non-compliance|3|||
160665418|NCT02335658|580155529|FG000|Overall Study|other reason|2|||
160665419|NCT02335658|580155530|FG001|Overall Study|other reason|3|||
160665420|NCT02032888|580155536|FG000|Treatment Period|Poor compliance/noncompliance|1|||
160665421|NCT02032888|580155537|FG001|Treatment Period|Poor compliance/noncompliance|1|||
160665422|NCT02032888|580155538|FG002|Treatment Period|Poor compliance/noncompliance|0|||
160665423|NCT02032888|580155536|FG000|Treatment Period|Other|1|||
160665424|NCT02032888|580155537|FG001|Treatment Period|Other|1|||
160665425|NCT02032888|580155538|FG002|Treatment Period|Other|0|||
160665426|NCT02032888|580155536|FG000|Follow-up Period|Lost to Follow-up|1|||
160665427|NCT02032888|580155537|FG001|Follow-up Period|Lost to Follow-up|1|||
160665428|NCT02032888|580155538|FG002|Follow-up Period|Lost to Follow-up|0|||
160665429|NCT02032888|580155536|FG000|Follow-up Period|Death|1|||
160665430|NCT02032888|580155537|FG001|Follow-up Period|Death|1|||
160665431|NCT02032888|580155538|FG002|Follow-up Period|Death|0|||
160665432|NCT02032888|580155536|FG000|Follow-up Period|Other|1|||
160665433|NCT02032888|580155537|FG001|Follow-up Period|Other|0|||
160665434|NCT02032888|580155538|FG002|Follow-up Period|Other|0|||
160665435|NCT02957942|580155539|FG000|Overall Study|Withdrawal by Subject|0|||
160665436|NCT02957942|580155540|FG001|Overall Study|Withdrawal by Subject|1|||
160665437|NCT02957942|580155539|FG000|Overall Study|Practicing experiment protocol|0|||
160665438|NCT02957942|580155540|FG001|Overall Study|Practicing experiment protocol|6|||
160665439|NCT02655679|580155556|FG000|Overall Study|Adverse Event|0|||
160665440|NCT02655679|580155557|FG001|Overall Study|Adverse Event|1|||
160665441|NCT02655679|580155558|FG002|Overall Study|Adverse Event|0|||
160665442|NCT02655679|580155559|FG003|Overall Study|Adverse Event|0|||
160665443|NCT02655679|580155560|FG004|Overall Study|Adverse Event|0|||
160665444|NCT02655679|580155556|FG000|Overall Study|Withdrawal by Subject|1|||
160665445|NCT02655679|580155557|FG001|Overall Study|Withdrawal by Subject|1|||
160665446|NCT02655679|580155558|FG002|Overall Study|Withdrawal by Subject|0|||
160665447|NCT02655679|580155559|FG003|Overall Study|Withdrawal by Subject|3|||
160665448|NCT02655679|580155560|FG004|Overall Study|Withdrawal by Subject|1|||
160665449|NCT02655679|580155556|FG000|Overall Study|Inability to Comply with the Protocol|1|||
160665450|NCT02655679|580155557|FG001|Overall Study|Inability to Comply with the Protocol|0|||
160665451|NCT02655679|580155558|FG002|Overall Study|Inability to Comply with the Protocol|0|||
160665452|NCT02655679|580155559|FG003|Overall Study|Inability to Comply with the Protocol|0|||
160665453|NCT02655679|580155560|FG004|Overall Study|Inability to Comply with the Protocol|0|||
160665454|NCT02655679|580155556|FG000|Overall Study|Lost to Follow-up|0|||
160665455|NCT02655679|580155557|FG001|Overall Study|Lost to Follow-up|1|||
160665456|NCT02655679|580155558|FG002|Overall Study|Lost to Follow-up|1|||
160665457|NCT02655679|580155559|FG003|Overall Study|Lost to Follow-up|1|||
160665458|NCT02655679|580155560|FG004|Overall Study|Lost to Follow-up|0|||
160665459|NCT02655679|580155556|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160665460|NCT02655679|580155557|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160665461|NCT02655679|580155558|FG002|Overall Study|Other Miscellaneous Reasons|0|||
160665462|NCT02655679|580155559|FG003|Overall Study|Other Miscellaneous Reasons|0|||
160665463|NCT02655679|580155560|FG004|Overall Study|Other Miscellaneous Reasons|0|||
160665464|NCT01754597|580155561|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
160665465|NCT01754597|580155562|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
160665466|NCT00819741|580155563|FG000|Overall Study|Adverse Event|5|||
160665467|NCT00819741|580155564|FG001|Overall Study|Adverse Event|2|||
160665468|NCT00819741|580155563|FG000|Overall Study|Lack of Efficacy|0|||
160665469|NCT00819741|580155564|FG001|Overall Study|Lack of Efficacy|2|||
160665470|NCT00819741|580155563|FG000|Overall Study|Lost to Follow-up|3|||
160665471|NCT00819741|580155564|FG001|Overall Study|Lost to Follow-up|1|||
160665472|NCT00819741|580155563|FG000|Overall Study|Protocol Violation|3|||
160665473|NCT00819741|580155564|FG001|Overall Study|Protocol Violation|4|||
160665474|NCT00819741|580155563|FG000|Overall Study|Withdrawal by Subject|2|||
160665475|NCT00819741|580155564|FG001|Overall Study|Withdrawal by Subject|2|||
160665476|NCT00819741|580155563|FG000|Overall Study|Unclassified|6|||
160665477|NCT00819741|580155564|FG001|Overall Study|Unclassified|0|||
160665478|NCT00819741|580155563|FG000|Overall Study|Reasons unknown|3|||
160665479|NCT00819741|580155564|FG001|Overall Study|Reasons unknown|3|||
160665480|NCT03447353|580157336|FG000|Overall Study|Failure at Screening Visit|2|||
160665481|NCT03447353|580157336|FG000|Overall Study|Lost to Follow-up|4|||
160665482|NCT03447353|580157336|FG000|Overall Study|Scheduling Conflicts|3|||
160665483|NCT03447353|580157336|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
160665484|NCT02175095|580157337|FG000|Overall Study|Withdrawal by Subject|3|||
160665485|NCT02635750|580157338|FG000|Part 1, Period 2|Adverse Event|1|||
160665486|NCT02635750|580157339|FG001|Part 1, Period 2|Adverse Event|0|||
160665487|NCT02635750|580157340|FG002|Part 1, Period 2|Adverse Event|0|||
160622278|NCT01521494|579996230|FG003|Overall Study|Physician Decision|0|||
160622279|NCT01521494|579996231|FG004|Overall Study|Physician Decision|2|||
160622280|NCT01140646|579996232|FG000|Overall Study|Adverse Event|4|||
160622281|NCT01140646|579996232|FG000|Overall Study|Refused Further Treatment|5|||
160622282|NCT00842829|579996236|FG000|Dose Titration Period|Adverse Event|11|||
160622283|NCT00842829|579996237|FG001|Dose Titration Period|Adverse Event|10|||
160622284|NCT00842829|579996238|FG002|Dose Titration Period|Adverse Event|0|||
160622285|NCT00842829|579996236|FG000|Dose Titration Period|Lack of Efficacy|4|||
160622286|NCT00842829|579996237|FG001|Dose Titration Period|Lack of Efficacy|1|||
160622287|NCT00842829|579996238|FG002|Dose Titration Period|Lack of Efficacy|0|||
160622288|NCT00842829|579996236|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
160622289|NCT00842829|579996237|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
160622290|NCT00842829|579996238|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
160622291|NCT00842829|579996236|FG000|Dose Titration Period|Withdrawal by Subject|2|||
160622292|NCT00842829|579996237|FG001|Dose Titration Period|Withdrawal by Subject|6|||
160622293|NCT00842829|579996238|FG002|Dose Titration Period|Withdrawal by Subject|0|||
160622294|NCT00842829|579996236|FG000|Dose Titration Period|Other|5|||
160622295|NCT00842829|579996237|FG001|Dose Titration Period|Other|4|||
160622296|NCT00842829|579996238|FG002|Dose Titration Period|Other|0|||
160622297|NCT00842829|579996236|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
160622298|NCT00842829|579996237|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
160622299|NCT00842829|579996238|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
160622300|NCT00842829|579996236|FG000|Dose Titration Period|Non-compliance to study drug|2|||
160622301|NCT00842829|579996237|FG001|Dose Titration Period|Non-compliance to study drug|1|||
160622302|NCT00842829|579996238|FG002|Dose Titration Period|Non-compliance to study drug|0|||
160622303|NCT00842829|579996236|FG000|Treatment Period|Adverse Event|0|||
160622304|NCT00842829|579996237|FG001|Treatment Period|Adverse Event|0|||
160622305|NCT00842829|579996238|FG002|Treatment Period|Adverse Event|15|||
160665488|NCT00462345|580157343|FG000|Overall Study|Withdrawal by Subject|2|||
160665489|NCT00462345|580157343|FG000|Overall Study|Did not complete second course|1|||
160665490|NCT02642653|580157345|FG000|Overall Study|Adverse Event|2|||
160665491|NCT02642653|580157346|FG001|Overall Study|Adverse Event|0|||
160665492|NCT02875392|580157350|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
160665493|NCT02875392|580157351|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
160665494|NCT00712959|580157359|FG000|Overall Study|Protocol Violation|3|||
160665495|NCT00712959|580157360|FG001|Overall Study|Protocol Violation|1|||
160665496|NCT00712959|580157359|FG000|Overall Study|Lost to Follow-up|13|||
160665497|NCT00712959|580157360|FG001|Overall Study|Lost to Follow-up|2|||
160665498|NCT00712959|580157359|FG000|Overall Study|Withdrawal by Subject|3|||
160665499|NCT00712959|580157360|FG001|Overall Study|Withdrawal by Subject|0|||
160665500|NCT03874715|580157361|FG000|Overall Study|Adverse Event|2|||
160665501|NCT03874715|580157362|FG001|Overall Study|Adverse Event|0|||
160665502|NCT03874715|580157361|FG000|Overall Study|Poor compliance to protocol|5|||
160665503|NCT03874715|580157362|FG001|Overall Study|Poor compliance to protocol|1|||
160665504|NCT03874715|580157361|FG000|Overall Study|Withdrawal by Subject|1|||
160665505|NCT03874715|580157362|FG001|Overall Study|Withdrawal by Subject|0|||
160665506|NCT03874715|580157361|FG000|Overall Study|Other-unspecified|1|||
160622306|NCT00842829|579996236|FG000|Treatment Period|Lack of Efficacy|0|||
160622307|NCT00842829|579996237|FG001|Treatment Period|Lack of Efficacy|0|||
160622308|NCT00842829|579996238|FG002|Treatment Period|Lack of Efficacy|6|||
160665507|NCT03874715|580157362|FG001|Overall Study|Other-unspecified|0|||
160665508|NCT00461786|580157363|FG000|Overall Study|Entry Criteria Not Met|2|||
160665509|NCT00461786|580157363|FG000|Overall Study|Inevaluable (Never Treated)|1|||
160665510|NCT00834067|580157365|FG000|Washout of 21 Days|Protocol Violation|0|||
160665511|NCT00834067|580157366|FG001|Washout of 21 Days|Protocol Violation|1|||
160665512|NCT00561015|580157368|FG000|Overall Study|Adverse Event|0|||
160665513|NCT00561015|580157369|FG001|Overall Study|Adverse Event|0|||
160665514|NCT00561015|580157370|FG002|Overall Study|Adverse Event|0|||
160665515|NCT00561015|580157371|FG003|Overall Study|Adverse Event|0|||
160665516|NCT00561015|580157372|FG004|Overall Study|Adverse Event|1|||
160665517|NCT00561015|580157373|FG005|Overall Study|Adverse Event|0|||
160665518|NCT00561015|580157368|FG000|Overall Study|Lost to Follow-up|2|||
160665519|NCT00561015|580157369|FG001|Overall Study|Lost to Follow-up|0|||
160665520|NCT00561015|580157370|FG002|Overall Study|Lost to Follow-up|0|||
160665521|NCT00561015|580157371|FG003|Overall Study|Lost to Follow-up|1|||
160665522|NCT00561015|580157372|FG004|Overall Study|Lost to Follow-up|0|||
160665523|NCT00561015|580157373|FG005|Overall Study|Lost to Follow-up|3|||
160622309|NCT00842829|579996236|FG000|Treatment Period|Unstable persistent cancer pain|0|||
160622310|NCT00842829|579996237|FG001|Treatment Period|Unstable persistent cancer pain|0|||
160622311|NCT00842829|579996238|FG002|Treatment Period|Unstable persistent cancer pain|5|||
160622312|NCT00842829|579996236|FG000|Treatment Period|Withdrawal by Subject|0|||
160622313|NCT00842829|579996237|FG001|Treatment Period|Withdrawal by Subject|0|||
160622314|NCT00842829|579996238|FG002|Treatment Period|Withdrawal by Subject|11|||
160622315|NCT00842829|579996236|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
160622316|NCT00842829|579996237|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
160622317|NCT00842829|579996238|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
160622318|NCT00842829|579996236|FG000|Treatment Period|Protocol Violation|0|||
160622319|NCT00842829|579996237|FG001|Treatment Period|Protocol Violation|0|||
160622320|NCT00842829|579996238|FG002|Treatment Period|Protocol Violation|2|||
160622321|NCT00842829|579996236|FG000|Treatment Period|Other|0|||
160622322|NCT00842829|579996237|FG001|Treatment Period|Other|0|||
160622323|NCT00842829|579996238|FG002|Treatment Period|Other|18|||
160622324|NCT00842829|579996236|FG000|Treatment Period|Non-compliance to study procedures|0|||
160622325|NCT00842829|579996237|FG001|Treatment Period|Non-compliance to study procedures|0|||
160622326|NCT00842829|579996238|FG002|Treatment Period|Non-compliance to study procedures|4|||
160622327|NCT00842829|579996236|FG000|Treatment Period|Unclear completion status|0|||
160622328|NCT00842829|579996237|FG001|Treatment Period|Unclear completion status|0|||
160622329|NCT00842829|579996238|FG002|Treatment Period|Unclear completion status|1|||
160622330|NCT00842829|579996236|FG000|Continuation Period|Adverse Event|0|||
160622331|NCT00842829|579996237|FG001|Continuation Period|Adverse Event|0|||
160622332|NCT00842829|579996238|FG002|Continuation Period|Adverse Event|32|||
160622333|NCT00842829|579996236|FG000|Continuation Period|Lack of Efficacy|0|||
160622334|NCT00842829|579996237|FG001|Continuation Period|Lack of Efficacy|0|||
160622335|NCT00842829|579996238|FG002|Continuation Period|Lack of Efficacy|6|||
160622336|NCT00842829|579996236|FG000|Continuation Period|Unstable persistent cancer pain|0|||
160622337|NCT00842829|579996237|FG001|Continuation Period|Unstable persistent cancer pain|0|||
160622338|NCT00842829|579996238|FG002|Continuation Period|Unstable persistent cancer pain|3|||
160622339|NCT00842829|579996236|FG000|Continuation Period|Withdrawal by Subject|0|||
160622340|NCT00842829|579996237|FG001|Continuation Period|Withdrawal by Subject|0|||
160622341|NCT00842829|579996238|FG002|Continuation Period|Withdrawal by Subject|10|||
160622342|NCT00842829|579996236|FG000|Continuation Period|Other|0|||
160622343|NCT00842829|579996237|FG001|Continuation Period|Other|0|||
160622344|NCT00842829|579996238|FG002|Continuation Period|Other|7|||
160622345|NCT00842829|579996236|FG000|Continuation Period|Non-compliance to study procedures|0|||
160622346|NCT00842829|579996237|FG001|Continuation Period|Non-compliance to study procedures|0|||
160622347|NCT00842829|579996238|FG002|Continuation Period|Non-compliance to study procedures|2|||
160622348|NCT00842829|579996236|FG000|Continuation Period|Non-compliance to study drug|0|||
160622349|NCT00842829|579996237|FG001|Continuation Period|Non-compliance to study drug|0|||
160622350|NCT00842829|579996238|FG002|Continuation Period|Non-compliance to study drug|1|||
160622351|NCT03417999|579996242|FG000|Overall Study|Withdrawal by Subject|1|||
160622352|NCT03417999|579996243|FG001|Overall Study|Withdrawal by Subject|0|||
160622353|NCT03417999|579996244|FG002|Overall Study|Withdrawal by Subject|0|||
160622354|NCT03417999|579996242|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
160622355|NCT03417999|579996243|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
160622356|NCT03417999|579996244|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
160622357|NCT03417999|579996242|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
160622358|NCT03417999|579996243|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
160622359|NCT03417999|579996244|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
160622360|NCT03417999|579996242|FG000|Overall Study|Inadequate study staff available to process samples|0|||
160622361|NCT03417999|579996243|FG001|Overall Study|Inadequate study staff available to process samples|0|||
160622362|NCT03417999|579996244|FG002|Overall Study|Inadequate study staff available to process samples|1|||
160622363|NCT02612194|579996248|FG000|Overall Study|Death|5|||
160622364|NCT02612194|579996249|FG001|Overall Study|Death|0|||
160622365|NCT02612194|579996250|FG002|Overall Study|Death|2|||
160622366|NCT02612194|579996248|FG000|Overall Study|Early Study Termination|1|||
160622367|NCT02612194|579996249|FG001|Overall Study|Early Study Termination|0|||
160622368|NCT02612194|579996250|FG002|Overall Study|Early Study Termination|0|||
160622369|NCT02539160|579996251|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
160622370|NCT02539160|579996252|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
160622371|NCT02539160|579996253|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
160622372|NCT02539160|579996254|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
160622373|NCT02539160|579996251|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
160622374|NCT02539160|579996252|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
160622375|NCT02539160|579996253|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
160622376|NCT02539160|579996254|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
160622377|NCT02539160|579996251|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
160622378|NCT02539160|579996252|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
160622379|NCT02539160|579996253|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
160665524|NCT00561015|580157368|FG000|Overall Study|Participant non-compliance|2|||
160665525|NCT00561015|580157369|FG001|Overall Study|Participant non-compliance|0|||
160665526|NCT00561015|580157370|FG002|Overall Study|Participant non-compliance|0|||
160665527|NCT00561015|580157371|FG003|Overall Study|Participant non-compliance|0|||
160665528|NCT00561015|580157372|FG004|Overall Study|Participant non-compliance|0|||
160665529|NCT00561015|580157373|FG005|Overall Study|Participant non-compliance|0|||
160665530|NCT03570749|580157374|FG000|Overall Study|Ongoing|26|||
160665531|NCT03570749|580157375|FG001|Overall Study|Ongoing|25|||
160665532|NCT03570749|580157376|FG002|Overall Study|Ongoing|25|||
160665533|NCT03570749|580157377|FG003|Overall Study|Ongoing|26|||
160665534|NCT03570749|580157378|FG004|Overall Study|Ongoing|140|||
160665535|NCT03570749|580157379|FG005|Overall Study|Ongoing|142|||
160665536|NCT03570749|580157380|FG006|Overall Study|Ongoing|220|||
160665537|NCT03570749|580157374|FG000|Overall Study|Adverse Event|0|||
160665538|NCT03570749|580157375|FG001|Overall Study|Adverse Event|0|||
160665539|NCT03570749|580157376|FG002|Overall Study|Adverse Event|0|||
160665540|NCT03570749|580157377|FG003|Overall Study|Adverse Event|0|||
160665541|NCT03570749|580157378|FG004|Overall Study|Adverse Event|2|||
160665542|NCT03570749|580157379|FG005|Overall Study|Adverse Event|3|||
160665543|NCT03570749|580157380|FG006|Overall Study|Adverse Event|6|||
160665544|NCT03570749|580157374|FG000|Overall Study|Lack of Efficacy|0|||
160665545|NCT03570749|580157375|FG001|Overall Study|Lack of Efficacy|0|||
160665546|NCT03570749|580157376|FG002|Overall Study|Lack of Efficacy|0|||
160665547|NCT03570749|580157377|FG003|Overall Study|Lack of Efficacy|0|||
160665548|NCT03570749|580157378|FG004|Overall Study|Lack of Efficacy|8|||
160665549|NCT03570749|580157379|FG005|Overall Study|Lack of Efficacy|2|||
160665550|NCT03570749|580157380|FG006|Overall Study|Lack of Efficacy|7|||
160665551|NCT03570749|580157374|FG000|Overall Study|Lost to Follow-up|0|||
160665552|NCT03570749|580157375|FG001|Overall Study|Lost to Follow-up|0|||
160665553|NCT03570749|580157376|FG002|Overall Study|Lost to Follow-up|0|||
160665554|NCT03570749|580157377|FG003|Overall Study|Lost to Follow-up|0|||
160665555|NCT03570749|580157378|FG004|Overall Study|Lost to Follow-up|5|||
160665556|NCT03570749|580157379|FG005|Overall Study|Lost to Follow-up|10|||
160665557|NCT03570749|580157380|FG006|Overall Study|Lost to Follow-up|10|||
160665558|NCT03570749|580157374|FG000|Overall Study|Pregnancy|0|||
160665559|NCT03570749|580157375|FG001|Overall Study|Pregnancy|0|||
160665560|NCT03570749|580157376|FG002|Overall Study|Pregnancy|0|||
160665561|NCT03570749|580157377|FG003|Overall Study|Pregnancy|0|||
160665562|NCT03570749|580157378|FG004|Overall Study|Pregnancy|0|||
160665563|NCT03570749|580157379|FG005|Overall Study|Pregnancy|1|||
160665564|NCT03570749|580157380|FG006|Overall Study|Pregnancy|1|||
160665565|NCT03570749|580157374|FG000|Overall Study|Screen Fail|0|||
160665566|NCT03570749|580157375|FG001|Overall Study|Screen Fail|0|||
160665567|NCT03570749|580157376|FG002|Overall Study|Screen Fail|0|||
160665568|NCT03570749|580157377|FG003|Overall Study|Screen Fail|0|||
160665569|NCT03570749|580157378|FG004|Overall Study|Screen Fail|0|||
160665570|NCT03570749|580157379|FG005|Overall Study|Screen Fail|0|||
160665571|NCT03570749|580157380|FG006|Overall Study|Screen Fail|1|||
160665572|NCT03570749|580157374|FG000|Overall Study|Withdrawal by Subject|2|||
160665573|NCT03570749|580157375|FG001|Overall Study|Withdrawal by Subject|3|||
160665574|NCT03570749|580157376|FG002|Overall Study|Withdrawal by Subject|2|||
160665575|NCT03570749|580157377|FG003|Overall Study|Withdrawal by Subject|1|||
160665576|NCT03570749|580157378|FG004|Overall Study|Withdrawal by Subject|17|||
160665577|NCT03570749|580157379|FG005|Overall Study|Withdrawal by Subject|12|||
160665578|NCT03570749|580157380|FG006|Overall Study|Withdrawal by Subject|15|||
160665579|NCT03570749|580157374|FG000|Overall Study|Other|0|||
160665580|NCT03570749|580157375|FG001|Overall Study|Other|0|||
160665581|NCT03570749|580157376|FG002|Overall Study|Other|0|||
160665582|NCT03570749|580157377|FG003|Overall Study|Other|0|||
160665583|NCT03570749|580157378|FG004|Overall Study|Other|17|||
160665584|NCT03570749|580157379|FG005|Overall Study|Other|14|||
160665585|NCT03570749|580157380|FG006|Overall Study|Other|21|||
160665586|NCT03616535|580157381|FG000|Overall Study|Death|2|||
160665587|NCT03616535|580157382|FG001|Overall Study|Death|0|||
160665588|NCT03616535|580157383|FG002|Overall Study|Death|0|||
160665589|NCT03616535|580157384|FG003|Overall Study|Death|1|||
160665590|NCT03616535|580157381|FG000|Overall Study|Lost to Follow-up|2|||
160665591|NCT03616535|580157382|FG001|Overall Study|Lost to Follow-up|1|||
160665592|NCT03616535|580157383|FG002|Overall Study|Lost to Follow-up|0|||
160665593|NCT03616535|580157384|FG003|Overall Study|Lost to Follow-up|2|||
160665594|NCT03616535|580157381|FG000|Overall Study|Withdrawal by Subject|1|||
160665595|NCT03616535|580157382|FG001|Overall Study|Withdrawal by Subject|2|||
160665596|NCT03616535|580157383|FG002|Overall Study|Withdrawal by Subject|5|||
160665597|NCT03616535|580157384|FG003|Overall Study|Withdrawal by Subject|1|||
160665598|NCT03616535|580157381|FG000|Overall Study|Not specified or change in eligibility|2|||
160665599|NCT03616535|580157382|FG001|Overall Study|Not specified or change in eligibility|3|||
160665600|NCT03616535|580157383|FG002|Overall Study|Not specified or change in eligibility|3|||
160665601|NCT03616535|580157384|FG003|Overall Study|Not specified or change in eligibility|1|||
160665602|NCT01796171|580157387|FG000|Enrolled|Death|0|||
160665603|NCT01796171|580157388|FG001|Enrolled|Death|0|||
160665604|NCT01796171|580157389|FG002|Enrolled|Death|0|||
160665605|NCT01796171|580157390|FG003|Enrolled|Death|0|||
160512246|NCT03541174|579603335|FG002|Part 2 Single-Blind|Pregnancy|0|||
160512247|NCT03541174|579603336|FG003|Part 2 Single-Blind|Pregnancy|1|||
160512248|NCT03541174|579603337|FG004|Part 2 Single-Blind|Pregnancy|0|||
160512249|NCT03541174|579603338|FG005|Part 2 Single-Blind|Pregnancy|0|||
160512250|NCT03541174|579603333|FG000|Part 2 Single-Blind|Other reasons|0|||
160512251|NCT03541174|579603334|FG001|Part 2 Single-Blind|Other reasons|0|||
160512252|NCT03541174|579603335|FG002|Part 2 Single-Blind|Other reasons|0|||
160512253|NCT03541174|579603336|FG003|Part 2 Single-Blind|Other reasons|32|||
160512254|NCT03541174|579603337|FG004|Part 2 Single-Blind|Other reasons|0|||
160512255|NCT03541174|579603338|FG005|Part 2 Single-Blind|Other reasons|0|||
160512256|NCT03541174|579603333|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
160512257|NCT03541174|579603334|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
160512258|NCT03541174|579603335|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
160512259|NCT03541174|579603336|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
160512260|NCT03541174|579603337|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
160512261|NCT03541174|579603338|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
160512262|NCT03541174|579603333|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
160512263|NCT03541174|579603334|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
160512264|NCT03541174|579603335|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
160512265|NCT03541174|579603336|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
160512266|NCT03541174|579603337|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
160512267|NCT03541174|579603338|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
160512268|NCT03541174|579603333|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
160512269|NCT03541174|579603334|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
160512270|NCT03541174|579603335|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
160512271|NCT03541174|579603336|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
160512272|NCT03541174|579603337|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
160512273|NCT03541174|579603338|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
160512274|NCT03541174|579603333|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
160512275|NCT03541174|579603334|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
160512276|NCT03541174|579603335|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
160512277|NCT03541174|579603336|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
160512278|NCT03541174|579603337|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
160512279|NCT03541174|579603338|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
160512280|NCT03541174|579603333|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
160512281|NCT03541174|579603334|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
160512282|NCT03541174|579603335|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
160512283|NCT03541174|579603336|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
160512284|NCT03541174|579603337|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
160512285|NCT03541174|579603338|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
160512286|NCT00605215|579603339|FG000|Overall Study|Death|0|||
160512287|NCT00605215|579603340|FG001|Overall Study|Death|0|||
160512288|NCT00605215|579603341|FG002|Overall Study|Death|1|||
160512289|NCT00605215|579603339|FG000|Overall Study|Adverse Event|19|||
160512290|NCT00605215|579603340|FG001|Overall Study|Adverse Event|21|||
160512291|NCT00605215|579603341|FG002|Overall Study|Adverse Event|26|||
160512292|NCT00605215|579603339|FG000|Overall Study|Refusal to sign the re-consent form|8|||
160512293|NCT00605215|579603340|FG001|Overall Study|Refusal to sign the re-consent form|3|||
160512294|NCT00605215|579603341|FG002|Overall Study|Refusal to sign the re-consent form|3|||
160512295|NCT00605215|579603339|FG000|Overall Study|Withdrawal by Subject|39|||
160512296|NCT00605215|579603340|FG001|Overall Study|Withdrawal by Subject|37|||
160512297|NCT00605215|579603341|FG002|Overall Study|Withdrawal by Subject|27|||
160512298|NCT00605215|579603339|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
160512299|NCT00605215|579603340|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
160512300|NCT00605215|579603341|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
160512301|NCT00605215|579603339|FG000|Overall Study|Protocol Violation|3|||
160512302|NCT00605215|579603340|FG001|Overall Study|Protocol Violation|4|||
160512303|NCT00605215|579603341|FG002|Overall Study|Protocol Violation|1|||
160512304|NCT00605215|579603339|FG000|Overall Study|Pregnancy|8|||
160512305|NCT00605215|579603340|FG001|Overall Study|Pregnancy|5|||
160512306|NCT00605215|579603341|FG002|Overall Study|Pregnancy|4|||
160512307|NCT00605215|579603339|FG000|Overall Study|Lost to Follow-up|8|||
160512308|NCT00605215|579603340|FG001|Overall Study|Lost to Follow-up|5|||
160512309|NCT00605215|579603341|FG002|Overall Study|Lost to Follow-up|2|||
160512310|NCT00605215|579603339|FG000|Overall Study|Other than specified|0|||
160512311|NCT00605215|579603340|FG001|Overall Study|Other than specified|2|||
160512312|NCT00605215|579603341|FG002|Overall Study|Other than specified|1|||
160512313|NCT00275262|579603348|FG000|Overall Study|Adverse Event|2|||
160512314|NCT00275262|579603349|FG001|Overall Study|Adverse Event|0|||
160512315|NCT00275262|579603348|FG000|Overall Study|Disease progression|2|||
160512316|NCT00275262|579603349|FG001|Overall Study|Disease progression|5|||
160512317|NCT00275262|579603348|FG000|Overall Study|Lost to Follow-up|0|||
160512318|NCT00275262|579603349|FG001|Overall Study|Lost to Follow-up|2|||
160512319|NCT00275262|579603348|FG000|Overall Study|Protocol Violation|0|||
160512320|NCT00275262|579603349|FG001|Overall Study|Protocol Violation|2|||
160512321|NCT00275262|579603348|FG000|Overall Study|Death|1|||
160512322|NCT00275262|579603349|FG001|Overall Study|Death|0|||
160512323|NCT00275262|579603348|FG000|Overall Study|Started Chemotherapy|1|||
160512324|NCT00275262|579603349|FG001|Overall Study|Started Chemotherapy|0|||
160512325|NCT04058366|579603352|FG000|Overall Study|Adverse Event|14|||
160512326|NCT04058366|579603352|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
160512327|NCT04058366|579603352|FG000|Overall Study|Commercial drug is available for participants|6|||
160512328|NCT04058366|579603352|FG000|Overall Study|Death|1|||
160512329|NCT04058366|579603352|FG000|Overall Study|Other non-compliance|2|||
160512330|NCT04058366|579603352|FG000|Overall Study|Other|6|||
160512331|NCT02738203|579603353|FG000|Overall Study|Failed IUD Insertion|2|||
160512332|NCT02738203|579603354|FG001|Overall Study|Failed IUD Insertion|2|||
160512333|NCT02738203|579603353|FG000|Overall Study|Protocol Violation|0|||
160512334|NCT02738203|579603354|FG001|Overall Study|Protocol Violation|1|||
160512335|NCT05087979|579603355|FG000|Overall Study|Converted to general anesthesia|1|||
160512336|NCT05087979|579603356|FG001|Overall Study|Converted to general anesthesia|0|||
160512337|NCT01290315|579603357|FG000|Overall Study|Adverse Event|0|||
160512338|NCT01290315|579603358|FG001|Overall Study|Adverse Event|0|||
160512339|NCT01290315|579603359|FG002|Overall Study|Adverse Event|0|||
160512340|NCT01290315|579603360|FG003|Overall Study|Adverse Event|3|||
160512341|NCT01290315|579603357|FG000|Overall Study|Selection criteria/compliance|2|||
160512342|NCT01290315|579603358|FG001|Overall Study|Selection criteria/compliance|1|||
160512343|NCT01290315|579603359|FG002|Overall Study|Selection criteria/compliance|0|||
160512344|NCT01290315|579603360|FG003|Overall Study|Selection criteria/compliance|2|||
160512345|NCT01290315|579603357|FG000|Overall Study|Lost to Follow-up|0|||
160512346|NCT01290315|579603358|FG001|Overall Study|Lost to Follow-up|1|||
160512347|NCT01290315|579603359|FG002|Overall Study|Lost to Follow-up|0|||
160512348|NCT01290315|579603360|FG003|Overall Study|Lost to Follow-up|0|||
160512349|NCT01290315|579603357|FG000|Overall Study|Withdrawal by Subject|1|||
160512350|NCT01290315|579603358|FG001|Overall Study|Withdrawal by Subject|1|||
160512351|NCT01290315|579603359|FG002|Overall Study|Withdrawal by Subject|0|||
160512352|NCT01290315|579603360|FG003|Overall Study|Withdrawal by Subject|0|||
160512353|NCT03725085|579603361|FG000|Overall Study|Lost to Follow-up|2|||
160512354|NCT00705679|579603362|FG000|Overall Study|Adverse Event|1|||
160512355|NCT00705679|579603363|FG001|Overall Study|Adverse Event|1|||
160512356|NCT00705679|579603364|FG002|Overall Study|Adverse Event|0|||
160512357|NCT00705679|579603365|FG003|Overall Study|Adverse Event|0|||
160512358|NCT00705679|579603366|FG004|Overall Study|Adverse Event|0|||
160512359|NCT00705679|579603362|FG000|Overall Study|Death|0|||
160512360|NCT00705679|579603363|FG001|Overall Study|Death|0|||
160512361|NCT00705679|579603364|FG002|Overall Study|Death|3|||
160512362|NCT00705679|579603365|FG003|Overall Study|Death|2|||
160512363|NCT00705679|579603366|FG004|Overall Study|Death|1|||
160512364|NCT00705679|579603362|FG000|Overall Study|Lost to Follow-up|32|||
160512365|NCT00705679|579603363|FG001|Overall Study|Lost to Follow-up|60|||
160512366|NCT00705679|579603364|FG002|Overall Study|Lost to Follow-up|44|||
160512367|NCT00705679|579603365|FG003|Overall Study|Lost to Follow-up|30|||
160512368|NCT00705679|579603366|FG004|Overall Study|Lost to Follow-up|35|||
160512369|NCT00705679|579603362|FG000|Overall Study|Physician Decision|0|||
160512370|NCT00705679|579603363|FG001|Overall Study|Physician Decision|1|||
160512371|NCT00705679|579603364|FG002|Overall Study|Physician Decision|0|||
160512372|NCT00705679|579603365|FG003|Overall Study|Physician Decision|1|||
160512373|NCT00705679|579603366|FG004|Overall Study|Physician Decision|0|||
160512374|NCT00705679|579603362|FG000|Overall Study|Withdrawal by Subject|32|||
160512375|NCT00705679|579603363|FG001|Overall Study|Withdrawal by Subject|77|||
160512376|NCT00705679|579603364|FG002|Overall Study|Withdrawal by Subject|68|||
160512377|NCT00705679|579603365|FG003|Overall Study|Withdrawal by Subject|47|||
160512378|NCT00705679|579603366|FG004|Overall Study|Withdrawal by Subject|33|||
160512379|NCT03527173|579603367|FG000|Overall Study|Lost to Follow-up|4|||
160512380|NCT03527173|579603368|FG001|Overall Study|Lost to Follow-up|2|||
160512381|NCT03527173|579603367|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
160512382|NCT03527173|579603368|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
160512383|NCT03527173|579603367|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
160512384|NCT03527173|579603368|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
160512385|NCT03527173|579603367|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
160512386|NCT03527173|579603368|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
160512387|NCT02704754|579603369|FG000|Overall Study|Lost to Follow-up|1|||
160512388|NCT02704754|579603370|FG001|Overall Study|Lost to Follow-up|1|||
160512389|NCT02704754|579603369|FG000|Overall Study|Lack of Efficacy|1|||
160512390|NCT02704754|579603370|FG001|Overall Study|Lack of Efficacy|0|||
160512391|NCT02704754|579603369|FG000|Overall Study|Withdrawal by Subject|1|||
160512392|NCT02704754|579603370|FG001|Overall Study|Withdrawal by Subject|0|||
160512393|NCT00423943|579603373|FG000|Overall Study|Withdrawal by Subject|3|||
160512394|NCT00423943|579603374|FG001|Overall Study|Withdrawal by Subject|1|||
160512395|NCT03730480|579603375|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
160512396|NCT01248780|579603376|FG000|Overall Study|Lack of Efficacy|2|||
160512397|NCT01248780|579603377|FG001|Overall Study|Lack of Efficacy|0|||
160512398|NCT01248780|579603376|FG000|Overall Study|Lost to Follow-up|0|||
160512399|NCT01248780|579603377|FG001|Overall Study|Lost to Follow-up|1|||
160512400|NCT01248780|579603376|FG000|Overall Study|Death|0|||
160512401|NCT01248780|579603377|FG001|Overall Study|Death|1|||
160512402|NCT01248780|579603376|FG000|Overall Study|Adverse Event|2|||
160512403|NCT01248780|579603377|FG001|Overall Study|Adverse Event|7|||
160512404|NCT01248780|579603376|FG000|Overall Study|Protocol Violation|1|||
160512405|NCT01248780|579603377|FG001|Overall Study|Protocol Violation|1|||
160512406|NCT01248780|579603376|FG000|Overall Study|Withdrawal by Subject|4|||
160512407|NCT01248780|579603377|FG001|Overall Study|Withdrawal by Subject|4|||
160512408|NCT01248780|579603376|FG000|Overall Study|Not treated|0|||
160512409|NCT01248780|579603377|FG001|Overall Study|Not treated|1|||
160512410|NCT00107120|579603381|FG000|Overall Study|Adverse Event|4|||
160512411|NCT00107120|579603382|FG001|Overall Study|Adverse Event|1|||
160512412|NCT00107120|579603381|FG000|Overall Study|Lack of Efficacy|5|||
160512413|NCT00107120|579603382|FG001|Overall Study|Lack of Efficacy|5|||
160512414|NCT00107120|579603381|FG000|Overall Study|Protocol Violation|3|||
160512415|NCT00107120|579603382|FG001|Overall Study|Protocol Violation|0|||
160512416|NCT00107120|579603381|FG000|Overall Study|Withdrawal by Subject|8|||
160512417|NCT00107120|579603382|FG001|Overall Study|Withdrawal by Subject|9|||
160512418|NCT00107120|579603381|FG000|Overall Study|Lost to Follow-up|8|||
160512419|NCT00107120|579603382|FG001|Overall Study|Lost to Follow-up|6|||
160512420|NCT00107120|579603381|FG000|Overall Study|Pregnancy|0|||
160512421|NCT00107120|579603382|FG001|Overall Study|Pregnancy|1|||
160512422|NCT00107120|579603381|FG000|Overall Study|moving away from site|1|||
160512423|NCT00107120|579603382|FG001|Overall Study|moving away from site|1|||
160512424|NCT00107120|579603381|FG000|Overall Study|death of parent|0|||
160512425|NCT00107120|579603382|FG001|Overall Study|death of parent|1|||
160512426|NCT04214600|579603385|FG000|Overall Study|Lost to Follow-up|9|||
160512427|NCT04214600|579603386|FG001|Overall Study|Lost to Follow-up|14|||
160512428|NCT00896051|579603387|FG000|Overall Study|Adverse Event|2|||
160512429|NCT00896051|579603388|FG001|Overall Study|Adverse Event|1|||
160512430|NCT00896051|579603387|FG000|Overall Study|Lost to Follow-up|3|||
160512431|NCT00896051|579603388|FG001|Overall Study|Lost to Follow-up|2|||
160512432|NCT00896051|579603387|FG000|Overall Study|Withdrawal by Subject|3|||
160512433|NCT00896051|579603388|FG001|Overall Study|Withdrawal by Subject|2|||
160512434|NCT00896051|579603387|FG000|Overall Study|Subject noncompliant|1|||
160512435|NCT00896051|579603388|FG001|Overall Study|Subject noncompliant|3|||
160512436|NCT00896051|579603387|FG000|Overall Study|Other|1|||
160512437|NCT00896051|579603388|FG001|Overall Study|Other|1|||
160512438|NCT02935452|579603389|FG000|Overall Study|work and life commintment|3|||
160512439|NCT02935452|579603390|FG001|Overall Study|work and life commintment|1|||
160512440|NCT01635920|579603392|FG000|Overall Study|Adverse Event|1|||
160512441|NCT01635920|579603393|FG001|Overall Study|Adverse Event|0|||
160512442|NCT01635920|579603392|FG000|Overall Study|Lost to Follow-up|0|||
160512443|NCT01635920|579603393|FG001|Overall Study|Lost to Follow-up|1|||
160512444|NCT01635920|579603392|FG000|Overall Study|Subject decision|2|||
160512445|NCT01635920|579603393|FG001|Overall Study|Subject decision|0|||
160512446|NCT01813929|579603394|FG000|Overall Study|Withdrawal by Subject|0|||
160512447|NCT01813929|579603395|FG001|Overall Study|Withdrawal by Subject|1|||
160512448|NCT00007345|579603396|FG000|Overall Study|Refused further treatment|0|||
160512449|NCT00007345|579603397|FG001|Overall Study|Refused further treatment|7|||
160512450|NCT00007345|579603396|FG000|Overall Study|Switched to alternative treatment|0|||
160622380|NCT02539160|579996254|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
160622381|NCT01681004|579996255|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
160622382|NCT01681004|579996256|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
160622383|NCT01681004|579996255|FG000|Study Completion|Lost to Follow-up|8|||
160622384|NCT01681004|579996256|FG001|Study Completion|Lost to Follow-up|3|||
160622385|NCT01681004|579996255|FG000|Study Completion|Physician Decision|1|||
160622386|NCT01681004|579996256|FG001|Study Completion|Physician Decision|3|||
160622387|NCT01681004|579996255|FG000|Study Completion|Site Termination|2|||
160622388|NCT01681004|579996256|FG001|Study Completion|Site Termination|1|||
160512451|NCT00007345|579603397|FG001|Overall Study|Switched to alternative treatment|3|||
160512452|NCT00007345|579603396|FG000|Overall Study|Intercurrent illness|1|||
160512453|NCT00007345|579603397|FG001|Overall Study|Intercurrent illness|0|||
160512454|NCT00007345|579603396|FG000|Overall Study|Death on study|1|||
160512455|NCT00007345|579603397|FG001|Overall Study|Death on study|1|||
160512456|NCT04433585|579603398|FG000|Overall Study|Withdrawal by Subject|15|||
160512457|NCT04433585|579603399|FG001|Overall Study|Withdrawal by Subject|3|||
160512458|NCT04433585|579603400|FG002|Overall Study|Withdrawal by Subject|15|||
160512459|NCT04433585|579603401|FG003|Overall Study|Withdrawal by Subject|6|||
160512460|NCT04433585|579603398|FG000|Overall Study|Adverse Event|10|||
160512461|NCT04433585|579603399|FG001|Overall Study|Adverse Event|4|||
160512462|NCT04433585|579603400|FG002|Overall Study|Adverse Event|1|||
160622389|NCT01681004|579996255|FG000|Study Completion|Death|1|||
160665606|NCT01796171|580157391|FG004|Enrolled|Death|0|||
160665607|NCT01796171|580157392|FG005|Enrolled|Death|0|||
160665608|NCT01796171|580157393|FG006|Enrolled|Death|0|||
160665609|NCT01796171|580157394|FG007|Enrolled|Death|0|||
160665610|NCT01796171|580157395|FG008|Enrolled|Death|0|||
160665611|NCT01796171|580157396|FG009|Enrolled|Death|0|||
160665612|NCT01796171|580157397|FG010|Enrolled|Death|0|||
160665613|NCT01796171|580157398|FG011|Enrolled|Death|0|||
160665614|NCT01796171|580157399|FG012|Enrolled|Death|0|||
160665615|NCT01796171|580157400|FG013|Enrolled|Death|0|||
160665616|NCT01796171|580157401|FG014|Enrolled|Death|1|||
160665617|NCT01796171|580157387|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
160665618|NCT01796171|580157388|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
160665619|NCT01796171|580157389|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
160665620|NCT01796171|580157390|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
160665621|NCT01796171|580157391|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
160665622|NCT01796171|580157392|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
160665623|NCT01796171|580157393|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
160665624|NCT01796171|580157394|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
160665625|NCT01796171|580157395|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
160665626|NCT01796171|580157396|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
160665627|NCT01796171|580157397|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
160665628|NCT01796171|580157398|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
160665629|NCT01796171|580157399|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
160665630|NCT01796171|580157400|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
160665631|NCT01796171|580157401|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
160665632|NCT01796171|580157387|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665633|NCT01796171|580157388|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665634|NCT01796171|580157389|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665635|NCT01796171|580157390|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665636|NCT01796171|580157391|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665637|NCT01796171|580157392|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665638|NCT01796171|580157393|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665639|NCT01796171|580157394|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665640|NCT01796171|580157395|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665641|NCT01796171|580157396|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665642|NCT01796171|580157397|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665643|NCT01796171|580157398|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665644|NCT01796171|580157399|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665645|NCT01796171|580157400|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
160665646|NCT01796171|580157401|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
160665647|NCT01796171|580157387|FG000|Treatment Period With Betalutin|Progressive disease|0|||
160665648|NCT01796171|580157388|FG001|Treatment Period With Betalutin|Progressive disease|1|||
160665649|NCT01796171|580157389|FG002|Treatment Period With Betalutin|Progressive disease|0|||
160665650|NCT01796171|580157390|FG003|Treatment Period With Betalutin|Progressive disease|0|||
160665651|NCT01796171|580157391|FG004|Treatment Period With Betalutin|Progressive disease|0|||
160665652|NCT01796171|580157392|FG005|Treatment Period With Betalutin|Progressive disease|0|||
160665653|NCT01796171|580157393|FG006|Treatment Period With Betalutin|Progressive disease|0|||
160665654|NCT01796171|580157394|FG007|Treatment Period With Betalutin|Progressive disease|0|||
160665655|NCT01796171|580157395|FG008|Treatment Period With Betalutin|Progressive disease|0|||
160665656|NCT01796171|580157396|FG009|Treatment Period With Betalutin|Progressive disease|0|||
160665657|NCT01796171|580157397|FG010|Treatment Period With Betalutin|Progressive disease|0|||
160665658|NCT01796171|580157398|FG011|Treatment Period With Betalutin|Progressive disease|0|||
160665659|NCT01796171|580157399|FG012|Treatment Period With Betalutin|Progressive disease|0|||
160665660|NCT01796171|580157400|FG013|Treatment Period With Betalutin|Progressive disease|0|||
160665661|NCT01796171|580157401|FG014|Treatment Period With Betalutin|Progressive disease|0|||
160665662|NCT01796171|580157387|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665663|NCT01796171|580157388|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665664|NCT01796171|580157389|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665665|NCT01796171|580157390|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665666|NCT01796171|580157391|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665667|NCT01796171|580157392|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665668|NCT01796171|580157393|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665669|NCT01796171|580157394|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665670|NCT01796171|580157395|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
160665671|NCT01796171|580157396|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665672|NCT01796171|580157397|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
160665673|NCT01796171|580157398|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
160665674|NCT01796171|580157399|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665675|NCT01796171|580157400|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665676|NCT01796171|580157401|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
160665677|NCT01796171|580157387|FG000|Treatment Period With Betalutin|Physician Decision|0|||
160665678|NCT01796171|580157388|FG001|Treatment Period With Betalutin|Physician Decision|0|||
160665679|NCT01796171|580157389|FG002|Treatment Period With Betalutin|Physician Decision|0|||
160665680|NCT01796171|580157390|FG003|Treatment Period With Betalutin|Physician Decision|0|||
160665681|NCT01796171|580157391|FG004|Treatment Period With Betalutin|Physician Decision|0|||
160665682|NCT01796171|580157392|FG005|Treatment Period With Betalutin|Physician Decision|0|||
160665683|NCT01796171|580157393|FG006|Treatment Period With Betalutin|Physician Decision|0|||
160665684|NCT01796171|580157394|FG007|Treatment Period With Betalutin|Physician Decision|0|||
160665685|NCT01796171|580157395|FG008|Treatment Period With Betalutin|Physician Decision|0|||
160665686|NCT01796171|580157396|FG009|Treatment Period With Betalutin|Physician Decision|0|||
160665687|NCT01796171|580157397|FG010|Treatment Period With Betalutin|Physician Decision|5|||
160665688|NCT01796171|580157398|FG011|Treatment Period With Betalutin|Physician Decision|1|||
160665689|NCT01796171|580157399|FG012|Treatment Period With Betalutin|Physician Decision|1|||
160665690|NCT01796171|580157400|FG013|Treatment Period With Betalutin|Physician Decision|0|||
160512463|NCT04433585|579603401|FG003|Overall Study|Adverse Event|0|||
160512464|NCT04433585|579603398|FG000|Overall Study|Due to the conflict in Ukraine|2|||
160512465|NCT04433585|579603399|FG001|Overall Study|Due to the conflict in Ukraine|1|||
160512466|NCT04433585|579603400|FG002|Overall Study|Due to the conflict in Ukraine|1|||
160512467|NCT04433585|579603401|FG003|Overall Study|Due to the conflict in Ukraine|2|||
160512468|NCT04433585|579603398|FG000|Overall Study|Physician Decision|1|||
160512469|NCT04433585|579603399|FG001|Overall Study|Physician Decision|2|||
160512470|NCT04433585|579603400|FG002|Overall Study|Physician Decision|0|||
160512471|NCT04433585|579603401|FG003|Overall Study|Physician Decision|0|||
160512472|NCT04433585|579603398|FG000|Overall Study|Lost to Follow-up|1|||
160512473|NCT04433585|579603399|FG001|Overall Study|Lost to Follow-up|1|||
160512474|NCT04433585|579603400|FG002|Overall Study|Lost to Follow-up|1|||
160512475|NCT04433585|579603401|FG003|Overall Study|Lost to Follow-up|0|||
160512476|NCT04433585|579603398|FG000|Overall Study|Lack of Efficacy|0|||
160512477|NCT04433585|579603399|FG001|Overall Study|Lack of Efficacy|1|||
160512478|NCT04433585|579603400|FG002|Overall Study|Lack of Efficacy|1|||
160512479|NCT04433585|579603401|FG003|Overall Study|Lack of Efficacy|1|||
160512480|NCT04433585|579603398|FG000|Overall Study|Death|0|||
160512481|NCT04433585|579603399|FG001|Overall Study|Death|1|||
160512482|NCT04433585|579603400|FG002|Overall Study|Death|0|||
160512483|NCT04433585|579603401|FG003|Overall Study|Death|0|||
160512484|NCT00194987|579603402|FG000|Overall Study|Withdrawal by Subject|0|||
160512485|NCT00194987|579603403|FG001|Overall Study|Withdrawal by Subject|3|||
160622390|NCT01681004|579996256|FG001|Study Completion|Death|1|||
160622391|NCT00372905|579996257|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
160622392|NCT00372905|579996258|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
160622393|NCT00372905|579996259|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
160622394|NCT00372905|579996260|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
160622395|NCT00372905|579996257|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
160622396|NCT00372905|579996258|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
160622397|NCT00372905|579996259|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
160622398|NCT00372905|579996260|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
160622399|NCT00372905|579996257|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
160622400|NCT00372905|579996258|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
160622401|NCT00372905|579996259|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
160622402|NCT00372905|579996260|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
160622403|NCT00372905|579996257|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
160622404|NCT00372905|579996258|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
160622405|NCT00372905|579996259|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
160622406|NCT00372905|579996260|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
160622407|NCT00372905|579996257|FG000|Follow up Until Relapse or Progression|Study closed|0|||
160622408|NCT00372905|579996258|FG001|Follow up Until Relapse or Progression|Study closed|0|||
160622409|NCT00372905|579996259|FG002|Follow up Until Relapse or Progression|Study closed|0|||
160622410|NCT00372905|579996260|FG003|Follow up Until Relapse or Progression|Study closed|3|||
160622411|NCT00372905|579996257|FG000|Follow up Until Relapse or Progression|Other|0|||
160622412|NCT00372905|579996258|FG001|Follow up Until Relapse or Progression|Other|1|||
160622413|NCT00372905|579996259|FG002|Follow up Until Relapse or Progression|Other|0|||
160622414|NCT00372905|579996260|FG003|Follow up Until Relapse or Progression|Other|0|||
160622415|NCT01728454|579996261|FG000|Stage 1 and 2|Pregnancy|1|||
160622416|NCT01728454|579996262|FG001|Stage 1 and 2|Pregnancy|0|||
160622417|NCT01728454|579996263|FG002|Stage 1 and 2|Pregnancy|0|||
160622418|NCT01728454|579996261|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
160622419|NCT01728454|579996262|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
160622420|NCT01728454|579996263|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
160622421|NCT01728454|579996261|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
160622422|NCT01728454|579996262|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
160622423|NCT01728454|579996263|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
160622424|NCT01728454|579996261|FG000|Stage 1 and 2|Lost to Follow-up|1|||
160622425|NCT01728454|579996262|FG001|Stage 1 and 2|Lost to Follow-up|1|||
160622426|NCT01728454|579996263|FG002|Stage 1 and 2|Lost to Follow-up|0|||
160622427|NCT01728454|579996261|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
160622428|NCT01728454|579996262|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
160622429|NCT01728454|579996263|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
160622430|NCT01728454|579996261|FG000|Stage 3|Reason Missing|0|||
160622431|NCT01728454|579996262|FG001|Stage 3|Reason Missing|0|||
160622432|NCT01728454|579996263|FG002|Stage 3|Reason Missing|1|||
160622433|NCT01728454|579996261|FG000|Stage 3|Subject Required Other Treatment|0|||
160622434|NCT01728454|579996262|FG001|Stage 3|Subject Required Other Treatment|1|||
160622435|NCT01728454|579996263|FG002|Stage 3|Subject Required Other Treatment|0|||
160622436|NCT01728454|579996261|FG000|Stage 3|Pregnancy|1|||
160622437|NCT01728454|579996262|FG001|Stage 3|Pregnancy|0|||
160622438|NCT01728454|579996263|FG002|Stage 3|Pregnancy|0|||
160622439|NCT01728454|579996261|FG000|Stage 3|Withdrew Consent|1|||
160622440|NCT01728454|579996262|FG001|Stage 3|Withdrew Consent|0|||
160622441|NCT01728454|579996263|FG002|Stage 3|Withdrew Consent|1|||
160622442|NCT01728454|579996261|FG000|Stage 3|Non-compliance with Protocol|0|||
160622443|NCT01728454|579996262|FG001|Stage 3|Non-compliance with Protocol|0|||
160622444|NCT01728454|579996263|FG002|Stage 3|Non-compliance with Protocol|1|||
160622445|NCT01728454|579996261|FG000|Stage 3|Lost to Follow-up|0|||
160622446|NCT01728454|579996262|FG001|Stage 3|Lost to Follow-up|3|||
160622447|NCT01728454|579996263|FG002|Stage 3|Lost to Follow-up|1|||
160622448|NCT01728454|579996261|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
160622449|NCT01728454|579996262|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
160622450|NCT01728454|579996263|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
160622451|NCT00689299|579996266|FG000|Overall Study|Adverse Event|2|||
160622452|NCT00689299|579996267|FG001|Overall Study|Adverse Event|1|||
160622453|NCT00689299|579996268|FG002|Overall Study|Adverse Event|1|||
160622454|NCT00689299|579996266|FG000|Overall Study|Lost to Follow-up|0|||
160622455|NCT00689299|579996267|FG001|Overall Study|Lost to Follow-up|1|||
160622456|NCT00689299|579996268|FG002|Overall Study|Lost to Follow-up|1|||
160622457|NCT00689299|579996266|FG000|Overall Study|Withdrawal by Subject|4|||
160622458|NCT00689299|579996267|FG001|Overall Study|Withdrawal by Subject|1|||
160622459|NCT00689299|579996268|FG002|Overall Study|Withdrawal by Subject|3|||
160622460|NCT00689299|579996266|FG000|Overall Study|Protocol Violation|1|||
160622461|NCT00689299|579996267|FG001|Overall Study|Protocol Violation|0|||
160622462|NCT00689299|579996268|FG002|Overall Study|Protocol Violation|0|||
160622463|NCT01190839|579996271|FG000|Overall Study|Adverse Event|32|||
160622464|NCT01190839|579996272|FG001|Overall Study|Adverse Event|41|||
160622465|NCT01190839|579996271|FG000|Overall Study|Protocol Violation|2|||
160622466|NCT01190839|579996272|FG001|Overall Study|Protocol Violation|2|||
160622467|NCT01190839|579996271|FG000|Overall Study|Lost to Follow-up|7|||
160622468|NCT01190839|579996272|FG001|Overall Study|Lost to Follow-up|1|||
160622469|NCT01190839|579996271|FG000|Overall Study|Death|1|||
160622470|NCT01190839|579996272|FG001|Overall Study|Death|0|||
160622471|NCT01190839|579996271|FG000|Overall Study|Trial stopped by Sponsor|71|||
160622472|NCT01190839|579996272|FG001|Overall Study|Trial stopped by Sponsor|68|||
160622473|NCT01190839|579996271|FG000|Overall Study|Undefined|35|||
160622474|NCT01190839|579996272|FG001|Overall Study|Undefined|31|||
160622475|NCT01190839|579996271|FG000|Overall Study|Randomized but not treated|2|||
160622476|NCT01190839|579996272|FG001|Overall Study|Randomized but not treated|4|||
160622477|NCT00695318|579996277|FG000|Overall Study|Lost to Follow-up|1|||
160622478|NCT00695318|579996278|FG001|Overall Study|Lost to Follow-up|0|||
160622479|NCT00695318|579996277|FG000|Overall Study|Withdrawal by Subject|2|||
160622480|NCT00695318|579996278|FG001|Overall Study|Withdrawal by Subject|0|||
160622481|NCT00695318|579996277|FG000|Overall Study|Death|1|||
160622482|NCT00695318|579996278|FG001|Overall Study|Death|1|||
160622483|NCT00695318|579996277|FG000|Overall Study|Study Terminated|1|||
160622484|NCT00695318|579996278|FG001|Overall Study|Study Terminated|0|||
160622485|NCT02058966|579996279|FG000|Open-Label Methamphetamine|Adverse Event|1|||
160622486|NCT02058966|579996279|FG000|First Intervention|Withdrawal by Subject|1|||
160622487|NCT01265511|579996280|FG000|Overall Study|Lack of Efficacy|2|||
160622488|NCT01265511|579996281|FG001|Overall Study|Lack of Efficacy|1|||
160622489|NCT01265511|579996280|FG000|Overall Study|Met stopping rules|0|||
160622490|NCT01265511|579996281|FG001|Overall Study|Met stopping rules|2|||
160622491|NCT01362062|579996282|FG000|Overall Study|Adverse Event|1|||
160622492|NCT01362062|579996283|FG001|Overall Study|Adverse Event|0|||
160622493|NCT01362062|579996282|FG000|Overall Study|Lost to Follow-up|11|||
160622494|NCT01362062|579996283|FG001|Overall Study|Lost to Follow-up|0|||
160622495|NCT01362062|579996282|FG000|Overall Study|Withdrawal by Subject|2|||
160622496|NCT01362062|579996283|FG001|Overall Study|Withdrawal by Subject|0|||
160622497|NCT01362062|579996282|FG000|Overall Study|Non-compliant participant|2|||
160622498|NCT01362062|579996283|FG001|Overall Study|Non-compliant participant|0|||
160622499|NCT01362062|579996282|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
160622500|NCT01362062|579996283|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
160622501|NCT01362062|579996282|FG000|Overall Study|Had significant improvement|9|||
160622502|NCT01362062|579996283|FG001|Overall Study|Had significant improvement|0|||
160622503|NCT00434876|579996284|FG000|Overall Study|Lost to Follow-up|1|||
160622504|NCT00434876|579996285|FG001|Overall Study|Lost to Follow-up|1|||
160622505|NCT00758394|579996286|FG000|2nd Intervention Order|Lost to Follow-up|0|||
160622506|NCT00758394|579996287|FG001|2nd Intervention Order|Lost to Follow-up|1|||
160622507|NCT00758394|579996288|FG002|2nd Intervention Order|Lost to Follow-up|0|||
160622508|NCT00758394|579996289|FG003|2nd Intervention Order|Lost to Follow-up|0|||
160622509|NCT00758394|579996286|FG000|3rd Intervention|Lost to Follow-up|1|||
160622510|NCT00758394|579996287|FG001|3rd Intervention|Lost to Follow-up|0|||
160622511|NCT00758394|579996288|FG002|3rd Intervention|Lost to Follow-up|0|||
160622512|NCT00758394|579996289|FG003|3rd Intervention|Lost to Follow-up|1|||
160622513|NCT00950755|579996293|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
160622514|NCT00950755|579996293|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
160622515|NCT00950755|579996293|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
160622516|NCT00950755|579996293|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
160622517|NCT00950755|579996293|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
160622518|NCT00950755|579996293|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
160622519|NCT00950755|579996293|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
160622520|NCT00950755|579996293|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
160622521|NCT00950755|579996293|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
160622522|NCT00950755|579996293|FG000|Long-Term Follow-Up|Death|8|||
160622523|NCT00508820|579996294|FG000|Overall Study|Adverse Event|6|||
160622524|NCT00508820|579996295|FG001|Overall Study|Adverse Event|10|||
160622525|NCT00508820|579996294|FG000|Overall Study|Death|6|||
160622526|NCT00508820|579996295|FG001|Overall Study|Death|8|||
160622527|NCT00508820|579996294|FG000|Overall Study|Lost to Follow-up|1|||
160622528|NCT00508820|579996295|FG001|Overall Study|Lost to Follow-up|1|||
160622529|NCT00508820|579996294|FG000|Overall Study|Physician Decision|8|||
160622530|NCT00508820|579996295|FG001|Overall Study|Physician Decision|2|||
160622531|NCT00508820|579996294|FG000|Overall Study|Pregnancy|0|||
160622532|NCT00508820|579996295|FG001|Overall Study|Pregnancy|2|||
160622533|NCT00508820|579996294|FG000|Overall Study|Protocol Violation|2|||
160622534|NCT00508820|579996295|FG001|Overall Study|Protocol Violation|0|||
160622535|NCT00508820|579996294|FG000|Overall Study|Withdrawal by Subject|10|||
160622536|NCT00508820|579996295|FG001|Overall Study|Withdrawal by Subject|12|||
160622537|NCT00508820|579996294|FG000|Overall Study|Other|11|||
160622538|NCT00508820|579996295|FG001|Overall Study|Other|2|||
160622539|NCT00508820|579996294|FG000|Overall Study|Noncompliance|1|||
160622540|NCT00508820|579996295|FG001|Overall Study|Noncompliance|0|||
160622541|NCT00508820|579996294|FG000|Overall Study|Requirement for alternative therapy|7|||
160512486|NCT01664598|579603404|FG000|Overall Study|Sponsor Decision|1|||
160512487|NCT01664598|579603404|FG000|Overall Study|Withdrawal of Informed Consent|4|||
160512488|NCT01664598|579603404|FG000|Overall Study|Adverse Event|1|||
160512489|NCT02929329|579603409|FG000|Overall Study|Withdrawal by Subject|24|||
160512490|NCT02929329|579603410|FG001|Overall Study|Withdrawal by Subject|21|||
160512491|NCT02929329|579603409|FG000|Overall Study|Lost to Follow-up|26|||
160512492|NCT02929329|579603410|FG001|Overall Study|Lost to Follow-up|20|||
160512493|NCT02929329|579603409|FG000|Overall Study|Death|1054|||
160512494|NCT02929329|579603410|FG001|Overall Study|Death|1051|||
160512495|NCT01097707|579603419|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
160622542|NCT00508820|579996295|FG001|Overall Study|Requirement for alternative therapy|15|||
160622543|NCT00508820|579996294|FG000|Overall Study|Protocol-specified Criteria|3|||
160622544|NCT00508820|579996295|FG001|Overall Study|Protocol-specified Criteria|12|||
160622545|NCT02926833|579998090|FG000|Overall Study|Death|1|||
160622546|NCT02926833|579998091|FG001|Overall Study|Death|1|||
160622547|NCT02926833|579998092|FG002|Overall Study|Death|2|||
160622548|NCT02926833|579998093|FG003|Overall Study|Death|13|||
160622549|NCT02926833|579998090|FG000|Overall Study|Lost to Follow-up|1|||
160622550|NCT02926833|579998091|FG001|Overall Study|Lost to Follow-up|2|||
160622551|NCT02926833|579998092|FG002|Overall Study|Lost to Follow-up|0|||
160622552|NCT02926833|579998093|FG003|Overall Study|Lost to Follow-up|3|||
160622553|NCT02926833|579998090|FG000|Overall Study|Full Consent Withdrawal|0|||
160622554|NCT02926833|579998091|FG001|Overall Study|Full Consent Withdrawal|0|||
160622555|NCT02926833|579998092|FG002|Overall Study|Full Consent Withdrawal|0|||
160622556|NCT02926833|579998093|FG003|Overall Study|Full Consent Withdrawal|2|||
160622557|NCT02926833|579998090|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
160622558|NCT02926833|579998091|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
160622559|NCT02926833|579998092|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
160622560|NCT02926833|579998093|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
160622561|NCT02926833|579998090|FG000|Overall Study|Investigator Decision|0|||
160622562|NCT02926833|579998091|FG001|Overall Study|Investigator Decision|1|||
160622563|NCT02926833|579998092|FG002|Overall Study|Investigator Decision|0|||
160622564|NCT02926833|579998093|FG003|Overall Study|Investigator Decision|0|||
160622565|NCT02926833|579998090|FG000|Overall Study|Adverse Event|0|||
160622566|NCT02926833|579998091|FG001|Overall Study|Adverse Event|0|||
160622567|NCT02926833|579998092|FG002|Overall Study|Adverse Event|1|||
160622568|NCT02926833|579998093|FG003|Overall Study|Adverse Event|0|||
160622569|NCT02926833|579998090|FG000|Overall Study|Partial Withdrawal of Consent|0|||
160622570|NCT02926833|579998091|FG001|Overall Study|Partial Withdrawal of Consent|0|||
160622571|NCT02926833|579998092|FG002|Overall Study|Partial Withdrawal of Consent|0|||
160622572|NCT02926833|579998093|FG003|Overall Study|Partial Withdrawal of Consent|1|||
160622573|NCT01945866|579998094|FG000|Overall Study|Eyes did not complete or were dropped|2|||
160622574|NCT01945866|579998095|FG001|Overall Study|Eyes did not complete or were dropped|0|||
160622575|NCT01018680|579998096|FG000|Overall Study|Adverse Event|23|||
160622576|NCT01018680|579998097|FG001|Overall Study|Adverse Event|40|||
160622577|NCT01018680|579998096|FG000|Overall Study|Withdrawal by Subject|10|||
160622578|NCT01018680|579998097|FG001|Overall Study|Withdrawal by Subject|10|||
160622579|NCT01018680|579998096|FG000|Overall Study|Protocol Violation|5|||
160622580|NCT01018680|579998097|FG001|Overall Study|Protocol Violation|8|||
160622581|NCT01018680|579998096|FG000|Overall Study|Sponsor Decision|6|||
160622582|NCT01018680|579998097|FG001|Overall Study|Sponsor Decision|7|||
160622583|NCT01018680|579998096|FG000|Overall Study|Lack of Efficacy|8|||
160622584|NCT01018680|579998097|FG001|Overall Study|Lack of Efficacy|2|||
160622585|NCT01018680|579998096|FG000|Overall Study|Lost to Follow-up|5|||
160622586|NCT01018680|579998097|FG001|Overall Study|Lost to Follow-up|3|||
160622587|NCT01018680|579998096|FG000|Overall Study|Entry Criteria Not Met|1|||
160622588|NCT01018680|579998097|FG001|Overall Study|Entry Criteria Not Met|4|||
160622589|NCT01018680|579998096|FG000|Overall Study|Physician Decision|3|||
160622590|NCT01018680|579998097|FG001|Overall Study|Physician Decision|1|||
160622591|NCT02930889|579998098|FG000|Overall Study|Lost to Follow-up|2|||
160622592|NCT02930889|579998098|FG000|Overall Study|Withdrawal by Subject|6|||
160622593|NCT02930889|579998098|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
160622594|NCT04398030|579998099|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
160622595|NCT04398030|579998100|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
160622596|NCT04398030|579998099|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
160622597|NCT04398030|579998100|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
160622598|NCT01004822|579998101|FG000|Overall Study|Objective progression or relapse|3|||
160622599|NCT01004822|579998102|FG001|Overall Study|Objective progression or relapse|3|||
160622600|NCT01004822|579998103|FG002|Overall Study|Objective progression or relapse|0|||
160512496|NCT01097707|579603420|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
160622601|NCT01004822|579998104|FG003|Overall Study|Objective progression or relapse|1|||
160622602|NCT01004822|579998105|FG004|Overall Study|Objective progression or relapse|2|||
160622603|NCT01004822|579998106|FG005|Overall Study|Objective progression or relapse|2|||
160622604|NCT01004822|579998107|FG006|Overall Study|Objective progression or relapse|1|||
160512497|NCT01097707|579603421|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
160665691|NCT01796171|580157401|FG014|Treatment Period With Betalutin|Physician Decision|0|||
160665692|NCT01796171|580157387|FG000|Treatment Period With Betalutin|Death|0|||
160665693|NCT01796171|580157388|FG001|Treatment Period With Betalutin|Death|0|||
160665694|NCT01796171|580157389|FG002|Treatment Period With Betalutin|Death|0|||
160665695|NCT01796171|580157390|FG003|Treatment Period With Betalutin|Death|0|||
160665696|NCT01796171|580157391|FG004|Treatment Period With Betalutin|Death|0|||
160665697|NCT01796171|580157392|FG005|Treatment Period With Betalutin|Death|0|||
160665698|NCT01796171|580157393|FG006|Treatment Period With Betalutin|Death|0|||
160665699|NCT01796171|580157394|FG007|Treatment Period With Betalutin|Death|0|||
160665700|NCT01796171|580157395|FG008|Treatment Period With Betalutin|Death|0|||
160512498|NCT01097707|579603422|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
160512499|NCT01097707|579603423|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
160512500|NCT01097707|579603419|FG000|Overall Study|Adverse Event|4|||
160512501|NCT01097707|579603420|FG001|Overall Study|Adverse Event|2|||
160512502|NCT01097707|579603421|FG002|Overall Study|Adverse Event|3|||
160512503|NCT01097707|579603422|FG003|Overall Study|Adverse Event|1|||
160512504|NCT01097707|579603423|FG004|Overall Study|Adverse Event|3|||
160512505|NCT01097707|579603419|FG000|Overall Study|Entry Criteria Not Met|2|||
160512506|NCT01097707|579603420|FG001|Overall Study|Entry Criteria Not Met|1|||
160512507|NCT01097707|579603421|FG002|Overall Study|Entry Criteria Not Met|1|||
160512508|NCT01097707|579603422|FG003|Overall Study|Entry Criteria Not Met|0|||
160512509|NCT01097707|579603423|FG004|Overall Study|Entry Criteria Not Met|1|||
160512510|NCT01097707|579603419|FG000|Overall Study|Lack of Efficacy|1|||
160512511|NCT01097707|579603420|FG001|Overall Study|Lack of Efficacy|0|||
160512512|NCT01097707|579603421|FG002|Overall Study|Lack of Efficacy|0|||
160512513|NCT01097707|579603422|FG003|Overall Study|Lack of Efficacy|1|||
160512514|NCT01097707|579603423|FG004|Overall Study|Lack of Efficacy|0|||
160512515|NCT01097707|579603419|FG000|Overall Study|Lost to Follow-up|1|||
160512516|NCT01097707|579603420|FG001|Overall Study|Lost to Follow-up|1|||
160512517|NCT01097707|579603421|FG002|Overall Study|Lost to Follow-up|2|||
160512518|NCT01097707|579603422|FG003|Overall Study|Lost to Follow-up|0|||
160512519|NCT01097707|579603423|FG004|Overall Study|Lost to Follow-up|3|||
160512520|NCT01097707|579603419|FG000|Overall Study|Protocol Violation|2|||
160512521|NCT01097707|579603420|FG001|Overall Study|Protocol Violation|2|||
160512522|NCT01097707|579603421|FG002|Overall Study|Protocol Violation|3|||
160512523|NCT01097707|579603422|FG003|Overall Study|Protocol Violation|2|||
160512524|NCT01097707|579603423|FG004|Overall Study|Protocol Violation|2|||
160512525|NCT01097707|579603419|FG000|Overall Study|Sponsor Decision|31|||
160512526|NCT01097707|579603420|FG001|Overall Study|Sponsor Decision|31|||
160512527|NCT01097707|579603421|FG002|Overall Study|Sponsor Decision|34|||
160512528|NCT01097707|579603422|FG003|Overall Study|Sponsor Decision|35|||
160512529|NCT01097707|579603423|FG004|Overall Study|Sponsor Decision|36|||
160512530|NCT01097707|579603419|FG000|Overall Study|Withdrawal by Subject|3|||
160512531|NCT01097707|579603420|FG001|Overall Study|Withdrawal by Subject|6|||
160512532|NCT01097707|579603421|FG002|Overall Study|Withdrawal by Subject|1|||
160512533|NCT01097707|579603422|FG003|Overall Study|Withdrawal by Subject|4|||
160512534|NCT01097707|579603423|FG004|Overall Study|Withdrawal by Subject|3|||
160512535|NCT01097707|579603419|FG000|Overall Study|Reason unknown|0|||
160512536|NCT01097707|579603420|FG001|Overall Study|Reason unknown|0|||
160512537|NCT01097707|579603421|FG002|Overall Study|Reason unknown|0|||
160512538|NCT01097707|579603422|FG003|Overall Study|Reason unknown|0|||
160512539|NCT01097707|579603423|FG004|Overall Study|Reason unknown|1|||
160512540|NCT03212989|579603424|FG000|Overall Study|Physician Decision|8|||
160512541|NCT03762200|579603435|FG000|Overall Study|Death|2|||
160512542|NCT02489968|579603436|FG000|Open-label Treatment Period|Adverse Event|14|||
160512543|NCT02489968|579603437|FG001|Open-label Treatment Period|Adverse Event|7|||
160512544|NCT02489968|579603438|FG002|Open-label Treatment Period|Adverse Event|0|||
160665701|NCT01796171|580157396|FG009|Treatment Period With Betalutin|Death|0|||
160665702|NCT01796171|580157397|FG010|Treatment Period With Betalutin|Death|2|||
160665703|NCT01796171|580157398|FG011|Treatment Period With Betalutin|Death|0|||
160665704|NCT01796171|580157399|FG012|Treatment Period With Betalutin|Death|0|||
160665705|NCT01796171|580157400|FG013|Treatment Period With Betalutin|Death|0|||
160512545|NCT02489968|579603439|FG003|Open-label Treatment Period|Adverse Event|0|||
160665706|NCT01796171|580157401|FG014|Treatment Period With Betalutin|Death|0|||
160665707|NCT01796171|580157387|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
160665708|NCT01796171|580157388|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
160665709|NCT01796171|580157389|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
160512546|NCT02489968|579603440|FG004|Open-label Treatment Period|Adverse Event|0|||
160512547|NCT02489968|579603441|FG005|Open-label Treatment Period|Adverse Event|0|||
160512548|NCT02489968|579603436|FG000|Open-label Treatment Period|Protocol Violation|2|||
160512549|NCT02489968|579603437|FG001|Open-label Treatment Period|Protocol Violation|2|||
160512550|NCT02489968|579603438|FG002|Open-label Treatment Period|Protocol Violation|0|||
160512551|NCT02489968|579603439|FG003|Open-label Treatment Period|Protocol Violation|0|||
160512552|NCT02489968|579603440|FG004|Open-label Treatment Period|Protocol Violation|0|||
160512553|NCT02489968|579603441|FG005|Open-label Treatment Period|Protocol Violation|0|||
160665710|NCT01796171|580157390|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
160665711|NCT01796171|580157391|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
160665712|NCT01796171|580157392|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
160665713|NCT01796171|580157393|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
160665714|NCT01796171|580157394|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
160665715|NCT01796171|580157395|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
160665716|NCT01796171|580157396|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
160665717|NCT01796171|580157397|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
160665718|NCT01796171|580157398|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
160665719|NCT01796171|580157399|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
160665720|NCT01796171|580157400|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
160665721|NCT01796171|580157401|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
160665722|NCT01796171|580157387|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665723|NCT01796171|580157388|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665724|NCT01796171|580157389|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665725|NCT01796171|580157390|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665726|NCT01796171|580157391|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665727|NCT01796171|580157392|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665728|NCT01796171|580157393|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665729|NCT01796171|580157394|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665730|NCT01796171|580157395|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665731|NCT01796171|580157396|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665732|NCT01796171|580157397|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
160665733|NCT01796171|580157398|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
160665734|NCT01796171|580157399|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665735|NCT01796171|580157400|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665736|NCT01796171|580157401|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160665737|NCT01796171|580157387|FG000|Follow-up Period|Start of further anticancer therapy|4|||
160665738|NCT01796171|580157388|FG001|Follow-up Period|Start of further anticancer therapy|25|||
160665739|NCT01796171|580157389|FG002|Follow-up Period|Start of further anticancer therapy|2|||
160665740|NCT01796171|580157390|FG003|Follow-up Period|Start of further anticancer therapy|1|||
160665741|NCT01796171|580157391|FG004|Follow-up Period|Start of further anticancer therapy|2|||
160665742|NCT01796171|580157392|FG005|Follow-up Period|Start of further anticancer therapy|2|||
160665743|NCT01796171|580157393|FG006|Follow-up Period|Start of further anticancer therapy|1|||
160665744|NCT01796171|580157394|FG007|Follow-up Period|Start of further anticancer therapy|15|||
160665745|NCT01796171|580157395|FG008|Follow-up Period|Start of further anticancer therapy|2|||
160665746|NCT01796171|580157396|FG009|Follow-up Period|Start of further anticancer therapy|0|||
160665747|NCT01796171|580157397|FG010|Follow-up Period|Start of further anticancer therapy|0|||
160665748|NCT01796171|580157398|FG011|Follow-up Period|Start of further anticancer therapy|0|||
160665749|NCT01796171|580157399|FG012|Follow-up Period|Start of further anticancer therapy|0|||
160665750|NCT01796171|580157400|FG013|Follow-up Period|Start of further anticancer therapy|0|||
160665751|NCT01796171|580157401|FG014|Follow-up Period|Start of further anticancer therapy|0|||
160665752|NCT01796171|580157387|FG000|Follow-up Period|Progressive disease|0|||
160665753|NCT01796171|580157388|FG001|Follow-up Period|Progressive disease|1|||
160665754|NCT01796171|580157389|FG002|Follow-up Period|Progressive disease|0|||
160665755|NCT01796171|580157390|FG003|Follow-up Period|Progressive disease|0|||
160665756|NCT01796171|580157391|FG004|Follow-up Period|Progressive disease|0|||
160665757|NCT01796171|580157392|FG005|Follow-up Period|Progressive disease|0|||
160665758|NCT01796171|580157393|FG006|Follow-up Period|Progressive disease|0|||
160665759|NCT01796171|580157394|FG007|Follow-up Period|Progressive disease|3|||
160665760|NCT01796171|580157395|FG008|Follow-up Period|Progressive disease|0|||
160665761|NCT01796171|580157396|FG009|Follow-up Period|Progressive disease|0|||
160512554|NCT02489968|579603436|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
160512555|NCT02489968|579603437|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
160512556|NCT02489968|579603438|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
160512557|NCT02489968|579603439|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
160512558|NCT02489968|579603440|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
160512559|NCT02489968|579603441|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
160512560|NCT02489968|579603436|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
160512561|NCT02489968|579603437|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
160512562|NCT02489968|579603438|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
160512563|NCT02489968|579603439|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
160665762|NCT01796171|580157397|FG010|Follow-up Period|Progressive disease|0|||
160665763|NCT01796171|580157398|FG011|Follow-up Period|Progressive disease|0|||
160512564|NCT02489968|579603440|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
160512565|NCT02489968|579603441|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
160512566|NCT02489968|579603436|FG000|Open-label Treatment Period|Other than specified above|204|||
160665764|NCT01796171|580157399|FG012|Follow-up Period|Progressive disease|0|||
160665765|NCT01796171|580157400|FG013|Follow-up Period|Progressive disease|0|||
160665766|NCT01796171|580157401|FG014|Follow-up Period|Progressive disease|0|||
160512567|NCT02489968|579603437|FG001|Open-label Treatment Period|Other than specified above|189|||
160512568|NCT02489968|579603438|FG002|Open-label Treatment Period|Other than specified above|0|||
160512569|NCT02489968|579603439|FG003|Open-label Treatment Period|Other than specified above|0|||
160665767|NCT01796171|580157387|FG000|Follow-up Period|Physician Decision|0|||
160665768|NCT01796171|580157388|FG001|Follow-up Period|Physician Decision|2|||
160665769|NCT01796171|580157389|FG002|Follow-up Period|Physician Decision|0|||
160512570|NCT02489968|579603440|FG004|Open-label Treatment Period|Other than specified above|0|||
160512571|NCT02489968|579603441|FG005|Open-label Treatment Period|Other than specified above|0|||
160512572|NCT02489968|579603436|FG000|Double-blind Treatment Period|Adverse Event|0|||
160512573|NCT02489968|579603437|FG001|Double-blind Treatment Period|Adverse Event|0|||
160512574|NCT02489968|579603438|FG002|Double-blind Treatment Period|Adverse Event|2|||
160512575|NCT02489968|579603439|FG003|Double-blind Treatment Period|Adverse Event|6|||
160512576|NCT02489968|579603440|FG004|Double-blind Treatment Period|Adverse Event|4|||
160512577|NCT02489968|579603441|FG005|Double-blind Treatment Period|Adverse Event|5|||
160512578|NCT02489968|579603436|FG000|Double-blind Treatment Period|Protocol Violation|0|||
160512579|NCT02489968|579603437|FG001|Double-blind Treatment Period|Protocol Violation|0|||
160512580|NCT02489968|579603438|FG002|Double-blind Treatment Period|Protocol Violation|0|||
160512581|NCT02489968|579603439|FG003|Double-blind Treatment Period|Protocol Violation|0|||
160512582|NCT02489968|579603440|FG004|Double-blind Treatment Period|Protocol Violation|1|||
160512583|NCT02489968|579603441|FG005|Double-blind Treatment Period|Protocol Violation|1|||
160512584|NCT02489968|579603436|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
160512585|NCT02489968|579603437|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
160512586|NCT02489968|579603438|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160512587|NCT02489968|579603439|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
160512588|NCT02489968|579603440|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
160512589|NCT02489968|579603441|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
160512590|NCT02489968|579603436|FG000|Double-blind Treatment Period|Other than specified above|0|||
160512591|NCT02489968|579603437|FG001|Double-blind Treatment Period|Other than specified above|0|||
160512592|NCT02489968|579603438|FG002|Double-blind Treatment Period|Other than specified above|0|||
160512593|NCT02489968|579603439|FG003|Double-blind Treatment Period|Other than specified above|0|||
160512594|NCT02489968|579603440|FG004|Double-blind Treatment Period|Other than specified above|1|||
160512595|NCT02489968|579603441|FG005|Double-blind Treatment Period|Other than specified above|0|||
160512596|NCT03738423|579603442|FG000|Overall Study|Withdrawal by Subject|9|||
160512597|NCT03738423|579603443|FG001|Overall Study|Withdrawal by Subject|12|||
160512598|NCT03738423|579603444|FG002|Overall Study|Withdrawal by Subject|9|||
160512599|NCT03738423|579603445|FG003|Overall Study|Withdrawal by Subject|12|||
160512600|NCT03738423|579603446|FG004|Overall Study|Withdrawal by Subject|10|||
160512601|NCT03738423|579603442|FG000|Overall Study|Lack of Efficacy|3|||
160512602|NCT03738423|579603443|FG001|Overall Study|Lack of Efficacy|1|||
160512603|NCT03738423|579603444|FG002|Overall Study|Lack of Efficacy|1|||
160512604|NCT03738423|579603445|FG003|Overall Study|Lack of Efficacy|1|||
160512605|NCT03738423|579603446|FG004|Overall Study|Lack of Efficacy|2|||
160512606|NCT03738423|579603442|FG000|Overall Study|Lost to Follow-up|1|||
160512607|NCT03738423|579603443|FG001|Overall Study|Lost to Follow-up|0|||
160512608|NCT03738423|579603444|FG002|Overall Study|Lost to Follow-up|1|||
160512609|NCT03738423|579603445|FG003|Overall Study|Lost to Follow-up|1|||
160512610|NCT03738423|579603446|FG004|Overall Study|Lost to Follow-up|0|||
160512611|NCT03738423|579603442|FG000|Overall Study|Protocol Violation|1|||
160512612|NCT03738423|579603443|FG001|Overall Study|Protocol Violation|0|||
160512613|NCT03738423|579603444|FG002|Overall Study|Protocol Violation|0|||
160512614|NCT03738423|579603445|FG003|Overall Study|Protocol Violation|0|||
160512615|NCT03738423|579603446|FG004|Overall Study|Protocol Violation|1|||
160512616|NCT03738423|579603442|FG000|Overall Study|Physician Decision|0|||
160512617|NCT03738423|579603443|FG001|Overall Study|Physician Decision|0|||
160512618|NCT03738423|579603444|FG002|Overall Study|Physician Decision|1|||
160512619|NCT03738423|579603445|FG003|Overall Study|Physician Decision|0|||
160512620|NCT03738423|579603446|FG004|Overall Study|Physician Decision|1|||
160512621|NCT03738423|579603442|FG000|Overall Study|Death|0|||
160512622|NCT03738423|579603443|FG001|Overall Study|Death|0|||
160512623|NCT03738423|579603444|FG002|Overall Study|Death|0|||
160512624|NCT03738423|579603445|FG003|Overall Study|Death|0|||
160512625|NCT03738423|579603446|FG004|Overall Study|Death|1|||
160512626|NCT03738423|579603442|FG000|Overall Study|Randomized but never treated|0|||
160512627|NCT03738423|579603443|FG001|Overall Study|Randomized but never treated|0|||
160512628|NCT03738423|579603444|FG002|Overall Study|Randomized but never treated|1|||
160512629|NCT03738423|579603445|FG003|Overall Study|Randomized but never treated|1|||
160512630|NCT03738423|579603446|FG004|Overall Study|Randomized but never treated|0|||
160512631|NCT01865747|579603448|FG000|Overall Study (ITT)|Adverse Event|32|||
160512632|NCT01865747|579603449|FG001|Overall Study (ITT)|Adverse Event|31|||
160512633|NCT01865747|579603448|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
160512634|NCT01865747|579603449|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
160512635|NCT01865747|579603448|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
160512636|NCT01865747|579603449|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
160665770|NCT01796171|580157390|FG003|Follow-up Period|Physician Decision|0|||
160512637|NCT01865747|579603448|FG000|Overall Study (ITT)|Protocol Violation|1|||
160512638|NCT01865747|579603449|FG001|Overall Study (ITT)|Protocol Violation|1|||
160512639|NCT01865747|579603448|FG000|Overall Study (ITT)|Physician Decision|5|||
160512640|NCT01865747|579603449|FG001|Overall Study (ITT)|Physician Decision|2|||
160512641|NCT01865747|579603448|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
160512642|NCT01865747|579603449|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
160512643|NCT01865747|579603448|FG000|Overall Study (ITT)|Sponsor Decision|0|||
160665771|NCT01796171|580157391|FG004|Follow-up Period|Physician Decision|0|||
160665772|NCT01796171|580157392|FG005|Follow-up Period|Physician Decision|0|||
160665773|NCT01796171|580157393|FG006|Follow-up Period|Physician Decision|0|||
160665774|NCT01796171|580157394|FG007|Follow-up Period|Physician Decision|0|||
160665775|NCT01796171|580157395|FG008|Follow-up Period|Physician Decision|0|||
160665776|NCT01796171|580157396|FG009|Follow-up Period|Physician Decision|0|||
160512644|NCT01865747|579603449|FG001|Overall Study (ITT)|Sponsor Decision|1|||
160512645|NCT01865747|579603448|FG000|Overall Study (ITT)|Progressive Disease|122|||
160512646|NCT01865747|579603449|FG001|Overall Study (ITT)|Progressive Disease|158|||
160512647|NCT01865747|579603448|FG000|Overall Study (ITT)|Reason Not Provided|0|||
160512648|NCT01865747|579603449|FG001|Overall Study (ITT)|Reason Not Provided|1|||
160512649|NCT01865747|579603448|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
160512650|NCT01865747|579603449|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
160512651|NCT01865747|579603448|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
160512652|NCT01865747|579603449|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
160512653|NCT01865747|579603448|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
160512654|NCT01865747|579603449|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
160512655|NCT01865747|579603448|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
160512656|NCT01865747|579603449|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
160512657|NCT01865747|579603448|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
160512658|NCT01865747|579603449|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
160512659|NCT01865747|579603448|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
160512660|NCT01865747|579603449|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
160512661|NCT01865747|579603448|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
160512662|NCT01865747|579603449|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
160512663|NCT01865747|579603448|FG000|Primary Intent to Treat (PITT)|Other|0|||
160512664|NCT01865747|579603449|FG001|Primary Intent to Treat (PITT)|Other|1|||
160512665|NCT00611975|579603452|FG000|Overall Study|Withdrawal by Subject|3|||
160512666|NCT00611975|579603453|FG001|Overall Study|Withdrawal by Subject|7|||
160512667|NCT00611975|579603452|FG000|Overall Study|Pregnancy|2|||
160512668|NCT00611975|579603453|FG001|Overall Study|Pregnancy|1|||
160512669|NCT04625413|579603454|FG000|Overall Study|Hospice|2|||
160512670|NCT04625413|579603454|FG000|Overall Study|Distress|1|||
160512671|NCT04625413|579603454|FG000|Overall Study|Not feeling well|1|||
160512672|NCT05618912|579603455|FG000|Overall Study|Lost to Follow-up|14|||
160512673|NCT05618912|579603456|FG001|Overall Study|Lost to Follow-up|19|||
160512674|NCT01342341|579605125|FG000|Overall Study|Lost to Follow-up|4|||
160512675|NCT01342341|579605126|FG001|Overall Study|Lost to Follow-up|4|||
160512676|NCT00266227|579605127|FG000|Initial Treatment|Adverse Event|0|||
160512677|NCT00266227|579605128|FG001|Initial Treatment|Adverse Event|0|||
160512678|NCT00266227|579605129|FG002|Initial Treatment|Adverse Event|13|||
160512679|NCT00266227|579605127|FG000|Initial Treatment|Lost to Follow-up|0|||
160512680|NCT00266227|579605128|FG001|Initial Treatment|Lost to Follow-up|0|||
160512681|NCT00266227|579605129|FG002|Initial Treatment|Lost to Follow-up|6|||
160512682|NCT00266227|579605127|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
160512683|NCT00266227|579605128|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
160512684|NCT00266227|579605129|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
160512685|NCT00266227|579605127|FG000|Initial Treatment|Physician decision to withdraw|0|||
160512686|NCT00266227|579605128|FG001|Initial Treatment|Physician decision to withdraw|0|||
160512687|NCT00266227|579605129|FG002|Initial Treatment|Physician decision to withdraw|12|||
160512688|NCT00266227|579605127|FG000|Initial Treatment|Pregnancy|0|||
160512689|NCT00266227|579605128|FG001|Initial Treatment|Pregnancy|0|||
160512690|NCT00266227|579605129|FG002|Initial Treatment|Pregnancy|1|||
160512691|NCT00266227|579605127|FG000|Retreatment: Up to Week 48|Death|1|||
160512692|NCT00266227|579605128|FG001|Retreatment: Up to Week 48|Death|0|||
160512693|NCT00266227|579605129|FG002|Retreatment: Up to Week 48|Death|0|||
160512694|NCT00266227|579605127|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
160512695|NCT00266227|579605128|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
160512696|NCT00266227|579605129|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
160512697|NCT00266227|579605127|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
160512698|NCT00266227|579605128|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
160512699|NCT00266227|579605129|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
160512700|NCT00266227|579605127|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
160512701|NCT00266227|579605128|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
160512702|NCT00266227|579605129|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
160512703|NCT00266227|579605127|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
160665777|NCT01796171|580157397|FG010|Follow-up Period|Physician Decision|5|||
160665778|NCT01796171|580157398|FG011|Follow-up Period|Physician Decision|0|||
160665779|NCT01796171|580157399|FG012|Follow-up Period|Physician Decision|0|||
160665780|NCT01796171|580157400|FG013|Follow-up Period|Physician Decision|0|||
160665781|NCT01796171|580157401|FG014|Follow-up Period|Physician Decision|0|||
160665782|NCT01796171|580157387|FG000|Follow-up Period|Withdrawal by Subject|0|||
160665783|NCT01796171|580157388|FG001|Follow-up Period|Withdrawal by Subject|1|||
160665784|NCT01796171|580157389|FG002|Follow-up Period|Withdrawal by Subject|0|||
160665785|NCT01796171|580157390|FG003|Follow-up Period|Withdrawal by Subject|0|||
160665786|NCT01796171|580157391|FG004|Follow-up Period|Withdrawal by Subject|0|||
160665787|NCT01796171|580157392|FG005|Follow-up Period|Withdrawal by Subject|1|||
160665788|NCT01796171|580157393|FG006|Follow-up Period|Withdrawal by Subject|0|||
160665789|NCT01796171|580157394|FG007|Follow-up Period|Withdrawal by Subject|0|||
160665790|NCT01796171|580157395|FG008|Follow-up Period|Withdrawal by Subject|0|||
160665791|NCT01796171|580157396|FG009|Follow-up Period|Withdrawal by Subject|0|||
160665792|NCT01796171|580157397|FG010|Follow-up Period|Withdrawal by Subject|3|||
160665793|NCT01796171|580157398|FG011|Follow-up Period|Withdrawal by Subject|1|||
160665794|NCT01796171|580157399|FG012|Follow-up Period|Withdrawal by Subject|0|||
160665795|NCT01796171|580157400|FG013|Follow-up Period|Withdrawal by Subject|0|||
160665796|NCT01796171|580157401|FG014|Follow-up Period|Withdrawal by Subject|0|||
160665797|NCT01796171|580157387|FG000|Follow-up Period|Death|0|||
160665798|NCT01796171|580157388|FG001|Follow-up Period|Death|0|||
160665799|NCT01796171|580157389|FG002|Follow-up Period|Death|0|||
160665800|NCT01796171|580157390|FG003|Follow-up Period|Death|0|||
160665801|NCT01796171|580157391|FG004|Follow-up Period|Death|0|||
160665802|NCT01796171|580157392|FG005|Follow-up Period|Death|0|||
160665803|NCT01796171|580157393|FG006|Follow-up Period|Death|1|||
160665804|NCT01796171|580157394|FG007|Follow-up Period|Death|0|||
160665805|NCT01796171|580157395|FG008|Follow-up Period|Death|0|||
160665806|NCT01796171|580157396|FG009|Follow-up Period|Death|0|||
160665807|NCT01796171|580157397|FG010|Follow-up Period|Death|17|||
160665808|NCT01796171|580157398|FG011|Follow-up Period|Death|9|||
160665809|NCT01796171|580157399|FG012|Follow-up Period|Death|1|||
160665810|NCT01796171|580157400|FG013|Follow-up Period|Death|0|||
160512704|NCT00266227|579605128|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
160512705|NCT00266227|579605129|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
160512706|NCT00266227|579605127|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
160512707|NCT00266227|579605128|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
160512708|NCT00266227|579605129|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
160512709|NCT00266227|579605127|FG000|Retreatment: Week 48 to Week 72|Death|1|||
160512710|NCT00266227|579605128|FG001|Retreatment: Week 48 to Week 72|Death|1|||
160512711|NCT00266227|579605129|FG002|Retreatment: Week 48 to Week 72|Death|0|||
160512712|NCT00266227|579605127|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
160512713|NCT00266227|579605128|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
160512714|NCT00266227|579605129|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
160512715|NCT00266227|579605127|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
160512716|NCT00266227|579605128|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
160512717|NCT00266227|579605129|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
160512718|NCT00266227|579605127|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
160512719|NCT00266227|579605128|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
160512720|NCT00266227|579605129|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
160512721|NCT00266227|579605127|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
160512722|NCT00266227|579605128|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
160512723|NCT00266227|579605129|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
160512724|NCT02680002|579605131|FG000|Overall Study|Lost to Follow-up|5|||
160512725|NCT02680002|579605132|FG001|Overall Study|Lost to Follow-up|1|||
160512726|NCT02680002|579605133|FG002|Overall Study|Lost to Follow-up|4|||
160512727|NCT02680002|579605134|FG003|Overall Study|Lost to Follow-up|2|||
160512728|NCT02680002|579605135|FG004|Overall Study|Lost to Follow-up|0|||
160512729|NCT02680002|579605136|FG005|Overall Study|Lost to Follow-up|2|||
160512730|NCT02680002|579605131|FG000|Overall Study|Physician Decision|5|||
160512731|NCT02680002|579605132|FG001|Overall Study|Physician Decision|1|||
160512732|NCT02680002|579605133|FG002|Overall Study|Physician Decision|1|||
160512733|NCT02680002|579605134|FG003|Overall Study|Physician Decision|1|||
160512734|NCT02680002|579605135|FG004|Overall Study|Physician Decision|1|||
160622605|NCT01004822|579998108|FG007|Overall Study|Objective progression or relapse|4|||
160622606|NCT01004822|579998101|FG000|Overall Study|Global deterioration of health status|0|||
160622607|NCT01004822|579998102|FG001|Overall Study|Global deterioration of health status|0|||
160622608|NCT01004822|579998103|FG002|Overall Study|Global deterioration of health status|0|||
160622609|NCT01004822|579998104|FG003|Overall Study|Global deterioration of health status|1|||
160622610|NCT01004822|579998105|FG004|Overall Study|Global deterioration of health status|0|||
160622611|NCT01004822|579998106|FG005|Overall Study|Global deterioration of health status|0|||
160622612|NCT01004822|579998107|FG006|Overall Study|Global deterioration of health status|1|||
160622613|NCT01004822|579998108|FG007|Overall Study|Global deterioration of health status|0|||
160622614|NCT01004822|579998101|FG000|Overall Study|No longer willing to continue|0|||
160622615|NCT01004822|579998102|FG001|Overall Study|No longer willing to continue|0|||
160622616|NCT01004822|579998103|FG002|Overall Study|No longer willing to continue|0|||
160622617|NCT01004822|579998104|FG003|Overall Study|No longer willing to continue|1|||
160622618|NCT01004822|579998105|FG004|Overall Study|No longer willing to continue|2|||
160622619|NCT01004822|579998106|FG005|Overall Study|No longer willing to continue|1|||
160622620|NCT01004822|579998107|FG006|Overall Study|No longer willing to continue|1|||
160622621|NCT01004822|579998108|FG007|Overall Study|No longer willing to continue|0|||
160622622|NCT01004822|579998101|FG000|Overall Study|Adverse Event|0|||
160622623|NCT01004822|579998102|FG001|Overall Study|Adverse Event|0|||
160622624|NCT01004822|579998103|FG002|Overall Study|Adverse Event|0|||
160622625|NCT01004822|579998104|FG003|Overall Study|Adverse Event|0|||
160622626|NCT01004822|579998105|FG004|Overall Study|Adverse Event|0|||
160622627|NCT01004822|579998106|FG005|Overall Study|Adverse Event|0|||
160622628|NCT01004822|579998107|FG006|Overall Study|Adverse Event|1|||
160622629|NCT01004822|579998108|FG007|Overall Study|Adverse Event|1|||
160622630|NCT01004822|579998101|FG000|Overall Study|Other|0|||
160622631|NCT01004822|579998102|FG001|Overall Study|Other|0|||
160622632|NCT01004822|579998103|FG002|Overall Study|Other|4|||
160622633|NCT01004822|579998104|FG003|Overall Study|Other|1|||
160622634|NCT01004822|579998105|FG004|Overall Study|Other|0|||
160622635|NCT01004822|579998106|FG005|Overall Study|Other|1|||
160622636|NCT01004822|579998107|FG006|Overall Study|Other|0|||
160622637|NCT01004822|579998108|FG007|Overall Study|Other|0|||
160622638|NCT03159455|579998111|FG000|Overall Study|Adverse Event|0|||
160622639|NCT03159455|579998112|FG001|Overall Study|Adverse Event|0|||
160622640|NCT03159455|579998113|FG002|Overall Study|Adverse Event|0|||
160622641|NCT03159455|579998114|FG003|Overall Study|Adverse Event|0|||
160622642|NCT03159455|579998115|FG004|Overall Study|Adverse Event|0|||
160622643|NCT03159455|579998116|FG005|Overall Study|Adverse Event|1|||
160622644|NCT05056311|579998117|FG000|Overall Study|Lost to Follow-up|14|||
160622645|NCT05056311|579998117|FG000|Overall Study|Withdrawal by Subject|1|||
160622646|NCT05056311|579998117|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
160622647|NCT03799198|579998123|FG000|Overall Study|Lost to Follow-up|4|||
160622648|NCT03799198|579998124|FG001|Overall Study|Lost to Follow-up|8|||
160622649|NCT03799198|579998123|FG000|Overall Study|Death|0|||
160622650|NCT03799198|579998124|FG001|Overall Study|Death|1|||
160622651|NCT00960869|579998126|FG000|Overall Study|Adverse Event|17|||
160622652|NCT00960869|579998127|FG001|Overall Study|Adverse Event|26|||
160622653|NCT00960869|579998126|FG000|Overall Study|Withdrawal by Subject|16|||
160622654|NCT00960869|579998127|FG001|Overall Study|Withdrawal by Subject|14|||
160622655|NCT00960869|579998126|FG000|Overall Study|Lost to Follow-up|1|||
160622656|NCT00960869|579998127|FG001|Overall Study|Lost to Follow-up|4|||
160622657|NCT00960869|579998126|FG000|Overall Study|Misc|19|||
160622658|NCT00960869|579998127|FG001|Overall Study|Misc|18|||
160622659|NCT02501642|579998128|FG000|Overall Study|Lost to Follow-up|7|||
160622660|NCT02501642|579998129|FG001|Overall Study|Lost to Follow-up|11|||
160622661|NCT00679042|579998140|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
160622662|NCT00679042|579998140|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
160622663|NCT00679042|579998140|FG000|5-Year Follow Up|Death|1|||
160622664|NCT00679042|579998140|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
160622665|NCT00679042|579998140|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
160622666|NCT00379639|579998141|FG000|Overall Study|Disease Progression|3|||
160622667|NCT00379639|579998142|FG001|Overall Study|Disease Progression|3|||
160665811|NCT01796171|580157401|FG014|Follow-up Period|Death|0|||
160512735|NCT02680002|579605136|FG005|Overall Study|Physician Decision|1|||
160512736|NCT02680002|579605131|FG000|Overall Study|Protocol Violation|1|||
160512737|NCT02680002|579605132|FG001|Overall Study|Protocol Violation|0|||
160512738|NCT02680002|579605133|FG002|Overall Study|Protocol Violation|1|||
160512739|NCT02680002|579605134|FG003|Overall Study|Protocol Violation|0|||
160512740|NCT02680002|579605135|FG004|Overall Study|Protocol Violation|1|||
160512741|NCT02680002|579605136|FG005|Overall Study|Protocol Violation|2|||
160512742|NCT02680002|579605131|FG000|Overall Study|Withdrawal by Subject|0|||
160512743|NCT02680002|579605132|FG001|Overall Study|Withdrawal by Subject|0|||
160512744|NCT02680002|579605133|FG002|Overall Study|Withdrawal by Subject|1|||
160512745|NCT02680002|579605134|FG003|Overall Study|Withdrawal by Subject|0|||
160512746|NCT02680002|579605135|FG004|Overall Study|Withdrawal by Subject|2|||
160512747|NCT02680002|579605136|FG005|Overall Study|Withdrawal by Subject|2|||
160512748|NCT02680002|579605131|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
160512749|NCT02680002|579605132|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
160512750|NCT02680002|579605133|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
160512751|NCT02680002|579605134|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
160512752|NCT02680002|579605135|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
160512753|NCT02680002|579605136|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
160512754|NCT02680002|579605131|FG000|Overall Study|Other|0|||
160512755|NCT02680002|579605132|FG001|Overall Study|Other|1|||
160512756|NCT02680002|579605133|FG002|Overall Study|Other|0|||
160512757|NCT02680002|579605134|FG003|Overall Study|Other|0|||
160512758|NCT02680002|579605135|FG004|Overall Study|Other|1|||
160512759|NCT02680002|579605136|FG005|Overall Study|Other|0|||
160512760|NCT02680002|579605131|FG000|Overall Study|Adverse Event|0|||
160512761|NCT02680002|579605132|FG001|Overall Study|Adverse Event|0|||
160512762|NCT02680002|579605133|FG002|Overall Study|Adverse Event|0|||
160512763|NCT02680002|579605134|FG003|Overall Study|Adverse Event|0|||
160512764|NCT02680002|579605135|FG004|Overall Study|Adverse Event|1|||
160512765|NCT02680002|579605136|FG005|Overall Study|Adverse Event|2|||
160512766|NCT04097301|579605139|FG000|Overall Study|Death|1|||
160512767|NCT04097301|579605139|FG000|Overall Study|Withdrawal by Subject|1|||
160512768|NCT04097301|579605139|FG000|Overall Study|Screening Failure|5|||
160512769|NCT01403610|579605143|FG000|Overall Study|Withdrawal by Subject|2|||
160512770|NCT01403610|579605144|FG001|Overall Study|Withdrawal by Subject|0|||
160512771|NCT01403610|579605145|FG002|Overall Study|Withdrawal by Subject|0|||
160512772|NCT01403610|579605146|FG003|Overall Study|Withdrawal by Subject|0|||
160512773|NCT01403610|579605143|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
160512774|NCT01403610|579605144|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
160512775|NCT01403610|579605145|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
160512776|NCT01403610|579605146|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
160512777|NCT00901186|579605147|FG000|Overall Study|Lack of Efficacy|0|||
160512778|NCT00901186|579605148|FG001|Overall Study|Lack of Efficacy|1|||
160512779|NCT00901186|579605147|FG000|Overall Study|Abnormal laboratory values|0|||
160512780|NCT00901186|579605148|FG001|Overall Study|Abnormal laboratory values|1|||
160512781|NCT00901186|579605147|FG000|Overall Study|Lost to Follow-up|2|||
160512782|NCT00901186|579605148|FG001|Overall Study|Lost to Follow-up|0|||
160512783|NCT00901186|579605147|FG000|Overall Study|Adverse Event|2|||
160512784|NCT00901186|579605148|FG001|Overall Study|Adverse Event|4|||
160512785|NCT00901186|579605147|FG000|Overall Study|Administration problems|0|||
160512786|NCT00901186|579605148|FG001|Overall Study|Administration problems|1|||
160512787|NCT00901186|579605147|FG000|Overall Study|Protocol deviations|5|||
160512788|NCT00901186|579605148|FG001|Overall Study|Protocol deviations|4|||
160512789|NCT02383056|579605149|FG000|Overall Study|Adverse Event|1|||
160512790|NCT02383056|579605150|FG001|Overall Study|Adverse Event|0|||
160512791|NCT02383056|579605149|FG000|Overall Study|Lost to Follow-up|0|||
160512792|NCT02383056|579605150|FG001|Overall Study|Lost to Follow-up|2|||
160512793|NCT01775475|579605151|FG000|Overall Study|Death|3|||
160512794|NCT01775475|579605152|FG001|Overall Study|Death|3|||
160512795|NCT02074553|579605156|FG000|Intervention Period 1|Family Emergency|0|||
160512796|NCT02074553|579605157|FG001|Intervention Period 1|Family Emergency|0|||
160512797|NCT02074553|579605158|FG002|Intervention Period 1|Family Emergency|0|||
160512798|NCT02074553|579605159|FG003|Intervention Period 1|Family Emergency|1|||
160512799|NCT02074553|579605160|FG004|Intervention Period 1|Family Emergency|0|||
160512800|NCT02074553|579605161|FG005|Intervention Period 1|Family Emergency|0|||
160512801|NCT02074553|579605162|FG006|Intervention Period 1|Family Emergency|0|||
160512802|NCT02074553|579605163|FG007|Intervention Period 1|Family Emergency|0|||
160512803|NCT02074553|579605156|FG000|Washout Period 1|Adverse Event|1|||
160512804|NCT02074553|579605157|FG001|Washout Period 1|Adverse Event|0|||
160512805|NCT02074553|579605158|FG002|Washout Period 1|Adverse Event|0|||
160512806|NCT02074553|579605159|FG003|Washout Period 1|Adverse Event|0|||
160512807|NCT02074553|579605160|FG004|Washout Period 1|Adverse Event|0|||
160512808|NCT02074553|579605161|FG005|Washout Period 1|Adverse Event|0|||
160512809|NCT02074553|579605162|FG006|Washout Period 1|Adverse Event|0|||
160512810|NCT02074553|579605163|FG007|Washout Period 1|Adverse Event|0|||
160512811|NCT02074553|579605156|FG000|Washout Period 1|Physician Decision|0|||
160512812|NCT02074553|579605157|FG001|Washout Period 1|Physician Decision|0|||
160512813|NCT02074553|579605158|FG002|Washout Period 1|Physician Decision|0|||
160512814|NCT02074553|579605159|FG003|Washout Period 1|Physician Decision|1|||
160512815|NCT02074553|579605160|FG004|Washout Period 1|Physician Decision|0|||
160512816|NCT02074553|579605161|FG005|Washout Period 1|Physician Decision|0|||
160512817|NCT02074553|579605162|FG006|Washout Period 1|Physician Decision|0|||
160512818|NCT02074553|579605163|FG007|Washout Period 1|Physician Decision|0|||
160512819|NCT02074553|579605156|FG000|Washout Period 1|Other|0|||
160512820|NCT02074553|579605157|FG001|Washout Period 1|Other|0|||
160512821|NCT02074553|579605158|FG002|Washout Period 1|Other|0|||
160512822|NCT02074553|579605159|FG003|Washout Period 1|Other|0|||
160512823|NCT02074553|579605160|FG004|Washout Period 1|Other|0|||
160512824|NCT02074553|579605161|FG005|Washout Period 1|Other|1|||
160512825|NCT02074553|579605162|FG006|Washout Period 1|Other|0|||
160512826|NCT02074553|579605163|FG007|Washout Period 1|Other|0|||
160512827|NCT02074553|579605156|FG000|Washout Period 2|Adverse Event|0|||
160512828|NCT02074553|579605157|FG001|Washout Period 2|Adverse Event|0|||
160512829|NCT02074553|579605158|FG002|Washout Period 2|Adverse Event|0|||
160512830|NCT02074553|579605159|FG003|Washout Period 2|Adverse Event|0|||
160512831|NCT02074553|579605160|FG004|Washout Period 2|Adverse Event|0|||
160512832|NCT02074553|579605161|FG005|Washout Period 2|Adverse Event|0|||
160512833|NCT02074553|579605162|FG006|Washout Period 2|Adverse Event|1|||
160512834|NCT02074553|579605163|FG007|Washout Period 2|Adverse Event|0|||
160512835|NCT02074553|579605156|FG000|Washout Period 2|Physician Decision|0|||
160512836|NCT02074553|579605157|FG001|Washout Period 2|Physician Decision|0|||
160512837|NCT02074553|579605158|FG002|Washout Period 2|Physician Decision|0|||
160512838|NCT02074553|579605159|FG003|Washout Period 2|Physician Decision|0|||
160512839|NCT02074553|579605160|FG004|Washout Period 2|Physician Decision|0|||
160512840|NCT02074553|579605161|FG005|Washout Period 2|Physician Decision|1|||
160512841|NCT02074553|579605162|FG006|Washout Period 2|Physician Decision|0|||
160512842|NCT02074553|579605163|FG007|Washout Period 2|Physician Decision|0|||
160512843|NCT02074553|579605156|FG000|Washout Period 2|Lost to Follow-up|0|||
160512844|NCT02074553|579605157|FG001|Washout Period 2|Lost to Follow-up|0|||
160512845|NCT02074553|579605158|FG002|Washout Period 2|Lost to Follow-up|1|||
160512846|NCT02074553|579605159|FG003|Washout Period 2|Lost to Follow-up|0|||
160512847|NCT02074553|579605160|FG004|Washout Period 2|Lost to Follow-up|0|||
160512848|NCT02074553|579605161|FG005|Washout Period 2|Lost to Follow-up|0|||
160512849|NCT02074553|579605162|FG006|Washout Period 2|Lost to Follow-up|0|||
160512850|NCT02074553|579605163|FG007|Washout Period 2|Lost to Follow-up|0|||
160512851|NCT02074553|579605156|FG000|Washout Period 3|Physician Decision|0|||
160512852|NCT02074553|579605157|FG001|Washout Period 3|Physician Decision|0|||
160512853|NCT02074553|579605158|FG002|Washout Period 3|Physician Decision|0|||
160512854|NCT02074553|579605159|FG003|Washout Period 3|Physician Decision|0|||
160512855|NCT02074553|579605160|FG004|Washout Period 3|Physician Decision|0|||
160512856|NCT02074553|579605161|FG005|Washout Period 3|Physician Decision|0|||
160512857|NCT02074553|579605162|FG006|Washout Period 3|Physician Decision|0|||
160512858|NCT02074553|579605163|FG007|Washout Period 3|Physician Decision|1|||
160512859|NCT02342743|579605164|FG000|Baseline Period|Withdrawal by Subject|3|||
160512860|NCT02342743|579605164|FG000|Baseline Period|Lost to Follow-up|2|||
160512861|NCT02342743|579605164|FG000|Baseline Period|Change in prophylactic medication|3|||
160512862|NCT02342743|579605164|FG000|Baseline Period|Screening failure regarding baseline|7|||
160512863|NCT02342743|579605164|FG000|Treatment Period|Withdrawal by Subject|2|||
160512864|NCT02342743|579605164|FG000|Treatment Period|Lost to Follow-up|8|||
160512865|NCT02342743|579605164|FG000|Treatment Period|Change in prophylactic medication|1|||
160512866|NCT00686725|579605165|FG000|Overall Study|Adverse Event|1|||
160512867|NCT00686725|579605166|FG001|Overall Study|Adverse Event|1|||
160512868|NCT00686725|579605165|FG000|Overall Study|Progressive Disease|17|||
160512869|NCT00686725|579605166|FG001|Overall Study|Progressive Disease|23|||
160512870|NCT00686725|579605165|FG000|Overall Study|Lost to Follow-up|7|||
160512871|NCT00686725|579605166|FG001|Overall Study|Lost to Follow-up|5|||
160512872|NCT00686725|579605165|FG000|Overall Study|Death|6|||
160512873|NCT00686725|579605166|FG001|Overall Study|Death|3|||
160512874|NCT00686725|579605165|FG000|Overall Study|Withdrawal by Subject|13|||
160512875|NCT00686725|579605166|FG001|Overall Study|Withdrawal by Subject|4|||
160512876|NCT00686725|579605165|FG000|Overall Study|Protocol Violation|1|||
160512877|NCT00686725|579605166|FG001|Overall Study|Protocol Violation|3|||
160512878|NCT00686725|579605165|FG000|Overall Study|Other|1|||
160512879|NCT00686725|579605166|FG001|Overall Study|Other|3|||
160512880|NCT03602066|579605167|FG000|Overall Study|Withdrawal by Subject|2|||
160512881|NCT03602066|579605168|FG001|Overall Study|Withdrawal by Subject|0|||
160512882|NCT03602066|579605167|FG000|Overall Study|Physician Decision|1|||
160512883|NCT03602066|579605168|FG001|Overall Study|Physician Decision|0|||
160512884|NCT00092495|579605169|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
160512885|NCT00092495|579605170|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
160512886|NCT00092495|579605171|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
160512887|NCT00092495|579605172|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
160512888|NCT00092495|579605173|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
160512889|NCT00092495|579605169|FG000|Base Study Vaccination Period|Extended|0|||
160512890|NCT00092495|579605170|FG001|Base Study Vaccination Period|Extended|0|||
160512891|NCT00092495|579605171|FG002|Base Study Vaccination Period|Extended|0|||
160512892|NCT00092495|579605172|FG003|Base Study Vaccination Period|Extended|1|||
160512893|NCT00092495|579605173|FG004|Base Study Vaccination Period|Extended|0|||
160512894|NCT00092495|579605169|FG000|Base Study Vaccination Period|*Clinical AE|1|||
160512895|NCT00092495|579605170|FG001|Base Study Vaccination Period|*Clinical AE|0|||
160512896|NCT00092495|579605171|FG002|Base Study Vaccination Period|*Clinical AE|1|||
160512897|NCT00092495|579605172|FG003|Base Study Vaccination Period|*Clinical AE|2|||
160512898|NCT00092495|579605173|FG004|Base Study Vaccination Period|*Clinical AE|0|||
160512899|NCT00092495|579605169|FG000|Base Study Vaccination Period|*Other reasons|1|||
160512900|NCT00092495|579605170|FG001|Base Study Vaccination Period|*Other reasons|0|||
160512901|NCT00092495|579605171|FG002|Base Study Vaccination Period|*Other reasons|0|||
160512902|NCT00092495|579605172|FG003|Base Study Vaccination Period|*Other reasons|1|||
160512903|NCT00092495|579605173|FG004|Base Study Vaccination Period|*Other reasons|0|||
160512904|NCT00092495|579605169|FG000|Base Study Vaccination Period|*Pregnancy|0|||
160512905|NCT00092495|579605170|FG001|Base Study Vaccination Period|*Pregnancy|2|||
160512906|NCT00092495|579605171|FG002|Base Study Vaccination Period|*Pregnancy|5|||
160512907|NCT00092495|579605172|FG003|Base Study Vaccination Period|*Pregnancy|7|||
160512908|NCT00092495|579605173|FG004|Base Study Vaccination Period|*Pregnancy|0|||
160512909|NCT00092495|579605169|FG000|Base Study Vaccination Period|Adverse Event|1|||
160512910|NCT00092495|579605170|FG001|Base Study Vaccination Period|Adverse Event|0|||
160512911|NCT00092495|579605171|FG002|Base Study Vaccination Period|Adverse Event|0|||
160512912|NCT00092495|579605172|FG003|Base Study Vaccination Period|Adverse Event|3|||
160512913|NCT00092495|579605173|FG004|Base Study Vaccination Period|Adverse Event|0|||
160512914|NCT00092495|579605169|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
160512915|NCT00092495|579605170|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
160512916|NCT00092495|579605171|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
160512917|NCT00092495|579605172|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
160512918|NCT00092495|579605173|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
160512919|NCT00092495|579605169|FG000|Base Study Vaccination Period|Moved|3|||
160512920|NCT00092495|579605170|FG001|Base Study Vaccination Period|Moved|1|||
160512921|NCT00092495|579605171|FG002|Base Study Vaccination Period|Moved|2|||
160622668|NCT00379639|579998143|FG002|Overall Study|Disease Progression|3|||
160622669|NCT00379639|579998144|FG003|Overall Study|Disease Progression|4|||
160622670|NCT00379639|579998145|FG004|Overall Study|Disease Progression|4|||
160622671|NCT00379639|579998141|FG000|Overall Study|Physician Decision|0|||
160622672|NCT00379639|579998142|FG001|Overall Study|Physician Decision|2|||
160622673|NCT00379639|579998143|FG002|Overall Study|Physician Decision|1|||
160622674|NCT00379639|579998144|FG003|Overall Study|Physician Decision|1|||
160622675|NCT00379639|579998145|FG004|Overall Study|Physician Decision|0|||
160622676|NCT00379639|579998141|FG000|Overall Study|Symptomatic Deterioration|0|||
160622677|NCT00379639|579998142|FG001|Overall Study|Symptomatic Deterioration|0|||
160622678|NCT00379639|579998143|FG002|Overall Study|Symptomatic Deterioration|1|||
160622679|NCT00379639|579998144|FG003|Overall Study|Symptomatic Deterioration|0|||
160622680|NCT00379639|579998145|FG004|Overall Study|Symptomatic Deterioration|1|||
160622681|NCT00379639|579998141|FG000|Overall Study|Adverse Event|0|||
160622682|NCT00379639|579998142|FG001|Overall Study|Adverse Event|0|||
160622683|NCT00379639|579998143|FG002|Overall Study|Adverse Event|1|||
160622684|NCT00379639|579998144|FG003|Overall Study|Adverse Event|0|||
160622685|NCT00379639|579998145|FG004|Overall Study|Adverse Event|1|||
160622686|NCT00379639|579998141|FG000|Overall Study|Lost to Follow-up|0|||
160622687|NCT00379639|579998142|FG001|Overall Study|Lost to Follow-up|0|||
160622688|NCT00379639|579998143|FG002|Overall Study|Lost to Follow-up|0|||
160622689|NCT00379639|579998144|FG003|Overall Study|Lost to Follow-up|1|||
160622690|NCT00379639|579998145|FG004|Overall Study|Lost to Follow-up|0|||
160622691|NCT00379639|579998141|FG000|Overall Study|Other|0|||
160665812|NCT01796171|580157387|FG000|Follow-up Period|Patient transferred to other hospital|0|||
160665813|NCT01796171|580157388|FG001|Follow-up Period|Patient transferred to other hospital|1|||
160665814|NCT01796171|580157389|FG002|Follow-up Period|Patient transferred to other hospital|0|||
160512922|NCT00092495|579605172|FG003|Base Study Vaccination Period|Moved|2|||
160512923|NCT00092495|579605173|FG004|Base Study Vaccination Period|Moved|0|||
160512924|NCT00092495|579605169|FG000|Base Study Vaccination Period|Other|1|||
160512925|NCT00092495|579605170|FG001|Base Study Vaccination Period|Other|1|||
160622692|NCT00379639|579998142|FG001|Overall Study|Other|0|||
160622693|NCT00379639|579998143|FG002|Overall Study|Other|3|||
160622694|NCT00379639|579998144|FG003|Overall Study|Other|0|||
160622695|NCT00379639|579998145|FG004|Overall Study|Other|0|||
160622696|NCT01590628|579998160|FG000|Overall Study|Death|2|||
160622697|NCT01590628|579998161|FG001|Overall Study|Death|0|||
160622698|NCT00761735|579998162|FG000|Overall Study|Lost to Follow-up|6|||
160622699|NCT00761735|579998162|FG000|Overall Study|Withdrawal by Subject|6|||
160665815|NCT01796171|580157390|FG003|Follow-up Period|Patient transferred to other hospital|0|||
160622700|NCT00761735|579998162|FG000|Overall Study|Non-compliance with protocol|1|||
160622701|NCT00761735|579998162|FG000|Overall Study|Administrative|1|||
160622702|NCT03764813|579998163|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
160665816|NCT01796171|580157391|FG004|Follow-up Period|Patient transferred to other hospital|0|||
160665817|NCT01796171|580157392|FG005|Follow-up Period|Patient transferred to other hospital|0|||
160665818|NCT01796171|580157393|FG006|Follow-up Period|Patient transferred to other hospital|0|||
160665819|NCT01796171|580157394|FG007|Follow-up Period|Patient transferred to other hospital|0|||
160665820|NCT01796171|580157395|FG008|Follow-up Period|Patient transferred to other hospital|0|||
160665821|NCT01796171|580157396|FG009|Follow-up Period|Patient transferred to other hospital|0|||
160665822|NCT01796171|580157397|FG010|Follow-up Period|Patient transferred to other hospital|0|||
160665823|NCT01796171|580157398|FG011|Follow-up Period|Patient transferred to other hospital|0|||
160665824|NCT01796171|580157399|FG012|Follow-up Period|Patient transferred to other hospital|0|||
160665825|NCT01796171|580157400|FG013|Follow-up Period|Patient transferred to other hospital|0|||
160665826|NCT01796171|580157401|FG014|Follow-up Period|Patient transferred to other hospital|0|||
160665827|NCT01796171|580157387|FG000|Follow-up Period|Sponsor Decision|0|||
160665828|NCT01796171|580157388|FG001|Follow-up Period|Sponsor Decision|0|||
160665829|NCT01796171|580157389|FG002|Follow-up Period|Sponsor Decision|0|||
160665830|NCT01796171|580157390|FG003|Follow-up Period|Sponsor Decision|0|||
160665831|NCT01796171|580157391|FG004|Follow-up Period|Sponsor Decision|0|||
160665832|NCT01796171|580157392|FG005|Follow-up Period|Sponsor Decision|0|||
160665833|NCT01796171|580157393|FG006|Follow-up Period|Sponsor Decision|0|||
160665834|NCT01796171|580157394|FG007|Follow-up Period|Sponsor Decision|0|||
160665835|NCT01796171|580157395|FG008|Follow-up Period|Sponsor Decision|0|||
160665836|NCT01796171|580157396|FG009|Follow-up Period|Sponsor Decision|0|||
160665837|NCT01796171|580157397|FG010|Follow-up Period|Sponsor Decision|40|||
160665838|NCT01796171|580157398|FG011|Follow-up Period|Sponsor Decision|15|||
160665839|NCT01796171|580157399|FG012|Follow-up Period|Sponsor Decision|7|||
160665840|NCT01796171|580157400|FG013|Follow-up Period|Sponsor Decision|0|||
160665841|NCT01796171|580157401|FG014|Follow-up Period|Sponsor Decision|0|||
160665842|NCT00418561|580157402|FG000|Overall Study|Participant's (guardian's) decision|0|||
160665843|NCT00418561|580157403|FG001|Overall Study|Participant's (guardian's) decision|1|||
160665844|NCT00418561|580157404|FG002|Overall Study|Participant's (guardian's) decision|0|||
160665845|NCT00455312|580157405|FG000|Overall Study|Death|0|||
160665846|NCT00455312|580157406|FG001|Overall Study|Death|1|||
160665847|NCT00834418|580157407|FG000|Overall Study|Adverse Event|0|||
160665848|NCT00834418|580157408|FG001|Overall Study|Adverse Event|2|||
160665849|NCT01705574|580157409|FG000|Double-Blind Phase|Lost to Follow-up|12|||
160665850|NCT01705574|580157410|FG001|Double-Blind Phase|Lost to Follow-up|16|||
160665851|NCT01705574|580157411|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160665852|NCT01705574|580157412|FG003|Double-Blind Phase|Lost to Follow-up|0|||
160665853|NCT01705574|580157409|FG000|Double-Blind Phase|Adverse Event|3|||
160665854|NCT01705574|580157410|FG001|Double-Blind Phase|Adverse Event|10|||
160665855|NCT01705574|580157411|FG002|Double-Blind Phase|Adverse Event|0|||
160665856|NCT01705574|580157412|FG003|Double-Blind Phase|Adverse Event|0|||
160665857|NCT01705574|580157409|FG000|Double-Blind Phase|Withdrew Consent|8|||
160665858|NCT01705574|580157410|FG001|Double-Blind Phase|Withdrew Consent|5|||
160665859|NCT01705574|580157411|FG002|Double-Blind Phase|Withdrew Consent|0|||
160665860|NCT01705574|580157412|FG003|Double-Blind Phase|Withdrew Consent|0|||
160665861|NCT01705574|580157409|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
160665862|NCT01705574|580157410|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
160665863|NCT01705574|580157411|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
160665864|NCT01705574|580157412|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
160665865|NCT01705574|580157409|FG000|Double-Blind Phase|Pregnancy|1|||
160665866|NCT01705574|580157410|FG001|Double-Blind Phase|Pregnancy|1|||
160665867|NCT01705574|580157411|FG002|Double-Blind Phase|Pregnancy|0|||
160665868|NCT01705574|580157412|FG003|Double-Blind Phase|Pregnancy|0|||
160665869|NCT01705574|580157409|FG000|Double-Blind Phase|Protocol Violation|1|||
160665870|NCT01705574|580157410|FG001|Double-Blind Phase|Protocol Violation|0|||
160665871|NCT01705574|580157411|FG002|Double-Blind Phase|Protocol Violation|0|||
160665872|NCT01705574|580157412|FG003|Double-Blind Phase|Protocol Violation|0|||
160665873|NCT01705574|580157409|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
160665874|NCT01705574|580157410|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
160665875|NCT01705574|580157411|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
160665876|NCT01705574|580157412|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
160665877|NCT01705574|580157409|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
160665878|NCT01705574|580157410|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
160665879|NCT01705574|580157411|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
160665880|NCT01705574|580157412|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
160665881|NCT01705574|580157409|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
160665882|NCT01705574|580157410|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
160665883|NCT01705574|580157411|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
160665884|NCT01705574|580157412|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
160665885|NCT01705574|580157409|FG000|Open-Label Extension Phase|Adverse Event|3|||
160665886|NCT01705574|580157410|FG001|Open-Label Extension Phase|Adverse Event|0|||
160665887|NCT01705574|580157411|FG002|Open-Label Extension Phase|Adverse Event|0|||
160665888|NCT01705574|580157412|FG003|Open-Label Extension Phase|Adverse Event|1|||
160665889|NCT01705574|580157409|FG000|Open-Label Extension Phase|Death|2|||
160512926|NCT00092495|579605171|FG002|Base Study Vaccination Period|Other|0|||
160512927|NCT00092495|579605172|FG003|Base Study Vaccination Period|Other|2|||
160512928|NCT00092495|579605173|FG004|Base Study Vaccination Period|Other|0|||
160512929|NCT00092495|579605169|FG000|Base Study Vaccination Period|Pregnancy|2|||
160512930|NCT00092495|579605170|FG001|Base Study Vaccination Period|Pregnancy|0|||
160512931|NCT00092495|579605171|FG002|Base Study Vaccination Period|Pregnancy|0|||
160512932|NCT00092495|579605172|FG003|Base Study Vaccination Period|Pregnancy|0|||
160512933|NCT00092495|579605173|FG004|Base Study Vaccination Period|Pregnancy|0|||
160512934|NCT00092495|579605169|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
160512935|NCT00092495|579605170|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
160512936|NCT00092495|579605171|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
160622703|NCT03764813|579998164|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
160622704|NCT03764813|579998165|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
160622705|NCT03764813|579998166|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
160622706|NCT00267202|579998176|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
160622707|NCT00267202|579998177|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
160622708|NCT00267202|579998176|FG000|Overall Study|Withdrawal by Subject|12|||
160622709|NCT00267202|579998177|FG001|Overall Study|Withdrawal by Subject|15|||
160622710|NCT00267202|579998176|FG000|Overall Study|Adverse Event|13|||
160622711|NCT00267202|579998177|FG001|Overall Study|Adverse Event|7|||
160622712|NCT00267202|579998176|FG000|Overall Study|Protocol Violation|2|||
160622713|NCT00267202|579998177|FG001|Overall Study|Protocol Violation|3|||
160622714|NCT00267202|579998176|FG000|Overall Study|Administrative problems|2|||
160622715|NCT00267202|579998177|FG001|Overall Study|Administrative problems|1|||
160622716|NCT00267202|579998176|FG000|Overall Study|Lost to Follow-up|3|||
160622717|NCT00267202|579998177|FG001|Overall Study|Lost to Follow-up|0|||
160622718|NCT03326323|579998178|FG000|Overall Study|Unable to receive ANH protocol|3|||
160622719|NCT00920582|579998179|FG000|Overall Study|Lost to Follow-up|5|||
160622720|NCT00920582|579998180|FG001|Overall Study|Lost to Follow-up|1|||
160622721|NCT00920582|579998181|FG002|Overall Study|Lost to Follow-up|2|||
160622722|NCT00920582|579998182|FG003|Overall Study|Lost to Follow-up|0|||
160622723|NCT00920582|579998179|FG000|Overall Study|Withdrawal by Subject|5|||
160622724|NCT00920582|579998180|FG001|Overall Study|Withdrawal by Subject|4|||
160622725|NCT00920582|579998181|FG002|Overall Study|Withdrawal by Subject|6|||
160622726|NCT00920582|579998182|FG003|Overall Study|Withdrawal by Subject|3|||
160622727|NCT00920582|579998179|FG000|Overall Study|Protocol Violation|1|||
160622728|NCT00920582|579998180|FG001|Overall Study|Protocol Violation|0|||
160622729|NCT00920582|579998181|FG002|Overall Study|Protocol Violation|0|||
160622730|NCT00920582|579998182|FG003|Overall Study|Protocol Violation|0|||
160622731|NCT00920582|579998179|FG000|Overall Study|Other|2|||
160622732|NCT00920582|579998180|FG001|Overall Study|Other|1|||
160622733|NCT00920582|579998181|FG002|Overall Study|Other|3|||
160622734|NCT00920582|579998182|FG003|Overall Study|Other|2|||
160622735|NCT00851721|579998187|FG000|Overall Study|planned surgery|1|||
160622736|NCT00851721|579998188|FG001|Overall Study|planned surgery|0|||
160622737|NCT00851721|579998187|FG000|Overall Study|Death|1|||
160622738|NCT00851721|579998188|FG001|Overall Study|Death|0|||
160622739|NCT00851721|579998187|FG000|Overall Study|Adverse Event|0|||
160622740|NCT00851721|579998188|FG001|Overall Study|Adverse Event|1|||
160622741|NCT04533204|579998189|FG000|Overall Study|Unable to understand training instructions|1|||
160622742|NCT04533204|579998190|FG001|Overall Study|Unable to understand training instructions|1|||
160622743|NCT01333501|579998191|FG000|Overall Study|Adverse Event|3|||
160622744|NCT01333501|579998192|FG001|Overall Study|Adverse Event|1|||
160622745|NCT01333501|579998191|FG000|Overall Study|Abnormal laboratory value|2|||
160622746|NCT01333501|579998192|FG001|Overall Study|Abnormal laboratory value|1|||
160622747|NCT01333501|579998191|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160622748|NCT01333501|579998192|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
160622749|NCT01333501|579998191|FG000|Overall Study|Withdrawn consent|3|||
160622750|NCT01333501|579998192|FG001|Overall Study|Withdrawn consent|12|||
160622751|NCT04034225|579998193|FG000|Overall Study|Death|3|||
160622752|NCT04034225|579998193|FG000|Overall Study|Withdrawal by Subject|2|||
160622753|NCT04034225|579998193|FG000|Overall Study|Study termination by Sponsor|18|||
160622754|NCT04034225|579998193|FG000|Overall Study|Physician Decision|1|||
160622755|NCT04034225|579998193|FG000|Overall Study|Lack of Efficacy|1|||
160622756|NCT00955682|579998194|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
160622757|NCT00955682|579998195|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
160622758|NCT04246996|579998203|FG000|Overall Study|Physician Decision|1|||
160622759|NCT04246996|579998204|FG001|Overall Study|Physician Decision|1|||
160622760|NCT04246996|579998203|FG000|Overall Study|Did not meet eligibility criteria|1|||
160622761|NCT04246996|579998204|FG001|Overall Study|Did not meet eligibility criteria|4|||
160622762|NCT01348828|579998207|FG000|Overall Study|Death|20|||
160622763|NCT01348828|579998207|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
160622764|NCT01348828|579998207|FG000|Overall Study|Conversion|2|||
160622765|NCT01348828|579998207|FG000|Overall Study|missed visit|1|||
160622766|NCT02442284|579998208|FG000|Overall Study|Adverse Event|1|||
160622767|NCT02442284|579998208|FG000|Overall Study|Withdrew Consent|2|||
160622768|NCT02442284|579998208|FG000|Overall Study|Lost to Follow-up|3|||
160622769|NCT02442284|579998208|FG000|Overall Study|Other|1|||
160622770|NCT01365468|579998212|FG000|Overall Study|Physician Decision|1|||
160622771|NCT01365468|579998213|FG001|Overall Study|Physician Decision|0|||
160622772|NCT01365468|579998212|FG000|Overall Study|Disease progression|1|||
160622773|NCT01365468|579998213|FG001|Overall Study|Disease progression|0|||
160622774|NCT01365468|579998212|FG000|Overall Study|Lost to Follow-up|2|||
160622775|NCT01365468|579998213|FG001|Overall Study|Lost to Follow-up|0|||
160622776|NCT00877929|579998214|FG000|Overall Study|Adverse Event|11|||
160622777|NCT00877929|579998215|FG001|Overall Study|Adverse Event|20|||
160622778|NCT00877929|579998214|FG000|Overall Study|Protocol Violation|3|||
160622779|NCT00877929|579998215|FG001|Overall Study|Protocol Violation|3|||
160622780|NCT00877929|579998214|FG000|Overall Study|Lost to Follow-up|0|||
160622781|NCT00877929|579998215|FG001|Overall Study|Lost to Follow-up|1|||
160622782|NCT00877929|579998214|FG000|Overall Study|Withdrawal by Subject|4|||
160622783|NCT00877929|579998215|FG001|Overall Study|Withdrawal by Subject|4|||
160622784|NCT00877929|579998214|FG000|Overall Study|Lack of Efficacy|0|||
160622785|NCT00877929|579998215|FG001|Overall Study|Lack of Efficacy|1|||
160622786|NCT00877929|579998214|FG000|Overall Study|Other reason (not specified)|2|||
160622787|NCT00877929|579998215|FG001|Overall Study|Other reason (not specified)|6|||
160622788|NCT00689728|579998216|FG000|Double-Blind Treatment|Adverse Event|1|||
160622789|NCT00689728|579998217|FG001|Double-Blind Treatment|Adverse Event|0|||
160622790|NCT00689728|579998218|FG002|Double-Blind Treatment|Adverse Event|0|||
160622791|NCT00689728|579998216|FG000|Double-Blind Treatment|Protocol Violation|0|||
160622792|NCT00689728|579998217|FG001|Double-Blind Treatment|Protocol Violation|0|||
160622793|NCT00689728|579998218|FG002|Double-Blind Treatment|Protocol Violation|1|||
160622794|NCT00689728|579998216|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
160622795|NCT00689728|579998217|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
160622796|NCT00689728|579998218|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
160622797|NCT00689728|579998216|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
160622798|NCT00689728|579998217|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
160622799|NCT00689728|579998218|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
160622800|NCT00689728|579998216|FG000|Rescue|Adverse Event|0|||
160622801|NCT00689728|579998217|FG001|Rescue|Adverse Event|1|||
160622802|NCT00689728|579998218|FG002|Rescue|Adverse Event|0|||
160622803|NCT00689728|579998216|FG000|Rescue|Withdrawal by Subject|1|||
160622804|NCT00689728|579998217|FG001|Rescue|Withdrawal by Subject|1|||
160622805|NCT00689728|579998218|FG002|Rescue|Withdrawal by Subject|1|||
160622806|NCT00689728|579998216|FG000|Optional Follow-Up|Adverse Event|1|||
160622807|NCT00689728|579998217|FG001|Optional Follow-Up|Adverse Event|0|||
160622808|NCT00689728|579998218|FG002|Optional Follow-Up|Adverse Event|0|||
160622809|NCT00689728|579998216|FG000|Optional Follow-Up|Lack of Efficacy|0|||
160622810|NCT00689728|579998217|FG001|Optional Follow-Up|Lack of Efficacy|1|||
160622811|NCT00689728|579998218|FG002|Optional Follow-Up|Lack of Efficacy|1|||
160622812|NCT00689728|579998216|FG000|Optional Follow-Up|Lost to Follow-up|0|||
160622813|NCT00689728|579998217|FG001|Optional Follow-Up|Lost to Follow-up|1|||
160622814|NCT00689728|579998218|FG002|Optional Follow-Up|Lost to Follow-up|1|||
160622815|NCT00689728|579998216|FG000|Optional Follow-Up|Protocol Violation|0|||
160622816|NCT00689728|579998217|FG001|Optional Follow-Up|Protocol Violation|0|||
160622817|NCT00689728|579998218|FG002|Optional Follow-Up|Protocol Violation|1|||
160622818|NCT00689728|579998216|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
160622819|NCT00689728|579998217|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
160622820|NCT00689728|579998218|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
160622821|NCT00660829|579998223|FG000|Overall Study|Adverse Event|3|||
160622822|NCT00660829|579998224|FG001|Overall Study|Adverse Event|4|||
160622823|NCT00660829|579998223|FG000|Overall Study|Lack of Efficacy|2|||
160622824|NCT00660829|579998224|FG001|Overall Study|Lack of Efficacy|3|||
160622825|NCT00660829|579998223|FG000|Overall Study|Non-Compliance|0|||
160622826|NCT00660829|579998224|FG001|Overall Study|Non-Compliance|4|||
160622827|NCT00660829|579998223|FG000|Overall Study|Withdrawal by Subject|1|||
160622828|NCT00660829|579998224|FG001|Overall Study|Withdrawal by Subject|2|||
160622829|NCT00660829|579998223|FG000|Overall Study|Lost to Follow-up|3|||
160622830|NCT00660829|579998224|FG001|Overall Study|Lost to Follow-up|2|||
160622831|NCT00660829|579998223|FG000|Overall Study|Other|9|||
160622832|NCT00660829|579998224|FG001|Overall Study|Other|4|||
160622833|NCT02127931|579998227|FG000|Overall Study|Glitch in Game|1|||
160622834|NCT01153971|579999667|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
160622835|NCT01153971|579999667|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
160622836|NCT01153971|579999667|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
160622837|NCT01153971|579999667|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
160622838|NCT01153971|579999667|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
160622839|NCT01153971|579999667|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
160622840|NCT01153971|579999667|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
160622841|NCT03410693|579999668|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
160622842|NCT03410693|579999669|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
160512937|NCT00092495|579605172|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
160512938|NCT00092495|579605173|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
160512939|NCT00092495|579605169|FG000|Base Study Vaccination Period|Protocol Violation|1|||
160512940|NCT00092495|579605170|FG001|Base Study Vaccination Period|Protocol Violation|0|||
160512941|NCT00092495|579605171|FG002|Base Study Vaccination Period|Protocol Violation|0|||
160512942|NCT00092495|579605172|FG003|Base Study Vaccination Period|Protocol Violation|0|||
160512943|NCT00092495|579605173|FG004|Base Study Vaccination Period|Protocol Violation|0|||
160512944|NCT00092495|579605169|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
160512945|NCT00092495|579605170|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
160512946|NCT00092495|579605171|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
160512947|NCT00092495|579605172|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
160512948|NCT00092495|579605173|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
160512949|NCT00092495|579605169|FG000|Base Study Follow-up Period|Extended|0|||
160512950|NCT00092495|579605170|FG001|Base Study Follow-up Period|Extended|0|||
160512951|NCT00092495|579605171|FG002|Base Study Follow-up Period|Extended|1|||
160512952|NCT00092495|579605172|FG003|Base Study Follow-up Period|Extended|2|||
160512953|NCT00092495|579605173|FG004|Base Study Follow-up Period|Extended|0|||
160512954|NCT00092495|579605169|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
160512955|NCT00092495|579605170|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
160512956|NCT00092495|579605171|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
160512957|NCT00092495|579605172|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
160512958|NCT00092495|579605173|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
160512959|NCT00092495|579605169|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
160512960|NCT00092495|579605170|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
160512961|NCT00092495|579605171|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
160512962|NCT00092495|579605172|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
160512963|NCT00092495|579605173|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
160512964|NCT00938470|579605176|FG000|Overall Study|Disease Progression|3|||
160512965|NCT00938470|579605177|FG001|Overall Study|Disease Progression|0|||
160512966|NCT00938470|579605176|FG000|Overall Study|Alternate Treatment|1|||
160665890|NCT01705574|580157410|FG001|Open-Label Extension Phase|Death|0|||
160665891|NCT01705574|580157411|FG002|Open-Label Extension Phase|Death|1|||
160665892|NCT01705574|580157412|FG003|Open-Label Extension Phase|Death|0|||
160665893|NCT01705574|580157409|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
160665894|NCT01705574|580157410|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
160665895|NCT01705574|580157411|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
160665896|NCT01705574|580157412|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
160665897|NCT01705574|580157409|FG000|Open-Label Extension Phase|Physician Decision|0|||
160665898|NCT01705574|580157410|FG001|Open-Label Extension Phase|Physician Decision|0|||
160512967|NCT00938470|579605177|FG001|Overall Study|Alternate Treatment|0|||
160512968|NCT00938470|579605176|FG000|Overall Study|Death|3|||
160512969|NCT00938470|579605177|FG001|Overall Study|Death|2|||
160512970|NCT00938470|579605176|FG000|Overall Study|Other Reason|0|||
160512971|NCT00938470|579605177|FG001|Overall Study|Other Reason|1|||
160512972|NCT04988867|579605186|FG000|Overall Study|Study terminated by Sponsor|12|||
160512973|NCT04988867|579605186|FG000|Overall Study|Adverse Event|2|||
160512974|NCT04988867|579605186|FG000|Overall Study|Study drug noncompliance|1|||
160512975|NCT01236534|579605189|FG000|Overall Study|Adverse Event|3|||
160512976|NCT01236534|579605190|FG001|Overall Study|Adverse Event|0|||
160512977|NCT01844687|579605193|FG000|Visit 1|Protocol Violation|3|||
160512978|NCT01844687|579605193|FG000|Visit 1|Lost to Follow-up|5|||
160512979|NCT01844687|579605193|FG000|Visit 2|Withdrawal by Subject|1|||
160512980|NCT01844687|579605193|FG000|Visit 2|Protocol Violation|1|||
160512981|NCT01844687|579605193|FG000|Visit 3|Lost to Follow-up|1|||
160512982|NCT01844687|579605193|FG000|Visit 3|Withdrawal by Subject|3|||
160512983|NCT01844687|579605193|FG000|Visit 3|child care problems|1|||
160512984|NCT01844687|579605193|FG000|Visit 4|Pregnancy|1|||
160512985|NCT01844687|579605193|FG000|Visit 4|Lost to Follow-up|1|||
160512986|NCT01844687|579605193|FG000|Visit 4|Withdrawal by Subject|2|||
160512987|NCT00158860|579605208|FG000|Overall Study|Adverse Event|3|||
160512988|NCT00158860|579605209|FG001|Overall Study|Adverse Event|6|||
160512989|NCT00158860|579605208|FG000|Overall Study|Lost to Follow-up|11|||
160512990|NCT00158860|579605209|FG001|Overall Study|Lost to Follow-up|17|||
160512991|NCT00158860|579605208|FG000|Overall Study|Protocol Violation|8|||
160512992|NCT00158860|579605209|FG001|Overall Study|Protocol Violation|23|||
160512993|NCT00158860|579605208|FG000|Overall Study|Withdrawal by Subject|7|||
160512994|NCT00158860|579605209|FG001|Overall Study|Withdrawal by Subject|17|||
160512995|NCT00158860|579605208|FG000|Overall Study|MOVING OUT OF STATE|1|||
160512996|NCT00158860|579605209|FG001|Overall Study|MOVING OUT OF STATE|0|||
160512997|NCT00158860|579605208|FG000|Overall Study|Pregnancy|3|||
160512998|NCT00158860|579605209|FG001|Overall Study|Pregnancy|3|||
160512999|NCT00158860|579605208|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
160513000|NCT00158860|579605209|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
160513001|NCT00158860|579605208|FG000|Overall Study|SPONSOR REQUEST|0|||
160513002|NCT00158860|579605209|FG001|Overall Study|SPONSOR REQUEST|1|||
160665899|NCT01705574|580157411|FG002|Open-Label Extension Phase|Physician Decision|2|||
160665900|NCT01705574|580157412|FG003|Open-Label Extension Phase|Physician Decision|0|||
160665901|NCT01705574|580157409|FG000|Open-Label Extension Phase|Pregnancy|0|||
160665902|NCT01705574|580157410|FG001|Open-Label Extension Phase|Pregnancy|0|||
160665903|NCT01705574|580157411|FG002|Open-Label Extension Phase|Pregnancy|1|||
160665904|NCT01705574|580157412|FG003|Open-Label Extension Phase|Pregnancy|1|||
160665905|NCT02659150|580157413|FG000|Subject Enrollment|Physician Decision|3|||
160665906|NCT02659150|580157413|FG000|Subject Enrollment|Withdrawal by Subject|2|||
160665907|NCT02659150|580157413|FG000|Baseline Imaging|Withdrawal by Subject|1|||
160665908|NCT02659150|580157413|FG000|Baseline Imaging|Physician Decision|1|||
160665909|NCT02659150|580157413|FG000|Study Drug Dosing|Adverse Event|1|||
160665910|NCT01827163|580157417|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
160665911|NCT01827163|580157417|FG000|Overall Study|Adverse Event|9|||
160665912|NCT03375463|580157418|FG000|Period 1|Lost to Follow-up|0|||
160665913|NCT03375463|580157419|FG001|Period 1|Lost to Follow-up|0|||
160665914|NCT03375463|580157420|FG002|Period 1|Lost to Follow-up|1|||
160665915|NCT03375463|580157421|FG003|Period 1|Lost to Follow-up|0|||
160665916|NCT03375463|580157422|FG004|Period 1|Lost to Follow-up|0|||
160665917|NCT03375463|580157423|FG005|Period 1|Lost to Follow-up|0|||
160665918|NCT03375463|580157418|FG000|Period 1|Adverse Event|0|||
160665919|NCT03375463|580157419|FG001|Period 1|Adverse Event|0|||
160665920|NCT03375463|580157420|FG002|Period 1|Adverse Event|0|||
160665921|NCT03375463|580157421|FG003|Period 1|Adverse Event|0|||
160665922|NCT03375463|580157422|FG004|Period 1|Adverse Event|1|||
160665923|NCT03375463|580157423|FG005|Period 1|Adverse Event|0|||
160665924|NCT03375463|580157418|FG000|Period 2|Lost to Follow-up|1|||
160665925|NCT03375463|580157419|FG001|Period 2|Lost to Follow-up|1|||
160665926|NCT03375463|580157420|FG002|Period 2|Lost to Follow-up|0|||
160665927|NCT03375463|580157421|FG003|Period 2|Lost to Follow-up|0|||
160665928|NCT03375463|580157422|FG004|Period 2|Lost to Follow-up|0|||
160665929|NCT03375463|580157423|FG005|Period 2|Lost to Follow-up|0|||
160665930|NCT02909907|580157424|FG000|Overall Study|Withdrawal by Subject|0|||
160665931|NCT02909907|580157425|FG001|Overall Study|Withdrawal by Subject|1|||
160665932|NCT02902211|580157426|FG000|First Three Months|Withdrawal by Subject|7|||
160665933|NCT02902211|580157427|FG001|First Three Months|Withdrawal by Subject|3|||
160665934|NCT02576938|580157435|FG000|Overall Study|Adverse Event|5|||
160665935|NCT02576938|580157436|FG001|Overall Study|Adverse Event|3|||
160665936|NCT02576938|580157437|FG002|Overall Study|Adverse Event|6|||
160665937|NCT02576938|580157435|FG000|Overall Study|Protocol Violation|1|||
160665938|NCT02576938|580157436|FG001|Overall Study|Protocol Violation|1|||
160665939|NCT02576938|580157437|FG002|Overall Study|Protocol Violation|1|||
160665940|NCT02576938|580157435|FG000|Overall Study|Withdrawal by Subject|3|||
160665941|NCT02576938|580157436|FG001|Overall Study|Withdrawal by Subject|2|||
160665942|NCT02576938|580157437|FG002|Overall Study|Withdrawal by Subject|4|||
160665943|NCT02576938|580157435|FG000|Overall Study|Lack of Efficacy|9|||
160665944|NCT02576938|580157436|FG001|Overall Study|Lack of Efficacy|4|||
160665945|NCT02576938|580157437|FG002|Overall Study|Lack of Efficacy|0|||
160665946|NCT02576938|580157435|FG000|Overall Study|Lost to Follow-up|2|||
160665947|NCT02576938|580157436|FG001|Overall Study|Lost to Follow-up|0|||
160665948|NCT02576938|580157437|FG002|Overall Study|Lost to Follow-up|1|||
160665949|NCT02576938|580157435|FG000|Overall Study|Physician Decision|0|||
160665950|NCT02576938|580157436|FG001|Overall Study|Physician Decision|1|||
160665951|NCT02576938|580157437|FG002|Overall Study|Physician Decision|0|||
160665952|NCT02576938|580157435|FG000|Overall Study|Met Exclusion Criteria|0|||
160665953|NCT02576938|580157436|FG001|Overall Study|Met Exclusion Criteria|1|||
160665954|NCT02576938|580157437|FG002|Overall Study|Met Exclusion Criteria|0|||
160665955|NCT03098394|580157441|FG000|Overall Study|Pregnancy|0|||
160665956|NCT03098394|580157442|FG001|Overall Study|Pregnancy|1|||
160665957|NCT00571064|580157443|FG000|Overall Study|Adverse Event|13|||
160665958|NCT00571064|580157443|FG000|Overall Study|Protocol Violation|4|||
160665959|NCT00571064|580157443|FG000|Overall Study|Withdrawal by Subject|2|||
160665960|NCT00571064|580157443|FG000|Overall Study|Other|2|||
160665961|NCT01518972|580157446|FG000|Overall Study|Lost to Follow-up|2|||
160513003|NCT00158860|579605208|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
160665962|NCT01518972|580157447|FG001|Overall Study|Lost to Follow-up|1|||
160665963|NCT01518972|580157446|FG000|Overall Study|Withdrawal by Subject|1|||
160665964|NCT01518972|580157447|FG001|Overall Study|Withdrawal by Subject|0|||
160665965|NCT01518972|580157446|FG000|Overall Study|Moved from area|1|||
160665966|NCT01518972|580157447|FG001|Overall Study|Moved from area|0|||
160665967|NCT01518972|580157446|FG000|Overall Study|Transportation problems|1|||
160665968|NCT01518972|580157447|FG001|Overall Study|Transportation problems|0|||
160665969|NCT01518972|580157446|FG000|Overall Study|Exclusionary medical condition|1|||
160665970|NCT01518972|580157447|FG001|Overall Study|Exclusionary medical condition|0|||
160665971|NCT01518972|580157446|FG000|Overall Study|Missed safety visits|0|||
160665972|NCT01518972|580157447|FG001|Overall Study|Missed safety visits|1|||
160665973|NCT01518972|580157446|FG000|Overall Study|Exclusionary medication|0|||
160665974|NCT01518972|580157447|FG001|Overall Study|Exclusionary medication|1|||
160665975|NCT01518972|580157446|FG000|Overall Study|Declined medication starting on day 12|0|||
160665976|NCT01518972|580157447|FG001|Overall Study|Declined medication starting on day 12|1|||
160665977|NCT00003659|580157453|FG000|Overall Study|Withdrawal by Subject|3|||
160665978|NCT04022954|580157454|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
160665979|NCT04022954|580157454|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
160665980|NCT04022954|580157454|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
160665981|NCT03637764|580157455|FG000|Overall Study|Adverse Event|2|||
160513004|NCT00158860|579605209|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
160513005|NCT00158860|579605208|FG000|Overall Study|Closed per sponsor|0|||
160513006|NCT00158860|579605209|FG001|Overall Study|Closed per sponsor|1|||
160513007|NCT04638920|579605210|FG000|Overall Study|Withdrawal by Subject|5|||
160513008|NCT03775434|579605211|FG000|Overall Study|Adverse Event|2|||
160513009|NCT03775434|579605211|FG000|Overall Study|Withdrawal by Subject|1|||
160513010|NCT03047395|579605212|FG000|Overall Study|Adverse Event|142|||
160513011|NCT03047395|579605212|FG000|Overall Study|Withdrawal by Subject|155|||
160513012|NCT03047395|579605212|FG000|Overall Study|Lost to Follow-up|144|||
160513013|NCT03047395|579605212|FG000|Overall Study|COVID-19 Infection|2|||
160513014|NCT03047395|579605212|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
160513015|NCT03047395|579605212|FG000|Overall Study|Other, Not Specified|117|||
160513016|NCT00620282|579605220|FG000|Overall Study|Adverse Event|0|||
160513017|NCT00620282|579605221|FG001|Overall Study|Adverse Event|1|||
160513018|NCT00620282|579605222|FG002|Overall Study|Adverse Event|0|||
160513019|NCT00620282|579605220|FG000|Overall Study|Arterial line unable to be placed|0|||
160513020|NCT00620282|579605221|FG001|Overall Study|Arterial line unable to be placed|0|||
160513021|NCT00620282|579605222|FG002|Overall Study|Arterial line unable to be placed|1|||
160513022|NCT00620282|579605220|FG000|Overall Study|Withdrawal by Subject|0|||
160513023|NCT00620282|579605221|FG001|Overall Study|Withdrawal by Subject|1|||
160513024|NCT00620282|579605222|FG002|Overall Study|Withdrawal by Subject|0|||
160513025|NCT02217475|579605223|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
160513026|NCT02217475|579605224|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
160513027|NCT02217475|579605225|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
160513028|NCT02217475|579605223|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
160513029|NCT02217475|579605224|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
160513030|NCT02217475|579605225|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
160513031|NCT02217475|579605223|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
160513032|NCT02217475|579605224|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
160513033|NCT02217475|579605225|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
160513034|NCT02217475|579605223|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
160513035|NCT02217475|579605224|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
160513036|NCT02217475|579605225|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
160513037|NCT02217475|579605223|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
160513038|NCT02217475|579605224|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
160513039|NCT02217475|579605225|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
160513040|NCT02217475|579605223|FG000|Discontinued After Period 1|Adverse Event|1|||
160513041|NCT02217475|579605224|FG001|Discontinued After Period 1|Adverse Event|2|||
160513042|NCT02217475|579605225|FG002|Discontinued After Period 1|Adverse Event|0|||
160513043|NCT02217475|579605223|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
160513044|NCT02217475|579605224|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
160513045|NCT02217475|579605225|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
160513046|NCT02217475|579605223|FG000|Discontinued After Period 1|Physician Decision|0|||
160513047|NCT02217475|579605224|FG001|Discontinued After Period 1|Physician Decision|0|||
160513048|NCT02217475|579605225|FG002|Discontinued After Period 1|Physician Decision|1|||
160513049|NCT02217475|579605223|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
160513050|NCT02217475|579605224|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
160513051|NCT02217475|579605225|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
160513052|NCT02217475|579605223|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
160513053|NCT02217475|579605224|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
160513054|NCT02217475|579605225|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
160513055|NCT02217475|579605223|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
160513056|NCT02217475|579605224|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
160513057|NCT02217475|579605225|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
160513058|NCT02217475|579605223|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
160513059|NCT02217475|579605224|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
160513060|NCT02217475|579605225|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
160513061|NCT02217475|579605223|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
160665982|NCT03637764|580157456|FG001|Overall Study|Adverse Event|0|||
160513062|NCT02217475|579605224|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
160513063|NCT02217475|579605225|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
160513064|NCT04738292|579605230|FG000|Overall Study|Death|1|||
160513065|NCT02442336|579605231|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
160665983|NCT03637764|580157457|FG002|Overall Study|Adverse Event|0|||
160665984|NCT03637764|580157458|FG003|Overall Study|Adverse Event|1|||
160665985|NCT03637764|580157455|FG000|Overall Study|Progressive Disease|23|||
160513066|NCT02442336|579605231|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
160513067|NCT02442336|579605231|FG000|Overall Study|Lost to Follow-up|11|||
160513068|NCT01237587|579605232|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
160513069|NCT01237587|579605233|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
160513070|NCT01237587|579605232|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
160513071|NCT01237587|579605233|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
160513072|NCT01237587|579605232|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
160513073|NCT01237587|579605233|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
160513074|NCT01237587|579605232|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
160513075|NCT01237587|579605233|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
160513076|NCT01237587|579605232|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
160513077|NCT01237587|579605233|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
160513078|NCT01237587|579605232|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
160513079|NCT01237587|579605233|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
160513080|NCT01237587|579605232|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
160513081|NCT01237587|579605233|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
160513082|NCT01237587|579605232|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
160622843|NCT03410693|579999668|FG000|Overall Study|Disc trt: Lost to follow up|0|||
160622844|NCT03410693|579999669|FG001|Overall Study|Disc trt: Lost to follow up|1|||
160622845|NCT03410693|579999668|FG000|Overall Study|Disc trt: radiological progression|58|||
160622846|NCT03410693|579999669|FG001|Overall Study|Disc trt: radiological progression|50|||
160622847|NCT03410693|579999668|FG000|Overall Study|Disc trt: Other|1|||
160622848|NCT03410693|579999669|FG001|Overall Study|Disc trt: Other|0|||
160622849|NCT03410693|579999668|FG000|Overall Study|Study drug never administered|1|||
160622850|NCT03410693|579999669|FG001|Overall Study|Study drug never administered|6|||
160622851|NCT03410693|579999668|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
160622852|NCT03410693|579999669|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
160622853|NCT03410693|579999668|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
160622854|NCT03410693|579999669|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
160622855|NCT03410693|579999668|FG000|Overall Study|Disc trt: Physician decision|0|||
160622856|NCT03410693|579999669|FG001|Overall Study|Disc trt: Physician decision|5|||
160622857|NCT03410693|579999668|FG000|Overall Study|Disc trt: clinical progression|1|||
160622858|NCT03410693|579999669|FG001|Overall Study|Disc trt: clinical progression|5|||
160622859|NCT03410693|579999668|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
160622860|NCT03410693|579999669|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
160622861|NCT00953576|579999670|FG000|Overall Study|Adverse Event|0|||
160622862|NCT00953576|579999671|FG001|Overall Study|Adverse Event|1|||
160622863|NCT00953576|579999670|FG000|Overall Study|Ineligible after Consent|2|||
160622864|NCT00953576|579999671|FG001|Overall Study|Ineligible after Consent|0|||
160622865|NCT00501969|579999672|FG000|Overall Study|Major Protocol Violation|4|||
160622866|NCT00501969|579999672|FG000|Overall Study|Lack of Efficacy|29|||
160622867|NCT00501969|579999672|FG000|Overall Study|Adverse Event|76|||
160622868|NCT00501969|579999672|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
160622869|NCT00501969|579999672|FG000|Overall Study|Subject withdrew consent|51|||
160622870|NCT00501969|579999672|FG000|Overall Study|Lost to Follow-up|4|||
160622871|NCT00501969|579999672|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
160622872|NCT00501969|579999672|FG000|Overall Study|Other: Sponsors Request|10|||
160622873|NCT00501969|579999672|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
160622874|NCT00501969|579999672|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
160622875|NCT00501969|579999672|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
160622876|NCT00501969|579999672|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
160622877|NCT00501969|579999672|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
160622878|NCT00501969|579999672|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
160622879|NCT00501969|579999672|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
160622880|NCT00501969|579999672|FG000|Overall Study|Other: As Required by Local EC|2|||
160622881|NCT00501969|579999672|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
160622882|NCT00501969|579999672|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
160622883|NCT00665366|579999673|FG000|Overall Study|Lack of Efficacy|11|||
160622884|NCT00665366|579999674|FG001|Overall Study|Lack of Efficacy|10|||
160622885|NCT00665366|579999673|FG000|Overall Study|Adverse Event|25|||
160622886|NCT00665366|579999674|FG001|Overall Study|Adverse Event|23|||
160622887|NCT00665366|579999673|FG000|Overall Study|Withdrawal by Subject|11|||
160622888|NCT00665366|579999674|FG001|Overall Study|Withdrawal by Subject|14|||
160622889|NCT00665366|579999673|FG000|Overall Study|Lost to Follow-up|3|||
160622890|NCT00665366|579999674|FG001|Overall Study|Lost to Follow-up|5|||
160513083|NCT01237587|579605233|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
160622891|NCT00665366|579999673|FG000|Overall Study|Poor compliance/noncompliance|3|||
160622892|NCT00665366|579999674|FG001|Overall Study|Poor compliance/noncompliance|5|||
160622893|NCT00665366|579999673|FG000|Overall Study|Pregnancy|1|||
160622894|NCT00665366|579999674|FG001|Overall Study|Pregnancy|0|||
160665986|NCT03637764|580157456|FG001|Overall Study|Progressive Disease|23|||
160665987|NCT03637764|580157457|FG002|Overall Study|Progressive Disease|18|||
160665988|NCT03637764|580157458|FG003|Overall Study|Progressive Disease|31|||
160665989|NCT03637764|580157455|FG000|Overall Study|Withdrawal by Subject|1|||
160665990|NCT03637764|580157456|FG001|Overall Study|Withdrawal by Subject|3|||
160665991|NCT03637764|580157457|FG002|Overall Study|Withdrawal by Subject|0|||
160665992|NCT03637764|580157458|FG003|Overall Study|Withdrawal by Subject|1|||
160665993|NCT02648438|580157459|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160665994|NCT02648438|580157460|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
160665995|NCT02648438|580157461|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
160665996|NCT02648438|580157459|FG000|Overall Study|Protocol Violation|2|||
160665997|NCT02648438|580157460|FG001|Overall Study|Protocol Violation|0|||
160665998|NCT02648438|580157461|FG002|Overall Study|Protocol Violation|0|||
160665999|NCT02648438|580157459|FG000|Overall Study|Withdrawal by Subject|1|||
160666000|NCT02648438|580157460|FG001|Overall Study|Withdrawal by Subject|1|||
160666001|NCT02648438|580157461|FG002|Overall Study|Withdrawal by Subject|0|||
160666002|NCT04400890|580157462|FG000|Overall Study|Withdrawal by Subject|3|||
160666003|NCT04400890|580157463|FG001|Overall Study|Withdrawal by Subject|2|||
160666004|NCT03925532|580157464|FG000|Overall Study|Lost to Follow-up|1|||
160666005|NCT02258074|580157465|FG000|Overall Study|Withdrawal by Subject|1|||
160666006|NCT02258074|580157466|FG001|Overall Study|Withdrawal by Subject|0|||
160666007|NCT02258074|580157467|FG002|Overall Study|Withdrawal by Subject|0|||
160666008|NCT02258074|580157468|FG003|Overall Study|Withdrawal by Subject|0|||
160666009|NCT05446870|580157469|FG000|Overall Study|Death|6|||
160666010|NCT05446870|580157470|FG001|Overall Study|Death|5|||
160666011|NCT05446870|580157469|FG000|Overall Study|Lost to Follow-up|0|||
160666012|NCT05446870|580157470|FG001|Overall Study|Lost to Follow-up|1|||
160666013|NCT05446870|580157469|FG000|Overall Study|Physician Decision|52|||
160666014|NCT05446870|580157470|FG001|Overall Study|Physician Decision|53|||
160666015|NCT05446870|580157469|FG000|Overall Study|Withdrawal by Subject|3|||
160666016|NCT05446870|580157470|FG001|Overall Study|Withdrawal by Subject|3|||
160666017|NCT04108858|580157471|FG000|Overall Study|Adverse Event|1|||
160666018|NCT03663179|580157474|FG000|Overall Study|Withdrawal by Subject|2|||
160666019|NCT03663179|580157475|FG001|Overall Study|Withdrawal by Subject|0|||
160666020|NCT03663179|580157474|FG000|Overall Study|Lost to Follow-up|1|||
160666021|NCT03663179|580157475|FG001|Overall Study|Lost to Follow-up|1|||
160666022|NCT03663179|580157474|FG000|Overall Study|Revealed exclusionary condition|1|||
160666023|NCT03663179|580157475|FG001|Overall Study|Revealed exclusionary condition|0|||
160666024|NCT01615198|580157476|FG000|Overall Study|Withdrawal by Subject|5|||
160666025|NCT01615198|580157477|FG001|Overall Study|Withdrawal by Subject|5|||
160666026|NCT01615198|580157476|FG000|Overall Study|Protocol deviation|1|||
160666027|NCT01615198|580157477|FG001|Overall Study|Protocol deviation|1|||
160666028|NCT01615198|580157476|FG000|Overall Study|Physician Decision|5|||
160666029|NCT01615198|580157477|FG001|Overall Study|Physician Decision|1|||
160666030|NCT01615198|580157476|FG000|Overall Study|Lost to Follow-up|1|||
160666031|NCT01615198|580157477|FG001|Overall Study|Lost to Follow-up|1|||
160666032|NCT01615198|580157476|FG000|Overall Study|Lack of Efficacy|1|||
160666033|NCT01615198|580157477|FG001|Overall Study|Lack of Efficacy|6|||
160666034|NCT01615198|580157476|FG000|Overall Study|Adverse Event|11|||
160666035|NCT01615198|580157477|FG001|Overall Study|Adverse Event|5|||
160666036|NCT01686438|580157478|FG000|Overall Study|Lost to Follow-up|8|||
160666037|NCT01686438|580157479|FG001|Overall Study|Lost to Follow-up|9|||
160666038|NCT01686438|580157480|FG002|Overall Study|Lost to Follow-up|10|||
160666039|NCT01686438|580157478|FG000|Overall Study|Adverse Event|0|||
160666040|NCT01686438|580157479|FG001|Overall Study|Adverse Event|0|||
160666041|NCT01686438|580157480|FG002|Overall Study|Adverse Event|1|||
160666042|NCT01686438|580157478|FG000|Overall Study|Protocol Violation|0|||
160666043|NCT01686438|580157479|FG001|Overall Study|Protocol Violation|0|||
160666044|NCT01686438|580157480|FG002|Overall Study|Protocol Violation|1|||
160666045|NCT01686438|580157478|FG000|Overall Study|Withdrawal by Subject|0|||
160666046|NCT01686438|580157479|FG001|Overall Study|Withdrawal by Subject|0|||
160666047|NCT01686438|580157480|FG002|Overall Study|Withdrawal by Subject|1|||
160666048|NCT00984126|580157481|FG000|Overall Study|Protocol Violation|0|||
160666049|NCT00984126|580157482|FG001|Overall Study|Protocol Violation|0|||
160666050|NCT00984126|580157483|FG002|Overall Study|Protocol Violation|1|||
160666051|NCT00984126|580157484|FG003|Overall Study|Protocol Violation|2|||
160666052|NCT00984126|580157481|FG000|Overall Study|Adverse Event|0|||
160666053|NCT00984126|580157482|FG001|Overall Study|Adverse Event|0|||
160666054|NCT00984126|580157483|FG002|Overall Study|Adverse Event|0|||
160666055|NCT00984126|580157484|FG003|Overall Study|Adverse Event|2|||
160666056|NCT00984126|580157481|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
160666057|NCT00984126|580157482|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
160666058|NCT00984126|580157483|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
160666059|NCT00984126|580157484|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
160666060|NCT00984126|580157481|FG000|Overall Study|Withdrawal criteria|0|||
160666061|NCT00984126|580157482|FG001|Overall Study|Withdrawal criteria|1|||
160666062|NCT00984126|580157483|FG002|Overall Study|Withdrawal criteria|3|||
160666063|NCT00984126|580157484|FG003|Overall Study|Withdrawal criteria|9|||
160666064|NCT01029340|580157487|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
160666065|NCT01029340|580157488|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
160666066|NCT01029340|580157489|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
160666067|NCT01029340|580157490|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
160666068|NCT01029340|580157491|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
160666069|NCT01029340|580157492|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
160666070|NCT01029340|580157487|FG000|Part B Treatment Period|Protocol Violation|0|||
160666071|NCT01029340|580157488|FG001|Part B Treatment Period|Protocol Violation|0|||
160666072|NCT01029340|580157489|FG002|Part B Treatment Period|Protocol Violation|1|||
160666073|NCT01029340|580157490|FG003|Part B Treatment Period|Protocol Violation|0|||
160666074|NCT01029340|580157491|FG004|Part B Treatment Period|Protocol Violation|0|||
160666075|NCT01029340|580157492|FG005|Part B Treatment Period|Protocol Violation|0|||
160666076|NCT01029340|580157487|FG000|Extension Period|Adverse Event|0|||
160666077|NCT01029340|580157488|FG001|Extension Period|Adverse Event|0|||
160666078|NCT01029340|580157489|FG002|Extension Period|Adverse Event|0|||
160666079|NCT01029340|580157490|FG003|Extension Period|Adverse Event|0|||
160666080|NCT01029340|580157491|FG004|Extension Period|Adverse Event|0|||
160666081|NCT01029340|580157492|FG005|Extension Period|Adverse Event|1|||
160666082|NCT01029340|580157487|FG000|Extension Period|starting another study|0|||
160666083|NCT01029340|580157488|FG001|Extension Period|starting another study|0|||
160666084|NCT01029340|580157489|FG002|Extension Period|starting another study|0|||
160666085|NCT01029340|580157490|FG003|Extension Period|starting another study|0|||
160666086|NCT01029340|580157491|FG004|Extension Period|starting another study|0|||
160666087|NCT01029340|580157492|FG005|Extension Period|starting another study|8|||
160666088|NCT01029340|580157487|FG000|Extension Period|non-compliance|0|||
160666089|NCT01029340|580157488|FG001|Extension Period|non-compliance|0|||
160666090|NCT01029340|580157489|FG002|Extension Period|non-compliance|0|||
160666091|NCT01029340|580157490|FG003|Extension Period|non-compliance|0|||
160666092|NCT01029340|580157491|FG004|Extension Period|non-compliance|0|||
160666093|NCT01029340|580157492|FG005|Extension Period|non-compliance|1|||
160666094|NCT01029340|580157487|FG000|Extension Period|Withdrawal by Subject|0|||
160666095|NCT01029340|580157488|FG001|Extension Period|Withdrawal by Subject|0|||
160666096|NCT01029340|580157489|FG002|Extension Period|Withdrawal by Subject|0|||
160666097|NCT01029340|580157490|FG003|Extension Period|Withdrawal by Subject|0|||
160666098|NCT01029340|580157491|FG004|Extension Period|Withdrawal by Subject|0|||
160666099|NCT01029340|580157492|FG005|Extension Period|Withdrawal by Subject|1|||
160666100|NCT01029340|580157487|FG000|Extension Period|Physician Decision|0|||
160666101|NCT01029340|580157488|FG001|Extension Period|Physician Decision|0|||
160666102|NCT01029340|580157489|FG002|Extension Period|Physician Decision|0|||
160666103|NCT01029340|580157490|FG003|Extension Period|Physician Decision|0|||
160666104|NCT01029340|580157491|FG004|Extension Period|Physician Decision|0|||
160666105|NCT01029340|580157492|FG005|Extension Period|Physician Decision|1|||
160666106|NCT02009163|580157497|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
160666107|NCT02009163|580157498|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
160666108|NCT02009163|580157499|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
160666109|NCT02009163|580157497|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
160513084|NCT01237587|579605232|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
160513085|NCT01237587|579605233|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
160666110|NCT02009163|580157498|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
160666111|NCT02009163|580157499|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
160666112|NCT02009163|580157497|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
160666113|NCT02009163|580157498|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
160666114|NCT02009163|580157499|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
160666115|NCT02009163|580157497|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
160666116|NCT02009163|580157498|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
160666117|NCT02009163|580157499|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
160666118|NCT02009163|580157497|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
160666119|NCT02009163|580157498|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
160666120|NCT02009163|580157499|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
160666121|NCT02009163|580157497|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
160666122|NCT02009163|580157498|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
160666123|NCT02009163|580157499|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
160666124|NCT02009163|580157497|FG000|Open-label Period (Non-randomized)|Other|13|||
160666125|NCT02009163|580157498|FG001|Open-label Period (Non-randomized)|Other|0|||
160666126|NCT02009163|580157499|FG002|Open-label Period (Non-randomized)|Other|0|||
160666127|NCT02009163|580157497|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
160666128|NCT02009163|580157498|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
160666129|NCT02009163|580157499|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
160666130|NCT02009163|580157497|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
160666131|NCT02009163|580157498|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
160666132|NCT02009163|580157499|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
160666133|NCT02009163|580157497|FG000|Randomized-withdrawal Period|Adverse Event|0|||
160666134|NCT02009163|580157498|FG001|Randomized-withdrawal Period|Adverse Event|0|||
160666135|NCT02009163|580157499|FG002|Randomized-withdrawal Period|Adverse Event|6|||
160666136|NCT02009163|580157497|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
160666137|NCT02009163|580157498|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
160666138|NCT02009163|580157499|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
160666139|NCT02009163|580157497|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
160666140|NCT02009163|580157498|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
160666141|NCT02009163|580157499|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
160666142|NCT02009163|580157497|FG000|Randomized-withdrawal Period|Pregnancy|0|||
160666143|NCT02009163|580157498|FG001|Randomized-withdrawal Period|Pregnancy|0|||
160666144|NCT02009163|580157499|FG002|Randomized-withdrawal Period|Pregnancy|2|||
160666145|NCT02009163|580157497|FG000|Randomized-withdrawal Period|Other|0|||
160666146|NCT02009163|580157498|FG001|Randomized-withdrawal Period|Other|9|||
160666147|NCT02009163|580157499|FG002|Randomized-withdrawal Period|Other|5|||
160666148|NCT02453386|580157500|FG000|Overall Study|Adverse Event|22|||
160666149|NCT02453386|580157501|FG001|Overall Study|Adverse Event|30|||
160666150|NCT02453386|580157502|FG002|Overall Study|Adverse Event|15|||
160666151|NCT02453386|580157500|FG000|Overall Study|Protocol Violation|1|||
160666152|NCT02453386|580157501|FG001|Overall Study|Protocol Violation|0|||
160666153|NCT02453386|580157502|FG002|Overall Study|Protocol Violation|1|||
160666154|NCT02453386|580157500|FG000|Overall Study|Withdrawal by Subject|10|||
160666155|NCT02453386|580157501|FG001|Overall Study|Withdrawal by Subject|9|||
160666156|NCT02453386|580157502|FG002|Overall Study|Withdrawal by Subject|9|||
160666157|NCT02453386|580157500|FG000|Overall Study|Sponsor Terminated Study|14|||
160666158|NCT02453386|580157501|FG001|Overall Study|Sponsor Terminated Study|8|||
160666159|NCT02453386|580157502|FG002|Overall Study|Sponsor Terminated Study|11|||
160666160|NCT02453386|580157500|FG000|Overall Study|Subject Terminated by Sponsor|1|||
160666161|NCT02453386|580157501|FG001|Overall Study|Subject Terminated by Sponsor|1|||
160666162|NCT02453386|580157502|FG002|Overall Study|Subject Terminated by Sponsor|1|||
160666163|NCT02453386|580157500|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
160666164|NCT02453386|580157501|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
160666165|NCT02453386|580157502|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
160666166|NCT02453386|580157500|FG000|Overall Study|Lost to Follow-up|0|||
160666167|NCT02453386|580157501|FG001|Overall Study|Lost to Follow-up|0|||
160666168|NCT02453386|580157502|FG002|Overall Study|Lost to Follow-up|1|||
160666169|NCT02453386|580157500|FG000|Overall Study|Other|1|||
160666170|NCT02453386|580157501|FG001|Overall Study|Other|0|||
160666171|NCT02453386|580157502|FG002|Overall Study|Other|1|||
160666172|NCT00359281|580157503|FG000|Overall Study|Adverse Event|1|||
160666173|NCT00359281|580157504|FG001|Overall Study|Adverse Event|0|||
160666174|NCT00359281|580157505|FG002|Overall Study|Adverse Event|0|||
160666175|NCT00359281|580157506|FG003|Overall Study|Adverse Event|0|||
160666176|NCT00359281|580157507|FG004|Overall Study|Adverse Event|0|||
160666177|NCT00359281|580157508|FG005|Overall Study|Adverse Event|0|||
160666178|NCT00359281|580157509|FG006|Overall Study|Adverse Event|1|||
160666179|NCT00359281|580157510|FG007|Overall Study|Adverse Event|0|||
160513086|NCT01237587|579605232|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
160513087|NCT01237587|579605233|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
160513088|NCT01237587|579605232|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
160513089|NCT01237587|579605233|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
160666180|NCT00359281|580157511|FG008|Overall Study|Adverse Event|0|||
160513090|NCT01237587|579605232|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
160666181|NCT00359281|580157503|FG000|Overall Study|Withdrawal by Subject|0|||
160666182|NCT00359281|580157504|FG001|Overall Study|Withdrawal by Subject|0|||
160666183|NCT00359281|580157505|FG002|Overall Study|Withdrawal by Subject|0|||
160666184|NCT00359281|580157506|FG003|Overall Study|Withdrawal by Subject|0|||
160666185|NCT00359281|580157507|FG004|Overall Study|Withdrawal by Subject|0|||
160666186|NCT00359281|580157508|FG005|Overall Study|Withdrawal by Subject|0|||
160666187|NCT00359281|580157509|FG006|Overall Study|Withdrawal by Subject|1|||
160666188|NCT00359281|580157510|FG007|Overall Study|Withdrawal by Subject|0|||
160666189|NCT00359281|580157511|FG008|Overall Study|Withdrawal by Subject|0|||
160666190|NCT01289262|580157514|FG000|Overall Study|Lost to Follow-up|29|||
160666191|NCT01289262|580157515|FG001|Overall Study|Lost to Follow-up|16|||
160666192|NCT01289262|580157514|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
160666193|NCT01289262|580157515|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
160666194|NCT01415986|580157518|FG000|Overall Study|Lost to Follow-up|1|||
160666195|NCT01474551|580157519|FG000|Overall Study|Death|1|||
160666196|NCT03122457|580157528|FG000|Overall Study|Withdrawal by Subject|6|||
160666197|NCT03769025|580157529|FG000|Overall Study|Withdrawal by Subject|1|||
160666198|NCT03769025|580157530|FG001|Overall Study|Withdrawal by Subject|1|||
160666199|NCT03769025|580157529|FG000|Overall Study|Lost to Follow-up|4|||
160666200|NCT03769025|580157530|FG001|Overall Study|Lost to Follow-up|3|||
160666201|NCT02911701|580157531|FG000|Overall Study|Withdrawal by Subject|2|||
160666202|NCT02911701|580157532|FG001|Overall Study|Withdrawal by Subject|4|||
160513091|NCT01237587|579605233|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
160513092|NCT01237587|579605232|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
160513093|NCT01237587|579605233|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
160513094|NCT01237587|579605232|FG000|Taper Phase|Adverse Event|0|||
160666203|NCT02911701|580157531|FG000|Overall Study|Adverse Event|1|||
160513095|NCT01237587|579605233|FG001|Taper Phase|Adverse Event|2|||
160513096|NCT01237587|579605232|FG000|Taper Phase|Protocol Violation|2|||
160513097|NCT01237587|579605233|FG001|Taper Phase|Protocol Violation|0|||
160513098|NCT01237587|579605232|FG000|Taper Phase|Lack of Efficacy|2|||
160513099|NCT01237587|579605233|FG001|Taper Phase|Lack of Efficacy|5|||
160513100|NCT01237587|579605232|FG000|Taper Phase|Parent/Guardian Decision|0|||
160513101|NCT01237587|579605233|FG001|Taper Phase|Parent/Guardian Decision|2|||
160513102|NCT01237587|579605232|FG000|Taper Phase|Sponsor Decision|1|||
160513103|NCT01237587|579605233|FG001|Taper Phase|Sponsor Decision|0|||
160513104|NCT01237587|579605232|FG000|Taper Phase|Withdrawal by Subject|0|||
160513105|NCT01237587|579605233|FG001|Taper Phase|Withdrawal by Subject|1|||
160513106|NCT01011387|579605234|FG000|Overall Study|Withdrawal by Subject|3|||
160513107|NCT01011387|579605234|FG000|Overall Study|Adverse Event|2|||
160513108|NCT01011387|579605234|FG000|Overall Study|Protocol Violation|1|||
160513109|NCT01139580|579605235|FG000|Overall Study|Adverse Event|5|||
160513110|NCT01139580|579605236|FG001|Overall Study|Adverse Event|4|||
160513111|NCT01139580|579605235|FG000|Overall Study|Lost to Follow-up|9|||
160513112|NCT01139580|579605236|FG001|Overall Study|Lost to Follow-up|1|||
160513113|NCT01139580|579605235|FG000|Overall Study|Lack of Efficacy|0|||
160513114|NCT01139580|579605236|FG001|Overall Study|Lack of Efficacy|2|||
160513115|NCT01139580|579605235|FG000|Overall Study|Withdrawal by Subject|6|||
160513116|NCT01139580|579605236|FG001|Overall Study|Withdrawal by Subject|9|||
160513117|NCT01139580|579605235|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
160513118|NCT01139580|579605236|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
160513119|NCT01139580|579605235|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
160513120|NCT01139580|579605236|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
160513121|NCT01139580|579605235|FG000|Overall Study|Misrandomized|1|||
160513122|NCT01139580|579605236|FG001|Overall Study|Misrandomized|0|||
160513123|NCT01139580|579605235|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
160513124|NCT01139580|579605236|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
160513125|NCT01139580|579605235|FG000|Overall Study|Participant Randomization in Error|0|||
160513126|NCT01139580|579605236|FG001|Overall Study|Participant Randomization in Error|1|||
160513127|NCT01285609|579605237|FG000|Randomized|Progressive Disease|41|||
160513128|NCT01285609|579605238|FG001|Randomized|Progressive Disease|61|||
160513129|NCT01285609|579605237|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
160513130|NCT01285609|579605238|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
160513131|NCT01285609|579605237|FG000|Randomized|Study Drug Toxicity|13|||
160513132|NCT01285609|579605238|FG001|Randomized|Study Drug Toxicity|14|||
160513133|NCT01285609|579605237|FG000|Randomized|Death|5|||
160513134|NCT01285609|579605238|FG001|Randomized|Death|7|||
160513135|NCT01285609|579605237|FG000|Randomized|Withdrawal by Subject|8|||
160513136|NCT01285609|579605238|FG001|Randomized|Withdrawal by Subject|11|||
160513137|NCT01285609|579605237|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
160513138|NCT01285609|579605238|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
160513139|NCT01285609|579605237|FG000|Randomized|Undisclosed Reasons|1|||
160513140|NCT01285609|579605238|FG001|Randomized|Undisclosed Reasons|0|||
160513141|NCT01285609|579605237|FG000|Randomized|Randomized but not Treated|4|||
160513142|NCT01285609|579605238|FG001|Randomized|Randomized but not Treated|4|||
160513143|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
160513144|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
160513145|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
160513146|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
160513147|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
160513148|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
160513149|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
160513150|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
160513151|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Death|11|||
160513152|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Death|3|||
160666204|NCT02911701|580157532|FG001|Overall Study|Adverse Event|0|||
160666205|NCT02441309|580157539|FG000|Overall Study|Disease progression|2|||
160666206|NCT02441309|580157540|FG001|Overall Study|Disease progression|1|||
160666207|NCT02441309|580157541|FG002|Overall Study|Disease progression|2|||
160666208|NCT02441309|580157539|FG000|Overall Study|Adverse Event|0|||
160666209|NCT02441309|580157540|FG001|Overall Study|Adverse Event|1|||
160666210|NCT02441309|580157541|FG002|Overall Study|Adverse Event|0|||
160666211|NCT02441309|580157539|FG000|Overall Study|Withdrawal by Subject|1|||
160666212|NCT02441309|580157540|FG001|Overall Study|Withdrawal by Subject|0|||
160666213|NCT02441309|580157541|FG002|Overall Study|Withdrawal by Subject|1|||
160666214|NCT02820350|580157547|FG000|Overall Study|Withdrawal by Subject|3|||
160666215|NCT02820350|580157547|FG000|Overall Study|Death|4|||
160666216|NCT03801707|580157548|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
160666217|NCT02222818|580159141|FG000|Period 1|Eligibility criteria not met|0|||
160666218|NCT02222818|580159142|FG001|Period 1|Eligibility criteria not met|3|||
160666219|NCT00834717|580159143|FG000|First Intervention|Adverse Event|1|||
160666220|NCT00834717|580159144|FG001|First Intervention|Adverse Event|0|||
160666221|NCT00834717|580159143|FG000|First Intervention|Withdrawal by Subject|0|||
160666222|NCT00834717|580159144|FG001|First Intervention|Withdrawal by Subject|1|||
160666223|NCT01660243|580159145|FG000|Overall Study|Adverse Event|1|||
160666224|NCT01660243|580159146|FG001|Overall Study|Adverse Event|0|||
160666225|NCT01660243|580159147|FG002|Overall Study|Adverse Event|1|||
160666226|NCT01660243|580159148|FG003|Overall Study|Adverse Event|0|||
160666227|NCT01660243|580159145|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
160666228|NCT01660243|580159146|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
160666229|NCT01660243|580159147|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
160666230|NCT01660243|580159148|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
160666231|NCT01660243|580159145|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
160666232|NCT01660243|580159146|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
160666233|NCT01660243|580159147|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
160666234|NCT01660243|580159148|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
160666235|NCT01660243|580159145|FG000|Overall Study|Randomization error|0|||
160666236|NCT01660243|580159146|FG001|Overall Study|Randomization error|0|||
160666237|NCT01660243|580159147|FG002|Overall Study|Randomization error|0|||
160666238|NCT01660243|580159148|FG003|Overall Study|Randomization error|1|||
160666239|NCT03025087|580159149|FG000|Overall Study|Physician Decision|3|||
160666240|NCT03025087|580159150|FG001|Overall Study|Physician Decision|3|||
160666241|NCT03025087|580159151|FG002|Overall Study|Physician Decision|0|||
160666242|NCT03025087|580159152|FG003|Overall Study|Physician Decision|0|||
160666243|NCT03025087|580159153|FG004|Overall Study|Physician Decision|0|||
160666244|NCT03025087|580159149|FG000|Overall Study|Withdrawal by Subject|1|||
160666245|NCT03025087|580159150|FG001|Overall Study|Withdrawal by Subject|1|||
160666246|NCT03025087|580159151|FG002|Overall Study|Withdrawal by Subject|0|||
160666247|NCT03025087|580159152|FG003|Overall Study|Withdrawal by Subject|0|||
160666248|NCT03025087|580159153|FG004|Overall Study|Withdrawal by Subject|0|||
160666249|NCT03025087|580159149|FG000|Overall Study|Unable to complete MRI|2|||
160666250|NCT03025087|580159150|FG001|Overall Study|Unable to complete MRI|2|||
160666251|NCT03025087|580159151|FG002|Overall Study|Unable to complete MRI|0|||
160666252|NCT03025087|580159152|FG003|Overall Study|Unable to complete MRI|0|||
160666253|NCT03025087|580159153|FG004|Overall Study|Unable to complete MRI|0|||
160666254|NCT04299087|580159154|FG000|Overall Study|Lost to Follow-up|2|||
160666255|NCT04299087|580159155|FG001|Overall Study|Lost to Follow-up|1|||
160666256|NCT00594035|580159156|FG000|Overall Study|Lost to Follow-up|1|||
160666257|NCT00594035|580159157|FG001|Overall Study|Lost to Follow-up|1|||
160666258|NCT00594035|580159156|FG000|Overall Study|Withdrawal by Subject|1|||
160666259|NCT00594035|580159157|FG001|Overall Study|Withdrawal by Subject|0|||
160666260|NCT00594035|580159156|FG000|Overall Study|Subject transferred to nursing home|0|||
160666261|NCT00594035|580159157|FG001|Overall Study|Subject transferred to nursing home|1|||
160666262|NCT00594035|580159156|FG000|Overall Study|Subject couldn't return due to job|0|||
160666263|NCT00594035|580159157|FG001|Overall Study|Subject couldn't return due to job|1|||
160666264|NCT00795821|580159158|FG000|Acute Treatment Phase|Adverse Event|23|||
160666265|NCT00795821|580159159|FG001|Acute Treatment Phase|Adverse Event|4|||
160666266|NCT00795821|580159158|FG000|Acute Treatment Phase|Death|1|||
160666267|NCT00795821|580159159|FG001|Acute Treatment Phase|Death|0|||
160666268|NCT00795821|580159158|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
160666269|NCT00795821|580159159|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
160666270|NCT00795821|580159158|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
160666271|NCT00795821|580159159|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
160666272|NCT00795821|580159158|FG000|Acute Treatment Phase|Physician Decision|1|||
160666273|NCT00795821|580159159|FG001|Acute Treatment Phase|Physician Decision|1|||
160666274|NCT00795821|580159158|FG000|Acute Treatment Phase|Protocol Violation|1|||
160666275|NCT00795821|580159159|FG001|Acute Treatment Phase|Protocol Violation|2|||
160666276|NCT00795821|580159158|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
160666277|NCT00795821|580159159|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
160666278|NCT00795821|580159158|FG000|Long-term Extension Phase|Adverse Event|25|||
160666279|NCT00795821|580159159|FG001|Long-term Extension Phase|Adverse Event|32|||
160666280|NCT00795821|580159158|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
160666281|NCT00795821|580159159|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
160666282|NCT00795821|580159158|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
160666283|NCT00795821|580159159|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
160666284|NCT00795821|580159158|FG000|Long-term Extension Phase|Physician Decision|1|||
160666285|NCT00795821|580159159|FG001|Long-term Extension Phase|Physician Decision|2|||
160666286|NCT00795821|580159158|FG000|Long-term Extension Phase|Protocol Violation|3|||
160666287|NCT00795821|580159159|FG001|Long-term Extension Phase|Protocol Violation|5|||
160666288|NCT00795821|580159158|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
160666289|NCT00795821|580159159|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
160666290|NCT00795821|580159158|FG000|Taper Phase|Adverse Event|2|||
160666291|NCT00795821|580159159|FG001|Taper Phase|Adverse Event|0|||
160666292|NCT00795821|580159158|FG000|Taper Phase|Lost to Follow-up|1|||
160666293|NCT00795821|580159159|FG001|Taper Phase|Lost to Follow-up|0|||
160622895|NCT00665366|579999673|FG000|Overall Study|No longer meets study criteria|0|||
160622896|NCT00665366|579999674|FG001|Overall Study|No longer meets study criteria|1|||
160622897|NCT00665366|579999673|FG000|Overall Study|Other reasons|4|||
160622898|NCT00665366|579999674|FG001|Overall Study|Other reasons|1|||
160622899|NCT03628781|579999675|FG000|Overall Study|Lost to Follow-up|16|||
160622900|NCT03628781|579999676|FG001|Overall Study|Lost to Follow-up|8|||
160622901|NCT03628781|579999675|FG000|Overall Study|Withdrawal by Subject|16|||
160622902|NCT03628781|579999676|FG001|Overall Study|Withdrawal by Subject|1|||
160622903|NCT03778021|579999677|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
160622904|NCT03778021|579999678|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
160622905|NCT02687815|579999679|FG000|Overall Study|Lost to Follow-up|2|||
160622906|NCT02687815|579999680|FG001|Overall Study|Lost to Follow-up|4|||
160622907|NCT02687815|579999679|FG000|Overall Study|Withdrawal by Subject|2|||
160622908|NCT02687815|579999680|FG001|Overall Study|Withdrawal by Subject|4|||
160622909|NCT01238861|579999687|FG000|Overall Study|Lost to Follow-up|4|||
160622910|NCT01238861|579999688|FG001|Overall Study|Lost to Follow-up|2|||
160622911|NCT01238861|579999689|FG002|Overall Study|Lost to Follow-up|3|||
160622912|NCT01238861|579999690|FG003|Overall Study|Lost to Follow-up|1|||
160622913|NCT01238861|579999691|FG004|Overall Study|Lost to Follow-up|1|||
160622914|NCT01238861|579999692|FG005|Overall Study|Lost to Follow-up|2|||
160622915|NCT01238861|579999687|FG000|Overall Study|Unplanned surgery|1|||
160622916|NCT01238861|579999688|FG001|Overall Study|Unplanned surgery|0|||
160622917|NCT01238861|579999689|FG002|Overall Study|Unplanned surgery|0|||
160622918|NCT01238861|579999690|FG003|Overall Study|Unplanned surgery|0|||
160622919|NCT01238861|579999691|FG004|Overall Study|Unplanned surgery|0|||
160622920|NCT01238861|579999692|FG005|Overall Study|Unplanned surgery|0|||
160622921|NCT01238861|579999687|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
160622922|NCT01238861|579999688|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
160622923|NCT01238861|579999689|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
160622924|NCT01238861|579999690|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
160622925|NCT01238861|579999691|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
160622926|NCT01238861|579999692|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
160622927|NCT01238861|579999687|FG000|Overall Study|Incorrect enrollment/randomization|0|||
160622928|NCT01238861|579999688|FG001|Overall Study|Incorrect enrollment/randomization|0|||
160622929|NCT01238861|579999689|FG002|Overall Study|Incorrect enrollment/randomization|1|||
160622930|NCT01238861|579999690|FG003|Overall Study|Incorrect enrollment/randomization|0|||
160622931|NCT01238861|579999691|FG004|Overall Study|Incorrect enrollment/randomization|1|||
160622932|NCT01238861|579999692|FG005|Overall Study|Incorrect enrollment/randomization|0|||
160622933|NCT01238861|579999687|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
160622934|NCT01238861|579999688|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
160622935|NCT01238861|579999689|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
160622936|NCT01238861|579999690|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
160622937|NCT01238861|579999691|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
160622938|NCT01238861|579999692|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
160622939|NCT01238861|579999687|FG000|Overall Study|Subject moved out of state/area|0|||
160666294|NCT00795821|580159158|FG000|Taper Phase|Physician Decision|2|||
160666295|NCT00795821|580159159|FG001|Taper Phase|Physician Decision|0|||
160666296|NCT00795821|580159158|FG000|Taper Phase|Withdrawal by Subject|4|||
160666297|NCT00795821|580159159|FG001|Taper Phase|Withdrawal by Subject|0|||
160666298|NCT00508651|580159164|FG000|Overall Study|Lost to Follow-up|3|||
160666299|NCT00508651|580159165|FG001|Overall Study|Lost to Follow-up|1|||
160666300|NCT00508651|580159164|FG000|Overall Study|Withdrawal by Subject|1|||
160513153|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
160513154|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
160513155|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Not Reported|0|||
160513156|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Not Reported|2|||
160513157|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
160513158|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
160513159|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
160513160|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
160513161|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
160513162|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
160513163|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
160513164|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
160513165|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
160513166|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
160513167|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
160513168|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
160513169|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
160513170|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
160513171|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
160513172|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
160513173|NCT01285609|579605237|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
160513174|NCT01285609|579605238|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
160513175|NCT01285609|579605237|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
160513176|NCT01285609|579605238|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
160513177|NCT01142115|579605239|FG000|First Intervention|Lack of Efficacy|1|||
160513178|NCT01142115|579605240|FG001|First Intervention|Lack of Efficacy|1|||
160513179|NCT01142115|579605239|FG000|First Intervention|Adverse Event|1|||
160513180|NCT01142115|579605240|FG001|First Intervention|Adverse Event|0|||
160513181|NCT03117998|579605245|FG000|Overall Study|Adverse Event|1|||
160513182|NCT03117998|579605246|FG001|Overall Study|Adverse Event|0|||
160513183|NCT03117998|579605247|FG002|Overall Study|Adverse Event|0|||
160513184|NCT03117998|579605248|FG003|Overall Study|Adverse Event|0|||
160622940|NCT01238861|579999688|FG001|Overall Study|Subject moved out of state/area|0|||
160622941|NCT01238861|579999689|FG002|Overall Study|Subject moved out of state/area|1|||
160622942|NCT01238861|579999690|FG003|Overall Study|Subject moved out of state/area|1|||
160622943|NCT01238861|579999691|FG004|Overall Study|Subject moved out of state/area|0|||
160622944|NCT01238861|579999692|FG005|Overall Study|Subject moved out of state/area|0|||
160622945|NCT01238861|579999687|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
160622946|NCT01238861|579999688|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
160622947|NCT01238861|579999689|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
160622948|NCT01238861|579999690|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
160622949|NCT01238861|579999691|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
160622950|NCT01238861|579999692|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
160622951|NCT01238861|579999687|FG000|Overall Study|Personal problems|0|||
160622952|NCT01238861|579999688|FG001|Overall Study|Personal problems|0|||
160622953|NCT01238861|579999689|FG002|Overall Study|Personal problems|0|||
160622954|NCT01238861|579999690|FG003|Overall Study|Personal problems|1|||
160622955|NCT01238861|579999691|FG004|Overall Study|Personal problems|0|||
160622956|NCT01238861|579999692|FG005|Overall Study|Personal problems|0|||
160622957|NCT01238861|579999687|FG000|Overall Study|Unable to continue visits|0|||
160622958|NCT01238861|579999688|FG001|Overall Study|Unable to continue visits|0|||
160622959|NCT01238861|579999689|FG002|Overall Study|Unable to continue visits|0|||
160622960|NCT01238861|579999690|FG003|Overall Study|Unable to continue visits|1|||
160622961|NCT01238861|579999691|FG004|Overall Study|Unable to continue visits|0|||
160622962|NCT01238861|579999692|FG005|Overall Study|Unable to continue visits|1|||
160622963|NCT01238861|579999687|FG000|Overall Study|Serious adverse event|0|||
160622964|NCT01238861|579999688|FG001|Overall Study|Serious adverse event|0|||
160622965|NCT01238861|579999689|FG002|Overall Study|Serious adverse event|0|||
160622966|NCT01238861|579999690|FG003|Overall Study|Serious adverse event|0|||
160622967|NCT01238861|579999691|FG004|Overall Study|Serious adverse event|0|||
160622968|NCT01238861|579999692|FG005|Overall Study|Serious adverse event|1|||
160622969|NCT01238861|579999687|FG000|Overall Study|Lack of compliance|0|||
160622970|NCT01238861|579999688|FG001|Overall Study|Lack of compliance|0|||
160622971|NCT01238861|579999689|FG002|Overall Study|Lack of compliance|0|||
160513185|NCT03117998|579605249|FG004|Overall Study|Adverse Event|0|||
160513186|NCT03117998|579605250|FG005|Overall Study|Adverse Event|0|||
160513187|NCT03117998|579605245|FG000|Overall Study|Withdrawal by Subject|0|||
160622972|NCT01238861|579999690|FG003|Overall Study|Lack of compliance|0|||
160622973|NCT01238861|579999691|FG004|Overall Study|Lack of compliance|0|||
160513188|NCT03117998|579605246|FG001|Overall Study|Withdrawal by Subject|0|||
160513189|NCT03117998|579605247|FG002|Overall Study|Withdrawal by Subject|2|||
160513190|NCT03117998|579605248|FG003|Overall Study|Withdrawal by Subject|3|||
160513191|NCT03117998|579605249|FG004|Overall Study|Withdrawal by Subject|3|||
160513192|NCT03117998|579605250|FG005|Overall Study|Withdrawal by Subject|0|||
160513193|NCT03117998|579605245|FG000|Overall Study|Physician Decision|0|||
160513194|NCT03117998|579605246|FG001|Overall Study|Physician Decision|1|||
160513195|NCT03117998|579605247|FG002|Overall Study|Physician Decision|1|||
160513196|NCT03117998|579605248|FG003|Overall Study|Physician Decision|0|||
160513197|NCT03117998|579605249|FG004|Overall Study|Physician Decision|0|||
160513198|NCT03117998|579605250|FG005|Overall Study|Physician Decision|0|||
160513199|NCT03117998|579605245|FG000|Overall Study|Lost to Follow-up|0|||
160513200|NCT03117998|579605246|FG001|Overall Study|Lost to Follow-up|0|||
160513201|NCT03117998|579605247|FG002|Overall Study|Lost to Follow-up|0|||
160513202|NCT03117998|579605248|FG003|Overall Study|Lost to Follow-up|1|||
160513203|NCT03117998|579605249|FG004|Overall Study|Lost to Follow-up|4|||
160513204|NCT03117998|579605250|FG005|Overall Study|Lost to Follow-up|0|||
160513205|NCT03117998|579605245|FG000|Overall Study|Subject noncompliance|0|||
160666301|NCT00508651|580159165|FG001|Overall Study|Withdrawal by Subject|1|||
160666302|NCT02146105|580159169|FG000|Overall Study|Adverse Event|1|||
160666303|NCT02146105|580159169|FG000|Overall Study|Withdrawal by Subject|5|||
160666304|NCT01319383|580159170|FG000|Overall Study|No ex vivo or in vivo response|4|||
160666305|NCT01319383|580159171|FG001|Overall Study|No ex vivo or in vivo response|0|||
160666306|NCT01319383|580159170|FG000|Overall Study|Physician Decision|3|||
160666307|NCT01319383|580159171|FG001|Overall Study|Physician Decision|0|||
160666308|NCT01319383|580159170|FG000|Overall Study|Lack of Efficacy|5|||
160513206|NCT03117998|579605246|FG001|Overall Study|Subject noncompliance|0|||
160513207|NCT03117998|579605247|FG002|Overall Study|Subject noncompliance|1|||
160513208|NCT03117998|579605248|FG003|Overall Study|Subject noncompliance|0|||
160513209|NCT03117998|579605249|FG004|Overall Study|Subject noncompliance|0|||
160513210|NCT03117998|579605250|FG005|Overall Study|Subject noncompliance|2|||
160513211|NCT03117998|579605245|FG000|Overall Study|Protocol Violation|0|||
160622974|NCT01238861|579999692|FG005|Overall Study|Lack of compliance|1|||
160622975|NCT01238861|579999687|FG000|Overall Study|Adverse Event|0|||
160622976|NCT01238861|579999688|FG001|Overall Study|Adverse Event|1|||
160622977|NCT01238861|579999689|FG002|Overall Study|Adverse Event|0|||
160622978|NCT01238861|579999690|FG003|Overall Study|Adverse Event|0|||
160622979|NCT01238861|579999691|FG004|Overall Study|Adverse Event|0|||
160622980|NCT01238861|579999692|FG005|Overall Study|Adverse Event|0|||
160622981|NCT01238861|579999687|FG000|Overall Study|Withdrawal by Subject|6|||
160622982|NCT01238861|579999688|FG001|Overall Study|Withdrawal by Subject|5|||
160622983|NCT01238861|579999689|FG002|Overall Study|Withdrawal by Subject|4|||
160622984|NCT01238861|579999690|FG003|Overall Study|Withdrawal by Subject|8|||
160622985|NCT01238861|579999691|FG004|Overall Study|Withdrawal by Subject|10|||
160622986|NCT01238861|579999692|FG005|Overall Study|Withdrawal by Subject|9|||
160622987|NCT01269346|579999693|FG000|Treatment Phase|Disease progression|3|||
160622988|NCT01269346|579999693|FG000|Treatment Phase|Adverse Event|3|||
160622989|NCT01269346|579999693|FG000|Treatment Phase|Withdrawal by Subject|1|||
160622990|NCT01269346|579999693|FG000|Treatment Phase|Other|2|||
160622991|NCT01269346|579999693|FG000|Extension Phase|Adverse Event|6|||
160622992|NCT01269346|579999693|FG000|Extension Phase|Withdrawal by Subject|4|||
160622993|NCT01269346|579999693|FG000|Extension Phase|Disease progression|22|||
160622994|NCT01269346|579999693|FG000|Extension Phase|Physician decision or participant choice|9|||
160622995|NCT01269346|579999693|FG000|Extension Phase|Clinical progression|1|||
160622996|NCT01269346|579999693|FG000|Extension Phase|Started a prohibited con med|1|||
160622997|NCT00247416|579999694|FG000|Overall Study|3 patients were found to be ineligible|1|||
160622998|NCT00247416|579999695|FG001|Overall Study|3 patients were found to be ineligible|2|||
160622999|NCT02660489|579999704|FG000|Overall Study|Lost to Follow-up|1|||
160623000|NCT02660489|579999705|FG001|Overall Study|Lost to Follow-up|1|||
160623001|NCT02660489|579999704|FG000|Overall Study|Adverse Event|1|||
160623002|NCT02660489|579999705|FG001|Overall Study|Adverse Event|3|||
160623003|NCT02660489|579999704|FG000|Overall Study|no rhinovirus infection|4|||
160623004|NCT02660489|579999705|FG001|Overall Study|no rhinovirus infection|4|||
160623005|NCT02322866|579999706|FG000|Overall Study|Adverse Event|6|||
160623006|NCT02322866|579999707|FG001|Overall Study|Adverse Event|11|||
160623007|NCT02322866|579999706|FG000|Overall Study|Withdrawal of Consent|16|||
160623008|NCT02322866|579999707|FG001|Overall Study|Withdrawal of Consent|25|||
160623009|NCT02322866|579999706|FG000|Overall Study|Lost to Follow-up|36|||
160666309|NCT01319383|580159171|FG001|Overall Study|Lack of Efficacy|9|||
160513212|NCT03117998|579605246|FG001|Overall Study|Protocol Violation|0|||
160513213|NCT03117998|579605247|FG002|Overall Study|Protocol Violation|0|||
160513214|NCT03117998|579605248|FG003|Overall Study|Protocol Violation|0|||
160623010|NCT02322866|579999707|FG001|Overall Study|Lost to Follow-up|39|||
160623011|NCT02322866|579999706|FG000|Overall Study|Protocol Violation|1|||
160666310|NCT01319383|580159170|FG000|Overall Study|No in vivo response to interval doses|0|||
160513215|NCT03117998|579605249|FG004|Overall Study|Protocol Violation|0|||
160513216|NCT03117998|579605250|FG005|Overall Study|Protocol Violation|1|||
160513217|NCT04927247|579605251|FG000|Overall Study|Other|2|||
160623012|NCT02322866|579999707|FG001|Overall Study|Protocol Violation|0|||
160666311|NCT01319383|580159171|FG001|Overall Study|No in vivo response to interval doses|1|||
160513218|NCT04927247|579605252|FG001|Overall Study|Other|1|||
160513219|NCT04927247|579605251|FG000|Overall Study|Physician Decision|0|||
160513220|NCT04927247|579605252|FG001|Overall Study|Physician Decision|1|||
160513221|NCT04927247|579605251|FG000|Overall Study|Adverse Event|1|||
160513222|NCT04927247|579605252|FG001|Overall Study|Adverse Event|0|||
160513223|NCT04828837|579605253|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
160513224|NCT04828837|579605254|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
160513225|NCT04828837|579605253|FG000|Overall Study|Lost to Follow-up|2|||
160513226|NCT04828837|579605254|FG001|Overall Study|Lost to Follow-up|6|||
160513227|NCT04828837|579605253|FG000|Overall Study|Lack of Efficacy|1|||
160513228|NCT04828837|579605254|FG001|Overall Study|Lack of Efficacy|0|||
160513229|NCT04828837|579605253|FG000|Overall Study|Admitted due to pneumothorax.|1|||
160513230|NCT04828837|579605254|FG001|Overall Study|Admitted due to pneumothorax.|0|||
160513231|NCT04828837|579605253|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
160513232|NCT04828837|579605254|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
160513233|NCT00320528|579605255|FG000|Study Period II|Adverse Event|3|||
160513234|NCT00320528|579605256|FG001|Study Period II|Adverse Event|4|||
160513235|NCT00320528|579605257|FG002|Study Period II|Adverse Event|8|||
160513236|NCT00320528|579605255|FG000|Study Period II|Parent/Caregiver Decision|8|||
160513237|NCT00320528|579605256|FG001|Study Period II|Parent/Caregiver Decision|3|||
160513238|NCT00320528|579605257|FG002|Study Period II|Parent/Caregiver Decision|11|||
160513239|NCT00320528|579605255|FG000|Study Period II|Withdrawal by Subject|0|||
160513240|NCT00320528|579605256|FG001|Study Period II|Withdrawal by Subject|1|||
160513241|NCT00320528|579605257|FG002|Study Period II|Withdrawal by Subject|1|||
160513242|NCT00320528|579605255|FG000|Study Period II|Entry Criteria Exclusion|0|||
160513243|NCT00320528|579605256|FG001|Study Period II|Entry Criteria Exclusion|2|||
160513244|NCT00320528|579605257|FG002|Study Period II|Entry Criteria Exclusion|2|||
160513245|NCT00320528|579605255|FG000|Study Period III|Adverse Event|1|||
160513246|NCT00320528|579605256|FG001|Study Period III|Adverse Event|0|||
160513247|NCT00320528|579605257|FG002|Study Period III|Adverse Event|0|||
160513248|NCT00320528|579605255|FG000|Study Period III|Lost to Follow-up|1|||
160513249|NCT00320528|579605256|FG001|Study Period III|Lost to Follow-up|0|||
160513250|NCT00320528|579605257|FG002|Study Period III|Lost to Follow-up|0|||
160513251|NCT00320528|579605255|FG000|Study Period III|Withdrawal by Subject|1|||
160513252|NCT00320528|579605256|FG001|Study Period III|Withdrawal by Subject|1|||
160513253|NCT00320528|579605257|FG002|Study Period III|Withdrawal by Subject|2|||
160513254|NCT00320528|579605255|FG000|Study Period III|Lack of Efficacy|2|||
160513255|NCT00320528|579605256|FG001|Study Period III|Lack of Efficacy|0|||
160513256|NCT00320528|579605257|FG002|Study Period III|Lack of Efficacy|0|||
160513257|NCT00320528|579605255|FG000|Study Period III|Parent/Caregiver Decision|14|||
160513258|NCT00320528|579605256|FG001|Study Period III|Parent/Caregiver Decision|3|||
160513259|NCT00320528|579605257|FG002|Study Period III|Parent/Caregiver Decision|11|||
160513260|NCT00320528|579605255|FG000|Study Period III|Protocol Violation|0|||
160513261|NCT00320528|579605256|FG001|Study Period III|Protocol Violation|1|||
160513262|NCT00320528|579605257|FG002|Study Period III|Protocol Violation|0|||
160513263|NCT00320528|579605255|FG000|Study Period III|Physician Decision|0|||
160513264|NCT00320528|579605256|FG001|Study Period III|Physician Decision|1|||
160513265|NCT00320528|579605257|FG002|Study Period III|Physician Decision|2|||
160513266|NCT00320528|579605255|FG000|Study Period III|Sponsor Decision|0|||
160513267|NCT00320528|579605256|FG001|Study Period III|Sponsor Decision|0|||
160513268|NCT00320528|579605257|FG002|Study Period III|Sponsor Decision|1|||
160666312|NCT03086460|580159174|FG000|Study Participants|Lost to Follow-up|2|||
160666313|NCT03086460|580159174|FG000|Study Participants|Protocol Violation|1|||
160666314|NCT03086460|580159174|FG000|Study Participants|Withdrawal by Subject|6|||
160666315|NCT03086460|580159174|FG000|Treatment A|Lost to Follow-up|1|||
160666316|NCT03086460|580159174|FG000|Treatment A|Protocol Violation|1|||
160666317|NCT03086460|580159174|FG000|Treatment A|Withdrawal by Subject|2|||
160666318|NCT03086460|580159174|FG000|Treatment C|Withdrawal by Subject|2|||
160666319|NCT03086460|580159174|FG000|Treatment E|Lost to Follow-up|1|||
160666320|NCT03086460|580159174|FG000|Treatment E|Withdrawal by Subject|3|||
160666321|NCT02718326|580159177|FG000|Overall Study|Adverse Event|4|||
160666322|NCT02718326|580159178|FG001|Overall Study|Adverse Event|9|||
160666323|NCT02718326|580159179|FG002|Overall Study|Adverse Event|0|||
160666324|NCT02718326|580159177|FG000|Overall Study|Death|8|||
160666325|NCT02718326|580159178|FG001|Overall Study|Death|1|||
160513269|NCT00320528|579605255|FG000|Study Period III|Atomoxetine Commercially Available|68|||
160513270|NCT00320528|579605256|FG001|Study Period III|Atomoxetine Commercially Available|25|||
160513271|NCT00320528|579605257|FG002|Study Period III|Atomoxetine Commercially Available|90|||
160513272|NCT01397422|579605258|FG000|Overall Study|Adverse Event|0|||
160513273|NCT01397422|579605259|FG001|Overall Study|Adverse Event|3|||
160513274|NCT01397422|579605260|FG002|Overall Study|Adverse Event|3|||
160513275|NCT01397422|579605261|FG003|Overall Study|Adverse Event|8|||
160513276|NCT01397422|579605258|FG000|Overall Study|Withdrawal by Subject|1|||
160513277|NCT01397422|579605259|FG001|Overall Study|Withdrawal by Subject|0|||
160513278|NCT01397422|579605260|FG002|Overall Study|Withdrawal by Subject|0|||
160666326|NCT02718326|580159179|FG002|Overall Study|Death|2|||
160666327|NCT02718326|580159177|FG000|Overall Study|Withdrawal by Subject|4|||
160513279|NCT01397422|579605261|FG003|Overall Study|Withdrawal by Subject|0|||
160513280|NCT01397422|579605258|FG000|Overall Study|Increased bradykinesia related to PD|1|||
160513281|NCT01397422|579605259|FG001|Overall Study|Increased bradykinesia related to PD|0|||
160513282|NCT01397422|579605260|FG002|Overall Study|Increased bradykinesia related to PD|0|||
160513283|NCT01397422|579605261|FG003|Overall Study|Increased bradykinesia related to PD|0|||
160513284|NCT00760474|579605267|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
160513285|NCT00760474|579605268|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
160513286|NCT00760474|579605267|FG000|Placebo Washout Period|Other|0|||
160513287|NCT00760474|579605268|FG001|Placebo Washout Period|Other|1|||
160513288|NCT00760474|579605267|FG000|Period 2 (P2)|Lost to Follow-up|1|||
160513289|NCT00760474|579605268|FG001|Period 2 (P2)|Lost to Follow-up|0|||
160513290|NCT00760474|579605267|FG000|Period 2 (P2)|Adverse Event|0|||
160513291|NCT00760474|579605268|FG001|Period 2 (P2)|Adverse Event|1|||
160623013|NCT02322866|579999706|FG000|Overall Study|Noncompliance with Treatment|3|||
160623014|NCT02322866|579999707|FG001|Overall Study|Noncompliance with Treatment|4|||
160623015|NCT02322866|579999706|FG000|Overall Study|Lack of Efficacy|3|||
160623016|NCT02322866|579999707|FG001|Overall Study|Lack of Efficacy|1|||
160623017|NCT02322866|579999706|FG000|Overall Study|Other Miscellaneous Reasons|6|||
160623018|NCT02322866|579999707|FG001|Overall Study|Other Miscellaneous Reasons|6|||
160623019|NCT03735680|579999710|FG000|Overall Study|Withdrawal by Subject|0|||
160623020|NCT03735680|579999711|FG001|Overall Study|Withdrawal by Subject|1|||
160623021|NCT03735680|579999712|FG002|Overall Study|Withdrawal by Subject|0|||
160623022|NCT03735680|579999713|FG003|Overall Study|Withdrawal by Subject|0|||
160623023|NCT03735680|579999714|FG004|Overall Study|Withdrawal by Subject|0|||
160623024|NCT03735680|579999715|FG005|Overall Study|Withdrawal by Subject|1|||
160623025|NCT03735680|579999710|FG000|Overall Study|Patient unable or unwilling to continue|0|||
160623026|NCT03735680|579999711|FG001|Overall Study|Patient unable or unwilling to continue|0|||
160623027|NCT03735680|579999712|FG002|Overall Study|Patient unable or unwilling to continue|1|||
160623028|NCT03735680|579999713|FG003|Overall Study|Patient unable or unwilling to continue|0|||
160623029|NCT03735680|579999714|FG004|Overall Study|Patient unable or unwilling to continue|0|||
160623030|NCT03735680|579999715|FG005|Overall Study|Patient unable or unwilling to continue|0|||
160623031|NCT03472586|579999729|FG000|Overall Study|Physician Decision|6|||
160623032|NCT03472586|579999729|FG000|Overall Study|Death|6|||
160623033|NCT03472586|579999729|FG000|Overall Study|Adverse Event|1|||
160623034|NCT01342445|579999730|FG000|Overall Study|Experienced side effects|0|||
160623035|NCT01342445|579999731|FG001|Overall Study|Experienced side effects|2|||
160623036|NCT02957149|579999734|FG000|Overall Study|Withdrawal by Subject|5|||
160623037|NCT06045026|579999735|FG000|Overall Study|Lost to Follow-up|60|||
160623038|NCT06045026|579999735|FG000|Overall Study|Adverse Event|12|||
160623039|NCT06045026|579999735|FG000|Overall Study|Withdrawal by Subject|3|||
160623040|NCT06045026|579999735|FG000|Overall Study|Enrollment closed|1|||
160623041|NCT01928758|579999736|FG000|Overall Study|Lost to Follow-up|14|||
160623042|NCT01928758|579999737|FG001|Overall Study|Lost to Follow-up|9|||
160623043|NCT01928758|579999736|FG000|Overall Study|Withdrawal by Subject|5|||
160623044|NCT01928758|579999737|FG001|Overall Study|Withdrawal by Subject|2|||
160623045|NCT01928758|579999736|FG000|Overall Study|Adverse Event|3|||
160623046|NCT01928758|579999737|FG001|Overall Study|Adverse Event|5|||
160623047|NCT01928758|579999736|FG000|Overall Study|Protocol Violation|3|||
160623048|NCT01928758|579999737|FG001|Overall Study|Protocol Violation|4|||
160623049|NCT02718131|579999738|FG000|Overall Study|Withdrawal by Subject|1|||
160623050|NCT02718131|579999739|FG001|Overall Study|Withdrawal by Subject|0|||
160623051|NCT02718131|579999738|FG000|Overall Study|Adverse Event|1|||
160623052|NCT02718131|579999739|FG001|Overall Study|Adverse Event|0|||
160623053|NCT02718131|579999738|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
160623054|NCT02718131|579999739|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
160623055|NCT02452320|579999740|FG000|Overall Study|Adverse Event|0|||
160623056|NCT02452320|579999741|FG001|Overall Study|Adverse Event|1|||
160623057|NCT03198559|579999742|FG000|Overall Study|Adverse Event|2|||
160623058|NCT03737812|579999743|FG000|Overall Study|Withdrawal by Subject|1|||
160623059|NCT03737812|579999744|FG001|Overall Study|Withdrawal by Subject|2|||
160623060|NCT03737812|579999745|FG002|Overall Study|Withdrawal by Subject|1|||
160623061|NCT03737812|579999743|FG000|Overall Study|Sponsor Discontinued the Study|4|||
160623062|NCT03737812|579999744|FG001|Overall Study|Sponsor Discontinued the Study|3|||
160623063|NCT03737812|579999745|FG002|Overall Study|Sponsor Discontinued the Study|2|||
160623064|NCT03737812|579999743|FG000|Overall Study|Adverse Event|0|||
160623065|NCT03737812|579999744|FG001|Overall Study|Adverse Event|1|||
160513292|NCT04664400|579605269|FG000|Overall Study|Withdrawal by Subject|2|||
160513293|NCT01394978|579605273|FG000|Overall Study|Withdrawal by Subject|2|||
160623066|NCT03737812|579999745|FG002|Overall Study|Adverse Event|0|||
160623067|NCT03737812|579999743|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
160623068|NCT03737812|579999744|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
160513294|NCT01394978|579605274|FG001|Overall Study|Withdrawal by Subject|4|||
160513295|NCT01394978|579605273|FG000|Overall Study|Lost to Follow-up|13|||
160623069|NCT03737812|579999745|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
160623070|NCT01474291|579999749|FG000|Overall Study|Not Evaluable for Efficacy|26|||
160623071|NCT01474291|579999749|FG000|Overall Study|Lack of Treatment Efficacy|88|||
160623072|NCT01474291|579999749|FG000|Overall Study|Adverse Event|53|||
160623073|NCT01474291|579999749|FG000|Overall Study|Lost to Follow-up|29|||
160623074|NCT01474291|579999749|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
160623075|NCT01474291|579999749|FG000|Overall Study|No Reason Reported|10|||
160623076|NCT01474291|579999749|FG000|Overall Study|Death|2|||
160623077|NCT03471507|579999750|FG000|Overall Study|Lost to Follow-up|1|||
160623078|NCT03471507|579999751|FG001|Overall Study|Lost to Follow-up|3|||
160623079|NCT03471507|579999750|FG000|Overall Study|Physician Decision|0|||
160623080|NCT03471507|579999751|FG001|Overall Study|Physician Decision|1|||
160623081|NCT03471507|579999750|FG000|Overall Study|Withdrawal by Subject|2|||
160623082|NCT03471507|579999751|FG001|Overall Study|Withdrawal by Subject|1|||
160623083|NCT01399619|579999753|FG000|Overall Study|Adverse Event|10|||
160623084|NCT01399619|579999754|FG001|Overall Study|Adverse Event|0|||
160623085|NCT01399619|579999755|FG002|Overall Study|Adverse Event|4|||
160623086|NCT01399619|579999756|FG003|Overall Study|Adverse Event|10|||
160623087|NCT01399619|579999753|FG000|Overall Study|Lack of Efficacy|9|||
160623088|NCT01399619|579999754|FG001|Overall Study|Lack of Efficacy|0|||
160623089|NCT01399619|579999755|FG002|Overall Study|Lack of Efficacy|5|||
160623090|NCT01399619|579999756|FG003|Overall Study|Lack of Efficacy|0|||
160623091|NCT01399619|579999753|FG000|Overall Study|Withdrawal by Subject|6|||
160623092|NCT01399619|579999754|FG001|Overall Study|Withdrawal by Subject|0|||
160623093|NCT01399619|579999755|FG002|Overall Study|Withdrawal by Subject|3|||
160623094|NCT01399619|579999756|FG003|Overall Study|Withdrawal by Subject|4|||
160623095|NCT01399619|579999753|FG000|Overall Study|Protocol Violation|0|||
160623096|NCT01399619|579999754|FG001|Overall Study|Protocol Violation|0|||
160623097|NCT01399619|579999755|FG002|Overall Study|Protocol Violation|0|||
160623098|NCT01399619|579999756|FG003|Overall Study|Protocol Violation|1|||
160623099|NCT01399619|579999753|FG000|Overall Study|Not treated|0|||
160623100|NCT01399619|579999754|FG001|Overall Study|Not treated|0|||
160623101|NCT01399619|579999755|FG002|Overall Study|Not treated|0|||
160623102|NCT01399619|579999756|FG003|Overall Study|Not treated|2|||
160623103|NCT02557308|579999759|FG000|Overall Study|Withdrawal by Subject|11|||
160623104|NCT02557308|579999760|FG001|Overall Study|Withdrawal by Subject|3|||
160623105|NCT02557308|579999761|FG002|Overall Study|Withdrawal by Subject|2|||
160623106|NCT02557308|579999762|FG003|Overall Study|Withdrawal by Subject|0|||
160623107|NCT02557308|579999763|FG004|Overall Study|Withdrawal by Subject|1|||
160623108|NCT02557308|579999764|FG005|Overall Study|Withdrawal by Subject|0|||
160623109|NCT02557308|579999765|FG006|Overall Study|Withdrawal by Subject|10|||
160623110|NCT02557308|579999766|FG007|Overall Study|Withdrawal by Subject|1|||
160623111|NCT02557308|579999759|FG000|Overall Study|Disease Progression|0|||
160623112|NCT02557308|579999760|FG001|Overall Study|Disease Progression|1|||
160623113|NCT02557308|579999761|FG002|Overall Study|Disease Progression|0|||
160623114|NCT02557308|579999762|FG003|Overall Study|Disease Progression|0|||
160623115|NCT02557308|579999763|FG004|Overall Study|Disease Progression|0|||
160623116|NCT02557308|579999764|FG005|Overall Study|Disease Progression|0|||
160623117|NCT02557308|579999765|FG006|Overall Study|Disease Progression|0|||
160623118|NCT02557308|579999766|FG007|Overall Study|Disease Progression|0|||
160623119|NCT02557308|579999759|FG000|Overall Study|Lack of Efficacy|3|||
160623120|NCT02557308|579999760|FG001|Overall Study|Lack of Efficacy|0|||
160623121|NCT02557308|579999761|FG002|Overall Study|Lack of Efficacy|0|||
160623122|NCT02557308|579999762|FG003|Overall Study|Lack of Efficacy|0|||
160623123|NCT02557308|579999763|FG004|Overall Study|Lack of Efficacy|0|||
160623124|NCT02557308|579999764|FG005|Overall Study|Lack of Efficacy|0|||
160623125|NCT02557308|579999765|FG006|Overall Study|Lack of Efficacy|1|||
160623126|NCT02557308|579999766|FG007|Overall Study|Lack of Efficacy|0|||
160623127|NCT02557308|579999759|FG000|Overall Study|Adverse Event|4|||
160623128|NCT02557308|579999760|FG001|Overall Study|Adverse Event|1|||
160623129|NCT02557308|579999761|FG002|Overall Study|Adverse Event|2|||
160623130|NCT02557308|579999762|FG003|Overall Study|Adverse Event|0|||
160623131|NCT02557308|579999763|FG004|Overall Study|Adverse Event|0|||
160623132|NCT02557308|579999764|FG005|Overall Study|Adverse Event|0|||
160623133|NCT02557308|579999765|FG006|Overall Study|Adverse Event|4|||
160623134|NCT02557308|579999766|FG007|Overall Study|Adverse Event|1|||
160623135|NCT02557308|579999759|FG000|Overall Study|Lost to Follow-up|2|||
160623136|NCT02557308|579999760|FG001|Overall Study|Lost to Follow-up|0|||
160623137|NCT02557308|579999761|FG002|Overall Study|Lost to Follow-up|1|||
160623138|NCT02557308|579999762|FG003|Overall Study|Lost to Follow-up|0|||
160623139|NCT02557308|579999763|FG004|Overall Study|Lost to Follow-up|0|||
160623140|NCT02557308|579999764|FG005|Overall Study|Lost to Follow-up|0|||
160623141|NCT02557308|579999765|FG006|Overall Study|Lost to Follow-up|2|||
160623142|NCT02557308|579999766|FG007|Overall Study|Lost to Follow-up|0|||
160623143|NCT02557308|579999759|FG000|Overall Study|Death|1|||
160623144|NCT02557308|579999760|FG001|Overall Study|Death|0|||
160623145|NCT02557308|579999761|FG002|Overall Study|Death|0|||
160623146|NCT02557308|579999762|FG003|Overall Study|Death|0|||
160623147|NCT02557308|579999763|FG004|Overall Study|Death|0|||
160623148|NCT02557308|579999764|FG005|Overall Study|Death|0|||
160623149|NCT02557308|579999765|FG006|Overall Study|Death|0|||
160623150|NCT02557308|579999766|FG007|Overall Study|Death|0|||
160623151|NCT02557308|579999759|FG000|Overall Study|Study Close|98|||
160666328|NCT02718326|580159178|FG001|Overall Study|Withdrawal by Subject|9|||
160666329|NCT02718326|580159179|FG002|Overall Study|Withdrawal by Subject|6|||
160666330|NCT02718326|580159177|FG000|Overall Study|Lost to Follow-up|18|||
160666331|NCT02718326|580159178|FG001|Overall Study|Lost to Follow-up|5|||
160666332|NCT02718326|580159179|FG002|Overall Study|Lost to Follow-up|14|||
160666333|NCT02718326|580159177|FG000|Overall Study|Protocol Deviation|1|||
160666334|NCT02718326|580159178|FG001|Overall Study|Protocol Deviation|0|||
160666335|NCT02718326|580159179|FG002|Overall Study|Protocol Deviation|0|||
160666336|NCT02718326|580159177|FG000|Overall Study|Pregnancy|1|||
160666337|NCT02718326|580159178|FG001|Overall Study|Pregnancy|0|||
160666338|NCT02718326|580159179|FG002|Overall Study|Pregnancy|0|||
160666339|NCT00583453|580159183|FG000|Overall Study|discontinued intervention|0|||
160666340|NCT00583453|580159184|FG001|Overall Study|discontinued intervention|2|||
160666341|NCT00905606|580159185|FG000|Period 1|Adverse Event|0|||
160666342|NCT00905606|580159186|FG001|Period 1|Adverse Event|1|||
160666343|NCT00905606|580159185|FG000|Washout|Withdrawal by Subject|1|||
160666344|NCT00905606|580159186|FG001|Washout|Withdrawal by Subject|0|||
160666345|NCT03868891|580159189|FG000|Overall Study|Adverse Event|1|||
160666346|NCT03868891|580159190|FG001|Overall Study|Adverse Event|0|||
160666347|NCT03868891|580159189|FG000|Overall Study|Lost to Follow-up|2|||
160666348|NCT03868891|580159190|FG001|Overall Study|Lost to Follow-up|1|||
160666349|NCT03868891|580159189|FG000|Overall Study|COVID-19 Restrictions|1|||
160666350|NCT03868891|580159190|FG001|Overall Study|COVID-19 Restrictions|2|||
160666351|NCT02246920|580159191|FG000|Overall Study|Adverse Event|3|||
160666352|NCT02246920|580159192|FG001|Overall Study|Adverse Event|1|||
160666353|NCT02246920|580159193|FG002|Overall Study|Adverse Event|1|||
160666354|NCT02246920|580159191|FG000|Overall Study|Lost to Follow-up|2|||
160666355|NCT02246920|580159192|FG001|Overall Study|Lost to Follow-up|1|||
160666356|NCT02246920|580159193|FG002|Overall Study|Lost to Follow-up|0|||
160666357|NCT02246920|580159191|FG000|Overall Study|Protocol Violation|2|||
160666358|NCT02246920|580159192|FG001|Overall Study|Protocol Violation|5|||
160666359|NCT02246920|580159193|FG002|Overall Study|Protocol Violation|1|||
160666360|NCT02246920|580159191|FG000|Overall Study|Withdrawal by Subject|0|||
160666361|NCT02246920|580159192|FG001|Overall Study|Withdrawal by Subject|0|||
160666362|NCT02246920|580159193|FG002|Overall Study|Withdrawal by Subject|1|||
160666363|NCT02678286|580159194|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
160666364|NCT02678286|580159195|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
160666365|NCT02678286|580159194|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
160666366|NCT02678286|580159195|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
160666367|NCT02678286|580159194|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
160666368|NCT02678286|580159195|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
160666369|NCT02678286|580159194|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
160666370|NCT02678286|580159195|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
160666371|NCT02678286|580159194|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
160666372|NCT02678286|580159195|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
160666373|NCT01363765|580159196|FG000|Overall Study|non-diagnostic|2621|||
160666374|NCT01363765|580159197|FG001|Overall Study|non-diagnostic|1124|||
160666375|NCT01363765|580159196|FG000|Overall Study|duplicate records|736|||
160666376|NCT01363765|580159197|FG001|Overall Study|duplicate records|3177|||
160666377|NCT01363765|580159196|FG000|Overall Study|non-resident|156|||
160666378|NCT01363765|580159197|FG001|Overall Study|non-resident|76|||
160666379|NCT01363765|580159196|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
160666380|NCT01363765|580159197|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
160666381|NCT01363765|580159196|FG000|Overall Study|smear during intervention|2170|||
160666382|NCT01363765|580159197|FG001|Overall Study|smear during intervention|0|||
160666383|NCT03247972|580159198|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
160666384|NCT03247972|580159198|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
160666385|NCT00609674|580159199|FG000|Overall Study|Adverse Event|1|||
160666386|NCT00609674|580159200|FG001|Overall Study|Adverse Event|1|||
160666387|NCT00609674|580159199|FG000|Overall Study|Protocol Violation|3|||
160666388|NCT00609674|580159200|FG001|Overall Study|Protocol Violation|5|||
160666389|NCT00609674|580159199|FG000|Overall Study|Lost to Follow-up|1|||
160666390|NCT00609674|580159200|FG001|Overall Study|Lost to Follow-up|0|||
160666391|NCT00609674|580159199|FG000|Overall Study|Withdrew consent|2|||
160666392|NCT00609674|580159200|FG001|Overall Study|Withdrew consent|1|||
160666393|NCT04408794|580159201|FG000|Overall Study|Adverse Event|43|||
160666394|NCT04408794|580159201|FG000|Overall Study|Infrequent study drug usage|43|||
160666395|NCT04408794|580159201|FG000|Overall Study|Lack of Efficacy|61|||
160666396|NCT04408794|580159201|FG000|Overall Study|Lost to Follow-up|33|||
160666397|NCT04408794|580159201|FG000|Overall Study|Non-compliance|6|||
160666398|NCT04408794|580159201|FG000|Overall Study|Physician Decision|1|||
160666399|NCT04408794|580159201|FG000|Overall Study|Pregnancy|6|||
160666400|NCT04408794|580159201|FG000|Overall Study|Protocol Deviation|9|||
160666401|NCT04408794|580159201|FG000|Overall Study|Sheehan-STS Result|1|||
160666402|NCT04408794|580159201|FG000|Overall Study|Withdrawal by Subject|57|||
160666403|NCT04408794|580159201|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
160666404|NCT04408794|580159201|FG000|Overall Study|Never Treated Migraine|5|||
160513296|NCT01394978|579605274|FG001|Overall Study|Lost to Follow-up|20|||
160513297|NCT01394978|579605273|FG000|Overall Study|Death|6|||
160513298|NCT01394978|579605274|FG001|Overall Study|Death|7|||
160513299|NCT01758900|579605279|FG000|Overall Study|difficulty for further intubation|7|||
160513300|NCT01758900|579605280|FG001|Overall Study|difficulty for further intubation|8|||
160513301|NCT04577001|579605281|FG000|Overall Study|Subject became ineligible|0|||
160513302|NCT04577001|579605282|FG001|Overall Study|Subject became ineligible|1|||
160513303|NCT02592876|579605287|FG000|Overall Study|Withdrawal by Subject|3|||
160513304|NCT02592876|579605288|FG001|Overall Study|Withdrawal by Subject|3|||
160513305|NCT02592876|579605287|FG000|Overall Study|Study Termination by Sponsor|32|||
160513306|NCT02592876|579605288|FG001|Overall Study|Study Termination by Sponsor|27|||
160513307|NCT02592876|579605287|FG000|Overall Study|Lost to Follow-up|0|||
160513308|NCT02592876|579605288|FG001|Overall Study|Lost to Follow-up|1|||
160513309|NCT02592876|579605287|FG000|Overall Study|Death|6|||
160513310|NCT02592876|579605288|FG001|Overall Study|Death|9|||
160513311|NCT00867308|579605289|FG000|Overall Study|Death|1|||
160513312|NCT00867308|579605290|FG001|Overall Study|Death|0|||
160513313|NCT00867308|579605289|FG000|Overall Study|Adverse Event|1|||
160513314|NCT00867308|579605290|FG001|Overall Study|Adverse Event|4|||
160513315|NCT00867308|579605289|FG000|Overall Study|Lack of Efficacy|6|||
160513316|NCT00867308|579605290|FG001|Overall Study|Lack of Efficacy|12|||
160513317|NCT00867308|579605289|FG000|Overall Study|Withdrawal by Subject|1|||
160513318|NCT00867308|579605290|FG001|Overall Study|Withdrawal by Subject|2|||
160513319|NCT00432666|579607153|FG000|Main Period|Adverse Event|1|||
160513320|NCT00432666|579607154|FG001|Main Period|Adverse Event|1|||
160513321|NCT00432666|579607153|FG000|Main Period|Consent Withdrawn|1|||
160513322|NCT00432666|579607154|FG001|Main Period|Consent Withdrawn|0|||
160513323|NCT00432666|579607153|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
160513324|NCT00432666|579607154|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
160513325|NCT00432666|579607153|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
160513326|NCT00432666|579607154|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
160513327|NCT00432666|579607153|FG000|Open-Label Extension Period|Adverse Event|5|||
160513328|NCT00432666|579607154|FG001|Open-Label Extension Period|Adverse Event|0|||
160513329|NCT00432666|579607153|FG000|Open-Label Extension Period|Consent withdrawn|10|||
160513330|NCT00432666|579607154|FG001|Open-Label Extension Period|Consent withdrawn|0|||
160513331|NCT00432666|579607153|FG000|Open-Label Extension Period|Physician Decision|3|||
160513332|NCT00432666|579607154|FG001|Open-Label Extension Period|Physician Decision|0|||
160513333|NCT01506453|579607155|FG000|Overall Study|Withdrawal prior to treatment|0|||
160513334|NCT01506453|579607156|FG001|Overall Study|Withdrawal prior to treatment|2|||
160513335|NCT02594163|579607167|FG000|Treatment Period|Progressive disease|2|||
160513336|NCT02594163|579607168|FG001|Treatment Period|Progressive disease|3|||
160513337|NCT02594163|579607167|FG000|Treatment Period|Adverse Event|1|||
160513338|NCT02594163|579607168|FG001|Treatment Period|Adverse Event|5|||
160513339|NCT02594163|579607167|FG000|Treatment Period|Physician Decision|1|||
160513340|NCT02594163|579607168|FG001|Treatment Period|Physician Decision|3|||
160513341|NCT02594163|579607167|FG000|Treatment Period|Study termination by sponsor|2|||
160513342|NCT02594163|579607168|FG001|Treatment Period|Study termination by sponsor|1|||
160513343|NCT02594163|579607167|FG000|Treatment Period|Other, Non-AE|1|||
160513344|NCT02594163|579607168|FG001|Treatment Period|Other, Non-AE|0|||
160513345|NCT02594163|579607167|FG000|Follow-up Period|Withdrawal by Subject|0|||
160513346|NCT02594163|579607168|FG001|Follow-up Period|Withdrawal by Subject|1|||
160513347|NCT02594163|579607167|FG000|Follow-up Period|Study Termination by Sponsor|6|||
160513348|NCT02594163|579607168|FG001|Follow-up Period|Study Termination by Sponsor|4|||
160513349|NCT02594163|579607167|FG000|Follow-up Period|Lost to Follow-up|1|||
160513350|NCT02594163|579607168|FG001|Follow-up Period|Lost to Follow-up|0|||
160513351|NCT02594163|579607167|FG000|Follow-up Period|Death|2|||
160513352|NCT02594163|579607168|FG001|Follow-up Period|Death|5|||
160513353|NCT02594163|579607167|FG000|Follow-up Period|Adverse Event|0|||
160513354|NCT02594163|579607168|FG001|Follow-up Period|Adverse Event|1|||
160513355|NCT02594163|579607167|FG000|Follow-up Period|Progressive Disease|2|||
160513356|NCT02594163|579607168|FG001|Follow-up Period|Progressive Disease|0|||
160513357|NCT02594163|579607167|FG000|Follow-up Period|Physician Decision|0|||
160623152|NCT02557308|579999760|FG001|Overall Study|Study Close|18|||
160623153|NCT02557308|579999761|FG002|Overall Study|Study Close|5|||
160623154|NCT02557308|579999762|FG003|Overall Study|Study Close|3|||
160513358|NCT02594163|579607168|FG001|Follow-up Period|Physician Decision|1|||
160513359|NCT01022268|579607171|FG000|Overall Study|Withdrawal by Subject|1|||
160623155|NCT02557308|579999763|FG004|Overall Study|Study Close|1|||
160513360|NCT01022268|579607172|FG001|Overall Study|Withdrawal by Subject|0|||
160513361|NCT01022268|579607171|FG000|Overall Study|Withdrawal by Subject|1|||
160513362|NCT01022268|579607172|FG001|Overall Study|Withdrawal by Subject|0|||
160513363|NCT00734097|579607173|FG000|Screening|Protocol Violation|12|||
160513364|NCT00734097|579607173|FG000|Screening|Withdrawal by Subject|5|||
160513365|NCT00734097|579607173|FG000|Screening|Lost to Follow-up|2|||
160513366|NCT00734097|579607173|FG000|Screening|Unconfirmed pregnancy|1|||
160513367|NCT00734097|579607173|FG000|Open Label|Lost to Follow-up|7|||
160623156|NCT02557308|579999764|FG005|Overall Study|Study Close|0|||
160623157|NCT02557308|579999765|FG006|Overall Study|Study Close|123|||
160513368|NCT00734097|579607173|FG000|Open Label|Withdrawal by Subject|5|||
160513369|NCT00734097|579607173|FG000|Open Label|Protocol Violation|4|||
160513370|NCT02233543|579607176|FG000|Period 1|Withdrawal by Subject|1|||
160513371|NCT02233543|579607177|FG001|Period 1|Withdrawal by Subject|0|||
160513372|NCT02233543|579607176|FG000|Period 1|Participants required other treatment.|2|||
160513373|NCT02233543|579607177|FG001|Period 1|Participants required other treatment.|3|||
160513374|NCT02233543|579607176|FG000|Period 2|Adverse Event|1|||
160513375|NCT02233543|579607177|FG001|Period 2|Adverse Event|0|||
160513376|NCT02233543|579607176|FG000|Period 2|Participant required other treatment.|0|||
160513377|NCT02233543|579607177|FG001|Period 2|Participant required other treatment.|1|||
160513378|NCT02233543|579607176|FG000|Period 2|COPD exacerbation|1|||
160513379|NCT02233543|579607177|FG001|Period 2|COPD exacerbation|0|||
160513380|NCT01302067|579607178|FG000|Overall Study|Death|0|||
160513381|NCT01302067|579607179|FG001|Overall Study|Death|0|||
160513382|NCT01302067|579607180|FG002|Overall Study|Death|1|||
160513383|NCT01302067|579607178|FG000|Overall Study|Physician Decision|9|||
160513384|NCT01302067|579607179|FG001|Overall Study|Physician Decision|5|||
160513385|NCT01302067|579607180|FG002|Overall Study|Physician Decision|14|||
160513386|NCT01302067|579607178|FG000|Overall Study|Lack of Efficacy|8|||
160513387|NCT01302067|579607179|FG001|Overall Study|Lack of Efficacy|4|||
160513388|NCT01302067|579607180|FG002|Overall Study|Lack of Efficacy|2|||
160513389|NCT01302067|579607178|FG000|Overall Study|Lost to Follow-up|9|||
160513390|NCT01302067|579607179|FG001|Overall Study|Lost to Follow-up|4|||
160513391|NCT01302067|579607180|FG002|Overall Study|Lost to Follow-up|15|||
160513392|NCT01302067|579607178|FG000|Overall Study|Withdrawal by Subject|13|||
160513393|NCT01302067|579607179|FG001|Overall Study|Withdrawal by Subject|6|||
160513394|NCT01302067|579607180|FG002|Overall Study|Withdrawal by Subject|10|||
160513395|NCT01302067|579607178|FG000|Overall Study|Other|1|||
160513396|NCT01302067|579607179|FG001|Overall Study|Other|1|||
160513397|NCT01302067|579607180|FG002|Overall Study|Other|3|||
160513398|NCT01302067|579607178|FG000|Overall Study|Protocol Violation|11|||
160513399|NCT01302067|579607179|FG001|Overall Study|Protocol Violation|0|||
160513400|NCT01302067|579607180|FG002|Overall Study|Protocol Violation|8|||
160513401|NCT01302067|579607178|FG000|Overall Study|Adverse Event|27|||
160513402|NCT01302067|579607179|FG001|Overall Study|Adverse Event|14|||
160513403|NCT01302067|579607180|FG002|Overall Study|Adverse Event|45|||
160513404|NCT00603304|579607181|FG000|Overall Study|Lost to Follow-up|5|||
160513405|NCT00603304|579607182|FG001|Overall Study|Lost to Follow-up|7|||
160513406|NCT00603304|579607181|FG000|Overall Study|Withdrawal by Subject|8|||
160513407|NCT00603304|579607182|FG001|Overall Study|Withdrawal by Subject|5|||
160513408|NCT00603304|579607181|FG000|Overall Study|Protocol Violation|1|||
160513409|NCT00603304|579607182|FG001|Overall Study|Protocol Violation|0|||
160513410|NCT00603304|579607181|FG000|Overall Study|Adverse Event|4|||
160513411|NCT00603304|579607182|FG001|Overall Study|Adverse Event|2|||
160513412|NCT00603304|579607181|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
160513413|NCT00603304|579607182|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
160513414|NCT00603304|579607181|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
160513415|NCT00603304|579607182|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
160513416|NCT00603304|579607181|FG000|Overall Study|Exclusionary Medication|2|||
160513417|NCT00603304|579607182|FG001|Overall Study|Exclusionary Medication|3|||
160513418|NCT00603304|579607181|FG000|Overall Study|Non-Compliant|0|||
160513419|NCT00603304|579607182|FG001|Overall Study|Non-Compliant|1|||
160513420|NCT00603304|579607181|FG000|Overall Study|Moved Away|0|||
160513421|NCT00603304|579607182|FG001|Overall Study|Moved Away|2|||
160513422|NCT00603304|579607181|FG000|Overall Study|Other|2|||
160513423|NCT00603304|579607182|FG001|Overall Study|Other|0|||
160513424|NCT00603304|579607181|FG000|Overall Study|Patient Decision|2|||
160513425|NCT00603304|579607182|FG001|Overall Study|Patient Decision|0|||
160513426|NCT01076192|579607183|FG000|Overall Study|Other|197|||
160513427|NCT01034176|579607184|FG000|Overall Study|Physician Decision|2|||
160513428|NCT01034176|579607185|FG001|Overall Study|Physician Decision|0|||
160513429|NCT01034176|579607184|FG000|Overall Study|Withdrawal by Subject|0|||
160513430|NCT01034176|579607185|FG001|Overall Study|Withdrawal by Subject|1|||
160513431|NCT01034176|579607184|FG000|Overall Study|Lost to Follow-up|0|||
160513432|NCT01034176|579607185|FG001|Overall Study|Lost to Follow-up|1|||
160513433|NCT02924428|579607188|FG000|Overall Study|Adverse Event|1|||
160513434|NCT02924428|579607189|FG001|Overall Study|Adverse Event|0|||
160513435|NCT02924428|579607188|FG000|Overall Study|Physician Decision|1|||
160513436|NCT02924428|579607189|FG001|Overall Study|Physician Decision|0|||
160513437|NCT02924428|579607188|FG000|Overall Study|Lost to Follow-up|2|||
160513438|NCT02924428|579607189|FG001|Overall Study|Lost to Follow-up|4|||
160513439|NCT02924428|579607188|FG000|Overall Study|Pregnancy|0|||
160513440|NCT02924428|579607189|FG001|Overall Study|Pregnancy|1|||
160513441|NCT03241225|579607193|FG000|Overall Study|Lost to Follow-up|2|||
160513442|NCT03241225|579607194|FG001|Overall Study|Lost to Follow-up|1|||
160513443|NCT03241225|579607193|FG000|Overall Study|Protocol Violation|4|||
160513444|NCT03241225|579607194|FG001|Overall Study|Protocol Violation|1|||
160623158|NCT02557308|579999766|FG007|Overall Study|Study Close|5|||
160623159|NCT02557308|579999759|FG000|Overall Study|Except for study close|5|||
160623160|NCT02557308|579999760|FG001|Overall Study|Except for study close|0|||
160623161|NCT02557308|579999761|FG002|Overall Study|Except for study close|0|||
160623162|NCT02557308|579999762|FG003|Overall Study|Except for study close|0|||
160623163|NCT02557308|579999763|FG004|Overall Study|Except for study close|3|||
160623164|NCT02557308|579999764|FG005|Overall Study|Except for study close|0|||
160623165|NCT02557308|579999765|FG006|Overall Study|Except for study close|6|||
160623166|NCT02557308|579999766|FG007|Overall Study|Except for study close|10|||
160623167|NCT03911401|579999767|FG000|Overall Study|Adverse Event|1|||
160623168|NCT03911401|579999768|FG001|Overall Study|Adverse Event|2|||
160623169|NCT03911401|579999769|FG002|Overall Study|Adverse Event|5|||
160623170|NCT03911401|579999767|FG000|Overall Study|Lack of Efficacy|1|||
160623171|NCT03911401|579999768|FG001|Overall Study|Lack of Efficacy|1|||
160623172|NCT03911401|579999769|FG002|Overall Study|Lack of Efficacy|8|||
160623173|NCT03911401|579999767|FG000|Overall Study|Physician Decision|0|||
160623174|NCT03911401|579999768|FG001|Overall Study|Physician Decision|0|||
160623175|NCT03911401|579999769|FG002|Overall Study|Physician Decision|1|||
160623176|NCT03911401|579999767|FG000|Overall Study|Withdrawal by Subject|1|||
160623177|NCT03911401|579999768|FG001|Overall Study|Withdrawal by Subject|2|||
160623178|NCT03911401|579999769|FG002|Overall Study|Withdrawal by Subject|0|||
160623179|NCT03911401|579999767|FG000|Overall Study|Withdrawal by parent/guardian|4|||
160623180|NCT03911401|579999768|FG001|Overall Study|Withdrawal by parent/guardian|4|||
160623181|NCT03911401|579999769|FG002|Overall Study|Withdrawal by parent/guardian|11|||
160623182|NCT03417245|579999771|FG000|Overall Study|Adverse Event|1|||
160623183|NCT03417245|579999772|FG001|Overall Study|Adverse Event|0|||
160623184|NCT03417245|579999771|FG000|Overall Study|Protocol Violation|1|||
160623185|NCT03417245|579999772|FG001|Overall Study|Protocol Violation|0|||
160623186|NCT03417245|579999771|FG000|Overall Study|Withdrawal by Subject|1|||
160623187|NCT03417245|579999772|FG001|Overall Study|Withdrawal by Subject|1|||
160623188|NCT02046993|579999773|FG000|Overall Study|Withdrawal by Subject|2|||
160623189|NCT02046993|579999774|FG001|Overall Study|Withdrawal by Subject|10|||
160623190|NCT02046993|579999773|FG000|Overall Study|Lost to Follow-up|1|||
160623191|NCT02046993|579999774|FG001|Overall Study|Lost to Follow-up|1|||
160623192|NCT00598442|579999780|FG000|Overall Study|Adverse Event|3|||
160623193|NCT00598442|579999781|FG001|Overall Study|Adverse Event|0|||
160623194|NCT00598442|579999782|FG002|Overall Study|Adverse Event|0|||
160623195|NCT00598442|579999780|FG000|Overall Study|Death|19|||
160623196|NCT00598442|579999781|FG001|Overall Study|Death|11|||
160623197|NCT00598442|579999782|FG002|Overall Study|Death|11|||
160623198|NCT00598442|579999780|FG000|Overall Study|Lost to Follow-up|4|||
160623199|NCT00598442|579999781|FG001|Overall Study|Lost to Follow-up|3|||
160623200|NCT00598442|579999782|FG002|Overall Study|Lost to Follow-up|3|||
160623201|NCT00598442|579999780|FG000|Overall Study|Physician Decision|2|||
160623202|NCT00598442|579999781|FG001|Overall Study|Physician Decision|1|||
160623203|NCT00598442|579999782|FG002|Overall Study|Physician Decision|1|||
160623204|NCT00598442|579999780|FG000|Overall Study|Withdrawal by Subject|8|||
160513445|NCT03241225|579607193|FG000|Overall Study|Withdrawal by Subject|1|||
160513446|NCT03241225|579607194|FG001|Overall Study|Withdrawal by Subject|0|||
160513447|NCT00852540|579607195|FG000|Overall Study|Adverse Event|10|||
160513448|NCT00852540|579607196|FG001|Overall Study|Adverse Event|3|||
160513449|NCT00852540|579607195|FG000|Overall Study|Lack of Efficacy|15|||
160513450|NCT00852540|579607196|FG001|Overall Study|Lack of Efficacy|3|||
160513451|NCT00852540|579607195|FG000|Overall Study|Protocol Violation|1|||
160513452|NCT00852540|579607196|FG001|Overall Study|Protocol Violation|2|||
160623205|NCT00598442|579999781|FG001|Overall Study|Withdrawal by Subject|16|||
160623206|NCT00598442|579999782|FG002|Overall Study|Withdrawal by Subject|6|||
160623207|NCT00598442|579999780|FG000|Overall Study|Noncompliance|0|||
160623208|NCT00598442|579999781|FG001|Overall Study|Noncompliance|2|||
160623209|NCT00598442|579999782|FG002|Overall Study|Noncompliance|1|||
160623210|NCT00598442|579999780|FG000|Overall Study|Relocation|1|||
160623211|NCT00598442|579999781|FG001|Overall Study|Relocation|4|||
160623212|NCT00598442|579999782|FG002|Overall Study|Relocation|0|||
160623213|NCT00598442|579999780|FG000|Overall Study|Renal transplant|0|||
160623214|NCT00598442|579999781|FG001|Overall Study|Renal transplant|0|||
160623215|NCT00598442|579999782|FG002|Overall Study|Renal transplant|1|||
160623216|NCT00598442|579999780|FG000|Overall Study|Site closed by sponsor|5|||
160623217|NCT00598442|579999781|FG001|Overall Study|Site closed by sponsor|2|||
160623218|NCT00598442|579999782|FG002|Overall Study|Site closed by sponsor|1|||
160623219|NCT00598442|579999780|FG000|Overall Study|Started dialysis|1|||
160623220|NCT00598442|579999781|FG001|Overall Study|Started dialysis|0|||
160623221|NCT00598442|579999782|FG002|Overall Study|Started dialysis|0|||
160623222|NCT00450814|579999790|FG000|Overall Study|Failed to complete the initial therapy|0|||
160623223|NCT00450814|579999791|FG001|Overall Study|Failed to complete the initial therapy|0|||
160623224|NCT00450814|579999792|FG002|Overall Study|Failed to complete the initial therapy|0|||
160623225|NCT00450814|579999793|FG003|Overall Study|Failed to complete the initial therapy|1|||
160623226|NCT00450814|579999794|FG004|Overall Study|Failed to complete the initial therapy|1|||
160623227|NCT00450814|579999795|FG005|Overall Study|Failed to complete the initial therapy|1|||
160623228|NCT00450814|579999796|FG006|Overall Study|Failed to complete the initial therapy|0|||
160623229|NCT00450814|579999797|FG007|Overall Study|Failed to complete the initial therapy|0|||
160623230|NCT00450814|579999798|FG008|Overall Study|Failed to complete the initial therapy|0|||
160623231|NCT00450814|579999799|FG009|Overall Study|Failed to complete the initial therapy|0|||
160623232|NCT00450814|579999800|FG010|Overall Study|Failed to complete the initial therapy|0|||
160623233|NCT00450814|579999790|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
160623234|NCT00450814|579999791|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
160623235|NCT00450814|579999792|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
160623236|NCT00450814|579999793|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
160623237|NCT00450814|579999794|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
160623238|NCT00450814|579999795|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
160623239|NCT00450814|579999796|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
160623240|NCT00450814|579999797|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
160623241|NCT00450814|579999798|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
160623242|NCT00450814|579999799|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
160513453|NCT00852540|579607195|FG000|Overall Study|Lost to Follow-up|2|||
160513454|NCT00852540|579607196|FG001|Overall Study|Lost to Follow-up|3|||
160513455|NCT00852540|579607195|FG000|Overall Study|Investigator Discretion|2|||
160513456|NCT00852540|579607196|FG001|Overall Study|Investigator Discretion|3|||
160513457|NCT00852540|579607195|FG000|Overall Study|Withdrawal by Subject|3|||
160513458|NCT00852540|579607196|FG001|Overall Study|Withdrawal by Subject|1|||
160513459|NCT00852540|579607195|FG000|Overall Study|Did Not Receive Study Drug|3|||
160513460|NCT00852540|579607196|FG001|Overall Study|Did Not Receive Study Drug|3|||
160513461|NCT04875676|579607206|FG000|Overall Study|Lost to Follow-up|1|||
160513462|NCT04875676|579607207|FG001|Overall Study|Lost to Follow-up|0|||
160513463|NCT04875676|579607208|FG002|Overall Study|Lost to Follow-up|0|||
160513464|NCT03064035|579607209|FG000|Overall Study|Did not receive allocated intervention|4|||
160513465|NCT03064035|579607210|FG001|Overall Study|Did not receive allocated intervention|2|||
160513466|NCT03064035|579607209|FG000|Overall Study|Lost to Follow-up|1|||
160513467|NCT03064035|579607210|FG001|Overall Study|Lost to Follow-up|1|||
160623243|NCT00450814|579999800|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
160623244|NCT03602976|579999805|FG000|Overall Study|Withdrawal by Subject|1|||
160623245|NCT04837807|579999806|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
160623246|NCT04837807|579999807|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
160513468|NCT03103763|579607211|FG000|Overall Study|Death|15|||
160513469|NCT03103763|579607212|FG001|Overall Study|Death|5|||
160513470|NCT03103763|579607213|FG002|Overall Study|Death|5|||
160513471|NCT03103763|579607211|FG000|Overall Study|Withdrawal by Subject|0|||
160513472|NCT03103763|579607212|FG001|Overall Study|Withdrawal by Subject|3|||
160513473|NCT03103763|579607213|FG002|Overall Study|Withdrawal by Subject|2|||
160623247|NCT04629534|579999808|FG000|Overall Study|Physician Decision|1|||
160623248|NCT04629534|579999809|FG001|Overall Study|Physician Decision|0|||
160623249|NCT04629534|579999808|FG000|Overall Study|Protocol Violation|0|||
160513474|NCT02336178|579607214|FG000|Overall Study|Lost to Follow-up|1|||
160513475|NCT02336178|579607214|FG000|Overall Study|Protocol Violation|1|||
160513476|NCT02336178|579607214|FG000|Overall Study|Withdrawal by Subject|1|||
160513477|NCT02336178|579607214|FG000|Overall Study|Other|1|||
160513478|NCT03245151|579607215|FG000|Overall Study|Withdrawal by Subject|2|||
160513479|NCT03245151|579607216|FG001|Overall Study|Withdrawal by Subject|0|||
160513480|NCT03245151|579607217|FG002|Overall Study|Withdrawal by Subject|0|||
160513481|NCT03245151|579607218|FG003|Overall Study|Withdrawal by Subject|2|||
160513482|NCT03245151|579607219|FG004|Overall Study|Withdrawal by Subject|1|||
160513483|NCT03245151|579607215|FG000|Overall Study|Death|3|||
160513484|NCT03245151|579607216|FG001|Overall Study|Death|14|||
160513485|NCT03245151|579607217|FG002|Overall Study|Death|9|||
160513486|NCT03245151|579607218|FG003|Overall Study|Death|16|||
160513487|NCT03245151|579607219|FG004|Overall Study|Death|7|||
160513488|NCT03245151|579607215|FG000|Overall Study|Sponsor's decision|0|||
160513489|NCT03245151|579607216|FG001|Overall Study|Sponsor's decision|1|||
160513490|NCT03245151|579607217|FG002|Overall Study|Sponsor's decision|0|||
160513491|NCT03245151|579607218|FG003|Overall Study|Sponsor's decision|0|||
160513492|NCT03245151|579607219|FG004|Overall Study|Sponsor's decision|0|||
160513493|NCT01970345|579607220|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
160513494|NCT01970345|579607221|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
160513495|NCT01970345|579607220|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
160513496|NCT01970345|579607221|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
160513497|NCT01552603|579607222|FG000|Overall Study|Physician Decision|1|||
160513498|NCT00618618|579607223|FG000|Overall Study|Patient Request|0|||
160513499|NCT00618618|579607224|FG001|Overall Study|Patient Request|0|||
160513500|NCT00618618|579607225|FG002|Overall Study|Patient Request|2|||
160513501|NCT00618618|579607226|FG003|Overall Study|Patient Request|0|||
160513502|NCT00618618|579607223|FG000|Overall Study|Inability to Complete Study Procedures|0|||
160513503|NCT00618618|579607224|FG001|Overall Study|Inability to Complete Study Procedures|1|||
160623250|NCT04629534|579999809|FG001|Overall Study|Protocol Violation|2|||
160623251|NCT03732534|579999810|FG000|Overall Study|Study terminated by Sponsor|6|||
160623252|NCT03907072|579999811|FG000|Overall Study|Study Terminated by Sponsor|2|||
160623253|NCT03907072|579999812|FG001|Overall Study|Study Terminated by Sponsor|2|||
160623254|NCT03907072|579999813|FG002|Overall Study|Study Terminated by Sponsor|2|||
160623255|NCT00265109|579999814|FG000|Overall Study|Withdrawal by Subject|5|||
160623256|NCT00265109|579999814|FG000|Overall Study|Adverse Event|1|||
160623257|NCT02463097|579999815|FG000|Overall Study|Withdrawal by Subject|1|||
160623258|NCT03556202|579999818|FG000|Extension Treatment Period|Adverse Event|18|||
160623259|NCT03556202|579999819|FG001|Extension Treatment Period|Adverse Event|14|||
160623260|NCT03556202|579999820|FG002|Extension Treatment Period|Adverse Event|9|||
160623261|NCT03556202|579999818|FG000|Extension Treatment Period|Death|2|||
160623262|NCT03556202|579999819|FG001|Extension Treatment Period|Death|6|||
160623263|NCT03556202|579999820|FG002|Extension Treatment Period|Death|0|||
160623264|NCT03556202|579999818|FG000|Extension Treatment Period|Lack of Efficacy|5|||
160623265|NCT03556202|579999819|FG001|Extension Treatment Period|Lack of Efficacy|12|||
160623266|NCT03556202|579999820|FG002|Extension Treatment Period|Lack of Efficacy|18|||
160623267|NCT03556202|579999818|FG000|Extension Treatment Period|Lost to Follow-up|9|||
160623268|NCT03556202|579999819|FG001|Extension Treatment Period|Lost to Follow-up|20|||
160623269|NCT03556202|579999820|FG002|Extension Treatment Period|Lost to Follow-up|2|||
160623270|NCT03556202|579999818|FG000|Extension Treatment Period|Pregnancy|2|||
160623271|NCT03556202|579999819|FG001|Extension Treatment Period|Pregnancy|4|||
160623272|NCT03556202|579999820|FG002|Extension Treatment Period|Pregnancy|3|||
160623273|NCT03556202|579999818|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
160623274|NCT03556202|579999819|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
160623275|NCT03556202|579999820|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
160623276|NCT03556202|579999818|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
160623277|NCT03556202|579999819|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
160623278|NCT03556202|579999820|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
160623279|NCT03556202|579999818|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
160623280|NCT03556202|579999819|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
160623281|NCT03556202|579999820|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
160623282|NCT03556202|579999818|FG000|Extension Treatment Period|Physician Decision|0|||
160623283|NCT03556202|579999819|FG001|Extension Treatment Period|Physician Decision|8|||
160623284|NCT03556202|579999820|FG002|Extension Treatment Period|Physician Decision|2|||
160623285|NCT03556202|579999818|FG000|Extension Treatment Period|Protocol Violation|0|||
160623286|NCT03556202|579999819|FG001|Extension Treatment Period|Protocol Violation|1|||
160623287|NCT03556202|579999820|FG002|Extension Treatment Period|Protocol Violation|1|||
160513504|NCT00618618|579607225|FG002|Overall Study|Inability to Complete Study Procedures|0|||
160513505|NCT00618618|579607226|FG003|Overall Study|Inability to Complete Study Procedures|0|||
160513506|NCT00618618|579607223|FG000|Overall Study|Lost to Follow-up|3|||
160513507|NCT00618618|579607224|FG001|Overall Study|Lost to Follow-up|0|||
160513508|NCT00618618|579607225|FG002|Overall Study|Lost to Follow-up|0|||
160623288|NCT03556202|579999818|FG000|Extension Treatment Period|Sponsor Decision|0|||
160513509|NCT00618618|579607226|FG003|Overall Study|Lost to Follow-up|1|||
160513510|NCT00618618|579607223|FG000|Overall Study|Non-compliance|1|||
160513511|NCT00618618|579607224|FG001|Overall Study|Non-compliance|1|||
160513512|NCT00618618|579607225|FG002|Overall Study|Non-compliance|0|||
160513513|NCT00618618|579607226|FG003|Overall Study|Non-compliance|0|||
160513514|NCT00618618|579607223|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
160513515|NCT00618618|579607224|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
160513516|NCT00618618|579607225|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
160513517|NCT00618618|579607226|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
160513518|NCT00618618|579607223|FG000|Overall Study|Death|0|||
160513519|NCT00618618|579607224|FG001|Overall Study|Death|1|||
160513520|NCT00618618|579607225|FG002|Overall Study|Death|0|||
160513521|NCT00618618|579607226|FG003|Overall Study|Death|0|||
160513522|NCT01236365|579607230|FG000|Overall Study|Lost to Follow-up|0|||
160513523|NCT01236365|579607231|FG001|Overall Study|Lost to Follow-up|2|||
160513524|NCT01236365|579607230|FG000|Overall Study|Moved Out of State|1|||
160513525|NCT01236365|579607231|FG001|Overall Study|Moved Out of State|0|||
160513526|NCT01236365|579607230|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
160513527|NCT01236365|579607231|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
160513528|NCT00558259|579607234|FG000|Overall Study|Adverse Event|50|||
160513529|NCT00558259|579607235|FG001|Overall Study|Adverse Event|81|||
160513530|NCT00558259|579607234|FG000|Overall Study|Protocol Violation|9|||
160513531|NCT00558259|579607235|FG001|Overall Study|Protocol Violation|5|||
160513532|NCT00558259|579607234|FG000|Overall Study|Withdrawal by Subject|12|||
160513533|NCT00558259|579607235|FG001|Overall Study|Withdrawal by Subject|13|||
160513534|NCT00006011|579607239|FG000|Overall Study|Disease progression|13|||
160513535|NCT00006011|579607240|FG001|Overall Study|Disease progression|6|||
160513536|NCT00006011|579607241|FG002|Overall Study|Disease progression|26|||
160513537|NCT00006011|579607239|FG000|Overall Study|Refused further treatment|15|||
160513538|NCT00006011|579607240|FG001|Overall Study|Refused further treatment|13|||
160513539|NCT00006011|579607241|FG002|Overall Study|Refused further treatment|26|||
160513540|NCT00006011|579607239|FG000|Overall Study|Adverse Event|15|||
160513541|NCT00006011|579607240|FG001|Overall Study|Adverse Event|39|||
160513542|NCT00006011|579607241|FG002|Overall Study|Adverse Event|5|||
160513543|NCT00006011|579607239|FG000|Overall Study|Death|0|||
160513544|NCT00006011|579607240|FG001|Overall Study|Death|1|||
160513545|NCT00006011|579607241|FG002|Overall Study|Death|2|||
160513546|NCT00006011|579607239|FG000|Overall Study|Other|4|||
160513547|NCT00006011|579607240|FG001|Overall Study|Other|2|||
160513548|NCT00006011|579607241|FG002|Overall Study|Other|5|||
160513549|NCT00006011|579607239|FG000|Overall Study|Ineligible|18|||
160513550|NCT00006011|579607240|FG001|Overall Study|Ineligible|16|||
160513551|NCT00006011|579607241|FG002|Overall Study|Ineligible|9|||
160513552|NCT01157676|579607248|FG000|Randomization|Death|1|||
160513553|NCT01157676|579607249|FG001|Randomization|Death|1|||
160513554|NCT01157676|579607248|FG000|Randomization|unresectable|2|||
160513555|NCT01157676|579607249|FG001|Randomization|unresectable|3|||
160513556|NCT01157676|579607248|FG000|Randomization|Withdrawal by Subject|17|||
160513557|NCT01157676|579607249|FG001|Randomization|Withdrawal by Subject|13|||
160513558|NCT01157676|579607248|FG000|Randomization|Physician Decision|1|||
160513559|NCT01157676|579607249|FG001|Randomization|Physician Decision|0|||
160513560|NCT01157676|579607248|FG000|Surgery|underwent open cystectomy|0|||
160513561|NCT01157676|579607249|FG001|Surgery|underwent open cystectomy|4|||
160623289|NCT03556202|579999819|FG001|Extension Treatment Period|Sponsor Decision|1|||
160623290|NCT03556202|579999820|FG002|Extension Treatment Period|Sponsor Decision|0|||
160623291|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
160623292|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
160623293|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
160623294|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Death|1|||
160623295|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Death|0|||
160623296|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Death|0|||
160623297|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
160513562|NCT01157676|579607248|FG000|Surgery|converted to open procedure|0|||
160513563|NCT01157676|579607249|FG001|Surgery|converted to open procedure|5|||
160513564|NCT01157676|579607248|FG000|Surgery|underwent robotic cystectomy|1|||
160513565|NCT01157676|579607249|FG001|Surgery|underwent robotic cystectomy|0|||
160623298|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
160513566|NCT00682890|579607250|FG000|Overall Study|Lost to Follow-up|1|||
160513567|NCT00682890|579607251|FG001|Overall Study|Lost to Follow-up|1|||
160513568|NCT00682890|579607250|FG000|Overall Study|subject moved away|0|||
160513569|NCT00682890|579607251|FG001|Overall Study|subject moved away|1|||
160513570|NCT00682890|579607250|FG000|Overall Study|heavy menstrual bleeding|1|||
160513571|NCT00682890|579607251|FG001|Overall Study|heavy menstrual bleeding|0|||
160513572|NCT00141219|579607254|FG000|Overall Study|Protocol violations|5|||
160513573|NCT00141219|579607255|FG001|Overall Study|Protocol violations|4|||
160513574|NCT00141219|579607254|FG000|Overall Study|Adverse Event|8|||
160513575|NCT00141219|579607255|FG001|Overall Study|Adverse Event|6|||
160623299|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
160513576|NCT00141219|579607254|FG000|Overall Study|Lack of Efficacy|5|||
160513577|NCT00141219|579607255|FG001|Overall Study|Lack of Efficacy|4|||
160513578|NCT00141219|579607254|FG000|Overall Study|Withdrawal by Subject|6|||
160513579|NCT00141219|579607255|FG001|Overall Study|Withdrawal by Subject|2|||
160513580|NCT01577745|579607256|FG000|Overall Study|Withdrawal by Subject|0|||
160513581|NCT01577745|579607257|FG001|Overall Study|Withdrawal by Subject|1|||
160513582|NCT01577745|579607258|FG002|Overall Study|Withdrawal by Subject|0|||
160513583|NCT01577745|579607259|FG003|Overall Study|Withdrawal by Subject|3|||
160513584|NCT01577745|579607260|FG004|Overall Study|Withdrawal by Subject|2|||
160513585|NCT01577745|579607261|FG005|Overall Study|Withdrawal by Subject|0|||
160513586|NCT01577745|579607256|FG000|Overall Study|Death|3|||
160513587|NCT01577745|579607257|FG001|Overall Study|Death|2|||
160513588|NCT01577745|579607258|FG002|Overall Study|Death|2|||
160513589|NCT01577745|579607259|FG003|Overall Study|Death|1|||
160513590|NCT01577745|579607260|FG004|Overall Study|Death|1|||
160513591|NCT01577745|579607261|FG005|Overall Study|Death|3|||
160513592|NCT01577745|579607256|FG000|Overall Study|Physician Decision|0|||
160513593|NCT01577745|579607257|FG001|Overall Study|Physician Decision|0|||
160513594|NCT01577745|579607258|FG002|Overall Study|Physician Decision|0|||
160513595|NCT01577745|579607259|FG003|Overall Study|Physician Decision|1|||
160513596|NCT01577745|579607260|FG004|Overall Study|Physician Decision|1|||
160513597|NCT01577745|579607261|FG005|Overall Study|Physician Decision|0|||
160513598|NCT01577745|579607256|FG000|Overall Study|Lost to Follow-up|0|||
160513599|NCT01577745|579607257|FG001|Overall Study|Lost to Follow-up|0|||
160513600|NCT01577745|579607258|FG002|Overall Study|Lost to Follow-up|0|||
160513601|NCT01577745|579607259|FG003|Overall Study|Lost to Follow-up|0|||
160513602|NCT01577745|579607260|FG004|Overall Study|Lost to Follow-up|0|||
160513603|NCT01577745|579607261|FG005|Overall Study|Lost to Follow-up|1|||
160513604|NCT01577745|579607256|FG000|Overall Study|Alternative Therapy|0|||
160513605|NCT01577745|579607257|FG001|Overall Study|Alternative Therapy|0|||
160513606|NCT01577745|579607258|FG002|Overall Study|Alternative Therapy|0|||
160513607|NCT01577745|579607259|FG003|Overall Study|Alternative Therapy|1|||
160513608|NCT01577745|579607260|FG004|Overall Study|Alternative Therapy|1|||
160513609|NCT01577745|579607261|FG005|Overall Study|Alternative Therapy|0|||
160513610|NCT01435616|579607262|FG000|Overall Study|Adverse Event|39|||
160513611|NCT01435616|579607263|FG001|Overall Study|Adverse Event|21|||
160513612|NCT01435616|579607262|FG000|Overall Study|Death|7|||
160513613|NCT01435616|579607263|FG001|Overall Study|Death|2|||
160623300|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
160623301|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
160623302|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
160623303|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
160623304|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
160623305|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
160623306|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
160623307|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
160623308|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
160623309|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
160623310|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
160623311|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
160623312|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
160623313|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
160623314|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
160623315|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
160623316|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
160623317|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
160623318|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
160623319|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
160623320|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
160623321|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
160623322|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
160666405|NCT02159950|580159207|FG000|Overall Study|Adverse Event|0|||
160513614|NCT01435616|579607262|FG000|Overall Study|Lost to Follow-up|22|||
160513615|NCT01435616|579607263|FG001|Overall Study|Lost to Follow-up|13|||
160513616|NCT01435616|579607262|FG000|Overall Study|Protocol Violation|16|||
160513617|NCT01435616|579607263|FG001|Overall Study|Protocol Violation|13|||
160513618|NCT01435616|579607262|FG000|Overall Study|Withdrawal by Subject|66|||
160666406|NCT02159950|580159208|FG001|Overall Study|Adverse Event|1|||
160666407|NCT02159950|580159207|FG000|Overall Study|Progression|0|||
160513619|NCT01435616|579607263|FG001|Overall Study|Withdrawal by Subject|24|||
160513620|NCT01435616|579607262|FG000|Overall Study|Physician Decision|20|||
160513621|NCT01435616|579607263|FG001|Overall Study|Physician Decision|7|||
160513622|NCT01435616|579607262|FG000|Overall Study|Sponsor Decision|1|||
160513623|NCT01435616|579607263|FG001|Overall Study|Sponsor Decision|0|||
160666408|NCT02159950|580159208|FG001|Overall Study|Progression|1|||
160513624|NCT00371683|579607265|FG000|DB Treatment Period-Randomized Patients|Death|1|||
160513625|NCT00371683|579607266|FG001|DB Treatment Period-Randomized Patients|Death|1|||
160513626|NCT00371683|579607265|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
160513627|NCT00371683|579607266|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
160513628|NCT00371683|579607265|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
160666409|NCT03872128|580159211|FG000|Overall Study|Dropped out before treatment|1|||
160666410|NCT03872128|580159212|FG001|Overall Study|Dropped out before treatment|0|||
160666411|NCT03872128|580159213|FG002|Overall Study|Dropped out before treatment|4|||
160666412|NCT03872128|580159211|FG000|Overall Study|Lost to Follow-up|2|||
160666413|NCT03872128|580159212|FG001|Overall Study|Lost to Follow-up|5|||
160666414|NCT03872128|580159213|FG002|Overall Study|Lost to Follow-up|8|||
160666415|NCT03285594|580159218|FG000|Overall Study|At the Participant's Own Request|10|||
160666416|NCT03285594|580159219|FG001|Overall Study|At the Participant's Own Request|5|||
160666417|NCT03285594|580159220|FG002|Overall Study|At the Participant's Own Request|21|||
160666418|NCT03285594|580159218|FG000|Overall Study|Adverse Event|2|||
160666419|NCT03285594|580159219|FG001|Overall Study|Adverse Event|2|||
160666420|NCT03285594|580159220|FG002|Overall Study|Adverse Event|6|||
160666421|NCT03285594|580159218|FG000|Overall Study|Poor Compliance to Protocol|0|||
160666422|NCT03285594|580159219|FG001|Overall Study|Poor Compliance to Protocol|0|||
160666423|NCT03285594|580159220|FG002|Overall Study|Poor Compliance to Protocol|1|||
160666424|NCT03285594|580159218|FG000|Overall Study|Lost to Follow-up|0|||
160666425|NCT03285594|580159219|FG001|Overall Study|Lost to Follow-up|0|||
160666426|NCT03285594|580159220|FG002|Overall Study|Lost to Follow-up|1|||
160666427|NCT03285594|580159218|FG000|Overall Study|Reason Not Specified|3|||
160666428|NCT03285594|580159219|FG001|Overall Study|Reason Not Specified|4|||
160666429|NCT03285594|580159220|FG002|Overall Study|Reason Not Specified|8|||
160666430|NCT00834431|580159221|FG000|First Intervention|Adverse Event|0|||
160666431|NCT00834431|580159222|FG001|First Intervention|Adverse Event|1|||
160666432|NCT00834431|580159221|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
160666433|NCT00834431|580159222|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
160666434|NCT03733444|580159227|FG000|Overall Study|Adverse Event|8|||
160666435|NCT03733444|580159228|FG001|Overall Study|Adverse Event|10|||
160666436|NCT03733444|580159229|FG002|Overall Study|Adverse Event|5|||
160666437|NCT03733444|580159227|FG000|Overall Study|Death|20|||
160666438|NCT03733444|580159228|FG001|Overall Study|Death|19|||
160666439|NCT03733444|580159229|FG002|Overall Study|Death|11|||
160666440|NCT03733444|580159227|FG000|Overall Study|Lost to Follow-up|3|||
160666441|NCT03733444|580159228|FG001|Overall Study|Lost to Follow-up|0|||
160666442|NCT03733444|580159229|FG002|Overall Study|Lost to Follow-up|1|||
160513629|NCT00371683|579607266|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
160513630|NCT00371683|579607265|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
160513631|NCT00371683|579607266|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
160513632|NCT00371683|579607265|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
160513633|NCT00371683|579607266|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
160513634|NCT00371683|579607265|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
160513635|NCT00371683|579607266|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
160513636|NCT00371683|579607265|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
160513637|NCT00371683|579607266|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
160513638|NCT00371683|579607265|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
160513639|NCT00371683|579607266|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
160513640|NCT00371683|579607265|FG000|Follow-Up Period - Randomized Patients|Death|0|||
160513641|NCT00371683|579607266|FG001|Follow-Up Period - Randomized Patients|Death|2|||
160513642|NCT00371683|579607265|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
160513643|NCT00371683|579607266|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
160513644|NCT00371683|579607265|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
160513645|NCT00371683|579607266|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
160513646|NCT01146782|579607267|FG000|Screening Cohort|Screen Failure|187|||
160513647|NCT01146782|579607267|FG000|Screening Cohort|Lost to Follow-up|4|||
160513648|NCT01146782|579607267|FG000|Screening Cohort|Physician Decision|1|||
160513649|NCT01146782|579607267|FG000|Screening Cohort|Withdrawal by Subject|29|||
160513650|NCT01146782|579607267|FG000|Safety Cohort|Screen Failure|61|||
160513651|NCT01146782|579607267|FG000|Safety Cohort|Withdrawal by Subject|4|||
160513652|NCT01146782|579607267|FG000|Safety Cohort|Control AHI <5|4|||
160513653|NCT01146782|579607267|FG000|Safety Cohort|TST <4 hrs|14|||
160513654|NCT01146782|579607267|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
160666443|NCT03733444|580159227|FG000|Overall Study|Lack of Efficacy|0|||
160666444|NCT03733444|580159228|FG001|Overall Study|Lack of Efficacy|1|||
160666445|NCT03733444|580159229|FG002|Overall Study|Lack of Efficacy|1|||
160666446|NCT03733444|580159227|FG000|Overall Study|Physician Decision|2|||
160666447|NCT03733444|580159228|FG001|Overall Study|Physician Decision|1|||
160666448|NCT03733444|580159229|FG002|Overall Study|Physician Decision|0|||
160666449|NCT03733444|580159227|FG000|Overall Study|Protocol Violation|2|||
160666450|NCT03733444|580159228|FG001|Overall Study|Protocol Violation|1|||
160666451|NCT03733444|580159229|FG002|Overall Study|Protocol Violation|0|||
160666452|NCT03733444|580159227|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
160513655|NCT01146782|579607267|FG000|Primary Endpoint Cohort|Physician Decision|1|||
160513656|NCT03208036|579607271|FG000|Baseline Assessment|Withdrawal by Subject|1|||
160513657|NCT03208036|579607272|FG001|Baseline Assessment|Withdrawal by Subject|1|||
160513658|NCT03208036|579607271|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
160513659|NCT03208036|579607272|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
160513660|NCT03208036|579607271|FG000|Intervention|Withdrawal by Subject|3|||
160513661|NCT03208036|579607272|FG001|Intervention|Withdrawal by Subject|2|||
160513662|NCT03208036|579607271|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
160513663|NCT03208036|579607272|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
160513664|NCT00700778|579607273|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
160513665|NCT00350103|579607274|FG000|Overall Study|Adverse Event|12|||
160513666|NCT00350103|579607275|FG001|Overall Study|Adverse Event|29|||
160513667|NCT00350103|579607276|FG002|Overall Study|Adverse Event|17|||
160513668|NCT00350103|579607274|FG000|Overall Study|Lack of Efficacy|5|||
160513669|NCT00350103|579607275|FG001|Overall Study|Lack of Efficacy|1|||
160666453|NCT03733444|580159228|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
160666454|NCT03733444|580159229|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
160666455|NCT03733444|580159227|FG000|Overall Study|Study Terminated by Sponsor|203|||
160666456|NCT03733444|580159228|FG001|Overall Study|Study Terminated by Sponsor|209|||
160666457|NCT03733444|580159229|FG002|Overall Study|Study Terminated by Sponsor|221|||
160513670|NCT00350103|579607276|FG002|Overall Study|Lack of Efficacy|3|||
160513671|NCT00350103|579607274|FG000|Overall Study|Withdrawal by Subject|6|||
160513672|NCT00350103|579607275|FG001|Overall Study|Withdrawal by Subject|6|||
160513673|NCT00350103|579607276|FG002|Overall Study|Withdrawal by Subject|8|||
160513674|NCT00350103|579607274|FG000|Overall Study|Protocol Violation|0|||
160513675|NCT00350103|579607275|FG001|Overall Study|Protocol Violation|0|||
160513676|NCT00350103|579607276|FG002|Overall Study|Protocol Violation|1|||
160513677|NCT00350103|579607274|FG000|Overall Study|Unsatisfactory Compliance|2|||
160513678|NCT00350103|579607275|FG001|Overall Study|Unsatisfactory Compliance|2|||
160513679|NCT00350103|579607276|FG002|Overall Study|Unsatisfactory Compliance|1|||
160513680|NCT00350103|579607274|FG000|Overall Study|Investigator´s decision|1|||
160666458|NCT03733444|580159227|FG000|Overall Study|Withdrawal by Subject|19|||
160513681|NCT00350103|579607275|FG001|Overall Study|Investigator´s decision|1|||
160513682|NCT00350103|579607276|FG002|Overall Study|Investigator´s decision|0|||
160513683|NCT00350103|579607274|FG000|Overall Study|Exclusion criteria met|0|||
160513684|NCT00350103|579607275|FG001|Overall Study|Exclusion criteria met|0|||
160513685|NCT00350103|579607276|FG002|Overall Study|Exclusion criteria met|1|||
160513686|NCT00350103|579607274|FG000|Overall Study|Patient relocated|0|||
160623323|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
160623324|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
160623325|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
160623326|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
160623327|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
160623328|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
160623329|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
160623330|NCT03556202|579999818|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
160623331|NCT03556202|579999819|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
160623332|NCT03556202|579999820|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
160623333|NCT05146999|579999821|FG000|Overall Study|Withdrew consent|6|||
160623334|NCT05146999|579999822|FG001|Overall Study|Withdrew consent|1|||
160623335|NCT05146999|579999821|FG000|Overall Study|Lost to Follow-up|3|||
160623336|NCT05146999|579999822|FG001|Overall Study|Lost to Follow-up|2|||
160623337|NCT05146999|579999821|FG000|Overall Study|Other|1|||
160623338|NCT05146999|579999822|FG001|Overall Study|Other|3|||
160623339|NCT02260791|579999826|FG000|Overall Study|Lost to Follow-up|4|||
160623340|NCT02260791|579999827|FG001|Overall Study|Lost to Follow-up|4|||
160623341|NCT02260791|579999826|FG000|Overall Study|Lack of Efficacy|2|||
160623342|NCT02260791|579999827|FG001|Overall Study|Lack of Efficacy|1|||
160623343|NCT02260791|579999826|FG000|Overall Study|Adverse Event|13|||
160623344|NCT02260791|579999827|FG001|Overall Study|Adverse Event|9|||
160623345|NCT02260791|579999826|FG000|Overall Study|Death|1|||
160623346|NCT02260791|579999827|FG001|Overall Study|Death|0|||
160623347|NCT02260791|579999826|FG000|Overall Study|Withdrawal by Subject|11|||
160623348|NCT02260791|579999827|FG001|Overall Study|Withdrawal by Subject|16|||
160623349|NCT02260791|579999826|FG000|Overall Study|Screen failure|0|||
160623350|NCT02260791|579999827|FG001|Overall Study|Screen failure|1|||
160623351|NCT02260791|579999826|FG000|Overall Study|Protocol deviation|2|||
160623352|NCT02260791|579999827|FG001|Overall Study|Protocol deviation|3|||
160623353|NCT01411917|579999828|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
160666459|NCT03733444|580159228|FG001|Overall Study|Withdrawal by Subject|18|||
160666460|NCT03733444|580159229|FG002|Overall Study|Withdrawal by Subject|16|||
160513687|NCT00350103|579607275|FG001|Overall Study|Patient relocated|0|||
160513688|NCT00350103|579607276|FG002|Overall Study|Patient relocated|1|||
160513689|NCT00350103|579607274|FG000|Overall Study|Need for prohibited medication|1|||
160513690|NCT00350103|579607275|FG001|Overall Study|Need for prohibited medication|0|||
160513691|NCT00350103|579607276|FG002|Overall Study|Need for prohibited medication|0|||
160513692|NCT00350103|579607274|FG000|Overall Study|Personal reasons|0|||
160513693|NCT00350103|579607275|FG001|Overall Study|Personal reasons|0|||
160513694|NCT00350103|579607276|FG002|Overall Study|Personal reasons|1|||
160513695|NCT00350103|579607274|FG000|Overall Study|Patient stopped feeling pain|1|||
160513696|NCT00350103|579607275|FG001|Overall Study|Patient stopped feeling pain|0|||
160513697|NCT00350103|579607276|FG002|Overall Study|Patient stopped feeling pain|0|||
160513698|NCT00350103|579607274|FG000|Overall Study|PR greater than 250ms|0|||
160513699|NCT00350103|579607275|FG001|Overall Study|PR greater than 250ms|0|||
160513700|NCT00350103|579607276|FG002|Overall Study|PR greater than 250ms|1|||
160513701|NCT00350103|579607274|FG000|Overall Study|Wrong calculation of QT interval|0|||
160513702|NCT00350103|579607275|FG001|Overall Study|Wrong calculation of QT interval|0|||
160513703|NCT00350103|579607276|FG002|Overall Study|Wrong calculation of QT interval|1|||
160513704|NCT00350103|579607274|FG000|Overall Study|Sponsor mistake|1|||
160513705|NCT00350103|579607275|FG001|Overall Study|Sponsor mistake|0|||
160513706|NCT00350103|579607276|FG002|Overall Study|Sponsor mistake|0|||
160513707|NCT00350103|579607274|FG000|Overall Study|Randomization mistake|0|||
160513708|NCT00350103|579607275|FG001|Overall Study|Randomization mistake|1|||
160513709|NCT00350103|579607276|FG002|Overall Study|Randomization mistake|1|||
160513710|NCT00350103|579607274|FG000|Overall Study|Sponsor´s decision|0|||
160513711|NCT00350103|579607275|FG001|Overall Study|Sponsor´s decision|1|||
160513712|NCT00350103|579607276|FG002|Overall Study|Sponsor´s decision|0|||
160513713|NCT00350103|579607274|FG000|Overall Study|Lost, Reason unknown|1|||
160513714|NCT00350103|579607275|FG001|Overall Study|Lost, Reason unknown|1|||
160513715|NCT00350103|579607276|FG002|Overall Study|Lost, Reason unknown|0|||
160513716|NCT01879553|579607277|FG000|Overall Study|Withdrawal by Subject|1|||
160513717|NCT01879553|579607278|FG001|Overall Study|Withdrawal by Subject|0|||
160513718|NCT00438672|579607279|FG000|Overall Study|Lost to Follow-up|7|||
160513719|NCT00438672|579607280|FG001|Overall Study|Lost to Follow-up|9|||
160513720|NCT02559895|579607281|FG000|Overall Study|Adverse Event|3|||
160513721|NCT02559895|579607282|FG001|Overall Study|Adverse Event|3|||
160513722|NCT02559895|579607283|FG002|Overall Study|Adverse Event|2|||
160513723|NCT02559895|579607284|FG003|Overall Study|Adverse Event|1|||
160513724|NCT02559895|579607281|FG000|Overall Study|Lack of Efficacy|2|||
160513725|NCT02559895|579607282|FG001|Overall Study|Lack of Efficacy|3|||
160513726|NCT02559895|579607283|FG002|Overall Study|Lack of Efficacy|2|||
160513727|NCT02559895|579607284|FG003|Overall Study|Lack of Efficacy|8|||
160513728|NCT02559895|579607281|FG000|Overall Study|Lost to Follow-up|22|||
160513729|NCT02559895|579607282|FG001|Overall Study|Lost to Follow-up|16|||
160513730|NCT02559895|579607283|FG002|Overall Study|Lost to Follow-up|12|||
160513731|NCT02559895|579607284|FG003|Overall Study|Lost to Follow-up|17|||
160513732|NCT02559895|579607281|FG000|Overall Study|Physician Decision|1|||
160513733|NCT02559895|579607282|FG001|Overall Study|Physician Decision|1|||
160513734|NCT02559895|579607283|FG002|Overall Study|Physician Decision|3|||
160513735|NCT02559895|579607284|FG003|Overall Study|Physician Decision|0|||
160623354|NCT01411917|579999829|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
160623355|NCT02354599|579999832|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160623356|NCT02354599|579999833|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
160623357|NCT02354599|579999834|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
160623358|NCT02354599|579999835|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
160623359|NCT02354599|579999836|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
160623360|NCT02354599|579999837|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
160623361|NCT02354599|579999832|FG000|Overall Study|Withdrawal by Subject|1|||
160623362|NCT02354599|579999833|FG001|Overall Study|Withdrawal by Subject|1|||
160623363|NCT02354599|579999834|FG002|Overall Study|Withdrawal by Subject|0|||
160623364|NCT02354599|579999835|FG003|Overall Study|Withdrawal by Subject|0|||
160623365|NCT02354599|579999836|FG004|Overall Study|Withdrawal by Subject|0|||
160623366|NCT02354599|579999837|FG005|Overall Study|Withdrawal by Subject|0|||
160666461|NCT03733444|580159227|FG000|Overall Study|Miscellaneous|1|||
160513736|NCT02559895|579607281|FG000|Overall Study|Withdrawal by Subject|16|||
160513737|NCT02559895|579607282|FG001|Overall Study|Withdrawal by Subject|9|||
160513738|NCT02559895|579607283|FG002|Overall Study|Withdrawal by Subject|20|||
160513739|NCT02559895|579607284|FG003|Overall Study|Withdrawal by Subject|9|||
160513740|NCT02559895|579607281|FG000|Overall Study|Study Burden|10|||
160513741|NCT02559895|579607282|FG001|Overall Study|Study Burden|16|||
160513742|NCT02559895|579607283|FG002|Overall Study|Study Burden|12|||
160513743|NCT02559895|579607284|FG003|Overall Study|Study Burden|22|||
160513744|NCT02559895|579607281|FG000|Overall Study|Other|1|||
160513745|NCT02559895|579607282|FG001|Overall Study|Other|5|||
160513746|NCT02559895|579607283|FG002|Overall Study|Other|3|||
160513747|NCT02559895|579607284|FG003|Overall Study|Other|3|||
160513748|NCT04540887|579607285|FG000|Overall Study|Withdrawal by Subject|2|||
160513749|NCT02217501|579607291|FG000|Overall Study|Death|3|||
160513750|NCT02217501|579607292|FG001|Overall Study|Death|4|||
160513751|NCT02019667|579607293|FG000|First Intervention (6 Months)|Adverse Event|0|||
160513752|NCT02019667|579607294|FG001|First Intervention (6 Months)|Adverse Event|1|||
160513753|NCT02019667|579607293|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
160513754|NCT02019667|579607294|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
160513755|NCT02019667|579607293|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
160513756|NCT02019667|579607294|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
160513757|NCT02432196|579607297|FG000|Overall Study|Exit - did not receive study device|1|||
160513758|NCT02432196|579607297|FG000|Overall Study|Death|2|||
160513759|NCT02432196|579607297|FG000|Overall Study|Reoperation|3|||
160513760|NCT01905150|579607305|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
160513761|NCT01905150|579607306|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
160513762|NCT03465904|579607307|FG000|Overall Study|Withdrawal by Subject|9|||
160513763|NCT03465904|579607308|FG001|Overall Study|Withdrawal by Subject|5|||
160513764|NCT03465904|579607307|FG000|Overall Study|Lost to Follow-up|11|||
160513765|NCT03465904|579607308|FG001|Overall Study|Lost to Follow-up|9|||
160513766|NCT03465904|579607307|FG000|Overall Study|Protocol Violation|20|||
160513767|NCT03465904|579607308|FG001|Overall Study|Protocol Violation|15|||
160513768|NCT03694275|579609803|FG000|Overall Study|Adverse Event|0|||
160513769|NCT03694275|579609804|FG001|Overall Study|Adverse Event|1|||
160513770|NCT03694275|579609803|FG000|Overall Study|Reason not Specified|0|||
160513771|NCT03694275|579609804|FG001|Overall Study|Reason not Specified|1|||
160513772|NCT01877837|579609805|FG000|Overall Study|Lost to Follow-up|1|||
160513773|NCT01877837|579609805|FG000|Overall Study|Ineligible|4|||
160513774|NCT00645801|579609806|FG000|Overall Study|unclear if patient took all the medication.|1|||
160513775|NCT00645801|579609807|FG001|Overall Study|unclear if patient took all the medication.|0|||
160513776|NCT00645801|579609806|FG000|Overall Study|Lost to Follow-up|19|||
160513777|NCT00645801|579609807|FG001|Overall Study|Lost to Follow-up|15|||
160513778|NCT00759915|579609808|FG000|Overall Study|Withdrawal by Subject|1|||
160513779|NCT00759915|579609809|FG001|Overall Study|Withdrawal by Subject|0|||
160513780|NCT00759915|579609808|FG000|Overall Study|Adverse Event|0|||
160513781|NCT00759915|579609809|FG001|Overall Study|Adverse Event|1|||
160513782|NCT00932113|579609812|FG000|Overall Study|Lost to Follow-up|1|||
160513783|NCT00932113|579609813|FG001|Overall Study|Lost to Follow-up|0|||
160513784|NCT01773291|579609814|FG000|Overall Study|Protocol Violation|1|||
160513785|NCT01773291|579609815|FG001|Overall Study|Protocol Violation|0|||
160513786|NCT01773291|579609816|FG002|Overall Study|Protocol Violation|0|||
160513787|NCT01773291|579609814|FG000|Overall Study|Withdrawal by Subject|0|||
160513788|NCT01773291|579609815|FG001|Overall Study|Withdrawal by Subject|0|||
160513789|NCT01773291|579609816|FG002|Overall Study|Withdrawal by Subject|1|||
160513790|NCT02480153|579609817|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
160513791|NCT02480153|579609818|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
160513792|NCT02480153|579609819|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
160513793|NCT02480153|579609817|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
160513794|NCT02480153|579609818|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
160513795|NCT02480153|579609819|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
160513796|NCT02480153|579609817|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
160513797|NCT02480153|579609818|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
160513798|NCT02480153|579609819|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
160513799|NCT02480153|579609817|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
160513800|NCT02480153|579609818|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
160513801|NCT02480153|579609819|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
160513802|NCT02480153|579609817|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
160513803|NCT02480153|579609818|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
160513804|NCT02480153|579609819|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
160513805|NCT02480153|579609817|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
160513806|NCT02480153|579609818|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
160513807|NCT02480153|579609819|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
160513808|NCT02480153|579609817|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
160513809|NCT02480153|579609818|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
160513810|NCT02480153|579609819|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
160513811|NCT02480153|579609817|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
160513812|NCT02480153|579609818|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
160513813|NCT02480153|579609819|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
160513814|NCT02480153|579609817|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
160513815|NCT02480153|579609818|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
160513816|NCT02480153|579609819|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
160623367|NCT00280059|579999838|FG000|Efficacy Assessment Phase|Death|2|||
160623368|NCT00280059|579999839|FG001|Efficacy Assessment Phase|Death|0|||
160623369|NCT00280059|579999838|FG000|Efficacy Assessment Phase|Adverse Event|33|||
160513817|NCT02480153|579609817|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
160513818|NCT02480153|579609818|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
160513819|NCT02480153|579609819|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
160513820|NCT02480153|579609817|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
160513821|NCT02480153|579609818|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
160513822|NCT02480153|579609819|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
160513823|NCT02480153|579609817|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
160513824|NCT02480153|579609818|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
160513825|NCT02480153|579609819|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
160513826|NCT02480153|579609817|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
160513827|NCT02480153|579609818|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
160513828|NCT02480153|579609819|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
160513829|NCT02480153|579609817|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
160513830|NCT02480153|579609818|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
160513831|NCT02480153|579609819|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
160513832|NCT02480153|579609817|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
160513833|NCT02480153|579609818|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
160513834|NCT02480153|579609819|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
160513835|NCT02480153|579609817|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
160513836|NCT02480153|579609818|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
160513837|NCT02480153|579609819|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
160513838|NCT02480153|579609817|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
160513839|NCT02480153|579609818|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
160513840|NCT02480153|579609819|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
160513841|NCT02480153|579609817|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
160513842|NCT02480153|579609818|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
160513843|NCT02480153|579609819|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
160513844|NCT00203476|579609820|FG000|Overall Study|Lost to Follow-up|1|||
160513845|NCT00203476|579609821|FG001|Overall Study|Lost to Follow-up|0|||
160513846|NCT00203476|579609822|FG002|Overall Study|Lost to Follow-up|0|||
160513847|NCT00203476|579609820|FG000|Overall Study|Withdrawal by Subject|0|||
160513848|NCT00203476|579609821|FG001|Overall Study|Withdrawal by Subject|1|||
160513849|NCT00203476|579609822|FG002|Overall Study|Withdrawal by Subject|0|||
160513850|NCT03310268|579609825|FG000|Overall Study|(Not specified)|1|||
160513851|NCT03310268|579609826|FG001|Overall Study|(Not specified)|5|||
160513852|NCT03310268|579609827|FG002|Overall Study|(Not specified)|0|||
160513853|NCT01346475|579609828|FG000|First Intervention|Lost to Follow-up|4|||
160513854|NCT01346475|579609829|FG001|First Intervention|Lost to Follow-up|3|||
160513855|NCT00621777|579609830|FG000|Open Phase|Adverse Event|20|||
160513856|NCT00621777|579609831|FG001|Open Phase|Adverse Event|0|||
160513857|NCT00621777|579609830|FG000|Open Phase|Did not abstain during open phase|56|||
160513858|NCT00621777|579609831|FG001|Open Phase|Did not abstain during open phase|0|||
160513859|NCT00621777|579609830|FG000|Open Phase|Withdrawal by Subject|17|||
160513860|NCT00621777|579609831|FG001|Open Phase|Withdrawal by Subject|0|||
160513861|NCT00621777|579609830|FG000|Open Phase|administrative|13|||
160513862|NCT00621777|579609831|FG001|Open Phase|administrative|0|||
160513863|NCT00621777|579609830|FG000|Open Phase|Lost to Follow-up|10|||
160513864|NCT00621777|579609831|FG001|Open Phase|Lost to Follow-up|0|||
160513865|NCT00621777|579609830|FG000|Randomized Phase|Adverse Event|3|||
160513866|NCT00621777|579609831|FG001|Randomized Phase|Adverse Event|3|||
160513867|NCT00621777|579609830|FG000|Randomized Phase|Lost to Follow-up|3|||
160513868|NCT00621777|579609831|FG001|Randomized Phase|Lost to Follow-up|3|||
160513869|NCT00621777|579609830|FG000|Randomized Phase|Withdrawal by Subject|1|||
160513870|NCT00621777|579609831|FG001|Randomized Phase|Withdrawal by Subject|9|||
160513871|NCT00621777|579609830|FG000|Randomized Phase|administrative|0|||
160513872|NCT00621777|579609831|FG001|Randomized Phase|administrative|3|||
160513873|NCT00621777|579609830|FG000|Randomized Phase|Death|0|||
160513874|NCT00621777|579609831|FG001|Randomized Phase|Death|1|||
160513875|NCT04797650|579609832|FG000|Overall Study|Reason Not Specified|5|||
160513876|NCT04797650|579609833|FG001|Overall Study|Reason Not Specified|12|||
160623370|NCT00280059|579999839|FG001|Efficacy Assessment Phase|Adverse Event|31|||
160623371|NCT00280059|579999838|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
160513877|NCT04797650|579609834|FG002|Overall Study|Reason Not Specified|5|||
160513878|NCT04797650|579609832|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
160513879|NCT04797650|579609833|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
160623372|NCT00280059|579999839|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
160623373|NCT00280059|579999838|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
160513880|NCT04797650|579609834|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
160513881|NCT04797650|579609832|FG000|Overall Study|Lack of Efficacy|1|||
160513882|NCT04797650|579609833|FG001|Overall Study|Lack of Efficacy|0|||
160513883|NCT04797650|579609834|FG002|Overall Study|Lack of Efficacy|1|||
160513884|NCT04797650|579609832|FG000|Overall Study|Non-compliance with Study Drug|0|||
160513885|NCT04797650|579609833|FG001|Overall Study|Non-compliance with Study Drug|0|||
160513886|NCT04797650|579609834|FG002|Overall Study|Non-compliance with Study Drug|2|||
160513887|NCT04797650|579609832|FG000|Overall Study|Lost to Follow-up|4|||
160513888|NCT04797650|579609833|FG001|Overall Study|Lost to Follow-up|6|||
160513889|NCT04797650|579609834|FG002|Overall Study|Lost to Follow-up|1|||
160513890|NCT00700258|579609841|FG000|Overall Study|Premature discontinuation of documentation|136|||
160513891|NCT00700258|579609841|FG000|Overall Study|Type of study end not documented|1|||
160513892|NCT00700258|579609841|FG000|Overall Study|Lost to Follow-up|81|||
160513893|NCT00700258|579609841|FG000|Overall Study|Premature discontinuation of therapy|1013|||
160513894|NCT00473265|579609842|FG000|Overall Study|Unrelated adverse event|5|||
160513895|NCT00473265|579609842|FG000|Overall Study|Off treatment early|15|||
160513896|NCT02663518|579609845|FG000|Part 1: Phase 1a Escalation|Death|0|||
160513897|NCT02663518|579609846|FG001|Part 1: Phase 1a Escalation|Death|0|||
160513898|NCT02663518|579609847|FG002|Part 1: Phase 1a Escalation|Death|1|||
160513899|NCT02663518|579609848|FG003|Part 1: Phase 1a Escalation|Death|0|||
160513900|NCT02663518|579609849|FG004|Part 1: Phase 1a Escalation|Death|0|||
160513901|NCT02663518|579609850|FG005|Part 1: Phase 1a Escalation|Death|0|||
160513902|NCT02663518|579609851|FG006|Part 1: Phase 1a Escalation|Death|0|||
160513903|NCT02663518|579609852|FG007|Part 1: Phase 1a Escalation|Death|0|||
160513904|NCT02663518|579609853|FG008|Part 1: Phase 1a Escalation|Death|0|||
160513905|NCT02663518|579609854|FG009|Part 1: Phase 1a Escalation|Death|0|||
160513906|NCT02663518|579609855|FG010|Part 1: Phase 1a Escalation|Death|0|||
160513907|NCT02663518|579609856|FG011|Part 1: Phase 1a Escalation|Death|0|||
160513908|NCT02663518|579609857|FG012|Part 1: Phase 1a Escalation|Death|0|||
160513909|NCT02663518|579609858|FG013|Part 1: Phase 1a Escalation|Death|0|||
160513910|NCT02663518|579609845|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513911|NCT02663518|579609846|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513912|NCT02663518|579609847|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
160513913|NCT02663518|579609848|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513914|NCT02663518|579609849|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513915|NCT02663518|579609850|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513916|NCT02663518|579609851|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513917|NCT02663518|579609852|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513918|NCT02663518|579609853|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513919|NCT02663518|579609854|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513920|NCT02663518|579609855|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513921|NCT02663518|579609856|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513922|NCT02663518|579609857|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513923|NCT02663518|579609858|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
160513924|NCT02663518|579609845|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
160513925|NCT02663518|579609846|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
160513926|NCT02663518|579609847|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
160513927|NCT02663518|579609848|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
160513928|NCT02663518|579609849|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
160513929|NCT02663518|579609850|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
160513930|NCT02663518|579609851|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
160513931|NCT02663518|579609852|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
160513932|NCT02663518|579609853|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
160513933|NCT02663518|579609854|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
160513934|NCT02663518|579609855|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
160513935|NCT02663518|579609856|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
160513936|NCT02663518|579609857|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
160513937|NCT02663518|579609858|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
160513938|NCT02663518|579609845|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
160513939|NCT02663518|579609846|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513940|NCT02663518|579609847|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
160513941|NCT02663518|579609848|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
160513942|NCT02663518|579609849|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513943|NCT02663518|579609850|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513944|NCT02663518|579609851|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513945|NCT02663518|579609852|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513946|NCT02663518|579609853|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513947|NCT02663518|579609854|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513948|NCT02663518|579609855|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513949|NCT02663518|579609856|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513950|NCT02663518|579609857|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513951|NCT02663518|579609858|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
160513952|NCT02663518|579609845|FG000|Part 1: Phase 1a Escalation|Other|0|||
160513953|NCT02663518|579609846|FG001|Part 1: Phase 1a Escalation|Other|0|||
160513954|NCT02663518|579609847|FG002|Part 1: Phase 1a Escalation|Other|2|||
160513955|NCT02663518|579609848|FG003|Part 1: Phase 1a Escalation|Other|0|||
160513956|NCT02663518|579609849|FG004|Part 1: Phase 1a Escalation|Other|0|||
160513957|NCT02663518|579609850|FG005|Part 1: Phase 1a Escalation|Other|0|||
160513958|NCT02663518|579609851|FG006|Part 1: Phase 1a Escalation|Other|0|||
160513959|NCT02663518|579609852|FG007|Part 1: Phase 1a Escalation|Other|0|||
160513960|NCT02663518|579609853|FG008|Part 1: Phase 1a Escalation|Other|0|||
160513961|NCT02663518|579609854|FG009|Part 1: Phase 1a Escalation|Other|0|||
160513962|NCT02663518|579609855|FG010|Part 1: Phase 1a Escalation|Other|0|||
160513963|NCT02663518|579609856|FG011|Part 1: Phase 1a Escalation|Other|0|||
160513964|NCT02663518|579609857|FG012|Part 1: Phase 1a Escalation|Other|0|||
160513965|NCT02663518|579609858|FG013|Part 1: Phase 1a Escalation|Other|0|||
160513966|NCT02663518|579609845|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513967|NCT02663518|579609846|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513968|NCT02663518|579609847|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513969|NCT02663518|579609848|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513970|NCT02663518|579609849|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
160513971|NCT02663518|579609850|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513972|NCT02663518|579609851|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
160513973|NCT02663518|579609852|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
160513974|NCT02663518|579609853|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513975|NCT02663518|579609854|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513976|NCT02663518|579609855|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513977|NCT02663518|579609856|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513978|NCT02663518|579609857|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513979|NCT02663518|579609858|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
160513980|NCT02663518|579609845|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513981|NCT02663518|579609846|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513982|NCT02663518|579609847|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513983|NCT02663518|579609848|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513984|NCT02663518|579609849|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
160513985|NCT02663518|579609850|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513986|NCT02663518|579609851|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
160513987|NCT02663518|579609852|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
160513988|NCT02663518|579609853|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513989|NCT02663518|579609854|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513990|NCT02663518|579609855|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513991|NCT02663518|579609856|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513992|NCT02663518|579609857|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513993|NCT02663518|579609858|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
160513994|NCT02663518|579609845|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160513995|NCT02663518|579609846|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160513996|NCT02663518|579609847|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160513997|NCT02663518|579609848|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160513998|NCT02663518|579609849|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
160513999|NCT02663518|579609850|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160514000|NCT02663518|579609851|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160514001|NCT02663518|579609852|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160514002|NCT02663518|579609853|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160514003|NCT02663518|579609854|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160514004|NCT02663518|579609855|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160514005|NCT02663518|579609856|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160514006|NCT02663518|579609857|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160514007|NCT02663518|579609858|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
160514008|NCT02663518|579609845|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
160514009|NCT02663518|579609846|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
160514010|NCT02663518|579609847|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
160514011|NCT02663518|579609848|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
160514012|NCT02663518|579609849|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
160514013|NCT02663518|579609850|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
160514014|NCT02663518|579609851|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
160514015|NCT02663518|579609852|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
160514016|NCT02663518|579609853|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
160514017|NCT02663518|579609854|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
160514018|NCT02663518|579609855|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
160514019|NCT02663518|579609856|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
160514020|NCT02663518|579609857|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
160514021|NCT02663518|579609858|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
160623374|NCT00280059|579999839|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
160623375|NCT00280059|579999838|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
160514022|NCT02663518|579609845|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
160623376|NCT00280059|579999839|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
160514023|NCT02663518|579609846|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514024|NCT02663518|579609847|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514025|NCT02663518|579609848|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514026|NCT02663518|579609849|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
160514027|NCT02663518|579609850|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514028|NCT02663518|579609851|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
160514029|NCT02663518|579609852|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514030|NCT02663518|579609853|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514031|NCT02663518|579609854|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514032|NCT02663518|579609855|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514033|NCT02663518|579609856|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514034|NCT02663518|579609857|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514035|NCT02663518|579609858|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
160514036|NCT02663518|579609845|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514037|NCT02663518|579609846|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514038|NCT02663518|579609847|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514039|NCT02663518|579609848|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514040|NCT02663518|579609849|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514041|NCT02663518|579609850|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514042|NCT02663518|579609851|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
160514043|NCT02663518|579609852|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514044|NCT02663518|579609853|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514045|NCT02663518|579609854|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514046|NCT02663518|579609855|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514047|NCT02663518|579609856|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514048|NCT02663518|579609857|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514049|NCT02663518|579609858|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
160514050|NCT02663518|579609845|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
160514051|NCT02663518|579609846|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
160514052|NCT02663518|579609847|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
160514053|NCT02663518|579609848|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
160514054|NCT02663518|579609849|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
160514055|NCT02663518|579609850|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
160514056|NCT02663518|579609851|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
160514057|NCT02663518|579609852|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
160514058|NCT02663518|579609853|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
160514059|NCT02663518|579609854|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
160514060|NCT02663518|579609855|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
160514061|NCT02663518|579609856|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
160514062|NCT02663518|579609857|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
160514063|NCT02663518|579609858|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
160514064|NCT02663518|579609845|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514065|NCT02663518|579609846|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514066|NCT02663518|579609847|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514067|NCT02663518|579609848|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514068|NCT02663518|579609849|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514069|NCT02663518|579609850|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514070|NCT02663518|579609851|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514071|NCT02663518|579609852|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514072|NCT02663518|579609853|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514073|NCT02663518|579609854|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514074|NCT02663518|579609855|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514075|NCT02663518|579609856|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514076|NCT02663518|579609857|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
160514077|NCT02663518|579609858|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
160514078|NCT02663518|579609845|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514079|NCT02663518|579609846|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514080|NCT02663518|579609847|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514081|NCT02663518|579609848|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514082|NCT02663518|579609849|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514083|NCT02663518|579609850|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514084|NCT02663518|579609851|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514085|NCT02663518|579609852|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160623377|NCT00280059|579999838|FG000|Efficacy Assessment Phase|Other|7|||
160623378|NCT00280059|579999839|FG001|Efficacy Assessment Phase|Other|8|||
160623379|NCT00280059|579999838|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
160623380|NCT00280059|579999839|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
160623381|NCT00495794|579999842|FG000|Overall Study|Pharmacist did not activate patient|522|||
160623382|NCT00495794|579999843|FG001|Overall Study|Pharmacist did not activate patient|0|||
160514086|NCT02663518|579609853|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514087|NCT02663518|579609854|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514088|NCT02663518|579609855|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514089|NCT02663518|579609856|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
160514090|NCT02663518|579609857|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514091|NCT02663518|579609858|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
160514092|NCT02663518|579609845|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
160514093|NCT02663518|579609846|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
160514094|NCT02663518|579609847|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
160514095|NCT02663518|579609848|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
160514096|NCT02663518|579609849|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
160514097|NCT02663518|579609850|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
160514098|NCT02663518|579609851|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
160514099|NCT02663518|579609852|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
160514100|NCT02663518|579609853|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
160514101|NCT02663518|579609854|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
160514102|NCT02663518|579609855|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
160514103|NCT02663518|579609856|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
160514104|NCT02663518|579609857|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
160514105|NCT02663518|579609858|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
160514106|NCT02663518|579609845|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
160514107|NCT02663518|579609846|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
160514108|NCT02663518|579609847|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
160514109|NCT02663518|579609848|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
160514110|NCT02663518|579609849|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
160514111|NCT02663518|579609850|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
160514112|NCT02663518|579609851|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
160514113|NCT02663518|579609852|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
160514114|NCT02663518|579609853|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
160514115|NCT02663518|579609854|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
160514116|NCT02663518|579609855|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
160514117|NCT02663518|579609856|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
160514118|NCT02663518|579609857|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
160514119|NCT02663518|579609858|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
160514120|NCT02663518|579609845|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514121|NCT02663518|579609846|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514122|NCT02663518|579609847|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514123|NCT02663518|579609848|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514124|NCT02663518|579609849|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514125|NCT02663518|579609850|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514126|NCT02663518|579609851|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514127|NCT02663518|579609852|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514128|NCT02663518|579609853|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514129|NCT02663518|579609854|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514130|NCT02663518|579609855|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514131|NCT02663518|579609856|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514132|NCT02663518|579609857|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
160514133|NCT02663518|579609858|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
160514134|NCT01888900|579609860|FG000|Overall Study|failed treatment|0|||
160514135|NCT01888900|579609861|FG001|Overall Study|failed treatment|2|||
160666462|NCT03733444|580159228|FG001|Overall Study|Miscellaneous|0|||
160514136|NCT01004848|579609862|FG000|Overall Study|Lost to Follow-up|55|||
160514137|NCT01004848|579609863|FG001|Overall Study|Lost to Follow-up|45|||
160514138|NCT01160289|579609864|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
160514139|NCT01160289|579609865|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
160514140|NCT01160289|579609866|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
160514141|NCT01160289|579609867|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
160514142|NCT01160289|579609868|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
160514143|NCT01160289|579609869|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
160514144|NCT01160289|579609864|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
160514145|NCT01160289|579609865|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
160514146|NCT01160289|579609866|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
160514147|NCT01160289|579609867|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
160514148|NCT01160289|579609868|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
160514149|NCT01160289|579609869|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
160514150|NCT01160289|579609864|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
160514151|NCT01160289|579609865|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
160514152|NCT01160289|579609866|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
160514153|NCT01160289|579609867|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
160514154|NCT01160289|579609868|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
160514155|NCT01160289|579609869|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
160514156|NCT01160289|579609864|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
160514157|NCT01160289|579609865|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
160514158|NCT01160289|579609866|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
160514159|NCT01160289|579609867|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
160514160|NCT01160289|579609868|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
160514161|NCT01160289|579609869|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
160514162|NCT01160289|579609864|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
160514163|NCT01160289|579609865|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
160514164|NCT01160289|579609866|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
160514165|NCT01160289|579609867|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
160514166|NCT01160289|579609868|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
160514167|NCT01160289|579609869|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
160514168|NCT01160289|579609864|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
160514169|NCT01160289|579609865|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
160514170|NCT01160289|579609866|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
160514171|NCT01160289|579609867|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
160514172|NCT01160289|579609868|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
160514173|NCT01160289|579609869|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
160514174|NCT01160289|579609864|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
160514175|NCT01160289|579609865|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
160514176|NCT01160289|579609866|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
160514177|NCT01160289|579609867|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
160514178|NCT01160289|579609868|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
160514179|NCT01160289|579609869|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
160514180|NCT01160289|579609864|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
160514181|NCT01160289|579609865|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
160514182|NCT01160289|579609866|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
160514183|NCT01160289|579609867|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
160514184|NCT01160289|579609868|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
160514185|NCT01160289|579609869|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
160514186|NCT01160289|579609864|FG000|Post-Randomization Period|Adverse Event|0|||
160514187|NCT01160289|579609865|FG001|Post-Randomization Period|Adverse Event|4|||
160514188|NCT01160289|579609866|FG002|Post-Randomization Period|Adverse Event|4|||
160514189|NCT01160289|579609867|FG003|Post-Randomization Period|Adverse Event|2|||
160514190|NCT01160289|579609868|FG004|Post-Randomization Period|Adverse Event|0|||
160514191|NCT01160289|579609869|FG005|Post-Randomization Period|Adverse Event|0|||
160514192|NCT01160289|579609864|FG000|Post-Randomization Period|Death|0|||
160514193|NCT01160289|579609865|FG001|Post-Randomization Period|Death|0|||
160514194|NCT01160289|579609866|FG002|Post-Randomization Period|Death|0|||
160514195|NCT01160289|579609867|FG003|Post-Randomization Period|Death|1|||
160514196|NCT01160289|579609868|FG004|Post-Randomization Period|Death|0|||
160514197|NCT01160289|579609869|FG005|Post-Randomization Period|Death|0|||
160514198|NCT01160289|579609864|FG000|Post-Randomization Period|Lack of Efficacy|0|||
160514199|NCT01160289|579609865|FG001|Post-Randomization Period|Lack of Efficacy|1|||
160514200|NCT01160289|579609866|FG002|Post-Randomization Period|Lack of Efficacy|0|||
160514201|NCT01160289|579609867|FG003|Post-Randomization Period|Lack of Efficacy|3|||
160514202|NCT01160289|579609868|FG004|Post-Randomization Period|Lack of Efficacy|0|||
160514203|NCT01160289|579609869|FG005|Post-Randomization Period|Lack of Efficacy|0|||
160514204|NCT01160289|579609864|FG000|Post-Randomization Period|Lost to Follow-up|0|||
160514205|NCT01160289|579609865|FG001|Post-Randomization Period|Lost to Follow-up|3|||
160514206|NCT01160289|579609866|FG002|Post-Randomization Period|Lost to Follow-up|2|||
160514207|NCT01160289|579609867|FG003|Post-Randomization Period|Lost to Follow-up|5|||
160514208|NCT01160289|579609868|FG004|Post-Randomization Period|Lost to Follow-up|3|||
160514209|NCT01160289|579609869|FG005|Post-Randomization Period|Lost to Follow-up|4|||
160514210|NCT01160289|579609864|FG000|Post-Randomization Period|Physician Decision|0|||
160514211|NCT01160289|579609865|FG001|Post-Randomization Period|Physician Decision|0|||
160623383|NCT01789476|580001701|FG000|Overall Study|Lack of Efficacy|6|||
160623384|NCT01789476|580001702|FG001|Overall Study|Lack of Efficacy|2|||
160623385|NCT01789476|580001701|FG000|Overall Study|Adverse Event|1|||
160514212|NCT01160289|579609866|FG002|Post-Randomization Period|Physician Decision|1|||
160514213|NCT01160289|579609867|FG003|Post-Randomization Period|Physician Decision|0|||
160514214|NCT01160289|579609868|FG004|Post-Randomization Period|Physician Decision|0|||
160623386|NCT01789476|580001702|FG001|Overall Study|Adverse Event|0|||
160514215|NCT01160289|579609869|FG005|Post-Randomization Period|Physician Decision|0|||
160514216|NCT01160289|579609864|FG000|Post-Randomization Period|Protocol Violation|0|||
160514217|NCT01160289|579609865|FG001|Post-Randomization Period|Protocol Violation|4|||
160514218|NCT01160289|579609866|FG002|Post-Randomization Period|Protocol Violation|2|||
160514219|NCT01160289|579609867|FG003|Post-Randomization Period|Protocol Violation|0|||
160514220|NCT01160289|579609868|FG004|Post-Randomization Period|Protocol Violation|1|||
160514221|NCT01160289|579609869|FG005|Post-Randomization Period|Protocol Violation|3|||
160514222|NCT01160289|579609864|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
160514223|NCT01160289|579609865|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
160514224|NCT01160289|579609866|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
160514225|NCT01160289|579609867|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
160514226|NCT01160289|579609868|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
160514227|NCT01160289|579609869|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
160514228|NCT01160289|579609864|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
160514229|NCT01160289|579609865|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
160514230|NCT01160289|579609866|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
160514231|NCT01160289|579609867|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
160514232|NCT01160289|579609868|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
160514233|NCT01160289|579609869|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
160514234|NCT01160289|579609864|FG000|Post-Randomization Period|Sponsor Decision|0|||
160514235|NCT01160289|579609865|FG001|Post-Randomization Period|Sponsor Decision|1|||
160514236|NCT01160289|579609866|FG002|Post-Randomization Period|Sponsor Decision|0|||
160514237|NCT01160289|579609867|FG003|Post-Randomization Period|Sponsor Decision|0|||
160514238|NCT01160289|579609868|FG004|Post-Randomization Period|Sponsor Decision|0|||
160514239|NCT01160289|579609869|FG005|Post-Randomization Period|Sponsor Decision|0|||
160514240|NCT01156792|579609874|FG000|Overall Study|Adverse Event|1|||
160514241|NCT01156792|579609874|FG000|Overall Study|Lack of Efficacy|36|||
160514242|NCT01156792|579609874|FG000|Overall Study|Protocol Violation|6|||
160514243|NCT01156792|579609874|FG000|Overall Study|Lost to Follow-up|3|||
160514244|NCT01156792|579609874|FG000|Overall Study|Physician Decision|3|||
160514245|NCT01156792|579609874|FG000|Overall Study|Withdrawal by Subject|9|||
160514246|NCT01156792|579609874|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
160514247|NCT00768079|579609875|FG000|Overall Study|Lost to Follow-up|2|||
160514248|NCT00768079|579609876|FG001|Overall Study|Lost to Follow-up|0|||
160514249|NCT00768079|579609877|FG002|Overall Study|Lost to Follow-up|4|||
160514250|NCT00768079|579609875|FG000|Overall Study|Participant incarcerated|0|||
160514251|NCT00768079|579609876|FG001|Overall Study|Participant incarcerated|1|||
160514252|NCT00768079|579609877|FG002|Overall Study|Participant incarcerated|0|||
160514253|NCT03271021|579609878|FG000|Overall Study|Adverse Event|3|||
160514254|NCT03271021|579609879|FG001|Overall Study|Adverse Event|2|||
160514255|NCT03271021|579609878|FG000|Overall Study|Withdrawal by Subject|36|||
160514256|NCT03271021|579609879|FG001|Overall Study|Withdrawal by Subject|53|||
160514257|NCT03271021|579609878|FG000|Overall Study|Lost to Follow-up|34|||
160514258|NCT03271021|579609879|FG001|Overall Study|Lost to Follow-up|39|||
160514259|NCT03271021|579609878|FG000|Overall Study|Protocol Violation|6|||
160514260|NCT03271021|579609879|FG001|Overall Study|Protocol Violation|4|||
160514261|NCT03271021|579609878|FG000|Overall Study|Abnormal Lab Results|1|||
160514262|NCT03271021|579609879|FG001|Overall Study|Abnormal Lab Results|0|||
160514263|NCT03271021|579609878|FG000|Overall Study|Miscellaneous|9|||
160514264|NCT03271021|579609879|FG001|Overall Study|Miscellaneous|8|||
160514265|NCT03215810|579609882|FG000|Overall Study|Still responding to nivolumab|1|||
160514266|NCT03215810|579609882|FG000|Overall Study|Insufficient TIL growth|1|||
160514267|NCT03215810|579609882|FG000|Overall Study|Decline in performance status|1|||
160623387|NCT01789476|580001701|FG000|Overall Study|Unable to get IV access|1|||
160623388|NCT01789476|580001702|FG001|Overall Study|Unable to get IV access|0|||
160623389|NCT03053102|580001703|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
160623390|NCT03053102|580001703|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
160623391|NCT01798056|580001704|FG000|Overall Study|Serious Adverse Event|13|||
160623392|NCT01798056|580001705|FG001|Overall Study|Serious Adverse Event|12|||
160623393|NCT01798056|580001704|FG000|Overall Study|Withdrawal by Subject|12|||
160623394|NCT01798056|580001705|FG001|Overall Study|Withdrawal by Subject|9|||
160623395|NCT01798056|580001704|FG000|Overall Study|Migrated/moved from study area|1|||
160623396|NCT01798056|580001705|FG001|Overall Study|Migrated/moved from study area|1|||
160623397|NCT01798056|580001704|FG000|Overall Study|Lost to Follow-up|1|||
160514268|NCT03215810|579609882|FG000|Overall Study|Withdrawal by Subject|1|||
160514269|NCT02313233|579609886|FG000|Overall Study|Withdrawal by Subject|1|||
160514270|NCT02313233|579609887|FG001|Overall Study|Withdrawal by Subject|2|||
160514271|NCT02313233|579609886|FG000|Overall Study|Administrative reason|1|||
160514272|NCT02313233|579609887|FG001|Overall Study|Administrative reason|1|||
160514273|NCT02095951|579609888|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
160623398|NCT01798056|580001705|FG001|Overall Study|Lost to Follow-up|1|||
160623399|NCT01798056|580001704|FG000|Overall Study|Other|0|||
160623400|NCT01798056|580001705|FG001|Overall Study|Other|2|||
160623401|NCT05064436|580001710|FG000|Overall Study|Other Reasons|1|||
160514274|NCT02095951|579609889|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
160514275|NCT03618823|579609890|FG000|Overall Study|Lost to Follow-up|63|||
160514276|NCT03618823|579609891|FG001|Overall Study|Lost to Follow-up|61|||
160514277|NCT05383508|579609892|FG000|Overall Study|Withdrawal by Subject|1|||
160514278|NCT05383508|579609893|FG001|Overall Study|Withdrawal by Subject|0|||
160514279|NCT05383508|579609894|FG002|Overall Study|Withdrawal by Subject|1|||
160514280|NCT05383508|579609895|FG003|Overall Study|Withdrawal by Subject|1|||
160514281|NCT05383508|579609896|FG004|Overall Study|Withdrawal by Subject|2|||
160514282|NCT05383508|579609897|FG005|Overall Study|Withdrawal by Subject|0|||
160514283|NCT01621568|579609899|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
160514284|NCT01621568|579609900|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
160514285|NCT01621568|579609899|FG000|Week 5-6 No Treatment|Death|1|||
160514286|NCT01621568|579609900|FG001|Week 5-6 No Treatment|Death|0|||
160514287|NCT01859988|579609901|FG000|Overall Study|Withdrawal by Subject|6|||
160514288|NCT01859988|579609902|FG001|Overall Study|Withdrawal by Subject|3|||
160514289|NCT01859988|579609903|FG002|Overall Study|Withdrawal by Subject|4|||
160514290|NCT01859988|579609904|FG003|Overall Study|Withdrawal by Subject|3|||
160514291|NCT01859988|579609905|FG004|Overall Study|Withdrawal by Subject|2|||
160514292|NCT01859988|579609906|FG005|Overall Study|Withdrawal by Subject|2|||
160514293|NCT01859988|579609901|FG000|Overall Study|Lack of Efficacy|1|||
160514294|NCT01859988|579609902|FG001|Overall Study|Lack of Efficacy|1|||
160514295|NCT01859988|579609903|FG002|Overall Study|Lack of Efficacy|5|||
160514296|NCT01859988|579609904|FG003|Overall Study|Lack of Efficacy|0|||
160514297|NCT01859988|579609905|FG004|Overall Study|Lack of Efficacy|7|||
160514298|NCT01859988|579609906|FG005|Overall Study|Lack of Efficacy|9|||
160514299|NCT01859988|579609901|FG000|Overall Study|Physician Decision|1|||
160514300|NCT01859988|579609902|FG001|Overall Study|Physician Decision|3|||
160514301|NCT01859988|579609903|FG002|Overall Study|Physician Decision|1|||
160514302|NCT01859988|579609904|FG003|Overall Study|Physician Decision|3|||
160514303|NCT01859988|579609905|FG004|Overall Study|Physician Decision|4|||
160514304|NCT01859988|579609906|FG005|Overall Study|Physician Decision|1|||
160514305|NCT01859988|579609901|FG000|Overall Study|Adverse Event|2|||
160514306|NCT01859988|579609902|FG001|Overall Study|Adverse Event|1|||
160514307|NCT01859988|579609903|FG002|Overall Study|Adverse Event|3|||
160514308|NCT01859988|579609904|FG003|Overall Study|Adverse Event|1|||
160514309|NCT01859988|579609905|FG004|Overall Study|Adverse Event|2|||
160514310|NCT01859988|579609906|FG005|Overall Study|Adverse Event|2|||
160514311|NCT01859988|579609901|FG000|Overall Study|Lost to Follow-up|1|||
160514312|NCT01859988|579609902|FG001|Overall Study|Lost to Follow-up|2|||
160514313|NCT01859988|579609903|FG002|Overall Study|Lost to Follow-up|3|||
160514314|NCT01859988|579609904|FG003|Overall Study|Lost to Follow-up|0|||
160514315|NCT01859988|579609905|FG004|Overall Study|Lost to Follow-up|3|||
160514316|NCT01859988|579609906|FG005|Overall Study|Lost to Follow-up|2|||
160514317|NCT01859988|579609901|FG000|Overall Study|Protocol Violation|0|||
160514318|NCT01859988|579609902|FG001|Overall Study|Protocol Violation|0|||
160514319|NCT01859988|579609903|FG002|Overall Study|Protocol Violation|1|||
160514320|NCT01859988|579609904|FG003|Overall Study|Protocol Violation|0|||
160514321|NCT01859988|579609905|FG004|Overall Study|Protocol Violation|0|||
160514322|NCT01859988|579609906|FG005|Overall Study|Protocol Violation|0|||
160514323|NCT01859988|579609901|FG000|Overall Study|Other than specified above|0|||
160514324|NCT01859988|579609902|FG001|Overall Study|Other than specified above|2|||
160514325|NCT01859988|579609903|FG002|Overall Study|Other than specified above|11|||
160514326|NCT01859988|579609904|FG003|Overall Study|Other than specified above|3|||
160514327|NCT01859988|579609905|FG004|Overall Study|Other than specified above|5|||
160514328|NCT01859988|579609906|FG005|Overall Study|Other than specified above|3|||
160514329|NCT00564889|579609907|FG000|Overall Study|Death|7|||
160514330|NCT00564889|579609907|FG000|Overall Study|Adverse Event|12|||
160514331|NCT00564889|579609907|FG000|Overall Study|Alternative treatment|3|||
160514332|NCT00564889|579609907|FG000|Overall Study|Disease progression|3|||
160514333|NCT00564889|579609907|FG000|Overall Study|Other, not specified|4|||
160514334|NCT00635427|579609908|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
160514335|NCT00635427|579609909|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
160514336|NCT00635427|579609910|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
160514337|NCT00635427|579609911|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
160514338|NCT00635427|579609912|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
160514339|NCT00635427|579609908|FG000|Overall Study|Death|0|||
160514340|NCT00635427|579609909|FG001|Overall Study|Death|0|||
160514341|NCT00635427|579609910|FG002|Overall Study|Death|0|||
160514342|NCT00635427|579609911|FG003|Overall Study|Death|1|||
160514343|NCT00635427|579609912|FG004|Overall Study|Death|0|||
160514344|NCT00635427|579609908|FG000|Overall Study|Termination Of Study By Sponsor|12|||
160514345|NCT00635427|579609909|FG001|Overall Study|Termination Of Study By Sponsor|6|||
160514346|NCT00635427|579609910|FG002|Overall Study|Termination Of Study By Sponsor|10|||
160514347|NCT00635427|579609911|FG003|Overall Study|Termination Of Study By Sponsor|6|||
160514348|NCT00635427|579609912|FG004|Overall Study|Termination Of Study By Sponsor|6|||
160514349|NCT00635427|579609908|FG000|Overall Study|Withdrawal Of Consent|0|||
160514350|NCT00635427|579609909|FG001|Overall Study|Withdrawal Of Consent|0|||
160514351|NCT00635427|579609910|FG002|Overall Study|Withdrawal Of Consent|0|||
160514352|NCT00635427|579609911|FG003|Overall Study|Withdrawal Of Consent|2|||
160514353|NCT00635427|579609912|FG004|Overall Study|Withdrawal Of Consent|2|||
160514354|NCT01506609|579609917|FG000|Overall Study|Adverse Event Related to Progression|0|||
160514355|NCT01506609|579609918|FG001|Overall Study|Adverse Event Related to Progression|0|||
160514356|NCT01506609|579609919|FG002|Overall Study|Adverse Event Related to Progression|0|||
160514357|NCT01506609|579609920|FG003|Overall Study|Adverse Event Related to Progression|3|||
160514358|NCT01506609|579609921|FG004|Overall Study|Adverse Event Related to Progression|7|||
160514359|NCT01506609|579609922|FG005|Overall Study|Adverse Event Related to Progression|3|||
160514360|NCT01506609|579609917|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
160514361|NCT01506609|579609918|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
160514362|NCT01506609|579609919|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
160514363|NCT01506609|579609920|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
160514364|NCT01506609|579609921|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
160514365|NCT01506609|579609922|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
160514366|NCT01506609|579609917|FG000|Overall Study|Withdrawal by Subject|0|||
160514367|NCT01506609|579609918|FG001|Overall Study|Withdrawal by Subject|0|||
160514368|NCT01506609|579609919|FG002|Overall Study|Withdrawal by Subject|0|||
160514369|NCT01506609|579609920|FG003|Overall Study|Withdrawal by Subject|9|||
160514370|NCT01506609|579609921|FG004|Overall Study|Withdrawal by Subject|7|||
160514371|NCT01506609|579609922|FG005|Overall Study|Withdrawal by Subject|7|||
160514372|NCT01506609|579609917|FG000|Overall Study|Lost to Follow-up|0|||
160514373|NCT01506609|579609918|FG001|Overall Study|Lost to Follow-up|0|||
160514374|NCT01506609|579609919|FG002|Overall Study|Lost to Follow-up|0|||
160514375|NCT01506609|579609920|FG003|Overall Study|Lost to Follow-up|1|||
160514376|NCT01506609|579609921|FG004|Overall Study|Lost to Follow-up|2|||
160514377|NCT01506609|579609922|FG005|Overall Study|Lost to Follow-up|0|||
160514378|NCT01506609|579609917|FG000|Overall Study|Sponsor Discontinued Study|0|||
160514379|NCT01506609|579609918|FG001|Overall Study|Sponsor Discontinued Study|0|||
160514380|NCT01506609|579609919|FG002|Overall Study|Sponsor Discontinued Study|0|||
160514381|NCT01506609|579609920|FG003|Overall Study|Sponsor Discontinued Study|2|||
160514382|NCT01506609|579609921|FG004|Overall Study|Sponsor Discontinued Study|2|||
160514383|NCT01506609|579609922|FG005|Overall Study|Sponsor Discontinued Study|0|||
160514384|NCT01506609|579609917|FG000|Overall Study|Progressive Disease per Protocol|1|||
160514385|NCT01506609|579609918|FG001|Overall Study|Progressive Disease per Protocol|0|||
160514386|NCT01506609|579609919|FG002|Overall Study|Progressive Disease per Protocol|0|||
160514387|NCT01506609|579609920|FG003|Overall Study|Progressive Disease per Protocol|64|||
160514388|NCT01506609|579609921|FG004|Overall Study|Progressive Disease per Protocol|57|||
160514389|NCT01506609|579609922|FG005|Overall Study|Progressive Disease per Protocol|74|||
160514390|NCT01506609|579609917|FG000|Overall Study|Other, Not Specified|0|||
160514391|NCT01506609|579609918|FG001|Overall Study|Other, Not Specified|0|||
160514392|NCT01506609|579609919|FG002|Overall Study|Other, Not Specified|0|||
160514393|NCT01506609|579609920|FG003|Overall Study|Other, Not Specified|10|||
160514394|NCT01506609|579609921|FG004|Overall Study|Other, Not Specified|7|||
160514395|NCT01506609|579609922|FG005|Overall Study|Other, Not Specified|3|||
160514396|NCT01506609|579609917|FG000|Overall Study|Missing / Unknown Reason|1|||
160514397|NCT01506609|579609918|FG001|Overall Study|Missing / Unknown Reason|0|||
160514398|NCT01506609|579609919|FG002|Overall Study|Missing / Unknown Reason|1|||
160514399|NCT01506609|579609920|FG003|Overall Study|Missing / Unknown Reason|4|||
160514400|NCT01506609|579609921|FG004|Overall Study|Missing / Unknown Reason|4|||
160514401|NCT01506609|579609922|FG005|Overall Study|Missing / Unknown Reason|2|||
160514402|NCT00577473|579609927|FG000|Overall Study|Protocol Violation|1|||
160514403|NCT00577473|579609928|FG001|Overall Study|Protocol Violation|4|||
160514404|NCT00577473|579609927|FG000|Overall Study|Adverse Event|8|||
160514405|NCT00577473|579609928|FG001|Overall Study|Adverse Event|5|||
160514406|NCT00577473|579609927|FG000|Overall Study|Withdrawal by Subject|2|||
160514407|NCT00577473|579609928|FG001|Overall Study|Withdrawal by Subject|6|||
160623402|NCT05064436|580001711|FG001|Overall Study|Other Reasons|0|||
160623403|NCT04511533|580001717|FG000|Treatment|Other|2|||
160623404|NCT04511533|580001717|FG000|Treatment|Withdrawal by Subject|11|||
160623405|NCT04511533|580001717|FG000|Treatment|Death|5|||
160623406|NCT04511533|580001717|FG000|Treatment|Physician Decision|1|||
160514408|NCT00577473|579609927|FG000|Overall Study|Physician Decision|2|||
160514409|NCT00577473|579609928|FG001|Overall Study|Physician Decision|2|||
160514410|NCT00577473|579609927|FG000|Overall Study|Lack of Efficacy|8|||
160514411|NCT00577473|579609928|FG001|Overall Study|Lack of Efficacy|7|||
160514412|NCT02595073|579609931|FG000|Overall Study|Progressive Disease|0|||
160514413|NCT02595073|579609932|FG001|Overall Study|Progressive Disease|1|||
160514414|NCT02595073|579609931|FG000|Overall Study|Protocol Violation|2|||
160514415|NCT02595073|579609932|FG001|Overall Study|Protocol Violation|0|||
160514416|NCT01990560|579609935|FG000|Overall Study|Withdrawal by Subject|1|||
160623407|NCT04511533|580001717|FG000|Treatment|Progressive Disease|61|||
160623408|NCT04511533|580001717|FG000|Follow-Up|Other|7|||
160623409|NCT04511533|580001717|FG000|Follow-Up|Withdrawal by Subject|5|||
160514417|NCT01324440|579609941|FG000|Overall Study|Subject moved|0|||
160514418|NCT01324440|579609942|FG001|Overall Study|Subject moved|1|||
160514419|NCT02884908|579609943|FG000|Overall Study|Lost to Follow-up|13|||
160514420|NCT02884908|579609944|FG001|Overall Study|Lost to Follow-up|18|||
160514421|NCT01801735|579609948|FG000|Overall Study|Adverse Event|79|||
160514422|NCT01801735|579609948|FG000|Overall Study|Lack of Efficacy|28|||
160514423|NCT01801735|579609948|FG000|Overall Study|Withdrawal by Subject|27|||
160514424|NCT01801735|579609948|FG000|Overall Study|Protocol Violation|25|||
160666463|NCT03733444|580159229|FG002|Overall Study|Miscellaneous|1|||
160666464|NCT03733444|580159227|FG000|Overall Study|Not Treated|1|||
160666465|NCT03733444|580159228|FG001|Overall Study|Not Treated|2|||
160666466|NCT03733444|580159229|FG002|Overall Study|Not Treated|1|||
160666467|NCT00556322|580159230|FG000|Overall Study|Insufficient therapeutic response|158|||
160666468|NCT00556322|580159231|FG001|Overall Study|Insufficient therapeutic response|168|||
160666469|NCT00556322|580159230|FG000|Overall Study|Adverse Event|7|||
160666470|NCT00556322|580159231|FG001|Overall Study|Adverse Event|4|||
160666471|NCT00556322|580159230|FG000|Overall Study|Other|4|||
160666472|NCT00556322|580159231|FG001|Overall Study|Other|1|||
160666473|NCT00556322|580159230|FG000|Overall Study|Lost to Follow-up|5|||
160514425|NCT01801735|579609948|FG000|Overall Study|Lost to Follow-up|15|||
160514426|NCT01801735|579609948|FG000|Overall Study|Non-compliance with Trial Drug|13|||
160514427|NCT01801735|579609948|FG000|Overall Study|Physician Decision|3|||
160514428|NCT01801735|579609948|FG000|Overall Study|Death|1|||
160514429|NCT01801735|579609948|FG000|Overall Study|Other, including site closure|19|||
160514430|NCT01293487|579609950|FG000|Overall Study|Lost to Follow-up|0|||
160514431|NCT01293487|579609951|FG001|Overall Study|Lost to Follow-up|0|||
160514432|NCT01293487|579609952|FG002|Overall Study|Lost to Follow-up|0|||
160514433|NCT01293487|579609953|FG003|Overall Study|Lost to Follow-up|1|||
160514434|NCT01293487|579609954|FG004|Overall Study|Lost to Follow-up|0|||
160514435|NCT01293487|579609955|FG005|Overall Study|Lost to Follow-up|0|||
160514436|NCT01293487|579609956|FG006|Overall Study|Lost to Follow-up|0|||
160514437|NCT01293487|579609957|FG007|Overall Study|Lost to Follow-up|0|||
160514438|NCT01293487|579609950|FG000|Overall Study|Withdrawal by Subject|0|||
160514439|NCT01293487|579609951|FG001|Overall Study|Withdrawal by Subject|0|||
160514440|NCT01293487|579609952|FG002|Overall Study|Withdrawal by Subject|0|||
160514441|NCT01293487|579609953|FG003|Overall Study|Withdrawal by Subject|0|||
160514442|NCT01293487|579609954|FG004|Overall Study|Withdrawal by Subject|0|||
160514443|NCT01293487|579609955|FG005|Overall Study|Withdrawal by Subject|0|||
160514444|NCT01293487|579609956|FG006|Overall Study|Withdrawal by Subject|0|||
160514445|NCT01293487|579609957|FG007|Overall Study|Withdrawal by Subject|2|||
160514446|NCT04860297|579609958|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
160514447|NCT04860297|579609959|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
160514448|NCT04860297|579609960|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
160514449|NCT04860297|579609961|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
160514450|NCT04860297|579609962|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
160514451|NCT04860297|579609963|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
160623410|NCT04511533|580001717|FG000|Follow-Up|Lost to Follow-up|2|||
160623411|NCT04511533|580001717|FG000|Follow-Up|Death|4|||
160623412|NCT01224171|580001718|FG000|Overall Study|Adverse Event|8|||
160623413|NCT01224171|580001719|FG001|Overall Study|Adverse Event|4|||
160623414|NCT01224171|580001718|FG000|Overall Study|Protocol Violation|0|||
160623415|NCT01224171|580001719|FG001|Overall Study|Protocol Violation|1|||
160623416|NCT01224171|580001718|FG000|Overall Study|Lack of Efficacy|5|||
160623417|NCT01224171|580001719|FG001|Overall Study|Lack of Efficacy|1|||
160623418|NCT01224171|580001718|FG000|Overall Study|Withdrawal of Consent|2|||
160623419|NCT01224171|580001719|FG001|Overall Study|Withdrawal of Consent|4|||
160623420|NCT01224171|580001718|FG000|Overall Study|Lost to Follow-up|0|||
160623421|NCT01224171|580001719|FG001|Overall Study|Lost to Follow-up|3|||
160623422|NCT01097057|580001720|FG000|Overall Study|Physician Decision|3|||
160623423|NCT01270139|580001721|FG000|Overall Study|Adverse Event|8|||
160623424|NCT01270139|580001722|FG001|Overall Study|Adverse Event|17|||
160623425|NCT01270139|580001723|FG002|Overall Study|Adverse Event|18|||
160623426|NCT01270139|580001721|FG000|Overall Study|Lost to Follow-up|10|||
160623427|NCT01270139|580001722|FG001|Overall Study|Lost to Follow-up|9|||
160666474|NCT00556322|580159231|FG001|Overall Study|Lost to Follow-up|3|||
160514452|NCT04860297|579609964|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
160666475|NCT00556322|580159230|FG000|Overall Study|Withdrawal by Subject|19|||
160666476|NCT00556322|580159231|FG001|Overall Study|Withdrawal by Subject|7|||
160666477|NCT00556322|580159230|FG000|Overall Study|Protocol Violation|5|||
160666478|NCT00556322|580159231|FG001|Overall Study|Protocol Violation|1|||
160514453|NCT04860297|579609965|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
160514454|NCT04860297|579609958|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
160514455|NCT04860297|579609959|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
160514456|NCT04860297|579609960|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
160623428|NCT01270139|580001723|FG002|Overall Study|Lost to Follow-up|2|||
160623429|NCT01161173|580001732|FG000|Overall Study|Protocol Violation|13|||
160623430|NCT01161173|580001732|FG000|Overall Study|Lost to Follow-up|7|||
160666479|NCT00556322|580159230|FG000|Overall Study|Ongoing at data cutoff|3|||
160514457|NCT04860297|579609961|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
160514458|NCT04860297|579609962|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
160514459|NCT04860297|579609963|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
160514460|NCT04860297|579609964|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
160514461|NCT04860297|579609965|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
160514462|NCT04860297|579609958|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
160514463|NCT04860297|579609959|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
160514464|NCT04860297|579609960|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
160514465|NCT04860297|579609961|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
160514466|NCT04860297|579609962|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
160514467|NCT04860297|579609963|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
160514468|NCT04860297|579609964|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
160514469|NCT04860297|579609965|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
160514470|NCT04860297|579609958|FG000|Part B (Booster Dose)|Other Than Specified|0|||
160514471|NCT04860297|579609959|FG001|Part B (Booster Dose)|Other Than Specified|0|||
160514472|NCT04860297|579609960|FG002|Part B (Booster Dose)|Other Than Specified|0|||
160514473|NCT04860297|579609961|FG003|Part B (Booster Dose)|Other Than Specified|0|||
160514474|NCT04860297|579609962|FG004|Part B (Booster Dose)|Other Than Specified|0|||
160514475|NCT04860297|579609963|FG005|Part B (Booster Dose)|Other Than Specified|1|||
160514476|NCT04860297|579609964|FG006|Part B (Booster Dose)|Other Than Specified|1|||
160514477|NCT04860297|579609965|FG007|Part B (Booster Dose)|Other Than Specified|0|||
160514478|NCT04860297|579609958|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
160514479|NCT04860297|579609959|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
160514480|NCT04860297|579609960|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
160514481|NCT04860297|579609961|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
160514482|NCT04860297|579609962|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
160514483|NCT04860297|579609963|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
160514484|NCT04860297|579609964|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
160514485|NCT04860297|579609965|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
160514486|NCT04860297|579609958|FG000|Part B (Booster Dose)|Death|0|||
160514487|NCT04860297|579609959|FG001|Part B (Booster Dose)|Death|0|||
160514488|NCT04860297|579609960|FG002|Part B (Booster Dose)|Death|0|||
160514489|NCT04860297|579609961|FG003|Part B (Booster Dose)|Death|0|||
160514490|NCT04860297|579609962|FG004|Part B (Booster Dose)|Death|1|||
160514491|NCT04860297|579609963|FG005|Part B (Booster Dose)|Death|2|||
160514492|NCT04860297|579609964|FG006|Part B (Booster Dose)|Death|1|||
160514493|NCT04860297|579609965|FG007|Part B (Booster Dose)|Death|0|||
160514494|NCT04860297|579609958|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
160514495|NCT04860297|579609959|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
160514496|NCT04860297|579609960|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
160514497|NCT04860297|579609961|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
160514498|NCT04860297|579609962|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
160514499|NCT04860297|579609963|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
160514500|NCT04860297|579609964|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
160514501|NCT04860297|579609965|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
160514502|NCT02971761|579609969|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
160514503|NCT02842151|579609971|FG000|Overall Study|Adverse Event|1|||
160514504|NCT02842151|579609971|FG000|Overall Study|Subject moved too far away|1|||
160514505|NCT03965351|579609974|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
160514506|NCT03965351|579609975|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
160514507|NCT03965351|579609974|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
160514508|NCT03965351|579609975|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
160514509|NCT01942785|579609979|FG000|Overall Study|Adverse Event|2|||
160514510|NCT01942785|579609979|FG000|Overall Study|Withdrawal by Subject|1|||
160514511|NCT01942785|579609979|FG000|Overall Study|Protocol Violation|1|||
160514512|NCT05038163|579609983|FG000|Stage 1|Did not complete survey|374|||
160514513|NCT05038163|579609984|FG001|Stage 1|Did not complete survey|0|||
160514514|NCT05038163|579609985|FG002|Stage 1|Did not complete survey|0|||
160514515|NCT05038163|579609986|FG003|Stage 1|Did not complete survey|0|||
160514516|NCT05038163|579609987|FG004|Stage 1|Did not complete survey|0|||
160514517|NCT05038163|579609988|FG005|Stage 1|Did not complete survey|0|||
160514518|NCT05038163|579609983|FG000|Stage 2|Did not complete Stage 2 survey|0|||
160623431|NCT01161173|580001732|FG000|Overall Study|Progressive Disease|82|||
160623432|NCT01161173|580001732|FG000|Overall Study|Withdrawal of Consent|5|||
160623433|NCT01161173|580001732|FG000|Overall Study|Unacceptable Toxicity|21|||
160623434|NCT01161173|580001732|FG000|Overall Study|Death|194|||
160623435|NCT01161173|580001732|FG000|Overall Study|End of Study|2|||
160623436|NCT01161173|580001732|FG000|Overall Study|Reasons Not Specified|23|||
160514519|NCT05038163|579609984|FG001|Stage 2|Did not complete Stage 2 survey|29|||
160514520|NCT05038163|579609985|FG002|Stage 2|Did not complete Stage 2 survey|30|||
160623437|NCT01911546|580001733|FG000|Overall Study|Lost to Follow-up|1|||
160514521|NCT05038163|579609986|FG003|Stage 2|Did not complete Stage 2 survey|24|||
160514522|NCT05038163|579609987|FG004|Stage 2|Did not complete Stage 2 survey|21|||
160514523|NCT05038163|579609988|FG005|Stage 2|Did not complete Stage 2 survey|100|||
160623438|NCT01911546|580001733|FG000|Overall Study|Everolimus was discontinued|5|||
160514524|NCT05453201|579609989|FG000|Overall Study|Withdrawal by Subject|1|||
160514525|NCT03562975|579609990|FG000|Overall Study|Death|1|||
160514526|NCT03562975|579609990|FG000|Overall Study|Lost to Follow-up|1|||
160514527|NCT03562975|579609990|FG000|Overall Study|Withdrawal by Subject|1|||
160514528|NCT01934790|579609991|FG000|Treatment|Adverse Event|3|||
160514529|NCT01934790|579609991|FG000|Treatment|Clinical progression|6|||
160514530|NCT01934790|579609991|FG000|Treatment|Radiological progression|4|||
160514531|NCT01934790|579609991|FG000|Treatment|Withdrawal by Subject|2|||
160514532|NCT01934790|579609991|FG000|Treatment|Study drug never administered|1|||
160514533|NCT01934790|579609991|FG000|Active Follow up|Death|20|||
160514534|NCT01934790|579609991|FG000|Active Follow up|Physician Decision|2|||
160514535|NCT01934790|579609991|FG000|Active Follow up|Progressive disease|1|||
160514536|NCT01934790|579609991|FG000|Active Follow up|Other reason|1|||
160514537|NCT00552929|579609994|FG000|Overall Study|Lost to Follow-up|0|||
160514538|NCT00552929|579609995|FG001|Overall Study|Lost to Follow-up|0|||
160514539|NCT00552929|579609996|FG002|Overall Study|Lost to Follow-up|0|||
160514540|NCT00552929|579609997|FG003|Overall Study|Lost to Follow-up|0|||
160514541|NCT00552929|579609998|FG004|Overall Study|Lost to Follow-up|0|||
160514542|NCT00552929|579609999|FG005|Overall Study|Lost to Follow-up|0|||
160514543|NCT00552929|579610000|FG006|Overall Study|Lost to Follow-up|0|||
160514544|NCT00552929|579610001|FG007|Overall Study|Lost to Follow-up|0|||
160514545|NCT00552929|579610002|FG008|Overall Study|Lost to Follow-up|1|||
160514546|NCT00552929|579610003|FG009|Overall Study|Lost to Follow-up|0|||
160514547|NCT00552929|579609994|FG000|Overall Study|Not Eligible|0|||
160514548|NCT00552929|579609995|FG001|Overall Study|Not Eligible|0|||
160514549|NCT00552929|579609996|FG002|Overall Study|Not Eligible|0|||
160514550|NCT00552929|579609997|FG003|Overall Study|Not Eligible|0|||
160514551|NCT00552929|579609998|FG004|Overall Study|Not Eligible|0|||
160514552|NCT00552929|579609999|FG005|Overall Study|Not Eligible|1|||
160514553|NCT00552929|579610000|FG006|Overall Study|Not Eligible|0|||
160514554|NCT00552929|579610001|FG007|Overall Study|Not Eligible|0|||
160514555|NCT00552929|579610002|FG008|Overall Study|Not Eligible|0|||
160514556|NCT00552929|579610003|FG009|Overall Study|Not Eligible|0|||
160514557|NCT01147536|579610004|FG000|Overall Study|Administrative study close|2|||
160514558|NCT01147536|579610004|FG000|Overall Study|Death|1|||
160514559|NCT00935818|579610005|FG000|Overall Study|Withdrawal by Subject|45|||
160514560|NCT00935818|579610006|FG001|Overall Study|Withdrawal by Subject|50|||
160514561|NCT00935818|579610005|FG000|Overall Study|Lost to Follow-up|40|||
160514562|NCT00935818|579610006|FG001|Overall Study|Lost to Follow-up|42|||
160514563|NCT00935818|579610005|FG000|Overall Study|Adverse Event|6|||
160514564|NCT00935818|579610006|FG001|Overall Study|Adverse Event|7|||
160514565|NCT00935818|579610005|FG000|Overall Study|Physician Decision|0|||
160514566|NCT00935818|579610006|FG001|Overall Study|Physician Decision|1|||
160514567|NCT02631577|579610007|FG000|Overall Study|Death|1|||
160514568|NCT02631577|579610008|FG001|Overall Study|Death|7|||
160514569|NCT02631577|579610007|FG000|Overall Study|Withdrawal by Subject|0|||
160514570|NCT02631577|579610008|FG001|Overall Study|Withdrawal by Subject|3|||
160514571|NCT00604825|579610011|FG000|Overall Study|Adverse Event|2|||
160514572|NCT00604825|579610012|FG001|Overall Study|Adverse Event|6|||
160514573|NCT00604825|579610013|FG002|Overall Study|Adverse Event|7|||
160514574|NCT00604825|579610014|FG003|Overall Study|Adverse Event|4|||
160514575|NCT00604825|579610011|FG000|Overall Study|Lost to Follow-up|0|||
160514576|NCT00604825|579610012|FG001|Overall Study|Lost to Follow-up|3|||
160514577|NCT00604825|579610013|FG002|Overall Study|Lost to Follow-up|1|||
160514578|NCT00604825|579610014|FG003|Overall Study|Lost to Follow-up|0|||
160514579|NCT00604825|579610011|FG000|Overall Study|Protocol Violation|0|||
160514580|NCT00604825|579610012|FG001|Overall Study|Protocol Violation|1|||
160514581|NCT00604825|579610013|FG002|Overall Study|Protocol Violation|0|||
160514582|NCT00604825|579610014|FG003|Overall Study|Protocol Violation|0|||
160514583|NCT00604825|579610011|FG000|Overall Study|Withdrawal by Subject|4|||
160514584|NCT00604825|579610012|FG001|Overall Study|Withdrawal by Subject|3|||
160514585|NCT00604825|579610013|FG002|Overall Study|Withdrawal by Subject|5|||
160514586|NCT00604825|579610014|FG003|Overall Study|Withdrawal by Subject|5|||
160514587|NCT00604825|579610011|FG000|Overall Study|Lack of Efficacy|3|||
160514588|NCT00604825|579610012|FG001|Overall Study|Lack of Efficacy|2|||
160514589|NCT00604825|579610013|FG002|Overall Study|Lack of Efficacy|1|||
160514590|NCT00604825|579610014|FG003|Overall Study|Lack of Efficacy|0|||
160514591|NCT00604825|579610011|FG000|Overall Study|Did not meet eligibility criteria|0|||
160514592|NCT00604825|579610012|FG001|Overall Study|Did not meet eligibility criteria|0|||
160514593|NCT00604825|579610013|FG002|Overall Study|Did not meet eligibility criteria|2|||
160514594|NCT00604825|579610014|FG003|Overall Study|Did not meet eligibility criteria|0|||
160514595|NCT00604825|579610011|FG000|Overall Study|Physician Decision|0|||
160514596|NCT00604825|579610012|FG001|Overall Study|Physician Decision|0|||
160514597|NCT00604825|579610013|FG002|Overall Study|Physician Decision|0|||
160514598|NCT00604825|579610014|FG003|Overall Study|Physician Decision|1|||
160514599|NCT00604825|579610011|FG000|Overall Study|Exclusion criterion met|0|||
160514600|NCT00604825|579610012|FG001|Overall Study|Exclusion criterion met|0|||
160514601|NCT00604825|579610013|FG002|Overall Study|Exclusion criterion met|0|||
160514602|NCT00604825|579610014|FG003|Overall Study|Exclusion criterion met|1|||
160514603|NCT00812331|579611639|FG000|Overall Study|Adverse Event|1|||
160514604|NCT00812331|579611640|FG001|Overall Study|Adverse Event|0|||
160514605|NCT00812331|579611641|FG002|Overall Study|Adverse Event|0|||
160514606|NCT00812331|579611642|FG003|Overall Study|Adverse Event|0|||
160514607|NCT00812331|579611643|FG004|Overall Study|Adverse Event|0|||
160514608|NCT02502799|579611644|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
160514609|NCT02502799|579611645|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
160514610|NCT02502799|579611646|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
160514611|NCT02502799|579611647|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
160514612|NCT02502799|579611644|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
160514613|NCT02502799|579611645|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
160514614|NCT02502799|579611646|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
160514615|NCT02502799|579611647|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
160514616|NCT02502799|579611644|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
160514617|NCT02502799|579611645|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
160514618|NCT02502799|579611646|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
160514619|NCT02502799|579611647|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
160514620|NCT02502799|579611644|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
160514621|NCT02502799|579611645|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
160514622|NCT02502799|579611646|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
160514623|NCT02502799|579611647|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
160514624|NCT02502799|579611644|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
160514625|NCT02502799|579611645|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
160514626|NCT02502799|579611646|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
160514627|NCT02502799|579611647|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
160514628|NCT00153062|579611653|FG000|Overall Study|Death|360|||
160514629|NCT00153062|579611654|FG001|Overall Study|Death|352|||
160514630|NCT00153062|579611655|FG002|Overall Study|Death|369|||
160514631|NCT00153062|579611656|FG003|Overall Study|Death|365|||
160514632|NCT00153062|579611653|FG000|Overall Study|Withdrawal by Subject|14|||
160514633|NCT00153062|579611654|FG001|Overall Study|Withdrawal by Subject|30|||
160514634|NCT00153062|579611655|FG002|Overall Study|Withdrawal by Subject|27|||
160514635|NCT00153062|579611656|FG003|Overall Study|Withdrawal by Subject|28|||
160514636|NCT00153062|579611653|FG000|Overall Study|Lost to Follow-up|12|||
160514637|NCT00153062|579611654|FG001|Overall Study|Lost to Follow-up|20|||
160514638|NCT00153062|579611655|FG002|Overall Study|Lost to Follow-up|15|||
160514639|NCT00153062|579611656|FG003|Overall Study|Lost to Follow-up|16|||
160514640|NCT00153062|579611653|FG000|Overall Study|Adverse Event|0|||
160514641|NCT00153062|579611654|FG001|Overall Study|Adverse Event|1|||
160514642|NCT00153062|579611655|FG002|Overall Study|Adverse Event|1|||
160514643|NCT00153062|579611656|FG003|Overall Study|Adverse Event|0|||
160514644|NCT00153062|579611653|FG000|Overall Study|Protocol Violation|0|||
160514645|NCT00153062|579611654|FG001|Overall Study|Protocol Violation|2|||
160514646|NCT00153062|579611655|FG002|Overall Study|Protocol Violation|1|||
160514647|NCT00153062|579611656|FG003|Overall Study|Protocol Violation|1|||
160514648|NCT00153062|579611653|FG000|Overall Study|No disposition data available|1|||
160514649|NCT00153062|579611654|FG001|Overall Study|No disposition data available|1|||
160514650|NCT00153062|579611655|FG002|Overall Study|No disposition data available|1|||
160514651|NCT00153062|579611656|FG003|Overall Study|No disposition data available|1|||
160514652|NCT00153062|579611653|FG000|Overall Study|Other|0|||
160514653|NCT00153062|579611654|FG001|Overall Study|Other|0|||
160514654|NCT00153062|579611655|FG002|Overall Study|Other|1|||
160514655|NCT00153062|579611656|FG003|Overall Study|Other|0|||
160514656|NCT02359877|579611657|FG000|Overall Study|Withdrawal by Subject|1|||
160514657|NCT02359877|579611658|FG001|Overall Study|Withdrawal by Subject|0|||
160514658|NCT02359877|579611659|FG002|Overall Study|Withdrawal by Subject|0|||
160514659|NCT02359877|579611660|FG003|Overall Study|Withdrawal by Subject|2|||
160514660|NCT02359877|579611657|FG000|Overall Study|Adverse Event|0|||
160514661|NCT02359877|579611658|FG001|Overall Study|Adverse Event|0|||
160514662|NCT02359877|579611659|FG002|Overall Study|Adverse Event|0|||
160514663|NCT02359877|579611660|FG003|Overall Study|Adverse Event|1|||
160514664|NCT01589237|579611673|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
160514665|NCT01589237|579611674|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
160514666|NCT01589237|579611675|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
160514667|NCT01589237|579611676|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
160514668|NCT01589237|579611673|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
160514669|NCT01589237|579611674|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
160514670|NCT01589237|579611675|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
160514671|NCT01589237|579611676|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
160514672|NCT01589237|579611673|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
160514673|NCT01589237|579611674|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
160514674|NCT01589237|579611675|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
160514675|NCT01589237|579611676|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
160514676|NCT01589237|579611673|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
160514677|NCT01589237|579611674|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
160514678|NCT01589237|579611675|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
160514679|NCT01589237|579611676|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
160514680|NCT00117845|579611677|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
160514681|NCT00910689|579611679|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
160514682|NCT00910689|579611680|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
160514683|NCT00910689|579611681|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
160514684|NCT00910689|579611682|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
160514685|NCT00910689|579611679|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
160514686|NCT00910689|579611680|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
160514687|NCT00910689|579611681|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
160514688|NCT00910689|579611682|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
160514689|NCT00910689|579611679|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
160514690|NCT00910689|579611680|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
160514691|NCT00910689|579611681|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
160514692|NCT00910689|579611682|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
160514693|NCT00910689|579611679|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
160514694|NCT00910689|579611680|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
160514695|NCT00910689|579611681|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
160514696|NCT00910689|579611682|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
160514697|NCT00910689|579611679|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
160514698|NCT00910689|579611680|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
160514699|NCT00910689|579611681|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
160514700|NCT00910689|579611682|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
160514701|NCT00910689|579611679|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
160514702|NCT00910689|579611680|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
160514703|NCT00910689|579611681|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
160514704|NCT00910689|579611682|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
160514705|NCT00910689|579611679|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
160514706|NCT00910689|579611680|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
160514707|NCT00910689|579611681|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
160514708|NCT00910689|579611682|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
160514709|NCT00910689|579611679|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
160514710|NCT00910689|579611680|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
160514711|NCT00910689|579611681|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
160514712|NCT00910689|579611682|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
160514713|NCT00910689|579611679|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
160514714|NCT00910689|579611680|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
160514715|NCT00910689|579611681|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
160514716|NCT00910689|579611682|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
160514717|NCT00910689|579611679|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
160514718|NCT00910689|579611680|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
160514719|NCT00910689|579611681|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
160514720|NCT00910689|579611682|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
160514721|NCT00910689|579611679|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
160514722|NCT00910689|579611680|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
160514723|NCT00910689|579611681|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
160514724|NCT00910689|579611682|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
160514725|NCT00910689|579611679|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
160514726|NCT00910689|579611680|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
160514727|NCT00910689|579611681|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
160514728|NCT00910689|579611682|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
160514729|NCT00910689|579611679|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
160514730|NCT00910689|579611680|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
160514731|NCT00910689|579611681|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
160514732|NCT00910689|579611682|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
160514733|NCT00910689|579611679|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
160514734|NCT00910689|579611680|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
160514735|NCT00910689|579611681|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
160514736|NCT00910689|579611682|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
160514737|NCT00910689|579611679|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
160514738|NCT00910689|579611680|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
160514739|NCT00910689|579611681|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
160514740|NCT00910689|579611682|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
160514741|NCT00910689|579611679|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
160514742|NCT00910689|579611680|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
160514743|NCT00910689|579611681|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
160514744|NCT00910689|579611682|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
160514745|NCT00910689|579611679|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
160514746|NCT00910689|579611680|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
160514747|NCT00910689|579611681|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
160514748|NCT00910689|579611682|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
160514749|NCT00910689|579611679|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
160514750|NCT00910689|579611680|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
160514751|NCT00910689|579611681|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
160514752|NCT00910689|579611682|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
160514753|NCT00910689|579611679|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
160514754|NCT00910689|579611680|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
160514755|NCT00910689|579611681|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
160514756|NCT00910689|579611682|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
160514757|NCT00910689|579611679|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
160514758|NCT00910689|579611680|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
160514759|NCT00910689|579611681|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
160514760|NCT00910689|579611682|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
160514761|NCT00910689|579611679|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
160514762|NCT00910689|579611680|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
160514763|NCT00910689|579611681|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
160514764|NCT00910689|579611682|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
160514765|NCT01290029|579611685|FG000|Overall Study|Other|2|||
160514766|NCT02349425|579611688|FG000|Period 1|Adverse Event|1|||
160514767|NCT02349425|579611689|FG001|Period 1|Adverse Event|1|||
160514768|NCT02349425|579611690|FG002|Period 1|Adverse Event|0|||
160514769|NCT02349425|579611691|FG003|Period 1|Adverse Event|0|||
160514770|NCT02349425|579611688|FG000|Period 2|Adverse Event|0|||
160514771|NCT02349425|579611689|FG001|Period 2|Adverse Event|1|||
160514772|NCT02349425|579611690|FG002|Period 2|Adverse Event|1|||
160514773|NCT02349425|579611691|FG003|Period 2|Adverse Event|0|||
160514774|NCT00616902|579611692|FG000|Overall Study|Termination of study|6|||
160514775|NCT00616902|579611693|FG001|Overall Study|Termination of study|6|||
160514776|NCT03207009|579611694|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
160514777|NCT01491672|579611695|FG000|Overall Study|Lost to Follow-up|0|||
160514778|NCT01491672|579611696|FG001|Overall Study|Lost to Follow-up|4|||
160514779|NCT01491672|579611697|FG002|Overall Study|Lost to Follow-up|1|||
160514780|NCT01491672|579611695|FG000|Overall Study|Withdrawal by Subject|6|||
160514781|NCT01491672|579611696|FG001|Overall Study|Withdrawal by Subject|7|||
160514782|NCT01491672|579611697|FG002|Overall Study|Withdrawal by Subject|0|||
160514783|NCT01491672|579611695|FG000|Overall Study|Adverse Event|8|||
160514784|NCT01491672|579611696|FG001|Overall Study|Adverse Event|10|||
160514785|NCT01491672|579611697|FG002|Overall Study|Adverse Event|4|||
160514786|NCT01491672|579611695|FG000|Overall Study|Disease progression|42|||
160514787|NCT01491672|579611696|FG001|Overall Study|Disease progression|34|||
160514788|NCT01491672|579611697|FG002|Overall Study|Disease progression|6|||
160514789|NCT01491672|579611695|FG000|Overall Study|Protocol deviation|0|||
160514790|NCT01491672|579611696|FG001|Overall Study|Protocol deviation|1|||
160514791|NCT01491672|579611697|FG002|Overall Study|Protocol deviation|0|||
160514792|NCT01491672|579611695|FG000|Overall Study|Death|0|||
160514793|NCT01491672|579611696|FG001|Overall Study|Death|4|||
160514794|NCT01491672|579611697|FG002|Overall Study|Death|0|||
160514795|NCT01143038|579611698|FG000|Overall Study|Withdrawal by Subject|4|||
160514796|NCT01143038|579611698|FG000|Overall Study|Requirement for alternative therapy|5|||
160514797|NCT01143038|579611698|FG000|Overall Study|Adverse Event|3|||
160514798|NCT01143038|579611698|FG000|Overall Study|Lost to Follow-up|2|||
160514799|NCT01143038|579611698|FG000|Overall Study|Protocol Deviation|1|||
160514800|NCT01143038|579611698|FG000|Overall Study|Death|1|||
160514801|NCT00657020|579611703|FG000|PERIOD 1|Adverse Event|0|||
160514802|NCT00657020|579611704|FG001|PERIOD 1|Adverse Event|1|||
160514803|NCT01183234|579611705|FG000|First Intervention|Adverse Event|1|||
160514804|NCT01183234|579611706|FG001|First Intervention|Adverse Event|0|||
160514805|NCT00822172|579611709|FG000|Overall Study|Adverse Event|10|||
160514806|NCT00822172|579611710|FG001|Overall Study|Adverse Event|12|||
160514807|NCT00822172|579611709|FG000|Overall Study|Death|1|||
160514808|NCT00822172|579611710|FG001|Overall Study|Death|0|||
160514809|NCT00822172|579611709|FG000|Overall Study|Lost to Follow-up|3|||
160514810|NCT00822172|579611710|FG001|Overall Study|Lost to Follow-up|1|||
160514811|NCT00822172|579611709|FG000|Overall Study|Withdrawal by Subject|1|||
160514812|NCT00822172|579611710|FG001|Overall Study|Withdrawal by Subject|4|||
160514813|NCT00822172|579611709|FG000|Overall Study|site closed|0|||
160514814|NCT00822172|579611710|FG001|Overall Study|site closed|1|||
160514815|NCT00822172|579611709|FG000|Overall Study|Other|0|||
160514816|NCT00822172|579611710|FG001|Overall Study|Other|1|||
160514817|NCT04772898|579611711|FG000|Overall Study|Withdrawal by Subject|0|||
160514818|NCT04772898|579611712|FG001|Overall Study|Withdrawal by Subject|1|||
160514819|NCT00309959|579611714|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
160514820|NCT02937454|579611715|FG000|Overall Study|Adverse Event|0|||
160666480|NCT00556322|580159231|FG001|Overall Study|Ongoing at data cutoff|5|||
160514821|NCT02937454|579611716|FG001|Overall Study|Adverse Event|1|||
160514822|NCT02937454|579611715|FG000|Overall Study|Death|98|||
160514823|NCT02937454|579611716|FG001|Overall Study|Death|95|||
160514824|NCT02937454|579611715|FG000|Overall Study|Lost to Follow-up|1|||
160514825|NCT02937454|579611716|FG001|Overall Study|Lost to Follow-up|1|||
160514826|NCT02937454|579611715|FG000|Overall Study|Physician Decision|0|||
160514827|NCT02937454|579611716|FG001|Overall Study|Physician Decision|1|||
160514828|NCT02937454|579611715|FG000|Overall Study|Protocol Violation|6|||
160514829|NCT02937454|579611716|FG001|Overall Study|Protocol Violation|10|||
160514830|NCT02937454|579611715|FG000|Overall Study|Withdrawal by Subject|27|||
160514831|NCT02937454|579611716|FG001|Overall Study|Withdrawal by Subject|15|||
160514832|NCT02937454|579611715|FG000|Overall Study|Other|8|||
160514833|NCT02937454|579611716|FG001|Overall Study|Other|5|||
160514834|NCT02947087|579611717|FG000|Overall Study|Withdrawal by Subject|3|||
160514835|NCT02947087|579611718|FG001|Overall Study|Withdrawal by Subject|2|||
160514836|NCT01253304|579611720|FG000|Overall Study|Adverse Event|0|||
160514837|NCT01253304|579611721|FG001|Overall Study|Adverse Event|0|||
160514838|NCT01253304|579611722|FG002|Overall Study|Adverse Event|0|||
160514839|NCT01253304|579611723|FG003|Overall Study|Adverse Event|1|||
160514840|NCT01474434|579611730|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
160514841|NCT01474434|579611731|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
160514842|NCT01474434|579611732|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
160514843|NCT01474434|579611733|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
160514844|NCT01474434|579611730|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
160514845|NCT01474434|579611731|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
160514846|NCT01474434|579611732|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
160514847|NCT01474434|579611733|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
160514848|NCT01474434|579611730|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
160514849|NCT01474434|579611731|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
160514850|NCT01474434|579611732|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
160514851|NCT01474434|579611733|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
160514852|NCT00993668|579611734|FG000|Single-Blind Period|Adverse Event|1|||
160514853|NCT00993668|579611735|FG001|Single-Blind Period|Adverse Event|1|||
160514854|NCT00993668|579611734|FG000|Single-Blind Period|Lack of Efficacy|0|||
160514855|NCT00993668|579611735|FG001|Single-Blind Period|Lack of Efficacy|1|||
160514856|NCT00993668|579611734|FG000|Single-Blind Period|Lost to Follow-up|3|||
160514857|NCT00993668|579611735|FG001|Single-Blind Period|Lost to Follow-up|1|||
160514858|NCT00993668|579611734|FG000|Open-Label Period|Adverse Event|9|||
160514859|NCT00993668|579611735|FG001|Open-Label Period|Adverse Event|8|||
160514860|NCT00993668|579611734|FG000|Open-Label Period|Lack of Efficacy|4|||
160514861|NCT00993668|579611735|FG001|Open-Label Period|Lack of Efficacy|3|||
160514862|NCT00993668|579611734|FG000|Open-Label Period|Withdrawal by Subject|4|||
160514863|NCT00993668|579611735|FG001|Open-Label Period|Withdrawal by Subject|3|||
160514864|NCT00993668|579611734|FG000|Open-Label Period|Lost to Follow-up|6|||
160514865|NCT00993668|579611735|FG001|Open-Label Period|Lost to Follow-up|1|||
160514866|NCT02207569|579611736|FG000|1-Month|Death|6|||
160514867|NCT02207569|579611736|FG000|1-Month|Withdrawal by Subject|2|||
160514868|NCT02207569|579611736|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
160514869|NCT02207569|579611736|FG000|6-Month|Death|8|||
160666481|NCT00556322|580159230|FG000|Overall Study|Death|20|||
160666482|NCT00556322|580159231|FG001|Overall Study|Death|14|||
160666483|NCT01788423|580159232|FG000|Overall Study|See Comments in Completed (above)|0|||
160666484|NCT01788423|580159233|FG001|Overall Study|See Comments in Completed (above)|4|||
160666485|NCT01788423|580159234|FG002|Overall Study|See Comments in Completed (above)|5|||
160666486|NCT01940341|580159237|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
160666487|NCT01940341|580159238|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
160666488|NCT01940341|580159239|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
160666489|NCT01940341|580159240|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
160666490|NCT01940341|580159237|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
160666491|NCT01940341|580159238|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
160514870|NCT02207569|579611736|FG000|6-Month|Withdrawal by Subject|2|||
160514871|NCT02207569|579611736|FG000|12-Month|Death|14|||
160666492|NCT01940341|580159239|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
160666493|NCT01940341|580159240|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
160666494|NCT01940341|580159237|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
160666495|NCT01940341|580159238|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
160666496|NCT01940341|580159239|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
160666497|NCT01940341|580159240|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
160666498|NCT01940341|580159237|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
160514872|NCT02207569|579611736|FG000|12-Month|Withdrawal by Subject|2|||
160514873|NCT02207569|579611736|FG000|24-Month|Death|23|||
160666499|NCT01940341|580159238|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
160514874|NCT02207569|579611736|FG000|24-Month|Withdrawal by Subject|3|||
160514875|NCT02207569|579611736|FG000|36-Month|Death|23|||
160514876|NCT02207569|579611736|FG000|36-Month|Withdrawal by Subject|4|||
160514877|NCT02207569|579611736|FG000|48-Month|Death|25|||
160514878|NCT02207569|579611736|FG000|48-Month|Withdrawal by Subject|2|||
160514879|NCT02207569|579611736|FG000|48-Month|Lost to Follow-up|4|||
160514880|NCT02207569|579611736|FG000|60-Month|Death|1|||
160514881|NCT02207569|579611736|FG000|60-Month|Lost to Follow-up|1|||
160514882|NCT02207569|579611736|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
160514883|NCT02207569|579611736|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
160514884|NCT02585232|579611737|FG000|Overall Study|Lost to Follow-up|8|||
160514885|NCT02585232|579611738|FG001|Overall Study|Lost to Follow-up|8|||
160514886|NCT02585232|579611737|FG000|Overall Study|Withdrawal by Subject|4|||
160514887|NCT02585232|579611738|FG001|Overall Study|Withdrawal by Subject|8|||
160514888|NCT02930226|579611741|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
160514889|NCT02930226|579611742|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
160514890|NCT02930226|579611743|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
160514891|NCT02930226|579611744|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
160514892|NCT02930226|579611745|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
160514893|NCT02930226|579611746|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
160514894|NCT00468559|579611747|FG000|Open-label Treatment Phase|Adverse Event|5|||
160514895|NCT00468559|579611748|FG001|Open-label Treatment Phase|Adverse Event|0|||
160514896|NCT00468559|579611749|FG002|Open-label Treatment Phase|Adverse Event|0|||
160514897|NCT00468559|579611747|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
160514898|NCT00468559|579611748|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
160514899|NCT00468559|579611749|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
160514900|NCT00468559|579611747|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
160514901|NCT00468559|579611748|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
160514902|NCT00468559|579611749|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
160514903|NCT00468559|579611747|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
160514904|NCT00468559|579611748|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
160514905|NCT00468559|579611749|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
160514906|NCT00468559|579611747|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
160514907|NCT00468559|579611748|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
160514908|NCT00468559|579611749|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
160514909|NCT00862719|579611750|FG000|Overall Study|Disease Progression|5|||
160514910|NCT00862719|579611751|FG001|Overall Study|Disease Progression|0|||
160514911|NCT00862719|579611752|FG002|Overall Study|Disease Progression|1|||
160514912|NCT00862719|579611753|FG003|Overall Study|Disease Progression|0|||
160514913|NCT00862719|579611750|FG000|Overall Study|Death|5|||
160514914|NCT00862719|579611751|FG001|Overall Study|Death|6|||
160514915|NCT00862719|579611752|FG002|Overall Study|Death|1|||
160514916|NCT00862719|579611753|FG003|Overall Study|Death|1|||
160514917|NCT00862719|579611750|FG000|Overall Study|Engraftment failure|0|||
160514918|NCT00862719|579611751|FG001|Overall Study|Engraftment failure|0|||
160514919|NCT00862719|579611752|FG002|Overall Study|Engraftment failure|1|||
160514920|NCT00862719|579611753|FG003|Overall Study|Engraftment failure|0|||
160514921|NCT00862719|579611750|FG000|Overall Study|Veno-Occlusive Disease|0|||
160514922|NCT00862719|579611751|FG001|Overall Study|Veno-Occlusive Disease|0|||
160514923|NCT00862719|579611752|FG002|Overall Study|Veno-Occlusive Disease|1|||
160514924|NCT00862719|579611753|FG003|Overall Study|Veno-Occlusive Disease|0|||
160514925|NCT01153958|579611754|FG000|Overall Study|Study Terminated|36|||
160514926|NCT01153958|579611755|FG001|Overall Study|Study Terminated|32|||
160514927|NCT02624791|579611756|FG000|Overall Study|Withdrawal by Subject|2|||
160514928|NCT02624791|579611757|FG001|Overall Study|Withdrawal by Subject|0|||
160514929|NCT02624791|579611758|FG002|Overall Study|Withdrawal by Subject|0|||
160514930|NCT02624791|579611759|FG003|Overall Study|Withdrawal by Subject|0|||
160514931|NCT02624791|579611760|FG004|Overall Study|Withdrawal by Subject|0|||
160514932|NCT02624791|579611761|FG005|Overall Study|Withdrawal by Subject|0|||
160514933|NCT01605916|579611764|FG000|Overall Study|Adverse Event|1|||
160514934|NCT01605916|579611765|FG001|Overall Study|Adverse Event|0|||
160514935|NCT01605916|579611766|FG002|Overall Study|Adverse Event|0|||
160514936|NCT01605916|579611767|FG003|Overall Study|Adverse Event|1|||
160514937|NCT01605916|579611768|FG004|Overall Study|Adverse Event|0|||
160514938|NCT01605916|579611764|FG000|Overall Study|Lack of Efficacy|2|||
160514939|NCT01605916|579611765|FG001|Overall Study|Lack of Efficacy|3|||
160514940|NCT01605916|579611766|FG002|Overall Study|Lack of Efficacy|3|||
160514941|NCT01605916|579611767|FG003|Overall Study|Lack of Efficacy|5|||
160514942|NCT01605916|579611768|FG004|Overall Study|Lack of Efficacy|4|||
160514943|NCT01605916|579611764|FG000|Overall Study|Withdrawal by Subject|1|||
160514944|NCT01605916|579611765|FG001|Overall Study|Withdrawal by Subject|1|||
160514945|NCT01605916|579611766|FG002|Overall Study|Withdrawal by Subject|0|||
160514946|NCT01605916|579611767|FG003|Overall Study|Withdrawal by Subject|0|||
160514947|NCT01605916|579611768|FG004|Overall Study|Withdrawal by Subject|2|||
160514948|NCT02414932|579611769|FG000|Overall Study|Withdrawal by Subject|2|||
160514949|NCT02414932|579611770|FG001|Overall Study|Withdrawal by Subject|3|||
160514950|NCT02414932|579611769|FG000|Overall Study|Adverse Event|1|||
160666500|NCT01940341|580159239|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
160666501|NCT01940341|580159240|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
160666502|NCT01940341|580159237|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
160666503|NCT01940341|580159238|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
160666504|NCT01940341|580159239|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
160666505|NCT01940341|580159240|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
160666506|NCT01940341|580159237|FG000|Period 1: Double-blind Phase|Death|0|||
160666507|NCT01940341|580159238|FG001|Period 1: Double-blind Phase|Death|1|||
160666508|NCT01940341|580159239|FG002|Period 1: Double-blind Phase|Death|0|||
160666509|NCT01940341|580159240|FG003|Period 1: Double-blind Phase|Death|0|||
160514951|NCT02414932|579611770|FG001|Overall Study|Adverse Event|0|||
160514952|NCT00470366|579611771|FG000|Overall Study|Adverse Event|3|||
160514953|NCT00470366|579611771|FG000|Overall Study|Poor compliance|1|||
160514954|NCT01021215|579611778|FG000|Overall Study|Lost to Follow-up|3|||
160514955|NCT01021215|579611779|FG001|Overall Study|Lost to Follow-up|0|||
160514956|NCT02859324|579611780|FG000|Overall Study|Death|4|||
160514957|NCT02859324|579611781|FG001|Overall Study|Death|6|||
160514958|NCT02859324|579611782|FG002|Overall Study|Death|5|||
160666510|NCT01940341|580159237|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
160666511|NCT01940341|580159238|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
160666512|NCT01940341|580159239|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
160666513|NCT01940341|580159240|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
160666514|NCT01940341|580159237|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
160666515|NCT01940341|580159238|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
160666516|NCT01940341|580159239|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
160666517|NCT01940341|580159240|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
160666518|NCT01940341|580159237|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
160666519|NCT01940341|580159238|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
160666520|NCT01940341|580159239|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
160666521|NCT01940341|580159240|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
160666522|NCT01940341|580159237|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
160666523|NCT01940341|580159238|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
160666524|NCT01940341|580159239|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
160666525|NCT01940341|580159240|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
160666526|NCT01940341|580159237|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
160666527|NCT01940341|580159238|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
160666528|NCT01940341|580159239|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
160666529|NCT01940341|580159240|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
160666530|NCT01940341|580159237|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
160666531|NCT01940341|580159238|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
160666532|NCT01940341|580159239|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
160666533|NCT01940341|580159240|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
160514959|NCT02859324|579611780|FG000|Overall Study|Other reasons|3|||
160514960|NCT02859324|579611781|FG001|Overall Study|Other reasons|3|||
160514961|NCT02859324|579611782|FG002|Overall Study|Other reasons|0|||
160514962|NCT01305200|579611783|FG000|Overall Study|Physician Decision|4|||
160514963|NCT01305200|579611784|FG001|Overall Study|Physician Decision|6|||
160514964|NCT01305200|579611785|FG002|Overall Study|Physician Decision|1|||
160514965|NCT01305200|579611783|FG000|Overall Study|Withdrawal by Subject|24|||
160514966|NCT01305200|579611784|FG001|Overall Study|Withdrawal by Subject|21|||
160514967|NCT01305200|579611785|FG002|Overall Study|Withdrawal by Subject|1|||
160514968|NCT01305200|579611783|FG000|Overall Study|Ineligible|1|||
160514969|NCT01305200|579611784|FG001|Overall Study|Ineligible|2|||
160514970|NCT01305200|579611785|FG002|Overall Study|Ineligible|1|||
160514971|NCT01305200|579611783|FG000|Overall Study|Death|0|||
160514972|NCT01305200|579611784|FG001|Overall Study|Death|2|||
160514973|NCT01305200|579611785|FG002|Overall Study|Death|0|||
160514974|NCT05593445|579611786|FG000|12-Week DBVC Period|Adverse Event|1|||
160514975|NCT05593445|579611787|FG001|12-Week DBVC Period|Adverse Event|0|||
160514976|NCT05593445|579611788|FG002|12-Week DBVC Period|Adverse Event|0|||
160514977|NCT05593445|579611789|FG003|12-Week DBVC Period|Adverse Event|0|||
160514978|NCT05593445|579611786|FG000|12-Week DBVC Period|Physician Decision|0|||
160514979|NCT05593445|579611787|FG001|12-Week DBVC Period|Physician Decision|1|||
160514980|NCT05593445|579611788|FG002|12-Week DBVC Period|Physician Decision|0|||
160514981|NCT05593445|579611789|FG003|12-Week DBVC Period|Physician Decision|0|||
160514982|NCT05593445|579611786|FG000|12-Week DBVC Period|Protocol Violation|0|||
160514983|NCT05593445|579611787|FG001|12-Week DBVC Period|Protocol Violation|1|||
160514984|NCT05593445|579611788|FG002|12-Week DBVC Period|Protocol Violation|0|||
160514985|NCT05593445|579611789|FG003|12-Week DBVC Period|Protocol Violation|0|||
160514986|NCT05593445|579611786|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
160514987|NCT05593445|579611787|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
160623439|NCT01319422|580001735|FG000|Overall Study|Withdrawal by Subject|1|||
160623440|NCT01319422|580001736|FG001|Overall Study|Withdrawal by Subject|0|||
160623441|NCT02918968|580001737|FG000|1st Line AAT|Progressive disease|9|||
160623442|NCT02918968|580001738|FG001|1st Line AAT|Progressive disease|4|||
160623443|NCT02918968|580001737|FG000|1st Line AAT|Adverse Event|12|||
160623444|NCT02918968|580001738|FG001|1st Line AAT|Adverse Event|3|||
160623445|NCT02918968|580001737|FG000|1st Line AAT|Physician Decision|4|||
160623446|NCT02918968|580001738|FG001|1st Line AAT|Physician Decision|2|||
160623447|NCT02918968|580001737|FG000|1st Line AAT|Withdrawal by Subject|2|||
160623448|NCT02918968|580001738|FG001|1st Line AAT|Withdrawal by Subject|1|||
160623449|NCT02918968|580001737|FG000|1st Line AAT|Lost to Follow-up|0|||
160623450|NCT02918968|580001738|FG001|1st Line AAT|Lost to Follow-up|1|||
160623451|NCT02918968|580001737|FG000|1st Line AAT|Death|1|||
160623452|NCT02918968|580001738|FG001|1st Line AAT|Death|0|||
160623453|NCT02918968|580001737|FG000|1st Line AAT|Miscellaneous|1|||
160623454|NCT02918968|580001738|FG001|1st Line AAT|Miscellaneous|0|||
160623455|NCT02918968|580001737|FG000|2nd Line AAT|Progressive disease|21|||
160623456|NCT02918968|580001738|FG001|2nd Line AAT|Progressive disease|3|||
160623457|NCT02918968|580001737|FG000|2nd Line AAT|Adverse Event|2|||
160623458|NCT02918968|580001738|FG001|2nd Line AAT|Adverse Event|5|||
160623459|NCT02918968|580001737|FG000|2nd Line AAT|Physician Decision|0|||
160623460|NCT02918968|580001738|FG001|2nd Line AAT|Physician Decision|1|||
160623461|NCT02918968|580001737|FG000|2nd Line AAT|Withdrawal by Subject|2|||
160623462|NCT02918968|580001738|FG001|2nd Line AAT|Withdrawal by Subject|2|||
160623463|NCT02918968|580001737|FG000|2nd Line AAT|Death|0|||
160623464|NCT02918968|580001738|FG001|2nd Line AAT|Death|1|||
160623465|NCT05602818|580001739|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
160623466|NCT05602818|580001740|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
160623467|NCT05602818|580001741|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
160623468|NCT05602818|580001742|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
160623469|NCT05602818|580001743|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
160623470|NCT05602818|580001744|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
160623471|NCT05602818|580001745|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
160623472|NCT05602818|580001746|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
160623473|NCT05602818|580001747|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
160623474|NCT05602818|580001748|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
160623475|NCT05602818|580001749|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
160623476|NCT05602818|580001750|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
160623477|NCT05602818|580001739|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
160623478|NCT05602818|580001740|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
160623479|NCT05602818|580001741|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
160623480|NCT05602818|580001742|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
160623481|NCT05602818|580001743|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
160623482|NCT05602818|580001744|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
160623483|NCT05602818|580001745|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
160623484|NCT05602818|580001746|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
160623485|NCT05602818|580001747|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
160623486|NCT05602818|580001748|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
160623487|NCT05602818|580001749|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
160623488|NCT05602818|580001750|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
160623489|NCT05602818|580001739|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
160623490|NCT05602818|580001740|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623491|NCT05602818|580001741|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623492|NCT05602818|580001742|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623493|NCT05602818|580001743|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623494|NCT05602818|580001744|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623495|NCT05602818|580001745|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623496|NCT05602818|580001746|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623497|NCT05602818|580001747|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623498|NCT05602818|580001748|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623499|NCT05602818|580001749|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623500|NCT05602818|580001750|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
160623501|NCT05602818|580001739|FG000|Qualification Phase (3 Days)|Other|1|||
160666534|NCT01940341|580159237|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
160666535|NCT01940341|580159238|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
160514988|NCT05593445|579611788|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
160514989|NCT05593445|579611789|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
160514990|NCT05593445|579611786|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
160514991|NCT05593445|579611787|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
160514992|NCT05593445|579611788|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
160514993|NCT05593445|579611789|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
160514994|NCT05593445|579611786|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
160666536|NCT01940341|580159239|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
160666537|NCT01940341|580159240|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
160666538|NCT01940341|580159237|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
160666539|NCT01940341|580159238|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
160666540|NCT01940341|580159239|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
160666541|NCT01940341|580159240|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
160666542|NCT01940341|580159237|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
160666543|NCT01940341|580159238|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
160666544|NCT01940341|580159239|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
160666545|NCT01940341|580159240|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
160666546|NCT01940341|580159237|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
160666547|NCT01940341|580159238|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
160666548|NCT01940341|580159239|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
160514995|NCT05593445|579611787|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
160514996|NCT05593445|579611788|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
160514997|NCT05593445|579611789|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
160514998|NCT05593445|579611786|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
160514999|NCT05593445|579611787|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
160515000|NCT05593445|579611788|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
160515001|NCT05593445|579611789|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
160666549|NCT01940341|580159240|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
160666550|NCT01940341|580159237|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
160666551|NCT01940341|580159238|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
160666552|NCT01940341|580159239|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
160666553|NCT01940341|580159240|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
160666554|NCT01940341|580159237|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
160666555|NCT01940341|580159238|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
160666556|NCT01940341|580159239|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
160666557|NCT01940341|580159240|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
160666558|NCT01940341|580159237|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
160666559|NCT01940341|580159238|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
160666560|NCT01940341|580159239|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
160666561|NCT01940341|580159240|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
160666562|NCT00446563|580159250|FG000|Overall Study|Adverse Event|4|||
160666563|NCT00446563|580159251|FG001|Overall Study|Adverse Event|3|||
160666564|NCT00446563|580159250|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160666565|NCT00446563|580159251|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160666566|NCT00446563|580159250|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160666567|NCT00446563|580159251|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160666568|NCT00446563|580159250|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160666569|NCT00446563|580159251|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160666570|NCT00446563|580159250|FG000|Overall Study|Withdrawal by Subject|2|||
160666571|NCT00446563|580159251|FG001|Overall Study|Withdrawal by Subject|1|||
160666572|NCT00446563|580159250|FG000|Overall Study|Administrative problems|0|||
160666573|NCT00446563|580159251|FG001|Overall Study|Administrative problems|1|||
160666574|NCT01169558|580159252|FG000|Overall Study|Disease progression|98|||
160666575|NCT01169558|580159252|FG000|Overall Study|Adverse Event|25|||
160666576|NCT01169558|580159252|FG000|Overall Study|Withdrawal of Consent|8|||
160666577|NCT01169558|580159252|FG000|Overall Study|Medical Decision|7|||
160515002|NCT05593445|579611786|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160666578|NCT01169558|580159252|FG000|Overall Study|Stable Disease|4|||
160666579|NCT01169558|580159252|FG000|Overall Study|Lost to Follow-up|4|||
160666580|NCT01169558|580159252|FG000|Overall Study|Need for Surgery|4|||
160666581|NCT01169558|580159252|FG000|Overall Study|Non-compliance|2|||
160666582|NCT01169558|580159252|FG000|Overall Study|Protocol Violation|2|||
160666583|NCT01169558|580159252|FG000|Overall Study|Partial response|2|||
160666584|NCT03134222|580159257|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
160515003|NCT05593445|579611787|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160515004|NCT05593445|579611788|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
160515005|NCT05593445|579611789|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160515006|NCT05559476|579611790|FG000|Overall Study|Adverse Event|2|||
160515007|NCT05559476|579611791|FG001|Overall Study|Adverse Event|0|||
160515008|NCT05559476|579611790|FG000|Overall Study|Lost to Follow-up|13|||
160515009|NCT05559476|579611791|FG001|Overall Study|Lost to Follow-up|12|||
160515010|NCT05559476|579611790|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
160515011|NCT05559476|579611791|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
160515012|NCT05559476|579611790|FG000|Overall Study|Other|0|||
160515013|NCT05559476|579611791|FG001|Overall Study|Other|2|||
160515014|NCT05110690|579611792|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
160515015|NCT05110690|579611792|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
160515016|NCT05110690|579611792|FG000|Completion of Intervention|Lost to Follow-up|1|||
160515017|NCT05110690|579611792|FG000|Completion of Intervention|Death|1|||
160515018|NCT05110690|579611792|FG000|Completion of Intervention|Withdrawal by Subject|2|||
160515019|NCT00925353|579611793|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
160515020|NCT03647488|579613971|FG000|Overall Study|Progressive disease|10|||
160515021|NCT03647488|579613972|FG001|Overall Study|Progressive disease|0|||
160515022|NCT03647488|579613973|FG002|Overall Study|Progressive disease|0|||
160515023|NCT03647488|579613971|FG000|Overall Study|Adverse Event|5|||
160515024|NCT03647488|579613972|FG001|Overall Study|Adverse Event|0|||
160515025|NCT03647488|579613973|FG002|Overall Study|Adverse Event|0|||
160515026|NCT03647488|579613971|FG000|Overall Study|Clinical progression|2|||
160515027|NCT03647488|579613972|FG001|Overall Study|Clinical progression|0|||
160515028|NCT03647488|579613973|FG002|Overall Study|Clinical progression|0|||
160515029|NCT03647488|579613971|FG000|Overall Study|Participant refused to take investigational product|1|||
160515030|NCT03647488|579613972|FG001|Overall Study|Participant refused to take investigational product|0|||
160515031|NCT03647488|579613973|FG002|Overall Study|Participant refused to take investigational product|0|||
160515032|NCT00189488|579613978|FG000|Overall Study|Ineligibility determined|1|||
160515033|NCT00189488|579613979|FG001|Overall Study|Ineligibility determined|0|||
160515034|NCT00189488|579613978|FG000|Overall Study|Protocol deviation|2|||
160515035|NCT00189488|579613979|FG001|Overall Study|Protocol deviation|1|||
160515036|NCT00189488|579613978|FG000|Overall Study|Adverse Event|2|||
160515037|NCT00189488|579613979|FG001|Overall Study|Adverse Event|1|||
160515038|NCT00189488|579613978|FG000|Overall Study|Withdrawal by Subject|2|||
160515039|NCT00189488|579613979|FG001|Overall Study|Withdrawal by Subject|6|||
160515040|NCT00189488|579613978|FG000|Overall Study|Disease progression|2|||
160515041|NCT00189488|579613979|FG001|Overall Study|Disease progression|4|||
160515042|NCT00189488|579613978|FG000|Overall Study|Administrative Decision|0|||
160515043|NCT00189488|579613979|FG001|Overall Study|Administrative Decision|2|||
160515044|NCT00189488|579613978|FG000|Overall Study|Death|5|||
160515045|NCT00189488|579613979|FG001|Overall Study|Death|8|||
160515046|NCT00189488|579613978|FG000|Overall Study|Other|1|||
160515047|NCT00189488|579613979|FG001|Overall Study|Other|0|||
160515048|NCT01190514|579613980|FG000|First Intervention (Period 1)|Adverse Event|1|||
160515049|NCT01190514|579613981|FG001|First Intervention (Period 1)|Adverse Event|0|||
160515050|NCT01190514|579613982|FG002|First Intervention (Period 1)|Adverse Event|0|||
160515051|NCT01190514|579613983|FG003|First Intervention (Period 1)|Adverse Event|0|||
160515052|NCT01190514|579613980|FG000|Third Intervention (Period 3)|Adverse Event|1|||
160515053|NCT01190514|579613981|FG001|Third Intervention (Period 3)|Adverse Event|0|||
160623502|NCT05602818|580001740|FG001|Qualification Phase (3 Days)|Other|0|||
160623503|NCT05602818|580001741|FG002|Qualification Phase (3 Days)|Other|0|||
160623504|NCT05602818|580001742|FG003|Qualification Phase (3 Days)|Other|0|||
160623505|NCT05602818|580001743|FG004|Qualification Phase (3 Days)|Other|0|||
160623506|NCT05602818|580001744|FG005|Qualification Phase (3 Days)|Other|0|||
160623507|NCT05602818|580001745|FG006|Qualification Phase (3 Days)|Other|0|||
160623508|NCT05602818|580001746|FG007|Qualification Phase (3 Days)|Other|0|||
160623509|NCT05602818|580001747|FG008|Qualification Phase (3 Days)|Other|0|||
160623510|NCT05602818|580001748|FG009|Qualification Phase (3 Days)|Other|0|||
160623511|NCT05602818|580001749|FG010|Qualification Phase (3 Days)|Other|0|||
160623512|NCT05602818|580001750|FG011|Qualification Phase (3 Days)|Other|0|||
160623513|NCT05602818|580001739|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160623514|NCT05602818|580001740|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
160623515|NCT05602818|580001741|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160515054|NCT01190514|579613982|FG002|Third Intervention (Period 3)|Adverse Event|0|||
160623516|NCT05602818|580001742|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160623517|NCT05602818|580001743|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160515055|NCT01190514|579613983|FG003|Third Intervention (Period 3)|Adverse Event|0|||
160515056|NCT00512317|579613984|FG000|Overall Study|Insufficient clinical response|36|||
160623518|NCT05602818|580001744|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160623519|NCT05602818|580001745|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160515057|NCT00512317|579613984|FG000|Overall Study|Withdrawal by Subject|23|||
160515058|NCT00512317|579613984|FG000|Overall Study|Sponsor closure of study|21|||
160515059|NCT00512317|579613984|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
160515060|NCT00512317|579613984|FG000|Overall Study|Adverse Event|13|||
160515061|NCT00512317|579613984|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
160515062|NCT00512317|579613984|FG000|Overall Study|Lost to Follow-up|2|||
160515063|NCT00512317|579613984|FG000|Overall Study|Other|2|||
160515064|NCT04101318|579613985|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
160515065|NCT04101318|579613986|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
160515066|NCT04101318|579613985|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
160515067|NCT04101318|579613986|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
160515068|NCT04101318|579613985|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
160515069|NCT04101318|579613986|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
160515070|NCT00370331|579613991|FG000|Overall Study|Adverse Event|4|||
160515071|NCT00370331|579613992|FG001|Overall Study|Adverse Event|13|||
160515072|NCT00370331|579613991|FG000|Overall Study|Withdrawal by Subject|2|||
160515073|NCT00370331|579613992|FG001|Overall Study|Withdrawal by Subject|4|||
160515074|NCT00370331|579613991|FG000|Overall Study|Lost to Follow-up|0|||
160515075|NCT00370331|579613992|FG001|Overall Study|Lost to Follow-up|3|||
160515076|NCT00370331|579613991|FG000|Overall Study|Lack of Efficacy|0|||
160515077|NCT00370331|579613992|FG001|Overall Study|Lack of Efficacy|1|||
160515078|NCT00370331|579613991|FG000|Overall Study|Non-compliance|0|||
160515079|NCT00370331|579613992|FG001|Overall Study|Non-compliance|1|||
160515080|NCT00370331|579613991|FG000|Overall Study|Protocol Violation|1|||
160515081|NCT00370331|579613992|FG001|Overall Study|Protocol Violation|1|||
160515082|NCT00545051|579613993|FG000|Overall Study|Adverse Event|7|||
160515083|NCT00545051|579613994|FG001|Overall Study|Adverse Event|3|||
160515084|NCT00545051|579613993|FG000|Overall Study|Death|1|||
160515085|NCT00545051|579613994|FG001|Overall Study|Death|0|||
160515086|NCT00545051|579613993|FG000|Overall Study|Violation of inclusion/exclusion|0|||
160515087|NCT00545051|579613994|FG001|Overall Study|Violation of inclusion/exclusion|2|||
160515088|NCT00545051|579613993|FG000|Overall Study|Protocol Violation|1|||
160515089|NCT00545051|579613994|FG001|Overall Study|Protocol Violation|0|||
160515090|NCT00545051|579613993|FG000|Overall Study|Withdrawal by Subject|0|||
160515091|NCT00545051|579613994|FG001|Overall Study|Withdrawal by Subject|1|||
160515092|NCT00545051|579613993|FG000|Overall Study|Administrative reasons|0|||
160515093|NCT00545051|579613994|FG001|Overall Study|Administrative reasons|1|||
160515094|NCT01375114|579613995|FG000|Overall Study|Lost to Follow-up|1|||
160515095|NCT01375114|579613996|FG001|Overall Study|Lost to Follow-up|0|||
160515096|NCT01375114|579613997|FG002|Overall Study|Lost to Follow-up|1|||
160515097|NCT01375114|579613995|FG000|Overall Study|Disease Progression|3|||
160515098|NCT01375114|579613996|FG001|Overall Study|Disease Progression|2|||
160515099|NCT01375114|579613997|FG002|Overall Study|Disease Progression|2|||
160515100|NCT01375114|579613995|FG000|Overall Study|Patient Changed Mind|0|||
160515101|NCT01375114|579613996|FG001|Overall Study|Patient Changed Mind|0|||
160515102|NCT01375114|579613997|FG002|Overall Study|Patient Changed Mind|2|||
160515103|NCT01375114|579613995|FG000|Overall Study|Pruritus|0|||
160515104|NCT01375114|579613996|FG001|Overall Study|Pruritus|0|||
160515105|NCT01375114|579613997|FG002|Overall Study|Pruritus|1|||
160515106|NCT01375114|579613995|FG000|Overall Study|Restlessness|0|||
160515107|NCT01375114|579613996|FG001|Overall Study|Restlessness|0|||
160515108|NCT01375114|579613997|FG002|Overall Study|Restlessness|1|||
160515109|NCT01375114|579613995|FG000|Overall Study|Diarrhea|0|||
160515110|NCT01375114|579613996|FG001|Overall Study|Diarrhea|0|||
160515111|NCT01375114|579613997|FG002|Overall Study|Diarrhea|1|||
160515112|NCT01375114|579613995|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
160515113|NCT01375114|579613996|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
160515114|NCT01375114|579613997|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
160515115|NCT01375114|579613995|FG000|Overall Study|Nausea|0|||
160515116|NCT01375114|579613996|FG001|Overall Study|Nausea|1|||
160515117|NCT01375114|579613997|FG002|Overall Study|Nausea|0|||
160515118|NCT01375114|579613995|FG000|Overall Study|Increased AST/ALT|0|||
160515119|NCT01375114|579613996|FG001|Overall Study|Increased AST/ALT|1|||
160515120|NCT01375114|579613997|FG002|Overall Study|Increased AST/ALT|0|||
160515121|NCT01375114|579613995|FG000|Overall Study|Vaginal Hemorrhage|0|||
160515122|NCT01375114|579613996|FG001|Overall Study|Vaginal Hemorrhage|1|||
160515123|NCT01375114|579613997|FG002|Overall Study|Vaginal Hemorrhage|0|||
160515124|NCT01375114|579613995|FG000|Overall Study|Family problem|0|||
160515125|NCT01375114|579613996|FG001|Overall Study|Family problem|1|||
160515126|NCT01375114|579613997|FG002|Overall Study|Family problem|0|||
160515127|NCT01375114|579613995|FG000|Overall Study|Protocol Violation|2|||
160515128|NCT01375114|579613996|FG001|Overall Study|Protocol Violation|0|||
160515129|NCT01375114|579613997|FG002|Overall Study|Protocol Violation|0|||
160515130|NCT00652327|579613998|FG000|Overall Study|Adverse Event|0|||
160515131|NCT00652327|579613999|FG001|Overall Study|Adverse Event|2|||
160515132|NCT00652327|579613998|FG000|Overall Study|Lost to Follow-up|0|||
160515133|NCT00652327|579613999|FG001|Overall Study|Lost to Follow-up|3|||
160515134|NCT01656733|579614005|FG000|Overall Study|No permission to collect birth outcomes|0|||
160515135|NCT01656733|579614006|FG001|Overall Study|No permission to collect birth outcomes|1|||
160515136|NCT01656733|579614005|FG000|Overall Study|Delivery at another hospital|0|||
160515137|NCT01656733|579614006|FG001|Overall Study|Delivery at another hospital|2|||
160515138|NCT01656733|579614005|FG000|Overall Study|Spontaneous abortion|0|||
160515139|NCT01656733|579614006|FG001|Overall Study|Spontaneous abortion|1|||
160515140|NCT02224690|579614007|FG000|Overall Study|Adverse Event|8|||
160515141|NCT02224690|579614008|FG001|Overall Study|Adverse Event|1|||
160515142|NCT02224690|579614007|FG000|Overall Study|Met Withdrawal Criteria|4|||
160515143|NCT02224690|579614008|FG001|Overall Study|Met Withdrawal Criteria|0|||
160515144|NCT02224690|579614007|FG000|Overall Study|Use of G-tube|1|||
160515145|NCT02224690|579614008|FG001|Overall Study|Use of G-tube|0|||
160515146|NCT02224690|579614007|FG000|Overall Study|Did not meet eligibility criteria|1|||
160515147|NCT02224690|579614008|FG001|Overall Study|Did not meet eligibility criteria|0|||
160515148|NCT01415531|579614009|FG000|Overall Study|Adverse Event|7|||
160515149|NCT01415531|579614010|FG001|Overall Study|Adverse Event|10|||
160515150|NCT01415531|579614009|FG000|Overall Study|Lack of Efficacy|3|||
160515151|NCT01415531|579614010|FG001|Overall Study|Lack of Efficacy|2|||
160515152|NCT01415531|579614009|FG000|Overall Study|Protocol Violation|0|||
160515153|NCT01415531|579614010|FG001|Overall Study|Protocol Violation|1|||
160515154|NCT01415531|579614009|FG000|Overall Study|Withdrawal by Subject|5|||
160515155|NCT01415531|579614010|FG001|Overall Study|Withdrawal by Subject|4|||
160515156|NCT01415531|579614009|FG000|Overall Study|Lost to Follow-up|6|||
160515157|NCT01415531|579614010|FG001|Overall Study|Lost to Follow-up|14|||
160515158|NCT01415531|579614009|FG000|Overall Study|Lack of Compliance|1|||
160515159|NCT01415531|579614010|FG001|Overall Study|Lack of Compliance|4|||
160515160|NCT01415531|579614009|FG000|Overall Study|Other Reasons|3|||
160515161|NCT01415531|579614010|FG001|Overall Study|Other Reasons|2|||
160515162|NCT05753670|579614013|FG000|Overall Study|Withdrawal by Subject|6|||
160515163|NCT05753670|579614014|FG001|Overall Study|Withdrawal by Subject|8|||
160515164|NCT05753670|579614013|FG000|Overall Study|Protocol Violation|3|||
160515165|NCT05753670|579614014|FG001|Overall Study|Protocol Violation|1|||
160515166|NCT00122460|579614015|FG000|Overall Study|investigational study phase ongoing|7|||
160515167|NCT00122460|579614016|FG001|Overall Study|investigational study phase ongoing|1|||
160515168|NCT01236339|579614017|FG000|Overall Study|Termination of study by sponsor|11|||
160515169|NCT01236339|579614018|FG001|Overall Study|Termination of study by sponsor|13|||
160515170|NCT02325557|579614019|FG000|Overall Study|Progressive disease|1|||
160515171|NCT02325557|579614020|FG001|Overall Study|Progressive disease|0|||
160515172|NCT02325557|579614021|FG002|Overall Study|Progressive disease|0|||
160515173|NCT02325557|579614022|FG003|Overall Study|Progressive disease|0|||
160515174|NCT02325557|579614019|FG000|Overall Study|Withdrawal by Subject|4|||
160515175|NCT02325557|579614020|FG001|Overall Study|Withdrawal by Subject|0|||
160515176|NCT02325557|579614021|FG002|Overall Study|Withdrawal by Subject|0|||
160515177|NCT02325557|579614022|FG003|Overall Study|Withdrawal by Subject|15|||
160515178|NCT02325557|579614019|FG000|Overall Study|Death|5|||
160515179|NCT02325557|579614020|FG001|Overall Study|Death|1|||
160515180|NCT02325557|579614021|FG002|Overall Study|Death|1|||
160515181|NCT02325557|579614022|FG003|Overall Study|Death|16|||
160515182|NCT02325557|579614019|FG000|Overall Study|Lost to Follow-up|0|||
160515183|NCT02325557|579614020|FG001|Overall Study|Lost to Follow-up|0|||
160515184|NCT02325557|579614021|FG002|Overall Study|Lost to Follow-up|1|||
160515185|NCT02325557|579614022|FG003|Overall Study|Lost to Follow-up|1|||
160515186|NCT02325557|579614019|FG000|Overall Study|Other|0|||
160515187|NCT02325557|579614020|FG001|Overall Study|Other|0|||
160623520|NCT05602818|580001746|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160623521|NCT05602818|580001747|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160623522|NCT05602818|580001748|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160623523|NCT05602818|580001749|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160623524|NCT05602818|580001750|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
160515188|NCT02325557|579614021|FG002|Overall Study|Other|0|||
160515189|NCT02325557|579614022|FG003|Overall Study|Other|5|||
160623525|NCT05602818|580001739|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
160623526|NCT05602818|580001740|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
160623527|NCT05602818|580001741|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
160515190|NCT02084056|579614023|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
160515191|NCT02084056|579614024|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
160515192|NCT02084056|579614025|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
160515193|NCT02084056|579614026|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
160515194|NCT02084056|579614023|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
160515195|NCT02084056|579614024|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
160515196|NCT02084056|579614025|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
160515197|NCT02084056|579614026|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
160515198|NCT00938860|579614027|FG000|Overall Study|Adverse Event|2|||
160515199|NCT00938860|579614028|FG001|Overall Study|Adverse Event|1|||
160515200|NCT00938860|579614027|FG000|Overall Study|Abnormal laboratory values|2|||
160515201|NCT00938860|579614028|FG001|Overall Study|Abnormal laboratory values|2|||
160515202|NCT00938860|579614027|FG000|Overall Study|Withdrawal by Subject|11|||
160515203|NCT00938860|579614028|FG001|Overall Study|Withdrawal by Subject|8|||
160515204|NCT00938860|579614027|FG000|Overall Study|Lost to Follow-up|4|||
160515205|NCT00938860|579614028|FG001|Overall Study|Lost to Follow-up|4|||
160515206|NCT00938860|579614027|FG000|Overall Study|Administration problems|2|||
160515207|NCT00938860|579614028|FG001|Overall Study|Administration problems|0|||
160515208|NCT00938860|579614027|FG000|Overall Study|Death|1|||
160515209|NCT00938860|579614028|FG001|Overall Study|Death|1|||
160515210|NCT00938860|579614027|FG000|Overall Study|Protocol Violation|3|||
160515211|NCT00938860|579614028|FG001|Overall Study|Protocol Violation|1|||
160515212|NCT01605019|579614029|FG000|Overall Study|pt did not meet transplant endpoint|3|||
160515213|NCT01605019|579614030|FG001|Overall Study|pt did not meet transplant endpoint|0|||
160515214|NCT00324116|579614034|FG000|Overall Study|Adverse Event|5|||
160515215|NCT00324116|579614034|FG000|Overall Study|Lack of Efficacy|17|||
160515216|NCT00324116|579614034|FG000|Overall Study|Withdrawal by Subject|5|||
160515217|NCT00324116|579614034|FG000|Overall Study|Other|5|||
160515218|NCT02703259|579614035|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
160515219|NCT02703259|579614036|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
160515220|NCT02703259|579614035|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
160515221|NCT02703259|579614036|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
160515222|NCT02703259|579614035|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
160515223|NCT02703259|579614036|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
160515224|NCT00528645|579614038|FG000|Overall Study|Adverse Event|3|||
160515225|NCT01642251|579614039|FG000|Overall Study|Progressive disease|0|||
160515226|NCT01642251|579614040|FG001|Overall Study|Progressive disease|0|||
160515227|NCT01642251|579614041|FG002|Overall Study|Progressive disease|3|||
160515228|NCT01642251|579614042|FG003|Overall Study|Progressive disease|3|||
160515229|NCT01642251|579614039|FG000|Overall Study|Adverse Event|0|||
160515230|NCT01642251|579614040|FG001|Overall Study|Adverse Event|0|||
160515231|NCT01642251|579614041|FG002|Overall Study|Adverse Event|5|||
160515232|NCT01642251|579614042|FG003|Overall Study|Adverse Event|4|||
160515233|NCT01642251|579614039|FG000|Overall Study|Death|0|||
160515234|NCT01642251|579614040|FG001|Overall Study|Death|0|||
160515235|NCT01642251|579614041|FG002|Overall Study|Death|1|||
160515236|NCT01642251|579614042|FG003|Overall Study|Death|3|||
160515237|NCT01642251|579614039|FG000|Overall Study|Withdrawal by Subject|0|||
160515238|NCT01642251|579614040|FG001|Overall Study|Withdrawal by Subject|0|||
160515239|NCT01642251|579614041|FG002|Overall Study|Withdrawal by Subject|1|||
160515240|NCT01642251|579614042|FG003|Overall Study|Withdrawal by Subject|3|||
160515241|NCT01642251|579614039|FG000|Overall Study|Alternative therapy|0|||
160515242|NCT01642251|579614040|FG001|Overall Study|Alternative therapy|0|||
160515243|NCT01642251|579614041|FG002|Overall Study|Alternative therapy|0|||
160515244|NCT01642251|579614042|FG003|Overall Study|Alternative therapy|2|||
160515245|NCT01642251|579614039|FG000|Overall Study|Other complicating disease|0|||
160515246|NCT01642251|579614040|FG001|Overall Study|Other complicating disease|0|||
160515247|NCT01642251|579614041|FG002|Overall Study|Other complicating disease|1|||
160515248|NCT01642251|579614042|FG003|Overall Study|Other complicating disease|0|||
160515249|NCT01642251|579614039|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
160515250|NCT01642251|579614040|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
160515251|NCT01642251|579614041|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
160515252|NCT01642251|579614042|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
160515253|NCT00998790|579614043|FG000|Overall Study|Withdrawal by Subject|21|||
160515254|NCT01993927|579614044|FG000|Overall Study|Case Report Forms Uncollected|18|||
160515255|NCT01993927|579614044|FG000|Overall Study|Protocol Violation|11|||
160515256|NCT00895154|579614045|FG000|Overall Study|Lost to Follow-up|1|||
160515257|NCT00895154|579614046|FG001|Overall Study|Lost to Follow-up|1|||
160515258|NCT00895154|579614045|FG000|Overall Study|Withdrawal by Subject|0|||
160515259|NCT00895154|579614046|FG001|Overall Study|Withdrawal by Subject|1|||
160515260|NCT00287690|579614049|FG000|Overall Study|Protocol Violation|20|||
160515261|NCT00287690|579614050|FG001|Overall Study|Protocol Violation|26|||
160515262|NCT00540046|579614051|FG000|Overall Study|Lost to Follow-up|33|||
160515263|NCT00540046|579614052|FG001|Overall Study|Lost to Follow-up|23|||
160515264|NCT00185965|579614056|FG000|Overall Study|Adverse Event|0|||
160515265|NCT00185965|579614057|FG001|Overall Study|Adverse Event|1|||
160515266|NCT01103362|579614058|FG000|Overall Study|study terminated|596|||
160515267|NCT02533531|579614059|FG000|Overall Study|Device did not turn on|1|||
160515268|NCT03814187|579614060|FG000|Overall Study|Sponsor's Administrative Decision|0|||
160515269|NCT03814187|579614061|FG001|Overall Study|Sponsor's Administrative Decision|0|||
160623528|NCT05602818|580001742|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
160515270|NCT03814187|579614062|FG002|Overall Study|Sponsor's Administrative Decision|272|||
160515271|NCT03814187|579614060|FG000|Overall Study|Death|80|||
160515272|NCT03814187|579614061|FG001|Overall Study|Death|81|||
160515273|NCT03814187|579614062|FG002|Overall Study|Death|4|||
160515274|NCT03814187|579614060|FG000|Overall Study|Withdrew Consent|77|||
160515275|NCT03814187|579614061|FG001|Overall Study|Withdrew Consent|78|||
160515276|NCT03814187|579614062|FG002|Overall Study|Withdrew Consent|2|||
160515277|NCT03814187|579614060|FG000|Overall Study|Lost to Follow-up|47|||
160515278|NCT03814187|579614061|FG001|Overall Study|Lost to Follow-up|52|||
160515279|NCT03814187|579614062|FG002|Overall Study|Lost to Follow-up|1|||
160515280|NCT03814187|579614060|FG000|Overall Study|Adverse Event|22|||
160515281|NCT03814187|579614061|FG001|Overall Study|Adverse Event|23|||
160515282|NCT03814187|579614062|FG002|Overall Study|Adverse Event|0|||
160515283|NCT03814187|579614060|FG000|Overall Study|Physician Decision|7|||
160515284|NCT03814187|579614061|FG001|Overall Study|Physician Decision|4|||
160515285|NCT03814187|579614062|FG002|Overall Study|Physician Decision|2|||
160515286|NCT03814187|579614060|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
160515287|NCT03814187|579614061|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
160515288|NCT03814187|579614062|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
160515289|NCT03814187|579614060|FG000|Overall Study|Other reasons|34|||
160515290|NCT03814187|579614061|FG001|Overall Study|Other reasons|40|||
160515291|NCT03814187|579614062|FG002|Overall Study|Other reasons|2|||
160515292|NCT02047903|579614063|FG000|Overall Study|Adverse Event|14|||
160515293|NCT02047903|579614063|FG000|Overall Study|Serious adverse event|10|||
160515294|NCT02047903|579614063|FG000|Overall Study|Withdrawal by Subject|16|||
160515295|NCT02047903|579614063|FG000|Overall Study|Lost to Follow-up|4|||
160515296|NCT02047903|579614063|FG000|Overall Study|Reason not listed|6|||
160515297|NCT02047903|579614063|FG000|Overall Study|Not Treated|9|||
160515298|NCT01014533|579614064|FG000|Overall Study|Protocol Violation|3|||
160515299|NCT01014533|579614065|FG001|Overall Study|Protocol Violation|2|||
160515300|NCT01014533|579614064|FG000|Overall Study|Withdrawal by Subject|2|||
160515301|NCT01014533|579614065|FG001|Overall Study|Withdrawal by Subject|0|||
160515302|NCT01014533|579614064|FG000|Overall Study|unable to come to appointment|0|||
160515303|NCT01014533|579614065|FG001|Overall Study|unable to come to appointment|3|||
160515304|NCT00513604|579614066|FG000|Overall Study|Not treated|2|||
160515305|NCT00513604|579614067|FG001|Overall Study|Not treated|0|||
160515306|NCT00513604|579614068|FG002|Overall Study|Not treated|1|||
160515307|NCT00513604|579614069|FG003|Overall Study|Not treated|0|||
160515308|NCT00513604|579614070|FG004|Overall Study|Not treated|0|||
160515309|NCT00513604|579614066|FG000|Overall Study|Death during treatment|0|||
160515310|NCT00513604|579614067|FG001|Overall Study|Death during treatment|3|||
160515311|NCT00513604|579614068|FG002|Overall Study|Death during treatment|2|||
160515312|NCT00513604|579614069|FG003|Overall Study|Death during treatment|0|||
160515313|NCT00513604|579614070|FG004|Overall Study|Death during treatment|0|||
160515314|NCT00412061|579614072|FG000|Double Blind Phase|Disease Progression|101|||
160515315|NCT00412061|579614073|FG001|Double Blind Phase|Disease Progression|154|||
160515316|NCT00412061|579614072|FG000|Double Blind Phase|Adverse Event|61|||
160515317|NCT00412061|579614073|FG001|Double Blind Phase|Adverse Event|16|||
160515318|NCT00412061|579614072|FG000|Double Blind Phase|Final Primary Analysis|26|||
160515319|NCT00412061|579614073|FG001|Double Blind Phase|Final Primary Analysis|14|||
160515320|NCT00412061|579614072|FG000|Double Blind Phase|Withdrawal by Subject|18|||
160515321|NCT00412061|579614073|FG001|Double Blind Phase|Withdrawal by Subject|20|||
160515322|NCT00412061|579614072|FG000|Double Blind Phase|Death|6|||
160515323|NCT00412061|579614073|FG001|Double Blind Phase|Death|3|||
160515324|NCT00412061|579614072|FG000|Double Blind Phase|Protocol Violation|3|||
160515325|NCT00412061|579614073|FG001|Double Blind Phase|Protocol Violation|4|||
160515326|NCT00412061|579614072|FG000|Double Blind Phase|New Cander Therapy|1|||
160515327|NCT00412061|579614073|FG001|Double Blind Phase|New Cander Therapy|1|||
160515328|NCT00412061|579614072|FG000|Double Blind Phase|Lost to Follow-up|0|||
160515329|NCT00412061|579614073|FG001|Double Blind Phase|Lost to Follow-up|1|||
160515330|NCT00412061|579614072|FG000|Open Label Phase|Disease Progression|0|||
160515331|NCT00412061|579614073|FG001|Open Label Phase|Disease Progression|86|||
160515332|NCT00412061|579614072|FG000|Open Label Phase|Adverse Event|0|||
160515333|NCT00412061|579614073|FG001|Open Label Phase|Adverse Event|46|||
160515334|NCT00412061|579614072|FG000|Open Label Phase|Withdrawal by Subject|0|||
160515335|NCT00412061|579614073|FG001|Open Label Phase|Withdrawal by Subject|15|||
160515336|NCT00412061|579614072|FG000|Open Label Phase|Administrative Problems|0|||
160515337|NCT00412061|579614073|FG001|Open Label Phase|Administrative Problems|13|||
160515338|NCT00412061|579614072|FG000|Open Label Phase|Death|0|||
160515339|NCT00412061|579614073|FG001|Open Label Phase|Death|7|||
160515340|NCT00412061|579614072|FG000|Open Label Phase|Lost to Follow-up|0|||
160515341|NCT00412061|579614073|FG001|Open Label Phase|Lost to Follow-up|2|||
160515342|NCT00412061|579614072|FG000|Open Label Phase|New Cancer Therapy|0|||
160515343|NCT00412061|579614073|FG001|Open Label Phase|New Cancer Therapy|1|||
160515344|NCT02689518|579614074|FG000|Overall Study|Withdrawal by Subject|3|||
160515345|NCT01942590|579614077|FG000|Overall Study|Withdrawal by Subject|0|||
160515346|NCT01942590|579614078|FG001|Overall Study|Withdrawal by Subject|1|||
160515347|NCT01942590|579614077|FG000|Overall Study|Adverse Event|1|||
160666585|NCT03134222|580159258|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
160515348|NCT01942590|579614078|FG001|Overall Study|Adverse Event|0|||
160515349|NCT02433340|579614081|FG000|Overall Study|Adverse Event|0|||
160515350|NCT02433340|579614082|FG001|Overall Study|Adverse Event|0|||
160666586|NCT03134222|580159259|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
160515351|NCT02433340|579614083|FG002|Overall Study|Adverse Event|1|||
160515352|NCT02433340|579614084|FG003|Overall Study|Adverse Event|0|||
160515353|NCT02433340|579614081|FG000|Overall Study|Withdrawal by Subject|1|||
160515354|NCT02433340|579614082|FG001|Overall Study|Withdrawal by Subject|0|||
160515355|NCT02433340|579614083|FG002|Overall Study|Withdrawal by Subject|1|||
160515356|NCT02433340|579614084|FG003|Overall Study|Withdrawal by Subject|2|||
160515357|NCT02433340|579614081|FG000|Overall Study|Lost to Follow-up|0|||
160515358|NCT02433340|579614082|FG001|Overall Study|Lost to Follow-up|1|||
160515359|NCT02433340|579614083|FG002|Overall Study|Lost to Follow-up|0|||
160515360|NCT02433340|579614084|FG003|Overall Study|Lost to Follow-up|0|||
160515361|NCT02433340|579614081|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
160515362|NCT02433340|579614082|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
160515363|NCT02433340|579614083|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
160515364|NCT02433340|579614084|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
160515365|NCT02433340|579614081|FG000|Overall Study|Other|0|||
160515366|NCT02433340|579614082|FG001|Overall Study|Other|1|||
160515367|NCT02433340|579614083|FG002|Overall Study|Other|0|||
160515368|NCT02433340|579614084|FG003|Overall Study|Other|0|||
160515369|NCT01226095|579614085|FG000|Overall Study|Poor compliance|1|||
160515370|NCT01688830|579614088|FG000|Overall Study|Lost to Follow-up|0|||
160515371|NCT01688830|579614089|FG001|Overall Study|Lost to Follow-up|0|||
160515372|NCT01688830|579614090|FG002|Overall Study|Lost to Follow-up|0|||
160515373|NCT01688830|579614091|FG003|Overall Study|Lost to Follow-up|0|||
160515374|NCT01688830|579614092|FG004|Overall Study|Lost to Follow-up|0|||
160515375|NCT01688830|579614093|FG005|Overall Study|Lost to Follow-up|0|||
160515376|NCT01688830|579614094|FG006|Overall Study|Lost to Follow-up|0|||
160515377|NCT01688830|579614095|FG007|Overall Study|Lost to Follow-up|0|||
160515378|NCT01688830|579614096|FG008|Overall Study|Lost to Follow-up|0|||
160515379|NCT01688830|579614097|FG009|Overall Study|Lost to Follow-up|0|||
160515380|NCT01688830|579614098|FG010|Overall Study|Lost to Follow-up|1|||
160515381|NCT01688830|579614099|FG011|Overall Study|Lost to Follow-up|0|||
160515382|NCT01688830|579614100|FG012|Overall Study|Lost to Follow-up|0|||
160515383|NCT01688830|579614101|FG013|Overall Study|Lost to Follow-up|0|||
160515384|NCT01688830|579614102|FG014|Overall Study|Lost to Follow-up|0|||
160515385|NCT01688830|579614103|FG015|Overall Study|Lost to Follow-up|0|||
160515386|NCT01688830|579614104|FG016|Overall Study|Lost to Follow-up|0|||
160515387|NCT01688830|579614105|FG017|Overall Study|Lost to Follow-up|0|||
160515388|NCT01688830|579614106|FG018|Overall Study|Lost to Follow-up|0|||
160515389|NCT01688830|579614107|FG019|Overall Study|Lost to Follow-up|0|||
160515390|NCT01688830|579614108|FG020|Overall Study|Lost to Follow-up|0|||
160515391|NCT04822597|579614109|FG000|Overall Study|Withdrawal by Subject|0|||
160515392|NCT04822597|579614110|FG001|Overall Study|Withdrawal by Subject|1|||
160515393|NCT04822597|579614111|FG002|Overall Study|Withdrawal by Subject|1|||
160515394|NCT04822597|579614112|FG003|Overall Study|Withdrawal by Subject|0|||
160515395|NCT04822597|579614109|FG000|Overall Study|Physician Decision|0|||
160515396|NCT04822597|579614110|FG001|Overall Study|Physician Decision|0|||
160515397|NCT04822597|579614111|FG002|Overall Study|Physician Decision|1|||
160515398|NCT04822597|579614112|FG003|Overall Study|Physician Decision|1|||
160515399|NCT04822597|579614109|FG000|Overall Study|Subject withdrawn after enrollment|0|||
160515400|NCT04822597|579614110|FG001|Overall Study|Subject withdrawn after enrollment|1|||
160515401|NCT04822597|579614111|FG002|Overall Study|Subject withdrawn after enrollment|0|||
160515402|NCT04822597|579614112|FG003|Overall Study|Subject withdrawn after enrollment|1|||
160515403|NCT04822597|579614109|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
160515404|NCT04822597|579614110|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
160515405|NCT04822597|579614111|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
160515406|NCT04822597|579614112|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
160515407|NCT00911768|579614113|FG000|Overall Study|Protocol Violation|5|||
160515408|NCT00911768|579614114|FG001|Overall Study|Protocol Violation|4|||
160515409|NCT00911768|579614113|FG000|Overall Study|Withdrawal by Subject|1|||
160515410|NCT00911768|579614114|FG001|Overall Study|Withdrawal by Subject|0|||
160515411|NCT03406078|579614116|FG000|Overall Study|Death|1|||
160515412|NCT03406078|579614117|FG001|Overall Study|Death|0|||
160515413|NCT03406078|579614116|FG000|Overall Study|Lost to Follow-up|0|||
160515414|NCT03406078|579614117|FG001|Overall Study|Lost to Follow-up|1|||
160515415|NCT03406078|579614116|FG000|Overall Study|Withdrawal by Subject|5|||
160515416|NCT03406078|579614117|FG001|Overall Study|Withdrawal by Subject|2|||
160515417|NCT03616977|579614121|FG000|Period 1|Physician Decision|0|||
160515418|NCT03616977|579614122|FG001|Period 1|Physician Decision|1|||
160515419|NCT03616977|579614121|FG000|Period 3|Adverse Event|1|||
160515420|NCT03616977|579614122|FG001|Period 3|Adverse Event|1|||
160515421|NCT00591851|579614123|FG000|Overall Study|Withdrawal by Subject|3|||
160515422|NCT00591851|579614123|FG000|Overall Study|Adverse Event|2|||
160515423|NCT00591851|579614123|FG000|Overall Study|Progressive Disease|1|||
160515424|NCT00515853|579614124|FG000|Overall Study|Lost to Follow-up|9|||
160515425|NCT00515853|579614125|FG001|Overall Study|Lost to Follow-up|13|||
160515426|NCT00515853|579614124|FG000|Overall Study|Withdrawal by Subject|6|||
160515427|NCT00515853|579614125|FG001|Overall Study|Withdrawal by Subject|4|||
160515428|NCT00943111|579614130|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
160515429|NCT00943111|579614131|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
160515430|NCT00943111|579614132|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
160515431|NCT00943111|579614130|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
160515432|NCT00943111|579614131|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
160515433|NCT00943111|579614132|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
160515434|NCT00943111|579614130|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
160515435|NCT00943111|579614131|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
160515436|NCT00943111|579614132|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
160515437|NCT00943111|579614130|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
160515438|NCT00943111|579614131|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
160515439|NCT00943111|579614132|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
160515440|NCT00943111|579614130|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
160515441|NCT00943111|579614131|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
160515442|NCT00943111|579614132|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
160515443|NCT00943111|579614130|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
160515444|NCT00943111|579614131|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
160515445|NCT00943111|579614132|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
160515446|NCT00943111|579614130|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
160515447|NCT00943111|579614131|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
160515448|NCT00943111|579614132|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
160515449|NCT00943111|579614130|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
160515450|NCT00943111|579614131|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
160515451|NCT00943111|579614132|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
160515452|NCT02665338|579614134|FG000|Overall Study|Withdrawal by Subject|0|||
160515453|NCT02665338|579614135|FG001|Overall Study|Withdrawal by Subject|1|||
160515454|NCT00998335|579614136|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
160515455|NCT00998335|579614137|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
160515456|NCT00953407|579615755|FG000|Overall Study|Failed inclusion criteria|1|||
160515457|NCT00953407|579615756|FG001|Overall Study|Failed inclusion criteria|1|||
160515458|NCT00953407|579615757|FG002|Overall Study|Failed inclusion criteria|1|||
160515459|NCT00953407|579615758|FG003|Overall Study|Failed inclusion criteria|1|||
160515460|NCT00953407|579615759|FG004|Overall Study|Failed inclusion criteria|1|||
160515461|NCT00953407|579615755|FG000|Overall Study|Lost to Follow-up|0|||
160515462|NCT00953407|579615756|FG001|Overall Study|Lost to Follow-up|0|||
160515463|NCT00953407|579615757|FG002|Overall Study|Lost to Follow-up|0|||
160515464|NCT00953407|579615758|FG003|Overall Study|Lost to Follow-up|1|||
160515465|NCT00953407|579615759|FG004|Overall Study|Lost to Follow-up|0|||
160515466|NCT02502097|579615760|FG000|Period 1|Adverse Event|0|||
160515467|NCT02502097|579615761|FG001|Period 1|Adverse Event|0|||
160515468|NCT02502097|579615762|FG002|Period 1|Adverse Event|1|||
160515469|NCT02502097|579615763|FG003|Period 1|Adverse Event|0|||
160515470|NCT02502097|579615760|FG000|Wash Out Period|Adverse Event|0|||
160515471|NCT02502097|579615761|FG001|Wash Out Period|Adverse Event|1|||
160515472|NCT02502097|579615762|FG002|Wash Out Period|Adverse Event|1|||
160515473|NCT02502097|579615763|FG003|Wash Out Period|Adverse Event|1|||
160515474|NCT02502097|579615760|FG000|Period 2|Adverse Event|0|||
160515475|NCT02502097|579615761|FG001|Period 2|Adverse Event|0|||
160515476|NCT02502097|579615762|FG002|Period 2|Adverse Event|1|||
160515477|NCT02502097|579615763|FG003|Period 2|Adverse Event|0|||
160515478|NCT02186223|579615764|FG000|Overall Study|Not eligible for device placement|6|||
160515479|NCT02186223|579615764|FG000|Overall Study|Unable to obtain femoral access|3|||
160515480|NCT02186223|579615764|FG000|Overall Study|Death|3|||
160515481|NCT02186223|579615764|FG000|Overall Study|Device in place less than 48 hours|9|||
160515482|NCT01111474|579615765|FG000|Overall Study|Lost to Follow-up|12|||
160515483|NCT00618982|579615766|FG000|Overall Study|Adverse Event|23|||
160515484|NCT00618982|579615766|FG000|Overall Study|Withdrawal by Subject|1|||
160515485|NCT00618982|579615766|FG000|Overall Study|Protocol Violation|1|||
160515486|NCT00618982|579615766|FG000|Overall Study|ongoing, still treated with study med.|25|||
160515487|NCT00706433|579615770|FG000|Overall Study|Lost to Follow-up|3|||
160515488|NCT00706433|579615771|FG001|Overall Study|Lost to Follow-up|1|||
160515489|NCT00706433|579615772|FG002|Overall Study|Lost to Follow-up|6|||
160515490|NCT00706433|579615773|FG003|Overall Study|Lost to Follow-up|0|||
160515491|NCT00706433|579615770|FG000|Overall Study|Withdrawal by Subject|1|||
160515492|NCT00706433|579615771|FG001|Overall Study|Withdrawal by Subject|2|||
160515493|NCT00706433|579615772|FG002|Overall Study|Withdrawal by Subject|3|||
160515494|NCT00706433|579615773|FG003|Overall Study|Withdrawal by Subject|1|||
160515495|NCT00706433|579615770|FG000|Overall Study|Adverse Event|0|||
160515496|NCT00706433|579615771|FG001|Overall Study|Adverse Event|0|||
160515497|NCT00706433|579615772|FG002|Overall Study|Adverse Event|1|||
160515498|NCT00706433|579615773|FG003|Overall Study|Adverse Event|0|||
160515499|NCT00706433|579615770|FG000|Overall Study|Protocol Violation|1|||
160515500|NCT00706433|579615771|FG001|Overall Study|Protocol Violation|0|||
160515501|NCT00706433|579615772|FG002|Overall Study|Protocol Violation|0|||
160515502|NCT00706433|579615773|FG003|Overall Study|Protocol Violation|0|||
160515503|NCT00706433|579615770|FG000|Overall Study|new job|0|||
160515504|NCT00706433|579615771|FG001|Overall Study|new job|0|||
160515505|NCT00706433|579615772|FG002|Overall Study|new job|0|||
160515506|NCT00706433|579615773|FG003|Overall Study|new job|1|||
160515507|NCT00717067|579615775|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
160515508|NCT00717067|579615776|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
160515509|NCT00717067|579615777|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
160515510|NCT00717067|579615778|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
160515511|NCT00717067|579615779|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
160515512|NCT02090959|579615780|FG000|Overall Study|Withdrawal by Subject|10|||
160515513|NCT02090959|579615780|FG000|Overall Study|Adverse Event|1|||
160515514|NCT02090959|579615780|FG000|Overall Study|Investigator decision|2|||
160515515|NCT02090959|579615780|FG000|Overall Study|Study termination|6|||
160515516|NCT02090959|579615780|FG000|Overall Study|Enrolled but not treated|1|||
160515517|NCT02090959|579615780|FG000|Overall Study|Transfer for compassionate use medicine|4|||
160515518|NCT02090959|579615780|FG000|Overall Study|Move to medical need program|3|||
160515519|NCT02090959|579615780|FG000|Overall Study|Entered in to other study|34|||
160515520|NCT02090959|579615780|FG000|Overall Study|Switched to commercial supply|88|||
160515521|NCT02090959|579615780|FG000|Overall Study|Other than specified|2|||
160515522|NCT00522873|579615781|FG000|Overall Study|Adverse Event|41|||
160515523|NCT00522873|579615782|FG001|Overall Study|Adverse Event|26|||
160515524|NCT00522873|579615781|FG000|Overall Study|Withdrawal by Subject|20|||
160515525|NCT00522873|579615782|FG001|Overall Study|Withdrawal by Subject|9|||
160623529|NCT05602818|580001743|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
160623530|NCT05602818|580001744|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
160623531|NCT05602818|580001745|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
160623532|NCT05602818|580001746|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
160623533|NCT05602818|580001747|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
160623534|NCT05602818|580001748|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
160623535|NCT05602818|580001749|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
160623536|NCT05602818|580001750|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
160623537|NCT05602818|580001739|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
160623538|NCT05602818|580001740|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
160623539|NCT05602818|580001741|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
160623540|NCT05602818|580001742|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
160623541|NCT05602818|580001743|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
160623542|NCT05602818|580001744|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
160623543|NCT05602818|580001745|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
160623544|NCT05602818|580001746|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
160623545|NCT05602818|580001747|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
160623546|NCT05602818|580001748|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
160623547|NCT05602818|580001749|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
160623548|NCT05602818|580001750|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
160623549|NCT05602818|580001739|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
160623550|NCT05602818|580001740|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
160623551|NCT05602818|580001741|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
160623552|NCT05602818|580001742|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
160623553|NCT05602818|580001743|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
160623554|NCT05602818|580001744|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
160623555|NCT05602818|580001745|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
160623556|NCT05602818|580001746|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
160623557|NCT05602818|580001747|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
160623558|NCT05602818|580001748|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
160623559|NCT05602818|580001749|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
160623560|NCT05602818|580001750|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
160623561|NCT00750061|580001751|FG000|Overall Study|Adverse Event|2|||
160623562|NCT00750061|580001752|FG001|Overall Study|Adverse Event|0|||
160623563|NCT00750061|580001751|FG000|Overall Study|Withdrawal by Subject|0|||
160623564|NCT00750061|580001752|FG001|Overall Study|Withdrawal by Subject|1|||
160623565|NCT00750061|580001751|FG000|Overall Study|Physician Decision|0|||
160623566|NCT00750061|580001752|FG001|Overall Study|Physician Decision|1|||
160623567|NCT03814499|580001755|FG000|Overall Study|Lost to Follow-up|3|||
160623568|NCT00229931|580001759|FG000|Overall Study|Death|1|||
160623569|NCT00229931|580001760|FG001|Overall Study|Death|0|||
160623570|NCT00229931|580001759|FG000|Overall Study|Lost to Follow-up|3|||
160623571|NCT00229931|580001760|FG001|Overall Study|Lost to Follow-up|2|||
160623572|NCT02992743|580001761|FG000|Overall Study|Withdrawal by Subject|1|||
160623573|NCT02992743|580001762|FG001|Overall Study|Withdrawal by Subject|1|||
160623574|NCT02992743|580001761|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
160623575|NCT02992743|580001762|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
160623576|NCT02992743|580001761|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
160623577|NCT02992743|580001762|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
160515526|NCT00522873|579615781|FG000|Overall Study|Protocol Violation|14|||
160515527|NCT00522873|579615782|FG001|Overall Study|Protocol Violation|4|||
160515528|NCT00522873|579615781|FG000|Overall Study|Lost to Follow-up|11|||
160666587|NCT03134222|580159260|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
160666588|NCT03134222|580159261|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
160666589|NCT03134222|580159257|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
160666590|NCT03134222|580159258|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
160666591|NCT03134222|580159259|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
160666592|NCT03134222|580159260|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
160666593|NCT03134222|580159261|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
160666594|NCT03134222|580159257|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
160666595|NCT03134222|580159258|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
160666596|NCT03134222|580159259|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
160666597|NCT03134222|580159260|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
160666598|NCT03134222|580159261|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
160666599|NCT03134222|580159257|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
160666600|NCT03134222|580159258|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
160666601|NCT03134222|580159259|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
160666602|NCT03134222|580159260|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
160666603|NCT03134222|580159261|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
160666604|NCT03134222|580159257|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
160666605|NCT03134222|580159258|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
160666606|NCT03134222|580159259|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
160666607|NCT03134222|580159260|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
160666608|NCT03134222|580159261|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
160666609|NCT03134222|580159257|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
160666610|NCT03134222|580159258|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
160666611|NCT03134222|580159259|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
160666612|NCT03134222|580159260|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
160666613|NCT03134222|580159261|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
160666614|NCT03134222|580159257|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
160666615|NCT03134222|580159258|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
160666616|NCT03134222|580159259|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
160623578|NCT02992743|580001761|FG000|Overall Study|No measurable disease|1|||
160623579|NCT02992743|580001762|FG001|Overall Study|No measurable disease|0|||
160623580|NCT02992743|580001761|FG000|Overall Study|Lost to Follow-up|0|||
160623581|NCT02992743|580001762|FG001|Overall Study|Lost to Follow-up|1|||
160623582|NCT00381680|580001763|FG000|Overall Study|Adverse Event|9|||
160623583|NCT00381680|580001764|FG001|Overall Study|Adverse Event|3|||
160623584|NCT00381680|580001763|FG000|Overall Study|Death|10|||
160623585|NCT00381680|580001764|FG001|Overall Study|Death|7|||
160623586|NCT00381680|580001763|FG000|Overall Study|Lost to Follow-up|3|||
160623587|NCT00381680|580001764|FG001|Overall Study|Lost to Follow-up|2|||
160623588|NCT00381680|580001763|FG000|Overall Study|Physician Decision|25|||
160623589|NCT00381680|580001764|FG001|Overall Study|Physician Decision|6|||
160623590|NCT00381680|580001763|FG000|Overall Study|Withdrawal by Subject|3|||
160623591|NCT00381680|580001764|FG001|Overall Study|Withdrawal by Subject|1|||
160623592|NCT00381680|580001763|FG000|Overall Study|Entry onto another COG Trial|1|||
160623593|NCT00381680|580001764|FG001|Overall Study|Entry onto another COG Trial|2|||
160623594|NCT00381680|580001763|FG000|Overall Study|Alternative Therapy|11|||
160623595|NCT00381680|580001764|FG001|Overall Study|Alternative Therapy|5|||
160623596|NCT00381680|580001763|FG000|Overall Study|Secondary Malignancy|3|||
160623597|NCT00381680|580001764|FG001|Overall Study|Secondary Malignancy|0|||
160623598|NCT00381680|580001763|FG000|Overall Study|Delay initiation|1|||
160623599|NCT00381680|580001764|FG001|Overall Study|Delay initiation|0|||
160623600|NCT00381680|580001763|FG000|Overall Study|Stem Cell Transplant|26|||
160623601|NCT00381680|580001764|FG001|Overall Study|Stem Cell Transplant|10|||
160623602|NCT00381680|580001763|FG000|Overall Study|Relapse|18|||
160623603|NCT00381680|580001764|FG001|Overall Study|Relapse|9|||
160623604|NCT00381680|580001763|FG000|Overall Study|Induction Failure|4|||
160623605|NCT00381680|580001764|FG001|Overall Study|Induction Failure|1|||
160623606|NCT00381680|580001763|FG000|Overall Study|Progression|1|||
160623607|NCT00381680|580001764|FG001|Overall Study|Progression|1|||
160623608|NCT00381680|580001763|FG000|Overall Study|Other not otherwise specified|7|||
160623609|NCT00381680|580001764|FG001|Overall Study|Other not otherwise specified|2|||
160623610|NCT00381680|580001763|FG000|Overall Study|Ineligible|3|||
160623611|NCT00381680|580001764|FG001|Overall Study|Ineligible|1|||
160623612|NCT03290131|580001765|FG000|Overall Study|Adverse Event|22|||
160623613|NCT03290131|580001766|FG001|Overall Study|Adverse Event|57|||
160623614|NCT03290131|580001767|FG002|Overall Study|Adverse Event|11|||
160623615|NCT03290131|580001765|FG000|Overall Study|Withdrawal by Subject|18|||
160623616|NCT03290131|580001766|FG001|Overall Study|Withdrawal by Subject|13|||
160623617|NCT03290131|580001767|FG002|Overall Study|Withdrawal by Subject|8|||
160623618|NCT03290131|580001765|FG000|Overall Study|MS Relapse|2|||
160623619|NCT03290131|580001766|FG001|Overall Study|MS Relapse|1|||
160623620|NCT03290131|580001767|FG002|Overall Study|MS Relapse|0|||
160623621|NCT03290131|580001765|FG000|Overall Study|Unknown reason|0|||
160666617|NCT03134222|580159260|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
160666618|NCT03134222|580159261|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
160666619|NCT03134222|580159257|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
160666620|NCT03134222|580159258|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
160666621|NCT03134222|580159259|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
160666622|NCT03134222|580159260|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
160666623|NCT03134222|580159261|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
160666624|NCT02605928|580159262|FG000|Overall Study|Model tuning phase|28|||
160666625|NCT02605928|580159262|FG000|Overall Study|Lack of Efficacy|5|||
160666626|NCT03482882|580159265|FG000|Overall Study|Adverse Event|3|||
160666627|NCT03482882|580159265|FG000|Overall Study|Lost to Follow-up|1|||
160666628|NCT03482882|580159265|FG000|Overall Study|Protocol Violation|2|||
160666629|NCT03482882|580159265|FG000|Overall Study|Not further specified|1|||
160666630|NCT04659603|580159268|FG000|Overall Study|Study terminated by sponsor|0|||
160666631|NCT04659603|580159269|FG001|Overall Study|Study terminated by sponsor|0|||
160666632|NCT04659603|580159270|FG002|Overall Study|Study terminated by sponsor|2|||
160666633|NCT04659603|580159268|FG000|Overall Study|Withdrawal by Subject|0|||
160666634|NCT04659603|580159269|FG001|Overall Study|Withdrawal by Subject|5|||
160666635|NCT04659603|580159270|FG002|Overall Study|Withdrawal by Subject|0|||
160666636|NCT04659603|580159268|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
160666637|NCT04659603|580159269|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
160666638|NCT04659603|580159270|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
160666639|NCT01110005|580159271|FG000|Overall Study|ineligible|1|||
160666640|NCT01110005|580159272|FG001|Overall Study|ineligible|2|||
160666641|NCT01110005|580159271|FG000|Overall Study|missing consent|3|||
160666642|NCT01110005|580159272|FG001|Overall Study|missing consent|2|||
160666643|NCT01110005|580159271|FG000|Overall Study|Withdrawal by Subject|0|||
160666644|NCT01110005|580159272|FG001|Overall Study|Withdrawal by Subject|1|||
160666645|NCT04646213|580159273|FG000|Overall Study|Physician Decision|3|||
160666646|NCT04646213|580159273|FG000|Overall Study|Withdrawal by Subject|2|||
160666647|NCT05341622|580159276|FG000|Overall Study|Death|0|||
160666648|NCT05341622|580159277|FG001|Overall Study|Death|0|||
160666649|NCT05341622|580159278|FG002|Overall Study|Death|0|||
160666650|NCT05341622|580159279|FG003|Overall Study|Death|0|||
160666651|NCT05341622|580159280|FG004|Overall Study|Death|1|||
160666652|NCT05341622|580159281|FG005|Overall Study|Death|0|||
160666653|NCT05341622|580159282|FG006|Overall Study|Death|0|||
160666654|NCT05341622|580159283|FG007|Overall Study|Death|1|||
160666655|NCT05341622|580159276|FG000|Overall Study|Invalid Address|0|||
160666656|NCT05341622|580159277|FG001|Overall Study|Invalid Address|1|||
160666657|NCT05341622|580159278|FG002|Overall Study|Invalid Address|0|||
160666658|NCT05341622|580159279|FG003|Overall Study|Invalid Address|0|||
160666659|NCT05341622|580159280|FG004|Overall Study|Invalid Address|0|||
160666660|NCT05341622|580159281|FG005|Overall Study|Invalid Address|0|||
160666661|NCT05341622|580159282|FG006|Overall Study|Invalid Address|0|||
160666662|NCT05341622|580159283|FG007|Overall Study|Invalid Address|0|||
160666663|NCT05341622|580159276|FG000|Overall Study|Ineligible|26|||
160666664|NCT05341622|580159277|FG001|Overall Study|Ineligible|21|||
160666665|NCT05341622|580159278|FG002|Overall Study|Ineligible|28|||
160666666|NCT05341622|580159279|FG003|Overall Study|Ineligible|24|||
160666667|NCT05341622|580159280|FG004|Overall Study|Ineligible|29|||
160666668|NCT05341622|580159281|FG005|Overall Study|Ineligible|31|||
160666669|NCT05341622|580159282|FG006|Overall Study|Ineligible|28|||
160666670|NCT05341622|580159283|FG007|Overall Study|Ineligible|26|||
160666671|NCT02658084|580159284|FG000|Overall Study|Withdrawal by Subject|1|||
160666672|NCT02658084|580159285|FG001|Overall Study|Withdrawal by Subject|0|||
160666673|NCT02658084|580159284|FG000|Overall Study|Study Termination|1|||
160666674|NCT02658084|580159285|FG001|Overall Study|Study Termination|0|||
160666675|NCT03290781|580159286|FG000|Overall Study|Adverse Event|5|||
160666676|NCT03290781|580159287|FG001|Overall Study|Adverse Event|7|||
160666677|NCT03290781|580159288|FG002|Overall Study|Adverse Event|4|||
160666678|NCT03290781|580159289|FG003|Overall Study|Adverse Event|1|||
160666679|NCT03290781|580159290|FG004|Overall Study|Adverse Event|0|||
160666680|NCT03290781|580159291|FG005|Overall Study|Adverse Event|0|||
160666681|NCT03290781|580159292|FG006|Overall Study|Adverse Event|0|||
160666682|NCT03290781|580159286|FG000|Overall Study|Death|0|||
160666683|NCT03290781|580159287|FG001|Overall Study|Death|0|||
160666684|NCT03290781|580159288|FG002|Overall Study|Death|1|||
160666685|NCT03290781|580159289|FG003|Overall Study|Death|0|||
160666686|NCT03290781|580159290|FG004|Overall Study|Death|1|||
160666687|NCT03290781|580159291|FG005|Overall Study|Death|0|||
160666688|NCT03290781|580159292|FG006|Overall Study|Death|0|||
160666689|NCT03290781|580159286|FG000|Overall Study|Withdrawal by Subject|6|||
160666690|NCT03290781|580159287|FG001|Overall Study|Withdrawal by Subject|5|||
160666691|NCT03290781|580159288|FG002|Overall Study|Withdrawal by Subject|9|||
160666692|NCT03290781|580159289|FG003|Overall Study|Withdrawal by Subject|10|||
160666693|NCT03290781|580159290|FG004|Overall Study|Withdrawal by Subject|1|||
160666694|NCT03290781|580159291|FG005|Overall Study|Withdrawal by Subject|2|||
160666695|NCT03290781|580159292|FG006|Overall Study|Withdrawal by Subject|0|||
160515529|NCT00522873|579615782|FG001|Overall Study|Lost to Follow-up|3|||
160515530|NCT00522873|579615781|FG000|Overall Study|Personal Reasons|8|||
160515531|NCT00522873|579615782|FG001|Overall Study|Personal Reasons|1|||
160515532|NCT00522873|579615781|FG000|Overall Study|Medication Errors|1|||
160515533|NCT00522873|579615782|FG001|Overall Study|Medication Errors|1|||
160515534|NCT00522873|579615781|FG000|Overall Study|Never Received Medication|1|||
160515535|NCT00522873|579615782|FG001|Overall Study|Never Received Medication|0|||
160515536|NCT02029846|579615783|FG000|Overall Study|n=1 each arm|1|||
160515537|NCT02029846|579615784|FG001|Overall Study|n=1 each arm|1|||
160515538|NCT02966301|579615785|FG000|Overall Study|Death|2|||
160515539|NCT02966301|579615785|FG000|Overall Study|Withdrawal by Subject|1|||
160515540|NCT01383499|579615796|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
160515541|NCT01383499|579615797|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
160515542|NCT01383499|579615798|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
160515543|NCT01383499|579615799|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
160515544|NCT02572882|579615801|FG000|Overall Study|Withdrawal by Subject|1|||
160515545|NCT02572882|579615801|FG000|Overall Study|Participant received kidney transplant|1|||
160515546|NCT01079663|579615804|FG000|Overall Study|Adverse Event|0|||
160515547|NCT01079663|579615805|FG001|Overall Study|Adverse Event|2|||
160515548|NCT01079663|579615804|FG000|Overall Study|Protocol Violation|0|||
160515549|NCT01079663|579615805|FG001|Overall Study|Protocol Violation|2|||
160515550|NCT03606668|579615806|FG000|Overall Study|Screen Failure|1|||
160515551|NCT03606668|579615806|FG000|Overall Study|Lost to Follow-up|1|||
160515552|NCT04447846|579615811|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
160515553|NCT00297232|579615812|FG000|Overall Study|Lack of Efficacy|7|||
160515554|NCT00297232|579615812|FG000|Overall Study|Lost to Follow-up|10|||
160515555|NCT00297232|579615812|FG000|Overall Study|Adverse Event|63|||
160515556|NCT00297232|579615812|FG000|Overall Study|Voluntary Withdrawal|120|||
160515557|NCT00297232|579615812|FG000|Overall Study|Subject was Noncompliant|9|||
160515558|NCT00297232|579615812|FG000|Overall Study|Death|9|||
160515559|NCT00297232|579615812|FG000|Overall Study|Anti-natalizumab Positive|8|||
160515560|NCT00297232|579615812|FG000|Overall Study|Switched to Commercial Tysabri|22|||
160515561|NCT00297232|579615812|FG000|Overall Study|Disease Progression|8|||
160515562|NCT00297232|579615812|FG000|Overall Study|Fear of PML|10|||
160515563|NCT00297232|579615812|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
160515564|NCT00297232|579615812|FG000|Overall Study|Miscellaneous|5|||
160515565|NCT00297232|579615812|FG000|Overall Study|Sponsor Decision|34|||
160515566|NCT00297232|579615812|FG000|Overall Study|Subject Relocated|7|||
160623622|NCT03290131|580001766|FG001|Overall Study|Unknown reason|1|||
160515567|NCT00297232|579615812|FG000|Overall Study|Subject Withdrew Consent|37|||
160515568|NCT00297232|579615812|FG000|Overall Study|Persistently Positive Antibodies|11|||
160515569|NCT00297232|579615812|FG000|Overall Study|Investigator Withdrew From Program|19|||
160515570|NCT00297232|579615812|FG000|Overall Study|Did Not Enroll to Week 264|34|||
160515571|NCT00297232|579615812|FG000|Overall Study|Did Not Enroll to Week 480|17|||
160515572|NCT00297232|579615812|FG000|Overall Study|No data available after Week 264|161|||
160515573|NCT00297232|579615812|FG000|Overall Study|Other|1|||
160515574|NCT03536143|579615813|FG000|Overall Study|Early termination, Sponsor decision|1|||
160515575|NCT00495586|579615814|FG000|Overall Study|Withdrawal by Subject|4|||
160515576|NCT00495586|579615815|FG001|Overall Study|Withdrawal by Subject|4|||
160515577|NCT01029652|579615816|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
160515578|NCT01029652|579615817|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
160515579|NCT01029652|579615816|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
160515580|NCT01029652|579615817|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
160515581|NCT01029652|579615816|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
160515582|NCT01029652|579615817|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
160515583|NCT01029652|579615816|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
160515584|NCT01029652|579615817|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
160515585|NCT01029652|579615816|FG000|Core Study (0-12 Weeks)|Death|0|||
160515586|NCT01029652|579615817|FG001|Core Study (0-12 Weeks)|Death|1|||
160515587|NCT01029652|579615816|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
160515588|NCT01029652|579615817|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
160515589|NCT01029652|579615816|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
160515590|NCT01029652|579615817|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
160515591|NCT01029652|579615816|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
160515592|NCT01029652|579615817|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
160515593|NCT01029652|579615816|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
160515594|NCT01029652|579615817|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
160515595|NCT01029652|579615816|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
160515596|NCT01029652|579615817|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
160515597|NCT01029652|579615816|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
160515598|NCT01029652|579615817|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
160515599|NCT01029652|579615816|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
160515600|NCT01029652|579615817|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
160515601|NCT06377488|579615818|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
160515602|NCT06377488|579615818|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
160515603|NCT06377488|579615818|FG000|Overall Study|Protocol Violation|1|||
160515604|NCT06377488|579615818|FG000|Overall Study|Lost to Follow-up|1|||
160515605|NCT06377488|579615818|FG000|Overall Study|Incorrect Lens Dispensed|2|||
160515606|NCT04745026|579615819|FG000|Overall Study|Physician Decision|1|||
160515607|NCT04745026|579615820|FG001|Overall Study|Physician Decision|0|||
160515608|NCT04745026|579615819|FG000|Overall Study|Adverse Event|2|||
160515609|NCT04745026|579615820|FG001|Overall Study|Adverse Event|2|||
160515610|NCT04745026|579615819|FG000|Overall Study|Protocol Violation|1|||
160515611|NCT04745026|579615820|FG001|Overall Study|Protocol Violation|3|||
160515612|NCT04745026|579615819|FG000|Overall Study|Lost to Follow-up|4|||
160515613|NCT04745026|579615820|FG001|Overall Study|Lost to Follow-up|3|||
160515614|NCT04745026|579615819|FG000|Overall Study|Withdrawal by Subject|5|||
160515615|NCT04745026|579615820|FG001|Overall Study|Withdrawal by Subject|5|||
160515616|NCT02399254|579615821|FG000|Overall Study|Physician Decision|2|||
160515617|NCT01076647|579615824|FG000|Overall Study|Adverse Event|4|||
160515618|NCT01076647|579615825|FG001|Overall Study|Adverse Event|1|||
160515619|NCT01076647|579615824|FG000|Overall Study|Lack of Efficacy|0|||
160515620|NCT01076647|579615825|FG001|Overall Study|Lack of Efficacy|1|||
160515621|NCT01076647|579615824|FG000|Overall Study|Protocol Violation|7|||
160515622|NCT01076647|579615825|FG001|Overall Study|Protocol Violation|9|||
160515623|NCT01076647|579615824|FG000|Overall Study|Withdrawal criteria|2|||
160515624|NCT01076647|579615825|FG001|Overall Study|Withdrawal criteria|2|||
160515625|NCT01076647|579615824|FG000|Overall Study|Unclassified|12|||
160515626|NCT01076647|579615825|FG001|Overall Study|Unclassified|12|||
160515627|NCT02292927|579615830|FG000|Overall Study|Protocol Violation|13|||
160515628|NCT02292927|579615831|FG001|Overall Study|Protocol Violation|7|||
160515629|NCT02962960|579615833|FG000|Overall Study|Withdrawal by Subject|1|||
160515630|NCT02962960|579615834|FG001|Overall Study|Withdrawal by Subject|1|||
160515631|NCT02962960|579615835|FG002|Overall Study|Withdrawal by Subject|0|||
160515632|NCT02962960|579615833|FG000|Overall Study|Adverse Event|1|||
160515633|NCT02962960|579615834|FG001|Overall Study|Adverse Event|1|||
160515634|NCT02962960|579615835|FG002|Overall Study|Adverse Event|0|||
160623623|NCT03290131|580001767|FG002|Overall Study|Unknown reason|0|||
160515635|NCT02962960|579615833|FG000|Overall Study|Protocol Violation|1|||
160515636|NCT02962960|579615834|FG001|Overall Study|Protocol Violation|0|||
160623624|NCT03099096|580001770|FG000|Overall Study|Adverse Event|1|||
160666696|NCT03290781|580159286|FG000|Overall Study|Physician Decision|0|||
160515637|NCT02962960|579615835|FG002|Overall Study|Protocol Violation|0|||
160515638|NCT01806623|579615837|FG000|Overall Study|Withdrawal by Subject|1|||
160515639|NCT01806623|579615837|FG000|Overall Study|Adverse Event|1|||
160666697|NCT03290781|580159287|FG001|Overall Study|Physician Decision|1|||
160666698|NCT03290781|580159288|FG002|Overall Study|Physician Decision|0|||
160666699|NCT03290781|580159289|FG003|Overall Study|Physician Decision|0|||
160666700|NCT03290781|580159290|FG004|Overall Study|Physician Decision|0|||
160666701|NCT03290781|580159291|FG005|Overall Study|Physician Decision|0|||
160666702|NCT03290781|580159292|FG006|Overall Study|Physician Decision|0|||
160666703|NCT03290781|580159286|FG000|Overall Study|Site Terminated by Sponsor|1|||
160666704|NCT03290781|580159287|FG001|Overall Study|Site Terminated by Sponsor|0|||
160666705|NCT03290781|580159288|FG002|Overall Study|Site Terminated by Sponsor|2|||
160666706|NCT03290781|580159289|FG003|Overall Study|Site Terminated by Sponsor|1|||
160666707|NCT03290781|580159290|FG004|Overall Study|Site Terminated by Sponsor|0|||
160666708|NCT03290781|580159291|FG005|Overall Study|Site Terminated by Sponsor|0|||
160666709|NCT03290781|580159292|FG006|Overall Study|Site Terminated by Sponsor|0|||
160666710|NCT03290781|580159286|FG000|Overall Study|Lost to Follow-up|0|||
160666711|NCT03290781|580159287|FG001|Overall Study|Lost to Follow-up|0|||
160666712|NCT03290781|580159288|FG002|Overall Study|Lost to Follow-up|0|||
160666713|NCT03290781|580159289|FG003|Overall Study|Lost to Follow-up|1|||
160666714|NCT03290781|580159290|FG004|Overall Study|Lost to Follow-up|0|||
160666715|NCT03290781|580159291|FG005|Overall Study|Lost to Follow-up|0|||
160666716|NCT03290781|580159292|FG006|Overall Study|Lost to Follow-up|0|||
160666717|NCT03290781|580159286|FG000|Overall Study|Protocol Deviation|2|||
160666718|NCT03290781|580159287|FG001|Overall Study|Protocol Deviation|0|||
160666719|NCT03290781|580159288|FG002|Overall Study|Protocol Deviation|0|||
160666720|NCT03290781|580159289|FG003|Overall Study|Protocol Deviation|1|||
160666721|NCT03290781|580159290|FG004|Overall Study|Protocol Deviation|0|||
160666722|NCT03290781|580159291|FG005|Overall Study|Protocol Deviation|0|||
160666723|NCT03290781|580159292|FG006|Overall Study|Protocol Deviation|0|||
160666724|NCT03290781|580159286|FG000|Overall Study|Disease Relapse|32|||
160666725|NCT03290781|580159287|FG001|Overall Study|Disease Relapse|5|||
160666726|NCT03290781|580159288|FG002|Overall Study|Disease Relapse|38|||
160666727|NCT03290781|580159289|FG003|Overall Study|Disease Relapse|7|||
160666728|NCT03290781|580159290|FG004|Overall Study|Disease Relapse|3|||
160666729|NCT03290781|580159291|FG005|Overall Study|Disease Relapse|1|||
160666730|NCT03290781|580159292|FG006|Overall Study|Disease Relapse|4|||
160666731|NCT03290781|580159286|FG000|Overall Study|Other|3|||
160666732|NCT03290781|580159287|FG001|Overall Study|Other|0|||
160666733|NCT03290781|580159288|FG002|Overall Study|Other|2|||
160666734|NCT03290781|580159289|FG003|Overall Study|Other|2|||
160666735|NCT03290781|580159290|FG004|Overall Study|Other|0|||
160666736|NCT03290781|580159291|FG005|Overall Study|Other|0|||
160666737|NCT03290781|580159292|FG006|Overall Study|Other|0|||
160666738|NCT04611789|580159293|FG000|Overall Study|Lost to Follow-up|1|||
160666739|NCT04611789|580159294|FG001|Overall Study|Lost to Follow-up|0|||
160666740|NCT04611789|580159295|FG002|Overall Study|Lost to Follow-up|0|||
160666741|NCT02057835|580160735|FG000|Overall Study|Withdrawal by Subject|0|||
160666742|NCT02057835|580160736|FG001|Overall Study|Withdrawal by Subject|2|||
160666743|NCT02057835|580160737|FG002|Overall Study|Withdrawal by Subject|0|||
160666744|NCT02057835|580160738|FG003|Overall Study|Withdrawal by Subject|0|||
160666745|NCT02057835|580160739|FG004|Overall Study|Withdrawal by Subject|0|||
160515640|NCT01806623|579615837|FG000|Overall Study|Did not meet the inclusion criteria|56|||
160515641|NCT01737827|579615838|FG000|Overall Study|Adverse Event|3|||
160515642|NCT01737827|579615839|FG001|Overall Study|Adverse Event|6|||
160515643|NCT01737827|579615840|FG002|Overall Study|Adverse Event|0|||
160515644|NCT01737827|579615838|FG000|Overall Study|Lost to Follow-up|0|||
160515645|NCT01737827|579615839|FG001|Overall Study|Lost to Follow-up|1|||
160515646|NCT01737827|579615840|FG002|Overall Study|Lost to Follow-up|0|||
160515647|NCT01737827|579615838|FG000|Overall Study|Physician Decision|0|||
160515648|NCT01737827|579615839|FG001|Overall Study|Physician Decision|2|||
160666746|NCT02057835|580160740|FG005|Overall Study|Withdrawal by Subject|0|||
160666747|NCT02057835|580160741|FG006|Overall Study|Withdrawal by Subject|0|||
160666748|NCT02057835|580160742|FG007|Overall Study|Withdrawal by Subject|0|||
160666749|NCT02057835|580160743|FG008|Overall Study|Withdrawal by Subject|0|||
160666750|NCT02057835|580160744|FG009|Overall Study|Withdrawal by Subject|0|||
160515649|NCT01737827|579615840|FG002|Overall Study|Physician Decision|0|||
160666751|NCT01376037|580160745|FG000|Overall Study|Lost to Follow-up|0|||
160666752|NCT01376037|580160746|FG001|Overall Study|Lost to Follow-up|2|||
160515650|NCT01737827|579615838|FG000|Overall Study|Progressive Disease|5|||
160515651|NCT01737827|579615839|FG001|Overall Study|Progressive Disease|16|||
160515652|NCT01737827|579615840|FG002|Overall Study|Progressive Disease|2|||
160666753|NCT02328040|580160747|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
160666754|NCT02328040|580160748|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
160666755|NCT03697109|580160752|FG000|Open-label (OL) Phase|Adverse Event|24|||
160666756|NCT03697109|580160753|FG001|Open-label (OL) Phase|Adverse Event|0|||
160666757|NCT03697109|580160754|FG002|Open-label (OL) Phase|Adverse Event|0|||
160666758|NCT03697109|580160752|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
160666759|NCT03697109|580160753|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
160666760|NCT03697109|580160754|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
160666761|NCT03697109|580160752|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
160666762|NCT03697109|580160753|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
160666763|NCT03697109|580160754|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
160666764|NCT03697109|580160752|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
160666765|NCT03697109|580160753|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
160666766|NCT03697109|580160754|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
160666767|NCT03697109|580160752|FG000|Open-label (OL) Phase|Physician Decision|2|||
160666768|NCT03697109|580160753|FG001|Open-label (OL) Phase|Physician Decision|0|||
160666769|NCT03697109|580160754|FG002|Open-label (OL) Phase|Physician Decision|0|||
160666770|NCT03697109|580160752|FG000|Open-label (OL) Phase|Death|2|||
160666771|NCT03697109|580160753|FG001|Open-label (OL) Phase|Death|0|||
160666772|NCT03697109|580160754|FG002|Open-label (OL) Phase|Death|0|||
160666773|NCT03697109|580160752|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
160666774|NCT03697109|580160753|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
160666775|NCT03697109|580160754|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
160666776|NCT03697109|580160752|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
160666777|NCT03697109|580160753|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
160666778|NCT03697109|580160754|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
160666779|NCT03697109|580160752|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
160666780|NCT03697109|580160753|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
160666781|NCT03697109|580160754|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
160666782|NCT04516967|580160756|FG000|Core Phase|Adverse Event|2|||
160666783|NCT04516967|580160757|FG001|Core Phase|Adverse Event|1|||
160666784|NCT04516967|580160758|FG002|Core Phase|Adverse Event|0|||
160666785|NCT04516967|580160756|FG000|Core Phase|Physician Decision|1|||
160666786|NCT04516967|580160757|FG001|Core Phase|Physician Decision|1|||
160666787|NCT04516967|580160758|FG002|Core Phase|Physician Decision|0|||
160666788|NCT04516967|580160756|FG000|Core Phase|Lack of Efficacy|7|||
160666789|NCT04516967|580160757|FG001|Core Phase|Lack of Efficacy|18|||
160666790|NCT04516967|580160758|FG002|Core Phase|Lack of Efficacy|0|||
160666791|NCT02301975|580160759|FG000|Overall Study|Adverse Event|8|||
160666792|NCT02301975|580160760|FG001|Overall Study|Adverse Event|3|||
160666793|NCT02301975|580160761|FG002|Overall Study|Adverse Event|2|||
160666794|NCT02301975|580160759|FG000|Overall Study|Lack of Efficacy|1|||
160666795|NCT02301975|580160760|FG001|Overall Study|Lack of Efficacy|1|||
160515653|NCT01737827|579615838|FG000|Overall Study|Study Terminated by Sponsor|0|||
160666796|NCT02301975|580160761|FG002|Overall Study|Lack of Efficacy|1|||
160666797|NCT02301975|580160759|FG000|Overall Study|Protocol Violation|3|||
160666798|NCT02301975|580160760|FG001|Overall Study|Protocol Violation|5|||
160666799|NCT02301975|580160761|FG002|Overall Study|Protocol Violation|3|||
160666800|NCT02301975|580160759|FG000|Overall Study|Lost to Follow-up|0|||
160666801|NCT02301975|580160760|FG001|Overall Study|Lost to Follow-up|2|||
160666802|NCT02301975|580160761|FG002|Overall Study|Lost to Follow-up|2|||
160666803|NCT02301975|580160759|FG000|Overall Study|Physician Decision|4|||
160666804|NCT02301975|580160760|FG001|Overall Study|Physician Decision|2|||
160666805|NCT02301975|580160761|FG002|Overall Study|Physician Decision|3|||
160666806|NCT02301975|580160759|FG000|Overall Study|Withdrawal by Subject|15|||
160666807|NCT02301975|580160760|FG001|Overall Study|Withdrawal by Subject|12|||
160515654|NCT01737827|579615839|FG001|Overall Study|Study Terminated by Sponsor|1|||
160515655|NCT01737827|579615840|FG002|Overall Study|Study Terminated by Sponsor|0|||
160515656|NCT01737827|579615838|FG000|Overall Study|Subject/Guardian Decision|0|||
160515657|NCT01737827|579615839|FG001|Overall Study|Subject/Guardian Decision|2|||
160515658|NCT01737827|579615840|FG002|Overall Study|Subject/Guardian Decision|0|||
160515659|NCT01451827|579615841|FG000|Overall Study|Adverse Event|2|||
160515660|NCT01451827|579615842|FG001|Overall Study|Adverse Event|0|||
160515661|NCT01451827|579615843|FG002|Overall Study|Adverse Event|1|||
160515662|NCT01451827|579615844|FG003|Overall Study|Adverse Event|1|||
160515663|NCT01451827|579615841|FG000|Overall Study|Protocol deviation|1|||
160515664|NCT01451827|579615842|FG001|Overall Study|Protocol deviation|0|||
160515665|NCT01451827|579615843|FG002|Overall Study|Protocol deviation|0|||
160515666|NCT01451827|579615844|FG003|Overall Study|Protocol deviation|0|||
160666808|NCT02301975|580160761|FG002|Overall Study|Withdrawal by Subject|11|||
160666809|NCT00835991|580160762|FG000|First Intervention|Adverse Event|0|||
160666810|NCT00835991|580160763|FG001|First Intervention|Adverse Event|1|||
160666811|NCT00835991|580160762|FG000|Washout|Protocol Violation|0|||
160515667|NCT01451827|579615841|FG000|Overall Study|Lost to Follow-up|0|||
160515668|NCT01451827|579615842|FG001|Overall Study|Lost to Follow-up|3|||
160515669|NCT01451827|579615843|FG002|Overall Study|Lost to Follow-up|0|||
160515670|NCT01451827|579615844|FG003|Overall Study|Lost to Follow-up|2|||
160515671|NCT01451827|579615841|FG000|Overall Study|Participant met withdrawal criteria|0|||
160666812|NCT00835991|580160763|FG001|Washout|Protocol Violation|2|||
160666813|NCT00835991|580160762|FG000|Washout|Withdrawal by Subject|3|||
160666814|NCT00835991|580160763|FG001|Washout|Withdrawal by Subject|1|||
160666815|NCT02149420|580160764|FG000|Core Study|Administrative problems|0|||
160666816|NCT02149420|580160765|FG001|Core Study|Administrative problems|1|||
160666817|NCT02149420|580160766|FG002|Core Study|Administrative problems|2|||
160666818|NCT02149420|580160764|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
160666819|NCT02149420|580160765|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
160666820|NCT02149420|580160766|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
160666821|NCT04278560|580160767|FG000|Overall Study|Adverse Event|1|||
160666822|NCT04278560|580160768|FG001|Overall Study|Adverse Event|2|||
160666823|NCT04278560|580160767|FG000|Overall Study|Withdrawal by Subject|0|||
160666824|NCT04278560|580160768|FG001|Overall Study|Withdrawal by Subject|1|||
160666825|NCT00440518|580160769|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
160666826|NCT00440518|580160770|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
160666827|NCT00440518|580160771|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
160666828|NCT00440518|580160769|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
160666829|NCT00440518|580160770|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
160666830|NCT00440518|580160771|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
160666831|NCT00440518|580160769|FG000|Randomized /Titration Period|Protocol Deviation|1|||
160666832|NCT00440518|580160770|FG001|Randomized /Titration Period|Protocol Deviation|0|||
160666833|NCT00440518|580160771|FG002|Randomized /Titration Period|Protocol Deviation|0|||
160666834|NCT00440518|580160769|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
160666835|NCT00440518|580160770|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
160515672|NCT01451827|579615842|FG001|Overall Study|Participant met withdrawal criteria|2|||
160515673|NCT01451827|579615843|FG002|Overall Study|Participant met withdrawal criteria|0|||
160515674|NCT01451827|579615844|FG003|Overall Study|Participant met withdrawal criteria|0|||
160515675|NCT01451827|579615841|FG000|Overall Study|Withdrawal by Subject|0|||
160515676|NCT01451827|579615842|FG001|Overall Study|Withdrawal by Subject|0|||
160515677|NCT01451827|579615843|FG002|Overall Study|Withdrawal by Subject|1|||
160515678|NCT01451827|579615844|FG003|Overall Study|Withdrawal by Subject|1|||
160515679|NCT01964924|579615845|FG000|Trametinib Monotherapy|Progression|19|||
160515680|NCT01964924|579615846|FG001|Trametinib Monotherapy|Progression|0|||
160515681|NCT01528345|579615847|FG000|Overall Study|Adverse Event|10|||
160515682|NCT01528345|579615848|FG001|Overall Study|Adverse Event|1|||
160515683|NCT01528345|579615847|FG000|Overall Study|Death|1|||
160515684|NCT01528345|579615848|FG001|Overall Study|Death|1|||
160515685|NCT01528345|579615847|FG000|Overall Study|Non-compliance with study treatment|1|||
160515686|NCT01528345|579615848|FG001|Overall Study|Non-compliance with study treatment|0|||
160515687|NCT01528345|579615847|FG000|Overall Study|Progressive Disease|26|||
160515688|NCT01528345|579615848|FG001|Overall Study|Progressive Disease|40|||
160515689|NCT01528345|579615847|FG000|Overall Study|Study Terminated by Sponsor|4|||
160515690|NCT01528345|579615848|FG001|Overall Study|Study Terminated by Sponsor|8|||
160515691|NCT01528345|579615847|FG000|Overall Study|Subject/Guardian Decision|5|||
160515692|NCT01528345|579615848|FG001|Overall Study|Subject/Guardian Decision|0|||
160515693|NCT03538301|579615858|FG000|Overall Study|Adverse Event|1|||
160515694|NCT03538301|579615859|FG001|Overall Study|Adverse Event|4|||
160515695|NCT03538301|579615860|FG002|Overall Study|Adverse Event|4|||
160515696|NCT03538301|579615858|FG000|Overall Study|Death|1|||
160515697|NCT03538301|579615859|FG001|Overall Study|Death|1|||
160515698|NCT03538301|579615860|FG002|Overall Study|Death|0|||
160515699|NCT03538301|579615858|FG000|Overall Study|Physician Decision|0|||
160515700|NCT03538301|579615859|FG001|Overall Study|Physician Decision|1|||
160515701|NCT03538301|579615860|FG002|Overall Study|Physician Decision|0|||
160515702|NCT03538301|579615858|FG000|Overall Study|Protocol Violation|0|||
160515703|NCT03538301|579615859|FG001|Overall Study|Protocol Violation|0|||
160515704|NCT03538301|579615860|FG002|Overall Study|Protocol Violation|1|||
160515705|NCT03538301|579615858|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
160515706|NCT03538301|579615859|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
160515707|NCT03538301|579615860|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
160515708|NCT03798691|579615861|FG000|Overall Study|Lost to Follow-up|2|||
160515709|NCT03798691|579615862|FG001|Overall Study|Lost to Follow-up|2|||
160515710|NCT01586910|579618000|FG000|Overall Study|Death|4|||
160515711|NCT01586910|579618001|FG001|Overall Study|Death|4|||
160515712|NCT01586910|579618000|FG000|Overall Study|Withdrawal by Subject|6|||
160515713|NCT01586910|579618001|FG001|Overall Study|Withdrawal by Subject|43|||
160515714|NCT01586910|579618000|FG000|Overall Study|Physician withdrew Subject|5|||
160515715|NCT01586910|579618001|FG001|Overall Study|Physician withdrew Subject|24|||
160515716|NCT00252733|579618002|FG000|Overall Study|Withdrawal by Subject|73|||
160515717|NCT00252733|579618003|FG001|Overall Study|Withdrawal by Subject|67|||
160515718|NCT00252733|579618002|FG000|Overall Study|Death|7|||
160515719|NCT00252733|579618003|FG001|Overall Study|Death|5|||
160515720|NCT00252733|579618002|FG000|Overall Study|Lost to Follow-up|12|||
160515721|NCT00252733|579618003|FG001|Overall Study|Lost to Follow-up|6|||
160515722|NCT00252733|579618002|FG000|Overall Study|Multiple Reasons|14|||
160515723|NCT00252733|579618003|FG001|Overall Study|Multiple Reasons|14|||
160666836|NCT00440518|580160771|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
160666837|NCT00440518|580160769|FG000|Randomized /Titration Period|Other|1|||
160515724|NCT04289051|579618004|FG000|Overall Study|Lost to Follow-up|0|||
160515725|NCT04289051|579618005|FG001|Overall Study|Lost to Follow-up|0|||
160515726|NCT04289051|579618006|FG002|Overall Study|Lost to Follow-up|2|||
160515727|NCT00156819|579618009|FG000|Overall Study|Lost to Follow-up|1|||
160515728|NCT00156819|579618010|FG001|Overall Study|Lost to Follow-up|1|||
160515729|NCT00156819|579618011|FG002|Overall Study|Lost to Follow-up|3|||
160515730|NCT01689337|579618012|FG000|Overall Study|Study Discontinuation|1|||
160515731|NCT00642772|579618014|FG000|Overall Study|Lost to Follow-up|3|||
160515732|NCT00642772|579618014|FG000|Overall Study|Withdrawal by Subject|7|||
160515733|NCT05398237|579618015|FG000|Overall Study|Withdrawal by Subject|1|||
160515734|NCT01248065|579618016|FG000|Overall Study|Lost to Follow-up|3|||
160666838|NCT00440518|580160770|FG001|Randomized /Titration Period|Other|0|||
160666839|NCT00440518|580160771|FG002|Randomized /Titration Period|Other|0|||
160515735|NCT01248065|579618017|FG001|Overall Study|Lost to Follow-up|5|||
160515736|NCT01248065|579618016|FG000|Overall Study|Withdrawal by Subject|14|||
160515737|NCT01248065|579618017|FG001|Overall Study|Withdrawal by Subject|11|||
160515738|NCT01248065|579618016|FG000|Overall Study|Adverse Event|3|||
160515739|NCT01248065|579618017|FG001|Overall Study|Adverse Event|0|||
160515740|NCT01248065|579618016|FG000|Overall Study|Third treatment failure event|3|||
160515741|NCT01248065|579618017|FG001|Overall Study|Third treatment failure event|1|||
160515742|NCT01248065|579618016|FG000|Overall Study|Other|3|||
160515743|NCT01248065|579618017|FG001|Overall Study|Other|5|||
160515744|NCT02781844|579618018|FG000|Treatment Period 1|Adverse Event|0|||
160515745|NCT02781844|579618019|FG001|Treatment Period 1|Adverse Event|0|||
160515746|NCT02781844|579618020|FG002|Treatment Period 1|Adverse Event|0|||
160515747|NCT02781844|579618021|FG003|Treatment Period 1|Adverse Event|0|||
160515748|NCT02781844|579618022|FG004|Treatment Period 1|Adverse Event|0|||
160515749|NCT02781844|579618023|FG005|Treatment Period 1|Adverse Event|1|||
160515750|NCT02781844|579618024|FG006|Treatment Period 1|Adverse Event|0|||
160515751|NCT02781844|579618025|FG007|Treatment Period 1|Adverse Event|0|||
160515752|NCT02354508|579618026|FG000|Period 1: Core Phase|Adverse Event|1|||
160515753|NCT02354508|579618027|FG001|Period 1: Core Phase|Adverse Event|1|||
160515754|NCT02354508|579618028|FG002|Period 1: Core Phase|Adverse Event|2|||
160515755|NCT02354508|579618026|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
160515756|NCT02354508|579618027|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
160515757|NCT02354508|579618028|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
160515758|NCT02354508|579618026|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
160515759|NCT02354508|579618027|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
160515760|NCT02354508|579618028|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
160515761|NCT02354508|579618026|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
160515762|NCT02354508|579618027|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
160515763|NCT02354508|579618028|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
160515764|NCT02354508|579618026|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
160515765|NCT02354508|579618027|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
160515766|NCT02354508|579618028|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
160515767|NCT02354508|579618026|FG000|Period 2: Extension Phase|Physician Decision|5|||
160515768|NCT02354508|579618027|FG001|Period 2: Extension Phase|Physician Decision|0|||
160515769|NCT02354508|579618028|FG002|Period 2: Extension Phase|Physician Decision|1|||
160515770|NCT02354508|579618026|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
160515771|NCT02354508|579618027|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
160515772|NCT02354508|579618028|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
160515773|NCT02354508|579618026|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
160515774|NCT02354508|579618027|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
160515775|NCT02354508|579618028|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
160515776|NCT02354508|579618026|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
160515777|NCT02354508|579618027|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
160515778|NCT02354508|579618028|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
160515779|NCT01014143|579618029|FG000|Second Intervention|Lost to Follow-up|2|||
160515780|NCT01014143|579618030|FG001|Second Intervention|Lost to Follow-up|0|||
160515781|NCT01014143|579618031|FG002|Second Intervention|Lost to Follow-up|0|||
160515782|NCT00461032|579618034|FG000|Overall Study|Adverse Event|5|||
160515783|NCT00461032|579618035|FG001|Overall Study|Adverse Event|6|||
160515784|NCT00461032|579618034|FG000|Overall Study|Lack of Efficacy|5|||
160515785|NCT00461032|579618035|FG001|Overall Study|Lack of Efficacy|1|||
160515786|NCT00461032|579618034|FG000|Overall Study|Lost to Follow-up|7|||
160515787|NCT00461032|579618035|FG001|Overall Study|Lost to Follow-up|12|||
160515788|NCT00461032|579618034|FG000|Overall Study|Protocol Violation|4|||
160515789|NCT00461032|579618035|FG001|Overall Study|Protocol Violation|4|||
160515790|NCT00461032|579618034|FG000|Overall Study|Withdrawal by Subject|7|||
160515791|NCT00461032|579618035|FG001|Overall Study|Withdrawal by Subject|15|||
160515792|NCT00461032|579618034|FG000|Overall Study|Patient Moved or Relocated|2|||
160515793|NCT00461032|579618035|FG001|Overall Study|Patient Moved or Relocated|1|||
160515794|NCT00461032|579618034|FG000|Overall Study|Other|7|||
160515795|NCT00461032|579618035|FG001|Overall Study|Other|5|||
160515796|NCT01878214|579618039|FG000|Overall Study|Withdrawal by Subject|18|||
160666840|NCT00440518|580160769|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
160666841|NCT00440518|580160770|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
160666842|NCT00440518|580160771|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
160666843|NCT00440518|580160769|FG000|Randomized /Titration Period|Adverse Event|2|||
160515797|NCT01878214|579618040|FG001|Overall Study|Withdrawal by Subject|7|||
160515798|NCT01878214|579618039|FG000|Overall Study|Death|0|||
160515799|NCT01878214|579618040|FG001|Overall Study|Death|1|||
160515800|NCT01878214|579618039|FG000|Overall Study|Lost to Follow-up|35|||
160515801|NCT01878214|579618040|FG001|Overall Study|Lost to Follow-up|36|||
160515802|NCT03038438|579618041|FG000|Overall Study|Death|3|||
160515803|NCT03038438|579618041|FG000|Overall Study|Lost to Follow-up|8|||
160515804|NCT03038438|579618041|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
160515805|NCT03038438|579618041|FG000|Overall Study|Withdrawal by Subject|5|||
160666844|NCT00440518|580160770|FG001|Randomized /Titration Period|Adverse Event|3|||
160666845|NCT00440518|580160771|FG002|Randomized /Titration Period|Adverse Event|0|||
160666846|NCT00440518|580160769|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
160666847|NCT00440518|580160770|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
160666848|NCT00440518|580160771|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
160666849|NCT00440518|580160769|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
160666850|NCT00440518|580160770|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
160666851|NCT00440518|580160771|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
160666852|NCT00440518|580160769|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
160666853|NCT00440518|580160770|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
160666854|NCT00440518|580160771|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
160666855|NCT00440518|580160769|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
160666856|NCT00440518|580160770|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
160666857|NCT00440518|580160771|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
160666858|NCT00440518|580160769|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
160666859|NCT00440518|580160770|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
160666860|NCT00440518|580160771|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
160666861|NCT00440518|580160769|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
160666862|NCT00440518|580160770|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
160666863|NCT00440518|580160771|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
160666864|NCT06195579|580160772|FG000|Overall Study|Withdrawal by Subject|1|||
160666865|NCT02545283|580160773|FG000|Overall Study|Lost to Follow-up|2|||
160666866|NCT02545283|580160774|FG001|Overall Study|Lost to Follow-up|4|||
160666867|NCT02545283|580160773|FG000|Overall Study|Withdrawal by Subject|5|||
160666868|NCT02545283|580160774|FG001|Overall Study|Withdrawal by Subject|9|||
160666869|NCT02545283|580160773|FG000|Overall Study|Death|109|||
160666870|NCT02545283|580160774|FG001|Overall Study|Death|211|||
160666871|NCT02545283|580160773|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
160666872|NCT02545283|580160774|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
160666873|NCT02545283|580160773|FG000|Overall Study|Study Terminated By Sponsor|33|||
160666874|NCT02545283|580160774|FG001|Overall Study|Study Terminated By Sponsor|71|||
160666875|NCT02436005|580160775|FG000|Second Intervention|Adverse Event|0|||
160666876|NCT02436005|580160776|FG001|Second Intervention|Adverse Event|1|||
160666877|NCT01558635|580160777|FG000|Overall Study|Death|1|||
160666878|NCT01558635|580160777|FG000|Overall Study|Withdrawal by Subject|2|||
160666879|NCT01558635|580160777|FG000|Overall Study|Physician Decision|1|||
160666880|NCT01558635|580160777|FG000|Overall Study|Subject received other treatment|1|||
160666881|NCT01558635|580160777|FG000|Overall Study|Reveal XT was explanted|1|||
160666882|NCT01735994|580160778|FG000|Overall Study|Withdrawal by Subject|6|||
160666883|NCT01735994|580160779|FG001|Overall Study|Withdrawal by Subject|4|||
160666884|NCT01735994|580160778|FG000|Overall Study|Injury|2|||
160666885|NCT01735994|580160779|FG001|Overall Study|Injury|0|||
160666886|NCT01735994|580160778|FG000|Overall Study|Kicked off team|5|||
160666887|NCT01735994|580160779|FG001|Overall Study|Kicked off team|0|||
160666888|NCT01735994|580160778|FG000|Overall Study|Lost to Follow-up|50|||
160666889|NCT01735994|580160779|FG001|Overall Study|Lost to Follow-up|62|||
160666890|NCT04994535|580160780|FG000|Overall Study|Lost to Follow-up|7|||
160666891|NCT04994535|580160781|FG001|Overall Study|Lost to Follow-up|7|||
160515806|NCT03038438|579618041|FG000|Overall Study|No 36-Month Follow-Up|18|||
160515807|NCT01174160|579618042|FG000|Overall Study|Adverse Event|1|||
160515808|NCT01174160|579618043|FG001|Overall Study|Adverse Event|0|||
160515809|NCT01174160|579618042|FG000|Overall Study|Lost to Follow-up|1|||
160515810|NCT01174160|579618043|FG001|Overall Study|Lost to Follow-up|0|||
160666892|NCT04994535|580160780|FG000|Overall Study|Withdrawal by Subject|10|||
160666893|NCT04994535|580160781|FG001|Overall Study|Withdrawal by Subject|7|||
160666894|NCT04994535|580160780|FG000|Overall Study|Other|1|||
160666895|NCT04994535|580160781|FG001|Overall Study|Other|1|||
160666896|NCT01158118|580160782|FG000|Overall Study|Screen failure|1|||
160666897|NCT01158118|580160783|FG001|Overall Study|Screen failure|0|||
160666898|NCT01158118|580160782|FG000|Overall Study|Donor match was a screen failure|0|||
160666899|NCT01158118|580160783|FG001|Overall Study|Donor match was a screen failure|1|||
160515811|NCT01174160|579618042|FG000|Overall Study|Physician Decision|1|||
160515812|NCT01174160|579618043|FG001|Overall Study|Physician Decision|0|||
160515813|NCT01174160|579618042|FG000|Overall Study|Protocol Violation|4|||
160515814|NCT01174160|579618043|FG001|Overall Study|Protocol Violation|6|||
160515815|NCT01174160|579618042|FG000|Overall Study|Withdrawal by Subject|1|||
160515816|NCT01174160|579618043|FG001|Overall Study|Withdrawal by Subject|0|||
160515817|NCT02038543|579618046|FG000|Overall Study|Screen Failure|0|||
160515818|NCT02038543|579618047|FG001|Overall Study|Screen Failure|0|||
160515819|NCT02038543|579618048|FG002|Overall Study|Screen Failure|0|||
160515820|NCT02038543|579618049|FG003|Overall Study|Screen Failure|1|||
160515821|NCT02038543|579618046|FG000|Overall Study|Withdrawal by Subject|0|||
160515822|NCT02038543|579618047|FG001|Overall Study|Withdrawal by Subject|0|||
160515823|NCT02038543|579618048|FG002|Overall Study|Withdrawal by Subject|0|||
160515824|NCT02038543|579618049|FG003|Overall Study|Withdrawal by Subject|1|||
160515825|NCT00093808|579618050|FG000|Overall Study|Cancel participation before receiving tx|1|||
160515826|NCT00093808|579618050|FG000|Overall Study|Protocol Violation|1|||
160515827|NCT03406260|579618051|FG000|Period 1|Adverse Event|0|||
160623625|NCT03099096|580001770|FG000|Overall Study|Physician Decision|1|||
160623626|NCT00361504|580001771|FG000|Overall Study|Withdrawal by Subject|94|||
160623627|NCT00361504|580001772|FG001|Overall Study|Withdrawal by Subject|31|||
160623628|NCT00361504|580001771|FG000|Overall Study|Lost to Follow-up|40|||
160623629|NCT00361504|580001772|FG001|Overall Study|Lost to Follow-up|7|||
160623630|NCT00361504|580001771|FG000|Overall Study|Adverse Event|203|||
160623631|NCT00361504|580001772|FG001|Overall Study|Adverse Event|82|||
160623632|NCT00361504|580001771|FG000|Overall Study|Lack of Efficacy|72|||
160623633|NCT00361504|580001772|FG001|Overall Study|Lack of Efficacy|7|||
160623634|NCT00361504|580001771|FG000|Overall Study|Resolution of Pain|2|||
160623635|NCT00361504|580001772|FG001|Overall Study|Resolution of Pain|0|||
160623636|NCT00361504|580001771|FG000|Overall Study|Study medication non compliant|42|||
160623637|NCT00361504|580001772|FG001|Overall Study|Study medication non compliant|15|||
160623638|NCT00361504|580001771|FG000|Overall Study|All other|28|||
160623639|NCT00361504|580001772|FG001|Overall Study|All other|3|||
160623640|NCT01374516|580001774|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
160623641|NCT01374516|580001775|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
160623642|NCT01374516|580001774|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
160623643|NCT01374516|580001775|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
160623644|NCT01374516|580001774|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
160623645|NCT01374516|580001775|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
160623646|NCT01374516|580001774|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
160623647|NCT01374516|580001775|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
160623648|NCT01374516|580001774|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
160623649|NCT01374516|580001775|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
160623650|NCT01374516|580001774|FG000|Surveillance Expansion Period|Protocol Violation|386|||
160623651|NCT01374516|580001775|FG001|Surveillance Expansion Period|Protocol Violation|217|||
160623652|NCT01374516|580001774|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
160623653|NCT01374516|580001775|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
160623654|NCT01374516|580001774|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
160623655|NCT01374516|580001775|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
160623656|NCT01374516|580001774|FG000|Surveillance Expansion Period|Serious adverse event|20|||
160623657|NCT01374516|580001775|FG001|Surveillance Expansion Period|Serious adverse event|5|||
160623658|NCT03125382|580001782|FG000|Randomization|screening failure|1|||
160623659|NCT03125382|580001783|FG001|Randomization|screening failure|4|||
160623660|NCT03125382|580001784|FG002|Randomization|screening failure|2|||
160623661|NCT03125382|580001785|FG003|Randomization|screening failure|0|||
160623662|NCT03125382|580001782|FG000|Follow-up|Death|1|||
160623663|NCT03125382|580001783|FG001|Follow-up|Death|2|||
160623664|NCT03125382|580001784|FG002|Follow-up|Death|1|||
160623665|NCT03125382|580001785|FG003|Follow-up|Death|2|||
160623666|NCT03125382|580001782|FG000|Follow-up|Lost to Follow-up|1|||
160623667|NCT03125382|580001783|FG001|Follow-up|Lost to Follow-up|4|||
160623668|NCT03125382|580001784|FG002|Follow-up|Lost to Follow-up|3|||
160623669|NCT03125382|580001785|FG003|Follow-up|Lost to Follow-up|1|||
160623670|NCT00612456|580001786|FG000|Overall Study|Adverse Event|1|||
160623671|NCT00612456|580001787|FG001|Overall Study|Adverse Event|0|||
160666900|NCT01158118|580160782|FG000|Overall Study|Suffered stroke prior to transplant|0|||
160666901|NCT01158118|580160783|FG001|Overall Study|Suffered stroke prior to transplant|1|||
160515828|NCT03406260|579618052|FG001|Period 1|Adverse Event|0|||
160515829|NCT03406260|579618053|FG002|Period 1|Adverse Event|0|||
160515830|NCT03406260|579618054|FG003|Period 1|Adverse Event|0|||
160515831|NCT03406260|579618055|FG004|Period 1|Adverse Event|1|||
160515832|NCT03406260|579618056|FG005|Period 1|Adverse Event|0|||
160515833|NCT02647866|579618057|FG000|Overall Study|Adverse Event|0|||
160515834|NCT02647866|579618058|FG001|Overall Study|Adverse Event|0|||
160515835|NCT02647866|579618059|FG002|Overall Study|Adverse Event|2|||
160515836|NCT02647866|579618060|FG003|Overall Study|Adverse Event|2|||
160623672|NCT00612456|580001788|FG002|Overall Study|Adverse Event|0|||
160623673|NCT00612456|580001786|FG000|Overall Study|Lack of Efficacy|1|||
160515837|NCT02647866|579618061|FG004|Overall Study|Adverse Event|1|||
160515838|NCT02647866|579618057|FG000|Overall Study|Disease Worsening|3|||
160515839|NCT02647866|579618058|FG001|Overall Study|Disease Worsening|1|||
160515840|NCT02647866|579618059|FG002|Overall Study|Disease Worsening|0|||
160515841|NCT02647866|579618060|FG003|Overall Study|Disease Worsening|0|||
160666902|NCT01158118|580160782|FG000|Overall Study|Death|0|||
160515842|NCT02647866|579618061|FG004|Overall Study|Disease Worsening|1|||
160515843|NCT02647866|579618057|FG000|Overall Study|Withdrawal by Subject|1|||
160515844|NCT02647866|579618058|FG001|Overall Study|Withdrawal by Subject|1|||
160515845|NCT02647866|579618059|FG002|Overall Study|Withdrawal by Subject|2|||
160515846|NCT02647866|579618060|FG003|Overall Study|Withdrawal by Subject|4|||
160515847|NCT02647866|579618061|FG004|Overall Study|Withdrawal by Subject|4|||
160515848|NCT02647866|579618057|FG000|Overall Study|Physician Decision|0|||
160515849|NCT02647866|579618058|FG001|Overall Study|Physician Decision|1|||
160515850|NCT02647866|579618059|FG002|Overall Study|Physician Decision|1|||
160515851|NCT02647866|579618060|FG003|Overall Study|Physician Decision|0|||
160515852|NCT02647866|579618061|FG004|Overall Study|Physician Decision|2|||
160515853|NCT02647866|579618057|FG000|Overall Study|Death|0|||
160515854|NCT02647866|579618058|FG001|Overall Study|Death|1|||
160515855|NCT02647866|579618059|FG002|Overall Study|Death|0|||
160515856|NCT02647866|579618060|FG003|Overall Study|Death|0|||
160515857|NCT02647866|579618061|FG004|Overall Study|Death|0|||
160515858|NCT02647866|579618057|FG000|Overall Study|Subject moved to different country|1|||
160515859|NCT02647866|579618058|FG001|Overall Study|Subject moved to different country|0|||
160515860|NCT02647866|579618059|FG002|Overall Study|Subject moved to different country|0|||
160515861|NCT02647866|579618060|FG003|Overall Study|Subject moved to different country|0|||
160515862|NCT02647866|579618061|FG004|Overall Study|Subject moved to different country|0|||
160515863|NCT00871780|579618062|FG000|Overall Study|Enrolled But Not Treated|6|||
160515864|NCT00871780|579618062|FG000|Overall Study|Withdrawal by Subject|9|||
160515865|NCT00871780|579618062|FG000|Overall Study|Adverse Event|6|||
160515866|NCT00871780|579618062|FG000|Overall Study|Voluntary Discontinuation|4|||
160515867|NCT00871780|579618062|FG000|Overall Study|Death|1|||
160515868|NCT00871780|579618062|FG000|Overall Study|Physician Decision|1|||
160515869|NCT02527343|579618066|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
160515870|NCT02527343|579618067|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
160515871|NCT02527343|579618068|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
160515872|NCT02527343|579618069|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
160515873|NCT02527343|579618070|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
160515874|NCT02527343|579618071|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
160515875|NCT02527343|579618066|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
160515876|NCT02527343|579618067|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
160515877|NCT02527343|579618068|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
160515878|NCT02527343|579618069|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
160515879|NCT02527343|579618070|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
160515880|NCT02527343|579618071|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
160515881|NCT02527343|579618066|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
160515882|NCT02527343|579618067|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
160515883|NCT02527343|579618068|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
160515884|NCT02527343|579618069|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
160515885|NCT02527343|579618070|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
160515886|NCT02527343|579618071|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
160515887|NCT02527343|579618066|FG000|RT Period: Weeks 1 to 52|Other|4|||
160515888|NCT02527343|579618067|FG001|RT Period: Weeks 1 to 52|Other|3|||
160515889|NCT02527343|579618068|FG002|RT Period: Weeks 1 to 52|Other|0|||
160515890|NCT02527343|579618069|FG003|RT Period: Weeks 1 to 52|Other|0|||
160515891|NCT02527343|579618070|FG004|RT Period: Weeks 1 to 52|Other|0|||
160515892|NCT02527343|579618071|FG005|RT Period: Weeks 1 to 52|Other|0|||
160515893|NCT02527343|579618066|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
160515894|NCT02527343|579618067|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
160515895|NCT02527343|579618068|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
160515896|NCT02527343|579618069|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
160515897|NCT02527343|579618070|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
160515898|NCT02527343|579618071|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
160515899|NCT02527343|579618066|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
160515900|NCT02527343|579618067|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
160515901|NCT02527343|579618068|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
160515902|NCT02527343|579618069|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
160515903|NCT02527343|579618070|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
160515904|NCT02527343|579618071|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
160515905|NCT02527343|579618066|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
160515906|NCT02527343|579618067|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
160515907|NCT02527343|579618068|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
160666903|NCT01158118|580160783|FG001|Overall Study|Death|1|||
160515908|NCT02527343|579618069|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
160515909|NCT02527343|579618070|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
160515910|NCT02527343|579618071|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
160515911|NCT02527343|579618066|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
160515912|NCT02527343|579618067|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
160515913|NCT02527343|579618068|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
160515914|NCT02527343|579618069|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
160515915|NCT02527343|579618070|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
160515916|NCT02527343|579618071|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
160515917|NCT02527343|579618066|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
160515918|NCT02527343|579618067|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
160515919|NCT02527343|579618068|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
160515920|NCT02527343|579618069|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
160515921|NCT02527343|579618070|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
160515922|NCT02527343|579618071|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
160515923|NCT02527343|579618066|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
160515924|NCT02527343|579618067|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
160515925|NCT02527343|579618068|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
160515926|NCT02527343|579618069|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
160515927|NCT02527343|579618070|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
160623674|NCT00612456|580001787|FG001|Overall Study|Lack of Efficacy|1|||
160623675|NCT00612456|580001788|FG002|Overall Study|Lack of Efficacy|0|||
160623676|NCT00612456|580001786|FG000|Overall Study|Withdrawal by Subject|0|||
160623677|NCT00612456|580001787|FG001|Overall Study|Withdrawal by Subject|1|||
160623678|NCT00612456|580001788|FG002|Overall Study|Withdrawal by Subject|0|||
160623679|NCT00808665|580001791|FG000|Overall Study|Withdrawal by Subject|1|||
160623680|NCT00808665|580001792|FG001|Overall Study|Withdrawal by Subject|0|||
160623681|NCT00808665|580001791|FG000|Overall Study|only required minimally invasive surgery|1|||
160623682|NCT00808665|580001792|FG001|Overall Study|only required minimally invasive surgery|0|||
160623683|NCT00808665|580001791|FG000|Overall Study|surgery cancelled|1|||
160623684|NCT00808665|580001792|FG001|Overall Study|surgery cancelled|0|||
160623685|NCT00808665|580001791|FG000|Overall Study|required an additional procedure|0|||
160623686|NCT00808665|580001792|FG001|Overall Study|required an additional procedure|1|||
160623687|NCT00808665|580001791|FG000|Overall Study|Physician Decision|3|||
160623688|NCT00808665|580001792|FG001|Overall Study|Physician Decision|1|||
160623689|NCT00808665|580001791|FG000|Overall Study|Medication stopped by resident|0|||
160623690|NCT00808665|580001792|FG001|Overall Study|Medication stopped by resident|1|||
160623691|NCT01757821|580001793|FG000|Overall Study|Adverse Event|1|||
160623692|NCT03831282|580001796|FG000|Overall Study|Could not place sensor|1|||
160623693|NCT00334893|580001797|FG000|Overall Study|Not Treated|1|||
160623694|NCT00334893|580001798|FG001|Overall Study|Not Treated|0|||
160623695|NCT00678652|580001801|FG000|Overall Study|Protocol Violation|2|||
160623696|NCT00678652|580001802|FG001|Overall Study|Protocol Violation|0|||
160623697|NCT00678652|580001803|FG002|Overall Study|Protocol Violation|0|||
160623698|NCT00678652|580001804|FG003|Overall Study|Protocol Violation|0|||
160623699|NCT00678652|580001801|FG000|Overall Study|Pregnancy|0|||
160623700|NCT00678652|580001802|FG001|Overall Study|Pregnancy|0|||
160623701|NCT00678652|580001803|FG002|Overall Study|Pregnancy|1|||
160623702|NCT00678652|580001804|FG003|Overall Study|Pregnancy|0|||
160623703|NCT00678652|580001801|FG000|Overall Study|Relocation|1|||
160623704|NCT00678652|580001802|FG001|Overall Study|Relocation|0|||
160623705|NCT00678652|580001803|FG002|Overall Study|Relocation|0|||
160623706|NCT00678652|580001804|FG003|Overall Study|Relocation|0|||
160623707|NCT03319160|580001805|FG000|Overall Study|Data not available.|7|||
160623708|NCT03604159|580001806|FG000|Overall Study|Lost to Follow-up|6|||
160623709|NCT03604159|580001807|FG001|Overall Study|Lost to Follow-up|7|||
160623710|NCT00665002|580001808|FG000|Overall Study|Progression/relapse during treatment|11|||
160623711|NCT00665002|580001808|FG000|Overall Study|Cytogenetic resistance|1|||
160623712|NCT00383292|580001811|FG000|Overall Study|Adverse Event|4|||
160623713|NCT00383292|580001812|FG001|Overall Study|Adverse Event|1|||
160623714|NCT00383292|580001813|FG002|Overall Study|Adverse Event|2|||
160623715|NCT00383292|580001811|FG000|Overall Study|Death|3|||
160623716|NCT00383292|580001812|FG001|Overall Study|Death|3|||
160623717|NCT00383292|580001813|FG002|Overall Study|Death|3|||
160623718|NCT00383292|580001811|FG000|Overall Study|Physician Decision|4|||
160623719|NCT00383292|580001812|FG001|Overall Study|Physician Decision|0|||
160623720|NCT00383292|580001813|FG002|Overall Study|Physician Decision|1|||
160623721|NCT00383292|580001811|FG000|Overall Study|Withdrawal by Subject|3|||
160623722|NCT00383292|580001812|FG001|Overall Study|Withdrawal by Subject|2|||
160623723|NCT00383292|580001813|FG002|Overall Study|Withdrawal by Subject|2|||
160623724|NCT00383292|580001811|FG000|Overall Study|Other|1|||
160623725|NCT00383292|580001812|FG001|Overall Study|Other|0|||
160623726|NCT00383292|580001813|FG002|Overall Study|Other|0|||
160623727|NCT00736840|580001816|FG000|Overall Study|Lost to Follow-up|13|||
160515928|NCT02527343|579618071|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
160515929|NCT02527343|579618066|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
160515930|NCT02527343|579618067|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
160515931|NCT02527343|579618068|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
160515932|NCT02527343|579618069|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
160515933|NCT02527343|579618070|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
160515934|NCT02527343|579618071|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
160515935|NCT02527343|579618066|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
160515936|NCT02527343|579618067|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
160515937|NCT02527343|579618068|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
160515938|NCT02527343|579618069|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
160515939|NCT02527343|579618070|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
160515940|NCT02527343|579618071|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
160515941|NCT02527343|579618066|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
160515942|NCT02527343|579618067|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
160515943|NCT02527343|579618068|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
160515944|NCT02527343|579618069|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
160515945|NCT02527343|579618070|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
160515946|NCT02527343|579618071|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
160515947|NCT05767021|579618072|FG000|Overall Study|Adverse Event|2|||
160515948|NCT05767021|579618072|FG000|Overall Study|Protocol Deviation|1|||
160515949|NCT05767021|579618072|FG000|Overall Study|Withdrawal by Subject|1|||
160515950|NCT05767021|579618072|FG000|Overall Study|Physician Decision|1|||
160515951|NCT05767021|579618072|FG000|Overall Study|Lack of Efficacy|11|||
160515952|NCT05767021|579618072|FG000|Overall Study|Assigned Treatment by Mistake|1|||
160515953|NCT00523640|579618077|FG000|Overall Study|Death|1|||
160515954|NCT02334423|579618080|FG000|Overall Study|Protocol Violation|10|||
160515955|NCT02334423|579618081|FG001|Overall Study|Protocol Violation|3|||
160515956|NCT04426851|579618082|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
160515957|NCT04426851|579618083|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
160515958|NCT04426851|579618082|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
160515959|NCT04426851|579618083|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
160515960|NCT02054741|579618084|FG000|Overall Study|Protocol Violation|13|||
160515961|NCT02054741|579618085|FG001|Overall Study|Protocol Violation|2|||
160515962|NCT02054741|579618084|FG000|Overall Study|Withdrawal by Subject|10|||
160515963|NCT02054741|579618085|FG001|Overall Study|Withdrawal by Subject|5|||
160515964|NCT02054741|579618084|FG000|Overall Study|Death|94|||
160515965|NCT02054741|579618085|FG001|Overall Study|Death|90|||
160515966|NCT02054741|579618084|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
160515967|NCT02054741|579618085|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
160515968|NCT01098097|579618086|FG000|Overall Study|Adverse Event|17|||
160515969|NCT01098097|579618086|FG000|Overall Study|Lost to Follow-up|18|||
160515970|NCT01098097|579618086|FG000|Overall Study|Status unknown|16|||
160515971|NCT01098097|579618086|FG000|Overall Study|No reason reported|31|||
160515972|NCT00394082|579618087|FG000|Overall Study|Unacceptable toxicity|15|||
160515973|NCT00394082|579618087|FG000|Overall Study|Adverse Event|4|||
160515974|NCT00394082|579618087|FG000|Overall Study|Physician Decision|4|||
160515975|NCT00394082|579618087|FG000|Overall Study|Withdrawal by Subject|2|||
160515976|NCT00394082|579618087|FG000|Overall Study|Other|1|||
160515977|NCT02344004|579618089|FG000|Overall Study|Adverse Event|11|||
160515978|NCT02344004|579618090|FG001|Overall Study|Adverse Event|1|||
160515979|NCT02344004|579618089|FG000|Overall Study|Death|9|||
160515980|NCT02344004|579618090|FG001|Overall Study|Death|7|||
160515981|NCT02344004|579618089|FG000|Overall Study|Physician Decision|4|||
160515982|NCT02344004|579618090|FG001|Overall Study|Physician Decision|1|||
160515983|NCT02344004|579618089|FG000|Overall Study|Withdrawal by Subject|22|||
160515984|NCT02344004|579618090|FG001|Overall Study|Withdrawal by Subject|5|||
160515985|NCT02344004|579618089|FG000|Overall Study|Rescue Medication|2|||
160515986|NCT02344004|579618090|FG001|Overall Study|Rescue Medication|0|||
160515987|NCT02344004|579618089|FG000|Overall Study|Other Not Specified|12|||
160515988|NCT02344004|579618090|FG001|Overall Study|Other Not Specified|0|||
160515989|NCT02344004|579618089|FG000|Overall Study|Protocol Violation|1|||
160515990|NCT02344004|579618090|FG001|Overall Study|Protocol Violation|0|||
160515991|NCT01768117|579618091|FG000|Overall Study|Lost to Follow-up|1|||
160515992|NCT01768117|579618091|FG000|Overall Study|Withdrawal by Subject|2|||
160515993|NCT01768117|579618091|FG000|Overall Study|Protocol Violation|3|||
160515994|NCT01502631|579618092|FG000|Overall Study|Adverse Event|5|||
160515995|NCT01502631|579618093|FG001|Overall Study|Adverse Event|8|||
160515996|NCT01502631|579618092|FG000|Overall Study|Lost to Follow-up|2|||
160515997|NCT01502631|579618093|FG001|Overall Study|Lost to Follow-up|2|||
160515998|NCT01502631|579618092|FG000|Overall Study|Participant withdrew consent|2|||
160515999|NCT01502631|579618093|FG001|Overall Study|Participant withdrew consent|4|||
160516000|NCT01502631|579618092|FG000|Overall Study|Participant non-compliant|1|||
160516001|NCT01502631|579618093|FG001|Overall Study|Participant non-compliant|0|||
160516002|NCT01502631|579618092|FG000|Overall Study|Investigator's decision|0|||
160516003|NCT01502631|579618093|FG001|Overall Study|Investigator's decision|1|||
160516004|NCT01502631|579618092|FG000|Overall Study|Other|10|||
160516005|NCT01502631|579618093|FG001|Overall Study|Other|5|||
160516006|NCT01945060|579618094|FG000|Overall Study|Lost to follow up|1|||
160516007|NCT01945060|579618095|FG001|Overall Study|Lost to follow up|0|||
160516008|NCT01945060|579618094|FG000|Overall Study|Distress related to IV access|0|||
160516009|NCT01945060|579618095|FG001|Overall Study|Distress related to IV access|1|||
160516010|NCT00138671|579618098|FG000|Overall Study|Death|0|||
160516011|NCT00138671|579618099|FG001|Overall Study|Death|3|||
160516012|NCT00138671|579618098|FG000|Overall Study|Adverse Event|6|||
160516013|NCT00138671|579618099|FG001|Overall Study|Adverse Event|3|||
160516014|NCT00138671|579618098|FG000|Overall Study|Lost to Follow-up|1|||
160516015|NCT00138671|579618099|FG001|Overall Study|Lost to Follow-up|2|||
160516016|NCT00138671|579618098|FG000|Overall Study|Withdrawal by Subject|3|||
160516017|NCT00138671|579618099|FG001|Overall Study|Withdrawal by Subject|5|||
160516018|NCT00138671|579618098|FG000|Overall Study|Other|3|||
160516019|NCT00138671|579618099|FG001|Overall Study|Other|3|||
160516020|NCT01488487|579618102|FG000|Overall Study|Adverse Event|6|||
160516021|NCT01488487|579618102|FG000|Overall Study|Death|1|||
160516022|NCT01488487|579618102|FG000|Overall Study|Withdrawal by Subject|2|||
160516023|NCT00395460|579618103|FG000|Overall Study|Withdrawal by Subject|1|||
160516024|NCT00395460|579618104|FG001|Overall Study|Withdrawal by Subject|0|||
160623728|NCT02815670|580001817|FG000|Overall Study|Prematurely discontinued of the trial|1|||
160623729|NCT01815099|580001820|FG000|Overall Study|Lack of Efficacy|1|||
160623730|NCT01815099|580001820|FG000|Overall Study|unable to attend study visits|1|||
160623731|NCT01475214|580001821|FG000|Overall Study|Lost to Follow-up|1|||
160623732|NCT01475214|580001822|FG001|Overall Study|Lost to Follow-up|0|||
160623733|NCT01475214|580001823|FG002|Overall Study|Lost to Follow-up|1|||
160623734|NCT01475214|580001821|FG000|Overall Study|Physician Decision|2|||
160623735|NCT01475214|580001822|FG001|Overall Study|Physician Decision|0|||
160623736|NCT01475214|580001823|FG002|Overall Study|Physician Decision|0|||
160623737|NCT01475214|580001821|FG000|Overall Study|Withdrawal by Subject|2|||
160623738|NCT01475214|580001822|FG001|Overall Study|Withdrawal by Subject|4|||
160623739|NCT01475214|580001823|FG002|Overall Study|Withdrawal by Subject|1|||
160623740|NCT00643851|580001824|FG000|Overall Study|Death|0|||
160623741|NCT00643851|580001825|FG001|Overall Study|Death|1|||
160623742|NCT00643851|580001826|FG002|Overall Study|Death|0|||
160623743|NCT00643851|580001824|FG000|Overall Study|Lack of Efficacy|0|||
160623744|NCT00643851|580001825|FG001|Overall Study|Lack of Efficacy|1|||
160623745|NCT00643851|580001826|FG002|Overall Study|Lack of Efficacy|0|||
160623746|NCT00643851|580001824|FG000|Overall Study|Adverse Event|2|||
160623747|NCT00643851|580001825|FG001|Overall Study|Adverse Event|6|||
160623748|NCT00643851|580001826|FG002|Overall Study|Adverse Event|6|||
160623749|NCT00643851|580001824|FG000|Overall Study|Lost to Follow-up|4|||
160623750|NCT00643851|580001825|FG001|Overall Study|Lost to Follow-up|6|||
160623751|NCT00643851|580001826|FG002|Overall Study|Lost to Follow-up|9|||
160623752|NCT00643851|580001824|FG000|Overall Study|Withdrawal by Subject|8|||
160623753|NCT00643851|580001825|FG001|Overall Study|Withdrawal by Subject|15|||
160623754|NCT00643851|580001826|FG002|Overall Study|Withdrawal by Subject|9|||
160623755|NCT00643851|580001824|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
160623756|NCT00643851|580001825|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
160623757|NCT00643851|580001826|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
160623758|NCT03289676|580001829|FG000|Overall Study|Withdrawal by Subject|2|||
160623759|NCT03289676|580001830|FG001|Overall Study|Withdrawal by Subject|0|||
160623760|NCT03289676|580001829|FG000|Overall Study|Protocol Violation|2|||
160623761|NCT03289676|580001830|FG001|Overall Study|Protocol Violation|0|||
160623762|NCT03289676|580001829|FG000|Overall Study|Lost to Follow-up|0|||
160623763|NCT03289676|580001830|FG001|Overall Study|Lost to Follow-up|1|||
160623764|NCT04806334|580001831|FG000|Overall Study|Withdrawal by Subject|1|||
160623765|NCT01636076|580001832|FG000|Overall Study|Terminated by sponsor|1|||
160623766|NCT01636076|580001833|FG001|Overall Study|Terminated by sponsor|1|||
160623767|NCT01636076|580001832|FG000|Overall Study|Lack of Efficacy|0|||
160623768|NCT01636076|580001833|FG001|Overall Study|Lack of Efficacy|1|||
160623769|NCT01636076|580001832|FG000|Overall Study|Lost to Follow-up|1|||
160623770|NCT01636076|580001833|FG001|Overall Study|Lost to Follow-up|0|||
160623771|NCT01636076|580001832|FG000|Overall Study|Physician Decision|1|||
160623772|NCT01636076|580001833|FG001|Overall Study|Physician Decision|1|||
160623773|NCT01636076|580001832|FG000|Overall Study|Non-compliance with study treatment|1|||
160623774|NCT01636076|580001833|FG001|Overall Study|Non-compliance with study treatment|1|||
160623775|NCT01636076|580001832|FG000|Overall Study|Adverse Event|6|||
160623776|NCT01636076|580001833|FG001|Overall Study|Adverse Event|11|||
160666904|NCT00604162|580160784|FG000|Overall Study|Physician Decision|3|||
160516025|NCT04223830|579618111|FG000|Overall Study|Lost to Follow-up|9|||
160516026|NCT04223830|579618111|FG000|Overall Study|Adverse Event|1|||
160516027|NCT01034163|579618112|FG000|Overall Study|Treatment completed as per protocol|8|||
160516028|NCT01034163|579618113|FG001|Overall Study|Treatment completed as per protocol|7|||
160516029|NCT01034163|579618112|FG000|Overall Study|Withdrawal by Subject|8|||
160623777|NCT01636076|580001832|FG000|Overall Study|Withdrawal by Subject|7|||
160623778|NCT01636076|580001833|FG001|Overall Study|Withdrawal by Subject|10|||
160666905|NCT00604162|580160784|FG000|Overall Study|Withdrawal by Subject|1|||
160516030|NCT01034163|579618113|FG001|Overall Study|Withdrawal by Subject|2|||
160516031|NCT01034163|579618112|FG000|Overall Study|Protocol deviation|1|||
160516032|NCT01034163|579618113|FG001|Overall Study|Protocol deviation|0|||
160516033|NCT01034163|579618112|FG000|Overall Study|Disease progression|3|||
160516034|NCT01034163|579618113|FG001|Overall Study|Disease progression|4|||
160516035|NCT01034163|579618112|FG000|Overall Study|Adverse Event|6|||
160516036|NCT01034163|579618113|FG001|Overall Study|Adverse Event|0|||
160516037|NCT01034163|579618112|FG000|Overall Study|Administrative problems|0|||
160516038|NCT01034163|579618113|FG001|Overall Study|Administrative problems|1|||
160516039|NCT01034163|579618112|FG000|Overall Study|Abnormal laboratory value|1|||
160516040|NCT01034163|579618113|FG001|Overall Study|Abnormal laboratory value|0|||
160516041|NCT00190749|579618118|FG000|Overall Study|Lost to Follow-up|8|||
160516042|NCT00190749|579618119|FG001|Overall Study|Lost to Follow-up|11|||
160516043|NCT00190749|579618118|FG000|Overall Study|Withdrawal by Subject|10|||
160516044|NCT00190749|579618119|FG001|Overall Study|Withdrawal by Subject|6|||
160516045|NCT00190749|579618118|FG000|Overall Study|Protocol Violation|5|||
160516046|NCT00190749|579618119|FG001|Overall Study|Protocol Violation|4|||
160516047|NCT00190749|579618118|FG000|Overall Study|Adverse Event|0|||
160516048|NCT00190749|579618119|FG001|Overall Study|Adverse Event|5|||
160516049|NCT00190749|579618118|FG000|Overall Study|Lack of Efficacy|2|||
160516050|NCT00190749|579618119|FG001|Overall Study|Lack of Efficacy|3|||
160516051|NCT00190749|579618118|FG000|Overall Study|Reason Not Specified|0|||
160516052|NCT00190749|579618119|FG001|Overall Study|Reason Not Specified|2|||
160516053|NCT00190749|579618118|FG000|Overall Study|Sponsor Decision|1|||
160516054|NCT00190749|579618119|FG001|Overall Study|Sponsor Decision|0|||
160516055|NCT02729753|579618120|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
160516056|NCT02729753|579618121|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
160516057|NCT01090427|579618122|FG000|After Controlled Period|Death|0|||
160516058|NCT01090427|579618123|FG001|After Controlled Period|Death|0|||
160516059|NCT01090427|579618124|FG002|After Controlled Period|Death|0|||
160666906|NCT00968812|580160787|FG000|Overall Study|Adverse Event|30|||
160666907|NCT00968812|580160788|FG001|Overall Study|Adverse Event|46|||
160666908|NCT00968812|580160789|FG002|Overall Study|Adverse Event|33|||
160666909|NCT00968812|580160787|FG000|Overall Study|Death|2|||
160666910|NCT00968812|580160788|FG001|Overall Study|Death|2|||
160666911|NCT00968812|580160789|FG002|Overall Study|Death|1|||
160666912|NCT00968812|580160787|FG000|Overall Study|Lack of Efficacy|9|||
160666913|NCT00968812|580160788|FG001|Overall Study|Lack of Efficacy|7|||
160666914|NCT00968812|580160789|FG002|Overall Study|Lack of Efficacy|16|||
160666915|NCT00968812|580160787|FG000|Overall Study|Lost to Follow-up|17|||
160666916|NCT00968812|580160788|FG001|Overall Study|Lost to Follow-up|12|||
160666917|NCT00968812|580160789|FG002|Overall Study|Lost to Follow-up|11|||
160666918|NCT00968812|580160787|FG000|Overall Study|Physician Decision|8|||
160666919|NCT00968812|580160788|FG001|Overall Study|Physician Decision|5|||
160666920|NCT00968812|580160789|FG002|Overall Study|Physician Decision|9|||
160666921|NCT00968812|580160787|FG000|Overall Study|Protocol Violation|7|||
160666922|NCT00968812|580160788|FG001|Overall Study|Protocol Violation|4|||
160666923|NCT00968812|580160789|FG002|Overall Study|Protocol Violation|3|||
160666924|NCT00968812|580160787|FG000|Overall Study|Withdrawal by Subject|17|||
160666925|NCT00968812|580160788|FG001|Overall Study|Withdrawal by Subject|23|||
160666926|NCT00968812|580160789|FG002|Overall Study|Withdrawal by Subject|25|||
160666927|NCT00968812|580160787|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
160666928|NCT00968812|580160788|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
160666929|NCT00968812|580160789|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
160666930|NCT00968812|580160787|FG000|Overall Study|Noncompliance with study drug|4|||
160666931|NCT00968812|580160788|FG001|Overall Study|Noncompliance with study drug|1|||
160666932|NCT00968812|580160789|FG002|Overall Study|Noncompliance with study drug|6|||
160666933|NCT00968812|580160787|FG000|Overall Study|Unable to take rescue therapy|12|||
160666934|NCT00968812|580160788|FG001|Overall Study|Unable to take rescue therapy|12|||
160666935|NCT00968812|580160789|FG002|Overall Study|Unable to take rescue therapy|17|||
160666936|NCT00968812|580160787|FG000|Overall Study|Other|25|||
160516060|NCT01090427|579618125|FG003|After Controlled Period|Death|0|||
160516061|NCT01090427|579618126|FG004|After Controlled Period|Death|0|||
160516062|NCT01090427|579618127|FG005|After Controlled Period|Death|1|||
160516063|NCT01090427|579618128|FG006|After Controlled Period|Death|0|||
160516064|NCT01090427|579618122|FG000|After Controlled Period|Lack of Efficacy|0|||
160516065|NCT01090427|579618123|FG001|After Controlled Period|Lack of Efficacy|0|||
160516066|NCT01090427|579618124|FG002|After Controlled Period|Lack of Efficacy|0|||
160516067|NCT01090427|579618125|FG003|After Controlled Period|Lack of Efficacy|0|||
160516068|NCT01090427|579618126|FG004|After Controlled Period|Lack of Efficacy|0|||
160516069|NCT01090427|579618127|FG005|After Controlled Period|Lack of Efficacy|3|||
160666937|NCT00968812|580160788|FG001|Overall Study|Other|37|||
160666938|NCT00968812|580160789|FG002|Overall Study|Other|40|||
160666939|NCT00834340|580160790|FG000|Washout|Adverse Event|1|||
160666940|NCT00834340|580160791|FG001|Washout|Adverse Event|0|||
160666941|NCT00834340|580160790|FG000|Washout|Withdrawal by Subject|1|||
160666942|NCT00834340|580160791|FG001|Washout|Withdrawal by Subject|0|||
160666943|NCT00395694|580160794|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
160666944|NCT00395694|580160795|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
160666945|NCT00395694|580160794|FG000|Continuation Phase|Adverse Event|1|||
160666946|NCT00395694|580160795|FG001|Continuation Phase|Adverse Event|0|||
160666947|NCT00395694|580160794|FG000|Continuation Phase|Lack of Efficacy|12|||
160666948|NCT00395694|580160795|FG001|Continuation Phase|Lack of Efficacy|11|||
160666949|NCT00395694|580160794|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
160666950|NCT00395694|580160795|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
160666951|NCT00395694|580160794|FG000|Continuation Phase|Poor Compliance|1|||
160666952|NCT00395694|580160795|FG001|Continuation Phase|Poor Compliance|0|||
160666953|NCT00395694|580160794|FG000|Continuation Phase|Withdrawal by Subject|0|||
160666954|NCT00395694|580160795|FG001|Continuation Phase|Withdrawal by Subject|2|||
160666955|NCT04238754|580160797|FG000|Washout - 1 Week|Lost to Follow-up|1|||
160666956|NCT04238754|580160798|FG001|Washout - 1 Week|Lost to Follow-up|0|||
160666957|NCT01175018|580160807|FG000|Overall Study|Adverse Event|3|||
160666958|NCT01175018|580160808|FG001|Overall Study|Adverse Event|1|||
160666959|NCT00835263|580160814|FG000|Second Intervention|Adverse Event|1|||
160666960|NCT00835263|580160815|FG001|Second Intervention|Adverse Event|0|||
160666961|NCT03249454|580160816|FG000|Overall Study|Withdrawal by Subject|0|||
160666962|NCT03249454|580160817|FG001|Overall Study|Withdrawal by Subject|0|||
160666963|NCT03249454|580160818|FG002|Overall Study|Withdrawal by Subject|0|||
160666964|NCT03249454|580160819|FG003|Overall Study|Withdrawal by Subject|0|||
160666965|NCT03249454|580160820|FG004|Overall Study|Withdrawal by Subject|0|||
160666966|NCT03249454|580160821|FG005|Overall Study|Withdrawal by Subject|0|||
160666967|NCT03249454|580160822|FG006|Overall Study|Withdrawal by Subject|0|||
160666968|NCT03249454|580160823|FG007|Overall Study|Withdrawal by Subject|0|||
160666969|NCT03249454|580160824|FG008|Overall Study|Withdrawal by Subject|0|||
160666970|NCT03249454|580160825|FG009|Overall Study|Withdrawal by Subject|1|||
160666971|NCT03249454|580160826|FG010|Overall Study|Withdrawal by Subject|1|||
160666972|NCT01913405|580160827|FG000|Overall Study|Withdrawal by Subject|1|||
160666973|NCT01913405|580160827|FG000|Overall Study|Adverse Event|1|||
160666974|NCT03987191|580160830|FG000|Overall Study|COVID-19 related research disruption|0|||
160666975|NCT03987191|580160831|FG001|Overall Study|COVID-19 related research disruption|2|||
160666976|NCT01020474|580160832|FG000|Overall Study|Adverse Event|4|||
160666977|NCT01020474|580160833|FG001|Overall Study|Adverse Event|4|||
160666978|NCT01020474|580160832|FG000|Overall Study|Protocol Violation|0|||
160666979|NCT01020474|580160833|FG001|Overall Study|Protocol Violation|2|||
160666980|NCT01020474|580160832|FG000|Overall Study|Withdrawal by Subject|5|||
160666981|NCT01020474|580160833|FG001|Overall Study|Withdrawal by Subject|7|||
160666982|NCT01020474|580160832|FG000|Overall Study|Other Reasons|1|||
160666983|NCT01020474|580160833|FG001|Overall Study|Other Reasons|1|||
160666984|NCT01020474|580160832|FG000|Overall Study|Insufficient Clinical Response|0|||
160666985|NCT01020474|580160833|FG001|Overall Study|Insufficient Clinical Response|3|||
160666986|NCT02689505|580160838|FG000|Overall Study|Progressive disease|2|||
160666987|NCT02689505|580160839|FG001|Overall Study|Progressive disease|2|||
160666988|NCT02689505|580160840|FG002|Overall Study|Progressive disease|3|||
160666989|NCT02689505|580160841|FG003|Overall Study|Progressive disease|9|||
160666990|NCT02689505|580160842|FG004|Overall Study|Progressive disease|1|||
160666991|NCT02689505|580160838|FG000|Overall Study|Dose Limiting Toxicity|0|||
160666992|NCT02689505|580160839|FG001|Overall Study|Dose Limiting Toxicity|1|||
160666993|NCT02689505|580160840|FG002|Overall Study|Dose Limiting Toxicity|0|||
160666994|NCT02689505|580160841|FG003|Overall Study|Dose Limiting Toxicity|0|||
160666995|NCT02689505|580160842|FG004|Overall Study|Dose Limiting Toxicity|2|||
160666996|NCT02689505|580160838|FG000|Overall Study|Other AE or clinical progression|0|||
160666997|NCT02689505|580160839|FG001|Overall Study|Other AE or clinical progression|2|||
160666998|NCT02689505|580160840|FG002|Overall Study|Other AE or clinical progression|0|||
160666999|NCT02689505|580160841|FG003|Overall Study|Other AE or clinical progression|2|||
160667000|NCT02689505|580160842|FG004|Overall Study|Other AE or clinical progression|0|||
160667001|NCT04887415|580160848|FG000|Overall Study|Lost to Follow-up|2|||
160667002|NCT05646251|580160849|FG000|Overall Study|Physician Decision|1|||
160667003|NCT05646251|580160850|FG001|Overall Study|Physician Decision|0|||
160667004|NCT05646251|580160851|FG002|Overall Study|Physician Decision|2|||
160667005|NCT03792477|580160852|FG000|Overall Study|Adverse Event|0|||
160667006|NCT03792477|580160853|FG001|Overall Study|Adverse Event|0|||
160667007|NCT03792477|580160854|FG002|Overall Study|Adverse Event|0|||
160667008|NCT03792477|580160855|FG003|Overall Study|Adverse Event|1|||
160667009|NCT03792477|580160856|FG004|Overall Study|Adverse Event|0|||
160667010|NCT03792477|580160852|FG000|Overall Study|Lost to Follow-up|0|||
160667011|NCT03792477|580160853|FG001|Overall Study|Lost to Follow-up|0|||
160667012|NCT03792477|580160854|FG002|Overall Study|Lost to Follow-up|2|||
160667013|NCT03792477|580160855|FG003|Overall Study|Lost to Follow-up|0|||
160667014|NCT03792477|580160856|FG004|Overall Study|Lost to Follow-up|0|||
160667015|NCT03792477|580160852|FG000|Overall Study|Other|0|||
160667016|NCT03792477|580160853|FG001|Overall Study|Other|0|||
160667017|NCT03792477|580160854|FG002|Overall Study|Other|0|||
160667018|NCT03792477|580160855|FG003|Overall Study|Other|0|||
160667019|NCT03792477|580160856|FG004|Overall Study|Other|1|||
160667020|NCT00840411|580160857|FG000|First Intervention|Adverse Event|1|||
160667021|NCT00840411|580160858|FG001|First Intervention|Adverse Event|0|||
160667022|NCT00840411|580160857|FG000|Washout|Withdrawal by Subject|1|||
160667023|NCT00840411|580160858|FG001|Washout|Withdrawal by Subject|0|||
160667024|NCT00651820|580160861|FG000|Overall Study|Lost to Follow-up|2|||
160667025|NCT00657553|580160865|FG000|Overall Study|low accrual, no analysis run|5|||
160667026|NCT00657553|580160866|FG001|Overall Study|low accrual, no analysis run|5|||
160667027|NCT01566721|580160867|FG000|Treatment Period|Withdrawal by Subject|35|||
160667028|NCT01566721|580160868|FG001|Treatment Period|Withdrawal by Subject|9|||
160667029|NCT01566721|580160867|FG000|Treatment Period|Disease Progression/Recurrence|37|||
160667030|NCT01566721|580160868|FG001|Treatment Period|Disease Progression/Recurrence|13|||
160667031|NCT01566721|580160867|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
160667032|NCT01566721|580160868|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
160667033|NCT01566721|580160867|FG000|Treatment Period|Other|13|||
160667034|NCT01566721|580160868|FG001|Treatment Period|Other|2|||
160667035|NCT01566721|580160867|FG000|Treatment Period|Lack of Compliance|5|||
160667036|NCT01566721|580160868|FG001|Treatment Period|Lack of Compliance|1|||
160667037|NCT01566721|580160867|FG000|Treatment Period|Adverse Event|100|||
160667038|NCT01566721|580160868|FG001|Treatment Period|Adverse Event|30|||
160667039|NCT01566721|580160867|FG000|Treatment Period|Pregnancy|1|||
160667040|NCT01566721|580160868|FG001|Treatment Period|Pregnancy|0|||
160667041|NCT01566721|580160867|FG000|Safety Follow-up|Physician Decision|6|||
160667042|NCT01566721|580160868|FG001|Safety Follow-up|Physician Decision|4|||
160667043|NCT01566721|580160867|FG000|Safety Follow-up|Lost to Follow-up|101|||
160667044|NCT01566721|580160868|FG001|Safety Follow-up|Lost to Follow-up|48|||
160667045|NCT01566721|580160867|FG000|Safety Follow-up|Withdrawal by Subject|155|||
160667046|NCT01566721|580160868|FG001|Safety Follow-up|Withdrawal by Subject|49|||
160667047|NCT01566721|580160867|FG000|Safety Follow-up|Death|28|||
160516070|NCT01090427|579618128|FG006|After Controlled Period|Lack of Efficacy|2|||
160516071|NCT01090427|579618122|FG000|After Controlled Period|Adverse Event|0|||
160516072|NCT01090427|579618123|FG001|After Controlled Period|Adverse Event|0|||
160516073|NCT01090427|579618124|FG002|After Controlled Period|Adverse Event|0|||
160516074|NCT01090427|579618125|FG003|After Controlled Period|Adverse Event|2|||
160516075|NCT01090427|579618126|FG004|After Controlled Period|Adverse Event|0|||
160516076|NCT01090427|579618127|FG005|After Controlled Period|Adverse Event|1|||
160516077|NCT01090427|579618128|FG006|After Controlled Period|Adverse Event|0|||
160516078|NCT01154010|579618129|FG000|Overall Study|Lost to Follow-up|0|||
160516079|NCT01154010|579618130|FG001|Overall Study|Lost to Follow-up|1|||
160667048|NCT01566721|580160868|FG001|Safety Follow-up|Death|4|||
160667049|NCT01566721|580160867|FG000|Safety Follow-up|Non-compliance|7|||
160667050|NCT01566721|580160868|FG001|Safety Follow-up|Non-compliance|3|||
160667051|NCT01566721|580160867|FG000|Safety Follow-up|Protocol Violation|7|||
160667052|NCT01566721|580160868|FG001|Safety Follow-up|Protocol Violation|0|||
160667053|NCT01566721|580160867|FG000|Safety Follow-up|Site closure|2|||
160667054|NCT01566721|580160868|FG001|Safety Follow-up|Site closure|3|||
160516080|NCT00439231|579618131|FG000|Overall Study|Lack of Efficacy|28|||
160516081|NCT02413333|579618137|FG000|Period 1|Adverse Event|1|||
160516082|NCT02413333|579618138|FG001|Period 1|Adverse Event|0|||
160516083|NCT02413333|579618137|FG000|Period 1|Reason Not Specified|0|||
160516084|NCT02413333|579618138|FG001|Period 1|Reason Not Specified|1|||
160516085|NCT02413333|579618137|FG000|Period 2|Protocol Deviation|1|||
160516086|NCT02413333|579618138|FG001|Period 2|Protocol Deviation|0|||
160516087|NCT01465347|579618139|FG000|Overall Study|Withdrawal by Subject|1|||
160516088|NCT01465347|579618140|FG001|Overall Study|Withdrawal by Subject|1|||
160516089|NCT01465347|579618139|FG000|Overall Study|Physician Decision|0|||
160516090|NCT01465347|579618140|FG001|Overall Study|Physician Decision|1|||
160516091|NCT01465347|579618139|FG000|Overall Study|Admitted to hospice|0|||
160516092|NCT01465347|579618140|FG001|Overall Study|Admitted to hospice|1|||
160516093|NCT02996474|579618141|FG000|Overall Study|Physician Decision|5|||
160516094|NCT04493502|579618142|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
160516095|NCT04493502|579618143|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
160516096|NCT04493502|579618142|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
160516097|NCT04493502|579618143|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
160516098|NCT04493502|579618142|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
160516099|NCT04493502|579618143|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
160516100|NCT04493502|579618142|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
160516101|NCT04493502|579618143|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
160516102|NCT04493502|579618142|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
160667055|NCT01566721|580160867|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
160667056|NCT01566721|580160868|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
160667057|NCT01566721|580160867|FG000|Safety Follow-up|Missing|7|||
160667058|NCT01566721|580160868|FG001|Safety Follow-up|Missing|2|||
160667059|NCT01566721|580160867|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
160667060|NCT01566721|580160868|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
160667061|NCT01566721|580160867|FG000|Safety Follow-up|Sponsor decision|1|||
160667062|NCT01566721|580160868|FG001|Safety Follow-up|Sponsor decision|0|||
160667063|NCT01566721|580160867|FG000|Safety Follow-up|Adverse Event|8|||
160516103|NCT04493502|579618143|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
160516104|NCT04493502|579618142|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
160516105|NCT04493502|579618143|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
160516106|NCT04493502|579618142|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
160516107|NCT04493502|579618143|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
160516108|NCT04493502|579618142|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
160516109|NCT04493502|579618143|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
160516110|NCT04493502|579618142|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
160516111|NCT04493502|579618143|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
160516112|NCT04493502|579618142|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
160516113|NCT04493502|579618143|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
160516114|NCT04493502|579618142|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
160516115|NCT04493502|579618143|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
160516116|NCT04493502|579618142|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
160516117|NCT04493502|579618143|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
160516118|NCT04493502|579618142|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
160516119|NCT04493502|579618143|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
160516120|NCT02891837|579618144|FG000|Overall Study|Lost to Follow-up|2|||
160516121|NCT02891837|579618145|FG001|Overall Study|Lost to Follow-up|0|||
160516122|NCT02891837|579618144|FG000|Overall Study|Withdrawal by Subject|1|||
160516123|NCT02891837|579618145|FG001|Overall Study|Withdrawal by Subject|0|||
160516124|NCT00709852|579618146|FG000|Period 1|Adverse Event|2|||
160516125|NCT00709852|579618147|FG001|Period 1|Adverse Event|0|||
160516126|NCT00709852|579618146|FG000|Period 1|Withdrawal by Subject|4|||
160516127|NCT00709852|579618147|FG001|Period 1|Withdrawal by Subject|2|||
160516128|NCT00709852|579618146|FG000|Period 1|Protocol Violation|1|||
160516129|NCT00709852|579618147|FG001|Period 1|Protocol Violation|0|||
160516130|NCT00709852|579618146|FG000|Period 1|Defective scanner|0|||
160667064|NCT01566721|580160868|FG001|Safety Follow-up|Adverse Event|4|||
160667065|NCT00811655|580160873|FG000|Overall Study|Physician Decision|1|||
160667066|NCT00787254|580160875|FG000|Overall Study|Adverse Event|24|||
160667067|NCT00787254|580160876|FG001|Overall Study|Adverse Event|23|||
160667068|NCT00787254|580160875|FG000|Overall Study|Protocol Violation|26|||
160667069|NCT00787254|580160876|FG001|Overall Study|Protocol Violation|23|||
160516131|NCT00709852|579618147|FG001|Period 1|Defective scanner|1|||
160516132|NCT00709852|579618146|FG000|Period 1|Lost to Follow-up|1|||
160516133|NCT00709852|579618147|FG001|Period 1|Lost to Follow-up|0|||
160516134|NCT00709852|579618146|FG000|Period 2|Protocol Violation|4|||
160516135|NCT00709852|579618147|FG001|Period 2|Protocol Violation|1|||
160516136|NCT00709852|579618146|FG000|Period 2|Adverse Event|1|||
160516137|NCT00709852|579618147|FG001|Period 2|Adverse Event|1|||
160516138|NCT00709852|579618146|FG000|Period 2|Lost to Follow-up|1|||
160516139|NCT00709852|579618147|FG001|Period 2|Lost to Follow-up|0|||
160516140|NCT00709852|579618146|FG000|Period 2|No 72-hour follow-up|3|||
160516141|NCT00709852|579618147|FG001|Period 2|No 72-hour follow-up|0|||
160516142|NCT01048671|579618148|FG000|Overall Study|Protocol Violation|0|||
160516143|NCT01048671|579618149|FG001|Overall Study|Protocol Violation|1|||
160516144|NCT01048671|579618150|FG002|Overall Study|Protocol Violation|1|||
160516145|NCT00296400|579618151|FG000|Overall Study|Adverse Event|7|||
160516146|NCT00296400|579618152|FG001|Overall Study|Adverse Event|7|||
160516147|NCT00296400|579618153|FG002|Overall Study|Adverse Event|7|||
160516148|NCT00296400|579618151|FG000|Overall Study|Withdrawal by Subject|5|||
160516149|NCT00296400|579618152|FG001|Overall Study|Withdrawal by Subject|6|||
160516150|NCT00296400|579618153|FG002|Overall Study|Withdrawal by Subject|2|||
160516151|NCT00296400|579618151|FG000|Overall Study|Incorrect enrollment|2|||
160516152|NCT00296400|579618152|FG001|Overall Study|Incorrect enrollment|0|||
160516153|NCT00296400|579618153|FG002|Overall Study|Incorrect enrollment|0|||
160516154|NCT00296400|579618151|FG000|Overall Study|Protocol Violation|1|||
160516155|NCT00296400|579618152|FG001|Overall Study|Protocol Violation|1|||
160516156|NCT00296400|579618153|FG002|Overall Study|Protocol Violation|1|||
160516157|NCT00296400|579618151|FG000|Overall Study|Lost to Follow-up|1|||
160516158|NCT00296400|579618152|FG001|Overall Study|Lost to Follow-up|1|||
160516159|NCT00296400|579618153|FG002|Overall Study|Lost to Follow-up|2|||
160516160|NCT00296400|579618151|FG000|Overall Study|Study specific discontinuation criteria|0|||
160667070|NCT00787254|580160875|FG000|Overall Study|Withdrawal by Subject|16|||
160516161|NCT00296400|579618152|FG001|Overall Study|Study specific discontinuation criteria|0|||
160516162|NCT00296400|579618153|FG002|Overall Study|Study specific discontinuation criteria|1|||
160516163|NCT00296400|579618151|FG000|Overall Study|Visit 10 was performed earlier|0|||
160667071|NCT00787254|580160876|FG001|Overall Study|Withdrawal by Subject|11|||
160667072|NCT00787254|580160875|FG000|Overall Study|Lack of Efficacy|4|||
160516164|NCT00296400|579618152|FG001|Overall Study|Visit 10 was performed earlier|1|||
160667073|NCT00787254|580160876|FG001|Overall Study|Lack of Efficacy|15|||
160516165|NCT00296400|579618153|FG002|Overall Study|Visit 10 was performed earlier|0|||
160516166|NCT00296400|579618151|FG000|Overall Study|Pregnancy|1|||
160516167|NCT00296400|579618152|FG001|Overall Study|Pregnancy|2|||
160516168|NCT00296400|579618153|FG002|Overall Study|Pregnancy|0|||
160516169|NCT01178385|579618158|FG000|Overall Study|Withdrawal by Subject|2|||
160516170|NCT01178385|579618159|FG001|Overall Study|Withdrawal by Subject|0|||
160516171|NCT00985946|579618160|FG000|Overall Study|Lost to Follow-up|6|||
160516172|NCT00985946|579618160|FG000|Overall Study|Withdrawal by Subject|1|||
160516173|NCT00928018|579618165|FG000|Overall Study|Withdrawal by Subject|1|||
160516174|NCT00928018|579618166|FG001|Overall Study|Withdrawal by Subject|0|||
160516175|NCT02008877|579618167|FG000|Overall Study|Inevaluable|0|||
160516176|NCT02008877|579618168|FG001|Overall Study|Inevaluable|1|||
160516177|NCT02008877|579618169|FG002|Overall Study|Inevaluable|0|||
160516178|NCT00847808|579618170|FG000|Overall Study|Adverse Event|7|||
160516179|NCT00847808|579618170|FG000|Overall Study|Protocol Violation|1|||
160516180|NCT00847808|579618170|FG000|Overall Study|Lost to Follow-up|1|||
160516181|NCT00847808|579618170|FG000|Overall Study|Withdrawal by Subject|4|||
160516182|NCT00847808|579618170|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
160516183|NCT00847808|579618170|FG000|Overall Study|Participant Took Excluded Medication|1|||
160516184|NCT05000931|579618180|FG000|Overall Study|Lost to Follow-up|1|||
160516185|NCT05326815|579618181|FG000|Overall Study|Withdrawal by Subject|3|||
160623779|NCT01159665|580001834|FG000|Overall Study|Withdrawal by Subject|0|||
160623780|NCT01159665|580001835|FG001|Overall Study|Withdrawal by Subject|1|||
160623781|NCT01159665|580001836|FG002|Overall Study|Withdrawal by Subject|0|||
160623782|NCT01159665|580001837|FG003|Overall Study|Withdrawal by Subject|0|||
160623783|NCT01159665|580001838|FG004|Overall Study|Withdrawal by Subject|0|||
160623784|NCT01159665|580001839|FG005|Overall Study|Withdrawal by Subject|0|||
160623785|NCT01130831|580001840|FG000|Overall Study|Withdrawal by Subject|7|||
160623786|NCT01130831|580001840|FG000|Overall Study|Death|4|||
160623787|NCT01130831|580001840|FG000|Overall Study|Information was missing|3|||
160623788|NCT00951912|580001841|FG000|Overall Study|Lack of Efficacy|1|||
160623789|NCT00951912|580001842|FG001|Overall Study|Lack of Efficacy|0|||
160623790|NCT00951912|580001843|FG002|Overall Study|Lack of Efficacy|0|||
160623791|NCT00951912|580001841|FG000|Overall Study|Adverse Event|0|||
160623792|NCT00951912|580001842|FG001|Overall Study|Adverse Event|1|||
160623793|NCT00951912|580001843|FG002|Overall Study|Adverse Event|1|||
160623794|NCT00951912|580001841|FG000|Overall Study|Lost to Follow-up|2|||
160623795|NCT00951912|580001842|FG001|Overall Study|Lost to Follow-up|2|||
160623796|NCT00951912|580001843|FG002|Overall Study|Lost to Follow-up|0|||
160623797|NCT00951912|580001841|FG000|Overall Study|Physician Decision|1|||
160623798|NCT00951912|580001842|FG001|Overall Study|Physician Decision|0|||
160623799|NCT00951912|580001843|FG002|Overall Study|Physician Decision|1|||
160623800|NCT00951912|580001841|FG000|Overall Study|Withdrawal by Subject|1|||
160623801|NCT00951912|580001842|FG001|Overall Study|Withdrawal by Subject|1|||
160623802|NCT00951912|580001843|FG002|Overall Study|Withdrawal by Subject|0|||
160623803|NCT00951912|580001841|FG000|Overall Study|Other:Depression|1|||
160623804|NCT00951912|580001842|FG001|Overall Study|Other:Depression|0|||
160623805|NCT00951912|580001843|FG002|Overall Study|Other:Depression|0|||
160623806|NCT00951912|580001841|FG000|Overall Study|Other: Colon cancer|1|||
160623807|NCT00951912|580001842|FG001|Overall Study|Other: Colon cancer|0|||
160623808|NCT00951912|580001843|FG002|Overall Study|Other: Colon cancer|0|||
160623809|NCT00951912|580001841|FG000|Overall Study|Other: Stroke|0|||
160623810|NCT00951912|580001842|FG001|Overall Study|Other: Stroke|1|||
160623811|NCT00951912|580001843|FG002|Overall Study|Other: Stroke|0|||
160623812|NCT02173158|580001845|FG000|Efficacy Phase|Adverse Event|1|||
160623813|NCT01377194|580001846|FG000|Overall Study|Adverse Event|3|||
160623814|NCT01377194|580001847|FG001|Overall Study|Adverse Event|12|||
160623815|NCT01377194|580001848|FG002|Overall Study|Adverse Event|19|||
160623816|NCT01377194|580001846|FG000|Overall Study|Lack of Efficacy|3|||
160623817|NCT01377194|580001847|FG001|Overall Study|Lack of Efficacy|3|||
160623818|NCT01377194|580001848|FG002|Overall Study|Lack of Efficacy|3|||
160623819|NCT01377194|580001846|FG000|Overall Study|Protocol Violation|4|||
160623820|NCT01377194|580001847|FG001|Overall Study|Protocol Violation|10|||
160623821|NCT01377194|580001848|FG002|Overall Study|Protocol Violation|6|||
160623822|NCT01377194|580001846|FG000|Overall Study|Withdrawal by Subject|8|||
160623823|NCT01377194|580001847|FG001|Overall Study|Withdrawal by Subject|10|||
160623824|NCT01377194|580001848|FG002|Overall Study|Withdrawal by Subject|7|||
160623825|NCT01377194|580001846|FG000|Overall Study|Lost to Follow-up|14|||
160623826|NCT01377194|580001847|FG001|Overall Study|Lost to Follow-up|8|||
160623827|NCT01377194|580001848|FG002|Overall Study|Lost to Follow-up|11|||
160623828|NCT01977573|580001851|FG000|Overall Study|Adverse Event|7|||
160623829|NCT01977573|580001852|FG001|Overall Study|Adverse Event|0|||
160623830|NCT01977573|580001853|FG002|Overall Study|Adverse Event|2|||
160623831|NCT01977573|580001854|FG003|Overall Study|Adverse Event|1|||
160623832|NCT01977573|580001851|FG000|Overall Study|Lost to Follow-up|1|||
160623833|NCT01977573|580001852|FG001|Overall Study|Lost to Follow-up|0|||
160516186|NCT05326815|579618181|FG000|Overall Study|Did not complete required labs|6|||
160516187|NCT05326815|579618181|FG000|Overall Study|Screen fail- abnormal labs|5|||
160516188|NCT00979134|579618182|FG000|Overall Study|Disease progression|18|||
160623834|NCT01977573|580001853|FG002|Overall Study|Lost to Follow-up|0|||
160516189|NCT00979134|579618183|FG001|Overall Study|Disease progression|2|||
160623835|NCT01977573|580001854|FG003|Overall Study|Lost to Follow-up|1|||
160516190|NCT00979134|579618184|FG002|Overall Study|Disease progression|5|||
160516191|NCT00979134|579618182|FG000|Overall Study|Adverse Event|0|||
160516192|NCT00979134|579618183|FG001|Overall Study|Adverse Event|0|||
160516193|NCT00979134|579618184|FG002|Overall Study|Adverse Event|2|||
160516194|NCT00979134|579618182|FG000|Overall Study|Withdrawal by Subject|1|||
160516195|NCT00979134|579618183|FG001|Overall Study|Withdrawal by Subject|1|||
160516196|NCT00979134|579618184|FG002|Overall Study|Withdrawal by Subject|2|||
160516197|NCT00979134|579618182|FG000|Overall Study|Lost to Follow-up|2|||
160516198|NCT00979134|579618183|FG001|Overall Study|Lost to Follow-up|2|||
160516199|NCT00979134|579618184|FG002|Overall Study|Lost to Follow-up|0|||
160516200|NCT00979134|579618182|FG000|Overall Study|Death|4|||
160516201|NCT00979134|579618183|FG001|Overall Study|Death|0|||
160516202|NCT00979134|579618184|FG002|Overall Study|Death|26|||
160516203|NCT00979134|579618182|FG000|Overall Study|Other|8|||
160516204|NCT00979134|579618183|FG001|Overall Study|Other|1|||
160516205|NCT00979134|579618184|FG002|Overall Study|Other|5|||
160516206|NCT04227704|579618185|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
160623836|NCT01977573|580001851|FG000|Overall Study|Physician Decision|1|||
160623837|NCT01977573|580001852|FG001|Overall Study|Physician Decision|0|||
160623838|NCT01977573|580001853|FG002|Overall Study|Physician Decision|0|||
160623839|NCT01977573|580001854|FG003|Overall Study|Physician Decision|0|||
160623840|NCT01977573|580001851|FG000|Overall Study|Protocol Violation|3|||
160623841|NCT01977573|580001852|FG001|Overall Study|Protocol Violation|1|||
160623842|NCT01977573|580001853|FG002|Overall Study|Protocol Violation|0|||
160623843|NCT01977573|580001854|FG003|Overall Study|Protocol Violation|0|||
160623844|NCT01977573|580001851|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
160623845|NCT01977573|580001852|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
160623846|NCT01977573|580001853|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
160623847|NCT01977573|580001854|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
160623848|NCT01977573|580001851|FG000|Overall Study|Withdrawal by Subject|6|||
160623849|NCT01977573|580001852|FG001|Overall Study|Withdrawal by Subject|1|||
160623850|NCT01977573|580001853|FG002|Overall Study|Withdrawal by Subject|1|||
160623851|NCT01977573|580001854|FG003|Overall Study|Withdrawal by Subject|1|||
160623852|NCT00323479|580001857|FG000|Overall Study|Adverse Event|2|||
160623853|NCT00323479|580001857|FG000|Overall Study|Withdrawal by Subject|2|||
160623854|NCT00323479|580001857|FG000|Overall Study|Protocol Violation|3|||
160623855|NCT00323479|580001857|FG000|Overall Study|house moving|1|||
160623856|NCT00967343|580001859|FG000|Overall Study|Study termination by sponsor|12|||
160623857|NCT00967343|580001859|FG000|Overall Study|Death|24|||
160623858|NCT00967343|580001859|FG000|Overall Study|Relapse|1|||
160623859|NCT00967343|580001859|FG000|Overall Study|Lost to Follow-up|1|||
160623860|NCT03044730|580001861|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
160623861|NCT03044730|580001861|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
160623862|NCT03044730|580001861|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
160623863|NCT03044730|580001861|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
160623864|NCT03044730|580001861|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
160623865|NCT03044730|580001861|FG000|Cycles 4 and Beyond|Adverse Event|1|||
160623866|NCT03044730|580001861|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
160623867|NCT03044730|580001861|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
160623868|NCT03044730|580001861|FG000|On Follow-up for 2 Years|Death|17|||
160623869|NCT01302366|580003663|FG000|Overall Study|patient choice or noncompliance|5|||
160623870|NCT00198107|580003666|FG000|Double-Blind Period|Adverse Event|1|||
160623871|NCT00198107|580003667|FG001|Double-Blind Period|Adverse Event|1|||
160623872|NCT00198107|580003668|FG002|Double-Blind Period|Adverse Event|0|||
160623873|NCT00198107|580003666|FG000|Double-Blind Period|Lack of Efficacy|2|||
160623874|NCT00198107|580003667|FG001|Double-Blind Period|Lack of Efficacy|0|||
160623875|NCT00198107|580003668|FG002|Double-Blind Period|Lack of Efficacy|0|||
160623876|NCT00198107|580003666|FG000|Double-Blind Period|Lost to Follow-up|2|||
160623877|NCT00198107|580003667|FG001|Double-Blind Period|Lost to Follow-up|1|||
160623878|NCT00198107|580003668|FG002|Double-Blind Period|Lost to Follow-up|0|||
160623879|NCT00198107|580003666|FG000|Double-Blind Period|Physician Decision|1|||
160623880|NCT00198107|580003667|FG001|Double-Blind Period|Physician Decision|0|||
160623881|NCT00198107|580003668|FG002|Double-Blind Period|Physician Decision|0|||
160623882|NCT00198107|580003666|FG000|Double-Blind Period|Withdrawal by Subject|0|||
160623883|NCT00198107|580003667|FG001|Double-Blind Period|Withdrawal by Subject|1|||
160623884|NCT00198107|580003668|FG002|Double-Blind Period|Withdrawal by Subject|0|||
160623885|NCT00198107|580003666|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
160623886|NCT00198107|580003667|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
160623887|NCT00198107|580003668|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
160623888|NCT02513732|580003669|FG000|Overall Study|Lost to Follow-up|11|||
160623889|NCT02513732|580003669|FG000|Overall Study|Death|9|||
160623890|NCT02513732|580003669|FG000|Overall Study|Changing hospital|2|||
160623891|NCT00467051|580003670|FG000|Overall Study|Adverse Event|2|||
160623892|NCT00934661|580003671|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
160667074|NCT00787254|580160875|FG000|Overall Study|NSAIDs discontinuation|1|||
160667075|NCT00787254|580160876|FG001|Overall Study|NSAIDs discontinuation|2|||
160667076|NCT00787254|580160875|FG000|Overall Study|Institution closed|1|||
160667077|NCT00787254|580160876|FG001|Overall Study|Institution closed|0|||
160667078|NCT00787254|580160875|FG000|Overall Study|Physician Decision|4|||
160667079|NCT00787254|580160876|FG001|Overall Study|Physician Decision|8|||
160667080|NCT00119015|580160877|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
160667081|NCT00119015|580160878|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
160667082|NCT00119015|580160879|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
160667083|NCT01802320|580160882|FG000|Overall Study|Death|1|||
160667084|NCT01802320|580160882|FG000|Overall Study|Withdrawal by Subject|1|||
160667085|NCT05152576|580160883|FG000|Overall Study|Lost to Follow-up|3|||
160667086|NCT05152576|580160884|FG001|Overall Study|Lost to Follow-up|0|||
160667087|NCT05152576|580160885|FG002|Overall Study|Lost to Follow-up|0|||
160667088|NCT05152576|580160886|FG003|Overall Study|Lost to Follow-up|1|||
160667089|NCT05152576|580160883|FG000|Overall Study|Withdrawal by Subject|0|||
160667090|NCT05152576|580160884|FG001|Overall Study|Withdrawal by Subject|1|||
160667091|NCT05152576|580160885|FG002|Overall Study|Withdrawal by Subject|0|||
160667092|NCT05152576|580160886|FG003|Overall Study|Withdrawal by Subject|1|||
160667093|NCT05152576|580160883|FG000|Overall Study|Other|2|||
160667094|NCT05152576|580160884|FG001|Overall Study|Other|0|||
160667095|NCT05152576|580160885|FG002|Overall Study|Other|0|||
160667096|NCT05152576|580160886|FG003|Overall Study|Other|0|||
160667097|NCT00859430|580160887|FG000|First Intervention|Withdrawal by Subject|0|||
160667098|NCT00859430|580160888|FG001|First Intervention|Withdrawal by Subject|1|||
160667099|NCT05265624|580162562|FG000|Overall Study|Lost to Follow-up|3|||
160667100|NCT05265624|580162563|FG001|Overall Study|Lost to Follow-up|0|||
160667101|NCT05265624|580162562|FG000|Overall Study|Withdrawal by Subject|1|||
160667102|NCT05265624|580162563|FG001|Overall Study|Withdrawal by Subject|0|||
160667103|NCT00001703|580162564|FG000|Overall Study|progressed disease|2|||
160667104|NCT00001703|580162564|FG000|Overall Study|No evidence of disease|1|||
160667105|NCT00001703|580162564|FG000|Overall Study|recurrent disease|2|||
160667106|NCT02286739|580162565|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
160667107|NCT02286739|580162566|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
160667108|NCT02286739|580162565|FG000|Overall Study|No Verasense type documented|0|||
160667109|NCT02286739|580162566|FG001|Overall Study|No Verasense type documented|23|||
160667110|NCT02286739|580162565|FG000|Overall Study|Adverse Event|1|||
160667111|NCT02286739|580162566|FG001|Overall Study|Adverse Event|2|||
160667112|NCT02286739|580162565|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
160667113|NCT02286739|580162566|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
160667114|NCT00834795|580162567|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
160667115|NCT00834795|580162568|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
160667116|NCT00834795|580162567|FG000|Second Intervention|Adverse Event|1|||
160667117|NCT00834795|580162568|FG001|Second Intervention|Adverse Event|0|||
160667118|NCT03165994|580162569|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
160667119|NCT03165994|580162569|FG000|Overall Study|Death|2|||
160667120|NCT03165994|580162569|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
160667121|NCT03165994|580162569|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
160667122|NCT03165994|580162569|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
160667123|NCT03165994|580162569|FG000|Overall Study|Miscellaneous|1|||
160667124|NCT00163657|580162570|FG000|Overall Study|Death|12|||
160667125|NCT00163657|580162571|FG001|Overall Study|Death|14|||
160667126|NCT00163657|580162572|FG002|Overall Study|Death|19|||
160667127|NCT00163657|580162570|FG000|Overall Study|graft loss|4|||
160667128|NCT00163657|580162571|FG001|Overall Study|graft loss|1|||
160667129|NCT00163657|580162572|FG002|Overall Study|graft loss|2|||
160667130|NCT00163657|580162570|FG000|Overall Study|Withdrawal by Subject|2|||
160667131|NCT00163657|580162571|FG001|Overall Study|Withdrawal by Subject|3|||
160667132|NCT00163657|580162572|FG002|Overall Study|Withdrawal by Subject|2|||
160667133|NCT00163657|580162570|FG000|Overall Study|Physician Decision|0|||
160667134|NCT00163657|580162571|FG001|Overall Study|Physician Decision|1|||
160667135|NCT00163657|580162572|FG002|Overall Study|Physician Decision|1|||
160667136|NCT00163657|580162570|FG000|Overall Study|Non Compliance|1|||
160667137|NCT00163657|580162571|FG001|Overall Study|Non Compliance|0|||
160667138|NCT00163657|580162572|FG002|Overall Study|Non Compliance|0|||
160667139|NCT00163657|580162570|FG000|Overall Study|Lost to Follow-up|1|||
160667140|NCT00163657|580162571|FG001|Overall Study|Lost to Follow-up|3|||
160667141|NCT00163657|580162572|FG002|Overall Study|Lost to Follow-up|10|||
160667142|NCT00163657|580162570|FG000|Overall Study|Other reason|0|||
160667143|NCT00163657|580162571|FG001|Overall Study|Other reason|1|||
160667144|NCT00163657|580162572|FG002|Overall Study|Other reason|3|||
160667145|NCT01531894|580162575|FG000|Overall Study|Physician Decision|8|||
160667146|NCT01531894|580162575|FG000|Overall Study|Death|1|||
160667147|NCT03635320|580162576|FG000|Overall Study|not implanted the device|1|||
160667148|NCT03635320|580162577|FG001|Overall Study|not implanted the device|2|||
160667149|NCT03635320|580162576|FG000|Overall Study|Withdrawal by Subject|11|||
160516207|NCT04227704|579618186|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
160516208|NCT04227704|579618187|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
160516209|NCT04227704|579618185|FG000|Overall Study|due to C/S being cancelled|1|||
160516210|NCT04227704|579618186|FG001|Overall Study|due to C/S being cancelled|0|||
160516211|NCT04227704|579618187|FG002|Overall Study|due to C/S being cancelled|0|||
160516212|NCT00729378|579620479|FG000|Baseline|Did not complete study measurements|72|||
160516213|NCT00729378|579620480|FG001|Baseline|Did not complete study measurements|33|||
160516214|NCT00729378|579620479|FG000|Baseline|Withdrawal by Subject|66|||
160516215|NCT00729378|579620480|FG001|Baseline|Withdrawal by Subject|59|||
160516216|NCT00729378|579620479|FG000|12-months|Lost to Follow-up|100|||
160516217|NCT00729378|579620480|FG001|12-months|Lost to Follow-up|65|||
160516218|NCT00729378|579620479|FG000|24-months|Lost to Follow-up|72|||
160516219|NCT00729378|579620480|FG001|24-months|Lost to Follow-up|51|||
160516220|NCT00729378|579620479|FG000|36-months|Lost to Follow-up|15|||
160516221|NCT00729378|579620480|FG001|36-months|Lost to Follow-up|6|||
160516222|NCT00484289|579620488|FG000|Long Term Phase|Adverse Event|1|||
160516223|NCT00484289|579620489|FG001|Long Term Phase|Adverse Event|17|||
160516224|NCT00484289|579620490|FG002|Long Term Phase|Adverse Event|5|||
160516225|NCT00484289|579620488|FG000|Long Term Phase|Withdrawal by Subject|0|||
160516226|NCT00484289|579620489|FG001|Long Term Phase|Withdrawal by Subject|7|||
160516227|NCT00484289|579620490|FG002|Long Term Phase|Withdrawal by Subject|6|||
160516228|NCT00484289|579620488|FG000|Long Term Phase|Inadequate response|2|||
160516229|NCT00484289|579620489|FG001|Long Term Phase|Inadequate response|7|||
160516230|NCT00484289|579620490|FG002|Long Term Phase|Inadequate response|4|||
160516231|NCT00484289|579620488|FG000|Long Term Phase|Other Reason|0|||
160516232|NCT00484289|579620489|FG001|Long Term Phase|Other Reason|5|||
160516233|NCT00484289|579620490|FG002|Long Term Phase|Other Reason|1|||
160516234|NCT00484289|579620488|FG000|Post Marketing Phase|Adverse Event|0|||
160516235|NCT00484289|579620489|FG001|Post Marketing Phase|Adverse Event|1|||
160516236|NCT00484289|579620490|FG002|Post Marketing Phase|Adverse Event|0|||
160516237|NCT00690443|579620491|FG000|Overall Study|Adverse Event|1|||
160516238|NCT00690443|579620492|FG001|Overall Study|Adverse Event|2|||
160516239|NCT02874924|579620495|FG000|Overall Study|Adverse Event|2|||
160516240|NCT02874924|579620496|FG001|Overall Study|Adverse Event|0|||
160516241|NCT02874924|579620497|FG002|Overall Study|Adverse Event|0|||
160516242|NCT02874924|579620495|FG000|Overall Study|Withdrawal by Subject|1|||
160516243|NCT02874924|579620496|FG001|Overall Study|Withdrawal by Subject|0|||
160623893|NCT00934661|580003672|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
160623894|NCT01846442|580003677|FG000|Overall Study|Adverse Event|2|||
160623895|NCT01846442|580003678|FG001|Overall Study|Adverse Event|4|||
160623896|NCT01846442|580003679|FG002|Overall Study|Adverse Event|2|||
160623897|NCT01846442|580003680|FG003|Overall Study|Adverse Event|1|||
160623898|NCT01846442|580003677|FG000|Overall Study|Lost to Follow-up|0|||
160623899|NCT01846442|580003678|FG001|Overall Study|Lost to Follow-up|0|||
160623900|NCT01846442|580003679|FG002|Overall Study|Lost to Follow-up|1|||
160623901|NCT01846442|580003680|FG003|Overall Study|Lost to Follow-up|0|||
160623902|NCT01846442|580003677|FG000|Overall Study|Withdrawal by Subject|3|||
160623903|NCT01846442|580003678|FG001|Overall Study|Withdrawal by Subject|2|||
160623904|NCT01846442|580003679|FG002|Overall Study|Withdrawal by Subject|0|||
160623905|NCT01846442|580003680|FG003|Overall Study|Withdrawal by Subject|1|||
160623906|NCT01846442|580003677|FG000|Overall Study|Left the city/Lost medication|1|||
160623907|NCT01846442|580003678|FG001|Overall Study|Left the city/Lost medication|0|||
160623908|NCT01846442|580003679|FG002|Overall Study|Left the city/Lost medication|1|||
160623909|NCT01846442|580003680|FG003|Overall Study|Left the city/Lost medication|1|||
160623910|NCT02777554|580003683|FG000|Overall Study|Adverse Event|4|||
160623911|NCT02777554|580003684|FG001|Overall Study|Adverse Event|4|||
160623912|NCT02777554|580003685|FG002|Overall Study|Adverse Event|0|||
160623913|NCT02777554|580003686|FG003|Overall Study|Adverse Event|1|||
160623914|NCT02777554|580003687|FG004|Overall Study|Adverse Event|0|||
160623915|NCT02777554|580003688|FG005|Overall Study|Adverse Event|0|||
160623916|NCT02777554|580003683|FG000|Overall Study|Withdrawal by Subject|3|||
160623917|NCT02777554|580003684|FG001|Overall Study|Withdrawal by Subject|1|||
160623918|NCT02777554|580003685|FG002|Overall Study|Withdrawal by Subject|1|||
160623919|NCT02777554|580003686|FG003|Overall Study|Withdrawal by Subject|0|||
160623920|NCT02777554|580003687|FG004|Overall Study|Withdrawal by Subject|0|||
160623921|NCT02777554|580003688|FG005|Overall Study|Withdrawal by Subject|0|||
160623922|NCT02777554|580003683|FG000|Overall Study|Discharged early due to hurricane|22|||
160623923|NCT02777554|580003684|FG001|Overall Study|Discharged early due to hurricane|20|||
160623924|NCT02777554|580003685|FG002|Overall Study|Discharged early due to hurricane|0|||
160623925|NCT02777554|580003686|FG003|Overall Study|Discharged early due to hurricane|0|||
160623926|NCT02777554|580003687|FG004|Overall Study|Discharged early due to hurricane|0|||
160516244|NCT02874924|579620497|FG002|Overall Study|Withdrawal by Subject|0|||
160516245|NCT02808143|579620498|FG000|Maintenance Phase|Disease recurrence|1|||
160516246|NCT02808143|579620499|FG001|Maintenance Phase|Disease recurrence|3|||
160516247|NCT02808143|579620498|FG000|Maintenance Phase|Disease progression|1|||
160516248|NCT02808143|579620499|FG001|Maintenance Phase|Disease progression|2|||
160516249|NCT02808143|579620498|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
160516250|NCT02808143|579620499|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
160516251|NCT02808143|579620498|FG000|Survival Follow-Up|Disease recurrence|0|||
160516252|NCT02808143|579620499|FG001|Survival Follow-Up|Disease recurrence|2|||
160516253|NCT02808143|579620498|FG000|Survival Follow-Up|Adverse Event|0|||
160516254|NCT02808143|579620499|FG001|Survival Follow-Up|Adverse Event|1|||
160516255|NCT02808143|579620498|FG000|Survival Follow-Up|Death|1|||
160516256|NCT02808143|579620499|FG001|Survival Follow-Up|Death|0|||
160516257|NCT01874431|579620500|FG000|Overall Study|Physician Decision|0|||
160516258|NCT01874431|579620501|FG001|Overall Study|Physician Decision|0|||
160516259|NCT01874431|579620502|FG002|Overall Study|Physician Decision|1|||
160516260|NCT01874431|579620503|FG003|Overall Study|Physician Decision|0|||
160516261|NCT01874431|579620504|FG004|Overall Study|Physician Decision|0|||
160516262|NCT01874431|579620505|FG005|Overall Study|Physician Decision|0|||
160516263|NCT01874431|579620506|FG006|Overall Study|Physician Decision|0|||
160516264|NCT01874431|579620507|FG007|Overall Study|Physician Decision|0|||
160516265|NCT01874431|579620500|FG000|Overall Study|Adverse Event|5|||
160516266|NCT01874431|579620501|FG001|Overall Study|Adverse Event|4|||
160516267|NCT01874431|579620502|FG002|Overall Study|Adverse Event|6|||
160516268|NCT01874431|579620503|FG003|Overall Study|Adverse Event|5|||
160516269|NCT01874431|579620504|FG004|Overall Study|Adverse Event|2|||
160516270|NCT01874431|579620505|FG005|Overall Study|Adverse Event|8|||
160516271|NCT01874431|579620506|FG006|Overall Study|Adverse Event|2|||
160516272|NCT01874431|579620507|FG007|Overall Study|Adverse Event|3|||
160516273|NCT01874431|579620500|FG000|Overall Study|Protocol Violation|1|||
160516274|NCT01874431|579620501|FG001|Overall Study|Protocol Violation|1|||
160516275|NCT01874431|579620502|FG002|Overall Study|Protocol Violation|1|||
160516276|NCT01874431|579620503|FG003|Overall Study|Protocol Violation|0|||
160516277|NCT01874431|579620504|FG004|Overall Study|Protocol Violation|3|||
160516278|NCT01874431|579620505|FG005|Overall Study|Protocol Violation|2|||
160516279|NCT01874431|579620506|FG006|Overall Study|Protocol Violation|1|||
160516280|NCT01874431|579620507|FG007|Overall Study|Protocol Violation|1|||
160516281|NCT01874431|579620500|FG000|Overall Study|Non-compliance|0|||
160516282|NCT01874431|579620501|FG001|Overall Study|Non-compliance|0|||
160516283|NCT01874431|579620502|FG002|Overall Study|Non-compliance|0|||
160516284|NCT01874431|579620503|FG003|Overall Study|Non-compliance|0|||
160516285|NCT01874431|579620504|FG004|Overall Study|Non-compliance|1|||
160516286|NCT01874431|579620505|FG005|Overall Study|Non-compliance|0|||
160516287|NCT01874431|579620506|FG006|Overall Study|Non-compliance|1|||
160516288|NCT01874431|579620507|FG007|Overall Study|Non-compliance|0|||
160516289|NCT01874431|579620500|FG000|Overall Study|Logistical difficulties|0|||
160516290|NCT01874431|579620501|FG001|Overall Study|Logistical difficulties|0|||
160516291|NCT01874431|579620502|FG002|Overall Study|Logistical difficulties|0|||
160516292|NCT01874431|579620503|FG003|Overall Study|Logistical difficulties|0|||
160516293|NCT01874431|579620504|FG004|Overall Study|Logistical difficulties|0|||
160516294|NCT01874431|579620505|FG005|Overall Study|Logistical difficulties|0|||
160516295|NCT01874431|579620506|FG006|Overall Study|Logistical difficulties|1|||
160516296|NCT01874431|579620507|FG007|Overall Study|Logistical difficulties|0|||
160516297|NCT01874431|579620500|FG000|Overall Study|Withdrawal by Subject|0|||
160516298|NCT01874431|579620501|FG001|Overall Study|Withdrawal by Subject|0|||
160516299|NCT01874431|579620502|FG002|Overall Study|Withdrawal by Subject|1|||
160516300|NCT01874431|579620503|FG003|Overall Study|Withdrawal by Subject|2|||
160516301|NCT01874431|579620504|FG004|Overall Study|Withdrawal by Subject|1|||
160516302|NCT01874431|579620505|FG005|Overall Study|Withdrawal by Subject|1|||
160623927|NCT02777554|580003688|FG005|Overall Study|Discharged early due to hurricane|0|||
160623928|NCT02777554|580003683|FG000|Overall Study|Other - Miscellaneous|1|||
160623929|NCT02777554|580003684|FG001|Overall Study|Other - Miscellaneous|0|||
160623930|NCT02777554|580003685|FG002|Overall Study|Other - Miscellaneous|0|||
160623931|NCT02777554|580003686|FG003|Overall Study|Other - Miscellaneous|0|||
160623932|NCT02777554|580003687|FG004|Overall Study|Other - Miscellaneous|0|||
160623933|NCT02777554|580003688|FG005|Overall Study|Other - Miscellaneous|0|||
160623934|NCT02147132|580003689|FG000|Overall Study|Lost to Follow-up|1|||
160623935|NCT02147132|580003690|FG001|Overall Study|Lost to Follow-up|0|||
160623936|NCT02147132|580003691|FG002|Overall Study|Lost to Follow-up|0|||
160623937|NCT02147132|580003692|FG003|Overall Study|Lost to Follow-up|0|||
160623938|NCT01013207|580003693|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
160623939|NCT01541644|580003698|FG000|Overall Study|Withdrawal by Subject|3|||
160623940|NCT01458535|580003701|FG000|Overall Study|Other|0|||
160516303|NCT01874431|579620506|FG006|Overall Study|Withdrawal by Subject|3|||
160516304|NCT01874431|579620507|FG007|Overall Study|Withdrawal by Subject|0|||
160516305|NCT01874431|579620500|FG000|Overall Study|Sponsor decision|0|||
160516306|NCT01874431|579620501|FG001|Overall Study|Sponsor decision|0|||
160516307|NCT01874431|579620502|FG002|Overall Study|Sponsor decision|0|||
160516308|NCT01874431|579620503|FG003|Overall Study|Sponsor decision|0|||
160516309|NCT01874431|579620504|FG004|Overall Study|Sponsor decision|1|||
160516310|NCT01874431|579620505|FG005|Overall Study|Sponsor decision|0|||
160516311|NCT01874431|579620506|FG006|Overall Study|Sponsor decision|0|||
160516312|NCT01874431|579620507|FG007|Overall Study|Sponsor decision|0|||
160516313|NCT01874431|579620500|FG000|Overall Study|Lost to Follow-up|0|||
160516314|NCT01874431|579620501|FG001|Overall Study|Lost to Follow-up|0|||
160516315|NCT01874431|579620502|FG002|Overall Study|Lost to Follow-up|1|||
160516316|NCT01874431|579620503|FG003|Overall Study|Lost to Follow-up|0|||
160516317|NCT01874431|579620504|FG004|Overall Study|Lost to Follow-up|0|||
160516318|NCT01874431|579620505|FG005|Overall Study|Lost to Follow-up|0|||
160516319|NCT01874431|579620506|FG006|Overall Study|Lost to Follow-up|0|||
160516320|NCT01874431|579620507|FG007|Overall Study|Lost to Follow-up|0|||
160516321|NCT03718533|579620509|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
160516322|NCT03718533|579620509|FG000|Overall Study|Protocol deviation|1|||
160516323|NCT03718533|579620509|FG000|Overall Study|Disease progression|1|||
160516324|NCT03718533|579620509|FG000|Overall Study|Relapse|1|||
160516325|NCT03718533|579620509|FG000|Overall Study|Physician Decision|2|||
160516326|NCT03718533|579620509|FG000|Overall Study|Physician Decision and Adverse Event|1|||
160516327|NCT01312857|579620516|FG000|Overall Study|Adverse Event|1|||
160516328|NCT01312857|579620517|FG001|Overall Study|Adverse Event|1|||
160516329|NCT01312857|579620516|FG000|Overall Study|Lost to Follow-up|2|||
160516330|NCT01312857|579620517|FG001|Overall Study|Lost to Follow-up|0|||
160516331|NCT01312857|579620516|FG000|Overall Study|Physician Decision|3|||
160516332|NCT01312857|579620517|FG001|Overall Study|Physician Decision|0|||
160516333|NCT01312857|579620516|FG000|Overall Study|Withdrawal by Subject|2|||
160516334|NCT01312857|579620517|FG001|Overall Study|Withdrawal by Subject|0|||
160516335|NCT04256629|579620522|FG000|Overall Study|Adverse Event|0|||
160516336|NCT04256629|579620523|FG001|Overall Study|Adverse Event|0|||
160516337|NCT04256629|579620524|FG002|Overall Study|Adverse Event|0|||
160516338|NCT04256629|579620525|FG003|Overall Study|Adverse Event|0|||
160516339|NCT04256629|579620526|FG004|Overall Study|Adverse Event|0|||
160516340|NCT04256629|579620527|FG005|Overall Study|Adverse Event|1|||
160516341|NCT04256629|579620522|FG000|Overall Study|Protocol Violation|0|||
160516342|NCT04256629|579620523|FG001|Overall Study|Protocol Violation|1|||
160516343|NCT04256629|579620524|FG002|Overall Study|Protocol Violation|0|||
160516344|NCT04256629|579620525|FG003|Overall Study|Protocol Violation|0|||
160516345|NCT04256629|579620526|FG004|Overall Study|Protocol Violation|0|||
160516346|NCT04256629|579620527|FG005|Overall Study|Protocol Violation|0|||
160516347|NCT00321373|579620528|FG000|Overall Study|Adverse Event|0|||
160516348|NCT00321373|579620529|FG001|Overall Study|Adverse Event|0|||
160516349|NCT00321373|579620530|FG002|Overall Study|Adverse Event|1|||
160516350|NCT00321373|579620528|FG000|Overall Study|Lost to Follow-up|1|||
160516351|NCT00321373|579620529|FG001|Overall Study|Lost to Follow-up|0|||
160516352|NCT00321373|579620530|FG002|Overall Study|Lost to Follow-up|1|||
160516353|NCT00321373|579620528|FG000|Overall Study|Withdrawal by Subject|1|||
160516354|NCT00321373|579620529|FG001|Overall Study|Withdrawal by Subject|0|||
160516355|NCT00321373|579620530|FG002|Overall Study|Withdrawal by Subject|0|||
160516356|NCT00321373|579620528|FG000|Overall Study|Other|0|||
160516357|NCT00321373|579620529|FG001|Overall Study|Other|0|||
160516358|NCT00321373|579620530|FG002|Overall Study|Other|1|||
160516359|NCT01774487|579620531|FG000|Overall Study|Did not tolerate taste|4|||
160516360|NCT01774487|579620532|FG001|Overall Study|Did not tolerate taste|4|||
160516361|NCT00477334|579620536|FG000|Overall Study|Discontinued prior to taking study drug|106|||
160516362|NCT00477334|579620537|FG001|Overall Study|Discontinued prior to taking study drug|53|||
160623941|NCT01458535|580003702|FG001|Overall Study|Other|0|||
160623942|NCT01458535|580003703|FG002|Overall Study|Other|0|||
160623943|NCT01458535|580003704|FG003|Overall Study|Other|0|||
160623944|NCT01458535|580003705|FG004|Overall Study|Other|1|||
160623945|NCT01458535|580003706|FG005|Overall Study|Other|1|||
160623946|NCT01458535|580003701|FG000|Overall Study|Withdrawal by Subject|0|||
160623947|NCT01458535|580003702|FG001|Overall Study|Withdrawal by Subject|0|||
160623948|NCT01458535|580003703|FG002|Overall Study|Withdrawal by Subject|2|||
160623949|NCT01458535|580003704|FG003|Overall Study|Withdrawal by Subject|0|||
160623950|NCT01458535|580003705|FG004|Overall Study|Withdrawal by Subject|1|||
160623951|NCT01458535|580003706|FG005|Overall Study|Withdrawal by Subject|1|||
160623952|NCT01458535|580003701|FG000|Overall Study|Lost to Follow-up|0|||
160623953|NCT01458535|580003702|FG001|Overall Study|Lost to Follow-up|2|||
160623954|NCT01458535|580003703|FG002|Overall Study|Lost to Follow-up|0|||
160623955|NCT01458535|580003704|FG003|Overall Study|Lost to Follow-up|3|||
160623956|NCT01458535|580003705|FG004|Overall Study|Lost to Follow-up|2|||
160516363|NCT00477334|579620536|FG000|Overall Study|Adverse Event|1|||
160516364|NCT00477334|579620537|FG001|Overall Study|Adverse Event|2|||
160516365|NCT00477334|579620536|FG000|Overall Study|Withdrawal by Subject|2|||
160516366|NCT00477334|579620537|FG001|Overall Study|Withdrawal by Subject|1|||
160516367|NCT00477334|579620536|FG000|Overall Study|Lost to Follow-up|15|||
160516368|NCT00477334|579620537|FG001|Overall Study|Lost to Follow-up|4|||
160516369|NCT00477334|579620536|FG000|Overall Study|Administrative Problems|39|||
160516370|NCT00477334|579620537|FG001|Overall Study|Administrative Problems|15|||
160623957|NCT01458535|580003706|FG005|Overall Study|Lost to Follow-up|2|||
160516371|NCT00477334|579620536|FG000|Overall Study|Protocol Violation|7|||
160516372|NCT00477334|579620537|FG001|Overall Study|Protocol Violation|1|||
160516373|NCT04275089|579620538|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
160623958|NCT01458535|580003701|FG000|Overall Study|Adverse Event|0|||
160516374|NCT02257567|579620542|FG000|Overall Study|Adverse Event|0|||
160516375|NCT02257567|579620543|FG001|Overall Study|Adverse Event|0|||
160516376|NCT02257567|579620544|FG002|Overall Study|Adverse Event|0|||
160516377|NCT02257567|579620545|FG003|Overall Study|Adverse Event|1|||
160516378|NCT02257567|579620546|FG004|Overall Study|Adverse Event|1|||
160516379|NCT02257567|579620547|FG005|Overall Study|Adverse Event|0|||
160516380|NCT02257567|579620548|FG006|Overall Study|Adverse Event|0|||
160516381|NCT02257567|579620549|FG007|Overall Study|Adverse Event|0|||
160516382|NCT02257567|579620550|FG008|Overall Study|Adverse Event|1|||
160516383|NCT02257567|579620551|FG009|Overall Study|Adverse Event|0|||
160516384|NCT02257567|579620552|FG010|Overall Study|Adverse Event|0|||
160516385|NCT02257567|579620542|FG000|Overall Study|Death|2|||
160516386|NCT02257567|579620543|FG001|Overall Study|Death|2|||
160516387|NCT02257567|579620544|FG002|Overall Study|Death|2|||
160516388|NCT02257567|579620545|FG003|Overall Study|Death|4|||
160516389|NCT02257567|579620546|FG004|Overall Study|Death|15|||
160516390|NCT02257567|579620547|FG005|Overall Study|Death|11|||
160516391|NCT02257567|579620548|FG006|Overall Study|Death|26|||
160516392|NCT02257567|579620549|FG007|Overall Study|Death|30|||
160516393|NCT02257567|579620550|FG008|Overall Study|Death|2|||
160516394|NCT02257567|579620551|FG009|Overall Study|Death|18|||
160516395|NCT02257567|579620552|FG010|Overall Study|Death|65|||
160516396|NCT02257567|579620542|FG000|Overall Study|Lost to Follow-up|0|||
160516397|NCT02257567|579620543|FG001|Overall Study|Lost to Follow-up|0|||
160516398|NCT02257567|579620544|FG002|Overall Study|Lost to Follow-up|0|||
160516399|NCT02257567|579620545|FG003|Overall Study|Lost to Follow-up|0|||
160516400|NCT02257567|579620546|FG004|Overall Study|Lost to Follow-up|2|||
160516401|NCT02257567|579620547|FG005|Overall Study|Lost to Follow-up|2|||
160516402|NCT02257567|579620548|FG006|Overall Study|Lost to Follow-up|0|||
160516403|NCT02257567|579620549|FG007|Overall Study|Lost to Follow-up|0|||
160516404|NCT02257567|579620550|FG008|Overall Study|Lost to Follow-up|0|||
160516405|NCT02257567|579620551|FG009|Overall Study|Lost to Follow-up|1|||
160516406|NCT02257567|579620552|FG010|Overall Study|Lost to Follow-up|1|||
160516407|NCT02257567|579620542|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
160516408|NCT02257567|579620543|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
160623959|NCT01458535|580003702|FG001|Overall Study|Adverse Event|0|||
160623960|NCT01458535|580003703|FG002|Overall Study|Adverse Event|0|||
160623961|NCT01458535|580003704|FG003|Overall Study|Adverse Event|1|||
160623962|NCT01458535|580003705|FG004|Overall Study|Adverse Event|0|||
160623963|NCT01458535|580003706|FG005|Overall Study|Adverse Event|0|||
160623964|NCT00151775|580003707|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
160623965|NCT00151775|580003708|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
160623966|NCT00151775|580003709|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
160623967|NCT00151775|580003710|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
160623968|NCT00151775|580003711|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
160623969|NCT00151775|580003712|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
160623970|NCT00151775|580003713|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
160623971|NCT00151775|580003714|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
160623972|NCT00151775|580003715|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
160623973|NCT00151775|580003716|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
160623974|NCT00151775|580003717|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
160623975|NCT00151775|580003718|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
160623976|NCT00151775|580003707|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
160623977|NCT00151775|580003708|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
160623978|NCT00151775|580003709|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
160623979|NCT00151775|580003710|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
160623980|NCT00151775|580003711|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
160623981|NCT00151775|580003712|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
160623982|NCT00151775|580003713|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
160623983|NCT00151775|580003714|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
160623984|NCT00151775|580003715|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
160516409|NCT02257567|579620544|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
160516410|NCT02257567|579620545|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
160516411|NCT02257567|579620546|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
160623985|NCT00151775|580003716|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
160623986|NCT00151775|580003717|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
160623987|NCT00151775|580003718|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
160516412|NCT02257567|579620547|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
160516413|NCT02257567|579620548|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
160516414|NCT02257567|579620549|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
160516415|NCT02257567|579620550|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
160516416|NCT02257567|579620551|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
160516417|NCT02257567|579620552|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
160516418|NCT02257567|579620542|FG000|Overall Study|Physician Decision|0|||
160516419|NCT02257567|579620543|FG001|Overall Study|Physician Decision|0|||
160516420|NCT02257567|579620544|FG002|Overall Study|Physician Decision|0|||
160516421|NCT02257567|579620545|FG003|Overall Study|Physician Decision|0|||
160516422|NCT02257567|579620546|FG004|Overall Study|Physician Decision|0|||
160516423|NCT02257567|579620547|FG005|Overall Study|Physician Decision|0|||
160516424|NCT02257567|579620548|FG006|Overall Study|Physician Decision|0|||
160516425|NCT02257567|579620549|FG007|Overall Study|Physician Decision|2|||
160516426|NCT02257567|579620550|FG008|Overall Study|Physician Decision|0|||
160516427|NCT02257567|579620551|FG009|Overall Study|Physician Decision|1|||
160516428|NCT02257567|579620552|FG010|Overall Study|Physician Decision|0|||
160516429|NCT02257567|579620542|FG000|Overall Study|Withdrawal by Subject|0|||
160516430|NCT02257567|579620543|FG001|Overall Study|Withdrawal by Subject|0|||
160516431|NCT02257567|579620544|FG002|Overall Study|Withdrawal by Subject|2|||
160516432|NCT02257567|579620545|FG003|Overall Study|Withdrawal by Subject|0|||
160516433|NCT02257567|579620546|FG004|Overall Study|Withdrawal by Subject|0|||
160516434|NCT02257567|579620547|FG005|Overall Study|Withdrawal by Subject|6|||
160516435|NCT02257567|579620548|FG006|Overall Study|Withdrawal by Subject|6|||
160516436|NCT02257567|579620549|FG007|Overall Study|Withdrawal by Subject|6|||
160516437|NCT02257567|579620550|FG008|Overall Study|Withdrawal by Subject|1|||
160516438|NCT02257567|579620551|FG009|Overall Study|Withdrawal by Subject|1|||
160516439|NCT02257567|579620552|FG010|Overall Study|Withdrawal by Subject|10|||
160516440|NCT00946101|579620553|FG000|Overall Study|Lost to Follow-up|2|||
160516441|NCT00946101|579620554|FG001|Overall Study|Lost to Follow-up|1|||
160516442|NCT00946101|579620553|FG000|Overall Study|Withdrawal of consent|2|||
160516443|NCT00946101|579620554|FG001|Overall Study|Withdrawal of consent|0|||
160516444|NCT00946101|579620553|FG000|Overall Study|Physician Decision|0|||
160516445|NCT00946101|579620554|FG001|Overall Study|Physician Decision|1|||
160516446|NCT01590017|579620555|FG000|Overall Study|Adverse Event|1|||
160516447|NCT01590017|579620555|FG000|Overall Study|Withdrawal by Subject|1|||
160516448|NCT01590017|579620555|FG000|Overall Study|Lack of Efficacy|1|||
160516449|NCT01590017|579620555|FG000|Overall Study|Physician Decision|1|||
160516450|NCT03625895|579620556|FG000|Overall Study|Protocol Violation|585|||
160516451|NCT03256851|579620557|FG000|Overall Study|Withdrawal by Subject|1|||
160516452|NCT03256851|579620558|FG001|Overall Study|Withdrawal by Subject|0|||
160516453|NCT02081417|579620559|FG000|Overall Study|Lost to Follow-up|26|||
160516454|NCT02081417|579620560|FG001|Overall Study|Lost to Follow-up|23|||
160516455|NCT02081417|579620559|FG000|Overall Study|Moved Away|1|||
160516456|NCT02081417|579620560|FG001|Overall Study|Moved Away|2|||
160516457|NCT02081417|579620559|FG000|Overall Study|Incarcerated|2|||
160516458|NCT02081417|579620560|FG001|Overall Study|Incarcerated|2|||
160516459|NCT02081417|579620559|FG000|Overall Study|Death|4|||
160516460|NCT02081417|579620560|FG001|Overall Study|Death|3|||
160516461|NCT02081417|579620559|FG000|Overall Study|Withdrawal by Subject|4|||
160516462|NCT02081417|579620560|FG001|Overall Study|Withdrawal by Subject|0|||
160516463|NCT02081417|579620559|FG000|Overall Study|Admitted to Residential Treatment|2|||
160516464|NCT02081417|579620560|FG001|Overall Study|Admitted to Residential Treatment|0|||
160516465|NCT02081417|579620559|FG000|Overall Study|Did not start treatment|17|||
160516466|NCT02081417|579620560|FG001|Overall Study|Did not start treatment|21|||
160516467|NCT01065844|579620563|FG000|Overall Study|Adverse Event|5|||
160516468|NCT03545503|579620566|FG000|Overall Study|Protocol Violation|14|||
160516469|NCT03545503|579620567|FG001|Overall Study|Protocol Violation|16|||
160516470|NCT04494256|579620568|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
160516471|NCT04494256|579620569|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
160516472|NCT04494256|579620570|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
160516473|NCT04494256|579620571|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
160516474|NCT04494256|579620572|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
160516475|NCT04494256|579620573|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
160516476|NCT04494256|579620574|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
160516477|NCT04494256|579620568|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
160516478|NCT04494256|579620569|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
160667150|NCT03635320|580162577|FG001|Overall Study|Withdrawal by Subject|6|||
160516479|NCT04494256|579620570|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
160516480|NCT04494256|579620571|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
160516481|NCT04494256|579620572|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
160516482|NCT04494256|579620573|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
160516483|NCT04494256|579620574|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
160516484|NCT04494256|579620568|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
160516485|NCT04494256|579620569|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
160516486|NCT04494256|579620570|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
160516487|NCT04494256|579620571|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
160516488|NCT04494256|579620572|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
160516489|NCT04494256|579620573|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
160516490|NCT04494256|579620574|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
160516491|NCT04494256|579620568|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
160516492|NCT04494256|579620569|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
160516493|NCT04494256|579620570|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
160516494|NCT04494256|579620571|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
160516495|NCT04494256|579620572|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
160516496|NCT04494256|579620573|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
160516497|NCT04494256|579620574|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
160516498|NCT04494256|579620568|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
160516499|NCT04494256|579620569|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
160516500|NCT04494256|579620570|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
160516501|NCT04494256|579620571|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
160516502|NCT04494256|579620572|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
160516503|NCT04494256|579620573|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
160516504|NCT04494256|579620574|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
160516505|NCT04494256|579620568|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
160516506|NCT04494256|579620569|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
160516507|NCT04494256|579620570|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
160516508|NCT04494256|579620571|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
160516509|NCT04494256|579620572|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
160516510|NCT04494256|579620573|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
160516511|NCT04494256|579620574|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
160516512|NCT04494256|579620568|FG000|Part 2: Open Label Period|Death|0|||
160516513|NCT04494256|579620569|FG001|Part 2: Open Label Period|Death|0|||
160516514|NCT04494256|579620570|FG002|Part 2: Open Label Period|Death|0|||
160516515|NCT04494256|579620571|FG003|Part 2: Open Label Period|Death|0|||
160516516|NCT04494256|579620572|FG004|Part 2: Open Label Period|Death|0|||
160516517|NCT04494256|579620573|FG005|Part 2: Open Label Period|Death|4|||
160516518|NCT04494256|579620574|FG006|Part 2: Open Label Period|Death|2|||
160516519|NCT04494256|579620568|FG000|Part 2: Open Label Period|Adverse Event|0|||
160516520|NCT04494256|579620569|FG001|Part 2: Open Label Period|Adverse Event|0|||
160516521|NCT04494256|579620570|FG002|Part 2: Open Label Period|Adverse Event|0|||
160516522|NCT04494256|579620571|FG003|Part 2: Open Label Period|Adverse Event|0|||
160516523|NCT04494256|579620572|FG004|Part 2: Open Label Period|Adverse Event|0|||
160516524|NCT04494256|579620573|FG005|Part 2: Open Label Period|Adverse Event|0|||
160516525|NCT04494256|579620574|FG006|Part 2: Open Label Period|Adverse Event|2|||
160516526|NCT04494256|579620568|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
160516527|NCT04494256|579620569|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
160516528|NCT04494256|579620570|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
160516529|NCT04494256|579620571|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
160516530|NCT04494256|579620572|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
160516531|NCT04494256|579620573|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
160516532|NCT04494256|579620574|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
160516533|NCT04494256|579620568|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
160516534|NCT04494256|579620569|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
160516535|NCT04494256|579620570|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
160516536|NCT04494256|579620571|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
160516537|NCT04494256|579620572|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
160516538|NCT04494256|579620573|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
160516539|NCT04494256|579620574|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
160516540|NCT04494256|579620568|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
160623988|NCT00151775|580003707|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160623989|NCT00151775|580003708|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
160623990|NCT00151775|580003709|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160623991|NCT00151775|580003710|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160623992|NCT00151775|580003711|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160623993|NCT00151775|580003712|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160623994|NCT00151775|580003713|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160623995|NCT00151775|580003714|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160623996|NCT00151775|580003715|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160667151|NCT00804856|580162579|FG000|Overall Study|Progressive Disease|3|||
160667152|NCT00804856|580162580|FG001|Overall Study|Progressive Disease|2|||
160667153|NCT00804856|580162581|FG002|Overall Study|Progressive Disease|4|||
160667154|NCT00804856|580162582|FG003|Overall Study|Progressive Disease|6|||
160667155|NCT00804856|580162583|FG004|Overall Study|Progressive Disease|4|||
160667156|NCT00804856|580162584|FG005|Overall Study|Progressive Disease|1|||
160667157|NCT00804856|580162585|FG006|Overall Study|Progressive Disease|8|||
160667158|NCT00804856|580162586|FG007|Overall Study|Progressive Disease|2|||
160667159|NCT00804856|580162587|FG008|Overall Study|Progressive Disease|4|||
160667160|NCT00804856|580162588|FG009|Overall Study|Progressive Disease|5|||
160667161|NCT00804856|580162589|FG010|Overall Study|Progressive Disease|12|||
160667162|NCT00804856|580162590|FG011|Overall Study|Progressive Disease|2|||
160667163|NCT00804856|580162591|FG012|Overall Study|Progressive Disease|2|||
160667164|NCT00804856|580162592|FG013|Overall Study|Progressive Disease|26|||
160667165|NCT00804856|580162593|FG014|Overall Study|Progressive Disease|20|||
160667166|NCT00804856|580162579|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667167|NCT00804856|580162580|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667168|NCT00804856|580162581|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667169|NCT00804856|580162582|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667170|NCT00804856|580162583|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160667171|NCT00804856|580162584|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667172|NCT00804856|580162585|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667173|NCT00804856|580162586|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667174|NCT00804856|580162587|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667175|NCT00804856|580162588|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667176|NCT00804856|580162589|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667177|NCT00804856|580162590|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667178|NCT00804856|580162591|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667179|NCT00804856|580162592|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160667180|NCT00804856|580162593|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160667181|NCT00804856|580162579|FG000|Overall Study|Other Adverse Event|1|||
160667182|NCT00804856|580162580|FG001|Overall Study|Other Adverse Event|1|||
160667183|NCT00804856|580162581|FG002|Overall Study|Other Adverse Event|1|||
160667184|NCT00804856|580162582|FG003|Overall Study|Other Adverse Event|2|||
160667185|NCT00804856|580162583|FG004|Overall Study|Other Adverse Event|2|||
160667186|NCT00804856|580162584|FG005|Overall Study|Other Adverse Event|1|||
160667187|NCT00804856|580162585|FG006|Overall Study|Other Adverse Event|3|||
160667188|NCT00804856|580162586|FG007|Overall Study|Other Adverse Event|0|||
160667189|NCT00804856|580162587|FG008|Overall Study|Other Adverse Event|0|||
160667190|NCT00804856|580162588|FG009|Overall Study|Other Adverse Event|1|||
160667191|NCT00804856|580162589|FG010|Overall Study|Other Adverse Event|5|||
160667192|NCT00804856|580162590|FG011|Overall Study|Other Adverse Event|2|||
160667193|NCT00804856|580162591|FG012|Overall Study|Other Adverse Event|0|||
160667194|NCT00804856|580162592|FG013|Overall Study|Other Adverse Event|6|||
160667195|NCT00804856|580162593|FG014|Overall Study|Other Adverse Event|13|||
160667196|NCT00804856|580162579|FG000|Overall Study|Non compliance with protocol|0|||
160667197|NCT00804856|580162580|FG001|Overall Study|Non compliance with protocol|0|||
160667198|NCT00804856|580162581|FG002|Overall Study|Non compliance with protocol|0|||
160667199|NCT00804856|580162582|FG003|Overall Study|Non compliance with protocol|0|||
160667200|NCT00804856|580162583|FG004|Overall Study|Non compliance with protocol|0|||
160667201|NCT00804856|580162584|FG005|Overall Study|Non compliance with protocol|0|||
160667202|NCT00804856|580162585|FG006|Overall Study|Non compliance with protocol|0|||
160667203|NCT00804856|580162586|FG007|Overall Study|Non compliance with protocol|0|||
160667204|NCT00804856|580162587|FG008|Overall Study|Non compliance with protocol|0|||
160667205|NCT00804856|580162588|FG009|Overall Study|Non compliance with protocol|0|||
160667206|NCT00804856|580162589|FG010|Overall Study|Non compliance with protocol|0|||
160667207|NCT00804856|580162590|FG011|Overall Study|Non compliance with protocol|0|||
160667208|NCT00804856|580162591|FG012|Overall Study|Non compliance with protocol|0|||
160667209|NCT00804856|580162592|FG013|Overall Study|Non compliance with protocol|2|||
160667210|NCT00804856|580162593|FG014|Overall Study|Non compliance with protocol|0|||
160667211|NCT00804856|580162579|FG000|Overall Study|Refused to continue medication|0|||
160516541|NCT04494256|579620569|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
160516542|NCT04494256|579620570|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
160667212|NCT00804856|580162580|FG001|Overall Study|Refused to continue medication|0|||
160667213|NCT00804856|580162581|FG002|Overall Study|Refused to continue medication|0|||
160667214|NCT00804856|580162582|FG003|Overall Study|Refused to continue medication|1|||
160667215|NCT00804856|580162583|FG004|Overall Study|Refused to continue medication|1|||
160667216|NCT00804856|580162584|FG005|Overall Study|Refused to continue medication|0|||
160667217|NCT00804856|580162585|FG006|Overall Study|Refused to continue medication|0|||
160667218|NCT00804856|580162586|FG007|Overall Study|Refused to continue medication|0|||
160667219|NCT00804856|580162587|FG008|Overall Study|Refused to continue medication|0|||
160516543|NCT04494256|579620571|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
160667220|NCT00804856|580162588|FG009|Overall Study|Refused to continue medication|0|||
160667221|NCT00804856|580162589|FG010|Overall Study|Refused to continue medication|3|||
160667222|NCT00804856|580162590|FG011|Overall Study|Refused to continue medication|0|||
160667223|NCT00804856|580162591|FG012|Overall Study|Refused to continue medication|1|||
160667224|NCT00804856|580162592|FG013|Overall Study|Refused to continue medication|1|||
160667225|NCT00804856|580162593|FG014|Overall Study|Refused to continue medication|5|||
160667226|NCT00804856|580162579|FG000|Overall Study|Other reason than listed above|0|||
160667227|NCT00804856|580162580|FG001|Overall Study|Other reason than listed above|0|||
160667228|NCT00804856|580162581|FG002|Overall Study|Other reason than listed above|0|||
160667229|NCT00804856|580162582|FG003|Overall Study|Other reason than listed above|0|||
160667230|NCT00804856|580162583|FG004|Overall Study|Other reason than listed above|0|||
160667231|NCT00804856|580162584|FG005|Overall Study|Other reason than listed above|1|||
160667232|NCT00804856|580162585|FG006|Overall Study|Other reason than listed above|0|||
160667233|NCT00804856|580162586|FG007|Overall Study|Other reason than listed above|0|||
160667234|NCT00804856|580162587|FG008|Overall Study|Other reason than listed above|1|||
160667235|NCT00804856|580162588|FG009|Overall Study|Other reason than listed above|0|||
160667236|NCT00804856|580162589|FG010|Overall Study|Other reason than listed above|3|||
160667237|NCT00804856|580162590|FG011|Overall Study|Other reason than listed above|1|||
160667238|NCT00804856|580162591|FG012|Overall Study|Other reason than listed above|1|||
160667239|NCT00804856|580162592|FG013|Overall Study|Other reason than listed above|10|||
160667240|NCT00804856|580162593|FG014|Overall Study|Other reason than listed above|3|||
160667241|NCT03049748|580162594|FG000|Overall Study|Lost to Follow-up|1|||
160667242|NCT03049748|580162595|FG001|Overall Study|Lost to Follow-up|0|||
160667243|NCT03049748|580162594|FG000|Overall Study|Death|3|||
160667244|NCT03049748|580162595|FG001|Overall Study|Death|0|||
160667245|NCT03049748|580162594|FG000|Overall Study|Withdrawal by Subject|0|||
160667246|NCT03049748|580162595|FG001|Overall Study|Withdrawal by Subject|3|||
160667247|NCT03049748|580162594|FG000|Overall Study|Protocol Violation|0|||
160667248|NCT03049748|580162595|FG001|Overall Study|Protocol Violation|2|||
160667249|NCT03049748|580162594|FG000|Overall Study|Moved out of state (relocation)|0|||
160667250|NCT03049748|580162595|FG001|Overall Study|Moved out of state (relocation)|1|||
160667251|NCT02682238|580162606|FG000|Overall Study|Lost to Follow-up|0|||
160667252|NCT02682238|580162607|FG001|Overall Study|Lost to Follow-up|2|||
160667253|NCT02682238|580162606|FG000|Overall Study|Withdrawal by Subject|1|||
160667254|NCT02682238|580162607|FG001|Overall Study|Withdrawal by Subject|0|||
160667255|NCT02682238|580162606|FG000|Overall Study|Adverse Event|1|||
160667256|NCT02682238|580162607|FG001|Overall Study|Adverse Event|0|||
160667257|NCT02682238|580162606|FG000|Overall Study|Non-compliance with Study Drug|1|||
160667258|NCT02682238|580162607|FG001|Overall Study|Non-compliance with Study Drug|0|||
160667259|NCT02682238|580162606|FG000|Overall Study|Non-compliance with Protocol|0|||
160667260|NCT02682238|580162607|FG001|Overall Study|Non-compliance with Protocol|2|||
160667261|NCT00960297|580162610|FG000|Overall Study|Physician Decision|1|||
160667262|NCT00960297|580162610|FG000|Overall Study|Venous port infection|1|||
160667263|NCT00960297|580162610|FG000|Overall Study|Disease progression|1|||
160667264|NCT00113386|580162618|FG000|Overall Study|Withdrawal by Subject|1|||
160667265|NCT00113386|580162619|FG001|Overall Study|Withdrawal by Subject|0|||
160667266|NCT00113386|580162618|FG000|Overall Study|Physician Decision|0|||
160667267|NCT00113386|580162619|FG001|Overall Study|Physician Decision|1|||
160667268|NCT00113386|580162618|FG000|Overall Study|Toxicity|3|||
160667269|NCT00113386|580162619|FG001|Overall Study|Toxicity|0|||
160667270|NCT00113386|580162618|FG000|Overall Study|Ineligible|1|||
160667271|NCT00113386|580162619|FG001|Overall Study|Ineligible|2|||
160667272|NCT00113386|580162618|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
160667273|NCT00113386|580162619|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
160667274|NCT02849457|580162620|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
160667275|NCT02849457|580162621|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
160667276|NCT02849457|580162622|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
160667277|NCT02849457|580162623|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
160667278|NCT03437265|580162629|FG000|Overall Study|Protocol Violation|6|||
160667279|NCT01667679|580162634|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
160667280|NCT01667679|580162635|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
160667281|NCT01667679|580162634|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
160667282|NCT01667679|580162635|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
160667283|NCT01667679|580162634|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
160667284|NCT01667679|580162635|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
160667285|NCT01667679|580162634|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
160667286|NCT01667679|580162635|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
160667287|NCT01667679|580162634|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
160667288|NCT01667679|580162635|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
160667289|NCT01667679|580162634|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
160667290|NCT01667679|580162635|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
160667291|NCT01667679|580162634|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
160516544|NCT04494256|579620572|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
160516545|NCT04494256|579620573|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
160516546|NCT04494256|579620574|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
160516547|NCT04494256|579620568|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
160516548|NCT04494256|579620569|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
160516549|NCT04494256|579620570|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
160516550|NCT04494256|579620571|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
160516551|NCT04494256|579620572|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
160516552|NCT04494256|579620573|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
160516553|NCT04494256|579620574|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
160516554|NCT04494256|579620568|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
160516555|NCT04494256|579620569|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
160516556|NCT04494256|579620570|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
160516557|NCT04494256|579620571|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
160516558|NCT04494256|579620572|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
160516559|NCT04494256|579620573|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
160516560|NCT04494256|579620574|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
160516561|NCT00262951|579620575|FG000|Overall Study|Progressive disease/relapse|3|||
160516562|NCT00262951|579620575|FG000|Overall Study|Adverse Event|7|||
160516563|NCT00262951|579620575|FG000|Overall Study|Death|1|||
160516564|NCT00262951|579620575|FG000|Overall Study|Withdrawal by Subject|1|||
160516565|NCT00262951|579620575|FG000|Overall Study|Alternative treatment|3|||
160516566|NCT00262951|579620575|FG000|Overall Study|Off treatment for other disease|1|||
160623997|NCT00151775|580003716|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160623998|NCT00151775|580003717|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160623999|NCT00151775|580003718|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
160624000|NCT00151775|580003707|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
160624001|NCT00151775|580003708|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
160624002|NCT00151775|580003709|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
160624003|NCT00151775|580003710|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
160624004|NCT00151775|580003711|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
160624005|NCT00151775|580003712|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
160624006|NCT00151775|580003713|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
160624007|NCT00151775|580003714|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
160624008|NCT00151775|580003715|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
160624009|NCT00151775|580003716|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
160624010|NCT00151775|580003717|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
160624011|NCT00151775|580003718|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
160624012|NCT00151775|580003707|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624013|NCT00151775|580003708|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624014|NCT00151775|580003709|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624015|NCT00151775|580003710|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624016|NCT00151775|580003711|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624017|NCT00151775|580003712|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
160624018|NCT00151775|580003713|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624019|NCT00151775|580003714|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624020|NCT00151775|580003715|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624021|NCT00151775|580003716|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624022|NCT00151775|580003717|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624023|NCT00151775|580003718|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
160624024|NCT00151775|580003707|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624025|NCT00151775|580003708|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624026|NCT00151775|580003709|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624027|NCT00151775|580003710|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624028|NCT00151775|580003711|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624029|NCT00151775|580003712|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
160624030|NCT00151775|580003713|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624031|NCT00151775|580003714|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624032|NCT00151775|580003715|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624033|NCT00151775|580003716|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624034|NCT00151775|580003717|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624035|NCT00151775|580003718|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
160624036|NCT00151775|580003707|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624037|NCT00151775|580003708|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624038|NCT00151775|580003709|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624039|NCT00151775|580003710|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624040|NCT00151775|580003711|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624041|NCT00151775|580003712|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624042|NCT00151775|580003713|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
160624043|NCT00151775|580003714|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624044|NCT00151775|580003715|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624045|NCT00151775|580003716|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624046|NCT00151775|580003717|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624047|NCT00151775|580003718|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
160624048|NCT00151775|580003707|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624049|NCT00151775|580003708|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624050|NCT00151775|580003709|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624051|NCT00151775|580003710|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624052|NCT00151775|580003711|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624053|NCT00151775|580003712|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
160624054|NCT00151775|580003713|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624055|NCT00151775|580003714|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624056|NCT00151775|580003715|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624057|NCT00151775|580003716|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624058|NCT00151775|580003717|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624059|NCT00151775|580003718|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
160624060|NCT00151775|580003707|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
160624061|NCT00151775|580003708|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
160624062|NCT00151775|580003709|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
160624063|NCT00151775|580003710|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
160624064|NCT00151775|580003711|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
160624065|NCT00151775|580003712|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
160624066|NCT00151775|580003713|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
160624067|NCT00151775|580003714|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
160624068|NCT00151775|580003715|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
160624069|NCT00151775|580003716|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
160624070|NCT00151775|580003717|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
160624071|NCT00151775|580003718|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
160624072|NCT00151775|580003707|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624073|NCT00151775|580003708|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624074|NCT00151775|580003709|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624075|NCT00151775|580003710|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624076|NCT00151775|580003711|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624077|NCT00151775|580003712|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624078|NCT00151775|580003713|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
160624079|NCT00151775|580003714|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624080|NCT00151775|580003715|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624081|NCT00151775|580003716|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624082|NCT00151775|580003717|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624083|NCT00151775|580003718|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
160624084|NCT00151775|580003707|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624085|NCT00151775|580003708|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624086|NCT00151775|580003709|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
160624087|NCT00151775|580003710|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624088|NCT00151775|580003711|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624089|NCT00151775|580003712|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624090|NCT00151775|580003713|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624091|NCT00151775|580003714|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624092|NCT00151775|580003715|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624093|NCT00151775|580003716|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624094|NCT00151775|580003717|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624095|NCT00151775|580003718|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
160624096|NCT00151775|580003707|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624097|NCT00151775|580003708|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624098|NCT00151775|580003709|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
160624099|NCT00151775|580003710|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624100|NCT00151775|580003711|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624101|NCT00151775|580003712|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624102|NCT00151775|580003713|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624103|NCT00151775|580003714|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624104|NCT00151775|580003715|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624105|NCT00151775|580003716|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624106|NCT00151775|580003717|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624107|NCT00151775|580003718|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
160624108|NCT00151775|580003707|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624109|NCT00151775|580003708|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624110|NCT00151775|580003709|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624111|NCT00151775|580003710|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624112|NCT00151775|580003711|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624113|NCT00151775|580003712|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624114|NCT00151775|580003713|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624115|NCT00151775|580003714|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624116|NCT00151775|580003715|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624117|NCT00151775|580003716|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624118|NCT00151775|580003717|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
160624119|NCT00151775|580003718|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
160624120|NCT00151775|580003707|FG000|Period 4: Open Label|Increased blood pressure|0|||
160624121|NCT00151775|580003708|FG001|Period 4: Open Label|Increased blood pressure|0|||
160624122|NCT00151775|580003709|FG002|Period 4: Open Label|Increased blood pressure|0|||
160624123|NCT00151775|580003710|FG003|Period 4: Open Label|Increased blood pressure|0|||
160624124|NCT00151775|580003711|FG004|Period 4: Open Label|Increased blood pressure|1|||
160624125|NCT00151775|580003712|FG005|Period 4: Open Label|Increased blood pressure|0|||
160624126|NCT00151775|580003713|FG006|Period 4: Open Label|Increased blood pressure|0|||
160624127|NCT00151775|580003714|FG007|Period 4: Open Label|Increased blood pressure|0|||
160624128|NCT00151775|580003715|FG008|Period 4: Open Label|Increased blood pressure|0|||
160624129|NCT00151775|580003716|FG009|Period 4: Open Label|Increased blood pressure|1|||
160624130|NCT00151775|580003717|FG010|Period 4: Open Label|Increased blood pressure|0|||
160624131|NCT00151775|580003718|FG011|Period 4: Open Label|Increased blood pressure|0|||
160624132|NCT00151775|580003707|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
160624133|NCT00151775|580003708|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
160624134|NCT00151775|580003709|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
160624135|NCT00151775|580003710|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
160624136|NCT00151775|580003711|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
160624137|NCT00151775|580003712|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
160624138|NCT00151775|580003713|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
160624139|NCT00151775|580003714|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
160624140|NCT00151775|580003715|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
160624141|NCT00151775|580003716|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
160624142|NCT00151775|580003717|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
160624143|NCT00151775|580003718|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
160624144|NCT00151775|580003707|FG000|Period 4: Open Label|Adverse Event|0|||
160624145|NCT00151775|580003708|FG001|Period 4: Open Label|Adverse Event|0|||
160624146|NCT00151775|580003709|FG002|Period 4: Open Label|Adverse Event|0|||
160624147|NCT00151775|580003710|FG003|Period 4: Open Label|Adverse Event|0|||
160624148|NCT00151775|580003711|FG004|Period 4: Open Label|Adverse Event|1|||
160624149|NCT00151775|580003712|FG005|Period 4: Open Label|Adverse Event|0|||
160624150|NCT00151775|580003713|FG006|Period 4: Open Label|Adverse Event|0|||
160624151|NCT00151775|580003714|FG007|Period 4: Open Label|Adverse Event|0|||
160624152|NCT00151775|580003715|FG008|Period 4: Open Label|Adverse Event|0|||
160624153|NCT00151775|580003716|FG009|Period 4: Open Label|Adverse Event|2|||
160624154|NCT00151775|580003717|FG010|Period 4: Open Label|Adverse Event|0|||
160624155|NCT00151775|580003718|FG011|Period 4: Open Label|Adverse Event|0|||
160624156|NCT00151775|580003707|FG000|Period 4: Open Label|Lost to Follow-up|0|||
160624157|NCT00151775|580003708|FG001|Period 4: Open Label|Lost to Follow-up|0|||
160624158|NCT00151775|580003709|FG002|Period 4: Open Label|Lost to Follow-up|0|||
160624159|NCT00151775|580003710|FG003|Period 4: Open Label|Lost to Follow-up|0|||
160624160|NCT00151775|580003711|FG004|Period 4: Open Label|Lost to Follow-up|17|||
160624161|NCT00151775|580003712|FG005|Period 4: Open Label|Lost to Follow-up|0|||
160624162|NCT00151775|580003713|FG006|Period 4: Open Label|Lost to Follow-up|0|||
160624163|NCT00151775|580003714|FG007|Period 4: Open Label|Lost to Follow-up|0|||
160624164|NCT00151775|580003715|FG008|Period 4: Open Label|Lost to Follow-up|0|||
160624165|NCT00151775|580003716|FG009|Period 4: Open Label|Lost to Follow-up|7|||
160624166|NCT00151775|580003717|FG010|Period 4: Open Label|Lost to Follow-up|0|||
160624167|NCT00151775|580003718|FG011|Period 4: Open Label|Lost to Follow-up|0|||
160624168|NCT00151775|580003707|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
160624169|NCT00151775|580003708|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
160624170|NCT00151775|580003709|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
160624171|NCT00151775|580003710|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
160624172|NCT00151775|580003711|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
160624173|NCT00151775|580003712|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
160624174|NCT00151775|580003713|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
160624175|NCT00151775|580003714|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
160516567|NCT02483585|579620576|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
160516568|NCT02483585|579620577|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
160516569|NCT02483585|579620576|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
160516570|NCT02483585|579620577|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
160516571|NCT02483585|579620576|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
160516572|NCT02483585|579620577|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
160516573|NCT02483585|579620576|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
160516574|NCT02483585|579620577|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
160516575|NCT02483585|579620576|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
160516576|NCT02483585|579620577|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
160516577|NCT02483585|579620576|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
160516578|NCT02483585|579620577|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
160516579|NCT02483585|579620576|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
160516580|NCT02483585|579620577|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
160516581|NCT00825916|579620581|FG000|Overall Study|Lost to Follow-up|4|||
160516582|NCT00825916|579620582|FG001|Overall Study|Lost to Follow-up|2|||
160516583|NCT00825916|579620583|FG002|Overall Study|Lost to Follow-up|1|||
160516584|NCT01778023|579620584|FG000|Overall Study|Withdrawal by Subject|0|||
160516585|NCT01778023|579620585|FG001|Overall Study|Withdrawal by Subject|3|||
160516586|NCT01000636|579620590|FG000|Overall Study|Withdrawal by Subject|1|||
160516587|NCT01000636|579620590|FG000|Overall Study|Adverse Event|1|||
160516588|NCT02319525|579620591|FG000|Overall Study|Withdrawal by Subject|2|||
160516589|NCT02319525|579620592|FG001|Overall Study|Withdrawal by Subject|1|||
160516590|NCT02424734|579620597|FG000|Overall Study|Treatment stopped to be discharged home|2|||
160516591|NCT02424734|579620598|FG001|Overall Study|Treatment stopped to be discharged home|2|||
160516592|NCT02424734|579620599|FG002|Overall Study|Treatment stopped to be discharged home|0|||
160516593|NCT01445301|579620600|FG000|Overall Study|Adverse Event|15|||
160516594|NCT01445301|579620601|FG001|Overall Study|Adverse Event|25|||
160516595|NCT01445301|579620602|FG002|Overall Study|Adverse Event|4|||
160516596|NCT01445301|579620600|FG000|Overall Study|Lack of Efficacy|0|||
160516597|NCT01445301|579620601|FG001|Overall Study|Lack of Efficacy|1|||
160516598|NCT01445301|579620602|FG002|Overall Study|Lack of Efficacy|0|||
160516599|NCT01445301|579620600|FG000|Overall Study|Protocol Violation|1|||
160516600|NCT01445301|579620601|FG001|Overall Study|Protocol Violation|0|||
160516601|NCT01445301|579620602|FG002|Overall Study|Protocol Violation|0|||
160516602|NCT01445301|579620600|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
160516603|NCT01445301|579620601|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
160516604|NCT01445301|579620602|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
160516605|NCT01445301|579620600|FG000|Overall Study|Physician Decision|0|||
160516606|NCT01445301|579620601|FG001|Overall Study|Physician Decision|2|||
160516607|NCT01445301|579620602|FG002|Overall Study|Physician Decision|0|||
160516608|NCT01445301|579620600|FG000|Overall Study|Withdrawal by Subject|5|||
160516609|NCT01445301|579620601|FG001|Overall Study|Withdrawal by Subject|6|||
160516610|NCT01445301|579620602|FG002|Overall Study|Withdrawal by Subject|4|||
160516611|NCT00752557|579620603|FG000|Overall Study|Withdrawal by Subject|4|||
160516612|NCT00752557|579620604|FG001|Overall Study|Withdrawal by Subject|3|||
160516613|NCT00752557|579620605|FG002|Overall Study|Withdrawal by Subject|3|||
160516614|NCT00752557|579620603|FG000|Overall Study|Unspecified resaons|0|||
160516615|NCT00752557|579620604|FG001|Overall Study|Unspecified resaons|2|||
160516616|NCT00752557|579620605|FG002|Overall Study|Unspecified resaons|2|||
160516617|NCT00752557|579620603|FG000|Overall Study|Lost to Follow-up|1|||
160516618|NCT00752557|579620604|FG001|Overall Study|Lost to Follow-up|0|||
160516619|NCT00752557|579620605|FG002|Overall Study|Lost to Follow-up|1|||
160516620|NCT02150343|579620606|FG000|Overall Study|Adverse Event|2|||
160516621|NCT02150343|579620607|FG001|Overall Study|Adverse Event|0|||
160516622|NCT02150343|579620608|FG002|Overall Study|Adverse Event|1|||
160516623|NCT02150343|579620609|FG003|Overall Study|Adverse Event|1|||
160516624|NCT02150343|579620606|FG000|Overall Study|Withdrawal by Subject|13|||
160516625|NCT02150343|579620607|FG001|Overall Study|Withdrawal by Subject|10|||
160516626|NCT02150343|579620608|FG002|Overall Study|Withdrawal by Subject|9|||
160516627|NCT02150343|579620609|FG003|Overall Study|Withdrawal by Subject|4|||
160516628|NCT02150343|579620606|FG000|Overall Study|Lost to Follow-up|4|||
160516629|NCT02150343|579620607|FG001|Overall Study|Lost to Follow-up|4|||
160516630|NCT02150343|579620608|FG002|Overall Study|Lost to Follow-up|2|||
160516631|NCT02150343|579620609|FG003|Overall Study|Lost to Follow-up|3|||
160516632|NCT02150343|579620606|FG000|Overall Study|Other|2|||
160516633|NCT02150343|579620607|FG001|Overall Study|Other|6|||
160516634|NCT02150343|579620608|FG002|Overall Study|Other|0|||
160516635|NCT02150343|579620609|FG003|Overall Study|Other|2|||
160516636|NCT00906945|579620610|FG000|Overall Study|Found to be not eligible|0|||
160516637|NCT00906945|579620611|FG001|Overall Study|Found to be not eligible|0|||
160516638|NCT00906945|579620612|FG002|Overall Study|Found to be not eligible|0|||
160516639|NCT00906945|579620613|FG003|Overall Study|Found to be not eligible|1|||
160516640|NCT00906945|579620614|FG004|Overall Study|Found to be not eligible|1|||
160516641|NCT00906945|579620615|FG005|Overall Study|Found to be not eligible|1|||
160516642|NCT00906945|579620610|FG000|Overall Study|Physician Decision|0|||
160624176|NCT00151775|580003715|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
160624177|NCT00151775|580003716|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
160624178|NCT00151775|580003717|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
160624179|NCT00151775|580003718|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
160624180|NCT00151775|580003707|FG000|Period 4: Open Label|Other|0|||
160624181|NCT00151775|580003708|FG001|Period 4: Open Label|Other|0|||
160624182|NCT00151775|580003709|FG002|Period 4: Open Label|Other|0|||
160624183|NCT00151775|580003710|FG003|Period 4: Open Label|Other|0|||
160624184|NCT00151775|580003711|FG004|Period 4: Open Label|Other|1|||
160624185|NCT00151775|580003712|FG005|Period 4: Open Label|Other|0|||
160624186|NCT00151775|580003713|FG006|Period 4: Open Label|Other|0|||
160624187|NCT00151775|580003714|FG007|Period 4: Open Label|Other|0|||
160624188|NCT00151775|580003715|FG008|Period 4: Open Label|Other|0|||
160624189|NCT00151775|580003716|FG009|Period 4: Open Label|Other|3|||
160624190|NCT00151775|580003717|FG010|Period 4: Open Label|Other|0|||
160624191|NCT00151775|580003718|FG011|Period 4: Open Label|Other|0|||
160624192|NCT00151775|580003707|FG000|Period 4: Open Label|Physician Decision|0|||
160624193|NCT00151775|580003708|FG001|Period 4: Open Label|Physician Decision|0|||
160624194|NCT00151775|580003709|FG002|Period 4: Open Label|Physician Decision|0|||
160624195|NCT00151775|580003710|FG003|Period 4: Open Label|Physician Decision|0|||
160624196|NCT00151775|580003711|FG004|Period 4: Open Label|Physician Decision|0|||
160624197|NCT00151775|580003712|FG005|Period 4: Open Label|Physician Decision|0|||
160624198|NCT00151775|580003713|FG006|Period 4: Open Label|Physician Decision|0|||
160667292|NCT01667679|580162635|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
160667293|NCT01667679|580162634|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
160667294|NCT01667679|580162635|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
160667295|NCT01667679|580162634|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
160667296|NCT01667679|580162635|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
160667297|NCT01667679|580162634|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
160667298|NCT01667679|580162635|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
160667299|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
160667300|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
160667301|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
160667302|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
160667303|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
160667304|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
160667305|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
160667306|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
160667307|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
160667308|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
160667309|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
160667310|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
160667311|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
160667312|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
160667313|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
160667314|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
160667315|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
160667316|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
160667317|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
160667318|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
160667319|NCT01667679|580162634|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
160667320|NCT01667679|580162635|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
160667321|NCT01444378|580162642|FG000|Overall Study|Lost to Follow-up|1|||
160667322|NCT01444378|580162642|FG000|Overall Study|Withdrawal by Subject|1|||
160667323|NCT01444378|580162642|FG000|Overall Study|Death|3|||
160667324|NCT01444378|580162642|FG000|Overall Study|Administrative Closure Of The Study|2|||
160667325|NCT01444378|580162642|FG000|Overall Study|Missed Visits|10|||
160667326|NCT02911792|580162643|FG000|Overall Study|Lost to Follow-up|3|||
160667327|NCT02911792|580162644|FG001|Overall Study|Lost to Follow-up|3|||
160624199|NCT00151775|580003714|FG007|Period 4: Open Label|Physician Decision|0|||
160624200|NCT00151775|580003715|FG008|Period 4: Open Label|Physician Decision|0|||
160624201|NCT00151775|580003716|FG009|Period 4: Open Label|Physician Decision|2|||
160624202|NCT00151775|580003717|FG010|Period 4: Open Label|Physician Decision|0|||
160624203|NCT00151775|580003718|FG011|Period 4: Open Label|Physician Decision|0|||
160624204|NCT00151775|580003707|FG000|Period 4: Open Label|Protocol Violation|0|||
160624205|NCT00151775|580003708|FG001|Period 4: Open Label|Protocol Violation|0|||
160624206|NCT00151775|580003709|FG002|Period 4: Open Label|Protocol Violation|0|||
160624207|NCT00151775|580003710|FG003|Period 4: Open Label|Protocol Violation|0|||
160624208|NCT00151775|580003711|FG004|Period 4: Open Label|Protocol Violation|1|||
160624209|NCT00151775|580003712|FG005|Period 4: Open Label|Protocol Violation|0|||
160667328|NCT02911792|580162645|FG002|Overall Study|Lost to Follow-up|3|||
160667329|NCT02911792|580162646|FG003|Overall Study|Lost to Follow-up|3|||
160667330|NCT00840073|580162649|FG000|Second Intervention|Missed 72 hour blood draw|1|||
160667331|NCT00840073|580162650|FG001|Second Intervention|Missed 72 hour blood draw|1|||
160667332|NCT02558491|580162651|FG000|First Invention|Withdrawal by Subject|3|||
160667333|NCT02558491|580162652|FG001|First Invention|Withdrawal by Subject|1|||
160667334|NCT02558491|580162651|FG000|First Invention|Data collection issues|1|||
160667335|NCT02558491|580162652|FG001|First Invention|Data collection issues|0|||
160667336|NCT02558491|580162651|FG000|First Invention|Stopping criteria|0|||
160667337|NCT02558491|580162652|FG001|First Invention|Stopping criteria|1|||
160667338|NCT02558491|580162651|FG000|First Invention|Changed parameters during trial|1|||
160667339|NCT02558491|580162652|FG001|First Invention|Changed parameters during trial|0|||
160667340|NCT02558491|580162651|FG000|Second Intervention|Withdrawal by Subject|1|||
160667341|NCT02558491|580162652|FG001|Second Intervention|Withdrawal by Subject|0|||
160667342|NCT02558491|580162651|FG000|Second Intervention|Stopping Criteria|1|||
160667343|NCT02558491|580162652|FG001|Second Intervention|Stopping Criteria|0|||
160667344|NCT03256695|580162653|FG000|Overall Study|Adverse Event|8|||
160667345|NCT03256695|580162653|FG000|Overall Study|Death|2|||
160667346|NCT03256695|580162653|FG000|Overall Study|Withdrawal by Subject|14|||
160667347|NCT03256695|580162653|FG000|Overall Study|Non-compliance with study drug|1|||
160667348|NCT03256695|580162653|FG000|Overall Study|Lost to Follow-up|3|||
160667349|NCT03256695|580162653|FG000|Overall Study|Lack of Efficacy|3|||
160667350|NCT03256695|580162653|FG000|Overall Study|Protocol Violation|5|||
160667351|NCT03256695|580162653|FG000|Overall Study|Other than specified|3|||
160667352|NCT02964039|580162654|FG000|Overall Study|Medical reason unrelated to study participation|1|||
160667353|NCT02964039|580162655|FG001|Overall Study|Medical reason unrelated to study participation|0|||
160667354|NCT02964039|580162656|FG002|Overall Study|Medical reason unrelated to study participation|3|||
160667355|NCT02964039|580162654|FG000|Overall Study|Research shutdown due to pandemic|2|||
160667356|NCT02964039|580162655|FG001|Overall Study|Research shutdown due to pandemic|0|||
160667357|NCT02964039|580162656|FG002|Overall Study|Research shutdown due to pandemic|1|||
160667358|NCT02964039|580162654|FG000|Overall Study|Withdrawal by Subject|0|||
160667359|NCT02964039|580162655|FG001|Overall Study|Withdrawal by Subject|1|||
160667360|NCT02964039|580162656|FG002|Overall Study|Withdrawal by Subject|0|||
160667361|NCT02964039|580162654|FG000|Overall Study|Lost to Follow-up|1|||
160667362|NCT02964039|580162655|FG001|Overall Study|Lost to Follow-up|0|||
160667363|NCT02964039|580162656|FG002|Overall Study|Lost to Follow-up|1|||
160667364|NCT01103713|580162657|FG000|Overall Study|Lost to Follow-up|2|||
160667365|NCT01103713|580162657|FG000|Overall Study|Withdrawal by Subject|8|||
160667366|NCT01103713|580162657|FG000|Overall Study|Study terminated by sponsor|2|||
160667367|NCT01103713|580162657|FG000|Overall Study|Other|1|||
160667368|NCT02645409|580162658|FG000|Overall Study|Withdrawal by Subject|3|||
160667369|NCT02645409|580162659|FG001|Overall Study|Withdrawal by Subject|0|||
160667370|NCT02645409|580162658|FG000|Overall Study|Physician Decision|1|||
160667371|NCT02645409|580162659|FG001|Overall Study|Physician Decision|0|||
160667372|NCT02089685|580162660|FG000|Overall Study|Adverse Event|1|||
160667373|NCT02089685|580162661|FG001|Overall Study|Adverse Event|0|||
160667374|NCT02089685|580162662|FG002|Overall Study|Adverse Event|0|||
160667375|NCT02089685|580162663|FG003|Overall Study|Adverse Event|0|||
160667376|NCT02089685|580162664|FG004|Overall Study|Adverse Event|1|||
160667377|NCT02089685|580162665|FG005|Overall Study|Adverse Event|0|||
160667378|NCT02089685|580162660|FG000|Overall Study|Clinical Progression|4|||
160667379|NCT02089685|580162661|FG001|Overall Study|Clinical Progression|0|||
160667380|NCT02089685|580162662|FG002|Overall Study|Clinical Progression|0|||
160667381|NCT02089685|580162663|FG003|Overall Study|Clinical Progression|5|||
160667382|NCT02089685|580162664|FG004|Overall Study|Clinical Progression|1|||
160667383|NCT02089685|580162665|FG005|Overall Study|Clinical Progression|2|||
160667384|NCT02089685|580162660|FG000|Overall Study|Excluded Medication|1|||
160667385|NCT02089685|580162661|FG001|Overall Study|Excluded Medication|0|||
160667386|NCT02089685|580162662|FG002|Overall Study|Excluded Medication|0|||
160667387|NCT02089685|580162663|FG003|Overall Study|Excluded Medication|11|||
160667388|NCT02089685|580162664|FG004|Overall Study|Excluded Medication|2|||
160667389|NCT02089685|580162665|FG005|Overall Study|Excluded Medication|1|||
160667390|NCT02089685|580162660|FG000|Overall Study|Progressive disease|13|||
160667391|NCT02089685|580162661|FG001|Overall Study|Progressive disease|10|||
160667392|NCT02089685|580162662|FG002|Overall Study|Progressive disease|3|||
160667393|NCT02089685|580162663|FG003|Overall Study|Progressive disease|51|||
160667394|NCT02089685|580162664|FG004|Overall Study|Progressive disease|17|||
160667395|NCT02089685|580162665|FG005|Overall Study|Progressive disease|12|||
160667396|NCT02089685|580162660|FG000|Overall Study|Follow up ended by sponsor|2|||
160667397|NCT02089685|580162661|FG001|Overall Study|Follow up ended by sponsor|2|||
160667398|NCT02089685|580162662|FG002|Overall Study|Follow up ended by sponsor|0|||
160667399|NCT02089685|580162663|FG003|Overall Study|Follow up ended by sponsor|70|||
160667400|NCT02089685|580162664|FG004|Overall Study|Follow up ended by sponsor|26|||
160667401|NCT02089685|580162665|FG005|Overall Study|Follow up ended by sponsor|26|||
160667402|NCT02089685|580162660|FG000|Overall Study|Withdrawal by Subject|0|||
160667403|NCT02089685|580162661|FG001|Overall Study|Withdrawal by Subject|2|||
160667404|NCT02089685|580162662|FG002|Overall Study|Withdrawal by Subject|0|||
160667405|NCT02089685|580162663|FG003|Overall Study|Withdrawal by Subject|8|||
160667406|NCT02089685|580162664|FG004|Overall Study|Withdrawal by Subject|1|||
160667407|NCT02089685|580162665|FG005|Overall Study|Withdrawal by Subject|1|||
160667408|NCT02089685|580162660|FG000|Overall Study|Status not recorded|1|||
160667409|NCT02089685|580162661|FG001|Overall Study|Status not recorded|0|||
160667410|NCT02089685|580162662|FG002|Overall Study|Status not recorded|0|||
160516643|NCT00906945|579620611|FG001|Overall Study|Physician Decision|0|||
160516644|NCT00906945|579620612|FG002|Overall Study|Physician Decision|0|||
160516645|NCT00906945|579620613|FG003|Overall Study|Physician Decision|0|||
160516646|NCT00906945|579620614|FG004|Overall Study|Physician Decision|0|||
160516647|NCT00906945|579620615|FG005|Overall Study|Physician Decision|1|||
160516648|NCT01210664|579620617|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
160516649|NCT01210664|579620618|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
160516650|NCT01210664|579620619|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
160667411|NCT02089685|580162663|FG003|Overall Study|Status not recorded|0|||
160667412|NCT02089685|580162664|FG004|Overall Study|Status not recorded|1|||
160667413|NCT02089685|580162665|FG005|Overall Study|Status not recorded|0|||
160667414|NCT02089685|580162660|FG000|Overall Study|Death|0|||
160667415|NCT02089685|580162661|FG001|Overall Study|Death|0|||
160667416|NCT02089685|580162662|FG002|Overall Study|Death|0|||
160667417|NCT02089685|580162663|FG003|Overall Study|Death|7|||
160667418|NCT02089685|580162664|FG004|Overall Study|Death|2|||
160667419|NCT02089685|580162665|FG005|Overall Study|Death|5|||
160667420|NCT02089685|580162660|FG000|Overall Study|Lost to Follow-up|0|||
160667421|NCT02089685|580162661|FG001|Overall Study|Lost to Follow-up|0|||
160667422|NCT02089685|580162662|FG002|Overall Study|Lost to Follow-up|0|||
160667423|NCT02089685|580162663|FG003|Overall Study|Lost to Follow-up|1|||
160667424|NCT02089685|580162664|FG004|Overall Study|Lost to Follow-up|0|||
160667425|NCT02089685|580162665|FG005|Overall Study|Lost to Follow-up|0|||
160667426|NCT02089685|580162660|FG000|Overall Study|Physician Decision|0|||
160667427|NCT02089685|580162661|FG001|Overall Study|Physician Decision|0|||
160667428|NCT02089685|580162662|FG002|Overall Study|Physician Decision|0|||
160667429|NCT02089685|580162663|FG003|Overall Study|Physician Decision|0|||
160667430|NCT02089685|580162664|FG004|Overall Study|Physician Decision|0|||
160667431|NCT02089685|580162665|FG005|Overall Study|Physician Decision|4|||
160667432|NCT02089685|580162660|FG000|Overall Study|Screen failure|1|||
160667433|NCT02089685|580162661|FG001|Overall Study|Screen failure|0|||
160667434|NCT02089685|580162662|FG002|Overall Study|Screen failure|0|||
160667435|NCT02089685|580162663|FG003|Overall Study|Screen failure|0|||
160667436|NCT02089685|580162664|FG004|Overall Study|Screen failure|0|||
160667437|NCT02089685|580162665|FG005|Overall Study|Screen failure|0|||
160667438|NCT03552393|580162668|FG000|Core Period|Kidney Transplant|1|||
160667439|NCT03552393|580162668|FG000|Core Period|Prohibited Medication|1|||
160667440|NCT03552393|580162668|FG000|Safety Extension Period|Kidney Transplant|4|||
160667441|NCT00465270|580162672|FG000|Overall Study|Death|7|||
160667442|NCT00465270|580162673|FG001|Overall Study|Death|11|||
160667443|NCT00465270|580162672|FG000|Overall Study|Withdrawal by Subject|34|||
160667444|NCT00465270|580162673|FG001|Overall Study|Withdrawal by Subject|78|||
160667445|NCT00465270|580162672|FG000|Overall Study|Lost to Follow-up|60|||
160667446|NCT00465270|580162673|FG001|Overall Study|Lost to Follow-up|67|||
160667447|NCT00465270|580162672|FG000|Overall Study|Investigator request|3|||
160667448|NCT00465270|580162673|FG001|Overall Study|Investigator request|4|||
160667449|NCT01576042|580162674|FG000|Overall Study|Physician Decision|2|||
160667450|NCT01576042|580162675|FG001|Overall Study|Physician Decision|0|||
160667451|NCT03233724|580162676|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
160667452|NCT03233724|580162677|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
160667453|NCT03233724|580162678|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
160667454|NCT03233724|580162679|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
160667455|NCT03233724|580162680|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
160667456|NCT03233724|580162676|FG000|Phase I Dose Escalation|Best interest of participant|1|||
160667457|NCT03233724|580162677|FG001|Phase I Dose Escalation|Best interest of participant|1|||
160667458|NCT03233724|580162678|FG002|Phase I Dose Escalation|Best interest of participant|1|||
160667459|NCT03233724|580162679|FG003|Phase I Dose Escalation|Best interest of participant|0|||
160667460|NCT03233724|580162680|FG004|Phase I Dose Escalation|Best interest of participant|0|||
160667461|NCT03233724|580162676|FG000|Phase I Dose Escalation|Physician Decision|0|||
160667462|NCT03233724|580162677|FG001|Phase I Dose Escalation|Physician Decision|0|||
160516651|NCT01210664|579620620|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
160516652|NCT01210664|579620617|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
160516653|NCT01210664|579620618|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
160667463|NCT03233724|580162678|FG002|Phase I Dose Escalation|Physician Decision|1|||
160667464|NCT03233724|580162679|FG003|Phase I Dose Escalation|Physician Decision|0|||
160667465|NCT03233724|580162680|FG004|Phase I Dose Escalation|Physician Decision|0|||
160667466|NCT03233724|580162676|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
160516654|NCT01210664|579620619|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
160516655|NCT01210664|579620620|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
160516656|NCT01210664|579620617|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
160516657|NCT01210664|579620618|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
160516658|NCT01210664|579620619|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
160516659|NCT01210664|579620620|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
160516660|NCT01853644|579620621|FG000|Registration and Treatment Start|Did not start treatment|1|||
160516661|NCT01853644|579620621|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
160516662|NCT01853644|579620621|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
160516663|NCT01853644|579620621|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
160516664|NCT01853644|579620621|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
160516665|NCT01853644|579620621|FG000|Continued Treatment After First Response|Adverse Event|2|||
160516666|NCT01853644|579620621|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
160516667|NCT02891408|579620622|FG000|Overall Study|Lost to Follow-up|0|||
160516668|NCT02891408|579620623|FG001|Overall Study|Lost to Follow-up|0|||
160516669|NCT02891408|579620624|FG002|Overall Study|Lost to Follow-up|1|||
160516670|NCT02891408|579620625|FG003|Overall Study|Lost to Follow-up|0|||
160516671|NCT02891408|579620626|FG004|Overall Study|Lost to Follow-up|0|||
160516672|NCT02891408|579620627|FG005|Overall Study|Lost to Follow-up|0|||
160516673|NCT02891408|579620628|FG006|Overall Study|Lost to Follow-up|0|||
160516674|NCT02679508|579620632|FG000|Healing Phase|Protocol Violation|1|||
160516675|NCT02679508|579620633|FG001|Healing Phase|Protocol Violation|1|||
160516676|NCT02679508|579620632|FG000|Healing Phase|Lost to Follow-up|1|||
160516677|NCT02679508|579620633|FG001|Healing Phase|Lost to Follow-up|0|||
160516678|NCT02679508|579620632|FG000|Maintenance Phase|Adverse Event|12|||
160516679|NCT02679508|579620633|FG001|Maintenance Phase|Adverse Event|2|||
160516680|NCT02679508|579620632|FG000|Maintenance Phase|Lost to Follow-up|0|||
160516681|NCT02679508|579620633|FG001|Maintenance Phase|Lost to Follow-up|1|||
160516682|NCT02679508|579620632|FG000|Maintenance Phase|Withdrawal by Subject|15|||
160516683|NCT02679508|579620633|FG001|Maintenance Phase|Withdrawal by Subject|8|||
160516684|NCT02679508|579620632|FG000|Maintenance Phase|Other|5|||
160516685|NCT02679508|579620633|FG001|Maintenance Phase|Other|4|||
160516686|NCT05172050|579620634|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
160516687|NCT05172050|579620635|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
160516688|NCT05172050|579620636|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
160516689|NCT05172050|579620634|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
160516690|NCT05172050|579620635|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
160516691|NCT05172050|579620636|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
160516692|NCT05172050|579620634|FG000|Overall Study|Other|2|||
160516693|NCT05172050|579620635|FG001|Overall Study|Other|2|||
160516694|NCT05172050|579620636|FG002|Overall Study|Other|1|||
160516695|NCT04617275|579620641|FG000|Treatment Period|Adverse Event|1|||
160516696|NCT04617275|579620642|FG001|Treatment Period|Adverse Event|6|||
160624210|NCT00151775|580003713|FG006|Period 4: Open Label|Protocol Violation|0|||
160624211|NCT00151775|580003714|FG007|Period 4: Open Label|Protocol Violation|0|||
160624212|NCT00151775|580003715|FG008|Period 4: Open Label|Protocol Violation|0|||
160624213|NCT00151775|580003716|FG009|Period 4: Open Label|Protocol Violation|0|||
160624214|NCT00151775|580003717|FG010|Period 4: Open Label|Protocol Violation|0|||
160624215|NCT00151775|580003718|FG011|Period 4: Open Label|Protocol Violation|0|||
160624216|NCT00474994|580003719|FG000|Overall Study|Patient Not treated|1|||
160624217|NCT00474994|580003719|FG000|Overall Study|Patient evaluable for toxicity only|3|||
160624218|NCT00474994|580003719|FG000|Overall Study|Patient found to be ineligible|1|||
160624219|NCT00278473|580003720|FG000|Overall Study|drop out|4|||
160624220|NCT00278473|580003721|FG001|Overall Study|drop out|3|||
160624221|NCT00761761|580003722|FG000|Overall Study|Lost to Follow-up|3|||
160624222|NCT00761761|580003723|FG001|Overall Study|Lost to Follow-up|1|||
160624223|NCT00761761|580003722|FG000|Overall Study|Withdrawal by Subject|3|||
160624224|NCT00761761|580003723|FG001|Overall Study|Withdrawal by Subject|0|||
160624225|NCT04001790|580003724|FG000|Overall Study|Withdrawal by Subject|1|||
160624226|NCT04001790|580003725|FG001|Overall Study|Withdrawal by Subject|2|||
160624227|NCT01711736|580003726|FG000|Overall Study|Lost to Follow-up|4|||
160624228|NCT01711736|580003727|FG001|Overall Study|Lost to Follow-up|1|||
160624229|NCT01711736|580003726|FG000|Overall Study|Withdrawal by Subject|6|||
160624230|NCT01711736|580003727|FG001|Overall Study|Withdrawal by Subject|6|||
160624231|NCT01711736|580003726|FG000|Overall Study|Migrated/moved from study area|2|||
160624232|NCT01711736|580003727|FG001|Overall Study|Migrated/moved from study area|1|||
160516697|NCT04617275|579620643|FG002|Treatment Period|Adverse Event|4|||
160516698|NCT04617275|579620644|FG003|Treatment Period|Adverse Event|6|||
160516699|NCT04617275|579620645|FG004|Treatment Period|Adverse Event|7|||
160516700|NCT04617275|579620646|FG005|Treatment Period|Adverse Event|8|||
160624233|NCT02706327|580003728|FG000|Overall Study|Lost to Follow-up|1|||
160624234|NCT02706327|580003729|FG001|Overall Study|Lost to Follow-up|1|||
160624235|NCT02706327|580003730|FG002|Overall Study|Lost to Follow-up|2|||
160624236|NCT02652793|580003733|FG000|Overall Study|Adverse Event|1|||
160624237|NCT02652793|580003733|FG000|Overall Study|Lost to Follow-up|2|||
160516701|NCT04617275|579620647|FG006|Treatment Period|Adverse Event|0|||
160516702|NCT04617275|579620648|FG007|Treatment Period|Adverse Event|12|||
160516703|NCT04617275|579620641|FG000|Treatment Period|Lost to Follow-up|0|||
160516704|NCT04617275|579620642|FG001|Treatment Period|Lost to Follow-up|0|||
160516705|NCT04617275|579620643|FG002|Treatment Period|Lost to Follow-up|2|||
160516706|NCT04617275|579620644|FG003|Treatment Period|Lost to Follow-up|0|||
160516707|NCT04617275|579620645|FG004|Treatment Period|Lost to Follow-up|0|||
160516708|NCT04617275|579620646|FG005|Treatment Period|Lost to Follow-up|3|||
160516709|NCT04617275|579620647|FG006|Treatment Period|Lost to Follow-up|0|||
160516710|NCT04617275|579620648|FG007|Treatment Period|Lost to Follow-up|2|||
160516711|NCT04617275|579620641|FG000|Treatment Period|No longer meets eligibility criteria|0|||
160516712|NCT04617275|579620642|FG001|Treatment Period|No longer meets eligibility criteria|0|||
160516713|NCT04617275|579620643|FG002|Treatment Period|No longer meets eligibility criteria|0|||
160516714|NCT04617275|579620644|FG003|Treatment Period|No longer meets eligibility criteria|1|||
160516715|NCT04617275|579620645|FG004|Treatment Period|No longer meets eligibility criteria|0|||
160516716|NCT04617275|579620646|FG005|Treatment Period|No longer meets eligibility criteria|0|||
160516717|NCT04617275|579620647|FG006|Treatment Period|No longer meets eligibility criteria|0|||
160516718|NCT04617275|579620648|FG007|Treatment Period|No longer meets eligibility criteria|0|||
160516719|NCT04617275|579620641|FG000|Treatment Period|Other|0|||
160516720|NCT04617275|579620642|FG001|Treatment Period|Other|1|||
160516721|NCT04617275|579620643|FG002|Treatment Period|Other|0|||
160516722|NCT04617275|579620644|FG003|Treatment Period|Other|0|||
160516723|NCT04617275|579620645|FG004|Treatment Period|Other|0|||
160516724|NCT04617275|579620646|FG005|Treatment Period|Other|0|||
160516725|NCT04617275|579620647|FG006|Treatment Period|Other|0|||
160516726|NCT04617275|579620648|FG007|Treatment Period|Other|0|||
160516727|NCT04617275|579620641|FG000|Treatment Period|Withdrawal by Subject|2|||
160516728|NCT04617275|579620642|FG001|Treatment Period|Withdrawal by Subject|0|||
160516729|NCT04617275|579620643|FG002|Treatment Period|Withdrawal by Subject|0|||
160667467|NCT03233724|580162677|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
160667468|NCT03233724|580162678|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
160667469|NCT03233724|580162679|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
160667470|NCT03233724|580162680|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
160667471|NCT02388191|580162681|FG000|Overall Study|Patient did not receive IUD|1|||
160667472|NCT02388191|580162682|FG001|Overall Study|Patient did not receive IUD|0|||
160667473|NCT01911676|580162683|FG000|Period 1 of Study|Withdrawal by Subject|4|||
160667474|NCT01911676|580162684|FG001|Period 1 of Study|Withdrawal by Subject|2|||
160667475|NCT01911676|580162685|FG002|Period 1 of Study|Withdrawal by Subject|1|||
160667476|NCT01911676|580162686|FG003|Period 1 of Study|Withdrawal by Subject|2|||
160667477|NCT01911676|580162683|FG000|Period 1 of Study|Physician Decision|2|||
160667478|NCT01911676|580162684|FG001|Period 1 of Study|Physician Decision|0|||
160667479|NCT01911676|580162685|FG002|Period 1 of Study|Physician Decision|0|||
160667480|NCT01911676|580162686|FG003|Period 1 of Study|Physician Decision|1|||
160667481|NCT01911676|580162683|FG000|Period 2 of Study|Physician Decision|2|||
160667482|NCT01911676|580162684|FG001|Period 2 of Study|Physician Decision|0|||
160667483|NCT01911676|580162685|FG002|Period 2 of Study|Physician Decision|0|||
160667484|NCT01911676|580162686|FG003|Period 2 of Study|Physician Decision|1|||
160667485|NCT01911676|580162683|FG000|Period 2 of Study|Lost to Follow-up|0|||
160667486|NCT01911676|580162684|FG001|Period 2 of Study|Lost to Follow-up|0|||
160667487|NCT01911676|580162685|FG002|Period 2 of Study|Lost to Follow-up|0|||
160667488|NCT01911676|580162686|FG003|Period 2 of Study|Lost to Follow-up|1|||
160667489|NCT00773253|580162687|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
160667490|NCT00773253|580162688|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
160667491|NCT03173547|580162689|FG000|Overall Study|Adverse Event|2|||
160667492|NCT03173547|580162690|FG001|Overall Study|Adverse Event|0|||
160667493|NCT03173547|580162689|FG000|Overall Study|Withdrawal by Subject|2|||
160667494|NCT03173547|580162690|FG001|Overall Study|Withdrawal by Subject|2|||
160667495|NCT01231906|580162691|FG000|Overall Study|Lack of Efficacy|75|||
160667496|NCT01231906|580162692|FG001|Overall Study|Lack of Efficacy|68|||
160667497|NCT01231906|580162691|FG000|Overall Study|Lost to Follow-up|1|||
160667498|NCT01231906|580162692|FG001|Overall Study|Lost to Follow-up|0|||
160667499|NCT01231906|580162691|FG000|Overall Study|Physician Decision|34|||
160667500|NCT01231906|580162692|FG001|Overall Study|Physician Decision|24|||
160667501|NCT01231906|580162691|FG000|Overall Study|Withdrawal by Subject|0|||
160667502|NCT01231906|580162692|FG001|Overall Study|Withdrawal by Subject|4|||
160667503|NCT01231906|580162691|FG000|Overall Study|Ineligible|10|||
160667504|NCT01231906|580162692|FG001|Overall Study|Ineligible|3|||
160667505|NCT01231906|580162691|FG000|Overall Study|No treatment|1|||
160667506|NCT01231906|580162692|FG001|Overall Study|No treatment|2|||
160667507|NCT01136174|580162693|FG000|Overall Study|Adverse Event|0|||
160667508|NCT01136174|580162694|FG001|Overall Study|Adverse Event|0|||
160516730|NCT04617275|579620644|FG003|Treatment Period|Withdrawal by Subject|2|||
160516731|NCT04617275|579620645|FG004|Treatment Period|Withdrawal by Subject|2|||
160516732|NCT04617275|579620646|FG005|Treatment Period|Withdrawal by Subject|0|||
160516733|NCT04617275|579620647|FG006|Treatment Period|Withdrawal by Subject|1|||
160516734|NCT04617275|579620648|FG007|Treatment Period|Withdrawal by Subject|2|||
160516735|NCT04617275|579620641|FG000|Follow-up Period|Adverse Event|1|||
160516736|NCT04617275|579620642|FG001|Follow-up Period|Adverse Event|1|||
160516737|NCT04617275|579620643|FG002|Follow-up Period|Adverse Event|2|||
160516738|NCT04617275|579620644|FG003|Follow-up Period|Adverse Event|3|||
160516739|NCT04617275|579620645|FG004|Follow-up Period|Adverse Event|4|||
160516740|NCT04617275|579620646|FG005|Follow-up Period|Adverse Event|3|||
160516741|NCT04617275|579620647|FG006|Follow-up Period|Adverse Event|0|||
160516742|NCT04617275|579620648|FG007|Follow-up Period|Adverse Event|3|||
160516743|NCT04617275|579620641|FG000|Follow-up Period|Lost to Follow-up|0|||
160516744|NCT04617275|579620642|FG001|Follow-up Period|Lost to Follow-up|1|||
160516745|NCT04617275|579620643|FG002|Follow-up Period|Lost to Follow-up|2|||
160516746|NCT04617275|579620644|FG003|Follow-up Period|Lost to Follow-up|0|||
160516747|NCT04617275|579620645|FG004|Follow-up Period|Lost to Follow-up|0|||
160516748|NCT04617275|579620646|FG005|Follow-up Period|Lost to Follow-up|4|||
160516749|NCT04617275|579620647|FG006|Follow-up Period|Lost to Follow-up|0|||
160516750|NCT04617275|579620648|FG007|Follow-up Period|Lost to Follow-up|3|||
160516751|NCT04617275|579620641|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
160516752|NCT04617275|579620642|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
160516753|NCT04617275|579620643|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
160516754|NCT04617275|579620644|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
160516755|NCT04617275|579620645|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
160516756|NCT04617275|579620646|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
160516757|NCT04617275|579620647|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
160516758|NCT04617275|579620648|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
160516759|NCT04617275|579620641|FG000|Follow-up Period|Other|0|||
160516760|NCT04617275|579620642|FG001|Follow-up Period|Other|1|||
160516761|NCT04617275|579620643|FG002|Follow-up Period|Other|0|||
160516762|NCT04617275|579620644|FG003|Follow-up Period|Other|0|||
160516763|NCT04617275|579620645|FG004|Follow-up Period|Other|0|||
160516764|NCT04617275|579620646|FG005|Follow-up Period|Other|0|||
160516765|NCT04617275|579620647|FG006|Follow-up Period|Other|0|||
160516766|NCT04617275|579620648|FG007|Follow-up Period|Other|0|||
160516767|NCT04617275|579620641|FG000|Follow-up Period|Withdrawal by Subject|2|||
160516768|NCT04617275|579620642|FG001|Follow-up Period|Withdrawal by Subject|0|||
160516769|NCT04617275|579620643|FG002|Follow-up Period|Withdrawal by Subject|0|||
160516770|NCT04617275|579620644|FG003|Follow-up Period|Withdrawal by Subject|2|||
160516771|NCT04617275|579620645|FG004|Follow-up Period|Withdrawal by Subject|2|||
160516772|NCT04617275|579620646|FG005|Follow-up Period|Withdrawal by Subject|0|||
160516773|NCT04617275|579620647|FG006|Follow-up Period|Withdrawal by Subject|1|||
160516774|NCT04617275|579620648|FG007|Follow-up Period|Withdrawal by Subject|2|||
160516775|NCT05917470|579620650|FG000|Overall Study|Progressive Disease|1|||
160516776|NCT05917470|579620651|FG001|Overall Study|Progressive Disease|1|||
160516777|NCT05917470|579620652|FG002|Overall Study|Progressive Disease|2|||
160516778|NCT05917470|579620653|FG003|Overall Study|Progressive Disease|3|||
160516779|NCT05917470|579620654|FG004|Overall Study|Progressive Disease|1|||
160516780|NCT05917470|579620655|FG005|Overall Study|Progressive Disease|1|||
160516781|NCT05917470|579620656|FG006|Overall Study|Progressive Disease|0|||
160516782|NCT05917470|579620657|FG007|Overall Study|Progressive Disease|0|||
160516783|NCT05917470|579620650|FG000|Overall Study|Withdrawal by Subject|0|||
160516784|NCT05917470|579620651|FG001|Overall Study|Withdrawal by Subject|0|||
160516785|NCT05917470|579620652|FG002|Overall Study|Withdrawal by Subject|1|||
160516786|NCT05917470|579620653|FG003|Overall Study|Withdrawal by Subject|0|||
160516787|NCT05917470|579620654|FG004|Overall Study|Withdrawal by Subject|0|||
160516788|NCT05917470|579620655|FG005|Overall Study|Withdrawal by Subject|0|||
160516789|NCT05917470|579620656|FG006|Overall Study|Withdrawal by Subject|0|||
160516790|NCT05917470|579620657|FG007|Overall Study|Withdrawal by Subject|0|||
160516791|NCT05917470|579620650|FG000|Overall Study|Sponsor Decision|0|||
160516792|NCT05917470|579620651|FG001|Overall Study|Sponsor Decision|0|||
160516793|NCT05917470|579620652|FG002|Overall Study|Sponsor Decision|1|||
160516794|NCT05917470|579620653|FG003|Overall Study|Sponsor Decision|0|||
160516795|NCT05917470|579620654|FG004|Overall Study|Sponsor Decision|2|||
160516796|NCT05917470|579620655|FG005|Overall Study|Sponsor Decision|1|||
160516797|NCT05917470|579620656|FG006|Overall Study|Sponsor Decision|3|||
160516798|NCT05917470|579620657|FG007|Overall Study|Sponsor Decision|3|||
160516799|NCT05917470|579620650|FG000|Overall Study|Adverse Event|0|||
160516800|NCT05917470|579620651|FG001|Overall Study|Adverse Event|0|||
160516801|NCT05917470|579620652|FG002|Overall Study|Adverse Event|0|||
160516802|NCT05917470|579620653|FG003|Overall Study|Adverse Event|0|||
160516803|NCT05917470|579620654|FG004|Overall Study|Adverse Event|0|||
160516804|NCT05917470|579620655|FG005|Overall Study|Adverse Event|1|||
160516805|NCT05917470|579620656|FG006|Overall Study|Adverse Event|0|||
160516806|NCT05917470|579620657|FG007|Overall Study|Adverse Event|0|||
160516807|NCT02317432|579620658|FG000|Overall Study|Death|4|||
160516808|NCT02317432|579620659|FG001|Overall Study|Death|1|||
160516809|NCT02317432|579620658|FG000|Overall Study|Lost to Follow-up|0|||
160516810|NCT02317432|579620659|FG001|Overall Study|Lost to Follow-up|5|||
160516811|NCT02317432|579620658|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
160667509|NCT01136174|580162695|FG002|Overall Study|Adverse Event|0|||
160516812|NCT02317432|579620659|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
160516813|NCT02518490|579622673|FG000|Overall Study|Withdrawal by Subject|1|||
160516814|NCT02518490|579622674|FG001|Overall Study|Withdrawal by Subject|1|||
160516815|NCT00346632|579622675|FG000|Overall Study|Progressive Disease|2|||
160516816|NCT00346632|579622676|FG001|Overall Study|Progressive Disease|2|||
160516817|NCT00346632|579622677|FG002|Overall Study|Progressive Disease|4|||
160516818|NCT00346632|579622678|FG003|Overall Study|Progressive Disease|3|||
160516819|NCT00346632|579622679|FG004|Overall Study|Progressive Disease|3|||
160516820|NCT00346632|579622680|FG005|Overall Study|Progressive Disease|1|||
160516821|NCT00346632|579622681|FG006|Overall Study|Progressive Disease|2|||
160516822|NCT00346632|579622682|FG007|Overall Study|Progressive Disease|2|||
160516823|NCT00346632|579622683|FG008|Overall Study|Progressive Disease|2|||
160516824|NCT00346632|579622684|FG009|Overall Study|Progressive Disease|2|||
160516825|NCT00346632|579622675|FG000|Overall Study|Adverse Event|0|||
160516826|NCT00346632|579622676|FG001|Overall Study|Adverse Event|0|||
160516827|NCT00346632|579622677|FG002|Overall Study|Adverse Event|0|||
160516828|NCT00346632|579622678|FG003|Overall Study|Adverse Event|0|||
160516829|NCT00346632|579622679|FG004|Overall Study|Adverse Event|1|||
160516830|NCT00346632|579622680|FG005|Overall Study|Adverse Event|1|||
160516831|NCT00346632|579622681|FG006|Overall Study|Adverse Event|1|||
160516832|NCT00346632|579622682|FG007|Overall Study|Adverse Event|0|||
160516833|NCT00346632|579622683|FG008|Overall Study|Adverse Event|0|||
160516834|NCT00346632|579622684|FG009|Overall Study|Adverse Event|0|||
160516835|NCT00346632|579622675|FG000|Overall Study|Death|0|||
160516836|NCT00346632|579622676|FG001|Overall Study|Death|0|||
160516837|NCT00346632|579622677|FG002|Overall Study|Death|1|||
160516838|NCT00346632|579622678|FG003|Overall Study|Death|0|||
160516839|NCT00346632|579622679|FG004|Overall Study|Death|0|||
160516840|NCT00346632|579622680|FG005|Overall Study|Death|0|||
160516841|NCT00346632|579622681|FG006|Overall Study|Death|0|||
160516842|NCT00346632|579622682|FG007|Overall Study|Death|0|||
160516843|NCT00346632|579622683|FG008|Overall Study|Death|0|||
160516844|NCT00346632|579622684|FG009|Overall Study|Death|0|||
160516845|NCT00346632|579622675|FG000|Overall Study|Protocol Violation|0|||
160516846|NCT00346632|579622676|FG001|Overall Study|Protocol Violation|0|||
160516847|NCT00346632|579622677|FG002|Overall Study|Protocol Violation|0|||
160516848|NCT00346632|579622678|FG003|Overall Study|Protocol Violation|0|||
160516849|NCT00346632|579622679|FG004|Overall Study|Protocol Violation|0|||
160516850|NCT00346632|579622680|FG005|Overall Study|Protocol Violation|0|||
160667510|NCT01136174|580162696|FG003|Overall Study|Adverse Event|4|||
160667511|NCT01249651|580162700|FG000|Overall Study|Withdrawal by Subject|4|||
160667512|NCT01249651|580162700|FG000|Overall Study|Adverse Event|1|||
160667513|NCT01249651|580162700|FG000|Overall Study|Protocol Violation|1|||
160667514|NCT01249651|580162700|FG000|Overall Study|Sponsor Decision|1|||
160667515|NCT03873272|580162711|FG000|Overall Study|Withdrawal by Subject|2|||
160667516|NCT03873272|580162712|FG001|Overall Study|Withdrawal by Subject|0|||
160667517|NCT03873272|580162713|FG002|Overall Study|Withdrawal by Subject|1|||
160667518|NCT03873272|580162711|FG000|Overall Study|Death|0|||
160667519|NCT03873272|580162712|FG001|Overall Study|Death|2|||
160667520|NCT03873272|580162713|FG002|Overall Study|Death|1|||
160667521|NCT03761173|580162714|FG000|Overall Study|Lost to Follow-up|93|||
160667522|NCT03761173|580162714|FG000|Overall Study|Withdrawal by Subject|74|||
160667523|NCT03761173|580162714|FG000|Overall Study|Death|45|||
160667524|NCT03761173|580162714|FG000|Overall Study|Withdrawal for Other Reasons|29|||
160667525|NCT03761173|580162714|FG000|Overall Study|Protocol Violation|1|||
160667526|NCT00316186|580162716|FG000|Overall Study|Adverse Event|6|||
160667527|NCT00316186|580162716|FG000|Overall Study|Disease Progression|4|||
160667528|NCT00316186|580162716|FG000|Overall Study|Lost to Follow-up|1|||
160667529|NCT00316186|580162716|FG000|Overall Study|Other|1|||
160667530|NCT01952691|580164131|FG000|Overall Study|Lost to Follow-up|2|||
160667531|NCT00199901|580164132|FG000|Overall Study|Protocol Violation|2|||
160667532|NCT00199901|580164133|FG001|Overall Study|Protocol Violation|0|||
160667533|NCT00199901|580164132|FG000|Overall Study|Withdrawal by Subject|1|||
160667534|NCT00199901|580164133|FG001|Overall Study|Withdrawal by Subject|0|||
160667535|NCT00199901|580164132|FG000|Overall Study|Progressive Disease|24|||
160667536|NCT00199901|580164133|FG001|Overall Study|Progressive Disease|24|||
160667537|NCT05776901|580164136|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
160667538|NCT00665925|580164146|FG000|Overall Study|Lack of Efficacy|10|||
160667539|NCT00665925|580164147|FG001|Overall Study|Lack of Efficacy|8|||
160667540|NCT00665925|580164148|FG002|Overall Study|Lack of Efficacy|9|||
160667541|NCT00665925|580164149|FG003|Overall Study|Lack of Efficacy|8|||
160667542|NCT00665925|580164146|FG000|Overall Study|Lost to Follow-up|1|||
160667543|NCT00665925|580164147|FG001|Overall Study|Lost to Follow-up|2|||
160516851|NCT00346632|579622681|FG006|Overall Study|Protocol Violation|1|||
160516852|NCT00346632|579622682|FG007|Overall Study|Protocol Violation|0|||
160516853|NCT00346632|579622683|FG008|Overall Study|Protocol Violation|0|||
160667544|NCT00665925|580164148|FG002|Overall Study|Lost to Follow-up|2|||
160516854|NCT00346632|579622684|FG009|Overall Study|Protocol Violation|0|||
160516855|NCT00346632|579622675|FG000|Overall Study|Withdrawal by Subject|0|||
160516856|NCT00346632|579622676|FG001|Overall Study|Withdrawal by Subject|0|||
160516857|NCT00346632|579622677|FG002|Overall Study|Withdrawal by Subject|0|||
160516858|NCT00346632|579622678|FG003|Overall Study|Withdrawal by Subject|0|||
160516859|NCT00346632|579622679|FG004|Overall Study|Withdrawal by Subject|0|||
160516860|NCT00346632|579622680|FG005|Overall Study|Withdrawal by Subject|0|||
160516861|NCT00346632|579622681|FG006|Overall Study|Withdrawal by Subject|1|||
160516862|NCT00346632|579622682|FG007|Overall Study|Withdrawal by Subject|0|||
160516863|NCT00346632|579622683|FG008|Overall Study|Withdrawal by Subject|0|||
160516864|NCT00346632|579622684|FG009|Overall Study|Withdrawal by Subject|0|||
160516865|NCT00346632|579622675|FG000|Overall Study|Switched to alternative treatment|0|||
160516866|NCT00346632|579622676|FG001|Overall Study|Switched to alternative treatment|0|||
160516867|NCT00346632|579622677|FG002|Overall Study|Switched to alternative treatment|1|||
160516868|NCT00346632|579622678|FG003|Overall Study|Switched to alternative treatment|0|||
160516869|NCT00346632|579622679|FG004|Overall Study|Switched to alternative treatment|0|||
160516870|NCT00346632|579622680|FG005|Overall Study|Switched to alternative treatment|0|||
160516871|NCT00346632|579622681|FG006|Overall Study|Switched to alternative treatment|0|||
160516872|NCT00346632|579622682|FG007|Overall Study|Switched to alternative treatment|0|||
160516873|NCT00346632|579622683|FG008|Overall Study|Switched to alternative treatment|0|||
160516874|NCT00346632|579622684|FG009|Overall Study|Switched to alternative treatment|0|||
160516875|NCT00346632|579622675|FG000|Overall Study|Not Stated|1|||
160516876|NCT00346632|579622676|FG001|Overall Study|Not Stated|1|||
160516877|NCT00346632|579622677|FG002|Overall Study|Not Stated|0|||
160516878|NCT00346632|579622678|FG003|Overall Study|Not Stated|0|||
160516879|NCT00346632|579622679|FG004|Overall Study|Not Stated|0|||
160516880|NCT00346632|579622680|FG005|Overall Study|Not Stated|0|||
160516881|NCT00346632|579622681|FG006|Overall Study|Not Stated|0|||
160516882|NCT00346632|579622682|FG007|Overall Study|Not Stated|2|||
160516883|NCT00346632|579622683|FG008|Overall Study|Not Stated|2|||
160516884|NCT00346632|579622684|FG009|Overall Study|Not Stated|1|||
160516885|NCT03587974|579622685|FG000|Overall Study|caregiver demented, care recipient died|3|||
160516886|NCT03587974|579622686|FG001|Overall Study|caregiver demented, care recipient died|3|||
160516887|NCT03587974|579622685|FG000|Overall Study|Withdrawal by Subject|2|||
160516888|NCT03587974|579622686|FG001|Overall Study|Withdrawal by Subject|1|||
160516889|NCT03486457|579622687|FG000|Up to Month 3|Adverse Event|2|||
160516890|NCT03486457|579622688|FG001|Up to Month 3|Adverse Event|5|||
160516891|NCT03486457|579622687|FG000|Up to Month 3|Lack of Efficacy|1|||
160516892|NCT03486457|579622688|FG001|Up to Month 3|Lack of Efficacy|0|||
160516893|NCT03486457|579622687|FG000|Up to Month 3|Withdrawal by Subject|1|||
160516894|NCT03486457|579622688|FG001|Up to Month 3|Withdrawal by Subject|0|||
160516895|NCT03486457|579622687|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
160516896|NCT03486457|579622688|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
160516897|NCT03486457|579622687|FG000|Up to Month 3|Other|1|||
160516898|NCT03486457|579622688|FG001|Up to Month 3|Other|0|||
160516899|NCT03486457|579622687|FG000|Month 3 to Month 6|Adverse Event|2|||
160667545|NCT00665925|580164149|FG003|Overall Study|Lost to Follow-up|2|||
160667546|NCT00665925|580164146|FG000|Overall Study|Withdrawal by Subject|2|||
160667547|NCT00665925|580164147|FG001|Overall Study|Withdrawal by Subject|2|||
160667548|NCT00665925|580164148|FG002|Overall Study|Withdrawal by Subject|3|||
160667549|NCT00665925|580164149|FG003|Overall Study|Withdrawal by Subject|2|||
160667550|NCT00665925|580164146|FG000|Overall Study|Physician Decision|0|||
160667551|NCT00665925|580164147|FG001|Overall Study|Physician Decision|0|||
160667552|NCT00665925|580164148|FG002|Overall Study|Physician Decision|1|||
160667553|NCT00665925|580164149|FG003|Overall Study|Physician Decision|2|||
160667554|NCT00665925|580164146|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
160667555|NCT00665925|580164147|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
160667556|NCT00665925|580164148|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
160667557|NCT00665925|580164149|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
160667558|NCT00665925|580164146|FG000|Overall Study|Adverse Event|1|||
160667559|NCT00665925|580164147|FG001|Overall Study|Adverse Event|5|||
160667560|NCT00665925|580164148|FG002|Overall Study|Adverse Event|10|||
160667561|NCT00665925|580164149|FG003|Overall Study|Adverse Event|5|||
160667562|NCT00665925|580164146|FG000|Overall Study|Enrolled by mistake|0|||
160667563|NCT00665925|580164147|FG001|Overall Study|Enrolled by mistake|0|||
160667564|NCT00665925|580164148|FG002|Overall Study|Enrolled by mistake|0|||
160516900|NCT03486457|579622688|FG001|Month 3 to Month 6|Adverse Event|0|||
160516901|NCT03486457|579622687|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
160516902|NCT03486457|579622688|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
160516903|NCT03486457|579622687|FG000|Month 3 to Month 6|Pregnancy|0|||
160516904|NCT03486457|579622688|FG001|Month 3 to Month 6|Pregnancy|1|||
160516905|NCT03486457|579622687|FG000|Month 3 to Month 6|Other|1|||
160516906|NCT03486457|579622688|FG001|Month 3 to Month 6|Other|0|||
160667565|NCT00665925|580164149|FG003|Overall Study|Enrolled by mistake|1|||
160667566|NCT00665925|580164146|FG000|Overall Study|Due to exclusion criteria|1|||
160667567|NCT00665925|580164147|FG001|Overall Study|Due to exclusion criteria|0|||
160516907|NCT01382706|579622689|FG000|Overall Study|Adverse Event|1|||
160516908|NCT01382706|579622689|FG000|Overall Study|Withdrawal by Subject|1|||
160516909|NCT04055090|579622690|FG000|Overall Study|screen failure|1|||
160667568|NCT00665925|580164148|FG002|Overall Study|Due to exclusion criteria|0|||
160516910|NCT04055090|579622691|FG001|Overall Study|screen failure|0|||
160516911|NCT04055090|579622690|FG000|Overall Study|Withdrawal by Subject|1|||
160516912|NCT04055090|579622691|FG001|Overall Study|Withdrawal by Subject|0|||
160516913|NCT00552240|579622697|FG000|Overall Study|Adverse Event|9|||
160516914|NCT00552240|579622698|FG001|Overall Study|Adverse Event|9|||
160516915|NCT00552240|579622697|FG000|Overall Study|Protocol Violation|1|||
160516916|NCT00552240|579622698|FG001|Overall Study|Protocol Violation|1|||
160516917|NCT00552240|579622697|FG000|Overall Study|Lost to Follow-up|5|||
160516918|NCT00552240|579622698|FG001|Overall Study|Lost to Follow-up|6|||
160516919|NCT00552240|579622697|FG000|Overall Study|Withdrawal by Subject|2|||
160516920|NCT00552240|579622698|FG001|Overall Study|Withdrawal by Subject|2|||
160516921|NCT00552240|579622697|FG000|Overall Study|Lack of Efficacy|6|||
160516922|NCT00552240|579622698|FG001|Overall Study|Lack of Efficacy|0|||
160516923|NCT00552240|579622697|FG000|Overall Study|Other|1|||
160516924|NCT00552240|579622698|FG001|Overall Study|Other|0|||
160516925|NCT02679573|579622699|FG000|Overall Study|Adverse Event|13|||
160516926|NCT02679573|579622700|FG001|Overall Study|Adverse Event|6|||
160516927|NCT02679573|579622699|FG000|Overall Study|Lack of Efficacy|12|||
160516928|NCT02679573|579622700|FG001|Overall Study|Lack of Efficacy|15|||
160516929|NCT02679573|579622699|FG000|Overall Study|Could not complete required study visits|6|||
160516930|NCT02679573|579622700|FG001|Overall Study|Could not complete required study visits|2|||
160516931|NCT02679573|579622699|FG000|Overall Study|Withdrawal by Subject|2|||
160516932|NCT02679573|579622700|FG001|Overall Study|Withdrawal by Subject|9|||
160516933|NCT02679573|579622699|FG000|Overall Study|Death|2|||
160516934|NCT02679573|579622700|FG001|Overall Study|Death|0|||
160516935|NCT02679573|579622699|FG000|Overall Study|Physician Decision|2|||
160516936|NCT02679573|579622700|FG001|Overall Study|Physician Decision|4|||
160516937|NCT02679573|579622699|FG000|Overall Study|Lost to Follow-up|0|||
160516938|NCT02679573|579622700|FG001|Overall Study|Lost to Follow-up|3|||
160516939|NCT02128542|579622701|FG000|Overall Study|Lost to Follow-up|3|||
160516940|NCT02128542|579622702|FG001|Overall Study|Lost to Follow-up|0|||
160516941|NCT02128542|579622701|FG000|Overall Study|Withdrew Consent|1|||
160516942|NCT02128542|579622702|FG001|Overall Study|Withdrew Consent|0|||
160516943|NCT00577577|579622708|FG000|Overall Study|Adverse Event|3|||
160516944|NCT00577577|579622709|FG001|Overall Study|Adverse Event|2|||
160516945|NCT00577577|579622708|FG000|Overall Study|Lost to Follow-up|1|||
160516946|NCT00577577|579622709|FG001|Overall Study|Lost to Follow-up|0|||
160516947|NCT00577577|579622708|FG000|Overall Study|Protocol Violation|0|||
160516948|NCT00577577|579622709|FG001|Overall Study|Protocol Violation|3|||
160516949|NCT00577577|579622708|FG000|Overall Study|Transportation|1|||
160516950|NCT00577577|579622709|FG001|Overall Study|Transportation|0|||
160516951|NCT00232544|579622710|FG000|Overall Study|Lost to Follow-up|20|||
160516952|NCT00232544|579622711|FG001|Overall Study|Lost to Follow-up|15|||
160516953|NCT00116753|579622712|FG000|Overall Study|Adverse Event|16|||
160516954|NCT00116753|579622713|FG001|Overall Study|Adverse Event|10|||
160516955|NCT00116753|579622714|FG002|Overall Study|Adverse Event|7|||
160516956|NCT00116753|579622712|FG000|Overall Study|Withdrawal by Subject|11|||
160516957|NCT00116753|579622713|FG001|Overall Study|Withdrawal by Subject|12|||
160516958|NCT00116753|579622714|FG002|Overall Study|Withdrawal by Subject|8|||
160516959|NCT00116753|579622712|FG000|Overall Study|Lost to Follow-up|0|||
160516960|NCT00116753|579622713|FG001|Overall Study|Lost to Follow-up|2|||
160516961|NCT00116753|579622714|FG002|Overall Study|Lost to Follow-up|1|||
160516962|NCT00116753|579622712|FG000|Overall Study|Protocol Violation|0|||
160516963|NCT00116753|579622713|FG001|Overall Study|Protocol Violation|0|||
160516964|NCT00116753|579622714|FG002|Overall Study|Protocol Violation|1|||
160516965|NCT00116753|579622712|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
160516966|NCT00116753|579622713|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
160516967|NCT00116753|579622714|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
160516968|NCT00116753|579622712|FG000|Overall Study|Disease Progression|3|||
160624238|NCT02652793|580003733|FG000|Overall Study|Withdrawal by Subject|1|||
160624239|NCT04963231|580003734|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
160624240|NCT04963231|580003735|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
160624241|NCT04963231|580003736|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
160516969|NCT00116753|579622713|FG001|Overall Study|Disease Progression|4|||
160516970|NCT00116753|579622714|FG002|Overall Study|Disease Progression|3|||
160516971|NCT00116753|579622712|FG000|Overall Study|Abnormal Echocardiogram|0|||
160516972|NCT00116753|579622713|FG001|Overall Study|Abnormal Echocardiogram|0|||
160516973|NCT00116753|579622714|FG002|Overall Study|Abnormal Echocardiogram|1|||
160516974|NCT00116753|579622712|FG000|Overall Study|Progressive Parkinson's Disease|1|||
160516975|NCT00116753|579622713|FG001|Overall Study|Progressive Parkinson's Disease|0|||
160516976|NCT00116753|579622714|FG002|Overall Study|Progressive Parkinson's Disease|0|||
160516977|NCT00116753|579622712|FG000|Overall Study|Dosing Error|0|||
160516978|NCT00116753|579622713|FG001|Overall Study|Dosing Error|1|||
160516979|NCT00116753|579622714|FG002|Overall Study|Dosing Error|0|||
160516980|NCT01200589|579622715|FG000|Overall Study|Withdrawal by Subject|13|||
160516981|NCT01200589|579622716|FG001|Overall Study|Withdrawal by Subject|11|||
160516982|NCT01200589|579622715|FG000|Overall Study|Physician Decision|2|||
160516983|NCT01200589|579622716|FG001|Overall Study|Physician Decision|2|||
160516984|NCT01200589|579622715|FG000|Overall Study|Lost to Follow-up|5|||
160516985|NCT01200589|579622716|FG001|Overall Study|Lost to Follow-up|4|||
160516986|NCT01200589|579622715|FG000|Overall Study|Study terminated|170|||
160516987|NCT01200589|579622716|FG001|Overall Study|Study terminated|172|||
160516988|NCT00986973|579622717|FG000|Overall Study|Withdrawn by study team|1|||
160516989|NCT00598273|579622718|FG000|Overall Study|Adverse Event|4|||
160516990|NCT00598273|579622719|FG001|Overall Study|Adverse Event|5|||
160516991|NCT00598273|579622720|FG002|Overall Study|Adverse Event|2|||
160516992|NCT00598273|579622718|FG000|Overall Study|Death|6|||
160516993|NCT00598273|579622719|FG001|Overall Study|Death|12|||
160516994|NCT00598273|579622720|FG002|Overall Study|Death|8|||
160516995|NCT00598273|579622718|FG000|Overall Study|Lost to Follow-up|8|||
160516996|NCT00598273|579622719|FG001|Overall Study|Lost to Follow-up|3|||
160516997|NCT00598273|579622720|FG002|Overall Study|Lost to Follow-up|5|||
160516998|NCT00598273|579622718|FG000|Overall Study|Physician Decision|0|||
160516999|NCT00598273|579622719|FG001|Overall Study|Physician Decision|0|||
160517000|NCT00598273|579622720|FG002|Overall Study|Physician Decision|1|||
160517001|NCT00598273|579622718|FG000|Overall Study|Withdrawal by Subject|12|||
160517002|NCT00598273|579622719|FG001|Overall Study|Withdrawal by Subject|10|||
160517003|NCT00598273|579622720|FG002|Overall Study|Withdrawal by Subject|10|||
160517004|NCT00598273|579622718|FG000|Overall Study|Noncompliance|3|||
160517005|NCT00598273|579622719|FG001|Overall Study|Noncompliance|2|||
160517006|NCT00598273|579622720|FG002|Overall Study|Noncompliance|3|||
160517007|NCT00598273|579622718|FG000|Overall Study|Relocation|0|||
160517008|NCT00598273|579622719|FG001|Overall Study|Relocation|2|||
160517009|NCT00598273|579622720|FG002|Overall Study|Relocation|4|||
160517010|NCT00598273|579622718|FG000|Overall Study|Renal transplant|1|||
160517011|NCT00598273|579622719|FG001|Overall Study|Renal transplant|0|||
160517012|NCT00598273|579622720|FG002|Overall Study|Renal transplant|1|||
160517013|NCT00598273|579622718|FG000|Overall Study|Site elected to close|1|||
160517014|NCT00598273|579622719|FG001|Overall Study|Site elected to close|0|||
160517015|NCT00598273|579622720|FG002|Overall Study|Site elected to close|0|||
160517016|NCT00598273|579622718|FG000|Overall Study|Started dialysis|6|||
160517017|NCT00598273|579622719|FG001|Overall Study|Started dialysis|4|||
160517018|NCT00598273|579622720|FG002|Overall Study|Started dialysis|5|||
160517019|NCT01590082|579622721|FG000|Overall Study|Withdrawal by Subject|1|||
160517020|NCT01590082|579622722|FG001|Overall Study|Withdrawal by Subject|0|||
160517021|NCT01590082|579622721|FG000|Overall Study|Ineligible|1|||
160517022|NCT01590082|579622722|FG001|Overall Study|Ineligible|0|||
160517023|NCT02549196|579622723|FG000|Overall Study|Protocol Violation|0|||
160517024|NCT02549196|579622724|FG001|Overall Study|Protocol Violation|0|||
160517025|NCT02549196|579622725|FG002|Overall Study|Protocol Violation|0|||
160517026|NCT02549196|579622726|FG003|Overall Study|Protocol Violation|1|||
160517027|NCT02549196|579622723|FG000|Overall Study|Withdrawal by Subject|1|||
160517028|NCT02549196|579622724|FG001|Overall Study|Withdrawal by Subject|0|||
160517029|NCT02549196|579622725|FG002|Overall Study|Withdrawal by Subject|1|||
160517030|NCT02549196|579622726|FG003|Overall Study|Withdrawal by Subject|0|||
160517031|NCT01442779|579622727|FG000|Overall Study|Withdrawal by Subject|3|||
160517032|NCT01442779|579622727|FG000|Overall Study|Death|3|||
160517033|NCT01442779|579622727|FG000|Overall Study|Non-compliance|1|||
160517034|NCT05249829|579622728|FG000|Overall Study|Participant Relocation|0|||
160517035|NCT05249829|579622729|FG001|Overall Study|Participant Relocation|1|||
160517036|NCT05249829|579622730|FG002|Overall Study|Participant Relocation|2|||
160517037|NCT05249829|579622731|FG003|Overall Study|Participant Relocation|2|||
160517038|NCT05249829|579622728|FG000|Overall Study|Withdrawal by Subject|9|||
160517039|NCT05249829|579622729|FG001|Overall Study|Withdrawal by Subject|17|||
160517040|NCT05249829|579622730|FG002|Overall Study|Withdrawal by Subject|40|||
160517041|NCT05249829|579622731|FG003|Overall Study|Withdrawal by Subject|35|||
160517042|NCT05249829|579622728|FG000|Overall Study|Physician Decision|1|||
160517043|NCT05249829|579622729|FG001|Overall Study|Physician Decision|0|||
160517044|NCT05249829|579622730|FG002|Overall Study|Physician Decision|0|||
160517045|NCT05249829|579622731|FG003|Overall Study|Physician Decision|0|||
160517046|NCT05249829|579622728|FG000|Overall Study|Lost to Follow-up|16|||
160517047|NCT05249829|579622729|FG001|Overall Study|Lost to Follow-up|16|||
160517048|NCT05249829|579622730|FG002|Overall Study|Lost to Follow-up|57|||
160517049|NCT05249829|579622731|FG003|Overall Study|Lost to Follow-up|60|||
160517050|NCT05249829|579622728|FG000|Overall Study|Adverse Event|2|||
160517051|NCT05249829|579622729|FG001|Overall Study|Adverse Event|2|||
160517052|NCT05249829|579622730|FG002|Overall Study|Adverse Event|2|||
160517053|NCT05249829|579622731|FG003|Overall Study|Adverse Event|2|||
160517054|NCT05249829|579622728|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
160517055|NCT05249829|579622729|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
160517056|NCT05249829|579622730|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
160517057|NCT05249829|579622731|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
160517058|NCT05249829|579622728|FG000|Overall Study|Protocol Violation|2|||
160517059|NCT05249829|579622729|FG001|Overall Study|Protocol Violation|0|||
160517060|NCT05249829|579622730|FG002|Overall Study|Protocol Violation|5|||
160517061|NCT05249829|579622731|FG003|Overall Study|Protocol Violation|3|||
160517062|NCT05249829|579622728|FG000|Overall Study|Death|0|||
160517063|NCT05249829|579622729|FG001|Overall Study|Death|1|||
160517064|NCT05249829|579622730|FG002|Overall Study|Death|2|||
160517065|NCT05249829|579622731|FG003|Overall Study|Death|4|||
160517066|NCT00196976|579622732|FG000|Primary Study|Migrated from study area|0|||
160517067|NCT00196976|579622733|FG001|Primary Study|Migrated from study area|0|||
160517068|NCT00196976|579622734|FG002|Primary Study|Migrated from study area|0|||
160517069|NCT00196976|579622735|FG003|Primary Study|Migrated from study area|0|||
160517070|NCT00196976|579622736|FG004|Primary Study|Migrated from study area|0|||
160517071|NCT00196976|579622737|FG005|Primary Study|Migrated from study area|0|||
160517072|NCT00196976|579622738|FG006|Primary Study|Migrated from study area|0|||
160517073|NCT00196976|579622739|FG007|Primary Study|Migrated from study area|1|||
160517074|NCT00196976|579622740|FG008|Primary Study|Migrated from study area|0|||
160517075|NCT00196976|579622741|FG009|Primary Study|Migrated from study area|0|||
160517076|NCT00196976|579622742|FG010|Primary Study|Migrated from study area|0|||
160517077|NCT00196976|579622743|FG011|Primary Study|Migrated from study area|0|||
160517078|NCT00196976|579622744|FG012|Primary Study|Migrated from study area|0|||
160517079|NCT00196976|579622745|FG013|Primary Study|Migrated from study area|0|||
160517080|NCT00196976|579622732|FG000|Primary Study|Protocol Violation|0|||
160517081|NCT00196976|579622733|FG001|Primary Study|Protocol Violation|1|||
160517082|NCT00196976|579622734|FG002|Primary Study|Protocol Violation|1|||
160517083|NCT00196976|579622735|FG003|Primary Study|Protocol Violation|0|||
160517084|NCT00196976|579622736|FG004|Primary Study|Protocol Violation|0|||
160517085|NCT00196976|579622737|FG005|Primary Study|Protocol Violation|0|||
160517086|NCT00196976|579622738|FG006|Primary Study|Protocol Violation|0|||
160517087|NCT00196976|579622739|FG007|Primary Study|Protocol Violation|0|||
160517088|NCT00196976|579622740|FG008|Primary Study|Protocol Violation|0|||
160517089|NCT00196976|579622741|FG009|Primary Study|Protocol Violation|0|||
160517090|NCT00196976|579622742|FG010|Primary Study|Protocol Violation|0|||
160517091|NCT00196976|579622743|FG011|Primary Study|Protocol Violation|0|||
160517092|NCT00196976|579622744|FG012|Primary Study|Protocol Violation|0|||
160517093|NCT00196976|579622745|FG013|Primary Study|Protocol Violation|0|||
160517094|NCT00196976|579622732|FG000|Primary Study|Withdrawal by Subject|1|||
160517095|NCT00196976|579622733|FG001|Primary Study|Withdrawal by Subject|0|||
160517096|NCT00196976|579622734|FG002|Primary Study|Withdrawal by Subject|1|||
160517097|NCT00196976|579622735|FG003|Primary Study|Withdrawal by Subject|1|||
160517098|NCT00196976|579622736|FG004|Primary Study|Withdrawal by Subject|2|||
160517099|NCT00196976|579622737|FG005|Primary Study|Withdrawal by Subject|1|||
160517100|NCT00196976|579622738|FG006|Primary Study|Withdrawal by Subject|0|||
160517101|NCT00196976|579622739|FG007|Primary Study|Withdrawal by Subject|0|||
160517102|NCT00196976|579622740|FG008|Primary Study|Withdrawal by Subject|0|||
160517103|NCT00196976|579622741|FG009|Primary Study|Withdrawal by Subject|1|||
160517104|NCT00196976|579622742|FG010|Primary Study|Withdrawal by Subject|0|||
160517105|NCT00196976|579622743|FG011|Primary Study|Withdrawal by Subject|0|||
160517106|NCT00196976|579622744|FG012|Primary Study|Withdrawal by Subject|0|||
160517107|NCT00196976|579622745|FG013|Primary Study|Withdrawal by Subject|0|||
160517108|NCT00196976|579622732|FG000|Primary Study|Lost to Follow-up|0|||
160517109|NCT00196976|579622733|FG001|Primary Study|Lost to Follow-up|0|||
160517110|NCT00196976|579622734|FG002|Primary Study|Lost to Follow-up|0|||
160517111|NCT00196976|579622735|FG003|Primary Study|Lost to Follow-up|0|||
160517112|NCT00196976|579622736|FG004|Primary Study|Lost to Follow-up|1|||
160624242|NCT04963231|580003734|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
160517113|NCT00196976|579622737|FG005|Primary Study|Lost to Follow-up|1|||
160624243|NCT04963231|580003735|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
160624244|NCT04963231|580003736|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
160624245|NCT04963231|580003734|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
160624246|NCT04963231|580003735|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
160624247|NCT04963231|580003736|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
160624248|NCT04963231|580003734|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
160624249|NCT04963231|580003735|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
160624250|NCT04963231|580003736|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
160624251|NCT04963231|580003734|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
160624252|NCT04963231|580003735|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
160624253|NCT04963231|580003736|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
160624254|NCT04963231|580003734|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
160517114|NCT00196976|579622738|FG006|Primary Study|Lost to Follow-up|0|||
160517115|NCT00196976|579622739|FG007|Primary Study|Lost to Follow-up|2|||
160517116|NCT00196976|579622740|FG008|Primary Study|Lost to Follow-up|0|||
160517117|NCT00196976|579622741|FG009|Primary Study|Lost to Follow-up|0|||
160517118|NCT00196976|579622742|FG010|Primary Study|Lost to Follow-up|0|||
160517119|NCT00196976|579622743|FG011|Primary Study|Lost to Follow-up|0|||
160517120|NCT00196976|579622744|FG012|Primary Study|Lost to Follow-up|0|||
160517121|NCT00196976|579622745|FG013|Primary Study|Lost to Follow-up|0|||
160517122|NCT00196976|579622732|FG000|Primary Study|Other|0|||
160517123|NCT00196976|579622733|FG001|Primary Study|Other|0|||
160517124|NCT00196976|579622734|FG002|Primary Study|Other|2|||
160517125|NCT00196976|579622735|FG003|Primary Study|Other|0|||
160517126|NCT00196976|579622736|FG004|Primary Study|Other|0|||
160667569|NCT00665925|580164149|FG003|Overall Study|Due to exclusion criteria|0|||
160667570|NCT04035187|580164152|FG000|Overall Study|Withdrawal by Subject|2|||
160667571|NCT04035187|580164153|FG001|Overall Study|Withdrawal by Subject|1|||
160667572|NCT04035187|580164154|FG002|Overall Study|Withdrawal by Subject|0|||
160667573|NCT04035187|580164155|FG003|Overall Study|Withdrawal by Subject|0|||
160667574|NCT04035187|580164152|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
160667575|NCT04035187|580164153|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
160667576|NCT04035187|580164154|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
160667577|NCT04035187|580164155|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
160667578|NCT02255149|580164168|FG000|Overall Study|Lost to Follow-up|2|||
160667579|NCT02255149|580164168|FG000|Overall Study|Withdrawal by Subject|1|||
160667580|NCT02255149|580164168|FG000|Overall Study|Withdrawal by PI|1|||
160667581|NCT02255149|580164168|FG000|Overall Study|Implant Failure|1|||
160667582|NCT00373256|580164174|FG000|Overall Study|Adverse Event (AE)|1|||
160667583|NCT00373256|580164175|FG001|Overall Study|Adverse Event (AE)|5|||
160667584|NCT00373256|580164174|FG000|Overall Study|Lost to Follow-up|2|||
160667585|NCT00373256|580164175|FG001|Overall Study|Lost to Follow-up|1|||
160667586|NCT00373256|580164174|FG000|Overall Study|Death|9|||
160667587|NCT00373256|580164175|FG001|Overall Study|Death|8|||
160667588|NCT00373256|580164174|FG000|Overall Study|Objective Progression or Relapse|111|||
160667589|NCT00373256|580164175|FG001|Overall Study|Objective Progression or Relapse|104|||
160667590|NCT00373256|580164174|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
160667591|NCT00373256|580164175|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
160667592|NCT00373256|580164174|FG000|Overall Study|Other|73|||
160667593|NCT00373256|580164175|FG001|Overall Study|Other|107|||
160667594|NCT00373256|580164174|FG000|Overall Study|Protocol Violation|0|||
160667595|NCT00373256|580164175|FG001|Overall Study|Protocol Violation|2|||
160667596|NCT00373256|580164174|FG000|Overall Study|Study Terminated by Sponsor|41|||
160667597|NCT00373256|580164175|FG001|Overall Study|Study Terminated by Sponsor|13|||
160667598|NCT05604170|580164176|FG000|Overall Study|Lack of Efficacy|5|||
160667599|NCT05604170|580164176|FG000|Overall Study|Adverse Event|6|||
160667600|NCT05604170|580164176|FG000|Overall Study|Physician Decision|6|||
160667601|NCT05604170|580164176|FG000|Overall Study|Lost to Follow-up|6|||
160667602|NCT05604170|580164176|FG000|Overall Study|Withdrawal by Subject|11|||
160667603|NCT05604170|580164176|FG000|Overall Study|Early study termination by sponsor|77|||
160667604|NCT05604170|580164176|FG000|Overall Study|Other|6|||
160667605|NCT03032172|580164179|FG000|Treatment Period|Adverse Event|0|||
160517127|NCT00196976|579622737|FG005|Primary Study|Other|0|||
160517128|NCT00196976|579622738|FG006|Primary Study|Other|0|||
160517129|NCT00196976|579622739|FG007|Primary Study|Other|0|||
160517130|NCT00196976|579622740|FG008|Primary Study|Other|0|||
160517131|NCT00196976|579622741|FG009|Primary Study|Other|0|||
160517132|NCT00196976|579622742|FG010|Primary Study|Other|0|||
160517133|NCT00196976|579622743|FG011|Primary Study|Other|0|||
160517134|NCT00196976|579622744|FG012|Primary Study|Other|0|||
160517135|NCT00196976|579622745|FG013|Primary Study|Other|0|||
160517136|NCT00196976|579622732|FG000|Booster Study|Withdrawal by Subject|0|||
160517137|NCT00196976|579622733|FG001|Booster Study|Withdrawal by Subject|0|||
160517138|NCT00196976|579622734|FG002|Booster Study|Withdrawal by Subject|0|||
160517139|NCT00196976|579622735|FG003|Booster Study|Withdrawal by Subject|0|||
160517140|NCT00196976|579622736|FG004|Booster Study|Withdrawal by Subject|0|||
160517141|NCT00196976|579622737|FG005|Booster Study|Withdrawal by Subject|0|||
160517142|NCT00196976|579622738|FG006|Booster Study|Withdrawal by Subject|0|||
160667606|NCT03032172|580164180|FG001|Treatment Period|Adverse Event|1|||
160667607|NCT03032172|580164181|FG002|Treatment Period|Adverse Event|0|||
160667608|NCT03032172|580164182|FG003|Treatment Period|Adverse Event|0|||
160517143|NCT00196976|579622739|FG007|Booster Study|Withdrawal by Subject|0|||
160667609|NCT03032172|580164183|FG004|Treatment Period|Adverse Event|0|||
160667610|NCT03032172|580164184|FG005|Treatment Period|Adverse Event|0|||
160667611|NCT03032172|580164185|FG006|Treatment Period|Adverse Event|0|||
160667612|NCT03032172|580164186|FG007|Treatment Period|Adverse Event|0|||
160517144|NCT00196976|579622740|FG008|Booster Study|Withdrawal by Subject|0|||
160667613|NCT03032172|580164179|FG000|Treatment Period|Lack of Efficacy|0|||
160667614|NCT03032172|580164180|FG001|Treatment Period|Lack of Efficacy|1|||
160667615|NCT03032172|580164181|FG002|Treatment Period|Lack of Efficacy|0|||
160517145|NCT00196976|579622741|FG009|Booster Study|Withdrawal by Subject|0|||
160667616|NCT03032172|580164182|FG003|Treatment Period|Lack of Efficacy|0|||
160667617|NCT03032172|580164183|FG004|Treatment Period|Lack of Efficacy|0|||
160667618|NCT03032172|580164184|FG005|Treatment Period|Lack of Efficacy|0|||
160517146|NCT00196976|579622742|FG010|Booster Study|Withdrawal by Subject|1|||
160517147|NCT00196976|579622743|FG011|Booster Study|Withdrawal by Subject|0|||
160517148|NCT00196976|579622744|FG012|Booster Study|Withdrawal by Subject|0|||
160517149|NCT00196976|579622745|FG013|Booster Study|Withdrawal by Subject|0|||
160667619|NCT03032172|580164185|FG006|Treatment Period|Lack of Efficacy|0|||
160667620|NCT03032172|580164186|FG007|Treatment Period|Lack of Efficacy|0|||
160517150|NCT00196976|579622732|FG000|Booster Study|Lost to Follow-up|0|||
160624255|NCT04963231|580003735|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
160624256|NCT04963231|580003736|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
160624257|NCT04963231|580003734|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
160624258|NCT04963231|580003735|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
160624259|NCT04963231|580003736|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
160624260|NCT01059175|580003737|FG000|Overall Study|Death|17|||
160624261|NCT01059175|580003738|FG001|Overall Study|Death|17|||
160624262|NCT01059175|580003737|FG000|Overall Study|Adverse Event|4|||
160624263|NCT01059175|580003738|FG001|Overall Study|Adverse Event|2|||
160624264|NCT01059175|580003737|FG000|Overall Study|Lost to Follow-up|0|||
160624265|NCT01059175|580003738|FG001|Overall Study|Lost to Follow-up|1|||
160624266|NCT04579666|580003739|FG000|RTP (Up to Week 52)|Adverse Event|4|||
160624267|NCT04579666|580003740|FG001|RTP (Up to Week 52)|Adverse Event|3|||
160624268|NCT04579666|580003741|FG002|RTP (Up to Week 52)|Adverse Event|0|||
160624269|NCT04579666|580003742|FG003|RTP (Up to Week 52)|Adverse Event|0|||
160624270|NCT04579666|580003739|FG000|RTP (Up to Week 52)|Death|24|||
160624271|NCT04579666|580003740|FG001|RTP (Up to Week 52)|Death|9|||
160624272|NCT04579666|580003741|FG002|RTP (Up to Week 52)|Death|0|||
160624273|NCT04579666|580003742|FG003|RTP (Up to Week 52)|Death|0|||
160624274|NCT04579666|580003739|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
160624275|NCT04579666|580003740|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
160624276|NCT04579666|580003741|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
160624277|NCT04579666|580003742|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
160624278|NCT04579666|580003739|FG000|RTP (Up to Week 52)|Physician Decision|4|||
160624279|NCT04579666|580003740|FG001|RTP (Up to Week 52)|Physician Decision|1|||
160624280|NCT04579666|580003741|FG002|RTP (Up to Week 52)|Physician Decision|0|||
160624281|NCT04579666|580003742|FG003|RTP (Up to Week 52)|Physician Decision|0|||
160624282|NCT04579666|580003739|FG000|RTP (Up to Week 52)|Progressive disease|1|||
160624283|NCT04579666|580003740|FG001|RTP (Up to Week 52)|Progressive disease|0|||
160624284|NCT04579666|580003741|FG002|RTP (Up to Week 52)|Progressive disease|0|||
160624285|NCT04579666|580003742|FG003|RTP (Up to Week 52)|Progressive disease|0|||
160624286|NCT04579666|580003739|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
160624287|NCT04579666|580003740|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
160624288|NCT04579666|580003741|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
160624289|NCT04579666|580003742|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
160624290|NCT04579666|580003739|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
160624291|NCT04579666|580003740|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
160624292|NCT04579666|580003741|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
160624293|NCT04579666|580003742|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
160624294|NCT04579666|580003739|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
160624295|NCT04579666|580003740|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
160624296|NCT04579666|580003741|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
160624297|NCT04579666|580003742|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
160624298|NCT04579666|580003739|FG000|RTP (Up to Week 52)|Other|2|||
160624299|NCT04579666|580003740|FG001|RTP (Up to Week 52)|Other|0|||
160624300|NCT04579666|580003741|FG002|RTP (Up to Week 52)|Other|0|||
160624301|NCT04579666|580003742|FG003|RTP (Up to Week 52)|Other|0|||
160624302|NCT04579666|580003739|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
160624303|NCT04579666|580003740|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
160624304|NCT04579666|580003741|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
160624305|NCT04579666|580003742|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
160624306|NCT04579666|580003739|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
160624307|NCT04579666|580003740|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
160624308|NCT04579666|580003741|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
160624309|NCT04579666|580003742|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
160624310|NCT04579666|580003739|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
160624311|NCT04579666|580003740|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
160624312|NCT04579666|580003741|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
160624313|NCT04579666|580003742|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
160624314|NCT04579666|580003739|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
160624315|NCT04579666|580003740|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
160624316|NCT04579666|580003741|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
160624317|NCT04579666|580003742|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
160624318|NCT04579666|580003739|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
160624319|NCT04579666|580003740|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
160624320|NCT04579666|580003741|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
160624321|NCT04579666|580003742|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
160624322|NCT05450198|580003743|FG000|Overall Study|Withdrawal by Subject|1|||
160624323|NCT05450198|580003744|FG001|Overall Study|Withdrawal by Subject|1|||
160624324|NCT05450198|580003745|FG002|Overall Study|Withdrawal by Subject|2|||
160624325|NCT05450198|580003746|FG003|Overall Study|Withdrawal by Subject|0|||
160624326|NCT05450198|580003743|FG000|Overall Study|Lost to Follow-up|1|||
160624327|NCT05450198|580003744|FG001|Overall Study|Lost to Follow-up|0|||
160624328|NCT05450198|580003745|FG002|Overall Study|Lost to Follow-up|2|||
160667621|NCT03032172|580164179|FG000|Treatment Period|Non-compliance With Study Drug|0|||
160667622|NCT03032172|580164180|FG001|Treatment Period|Non-compliance With Study Drug|1|||
160667623|NCT03032172|580164181|FG002|Treatment Period|Non-compliance With Study Drug|0|||
160667624|NCT03032172|580164182|FG003|Treatment Period|Non-compliance With Study Drug|0|||
160667625|NCT03032172|580164183|FG004|Treatment Period|Non-compliance With Study Drug|0|||
160667626|NCT03032172|580164184|FG005|Treatment Period|Non-compliance With Study Drug|0|||
160667627|NCT03032172|580164185|FG006|Treatment Period|Non-compliance With Study Drug|0|||
160667628|NCT03032172|580164186|FG007|Treatment Period|Non-compliance With Study Drug|0|||
160667629|NCT03032172|580164179|FG000|Treatment Period|Reason Not Specified|0|||
160667630|NCT03032172|580164180|FG001|Treatment Period|Reason Not Specified|4|||
160667631|NCT03032172|580164181|FG002|Treatment Period|Reason Not Specified|1|||
160667632|NCT03032172|580164182|FG003|Treatment Period|Reason Not Specified|0|||
160667633|NCT03032172|580164183|FG004|Treatment Period|Reason Not Specified|0|||
160667634|NCT03032172|580164184|FG005|Treatment Period|Reason Not Specified|0|||
160667635|NCT03032172|580164185|FG006|Treatment Period|Reason Not Specified|0|||
160667636|NCT03032172|580164186|FG007|Treatment Period|Reason Not Specified|0|||
160667637|NCT03032172|580164179|FG000|Treatment Period|Physician Decision|0|||
160667638|NCT03032172|580164180|FG001|Treatment Period|Physician Decision|2|||
160667639|NCT03032172|580164181|FG002|Treatment Period|Physician Decision|1|||
160667640|NCT03032172|580164182|FG003|Treatment Period|Physician Decision|0|||
160667641|NCT03032172|580164183|FG004|Treatment Period|Physician Decision|0|||
160667642|NCT03032172|580164184|FG005|Treatment Period|Physician Decision|0|||
160667643|NCT03032172|580164185|FG006|Treatment Period|Physician Decision|0|||
160667644|NCT03032172|580164186|FG007|Treatment Period|Physician Decision|0|||
160667645|NCT03032172|580164179|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
160667646|NCT03032172|580164180|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
160667647|NCT03032172|580164181|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
160667648|NCT03032172|580164182|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
160667649|NCT03032172|580164183|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
160517151|NCT00196976|579622733|FG001|Booster Study|Lost to Follow-up|0|||
160517152|NCT00196976|579622734|FG002|Booster Study|Lost to Follow-up|0|||
160667650|NCT03032172|580164184|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
160667651|NCT03032172|580164185|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
160667652|NCT03032172|580164186|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
160667653|NCT03032172|580164179|FG000|Treatment Period|Withdrawal by Subject|2|||
160667654|NCT03032172|580164180|FG001|Treatment Period|Withdrawal by Subject|0|||
160667655|NCT03032172|580164181|FG002|Treatment Period|Withdrawal by Subject|3|||
160667656|NCT03032172|580164182|FG003|Treatment Period|Withdrawal by Subject|0|||
160667657|NCT03032172|580164183|FG004|Treatment Period|Withdrawal by Subject|0|||
160667658|NCT03032172|580164184|FG005|Treatment Period|Withdrawal by Subject|0|||
160667659|NCT03032172|580164185|FG006|Treatment Period|Withdrawal by Subject|0|||
160517153|NCT00196976|579622735|FG003|Booster Study|Lost to Follow-up|0|||
160517154|NCT00196976|579622736|FG004|Booster Study|Lost to Follow-up|0|||
160517155|NCT00196976|579622737|FG005|Booster Study|Lost to Follow-up|0|||
160517156|NCT00196976|579622738|FG006|Booster Study|Lost to Follow-up|0|||
160517157|NCT00196976|579622739|FG007|Booster Study|Lost to Follow-up|0|||
160517158|NCT00196976|579622740|FG008|Booster Study|Lost to Follow-up|0|||
160517159|NCT00196976|579622741|FG009|Booster Study|Lost to Follow-up|0|||
160517160|NCT00196976|579622742|FG010|Booster Study|Lost to Follow-up|1|||
160517161|NCT00196976|579622743|FG011|Booster Study|Lost to Follow-up|2|||
160517162|NCT00196976|579622744|FG012|Booster Study|Lost to Follow-up|0|||
160517163|NCT00196976|579622745|FG013|Booster Study|Lost to Follow-up|0|||
160517164|NCT01535560|579622746|FG000|Overall Study|Adverse Event|12|||
160517165|NCT01535560|579622747|FG001|Overall Study|Adverse Event|7|||
160517166|NCT01535560|579622746|FG000|Overall Study|Lost to Follow-up|1|||
160517167|NCT01535560|579622747|FG001|Overall Study|Lost to Follow-up|3|||
160517168|NCT01535560|579622746|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
160517169|NCT01535560|579622747|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
160517170|NCT01535560|579622746|FG000|Overall Study|Treatment Failure|21|||
160517171|NCT01535560|579622747|FG001|Overall Study|Treatment Failure|83|||
160667660|NCT03032172|580164186|FG007|Treatment Period|Withdrawal by Subject|0|||
160667661|NCT03032172|580164179|FG000|Open-label Extension Period|Death|0|||
160517172|NCT01535560|579622746|FG000|Overall Study|Other|0|||
160517173|NCT01535560|579622747|FG001|Overall Study|Other|1|||
160517174|NCT01535560|579622746|FG000|Overall Study|Randomized in Error|0|||
160517175|NCT01535560|579622747|FG001|Overall Study|Randomized in Error|1|||
160517176|NCT02009761|579622748|FG000|Overall Study|Adverse Event|4|||
160517177|NCT02842827|579622749|FG000|Overall Study|Adverse Event|0|||
160667662|NCT03032172|580164180|FG001|Open-label Extension Period|Death|0|||
160667663|NCT03032172|580164181|FG002|Open-label Extension Period|Death|0|||
160667664|NCT03032172|580164182|FG003|Open-label Extension Period|Death|0|||
160667665|NCT03032172|580164183|FG004|Open-label Extension Period|Death|0|||
160667666|NCT03032172|580164184|FG005|Open-label Extension Period|Death|0|||
160517178|NCT02842827|579622750|FG001|Overall Study|Adverse Event|1|||
160517179|NCT02842827|579622751|FG002|Overall Study|Adverse Event|0|||
160517180|NCT02842827|579622752|FG003|Overall Study|Adverse Event|1|||
160517181|NCT02842827|579622753|FG004|Overall Study|Adverse Event|0|||
160517182|NCT02842827|579622754|FG005|Overall Study|Adverse Event|1|||
160517183|NCT02842827|579622755|FG006|Overall Study|Adverse Event|0|||
160517184|NCT02842827|579622756|FG007|Overall Study|Adverse Event|0|||
160517185|NCT02842827|579622749|FG000|Overall Study|Death|1|||
160517186|NCT02842827|579622750|FG001|Overall Study|Death|0|||
160517187|NCT02842827|579622751|FG002|Overall Study|Death|2|||
160517188|NCT02842827|579622752|FG003|Overall Study|Death|3|||
160517189|NCT02842827|579622753|FG004|Overall Study|Death|2|||
160517190|NCT02842827|579622754|FG005|Overall Study|Death|1|||
160517191|NCT02842827|579622755|FG006|Overall Study|Death|0|||
160517192|NCT02842827|579622756|FG007|Overall Study|Death|4|||
160517193|NCT02842827|579622749|FG000|Overall Study|Physician Decision|1|||
160517194|NCT02842827|579622750|FG001|Overall Study|Physician Decision|3|||
160517195|NCT02842827|579622751|FG002|Overall Study|Physician Decision|0|||
160517196|NCT02842827|579622752|FG003|Overall Study|Physician Decision|0|||
160517197|NCT02842827|579622753|FG004|Overall Study|Physician Decision|1|||
160517198|NCT02842827|579622754|FG005|Overall Study|Physician Decision|4|||
160517199|NCT02842827|579622755|FG006|Overall Study|Physician Decision|2|||
160517200|NCT02842827|579622756|FG007|Overall Study|Physician Decision|1|||
160517201|NCT02842827|579622749|FG000|Overall Study|Protocol Defined Disease Progression|0|||
160517202|NCT02842827|579622750|FG001|Overall Study|Protocol Defined Disease Progression|0|||
160517203|NCT02842827|579622751|FG002|Overall Study|Protocol Defined Disease Progression|0|||
160517204|NCT02842827|579622752|FG003|Overall Study|Protocol Defined Disease Progression|0|||
160517205|NCT02842827|579622753|FG004|Overall Study|Protocol Defined Disease Progression|0|||
160517206|NCT02842827|579622754|FG005|Overall Study|Protocol Defined Disease Progression|1|||
160517207|NCT02842827|579622755|FG006|Overall Study|Protocol Defined Disease Progression|0|||
160517208|NCT02842827|579622756|FG007|Overall Study|Protocol Defined Disease Progression|0|||
160517209|NCT02842827|579622749|FG000|Overall Study|Participant Withdrawal of Consent|1|||
160517210|NCT02842827|579622750|FG001|Overall Study|Participant Withdrawal of Consent|2|||
160517211|NCT02842827|579622751|FG002|Overall Study|Participant Withdrawal of Consent|2|||
160517212|NCT02842827|579622752|FG003|Overall Study|Participant Withdrawal of Consent|2|||
160517213|NCT02842827|579622753|FG004|Overall Study|Participant Withdrawal of Consent|2|||
160517214|NCT02842827|579622754|FG005|Overall Study|Participant Withdrawal of Consent|1|||
160517215|NCT02842827|579622755|FG006|Overall Study|Participant Withdrawal of Consent|2|||
160517216|NCT02842827|579622756|FG007|Overall Study|Participant Withdrawal of Consent|1|||
160517217|NCT01815138|579622757|FG000|Overall Study|Withdrawal by Subject|0|||
160517218|NCT01815138|579622758|FG001|Overall Study|Withdrawal by Subject|1|||
160517219|NCT01815138|579622757|FG000|Overall Study|Physician Decision|8|||
160517220|NCT01815138|579622758|FG001|Overall Study|Physician Decision|5|||
160517221|NCT00825825|579622759|FG000|First Medication Period (14 Days)|Adverse Event|1|||
160517222|NCT00825825|579622760|FG001|First Medication Period (14 Days)|Adverse Event|0|||
160517223|NCT00825825|579622761|FG002|First Medication Period (14 Days)|Adverse Event|0|||
160517224|NCT00825825|579622762|FG003|First Medication Period (14 Days)|Adverse Event|0|||
160517225|NCT00825825|579622763|FG004|First Medication Period (14 Days)|Adverse Event|0|||
160517226|NCT00825825|579622764|FG005|First Medication Period (14 Days)|Adverse Event|1|||
160517227|NCT00825825|579622759|FG000|First Medication Period (14 Days)|Physician Decision|2|||
160517228|NCT00825825|579622760|FG001|First Medication Period (14 Days)|Physician Decision|0|||
160517229|NCT00825825|579622761|FG002|First Medication Period (14 Days)|Physician Decision|1|||
160517230|NCT00825825|579622762|FG003|First Medication Period (14 Days)|Physician Decision|0|||
160517231|NCT00825825|579622763|FG004|First Medication Period (14 Days)|Physician Decision|0|||
160517232|NCT00825825|579622764|FG005|First Medication Period (14 Days)|Physician Decision|1|||
160517233|NCT00825825|579622759|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
160517234|NCT00825825|579622760|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
160517235|NCT00825825|579622761|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
160517236|NCT00825825|579622762|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
160517237|NCT00825825|579622763|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
160517238|NCT00825825|579622764|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
160517239|NCT00825825|579622759|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
160517240|NCT00825825|579622760|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
160517241|NCT00825825|579622761|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
160517242|NCT00825825|579622762|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
160517243|NCT00825825|579622763|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
160517244|NCT00825825|579622764|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
160517245|NCT00825825|579622759|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
160517246|NCT00825825|579622760|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
160517247|NCT00825825|579622761|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
160517248|NCT00825825|579622762|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
160517249|NCT00825825|579622763|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
160517250|NCT00825825|579622764|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
160517251|NCT00825825|579622759|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
160517252|NCT00825825|579622760|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
160517253|NCT00825825|579622761|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
160517254|NCT00825825|579622762|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
160517255|NCT00825825|579622763|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
160517256|NCT00825825|579622764|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
160517257|NCT00825825|579622759|FG000|Third Medication Period (14 Days)|poor data quality|0|||
160517258|NCT00825825|579622760|FG001|Third Medication Period (14 Days)|poor data quality|1|||
160517259|NCT00825825|579622761|FG002|Third Medication Period (14 Days)|poor data quality|0|||
160517260|NCT00825825|579622762|FG003|Third Medication Period (14 Days)|poor data quality|0|||
160517261|NCT00825825|579622763|FG004|Third Medication Period (14 Days)|poor data quality|0|||
160517262|NCT00825825|579622764|FG005|Third Medication Period (14 Days)|poor data quality|0|||
160517263|NCT02649946|579622770|FG000|Overall Study|Withdrawal by Subject|1|||
160517264|NCT02649946|579622771|FG001|Overall Study|Withdrawal by Subject|1|||
160517265|NCT02649946|579622770|FG000|Overall Study|Death|7|||
160517266|NCT02649946|579622771|FG001|Overall Study|Death|9|||
160517267|NCT02649946|579622770|FG000|Overall Study|Physician Decision|1|||
160517268|NCT02649946|579622771|FG001|Overall Study|Physician Decision|0|||
160517269|NCT02649946|579622770|FG000|Overall Study|Lost to Follow-up|2|||
160517270|NCT02649946|579622771|FG001|Overall Study|Lost to Follow-up|1|||
160517271|NCT02649946|579622770|FG000|Overall Study|Erroneously enrolled|1|||
160517272|NCT02649946|579622771|FG001|Overall Study|Erroneously enrolled|0|||
160517273|NCT02649946|579622770|FG000|Overall Study|Missed 6-month follow-up visit|0|||
160517274|NCT02649946|579622771|FG001|Overall Study|Missed 6-month follow-up visit|4|||
160517275|NCT00950950|579622772|FG000|Overall Study|Adverse Event|1|||
160517276|NCT00950950|579622773|FG001|Overall Study|Adverse Event|0|||
160517277|NCT00950950|579622772|FG000|Overall Study|Withdrawal by Subject|0|||
160517278|NCT00950950|579622773|FG001|Overall Study|Withdrawal by Subject|1|||
160517279|NCT01047293|579622774|FG000|Overall Study|DLT criteria not fulfilled|1|||
160517280|NCT01047293|579622775|FG001|Overall Study|DLT criteria not fulfilled|1|||
160517281|NCT01047293|579622776|FG002|Overall Study|DLT criteria not fulfilled|0|||
160517282|NCT01047293|579622777|FG003|Overall Study|DLT criteria not fulfilled|0|||
160517283|NCT00757783|579622778|FG000|Overall Study|Adverse Event|0|||
160517284|NCT00757783|579622779|FG001|Overall Study|Adverse Event|2|||
160517285|NCT00757783|579622778|FG000|Overall Study|Lost to Follow-up|1|||
160517286|NCT00757783|579622779|FG001|Overall Study|Lost to Follow-up|1|||
160517287|NCT00757783|579622778|FG000|Overall Study|Protocol Violation|1|||
160517288|NCT00757783|579622779|FG001|Overall Study|Protocol Violation|0|||
160517289|NCT00757783|579622778|FG000|Overall Study|Withdrawal by Subject|2|||
160517290|NCT00757783|579622779|FG001|Overall Study|Withdrawal by Subject|1|||
160517291|NCT00757783|579622778|FG000|Overall Study|Other|1|||
160517292|NCT00757783|579622779|FG001|Overall Study|Other|2|||
160517293|NCT02372136|579622780|FG000|Overall Study|Death|3|||
160517294|NCT02372136|579622781|FG001|Overall Study|Death|1|||
160517295|NCT01588496|579622782|FG000|Overall Study|Withdrawal by Subject|0|||
160517296|NCT01588496|579622783|FG001|Overall Study|Withdrawal by Subject|1|||
160517297|NCT01588496|579622784|FG002|Overall Study|Withdrawal by Subject|0|||
160517298|NCT03143166|579622785|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
160517299|NCT05924945|579622786|FG000|Overall Study|Withdrawal by Subject|3|||
160517300|NCT05924945|579622787|FG001|Overall Study|Withdrawal by Subject|4|||
160517301|NCT02003573|579622802|FG000|Overall Study|Progressive disease|2|||
160517302|NCT02003573|579622803|FG001|Overall Study|Progressive disease|0|||
160517303|NCT02003573|579622804|FG002|Overall Study|Progressive disease|1|||
160517304|NCT02003573|579622802|FG000|Overall Study|Other Adverse event|0|||
160517305|NCT02003573|579622803|FG001|Overall Study|Other Adverse event|1|||
160517306|NCT02003573|579622804|FG002|Overall Study|Other Adverse event|1|||
160517307|NCT02003573|579622802|FG000|Overall Study|Refuse to take trial medication|0|||
160517308|NCT02003573|579622803|FG001|Overall Study|Refuse to take trial medication|1|||
160517309|NCT02003573|579622804|FG002|Overall Study|Refuse to take trial medication|1|||
160517310|NCT02003573|579622802|FG000|Overall Study|Other than specified|1|||
160517311|NCT02003573|579622803|FG001|Overall Study|Other than specified|2|||
160517312|NCT02003573|579622804|FG002|Overall Study|Other than specified|3|||
160517313|NCT03683823|579622811|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
160517314|NCT03683823|579622812|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
160517315|NCT03683823|579622811|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
160517316|NCT03683823|579622812|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
160517317|NCT03683823|579622811|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
160517318|NCT03683823|579622812|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
160517319|NCT05026710|579622814|FG000|Overall Study|No longer met eligibility criteria|3|||
160517320|NCT05026710|579622815|FG001|Overall Study|No longer met eligibility criteria|1|||
160517321|NCT01323972|579622816|FG000|Overall Study|Withdrawal by Subject|1|||
160517322|NCT01323972|579622817|FG001|Overall Study|Withdrawal by Subject|0|||
160517323|NCT01323972|579622818|FG002|Overall Study|Withdrawal by Subject|1|||
160517324|NCT01323972|579622819|FG003|Overall Study|Withdrawal by Subject|0|||
160517325|NCT01323972|579622816|FG000|Overall Study|Migrated/moved from study area|1|||
160517326|NCT01323972|579622817|FG001|Overall Study|Migrated/moved from study area|2|||
160517327|NCT01323972|579622818|FG002|Overall Study|Migrated/moved from study area|0|||
160517328|NCT01323972|579622819|FG003|Overall Study|Migrated/moved from study area|0|||
160517329|NCT01323972|579622816|FG000|Overall Study|Lost to Follow-up|0|||
160517330|NCT01323972|579622817|FG001|Overall Study|Lost to Follow-up|1|||
160517331|NCT01323972|579622818|FG002|Overall Study|Lost to Follow-up|1|||
160517332|NCT01323972|579622819|FG003|Overall Study|Lost to Follow-up|1|||
160517333|NCT00994682|579622820|FG000|Double Bilnd|Withdrawal by Subject|5|||
160517334|NCT00994682|579622821|FG001|Double Bilnd|Withdrawal by Subject|6|||
160517335|NCT00994682|579622820|FG000|Double Bilnd|Lost to Follow-up|3|||
160517336|NCT00994682|579622821|FG001|Double Bilnd|Lost to Follow-up|3|||
160517337|NCT00994682|579622820|FG000|Double Bilnd|Adverse Event|1|||
160517338|NCT00994682|579622821|FG001|Double Bilnd|Adverse Event|0|||
160517339|NCT00994682|579622820|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
160517340|NCT00994682|579622821|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
160517341|NCT00994682|579622820|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
160517342|NCT00994682|579622821|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
160517343|NCT00994682|579622820|FG000|Pioglitazone Open Label|Physician Decision|6|||
160517344|NCT00994682|579622821|FG001|Pioglitazone Open Label|Physician Decision|1|||
160517345|NCT03218397|579622822|FG000|Overall Study|Prior positive blood culture|8|||
160517346|NCT03218397|579622823|FG001|Overall Study|Prior positive blood culture|13|||
160517347|NCT03218397|579622822|FG000|Overall Study|Comfort care|8|||
160517348|NCT03218397|579622823|FG001|Overall Study|Comfort care|5|||
160517349|NCT03218397|579622822|FG000|Overall Study|Comfort care and positive blood culture|1|||
160517350|NCT03218397|579622823|FG001|Overall Study|Comfort care and positive blood culture|0|||
160517351|NCT03218397|579622822|FG000|Overall Study|Comfort care and mixed culture|0|||
160517352|NCT03218397|579622823|FG001|Overall Study|Comfort care and mixed culture|1|||
160517353|NCT03218397|579622822|FG000|Overall Study|Mixed culture|2|||
160517354|NCT03218397|579622823|FG001|Overall Study|Mixed culture|2|||
160517355|NCT03218397|579622822|FG000|Overall Study|Inaccessible hospital records|2|||
160517356|NCT03218397|579622823|FG001|Overall Study|Inaccessible hospital records|5|||
160517357|NCT03218397|579622822|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
160517358|NCT03218397|579622823|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
160517359|NCT03218397|579622822|FG000|Overall Study|Randomized during laboratory off hours|2|||
160517360|NCT03218397|579622823|FG001|Overall Study|Randomized during laboratory off hours|1|||
160517361|NCT01796548|579622826|FG000|Overall Study|Lost to Follow-up|1|||
160517362|NCT01796548|579622826|FG000|Overall Study|Other|2|||
160517363|NCT01049217|579622829|FG000|Overall Study|Adverse Event|2|||
160517364|NCT01049217|579622830|FG001|Overall Study|Adverse Event|1|||
160517365|NCT01049217|579622829|FG000|Overall Study|Lack of Efficacy|1|||
160517366|NCT01049217|579622830|FG001|Overall Study|Lack of Efficacy|1|||
160517367|NCT01049217|579622829|FG000|Overall Study|Lost to Follow-up|3|||
160517368|NCT01049217|579622830|FG001|Overall Study|Lost to Follow-up|8|||
160517369|NCT01049217|579622829|FG000|Overall Study|Withdrawal by Subject|4|||
160517370|NCT01049217|579622830|FG001|Overall Study|Withdrawal by Subject|3|||
160517371|NCT01049217|579622829|FG000|Overall Study|Protocol Violation|1|||
160517372|NCT01049217|579622830|FG001|Overall Study|Protocol Violation|3|||
160517373|NCT01049217|579622829|FG000|Overall Study|Pregnancy|1|||
160517374|NCT01049217|579622830|FG001|Overall Study|Pregnancy|0|||
160517375|NCT01049217|579622829|FG000|Overall Study|Study Terminated by Sponsor|43|||
160517376|NCT01049217|579622830|FG001|Overall Study|Study Terminated by Sponsor|43|||
160517377|NCT01049217|579622829|FG000|Overall Study|Other|1|||
160517378|NCT01049217|579622830|FG001|Overall Study|Other|2|||
160517379|NCT01049217|579622829|FG000|Overall Study|Randomized but not Treated|0|||
160517380|NCT01049217|579622830|FG001|Overall Study|Randomized but not Treated|2|||
160517381|NCT00126503|579622831|FG000|Overall Study|disease progression|23|||
160517382|NCT00126503|579622832|FG001|Overall Study|disease progression|14|||
160517383|NCT00126503|579622831|FG000|Overall Study|Withdrawal by Subject|0|||
160517384|NCT00126503|579622832|FG001|Overall Study|Withdrawal by Subject|1|||
160624329|NCT05450198|580003746|FG003|Overall Study|Lost to Follow-up|1|||
160624330|NCT01982942|580003747|FG000|Overall Study|Adverse Event|10|||
160517385|NCT00126503|579622831|FG000|Overall Study|alternative therapy|1|||
160517386|NCT00126503|579622832|FG001|Overall Study|alternative therapy|1|||
160517387|NCT00126503|579622831|FG000|Overall Study|other complicating disease|4|||
160517388|NCT00126503|579622832|FG001|Overall Study|other complicating disease|1|||
160517389|NCT00126503|579622831|FG000|Overall Study|Death|3|||
160517390|NCT00126503|579622832|FG001|Overall Study|Death|0|||
160517391|NCT00126503|579622831|FG000|Overall Study|Adverse Event|13|||
160517392|NCT00126503|579622832|FG001|Overall Study|Adverse Event|3|||
160517393|NCT00126503|579622831|FG000|Overall Study|non-compliant|1|||
160517394|NCT00126503|579622832|FG001|Overall Study|non-compliant|0|||
160624331|NCT01982942|580003748|FG001|Overall Study|Adverse Event|5|||
160517395|NCT00126503|579622831|FG000|Overall Study|Physician Decision|2|||
160517396|NCT00126503|579622832|FG001|Overall Study|Physician Decision|1|||
160517397|NCT00589121|579622833|FG000|Overall Study|Protocol Violation|2|||
160517398|NCT00589121|579622834|FG001|Overall Study|Protocol Violation|6|||
160517399|NCT00589121|579622833|FG000|Overall Study|No protocol treatment received|0|||
160517400|NCT00589121|579622834|FG001|Overall Study|No protocol treatment received|1|||
160517401|NCT02495792|579622835|FG000|Overall Study|Lost to Follow-up|5|||
160517402|NCT02495792|579622836|FG001|Overall Study|Lost to Follow-up|9|||
160517403|NCT02495792|579622835|FG000|Overall Study|Protocol Violation|32|||
160517404|NCT02495792|579622836|FG001|Overall Study|Protocol Violation|31|||
160517405|NCT03519971|579622837|FG000|Overall Study|Death|142|||
160517406|NCT03519971|579622838|FG001|Overall Study|Death|69|||
160517407|NCT03519971|579622837|FG000|Overall Study|Lost to Follow-up|0|||
160517408|NCT03519971|579622838|FG001|Overall Study|Lost to Follow-up|1|||
160517409|NCT03519971|579622837|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
160517410|NCT03519971|579622838|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
160517411|NCT03519971|579622837|FG000|Overall Study|Withdrawal by Subject|3|||
160517412|NCT03519971|579622838|FG001|Overall Study|Withdrawal by Subject|2|||
160517413|NCT03519971|579622837|FG000|Overall Study|Other|1|||
160517414|NCT03519971|579622838|FG001|Overall Study|Other|0|||
160517415|NCT00925132|579622839|FG000|Overall Study|Withdrawal by Subject|2|||
160517416|NCT00925132|579622840|FG001|Overall Study|Withdrawal by Subject|0|||
160517417|NCT00925132|579622841|FG002|Overall Study|Withdrawal by Subject|0|||
160517418|NCT00925132|579622842|FG003|Overall Study|Withdrawal by Subject|0|||
160517419|NCT00925132|579622843|FG004|Overall Study|Withdrawal by Subject|1|||
160517420|NCT00925132|579622839|FG000|Overall Study|Removed due to disease progression|0|||
160517421|NCT00925132|579622840|FG001|Overall Study|Removed due to disease progression|0|||
160517422|NCT00925132|579622841|FG002|Overall Study|Removed due to disease progression|0|||
160517423|NCT00925132|579622842|FG003|Overall Study|Removed due to disease progression|0|||
160517424|NCT00925132|579622843|FG004|Overall Study|Removed due to disease progression|4|||
160517425|NCT02545933|579622844|FG000|Overall Study|Adverse Event|3|||
160517426|NCT02545933|579622845|FG001|Overall Study|Adverse Event|0|||
160517427|NCT02545933|579622846|FG002|Overall Study|Adverse Event|0|||
160517428|NCT02545933|579622844|FG000|Overall Study|Withdrawal by Subject|2|||
160517429|NCT02545933|579622845|FG001|Overall Study|Withdrawal by Subject|3|||
160517430|NCT02545933|579622846|FG002|Overall Study|Withdrawal by Subject|3|||
160517431|NCT02545933|579622844|FG000|Overall Study|Protocol Violation|1|||
160517432|NCT02545933|579622845|FG001|Overall Study|Protocol Violation|0|||
160517433|NCT02545933|579622846|FG002|Overall Study|Protocol Violation|1|||
160517434|NCT03149549|579622847|FG000|Study Discontinuation--Treatment Period|Death|0|||
160517435|NCT03149549|579622848|FG001|Study Discontinuation--Treatment Period|Death|0|||
160517436|NCT03149549|579622849|FG002|Study Discontinuation--Treatment Period|Death|0|||
160517437|NCT03149549|579622850|FG003|Study Discontinuation--Treatment Period|Death|1|||
160517438|NCT03149549|579622851|FG004|Study Discontinuation--Treatment Period|Death|2|||
160517439|NCT03149549|579622852|FG005|Study Discontinuation--Treatment Period|Death|1|||
160517440|NCT03149549|579622853|FG006|Study Discontinuation--Treatment Period|Death|1|||
160517441|NCT03149549|579622854|FG007|Study Discontinuation--Treatment Period|Death|2|||
160517442|NCT03149549|579622855|FG008|Study Discontinuation--Treatment Period|Death|4|||
160517443|NCT03149549|579622856|FG009|Study Discontinuation--Treatment Period|Death|1|||
160517444|NCT03149549|579622857|FG010|Study Discontinuation--Treatment Period|Death|0|||
160517445|NCT03149549|579622858|FG011|Study Discontinuation--Treatment Period|Death|0|||
160517446|NCT03149549|579622859|FG012|Study Discontinuation--Treatment Period|Death|1|||
160517447|NCT03149549|579622847|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517448|NCT03149549|579622848|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517449|NCT03149549|579622849|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517450|NCT03149549|579622850|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517451|NCT03149549|579622851|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517452|NCT03149549|579622852|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517453|NCT03149549|579622853|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517454|NCT03149549|579622854|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
160517455|NCT03149549|579622855|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517456|NCT03149549|579622856|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517457|NCT03149549|579622857|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517458|NCT03149549|579622858|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
160517459|NCT03149549|579622859|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
160517460|NCT03149549|579622847|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
160517461|NCT03149549|579622848|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
160517462|NCT03149549|579622849|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
160517463|NCT03149549|579622850|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
160517464|NCT03149549|579622851|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
160624332|NCT01982942|580003747|FG000|Overall Study|Lost to Follow-up|4|||
160624333|NCT01982942|580003748|FG001|Overall Study|Lost to Follow-up|3|||
160624334|NCT01982942|580003747|FG000|Overall Study|Multiple sclerosis progression|3|||
160624335|NCT01982942|580003748|FG001|Overall Study|Multiple sclerosis progression|2|||
160517465|NCT03149549|579622852|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
160517466|NCT03149549|579622853|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
160517467|NCT03149549|579622854|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
160517468|NCT03149549|579622855|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
160517469|NCT03149549|579622856|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
160517470|NCT03149549|579622857|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
160517471|NCT03149549|579622858|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
160517472|NCT03149549|579622859|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
160517473|NCT03149549|579622847|FG000|Study Discontinuation--Treatment Period|Other|0|||
160517474|NCT03149549|579622848|FG001|Study Discontinuation--Treatment Period|Other|0|||
160517475|NCT03149549|579622849|FG002|Study Discontinuation--Treatment Period|Other|0|||
160517476|NCT03149549|579622850|FG003|Study Discontinuation--Treatment Period|Other|0|||
160517477|NCT03149549|579622851|FG004|Study Discontinuation--Treatment Period|Other|0|||
160517478|NCT03149549|579622852|FG005|Study Discontinuation--Treatment Period|Other|0|||
160517479|NCT03149549|579622853|FG006|Study Discontinuation--Treatment Period|Other|0|||
160517480|NCT03149549|579622854|FG007|Study Discontinuation--Treatment Period|Other|1|||
160517481|NCT03149549|579622855|FG008|Study Discontinuation--Treatment Period|Other|0|||
160517482|NCT03149549|579622856|FG009|Study Discontinuation--Treatment Period|Other|1|||
160517483|NCT03149549|579622857|FG010|Study Discontinuation--Treatment Period|Other|0|||
160517484|NCT03149549|579622858|FG011|Study Discontinuation--Treatment Period|Other|0|||
160517485|NCT03149549|579622859|FG012|Study Discontinuation--Treatment Period|Other|0|||
160517486|NCT03149549|579622847|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
160517487|NCT03149549|579622848|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
160517488|NCT03149549|579622849|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
160517489|NCT03149549|579622850|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
160517490|NCT03149549|579622851|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
160517491|NCT03149549|579622852|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
160517492|NCT03149549|579622853|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
160517493|NCT03149549|579622854|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
160517494|NCT03149549|579622855|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
160517495|NCT03149549|579622856|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
160517496|NCT03149549|579622857|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
160517497|NCT03149549|579622858|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
160517498|NCT03149549|579622859|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
160517499|NCT03149549|579622847|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
160517500|NCT03149549|579622848|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
160517501|NCT03149549|579622849|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
160517502|NCT03149549|579622850|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
160517503|NCT03149549|579622851|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
160517504|NCT03149549|579622852|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
160517505|NCT03149549|579622853|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
160517506|NCT03149549|579622854|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
160517507|NCT03149549|579622855|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
160517508|NCT03149549|579622856|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
160517509|NCT03149549|579622857|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
160517510|NCT03149549|579622858|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
160517511|NCT03149549|579622859|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
160517512|NCT03149549|579622847|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
160517513|NCT03149549|579622848|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
160517514|NCT03149549|579622849|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
160517515|NCT03149549|579622850|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
160517516|NCT03149549|579622851|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
160517517|NCT03149549|579622852|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
160517518|NCT03149549|579622853|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
160517519|NCT03149549|579622854|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
160517520|NCT03149549|579622855|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
160517521|NCT03149549|579622856|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
160517522|NCT03149549|579622857|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
160517523|NCT03149549|579622858|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
160517524|NCT03149549|579622859|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
160517525|NCT03149549|579622847|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
160517526|NCT03149549|579622848|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
160517527|NCT03149549|579622849|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
160517528|NCT03149549|579622850|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
160517529|NCT03149549|579622851|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
160517530|NCT03149549|579622852|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
160517531|NCT03149549|579622853|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
160517532|NCT03149549|579622854|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
160517533|NCT03149549|579622855|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
160517534|NCT03149549|579622856|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
160517535|NCT03149549|579622857|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
160517536|NCT03149549|579622858|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
160517537|NCT03149549|579622859|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
160517538|NCT03149549|579622847|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
160517539|NCT03149549|579622848|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
160517540|NCT03149549|579622849|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
160517541|NCT03149549|579622850|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
160517542|NCT03149549|579622851|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
160517543|NCT03149549|579622852|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
160517544|NCT03149549|579622853|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
160517545|NCT03149549|579622854|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
160517546|NCT03149549|579622855|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
160517547|NCT03149549|579622856|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
160517548|NCT03149549|579622857|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
160517549|NCT03149549|579622858|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
160517550|NCT03149549|579622859|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
160517551|NCT01328717|579624846|FG000|Overall Study|Adverse Event|1|||
160517552|NCT00346268|579624847|FG000|Overall Study|Adverse Event|1|||
160517553|NCT00346268|579624848|FG001|Overall Study|Adverse Event|0|||
160517554|NCT00346268|579624847|FG000|Overall Study|Protocol Violation|1|||
160517555|NCT00346268|579624848|FG001|Overall Study|Protocol Violation|0|||
160517556|NCT00346268|579624847|FG000|Overall Study|Participant refused|0|||
160517557|NCT00346268|579624848|FG001|Overall Study|Participant refused|3|||
160517558|NCT01177722|579624853|FG000|Overall Study|Serious Adverse Event|0|||
160517559|NCT01177722|579624854|FG001|Overall Study|Serious Adverse Event|0|||
160517560|NCT01177722|579624855|FG002|Overall Study|Serious Adverse Event|1|||
160517561|NCT01177722|579624856|FG003|Overall Study|Serious Adverse Event|0|||
160517562|NCT01177722|579624853|FG000|Overall Study|Protocol Violation|0|||
160517563|NCT01177722|579624854|FG001|Overall Study|Protocol Violation|0|||
160517564|NCT01177722|579624855|FG002|Overall Study|Protocol Violation|1|||
160517565|NCT01177722|579624856|FG003|Overall Study|Protocol Violation|0|||
160517566|NCT01177722|579624853|FG000|Overall Study|Lost to Follow-up|3|||
160517567|NCT01177722|579624854|FG001|Overall Study|Lost to Follow-up|4|||
160517568|NCT01177722|579624855|FG002|Overall Study|Lost to Follow-up|3|||
160517569|NCT01177722|579624856|FG003|Overall Study|Lost to Follow-up|1|||
160517570|NCT01177722|579624853|FG000|Overall Study|Withdrawal by Subject|10|||
160517571|NCT01177722|579624854|FG001|Overall Study|Withdrawal by Subject|6|||
160517572|NCT01177722|579624855|FG002|Overall Study|Withdrawal by Subject|4|||
160517573|NCT01177722|579624856|FG003|Overall Study|Withdrawal by Subject|6|||
160517574|NCT02831387|579624857|FG000|Overall Study|Withdrawal by Subject|1|||
160517575|NCT02831387|579624858|FG001|Overall Study|Withdrawal by Subject|1|||
160517576|NCT02831387|579624857|FG000|Overall Study|Discontinued due to stock recovery|0|||
160517577|NCT02831387|579624858|FG001|Overall Study|Discontinued due to stock recovery|1|||
160517578|NCT01828073|579624859|FG000|Overall Study|Lost to Follow-up|1|||
160517579|NCT01828073|579624860|FG001|Overall Study|Lost to Follow-up|2|||
160517580|NCT01201317|579624867|FG000|Overall Study|Withdrawal by Subject|5|||
160517581|NCT01201317|579624868|FG001|Overall Study|Withdrawal by Subject|0|||
160517582|NCT01201317|579624869|FG002|Overall Study|Withdrawal by Subject|3|||
160517583|NCT01201317|579624867|FG000|Overall Study|Adverse Event|2|||
160517584|NCT01201317|579624868|FG001|Overall Study|Adverse Event|2|||
160517585|NCT01201317|579624869|FG002|Overall Study|Adverse Event|2|||
160517586|NCT01201317|579624867|FG000|Overall Study|Screen failure|1|||
160517587|NCT01201317|579624868|FG001|Overall Study|Screen failure|1|||
160624336|NCT01982942|580003747|FG000|Overall Study|Wanted to try therapy not permitted|1|||
160624337|NCT01982942|580003748|FG001|Overall Study|Wanted to try therapy not permitted|0|||
160624338|NCT01982942|580003747|FG000|Overall Study|Subject declined future visits|0|||
160624339|NCT01982942|580003748|FG001|Overall Study|Subject declined future visits|1|||
160624340|NCT01982942|580003747|FG000|Overall Study|Left geographical area|2|||
160624341|NCT01982942|580003748|FG001|Overall Study|Left geographical area|0|||
160624342|NCT01982942|580003747|FG000|Overall Study|Too many pills|1|||
160624343|NCT01982942|580003748|FG001|Overall Study|Too many pills|0|||
160624344|NCT01982942|580003747|FG000|Overall Study|MS Relapse|0|||
160624345|NCT01982942|580003748|FG001|Overall Study|MS Relapse|1|||
160624346|NCT01982942|580003747|FG000|Overall Study|Chose to join a stem cell trial|0|||
160624347|NCT01982942|580003748|FG001|Overall Study|Chose to join a stem cell trial|1|||
160624348|NCT01982942|580003747|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
160517588|NCT01201317|579624869|FG002|Overall Study|Screen failure|0|||
160517589|NCT01201317|579624867|FG000|Overall Study|Protocol Violation|0|||
160517590|NCT01201317|579624868|FG001|Overall Study|Protocol Violation|1|||
160517591|NCT01201317|579624869|FG002|Overall Study|Protocol Violation|1|||
160517592|NCT01201317|579624867|FG000|Overall Study|Death|0|||
160517593|NCT01201317|579624868|FG001|Overall Study|Death|1|||
160517594|NCT01201317|579624869|FG002|Overall Study|Death|0|||
160517595|NCT01201317|579624867|FG000|Overall Study|Study-specific withdrawal criteria|0|||
160517596|NCT01201317|579624868|FG001|Overall Study|Study-specific withdrawal criteria|0|||
160517597|NCT01201317|579624869|FG002|Overall Study|Study-specific withdrawal criteria|1|||
160517598|NCT01201317|579624867|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
160517599|NCT01201317|579624868|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
160517600|NCT01201317|579624869|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
160517601|NCT01201317|579624867|FG000|Overall Study|Decrease in renal function|0|||
160517602|NCT01201317|579624868|FG001|Overall Study|Decrease in renal function|1|||
160517603|NCT01201317|579624869|FG002|Overall Study|Decrease in renal function|0|||
160517604|NCT01201317|579624867|FG000|Overall Study|Lack of Efficacy|1|||
160517605|NCT01201317|579624868|FG001|Overall Study|Lack of Efficacy|0|||
160517606|NCT01201317|579624869|FG002|Overall Study|Lack of Efficacy|0|||
160517607|NCT01201317|579624867|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
160517608|NCT01201317|579624868|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
160517609|NCT01201317|579624869|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
160517610|NCT00876928|579624871|FG000|Overall Study|Lost to Follow-up|2|||
160517611|NCT00876928|579624872|FG001|Overall Study|Lost to Follow-up|5|||
160517612|NCT00876928|579624871|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
160517613|NCT00876928|579624872|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
160517614|NCT02795429|579624873|FG000|Overall Study|Adverse Event|1|||
160517615|NCT02795429|579624874|FG001|Overall Study|Adverse Event|2|||
160517616|NCT02795429|579624875|FG002|Overall Study|Adverse Event|1|||
160517617|NCT02795429|579624876|FG003|Overall Study|Adverse Event|2|||
160517618|NCT02795429|579624877|FG004|Overall Study|Adverse Event|1|||
160517619|NCT02795429|579624873|FG000|Overall Study|Death|1|||
160517620|NCT02795429|579624874|FG001|Overall Study|Death|0|||
160517621|NCT02795429|579624875|FG002|Overall Study|Death|1|||
160517622|NCT02795429|579624876|FG003|Overall Study|Death|2|||
160517623|NCT02795429|579624877|FG004|Overall Study|Death|1|||
160517624|NCT02795429|579624873|FG000|Overall Study|Physician Decision|0|||
160517625|NCT02795429|579624874|FG001|Overall Study|Physician Decision|0|||
160517626|NCT02795429|579624875|FG002|Overall Study|Physician Decision|2|||
160517627|NCT02795429|579624876|FG003|Overall Study|Physician Decision|1|||
160517628|NCT02795429|579624877|FG004|Overall Study|Physician Decision|5|||
160517629|NCT02795429|579624873|FG000|Overall Study|Progressive disease|3|||
160517630|NCT02795429|579624874|FG001|Overall Study|Progressive disease|7|||
160517631|NCT02795429|579624875|FG002|Overall Study|Progressive disease|6|||
160517632|NCT02795429|579624876|FG003|Overall Study|Progressive disease|26|||
160517633|NCT02795429|579624877|FG004|Overall Study|Progressive disease|20|||
160517634|NCT02795429|579624873|FG000|Overall Study|Subject/guardian decision|1|||
160667667|NCT03032172|580164185|FG006|Open-label Extension Period|Death|0|||
160667668|NCT03032172|580164186|FG007|Open-label Extension Period|Death|2|||
160667669|NCT03032172|580164179|FG000|Open-label Extension Period|Reason Not Specified|0|||
160667670|NCT03032172|580164180|FG001|Open-label Extension Period|Reason Not Specified|0|||
160667671|NCT03032172|580164181|FG002|Open-label Extension Period|Reason Not Specified|0|||
160667672|NCT03032172|580164182|FG003|Open-label Extension Period|Reason Not Specified|0|||
160517635|NCT02795429|579624874|FG001|Overall Study|Subject/guardian decision|1|||
160517636|NCT02795429|579624875|FG002|Overall Study|Subject/guardian decision|1|||
160517637|NCT02795429|579624876|FG003|Overall Study|Subject/guardian decision|1|||
160517638|NCT02795429|579624877|FG004|Overall Study|Subject/guardian decision|3|||
160517639|NCT05220254|579624878|FG000|Overall Study|Withdrawal by Subject|4|||
160517640|NCT05220254|579624878|FG000|Overall Study|Removed due to ineligibility|1|||
160517641|NCT05220254|579624878|FG000|Overall Study|Lost to Follow-up|7|||
160517642|NCT01557283|579624881|FG000|Overall Study|Lost to Follow-up|7|||
160517643|NCT01557283|579624881|FG000|Overall Study|Non-responder|19|||
160517644|NCT01557283|579624881|FG000|Overall Study|Adverse Event|7|||
160517645|NCT01557283|579624881|FG000|Overall Study|Lack of Efficacy|1|||
160667673|NCT03032172|580164183|FG004|Open-label Extension Period|Reason Not Specified|0|||
160667674|NCT03032172|580164184|FG005|Open-label Extension Period|Reason Not Specified|5|||
160667675|NCT03032172|580164185|FG006|Open-label Extension Period|Reason Not Specified|3|||
160517646|NCT01557283|579624881|FG000|Overall Study|Non-compliance|1|||
160517647|NCT01557283|579624881|FG000|Overall Study|Withdrawal by Subject|1|||
160517648|NCT01557283|579624881|FG000|Overall Study|Participant's weight too high for dose|1|||
160517649|NCT01557283|579624881|FG000|Overall Study|Worsening of psoriasis|1|||
160517650|NCT01557283|579624881|FG000|Overall Study|Other|6|||
160517651|NCT01765192|579624885|FG000|Treatment Period 1|Adverse Event|0|||
160667676|NCT03032172|580164186|FG007|Open-label Extension Period|Reason Not Specified|0|||
160667677|NCT03032172|580164179|FG000|Open-label Extension Period|Pregnancy|0|||
160517652|NCT01765192|579624886|FG001|Treatment Period 1|Adverse Event|1|||
160667678|NCT03032172|580164180|FG001|Open-label Extension Period|Pregnancy|0|||
160517653|NCT01765192|579624885|FG000|Washout Period|Voluntary Withdrawal|1|||
160517654|NCT01765192|579624886|FG001|Washout Period|Voluntary Withdrawal|1|||
160667679|NCT03032172|580164181|FG002|Open-label Extension Period|Pregnancy|0|||
160517655|NCT01765192|579624885|FG000|Washout Period|Reason not specified|1|||
160517656|NCT01765192|579624886|FG001|Washout Period|Reason not specified|0|||
160517657|NCT01765192|579624885|FG000|Treatment Period 2|Reason not specified|0|||
160517658|NCT01765192|579624886|FG001|Treatment Period 2|Reason not specified|2|||
160517659|NCT01765192|579624885|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
160517660|NCT01765192|579624886|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
160517661|NCT01016977|579624889|FG000|Overall Study|Lost to Follow-up|1|||
160517662|NCT01016977|579624890|FG001|Overall Study|Lost to Follow-up|0|||
160517663|NCT01016977|579624889|FG000|Overall Study|Withdrawal by Subject|2|||
160517664|NCT01016977|579624890|FG001|Overall Study|Withdrawal by Subject|2|||
160517665|NCT02080221|579624891|FG000|Overall Study|Withdrawal by Subject|1|||
160517666|NCT02080221|579624891|FG000|Overall Study|Clinical Progression of Disease|1|||
160517667|NCT03184870|579624897|FG000|Initial Treatment|Death|6|||
160517668|NCT03184870|579624898|FG001|Initial Treatment|Death|6|||
160517669|NCT03184870|579624899|FG002|Initial Treatment|Death|8|||
160517670|NCT03184870|579624900|FG003|Initial Treatment|Death|8|||
160517671|NCT03184870|579624901|FG004|Initial Treatment|Death|6|||
160517672|NCT03184870|579624902|FG005|Initial Treatment|Death|6|||
160517673|NCT03184870|579624903|FG006|Initial Treatment|Death|6|||
160517674|NCT03184870|579624904|FG007|Initial Treatment|Death|7|||
160517675|NCT03184870|579624905|FG008|Initial Treatment|Death|1|||
160517676|NCT03184870|579624906|FG009|Initial Treatment|Death|2|||
160517677|NCT03184870|579624907|FG010|Initial Treatment|Death|26|||
160517678|NCT03184870|579624908|FG011|Initial Treatment|Death|28|||
160517679|NCT03184870|579624909|FG012|Initial Treatment|Death|10|||
160517680|NCT03184870|579624910|FG013|Initial Treatment|Death|33|||
160517681|NCT03184870|579624911|FG014|Initial Treatment|Death|34|||
160517682|NCT03184870|579624912|FG015|Initial Treatment|Death|26|||
160517683|NCT03184870|579624913|FG016|Initial Treatment|Death|20|||
160517684|NCT03184870|579624914|FG017|Initial Treatment|Death|18|||
160517685|NCT03184870|579624897|FG000|Initial Treatment|Other Reasons|2|||
160517686|NCT03184870|579624898|FG001|Initial Treatment|Other Reasons|2|||
160517687|NCT03184870|579624899|FG002|Initial Treatment|Other Reasons|0|||
160517688|NCT03184870|579624900|FG003|Initial Treatment|Other Reasons|1|||
160517689|NCT03184870|579624901|FG004|Initial Treatment|Other Reasons|0|||
160517690|NCT03184870|579624902|FG005|Initial Treatment|Other Reasons|0|||
160517691|NCT03184870|579624903|FG006|Initial Treatment|Other Reasons|0|||
160517692|NCT03184870|579624904|FG007|Initial Treatment|Other Reasons|2|||
160517693|NCT03184870|579624905|FG008|Initial Treatment|Other Reasons|0|||
160517694|NCT03184870|579624906|FG009|Initial Treatment|Other Reasons|0|||
160517695|NCT03184870|579624907|FG010|Initial Treatment|Other Reasons|4|||
160517696|NCT03184870|579624908|FG011|Initial Treatment|Other Reasons|2|||
160517697|NCT03184870|579624909|FG012|Initial Treatment|Other Reasons|2|||
160517698|NCT03184870|579624910|FG013|Initial Treatment|Other Reasons|0|||
160517699|NCT03184870|579624911|FG014|Initial Treatment|Other Reasons|0|||
160517700|NCT03184870|579624912|FG015|Initial Treatment|Other Reasons|1|||
160517701|NCT03184870|579624913|FG016|Initial Treatment|Other Reasons|0|||
160517702|NCT03184870|579624914|FG017|Initial Treatment|Other Reasons|2|||
160517703|NCT03184870|579624897|FG000|Initial Treatment|Lost to Follow-up|2|||
160517704|NCT03184870|579624898|FG001|Initial Treatment|Lost to Follow-up|0|||
160517705|NCT03184870|579624899|FG002|Initial Treatment|Lost to Follow-up|0|||
160517706|NCT03184870|579624900|FG003|Initial Treatment|Lost to Follow-up|1|||
160517707|NCT03184870|579624901|FG004|Initial Treatment|Lost to Follow-up|1|||
160517708|NCT03184870|579624902|FG005|Initial Treatment|Lost to Follow-up|1|||
160517709|NCT03184870|579624903|FG006|Initial Treatment|Lost to Follow-up|0|||
160517710|NCT03184870|579624904|FG007|Initial Treatment|Lost to Follow-up|2|||
160517711|NCT03184870|579624905|FG008|Initial Treatment|Lost to Follow-up|0|||
160517712|NCT03184870|579624906|FG009|Initial Treatment|Lost to Follow-up|0|||
160517713|NCT03184870|579624907|FG010|Initial Treatment|Lost to Follow-up|2|||
160517714|NCT03184870|579624908|FG011|Initial Treatment|Lost to Follow-up|0|||
160517715|NCT03184870|579624909|FG012|Initial Treatment|Lost to Follow-up|2|||
160517716|NCT03184870|579624910|FG013|Initial Treatment|Lost to Follow-up|2|||
160517717|NCT03184870|579624911|FG014|Initial Treatment|Lost to Follow-up|0|||
160517718|NCT03184870|579624912|FG015|Initial Treatment|Lost to Follow-up|0|||
160517719|NCT03184870|579624913|FG016|Initial Treatment|Lost to Follow-up|2|||
160667680|NCT03032172|580164182|FG003|Open-label Extension Period|Pregnancy|0|||
160517720|NCT03184870|579624914|FG017|Initial Treatment|Lost to Follow-up|2|||
160517721|NCT03184870|579624897|FG000|Initial Treatment|Withdrawal by Subject|0|||
160517722|NCT03184870|579624898|FG001|Initial Treatment|Withdrawal by Subject|0|||
160517723|NCT03184870|579624899|FG002|Initial Treatment|Withdrawal by Subject|2|||
160517724|NCT03184870|579624900|FG003|Initial Treatment|Withdrawal by Subject|1|||
160517725|NCT03184870|579624901|FG004|Initial Treatment|Withdrawal by Subject|1|||
160517726|NCT03184870|579624902|FG005|Initial Treatment|Withdrawal by Subject|0|||
160517727|NCT03184870|579624903|FG006|Initial Treatment|Withdrawal by Subject|1|||
160517728|NCT03184870|579624904|FG007|Initial Treatment|Withdrawal by Subject|0|||
160667681|NCT03032172|580164183|FG004|Open-label Extension Period|Pregnancy|0|||
160517729|NCT03184870|579624905|FG008|Initial Treatment|Withdrawal by Subject|0|||
160517730|NCT03184870|579624906|FG009|Initial Treatment|Withdrawal by Subject|0|||
160517731|NCT03184870|579624907|FG010|Initial Treatment|Withdrawal by Subject|0|||
160517732|NCT03184870|579624908|FG011|Initial Treatment|Withdrawal by Subject|2|||
160517733|NCT03184870|579624909|FG012|Initial Treatment|Withdrawal by Subject|3|||
160517734|NCT03184870|579624910|FG013|Initial Treatment|Withdrawal by Subject|0|||
160517735|NCT03184870|579624911|FG014|Initial Treatment|Withdrawal by Subject|1|||
160517736|NCT03184870|579624912|FG015|Initial Treatment|Withdrawal by Subject|5|||
160517737|NCT03184870|579624913|FG016|Initial Treatment|Withdrawal by Subject|2|||
160517738|NCT03184870|579624914|FG017|Initial Treatment|Withdrawal by Subject|2|||
160517739|NCT03184870|579624897|FG000|Initial Treatment|Moved to crossover treatment|0|||
160517740|NCT03184870|579624898|FG001|Initial Treatment|Moved to crossover treatment|0|||
160517741|NCT03184870|579624899|FG002|Initial Treatment|Moved to crossover treatment|0|||
160517742|NCT03184870|579624900|FG003|Initial Treatment|Moved to crossover treatment|0|||
160517743|NCT03184870|579624901|FG004|Initial Treatment|Moved to crossover treatment|0|||
160517744|NCT03184870|579624902|FG005|Initial Treatment|Moved to crossover treatment|0|||
160517745|NCT03184870|579624903|FG006|Initial Treatment|Moved to crossover treatment|0|||
160517746|NCT03184870|579624904|FG007|Initial Treatment|Moved to crossover treatment|0|||
160517747|NCT03184870|579624905|FG008|Initial Treatment|Moved to crossover treatment|0|||
160517748|NCT03184870|579624906|FG009|Initial Treatment|Moved to crossover treatment|0|||
160667682|NCT03032172|580164184|FG005|Open-label Extension Period|Pregnancy|0|||
160667683|NCT03032172|580164185|FG006|Open-label Extension Period|Pregnancy|1|||
160667684|NCT03032172|580164186|FG007|Open-label Extension Period|Pregnancy|0|||
160667685|NCT03032172|580164179|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
160667686|NCT03032172|580164180|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
160667687|NCT03032172|580164181|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
160517749|NCT03184870|579624907|FG010|Initial Treatment|Moved to crossover treatment|0|||
160517750|NCT03184870|579624908|FG011|Initial Treatment|Moved to crossover treatment|0|||
160517751|NCT03184870|579624909|FG012|Initial Treatment|Moved to crossover treatment|9|||
160517752|NCT03184870|579624910|FG013|Initial Treatment|Moved to crossover treatment|0|||
160517753|NCT03184870|579624911|FG014|Initial Treatment|Moved to crossover treatment|0|||
160517754|NCT03184870|579624912|FG015|Initial Treatment|Moved to crossover treatment|0|||
160517755|NCT03184870|579624913|FG016|Initial Treatment|Moved to crossover treatment|0|||
160517756|NCT03184870|579624914|FG017|Initial Treatment|Moved to crossover treatment|0|||
160517757|NCT03184870|579624897|FG000|Crossover Treatment|Other reasons|0|||
160517758|NCT03184870|579624898|FG001|Crossover Treatment|Other reasons|0|||
160517759|NCT03184870|579624899|FG002|Crossover Treatment|Other reasons|0|||
160517760|NCT03184870|579624900|FG003|Crossover Treatment|Other reasons|0|||
160517761|NCT03184870|579624901|FG004|Crossover Treatment|Other reasons|0|||
160517762|NCT03184870|579624902|FG005|Crossover Treatment|Other reasons|0|||
160517763|NCT03184870|579624903|FG006|Crossover Treatment|Other reasons|0|||
160517764|NCT03184870|579624904|FG007|Crossover Treatment|Other reasons|0|||
160517765|NCT03184870|579624905|FG008|Crossover Treatment|Other reasons|0|||
160517766|NCT03184870|579624906|FG009|Crossover Treatment|Other reasons|0|||
160517767|NCT03184870|579624907|FG010|Crossover Treatment|Other reasons|0|||
160667688|NCT03032172|580164182|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
160667689|NCT03032172|580164183|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
160667690|NCT03032172|580164184|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
160667691|NCT03032172|580164185|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
160667692|NCT03032172|580164186|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
160667693|NCT06284525|580164192|FG000|Overall Study|Withdrawal by Subject|1|||
160667694|NCT00834522|580164193|FG000|Washout|Adverse Event|1|||
160667695|NCT00834522|580164194|FG001|Washout|Adverse Event|0|||
160667696|NCT00834522|580164193|FG000|Washout|Withdrawal by Subject|2|||
160667697|NCT00834522|580164194|FG001|Washout|Withdrawal by Subject|1|||
160667698|NCT00519194|580164195|FG000|Overall Study|Withdrawal by Subject|9|||
160667699|NCT00519194|580164195|FG000|Overall Study|Death|9|||
160667700|NCT00519194|580164195|FG000|Overall Study|Lost to Follow-up|3|||
160667701|NCT01111461|580164196|FG000|Overall Study|Adverse Event|32|||
160517768|NCT03184870|579624908|FG011|Crossover Treatment|Other reasons|0|||
160517769|NCT03184870|579624909|FG012|Crossover Treatment|Other reasons|0|||
160517770|NCT03184870|579624910|FG013|Crossover Treatment|Other reasons|0|||
160517771|NCT03184870|579624911|FG014|Crossover Treatment|Other reasons|0|||
160517772|NCT03184870|579624912|FG015|Crossover Treatment|Other reasons|0|||
160517773|NCT03184870|579624913|FG016|Crossover Treatment|Other reasons|0|||
160667702|NCT01111461|580164196|FG000|Overall Study|Participant choice|11|||
160667703|NCT01111461|580164196|FG000|Overall Study|Lost to Follow-up|1|||
160517774|NCT03184870|579624914|FG017|Crossover Treatment|Other reasons|2|||
160517775|NCT03184870|579624897|FG000|Crossover Treatment|Death|0|||
160667704|NCT01111461|580164196|FG000|Overall Study|Withdrawal by Subject|1|||
160667705|NCT01111461|580164196|FG000|Overall Study|Other|6|||
160667706|NCT03600805|580164207|FG000|Overall Study|Adverse Event|2|||
160667707|NCT03600805|580164208|FG001|Overall Study|Adverse Event|1|||
160517776|NCT03184870|579624898|FG001|Crossover Treatment|Death|0|||
160517777|NCT03184870|579624899|FG002|Crossover Treatment|Death|0|||
160517778|NCT03184870|579624900|FG003|Crossover Treatment|Death|0|||
160517779|NCT03184870|579624901|FG004|Crossover Treatment|Death|0|||
160517780|NCT03184870|579624902|FG005|Crossover Treatment|Death|0|||
160517781|NCT03184870|579624903|FG006|Crossover Treatment|Death|0|||
160667708|NCT03600805|580164209|FG002|Overall Study|Adverse Event|1|||
160517782|NCT03184870|579624904|FG007|Crossover Treatment|Death|0|||
160517783|NCT03184870|579624905|FG008|Crossover Treatment|Death|0|||
160517784|NCT03184870|579624906|FG009|Crossover Treatment|Death|0|||
160517785|NCT03184870|579624907|FG010|Crossover Treatment|Death|0|||
160517786|NCT03184870|579624908|FG011|Crossover Treatment|Death|0|||
160517787|NCT03184870|579624909|FG012|Crossover Treatment|Death|0|||
160517788|NCT03184870|579624910|FG013|Crossover Treatment|Death|0|||
160517789|NCT03184870|579624911|FG014|Crossover Treatment|Death|0|||
160517790|NCT03184870|579624912|FG015|Crossover Treatment|Death|0|||
160517791|NCT03184870|579624913|FG016|Crossover Treatment|Death|0|||
160517792|NCT03184870|579624914|FG017|Crossover Treatment|Death|7|||
160517793|NCT05081388|579624915|FG000|Overall Study|Adverse Event|1|||
160517794|NCT05081388|579624916|FG001|Overall Study|Adverse Event|0|||
160517795|NCT05081388|579624917|FG002|Overall Study|Adverse Event|0|||
160517796|NCT05081388|579624918|FG003|Overall Study|Adverse Event|0|||
160517797|NCT05081388|579624919|FG004|Overall Study|Adverse Event|0|||
160517798|NCT05081388|579624915|FG000|Overall Study|Lost to Follow-up|0|||
160517799|NCT05081388|579624916|FG001|Overall Study|Lost to Follow-up|1|||
160517800|NCT05081388|579624917|FG002|Overall Study|Lost to Follow-up|0|||
160517801|NCT05081388|579624918|FG003|Overall Study|Lost to Follow-up|0|||
160517802|NCT05081388|579624919|FG004|Overall Study|Lost to Follow-up|0|||
160517803|NCT05081388|579624915|FG000|Overall Study|Subject decision|0|||
160517804|NCT05081388|579624916|FG001|Overall Study|Subject decision|0|||
160517805|NCT05081388|579624917|FG002|Overall Study|Subject decision|0|||
160517806|NCT05081388|579624918|FG003|Overall Study|Subject decision|1|||
160517807|NCT05081388|579624919|FG004|Overall Study|Subject decision|0|||
160517808|NCT03786783|579624920|FG000|Overall Study|Death|1|||
160517809|NCT03786783|579624920|FG000|Overall Study|Physician Decision|6|||
160517810|NCT03786783|579624920|FG000|Overall Study|Withdrawal by Subject|2|||
160517811|NCT03786783|579624920|FG000|Overall Study|Disease Progression|7|||
160517812|NCT03786783|579624920|FG000|Overall Study|Patient/Parent Refusal|4|||
160517813|NCT01776541|579624921|FG000|Overall Study|Administrative Reason|6|||
160517814|NCT01776541|579624922|FG001|Overall Study|Administrative Reason|2|||
160517815|NCT01776541|579624921|FG000|Overall Study|Death|4|||
160517816|NCT01776541|579624922|FG001|Overall Study|Death|0|||
160517817|NCT01776541|579624921|FG000|Overall Study|Lost to Follow-up|27|||
160517818|NCT01776541|579624922|FG001|Overall Study|Lost to Follow-up|48|||
160517819|NCT01776541|579624921|FG000|Overall Study|Unclassified|5|||
160517820|NCT01776541|579624922|FG001|Overall Study|Unclassified|4|||
160517821|NCT01776541|579624921|FG000|Overall Study|Protocol Violation|2|||
160517822|NCT01776541|579624922|FG001|Overall Study|Protocol Violation|1|||
160517823|NCT01776541|579624921|FG000|Overall Study|Withdrawal by Subject|12|||
160517824|NCT01776541|579624922|FG001|Overall Study|Withdrawal by Subject|20|||
160517825|NCT04279392|579624925|FG000|Overall Study|Physician Decision|1|||
160517826|NCT04279392|579624926|FG001|Overall Study|Physician Decision|0|||
160517827|NCT01981473|579624927|FG000|Overall Study|Incorrect diagnosis of RA|0|||
160517828|NCT01981473|579624928|FG001|Overall Study|Incorrect diagnosis of RA|0|||
160517829|NCT01981473|579624929|FG002|Overall Study|Incorrect diagnosis of RA|1|||
160517830|NCT01981473|579624927|FG000|Overall Study|Received treatment for < 6 months|0|||
160517831|NCT01981473|579624928|FG001|Overall Study|Received treatment for < 6 months|0|||
160517832|NCT01981473|579624929|FG002|Overall Study|Received treatment for < 6 months|1|||
160517833|NCT01981473|579624927|FG000|Overall Study|Received treatment for >24 months|2|||
160517834|NCT01981473|579624928|FG001|Overall Study|Received treatment for >24 months|0|||
160517835|NCT01981473|579624929|FG002|Overall Study|Received treatment for >24 months|6|||
160517836|NCT00738582|579624930|FG000|Combination Therapy|Completed Combination Therapy|1|||
160624349|NCT01982942|580003748|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
160624350|NCT02213666|580003751|FG000|Overall Study|Withdrawal by Subject|1|||
160624351|NCT02190604|580003752|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624352|NCT02190604|580003753|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624353|NCT02190604|580003754|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624354|NCT02190604|580003755|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624355|NCT02190604|580003756|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624356|NCT02190604|580003757|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160667709|NCT03600805|580164210|FG003|Overall Study|Adverse Event|7|||
160517837|NCT00738582|579624931|FG001|Combination Therapy|Completed Combination Therapy|0|||
160517838|NCT00738582|579624930|FG000|Combination Therapy|Physician Decision|1|||
160517839|NCT00738582|579624931|FG001|Combination Therapy|Physician Decision|0|||
160517840|NCT00738582|579624930|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
160517841|NCT00738582|579624931|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
160624357|NCT02190604|580003758|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624358|NCT02190604|580003759|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624359|NCT02190604|580003760|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160517842|NCT00738582|579624930|FG000|Combination Therapy|Other|5|||
160517843|NCT00738582|579624931|FG001|Combination Therapy|Other|0|||
160517844|NCT00738582|579624930|FG000|Combination Therapy|Adverse Event|16|||
160517845|NCT00738582|579624931|FG001|Combination Therapy|Adverse Event|0|||
160517846|NCT00738582|579624930|FG000|Combination Therapy|Progressive Disease|9|||
160517847|NCT00738582|579624931|FG001|Combination Therapy|Progressive Disease|0|||
160517848|NCT00738582|579624930|FG000|Maintenance Therapy|Other|0|||
160517849|NCT00738582|579624931|FG001|Maintenance Therapy|Other|2|||
160517850|NCT00738582|579624930|FG000|Maintenance Therapy|Adverse Event|0|||
160517851|NCT00738582|579624931|FG001|Maintenance Therapy|Adverse Event|6|||
160517852|NCT00738582|579624930|FG000|Maintenance Therapy|Progressive Disease|0|||
160517853|NCT00738582|579624931|FG001|Maintenance Therapy|Progressive Disease|47|||
160517854|NCT00738582|579624930|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
160517855|NCT00738582|579624931|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
160517856|NCT00903006|579624934|FG000|Overall Study|Withdrawal by Subject|2|||
160517857|NCT00903006|579624935|FG001|Overall Study|Withdrawal by Subject|0|||
160517858|NCT00903006|579624936|FG002|Overall Study|Withdrawal by Subject|0|||
160517859|NCT00903006|579624937|FG003|Overall Study|Withdrawal by Subject|0|||
160517860|NCT00903006|579624934|FG000|Overall Study|Progressive Disease|0|||
160517861|NCT00903006|579624935|FG001|Overall Study|Progressive Disease|3|||
160517862|NCT00903006|579624936|FG002|Overall Study|Progressive Disease|1|||
160517863|NCT00903006|579624937|FG003|Overall Study|Progressive Disease|0|||
160517864|NCT03405792|579624938|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
160517865|NCT03405792|579624939|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
160517866|NCT03405792|579624938|FG000|Overall Study|o Did not receive pembrolizumab|1|||
160517867|NCT03405792|579624939|FG001|Overall Study|o Did not receive pembrolizumab|0|||
160517868|NCT04882995|579624940|FG000|Overall Study|Withdrawal by Subject|1|||
160517869|NCT04882995|579624941|FG001|Overall Study|Withdrawal by Subject|2|||
160517870|NCT04882995|579624940|FG000|Overall Study|Protocol Violation|4|||
160517871|NCT04882995|579624941|FG001|Overall Study|Protocol Violation|4|||
160517872|NCT04882995|579624940|FG000|Overall Study|Surgery postponed due to COVID|1|||
160517873|NCT04882995|579624941|FG001|Overall Study|Surgery postponed due to COVID|1|||
160517874|NCT00372229|579624942|FG000|Study Phase|Graft loss|0|||
160517875|NCT00372229|579624943|FG001|Study Phase|Graft loss|3|||
160517876|NCT00372229|579624942|FG000|Study Phase|Protocol Violation|3|||
160517877|NCT00372229|579624943|FG001|Study Phase|Protocol Violation|4|||
160517878|NCT00372229|579624942|FG000|Study Phase|Consent withdrawn|16|||
160517879|NCT00372229|579624943|FG001|Study Phase|Consent withdrawn|14|||
160517880|NCT00372229|579624942|FG000|Study Phase|Refused treatment/did not cooperate|3|||
160517881|NCT00372229|579624943|FG001|Study Phase|Refused treatment/did not cooperate|1|||
160517882|NCT00372229|579624942|FG000|Study Phase|Death|3|||
160517883|NCT00372229|579624943|FG001|Study Phase|Death|2|||
160517884|NCT00372229|579624942|FG000|Study Phase|Reason not specified|3|||
160517885|NCT00372229|579624943|FG001|Study Phase|Reason not specified|2|||
160517886|NCT00372229|579624942|FG000|Study Phase|Lost to Follow-up|3|||
160517887|NCT00372229|579624943|FG001|Study Phase|Lost to Follow-up|3|||
160517888|NCT00372229|579624942|FG000|Follow-Up Phase|Graft loss|8|||
160517889|NCT00372229|579624943|FG001|Follow-Up Phase|Graft loss|7|||
160517890|NCT00372229|579624942|FG000|Follow-Up Phase|Consent withdrawn|13|||
160517891|NCT00372229|579624943|FG001|Follow-Up Phase|Consent withdrawn|19|||
160517892|NCT00372229|579624942|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
160517893|NCT00372229|579624943|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
160517894|NCT00372229|579624942|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
160517895|NCT00372229|579624943|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
160517896|NCT00372229|579624942|FG000|Follow-Up Phase|Death|9|||
160517897|NCT00372229|579624943|FG001|Follow-Up Phase|Death|12|||
160517898|NCT00372229|579624942|FG000|Follow-Up Phase|Administrative|1|||
160517899|NCT00372229|579624943|FG001|Follow-Up Phase|Administrative|0|||
160517900|NCT00372229|579624942|FG000|Follow-Up Phase|Reason not specified|2|||
160517901|NCT00372229|579624943|FG001|Follow-Up Phase|Reason not specified|3|||
160517902|NCT00372229|579624942|FG000|Follow-Up Phase|Lost to Follow-up|12|||
160517903|NCT00372229|579624943|FG001|Follow-Up Phase|Lost to Follow-up|10|||
160517904|NCT01347762|579624944|FG000|Overall Study|Lost to Follow-up|0|||
160517905|NCT01347762|579624945|FG001|Overall Study|Lost to Follow-up|1|||
160517906|NCT01347762|579624946|FG002|Overall Study|Lost to Follow-up|6|||
160517907|NCT01347762|579624947|FG003|Overall Study|Lost to Follow-up|5|||
160517908|NCT01347762|579624944|FG000|Overall Study|Withdrawal by Subject|4|||
160517909|NCT01347762|579624945|FG001|Overall Study|Withdrawal by Subject|1|||
160517910|NCT01347762|579624946|FG002|Overall Study|Withdrawal by Subject|3|||
160517911|NCT01347762|579624947|FG003|Overall Study|Withdrawal by Subject|3|||
160517912|NCT03235284|579624948|FG000|Overall Study|Adverse Event|1|||
160517913|NCT03235284|579624949|FG001|Overall Study|Adverse Event|2|||
160517914|NCT03235284|579624950|FG002|Overall Study|Adverse Event|1|||
160517915|NCT05478499|579624951|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
160517916|NCT05478499|579624952|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
160517917|NCT05478499|579624951|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
160517918|NCT05478499|579624952|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
160517919|NCT05478499|579624951|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
160517920|NCT05478499|579624952|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
160517921|NCT05478499|579624951|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
160517922|NCT05478499|579624952|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
160517923|NCT05478499|579624951|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
160517924|NCT05478499|579624952|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
160517925|NCT05478499|579624951|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
160517926|NCT05478499|579624952|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
160517927|NCT05478499|579624951|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
160517928|NCT05478499|579624952|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
160517929|NCT05478499|579624951|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
160517930|NCT05478499|579624952|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
160517931|NCT05478499|579624951|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
160517932|NCT05478499|579624952|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
160517933|NCT05478499|579624951|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
160517934|NCT05478499|579624952|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
160517935|NCT05478499|579624951|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
160517936|NCT05478499|579624952|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
160517937|NCT00249002|579624953|FG000|Overall Study|Adverse Event|2|||
160517938|NCT00249002|579624953|FG000|Overall Study|Study cancellation|3|||
160517939|NCT00249002|579624953|FG000|Overall Study|Other|2|||
160517940|NCT02476279|579624954|FG000|Overall Study|Lost to Follow-up|1|||
160517941|NCT02476279|579624955|FG001|Overall Study|Lost to Follow-up|1|||
160517942|NCT03451162|579624956|FG000|Overall Study|Lost to Follow-up|1|||
160517943|NCT03451162|579624957|FG001|Overall Study|Lost to Follow-up|0|||
160517944|NCT03451162|579624958|FG002|Overall Study|Lost to Follow-up|0|||
160517945|NCT03451162|579624959|FG003|Overall Study|Lost to Follow-up|0|||
160517946|NCT03451162|579624960|FG004|Overall Study|Lost to Follow-up|0|||
160517947|NCT03451162|579624956|FG000|Overall Study|Physician Decision|0|||
160517948|NCT03451162|579624957|FG001|Overall Study|Physician Decision|1|||
160517949|NCT03451162|579624958|FG002|Overall Study|Physician Decision|0|||
160517950|NCT03451162|579624959|FG003|Overall Study|Physician Decision|0|||
160517951|NCT03451162|579624960|FG004|Overall Study|Physician Decision|0|||
160517952|NCT03451162|579624956|FG000|Overall Study|Withdrawal by Subject|1|||
160517953|NCT03451162|579624957|FG001|Overall Study|Withdrawal by Subject|1|||
160517954|NCT03451162|579624958|FG002|Overall Study|Withdrawal by Subject|0|||
160517955|NCT03451162|579624959|FG003|Overall Study|Withdrawal by Subject|0|||
160517956|NCT03451162|579624960|FG004|Overall Study|Withdrawal by Subject|0|||
160517957|NCT01831856|579624961|FG000|Overall Study|Adverse Event|5|||
160517958|NCT01831856|579624962|FG001|Overall Study|Adverse Event|8|||
160517959|NCT01831856|579624961|FG000|Overall Study|Lack of Efficacy|13|||
160517960|NCT01831856|579624962|FG001|Overall Study|Lack of Efficacy|11|||
160517961|NCT01831856|579624961|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
160517962|NCT01831856|579624962|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
160517963|NCT04964414|579624964|FG000|Overall Study|Lost to Follow-up|10|||
160517964|NCT04964414|579624965|FG001|Overall Study|Lost to Follow-up|8|||
160517965|NCT04964414|579624964|FG000|Overall Study|Withdrawal by Subject|1|||
160517966|NCT04964414|579624965|FG001|Overall Study|Withdrawal by Subject|1|||
160517967|NCT00609765|579624966|FG000|Overall Study|Study ended prior to 12 months|1|||
160517968|NCT03265938|579624969|FG000|Overall Study|Withdrawal by Subject|1|||
160517969|NCT03265938|579624969|FG000|Overall Study|Physician Decision|1|||
160517970|NCT03265938|579624969|FG000|Overall Study|friable mass|6|||
160517971|NCT00705523|579624970|FG000|Overall Study|Lost to Follow-up|2|||
160517972|NCT00705523|579624971|FG001|Overall Study|Lost to Follow-up|3|||
160517973|NCT02471833|579624972|FG000|Overall Study|Lost to Follow-up|1|||
160517974|NCT02471833|579624973|FG001|Overall Study|Lost to Follow-up|0|||
160667710|NCT03600805|580164207|FG000|Overall Study|Lack of Efficacy|2|||
160667711|NCT03600805|580164208|FG001|Overall Study|Lack of Efficacy|1|||
160667712|NCT03600805|580164209|FG002|Overall Study|Lack of Efficacy|0|||
160667713|NCT03600805|580164210|FG003|Overall Study|Lack of Efficacy|0|||
160667714|NCT03600805|580164207|FG000|Overall Study|Withdrawal by Subject|1|||
160667715|NCT03600805|580164208|FG001|Overall Study|Withdrawal by Subject|0|||
160667716|NCT03600805|580164209|FG002|Overall Study|Withdrawal by Subject|0|||
160667717|NCT03600805|580164210|FG003|Overall Study|Withdrawal by Subject|1|||
160667718|NCT03600805|580164207|FG000|Overall Study|Other unspecified|14|||
160667719|NCT03600805|580164208|FG001|Overall Study|Other unspecified|6|||
160667720|NCT03600805|580164209|FG002|Overall Study|Other unspecified|7|||
160667721|NCT03600805|580164210|FG003|Overall Study|Other unspecified|11|||
160667722|NCT03343535|580164215|FG000|Overall Study|Lost to Follow-up|1|||
160667723|NCT03343535|580164215|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
160517975|NCT02471833|579624974|FG002|Overall Study|Lost to Follow-up|0|||
160517976|NCT02471833|579624972|FG000|Overall Study|Withdrawal by Subject|2|||
160517977|NCT02471833|579624973|FG001|Overall Study|Withdrawal by Subject|1|||
160517978|NCT02471833|579624974|FG002|Overall Study|Withdrawal by Subject|5|||
160517979|NCT02673515|579624975|FG000|Overall Study|Lack of motivation|2|||
160517980|NCT02673515|579624976|FG001|Overall Study|Lack of motivation|1|||
160517981|NCT01946438|579624977|FG000|Overall Study|Adverse Event|0|||
160517982|NCT01946438|579624978|FG001|Overall Study|Adverse Event|0|||
160667724|NCT03343535|580164215|FG000|Overall Study|Death|12|||
160517983|NCT01946438|579624979|FG002|Overall Study|Adverse Event|0|||
160667725|NCT00123734|580164220|FG000|Overall Study|Death|3|||
160667726|NCT00123734|580164220|FG000|Overall Study|Lost to Follow-up|3|||
160517984|NCT01946438|579624980|FG003|Overall Study|Adverse Event|1|||
160517985|NCT01946438|579624977|FG000|Overall Study|Serious Adverse event|1|||
160517986|NCT01946438|579624978|FG001|Overall Study|Serious Adverse event|0|||
160517987|NCT01946438|579624979|FG002|Overall Study|Serious Adverse event|0|||
160517988|NCT01946438|579624980|FG003|Overall Study|Serious Adverse event|0|||
160517989|NCT01946438|579624977|FG000|Overall Study|Protocol Violation|0|||
160517990|NCT01946438|579624978|FG001|Overall Study|Protocol Violation|0|||
160517991|NCT01946438|579624979|FG002|Overall Study|Protocol Violation|1|||
160517992|NCT01946438|579624980|FG003|Overall Study|Protocol Violation|0|||
160517993|NCT01946438|579624977|FG000|Overall Study|Withdrawal by Subject|1|||
160517994|NCT01946438|579624978|FG001|Overall Study|Withdrawal by Subject|0|||
160517995|NCT01946438|579624979|FG002|Overall Study|Withdrawal by Subject|0|||
160517996|NCT01946438|579624980|FG003|Overall Study|Withdrawal by Subject|0|||
160517997|NCT02412371|579624983|FG000|Overall Study|Withdrawal by Subject|0|||
160517998|NCT02412371|579624984|FG001|Overall Study|Withdrawal by Subject|2|||
160517999|NCT02412371|579624985|FG002|Overall Study|Withdrawal by Subject|0|||
160518000|NCT02412371|579624986|FG003|Overall Study|Withdrawal by Subject|1|||
160518001|NCT02412371|579624987|FG004|Overall Study|Withdrawal by Subject|1|||
160518002|NCT02412371|579624988|FG005|Overall Study|Withdrawal by Subject|0|||
160518003|NCT02412371|579624983|FG000|Overall Study|Sponsor Discontinued Study|1|||
160518004|NCT02412371|579624984|FG001|Overall Study|Sponsor Discontinued Study|4|||
160518005|NCT02412371|579624985|FG002|Overall Study|Sponsor Discontinued Study|6|||
160518006|NCT02412371|579624986|FG003|Overall Study|Sponsor Discontinued Study|4|||
160518007|NCT02412371|579624987|FG004|Overall Study|Sponsor Discontinued Study|5|||
160518008|NCT02412371|579624988|FG005|Overall Study|Sponsor Discontinued Study|0|||
160518009|NCT02412371|579624983|FG000|Overall Study|Death|4|||
160518010|NCT02412371|579624984|FG001|Overall Study|Death|2|||
160518011|NCT02412371|579624985|FG002|Overall Study|Death|1|||
160518012|NCT02412371|579624986|FG003|Overall Study|Death|3|||
160518013|NCT02412371|579624987|FG004|Overall Study|Death|5|||
160518014|NCT02412371|579624988|FG005|Overall Study|Death|2|||
160518015|NCT02412371|579624983|FG000|Overall Study|Other|2|||
160518016|NCT02412371|579624984|FG001|Overall Study|Other|1|||
160518017|NCT02412371|579624985|FG002|Overall Study|Other|0|||
160518018|NCT02412371|579624986|FG003|Overall Study|Other|0|||
160518019|NCT02412371|579624987|FG004|Overall Study|Other|1|||
160518020|NCT02412371|579624988|FG005|Overall Study|Other|3|||
160518021|NCT02523599|579624989|FG000|Overall Study|Adverse Event|1|||
160518022|NCT02523599|579624990|FG001|Overall Study|Adverse Event|0|||
160518023|NCT02523599|579624989|FG000|Overall Study|Physician Decision|1|||
160518024|NCT02523599|579624990|FG001|Overall Study|Physician Decision|0|||
160518025|NCT02523599|579624989|FG000|Overall Study|Lost to Follow-up|4|||
160518026|NCT02523599|579624990|FG001|Overall Study|Lost to Follow-up|1|||
160518027|NCT02523599|579624989|FG000|Overall Study|Did not return for Day 30 visit|2|||
160518028|NCT02523599|579624990|FG001|Overall Study|Did not return for Day 30 visit|0|||
160518029|NCT01892540|579624991|FG000|Overall Study|Did not complete PET/MRI|0|||
160518030|NCT01892540|579624992|FG001|Overall Study|Did not complete PET/MRI|0|||
160624360|NCT02190604|580003761|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624361|NCT02190604|580003762|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624362|NCT02190604|580003763|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624363|NCT02190604|580003764|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624364|NCT02190604|580003765|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624365|NCT02190604|580003766|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
160624366|NCT02190604|580003767|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624367|NCT02190604|580003768|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624368|NCT02190604|580003769|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624369|NCT02190604|580003770|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
160624370|NCT02190604|580003752|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624371|NCT02190604|580003753|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624372|NCT02190604|580003754|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624373|NCT02190604|580003755|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624374|NCT02190604|580003756|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624375|NCT02190604|580003757|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624376|NCT02190604|580003758|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624377|NCT02190604|580003759|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624378|NCT02190604|580003760|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624379|NCT02190604|580003761|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624380|NCT02190604|580003762|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624381|NCT02190604|580003763|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624382|NCT02190604|580003764|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624383|NCT02190604|580003765|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
160667727|NCT00123734|580164220|FG000|Overall Study|Dropout|1|||
160518031|NCT01892540|579624993|FG002|Overall Study|Did not complete PET/MRI|2|||
160518032|NCT01892540|579624991|FG000|Overall Study|Did not fit in scanner|0|||
160518033|NCT01892540|579624992|FG001|Overall Study|Did not fit in scanner|0|||
160518034|NCT01892540|579624993|FG002|Overall Study|Did not fit in scanner|1|||
160518035|NCT01370590|579624994|FG000|Period 1|Adverse Event|8|||
160518036|NCT01370590|579624995|FG001|Period 1|Adverse Event|4|||
160518037|NCT01370590|579624994|FG000|Period 1|Lost to Follow-up|2|||
160518038|NCT01370590|579624995|FG001|Period 1|Lost to Follow-up|2|||
160518039|NCT01370590|579624994|FG000|Period 1|Protocol Violation|2|||
160518040|NCT01370590|579624995|FG001|Period 1|Protocol Violation|2|||
160518041|NCT01370590|579624994|FG000|Period 1|Withdrawal by Subject|4|||
160518042|NCT01370590|579624995|FG001|Period 1|Withdrawal by Subject|2|||
160518043|NCT01370590|579624994|FG000|Period 1|Could not access randomization system|0|||
160518044|NCT01370590|579624995|FG001|Period 1|Could not access randomization system|1|||
160518045|NCT01370590|579624994|FG000|Crossover Washout Period|Adverse Event|1|||
160518046|NCT01370590|579624995|FG001|Crossover Washout Period|Adverse Event|4|||
160518047|NCT01370590|579624994|FG000|Crossover Washout Period|Lost to Follow-up|2|||
160518048|NCT01370590|579624995|FG001|Crossover Washout Period|Lost to Follow-up|0|||
160518049|NCT01370590|579624994|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
160518050|NCT01370590|579624995|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
160518051|NCT01370590|579624994|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
160518052|NCT01370590|579624995|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
160518053|NCT01370590|579624994|FG000|Period 2|Adverse Event|0|||
160518054|NCT01370590|579624995|FG001|Period 2|Adverse Event|1|||
160518055|NCT01370590|579624994|FG000|Period 2|Withdrawal by Subject|1|||
160518056|NCT01370590|579624995|FG001|Period 2|Withdrawal by Subject|1|||
160518057|NCT03141905|579624996|FG000|Overall Study|Death|3|||
160518058|NCT03141905|579624997|FG001|Overall Study|Death|2|||
160518059|NCT03141905|579624996|FG000|Overall Study|Withdrawal by Subject|1|||
160518060|NCT03141905|579624997|FG001|Overall Study|Withdrawal by Subject|0|||
160518061|NCT03141905|579624996|FG000|Overall Study|Lost to Follow-up|3|||
160518062|NCT03141905|579624997|FG001|Overall Study|Lost to Follow-up|7|||
160518063|NCT03141905|579624996|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
160518064|NCT03141905|579624997|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
160518065|NCT05180500|579624998|FG000|Overall Study|Adverse Event|1|||
160518066|NCT05180500|579624999|FG001|Overall Study|Adverse Event|0|||
160518067|NCT05180500|579624998|FG000|Overall Study|Withdrawal by Subject|2|||
160518068|NCT05180500|579624999|FG001|Overall Study|Withdrawal by Subject|0|||
160518069|NCT04927884|579625004|FG000|Overall Study|Progressive Disease|2|||
160518070|NCT01775124|579625005|FG000|Core Period|Disease Progression|0|||
160518071|NCT01775124|579625006|FG001|Core Period|Disease Progression|1|||
160518072|NCT01775124|579625005|FG000|Core Period|Physician Decision|1|||
160518073|NCT01775124|579625006|FG001|Core Period|Physician Decision|1|||
160518074|NCT01775124|579625005|FG000|Core Period|Death|0|||
160518075|NCT01775124|579625006|FG001|Core Period|Death|1|||
160518076|NCT01775124|579625005|FG000|Core Period|Administrative problems|1|||
160518077|NCT01775124|579625006|FG001|Core Period|Administrative problems|0|||
160518078|NCT01775124|579625005|FG000|Core Period|Withdrawal by Subject|4|||
160518079|NCT01775124|579625006|FG001|Core Period|Withdrawal by Subject|2|||
160518080|NCT01775124|579625005|FG000|Core Period|Adverse Event|5|||
160518081|NCT01775124|579625006|FG001|Core Period|Adverse Event|5|||
160518082|NCT01775124|579625005|FG000|Extension Period|Adverse Event|3|||
160518083|NCT01775124|579625006|FG001|Extension Period|Adverse Event|2|||
160518084|NCT01775124|579625005|FG000|Extension Period|Physician Decision|0|||
160518085|NCT01775124|579625006|FG001|Extension Period|Physician Decision|2|||
160518086|NCT01775124|579625005|FG000|Extension Period|Administrative problems|0|||
160518087|NCT01775124|579625006|FG001|Extension Period|Administrative problems|1|||
160518088|NCT01775124|579625005|FG000|Extension Period|Lost to Follow-up|0|||
160518089|NCT01775124|579625006|FG001|Extension Period|Lost to Follow-up|1|||
160518090|NCT01775124|579625005|FG000|Extension Period|Withdrawal by Subject|9|||
160518091|NCT01775124|579625006|FG001|Extension Period|Withdrawal by Subject|12|||
160518092|NCT00727311|579625007|FG000|Overall Study|Did not receive drug|316|||
160667728|NCT00123734|580164220|FG000|Overall Study|Withdrawal by Subject|1|||
160667729|NCT00107991|580164221|FG000|Eligibility Assessment|Disease not severe enough|7|||
160667730|NCT00107991|580164221|FG000|Eligibility Assessment|Unwilling to participate|7|||
160667731|NCT00107991|580164221|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
160667732|NCT00107991|580164221|FG000|Eligibility Assessment|Abnormal labs|2|||
160667733|NCT00107991|580164221|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
160518093|NCT00727311|579625007|FG000|Overall Study|Missing end of therapy data|205|||
160518094|NCT00727311|579625007|FG000|Overall Study|Adverse Event|58|||
160518095|NCT00727311|579625007|FG000|Overall Study|Lack of Efficacy|242|||
160518096|NCT00727311|579625007|FG000|Overall Study|Lost to Follow-up|73|||
160518097|NCT00727311|579625007|FG000|Overall Study|Withdrawal by Subject|77|||
160518098|NCT00727311|579625007|FG000|Overall Study|Other|97|||
160518099|NCT00727311|579625007|FG000|Overall Study|Multiple reasons|39|||
160518100|NCT03992846|579625008|FG000|Overall Study|Adverse Event|8|||
160518101|NCT03992846|579625009|FG001|Overall Study|Adverse Event|6|||
160518102|NCT03992846|579625010|FG002|Overall Study|Adverse Event|3|||
160518103|NCT03992846|579625008|FG000|Overall Study|Lost to Follow-up|0|||
160518104|NCT03992846|579625009|FG001|Overall Study|Lost to Follow-up|1|||
160518105|NCT03992846|579625010|FG002|Overall Study|Lost to Follow-up|1|||
160518106|NCT03992846|579625008|FG000|Overall Study|Pregnancy|2|||
160518107|NCT03992846|579625009|FG001|Overall Study|Pregnancy|0|||
160518108|NCT03992846|579625010|FG002|Overall Study|Pregnancy|1|||
160518109|NCT03992846|579625008|FG000|Overall Study|Protocol Violation|1|||
160518110|NCT03992846|579625009|FG001|Overall Study|Protocol Violation|2|||
160518111|NCT03992846|579625010|FG002|Overall Study|Protocol Violation|0|||
160518112|NCT03992846|579625008|FG000|Overall Study|Withdrawal by Subject|8|||
160518113|NCT03992846|579625009|FG001|Overall Study|Withdrawal by Subject|10|||
160518114|NCT03992846|579625010|FG002|Overall Study|Withdrawal by Subject|20|||
160518115|NCT03992846|579625008|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
160518116|NCT03992846|579625009|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
160518117|NCT03992846|579625010|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
160518118|NCT00031551|579626979|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
160518119|NCT00031551|579626980|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
160518120|NCT01919814|579626983|FG000|Overall Study|Adverse Event|1|||
160518121|NCT01919814|579626984|FG001|Overall Study|Adverse Event|0|||
160518122|NCT01919814|579626983|FG000|Overall Study|Protocol Violation|1|||
160518123|NCT01919814|579626984|FG001|Overall Study|Protocol Violation|0|||
160518124|NCT01919814|579626983|FG000|Overall Study|Withdrawal by Subject|1|||
160518125|NCT01919814|579626984|FG001|Overall Study|Withdrawal by Subject|0|||
160518126|NCT02164383|579626985|FG000|Overall Study|Lost to Follow-up|1|||
160518127|NCT02164383|579626986|FG001|Overall Study|Lost to Follow-up|0|||
160518128|NCT01036763|579626987|FG000|Overall Study|Adverse Event|25|||
160518129|NCT01036763|579626987|FG000|Overall Study|Lost to Follow-up|28|||
160518130|NCT01036763|579626987|FG000|Overall Study|Other reason (not specified)|40|||
160518131|NCT01672723|579626988|FG000|First Intervention|Adverse Event|3|||
160518132|NCT01672723|579626989|FG001|First Intervention|Adverse Event|0|||
160518133|NCT00743275|579626990|FG000|Overall Study|Protocol Violation|0|||
160518134|NCT00743275|579626991|FG001|Overall Study|Protocol Violation|1|||
160518135|NCT00192647|579626995|FG000|Overall Study|Death|1|||
160518136|NCT00192647|579626996|FG001|Overall Study|Death|1|||
160518137|NCT00192647|579626995|FG000|Overall Study|Adverse Event|35|||
160518138|NCT00192647|579626996|FG001|Overall Study|Adverse Event|29|||
160518139|NCT00192647|579626995|FG000|Overall Study|Laboratory Test Abnormality|4|||
160518140|NCT00192647|579626996|FG001|Overall Study|Laboratory Test Abnormality|2|||
160518141|NCT00192647|579626995|FG000|Overall Study|Insufficient Therapeutic Response|53|||
160518142|NCT00192647|579626996|FG001|Overall Study|Insufficient Therapeutic Response|83|||
160518143|NCT00192647|579626995|FG000|Overall Study|Entry Criteria Violation|6|||
160518144|NCT00192647|579626996|FG001|Overall Study|Entry Criteria Violation|6|||
160518145|NCT00192647|579626995|FG000|Overall Study|Protocol Violation|3|||
160518146|NCT00192647|579626996|FG001|Overall Study|Protocol Violation|1|||
160518147|NCT00192647|579626995|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
160518148|NCT00192647|579626996|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
160518149|NCT00192647|579626995|FG000|Overall Study|Failure to Return|11|||
160518150|NCT00192647|579626996|FG001|Overall Study|Failure to Return|13|||
160518151|NCT00192647|579626995|FG000|Overall Study|Other/Administrative|5|||
160518152|NCT00192647|579626996|FG001|Overall Study|Other/Administrative|3|||
160518153|NCT03057977|579626998|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
160518154|NCT03057977|579626999|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
160518155|NCT03057977|579626998|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
160518156|NCT03057977|579626999|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
160518157|NCT03057977|579626998|FG000|Discontinuation From Treatment|Protocol Violation|6|||
160518158|NCT03057977|579626999|FG001|Discontinuation From Treatment|Protocol Violation|5|||
160518159|NCT03057977|579626998|FG000|Discontinuation From Treatment|Not treated|4|||
160518160|NCT03057977|579626999|FG001|Discontinuation From Treatment|Not treated|0|||
160518161|NCT03057977|579626998|FG000|Discontinuation From Treatment|Adverse Event|343|||
160518162|NCT03057977|579626999|FG001|Discontinuation From Treatment|Adverse Event|337|||
160518163|NCT03057977|579626998|FG000|Discontinuation From Treatment|Reason Unknown|0|||
160518164|NCT03057977|579626999|FG001|Discontinuation From Treatment|Reason Unknown|1|||
160518165|NCT03057977|579626998|FG000|Discontinuation From Treatment|Personal Reasons|1|||
160518166|NCT03057977|579626999|FG001|Discontinuation From Treatment|Personal Reasons|1|||
160518167|NCT03057977|579626998|FG000|Discontinuation From Treatment|Unblinded medication|1|||
160518168|NCT03057977|579626999|FG001|Discontinuation From Treatment|Unblinded medication|0|||
160518169|NCT03057977|579626998|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
160624384|NCT02190604|580003766|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624385|NCT02190604|580003767|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624386|NCT02190604|580003768|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624387|NCT02190604|580003769|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624388|NCT02190604|580003770|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
160624389|NCT02797951|580003771|FG000|Overall Study|Adverse Event|4|||
160624390|NCT02797951|580003771|FG000|Overall Study|Death|1|||
160624391|NCT02797951|580003771|FG000|Overall Study|Lack of Efficacy|19|||
160624392|NCT02797951|580003771|FG000|Overall Study|Lost to Follow-up|4|||
160518170|NCT03057977|579626999|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
160518171|NCT03057977|579626998|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
160518172|NCT03057977|579626999|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
160518173|NCT03057977|579626998|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
160518174|NCT03057977|579626999|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
160518175|NCT03057977|579626998|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
160518176|NCT03057977|579626999|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
160518177|NCT03057977|579626998|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
160518178|NCT03057977|579626999|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
160518179|NCT03057977|579626998|FG000|Discontinuation From Treatment|Not attending study visit|3|||
160518180|NCT03057977|579626999|FG001|Discontinuation From Treatment|Not attending study visit|10|||
160518181|NCT03057977|579626998|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
160518182|NCT03057977|579626999|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
160518183|NCT03057977|579626998|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
160518184|NCT03057977|579626999|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
160518185|NCT03057977|579626998|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
160518186|NCT03057977|579626999|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
160518187|NCT03057977|579626998|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
160518188|NCT03057977|579626999|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
160518189|NCT03057977|579626998|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
160518190|NCT03057977|579626999|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
160518191|NCT01350336|579627000|FG000|Overall Study|Lost to Follow-up|31|||
160518192|NCT01350336|579627000|FG000|Overall Study|Withdrawal by Subject|14|||
160518193|NCT01350336|579627000|FG000|Overall Study|Physician Decision|8|||
160518194|NCT01350336|579627000|FG000|Overall Study|Death|4|||
160518195|NCT04964388|579627001|FG000|Overall Study|Lost to Follow-up|3|||
160518196|NCT04964388|579627002|FG001|Overall Study|Lost to Follow-up|2|||
160518197|NCT04776148|579627004|FG000|Overall Study|Death|249|||
160518198|NCT04776148|579627005|FG001|Overall Study|Death|260|||
160518199|NCT04776148|579627004|FG000|Overall Study|Lost to Follow-up|0|||
160518200|NCT04776148|579627005|FG001|Overall Study|Lost to Follow-up|1|||
160518201|NCT04776148|579627004|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160518202|NCT04776148|579627005|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160518203|NCT04776148|579627004|FG000|Overall Study|Withdrawal by Subject|3|||
160518204|NCT04776148|579627005|FG001|Overall Study|Withdrawal by Subject|4|||
160518205|NCT04776148|579627004|FG000|Overall Study|Sponsor Decision|30|||
160518206|NCT04776148|579627005|FG001|Overall Study|Sponsor Decision|15|||
160518207|NCT00918580|579627008|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
160518208|NCT00918580|579627008|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
160518209|NCT00918580|579627008|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
160518210|NCT00918580|579627008|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
160518211|NCT00918580|579627008|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
160518212|NCT00918580|579627008|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
160518213|NCT00918580|579627008|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
160518214|NCT00701220|579627009|FG000|Overall Study|Withdrawal by Subject|0|||
160518215|NCT00701220|579627010|FG001|Overall Study|Withdrawal by Subject|2|||
160518216|NCT00701220|579627009|FG000|Overall Study|Protocol Violation|2|||
160518217|NCT00701220|579627010|FG001|Overall Study|Protocol Violation|0|||
160518218|NCT00069108|579627011|FG000|Overall Study|Withdrawal by Subject|5|||
160518219|NCT00069108|579627012|FG001|Overall Study|Withdrawal by Subject|9|||
160518220|NCT00069108|579627011|FG000|Overall Study|Adverse Event|64|||
160518221|NCT00069108|579627012|FG001|Overall Study|Adverse Event|42|||
160518222|NCT00069108|579627011|FG000|Overall Study|Death|6|||
160518223|NCT00069108|579627012|FG001|Overall Study|Death|6|||
160518224|NCT00069108|579627011|FG000|Overall Study|Administration|15|||
160667734|NCT00107991|580164221|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
160667735|NCT00107991|580164221|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
160667736|NCT00107991|580164221|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
160667737|NCT00107991|580164221|FG000|12 Week Treatment Period|Adverse Event|1|||
160667738|NCT00107991|580164221|FG000|12 Week Treatment Period|Protocol Violation|1|||
160667739|NCT00107991|580164221|FG000|12 Week Treatment Period|Incarcerated|1|||
160667740|NCT00107991|580164221|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
160667741|NCT03669861|580164222|FG000|Overall Study|Disease Flare|5|||
160518225|NCT00069108|579627012|FG001|Overall Study|Administration|4|||
160518226|NCT00069108|579627011|FG000|Overall Study|Insufficient therapy|117|||
160518227|NCT00069108|579627012|FG001|Overall Study|Insufficient therapy|144|||
160518228|NCT00069108|579627011|FG000|Overall Study|Violation criteria|1|||
160667742|NCT03669861|580164222|FG000|Overall Study|Lack of Efficacy|2|||
160667743|NCT02760927|580164223|FG000|Overall Study|Tube Slippage from Device|1|||
160518229|NCT00069108|579627012|FG001|Overall Study|Violation criteria|4|||
160518230|NCT00069108|579627011|FG000|Overall Study|Refused treatment|5|||
160518231|NCT00069108|579627012|FG001|Overall Study|Refused treatment|10|||
160518232|NCT01411215|579627013|FG000|Overall Study|Adverse Event|1|||
160518233|NCT01411215|579627014|FG001|Overall Study|Adverse Event|2|||
160518234|NCT01411215|579627013|FG000|Overall Study|Lack of Efficacy|2|||
160518235|NCT01411215|579627014|FG001|Overall Study|Lack of Efficacy|4|||
160518236|NCT01411215|579627013|FG000|Overall Study|Lost to Follow-up|12|||
160518237|NCT01411215|579627014|FG001|Overall Study|Lost to Follow-up|18|||
160518238|NCT01411215|579627013|FG000|Overall Study|Did not meet entrance criteria|0|||
160518239|NCT01411215|579627014|FG001|Overall Study|Did not meet entrance criteria|1|||
160518240|NCT01411215|579627013|FG000|Overall Study|Study terminated by sponsor|2|||
160518241|NCT01411215|579627014|FG001|Overall Study|Study terminated by sponsor|15|||
160518242|NCT01411215|579627013|FG000|Overall Study|Protocol Violation|3|||
160518243|NCT01411215|579627014|FG001|Overall Study|Protocol Violation|5|||
160518244|NCT01411215|579627013|FG000|Overall Study|Withdrawal by Subject|34|||
160518245|NCT01411215|579627014|FG001|Overall Study|Withdrawal by Subject|21|||
160518246|NCT01411215|579627013|FG000|Overall Study|Other|12|||
160518247|NCT01411215|579627014|FG001|Overall Study|Other|17|||
160518248|NCT01411215|579627013|FG000|Overall Study|Screen failure|0|||
160518249|NCT01411215|579627014|FG001|Overall Study|Screen failure|1|||
160518250|NCT00903630|579627015|FG000|Phase 2|Adverse Event|0|||
160518251|NCT00903630|579627016|FG001|Phase 2|Adverse Event|0|||
160518252|NCT00903630|579627017|FG002|Phase 2|Adverse Event|1|||
160518253|NCT03658668|579627019|FG000|Overall Study|Time Commitment|1|||
160518254|NCT03658668|579627020|FG001|Overall Study|Time Commitment|1|||
160518255|NCT04634825|579627021|FG000|Overall Study|Death|10|||
160518256|NCT04634825|579627022|FG001|Overall Study|Death|3|||
160518257|NCT04634825|579627021|FG000|Overall Study|Lost to Follow-up|1|||
160518258|NCT04634825|579627022|FG001|Overall Study|Lost to Follow-up|0|||
160518259|NCT04634825|579627021|FG000|Overall Study|Study terminated by sponsor|35|||
160518260|NCT04634825|579627022|FG001|Overall Study|Study terminated by sponsor|11|||
160518261|NCT04634825|579627021|FG000|Overall Study|Withdrawal by Subject|2|||
160518262|NCT04634825|579627022|FG001|Overall Study|Withdrawal by Subject|0|||
160518263|NCT01952054|579627023|FG000|Overall Study|Physician Decision|1|||
160518264|NCT00402597|579627024|FG000|Overall Study|Death|15|||
160518265|NCT00402597|579627025|FG001|Overall Study|Death|7|||
160518266|NCT00402597|579627026|FG002|Overall Study|Death|6|||
160518267|NCT00402597|579627027|FG003|Overall Study|Death|4|||
160518268|NCT00402597|579627028|FG004|Overall Study|Death|6|||
160518269|NCT00402597|579627024|FG000|Overall Study|Adverse Event|81|||
160518270|NCT00402597|579627025|FG001|Overall Study|Adverse Event|18|||
160518271|NCT00402597|579627026|FG002|Overall Study|Adverse Event|106|||
160518272|NCT00402597|579627027|FG003|Overall Study|Adverse Event|39|||
160518273|NCT00402597|579627028|FG004|Overall Study|Adverse Event|71|||
160518274|NCT00402597|579627024|FG000|Overall Study|Lost to Follow-up|8|||
160518275|NCT00402597|579627025|FG001|Overall Study|Lost to Follow-up|1|||
160518276|NCT00402597|579627026|FG002|Overall Study|Lost to Follow-up|8|||
160518277|NCT00402597|579627027|FG003|Overall Study|Lost to Follow-up|2|||
160518278|NCT00402597|579627028|FG004|Overall Study|Lost to Follow-up|3|||
160518279|NCT00402597|579627024|FG000|Overall Study|Withdrawal by Subject|57|||
160518280|NCT00402597|579627025|FG001|Overall Study|Withdrawal by Subject|16|||
160518281|NCT00402597|579627026|FG002|Overall Study|Withdrawal by Subject|65|||
160518282|NCT00402597|579627027|FG003|Overall Study|Withdrawal by Subject|15|||
160518283|NCT00402597|579627028|FG004|Overall Study|Withdrawal by Subject|24|||
160518284|NCT00402597|579627024|FG000|Overall Study|reason not specified|30|||
160518285|NCT00402597|579627025|FG001|Overall Study|reason not specified|4|||
160518286|NCT00402597|579627026|FG002|Overall Study|reason not specified|27|||
160518287|NCT00402597|579627027|FG003|Overall Study|reason not specified|14|||
160518288|NCT00402597|579627028|FG004|Overall Study|reason not specified|20|||
160518289|NCT01100034|579627029|FG000|Overall Study|Lost to Follow-up|11|||
160518290|NCT01100034|579627029|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
160518291|NCT01100034|579627029|FG000|Overall Study|Withdrawal by Subject|4|||
160518292|NCT01100034|579627029|FG000|Overall Study|Sponsor decision|21|||
160518293|NCT01100034|579627029|FG000|Overall Study|Participated in another clinical trial|1|||
160518294|NCT01100034|579627029|FG000|Overall Study|Participants moved to another hospital|4|||
160518295|NCT01100034|579627029|FG000|Overall Study|Site closed due to non-responsiveness|1|||
160518296|NCT05208866|579627030|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
160518297|NCT00836095|579627033|FG000|Overall Study|Physician Decision|0|||
160518298|NCT00836095|579627034|FG001|Overall Study|Physician Decision|3|||
160518299|NCT01602562|579627035|FG000|Overall Study|Adverse Event|3|||
160518300|NCT01602562|579627036|FG001|Overall Study|Adverse Event|1|||
160518301|NCT01602562|579627035|FG000|Overall Study|Physician Decision|1|||
160518302|NCT01602562|579627036|FG001|Overall Study|Physician Decision|1|||
160518303|NCT01602562|579627035|FG000|Overall Study|Withdrawal by Subject|1|||
160518304|NCT01602562|579627036|FG001|Overall Study|Withdrawal by Subject|1|||
160518305|NCT03881553|579627038|FG000|Overall Study|Discharged prior to participation|1|||
160518306|NCT03881553|579627039|FG001|Overall Study|Discharged prior to participation|1|||
160518307|NCT03881553|579627040|FG002|Overall Study|Discharged prior to participation|0|||
160518308|NCT03881553|579627038|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
160518309|NCT03881553|579627039|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
160518310|NCT03881553|579627040|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
160518311|NCT01718353|579627041|FG000|Overall Study|Lost to Follow-up|0|||
160518312|NCT01718353|579627042|FG001|Overall Study|Lost to Follow-up|1|||
160518313|NCT01718353|579627041|FG000|Overall Study|Principal Investigator's Decision|10|||
160518314|NCT01718353|579627042|FG001|Overall Study|Principal Investigator's Decision|4|||
160518315|NCT01718353|579627041|FG000|Overall Study|Randomized but not treated|2|||
160518316|NCT01718353|579627042|FG001|Overall Study|Randomized but not treated|0|||
160518317|NCT01959516|579627043|FG000|Epoch 1|Adverse Event|4|||
160518318|NCT01959516|579627044|FG001|Epoch 1|Adverse Event|1|||
160518319|NCT01959516|579627043|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
160518320|NCT01959516|579627044|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
160518321|NCT01959516|579627043|FG000|Epoch 1|Subject withdrew consent|3|||
160518322|NCT01959516|579627044|FG001|Epoch 1|Subject withdrew consent|2|||
160518323|NCT01959516|579627043|FG000|Epoch 1|Administrative problems|1|||
160518324|NCT01959516|579627044|FG001|Epoch 1|Administrative problems|0|||
160518325|NCT01959516|579627043|FG000|Epoch 1|Use of prohibited treatment|1|||
160518326|NCT01959516|579627044|FG001|Epoch 1|Use of prohibited treatment|0|||
160518327|NCT01959516|579627043|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
160518328|NCT01959516|579627044|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
160518329|NCT01959516|579627043|FG000|Epoch 1|Protocol deviation|0|||
160518330|NCT01959516|579627044|FG001|Epoch 1|Protocol deviation|1|||
160518331|NCT01959516|579627043|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
160518332|NCT01959516|579627044|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
160518333|NCT01959516|579627043|FG000|Epoch 2|Subject withdrew consent|1|||
160518334|NCT01959516|579627044|FG001|Epoch 2|Subject withdrew consent|0|||
160518335|NCT01959516|579627043|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
160518336|NCT01959516|579627044|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
160518337|NCT02581631|579627053|FG000|Overall Study|Disease progression|29|||
160518338|NCT02581631|579627054|FG001|Overall Study|Disease progression|19|||
160518339|NCT02581631|579627055|FG002|Overall Study|Disease progression|13|||
160518340|NCT02581631|579627056|FG003|Overall Study|Disease progression|5|||
160518341|NCT02581631|579627057|FG004|Overall Study|Disease progression|8|||
160518342|NCT02581631|579627053|FG000|Overall Study|Study drug toxicity|4|||
160518343|NCT02581631|579627054|FG001|Overall Study|Study drug toxicity|6|||
160518344|NCT02581631|579627055|FG002|Overall Study|Study drug toxicity|7|||
160518345|NCT02581631|579627056|FG003|Overall Study|Study drug toxicity|0|||
160518346|NCT02581631|579627057|FG004|Overall Study|Study drug toxicity|3|||
160518347|NCT02581631|579627053|FG000|Overall Study|AE unrelated to study drug|3|||
160518348|NCT02581631|579627054|FG001|Overall Study|AE unrelated to study drug|1|||
160518349|NCT02581631|579627055|FG002|Overall Study|AE unrelated to study drug|1|||
160518350|NCT02581631|579627056|FG003|Overall Study|AE unrelated to study drug|0|||
160518351|NCT02581631|579627057|FG004|Overall Study|AE unrelated to study drug|2|||
160518352|NCT02581631|579627053|FG000|Overall Study|Request to discontinue|1|||
160518353|NCT02581631|579627054|FG001|Overall Study|Request to discontinue|0|||
160518354|NCT02581631|579627055|FG002|Overall Study|Request to discontinue|3|||
160518355|NCT02581631|579627056|FG003|Overall Study|Request to discontinue|0|||
160518356|NCT02581631|579627057|FG004|Overall Study|Request to discontinue|1|||
160518357|NCT02581631|579627053|FG000|Overall Study|participant withdrew consent|3|||
160518358|NCT02581631|579627054|FG001|Overall Study|participant withdrew consent|0|||
160518359|NCT02581631|579627055|FG002|Overall Study|participant withdrew consent|1|||
160518360|NCT02581631|579627056|FG003|Overall Study|participant withdrew consent|0|||
160518361|NCT02581631|579627057|FG004|Overall Study|participant withdrew consent|0|||
160518362|NCT02581631|579627053|FG000|Overall Study|Maximum clinical benefit|1|||
160518363|NCT02581631|579627054|FG001|Overall Study|Maximum clinical benefit|7|||
160518364|NCT02581631|579627055|FG002|Overall Study|Maximum clinical benefit|1|||
160518365|NCT02581631|579627056|FG003|Overall Study|Maximum clinical benefit|3|||
160518366|NCT02581631|579627057|FG004|Overall Study|Maximum clinical benefit|13|||
160518367|NCT02581631|579627053|FG000|Overall Study|Other Reasons|1|||
160518368|NCT02581631|579627054|FG001|Overall Study|Other Reasons|0|||
160518369|NCT02581631|579627055|FG002|Overall Study|Other Reasons|2|||
160518370|NCT02581631|579627056|FG003|Overall Study|Other Reasons|2|||
160518371|NCT02581631|579627057|FG004|Overall Study|Other Reasons|3|||
160624393|NCT02797951|580003771|FG000|Overall Study|Physician Decision|6|||
160624394|NCT02797951|580003771|FG000|Overall Study|Withdrawal by Subject|15|||
160624395|NCT01901393|580003772|FG000|Overall Study|Adverse Event|1|||
160624396|NCT01901393|580003773|FG001|Overall Study|Adverse Event|0|||
160518372|NCT02581631|579627053|FG000|Overall Study|Poor/Non-Compliance|0|||
160518373|NCT02581631|579627054|FG001|Overall Study|Poor/Non-Compliance|0|||
160518374|NCT02581631|579627055|FG002|Overall Study|Poor/Non-Compliance|1|||
160518375|NCT02581631|579627056|FG003|Overall Study|Poor/Non-Compliance|0|||
160518376|NCT02581631|579627057|FG004|Overall Study|Poor/Non-Compliance|0|||
160518377|NCT01759368|579627058|FG000|Overall Study|Lost to Follow-up|1|||
160518378|NCT01759368|579627059|FG001|Overall Study|Lost to Follow-up|0|||
160518379|NCT01191268|579627060|FG000|Overall Study|Withdrawal by Subject|19|||
160518380|NCT01191268|579627061|FG001|Overall Study|Withdrawal by Subject|25|||
160518381|NCT01191268|579627062|FG002|Overall Study|Withdrawal by Subject|21|||
160518382|NCT01191268|579627060|FG000|Overall Study|Adverse Event|21|||
160518383|NCT01191268|579627061|FG001|Overall Study|Adverse Event|13|||
160518384|NCT01191268|579627062|FG002|Overall Study|Adverse Event|8|||
160518385|NCT01191268|579627060|FG000|Overall Study|Physician Decision|6|||
160518386|NCT01191268|579627061|FG001|Overall Study|Physician Decision|8|||
160518387|NCT01191268|579627062|FG002|Overall Study|Physician Decision|9|||
160518388|NCT01191268|579627060|FG000|Overall Study|Lost to Follow-up|8|||
160518389|NCT01191268|579627061|FG001|Overall Study|Lost to Follow-up|5|||
160518390|NCT01191268|579627062|FG002|Overall Study|Lost to Follow-up|9|||
160518391|NCT01191268|579627060|FG000|Overall Study|Entry Criteria Not Met|3|||
160518392|NCT01191268|579627061|FG001|Overall Study|Entry Criteria Not Met|1|||
160518393|NCT01191268|579627062|FG002|Overall Study|Entry Criteria Not Met|1|||
160518394|NCT01191268|579627060|FG000|Overall Study|Death|0|||
160518395|NCT01191268|579627061|FG001|Overall Study|Death|1|||
160518396|NCT01191268|579627062|FG002|Overall Study|Death|3|||
160518397|NCT01191268|579627060|FG000|Overall Study|Protocol Violation|1|||
160518398|NCT01191268|579627061|FG001|Overall Study|Protocol Violation|0|||
160518399|NCT01191268|579627062|FG002|Overall Study|Protocol Violation|1|||
160518400|NCT01191268|579627060|FG000|Overall Study|Sponsor Decision|0|||
160518401|NCT01191268|579627061|FG001|Overall Study|Sponsor Decision|2|||
160518402|NCT01191268|579627062|FG002|Overall Study|Sponsor Decision|0|||
160518403|NCT00336895|579627063|FG000|Overall Study|diarrhea|1|||
160518404|NCT00336895|579627063|FG000|Overall Study|nausea and upset stomach|1|||
160518405|NCT00336895|579627063|FG000|Overall Study|Physician Decision|1|||
160518406|NCT00336895|579627063|FG000|Overall Study|screen failed|1|||
160518407|NCT01959334|579627064|FG000|Second Dose|Adverse Event|1|||
160518408|NCT01959334|579627065|FG001|Second Dose|Adverse Event|0|||
160518409|NCT01959334|579627064|FG000|Third Dose|Adverse Event|0|||
160518410|NCT01959334|579627065|FG001|Third Dose|Adverse Event|1|||
160518411|NCT01313689|579627066|FG000|24-Week Randomization 1|Adverse Event|10|||
160518412|NCT01313689|579627067|FG001|24-Week Randomization 1|Adverse Event|5|||
160518413|NCT01313689|579627068|FG002|24-Week Randomization 1|Adverse Event|0|||
160518414|NCT01313689|579627069|FG003|24-Week Randomization 1|Adverse Event|0|||
160518415|NCT01313689|579627070|FG004|24-Week Randomization 1|Adverse Event|0|||
160518416|NCT01313689|579627066|FG000|24-Week Randomization 1|Physician Decision|4|||
160518417|NCT01313689|579627067|FG001|24-Week Randomization 1|Physician Decision|5|||
160518418|NCT01313689|579627068|FG002|24-Week Randomization 1|Physician Decision|0|||
160518419|NCT01313689|579627069|FG003|24-Week Randomization 1|Physician Decision|0|||
160518420|NCT01313689|579627070|FG004|24-Week Randomization 1|Physician Decision|0|||
160518421|NCT01313689|579627066|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
160518422|NCT01313689|579627067|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
160518423|NCT01313689|579627068|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
160518424|NCT01313689|579627069|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
160518425|NCT01313689|579627070|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
160518426|NCT01313689|579627066|FG000|24-Week Randomization 2|Adverse Event|0|||
160518427|NCT01313689|579627067|FG001|24-Week Randomization 2|Adverse Event|0|||
160624397|NCT00697255|580003778|FG000|Stage 1a|Insufficient ovarian response|1|||
160624398|NCT00697255|580003779|FG001|Stage 1a|Insufficient ovarian response|0|||
160624399|NCT00697255|580003778|FG000|Stage 1a|Multifollicular growth|1|||
160624400|NCT00697255|580003779|FG001|Stage 1a|Multifollicular growth|0|||
160624401|NCT00697255|580003778|FG000|Stage 1a|Not growing of dominant follicle|1|||
160624402|NCT00697255|580003779|FG001|Stage 1a|Not growing of dominant follicle|0|||
160624403|NCT00697255|580003778|FG000|Stage 1b|Not growing of dominant follicle|0|||
160624404|NCT00697255|580003779|FG001|Stage 1b|Not growing of dominant follicle|1|||
160624405|NCT00697255|580003778|FG000|Stage 1b|Insufficient ovarian response|0|||
160624406|NCT00697255|580003779|FG001|Stage 1b|Insufficient ovarian response|1|||
160624407|NCT05664672|580003789|FG000|Overall Study|Adverse Event|0|||
160624408|NCT05664672|580003790|FG001|Overall Study|Adverse Event|0|||
160624409|NCT05664672|580003791|FG002|Overall Study|Adverse Event|0|||
160624410|NCT05664672|580003792|FG003|Overall Study|Adverse Event|0|||
160624411|NCT05664672|580003793|FG004|Overall Study|Adverse Event|0|||
160624412|NCT05664672|580003794|FG005|Overall Study|Adverse Event|1|||
160624413|NCT05664672|580003789|FG000|Overall Study|Withdrawal by Subject|0|||
160624414|NCT05664672|580003790|FG001|Overall Study|Withdrawal by Subject|1|||
160624415|NCT05664672|580003791|FG002|Overall Study|Withdrawal by Subject|3|||
160624416|NCT05664672|580003792|FG003|Overall Study|Withdrawal by Subject|0|||
160624417|NCT05664672|580003793|FG004|Overall Study|Withdrawal by Subject|5|||
160518428|NCT01313689|579627068|FG002|24-Week Randomization 2|Adverse Event|2|||
160518429|NCT01313689|579627069|FG003|24-Week Randomization 2|Adverse Event|0|||
160518430|NCT01313689|579627070|FG004|24-Week Randomization 2|Adverse Event|8|||
160624418|NCT05664672|580003794|FG005|Overall Study|Withdrawal by Subject|6|||
160624419|NCT05664672|580003789|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
160624420|NCT05664672|580003790|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
160624421|NCT05664672|580003791|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
160518431|NCT01313689|579627066|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
160518432|NCT01313689|579627067|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
160518433|NCT01313689|579627068|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
160518434|NCT01313689|579627069|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
160518435|NCT01313689|579627070|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
160518436|NCT01313689|579627066|FG000|24-Week Randomization 2|Physician Decision|0|||
160518437|NCT01313689|579627067|FG001|24-Week Randomization 2|Physician Decision|0|||
160518438|NCT01313689|579627068|FG002|24-Week Randomization 2|Physician Decision|0|||
160518439|NCT01313689|579627069|FG003|24-Week Randomization 2|Physician Decision|0|||
160518440|NCT01313689|579627070|FG004|24-Week Randomization 2|Physician Decision|4|||
160518441|NCT01768637|579627071|FG000|Overall Study|Lost to Follow-up|2|||
160518442|NCT01768637|579627072|FG001|Overall Study|Lost to Follow-up|7|||
160518443|NCT01768637|579627071|FG000|Overall Study|Difficult blood draw|1|||
160518444|NCT01768637|579627072|FG001|Overall Study|Difficult blood draw|0|||
160518445|NCT01054170|579627073|FG000|Overall Study|Protocol Violation|1|||
160518446|NCT01054170|579627074|FG001|Overall Study|Protocol Violation|0|||
160518447|NCT01054170|579627073|FG000|Overall Study|Withdrawal by Subject|3|||
160518448|NCT01054170|579627074|FG001|Overall Study|Withdrawal by Subject|2|||
160518449|NCT01054170|579627073|FG000|Overall Study|Adverse Event|0|||
160518450|NCT01054170|579627074|FG001|Overall Study|Adverse Event|4|||
160518451|NCT02951767|579627075|FG000|Overall Study|Study Terminated By Sponsor|9|||
160518452|NCT02951767|579627075|FG000|Overall Study|Withdrawal by Subject|11|||
160518453|NCT02951767|579627075|FG000|Overall Study|Death|96|||
160518454|NCT02951767|579627075|FG000|Overall Study|Lost to Follow-up|2|||
160518455|NCT02951767|579627075|FG000|Overall Study|Physician Decision|1|||
160518456|NCT01337115|579627079|FG000|Overall Study|Protocol Violation|2|||
160518457|NCT01337115|579627080|FG001|Overall Study|Protocol Violation|0|||
160518458|NCT03426267|579627089|FG000|Overall Study|Physician Decision|1|||
160518459|NCT03426267|579627090|FG001|Overall Study|Physician Decision|4|||
160518460|NCT03426267|579627089|FG000|Overall Study|Lost to Follow-up|1|||
160518461|NCT03426267|579627090|FG001|Overall Study|Lost to Follow-up|0|||
160518462|NCT03426267|579627089|FG000|Overall Study|Withdrawal by Subject|4|||
160518463|NCT03426267|579627090|FG001|Overall Study|Withdrawal by Subject|10|||
160518464|NCT03426267|579627089|FG000|Overall Study|Protocol Violation|1|||
160518465|NCT03426267|579627090|FG001|Overall Study|Protocol Violation|3|||
160518466|NCT03426267|579627089|FG000|Overall Study|Adverse Event|9|||
160518467|NCT03426267|579627090|FG001|Overall Study|Adverse Event|27|||
160518468|NCT03426267|579627089|FG000|Overall Study|Prohibited Treatment Intake|2|||
160624422|NCT05664672|580003792|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
160624423|NCT05664672|580003793|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
160624424|NCT05664672|580003794|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
160624425|NCT05664672|580003789|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
160624426|NCT05664672|580003790|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
160624427|NCT05664672|580003791|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
160624428|NCT05664672|580003792|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
160624429|NCT05664672|580003793|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
160624430|NCT05664672|580003794|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
160624431|NCT04095039|580003797|FG000|Overall Study|Withdrawal by Subject|2|||
160624432|NCT04095039|580003798|FG001|Overall Study|Withdrawal by Subject|16|||
160624433|NCT04095039|580003797|FG000|Overall Study|Transplanted|21|||
160624434|NCT04095039|580003798|FG001|Overall Study|Transplanted|24|||
160624435|NCT04095039|580003797|FG000|Overall Study|Transferred to Non-study Facility|47|||
160624436|NCT04095039|580003798|FG001|Overall Study|Transferred to Non-study Facility|44|||
160624437|NCT04095039|580003797|FG000|Overall Study|Withdrawal from internvention target|0|||
160624438|NCT04095039|580003798|FG001|Overall Study|Withdrawal from internvention target|2|||
160624439|NCT04095039|580003797|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
160624440|NCT04095039|580003798|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
160624441|NCT04095039|580003797|FG000|Overall Study|Cacliphylaxis|0|||
160624442|NCT04095039|580003798|FG001|Overall Study|Cacliphylaxis|1|||
160624443|NCT04095039|580003797|FG000|Overall Study|Pregnancy|1|||
160624444|NCT04095039|580003798|FG001|Overall Study|Pregnancy|0|||
160624445|NCT04768881|580003799|FG000|Overall Study|Completed Study Follow-up|0|||
160624446|NCT04768881|580003800|FG001|Overall Study|Completed Study Follow-up|2|||
160624447|NCT04768881|580003799|FG000|Overall Study|Death|3|||
160624448|NCT04768881|580003800|FG001|Overall Study|Death|2|||
160624449|NCT04768881|580003799|FG000|Overall Study|Study Terminated by Sponsor|2|||
160624450|NCT04768881|580003800|FG001|Overall Study|Study Terminated by Sponsor|2|||
160624451|NCT04768881|580003799|FG000|Overall Study|Withdrawal by Subject|2|||
160624452|NCT04768881|580003800|FG001|Overall Study|Withdrawal by Subject|0|||
160624453|NCT04768881|580003799|FG000|Overall Study|Other|2|||
160624454|NCT04768881|580003800|FG001|Overall Study|Other|0|||
160624455|NCT04236986|580003803|FG000|Overall Study|Withdrawal by Subject|3|||
160624456|NCT04236986|580003804|FG001|Overall Study|Withdrawal by Subject|1|||
160624457|NCT01365182|580003811|FG000|Overall Study|Withdrawal by Subject|10|||
160624458|NCT01365182|580003812|FG001|Overall Study|Withdrawal by Subject|13|||
160518469|NCT03426267|579627090|FG001|Overall Study|Prohibited Treatment Intake|3|||
160518470|NCT03426267|579627089|FG000|Overall Study|Lack of Efficacy|0|||
160518471|NCT03426267|579627090|FG001|Overall Study|Lack of Efficacy|25|||
160518472|NCT03426267|579627089|FG000|Overall Study|other|3|||
160518473|NCT03426267|579627090|FG001|Overall Study|other|0|||
160518474|NCT02054520|579627097|FG000|Overall Study|Adverse Event|1|||
160518475|NCT02054520|579627098|FG001|Overall Study|Adverse Event|4|||
160518476|NCT02054520|579627099|FG002|Overall Study|Adverse Event|2|||
160518477|NCT02054520|579627100|FG003|Overall Study|Adverse Event|1|||
160518478|NCT02054520|579627101|FG004|Overall Study|Adverse Event|1|||
160518479|NCT02054520|579627102|FG005|Overall Study|Adverse Event|0|||
160518480|NCT02054520|579627097|FG000|Overall Study|Lack of Efficacy|7|||
160518481|NCT02054520|579627098|FG001|Overall Study|Lack of Efficacy|0|||
160518482|NCT02054520|579627099|FG002|Overall Study|Lack of Efficacy|2|||
160518483|NCT02054520|579627100|FG003|Overall Study|Lack of Efficacy|1|||
160518484|NCT02054520|579627101|FG004|Overall Study|Lack of Efficacy|3|||
160518485|NCT02054520|579627102|FG005|Overall Study|Lack of Efficacy|2|||
160518486|NCT02054520|579627097|FG000|Overall Study|Withdrawal by Subject|1|||
160518487|NCT02054520|579627098|FG001|Overall Study|Withdrawal by Subject|0|||
160518488|NCT02054520|579627099|FG002|Overall Study|Withdrawal by Subject|0|||
160518489|NCT02054520|579627100|FG003|Overall Study|Withdrawal by Subject|2|||
160518490|NCT02054520|579627101|FG004|Overall Study|Withdrawal by Subject|1|||
160518491|NCT02054520|579627102|FG005|Overall Study|Withdrawal by Subject|0|||
160518492|NCT02054520|579627097|FG000|Overall Study|Physician Decision|0|||
160518493|NCT02054520|579627098|FG001|Overall Study|Physician Decision|1|||
160518494|NCT02054520|579627099|FG002|Overall Study|Physician Decision|0|||
160518495|NCT02054520|579627100|FG003|Overall Study|Physician Decision|1|||
160518496|NCT02054520|579627101|FG004|Overall Study|Physician Decision|0|||
160518497|NCT02054520|579627102|FG005|Overall Study|Physician Decision|1|||
160518498|NCT02054520|579627097|FG000|Overall Study|Study terminated by Sponsor|0|||
160518499|NCT02054520|579627098|FG001|Overall Study|Study terminated by Sponsor|0|||
160624459|NCT01365182|580003813|FG002|Overall Study|Withdrawal by Subject|12|||
160624460|NCT02309372|580003814|FG000|Overall Study|Lost to Follow-up|3|||
160667744|NCT00705666|580164224|FG000|Overall Study|No post-treatment questionnaire|279|||
160667745|NCT00705666|580164224|FG000|Overall Study|Withdrawal by Subject|21|||
160667746|NCT00705666|580164224|FG000|Overall Study|Physician Decision|7|||
160667747|NCT00705666|580164224|FG000|Overall Study|Lost to Follow-up|5|||
160667748|NCT00705666|580164224|FG000|Overall Study|Death|1|||
160667749|NCT00705666|580164224|FG000|Overall Study|Adverse Event|4|||
160667750|NCT00705666|580164224|FG000|Overall Study|Other|12|||
160667751|NCT00705666|580164224|FG000|Overall Study|Other|2|||
160667752|NCT00705666|580164224|FG000|Overall Study|Lack of data|3|||
160667753|NCT00705666|580164224|FG000|Overall Study|Untreated|5|||
160667754|NCT00429416|580164226|FG000|Overall Study|Death|1|||
160667755|NCT02530905|580164227|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
160667756|NCT02530905|580164228|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
160667757|NCT02530905|580164229|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
160667758|NCT00415363|580164231|FG000|Overall Study|Withdrawal by Subject|4|||
160667759|NCT00415363|580164232|FG001|Overall Study|Withdrawal by Subject|4|||
160667760|NCT00415363|580164231|FG000|Overall Study|Adverse Event|4|||
160667761|NCT00415363|580164232|FG001|Overall Study|Adverse Event|4|||
160667762|NCT00415363|580164231|FG000|Overall Study|Lost to Follow-up|2|||
160667763|NCT00415363|580164232|FG001|Overall Study|Lost to Follow-up|1|||
160624461|NCT02309372|580003815|FG001|Overall Study|Lost to Follow-up|2|||
160624462|NCT02811640|580003820|FG000|Overall Study|Technology malfunction|2|||
160624463|NCT04369742|580003835|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
160624464|NCT04369742|580003836|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
160624465|NCT04369742|580003835|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
160624466|NCT04369742|580003836|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
160624467|NCT01207427|580003838|FG000|Double-blind Treatment Period|Adverse Event|0|||
160624468|NCT01207427|580003839|FG001|Double-blind Treatment Period|Adverse Event|1|||
160624469|NCT01207427|580003840|FG002|Double-blind Treatment Period|Adverse Event|0|||
160624470|NCT01207427|580003838|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
160624471|NCT01207427|580003839|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
160667764|NCT00415363|580164231|FG000|Overall Study|Physician Decision|3|||
160667765|NCT00415363|580164232|FG001|Overall Study|Physician Decision|1|||
160667766|NCT00415363|580164231|FG000|Overall Study|Death|16|||
160518500|NCT02054520|579627099|FG002|Overall Study|Study terminated by Sponsor|2|||
160518501|NCT02054520|579627100|FG003|Overall Study|Study terminated by Sponsor|1|||
160518502|NCT02054520|579627101|FG004|Overall Study|Study terminated by Sponsor|0|||
160518503|NCT02054520|579627102|FG005|Overall Study|Study terminated by Sponsor|0|||
160624472|NCT01207427|580003840|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
160518504|NCT01272804|579627103|FG000|Overall Study|Adverse Event|1|||
160624473|NCT01207427|580003838|FG000|Double-blind Treatment Period|Protocol Violation|2|||
160624474|NCT01207427|580003839|FG001|Double-blind Treatment Period|Protocol Violation|1|||
160518505|NCT01272804|579627104|FG001|Overall Study|Adverse Event|0|||
160518506|NCT01272804|579627105|FG002|Overall Study|Adverse Event|0|||
160667767|NCT00415363|580164232|FG001|Overall Study|Death|12|||
160667768|NCT00415363|580164231|FG000|Overall Study|Progressive disease|26|||
160667769|NCT00415363|580164232|FG001|Overall Study|Progressive disease|32|||
160518507|NCT01272804|579627106|FG003|Overall Study|Adverse Event|0|||
160518508|NCT01272804|579627107|FG004|Overall Study|Adverse Event|2|||
160518509|NCT01272804|579627108|FG005|Overall Study|Adverse Event|1|||
160518510|NCT03801915|579627109|FG000|Overall Study|Screen failure|0|||
160518511|NCT03801915|579627110|FG001|Overall Study|Screen failure|0|||
160518512|NCT03801915|579627111|FG002|Overall Study|Screen failure|1|||
160518513|NCT03801915|579627109|FG000|Overall Study|Ineligible|1|||
160518514|NCT03801915|579627110|FG001|Overall Study|Ineligible|0|||
160518515|NCT03801915|579627111|FG002|Overall Study|Ineligible|0|||
160518516|NCT03801915|579627109|FG000|Overall Study|Physician Decision|2|||
160518517|NCT03801915|579627110|FG001|Overall Study|Physician Decision|1|||
160518518|NCT03801915|579627111|FG002|Overall Study|Physician Decision|0|||
160518519|NCT02308020|579627112|FG000|Overall Study|Lost to Follow-up|1|||
160518520|NCT02308020|579627113|FG001|Overall Study|Lost to Follow-up|7|||
160518521|NCT02308020|579627114|FG002|Overall Study|Lost to Follow-up|0|||
160518522|NCT02308020|579627115|FG003|Overall Study|Lost to Follow-up|0|||
160518523|NCT02308020|579627116|FG004|Overall Study|Lost to Follow-up|1|||
160518524|NCT02308020|579627117|FG005|Overall Study|Lost to Follow-up|2|||
160518525|NCT02308020|579627112|FG000|Overall Study|Sponsor Decision|0|||
160518526|NCT02308020|579627113|FG001|Overall Study|Sponsor Decision|8|||
160518527|NCT02308020|579627114|FG002|Overall Study|Sponsor Decision|0|||
160518528|NCT02308020|579627115|FG003|Overall Study|Sponsor Decision|2|||
160518529|NCT02308020|579627116|FG004|Overall Study|Sponsor Decision|2|||
160518530|NCT02308020|579627117|FG005|Overall Study|Sponsor Decision|1|||
160518531|NCT02308020|579627112|FG000|Overall Study|Withdrawal by Subject|3|||
160518532|NCT02308020|579627113|FG001|Overall Study|Withdrawal by Subject|5|||
160518533|NCT02308020|579627114|FG002|Overall Study|Withdrawal by Subject|3|||
160518534|NCT02308020|579627115|FG003|Overall Study|Withdrawal by Subject|2|||
160518535|NCT02308020|579627116|FG004|Overall Study|Withdrawal by Subject|1|||
160518536|NCT02308020|579627117|FG005|Overall Study|Withdrawal by Subject|2|||
160518537|NCT01211288|579627118|FG000|Overall Study|Lost to Follow-up|1|||
160518538|NCT01211288|579627119|FG001|Overall Study|Lost to Follow-up|1|||
160518539|NCT01270971|579627120|FG000|Overall Study|Withdrawal by Subject|24|||
160518540|NCT01270971|579627121|FG001|Overall Study|Withdrawal by Subject|11|||
160518541|NCT01270971|579627120|FG000|Overall Study|Lost to Follow-up|18|||
160518542|NCT01270971|579627121|FG001|Overall Study|Lost to Follow-up|5|||
160518543|NCT01270971|579627120|FG000|Overall Study|Adverse Event|1|||
160518544|NCT01270971|579627121|FG001|Overall Study|Adverse Event|2|||
160518545|NCT01270971|579627120|FG000|Overall Study|Non compliance|2|||
160518546|NCT01270971|579627121|FG001|Overall Study|Non compliance|2|||
160518547|NCT01270971|579627120|FG000|Overall Study|Non-specific|7|||
160518548|NCT01270971|579627121|FG001|Overall Study|Non-specific|3|||
160518549|NCT01551212|579627122|FG000|Overall Study|Graft loss/Retransplantation|0|||
160518550|NCT01551212|579627123|FG001|Overall Study|Graft loss/Retransplantation|1|||
160518551|NCT01551212|579627122|FG000|Overall Study|Administrative problems|1|||
160518552|NCT01551212|579627123|FG001|Overall Study|Administrative problems|2|||
160518553|NCT01551212|579627122|FG000|Overall Study|Lost to Follow-up|0|||
160518554|NCT01551212|579627123|FG001|Overall Study|Lost to Follow-up|1|||
160518555|NCT01551212|579627122|FG000|Overall Study|Protocol Violation|0|||
160518556|NCT01551212|579627123|FG001|Overall Study|Protocol Violation|1|||
160518557|NCT01551212|579627122|FG000|Overall Study|Withdrawal by Subject|0|||
160518558|NCT01551212|579627123|FG001|Overall Study|Withdrawal by Subject|7|||
160518559|NCT01551212|579627122|FG000|Overall Study|Death|2|||
160518560|NCT01551212|579627123|FG001|Overall Study|Death|4|||
160518561|NCT01551212|579627122|FG000|Overall Study|Never Received Study Treatment|2|||
160518562|NCT01551212|579627123|FG001|Overall Study|Never Received Study Treatment|4|||
160518563|NCT04217590|579627124|FG000|Overall Study|Other|1|||
160518564|NCT04217590|579627125|FG001|Overall Study|Other|1|||
160518565|NCT04217590|579627124|FG000|Overall Study|Withdrawal by Subject|3|||
160518566|NCT04217590|579627125|FG001|Overall Study|Withdrawal by Subject|1|||
160518567|NCT04217590|579627124|FG000|Overall Study|Death|0|||
160518568|NCT04217590|579627125|FG001|Overall Study|Death|1|||
160518569|NCT01013285|579627126|FG000|Overall Study|Death|48|||
160518570|NCT01013285|579627127|FG001|Overall Study|Death|89|||
160518571|NCT01395888|579627128|FG000|2-week Run-in Period|Adverse Event|2|||
160518572|NCT01395888|579627129|FG001|2-week Run-in Period|Adverse Event|0|||
160667770|NCT00813592|580164233|FG000|Overall Study|Disease assessment was not completed per|2|||
160518573|NCT01395888|579627130|FG002|2-week Run-in Period|Adverse Event|0|||
160518574|NCT01395888|579627128|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
160518575|NCT01395888|579627129|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
160518576|NCT01395888|579627130|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
160518577|NCT01395888|579627128|FG000|2-week Run-in Period|Lost to Follow-up|1|||
160518578|NCT01395888|579627129|FG001|2-week Run-in Period|Lost to Follow-up|0|||
160518579|NCT01395888|579627130|FG002|2-week Run-in Period|Lost to Follow-up|0|||
160518580|NCT01395888|579627128|FG000|2-week Run-in Period|Protocol Violation|2|||
160518581|NCT01395888|579627129|FG001|2-week Run-in Period|Protocol Violation|0|||
160518582|NCT01395888|579627130|FG002|2-week Run-in Period|Protocol Violation|0|||
160518583|NCT01395888|579627128|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
160518584|NCT01395888|579627129|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
160518585|NCT01395888|579627130|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
160518586|NCT01395888|579627128|FG000|Treatment Period (TP)|Adverse Event|0|||
160518587|NCT01395888|579627129|FG001|Treatment Period (TP)|Adverse Event|7|||
160518588|NCT01395888|579627130|FG002|Treatment Period (TP)|Adverse Event|6|||
160518589|NCT01395888|579627128|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
160518590|NCT01395888|579627129|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
160518591|NCT01395888|579627130|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
160518592|NCT01395888|579627128|FG000|Treatment Period (TP)|Protocol Violation|0|||
160518593|NCT01395888|579627129|FG001|Treatment Period (TP)|Protocol Violation|1|||
160518594|NCT01395888|579627130|FG002|Treatment Period (TP)|Protocol Violation|5|||
160518595|NCT01395888|579627128|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
160518596|NCT01395888|579627129|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
160518597|NCT01395888|579627130|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
160518598|NCT01395888|579627128|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
160518599|NCT01395888|579627129|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
160518600|NCT01395888|579627130|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
160518601|NCT02457559|579627131|FG000|Overall Study|Progressive Disease|1|||
160518602|NCT02457559|579627132|FG001|Overall Study|Progressive Disease|2|||
160518603|NCT02457559|579627133|FG002|Overall Study|Progressive Disease|3|||
160518604|NCT02457559|579627134|FG003|Overall Study|Progressive Disease|0|||
160518605|NCT02457559|579627135|FG004|Overall Study|Progressive Disease|0|||
160518606|NCT02457559|579627136|FG005|Overall Study|Progressive Disease|2|||
160667771|NCT01588236|580164238|FG000|Overall Study|Adverse Event|5|||
160667772|NCT01588236|580164239|FG001|Overall Study|Adverse Event|4|||
160667773|NCT01588236|580164240|FG002|Overall Study|Adverse Event|1|||
160667774|NCT01588236|580164238|FG000|Overall Study|Lost to Follow-up|8|||
160667775|NCT01588236|580164239|FG001|Overall Study|Lost to Follow-up|13|||
160667776|NCT01588236|580164240|FG002|Overall Study|Lost to Follow-up|6|||
160667777|NCT01588236|580164238|FG000|Overall Study|Physician Decision|1|||
160667778|NCT01588236|580164239|FG001|Overall Study|Physician Decision|2|||
160667779|NCT01588236|580164240|FG002|Overall Study|Physician Decision|0|||
160667780|NCT01588236|580164238|FG000|Overall Study|Protocol Violation|0|||
160667781|NCT01588236|580164239|FG001|Overall Study|Protocol Violation|1|||
160667782|NCT01588236|580164240|FG002|Overall Study|Protocol Violation|1|||
160667783|NCT01588236|580164238|FG000|Overall Study|Withdrawal by Subject|14|||
160667784|NCT01588236|580164239|FG001|Overall Study|Withdrawal by Subject|16|||
160667785|NCT01588236|580164240|FG002|Overall Study|Withdrawal by Subject|18|||
160667786|NCT01588236|580164238|FG000|Overall Study|Exclusion Criteria met during study|2|||
160667787|NCT01588236|580164239|FG001|Overall Study|Exclusion Criteria met during study|1|||
160667788|NCT01588236|580164240|FG002|Overall Study|Exclusion Criteria met during study|0|||
160667789|NCT01588236|580164238|FG000|Overall Study|sponsor decision|1|||
160667790|NCT01588236|580164239|FG001|Overall Study|sponsor decision|6|||
160667791|NCT01588236|580164240|FG002|Overall Study|sponsor decision|2|||
160667792|NCT01958294|580165249|FG000|Overall Study|Clinical Circumstances|2|||
160667793|NCT00682461|580165250|FG000|Overall Study|Adverse Event|5|||
160667794|NCT00682461|580165251|FG001|Overall Study|Adverse Event|7|||
160667795|NCT00682461|580165250|FG000|Overall Study|Lost to Follow-up|8|||
160667796|NCT00682461|580165251|FG001|Overall Study|Lost to Follow-up|5|||
160667797|NCT00682461|580165250|FG000|Overall Study|Withdrawal by Subject|12|||
160667798|NCT00682461|580165251|FG001|Overall Study|Withdrawal by Subject|19|||
160518607|NCT02457559|579627137|FG006|Overall Study|Progressive Disease|1|||
160518608|NCT02457559|579627138|FG007|Overall Study|Progressive Disease|0|||
160518609|NCT02457559|579627139|FG008|Overall Study|Progressive Disease|1|||
160518610|NCT02457559|579627140|FG009|Overall Study|Progressive Disease|1|||
160518611|NCT02457559|579627141|FG010|Overall Study|Progressive Disease|1|||
160518612|NCT02457559|579627131|FG000|Overall Study|Investigator's Discretion|0|||
160518613|NCT02457559|579627132|FG001|Overall Study|Investigator's Discretion|0|||
160667829|NCT06144424|580165260|FG000|Overall Study|Withdrawal by Subject|2|||
160667830|NCT06144424|580165261|FG001|Overall Study|Withdrawal by Subject|0|||
160667831|NCT06144424|580165260|FG000|Overall Study|Incarceration|1|||
160667832|NCT06144424|580165261|FG001|Overall Study|Incarceration|0|||
160667833|NCT01547286|580165270|FG000|Overall Study|Did not meet all eligibility criteria|1|||
160667834|NCT01547286|580165270|FG000|Overall Study|Physician Decision|1|||
160667835|NCT03415308|580165273|FG000|Overall Study|Lost to Follow-up|0|||
160667836|NCT03415308|580165274|FG001|Overall Study|Lost to Follow-up|0|||
160667837|NCT03415308|580165275|FG002|Overall Study|Lost to Follow-up|1|||
160667838|NCT03415308|580165273|FG000|Overall Study|Scheduling Conflicts|0|||
160667839|NCT03415308|580165274|FG001|Overall Study|Scheduling Conflicts|0|||
160667840|NCT03415308|580165275|FG002|Overall Study|Scheduling Conflicts|7|||
160667841|NCT01471353|580165278|FG000|Overall Study|remain on study|3|||
160667842|NCT03123094|580165281|FG000|Overall Study|Withdrawal by Subject|0|||
160667843|NCT03123094|580165282|FG001|Overall Study|Withdrawal by Subject|2|||
160667844|NCT03123094|580165283|FG002|Overall Study|Withdrawal by Subject|1|||
160667845|NCT03123094|580165284|FG003|Overall Study|Withdrawal by Subject|0|||
160667846|NCT03123094|580165285|FG004|Overall Study|Withdrawal by Subject|1|||
160667847|NCT00081653|580165286|FG000|Overall Study|Adverse Event|23|||
160667848|NCT00081653|580165287|FG001|Overall Study|Adverse Event|17|||
160667849|NCT00081653|580165286|FG000|Overall Study|Lost to Follow-up|2|||
160667850|NCT00081653|580165287|FG001|Overall Study|Lost to Follow-up|4|||
160667851|NCT00081653|580165286|FG000|Overall Study|Refused Treatment|18|||
160667852|NCT00081653|580165287|FG001|Overall Study|Refused Treatment|14|||
160667853|NCT00081653|580165286|FG000|Overall Study|Low bone mineral density|1|||
160667854|NCT00081653|580165287|FG001|Overall Study|Low bone mineral density|0|||
160667855|NCT00081653|580165286|FG000|Overall Study|Bone loss|2|||
160667856|NCT00081653|580165287|FG001|Overall Study|Bone loss|0|||
160667857|NCT00081653|580165286|FG000|Overall Study|Participant leaving country|1|||
160667858|NCT00081653|580165287|FG001|Overall Study|Participant leaving country|0|||
160667859|NCT00081653|580165286|FG000|Overall Study|Loss of bone mass|0|||
160667860|NCT00081653|580165287|FG001|Overall Study|Loss of bone mass|2|||
160667861|NCT00736190|580165288|FG000|Overall Study|Pregnancy|1|||
160667862|NCT00736190|580165288|FG000|Overall Study|Withdrawal by Subject|1|||
160667863|NCT00736190|580165288|FG000|Overall Study|Adverse Event|1|||
160667864|NCT03246503|580165289|FG000|Overall Study|Lost to Follow-up|23|||
160667865|NCT03246503|580165289|FG000|Overall Study|Withdrawal by Subject|20|||
160667866|NCT03246503|580165289|FG000|Overall Study|Physician Decision|5|||
160667867|NCT03246503|580165289|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
160667868|NCT05014828|580165290|FG000|Overall Study|Study Completed by Sponsor|16|||
160667869|NCT05014828|580165291|FG001|Overall Study|Study Completed by Sponsor|16|||
160667870|NCT05014828|580165292|FG002|Overall Study|Study Completed by Sponsor|3|||
160518614|NCT02457559|579627133|FG002|Overall Study|Investigator's Discretion|2|||
160518615|NCT02457559|579627134|FG003|Overall Study|Investigator's Discretion|0|||
160518616|NCT02457559|579627135|FG004|Overall Study|Investigator's Discretion|1|||
160518617|NCT02457559|579627136|FG005|Overall Study|Investigator's Discretion|0|||
160518618|NCT02457559|579627137|FG006|Overall Study|Investigator's Discretion|1|||
160518619|NCT02457559|579627138|FG007|Overall Study|Investigator's Discretion|0|||
160518620|NCT02457559|579627139|FG008|Overall Study|Investigator's Discretion|1|||
160667871|NCT05014828|580165293|FG003|Overall Study|Study Completed by Sponsor|3|||
160667872|NCT05014828|580165290|FG000|Overall Study|Death|11|||
160667873|NCT05014828|580165291|FG001|Overall Study|Death|6|||
160667874|NCT05014828|580165292|FG002|Overall Study|Death|0|||
160667875|NCT05014828|580165293|FG003|Overall Study|Death|0|||
160667876|NCT05014828|580165290|FG000|Overall Study|Lost to Follow-up|0|||
160667877|NCT05014828|580165291|FG001|Overall Study|Lost to Follow-up|0|||
160518621|NCT02457559|579627140|FG009|Overall Study|Investigator's Discretion|0|||
160667878|NCT05014828|580165292|FG002|Overall Study|Lost to Follow-up|2|||
160667879|NCT05014828|580165293|FG003|Overall Study|Lost to Follow-up|0|||
160667880|NCT05014828|580165290|FG000|Overall Study|Miscellaneous.|0|||
160667881|NCT05014828|580165291|FG001|Overall Study|Miscellaneous.|1|||
160667882|NCT05014828|580165292|FG002|Overall Study|Miscellaneous.|0|||
160667883|NCT05014828|580165293|FG003|Overall Study|Miscellaneous.|0|||
160667884|NCT01370317|580165296|FG000|Overall Study|Participant withdrew consent|1|||
160667885|NCT01370317|580165297|FG001|Overall Study|Participant withdrew consent|0|||
160667886|NCT01370317|580165296|FG000|Overall Study|Protocol deviation|0|||
160667887|NCT01370317|580165297|FG001|Overall Study|Protocol deviation|1|||
160667888|NCT00075478|580165298|FG000|Overall Study|not eligible|1|||
160624475|NCT01207427|580003840|FG002|Double-blind Treatment Period|Protocol Violation|1|||
160624476|NCT01207427|580003838|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
160624477|NCT01207427|580003839|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
160624478|NCT01207427|580003840|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160624479|NCT00422227|580003841|FG000|Overall Study|Adverse Event|3|||
160624480|NCT00422227|580003842|FG001|Overall Study|Adverse Event|8|||
160624481|NCT00422227|580003841|FG000|Overall Study|Lost to Follow-up|1|||
160624482|NCT00422227|580003842|FG001|Overall Study|Lost to Follow-up|3|||
160624483|NCT00422227|580003841|FG000|Overall Study|Withdrawal by Subject|0|||
160624484|NCT00422227|580003842|FG001|Overall Study|Withdrawal by Subject|4|||
160624485|NCT01230489|580003843|FG000|Overall Study|Death|2|||
160624486|NCT01230489|580003843|FG000|Overall Study|Adverse Event|2|||
160624487|NCT01230489|580003843|FG000|Overall Study|Treatment modality changed|1|||
160624488|NCT00686894|580003844|FG000|Overall Study|Relapse|2|||
160624489|NCT00686894|580003844|FG000|Overall Study|Protocol Violation|4|||
160624490|NCT04576702|580005430|FG000|Overall Study|Death|1|||
160624491|NCT04576702|580005431|FG001|Overall Study|Death|0|||
160624492|NCT04576702|580005432|FG002|Overall Study|Death|0|||
160624493|NCT04576702|580005433|FG003|Overall Study|Death|0|||
160624494|NCT04576702|580005430|FG000|Overall Study|Withdrawal by Subject|0|||
160624495|NCT04576702|580005431|FG001|Overall Study|Withdrawal by Subject|2|||
160624496|NCT04576702|580005432|FG002|Overall Study|Withdrawal by Subject|1|||
160624497|NCT04576702|580005433|FG003|Overall Study|Withdrawal by Subject|0|||
160624498|NCT04576702|580005430|FG000|Overall Study|Lost to Follow-up|3|||
160624499|NCT04576702|580005431|FG001|Overall Study|Lost to Follow-up|3|||
160624500|NCT04576702|580005432|FG002|Overall Study|Lost to Follow-up|3|||
160624501|NCT04576702|580005433|FG003|Overall Study|Lost to Follow-up|4|||
160624502|NCT01151085|580005434|FG000|Overall Study|Lost to Follow-up|31|||
160624503|NCT01151085|580005434|FG000|Overall Study|Protocol Violation|25|||
160624504|NCT01243762|580005435|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
160624505|NCT01243762|580005436|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
160624506|NCT01243762|580005437|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
160624507|NCT01243762|580005438|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
160624508|NCT01243762|580005439|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
160624509|NCT01243762|580005440|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
160624510|NCT01243762|580005441|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
160624511|NCT01243762|580005435|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
160624512|NCT01243762|580005436|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
160624513|NCT01243762|580005437|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
160624514|NCT01243762|580005438|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
160624515|NCT01243762|580005439|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
160624516|NCT01243762|580005440|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
160624517|NCT01243762|580005441|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
160624518|NCT01243762|580005435|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
160624519|NCT01243762|580005436|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
160624520|NCT01243762|580005437|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
160624521|NCT01243762|580005438|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
160624522|NCT01243762|580005439|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
160624523|NCT01243762|580005440|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
160624524|NCT01243762|580005441|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
160624525|NCT01243762|580005435|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
160624526|NCT01243762|580005436|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
160624527|NCT01243762|580005437|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
160624528|NCT01243762|580005438|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
160624529|NCT01243762|580005439|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
160624530|NCT01243762|580005440|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
160624531|NCT01243762|580005441|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
160624532|NCT01243762|580005435|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
160624533|NCT01243762|580005436|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
160624534|NCT01243762|580005437|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
160624535|NCT01243762|580005438|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
160624536|NCT01243762|580005439|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
160624537|NCT01243762|580005440|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
160624538|NCT01243762|580005441|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
160624539|NCT01243762|580005435|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
160624540|NCT01243762|580005436|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
160624541|NCT01243762|580005437|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
160624542|NCT01243762|580005438|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
160624543|NCT01243762|580005439|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
160624544|NCT01243762|580005440|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
160624545|NCT01243762|580005441|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
160624546|NCT01243762|580005435|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
160667889|NCT00075478|580165299|FG001|Overall Study|not eligible|0|||
160667890|NCT00075478|580165298|FG000|Overall Study|Physician Decision|0|||
160667891|NCT00075478|580165299|FG001|Overall Study|Physician Decision|1|||
160667892|NCT00824291|580165303|FG000|Overall Study|Adverse Event|15|||
160667893|NCT00824291|580165304|FG001|Overall Study|Adverse Event|6|||
160667894|NCT00824291|580165303|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
160667895|NCT00824291|580165304|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
160667896|NCT00824291|580165303|FG000|Overall Study|Lost to Follow-up|11|||
160667897|NCT00824291|580165304|FG001|Overall Study|Lost to Follow-up|9|||
160667898|NCT00824291|580165303|FG000|Overall Study|Non-compliance|1|||
160667899|NCT00824291|580165304|FG001|Overall Study|Non-compliance|1|||
160667900|NCT00824291|580165303|FG000|Overall Study|Protocol Violation|4|||
160667901|NCT00824291|580165304|FG001|Overall Study|Protocol Violation|1|||
160667902|NCT00824291|580165303|FG000|Overall Study|Withdrawal by Subject|14|||
160667903|NCT00824291|580165304|FG001|Overall Study|Withdrawal by Subject|8|||
160667904|NCT00824291|580165303|FG000|Overall Study|Lack of Efficacy|7|||
160667905|NCT00824291|580165304|FG001|Overall Study|Lack of Efficacy|8|||
160667906|NCT00824291|580165303|FG000|Overall Study|Participant on prohibited medication|1|||
160667907|NCT00824291|580165304|FG001|Overall Study|Participant on prohibited medication|0|||
160667908|NCT00392665|580165308|FG000|Overall Study|Death|16|||
160667909|NCT00392665|580165309|FG001|Overall Study|Death|14|||
160667910|NCT00392665|580165308|FG000|Overall Study|Lost to Follow-up|1|||
160667911|NCT00392665|580165309|FG001|Overall Study|Lost to Follow-up|1|||
160667912|NCT03673670|580165310|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
160667913|NCT03673670|580165311|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
160667914|NCT03673670|580165312|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
160667915|NCT03673670|580165313|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
160667916|NCT03673670|580165314|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
160667917|NCT03673670|580165315|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
160667918|NCT03673670|580165310|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
160667919|NCT03673670|580165311|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
160667920|NCT03673670|580165312|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
160667921|NCT03673670|580165313|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
160667922|NCT03673670|580165314|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
160667923|NCT03673670|580165315|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
160667924|NCT03673670|580165310|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
160667925|NCT03673670|580165311|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
160667926|NCT03673670|580165312|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
160667927|NCT03673670|580165313|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
160667928|NCT03673670|580165314|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
160667929|NCT03673670|580165315|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
160667930|NCT03673670|580165310|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
160667931|NCT03673670|580165311|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
160667932|NCT03673670|580165312|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
160667933|NCT03673670|580165313|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
160667934|NCT03673670|580165314|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
160667935|NCT03673670|580165315|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
160667936|NCT03673670|580165310|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
160667937|NCT03673670|580165311|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
160667938|NCT03673670|580165312|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
160667939|NCT03673670|580165313|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
160667940|NCT03673670|580165314|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
160667941|NCT03673670|580165315|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
160667942|NCT03673670|580165310|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
160667943|NCT03673670|580165311|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
160667944|NCT03673670|580165312|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
160667945|NCT03673670|580165313|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
160667946|NCT03673670|580165314|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
160518622|NCT02457559|579627141|FG010|Overall Study|Investigator's Discretion|1|||
160518623|NCT02457559|579627131|FG000|Overall Study|Adverse Event|0|||
160518624|NCT02457559|579627132|FG001|Overall Study|Adverse Event|1|||
160518625|NCT02457559|579627133|FG002|Overall Study|Adverse Event|2|||
160518626|NCT02457559|579627134|FG003|Overall Study|Adverse Event|0|||
160667947|NCT03673670|580165315|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
160518627|NCT02457559|579627135|FG004|Overall Study|Adverse Event|0|||
160667948|NCT03673670|580165310|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
160667949|NCT03673670|580165311|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
160667950|NCT03673670|580165312|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
160667951|NCT03673670|580165313|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
160667952|NCT03673670|580165314|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
160667953|NCT03673670|580165315|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
160667954|NCT01058668|580165316|FG000|Double-blind Treatment Phase|Adverse Event|8|||
160518628|NCT02457559|579627136|FG005|Overall Study|Adverse Event|0|||
160518629|NCT02457559|579627137|FG006|Overall Study|Adverse Event|0|||
160518630|NCT02457559|579627138|FG007|Overall Study|Adverse Event|0|||
160518631|NCT02457559|579627139|FG008|Overall Study|Adverse Event|0|||
160518632|NCT02457559|579627140|FG009|Overall Study|Adverse Event|0|||
160518633|NCT02457559|579627141|FG010|Overall Study|Adverse Event|0|||
160518634|NCT02457559|579627131|FG000|Overall Study|Reason not Specified|1|||
160518635|NCT02457559|579627132|FG001|Overall Study|Reason not Specified|0|||
160518636|NCT02457559|579627133|FG002|Overall Study|Reason not Specified|0|||
160624547|NCT01243762|580005436|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
160624548|NCT01243762|580005437|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
160624549|NCT01243762|580005438|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
160624550|NCT01243762|580005439|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
160624551|NCT01243762|580005440|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
160624552|NCT01243762|580005441|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
160624553|NCT01243762|580005435|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
160624554|NCT01243762|580005436|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
160624555|NCT01243762|580005437|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
160624556|NCT01243762|580005438|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
160624557|NCT01243762|580005439|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
160624558|NCT01243762|580005440|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
160624559|NCT01243762|580005441|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
160624560|NCT02059265|580005442|FG000|Overall Study|Ineligible|4|||
160624561|NCT00998166|580005443|FG000|Overall Study|Early Study Termination|8|||
160624562|NCT02985996|580005447|FG000|Overall Study|Withdrawal by Subject|0|||
160624563|NCT02985996|580005448|FG001|Overall Study|Withdrawal by Subject|0|||
160624564|NCT02985996|580005449|FG002|Overall Study|Withdrawal by Subject|1|||
160624565|NCT02985996|580005450|FG003|Overall Study|Withdrawal by Subject|0|||
160624566|NCT02985996|580005451|FG004|Overall Study|Withdrawal by Subject|0|||
160624567|NCT02985996|580005447|FG000|Overall Study|Protocol Violation|0|||
160624568|NCT02985996|580005448|FG001|Overall Study|Protocol Violation|1|||
160624569|NCT02985996|580005449|FG002|Overall Study|Protocol Violation|0|||
160624570|NCT02985996|580005450|FG003|Overall Study|Protocol Violation|0|||
160624571|NCT02985996|580005451|FG004|Overall Study|Protocol Violation|0|||
160624572|NCT00401726|580005452|FG000|Overall Study|Adverse Event|34|||
160624573|NCT00401726|580005453|FG001|Overall Study|Adverse Event|45|||
160624574|NCT00401726|580005452|FG000|Overall Study|Death|0|||
160624575|NCT00401726|580005453|FG001|Overall Study|Death|3|||
160624576|NCT00401726|580005452|FG000|Overall Study|Sponsor Request|0|||
160624577|NCT00401726|580005453|FG001|Overall Study|Sponsor Request|1|||
160624578|NCT00401726|580005452|FG000|Overall Study|Physician Decision|3|||
160624579|NCT00401726|580005453|FG001|Overall Study|Physician Decision|6|||
160624580|NCT00401726|580005452|FG000|Overall Study|Lost to Follow-up|23|||
160624581|NCT00401726|580005453|FG001|Overall Study|Lost to Follow-up|20|||
160624582|NCT00401726|580005452|FG000|Overall Study|Protocol Violation|6|||
160624583|NCT00401726|580005453|FG001|Overall Study|Protocol Violation|3|||
160624584|NCT00401726|580005452|FG000|Overall Study|Withdrawal by Subject|18|||
160624585|NCT00401726|580005453|FG001|Overall Study|Withdrawal by Subject|24|||
160624586|NCT00401726|580005452|FG000|Overall Study|Lack of Efficacy|4|||
160624587|NCT00401726|580005453|FG001|Overall Study|Lack of Efficacy|6|||
160624588|NCT00401726|580005452|FG000|Overall Study|Protocol Deviation|9|||
160624589|NCT00401726|580005453|FG001|Overall Study|Protocol Deviation|4|||
160624590|NCT00814502|580005456|FG000|Overall Study|Adverse Event|1|||
160624591|NCT00814502|580005457|FG001|Overall Study|Adverse Event|0|||
160624592|NCT00814502|580005456|FG000|Overall Study|Withdrawal by Subject|0|||
160624593|NCT00814502|580005457|FG001|Overall Study|Withdrawal by Subject|2|||
160624594|NCT03735849|580005459|FG000|Overall Study|Lost to Follow-up|1|||
160624595|NCT03735849|580005460|FG001|Overall Study|Lost to Follow-up|0|||
160624596|NCT03735849|580005461|FG002|Overall Study|Lost to Follow-up|0|||
160624597|NCT03735849|580005459|FG000|Overall Study|Participant unable to adhere to visit|1|||
160624598|NCT03735849|580005460|FG001|Overall Study|Participant unable to adhere to visit|0|||
160624599|NCT03735849|580005461|FG002|Overall Study|Participant unable to adhere to visit|0|||
160624600|NCT03735849|580005459|FG000|Overall Study|Not Randomized|0|||
160624601|NCT03735849|580005460|FG001|Overall Study|Not Randomized|0|||
160624602|NCT03735849|580005461|FG002|Overall Study|Not Randomized|4|||
160624603|NCT04585906|580005464|FG000|Overall Study|Lost to Follow-up|8|||
160624604|NCT04585906|580005465|FG001|Overall Study|Lost to Follow-up|5|||
160624605|NCT04626947|580005466|FG000|Overall Study|Study terminated|14|||
160624606|NCT01428882|580005479|FG000|Overall Study|Lack of Efficacy|2|||
160624607|NCT01428882|580005480|FG001|Overall Study|Lack of Efficacy|7|||
160624608|NCT01428882|580005479|FG000|Overall Study|Protocol Violation|4|||
160518637|NCT02457559|579627134|FG003|Overall Study|Reason not Specified|0|||
160624609|NCT01428882|580005480|FG001|Overall Study|Protocol Violation|3|||
160624610|NCT04246593|580005481|FG000|Overall Study|Withdrawal by Subject|14|||
160624611|NCT04246593|580005482|FG001|Overall Study|Withdrawal by Subject|13|||
160624612|NCT04246593|580005481|FG000|Overall Study|Lost to Follow-up|124|||
160624613|NCT04246593|580005482|FG001|Overall Study|Lost to Follow-up|71|||
160667955|NCT01058668|580165317|FG001|Double-blind Treatment Phase|Adverse Event|15|||
160667956|NCT01058668|580165318|FG002|Double-blind Treatment Phase|Adverse Event|25|||
160667957|NCT01058668|580165316|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
160667958|NCT01058668|580165317|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
160667959|NCT01058668|580165318|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
160667960|NCT01058668|580165316|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
160667961|NCT01058668|580165317|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
160667962|NCT01058668|580165318|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
160667963|NCT01058668|580165316|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
160667964|NCT01058668|580165317|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
160667965|NCT01058668|580165318|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
160667966|NCT01058668|580165316|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
160667967|NCT01058668|580165317|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
160667968|NCT01058668|580165318|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
160667969|NCT01058668|580165316|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
160667970|NCT01058668|580165317|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
160667971|NCT01058668|580165318|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
160667972|NCT02294786|580165321|FG000|Overall Study|Withdrawal by Subject|0|||
160667973|NCT02294786|580165322|FG001|Overall Study|Withdrawal by Subject|1|||
160667974|NCT02294786|580165321|FG000|Overall Study|Physician Decision|6|||
160667975|NCT02294786|580165322|FG001|Overall Study|Physician Decision|7|||
160667976|NCT02294786|580165321|FG000|Overall Study|Lost to Follow-up|1|||
160667977|NCT02294786|580165322|FG001|Overall Study|Lost to Follow-up|2|||
160667978|NCT02294786|580165321|FG000|Overall Study|Protocol Violation|1|||
160667979|NCT02294786|580165322|FG001|Overall Study|Protocol Violation|0|||
160667980|NCT02294786|580165321|FG000|Overall Study|Adverse Event|1|||
160667981|NCT02294786|580165322|FG001|Overall Study|Adverse Event|1|||
160667982|NCT02294786|580165321|FG000|Overall Study|Death|2|||
160667983|NCT02294786|580165322|FG001|Overall Study|Death|3|||
160667984|NCT01778010|580165323|FG000|Overall Study|Withdrawal by Subject|2|||
160667985|NCT01778010|580165323|FG000|Overall Study|abnormal ECG before meds|1|||
160667986|NCT01778010|580165323|FG000|Overall Study|Arrested|1|||
160667987|NCT01778010|580165323|FG000|Overall Study|rash while on placebo|1|||
160667988|NCT02159183|580165326|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
160667989|NCT02159183|580165327|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
160667990|NCT02159183|580165326|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
160667991|NCT02159183|580165327|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
160667992|NCT02159183|580165326|FG000|Analysis After the 36 Months Follow-up|Death|0|||
160667993|NCT02159183|580165327|FG001|Analysis After the 36 Months Follow-up|Death|1|||
160667994|NCT02159183|580165326|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
160667995|NCT02159183|580165327|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
160667996|NCT02159183|580165326|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
160667997|NCT02159183|580165327|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
160667998|NCT03406156|580165329|FG000|Overall Study|Death|9|||
160667999|NCT03406156|580165330|FG001|Overall Study|Death|3|||
160668000|NCT03406156|580165329|FG000|Overall Study|Withdrawal by Subject|1|||
160668001|NCT03406156|580165330|FG001|Overall Study|Withdrawal by Subject|2|||
160668002|NCT03406156|580165329|FG000|Overall Study|COVID-19 infection|1|||
160668003|NCT03406156|580165330|FG001|Overall Study|COVID-19 infection|0|||
160668004|NCT03406156|580165329|FG000|Overall Study|Non-compliance with study procedures|1|||
160668005|NCT03406156|580165330|FG001|Overall Study|Non-compliance with study procedures|1|||
160668006|NCT03406156|580165329|FG000|Overall Study|Lost to Follow-up|0|||
160668007|NCT03406156|580165330|FG001|Overall Study|Lost to Follow-up|2|||
160668008|NCT03406156|580165329|FG000|Overall Study|Other, not specified|72|||
160668009|NCT03406156|580165330|FG001|Overall Study|Other, not specified|28|||
160668010|NCT05479058|580165333|FG000|Overall Study|Withdrawal by Subject|1|||
160668011|NCT05479058|580165334|FG001|Overall Study|Withdrawal by Subject|1|||
160668012|NCT05479058|580165333|FG000|Overall Study|Study terminated by sponsor|10|||
160668013|NCT05479058|580165334|FG001|Overall Study|Study terminated by sponsor|10|||
160668014|NCT05630885|580165335|FG000|Study Completion|Took prohibited medications|2|||
160668015|NCT05630885|580165336|FG001|Study Completion|Took prohibited medications|0|||
160668016|NCT05630885|580165335|FG000|Study Completion|Non-compliance with study drug|1|||
160668017|NCT05630885|580165336|FG001|Study Completion|Non-compliance with study drug|0|||
160668018|NCT05630885|580165335|FG000|Study Completion|Adverse Event|1|||
160668019|NCT05630885|580165336|FG001|Study Completion|Adverse Event|0|||
160668020|NCT05630885|580165335|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
160668021|NCT05630885|580165336|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
160668022|NCT05630885|580165335|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
160668023|NCT05630885|580165336|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
160668024|NCT03419403|580165339|FG000|Overall Study|Withdrawal by Subject|5|||
160668025|NCT03419403|580165340|FG001|Overall Study|Withdrawal by Subject|2|||
160668026|NCT03419403|580165341|FG002|Overall Study|Withdrawal by Subject|5|||
160668027|NCT03419403|580165342|FG003|Overall Study|Withdrawal by Subject|1|||
160668028|NCT03419403|580165339|FG000|Overall Study|Progressive disease (per protocol)|0|||
160668029|NCT03419403|580165340|FG001|Overall Study|Progressive disease (per protocol)|2|||
160668030|NCT03419403|580165341|FG002|Overall Study|Progressive disease (per protocol)|2|||
160668031|NCT03419403|580165342|FG003|Overall Study|Progressive disease (per protocol)|0|||
160668032|NCT03419403|580165339|FG000|Overall Study|Other, not specified|6|||
160668033|NCT03419403|580165340|FG001|Overall Study|Other, not specified|4|||
160668034|NCT03419403|580165341|FG002|Overall Study|Other, not specified|5|||
160668035|NCT03419403|580165342|FG003|Overall Study|Other, not specified|1|||
160668036|NCT03419403|580165339|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
160668037|NCT03419403|580165340|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
160668038|NCT03419403|580165341|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
160668039|NCT03419403|580165342|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
160668040|NCT00505622|580165345|FG000|Overall Study|Adverse Event|5|||
160668041|NCT00505622|580165346|FG001|Overall Study|Adverse Event|6|||
160668042|NCT00505622|580165347|FG002|Overall Study|Adverse Event|4|||
160668043|NCT00505622|580165345|FG000|Overall Study|Protocol Violation|1|||
160668044|NCT00505622|580165346|FG001|Overall Study|Protocol Violation|1|||
160668045|NCT00505622|580165347|FG002|Overall Study|Protocol Violation|0|||
160668046|NCT00505622|580165345|FG000|Overall Study|Withdrawal by Subject|0|||
160668047|NCT00505622|580165346|FG001|Overall Study|Withdrawal by Subject|3|||
160668048|NCT00505622|580165347|FG002|Overall Study|Withdrawal by Subject|2|||
160668049|NCT00505622|580165345|FG000|Overall Study|Study termination by sponsor|115|||
160668050|NCT00505622|580165346|FG001|Overall Study|Study termination by sponsor|98|||
160668051|NCT00505622|580165347|FG002|Overall Study|Study termination by sponsor|90|||
160668052|NCT03084471|580165350|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
160668053|NCT03084471|580165350|FG000|Overall Study|Condition under investigation worsened|84|||
160668054|NCT03084471|580165350|FG000|Overall Study|Lack of therapeutic response|2|||
160668055|NCT03084471|580165350|FG000|Overall Study|Protocol Violation|1|||
160668056|NCT03084471|580165350|FG000|Overall Study|Adverse Event|73|||
160668057|NCT03084471|580165350|FG000|Overall Study|Withdrawal by Subject|12|||
160668058|NCT03084471|580165350|FG000|Overall Study|Disease relapse|181|||
160668059|NCT03084471|580165350|FG000|Overall Study|Subjective disease progression|359|||
160668060|NCT03084471|580165350|FG000|Overall Study|Other (as recorded)|33|||
160668061|NCT03084471|580165350|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
160668062|NCT02414152|580165353|FG000|Overall Study|Withdrawal by Subject|1|||
160668063|NCT02414152|580165353|FG000|Overall Study|Lack of Efficacy|1|||
160668064|NCT01757392|580165354|FG000|Overall Study|Withdrawal by Subject|1|||
160668065|NCT01757392|580165354|FG000|Overall Study|Screen Fail|3|||
160668066|NCT00841698|580165359|FG000|First Intervention|Withdrawal by Subject|1|||
160668067|NCT00841698|580165360|FG001|First Intervention|Withdrawal by Subject|0|||
160668068|NCT04078022|580165365|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
160668069|NCT04078022|580165366|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
160668070|NCT01250912|580165367|FG000|Overall Study|Lost to Follow-up|1|||
160668071|NCT04825275|580167700|FG000|Overall Study|Withdrawal by Subject|1|||
160668072|NCT04825275|580167701|FG001|Overall Study|Withdrawal by Subject|0|||
160668073|NCT02566850|580167705|FG000|Overall Study|Protocol Violation|1|||
160668074|NCT06298396|580167708|FG000|Default MAP|Protocol Violation|1|||
160668075|NCT06137781|580167709|FG000|Baseline measurements|Lost to Follow-up|2|||
160518638|NCT02457559|579627135|FG004|Overall Study|Reason not Specified|0|||
160518639|NCT02457559|579627136|FG005|Overall Study|Reason not Specified|0|||
160518640|NCT02457559|579627137|FG006|Overall Study|Reason not Specified|0|||
160518641|NCT02457559|579627138|FG007|Overall Study|Reason not Specified|0|||
160518642|NCT02457559|579627139|FG008|Overall Study|Reason not Specified|0|||
160518643|NCT02457559|579627140|FG009|Overall Study|Reason not Specified|2|||
160518644|NCT02457559|579627141|FG010|Overall Study|Reason not Specified|0|||
160668076|NCT06137781|580167709|FG000|Baseline measurements|Withdrawal by Subject|1|||
160668077|NCT06137781|580167709|FG000|Baseline measurements|Expedited surgery|1|||
160668078|NCT06137781|580167709|FG000|Intervention period|Lost to Follow-up|2|||
160668079|NCT06137781|580167709|FG000|Intervention period|Withdrawal by Subject|3|||
160668080|NCT06137781|580167709|FG000|Intervention period|Expedited surgery|1|||
160668081|NCT06137781|580167709|FG000|Intervention period|Adverse Event|1|||
160518645|NCT02457559|579627131|FG000|Overall Study|Death|0|||
160518646|NCT02457559|579627132|FG001|Overall Study|Death|0|||
160518647|NCT02457559|579627133|FG002|Overall Study|Death|0|||
160668082|NCT05005442|580167710|FG000|Overall Study|Death|14|||
160668083|NCT05005442|580167711|FG001|Overall Study|Death|10|||
160668084|NCT05005442|580167712|FG002|Overall Study|Death|8|||
160668085|NCT05005442|580167713|FG003|Overall Study|Death|22|||
160668086|NCT05005442|580167714|FG004|Overall Study|Death|13|||
160668087|NCT05005442|580167715|FG005|Overall Study|Death|15|||
160668088|NCT05005442|580167710|FG000|Overall Study|Lost to Follow-up|0|||
160668089|NCT05005442|580167711|FG001|Overall Study|Lost to Follow-up|2|||
160668090|NCT05005442|580167712|FG002|Overall Study|Lost to Follow-up|0|||
160668091|NCT05005442|580167713|FG003|Overall Study|Lost to Follow-up|0|||
160668092|NCT05005442|580167714|FG004|Overall Study|Lost to Follow-up|1|||
160518648|NCT02457559|579627134|FG003|Overall Study|Death|0|||
160518649|NCT02457559|579627135|FG004|Overall Study|Death|0|||
160518650|NCT02457559|579627136|FG005|Overall Study|Death|0|||
160518651|NCT02457559|579627137|FG006|Overall Study|Death|0|||
160518652|NCT02457559|579627138|FG007|Overall Study|Death|0|||
160518653|NCT02457559|579627139|FG008|Overall Study|Death|1|||
160518654|NCT02457559|579627140|FG009|Overall Study|Death|1|||
160518655|NCT02457559|579627141|FG010|Overall Study|Death|0|||
160518656|NCT05590884|579627142|FG000|Overall Study|Withdrawal by Subject|1|||
160518657|NCT05590884|579627143|FG001|Overall Study|Withdrawal by Subject|0|||
160518658|NCT05590884|579627144|FG002|Overall Study|Withdrawal by Subject|0|||
160518659|NCT04134845|579627154|FG000|Overall Study|withdrawl by PI|12|||
160518660|NCT04134845|579627155|FG001|Overall Study|withdrawl by PI|5|||
160518661|NCT03110224|579627156|FG000|Overall Study|Death|3|||
160518662|NCT03110224|579627156|FG000|Overall Study|Lost to Follow-up|132|||
160518663|NCT03110224|579627156|FG000|Overall Study|Physician Decision|2|||
160518664|NCT03110224|579627156|FG000|Overall Study|Site Closed by Physician|35|||
160518665|NCT03110224|579627156|FG000|Overall Study|Site Closed by Sponsor|202|||
160518666|NCT03110224|579627156|FG000|Overall Study|Withdrawal by Subject|9|||
160518667|NCT05195489|579629107|FG000|Overall Study|Lost to Follow-up|1|||
160518668|NCT05195489|579629108|FG001|Overall Study|Lost to Follow-up|0|||
160518669|NCT05195489|579629107|FG000|Overall Study|Protocol Violation|0|||
160518670|NCT05195489|579629108|FG001|Overall Study|Protocol Violation|2|||
160518671|NCT05195489|579629107|FG000|Overall Study|Withdrawal by Subject|1|||
160518672|NCT05195489|579629108|FG001|Overall Study|Withdrawal by Subject|1|||
160518673|NCT05195489|579629107|FG000|Overall Study|Removed|0|||
160518674|NCT05195489|579629108|FG001|Overall Study|Removed|1|||
160518675|NCT00409773|579629110|FG000|Overall Study|Adverse Event|3|||
160518676|NCT00409773|579629111|FG001|Overall Study|Adverse Event|4|||
160518677|NCT00409773|579629112|FG002|Overall Study|Adverse Event|4|||
160518678|NCT00409773|579629113|FG003|Overall Study|Adverse Event|2|||
160518679|NCT00409773|579629114|FG004|Overall Study|Adverse Event|6|||
160518680|NCT00409773|579629110|FG000|Overall Study|Lost to Follow-up|6|||
160518681|NCT00409773|579629111|FG001|Overall Study|Lost to Follow-up|1|||
160518682|NCT00409773|579629112|FG002|Overall Study|Lost to Follow-up|2|||
160518683|NCT00409773|579629113|FG003|Overall Study|Lost to Follow-up|3|||
160518684|NCT00409773|579629114|FG004|Overall Study|Lost to Follow-up|1|||
160518685|NCT00409773|579629110|FG000|Overall Study|Physician Decision|0|||
160518686|NCT00409773|579629111|FG001|Overall Study|Physician Decision|0|||
160518687|NCT00409773|579629112|FG002|Overall Study|Physician Decision|0|||
160518688|NCT00409773|579629113|FG003|Overall Study|Physician Decision|2|||
160518689|NCT00409773|579629114|FG004|Overall Study|Physician Decision|0|||
160518690|NCT00409773|579629110|FG000|Overall Study|Protocol Violation|0|||
160518691|NCT00409773|579629111|FG001|Overall Study|Protocol Violation|2|||
160518692|NCT00409773|579629112|FG002|Overall Study|Protocol Violation|3|||
160518693|NCT00409773|579629113|FG003|Overall Study|Protocol Violation|3|||
160518694|NCT00409773|579629114|FG004|Overall Study|Protocol Violation|1|||
160518695|NCT00409773|579629110|FG000|Overall Study|Withdrawal by Subject|0|||
160518696|NCT00409773|579629111|FG001|Overall Study|Withdrawal by Subject|0|||
160518697|NCT00409773|579629112|FG002|Overall Study|Withdrawal by Subject|0|||
160518698|NCT00409773|579629113|FG003|Overall Study|Withdrawal by Subject|2|||
160518699|NCT00409773|579629114|FG004|Overall Study|Withdrawal by Subject|1|||
160518700|NCT00409773|579629110|FG000|Overall Study|Lack of Eligibility|0|||
160518701|NCT00409773|579629111|FG001|Overall Study|Lack of Eligibility|0|||
160518702|NCT00409773|579629112|FG002|Overall Study|Lack of Eligibility|0|||
160518703|NCT00409773|579629113|FG003|Overall Study|Lack of Eligibility|0|||
160518704|NCT00409773|579629114|FG004|Overall Study|Lack of Eligibility|1|||
160518705|NCT01201343|579629115|FG000|Overall Study|Adverse Event|6|||
160624614|NCT04246593|580005481|FG000|Overall Study|Moved out of area/became ineligible|3|||
160624615|NCT04246593|580005482|FG001|Overall Study|Moved out of area/became ineligible|1|||
160624616|NCT04246593|580005481|FG000|Overall Study|Reason unknown|4|||
160518706|NCT01201343|579629115|FG000|Overall Study|Withdrawal by Subject|5|||
160518707|NCT01201343|579629115|FG000|Overall Study|Lost to Follow-up|2|||
160518708|NCT01201343|579629115|FG000|Overall Study|Lack of Efficacy|2|||
160518709|NCT01201343|579629115|FG000|Overall Study|Participant wrongly included in trial|1|||
160518710|NCT01201343|579629115|FG000|Overall Study|Randomized, not treated|3|||
160518711|NCT01440374|579629116|FG000|Part 1: Open-label Phase|Adverse Event|5|||
160518712|NCT01440374|579629117|FG001|Part 1: Open-label Phase|Adverse Event|0|||
160518713|NCT01440374|579629118|FG002|Part 1: Open-label Phase|Adverse Event|0|||
160518714|NCT01440374|579629119|FG003|Part 1: Open-label Phase|Adverse Event|0|||
160518715|NCT01440374|579629116|FG000|Part 1: Open-label Phase|Physician Decision|1|||
160518716|NCT01440374|579629117|FG001|Part 1: Open-label Phase|Physician Decision|0|||
160518717|NCT01440374|579629118|FG002|Part 1: Open-label Phase|Physician Decision|0|||
160624617|NCT04246593|580005482|FG001|Overall Study|Reason unknown|2|||
160518718|NCT01440374|579629119|FG003|Part 1: Open-label Phase|Physician Decision|0|||
160518719|NCT01440374|579629116|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
160518720|NCT01440374|579629117|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
160518721|NCT01440374|579629118|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
160518722|NCT01440374|579629119|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
160518723|NCT01440374|579629116|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
160518724|NCT01440374|579629117|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
160518725|NCT01440374|579629118|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
160518726|NCT01440374|579629119|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
160518727|NCT01440374|579629116|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
160518728|NCT01440374|579629117|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
160518729|NCT01440374|579629118|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
160518730|NCT01440374|579629119|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
160518731|NCT01440374|579629116|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
160518732|NCT01440374|579629117|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
160518733|NCT01440374|579629118|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
160518734|NCT01440374|579629119|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
160518735|NCT01440374|579629116|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
160518736|NCT01440374|579629117|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
160518737|NCT01440374|579629118|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
160518738|NCT01440374|579629119|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
160518739|NCT01440374|579629116|FG000|Part 2; Double-blind Phase|Not treated|0|||
160518740|NCT01440374|579629117|FG001|Part 2; Double-blind Phase|Not treated|0|||
160518741|NCT01440374|579629118|FG002|Part 2; Double-blind Phase|Not treated|1|||
160518742|NCT01440374|579629119|FG003|Part 2; Double-blind Phase|Not treated|0|||
160518743|NCT01440374|579629116|FG000|Part 3: Extension|Withdrawal by Subject|0|||
160518744|NCT01440374|579629117|FG001|Part 3: Extension|Withdrawal by Subject|0|||
160518745|NCT01440374|579629118|FG002|Part 3: Extension|Withdrawal by Subject|0|||
160518746|NCT01440374|579629119|FG003|Part 3: Extension|Withdrawal by Subject|5|||
160518747|NCT01440374|579629116|FG000|Part 3: Extension|Adverse Event|0|||
160518748|NCT01440374|579629117|FG001|Part 3: Extension|Adverse Event|0|||
160518749|NCT01440374|579629118|FG002|Part 3: Extension|Adverse Event|0|||
160518750|NCT01440374|579629119|FG003|Part 3: Extension|Adverse Event|13|||
160518751|NCT01440374|579629116|FG000|Part 3: Extension|Physician Decision|0|||
160518752|NCT01440374|579629117|FG001|Part 3: Extension|Physician Decision|0|||
160518753|NCT01440374|579629118|FG002|Part 3: Extension|Physician Decision|0|||
160518754|NCT01440374|579629119|FG003|Part 3: Extension|Physician Decision|14|||
160518755|NCT04812548|579629121|FG000|Overall Study|Adverse Event|2|||
160518756|NCT04812548|579629122|FG001|Overall Study|Adverse Event|7|||
160518757|NCT04812548|579629121|FG000|Overall Study|HSCT Planned|2|||
160518758|NCT04812548|579629122|FG001|Overall Study|HSCT Planned|3|||
160518759|NCT04812548|579629121|FG000|Overall Study|Progressive Disease|0|||
160518760|NCT04812548|579629122|FG001|Overall Study|Progressive Disease|2|||
160518761|NCT04812548|579629121|FG000|Overall Study|Death|0|||
160518762|NCT04812548|579629122|FG001|Overall Study|Death|1|||
160518763|NCT04812548|579629121|FG000|Overall Study|Post Study Access to Treatment|0|||
160518764|NCT04812548|579629122|FG001|Overall Study|Post Study Access to Treatment|1|||
160518765|NCT04812548|579629121|FG000|Overall Study|Withdrawal by Subject|0|||
160518766|NCT04812548|579629122|FG001|Overall Study|Withdrawal by Subject|1|||
160518767|NCT04812548|579629121|FG000|Overall Study|Physician Decision|1|||
160518768|NCT04812548|579629122|FG001|Overall Study|Physician Decision|0|||
160518769|NCT02141984|579629123|FG000|Overall Study|Lack of Efficacy|2|||
160518770|NCT02079610|579629124|FG000|Overall Study|Withdrawal by Subject|1|||
160518771|NCT02079610|579629125|FG001|Overall Study|Withdrawal by Subject|1|||
160518772|NCT01716117|579629126|FG000|Overall Study|Death|5|||
160518773|NCT01716117|579629127|FG001|Overall Study|Death|2|||
160518774|NCT01716117|579629126|FG000|Overall Study|Withdrawal by Subject|2|||
160518775|NCT01716117|579629127|FG001|Overall Study|Withdrawal by Subject|0|||
160518776|NCT03645057|579629129|FG000|Randomization to Baseline|Lost to Follow-up|1|||
160518777|NCT03645057|579629130|FG001|Randomization to Baseline|Lost to Follow-up|0|||
160518778|NCT03645057|579629131|FG002|Randomization to Baseline|Lost to Follow-up|1|||
160518779|NCT03645057|579629132|FG003|Randomization to Baseline|Lost to Follow-up|0|||
160518780|NCT03645057|579629129|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
160518781|NCT03645057|579629130|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
160518782|NCT03645057|579629131|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
160518783|NCT03645057|579629132|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
160518784|NCT03645057|579629129|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
160518785|NCT03645057|579629130|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
160518786|NCT03645057|579629131|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
160518787|NCT03645057|579629132|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
160518788|NCT03645057|579629129|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
160518789|NCT03645057|579629130|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
160518790|NCT03645057|579629131|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
160518791|NCT03645057|579629132|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
160518792|NCT01171807|579629133|FG000|Overall Study|Treatment failure|2|||
160518793|NCT01171807|579629134|FG001|Overall Study|Treatment failure|4|||
160518794|NCT01171807|579629133|FG000|Overall Study|Non compliance|1|||
160518795|NCT01171807|579629134|FG001|Overall Study|Non compliance|0|||
160518796|NCT01171807|579629133|FG000|Overall Study|Lost to Follow-up|3|||
160518797|NCT01171807|579629134|FG001|Overall Study|Lost to Follow-up|0|||
160668093|NCT05005442|580167715|FG005|Overall Study|Lost to Follow-up|0|||
160668094|NCT05005442|580167710|FG000|Overall Study|Physician Decision|0|||
160668095|NCT05005442|580167711|FG001|Overall Study|Physician Decision|0|||
160668096|NCT05005442|580167712|FG002|Overall Study|Physician Decision|1|||
160668097|NCT05005442|580167713|FG003|Overall Study|Physician Decision|0|||
160668098|NCT05005442|580167714|FG004|Overall Study|Physician Decision|2|||
160668099|NCT05005442|580167715|FG005|Overall Study|Physician Decision|0|||
160668100|NCT05005442|580167710|FG000|Overall Study|Sponsor decision|26|||
160668101|NCT05005442|580167711|FG001|Overall Study|Sponsor decision|26|||
160668102|NCT05005442|580167712|FG002|Overall Study|Sponsor decision|10|||
160668103|NCT05005442|580167713|FG003|Overall Study|Sponsor decision|5|||
160668104|NCT05005442|580167714|FG004|Overall Study|Sponsor decision|9|||
160668105|NCT05005442|580167715|FG005|Overall Study|Sponsor decision|12|||
160668106|NCT05005442|580167710|FG000|Overall Study|Withdrawal by Subject|2|||
160668107|NCT05005442|580167711|FG001|Overall Study|Withdrawal by Subject|2|||
160668108|NCT05005442|580167712|FG002|Overall Study|Withdrawal by Subject|1|||
160668109|NCT05005442|580167713|FG003|Overall Study|Withdrawal by Subject|3|||
160668110|NCT05005442|580167714|FG004|Overall Study|Withdrawal by Subject|0|||
160668111|NCT05005442|580167715|FG005|Overall Study|Withdrawal by Subject|5|||
160668112|NCT05005442|580167710|FG000|Overall Study|Site terminated by sponsor|0|||
160668113|NCT05005442|580167711|FG001|Overall Study|Site terminated by sponsor|2|||
160668114|NCT05005442|580167712|FG002|Overall Study|Site terminated by sponsor|0|||
160668115|NCT05005442|580167713|FG003|Overall Study|Site terminated by sponsor|0|||
160668116|NCT05005442|580167714|FG004|Overall Study|Site terminated by sponsor|0|||
160668117|NCT05005442|580167715|FG005|Overall Study|Site terminated by sponsor|1|||
160668118|NCT03696160|580167722|FG000|Overall Study|Withdrew before IMP dosing|2|||
160668119|NCT03696160|580167723|FG001|Overall Study|Withdrew before IMP dosing|3|||
160668120|NCT00334815|580167724|FG000|Overall Study|Adverse Event|3|||
160668121|NCT00334815|580167725|FG001|Overall Study|Adverse Event|2|||
160668122|NCT00334815|580167724|FG000|Overall Study|Death|0|||
160668123|NCT00334815|580167725|FG001|Overall Study|Death|2|||
160668124|NCT00334815|580167724|FG000|Overall Study|Progression|1|||
160668125|NCT00334815|580167725|FG001|Overall Study|Progression|0|||
160668126|NCT00334815|580167724|FG000|Overall Study|ineligible|1|||
160668127|NCT00334815|580167725|FG001|Overall Study|ineligible|1|||
160518798|NCT01901341|579629135|FG000|Overall Study|Adverse Event|4|||
160518799|NCT01901341|579629136|FG001|Overall Study|Adverse Event|2|||
160518800|NCT01901341|579629135|FG000|Overall Study|Lack of Efficacy|0|||
160518801|NCT01901341|579629136|FG001|Overall Study|Lack of Efficacy|2|||
160518802|NCT01901341|579629135|FG000|Overall Study|Lost to Follow-up|0|||
160518803|NCT01901341|579629136|FG001|Overall Study|Lost to Follow-up|1|||
160518804|NCT01901341|579629135|FG000|Overall Study|Protocol Violation|2|||
160518805|NCT01901341|579629136|FG001|Overall Study|Protocol Violation|0|||
160518806|NCT01901341|579629135|FG000|Overall Study|Study Terminated by Sponsor|13|||
160668128|NCT00334815|580167724|FG000|Overall Study|patient refused treatment|0|||
160668129|NCT00334815|580167725|FG001|Overall Study|patient refused treatment|1|||
160668130|NCT00334815|580167724|FG000|Overall Study|Physician Decision|2|||
160668131|NCT00334815|580167725|FG001|Overall Study|Physician Decision|4|||
160668132|NCT04970810|580167726|FG000|Overall Study|deemed ineligible after randomization|3|||
160668133|NCT04970810|580167727|FG001|Overall Study|deemed ineligible after randomization|0|||
160668134|NCT04970810|580167728|FG002|Overall Study|deemed ineligible after randomization|4|||
160668135|NCT04742491|580167731|FG000|Overall Study|Death|2|||
160668136|NCT04742491|580167732|FG001|Overall Study|Death|0|||
160668137|NCT04742491|580167731|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
160668138|NCT04742491|580167732|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
160668139|NCT04742491|580167731|FG000|Overall Study|Lost to Follow-up|6|||
160518807|NCT01901341|579629136|FG001|Overall Study|Study Terminated by Sponsor|15|||
160518808|NCT01901341|579629135|FG000|Overall Study|Withdrawal by Subject|1|||
160518809|NCT01901341|579629136|FG001|Overall Study|Withdrawal by Subject|1|||
160518810|NCT00250679|579629137|FG000|Overall Study|Adverse Event|12|||
160518811|NCT00250679|579629138|FG001|Overall Study|Adverse Event|15|||
160518812|NCT00250679|579629139|FG002|Overall Study|Adverse Event|16|||
160518813|NCT00250679|579629137|FG000|Overall Study|Protocol Violation|2|||
160518814|NCT00250679|579629138|FG001|Overall Study|Protocol Violation|4|||
160518815|NCT00250679|579629139|FG002|Overall Study|Protocol Violation|3|||
160668140|NCT04742491|580167732|FG001|Overall Study|Lost to Follow-up|8|||
160668141|NCT04742491|580167731|FG000|Overall Study|Withdrawal by Subject|4|||
160668142|NCT04742491|580167732|FG001|Overall Study|Withdrawal by Subject|2|||
160668143|NCT04742491|580167731|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
160668144|NCT04742491|580167732|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
160668145|NCT04742491|580167731|FG000|Overall Study|Participant refused further participation|2|||
160668146|NCT04742491|580167732|FG001|Overall Study|Participant refused further participation|7|||
160518816|NCT00250679|579629137|FG000|Overall Study|Withdrawal by Subject|15|||
160518817|NCT00250679|579629138|FG001|Overall Study|Withdrawal by Subject|18|||
160518818|NCT00250679|579629139|FG002|Overall Study|Withdrawal by Subject|15|||
160518819|NCT00250679|579629137|FG000|Overall Study|Lost to Follow-up|3|||
160518820|NCT00250679|579629138|FG001|Overall Study|Lost to Follow-up|4|||
160518821|NCT00250679|579629139|FG002|Overall Study|Lost to Follow-up|2|||
160518822|NCT00250679|579629137|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
160518823|NCT00250679|579629138|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
160518824|NCT00250679|579629139|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
160518825|NCT00250679|579629137|FG000|Overall Study|Lack of Efficacy|0|||
160518826|NCT00250679|579629138|FG001|Overall Study|Lack of Efficacy|1|||
160518827|NCT00250679|579629139|FG002|Overall Study|Lack of Efficacy|3|||
160668147|NCT04742491|580167731|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
160668148|NCT04742491|580167732|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
160668149|NCT04742491|580167731|FG000|Overall Study|Other reasons|3|||
160668150|NCT04742491|580167732|FG001|Overall Study|Other reasons|4|||
160668151|NCT03317899|580167736|FG000|Overall Study|Death|6|||
160668152|NCT03317899|580167737|FG001|Overall Study|Death|9|||
160668153|NCT00933686|580167738|FG000|Overall Study|Protocol Violation|0|||
160668154|NCT00933686|580167739|FG001|Overall Study|Protocol Violation|1|||
160668155|NCT00933686|580167738|FG000|Overall Study|Lost to Follow-up|2|||
160668156|NCT00933686|580167739|FG001|Overall Study|Lost to Follow-up|2|||
160668157|NCT00933686|580167738|FG000|Overall Study|Withdrawal by Subject|6|||
160668158|NCT00933686|580167739|FG001|Overall Study|Withdrawal by Subject|5|||
160668159|NCT00933686|580167738|FG000|Overall Study|Adverse Event|1|||
160668160|NCT00933686|580167739|FG001|Overall Study|Adverse Event|1|||
160668161|NCT00933686|580167738|FG000|Overall Study|Physician Decision|1|||
160668162|NCT00933686|580167739|FG001|Overall Study|Physician Decision|0|||
160668163|NCT00933686|580167738|FG000|Overall Study|Failure to show up at endpoint visits|0|||
160668164|NCT00933686|580167739|FG001|Overall Study|Failure to show up at endpoint visits|2|||
160668165|NCT01244620|580167742|FG000|Overall Study|Study terminated|4|||
160668166|NCT01244620|580167743|FG001|Overall Study|Study terminated|4|||
160668167|NCT01244620|580167744|FG002|Overall Study|Study terminated|4|||
160668168|NCT01244620|580167745|FG003|Overall Study|Study terminated|4|||
160668169|NCT02321098|580167746|FG000|12 Weeks Treament|Lost to Follow-up|1|||
160668170|NCT02321098|580167747|FG001|12 Weeks Treament|Lost to Follow-up|1|||
160668171|NCT02321098|580167748|FG002|12 Weeks Treament|Lost to Follow-up|0|||
160668172|NCT02321098|580167746|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
160668173|NCT02321098|580167747|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
160668174|NCT02321098|580167748|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
160668175|NCT02321098|580167746|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
160668176|NCT02321098|580167747|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
160668177|NCT02321098|580167748|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
160668178|NCT02321098|580167746|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
160668179|NCT02321098|580167747|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
160668180|NCT02321098|580167748|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
160668181|NCT01663233|580167749|FG000|Overall Study|Withdrawal by Subject|3|||
160668182|NCT01663233|580167750|FG001|Overall Study|Withdrawal by Subject|2|||
160668183|NCT01663233|580167749|FG000|Overall Study|Protocol Deviation|1|||
160668184|NCT01663233|580167750|FG001|Overall Study|Protocol Deviation|4|||
160668185|NCT01663233|580167749|FG000|Overall Study|Lost to Follow-up|0|||
160668186|NCT01663233|580167750|FG001|Overall Study|Lost to Follow-up|1|||
160668187|NCT00796328|580167753|FG000|Overall Study|experienced hypotension requiring tx|6|||
160668188|NCT03261167|580167754|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
160668189|NCT03261167|580167755|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
160668190|NCT03261167|580167754|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
160668191|NCT03261167|580167755|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
160668192|NCT03261167|580167754|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
160518828|NCT00250679|579629137|FG000|Overall Study|Technical Holter issues|1|||
160518829|NCT00250679|579629138|FG001|Overall Study|Technical Holter issues|0|||
160518830|NCT00250679|579629139|FG002|Overall Study|Technical Holter issues|2|||
160518831|NCT00250679|579629137|FG000|Overall Study|Moved|1|||
160668193|NCT03261167|580167755|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
160668194|NCT03261167|580167754|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
160668195|NCT03261167|580167755|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
160668196|NCT03261167|580167754|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
160668197|NCT03261167|580167755|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
160668198|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Adverse Event|11|||
160668199|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Adverse Event|23|||
160668200|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Adverse Event|29|||
160668201|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Adverse Event|2|||
160518832|NCT00250679|579629138|FG001|Overall Study|Moved|1|||
160518833|NCT00250679|579629139|FG002|Overall Study|Moved|0|||
160518834|NCT00250679|579629137|FG000|Overall Study|Non-compliance|1|||
160668202|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Adverse Event|8|||
160668203|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
160668204|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
160668205|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
160518835|NCT00250679|579629138|FG001|Overall Study|Non-compliance|1|||
160668206|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
160668207|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
160668208|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
160668209|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
160668210|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
160668211|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
160668212|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
160668213|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
160668214|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
160668215|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
160668216|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
160668217|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
160668218|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
160668219|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
160668220|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
160518836|NCT00250679|579629139|FG002|Overall Study|Non-compliance|0|||
160518837|NCT00250679|579629137|FG000|Overall Study|various single events: hip surgery,diary|3|||
160518838|NCT00250679|579629138|FG001|Overall Study|various single events: hip surgery,diary|1|||
160518839|NCT00250679|579629139|FG002|Overall Study|various single events: hip surgery,diary|1|||
160518840|NCT00448279|579629140|FG000|Overall Study|Lost to Follow-up|2|||
160518841|NCT00448279|579629141|FG001|Overall Study|Lost to Follow-up|2|||
160518842|NCT00448279|579629140|FG000|Overall Study|Adverse Event|1|||
160518843|NCT00448279|579629141|FG001|Overall Study|Adverse Event|1|||
160518844|NCT00448279|579629140|FG000|Overall Study|Disease progression|16|||
160518845|NCT00448279|579629141|FG001|Overall Study|Disease progression|18|||
160518846|NCT00448279|579629140|FG000|Overall Study|Withdrawal by Subject|4|||
160518847|NCT00448279|579629141|FG001|Overall Study|Withdrawal by Subject|3|||
160518848|NCT00448279|579629140|FG000|Overall Study|Other|6|||
160518849|NCT00448279|579629141|FG001|Overall Study|Other|4|||
160518850|NCT00448279|579629140|FG000|Overall Study|Protocol Violation|0|||
160518851|NCT00448279|579629141|FG001|Overall Study|Protocol Violation|1|||
160518852|NCT03907410|579629142|FG000|Overall Study|Lost to Follow-up|4|||
160518853|NCT03907410|579629143|FG001|Overall Study|Lost to Follow-up|1|||
160518854|NCT03907410|579629144|FG002|Overall Study|Lost to Follow-up|1|||
160518855|NCT03907410|579629142|FG000|Overall Study|Lost to follow-up and research burden|0|||
160518856|NCT03907410|579629143|FG001|Overall Study|Lost to follow-up and research burden|0|||
160518857|NCT03907410|579629144|FG002|Overall Study|Lost to follow-up and research burden|1|||
160518858|NCT00757588|579629145|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
160518859|NCT00757588|579629146|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
160518860|NCT00757588|579629145|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
160518861|NCT00757588|579629146|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
160518862|NCT00757588|579629145|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
160518863|NCT00757588|579629146|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
160518864|NCT00757588|579629145|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
160518865|NCT00757588|579629146|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
160518866|NCT00757588|579629145|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
160518867|NCT00757588|579629146|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
160518868|NCT00757588|579629145|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
160518869|NCT00757588|579629146|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
160518870|NCT00757588|579629145|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
160518871|NCT00757588|579629146|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
160518872|NCT00757588|579629145|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
160518873|NCT00757588|579629146|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
160518874|NCT00757588|579629145|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
160518875|NCT00757588|579629146|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
160518876|NCT00757588|579629145|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
160518877|NCT00757588|579629146|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
160518878|NCT00757588|579629145|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
160518879|NCT00757588|579629146|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
160518880|NCT00757588|579629145|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
160518881|NCT00757588|579629146|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
160518882|NCT00757588|579629145|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
160518883|NCT00757588|579629146|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
160668221|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
160668222|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
160668223|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
160668224|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
160518884|NCT00757588|579629145|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
160518885|NCT00757588|579629146|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
160668225|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
160668226|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
160668227|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
160668228|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
160668229|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
160668230|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
160668231|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
160668232|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
160668233|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Move|0|||
160668234|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Move|1|||
160668235|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Move|0|||
160668236|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Move|0|||
160668237|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Move|0|||
160668238|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
160668239|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
160668240|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
160668241|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
160668242|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
160668243|NCT00318461|580167764|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
160668244|NCT00318461|580167765|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
160668245|NCT00318461|580167766|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
160668246|NCT00318461|580167767|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
160668247|NCT00318461|580167768|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
160668248|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Work commitment|0|||
160668249|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Work commitment|0|||
160668250|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Work commitment|0|||
160668251|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Work commitment|0|||
160668252|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Work commitment|1|||
160668253|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Investigator decision|0|||
160668254|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Investigator decision|0|||
160668255|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Investigator decision|0|||
160668256|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Investigator decision|0|||
160668257|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Investigator decision|1|||
160668258|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Lack of time|1|||
160668259|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Lack of time|0|||
160668260|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Lack of time|0|||
160668261|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Lack of time|0|||
160668262|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Lack of time|0|||
160668263|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
160668264|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
160668265|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
160668266|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
160668267|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
160668268|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
160668269|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
160668270|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
160668271|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
160668272|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
160668273|NCT00318461|580167764|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
160668274|NCT00318461|580167765|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
160668275|NCT00318461|580167766|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
160668276|NCT00318461|580167767|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
160668277|NCT00318461|580167768|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
160668278|NCT00318461|580167764|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
160668279|NCT00318461|580167765|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
160668280|NCT00318461|580167766|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
160668281|NCT00318461|580167767|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
160668282|NCT00318461|580167768|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
160668283|NCT00318461|580167764|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
160668284|NCT00318461|580167765|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
160668285|NCT00318461|580167766|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
160668286|NCT00318461|580167767|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
160668287|NCT00318461|580167768|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
160668288|NCT00318461|580167764|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
160668289|NCT00318461|580167765|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
160668290|NCT00318461|580167766|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
160668291|NCT00318461|580167767|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
160668292|NCT00318461|580167768|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
160668293|NCT00318461|580167764|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
160668294|NCT00318461|580167765|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
160668295|NCT00318461|580167766|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
160668296|NCT00318461|580167767|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
160668297|NCT00318461|580167768|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
160668298|NCT00318461|580167764|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
160668299|NCT00318461|580167765|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
160668300|NCT00318461|580167766|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
160668301|NCT00318461|580167767|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
160668302|NCT00318461|580167768|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
160668303|NCT00796653|580167769|FG000|Overall Study|Adverse Event|19|||
160668304|NCT00796653|580167770|FG001|Overall Study|Adverse Event|16|||
160668305|NCT00796653|580167771|FG002|Overall Study|Adverse Event|16|||
160668306|NCT00796653|580167772|FG003|Overall Study|Adverse Event|16|||
160668307|NCT00796653|580167769|FG000|Overall Study|Lost to Follow-up|2|||
160668308|NCT00796653|580167770|FG001|Overall Study|Lost to Follow-up|1|||
160668309|NCT00796653|580167771|FG002|Overall Study|Lost to Follow-up|2|||
160668310|NCT00796653|580167772|FG003|Overall Study|Lost to Follow-up|3|||
160668311|NCT00796653|580167769|FG000|Overall Study|Withdrawal by Subject|16|||
160668312|NCT00796653|580167770|FG001|Overall Study|Withdrawal by Subject|8|||
160668313|NCT00796653|580167771|FG002|Overall Study|Withdrawal by Subject|8|||
160668314|NCT00796653|580167772|FG003|Overall Study|Withdrawal by Subject|13|||
160518886|NCT00757588|579629145|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
160518887|NCT00757588|579629146|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
160518888|NCT00757588|579629145|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
160518889|NCT00757588|579629146|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
160518890|NCT02563522|579629147|FG000|Overall Study|Adverse Event|2|||
160518891|NCT02563522|579629148|FG001|Overall Study|Adverse Event|3|||
160518892|NCT02563522|579629147|FG000|Overall Study|Lost to Follow-up|1|||
160518893|NCT02563522|579629148|FG001|Overall Study|Lost to Follow-up|0|||
160518894|NCT02563522|579629147|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
160518895|NCT02563522|579629148|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
160518896|NCT01052103|579629149|FG000|Overall Study|Adverse Event|10|||
160518897|NCT01052103|579629150|FG001|Overall Study|Adverse Event|6|||
160518898|NCT01052103|579629149|FG000|Overall Study|Entry Criteria Not Met|3|||
160518899|NCT01052103|579629150|FG001|Overall Study|Entry Criteria Not Met|1|||
160518900|NCT01052103|579629149|FG000|Overall Study|Lost to Follow-up|3|||
160518901|NCT01052103|579629150|FG001|Overall Study|Lost to Follow-up|5|||
160518902|NCT01052103|579629149|FG000|Overall Study|Protocol Violation|10|||
160668315|NCT00796653|580167769|FG000|Overall Study|Lack of Efficacy|8|||
160668316|NCT00796653|580167770|FG001|Overall Study|Lack of Efficacy|1|||
160668317|NCT00796653|580167771|FG002|Overall Study|Lack of Efficacy|3|||
160668318|NCT00796653|580167772|FG003|Overall Study|Lack of Efficacy|2|||
160668319|NCT00796653|580167769|FG000|Overall Study|Non compliance with protocol|2|||
160668320|NCT00796653|580167770|FG001|Overall Study|Non compliance with protocol|2|||
160668321|NCT00796653|580167771|FG002|Overall Study|Non compliance with protocol|0|||
160668322|NCT00796653|580167772|FG003|Overall Study|Non compliance with protocol|2|||
160668323|NCT00796653|580167769|FG000|Overall Study|Other reason not described above|4|||
160668324|NCT00796653|580167770|FG001|Overall Study|Other reason not described above|9|||
160668325|NCT00796653|580167771|FG002|Overall Study|Other reason not described above|7|||
160668326|NCT00796653|580167772|FG003|Overall Study|Other reason not described above|4|||
160668327|NCT00835692|580167778|FG000|First Intervention|Withdrawal by Subject|1|||
160668328|NCT00835692|580167779|FG001|First Intervention|Withdrawal by Subject|0|||
160668329|NCT00191815|580167782|FG000|Overall Study|Adverse Event|2|||
160668330|NCT00191815|580167782|FG000|Overall Study|Disease progression or relapse|24|||
160668331|NCT00191815|580167782|FG000|Overall Study|Death|2|||
160668332|NCT00191815|580167782|FG000|Overall Study|Protocol Violation|3|||
160668333|NCT00191815|580167782|FG000|Overall Study|Physician Decision|2|||
160668334|NCT00191815|580167782|FG000|Overall Study|Withdrawal by Subject|7|||
160668335|NCT03644550|580167783|FG000|Overall Study|Withdrawal by Subject|3|||
160668336|NCT03644550|580167783|FG000|Overall Study|Progressive disease|15|||
160668337|NCT01929863|580167784|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
160668338|NCT01929863|580167785|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
160518903|NCT01052103|579629150|FG001|Overall Study|Protocol Violation|4|||
160668339|NCT01929863|580167784|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
160668340|NCT01929863|580167785|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
160668341|NCT01929863|580167784|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
160518904|NCT01052103|579629149|FG000|Overall Study|Scheduling conflict|2|||
160518905|NCT01052103|579629150|FG001|Overall Study|Scheduling conflict|1|||
160518906|NCT01052103|579629149|FG000|Overall Study|Sponsor Decision|2|||
160668342|NCT01929863|580167785|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
160668343|NCT01218867|580167786|FG000|Overall Study|Death during treatment|0|||
160668344|NCT01218867|580167787|FG001|Overall Study|Death during treatment|0|||
160668345|NCT01218867|580167788|FG002|Overall Study|Death during treatment|0|||
160668346|NCT01218867|580167789|FG003|Overall Study|Death during treatment|0|||
160668347|NCT01218867|580167790|FG004|Overall Study|Death during treatment|0|||
160668348|NCT01218867|580167791|FG005|Overall Study|Death during treatment|0|||
160668349|NCT01218867|580167792|FG006|Overall Study|Death during treatment|1|||
160668350|NCT01218867|580167793|FG007|Overall Study|Death during treatment|0|||
160668351|NCT01218867|580167794|FG008|Overall Study|Death during treatment|0|||
160668352|NCT01218867|580167795|FG009|Overall Study|Death during treatment|0|||
160668353|NCT01218867|580167796|FG010|Overall Study|Death during treatment|0|||
160668354|NCT00251979|580167797|FG000|Overall Study|Protocol Violation|3|||
160668355|NCT00251979|580167798|FG001|Overall Study|Protocol Violation|5|||
160668356|NCT00251979|580167797|FG000|Overall Study|Adverse Event|11|||
160668357|NCT00251979|580167798|FG001|Overall Study|Adverse Event|17|||
160668358|NCT00251979|580167797|FG000|Overall Study|Withdrawal by Subject|13|||
160668359|NCT00251979|580167798|FG001|Overall Study|Withdrawal by Subject|7|||
160668360|NCT00251979|580167797|FG000|Overall Study|Lost to Follow-up|8|||
160668361|NCT00251979|580167798|FG001|Overall Study|Lost to Follow-up|6|||
160668362|NCT00251979|580167797|FG000|Overall Study|Death|3|||
160668363|NCT00251979|580167798|FG001|Overall Study|Death|5|||
160668364|NCT01878292|580167808|FG000|Randomized|Protocol Violation|1|||
160668365|NCT01878292|580167809|FG001|Randomized|Protocol Violation|0|||
160668366|NCT01878292|580167810|FG002|Randomized|Protocol Violation|0|||
160668367|NCT01878292|580167808|FG000|Randomized|Lost to Follow-up|1|||
160668368|NCT01878292|580167809|FG001|Randomized|Lost to Follow-up|0|||
160668369|NCT01878292|580167810|FG002|Randomized|Lost to Follow-up|0|||
160668370|NCT01878292|580167808|FG000|Randomized|Adverse Event|1|||
160668371|NCT01878292|580167809|FG001|Randomized|Adverse Event|0|||
160668372|NCT01878292|580167810|FG002|Randomized|Adverse Event|0|||
160668373|NCT01878292|580167808|FG000|Double-blind Treatment Period|Other Reasons|2|||
160668374|NCT01878292|580167809|FG001|Double-blind Treatment Period|Other Reasons|0|||
160668375|NCT01878292|580167810|FG002|Double-blind Treatment Period|Other Reasons|0|||
160668376|NCT01878292|580167808|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
160668377|NCT01878292|580167809|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
160668378|NCT01878292|580167810|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
160668379|NCT01878292|580167808|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
160668380|NCT01878292|580167809|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
160668381|NCT01878292|580167810|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
160668382|NCT01878292|580167808|FG000|Double-blind Treatment Period|Protocol Violation|3|||
160668383|NCT01878292|580167809|FG001|Double-blind Treatment Period|Protocol Violation|4|||
160668384|NCT01878292|580167810|FG002|Double-blind Treatment Period|Protocol Violation|2|||
160668385|NCT01878292|580167808|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
160668386|NCT01878292|580167809|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
160668387|NCT01878292|580167810|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
160668388|NCT01878292|580167808|FG000|Double-blind Treatment Period|Adverse Event|4|||
160668389|NCT01878292|580167809|FG001|Double-blind Treatment Period|Adverse Event|9|||
160668390|NCT01878292|580167810|FG002|Double-blind Treatment Period|Adverse Event|8|||
160668391|NCT01878292|580167808|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
160668392|NCT01878292|580167809|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
160668393|NCT01878292|580167810|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
160668394|NCT01348789|580167811|FG000|Overall Study|Protocol Violation|2|||
160668395|NCT01348789|580167811|FG000|Overall Study|Withdrawal by Subject|2|||
160668396|NCT00323882|580167812|FG000|Overall Study|Adverse Event|2|||
160668397|NCT00323882|580167813|FG001|Overall Study|Adverse Event|1|||
160668398|NCT00323882|580167814|FG002|Overall Study|Adverse Event|1|||
160668399|NCT00323882|580167815|FG003|Overall Study|Adverse Event|1|||
160668400|NCT00323882|580167816|FG004|Overall Study|Adverse Event|3|||
160668401|NCT00323882|580167812|FG000|Overall Study|Disease Progression|6|||
160518907|NCT01052103|579629150|FG001|Overall Study|Sponsor Decision|0|||
160518908|NCT01052103|579629149|FG000|Overall Study|Withdrawal by Subject|3|||
160518909|NCT01052103|579629150|FG001|Overall Study|Withdrawal by Subject|6|||
160518910|NCT01052103|579629149|FG000|Overall Study|Perceived Lack of Efficacy|1|||
160668402|NCT00323882|580167813|FG001|Overall Study|Disease Progression|4|||
160668403|NCT00323882|580167814|FG002|Overall Study|Disease Progression|10|||
160668404|NCT00323882|580167815|FG003|Overall Study|Disease Progression|5|||
160668405|NCT00323882|580167816|FG004|Overall Study|Disease Progression|22|||
160668406|NCT00323882|580167812|FG000|Overall Study|Death|0|||
160668407|NCT00323882|580167813|FG001|Overall Study|Death|1|||
160668408|NCT00323882|580167814|FG002|Overall Study|Death|1|||
160668409|NCT00323882|580167815|FG003|Overall Study|Death|0|||
160668410|NCT00323882|580167816|FG004|Overall Study|Death|5|||
160668411|NCT00323882|580167812|FG000|Overall Study|Lost to Follow-up|0|||
160518911|NCT01052103|579629150|FG001|Overall Study|Perceived Lack of Efficacy|0|||
160668412|NCT00323882|580167813|FG001|Overall Study|Lost to Follow-up|0|||
160668413|NCT00323882|580167814|FG002|Overall Study|Lost to Follow-up|1|||
160668414|NCT00323882|580167815|FG003|Overall Study|Lost to Follow-up|0|||
160668415|NCT00323882|580167816|FG004|Overall Study|Lost to Follow-up|1|||
160668416|NCT00323882|580167812|FG000|Overall Study|Other|0|||
160668417|NCT00323882|580167813|FG001|Overall Study|Other|0|||
160668418|NCT00323882|580167814|FG002|Overall Study|Other|0|||
160668419|NCT00323882|580167815|FG003|Overall Study|Other|1|||
160668420|NCT00323882|580167816|FG004|Overall Study|Other|1|||
160668421|NCT02152163|580167825|FG000|Overall Study|Physician Decision|12|||
160668422|NCT02152163|580167826|FG001|Overall Study|Physician Decision|13|||
160668423|NCT03123471|580167827|FG000|Placebo-controlled Phase|Adverse Event|3|||
160668424|NCT03123471|580167828|FG001|Placebo-controlled Phase|Adverse Event|8|||
160668425|NCT03123471|580167827|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
160668426|NCT03123471|580167828|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
160668427|NCT03123471|580167827|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
160668428|NCT03123471|580167828|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
160668429|NCT03123471|580167827|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
160668430|NCT03123471|580167828|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
160668431|NCT03123471|580167827|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
160668432|NCT03123471|580167828|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
160668433|NCT03123471|580167827|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
160668434|NCT03123471|580167828|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
160668435|NCT03123471|580167827|FG000|Placebo-controlled Phase|Miscellaneous|0|||
160668436|NCT03123471|580167828|FG001|Placebo-controlled Phase|Miscellaneous|1|||
160668437|NCT03123471|580167827|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
160668438|NCT03123471|580167828|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
160668439|NCT03123471|580167827|FG000|Apremilast Extension Phase|Adverse Event|1|||
160668440|NCT03123471|580167828|FG001|Apremilast Extension Phase|Adverse Event|5|||
160668441|NCT03123471|580167827|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
160668442|NCT03123471|580167828|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
160668443|NCT03123471|580167827|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
160668444|NCT03123471|580167828|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
160668445|NCT02358538|580167831|FG000|Through Week 26|Adverse Event|0|||
160668446|NCT02358538|580167832|FG001|Through Week 26|Adverse Event|1|||
160668447|NCT02358538|580167833|FG002|Through Week 26|Adverse Event|1|||
160668448|NCT02358538|580167834|FG003|Through Week 26|Adverse Event|2|||
160668449|NCT02358538|580167831|FG000|Through Week 26|Lack of Efficacy|1|||
160668450|NCT02358538|580167832|FG001|Through Week 26|Lack of Efficacy|1|||
160668451|NCT02358538|580167833|FG002|Through Week 26|Lack of Efficacy|3|||
160668452|NCT02358538|580167834|FG003|Through Week 26|Lack of Efficacy|3|||
160668453|NCT02358538|580167831|FG000|Through Week 26|Withdrawal by Subject|1|||
160668454|NCT02358538|580167832|FG001|Through Week 26|Withdrawal by Subject|0|||
160668455|NCT02358538|580167833|FG002|Through Week 26|Withdrawal by Subject|0|||
160668456|NCT02358538|580167834|FG003|Through Week 26|Withdrawal by Subject|0|||
160668457|NCT02358538|580167831|FG000|Through Week 26|Non-Compliance|0|||
160668458|NCT02358538|580167832|FG001|Through Week 26|Non-Compliance|0|||
160668459|NCT02358538|580167833|FG002|Through Week 26|Non-Compliance|1|||
160668460|NCT02358538|580167834|FG003|Through Week 26|Non-Compliance|0|||
160668461|NCT02358538|580167831|FG000|Through Week 26|Family did not see benefit from IP|1|||
160668462|NCT02358538|580167832|FG001|Through Week 26|Family did not see benefit from IP|0|||
160668463|NCT02358538|580167833|FG002|Through Week 26|Family did not see benefit from IP|0|||
160668464|NCT02358538|580167834|FG003|Through Week 26|Family did not see benefit from IP|0|||
160668465|NCT02358538|580167831|FG000|52 Week Extension Period|Lack of Efficacy|0|||
160668466|NCT02358538|580167832|FG001|52 Week Extension Period|Lack of Efficacy|0|||
160668467|NCT02358538|580167833|FG002|52 Week Extension Period|Lack of Efficacy|2|||
160668468|NCT02358538|580167834|FG003|52 Week Extension Period|Lack of Efficacy|4|||
160668469|NCT01686477|580167835|FG000|Feeding Intervention|Death|1|||
160668470|NCT01686477|580167836|FG001|Feeding Intervention|Death|0|||
160668471|NCT01686477|580167837|FG002|Feeding Intervention|Death|1|||
160518912|NCT00799513|579629151|FG000|Overall Study|Physician Decision|1|||
160668472|NCT01686477|580167835|FG000|Feeding Intervention|Withdrawal by Subject|0|||
160668473|NCT01686477|580167836|FG001|Feeding Intervention|Withdrawal by Subject|6|||
160668474|NCT01686477|580167837|FG002|Feeding Intervention|Withdrawal by Subject|0|||
160668475|NCT01686477|580167835|FG000|Feeding Intervention|Physician Decision|1|||
160668476|NCT01686477|580167836|FG001|Feeding Intervention|Physician Decision|2|||
160668477|NCT01686477|580167837|FG002|Feeding Intervention|Physician Decision|0|||
160668478|NCT01686477|580167835|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
160668479|NCT01686477|580167836|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
160668480|NCT01686477|580167837|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
160668481|NCT01686477|580167835|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
160518913|NCT00799513|579629151|FG000|Overall Study|Adverse Event|1|||
160668482|NCT01686477|580167836|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
160668483|NCT01686477|580167837|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
160668484|NCT01686477|580167835|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
160668485|NCT01686477|580167836|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
160668486|NCT01686477|580167837|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
160668487|NCT01686477|580167835|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
160668488|NCT01686477|580167836|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
160668489|NCT01686477|580167837|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
160668490|NCT01686477|580167835|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
160668491|NCT01686477|580167836|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
160668492|NCT01686477|580167837|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
160668493|NCT01686477|580167835|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
160668494|NCT01686477|580167836|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
160668495|NCT01686477|580167837|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
160668496|NCT01686477|580167835|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
160668497|NCT01686477|580167836|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
160668498|NCT01686477|580167837|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
160668499|NCT06999265|580167839|FG000|Overall Study|Lost to Follow-up|1|||
160668500|NCT06999265|580167840|FG001|Overall Study|Lost to Follow-up|1|||
160668501|NCT00730691|580167841|FG000|Overall Study|Adverse Event|4|||
160668502|NCT00730691|580167842|FG001|Overall Study|Adverse Event|8|||
160668503|NCT00730691|580167843|FG002|Overall Study|Adverse Event|11|||
160668504|NCT00730691|580167844|FG003|Overall Study|Adverse Event|11|||
160668505|NCT00730691|580167845|FG004|Overall Study|Adverse Event|23|||
160668506|NCT00730691|580167841|FG000|Overall Study|Lack of Efficacy|4|||
160668507|NCT00730691|580167842|FG001|Overall Study|Lack of Efficacy|4|||
160668508|NCT00730691|580167843|FG002|Overall Study|Lack of Efficacy|2|||
160668509|NCT00730691|580167844|FG003|Overall Study|Lack of Efficacy|1|||
160668510|NCT00730691|580167845|FG004|Overall Study|Lack of Efficacy|1|||
160668511|NCT00730691|580167841|FG000|Overall Study|Non-compliance with Study Drug|6|||
160668512|NCT00730691|580167842|FG001|Overall Study|Non-compliance with Study Drug|1|||
160668513|NCT00730691|580167843|FG002|Overall Study|Non-compliance with Study Drug|6|||
160668514|NCT00730691|580167844|FG003|Overall Study|Non-compliance with Study Drug|3|||
160668515|NCT00730691|580167845|FG004|Overall Study|Non-compliance with Study Drug|3|||
160668516|NCT00730691|580167841|FG000|Overall Study|Protocol Deviations|3|||
160668517|NCT00730691|580167842|FG001|Overall Study|Protocol Deviations|5|||
160668518|NCT00730691|580167843|FG002|Overall Study|Protocol Deviations|3|||
160668519|NCT00730691|580167844|FG003|Overall Study|Protocol Deviations|7|||
160668520|NCT00730691|580167845|FG004|Overall Study|Protocol Deviations|5|||
160668521|NCT00730691|580167841|FG000|Overall Study|Withdrawal of Consent|7|||
160668522|NCT00730691|580167842|FG001|Overall Study|Withdrawal of Consent|9|||
160668523|NCT00730691|580167843|FG002|Overall Study|Withdrawal of Consent|3|||
160668524|NCT00730691|580167844|FG003|Overall Study|Withdrawal of Consent|6|||
160668525|NCT00730691|580167845|FG004|Overall Study|Withdrawal of Consent|3|||
160668526|NCT00730691|580167841|FG000|Overall Study|Lost to Follow-up|11|||
160668527|NCT00730691|580167842|FG001|Overall Study|Lost to Follow-up|8|||
160668528|NCT00730691|580167843|FG002|Overall Study|Lost to Follow-up|13|||
160668529|NCT00730691|580167844|FG003|Overall Study|Lost to Follow-up|15|||
160668530|NCT00730691|580167845|FG004|Overall Study|Lost to Follow-up|13|||
160668531|NCT00730691|580167841|FG000|Overall Study|Other|1|||
160668532|NCT00730691|580167842|FG001|Overall Study|Other|1|||
160668533|NCT00730691|580167843|FG002|Overall Study|Other|1|||
160668534|NCT00730691|580167844|FG003|Overall Study|Other|2|||
160668535|NCT00730691|580167845|FG004|Overall Study|Other|2|||
160668536|NCT02178787|580167846|FG000|Overall Study|Lost to Follow-up|1|||
160668537|NCT02178787|580167847|FG001|Overall Study|Lost to Follow-up|0|||
160668538|NCT02178787|580167846|FG000|Overall Study|Withdrawal by Subject|0|||
160668539|NCT02178787|580167847|FG001|Overall Study|Withdrawal by Subject|2|||
160668540|NCT02178787|580167846|FG000|Overall Study|No TCD window|3|||
160668541|NCT02178787|580167847|FG001|Overall Study|No TCD window|7|||
160668542|NCT02178787|580167846|FG000|Overall Study|Physician Decision|1|||
160668543|NCT02178787|580167847|FG001|Overall Study|Physician Decision|0|||
160668544|NCT02554890|580167848|FG000|Double-blind|Adverse Event|45|||
160668545|NCT02554890|580167849|FG001|Double-blind|Adverse Event|51|||
160668546|NCT02554890|580167848|FG000|Double-blind|Death|6|||
160668547|NCT02554890|580167849|FG001|Double-blind|Death|4|||
160668548|NCT02554890|580167848|FG000|Double-blind|Protocol Violation|1|||
160668549|NCT02554890|580167849|FG001|Double-blind|Protocol Violation|1|||
160668550|NCT02554890|580167848|FG000|Double-blind|Physician Decision|4|||
160668551|NCT02554890|580167849|FG001|Double-blind|Physician Decision|3|||
160668552|NCT02554890|580167848|FG000|Double-blind|Subject/Guardian decision|21|||
160668553|NCT02554890|580167849|FG001|Double-blind|Subject/Guardian decision|16|||
160668554|NCT02554890|580167848|FG000|Double-blind|Lost to Follow-up|7|||
160668555|NCT02554890|580167849|FG001|Double-blind|Lost to Follow-up|5|||
160668556|NCT02554890|580167848|FG000|Double-blind|Technical problems|1|||
160668557|NCT02554890|580167849|FG001|Double-blind|Technical problems|0|||
160668558|NCT02554890|580167848|FG000|Double-blind|Withdrawal by Subject|5|||
160668559|NCT02554890|580167849|FG001|Double-blind|Withdrawal by Subject|6|||
160668560|NCT02554890|580167848|FG000|Double-blind|Noncompliance with study treatment|6|||
160668561|NCT02554890|580167849|FG001|Double-blind|Noncompliance with study treatment|5|||
160668562|NCT02554890|580167848|FG000|Open-label|Adverse Event|0|||
160668563|NCT02554890|580167849|FG001|Open-label|Adverse Event|30|||
160668564|NCT02554890|580167848|FG000|Open-label|Death|0|||
160668565|NCT02554890|580167849|FG001|Open-label|Death|1|||
160668566|NCT02554890|580167848|FG000|Open-label|Physician Decision|0|||
160668567|NCT02554890|580167849|FG001|Open-label|Physician Decision|1|||
160668568|NCT02554890|580167848|FG000|Open-label|Subject/Guardian decision|0|||
160668569|NCT02554890|580167849|FG001|Open-label|Subject/Guardian decision|11|||
160668570|NCT02554890|580167848|FG000|Open-label|Lost to Follow-up|0|||
160668571|NCT02554890|580167849|FG001|Open-label|Lost to Follow-up|7|||
160668572|NCT02554890|580167848|FG000|Open-label|Technical problems|0|||
160668573|NCT02554890|580167849|FG001|Open-label|Technical problems|1|||
160668574|NCT02554890|580167848|FG000|Open-label|Withdrawal by Subject|0|||
160668575|NCT02554890|580167849|FG001|Open-label|Withdrawal by Subject|1|||
160668576|NCT03649477|580167855|FG000|Overall Study|Adverse Event|2|||
160668577|NCT03649477|580167856|FG001|Overall Study|Adverse Event|0|||
160668578|NCT03649477|580167857|FG002|Overall Study|Adverse Event|0|||
160668579|NCT04544410|580167858|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
160668580|NCT04544410|580167859|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
160668581|NCT04544410|580167858|FG000|Double-blind Treatment Period|Adverse Event|1|||
160668582|NCT04544410|580167859|FG001|Double-blind Treatment Period|Adverse Event|0|||
160668583|NCT04544410|580167858|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
160668584|NCT04544410|580167859|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
160668585|NCT04544410|580167858|FG000|Double-blind Treatment Period|Protocol Violation|1|||
160668586|NCT04544410|580167859|FG001|Double-blind Treatment Period|Protocol Violation|0|||
160668587|NCT04544410|580167858|FG000|Open-Label Treatment Period|Study Terminated|15|||
160668588|NCT04544410|580167859|FG001|Open-Label Treatment Period|Study Terminated|19|||
160668589|NCT04544410|580167858|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
160668590|NCT04544410|580167859|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
160668591|NCT04544410|580167858|FG000|Open-Label Treatment Period|Adverse Event|0|||
160668592|NCT04544410|580167859|FG001|Open-Label Treatment Period|Adverse Event|1|||
160668593|NCT04544410|580167858|FG000|Open-Label Treatment Period|Physician Decision|1|||
160668594|NCT04544410|580167859|FG001|Open-Label Treatment Period|Physician Decision|0|||
160668595|NCT04544410|580167858|FG000|Open-Label Treatment Period|Other|0|||
160668596|NCT04544410|580167859|FG001|Open-Label Treatment Period|Other|1|||
160668597|NCT02430480|580167860|FG000|Overall Study|Death|1|||
160668598|NCT02430480|580167860|FG000|Overall Study|Anesthesia concerns|1|||
160668599|NCT02430480|580167860|FG000|Overall Study|Progressed on treatment|1|||
160668600|NCT01030133|580167861|FG000|Overall Study|failed to experience pain at level 7/10|2|||
160668601|NCT01030133|580167862|FG001|Overall Study|failed to experience pain at level 7/10|2|||
160668602|NCT01097577|580167870|FG000|Overall Study|Adverse Event|0|||
160668603|NCT01097577|580167871|FG001|Overall Study|Adverse Event|1|||
160668604|NCT04493684|580167872|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
160668605|NCT04493684|580167873|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668606|NCT04493684|580167874|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
160668607|NCT04493684|580167875|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668608|NCT04493684|580167876|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668609|NCT04493684|580167877|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
160668610|NCT04493684|580167878|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668611|NCT04493684|580167879|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668612|NCT04493684|580167880|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668613|NCT04493684|580167881|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668614|NCT04493684|580167882|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668615|NCT04493684|580167883|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668616|NCT04493684|580167884|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668617|NCT04493684|580167885|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668618|NCT04493684|580167886|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668619|NCT04493684|580167887|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668620|NCT04493684|580167888|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
160668621|NCT04493684|580167872|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
160668622|NCT04493684|580167873|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668623|NCT04493684|580167874|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668624|NCT04493684|580167875|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668625|NCT04493684|580167876|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668626|NCT04493684|580167877|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668627|NCT04493684|580167878|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668628|NCT04493684|580167879|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668629|NCT04493684|580167880|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668630|NCT04493684|580167881|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668631|NCT04493684|580167882|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668632|NCT04493684|580167883|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668633|NCT04493684|580167884|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668634|NCT04493684|580167885|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668635|NCT04493684|580167886|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668636|NCT04493684|580167887|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668637|NCT04493684|580167888|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
160668638|NCT04493684|580167872|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668639|NCT04493684|580167873|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668640|NCT04493684|580167874|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668641|NCT04493684|580167875|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668642|NCT04493684|580167876|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668643|NCT04493684|580167877|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668644|NCT04493684|580167878|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
160668645|NCT04493684|580167879|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668646|NCT04493684|580167880|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668647|NCT04493684|580167881|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668648|NCT04493684|580167882|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668649|NCT04493684|580167883|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668650|NCT04493684|580167884|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668651|NCT04493684|580167885|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668652|NCT04493684|580167886|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668653|NCT04493684|580167887|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668654|NCT04493684|580167888|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160668655|NCT04493684|580167872|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
160668656|NCT04493684|580167873|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668657|NCT04493684|580167874|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668658|NCT04493684|580167875|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668659|NCT04493684|580167876|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668660|NCT04493684|580167877|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668661|NCT04493684|580167878|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668662|NCT04493684|580167879|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668663|NCT04493684|580167880|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668664|NCT04493684|580167881|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668665|NCT04493684|580167882|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668666|NCT04493684|580167883|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668667|NCT04493684|580167884|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668668|NCT04493684|580167885|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668669|NCT04493684|580167886|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668670|NCT04493684|580167887|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668671|NCT04493684|580167888|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160668672|NCT04493684|580167872|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668673|NCT04493684|580167873|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668674|NCT04493684|580167874|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668675|NCT04493684|580167875|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668676|NCT04493684|580167876|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668677|NCT04493684|580167877|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
160668678|NCT04493684|580167878|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668679|NCT04493684|580167879|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668680|NCT04493684|580167880|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668681|NCT04493684|580167881|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668682|NCT04493684|580167882|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668683|NCT04493684|580167883|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668684|NCT04493684|580167884|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668685|NCT04493684|580167885|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668686|NCT04493684|580167886|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668687|NCT04493684|580167887|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668688|NCT04493684|580167888|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
160668689|NCT04493684|580167872|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668690|NCT04493684|580167873|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668691|NCT04493684|580167874|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668692|NCT04493684|580167875|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668693|NCT04493684|580167876|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668694|NCT04493684|580167877|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668695|NCT04493684|580167878|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668696|NCT04493684|580167879|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668697|NCT04493684|580167880|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668698|NCT04493684|580167881|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668699|NCT04493684|580167882|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668700|NCT04493684|580167883|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
160668701|NCT04493684|580167884|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668702|NCT04493684|580167885|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668703|NCT04493684|580167886|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668704|NCT04493684|580167887|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668705|NCT04493684|580167888|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
160668706|NCT04493684|580167872|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668707|NCT04493684|580167873|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668708|NCT04493684|580167874|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668709|NCT04493684|580167875|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668710|NCT04493684|580167876|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668711|NCT04493684|580167877|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668712|NCT04493684|580167878|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668713|NCT04493684|580167879|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668714|NCT04493684|580167880|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668715|NCT04493684|580167881|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668716|NCT04493684|580167882|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668717|NCT04493684|580167883|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668718|NCT04493684|580167884|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668719|NCT04493684|580167885|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668720|NCT04493684|580167886|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668721|NCT04493684|580167887|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
160668722|NCT04493684|580167888|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
160668723|NCT04493684|580167872|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668724|NCT04493684|580167873|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668725|NCT04493684|580167874|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668726|NCT04493684|580167875|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668727|NCT04493684|580167876|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668728|NCT04493684|580167877|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668729|NCT04493684|580167878|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668730|NCT04493684|580167879|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668731|NCT04493684|580167880|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668732|NCT04493684|580167881|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668733|NCT04493684|580167882|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668734|NCT04493684|580167883|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668735|NCT04493684|580167884|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668736|NCT04493684|580167885|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668737|NCT04493684|580167886|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668738|NCT04493684|580167887|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
160668739|NCT04493684|580167888|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
160668740|NCT05710718|580169288|FG000|Overall Study|Withdrawal by Subject|5|||
160668741|NCT05710718|580169289|FG001|Overall Study|Withdrawal by Subject|1|||
160668742|NCT05710718|580169288|FG000|Overall Study|Lost to Follow-up|0|||
160668743|NCT05710718|580169289|FG001|Overall Study|Lost to Follow-up|1|||
160668744|NCT05710718|580169288|FG000|Overall Study|Death|0|||
160668745|NCT05710718|580169289|FG001|Overall Study|Death|1|||
160668746|NCT04372238|580169290|FG000|Overall Study|Duplicate|3|||
160668747|NCT04372238|580169291|FG001|Overall Study|Duplicate|3|||
160668748|NCT04372238|580169290|FG000|Overall Study|Did not consent for data linkage|6|||
160668749|NCT04372238|580169291|FG001|Overall Study|Did not consent for data linkage|10|||
160518914|NCT00666679|579629153|FG000|First Intervention|Lost to Follow-up|1|||
160518915|NCT00666679|579629154|FG001|First Intervention|Lost to Follow-up|0|||
160518916|NCT00666679|579629153|FG000|First Intervention|Protocol Violation|1|||
160518917|NCT00666679|579629154|FG001|First Intervention|Protocol Violation|0|||
160668750|NCT02591420|580169292|FG000|Overall Study|Lost to Follow-up|0|||
160668751|NCT02591420|580169293|FG001|Overall Study|Lost to Follow-up|1|||
160668752|NCT02591420|580169294|FG002|Overall Study|Lost to Follow-up|2|||
160668753|NCT04241458|580169295|FG000|Overall Study|Withdrawal by Subject|0|||
160668754|NCT04241458|580169296|FG001|Overall Study|Withdrawal by Subject|0|||
160668755|NCT04241458|580169297|FG002|Overall Study|Withdrawal by Subject|0|||
160668756|NCT04241458|580169298|FG003|Overall Study|Withdrawal by Subject|0|||
160668757|NCT04241458|580169299|FG004|Overall Study|Withdrawal by Subject|1|||
160668758|NCT01528696|580169303|FG000|Overall Study|See detailed description|18|||
160668759|NCT01528696|580169304|FG001|Overall Study|See detailed description|19|||
160668760|NCT00446966|580169305|FG000|Overall Study|Lost to Follow-up|10|||
160668761|NCT00446966|580169306|FG001|Overall Study|Lost to Follow-up|7|||
160668762|NCT00836472|580169308|FG000|Washout|Adverse Event|1|||
160668763|NCT00836472|580169309|FG001|Washout|Adverse Event|2|||
160668764|NCT00836472|580169308|FG000|Washout|Withdrawal by Subject|1|||
160668765|NCT00836472|580169309|FG001|Washout|Withdrawal by Subject|1|||
160668766|NCT01695239|580169310|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
160668767|NCT01695239|580169311|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
160668768|NCT01695239|580169312|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
160668769|NCT01695239|580169313|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
160668770|NCT01695239|580169314|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160668771|NCT01695239|580169315|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160668772|NCT01695239|580169316|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160668773|NCT01695239|580169317|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160668774|NCT01695239|580169318|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160668775|NCT01695239|580169319|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160668776|NCT01695239|580169320|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160668777|NCT01695239|580169321|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160668778|NCT01695239|580169322|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160668779|NCT01695239|580169323|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160668780|NCT01695239|580169310|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
160668781|NCT01695239|580169311|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
160668782|NCT01695239|580169312|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
160668783|NCT01695239|580169313|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
160668784|NCT01695239|580169314|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160668785|NCT01695239|580169315|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160668786|NCT01695239|580169316|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160668787|NCT01695239|580169317|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160668788|NCT01695239|580169318|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160668789|NCT01695239|580169319|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160668790|NCT01695239|580169320|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160668791|NCT01695239|580169321|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160668792|NCT01695239|580169322|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160668793|NCT01695239|580169323|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
160668794|NCT01695239|580169310|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
160668795|NCT01695239|580169311|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668796|NCT01695239|580169312|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
160668797|NCT01695239|580169313|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668798|NCT01695239|580169314|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668799|NCT01695239|580169315|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668800|NCT01695239|580169316|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668801|NCT01695239|580169317|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668802|NCT01695239|580169318|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668803|NCT01695239|580169319|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668804|NCT01695239|580169320|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668805|NCT01695239|580169321|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668806|NCT01695239|580169322|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668807|NCT01695239|580169323|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
160668808|NCT01695239|580169310|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
160668809|NCT01695239|580169311|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
160668810|NCT01695239|580169312|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
160668811|NCT01695239|580169313|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160668812|NCT01695239|580169314|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160668813|NCT01695239|580169315|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160668814|NCT01695239|580169316|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160668815|NCT01695239|580169317|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160668816|NCT01695239|580169318|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160668817|NCT01695239|580169319|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160668818|NCT01695239|580169320|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160518918|NCT00666679|579629153|FG000|First Intervention|Withdrawal by Subject|1|||
160518919|NCT00666679|579629154|FG001|First Intervention|Withdrawal by Subject|0|||
160518920|NCT00666679|579629153|FG000|First Intervention|Randomized did not start treatment|1|||
160518921|NCT00666679|579629154|FG001|First Intervention|Randomized did not start treatment|1|||
160668819|NCT01695239|580169321|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160668820|NCT01695239|580169322|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160668821|NCT01695239|580169323|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
160668822|NCT01695239|580169310|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
160668823|NCT01695239|580169311|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668824|NCT01695239|580169312|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
160668825|NCT01695239|580169313|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668826|NCT01695239|580169314|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668827|NCT01695239|580169315|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668828|NCT01695239|580169316|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668829|NCT01695239|580169317|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668830|NCT01695239|580169318|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668831|NCT01695239|580169319|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668832|NCT01695239|580169320|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668833|NCT01695239|580169321|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668834|NCT01695239|580169322|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668835|NCT01695239|580169323|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
160668836|NCT01695239|580169310|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
160668837|NCT01695239|580169311|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668838|NCT01695239|580169312|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
160668839|NCT01695239|580169313|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668840|NCT01695239|580169314|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668841|NCT01695239|580169315|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668842|NCT01695239|580169316|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668843|NCT01695239|580169317|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668844|NCT01695239|580169318|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668845|NCT01695239|580169319|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668846|NCT01695239|580169320|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668847|NCT01695239|580169321|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668848|NCT01695239|580169322|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668849|NCT01695239|580169323|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160668850|NCT01695239|580169310|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
160668851|NCT01695239|580169311|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668852|NCT01695239|580169312|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668853|NCT01695239|580169313|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668854|NCT01695239|580169314|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668855|NCT01695239|580169315|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668856|NCT01695239|580169316|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668857|NCT01695239|580169317|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668858|NCT01695239|580169318|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668859|NCT01695239|580169319|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668860|NCT01695239|580169320|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668861|NCT01695239|580169321|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668862|NCT01695239|580169322|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668863|NCT01695239|580169323|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160668864|NCT01695239|580169310|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668865|NCT01695239|580169311|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668866|NCT01695239|580169312|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668867|NCT01695239|580169313|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668868|NCT01695239|580169314|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668869|NCT01695239|580169315|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668870|NCT01695239|580169316|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668871|NCT01695239|580169317|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
160668872|NCT01695239|580169318|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668873|NCT01695239|580169319|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668874|NCT01695239|580169320|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668875|NCT01695239|580169321|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668876|NCT01695239|580169322|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668877|NCT01695239|580169323|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160668878|NCT01695239|580169310|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668879|NCT01695239|580169311|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668880|NCT01695239|580169312|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668881|NCT01695239|580169313|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160518922|NCT00666679|579629153|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
160518923|NCT00666679|579629154|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
160518924|NCT00666679|579629153|FG000|Washout Period of 1 Week|Protocol Violation|0|||
160518925|NCT00666679|579629154|FG001|Washout Period of 1 Week|Protocol Violation|1|||
160518926|NCT00666679|579629153|FG000|Second Intervention|Adverse Event|1|||
160518927|NCT00666679|579629154|FG001|Second Intervention|Adverse Event|0|||
160518928|NCT00666679|579629153|FG000|Second Intervention|Death|0|||
160518929|NCT00666679|579629154|FG001|Second Intervention|Death|1|||
160518930|NCT04371198|579629155|FG000|Overall Study|inadequate sample|4|||
160518931|NCT00211185|579629156|FG000|Overall Study|Death|2|||
160518932|NCT00211185|579629156|FG000|Overall Study|Disease progression|7|||
160518933|NCT00211185|579629156|FG000|Overall Study|Withdrawal by Subject|6|||
160518934|NCT00211185|579629156|FG000|Overall Study|Physician Decision|5|||
160518935|NCT02208999|579629157|FG000|Overall Study|Lost to Follow-up|1|||
160518936|NCT00319839|579629158|FG000|Overall Study|Adverse Event|5|||
160518937|NCT00319839|579629158|FG000|Overall Study|Withdrawal by Subject|1|||
160518938|NCT00986674|579629159|FG000|Overall Study|Lack of Efficacy|28|||
160518939|NCT00986674|579629160|FG001|Overall Study|Lack of Efficacy|25|||
160518940|NCT00986674|579629161|FG002|Overall Study|Lack of Efficacy|23|||
160518941|NCT00986674|579629159|FG000|Overall Study|Adverse Event|4|||
160518942|NCT00986674|579629160|FG001|Overall Study|Adverse Event|8|||
160518943|NCT00986674|579629161|FG002|Overall Study|Adverse Event|9|||
160518944|NCT00986674|579629159|FG000|Overall Study|Death|5|||
160518945|NCT00986674|579629160|FG001|Overall Study|Death|0|||
160518946|NCT00986674|579629161|FG002|Overall Study|Death|4|||
160518947|NCT00986674|579629159|FG000|Overall Study|Withdrawal by Subject|6|||
160518948|NCT00986674|579629160|FG001|Overall Study|Withdrawal by Subject|2|||
160518949|NCT00986674|579629161|FG002|Overall Study|Withdrawal by Subject|1|||
160518950|NCT00986674|579629159|FG000|Overall Study|alternative therapy|0|||
160518951|NCT00986674|579629160|FG001|Overall Study|alternative therapy|0|||
160518952|NCT00986674|579629161|FG002|Overall Study|alternative therapy|1|||
160518953|NCT00986674|579629159|FG000|Overall Study|not start protocol therapy|4|||
160518954|NCT00986674|579629160|FG001|Overall Study|not start protocol therapy|3|||
160518955|NCT00986674|579629161|FG002|Overall Study|not start protocol therapy|1|||
160518956|NCT00986674|579629159|FG000|Overall Study|unknown/not specify|0|||
160518957|NCT00986674|579629160|FG001|Overall Study|unknown/not specify|7|||
160518958|NCT00986674|579629161|FG002|Overall Study|unknown/not specify|9|||
160518959|NCT00690820|579629162|FG000|Period 1|Withdrawal by Subject|0|||
160624618|NCT01694849|580005491|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
160624619|NCT01694849|580005492|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
160624620|NCT01694849|580005493|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
160624621|NCT01694849|580005491|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
160624622|NCT01694849|580005492|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
160624623|NCT01694849|580005493|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
160624624|NCT01694849|580005491|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
160624625|NCT01694849|580005492|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
160624626|NCT01694849|580005493|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
160624627|NCT01694849|580005491|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
160624628|NCT01694849|580005492|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
160624629|NCT01694849|580005493|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
160624630|NCT01694849|580005491|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
160624631|NCT01694849|580005492|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
160624632|NCT01694849|580005493|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
160624633|NCT01694849|580005491|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
160624634|NCT01694849|580005492|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
160624635|NCT01694849|580005493|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
160624636|NCT01694849|580005491|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
160624637|NCT01694849|580005492|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
160624638|NCT01694849|580005493|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
160624639|NCT01694849|580005491|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
160624640|NCT01694849|580005492|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
160624641|NCT01694849|580005493|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
160624642|NCT01012765|580005494|FG000|Treatment Period 1|Adverse Event|1|||
160624643|NCT01012765|580005495|FG001|Treatment Period 1|Adverse Event|0|||
160624644|NCT01012765|580005496|FG002|Treatment Period 1|Adverse Event|1|||
160624645|NCT01012765|580005497|FG003|Treatment Period 1|Adverse Event|0|||
160624646|NCT01012765|580005498|FG004|Treatment Period 1|Adverse Event|0|||
160624647|NCT01012765|580005499|FG005|Treatment Period 1|Adverse Event|0|||
160624648|NCT01012765|580005494|FG000|Treatment Period 1|Withdrawal by Subject|2|||
160624649|NCT01012765|580005495|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160624650|NCT01012765|580005496|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160624651|NCT01012765|580005497|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160518960|NCT00690820|579629163|FG001|Period 1|Withdrawal by Subject|1|||
160668882|NCT01695239|580169314|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668883|NCT01695239|580169315|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668884|NCT01695239|580169316|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668885|NCT01695239|580169317|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
160668886|NCT01695239|580169318|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668887|NCT01695239|580169319|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668888|NCT01695239|580169320|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668889|NCT01695239|580169321|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668890|NCT01695239|580169322|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668891|NCT01695239|580169323|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160668892|NCT01695239|580169310|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668893|NCT01695239|580169311|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668894|NCT01695239|580169312|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668895|NCT01695239|580169313|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668896|NCT01695239|580169314|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668897|NCT01695239|580169315|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668898|NCT01695239|580169316|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668899|NCT01695239|580169317|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
160668900|NCT01695239|580169318|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668901|NCT01695239|580169319|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668902|NCT01695239|580169320|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668903|NCT01695239|580169321|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668904|NCT01695239|580169322|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668905|NCT01695239|580169323|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160668906|NCT01695239|580169310|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668907|NCT01695239|580169311|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668908|NCT01695239|580169312|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668909|NCT01695239|580169313|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668910|NCT01695239|580169314|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668911|NCT01695239|580169315|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668912|NCT01695239|580169316|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668913|NCT01695239|580169317|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668914|NCT01695239|580169318|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
160668915|NCT01695239|580169319|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
160668916|NCT01695239|580169320|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668917|NCT01695239|580169321|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668918|NCT01695239|580169322|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668919|NCT01695239|580169323|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160668920|NCT01695239|580169310|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
160668921|NCT01695239|580169311|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
160668922|NCT01695239|580169312|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
160668923|NCT01695239|580169313|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
160668924|NCT01695239|580169314|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
160668925|NCT01695239|580169315|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
160668926|NCT01695239|580169316|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
160668927|NCT01695239|580169317|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
160668928|NCT01695239|580169318|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
160668929|NCT01695239|580169319|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
160668930|NCT01695239|580169320|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
160668931|NCT01695239|580169321|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
160668932|NCT01695239|580169322|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
160668933|NCT01695239|580169323|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
160668934|NCT01695239|580169310|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668935|NCT01695239|580169311|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668936|NCT01695239|580169312|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668937|NCT01695239|580169313|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668938|NCT01695239|580169314|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668939|NCT01695239|580169315|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668940|NCT01695239|580169316|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668941|NCT01695239|580169317|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668942|NCT01695239|580169318|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
160668943|NCT01695239|580169319|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
160668944|NCT01695239|580169320|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668945|NCT01695239|580169321|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668946|NCT01695239|580169322|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668947|NCT01695239|580169323|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160668948|NCT01695239|580169310|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
160668949|NCT01695239|580169311|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
160668950|NCT01695239|580169312|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
160668951|NCT01695239|580169313|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
160668952|NCT01695239|580169314|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
160668953|NCT01695239|580169315|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
160668954|NCT01695239|580169316|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
160668955|NCT01695239|580169317|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
160668956|NCT01695239|580169318|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
160668957|NCT01695239|580169319|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
160668958|NCT01695239|580169320|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
160668959|NCT01695239|580169321|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
160668960|NCT01695239|580169322|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
160668961|NCT01695239|580169323|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
160668962|NCT01695239|580169310|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668963|NCT01695239|580169311|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668964|NCT01695239|580169312|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668965|NCT01695239|580169313|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668966|NCT01695239|580169314|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668967|NCT01695239|580169315|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668968|NCT01695239|580169316|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668969|NCT01695239|580169317|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668970|NCT01695239|580169318|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
160668971|NCT01695239|580169319|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
160668972|NCT01695239|580169320|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668973|NCT01695239|580169321|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668974|NCT01695239|580169322|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668975|NCT01695239|580169323|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
160668976|NCT01695239|580169310|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668977|NCT01695239|580169311|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668978|NCT01695239|580169312|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668979|NCT01695239|580169313|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668980|NCT01695239|580169314|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668981|NCT01695239|580169315|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668982|NCT01695239|580169316|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668983|NCT01695239|580169317|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668984|NCT01695239|580169318|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
160668985|NCT01695239|580169319|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
160668986|NCT01695239|580169320|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668987|NCT01695239|580169321|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668988|NCT01695239|580169322|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668989|NCT01695239|580169323|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160668990|NCT01695239|580169310|FG000|Extension Long-Term Extension Periods|Death|0|||
160668991|NCT01695239|580169311|FG001|Extension Long-Term Extension Periods|Death|0|||
160668992|NCT01695239|580169312|FG002|Extension Long-Term Extension Periods|Death|0|||
160668993|NCT01695239|580169313|FG003|Extension Long-Term Extension Periods|Death|0|||
160668994|NCT01695239|580169314|FG004|Extension Long-Term Extension Periods|Death|0|||
160668995|NCT01695239|580169315|FG005|Extension Long-Term Extension Periods|Death|0|||
160668996|NCT01695239|580169316|FG006|Extension Long-Term Extension Periods|Death|0|||
160668997|NCT01695239|580169317|FG007|Extension Long-Term Extension Periods|Death|0|||
160668998|NCT01695239|580169318|FG008|Extension Long-Term Extension Periods|Death|1|||
160668999|NCT01695239|580169319|FG009|Extension Long-Term Extension Periods|Death|0|||
160669000|NCT01695239|580169320|FG010|Extension Long-Term Extension Periods|Death|0|||
160669001|NCT01695239|580169321|FG011|Extension Long-Term Extension Periods|Death|0|||
160669002|NCT01695239|580169322|FG012|Extension Long-Term Extension Periods|Death|0|||
160669003|NCT01695239|580169323|FG013|Extension Long-Term Extension Periods|Death|0|||
160669004|NCT01695239|580169310|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160669005|NCT01695239|580169311|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160669006|NCT01695239|580169312|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160669007|NCT01695239|580169313|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160669008|NCT01695239|580169314|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160518961|NCT04025580|579629164|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
160518962|NCT04025580|579629165|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
160518963|NCT04025580|579629166|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
160669009|NCT01695239|580169315|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160669010|NCT01695239|580169316|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160669011|NCT01695239|580169317|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160669012|NCT01695239|580169318|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160669013|NCT01695239|580169319|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160669014|NCT01695239|580169320|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160669015|NCT01695239|580169321|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
160669016|NCT01695239|580169322|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
160669017|NCT01695239|580169323|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
160669018|NCT01695239|580169310|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669019|NCT01695239|580169311|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669020|NCT01695239|580169312|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669021|NCT01695239|580169313|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669022|NCT01695239|580169314|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669023|NCT01695239|580169315|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669024|NCT01695239|580169316|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669025|NCT01695239|580169317|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669026|NCT01695239|580169318|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669027|NCT01695239|580169319|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669028|NCT01695239|580169320|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669029|NCT01695239|580169321|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160669030|NCT01695239|580169322|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
160669031|NCT01695239|580169323|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
160669032|NCT01695239|580169310|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669033|NCT01695239|580169311|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669034|NCT01695239|580169312|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669035|NCT01695239|580169313|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669036|NCT01695239|580169314|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669037|NCT01695239|580169315|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669038|NCT01695239|580169316|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669039|NCT01695239|580169317|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669040|NCT01695239|580169318|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669041|NCT01695239|580169319|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669042|NCT01695239|580169320|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669043|NCT01695239|580169321|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669044|NCT01695239|580169322|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
160669045|NCT01695239|580169323|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
160669046|NCT01695239|580169310|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669047|NCT01695239|580169311|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669048|NCT01695239|580169312|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669049|NCT01695239|580169313|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669050|NCT01695239|580169314|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669051|NCT01695239|580169315|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669052|NCT01695239|580169316|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669053|NCT01695239|580169317|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669054|NCT01695239|580169318|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669055|NCT01695239|580169319|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669056|NCT01695239|580169320|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669057|NCT01695239|580169321|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669058|NCT01695239|580169322|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160669059|NCT01695239|580169323|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
160669060|NCT03502811|580169324|FG000|Overall Study|Death|157|||
160669061|NCT03502811|580169324|FG000|Overall Study|Withdrawal by Subject|105|||
160669062|NCT03502811|580169324|FG000|Overall Study|Lost to Follow-up|26|||
160669063|NCT03502811|580169324|FG000|Overall Study|No Visits (Missed)|31|||
160669064|NCT03913377|580169325|FG000|Period 1|Test Article no longer available|0|||
160669065|NCT03913377|580169326|FG001|Period 1|Test Article no longer available|1|||
160669066|NCT03913377|580169327|FG002|Period 1|Test Article no longer available|0|||
160669067|NCT03913377|580169325|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
160669068|NCT03913377|580169326|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
160669069|NCT03913377|580169327|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
160669070|NCT05239195|580169328|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
160669071|NCT05239195|580169329|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
160518964|NCT03305731|579629168|FG000|Overall Study|Protocol Violation|1|||
160518965|NCT01127139|579629171|FG000|Overall Study|Adverse Event|40|||
160518966|NCT01127139|579629171|FG000|Overall Study|Incompliance|12|||
160518967|NCT01127139|579629171|FG000|Overall Study|Lack of Efficacy|4|||
160518968|NCT01127139|579629171|FG000|Overall Study|Reason not specified|1|||
160669072|NCT02241551|580169330|FG000|Overall Study|Adverse Event|1|||
160669073|NCT02241551|580169331|FG001|Overall Study|Adverse Event|0|||
160669074|NCT02751424|580169341|FG000|Part 2|Adverse Event|0|||
160669075|NCT02751424|580169342|FG001|Part 2|Adverse Event|0|||
160669076|NCT02751424|580169343|FG002|Part 2|Adverse Event|0|||
160669077|NCT02751424|580169344|FG003|Part 2|Adverse Event|0|||
160669078|NCT02751424|580169345|FG004|Part 2|Adverse Event|0|||
160669079|NCT02751424|580169346|FG005|Part 2|Adverse Event|0|||
160669080|NCT02751424|580169347|FG006|Part 2|Adverse Event|0|||
160669081|NCT02751424|580169348|FG007|Part 2|Adverse Event|5|||
160669082|NCT02751424|580169349|FG008|Part 2|Adverse Event|0|||
160669083|NCT02197416|580169350|FG000|Overall Study|Other reasons|0|||
160669084|NCT02197416|580169351|FG001|Overall Study|Other reasons|2|||
160669085|NCT02197416|580169352|FG002|Overall Study|Other reasons|5|||
160669086|NCT02197416|580169350|FG000|Overall Study|Withdrawal by Subject|0|||
160669087|NCT02197416|580169351|FG001|Overall Study|Withdrawal by Subject|2|||
160669088|NCT02197416|580169352|FG002|Overall Study|Withdrawal by Subject|1|||
160669089|NCT02197416|580169350|FG000|Overall Study|Protocol Violation|1|||
160669090|NCT02197416|580169351|FG001|Overall Study|Protocol Violation|0|||
160669091|NCT02197416|580169352|FG002|Overall Study|Protocol Violation|1|||
160669092|NCT02197416|580169350|FG000|Overall Study|Adverse Event|0|||
160669093|NCT02197416|580169351|FG001|Overall Study|Adverse Event|0|||
160669094|NCT02197416|580169352|FG002|Overall Study|Adverse Event|1|||
160669095|NCT00716625|580169353|FG000|Overall Study|Safety was not Assessable|1|||
160669096|NCT01492439|580169354|FG000|Overall Study|Withdrew from RTE|4|||
160669097|NCT01492439|580169355|FG001|Overall Study|Withdrew from RTE|9|||
160669098|NCT04349267|580169356|FG000|Overall Study|Adverse Event|0|||
160669099|NCT04349267|580169357|FG001|Overall Study|Adverse Event|0|||
160669100|NCT04349267|580169358|FG002|Overall Study|Adverse Event|0|||
160669101|NCT04349267|580169359|FG003|Overall Study|Adverse Event|0|||
160669102|NCT04349267|580169360|FG004|Overall Study|Adverse Event|0|||
160669103|NCT04349267|580169361|FG005|Overall Study|Adverse Event|1|||
160669104|NCT04349267|580169362|FG006|Overall Study|Adverse Event|0|||
160669105|NCT04349267|580169356|FG000|Overall Study|Other reason|0|||
160669106|NCT04349267|580169357|FG001|Overall Study|Other reason|1|||
160669107|NCT04349267|580169358|FG002|Overall Study|Other reason|0|||
160669108|NCT04349267|580169359|FG003|Overall Study|Other reason|0|||
160669109|NCT04349267|580169360|FG004|Overall Study|Other reason|1|||
160669110|NCT04349267|580169361|FG005|Overall Study|Other reason|1|||
160669111|NCT04349267|580169362|FG006|Overall Study|Other reason|1|||
160669112|NCT04349267|580169356|FG000|Overall Study|Disease Progression|2|||
160669113|NCT04349267|580169357|FG001|Overall Study|Disease Progression|0|||
160669114|NCT04349267|580169358|FG002|Overall Study|Disease Progression|2|||
160669115|NCT04349267|580169359|FG003|Overall Study|Disease Progression|3|||
160669116|NCT04349267|580169360|FG004|Overall Study|Disease Progression|3|||
160669117|NCT04349267|580169361|FG005|Overall Study|Disease Progression|7|||
160669118|NCT04349267|580169362|FG006|Overall Study|Disease Progression|10|||
160669119|NCT04349267|580169356|FG000|Overall Study|Participant withdrew consent|0|||
160669120|NCT04349267|580169357|FG001|Overall Study|Participant withdrew consent|1|||
160669121|NCT04349267|580169358|FG002|Overall Study|Participant withdrew consent|0|||
160669122|NCT04349267|580169359|FG003|Overall Study|Participant withdrew consent|0|||
160669123|NCT04349267|580169360|FG004|Overall Study|Participant withdrew consent|0|||
160669124|NCT04349267|580169361|FG005|Overall Study|Participant withdrew consent|0|||
160669125|NCT04349267|580169362|FG006|Overall Study|Participant withdrew consent|1|||
160669126|NCT03689400|580169363|FG000|Overall Study|Lost to Follow-up|4|||
160669127|NCT03128723|580169364|FG000|Overall Study|Withdrawal by Subject|2|||
160669128|NCT04618211|580169365|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
160669129|NCT04618211|580169366|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
160669130|NCT04618211|580169367|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
160669131|NCT04618211|580169365|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
160669132|NCT04618211|580169366|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
160518969|NCT01136772|579629172|FG000|Overall Study|Adverse Event|15|||
160518970|NCT01136772|579629173|FG001|Overall Study|Adverse Event|14|||
160669133|NCT04618211|580169367|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
160669134|NCT04618211|580169365|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
160669135|NCT04618211|580169366|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
160669136|NCT04618211|580169367|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
160669137|NCT01383486|580169368|FG000|Overall Study|Lost to Follow-up|10|||
160669138|NCT01383486|580169368|FG000|Overall Study|Incomplete information for analysis|2|||
160518971|NCT01136772|579629172|FG000|Overall Study|Lack of Efficacy|42|||
160669139|NCT01383486|580169368|FG000|Overall Study|Did not take any product|6|||
160669140|NCT01839279|580169370|FG000|Overall Study|Adverse Event|4|||
160669141|NCT01839279|580169371|FG001|Overall Study|Adverse Event|1|||
160669142|NCT01839279|580169372|FG002|Overall Study|Adverse Event|1|||
160669143|NCT01839279|580169370|FG000|Overall Study|Withdrawal by Subject|4|||
160669144|NCT01839279|580169371|FG001|Overall Study|Withdrawal by Subject|1|||
160669145|NCT01839279|580169372|FG002|Overall Study|Withdrawal by Subject|1|||
160669146|NCT01839279|580169370|FG000|Overall Study|Classified as 'Other'|5|||
160669147|NCT01839279|580169371|FG001|Overall Study|Classified as 'Other'|0|||
160669148|NCT01839279|580169372|FG002|Overall Study|Classified as 'Other'|0|||
160669149|NCT03199963|580169373|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
160669150|NCT03199963|580169374|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
160669151|NCT03199963|580169373|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
160669152|NCT03199963|580169374|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
160669153|NCT03199963|580169373|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
160669154|NCT03199963|580169374|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
160669155|NCT03199963|580169373|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
160669156|NCT03199963|580169374|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
160669157|NCT03199963|580169373|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
160669158|NCT03199963|580169374|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
160669159|NCT03199963|580169373|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
160669160|NCT03199963|580169374|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
160669161|NCT02105272|580169381|FG000|Overall Study|Adverse Event|1|||
160669162|NCT02105272|580169382|FG001|Overall Study|Adverse Event|2|||
160669163|NCT02105272|580169381|FG000|Overall Study|Physician Decision|0|||
160669164|NCT02105272|580169382|FG001|Overall Study|Physician Decision|1|||
160669165|NCT02105272|580169381|FG000|Overall Study|Protocol Violation|2|||
160669166|NCT02105272|580169382|FG001|Overall Study|Protocol Violation|0|||
160669167|NCT02105272|580169381|FG000|Overall Study|Withdrawal by Subject|2|||
160669168|NCT02105272|580169382|FG001|Overall Study|Withdrawal by Subject|0|||
160669169|NCT03930732|580169383|FG000|Overall Study|Adverse Event|9|||
160669170|NCT03930732|580169384|FG001|Overall Study|Adverse Event|7|||
160669171|NCT03930732|580169383|FG000|Overall Study|Poor compliance to protocol|0|||
160669172|NCT03930732|580169384|FG001|Overall Study|Poor compliance to protocol|1|||
160669173|NCT03930732|580169383|FG000|Overall Study|Withdrawal by Subject|23|||
160669174|NCT03930732|580169384|FG001|Overall Study|Withdrawal by Subject|11|||
160669175|NCT03930732|580169383|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
160669176|NCT03930732|580169384|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
160669177|NCT03930732|580169383|FG000|Overall Study|Other reason not related to COVID-19|5|||
160669178|NCT03930732|580169384|FG001|Overall Study|Other reason not related to COVID-19|8|||
160669179|NCT04128761|580169391|FG000|Overall Study|Lost to Follow-up|5|||
160669180|NCT04128761|580169392|FG001|Overall Study|Lost to Follow-up|6|||
160669181|NCT06539676|580169393|FG000|Overall Study|Early study termination|1|||
160669182|NCT06539676|580169394|FG001|Overall Study|Early study termination|0|||
160669183|NCT06539676|580169395|FG002|Overall Study|Early study termination|6|||
160669184|NCT00830024|580169398|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
160669185|NCT00830024|580169399|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
160669186|NCT01056484|580170522|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
160669187|NCT01056484|580170523|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
160669188|NCT01056484|580170522|FG000|Randomized Controlled Trial|Physician Decision|1|||
160669189|NCT01056484|580170523|FG001|Randomized Controlled Trial|Physician Decision|0|||
160669190|NCT01056484|580170522|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
160669191|NCT01056484|580170523|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
160669192|NCT00835575|580170526|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
160669193|NCT00835575|580170527|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
160669194|NCT01440803|580170528|FG000|Overall Study|Met study stopping rule|2|||
160669195|NCT01440803|580170529|FG001|Overall Study|Met study stopping rule|1|||
160669196|NCT01440803|580170528|FG000|Overall Study|Lost to Follow-up|0|||
160669197|NCT01440803|580170529|FG001|Overall Study|Lost to Follow-up|2|||
160669198|NCT01440803|580170528|FG000|Overall Study|Withdrawal by Subject|0|||
160669199|NCT01440803|580170529|FG001|Overall Study|Withdrawal by Subject|1|||
160669200|NCT01204294|580170530|FG000|Overall Study|Adverse Event|2|||
160669201|NCT01204294|580170531|FG001|Overall Study|Adverse Event|6|||
160669202|NCT01204294|580170532|FG002|Overall Study|Adverse Event|0|||
160669203|NCT01204294|580170533|FG003|Overall Study|Adverse Event|7|||
160669204|NCT01204294|580170534|FG004|Overall Study|Adverse Event|1|||
160518972|NCT01136772|579629173|FG001|Overall Study|Lack of Efficacy|39|||
160669205|NCT01204294|580170535|FG005|Overall Study|Adverse Event|4|||
160669206|NCT01204294|580170536|FG006|Overall Study|Adverse Event|0|||
160669207|NCT01204294|580170530|FG000|Overall Study|Protocol Violation|1|||
160669208|NCT01204294|580170531|FG001|Overall Study|Protocol Violation|0|||
160669209|NCT01204294|580170532|FG002|Overall Study|Protocol Violation|2|||
160669210|NCT01204294|580170533|FG003|Overall Study|Protocol Violation|1|||
160669211|NCT01204294|580170534|FG004|Overall Study|Protocol Violation|0|||
160669212|NCT01204294|580170535|FG005|Overall Study|Protocol Violation|0|||
160669213|NCT01204294|580170536|FG006|Overall Study|Protocol Violation|0|||
160669214|NCT01204294|580170530|FG000|Overall Study|Withdrawal by Subject|0|||
160669215|NCT01204294|580170531|FG001|Overall Study|Withdrawal by Subject|2|||
160669216|NCT01204294|580170532|FG002|Overall Study|Withdrawal by Subject|2|||
160669217|NCT01204294|580170533|FG003|Overall Study|Withdrawal by Subject|1|||
160669218|NCT01204294|580170534|FG004|Overall Study|Withdrawal by Subject|1|||
160669219|NCT01204294|580170535|FG005|Overall Study|Withdrawal by Subject|1|||
160669220|NCT01204294|580170536|FG006|Overall Study|Withdrawal by Subject|2|||
160669221|NCT01204294|580170530|FG000|Overall Study|Lack of Efficacy|0|||
160669222|NCT01204294|580170531|FG001|Overall Study|Lack of Efficacy|0|||
160669223|NCT01204294|580170532|FG002|Overall Study|Lack of Efficacy|0|||
160669224|NCT01204294|580170533|FG003|Overall Study|Lack of Efficacy|2|||
160669225|NCT01204294|580170534|FG004|Overall Study|Lack of Efficacy|0|||
160669226|NCT01204294|580170535|FG005|Overall Study|Lack of Efficacy|0|||
160669227|NCT01204294|580170536|FG006|Overall Study|Lack of Efficacy|0|||
160669228|NCT01204294|580170530|FG000|Overall Study|Other (house moving)|0|||
160669229|NCT01204294|580170531|FG001|Overall Study|Other (house moving)|0|||
160669230|NCT01204294|580170532|FG002|Overall Study|Other (house moving)|1|||
160669231|NCT01204294|580170533|FG003|Overall Study|Other (house moving)|0|||
160669232|NCT01204294|580170534|FG004|Overall Study|Other (house moving)|0|||
160669233|NCT01204294|580170535|FG005|Overall Study|Other (house moving)|0|||
160669234|NCT01204294|580170536|FG006|Overall Study|Other (house moving)|0|||
160669235|NCT02075463|580170537|FG000|Overall Study|Adverse Event|3|||
160669236|NCT02075463|580170537|FG000|Overall Study|Par. reached stopping criteria|4|||
160669237|NCT02075463|580170537|FG000|Overall Study|Withdrawal by Subject|1|||
160669238|NCT00673660|580170538|FG000|Overall Study|Lost to Follow-up|107|||
160669239|NCT01527006|580170539|FG000|Core Study|Adverse Event|0|||
160669240|NCT01527006|580170540|FG001|Core Study|Adverse Event|2|||
160669241|NCT01527006|580170539|FG000|Core Study|Lost to Follow-up|0|||
160669242|NCT01527006|580170540|FG001|Core Study|Lost to Follow-up|1|||
160669243|NCT01527006|580170539|FG000|Core Study|Subject Choice|1|||
160669244|NCT01527006|580170540|FG001|Core Study|Subject Choice|0|||
160669245|NCT01527006|580170539|FG000|Core Study|Inadequate Therapeutic Effect|1|||
160669246|NCT01527006|580170540|FG001|Core Study|Inadequate Therapeutic Effect|0|||
160669247|NCT01527006|580170539|FG000|Core Study|Withdrawal by Subject|0|||
160669248|NCT01527006|580170540|FG001|Core Study|Withdrawal by Subject|1|||
160669249|NCT01527006|580170539|FG000|Core Study|Other|0|||
160669250|NCT01527006|580170540|FG001|Core Study|Other|2|||
160669251|NCT01527006|580170539|FG000|Extension Phase|Adverse Event|4|||
160669252|NCT01527006|580170540|FG001|Extension Phase|Adverse Event|2|||
160669253|NCT01527006|580170539|FG000|Extension Phase|Lost to Follow-up|0|||
160669254|NCT01527006|580170540|FG001|Extension Phase|Lost to Follow-up|1|||
160669255|NCT01527006|580170539|FG000|Extension Phase|Subject Choice|1|||
160669256|NCT01527006|580170540|FG001|Extension Phase|Subject Choice|1|||
160669257|NCT01527006|580170539|FG000|Extension Phase|Inadequate therapeutic effect|1|||
160669258|NCT01527006|580170540|FG001|Extension Phase|Inadequate therapeutic effect|1|||
160669259|NCT01527006|580170539|FG000|Extension Phase|Other|0|||
160669260|NCT01527006|580170540|FG001|Extension Phase|Other|3|||
160669261|NCT00245063|580170541|FG000|Overall Study|Adverse Event|6|||
160669262|NCT00245063|580170542|FG001|Overall Study|Adverse Event|5|||
160669263|NCT00245063|580170541|FG000|Overall Study|Death|1|||
160669264|NCT00245063|580170542|FG001|Overall Study|Death|0|||
160669265|NCT05919823|580170547|FG000|Pre-Treatment Period|Screen failure|1|||
160669266|NCT05919823|580170548|FG001|Pre-Treatment Period|Screen failure|0|||
160669267|NCT05919823|580170549|FG002|Pre-Treatment Period|Screen failure|0|||
160518973|NCT01136772|579629172|FG000|Overall Study|Administrative|14|||
160518974|NCT01136772|579629173|FG001|Overall Study|Administrative|12|||
160518975|NCT01136772|579629172|FG000|Overall Study|Withdrawal by Subject|33|||
160518976|NCT01136772|579629173|FG001|Overall Study|Withdrawal by Subject|36|||
160518977|NCT01136772|579629172|FG000|Overall Study|Did not receive injection|10|||
160518978|NCT01136772|579629173|FG001|Overall Study|Did not receive injection|7|||
160518979|NCT01136772|579629172|FG000|Overall Study|Did not follow up after first injection|2|||
160518980|NCT01136772|579629173|FG001|Overall Study|Did not follow up after first injection|2|||
160518981|NCT03421431|579629179|FG000|Overall Study|Adverse Event|2|||
160518982|NCT03421431|579629180|FG001|Overall Study|Adverse Event|1|||
160518983|NCT03421431|579629181|FG002|Overall Study|Adverse Event|12|||
160518984|NCT03421431|579629179|FG000|Overall Study|Lost to Follow-up|1|||
160518985|NCT03421431|579629180|FG001|Overall Study|Lost to Follow-up|1|||
160518986|NCT03421431|579629181|FG002|Overall Study|Lost to Follow-up|1|||
160518987|NCT03421431|579629179|FG000|Overall Study|Withdrawal by Subject|3|||
160518988|NCT03421431|579629180|FG001|Overall Study|Withdrawal by Subject|2|||
160518989|NCT03421431|579629181|FG002|Overall Study|Withdrawal by Subject|1|||
160518990|NCT03421431|579629179|FG000|Overall Study|Protocol Violation|0|||
160518991|NCT03421431|579629180|FG001|Overall Study|Protocol Violation|1|||
160518992|NCT03421431|579629181|FG002|Overall Study|Protocol Violation|0|||
160518993|NCT03421431|579629179|FG000|Overall Study|Participant met Stopping Rules|0|||
160669268|NCT05919823|580170550|FG003|Pre-Treatment Period|Screen failure|0|||
160669269|NCT05919823|580170547|FG000|Pre-Treatment Period|Protocol Violation|0|||
160669270|NCT05919823|580170548|FG001|Pre-Treatment Period|Protocol Violation|1|||
160669271|NCT05919823|580170549|FG002|Pre-Treatment Period|Protocol Violation|0|||
160669272|NCT05919823|580170550|FG003|Pre-Treatment Period|Protocol Violation|0|||
160669273|NCT05919823|580170547|FG000|Double-Blind Period|Adverse Event|8|||
160669274|NCT05919823|580170548|FG001|Double-Blind Period|Adverse Event|9|||
160669275|NCT05919823|580170549|FG002|Double-Blind Period|Adverse Event|0|||
160669276|NCT05919823|580170550|FG003|Double-Blind Period|Adverse Event|0|||
160669277|NCT05919823|580170547|FG000|Double-Blind Period|Protocol Violation|2|||
160669278|NCT05919823|580170548|FG001|Double-Blind Period|Protocol Violation|1|||
160669279|NCT05919823|580170549|FG002|Double-Blind Period|Protocol Violation|0|||
160669280|NCT05919823|580170550|FG003|Double-Blind Period|Protocol Violation|0|||
160669281|NCT05919823|580170547|FG000|Double-Blind Period|Participant withdrew consent|11|||
160669282|NCT05919823|580170548|FG001|Double-Blind Period|Participant withdrew consent|7|||
160669283|NCT05919823|580170549|FG002|Double-Blind Period|Participant withdrew consent|0|||
160669284|NCT05919823|580170550|FG003|Double-Blind Period|Participant withdrew consent|0|||
160669285|NCT05919823|580170547|FG000|Double-Blind Period|Other reasons|2|||
160669286|NCT05919823|580170548|FG001|Double-Blind Period|Other reasons|3|||
160669287|NCT05919823|580170549|FG002|Double-Blind Period|Other reasons|0|||
160669288|NCT05919823|580170550|FG003|Double-Blind Period|Other reasons|0|||
160669289|NCT05919823|580170547|FG000|Open Label Period|Adverse Event|0|||
160669290|NCT05919823|580170548|FG001|Open Label Period|Adverse Event|0|||
160669291|NCT05919823|580170549|FG002|Open Label Period|Adverse Event|2|||
160669292|NCT05919823|580170550|FG003|Open Label Period|Adverse Event|4|||
160669293|NCT05919823|580170547|FG000|Open Label Period|Lost to Follow-up|0|||
160669294|NCT05919823|580170548|FG001|Open Label Period|Lost to Follow-up|0|||
160669295|NCT05919823|580170549|FG002|Open Label Period|Lost to Follow-up|1|||
160669296|NCT05919823|580170550|FG003|Open Label Period|Lost to Follow-up|0|||
160669297|NCT05919823|580170547|FG000|Open Label Period|Protocol Violation|0|||
160669298|NCT05919823|580170548|FG001|Open Label Period|Protocol Violation|0|||
160669299|NCT05919823|580170549|FG002|Open Label Period|Protocol Violation|0|||
160669300|NCT05919823|580170550|FG003|Open Label Period|Protocol Violation|1|||
160669301|NCT05919823|580170547|FG000|Open Label Period|Participant withdrew consent|0|||
160669302|NCT05919823|580170548|FG001|Open Label Period|Participant withdrew consent|0|||
160669303|NCT05919823|580170549|FG002|Open Label Period|Participant withdrew consent|8|||
160669304|NCT05919823|580170550|FG003|Open Label Period|Participant withdrew consent|6|||
160669305|NCT05919823|580170547|FG000|Open Label Period|Death|0|||
160669306|NCT05919823|580170548|FG001|Open Label Period|Death|0|||
160669307|NCT05919823|580170549|FG002|Open Label Period|Death|0|||
160669308|NCT05919823|580170550|FG003|Open Label Period|Death|1|||
160669309|NCT05919823|580170547|FG000|Open Label Period|Other reasons|0|||
160669310|NCT05919823|580170548|FG001|Open Label Period|Other reasons|0|||
160669311|NCT05919823|580170549|FG002|Open Label Period|Other reasons|9|||
160669312|NCT05919823|580170550|FG003|Open Label Period|Other reasons|5|||
160669313|NCT01648582|580170551|FG000|Overall Study|Adverse Event|6|||
160669314|NCT01648582|580170552|FG001|Overall Study|Adverse Event|11|||
160669315|NCT01648582|580170553|FG002|Overall Study|Adverse Event|2|||
160669316|NCT01648582|580170551|FG000|Overall Study|Lost to Follow-up|9|||
160669317|NCT01648582|580170552|FG001|Overall Study|Lost to Follow-up|6|||
160669318|NCT01648582|580170553|FG002|Overall Study|Lost to Follow-up|8|||
160669319|NCT01648582|580170551|FG000|Overall Study|Protocol Violation|1|||
160669320|NCT01648582|580170552|FG001|Overall Study|Protocol Violation|2|||
160669321|NCT01648582|580170553|FG002|Overall Study|Protocol Violation|1|||
160669322|NCT01648582|580170551|FG000|Overall Study|Withdrawal by Subject|15|||
160669323|NCT01648582|580170552|FG001|Overall Study|Withdrawal by Subject|17|||
160669324|NCT01648582|580170553|FG002|Overall Study|Withdrawal by Subject|17|||
160669325|NCT01648582|580170551|FG000|Overall Study|Physician Decision|0|||
160669326|NCT01648582|580170552|FG001|Overall Study|Physician Decision|1|||
160669327|NCT01648582|580170553|FG002|Overall Study|Physician Decision|3|||
160669328|NCT01648582|580170551|FG000|Overall Study|Death|1|||
160669329|NCT01648582|580170552|FG001|Overall Study|Death|0|||
160669330|NCT01648582|580170553|FG002|Overall Study|Death|0|||
160669331|NCT01648582|580170551|FG000|Overall Study|Sponsor Decision|0|||
160669332|NCT01648582|580170552|FG001|Overall Study|Sponsor Decision|1|||
160669333|NCT01648582|580170553|FG002|Overall Study|Sponsor Decision|1|||
160518994|NCT03421431|579629180|FG001|Overall Study|Participant met Stopping Rules|1|||
160518995|NCT03421431|579629181|FG002|Overall Study|Participant met Stopping Rules|0|||
160518996|NCT00141726|579629183|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
160518997|NCT00235326|579629191|FG000|Overall Study|Lost to Follow-up|746|||
160518998|NCT00235326|579629192|FG001|Overall Study|Lost to Follow-up|1400|||
160518999|NCT00455325|579629194|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
160519000|NCT00455325|579629195|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
160519001|NCT00455325|579629196|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
160519002|NCT00455325|579629197|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
160519003|NCT00455325|579629194|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
160669334|NCT00466167|580170565|FG000|Overall Study|Adverse Event|8|||
160669335|NCT00466167|580170566|FG001|Overall Study|Adverse Event|8|||
160669336|NCT00466167|580170567|FG002|Overall Study|Adverse Event|7|||
160519004|NCT00455325|579629195|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
160669337|NCT00466167|580170565|FG000|Overall Study|Lack of Efficacy|2|||
160669338|NCT00466167|580170566|FG001|Overall Study|Lack of Efficacy|0|||
160669339|NCT00466167|580170567|FG002|Overall Study|Lack of Efficacy|3|||
160669340|NCT00466167|580170565|FG000|Overall Study|Protocol Violation|1|||
160669341|NCT00466167|580170566|FG001|Overall Study|Protocol Violation|1|||
160519005|NCT00455325|579629196|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
160519006|NCT00455325|579629197|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
160519007|NCT00455325|579629194|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
160519008|NCT00455325|579629195|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
160519009|NCT00455325|579629196|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
160519010|NCT00455325|579629197|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
160519011|NCT00455325|579629194|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
160519012|NCT00455325|579629195|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
160519013|NCT00455325|579629196|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
160519014|NCT00455325|579629197|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
160519015|NCT00455325|579629194|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
160519016|NCT00455325|579629195|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
160519017|NCT00455325|579629196|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
160519018|NCT00455325|579629197|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
160519019|NCT00455325|579629194|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
160519020|NCT00455325|579629195|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
160519021|NCT00455325|579629196|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
160519022|NCT00455325|579629197|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
160519023|NCT00455325|579629194|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
160519024|NCT00455325|579629195|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
160519025|NCT00455325|579629196|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
160519026|NCT00455325|579629197|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
160519027|NCT02435966|579629198|FG000|Overall Study|Withdrawal by Subject|0|||
160519028|NCT02435966|579629199|FG001|Overall Study|Withdrawal by Subject|1|||
160519029|NCT02435966|579629200|FG002|Overall Study|Withdrawal by Subject|0|||
160519030|NCT00928746|579629204|FG000|Overall Study|Adverse Event|2|||
160519031|NCT00928746|579629204|FG000|Overall Study|Protocol Violation|1|||
160519032|NCT00928746|579629204|FG000|Overall Study|Withdrawal by Subject|1|||
160519033|NCT00928746|579629204|FG000|Overall Study|Other|2|||
160519034|NCT02745392|579629209|FG000|Overall Study|Lost to Follow-up|0|||
160519035|NCT02745392|579629210|FG001|Overall Study|Lost to Follow-up|1|||
160519036|NCT02745392|579629211|FG002|Overall Study|Lost to Follow-up|0|||
160519037|NCT02745392|579629212|FG003|Overall Study|Lost to Follow-up|0|||
160519038|NCT02004353|579629217|FG000|Overall Study|Voluntary participation|1334|||
160519039|NCT01691768|579629218|FG000|Overall Study|Death|0|||
160519040|NCT01691768|579629219|FG001|Overall Study|Death|2|||
160519041|NCT01691768|579629218|FG000|Overall Study|Lost to Follow-up|4|||
160519042|NCT01691768|579629219|FG001|Overall Study|Lost to Follow-up|3|||
160519043|NCT01691768|579629218|FG000|Overall Study|Withdrawal by Subject|10|||
160519044|NCT01691768|579629219|FG001|Overall Study|Withdrawal by Subject|9|||
160519045|NCT01691768|579629218|FG000|Overall Study|Relocated|0|||
160519046|NCT01691768|579629219|FG001|Overall Study|Relocated|1|||
160519047|NCT01691768|579629218|FG000|Overall Study|Investigator decision|1|||
160519048|NCT01691768|579629219|FG001|Overall Study|Investigator decision|1|||
160519049|NCT02481947|579629230|FG000|Overall Study|Withdrawal by Subject|24|||
160519050|NCT02481947|579629231|FG001|Overall Study|Withdrawal by Subject|10|||
160519051|NCT02481947|579629230|FG000|Overall Study|Lost to Follow-up|11|||
160519052|NCT02481947|579629231|FG001|Overall Study|Lost to Follow-up|5|||
160519053|NCT02481947|579629230|FG000|Overall Study|Adverse Event|6|||
160519054|NCT02481947|579629231|FG001|Overall Study|Adverse Event|11|||
160519055|NCT02481947|579629230|FG000|Overall Study|Physician Decision|4|||
160519056|NCT02481947|579629231|FG001|Overall Study|Physician Decision|5|||
160519057|NCT02481947|579629230|FG000|Overall Study|Protocol Violation|1|||
160519058|NCT02481947|579629231|FG001|Overall Study|Protocol Violation|5|||
160519059|NCT01007448|579629232|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
160519060|NCT01007448|579629233|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
160519061|NCT01007448|579629232|FG000|Overall Study|Staph Skin Infection Flare|1|||
160519062|NCT01007448|579629233|FG001|Overall Study|Staph Skin Infection Flare|0|||
160519063|NCT01007448|579629232|FG000|Overall Study|Participant Leaving the Country|1|||
160519064|NCT01007448|579629233|FG001|Overall Study|Participant Leaving the Country|0|||
160519065|NCT01007448|579629232|FG000|Overall Study|Participant Given Prohibited Medication|1|||
160669342|NCT00466167|580170567|FG002|Overall Study|Protocol Violation|2|||
160669343|NCT00466167|580170565|FG000|Overall Study|Lost to Follow-up|3|||
160669344|NCT00466167|580170566|FG001|Overall Study|Lost to Follow-up|2|||
160669345|NCT00466167|580170567|FG002|Overall Study|Lost to Follow-up|2|||
160669346|NCT00466167|580170565|FG000|Overall Study|Withdrawal by Subject|4|||
160669347|NCT00466167|580170566|FG001|Overall Study|Withdrawal by Subject|1|||
160669348|NCT00466167|580170567|FG002|Overall Study|Withdrawal by Subject|6|||
160519066|NCT01007448|579629233|FG001|Overall Study|Participant Given Prohibited Medication|0|||
160669349|NCT00466167|580170565|FG000|Overall Study|patient did not meet inclusion criteria|1|||
160519067|NCT01007448|579629232|FG000|Overall Study|Progressive Disease|1|||
160519068|NCT01007448|579629233|FG001|Overall Study|Progressive Disease|2|||
160519069|NCT01007448|579629232|FG000|Overall Study|Lack of Efficacy|2|||
160519070|NCT01007448|579629233|FG001|Overall Study|Lack of Efficacy|0|||
160519071|NCT01007448|579629232|FG000|Overall Study|Withdrawal by Subject|2|||
160669350|NCT00466167|580170566|FG001|Overall Study|patient did not meet inclusion criteria|0|||
160669351|NCT00466167|580170567|FG002|Overall Study|patient did not meet inclusion criteria|1|||
160669352|NCT00466167|580170565|FG000|Overall Study|Not treated|1|||
160669353|NCT00466167|580170566|FG001|Overall Study|Not treated|0|||
160669354|NCT00466167|580170567|FG002|Overall Study|Not treated|0|||
160669355|NCT03534193|580170568|FG000|Overall Study|Lost to Follow-up|1|||
160669356|NCT03534193|580170569|FG001|Overall Study|Lost to Follow-up|3|||
160669357|NCT02699463|580170570|FG000|Overall Study|Lost to Follow-up|11|||
160669358|NCT02699463|580170571|FG001|Overall Study|Lost to Follow-up|8|||
160669359|NCT02699463|580170570|FG000|Overall Study|Withdrawal by Subject|4|||
160669360|NCT02699463|580170571|FG001|Overall Study|Withdrawal by Subject|1|||
160669361|NCT02488239|580170572|FG000|Overall Study|Death|3|||
160669362|NCT02488239|580170572|FG000|Overall Study|Withdrawal by Subject|3|||
160669363|NCT02488239|580170572|FG000|Overall Study|Physician Decision|2|||
160669364|NCT02488239|580170572|FG000|Overall Study|Consent ineligible|1|||
160669365|NCT02488239|580170572|FG000|Overall Study|Did not undergo implant procedure|1|||
160669366|NCT04414930|580170573|FG000|Overall Study|Withdrawal by Subject|1|||
160669367|NCT04414930|580170574|FG001|Overall Study|Withdrawal by Subject|3|||
160669368|NCT03325881|580170575|FG000|Overall Study|Protocol Violation|0|||
160669369|NCT03325881|580170576|FG001|Overall Study|Protocol Violation|1|||
160669370|NCT03325881|580170575|FG000|Overall Study|Withdrawal by Subject|0|||
160669371|NCT03325881|580170576|FG001|Overall Study|Withdrawal by Subject|2|||
160669372|NCT03325881|580170575|FG000|Overall Study|Lack of Efficacy|2|||
160669373|NCT03325881|580170576|FG001|Overall Study|Lack of Efficacy|0|||
160669374|NCT03325881|580170575|FG000|Overall Study|Not treated|1|||
160669375|NCT03325881|580170576|FG001|Overall Study|Not treated|0|||
160669376|NCT01848938|580170596|FG000|Overall Study|Lost to Follow-up|1|||
160669377|NCT01848938|580170597|FG001|Overall Study|Lost to Follow-up|1|||
160669378|NCT00909038|580170598|FG000|Overall Study|Protocol Violation|187|||
160669379|NCT00909038|580170598|FG000|Overall Study|Non-evaluable Subjects|230|||
160669380|NCT00207090|580170599|FG000|Overall Study|Study drug toxicity|3|||
160669381|NCT00207090|580170599|FG000|Overall Study|Chest wall mass larger|1|||
160669382|NCT00207090|580170599|FG000|Overall Study|Disease progression/relapse|2|||
160669383|NCT00207090|580170599|FG000|Overall Study|Physician Decision|1|||
160669384|NCT00909753|580170602|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
160669385|NCT00909753|580170603|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
160669386|NCT00909753|580170602|FG000|Period: Second Intervention|Protocol Violation|1|||
160669387|NCT00909753|580170603|FG001|Period: Second Intervention|Protocol Violation|0|||
160669388|NCT01895335|580170608|FG000|Overall Study|Adverse Event|106|||
160669389|NCT01895335|580170608|FG000|Overall Study|Lack of Efficacy|53|||
160669390|NCT01895335|580170608|FG000|Overall Study|Poor Compliance to Protocol|11|||
160669391|NCT01895335|580170608|FG000|Overall Study|Included But Not treated|1|||
160669392|NCT01895335|580170608|FG000|Overall Study|Other than Specified Above|44|||
160669393|NCT03480763|580170609|FG000|Overall Study|Withdrawal by Subject|18|||
160669394|NCT03480763|580170610|FG001|Overall Study|Withdrawal by Subject|10|||
160669395|NCT03480763|580170609|FG000|Overall Study|Lost to Follow-up|4|||
160669396|NCT03480763|580170610|FG001|Overall Study|Lost to Follow-up|7|||
160669397|NCT03480763|580170609|FG000|Overall Study|non-study pneumococcal vaccine|1|||
160669398|NCT03480763|580170610|FG001|Overall Study|non-study pneumococcal vaccine|0|||
160669399|NCT03480763|580170609|FG000|Overall Study|oncological treatment|0|||
160669400|NCT03480763|580170610|FG001|Overall Study|oncological treatment|2|||
160669401|NCT03480763|580170609|FG000|Overall Study|pain with vaccination|1|||
160669402|NCT03480763|580170610|FG001|Overall Study|pain with vaccination|0|||
160669403|NCT01647828|580170611|FG000|Overall Study|Death|3|||
160669404|NCT01647828|580170612|FG001|Overall Study|Death|4|||
160669405|NCT01647828|580170613|FG002|Overall Study|Death|4|||
160669406|NCT01647828|580170614|FG003|Overall Study|Death|5|||
160669407|NCT01647828|580170615|FG004|Overall Study|Death|6|||
160669408|NCT01647828|580170616|FG005|Overall Study|Death|3|||
160669409|NCT01647828|580170617|FG006|Overall Study|Death|10|||
160669410|NCT01647828|580170618|FG007|Overall Study|Death|60|||
160669411|NCT01647828|580170619|FG008|Overall Study|Death|71|||
160669412|NCT01647828|580170611|FG000|Overall Study|Withdrawal by Subject|2|||
160669413|NCT01647828|580170612|FG001|Overall Study|Withdrawal by Subject|0|||
160669414|NCT01647828|580170613|FG002|Overall Study|Withdrawal by Subject|0|||
160669415|NCT01647828|580170614|FG003|Overall Study|Withdrawal by Subject|1|||
160669416|NCT01647828|580170615|FG004|Overall Study|Withdrawal by Subject|0|||
160669417|NCT01647828|580170616|FG005|Overall Study|Withdrawal by Subject|0|||
160669418|NCT01647828|580170617|FG006|Overall Study|Withdrawal by Subject|1|||
160669419|NCT01647828|580170618|FG007|Overall Study|Withdrawal by Subject|0|||
160669420|NCT01647828|580170619|FG008|Overall Study|Withdrawal by Subject|2|||
160669421|NCT01647828|580170611|FG000|Overall Study|Study terminated by Sponsor|0|||
160669422|NCT01647828|580170612|FG001|Overall Study|Study terminated by Sponsor|0|||
160669423|NCT01647828|580170613|FG002|Overall Study|Study terminated by Sponsor|0|||
160669424|NCT01647828|580170614|FG003|Overall Study|Study terminated by Sponsor|0|||
160669425|NCT01647828|580170615|FG004|Overall Study|Study terminated by Sponsor|0|||
160669426|NCT01647828|580170616|FG005|Overall Study|Study terminated by Sponsor|0|||
160669427|NCT01647828|580170617|FG006|Overall Study|Study terminated by Sponsor|1|||
160624652|NCT01012765|580005498|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160624653|NCT01012765|580005499|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160624654|NCT01012765|580005494|FG000|Treatment Period 1|Administrative problems|0|||
160624655|NCT01012765|580005495|FG001|Treatment Period 1|Administrative problems|0|||
160624656|NCT01012765|580005496|FG002|Treatment Period 1|Administrative problems|1|||
160624657|NCT01012765|580005497|FG003|Treatment Period 1|Administrative problems|1|||
160624658|NCT01012765|580005498|FG004|Treatment Period 1|Administrative problems|1|||
160624659|NCT01012765|580005499|FG005|Treatment Period 1|Administrative problems|0|||
160624660|NCT01012765|580005494|FG000|Treatment Period 1|Protocol Violation|0|||
160624661|NCT01012765|580005495|FG001|Treatment Period 1|Protocol Violation|0|||
160624662|NCT01012765|580005496|FG002|Treatment Period 1|Protocol Violation|0|||
160624663|NCT01012765|580005497|FG003|Treatment Period 1|Protocol Violation|2|||
160624664|NCT01012765|580005498|FG004|Treatment Period 1|Protocol Violation|1|||
160624665|NCT01012765|580005499|FG005|Treatment Period 1|Protocol Violation|0|||
160624666|NCT01012765|580005494|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
160624667|NCT01012765|580005495|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
160624668|NCT01012765|580005496|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
160624669|NCT01012765|580005497|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
160624670|NCT01012765|580005498|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
160624671|NCT01012765|580005499|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
160624672|NCT01012765|580005494|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160624673|NCT01012765|580005495|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160624674|NCT01012765|580005496|FG002|Treatment Period 2|Withdrawal by Subject|1|||
160624675|NCT01012765|580005497|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160624676|NCT01012765|580005498|FG004|Treatment Period 2|Withdrawal by Subject|1|||
160624677|NCT01012765|580005499|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160624678|NCT01012765|580005494|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
160624679|NCT01012765|580005495|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
160624680|NCT01012765|580005496|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
160624681|NCT01012765|580005497|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
160624682|NCT01012765|580005498|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
160624683|NCT01012765|580005499|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
160624684|NCT01012765|580005494|FG000|Treatment Period 2|Adverse Event|0|||
160624685|NCT01012765|580005495|FG001|Treatment Period 2|Adverse Event|1|||
160624686|NCT01012765|580005496|FG002|Treatment Period 2|Adverse Event|1|||
160624687|NCT01012765|580005497|FG003|Treatment Period 2|Adverse Event|0|||
160624688|NCT01012765|580005498|FG004|Treatment Period 2|Adverse Event|0|||
160624689|NCT01012765|580005499|FG005|Treatment Period 2|Adverse Event|0|||
160624690|NCT01012765|580005494|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
160624691|NCT01012765|580005495|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
160624692|NCT01012765|580005496|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
160624693|NCT01012765|580005497|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
160624694|NCT01012765|580005498|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
160624695|NCT01012765|580005499|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
160624696|NCT01326312|580005500|FG000|Overall Study|Adverse Event|11|||
160624697|NCT01326312|580005501|FG001|Overall Study|Adverse Event|11|||
160624698|NCT01326312|580005502|FG002|Overall Study|Adverse Event|1|||
160624699|NCT01326312|580005500|FG000|Overall Study|Withdrawal by Subject|1|||
160624700|NCT01326312|580005501|FG001|Overall Study|Withdrawal by Subject|2|||
160624701|NCT01326312|580005502|FG002|Overall Study|Withdrawal by Subject|1|||
160624702|NCT01326312|580005500|FG000|Overall Study|Protocol Violation|0|||
160624703|NCT01326312|580005501|FG001|Overall Study|Protocol Violation|1|||
160624704|NCT01326312|580005502|FG002|Overall Study|Protocol Violation|0|||
160624705|NCT01326312|580005500|FG000|Overall Study|Lack of Efficacy|13|||
160624706|NCT01326312|580005501|FG001|Overall Study|Lack of Efficacy|7|||
160624707|NCT01326312|580005502|FG002|Overall Study|Lack of Efficacy|1|||
160624708|NCT01326312|580005500|FG000|Overall Study|Death|1|||
160624709|NCT01326312|580005501|FG001|Overall Study|Death|0|||
160624710|NCT01326312|580005502|FG002|Overall Study|Death|1|||
160624711|NCT01326312|580005500|FG000|Overall Study|progressive disease|0|||
160624712|NCT01326312|580005501|FG001|Overall Study|progressive disease|1|||
160624713|NCT01326312|580005502|FG002|Overall Study|progressive disease|1|||
160624714|NCT01326312|580005500|FG000|Overall Study|Study terminated by Sponsor|8|||
160624715|NCT01326312|580005501|FG001|Overall Study|Study terminated by Sponsor|32|||
160624716|NCT01326312|580005502|FG002|Overall Study|Study terminated by Sponsor|46|||
160624717|NCT01326312|580005500|FG000|Overall Study|Treatment arm terminated|19|||
160624718|NCT01326312|580005501|FG001|Overall Study|Treatment arm terminated|0|||
160624719|NCT01326312|580005502|FG002|Overall Study|Treatment arm terminated|0|||
160624720|NCT01326312|580005500|FG000|Overall Study|QTc > 500|0|||
160624721|NCT01326312|580005501|FG001|Overall Study|QTc > 500|1|||
160624722|NCT01326312|580005502|FG002|Overall Study|QTc > 500|0|||
160624723|NCT02243306|580005505|FG000|Overall Study|Adverse Event|0|||
160624724|NCT02243306|580005506|FG001|Overall Study|Adverse Event|1|||
160624725|NCT02243306|580005505|FG000|Overall Study|Other: Reached stopping criteria|0|||
160624726|NCT02243306|580005506|FG001|Overall Study|Other: Reached stopping criteria|1|||
160669428|NCT01647828|580170618|FG007|Overall Study|Study terminated by Sponsor|26|||
160669429|NCT01647828|580170619|FG008|Overall Study|Study terminated by Sponsor|16|||
160669430|NCT01647828|580170611|FG000|Overall Study|Lost to Follow-up|0|||
160669431|NCT01647828|580170612|FG001|Overall Study|Lost to Follow-up|0|||
160669432|NCT01647828|580170613|FG002|Overall Study|Lost to Follow-up|0|||
160669433|NCT01647828|580170614|FG003|Overall Study|Lost to Follow-up|0|||
160669434|NCT01647828|580170615|FG004|Overall Study|Lost to Follow-up|0|||
160669435|NCT01647828|580170616|FG005|Overall Study|Lost to Follow-up|0|||
160669436|NCT01647828|580170617|FG006|Overall Study|Lost to Follow-up|0|||
160669437|NCT01647828|580170618|FG007|Overall Study|Lost to Follow-up|2|||
160669438|NCT01647828|580170619|FG008|Overall Study|Lost to Follow-up|0|||
160669439|NCT00115063|580170622|FG000|Overall Study|Lost to Follow-up|98|||
160669440|NCT00115063|580170623|FG001|Overall Study|Lost to Follow-up|104|||
160669441|NCT00115063|580170622|FG000|Overall Study|Death|1|||
160669442|NCT00115063|580170623|FG001|Overall Study|Death|0|||
160669443|NCT00185458|580170626|FG000|Contraception Phase|Adverse Event|37|||
160669444|NCT00185458|580170626|FG000|Contraception Phase|Lost to Follow-up|10|||
160669445|NCT00185458|580170626|FG000|Contraception Phase|Protocol Violation|2|||
160669446|NCT00185458|580170626|FG000|Contraception Phase|Physician Decision|2|||
160669447|NCT00185458|580170626|FG000|Contraception Phase|Withdrawal by Subject|7|||
160669448|NCT00185458|580170626|FG000|HRT Phase|Adverse Event|18|||
160669449|NCT00185458|580170626|FG000|HRT Phase|Lost to Follow-up|4|||
160669450|NCT00185458|580170626|FG000|HRT Phase|Protocol Violation|2|||
160669451|NCT00185458|580170626|FG000|HRT Phase|Withdrawal by Subject|3|||
160669452|NCT00835536|580170627|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
160669453|NCT00835536|580170628|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
160669454|NCT01154231|580170631|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
160669455|NCT01154231|580170631|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
160669456|NCT01750294|580171774|FG000|Overall Study|Withdrawal by Subject|1|||
160669457|NCT01750294|580171774|FG000|Overall Study|Safety Endpoint|1|||
160669458|NCT01624233|580171775|FG000|Period 2 - Induction|Adverse Event|1|||
160669459|NCT01624233|580171775|FG000|Period 3 - Maintenance|Adverse Event|2|||
160669460|NCT01624233|580171775|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
160669461|NCT01624233|580171775|FG000|Period 3 - Maintenance|Physician Decision|2|||
160669462|NCT01624233|580171775|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
160669463|NCT01624233|580171775|FG000|Period 4 - Drug Free Period|Relapsed|61|||
160669464|NCT01624233|580171775|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
160669465|NCT01624233|580171775|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
160669466|NCT01624233|580171775|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
160669467|NCT01624233|580171775|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
160669468|NCT01624233|580171775|FG000|Period 6: Follow-up|Adverse Event|3|||
160669469|NCT01624233|580171775|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
160669470|NCT01624233|580171775|FG000|Period 6: Follow-up|Physician Decision|1|||
160669471|NCT01624233|580171775|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
160669472|NCT03121586|580171778|FG000|Overall Study|Study terminated by sponsor|0|||
160669473|NCT03121586|580171779|FG001|Overall Study|Study terminated by sponsor|0|||
160669474|NCT03121586|580171780|FG002|Overall Study|Study terminated by sponsor|99|||
160669475|NCT03121586|580171778|FG000|Overall Study|Withdrawal by Subject|37|||
160669476|NCT03121586|580171779|FG001|Overall Study|Withdrawal by Subject|14|||
160669477|NCT03121586|580171780|FG002|Overall Study|Withdrawal by Subject|9|||
160669478|NCT03121586|580171778|FG000|Overall Study|Not further specified|6|||
160669479|NCT03121586|580171779|FG001|Overall Study|Not further specified|11|||
160669480|NCT03121586|580171780|FG002|Overall Study|Not further specified|10|||
160669481|NCT03121586|580171778|FG000|Overall Study|Adverse Event|16|||
160669482|NCT03121586|580171779|FG001|Overall Study|Adverse Event|5|||
160669483|NCT03121586|580171780|FG002|Overall Study|Adverse Event|6|||
160669484|NCT03121586|580171778|FG000|Overall Study|Protocol Violation|0|||
160669485|NCT03121586|580171779|FG001|Overall Study|Protocol Violation|5|||
160669486|NCT03121586|580171780|FG002|Overall Study|Protocol Violation|0|||
160669487|NCT03121586|580171778|FG000|Overall Study|Lack of Efficacy|3|||
160669488|NCT03121586|580171779|FG001|Overall Study|Lack of Efficacy|3|||
160669489|NCT03121586|580171780|FG002|Overall Study|Lack of Efficacy|1|||
160669490|NCT03121586|580171778|FG000|Overall Study|Physician Decision|2|||
160669491|NCT03121586|580171779|FG001|Overall Study|Physician Decision|2|||
160669492|NCT03121586|580171780|FG002|Overall Study|Physician Decision|0|||
160669493|NCT03121586|580171778|FG000|Overall Study|Noncompliance with study drug|5|||
160669494|NCT03121586|580171779|FG001|Overall Study|Noncompliance with study drug|3|||
160669495|NCT03121586|580171780|FG002|Overall Study|Noncompliance with study drug|5|||
160669496|NCT03121586|580171778|FG000|Overall Study|Lost to Follow-up|4|||
160669497|NCT03121586|580171779|FG001|Overall Study|Lost to Follow-up|2|||
160669498|NCT03121586|580171780|FG002|Overall Study|Lost to Follow-up|0|||
160669499|NCT03121586|580171778|FG000|Overall Study|Death|2|||
160519072|NCT01007448|579629233|FG001|Overall Study|Withdrawal by Subject|3|||
160669500|NCT03121586|580171779|FG001|Overall Study|Death|0|||
160669501|NCT03121586|580171780|FG002|Overall Study|Death|0|||
160669502|NCT06381102|580171781|FG000|Washout 5 Days|Withdrawal by Subject|0|||
160669503|NCT06381102|580171782|FG001|Washout 5 Days|Withdrawal by Subject|2|||
160669504|NCT02832063|580171784|FG000|Overall Study|Adverse Event|2|||
160519073|NCT01007448|579629232|FG000|Overall Study|Adverse Event|1|||
160519074|NCT01007448|579629233|FG001|Overall Study|Adverse Event|4|||
160519075|NCT02751320|579629234|FG000|Overall Study|Adverse Event|2|||
160519076|NCT02751320|579629234|FG000|Overall Study|Withdrawal by Subject|1|||
160519077|NCT03426605|579629235|FG000|Overall Study|AML relapse or progression|2|||
160519078|NCT03426605|579629236|FG001|Overall Study|AML relapse or progression|1|||
160624727|NCT02243306|580005505|FG000|Overall Study|Physician Decision|0|||
160624728|NCT02243306|580005506|FG001|Overall Study|Physician Decision|1|||
160624729|NCT02221882|580005507|FG000|Overall Study|Withdrawal by Subject|0|||
160624730|NCT02221882|580005508|FG001|Overall Study|Withdrawal by Subject|0|||
160624731|NCT02221882|580005509|FG002|Overall Study|Withdrawal by Subject|4|||
160624732|NCT02221882|580005510|FG003|Overall Study|Withdrawal by Subject|2|||
160624733|NCT02221882|580005511|FG004|Overall Study|Withdrawal by Subject|2|||
160624734|NCT02221882|580005512|FG005|Overall Study|Withdrawal by Subject|2|||
160624735|NCT02221882|580005507|FG000|Overall Study|Death|0|||
160624736|NCT02221882|580005508|FG001|Overall Study|Death|1|||
160624737|NCT02221882|580005509|FG002|Overall Study|Death|0|||
160624738|NCT02221882|580005510|FG003|Overall Study|Death|0|||
160624739|NCT02221882|580005511|FG004|Overall Study|Death|0|||
160624740|NCT02221882|580005512|FG005|Overall Study|Death|0|||
160624741|NCT01463631|580005513|FG000|Overall Study|Withdrawal by Subject|0|||
160624742|NCT01463631|580005514|FG001|Overall Study|Withdrawal by Subject|0|||
160624743|NCT01463631|580005515|FG002|Overall Study|Withdrawal by Subject|0|||
160624744|NCT01463631|580005516|FG003|Overall Study|Withdrawal by Subject|1|||
160624745|NCT01463631|580005513|FG000|Overall Study|Death|0|||
160624746|NCT01463631|580005514|FG001|Overall Study|Death|0|||
160624747|NCT01463631|580005515|FG002|Overall Study|Death|1|||
160624748|NCT01463631|580005516|FG003|Overall Study|Death|0|||
160624749|NCT01463631|580005513|FG000|Overall Study|Progressive Disease|0|||
160624750|NCT01463631|580005514|FG001|Overall Study|Progressive Disease|0|||
160624751|NCT01463631|580005515|FG002|Overall Study|Progressive Disease|0|||
160624752|NCT01463631|580005516|FG003|Overall Study|Progressive Disease|5|||
160624753|NCT02370173|580005521|FG000|Overall Study|Protocol Violation|1|||
160624754|NCT02370173|580005522|FG001|Overall Study|Protocol Violation|1|||
160624755|NCT02370173|580005521|FG000|Overall Study|Withdrawal by Subject|2|||
160624756|NCT02370173|580005522|FG001|Overall Study|Withdrawal by Subject|2|||
160624757|NCT00307736|580005527|FG000|Overall Study|Adverse Event|0|||
160624758|NCT00307736|580005528|FG001|Overall Study|Adverse Event|0|||
160624759|NCT00307736|580005529|FG002|Overall Study|Adverse Event|1|||
160624760|NCT00307736|580005530|FG003|Overall Study|Adverse Event|3|||
160624761|NCT00307736|580005527|FG000|Overall Study|Withdrawal by Subject|0|||
160624762|NCT00307736|580005528|FG001|Overall Study|Withdrawal by Subject|0|||
160624763|NCT00307736|580005529|FG002|Overall Study|Withdrawal by Subject|2|||
160624764|NCT00307736|580005530|FG003|Overall Study|Withdrawal by Subject|0|||
160624765|NCT01990339|580005533|FG000|Overall Study|Data Not Available|49|||
160624766|NCT01990339|580005533|FG000|Overall Study|Voluntary Withdrawal|1402|||
160624767|NCT01990339|580005533|FG000|Overall Study|Lost to Follow-up|861|||
160624768|NCT01728194|580005536|FG000|Overall Study|Lost to Follow-up|4|||
160624769|NCT01728194|580005537|FG001|Overall Study|Lost to Follow-up|3|||
160624770|NCT01728194|580005536|FG000|Overall Study|Physician Decision|4|||
160624771|NCT01728194|580005537|FG001|Overall Study|Physician Decision|0|||
160624772|NCT01728194|580005536|FG000|Overall Study|Withdrawal by Subject|7|||
160624773|NCT01728194|580005537|FG001|Overall Study|Withdrawal by Subject|3|||
160624774|NCT01728194|580005536|FG000|Overall Study|Perceived Medication Side Effects|4|||
160624775|NCT01728194|580005537|FG001|Overall Study|Perceived Medication Side Effects|0|||
160624776|NCT01728194|580005536|FG000|Overall Study|Family Member Request|1|||
160624777|NCT01728194|580005537|FG001|Overall Study|Family Member Request|0|||
160624778|NCT00242658|580005538|FG000|Overall Study|Lost to Follow-up|22|||
160624779|NCT00242658|580005539|FG001|Overall Study|Lost to Follow-up|19|||
160624780|NCT04604015|580005540|FG000|Overall Study|Incomplete Data Collection|33|||
160624781|NCT01314261|580005541|FG000|Overall Study|Adverse Event|1|||
160624782|NCT01314261|580005542|FG001|Overall Study|Adverse Event|0|||
160624783|NCT01314261|580005543|FG002|Overall Study|Adverse Event|0|||
160624784|NCT01314261|580005544|FG003|Overall Study|Adverse Event|0|||
160624785|NCT01314261|580005541|FG000|Overall Study|Withdrawal by Subject|0|||
160624786|NCT01314261|580005542|FG001|Overall Study|Withdrawal by Subject|3|||
160624787|NCT01314261|580005543|FG002|Overall Study|Withdrawal by Subject|1|||
160624788|NCT01314261|580005544|FG003|Overall Study|Withdrawal by Subject|0|||
160624789|NCT01314261|580005541|FG000|Overall Study|Lost to Follow-up|1|||
160624790|NCT01314261|580005542|FG001|Overall Study|Lost to Follow-up|0|||
160624791|NCT01314261|580005543|FG002|Overall Study|Lost to Follow-up|2|||
160624792|NCT01314261|580005544|FG003|Overall Study|Lost to Follow-up|2|||
160624793|NCT01314261|580005541|FG000|Overall Study|Virologic Failure|0|||
160624794|NCT01314261|580005542|FG001|Overall Study|Virologic Failure|1|||
160624795|NCT01314261|580005543|FG002|Overall Study|Virologic Failure|0|||
160624796|NCT01314261|580005544|FG003|Overall Study|Virologic Failure|1|||
160669505|NCT02832063|580171785|FG001|Overall Study|Adverse Event|1|||
160669506|NCT02832063|580171784|FG000|Overall Study|Physician Decision|5|||
160669507|NCT02832063|580171785|FG001|Overall Study|Physician Decision|7|||
160669508|NCT02832063|580171784|FG000|Overall Study|Lost to Follow-up|15|||
160669509|NCT02832063|580171785|FG001|Overall Study|Lost to Follow-up|8|||
160669510|NCT02832063|580171784|FG000|Overall Study|Withdrawal by Subject|10|||
160669511|NCT02832063|580171785|FG001|Overall Study|Withdrawal by Subject|21|||
160669512|NCT02832063|580171784|FG000|Overall Study|Other|2|||
160669513|NCT02832063|580171785|FG001|Overall Study|Other|1|||
160669514|NCT03733730|580171786|FG000|Overall Study|Lost to Follow-up|1|||
160669515|NCT03733730|580171787|FG001|Overall Study|Lost to Follow-up|32|||
160669516|NCT03733730|580171786|FG000|Overall Study|Other|1|||
160669517|NCT03733730|580171787|FG001|Overall Study|Other|0|||
160669518|NCT03733730|580171786|FG000|Overall Study|Adverse Event|0|||
160669519|NCT03733730|580171787|FG001|Overall Study|Adverse Event|4|||
160669520|NCT03733730|580171786|FG000|Overall Study|Death|0|||
160669521|NCT03733730|580171787|FG001|Overall Study|Death|5|||
160669522|NCT03733730|580171786|FG000|Overall Study|Withdrawal by Subject|0|||
160669523|NCT03733730|580171787|FG001|Overall Study|Withdrawal by Subject|8|||
160669524|NCT00772603|580171788|FG000|Overall Study|Withdrawal by Subject|11|||
160669525|NCT00772603|580171789|FG001|Overall Study|Withdrawal by Subject|10|||
160669526|NCT00772603|580171790|FG002|Overall Study|Withdrawal by Subject|6|||
160669527|NCT00772603|580171788|FG000|Overall Study|Adverse Event|37|||
160669528|NCT00772603|580171789|FG001|Overall Study|Adverse Event|18|||
160669529|NCT00772603|580171790|FG002|Overall Study|Adverse Event|10|||
160669530|NCT00772603|580171788|FG000|Overall Study|Subject Non-compliance|1|||
160669531|NCT00772603|580171789|FG001|Overall Study|Subject Non-compliance|6|||
160669532|NCT00772603|580171790|FG002|Overall Study|Subject Non-compliance|4|||
160669533|NCT00772603|580171788|FG000|Overall Study|Protocol Violation|0|||
160669534|NCT00772603|580171789|FG001|Overall Study|Protocol Violation|1|||
160669535|NCT00772603|580171790|FG002|Overall Study|Protocol Violation|1|||
160669536|NCT00772603|580171788|FG000|Overall Study|Lost to Follow-up|1|||
160669537|NCT00772603|580171789|FG001|Overall Study|Lost to Follow-up|5|||
160669538|NCT00772603|580171790|FG002|Overall Study|Lost to Follow-up|2|||
160669539|NCT00772603|580171788|FG000|Overall Study|Physician Decision|0|||
160669540|NCT00772603|580171789|FG001|Overall Study|Physician Decision|0|||
160669541|NCT00772603|580171790|FG002|Overall Study|Physician Decision|1|||
160669542|NCT00772603|580171788|FG000|Overall Study|Other|2|||
160669543|NCT00772603|580171789|FG001|Overall Study|Other|0|||
160669544|NCT00772603|580171790|FG002|Overall Study|Other|2|||
160669545|NCT01564394|580171793|FG000|Overall Study|Withdrawal by Subject|6|||
160669546|NCT01564394|580171794|FG001|Overall Study|Withdrawal by Subject|10|||
160669547|NCT00859521|580171795|FG000|Washout|Withdrawal by Subject|0|||
160669548|NCT00859521|580171796|FG001|Washout|Withdrawal by Subject|1|||
160669549|NCT01609257|580171797|FG000|Overall Study|Lost to Follow-up|2|||
160669550|NCT01609257|580171798|FG001|Overall Study|Lost to Follow-up|1|||
160669551|NCT01609257|580171797|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
160669552|NCT01609257|580171798|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
160669553|NCT01609257|580171797|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
160669554|NCT01609257|580171798|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
160669555|NCT02125461|580171799|FG000|Overall Study|Withdrawal by Subject|30|||
160669556|NCT02125461|580171800|FG001|Overall Study|Withdrawal by Subject|16|||
160669557|NCT02125461|580171799|FG000|Overall Study|Lost to Follow-up|8|||
160669558|NCT02125461|580171800|FG001|Overall Study|Lost to Follow-up|3|||
160669559|NCT02125461|580171799|FG000|Overall Study|Death|260|||
160669560|NCT02125461|580171800|FG001|Overall Study|Death|149|||
160669561|NCT02125461|580171799|FG000|Overall Study|Missing Termination Reason|0|||
160669562|NCT02125461|580171800|FG001|Overall Study|Missing Termination Reason|1|||
160669563|NCT03552484|580171809|FG000|Overall Study|Death|6|||
160669564|NCT03552484|580171810|FG001|Overall Study|Death|4|||
160669565|NCT03552484|580171809|FG000|Overall Study|Lost to Follow-up|0|||
160519079|NCT03426605|579629237|FG002|Overall Study|AML relapse or progression|2|||
160519080|NCT03426605|579629238|FG003|Overall Study|AML relapse or progression|2|||
160669566|NCT03552484|580171810|FG001|Overall Study|Lost to Follow-up|16|||
160669567|NCT03499353|580171811|FG000|Treatment|Adverse Event|3|||
160669568|NCT03499353|580171811|FG000|Treatment|Progressive Disease|10|||
160669569|NCT03499353|580171811|FG000|Treatment|Other|1|||
160669570|NCT03499353|580171811|FG000|Treatment|Withdrawal by Subject|2|||
160669571|NCT03499353|580171811|FG000|Long-Term Follow-up|Death|2|||
160669572|NCT03499353|580171811|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
160669573|NCT03499353|580171811|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
160669574|NCT00469898|580171818|FG000|Overall Study|Adverse Event|7|||
160669575|NCT00469898|580171818|FG000|Overall Study|Withdrawal by Subject|4|||
160669576|NCT00469898|580171818|FG000|Overall Study|Death|4|||
160669577|NCT00469898|580171818|FG000|Overall Study|Disease progression|9|||
160669578|NCT00469898|580171818|FG000|Overall Study|Decreased performance status|1|||
160669579|NCT02663349|580171821|FG000|Overall Study|Withdrawal by Subject|6|||
160669580|NCT00848536|580171822|FG000|Overall Study|Adverse Event|2|||
160669581|NCT00848536|580171823|FG001|Overall Study|Adverse Event|2|||
160669582|NCT00848536|580171822|FG000|Overall Study|Withdrawal by Subject|0|||
160669583|NCT00848536|580171823|FG001|Overall Study|Withdrawal by Subject|1|||
160669584|NCT00848536|580171822|FG000|Overall Study|Protocol Violation|0|||
160519081|NCT03426605|579629235|FG000|Overall Study|Treatment failure|3|||
160519082|NCT03426605|579629236|FG001|Overall Study|Treatment failure|2|||
160519083|NCT03426605|579629237|FG002|Overall Study|Treatment failure|0|||
160519084|NCT03426605|579629238|FG003|Overall Study|Treatment failure|0|||
160519085|NCT03426605|579629235|FG000|Overall Study|Adverse Event|1|||
160519086|NCT03426605|579629236|FG001|Overall Study|Adverse Event|0|||
160519087|NCT03426605|579629237|FG002|Overall Study|Adverse Event|1|||
160519088|NCT03426605|579629238|FG003|Overall Study|Adverse Event|1|||
160519089|NCT03426605|579629235|FG000|Overall Study|Withdrawal by Subject|0|||
160519090|NCT03426605|579629236|FG001|Overall Study|Withdrawal by Subject|0|||
160519091|NCT03426605|579629237|FG002|Overall Study|Withdrawal by Subject|1|||
160519092|NCT03426605|579629238|FG003|Overall Study|Withdrawal by Subject|1|||
160519093|NCT01920854|579629241|FG000|Overall Study|Withdrawal by Subject|1|||
160519094|NCT01920854|579629242|FG001|Overall Study|Withdrawal by Subject|0|||
160519095|NCT01920854|579629243|FG002|Overall Study|Withdrawal by Subject|0|||
160519096|NCT01920854|579629244|FG003|Overall Study|Withdrawal by Subject|0|||
160519097|NCT01920854|579629245|FG004|Overall Study|Withdrawal by Subject|1|||
160519098|NCT01920854|579629246|FG005|Overall Study|Withdrawal by Subject|0|||
160519099|NCT01920854|579629247|FG006|Overall Study|Withdrawal by Subject|1|||
160519100|NCT02027623|579629248|FG000|Overall Study|Lost to Follow-up|3|||
160519101|NCT02027623|579629249|FG001|Overall Study|Lost to Follow-up|3|||
160519102|NCT02027623|579629248|FG000|Overall Study|Withdrawal by Subject|6|||
160519103|NCT02027623|579629249|FG001|Overall Study|Withdrawal by Subject|9|||
160519104|NCT01886378|579629250|FG000|Overall Study|Adverse Event|1|||
160519105|NCT01886378|579629250|FG000|Overall Study|Withdrawal by Subject|4|||
160519106|NCT03333837|579629260|FG000|Overall Study|Adverse Event|2|||
160519107|NCT03333837|579629261|FG001|Overall Study|Adverse Event|1|||
160519108|NCT03333837|579629262|FG002|Overall Study|Adverse Event|1|||
160519109|NCT03333837|579629263|FG003|Overall Study|Adverse Event|1|||
160519110|NCT03333837|579629264|FG004|Overall Study|Adverse Event|0|||
160519111|NCT03333837|579629260|FG000|Overall Study|Caregiver withdrew|0|||
160519112|NCT03333837|579629261|FG001|Overall Study|Caregiver withdrew|2|||
160519113|NCT03333837|579629262|FG002|Overall Study|Caregiver withdrew|1|||
160519114|NCT03333837|579629263|FG003|Overall Study|Caregiver withdrew|0|||
160519115|NCT03333837|579629264|FG004|Overall Study|Caregiver withdrew|0|||
160519116|NCT03333837|579629260|FG000|Overall Study|Withdrawal by Subject|0|||
160519117|NCT03333837|579629261|FG001|Overall Study|Withdrawal by Subject|0|||
160519118|NCT03333837|579629262|FG002|Overall Study|Withdrawal by Subject|1|||
160519119|NCT03333837|579629263|FG003|Overall Study|Withdrawal by Subject|1|||
160519120|NCT03333837|579629264|FG004|Overall Study|Withdrawal by Subject|3|||
160519121|NCT03333837|579629260|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
160519122|NCT03333837|579629261|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
160519123|NCT03333837|579629262|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
160519124|NCT03333837|579629263|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
160519125|NCT03333837|579629264|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
160519126|NCT02232243|579629268|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
160519127|NCT02232243|579629269|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
160519128|NCT02232243|579629270|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
160519129|NCT00704405|579629271|FG000|Overall Study (NC Population)|Adverse Event|1|||
160519130|NCT00704405|579629272|FG001|Overall Study (NC Population)|Adverse Event|0|||
160519131|NCT00704405|579629273|FG002|Overall Study (NC Population)|Adverse Event|0|||
160519132|NCT00704405|579629274|FG003|Overall Study (NC Population)|Adverse Event|0|||
160519133|NCT00704405|579629275|FG004|Overall Study (NC Population)|Adverse Event|0|||
160519134|NCT00704405|579629271|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
160519135|NCT00704405|579629272|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
160519136|NCT00704405|579629273|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
160519137|NCT00704405|579629274|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
160519138|NCT00704405|579629275|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
160519139|NCT00704405|579629271|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
160519140|NCT00704405|579629272|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
160519141|NCT00704405|579629273|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
160519142|NCT00704405|579629274|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
160519143|NCT00704405|579629275|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
160519144|NCT00704405|579629271|FG000|Overall Study (NC Population)|Other|0|||
160519145|NCT00704405|579629272|FG001|Overall Study (NC Population)|Other|0|||
160519146|NCT00704405|579629273|FG002|Overall Study (NC Population)|Other|0|||
160519147|NCT00704405|579629274|FG003|Overall Study (NC Population)|Other|0|||
160669585|NCT00848536|580171823|FG001|Overall Study|Protocol Violation|1|||
160519148|NCT00704405|579629275|FG004|Overall Study (NC Population)|Other|1|||
160669586|NCT00848536|580171822|FG000|Overall Study|Noncompliance|1|||
160669587|NCT00848536|580171823|FG001|Overall Study|Noncompliance|0|||
160669588|NCT00848536|580171822|FG000|Overall Study|Inadequate Control of IOP|1|||
160669589|NCT00848536|580171823|FG001|Overall Study|Inadequate Control of IOP|1|||
160669590|NCT00848536|580171822|FG000|Overall Study|Patient Moved|0|||
160669591|NCT00848536|580171823|FG001|Overall Study|Patient Moved|2|||
160669592|NCT01175135|580171824|FG000|Overall Study|Adverse Event|2|||
160669593|NCT01175135|580171825|FG001|Overall Study|Adverse Event|5|||
160669594|NCT01175135|580171826|FG002|Overall Study|Adverse Event|3|||
160669595|NCT01175135|580171827|FG003|Overall Study|Adverse Event|4|||
160669596|NCT01175135|580171824|FG000|Overall Study|Death|1|||
160669597|NCT01175135|580171825|FG001|Overall Study|Death|0|||
160669598|NCT01175135|580171826|FG002|Overall Study|Death|0|||
160669599|NCT01175135|580171827|FG003|Overall Study|Death|0|||
160669600|NCT01175135|580171824|FG000|Overall Study|Lack of Efficacy|4|||
160669601|NCT01175135|580171825|FG001|Overall Study|Lack of Efficacy|5|||
160669602|NCT01175135|580171826|FG002|Overall Study|Lack of Efficacy|0|||
160669603|NCT01175135|580171827|FG003|Overall Study|Lack of Efficacy|5|||
160669604|NCT01175135|580171824|FG000|Overall Study|Lost to Follow-up|1|||
160669605|NCT01175135|580171825|FG001|Overall Study|Lost to Follow-up|2|||
160669606|NCT01175135|580171826|FG002|Overall Study|Lost to Follow-up|0|||
160669607|NCT01175135|580171827|FG003|Overall Study|Lost to Follow-up|0|||
160669608|NCT01175135|580171824|FG000|Overall Study|Protocol Violation|1|||
160669609|NCT01175135|580171825|FG001|Overall Study|Protocol Violation|1|||
160669610|NCT01175135|580171826|FG002|Overall Study|Protocol Violation|0|||
160669611|NCT01175135|580171827|FG003|Overall Study|Protocol Violation|0|||
160669612|NCT01175135|580171824|FG000|Overall Study|Withdrawal by Subject|4|||
160669613|NCT01175135|580171825|FG001|Overall Study|Withdrawal by Subject|8|||
160669614|NCT01175135|580171826|FG002|Overall Study|Withdrawal by Subject|5|||
160669615|NCT01175135|580171827|FG003|Overall Study|Withdrawal by Subject|5|||
160669616|NCT01175135|580171824|FG000|Overall Study|Other|3|||
160519149|NCT00704405|579629271|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
160519150|NCT00704405|579629272|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
160519151|NCT00704405|579629273|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
160669617|NCT01175135|580171825|FG001|Overall Study|Other|1|||
160669618|NCT01175135|580171826|FG002|Overall Study|Other|3|||
160669619|NCT01175135|580171827|FG003|Overall Study|Other|0|||
160669620|NCT01175135|580171824|FG000|Overall Study|Randomized But Not Treated|0|||
160669621|NCT01175135|580171825|FG001|Overall Study|Randomized But Not Treated|0|||
160669622|NCT01175135|580171826|FG002|Overall Study|Randomized But Not Treated|1|||
160669623|NCT01175135|580171827|FG003|Overall Study|Randomized But Not Treated|0|||
160669624|NCT01590563|580171830|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
160669625|NCT05470699|580171834|FG000|Overall Study|Did not receive intervention|13|||
160669626|NCT05470699|580171834|FG000|Overall Study|Ineligible|1|||
160669627|NCT01370733|580171835|FG000|Overall Study|Withdrawal by Subject|8|||
160669628|NCT01370733|580171836|FG001|Overall Study|Withdrawal by Subject|8|||
160669629|NCT01370733|580171835|FG000|Overall Study|Lost to Follow-up|3|||
160669630|NCT01370733|580171836|FG001|Overall Study|Lost to Follow-up|0|||
160669631|NCT01370733|580171835|FG000|Overall Study|Adverse Event|2|||
160669632|NCT01370733|580171836|FG001|Overall Study|Adverse Event|4|||
160669633|NCT01370733|580171835|FG000|Overall Study|Lack of Efficacy|3|||
160669634|NCT01370733|580171836|FG001|Overall Study|Lack of Efficacy|5|||
160669635|NCT01370733|580171835|FG000|Overall Study|Physician Decision|0|||
160669636|NCT01370733|580171836|FG001|Overall Study|Physician Decision|2|||
160669637|NCT01370733|580171835|FG000|Overall Study|Protocol Violation|1|||
160519152|NCT00704405|579629274|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
160519153|NCT00704405|579629275|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
160669638|NCT01370733|580171836|FG001|Overall Study|Protocol Violation|3|||
160669639|NCT03676634|580171837|FG000|Overall Study|Red blood cell loss|1|||
160669640|NCT03676634|580171837|FG000|Overall Study|Out-of-limit pulse|2|||
160669641|NCT02294981|580171838|FG000|Overall Study|Lost to Follow-up|1|||
160669642|NCT01983969|580171842|FG000|Overall Study|Disease Progression|0|||
160669643|NCT01983969|580171843|FG001|Overall Study|Disease Progression|1|||
160669644|NCT01983969|580171844|FG002|Overall Study|Disease Progression|0|||
160669645|NCT00268203|580171845|FG000|Overall Study|Lost to Follow-up|92|||
160669646|NCT00268203|580171845|FG000|Overall Study|Withdrawal by Subject|9|||
160669647|NCT00268203|580171845|FG000|Overall Study|Received Other NHL Therapy|7|||
160669648|NCT00268203|580171845|FG000|Overall Study|Progressive Disease|359|||
160669649|NCT00268203|580171845|FG000|Overall Study|Death|84|||
160669650|NCT00268203|580171845|FG000|Overall Study|Reason Not Specified|34|||
160669651|NCT00268203|580171845|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
160669652|NCT04589650|580171848|FG000|Overall Study|Subject decision|6|||
160669653|NCT04589650|580171849|FG001|Overall Study|Subject decision|2|||
160669654|NCT04589650|580171850|FG002|Overall Study|Subject decision|2|||
160669655|NCT04589650|580171851|FG003|Overall Study|Subject decision|0|||
160669656|NCT04589650|580171852|FG004|Overall Study|Subject decision|0|||
160669657|NCT04589650|580171853|FG005|Overall Study|Subject decision|0|||
160669658|NCT04589650|580171848|FG000|Overall Study|Adverse Event|3|||
160669659|NCT04589650|580171849|FG001|Overall Study|Adverse Event|1|||
160519154|NCT00704405|579629271|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
160519155|NCT00704405|579629272|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
160519156|NCT00704405|579629273|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
160519157|NCT00704405|579629274|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
160519158|NCT00704405|579629275|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
160519159|NCT02374671|579629276|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
160519160|NCT02374671|579629277|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
160624797|NCT02576652|580005549|FG000|Overall Study|Withdrawal by Subject|2|||
160624798|NCT00553319|580005551|FG000|Overall Study|Lost to Follow-up|10|||
160624799|NCT00553319|580005552|FG001|Overall Study|Lost to Follow-up|9|||
160624800|NCT00553319|580005553|FG002|Overall Study|Lost to Follow-up|5|||
160624801|NCT00553319|580005551|FG000|Overall Study|wanted treatment elsewhere|2|||
160624802|NCT00553319|580005552|FG001|Overall Study|wanted treatment elsewhere|1|||
160624803|NCT00553319|580005553|FG002|Overall Study|wanted treatment elsewhere|1|||
160624804|NCT00553319|580005551|FG000|Overall Study|non-compliance|0|||
160624805|NCT00553319|580005552|FG001|Overall Study|non-compliance|0|||
160624806|NCT00553319|580005553|FG002|Overall Study|non-compliance|2|||
160624807|NCT00553319|580005551|FG000|Overall Study|incarceration|1|||
160624808|NCT00553319|580005552|FG001|Overall Study|incarceration|0|||
160624809|NCT00553319|580005553|FG002|Overall Study|incarceration|0|||
160624810|NCT00553319|580005551|FG000|Overall Study|moved|1|||
160624811|NCT00553319|580005552|FG001|Overall Study|moved|0|||
160624812|NCT00553319|580005553|FG002|Overall Study|moved|1|||
160624813|NCT03575975|580005555|FG000|Overall Study|Lost to Follow-up|1|||
160624814|NCT03575975|580005556|FG001|Overall Study|Lost to Follow-up|0|||
160624815|NCT03575975|580005557|FG002|Overall Study|Lost to Follow-up|0|||
160624816|NCT00465894|580005558|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
160624817|NCT00465894|580005559|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
160624818|NCT00465894|580005558|FG000|Treatment For 12 Weeks|Family Issues|1|||
160624819|NCT00465894|580005559|FG001|Treatment For 12 Weeks|Family Issues|1|||
160624820|NCT00465894|580005558|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
160624821|NCT00465894|580005559|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
160624822|NCT00129220|580005560|FG000|Study Period II|Adverse Event|9|||
160624823|NCT00129220|580005561|FG001|Study Period II|Adverse Event|5|||
160624824|NCT00129220|580005562|FG002|Study Period II|Adverse Event|7|||
160624825|NCT00129220|580005560|FG000|Study Period II|Lack of Efficacy|15|||
160624826|NCT00129220|580005561|FG001|Study Period II|Lack of Efficacy|1|||
160624827|NCT00129220|580005562|FG002|Study Period II|Lack of Efficacy|28|||
160624828|NCT00129220|580005560|FG000|Study Period II|Entry Criteria Not Met|2|||
160624829|NCT00129220|580005561|FG001|Study Period II|Entry Criteria Not Met|0|||
160624830|NCT00129220|580005562|FG002|Study Period II|Entry Criteria Not Met|2|||
160624831|NCT00129220|580005560|FG000|Study Period II|Protocol Violation|4|||
160624832|NCT00129220|580005561|FG001|Study Period II|Protocol Violation|2|||
160624833|NCT00129220|580005562|FG002|Study Period II|Protocol Violation|1|||
160624834|NCT00129220|580005560|FG000|Study Period II|Physician Decision|0|||
160624835|NCT00129220|580005561|FG001|Study Period II|Physician Decision|1|||
160624836|NCT00129220|580005562|FG002|Study Period II|Physician Decision|0|||
160624837|NCT00129220|580005560|FG000|Study Period II|Withdrawal by Subject|1|||
160624838|NCT00129220|580005561|FG001|Study Period II|Withdrawal by Subject|3|||
160624839|NCT00129220|580005562|FG002|Study Period II|Withdrawal by Subject|4|||
160624840|NCT00129220|580005560|FG000|Study Period II|Reason Not Specified|2|||
160624841|NCT00129220|580005561|FG001|Study Period II|Reason Not Specified|0|||
160624842|NCT00129220|580005562|FG002|Study Period II|Reason Not Specified|5|||
160624843|NCT00129220|580005560|FG000|Study Period III|Adverse Event|1|||
160624844|NCT00129220|580005561|FG001|Study Period III|Adverse Event|0|||
160624845|NCT00129220|580005562|FG002|Study Period III|Adverse Event|3|||
160624846|NCT00129220|580005560|FG000|Study Period III|Protocol Violation|1|||
160624847|NCT00129220|580005561|FG001|Study Period III|Protocol Violation|1|||
160624848|NCT00129220|580005562|FG002|Study Period III|Protocol Violation|2|||
160624849|NCT00129220|580005560|FG000|Study Period III|Withdrawal by Subject|1|||
160624850|NCT00129220|580005561|FG001|Study Period III|Withdrawal by Subject|0|||
160624851|NCT00129220|580005562|FG002|Study Period III|Withdrawal by Subject|3|||
160624852|NCT00129220|580005560|FG000|Study Period III|Sponsor Decision|1|||
160624853|NCT00129220|580005561|FG001|Study Period III|Sponsor Decision|0|||
160624854|NCT00129220|580005562|FG002|Study Period III|Sponsor Decision|0|||
160624855|NCT00129220|580005560|FG000|Study Period III|Reason Not Specified|9|||
160624856|NCT00129220|580005561|FG001|Study Period III|Reason Not Specified|0|||
160624857|NCT00129220|580005562|FG002|Study Period III|Reason Not Specified|2|||
160624858|NCT00540228|580005564|FG000|Overall Study|Adverse Event|2|||
160624859|NCT00540228|580005565|FG001|Overall Study|Adverse Event|0|||
160624860|NCT00540228|580005566|FG002|Overall Study|Adverse Event|0|||
160624861|NCT00540228|580005567|FG003|Overall Study|Adverse Event|0|||
160624862|NCT00540228|580005568|FG004|Overall Study|Adverse Event|0|||
160624863|NCT00540228|580005564|FG000|Overall Study|Lost to Follow-up|1|||
160624864|NCT00540228|580005565|FG001|Overall Study|Lost to Follow-up|1|||
160624865|NCT00540228|580005566|FG002|Overall Study|Lost to Follow-up|0|||
160624866|NCT00540228|580005567|FG003|Overall Study|Lost to Follow-up|0|||
160519161|NCT02374671|579629278|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
160519162|NCT02374671|579629276|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
160519163|NCT02374671|579629277|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
160519164|NCT02374671|579629278|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
160519165|NCT02374671|579629276|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
160519166|NCT02374671|579629277|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
160519167|NCT02374671|579629278|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
160519168|NCT02374671|579629276|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
160519169|NCT02374671|579629277|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
160519170|NCT02374671|579629278|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
160519171|NCT02374671|579629276|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
160519172|NCT02374671|579629277|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
160624867|NCT00540228|580005568|FG004|Overall Study|Lost to Follow-up|0|||
160624868|NCT01883362|580005569|FG000|Treatment|Adverse Event|1|||
160624869|NCT01883362|580005570|FG001|Treatment|Adverse Event|8|||
160624870|NCT01883362|580005569|FG000|Treatment|Withdrawal by Subject|6|||
160624871|NCT01883362|580005570|FG001|Treatment|Withdrawal by Subject|2|||
160624872|NCT01883362|580005569|FG000|Treatment|Administrative problems|4|||
160624873|NCT01883362|580005570|FG001|Treatment|Administrative problems|1|||
160624874|NCT01883362|580005569|FG000|Treatment|Relapse|4|||
160624875|NCT01883362|580005570|FG001|Treatment|Relapse|2|||
160624876|NCT01883362|580005569|FG000|Treatment|Randomized, not treated|1|||
160624877|NCT01883362|580005570|FG001|Treatment|Randomized, not treated|1|||
160624878|NCT01883362|580005569|FG000|Post Treatment Follow-up|Protocol Violation|0|||
160624879|NCT01883362|580005570|FG001|Post Treatment Follow-up|Protocol Violation|1|||
160624880|NCT01883362|580005569|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
160624881|NCT01883362|580005570|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
160624882|NCT01883362|580005569|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
160624883|NCT01883362|580005570|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
160624884|NCT01883362|580005569|FG000|Post Treatment Follow-up|Administrative problems|2|||
160624885|NCT01883362|580005570|FG001|Post Treatment Follow-up|Administrative problems|0|||
160624886|NCT01883362|580005569|FG000|Post Treatment Follow-up|Death|8|||
160624887|NCT01883362|580005570|FG001|Post Treatment Follow-up|Death|4|||
160624888|NCT01883362|580005569|FG000|Post Treatment Follow-up|Relapse|1|||
160624889|NCT01883362|580005570|FG001|Post Treatment Follow-up|Relapse|2|||
160624890|NCT02569996|580005571|FG000|Overall Study|Adverse Event|6|||
160624891|NCT02569996|580005571|FG000|Overall Study|Physician Decision|3|||
160624892|NCT02569996|580005571|FG000|Overall Study|Progression of the disease|18|||
160624893|NCT02569996|580005571|FG000|Overall Study|New anti-lymphoma treatment|1|||
160624894|NCT02569996|580005571|FG000|Overall Study|Non-compliance|9|||
160624895|NCT02569996|580005571|FG000|Overall Study|Withdrawal by Subject|5|||
160624896|NCT02569996|580005571|FG000|Overall Study|Lost to Follow-up|5|||
160624897|NCT02569996|580005571|FG000|Overall Study|Complete remission|7|||
160624898|NCT02569996|580005571|FG000|Overall Study|Unknown reason|1|||
160624899|NCT01383317|580005574|FG000|Overall Study|Lost to Follow-up|2|||
160624900|NCT01383317|580005575|FG001|Overall Study|Lost to Follow-up|1|||
160624901|NCT01383317|580005574|FG000|Overall Study|Death|1|||
160624902|NCT01383317|580005575|FG001|Overall Study|Death|0|||
160624903|NCT01383317|580005574|FG000|Overall Study|Adverse Event|0|||
160624904|NCT01383317|580005575|FG001|Overall Study|Adverse Event|1|||
160624905|NCT01349816|580005576|FG000|Overall Study|Withdrawal by Subject|4|||
160624906|NCT01349816|580005576|FG000|Overall Study|Physician Decision|1|||
160624907|NCT01349816|580005576|FG000|Overall Study|Adverse Event|14|||
160624908|NCT01349816|580005576|FG000|Overall Study|Lost to Follow-up|2|||
160624909|NCT01349816|580005576|FG000|Overall Study|Protocol Violation|1|||
160624910|NCT01349816|580005576|FG000|Overall Study|Protocol-specified criteria|8|||
160624911|NCT02911285|580005577|FG000|Overall Study|Lost to Follow-up|8|||
160624912|NCT02911285|580005578|FG001|Overall Study|Lost to Follow-up|5|||
160624913|NCT02911285|580005577|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
160624914|NCT02911285|580005578|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
160624915|NCT02451137|580005580|FG000|Overall Study|Randomized but not treated|19|||
160624916|NCT02451137|580005581|FG001|Overall Study|Randomized but not treated|27|||
160624917|NCT02451137|580005580|FG000|Overall Study|Adverse Event|43|||
160624918|NCT02451137|580005581|FG001|Overall Study|Adverse Event|42|||
160624919|NCT02451137|580005580|FG000|Overall Study|Lack of Efficacy|4|||
160624920|NCT02451137|580005581|FG001|Overall Study|Lack of Efficacy|9|||
160624921|NCT02451137|580005580|FG000|Overall Study|Participant decision:discontinue insulin|41|||
160624922|NCT02451137|580005581|FG001|Overall Study|Participant decision:discontinue insulin|43|||
160624923|NCT02451137|580005580|FG000|Overall Study|Hypoglycemia|2|||
160624924|NCT02451137|580005581|FG001|Overall Study|Hypoglycemia|1|||
160624925|NCT02451137|580005580|FG000|Overall Study|Investigator's decision|23|||
160624926|NCT02451137|580005581|FG001|Overall Study|Investigator's decision|19|||
160624927|NCT02451137|580005580|FG000|Overall Study|Lost to Follow-up|53|||
160669660|NCT04589650|580171850|FG002|Overall Study|Adverse Event|1|||
160669661|NCT04589650|580171851|FG003|Overall Study|Adverse Event|1|||
160669662|NCT04589650|580171852|FG004|Overall Study|Adverse Event|0|||
160669663|NCT04589650|580171853|FG005|Overall Study|Adverse Event|1|||
160669664|NCT04589650|580171848|FG000|Overall Study|Physician Decision|1|||
160669665|NCT04589650|580171849|FG001|Overall Study|Physician Decision|1|||
160669666|NCT04589650|580171850|FG002|Overall Study|Physician Decision|0|||
160669667|NCT04589650|580171851|FG003|Overall Study|Physician Decision|0|||
160669668|NCT04589650|580171852|FG004|Overall Study|Physician Decision|0|||
160669669|NCT04589650|580171853|FG005|Overall Study|Physician Decision|0|||
160669670|NCT04589650|580171848|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160669671|NCT04589650|580171849|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160669672|NCT04589650|580171850|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160669673|NCT04589650|580171851|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
160669674|NCT04589650|580171852|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
160669675|NCT04589650|580171853|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
160669676|NCT04589650|580171848|FG000|Overall Study|Death|0|||
160669677|NCT04589650|580171849|FG001|Overall Study|Death|0|||
160669678|NCT04589650|580171850|FG002|Overall Study|Death|0|||
160669679|NCT04589650|580171851|FG003|Overall Study|Death|1|||
160669680|NCT04589650|580171852|FG004|Overall Study|Death|0|||
160669681|NCT04589650|580171853|FG005|Overall Study|Death|0|||
160669682|NCT04589650|580171848|FG000|Overall Study|Guardian Decision|0|||
160669683|NCT04589650|580171849|FG001|Overall Study|Guardian Decision|0|||
160669684|NCT04589650|580171850|FG002|Overall Study|Guardian Decision|0|||
160669685|NCT04589650|580171851|FG003|Overall Study|Guardian Decision|1|||
160669686|NCT04589650|580171852|FG004|Overall Study|Guardian Decision|0|||
160669687|NCT04589650|580171853|FG005|Overall Study|Guardian Decision|0|||
160669688|NCT00950989|580171854|FG000|Overall Study|Death|0|||
160669689|NCT00950989|580171855|FG001|Overall Study|Death|0|||
160669690|NCT00950989|580171856|FG002|Overall Study|Death|1|||
160669691|NCT00950989|580171857|FG003|Overall Study|Death|0|||
160669692|NCT00950989|580171854|FG000|Overall Study|Administrative Decision|0|||
160669693|NCT00950989|580171855|FG001|Overall Study|Administrative Decision|1|||
160669694|NCT00950989|580171856|FG002|Overall Study|Administrative Decision|0|||
160669695|NCT00950989|580171857|FG003|Overall Study|Administrative Decision|0|||
160669696|NCT00950989|580171854|FG000|Overall Study|Disease Progression|0|||
160669697|NCT00950989|580171855|FG001|Overall Study|Disease Progression|0|||
160669698|NCT00950989|580171856|FG002|Overall Study|Disease Progression|1|||
160669699|NCT00950989|580171857|FG003|Overall Study|Disease Progression|0|||
160669700|NCT00950989|580171854|FG000|Overall Study|Withdrawal by Subject|2|||
160669701|NCT00950989|580171855|FG001|Overall Study|Withdrawal by Subject|1|||
160669702|NCT00950989|580171856|FG002|Overall Study|Withdrawal by Subject|0|||
160669703|NCT00950989|580171857|FG003|Overall Study|Withdrawal by Subject|0|||
160669704|NCT00950989|580171854|FG000|Overall Study|Adverse Event|2|||
160669705|NCT00950989|580171855|FG001|Overall Study|Adverse Event|1|||
160669706|NCT00950989|580171856|FG002|Overall Study|Adverse Event|1|||
160669707|NCT00950989|580171857|FG003|Overall Study|Adverse Event|0|||
160669708|NCT03804983|580171858|FG000|Overall Study|Adverse Event|0|||
160669709|NCT03804983|580171859|FG001|Overall Study|Adverse Event|1|||
160669710|NCT03804983|580171858|FG000|Overall Study|Family Obligation|1|||
160669711|NCT03804983|580171859|FG001|Overall Study|Family Obligation|0|||
160669712|NCT03600376|580171860|FG000|Overall Study|Adverse Event|1|||
160669713|NCT03600376|580171861|FG001|Overall Study|Adverse Event|1|||
160669714|NCT03600376|580171860|FG000|Overall Study|Transferred to other facility|1|||
160669715|NCT03600376|580171861|FG001|Overall Study|Transferred to other facility|0|||
160669716|NCT03600376|580171860|FG000|Overall Study|Investigator Decision|0|||
160669717|NCT03600376|580171861|FG001|Overall Study|Investigator Decision|4|||
160669718|NCT03600376|580171860|FG000|Overall Study|Determined to be ineligible for study|0|||
160669719|NCT03600376|580171861|FG001|Overall Study|Determined to be ineligible for study|1|||
160669720|NCT06041256|580171862|FG000|Overall Study|Withdrawal by Subject|1|||
160669721|NCT06041256|580171863|FG001|Overall Study|Withdrawal by Subject|0|||
160669722|NCT06041256|580171864|FG002|Overall Study|Withdrawal by Subject|3|||
160669723|NCT06041256|580171865|FG003|Overall Study|Withdrawal by Subject|1|||
160669724|NCT06041256|580171866|FG004|Overall Study|Withdrawal by Subject|1|||
160669725|NCT06041256|580171862|FG000|Overall Study|Rescue|17|||
160669726|NCT06041256|580171863|FG001|Overall Study|Rescue|6|||
160669727|NCT06041256|580171864|FG002|Overall Study|Rescue|9|||
160669728|NCT06041256|580171865|FG003|Overall Study|Rescue|6|||
160669729|NCT06041256|580171866|FG004|Overall Study|Rescue|2|||
160669730|NCT01963728|580171867|FG000|Overall Study|Study terminated early|0|||
160669731|NCT01963728|580171868|FG001|Overall Study|Study terminated early|1|||
160669732|NCT03114891|580171869|FG000|First Treatment Round|Lost to Follow-up|0|||
160669733|NCT03114891|580171870|FG001|First Treatment Round|Lost to Follow-up|1|||
160669734|NCT03114891|580171871|FG002|First Treatment Round|Lost to Follow-up|1|||
160669735|NCT03114891|580171872|FG003|First Treatment Round|Lost to Follow-up|0|||
160669736|NCT03114891|580171869|FG000|First Treatment Round|Withdrawal by Subject|0|||
160669737|NCT03114891|580171870|FG001|First Treatment Round|Withdrawal by Subject|2|||
160669738|NCT03114891|580171871|FG002|First Treatment Round|Withdrawal by Subject|0|||
160669739|NCT03114891|580171872|FG003|First Treatment Round|Withdrawal by Subject|1|||
160669740|NCT03114891|580171869|FG000|3 Week Break|Lost to Follow-up|1|||
160669741|NCT03114891|580171870|FG001|3 Week Break|Lost to Follow-up|0|||
160669742|NCT03114891|580171871|FG002|3 Week Break|Lost to Follow-up|0|||
160669743|NCT03114891|580171872|FG003|3 Week Break|Lost to Follow-up|1|||
160669744|NCT03114891|580171869|FG000|3 Week Break|Withdrawal by Subject|0|||
160669745|NCT03114891|580171870|FG001|3 Week Break|Withdrawal by Subject|1|||
160669746|NCT03114891|580171871|FG002|3 Week Break|Withdrawal by Subject|0|||
160669747|NCT03114891|580171872|FG003|3 Week Break|Withdrawal by Subject|0|||
160669748|NCT03114891|580171869|FG000|Second Treatment Round|Lost to Follow-up|1|||
160669749|NCT03114891|580171870|FG001|Second Treatment Round|Lost to Follow-up|0|||
160669750|NCT03114891|580171871|FG002|Second Treatment Round|Lost to Follow-up|0|||
160669751|NCT03114891|580171872|FG003|Second Treatment Round|Lost to Follow-up|0|||
160669752|NCT03114891|580171869|FG000|Second Treatment Round|Physician Decision|1|||
160669753|NCT03114891|580171870|FG001|Second Treatment Round|Physician Decision|0|||
160669754|NCT03114891|580171871|FG002|Second Treatment Round|Physician Decision|0|||
160669755|NCT03114891|580171872|FG003|Second Treatment Round|Physician Decision|0|||
160669756|NCT00443651|580173003|FG000|Overall Study|Death|1|||
160669757|NCT00443651|580173004|FG001|Overall Study|Death|5|||
160669758|NCT00443651|580173003|FG000|Overall Study|Adverse Event|5|||
160669759|NCT00443651|580173004|FG001|Overall Study|Adverse Event|6|||
160669760|NCT00443651|580173003|FG000|Overall Study|Lost to Follow-up|18|||
160669761|NCT00443651|580173004|FG001|Overall Study|Lost to Follow-up|12|||
160669762|NCT00443651|580173003|FG000|Overall Study|Patient's/Guardian's Decision|58|||
160669763|NCT00443651|580173004|FG001|Overall Study|Patient's/Guardian's Decision|30|||
160669764|NCT00443651|580173003|FG000|Overall Study|Physician Decision|13|||
160669765|NCT00443651|580173004|FG001|Overall Study|Physician Decision|4|||
160669766|NCT00443651|580173003|FG000|Overall Study|Pregnancy|0|||
160669767|NCT00443651|580173004|FG001|Overall Study|Pregnancy|1|||
160669768|NCT00316277|580173008|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
160669769|NCT00316277|580173009|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
160669770|NCT00316277|580173008|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
160669771|NCT00316277|580173009|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
160669772|NCT00316277|580173008|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
160669773|NCT00316277|580173009|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
160669774|NCT00316277|580173008|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
160669775|NCT00316277|580173009|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
160669776|NCT00316277|580173008|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
160669777|NCT00316277|580173009|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
160669778|NCT00927069|580173010|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
160669779|NCT00927069|580173011|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
160669780|NCT00927069|580173012|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
160669781|NCT00927069|580173013|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
160669782|NCT00927069|580173010|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
160669783|NCT00927069|580173011|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
160669784|NCT00927069|580173012|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
160669785|NCT00927069|580173013|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
160669786|NCT00927069|580173010|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
160669787|NCT00927069|580173011|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
160669788|NCT00927069|580173012|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
160669789|NCT00927069|580173013|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
160669790|NCT00927069|580173010|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
160669791|NCT00927069|580173011|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
160669792|NCT00927069|580173012|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
160669793|NCT00927069|580173013|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
160669794|NCT00927069|580173010|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
160669795|NCT00927069|580173011|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
160669796|NCT00927069|580173012|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
160669797|NCT00927069|580173013|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
160669798|NCT04089553|580173014|FG000|Overall Study|Death|1|||
160669799|NCT04089553|580173015|FG001|Overall Study|Death|1|||
160669800|NCT04089553|580173014|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
160669801|NCT04089553|580173015|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
160669802|NCT04089553|580173014|FG000|Overall Study|Withdrawal by Subject|3|||
160669803|NCT04089553|580173015|FG001|Overall Study|Withdrawal by Subject|3|||
160669804|NCT04089553|580173014|FG000|Overall Study|Physician Decision|1|||
160669805|NCT04089553|580173015|FG001|Overall Study|Physician Decision|0|||
160669806|NCT04089553|580173014|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
160669807|NCT04089553|580173015|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
160669808|NCT04089553|580173014|FG000|Overall Study|Other|1|||
160669809|NCT04089553|580173015|FG001|Overall Study|Other|0|||
160669810|NCT04089553|580173014|FG000|Overall Study|Adverse Event|1|||
160669811|NCT04089553|580173015|FG001|Overall Study|Adverse Event|1|||
160669812|NCT01572662|580173016|FG000|Overall Study|Withdrawal by Subject|1|||
160624928|NCT02451137|580005581|FG001|Overall Study|Lost to Follow-up|61|||
160669813|NCT01572662|580173017|FG001|Overall Study|Withdrawal by Subject|0|||
160669814|NCT01572662|580173016|FG000|Overall Study|Physician Decision|0|||
160669815|NCT01572662|580173017|FG001|Overall Study|Physician Decision|1|||
160669816|NCT03364192|580173018|FG000|Overall Study|Ineligible|10|||
160669817|NCT03364192|580173018|FG000|Overall Study|Withdrawal by Subject|5|||
160669818|NCT03364192|580173018|FG000|Overall Study|Lost to Follow-up|1|||
160669819|NCT04692155|580173019|FG000|Overall Study|Death|1|||
160669820|NCT04547192|580173020|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
160669821|NCT04547192|580173021|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
160669822|NCT04547192|580173022|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
160669823|NCT04547192|580173023|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
160669824|NCT04547192|580173020|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
160669825|NCT04547192|580173021|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
160669826|NCT04547192|580173022|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
160669827|NCT04547192|580173023|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
160669828|NCT04547192|580173020|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
160669829|NCT04547192|580173021|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
160669830|NCT04547192|580173022|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
160624929|NCT02451137|580005580|FG000|Overall Study|Physician Decision|6|||
160624930|NCT02451137|580005581|FG001|Overall Study|Physician Decision|5|||
160624931|NCT02451137|580005580|FG000|Overall Study|Sponsor decision|13|||
160624932|NCT02451137|580005581|FG001|Overall Study|Sponsor decision|25|||
160624933|NCT02451137|580005580|FG000|Overall Study|Withdrawal by Subject|40|||
160624934|NCT02451137|580005581|FG001|Overall Study|Withdrawal by Subject|63|||
160624935|NCT02451137|580005580|FG000|Overall Study|Other than specified above|2|||
160624936|NCT02451137|580005581|FG001|Overall Study|Other than specified above|3|||
160624937|NCT03996694|580007864|FG000|First Washout (7 Days)|positive urine drug screen|0|||
160624938|NCT03996694|580007865|FG001|First Washout (7 Days)|positive urine drug screen|0|||
160624939|NCT03996694|580007866|FG002|First Washout (7 Days)|positive urine drug screen|1|||
160624940|NCT03996694|580007867|FG003|First Washout (7 Days)|positive urine drug screen|0|||
160624941|NCT03996694|580007868|FG004|First Washout (7 Days)|positive urine drug screen|0|||
160624942|NCT03996694|580007869|FG005|First Washout (7 Days)|positive urine drug screen|0|||
160624943|NCT03996694|580007864|FG000|First Washout (7 Days)|Adverse Event|0|||
160624944|NCT03996694|580007865|FG001|First Washout (7 Days)|Adverse Event|1|||
160624945|NCT03996694|580007866|FG002|First Washout (7 Days)|Adverse Event|0|||
160624946|NCT03996694|580007867|FG003|First Washout (7 Days)|Adverse Event|0|||
160624947|NCT03996694|580007868|FG004|First Washout (7 Days)|Adverse Event|0|||
160624948|NCT03996694|580007869|FG005|First Washout (7 Days)|Adverse Event|0|||
160624949|NCT03996694|580007864|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
160624950|NCT03996694|580007865|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
160624951|NCT03996694|580007866|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
160624952|NCT03996694|580007867|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
160624953|NCT03996694|580007868|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
160624954|NCT03996694|580007869|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
160624955|NCT03996694|580007864|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
160624956|NCT03996694|580007865|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
160624957|NCT03996694|580007866|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
160624958|NCT03996694|580007867|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
160624959|NCT03996694|580007868|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
160624960|NCT03996694|580007869|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
160624961|NCT02842736|580007870|FG000|Overall Study|Lost to Follow-up|13|||
160624962|NCT02842736|580007870|FG000|Overall Study|Intervention for menstrual bleeding|17|||
160624963|NCT02842736|580007870|FG000|Overall Study|Withdrawal by Subject|4|||
160624964|NCT02842736|580007870|FG000|Overall Study|Pregnancy|3|||
160624965|NCT02842736|580007870|FG000|Overall Study|Hysterectomy for fibroids|2|||
160624966|NCT02842736|580007870|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
160624967|NCT02842736|580007870|FG000|Overall Study|IUD: Mirena|1|||
160624968|NCT03323034|580007871|FG000|Overall Study|Lack of Efficacy|5|||
160624969|NCT03323034|580007872|FG001|Overall Study|Lack of Efficacy|5|||
160624970|NCT03323034|580007873|FG002|Overall Study|Lack of Efficacy|6|||
160624971|NCT03323034|580007874|FG003|Overall Study|Lack of Efficacy|5|||
160669831|NCT04547192|580173023|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
160669832|NCT04547192|580173020|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
160669833|NCT04547192|580173021|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
160669834|NCT04547192|580173022|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
160669835|NCT04547192|580173023|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
160669836|NCT04547192|580173020|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
160669837|NCT04547192|580173021|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
160669838|NCT04547192|580173022|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
160669839|NCT04547192|580173023|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
160669840|NCT01535222|580173024|FG000|Overall Study|Inclusion/exclusion|0|||
160669841|NCT01535222|580173025|FG001|Overall Study|Inclusion/exclusion|0|||
160669842|NCT01535222|580173026|FG002|Overall Study|Inclusion/exclusion|1|||
160669843|NCT01535222|580173027|FG003|Overall Study|Inclusion/exclusion|0|||
160669844|NCT01535222|580173028|FG004|Overall Study|Inclusion/exclusion|0|||
160669845|NCT01535222|580173029|FG005|Overall Study|Inclusion/exclusion|0|||
160669846|NCT00935012|580173032|FG000|Overall Study|Death|19|||
160669847|NCT00935012|580173032|FG000|Overall Study|Withdrawal by Subject|3|||
160669848|NCT00935012|580173032|FG000|Overall Study|Other|5|||
160669849|NCT00935012|580173032|FG000|Overall Study|Adverse Event|2|||
160669850|NCT01442155|580173033|FG000|Overall Study|Complete remission|35|||
160669851|NCT01442155|580173033|FG000|Overall Study|Recurrence|26|||
160669852|NCT01442155|580173033|FG000|Overall Study|Adverse Event|2|||
160669853|NCT01442155|580173033|FG000|Overall Study|Lost to Follow-up|2|||
160669854|NCT01484912|580173042|FG000|Overall Study|Withdrawal by Subject|1|||
160669855|NCT01484912|580173043|FG001|Overall Study|Withdrawal by Subject|0|||
160669856|NCT01484912|580173042|FG000|Overall Study|Physician Decision|0|||
160669857|NCT01484912|580173043|FG001|Overall Study|Physician Decision|1|||
160669858|NCT00829712|580173044|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
160669859|NCT00829712|580173045|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
160669860|NCT01188681|580173046|FG000|Overall Study|bladder cancer|0|||
160669861|NCT01188681|580173047|FG001|Overall Study|bladder cancer|0|||
160669862|NCT01188681|580173048|FG002|Overall Study|bladder cancer|1|||
160669863|NCT01188681|580173049|FG003|Overall Study|bladder cancer|0|||
160669864|NCT01188681|580173046|FG000|Overall Study|Withdrawal by Subject|0|||
160669865|NCT01188681|580173047|FG001|Overall Study|Withdrawal by Subject|0|||
160669866|NCT01188681|580173048|FG002|Overall Study|Withdrawal by Subject|0|||
160669867|NCT01188681|580173049|FG003|Overall Study|Withdrawal by Subject|1|||
160669868|NCT01004510|580173055|FG000|Overall Study|Adverse Event|1|||
160669869|NCT02911025|580173060|FG000|Overall Study|Lost to Follow-up|3|||
160669870|NCT03719040|580173061|FG000|Overall Study|Withdrawal by Subject|177|||
160669871|NCT03719040|580173061|FG000|Overall Study|Lost to Follow-up|26|||
160669872|NCT02923349|580173067|FG000|Overall Study|Other|1|||
160669873|NCT02923349|580173068|FG001|Overall Study|Other|2|||
160669874|NCT02923349|580173069|FG002|Overall Study|Other|4|||
160669875|NCT02923349|580173070|FG003|Overall Study|Other|1|||
160669876|NCT02923349|580173071|FG004|Overall Study|Other|3|||
160669877|NCT02923349|580173072|FG005|Overall Study|Other|0|||
160669878|NCT02923349|580173073|FG006|Overall Study|Other|1|||
160669879|NCT02923349|580173067|FG000|Overall Study|Withdrawal by Subject|2|||
160669880|NCT02923349|580173068|FG001|Overall Study|Withdrawal by Subject|2|||
160669881|NCT02923349|580173069|FG002|Overall Study|Withdrawal by Subject|8|||
160669882|NCT02923349|580173070|FG003|Overall Study|Withdrawal by Subject|10|||
160669883|NCT02923349|580173071|FG004|Overall Study|Withdrawal by Subject|12|||
160669884|NCT02923349|580173072|FG005|Overall Study|Withdrawal by Subject|3|||
160669885|NCT02923349|580173073|FG006|Overall Study|Withdrawal by Subject|0|||
160669886|NCT02923349|580173067|FG000|Overall Study|Physician Decision|0|||
160669887|NCT02923349|580173068|FG001|Overall Study|Physician Decision|0|||
160669888|NCT02923349|580173069|FG002|Overall Study|Physician Decision|0|||
160669889|NCT02923349|580173070|FG003|Overall Study|Physician Decision|1|||
160669890|NCT02923349|580173071|FG004|Overall Study|Physician Decision|1|||
160669891|NCT02923349|580173072|FG005|Overall Study|Physician Decision|0|||
160669892|NCT02923349|580173073|FG006|Overall Study|Physician Decision|2|||
160669893|NCT02923349|580173067|FG000|Overall Study|Lost to Follow-up|0|||
160669894|NCT02923349|580173068|FG001|Overall Study|Lost to Follow-up|0|||
160669895|NCT02923349|580173069|FG002|Overall Study|Lost to Follow-up|3|||
160669896|NCT02923349|580173070|FG003|Overall Study|Lost to Follow-up|0|||
160669897|NCT02923349|580173071|FG004|Overall Study|Lost to Follow-up|1|||
160669898|NCT02923349|580173072|FG005|Overall Study|Lost to Follow-up|1|||
160669899|NCT02923349|580173073|FG006|Overall Study|Lost to Follow-up|0|||
160669900|NCT02923349|580173067|FG000|Overall Study|Death|1|||
160669901|NCT02923349|580173068|FG001|Overall Study|Death|0|||
160669902|NCT02923349|580173069|FG002|Overall Study|Death|2|||
160669903|NCT02923349|580173070|FG003|Overall Study|Death|4|||
160669904|NCT02923349|580173071|FG004|Overall Study|Death|2|||
160669905|NCT02923349|580173072|FG005|Overall Study|Death|3|||
160669906|NCT02923349|580173073|FG006|Overall Study|Death|0|||
160669907|NCT00796562|580173079|FG000|Overall Study|Death|49|||
160669908|NCT05655520|580173080|FG000|Overall Study|Adverse Event|2|||
160669909|NCT05655520|580173081|FG001|Overall Study|Adverse Event|3|||
160669910|NCT05655520|580173080|FG000|Overall Study|Physician Decision|2|||
160669911|NCT05655520|580173081|FG001|Overall Study|Physician Decision|0|||
160669912|NCT05655520|580173080|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160669913|NCT05655520|580173081|FG001|Overall Study|Non-Compliance with Study Drug|2|||
160669914|NCT05655520|580173080|FG000|Overall Study|Lost to Follow-up|1|||
160669915|NCT05655520|580173081|FG001|Overall Study|Lost to Follow-up|0|||
160519173|NCT02374671|579629278|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
160519174|NCT03169101|579629282|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
160519175|NCT03169101|579629283|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
160519176|NCT03169101|579629284|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
160519177|NCT03169101|579629285|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
160519178|NCT02641496|579629286|FG000|Overall Study|Lost to Follow-up|13|||
160519179|NCT02641496|579629287|FG001|Overall Study|Lost to Follow-up|12|||
160519180|NCT02641496|579629286|FG000|Overall Study|Withdrawal by Subject|1|||
160519181|NCT02641496|579629287|FG001|Overall Study|Withdrawal by Subject|0|||
160519186|NCT01620255|579630976|FG000|Overall Study|Withdrawal by Subject|4|||
160519187|NCT01620255|579630977|FG001|Overall Study|Withdrawal by Subject|1|||
160519188|NCT01620255|579630978|FG002|Overall Study|Withdrawal by Subject|1|||
160519189|NCT01620255|579630979|FG003|Overall Study|Withdrawal by Subject|2|||
160519190|NCT01620255|579630980|FG004|Overall Study|Withdrawal by Subject|4|||
160519191|NCT01620255|579630976|FG000|Overall Study|Participant underwent fecal transplant|0|||
160519192|NCT01620255|579630977|FG001|Overall Study|Participant underwent fecal transplant|0|||
160519193|NCT01620255|579630978|FG002|Overall Study|Participant underwent fecal transplant|1|||
160519194|NCT01620255|579630979|FG003|Overall Study|Participant underwent fecal transplant|0|||
160519195|NCT01620255|579630980|FG004|Overall Study|Participant underwent fecal transplant|0|||
160519196|NCT01620255|579630976|FG000|Overall Study|Non-compliance|0|||
160519197|NCT01620255|579630977|FG001|Overall Study|Non-compliance|1|||
160519198|NCT01620255|579630978|FG002|Overall Study|Non-compliance|0|||
160519199|NCT01620255|579630979|FG003|Overall Study|Non-compliance|0|||
160519200|NCT01620255|579630980|FG004|Overall Study|Non-compliance|0|||
160519201|NCT01620255|579630976|FG000|Overall Study|Adverse Event|0|||
160519202|NCT01620255|579630977|FG001|Overall Study|Adverse Event|4|||
160519203|NCT01620255|579630978|FG002|Overall Study|Adverse Event|0|||
160519204|NCT01620255|579630979|FG003|Overall Study|Adverse Event|1|||
160519205|NCT01620255|579630980|FG004|Overall Study|Adverse Event|1|||
160519206|NCT01620255|579630976|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
160519207|NCT01620255|579630977|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
160519208|NCT01620255|579630978|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
160519209|NCT01620255|579630979|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
160519210|NCT01620255|579630980|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
160519211|NCT01873495|579630987|FG000|Overall Study|Withdrawal by Subject|1|||
160519212|NCT01873495|579630987|FG000|Overall Study|Physician Decision|3|||
160519213|NCT01873495|579630987|FG000|Overall Study|Adverse Event|1|||
160519214|NCT01873495|579630987|FG000|Overall Study|Removed for Transplantation|1|||
160519215|NCT01873495|579630987|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
160519216|NCT01155375|579630991|FG000|Overall Study|Adverse Event|1|||
160519217|NCT01155375|579630992|FG001|Overall Study|Adverse Event|0|||
160519218|NCT04335812|579630993|FG000|Overall Study|Withdrawal by Subject|1|||
160519219|NCT04335812|579630994|FG001|Overall Study|Withdrawal by Subject|3|||
160519220|NCT04335812|579630993|FG000|Overall Study|Lost to Follow-up|12|||
160519221|NCT04335812|579630994|FG001|Overall Study|Lost to Follow-up|12|||
160519222|NCT04335812|579630993|FG000|Overall Study|Did not engage in the intervention|22|||
160519223|NCT04335812|579630994|FG001|Overall Study|Did not engage in the intervention|18|||
160519224|NCT03864146|579630998|FG000|Overall Study|Lost to Follow-up|14|||
160519225|NCT03864146|579630999|FG001|Overall Study|Lost to Follow-up|23|||
160519226|NCT03864146|579630998|FG000|Overall Study|Withdrawal by Subject|3|||
160519227|NCT03864146|579630999|FG001|Overall Study|Withdrawal by Subject|2|||
160519228|NCT04874415|579631000|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
160519229|NCT04874415|579631001|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
160519230|NCT04874415|579631002|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
160519231|NCT04874415|579631003|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
160519232|NCT04874415|579631004|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
160519233|NCT04874415|579631005|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
160519234|NCT04874415|579631006|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
160519235|NCT04874415|579631007|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
160519236|NCT04874415|579631008|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
160519237|NCT04874415|579631009|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
160519238|NCT04874415|579631010|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
160519239|NCT04874415|579631011|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
160519240|NCT04874415|579631012|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
160519241|NCT04874415|579631013|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
160519242|NCT04874415|579631014|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
160624972|NCT03323034|580007875|FG004|Overall Study|Lack of Efficacy|5|||
160624973|NCT03323034|580007871|FG000|Overall Study|Physician Decision|0|||
160669916|NCT05655520|580173080|FG000|Overall Study|Withdrawal by Subject|4|||
160669917|NCT05655520|580173081|FG001|Overall Study|Withdrawal by Subject|4|||
160669918|NCT05655520|580173080|FG000|Overall Study|Study Terminated by Sponsor|61|||
160669919|NCT05655520|580173081|FG001|Overall Study|Study Terminated by Sponsor|68|||
160669920|NCT00424047|580173082|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
160669921|NCT00424047|580173083|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
160669922|NCT00424047|580173082|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
160669923|NCT00424047|580173083|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
160669924|NCT00424047|580173082|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
160669925|NCT00424047|580173083|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
160669926|NCT00424047|580173082|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
160669927|NCT00424047|580173083|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
160669928|NCT00424047|580173082|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
160669929|NCT00424047|580173083|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
160669930|NCT00424047|580173082|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
160669931|NCT00424047|580173083|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
160669932|NCT00424047|580173082|FG000|On Study at Time of Unblinding|Adverse Event|22|||
160669933|NCT00424047|580173083|FG001|On Study at Time of Unblinding|Adverse Event|12|||
160669934|NCT00424047|580173082|FG000|On Study at Time of Unblinding|Progression of disease|92|||
160669935|NCT00424047|580173083|FG001|On Study at Time of Unblinding|Progression of disease|128|||
160669936|NCT00424047|580173082|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
160669937|NCT00424047|580173083|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
160669938|NCT00424047|580173082|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
160669939|NCT00424047|580173083|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
160669940|NCT00424047|580173082|FG000|On Study at Time of Unblinding|Death|11|||
160669941|NCT00424047|580173083|FG001|On Study at Time of Unblinding|Death|11|||
160669942|NCT00424047|580173082|FG000|On Study at Time of Unblinding|Other|5|||
160669943|NCT00424047|580173083|FG001|On Study at Time of Unblinding|Other|4|||
160669944|NCT00424047|580173082|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
160669945|NCT00424047|580173083|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
160669946|NCT00424047|580173082|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
160669947|NCT00424047|580173083|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
160669948|NCT00424047|580173082|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
160669949|NCT00424047|580173083|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
160669950|NCT00424047|580173082|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
160669951|NCT00424047|580173083|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
160669952|NCT00424047|580173082|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
160669953|NCT00424047|580173083|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
160669954|NCT01229150|580173087|FG000|Overall Study|Toxicity|2|||
160669955|NCT01229150|580173088|FG001|Overall Study|Toxicity|2|||
160669956|NCT01229150|580173089|FG002|Overall Study|Toxicity|0|||
160669957|NCT01229150|580173090|FG003|Overall Study|Toxicity|0|||
160669958|NCT05248204|580173091|FG000|Overall Study|Lost to Follow-up|13|||
160669959|NCT05248204|580173092|FG001|Overall Study|Lost to Follow-up|13|||
160669960|NCT05248204|580173091|FG000|Overall Study|Protocol Violation|1|||
160669961|NCT05248204|580173092|FG001|Overall Study|Protocol Violation|0|||
160669962|NCT01473953|580173093|FG000|Overall Study|Other|1|||
160669963|NCT01473953|580173094|FG001|Overall Study|Other|0|||
160669964|NCT01473953|580173095|FG002|Overall Study|Other|0|||
160669965|NCT01473953|580173096|FG003|Overall Study|Other|0|||
160669966|NCT01473953|580173097|FG004|Overall Study|Other|0|||
160669967|NCT03100344|580173098|FG000|Overall Study|Adverse Event|0|||
160669968|NCT03100344|580173099|FG001|Overall Study|Adverse Event|3|||
160669969|NCT03100344|580173100|FG002|Overall Study|Adverse Event|2|||
160669970|NCT03100344|580173101|FG003|Overall Study|Adverse Event|3|||
160669971|NCT03100344|580173098|FG000|Overall Study|Lack of Efficacy|2|||
160669972|NCT03100344|580173099|FG001|Overall Study|Lack of Efficacy|0|||
160669973|NCT03100344|580173100|FG002|Overall Study|Lack of Efficacy|0|||
160669974|NCT03100344|580173101|FG003|Overall Study|Lack of Efficacy|0|||
160669975|NCT03100344|580173098|FG000|Overall Study|Protocol Violation|1|||
160519243|NCT04874415|579631015|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
160519244|NCT04874415|579631000|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
160669976|NCT03100344|580173099|FG001|Overall Study|Protocol Violation|0|||
160669977|NCT03100344|580173100|FG002|Overall Study|Protocol Violation|0|||
160669978|NCT03100344|580173101|FG003|Overall Study|Protocol Violation|0|||
160669979|NCT03100344|580173098|FG000|Overall Study|Withdrawal by Subject|10|||
160669980|NCT03100344|580173099|FG001|Overall Study|Withdrawal by Subject|7|||
160669981|NCT03100344|580173100|FG002|Overall Study|Withdrawal by Subject|4|||
160669982|NCT03100344|580173101|FG003|Overall Study|Withdrawal by Subject|8|||
160669983|NCT03100344|580173098|FG000|Overall Study|Lost to Follow-up|1|||
160669984|NCT03100344|580173099|FG001|Overall Study|Lost to Follow-up|1|||
160669985|NCT03100344|580173100|FG002|Overall Study|Lost to Follow-up|1|||
160669986|NCT03100344|580173101|FG003|Overall Study|Lost to Follow-up|1|||
160669987|NCT01010503|580173102|FG000|Overall Study|Adverse Event|1|||
160669988|NCT01010503|580173102|FG000|Overall Study|Death|1|||
160669989|NCT06336356|580173103|FG000|Overall Study|Withdrawal by Subject|1|||
160669990|NCT06336356|580173104|FG001|Overall Study|Withdrawal by Subject|0|||
160669991|NCT06336356|580173103|FG000|Overall Study|Lost to Follow Up|1|||
160669992|NCT06336356|580173104|FG001|Overall Study|Lost to Follow Up|0|||
160669993|NCT00725322|580173105|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
160669994|NCT00725322|580173106|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
160669995|NCT00725322|580173105|FG000|Washout (28 Days)|Protocol Violation|0|||
160669996|NCT00725322|580173106|FG001|Washout (28 Days)|Protocol Violation|1|||
160669997|NCT04827394|580173111|FG000|Overall Study|Physician Decision|0|||
160669998|NCT04827394|580173112|FG001|Overall Study|Physician Decision|2|||
160669999|NCT05871151|580173113|FG000|Overall Study|Lost to Follow-up|1|||
160670000|NCT05871151|580173114|FG001|Overall Study|Lost to Follow-up|0|||
160670001|NCT05871151|580173113|FG000|Overall Study|Unrelated illness|0|||
160670002|NCT05871151|580173114|FG001|Overall Study|Unrelated illness|1|||
160670003|NCT03578809|580174616|FG000|Overall Study|Death|0|||
160670004|NCT03578809|580174617|FG001|Overall Study|Death|2|||
160670005|NCT03578809|580174618|FG002|Overall Study|Death|0|||
160670006|NCT03578809|580174619|FG003|Overall Study|Death|1|||
160670007|NCT03578809|580174616|FG000|Overall Study|Lost to Follow-up|0|||
160670008|NCT03578809|580174617|FG001|Overall Study|Lost to Follow-up|1|||
160670009|NCT03578809|580174618|FG002|Overall Study|Lost to Follow-up|0|||
160670010|NCT03578809|580174619|FG003|Overall Study|Lost to Follow-up|0|||
160670011|NCT03578809|580174616|FG000|Overall Study|Withdrawal by Subject|3|||
160670012|NCT03578809|580174617|FG001|Overall Study|Withdrawal by Subject|5|||
160670013|NCT03578809|580174618|FG002|Overall Study|Withdrawal by Subject|2|||
160670014|NCT03578809|580174619|FG003|Overall Study|Withdrawal by Subject|0|||
160670015|NCT03578809|580174616|FG000|Overall Study|Other|3|||
160670016|NCT03578809|580174617|FG001|Overall Study|Other|6|||
160670017|NCT03578809|580174618|FG002|Overall Study|Other|2|||
160670018|NCT03578809|580174619|FG003|Overall Study|Other|8|||
160670019|NCT00830258|580174620|FG000|First Intervention|Adverse Event|1|||
160670020|NCT00830258|580174621|FG001|First Intervention|Adverse Event|0|||
160670021|NCT00830258|580174620|FG000|Washout: 7 Days|Protocol Violation|1|||
160670022|NCT00830258|580174621|FG001|Washout: 7 Days|Protocol Violation|0|||
160670023|NCT03599193|580174622|FG000|Overall Study|Adverse Event|0|||
160670024|NCT03599193|580174623|FG001|Overall Study|Adverse Event|2|||
160670025|NCT03599193|580174622|FG000|Overall Study|Withdrawal by Subject|1|||
160670026|NCT03599193|580174623|FG001|Overall Study|Withdrawal by Subject|0|||
160670027|NCT03599193|580174622|FG000|Overall Study|Protocol Violation|1|||
160670028|NCT03599193|580174623|FG001|Overall Study|Protocol Violation|0|||
160670029|NCT03599193|580174622|FG000|Overall Study|Lost to Follow-up|0|||
160670030|NCT03599193|580174623|FG001|Overall Study|Lost to Follow-up|1|||
160670031|NCT00798603|580174624|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
160670032|NCT00798603|580174624|FG000|Overall Study|Withdrawal by Subject|10|||
160670033|NCT00798603|580174624|FG000|Overall Study|Adverse Event|22|||
160670034|NCT00798603|580174624|FG000|Overall Study|Physician Decision|1|||
160670035|NCT00798603|580174624|FG000|Overall Study|Lack of insurance coverage|1|||
160670036|NCT00835705|580174625|FG000|First Intervention|Difficulty with vein|1|||
160670037|NCT00835705|580174626|FG001|First Intervention|Difficulty with vein|0|||
160670038|NCT00835705|580174625|FG000|Second Intervention|Difficulty with vein|1|||
160670039|NCT00835705|580174626|FG001|Second Intervention|Difficulty with vein|0|||
160670040|NCT01116739|580174627|FG000|Overall Study|Child had 2 years of HS|110|||
160670041|NCT01116739|580174628|FG001|Overall Study|Child had 2 years of HS|128|||
160670042|NCT01116739|580174627|FG000|Overall Study|Withdrawal by Subject|6|||
160670043|NCT01116739|580174628|FG001|Overall Study|Withdrawal by Subject|0|||
160670044|NCT01116739|580174627|FG000|Overall Study|child too young|2|||
160670045|NCT01116739|580174628|FG001|Overall Study|child too young|6|||
160670046|NCT01116739|580174627|FG000|Overall Study|child not enrolled in head start|10|||
160670047|NCT01116739|580174628|FG001|Overall Study|child not enrolled in head start|2|||
160670048|NCT01116739|580174627|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
160670049|NCT01116739|580174628|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
160670050|NCT05090839|580174629|FG000|Overall Study|Lost to Follow-up|2|||
160670051|NCT05090839|580174630|FG001|Overall Study|Lost to Follow-up|3|||
160670052|NCT05090839|580174631|FG002|Overall Study|Lost to Follow-up|1|||
160670053|NCT05090839|580174632|FG003|Overall Study|Lost to Follow-up|1|||
160670054|NCT04406194|580174635|FG000|Period 1|Withdrawal by Subject|0|||
160670055|NCT04406194|580174636|FG001|Period 1|Withdrawal by Subject|1|||
160670056|NCT04102345|580174637|FG000|Overall Study|Withdrawal by Subject|1|||
160670057|NCT04102345|580174638|FG001|Overall Study|Withdrawal by Subject|0|||
160670058|NCT01987765|580174639|FG000|Overall Study|Protocol Violation|65|||
160670059|NCT01987765|580174639|FG000|Overall Study|Lost to Follow-up|37|||
160670060|NCT03606174|580174642|FG000|Overall Study|Death|37|||
160670061|NCT03606174|580174643|FG001|Overall Study|Death|15|||
160670062|NCT03606174|580174644|FG002|Overall Study|Death|15|||
160670063|NCT03606174|580174645|FG003|Overall Study|Death|7|||
160670064|NCT03606174|580174646|FG004|Overall Study|Death|35|||
160670065|NCT03606174|580174647|FG005|Overall Study|Death|12|||
160670066|NCT03606174|580174648|FG006|Overall Study|Death|35|||
160670067|NCT03606174|580174649|FG007|Overall Study|Death|8|||
160670068|NCT03606174|580174650|FG008|Overall Study|Death|5|||
160670069|NCT03606174|580174651|FG009|Overall Study|Death|3|||
160670070|NCT03606174|580174652|FG010|Overall Study|Death|0|||
160670071|NCT03606174|580174642|FG000|Overall Study|Lost to Follow-up|0|||
160670072|NCT03606174|580174643|FG001|Overall Study|Lost to Follow-up|0|||
160670073|NCT03606174|580174644|FG002|Overall Study|Lost to Follow-up|0|||
160670074|NCT03606174|580174645|FG003|Overall Study|Lost to Follow-up|0|||
160670075|NCT03606174|580174646|FG004|Overall Study|Lost to Follow-up|1|||
160670076|NCT03606174|580174647|FG005|Overall Study|Lost to Follow-up|1|||
160670077|NCT03606174|580174648|FG006|Overall Study|Lost to Follow-up|0|||
160670078|NCT03606174|580174649|FG007|Overall Study|Lost to Follow-up|0|||
160670079|NCT03606174|580174650|FG008|Overall Study|Lost to Follow-up|0|||
160670080|NCT03606174|580174651|FG009|Overall Study|Lost to Follow-up|0|||
160670081|NCT03606174|580174652|FG010|Overall Study|Lost to Follow-up|0|||
160670082|NCT03606174|580174642|FG000|Overall Study|Withdrawal by Subject|6|||
160670083|NCT03606174|580174643|FG001|Overall Study|Withdrawal by Subject|0|||
160670084|NCT03606174|580174644|FG002|Overall Study|Withdrawal by Subject|0|||
160670085|NCT03606174|580174645|FG003|Overall Study|Withdrawal by Subject|1|||
160670086|NCT03606174|580174646|FG004|Overall Study|Withdrawal by Subject|2|||
160670087|NCT03606174|580174647|FG005|Overall Study|Withdrawal by Subject|1|||
160670088|NCT03606174|580174648|FG006|Overall Study|Withdrawal by Subject|4|||
160670089|NCT03606174|580174649|FG007|Overall Study|Withdrawal by Subject|0|||
160670090|NCT03606174|580174650|FG008|Overall Study|Withdrawal by Subject|0|||
160670091|NCT03606174|580174651|FG009|Overall Study|Withdrawal by Subject|0|||
160670092|NCT03606174|580174652|FG010|Overall Study|Withdrawal by Subject|1|||
160670093|NCT03606174|580174642|FG000|Overall Study|Study Terminated by Sponsor|5|||
160670094|NCT03606174|580174643|FG001|Overall Study|Study Terminated by Sponsor|7|||
160670095|NCT03606174|580174644|FG002|Overall Study|Study Terminated by Sponsor|3|||
160670096|NCT03606174|580174645|FG003|Overall Study|Study Terminated by Sponsor|0|||
160670097|NCT03606174|580174646|FG004|Overall Study|Study Terminated by Sponsor|11|||
160670098|NCT03606174|580174647|FG005|Overall Study|Study Terminated by Sponsor|6|||
160670099|NCT03606174|580174648|FG006|Overall Study|Study Terminated by Sponsor|12|||
160670100|NCT03606174|580174649|FG007|Overall Study|Study Terminated by Sponsor|1|||
160670101|NCT03606174|580174650|FG008|Overall Study|Study Terminated by Sponsor|3|||
160670102|NCT03606174|580174651|FG009|Overall Study|Study Terminated by Sponsor|1|||
160670103|NCT03606174|580174652|FG010|Overall Study|Study Terminated by Sponsor|2|||
160670104|NCT03606174|580174642|FG000|Overall Study|Miscellaneous|1|||
160670105|NCT03606174|580174643|FG001|Overall Study|Miscellaneous|1|||
160670106|NCT03606174|580174644|FG002|Overall Study|Miscellaneous|0|||
160670107|NCT03606174|580174645|FG003|Overall Study|Miscellaneous|1|||
160670108|NCT03606174|580174646|FG004|Overall Study|Miscellaneous|4|||
160670109|NCT03606174|580174647|FG005|Overall Study|Miscellaneous|7|||
160670110|NCT03606174|580174648|FG006|Overall Study|Miscellaneous|5|||
160670111|NCT03606174|580174649|FG007|Overall Study|Miscellaneous|0|||
160670112|NCT03606174|580174650|FG008|Overall Study|Miscellaneous|0|||
160670113|NCT03606174|580174651|FG009|Overall Study|Miscellaneous|0|||
160670114|NCT03606174|580174652|FG010|Overall Study|Miscellaneous|1|||
160670115|NCT01117623|580174653|FG000|Overall Study|Adverse Event|0|||
160670116|NCT01117623|580174654|FG001|Overall Study|Adverse Event|2|||
160670117|NCT01117623|580174655|FG002|Overall Study|Adverse Event|4|||
160670118|NCT01117623|580174656|FG003|Overall Study|Adverse Event|0|||
160670119|NCT01117623|580174657|FG004|Overall Study|Adverse Event|2|||
160670120|NCT01117623|580174658|FG005|Overall Study|Adverse Event|0|||
160670121|NCT01117623|580174659|FG006|Overall Study|Adverse Event|0|||
160670122|NCT01117623|580174660|FG007|Overall Study|Adverse Event|2|||
160670123|NCT01117623|580174653|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
160670124|NCT01117623|580174654|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
160670125|NCT01117623|580174655|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
160670126|NCT01117623|580174656|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
160670127|NCT01117623|580174657|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
160670128|NCT01117623|580174658|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
160519245|NCT04874415|579631001|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
160519246|NCT04874415|579631002|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
160519247|NCT04874415|579631003|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
160670129|NCT01117623|580174659|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
160670130|NCT01117623|580174660|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
160670131|NCT01117623|580174653|FG000|Overall Study|Withdrawal by Subject|0|||
160670132|NCT01117623|580174654|FG001|Overall Study|Withdrawal by Subject|0|||
160670133|NCT01117623|580174655|FG002|Overall Study|Withdrawal by Subject|2|||
160670134|NCT01117623|580174656|FG003|Overall Study|Withdrawal by Subject|0|||
160670135|NCT01117623|580174657|FG004|Overall Study|Withdrawal by Subject|0|||
160670136|NCT01117623|580174658|FG005|Overall Study|Withdrawal by Subject|1|||
160670137|NCT01117623|580174659|FG006|Overall Study|Withdrawal by Subject|1|||
160670138|NCT01117623|580174660|FG007|Overall Study|Withdrawal by Subject|1|||
160670139|NCT01117623|580174653|FG000|Overall Study|Non-compliance with study medication|0|||
160670140|NCT01117623|580174654|FG001|Overall Study|Non-compliance with study medication|0|||
160670141|NCT01117623|580174655|FG002|Overall Study|Non-compliance with study medication|0|||
160670142|NCT01117623|580174656|FG003|Overall Study|Non-compliance with study medication|0|||
160670143|NCT01117623|580174657|FG004|Overall Study|Non-compliance with study medication|0|||
160670144|NCT01117623|580174658|FG005|Overall Study|Non-compliance with study medication|0|||
160670145|NCT01117623|580174659|FG006|Overall Study|Non-compliance with study medication|0|||
160670146|NCT01117623|580174660|FG007|Overall Study|Non-compliance with study medication|1|||
160670147|NCT01117623|580174653|FG000|Overall Study|Invest. text: completed all planned txs|0|||
160670148|NCT01117623|580174654|FG001|Overall Study|Invest. text: completed all planned txs|0|||
160670149|NCT01117623|580174655|FG002|Overall Study|Invest. text: completed all planned txs|0|||
160670150|NCT01117623|580174656|FG003|Overall Study|Invest. text: completed all planned txs|0|||
160670151|NCT01117623|580174657|FG004|Overall Study|Invest. text: completed all planned txs|0|||
160670152|NCT01117623|580174658|FG005|Overall Study|Invest. text: completed all planned txs|1|||
160670153|NCT01117623|580174659|FG006|Overall Study|Invest. text: completed all planned txs|0|||
160670154|NCT01117623|580174660|FG007|Overall Study|Invest. text: completed all planned txs|0|||
160670155|NCT01205035|580174666|FG000|Overall Study|Withdrawal by Subject|1|||
160670156|NCT01205035|580174667|FG001|Overall Study|Withdrawal by Subject|0|||
160670157|NCT01205035|580174666|FG000|Overall Study|Physician Decision|1|||
160670158|NCT01205035|580174667|FG001|Overall Study|Physician Decision|0|||
160670159|NCT00928057|580174668|FG000|Overall Study|Adverse Event|1|||
160670160|NCT00928057|580174669|FG001|Overall Study|Adverse Event|2|||
160670161|NCT00928057|580174668|FG000|Overall Study|Withdrawal by Subject|1|||
160670162|NCT00928057|580174669|FG001|Overall Study|Withdrawal by Subject|0|||
160670163|NCT00928057|580174668|FG000|Overall Study|Lost to Follow-up|0|||
160670164|NCT00928057|580174669|FG001|Overall Study|Lost to Follow-up|1|||
160670165|NCT00928057|580174668|FG000|Overall Study|Protocol Violation|0|||
160670166|NCT00928057|580174669|FG001|Overall Study|Protocol Violation|1|||
160670167|NCT05497557|580174670|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
160670168|NCT05497557|580174671|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
160670169|NCT05497557|580174672|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
160670170|NCT01896934|580174673|FG000|Overall Study|Adverse Event|1|||
160670171|NCT01896934|580174673|FG000|Overall Study|Withdrawal by Subject|1|||
160670172|NCT04590027|580174674|FG000|Overall Study|Lost to Follow-up|17|||
160670173|NCT04590027|580174675|FG001|Overall Study|Lost to Follow-up|14|||
160670174|NCT04590027|580174674|FG000|Overall Study|Protocol Violation|0|||
160670175|NCT04590027|580174675|FG001|Overall Study|Protocol Violation|3|||
160670176|NCT03497130|580174676|FG000|Overall Study|Lost to Follow-up|1|||
160670177|NCT03497130|580174677|FG001|Overall Study|Lost to Follow-up|1|||
160670178|NCT04345653|580174678|FG000|Overall Study|Withdrawal by Subject|2|||
160670179|NCT00418938|580174679|FG000|Overall Study|Reimbursement|1|||
160670180|NCT00418938|580174680|FG001|Overall Study|Reimbursement|0|||
160670181|NCT00418938|580174679|FG000|Overall Study|Administrative decision|3|||
160670182|NCT00418938|580174680|FG001|Overall Study|Administrative decision|3|||
160670183|NCT00418938|580174679|FG000|Overall Study|Withdrawal by Subject|16|||
160670184|NCT00418938|580174680|FG001|Overall Study|Withdrawal by Subject|15|||
160670185|NCT00418938|580174679|FG000|Overall Study|Lost to Follow-up|1|||
160670186|NCT00418938|580174680|FG001|Overall Study|Lost to Follow-up|3|||
160670187|NCT00418938|580174679|FG000|Overall Study|Adverse Event|1|||
160670188|NCT00418938|580174680|FG001|Overall Study|Adverse Event|1|||
160670189|NCT00418938|580174679|FG000|Overall Study|On-going|1|||
160670190|NCT00418938|580174680|FG001|Overall Study|On-going|1|||
160670191|NCT00418938|580174679|FG000|Overall Study|Ineligibility Determined|1|||
160670192|NCT00418938|580174680|FG001|Overall Study|Ineligibility Determined|0|||
160670193|NCT00205777|580174681|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
160670194|NCT00205777|580174682|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
160519248|NCT04874415|579631004|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
160519249|NCT04874415|579631005|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
160519250|NCT04874415|579631006|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
160519251|NCT04874415|579631007|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
160519252|NCT04874415|579631008|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
160519253|NCT04874415|579631009|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
160519254|NCT04874415|579631010|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
160519255|NCT04874415|579631011|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
160519256|NCT04874415|579631012|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
160670195|NCT00205777|580174683|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
160670196|NCT00205777|580174684|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
160670197|NCT00205777|580174685|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
160670198|NCT00205777|580174686|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
160670199|NCT00205777|580174681|FG000|Core Study (Up to 3 Years)|Death|9|||
160670200|NCT00205777|580174682|FG001|Core Study (Up to 3 Years)|Death|7|||
160670201|NCT00205777|580174683|FG002|Core Study (Up to 3 Years)|Death|14|||
160670202|NCT00205777|580174684|FG003|Core Study (Up to 3 Years)|Death|7|||
160670203|NCT00205777|580174685|FG004|Core Study (Up to 3 Years)|Death|0|||
160670204|NCT00205777|580174686|FG005|Core Study (Up to 3 Years)|Death|0|||
160670205|NCT00205777|580174681|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
160670206|NCT00205777|580174682|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
160670207|NCT00205777|580174683|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
160670208|NCT00205777|580174684|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
160670209|NCT00205777|580174685|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
160670210|NCT00205777|580174686|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
160670211|NCT00205777|580174681|FG000|Core Study (Up to 3 Years)|Other Event|49|||
160670212|NCT00205777|580174682|FG001|Core Study (Up to 3 Years)|Other Event|52|||
160670213|NCT00205777|580174683|FG002|Core Study (Up to 3 Years)|Other Event|41|||
160670214|NCT00205777|580174684|FG003|Core Study (Up to 3 Years)|Other Event|58|||
160670215|NCT00205777|580174685|FG004|Core Study (Up to 3 Years)|Other Event|0|||
160670216|NCT00205777|580174686|FG005|Core Study (Up to 3 Years)|Other Event|0|||
160670217|NCT00205777|580174681|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
160670218|NCT00205777|580174682|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
160670219|NCT00205777|580174683|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
160670220|NCT00205777|580174684|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
160670221|NCT00205777|580174685|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
160670222|NCT00205777|580174686|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
160670223|NCT00205777|580174681|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
160670224|NCT00205777|580174682|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
160670225|NCT00205777|580174683|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
160670226|NCT00205777|580174684|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
160670227|NCT00205777|580174685|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
160670228|NCT00205777|580174686|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
160670229|NCT00205777|580174681|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
160670230|NCT00205777|580174682|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
160670231|NCT00205777|580174683|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
160670232|NCT00205777|580174684|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
160670233|NCT00205777|580174685|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
160670234|NCT00205777|580174686|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
160670235|NCT00205777|580174681|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
160670236|NCT00205777|580174682|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
160670237|NCT00205777|580174683|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
160670238|NCT00205777|580174684|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
160670239|NCT00205777|580174685|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
160670240|NCT00205777|580174686|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
160670241|NCT00205777|580174681|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
160670242|NCT00205777|580174682|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
160670243|NCT00205777|580174683|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
160670244|NCT00205777|580174684|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
160670245|NCT00205777|580174685|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
160670246|NCT00205777|580174686|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
160670247|NCT00205777|580174681|FG000|Completed Core Study, Entered SE I|Other Event|52|||
160670248|NCT00205777|580174682|FG001|Completed Core Study, Entered SE I|Other Event|46|||
160670249|NCT00205777|580174683|FG002|Completed Core Study, Entered SE I|Other Event|47|||
160670250|NCT00205777|580174684|FG003|Completed Core Study, Entered SE I|Other Event|50|||
160670251|NCT00205777|580174685|FG004|Completed Core Study, Entered SE I|Other Event|0|||
160670252|NCT00205777|580174686|FG005|Completed Core Study, Entered SE I|Other Event|0|||
160670253|NCT00205777|580174681|FG000|Study Extension I|Adverse Event|57|||
160670254|NCT00205777|580174682|FG001|Study Extension I|Adverse Event|0|||
160670255|NCT00205777|580174683|FG002|Study Extension I|Adverse Event|0|||
160670256|NCT00205777|580174684|FG003|Study Extension I|Adverse Event|61|||
160670257|NCT00205777|580174685|FG004|Study Extension I|Adverse Event|58|||
160670258|NCT00205777|580174686|FG005|Study Extension I|Adverse Event|0|||
160670259|NCT00205777|580174681|FG000|Study Extension I|Death|5|||
160670260|NCT00205777|580174682|FG001|Study Extension I|Death|0|||
160670261|NCT00205777|580174683|FG002|Study Extension I|Death|0|||
160670262|NCT00205777|580174684|FG003|Study Extension I|Death|1|||
160670263|NCT00205777|580174685|FG004|Study Extension I|Death|2|||
160670264|NCT00205777|580174686|FG005|Study Extension I|Death|0|||
160670265|NCT00205777|580174681|FG000|Study Extension I|Withdrawal by Subject|99|||
160670266|NCT00205777|580174682|FG001|Study Extension I|Withdrawal by Subject|0|||
160670267|NCT00205777|580174683|FG002|Study Extension I|Withdrawal by Subject|0|||
160670268|NCT00205777|580174684|FG003|Study Extension I|Withdrawal by Subject|106|||
160670269|NCT00205777|580174685|FG004|Study Extension I|Withdrawal by Subject|89|||
160670270|NCT00205777|580174686|FG005|Study Extension I|Withdrawal by Subject|0|||
160670271|NCT00205777|580174681|FG000|Study Extension I|Protocol Violation|4|||
160670272|NCT00205777|580174682|FG001|Study Extension I|Protocol Violation|0|||
160519257|NCT04874415|579631013|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
160519258|NCT04874415|579631014|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
160519259|NCT04874415|579631015|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
160519260|NCT04874415|579631000|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519261|NCT04874415|579631001|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519262|NCT04874415|579631002|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519263|NCT04874415|579631003|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519264|NCT04874415|579631004|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
160519265|NCT04874415|579631005|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519266|NCT04874415|579631006|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519267|NCT04874415|579631007|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519268|NCT04874415|579631008|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519269|NCT04874415|579631009|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519270|NCT04874415|579631010|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519271|NCT04874415|579631011|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519272|NCT04874415|579631012|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519273|NCT04874415|579631013|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519274|NCT04874415|579631014|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519275|NCT04874415|579631015|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
160519276|NCT05062759|579631018|FG000|Overall Study|Death|0|||
160519277|NCT05062759|579631019|FG001|Overall Study|Death|1|||
160519278|NCT05062759|579631018|FG000|Overall Study|Lost to Follow-up|1|||
160519279|NCT05062759|579631019|FG001|Overall Study|Lost to Follow-up|0|||
160519280|NCT04981366|579631020|FG000|Overall Study|Withdrawal by Subject|5|||
160519281|NCT04981366|579631021|FG001|Overall Study|Withdrawal by Subject|4|||
160519282|NCT04981366|579631022|FG002|Overall Study|Withdrawal by Subject|8|||
160519283|NCT04981366|579631020|FG000|Overall Study|Health issues unrelated to the trial|1|||
160519284|NCT04981366|579631021|FG001|Overall Study|Health issues unrelated to the trial|2|||
160519285|NCT04981366|579631022|FG002|Overall Study|Health issues unrelated to the trial|0|||
160519286|NCT01112306|579631023|FG000|Overall Study|Death|175|||
160519287|NCT01112306|579631023|FG000|Overall Study|Lost to Follow-up|9|||
160519288|NCT01112306|579631023|FG000|Overall Study|Withdrawal by Subject|31|||
160519289|NCT01112306|579631023|FG000|Overall Study|Other|70|||
160519290|NCT00881608|579631024|FG000|Overall Study|Study prematurely terminated|11|||
160519291|NCT03214094|579631025|FG000|Overall Study|Case Report Forms Uncollected|14|||
160519292|NCT03214094|579631025|FG000|Overall Study|Protocol Deviation|46|||
160519293|NCT00655486|579631030|FG000|Overall Study|Adverse Event|10|||
160519294|NCT00655486|579631030|FG000|Overall Study|Lack of Efficacy|8|||
160519295|NCT00655486|579631030|FG000|Overall Study|Withdrawal by Subject|4|||
160519296|NCT00655486|579631030|FG000|Overall Study|Protocol Violation|1|||
160519297|NCT00655486|579631030|FG000|Overall Study|Unsatisfactory compliance|2|||
160519298|NCT00655486|579631030|FG000|Overall Study|Other: Pregnancy|1|||
160519299|NCT00655486|579631030|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
160519300|NCT00655486|579631030|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
160519301|NCT00310037|579631031|FG000|Overall Study|Adverse Event|7|||
160519302|NCT00310037|579631032|FG001|Overall Study|Adverse Event|14|||
160519303|NCT00310037|579631031|FG000|Overall Study|Withdrawal by Subject|4|||
160519304|NCT00310037|579631032|FG001|Overall Study|Withdrawal by Subject|3|||
160519305|NCT00310037|579631031|FG000|Overall Study|Progression|6|||
160519306|NCT00310037|579631032|FG001|Overall Study|Progression|0|||
160519307|NCT00310037|579631031|FG000|Overall Study|Non-protocol treatment|1|||
160519308|NCT00310037|579631032|FG001|Overall Study|Non-protocol treatment|0|||
160519309|NCT00440999|579631043|FG000|Overall Study|Adverse Event|0|||
160519310|NCT00440999|579631044|FG001|Overall Study|Adverse Event|2|||
160519311|NCT00440999|579631043|FG000|Overall Study|Lack of Efficacy|6|||
160519312|NCT00440999|579631044|FG001|Overall Study|Lack of Efficacy|7|||
160519313|NCT00440999|579631043|FG000|Overall Study|Lost to Follow-up|19|||
160519314|NCT00440999|579631044|FG001|Overall Study|Lost to Follow-up|12|||
160519315|NCT00440999|579631043|FG000|Overall Study|Protocol Violation|1|||
160519316|NCT00440999|579631044|FG001|Overall Study|Protocol Violation|0|||
160519317|NCT00440999|579631043|FG000|Overall Study|Withdrawal by Subject|2|||
160519318|NCT00440999|579631044|FG001|Overall Study|Withdrawal by Subject|5|||
160519319|NCT00440999|579631043|FG000|Overall Study|Subjets missed the visit|1|||
160519320|NCT00440999|579631044|FG001|Overall Study|Subjets missed the visit|0|||
160519321|NCT00440999|579631043|FG000|Overall Study|Mixed infection at entry|1|||
160519322|NCT00440999|579631044|FG001|Overall Study|Mixed infection at entry|0|||
160519323|NCT00440999|579631043|FG000|Overall Study|P. falciparum malaria|5|||
160519324|NCT00440999|579631044|FG001|Overall Study|P. falciparum malaria|14|||
160624974|NCT03323034|580007872|FG001|Overall Study|Physician Decision|0|||
160519325|NCT00440999|579631043|FG000|Overall Study|Subj left hosp without inform staff|0|||
160624975|NCT03323034|580007873|FG002|Overall Study|Physician Decision|0|||
160670273|NCT00205777|580174683|FG002|Study Extension I|Protocol Violation|0|||
160670274|NCT00205777|580174684|FG003|Study Extension I|Protocol Violation|8|||
160670275|NCT00205777|580174685|FG004|Study Extension I|Protocol Violation|8|||
160670276|NCT00205777|580174686|FG005|Study Extension I|Protocol Violation|0|||
160670277|NCT00205777|580174681|FG000|Study Extension I|Lack of Efficacy|0|||
160670278|NCT00205777|580174682|FG001|Study Extension I|Lack of Efficacy|0|||
160670279|NCT00205777|580174683|FG002|Study Extension I|Lack of Efficacy|0|||
160670280|NCT00205777|580174684|FG003|Study Extension I|Lack of Efficacy|1|||
160670281|NCT00205777|580174685|FG004|Study Extension I|Lack of Efficacy|2|||
160670282|NCT00205777|580174686|FG005|Study Extension I|Lack of Efficacy|0|||
160670283|NCT00205777|580174681|FG000|Study Extension I|Failed to return|15|||
160670284|NCT00205777|580174682|FG001|Study Extension I|Failed to return|0|||
160670285|NCT00205777|580174683|FG002|Study Extension I|Failed to return|0|||
160670286|NCT00205777|580174684|FG003|Study Extension I|Failed to return|17|||
160670287|NCT00205777|580174685|FG004|Study Extension I|Failed to return|13|||
160670288|NCT00205777|580174686|FG005|Study Extension I|Failed to return|0|||
160670289|NCT00205777|580174681|FG000|Study Extension I|Other Event|34|||
160670290|NCT00205777|580174682|FG001|Study Extension I|Other Event|0|||
160670291|NCT00205777|580174683|FG002|Study Extension I|Other Event|0|||
160670292|NCT00205777|580174684|FG003|Study Extension I|Other Event|34|||
160670293|NCT00205777|580174685|FG004|Study Extension I|Other Event|29|||
160670294|NCT00205777|580174686|FG005|Study Extension I|Other Event|0|||
160670295|NCT00205777|580174681|FG000|Study Extension I|Withdrawn as per protocol|0|||
160670296|NCT00205777|580174682|FG001|Study Extension I|Withdrawn as per protocol|0|||
160670297|NCT00205777|580174683|FG002|Study Extension I|Withdrawn as per protocol|1070|||
160670298|NCT00205777|580174684|FG003|Study Extension I|Withdrawn as per protocol|0|||
160670299|NCT00205777|580174685|FG004|Study Extension I|Withdrawn as per protocol|0|||
160670300|NCT00205777|580174686|FG005|Study Extension I|Withdrawn as per protocol|0|||
160670301|NCT00205777|580174681|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
160670302|NCT00205777|580174682|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
160670303|NCT00205777|580174683|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
160670304|NCT00205777|580174684|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
160670305|NCT00205777|580174685|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
160670306|NCT00205777|580174686|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
160670307|NCT00205777|580174681|FG000|Study Extension II|Adverse Event|0|||
160670308|NCT00205777|580174682|FG001|Study Extension II|Adverse Event|0|||
160670309|NCT00205777|580174683|FG002|Study Extension II|Adverse Event|0|||
160670310|NCT00205777|580174684|FG003|Study Extension II|Adverse Event|14|||
160670311|NCT00205777|580174685|FG004|Study Extension II|Adverse Event|0|||
160670312|NCT00205777|580174686|FG005|Study Extension II|Adverse Event|30|||
160670313|NCT00205777|580174681|FG000|Study Extension II|Death|0|||
160670314|NCT00205777|580174682|FG001|Study Extension II|Death|0|||
160670315|NCT00205777|580174683|FG002|Study Extension II|Death|0|||
160670316|NCT00205777|580174684|FG003|Study Extension II|Death|2|||
160670317|NCT00205777|580174685|FG004|Study Extension II|Death|0|||
160670318|NCT00205777|580174686|FG005|Study Extension II|Death|5|||
160670319|NCT00205777|580174681|FG000|Study Extension II|Withdrawal by Subject|0|||
160670320|NCT00205777|580174682|FG001|Study Extension II|Withdrawal by Subject|0|||
160670321|NCT00205777|580174683|FG002|Study Extension II|Withdrawal by Subject|0|||
160670322|NCT00205777|580174684|FG003|Study Extension II|Withdrawal by Subject|35|||
160670323|NCT00205777|580174685|FG004|Study Extension II|Withdrawal by Subject|0|||
160670324|NCT00205777|580174686|FG005|Study Extension II|Withdrawal by Subject|59|||
160670325|NCT00205777|580174681|FG000|Study Extension II|Protocol Violation|0|||
160670326|NCT00205777|580174682|FG001|Study Extension II|Protocol Violation|0|||
160670327|NCT00205777|580174683|FG002|Study Extension II|Protocol Violation|0|||
160670328|NCT00205777|580174684|FG003|Study Extension II|Protocol Violation|1|||
160670329|NCT00205777|580174685|FG004|Study Extension II|Protocol Violation|0|||
160519326|NCT00440999|579631044|FG001|Overall Study|Subj left hosp without inform staff|1|||
160519327|NCT05559099|579631047|FG000|Overall Study|Death|5|||
160519328|NCT05559099|579631048|FG001|Overall Study|Death|4|||
160670330|NCT00205777|580174686|FG005|Study Extension II|Protocol Violation|10|||
160519329|NCT05559099|579631047|FG000|Overall Study|Lost to Follow-up|0|||
160519330|NCT05559099|579631048|FG001|Overall Study|Lost to Follow-up|2|||
160670331|NCT00205777|580174681|FG000|Study Extension II|Lack of Efficacy|0|||
160670332|NCT00205777|580174682|FG001|Study Extension II|Lack of Efficacy|0|||
160670333|NCT00205777|580174683|FG002|Study Extension II|Lack of Efficacy|0|||
160670334|NCT00205777|580174684|FG003|Study Extension II|Lack of Efficacy|0|||
160670335|NCT00205777|580174685|FG004|Study Extension II|Lack of Efficacy|0|||
160670336|NCT00205777|580174686|FG005|Study Extension II|Lack of Efficacy|1|||
160670337|NCT00205777|580174681|FG000|Study Extension II|Failed to return|0|||
160670338|NCT00205777|580174682|FG001|Study Extension II|Failed to return|0|||
160670339|NCT00205777|580174683|FG002|Study Extension II|Failed to return|0|||
160670340|NCT00205777|580174684|FG003|Study Extension II|Failed to return|14|||
160670341|NCT00205777|580174685|FG004|Study Extension II|Failed to return|0|||
160670342|NCT00205777|580174686|FG005|Study Extension II|Failed to return|26|||
160670343|NCT00205777|580174681|FG000|Study Extension II|Other Event|0|||
160670344|NCT00205777|580174682|FG001|Study Extension II|Other Event|0|||
160670345|NCT00205777|580174683|FG002|Study Extension II|Other Event|0|||
160670346|NCT00205777|580174684|FG003|Study Extension II|Other Event|12|||
160670347|NCT00205777|580174685|FG004|Study Extension II|Other Event|0|||
160670348|NCT00205777|580174686|FG005|Study Extension II|Other Event|20|||
160670349|NCT00205777|580174681|FG000|Study Extension II|Enrolled but not treated|0|||
160670350|NCT00205777|580174682|FG001|Study Extension II|Enrolled but not treated|0|||
160670351|NCT00205777|580174683|FG002|Study Extension II|Enrolled but not treated|0|||
160670352|NCT00205777|580174684|FG003|Study Extension II|Enrolled but not treated|71|||
160670353|NCT00205777|580174685|FG004|Study Extension II|Enrolled but not treated|0|||
160670354|NCT00205777|580174686|FG005|Study Extension II|Enrolled but not treated|131|||
160670355|NCT00700739|580174690|FG000|Overall Study|Lost to Follow-up|4|||
160670356|NCT00700739|580174691|FG001|Overall Study|Lost to Follow-up|4|||
160670357|NCT00003470|580174695|FG000|Overall Study|Not evaluable|6|||
160670358|NCT04631562|580174698|FG000|Overall Study|Withdrawal by Subject|0|||
160670359|NCT04631562|580174699|FG001|Overall Study|Withdrawal by Subject|0|||
160519331|NCT05559099|579631047|FG000|Overall Study|Adverse Event|1|||
160519332|NCT05559099|579631048|FG001|Overall Study|Adverse Event|1|||
160519333|NCT04018092|579631049|FG000|Overall Study|Withdrawal by Subject|1|||
160519334|NCT04018092|579631050|FG001|Overall Study|Withdrawal by Subject|1|||
160519335|NCT04018092|579631049|FG000|Overall Study|Withdrawal by Subject|1|||
160519336|NCT04018092|579631050|FG001|Overall Study|Withdrawal by Subject|1|||
160519337|NCT04218084|579631051|FG000|Overall Study|Adverse Event|7|||
160519338|NCT04218084|579631052|FG001|Overall Study|Adverse Event|2|||
160519339|NCT04218084|579631051|FG000|Overall Study|Withdrawal of Consent|4|||
160519340|NCT04218084|579631052|FG001|Overall Study|Withdrawal of Consent|5|||
160519341|NCT04218084|579631051|FG000|Overall Study|Physician Decision|1|||
160519342|NCT04218084|579631052|FG001|Overall Study|Physician Decision|1|||
160519343|NCT04218084|579631051|FG000|Overall Study|Lost to Follow-up|1|||
160519344|NCT04218084|579631052|FG001|Overall Study|Lost to Follow-up|1|||
160519345|NCT04218084|579631051|FG000|Overall Study|Non-compliance with study drug|1|||
160519346|NCT04218084|579631052|FG001|Overall Study|Non-compliance with study drug|1|||
160519347|NCT04218084|579631051|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
160519348|NCT04218084|579631052|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
160519349|NCT04218084|579631051|FG000|Overall Study|Other|0|||
160519350|NCT04218084|579631052|FG001|Overall Study|Other|1|||
160519351|NCT04218084|579631051|FG000|Overall Study|Ongoing at data cut-off date|62|||
160519352|NCT04218084|579631052|FG001|Overall Study|Ongoing at data cut-off date|58|||
160519353|NCT06469242|579631053|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
160519354|NCT06469242|579631054|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
160519355|NCT06469242|579631053|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
160519356|NCT06469242|579631054|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
160519357|NCT05041101|579631055|FG000|Overall Study|Adverse Event|1|||
160519358|NCT05041101|579631056|FG001|Overall Study|Adverse Event|0|||
160519359|NCT05041101|579631057|FG002|Overall Study|Adverse Event|0|||
160519360|NCT05041101|579631055|FG000|Overall Study|Diease Progression|5|||
160519361|NCT05041101|579631056|FG001|Overall Study|Diease Progression|0|||
160519362|NCT05041101|579631057|FG002|Overall Study|Diease Progression|0|||
160519363|NCT01205152|579631058|FG000|Overall Study|Death|1|||
160519364|NCT02783768|579631059|FG000|Overall Study|Lost to Follow-up|1|||
160519365|NCT02783768|579631060|FG001|Overall Study|Lost to Follow-up|0|||
160519366|NCT01853137|579631061|FG000|Overall Study|Lost to Follow-up|4|||
160519367|NCT01853137|579631062|FG001|Overall Study|Lost to Follow-up|1|||
160670360|NCT04631562|580174700|FG002|Overall Study|Withdrawal by Subject|0|||
160670361|NCT04631562|580174701|FG003|Overall Study|Withdrawal by Subject|0|||
160670362|NCT04631562|580174702|FG004|Overall Study|Withdrawal by Subject|0|||
160519368|NCT00842985|579631063|FG000|Screening|Did not meet entrance requirements|27|||
160670363|NCT04631562|580174703|FG005|Overall Study|Withdrawal by Subject|0|||
160670364|NCT04631562|580174704|FG006|Overall Study|Withdrawal by Subject|0|||
160670365|NCT04631562|580174705|FG007|Overall Study|Withdrawal by Subject|1|||
160670366|NCT04631562|580174706|FG008|Overall Study|Withdrawal by Subject|0|||
160670367|NCT04631562|580174698|FG000|Overall Study|Other|0|||
160519369|NCT00842985|579631063|FG000|First Intervention|Withdrawal by Subject|3|||
160519370|NCT00842985|579631063|FG000|First Intervention|Protocol Violation|3|||
160519371|NCT00842985|579631063|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
160519372|NCT00842985|579631063|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
160670368|NCT04631562|580174699|FG001|Overall Study|Other|0|||
160670369|NCT04631562|580174700|FG002|Overall Study|Other|0|||
160519373|NCT01037244|579631064|FG000|Overall Study|Adverse Event|3|||
160519374|NCT01037244|579631065|FG001|Overall Study|Adverse Event|2|||
160670370|NCT04631562|580174701|FG003|Overall Study|Other|0|||
160670371|NCT04631562|580174702|FG004|Overall Study|Other|0|||
160670372|NCT04631562|580174703|FG005|Overall Study|Other|0|||
160670373|NCT04631562|580174704|FG006|Overall Study|Other|0|||
160670374|NCT04631562|580174705|FG007|Overall Study|Other|0|||
160670375|NCT04631562|580174706|FG008|Overall Study|Other|1|||
160519375|NCT01037244|579631066|FG002|Overall Study|Adverse Event|6|||
160519376|NCT01037244|579631067|FG003|Overall Study|Adverse Event|3|||
160670376|NCT04631562|580174698|FG000|Overall Study|Lost to Follow-up|0|||
160670377|NCT04631562|580174699|FG001|Overall Study|Lost to Follow-up|0|||
160670378|NCT04631562|580174700|FG002|Overall Study|Lost to Follow-up|0|||
160670379|NCT04631562|580174701|FG003|Overall Study|Lost to Follow-up|1|||
160670380|NCT04631562|580174702|FG004|Overall Study|Lost to Follow-up|0|||
160670381|NCT04631562|580174703|FG005|Overall Study|Lost to Follow-up|0|||
160670382|NCT04631562|580174704|FG006|Overall Study|Lost to Follow-up|0|||
160670383|NCT04631562|580174705|FG007|Overall Study|Lost to Follow-up|0|||
160670384|NCT04631562|580174706|FG008|Overall Study|Lost to Follow-up|0|||
160670385|NCT04631562|580174698|FG000|Overall Study|Adverse Event|0|||
160670386|NCT04631562|580174699|FG001|Overall Study|Adverse Event|0|||
160670387|NCT04631562|580174700|FG002|Overall Study|Adverse Event|0|||
160670388|NCT04631562|580174701|FG003|Overall Study|Adverse Event|0|||
160670389|NCT04631562|580174702|FG004|Overall Study|Adverse Event|0|||
160670390|NCT04631562|580174703|FG005|Overall Study|Adverse Event|0|||
160670391|NCT04631562|580174704|FG006|Overall Study|Adverse Event|1|||
160670392|NCT04631562|580174705|FG007|Overall Study|Adverse Event|0|||
160670393|NCT04631562|580174706|FG008|Overall Study|Adverse Event|0|||
160670394|NCT03503318|580174707|FG000|Overall Study|Death|1|||
160670395|NCT03503318|580174708|FG001|Overall Study|Death|0|||
160670396|NCT03503318|580174709|FG002|Overall Study|Death|4|||
160670397|NCT03503318|580174707|FG000|Overall Study|Adverse Event|3|||
160670398|NCT03503318|580174708|FG001|Overall Study|Adverse Event|4|||
160670399|NCT03503318|580174709|FG002|Overall Study|Adverse Event|2|||
160670400|NCT03503318|580174707|FG000|Overall Study|Withdrawal by Subject|12|||
160670401|NCT03503318|580174708|FG001|Overall Study|Withdrawal by Subject|17|||
160670402|NCT03503318|580174709|FG002|Overall Study|Withdrawal by Subject|16|||
160670403|NCT03503318|580174707|FG000|Overall Study|Protocol Violation|5|||
160670404|NCT03503318|580174708|FG001|Overall Study|Protocol Violation|0|||
160670405|NCT03503318|580174709|FG002|Overall Study|Protocol Violation|3|||
160670406|NCT03503318|580174707|FG000|Overall Study|Lost to Follow-up|17|||
160670407|NCT03503318|580174708|FG001|Overall Study|Lost to Follow-up|15|||
160670408|NCT03503318|580174709|FG002|Overall Study|Lost to Follow-up|12|||
160670409|NCT03503318|580174707|FG000|Overall Study|Other than specified|1|||
160670410|NCT03503318|580174708|FG001|Overall Study|Other than specified|3|||
160670411|NCT03503318|580174709|FG002|Overall Study|Other than specified|3|||
160670412|NCT01794845|580174712|FG000|Overall Study|Withdrawal by Subject|1|||
160670413|NCT02139826|580174713|FG000|Overall Study|Adverse Event|1|||
160670414|NCT00867360|580174714|FG000|Overall Study|Withdrawal by Subject|1|||
160670415|NCT00867360|580174715|FG001|Overall Study|Withdrawal by Subject|0|||
160670416|NCT00867360|580174714|FG000|Overall Study|Physician Decision|0|||
160670417|NCT00867360|580174715|FG001|Overall Study|Physician Decision|1|||
160670418|NCT00436163|580174716|FG000|Overall Study|Lost to Follow-up|2|||
160670419|NCT00436163|580174716|FG000|Overall Study|Adverse Event|1|||
160670420|NCT02597049|580174717|FG000|Overall Study|Lost to Follow-up|0|||
160670421|NCT02597049|580174718|FG001|Overall Study|Lost to Follow-up|3|||
160670422|NCT02597049|580174719|FG002|Overall Study|Lost to Follow-up|2|||
160670423|NCT02597049|580174717|FG000|Overall Study|Withdrawal by Subject|2|||
160670424|NCT02597049|580174718|FG001|Overall Study|Withdrawal by Subject|2|||
160670425|NCT02597049|580174719|FG002|Overall Study|Withdrawal by Subject|1|||
160670426|NCT02597049|580174717|FG000|Overall Study|Adverse Event|2|||
160670427|NCT02597049|580174718|FG001|Overall Study|Adverse Event|0|||
160670428|NCT02597049|580174719|FG002|Overall Study|Adverse Event|0|||
160670429|NCT02597049|580174717|FG000|Overall Study|Death|2|||
160670430|NCT02597049|580174718|FG001|Overall Study|Death|0|||
160670431|NCT02597049|580174719|FG002|Overall Study|Death|0|||
160670432|NCT02597049|580174717|FG000|Overall Study|Noncompliant with Study Visits|1|||
160670433|NCT02597049|580174718|FG001|Overall Study|Noncompliant with Study Visits|0|||
160670434|NCT02597049|580174719|FG002|Overall Study|Noncompliant with Study Visits|0|||
160670435|NCT06647173|580174720|FG000|Overall Study|Lost to Follow-up|24|||
160670436|NCT01120028|580174721|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
160670437|NCT01120028|580174722|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
160670438|NCT01120028|580174723|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
160670439|NCT01120028|580174724|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
160670440|NCT01120028|580174721|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
160670441|NCT01120028|580174722|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
160670442|NCT01120028|580174723|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
160670443|NCT01120028|580174724|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
160670444|NCT03250117|580174725|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
160670445|NCT03250117|580174726|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
160670446|NCT03250117|580174727|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
160670447|NCT03250117|580174728|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
160670448|NCT04063878|580174729|FG000|Overall Study|Withdrawal by Subject|2|||
160670449|NCT04063878|580174729|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
160670450|NCT02751827|580174730|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
160670451|NCT02751827|580174731|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
160670452|NCT02751827|580174732|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
160670453|NCT01248728|580174733|FG000|Overall Study|Adverse Event|1|||
160670454|NCT01248728|580174734|FG001|Overall Study|Adverse Event|1|||
160670455|NCT01248728|580174733|FG000|Overall Study|Withdrawal by Subject|2|||
160670456|NCT01248728|580174734|FG001|Overall Study|Withdrawal by Subject|1|||
160670457|NCT01248728|580174733|FG000|Overall Study|Lack of Efficacy|1|||
160670458|NCT01248728|580174734|FG001|Overall Study|Lack of Efficacy|0|||
160670459|NCT00147498|580174735|FG000|Overall Study|Adverse Event|1|||
160670460|NCT00147498|580174736|FG001|Overall Study|Adverse Event|6|||
160670461|NCT00147498|580174737|FG002|Overall Study|Adverse Event|7|||
160670462|NCT00147498|580174738|FG003|Overall Study|Adverse Event|3|||
160670463|NCT00147498|580174735|FG000|Overall Study|Lack of Efficacy|1|||
160670464|NCT00147498|580174736|FG001|Overall Study|Lack of Efficacy|1|||
160670465|NCT00147498|580174737|FG002|Overall Study|Lack of Efficacy|1|||
160670466|NCT00147498|580174738|FG003|Overall Study|Lack of Efficacy|8|||
160670467|NCT00147498|580174735|FG000|Overall Study|Laboratory abnormality|0|||
160670468|NCT00147498|580174736|FG001|Overall Study|Laboratory abnormality|0|||
160670469|NCT00147498|580174737|FG002|Overall Study|Laboratory abnormality|2|||
160670470|NCT00147498|580174738|FG003|Overall Study|Laboratory abnormality|0|||
160670471|NCT00147498|580174735|FG000|Overall Study|Participant defaulted|0|||
160670472|NCT00147498|580174736|FG001|Overall Study|Participant defaulted|1|||
160670473|NCT00147498|580174737|FG002|Overall Study|Participant defaulted|4|||
160670474|NCT00147498|580174738|FG003|Overall Study|Participant defaulted|3|||
160670475|NCT00147498|580174735|FG000|Overall Study|Other|1|||
160670476|NCT00147498|580174736|FG001|Overall Study|Other|1|||
160670477|NCT00147498|580174737|FG002|Overall Study|Other|3|||
160670478|NCT00147498|580174738|FG003|Overall Study|Other|3|||
160670479|NCT01838681|580174739|FG000|Period A|Adverse Event|39|||
160670480|NCT01838681|580174740|FG001|Period A|Adverse Event|0|||
160670481|NCT01838681|580174741|FG002|Period A|Adverse Event|0|||
160670482|NCT01838681|580174742|FG003|Period A|Adverse Event|0|||
160670483|NCT01838681|580174739|FG000|Period A|Lack of Efficacy|21|||
160670484|NCT01838681|580174740|FG001|Period A|Lack of Efficacy|0|||
160670485|NCT01838681|580174741|FG002|Period A|Lack of Efficacy|0|||
160670486|NCT01838681|580174742|FG003|Period A|Lack of Efficacy|0|||
160670487|NCT01838681|580174739|FG000|Period A|Early response|148|||
160670488|NCT01838681|580174740|FG001|Period A|Early response|0|||
160670489|NCT01838681|580174741|FG002|Period A|Early response|0|||
160670490|NCT01838681|580174742|FG003|Period A|Early response|0|||
160670491|NCT01838681|580174739|FG000|Period A|Withdrawal by Subject|70|||
160670492|NCT01838681|580174740|FG001|Period A|Withdrawal by Subject|0|||
160519377|NCT01037244|579631064|FG000|Overall Study|Lack of Efficacy|1|||
160519378|NCT01037244|579631065|FG001|Overall Study|Lack of Efficacy|1|||
160519379|NCT01037244|579631066|FG002|Overall Study|Lack of Efficacy|0|||
160519380|NCT01037244|579631067|FG003|Overall Study|Lack of Efficacy|1|||
160519381|NCT01037244|579631064|FG000|Overall Study|Lost to Follow-up|3|||
160519382|NCT01037244|579631065|FG001|Overall Study|Lost to Follow-up|3|||
160519383|NCT01037244|579631066|FG002|Overall Study|Lost to Follow-up|4|||
160519384|NCT01037244|579631067|FG003|Overall Study|Lost to Follow-up|4|||
160519385|NCT01037244|579631064|FG000|Overall Study|Withdrawal by Subject|1|||
160519386|NCT01037244|579631065|FG001|Overall Study|Withdrawal by Subject|5|||
160519387|NCT01037244|579631066|FG002|Overall Study|Withdrawal by Subject|3|||
160519388|NCT01037244|579631067|FG003|Overall Study|Withdrawal by Subject|5|||
160519389|NCT01037244|579631064|FG000|Overall Study|Partner Withdrew Consent|2|||
160670493|NCT01838681|580174741|FG002|Period A|Withdrawal by Subject|0|||
160670494|NCT01838681|580174742|FG003|Period A|Withdrawal by Subject|0|||
160670495|NCT01838681|580174739|FG000|Period A|Protocol Violation|16|||
160670496|NCT01838681|580174740|FG001|Period A|Protocol Violation|0|||
160670497|NCT01838681|580174741|FG002|Period A|Protocol Violation|0|||
160670498|NCT01838681|580174742|FG003|Period A|Protocol Violation|0|||
160670499|NCT01838681|580174739|FG000|Period A|Non-compliance with IMP|6|||
160670500|NCT01838681|580174740|FG001|Period A|Non-compliance with IMP|0|||
160670501|NCT01838681|580174741|FG002|Period A|Non-compliance with IMP|0|||
160670502|NCT01838681|580174742|FG003|Period A|Non-compliance with IMP|0|||
160670503|NCT01838681|580174739|FG000|Period A|Lost to Follow-up|4|||
160670504|NCT01838681|580174740|FG001|Period A|Lost to Follow-up|0|||
160670505|NCT01838681|580174741|FG002|Period A|Lost to Follow-up|0|||
160670506|NCT01838681|580174742|FG003|Period A|Lost to Follow-up|0|||
160670507|NCT01838681|580174739|FG000|Period A|Withdrawal before treatment|4|||
160670508|NCT01838681|580174740|FG001|Period A|Withdrawal before treatment|0|||
160670509|NCT01838681|580174741|FG002|Period A|Withdrawal before treatment|0|||
160670510|NCT01838681|580174742|FG003|Period A|Withdrawal before treatment|0|||
160670511|NCT01838681|580174739|FG000|Period A|Administrative or other reasons|17|||
160519390|NCT01037244|579631065|FG001|Overall Study|Partner Withdrew Consent|1|||
160670512|NCT01838681|580174740|FG001|Period A|Administrative or other reasons|0|||
160670513|NCT01838681|580174741|FG002|Period A|Administrative or other reasons|0|||
160670514|NCT01838681|580174742|FG003|Period A|Administrative or other reasons|0|||
160670515|NCT01838681|580174739|FG000|Period B/A+|Adverse Event|0|||
160670516|NCT01838681|580174740|FG001|Period B/A+|Adverse Event|13|||
160670517|NCT01838681|580174741|FG002|Period B/A+|Adverse Event|27|||
160670518|NCT01838681|580174742|FG003|Period B/A+|Adverse Event|16|||
160670519|NCT01838681|580174739|FG000|Period B/A+|Lack of Efficacy|0|||
160670520|NCT01838681|580174740|FG001|Period B/A+|Lack of Efficacy|9|||
160670521|NCT01838681|580174741|FG002|Period B/A+|Lack of Efficacy|11|||
160670522|NCT01838681|580174742|FG003|Period B/A+|Lack of Efficacy|6|||
160670523|NCT01838681|580174739|FG000|Period B/A+|Withdrawal by Subject|0|||
160670524|NCT01838681|580174740|FG001|Period B/A+|Withdrawal by Subject|28|||
160670525|NCT01838681|580174741|FG002|Period B/A+|Withdrawal by Subject|35|||
160670526|NCT01838681|580174742|FG003|Period B/A+|Withdrawal by Subject|47|||
160670527|NCT01838681|580174739|FG000|Period B/A+|Protocol Violation|0|||
160670528|NCT01838681|580174740|FG001|Period B/A+|Protocol Violation|1|||
160670529|NCT01838681|580174741|FG002|Period B/A+|Protocol Violation|4|||
160670530|NCT01838681|580174742|FG003|Period B/A+|Protocol Violation|6|||
160670531|NCT01838681|580174739|FG000|Period B/A+|Non-compliance with IMP|0|||
160670532|NCT01838681|580174740|FG001|Period B/A+|Non-compliance with IMP|2|||
160670533|NCT01838681|580174741|FG002|Period B/A+|Non-compliance with IMP|3|||
160670534|NCT01838681|580174742|FG003|Period B/A+|Non-compliance with IMP|3|||
160670535|NCT01838681|580174739|FG000|Period B/A+|Lost to Follow-up|0|||
160670536|NCT01838681|580174740|FG001|Period B/A+|Lost to Follow-up|2|||
160670537|NCT01838681|580174741|FG002|Period B/A+|Lost to Follow-up|5|||
160670538|NCT01838681|580174742|FG003|Period B/A+|Lost to Follow-up|11|||
160670539|NCT01838681|580174739|FG000|Period B/A+|Withdrawal before treatment|0|||
160670540|NCT01838681|580174740|FG001|Period B/A+|Withdrawal before treatment|1|||
160670541|NCT01838681|580174741|FG002|Period B/A+|Withdrawal before treatment|0|||
160670542|NCT01838681|580174742|FG003|Period B/A+|Withdrawal before treatment|0|||
160670543|NCT01838681|580174739|FG000|Period B/A+|Administrative or other reasons|0|||
160670544|NCT01838681|580174740|FG001|Period B/A+|Administrative or other reasons|6|||
160670545|NCT01838681|580174741|FG002|Period B/A+|Administrative or other reasons|10|||
160670546|NCT01838681|580174742|FG003|Period B/A+|Administrative or other reasons|28|||
160670547|NCT00312897|580174745|FG000|Overall Study|Adverse Event|1|||
160670548|NCT00312897|580174746|FG001|Overall Study|Adverse Event|0|||
160670549|NCT00312897|580174745|FG000|Overall Study|Lost to Follow-up|2|||
160670550|NCT00312897|580174746|FG001|Overall Study|Lost to Follow-up|0|||
160670551|NCT00312897|580174745|FG000|Overall Study|Physician Decision|1|||
160670552|NCT00312897|580174746|FG001|Overall Study|Physician Decision|0|||
160670553|NCT00312897|580174745|FG000|Overall Study|Withdrawal by Subject|1|||
160670554|NCT00312897|580174746|FG001|Overall Study|Withdrawal by Subject|3|||
160670555|NCT00312897|580174745|FG000|Overall Study|Pregnancy|1|||
160670556|NCT00312897|580174746|FG001|Overall Study|Pregnancy|0|||
160670557|NCT00312897|580174745|FG000|Overall Study|discontinued prior to getting treatment|0|||
160670558|NCT00312897|580174746|FG001|Overall Study|discontinued prior to getting treatment|3|||
160670559|NCT00902538|580174747|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
160670560|NCT00902538|580174748|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
160670561|NCT00902538|580174749|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
160670562|NCT00902538|580174750|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
160670563|NCT00902538|580174751|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
160670564|NCT00902538|580174752|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
160670565|NCT00902538|580174747|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
160670566|NCT00902538|580174748|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
160670567|NCT00902538|580174749|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
160670568|NCT00902538|580174750|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
160670569|NCT00902538|580174751|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
160670570|NCT00902538|580174752|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
160670571|NCT00902538|580174747|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
160670572|NCT00902538|580174748|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
160670573|NCT00902538|580174749|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
160624976|NCT03323034|580007874|FG003|Overall Study|Physician Decision|0|||
160624977|NCT03323034|580007875|FG004|Overall Study|Physician Decision|1|||
160624978|NCT03323034|580007871|FG000|Overall Study|Withdrawal by Subject|1|||
160624979|NCT03323034|580007872|FG001|Overall Study|Withdrawal by Subject|1|||
160624980|NCT03323034|580007873|FG002|Overall Study|Withdrawal by Subject|0|||
160624981|NCT03323034|580007874|FG003|Overall Study|Withdrawal by Subject|1|||
160624982|NCT03323034|580007875|FG004|Overall Study|Withdrawal by Subject|0|||
160624983|NCT02646566|580007876|FG000|Overall Study|Lost to Follow-up|5|||
160624984|NCT02646566|580007877|FG001|Overall Study|Lost to Follow-up|4|||
160624985|NCT02646566|580007878|FG002|Overall Study|Lost to Follow-up|5|||
160624986|NCT02646566|580007876|FG000|Overall Study|Treatment failure|1|||
160624987|NCT02646566|580007877|FG001|Overall Study|Treatment failure|0|||
160624988|NCT02646566|580007878|FG002|Overall Study|Treatment failure|0|||
160624989|NCT00953017|580007879|FG000|Overall Study|DId not show up for colonoscopy|4|||
160624990|NCT00953017|580007880|FG001|Overall Study|DId not show up for colonoscopy|4|||
160624991|NCT00953017|580007881|FG002|Overall Study|DId not show up for colonoscopy|5|||
160624992|NCT00953017|580007882|FG003|Overall Study|DId not show up for colonoscopy|4|||
160624993|NCT00953017|580007879|FG000|Overall Study|Incomplete data|1|||
160624994|NCT00953017|580007880|FG001|Overall Study|Incomplete data|1|||
160624995|NCT00953017|580007881|FG002|Overall Study|Incomplete data|0|||
160624996|NCT00953017|580007882|FG003|Overall Study|Incomplete data|0|||
160624997|NCT00953017|580007879|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
160624998|NCT00953017|580007880|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
160624999|NCT00953017|580007881|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
160625000|NCT00953017|580007882|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
160625001|NCT00953017|580007879|FG000|Overall Study|Brown stool prior to procedure|0|||
160625002|NCT00953017|580007880|FG001|Overall Study|Brown stool prior to procedure|0|||
160625003|NCT00953017|580007881|FG002|Overall Study|Brown stool prior to procedure|1|||
160625004|NCT00953017|580007882|FG003|Overall Study|Brown stool prior to procedure|0|||
160625005|NCT00798161|580007883|FG000|Overall Study|Adverse Event|3|||
160625006|NCT00798161|580007884|FG001|Overall Study|Adverse Event|4|||
160625007|NCT00798161|580007885|FG002|Overall Study|Adverse Event|6|||
160625008|NCT00798161|580007886|FG003|Overall Study|Adverse Event|6|||
160625009|NCT00798161|580007887|FG004|Overall Study|Adverse Event|5|||
160625010|NCT00798161|580007888|FG005|Overall Study|Adverse Event|2|||
160625011|NCT00798161|580007889|FG006|Overall Study|Adverse Event|4|||
160625012|NCT00798161|580007883|FG000|Overall Study|Protocol Violation|2|||
160625013|NCT00798161|580007884|FG001|Overall Study|Protocol Violation|1|||
160625014|NCT00798161|580007885|FG002|Overall Study|Protocol Violation|3|||
160625015|NCT00798161|580007886|FG003|Overall Study|Protocol Violation|3|||
160625016|NCT00798161|580007887|FG004|Overall Study|Protocol Violation|3|||
160625017|NCT00798161|580007888|FG005|Overall Study|Protocol Violation|2|||
160625018|NCT00798161|580007889|FG006|Overall Study|Protocol Violation|0|||
160625019|NCT00798161|580007883|FG000|Overall Study|Lost to Follow-up|1|||
160625020|NCT00798161|580007884|FG001|Overall Study|Lost to Follow-up|3|||
160625021|NCT00798161|580007885|FG002|Overall Study|Lost to Follow-up|4|||
160625022|NCT00798161|580007886|FG003|Overall Study|Lost to Follow-up|3|||
160625023|NCT00798161|580007887|FG004|Overall Study|Lost to Follow-up|4|||
160625024|NCT00798161|580007888|FG005|Overall Study|Lost to Follow-up|0|||
160625025|NCT00798161|580007889|FG006|Overall Study|Lost to Follow-up|0|||
160625026|NCT00798161|580007883|FG000|Overall Study|Withdrawal by Subject|5|||
160625027|NCT00798161|580007884|FG001|Overall Study|Withdrawal by Subject|4|||
160625028|NCT00798161|580007885|FG002|Overall Study|Withdrawal by Subject|5|||
160625029|NCT00798161|580007886|FG003|Overall Study|Withdrawal by Subject|4|||
160625030|NCT00798161|580007887|FG004|Overall Study|Withdrawal by Subject|2|||
160625031|NCT00798161|580007888|FG005|Overall Study|Withdrawal by Subject|3|||
160625032|NCT00798161|580007889|FG006|Overall Study|Withdrawal by Subject|1|||
160625033|NCT00798161|580007883|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
160625034|NCT00798161|580007884|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
160625035|NCT00798161|580007885|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
160625036|NCT00798161|580007886|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
160625037|NCT00798161|580007887|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
160625038|NCT00798161|580007888|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
160625039|NCT00798161|580007889|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
160625040|NCT00423137|580007892|FG000|Overall Study|Lost to Follow-up|0|||
160625041|NCT00423137|580007893|FG001|Overall Study|Lost to Follow-up|0|||
160625042|NCT00423137|580007894|FG002|Overall Study|Lost to Follow-up|1|||
160625043|NCT00423137|580007895|FG003|Overall Study|Lost to Follow-up|0|||
160625044|NCT00423137|580007892|FG000|Overall Study|Protocol Violation|0|||
160625045|NCT00423137|580007893|FG001|Overall Study|Protocol Violation|0|||
160625046|NCT00423137|580007894|FG002|Overall Study|Protocol Violation|0|||
160625047|NCT00423137|580007895|FG003|Overall Study|Protocol Violation|1|||
160625048|NCT00423137|580007892|FG000|Overall Study|Adverse Event Study disease worse|1|||
160670574|NCT00902538|580174750|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
160670575|NCT00902538|580174751|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
160670576|NCT00902538|580174752|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
160670577|NCT00902538|580174747|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
160670578|NCT00902538|580174748|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
160670579|NCT00902538|580174749|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
160670580|NCT00902538|580174750|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
160670581|NCT00902538|580174751|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
160670582|NCT00902538|580174752|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
160670583|NCT00902538|580174747|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
160670584|NCT00902538|580174748|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
160670585|NCT00902538|580174749|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
160670586|NCT00902538|580174750|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
160670587|NCT00902538|580174751|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
160670588|NCT00902538|580174752|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
160670589|NCT00902538|580174747|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
160670590|NCT00902538|580174748|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
160670591|NCT00902538|580174749|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
160670592|NCT00902538|580174750|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
160670593|NCT00902538|580174751|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
160670594|NCT00902538|580174752|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
160670595|NCT00902538|580174747|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
160670596|NCT00902538|580174748|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
160670597|NCT00902538|580174749|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
160670598|NCT00902538|580174750|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
160670599|NCT00902538|580174751|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
160670600|NCT00902538|580174752|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
160670601|NCT00902538|580174747|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
160670602|NCT00902538|580174748|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
160670603|NCT00902538|580174749|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
160670604|NCT00902538|580174750|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
160670605|NCT00902538|580174751|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
160670606|NCT00902538|580174752|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
160670607|NCT00902538|580174747|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
160670608|NCT00902538|580174748|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
160670609|NCT00902538|580174749|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
160670610|NCT00902538|580174750|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
160670611|NCT00902538|580174751|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
160670612|NCT00902538|580174752|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
160670613|NCT00902538|580174747|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
160670614|NCT00902538|580174748|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
160670615|NCT00902538|580174749|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
160670616|NCT00902538|580174750|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
160670617|NCT00902538|580174751|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
160670618|NCT00902538|580174752|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
160670619|NCT00902538|580174747|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
160670620|NCT00902538|580174748|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
160670621|NCT00902538|580174749|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
160670622|NCT00902538|580174750|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
160670623|NCT00902538|580174751|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
160670624|NCT00902538|580174752|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
160670625|NCT00902538|580174747|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
160670626|NCT00902538|580174748|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
160670627|NCT00902538|580174749|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
160670628|NCT00902538|580174750|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
160670629|NCT00902538|580174751|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
160670630|NCT00902538|580174752|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
160670631|NCT00902538|580174747|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
160670632|NCT00902538|580174748|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
160670633|NCT00902538|580174749|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
160670634|NCT00902538|580174750|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
160670635|NCT00902538|580174751|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
160519391|NCT01037244|579631066|FG002|Overall Study|Partner Withdrew Consent|0|||
160519392|NCT01037244|579631067|FG003|Overall Study|Partner Withdrew Consent|0|||
160519393|NCT01037244|579631064|FG000|Overall Study|Various|3|||
160519394|NCT01037244|579631065|FG001|Overall Study|Various|2|||
160670636|NCT00902538|580174752|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
160670637|NCT00902538|580174747|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
160670638|NCT00902538|580174748|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
160670639|NCT00902538|580174749|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
160670640|NCT00902538|580174750|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
160670641|NCT00902538|580174751|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
160670642|NCT00902538|580174752|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
160670643|NCT00902538|580174747|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
160670644|NCT00902538|580174748|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
160670645|NCT00902538|580174749|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
160670646|NCT00902538|580174750|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
160670647|NCT00902538|580174751|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
160670648|NCT00902538|580174752|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
160670649|NCT00902538|580174747|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
160670650|NCT00902538|580174748|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
160670651|NCT00902538|580174749|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
160670652|NCT00902538|580174750|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
160670653|NCT00902538|580174751|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
160670654|NCT00902538|580174752|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
160670655|NCT00902538|580174747|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
160670656|NCT00902538|580174748|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
160670657|NCT00902538|580174749|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
160670658|NCT00902538|580174750|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
160670659|NCT00902538|580174751|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
160670660|NCT00902538|580174752|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
160670661|NCT01279486|580174755|FG000|Overall Study|Lost to Follow-up|1|||
160670662|NCT03215706|580174759|FG000|Randomization|Adverse Event unrelated to study drug|1|||
160670663|NCT03215706|580174760|FG001|Randomization|Adverse Event unrelated to study drug|0|||
160670664|NCT03215706|580174759|FG000|Randomization|participant withdrew consent|1|||
160670665|NCT03215706|580174760|FG001|Randomization|participant withdrew consent|3|||
160670666|NCT03215706|580174759|FG000|Randomization|no longer meets study criteria|1|||
160670667|NCT03215706|580174760|FG001|Randomization|no longer meets study criteria|4|||
160670668|NCT03215706|580174759|FG000|Randomization|other reasons|0|||
160670669|NCT03215706|580174760|FG001|Randomization|other reasons|2|||
160670670|NCT03215706|580174759|FG000|Treatment Period|Disease Progression|184|||
160670671|NCT03215706|580174760|FG001|Treatment Period|Disease Progression|174|||
160670672|NCT03215706|580174759|FG000|Treatment Period|Study Drug Toxicity|70|||
160670673|NCT03215706|580174760|FG001|Treatment Period|Study Drug Toxicity|24|||
160670674|NCT03215706|580174759|FG000|Treatment Period|Death|7|||
160670675|NCT03215706|580174760|FG001|Treatment Period|Death|1|||
160670676|NCT03215706|580174759|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
160670677|NCT03215706|580174760|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
160670678|NCT03215706|580174759|FG000|Treatment Period|Request to D/C treatment|2|||
160670679|NCT03215706|580174760|FG001|Treatment Period|Request to D/C treatment|10|||
160670680|NCT03215706|580174759|FG000|Treatment Period|Participant withdrew consent|4|||
160670681|NCT03215706|580174760|FG001|Treatment Period|Participant withdrew consent|5|||
160670682|NCT03215706|580174759|FG000|Treatment Period|Lost to Follow-up|0|||
160670683|NCT03215706|580174760|FG001|Treatment Period|Lost to Follow-up|1|||
160670684|NCT03215706|580174759|FG000|Treatment Period|Administrative reason by sponsor|0|||
160670685|NCT03215706|580174760|FG001|Treatment Period|Administrative reason by sponsor|2|||
160670686|NCT03215706|580174759|FG000|Treatment Period|other reasons|10|||
160670687|NCT03215706|580174760|FG001|Treatment Period|other reasons|5|||
160670688|NCT03215706|580174759|FG000|Treatment Period|Not reported|1|||
160670689|NCT03215706|580174760|FG001|Treatment Period|Not reported|0|||
160670690|NCT05511935|580176356|FG000|Overall Study|Lost to Follow-up|9|||
160670691|NCT05511935|580176357|FG001|Overall Study|Lost to Follow-up|27|||
160670692|NCT02888756|580176358|FG000|Analytical Treatment Interruption|Physician Decision|10|||
160670693|NCT02888756|580176359|FG001|Analytical Treatment Interruption|Physician Decision|6|||
160670694|NCT02888756|580176360|FG002|Analytical Treatment Interruption|Physician Decision|5|||
160670695|NCT01015287|580176363|FG000|Overall Study|Death|21|||
160519395|NCT01037244|579631066|FG002|Overall Study|Various|1|||
160519396|NCT01037244|579631067|FG003|Overall Study|Various|1|||
160519397|NCT00848926|579631068|FG000|Treatment Period|Progressive disease|45|||
160519398|NCT00848926|579631068|FG000|Treatment Period|Adverse Event|20|||
160519399|NCT00848926|579631068|FG000|Treatment Period|Physician Decision|12|||
160670696|NCT01015287|580176364|FG001|Overall Study|Death|16|||
160670697|NCT01015287|580176363|FG000|Overall Study|Adverse Event|1|||
160670698|NCT01015287|580176364|FG001|Overall Study|Adverse Event|0|||
160670699|NCT01015287|580176363|FG000|Overall Study|Sponsor Decision|3|||
160670700|NCT01015287|580176364|FG001|Overall Study|Sponsor Decision|7|||
160519400|NCT00848926|579631068|FG000|Treatment Period|Withdrawal by Subject|7|||
160670701|NCT01015287|580176363|FG000|Overall Study|Physician Decision|19|||
160670702|NCT01015287|580176364|FG001|Overall Study|Physician Decision|21|||
160670703|NCT01015287|580176363|FG000|Overall Study|Withdrawal by Subject|14|||
160670704|NCT01015287|580176364|FG001|Overall Study|Withdrawal by Subject|19|||
160670705|NCT01015287|580176363|FG000|Overall Study|Entry Criteria not Met|11|||
160670706|NCT01015287|580176364|FG001|Overall Study|Entry Criteria not Met|14|||
160670707|NCT01015287|580176363|FG000|Overall Study|Lost to Follow-up|2|||
160670708|NCT01015287|580176364|FG001|Overall Study|Lost to Follow-up|1|||
160670709|NCT01015287|580176363|FG000|Overall Study|Protocol Violation|1|||
160670710|NCT01015287|580176364|FG001|Overall Study|Protocol Violation|1|||
160670711|NCT01592240|580176365|FG000|Overall Study|Adverse Event|1|||
160670712|NCT01592240|580176366|FG001|Overall Study|Adverse Event|0|||
160519401|NCT00848926|579631068|FG000|Follow-up Period|Lost to Follow-up|7|||
160519402|NCT00848926|579631068|FG000|Follow-up Period|Withdrawal by Subject|3|||
160519403|NCT00848926|579631068|FG000|Follow-up Period|Other|2|||
160519404|NCT01122862|579631069|FG000|Period 1|Protocol Violation|0|||
160519405|NCT01122862|579631070|FG001|Period 1|Protocol Violation|1|||
160519406|NCT01122862|579631071|FG002|Period 1|Protocol Violation|0|||
160519407|NCT01122862|579631069|FG000|Period 2|Adverse Event|0|||
160519408|NCT01122862|579631070|FG001|Period 2|Adverse Event|0|||
160519409|NCT01122862|579631071|FG002|Period 2|Adverse Event|1|||
160519410|NCT00966277|579631074|FG000|Overall Study|Withdrawal by Subject|3|||
160519411|NCT00966277|579631075|FG001|Overall Study|Withdrawal by Subject|0|||
160519412|NCT00966277|579631074|FG000|Overall Study|Ineligible|1|||
160519413|NCT00966277|579631075|FG001|Overall Study|Ineligible|3|||
160519414|NCT00966277|579631074|FG000|Overall Study|Treatment Plan Changed|0|||
160519415|NCT00966277|579631075|FG001|Overall Study|Treatment Plan Changed|1|||
160519416|NCT01249274|579631076|FG000|Overall Study|Lost to Follow-up|3|||
160519417|NCT01249274|579631077|FG001|Overall Study|Lost to Follow-up|4|||
160519418|NCT01249274|579631076|FG000|Overall Study|Received inpatient substance treatment|1|||
160519419|NCT01249274|579631077|FG001|Overall Study|Received inpatient substance treatment|2|||
160519420|NCT01498653|579631078|FG000|Overall Study|Adverse Event|2|||
160519421|NCT01498653|579631079|FG001|Overall Study|Adverse Event|2|||
160519422|NCT01498653|579631078|FG000|Overall Study|Lack of Efficacy|12|||
160519423|NCT01498653|579631079|FG001|Overall Study|Lack of Efficacy|26|||
160519424|NCT01498653|579631078|FG000|Overall Study|Protocol Violation|0|||
160519425|NCT01498653|579631079|FG001|Overall Study|Protocol Violation|4|||
160519426|NCT01498653|579631078|FG000|Overall Study|Lost to Follow-up|1|||
160519427|NCT01498653|579631079|FG001|Overall Study|Lost to Follow-up|0|||
160519428|NCT01498653|579631078|FG000|Overall Study|Physician Decision|2|||
160519429|NCT01498653|579631079|FG001|Overall Study|Physician Decision|0|||
160519430|NCT01498653|579631078|FG000|Overall Study|Withdrawal by Subject|2|||
160519431|NCT01498653|579631079|FG001|Overall Study|Withdrawal by Subject|3|||
160519432|NCT02070588|579631085|FG000|Overall Study|Withdrawal by Subject|29|||
160519433|NCT02070588|579631086|FG001|Overall Study|Withdrawal by Subject|1|||
160519434|NCT02070588|579631087|FG002|Overall Study|Withdrawal by Subject|0|||
160519435|NCT02070588|579631085|FG000|Overall Study|Writhdrawal due to early termination|9|||
160519436|NCT02070588|579631086|FG001|Overall Study|Writhdrawal due to early termination|0|||
160519437|NCT02070588|579631087|FG002|Overall Study|Writhdrawal due to early termination|0|||
160519438|NCT02070588|579631085|FG000|Overall Study|Adverse Event|1|||
160670713|NCT01592240|580176367|FG002|Overall Study|Adverse Event|0|||
160670714|NCT01592240|580176368|FG003|Overall Study|Adverse Event|1|||
160670715|NCT01592240|580176369|FG004|Overall Study|Adverse Event|1|||
160670716|NCT01592240|580176370|FG005|Overall Study|Adverse Event|0|||
160519439|NCT02070588|579631086|FG001|Overall Study|Adverse Event|0|||
160519440|NCT02070588|579631087|FG002|Overall Study|Adverse Event|0|||
160519441|NCT02216357|579631088|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
160519442|NCT02216357|579631089|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
160519443|NCT01790126|579631091|FG000|Overall Study|PSA Progression|12|||
160519444|NCT01790126|579631092|FG001|Overall Study|PSA Progression|16|||
160519445|NCT01790126|579631093|FG002|Overall Study|PSA Progression|16|||
160519446|NCT01790126|579631091|FG000|Overall Study|Other|5|||
160519447|NCT01790126|579631092|FG001|Overall Study|Other|4|||
160519448|NCT01790126|579631093|FG002|Overall Study|Other|8|||
160519449|NCT01790126|579631091|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
160519450|NCT01790126|579631092|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
160519451|NCT01790126|579631093|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
160519452|NCT01790126|579631091|FG000|Overall Study|Withdrawal by Physician|1|||
160519453|NCT01790126|579631092|FG001|Overall Study|Withdrawal by Physician|1|||
160670717|NCT01592240|580176371|FG006|Overall Study|Adverse Event|0|||
160519454|NCT01790126|579631093|FG002|Overall Study|Withdrawal by Physician|2|||
160519455|NCT01790126|579631091|FG000|Overall Study|Withdrawal by Subject|3|||
160519456|NCT01790126|579631092|FG001|Overall Study|Withdrawal by Subject|1|||
160519457|NCT01790126|579631093|FG002|Overall Study|Withdrawal by Subject|2|||
160519458|NCT01790126|579631091|FG000|Overall Study|Lost to Follow-up|1|||
160670718|NCT01592240|580176365|FG000|Overall Study|Death|0|||
160670719|NCT01592240|580176366|FG001|Overall Study|Death|1|||
160670720|NCT01592240|580176367|FG002|Overall Study|Death|0|||
160670721|NCT01592240|580176368|FG003|Overall Study|Death|0|||
160670722|NCT01592240|580176369|FG004|Overall Study|Death|0|||
160670723|NCT01592240|580176370|FG005|Overall Study|Death|0|||
160670724|NCT01592240|580176371|FG006|Overall Study|Death|0|||
160670725|NCT01592240|580176365|FG000|Overall Study|Lost to Follow-up|1|||
160670726|NCT01592240|580176366|FG001|Overall Study|Lost to Follow-up|3|||
160670727|NCT01592240|580176367|FG002|Overall Study|Lost to Follow-up|1|||
160670728|NCT01592240|580176368|FG003|Overall Study|Lost to Follow-up|0|||
160670729|NCT01592240|580176369|FG004|Overall Study|Lost to Follow-up|3|||
160670730|NCT01592240|580176370|FG005|Overall Study|Lost to Follow-up|2|||
160670731|NCT01592240|580176371|FG006|Overall Study|Lost to Follow-up|0|||
160670732|NCT01592240|580176365|FG000|Overall Study|Protocol Violation|0|||
160670733|NCT01592240|580176366|FG001|Overall Study|Protocol Violation|0|||
160670734|NCT01592240|580176367|FG002|Overall Study|Protocol Violation|0|||
160670735|NCT01592240|580176368|FG003|Overall Study|Protocol Violation|0|||
160670736|NCT01592240|580176369|FG004|Overall Study|Protocol Violation|0|||
160670737|NCT01592240|580176370|FG005|Overall Study|Protocol Violation|1|||
160670738|NCT01592240|580176371|FG006|Overall Study|Protocol Violation|0|||
160670739|NCT01592240|580176365|FG000|Overall Study|Withdrawal by Subject|0|||
160670740|NCT01592240|580176366|FG001|Overall Study|Withdrawal by Subject|4|||
160670741|NCT01592240|580176367|FG002|Overall Study|Withdrawal by Subject|4|||
160670742|NCT01592240|580176368|FG003|Overall Study|Withdrawal by Subject|1|||
160670743|NCT01592240|580176369|FG004|Overall Study|Withdrawal by Subject|3|||
160670744|NCT01592240|580176370|FG005|Overall Study|Withdrawal by Subject|0|||
160670745|NCT01592240|580176371|FG006|Overall Study|Withdrawal by Subject|2|||
160670746|NCT01592240|580176365|FG000|Overall Study|Other|0|||
160670747|NCT01592240|580176366|FG001|Overall Study|Other|3|||
160670748|NCT01592240|580176367|FG002|Overall Study|Other|1|||
160670749|NCT01592240|580176368|FG003|Overall Study|Other|1|||
160670750|NCT01592240|580176369|FG004|Overall Study|Other|0|||
160670751|NCT01592240|580176370|FG005|Overall Study|Other|0|||
160670752|NCT01592240|580176371|FG006|Overall Study|Other|1|||
160670753|NCT01592240|580176365|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
160670754|NCT01592240|580176366|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
160670755|NCT01592240|580176367|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
160670756|NCT01592240|580176368|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
160670757|NCT01592240|580176369|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
160670758|NCT01592240|580176370|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
160670759|NCT01592240|580176371|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
160670760|NCT02727192|580176378|FG000|Overall Study|Lost to Follow-up|1|||
160670761|NCT02727192|580176379|FG001|Overall Study|Lost to Follow-up|0|||
160670762|NCT02727192|580176380|FG002|Overall Study|Lost to Follow-up|0|||
160670763|NCT03206749|580176382|FG000|Overall Study|Withdrawal of consent|5|||
160670764|NCT03206749|580176383|FG001|Overall Study|Withdrawal of consent|3|||
160670765|NCT03206749|580176384|FG002|Overall Study|Withdrawal of consent|6|||
160519459|NCT01790126|579631092|FG001|Overall Study|Lost to Follow-up|0|||
160519460|NCT01790126|579631093|FG002|Overall Study|Lost to Follow-up|1|||
160519461|NCT01790126|579631091|FG000|Overall Study|Adverse Event|0|||
160519462|NCT01790126|579631092|FG001|Overall Study|Adverse Event|2|||
160519463|NCT01790126|579631093|FG002|Overall Study|Adverse Event|0|||
160519464|NCT01790126|579631091|FG000|Overall Study|Death|2|||
160519465|NCT01790126|579631092|FG001|Overall Study|Death|0|||
160519466|NCT01790126|579631093|FG002|Overall Study|Death|0|||
160519467|NCT01790126|579631091|FG000|Overall Study|Radiographic Progression|3|||
160670766|NCT03206749|580176382|FG000|Overall Study|Lost to Follow-up|0|||
160670767|NCT03206749|580176383|FG001|Overall Study|Lost to Follow-up|0|||
160670768|NCT03206749|580176384|FG002|Overall Study|Lost to Follow-up|1|||
160670769|NCT02451696|580176386|FG000|Overall Study|Surgery postponed|1|||
160670770|NCT02451696|580176387|FG001|Overall Study|Surgery postponed|0|||
160670771|NCT00198133|580176388|FG000|Overall Study|Disease progression|2|||
160670772|NCT00198133|580176389|FG001|Overall Study|Disease progression|5|||
160670773|NCT00198133|580176388|FG000|Overall Study|Adverse Event|1|||
160519468|NCT01790126|579631092|FG001|Overall Study|Radiographic Progression|1|||
160519469|NCT01790126|579631093|FG002|Overall Study|Radiographic Progression|0|||
160519470|NCT01477333|579631094|FG000|Overall Study|Adverse Event|1|||
160519471|NCT01477333|579631094|FG000|Overall Study|Withdrawal by Subject|1|||
160519472|NCT01477333|579631094|FG000|Overall Study|Clinical Deterioration|1|||
160519473|NCT01178671|579631095|FG000|Overall Study|Adverse Event|4|||
160519474|NCT01178671|579631096|FG001|Overall Study|Adverse Event|6|||
160519475|NCT01178671|579631095|FG000|Overall Study|Protocol Violation|1|||
160519476|NCT01178671|579631096|FG001|Overall Study|Protocol Violation|1|||
160670774|NCT00198133|580176389|FG001|Overall Study|Adverse Event|3|||
160519477|NCT01178671|579631095|FG000|Overall Study|Lack of Efficacy|0|||
160519478|NCT01178671|579631096|FG001|Overall Study|Lack of Efficacy|1|||
160519479|NCT01178671|579631095|FG000|Overall Study|Lost to Follow-up|3|||
160519480|NCT01178671|579631096|FG001|Overall Study|Lost to Follow-up|1|||
160519481|NCT01178671|579631095|FG000|Overall Study|Physician Decision|4|||
160670775|NCT00198133|580176388|FG000|Overall Study|Withdrawal by Subject|1|||
160670776|NCT00198133|580176389|FG001|Overall Study|Withdrawal by Subject|0|||
160670777|NCT00198133|580176388|FG000|Overall Study|Physician Decision|1|||
160670778|NCT00198133|580176389|FG001|Overall Study|Physician Decision|0|||
160670779|NCT01557751|580176390|FG000|Overall Study|Physician Decision|3|||
160670780|NCT00488774|580176391|FG000|Overall Study|Withdrawal of consent|2|||
160670781|NCT00488774|580176392|FG001|Overall Study|Withdrawal of consent|2|||
160670782|NCT00488774|580176393|FG002|Overall Study|Withdrawal of consent|2|||
160670783|NCT00488774|580176394|FG003|Overall Study|Withdrawal of consent|0|||
160670784|NCT00488774|580176391|FG000|Overall Study|Other|6|||
160670785|NCT00488774|580176392|FG001|Overall Study|Other|3|||
160670786|NCT00488774|580176393|FG002|Overall Study|Other|2|||
160670787|NCT00488774|580176394|FG003|Overall Study|Other|2|||
160670788|NCT00488774|580176391|FG000|Overall Study|Lost to Follow-up|0|||
160670789|NCT00488774|580176392|FG001|Overall Study|Lost to Follow-up|0|||
160670790|NCT00488774|580176393|FG002|Overall Study|Lost to Follow-up|1|||
160670791|NCT00488774|580176394|FG003|Overall Study|Lost to Follow-up|1|||
160670792|NCT05523895|580176395|FG000|Overall Study|Adverse Event|2|||
160670793|NCT05523895|580176396|FG001|Overall Study|Adverse Event|1|||
160670794|NCT05523895|580176397|FG002|Overall Study|Adverse Event|1|||
160670795|NCT05523895|580176395|FG000|Overall Study|Lost to Follow-up|0|||
160670796|NCT05523895|580176396|FG001|Overall Study|Lost to Follow-up|1|||
160670797|NCT05523895|580176397|FG002|Overall Study|Lost to Follow-up|2|||
160670798|NCT05523895|580176395|FG000|Overall Study|Noncompliance with study drug|1|||
160670799|NCT05523895|580176396|FG001|Overall Study|Noncompliance with study drug|1|||
160670800|NCT05523895|580176397|FG002|Overall Study|Noncompliance with study drug|1|||
160670801|NCT05523895|580176395|FG000|Overall Study|Protocol Violation|0|||
160670802|NCT05523895|580176396|FG001|Overall Study|Protocol Violation|2|||
160670803|NCT05523895|580176397|FG002|Overall Study|Protocol Violation|0|||
160670804|NCT05523895|580176395|FG000|Overall Study|Withdrawal by Subject|1|||
160670805|NCT05523895|580176396|FG001|Overall Study|Withdrawal by Subject|3|||
160670806|NCT05523895|580176397|FG002|Overall Study|Withdrawal by Subject|1|||
160670807|NCT05523895|580176395|FG000|Overall Study|Not further specified|0|||
160670808|NCT05523895|580176396|FG001|Overall Study|Not further specified|3|||
160670809|NCT05523895|580176397|FG002|Overall Study|Not further specified|1|||
160670810|NCT03674892|580176398|FG000|Overall Study|Lack of Efficacy|5|||
160670811|NCT03674892|580176398|FG000|Overall Study|Lost to Follow-up|3|||
160670812|NCT03674892|580176398|FG000|Overall Study|Migraine|2|||
160670813|NCT03674892|580176398|FG000|Overall Study|Excessive Tearing|1|||
160670814|NCT03674892|580176398|FG000|Overall Study|Increased Eye Pain|1|||
160670815|NCT03674892|580176398|FG000|Overall Study|Increased Facial Pain|1|||
160670816|NCT03674892|580176398|FG000|Overall Study|Sinus Irritation|1|||
160670817|NCT03674892|580176398|FG000|Overall Study|Sinus Infection|1|||
160670818|NCT05099380|580176399|FG000|Overall Study|Subject enrolled in error|1|||
160670819|NCT05099380|580176400|FG001|Overall Study|Subject enrolled in error|0|||
160670820|NCT05099380|580176399|FG000|Overall Study|Study Procedure|1|||
160670821|NCT05099380|580176400|FG001|Overall Study|Study Procedure|0|||
160670822|NCT05099380|580176399|FG000|Overall Study|Protocol Violation|1|||
160670823|NCT05099380|580176400|FG001|Overall Study|Protocol Violation|0|||
160670824|NCT05099380|580176399|FG000|Overall Study|Adverse Event|1|||
160670825|NCT05099380|580176400|FG001|Overall Study|Adverse Event|1|||
160670826|NCT05099380|580176399|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
160670827|NCT05099380|580176400|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
160670828|NCT03276754|580176403|FG000|Overall Study|Withdrawal of informed consent|4|||
160670829|NCT03276754|580176403|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
160670830|NCT03276754|580176403|FG000|Overall Study|Lost to Follow-up|27|||
160670831|NCT03276754|580176403|FG000|Overall Study|No data reported at Month 24|31|||
160670832|NCT03276754|580176403|FG000|Overall Study|Death|39|||
160670833|NCT05041361|580176404|FG000|Overall Study|Lost to Follow-up|1|||
160670834|NCT05041361|580176405|FG001|Overall Study|Lost to Follow-up|3|||
160670835|NCT03605342|580176406|FG000|Overall Study|Withdrawal by Subject|9|||
160670836|NCT03605342|580176407|FG001|Overall Study|Withdrawal by Subject|7|||
160670837|NCT03605342|580176406|FG000|Overall Study|Lost to Follow-up|1|||
160670838|NCT03605342|580176407|FG001|Overall Study|Lost to Follow-up|1|||
160670839|NCT00918645|580176420|FG000|Overall Study|Withdrawal by Subject|1|||
160670840|NCT05133180|580176421|FG000|Overall Study|Withdrawal of consent|1|||
160670841|NCT05133180|580176422|FG001|Overall Study|Withdrawal of consent|1|||
160670842|NCT05133180|580176421|FG000|Overall Study|Lost to Follow-up|1|||
160670843|NCT05133180|580176422|FG001|Overall Study|Lost to Follow-up|1|||
160519482|NCT01178671|579631096|FG001|Overall Study|Physician Decision|6|||
160670844|NCT05133180|580176421|FG000|Overall Study|Documented disease progression|0|||
160670845|NCT05133180|580176422|FG001|Overall Study|Documented disease progression|1|||
160670846|NCT01604941|580176425|FG000|Overall Study|Adverse Event|1|||
160670847|NCT01604941|580176426|FG001|Overall Study|Adverse Event|2|||
160670848|NCT01604941|580176427|FG002|Overall Study|Adverse Event|0|||
160670849|NCT01604941|580176428|FG003|Overall Study|Adverse Event|0|||
160670850|NCT01604941|580176429|FG004|Overall Study|Adverse Event|1|||
160670851|NCT01604941|580176430|FG005|Overall Study|Adverse Event|5|||
160670852|NCT01604941|580176425|FG000|Overall Study|Non-compliance|1|||
160670853|NCT01604941|580176426|FG001|Overall Study|Non-compliance|0|||
160670854|NCT01604941|580176427|FG002|Overall Study|Non-compliance|0|||
160670855|NCT01604941|580176428|FG003|Overall Study|Non-compliance|0|||
160670856|NCT01604941|580176429|FG004|Overall Study|Non-compliance|0|||
160670857|NCT01604941|580176430|FG005|Overall Study|Non-compliance|0|||
160670858|NCT01604941|580176425|FG000|Overall Study|Participant Decision|0|||
160670859|NCT01604941|580176426|FG001|Overall Study|Participant Decision|0|||
160670860|NCT01604941|580176427|FG002|Overall Study|Participant Decision|0|||
160670861|NCT01604941|580176428|FG003|Overall Study|Participant Decision|0|||
160670862|NCT01604941|580176429|FG004|Overall Study|Participant Decision|0|||
160670863|NCT01604941|580176430|FG005|Overall Study|Participant Decision|2|||
160670864|NCT01604941|580176425|FG000|Overall Study|Early Study Termination|9|||
160670865|NCT01604941|580176426|FG001|Overall Study|Early Study Termination|2|||
160670866|NCT01604941|580176427|FG002|Overall Study|Early Study Termination|3|||
160670867|NCT01604941|580176428|FG003|Overall Study|Early Study Termination|3|||
160670868|NCT01604941|580176429|FG004|Overall Study|Early Study Termination|0|||
160670869|NCT01604941|580176430|FG005|Overall Study|Early Study Termination|0|||
160670870|NCT03366792|580176431|FG000|Overall Study|Withdrawal by Subject|7|||
160670871|NCT03366792|580176431|FG000|Overall Study|Lost to Follow-up|2|||
160670872|NCT03366792|580176431|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
160670873|NCT03366792|580176431|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
160670874|NCT00216736|580176436|FG000|Overall Study|Lost to Follow-up|1|||
160670875|NCT00216736|580176437|FG001|Overall Study|Lost to Follow-up|1|||
160670876|NCT00807495|580176438|FG000|Overall Study|Adverse Event|6|||
160670877|NCT00807495|580176439|FG001|Overall Study|Adverse Event|3|||
160670878|NCT00807495|580176440|FG002|Overall Study|Adverse Event|1|||
160670879|NCT00807495|580176441|FG003|Overall Study|Adverse Event|1|||
160670880|NCT00807495|580176442|FG004|Overall Study|Adverse Event|2|||
160670881|NCT00807495|580176438|FG000|Overall Study|Withdrawal by Patient|2|||
160670882|NCT00807495|580176439|FG001|Overall Study|Withdrawal by Patient|0|||
160670883|NCT00807495|580176440|FG002|Overall Study|Withdrawal by Patient|1|||
160670884|NCT00807495|580176441|FG003|Overall Study|Withdrawal by Patient|0|||
160670885|NCT00807495|580176442|FG004|Overall Study|Withdrawal by Patient|0|||
160670886|NCT00807495|580176438|FG000|Overall Study|Reason Not Specified|0|||
160670887|NCT00807495|580176439|FG001|Overall Study|Reason Not Specified|3|||
160670888|NCT00807495|580176440|FG002|Overall Study|Reason Not Specified|2|||
160670889|NCT00807495|580176441|FG003|Overall Study|Reason Not Specified|0|||
160670890|NCT00807495|580176442|FG004|Overall Study|Reason Not Specified|3|||
160670891|NCT00841542|580176444|FG000|Period 1|Adverse Event|1|||
160670892|NCT00841542|580176445|FG001|Period 1|Adverse Event|0|||
160670893|NCT03214588|580176446|FG000|Overall Study|Adverse Event|1|||
160670894|NCT03214588|580176447|FG001|Overall Study|Adverse Event|0|||
160670895|NCT03214588|580176448|FG002|Overall Study|Adverse Event|2|||
160670896|NCT03214588|580176446|FG000|Overall Study|Reason Not Specified|0|||
160670897|NCT03214588|580176447|FG001|Overall Study|Reason Not Specified|1|||
160670898|NCT03214588|580176448|FG002|Overall Study|Reason Not Specified|0|||
160670899|NCT03808376|580176449|FG000|Overall Study|Withdrawal by Subject|10|||
160670900|NCT02679729|580176450|FG000|Overall Study|Lost to Follow-up|0|||
160670901|NCT02679729|580176451|FG001|Overall Study|Lost to Follow-up|1|||
160670902|NCT02679729|580176452|FG002|Overall Study|Lost to Follow-up|0|||
160670903|NCT02679729|580176453|FG003|Overall Study|Lost to Follow-up|0|||
160670904|NCT02679729|580176454|FG004|Overall Study|Lost to Follow-up|1|||
160670905|NCT02679729|580176455|FG005|Overall Study|Lost to Follow-up|0|||
160670906|NCT02679729|580176456|FG006|Overall Study|Lost to Follow-up|0|||
160670907|NCT02679729|580176457|FG007|Overall Study|Lost to Follow-up|0|||
160670908|NCT02679729|580176458|FG008|Overall Study|Lost to Follow-up|0|||
160670909|NCT02679729|580176450|FG000|Overall Study|Participant decision|0|||
160670910|NCT02679729|580176451|FG001|Overall Study|Participant decision|1|||
160670911|NCT02679729|580176452|FG002|Overall Study|Participant decision|0|||
160670912|NCT02679729|580176453|FG003|Overall Study|Participant decision|0|||
160670913|NCT02679729|580176454|FG004|Overall Study|Participant decision|0|||
160670914|NCT02679729|580176455|FG005|Overall Study|Participant decision|0|||
160670915|NCT02679729|580176456|FG006|Overall Study|Participant decision|1|||
160670916|NCT02679729|580176457|FG007|Overall Study|Participant decision|0|||
160670917|NCT02679729|580176458|FG008|Overall Study|Participant decision|0|||
160670918|NCT00748566|580176459|FG000|Overall Study|Adverse Event|49|||
160670919|NCT00748566|580176459|FG000|Overall Study|Death|1|||
160670920|NCT00748566|580176459|FG000|Overall Study|Lack of Efficacy|12|||
160670921|NCT00748566|580176459|FG000|Overall Study|Lost to Follow-up|1|||
160670922|NCT00748566|580176459|FG000|Overall Study|Protocol Violation|13|||
160670923|NCT00748566|580176459|FG000|Overall Study|Withdrawal by Subject|22|||
160670924|NCT00748566|580176459|FG000|Overall Study|Study terminated by sponsor|5|||
160670925|NCT00748566|580176459|FG000|Overall Study|Other|9|||
160670926|NCT00624286|580176462|FG000|Overall Study|Protocol Deviation|7|||
160670927|NCT00624286|580176463|FG001|Overall Study|Protocol Deviation|9|||
160670928|NCT00624286|580176462|FG000|Overall Study|Adverse Event|6|||
160670929|NCT00624286|580176463|FG001|Overall Study|Adverse Event|3|||
160670930|NCT00624286|580176462|FG000|Overall Study|Withdrawal by Subject|5|||
160670931|NCT00624286|580176463|FG001|Overall Study|Withdrawal by Subject|4|||
160670932|NCT00624286|580176462|FG000|Overall Study|Lost to Follow-up|3|||
160625049|NCT00423137|580007893|FG001|Overall Study|Adverse Event Study disease worse|0|||
160625050|NCT00423137|580007894|FG002|Overall Study|Adverse Event Study disease worse|3|||
160625051|NCT00423137|580007895|FG003|Overall Study|Adverse Event Study disease worse|1|||
160625052|NCT00423137|580007892|FG000|Overall Study|Adverse Event Other|0|||
160625053|NCT00423137|580007893|FG001|Overall Study|Adverse Event Other|0|||
160625054|NCT00423137|580007894|FG002|Overall Study|Adverse Event Other|2|||
160625055|NCT00423137|580007895|FG003|Overall Study|Adverse Event Other|0|||
160625056|NCT03246152|580007896|FG000|Overall Study|Lost to Follow-up|2|||
160625057|NCT03246152|580007896|FG000|Overall Study|Protocol Violation|1|||
160625058|NCT00003526|580007897|FG000|Overall Study|Not evaluable|6|||
160625059|NCT00465101|580007898|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
160625060|NCT00465101|580007898|FG000|Overall Study|Change in health precluded follow up|4|||
160625061|NCT00465101|580007898|FG000|Overall Study|Did not meet study criteria|4|||
160625062|NCT00465101|580007898|FG000|Overall Study|Lost to Follow-up|5|||
160625063|NCT00465101|580007898|FG000|Overall Study|Other|6|||
160625064|NCT00465101|580007898|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
160625065|NCT00465101|580007898|FG000|Overall Study|Patient postponed procedure|1|||
160625066|NCT00465101|580007898|FG000|Overall Study|Site closed due to IRB expiration|1|||
160625067|NCT00465101|580007898|FG000|Overall Study|Unable to obtain IRB approval|1|||
160625068|NCT00465101|580007898|FG000|Overall Study|Death|3|||
160625069|NCT00465101|580007898|FG000|Overall Study|Withdrawal by Subject|25|||
160625070|NCT00465101|580007898|FG000|Overall Study|Physician Decision|1|||
160625071|NCT00465101|580007898|FG000|Overall Study|Withdrew consent prior to procedure|3|||
160625072|NCT02067728|580007901|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
160625073|NCT02067728|580007902|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
160625074|NCT02067728|580007901|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
160625075|NCT02067728|580007902|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
160625076|NCT02067728|580007901|FG000|6 Month Measurements|Unable to attend|114|||
160625077|NCT02067728|580007902|FG001|6 Month Measurements|Unable to attend|97|||
160625078|NCT00933543|580007904|FG000|Overall Study|Adverse Event|2|||
160625079|NCT00933543|580007905|FG001|Overall Study|Adverse Event|1|||
160625080|NCT00933543|580007904|FG000|Overall Study|Lost to Follow-up|0|||
160625081|NCT00933543|580007905|FG001|Overall Study|Lost to Follow-up|1|||
160625082|NCT00933543|580007904|FG000|Overall Study|Withdrawal by Subject|0|||
160625083|NCT00933543|580007905|FG001|Overall Study|Withdrawal by Subject|1|||
160625084|NCT00933543|580007904|FG000|Overall Study|Lack of Efficacy|0|||
160625085|NCT00933543|580007905|FG001|Overall Study|Lack of Efficacy|3|||
160625086|NCT00933543|580007904|FG000|Overall Study|Other|1|||
160625087|NCT00933543|580007905|FG001|Overall Study|Other|1|||
160625088|NCT04988035|580007907|FG000|Overall Study|Death|19|||
160625089|NCT04988035|580007908|FG001|Overall Study|Death|13|||
160625090|NCT04988035|580007907|FG000|Overall Study|Lost to Follow-up|12|||
160625091|NCT04988035|580007908|FG001|Overall Study|Lost to Follow-up|6|||
160625092|NCT04988035|580007907|FG000|Overall Study|Protocol Violation|0|||
160625093|NCT04988035|580007908|FG001|Overall Study|Protocol Violation|1|||
160625094|NCT04988035|580007907|FG000|Overall Study|Withdrawal by Subject|2|||
160625095|NCT04988035|580007908|FG001|Overall Study|Withdrawal by Subject|4|||
160625096|NCT04988035|580007907|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
160625097|NCT04988035|580007908|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
160625098|NCT03532048|580007909|FG000|Overall Study|Lost to Follow-up|12|||
160625099|NCT03532048|580007910|FG001|Overall Study|Lost to Follow-up|17|||
160625100|NCT03532048|580007909|FG000|Overall Study|Withdrawal by Subject|7|||
160625101|NCT03532048|580007910|FG001|Overall Study|Withdrawal by Subject|0|||
160625102|NCT04113746|580007915|FG000|Overall Study|Lost to Follow-up|4|||
160625103|NCT04113746|580007916|FG001|Overall Study|Lost to Follow-up|4|||
160625104|NCT01050998|580007917|FG000|Overall Study|Adverse Event|1|||
160625105|NCT01050998|580007918|FG001|Overall Study|Adverse Event|0|||
160625106|NCT01050998|580007919|FG002|Overall Study|Adverse Event|1|||
160625107|NCT01050998|580007920|FG003|Overall Study|Adverse Event|0|||
160625108|NCT01050998|580007921|FG004|Overall Study|Adverse Event|2|||
160625109|NCT01050998|580007917|FG000|Overall Study|Withdrawal by Subject|0|||
160625110|NCT01050998|580007918|FG001|Overall Study|Withdrawal by Subject|0|||
160625111|NCT01050998|580007919|FG002|Overall Study|Withdrawal by Subject|0|||
160625112|NCT01050998|580007920|FG003|Overall Study|Withdrawal by Subject|1|||
160625113|NCT01050998|580007921|FG004|Overall Study|Withdrawal by Subject|3|||
160625114|NCT01050998|580007917|FG000|Overall Study|Other|3|||
160625115|NCT01050998|580007918|FG001|Overall Study|Other|2|||
160625116|NCT01050998|580007919|FG002|Overall Study|Other|1|||
160625117|NCT01050998|580007920|FG003|Overall Study|Other|1|||
160625118|NCT01050998|580007921|FG004|Overall Study|Other|5|||
160625119|NCT01050998|580007917|FG000|Overall Study|Data integrity issues|0|||
160625120|NCT01050998|580007918|FG001|Overall Study|Data integrity issues|0|||
160625121|NCT01050998|580007919|FG002|Overall Study|Data integrity issues|1|||
160625122|NCT01050998|580007920|FG003|Overall Study|Data integrity issues|1|||
160625123|NCT01050998|580007921|FG004|Overall Study|Data integrity issues|4|||
160625124|NCT00499694|580007924|FG000|Overall Study|Patient never received treatment.|1|||
160625125|NCT00976989|580007927|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
160625126|NCT00976989|580007928|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
160625127|NCT00976989|580007929|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
160625128|NCT00976989|580007927|FG000|Overall Study|Death|5|||
160625129|NCT00976989|580007928|FG001|Overall Study|Death|7|||
160625130|NCT00976989|580007929|FG002|Overall Study|Death|10|||
160625131|NCT00976989|580007927|FG000|Overall Study|Refused Treatment|4|||
160625132|NCT00976989|580007928|FG001|Overall Study|Refused Treatment|3|||
160625133|NCT00976989|580007929|FG002|Overall Study|Refused Treatment|5|||
160625134|NCT00976989|580007927|FG000|Overall Study|Failure to Return|2|||
160625135|NCT00976989|580007928|FG001|Overall Study|Failure to Return|1|||
160625136|NCT00976989|580007929|FG002|Overall Study|Failure to Return|0|||
160625137|NCT00976989|580007927|FG000|Overall Study|Recurrence of Disease|0|||
160625138|NCT00976989|580007928|FG001|Overall Study|Recurrence of Disease|1|||
160625139|NCT00976989|580007929|FG002|Overall Study|Recurrence of Disease|0|||
160625140|NCT00976989|580007927|FG000|Overall Study|Other|1|||
160625141|NCT00976989|580007928|FG001|Overall Study|Other|0|||
160625142|NCT00976989|580007929|FG002|Overall Study|Other|1|||
160625143|NCT00570492|580007930|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
160625144|NCT00570492|580007931|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
160625145|NCT00570492|580007932|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
160625146|NCT00570492|580007930|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
160625147|NCT00570492|580007931|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
160625148|NCT00570492|580007932|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
160625149|NCT00570492|580007930|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
160625150|NCT00570492|580007931|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
160625151|NCT00570492|580007932|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
160625152|NCT00570492|580007930|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
160625153|NCT00570492|580007931|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
160625154|NCT00570492|580007932|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
160625155|NCT00570492|580007930|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
160625156|NCT00570492|580007931|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
160625157|NCT00570492|580007932|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
160625158|NCT00570492|580007930|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
160625159|NCT00570492|580007931|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
160625160|NCT00570492|580007932|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
160625161|NCT00570492|580007930|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
160625162|NCT00570492|580007931|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
160625163|NCT00570492|580007932|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
160625164|NCT00570492|580007930|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160625165|NCT00570492|580007931|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
160625166|NCT00570492|580007932|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
160625167|NCT00570492|580007930|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
160625168|NCT00570492|580007931|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
160625169|NCT00570492|580007932|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
160625170|NCT00570492|580007930|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
160625171|NCT00570492|580007931|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
160625172|NCT00570492|580007932|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
160625173|NCT00570492|580007930|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
160625174|NCT00570492|580007931|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
160625175|NCT00570492|580007932|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
160625176|NCT00570492|580007930|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
160625177|NCT00570492|580007931|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
160625178|NCT00570492|580007932|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
160625179|NCT00570492|580007930|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
160625180|NCT00570492|580007931|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
160625181|NCT00570492|580007932|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
160625182|NCT00570492|580007930|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
160625183|NCT00570492|580007931|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
160625184|NCT00570492|580007932|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
160625185|NCT00908375|580007933|FG000|Overall Study|Withdrawal by Subject|2|||
160625186|NCT00908375|580007934|FG001|Overall Study|Withdrawal by Subject|4|||
160625187|NCT00908375|580007933|FG000|Overall Study|Lost to Follow-up|8|||
160625188|NCT00908375|580007934|FG001|Overall Study|Lost to Follow-up|6|||
160625189|NCT00903357|580007935|FG000|First Intervention|Withdrawal by Subject|5|||
160625190|NCT00903357|580007936|FG001|First Intervention|Withdrawal by Subject|3|||
160625191|NCT00903357|580007935|FG000|First Intervention|Flu|0|||
160670933|NCT00624286|580176463|FG001|Overall Study|Lost to Follow-up|2|||
160670934|NCT00624286|580176462|FG000|Overall Study|Administrative problems|3|||
160670935|NCT00624286|580176463|FG001|Overall Study|Administrative problems|0|||
160670936|NCT00624286|580176462|FG000|Overall Study|Lack of Efficacy|1|||
160670937|NCT00624286|580176463|FG001|Overall Study|Lack of Efficacy|6|||
160670938|NCT00624286|580176462|FG000|Overall Study|Not stated|0|||
160670939|NCT00624286|580176463|FG001|Overall Study|Not stated|1|||
160670940|NCT00624286|580176462|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160670941|NCT00624286|580176463|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160670942|NCT00624286|580176462|FG000|Overall Study|Death|0|||
160670943|NCT00624286|580176463|FG001|Overall Study|Death|1|||
160670944|NCT01442376|580176468|FG000|Overall Study|Adverse Event|0|||
160670945|NCT01442376|580176469|FG001|Overall Study|Adverse Event|3|||
160670946|NCT01442376|580176470|FG002|Overall Study|Adverse Event|2|||
160670947|NCT01442376|580176468|FG000|Overall Study|Death|0|||
160670948|NCT01442376|580176469|FG001|Overall Study|Death|1|||
160670949|NCT01442376|580176470|FG002|Overall Study|Death|1|||
160670950|NCT01442376|580176468|FG000|Overall Study|Withdrawal of consent|0|||
160670951|NCT01442376|580176469|FG001|Overall Study|Withdrawal of consent|0|||
160670952|NCT01442376|580176470|FG002|Overall Study|Withdrawal of consent|1|||
160670953|NCT01442376|580176468|FG000|Overall Study|Patients not treated|2|||
160670954|NCT01442376|580176469|FG001|Overall Study|Patients not treated|3|||
160670955|NCT01442376|580176470|FG002|Overall Study|Patients not treated|1|||
160670956|NCT01442376|580176468|FG000|Overall Study|Not eligible for subsequent cycles|1|||
160670957|NCT01442376|580176469|FG001|Overall Study|Not eligible for subsequent cycles|2|||
160670958|NCT01442376|580176470|FG002|Overall Study|Not eligible for subsequent cycles|0|||
160670959|NCT04404725|580176471|FG000|First Intervention|Withdrawal by Subject|0|||
160670960|NCT04404725|580176472|FG001|First Intervention|Withdrawal by Subject|2|||
160670961|NCT04404725|580176471|FG000|Second Intervention|Adverse Event|1|||
160670962|NCT04404725|580176472|FG001|Second Intervention|Adverse Event|1|||
160670963|NCT04404725|580176471|FG000|Second Intervention|Withdrawal by Subject|0|||
160670964|NCT04404725|580176472|FG001|Second Intervention|Withdrawal by Subject|1|||
160670965|NCT01075516|580176473|FG000|Overall Study|Death|5|||
160670966|NCT01075516|580176474|FG001|Overall Study|Death|9|||
160670967|NCT01075516|580176473|FG000|Overall Study|Lost to Follow-up|10|||
160670968|NCT01075516|580176474|FG001|Overall Study|Lost to Follow-up|2|||
160670969|NCT01075516|580176473|FG000|Overall Study|Withdrawal by Subject|3|||
160670970|NCT01075516|580176474|FG001|Overall Study|Withdrawal by Subject|5|||
160670971|NCT02252016|580176475|FG000|Overall Study|Lost to Follow-up|2|||
160670972|NCT02252016|580176476|FG001|Overall Study|Lost to Follow-up|1|||
160670973|NCT02252016|580176475|FG000|Overall Study|Physician Decision|1|||
160670974|NCT02252016|580176476|FG001|Overall Study|Physician Decision|0|||
160670975|NCT02252016|580176475|FG000|Overall Study|Withdrawal by Subject|0|||
160670976|NCT02252016|580176476|FG001|Overall Study|Withdrawal by Subject|2|||
160670977|NCT03498560|580176486|FG000|Overall Study|Found Ineligible|2|||
160670978|NCT03498560|580176486|FG000|Overall Study|Withdrawal by Subject|14|||
160670979|NCT03498560|580176486|FG000|Overall Study|Lost to Follow-up|4|||
160670980|NCT03498560|580176486|FG000|Overall Study|Death|1|||
160670981|NCT00112437|580176487|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
160670982|NCT00112437|580176488|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
160670983|NCT00112437|580176489|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
160670984|NCT00112437|580176490|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
160670985|NCT00112437|580176491|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
160670986|NCT00112437|580176492|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670987|NCT00112437|580176493|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670988|NCT00112437|580176494|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670989|NCT00112437|580176495|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670990|NCT00112437|580176496|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670991|NCT00112437|580176497|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670992|NCT00112437|580176498|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670993|NCT00112437|580176499|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670994|NCT00112437|580176500|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670995|NCT00112437|580176501|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670996|NCT00112437|580176502|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670997|NCT00112437|580176503|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670998|NCT00112437|580176504|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
160670999|NCT00112437|580176505|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
160671000|NCT00112437|580176506|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
160671001|NCT00112437|580176507|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
160671002|NCT00112437|580176508|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
160671003|NCT00112437|580176509|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
160671004|NCT00112437|580176510|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
160671005|NCT00112437|580176511|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
160671006|NCT00112437|580176512|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
160671007|NCT00112437|580176487|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671008|NCT00112437|580176488|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
160671009|NCT00112437|580176489|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671010|NCT00112437|580176490|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671011|NCT00112437|580176491|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671012|NCT00112437|580176492|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671013|NCT00112437|580176493|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671014|NCT00112437|580176494|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671015|NCT00112437|580176495|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671016|NCT00112437|580176496|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671017|NCT00112437|580176497|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671018|NCT00112437|580176498|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671019|NCT00112437|580176499|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671020|NCT00112437|580176500|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671021|NCT00112437|580176501|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671022|NCT00112437|580176502|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671023|NCT00112437|580176503|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671024|NCT00112437|580176504|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671025|NCT00112437|580176505|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671026|NCT00112437|580176506|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671027|NCT00112437|580176507|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671028|NCT00112437|580176508|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671029|NCT00112437|580176509|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671030|NCT00112437|580176510|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671031|NCT00112437|580176511|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671032|NCT00112437|580176512|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160671033|NCT00112437|580176487|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671034|NCT00112437|580176488|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
160671035|NCT00112437|580176489|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671036|NCT00112437|580176490|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671037|NCT00112437|580176491|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671038|NCT00112437|580176492|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671039|NCT00112437|580176493|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671040|NCT00112437|580176494|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671041|NCT00112437|580176495|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671042|NCT00112437|580176496|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671043|NCT00112437|580176497|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671044|NCT00112437|580176498|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671045|NCT00112437|580176499|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671046|NCT00112437|580176500|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671047|NCT00112437|580176501|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671048|NCT00112437|580176502|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671049|NCT00112437|580176503|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671050|NCT00112437|580176504|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671051|NCT00112437|580176505|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671052|NCT00112437|580176506|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671053|NCT00112437|580176507|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671054|NCT00112437|580176508|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671055|NCT00112437|580176509|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671056|NCT00112437|580176510|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671057|NCT00112437|580176511|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671058|NCT00112437|580176512|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160671059|NCT00112437|580176487|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
160671060|NCT00112437|580176488|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671061|NCT00112437|580176489|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
160671062|NCT00112437|580176490|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
160671063|NCT00112437|580176491|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
160671064|NCT00112437|580176492|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671065|NCT00112437|580176493|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671066|NCT00112437|580176494|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671067|NCT00112437|580176495|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671068|NCT00112437|580176496|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671069|NCT00112437|580176497|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671070|NCT00112437|580176498|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671071|NCT00112437|580176499|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671072|NCT00112437|580176500|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671073|NCT00112437|580176501|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671074|NCT00112437|580176502|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671075|NCT00112437|580176503|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671076|NCT00112437|580176504|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671077|NCT00112437|580176505|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160625192|NCT00903357|580007936|FG001|First Intervention|Flu|1|||
160625193|NCT00903357|580007935|FG000|Wash Out Period of 2 Weeks|Flu|0|||
160625194|NCT00903357|580007936|FG001|Wash Out Period of 2 Weeks|Flu|1|||
160625195|NCT00903357|580007935|FG000|Second Intervention|Lost to Follow-up|1|||
160625196|NCT00903357|580007936|FG001|Second Intervention|Lost to Follow-up|0|||
160625197|NCT02279888|580007938|FG000|Overall Study|Death|326|||
160625198|NCT02279888|580007938|FG000|Overall Study|Withdrawal by Subject|38|||
160625199|NCT02279888|580007938|FG000|Overall Study|Lost to Follow-up|21|||
160625200|NCT02279888|580007938|FG000|Overall Study|Physician Decision|62|||
160625201|NCT02279888|580007938|FG000|Overall Study|Subject Non-compliance|43|||
160625202|NCT02279888|580007938|FG000|Overall Study|Not implanted|14|||
160625203|NCT02279888|580007938|FG000|Overall Study|Visit not performed|26|||
160625204|NCT01484691|580007940|FG000|Overall Study|Withdrawal by Subject|1|||
160625205|NCT01484691|580007941|FG001|Overall Study|Withdrawal by Subject|1|||
160625206|NCT01484691|580007942|FG002|Overall Study|Withdrawal by Subject|1|||
160625207|NCT01484691|580007940|FG000|Overall Study|Physician Decision|0|||
160625208|NCT01484691|580007941|FG001|Overall Study|Physician Decision|2|||
160625209|NCT01484691|580007942|FG002|Overall Study|Physician Decision|1|||
160625210|NCT03480243|580007947|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
160625211|NCT03480243|580007947|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
160625212|NCT04668157|580007948|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
160625213|NCT04668157|580007949|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
160625214|NCT04668157|580007948|FG000|Treatment Period (52 Weeks)|Other|0|||
160625215|NCT04668157|580007949|FG001|Treatment Period (52 Weeks)|Other|2|||
160625216|NCT03958045|580007950|FG000|Overall Study|Withdrawal by Subject|1|||
160625217|NCT02283411|580007955|FG000|Overall Study|Withdrawal by Subject|3|||
160625218|NCT02283411|580007955|FG000|Overall Study|Screen Failed|28|||
160625219|NCT05437211|580007956|FG000|Overall Study|Patient's decision|1|||
160625220|NCT05437211|580007957|FG001|Overall Study|Patient's decision|1|||
160625221|NCT03282123|580007959|FG000|Overall Study|Withdrawal by Subject|5|||
160625222|NCT03457701|580007960|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
160625223|NCT03457701|580007961|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
160625224|NCT03457701|580007960|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
160625225|NCT03457701|580007961|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
160625226|NCT03329404|580007962|FG000|Overall Study|The study was suspended.|1|||
160625227|NCT03329404|580007963|FG001|Overall Study|The study was suspended.|4|||
160625228|NCT00796367|580007967|FG000|Overall Study|Adverse Event|6|||
160625229|NCT00796367|580007968|FG001|Overall Study|Adverse Event|4|||
160625230|NCT00796367|580007969|FG002|Overall Study|Adverse Event|7|||
160625231|NCT00796367|580007967|FG000|Overall Study|Lost to Follow-up|5|||
160625232|NCT00796367|580007968|FG001|Overall Study|Lost to Follow-up|4|||
160625233|NCT00796367|580007969|FG002|Overall Study|Lost to Follow-up|21|||
160625234|NCT00796367|580007967|FG000|Overall Study|Withdrawal by Subject|9|||
160625235|NCT00796367|580007968|FG001|Overall Study|Withdrawal by Subject|11|||
160625236|NCT00796367|580007969|FG002|Overall Study|Withdrawal by Subject|12|||
160625237|NCT00796367|580007967|FG000|Overall Study|Lack of Efficacy|2|||
160625238|NCT00796367|580007968|FG001|Overall Study|Lack of Efficacy|1|||
160625239|NCT00796367|580007969|FG002|Overall Study|Lack of Efficacy|0|||
160625240|NCT00796367|580007967|FG000|Overall Study|non compliance|3|||
160625241|NCT00796367|580007968|FG001|Overall Study|non compliance|1|||
160625242|NCT00796367|580007969|FG002|Overall Study|non compliance|1|||
160625243|NCT00796367|580007967|FG000|Overall Study|Pregnancy|1|||
160625244|NCT00796367|580007968|FG001|Overall Study|Pregnancy|0|||
160625245|NCT00796367|580007969|FG002|Overall Study|Pregnancy|1|||
160625246|NCT00796367|580007967|FG000|Overall Study|Requirement for restricted medication|2|||
160625247|NCT00796367|580007968|FG001|Overall Study|Requirement for restricted medication|0|||
160625248|NCT00796367|580007969|FG002|Overall Study|Requirement for restricted medication|2|||
160625249|NCT00796367|580007967|FG000|Overall Study|other|2|||
160625250|NCT00796367|580007968|FG001|Overall Study|other|4|||
160625251|NCT00796367|580007969|FG002|Overall Study|other|3|||
160625252|NCT04409262|580007985|FG000|Overall Study|Adverse Event|0|||
160625253|NCT04409262|580007986|FG001|Overall Study|Adverse Event|2|||
160625254|NCT04409262|580007985|FG000|Overall Study|Death|55|||
160625255|NCT04409262|580007986|FG001|Overall Study|Death|97|||
160625256|NCT04409262|580007985|FG000|Overall Study|Lost to Follow-up|12|||
160625257|NCT04409262|580007986|FG001|Overall Study|Lost to Follow-up|23|||
160625258|NCT04409262|580007985|FG000|Overall Study|Lack of Staff|0|||
160625259|NCT04409262|580007986|FG001|Overall Study|Lack of Staff|1|||
160625260|NCT04409262|580007985|FG000|Overall Study|Protocol Violation|3|||
160625261|NCT04409262|580007986|FG001|Overall Study|Protocol Violation|1|||
160625262|NCT04409262|580007985|FG000|Overall Study|Withdrawal by Subject|5|||
160625263|NCT04409262|580007986|FG001|Overall Study|Withdrawal by Subject|10|||
160625264|NCT01326481|580007990|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
160625265|NCT04794491|580007991|FG000|Overall Study|Adverse Event|1|||
160625266|NCT04794491|580007991|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
160625267|NCT04794491|580007991|FG000|Overall Study|Noncompliance With Study Intervention|1|||
160519483|NCT04620811|579631097|FG000|Overall Study|Withdrawal by Subject|18|||
160519484|NCT04620811|579631098|FG001|Overall Study|Withdrawal by Subject|15|||
160519485|NCT04620811|579631097|FG000|Overall Study|Adverse Event|6|||
160519486|NCT04620811|579631098|FG001|Overall Study|Adverse Event|11|||
160519487|NCT04620811|579631097|FG000|Overall Study|Lost to Follow-up|4|||
160519488|NCT04620811|579631098|FG001|Overall Study|Lost to Follow-up|8|||
160519489|NCT04620811|579631097|FG000|Overall Study|Physician Decision|1|||
160519490|NCT04620811|579631098|FG001|Overall Study|Physician Decision|4|||
160519491|NCT04620811|579631097|FG000|Overall Study|Sponsor Decision|0|||
160519492|NCT04620811|579631098|FG001|Overall Study|Sponsor Decision|1|||
160519493|NCT04620811|579631097|FG000|Overall Study|Elevation of ALT or AST|1|||
160519494|NCT04620811|579631098|FG001|Overall Study|Elevation of ALT or AST|0|||
160519495|NCT04620811|579631097|FG000|Overall Study|Other|3|||
160519496|NCT04620811|579631098|FG001|Overall Study|Other|5|||
160519497|NCT01078675|579631099|FG000|Overall Study|Withdrawal by Subject|7|||
160519498|NCT01078675|579631100|FG001|Overall Study|Withdrawal by Subject|3|||
160519499|NCT01078675|579631099|FG000|Overall Study|Protocol Violation|56|||
160519500|NCT01078675|579631100|FG001|Overall Study|Protocol Violation|0|||
160519501|NCT01078675|579631099|FG000|Overall Study|Provided in CRF for specific reasons|2|||
160519502|NCT01078675|579631100|FG001|Overall Study|Provided in CRF for specific reasons|3|||
160519503|NCT01078675|579631099|FG000|Overall Study|Adverse Event|3|||
160519504|NCT01078675|579631100|FG001|Overall Study|Adverse Event|0|||
160519505|NCT02513303|579631101|FG000|Overall Study|Withdrawal by Subject|9|||
160519506|NCT02513303|579631102|FG001|Overall Study|Withdrawal by Subject|7|||
160519507|NCT02513303|579631103|FG002|Overall Study|Withdrawal by Subject|2|||
160519508|NCT02513303|579631101|FG000|Overall Study|Lost to Follow-up|2|||
160519509|NCT02513303|579631102|FG001|Overall Study|Lost to Follow-up|4|||
160519510|NCT02513303|579631103|FG002|Overall Study|Lost to Follow-up|0|||
160519511|NCT02513303|579631101|FG000|Overall Study|Adverse Event|0|||
160519512|NCT02513303|579631102|FG001|Overall Study|Adverse Event|1|||
160519513|NCT02513303|579631103|FG002|Overall Study|Adverse Event|0|||
160519514|NCT02513303|579631101|FG000|Overall Study|Physician Decision|1|||
160519515|NCT02513303|579631102|FG001|Overall Study|Physician Decision|1|||
160519516|NCT02513303|579631103|FG002|Overall Study|Physician Decision|0|||
160519517|NCT02513303|579631101|FG000|Overall Study|Death|8|||
160519518|NCT02513303|579631102|FG001|Overall Study|Death|4|||
160519519|NCT02513303|579631103|FG002|Overall Study|Death|2|||
160519520|NCT00490724|579631104|FG000|Period I|Physician Decision|0|||
160519521|NCT00490724|579631105|FG001|Period I|Physician Decision|0|||
160519522|NCT00490724|579631106|FG002|Period I|Physician Decision|1|||
160519523|NCT00490724|579631104|FG000|Period II|Treatment Discontinuation|3|||
160519524|NCT00490724|579631105|FG001|Period II|Treatment Discontinuation|1|||
160519525|NCT00490724|579631106|FG002|Period II|Treatment Discontinuation|3|||
160519526|NCT03866473|579631107|FG000|Phase 1|Death|1|||
160519527|NCT03866473|579631108|FG001|Phase 1|Death|0|||
160519528|NCT03866473|579631107|FG000|Phase 2|Death|0|||
160519529|NCT03866473|579631108|FG001|Phase 2|Death|2|||
160519530|NCT03866473|579631107|FG000|Phase 2|Dropped|1|||
160519531|NCT03866473|579631108|FG001|Phase 2|Dropped|1|||
160519532|NCT03866473|579631107|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
160519533|NCT03866473|579631108|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
160519534|NCT00600886|579631109|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
160519535|NCT00600886|579631110|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
160519536|NCT00600886|579631109|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
160519537|NCT00600886|579631110|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
160519538|NCT00600886|579631109|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
160519539|NCT00600886|579631110|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
160519540|NCT00600886|579631109|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
160519541|NCT00600886|579631110|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
160519542|NCT00600886|579631109|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
160519543|NCT00600886|579631110|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
160519544|NCT00600886|579631109|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
160519545|NCT00600886|579631110|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
160519546|NCT00600886|579631109|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
160519547|NCT00600886|579631110|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
160519548|NCT00600886|579631109|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
160519549|NCT00600886|579631110|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
160625268|NCT04794491|580007991|FG000|Overall Study|Withdrawal by Subject|2|||
160519550|NCT00600886|579631109|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
160519551|NCT00600886|579631110|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
160519552|NCT00600886|579631109|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
160519553|NCT00600886|579631110|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
160519554|NCT00600886|579631109|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
160519555|NCT00600886|579631110|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
160625269|NCT00948896|580007992|FG000|Randomization to 24 Months of Age|Death|1|||
160625270|NCT00948896|580007993|FG001|Randomization to 24 Months of Age|Death|0|||
160625271|NCT00948896|580007994|FG002|Randomization to 24 Months of Age|Death|0|||
160625272|NCT00948896|580007995|FG003|Randomization to 24 Months of Age|Death|0|||
160625273|NCT00948896|580007996|FG004|Randomization to 24 Months of Age|Death|2|||
160625274|NCT00948896|580007997|FG005|Randomization to 24 Months of Age|Death|1|||
160625275|NCT00948896|580007998|FG006|Randomization to 24 Months of Age|Death|2|||
160625276|NCT00948896|580007999|FG007|Randomization to 24 Months of Age|Death|1|||
160625277|NCT00948896|580007992|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
160625278|NCT00948896|580007993|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
160625279|NCT00948896|580007994|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
160625280|NCT00948896|580007995|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
160625281|NCT00948896|580007996|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
160625282|NCT00948896|580007997|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
160625283|NCT00948896|580007998|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
160625284|NCT00948896|580007999|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
160625285|NCT00948896|580007992|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
160625286|NCT00948896|580007993|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
160625287|NCT00948896|580007994|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
160625288|NCT00948896|580007995|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
160625289|NCT00948896|580007996|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
160625290|NCT00948896|580007997|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
160625291|NCT00948896|580007998|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
160625292|NCT00948896|580007999|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
160625293|NCT00948896|580007992|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
160625294|NCT00948896|580007993|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
160625295|NCT00948896|580007994|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
160625296|NCT00948896|580007995|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
160625297|NCT00948896|580007996|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
160625298|NCT00948896|580007997|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
160625299|NCT00948896|580007998|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
160625300|NCT00948896|580007999|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
160625301|NCT00948896|580007992|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
160625302|NCT00948896|580007993|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
160625303|NCT00948896|580007994|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
160625304|NCT00948896|580007995|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
160625305|NCT00948896|580007996|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
160625306|NCT00948896|580007997|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
160625307|NCT00948896|580007998|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
160625308|NCT00948896|580007999|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
160625309|NCT00948896|580007992|FG000|24 Months of Age to 36 Months of Age|Death|0|||
160625310|NCT00948896|580007993|FG001|24 Months of Age to 36 Months of Age|Death|2|||
160625311|NCT00948896|580007994|FG002|24 Months of Age to 36 Months of Age|Death|2|||
160625312|NCT00948896|580007995|FG003|24 Months of Age to 36 Months of Age|Death|0|||
160625313|NCT00948896|580007996|FG004|24 Months of Age to 36 Months of Age|Death|0|||
160625314|NCT00948896|580007997|FG005|24 Months of Age to 36 Months of Age|Death|1|||
160625315|NCT00948896|580007998|FG006|24 Months of Age to 36 Months of Age|Death|0|||
160625316|NCT00948896|580007999|FG007|24 Months of Age to 36 Months of Age|Death|0|||
160625317|NCT00948896|580007992|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
160625318|NCT00948896|580007993|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
160625319|NCT00948896|580007994|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
160625320|NCT00948896|580007995|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
160625321|NCT00948896|580007996|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
160625322|NCT00948896|580007997|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
160625323|NCT00948896|580007998|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
160625324|NCT00948896|580007999|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
160625325|NCT00948896|580007992|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
160625326|NCT00948896|580007993|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
160625327|NCT00948896|580007994|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
160625328|NCT00948896|580007995|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
160625329|NCT00948896|580007996|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
160625330|NCT00948896|580007997|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
160625331|NCT00948896|580007998|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
160625332|NCT00948896|580007999|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
160625333|NCT00948896|580007992|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
160625334|NCT00948896|580007993|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
160625335|NCT00948896|580007994|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
160625336|NCT00948896|580007995|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
160625337|NCT00948896|580007996|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
160625338|NCT00948896|580007997|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
160625339|NCT00948896|580007998|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
160625340|NCT00948896|580007999|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
160625341|NCT00948896|580007992|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
160625342|NCT00948896|580007993|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
160625343|NCT00948896|580007994|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
160625344|NCT00948896|580007995|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
160625345|NCT00948896|580007996|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
160625346|NCT00948896|580007997|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
160625347|NCT00948896|580007998|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
160625348|NCT00948896|580007999|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
160625349|NCT00945815|580008000|FG000|Overall Study|Death|3|||
160625350|NCT00945815|580008000|FG000|Overall Study|Not protocol specified|1|||
160625351|NCT00945815|580008000|FG000|Overall Study|Ineligible|3|||
160625352|NCT00945815|580008000|FG000|Overall Study|Did not begin protocol therapy|1|||
160625353|NCT01038609|580008005|FG000|Overall Study|Adverse Event|0|||
160625354|NCT01038609|580008006|FG001|Overall Study|Adverse Event|0|||
160625355|NCT01038609|580008007|FG002|Overall Study|Adverse Event|1|||
160625356|NCT01038609|580008008|FG003|Overall Study|Adverse Event|0|||
160625357|NCT01038609|580008009|FG004|Overall Study|Adverse Event|0|||
160625358|NCT01038609|580008005|FG000|Overall Study|Dosing Error|0|||
160625359|NCT01038609|580008006|FG001|Overall Study|Dosing Error|0|||
160625360|NCT01038609|580008007|FG002|Overall Study|Dosing Error|0|||
160625361|NCT01038609|580008008|FG003|Overall Study|Dosing Error|1|||
160625362|NCT01038609|580008009|FG004|Overall Study|Dosing Error|1|||
160625363|NCT01038609|580008005|FG000|Overall Study|Death in the Family|1|||
160625364|NCT01038609|580008006|FG001|Overall Study|Death in the Family|0|||
160625365|NCT01038609|580008007|FG002|Overall Study|Death in the Family|0|||
160625366|NCT01038609|580008008|FG003|Overall Study|Death in the Family|0|||
160625367|NCT01038609|580008009|FG004|Overall Study|Death in the Family|0|||
160625368|NCT01038609|580008005|FG000|Overall Study|Refusal of Blood Draws|0|||
160625369|NCT01038609|580008006|FG001|Overall Study|Refusal of Blood Draws|1|||
160625370|NCT01038609|580008007|FG002|Overall Study|Refusal of Blood Draws|0|||
160625371|NCT01038609|580008008|FG003|Overall Study|Refusal of Blood Draws|0|||
160625372|NCT01038609|580008009|FG004|Overall Study|Refusal of Blood Draws|0|||
160625373|NCT02129192|580008010|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
160625374|NCT02129192|580008011|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
160625375|NCT01231620|580008012|FG000|Overall Study|Physician Decision|3|||
160625376|NCT01231620|580008013|FG001|Overall Study|Physician Decision|5|||
160625377|NCT01231620|580008014|FG002|Overall Study|Physician Decision|10|||
160625378|NCT01231620|580008012|FG000|Overall Study|Death|12|||
160625379|NCT01231620|580008013|FG001|Overall Study|Death|14|||
160625380|NCT01231620|580008014|FG002|Overall Study|Death|11|||
160625381|NCT01231620|580008012|FG000|Overall Study|Adverse Event|2|||
160625382|NCT01231620|580008013|FG001|Overall Study|Adverse Event|2|||
160625383|NCT01231620|580008014|FG002|Overall Study|Adverse Event|1|||
160625384|NCT01231620|580008012|FG000|Overall Study|Withdrawal by Subject|6|||
160625385|NCT01231620|580008013|FG001|Overall Study|Withdrawal by Subject|6|||
160625386|NCT01231620|580008014|FG002|Overall Study|Withdrawal by Subject|8|||
160625387|NCT01231620|580008012|FG000|Overall Study|Lost to Follow-up|3|||
160625388|NCT01231620|580008013|FG001|Overall Study|Lost to Follow-up|4|||
160625389|NCT01231620|580008014|FG002|Overall Study|Lost to Follow-up|9|||
160625390|NCT04557189|580008023|FG000|Overall Study|Adverse Event|0|||
160625391|NCT04557189|580008024|FG001|Overall Study|Adverse Event|1|||
160625392|NCT04557189|580008023|FG000|Overall Study|Lost to Follow-up|1|||
160625393|NCT04557189|580008024|FG001|Overall Study|Lost to Follow-up|1|||
160625394|NCT04557189|580008023|FG000|Overall Study|Withdrawal by Subject|2|||
160625395|NCT04557189|580008024|FG001|Overall Study|Withdrawal by Subject|1|||
160625396|NCT04557189|580008023|FG000|Overall Study|Reason not Specified|3|||
160625397|NCT04557189|580008024|FG001|Overall Study|Reason not Specified|6|||
160625398|NCT03590613|580008025|FG000|Period 2, 4 Days|Physician Decision|0|||
160625399|NCT03590613|580008026|FG001|Period 2, 4 Days|Physician Decision|0|||
160625400|NCT03590613|580008027|FG002|Period 2, 4 Days|Physician Decision|0|||
160625401|NCT03590613|580008028|FG003|Period 2, 4 Days|Physician Decision|1|||
160625402|NCT02441517|580008029|FG000|Overall Study|Lost to Follow-up|1|||
160625403|NCT02441517|580008029|FG000|Overall Study|Withdrawal by Subject|2|||
160625404|NCT02441517|580008029|FG000|Overall Study|Study Terminated by Sponsor|1|||
160625405|NCT00869362|580009542|FG000|Overall Study|Death|0|||
160625406|NCT00869362|580009543|FG001|Overall Study|Death|2|||
160625407|NCT00869362|580009542|FG000|Overall Study|Lost to Follow-up|1|||
160625408|NCT00869362|580009543|FG001|Overall Study|Lost to Follow-up|3|||
160625409|NCT02389621|580009545|FG000|Treatment Period|Withdrawal by Subject|1|||
160625410|NCT02389621|580009546|FG001|Treatment Period|Withdrawal by Subject|1|||
160625411|NCT02389621|580009545|FG000|Posttreatment Period|Adverse Event|3|||
160625412|NCT02389621|580009546|FG001|Posttreatment Period|Adverse Event|1|||
160625413|NCT02389621|580009545|FG000|Posttreatment Period|Withdrawal by Subject|3|||
160625414|NCT02389621|580009546|FG001|Posttreatment Period|Withdrawal by Subject|2|||
160625415|NCT02389621|580009545|FG000|Posttreatment Period|Lost to Follow-up|1|||
160625416|NCT02389621|580009546|FG001|Posttreatment Period|Lost to Follow-up|1|||
160625417|NCT02389621|580009545|FG000|Posttreatment Period|Other - Miscellaneous|2|||
160625418|NCT02389621|580009546|FG001|Posttreatment Period|Other - Miscellaneous|0|||
160625419|NCT02815540|580009553|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
160625420|NCT04887922|580009561|FG000|1st Randomization|Decided not to have surgery|0|||
160625421|NCT04887922|580009562|FG001|1st Randomization|Decided not to have surgery|1|||
160625422|NCT04887922|580009563|FG002|1st Randomization|Decided not to have surgery|0|||
160625423|NCT04887922|580009564|FG003|1st Randomization|Decided not to have surgery|0|||
160625424|NCT04887922|580009565|FG004|1st Randomization|Decided not to have surgery|0|||
160625425|NCT00594568|580009568|FG000|Initial Treatment|Adverse Event|51|||
160625426|NCT00594568|580009569|FG001|Initial Treatment|Adverse Event|121|||
160625427|NCT00594568|580009570|FG002|Initial Treatment|Adverse Event|144|||
160625428|NCT00594568|580009568|FG000|Initial Treatment|Death|6|||
160625429|NCT00594568|580009569|FG001|Initial Treatment|Death|11|||
160625430|NCT00594568|580009570|FG002|Initial Treatment|Death|15|||
160625431|NCT00594568|580009568|FG000|Initial Treatment|Lost to Follow-up|4|||
160625432|NCT00594568|580009569|FG001|Initial Treatment|Lost to Follow-up|1|||
160625433|NCT00594568|580009570|FG002|Initial Treatment|Lost to Follow-up|4|||
160625434|NCT00594568|580009568|FG000|Initial Treatment|Physician Decision|3|||
160625435|NCT00594568|580009569|FG001|Initial Treatment|Physician Decision|2|||
160625436|NCT00594568|580009570|FG002|Initial Treatment|Physician Decision|4|||
160625437|NCT00594568|580009568|FG000|Initial Treatment|Protocol Violation|2|||
160625438|NCT00594568|580009569|FG001|Initial Treatment|Protocol Violation|2|||
160625439|NCT00594568|580009570|FG002|Initial Treatment|Protocol Violation|5|||
160625440|NCT00594568|580009568|FG000|Initial Treatment|Withdrawal by Subject|25|||
160625441|NCT00594568|580009569|FG001|Initial Treatment|Withdrawal by Subject|31|||
160625442|NCT00594568|580009570|FG002|Initial Treatment|Withdrawal by Subject|46|||
160625443|NCT00594568|580009568|FG000|Initial Treatment|Sponsor decision|193|||
160625444|NCT00594568|580009569|FG001|Initial Treatment|Sponsor decision|142|||
160625445|NCT00594568|580009570|FG002|Initial Treatment|Sponsor decision|147|||
160625446|NCT00594568|580009568|FG000|Initial Treatment|Caregiver decision|21|||
160625447|NCT00594568|580009569|FG001|Initial Treatment|Caregiver decision|36|||
160625448|NCT00594568|580009570|FG002|Initial Treatment|Caregiver decision|36|||
160625449|NCT00594568|580009568|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
160625450|NCT00594568|580009569|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
160625451|NCT00594568|580009570|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
160625452|NCT00594568|580009568|FG000|Initial Treatment|Entry criteria exclusion|0|||
160625453|NCT00594568|580009569|FG001|Initial Treatment|Entry criteria exclusion|1|||
160625454|NCT00594568|580009570|FG002|Initial Treatment|Entry criteria exclusion|1|||
160625455|NCT00594568|580009568|FG000|Delayed Start|Death|0|||
160625456|NCT00594568|580009569|FG001|Delayed Start|Death|0|||
160625457|NCT00594568|580009570|FG002|Delayed Start|Death|1|||
160625458|NCT00594568|580009568|FG000|Delayed Start|Adverse Event|12|||
160625459|NCT00594568|580009569|FG001|Delayed Start|Adverse Event|2|||
160625460|NCT00594568|580009570|FG002|Delayed Start|Adverse Event|2|||
160625461|NCT00594568|580009568|FG000|Delayed Start|Withdrawal by Subject|4|||
160625462|NCT00594568|580009569|FG001|Delayed Start|Withdrawal by Subject|3|||
160625463|NCT00594568|580009570|FG002|Delayed Start|Withdrawal by Subject|0|||
160625464|NCT00594568|580009568|FG000|Delayed Start|Physician Decision|0|||
160625465|NCT00594568|580009569|FG001|Delayed Start|Physician Decision|0|||
160625466|NCT00594568|580009570|FG002|Delayed Start|Physician Decision|1|||
160625467|NCT00594568|580009568|FG000|Delayed Start|Lost to Follow-up|0|||
160625468|NCT00594568|580009569|FG001|Delayed Start|Lost to Follow-up|0|||
160625469|NCT00594568|580009570|FG002|Delayed Start|Lost to Follow-up|1|||
160625470|NCT00594568|580009568|FG000|Delayed Start|Caregiver Decision|5|||
160625471|NCT00594568|580009569|FG001|Delayed Start|Caregiver Decision|6|||
160625472|NCT00594568|580009570|FG002|Delayed Start|Caregiver Decision|2|||
160625473|NCT00594568|580009568|FG000|Delayed Start|Sponsor Decision|77|||
160625474|NCT00594568|580009569|FG001|Delayed Start|Sponsor Decision|66|||
160625475|NCT00594568|580009570|FG002|Delayed Start|Sponsor Decision|59|||
160625476|NCT00594568|580009568|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
160625477|NCT00594568|580009569|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
160625478|NCT00594568|580009570|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
160625479|NCT00594568|580009568|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
160625480|NCT00594568|580009569|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
160625481|NCT00594568|580009570|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
160625482|NCT00594568|580009568|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
160625483|NCT00594568|580009569|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
160625484|NCT00594568|580009570|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
160625485|NCT00594568|580009568|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
160625486|NCT00594568|580009569|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
160625487|NCT00594568|580009570|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
160625488|NCT00594568|580009568|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
160625489|NCT00594568|580009569|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
160625490|NCT00594568|580009570|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
160625491|NCT00594568|580009568|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
160671078|NCT00112437|580176506|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671079|NCT00112437|580176507|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671080|NCT00112437|580176508|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671081|NCT00112437|580176509|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671082|NCT00112437|580176510|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671083|NCT00112437|580176511|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671084|NCT00112437|580176512|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160671085|NCT00112437|580176487|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
160671086|NCT00112437|580176488|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
160671087|NCT00112437|580176489|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
160671088|NCT00112437|580176490|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
160671089|NCT00112437|580176491|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
160671090|NCT00112437|580176492|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671091|NCT00112437|580176493|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671092|NCT00112437|580176494|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671093|NCT00112437|580176495|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671094|NCT00112437|580176496|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671095|NCT00112437|580176497|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671096|NCT00112437|580176498|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671097|NCT00112437|580176499|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671098|NCT00112437|580176500|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671099|NCT00112437|580176501|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671100|NCT00112437|580176502|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671101|NCT00112437|580176503|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671102|NCT00112437|580176504|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671103|NCT00112437|580176505|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671104|NCT00112437|580176506|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671105|NCT00112437|580176507|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671106|NCT00112437|580176508|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671107|NCT00112437|580176509|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671108|NCT00112437|580176510|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671109|NCT00112437|580176511|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671110|NCT00112437|580176512|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
160671111|NCT00112437|580176487|FG000|Year 1 (12-Month Base Study)|moved|0|||
160671112|NCT00112437|580176488|FG001|Year 1 (12-Month Base Study)|moved|1|||
160671113|NCT00112437|580176489|FG002|Year 1 (12-Month Base Study)|moved|1|||
160671114|NCT00112437|580176490|FG003|Year 1 (12-Month Base Study)|moved|0|||
160671115|NCT00112437|580176491|FG004|Year 1 (12-Month Base Study)|moved|0|||
160671116|NCT00112437|580176492|FG005|Year 1 (12-Month Base Study)|moved|0|||
160671117|NCT00112437|580176493|FG006|Year 1 (12-Month Base Study)|moved|0|||
160671118|NCT00112437|580176494|FG007|Year 1 (12-Month Base Study)|moved|0|||
160671119|NCT00112437|580176495|FG008|Year 1 (12-Month Base Study)|moved|0|||
160671120|NCT00112437|580176496|FG009|Year 1 (12-Month Base Study)|moved|0|||
160671121|NCT00112437|580176497|FG010|Year 1 (12-Month Base Study)|moved|0|||
160671122|NCT00112437|580176498|FG011|Year 1 (12-Month Base Study)|moved|0|||
160671123|NCT00112437|580176499|FG012|Year 1 (12-Month Base Study)|moved|0|||
160671124|NCT00112437|580176500|FG013|Year 1 (12-Month Base Study)|moved|0|||
160671125|NCT00112437|580176501|FG014|Year 1 (12-Month Base Study)|moved|0|||
160671126|NCT00112437|580176502|FG015|Year 1 (12-Month Base Study)|moved|0|||
160671127|NCT00112437|580176503|FG016|Year 1 (12-Month Base Study)|moved|0|||
160671128|NCT00112437|580176504|FG017|Year 1 (12-Month Base Study)|moved|0|||
160671129|NCT00112437|580176505|FG018|Year 1 (12-Month Base Study)|moved|0|||
160671130|NCT00112437|580176506|FG019|Year 1 (12-Month Base Study)|moved|0|||
160671131|NCT00112437|580176507|FG020|Year 1 (12-Month Base Study)|moved|0|||
160671132|NCT00112437|580176508|FG021|Year 1 (12-Month Base Study)|moved|0|||
160671133|NCT00112437|580176509|FG022|Year 1 (12-Month Base Study)|moved|0|||
160671134|NCT00112437|580176510|FG023|Year 1 (12-Month Base Study)|moved|0|||
160671135|NCT00112437|580176511|FG024|Year 1 (12-Month Base Study)|moved|0|||
160671136|NCT00112437|580176512|FG025|Year 1 (12-Month Base Study)|moved|0|||
160671137|NCT00112437|580176487|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671138|NCT00112437|580176488|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671139|NCT00112437|580176489|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160625492|NCT00594568|580009569|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
160625493|NCT00594568|580009570|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
160625494|NCT01366846|580009574|FG000|Overall Study|Withdrawal by Subject|2|||
160625495|NCT01366846|580009575|FG001|Overall Study|Withdrawal by Subject|0|||
160625496|NCT01366846|580009576|FG002|Overall Study|Withdrawal by Subject|0|||
160625497|NCT01366846|580009577|FG003|Overall Study|Withdrawal by Subject|0|||
160625498|NCT01366846|580009574|FG000|Overall Study|Communication Difficulties|1|||
160625499|NCT01366846|580009575|FG001|Overall Study|Communication Difficulties|4|||
160625500|NCT01366846|580009576|FG002|Overall Study|Communication Difficulties|0|||
160625501|NCT01366846|580009577|FG003|Overall Study|Communication Difficulties|1|||
160625502|NCT01366846|580009574|FG000|Overall Study|Scheduling Conflicts|0|||
160625503|NCT01366846|580009575|FG001|Overall Study|Scheduling Conflicts|0|||
160625504|NCT01366846|580009576|FG002|Overall Study|Scheduling Conflicts|1|||
160625505|NCT01366846|580009577|FG003|Overall Study|Scheduling Conflicts|0|||
160625506|NCT00290511|580009578|FG000|Overall Study|Adverse Event|1|||
160625507|NCT00290511|580009578|FG000|Overall Study|Death|1|||
160625508|NCT00290511|580009578|FG000|Overall Study|Physician Decision|1|||
160625509|NCT00290511|580009578|FG000|Overall Study|Withdrawal by Subject|1|||
160625510|NCT04341727|580009583|FG000|Overall Study|Withdrawal by Subject|0|||
160625511|NCT04341727|580009584|FG001|Overall Study|Withdrawal by Subject|0|||
160625512|NCT04341727|580009585|FG002|Overall Study|Withdrawal by Subject|1|||
160625513|NCT04341727|580009586|FG003|Overall Study|Withdrawal by Subject|0|||
160625514|NCT04341727|580009583|FG000|Overall Study|Lost to Follow-up|0|||
160625515|NCT04341727|580009584|FG001|Overall Study|Lost to Follow-up|0|||
160625516|NCT04341727|580009585|FG002|Overall Study|Lost to Follow-up|0|||
160625517|NCT04341727|580009586|FG003|Overall Study|Lost to Follow-up|1|||
160625518|NCT00447265|580009587|FG000|Overall Study|Physician Decision|1|||
160625519|NCT00447265|580009588|FG001|Overall Study|Physician Decision|0|||
160625520|NCT00503035|580009589|FG000|Overall Study|Lost to Follow-up|2|||
160625521|NCT00503035|580009589|FG000|Overall Study|Physician Decision|3|||
160625522|NCT00503035|580009589|FG000|Overall Study|Ineligible|15|||
160625523|NCT04311411|580009592|FG000|Overall Study|Adverse Event|2|||
160625524|NCT04311411|580009593|FG001|Overall Study|Adverse Event|3|||
160625525|NCT04311411|580009594|FG002|Overall Study|Adverse Event|2|||
160625526|NCT04311411|580009592|FG000|Overall Study|Withdrawal by Subject|3|||
160625527|NCT04311411|580009593|FG001|Overall Study|Withdrawal by Subject|3|||
160625528|NCT04311411|580009594|FG002|Overall Study|Withdrawal by Subject|0|||
160625529|NCT01976663|580009598|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
160625530|NCT01976663|580009598|FG000|Overall Study|Personal Reasons|6|||
160625531|NCT01976663|580009598|FG000|Overall Study|Withdrawal by Subject|4|||
160625532|NCT01976663|580009598|FG000|Overall Study|Screen Failure|3|||
160625533|NCT01976663|580009598|FG000|Overall Study|Adverse Event|2|||
160625534|NCT01976663|580009598|FG000|Overall Study|Lost to Follow-up|3|||
160625535|NCT05028816|580009599|FG000|Overall Study|Lost to Follow-up|5|||
160625536|NCT05028816|580009600|FG001|Overall Study|Lost to Follow-up|3|||
160625537|NCT05028816|580009599|FG000|Overall Study|Withdrawal by Subject|4|||
160625538|NCT05028816|580009600|FG001|Overall Study|Withdrawal by Subject|1|||
160625539|NCT05028816|580009599|FG000|Overall Study|Physician Decision|1|||
160625540|NCT05028816|580009600|FG001|Overall Study|Physician Decision|0|||
160625541|NCT04780776|580009606|FG000|Titration Week 1-5|Lost to Follow-up|2|||
160625542|NCT04780776|580009607|FG001|Titration Week 1-5|Lost to Follow-up|8|||
160625543|NCT04780776|580009606|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
160625544|NCT04780776|580009607|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
160625545|NCT04780776|580009606|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
160625546|NCT04780776|580009607|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
160625547|NCT03113760|580009609|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
160625548|NCT03113760|580009610|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
160625549|NCT03113760|580009611|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
160625550|NCT03113760|580009612|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
160625551|NCT03113760|580009609|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
160625552|NCT03113760|580009610|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
160625553|NCT03113760|580009611|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
160625554|NCT03113760|580009612|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
160625555|NCT03113760|580009609|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
160625556|NCT03113760|580009610|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
160625557|NCT03113760|580009611|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
160625558|NCT03113760|580009612|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
160625559|NCT04196023|580009617|FG000|Overall Study|Withdrawal by Subject|0|||
160625560|NCT04196023|580009618|FG001|Overall Study|Withdrawal by Subject|1|||
160625561|NCT04196023|580009617|FG000|Overall Study|Adverse Event|3|||
160625562|NCT04196023|580009618|FG001|Overall Study|Adverse Event|1|||
160625563|NCT04196023|580009617|FG000|Overall Study|Lost to Follow-up|0|||
160625564|NCT04196023|580009618|FG001|Overall Study|Lost to Follow-up|1|||
160625565|NCT04359758|580009625|FG000|Overall Study|Protocol Violation|3|||
160625566|NCT04359758|580009626|FG001|Overall Study|Protocol Violation|2|||
160625567|NCT03557775|580009630|FG000|Overall Study|Withdrawal by Subject|1|||
160671140|NCT00112437|580176490|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
160671141|NCT00112437|580176491|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671142|NCT00112437|580176492|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671143|NCT00112437|580176493|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671144|NCT00112437|580176494|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671145|NCT00112437|580176495|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671146|NCT00112437|580176496|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671147|NCT00112437|580176497|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671148|NCT00112437|580176498|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671149|NCT00112437|580176499|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671150|NCT00112437|580176500|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671151|NCT00112437|580176501|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671152|NCT00112437|580176502|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671153|NCT00112437|580176503|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671154|NCT00112437|580176504|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671155|NCT00112437|580176505|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671156|NCT00112437|580176506|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671157|NCT00112437|580176507|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671158|NCT00112437|580176508|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671159|NCT00112437|580176509|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671160|NCT00112437|580176510|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671161|NCT00112437|580176511|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671162|NCT00112437|580176512|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
160671163|NCT00112437|580176487|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671164|NCT00112437|580176488|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671165|NCT00112437|580176489|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671166|NCT00112437|580176490|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671167|NCT00112437|580176491|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
160671168|NCT00112437|580176492|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671169|NCT00112437|580176493|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671170|NCT00112437|580176494|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671171|NCT00112437|580176495|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671172|NCT00112437|580176496|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671173|NCT00112437|580176497|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671174|NCT00112437|580176498|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671175|NCT00112437|580176499|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671176|NCT00112437|580176500|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671177|NCT00112437|580176501|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671178|NCT00112437|580176502|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671179|NCT00112437|580176503|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671180|NCT00112437|580176504|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671181|NCT00112437|580176505|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671182|NCT00112437|580176506|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671183|NCT00112437|580176507|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671184|NCT00112437|580176508|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671185|NCT00112437|580176509|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671186|NCT00112437|580176510|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671187|NCT00112437|580176511|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671188|NCT00112437|580176512|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160671189|NCT00112437|580176487|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
160671190|NCT00112437|580176488|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
160671191|NCT00112437|580176489|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
160671192|NCT00112437|580176490|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
160671193|NCT00112437|580176491|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
160671194|NCT00112437|580176492|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
160671195|NCT00112437|580176493|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
160671196|NCT00112437|580176494|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
160671197|NCT00112437|580176495|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
160671198|NCT00112437|580176496|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
160671199|NCT00112437|580176497|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
160671200|NCT00112437|580176498|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
160671201|NCT00112437|580176499|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
160671202|NCT00112437|580176500|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
160671203|NCT00112437|580176501|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
160671204|NCT00112437|580176502|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
160671205|NCT00112437|580176503|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
160671206|NCT00112437|580176504|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
160671207|NCT00112437|580176505|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
160671208|NCT00112437|580176506|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
160671209|NCT00112437|580176507|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
160671210|NCT00112437|580176508|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
160671211|NCT00112437|580176509|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
160671212|NCT00112437|580176510|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
160625568|NCT03557775|580009631|FG001|Overall Study|Withdrawal by Subject|2|||
160625569|NCT03557775|580009632|FG002|Overall Study|Withdrawal by Subject|4|||
160625570|NCT03557775|580009630|FG000|Overall Study|Physician Decision|0|||
160625571|NCT03557775|580009631|FG001|Overall Study|Physician Decision|1|||
160625572|NCT03557775|580009632|FG002|Overall Study|Physician Decision|0|||
160625573|NCT00308555|580009633|FG000|Overall Study|Withdrawal by Subject|1|||
160625574|NCT00308555|580009634|FG001|Overall Study|Withdrawal by Subject|0|||
160671213|NCT00112437|580176511|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
160671214|NCT00112437|580176512|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
160671215|NCT00112437|580176487|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671216|NCT00112437|580176488|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671217|NCT00112437|580176489|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671218|NCT00112437|580176490|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671219|NCT00112437|580176491|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671220|NCT00112437|580176492|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
160671221|NCT00112437|580176493|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
160671222|NCT00112437|580176494|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671223|NCT00112437|580176495|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671224|NCT00112437|580176496|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
160671225|NCT00112437|580176497|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671226|NCT00112437|580176498|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671227|NCT00112437|580176499|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671228|NCT00112437|580176500|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671229|NCT00112437|580176501|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160625575|NCT00308555|580009633|FG000|Overall Study|Physician Decision|2|||
160671230|NCT00112437|580176502|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671231|NCT00112437|580176503|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671232|NCT00112437|580176504|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671233|NCT00112437|580176505|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671234|NCT00112437|580176506|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671235|NCT00112437|580176507|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671236|NCT00112437|580176508|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671237|NCT00112437|580176509|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671238|NCT00112437|580176510|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671239|NCT00112437|580176511|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671240|NCT00112437|580176512|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160671241|NCT00112437|580176487|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671242|NCT00112437|580176488|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671243|NCT00112437|580176489|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671244|NCT00112437|580176490|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671245|NCT00112437|580176491|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671246|NCT00112437|580176492|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671247|NCT00112437|580176493|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671248|NCT00112437|580176494|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671249|NCT00112437|580176495|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
160671250|NCT00112437|580176496|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671251|NCT00112437|580176497|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671252|NCT00112437|580176498|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671253|NCT00112437|580176499|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671254|NCT00112437|580176500|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671255|NCT00112437|580176501|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671256|NCT00112437|580176502|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671257|NCT00112437|580176503|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671258|NCT00112437|580176504|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671259|NCT00112437|580176505|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671260|NCT00112437|580176506|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671261|NCT00112437|580176507|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671262|NCT00112437|580176508|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671263|NCT00112437|580176509|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160625576|NCT00308555|580009634|FG001|Overall Study|Physician Decision|0|||
160625577|NCT00234533|580009643|FG000|Overall Study|Withdrawal by Subject|6|||
160625578|NCT00234533|580009643|FG000|Overall Study|Adverse Event|2|||
160671264|NCT00112437|580176510|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671265|NCT00112437|580176511|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671266|NCT00112437|580176512|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
160671267|NCT00112437|580176487|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671268|NCT00112437|580176488|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671269|NCT00112437|580176489|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671270|NCT00112437|580176490|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671271|NCT00112437|580176491|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671272|NCT00112437|580176492|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671273|NCT00112437|580176493|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671274|NCT00112437|580176494|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671275|NCT00112437|580176495|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
160671276|NCT00112437|580176496|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671277|NCT00112437|580176497|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671278|NCT00112437|580176498|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671279|NCT00112437|580176499|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671280|NCT00112437|580176500|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671281|NCT00112437|580176501|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671282|NCT00112437|580176502|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671283|NCT00112437|580176503|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671284|NCT00112437|580176504|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671285|NCT00112437|580176505|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671286|NCT00112437|580176506|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671287|NCT00112437|580176507|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671288|NCT00112437|580176508|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671289|NCT00112437|580176509|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671290|NCT00112437|580176510|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671291|NCT00112437|580176511|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671292|NCT00112437|580176512|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
160671293|NCT00112437|580176487|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671294|NCT00112437|580176488|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671295|NCT00112437|580176489|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671296|NCT00112437|580176490|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671297|NCT00112437|580176491|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671298|NCT00112437|580176492|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
160671299|NCT00112437|580176493|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
160671300|NCT00112437|580176494|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
160671301|NCT00112437|580176495|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
160671302|NCT00112437|580176496|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
160671303|NCT00112437|580176497|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671304|NCT00112437|580176498|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671305|NCT00112437|580176499|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671306|NCT00112437|580176500|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671307|NCT00112437|580176501|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671308|NCT00112437|580176502|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671309|NCT00112437|580176503|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671310|NCT00112437|580176504|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671311|NCT00112437|580176505|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671312|NCT00112437|580176506|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671313|NCT00112437|580176507|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671314|NCT00112437|580176508|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671315|NCT00112437|580176509|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671316|NCT00112437|580176510|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671317|NCT00112437|580176511|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671318|NCT00112437|580176512|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
160671319|NCT00112437|580176487|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671320|NCT00112437|580176488|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671321|NCT00112437|580176489|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671322|NCT00112437|580176490|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671323|NCT00112437|580176491|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671324|NCT00112437|580176492|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671325|NCT00112437|580176493|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671326|NCT00112437|580176494|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671327|NCT00112437|580176495|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671328|NCT00112437|580176496|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
160671329|NCT00112437|580176497|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671330|NCT00112437|580176498|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671331|NCT00112437|580176499|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160625579|NCT00234533|580009643|FG000|Overall Study|Enrolled but not treated|3|||
160625580|NCT04338685|580009644|FG000|Overall Study|Death|3|||
160625581|NCT04338685|580009645|FG001|Overall Study|Death|4|||
160625582|NCT04338685|580009646|FG002|Overall Study|Death|2|||
160625583|NCT04338685|580009647|FG003|Overall Study|Death|4|||
160625584|NCT04338685|580009648|FG004|Overall Study|Death|4|||
160625585|NCT04338685|580009649|FG005|Overall Study|Death|8|||
160625586|NCT04338685|580009650|FG006|Overall Study|Death|1|||
160625587|NCT04338685|580009651|FG007|Overall Study|Death|0|||
160625588|NCT04338685|580009652|FG008|Overall Study|Death|0|||
160625589|NCT04338685|580009644|FG000|Overall Study|Study terminated by Sponsor|0|||
160625590|NCT04338685|580009645|FG001|Overall Study|Study terminated by Sponsor|0|||
160625591|NCT04338685|580009646|FG002|Overall Study|Study terminated by Sponsor|1|||
160625592|NCT04338685|580009647|FG003|Overall Study|Study terminated by Sponsor|4|||
160625593|NCT04338685|580009648|FG004|Overall Study|Study terminated by Sponsor|0|||
160625594|NCT04338685|580009649|FG005|Overall Study|Study terminated by Sponsor|5|||
160625595|NCT04338685|580009650|FG006|Overall Study|Study terminated by Sponsor|2|||
160625596|NCT04338685|580009651|FG007|Overall Study|Study terminated by Sponsor|4|||
160625597|NCT04338685|580009652|FG008|Overall Study|Study terminated by Sponsor|1|||
160625598|NCT04338685|580009644|FG000|Overall Study|Withdrawal by Subject|1|||
160625599|NCT04338685|580009645|FG001|Overall Study|Withdrawal by Subject|2|||
160625600|NCT04338685|580009646|FG002|Overall Study|Withdrawal by Subject|0|||
160625601|NCT04338685|580009647|FG003|Overall Study|Withdrawal by Subject|2|||
160625602|NCT04338685|580009648|FG004|Overall Study|Withdrawal by Subject|0|||
160625603|NCT04338685|580009649|FG005|Overall Study|Withdrawal by Subject|5|||
160625604|NCT04338685|580009650|FG006|Overall Study|Withdrawal by Subject|1|||
160625605|NCT04338685|580009651|FG007|Overall Study|Withdrawal by Subject|1|||
160625606|NCT04338685|580009652|FG008|Overall Study|Withdrawal by Subject|0|||
160625607|NCT02967055|580009653|FG000|Overall Study|Excluded|40|||
160625608|NCT02967055|580009653|FG000|Overall Study|Screen fail|3|||
160625609|NCT02967055|580009653|FG000|Overall Study|Lost to Follow-up|2|||
160625610|NCT02967055|580009653|FG000|Overall Study|Stopped due to side effects|3|||
160625611|NCT02967055|580009653|FG000|Overall Study|Stopped due to drug cost|1|||
160625612|NCT00752206|580009654|FG000|Overall Study|Disease progression|8|||
160625613|NCT00752206|580009655|FG001|Overall Study|Disease progression|11|||
160625614|NCT00752206|580009654|FG000|Overall Study|Pregnancy|1|||
160625615|NCT00752206|580009655|FG001|Overall Study|Pregnancy|0|||
160625616|NCT01683565|580009658|FG000|Overall Study|Lost to Follow-up|2|||
160625617|NCT01683565|580009659|FG001|Overall Study|Lost to Follow-up|0|||
160625618|NCT01683565|580009658|FG000|Overall Study|Discontinued Intervention|1|||
160625619|NCT01683565|580009659|FG001|Overall Study|Discontinued Intervention|1|||
160625620|NCT00764465|580009660|FG000|Overall Study|Adverse Event|2|||
160625621|NCT00764465|580009661|FG001|Overall Study|Adverse Event|0|||
160625622|NCT00764465|580009662|FG002|Overall Study|Adverse Event|0|||
160625623|NCT00764465|580009663|FG003|Overall Study|Adverse Event|1|||
160625624|NCT00764465|580009664|FG004|Overall Study|Adverse Event|1|||
160625625|NCT00764465|580009665|FG005|Overall Study|Adverse Event|1|||
160625626|NCT00764465|580009660|FG000|Overall Study|Withdrawal by Subject|0|||
160625627|NCT00764465|580009661|FG001|Overall Study|Withdrawal by Subject|1|||
160625628|NCT00764465|580009662|FG002|Overall Study|Withdrawal by Subject|1|||
160625629|NCT00764465|580009663|FG003|Overall Study|Withdrawal by Subject|0|||
160625630|NCT00764465|580009664|FG004|Overall Study|Withdrawal by Subject|0|||
160625631|NCT00764465|580009665|FG005|Overall Study|Withdrawal by Subject|0|||
160625632|NCT00674440|580009666|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
160625633|NCT00674440|580009666|FG000|Overall Study|did not have surgery, so unevaluable|7|||
160625634|NCT00674440|580009666|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
160625635|NCT01195662|580009667|FG000|Double Blind Treatment Period|Adverse Event|4|||
160625636|NCT01195662|580009668|FG001|Double Blind Treatment Period|Adverse Event|1|||
160625637|NCT01195662|580009669|FG002|Double Blind Treatment Period|Adverse Event|2|||
160625638|NCT01195662|580009667|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
160625639|NCT01195662|580009668|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
160625640|NCT01195662|580009669|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
160625641|NCT01195662|580009667|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
160625642|NCT01195662|580009668|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
160625643|NCT01195662|580009669|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
160625644|NCT01195662|580009667|FG000|Double Blind Treatment Period|Administrative reason|2|||
160625645|NCT01195662|580009668|FG001|Double Blind Treatment Period|Administrative reason|1|||
160625646|NCT01195662|580009669|FG002|Double Blind Treatment Period|Administrative reason|1|||
160625647|NCT01195662|580009667|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
160625648|NCT01195662|580009668|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
160625649|NCT01195662|580009669|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
160625650|NCT01195662|580009667|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
160625651|NCT01195662|580009668|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
160625652|NCT01195662|580009669|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
160671332|NCT00112437|580176500|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160625653|NCT01195662|580009667|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
160625654|NCT01195662|580009668|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
160625655|NCT01195662|580009669|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
160625656|NCT01195662|580009667|FG000|Double Blind Treatment Period|Non-specified|3|||
160625657|NCT01195662|580009668|FG001|Double Blind Treatment Period|Non-specified|0|||
160625658|NCT01195662|580009669|FG002|Double Blind Treatment Period|Non-specified|0|||
160625659|NCT01195662|580009667|FG000|Double Blind Treatment Period|Missing disposition information|0|||
160625660|NCT01195662|580009668|FG001|Double Blind Treatment Period|Missing disposition information|1|||
160625661|NCT01195662|580009669|FG002|Double Blind Treatment Period|Missing disposition information|1|||
160625662|NCT01195662|580009667|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
160625663|NCT01195662|580009668|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
160625664|NCT01195662|580009669|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
160625665|NCT01195662|580009667|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
160625666|NCT01195662|580009668|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
160625667|NCT01195662|580009669|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
160625668|NCT01590810|580009670|FG000|Overall Study|Physician Decision|0|||
160625669|NCT01590810|580009671|FG001|Overall Study|Physician Decision|1|||
160625670|NCT01590810|580009672|FG002|Overall Study|Physician Decision|1|||
160625671|NCT01590810|580009673|FG003|Overall Study|Physician Decision|0|||
160625672|NCT01590810|580009674|FG004|Overall Study|Physician Decision|0|||
160625673|NCT01087944|580009683|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
160625674|NCT01087944|580009684|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
160625675|NCT01087944|580009683|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
160625676|NCT01087944|580009684|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
160625677|NCT01731600|580009687|FG000|Overall Study|Adverse Event|2|||
160625678|NCT01731600|580009688|FG001|Overall Study|Adverse Event|0|||
160625679|NCT01731600|580009687|FG000|Overall Study|Withdrawal criteria|1|||
160625680|NCT01731600|580009688|FG001|Overall Study|Withdrawal criteria|0|||
160625681|NCT01731600|580009687|FG000|Overall Study|Other reasons|3|||
160625682|NCT01731600|580009688|FG001|Overall Study|Other reasons|0|||
160625683|NCT03039699|580009689|FG000|Overall Study|Incorrect inclusion|5|||
160625684|NCT03039699|580009690|FG001|Overall Study|Incorrect inclusion|4|||
160625685|NCT03039699|580009689|FG000|Overall Study|Lack of data to assess study endpoint|5|||
160625686|NCT03039699|580009690|FG001|Overall Study|Lack of data to assess study endpoint|3|||
160625687|NCT03039699|580009689|FG000|Overall Study|Bacterial infection|12|||
160625688|NCT03039699|580009690|FG001|Overall Study|Bacterial infection|28|||
160625689|NCT03280628|580011827|FG000|Overall Study|Lost to Follow-up|8|||
160625690|NCT03280628|580011828|FG001|Overall Study|Lost to Follow-up|6|||
160625691|NCT03280628|580011829|FG002|Overall Study|Lost to Follow-up|11|||
160625692|NCT02163759|580011836|FG000|Overall Study|Withdrawal by Subject|1|||
160625693|NCT02163759|580011837|FG001|Overall Study|Withdrawal by Subject|5|||
160625694|NCT02163759|580011838|FG002|Overall Study|Withdrawal by Subject|1|||
160625695|NCT02163759|580011836|FG000|Overall Study|Adverse Event|0|||
160625696|NCT02163759|580011837|FG001|Overall Study|Adverse Event|0|||
160625697|NCT02163759|580011838|FG002|Overall Study|Adverse Event|1|||
160625698|NCT02163759|580011836|FG000|Overall Study|Death|0|||
160625699|NCT02163759|580011837|FG001|Overall Study|Death|0|||
160625700|NCT02163759|580011838|FG002|Overall Study|Death|1|||
160625701|NCT01479777|580011843|FG000|Overall Study|Physician Decision|2|||
160625702|NCT00451191|580011844|FG000|Overall Study|withdrawal or received alternate tx|15|||
160625703|NCT00451191|580011845|FG001|Overall Study|withdrawal or received alternate tx|11|||
160625704|NCT00656669|580011853|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
160625705|NCT00656669|580011853|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
160625706|NCT00656669|580011853|FG000|AC (Cycles 6-9)|Adverse Event|1|||
160625707|NCT00656669|580011853|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
160625708|NCT03575806|580011858|FG000|Overall Study|Withdrawal by Subject|0|||
160625709|NCT03575806|580011859|FG001|Overall Study|Withdrawal by Subject|2|||
160625710|NCT03575806|580011858|FG000|Overall Study|Protocol Violation|0|||
160625711|NCT03575806|580011859|FG001|Overall Study|Protocol Violation|2|||
160625712|NCT00219349|580011860|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
160625713|NCT00219349|580011860|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
160625714|NCT00219349|580011860|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
160625715|NCT00219349|580011860|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
160625716|NCT01241591|580011862|FG000|Overall Study|Lack of Efficacy|5|||
160625717|NCT01241591|580011863|FG001|Overall Study|Lack of Efficacy|2|||
160625718|NCT01241591|580011864|FG002|Overall Study|Lack of Efficacy|2|||
160625719|NCT01241591|580011865|FG003|Overall Study|Lack of Efficacy|3|||
160625720|NCT01241591|580011862|FG000|Overall Study|Protocol Violation|5|||
160625721|NCT01241591|580011863|FG001|Overall Study|Protocol Violation|2|||
160625722|NCT01241591|580011864|FG002|Overall Study|Protocol Violation|3|||
160625723|NCT01241591|580011865|FG003|Overall Study|Protocol Violation|0|||
160625724|NCT01241591|580011862|FG000|Overall Study|Lost to Follow-up|1|||
160671333|NCT00112437|580176501|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160625725|NCT01241591|580011863|FG001|Overall Study|Lost to Follow-up|2|||
160671334|NCT00112437|580176502|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671335|NCT00112437|580176503|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671336|NCT00112437|580176504|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671337|NCT00112437|580176505|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671338|NCT00112437|580176506|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671339|NCT00112437|580176507|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671340|NCT00112437|580176508|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671341|NCT00112437|580176509|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671342|NCT00112437|580176510|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671343|NCT00112437|580176511|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671344|NCT00112437|580176512|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160671345|NCT00112437|580176487|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671346|NCT00112437|580176488|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671347|NCT00112437|580176489|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671348|NCT00112437|580176490|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671349|NCT00112437|580176491|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671350|NCT00112437|580176492|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671351|NCT00112437|580176493|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671352|NCT00112437|580176494|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671353|NCT00112437|580176495|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671354|NCT00112437|580176496|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
160671355|NCT00112437|580176497|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671356|NCT00112437|580176498|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671357|NCT00112437|580176499|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671358|NCT00112437|580176500|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671359|NCT00112437|580176501|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671360|NCT00112437|580176502|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671361|NCT00112437|580176503|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671362|NCT00112437|580176504|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671363|NCT00112437|580176505|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671364|NCT00112437|580176506|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671365|NCT00112437|580176507|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671366|NCT00112437|580176508|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671367|NCT00112437|580176509|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671368|NCT00112437|580176510|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671369|NCT00112437|580176511|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671370|NCT00112437|580176512|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
160671371|NCT00112437|580176487|FG000|Year 2 (12-Month Extension)|Moved|0|||
160671372|NCT00112437|580176488|FG001|Year 2 (12-Month Extension)|Moved|0|||
160671373|NCT00112437|580176489|FG002|Year 2 (12-Month Extension)|Moved|0|||
160671374|NCT00112437|580176490|FG003|Year 2 (12-Month Extension)|Moved|0|||
160671375|NCT00112437|580176491|FG004|Year 2 (12-Month Extension)|Moved|0|||
160671376|NCT00112437|580176492|FG005|Year 2 (12-Month Extension)|Moved|0|||
160671377|NCT00112437|580176493|FG006|Year 2 (12-Month Extension)|Moved|0|||
160671378|NCT00112437|580176494|FG007|Year 2 (12-Month Extension)|Moved|0|||
160671379|NCT00112437|580176495|FG008|Year 2 (12-Month Extension)|Moved|0|||
160671380|NCT00112437|580176496|FG009|Year 2 (12-Month Extension)|Moved|1|||
160671381|NCT00112437|580176497|FG010|Year 2 (12-Month Extension)|Moved|0|||
160671382|NCT00112437|580176498|FG011|Year 2 (12-Month Extension)|Moved|0|||
160671383|NCT00112437|580176499|FG012|Year 2 (12-Month Extension)|Moved|0|||
160671384|NCT00112437|580176500|FG013|Year 2 (12-Month Extension)|Moved|0|||
160671385|NCT00112437|580176501|FG014|Year 2 (12-Month Extension)|Moved|0|||
160671386|NCT00112437|580176502|FG015|Year 2 (12-Month Extension)|Moved|0|||
160671387|NCT00112437|580176503|FG016|Year 2 (12-Month Extension)|Moved|0|||
160671388|NCT00112437|580176504|FG017|Year 2 (12-Month Extension)|Moved|0|||
160671389|NCT00112437|580176505|FG018|Year 2 (12-Month Extension)|Moved|0|||
160671390|NCT00112437|580176506|FG019|Year 2 (12-Month Extension)|Moved|0|||
160671391|NCT00112437|580176507|FG020|Year 2 (12-Month Extension)|Moved|0|||
160671392|NCT00112437|580176508|FG021|Year 2 (12-Month Extension)|Moved|0|||
160671393|NCT00112437|580176509|FG022|Year 2 (12-Month Extension)|Moved|0|||
160671394|NCT00112437|580176510|FG023|Year 2 (12-Month Extension)|Moved|0|||
160671395|NCT00112437|580176511|FG024|Year 2 (12-Month Extension)|Moved|0|||
160671396|NCT00112437|580176512|FG025|Year 2 (12-Month Extension)|Moved|0|||
160671397|NCT00112437|580176487|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
160671398|NCT00112437|580176488|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
160671399|NCT00112437|580176489|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
160671400|NCT00112437|580176490|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
160671401|NCT00112437|580176491|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
160671402|NCT00112437|580176492|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
160671403|NCT00112437|580176493|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
160671404|NCT00112437|580176494|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
160671405|NCT00112437|580176495|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
160671406|NCT00112437|580176496|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
160671407|NCT00112437|580176497|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
160671408|NCT00112437|580176498|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
160671409|NCT00112437|580176499|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
160671410|NCT00112437|580176500|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
160671411|NCT00112437|580176501|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
160671412|NCT00112437|580176502|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
160671413|NCT00112437|580176503|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
160671414|NCT00112437|580176504|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
160671415|NCT00112437|580176505|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
160671416|NCT00112437|580176506|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
160671417|NCT00112437|580176507|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
160671418|NCT00112437|580176508|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
160671419|NCT00112437|580176509|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
160671420|NCT00112437|580176510|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
160671421|NCT00112437|580176511|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
160671422|NCT00112437|580176512|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
160671423|NCT00112437|580176487|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671424|NCT00112437|580176488|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671425|NCT00112437|580176489|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671426|NCT00112437|580176490|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671427|NCT00112437|580176491|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671428|NCT00112437|580176492|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671429|NCT00112437|580176493|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671430|NCT00112437|580176494|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160625726|NCT01241591|580011864|FG002|Overall Study|Lost to Follow-up|2|||
160625727|NCT01241591|580011865|FG003|Overall Study|Lost to Follow-up|2|||
160625728|NCT01241591|580011862|FG000|Overall Study|Screen Failure|3|||
160625729|NCT01241591|580011863|FG001|Overall Study|Screen Failure|2|||
160625730|NCT01241591|580011864|FG002|Overall Study|Screen Failure|1|||
160625731|NCT01241591|580011865|FG003|Overall Study|Screen Failure|0|||
160625732|NCT01241591|580011862|FG000|Overall Study|Withdrawal by Subject|6|||
160625733|NCT01241591|580011863|FG001|Overall Study|Withdrawal by Subject|4|||
160625734|NCT01241591|580011864|FG002|Overall Study|Withdrawal by Subject|2|||
160625735|NCT01241591|580011865|FG003|Overall Study|Withdrawal by Subject|2|||
160625736|NCT01241591|580011862|FG000|Overall Study|Other|0|||
160625737|NCT01241591|580011863|FG001|Overall Study|Other|1|||
160625738|NCT01241591|580011864|FG002|Overall Study|Other|0|||
160625739|NCT01241591|580011865|FG003|Overall Study|Other|1|||
160625740|NCT01241591|580011862|FG000|Overall Study|Adverse Event|3|||
160671431|NCT00112437|580176495|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671432|NCT00112437|580176496|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671433|NCT00112437|580176497|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671434|NCT00112437|580176498|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
160671435|NCT00112437|580176499|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671436|NCT00112437|580176500|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
160671437|NCT00112437|580176501|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671438|NCT00112437|580176502|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
160671439|NCT00112437|580176503|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671440|NCT00112437|580176504|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671441|NCT00112437|580176505|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
160671442|NCT00112437|580176506|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671443|NCT00112437|580176507|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671444|NCT00112437|580176508|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160625741|NCT01241591|580011863|FG001|Overall Study|Adverse Event|11|||
160625742|NCT01241591|580011864|FG002|Overall Study|Adverse Event|12|||
160625743|NCT01241591|580011865|FG003|Overall Study|Adverse Event|4|||
160625744|NCT01945034|580011866|FG000|Overall Study|Medication Error|0|||
160671445|NCT00112437|580176509|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671446|NCT00112437|580176510|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671447|NCT00112437|580176511|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671448|NCT00112437|580176512|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
160671449|NCT00112437|580176487|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671450|NCT00112437|580176488|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671451|NCT00112437|580176489|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671452|NCT00112437|580176490|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671453|NCT00112437|580176491|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671454|NCT00112437|580176492|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671455|NCT00112437|580176493|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671456|NCT00112437|580176494|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671457|NCT00112437|580176495|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160625745|NCT01945034|580011867|FG001|Overall Study|Medication Error|1|||
160671458|NCT00112437|580176496|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160625746|NCT01945034|580011868|FG002|Overall Study|Medication Error|0|||
160625747|NCT01945034|580011866|FG000|Overall Study|Withdrawal by Subject|0|||
160625748|NCT01945034|580011867|FG001|Overall Study|Withdrawal by Subject|3|||
160625749|NCT01945034|580011868|FG002|Overall Study|Withdrawal by Subject|1|||
160625750|NCT01945034|580011866|FG000|Overall Study|Other|0|||
160625751|NCT01945034|580011867|FG001|Overall Study|Other|1|||
160625752|NCT01945034|580011868|FG002|Overall Study|Other|3|||
160625753|NCT01945034|580011866|FG000|Overall Study|Lost to Follow-up|0|||
160625754|NCT01945034|580011867|FG001|Overall Study|Lost to Follow-up|0|||
160625755|NCT01945034|580011868|FG002|Overall Study|Lost to Follow-up|2|||
160625756|NCT01945034|580011866|FG000|Overall Study|Protocol Violation|1|||
160625757|NCT01945034|580011867|FG001|Overall Study|Protocol Violation|0|||
160625758|NCT01945034|580011868|FG002|Overall Study|Protocol Violation|1|||
160625759|NCT01300741|580011872|FG000|Overall Study|Lens deposits|1|||
160625760|NCT01300741|580011872|FG000|Overall Study|Lost to Follow-up|1|||
160625761|NCT01300741|580011872|FG000|Overall Study|Discomfort|1|||
160625762|NCT04854421|580011873|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
160625763|NCT04854421|580011874|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
160625764|NCT00718809|580011876|FG000|Overall Study|Disease progression|9|||
160625765|NCT00718809|580011877|FG001|Overall Study|Disease progression|7|||
160625766|NCT00718809|580011876|FG000|Overall Study|Adverse Event|1|||
160625767|NCT00718809|580011877|FG001|Overall Study|Adverse Event|1|||
160625768|NCT00718809|580011876|FG000|Overall Study|Withdrawal by Subject|0|||
160625769|NCT00718809|580011877|FG001|Overall Study|Withdrawal by Subject|1|||
160625770|NCT00718809|580011876|FG000|Overall Study|Lost to Follow-up|1|||
160625771|NCT00718809|580011877|FG001|Overall Study|Lost to Follow-up|0|||
160625772|NCT00718809|580011876|FG000|Overall Study|Noncompliance|1|||
160625773|NCT00718809|580011877|FG001|Overall Study|Noncompliance|0|||
160625774|NCT00463385|580011878|FG000|Overall Study|Other|4|||
160625775|NCT00463385|580011879|FG001|Overall Study|Other|3|||
160625776|NCT00463385|580011880|FG002|Overall Study|Other|6|||
160625777|NCT00463385|580011881|FG003|Overall Study|Other|4|||
160625778|NCT00463385|580011878|FG000|Overall Study|Adverse Event|5|||
160625779|NCT00463385|580011879|FG001|Overall Study|Adverse Event|8|||
160625780|NCT00463385|580011880|FG002|Overall Study|Adverse Event|4|||
160625781|NCT00463385|580011881|FG003|Overall Study|Adverse Event|2|||
160625782|NCT00463385|580011878|FG000|Overall Study|Lack of Efficacy|6|||
160625783|NCT00463385|580011879|FG001|Overall Study|Lack of Efficacy|6|||
160625784|NCT00463385|580011880|FG002|Overall Study|Lack of Efficacy|7|||
160625785|NCT00463385|580011881|FG003|Overall Study|Lack of Efficacy|9|||
160625786|NCT00463385|580011878|FG000|Overall Study|Withdrawal by Subject|3|||
160625787|NCT00463385|580011879|FG001|Overall Study|Withdrawal by Subject|3|||
160625788|NCT00463385|580011880|FG002|Overall Study|Withdrawal by Subject|3|||
160625789|NCT00463385|580011881|FG003|Overall Study|Withdrawal by Subject|4|||
160625790|NCT00463385|580011878|FG000|Overall Study|Lost to Follow-up|0|||
160625791|NCT00463385|580011879|FG001|Overall Study|Lost to Follow-up|0|||
160625792|NCT00463385|580011880|FG002|Overall Study|Lost to Follow-up|0|||
160625793|NCT00463385|580011881|FG003|Overall Study|Lost to Follow-up|1|||
160625794|NCT00463385|580011878|FG000|Overall Study|Death|2|||
160625795|NCT00463385|580011879|FG001|Overall Study|Death|1|||
160625796|NCT00463385|580011880|FG002|Overall Study|Death|2|||
160625797|NCT00463385|580011881|FG003|Overall Study|Death|0|||
160625798|NCT00463385|580011878|FG000|Overall Study|Missing|2|||
160625799|NCT00463385|580011879|FG001|Overall Study|Missing|0|||
160625800|NCT00463385|580011880|FG002|Overall Study|Missing|0|||
160625801|NCT00463385|580011881|FG003|Overall Study|Missing|2|||
160625802|NCT00463385|580011878|FG000|Overall Study|1 participant received commercial drug|0|||
160625803|NCT00463385|580011879|FG001|Overall Study|1 participant received commercial drug|1|||
160625804|NCT00463385|580011880|FG002|Overall Study|1 participant received commercial drug|0|||
160625805|NCT00463385|580011881|FG003|Overall Study|1 participant received commercial drug|0|||
160625806|NCT00726882|580011882|FG000|Overall Study|Withdrawal by Subject|5|||
160625807|NCT00726882|580011882|FG000|Overall Study|Lost to Follow-up|7|||
160625808|NCT00726882|580011882|FG000|Overall Study|Other|10|||
160625809|NCT00344968|580011883|FG000|Overall Study|Adverse Event|5|||
160625810|NCT00344968|580011884|FG001|Overall Study|Adverse Event|4|||
160625811|NCT00344968|580011885|FG002|Overall Study|Adverse Event|15|||
160625812|NCT00344968|580011883|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160625813|NCT00344968|580011884|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160625814|NCT00344968|580011885|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
160625815|NCT00344968|580011883|FG000|Overall Study|Protocol Violation|2|||
160625816|NCT00344968|580011884|FG001|Overall Study|Protocol Violation|2|||
160671459|NCT00112437|580176497|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671460|NCT00112437|580176498|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671461|NCT00112437|580176499|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671462|NCT00112437|580176500|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671463|NCT00112437|580176501|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671464|NCT00112437|580176502|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
160671465|NCT00112437|580176503|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671466|NCT00112437|580176504|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671467|NCT00112437|580176505|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671468|NCT00112437|580176506|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671469|NCT00112437|580176507|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671470|NCT00112437|580176508|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671471|NCT00112437|580176509|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671472|NCT00112437|580176510|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671473|NCT00112437|580176511|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671474|NCT00112437|580176512|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160671475|NCT00112437|580176487|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671476|NCT00112437|580176488|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671477|NCT00112437|580176489|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671478|NCT00112437|580176490|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671479|NCT00112437|580176491|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671480|NCT00112437|580176492|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671481|NCT00112437|580176493|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671482|NCT00112437|580176494|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671483|NCT00112437|580176495|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671484|NCT00112437|580176496|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671485|NCT00112437|580176497|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671486|NCT00112437|580176498|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671487|NCT00112437|580176499|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671488|NCT00112437|580176500|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671489|NCT00112437|580176501|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671490|NCT00112437|580176502|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
160671491|NCT00112437|580176503|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671492|NCT00112437|580176504|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671493|NCT00112437|580176505|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671494|NCT00112437|580176506|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671495|NCT00112437|580176507|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671496|NCT00112437|580176508|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671497|NCT00112437|580176509|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671498|NCT00112437|580176510|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671499|NCT00112437|580176511|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671500|NCT00112437|580176512|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
160671501|NCT00112437|580176487|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671502|NCT00112437|580176488|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671503|NCT00112437|580176489|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671504|NCT00112437|580176490|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671505|NCT00112437|580176491|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671506|NCT00112437|580176492|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671507|NCT00112437|580176493|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671508|NCT00112437|580176494|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671509|NCT00112437|580176495|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671510|NCT00112437|580176496|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671511|NCT00112437|580176497|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671512|NCT00112437|580176498|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
160671513|NCT00112437|580176499|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671514|NCT00112437|580176500|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671515|NCT00112437|580176501|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
160671516|NCT00112437|580176502|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671517|NCT00112437|580176503|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671518|NCT00112437|580176504|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671519|NCT00112437|580176505|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671520|NCT00112437|580176506|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671521|NCT00112437|580176507|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671522|NCT00112437|580176508|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671523|NCT00112437|580176509|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671524|NCT00112437|580176510|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671525|NCT00112437|580176511|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671526|NCT00112437|580176512|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160671527|NCT00112437|580176487|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671528|NCT00112437|580176488|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671529|NCT00112437|580176489|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671530|NCT00112437|580176490|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671531|NCT00112437|580176491|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671532|NCT00112437|580176492|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671533|NCT00112437|580176493|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671534|NCT00112437|580176494|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671535|NCT00112437|580176495|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671536|NCT00112437|580176496|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671537|NCT00112437|580176497|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
160671538|NCT00112437|580176498|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
160671539|NCT00112437|580176499|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671540|NCT00112437|580176500|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671541|NCT00112437|580176501|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671542|NCT00112437|580176502|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671543|NCT00112437|580176503|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671544|NCT00112437|580176504|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671545|NCT00112437|580176505|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671546|NCT00112437|580176506|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671547|NCT00112437|580176507|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671548|NCT00112437|580176508|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671549|NCT00112437|580176509|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671550|NCT00112437|580176510|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671551|NCT00112437|580176511|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671552|NCT00112437|580176512|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160671553|NCT00112437|580176487|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671554|NCT00112437|580176488|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671555|NCT00112437|580176489|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671556|NCT00112437|580176490|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671557|NCT00112437|580176491|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671558|NCT00112437|580176492|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671559|NCT00112437|580176493|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671560|NCT00112437|580176494|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671561|NCT00112437|580176495|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671562|NCT00112437|580176496|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671563|NCT00112437|580176497|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671564|NCT00112437|580176498|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671565|NCT00112437|580176499|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671566|NCT00112437|580176500|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671567|NCT00112437|580176501|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671568|NCT00112437|580176502|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671569|NCT00112437|580176503|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671570|NCT00112437|580176504|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671571|NCT00112437|580176505|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671572|NCT00112437|580176506|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671573|NCT00112437|580176507|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
160671574|NCT00112437|580176508|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
160671575|NCT00112437|580176509|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671576|NCT00112437|580176510|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671577|NCT00112437|580176511|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671578|NCT00112437|580176512|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
160671579|NCT00112437|580176487|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671580|NCT00112437|580176488|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671581|NCT00112437|580176489|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671582|NCT00112437|580176490|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671583|NCT00112437|580176491|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671584|NCT00112437|580176492|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671585|NCT00112437|580176493|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671586|NCT00112437|580176494|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671587|NCT00112437|580176495|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671588|NCT00112437|580176496|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671589|NCT00112437|580176497|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671590|NCT00112437|580176498|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671591|NCT00112437|580176499|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671592|NCT00112437|580176500|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671593|NCT00112437|580176501|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671594|NCT00112437|580176502|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671595|NCT00112437|580176503|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671596|NCT00112437|580176504|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671597|NCT00112437|580176505|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671598|NCT00112437|580176506|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671599|NCT00112437|580176507|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
160671600|NCT00112437|580176508|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671601|NCT00112437|580176509|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671602|NCT00112437|580176510|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671603|NCT00112437|580176511|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671604|NCT00112437|580176512|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160671605|NCT00112437|580176487|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671606|NCT00112437|580176488|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671607|NCT00112437|580176489|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671608|NCT00112437|580176490|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671609|NCT00112437|580176491|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671610|NCT00112437|580176492|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671611|NCT00112437|580176493|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671612|NCT00112437|580176494|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671613|NCT00112437|580176495|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671614|NCT00112437|580176496|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671615|NCT00112437|580176497|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671616|NCT00112437|580176498|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671617|NCT00112437|580176499|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671618|NCT00112437|580176500|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671619|NCT00112437|580176501|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671620|NCT00112437|580176502|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671621|NCT00112437|580176503|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671622|NCT00112437|580176504|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671623|NCT00112437|580176505|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671624|NCT00112437|580176506|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671625|NCT00112437|580176507|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671626|NCT00112437|580176508|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
160671627|NCT00112437|580176509|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671628|NCT00112437|580176510|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671629|NCT00112437|580176511|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671630|NCT00112437|580176512|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160671631|NCT00112437|580176487|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671632|NCT00112437|580176488|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671633|NCT00112437|580176489|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671634|NCT00112437|580176490|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671635|NCT00112437|580176491|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671636|NCT00112437|580176492|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671637|NCT00112437|580176493|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671638|NCT00112437|580176494|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671639|NCT00112437|580176495|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671640|NCT00112437|580176496|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671641|NCT00112437|580176497|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671642|NCT00112437|580176498|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671643|NCT00112437|580176499|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671644|NCT00112437|580176500|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671645|NCT00112437|580176501|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671646|NCT00112437|580176502|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671647|NCT00112437|580176503|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671648|NCT00112437|580176504|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671649|NCT00112437|580176505|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671650|NCT00112437|580176506|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671651|NCT00112437|580176507|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671652|NCT00112437|580176508|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
160671653|NCT00112437|580176509|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671654|NCT00112437|580176510|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671655|NCT00112437|580176511|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671656|NCT00112437|580176512|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
160671657|NCT00112437|580176487|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671658|NCT00112437|580176488|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671659|NCT00112437|580176489|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160625817|NCT00344968|580011885|FG002|Overall Study|Protocol Violation|5|||
160625818|NCT00344968|580011883|FG000|Overall Study|Withdrawal by Subject|14|||
160625819|NCT00344968|580011884|FG001|Overall Study|Withdrawal by Subject|31|||
160625820|NCT00344968|580011885|FG002|Overall Study|Withdrawal by Subject|27|||
160625821|NCT00344968|580011883|FG000|Overall Study|Lost to Follow-up|24|||
160625822|NCT00344968|580011884|FG001|Overall Study|Lost to Follow-up|37|||
160625823|NCT00344968|580011885|FG002|Overall Study|Lost to Follow-up|37|||
160625824|NCT00344968|580011883|FG000|Overall Study|Death|11|||
160625825|NCT00344968|580011884|FG001|Overall Study|Death|27|||
160625826|NCT00344968|580011885|FG002|Overall Study|Death|31|||
160625827|NCT00344968|580011883|FG000|Overall Study|Other|0|||
160625828|NCT00344968|580011884|FG001|Overall Study|Other|1|||
160625829|NCT00344968|580011885|FG002|Overall Study|Other|0|||
160625830|NCT02526017|580011886|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
160625831|NCT02526017|580011887|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
160625832|NCT02526017|580011888|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
160625833|NCT02526017|580011889|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
160625834|NCT02526017|580011890|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
160625835|NCT02526017|580011891|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
160625836|NCT02526017|580011892|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
160625837|NCT02526017|580011893|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
160625838|NCT02526017|580011894|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
160625839|NCT01548573|580011895|FG000|Overall Study|Death|3|||
160625840|NCT01548573|580011895|FG000|Overall Study|Withdrawal by Subject|2|||
160625841|NCT03358407|580011903|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
160625842|NCT03358407|580011904|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
160625843|NCT03358407|580011905|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
160625844|NCT03358407|580011906|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
160625845|NCT03358407|580011907|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
160625846|NCT03358407|580011908|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
160625847|NCT03358407|580011909|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
160625848|NCT03358407|580011910|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
160625849|NCT03358407|580011911|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
160625850|NCT03358407|580011912|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
160625851|NCT03358407|580011903|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625852|NCT03358407|580011904|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625853|NCT03358407|580011905|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625854|NCT03358407|580011906|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625855|NCT03358407|580011907|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
160625856|NCT03358407|580011908|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625857|NCT03358407|580011909|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625858|NCT03358407|580011910|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625859|NCT03358407|580011911|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625860|NCT03358407|580011912|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625861|NCT03358407|580011903|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
160625862|NCT03358407|580011904|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
160625863|NCT03358407|580011905|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
160625864|NCT03358407|580011906|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
160625865|NCT03358407|580011907|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
160625866|NCT03358407|580011908|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
160625867|NCT03358407|580011909|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
160625868|NCT03358407|580011910|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
160625869|NCT03358407|580011911|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
160625870|NCT03358407|580011912|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
160625871|NCT03358407|580011903|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
160625872|NCT03358407|580011904|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
160625873|NCT03358407|580011905|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
160625874|NCT03358407|580011906|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
160625875|NCT03358407|580011907|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
160625876|NCT03358407|580011908|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
160625877|NCT03358407|580011909|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
160625878|NCT03358407|580011910|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
160625879|NCT03358407|580011911|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
160625880|NCT03358407|580011912|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
160625881|NCT03358407|580011903|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625882|NCT03358407|580011904|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160671660|NCT00112437|580176490|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671661|NCT00112437|580176491|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671662|NCT00112437|580176492|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671663|NCT00112437|580176493|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671664|NCT00112437|580176494|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671665|NCT00112437|580176495|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671666|NCT00112437|580176496|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671667|NCT00112437|580176497|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671668|NCT00112437|580176498|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671669|NCT00112437|580176499|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671670|NCT00112437|580176500|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671671|NCT00112437|580176501|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671672|NCT00112437|580176502|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671673|NCT00112437|580176503|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671674|NCT00112437|580176504|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671675|NCT00112437|580176505|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671676|NCT00112437|580176506|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671677|NCT00112437|580176507|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
160671678|NCT00112437|580176508|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
160671679|NCT00112437|580176509|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671680|NCT00112437|580176510|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671681|NCT00112437|580176511|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671682|NCT00112437|580176512|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160671683|NCT00112437|580176487|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671684|NCT00112437|580176488|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671685|NCT00112437|580176489|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671686|NCT00112437|580176490|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671687|NCT00112437|580176491|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671688|NCT00112437|580176492|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671689|NCT00112437|580176493|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671690|NCT00112437|580176494|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671691|NCT00112437|580176495|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671692|NCT00112437|580176496|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160625883|NCT03358407|580011905|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625884|NCT03358407|580011906|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625885|NCT03358407|580011907|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625886|NCT03358407|580011908|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
160625887|NCT03358407|580011909|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
160625888|NCT03358407|580011910|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625889|NCT03358407|580011911|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625890|NCT03358407|580011912|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
160625891|NCT03358407|580011903|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
160625892|NCT03358407|580011904|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
160625893|NCT03358407|580011905|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
160625894|NCT03358407|580011906|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
160625895|NCT03358407|580011907|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
160625896|NCT03358407|580011908|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
160625897|NCT03358407|580011909|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
160625898|NCT03358407|580011910|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
160625899|NCT03358407|580011911|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
160625900|NCT03358407|580011912|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
160625901|NCT00483574|580011913|FG000|Overall Study|Adverse Event|6|||
160625902|NCT00483574|580011914|FG001|Overall Study|Adverse Event|0|||
160625903|NCT00483574|580011913|FG000|Overall Study|Protocol Violation|28|||
160625904|NCT00483574|580011914|FG001|Overall Study|Protocol Violation|9|||
160625905|NCT00483574|580011913|FG000|Overall Study|Lost to Follow-up|16|||
160625906|NCT00483574|580011914|FG001|Overall Study|Lost to Follow-up|4|||
160625907|NCT00483574|580011913|FG000|Overall Study|Withdrawal by Subject|52|||
160625908|NCT00483574|580011914|FG001|Overall Study|Withdrawal by Subject|0|||
160625909|NCT03605758|580011915|FG000|Overall Study|Lost to Follow-up|2|||
160625910|NCT03605758|580011916|FG001|Overall Study|Lost to Follow-up|1|||
160625911|NCT03605758|580011915|FG000|Overall Study|Illness|0|||
160625912|NCT03605758|580011916|FG001|Overall Study|Illness|1|||
160625913|NCT03605758|580011915|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
160625914|NCT03605758|580011916|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
160625915|NCT04753606|580011919|FG000|Overall Study|Adverse Event|1|||
160671693|NCT00112437|580176497|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671694|NCT00112437|580176498|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671695|NCT00112437|580176499|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671696|NCT00112437|580176500|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671697|NCT00112437|580176501|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671698|NCT00112437|580176502|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160625916|NCT04753606|580011920|FG001|Overall Study|Adverse Event|0|||
160625917|NCT04753606|580011921|FG002|Overall Study|Adverse Event|0|||
160625918|NCT00489411|580011922|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
160625919|NCT00489411|580011923|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
160625920|NCT00489411|580011922|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
160625921|NCT00489411|580011923|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
160625922|NCT00489411|580011922|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
160625923|NCT00489411|580011923|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
160625924|NCT00489411|580011922|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
160625925|NCT00489411|580011923|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
160625926|NCT00489411|580011922|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
160625927|NCT00489411|580011923|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
160625928|NCT01748162|580011924|FG000|Overall Study|no additional croup episodes to evaluate|2|||
160625929|NCT01748162|580011925|FG001|Overall Study|no additional croup episodes to evaluate|2|||
160625930|NCT01748162|580011924|FG000|Overall Study|participant consented but did not begin|0|||
160625931|NCT01748162|580011925|FG001|Overall Study|participant consented but did not begin|1|||
160625932|NCT01748162|580011924|FG000|Overall Study|reasons not available|3|||
160625933|NCT01748162|580011925|FG001|Overall Study|reasons not available|2|||
160625934|NCT03219372|580011926|FG000|Overall Study|Withdrawal by Subject|1|||
160625935|NCT03219372|580011927|FG001|Overall Study|Withdrawal by Subject|0|||
160625936|NCT03841331|580011928|FG000|Overall Study|Withdrawal by Subject|4|||
160625937|NCT03841331|580011929|FG001|Overall Study|Withdrawal by Subject|9|||
160625938|NCT03841331|580011928|FG000|Overall Study|Lost to Follow-up|5|||
160625939|NCT03841331|580011929|FG001|Overall Study|Lost to Follow-up|1|||
160625940|NCT04145531|580011930|FG000|Part A|Adverse Event|2|||
160625941|NCT04145531|580011931|FG001|Part A|Adverse Event|12|||
160625942|NCT04145531|580011932|FG002|Part A|Adverse Event|6|||
160625943|NCT04145531|580011933|FG003|Part A|Adverse Event|0|||
160625944|NCT04145531|580011930|FG000|Part A|Death|1|||
160625945|NCT04145531|580011931|FG001|Part A|Death|2|||
160625946|NCT04145531|580011932|FG002|Part A|Death|0|||
160625947|NCT04145531|580011933|FG003|Part A|Death|0|||
160625948|NCT04145531|580011930|FG000|Part A|Physician Decision|2|||
160625949|NCT04145531|580011931|FG001|Part A|Physician Decision|5|||
160625950|NCT04145531|580011932|FG002|Part A|Physician Decision|2|||
160625951|NCT04145531|580011933|FG003|Part A|Physician Decision|0|||
160625952|NCT04145531|580011930|FG000|Part A|Progressive disease|0|||
160625953|NCT04145531|580011931|FG001|Part A|Progressive disease|2|||
160625954|NCT04145531|580011932|FG002|Part A|Progressive disease|1|||
160625955|NCT04145531|580011933|FG003|Part A|Progressive disease|0|||
160625956|NCT04145531|580011930|FG000|Part A|Protocol deviation|0|||
160625957|NCT04145531|580011931|FG001|Part A|Protocol deviation|0|||
160625958|NCT04145531|580011932|FG002|Part A|Protocol deviation|1|||
160625959|NCT04145531|580011933|FG003|Part A|Protocol deviation|0|||
160625960|NCT04145531|580011930|FG000|Part A|Withdrawal by parent or guardian|1|||
160625961|NCT04145531|580011931|FG001|Part A|Withdrawal by parent or guardian|0|||
160625962|NCT04145531|580011932|FG002|Part A|Withdrawal by parent or guardian|0|||
160625963|NCT04145531|580011933|FG003|Part A|Withdrawal by parent or guardian|0|||
160625964|NCT04145531|580011930|FG000|Part A|Withdrawal by participant|0|||
160625965|NCT04145531|580011931|FG001|Part A|Withdrawal by participant|0|||
160625966|NCT04145531|580011932|FG002|Part A|Withdrawal by participant|1|||
160625967|NCT04145531|580011933|FG003|Part A|Withdrawal by participant|0|||
160625968|NCT04145531|580011930|FG000|Part A|Other|0|||
160625969|NCT04145531|580011931|FG001|Part A|Other|0|||
160625970|NCT04145531|580011932|FG002|Part A|Other|1|||
160625971|NCT04145531|580011933|FG003|Part A|Other|0|||
160625972|NCT04145531|580011930|FG000|Part B|Adverse Event|0|||
160625973|NCT04145531|580011931|FG001|Part B|Adverse Event|0|||
160625974|NCT04145531|580011932|FG002|Part B|Adverse Event|0|||
160625975|NCT04145531|580011933|FG003|Part B|Adverse Event|21|||
160625976|NCT04145531|580011930|FG000|Part B|Physician Decision|0|||
160625977|NCT04145531|580011931|FG001|Part B|Physician Decision|0|||
160625978|NCT04145531|580011932|FG002|Part B|Physician Decision|0|||
160625979|NCT04145531|580011933|FG003|Part B|Physician Decision|7|||
160625980|NCT04145531|580011930|FG000|Part B|Progressive disease|0|||
160625981|NCT04145531|580011931|FG001|Part B|Progressive disease|0|||
160625982|NCT04145531|580011932|FG002|Part B|Progressive disease|0|||
160625983|NCT04145531|580011933|FG003|Part B|Progressive disease|1|||
160625984|NCT04145531|580011930|FG000|Part B|Recurrent disease|0|||
160625985|NCT04145531|580011931|FG001|Part B|Recurrent disease|0|||
160625986|NCT04145531|580011932|FG002|Part B|Recurrent disease|0|||
160625987|NCT04145531|580011933|FG003|Part B|Recurrent disease|1|||
160625988|NCT04145531|580011930|FG000|Part B|Withdrawal by parent or guardian|0|||
160625989|NCT04145531|580011931|FG001|Part B|Withdrawal by parent or guardian|0|||
160519556|NCT00600886|579631109|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
160519557|NCT00600886|579631110|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
160519558|NCT00600886|579631109|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
160519559|NCT00600886|579631110|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
160519560|NCT00600886|579631109|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
160519561|NCT00600886|579631110|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
160519562|NCT00600886|579631109|FG000|Extension - Same Treatment (FAS)|Death|1|||
160519563|NCT00600886|579631110|FG001|Extension - Same Treatment (FAS)|Death|1|||
160519564|NCT00600886|579631109|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
160519565|NCT00600886|579631110|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
160519566|NCT00600886|579631109|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
160519567|NCT00600886|579631110|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
160519568|NCT00600886|579631109|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
160519569|NCT00600886|579631110|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
160519570|NCT00600886|579631109|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
160519571|NCT00600886|579631110|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
160519572|NCT00600886|579631109|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
160519573|NCT00600886|579631110|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
160519574|NCT00600886|579631109|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
160519575|NCT00600886|579631110|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
160519576|NCT00600886|579631109|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
160519577|NCT00600886|579631110|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
160519578|NCT00600886|579631109|FG000|Extension - After Crossover (CAS)|Death|1|||
160519579|NCT00600886|579631110|FG001|Extension - After Crossover (CAS)|Death|0|||
160519580|NCT01028027|579631111|FG000|Overall Study|Lost to Follow-up|4|||
160519581|NCT01028027|579631112|FG001|Overall Study|Lost to Follow-up|1|||
160519582|NCT01028027|579631111|FG000|Overall Study|Withdrawal by Subject|5|||
160519583|NCT01028027|579631112|FG001|Overall Study|Withdrawal by Subject|3|||
160519584|NCT01028027|579631111|FG000|Overall Study|Adverse Event|4|||
160519585|NCT01028027|579631112|FG001|Overall Study|Adverse Event|7|||
160519586|NCT01028027|579631111|FG000|Overall Study|Protocol Violation|3|||
160519587|NCT01028027|579631112|FG001|Overall Study|Protocol Violation|1|||
160519588|NCT01028027|579631111|FG000|Overall Study|Lack of Efficacy|0|||
160519589|NCT01028027|579631112|FG001|Overall Study|Lack of Efficacy|1|||
160519590|NCT04443153|579631115|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
160519591|NCT04443153|579631116|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
160519592|NCT04443153|579631115|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
160519593|NCT04443153|579631116|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
160519594|NCT04443153|579631115|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
160519595|NCT04443153|579631116|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
160519596|NCT04443153|579631115|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
160519597|NCT04443153|579631116|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
160519598|NCT03035201|579631120|FG000|Overall Study|Death|9|||
160519599|NCT03035201|579631121|FG001|Overall Study|Death|12|||
160519600|NCT03035201|579631122|FG002|Overall Study|Death|9|||
160519601|NCT03035201|579631123|FG003|Overall Study|Death|10|||
160519602|NCT03035201|579631120|FG000|Overall Study|Withdrawal by Subject|51|||
160519603|NCT03035201|579631121|FG001|Overall Study|Withdrawal by Subject|49|||
160519604|NCT03035201|579631122|FG002|Overall Study|Withdrawal by Subject|37|||
160519605|NCT03035201|579631123|FG003|Overall Study|Withdrawal by Subject|46|||
160519606|NCT03035201|579631120|FG000|Overall Study|Lost to Follow-up|67|||
160519607|NCT03035201|579631121|FG001|Overall Study|Lost to Follow-up|51|||
160519608|NCT03035201|579631122|FG002|Overall Study|Lost to Follow-up|64|||
160519609|NCT03035201|579631123|FG003|Overall Study|Lost to Follow-up|69|||
160519610|NCT05328167|579631131|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
160519611|NCT05328167|579631131|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
160519612|NCT03727438|579631132|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
160519613|NCT03727438|579631133|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
160519614|NCT03727438|579631132|FG000|Intervention Period|Excluded (health)|1|||
160519615|NCT03727438|579631133|FG001|Intervention Period|Excluded (health)|0|||
160519616|NCT03727438|579631132|FG000|Intervention Period|Withdrawal by Subject|3|||
160519617|NCT03727438|579631133|FG001|Intervention Period|Withdrawal by Subject|1|||
160519618|NCT03727438|579631132|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
160519619|NCT03727438|579631133|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
160519620|NCT03727438|579631132|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
160519621|NCT03727438|579631133|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
160519622|NCT03727438|579631132|FG000|8 Week Assessment|Withdrawal by Subject|6|||
160519623|NCT03727438|579631133|FG001|8 Week Assessment|Withdrawal by Subject|1|||
160519624|NCT03727438|579631132|FG000|6 mo Assessment|did not complete assessment|10|||
160519625|NCT03727438|579631133|FG001|6 mo Assessment|did not complete assessment|11|||
160671699|NCT00112437|580176503|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671700|NCT00112437|580176504|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671701|NCT00112437|580176505|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671702|NCT00112437|580176506|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671703|NCT00112437|580176507|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671704|NCT00112437|580176508|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671705|NCT00112437|580176509|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
160671706|NCT00112437|580176510|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
160671707|NCT00112437|580176511|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
160671708|NCT00112437|580176512|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
160671709|NCT00112437|580176487|FG000|Years 6-10 (60-Month Extension)|Death|0|||
160671710|NCT00112437|580176488|FG001|Years 6-10 (60-Month Extension)|Death|0|||
160671711|NCT00112437|580176489|FG002|Years 6-10 (60-Month Extension)|Death|0|||
160671712|NCT00112437|580176490|FG003|Years 6-10 (60-Month Extension)|Death|0|||
160671713|NCT00112437|580176491|FG004|Years 6-10 (60-Month Extension)|Death|0|||
160625990|NCT04145531|580011932|FG002|Part B|Withdrawal by parent or guardian|0|||
160625991|NCT04145531|580011933|FG003|Part B|Withdrawal by parent or guardian|3|||
160625992|NCT04145531|580011930|FG000|Part B|Withdrawal by participant|0|||
160625993|NCT04145531|580011931|FG001|Part B|Withdrawal by participant|0|||
160625994|NCT04145531|580011932|FG002|Part B|Withdrawal by participant|0|||
160625995|NCT04145531|580011933|FG003|Part B|Withdrawal by participant|1|||
160625996|NCT04145531|580011930|FG000|Part B|Other|0|||
160625997|NCT04145531|580011931|FG001|Part B|Other|0|||
160625998|NCT04145531|580011932|FG002|Part B|Other|0|||
160625999|NCT04145531|580011933|FG003|Part B|Other|1|||
160626000|NCT00442572|580011938|FG000|Overall Study|Relapse|8|||
160626001|NCT00442572|580011939|FG001|Overall Study|Relapse|1|||
160671714|NCT00112437|580176492|FG005|Years 6-10 (60-Month Extension)|Death|0|||
160671715|NCT00112437|580176493|FG006|Years 6-10 (60-Month Extension)|Death|0|||
160671716|NCT00112437|580176494|FG007|Years 6-10 (60-Month Extension)|Death|0|||
160671717|NCT00112437|580176495|FG008|Years 6-10 (60-Month Extension)|Death|0|||
160671718|NCT00112437|580176496|FG009|Years 6-10 (60-Month Extension)|Death|0|||
160671719|NCT00112437|580176497|FG010|Years 6-10 (60-Month Extension)|Death|0|||
160671720|NCT00112437|580176498|FG011|Years 6-10 (60-Month Extension)|Death|0|||
160671721|NCT00112437|580176499|FG012|Years 6-10 (60-Month Extension)|Death|0|||
160671722|NCT00112437|580176500|FG013|Years 6-10 (60-Month Extension)|Death|0|||
160671723|NCT00112437|580176501|FG014|Years 6-10 (60-Month Extension)|Death|0|||
160671724|NCT00112437|580176502|FG015|Years 6-10 (60-Month Extension)|Death|0|||
160671725|NCT00112437|580176503|FG016|Years 6-10 (60-Month Extension)|Death|0|||
160671726|NCT00112437|580176504|FG017|Years 6-10 (60-Month Extension)|Death|0|||
160671727|NCT00112437|580176505|FG018|Years 6-10 (60-Month Extension)|Death|0|||
160671728|NCT00112437|580176506|FG019|Years 6-10 (60-Month Extension)|Death|0|||
160671729|NCT00112437|580176507|FG020|Years 6-10 (60-Month Extension)|Death|0|||
160671730|NCT00112437|580176508|FG021|Years 6-10 (60-Month Extension)|Death|0|||
160671731|NCT00112437|580176509|FG022|Years 6-10 (60-Month Extension)|Death|0|||
160671732|NCT00112437|580176510|FG023|Years 6-10 (60-Month Extension)|Death|2|||
160671733|NCT00112437|580176511|FG024|Years 6-10 (60-Month Extension)|Death|0|||
160671734|NCT00112437|580176512|FG025|Years 6-10 (60-Month Extension)|Death|0|||
160671735|NCT00112437|580176487|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671736|NCT00112437|580176488|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671737|NCT00112437|580176489|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671738|NCT00112437|580176490|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671739|NCT00112437|580176491|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671740|NCT00112437|580176492|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671741|NCT00112437|580176493|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671742|NCT00112437|580176494|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160626002|NCT00442572|580011938|FG000|Overall Study|Lost to Follow-up|0|||
160626003|NCT00442572|580011939|FG001|Overall Study|Lost to Follow-up|1|||
160626004|NCT00442572|580011938|FG000|Overall Study|Withdrawal by Subject|0|||
160671743|NCT00112437|580176495|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160626005|NCT00442572|580011939|FG001|Overall Study|Withdrawal by Subject|1|||
160626006|NCT04366258|580011940|FG000|Baseline Assessments|Screen Failure|21|||
160626007|NCT04366258|580011940|FG000|Baseline Assessments|Early Termination|3|||
160671744|NCT00112437|580176496|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160626008|NCT00276458|580011942|FG000|Overall Study|Adverse Event|0|||
160626009|NCT00276458|580011943|FG001|Overall Study|Adverse Event|2|||
160626010|NCT00276458|580011942|FG000|Overall Study|Lost to Follow-up|2|||
160626011|NCT00276458|580011943|FG001|Overall Study|Lost to Follow-up|2|||
160671745|NCT00112437|580176497|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671746|NCT00112437|580176498|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671747|NCT00112437|580176499|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671748|NCT00112437|580176500|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671749|NCT00112437|580176501|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671750|NCT00112437|580176502|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671751|NCT00112437|580176503|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160626012|NCT00276458|580011942|FG000|Overall Study|Protocol Violation|4|||
160626013|NCT00276458|580011943|FG001|Overall Study|Protocol Violation|3|||
160626014|NCT00978120|580011946|FG000|Overall Study|Death|0|||
160626015|NCT00978120|580011947|FG001|Overall Study|Death|0|||
160626016|NCT00978120|580011948|FG002|Overall Study|Death|0|||
160626017|NCT00978120|580011949|FG003|Overall Study|Death|1|||
160626018|NCT00978120|580011946|FG000|Overall Study|Lost to Follow-up|0|||
160626019|NCT00978120|580011947|FG001|Overall Study|Lost to Follow-up|0|||
160626020|NCT00978120|580011948|FG002|Overall Study|Lost to Follow-up|3|||
160626021|NCT00978120|580011949|FG003|Overall Study|Lost to Follow-up|0|||
160626022|NCT00978120|580011946|FG000|Overall Study|Withdrawal by Subject|2|||
160626023|NCT00978120|580011947|FG001|Overall Study|Withdrawal by Subject|0|||
160626024|NCT00978120|580011948|FG002|Overall Study|Withdrawal by Subject|0|||
160626025|NCT00978120|580011949|FG003|Overall Study|Withdrawal by Subject|0|||
160626026|NCT00978120|580011946|FG000|Overall Study|Moved out of state|0|||
160626027|NCT00978120|580011947|FG001|Overall Study|Moved out of state|0|||
160626028|NCT00978120|580011948|FG002|Overall Study|Moved out of state|0|||
160626029|NCT00978120|580011949|FG003|Overall Study|Moved out of state|1|||
160626030|NCT03205046|580011951|FG000|Overall Study|Death|10|||
160626031|NCT03205046|580011952|FG001|Overall Study|Death|6|||
160626032|NCT03205046|580011951|FG000|Overall Study|Withdrawal by Subject|1|||
160626033|NCT03205046|580011952|FG001|Overall Study|Withdrawal by Subject|2|||
160626034|NCT03205046|580011951|FG000|Overall Study|Lost to Follow-up|0|||
160626035|NCT03205046|580011952|FG001|Overall Study|Lost to Follow-up|1|||
160626036|NCT03205046|580011951|FG000|Overall Study|Study terminated by sponsor|2|||
160626037|NCT03205046|580011952|FG001|Overall Study|Study terminated by sponsor|1|||
160626038|NCT01023815|580011953|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
160626039|NCT01023815|580011954|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
160626040|NCT01023815|580011955|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
160626041|NCT01023815|580011956|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
160626042|NCT01023815|580011953|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
160626043|NCT01023815|580011954|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
160626044|NCT01023815|580011955|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
160626045|NCT01023815|580011956|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
160626046|NCT01023815|580011953|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
160626047|NCT01023815|580011954|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
160626048|NCT01023815|580011955|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
160626049|NCT01023815|580011956|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
160626050|NCT01023815|580011953|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
160626051|NCT01023815|580011954|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
160626052|NCT01023815|580011955|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
160626053|NCT01023815|580011956|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
160626054|NCT01023815|580011953|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
160626055|NCT01023815|580011954|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
160626056|NCT01023815|580011955|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
160626057|NCT01023815|580011956|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
160626058|NCT01977625|580011960|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
160626059|NCT01977625|580011961|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
160626060|NCT01977625|580011960|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160626061|NCT01977625|580011961|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
160626062|NCT00634933|580011964|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
160626063|NCT00634933|580011965|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
160626064|NCT00634933|580011966|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
160626065|NCT00634933|580011967|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
160626066|NCT00634933|580011968|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
160626067|NCT00634933|580011964|FG000|Part A: Baseline to Week 24|Death|1|||
160626068|NCT00634933|580011965|FG001|Part A: Baseline to Week 24|Death|0|||
160626069|NCT00634933|580011966|FG002|Part A: Baseline to Week 24|Death|0|||
160626070|NCT00634933|580011967|FG003|Part A: Baseline to Week 24|Death|0|||
160626071|NCT00634933|580011968|FG004|Part A: Baseline to Week 24|Death|0|||
160626072|NCT00634933|580011964|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
160626073|NCT00634933|580011965|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
160626074|NCT00634933|580011966|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
160626075|NCT00634933|580011967|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
160626076|NCT00634933|580011968|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
160626077|NCT00634933|580011964|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
160626078|NCT00634933|580011965|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
160626079|NCT00634933|580011966|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
160626080|NCT00634933|580011967|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
160626081|NCT00634933|580011968|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
160626082|NCT00634933|580011964|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
160626083|NCT00634933|580011965|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
160626084|NCT00634933|580011966|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
160626085|NCT00634933|580011967|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
160626086|NCT00634933|580011968|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
160626087|NCT00634933|580011964|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
160626088|NCT00634933|580011965|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
160626089|NCT00634933|580011966|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
160626090|NCT00634933|580011967|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
160626091|NCT00634933|580011968|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
160626092|NCT00634933|580011964|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
160626093|NCT00634933|580011965|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
160626094|NCT00634933|580011966|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
160626095|NCT00634933|580011967|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
160626096|NCT00634933|580011968|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
160626097|NCT00634933|580011964|FG000|Part A: Baseline to Week 24|Other|1|||
160626098|NCT00634933|580011965|FG001|Part A: Baseline to Week 24|Other|8|||
160626099|NCT00634933|580011966|FG002|Part A: Baseline to Week 24|Other|5|||
160626100|NCT00634933|580011967|FG003|Part A: Baseline to Week 24|Other|0|||
160626101|NCT00634933|580011968|FG004|Part A: Baseline to Week 24|Other|0|||
160626102|NCT00634933|580011964|FG000|Between Part A and Part B|Physician Decision|0|||
160626103|NCT00634933|580011965|FG001|Between Part A and Part B|Physician Decision|1|||
160626104|NCT00634933|580011966|FG002|Between Part A and Part B|Physician Decision|0|||
160626105|NCT00634933|580011967|FG003|Between Part A and Part B|Physician Decision|0|||
160626106|NCT00634933|580011968|FG004|Between Part A and Part B|Physician Decision|0|||
160626107|NCT00634933|580011964|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
160626108|NCT00634933|580011965|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
160626109|NCT00634933|580011966|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
160626110|NCT00634933|580011967|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
160626111|NCT00634933|580011968|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
160626112|NCT00634933|580011964|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
160626113|NCT00634933|580011965|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
160626114|NCT00634933|580011966|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
160626115|NCT00634933|580011967|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
160626116|NCT00634933|580011968|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
160626117|NCT00634933|580011964|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
160626118|NCT00634933|580011965|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
160626119|NCT00634933|580011966|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
160626120|NCT00634933|580011967|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
160626121|NCT00634933|580011968|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
160626122|NCT00634933|580011964|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
160626123|NCT00634933|580011965|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
160626124|NCT00634933|580011966|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
160626125|NCT00634933|580011967|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
160626126|NCT00634933|580011968|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
160626127|NCT00634933|580011964|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
160626128|NCT00634933|580011965|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
160626129|NCT00634933|580011966|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
160626130|NCT00634933|580011967|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
160626131|NCT00634933|580011968|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
160626132|NCT00634933|580011964|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
160626133|NCT00634933|580011965|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
160626134|NCT00634933|580011966|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
160626135|NCT00634933|580011967|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
160626136|NCT00634933|580011968|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
160626137|NCT00634933|580011964|FG000|Part B: Week 24 to Week 52|Other|0|||
160626138|NCT00634933|580011965|FG001|Part B: Week 24 to Week 52|Other|0|||
160626139|NCT00634933|580011966|FG002|Part B: Week 24 to Week 52|Other|5|||
160626140|NCT00634933|580011967|FG003|Part B: Week 24 to Week 52|Other|0|||
160626141|NCT00634933|580011968|FG004|Part B: Week 24 to Week 52|Other|1|||
160626142|NCT00429026|580011969|FG000|Overall Study|Inevaluable for response.|40|||
160626143|NCT02304484|580011970|FG000|Overall Study|Death|9|||
160626144|NCT02304484|580011970|FG000|Overall Study|Withdrawal by Subject|14|||
160626145|NCT02304484|580011970|FG000|Overall Study|Lost to Follow-up|2|||
160626146|NCT01539512|580011971|FG000|Overall Study|Adverse Event|9|||
160626147|NCT01539512|580011972|FG001|Overall Study|Adverse Event|7|||
160626148|NCT01539512|580011971|FG000|Overall Study|Physician Decision|1|||
160626149|NCT01539512|580011972|FG001|Overall Study|Physician Decision|1|||
160626150|NCT01539512|580011971|FG000|Overall Study|Withdrawal by Subject|12|||
160626151|NCT01539512|580011972|FG001|Overall Study|Withdrawal by Subject|5|||
160626152|NCT01539512|580011971|FG000|Overall Study|Richter's Transformation|1|||
160626153|NCT01539512|580011972|FG001|Overall Study|Richter's Transformation|0|||
160626154|NCT03522506|580011973|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160626155|NCT03522506|580011974|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160626156|NCT03522506|580011975|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160626157|NCT03522506|580011976|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
160626158|NCT03522506|580011973|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
160626159|NCT03522506|580011974|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
160626160|NCT03522506|580011975|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
160626161|NCT03522506|580011976|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
160626162|NCT04365387|580011977|FG000|Overall Study|Adverse Event|4|||
160626163|NCT04365387|580011978|FG001|Overall Study|Adverse Event|2|||
160626164|NCT04365387|580011977|FG000|Overall Study|Participants request|14|||
160626165|NCT04365387|580011978|FG001|Overall Study|Participants request|14|||
160626166|NCT04365387|580011977|FG000|Overall Study|Lost to Follow-up|8|||
160626167|NCT04365387|580011978|FG001|Overall Study|Lost to Follow-up|5|||
160626168|NCT04365387|580011977|FG000|Overall Study|Protocol deviation|3|||
160626169|NCT04365387|580011978|FG001|Overall Study|Protocol deviation|4|||
160626170|NCT04365387|580011977|FG000|Overall Study|Participant compliance with visit schedule|1|||
160626171|NCT04365387|580011978|FG001|Overall Study|Participant compliance with visit schedule|0|||
160626172|NCT04365387|580011977|FG000|Overall Study|Participant incarcerated|1|||
160626173|NCT04365387|580011978|FG001|Overall Study|Participant incarcerated|0|||
160626174|NCT04365387|580011977|FG000|Overall Study|Participant moved out of town (relocated)|0|||
160626175|NCT04365387|580011978|FG001|Overall Study|Participant moved out of town (relocated)|1|||
160626176|NCT04365387|580011977|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
160626177|NCT04365387|580011978|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
160626178|NCT04365387|580011977|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
160626179|NCT04365387|580011978|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
160626180|NCT05770401|580011979|FG000|Overall Study|Lost to Follow-up|5|||
160626181|NCT05770401|580011980|FG001|Overall Study|Lost to Follow-up|4|||
160626182|NCT01298323|580011983|FG000|Overall Study|Adverse Event|2|||
160626183|NCT01298323|580011984|FG001|Overall Study|Adverse Event|4|||
160626184|NCT01298323|580011983|FG000|Overall Study|Death|11|||
160626185|NCT01298323|580011984|FG001|Overall Study|Death|16|||
160626186|NCT01298323|580011983|FG000|Overall Study|Lost to Follow-up|1|||
160626187|NCT01298323|580011984|FG001|Overall Study|Lost to Follow-up|0|||
160626188|NCT01298323|580011983|FG000|Overall Study|Withdrawal by Subject|6|||
160626189|NCT01298323|580011984|FG001|Overall Study|Withdrawal by Subject|3|||
160626190|NCT01298323|580011983|FG000|Overall Study|Protocol Violation|1|||
160626191|NCT01298323|580011984|FG001|Overall Study|Protocol Violation|0|||
160626192|NCT01298323|580011983|FG000|Overall Study|Other|10|||
160626193|NCT01298323|580011984|FG001|Overall Study|Other|9|||
160626194|NCT01298323|580011983|FG000|Overall Study|Ongoing|55|||
160626195|NCT01298323|580011984|FG001|Overall Study|Ongoing|55|||
160626196|NCT01298323|580011983|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160626197|NCT01298323|580011984|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160626198|NCT01761565|580011985|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
160626199|NCT02161380|580011986|FG000|Overall Study|Lost to Follow-up|0|||
160626200|NCT02161380|580011987|FG001|Overall Study|Lost to Follow-up|1|||
160626201|NCT02161380|580011988|FG002|Overall Study|Lost to Follow-up|0|||
160626202|NCT02161380|580011989|FG003|Overall Study|Lost to Follow-up|0|||
160626203|NCT02400281|580011991|FG000|Overall Study|Adverse Event|0|||
160626204|NCT02400281|580011992|FG001|Overall Study|Adverse Event|0|||
160626205|NCT02400281|580011993|FG002|Overall Study|Adverse Event|1|||
160626206|NCT02400281|580011994|FG003|Overall Study|Adverse Event|0|||
160626207|NCT02400281|580011995|FG004|Overall Study|Adverse Event|1|||
160626208|NCT02400281|580011996|FG005|Overall Study|Adverse Event|0|||
160626209|NCT02400281|580011991|FG000|Overall Study|Physician Decision|0|||
160626210|NCT02400281|580011992|FG001|Overall Study|Physician Decision|0|||
160626211|NCT02400281|580011993|FG002|Overall Study|Physician Decision|1|||
160626212|NCT02400281|580011994|FG003|Overall Study|Physician Decision|0|||
160626213|NCT02400281|580011995|FG004|Overall Study|Physician Decision|0|||
160626214|NCT02400281|580011996|FG005|Overall Study|Physician Decision|0|||
160626215|NCT03655951|580011997|FG000|Overall Study|Lost to Follow-up|39|||
160626216|NCT03655951|580011998|FG001|Overall Study|Lost to Follow-up|20|||
160626217|NCT03655951|580011997|FG000|Overall Study|Withdrawal by Subject|0|||
160626218|NCT03655951|580011998|FG001|Overall Study|Withdrawal by Subject|1|||
160626219|NCT01078974|580012003|FG000|Overall Study|Adverse Event|3|||
160626220|NCT01393444|580012004|FG000|Overall Study|Withdrawal by Subject|1|||
160626221|NCT01393444|580012004|FG000|Overall Study|Determined ineligible during screening.|2|||
160626222|NCT01397409|580012007|FG000|Stage 2|Adverse Event|0|||
160626223|NCT01397409|580012008|FG001|Stage 2|Adverse Event|0|||
160626224|NCT01397409|580012009|FG002|Stage 2|Adverse Event|0|||
160626225|NCT01397409|580012010|FG003|Stage 2|Adverse Event|0|||
160626226|NCT01397409|580012011|FG004|Stage 2|Adverse Event|6|||
160626227|NCT01397409|580012012|FG005|Stage 2|Adverse Event|3|||
160626228|NCT01397409|580012013|FG006|Stage 2|Adverse Event|0|||
160626229|NCT01397409|580012014|FG007|Stage 2|Adverse Event|0|||
160626230|NCT01397409|580012015|FG008|Stage 2|Adverse Event|0|||
160626231|NCT01397409|580012016|FG009|Stage 2|Adverse Event|0|||
160626232|NCT01397409|580012007|FG000|Stage 2|Personal Reasons|0|||
160626233|NCT01397409|580012008|FG001|Stage 2|Personal Reasons|0|||
160671752|NCT00112437|580176504|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671753|NCT00112437|580176505|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671754|NCT00112437|580176506|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671755|NCT00112437|580176507|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671756|NCT00112437|580176508|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671757|NCT00112437|580176509|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671758|NCT00112437|580176510|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671759|NCT00112437|580176511|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
160671760|NCT00112437|580176512|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
160671761|NCT00112437|580176487|FG000|Years 6-10 (60-Month Extension)|Other|0|||
160671762|NCT00112437|580176488|FG001|Years 6-10 (60-Month Extension)|Other|0|||
160671763|NCT00112437|580176489|FG002|Years 6-10 (60-Month Extension)|Other|0|||
160671764|NCT00112437|580176490|FG003|Years 6-10 (60-Month Extension)|Other|0|||
160671765|NCT00112437|580176491|FG004|Years 6-10 (60-Month Extension)|Other|0|||
160671766|NCT00112437|580176492|FG005|Years 6-10 (60-Month Extension)|Other|0|||
160671767|NCT00112437|580176493|FG006|Years 6-10 (60-Month Extension)|Other|0|||
160671768|NCT00112437|580176494|FG007|Years 6-10 (60-Month Extension)|Other|0|||
160671769|NCT00112437|580176495|FG008|Years 6-10 (60-Month Extension)|Other|0|||
160671770|NCT00112437|580176496|FG009|Years 6-10 (60-Month Extension)|Other|0|||
160671771|NCT00112437|580176497|FG010|Years 6-10 (60-Month Extension)|Other|0|||
160671772|NCT00112437|580176498|FG011|Years 6-10 (60-Month Extension)|Other|0|||
160671773|NCT00112437|580176499|FG012|Years 6-10 (60-Month Extension)|Other|0|||
160671774|NCT00112437|580176500|FG013|Years 6-10 (60-Month Extension)|Other|0|||
160671775|NCT00112437|580176501|FG014|Years 6-10 (60-Month Extension)|Other|0|||
160671776|NCT00112437|580176502|FG015|Years 6-10 (60-Month Extension)|Other|0|||
160671777|NCT00112437|580176503|FG016|Years 6-10 (60-Month Extension)|Other|0|||
160671778|NCT00112437|580176504|FG017|Years 6-10 (60-Month Extension)|Other|0|||
160671779|NCT00112437|580176505|FG018|Years 6-10 (60-Month Extension)|Other|0|||
160671780|NCT00112437|580176506|FG019|Years 6-10 (60-Month Extension)|Other|0|||
160671781|NCT00112437|580176507|FG020|Years 6-10 (60-Month Extension)|Other|0|||
160671782|NCT00112437|580176508|FG021|Years 6-10 (60-Month Extension)|Other|0|||
160671783|NCT00112437|580176509|FG022|Years 6-10 (60-Month Extension)|Other|0|||
160671784|NCT00112437|580176510|FG023|Years 6-10 (60-Month Extension)|Other|0|||
160671785|NCT00112437|580176511|FG024|Years 6-10 (60-Month Extension)|Other|1|||
160671786|NCT00112437|580176512|FG025|Years 6-10 (60-Month Extension)|Other|0|||
160671787|NCT00112437|580176487|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671788|NCT00112437|580176488|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671789|NCT00112437|580176489|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671790|NCT00112437|580176490|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671791|NCT00112437|580176491|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671792|NCT00112437|580176492|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671793|NCT00112437|580176493|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671794|NCT00112437|580176494|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671795|NCT00112437|580176495|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671796|NCT00112437|580176496|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671797|NCT00112437|580176497|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671798|NCT00112437|580176498|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671799|NCT00112437|580176499|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671800|NCT00112437|580176500|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671801|NCT00112437|580176501|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671802|NCT00112437|580176502|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671803|NCT00112437|580176503|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671804|NCT00112437|580176504|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671805|NCT00112437|580176505|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671806|NCT00112437|580176506|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671807|NCT00112437|580176507|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671808|NCT00112437|580176508|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671809|NCT00112437|580176509|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671810|NCT00112437|580176510|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
160671811|NCT00112437|580176511|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671812|NCT00112437|580176512|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160671813|NCT00112437|580176487|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671814|NCT00112437|580176488|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671815|NCT00112437|580176489|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671816|NCT00112437|580176490|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671817|NCT00112437|580176491|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671818|NCT00112437|580176492|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671819|NCT00112437|580176493|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671820|NCT00112437|580176494|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671821|NCT00112437|580176495|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671822|NCT00112437|580176496|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671823|NCT00112437|580176497|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671824|NCT00112437|580176498|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671825|NCT00112437|580176499|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671826|NCT00112437|580176500|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671827|NCT00112437|580176501|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671828|NCT00112437|580176502|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671829|NCT00112437|580176503|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671830|NCT00112437|580176504|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671831|NCT00112437|580176505|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671832|NCT00112437|580176506|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671833|NCT00112437|580176507|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671834|NCT00112437|580176508|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671835|NCT00112437|580176509|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
160671836|NCT00112437|580176510|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
160671837|NCT00112437|580176511|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160671838|NCT00112437|580176512|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
160671839|NCT01824576|580176515|FG000|Overall Study|Device deficiency|2|||
160671840|NCT03218787|580176519|FG000|Overall Study|Lost to Follow-up|12|||
160671841|NCT03218787|580176519|FG000|Overall Study|Withdrawal by Subject|72|||
160671842|NCT03218787|580176519|FG000|Overall Study|Physician Decision|11|||
160671843|NCT03218787|580176519|FG000|Overall Study|Death|111|||
160671844|NCT02896296|580176520|FG000|Overall Study|Adverse Event|1|||
160671845|NCT02896296|580176520|FG000|Overall Study|Lost to Follow-up|19|||
160671846|NCT02896296|580176520|FG000|Overall Study|Pregnancy|1|||
160671847|NCT02896296|580176520|FG000|Overall Study|Physician Decision|2|||
160671848|NCT02896296|580176520|FG000|Overall Study|Withdrawal by Subject|10|||
160626234|NCT01397409|580012009|FG002|Stage 2|Personal Reasons|0|||
160626235|NCT01397409|580012010|FG003|Stage 2|Personal Reasons|0|||
160626236|NCT01397409|580012011|FG004|Stage 2|Personal Reasons|1|||
160626237|NCT01397409|580012012|FG005|Stage 2|Personal Reasons|0|||
160626238|NCT01397409|580012013|FG006|Stage 2|Personal Reasons|0|||
160626239|NCT01397409|580012014|FG007|Stage 2|Personal Reasons|0|||
160626240|NCT01397409|580012015|FG008|Stage 2|Personal Reasons|0|||
160626241|NCT01397409|580012016|FG009|Stage 2|Personal Reasons|0|||
160626242|NCT01397409|580012007|FG000|Stage 2|Other Miscellaneous Reasons|0|||
160626243|NCT01397409|580012008|FG001|Stage 2|Other Miscellaneous Reasons|0|||
160626244|NCT01397409|580012009|FG002|Stage 2|Other Miscellaneous Reasons|0|||
160626245|NCT01397409|580012010|FG003|Stage 2|Other Miscellaneous Reasons|0|||
160626246|NCT01397409|580012011|FG004|Stage 2|Other Miscellaneous Reasons|1|||
160626247|NCT01397409|580012012|FG005|Stage 2|Other Miscellaneous Reasons|1|||
160626248|NCT01397409|580012013|FG006|Stage 2|Other Miscellaneous Reasons|0|||
160626249|NCT01397409|580012014|FG007|Stage 2|Other Miscellaneous Reasons|0|||
160626250|NCT01397409|580012015|FG008|Stage 2|Other Miscellaneous Reasons|0|||
160626251|NCT01397409|580012016|FG009|Stage 2|Other Miscellaneous Reasons|0|||
160626252|NCT01397409|580012007|FG000|Stage 3|Adverse Event|0|||
160626253|NCT01397409|580012008|FG001|Stage 3|Adverse Event|0|||
160626254|NCT01397409|580012009|FG002|Stage 3|Adverse Event|0|||
160626255|NCT01397409|580012010|FG003|Stage 3|Adverse Event|0|||
160626256|NCT01397409|580012011|FG004|Stage 3|Adverse Event|0|||
160626257|NCT01397409|580012012|FG005|Stage 3|Adverse Event|0|||
160626258|NCT01397409|580012013|FG006|Stage 3|Adverse Event|0|||
160626259|NCT01397409|580012014|FG007|Stage 3|Adverse Event|1|||
160626260|NCT01397409|580012015|FG008|Stage 3|Adverse Event|0|||
160626261|NCT01397409|580012016|FG009|Stage 3|Adverse Event|0|||
160626262|NCT01397409|580012007|FG000|Stage 3|Other Miscellaneous Reasons|0|||
160626263|NCT01397409|580012008|FG001|Stage 3|Other Miscellaneous Reasons|0|||
160626264|NCT01397409|580012009|FG002|Stage 3|Other Miscellaneous Reasons|0|||
160626265|NCT01397409|580012010|FG003|Stage 3|Other Miscellaneous Reasons|0|||
160626266|NCT01397409|580012011|FG004|Stage 3|Other Miscellaneous Reasons|0|||
160626267|NCT01397409|580012012|FG005|Stage 3|Other Miscellaneous Reasons|0|||
160626268|NCT01397409|580012013|FG006|Stage 3|Other Miscellaneous Reasons|0|||
160626269|NCT01397409|580012014|FG007|Stage 3|Other Miscellaneous Reasons|1|||
160626270|NCT01397409|580012015|FG008|Stage 3|Other Miscellaneous Reasons|0|||
160626271|NCT01397409|580012016|FG009|Stage 3|Other Miscellaneous Reasons|0|||
160626272|NCT03418727|580012017|FG000|Overall Study|Adverse Event|1|||
160626273|NCT03418727|580012018|FG001|Overall Study|Adverse Event|2|||
160626274|NCT03418727|580012019|FG002|Overall Study|Adverse Event|0|||
160626275|NCT03418727|580012017|FG000|Overall Study|Withdrawal by Subject|0|||
160626276|NCT03418727|580012018|FG001|Overall Study|Withdrawal by Subject|0|||
160626277|NCT03418727|580012019|FG002|Overall Study|Withdrawal by Subject|2|||
160671849|NCT02896296|580176520|FG000|Overall Study|Site closing|7|||
160671850|NCT02896296|580176520|FG000|Overall Study|Incarceration|1|||
160671851|NCT02896296|580176520|FG000|Overall Study|Relocation|1|||
160671852|NCT01841554|580176523|FG000|Overall Study|Death|7|||
160671853|NCT01841554|580176523|FG000|Overall Study|No Implantation|1|||
160671854|NCT01841554|580176523|FG000|Overall Study|Discontinued Follow Up|5|||
160671855|NCT01841554|580176523|FG000|Overall Study|Study exit due to secondary intervention|6|||
160671856|NCT04633564|580176524|FG000|Period 1|Adverse Event|28|||
160671857|NCT04633564|580176525|FG001|Period 1|Adverse Event|19|||
160671858|NCT04633564|580176524|FG000|Period 1|Death|8|||
160671859|NCT04633564|580176525|FG001|Period 1|Death|7|||
160671860|NCT04633564|580176524|FG000|Period 1|Lost to Follow-up|3|||
160671861|NCT04633564|580176525|FG001|Period 1|Lost to Follow-up|5|||
160671862|NCT04633564|580176524|FG000|Period 1|Physician Decision|4|||
160671863|NCT04633564|580176525|FG001|Period 1|Physician Decision|12|||
160671864|NCT04633564|580176524|FG000|Period 1|Protocol Violation|0|||
160671865|NCT04633564|580176525|FG001|Period 1|Protocol Violation|1|||
160671866|NCT04633564|580176524|FG000|Period 1|Withdrawal by Subject|10|||
160671867|NCT04633564|580176525|FG001|Period 1|Withdrawal by Subject|8|||
160671868|NCT04633564|580176524|FG000|Period 1|Progressive disease|47|||
160671869|NCT04633564|580176525|FG001|Period 1|Progressive disease|51|||
160671870|NCT04633564|580176524|FG000|Period 1|Terminated by Sponsor|8|||
160671871|NCT04633564|580176525|FG001|Period 1|Terminated by Sponsor|6|||
160671872|NCT04633564|580176524|FG000|Period 2|Adverse Event|3|||
160671873|NCT04633564|580176525|FG001|Period 2|Adverse Event|4|||
160671874|NCT04633564|580176524|FG000|Period 2|Death|0|||
160671875|NCT04633564|580176525|FG001|Period 2|Death|2|||
160671876|NCT04633564|580176524|FG000|Period 2|Lost to Follow-up|0|||
160671877|NCT04633564|580176525|FG001|Period 2|Lost to Follow-up|1|||
160671878|NCT04633564|580176524|FG000|Period 2|Physician Decision|2|||
160671879|NCT04633564|580176525|FG001|Period 2|Physician Decision|4|||
160671880|NCT04633564|580176524|FG000|Period 2|Withdrawal by Subject|5|||
160671881|NCT04633564|580176525|FG001|Period 2|Withdrawal by Subject|1|||
160671882|NCT04633564|580176524|FG000|Period 2|Progressive Disease|74|||
160671883|NCT04633564|580176525|FG001|Period 2|Progressive Disease|82|||
160671884|NCT04633564|580176524|FG000|Period 2|Terminated by Sponsor|9|||
160671885|NCT04633564|580176525|FG001|Period 2|Terminated by Sponsor|3|||
160671886|NCT04198363|580176526|FG000|Overall Study|Adverse Event|1|||
160671887|NCT04198363|580176527|FG001|Overall Study|Adverse Event|1|||
160671888|NCT04198363|580176526|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
160671889|NCT04198363|580176527|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
160671890|NCT04198363|580176526|FG000|Overall Study|Reason not Specified|1|||
160671891|NCT04198363|580176527|FG001|Overall Study|Reason not Specified|0|||
160671892|NCT03500094|580176532|FG000|Overall Study|Withdrawal by Subject|1|||
160671893|NCT03500094|580176532|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
160671894|NCT03500094|580176532|FG000|Overall Study|Lost to Follow-up|1|||
160671895|NCT03506633|580178550|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
160671896|NCT03506633|580178551|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
160671897|NCT00640341|580178554|FG000|Overall Study|Adverse Event|0|||
160671898|NCT00640341|580178555|FG001|Overall Study|Adverse Event|0|||
160671899|NCT00640341|580178556|FG002|Overall Study|Adverse Event|1|||
160671900|NCT00640341|580178554|FG000|Overall Study|Positive Slit Lamp Findings|0|||
160671901|NCT00640341|580178555|FG001|Overall Study|Positive Slit Lamp Findings|0|||
160671902|NCT00640341|580178556|FG002|Overall Study|Positive Slit Lamp Findings|1|||
160671903|NCT00640341|580178554|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
160626278|NCT01791543|580012020|FG000|Overall Study|Lost to Follow-up|1|||
160626279|NCT01791543|580012020|FG000|Overall Study|Adverse Event|1|||
160626280|NCT03145207|580012021|FG000|Overall Study|volunteer started taking allergy shots|1|||
160626281|NCT03145207|580012021|FG000|Overall Study|baseline blood pressure high|1|||
160626282|NCT01790633|580012022|FG000|Overall Study|Protocol Violation|1|||
160626283|NCT01790633|580012023|FG001|Overall Study|Protocol Violation|2|||
160626284|NCT01790633|580012022|FG000|Overall Study|Did not have serology performed|47|||
160626285|NCT01790633|580012023|FG001|Overall Study|Did not have serology performed|0|||
160626286|NCT01790633|580012022|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
160626287|NCT01790633|580012023|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
160626288|NCT01396434|580012024|FG000|Overall Study|Lost to Follow-up|1|||
160626289|NCT01396434|580012025|FG001|Overall Study|Lost to Follow-up|0|||
160626290|NCT01396434|580012026|FG002|Overall Study|Lost to Follow-up|0|||
160626291|NCT01396434|580012024|FG000|Overall Study|Other|10|||
160626292|NCT01396434|580012025|FG001|Overall Study|Other|0|||
160671904|NCT00640341|580178555|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
160671905|NCT00640341|580178556|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
160671906|NCT00640341|580178554|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
160671907|NCT00640341|580178555|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
160671908|NCT00640341|580178556|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
160671909|NCT00640341|580178554|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
160671910|NCT00640341|580178555|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
160671911|NCT00640341|580178556|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
160671912|NCT00640341|580178554|FG000|Overall Study|Lost to Follow-up|2|||
160671913|NCT00640341|580178555|FG001|Overall Study|Lost to Follow-up|0|||
160671914|NCT00640341|580178556|FG002|Overall Study|Lost to Follow-up|0|||
160671915|NCT00640341|580178554|FG000|Overall Study|Withdrawal by Subject|4|||
160671916|NCT00640341|580178555|FG001|Overall Study|Withdrawal by Subject|0|||
160671917|NCT00640341|580178556|FG002|Overall Study|Withdrawal by Subject|1|||
160671918|NCT00640341|580178554|FG000|Overall Study|Unacceptable Lens Movement|1|||
160671919|NCT00640341|580178555|FG001|Overall Study|Unacceptable Lens Movement|0|||
160671920|NCT00640341|580178556|FG002|Overall Study|Unacceptable Lens Movement|0|||
160671921|NCT00640341|580178554|FG000|Overall Study|Poor fit/Uncomfortable|4|||
160671922|NCT00640341|580178555|FG001|Overall Study|Poor fit/Uncomfortable|0|||
160671923|NCT00640341|580178556|FG002|Overall Study|Poor fit/Uncomfortable|0|||
160671924|NCT00640341|580178554|FG000|Overall Study|Ineligable at Baseline|5|||
160671925|NCT00640341|580178555|FG001|Overall Study|Ineligable at Baseline|3|||
160671926|NCT00640341|580178556|FG002|Overall Study|Ineligable at Baseline|2|||
160671927|NCT00640341|580178554|FG000|Overall Study|Adverse event and positive slit lamp|1|||
160671928|NCT00640341|580178555|FG001|Overall Study|Adverse event and positive slit lamp|0|||
160671929|NCT00640341|580178556|FG002|Overall Study|Adverse event and positive slit lamp|0|||
160671930|NCT03247686|580178559|FG000|Overall Study|Withdrawal by Subject|1|||
160671931|NCT03247686|580178560|FG001|Overall Study|Withdrawal by Subject|2|||
160671932|NCT01541215|580178563|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
160671933|NCT01541215|580178564|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
160671934|NCT01541215|580178563|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
160671935|NCT01541215|580178564|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
160671936|NCT01541215|580178563|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
160671937|NCT01541215|580178564|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
160671938|NCT01541215|580178563|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
160671939|NCT01541215|580178564|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
160671940|NCT01541215|580178563|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
160671941|NCT01541215|580178564|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
160671942|NCT01541215|580178563|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
160671943|NCT01541215|580178564|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
160671944|NCT02302716|580178565|FG000|Overall Study|Adverse Event|1|||
160671945|NCT02302716|580178566|FG001|Overall Study|Adverse Event|1|||
160671946|NCT02302716|580178565|FG000|Overall Study|Death|0|||
160671947|NCT02302716|580178566|FG001|Overall Study|Death|1|||
160671948|NCT02302716|580178565|FG000|Overall Study|Lack of Efficacy|0|||
160671949|NCT02302716|580178566|FG001|Overall Study|Lack of Efficacy|1|||
160671950|NCT02302716|580178565|FG000|Overall Study|Lost to Follow-up|2|||
160671951|NCT02302716|580178566|FG001|Overall Study|Lost to Follow-up|4|||
160671952|NCT02302716|580178565|FG000|Overall Study|Physician Decision|3|||
160671953|NCT02302716|580178566|FG001|Overall Study|Physician Decision|4|||
160671954|NCT02302716|580178565|FG000|Overall Study|Withdrawal by Subject|13|||
160671955|NCT02302716|580178566|FG001|Overall Study|Withdrawal by Subject|7|||
160671956|NCT02302716|580178565|FG000|Overall Study|Protocol Violation|0|||
160671957|NCT02302716|580178566|FG001|Overall Study|Protocol Violation|1|||
160671958|NCT00521586|580178574|FG000|Initial Vaccination (Year 0)|Subject request|8|||
160671959|NCT00521586|580178575|FG001|Initial Vaccination (Year 0)|Subject request|11|||
160671960|NCT00521586|580178574|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
160671961|NCT00521586|580178575|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
160671962|NCT00521586|580178574|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
160671963|NCT00521586|580178575|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
160671964|NCT00521586|580178574|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
160671965|NCT00521586|580178575|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
160671966|NCT00521586|580178574|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
160671967|NCT00521586|580178575|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
160671968|NCT00521586|580178574|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
160671969|NCT00521586|580178575|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
160671970|NCT00521586|580178574|FG000|Initial Vaccination (Year 0)|Death|1|||
160671971|NCT00521586|580178575|FG001|Initial Vaccination (Year 0)|Death|0|||
160671972|NCT00521586|580178574|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
160671973|NCT00521586|580178575|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
160671974|NCT00521586|580178574|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
160671975|NCT00521586|580178575|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
160671976|NCT00521586|580178574|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
160671977|NCT00521586|580178575|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
160671978|NCT00521586|580178574|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
160671979|NCT00521586|580178575|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
160671980|NCT00521586|580178574|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
160671981|NCT00521586|580178575|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
160671982|NCT00521586|580178574|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
160671983|NCT00521586|580178575|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
160671984|NCT00521586|580178574|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
160671985|NCT00521586|580178575|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
160671986|NCT00521586|580178574|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
160626293|NCT01396434|580012026|FG002|Overall Study|Other|0|||
160626294|NCT01740297|580013563|FG000|Overall Study|Withdrawal by Subject|4|||
160626295|NCT01740297|580013564|FG001|Overall Study|Withdrawal by Subject|16|||
160626296|NCT01740297|580013565|FG002|Overall Study|Withdrawal by Subject|17|||
160626297|NCT01740297|580013563|FG000|Overall Study|Death|8|||
160626298|NCT01740297|580013564|FG001|Overall Study|Death|46|||
160626299|NCT01740297|580013565|FG002|Overall Study|Death|40|||
160626300|NCT01740297|580013563|FG000|Overall Study|Lost to Follow-up|1|||
160626301|NCT01740297|580013564|FG001|Overall Study|Lost to Follow-up|2|||
160626302|NCT01740297|580013565|FG002|Overall Study|Lost to Follow-up|4|||
160626303|NCT00563706|580013570|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
160626304|NCT00563706|580013571|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
160626305|NCT00563706|580013572|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
160626306|NCT00563706|580013573|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
160626307|NCT00563706|580013574|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
160626308|NCT00563706|580013575|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
160626309|NCT00563706|580013576|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
160626310|NCT00563706|580013577|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
160626311|NCT00563706|580013578|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
160626312|NCT00563706|580013570|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
160626313|NCT00563706|580013571|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
160626314|NCT00563706|580013572|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
160626315|NCT00563706|580013573|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
160626316|NCT00563706|580013574|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
160626317|NCT00563706|580013575|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
160626318|NCT00563706|580013576|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
160626319|NCT00563706|580013577|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
160626320|NCT00563706|580013578|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
160626321|NCT00563706|580013570|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
160626322|NCT00563706|580013571|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
160626323|NCT00563706|580013572|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
160626324|NCT00563706|580013573|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
160626325|NCT00563706|580013574|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
160626326|NCT00563706|580013575|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
160626327|NCT00563706|580013576|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
160626328|NCT00563706|580013577|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
160626329|NCT00563706|580013578|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
160626330|NCT00563706|580013570|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
160626331|NCT00563706|580013571|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
160626332|NCT00563706|580013572|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
160626333|NCT00563706|580013573|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
160626334|NCT00563706|580013574|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
160626335|NCT00563706|580013575|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
160626336|NCT00563706|580013576|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
160626337|NCT00563706|580013577|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
160626338|NCT00563706|580013578|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
160626339|NCT00563706|580013570|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
160626340|NCT00563706|580013571|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
160626341|NCT00563706|580013572|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
160626342|NCT00563706|580013573|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
160626343|NCT00563706|580013574|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
160626344|NCT00563706|580013575|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
160626345|NCT00563706|580013576|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
160626346|NCT00563706|580013577|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
160626347|NCT00563706|580013578|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
160626348|NCT00761462|580013581|FG000|Treatment|Subjects never received study medication|23|||
160626349|NCT00761462|580013582|FG001|Treatment|Subjects never received study medication|12|||
160626350|NCT00761462|580013581|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
160626351|NCT00761462|580013582|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
160626352|NCT00761462|580013581|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
160626353|NCT00761462|580013582|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
160626354|NCT00761462|580013581|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
160626355|NCT00761462|580013582|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
160626356|NCT02985541|580013583|FG000|Overall Study|Withdrawal by Subject|33|||
160626357|NCT02985541|580013583|FG000|Overall Study|Lost to Follow-up|26|||
160519626|NCT06729606|579631134|FG000|Overall Study|Adverse Event|0|||
160519627|NCT06729606|579631135|FG001|Overall Study|Adverse Event|2|||
160519628|NCT06729606|579631134|FG000|Overall Study|Death|1|||
160519629|NCT06729606|579631135|FG001|Overall Study|Death|0|||
160519630|NCT06729606|579631134|FG000|Overall Study|Physician Decision|0|||
160519631|NCT06729606|579631135|FG001|Overall Study|Physician Decision|1|||
160519632|NCT06729606|579631134|FG000|Overall Study|Withdrawal by Subject|2|||
160519633|NCT06729606|579631135|FG001|Overall Study|Withdrawal by Subject|4|||
160519634|NCT03170349|579631136|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
160519635|NCT03170349|579631136|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
160519636|NCT03170349|579631136|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
160519637|NCT03170349|579631136|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
160519638|NCT03170349|579631136|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
160519639|NCT03170349|579631136|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
160519640|NCT03170349|579631136|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
160519641|NCT03170349|579631136|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
160519642|NCT03170349|579631136|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
160519643|NCT03170349|579631136|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
160519644|NCT03170349|579631136|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
160519645|NCT03170349|579631136|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
160519646|NCT03170349|579631136|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
160519647|NCT03170349|579631136|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
160519648|NCT03170349|579631136|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
160519649|NCT03170349|579631136|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
160519650|NCT03440320|579632816|FG000|Overall Study|Withdrawal by Subject|0|||
160519651|NCT03440320|579632817|FG001|Overall Study|Withdrawal by Subject|1|||
160519652|NCT01912456|579632818|FG000|Period 1|Physician Decision|0|||
160519653|NCT01912456|579632819|FG001|Period 1|Physician Decision|0|||
160519654|NCT01912456|579632820|FG002|Period 1|Physician Decision|1|||
160519655|NCT01912456|579632821|FG003|Period 1|Physician Decision|0|||
160519656|NCT01912456|579632818|FG000|Period 1|non-compliance|1|||
160519657|NCT01912456|579632819|FG001|Period 1|non-compliance|0|||
160519658|NCT01912456|579632820|FG002|Period 1|non-compliance|0|||
160519659|NCT01912456|579632821|FG003|Period 1|non-compliance|1|||
160519660|NCT01912456|579632818|FG000|Period 1|Adverse Event|1|||
160519661|NCT01912456|579632819|FG001|Period 1|Adverse Event|0|||
160519662|NCT01912456|579632820|FG002|Period 1|Adverse Event|0|||
160519663|NCT01912456|579632821|FG003|Period 1|Adverse Event|1|||
160519664|NCT01912456|579632818|FG000|Period 1|Withdrawal by Subject|0|||
160519665|NCT01912456|579632819|FG001|Period 1|Withdrawal by Subject|1|||
160519666|NCT01912456|579632820|FG002|Period 1|Withdrawal by Subject|1|||
160519667|NCT01912456|579632821|FG003|Period 1|Withdrawal by Subject|1|||
160519668|NCT01912456|579632818|FG000|Period 2|Lack of Efficacy|0|||
160519669|NCT01912456|579632819|FG001|Period 2|Lack of Efficacy|2|||
160519670|NCT01912456|579632820|FG002|Period 2|Lack of Efficacy|0|||
160519671|NCT01912456|579632821|FG003|Period 2|Lack of Efficacy|0|||
160519672|NCT01912456|579632818|FG000|Period 2|Adverse Event|0|||
160519673|NCT01912456|579632819|FG001|Period 2|Adverse Event|0|||
160519674|NCT01912456|579632820|FG002|Period 2|Adverse Event|0|||
160519675|NCT01912456|579632821|FG003|Period 2|Adverse Event|1|||
160519676|NCT01340196|579632822|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
160519677|NCT00001962|579632824|FG000|Overall Study|Lack of Efficacy|18|||
160519678|NCT00001962|579632824|FG000|Overall Study|Lack of Accrual|6|||
160519679|NCT00001962|579632824|FG000|Overall Study|Death|1|||
160519680|NCT00001962|579632824|FG000|Overall Study|Lost to Follow-up|2|||
160519681|NCT00001962|579632824|FG000|Overall Study|Adverse Event|1|||
160519682|NCT00171704|579632825|FG000|Overall Study|Adverse Event|24|||
160519683|NCT00171704|579632826|FG001|Overall Study|Adverse Event|33|||
160519684|NCT00171704|579632825|FG000|Overall Study|Disease Progression|14|||
160519685|NCT00171704|579632826|FG001|Overall Study|Disease Progression|9|||
160519686|NCT00171704|579632825|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
160519687|NCT00171704|579632826|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
160519688|NCT00171704|579632825|FG000|Overall Study|Administrative Problems|2|||
160519689|NCT00171704|579632826|FG001|Overall Study|Administrative Problems|1|||
160519690|NCT00171704|579632825|FG000|Overall Study|Death|2|||
160519691|NCT00171704|579632826|FG001|Overall Study|Death|2|||
160519692|NCT00171704|579632825|FG000|Overall Study|Withdrawal by Subject|1|||
160519693|NCT00171704|579632826|FG001|Overall Study|Withdrawal by Subject|3|||
160519694|NCT00171704|579632825|FG000|Overall Study|Protocol Violation|0|||
160519695|NCT00171704|579632826|FG001|Overall Study|Protocol Violation|1|||
160519696|NCT00320541|579632829|FG000|Overall Study|Adverse Event|21|||
160519697|NCT00320541|579632830|FG001|Overall Study|Adverse Event|19|||
160519698|NCT00320541|579632829|FG000|Overall Study|Protocol Violation|0|||
160519699|NCT00320541|579632830|FG001|Overall Study|Protocol Violation|1|||
160519700|NCT00320541|579632829|FG000|Overall Study|Withdrawal by Subject|12|||
160519701|NCT00320541|579632830|FG001|Overall Study|Withdrawal by Subject|16|||
160519702|NCT00320541|579632829|FG000|Overall Study|Physician Decision|9|||
160519703|NCT00320541|579632830|FG001|Overall Study|Physician Decision|13|||
160626358|NCT02985541|580013583|FG000|Overall Study|Adverse Event|27|||
160626359|NCT02985541|580013583|FG000|Overall Study|Physician Decision|2|||
160626360|NCT02985541|580013583|FG000|Overall Study|Pregnancy|2|||
160626361|NCT02985541|580013583|FG000|Overall Study|Wish for pregnancy|44|||
160626362|NCT02985541|580013583|FG000|Overall Study|Other reason|5|||
160626363|NCT02985541|580013583|FG000|Overall Study|Not valid for analysis|2|||
160626364|NCT02383966|580013584|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
160626365|NCT02383966|580013585|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
160626366|NCT02383966|580013584|FG000|Overall Study|Randomized, but not treated|1|||
160626367|NCT02383966|580013585|FG001|Overall Study|Randomized, but not treated|3|||
160626368|NCT03839693|580013601|FG000|Overall Study|Lost to Follow-up|0|||
160626369|NCT03839693|580013602|FG001|Overall Study|Lost to Follow-up|2|||
160626370|NCT03839693|580013603|FG002|Overall Study|Lost to Follow-up|2|||
160626371|NCT03839693|580013601|FG000|Overall Study|Withdrawal by Subject|1|||
160626372|NCT03839693|580013602|FG001|Overall Study|Withdrawal by Subject|0|||
160626373|NCT03839693|580013603|FG002|Overall Study|Withdrawal by Subject|2|||
160626374|NCT03839693|580013601|FG000|Overall Study|subject moved out of the area|1|||
160626375|NCT03839693|580013602|FG001|Overall Study|subject moved out of the area|0|||
160626376|NCT03839693|580013603|FG002|Overall Study|subject moved out of the area|0|||
160626377|NCT00270205|580013612|FG000|Overall Study|Lost to Follow-up|1|||
160626378|NCT00270205|580013613|FG001|Overall Study|Lost to Follow-up|0|||
160626379|NCT00270205|580013614|FG002|Overall Study|Lost to Follow-up|0|||
160626380|NCT00270205|580013615|FG003|Overall Study|Lost to Follow-up|1|||
160626381|NCT00066573|580013616|FG000|Overall Study|Did not received protocol treatment|28|||
160626382|NCT00066573|580013617|FG001|Overall Study|Did not received protocol treatment|28|||
160626383|NCT00700115|580013618|FG000|Overall Study|Withdrawal by Subject|1|||
160626384|NCT00700115|580013619|FG001|Overall Study|Withdrawal by Subject|0|||
160626385|NCT00700115|580013618|FG000|Overall Study|Lost to Follow-up|0|||
160626386|NCT00700115|580013619|FG001|Overall Study|Lost to Follow-up|1|||
160626387|NCT02983305|580013624|FG000|Overall Study|incomplete data|2|||
160626388|NCT02983305|580013625|FG001|Overall Study|incomplete data|0|||
160626389|NCT00822237|580013626|FG000|Dose 1 Vaccination|Not vaccinated|3|||
160626390|NCT00822237|580013627|FG001|Dose 1 Vaccination|Not vaccinated|0|||
160626391|NCT00822237|580013626|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
160626392|NCT00822237|580013627|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
160626393|NCT00822237|580013626|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
160626394|NCT00822237|580013627|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
160626395|NCT00822237|580013626|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
160626396|NCT00822237|580013627|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
160626397|NCT00822237|580013626|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
160626398|NCT00822237|580013627|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
160626399|NCT03433482|580013628|FG000|Overall Study|Lost to Follow-up|1|||
160626400|NCT03433482|580013629|FG001|Overall Study|Lost to Follow-up|0|||
160626401|NCT03433482|580013630|FG002|Overall Study|Lost to Follow-up|1|||
160626402|NCT03433482|580013631|FG003|Overall Study|Lost to Follow-up|1|||
160626403|NCT03433482|580013628|FG000|Overall Study|Withdrawal by Subject|0|||
160626404|NCT03433482|580013629|FG001|Overall Study|Withdrawal by Subject|0|||
160626405|NCT03433482|580013630|FG002|Overall Study|Withdrawal by Subject|1|||
160626406|NCT03433482|580013631|FG003|Overall Study|Withdrawal by Subject|0|||
160626407|NCT03433482|580013628|FG000|Overall Study|Unknown reason|0|||
160626408|NCT03433482|580013629|FG001|Overall Study|Unknown reason|0|||
160626409|NCT03433482|580013630|FG002|Overall Study|Unknown reason|2|||
160626410|NCT03433482|580013631|FG003|Overall Study|Unknown reason|0|||
160626411|NCT00437294|580013632|FG000|Overall Study|Adverse Event|5|||
160626412|NCT00437294|580013633|FG001|Overall Study|Adverse Event|4|||
160626413|NCT00437294|580013632|FG000|Overall Study|Death|5|||
160626414|NCT00437294|580013633|FG001|Overall Study|Death|2|||
160626415|NCT00437294|580013632|FG000|Overall Study|Physician Decision|0|||
160626416|NCT00437294|580013633|FG001|Overall Study|Physician Decision|3|||
160626417|NCT00437294|580013632|FG000|Overall Study|Withdrawal by Subject|5|||
160626418|NCT00437294|580013633|FG001|Overall Study|Withdrawal by Subject|0|||
160626419|NCT00437294|580013632|FG000|Overall Study|Progressive Disease|19|||
160626420|NCT00437294|580013633|FG001|Overall Study|Progressive Disease|23|||
160626421|NCT00437294|580013632|FG000|Overall Study|Sponsor Decision|8|||
160626422|NCT00437294|580013633|FG001|Overall Study|Sponsor Decision|9|||
160626423|NCT00437294|580013632|FG000|Overall Study|Protocol Violation|0|||
160626424|NCT00437294|580013633|FG001|Overall Study|Protocol Violation|1|||
160626425|NCT00437294|580013632|FG000|Overall Study|Entry criteria not met|1|||
160626426|NCT00437294|580013633|FG001|Overall Study|Entry criteria not met|1|||
160626427|NCT01473602|580013644|FG000|Overall Study|Adverse Event|1|||
160626428|NCT01473602|580013645|FG001|Overall Study|Adverse Event|2|||
160626429|NCT01473602|580013644|FG000|Overall Study|Death|0|||
160626430|NCT01473602|580013645|FG001|Overall Study|Death|1|||
160626431|NCT01473602|580013644|FG000|Overall Study|Lost to Follow-up|1|||
160626432|NCT01473602|580013645|FG001|Overall Study|Lost to Follow-up|1|||
160626433|NCT01473602|580013644|FG000|Overall Study|Withdrawal by Subject|5|||
160626434|NCT01473602|580013645|FG001|Overall Study|Withdrawal by Subject|4|||
160626435|NCT01473602|580013644|FG000|Overall Study|Physician Decision|1|||
160626436|NCT01473602|580013645|FG001|Overall Study|Physician Decision|0|||
160626437|NCT00449761|580013647|FG000|Overall Study|Disease progression|12|||
160626438|NCT00449761|580013647|FG000|Overall Study|Death|5|||
160626439|NCT00449761|580013647|FG000|Overall Study|New cancer therapy|1|||
160626440|NCT00560573|580013648|FG000|Overall Study|Death|4|||
160626441|NCT00560573|580013649|FG001|Overall Study|Death|1|||
160626442|NCT00560573|580013650|FG002|Overall Study|Death|4|||
160626443|NCT00560573|580013651|FG003|Overall Study|Death|5|||
160626444|NCT00560573|580013652|FG004|Overall Study|Death|1|||
160626445|NCT00560573|580013653|FG005|Overall Study|Death|10|||
160626446|NCT00560573|580013648|FG000|Overall Study|Lost to Follow-up|0|||
160626447|NCT00560573|580013649|FG001|Overall Study|Lost to Follow-up|0|||
160626448|NCT00560573|580013650|FG002|Overall Study|Lost to Follow-up|0|||
160626449|NCT00560573|580013651|FG003|Overall Study|Lost to Follow-up|1|||
160626450|NCT00560573|580013652|FG004|Overall Study|Lost to Follow-up|1|||
160626451|NCT00560573|580013653|FG005|Overall Study|Lost to Follow-up|0|||
160626452|NCT00560573|580013648|FG000|Overall Study|Withdrawal by Subject|0|||
160626453|NCT00560573|580013649|FG001|Overall Study|Withdrawal by Subject|0|||
160626454|NCT00560573|580013650|FG002|Overall Study|Withdrawal by Subject|0|||
160626455|NCT00560573|580013651|FG003|Overall Study|Withdrawal by Subject|1|||
160626456|NCT00560573|580013652|FG004|Overall Study|Withdrawal by Subject|1|||
160626457|NCT00560573|580013653|FG005|Overall Study|Withdrawal by Subject|0|||
160626458|NCT00560573|580013648|FG000|Overall Study|Other|2|||
160626459|NCT00560573|580013649|FG001|Overall Study|Other|2|||
160626460|NCT00560573|580013650|FG002|Overall Study|Other|2|||
160626461|NCT00560573|580013651|FG003|Overall Study|Other|3|||
160626462|NCT00560573|580013652|FG004|Overall Study|Other|3|||
160626463|NCT00560573|580013653|FG005|Overall Study|Other|3|||
160626464|NCT00560573|580013648|FG000|Overall Study|Enrolled, not treated|0|||
160626465|NCT00560573|580013649|FG001|Overall Study|Enrolled, not treated|0|||
160626466|NCT00560573|580013650|FG002|Overall Study|Enrolled, not treated|0|||
160626467|NCT00560573|580013651|FG003|Overall Study|Enrolled, not treated|0|||
160626468|NCT00560573|580013652|FG004|Overall Study|Enrolled, not treated|1|||
160626469|NCT00560573|580013653|FG005|Overall Study|Enrolled, not treated|0|||
160626470|NCT01422876|580013657|FG000|Week 24|Lost to Follow-up|1|||
160626471|NCT01422876|580013658|FG001|Week 24|Lost to Follow-up|1|||
160626472|NCT01422876|580013659|FG002|Week 24|Lost to Follow-up|2|||
160626473|NCT01422876|580013660|FG003|Week 24|Lost to Follow-up|4|||
160626474|NCT01422876|580013661|FG004|Week 24|Lost to Follow-up|2|||
160626475|NCT01422876|580013662|FG005|Week 24|Lost to Follow-up|0|||
160626476|NCT01422876|580013663|FG006|Week 24|Lost to Follow-up|1|||
160626477|NCT01422876|580013664|FG007|Week 24|Lost to Follow-up|3|||
160626478|NCT01422876|580013665|FG008|Week 24|Lost to Follow-up|3|||
160626479|NCT01422876|580013666|FG009|Week 24|Lost to Follow-up|4|||
160626480|NCT01422876|580013657|FG000|Week 24|Consent withdrawn|5|||
160626481|NCT01422876|580013658|FG001|Week 24|Consent withdrawn|1|||
160626482|NCT01422876|580013659|FG002|Week 24|Consent withdrawn|3|||
160626483|NCT01422876|580013660|FG003|Week 24|Consent withdrawn|4|||
160626484|NCT01422876|580013661|FG004|Week 24|Consent withdrawn|5|||
160626485|NCT01422876|580013662|FG005|Week 24|Consent withdrawn|6|||
160626486|NCT01422876|580013663|FG006|Week 24|Consent withdrawn|5|||
160626487|NCT01422876|580013664|FG007|Week 24|Consent withdrawn|4|||
160626488|NCT01422876|580013665|FG008|Week 24|Consent withdrawn|3|||
160626489|NCT01422876|580013666|FG009|Week 24|Consent withdrawn|6|||
160626490|NCT01422876|580013657|FG000|Week 24|Death|0|||
160626491|NCT01422876|580013658|FG001|Week 24|Death|1|||
160626492|NCT01422876|580013659|FG002|Week 24|Death|0|||
160626493|NCT01422876|580013660|FG003|Week 24|Death|0|||
160626494|NCT01422876|580013661|FG004|Week 24|Death|0|||
160626495|NCT01422876|580013662|FG005|Week 24|Death|0|||
160626496|NCT01422876|580013663|FG006|Week 24|Death|0|||
160626497|NCT01422876|580013664|FG007|Week 24|Death|0|||
160626498|NCT01422876|580013665|FG008|Week 24|Death|0|||
160626499|NCT01422876|580013666|FG009|Week 24|Death|0|||
160626500|NCT01422876|580013657|FG000|Week 52|Lost to Follow-up|3|||
160626501|NCT01422876|580013658|FG001|Week 52|Lost to Follow-up|5|||
160626502|NCT01422876|580013659|FG002|Week 52|Lost to Follow-up|7|||
160626503|NCT01422876|580013660|FG003|Week 52|Lost to Follow-up|5|||
160626504|NCT01422876|580013661|FG004|Week 52|Lost to Follow-up|8|||
160626505|NCT01422876|580013662|FG005|Week 52|Lost to Follow-up|5|||
160626506|NCT01422876|580013663|FG006|Week 52|Lost to Follow-up|5|||
160626507|NCT01422876|580013664|FG007|Week 52|Lost to Follow-up|8|||
160626508|NCT01422876|580013665|FG008|Week 52|Lost to Follow-up|7|||
160626509|NCT01422876|580013666|FG009|Week 52|Lost to Follow-up|8|||
160626510|NCT01422876|580013657|FG000|Week 52|Consent withdrawn|9|||
160626511|NCT01422876|580013658|FG001|Week 52|Consent withdrawn|4|||
160626512|NCT01422876|580013659|FG002|Week 52|Consent withdrawn|6|||
160626513|NCT01422876|580013660|FG003|Week 52|Consent withdrawn|12|||
160626514|NCT01422876|580013661|FG004|Week 52|Consent withdrawn|7|||
160626515|NCT01422876|580013662|FG005|Week 52|Consent withdrawn|12|||
160626516|NCT01422876|580013663|FG006|Week 52|Consent withdrawn|10|||
160626517|NCT01422876|580013664|FG007|Week 52|Consent withdrawn|12|||
160626518|NCT01422876|580013665|FG008|Week 52|Consent withdrawn|13|||
160626519|NCT01422876|580013666|FG009|Week 52|Consent withdrawn|9|||
160626520|NCT01422876|580013657|FG000|Week 52|Death|0|||
160626521|NCT01422876|580013658|FG001|Week 52|Death|1|||
160626522|NCT01422876|580013659|FG002|Week 52|Death|0|||
160626523|NCT01422876|580013660|FG003|Week 52|Death|1|||
160626524|NCT01422876|580013661|FG004|Week 52|Death|0|||
160626525|NCT01422876|580013662|FG005|Week 52|Death|0|||
160626526|NCT01422876|580013663|FG006|Week 52|Death|1|||
160626527|NCT01422876|580013664|FG007|Week 52|Death|3|||
160626528|NCT01422876|580013665|FG008|Week 52|Death|1|||
160626529|NCT01422876|580013666|FG009|Week 52|Death|0|||
160626530|NCT00536991|580013668|FG000|Overall Study|Withdrawal by Subject|10|||
160626531|NCT00536991|580013668|FG000|Overall Study|Physician Decision|1|||
160626532|NCT00536991|580013668|FG000|Overall Study|patient ineligible|2|||
160626533|NCT00054639|580013669|FG000|Overall Study|Lack of Efficacy|1|||
160626534|NCT00054639|580013669|FG000|Overall Study|Physician Decision|1|||
160626535|NCT01600755|580013670|FG000|Overall Study|Withdrawal by Subject|6|||
160626536|NCT00938392|580013675|FG000|Overall Study|Adverse Event|0|||
160626537|NCT00938392|580013676|FG001|Overall Study|Adverse Event|1|||
160626538|NCT00938392|580013675|FG000|Overall Study|Withdrawal by Subject|0|||
160626539|NCT00938392|580013676|FG001|Overall Study|Withdrawal by Subject|1|||
160626540|NCT00938392|580013675|FG000|Overall Study|Lost to Follow-up|2|||
160626541|NCT00938392|580013676|FG001|Overall Study|Lost to Follow-up|2|||
160626542|NCT00122954|580013677|FG000|Overall Study|Withdrawal by Subject|2|||
160626543|NCT00122954|580013678|FG001|Overall Study|Withdrawal by Subject|2|||
160626544|NCT00122954|580013677|FG000|Overall Study|Protocol Violation|0|||
160626545|NCT00122954|580013678|FG001|Overall Study|Protocol Violation|1|||
160626546|NCT00558831|580013679|FG000|Overall Study|Lost to Follow-up|1|||
160626547|NCT02204449|580013680|FG000|Overall Study|Lost to Follow-up|7|||
160626548|NCT02204449|580013681|FG001|Overall Study|Lost to Follow-up|9|||
160626549|NCT02204449|580013680|FG000|Overall Study|Death|0|||
160626550|NCT02204449|580013681|FG001|Overall Study|Death|1|||
160626551|NCT02204449|580013680|FG000|Overall Study|Withdrawal by Subject|0|||
160626552|NCT02204449|580013681|FG001|Overall Study|Withdrawal by Subject|1|||
160626553|NCT02856282|580013682|FG000|Overall Study|Withdrawal by Subject|1|||
160626554|NCT00057330|580013683|FG000|Overall Study|Adverse Event|9|||
160626555|NCT00057330|580013684|FG001|Overall Study|Adverse Event|12|||
160626556|NCT00057330|580013683|FG000|Overall Study|Death|1|||
160626557|NCT00057330|580013684|FG001|Overall Study|Death|0|||
160626558|NCT00057330|580013683|FG000|Overall Study|Protocol Violation|1|||
160626559|NCT00057330|580013684|FG001|Overall Study|Protocol Violation|1|||
160626560|NCT00057330|580013683|FG000|Overall Study|Withdrawal by Subject|115|||
160626561|NCT00057330|580013684|FG001|Overall Study|Withdrawal by Subject|84|||
160626562|NCT00057330|580013683|FG000|Overall Study|Lost to Follow-up|745|||
160626563|NCT00057330|580013684|FG001|Overall Study|Lost to Follow-up|617|||
160626564|NCT00057330|580013683|FG000|Overall Study|Physician Decision|1|||
160626565|NCT00057330|580013684|FG001|Overall Study|Physician Decision|0|||
160626566|NCT00057330|580013683|FG000|Overall Study|Other|260|||
160626567|NCT00057330|580013684|FG001|Overall Study|Other|206|||
160626568|NCT01491737|580013688|FG000|Overall Study|Withdrawal by Subject|20|||
160626569|NCT01491737|580013689|FG001|Overall Study|Withdrawal by Subject|17|||
160626570|NCT01491737|580013688|FG000|Overall Study|Lost to Follow-up|2|||
160626571|NCT01491737|580013689|FG001|Overall Study|Lost to Follow-up|10|||
160626572|NCT01491737|580013688|FG000|Overall Study|Death|63|||
160626573|NCT01491737|580013689|FG001|Overall Study|Death|57|||
160626574|NCT01491737|580013688|FG000|Overall Study|Study Termination by Sponsor|36|||
160626575|NCT01491737|580013689|FG001|Overall Study|Study Termination by Sponsor|36|||
160626576|NCT01491737|580013688|FG000|Overall Study|Reason Not Specified|8|||
160626577|NCT01491737|580013689|FG001|Overall Study|Reason Not Specified|9|||
160626578|NCT00494234|580013692|FG000|Overall Study|Withdrawal by Subject|1|||
160626579|NCT00494234|580013693|FG001|Overall Study|Withdrawal by Subject|0|||
160626580|NCT00494234|580013692|FG000|Overall Study|Disease progression|11|||
160626581|NCT00494234|580013693|FG001|Overall Study|Disease progression|8|||
160626582|NCT00494234|580013692|FG000|Overall Study|Death|2|||
160626583|NCT00494234|580013693|FG001|Overall Study|Death|1|||
160626584|NCT02743117|580013697|FG000|Overall Study|Lost to Follow-up|0|||
160626585|NCT02743117|580013698|FG001|Overall Study|Lost to Follow-up|1|||
160626586|NCT02743117|580013697|FG000|Overall Study|Other|1|||
160626587|NCT02743117|580013698|FG001|Overall Study|Other|0|||
160626588|NCT00779857|580013699|FG000|Overall Study|Death|1|||
160626589|NCT00779857|580013699|FG000|Overall Study|Withdrawal by Subject|3|||
160626590|NCT00779857|580013699|FG000|Overall Study|Missed Visit|2|||
160626591|NCT04640168|580013700|FG000|Overall Study|Withdrawal by Subject|8|||
160626592|NCT04640168|580013701|FG001|Overall Study|Withdrawal by Subject|7|||
160626593|NCT04640168|580013700|FG000|Overall Study|Lost to Follow-up|1|||
160626594|NCT04640168|580013701|FG001|Overall Study|Lost to Follow-up|0|||
160626595|NCT04640168|580013700|FG000|Overall Study|Enrolled but not treated|12|||
160626596|NCT04640168|580013701|FG001|Overall Study|Enrolled but not treated|12|||
160626597|NCT01250418|580013705|FG000|Overall Study|monitor data failure|1|||
160626598|NCT01250418|580013706|FG001|Overall Study|monitor data failure|1|||
160626599|NCT04524507|580013707|FG000|Overall Study|Lost to Follow-up|2|||
160626600|NCT04524507|580013708|FG001|Overall Study|Lost to Follow-up|4|||
160626601|NCT04524507|580013707|FG000|Overall Study|Withdrawal by Subject|2|||
160626602|NCT04524507|580013708|FG001|Overall Study|Withdrawal by Subject|9|||
160626603|NCT04524507|580013707|FG000|Overall Study|Death|2|||
160626604|NCT04524507|580013708|FG001|Overall Study|Death|10|||
160626605|NCT00412360|580013709|FG000|Overall Study|Lost to Follow-up|0|||
160626606|NCT00412360|580013710|FG001|Overall Study|Lost to Follow-up|1|||
160626607|NCT00412360|580013709|FG000|Overall Study|Not Transplanted|1|||
160626608|NCT00412360|580013710|FG001|Overall Study|Not Transplanted|2|||
160626609|NCT04678557|580013712|FG000|Overall Study|Withdrawal by Subject|1|||
160626610|NCT04678557|580013713|FG001|Overall Study|Withdrawal by Subject|0|||
160626611|NCT04678557|580013712|FG000|Overall Study|Lack of Efficacy|0|||
160626612|NCT04678557|580013713|FG001|Overall Study|Lack of Efficacy|13|||
160626613|NCT04678557|580013712|FG000|Overall Study|Safety Evaluation|0|||
160626614|NCT04678557|580013713|FG001|Overall Study|Safety Evaluation|1|||
160626615|NCT01361308|580015387|FG000|Overall Study|Withdrawal by Subject|9|||
160626616|NCT01361308|580015388|FG001|Overall Study|Withdrawal by Subject|13|||
160626617|NCT01361308|580015387|FG000|Overall Study|Physician Decision|3|||
160626618|NCT01361308|580015388|FG001|Overall Study|Physician Decision|3|||
160626619|NCT01361308|580015387|FG000|Overall Study|Lack of Efficacy|2|||
160626620|NCT01361308|580015388|FG001|Overall Study|Lack of Efficacy|0|||
160626621|NCT01361308|580015387|FG000|Overall Study|Protocol Violation|1|||
160626622|NCT01361308|580015388|FG001|Overall Study|Protocol Violation|0|||
160626623|NCT01361308|580015387|FG000|Overall Study|Lost to Follow-up|5|||
160626624|NCT01361308|580015388|FG001|Overall Study|Lost to Follow-up|4|||
160626625|NCT01361308|580015387|FG000|Overall Study|Adverse Event|8|||
160626626|NCT01361308|580015388|FG001|Overall Study|Adverse Event|4|||
160626627|NCT01361308|580015387|FG000|Overall Study|Eligibility Criteria Not Met|2|||
160626628|NCT01361308|580015388|FG001|Overall Study|Eligibility Criteria Not Met|3|||
160626629|NCT01361308|580015387|FG000|Overall Study|Failed C-SSRS|5|||
160626630|NCT01361308|580015388|FG001|Overall Study|Failed C-SSRS|2|||
160626631|NCT01361308|580015387|FG000|Overall Study|Other|0|||
160626632|NCT01361308|580015388|FG001|Overall Study|Other|1|||
160626633|NCT02503215|580015389|FG000|Overall Study|Unable to wear compression stockings|1|||
160626634|NCT02503215|580015389|FG000|Overall Study|Unable to use positive airway pressure|2|||
160626635|NCT00706901|580015390|FG000|Overall Study|Lost to Follow-up|2|||
160626636|NCT00706901|580015391|FG001|Overall Study|Lost to Follow-up|3|||
160626637|NCT00706901|580015392|FG002|Overall Study|Lost to Follow-up|2|||
160626638|NCT00706901|580015390|FG000|Overall Study|Withdrawal by Subject|4|||
160626639|NCT00706901|580015391|FG001|Overall Study|Withdrawal by Subject|2|||
160626640|NCT00706901|580015392|FG002|Overall Study|Withdrawal by Subject|5|||
160626641|NCT00706901|580015390|FG000|Overall Study|In Jail|1|||
160626642|NCT00706901|580015391|FG001|Overall Study|In Jail|0|||
160626643|NCT00706901|580015392|FG002|Overall Study|In Jail|1|||
160626644|NCT00706901|580015390|FG000|Overall Study|Death|1|||
160626645|NCT00706901|580015391|FG001|Overall Study|Death|0|||
160626646|NCT00706901|580015392|FG002|Overall Study|Death|0|||
160626647|NCT01646268|580015394|FG000|Overall Study|Adverse Event|6|||
160626648|NCT01646268|580015395|FG001|Overall Study|Adverse Event|7|||
160626649|NCT01646268|580015394|FG000|Overall Study|Lack of Efficacy|1|||
160626650|NCT01646268|580015395|FG001|Overall Study|Lack of Efficacy|3|||
160626651|NCT01646268|580015394|FG000|Overall Study|Protocol Violation|0|||
160626652|NCT01646268|580015395|FG001|Overall Study|Protocol Violation|1|||
160626653|NCT01646268|580015394|FG000|Overall Study|Withdrawal by Subject|2|||
160626654|NCT01646268|580015395|FG001|Overall Study|Withdrawal by Subject|5|||
160626655|NCT01646268|580015394|FG000|Overall Study|Other|2|||
160626656|NCT01646268|580015395|FG001|Overall Study|Other|0|||
160626657|NCT02222246|580015396|FG000|Overall Study|No Emergency Department Visits|27|||
160626658|NCT02222246|580015397|FG001|Overall Study|No Emergency Department Visits|26|||
160626659|NCT02222246|580015396|FG000|Overall Study|Physician Decision|0|||
160626660|NCT02222246|580015397|FG001|Overall Study|Physician Decision|1|||
160626661|NCT01308476|580015400|FG000|Overall Study|Lost to Follow-up|2|||
160626662|NCT01308476|580015401|FG001|Overall Study|Lost to Follow-up|2|||
160626663|NCT01308476|580015400|FG000|Overall Study|Other|1|||
160626664|NCT01308476|580015401|FG001|Overall Study|Other|0|||
160626665|NCT03772574|580015402|FG000|Overall Study|Protocol Violation|2|||
160626666|NCT03772574|580015403|FG001|Overall Study|Protocol Violation|0|||
160626667|NCT03772574|580015404|FG002|Overall Study|Protocol Violation|0|||
160626668|NCT03772574|580015402|FG000|Overall Study|Discomfort|0|||
160626669|NCT03772574|580015403|FG001|Overall Study|Discomfort|5|||
160626670|NCT03772574|580015404|FG002|Overall Study|Discomfort|4|||
160626671|NCT00812968|580015407|FG000|Overall Study|Relapse after erythroid response|6|||
160626672|NCT00812968|580015407|FG000|Overall Study|Disease progression|1|||
160626673|NCT00812968|580015407|FG000|Overall Study|No further treatment required|1|||
160626674|NCT00812968|580015407|FG000|Overall Study|Study closed due to marketing approval|3|||
160626675|NCT02696382|580015408|FG000|Overall Study|Death|7|||
160626676|NCT02696382|580015409|FG001|Overall Study|Death|2|||
160626677|NCT02696382|580015408|FG000|Overall Study|Withdrawal by Subject|5|||
160626678|NCT02696382|580015409|FG001|Overall Study|Withdrawal by Subject|12|||
160626679|NCT02696382|580015408|FG000|Overall Study|Lost to Follow-up|4|||
160626680|NCT02696382|580015409|FG001|Overall Study|Lost to Follow-up|7|||
160626681|NCT00505765|580015415|FG000|Overall Study|Withdrawal by Subject|1|||
160626682|NCT00505765|580015416|FG001|Overall Study|Withdrawal by Subject|0|||
160671987|NCT00521586|580178575|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
160671988|NCT00521586|580178574|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
160671989|NCT00521586|580178575|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
160671990|NCT00521586|580178574|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
160671991|NCT00521586|580178575|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
160671992|NCT00521586|580178574|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
160671993|NCT00521586|580178575|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
160671994|NCT00521586|580178574|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
160671995|NCT00521586|580178575|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
160671996|NCT00529763|580178576|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
160671997|NCT00529763|580178577|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
160671998|NCT00529763|580178578|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
160671999|NCT00529763|580178576|FG000|Overall Study|Death|1|||
160672000|NCT00529763|580178577|FG001|Overall Study|Death|1|||
160672001|NCT00529763|580178578|FG002|Overall Study|Death|1|||
160672002|NCT00529763|580178576|FG000|Overall Study|Disease Progression|10|||
160672003|NCT00529763|580178577|FG001|Overall Study|Disease Progression|16|||
160672004|NCT00529763|580178578|FG002|Overall Study|Disease Progression|11|||
160672005|NCT00529763|580178576|FG000|Overall Study|Lost to Follow-up|1|||
160672006|NCT00529763|580178577|FG001|Overall Study|Lost to Follow-up|2|||
160672007|NCT00529763|580178578|FG002|Overall Study|Lost to Follow-up|3|||
160672008|NCT00529763|580178576|FG000|Overall Study|Stem Cell Transplant|0|||
160672009|NCT00529763|580178577|FG001|Overall Study|Stem Cell Transplant|3|||
160672010|NCT00529763|580178578|FG002|Overall Study|Stem Cell Transplant|1|||
160672011|NCT00529763|580178576|FG000|Overall Study|Study Drug Toxicity|3|||
160672012|NCT00529763|580178577|FG001|Overall Study|Study Drug Toxicity|6|||
160672013|NCT00529763|580178578|FG002|Overall Study|Study Drug Toxicity|4|||
160672014|NCT00529763|580178576|FG000|Overall Study|Participant Withdrew Consent|2|||
160672015|NCT00529763|580178577|FG001|Overall Study|Participant Withdrew Consent|3|||
160672016|NCT00529763|580178578|FG002|Overall Study|Participant Withdrew Consent|4|||
160672017|NCT00529763|580178576|FG000|Overall Study|Other reasons|2|||
160672018|NCT00529763|580178577|FG001|Overall Study|Other reasons|0|||
160672019|NCT00529763|580178578|FG002|Overall Study|Other reasons|2|||
160672020|NCT00529763|580178576|FG000|Overall Study|Participant request to discontinue treatment|1|||
160672021|NCT00529763|580178577|FG001|Overall Study|Participant request to discontinue treatment|1|||
160672022|NCT00529763|580178578|FG002|Overall Study|Participant request to discontinue treatment|3|||
160672023|NCT03669250|580178579|FG000|Overall Study|Adverse Event|0|||
160672024|NCT03669250|580178580|FG001|Overall Study|Adverse Event|0|||
160672025|NCT03669250|580178581|FG002|Overall Study|Adverse Event|0|||
160672026|NCT03669250|580178582|FG003|Overall Study|Adverse Event|0|||
160672027|NCT03669250|580178583|FG004|Overall Study|Adverse Event|1|||
160672028|NCT03669250|580178584|FG005|Overall Study|Adverse Event|0|||
160672029|NCT03669250|580178579|FG000|Overall Study|Withdrawal by Subject|0|||
160672030|NCT03669250|580178580|FG001|Overall Study|Withdrawal by Subject|1|||
160672031|NCT03669250|580178581|FG002|Overall Study|Withdrawal by Subject|0|||
160672032|NCT03669250|580178582|FG003|Overall Study|Withdrawal by Subject|1|||
160672033|NCT03669250|580178583|FG004|Overall Study|Withdrawal by Subject|0|||
160672034|NCT03669250|580178584|FG005|Overall Study|Withdrawal by Subject|0|||
160672035|NCT00828321|580178585|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
160672036|NCT00828321|580178586|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
160672037|NCT00828321|580178585|FG000|Second Intervention|Protocol Violation|0|||
160672038|NCT00828321|580178586|FG001|Second Intervention|Protocol Violation|1|||
160672039|NCT02997176|580178587|FG000|Overall Study|Adverse Event|0|||
160672040|NCT02997176|580178588|FG001|Overall Study|Adverse Event|0|||
160672041|NCT02997176|580178589|FG002|Overall Study|Adverse Event|0|||
160672042|NCT02997176|580178590|FG003|Overall Study|Adverse Event|8|||
160672043|NCT02997176|580178587|FG000|Overall Study|Progressive Disease|1|||
160672044|NCT02997176|580178588|FG001|Overall Study|Progressive Disease|0|||
160672045|NCT02997176|580178589|FG002|Overall Study|Progressive Disease|1|||
160672046|NCT02997176|580178590|FG003|Overall Study|Progressive Disease|1|||
160672047|NCT02997176|580178587|FG000|Overall Study|Death|0|||
160672048|NCT02997176|580178588|FG001|Overall Study|Death|0|||
160672049|NCT02997176|580178589|FG002|Overall Study|Death|1|||
160672050|NCT02997176|580178590|FG003|Overall Study|Death|1|||
160672051|NCT02997176|580178587|FG000|Overall Study|Withdrawal by Subject|0|||
160672052|NCT02997176|580178588|FG001|Overall Study|Withdrawal by Subject|2|||
160672053|NCT02997176|580178589|FG002|Overall Study|Withdrawal by Subject|0|||
160672054|NCT02997176|580178590|FG003|Overall Study|Withdrawal by Subject|1|||
160672055|NCT00691704|580178593|FG000|Induction Therapy|Disease Progression|1|||
160672056|NCT00691704|580178593|FG000|Induction Therapy|Active Hepatitis|1|||
160672057|NCT00691704|580178593|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
160672058|NCT00691704|580178593|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
160672059|NCT00691704|580178593|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
160672060|NCT01993186|580178594|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
160672061|NCT01993186|580178595|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
160672062|NCT01993186|580178594|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
160672063|NCT01993186|580178595|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
160672064|NCT01993186|580178594|FG000|Open-Label Extension Period|Other, Not Specified|0|||
160672065|NCT01993186|580178595|FG001|Open-Label Extension Period|Other, Not Specified|1|||
160672066|NCT01993186|580178594|FG000|Open-Label Extension Period|Adverse Event|1|||
160672067|NCT01993186|580178595|FG001|Open-Label Extension Period|Adverse Event|0|||
160672068|NCT01993186|580178594|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
160672069|NCT01993186|580178595|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
160672070|NCT01993186|580178594|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
160672071|NCT01993186|580178595|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
160672072|NCT01993186|580178594|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
160672073|NCT01993186|580178595|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
160672074|NCT04523480|580178596|FG000|Overall Study|Lost to Follow-up|30|||
160672075|NCT04523480|580178597|FG001|Overall Study|Lost to Follow-up|35|||
160672076|NCT04523480|580178598|FG002|Overall Study|Lost to Follow-up|0|||
160672077|NCT02752074|580178599|FG000|Overall Study|Lost to Follow-up|1|||
160672078|NCT02752074|580178600|FG001|Overall Study|Lost to Follow-up|4|||
160672079|NCT02752074|580178599|FG000|Overall Study|Death|146|||
160672080|NCT02752074|580178600|FG001|Overall Study|Death|129|||
160672081|NCT02752074|580178599|FG000|Overall Study|Withdrawal by Subject|9|||
160672082|NCT02752074|580178600|FG001|Overall Study|Withdrawal by Subject|10|||
160672083|NCT01959672|580178606|FG000|Overall Study|Death|1|||
160672084|NCT02392195|580178607|FG000|Overall Study|Lost to Follow-up|4|||
160672085|NCT02392195|580178607|FG000|Overall Study|Withdrawal by Subject|4|||
160672086|NCT00840216|580178608|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
160672087|NCT00840216|580178609|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
160672088|NCT00545792|580178610|FG000|Overall Study|Withdrawal by Subject|1|||
160672089|NCT01642277|580178612|FG000|Overall Study|Adverse Event|10|||
160672090|NCT01642277|580178613|FG001|Overall Study|Adverse Event|0|||
160672091|NCT01642277|580178612|FG000|Overall Study|Physician Decision|2|||
160672092|NCT01642277|580178613|FG001|Overall Study|Physician Decision|0|||
160672093|NCT01642277|580178612|FG000|Overall Study|Protocol Violation|1|||
160672094|NCT01642277|580178613|FG001|Overall Study|Protocol Violation|0|||
160672095|NCT01642277|580178612|FG000|Overall Study|Withdrawal by Subject|11|||
160672096|NCT01642277|580178613|FG001|Overall Study|Withdrawal by Subject|0|||
160672097|NCT03679598|580178614|FG000|Overall Study|Adverse Event|2|||
160672098|NCT03679598|580178615|FG001|Overall Study|Adverse Event|0|||
160672099|NCT02842853|580178616|FG000|Overall Study|Non-compliance with the protocol|3|||
160672100|NCT02842853|580178617|FG001|Overall Study|Non-compliance with the protocol|7|||
160672101|NCT02842853|580178618|FG002|Overall Study|Non-compliance with the protocol|2|||
160672102|NCT02842853|580178619|FG003|Overall Study|Non-compliance with the protocol|5|||
160672103|NCT02842853|580178616|FG000|Overall Study|Subject met exclusion criteria|0|||
160672104|NCT02842853|580178617|FG001|Overall Study|Subject met exclusion criteria|1|||
160672105|NCT02842853|580178618|FG002|Overall Study|Subject met exclusion criteria|0|||
160672106|NCT02842853|580178619|FG003|Overall Study|Subject met exclusion criteria|0|||
160672107|NCT02842853|580178616|FG000|Overall Study|Withdrawal by Subject|11|||
160672108|NCT02842853|580178617|FG001|Overall Study|Withdrawal by Subject|13|||
160672109|NCT02842853|580178618|FG002|Overall Study|Withdrawal by Subject|9|||
160672110|NCT02842853|580178619|FG003|Overall Study|Withdrawal by Subject|8|||
160672111|NCT02842853|580178616|FG000|Overall Study|Lost to Follow-up|9|||
160672112|NCT02842853|580178617|FG001|Overall Study|Lost to Follow-up|13|||
160672113|NCT02842853|580178618|FG002|Overall Study|Lost to Follow-up|10|||
160672114|NCT02842853|580178619|FG003|Overall Study|Lost to Follow-up|11|||
160672115|NCT01380782|580178620|FG000|Overall Study|Adverse Event|0|||
160672116|NCT01380782|580178621|FG001|Overall Study|Adverse Event|1|||
160672117|NCT01380782|580178622|FG002|Overall Study|Adverse Event|0|||
160672118|NCT01380782|580178623|FG003|Overall Study|Adverse Event|0|||
160672119|NCT01380782|580178620|FG000|Overall Study|Death|1|||
160672120|NCT01380782|580178621|FG001|Overall Study|Death|0|||
160672121|NCT01380782|580178622|FG002|Overall Study|Death|0|||
160672122|NCT01380782|580178623|FG003|Overall Study|Death|0|||
160672123|NCT01380782|580178620|FG000|Overall Study|Lack of Efficacy|10|||
160672124|NCT01380782|580178621|FG001|Overall Study|Lack of Efficacy|9|||
160672125|NCT01380782|580178622|FG002|Overall Study|Lack of Efficacy|10|||
160672126|NCT01380782|580178623|FG003|Overall Study|Lack of Efficacy|3|||
160672127|NCT01380782|580178620|FG000|Overall Study|Physician Decision|1|||
160672128|NCT01380782|580178621|FG001|Overall Study|Physician Decision|0|||
160672129|NCT01380782|580178622|FG002|Overall Study|Physician Decision|0|||
160672130|NCT01380782|580178623|FG003|Overall Study|Physician Decision|0|||
160672131|NCT01380782|580178620|FG000|Overall Study|Withdrawal by Subject|0|||
160672132|NCT01380782|580178621|FG001|Overall Study|Withdrawal by Subject|0|||
160672133|NCT01380782|580178622|FG002|Overall Study|Withdrawal by Subject|1|||
160672134|NCT01380782|580178623|FG003|Overall Study|Withdrawal by Subject|1|||
160672135|NCT01403194|580178627|FG000|Overall Study|Screen Failure|2|||
160672136|NCT01403194|580178627|FG000|Overall Study|Lost to Follow-up|8|||
160672137|NCT03428750|580178628|FG000|Overall Study|Withdrawal by Subject|11|||
160672138|NCT03428750|580178629|FG001|Overall Study|Withdrawal by Subject|10|||
160672139|NCT03428750|580178628|FG000|Overall Study|Lost to Follow-up|3|||
160672140|NCT03428750|580178629|FG001|Overall Study|Lost to Follow-up|9|||
160672141|NCT03428750|580178628|FG000|Overall Study|Adverse Event|9|||
160672142|NCT03428750|580178629|FG001|Overall Study|Adverse Event|1|||
160672143|NCT03428750|580178628|FG000|Overall Study|Protocol Violation|1|||
160672144|NCT03428750|580178629|FG001|Overall Study|Protocol Violation|0|||
160672145|NCT03428750|580178628|FG000|Overall Study|Administrative|0|||
160672146|NCT03428750|580178629|FG001|Overall Study|Administrative|1|||
160672147|NCT00274651|580178632|FG000|Overall Study|Adverse Event|6|||
160672148|NCT00274651|580178633|FG001|Overall Study|Adverse Event|3|||
160672149|NCT00274651|580178632|FG000|Overall Study|Lack of Efficacy|13|||
160672150|NCT00274651|580178633|FG001|Overall Study|Lack of Efficacy|6|||
160672151|NCT00274651|580178632|FG000|Overall Study|Death|1|||
160672152|NCT00274651|580178633|FG001|Overall Study|Death|3|||
160672153|NCT00274651|580178632|FG000|Overall Study|Withdrawal by Subject|0|||
160672154|NCT00274651|580178633|FG001|Overall Study|Withdrawal by Subject|1|||
160672155|NCT00274651|580178632|FG000|Overall Study|Physician Decision|8|||
160672156|NCT00274651|580178633|FG001|Overall Study|Physician Decision|7|||
160672157|NCT04474405|580178634|FG000|Overall Study|Withdrawal by Subject|0|||
160672158|NCT04474405|580178635|FG001|Overall Study|Withdrawal by Subject|0|||
160672159|NCT04474405|580178636|FG002|Overall Study|Withdrawal by Subject|1|||
160672160|NCT04474405|580178637|FG003|Overall Study|Withdrawal by Subject|0|||
160672161|NCT04474405|580178638|FG004|Overall Study|Withdrawal by Subject|1|||
160672162|NCT04474405|580178639|FG005|Overall Study|Withdrawal by Subject|0|||
160672163|NCT04474405|580178634|FG000|Overall Study|Other|0|||
160672164|NCT04474405|580178635|FG001|Overall Study|Other|0|||
160672165|NCT04474405|580178636|FG002|Overall Study|Other|0|||
160672166|NCT04474405|580178637|FG003|Overall Study|Other|0|||
160672167|NCT04474405|580178638|FG004|Overall Study|Other|3|||
160672168|NCT04474405|580178639|FG005|Overall Study|Other|0|||
160672169|NCT03446768|580178640|FG000|Overall Study|Withdrawal by Subject|0|||
160672170|NCT03446768|580178641|FG001|Overall Study|Withdrawal by Subject|1|||
160672171|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
160672172|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
160672173|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
160672174|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
160672175|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
160672176|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
160672177|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
160672178|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
160672179|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
160672180|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
160672181|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
160672182|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
160626683|NCT00505765|580015417|FG002|Overall Study|Withdrawal by Subject|0|||
160626684|NCT00505765|580015415|FG000|Overall Study|Adverse Event|1|||
160626685|NCT00505765|580015416|FG001|Overall Study|Adverse Event|2|||
160626686|NCT00505765|580015417|FG002|Overall Study|Adverse Event|0|||
160626687|NCT00505765|580015415|FG000|Overall Study|Noncompliance|0|||
160626688|NCT00505765|580015416|FG001|Overall Study|Noncompliance|1|||
160626689|NCT00505765|580015417|FG002|Overall Study|Noncompliance|3|||
160626690|NCT01207219|580015419|FG000|Overall Study|changed diagnosis during study period|5|||
160626691|NCT01207219|580015420|FG001|Overall Study|changed diagnosis during study period|3|||
160626692|NCT01207219|580015421|FG002|Overall Study|changed diagnosis during study period|1|||
160626693|NCT01207219|580015419|FG000|Overall Study|Lost to Follow-up|6|||
160626694|NCT01207219|580015420|FG001|Overall Study|Lost to Follow-up|8|||
160626695|NCT01207219|580015421|FG002|Overall Study|Lost to Follow-up|6|||
160626696|NCT01012609|580015422|FG000|Overall Study|Withdrawal by Subject|1|||
160672183|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
160672184|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
160672185|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
160626697|NCT01012609|580015423|FG001|Overall Study|Withdrawal by Subject|1|||
160626698|NCT01453296|580015424|FG000|Treatment Period 1|Adverse Event|0|||
160626699|NCT01453296|580015425|FG001|Treatment Period 1|Adverse Event|1|||
160626700|NCT01453296|580015424|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
160626701|NCT01453296|580015425|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
160626702|NCT01453296|580015424|FG000|Treatment Period 2|Adverse Event|1|||
160672186|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
160672187|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
160672188|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
160672189|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
160672190|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
160672191|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
160626703|NCT01453296|580015425|FG001|Treatment Period 2|Adverse Event|0|||
160626704|NCT01453296|580015424|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160626705|NCT01453296|580015425|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160626706|NCT00620776|580015426|FG000|Overall Study|Did not receive treatment|3|||
160626707|NCT00620776|580015427|FG001|Overall Study|Did not receive treatment|5|||
160626708|NCT00620776|580015426|FG000|Overall Study|Adverse Event|2|||
160626709|NCT00620776|580015427|FG001|Overall Study|Adverse Event|3|||
160626710|NCT00620776|580015426|FG000|Overall Study|Lack of Efficacy|2|||
160626711|NCT00620776|580015427|FG001|Overall Study|Lack of Efficacy|1|||
160626712|NCT00620776|580015426|FG000|Overall Study|Lost to Follow-up|2|||
160626713|NCT00620776|580015427|FG001|Overall Study|Lost to Follow-up|5|||
160626714|NCT00620776|580015426|FG000|Overall Study|Withdrawal by Subject|3|||
160626715|NCT00620776|580015427|FG001|Overall Study|Withdrawal by Subject|2|||
160672192|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
160672193|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
160672194|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
160672195|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
160672196|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
160672197|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
160672198|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
160672199|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
160672200|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
160672201|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
160672202|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
160672203|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
160672204|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
160672205|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
160672206|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
160672207|NCT04194801|580178642|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
160672208|NCT04194801|580178643|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
160672209|NCT04194801|580178644|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
160672210|NCT04194801|580178642|FG000|Part Ib/II End of Study|Death|2|||
160672211|NCT04194801|580178643|FG001|Part Ib/II End of Study|Death|3|||
160672212|NCT04194801|580178644|FG002|Part Ib/II End of Study|Death|3|||
160672213|NCT04194801|580178642|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
160672214|NCT04194801|580178643|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
160672215|NCT04194801|580178644|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
160672216|NCT04194801|580178642|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
160672217|NCT04194801|580178643|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
160672218|NCT04194801|580178644|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
160672219|NCT04194801|580178642|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
160672220|NCT04194801|580178643|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
160672221|NCT04194801|580178644|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
160672222|NCT04194801|580178642|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
160672223|NCT04194801|580178643|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
160672224|NCT04194801|580178644|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
160672225|NCT04723693|580178648|FG000|Overall Study|Withdrawal by Subject|2|||
160672226|NCT02157974|580178649|FG000|Overall Study|Withdrawal by Subject|0|||
160672227|NCT02157974|580178650|FG001|Overall Study|Withdrawal by Subject|1|||
160672228|NCT02157974|580178651|FG002|Overall Study|Withdrawal by Subject|0|||
160672229|NCT02157974|580178652|FG003|Overall Study|Withdrawal by Subject|0|||
160672230|NCT02157974|580178653|FG004|Overall Study|Withdrawal by Subject|0|||
160672231|NCT02157974|580178649|FG000|Overall Study|Screen Failure|0|||
160672232|NCT02157974|580178650|FG001|Overall Study|Screen Failure|1|||
160672233|NCT02157974|580178651|FG002|Overall Study|Screen Failure|0|||
160672234|NCT02157974|580178652|FG003|Overall Study|Screen Failure|0|||
160672235|NCT02157974|580178653|FG004|Overall Study|Screen Failure|0|||
160672236|NCT02157974|580178649|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
160672237|NCT02157974|580178650|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
160626716|NCT00924820|580015428|FG000|Overall Study|Death|2|||
160626717|NCT00924820|580015428|FG000|Overall Study|Ineligible, Screen Failure|5|||
160626718|NCT04983589|580015429|FG000|Overall Study|Withdrawal by Subject|0|||
160626719|NCT04983589|580015430|FG001|Overall Study|Withdrawal by Subject|3|||
160626720|NCT04983589|580015429|FG000|Overall Study|COVID-19 Infection|1|||
160626721|NCT04983589|580015430|FG001|Overall Study|COVID-19 Infection|0|||
160626722|NCT04983589|580015429|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
160626723|NCT04983589|580015430|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
160672238|NCT02157974|580178651|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
160626724|NCT00761969|580015431|FG000|Overall Study|Death|112|||
160626725|NCT00761969|580015432|FG001|Overall Study|Death|47|||
160672239|NCT02157974|580178652|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
160672240|NCT02157974|580178653|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
160519704|NCT00320541|579632829|FG000|Overall Study|Other|3|||
160519705|NCT00320541|579632830|FG001|Overall Study|Other|4|||
160519706|NCT00320541|579632829|FG000|Overall Study|Sponsor Decision|2|||
160519707|NCT00320541|579632830|FG001|Overall Study|Sponsor Decision|1|||
160519708|NCT00320541|579632829|FG000|Overall Study|Death due to Study Disease|1|||
160519709|NCT00320541|579632830|FG001|Overall Study|Death due to Study Disease|3|||
160519710|NCT00320541|579632829|FG000|Overall Study|Death due to Adverse Event(s)|1|||
160519711|NCT00320541|579632830|FG001|Overall Study|Death due to Adverse Event(s)|0|||
160519712|NCT00320541|579632829|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
160519713|NCT00320541|579632830|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
160519714|NCT04281004|579632833|FG000|Overall Study|Physician Decision|1|||
160519715|NCT04281004|579632834|FG001|Overall Study|Physician Decision|0|||
160519716|NCT00701779|579632835|FG000|Overall Study|Adverse Event|6|||
160519717|NCT00701779|579632835|FG000|Overall Study|Lost to Follow-up|1|||
160519718|NCT00701779|579632835|FG000|Overall Study|Withdrawal by Subject|2|||
160519719|NCT02245672|579632836|FG000|Overall Study|Adverse Event|4|||
160519720|NCT02245672|579632837|FG001|Overall Study|Adverse Event|4|||
160519721|NCT02245672|579632838|FG002|Overall Study|Adverse Event|4|||
160519722|NCT02245672|579632836|FG000|Overall Study|Lost to Follow-up|3|||
160519723|NCT02245672|579632837|FG001|Overall Study|Lost to Follow-up|5|||
160519724|NCT02245672|579632838|FG002|Overall Study|Lost to Follow-up|1|||
160519725|NCT02245672|579632836|FG000|Overall Study|Withdrawal by Subject|6|||
160519726|NCT02245672|579632837|FG001|Overall Study|Withdrawal by Subject|3|||
160519727|NCT02245672|579632838|FG002|Overall Study|Withdrawal by Subject|0|||
160519728|NCT02245672|579632836|FG000|Overall Study|Randomized in error (not treated)|0|||
160519729|NCT02245672|579632837|FG001|Overall Study|Randomized in error (not treated)|1|||
160519730|NCT02245672|579632838|FG002|Overall Study|Randomized in error (not treated)|0|||
160519731|NCT04363801|579632846|FG000|Overall Study|Death|18|||
160519732|NCT04363801|579632847|FG001|Overall Study|Death|14|||
160519733|NCT04363801|579632848|FG002|Overall Study|Death|16|||
160519734|NCT04363801|579632849|FG003|Overall Study|Death|48|||
160519735|NCT04363801|579632850|FG004|Overall Study|Death|38|||
160519736|NCT04363801|579632846|FG000|Overall Study|Withdrawal by Subject|1|||
160519737|NCT04363801|579632847|FG001|Overall Study|Withdrawal by Subject|6|||
160519738|NCT04363801|579632848|FG002|Overall Study|Withdrawal by Subject|1|||
160519739|NCT04363801|579632849|FG003|Overall Study|Withdrawal by Subject|4|||
160519740|NCT04363801|579632850|FG004|Overall Study|Withdrawal by Subject|14|||
160519741|NCT04363801|579632846|FG000|Overall Study|Sponsor Decision|6|||
160519742|NCT04363801|579632847|FG001|Overall Study|Sponsor Decision|4|||
160519743|NCT04363801|579632848|FG002|Overall Study|Sponsor Decision|10|||
160519744|NCT04363801|579632849|FG003|Overall Study|Sponsor Decision|33|||
160519745|NCT04363801|579632850|FG004|Overall Study|Sponsor Decision|32|||
160519746|NCT04363801|579632846|FG000|Overall Study|Lost to Follow-up|0|||
160519747|NCT04363801|579632847|FG001|Overall Study|Lost to Follow-up|0|||
160519748|NCT04363801|579632848|FG002|Overall Study|Lost to Follow-up|1|||
160519749|NCT04363801|579632849|FG003|Overall Study|Lost to Follow-up|0|||
160519750|NCT04363801|579632850|FG004|Overall Study|Lost to Follow-up|1|||
160519751|NCT01146054|579632851|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
160519752|NCT01146054|579632851|FG000|Overall Study|Rapid tumor progression|2|||
160519753|NCT01146054|579632851|FG000|Overall Study|Other illness precluded treatment|2|||
160519754|NCT01146054|579632851|FG000|Overall Study|Lost to Follow-up|1|||
160519755|NCT02901041|579632852|FG000|Overall Study|Withdrawal by PI|4|||
160519756|NCT02901041|579632853|FG001|Overall Study|Withdrawal by PI|8|||
160519757|NCT02901041|579632852|FG000|Overall Study|Withdrawal by Subject|7|||
160519758|NCT02901041|579632853|FG001|Overall Study|Withdrawal by Subject|3|||
160519759|NCT03818204|579632854|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519760|NCT03818204|579632855|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519761|NCT03818204|579632856|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519762|NCT03818204|579632857|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519763|NCT03818204|579632858|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
160519764|NCT03818204|579632859|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519765|NCT03818204|579632860|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519766|NCT03818204|579632861|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519767|NCT03818204|579632862|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519768|NCT03818204|579632863|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519769|NCT03818204|579632864|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519770|NCT03818204|579632865|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519771|NCT03818204|579632866|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519772|NCT03818204|579632867|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
160519773|NCT03818204|579632868|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519774|NCT03818204|579632869|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519775|NCT03818204|579632870|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519776|NCT03818204|579632871|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160626726|NCT00761969|580015431|FG000|Overall Study|Lost to Follow-up|88|||
160626727|NCT00761969|580015432|FG001|Overall Study|Lost to Follow-up|93|||
160626728|NCT01725217|580015433|FG000|Overall Study|Withdrawal by Subject|1|||
160626729|NCT01725217|580015434|FG001|Overall Study|Withdrawal by Subject|0|||
160626730|NCT01725217|580015435|FG002|Overall Study|Withdrawal by Subject|0|||
160626731|NCT00585468|580015436|FG000|First Intervention|Withdrawal by Subject|1|||
160672241|NCT01808651|580178654|FG000|Study Period 1|Lost to Follow-up|1|||
160672242|NCT01808651|580178655|FG001|Study Period 1|Lost to Follow-up|3|||
160672243|NCT01808651|580178656|FG002|Study Period 1|Lost to Follow-up|0|||
160672244|NCT01808651|580178654|FG000|Study Period 1|Protocol Violation|1|||
160672245|NCT01808651|580178655|FG001|Study Period 1|Protocol Violation|0|||
160672246|NCT01808651|580178656|FG002|Study Period 1|Protocol Violation|1|||
160672247|NCT01808651|580178654|FG000|Study Period 1|Physician Decision|3|||
160672248|NCT01808651|580178655|FG001|Study Period 1|Physician Decision|2|||
160672249|NCT01808651|580178656|FG002|Study Period 1|Physician Decision|0|||
160672250|NCT01808651|580178654|FG000|Study Period 1|Lack of Efficacy|2|||
160672251|NCT01808651|580178655|FG001|Study Period 1|Lack of Efficacy|1|||
160672252|NCT01808651|580178656|FG002|Study Period 1|Lack of Efficacy|0|||
160672253|NCT01808651|580178654|FG000|Study Period 1|Adverse Event|10|||
160672254|NCT01808651|580178655|FG001|Study Period 1|Adverse Event|4|||
160672255|NCT01808651|580178656|FG002|Study Period 1|Adverse Event|1|||
160672256|NCT01808651|580178654|FG000|Study Period 1|Participant Decision|9|||
160672257|NCT01808651|580178655|FG001|Study Period 1|Participant Decision|7|||
160672258|NCT01808651|580178656|FG002|Study Period 1|Participant Decision|3|||
160672259|NCT02213263|580178661|FG000|Overall Study|Insufficient clinical response|4|||
160672260|NCT02213263|580178662|FG001|Overall Study|Insufficient clinical response|3|||
160672261|NCT02213263|580178661|FG000|Overall Study|Lost to Follow-up|0|||
160672262|NCT02213263|580178662|FG001|Overall Study|Lost to Follow-up|1|||
160672263|NCT02213263|580178661|FG000|Overall Study|No longer willing to participate|3|||
160672264|NCT02213263|580178662|FG001|Overall Study|No longer willing to participate|4|||
160672265|NCT02213263|580178661|FG000|Overall Study|Progressive disease|20|||
160672266|NCT02213263|580178662|FG001|Overall Study|Progressive disease|14|||
160672267|NCT02213263|580178661|FG000|Overall Study|Protocol Violation|0|||
160672268|NCT02213263|580178662|FG001|Overall Study|Protocol Violation|1|||
160672269|NCT02213263|580178661|FG000|Overall Study|Adverse Event|1|||
160672270|NCT02213263|580178662|FG001|Overall Study|Adverse Event|3|||
160672271|NCT05752721|580178663|FG000|Overall Study|Lost to Follow-up|22|||
160672272|NCT05752721|580178664|FG001|Overall Study|Lost to Follow-up|20|||
160672273|NCT05752721|580178663|FG000|Overall Study|Withdrawal by Subject|15|||
160672274|NCT05752721|580178664|FG001|Overall Study|Withdrawal by Subject|12|||
160672275|NCT00263588|580178665|FG000|Overall Study|Death|54|||
160672276|NCT00263588|580178666|FG001|Overall Study|Death|90|||
160672277|NCT00263588|580178665|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
160672278|NCT00263588|580178666|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
160672279|NCT00263588|580178665|FG000|Overall Study|Lost to Follow-up|7|||
160672280|NCT00263588|580178666|FG001|Overall Study|Lost to Follow-up|10|||
160672281|NCT00263588|580178665|FG000|Overall Study|Withdrawal by Subject|3|||
160672282|NCT00263588|580178666|FG001|Overall Study|Withdrawal by Subject|4|||
160672283|NCT00263588|580178665|FG000|Overall Study|Protocol Violation|0|||
160672284|NCT00263588|580178666|FG001|Overall Study|Protocol Violation|1|||
160672285|NCT00263588|580178665|FG000|Overall Study|Investigator decision|7|||
160672286|NCT00263588|580178666|FG001|Overall Study|Investigator decision|15|||
160672287|NCT00263588|580178665|FG000|Overall Study|Sponsor terminated study|0|||
160672288|NCT00263588|580178666|FG001|Overall Study|Sponsor terminated study|1|||
160672289|NCT00463684|580178678|FG000|Overall Study|Withdrawal by Subject|1|||
160672290|NCT00463684|580178678|FG000|Overall Study|Lost to Follow-up|3|||
160672291|NCT01906372|580178679|FG000|Overall Study|Withdrawal by Subject|2|||
160672292|NCT03629054|580178680|FG000|Period 2 (4 Days)|Not treated|0|||
160672293|NCT03629054|580178681|FG001|Period 2 (4 Days)|Not treated|1|||
160672294|NCT02462837|580178682|FG000|Overall Study|pt developed hives|1|||
160626732|NCT00585468|580015437|FG001|First Intervention|Withdrawal by Subject|1|||
160626733|NCT02940392|580015442|FG000|Overall Study|Lost to Follow-up|3|||
160626734|NCT02940392|580015442|FG000|Overall Study|Retreatment|3|||
160626735|NCT02940392|580015442|FG000|Overall Study|Death|2|||
160672295|NCT02462837|580178683|FG001|Overall Study|pt developed hives|0|||
160672296|NCT02462837|580178682|FG000|Overall Study|Withdrawal by Subject|1|||
160672297|NCT02462837|580178683|FG001|Overall Study|Withdrawal by Subject|0|||
160672298|NCT00924638|580178687|FG000|Overall Study|Death|3|||
160672299|NCT00924638|580178688|FG001|Overall Study|Death|2|||
160672300|NCT00924638|580178687|FG000|Overall Study|Lost to Follow-up|1|||
160672301|NCT00924638|580178688|FG001|Overall Study|Lost to Follow-up|1|||
160672302|NCT00924638|580178687|FG000|Overall Study|Withdrawal by Subject|5|||
160672303|NCT00924638|580178688|FG001|Overall Study|Withdrawal by Subject|7|||
160672304|NCT00924638|580178687|FG000|Overall Study|Physician Decision|3|||
160626736|NCT00762073|580015445|FG000|Overall Study|Lack of Efficacy|1|||
160672305|NCT00924638|580178688|FG001|Overall Study|Physician Decision|3|||
160672306|NCT01316055|580178689|FG000|Overall Study|Lost to Follow-up|1|||
160672307|NCT01316055|580178690|FG001|Overall Study|Lost to Follow-up|0|||
160672308|NCT01316055|580178691|FG002|Overall Study|Lost to Follow-up|0|||
160626737|NCT00762073|580015446|FG001|Overall Study|Lack of Efficacy|1|||
160626738|NCT00762073|580015447|FG002|Overall Study|Lack of Efficacy|0|||
160626739|NCT00762073|580015448|FG003|Overall Study|Lack of Efficacy|0|||
160626740|NCT00762073|580015445|FG000|Overall Study|Adverse Event|1|||
160626741|NCT00762073|580015446|FG001|Overall Study|Adverse Event|0|||
160626742|NCT00762073|580015447|FG002|Overall Study|Adverse Event|1|||
160626743|NCT00762073|580015448|FG003|Overall Study|Adverse Event|1|||
160626744|NCT00762073|580015445|FG000|Overall Study|Significant Subject Noncompliance|0|||
160626745|NCT00762073|580015446|FG001|Overall Study|Significant Subject Noncompliance|1|||
160626746|NCT00762073|580015447|FG002|Overall Study|Significant Subject Noncompliance|0|||
160626747|NCT00762073|580015448|FG003|Overall Study|Significant Subject Noncompliance|1|||
160626748|NCT00762073|580015445|FG000|Overall Study|Withdrawal by Subject|1|||
160626749|NCT00762073|580015446|FG001|Overall Study|Withdrawal by Subject|2|||
160626750|NCT00762073|580015447|FG002|Overall Study|Withdrawal by Subject|1|||
160626751|NCT00762073|580015448|FG003|Overall Study|Withdrawal by Subject|1|||
160626752|NCT00762073|580015445|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
160626753|NCT00762073|580015446|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
160626754|NCT00762073|580015447|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
160626755|NCT00762073|580015448|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
160626756|NCT01068418|580015449|FG000|Overall Study|Physician Decision|12|||
160626757|NCT02319642|580015450|FG000|Overall Study|Adverse Event|2|||
160626758|NCT02319642|580015451|FG001|Overall Study|Adverse Event|4|||
160626759|NCT02319642|580015450|FG000|Overall Study|Lack of Efficacy|1|||
160626760|NCT02319642|580015451|FG001|Overall Study|Lack of Efficacy|1|||
160626761|NCT02319642|580015450|FG000|Overall Study|Withdrawal by Subject|1|||
160626762|NCT02319642|580015451|FG001|Overall Study|Withdrawal by Subject|1|||
160626763|NCT01265875|580015452|FG000|Overall Study|Uncooperative/unreliable|1|||
160626764|NCT01049360|580015455|FG000|Period 1|Adverse Event|0|||
160626765|NCT01049360|580015456|FG001|Period 1|Adverse Event|1|||
160626766|NCT01049360|580015457|FG002|Period 1|Adverse Event|0|||
160626767|NCT01049360|580015458|FG003|Period 1|Adverse Event|1|||
160626768|NCT01049360|580015459|FG004|Period 1|Adverse Event|0|||
160626769|NCT01049360|580015460|FG005|Period 1|Adverse Event|0|||
160626770|NCT01049360|580015461|FG006|Period 1|Adverse Event|0|||
160626771|NCT01049360|580015462|FG007|Period 1|Adverse Event|1|||
160626772|NCT01049360|580015463|FG008|Period 1|Adverse Event|0|||
160626773|NCT01049360|580015464|FG009|Period 1|Adverse Event|0|||
160626774|NCT01049360|580015465|FG010|Period 1|Adverse Event|0|||
160626775|NCT01049360|580015466|FG011|Period 1|Adverse Event|0|||
160626776|NCT01049360|580015467|FG012|Period 1|Adverse Event|1|||
160626777|NCT01049360|580015468|FG013|Period 1|Adverse Event|1|||
160626778|NCT01049360|580015469|FG014|Period 1|Adverse Event|0|||
160626779|NCT01049360|580015470|FG015|Period 1|Adverse Event|0|||
160626780|NCT01049360|580015471|FG016|Period 1|Adverse Event|1|||
160626781|NCT01049360|580015472|FG017|Period 1|Adverse Event|0|||
160626782|NCT01049360|580015473|FG018|Period 1|Adverse Event|1|||
160626783|NCT01049360|580015474|FG019|Period 1|Adverse Event|0|||
160626784|NCT01049360|580015455|FG000|Period 1|Did not meet inc/exc criteria|0|||
160626785|NCT01049360|580015456|FG001|Period 1|Did not meet inc/exc criteria|0|||
160626786|NCT01049360|580015457|FG002|Period 1|Did not meet inc/exc criteria|0|||
160626787|NCT01049360|580015458|FG003|Period 1|Did not meet inc/exc criteria|0|||
160626788|NCT01049360|580015459|FG004|Period 1|Did not meet inc/exc criteria|0|||
160626789|NCT01049360|580015460|FG005|Period 1|Did not meet inc/exc criteria|0|||
160626790|NCT01049360|580015461|FG006|Period 1|Did not meet inc/exc criteria|0|||
160626791|NCT01049360|580015462|FG007|Period 1|Did not meet inc/exc criteria|1|||
160626792|NCT01049360|580015463|FG008|Period 1|Did not meet inc/exc criteria|1|||
160626793|NCT01049360|580015464|FG009|Period 1|Did not meet inc/exc criteria|0|||
160626794|NCT01049360|580015465|FG010|Period 1|Did not meet inc/exc criteria|0|||
160626795|NCT01049360|580015466|FG011|Period 1|Did not meet inc/exc criteria|0|||
160626796|NCT01049360|580015467|FG012|Period 1|Did not meet inc/exc criteria|0|||
160626797|NCT01049360|580015468|FG013|Period 1|Did not meet inc/exc criteria|0|||
160626798|NCT01049360|580015469|FG014|Period 1|Did not meet inc/exc criteria|0|||
160626799|NCT01049360|580015470|FG015|Period 1|Did not meet inc/exc criteria|0|||
160626800|NCT01049360|580015471|FG016|Period 1|Did not meet inc/exc criteria|0|||
160626801|NCT01049360|580015472|FG017|Period 1|Did not meet inc/exc criteria|0|||
160626802|NCT01049360|580015473|FG018|Period 1|Did not meet inc/exc criteria|0|||
160626803|NCT01049360|580015474|FG019|Period 1|Did not meet inc/exc criteria|0|||
160626804|NCT01049360|580015455|FG000|Period 1|Withdrawal by Subject|0|||
160626805|NCT01049360|580015456|FG001|Period 1|Withdrawal by Subject|0|||
160626806|NCT01049360|580015457|FG002|Period 1|Withdrawal by Subject|0|||
160626807|NCT01049360|580015458|FG003|Period 1|Withdrawal by Subject|0|||
160626808|NCT01049360|580015459|FG004|Period 1|Withdrawal by Subject|0|||
160626809|NCT01049360|580015460|FG005|Period 1|Withdrawal by Subject|0|||
160626810|NCT01049360|580015461|FG006|Period 1|Withdrawal by Subject|0|||
160626811|NCT01049360|580015462|FG007|Period 1|Withdrawal by Subject|0|||
160626812|NCT01049360|580015463|FG008|Period 1|Withdrawal by Subject|1|||
160626813|NCT01049360|580015464|FG009|Period 1|Withdrawal by Subject|0|||
160626814|NCT01049360|580015465|FG010|Period 1|Withdrawal by Subject|1|||
160626815|NCT01049360|580015466|FG011|Period 1|Withdrawal by Subject|0|||
160626816|NCT01049360|580015467|FG012|Period 1|Withdrawal by Subject|1|||
160626817|NCT01049360|580015468|FG013|Period 1|Withdrawal by Subject|0|||
160626818|NCT01049360|580015469|FG014|Period 1|Withdrawal by Subject|0|||
160626819|NCT01049360|580015470|FG015|Period 1|Withdrawal by Subject|0|||
160626820|NCT01049360|580015471|FG016|Period 1|Withdrawal by Subject|0|||
160672309|NCT01899053|580178696|FG000|Overall Study|Progressive Disease|4|||
160672310|NCT01899053|580178697|FG001|Overall Study|Progressive Disease|0|||
160672311|NCT01899053|580178698|FG002|Overall Study|Progressive Disease|3|||
160672312|NCT01899053|580178699|FG003|Overall Study|Progressive Disease|0|||
160672313|NCT01899053|580178700|FG004|Overall Study|Progressive Disease|3|||
160672314|NCT01899053|580178701|FG005|Overall Study|Progressive Disease|1|||
160626821|NCT01049360|580015472|FG017|Period 1|Withdrawal by Subject|0|||
160626822|NCT01049360|580015473|FG018|Period 1|Withdrawal by Subject|0|||
160626823|NCT01049360|580015474|FG019|Period 1|Withdrawal by Subject|0|||
160626824|NCT01049360|580015455|FG000|Period 2|Protocol Violation|0|||
160626825|NCT01049360|580015456|FG001|Period 2|Protocol Violation|0|||
160626826|NCT01049360|580015457|FG002|Period 2|Protocol Violation|0|||
160626827|NCT01049360|580015458|FG003|Period 2|Protocol Violation|1|||
160626828|NCT01049360|580015459|FG004|Period 2|Protocol Violation|0|||
160626829|NCT01049360|580015460|FG005|Period 2|Protocol Violation|0|||
160626830|NCT01049360|580015461|FG006|Period 2|Protocol Violation|0|||
160626831|NCT01049360|580015462|FG007|Period 2|Protocol Violation|0|||
160626832|NCT01049360|580015463|FG008|Period 2|Protocol Violation|0|||
160626833|NCT01049360|580015464|FG009|Period 2|Protocol Violation|0|||
160626834|NCT01049360|580015465|FG010|Period 2|Protocol Violation|0|||
160626835|NCT01049360|580015466|FG011|Period 2|Protocol Violation|0|||
160626836|NCT01049360|580015467|FG012|Period 2|Protocol Violation|0|||
160626837|NCT01049360|580015468|FG013|Period 2|Protocol Violation|0|||
160626838|NCT01049360|580015469|FG014|Period 2|Protocol Violation|1|||
160626839|NCT01049360|580015470|FG015|Period 2|Protocol Violation|1|||
160626840|NCT01049360|580015471|FG016|Period 2|Protocol Violation|0|||
160626841|NCT01049360|580015472|FG017|Period 2|Protocol Violation|0|||
160626842|NCT01049360|580015473|FG018|Period 2|Protocol Violation|0|||
160626843|NCT01049360|580015474|FG019|Period 2|Protocol Violation|0|||
160626844|NCT01049360|580015455|FG000|Period 2|Adverse Event|0|||
160626845|NCT01049360|580015456|FG001|Period 2|Adverse Event|1|||
160626846|NCT01049360|580015457|FG002|Period 2|Adverse Event|0|||
160626847|NCT01049360|580015458|FG003|Period 2|Adverse Event|0|||
160626848|NCT01049360|580015459|FG004|Period 2|Adverse Event|0|||
160626849|NCT01049360|580015460|FG005|Period 2|Adverse Event|0|||
160626850|NCT01049360|580015461|FG006|Period 2|Adverse Event|0|||
160626851|NCT01049360|580015462|FG007|Period 2|Adverse Event|0|||
160626852|NCT01049360|580015463|FG008|Period 2|Adverse Event|1|||
160626853|NCT01049360|580015464|FG009|Period 2|Adverse Event|0|||
160626854|NCT01049360|580015465|FG010|Period 2|Adverse Event|0|||
160626855|NCT01049360|580015466|FG011|Period 2|Adverse Event|0|||
160626856|NCT01049360|580015467|FG012|Period 2|Adverse Event|0|||
160626857|NCT01049360|580015468|FG013|Period 2|Adverse Event|0|||
160626858|NCT01049360|580015469|FG014|Period 2|Adverse Event|0|||
160626859|NCT01049360|580015470|FG015|Period 2|Adverse Event|0|||
160626860|NCT01049360|580015471|FG016|Period 2|Adverse Event|0|||
160626861|NCT01049360|580015472|FG017|Period 2|Adverse Event|0|||
160626862|NCT01049360|580015473|FG018|Period 2|Adverse Event|0|||
160626863|NCT01049360|580015474|FG019|Period 2|Adverse Event|1|||
160626864|NCT01049360|580015455|FG000|Period 2|Withdrawal by Subject|0|||
160626865|NCT01049360|580015456|FG001|Period 2|Withdrawal by Subject|0|||
160626866|NCT01049360|580015457|FG002|Period 2|Withdrawal by Subject|0|||
160626867|NCT01049360|580015458|FG003|Period 2|Withdrawal by Subject|1|||
160626868|NCT01049360|580015459|FG004|Period 2|Withdrawal by Subject|0|||
160626869|NCT01049360|580015460|FG005|Period 2|Withdrawal by Subject|0|||
160626870|NCT01049360|580015461|FG006|Period 2|Withdrawal by Subject|0|||
160626871|NCT01049360|580015462|FG007|Period 2|Withdrawal by Subject|0|||
160626872|NCT01049360|580015463|FG008|Period 2|Withdrawal by Subject|0|||
160672315|NCT01899053|580178702|FG006|Overall Study|Progressive Disease|1|||
160626873|NCT01049360|580015464|FG009|Period 2|Withdrawal by Subject|0|||
160626874|NCT01049360|580015465|FG010|Period 2|Withdrawal by Subject|0|||
160626875|NCT01049360|580015466|FG011|Period 2|Withdrawal by Subject|0|||
160626876|NCT01049360|580015467|FG012|Period 2|Withdrawal by Subject|0|||
160626877|NCT01049360|580015468|FG013|Period 2|Withdrawal by Subject|0|||
160626878|NCT01049360|580015469|FG014|Period 2|Withdrawal by Subject|1|||
160672316|NCT01899053|580178703|FG007|Overall Study|Progressive Disease|1|||
160626879|NCT01049360|580015470|FG015|Period 2|Withdrawal by Subject|0|||
160626880|NCT01049360|580015471|FG016|Period 2|Withdrawal by Subject|0|||
160626881|NCT01049360|580015472|FG017|Period 2|Withdrawal by Subject|0|||
160626882|NCT01049360|580015473|FG018|Period 2|Withdrawal by Subject|0|||
160626883|NCT01049360|580015474|FG019|Period 2|Withdrawal by Subject|1|||
160626884|NCT01049360|580015455|FG000|Period 2|Lack of Efficacy|0|||
160626885|NCT01049360|580015456|FG001|Period 2|Lack of Efficacy|0|||
160626886|NCT01049360|580015457|FG002|Period 2|Lack of Efficacy|0|||
160626887|NCT01049360|580015458|FG003|Period 2|Lack of Efficacy|0|||
160626888|NCT01049360|580015459|FG004|Period 2|Lack of Efficacy|0|||
160672317|NCT01899053|580178704|FG008|Overall Study|Progressive Disease|4|||
160672318|NCT01899053|580178705|FG009|Overall Study|Progressive Disease|3|||
160672319|NCT01899053|580178706|FG010|Overall Study|Progressive Disease|12|||
160672320|NCT01899053|580178707|FG011|Overall Study|Progressive Disease|5|||
160672321|NCT01899053|580178708|FG012|Overall Study|Progressive Disease|8|||
160672322|NCT01899053|580178709|FG013|Overall Study|Progressive Disease|17|||
160672323|NCT01899053|580178696|FG000|Overall Study|Adverse Event|1|||
160672324|NCT01899053|580178697|FG001|Overall Study|Adverse Event|1|||
160672325|NCT01899053|580178698|FG002|Overall Study|Adverse Event|1|||
160672326|NCT01899053|580178699|FG003|Overall Study|Adverse Event|3|||
160672327|NCT01899053|580178700|FG004|Overall Study|Adverse Event|1|||
160672328|NCT01899053|580178701|FG005|Overall Study|Adverse Event|1|||
160672329|NCT01899053|580178702|FG006|Overall Study|Adverse Event|1|||
160672330|NCT01899053|580178703|FG007|Overall Study|Adverse Event|0|||
160672331|NCT01899053|580178704|FG008|Overall Study|Adverse Event|2|||
160672332|NCT01899053|580178705|FG009|Overall Study|Adverse Event|0|||
160672333|NCT01899053|580178706|FG010|Overall Study|Adverse Event|3|||
160672334|NCT01899053|580178707|FG011|Overall Study|Adverse Event|1|||
160672335|NCT01899053|580178708|FG012|Overall Study|Adverse Event|2|||
160672336|NCT01899053|580178709|FG013|Overall Study|Adverse Event|2|||
160672337|NCT01899053|580178696|FG000|Overall Study|Reason Not Specified|0|||
160672338|NCT01899053|580178697|FG001|Overall Study|Reason Not Specified|0|||
160672339|NCT01899053|580178698|FG002|Overall Study|Reason Not Specified|0|||
160672340|NCT01899053|580178699|FG003|Overall Study|Reason Not Specified|0|||
160672341|NCT01899053|580178700|FG004|Overall Study|Reason Not Specified|0|||
160672342|NCT01899053|580178701|FG005|Overall Study|Reason Not Specified|0|||
160672343|NCT01899053|580178702|FG006|Overall Study|Reason Not Specified|1|||
160672344|NCT01899053|580178703|FG007|Overall Study|Reason Not Specified|0|||
160672345|NCT01899053|580178704|FG008|Overall Study|Reason Not Specified|0|||
160672346|NCT01899053|580178705|FG009|Overall Study|Reason Not Specified|0|||
160672347|NCT01899053|580178706|FG010|Overall Study|Reason Not Specified|0|||
160672348|NCT01899053|580178707|FG011|Overall Study|Reason Not Specified|0|||
160672349|NCT01899053|580178708|FG012|Overall Study|Reason Not Specified|1|||
160672350|NCT01899053|580178709|FG013|Overall Study|Reason Not Specified|0|||
160672351|NCT01899053|580178696|FG000|Overall Study|Withdrawal by Subject|1|||
160672352|NCT01899053|580178697|FG001|Overall Study|Withdrawal by Subject|1|||
160672353|NCT01899053|580178698|FG002|Overall Study|Withdrawal by Subject|2|||
160672354|NCT01899053|580178699|FG003|Overall Study|Withdrawal by Subject|0|||
160672355|NCT01899053|580178700|FG004|Overall Study|Withdrawal by Subject|2|||
160672356|NCT01899053|580178701|FG005|Overall Study|Withdrawal by Subject|0|||
160672357|NCT01899053|580178702|FG006|Overall Study|Withdrawal by Subject|0|||
160672358|NCT01899053|580178703|FG007|Overall Study|Withdrawal by Subject|1|||
160672359|NCT01899053|580178704|FG008|Overall Study|Withdrawal by Subject|0|||
160672360|NCT01899053|580178705|FG009|Overall Study|Withdrawal by Subject|0|||
160672361|NCT01899053|580178706|FG010|Overall Study|Withdrawal by Subject|0|||
160672362|NCT01899053|580178707|FG011|Overall Study|Withdrawal by Subject|0|||
160672363|NCT01899053|580178708|FG012|Overall Study|Withdrawal by Subject|1|||
160672364|NCT01899053|580178709|FG013|Overall Study|Withdrawal by Subject|1|||
160672365|NCT01899053|580178696|FG000|Overall Study|Protocol Violation|0|||
160672366|NCT01899053|580178697|FG001|Overall Study|Protocol Violation|0|||
160672367|NCT01899053|580178698|FG002|Overall Study|Protocol Violation|1|||
160672368|NCT01899053|580178699|FG003|Overall Study|Protocol Violation|0|||
160672369|NCT01899053|580178700|FG004|Overall Study|Protocol Violation|0|||
160672370|NCT01899053|580178701|FG005|Overall Study|Protocol Violation|0|||
160672371|NCT01899053|580178702|FG006|Overall Study|Protocol Violation|0|||
160672372|NCT01899053|580178703|FG007|Overall Study|Protocol Violation|0|||
160672373|NCT01899053|580178704|FG008|Overall Study|Protocol Violation|0|||
160672374|NCT01899053|580178705|FG009|Overall Study|Protocol Violation|0|||
160672375|NCT01899053|580178706|FG010|Overall Study|Protocol Violation|0|||
160672376|NCT01899053|580178707|FG011|Overall Study|Protocol Violation|0|||
160672377|NCT01899053|580178708|FG012|Overall Study|Protocol Violation|0|||
160672378|NCT01899053|580178709|FG013|Overall Study|Protocol Violation|0|||
160672379|NCT01899053|580178696|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
160672380|NCT01899053|580178697|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
160672381|NCT01899053|580178698|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672382|NCT01899053|580178699|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672383|NCT01899053|580178700|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672384|NCT01899053|580178701|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672385|NCT01899053|580178702|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672386|NCT01899053|580178703|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672387|NCT01899053|580178704|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672388|NCT01899053|580178705|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672389|NCT01899053|580178706|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
160672390|NCT01899053|580178707|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672391|NCT01899053|580178708|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672392|NCT01899053|580178709|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
160672393|NCT01899053|580178696|FG000|Overall Study|Symptomatic Deterioration|0|||
160672394|NCT01899053|580178697|FG001|Overall Study|Symptomatic Deterioration|0|||
160626889|NCT01049360|580015460|FG005|Period 2|Lack of Efficacy|1|||
160626890|NCT01049360|580015461|FG006|Period 2|Lack of Efficacy|0|||
160626891|NCT01049360|580015462|FG007|Period 2|Lack of Efficacy|0|||
160626892|NCT01049360|580015463|FG008|Period 2|Lack of Efficacy|0|||
160626893|NCT01049360|580015464|FG009|Period 2|Lack of Efficacy|0|||
160626894|NCT01049360|580015465|FG010|Period 2|Lack of Efficacy|0|||
160626895|NCT01049360|580015466|FG011|Period 2|Lack of Efficacy|0|||
160626896|NCT01049360|580015467|FG012|Period 2|Lack of Efficacy|0|||
160626897|NCT01049360|580015468|FG013|Period 2|Lack of Efficacy|0|||
160626898|NCT01049360|580015469|FG014|Period 2|Lack of Efficacy|0|||
160626899|NCT01049360|580015470|FG015|Period 2|Lack of Efficacy|0|||
160626900|NCT01049360|580015471|FG016|Period 2|Lack of Efficacy|0|||
160626901|NCT01049360|580015472|FG017|Period 2|Lack of Efficacy|0|||
160626902|NCT01049360|580015473|FG018|Period 2|Lack of Efficacy|0|||
160626903|NCT01049360|580015474|FG019|Period 2|Lack of Efficacy|0|||
160626904|NCT01049360|580015455|FG000|Period 4|Protocol Violation|0|||
160626905|NCT01049360|580015456|FG001|Period 4|Protocol Violation|0|||
160626906|NCT01049360|580015457|FG002|Period 4|Protocol Violation|0|||
160626907|NCT01049360|580015458|FG003|Period 4|Protocol Violation|0|||
160626908|NCT01049360|580015459|FG004|Period 4|Protocol Violation|0|||
160626909|NCT01049360|580015460|FG005|Period 4|Protocol Violation|0|||
160626910|NCT01049360|580015461|FG006|Period 4|Protocol Violation|0|||
160626911|NCT01049360|580015462|FG007|Period 4|Protocol Violation|0|||
160626912|NCT01049360|580015463|FG008|Period 4|Protocol Violation|0|||
160626913|NCT01049360|580015464|FG009|Period 4|Protocol Violation|0|||
160626914|NCT01049360|580015465|FG010|Period 4|Protocol Violation|0|||
160626915|NCT01049360|580015466|FG011|Period 4|Protocol Violation|0|||
160626916|NCT01049360|580015467|FG012|Period 4|Protocol Violation|0|||
160626917|NCT01049360|580015468|FG013|Period 4|Protocol Violation|0|||
160626918|NCT01049360|580015469|FG014|Period 4|Protocol Violation|0|||
160626919|NCT01049360|580015470|FG015|Period 4|Protocol Violation|0|||
160626920|NCT01049360|580015471|FG016|Period 4|Protocol Violation|0|||
160626921|NCT01049360|580015472|FG017|Period 4|Protocol Violation|1|||
160626922|NCT01049360|580015473|FG018|Period 4|Protocol Violation|0|||
160626923|NCT01049360|580015474|FG019|Period 4|Protocol Violation|0|||
160626924|NCT01049360|580015455|FG000|Period 4|Withdrawal by Subject|0|||
160626925|NCT01049360|580015456|FG001|Period 4|Withdrawal by Subject|0|||
160626926|NCT01049360|580015457|FG002|Period 4|Withdrawal by Subject|0|||
160626927|NCT01049360|580015458|FG003|Period 4|Withdrawal by Subject|1|||
160626928|NCT01049360|580015459|FG004|Period 4|Withdrawal by Subject|0|||
160626929|NCT01049360|580015460|FG005|Period 4|Withdrawal by Subject|0|||
160626930|NCT01049360|580015461|FG006|Period 4|Withdrawal by Subject|0|||
160626931|NCT01049360|580015462|FG007|Period 4|Withdrawal by Subject|0|||
160626932|NCT01049360|580015463|FG008|Period 4|Withdrawal by Subject|0|||
160626933|NCT01049360|580015464|FG009|Period 4|Withdrawal by Subject|0|||
160626934|NCT01049360|580015465|FG010|Period 4|Withdrawal by Subject|0|||
160626935|NCT01049360|580015466|FG011|Period 4|Withdrawal by Subject|0|||
160626936|NCT01049360|580015467|FG012|Period 4|Withdrawal by Subject|0|||
160626937|NCT01049360|580015468|FG013|Period 4|Withdrawal by Subject|0|||
160626938|NCT01049360|580015469|FG014|Period 4|Withdrawal by Subject|0|||
160626939|NCT01049360|580015470|FG015|Period 4|Withdrawal by Subject|0|||
160626940|NCT01049360|580015471|FG016|Period 4|Withdrawal by Subject|0|||
160626941|NCT01049360|580015472|FG017|Period 4|Withdrawal by Subject|0|||
160626942|NCT01049360|580015473|FG018|Period 4|Withdrawal by Subject|0|||
160626943|NCT01049360|580015474|FG019|Period 4|Withdrawal by Subject|0|||
160626944|NCT05147311|580015477|FG000|Overall Study|Did not complete survey|2|||
160626945|NCT05147311|580015478|FG001|Overall Study|Did not complete survey|1|||
160626946|NCT05147311|580015477|FG000|Overall Study|Patient too sick|1|||
160626947|NCT05147311|580015478|FG001|Overall Study|Patient too sick|2|||
160626948|NCT05147311|580015477|FG000|Overall Study|Death|0|||
160626949|NCT05147311|580015478|FG001|Overall Study|Death|1|||
160626950|NCT05147311|580015477|FG000|Overall Study|Declined survey|1|||
160626951|NCT05147311|580015478|FG001|Overall Study|Declined survey|0|||
160626952|NCT00145795|580015480|FG000|Overall Study|Adverse Event|1|||
160626953|NCT00145795|580015481|FG001|Overall Study|Adverse Event|0|||
160626954|NCT04419558|580015482|FG000|DB Period (48 Weeks)|Adverse Event|6|||
160626955|NCT04419558|580015483|FG001|DB Period (48 Weeks)|Adverse Event|6|||
160626956|NCT04419558|580015482|FG000|DB Period (48 Weeks)|Death|14|||
160626957|NCT04419558|580015483|FG001|DB Period (48 Weeks)|Death|11|||
160626958|NCT04419558|580015482|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
160626959|NCT04419558|580015483|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
160626960|NCT04419558|580015482|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
160626961|NCT04419558|580015483|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
160626962|NCT04419558|580015482|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
160626963|NCT04419558|580015483|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
160626964|NCT04419558|580015482|FG000|DB Period (48 Weeks)|Disease Progression|1|||
160626965|NCT04419558|580015483|FG001|DB Period (48 Weeks)|Disease Progression|0|||
160626966|NCT04419558|580015482|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
160626967|NCT04419558|580015483|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
160626968|NCT04419558|580015482|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
160626969|NCT04419558|580015483|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
160626970|NCT04419558|580015482|FG000|DB Period (48 Weeks)|Participant Decision|4|||
160626971|NCT04419558|580015483|FG001|DB Period (48 Weeks)|Participant Decision|3|||
160626972|NCT04419558|580015482|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
160626973|NCT04419558|580015483|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
160626974|NCT04419558|580015482|FG000|OLE Period (48 Weeks)|Death|4|||
160626975|NCT04419558|580015483|FG001|OLE Period (48 Weeks)|Death|6|||
160626976|NCT04419558|580015482|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
160626977|NCT04419558|580015483|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
160626978|NCT04419558|580015482|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
160626979|NCT04419558|580015483|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
160626980|NCT01015118|580015487|FG000|Overall Study|Protocol Violation|5|||
160626981|NCT01015118|580015488|FG001|Overall Study|Protocol Violation|6|||
160626982|NCT01015118|580015487|FG000|Overall Study|Withdrawal by Subject|103|||
160626983|NCT01015118|580015488|FG001|Overall Study|Withdrawal by Subject|27|||
160626984|NCT01015118|580015487|FG000|Overall Study|Other Adverse Event (AE)|141|||
160626985|NCT01015118|580015488|FG001|Overall Study|Other Adverse Event (AE)|33|||
160626986|NCT01015118|580015487|FG000|Overall Study|Worsening or AE of underlying disease|5|||
160626987|NCT01015118|580015488|FG001|Overall Study|Worsening or AE of underlying disease|4|||
160626988|NCT01015118|580015487|FG000|Overall Study|Progressive disease|364|||
160626989|NCT01015118|580015488|FG001|Overall Study|Progressive disease|229|||
160626990|NCT01015118|580015487|FG000|Overall Study|Not treated|9|||
160626991|NCT01015118|580015488|FG001|Overall Study|Not treated|5|||
160626992|NCT01015118|580015487|FG000|Overall Study|Other than stated above|42|||
160626993|NCT01015118|580015488|FG001|Overall Study|Other than stated above|23|||
160626994|NCT02388906|580015493|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
160626995|NCT02388906|580015494|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
160626996|NCT02388906|580015493|FG000|Treatment Period|Disease progression|121|||
160626997|NCT02388906|580015494|FG001|Treatment Period|Disease progression|100|||
160626998|NCT02388906|580015493|FG000|Treatment Period|Study drug toxicity|41|||
160626999|NCT02388906|580015494|FG001|Treatment Period|Study drug toxicity|208|||
160627000|NCT02388906|580015493|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
160627001|NCT02388906|580015494|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
160627002|NCT02388906|580015493|FG000|Treatment Period|Participant request to stop treatment|5|||
160627003|NCT02388906|580015494|FG001|Treatment Period|Participant request to stop treatment|9|||
160627004|NCT02388906|580015493|FG000|Treatment Period|Participant withdrew consent|2|||
160627005|NCT02388906|580015494|FG001|Treatment Period|Participant withdrew consent|3|||
160627006|NCT02388906|580015493|FG000|Treatment Period|Poor/non-compliance|0|||
160627007|NCT02388906|580015494|FG001|Treatment Period|Poor/non-compliance|1|||
160627008|NCT02388906|580015493|FG000|Treatment Period|Participant no longer meets study criteria|0|||
160627009|NCT02388906|580015494|FG001|Treatment Period|Participant no longer meets study criteria|1|||
160627010|NCT02388906|580015493|FG000|Treatment Period|Other reasons|3|||
160627011|NCT02388906|580015494|FG001|Treatment Period|Other reasons|3|||
160627012|NCT00402298|580015503|FG000|Overall Study|Withdrawal by Subject|1|||
160627013|NCT00402298|580015504|FG001|Overall Study|Withdrawal by Subject|0|||
160627014|NCT00480077|580015505|FG000|Overall Study|Death|19|||
160627015|NCT00480077|580015506|FG001|Overall Study|Death|15|||
160627016|NCT00480077|580015505|FG000|Overall Study|early exit|12|||
160627017|NCT00480077|580015506|FG001|Overall Study|early exit|11|||
160627018|NCT00071006|580015509|FG000|Overall Study|Lack of Efficacy|7|||
160627019|NCT00071006|580015509|FG000|Overall Study|Adverse Event|1|||
160627020|NCT00071006|580015509|FG000|Overall Study|Withdrawal by Subject|1|||
160627021|NCT00071006|580015509|FG000|Overall Study|Other|3|||
160627022|NCT00859313|580015510|FG000|Overall Study|Lack of Efficacy|2|||
160627023|NCT00859313|580015510|FG000|Overall Study|Adverse Event|1|||
160627024|NCT00859313|580015510|FG000|Overall Study|staff error|1|||
160627025|NCT05939388|580015511|FG000|Overall Study|Lost to Follow-up|1|||
160627026|NCT03901274|580015512|FG000|Overall Study|Lost to Follow-up|120|||
160627027|NCT03901274|580015513|FG001|Overall Study|Lost to Follow-up|124|||
160627028|NCT03901274|580015512|FG000|Overall Study|Withdrawal by Subject|0|||
160627029|NCT03901274|580015513|FG001|Overall Study|Withdrawal by Subject|6|||
160627030|NCT04410991|580015526|FG000|Overall Study|Poor compliance to protocol|5|||
160627031|NCT04410991|580015527|FG001|Overall Study|Poor compliance to protocol|4|||
160627032|NCT04410991|580015526|FG000|Overall Study|Withdrawal by Subject|59|||
160627033|NCT04410991|580015527|FG001|Overall Study|Withdrawal by Subject|55|||
160627034|NCT04410991|580015526|FG000|Overall Study|Other|10|||
160627035|NCT04410991|580015527|FG001|Overall Study|Other|4|||
160627036|NCT00938366|580015529|FG000|Overall Study|Withdrawal by Subject|1|||
160627037|NCT00938366|580015530|FG001|Overall Study|Withdrawal by Subject|0|||
160627038|NCT05966129|580015531|FG000|Overall Study|Death|1|||
160627039|NCT05966129|580015532|FG001|Overall Study|Death|2|||
160627040|NCT05966129|580015531|FG000|Overall Study|Lost to Follow-up|63|||
160627041|NCT05966129|580015532|FG001|Overall Study|Lost to Follow-up|66|||
160627042|NCT05966129|580015531|FG000|Overall Study|Protocol Violation|1|||
160627043|NCT05966129|580015532|FG001|Overall Study|Protocol Violation|0|||
160627044|NCT05966129|580015531|FG000|Overall Study|Withdrawal by Subject|26|||
160627045|NCT05966129|580015532|FG001|Overall Study|Withdrawal by Subject|25|||
160627046|NCT05966129|580015531|FG000|Overall Study|Surgery not completed|63|||
160627047|NCT05966129|580015532|FG001|Overall Study|Surgery not completed|69|||
160627048|NCT05966129|580015531|FG000|Overall Study|Surgery logistics issue|2|||
160627049|NCT05966129|580015532|FG001|Overall Study|Surgery logistics issue|1|||
160627050|NCT05182840|580015533|FG000|Run-in Period|Not treated|0|||
160627051|NCT05182840|580015534|FG001|Run-in Period|Not treated|1|||
160627052|NCT05182840|580015535|FG002|Run-in Period|Not treated|0|||
160627053|NCT05182840|580015536|FG003|Run-in Period|Not treated|0|||
160627054|NCT05182840|580015537|FG004|Run-in Period|Not treated|0|||
160627055|NCT05182840|580015538|FG005|Run-in Period|Not treated|0|||
160627056|NCT05182840|580015539|FG006|Run-in Period|Not treated|0|||
160627057|NCT05182840|580015540|FG007|Run-in Period|Not treated|0|||
160627058|NCT05182840|580015541|FG008|Run-in Period|Not treated|0|||
160627059|NCT05182840|580015542|FG009|Run-in Period|Not treated|0|||
160627060|NCT05182840|580015533|FG000|Run-in Period|Other reason but not sponsor termination|14|||
160627061|NCT05182840|580015534|FG001|Run-in Period|Other reason but not sponsor termination|18|||
160627062|NCT05182840|580015535|FG002|Run-in Period|Other reason but not sponsor termination|0|||
160627063|NCT05182840|580015536|FG003|Run-in Period|Other reason but not sponsor termination|0|||
160627064|NCT05182840|580015537|FG004|Run-in Period|Other reason but not sponsor termination|0|||
160627065|NCT05182840|580015538|FG005|Run-in Period|Other reason but not sponsor termination|0|||
160627066|NCT05182840|580015539|FG006|Run-in Period|Other reason but not sponsor termination|0|||
160627067|NCT05182840|580015540|FG007|Run-in Period|Other reason but not sponsor termination|0|||
160627068|NCT05182840|580015541|FG008|Run-in Period|Other reason but not sponsor termination|0|||
160627069|NCT05182840|580015542|FG009|Run-in Period|Other reason but not sponsor termination|0|||
160627070|NCT05182840|580015533|FG000|Run-in Period|No reason available|2|||
160627071|NCT05182840|580015534|FG001|Run-in Period|No reason available|2|||
160627072|NCT05182840|580015535|FG002|Run-in Period|No reason available|0|||
160627073|NCT05182840|580015536|FG003|Run-in Period|No reason available|0|||
160627074|NCT05182840|580015537|FG004|Run-in Period|No reason available|0|||
160627075|NCT05182840|580015538|FG005|Run-in Period|No reason available|0|||
160627076|NCT05182840|580015539|FG006|Run-in Period|No reason available|0|||
160627077|NCT05182840|580015540|FG007|Run-in Period|No reason available|0|||
160627078|NCT05182840|580015541|FG008|Run-in Period|No reason available|0|||
160627079|NCT05182840|580015542|FG009|Run-in Period|No reason available|0|||
160627080|NCT05182840|580015533|FG000|Run-in Period|Burden of study procedures|2|||
160627081|NCT05182840|580015534|FG001|Run-in Period|Burden of study procedures|2|||
160627082|NCT05182840|580015535|FG002|Run-in Period|Burden of study procedures|0|||
160627083|NCT05182840|580015536|FG003|Run-in Period|Burden of study procedures|0|||
160627084|NCT05182840|580015537|FG004|Run-in Period|Burden of study procedures|0|||
160627085|NCT05182840|580015538|FG005|Run-in Period|Burden of study procedures|0|||
160627086|NCT05182840|580015539|FG006|Run-in Period|Burden of study procedures|0|||
160627087|NCT05182840|580015540|FG007|Run-in Period|Burden of study procedures|0|||
160627088|NCT05182840|580015541|FG008|Run-in Period|Burden of study procedures|0|||
160627089|NCT05182840|580015542|FG009|Run-in Period|Burden of study procedures|0|||
160627090|NCT05182840|580015533|FG000|Run-in Period|Change of residence|1|||
160627091|NCT05182840|580015534|FG001|Run-in Period|Change of residence|0|||
160627092|NCT05182840|580015535|FG002|Run-in Period|Change of residence|0|||
160627093|NCT05182840|580015536|FG003|Run-in Period|Change of residence|0|||
160627094|NCT05182840|580015537|FG004|Run-in Period|Change of residence|0|||
160627095|NCT05182840|580015538|FG005|Run-in Period|Change of residence|0|||
160627096|NCT05182840|580015539|FG006|Run-in Period|Change of residence|0|||
160627097|NCT05182840|580015540|FG007|Run-in Period|Change of residence|0|||
160627098|NCT05182840|580015541|FG008|Run-in Period|Change of residence|0|||
160627099|NCT05182840|580015542|FG009|Run-in Period|Change of residence|0|||
160627100|NCT05182840|580015533|FG000|Run-in Period|Adverse Event|5|||
160627101|NCT05182840|580015534|FG001|Run-in Period|Adverse Event|5|||
160627102|NCT05182840|580015535|FG002|Run-in Period|Adverse Event|0|||
160627103|NCT05182840|580015536|FG003|Run-in Period|Adverse Event|0|||
160627104|NCT05182840|580015537|FG004|Run-in Period|Adverse Event|0|||
160627105|NCT05182840|580015538|FG005|Run-in Period|Adverse Event|0|||
160627106|NCT05182840|580015539|FG006|Run-in Period|Adverse Event|0|||
160627107|NCT05182840|580015540|FG007|Run-in Period|Adverse Event|0|||
160627108|NCT05182840|580015541|FG008|Run-in Period|Adverse Event|0|||
160627109|NCT05182840|580015542|FG009|Run-in Period|Adverse Event|0|||
160627110|NCT05182840|580015533|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
160627111|NCT05182840|580015534|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
160627112|NCT05182840|580015535|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
160627113|NCT05182840|580015536|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
160627114|NCT05182840|580015537|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
160627115|NCT05182840|580015538|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
160627116|NCT05182840|580015539|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
160627117|NCT05182840|580015540|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
160627118|NCT05182840|580015541|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
160627119|NCT05182840|580015542|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
160627120|NCT05182840|580015533|FG000|Treatment Period|Reason missing|0|||
160627121|NCT05182840|580015534|FG001|Treatment Period|Reason missing|0|||
160627122|NCT05182840|580015535|FG002|Treatment Period|Reason missing|1|||
160627123|NCT05182840|580015536|FG003|Treatment Period|Reason missing|0|||
160627124|NCT05182840|580015537|FG004|Treatment Period|Reason missing|0|||
160627125|NCT05182840|580015538|FG005|Treatment Period|Reason missing|0|||
160627126|NCT05182840|580015539|FG006|Treatment Period|Reason missing|0|||
160627127|NCT05182840|580015540|FG007|Treatment Period|Reason missing|0|||
160627128|NCT05182840|580015541|FG008|Treatment Period|Reason missing|0|||
160627129|NCT05182840|580015542|FG009|Treatment Period|Reason missing|0|||
160627130|NCT05182840|580015533|FG000|Treatment Period|Other but not sponsor termination|0|||
160627131|NCT05182840|580015534|FG001|Treatment Period|Other but not sponsor termination|0|||
160627132|NCT05182840|580015535|FG002|Treatment Period|Other but not sponsor termination|8|||
160627133|NCT05182840|580015536|FG003|Treatment Period|Other but not sponsor termination|6|||
160627134|NCT05182840|580015537|FG004|Treatment Period|Other but not sponsor termination|6|||
160627135|NCT05182840|580015538|FG005|Treatment Period|Other but not sponsor termination|7|||
160627136|NCT05182840|580015539|FG006|Treatment Period|Other but not sponsor termination|5|||
160627137|NCT05182840|580015540|FG007|Treatment Period|Other but not sponsor termination|8|||
160627138|NCT05182840|580015541|FG008|Treatment Period|Other but not sponsor termination|7|||
160627139|NCT05182840|580015542|FG009|Treatment Period|Other but not sponsor termination|2|||
160627140|NCT05182840|580015533|FG000|Treatment Period|Protocol deviation|0|||
160627141|NCT05182840|580015534|FG001|Treatment Period|Protocol deviation|0|||
160627142|NCT05182840|580015535|FG002|Treatment Period|Protocol deviation|0|||
160627143|NCT05182840|580015536|FG003|Treatment Period|Protocol deviation|0|||
160627144|NCT05182840|580015537|FG004|Treatment Period|Protocol deviation|0|||
160627145|NCT05182840|580015538|FG005|Treatment Period|Protocol deviation|0|||
160627146|NCT05182840|580015539|FG006|Treatment Period|Protocol deviation|0|||
160627147|NCT05182840|580015540|FG007|Treatment Period|Protocol deviation|0|||
160627148|NCT05182840|580015541|FG008|Treatment Period|Protocol deviation|1|||
160627149|NCT05182840|580015542|FG009|Treatment Period|Protocol deviation|0|||
160627150|NCT05182840|580015533|FG000|Treatment Period|No reason available|0|||
160627151|NCT05182840|580015534|FG001|Treatment Period|No reason available|0|||
160627152|NCT05182840|580015535|FG002|Treatment Period|No reason available|0|||
160627153|NCT05182840|580015536|FG003|Treatment Period|No reason available|1|||
160627154|NCT05182840|580015537|FG004|Treatment Period|No reason available|0|||
160627155|NCT05182840|580015538|FG005|Treatment Period|No reason available|2|||
160627156|NCT05182840|580015539|FG006|Treatment Period|No reason available|0|||
160627157|NCT05182840|580015540|FG007|Treatment Period|No reason available|1|||
160627158|NCT05182840|580015541|FG008|Treatment Period|No reason available|0|||
160627159|NCT05182840|580015542|FG009|Treatment Period|No reason available|0|||
160627160|NCT05182840|580015533|FG000|Treatment Period|Burden of study procedures|0|||
160627161|NCT05182840|580015534|FG001|Treatment Period|Burden of study procedures|0|||
160627162|NCT05182840|580015535|FG002|Treatment Period|Burden of study procedures|0|||
160627163|NCT05182840|580015536|FG003|Treatment Period|Burden of study procedures|0|||
160627164|NCT05182840|580015537|FG004|Treatment Period|Burden of study procedures|1|||
160627165|NCT05182840|580015538|FG005|Treatment Period|Burden of study procedures|0|||
160627166|NCT05182840|580015539|FG006|Treatment Period|Burden of study procedures|0|||
160627167|NCT05182840|580015540|FG007|Treatment Period|Burden of study procedures|0|||
160627168|NCT05182840|580015541|FG008|Treatment Period|Burden of study procedures|0|||
160627169|NCT05182840|580015542|FG009|Treatment Period|Burden of study procedures|0|||
160627170|NCT05182840|580015533|FG000|Treatment Period|Change of residence|0|||
160627171|NCT05182840|580015534|FG001|Treatment Period|Change of residence|0|||
160627172|NCT05182840|580015535|FG002|Treatment Period|Change of residence|0|||
160627173|NCT05182840|580015536|FG003|Treatment Period|Change of residence|0|||
160627174|NCT05182840|580015537|FG004|Treatment Period|Change of residence|0|||
160627175|NCT05182840|580015538|FG005|Treatment Period|Change of residence|1|||
160627176|NCT05182840|580015539|FG006|Treatment Period|Change of residence|0|||
160627177|NCT05182840|580015540|FG007|Treatment Period|Change of residence|0|||
160627178|NCT05182840|580015541|FG008|Treatment Period|Change of residence|0|||
160627179|NCT05182840|580015542|FG009|Treatment Period|Change of residence|0|||
160627180|NCT05182840|580015533|FG000|Treatment Period|Adverse Event|0|||
160627181|NCT05182840|580015534|FG001|Treatment Period|Adverse Event|0|||
160627182|NCT05182840|580015535|FG002|Treatment Period|Adverse Event|4|||
160627183|NCT05182840|580015536|FG003|Treatment Period|Adverse Event|16|||
160627184|NCT05182840|580015537|FG004|Treatment Period|Adverse Event|12|||
160627185|NCT05182840|580015538|FG005|Treatment Period|Adverse Event|6|||
160627186|NCT05182840|580015539|FG006|Treatment Period|Adverse Event|4|||
160627187|NCT05182840|580015540|FG007|Treatment Period|Adverse Event|8|||
160627188|NCT05182840|580015541|FG008|Treatment Period|Adverse Event|16|||
160627189|NCT05182840|580015542|FG009|Treatment Period|Adverse Event|5|||
160672395|NCT01899053|580178698|FG002|Overall Study|Symptomatic Deterioration|0|||
160627190|NCT05182840|580015533|FG000|Treatment Period|Not treated with study drug|0|||
160627191|NCT05182840|580015534|FG001|Treatment Period|Not treated with study drug|0|||
160627192|NCT05182840|580015535|FG002|Treatment Period|Not treated with study drug|0|||
160627193|NCT05182840|580015536|FG003|Treatment Period|Not treated with study drug|1|||
160627194|NCT05182840|580015537|FG004|Treatment Period|Not treated with study drug|0|||
160627195|NCT05182840|580015538|FG005|Treatment Period|Not treated with study drug|0|||
160627196|NCT05182840|580015539|FG006|Treatment Period|Not treated with study drug|1|||
160627197|NCT05182840|580015540|FG007|Treatment Period|Not treated with study drug|1|||
160627198|NCT05182840|580015541|FG008|Treatment Period|Not treated with study drug|0|||
160627199|NCT05182840|580015542|FG009|Treatment Period|Not treated with study drug|0|||
160627200|NCT00157157|580015548|FG000|Overall Study|Withdrawal by Subject|6|||
160627201|NCT00157157|580015548|FG000|Overall Study|Physician Decision|1|||
160627202|NCT00157157|580015548|FG000|Overall Study|Lost to Follow-up|1|||
160627203|NCT00157157|580015548|FG000|Overall Study|Enrolled in another study|1|||
160627204|NCT00157157|580015548|FG000|Overall Study|Met exclusion criteria|1|||
160627205|NCT00157157|580015548|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
160627206|NCT02260804|580015549|FG000|Induction Study Period|Protocol Violation|2|||
160627207|NCT02260804|580015550|FG001|Induction Study Period|Protocol Violation|0|||
160627208|NCT02260804|580015549|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
160627209|NCT02260804|580015550|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
160627210|NCT02260804|580015549|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
160627211|NCT02260804|580015550|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
160627212|NCT02260804|580015549|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
160627213|NCT02260804|580015550|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
160627214|NCT02260804|580015549|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
160627215|NCT02260804|580015550|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
160627216|NCT02260804|580015549|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
160627217|NCT02260804|580015550|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
160627218|NCT02260804|580015549|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
160627219|NCT02260804|580015550|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
160627220|NCT02260804|580015549|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
160627221|NCT02260804|580015550|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
160627222|NCT02260804|580015549|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
160627223|NCT02260804|580015550|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
160627224|NCT02260804|580015549|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
160627225|NCT02260804|580015550|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
160627226|NCT02260804|580015549|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
160627227|NCT02260804|580015550|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
160627228|NCT00509223|580018222|FG000|Overall Study|Lost to Follow-up|1|||
160627229|NCT00509223|580018223|FG001|Overall Study|Lost to Follow-up|1|||
160627230|NCT00509223|580018222|FG000|Overall Study|Adverse Event|1|||
160627231|NCT00509223|580018223|FG001|Overall Study|Adverse Event|1|||
160627232|NCT00509223|580018222|FG000|Overall Study|Withdrawal by Subject|25|||
160627233|NCT00509223|580018223|FG001|Overall Study|Withdrawal by Subject|6|||
160627234|NCT00509223|580018222|FG000|Overall Study|Including: subject change of address|5|||
160627235|NCT00509223|580018223|FG001|Overall Study|Including: subject change of address|2|||
160627236|NCT00509223|580018222|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
160627237|NCT00509223|580018223|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
160627238|NCT02064231|580018224|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
160627239|NCT02064231|580018225|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
160627240|NCT02064231|580018226|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
160627241|NCT02064231|580018227|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
160627242|NCT02064231|580018224|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
160627243|NCT02064231|580018225|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
160627244|NCT02064231|580018226|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
160627245|NCT02064231|580018227|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
160627246|NCT02064231|580018224|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
160627247|NCT02064231|580018225|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
160627248|NCT02064231|580018226|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
160627249|NCT02064231|580018227|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
160627250|NCT02064231|580018224|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
160627251|NCT02064231|580018225|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
160627252|NCT02064231|580018226|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
160627253|NCT02064231|580018227|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
160627254|NCT01339273|580018228|FG000|Overall Study|Lost to Follow-up|8|||
160627255|NCT01339273|580018229|FG001|Overall Study|Lost to Follow-up|8|||
160627256|NCT04478994|580018230|FG000|Overall Study|Withdrawal by Subject|1|||
160627257|NCT04478994|580018231|FG001|Overall Study|Withdrawal by Subject|1|||
160627258|NCT00518531|580018232|FG000|Treatment Period 1|Adverse Event|5|||
160627259|NCT00518531|580018233|FG001|Treatment Period 1|Adverse Event|0|||
160627260|NCT00518531|580018232|FG000|Treatment Period 1|Lost to Follow-up|5|||
160627261|NCT00518531|580018233|FG001|Treatment Period 1|Lost to Follow-up|3|||
160627262|NCT00518531|580018232|FG000|Treatment Period 1|Physician Decision|1|||
160627263|NCT00518531|580018233|FG001|Treatment Period 1|Physician Decision|0|||
160627264|NCT00518531|580018232|FG000|Treatment Period 1|Protocol Violation|2|||
160627265|NCT00518531|580018233|FG001|Treatment Period 1|Protocol Violation|0|||
160627266|NCT00518531|580018232|FG000|Treatment Period 1|Withdrawal by Subject|4|||
160627267|NCT00518531|580018233|FG001|Treatment Period 1|Withdrawal by Subject|6|||
160627268|NCT00518531|580018232|FG000|Treatment Period 1|Early crossover|1|||
160627269|NCT00518531|580018233|FG001|Treatment Period 1|Early crossover|3|||
160627270|NCT00518531|580018232|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160627271|NCT00518531|580018233|FG001|Treatment Period 2|Withdrawal by Subject|8|||
160627272|NCT00518531|580018232|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
160627273|NCT00518531|580018233|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
160627274|NCT00518531|580018232|FG000|Treatment Period 2|Adverse Event|1|||
160627275|NCT00518531|580018233|FG001|Treatment Period 2|Adverse Event|7|||
160627276|NCT00518531|580018232|FG000|Treatment Period 2|Protocol-specified criteria|0|||
160627277|NCT00518531|580018233|FG001|Treatment Period 2|Protocol-specified criteria|1|||
160627278|NCT00518531|580018232|FG000|Treatment Period 2|Non-compliance|1|||
160627279|NCT00518531|580018233|FG001|Treatment Period 2|Non-compliance|2|||
160627280|NCT00457249|580018234|FG000|Overall Study|Lost to Follow-up|3|||
160627281|NCT00457249|580018235|FG001|Overall Study|Lost to Follow-up|0|||
160627282|NCT00457249|580018234|FG000|Overall Study|Protocol Violation|4|||
160627283|NCT00457249|580018235|FG001|Overall Study|Protocol Violation|1|||
160627284|NCT00457249|580018234|FG000|Overall Study|Withdrawal by Subject|3|||
160627285|NCT00457249|580018235|FG001|Overall Study|Withdrawal by Subject|1|||
160627286|NCT00457249|580018234|FG000|Overall Study|Serious Adverse Events|2|||
160627287|NCT00457249|580018235|FG001|Overall Study|Serious Adverse Events|0|||
160627288|NCT04621227|580018238|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
160627289|NCT04621227|580018238|FG000|Period 3 (29 Days)|Adverse Event|1|||
160627290|NCT04621227|580018238|FG000|Period 8 (2 Days)|Adverse Event|1|||
160627291|NCT02916056|580018239|FG000|Overall Study|Adverse Event|6|||
160627292|NCT02916056|580018239|FG000|Overall Study|Lost to Follow-up|1|||
160627293|NCT02916056|580018239|FG000|Overall Study|Other|12|||
160627294|NCT02916056|580018239|FG000|Overall Study|Protocol Violation|1|||
160627295|NCT02916056|580018239|FG000|Overall Study|Withdrawal by Subject|8|||
160627296|NCT02916056|580018239|FG000|Overall Study|Study Terminated by Sponsor|269|||
160627297|NCT00124709|580018240|FG000|Overall Study|Randomized but did not take medication|3|||
160627298|NCT00124709|580018241|FG001|Overall Study|Randomized but did not take medication|1|||
160627299|NCT00124709|580018240|FG000|Overall Study|Adverse Event|3|||
160627300|NCT00124709|580018241|FG001|Overall Study|Adverse Event|0|||
160627301|NCT00124709|580018240|FG000|Overall Study|Lack of Efficacy|5|||
160627302|NCT00124709|580018241|FG001|Overall Study|Lack of Efficacy|10|||
160627303|NCT00124709|580018240|FG000|Overall Study|Protocol Violation|3|||
160627304|NCT00124709|580018241|FG001|Overall Study|Protocol Violation|5|||
160627305|NCT00124709|580018240|FG000|Overall Study|Withdrawal by Subject|127|||
160627306|NCT00124709|580018241|FG001|Overall Study|Withdrawal by Subject|136|||
160627307|NCT00124709|580018240|FG000|Overall Study|Lost to Follow-up|114|||
160627308|NCT00124709|580018241|FG001|Overall Study|Lost to Follow-up|120|||
160627309|NCT01728376|580018242|FG000|Overall Study|Adverse Event|1|||
160627310|NCT01728376|580018243|FG001|Overall Study|Adverse Event|1|||
160627311|NCT01728376|580018244|FG002|Overall Study|Adverse Event|1|||
160627312|NCT01728376|580018245|FG003|Overall Study|Adverse Event|1|||
160627313|NCT01728376|580018246|FG004|Overall Study|Adverse Event|1|||
160627314|NCT01728376|580018247|FG005|Overall Study|Adverse Event|0|||
160627315|NCT01728376|580018242|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
160627316|NCT01728376|580018243|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
160627317|NCT01728376|580018244|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
160627318|NCT01728376|580018245|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
160627319|NCT01728376|580018246|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
160627320|NCT01728376|580018247|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
160627321|NCT01728376|580018242|FG000|Overall Study|No relevant bacteria|2|||
160627322|NCT01728376|580018243|FG001|Overall Study|No relevant bacteria|0|||
160627323|NCT01728376|580018244|FG002|Overall Study|No relevant bacteria|0|||
160627324|NCT01728376|580018245|FG003|Overall Study|No relevant bacteria|0|||
160627325|NCT01728376|580018246|FG004|Overall Study|No relevant bacteria|1|||
160627326|NCT01728376|580018247|FG005|Overall Study|No relevant bacteria|1|||
160627327|NCT01728376|580018242|FG000|Overall Study|Did not receive treatment|0|||
160627328|NCT01728376|580018243|FG001|Overall Study|Did not receive treatment|1|||
160672396|NCT01899053|580178699|FG003|Overall Study|Symptomatic Deterioration|0|||
160627329|NCT01728376|580018244|FG002|Overall Study|Did not receive treatment|0|||
160627330|NCT01728376|580018245|FG003|Overall Study|Did not receive treatment|0|||
160627331|NCT01728376|580018246|FG004|Overall Study|Did not receive treatment|0|||
160627332|NCT01728376|580018247|FG005|Overall Study|Did not receive treatment|0|||
160627333|NCT01728376|580018242|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
160627334|NCT01728376|580018243|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
160627335|NCT01728376|580018244|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
160627336|NCT01728376|580018245|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
160627337|NCT01728376|580018246|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
160627338|NCT01728376|580018247|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
160627339|NCT02094573|580018249|FG000|Overall Study|Adverse Event|4|||
160627340|NCT02094573|580018250|FG001|Overall Study|Adverse Event|14|||
160627341|NCT02094573|580018249|FG000|Overall Study|Clinical Progressive Disease|9|||
160627342|NCT02094573|580018250|FG001|Overall Study|Clinical Progressive Disease|13|||
160627343|NCT02094573|580018249|FG000|Overall Study|Death|11|||
160627344|NCT02094573|580018250|FG001|Overall Study|Death|3|||
160627345|NCT02094573|580018249|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
160627346|NCT02094573|580018250|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
160627347|NCT02094573|580018249|FG000|Overall Study|Non-compliance with Study Drug|1|||
160627348|NCT02094573|580018250|FG001|Overall Study|Non-compliance with Study Drug|1|||
160627349|NCT02094573|580018249|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
160627350|NCT02094573|580018250|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
160627351|NCT02094573|580018249|FG000|Overall Study|Physician Decision|4|||
160627352|NCT02094573|580018250|FG001|Overall Study|Physician Decision|4|||
160627353|NCT02094573|580018249|FG000|Overall Study|Site Terminated by Sponsor|10|||
160627354|NCT02094573|580018250|FG001|Overall Study|Site Terminated by Sponsor|17|||
160627355|NCT02094573|580018249|FG000|Overall Study|Withdrawal by Subject|6|||
160627356|NCT02094573|580018250|FG001|Overall Study|Withdrawal by Subject|8|||
160627357|NCT02094573|580018249|FG000|Overall Study|Randomized but not Treated|3|||
160627358|NCT02094573|580018250|FG001|Overall Study|Randomized but not Treated|0|||
160627359|NCT02411110|580018251|FG000|Treatment Period 1|Adverse Event|4|||
160627360|NCT02411110|580018252|FG001|Treatment Period 1|Adverse Event|2|||
160627361|NCT02411110|580018251|FG000|Treatment Period 1|Lost to Follow-up|1|||
160627362|NCT02411110|580018252|FG001|Treatment Period 1|Lost to Follow-up|0|||
160627363|NCT02411110|580018251|FG000|Treatment Period 1|Personal Reasons|2|||
160627364|NCT02411110|580018252|FG001|Treatment Period 1|Personal Reasons|5|||
160627365|NCT02411110|580018251|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
160627366|NCT02411110|580018252|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
160627367|NCT02411110|580018251|FG000|Treatment Period 2|Adverse Event|1|||
160627368|NCT02411110|580018252|FG001|Treatment Period 2|Adverse Event|0|||
160627369|NCT02411110|580018251|FG000|Treatment Period 2|Lost to Follow-up|0|||
160627370|NCT02411110|580018252|FG001|Treatment Period 2|Lost to Follow-up|2|||
160627371|NCT02411110|580018251|FG000|Treatment Period 2|Personal Reasons|0|||
160627372|NCT02411110|580018252|FG001|Treatment Period 2|Personal Reasons|2|||
160627373|NCT04888377|580018253|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
160627374|NCT04888377|580018254|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
160627375|NCT04888377|580018253|FG000|Overall Study|Physician Decision|6|||
160627376|NCT04888377|580018254|FG001|Overall Study|Physician Decision|6|||
160627377|NCT04888377|580018253|FG000|Overall Study|Withdrawal by Subject|7|||
160627378|NCT04888377|580018254|FG001|Overall Study|Withdrawal by Subject|3|||
160627379|NCT00526162|580018255|FG000|Overall Study|Device not implanted|3|||
160627380|NCT05279807|580018256|FG000|Overall Study|Withdrawal by Subject|1|||
160627381|NCT05279807|580018257|FG001|Overall Study|Withdrawal by Subject|0|||
160627382|NCT05279807|580018256|FG000|Overall Study|Adverse Event|0|||
160627383|NCT05279807|580018257|FG001|Overall Study|Adverse Event|1|||
160627384|NCT05279807|580018256|FG000|Overall Study|Laboratory Abnormal Results|1|||
160627385|NCT05279807|580018257|FG001|Overall Study|Laboratory Abnormal Results|0|||
160627386|NCT05299359|580018262|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
160627387|NCT05299359|580018263|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
160627388|NCT05299359|580018262|FG000|Main Part: Day 1 up to Day 366|Other|2|||
160627389|NCT05299359|580018263|FG001|Main Part: Day 1 up to Day 366|Other|0|||
160627390|NCT05299359|580018262|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
160627391|NCT05299359|580018263|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
160627392|NCT05299359|580018262|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
160627393|NCT05299359|580018263|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
160627394|NCT05299359|580018262|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
160627395|NCT05299359|580018263|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
160627396|NCT05299359|580018262|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
160627397|NCT05299359|580018263|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
160627398|NCT05299359|580018262|FG000|Extension Part: Day 1 to Day 366|Other|0|||
160627399|NCT05299359|580018263|FG001|Extension Part: Day 1 to Day 366|Other|1|||
160627400|NCT04242446|580018264|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
160627401|NCT04242446|580018265|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
160627402|NCT04242446|580018266|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
160627403|NCT04242446|580018267|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
160627404|NCT04242446|580018268|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
160627405|NCT04242446|580018269|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
160627406|NCT04242446|580018270|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
160627407|NCT04242446|580018264|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
160627408|NCT04242446|580018265|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
160627409|NCT04242446|580018266|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
160627410|NCT04242446|580018267|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
160627411|NCT04242446|580018268|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
160627412|NCT04242446|580018269|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
160627413|NCT04242446|580018270|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
160627414|NCT04242446|580018264|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
160627415|NCT04242446|580018265|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
160627416|NCT04242446|580018266|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
160627417|NCT04242446|580018267|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
160627418|NCT04242446|580018268|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
160627419|NCT04242446|580018269|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
160627420|NCT04242446|580018270|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
160627421|NCT04242446|580018264|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
160627422|NCT04242446|580018265|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
160627423|NCT04242446|580018266|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
160627424|NCT04242446|580018267|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
160627425|NCT04242446|580018268|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
160627426|NCT04242446|580018269|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
160672397|NCT01899053|580178700|FG004|Overall Study|Symptomatic Deterioration|0|||
160672398|NCT01899053|580178701|FG005|Overall Study|Symptomatic Deterioration|1|||
160627427|NCT04242446|580018270|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
160627428|NCT04242446|580018264|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
160627429|NCT04242446|580018265|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
160627430|NCT04242446|580018266|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
160627431|NCT04242446|580018267|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
160627432|NCT04242446|580018268|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
160627433|NCT04242446|580018269|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
160627434|NCT04242446|580018270|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
160627435|NCT04242446|580018264|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
160627436|NCT04242446|580018265|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
160627437|NCT04242446|580018266|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
160627438|NCT04242446|580018267|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
160627439|NCT04242446|580018268|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
160627440|NCT04242446|580018269|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
160627441|NCT04242446|580018270|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
160627442|NCT04242446|580018264|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
160627443|NCT04242446|580018265|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
160627444|NCT04242446|580018266|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
160627445|NCT04242446|580018267|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
160627446|NCT04242446|580018268|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
160627447|NCT04242446|580018269|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
160627448|NCT04242446|580018270|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
160627449|NCT04242446|580018264|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
160627450|NCT04242446|580018265|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
160627451|NCT04242446|580018266|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
160627452|NCT04242446|580018267|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
160627453|NCT04242446|580018268|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
160627454|NCT04242446|580018269|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
160627455|NCT04242446|580018270|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
160627456|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
160627457|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
160627458|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
160627459|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
160627460|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
160627461|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
160627462|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
160627463|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
160672399|NCT01899053|580178702|FG006|Overall Study|Symptomatic Deterioration|0|||
160672400|NCT01899053|580178703|FG007|Overall Study|Symptomatic Deterioration|1|||
160672401|NCT01899053|580178704|FG008|Overall Study|Symptomatic Deterioration|0|||
160672402|NCT01899053|580178705|FG009|Overall Study|Symptomatic Deterioration|0|||
160672403|NCT01899053|580178706|FG010|Overall Study|Symptomatic Deterioration|0|||
160672404|NCT01899053|580178707|FG011|Overall Study|Symptomatic Deterioration|1|||
160672405|NCT01899053|580178708|FG012|Overall Study|Symptomatic Deterioration|2|||
160672406|NCT01899053|580178709|FG013|Overall Study|Symptomatic Deterioration|0|||
160672407|NCT02011945|580178710|FG000|Overall Study|Participant requested to Discontinue|0|||
160672408|NCT02011945|580178711|FG001|Overall Study|Participant requested to Discontinue|1|||
160672409|NCT02011945|580178712|FG002|Overall Study|Participant requested to Discontinue|1|||
160672410|NCT02011945|580178710|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
160672411|NCT02011945|580178711|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
160672412|NCT02011945|580178712|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
160672413|NCT02011945|580178710|FG000|Overall Study|Study Drug Toxicity|0|||
160672414|NCT02011945|580178711|FG001|Overall Study|Study Drug Toxicity|0|||
160672415|NCT02011945|580178712|FG002|Overall Study|Study Drug Toxicity|1|||
160672416|NCT02011945|580178710|FG000|Overall Study|Treatment Failure|0|||
160672417|NCT02011945|580178711|FG001|Overall Study|Treatment Failure|7|||
160672418|NCT02011945|580178712|FG002|Overall Study|Treatment Failure|6|||
160672419|NCT02011945|580178710|FG000|Overall Study|No Longer Meets Study Criteria|1|||
160672420|NCT02011945|580178711|FG001|Overall Study|No Longer Meets Study Criteria|0|||
160672421|NCT02011945|580178712|FG002|Overall Study|No Longer Meets Study Criteria|0|||
160672422|NCT02011945|580178710|FG000|Overall Study|Proceeded to stem cell transplant|0|||
160672423|NCT02011945|580178711|FG001|Overall Study|Proceeded to stem cell transplant|0|||
160672424|NCT02011945|580178712|FG002|Overall Study|Proceeded to stem cell transplant|1|||
160672425|NCT02011945|580178710|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
160672426|NCT02011945|580178711|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
160672427|NCT02011945|580178712|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
160672428|NCT01891357|580178713|FG000|Overall Study|Protocol Violation|3|||
160672429|NCT03733145|580178714|FG000|Overall Study|screenfail|3|||
160672430|NCT03733145|580178715|FG001|Overall Study|screenfail|3|||
160672431|NCT03733145|580178716|FG002|Overall Study|screenfail|2|||
160672432|NCT00829764|580178717|FG000|First Intervention|Adverse Event|1|||
160672433|NCT00829764|580178718|FG001|First Intervention|Adverse Event|0|||
160672434|NCT00829764|580178717|FG000|First Intervention|Withdrawal by Subject|1|||
160672435|NCT00829764|580178718|FG001|First Intervention|Withdrawal by Subject|1|||
160672436|NCT00258856|580180417|FG000|Overall Study|Lost to Follow-up|1|||
160672437|NCT00258856|580180418|FG001|Overall Study|Lost to Follow-up|0|||
160672438|NCT00258856|580180419|FG002|Overall Study|Lost to Follow-up|2|||
160672439|NCT00258856|580180420|FG003|Overall Study|Lost to Follow-up|0|||
160672440|NCT00258856|580180417|FG000|Overall Study|Non-compliance|2|||
160672441|NCT00258856|580180418|FG001|Overall Study|Non-compliance|0|||
160672442|NCT00258856|580180419|FG002|Overall Study|Non-compliance|0|||
160672443|NCT00258856|580180420|FG003|Overall Study|Non-compliance|1|||
160672444|NCT02488109|580180426|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
160672445|NCT02488109|580180427|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
160672446|NCT02488109|580180426|FG000|12-month Follow-Up|Lost to Follow-up|4|||
160672447|NCT02488109|580180427|FG001|12-month Follow-Up|Lost to Follow-up|7|||
160672448|NCT03969641|580180428|FG000|Overall Study|Lost to Follow-up|5|||
160672449|NCT03969641|580180429|FG001|Overall Study|Lost to Follow-up|3|||
160672450|NCT03969641|580180428|FG000|Overall Study|Withdrawal by Subject|1|||
160672451|NCT03969641|580180429|FG001|Overall Study|Withdrawal by Subject|2|||
160672452|NCT03969641|580180428|FG000|Overall Study|Found to be ineligible|1|||
160672453|NCT03969641|580180429|FG001|Overall Study|Found to be ineligible|1|||
160672454|NCT03969641|580180428|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
160672455|NCT03969641|580180429|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
160672456|NCT03969641|580180428|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
160672457|NCT03969641|580180429|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
160672458|NCT03969641|580180428|FG000|Overall Study|Elective termination|0|||
160672459|NCT03969641|580180429|FG001|Overall Study|Elective termination|1|||
160672460|NCT00557245|580180445|FG000|Overall Study|Lost to Follow-up|7|||
160672461|NCT00557245|580180446|FG001|Overall Study|Lost to Follow-up|8|||
160672462|NCT00557245|580180447|FG002|Overall Study|Lost to Follow-up|10|||
160672463|NCT00557245|580180445|FG000|Overall Study|Ineligible|5|||
160672464|NCT00557245|580180446|FG001|Overall Study|Ineligible|4|||
160672465|NCT00557245|580180447|FG002|Overall Study|Ineligible|2|||
160672466|NCT02658019|580180448|FG000|Overall Study|Adverse Event|1|||
160672467|NCT02316223|580180450|FG000|Overall Study|Lack of Efficacy|0|||
160672468|NCT02316223|580180451|FG001|Overall Study|Lack of Efficacy|1|||
160672469|NCT02316223|580180452|FG002|Overall Study|Lack of Efficacy|1|||
160672470|NCT02316223|580180450|FG000|Overall Study|Lost to Follow-up|27|||
160672471|NCT02316223|580180451|FG001|Overall Study|Lost to Follow-up|34|||
160672472|NCT02316223|580180452|FG002|Overall Study|Lost to Follow-up|36|||
160672473|NCT02316223|580180450|FG000|Overall Study|COPD Diagnosis|3|||
160672474|NCT02316223|580180451|FG001|Overall Study|COPD Diagnosis|2|||
160672475|NCT02316223|580180452|FG002|Overall Study|COPD Diagnosis|3|||
160627464|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
160627465|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
160627466|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
160627467|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
160627468|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
160627469|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
160627470|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
160627471|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
160627472|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
160627473|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
160627474|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
160627475|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
160627476|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
160627477|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
160627478|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
160627479|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
160627480|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
160627481|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
160627482|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
160627483|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
160627484|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
160627485|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
160627486|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
160627487|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
160627488|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
160627489|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
160627490|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
160627491|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
160627492|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
160627493|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
160627494|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
160627495|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
160627496|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
160627497|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
160627498|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
160627499|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
160627500|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
160627501|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
160627502|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
160627503|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
160627504|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
160627505|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
160627506|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
160627507|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
160627508|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
160627509|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
160627510|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
160627511|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
160627512|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
160627513|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
160627514|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
160627515|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
160627516|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
160672476|NCT02316223|580180450|FG000|Overall Study|Reside outside study area|1|||
160672477|NCT02316223|580180451|FG001|Overall Study|Reside outside study area|1|||
160672478|NCT02316223|580180452|FG002|Overall Study|Reside outside study area|1|||
160672479|NCT02316223|580180450|FG000|Overall Study|No asthma|2|||
160672480|NCT02316223|580180451|FG001|Overall Study|No asthma|0|||
160672481|NCT02316223|580180452|FG002|Overall Study|No asthma|0|||
160672482|NCT02316223|580180450|FG000|Overall Study|Discontinued by PI|11|||
160672483|NCT02316223|580180451|FG001|Overall Study|Discontinued by PI|19|||
160672484|NCT02316223|580180452|FG002|Overall Study|Discontinued by PI|3|||
160672485|NCT03234907|580180453|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
160672486|NCT03234907|580180454|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
160672487|NCT03234907|580180455|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
160672488|NCT03234907|580180456|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
160672489|NCT03234907|580180457|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
160672490|NCT03234907|580180458|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
160672491|NCT03234907|580180453|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
160672492|NCT03234907|580180454|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
160672493|NCT03234907|580180455|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
160672494|NCT03234907|580180456|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
160672495|NCT03234907|580180457|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
160672496|NCT03234907|580180458|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
160672497|NCT03234907|580180453|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
160672498|NCT03234907|580180454|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
160672499|NCT03234907|580180455|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
160672500|NCT03234907|580180456|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
160672501|NCT03234907|580180457|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
160672502|NCT03234907|580180458|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
160672503|NCT03234907|580180453|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
160672504|NCT03234907|580180454|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
160672505|NCT03234907|580180455|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
160672506|NCT03234907|580180456|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
160672507|NCT03234907|580180457|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
160672508|NCT03234907|580180458|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
160672509|NCT03234907|580180453|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
160672510|NCT03234907|580180454|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
160672511|NCT03234907|580180455|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
160672512|NCT03234907|580180456|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
160672513|NCT03234907|580180457|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
160672514|NCT03234907|580180458|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
160672515|NCT03234907|580180453|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
160672516|NCT03234907|580180454|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
160672517|NCT03234907|580180455|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
160672518|NCT03234907|580180456|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
160672519|NCT03234907|580180457|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
160672520|NCT03234907|580180458|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
160672521|NCT03234907|580180453|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
160672522|NCT03234907|580180454|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
160672523|NCT03234907|580180455|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
160672524|NCT03234907|580180456|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
160672525|NCT03234907|580180457|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
160672526|NCT03234907|580180458|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
160672527|NCT02986139|580180459|FG000|Overall Study|Sponsor Decision|1|||
160672528|NCT02986139|580180460|FG001|Overall Study|Sponsor Decision|2|||
160672529|NCT02986139|580180459|FG000|Overall Study|Withdrawal by Subject|0|||
160672530|NCT02986139|580180460|FG001|Overall Study|Withdrawal by Subject|1|||
160672531|NCT02986139|580180459|FG000|Overall Study|Lost to Follow-up|0|||
160672532|NCT02986139|580180460|FG001|Overall Study|Lost to Follow-up|1|||
160672533|NCT02583048|580180461|FG000|Overall Study|Withdrawal by Subject|0|||
160672534|NCT02583048|580180462|FG001|Overall Study|Withdrawal by Subject|1|||
160627517|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
160627518|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
160627519|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
160627520|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
160627521|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
160627522|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
160627523|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
160627524|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
160672535|NCT02583048|580180463|FG002|Overall Study|Withdrawal by Subject|0|||
160672536|NCT02583048|580180461|FG000|Overall Study|Failed to meet eligibility criterion|0|||
160672537|NCT02583048|580180462|FG001|Overall Study|Failed to meet eligibility criterion|0|||
160672538|NCT02583048|580180463|FG002|Overall Study|Failed to meet eligibility criterion|1|||
160672539|NCT00414726|580180467|FG000|Overall Study|Withdrawal by Subject|0|||
160672540|NCT00414726|580180468|FG001|Overall Study|Withdrawal by Subject|1|||
160627525|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
160627526|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
160627527|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
160627528|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
160627529|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
160627530|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
160627531|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
160627532|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
160627533|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
160627534|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
160627535|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
160627536|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
160627537|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
160627538|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
160627539|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
160627540|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
160627541|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
160627542|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
160672541|NCT02107196|580180469|FG000|12-week Treatment Period|Adverse Event|6|||
160672542|NCT02107196|580180470|FG001|12-week Treatment Period|Adverse Event|3|||
160672543|NCT02107196|580180469|FG000|12-week Treatment Period|Lack of Efficacy|2|||
160672544|NCT02107196|580180470|FG001|12-week Treatment Period|Lack of Efficacy|1|||
160672545|NCT02107196|580180469|FG000|12-week Treatment Period|Lost to Follow-up|3|||
160672546|NCT02107196|580180470|FG001|12-week Treatment Period|Lost to Follow-up|6|||
160672547|NCT02107196|580180469|FG000|12-week Treatment Period|Physician Decision|0|||
160672548|NCT02107196|580180470|FG001|12-week Treatment Period|Physician Decision|1|||
160672549|NCT02107196|580180469|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
160672550|NCT02107196|580180470|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
160672551|NCT02107196|580180469|FG000|12-week Treatment Period|Protocol Violation|7|||
160672552|NCT02107196|580180470|FG001|12-week Treatment Period|Protocol Violation|8|||
160672553|NCT02107196|580180469|FG000|12-week Treatment Period|Reason Missing|11|||
160672554|NCT02107196|580180470|FG001|12-week Treatment Period|Reason Missing|8|||
160672555|NCT02107196|580180469|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
160672556|NCT02107196|580180470|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
160672557|NCT02107196|580180469|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
160672558|NCT02107196|580180470|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
160672559|NCT02107196|580180469|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
160672560|NCT02107196|580180470|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
160672561|NCT02107196|580180469|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
160672562|NCT02107196|580180470|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
160672563|NCT00660660|580180473|FG000|Overall Study|Adverse Event|1|||
160672564|NCT00660660|580180474|FG001|Overall Study|Adverse Event|0|||
160672565|NCT00660660|580180473|FG000|Overall Study|Lost to Follow-up|0|||
160672566|NCT00660660|580180474|FG001|Overall Study|Lost to Follow-up|6|||
160672567|NCT00660660|580180473|FG000|Overall Study|Lack of Efficacy|0|||
160672568|NCT00660660|580180474|FG001|Overall Study|Lack of Efficacy|2|||
160672569|NCT00660660|580180473|FG000|Overall Study|Withdrawal by Subject|3|||
160672570|NCT00660660|580180474|FG001|Overall Study|Withdrawal by Subject|0|||
160672571|NCT00660660|580180473|FG000|Overall Study|Incorrect enrollment and other|0|||
160672572|NCT00660660|580180474|FG001|Overall Study|Incorrect enrollment and other|1|||
160672573|NCT00660660|580180473|FG000|Overall Study|New medication after randomization|1|||
160672574|NCT00660660|580180474|FG001|Overall Study|New medication after randomization|0|||
160672575|NCT01630616|580180475|FG000|Overall Study|Adverse Event|0|||
160672576|NCT01630616|580180476|FG001|Overall Study|Adverse Event|0|||
160672577|NCT01630616|580180477|FG002|Overall Study|Adverse Event|0|||
160672578|NCT01630616|580180478|FG003|Overall Study|Adverse Event|1|||
160672579|NCT01630616|580180479|FG004|Overall Study|Adverse Event|0|||
160672580|NCT01630616|580180480|FG005|Overall Study|Adverse Event|0|||
160672581|NCT01630616|580180475|FG000|Overall Study|Withdrawal by Subject|0|||
160672582|NCT01630616|580180476|FG001|Overall Study|Withdrawal by Subject|0|||
160672583|NCT01630616|580180477|FG002|Overall Study|Withdrawal by Subject|0|||
160672584|NCT01630616|580180478|FG003|Overall Study|Withdrawal by Subject|2|||
160672585|NCT01630616|580180479|FG004|Overall Study|Withdrawal by Subject|0|||
160672586|NCT01630616|580180480|FG005|Overall Study|Withdrawal by Subject|0|||
160672587|NCT00640393|580180482|FG000|Part 1|Lost to Follow-up|2|||
160519777|NCT03818204|579632872|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160519778|NCT03818204|579632854|FG000|Overall Study|Physician Decision|0|||
160519779|NCT03818204|579632855|FG001|Overall Study|Physician Decision|0|||
160519780|NCT03818204|579632856|FG002|Overall Study|Physician Decision|0|||
160519781|NCT03818204|579632857|FG003|Overall Study|Physician Decision|0|||
160519782|NCT03818204|579632858|FG004|Overall Study|Physician Decision|0|||
160519783|NCT03818204|579632859|FG005|Overall Study|Physician Decision|0|||
160519784|NCT03818204|579632860|FG006|Overall Study|Physician Decision|0|||
160519785|NCT03818204|579632861|FG007|Overall Study|Physician Decision|0|||
160519786|NCT03818204|579632862|FG008|Overall Study|Physician Decision|0|||
160519787|NCT03818204|579632863|FG009|Overall Study|Physician Decision|0|||
160519788|NCT03818204|579632864|FG010|Overall Study|Physician Decision|0|||
160519789|NCT03818204|579632865|FG011|Overall Study|Physician Decision|0|||
160519790|NCT03818204|579632866|FG012|Overall Study|Physician Decision|0|||
160519791|NCT03818204|579632867|FG013|Overall Study|Physician Decision|0|||
160519792|NCT03818204|579632868|FG014|Overall Study|Physician Decision|1|||
160519793|NCT03818204|579632869|FG015|Overall Study|Physician Decision|0|||
160519794|NCT03818204|579632870|FG016|Overall Study|Physician Decision|0|||
160519795|NCT03818204|579632871|FG017|Overall Study|Physician Decision|0|||
160519796|NCT03818204|579632872|FG018|Overall Study|Physician Decision|0|||
160519797|NCT00887250|579632873|FG000|Overall Study|Adverse Event|3|||
160519798|NCT00887250|579632874|FG001|Overall Study|Adverse Event|0|||
160519799|NCT00887250|579632875|FG002|Overall Study|Adverse Event|7|||
160519800|NCT00887250|579632873|FG000|Overall Study|Lack of Efficacy|9|||
160519801|NCT00887250|579632874|FG001|Overall Study|Lack of Efficacy|6|||
160519802|NCT00887250|579632875|FG002|Overall Study|Lack of Efficacy|1|||
160519803|NCT00887250|579632873|FG000|Overall Study|Lost to Follow-up|2|||
160519804|NCT00887250|579632874|FG001|Overall Study|Lost to Follow-up|3|||
160519805|NCT00887250|579632875|FG002|Overall Study|Lost to Follow-up|1|||
160519806|NCT00887250|579632873|FG000|Overall Study|Protocol Violation|2|||
160519807|NCT00887250|579632874|FG001|Overall Study|Protocol Violation|2|||
160519808|NCT00887250|579632875|FG002|Overall Study|Protocol Violation|1|||
160519809|NCT00887250|579632873|FG000|Overall Study|Withdrawal by Subject|2|||
160519810|NCT00887250|579632874|FG001|Overall Study|Withdrawal by Subject|1|||
160519811|NCT00887250|579632875|FG002|Overall Study|Withdrawal by Subject|2|||
160519812|NCT00887250|579632873|FG000|Overall Study|Patient uncooperative|0|||
160519813|NCT00887250|579632874|FG001|Overall Study|Patient uncooperative|0|||
160519814|NCT00887250|579632875|FG002|Overall Study|Patient uncooperative|1|||
160519815|NCT05754333|579632876|FG000|Overall Study|Miscellaneous|3|||
160519816|NCT05754333|579632877|FG001|Overall Study|Miscellaneous|0|||
160519817|NCT05754333|579632878|FG002|Overall Study|Miscellaneous|0|||
160519818|NCT05754333|579632879|FG003|Overall Study|Miscellaneous|0|||
160519819|NCT05754333|579632876|FG000|Overall Study|Lost to Follow-up|2|||
160519820|NCT05754333|579632877|FG001|Overall Study|Lost to Follow-up|1|||
160519821|NCT05754333|579632878|FG002|Overall Study|Lost to Follow-up|0|||
160519822|NCT05754333|579632879|FG003|Overall Study|Lost to Follow-up|1|||
160519823|NCT03401229|579632886|FG000|Overall Study|Lost to Follow-up|2|||
160519824|NCT03401229|579632887|FG001|Overall Study|Lost to Follow-up|1|||
160519825|NCT03401229|579632886|FG000|Overall Study|Other|1|||
160519826|NCT03401229|579632887|FG001|Overall Study|Other|3|||
160519827|NCT03401229|579632886|FG000|Overall Study|Adverse Event|8|||
160519828|NCT03401229|579632887|FG001|Overall Study|Adverse Event|6|||
160519829|NCT03401229|579632886|FG000|Overall Study|Withdrawal by Subject|29|||
160519830|NCT03401229|579632887|FG001|Overall Study|Withdrawal by Subject|26|||
160519831|NCT03401229|579632886|FG000|Overall Study|COVID-19|0|||
160519832|NCT03401229|579632887|FG001|Overall Study|COVID-19|1|||
160519833|NCT05333224|579632888|FG000|Overall Study - Infants|Lost to Follow-up|1|||
160519834|NCT05333224|579632889|FG001|Overall Study - Infants|Lost to Follow-up|1|||
160519835|NCT00819390|579632892|FG000|Overall Study|Lost to Follow-up|1|||
160519836|NCT00819390|579632893|FG001|Overall Study|Lost to Follow-up|1|||
160519837|NCT00819390|579632894|FG002|Overall Study|Lost to Follow-up|0|||
160519838|NCT00819390|579632895|FG003|Overall Study|Lost to Follow-up|0|||
160519839|NCT00819390|579632892|FG000|Overall Study|Withdrawal by Subject|2|||
160519840|NCT00819390|579632893|FG001|Overall Study|Withdrawal by Subject|0|||
160519841|NCT00819390|579632894|FG002|Overall Study|Withdrawal by Subject|0|||
160519842|NCT00819390|579632895|FG003|Overall Study|Withdrawal by Subject|0|||
160519843|NCT00819390|579632892|FG000|Overall Study|Adverse Event|0|||
160519844|NCT00819390|579632893|FG001|Overall Study|Adverse Event|0|||
160519845|NCT00819390|579632894|FG002|Overall Study|Adverse Event|1|||
160519846|NCT00819390|579632895|FG003|Overall Study|Adverse Event|0|||
160519847|NCT00679627|579632896|FG000|Overall Study|Death|41|||
160519848|NCT00679627|579632897|FG001|Overall Study|Death|29|||
160519849|NCT00679627|579632896|FG000|Overall Study|Adverse Event|43|||
160519850|NCT00679627|579632897|FG001|Overall Study|Adverse Event|53|||
160519851|NCT00679627|579632896|FG000|Overall Study|Withdrawal by Subject|168|||
160519852|NCT00679627|579632897|FG001|Overall Study|Withdrawal by Subject|172|||
160519853|NCT00679627|579632896|FG000|Overall Study|Lost to Follow-up|22|||
160519854|NCT00679627|579632897|FG001|Overall Study|Lost to Follow-up|26|||
160519855|NCT00679627|579632896|FG000|Overall Study|Early Study Closure|425|||
160627543|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
160627544|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
160627545|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
160627546|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
160627547|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
160627548|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
160627549|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
160627550|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
160627551|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
160627552|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
160627553|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
160627554|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
160627555|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
160627556|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
160627557|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
160627558|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
160627559|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
160627560|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
160627561|NCT04242446|580018264|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
160627562|NCT04242446|580018265|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
160627563|NCT04242446|580018266|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
160627564|NCT04242446|580018267|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
160627565|NCT04242446|580018268|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
160627566|NCT04242446|580018269|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
160627567|NCT04242446|580018270|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
160627568|NCT05993299|580018274|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
160627569|NCT05993299|580018274|FG000|Overall Study|Ongoing|4|||
160627570|NCT05644756|580018275|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
160627571|NCT05644756|580018275|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
160627572|NCT03110107|580018276|FG000|Treatment Period|Disease Progression|3|||
160627573|NCT03110107|580018277|FG001|Treatment Period|Disease Progression|9|||
160627574|NCT03110107|580018278|FG002|Treatment Period|Disease Progression|8|||
160627575|NCT03110107|580018279|FG003|Treatment Period|Disease Progression|11|||
160627576|NCT03110107|580018280|FG004|Treatment Period|Disease Progression|8|||
160627577|NCT03110107|580018281|FG005|Treatment Period|Disease Progression|4|||
160627578|NCT03110107|580018282|FG006|Treatment Period|Disease Progression|6|||
160627579|NCT03110107|580018283|FG007|Treatment Period|Disease Progression|7|||
160627580|NCT03110107|580018284|FG008|Treatment Period|Disease Progression|2|||
160627581|NCT03110107|580018285|FG009|Treatment Period|Disease Progression|10|||
160627582|NCT03110107|580018286|FG010|Treatment Period|Disease Progression|5|||
160627583|NCT03110107|580018287|FG011|Treatment Period|Disease Progression|2|||
160627584|NCT03110107|580018288|FG012|Treatment Period|Disease Progression|0|||
160627585|NCT03110107|580018289|FG013|Treatment Period|Disease Progression|5|||
160627586|NCT03110107|580018290|FG014|Treatment Period|Disease Progression|14|||
160627587|NCT03110107|580018291|FG015|Treatment Period|Disease Progression|14|||
160627588|NCT03110107|580018292|FG016|Treatment Period|Disease Progression|4|||
160627589|NCT03110107|580018293|FG017|Treatment Period|Disease Progression|3|||
160627590|NCT03110107|580018294|FG018|Treatment Period|Disease Progression|16|||
160627591|NCT03110107|580018295|FG019|Treatment Period|Disease Progression|14|||
160627592|NCT03110107|580018296|FG020|Treatment Period|Disease Progression|12|||
160627593|NCT03110107|580018297|FG021|Treatment Period|Disease Progression|16|||
160627594|NCT03110107|580018298|FG022|Treatment Period|Disease Progression|18|||
160627595|NCT03110107|580018299|FG023|Treatment Period|Disease Progression|13|||
160627596|NCT03110107|580018300|FG024|Treatment Period|Disease Progression|16|||
160627597|NCT03110107|580018301|FG025|Treatment Period|Disease Progression|31|||
160627598|NCT03110107|580018276|FG000|Treatment Period|Study drug toxicity|1|||
160627599|NCT03110107|580018277|FG001|Treatment Period|Study drug toxicity|0|||
160627600|NCT03110107|580018278|FG002|Treatment Period|Study drug toxicity|1|||
160627601|NCT03110107|580018279|FG003|Treatment Period|Study drug toxicity|2|||
160627602|NCT03110107|580018280|FG004|Treatment Period|Study drug toxicity|0|||
160627603|NCT03110107|580018281|FG005|Treatment Period|Study drug toxicity|3|||
160627604|NCT03110107|580018282|FG006|Treatment Period|Study drug toxicity|1|||
160627605|NCT03110107|580018283|FG007|Treatment Period|Study drug toxicity|1|||
160627606|NCT03110107|580018284|FG008|Treatment Period|Study drug toxicity|3|||
160627607|NCT03110107|580018285|FG009|Treatment Period|Study drug toxicity|2|||
160627608|NCT03110107|580018286|FG010|Treatment Period|Study drug toxicity|0|||
160627609|NCT03110107|580018287|FG011|Treatment Period|Study drug toxicity|2|||
160627610|NCT03110107|580018288|FG012|Treatment Period|Study drug toxicity|0|||
160627611|NCT03110107|580018289|FG013|Treatment Period|Study drug toxicity|0|||
160627612|NCT03110107|580018290|FG014|Treatment Period|Study drug toxicity|2|||
160627613|NCT03110107|580018291|FG015|Treatment Period|Study drug toxicity|3|||
160627614|NCT03110107|580018292|FG016|Treatment Period|Study drug toxicity|3|||
160627615|NCT03110107|580018293|FG017|Treatment Period|Study drug toxicity|3|||
160627616|NCT03110107|580018294|FG018|Treatment Period|Study drug toxicity|1|||
160627617|NCT03110107|580018295|FG019|Treatment Period|Study drug toxicity|2|||
160627618|NCT03110107|580018296|FG020|Treatment Period|Study drug toxicity|2|||
160627619|NCT03110107|580018297|FG021|Treatment Period|Study drug toxicity|0|||
160627620|NCT03110107|580018298|FG022|Treatment Period|Study drug toxicity|2|||
160627621|NCT03110107|580018299|FG023|Treatment Period|Study drug toxicity|6|||
160627622|NCT03110107|580018300|FG024|Treatment Period|Study drug toxicity|7|||
160627623|NCT03110107|580018301|FG025|Treatment Period|Study drug toxicity|6|||
160627624|NCT03110107|580018276|FG000|Treatment Period|Death|0|||
160627625|NCT03110107|580018277|FG001|Treatment Period|Death|0|||
160627626|NCT03110107|580018278|FG002|Treatment Period|Death|0|||
160627627|NCT03110107|580018279|FG003|Treatment Period|Death|0|||
160627628|NCT03110107|580018280|FG004|Treatment Period|Death|0|||
160627629|NCT03110107|580018281|FG005|Treatment Period|Death|0|||
160627630|NCT03110107|580018282|FG006|Treatment Period|Death|0|||
160627631|NCT03110107|580018283|FG007|Treatment Period|Death|0|||
160627632|NCT03110107|580018284|FG008|Treatment Period|Death|0|||
160627633|NCT03110107|580018285|FG009|Treatment Period|Death|0|||
160627634|NCT03110107|580018286|FG010|Treatment Period|Death|0|||
160627635|NCT03110107|580018287|FG011|Treatment Period|Death|0|||
160627636|NCT03110107|580018288|FG012|Treatment Period|Death|1|||
160627637|NCT03110107|580018289|FG013|Treatment Period|Death|0|||
160627638|NCT03110107|580018290|FG014|Treatment Period|Death|0|||
160627639|NCT03110107|580018291|FG015|Treatment Period|Death|0|||
160627640|NCT03110107|580018292|FG016|Treatment Period|Death|0|||
160627641|NCT03110107|580018293|FG017|Treatment Period|Death|0|||
160627642|NCT03110107|580018294|FG018|Treatment Period|Death|0|||
160627643|NCT03110107|580018295|FG019|Treatment Period|Death|0|||
160627644|NCT03110107|580018296|FG020|Treatment Period|Death|0|||
160627645|NCT03110107|580018297|FG021|Treatment Period|Death|0|||
160627646|NCT03110107|580018298|FG022|Treatment Period|Death|0|||
160627647|NCT03110107|580018299|FG023|Treatment Period|Death|0|||
160627648|NCT03110107|580018300|FG024|Treatment Period|Death|0|||
160627649|NCT03110107|580018301|FG025|Treatment Period|Death|0|||
160627650|NCT03110107|580018276|FG000|Treatment Period|Adverse Event|0|||
160627651|NCT03110107|580018277|FG001|Treatment Period|Adverse Event|0|||
160627652|NCT03110107|580018278|FG002|Treatment Period|Adverse Event|1|||
160627653|NCT03110107|580018279|FG003|Treatment Period|Adverse Event|0|||
160627654|NCT03110107|580018280|FG004|Treatment Period|Adverse Event|0|||
160627655|NCT03110107|580018281|FG005|Treatment Period|Adverse Event|2|||
160627656|NCT03110107|580018282|FG006|Treatment Period|Adverse Event|0|||
160627657|NCT03110107|580018283|FG007|Treatment Period|Adverse Event|2|||
160627658|NCT03110107|580018284|FG008|Treatment Period|Adverse Event|0|||
160627659|NCT03110107|580018285|FG009|Treatment Period|Adverse Event|1|||
160627660|NCT03110107|580018286|FG010|Treatment Period|Adverse Event|0|||
160627661|NCT03110107|580018287|FG011|Treatment Period|Adverse Event|0|||
160627662|NCT03110107|580018288|FG012|Treatment Period|Adverse Event|0|||
160627663|NCT03110107|580018289|FG013|Treatment Period|Adverse Event|0|||
160627664|NCT03110107|580018290|FG014|Treatment Period|Adverse Event|0|||
160627665|NCT03110107|580018291|FG015|Treatment Period|Adverse Event|2|||
160627666|NCT03110107|580018292|FG016|Treatment Period|Adverse Event|0|||
160627667|NCT03110107|580018293|FG017|Treatment Period|Adverse Event|1|||
160627668|NCT03110107|580018294|FG018|Treatment Period|Adverse Event|2|||
160627669|NCT03110107|580018295|FG019|Treatment Period|Adverse Event|1|||
160627670|NCT03110107|580018296|FG020|Treatment Period|Adverse Event|4|||
160627671|NCT03110107|580018297|FG021|Treatment Period|Adverse Event|2|||
160627672|NCT03110107|580018298|FG022|Treatment Period|Adverse Event|2|||
160627673|NCT03110107|580018299|FG023|Treatment Period|Adverse Event|2|||
160627674|NCT03110107|580018300|FG024|Treatment Period|Adverse Event|2|||
160627675|NCT03110107|580018301|FG025|Treatment Period|Adverse Event|4|||
160627676|NCT03110107|580018276|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
160627677|NCT03110107|580018277|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
160627678|NCT03110107|580018278|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
160627679|NCT03110107|580018279|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
160627680|NCT03110107|580018280|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
160627681|NCT03110107|580018281|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
160627682|NCT03110107|580018282|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
160627683|NCT03110107|580018283|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
160627684|NCT03110107|580018284|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
160627685|NCT03110107|580018285|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
160627686|NCT03110107|580018286|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
160627687|NCT03110107|580018287|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
160627688|NCT03110107|580018288|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
160627689|NCT03110107|580018289|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
160627690|NCT03110107|580018290|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
160627691|NCT03110107|580018291|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
160627692|NCT03110107|580018292|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
160627693|NCT03110107|580018293|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
160627694|NCT03110107|580018294|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
160627695|NCT03110107|580018295|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
160627696|NCT03110107|580018296|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
160627697|NCT03110107|580018297|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
160627698|NCT03110107|580018298|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
160627699|NCT03110107|580018299|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
160627700|NCT03110107|580018300|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
160627701|NCT03110107|580018301|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
160627702|NCT03110107|580018276|FG000|Treatment Period|Participant withdrew consent|0|||
160627703|NCT03110107|580018277|FG001|Treatment Period|Participant withdrew consent|0|||
160627704|NCT03110107|580018278|FG002|Treatment Period|Participant withdrew consent|1|||
160627705|NCT03110107|580018279|FG003|Treatment Period|Participant withdrew consent|0|||
160627706|NCT03110107|580018280|FG004|Treatment Period|Participant withdrew consent|4|||
160627707|NCT03110107|580018281|FG005|Treatment Period|Participant withdrew consent|3|||
160627708|NCT03110107|580018282|FG006|Treatment Period|Participant withdrew consent|0|||
160627709|NCT03110107|580018283|FG007|Treatment Period|Participant withdrew consent|0|||
160627710|NCT03110107|580018284|FG008|Treatment Period|Participant withdrew consent|0|||
160627711|NCT03110107|580018285|FG009|Treatment Period|Participant withdrew consent|1|||
160627712|NCT03110107|580018286|FG010|Treatment Period|Participant withdrew consent|0|||
160627713|NCT03110107|580018287|FG011|Treatment Period|Participant withdrew consent|0|||
160627714|NCT03110107|580018288|FG012|Treatment Period|Participant withdrew consent|0|||
160627715|NCT03110107|580018289|FG013|Treatment Period|Participant withdrew consent|0|||
160627716|NCT03110107|580018290|FG014|Treatment Period|Participant withdrew consent|0|||
160627717|NCT03110107|580018291|FG015|Treatment Period|Participant withdrew consent|0|||
160627718|NCT03110107|580018292|FG016|Treatment Period|Participant withdrew consent|0|||
160627719|NCT03110107|580018293|FG017|Treatment Period|Participant withdrew consent|0|||
160627720|NCT03110107|580018294|FG018|Treatment Period|Participant withdrew consent|0|||
160627721|NCT03110107|580018295|FG019|Treatment Period|Participant withdrew consent|1|||
160627722|NCT03110107|580018296|FG020|Treatment Period|Participant withdrew consent|0|||
160627723|NCT03110107|580018297|FG021|Treatment Period|Participant withdrew consent|2|||
160627724|NCT03110107|580018298|FG022|Treatment Period|Participant withdrew consent|0|||
160627725|NCT03110107|580018299|FG023|Treatment Period|Participant withdrew consent|0|||
160627726|NCT03110107|580018300|FG024|Treatment Period|Participant withdrew consent|0|||
160627727|NCT03110107|580018301|FG025|Treatment Period|Participant withdrew consent|2|||
160627728|NCT03110107|580018276|FG000|Treatment Period|Participants no longer meets study criteria|0|||
160627729|NCT03110107|580018277|FG001|Treatment Period|Participants no longer meets study criteria|0|||
160627730|NCT03110107|580018278|FG002|Treatment Period|Participants no longer meets study criteria|0|||
160627731|NCT03110107|580018279|FG003|Treatment Period|Participants no longer meets study criteria|0|||
160627732|NCT03110107|580018280|FG004|Treatment Period|Participants no longer meets study criteria|0|||
160627733|NCT03110107|580018281|FG005|Treatment Period|Participants no longer meets study criteria|0|||
160627734|NCT03110107|580018282|FG006|Treatment Period|Participants no longer meets study criteria|0|||
160627735|NCT03110107|580018283|FG007|Treatment Period|Participants no longer meets study criteria|0|||
160627736|NCT03110107|580018284|FG008|Treatment Period|Participants no longer meets study criteria|0|||
160627737|NCT03110107|580018285|FG009|Treatment Period|Participants no longer meets study criteria|0|||
160627738|NCT03110107|580018286|FG010|Treatment Period|Participants no longer meets study criteria|0|||
160627739|NCT03110107|580018287|FG011|Treatment Period|Participants no longer meets study criteria|0|||
160627740|NCT03110107|580018288|FG012|Treatment Period|Participants no longer meets study criteria|0|||
160627741|NCT03110107|580018289|FG013|Treatment Period|Participants no longer meets study criteria|0|||
160627742|NCT03110107|580018290|FG014|Treatment Period|Participants no longer meets study criteria|0|||
160627743|NCT03110107|580018291|FG015|Treatment Period|Participants no longer meets study criteria|0|||
160672588|NCT00640393|580180483|FG001|Part 1|Lost to Follow-up|0|||
160672589|NCT00640393|580180484|FG002|Part 1|Lost to Follow-up|0|||
160672590|NCT00640393|580180482|FG000|Part 1|Withdrawal by Subject|3|||
160672591|NCT00640393|580180483|FG001|Part 1|Withdrawal by Subject|0|||
160627744|NCT03110107|580018292|FG016|Treatment Period|Participants no longer meets study criteria|0|||
160627745|NCT03110107|580018293|FG017|Treatment Period|Participants no longer meets study criteria|0|||
160627746|NCT03110107|580018294|FG018|Treatment Period|Participants no longer meets study criteria|0|||
160627747|NCT03110107|580018295|FG019|Treatment Period|Participants no longer meets study criteria|0|||
160627748|NCT03110107|580018296|FG020|Treatment Period|Participants no longer meets study criteria|0|||
160627749|NCT03110107|580018297|FG021|Treatment Period|Participants no longer meets study criteria|0|||
160627750|NCT03110107|580018298|FG022|Treatment Period|Participants no longer meets study criteria|0|||
160627751|NCT03110107|580018299|FG023|Treatment Period|Participants no longer meets study criteria|1|||
160627752|NCT03110107|580018300|FG024|Treatment Period|Participants no longer meets study criteria|0|||
160627753|NCT03110107|580018301|FG025|Treatment Period|Participants no longer meets study criteria|0|||
160627754|NCT03110107|580018276|FG000|Treatment Period|Other Reasons|0|||
160627755|NCT03110107|580018277|FG001|Treatment Period|Other Reasons|0|||
160627756|NCT03110107|580018278|FG002|Treatment Period|Other Reasons|1|||
160627757|NCT03110107|580018279|FG003|Treatment Period|Other Reasons|1|||
160627758|NCT03110107|580018280|FG004|Treatment Period|Other Reasons|0|||
160627759|NCT03110107|580018281|FG005|Treatment Period|Other Reasons|1|||
160627760|NCT03110107|580018282|FG006|Treatment Period|Other Reasons|0|||
160627761|NCT03110107|580018283|FG007|Treatment Period|Other Reasons|0|||
160627762|NCT03110107|580018284|FG008|Treatment Period|Other Reasons|0|||
160627763|NCT03110107|580018285|FG009|Treatment Period|Other Reasons|0|||
160627764|NCT03110107|580018286|FG010|Treatment Period|Other Reasons|0|||
160627765|NCT03110107|580018287|FG011|Treatment Period|Other Reasons|0|||
160627766|NCT03110107|580018288|FG012|Treatment Period|Other Reasons|0|||
160627767|NCT03110107|580018289|FG013|Treatment Period|Other Reasons|0|||
160627768|NCT03110107|580018290|FG014|Treatment Period|Other Reasons|0|||
160627769|NCT03110107|580018291|FG015|Treatment Period|Other Reasons|0|||
160627770|NCT03110107|580018292|FG016|Treatment Period|Other Reasons|0|||
160627771|NCT03110107|580018293|FG017|Treatment Period|Other Reasons|0|||
160627772|NCT03110107|580018294|FG018|Treatment Period|Other Reasons|0|||
160627773|NCT03110107|580018295|FG019|Treatment Period|Other Reasons|0|||
160627774|NCT03110107|580018296|FG020|Treatment Period|Other Reasons|0|||
160627775|NCT03110107|580018297|FG021|Treatment Period|Other Reasons|0|||
160627776|NCT03110107|580018298|FG022|Treatment Period|Other Reasons|0|||
160627777|NCT03110107|580018299|FG023|Treatment Period|Other Reasons|0|||
160627778|NCT03110107|580018300|FG024|Treatment Period|Other Reasons|1|||
160627779|NCT03110107|580018301|FG025|Treatment Period|Other Reasons|0|||
160627780|NCT03985982|580018305|FG000|Double-Blind Phase|Lost to Follow-up|4|||
160627781|NCT03985982|580018306|FG001|Double-Blind Phase|Lost to Follow-up|3|||
160627782|NCT03985982|580018307|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160627783|NCT03985982|580018305|FG000|Double-Blind Phase|Physician Decision|1|||
160627784|NCT03985982|580018306|FG001|Double-Blind Phase|Physician Decision|0|||
160627785|NCT03985982|580018307|FG002|Double-Blind Phase|Physician Decision|0|||
160627786|NCT03985982|580018305|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
160627787|NCT03985982|580018306|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
160627788|NCT03985982|580018307|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160627789|NCT03985982|580018305|FG000|Double-Blind Phase|COVID-19|1|||
160627790|NCT03985982|580018306|FG001|Double-Blind Phase|COVID-19|0|||
160627791|NCT03985982|580018307|FG002|Double-Blind Phase|COVID-19|0|||
160627792|NCT03985982|580018305|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
160627793|NCT03985982|580018306|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
160627794|NCT03985982|580018307|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
160627795|NCT03985982|580018305|FG000|Open-Label Phase|Lost to Follow-up|0|||
160627796|NCT03985982|580018306|FG001|Open-Label Phase|Lost to Follow-up|0|||
160627797|NCT03985982|580018307|FG002|Open-Label Phase|Lost to Follow-up|13|||
160627798|NCT03985982|580018305|FG000|Open-Label Phase|Physician Decision|0|||
160627799|NCT03985982|580018306|FG001|Open-Label Phase|Physician Decision|0|||
160627800|NCT03985982|580018307|FG002|Open-Label Phase|Physician Decision|2|||
160627801|NCT03985982|580018305|FG000|Open-Label Phase|Withdrawal by Subject|0|||
160627802|NCT03985982|580018306|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160627803|NCT03985982|580018307|FG002|Open-Label Phase|Withdrawal by Subject|11|||
160627804|NCT03927989|580018310|FG000|Overall Study|Withdrawal by Subject|0|||
160672592|NCT00640393|580180484|FG002|Part 1|Withdrawal by Subject|0|||
160627805|NCT03927989|580018311|FG001|Overall Study|Withdrawal by Subject|1|||
160627806|NCT03193996|580018315|FG000|Overall Study|Withdrawal by Subject|4|||
160627807|NCT03193996|580018315|FG000|Overall Study|Lost to Follow-up|4|||
160627808|NCT03193996|580018315|FG000|Overall Study|Physician Decision|2|||
160627809|NCT03193996|580018315|FG000|Overall Study|Pregnancy|1|||
160627810|NCT03193996|580018315|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
160627811|NCT03193996|580018315|FG000|Overall Study|Complicating disease|1|||
160627812|NCT00593385|580018316|FG000|Overall Study|Death|14|||
160627813|NCT00593385|580018316|FG000|Overall Study|Lost to Follow-up|17|||
160627814|NCT00593385|580018316|FG000|Overall Study|Withdrawal by Subject|9|||
160627815|NCT03253809|580018319|FG000|Overall Study|Unable to obtain study related data|14|||
160627816|NCT03992456|580018320|FG000|Overall Study|Withdrawal by Subject|1|||
160627817|NCT03992456|580018321|FG001|Overall Study|Withdrawal by Subject|0|||
160627818|NCT03992456|580018320|FG000|Overall Study|Disease progression|4|||
160627819|NCT03992456|580018321|FG001|Overall Study|Disease progression|5|||
160627820|NCT03992456|580018320|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
160627821|NCT03992456|580018321|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
160627822|NCT03155269|580018322|FG000|Overall Study|Withdrawal by Subject|4|||
160627823|NCT03155269|580018323|FG001|Overall Study|Withdrawal by Subject|5|||
160627824|NCT03155269|580018322|FG000|Overall Study|Lost to Follow-up|1|||
160627825|NCT03155269|580018323|FG001|Overall Study|Lost to Follow-up|2|||
160627826|NCT00910000|580018326|FG000|Overall Study|Adverse Event|0|||
160627827|NCT00910000|580018327|FG001|Overall Study|Adverse Event|3|||
160627828|NCT00910000|580018328|FG002|Overall Study|Adverse Event|2|||
160627829|NCT00910000|580018329|FG003|Overall Study|Adverse Event|2|||
160627830|NCT00910000|580018330|FG004|Overall Study|Adverse Event|0|||
160627831|NCT00910000|580018331|FG005|Overall Study|Adverse Event|1|||
160627832|NCT00910000|580018326|FG000|Overall Study|Withdrawal by Subject|0|||
160627833|NCT00910000|580018327|FG001|Overall Study|Withdrawal by Subject|0|||
160627834|NCT00910000|580018328|FG002|Overall Study|Withdrawal by Subject|1|||
160627835|NCT00910000|580018329|FG003|Overall Study|Withdrawal by Subject|0|||
160627836|NCT00910000|580018330|FG004|Overall Study|Withdrawal by Subject|1|||
160627837|NCT00910000|580018331|FG005|Overall Study|Withdrawal by Subject|0|||
160627838|NCT04637815|580018332|FG000|Overall Study|Death|1|||
160627839|NCT04637815|580018333|FG001|Overall Study|Death|0|||
160627840|NCT04637815|580018332|FG000|Overall Study|Lost to Follow-up|5|||
160627841|NCT04637815|580018333|FG001|Overall Study|Lost to Follow-up|2|||
160627842|NCT02594384|580018334|FG000|Overall Study|Disease Progression|3|||
160627843|NCT02594384|580018335|FG001|Overall Study|Disease Progression|7|||
160627844|NCT02594384|580018336|FG002|Overall Study|Disease Progression|0|||
160627845|NCT02594384|580018337|FG003|Overall Study|Disease Progression|2|||
160627846|NCT02594384|580018338|FG004|Overall Study|Disease Progression|2|||
160627847|NCT02594384|580018339|FG005|Overall Study|Disease Progression|12|||
160627848|NCT02594384|580018340|FG006|Overall Study|Disease Progression|5|||
160627849|NCT02594384|580018341|FG007|Overall Study|Disease Progression|5|||
160627850|NCT02594384|580018334|FG000|Overall Study|Adverse Event|0|||
160627851|NCT02594384|580018335|FG001|Overall Study|Adverse Event|1|||
160627852|NCT02594384|580018336|FG002|Overall Study|Adverse Event|4|||
160627853|NCT02594384|580018337|FG003|Overall Study|Adverse Event|1|||
160627854|NCT02594384|580018338|FG004|Overall Study|Adverse Event|0|||
160627855|NCT02594384|580018339|FG005|Overall Study|Adverse Event|6|||
160627856|NCT02594384|580018340|FG006|Overall Study|Adverse Event|1|||
160627857|NCT02594384|580018341|FG007|Overall Study|Adverse Event|1|||
160627858|NCT02594384|580018334|FG000|Overall Study|Withdrawal by Subject|0|||
160627859|NCT02594384|580018335|FG001|Overall Study|Withdrawal by Subject|0|||
160627860|NCT02594384|580018336|FG002|Overall Study|Withdrawal by Subject|0|||
160627861|NCT02594384|580018337|FG003|Overall Study|Withdrawal by Subject|1|||
160627862|NCT02594384|580018338|FG004|Overall Study|Withdrawal by Subject|0|||
160627863|NCT02594384|580018339|FG005|Overall Study|Withdrawal by Subject|0|||
160627864|NCT02594384|580018340|FG006|Overall Study|Withdrawal by Subject|0|||
160627865|NCT02594384|580018341|FG007|Overall Study|Withdrawal by Subject|1|||
160627866|NCT02594384|580018334|FG000|Overall Study|Physician Decision|0|||
160627867|NCT02594384|580018335|FG001|Overall Study|Physician Decision|0|||
160627868|NCT02594384|580018336|FG002|Overall Study|Physician Decision|0|||
160627869|NCT02594384|580018337|FG003|Overall Study|Physician Decision|0|||
160627870|NCT02594384|580018338|FG004|Overall Study|Physician Decision|0|||
160627871|NCT02594384|580018339|FG005|Overall Study|Physician Decision|1|||
160627872|NCT02594384|580018340|FG006|Overall Study|Physician Decision|2|||
160627873|NCT02594384|580018341|FG007|Overall Study|Physician Decision|0|||
160627874|NCT02594384|580018334|FG000|Overall Study|Progressive Leukocytosis|0|||
160627875|NCT02594384|580018335|FG001|Overall Study|Progressive Leukocytosis|0|||
160627876|NCT02594384|580018336|FG002|Overall Study|Progressive Leukocytosis|1|||
160627877|NCT02594384|580018337|FG003|Overall Study|Progressive Leukocytosis|0|||
160627878|NCT02594384|580018338|FG004|Overall Study|Progressive Leukocytosis|0|||
160627879|NCT02594384|580018339|FG005|Overall Study|Progressive Leukocytosis|0|||
160627880|NCT02594384|580018340|FG006|Overall Study|Progressive Leukocytosis|0|||
160627881|NCT02594384|580018341|FG007|Overall Study|Progressive Leukocytosis|0|||
160627882|NCT02594384|580018334|FG000|Overall Study|Lack of Efficacy|0|||
160627883|NCT02594384|580018335|FG001|Overall Study|Lack of Efficacy|0|||
160672593|NCT00640393|580180482|FG000|Randomization|Withdrawn per protocol|17|||
160627884|NCT02594384|580018336|FG002|Overall Study|Lack of Efficacy|0|||
160627885|NCT02594384|580018337|FG003|Overall Study|Lack of Efficacy|0|||
160627886|NCT02594384|580018338|FG004|Overall Study|Lack of Efficacy|1|||
160627887|NCT02594384|580018339|FG005|Overall Study|Lack of Efficacy|0|||
160627888|NCT02594384|580018340|FG006|Overall Study|Lack of Efficacy|0|||
160627889|NCT02594384|580018341|FG007|Overall Study|Lack of Efficacy|0|||
160627890|NCT02594384|580018334|FG000|Overall Study|Substantial noncompliance|0|||
160627891|NCT02594384|580018335|FG001|Overall Study|Substantial noncompliance|0|||
160627892|NCT02594384|580018336|FG002|Overall Study|Substantial noncompliance|0|||
160627893|NCT02594384|580018337|FG003|Overall Study|Substantial noncompliance|0|||
160627894|NCT02594384|580018338|FG004|Overall Study|Substantial noncompliance|0|||
160627895|NCT02594384|580018339|FG005|Overall Study|Substantial noncompliance|0|||
160627896|NCT02594384|580018340|FG006|Overall Study|Substantial noncompliance|1|||
160627897|NCT02594384|580018341|FG007|Overall Study|Substantial noncompliance|0|||
160627898|NCT02686749|580018344|FG000|Overall Study|terminated for poor enrollment|2|||
160627899|NCT02686749|580018345|FG001|Overall Study|terminated for poor enrollment|2|||
160627900|NCT00483119|580018348|FG000|Overall Study|Adverse Event|0|||
160627901|NCT00483119|580018349|FG001|Overall Study|Adverse Event|1|||
160627902|NCT00483119|580018348|FG000|Overall Study|Physician Decision|1|||
160627903|NCT00483119|580018349|FG001|Overall Study|Physician Decision|0|||
160627904|NCT04409509|580018350|FG000|Overall Study|Failure to meet randomization requirement|1|||
160627905|NCT04409509|580018351|FG001|Overall Study|Failure to meet randomization requirement|0|||
160627906|NCT04409509|580018350|FG000|Overall Study|Adverse Event|0|||
160627907|NCT04409509|580018351|FG001|Overall Study|Adverse Event|1|||
160627908|NCT04409509|580018350|FG000|Overall Study|Death|11|||
160627909|NCT04409509|580018351|FG001|Overall Study|Death|10|||
160627910|NCT04409509|580018350|FG000|Overall Study|Non-compliance with study drug|0|||
160627911|NCT04409509|580018351|FG001|Overall Study|Non-compliance with study drug|1|||
160627912|NCT04409509|580018350|FG000|Overall Study|Lost to Follow-up|0|||
160627913|NCT04409509|580018351|FG001|Overall Study|Lost to Follow-up|3|||
160627914|NCT04409509|580018350|FG000|Overall Study|Withdrawal by Subject|0|||
160627915|NCT04409509|580018351|FG001|Overall Study|Withdrawal by Subject|3|||
160627916|NCT04409509|580018350|FG000|Overall Study|Randomized by mistake|0|||
160627917|NCT04409509|580018351|FG001|Overall Study|Randomized by mistake|1|||
160627918|NCT04409509|580018350|FG000|Overall Study|Other|1|||
160627919|NCT04409509|580018351|FG001|Overall Study|Other|1|||
160627920|NCT04668066|580018352|FG000|Part 1: Treatment Phase|Adverse Event|0|||
160627921|NCT04668066|580018353|FG001|Part 1: Treatment Phase|Adverse Event|0|||
160627922|NCT04668066|580018354|FG002|Part 1: Treatment Phase|Adverse Event|0|||
160627923|NCT04668066|580018355|FG003|Part 1: Treatment Phase|Adverse Event|0|||
160627924|NCT04668066|580018356|FG004|Part 1: Treatment Phase|Adverse Event|0|||
160627925|NCT04668066|580018357|FG005|Part 1: Treatment Phase|Adverse Event|0|||
160627926|NCT04668066|580018358|FG006|Part 1: Treatment Phase|Adverse Event|0|||
160627927|NCT04668066|580018359|FG007|Part 1: Treatment Phase|Adverse Event|0|||
160627928|NCT04668066|580018360|FG008|Part 1: Treatment Phase|Adverse Event|0|||
160627929|NCT04668066|580018361|FG009|Part 1: Treatment Phase|Adverse Event|0|||
160627930|NCT04668066|580018362|FG010|Part 1: Treatment Phase|Adverse Event|0|||
160627931|NCT04668066|580018363|FG011|Part 1: Treatment Phase|Adverse Event|1|||
160627932|NCT04668066|580018364|FG012|Part 1: Treatment Phase|Adverse Event|1|||
160627933|NCT04668066|580018365|FG013|Part 1: Treatment Phase|Adverse Event|0|||
160627934|NCT04668066|580018366|FG014|Part 1: Treatment Phase|Adverse Event|0|||
160627935|NCT04668066|580018367|FG015|Part 1: Treatment Phase|Adverse Event|0|||
160627936|NCT04668066|580018368|FG016|Part 1: Treatment Phase|Adverse Event|0|||
160627937|NCT04668066|580018369|FG017|Part 1: Treatment Phase|Adverse Event|0|||
160627938|NCT04668066|580018370|FG018|Part 1: Treatment Phase|Adverse Event|0|||
160627939|NCT04668066|580018352|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627940|NCT04668066|580018353|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627941|NCT04668066|580018354|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
160627942|NCT04668066|580018355|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627943|NCT04668066|580018356|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627944|NCT04668066|580018357|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627945|NCT04668066|580018358|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627946|NCT04668066|580018359|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627947|NCT04668066|580018360|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627948|NCT04668066|580018361|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627949|NCT04668066|580018362|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627950|NCT04668066|580018363|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627951|NCT04668066|580018364|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627952|NCT04668066|580018365|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627953|NCT04668066|580018366|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627954|NCT04668066|580018367|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627955|NCT04668066|580018368|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627956|NCT04668066|580018369|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627957|NCT04668066|580018370|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
160627958|NCT04668066|580018352|FG000|Part 1: Treatment Phase|Other|0|||
160627959|NCT04668066|580018353|FG001|Part 1: Treatment Phase|Other|0|||
160627960|NCT04668066|580018354|FG002|Part 1: Treatment Phase|Other|0|||
160627961|NCT04668066|580018355|FG003|Part 1: Treatment Phase|Other|0|||
160627962|NCT04668066|580018356|FG004|Part 1: Treatment Phase|Other|0|||
160627963|NCT04668066|580018357|FG005|Part 1: Treatment Phase|Other|0|||
160627964|NCT04668066|580018358|FG006|Part 1: Treatment Phase|Other|0|||
160627965|NCT04668066|580018359|FG007|Part 1: Treatment Phase|Other|0|||
160627966|NCT04668066|580018360|FG008|Part 1: Treatment Phase|Other|0|||
160627967|NCT04668066|580018361|FG009|Part 1: Treatment Phase|Other|0|||
160627968|NCT04668066|580018362|FG010|Part 1: Treatment Phase|Other|0|||
160627969|NCT04668066|580018363|FG011|Part 1: Treatment Phase|Other|1|||
160627970|NCT04668066|580018364|FG012|Part 1: Treatment Phase|Other|0|||
160627971|NCT04668066|580018365|FG013|Part 1: Treatment Phase|Other|0|||
160627972|NCT04668066|580018366|FG014|Part 1: Treatment Phase|Other|0|||
160627973|NCT04668066|580018367|FG015|Part 1: Treatment Phase|Other|0|||
160627974|NCT04668066|580018368|FG016|Part 1: Treatment Phase|Other|0|||
160627975|NCT04668066|580018369|FG017|Part 1: Treatment Phase|Other|0|||
160627976|NCT04668066|580018370|FG018|Part 1: Treatment Phase|Other|0|||
160627977|NCT04668066|580018352|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627978|NCT04668066|580018353|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627979|NCT04668066|580018354|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627980|NCT04668066|580018355|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627981|NCT04668066|580018356|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627982|NCT04668066|580018357|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627983|NCT04668066|580018358|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627984|NCT04668066|580018359|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627985|NCT04668066|580018360|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627986|NCT04668066|580018361|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627987|NCT04668066|580018362|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627988|NCT04668066|580018363|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627989|NCT04668066|580018364|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
160627990|NCT04668066|580018365|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627991|NCT04668066|580018366|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627992|NCT04668066|580018367|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
160627993|NCT04668066|580018368|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627994|NCT04668066|580018369|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627995|NCT04668066|580018370|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
160627996|NCT04668066|580018352|FG000|Part 1: Follow-Up|Adverse Event|0|||
160627997|NCT04668066|580018353|FG001|Part 1: Follow-Up|Adverse Event|0|||
160627998|NCT04668066|580018354|FG002|Part 1: Follow-Up|Adverse Event|0|||
160627999|NCT04668066|580018355|FG003|Part 1: Follow-Up|Adverse Event|0|||
160628000|NCT04668066|580018356|FG004|Part 1: Follow-Up|Adverse Event|0|||
160628001|NCT04668066|580018357|FG005|Part 1: Follow-Up|Adverse Event|0|||
160628002|NCT04668066|580018358|FG006|Part 1: Follow-Up|Adverse Event|0|||
160628003|NCT04668066|580018359|FG007|Part 1: Follow-Up|Adverse Event|0|||
160628004|NCT04668066|580018360|FG008|Part 1: Follow-Up|Adverse Event|0|||
160628005|NCT04668066|580018361|FG009|Part 1: Follow-Up|Adverse Event|0|||
160628006|NCT04668066|580018362|FG010|Part 1: Follow-Up|Adverse Event|0|||
160628007|NCT04668066|580018363|FG011|Part 1: Follow-Up|Adverse Event|1|||
160628008|NCT04668066|580018364|FG012|Part 1: Follow-Up|Adverse Event|0|||
160628009|NCT04668066|580018365|FG013|Part 1: Follow-Up|Adverse Event|0|||
160628010|NCT04668066|580018366|FG014|Part 1: Follow-Up|Adverse Event|0|||
160628011|NCT04668066|580018367|FG015|Part 1: Follow-Up|Adverse Event|0|||
160628012|NCT04668066|580018368|FG016|Part 1: Follow-Up|Adverse Event|0|||
160628013|NCT04668066|580018369|FG017|Part 1: Follow-Up|Adverse Event|0|||
160628014|NCT04668066|580018370|FG018|Part 1: Follow-Up|Adverse Event|0|||
160628015|NCT04668066|580018352|FG000|Part 1: Follow-Up|Other|0|||
160628016|NCT04668066|580018353|FG001|Part 1: Follow-Up|Other|0|||
160628017|NCT04668066|580018354|FG002|Part 1: Follow-Up|Other|0|||
160628018|NCT04668066|580018355|FG003|Part 1: Follow-Up|Other|0|||
160628019|NCT04668066|580018356|FG004|Part 1: Follow-Up|Other|0|||
160628020|NCT04668066|580018357|FG005|Part 1: Follow-Up|Other|0|||
160628021|NCT04668066|580018358|FG006|Part 1: Follow-Up|Other|0|||
160628022|NCT04668066|580018359|FG007|Part 1: Follow-Up|Other|0|||
160628023|NCT04668066|580018360|FG008|Part 1: Follow-Up|Other|0|||
160628024|NCT04668066|580018361|FG009|Part 1: Follow-Up|Other|0|||
160628025|NCT04668066|580018362|FG010|Part 1: Follow-Up|Other|0|||
160628026|NCT04668066|580018363|FG011|Part 1: Follow-Up|Other|1|||
160628027|NCT04668066|580018364|FG012|Part 1: Follow-Up|Other|1|||
160628028|NCT04668066|580018365|FG013|Part 1: Follow-Up|Other|0|||
160628029|NCT04668066|580018366|FG014|Part 1: Follow-Up|Other|0|||
160628030|NCT04668066|580018367|FG015|Part 1: Follow-Up|Other|0|||
160628031|NCT04668066|580018368|FG016|Part 1: Follow-Up|Other|0|||
160628032|NCT04668066|580018369|FG017|Part 1: Follow-Up|Other|0|||
160628033|NCT04668066|580018370|FG018|Part 1: Follow-Up|Other|0|||
160628034|NCT04668066|580018352|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628035|NCT04668066|580018353|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628036|NCT04668066|580018354|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628037|NCT04668066|580018355|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628038|NCT04668066|580018356|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628039|NCT04668066|580018357|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628040|NCT04668066|580018358|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628041|NCT04668066|580018359|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628042|NCT04668066|580018360|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628043|NCT04668066|580018361|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628044|NCT04668066|580018362|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628045|NCT04668066|580018363|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628046|NCT04668066|580018364|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
160628047|NCT04668066|580018365|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628048|NCT04668066|580018366|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628049|NCT04668066|580018367|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
160628050|NCT04668066|580018368|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628051|NCT04668066|580018369|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628052|NCT04668066|580018370|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
160628053|NCT04668066|580018352|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628054|NCT04668066|580018353|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628055|NCT04668066|580018354|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628056|NCT04668066|580018355|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628057|NCT04668066|580018356|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628058|NCT04668066|580018357|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628059|NCT04668066|580018358|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628060|NCT04668066|580018359|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628061|NCT04668066|580018360|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628062|NCT04668066|580018361|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628063|NCT04668066|580018362|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628064|NCT04668066|580018363|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628065|NCT04668066|580018364|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160672594|NCT00640393|580180483|FG001|Randomization|Withdrawn per protocol|0|||
160672595|NCT00640393|580180484|FG002|Randomization|Withdrawn per protocol|0|||
160672596|NCT00640393|580180482|FG000|Randomization|Never randomized by site|2|||
160672597|NCT00640393|580180483|FG001|Randomization|Never randomized by site|0|||
160672598|NCT00640393|580180484|FG002|Randomization|Never randomized by site|0|||
160672599|NCT00640393|580180482|FG000|Part 2|Lost to Follow-up|0|||
160672600|NCT00640393|580180483|FG001|Part 2|Lost to Follow-up|2|||
160628066|NCT04668066|580018365|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628067|NCT04668066|580018366|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628068|NCT04668066|580018367|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628069|NCT04668066|580018368|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628070|NCT04668066|580018369|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
160628071|NCT04668066|580018370|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
160628072|NCT04668066|580018352|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628073|NCT04668066|580018353|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628074|NCT04668066|580018354|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628075|NCT04668066|580018355|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628076|NCT04668066|580018356|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628077|NCT04668066|580018357|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628078|NCT04668066|580018358|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628079|NCT04668066|580018359|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628080|NCT04668066|580018360|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628081|NCT04668066|580018361|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628082|NCT04668066|580018362|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628083|NCT04668066|580018363|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628084|NCT04668066|580018364|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628085|NCT04668066|580018365|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628086|NCT04668066|580018366|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628087|NCT04668066|580018367|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628088|NCT04668066|580018368|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628089|NCT04668066|580018369|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
160628090|NCT04668066|580018370|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
160628091|NCT04668066|580018352|FG000|Part 2: Treatment Phase|Other|0|||
160628092|NCT04668066|580018353|FG001|Part 2: Treatment Phase|Other|0|||
160628093|NCT04668066|580018354|FG002|Part 2: Treatment Phase|Other|0|||
160628094|NCT04668066|580018355|FG003|Part 2: Treatment Phase|Other|0|||
160628095|NCT04668066|580018356|FG004|Part 2: Treatment Phase|Other|0|||
160628096|NCT04668066|580018357|FG005|Part 2: Treatment Phase|Other|0|||
160628097|NCT04668066|580018358|FG006|Part 2: Treatment Phase|Other|0|||
160628098|NCT04668066|580018359|FG007|Part 2: Treatment Phase|Other|0|||
160628099|NCT04668066|580018360|FG008|Part 2: Treatment Phase|Other|0|||
160628100|NCT04668066|580018361|FG009|Part 2: Treatment Phase|Other|0|||
160628101|NCT04668066|580018362|FG010|Part 2: Treatment Phase|Other|0|||
160628102|NCT04668066|580018363|FG011|Part 2: Treatment Phase|Other|0|||
160628103|NCT04668066|580018364|FG012|Part 2: Treatment Phase|Other|0|||
160628104|NCT04668066|580018365|FG013|Part 2: Treatment Phase|Other|0|||
160628105|NCT04668066|580018366|FG014|Part 2: Treatment Phase|Other|0|||
160672601|NCT00640393|580180484|FG002|Part 2|Lost to Follow-up|2|||
160672602|NCT00640393|580180482|FG000|Part 2|Withdrawal by Subject|0|||
160628106|NCT04668066|580018367|FG015|Part 2: Treatment Phase|Other|0|||
160628107|NCT04668066|580018368|FG016|Part 2: Treatment Phase|Other|0|||
160628108|NCT04668066|580018369|FG017|Part 2: Treatment Phase|Other|0|||
160628109|NCT04668066|580018370|FG018|Part 2: Treatment Phase|Other|1|||
160628110|NCT04668066|580018352|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628111|NCT04668066|580018353|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628112|NCT04668066|580018354|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
160672603|NCT00640393|580180483|FG001|Part 2|Withdrawal by Subject|6|||
160672604|NCT00640393|580180484|FG002|Part 2|Withdrawal by Subject|1|||
160672605|NCT00640393|580180482|FG000|Part 2|Non-adherence|0|||
160628113|NCT04668066|580018355|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628114|NCT04668066|580018356|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628115|NCT04668066|580018357|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628116|NCT04668066|580018358|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628117|NCT04668066|580018359|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628118|NCT04668066|580018360|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628119|NCT04668066|580018361|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628120|NCT04668066|580018362|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628121|NCT04668066|580018363|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628122|NCT04668066|580018364|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628123|NCT04668066|580018365|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628124|NCT04668066|580018366|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628125|NCT04668066|580018367|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628126|NCT04668066|580018368|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628127|NCT04668066|580018369|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
160628128|NCT04668066|580018370|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
160628129|NCT02369874|580018371|FG000|Overall Study|Lost to Follow-up|2|||
160628130|NCT02369874|580018372|FG001|Overall Study|Lost to Follow-up|2|||
160628131|NCT02369874|580018373|FG002|Overall Study|Lost to Follow-up|2|||
160628132|NCT02369874|580018371|FG000|Overall Study|Withdrawal by Subject|7|||
160628133|NCT02369874|580018372|FG001|Overall Study|Withdrawal by Subject|9|||
160628134|NCT02369874|580018373|FG002|Overall Study|Withdrawal by Subject|27|||
160519856|NCT00679627|579632897|FG001|Overall Study|Early Study Closure|405|||
160519857|NCT02709096|579632903|FG000|Overall Study|non-compliance|1|||
160519858|NCT02709096|579632904|FG001|Overall Study|non-compliance|1|||
160519859|NCT00818649|579632905|FG000|Overall Study|Declining performance status|2|||
160519860|NCT00818649|579632905|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
160519861|NCT00818649|579632905|FG000|Overall Study|Adverse Event|1|||
160519862|NCT03513588|579632906|FG000|Overall Study|Lost to Follow-up|0|||
160519863|NCT03513588|579632907|FG001|Overall Study|Lost to Follow-up|1|||
160519864|NCT03513588|579632908|FG002|Overall Study|Lost to Follow-up|1|||
160519865|NCT03513588|579632906|FG000|Overall Study|Study dosing paused by sponsor|1|||
160519866|NCT03513588|579632907|FG001|Overall Study|Study dosing paused by sponsor|1|||
160519867|NCT03513588|579632908|FG002|Overall Study|Study dosing paused by sponsor|0|||
160519868|NCT03513588|579632906|FG000|Overall Study|Death|0|||
160519869|NCT03513588|579632907|FG001|Overall Study|Death|0|||
160519870|NCT03513588|579632908|FG002|Overall Study|Death|1|||
160519871|NCT00505284|579632909|FG000|Overall Study|Adverse Event|3|||
160519872|NCT00505284|579632910|FG001|Overall Study|Adverse Event|7|||
160519873|NCT00505284|579632911|FG002|Overall Study|Adverse Event|9|||
160519874|NCT00505284|579632912|FG003|Overall Study|Adverse Event|14|||
160519875|NCT00505284|579632913|FG004|Overall Study|Adverse Event|22|||
160519876|NCT00505284|579632909|FG000|Overall Study|Protocol Violation|0|||
160519877|NCT00505284|579632910|FG001|Overall Study|Protocol Violation|1|||
160519878|NCT00505284|579632911|FG002|Overall Study|Protocol Violation|1|||
160519879|NCT00505284|579632912|FG003|Overall Study|Protocol Violation|0|||
160519880|NCT00505284|579632913|FG004|Overall Study|Protocol Violation|0|||
160519881|NCT00505284|579632909|FG000|Overall Study|Withdrawal by Subject|2|||
160519882|NCT00505284|579632910|FG001|Overall Study|Withdrawal by Subject|6|||
160519883|NCT00505284|579632911|FG002|Overall Study|Withdrawal by Subject|1|||
160519884|NCT00505284|579632912|FG003|Overall Study|Withdrawal by Subject|0|||
160519885|NCT00505284|579632913|FG004|Overall Study|Withdrawal by Subject|6|||
160519886|NCT00505284|579632909|FG000|Overall Study|Lack of Efficacy|0|||
160519887|NCT00505284|579632910|FG001|Overall Study|Lack of Efficacy|1|||
160519888|NCT00505284|579632911|FG002|Overall Study|Lack of Efficacy|1|||
160519889|NCT00505284|579632912|FG003|Overall Study|Lack of Efficacy|1|||
160519890|NCT00505284|579632913|FG004|Overall Study|Lack of Efficacy|1|||
160519891|NCT00505284|579632909|FG000|Overall Study|Physician Decision|0|||
160519892|NCT00505284|579632910|FG001|Overall Study|Physician Decision|1|||
160519893|NCT00505284|579632911|FG002|Overall Study|Physician Decision|0|||
160519894|NCT00505284|579632912|FG003|Overall Study|Physician Decision|0|||
160519895|NCT00505284|579632913|FG004|Overall Study|Physician Decision|0|||
160519896|NCT00505284|579632909|FG000|Overall Study|Other|5|||
160519897|NCT00505284|579632910|FG001|Overall Study|Other|0|||
160519898|NCT00505284|579632911|FG002|Overall Study|Other|0|||
160519899|NCT00505284|579632912|FG003|Overall Study|Other|4|||
160519900|NCT00505284|579632913|FG004|Overall Study|Other|4|||
160519901|NCT01275131|579632914|FG000|Period 1|Withdrawal by Subject|1|||
160519902|NCT01275131|579632915|FG001|Period 1|Withdrawal by Subject|0|||
160519903|NCT01275131|579632916|FG002|Period 1|Withdrawal by Subject|3|||
160519904|NCT01275131|579632917|FG003|Period 1|Withdrawal by Subject|2|||
160519905|NCT01275131|579632914|FG000|Period 1|Physician Decision|1|||
160519906|NCT01275131|579632915|FG001|Period 1|Physician Decision|0|||
160519907|NCT01275131|579632916|FG002|Period 1|Physician Decision|0|||
160519908|NCT01275131|579632917|FG003|Period 1|Physician Decision|0|||
160519909|NCT01275131|579632914|FG000|Period 2 (Crossover)|Adverse Event|0|||
160519910|NCT01275131|579632915|FG001|Period 2 (Crossover)|Adverse Event|1|||
160519911|NCT01275131|579632916|FG002|Period 2 (Crossover)|Adverse Event|0|||
160628135|NCT02369874|580018371|FG000|Overall Study|Miscellaneous|1|||
160628136|NCT02369874|580018372|FG001|Overall Study|Miscellaneous|1|||
160628137|NCT02369874|580018373|FG002|Overall Study|Miscellaneous|0|||
160628138|NCT02369874|580018371|FG000|Overall Study|On Treatment/Off Study|34|||
160628139|NCT02369874|580018372|FG001|Overall Study|On Treatment/Off Study|45|||
160628140|NCT02369874|580018373|FG002|Overall Study|On Treatment/Off Study|32|||
160628141|NCT02058849|580018374|FG000|Overall Study|Hospitalization|1|||
160628142|NCT02058849|580018375|FG001|Overall Study|Hospitalization|1|||
160628143|NCT02058849|580018374|FG000|Overall Study|Death|1|||
160628144|NCT02058849|580018375|FG001|Overall Study|Death|0|||
160628145|NCT02058849|580018374|FG000|Overall Study|Lost to Follow-up|1|||
160628146|NCT02058849|580018375|FG001|Overall Study|Lost to Follow-up|0|||
160628147|NCT02058849|580018374|FG000|Overall Study|Withdrawal by Subject|4|||
160628148|NCT02058849|580018375|FG001|Overall Study|Withdrawal by Subject|0|||
160628149|NCT02331680|580018376|FG000|Overall Study|Adverse Event|3|||
160628150|NCT02331680|580018377|FG001|Overall Study|Adverse Event|0|||
160628151|NCT02331680|580018378|FG002|Overall Study|Adverse Event|2|||
160628152|NCT02331680|580018376|FG000|Overall Study|Physician Decision|1|||
160628153|NCT02331680|580018377|FG001|Overall Study|Physician Decision|1|||
160628154|NCT02331680|580018378|FG002|Overall Study|Physician Decision|2|||
160628155|NCT02331680|580018376|FG000|Overall Study|Withdrawal by Subject|0|||
160628156|NCT02331680|580018377|FG001|Overall Study|Withdrawal by Subject|1|||
160628157|NCT02331680|580018378|FG002|Overall Study|Withdrawal by Subject|2|||
160628158|NCT02331680|580018376|FG000|Overall Study|Met withdrawal criteria|2|||
160628159|NCT02331680|580018377|FG001|Overall Study|Met withdrawal criteria|2|||
160628160|NCT02331680|580018378|FG002|Overall Study|Met withdrawal criteria|5|||
160628161|NCT02331680|580018376|FG000|Overall Study|Non-compliance with study drug|0|||
160628162|NCT02331680|580018377|FG001|Overall Study|Non-compliance with study drug|0|||
160628163|NCT02331680|580018378|FG002|Overall Study|Non-compliance with study drug|1|||
160628164|NCT02331680|580018376|FG000|Overall Study|Protocol Violation|0|||
160628165|NCT02331680|580018377|FG001|Overall Study|Protocol Violation|0|||
160628166|NCT02331680|580018378|FG002|Overall Study|Protocol Violation|3|||
160628167|NCT02219477|580018379|FG000|Overall Study|Adverse Event|0|||
160628168|NCT02219477|580018380|FG001|Overall Study|Adverse Event|1|||
160628169|NCT02219477|580018381|FG002|Overall Study|Adverse Event|1|||
160628170|NCT02219477|580018379|FG000|Overall Study|Withdrawal by Subject|0|||
160628171|NCT02219477|580018380|FG001|Overall Study|Withdrawal by Subject|1|||
160628172|NCT02219477|580018381|FG002|Overall Study|Withdrawal by Subject|0|||
160628173|NCT00596466|580018382|FG000|Overall Study|Lack of Efficacy|5|||
160628174|NCT00596466|580018382|FG000|Overall Study|Adverse Event|4|||
160628175|NCT00596466|580018382|FG000|Overall Study|Withdrawal by Subject|2|||
160628176|NCT00596466|580018382|FG000|Overall Study|Protocol Violation|2|||
160628177|NCT00596466|580018382|FG000|Overall Study|Unpecified|2|||
160628178|NCT00596466|580018382|FG000|Overall Study|Enrolled, not treated|2|||
160628179|NCT04505592|580018383|FG000|Overall Study|Death|2|||
160628180|NCT04505592|580018384|FG001|Overall Study|Death|1|||
160628181|NCT01891669|580018386|FG000|Overall Study|Death|0|||
160628182|NCT01891669|580018387|FG001|Overall Study|Death|0|||
160628183|NCT01891669|580018388|FG002|Overall Study|Death|0|||
160628184|NCT01891669|580018389|FG003|Overall Study|Death|0|||
160628185|NCT01891669|580018390|FG004|Overall Study|Death|0|||
160628186|NCT01891669|580018391|FG005|Overall Study|Death|0|||
160628187|NCT01891669|580018392|FG006|Overall Study|Death|0|||
160672606|NCT00640393|580180483|FG001|Part 2|Non-adherence|1|||
160672607|NCT00640393|580180484|FG002|Part 2|Non-adherence|0|||
160672608|NCT00640393|580180482|FG000|Part 2|Adverse Event|0|||
160672609|NCT00640393|580180483|FG001|Part 2|Adverse Event|1|||
160672610|NCT00640393|580180484|FG002|Part 2|Adverse Event|0|||
160672611|NCT00608322|580180490|FG000|Overall Study|Death|2|||
160672612|NCT00608322|580180491|FG001|Overall Study|Death|1|||
160672613|NCT04002648|580180492|FG000|Overall Study|Lost to Follow-up|2|||
160672614|NCT04002648|580180493|FG001|Overall Study|Lost to Follow-up|0|||
160672615|NCT00606281|580180494|FG000|Overall Study|Adverse Event|11|||
160628188|NCT01891669|580018393|FG007|Overall Study|Death|1|||
160672616|NCT00606281|580180495|FG001|Overall Study|Adverse Event|12|||
160672617|NCT00606281|580180494|FG000|Overall Study|Death|1|||
160672618|NCT00606281|580180495|FG001|Overall Study|Death|0|||
160672619|NCT00606281|580180494|FG000|Overall Study|Lack of Efficacy|28|||
160672620|NCT00606281|580180495|FG001|Overall Study|Lack of Efficacy|35|||
160628189|NCT01891669|580018394|FG008|Overall Study|Death|0|||
160672621|NCT00606281|580180494|FG000|Overall Study|Physician Decision|0|||
160672622|NCT00606281|580180495|FG001|Overall Study|Physician Decision|1|||
160628190|NCT01891669|580018395|FG009|Overall Study|Death|1|||
160628191|NCT01891669|580018386|FG000|Overall Study|Withdrawal by Subject|1|||
160672623|NCT00606281|580180494|FG000|Overall Study|Protocol Violation|3|||
160672624|NCT00606281|580180495|FG001|Overall Study|Protocol Violation|3|||
160672625|NCT00606281|580180494|FG000|Overall Study|Withdrawal by Subject|11|||
160628192|NCT01891669|580018387|FG001|Overall Study|Withdrawal by Subject|1|||
160628193|NCT01891669|580018388|FG002|Overall Study|Withdrawal by Subject|0|||
160628194|NCT01891669|580018389|FG003|Overall Study|Withdrawal by Subject|0|||
160628195|NCT01891669|580018390|FG004|Overall Study|Withdrawal by Subject|0|||
160672626|NCT00606281|580180495|FG001|Overall Study|Withdrawal by Subject|13|||
160628196|NCT01891669|580018391|FG005|Overall Study|Withdrawal by Subject|0|||
160628197|NCT01891669|580018392|FG006|Overall Study|Withdrawal by Subject|1|||
160628198|NCT01891669|580018393|FG007|Overall Study|Withdrawal by Subject|2|||
160628199|NCT01891669|580018394|FG008|Overall Study|Withdrawal by Subject|1|||
160628200|NCT01891669|580018395|FG009|Overall Study|Withdrawal by Subject|1|||
160628201|NCT01891669|580018386|FG000|Overall Study|Other|1|||
160628202|NCT01891669|580018387|FG001|Overall Study|Other|0|||
160628203|NCT01891669|580018388|FG002|Overall Study|Other|0|||
160628204|NCT01891669|580018389|FG003|Overall Study|Other|0|||
160628205|NCT01891669|580018390|FG004|Overall Study|Other|0|||
160628206|NCT01891669|580018391|FG005|Overall Study|Other|0|||
160628207|NCT01891669|580018392|FG006|Overall Study|Other|0|||
160628208|NCT01891669|580018393|FG007|Overall Study|Other|1|||
160628209|NCT01891669|580018394|FG008|Overall Study|Other|0|||
160628210|NCT01891669|580018395|FG009|Overall Study|Other|0|||
160628211|NCT04298229|580018396|FG000|Overall Study|Physician Decision|1|||
160628212|NCT04298229|580018397|FG001|Overall Study|Physician Decision|1|||
160628213|NCT04298229|580018396|FG000|Overall Study|Withdrawal by Subject|1|||
160628214|NCT04298229|580018397|FG001|Overall Study|Withdrawal by Subject|1|||
160628215|NCT04298229|580018396|FG000|Overall Study|Did not receive IV loop diuretics|2|||
160628216|NCT04298229|580018397|FG001|Overall Study|Did not receive IV loop diuretics|0|||
160628217|NCT00262119|580018398|FG000|Overall Study|Lost to Follow-up|38|||
160628218|NCT00262119|580018399|FG001|Overall Study|Lost to Follow-up|51|||
160628219|NCT00262119|580018400|FG002|Overall Study|Lost to Follow-up|42|||
160628220|NCT00262119|580018398|FG000|Overall Study|Death|20|||
160628221|NCT00262119|580018399|FG001|Overall Study|Death|19|||
160628222|NCT00262119|580018400|FG002|Overall Study|Death|16|||
160628223|NCT05261126|580018405|FG000|Overall Study|Death|0|||
160628224|NCT05261126|580018406|FG001|Overall Study|Death|0|||
160628225|NCT05261126|580018407|FG002|Overall Study|Death|1|||
160628226|NCT05261126|580018408|FG003|Overall Study|Death|0|||
160628227|NCT05261126|580018409|FG004|Overall Study|Death|0|||
160628228|NCT05261126|580018405|FG000|Overall Study|Lost to Follow-up|0|||
160628229|NCT05261126|580018406|FG001|Overall Study|Lost to Follow-up|0|||
160628230|NCT05261126|580018407|FG002|Overall Study|Lost to Follow-up|0|||
160628231|NCT05261126|580018408|FG003|Overall Study|Lost to Follow-up|0|||
160628232|NCT05261126|580018409|FG004|Overall Study|Lost to Follow-up|1|||
160628233|NCT05261126|580018405|FG000|Overall Study|Physician Decision|1|||
160628234|NCT05261126|580018406|FG001|Overall Study|Physician Decision|0|||
160628235|NCT05261126|580018407|FG002|Overall Study|Physician Decision|0|||
160628236|NCT05261126|580018408|FG003|Overall Study|Physician Decision|0|||
160628237|NCT05261126|580018409|FG004|Overall Study|Physician Decision|0|||
160628238|NCT05261126|580018405|FG000|Overall Study|Screen Failure|0|||
160628239|NCT05261126|580018406|FG001|Overall Study|Screen Failure|0|||
160628240|NCT05261126|580018407|FG002|Overall Study|Screen Failure|0|||
160628241|NCT05261126|580018408|FG003|Overall Study|Screen Failure|0|||
160628242|NCT05261126|580018409|FG004|Overall Study|Screen Failure|1|||
160628243|NCT05261126|580018405|FG000|Overall Study|Withdrawal by Subject|1|||
160628244|NCT05261126|580018406|FG001|Overall Study|Withdrawal by Subject|0|||
160628245|NCT05261126|580018407|FG002|Overall Study|Withdrawal by Subject|1|||
160628246|NCT05261126|580018408|FG003|Overall Study|Withdrawal by Subject|1|||
160628247|NCT05261126|580018409|FG004|Overall Study|Withdrawal by Subject|0|||
160628248|NCT05261126|580018405|FG000|Overall Study|Not Recorded|0|||
160628249|NCT05261126|580018406|FG001|Overall Study|Not Recorded|0|||
160628250|NCT05261126|580018407|FG002|Overall Study|Not Recorded|0|||
160628251|NCT05261126|580018408|FG003|Overall Study|Not Recorded|1|||
160628252|NCT05261126|580018409|FG004|Overall Study|Not Recorded|0|||
160628253|NCT05570604|580018410|FG000|Overall Study|Lost to Follow-up|1|||
160628254|NCT05570604|580018411|FG001|Overall Study|Lost to Follow-up|5|||
160628255|NCT05570604|580018410|FG000|Overall Study|Illness|2|||
160628256|NCT05570604|580018411|FG001|Overall Study|Illness|2|||
160628257|NCT04527380|580018414|FG000|Overall Study|Lack of Efficacy|0|||
160628258|NCT04527380|580018415|FG001|Overall Study|Lack of Efficacy|1|||
160628259|NCT04527380|580018414|FG000|Overall Study|Withdrawal by Subject|1|||
160628260|NCT04527380|580018415|FG001|Overall Study|Withdrawal by Subject|0|||
160628261|NCT04479358|580018416|FG000|Overall Study|Withdrawal by Subject|0|||
160628262|NCT04479358|580018417|FG001|Overall Study|Withdrawal by Subject|0|||
160628263|NCT04479358|580018418|FG002|Overall Study|Withdrawal by Subject|1|||
160628264|NCT04479358|580018419|FG003|Overall Study|Withdrawal by Subject|0|||
160628265|NCT04479358|580018420|FG004|Overall Study|Withdrawal by Subject|0|||
160628266|NCT04479358|580018421|FG005|Overall Study|Withdrawal by Subject|1|||
160628267|NCT05116241|580018428|FG000|Study|Withdrawal by Subject|5|||
160628268|NCT05116241|580018429|FG001|Study|Withdrawal by Subject|2|||
160628269|NCT05116241|580018430|FG002|Study|Withdrawal by Subject|1|||
160628270|NCT05116241|580018428|FG000|Study|Lost to Follow-up|0|||
160628271|NCT05116241|580018429|FG001|Study|Lost to Follow-up|2|||
160672627|NCT00606281|580180494|FG000|Overall Study|Progression to depressive phase|1|||
160628272|NCT05116241|580018430|FG002|Study|Lost to Follow-up|2|||
160628273|NCT01215968|580018443|FG000|Overall Study|Adverse Event|0|||
160628274|NCT01215968|580018444|FG001|Overall Study|Adverse Event|2|||
160628275|NCT01215968|580018443|FG000|Overall Study|Protocol Violation|2|||
160628276|NCT01215968|580018444|FG001|Overall Study|Protocol Violation|4|||
160628277|NCT01215968|580018443|FG000|Overall Study|Not received study drug|0|||
160628278|NCT01215968|580018444|FG001|Overall Study|Not received study drug|1|||
160628279|NCT02396849|580018448|FG000|Overall Study|Lost to Follow-up|1|||
160628280|NCT02396849|580018449|FG001|Overall Study|Lost to Follow-up|1|||
160628281|NCT02396849|580018448|FG000|Overall Study|Did not tolerate intervention|1|||
160628282|NCT02396849|580018449|FG001|Overall Study|Did not tolerate intervention|1|||
160628283|NCT03328325|580018450|FG000|Overall Study|Lost to Follow-up|4|||
160628284|NCT03328325|580018450|FG000|Overall Study|Physician Decision|1|||
160628285|NCT03328325|580018450|FG000|Overall Study|Withdrawal by Subject|3|||
160628286|NCT03328325|580018450|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
160628287|NCT00931515|580018451|FG000|Overall Study|Lost to Follow-up|2|||
160628288|NCT00931515|580018452|FG001|Overall Study|Lost to Follow-up|5|||
160628289|NCT00985114|580018453|FG000|Overall Study|Adverse Event|1|||
160628290|NCT00985114|580018454|FG001|Overall Study|Adverse Event|0|||
160628291|NCT00985114|580018453|FG000|Overall Study|Withdrawal by Subject|0|||
160628292|NCT00985114|580018454|FG001|Overall Study|Withdrawal by Subject|2|||
160628293|NCT02950831|580018455|FG000|Overall Study|Lost to Follow-up|1|||
160628294|NCT02950831|580018455|FG000|Overall Study|Withdrawal by Subject|3|||
160628295|NCT02950831|580018455|FG000|Overall Study|stimulation trail failure|5|||
160628296|NCT00602927|580019900|FG000|Period 1: 13 Days|Protocol Violation|2|||
160628297|NCT00602927|580019901|FG001|Period 1: 13 Days|Protocol Violation|4|||
160628298|NCT00602927|580019900|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
160628299|NCT00602927|580019901|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
160628300|NCT00602927|580019900|FG000|Period 1: 13 Days|Time|1|||
160628301|NCT00602927|580019901|FG001|Period 1: 13 Days|Time|0|||
160628302|NCT00602927|580019900|FG000|Period 1: 13 Days|Claustrophobia|0|||
160628303|NCT00602927|580019901|FG001|Period 1: 13 Days|Claustrophobia|1|||
160628304|NCT00602927|580019900|FG000|Period 2: 14 Days|Protocol Violation|0|||
160628305|NCT00602927|580019901|FG001|Period 2: 14 Days|Protocol Violation|2|||
160628306|NCT00602927|580019900|FG000|Period 3: 13 Days|Protocol Violation|0|||
160628307|NCT00602927|580019901|FG001|Period 3: 13 Days|Protocol Violation|1|||
160628308|NCT00602927|580019900|FG000|Period 3: 13 Days|MRI data quality|2|||
160628309|NCT00602927|580019901|FG001|Period 3: 13 Days|MRI data quality|2|||
160628310|NCT01741259|580019907|FG000|Overall Study|Protocol Violation|6|||
160628311|NCT01741259|580019908|FG001|Overall Study|Protocol Violation|4|||
160628312|NCT01741259|580019907|FG000|Overall Study|Withdrawal by Subject|0|||
160628313|NCT01741259|580019908|FG001|Overall Study|Withdrawal by Subject|2|||
160628314|NCT02875340|580019914|FG000|Overall Study|Death|2|||
160628315|NCT02875340|580019914|FG000|Overall Study|Withdrawal by Subject|2|||
160628316|NCT02875340|580019914|FG000|Overall Study|Physician Decision|3|||
160628317|NCT02875340|580019914|FG000|Overall Study|Adverse Event|1|||
160628318|NCT01160770|580019917|FG000|Overall Study|Adverse Event|10|||
160628319|NCT01160770|580019917|FG000|Overall Study|Protocol Violation|2|||
160628320|NCT01160770|580019917|FG000|Overall Study|Subject/parent/caregiver request|33|||
160628321|NCT01160770|580019917|FG000|Overall Study|Physician Decision|1|||
160628322|NCT01160770|580019917|FG000|Overall Study|Lost to Follow-up|7|||
160628323|NCT01160770|580019917|FG000|Overall Study|Study termination or sponsor request|1|||
160628324|NCT01160770|580019917|FG000|Overall Study|Death|9|||
160628325|NCT01160770|580019917|FG000|Overall Study|Lack of Efficacy|15|||
160628326|NCT01160770|580019917|FG000|Overall Study|Other Reasons|1|||
160628327|NCT03587116|580019922|FG000|Overall Study|Lost to Follow-up|0|||
160628328|NCT03587116|580019923|FG001|Overall Study|Lost to Follow-up|1|||
160628329|NCT03587116|580019922|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
160628330|NCT03587116|580019923|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
160628331|NCT03587116|580019922|FG000|Overall Study|Withdrawal by Subject|4|||
160628332|NCT03587116|580019923|FG001|Overall Study|Withdrawal by Subject|0|||
160628333|NCT03526549|580019925|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
160628334|NCT03526549|580019926|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
160628335|NCT03526549|580019925|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
160628336|NCT03526549|580019926|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
160628337|NCT03526549|580019925|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
160628338|NCT03526549|580019926|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
160628339|NCT03526549|580019925|FG000|Open-label Phase|Adverse Event|4|||
160628340|NCT03526549|580019926|FG001|Open-label Phase|Adverse Event|0|||
160628341|NCT03526549|580019925|FG000|Open-label Phase|Withdrawal by Subject|54|||
160628342|NCT03526549|580019926|FG001|Open-label Phase|Withdrawal by Subject|0|||
160628343|NCT03526549|580019925|FG000|Open-label Phase|Lost to Follow-up|35|||
160628344|NCT03526549|580019926|FG001|Open-label Phase|Lost to Follow-up|0|||
160628345|NCT03526549|580019925|FG000|Open-label Phase|Other than Specified|5|||
160628346|NCT03526549|580019926|FG001|Open-label Phase|Other than Specified|0|||
160628347|NCT05981365|580019927|FG000|Period 1|Adverse Event|1|||
160628348|NCT05981365|580019928|FG001|Period 1|Adverse Event|0|||
160628349|NCT02593175|580019929|FG000|Overall Study|Adverse Event|5|||
160628350|NCT02593175|580019929|FG000|Overall Study|Disease progression|4|||
160628351|NCT00478933|580019930|FG000|Overall Study|Protocol Violation|22|||
160628352|NCT00478933|580019930|FG000|Overall Study|Informed consent not verified|3|||
160628353|NCT00478933|580019930|FG000|Overall Study|Inadequate data available|53|||
160628354|NCT00643006|580019932|FG000|Overall Study|Lost to Follow-up|5|||
160628355|NCT00643006|580019933|FG001|Overall Study|Lost to Follow-up|4|||
160628356|NCT02506101|580019934|FG000|Overall Study|Transportation issues|1|||
160628357|NCT02506101|580019935|FG001|Overall Study|Transportation issues|0|||
160628358|NCT02506101|580019934|FG000|Overall Study|No enrollment and staff unavailability|1|||
160628359|NCT02506101|580019935|FG001|Overall Study|No enrollment and staff unavailability|0|||
160628360|NCT03586427|580019939|FG000|Overall Study|Lost to Follow-up|0|||
160628361|NCT03586427|580019940|FG001|Overall Study|Lost to Follow-up|3|||
160628362|NCT03586427|580019941|FG002|Overall Study|Lost to Follow-up|1|||
160628363|NCT03586427|580019942|FG003|Overall Study|Lost to Follow-up|3|||
160628364|NCT03586427|580019943|FG004|Overall Study|Lost to Follow-up|3|||
160628365|NCT03586427|580019939|FG000|Overall Study|Withdrawal by Subject|0|||
160628366|NCT03586427|580019940|FG001|Overall Study|Withdrawal by Subject|1|||
160628367|NCT03586427|580019941|FG002|Overall Study|Withdrawal by Subject|2|||
160628368|NCT03586427|580019942|FG003|Overall Study|Withdrawal by Subject|1|||
160628369|NCT03586427|580019943|FG004|Overall Study|Withdrawal by Subject|1|||
160628370|NCT03586427|580019939|FG000|Overall Study|Adverse Event|0|||
160628371|NCT03586427|580019940|FG001|Overall Study|Adverse Event|0|||
160628372|NCT03586427|580019941|FG002|Overall Study|Adverse Event|1|||
160628373|NCT03586427|580019942|FG003|Overall Study|Adverse Event|0|||
160628374|NCT03586427|580019943|FG004|Overall Study|Adverse Event|0|||
160628375|NCT03586427|580019939|FG000|Overall Study|Protocol Violation|0|||
160628376|NCT03586427|580019940|FG001|Overall Study|Protocol Violation|0|||
160628377|NCT03586427|580019941|FG002|Overall Study|Protocol Violation|1|||
160628378|NCT03586427|580019942|FG003|Overall Study|Protocol Violation|0|||
160628379|NCT03586427|580019943|FG004|Overall Study|Protocol Violation|1|||
160628380|NCT03586427|580019939|FG000|Overall Study|Noncompliance with study drug|0|||
160628381|NCT03586427|580019940|FG001|Overall Study|Noncompliance with study drug|0|||
160628382|NCT03586427|580019941|FG002|Overall Study|Noncompliance with study drug|1|||
160628383|NCT03586427|580019942|FG003|Overall Study|Noncompliance with study drug|0|||
160628384|NCT03586427|580019943|FG004|Overall Study|Noncompliance with study drug|0|||
160628385|NCT01471197|580019948|FG000|Overall Study|Disease Progression|4|||
160628386|NCT01471197|580019949|FG001|Overall Study|Disease Progression|2|||
160628387|NCT01471197|580019948|FG000|Overall Study|Death|1|||
160628388|NCT01471197|580019949|FG001|Overall Study|Death|0|||
160628389|NCT01471197|580019948|FG000|Overall Study|Study Drug Toxicity|1|||
160628390|NCT01471197|580019949|FG001|Overall Study|Study Drug Toxicity|0|||
160628391|NCT01353586|580019953|FG000|Overall Study|Procedure terminated prior to ablation|3|||
160628392|NCT01353586|580019954|FG001|Overall Study|Procedure terminated prior to ablation|0|||
160628393|NCT01353586|580019953|FG000|Overall Study|Never had insertion of study catheter|4|||
160628394|NCT01353586|580019954|FG001|Overall Study|Never had insertion of study catheter|1|||
160628395|NCT01353586|580019953|FG000|Overall Study|Neurological exam not done|0|||
160628396|NCT01353586|580019954|FG001|Overall Study|Neurological exam not done|1|||
160628397|NCT00326625|580019959|FG000|Overall Study|Adverse Event|20|||
160628398|NCT00326625|580019960|FG001|Overall Study|Adverse Event|9|||
160628399|NCT00326625|580019959|FG000|Overall Study|Withdrawal by Subject|15|||
160628400|NCT00326625|580019960|FG001|Overall Study|Withdrawal by Subject|12|||
160628401|NCT00326625|580019959|FG000|Overall Study|Death|18|||
160628402|NCT00326625|580019960|FG001|Overall Study|Death|16|||
160628403|NCT00326625|580019959|FG000|Overall Study|Lost to Follow-up|1|||
160628404|NCT00326625|580019960|FG001|Overall Study|Lost to Follow-up|0|||
160628405|NCT00326625|580019959|FG000|Overall Study|prescheduled medical intervention|0|||
160628406|NCT00326625|580019960|FG001|Overall Study|prescheduled medical intervention|1|||
160628407|NCT03919669|580019961|FG000|Overall Study|Withdrawal by Subject|1|||
160628408|NCT03919669|580019962|FG001|Overall Study|Withdrawal by Subject|0|||
160628409|NCT03919669|580019963|FG002|Overall Study|Withdrawal by Subject|0|||
160628410|NCT00625846|580019964|FG000|Overall Study|Withdrawal by Subject|2|||
160628411|NCT00625846|580019965|FG001|Overall Study|Withdrawal by Subject|0|||
160628412|NCT00625846|580019966|FG002|Overall Study|Withdrawal by Subject|1|||
160628413|NCT00625846|580019967|FG003|Overall Study|Withdrawal by Subject|2|||
160628414|NCT00455923|580019968|FG000|Overall Study|Pregnancy|0|||
160628415|NCT00455923|580019969|FG001|Overall Study|Pregnancy|2|||
160628416|NCT00455923|580019968|FG000|Overall Study|Other|3|||
160628417|NCT00455923|580019969|FG001|Overall Study|Other|1|||
160628418|NCT03707145|580019974|FG000|Overall Study|Lost to Follow-up|0|||
160628419|NCT03707145|580019975|FG001|Overall Study|Lost to Follow-up|1|||
160628420|NCT03707145|580019976|FG002|Overall Study|Lost to Follow-up|1|||
160628421|NCT03707145|580019977|FG003|Overall Study|Lost to Follow-up|0|||
160628422|NCT04221477|580019978|FG000|Overall Study|Adverse Event|1|||
160628423|NCT04221477|580019979|FG001|Overall Study|Adverse Event|1|||
160628424|NCT04221477|580019978|FG000|Overall Study|Death|5|||
160628425|NCT04221477|580019979|FG001|Overall Study|Death|4|||
160628426|NCT04221477|580019978|FG000|Overall Study|Lack of Efficacy|1|||
160628427|NCT04221477|580019979|FG001|Overall Study|Lack of Efficacy|2|||
160628428|NCT04221477|580019978|FG000|Overall Study|Lost to Follow-up|1|||
160628429|NCT04221477|580019979|FG001|Overall Study|Lost to Follow-up|2|||
160628430|NCT04221477|580019978|FG000|Overall Study|Non-compliance with Study Drug|1|||
160628431|NCT04221477|580019979|FG001|Overall Study|Non-compliance with Study Drug|0|||
160628432|NCT04221477|580019978|FG000|Overall Study|Reason not Specified|0|||
160628433|NCT04221477|580019979|FG001|Overall Study|Reason not Specified|5|||
160628434|NCT04221477|580019978|FG000|Overall Study|Physician Decision|0|||
160628435|NCT04221477|580019979|FG001|Overall Study|Physician Decision|6|||
160628436|NCT04221477|580019978|FG000|Overall Study|Withdrawal by Subject|10|||
160628437|NCT04221477|580019979|FG001|Overall Study|Withdrawal by Subject|14|||
160628438|NCT04221477|580019978|FG000|Overall Study|Ongoing in the Study|116|||
160628439|NCT04221477|580019979|FG001|Overall Study|Ongoing in the Study|102|||
160628440|NCT02242942|580019980|FG000|Overall Study|Death|17|||
160628441|NCT02242942|580019981|FG001|Overall Study|Death|20|||
160628442|NCT02242942|580019982|FG002|Overall Study|Death|2|||
160628443|NCT02242942|580019980|FG000|Overall Study|Physician Decision|1|||
160628444|NCT02242942|580019981|FG001|Overall Study|Physician Decision|0|||
160628445|NCT02242942|580019982|FG002|Overall Study|Physician Decision|0|||
160628446|NCT02242942|580019980|FG000|Overall Study|Withdrawal by Subject|8|||
160628447|NCT02242942|580019981|FG001|Overall Study|Withdrawal by Subject|10|||
160628448|NCT02242942|580019982|FG002|Overall Study|Withdrawal by Subject|0|||
160628449|NCT02242942|580019980|FG000|Overall Study|On-going in Study|190|||
160628450|NCT02242942|580019981|FG001|Overall Study|On-going in Study|186|||
160628451|NCT02242942|580019982|FG002|Overall Study|On-going in Study|11|||
160628452|NCT04784455|580019983|FG000|Overall Study|Death|4|||
160628453|NCT05643573|580019986|FG000|Overall Study|Adverse Event|117|||
160628454|NCT05643573|580019987|FG001|Overall Study|Adverse Event|90|||
160628455|NCT05643573|580019986|FG000|Overall Study|Death|53|||
160628456|NCT05643573|580019987|FG001|Overall Study|Death|57|||
160628457|NCT05643573|580019986|FG000|Overall Study|Lost to Follow-up|6|||
160628458|NCT05643573|580019987|FG001|Overall Study|Lost to Follow-up|3|||
160628459|NCT05643573|580019986|FG000|Overall Study|Other|18|||
160628460|NCT05643573|580019987|FG001|Overall Study|Other|15|||
160628461|NCT05643573|580019986|FG000|Overall Study|Outcome event|64|||
160628462|NCT05643573|580019987|FG001|Overall Study|Outcome event|36|||
160628463|NCT05643573|580019986|FG000|Overall Study|Physician Decision|33|||
160628464|NCT05643573|580019987|FG001|Overall Study|Physician Decision|19|||
160628465|NCT05643573|580019986|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
160628466|NCT05643573|580019987|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
160628467|NCT05643573|580019986|FG000|Overall Study|Site terminated by sponsor|10|||
160628468|NCT05643573|580019987|FG001|Overall Study|Site terminated by sponsor|10|||
160628469|NCT05643573|580019986|FG000|Overall Study|Study terminated by sponsor|1|||
160628470|NCT05643573|580019987|FG001|Overall Study|Study terminated by sponsor|0|||
160628471|NCT05643573|580019986|FG000|Overall Study|Withdrawal by Subject|178|||
160628472|NCT05643573|580019987|FG001|Overall Study|Withdrawal by Subject|130|||
160628473|NCT04242498|580019990|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
160628474|NCT04242498|580019991|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
160628475|NCT04242498|580019992|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
160628476|NCT04242498|580019993|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
160628477|NCT04242498|580019994|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
160628478|NCT04242498|580019995|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
160628479|NCT04242498|580019996|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
160628480|NCT04242498|580019990|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
160628481|NCT04242498|580019991|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
160628482|NCT04242498|580019992|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
160628483|NCT04242498|580019993|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
160628484|NCT04242498|580019994|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
160628485|NCT04242498|580019995|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
160628486|NCT04242498|580019996|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
160628487|NCT04242498|580019990|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
160628488|NCT04242498|580019991|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
160628489|NCT04242498|580019992|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
160628490|NCT04242498|580019993|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
160628491|NCT04242498|580019994|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
160628492|NCT04242498|580019995|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
160628493|NCT04242498|580019996|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
160628494|NCT04242498|580019990|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
160672628|NCT00606281|580180495|FG001|Overall Study|Progression to depressive phase|1|||
160628495|NCT04242498|580019991|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
160628496|NCT04242498|580019992|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
160628497|NCT04242498|580019993|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
160628498|NCT04242498|580019994|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
160628499|NCT04242498|580019995|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
160628500|NCT04242498|580019996|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
160672629|NCT00606281|580180494|FG000|Overall Study|Change of residence or other commitments|1|||
160628501|NCT04242498|580019990|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
160628502|NCT04242498|580019991|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
160628503|NCT04242498|580019992|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
160628504|NCT04242498|580019993|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
160628505|NCT04242498|580019994|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
160628506|NCT04242498|580019995|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
160628507|NCT04242498|580019996|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
160628508|NCT04242498|580019990|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
160628509|NCT04242498|580019991|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
160628510|NCT04242498|580019992|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
160628511|NCT04242498|580019993|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
160628512|NCT04242498|580019994|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
160628513|NCT04242498|580019995|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
160628514|NCT04242498|580019996|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
160628515|NCT04242498|580019990|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
160628516|NCT04242498|580019991|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
160628517|NCT04242498|580019992|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
160628518|NCT04242498|580019993|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
160628519|NCT04242498|580019994|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
160628520|NCT04242498|580019995|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
160628521|NCT04242498|580019996|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
160628522|NCT04242498|580019990|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
160628523|NCT04242498|580019991|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
160628524|NCT04242498|580019992|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
160628525|NCT04242498|580019993|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
160628526|NCT04242498|580019994|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
160628527|NCT04242498|580019995|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
160628528|NCT04242498|580019996|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
160628529|NCT04242498|580019990|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
160628530|NCT04242498|580019991|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
160628531|NCT04242498|580019992|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
160672630|NCT00606281|580180495|FG001|Overall Study|Change of residence or other commitments|1|||
160672631|NCT03131895|580180497|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
160672632|NCT03131895|580180498|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
160672633|NCT03131895|580180499|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
160672634|NCT03131895|580180500|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
160672635|NCT03131895|580180497|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
160672636|NCT03131895|580180498|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
160672637|NCT03131895|580180499|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
160672638|NCT03131895|580180500|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
160672639|NCT03131895|580180497|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160628532|NCT04242498|580019993|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
160628533|NCT04242498|580019994|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
160628534|NCT04242498|580019995|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
160628535|NCT04242498|580019996|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
160628536|NCT04242498|580019990|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
160628537|NCT04242498|580019991|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
160628538|NCT04242498|580019992|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
160628539|NCT04242498|580019993|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
160628540|NCT04242498|580019994|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
160628541|NCT04242498|580019995|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
160628542|NCT04242498|580019996|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
160628543|NCT04242498|580019990|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
160672640|NCT03131895|580180498|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
160672641|NCT03131895|580180499|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160672642|NCT03131895|580180500|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
160672643|NCT03131895|580180497|FG000|Washout Period (at Least 5 Days)|Other|0|||
160672644|NCT03131895|580180498|FG001|Washout Period (at Least 5 Days)|Other|0|||
160672645|NCT03131895|580180499|FG002|Washout Period (at Least 5 Days)|Other|2|||
160672646|NCT03131895|580180500|FG003|Washout Period (at Least 5 Days)|Other|0|||
160672647|NCT03131895|580180497|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
160672648|NCT03131895|580180498|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
160628544|NCT04242498|580019991|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
160628545|NCT04242498|580019992|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
160628546|NCT04242498|580019993|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
160628547|NCT04242498|580019994|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
160628548|NCT04242498|580019995|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
160628549|NCT04242498|580019996|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
160628550|NCT04242498|580019990|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
160628551|NCT04242498|580019991|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
160628552|NCT04242498|580019992|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
160628553|NCT04242498|580019993|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
160628554|NCT04242498|580019994|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
160628555|NCT04242498|580019995|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
160628556|NCT04242498|580019996|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
160628557|NCT04242498|580019990|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
160628558|NCT04242498|580019991|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
160628559|NCT04242498|580019992|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
160628560|NCT04242498|580019993|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
160628561|NCT04242498|580019994|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
160628562|NCT04242498|580019995|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
160628563|NCT04242498|580019996|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
160628564|NCT04242498|580019990|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
160628565|NCT04242498|580019991|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
160628566|NCT04242498|580019992|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
160628567|NCT04242498|580019993|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
160628568|NCT04242498|580019994|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
160628569|NCT04242498|580019995|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
160628570|NCT04242498|580019996|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
160628571|NCT04242498|580019990|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
160628572|NCT04242498|580019991|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
160628573|NCT04242498|580019992|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
160628574|NCT04242498|580019993|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
160628575|NCT04242498|580019994|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
160628576|NCT04242498|580019995|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
160628577|NCT04242498|580019996|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
160628578|NCT04242498|580019990|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
160628579|NCT04242498|580019991|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
160628580|NCT04242498|580019992|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
160628581|NCT04242498|580019993|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
160628582|NCT04242498|580019994|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
160628583|NCT04242498|580019995|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
160628584|NCT04242498|580019996|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
160628585|NCT03205605|580019999|FG000|Overall Study|Withdrawal by Subject|1|||
160628586|NCT01958619|580020000|FG000|Overall Study|Protocol Violation|2|||
160628587|NCT01958619|580020001|FG001|Overall Study|Protocol Violation|0|||
160628588|NCT01958619|580020002|FG002|Overall Study|Protocol Violation|1|||
160628589|NCT01958619|580020003|FG003|Overall Study|Protocol Violation|0|||
160628590|NCT03795233|580020004|FG000|Overall Study|Withdrawal by Subject|2|||
160628591|NCT03795233|580020005|FG001|Overall Study|Withdrawal by Subject|1|||
160628592|NCT03795233|580020004|FG000|Overall Study|Lost to Follow-up|1|||
160628593|NCT03795233|580020005|FG001|Overall Study|Lost to Follow-up|0|||
160628594|NCT03795233|580020004|FG000|Overall Study|Death|1|||
160628595|NCT03795233|580020005|FG001|Overall Study|Death|0|||
160672649|NCT03131895|580180499|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
160672650|NCT03131895|580180500|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
160672651|NCT03131895|580180497|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
160672652|NCT03131895|580180498|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
160672653|NCT03131895|580180499|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
160672654|NCT03131895|580180500|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
160672655|NCT00540423|580180501|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160672656|NCT00540423|580180502|FG001|Double-Blind Treatment Period|Adverse Event|1|||
160672657|NCT00540423|580180503|FG002|Double-Blind Treatment Period|Adverse Event|0|||
160628596|NCT02756182|580020006|FG000|Overall Study|StudyTechnical Difficulties|4|||
160628597|NCT01054443|580020007|FG000|Overall Study|Withdrawal by Subject|0|||
160628598|NCT01054443|580020008|FG001|Overall Study|Withdrawal by Subject|0|||
160628599|NCT01054443|580020009|FG002|Overall Study|Withdrawal by Subject|0|||
160628600|NCT01054443|580020010|FG003|Overall Study|Withdrawal by Subject|1|||
160628601|NCT01119118|580020012|FG000|Overall Study|Adverse Event|1|||
160628602|NCT01965600|580020016|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
160628603|NCT01965600|580020017|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
160628604|NCT01965600|580020018|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
160628605|NCT01965600|580020019|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
160628606|NCT01965600|580020016|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
160628607|NCT01965600|580020017|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
160628608|NCT01965600|580020018|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
160628609|NCT01965600|580020019|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
160628610|NCT01965600|580020016|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
160628611|NCT01965600|580020017|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
160628612|NCT01965600|580020018|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
160628613|NCT01965600|580020019|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
160628614|NCT01965600|580020016|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
160628615|NCT01965600|580020017|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
160628616|NCT01965600|580020018|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
160628617|NCT01965600|580020019|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
160628618|NCT01965600|580020016|FG000|Second Intervention|Study terminated by Sponsor|0|||
160628619|NCT01965600|580020017|FG001|Second Intervention|Study terminated by Sponsor|0|||
160628620|NCT01965600|580020018|FG002|Second Intervention|Study terminated by Sponsor|2|||
160628621|NCT01965600|580020019|FG003|Second Intervention|Study terminated by Sponsor|2|||
160628622|NCT00828009|580020020|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
160628623|NCT00828009|580020020|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
160628624|NCT00828009|580020020|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
160628625|NCT00828009|580020020|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
160628626|NCT00828009|580020020|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
160628627|NCT00828009|580020020|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
160628628|NCT00828009|580020020|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
160628629|NCT00828009|580020020|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
160628630|NCT00828009|580020020|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
160628631|NCT00828009|580020020|FG000|Step 2 - Maintenance Therapy|Death|1|||
160628632|NCT00828009|580020020|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
160628633|NCT00828009|580020020|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
160628634|NCT00828009|580020020|FG000|Step 2 - Maintenance Therapy|Other|1|||
160628635|NCT03099265|580021350|FG000|Overall Study|Adverse Event|1|||
160628636|NCT00396318|580021358|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
160628637|NCT05604521|580021360|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
160672658|NCT00540423|580180501|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
160672659|NCT00540423|580180502|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
160672660|NCT00540423|580180503|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
160672661|NCT00918684|580180506|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
160672662|NCT00918684|580180506|FG000|Treatment Phase|Lack of Efficacy|6|||
160672663|NCT00918684|580180506|FG000|Treatment Phase|Lost to Follow-up|2|||
160672664|NCT00918684|580180506|FG000|Treatment Phase|Physician Decision|8|||
160672665|NCT00918684|580180506|FG000|Treatment Phase|Protocol Violation|1|||
160672666|NCT00918684|580180506|FG000|Treatment Phase|Withdrawal by Subject|8|||
160672667|NCT00989950|580180508|FG000|Randomized Phase|Protocol Violation|1|||
160672668|NCT00989950|580180509|FG001|Randomized Phase|Protocol Violation|0|||
160672669|NCT00989950|580180510|FG002|Randomized Phase|Protocol Violation|0|||
160672670|NCT00989950|580180511|FG003|Randomized Phase|Protocol Violation|0|||
160672671|NCT00989950|580180508|FG000|Randomized Phase|Adverse Event|0|||
160672672|NCT00989950|580180509|FG001|Randomized Phase|Adverse Event|1|||
160628638|NCT05604521|580021361|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
160628639|NCT05604521|580021360|FG000|Overall Study|Adverse Event|1|||
160672673|NCT00989950|580180510|FG002|Randomized Phase|Adverse Event|0|||
160672674|NCT00989950|580180511|FG003|Randomized Phase|Adverse Event|0|||
160628640|NCT05604521|580021361|FG001|Overall Study|Adverse Event|0|||
160628641|NCT00242567|580021362|FG000|Overall Study|Adverse Event|70|||
160628642|NCT00242567|580021363|FG001|Overall Study|Adverse Event|43|||
160628643|NCT00242567|580021362|FG000|Overall Study|Disease Progression|17|||
160672675|NCT02845336|580180513|FG000|Overall Study|Lost to Follow-up|3|||
160672676|NCT02845336|580180514|FG001|Overall Study|Lost to Follow-up|1|||
160672677|NCT02845336|580180513|FG000|Overall Study|Inability to get medication|2|||
160672678|NCT02845336|580180514|FG001|Overall Study|Inability to get medication|0|||
160672679|NCT03488108|580180516|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
160672680|NCT03488108|580180517|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
160672681|NCT03488108|580180516|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
160672682|NCT03488108|580180517|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
160672683|NCT02054715|580180518|FG000|Baseline/Follow-up 1|Refused|1|||
160672684|NCT02054715|580180519|FG001|Baseline/Follow-up 1|Refused|3|||
160672685|NCT02054715|580180518|FG000|Baseline/Follow-up 1|Medical|0|||
160672686|NCT02054715|580180519|FG001|Baseline/Follow-up 1|Medical|1|||
160672687|NCT02054715|580180518|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
160672688|NCT02054715|580180519|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
160672689|NCT02054715|580180518|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
160672690|NCT02054715|580180519|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
160672691|NCT02054715|580180518|FG000|Baseline/Follow-up 1|No Reason|0|||
160672692|NCT02054715|580180519|FG001|Baseline/Follow-up 1|No Reason|1|||
160672693|NCT02054715|580180518|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
160672694|NCT02054715|580180519|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
160672695|NCT02054715|580180518|FG000|Baseline/Follow-up 1|Ineligible|3|||
160672696|NCT02054715|580180519|FG001|Baseline/Follow-up 1|Ineligible|0|||
160672697|NCT02054715|580180518|FG000|Baseline/Follow-up 1|Hospitalization|1|||
160672698|NCT02054715|580180519|FG001|Baseline/Follow-up 1|Hospitalization|0|||
160672699|NCT02054715|580180518|FG000|Baseline/Follow-up 1|Changed Mind|1|||
160672700|NCT02054715|580180519|FG001|Baseline/Follow-up 1|Changed Mind|0|||
160672701|NCT02054715|580180518|FG000|Follow-up 2|Lost to Followup|3|||
160672702|NCT02054715|580180519|FG001|Follow-up 2|Lost to Followup|1|||
160672703|NCT02054715|580180518|FG000|Follow-up 2|Refused|3|||
160672704|NCT02054715|580180519|FG001|Follow-up 2|Refused|2|||
160672705|NCT02054715|580180518|FG000|Follow-up 2|Followup Not Completed|3|||
160672706|NCT02054715|580180519|FG001|Follow-up 2|Followup Not Completed|4|||
160628644|NCT00242567|580021363|FG001|Overall Study|Disease Progression|22|||
160628645|NCT00242567|580021362|FG000|Overall Study|Symptomatic deterioration|9|||
160628646|NCT00242567|580021363|FG001|Overall Study|Symptomatic deterioration|3|||
160628647|NCT00242567|580021362|FG000|Overall Study|Lack of Efficacy|2|||
160628648|NCT00242567|580021363|FG001|Overall Study|Lack of Efficacy|2|||
160628649|NCT00242567|580021362|FG000|Overall Study|Lost to Follow-up|9|||
160628650|NCT00242567|580021363|FG001|Overall Study|Lost to Follow-up|19|||
160628651|NCT00242567|580021362|FG000|Overall Study|Withdrawal by Subject|33|||
160628652|NCT00242567|580021363|FG001|Overall Study|Withdrawal by Subject|28|||
160628653|NCT00242567|580021362|FG000|Overall Study|Protocol Violation|12|||
160628654|NCT00242567|580021363|FG001|Overall Study|Protocol Violation|12|||
160628655|NCT00242567|580021362|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
160628656|NCT00242567|580021363|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
160628657|NCT00242567|580021362|FG000|Overall Study|Other|14|||
160628658|NCT00242567|580021363|FG001|Overall Study|Other|9|||
160628659|NCT00630994|580021364|FG000|Overall Study|Adverse Event|1|||
160628660|NCT00630994|580021364|FG000|Overall Study|Disease Progression|1|||
160628661|NCT00630994|580021364|FG000|Overall Study|Lack of Efficacy|1|||
160628662|NCT00630994|580021364|FG000|Overall Study|Other|1|||
160628663|NCT05553600|580021365|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
160628664|NCT05553600|580021366|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
160628665|NCT05553600|580021367|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
160628666|NCT05553600|580021368|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
160628667|NCT05553600|580021365|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
160628668|NCT05553600|580021366|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
160628669|NCT05553600|580021367|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
160628670|NCT05553600|580021368|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
160628671|NCT05553600|580021365|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
160628672|NCT05553600|580021366|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
160628673|NCT05553600|580021367|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
160628674|NCT05553600|580021368|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
160628675|NCT05553600|580021365|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
160628676|NCT05553600|580021366|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
160628677|NCT05553600|580021367|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
160672707|NCT02054715|580180518|FG000|Follow-up 2|Ineligible|4|||
160672708|NCT02054715|580180519|FG001|Follow-up 2|Ineligible|5|||
160672709|NCT02054715|580180518|FG000|Follow-up 2|Death|3|||
160672710|NCT02054715|580180519|FG001|Follow-up 2|Death|3|||
160672711|NCT02054715|580180518|FG000|Follow-up 2|Hospitalization|0|||
160672712|NCT02054715|580180519|FG001|Follow-up 2|Hospitalization|2|||
160672713|NCT02054715|580180518|FG000|Follow-up 2|Changed MD/Facility|0|||
160672714|NCT02054715|580180519|FG001|Follow-up 2|Changed MD/Facility|1|||
160672715|NCT02054715|580180518|FG000|Follow-up 2|Changed Mind|0|||
160672716|NCT02054715|580180519|FG001|Follow-up 2|Changed Mind|1|||
160672717|NCT02054715|580180518|FG000|Follow-up 2|No Reason|2|||
160628678|NCT05553600|580021368|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
160672718|NCT02054715|580180519|FG001|Follow-up 2|No Reason|0|||
160628679|NCT05553600|580021365|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
160628680|NCT05553600|580021366|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
160628681|NCT05553600|580021367|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
160628682|NCT05553600|580021368|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
160628683|NCT05553600|580021365|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
160628684|NCT05553600|580021366|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
160628685|NCT05553600|580021367|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
160628686|NCT05553600|580021368|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
160628687|NCT05553600|580021365|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
160628688|NCT05553600|580021366|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
160628689|NCT05553600|580021367|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
160628690|NCT05553600|580021368|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
160628691|NCT05553600|580021365|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
160628692|NCT05553600|580021366|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
160628693|NCT05553600|580021367|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
160628694|NCT05553600|580021368|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
160628695|NCT05553600|580021365|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
160628696|NCT05553600|580021366|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
160628697|NCT05553600|580021367|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
160628698|NCT05553600|580021368|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
160628699|NCT05553600|580021365|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
160628700|NCT05553600|580021366|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
160628701|NCT05553600|580021367|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
160628702|NCT05553600|580021368|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
160628703|NCT05553600|580021365|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
160628704|NCT05553600|580021366|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
160628705|NCT05553600|580021367|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
160628706|NCT05553600|580021368|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
160628707|NCT05553600|580021365|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
160628708|NCT05553600|580021366|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
160628709|NCT05553600|580021367|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
160628710|NCT05553600|580021368|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
160628711|NCT00924313|580021373|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
160628712|NCT01298362|580021374|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
160628713|NCT01298362|580021375|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
160628714|NCT02871921|580021378|FG000|Overall Study|Withdrawal by Subject|34|||
160628715|NCT02871921|580021379|FG001|Overall Study|Withdrawal by Subject|27|||
160628716|NCT02871921|580021380|FG002|Overall Study|Withdrawal by Subject|27|||
160628717|NCT02871921|580021381|FG003|Overall Study|Withdrawal by Subject|30|||
160628718|NCT00890409|580021387|FG000|Overall Study|Lost to Follow-up|20|||
160628719|NCT00890409|580021388|FG001|Overall Study|Lost to Follow-up|21|||
160628720|NCT02353572|580021389|FG000|Overall Study|Withdrawal by Subject|1|||
160628721|NCT02353572|580021389|FG000|Overall Study|Study terminated|2|||
160628722|NCT02060188|580021401|FG000|Overall Study|Disease Progression|36|||
160628723|NCT02060188|580021402|FG001|Overall Study|Disease Progression|42|||
160628724|NCT02060188|580021403|FG002|Overall Study|Disease Progression|8|||
160628725|NCT02060188|580021404|FG003|Overall Study|Disease Progression|5|||
160628726|NCT02060188|580021405|FG004|Overall Study|Disease Progression|6|||
160628727|NCT02060188|580021406|FG005|Overall Study|Disease Progression|3|||
160628728|NCT02060188|580021407|FG006|Overall Study|Disease Progression|23|||
160628729|NCT02060188|580021408|FG007|Overall Study|Disease Progression|20|||
160628730|NCT02060188|580021409|FG008|Overall Study|Disease Progression|43|||
160628731|NCT02060188|580021401|FG000|Overall Study|Study Drug Toxicity|10|||
160628732|NCT02060188|580021402|FG001|Overall Study|Study Drug Toxicity|18|||
160628733|NCT02060188|580021403|FG002|Overall Study|Study Drug Toxicity|7|||
160628734|NCT02060188|580021404|FG003|Overall Study|Study Drug Toxicity|4|||
160628735|NCT02060188|580021405|FG004|Overall Study|Study Drug Toxicity|3|||
160672719|NCT02054715|580180518|FG000|Follow-up 2|Treatment Change or Delay|1|||
160628736|NCT02060188|580021406|FG005|Overall Study|Study Drug Toxicity|0|||
160628737|NCT02060188|580021407|FG006|Overall Study|Study Drug Toxicity|2|||
160628738|NCT02060188|580021408|FG007|Overall Study|Study Drug Toxicity|5|||
160628739|NCT02060188|580021409|FG008|Overall Study|Study Drug Toxicity|0|||
160628740|NCT02060188|580021401|FG000|Overall Study|Adverse event unrelated to study drug|2|||
160628741|NCT02060188|580021402|FG001|Overall Study|Adverse event unrelated to study drug|5|||
160628742|NCT02060188|580021403|FG002|Overall Study|Adverse event unrelated to study drug|6|||
160628743|NCT02060188|580021404|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160628744|NCT02060188|580021405|FG004|Overall Study|Adverse event unrelated to study drug|1|||
160672720|NCT02054715|580180519|FG001|Follow-up 2|Treatment Change or Delay|0|||
160672721|NCT00674128|580180520|FG000|Overall Study|Withdrawal by Subject|25|||
160628745|NCT02060188|580021406|FG005|Overall Study|Adverse event unrelated to study drug|0|||
160628746|NCT02060188|580021407|FG006|Overall Study|Adverse event unrelated to study drug|4|||
160628747|NCT02060188|580021408|FG007|Overall Study|Adverse event unrelated to study drug|4|||
160628748|NCT02060188|580021409|FG008|Overall Study|Adverse event unrelated to study drug|1|||
160628749|NCT02060188|580021401|FG000|Overall Study|Participant request to discontinue study treatment|7|||
160628750|NCT02060188|580021402|FG001|Overall Study|Participant request to discontinue study treatment|7|||
160628751|NCT02060188|580021403|FG002|Overall Study|Participant request to discontinue study treatment|4|||
160628752|NCT02060188|580021404|FG003|Overall Study|Participant request to discontinue study treatment|0|||
160628753|NCT02060188|580021405|FG004|Overall Study|Participant request to discontinue study treatment|0|||
160628754|NCT02060188|580021406|FG005|Overall Study|Participant request to discontinue study treatment|0|||
160628755|NCT02060188|580021407|FG006|Overall Study|Participant request to discontinue study treatment|1|||
160628756|NCT02060188|580021408|FG007|Overall Study|Participant request to discontinue study treatment|1|||
160628757|NCT02060188|580021409|FG008|Overall Study|Participant request to discontinue study treatment|0|||
160628758|NCT02060188|580021401|FG000|Overall Study|Participant withdrew consent|3|||
160628759|NCT02060188|580021402|FG001|Overall Study|Participant withdrew consent|0|||
160628760|NCT02060188|580021403|FG002|Overall Study|Participant withdrew consent|0|||
160628761|NCT02060188|580021404|FG003|Overall Study|Participant withdrew consent|0|||
160628762|NCT02060188|580021405|FG004|Overall Study|Participant withdrew consent|0|||
160628763|NCT02060188|580021406|FG005|Overall Study|Participant withdrew consent|0|||
160628764|NCT02060188|580021407|FG006|Overall Study|Participant withdrew consent|0|||
160628765|NCT02060188|580021408|FG007|Overall Study|Participant withdrew consent|0|||
160628766|NCT02060188|580021409|FG008|Overall Study|Participant withdrew consent|0|||
160628767|NCT02060188|580021401|FG000|Overall Study|Maximum clinical benefit|13|||
160628768|NCT02060188|580021402|FG001|Overall Study|Maximum clinical benefit|38|||
160628769|NCT02060188|580021403|FG002|Overall Study|Maximum clinical benefit|19|||
160628770|NCT02060188|580021404|FG003|Overall Study|Maximum clinical benefit|0|||
160628771|NCT02060188|580021405|FG004|Overall Study|Maximum clinical benefit|0|||
160628772|NCT02060188|580021406|FG005|Overall Study|Maximum clinical benefit|0|||
160628773|NCT02060188|580021407|FG006|Overall Study|Maximum clinical benefit|0|||
160628774|NCT02060188|580021408|FG007|Overall Study|Maximum clinical benefit|10|||
160628775|NCT02060188|580021409|FG008|Overall Study|Maximum clinical benefit|0|||
160628776|NCT02060188|580021401|FG000|Overall Study|Other reason|3|||
160628777|NCT02060188|580021402|FG001|Overall Study|Other reason|7|||
160628778|NCT02060188|580021403|FG002|Overall Study|Other reason|0|||
160628779|NCT02060188|580021404|FG003|Overall Study|Other reason|1|||
160628780|NCT02060188|580021405|FG004|Overall Study|Other reason|0|||
160628781|NCT02060188|580021406|FG005|Overall Study|Other reason|0|||
160628782|NCT02060188|580021407|FG006|Overall Study|Other reason|0|||
160628783|NCT02060188|580021408|FG007|Overall Study|Other reason|9|||
160628784|NCT02060188|580021409|FG008|Overall Study|Other reason|0|||
160628785|NCT02060188|580021401|FG000|Overall Study|Death|0|||
160628786|NCT02060188|580021402|FG001|Overall Study|Death|1|||
160628787|NCT02060188|580021403|FG002|Overall Study|Death|0|||
160628788|NCT02060188|580021404|FG003|Overall Study|Death|0|||
160628789|NCT02060188|580021405|FG004|Overall Study|Death|0|||
160628790|NCT02060188|580021406|FG005|Overall Study|Death|0|||
160628791|NCT02060188|580021407|FG006|Overall Study|Death|0|||
160628792|NCT02060188|580021408|FG007|Overall Study|Death|1|||
160628793|NCT02060188|580021409|FG008|Overall Study|Death|0|||
160628794|NCT02060188|580021401|FG000|Overall Study|Administrative reasons by sponsor|0|||
160628795|NCT02060188|580021402|FG001|Overall Study|Administrative reasons by sponsor|1|||
160628796|NCT02060188|580021403|FG002|Overall Study|Administrative reasons by sponsor|0|||
160628797|NCT02060188|580021404|FG003|Overall Study|Administrative reasons by sponsor|0|||
160628798|NCT02060188|580021405|FG004|Overall Study|Administrative reasons by sponsor|0|||
160628799|NCT02060188|580021406|FG005|Overall Study|Administrative reasons by sponsor|0|||
160628800|NCT02060188|580021407|FG006|Overall Study|Administrative reasons by sponsor|0|||
160628801|NCT02060188|580021408|FG007|Overall Study|Administrative reasons by sponsor|0|||
160628802|NCT02060188|580021409|FG008|Overall Study|Administrative reasons by sponsor|0|||
160628803|NCT02060188|580021401|FG000|Overall Study|Lost to Follow-up|0|||
160628804|NCT02060188|580021402|FG001|Overall Study|Lost to Follow-up|0|||
160628805|NCT02060188|580021403|FG002|Overall Study|Lost to Follow-up|1|||
160628806|NCT02060188|580021404|FG003|Overall Study|Lost to Follow-up|0|||
160628807|NCT02060188|580021405|FG004|Overall Study|Lost to Follow-up|0|||
160628808|NCT02060188|580021406|FG005|Overall Study|Lost to Follow-up|0|||
160628809|NCT02060188|580021407|FG006|Overall Study|Lost to Follow-up|0|||
160672722|NCT00674128|580180521|FG001|Overall Study|Withdrawal by Subject|23|||
160628810|NCT02060188|580021408|FG007|Overall Study|Lost to Follow-up|0|||
160628811|NCT02060188|580021409|FG008|Overall Study|Lost to Follow-up|0|||
160628812|NCT04882085|580021410|FG000|Overall Study|Death|6|||
160628813|NCT04882085|580021411|FG001|Overall Study|Death|9|||
160628814|NCT04882085|580021410|FG000|Overall Study|Withdrawal by Subject|0|||
160628815|NCT04882085|580021411|FG001|Overall Study|Withdrawal by Subject|3|||
160628816|NCT04882085|580021410|FG000|Overall Study|Randomized not treated|1|||
160628817|NCT04882085|580021411|FG001|Overall Study|Randomized not treated|0|||
160628818|NCT04455620|580021415|FG000|Overall Study|Withdrawal by Subject|0|||
160628819|NCT04455620|580021416|FG001|Overall Study|Withdrawal by Subject|0|||
160628820|NCT04455620|580021417|FG002|Overall Study|Withdrawal by Subject|2|||
160628821|NCT04455620|580021418|FG003|Overall Study|Withdrawal by Subject|0|||
160628822|NCT04455620|580021419|FG004|Overall Study|Withdrawal by Subject|1|||
160628823|NCT04455620|580021415|FG000|Overall Study|Lost to Follow-up|0|||
160628824|NCT04455620|580021416|FG001|Overall Study|Lost to Follow-up|0|||
160628825|NCT04455620|580021417|FG002|Overall Study|Lost to Follow-up|1|||
160628826|NCT04455620|580021418|FG003|Overall Study|Lost to Follow-up|1|||
160628827|NCT04455620|580021419|FG004|Overall Study|Lost to Follow-up|0|||
160628828|NCT04455620|580021415|FG000|Overall Study|Death|1|||
160628829|NCT04455620|580021416|FG001|Overall Study|Death|6|||
160628830|NCT04455620|580021417|FG002|Overall Study|Death|20|||
160628831|NCT04455620|580021418|FG003|Overall Study|Death|1|||
160628832|NCT04455620|580021419|FG004|Overall Study|Death|7|||
160628833|NCT04455620|580021415|FG000|Overall Study|Study Termination|0|||
160628834|NCT04455620|580021416|FG001|Overall Study|Study Termination|2|||
160628835|NCT04455620|580021417|FG002|Overall Study|Study Termination|1|||
160628836|NCT04455620|580021418|FG003|Overall Study|Study Termination|0|||
160628837|NCT04455620|580021419|FG004|Overall Study|Study Termination|6|||
160628838|NCT05681715|580021420|FG000|Training Period (6-weeks)|Adverse Event|3|||
160628839|NCT05681715|580021421|FG001|Training Period (6-weeks)|Adverse Event|0|||
160628840|NCT05681715|580021422|FG002|Training Period (6-weeks)|Adverse Event|0|||
160628841|NCT05681715|580021420|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
160628842|NCT05681715|580021421|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
160628843|NCT05681715|580021422|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
160628844|NCT05681715|580021420|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
160628845|NCT05681715|580021421|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
160628846|NCT05681715|580021422|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
160628847|NCT05681715|580021420|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
160628848|NCT05681715|580021421|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
160628849|NCT05681715|580021422|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
160628850|NCT05681715|580021420|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
160628851|NCT05681715|580021421|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
160628852|NCT05681715|580021422|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
160628853|NCT05681715|580021420|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
160628854|NCT05681715|580021421|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
160628855|NCT05681715|580021422|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
160628856|NCT05681715|580021420|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
160628857|NCT05681715|580021421|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
160628858|NCT05681715|580021422|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
160628859|NCT05681715|580021420|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
160628860|NCT05681715|580021421|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
160628861|NCT05681715|580021422|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
160628862|NCT05455684|580021423|FG000|Overall Study|Withdrawal by Subject|7|||
160628863|NCT05455684|580021424|FG001|Overall Study|Withdrawal by Subject|4|||
160628864|NCT05455684|580021423|FG000|Overall Study|Lost to Follow-up|3|||
160628865|NCT05455684|580021424|FG001|Overall Study|Lost to Follow-up|3|||
160628866|NCT05455684|580021423|FG000|Overall Study|Adverse Event|2|||
160628867|NCT05455684|580021424|FG001|Overall Study|Adverse Event|3|||
160628868|NCT05455684|580021423|FG000|Overall Study|Protocol Violation|1|||
160628869|NCT05455684|580021424|FG001|Overall Study|Protocol Violation|1|||
160628870|NCT05455684|580021423|FG000|Overall Study|Non-Compliant with study drug|0|||
160628871|NCT05455684|580021424|FG001|Overall Study|Non-Compliant with study drug|1|||
160628872|NCT05455684|580021423|FG000|Overall Study|Other|1|||
160628873|NCT05455684|580021424|FG001|Overall Study|Other|2|||
160628874|NCT05455684|580021423|FG000|Overall Study|Randomized but not treated|1|||
160628875|NCT05455684|580021424|FG001|Overall Study|Randomized but not treated|0|||
160628876|NCT05204563|580021425|FG000|Overall Study|Other than Specified|2|||
160628877|NCT05204563|580021426|FG001|Overall Study|Other than Specified|1|||
160628878|NCT05204563|580021425|FG000|Overall Study|Death|18|||
160628879|NCT05204563|580021426|FG001|Overall Study|Death|4|||
160628880|NCT05204563|580021425|FG000|Overall Study|Lost to Follow-up|6|||
160628881|NCT05204563|580021426|FG001|Overall Study|Lost to Follow-up|3|||
160628882|NCT05204563|580021425|FG000|Overall Study|Withdrawal by Subject|12|||
160628883|NCT05204563|580021426|FG001|Overall Study|Withdrawal by Subject|3|||
160628884|NCT05204563|580021425|FG000|Overall Study|Enrolled, Not Treated|1|||
160628885|NCT05204563|580021426|FG001|Overall Study|Enrolled, Not Treated|0|||
160628886|NCT04411641|580021427|FG000|DB Period|Other|7|||
160628887|NCT04411641|580021428|FG001|DB Period|Other|27|||
160628888|NCT04411641|580021429|FG002|DB Period|Other|0|||
160628889|NCT04411641|580021430|FG003|DB Period|Other|0|||
160628890|NCT04411641|580021427|FG000|DB Period|Withdrawal by Subject|67|||
160628891|NCT04411641|580021428|FG001|DB Period|Withdrawal by Subject|122|||
160628892|NCT04411641|580021429|FG002|DB Period|Withdrawal by Subject|0|||
160628893|NCT04411641|580021430|FG003|DB Period|Withdrawal by Subject|0|||
160628894|NCT04411641|580021427|FG000|DB Period|Progressive disease|76|||
160628895|NCT04411641|580021428|FG001|DB Period|Progressive disease|116|||
160628896|NCT04411641|580021429|FG002|DB Period|Progressive disease|0|||
160628897|NCT04411641|580021430|FG003|DB Period|Progressive disease|0|||
160628898|NCT04411641|580021427|FG000|DB Period|Poor compliance to protocol|1|||
160628899|NCT04411641|580021428|FG001|DB Period|Poor compliance to protocol|5|||
160628900|NCT04411641|580021429|FG002|DB Period|Poor compliance to protocol|0|||
160628901|NCT04411641|580021430|FG003|DB Period|Poor compliance to protocol|0|||
160628902|NCT04411641|580021427|FG000|DB Period|Lack of Efficacy|19|||
160628903|NCT04411641|580021428|FG001|DB Period|Lack of Efficacy|19|||
160628904|NCT04411641|580021429|FG002|DB Period|Lack of Efficacy|0|||
160628905|NCT04411641|580021430|FG003|DB Period|Lack of Efficacy|0|||
160628906|NCT04411641|580021427|FG000|DB Period|Adverse Event|13|||
160628907|NCT04411641|580021428|FG001|DB Period|Adverse Event|29|||
160628908|NCT04411641|580021429|FG002|DB Period|Adverse Event|0|||
160628909|NCT04411641|580021430|FG003|DB Period|Adverse Event|0|||
160628910|NCT04411641|580021427|FG000|DB Period|Randomized and not treated|2|||
160628911|NCT04411641|580021428|FG001|DB Period|Randomized and not treated|2|||
160628912|NCT04411641|580021429|FG002|DB Period|Randomized and not treated|0|||
160628913|NCT04411641|580021430|FG003|DB Period|Randomized and not treated|0|||
160628914|NCT04411641|580021427|FG000|OL|Withdrawal by Subject|0|||
160628915|NCT04411641|580021428|FG001|OL|Withdrawal by Subject|0|||
160628916|NCT04411641|580021429|FG002|OL|Withdrawal by Subject|6|||
160628917|NCT04411641|580021430|FG003|OL|Withdrawal by Subject|17|||
160628918|NCT04411641|580021427|FG000|OL|Progressive disease|0|||
160628919|NCT04411641|580021428|FG001|OL|Progressive disease|0|||
160628920|NCT04411641|580021429|FG002|OL|Progressive disease|1|||
160628921|NCT04411641|580021430|FG003|OL|Progressive disease|2|||
160628922|NCT04411641|580021427|FG000|OL|Poor compliance to protocol|0|||
160628923|NCT04411641|580021428|FG001|OL|Poor compliance to protocol|0|||
160628924|NCT04411641|580021429|FG002|OL|Poor compliance to protocol|1|||
160628925|NCT04411641|580021430|FG003|OL|Poor compliance to protocol|0|||
160628926|NCT04411641|580021427|FG000|OL|Adverse Event|0|||
160628927|NCT04411641|580021428|FG001|OL|Adverse Event|0|||
160628928|NCT04411641|580021429|FG002|OL|Adverse Event|1|||
160628929|NCT04411641|580021430|FG003|OL|Adverse Event|0|||
160628930|NCT04411641|580021427|FG000|OL|Other|0|||
160628931|NCT04411641|580021428|FG001|OL|Other|0|||
160628932|NCT04411641|580021429|FG002|OL|Other|0|||
160628933|NCT04411641|580021430|FG003|OL|Other|6|||
160628934|NCT02268214|580021434|FG000|Overall Study|Subject no longer meets study criteria|0|||
160628935|NCT02268214|580021435|FG001|Overall Study|Subject no longer meets study criteria|2|||
160628936|NCT02268214|580021436|FG002|Overall Study|Subject no longer meets study criteria|0|||
160628937|NCT02268214|580021434|FG000|Overall Study|Pregnancy|2|||
160628938|NCT02268214|580021435|FG001|Overall Study|Pregnancy|2|||
160628939|NCT02268214|580021436|FG002|Overall Study|Pregnancy|1|||
160628940|NCT02268214|580021434|FG000|Overall Study|Lost to Follow-up|3|||
160628941|NCT02268214|580021435|FG001|Overall Study|Lost to Follow-up|3|||
160628942|NCT02268214|580021436|FG002|Overall Study|Lost to Follow-up|4|||
160628943|NCT02268214|580021434|FG000|Overall Study|Lack of Efficacy|1|||
160628944|NCT02268214|580021435|FG001|Overall Study|Lack of Efficacy|0|||
160628945|NCT02268214|580021436|FG002|Overall Study|Lack of Efficacy|2|||
160628946|NCT02268214|580021434|FG000|Overall Study|Adverse Event|11|||
160628947|NCT02268214|580021435|FG001|Overall Study|Adverse Event|14|||
160628948|NCT02268214|580021436|FG002|Overall Study|Adverse Event|9|||
160628949|NCT02268214|580021434|FG000|Overall Study|Withdrawal by Subject|4|||
160628950|NCT02268214|580021435|FG001|Overall Study|Withdrawal by Subject|5|||
160628951|NCT02268214|580021436|FG002|Overall Study|Withdrawal by Subject|10|||
160628952|NCT02268214|580021434|FG000|Overall Study|Subject request to discontinue treatment|10|||
160628953|NCT02268214|580021435|FG001|Overall Study|Subject request to discontinue treatment|8|||
160628954|NCT02268214|580021436|FG002|Overall Study|Subject request to discontinue treatment|6|||
160628955|NCT02268214|580021434|FG000|Overall Study|Poor/non-compliance|2|||
160628956|NCT02268214|580021435|FG001|Overall Study|Poor/non-compliance|1|||
160628957|NCT02268214|580021436|FG002|Overall Study|Poor/non-compliance|2|||
160628958|NCT02268214|580021434|FG000|Overall Study|Other reasons|7|||
160672723|NCT01825798|580180522|FG000|Overall Study|Adverse Event|1|||
160628959|NCT02268214|580021435|FG001|Overall Study|Other reasons|3|||
160628960|NCT02268214|580021436|FG002|Overall Study|Other reasons|3|||
160628961|NCT02268214|580021434|FG000|Overall Study|Not entering long-term period|2|||
160628962|NCT02268214|580021435|FG001|Overall Study|Not entering long-term period|3|||
160628963|NCT02268214|580021436|FG002|Overall Study|Not entering long-term period|5|||
160628964|NCT04342390|580021438|FG000|Overall Study|Lost to Follow-up|3|||
160628965|NCT04342390|580021439|FG001|Overall Study|Lost to Follow-up|0|||
160628966|NCT02951130|580021440|FG000|Overall Study|Protocol Violation|1|||
160628967|NCT02951130|580021441|FG001|Overall Study|Protocol Violation|1|||
160628968|NCT04584294|580021442|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
160628969|NCT04584294|580021443|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
160628970|NCT04584294|580021442|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
160628971|NCT04584294|580021443|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
160628972|NCT04584294|580021442|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
160628973|NCT04584294|580021443|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
160628974|NCT04584294|580021442|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
160628975|NCT04584294|580021443|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
160628976|NCT04584294|580021442|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
160628977|NCT04584294|580021443|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
160628978|NCT04584294|580021442|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
160628979|NCT04584294|580021443|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
160628980|NCT02500732|580021453|FG000|Overall Study|Physician Decision|0|||
160628981|NCT02500732|580021454|FG001|Overall Study|Physician Decision|1|||
160628982|NCT01003691|580021455|FG000|Overall Study|Adverse Event|0|||
160628983|NCT01003691|580021456|FG001|Overall Study|Adverse Event|0|||
160628984|NCT01003691|580021457|FG002|Overall Study|Adverse Event|0|||
160628985|NCT01003691|580021458|FG003|Overall Study|Adverse Event|1|||
160628986|NCT01869959|580021462|FG000|Randomization Period|Physician Decision|0|||
160628987|NCT01869959|580021463|FG001|Randomization Period|Physician Decision|0|||
160628988|NCT01869959|580021464|FG002|Randomization Period|Physician Decision|0|||
160628989|NCT01869959|580021465|FG003|Randomization Period|Physician Decision|0|||
160628990|NCT01869959|580021466|FG004|Randomization Period|Physician Decision|1|||
160628991|NCT01869959|580021462|FG000|Treatment Period|Adverse Event|1|||
160628992|NCT01869959|580021463|FG001|Treatment Period|Adverse Event|0|||
160628993|NCT01869959|580021464|FG002|Treatment Period|Adverse Event|3|||
160628994|NCT01869959|580021465|FG003|Treatment Period|Adverse Event|1|||
160628995|NCT01869959|580021466|FG004|Treatment Period|Adverse Event|0|||
160628996|NCT01869959|580021462|FG000|Treatment Period|Sponsor decision|0|||
160628997|NCT01869959|580021463|FG001|Treatment Period|Sponsor decision|1|||
160628998|NCT01869959|580021464|FG002|Treatment Period|Sponsor decision|0|||
160628999|NCT01869959|580021465|FG003|Treatment Period|Sponsor decision|1|||
160629000|NCT01869959|580021466|FG004|Treatment Period|Sponsor decision|0|||
160629001|NCT01869959|580021462|FG000|Treatment Period|Withdrawal by Subject|0|||
160629002|NCT01869959|580021463|FG001|Treatment Period|Withdrawal by Subject|1|||
160629003|NCT01869959|580021464|FG002|Treatment Period|Withdrawal by Subject|0|||
160629004|NCT01869959|580021465|FG003|Treatment Period|Withdrawal by Subject|0|||
160629005|NCT01869959|580021466|FG004|Treatment Period|Withdrawal by Subject|0|||
160629006|NCT02711306|580021467|FG000|Overall Study|Withdrawal by Subject|2|||
160629007|NCT02711306|580021468|FG001|Overall Study|Withdrawal by Subject|2|||
160629008|NCT00157820|580021469|FG000|Randomized|Physician Decision|4|||
160629009|NCT00157820|580021470|FG001|Randomized|Physician Decision|2|||
160629010|NCT00157820|580021471|FG002|Randomized|Physician Decision|3|||
160629011|NCT00157820|580021469|FG000|Randomized|Withdrawal by Subject|1|||
160629012|NCT00157820|580021470|FG001|Randomized|Withdrawal by Subject|2|||
160629013|NCT00157820|580021471|FG002|Randomized|Withdrawal by Subject|3|||
160629014|NCT00157820|580021469|FG000|Randomized|Protocol Violation|2|||
160629015|NCT00157820|580021470|FG001|Randomized|Protocol Violation|1|||
160629016|NCT00157820|580021471|FG002|Randomized|Protocol Violation|2|||
160629017|NCT00157820|580021469|FG000|1st 8 Month|Death|7|||
160629018|NCT00157820|580021470|FG001|1st 8 Month|Death|8|||
160629019|NCT00157820|580021471|FG002|1st 8 Month|Death|3|||
160629020|NCT00157820|580021469|FG000|1st 8 Month|Lost to Follow-up|1|||
160629021|NCT00157820|580021470|FG001|1st 8 Month|Lost to Follow-up|2|||
160629022|NCT00157820|580021471|FG002|1st 8 Month|Lost to Follow-up|1|||
160629023|NCT00157820|580021469|FG000|1st 8 Month|Premature cross-over|0|||
160629024|NCT00157820|580021470|FG001|1st 8 Month|Premature cross-over|2|||
160629025|NCT00157820|580021471|FG002|1st 8 Month|Premature cross-over|2|||
160629026|NCT00157820|580021469|FG000|2nd 8 Months|Death|3|||
160629027|NCT00157820|580021470|FG001|2nd 8 Months|Death|1|||
160629028|NCT00157820|580021471|FG002|2nd 8 Months|Death|3|||
160629029|NCT00157820|580021469|FG000|2nd 8 Months|Lost to Follow-up|1|||
160629030|NCT00157820|580021470|FG001|2nd 8 Months|Lost to Follow-up|5|||
160629031|NCT00157820|580021471|FG002|2nd 8 Months|Lost to Follow-up|2|||
160629032|NCT00157820|580021469|FG000|2nd 8 Months|Premature cross-over|1|||
160629033|NCT00157820|580021470|FG001|2nd 8 Months|Premature cross-over|7|||
160629034|NCT00157820|580021471|FG002|2nd 8 Months|Premature cross-over|9|||
160629035|NCT01676818|580021472|FG000|Overall Study|Physician Decision|1|||
160629036|NCT01676818|580021472|FG000|Overall Study|Withdrawal by Subject|1|||
160629037|NCT01100073|580022892|FG000|Overall Study|Lack of Efficacy|4|||
160629038|NCT01100073|580022892|FG000|Overall Study|Insufficient Tolerability|21|||
160629039|NCT01100073|580022892|FG000|Overall Study|Withdrawal by Subject|13|||
160629040|NCT01100073|580022892|FG000|Overall Study|Lost to Follow-up|39|||
160629041|NCT01100073|580022892|FG000|Overall Study|Lack of effect + patient's wish|2|||
160629042|NCT01100073|580022892|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
160629043|NCT01100073|580022892|FG000|Overall Study|Other|8|||
160629044|NCT01100073|580022892|FG000|Overall Study|Missing|5|||
160629045|NCT00299546|580022893|FG000|Overall Study|Death|3|||
160629046|NCT00299546|580022894|FG001|Overall Study|Death|2|||
160629047|NCT00299546|580022895|FG002|Overall Study|Death|0|||
160629048|NCT00299546|580022893|FG000|Overall Study|Lost to Follow-up|2|||
160629049|NCT00299546|580022894|FG001|Overall Study|Lost to Follow-up|2|||
160629050|NCT00299546|580022895|FG002|Overall Study|Lost to Follow-up|5|||
160629051|NCT00299546|580022893|FG000|Overall Study|Adverse Event|37|||
160629052|NCT00299546|580022894|FG001|Overall Study|Adverse Event|22|||
160629053|NCT00299546|580022895|FG002|Overall Study|Adverse Event|27|||
160629054|NCT00299546|580022893|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
160629055|NCT00299546|580022894|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
160629056|NCT00299546|580022895|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
160629057|NCT00299546|580022893|FG000|Overall Study|Other|24|||
160629058|NCT00299546|580022894|FG001|Overall Study|Other|26|||
160629059|NCT00299546|580022895|FG002|Overall Study|Other|19|||
160629060|NCT00299546|580022893|FG000|Overall Study|Not treated|0|||
160629061|NCT00299546|580022894|FG001|Overall Study|Not treated|1|||
160629062|NCT00299546|580022895|FG002|Overall Study|Not treated|1|||
160629063|NCT01656850|580022896|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
160629064|NCT01656850|580022897|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
160629065|NCT00968539|580022898|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
160629066|NCT00968539|580022899|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160629067|NCT00326118|580022900|FG000|Active Phase|Withdrawal by Subject|4|||
160629068|NCT00326118|580022901|FG001|Active Phase|Withdrawal by Subject|1|||
160629069|NCT02074982|580022908|FG000|Overall Study|Adverse Event|15|||
160629070|NCT02074982|580022909|FG001|Overall Study|Adverse Event|7|||
160629071|NCT02074982|580022908|FG000|Overall Study|Lack of Efficacy|6|||
160629072|NCT02074982|580022909|FG001|Overall Study|Lack of Efficacy|1|||
160629073|NCT02074982|580022908|FG000|Overall Study|Lost to Follow-up|9|||
160629074|NCT02074982|580022909|FG001|Overall Study|Lost to Follow-up|10|||
160629075|NCT02074982|580022908|FG000|Overall Study|Non-compliance with study treatment|0|||
160629076|NCT02074982|580022909|FG001|Overall Study|Non-compliance with study treatment|2|||
160629077|NCT02074982|580022908|FG000|Overall Study|Physician Decision|1|||
160629078|NCT02074982|580022909|FG001|Overall Study|Physician Decision|1|||
160629079|NCT02074982|580022908|FG000|Overall Study|Pregnancy|1|||
160629080|NCT02074982|580022909|FG001|Overall Study|Pregnancy|2|||
160629081|NCT02074982|580022908|FG000|Overall Study|Protocol deviation|4|||
160629082|NCT02074982|580022909|FG001|Overall Study|Protocol deviation|3|||
160629083|NCT02074982|580022908|FG000|Overall Study|Technical problems|0|||
160629084|NCT02074982|580022909|FG001|Overall Study|Technical problems|2|||
160629085|NCT02074982|580022908|FG000|Overall Study|Subject/guardian decision|15|||
160629086|NCT02074982|580022909|FG001|Overall Study|Subject/guardian decision|24|||
160629087|NCT02074982|580022908|FG000|Overall Study|Death|0|||
160629088|NCT02074982|580022909|FG001|Overall Study|Death|2|||
160629089|NCT02525627|580022916|FG000|Overall Study|Revision|1|||
160629090|NCT02525627|580022917|FG001|Overall Study|Revision|1|||
160629091|NCT02525627|580022916|FG000|Overall Study|Withdrawal by Subject|1|||
160629092|NCT02525627|580022917|FG001|Overall Study|Withdrawal by Subject|2|||
160629093|NCT02525627|580022916|FG000|Overall Study|Death|1|||
160629094|NCT02525627|580022917|FG001|Overall Study|Death|0|||
160629095|NCT02525627|580022916|FG000|Overall Study|Site terminated|11|||
160629096|NCT02525627|580022917|FG001|Overall Study|Site terminated|10|||
160629097|NCT03710824|580022921|FG000|Overall Study|Withdrawal by Subject|1|||
160629098|NCT03710824|580022921|FG000|Overall Study|Lost to Follow-up|3|||
160629099|NCT03710824|580022921|FG000|Overall Study|Adverse Event|25|||
160629100|NCT03710824|580022921|FG000|Overall Study|Treatment discontinuation|2|||
160629101|NCT01605370|580022922|FG000|Overall Study|Adverse Event|1|||
160629102|NCT01605370|580022923|FG001|Overall Study|Adverse Event|0|||
160629103|NCT01317199|580022927|FG000|Dose-escalation Phase 1|Physician Decision|5|||
160629104|NCT01317199|580022928|FG001|Dose-escalation Phase 1|Physician Decision|0|||
160629105|NCT01317199|580022929|FG002|Dose-escalation Phase 1|Physician Decision|0|||
160629106|NCT01317199|580022930|FG003|Dose-escalation Phase 1|Physician Decision|0|||
160629107|NCT01317199|580022927|FG000|Dose-escalation Phase 1|Disease progression|1|||
160629108|NCT01317199|580022928|FG001|Dose-escalation Phase 1|Disease progression|0|||
160629109|NCT01317199|580022929|FG002|Dose-escalation Phase 1|Disease progression|0|||
160629110|NCT01317199|580022930|FG003|Dose-escalation Phase 1|Disease progression|0|||
160629111|NCT01317199|580022927|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
160629112|NCT01317199|580022928|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
160629113|NCT01317199|580022929|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
160629114|NCT01317199|580022930|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
160629115|NCT01317199|580022927|FG000|Randomized Phase 2|Disease progression|0|||
160629116|NCT01317199|580022928|FG001|Randomized Phase 2|Disease progression|3|||
160629117|NCT01317199|580022929|FG002|Randomized Phase 2|Disease progression|7|||
160629118|NCT01317199|580022930|FG003|Randomized Phase 2|Disease progression|5|||
160629119|NCT01317199|580022927|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
160629120|NCT01317199|580022928|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
160629121|NCT01317199|580022929|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
160629122|NCT01317199|580022930|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
160672724|NCT01825798|580180523|FG001|Overall Study|Adverse Event|5|||
160672725|NCT01825798|580180522|FG000|Overall Study|Lost to Follow-up|1|||
160672726|NCT01825798|580180523|FG001|Overall Study|Lost to Follow-up|0|||
160672727|NCT02471807|580180533|FG000|Overall Study|Death|14|||
160672728|NCT02471807|580180533|FG000|Overall Study|Withdrawal by Subject|2|||
160672729|NCT02471807|580180533|FG000|Overall Study|Explant|5|||
160672730|NCT02471807|580180533|FG000|Overall Study|Lost to Follow-up|1|||
160672731|NCT01559363|580180534|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
160672732|NCT01559363|580180535|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
160672733|NCT01559363|580180536|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
160672734|NCT01559363|580180537|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
160672735|NCT01559363|580180538|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
160672736|NCT01559363|580180539|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
160672737|NCT01559363|580180534|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
160672738|NCT01559363|580180535|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
160672739|NCT01559363|580180536|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
160672740|NCT01559363|580180537|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
160672741|NCT01559363|580180538|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
160672742|NCT01559363|580180539|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
160672743|NCT01559363|580180534|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
160672744|NCT01559363|580180535|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
160672745|NCT01559363|580180536|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
160672746|NCT01559363|580180537|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
160672747|NCT01559363|580180538|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
160672748|NCT01559363|580180539|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
160672749|NCT01559363|580180534|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
160672750|NCT01559363|580180535|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
160672751|NCT01559363|580180536|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
160672752|NCT01559363|580180537|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
160672753|NCT01559363|580180538|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
160672754|NCT01559363|580180539|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
160672755|NCT01559363|580180534|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
160672756|NCT01559363|580180535|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
160672757|NCT01559363|580180536|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
160672758|NCT01559363|580180537|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
160672759|NCT01559363|580180538|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
160672760|NCT01559363|580180539|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
160672761|NCT01559363|580180534|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
160672762|NCT01559363|580180535|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
160672763|NCT01559363|580180536|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
160672764|NCT01559363|580180537|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
160672765|NCT01559363|580180538|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
160672766|NCT01559363|580180539|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
160672767|NCT01559363|580180534|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
160672768|NCT01559363|580180535|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
160672769|NCT01559363|580180536|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
160672770|NCT01559363|580180537|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
160672771|NCT01559363|580180538|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
160672772|NCT01559363|580180539|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
160672773|NCT00834873|580180541|FG000|First Intervention|Adverse Event|0|||
160672774|NCT00834873|580180542|FG001|First Intervention|Adverse Event|1|||
160672775|NCT02055547|580180546|FG000|Overall Study|Protocol Violation|0|||
160672776|NCT02055547|580180547|FG001|Overall Study|Protocol Violation|0|||
160672777|NCT02055547|580180548|FG002|Overall Study|Protocol Violation|1|||
160672778|NCT02055547|580180549|FG003|Overall Study|Protocol Violation|0|||
160672779|NCT02055547|580180550|FG004|Overall Study|Protocol Violation|0|||
160672780|NCT02055547|580180551|FG005|Overall Study|Protocol Violation|0|||
160672781|NCT02055547|580180552|FG006|Overall Study|Protocol Violation|1|||
160672782|NCT02055547|580180553|FG007|Overall Study|Protocol Violation|0|||
160672783|NCT02055547|580180554|FG008|Overall Study|Protocol Violation|0|||
160672784|NCT02055547|580180555|FG009|Overall Study|Protocol Violation|0|||
160672785|NCT02055547|580180556|FG010|Overall Study|Protocol Violation|0|||
160672786|NCT02055547|580180557|FG011|Overall Study|Protocol Violation|0|||
160672787|NCT02055547|580180558|FG012|Overall Study|Protocol Violation|0|||
160672788|NCT02055547|580180559|FG013|Overall Study|Protocol Violation|0|||
160672789|NCT02055547|580180560|FG014|Overall Study|Protocol Violation|0|||
160672790|NCT02055547|580180561|FG015|Overall Study|Protocol Violation|0|||
160672791|NCT02055547|580180562|FG016|Overall Study|Protocol Violation|0|||
160672792|NCT02055547|580180563|FG017|Overall Study|Protocol Violation|0|||
160672793|NCT02055547|580180564|FG018|Overall Study|Protocol Violation|0|||
160672794|NCT02055547|580180546|FG000|Overall Study|Physician Decision|0|||
160672795|NCT02055547|580180547|FG001|Overall Study|Physician Decision|1|||
160672796|NCT02055547|580180548|FG002|Overall Study|Physician Decision|1|||
160672797|NCT02055547|580180549|FG003|Overall Study|Physician Decision|0|||
160672798|NCT02055547|580180550|FG004|Overall Study|Physician Decision|1|||
160672799|NCT02055547|580180551|FG005|Overall Study|Physician Decision|0|||
160672800|NCT02055547|580180552|FG006|Overall Study|Physician Decision|0|||
160672801|NCT02055547|580180553|FG007|Overall Study|Physician Decision|0|||
160672802|NCT02055547|580180554|FG008|Overall Study|Physician Decision|0|||
160672803|NCT02055547|580180555|FG009|Overall Study|Physician Decision|1|||
160672804|NCT02055547|580180556|FG010|Overall Study|Physician Decision|1|||
160672805|NCT02055547|580180557|FG011|Overall Study|Physician Decision|0|||
160672806|NCT02055547|580180558|FG012|Overall Study|Physician Decision|0|||
160672807|NCT02055547|580180559|FG013|Overall Study|Physician Decision|0|||
160672808|NCT02055547|580180560|FG014|Overall Study|Physician Decision|0|||
160672809|NCT02055547|580180561|FG015|Overall Study|Physician Decision|0|||
160672810|NCT02055547|580180562|FG016|Overall Study|Physician Decision|0|||
160672811|NCT02055547|580180563|FG017|Overall Study|Physician Decision|0|||
160672812|NCT02055547|580180564|FG018|Overall Study|Physician Decision|0|||
160672813|NCT02055547|580180546|FG000|Overall Study|Adverse Event|0|||
160672814|NCT02055547|580180547|FG001|Overall Study|Adverse Event|0|||
160672815|NCT02055547|580180548|FG002|Overall Study|Adverse Event|0|||
160672816|NCT02055547|580180549|FG003|Overall Study|Adverse Event|0|||
160672817|NCT02055547|580180550|FG004|Overall Study|Adverse Event|0|||
160672818|NCT02055547|580180551|FG005|Overall Study|Adverse Event|0|||
160672819|NCT02055547|580180552|FG006|Overall Study|Adverse Event|1|||
160672820|NCT02055547|580180553|FG007|Overall Study|Adverse Event|0|||
160672821|NCT02055547|580180554|FG008|Overall Study|Adverse Event|1|||
160672822|NCT02055547|580180555|FG009|Overall Study|Adverse Event|0|||
160672823|NCT02055547|580180556|FG010|Overall Study|Adverse Event|0|||
160672824|NCT02055547|580180557|FG011|Overall Study|Adverse Event|0|||
160672825|NCT02055547|580180558|FG012|Overall Study|Adverse Event|0|||
160672826|NCT02055547|580180559|FG013|Overall Study|Adverse Event|0|||
160672827|NCT02055547|580180560|FG014|Overall Study|Adverse Event|0|||
160672828|NCT02055547|580180561|FG015|Overall Study|Adverse Event|0|||
160672829|NCT02055547|580180562|FG016|Overall Study|Adverse Event|0|||
160672830|NCT02055547|580180563|FG017|Overall Study|Adverse Event|0|||
160672831|NCT02055547|580180564|FG018|Overall Study|Adverse Event|0|||
160672832|NCT02055547|580180546|FG000|Overall Study|Withdrawal by Subject|0|||
160672833|NCT02055547|580180547|FG001|Overall Study|Withdrawal by Subject|0|||
160672834|NCT02055547|580180548|FG002|Overall Study|Withdrawal by Subject|0|||
160672835|NCT02055547|580180549|FG003|Overall Study|Withdrawal by Subject|0|||
160672836|NCT02055547|580180550|FG004|Overall Study|Withdrawal by Subject|0|||
160672837|NCT02055547|580180551|FG005|Overall Study|Withdrawal by Subject|1|||
160672838|NCT02055547|580180552|FG006|Overall Study|Withdrawal by Subject|0|||
160672839|NCT02055547|580180553|FG007|Overall Study|Withdrawal by Subject|0|||
160672840|NCT02055547|580180554|FG008|Overall Study|Withdrawal by Subject|1|||
160672841|NCT02055547|580180555|FG009|Overall Study|Withdrawal by Subject|0|||
160672842|NCT02055547|580180556|FG010|Overall Study|Withdrawal by Subject|0|||
160672843|NCT02055547|580180557|FG011|Overall Study|Withdrawal by Subject|0|||
160672844|NCT02055547|580180558|FG012|Overall Study|Withdrawal by Subject|0|||
160672845|NCT02055547|580180559|FG013|Overall Study|Withdrawal by Subject|1|||
160672846|NCT02055547|580180560|FG014|Overall Study|Withdrawal by Subject|0|||
160672847|NCT02055547|580180561|FG015|Overall Study|Withdrawal by Subject|1|||
160672848|NCT02055547|580180562|FG016|Overall Study|Withdrawal by Subject|0|||
160672849|NCT02055547|580180563|FG017|Overall Study|Withdrawal by Subject|0|||
160672850|NCT02055547|580180564|FG018|Overall Study|Withdrawal by Subject|0|||
160672851|NCT02055547|580180546|FG000|Overall Study|Lost to Follow-up|0|||
160672852|NCT02055547|580180547|FG001|Overall Study|Lost to Follow-up|0|||
160672853|NCT02055547|580180548|FG002|Overall Study|Lost to Follow-up|1|||
160672854|NCT02055547|580180549|FG003|Overall Study|Lost to Follow-up|0|||
160672855|NCT02055547|580180550|FG004|Overall Study|Lost to Follow-up|0|||
160672856|NCT02055547|580180551|FG005|Overall Study|Lost to Follow-up|0|||
160672857|NCT02055547|580180552|FG006|Overall Study|Lost to Follow-up|0|||
160672858|NCT02055547|580180553|FG007|Overall Study|Lost to Follow-up|0|||
160672859|NCT02055547|580180554|FG008|Overall Study|Lost to Follow-up|0|||
160672860|NCT02055547|580180555|FG009|Overall Study|Lost to Follow-up|0|||
160672861|NCT02055547|580180556|FG010|Overall Study|Lost to Follow-up|0|||
160672862|NCT02055547|580180557|FG011|Overall Study|Lost to Follow-up|0|||
160672863|NCT02055547|580180558|FG012|Overall Study|Lost to Follow-up|0|||
160672864|NCT02055547|580180559|FG013|Overall Study|Lost to Follow-up|0|||
160672865|NCT02055547|580180560|FG014|Overall Study|Lost to Follow-up|0|||
160672866|NCT02055547|580180561|FG015|Overall Study|Lost to Follow-up|0|||
160672867|NCT02055547|580180562|FG016|Overall Study|Lost to Follow-up|0|||
160672868|NCT02055547|580180563|FG017|Overall Study|Lost to Follow-up|0|||
160672869|NCT02055547|580180564|FG018|Overall Study|Lost to Follow-up|0|||
160672870|NCT01653704|580180565|FG000|Overall Study|Technical failure during recording|1|||
160672871|NCT01653704|580180566|FG001|Overall Study|Technical failure during recording|1|||
160672872|NCT01653704|580180565|FG000|Overall Study|Performance not reflective of training|1|||
160672873|NCT01653704|580180566|FG001|Overall Study|Performance not reflective of training|0|||
160672874|NCT01456221|580180567|FG000|Overall Study|Withdrawal by Subject|56|||
160672875|NCT01456221|580180568|FG001|Overall Study|Withdrawal by Subject|49|||
160672876|NCT01456221|580180567|FG000|Overall Study|Lost to Follow-up|1|||
160672877|NCT01456221|580180568|FG001|Overall Study|Lost to Follow-up|4|||
160672878|NCT01456221|580180567|FG000|Overall Study|Received medication|3|||
160672879|NCT01456221|580180568|FG001|Overall Study|Received medication|2|||
160672880|NCT01456221|580180567|FG000|Overall Study|Incomplete data|4|||
160672881|NCT01456221|580180568|FG001|Overall Study|Incomplete data|2|||
160672882|NCT03966911|580180569|FG000|Overall Study|Adverse Event|1|||
160672883|NCT03966911|580180570|FG001|Overall Study|Adverse Event|1|||
160672884|NCT03966911|580180569|FG000|Overall Study|Withdrawal by Subject|8|||
160672885|NCT03966911|580180570|FG001|Overall Study|Withdrawal by Subject|2|||
160672886|NCT03966911|580180569|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
160672887|NCT03966911|580180570|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
160672888|NCT00985751|580180572|FG000|Overall Study|Adverse Event|0|||
160672889|NCT00985751|580180573|FG001|Overall Study|Adverse Event|0|||
160672890|NCT00985751|580180574|FG002|Overall Study|Adverse Event|0|||
160672891|NCT00985751|580180575|FG003|Overall Study|Adverse Event|0|||
160672892|NCT00985751|580180576|FG004|Overall Study|Adverse Event|1|||
160672893|NCT01986647|580180577|FG000|Overall Study|Lost to Follow-up|4|||
160672894|NCT01986647|580180578|FG001|Overall Study|Lost to Follow-up|1|||
160672895|NCT01986647|580180579|FG002|Overall Study|Lost to Follow-up|4|||
160672896|NCT01986647|580180580|FG003|Overall Study|Lost to Follow-up|4|||
160672897|NCT01986647|580180577|FG000|Overall Study|Withdrawal by Subject|1|||
160672898|NCT01986647|580180578|FG001|Overall Study|Withdrawal by Subject|3|||
160672899|NCT01986647|580180579|FG002|Overall Study|Withdrawal by Subject|2|||
160672900|NCT01986647|580180580|FG003|Overall Study|Withdrawal by Subject|3|||
160672901|NCT01986647|580180577|FG000|Overall Study|Health|5|||
160672902|NCT01986647|580180578|FG001|Overall Study|Health|3|||
160672903|NCT01986647|580180579|FG002|Overall Study|Health|6|||
160672904|NCT01986647|580180580|FG003|Overall Study|Health|4|||
160672905|NCT01960296|580180581|FG000|Overall Study|Postponed surgery|1|||
160672906|NCT01960296|580180582|FG001|Overall Study|Postponed surgery|0|||
160672907|NCT01960296|580180581|FG000|Overall Study|Received different procedure|1|||
160629123|NCT01317199|580022927|FG000|Randomized Phase 2|Adverse Event|0|||
160629124|NCT01317199|580022928|FG001|Randomized Phase 2|Adverse Event|0|||
160629125|NCT01317199|580022929|FG002|Randomized Phase 2|Adverse Event|0|||
160629126|NCT01317199|580022930|FG003|Randomized Phase 2|Adverse Event|1|||
160629127|NCT01317199|580022927|FG000|Randomized Phase 2|Comorbidities|0|||
160629128|NCT01317199|580022928|FG001|Randomized Phase 2|Comorbidities|2|||
160629129|NCT01317199|580022929|FG002|Randomized Phase 2|Comorbidities|2|||
160629130|NCT01317199|580022930|FG003|Randomized Phase 2|Comorbidities|2|||
160629131|NCT01317199|580022927|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
160629132|NCT01317199|580022928|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
160629133|NCT01317199|580022929|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
160629134|NCT01317199|580022930|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
160629135|NCT01317199|580022927|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
160629136|NCT01317199|580022928|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
160629137|NCT01317199|580022929|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
160629138|NCT01317199|580022930|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
160629139|NCT01317199|580022927|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
160629140|NCT01317199|580022928|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
160629141|NCT01317199|580022929|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
160629142|NCT01317199|580022930|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
160629143|NCT01317199|580022927|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
160629144|NCT01317199|580022928|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
160629145|NCT01317199|580022929|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
160629146|NCT01317199|580022930|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
160629147|NCT01283009|580022931|FG000|Overall Study|Death|83|||
160629148|NCT01283009|580022932|FG001|Overall Study|Death|78|||
160629149|NCT01283009|580022931|FG000|Overall Study|Study ended early|23|||
160629150|NCT01283009|580022932|FG001|Overall Study|Study ended early|26|||
160629151|NCT01283009|580022931|FG000|Overall Study|Withdrawal by Subject|10|||
160629152|NCT01283009|580022932|FG001|Overall Study|Withdrawal by Subject|8|||
160629153|NCT01283009|580022931|FG000|Overall Study|Physician Decision|1|||
160629154|NCT01283009|580022932|FG001|Overall Study|Physician Decision|1|||
160629155|NCT01283009|580022931|FG000|Overall Study|Lost to Follow-up|1|||
160629156|NCT01283009|580022932|FG001|Overall Study|Lost to Follow-up|0|||
160629157|NCT01283009|580022931|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
160629158|NCT01283009|580022932|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
160629159|NCT01353209|580022933|FG000|Overall Study|Adverse Event|1|||
160672908|NCT01960296|580180582|FG001|Overall Study|Received different procedure|3|||
160672909|NCT02003391|580180583|FG000|Overall Study|Withdrawal by Subject|2|||
160672910|NCT02003391|580180584|FG001|Overall Study|Withdrawal by Subject|1|||
160672911|NCT02003391|580180583|FG000|Overall Study|Protocol Violation|0|||
160672912|NCT02003391|580180584|FG001|Overall Study|Protocol Violation|1|||
160672913|NCT02003391|580180583|FG000|Overall Study|Adverse Event|1|||
160672914|NCT02003391|580180584|FG001|Overall Study|Adverse Event|0|||
160672915|NCT02272803|580180585|FG000|Overall Study|Disease progression|16|||
160672916|NCT02272803|580180586|FG001|Overall Study|Disease progression|8|||
160672917|NCT02272803|580180585|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
160672918|NCT02272803|580180586|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
160672919|NCT02272803|580180585|FG000|Overall Study|Study drug toxicity|4|||
160672920|NCT02272803|580180586|FG001|Overall Study|Study drug toxicity|9|||
160672921|NCT02272803|580180585|FG000|Overall Study|Participant request to discontinue study treatment|3|||
160672922|NCT02272803|580180586|FG001|Overall Study|Participant request to discontinue study treatment|7|||
160672923|NCT02272803|580180585|FG000|Overall Study|Maximum clinical benefit|4|||
160672924|NCT02272803|580180586|FG001|Overall Study|Maximum clinical benefit|2|||
160672925|NCT02272803|580180585|FG000|Overall Study|Poor/non-compliance|2|||
160672926|NCT02272803|580180586|FG001|Overall Study|Poor/non-compliance|2|||
160672927|NCT02272803|580180585|FG000|Overall Study|Withdrawal by Subject|2|||
160672928|NCT02272803|580180586|FG001|Overall Study|Withdrawal by Subject|1|||
160672929|NCT02272803|580180585|FG000|Overall Study|Death|0|||
160672930|NCT02272803|580180586|FG001|Overall Study|Death|1|||
160672931|NCT02272803|580180585|FG000|Overall Study|Other reasons|1|||
160672932|NCT02272803|580180586|FG001|Overall Study|Other reasons|3|||
160672933|NCT02272803|580180585|FG000|Overall Study|Administrative reason by sponsor|5|||
160672934|NCT02272803|580180586|FG001|Overall Study|Administrative reason by sponsor|4|||
160672935|NCT02611323|580180587|FG000|Overall Study|Death|3|||
160672936|NCT02611323|580180588|FG001|Overall Study|Death|1|||
160672937|NCT02611323|580180589|FG002|Overall Study|Death|0|||
160672938|NCT02611323|580180590|FG003|Overall Study|Death|0|||
160672939|NCT02611323|580180591|FG004|Overall Study|Death|1|||
160672940|NCT02611323|580180592|FG005|Overall Study|Death|1|||
160672941|NCT02611323|580180593|FG006|Overall Study|Death|8|||
160672942|NCT02611323|580180594|FG007|Overall Study|Death|0|||
160672943|NCT02611323|580180595|FG008|Overall Study|Death|4|||
160672944|NCT02611323|580180596|FG009|Overall Study|Death|6|||
160672945|NCT02611323|580180597|FG010|Overall Study|Death|26|||
160672946|NCT02611323|580180587|FG000|Overall Study|Lost to Follow-up|1|||
160672947|NCT02611323|580180588|FG001|Overall Study|Lost to Follow-up|0|||
160672948|NCT02611323|580180589|FG002|Overall Study|Lost to Follow-up|0|||
160672949|NCT02611323|580180590|FG003|Overall Study|Lost to Follow-up|0|||
160672950|NCT02611323|580180591|FG004|Overall Study|Lost to Follow-up|0|||
160672951|NCT02611323|580180592|FG005|Overall Study|Lost to Follow-up|0|||
160672952|NCT02611323|580180593|FG006|Overall Study|Lost to Follow-up|3|||
160672953|NCT02611323|580180594|FG007|Overall Study|Lost to Follow-up|0|||
160672954|NCT02611323|580180595|FG008|Overall Study|Lost to Follow-up|0|||
160672955|NCT02611323|580180596|FG009|Overall Study|Lost to Follow-up|0|||
160672956|NCT02611323|580180597|FG010|Overall Study|Lost to Follow-up|2|||
160672957|NCT02611323|580180587|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
160672958|NCT02611323|580180588|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
160672959|NCT02611323|580180589|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
160672960|NCT02611323|580180590|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
160672961|NCT02611323|580180591|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
160672962|NCT02611323|580180592|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
160672963|NCT02611323|580180593|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
160672964|NCT02611323|580180594|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
160672965|NCT02611323|580180595|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
160672966|NCT02611323|580180596|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
160672967|NCT02611323|580180597|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
160672968|NCT02611323|580180587|FG000|Overall Study|Progressive Disease|0|||
160672969|NCT02611323|580180588|FG001|Overall Study|Progressive Disease|0|||
160672970|NCT02611323|580180589|FG002|Overall Study|Progressive Disease|0|||
160672971|NCT02611323|580180590|FG003|Overall Study|Progressive Disease|0|||
160672972|NCT02611323|580180591|FG004|Overall Study|Progressive Disease|0|||
160672973|NCT02611323|580180592|FG005|Overall Study|Progressive Disease|0|||
160672974|NCT02611323|580180593|FG006|Overall Study|Progressive Disease|0|||
160672975|NCT02611323|580180594|FG007|Overall Study|Progressive Disease|0|||
160672976|NCT02611323|580180595|FG008|Overall Study|Progressive Disease|0|||
160672977|NCT02611323|580180596|FG009|Overall Study|Progressive Disease|0|||
160672978|NCT02611323|580180597|FG010|Overall Study|Progressive Disease|1|||
160672979|NCT02611323|580180587|FG000|Overall Study|Withdrawal by Subject|1|||
160672980|NCT02611323|580180588|FG001|Overall Study|Withdrawal by Subject|0|||
160672981|NCT02611323|580180589|FG002|Overall Study|Withdrawal by Subject|0|||
160672982|NCT02611323|580180590|FG003|Overall Study|Withdrawal by Subject|0|||
160672983|NCT02611323|580180591|FG004|Overall Study|Withdrawal by Subject|0|||
160672984|NCT02611323|580180592|FG005|Overall Study|Withdrawal by Subject|0|||
160672985|NCT02611323|580180593|FG006|Overall Study|Withdrawal by Subject|0|||
160672986|NCT02611323|580180594|FG007|Overall Study|Withdrawal by Subject|1|||
160672987|NCT02611323|580180595|FG008|Overall Study|Withdrawal by Subject|0|||
160672988|NCT02611323|580180596|FG009|Overall Study|Withdrawal by Subject|1|||
160672989|NCT02611323|580180597|FG010|Overall Study|Withdrawal by Subject|0|||
160672990|NCT00243347|580180598|FG000|Overall Study|Lack of Efficacy|4|||
160629160|NCT01353209|580022934|FG001|Overall Study|Adverse Event|1|||
160629161|NCT00183170|580022943|FG000|First Intervention|Did not complete study|1|||
160629162|NCT00183170|580022944|FG001|First Intervention|Did not complete study|0|||
160629163|NCT00183170|580022943|FG000|First Intervention|Did not meet targeted BrAC|1|||
160629164|NCT00183170|580022944|FG001|First Intervention|Did not meet targeted BrAC|0|||
160629165|NCT00183170|580022943|FG000|Washout 1 Week|Did not complete study|6|||
160629166|NCT00183170|580022944|FG001|Washout 1 Week|Did not complete study|8|||
160629167|NCT00183170|580022943|FG000|Second Intervention|Did not complete study|1|||
160629168|NCT00183170|580022944|FG001|Second Intervention|Did not complete study|0|||
160629169|NCT00183170|580022943|FG000|Second Intervention|Did not meet targeted BrAC|0|||
160629170|NCT00183170|580022944|FG001|Second Intervention|Did not meet targeted BrAC|2|||
160629171|NCT05102162|580022945|FG000|Overall Study|Withdrawal by Subject|3|||
160629172|NCT05102162|580022946|FG001|Overall Study|Withdrawal by Subject|0|||
160629173|NCT05102162|580022945|FG000|Overall Study|Baseline cultures negative|4|||
160629174|NCT05102162|580022946|FG001|Overall Study|Baseline cultures negative|2|||
160629175|NCT05102162|580022945|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
160629176|NCT05102162|580022946|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
160629177|NCT05102162|580022945|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
160629178|NCT05102162|580022946|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
160629179|NCT05027958|580022947|FG000|Overall Study|Lost to Follow-up|1|||
160629180|NCT05027958|580022948|FG001|Overall Study|Lost to Follow-up|1|||
160629181|NCT05027958|580022947|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
160629182|NCT05027958|580022948|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
160629183|NCT05027958|580022947|FG000|Overall Study|Physician Decision|1|||
160629184|NCT05027958|580022948|FG001|Overall Study|Physician Decision|4|||
160629185|NCT05027958|580022947|FG000|Overall Study|Adverse Event|0|||
160629186|NCT05027958|580022948|FG001|Overall Study|Adverse Event|1|||
160629187|NCT01870921|580022949|FG000|Overall Study|Subject decision|80|||
160629188|NCT01870921|580022949|FG000|Overall Study|Severe non-compliance to protocol|7|||
160629189|NCT01870921|580022949|FG000|Overall Study|Subject Lost to Follow up|2|||
160629190|NCT01870921|580022949|FG000|Overall Study|Other|1|||
160629191|NCT01244516|580022950|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
160629192|NCT01244516|580022951|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
160629193|NCT01244516|580022952|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
160629194|NCT01244516|580022950|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
160629195|NCT01244516|580022951|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
160629196|NCT01244516|580022952|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
160629197|NCT01244516|580022950|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
160629198|NCT01244516|580022951|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
160629199|NCT01244516|580022952|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
160629200|NCT01244516|580022950|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
160629201|NCT01244516|580022951|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
160629202|NCT01244516|580022952|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
160629203|NCT01244516|580022950|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
160629204|NCT01244516|580022951|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
160629205|NCT01244516|580022952|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
160629206|NCT01244516|580022950|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
160629207|NCT01244516|580022951|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
160629208|NCT01244516|580022952|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
160629209|NCT01244516|580022950|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
160629210|NCT01244516|580022951|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
160629211|NCT01244516|580022952|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
160629212|NCT01102972|580022955|FG000|Overall Study|Adverse Event|8|||
160629213|NCT01102972|580022956|FG001|Overall Study|Adverse Event|2|||
160629214|NCT01102972|580022955|FG000|Overall Study|Lack of Efficacy|2|||
160629215|NCT01102972|580022956|FG001|Overall Study|Lack of Efficacy|1|||
160629216|NCT01102972|580022955|FG000|Overall Study|Protocol Violation|1|||
160629217|NCT01102972|580022956|FG001|Overall Study|Protocol Violation|0|||
160629218|NCT01102972|580022955|FG000|Overall Study|Lost to Follow-up|10|||
160629219|NCT01102972|580022956|FG001|Overall Study|Lost to Follow-up|5|||
160629220|NCT01102972|580022955|FG000|Overall Study|Investigator Discretion|2|||
160629221|NCT01102972|580022956|FG001|Overall Study|Investigator Discretion|0|||
160629222|NCT01102972|580022955|FG000|Overall Study|Withdrawal by Subject|6|||
160629223|NCT01102972|580022956|FG001|Overall Study|Withdrawal by Subject|6|||
160629224|NCT03664024|580022960|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
160629225|NCT03664024|580022960|FG000|Overall Study|Lost to Follow-up|2|||
160629226|NCT03664024|580022960|FG000|Overall Study|Withdrawal by Subject|2|||
160629227|NCT03664024|580022960|FG000|Overall Study|Death|80|||
160629228|NCT01157065|580022961|FG000|Overall Study|Death|0|||
160629229|NCT01157065|580022962|FG001|Overall Study|Death|1|||
160629230|NCT02325739|580022963|FG000|Phase I Part|Adverse Event|1|||
160629231|NCT02325739|580022964|FG001|Phase I Part|Adverse Event|0|||
160629232|NCT02325739|580022965|FG002|Phase I Part|Adverse Event|1|||
160672991|NCT00243347|580180598|FG000|Overall Study|Adverse Event|2|||
160672992|NCT00243347|580180598|FG000|Overall Study|Death|1|||
160672993|NCT00243347|580180598|FG000|Overall Study|Withdrawal by Subject|5|||
160672994|NCT00243347|580180598|FG000|Overall Study|Condition worsened|7|||
160672995|NCT03531827|580180603|FG000|Overall Study|Adverse Event|2|||
160672996|NCT03531827|580180604|FG001|Overall Study|Adverse Event|0|||
160672997|NCT03531827|580180603|FG000|Overall Study|Progressive disease|1|||
160672998|NCT03531827|580180604|FG001|Overall Study|Progressive disease|0|||
160672999|NCT03067987|580180605|FG000|Overall Study|Lost to Follow-up|7|||
160673000|NCT03067987|580180606|FG001|Overall Study|Lost to Follow-up|10|||
160673001|NCT03067987|580180605|FG000|Overall Study|Protocol Violation|1|||
160673002|NCT03067987|580180606|FG001|Overall Study|Protocol Violation|2|||
160673003|NCT03067987|580180605|FG000|Overall Study|Withdrawal by Subject|2|||
160673004|NCT03067987|580180606|FG001|Overall Study|Withdrawal by Subject|1|||
160673005|NCT00754052|580182143|FG000|Overall Study|Study terminated by Sponsor|5|||
160673006|NCT00754052|580182144|FG001|Overall Study|Study terminated by Sponsor|3|||
160673007|NCT00516295|580182148|FG000|Overall Study|Lack of Efficacy|2|||
160673008|NCT00516295|580182149|FG001|Overall Study|Lack of Efficacy|0|||
160673009|NCT00516295|580182150|FG002|Overall Study|Lack of Efficacy|0|||
160673010|NCT00516295|580182148|FG000|Overall Study|Ineligible|1|||
160673011|NCT00516295|580182149|FG001|Overall Study|Ineligible|0|||
160673012|NCT00516295|580182150|FG002|Overall Study|Ineligible|0|||
160673013|NCT00183196|580182154|FG000|Overall Study|Withdrawal by Subject|18|||
160673014|NCT00183196|580182155|FG001|Overall Study|Withdrawal by Subject|11|||
160673015|NCT00183196|580182156|FG002|Overall Study|Withdrawal by Subject|13|||
160673016|NCT00183196|580182154|FG000|Overall Study|Adverse Event|1|||
160673017|NCT00183196|580182155|FG001|Overall Study|Adverse Event|2|||
160673018|NCT00183196|580182156|FG002|Overall Study|Adverse Event|2|||
160673019|NCT00183196|580182154|FG000|Overall Study|Legal event|1|||
160673020|NCT00183196|580182155|FG001|Overall Study|Legal event|1|||
160673021|NCT00183196|580182156|FG002|Overall Study|Legal event|1|||
160673022|NCT00183196|580182154|FG000|Overall Study|Required more intensive care|0|||
160673023|NCT00183196|580182155|FG001|Overall Study|Required more intensive care|1|||
160673024|NCT00183196|580182156|FG002|Overall Study|Required more intensive care|2|||
160673025|NCT01701063|580182163|FG000|Overall Study|Lost to Follow-up|0|||
160673026|NCT01701063|580182164|FG001|Overall Study|Lost to Follow-up|1|||
160673027|NCT01701063|580182165|FG002|Overall Study|Lost to Follow-up|0|||
160673028|NCT01701063|580182163|FG000|Overall Study|Withdrawal by Subject|0|||
160673029|NCT01701063|580182164|FG001|Overall Study|Withdrawal by Subject|0|||
160673030|NCT01701063|580182165|FG002|Overall Study|Withdrawal by Subject|1|||
160629233|NCT02325739|580022966|FG003|Phase I Part|Adverse Event|2|||
160629234|NCT02325739|580022967|FG004|Phase I Part|Adverse Event|3|||
160629235|NCT02325739|580022968|FG005|Phase I Part|Adverse Event|1|||
160629236|NCT02325739|580022969|FG006|Phase I Part|Adverse Event|0|||
160629237|NCT02325739|580022970|FG007|Phase I Part|Adverse Event|2|||
160629238|NCT02325739|580022971|FG008|Phase I Part|Adverse Event|0|||
160629239|NCT02325739|580022972|FG009|Phase I Part|Adverse Event|0|||
160629240|NCT02325739|580022973|FG010|Phase I Part|Adverse Event|0|||
160629241|NCT02325739|580022963|FG000|Phase I Part|Progressive disease|9|||
160629242|NCT02325739|580022964|FG001|Phase I Part|Progressive disease|6|||
160629243|NCT02325739|580022965|FG002|Phase I Part|Progressive disease|3|||
160629244|NCT02325739|580022966|FG003|Phase I Part|Progressive disease|23|||
160629245|NCT02325739|580022967|FG004|Phase I Part|Progressive disease|14|||
160629246|NCT02325739|580022968|FG005|Phase I Part|Progressive disease|6|||
160629247|NCT02325739|580022969|FG006|Phase I Part|Progressive disease|6|||
160629248|NCT02325739|580022970|FG007|Phase I Part|Progressive disease|3|||
160629249|NCT02325739|580022971|FG008|Phase I Part|Progressive disease|0|||
160629250|NCT02325739|580022972|FG009|Phase I Part|Progressive disease|0|||
160629251|NCT02325739|580022973|FG010|Phase I Part|Progressive disease|0|||
160629252|NCT02325739|580022963|FG000|Phase I Part|Subject/guardian decision|1|||
160629253|NCT02325739|580022964|FG001|Phase I Part|Subject/guardian decision|0|||
160629254|NCT02325739|580022965|FG002|Phase I Part|Subject/guardian decision|1|||
160629255|NCT02325739|580022966|FG003|Phase I Part|Subject/guardian decision|1|||
160629256|NCT02325739|580022967|FG004|Phase I Part|Subject/guardian decision|0|||
160673031|NCT01701063|580182163|FG000|Overall Study|Other|0|||
160629257|NCT02325739|580022968|FG005|Phase I Part|Subject/guardian decision|0|||
160629258|NCT02325739|580022969|FG006|Phase I Part|Subject/guardian decision|0|||
160629259|NCT02325739|580022970|FG007|Phase I Part|Subject/guardian decision|1|||
160629260|NCT02325739|580022971|FG008|Phase I Part|Subject/guardian decision|0|||
160673032|NCT01701063|580182164|FG001|Overall Study|Other|0|||
160673033|NCT01701063|580182165|FG002|Overall Study|Other|1|||
160673034|NCT00635648|580182166|FG000|Overall Study|Adverse Event|12|||
160673035|NCT00635648|580182166|FG000|Overall Study|Withdrawal by Subject|9|||
160673036|NCT00635648|580182166|FG000|Overall Study|Physician Decision|4|||
160673037|NCT00635648|580182166|FG000|Overall Study|Rapid progression of baseline disease|4|||
160673038|NCT00635648|580182166|FG000|Overall Study|Use of other antifungal agent needed|1|||
160673039|NCT00635648|580182166|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
160673040|NCT00635648|580182166|FG000|Overall Study|Noncompliance with protocol|1|||
160673041|NCT00635648|580182166|FG000|Overall Study|Other reason|2|||
160673042|NCT00294047|580182167|FG000|Month 48|Adverse Event|28|||
160673043|NCT00294047|580182168|FG001|Month 48|Adverse Event|13|||
160673044|NCT00294047|580182167|FG000|Month 48|Protocol Violation|4|||
160673045|NCT00294047|580182168|FG001|Month 48|Protocol Violation|4|||
160673046|NCT00294047|580182167|FG000|Month 48|Withdrawal by Subject|111|||
160673047|NCT00294047|580182168|FG001|Month 48|Withdrawal by Subject|115|||
160673048|NCT00294047|580182167|FG000|Month 48|Lost to Follow-up|272|||
160673049|NCT00294047|580182168|FG001|Month 48|Lost to Follow-up|287|||
160673050|NCT00294047|580182167|FG000|Month 48|Other|10|||
160673051|NCT00294047|580182168|FG001|Month 48|Other|14|||
160673052|NCT00294047|580182167|FG000|Month 84|Adverse Event|4|||
160673053|NCT00294047|580182168|FG001|Month 84|Adverse Event|2|||
160673054|NCT00294047|580182167|FG000|Month 84|Protocol Violation|1|||
160673055|NCT00294047|580182168|FG001|Month 84|Protocol Violation|1|||
160673056|NCT00294047|580182167|FG000|Month 84|Withdrawal by Subject|33|||
160673057|NCT00294047|580182168|FG001|Month 84|Withdrawal by Subject|31|||
160673058|NCT00294047|580182167|FG000|Month 84|Lost to Follow-up|187|||
160673059|NCT00294047|580182168|FG001|Month 84|Lost to Follow-up|190|||
160673060|NCT00294047|580182167|FG000|Month 84|Absent Cervix|2|||
160673061|NCT00294047|580182168|FG001|Month 84|Absent Cervix|0|||
160673062|NCT00294047|580182167|FG000|Month 84|Work related reasons|4|||
160673063|NCT00294047|580182168|FG001|Month 84|Work related reasons|2|||
160673064|NCT00294047|580182167|FG000|Month 84|Center closed, subject did not transfer|1|||
160673065|NCT00294047|580182168|FG001|Month 84|Center closed, subject did not transfer|0|||
160673066|NCT00294047|580182167|FG000|Month 84|Family problems|2|||
160673067|NCT00294047|580182168|FG001|Month 84|Family problems|2|||
160673068|NCT00294047|580182167|FG000|Month 84|Lack of time|3|||
160673069|NCT00294047|580182168|FG001|Month 84|Lack of time|1|||
160673070|NCT00294047|580182167|FG000|Month 84|Personal reason|2|||
160673071|NCT00294047|580182168|FG001|Month 84|Personal reason|4|||
160673072|NCT00294047|580182167|FG000|Month 84|Subject does not want male physician|1|||
160673073|NCT00294047|580182168|FG001|Month 84|Subject does not want male physician|0|||
160673074|NCT00294047|580182167|FG000|Month 84|Transport reimbursement delayed|0|||
160629261|NCT02325739|580022972|FG009|Phase I Part|Subject/guardian decision|0|||
160629262|NCT02325739|580022973|FG010|Phase I Part|Subject/guardian decision|0|||
160629263|NCT02325739|580022963|FG000|Phase I Part|Death|0|||
160629264|NCT02325739|580022964|FG001|Phase I Part|Death|0|||
160629265|NCT02325739|580022965|FG002|Phase I Part|Death|0|||
160629266|NCT02325739|580022966|FG003|Phase I Part|Death|0|||
160629267|NCT02325739|580022967|FG004|Phase I Part|Death|2|||
160629268|NCT02325739|580022968|FG005|Phase I Part|Death|0|||
160629269|NCT02325739|580022969|FG006|Phase I Part|Death|0|||
160629270|NCT02325739|580022970|FG007|Phase I Part|Death|0|||
160629271|NCT02325739|580022971|FG008|Phase I Part|Death|0|||
160629272|NCT02325739|580022972|FG009|Phase I Part|Death|0|||
160629273|NCT02325739|580022973|FG010|Phase I Part|Death|0|||
160629274|NCT02325739|580022963|FG000|Phase II Part|Adverse Event|0|||
160629275|NCT02325739|580022964|FG001|Phase II Part|Adverse Event|0|||
160629276|NCT02325739|580022965|FG002|Phase II Part|Adverse Event|0|||
160629277|NCT02325739|580022966|FG003|Phase II Part|Adverse Event|0|||
160629278|NCT02325739|580022967|FG004|Phase II Part|Adverse Event|0|||
160629279|NCT02325739|580022968|FG005|Phase II Part|Adverse Event|0|||
160629280|NCT02325739|580022969|FG006|Phase II Part|Adverse Event|0|||
160629281|NCT02325739|580022970|FG007|Phase II Part|Adverse Event|0|||
160629282|NCT02325739|580022971|FG008|Phase II Part|Adverse Event|4|||
160629283|NCT02325739|580022972|FG009|Phase II Part|Adverse Event|5|||
160629284|NCT02325739|580022973|FG010|Phase II Part|Adverse Event|1|||
160629285|NCT02325739|580022963|FG000|Phase II Part|Physician Decision|0|||
160629286|NCT02325739|580022964|FG001|Phase II Part|Physician Decision|0|||
160629287|NCT02325739|580022965|FG002|Phase II Part|Physician Decision|0|||
160629288|NCT02325739|580022966|FG003|Phase II Part|Physician Decision|0|||
160629289|NCT02325739|580022967|FG004|Phase II Part|Physician Decision|0|||
160629290|NCT02325739|580022968|FG005|Phase II Part|Physician Decision|0|||
160629291|NCT02325739|580022969|FG006|Phase II Part|Physician Decision|0|||
160629292|NCT02325739|580022970|FG007|Phase II Part|Physician Decision|0|||
160673075|NCT00294047|580182168|FG001|Month 84|Transport reimbursement delayed|1|||
160673076|NCT00294047|580182167|FG000|Month 84|Unable to reach study site|1|||
160673077|NCT00294047|580182168|FG001|Month 84|Unable to reach study site|0|||
160673078|NCT00294047|580182167|FG000|Month 84|Under investigation locally|1|||
160673079|NCT00294047|580182168|FG001|Month 84|Under investigation locally|0|||
160673080|NCT00294047|580182167|FG000|Month 84|Visit missed|0|||
160629293|NCT02325739|580022971|FG008|Phase II Part|Physician Decision|0|||
160629294|NCT02325739|580022972|FG009|Phase II Part|Physician Decision|1|||
160629295|NCT02325739|580022973|FG010|Phase II Part|Physician Decision|0|||
160629296|NCT02325739|580022963|FG000|Phase II Part|Progressive disease|0|||
160629297|NCT02325739|580022964|FG001|Phase II Part|Progressive disease|0|||
160673081|NCT00294047|580182168|FG001|Month 84|Visit missed|1|||
160629298|NCT02325739|580022965|FG002|Phase II Part|Progressive disease|0|||
160629299|NCT02325739|580022966|FG003|Phase II Part|Progressive disease|0|||
160673082|NCT00294047|580182167|FG000|Month 84|No consent for Month 84 Follow-up|731|||
160673083|NCT00294047|580182168|FG001|Month 84|No consent for Month 84 Follow-up|754|||
160673084|NCT00506831|580182169|FG000|Overall Study|Death|1|||
160629300|NCT02325739|580022967|FG004|Phase II Part|Progressive disease|0|||
160629301|NCT02325739|580022968|FG005|Phase II Part|Progressive disease|0|||
160629302|NCT02325739|580022969|FG006|Phase II Part|Progressive disease|0|||
160629303|NCT02325739|580022970|FG007|Phase II Part|Progressive disease|0|||
160629304|NCT02325739|580022971|FG008|Phase II Part|Progressive disease|22|||
160629305|NCT02325739|580022972|FG009|Phase II Part|Progressive disease|29|||
160629306|NCT02325739|580022973|FG010|Phase II Part|Progressive disease|18|||
160629307|NCT02325739|580022963|FG000|Phase II Part|Subject/guardian decision|0|||
160629308|NCT02325739|580022964|FG001|Phase II Part|Subject/guardian decision|0|||
160629309|NCT02325739|580022965|FG002|Phase II Part|Subject/guardian decision|0|||
160629310|NCT02325739|580022966|FG003|Phase II Part|Subject/guardian decision|0|||
160629311|NCT02325739|580022967|FG004|Phase II Part|Subject/guardian decision|0|||
160629312|NCT02325739|580022968|FG005|Phase II Part|Subject/guardian decision|0|||
160629313|NCT02325739|580022969|FG006|Phase II Part|Subject/guardian decision|0|||
160629314|NCT02325739|580022970|FG007|Phase II Part|Subject/guardian decision|0|||
160629315|NCT02325739|580022971|FG008|Phase II Part|Subject/guardian decision|4|||
160629316|NCT02325739|580022972|FG009|Phase II Part|Subject/guardian decision|1|||
160629317|NCT02325739|580022973|FG010|Phase II Part|Subject/guardian decision|1|||
160629318|NCT03075826|580022975|FG000|Overall Study|Withdrawal by Subject|1|||
160629319|NCT03075826|580022975|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
160629320|NCT04456998|580022980|FG000|Overall Study|Adverse Event|0|||
160629321|NCT04456998|580022981|FG001|Overall Study|Adverse Event|4|||
160629322|NCT04456998|580022980|FG000|Overall Study|Protocol Deviation|0|||
160629323|NCT04456998|580022981|FG001|Overall Study|Protocol Deviation|1|||
160629324|NCT04456998|580022980|FG000|Overall Study|Withdrawal by Subject|0|||
160629325|NCT04456998|580022981|FG001|Overall Study|Withdrawal by Subject|1|||
160629326|NCT04228107|580022985|FG000|Overall Study|Protocol Violation|1|||
160629327|NCT04228107|580022986|FG001|Overall Study|Protocol Violation|0|||
160629328|NCT04228107|580022985|FG000|Overall Study|Withdrawal by Subject|6|||
160629329|NCT04228107|580022986|FG001|Overall Study|Withdrawal by Subject|0|||
160629330|NCT04228107|580022985|FG000|Overall Study|Lost to Follow-up|18|||
160629331|NCT04228107|580022986|FG001|Overall Study|Lost to Follow-up|0|||
160629332|NCT04228107|580022985|FG000|Overall Study|No controller use data|1|||
160629333|NCT04228107|580022986|FG001|Overall Study|No controller use data|0|||
160629334|NCT04228107|580022985|FG000|Overall Study|No medication data collected|1|||
160629335|NCT04228107|580022986|FG001|Overall Study|No medication data collected|0|||
160629336|NCT00965562|580022987|FG000|Overall Study|Lost to Follow-up|1|||
160629337|NCT00965562|580022988|FG001|Overall Study|Lost to Follow-up|2|||
160629338|NCT00965562|580022989|FG002|Overall Study|Lost to Follow-up|3|||
160629339|NCT00965562|580022987|FG000|Overall Study|Withdrawal by Subject|2|||
160629340|NCT00965562|580022988|FG001|Overall Study|Withdrawal by Subject|2|||
160629341|NCT00965562|580022989|FG002|Overall Study|Withdrawal by Subject|0|||
160629342|NCT03792633|580022990|FG000|Overall Study|Alternative Treatment|17|||
160629343|NCT03792633|580022991|FG001|Overall Study|Alternative Treatment|19|||
160629344|NCT03792633|580022990|FG000|Overall Study|Death|2|||
160629345|NCT03792633|580022991|FG001|Overall Study|Death|0|||
160629346|NCT03792633|580022990|FG000|Overall Study|Disease progression|8|||
160629347|NCT03792633|580022991|FG001|Overall Study|Disease progression|9|||
160629348|NCT03792633|580022990|FG000|Overall Study|Lost to Follow-up|1|||
160629349|NCT03792633|580022991|FG001|Overall Study|Lost to Follow-up|1|||
160629350|NCT03792633|580022990|FG000|Overall Study|Screen fail|1|||
160629351|NCT03792633|580022991|FG001|Overall Study|Screen fail|0|||
160629352|NCT03792633|580022990|FG000|Overall Study|Second malignancy|0|||
160629353|NCT03792633|580022991|FG001|Overall Study|Second malignancy|1|||
160629354|NCT00145119|580022992|FG000|Overall Study|Death|45|||
160629355|NCT01233284|580023003|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
160629356|NCT01233284|580023004|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
160629357|NCT01233284|580023005|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
160629358|NCT01233284|580023006|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
160629359|NCT01233284|580023007|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
160629360|NCT01233284|580023003|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
160629361|NCT01233284|580023004|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
160629362|NCT01233284|580023005|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
160629363|NCT01233284|580023006|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
160629364|NCT01233284|580023007|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
160629365|NCT01233284|580023003|FG000|Period 1 (4 Weeks)|Other|0|||
160629366|NCT01233284|580023004|FG001|Period 1 (4 Weeks)|Other|0|||
160629367|NCT01233284|580023005|FG002|Period 1 (4 Weeks)|Other|1|||
160629368|NCT01233284|580023006|FG003|Period 1 (4 Weeks)|Other|0|||
160629369|NCT01233284|580023007|FG004|Period 1 (4 Weeks)|Other|0|||
160629370|NCT01233284|580023003|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160629371|NCT01233284|580023004|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160629372|NCT01233284|580023005|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
160629373|NCT01233284|580023006|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160629374|NCT01233284|580023007|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160629375|NCT01233284|580023003|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
160629376|NCT01233284|580023004|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
160629377|NCT01233284|580023005|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
160629378|NCT01233284|580023006|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
160629379|NCT01233284|580023007|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
160629380|NCT01233284|580023003|FG000|Period 3 (4 Weeks)|Other|0|||
160629381|NCT01233284|580023004|FG001|Period 3 (4 Weeks)|Other|0|||
160629382|NCT01233284|580023005|FG002|Period 3 (4 Weeks)|Other|0|||
160629383|NCT01233284|580023006|FG003|Period 3 (4 Weeks)|Other|1|||
160629384|NCT01233284|580023007|FG004|Period 3 (4 Weeks)|Other|0|||
160629385|NCT01233284|580023003|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
160629386|NCT01233284|580023004|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
160629387|NCT01233284|580023005|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
160629388|NCT01233284|580023006|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
160629389|NCT01233284|580023007|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
160629390|NCT01233284|580023003|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
160629391|NCT01233284|580023004|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
160629392|NCT01233284|580023005|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
160629393|NCT01233284|580023006|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
160629394|NCT01233284|580023007|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
160629395|NCT03759340|580023008|FG000|Overall Study|Adverse Event|2|||
160629396|NCT03759340|580023008|FG000|Overall Study|Lost to Follow-up|1|||
160629397|NCT03759340|580023008|FG000|Overall Study|Withdrawal by Subject|15|||
160629398|NCT03759340|580023008|FG000|Overall Study|Study Terminated by Sponsor|38|||
160629399|NCT04814654|580023009|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
160629400|NCT04814654|580023010|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
160629401|NCT04814654|580023011|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
160629402|NCT02207413|580023021|FG000|Overall Study|Withdrawal by Subject|1|||
160629403|NCT02207413|580023022|FG001|Overall Study|Withdrawal by Subject|0|||
160629404|NCT02207413|580023023|FG002|Overall Study|Withdrawal by Subject|0|||
160629405|NCT02207413|580023024|FG003|Overall Study|Withdrawal by Subject|0|||
160629406|NCT02207413|580023025|FG004|Overall Study|Withdrawal by Subject|3|||
160629407|NCT02207413|580023026|FG005|Overall Study|Withdrawal by Subject|7|||
160629408|NCT02207413|580023021|FG000|Overall Study|Lost to Follow-up|0|||
160629409|NCT02207413|580023022|FG001|Overall Study|Lost to Follow-up|0|||
160629410|NCT02207413|580023023|FG002|Overall Study|Lost to Follow-up|0|||
160629411|NCT02207413|580023024|FG003|Overall Study|Lost to Follow-up|1|||
160629412|NCT02207413|580023025|FG004|Overall Study|Lost to Follow-up|1|||
160629413|NCT02207413|580023026|FG005|Overall Study|Lost to Follow-up|5|||
160629414|NCT02207413|580023021|FG000|Overall Study|Adverse Event|0|||
160629415|NCT02207413|580023022|FG001|Overall Study|Adverse Event|0|||
160629416|NCT02207413|580023023|FG002|Overall Study|Adverse Event|0|||
160629417|NCT02207413|580023024|FG003|Overall Study|Adverse Event|0|||
160629418|NCT02207413|580023025|FG004|Overall Study|Adverse Event|2|||
160629419|NCT02207413|580023026|FG005|Overall Study|Adverse Event|1|||
160629420|NCT02207413|580023021|FG000|Overall Study|Migrated/moved from study area|0|||
160629421|NCT02207413|580023022|FG001|Overall Study|Migrated/moved from study area|0|||
160629422|NCT02207413|580023023|FG002|Overall Study|Migrated/moved from study area|0|||
160629423|NCT02207413|580023024|FG003|Overall Study|Migrated/moved from study area|0|||
160629424|NCT02207413|580023025|FG004|Overall Study|Migrated/moved from study area|1|||
160629425|NCT02207413|580023026|FG005|Overall Study|Migrated/moved from study area|0|||
160629426|NCT04075656|580023027|FG000|Overall Study|Withdrawal by Subject|5|||
160629427|NCT04075656|580023028|FG001|Overall Study|Withdrawal by Subject|5|||
160629428|NCT01519635|580024912|FG000|Overall Study|Withdrawal by Subject|0|||
160629429|NCT01519635|580024913|FG001|Overall Study|Withdrawal by Subject|1|||
160629430|NCT01519635|580024912|FG000|Overall Study|No possibility to put a catheter|1|||
160629431|NCT01519635|580024913|FG001|Overall Study|No possibility to put a catheter|2|||
160629432|NCT00347776|580024914|FG000|1.5 Month Follow-up|Death|2|||
160629433|NCT00347776|580024915|FG001|1.5 Month Follow-up|Death|0|||
160629434|NCT00347776|580024916|FG002|1.5 Month Follow-up|Death|0|||
160629435|NCT00347776|580024914|FG000|1.5 Month Follow-up|reached the endpoint|12|||
160629436|NCT00347776|580024915|FG001|1.5 Month Follow-up|reached the endpoint|8|||
160629437|NCT00347776|580024916|FG002|1.5 Month Follow-up|reached the endpoint|12|||
160629438|NCT00347776|580024914|FG000|6 Month Follow-up|Death|2|||
160629439|NCT00347776|580024915|FG001|6 Month Follow-up|Death|1|||
160629440|NCT00347776|580024916|FG002|6 Month Follow-up|Death|3|||
160629441|NCT00347776|580024914|FG000|6 Month Follow-up|reached endpont|20|||
160629442|NCT00347776|580024915|FG001|6 Month Follow-up|reached endpont|12|||
160629443|NCT00347776|580024916|FG002|6 Month Follow-up|reached endpont|15|||
160629444|NCT00347776|580024914|FG000|12 Month Follow-up|Lost to Follow-up|7|||
160629445|NCT00347776|580024915|FG001|12 Month Follow-up|Lost to Follow-up|6|||
160629446|NCT00347776|580024916|FG002|12 Month Follow-up|Lost to Follow-up|6|||
160629447|NCT00347776|580024914|FG000|12 Month Follow-up|Death|3|||
160629448|NCT00347776|580024915|FG001|12 Month Follow-up|Death|4|||
160629449|NCT00347776|580024916|FG002|12 Month Follow-up|Death|4|||
160629450|NCT00347776|580024914|FG000|12 Month Follow-up|Reached endpoint|13|||
160629451|NCT00347776|580024915|FG001|12 Month Follow-up|Reached endpoint|6|||
160629452|NCT00347776|580024916|FG002|12 Month Follow-up|Reached endpoint|9|||
160629453|NCT00848965|580024917|FG000|Overall Study|Adverse Event|1|||
160673085|NCT00506831|580182169|FG000|Overall Study|Withdrawal by Subject|1|||
160629454|NCT00848965|580024917|FG000|Overall Study|Withdrawal by Subject|1|||
160629455|NCT02329834|580024918|FG000|Overall Study|Physician Decision|1|||
160629456|NCT02329834|580024919|FG001|Overall Study|Physician Decision|0|||
160629457|NCT00578448|580024922|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
160629458|NCT00578448|580024922|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
160629459|NCT00578448|580024922|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
160629460|NCT00578448|580024922|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
160629461|NCT01976104|580024923|FG000|Overall Study|Adverse Event|0|||
160629462|NCT01976104|580024924|FG001|Overall Study|Adverse Event|0|||
160629463|NCT01976104|580024925|FG002|Overall Study|Adverse Event|1|||
160629464|NCT01976104|580024926|FG003|Overall Study|Adverse Event|0|||
160629465|NCT01976104|580024923|FG000|Overall Study|Lost to Follow-up|3|||
160629466|NCT01976104|580024924|FG001|Overall Study|Lost to Follow-up|0|||
160629467|NCT01976104|580024925|FG002|Overall Study|Lost to Follow-up|1|||
160629468|NCT01976104|580024926|FG003|Overall Study|Lost to Follow-up|1|||
160629469|NCT01976104|580024923|FG000|Overall Study|Subject Choice|0|||
160629470|NCT01976104|580024924|FG001|Overall Study|Subject Choice|1|||
160629471|NCT01976104|580024925|FG002|Overall Study|Subject Choice|0|||
160629472|NCT01976104|580024926|FG003|Overall Study|Subject Choice|1|||
160629473|NCT01976104|580024923|FG000|Overall Study|Withdrawal by Subject|3|||
160629474|NCT01976104|580024924|FG001|Overall Study|Withdrawal by Subject|0|||
160629475|NCT01976104|580024925|FG002|Overall Study|Withdrawal by Subject|0|||
160629476|NCT01976104|580024926|FG003|Overall Study|Withdrawal by Subject|1|||
160629477|NCT01976104|580024923|FG000|Overall Study|Other|0|||
160629478|NCT01976104|580024924|FG001|Overall Study|Other|1|||
160629479|NCT01976104|580024925|FG002|Overall Study|Other|0|||
160629480|NCT01976104|580024926|FG003|Overall Study|Other|0|||
160629481|NCT01301625|580024933|FG000|Overall Study|Death|5|||
160629482|NCT01301625|580024933|FG000|Overall Study|Not Due|21|||
160629483|NCT01301625|580024933|FG000|Overall Study|Expected|8|||
160629484|NCT01301625|580024933|FG000|Overall Study|Lost to Follow-up|1|||
160629485|NCT02181673|580024939|FG000|Up to Week 24|Adverse Event|2|||
160629486|NCT02181673|580024940|FG001|Up to Week 24|Adverse Event|0|||
160629487|NCT02181673|580024941|FG002|Up to Week 24|Adverse Event|3|||
160629488|NCT02181673|580024939|FG000|Up to Week 24|Death|1|||
160629489|NCT02181673|580024940|FG001|Up to Week 24|Death|0|||
160629490|NCT02181673|580024941|FG002|Up to Week 24|Death|0|||
160629491|NCT02181673|580024939|FG000|Up to Week 24|Lack of Efficacy|1|||
160673086|NCT01410227|580182170|FG000|Overall Study|Adverse Event|1|||
160673087|NCT01410227|580182171|FG001|Overall Study|Adverse Event|0|||
160673088|NCT01410227|580182172|FG002|Overall Study|Adverse Event|0|||
160673089|NCT01410227|580182173|FG003|Overall Study|Adverse Event|0|||
160673090|NCT01410227|580182170|FG000|Overall Study|Withdrawal by Subject|3|||
160673091|NCT01410227|580182171|FG001|Overall Study|Withdrawal by Subject|0|||
160673092|NCT01410227|580182172|FG002|Overall Study|Withdrawal by Subject|1|||
160673093|NCT01410227|580182173|FG003|Overall Study|Withdrawal by Subject|0|||
160673094|NCT01410227|580182170|FG000|Overall Study|Pregnancy|0|||
160673095|NCT01410227|580182171|FG001|Overall Study|Pregnancy|0|||
160673096|NCT01410227|580182172|FG002|Overall Study|Pregnancy|0|||
160673097|NCT01410227|580182173|FG003|Overall Study|Pregnancy|1|||
160673098|NCT01410227|580182170|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
160673099|NCT01410227|580182171|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
160673100|NCT01410227|580182172|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
160673101|NCT01410227|580182173|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
160673102|NCT00731939|580182181|FG000|Overall Study|Adverse Event|6|||
160673103|NCT00731939|580182181|FG000|Overall Study|Lost to Follow-up|15|||
160673104|NCT00731939|580182181|FG000|Overall Study|Not implanted with study device|9|||
160629492|NCT02181673|580024940|FG001|Up to Week 24|Lack of Efficacy|0|||
160629493|NCT02181673|580024941|FG002|Up to Week 24|Lack of Efficacy|0|||
160629494|NCT02181673|580024939|FG000|Up to Week 24|Lost to Follow-up|1|||
160629495|NCT02181673|580024940|FG001|Up to Week 24|Lost to Follow-up|0|||
160629496|NCT02181673|580024941|FG002|Up to Week 24|Lost to Follow-up|0|||
160629497|NCT02181673|580024939|FG000|Up to Week 24|Physician Decision|0|||
160673105|NCT00731939|580182181|FG000|Overall Study|Withdrawal by Subject|2|||
160673106|NCT00731939|580182181|FG000|Overall Study|Did not meet enrollment criteria|2|||
160629498|NCT02181673|580024940|FG001|Up to Week 24|Physician Decision|0|||
160673107|NCT02280863|580182182|FG000|Integrated Platform|Met stopping criteria|0|||
160629499|NCT02181673|580024941|FG002|Up to Week 24|Physician Decision|3|||
160629500|NCT02181673|580024939|FG000|Up to Week 24|Withdrawal by Subject|10|||
160673108|NCT02280863|580182183|FG001|Integrated Platform|Met stopping criteria|1|||
160673109|NCT02622386|580182186|FG000|First Assignment|Withdrawal by Subject|3|||
160673110|NCT02622386|580182187|FG001|First Assignment|Withdrawal by Subject|2|||
160673111|NCT02622386|580182186|FG000|Washout|Withdrawal by Subject|4|||
160629501|NCT02181673|580024940|FG001|Up to Week 24|Withdrawal by Subject|0|||
160629502|NCT02181673|580024941|FG002|Up to Week 24|Withdrawal by Subject|1|||
160629503|NCT02181673|580024939|FG000|Up to Week 24|Other|2|||
160629504|NCT02181673|580024940|FG001|Up to Week 24|Other|0|||
160673112|NCT02622386|580182187|FG001|Washout|Withdrawal by Subject|4|||
160629505|NCT02181673|580024941|FG002|Up to Week 24|Other|3|||
160629506|NCT02181673|580024939|FG000|Up to Week 24|Randomized not Treated|0|||
160629507|NCT02181673|580024940|FG001|Up to Week 24|Randomized not Treated|0|||
160629508|NCT02181673|580024941|FG002|Up to Week 24|Randomized not Treated|1|||
160629509|NCT02181673|580024939|FG000|Week 24-Week 60|Adverse Event|0|||
160629510|NCT02181673|580024940|FG001|Week 24-Week 60|Adverse Event|4|||
160629511|NCT02181673|580024941|FG002|Week 24-Week 60|Adverse Event|10|||
160629512|NCT02181673|580024939|FG000|Week 24-Week 60|Other|0|||
160629513|NCT02181673|580024940|FG001|Week 24-Week 60|Other|2|||
160629514|NCT02181673|580024941|FG002|Week 24-Week 60|Other|1|||
160629515|NCT02181673|580024939|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
160629516|NCT02181673|580024940|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
160629517|NCT02181673|580024941|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
160629518|NCT02181673|580024939|FG000|Week 24-Week 60|Pregnancy|0|||
160629519|NCT02181673|580024940|FG001|Week 24-Week 60|Pregnancy|0|||
160629520|NCT02181673|580024941|FG002|Week 24-Week 60|Pregnancy|1|||
160629521|NCT02181673|580024939|FG000|Week 24-Week 60|Lack of Efficacy|0|||
160629522|NCT02181673|580024940|FG001|Week 24-Week 60|Lack of Efficacy|0|||
160629523|NCT02181673|580024941|FG002|Week 24-Week 60|Lack of Efficacy|1|||
160629524|NCT02181673|580024939|FG000|Week 24-Week 60|Lost to Follow-up|0|||
160629525|NCT02181673|580024940|FG001|Week 24-Week 60|Lost to Follow-up|0|||
160629526|NCT02181673|580024941|FG002|Week 24-Week 60|Lost to Follow-up|1|||
160629527|NCT02181673|580024939|FG000|Week 24-Week 60|Physician Decision|0|||
160629528|NCT02181673|580024940|FG001|Week 24-Week 60|Physician Decision|0|||
160629529|NCT02181673|580024941|FG002|Week 24-Week 60|Physician Decision|1|||
160629530|NCT00433771|580024942|FG000|Overall Study|screen fail|14|||
160629531|NCT00433771|580024942|FG000|Overall Study|Treated and later found to be ineligible|2|||
160629532|NCT00433771|580024942|FG000|Overall Study|Death|2|||
160629533|NCT00433771|580024942|FG000|Overall Study|Failure to deploy stent|1|||
160629534|NCT00138658|580024943|FG000|Overall Study|Adverse Event|23|||
160629535|NCT00138658|580024943|FG000|Overall Study|Death|1|||
160629536|NCT00138658|580024943|FG000|Overall Study|Disease Progression|21|||
160629537|NCT00138658|580024943|FG000|Overall Study|Physician Decision|11|||
160629538|NCT00138658|580024943|FG000|Overall Study|Withdrawal by Subject|5|||
160629539|NCT00320801|580024948|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
160629540|NCT00320801|580024949|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
160629541|NCT00320801|580024950|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
160629542|NCT00320801|580024951|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
160629543|NCT00320801|580024948|FG000|Open-label Run-in Period|Adverse Event|33|||
160629544|NCT00320801|580024949|FG001|Open-label Run-in Period|Adverse Event|0|||
160629545|NCT00320801|580024950|FG002|Open-label Run-in Period|Adverse Event|0|||
160629546|NCT00320801|580024951|FG003|Open-label Run-in Period|Adverse Event|0|||
160629547|NCT00320801|580024948|FG000|Open-label Run-in Period|Administrative|10|||
160629548|NCT00320801|580024949|FG001|Open-label Run-in Period|Administrative|0|||
160629549|NCT00320801|580024950|FG002|Open-label Run-in Period|Administrative|0|||
160629550|NCT00320801|580024951|FG003|Open-label Run-in Period|Administrative|0|||
160629551|NCT00320801|580024948|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
160629552|NCT00320801|580024949|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
160629553|NCT00320801|580024950|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
160629554|NCT00320801|580024951|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
160629555|NCT00320801|580024948|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
160629556|NCT00320801|580024949|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
160629557|NCT00320801|580024950|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
160629558|NCT00320801|580024951|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
160629559|NCT00320801|580024948|FG000|Open-label Run-in Period|Did not qualify|1|||
160629560|NCT00320801|580024949|FG001|Open-label Run-in Period|Did not qualify|0|||
160629561|NCT00320801|580024950|FG002|Open-label Run-in Period|Did not qualify|0|||
160629562|NCT00320801|580024951|FG003|Open-label Run-in Period|Did not qualify|0|||
160629563|NCT00320801|580024948|FG000|Double-blind Phase|Withdrawal by Subject|0|||
160629564|NCT00320801|580024949|FG001|Double-blind Phase|Withdrawal by Subject|0|||
160629565|NCT00320801|580024950|FG002|Double-blind Phase|Withdrawal by Subject|1|||
160629566|NCT00320801|580024951|FG003|Double-blind Phase|Withdrawal by Subject|0|||
160629567|NCT00320801|580024948|FG000|Double-blind Phase|Adverse Event|0|||
160629568|NCT00320801|580024949|FG001|Double-blind Phase|Adverse Event|2|||
160629569|NCT00320801|580024950|FG002|Double-blind Phase|Adverse Event|8|||
160629570|NCT00320801|580024951|FG003|Double-blind Phase|Adverse Event|0|||
160629571|NCT00320801|580024948|FG000|Double-blind Phase|Administrative|0|||
160629572|NCT00320801|580024949|FG001|Double-blind Phase|Administrative|0|||
160629573|NCT00320801|580024950|FG002|Double-blind Phase|Administrative|4|||
160629574|NCT00320801|580024951|FG003|Double-blind Phase|Administrative|0|||
160629575|NCT00320801|580024948|FG000|Double-blind Phase|Lack of Efficacy|0|||
160629576|NCT00320801|580024949|FG001|Double-blind Phase|Lack of Efficacy|9|||
160629577|NCT00320801|580024950|FG002|Double-blind Phase|Lack of Efficacy|1|||
160629578|NCT00320801|580024951|FG003|Double-blind Phase|Lack of Efficacy|0|||
160629579|NCT00320801|580024948|FG000|Extension Phase|Withdrawal by Subject|0|||
160629580|NCT00320801|580024949|FG001|Extension Phase|Withdrawal by Subject|0|||
160629581|NCT00320801|580024950|FG002|Extension Phase|Withdrawal by Subject|0|||
160629582|NCT00320801|580024951|FG003|Extension Phase|Withdrawal by Subject|6|||
160629583|NCT00320801|580024948|FG000|Extension Phase|Adverse Event|0|||
160629584|NCT00320801|580024949|FG001|Extension Phase|Adverse Event|0|||
160629585|NCT00320801|580024950|FG002|Extension Phase|Adverse Event|0|||
160629586|NCT00320801|580024951|FG003|Extension Phase|Adverse Event|8|||
160629587|NCT00320801|580024948|FG000|Extension Phase|Administrative|0|||
160629588|NCT00320801|580024949|FG001|Extension Phase|Administrative|0|||
160629589|NCT00320801|580024950|FG002|Extension Phase|Administrative|0|||
160629590|NCT00320801|580024951|FG003|Extension Phase|Administrative|29|||
160629591|NCT00320801|580024948|FG000|Extension Phase|Lack of Efficacy|0|||
160629592|NCT00320801|580024949|FG001|Extension Phase|Lack of Efficacy|0|||
160629593|NCT00320801|580024950|FG002|Extension Phase|Lack of Efficacy|0|||
160629594|NCT00320801|580024951|FG003|Extension Phase|Lack of Efficacy|2|||
160629595|NCT00320801|580024948|FG000|Extension Phase|Lost to Follow-up|0|||
160629596|NCT00320801|580024949|FG001|Extension Phase|Lost to Follow-up|0|||
160629597|NCT00320801|580024950|FG002|Extension Phase|Lost to Follow-up|0|||
160629598|NCT00320801|580024951|FG003|Extension Phase|Lost to Follow-up|3|||
160629599|NCT00337727|580024952|FG000|Overall Study|Adverse Event|5|||
160629600|NCT00337727|580024953|FG001|Overall Study|Adverse Event|3|||
160629601|NCT00337727|580024952|FG000|Overall Study|Lost to Follow-up|5|||
160629602|NCT00337727|580024953|FG001|Overall Study|Lost to Follow-up|4|||
160629603|NCT00337727|580024952|FG000|Overall Study|Physician Decision|1|||
160629604|NCT00337727|580024953|FG001|Overall Study|Physician Decision|0|||
160629605|NCT00337727|580024952|FG000|Overall Study|Protocol Violation|4|||
160629606|NCT00337727|580024953|FG001|Overall Study|Protocol Violation|0|||
160629607|NCT00337727|580024952|FG000|Overall Study|Withdrawal by Subject|3|||
160629608|NCT00337727|580024953|FG001|Overall Study|Withdrawal by Subject|5|||
160629609|NCT00491322|580024955|FG000|Overall Study|Protocol Violation|1|||
160629610|NCT00491322|580024956|FG001|Overall Study|Protocol Violation|0|||
160629611|NCT00491322|580024955|FG000|Overall Study|Pregnancy|0|||
160629612|NCT00491322|580024956|FG001|Overall Study|Pregnancy|1|||
160629613|NCT06067191|580024959|FG000|Overall Study|Withdrawal by Subject|0|||
160629614|NCT06067191|580024960|FG001|Overall Study|Withdrawal by Subject|1|||
160629615|NCT00807040|580024964|FG000|Overall Study|Death|24|||
160629616|NCT00807040|580024965|FG001|Overall Study|Death|29|||
160629617|NCT00807040|580024964|FG000|Overall Study|Withdrawal by Subject|8|||
160629618|NCT00807040|580024965|FG001|Overall Study|Withdrawal by Subject|6|||
160629619|NCT00807040|580024964|FG000|Overall Study|Lost to Follow-up|4|||
160629620|NCT00807040|580024965|FG001|Overall Study|Lost to Follow-up|6|||
160629621|NCT01067339|580024966|FG000|Overall Study|Withdrawal by Subject|6|||
160629622|NCT01067339|580024967|FG001|Overall Study|Withdrawal by Subject|5|||
160629623|NCT00572910|580024969|FG000|Overall Study|Adverse Event|1|||
160629624|NCT00572910|580024970|FG001|Overall Study|Adverse Event|2|||
160629625|NCT00572910|580024971|FG002|Overall Study|Adverse Event|0|||
160629626|NCT00572910|580024972|FG003|Overall Study|Adverse Event|2|||
160629627|NCT00572910|580024973|FG004|Overall Study|Adverse Event|0|||
160629628|NCT00572910|580024974|FG005|Overall Study|Adverse Event|0|||
160629629|NCT00572910|580024975|FG006|Overall Study|Adverse Event|4|||
160629630|NCT00572910|580024976|FG007|Overall Study|Adverse Event|2|||
160629631|NCT00572910|580024977|FG008|Overall Study|Adverse Event|1|||
160629632|NCT00572910|580024978|FG009|Overall Study|Adverse Event|3|||
160629633|NCT00572910|580024979|FG010|Overall Study|Adverse Event|2|||
160629634|NCT00572910|580024969|FG000|Overall Study|Lost to Follow-up|0|||
160629635|NCT00572910|580024970|FG001|Overall Study|Lost to Follow-up|1|||
160629636|NCT00572910|580024971|FG002|Overall Study|Lost to Follow-up|1|||
160629637|NCT00572910|580024972|FG003|Overall Study|Lost to Follow-up|2|||
160629638|NCT00572910|580024973|FG004|Overall Study|Lost to Follow-up|1|||
160629639|NCT00572910|580024974|FG005|Overall Study|Lost to Follow-up|0|||
160629640|NCT00572910|580024975|FG006|Overall Study|Lost to Follow-up|0|||
160629641|NCT00572910|580024976|FG007|Overall Study|Lost to Follow-up|0|||
160629642|NCT00572910|580024977|FG008|Overall Study|Lost to Follow-up|0|||
160629643|NCT00572910|580024978|FG009|Overall Study|Lost to Follow-up|1|||
160629644|NCT00572910|580024979|FG010|Overall Study|Lost to Follow-up|0|||
160629645|NCT00572910|580024969|FG000|Overall Study|Withdrawal by Subject|3|||
160629646|NCT00572910|580024970|FG001|Overall Study|Withdrawal by Subject|0|||
160629647|NCT00572910|580024971|FG002|Overall Study|Withdrawal by Subject|1|||
160629648|NCT00572910|580024972|FG003|Overall Study|Withdrawal by Subject|0|||
160629649|NCT00572910|580024973|FG004|Overall Study|Withdrawal by Subject|1|||
160629650|NCT00572910|580024974|FG005|Overall Study|Withdrawal by Subject|3|||
160629651|NCT00572910|580024975|FG006|Overall Study|Withdrawal by Subject|0|||
160629652|NCT00572910|580024976|FG007|Overall Study|Withdrawal by Subject|2|||
160629653|NCT00572910|580024977|FG008|Overall Study|Withdrawal by Subject|2|||
160629654|NCT00572910|580024978|FG009|Overall Study|Withdrawal by Subject|2|||
160629655|NCT00572910|580024979|FG010|Overall Study|Withdrawal by Subject|1|||
160629656|NCT00806416|580024983|FG000|Period 1 - Part I|Adverse Event|0|||
160629657|NCT00806416|580024984|FG001|Period 1 - Part I|Adverse Event|1|||
160629658|NCT00806416|580024985|FG002|Period 1 - Part I|Adverse Event|0|||
160629659|NCT00806416|580024986|FG003|Period 1 - Part I|Adverse Event|0|||
160629660|NCT00806416|580024983|FG000|Period 1 - Part I|Lost to Follow-up|0|||
160629661|NCT00806416|580024984|FG001|Period 1 - Part I|Lost to Follow-up|2|||
160629662|NCT00806416|580024985|FG002|Period 1 - Part I|Lost to Follow-up|0|||
160629663|NCT00806416|580024986|FG003|Period 1 - Part I|Lost to Follow-up|0|||
160629664|NCT00806416|580024983|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
160629665|NCT00806416|580024984|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
160629666|NCT00806416|580024985|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
160629667|NCT00806416|580024986|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
160629668|NCT00806416|580024983|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
160629669|NCT00806416|580024984|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
160629670|NCT00806416|580024985|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
160629671|NCT00806416|580024986|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
160629672|NCT05275673|580024992|FG000|Overall Study|Study Termination by Sponsor|2|||
160629673|NCT05275673|580024993|FG001|Overall Study|Study Termination by Sponsor|3|||
160629674|NCT05275673|580024992|FG000|Overall Study|Death|1|||
160629675|NCT05275673|580024993|FG001|Overall Study|Death|0|||
160629676|NCT05275673|580024992|FG000|Overall Study|Withdrawal by Subject|1|||
160629677|NCT05275673|580024993|FG001|Overall Study|Withdrawal by Subject|0|||
160629678|NCT03426995|580024994|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629679|NCT03426995|580024995|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629680|NCT03426995|580024996|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
160629681|NCT03426995|580024997|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629682|NCT03426995|580024998|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629683|NCT03426995|580024999|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629684|NCT03426995|580025000|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629685|NCT03426995|580025001|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629686|NCT03426995|580025002|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629687|NCT03426995|580025003|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629688|NCT03426995|580025004|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629689|NCT03426995|580025005|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629690|NCT03426995|580025006|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629691|NCT03426995|580025007|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629692|NCT03426995|580025008|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629693|NCT03426995|580025009|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629694|NCT03426995|580025010|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629695|NCT03426995|580025011|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629696|NCT03426995|580025012|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
160629697|NCT03426995|580024994|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629698|NCT03426995|580024995|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629699|NCT03426995|580024996|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629700|NCT03426995|580024997|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629701|NCT03426995|580024998|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629702|NCT03426995|580024999|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
160629703|NCT03426995|580025000|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629704|NCT03426995|580025001|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629705|NCT03426995|580025002|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629706|NCT03426995|580025003|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629707|NCT03426995|580025004|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629708|NCT03426995|580025005|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629709|NCT03426995|580025006|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629710|NCT03426995|580025007|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629711|NCT03426995|580025008|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629712|NCT03426995|580025009|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629713|NCT03426995|580025010|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629714|NCT03426995|580025011|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629715|NCT03426995|580025012|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
160629716|NCT03426995|580024994|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629717|NCT03426995|580024995|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629718|NCT03426995|580024996|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629719|NCT03426995|580024997|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629720|NCT03426995|580024998|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
160629721|NCT03426995|580024999|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
160629722|NCT03426995|580025000|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629723|NCT03426995|580025001|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629724|NCT03426995|580025002|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629725|NCT03426995|580025003|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629726|NCT03426995|580025004|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629727|NCT03426995|580025005|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160673113|NCT02622386|580182186|FG000|Second Assignment|Withdrawal by Subject|0|||
160673114|NCT02622386|580182187|FG001|Second Assignment|Withdrawal by Subject|2|||
160673115|NCT00985439|580182188|FG000|Overall Study|Adverse Event|0|||
160673116|NCT00985439|580182189|FG001|Overall Study|Adverse Event|0|||
160673117|NCT00985439|580182190|FG002|Overall Study|Adverse Event|1|||
160673118|NCT00985439|580182191|FG003|Overall Study|Adverse Event|0|||
160673119|NCT01174186|580182192|FG000|Overall Study|Lost to Follow-up|0|||
160673120|NCT01174186|580182193|FG001|Overall Study|Lost to Follow-up|1|||
160673121|NCT01174186|580182192|FG000|Overall Study|Withdrawal by Subject|0|||
160673122|NCT01174186|580182193|FG001|Overall Study|Withdrawal by Subject|2|||
160673123|NCT05274763|580182194|FG000|Overall Study|Lost to Follow-up|1|||
160673124|NCT00484679|580182195|FG000|Overall Study|Withdrawal by Subject|3|||
160673125|NCT00402103|580182196|FG000|Overall Study|Adverse Event|60|||
160673126|NCT00402103|580182197|FG001|Overall Study|Adverse Event|7|||
160673127|NCT00402103|580182196|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160673128|NCT00402103|580182197|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160673129|NCT00402103|580182196|FG000|Overall Study|Condition no longer requires study drug|2|||
160673130|NCT00402103|580182197|FG001|Overall Study|Condition no longer requires study drug|0|||
160673131|NCT00402103|580182196|FG000|Overall Study|Protocol Deviation|8|||
160673132|NCT00402103|580182197|FG001|Overall Study|Protocol Deviation|0|||
160673133|NCT00402103|580182196|FG000|Overall Study|Patient withdrew consent|12|||
160673134|NCT00402103|580182197|FG001|Overall Study|Patient withdrew consent|1|||
160673135|NCT00402103|580182196|FG000|Overall Study|Lost to Follow-up|6|||
160673136|NCT00402103|580182197|FG001|Overall Study|Lost to Follow-up|3|||
160673137|NCT00402103|580182196|FG000|Overall Study|Administrative problems|2|||
160673138|NCT00402103|580182197|FG001|Overall Study|Administrative problems|0|||
160673139|NCT00418145|580182200|FG000|Overall Study|study terminated|6|||
160673140|NCT00472212|580182201|FG000|Overall Study|Lost to Follow-up|6|||
160673141|NCT00472212|580182202|FG001|Overall Study|Lost to Follow-up|4|||
160673142|NCT00425308|580182203|FG000|Overall Study|Adverse Event|2|||
160673143|NCT00425308|580182204|FG001|Overall Study|Adverse Event|1|||
160673144|NCT00425308|580182203|FG000|Overall Study|Withdrawal by Subject|1|||
160673145|NCT00425308|580182204|FG001|Overall Study|Withdrawal by Subject|0|||
160673146|NCT00425308|580182203|FG000|Overall Study|Death|1|||
160673147|NCT00425308|580182204|FG001|Overall Study|Death|0|||
160673148|NCT01075282|580182205|FG000|Overall Study|Withdrawal by Subject|11|||
160673149|NCT01075282|580182206|FG001|Overall Study|Withdrawal by Subject|7|||
160673150|NCT01075282|580182207|FG002|Overall Study|Withdrawal by Subject|11|||
160673151|NCT01075282|580182205|FG000|Overall Study|Adverse Event|9|||
160673152|NCT01075282|580182206|FG001|Overall Study|Adverse Event|8|||
160673153|NCT01075282|580182207|FG002|Overall Study|Adverse Event|5|||
160673154|NCT01075282|580182205|FG000|Overall Study|Entry Criteria Not Met|3|||
160673155|NCT01075282|580182206|FG001|Overall Study|Entry Criteria Not Met|2|||
160673156|NCT01075282|580182207|FG002|Overall Study|Entry Criteria Not Met|0|||
160673157|NCT01075282|580182205|FG000|Overall Study|Lost to Follow-up|3|||
160673158|NCT01075282|580182206|FG001|Overall Study|Lost to Follow-up|3|||
160673159|NCT01075282|580182207|FG002|Overall Study|Lost to Follow-up|3|||
160673160|NCT01075282|580182205|FG000|Overall Study|Physician Decision|3|||
160673161|NCT01075282|580182206|FG001|Overall Study|Physician Decision|3|||
160673162|NCT01075282|580182207|FG002|Overall Study|Physician Decision|3|||
160673163|NCT01075282|580182205|FG000|Overall Study|Lack of Efficacy|1|||
160673164|NCT01075282|580182206|FG001|Overall Study|Lack of Efficacy|1|||
160673165|NCT01075282|580182207|FG002|Overall Study|Lack of Efficacy|0|||
160673166|NCT01075282|580182205|FG000|Overall Study|Treatment Non-compliance|1|||
160673167|NCT01075282|580182206|FG001|Overall Study|Treatment Non-compliance|2|||
160629728|NCT03426995|580025006|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629729|NCT03426995|580025007|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629730|NCT03426995|580025008|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629731|NCT03426995|580025009|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629732|NCT03426995|580025010|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629733|NCT03426995|580025011|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629734|NCT03426995|580025012|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
160629735|NCT03426995|580024994|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160673168|NCT01075282|580182207|FG002|Overall Study|Treatment Non-compliance|2|||
160673169|NCT01075282|580182205|FG000|Overall Study|Protocol Violation|0|||
160673170|NCT01075282|580182206|FG001|Overall Study|Protocol Violation|2|||
160673171|NCT01075282|580182207|FG002|Overall Study|Protocol Violation|1|||
160673172|NCT01075282|580182205|FG000|Overall Study|Death|0|||
160673173|NCT01075282|580182206|FG001|Overall Study|Death|1|||
160629736|NCT03426995|580024995|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160673174|NCT01075282|580182207|FG002|Overall Study|Death|2|||
160673175|NCT00367133|580182208|FG000|2 Years|Death|20|||
160673176|NCT00367133|580182209|FG001|2 Years|Death|12|||
160673177|NCT00367133|580182210|FG002|2 Years|Death|12|||
160673178|NCT00367133|580182208|FG000|2 Years|Dropped|34|||
160673179|NCT00367133|580182209|FG001|2 Years|Dropped|19|||
160673180|NCT00367133|580182210|FG002|2 Years|Dropped|33|||
160673181|NCT00367133|580182208|FG000|2 Years|Missed visit|4|||
160673182|NCT00367133|580182209|FG001|2 Years|Missed visit|5|||
160629737|NCT03426995|580024996|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629738|NCT03426995|580024997|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629739|NCT03426995|580024998|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629740|NCT03426995|580024999|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160673183|NCT00367133|580182210|FG002|2 Years|Missed visit|4|||
160673184|NCT00847535|580182211|FG000|Overall Study|Withdrawal by Subject|2|||
160673185|NCT00847535|580182212|FG001|Overall Study|Withdrawal by Subject|1|||
160673186|NCT00847535|580182213|FG002|Overall Study|Withdrawal by Subject|1|||
160673187|NCT00847535|580182211|FG000|Overall Study|Lost to Follow-up|0|||
160673188|NCT00847535|580182212|FG001|Overall Study|Lost to Follow-up|1|||
160673189|NCT00847535|580182213|FG002|Overall Study|Lost to Follow-up|0|||
160673190|NCT01252953|580182214|FG000|Overall Study|Withdrawal by Subject|16|||
160673191|NCT01252953|580182215|FG001|Overall Study|Withdrawal by Subject|17|||
160673192|NCT01252953|580182214|FG000|Overall Study|Lost to Follow-up|22|||
160673193|NCT01252953|580182215|FG001|Overall Study|Lost to Follow-up|21|||
160673194|NCT00906399|580182218|FG000|Year 1|Randomized But Not Treated|0|||
160673195|NCT00906399|580182219|FG001|Year 1|Randomized But Not Treated|1|||
160673196|NCT00906399|580182220|FG002|Year 1|Randomized But Not Treated|3|||
160673197|NCT00906399|580182221|FG003|Year 1|Randomized But Not Treated|0|||
160673198|NCT00906399|580182222|FG004|Year 1|Randomized But Not Treated|0|||
160673199|NCT00906399|580182223|FG005|Year 1|Randomized But Not Treated|0|||
160673200|NCT00906399|580182224|FG006|Year 1|Randomized But Not Treated|0|||
160673201|NCT00906399|580182218|FG000|Year 1|Adverse Event|4|||
160673202|NCT00906399|580182219|FG001|Year 1|Adverse Event|22|||
160673203|NCT00906399|580182220|FG002|Year 1|Adverse Event|24|||
160673204|NCT00906399|580182221|FG003|Year 1|Adverse Event|0|||
160673205|NCT00906399|580182222|FG004|Year 1|Adverse Event|0|||
160673206|NCT00906399|580182223|FG005|Year 1|Adverse Event|0|||
160673207|NCT00906399|580182224|FG006|Year 1|Adverse Event|0|||
160629741|NCT03426995|580025000|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629742|NCT03426995|580025001|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629743|NCT03426995|580025002|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629744|NCT03426995|580025003|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629745|NCT03426995|580025004|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
160629746|NCT03426995|580025005|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629747|NCT03426995|580025006|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629748|NCT03426995|580025007|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629749|NCT03426995|580025008|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629750|NCT03426995|580025009|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629751|NCT03426995|580025010|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629752|NCT03426995|580025011|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629753|NCT03426995|580025012|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
160629754|NCT03426995|580024994|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629755|NCT03426995|580024995|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629756|NCT03426995|580024996|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629757|NCT03426995|580024997|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629758|NCT03426995|580024998|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629759|NCT03426995|580024999|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629760|NCT03426995|580025000|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629761|NCT03426995|580025001|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
160629762|NCT03426995|580025002|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629763|NCT03426995|580025003|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629764|NCT03426995|580025004|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629765|NCT03426995|580025005|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629766|NCT03426995|580025006|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629767|NCT03426995|580025007|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629768|NCT03426995|580025008|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629769|NCT03426995|580025009|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629770|NCT03426995|580025010|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629771|NCT03426995|580025011|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629772|NCT03426995|580025012|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
160629773|NCT03426995|580024994|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629774|NCT03426995|580024995|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160673208|NCT00906399|580182218|FG000|Year 1|Lost to Follow-up|4|||
160673209|NCT00906399|580182219|FG001|Year 1|Lost to Follow-up|4|||
160673210|NCT00906399|580182220|FG002|Year 1|Lost to Follow-up|2|||
160673211|NCT00906399|580182221|FG003|Year 1|Lost to Follow-up|0|||
160673212|NCT00906399|580182222|FG004|Year 1|Lost to Follow-up|0|||
160673213|NCT00906399|580182223|FG005|Year 1|Lost to Follow-up|0|||
160673214|NCT00906399|580182224|FG006|Year 1|Lost to Follow-up|0|||
160673215|NCT00906399|580182218|FG000|Year 1|Withdrawal by Subject|30|||
160673216|NCT00906399|580182219|FG001|Year 1|Withdrawal by Subject|32|||
160673217|NCT00906399|580182220|FG002|Year 1|Withdrawal by Subject|36|||
160673218|NCT00906399|580182221|FG003|Year 1|Withdrawal by Subject|0|||
160673219|NCT00906399|580182222|FG004|Year 1|Withdrawal by Subject|0|||
160673220|NCT00906399|580182223|FG005|Year 1|Withdrawal by Subject|0|||
160673221|NCT00906399|580182224|FG006|Year 1|Withdrawal by Subject|0|||
160673222|NCT00906399|580182218|FG000|Year 1|Physician Decision|0|||
160673223|NCT00906399|580182219|FG001|Year 1|Physician Decision|1|||
160673224|NCT00906399|580182220|FG002|Year 1|Physician Decision|3|||
160673225|NCT00906399|580182221|FG003|Year 1|Physician Decision|0|||
160673226|NCT00906399|580182222|FG004|Year 1|Physician Decision|0|||
160673227|NCT00906399|580182223|FG005|Year 1|Physician Decision|0|||
160673228|NCT00906399|580182224|FG006|Year 1|Physician Decision|0|||
160673229|NCT00906399|580182218|FG000|Year 1|Death|2|||
160673230|NCT00906399|580182219|FG001|Year 1|Death|1|||
160673231|NCT00906399|580182220|FG002|Year 1|Death|1|||
160673232|NCT00906399|580182221|FG003|Year 1|Death|0|||
160673233|NCT00906399|580182222|FG004|Year 1|Death|0|||
160673234|NCT00906399|580182223|FG005|Year 1|Death|0|||
160673235|NCT00906399|580182224|FG006|Year 1|Death|0|||
160673236|NCT00906399|580182218|FG000|Year 1|Other|4|||
160673237|NCT00906399|580182219|FG001|Year 1|Other|2|||
160673238|NCT00906399|580182220|FG002|Year 1|Other|7|||
160673239|NCT00906399|580182221|FG003|Year 1|Other|0|||
160673240|NCT00906399|580182222|FG004|Year 1|Other|0|||
160673241|NCT00906399|580182223|FG005|Year 1|Other|0|||
160673242|NCT00906399|580182224|FG006|Year 1|Other|0|||
160673243|NCT00906399|580182218|FG000|Year 2|Adverse Event|0|||
160673244|NCT00906399|580182219|FG001|Year 2|Adverse Event|0|||
160673245|NCT00906399|580182220|FG002|Year 2|Adverse Event|0|||
160673246|NCT00906399|580182221|FG003|Year 2|Adverse Event|9|||
160673247|NCT00906399|580182222|FG004|Year 2|Adverse Event|8|||
160673248|NCT00906399|580182223|FG005|Year 2|Adverse Event|11|||
160673249|NCT00906399|580182224|FG006|Year 2|Adverse Event|6|||
160673250|NCT00906399|580182218|FG000|Year 2|Lost to Follow-up|0|||
160673251|NCT00906399|580182219|FG001|Year 2|Lost to Follow-up|0|||
160673252|NCT00906399|580182220|FG002|Year 2|Lost to Follow-up|0|||
160673253|NCT00906399|580182221|FG003|Year 2|Lost to Follow-up|1|||
160673254|NCT00906399|580182222|FG004|Year 2|Lost to Follow-up|4|||
160673255|NCT00906399|580182223|FG005|Year 2|Lost to Follow-up|2|||
160673256|NCT00906399|580182224|FG006|Year 2|Lost to Follow-up|4|||
160673257|NCT00906399|580182218|FG000|Year 2|Withdrawal by Subject|0|||
160673258|NCT00906399|580182219|FG001|Year 2|Withdrawal by Subject|0|||
160673259|NCT00906399|580182220|FG002|Year 2|Withdrawal by Subject|0|||
160673260|NCT00906399|580182221|FG003|Year 2|Withdrawal by Subject|17|||
160673261|NCT00906399|580182222|FG004|Year 2|Withdrawal by Subject|18|||
160673262|NCT00906399|580182223|FG005|Year 2|Withdrawal by Subject|27|||
160673263|NCT00906399|580182224|FG006|Year 2|Withdrawal by Subject|13|||
160673264|NCT00906399|580182218|FG000|Year 2|Physician Decision|0|||
160673265|NCT00906399|580182219|FG001|Year 2|Physician Decision|0|||
160673266|NCT00906399|580182220|FG002|Year 2|Physician Decision|0|||
160673267|NCT00906399|580182221|FG003|Year 2|Physician Decision|0|||
160673268|NCT00906399|580182222|FG004|Year 2|Physician Decision|2|||
160673269|NCT00906399|580182223|FG005|Year 2|Physician Decision|6|||
160673270|NCT00906399|580182224|FG006|Year 2|Physician Decision|3|||
160673271|NCT00906399|580182218|FG000|Year 2|Death|0|||
160673272|NCT00906399|580182219|FG001|Year 2|Death|0|||
160673273|NCT00906399|580182220|FG002|Year 2|Death|0|||
160673274|NCT00906399|580182221|FG003|Year 2|Death|1|||
160673275|NCT00906399|580182222|FG004|Year 2|Death|0|||
160673276|NCT00906399|580182223|FG005|Year 2|Death|0|||
160673277|NCT00906399|580182224|FG006|Year 2|Death|3|||
160673278|NCT00906399|580182218|FG000|Year 2|Other|0|||
160673279|NCT00906399|580182219|FG001|Year 2|Other|0|||
160673280|NCT00906399|580182220|FG002|Year 2|Other|0|||
160673281|NCT00906399|580182221|FG003|Year 2|Other|2|||
160673282|NCT00906399|580182222|FG004|Year 2|Other|3|||
160673283|NCT00906399|580182223|FG005|Year 2|Other|1|||
160673284|NCT00906399|580182224|FG006|Year 2|Other|0|||
160673285|NCT00863330|580182229|FG000|Overall Study|study terminated early due to administra|6|||
160673286|NCT05098743|580182230|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
160673287|NCT05098743|580182231|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
160673288|NCT05098743|580182230|FG000|Overall Study|Lost to Follow-up|1|||
160673289|NCT05098743|580182231|FG001|Overall Study|Lost to Follow-up|2|||
160673290|NCT00868998|580182232|FG000|Overall Study|Screen Failure|1|||
160673291|NCT00868998|580182232|FG000|Overall Study|Withdrawal by Subject|1|||
160673292|NCT00868998|580182232|FG000|Overall Study|Progression of disease|2|||
160673293|NCT00868998|580182232|FG000|Overall Study|Death|1|||
160673294|NCT01483820|580182234|FG000|Overall Study|Lack of Efficacy|6|||
160673295|NCT01483820|580182234|FG000|Overall Study|Adverse Event|1|||
160673296|NCT01483820|580182234|FG000|Overall Study|Death|1|||
160673297|NCT00474188|580182238|FG000|Overall Study|Withdrawal by Subject|1|||
160673298|NCT00474188|580182238|FG000|Overall Study|Study discontinued by sponsor|5|||
160673299|NCT03541252|580182239|FG000|Overall Study|Withdrawal by Subject|1|||
160673300|NCT01576705|580182246|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
160673301|NCT01576705|580182247|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
160673302|NCT01576705|580182248|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
160673303|NCT01576705|580182249|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
160673304|NCT01576705|580182246|FG000|Overall Study|invalid ICF|0|||
160629775|NCT03426995|580024996|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629776|NCT03426995|580024997|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629777|NCT03426995|580024998|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629778|NCT03426995|580024999|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629779|NCT03426995|580025000|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629780|NCT03426995|580025001|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629781|NCT03426995|580025002|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629782|NCT03426995|580025003|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629783|NCT03426995|580025004|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629784|NCT03426995|580025005|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629785|NCT03426995|580025006|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629786|NCT03426995|580025007|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629787|NCT03426995|580025008|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
160629788|NCT03426995|580025009|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
160629789|NCT03426995|580025010|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629790|NCT03426995|580025011|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629791|NCT03426995|580025012|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
160629792|NCT03426995|580024994|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629793|NCT03426995|580024995|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629794|NCT03426995|580024996|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629795|NCT03426995|580024997|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629796|NCT03426995|580024998|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629797|NCT03426995|580024999|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629798|NCT03426995|580025000|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629799|NCT03426995|580025001|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629800|NCT03426995|580025002|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629801|NCT03426995|580025003|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629802|NCT03426995|580025004|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629803|NCT03426995|580025005|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629804|NCT03426995|580025006|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629805|NCT03426995|580025007|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629806|NCT03426995|580025008|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
160629807|NCT03426995|580025009|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
160629808|NCT03426995|580025010|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629809|NCT03426995|580025011|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629810|NCT03426995|580025012|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
160629811|NCT00227591|580025013|FG000|Overall Study|Withdrawal by Subject|1|||
160629812|NCT02335411|580025014|FG000|Overall Study|Death|223|||
160629813|NCT02335411|580025015|FG001|Overall Study|Death|22|||
160629814|NCT02335411|580025016|FG002|Overall Study|Death|26|||
160629815|NCT02335411|580025014|FG000|Overall Study|Physician Decision|3|||
160629816|NCT02335411|580025015|FG001|Overall Study|Physician Decision|0|||
160629817|NCT02335411|580025016|FG002|Overall Study|Physician Decision|0|||
160629818|NCT02335411|580025014|FG000|Overall Study|Protocol Violation|1|||
160629819|NCT02335411|580025015|FG001|Overall Study|Protocol Violation|0|||
160629820|NCT02335411|580025016|FG002|Overall Study|Protocol Violation|0|||
160629821|NCT02335411|580025014|FG000|Overall Study|Withdrawal by Subject|11|||
160629822|NCT02335411|580025015|FG001|Overall Study|Withdrawal by Subject|0|||
160629823|NCT02335411|580025016|FG002|Overall Study|Withdrawal by Subject|3|||
160629824|NCT02335411|580025014|FG000|Overall Study|Sponsor Decision|12|||
160629825|NCT02335411|580025015|FG001|Overall Study|Sponsor Decision|3|||
160629826|NCT02335411|580025016|FG002|Overall Study|Sponsor Decision|2|||
160629827|NCT02335411|580025014|FG000|Overall Study|Adverse Event|9|||
160629828|NCT02335411|580025015|FG001|Overall Study|Adverse Event|0|||
160629829|NCT02335411|580025016|FG002|Overall Study|Adverse Event|0|||
160629830|NCT01886105|580025017|FG000|Overall Study|Lack of Efficacy|3|||
160629831|NCT01360021|580025020|FG000|Overall Study|Eligibility criteria + other|2|||
160629832|NCT01360021|580025021|FG001|Overall Study|Eligibility criteria + other|1|||
160629833|NCT01360021|580025022|FG002|Overall Study|Eligibility criteria + other|1|||
160629834|NCT01360021|580025020|FG000|Overall Study|Protocol Violation|0|||
160629835|NCT01360021|580025021|FG001|Overall Study|Protocol Violation|0|||
160629836|NCT01360021|580025022|FG002|Overall Study|Protocol Violation|1|||
160629837|NCT01360021|580025020|FG000|Overall Study|Withdrawal by Subject|4|||
160629838|NCT01360021|580025021|FG001|Overall Study|Withdrawal by Subject|0|||
160629839|NCT01360021|580025022|FG002|Overall Study|Withdrawal by Subject|2|||
160629840|NCT01360021|580025020|FG000|Overall Study|Adverse Event|2|||
160629841|NCT01360021|580025021|FG001|Overall Study|Adverse Event|3|||
160629842|NCT01360021|580025022|FG002|Overall Study|Adverse Event|3|||
160629843|NCT00650806|580025025|FG000|Overall Study|Adverse Event|0|||
160629844|NCT00650806|580025026|FG001|Overall Study|Adverse Event|5|||
160673305|NCT01576705|580182247|FG001|Overall Study|invalid ICF|1|||
160673306|NCT01576705|580182248|FG002|Overall Study|invalid ICF|0|||
160673307|NCT01576705|580182249|FG003|Overall Study|invalid ICF|0|||
160673308|NCT00227370|580182254|FG000|Overall Study|Withdrawal by Subject|1|||
160673309|NCT00227370|580182255|FG001|Overall Study|Withdrawal by Subject|2|||
160673310|NCT00227370|580182254|FG000|Overall Study|Death|3|||
160673311|NCT00227370|580182255|FG001|Overall Study|Death|4|||
160673312|NCT00227370|580182254|FG000|Overall Study|Adverse Event|6|||
160673313|NCT00227370|580182255|FG001|Overall Study|Adverse Event|11|||
160673314|NCT00227370|580182254|FG000|Overall Study|Physician Decision|9|||
160673315|NCT00227370|580182255|FG001|Overall Study|Physician Decision|6|||
160673316|NCT00227370|580182254|FG000|Overall Study|Other reasons|2|||
160673317|NCT00227370|580182255|FG001|Overall Study|Other reasons|1|||
160673318|NCT03846193|580182256|FG000|Overall Study|Physician Decision|0|||
160673319|NCT03846193|580182257|FG001|Overall Study|Physician Decision|0|||
160673320|NCT03846193|580182258|FG002|Overall Study|Physician Decision|1|||
160673321|NCT03846193|580182259|FG003|Overall Study|Physician Decision|0|||
160673322|NCT03846193|580182260|FG004|Overall Study|Physician Decision|0|||
160673323|NCT03846193|580182256|FG000|Overall Study|Lost to Follow-up|0|||
160673324|NCT03846193|580182257|FG001|Overall Study|Lost to Follow-up|0|||
160673325|NCT03846193|580182258|FG002|Overall Study|Lost to Follow-up|0|||
160673326|NCT03846193|580182259|FG003|Overall Study|Lost to Follow-up|0|||
160673327|NCT03846193|580182260|FG004|Overall Study|Lost to Follow-up|1|||
160673328|NCT03846193|580182256|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
160673329|NCT03846193|580182257|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
160629845|NCT00650806|580025027|FG002|Overall Study|Adverse Event|3|||
160673330|NCT03846193|580182258|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
160673331|NCT03846193|580182259|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
160673332|NCT03846193|580182260|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
160673333|NCT03961204|580182262|FG000|Overall Study|Withdrawal by Subject|2|||
160673334|NCT03961204|580182262|FG000|Overall Study|Lost to Follow-up|3|||
160673335|NCT03961204|580182262|FG000|Overall Study|Other|1|||
160673336|NCT03961204|580182262|FG000|Overall Study|Missing|1|||
160673337|NCT02218216|580182263|FG000|Overall Study|Study terminated before completed|6|||
160673338|NCT02218216|580182264|FG001|Overall Study|Study terminated before completed|0|||
160673339|NCT02218216|580182265|FG002|Overall Study|Study terminated before completed|0|||
160673340|NCT02452463|580182268|FG000|Overall Study|Death|1|||
160673341|NCT02452463|580182269|FG001|Overall Study|Death|0|||
160673342|NCT02452463|580182270|FG002|Overall Study|Death|0|||
160673343|NCT02452463|580182268|FG000|Overall Study|Study Suspended|1|||
160673344|NCT02452463|580182269|FG001|Overall Study|Study Suspended|0|||
160673345|NCT02452463|580182270|FG002|Overall Study|Study Suspended|0|||
160673346|NCT02452463|580182268|FG000|Overall Study|Recommended by DSMB|0|||
160629846|NCT00650806|580025028|FG003|Overall Study|Adverse Event|4|||
160629847|NCT00650806|580025025|FG000|Overall Study|Lost to Follow-up|7|||
160629848|NCT00650806|580025026|FG001|Overall Study|Lost to Follow-up|6|||
160629849|NCT00650806|580025027|FG002|Overall Study|Lost to Follow-up|11|||
160629850|NCT00650806|580025028|FG003|Overall Study|Lost to Follow-up|10|||
160629851|NCT00650806|580025025|FG000|Overall Study|Protocol Violation|0|||
160629852|NCT00650806|580025026|FG001|Overall Study|Protocol Violation|0|||
160629853|NCT00650806|580025027|FG002|Overall Study|Protocol Violation|0|||
160629854|NCT00650806|580025028|FG003|Overall Study|Protocol Violation|1|||
160629855|NCT00650806|580025025|FG000|Overall Study|Pregnancy|0|||
160629856|NCT00650806|580025026|FG001|Overall Study|Pregnancy|0|||
160629857|NCT00650806|580025027|FG002|Overall Study|Pregnancy|0|||
160629858|NCT00650806|580025028|FG003|Overall Study|Pregnancy|1|||
160629859|NCT00650806|580025025|FG000|Overall Study|Withdrawal by Subject|7|||
160673347|NCT02452463|580182269|FG001|Overall Study|Recommended by DSMB|1|||
160673348|NCT02452463|580182270|FG002|Overall Study|Recommended by DSMB|0|||
160673349|NCT02452463|580182268|FG000|Overall Study|Withdrawal by Subject|0|||
160673350|NCT02452463|580182269|FG001|Overall Study|Withdrawal by Subject|1|||
160673351|NCT02452463|580182270|FG002|Overall Study|Withdrawal by Subject|0|||
160673352|NCT01131260|580182271|FG000|Overall Study|Randomization error|5|||
160673353|NCT01131260|580182272|FG001|Overall Study|Randomization error|1|||
160673354|NCT01131260|580182271|FG000|Overall Study|Declined to continue participation|8|||
160673355|NCT01131260|580182272|FG001|Overall Study|Declined to continue participation|13|||
160673356|NCT01131260|580182271|FG000|Overall Study|Physician Decision|22|||
160673357|NCT01131260|580182272|FG001|Overall Study|Physician Decision|24|||
160673358|NCT01131260|580182271|FG000|Overall Study|Technical problems|7|||
160629860|NCT00650806|580025026|FG001|Overall Study|Withdrawal by Subject|5|||
160629861|NCT00650806|580025027|FG002|Overall Study|Withdrawal by Subject|8|||
160629862|NCT00650806|580025028|FG003|Overall Study|Withdrawal by Subject|6|||
160629863|NCT00650806|580025025|FG000|Overall Study|Noncompliance with study drug regimen|1|||
160629864|NCT00650806|580025026|FG001|Overall Study|Noncompliance with study drug regimen|1|||
160673359|NCT01131260|580182272|FG001|Overall Study|Technical problems|6|||
160673360|NCT01131260|580182271|FG000|Overall Study|Staff error|2|||
160673361|NCT01131260|580182272|FG001|Overall Study|Staff error|1|||
160629865|NCT00650806|580025027|FG002|Overall Study|Noncompliance with study drug regimen|0|||
160629866|NCT00650806|580025028|FG003|Overall Study|Noncompliance with study drug regimen|0|||
160629867|NCT00650806|580025025|FG000|Overall Study|Study terminated by sponsor|2|||
160629868|NCT00650806|580025026|FG001|Overall Study|Study terminated by sponsor|3|||
160629869|NCT00650806|580025027|FG002|Overall Study|Study terminated by sponsor|5|||
160629870|NCT00650806|580025028|FG003|Overall Study|Study terminated by sponsor|4|||
160629871|NCT00650806|580025025|FG000|Overall Study|Other|1|||
160629872|NCT00650806|580025026|FG001|Overall Study|Other|1|||
160629873|NCT00650806|580025027|FG002|Overall Study|Other|2|||
160629874|NCT00650806|580025028|FG003|Overall Study|Other|0|||
160629875|NCT02596009|580025031|FG000|Overall Study|Administrative problems|0|||
160629876|NCT02596009|580025032|FG001|Overall Study|Administrative problems|1|||
160629877|NCT02596009|580025033|FG002|Overall Study|Administrative problems|0|||
160629878|NCT02596009|580025034|FG003|Overall Study|Administrative problems|0|||
160629879|NCT02596009|580025035|FG004|Overall Study|Administrative problems|0|||
160629880|NCT02596009|580025036|FG005|Overall Study|Administrative problems|0|||
160629881|NCT04755283|580025037|FG000|Overall Study|Withdrawal by Subject|14|||
160629882|NCT04755283|580025038|FG001|Overall Study|Withdrawal by Subject|3|||
160629883|NCT04755283|580025039|FG002|Overall Study|Withdrawal by Subject|6|||
160629884|NCT04755283|580025037|FG000|Overall Study|Lost to Follow-up|0|||
160629885|NCT04755283|580025038|FG001|Overall Study|Lost to Follow-up|0|||
160629886|NCT04755283|580025039|FG002|Overall Study|Lost to Follow-up|1|||
160629887|NCT04755283|580025037|FG000|Overall Study|Death|31|||
160629888|NCT04755283|580025038|FG001|Overall Study|Death|36|||
160629889|NCT04755283|580025039|FG002|Overall Study|Death|34|||
160629890|NCT03179462|580025042|FG000|Overall Study|screening failure|1|||
160629891|NCT03179462|580025043|FG001|Overall Study|screening failure|2|||
160629892|NCT03179462|580025044|FG002|Overall Study|screening failure|0|||
160629893|NCT04410978|580025051|FG000|Overall Study|Poor compliance to protocol|2|||
160629894|NCT04410978|580025052|FG001|Overall Study|Poor compliance to protocol|4|||
160629895|NCT04410978|580025051|FG000|Overall Study|Withdrawal by Subject|64|||
160629896|NCT04410978|580025052|FG001|Overall Study|Withdrawal by Subject|66|||
160629897|NCT04410978|580025051|FG000|Overall Study|Other|6|||
160629898|NCT04410978|580025052|FG001|Overall Study|Other|7|||
160629899|NCT04410978|580025051|FG000|Overall Study|Missing study status|1|||
160629900|NCT04410978|580025052|FG001|Overall Study|Missing study status|0|||
160629901|NCT02684162|580025053|FG000|Overall Study|Physician Decision|0|||
160629902|NCT02684162|580025054|FG001|Overall Study|Physician Decision|1|||
160629903|NCT02684162|580025055|FG002|Overall Study|Physician Decision|0|||
160629904|NCT05153629|580025056|FG000|Overall Study|Withdrawal by Subject|0|||
160629905|NCT05153629|580025057|FG001|Overall Study|Withdrawal by Subject|2|||
160629906|NCT04089566|580025062|FG000|Overall Study|Death|0|||
160629907|NCT04089566|580025063|FG001|Overall Study|Death|6|||
160629908|NCT04089566|580025064|FG002|Overall Study|Death|10|||
160629909|NCT04089566|580025065|FG003|Overall Study|Death|0|||
160629910|NCT04089566|580025066|FG004|Overall Study|Death|0|||
160629911|NCT04089566|580025067|FG005|Overall Study|Death|0|||
160629912|NCT04089566|580025062|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
160629913|NCT04089566|580025063|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
160629914|NCT04089566|580025064|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
160629915|NCT04089566|580025065|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
160629916|NCT04089566|580025066|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
160629917|NCT04089566|580025067|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
160629918|NCT04089566|580025062|FG000|Overall Study|Reason not Specified|0|||
160629919|NCT04089566|580025063|FG001|Overall Study|Reason not Specified|4|||
160629920|NCT04089566|580025064|FG002|Overall Study|Reason not Specified|4|||
160629921|NCT04089566|580025065|FG003|Overall Study|Reason not Specified|1|||
160629922|NCT04089566|580025066|FG004|Overall Study|Reason not Specified|0|||
160629923|NCT04089566|580025067|FG005|Overall Study|Reason not Specified|0|||
160629924|NCT01083121|580025068|FG000|Overall Study|Use of Humira outside the approved label|81|||
160629925|NCT05403502|580025069|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
160629926|NCT05403502|580025069|FG000|Humalog Lead-In Period|Physician Decision|2|||
160629927|NCT05403502|580025069|FG000|Humalog Lead-In Period|Protocol Violation|1|||
160629928|NCT05403502|580025069|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
160629929|NCT05403502|580025069|FG000|Lyumjev Treatment Period|Physician Decision|2|||
160629930|NCT01058707|580025071|FG000|Overall Study|Disease Progression|15|||
160629931|NCT01058707|580025072|FG001|Overall Study|Disease Progression|20|||
160629932|NCT01058707|580025073|FG002|Overall Study|Disease Progression|20|||
160629933|NCT01058707|580025074|FG003|Overall Study|Disease Progression|15|||
160629934|NCT01058707|580025075|FG004|Overall Study|Disease Progression|23|||
160629935|NCT01058707|580025076|FG005|Overall Study|Disease Progression|10|||
160629936|NCT01058707|580025077|FG006|Overall Study|Disease Progression|12|||
160629937|NCT01058707|580025071|FG000|Overall Study|Adverse Event|11|||
160629938|NCT01058707|580025072|FG001|Overall Study|Adverse Event|4|||
160629939|NCT01058707|580025073|FG002|Overall Study|Adverse Event|7|||
160629940|NCT01058707|580025074|FG003|Overall Study|Adverse Event|6|||
160629941|NCT01058707|580025075|FG004|Overall Study|Adverse Event|7|||
160629942|NCT01058707|580025076|FG005|Overall Study|Adverse Event|3|||
160629943|NCT01058707|580025077|FG006|Overall Study|Adverse Event|1|||
160673362|NCT01131260|580182271|FG000|Overall Study|Ineligible|0|||
160673363|NCT01131260|580182272|FG001|Overall Study|Ineligible|2|||
160673364|NCT01494532|580182275|FG000|Overall Study|Adverse Event|4|||
160673365|NCT01494532|580182276|FG001|Overall Study|Adverse Event|1|||
160673366|NCT01494532|580182277|FG002|Overall Study|Adverse Event|8|||
160673367|NCT01494532|580182278|FG003|Overall Study|Adverse Event|6|||
160673368|NCT01494532|580182279|FG004|Overall Study|Adverse Event|5|||
160673369|NCT01494532|580182280|FG005|Overall Study|Adverse Event|0|||
160673370|NCT01494532|580182275|FG000|Overall Study|Lack of Efficacy|0|||
160673371|NCT01494532|580182276|FG001|Overall Study|Lack of Efficacy|0|||
160673372|NCT01494532|580182277|FG002|Overall Study|Lack of Efficacy|0|||
160673373|NCT01494532|580182278|FG003|Overall Study|Lack of Efficacy|0|||
160673374|NCT01494532|580182279|FG004|Overall Study|Lack of Efficacy|2|||
160673375|NCT01494532|580182280|FG005|Overall Study|Lack of Efficacy|0|||
160673376|NCT01494532|580182275|FG000|Overall Study|Protocol deviation|2|||
160673377|NCT01494532|580182276|FG001|Overall Study|Protocol deviation|1|||
160673378|NCT01494532|580182277|FG002|Overall Study|Protocol deviation|3|||
160673379|NCT01494532|580182278|FG003|Overall Study|Protocol deviation|2|||
160673380|NCT01494532|580182279|FG004|Overall Study|Protocol deviation|3|||
160673381|NCT01494532|580182280|FG005|Overall Study|Protocol deviation|0|||
160673382|NCT01494532|580182275|FG000|Overall Study|Protocol-defined stopping criteria|0|||
160673383|NCT01494532|580182276|FG001|Overall Study|Protocol-defined stopping criteria|0|||
160673384|NCT01494532|580182277|FG002|Overall Study|Protocol-defined stopping criteria|1|||
160673385|NCT01494532|580182278|FG003|Overall Study|Protocol-defined stopping criteria|0|||
160673386|NCT01494532|580182279|FG004|Overall Study|Protocol-defined stopping criteria|0|||
160673387|NCT01494532|580182280|FG005|Overall Study|Protocol-defined stopping criteria|0|||
160673388|NCT01494532|580182275|FG000|Overall Study|Lost to Follow-up|1|||
160673389|NCT01494532|580182276|FG001|Overall Study|Lost to Follow-up|0|||
160673390|NCT01494532|580182277|FG002|Overall Study|Lost to Follow-up|0|||
160673391|NCT01494532|580182278|FG003|Overall Study|Lost to Follow-up|2|||
160673392|NCT01494532|580182279|FG004|Overall Study|Lost to Follow-up|0|||
160673393|NCT01494532|580182280|FG005|Overall Study|Lost to Follow-up|0|||
160673394|NCT01494532|580182275|FG000|Overall Study|Physician Decision|0|||
160673395|NCT01494532|580182276|FG001|Overall Study|Physician Decision|1|||
160673396|NCT01494532|580182277|FG002|Overall Study|Physician Decision|1|||
160673397|NCT01494532|580182278|FG003|Overall Study|Physician Decision|2|||
160673398|NCT01494532|580182279|FG004|Overall Study|Physician Decision|0|||
160673399|NCT01494532|580182280|FG005|Overall Study|Physician Decision|0|||
160673400|NCT01494532|580182275|FG000|Overall Study|Withdrawal by Subject|3|||
160673401|NCT01494532|580182276|FG001|Overall Study|Withdrawal by Subject|1|||
160673402|NCT01494532|580182277|FG002|Overall Study|Withdrawal by Subject|4|||
160673403|NCT01494532|580182278|FG003|Overall Study|Withdrawal by Subject|3|||
160673404|NCT01494532|580182279|FG004|Overall Study|Withdrawal by Subject|2|||
160673405|NCT01494532|580182280|FG005|Overall Study|Withdrawal by Subject|0|||
160673406|NCT00679081|580182281|FG000|Overall Study|Lost to Follow-up|1|||
160673407|NCT01404988|580182284|FG000|Overall Study|Death|2|||
160673408|NCT01404988|580182285|FG001|Overall Study|Death|0|||
160673409|NCT01404988|580182286|FG002|Overall Study|Death|2|||
160673410|NCT01404988|580182284|FG000|Overall Study|Adverse Event|1|||
160673411|NCT01404988|580182285|FG001|Overall Study|Adverse Event|0|||
160673412|NCT01404988|580182286|FG002|Overall Study|Adverse Event|0|||
160673413|NCT01404988|580182284|FG000|Overall Study|Withdrawal by Subject|2|||
160673414|NCT01404988|580182285|FG001|Overall Study|Withdrawal by Subject|2|||
160673415|NCT01404988|580182286|FG002|Overall Study|Withdrawal by Subject|0|||
160673416|NCT01404988|580182284|FG000|Overall Study|Lost to Follow-up|1|||
160673417|NCT01404988|580182285|FG001|Overall Study|Lost to Follow-up|2|||
160673418|NCT01404988|580182286|FG002|Overall Study|Lost to Follow-up|1|||
160673419|NCT04594252|580182287|FG000|Overall Study|Adverse Event|0|||
160673420|NCT04594252|580182288|FG001|Overall Study|Adverse Event|2|||
160673421|NCT01109849|580183761|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
160673422|NCT01109849|580183762|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
160673423|NCT01109849|580183763|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
160673424|NCT01109849|580183764|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
160673425|NCT01109849|580183765|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
160673426|NCT01109849|580183761|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
160673427|NCT01109849|580183762|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
160673428|NCT01109849|580183763|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
160673429|NCT01109849|580183764|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
160673430|NCT01109849|580183765|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
160673431|NCT01109849|580183761|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
160673432|NCT01109849|580183762|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
160673433|NCT01109849|580183763|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
160673434|NCT01109849|580183764|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
160673435|NCT01109849|580183765|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
160673436|NCT01109849|580183761|FG000|Initial Randomization: ADHD Treatment|move away|2|||
160673437|NCT01109849|580183762|FG001|Initial Randomization: ADHD Treatment|move away|7|||
160673438|NCT01109849|580183763|FG002|Initial Randomization: ADHD Treatment|move away|0|||
160673439|NCT01109849|580183764|FG003|Initial Randomization: ADHD Treatment|move away|0|||
160673440|NCT01109849|580183765|FG004|Initial Randomization: ADHD Treatment|move away|0|||
160673441|NCT01109849|580183761|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
160673442|NCT01109849|580183762|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
160673443|NCT01109849|580183763|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
160673444|NCT01109849|580183764|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
160673445|NCT01109849|580183765|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
160673446|NCT01109849|580183761|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
160673447|NCT01109849|580183762|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
160673448|NCT01109849|580183763|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
160673449|NCT01109849|580183764|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
160673450|NCT01109849|580183765|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
160673451|NCT02485158|580183767|FG000|Overall Study|Withdrawal by Subject|3|||
160673452|NCT02485158|580183767|FG000|Overall Study|expected drug side effect|1|||
160673453|NCT01098851|580183768|FG000|Overall Study|Equipment failure|1|||
160673454|NCT01098851|580183769|FG001|Overall Study|Equipment failure|0|||
160673455|NCT03087786|580183770|FG000|Overall Study|Withdrawal by Subject|2|||
160673456|NCT03087786|580183771|FG001|Overall Study|Withdrawal by Subject|0|||
160673457|NCT02651987|580183772|FG000|Overall Study|Adverse Event|2|||
160673458|NCT02651987|580183773|FG001|Overall Study|Adverse Event|2|||
160673459|NCT02651987|580183772|FG000|Overall Study|Consent Withdrawn|2|||
160673460|NCT02651987|580183773|FG001|Overall Study|Consent Withdrawn|0|||
160673461|NCT02651987|580183772|FG000|Overall Study|Local PD|0|||
160673462|NCT02651987|580183773|FG001|Overall Study|Local PD|2|||
160673463|NCT02651987|580183772|FG000|Overall Study|Investigator Decision|1|||
160629944|NCT01058707|580025071|FG000|Overall Study|Subject Decision|5|||
160629945|NCT01058707|580025072|FG001|Overall Study|Subject Decision|3|||
160629946|NCT01058707|580025073|FG002|Overall Study|Subject Decision|3|||
160629947|NCT01058707|580025074|FG003|Overall Study|Subject Decision|1|||
160629948|NCT01058707|580025075|FG004|Overall Study|Subject Decision|2|||
160629949|NCT01058707|580025076|FG005|Overall Study|Subject Decision|3|||
160673464|NCT02651987|580183773|FG001|Overall Study|Investigator Decision|1|||
160673465|NCT04661202|580183774|FG000|Overall Study|Withdrawal by Subject|1|||
160673466|NCT04661202|580183775|FG001|Overall Study|Withdrawal by Subject|1|||
160673467|NCT04661202|580183774|FG000|Overall Study|Lack of Efficacy|2|||
160673468|NCT04661202|580183775|FG001|Overall Study|Lack of Efficacy|0|||
160673469|NCT02725515|580183776|FG000|Overall Study|Refused infusion (no study treatment)|1|||
160673470|NCT02725515|580183777|FG001|Overall Study|Refused infusion (no study treatment)|0|||
160673471|NCT02725515|580183776|FG000|Overall Study|Loss of Improvement per Protocol|14|||
160673472|NCT02725515|580183777|FG001|Overall Study|Loss of Improvement per Protocol|25|||
160673473|NCT02725515|580183776|FG000|Overall Study|Withdrawal by Subject|2|||
160673474|NCT02725515|580183777|FG001|Overall Study|Withdrawal by Subject|1|||
160673475|NCT02725515|580183776|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160673476|NCT02725515|580183777|FG001|Overall Study|Non-Compliance With Study Drug|3|||
160673477|NCT02725515|580183776|FG000|Overall Study|Lost to Follow-up|1|||
160673478|NCT02725515|580183777|FG001|Overall Study|Lost to Follow-up|1|||
160673479|NCT02725515|580183776|FG000|Overall Study|Adverse Event|7|||
160673480|NCT02725515|580183777|FG001|Overall Study|Adverse Event|2|||
160673481|NCT02725515|580183776|FG000|Overall Study|No Documented Disease Improvement|0|||
160673482|NCT02725515|580183777|FG001|Overall Study|No Documented Disease Improvement|1|||
160673483|NCT02725515|580183776|FG000|Overall Study|Completed Study Under Original Protocol|0|||
160673484|NCT02725515|580183777|FG001|Overall Study|Completed Study Under Original Protocol|1|||
160673485|NCT02725515|580183776|FG000|Overall Study|Lack of Response|0|||
160673486|NCT02725515|580183777|FG001|Overall Study|Lack of Response|1|||
160673487|NCT02313558|580183778|FG000|Overall Study|Withdrawal by Subject|2|||
160673488|NCT02313558|580183779|FG001|Overall Study|Withdrawal by Subject|0|||
160673489|NCT02313558|580183778|FG000|Overall Study|Lost to Follow-up|4|||
160673490|NCT02313558|580183779|FG001|Overall Study|Lost to Follow-up|4|||
160673491|NCT04158687|580183782|FG000|Overall Study|Adverse Event|2|||
160629950|NCT01058707|580025077|FG006|Overall Study|Subject Decision|6|||
160629951|NCT01058707|580025071|FG000|Overall Study|Lost to Follow-up|0|||
160629952|NCT01058707|580025072|FG001|Overall Study|Lost to Follow-up|0|||
160629953|NCT01058707|580025073|FG002|Overall Study|Lost to Follow-up|1|||
160629954|NCT01058707|580025074|FG003|Overall Study|Lost to Follow-up|0|||
160673492|NCT04158687|580183783|FG001|Overall Study|Adverse Event|3|||
160673493|NCT04158687|580183784|FG002|Overall Study|Adverse Event|0|||
160673494|NCT04158687|580183785|FG003|Overall Study|Adverse Event|3|||
160673495|NCT04158687|580183782|FG000|Overall Study|Lost to Follow-up|5|||
160673496|NCT04158687|580183783|FG001|Overall Study|Lost to Follow-up|12|||
160629955|NCT01058707|580025075|FG004|Overall Study|Lost to Follow-up|0|||
160673497|NCT04158687|580183784|FG002|Overall Study|Lost to Follow-up|4|||
160673498|NCT04158687|580183785|FG003|Overall Study|Lost to Follow-up|5|||
160673499|NCT04158687|580183782|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
160673500|NCT04158687|580183783|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
160629956|NCT01058707|580025076|FG005|Overall Study|Lost to Follow-up|0|||
160629957|NCT01058707|580025077|FG006|Overall Study|Lost to Follow-up|0|||
160629958|NCT01058707|580025071|FG000|Overall Study|Reason Not Specified|0|||
160673501|NCT04158687|580183784|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
160673502|NCT04158687|580183785|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
160673503|NCT04158687|580183782|FG000|Overall Study|Non-Compliance with Study Medication|2|||
160673504|NCT04158687|580183783|FG001|Overall Study|Non-Compliance with Study Medication|2|||
160673505|NCT04158687|580183784|FG002|Overall Study|Non-Compliance with Study Medication|3|||
160673506|NCT04158687|580183785|FG003|Overall Study|Non-Compliance with Study Medication|0|||
160673507|NCT04158687|580183782|FG000|Overall Study|Investigator Decision|0|||
160673508|NCT04158687|580183783|FG001|Overall Study|Investigator Decision|0|||
160673509|NCT04158687|580183784|FG002|Overall Study|Investigator Decision|2|||
160673510|NCT04158687|580183785|FG003|Overall Study|Investigator Decision|0|||
160673511|NCT04158687|580183782|FG000|Overall Study|Protocol Violation|0|||
160673512|NCT04158687|580183783|FG001|Overall Study|Protocol Violation|2|||
160673513|NCT04158687|580183784|FG002|Overall Study|Protocol Violation|1|||
160673514|NCT04158687|580183785|FG003|Overall Study|Protocol Violation|0|||
160673515|NCT04158687|580183782|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
160673516|NCT04158687|580183783|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
160673517|NCT04158687|580183784|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
160673518|NCT04158687|580183785|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
160673519|NCT04158687|580183782|FG000|Overall Study|Reason not Specified|3|||
160673520|NCT04158687|580183783|FG001|Overall Study|Reason not Specified|2|||
160673521|NCT04158687|580183784|FG002|Overall Study|Reason not Specified|4|||
160673522|NCT04158687|580183785|FG003|Overall Study|Reason not Specified|4|||
160673523|NCT00385736|580183790|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
160673524|NCT00385736|580183791|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
160673525|NCT00385736|580183792|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
160673526|NCT00385736|580183790|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
160673527|NCT00385736|580183791|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
160673528|NCT00385736|580183792|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
160673529|NCT00385736|580183790|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
160673530|NCT00385736|580183791|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
160673531|NCT00385736|580183792|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
160673532|NCT00385736|580183790|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
160673533|NCT00385736|580183791|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
160629959|NCT01058707|580025072|FG001|Overall Study|Reason Not Specified|3|||
160629960|NCT01058707|580025073|FG002|Overall Study|Reason Not Specified|2|||
160629961|NCT01058707|580025074|FG003|Overall Study|Reason Not Specified|0|||
160629962|NCT01058707|580025075|FG004|Overall Study|Reason Not Specified|7|||
160629963|NCT01058707|580025076|FG005|Overall Study|Reason Not Specified|1|||
160629964|NCT01058707|580025077|FG006|Overall Study|Reason Not Specified|7|||
160629965|NCT00795886|580025082|FG000|Overall Study|Death|10|||
160629966|NCT05554471|580025083|FG000|Overall Study|Physician Decision|2|||
160629967|NCT05554471|580025084|FG001|Overall Study|Physician Decision|1|||
160629968|NCT05554471|580025083|FG000|Overall Study|Lost to Follow-up|2|||
160629969|NCT05554471|580025084|FG001|Overall Study|Lost to Follow-up|1|||
160629970|NCT05554471|580025083|FG000|Overall Study|Death|0|||
160629971|NCT05554471|580025084|FG001|Overall Study|Death|1|||
160629972|NCT03505606|580026716|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
160629973|NCT03505606|580026717|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
160629974|NCT03505606|580026718|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
160629975|NCT03505606|580026716|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
160629976|NCT03505606|580026717|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
160629977|NCT03505606|580026718|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
160629978|NCT03505606|580026716|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
160629979|NCT03505606|580026717|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
160629980|NCT03505606|580026718|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
160629981|NCT03505606|580026716|FG000|Overall Study|Poor compliance with refractive correction|0|||
160629982|NCT03505606|580026717|FG001|Overall Study|Poor compliance with refractive correction|0|||
160629983|NCT03505606|580026718|FG002|Overall Study|Poor compliance with refractive correction|1|||
160673534|NCT00385736|580183792|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
160673535|NCT00385736|580183790|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
160673536|NCT00385736|580183791|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
160673537|NCT00385736|580183792|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
160673538|NCT00385736|580183790|FG000|Efficacy Analysis Set - Induction|Other|0|||
160673539|NCT00385736|580183791|FG001|Efficacy Analysis Set - Induction|Other|0|||
160673540|NCT00385736|580183792|FG002|Efficacy Analysis Set - Induction|Other|1|||
160673541|NCT00385736|580183790|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
160673542|NCT00385736|580183791|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
160629984|NCT03505606|580026716|FG000|Overall Study|Insufficient anisometropia|0|||
160629985|NCT03505606|580026717|FG001|Overall Study|Insufficient anisometropia|0|||
160629986|NCT03505606|580026718|FG002|Overall Study|Insufficient anisometropia|2|||
160629987|NCT03505606|580026716|FG000|Overall Study|Ectopia Lentis|0|||
160629988|NCT03505606|580026717|FG001|Overall Study|Ectopia Lentis|0|||
160629989|NCT03505606|580026718|FG002|Overall Study|Ectopia Lentis|1|||
160629990|NCT03505606|580026716|FG000|Overall Study|alternation of amblyopic eye|0|||
160629991|NCT03505606|580026717|FG001|Overall Study|alternation of amblyopic eye|1|||
160629992|NCT03505606|580026718|FG002|Overall Study|alternation of amblyopic eye|0|||
160629993|NCT02087865|580026721|FG000|Overall Study|Withdrawal by Subject|6|||
160629994|NCT02087865|580026722|FG001|Overall Study|Withdrawal by Subject|0|||
160629995|NCT02087865|580026723|FG002|Overall Study|Withdrawal by Subject|1|||
160629996|NCT02087865|580026721|FG000|Overall Study|Lost to Follow-up|0|||
160629997|NCT02087865|580026722|FG001|Overall Study|Lost to Follow-up|0|||
160629998|NCT02087865|580026723|FG002|Overall Study|Lost to Follow-up|1|||
160629999|NCT02087865|580026721|FG000|Overall Study|Drug Non-compliance|0|||
160630000|NCT02087865|580026722|FG001|Overall Study|Drug Non-compliance|2|||
160630001|NCT02087865|580026723|FG002|Overall Study|Drug Non-compliance|0|||
160630002|NCT02087865|580026721|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
160630003|NCT02087865|580026722|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
160630004|NCT02087865|580026723|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
160630005|NCT01392469|580026724|FG000|Overall Study|Adverse Event|2|||
160630006|NCT01392469|580026724|FG000|Overall Study|Withdrawal by Subject|1|||
160630007|NCT01392469|580026724|FG000|Overall Study|Protocol Violation|1|||
160630008|NCT04292171|580026727|FG000|Overall Study|Pharmacy error|2|||
160630009|NCT04292171|580026728|FG001|Overall Study|Pharmacy error|0|||
160630010|NCT04292171|580026727|FG000|Overall Study|Delivered prior to procedure|0|||
160630011|NCT04292171|580026728|FG001|Overall Study|Delivered prior to procedure|1|||
160630012|NCT04633434|580026729|FG000|Overall Study|Lost to Follow-up|32|||
160630013|NCT04633434|580026730|FG001|Overall Study|Lost to Follow-up|32|||
160630014|NCT02116309|580026743|FG000|Overall Study|Lost to Follow-up|0|||
160630015|NCT02116309|580026744|FG001|Overall Study|Lost to Follow-up|1|||
160630016|NCT03292731|580026745|FG000|Overall Study|Protocol Violation|4|||
160630017|NCT03292731|580026746|FG001|Overall Study|Protocol Violation|11|||
160630018|NCT03292731|580026747|FG002|Overall Study|Protocol Violation|1|||
160630019|NCT00471237|580026748|FG000|Overall Study|Adverse Event|6|||
160630020|NCT00471237|580026749|FG001|Overall Study|Adverse Event|5|||
160630021|NCT00471237|580026750|FG002|Overall Study|Adverse Event|4|||
160630022|NCT00471237|580026751|FG003|Overall Study|Adverse Event|8|||
160630023|NCT00471237|580026752|FG004|Overall Study|Adverse Event|7|||
160630024|NCT00471237|580026753|FG005|Overall Study|Adverse Event|5|||
160630025|NCT00471237|580026754|FG006|Overall Study|Adverse Event|0|||
160630026|NCT00471237|580026748|FG000|Overall Study|Lost to Follow-up|1|||
160630027|NCT00471237|580026749|FG001|Overall Study|Lost to Follow-up|1|||
160630028|NCT00471237|580026750|FG002|Overall Study|Lost to Follow-up|0|||
160630029|NCT00471237|580026751|FG003|Overall Study|Lost to Follow-up|2|||
160630030|NCT00471237|580026752|FG004|Overall Study|Lost to Follow-up|3|||
160630031|NCT00471237|580026753|FG005|Overall Study|Lost to Follow-up|0|||
160630032|NCT00471237|580026754|FG006|Overall Study|Lost to Follow-up|0|||
160630033|NCT00471237|580026748|FG000|Overall Study|Protocol Violation|3|||
160630034|NCT00471237|580026749|FG001|Overall Study|Protocol Violation|6|||
160630035|NCT00471237|580026750|FG002|Overall Study|Protocol Violation|3|||
160630036|NCT00471237|580026751|FG003|Overall Study|Protocol Violation|2|||
160630037|NCT00471237|580026752|FG004|Overall Study|Protocol Violation|2|||
160630038|NCT00471237|580026753|FG005|Overall Study|Protocol Violation|4|||
160630039|NCT00471237|580026754|FG006|Overall Study|Protocol Violation|1|||
160630040|NCT00471237|580026748|FG000|Overall Study|Withdrawal by Subject|8|||
160630041|NCT00471237|580026749|FG001|Overall Study|Withdrawal by Subject|6|||
160630042|NCT00471237|580026750|FG002|Overall Study|Withdrawal by Subject|5|||
160630043|NCT00471237|580026751|FG003|Overall Study|Withdrawal by Subject|8|||
160630044|NCT00471237|580026752|FG004|Overall Study|Withdrawal by Subject|7|||
160630045|NCT00471237|580026753|FG005|Overall Study|Withdrawal by Subject|4|||
160630046|NCT00471237|580026754|FG006|Overall Study|Withdrawal by Subject|2|||
160630047|NCT00471237|580026748|FG000|Overall Study|Sponsor terminated study|20|||
160630048|NCT00471237|580026749|FG001|Overall Study|Sponsor terminated study|23|||
160630049|NCT00471237|580026750|FG002|Overall Study|Sponsor terminated study|19|||
160630050|NCT00471237|580026751|FG003|Overall Study|Sponsor terminated study|22|||
160630051|NCT00471237|580026752|FG004|Overall Study|Sponsor terminated study|18|||
160630052|NCT00471237|580026753|FG005|Overall Study|Sponsor terminated study|24|||
160630053|NCT00471237|580026754|FG006|Overall Study|Sponsor terminated study|0|||
160630054|NCT00471237|580026748|FG000|Overall Study|Non-compliance|0|||
160630055|NCT00471237|580026749|FG001|Overall Study|Non-compliance|1|||
160630056|NCT00471237|580026750|FG002|Overall Study|Non-compliance|0|||
160630057|NCT00471237|580026751|FG003|Overall Study|Non-compliance|1|||
160630058|NCT00471237|580026752|FG004|Overall Study|Non-compliance|0|||
160630059|NCT00471237|580026753|FG005|Overall Study|Non-compliance|0|||
160630060|NCT00471237|580026754|FG006|Overall Study|Non-compliance|0|||
160630061|NCT00471237|580026748|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
160673543|NCT00385736|580183792|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
160673544|NCT00385736|580183790|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
160673545|NCT00385736|580183791|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
160673546|NCT00385736|580183792|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
160673547|NCT00385736|580183790|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
160673548|NCT00385736|580183791|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
160673549|NCT00385736|580183792|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
160673550|NCT00385736|580183790|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
160673551|NCT00385736|580183791|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
160673552|NCT00385736|580183792|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
160673553|NCT00385736|580183790|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
160673554|NCT00385736|580183791|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
160673555|NCT00385736|580183792|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
160673556|NCT00385736|580183790|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
160673557|NCT00385736|580183791|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
160673558|NCT00385736|580183792|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
160673559|NCT00385736|580183790|FG000|Safety Analysis Set|Adverse Event|23|||
160673560|NCT00385736|580183791|FG001|Safety Analysis Set|Adverse Event|15|||
160673561|NCT00385736|580183792|FG002|Safety Analysis Set|Adverse Event|23|||
160673562|NCT00385736|580183790|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
160673563|NCT00385736|580183791|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
160673564|NCT00385736|580183792|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
160673565|NCT00385736|580183790|FG000|Safety Analysis Set|Lost to Follow-up|0|||
160673566|NCT00385736|580183791|FG001|Safety Analysis Set|Lost to Follow-up|2|||
160673567|NCT00385736|580183792|FG002|Safety Analysis Set|Lost to Follow-up|2|||
160673568|NCT00385736|580183790|FG000|Safety Analysis Set|Lack of Efficacy|38|||
160673569|NCT00385736|580183791|FG001|Safety Analysis Set|Lack of Efficacy|16|||
160673570|NCT00385736|580183792|FG002|Safety Analysis Set|Lack of Efficacy|31|||
160673571|NCT00385736|580183790|FG000|Safety Analysis Set|Protocol Violation|2|||
160673572|NCT00385736|580183791|FG001|Safety Analysis Set|Protocol Violation|1|||
160673573|NCT00385736|580183792|FG002|Safety Analysis Set|Protocol Violation|6|||
160673574|NCT00385736|580183790|FG000|Safety Analysis Set|Other|1|||
160673575|NCT00385736|580183791|FG001|Safety Analysis Set|Other|4|||
160673576|NCT00385736|580183792|FG002|Safety Analysis Set|Other|4|||
160673577|NCT01919112|580183800|FG000|Secondary Analysis-day 30|Death|1|||
160673578|NCT01919112|580183801|FG001|Secondary Analysis-day 30|Death|1|||
160673579|NCT01919112|580183802|FG002|Secondary Analysis-day 30|Death|1|||
160673580|NCT01919112|580183800|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
160673581|NCT01919112|580183801|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
160673582|NCT01919112|580183802|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
160673583|NCT02043132|580183803|FG000|Overall Study|Lost to Follow-up|1|||
160673584|NCT02043132|580183804|FG001|Overall Study|Lost to Follow-up|1|||
160673585|NCT02043132|580183803|FG000|Overall Study|screen failures|4|||
160673586|NCT02043132|580183804|FG001|Overall Study|screen failures|8|||
160673587|NCT00835666|580183805|FG000|Washout|Protocol Violation|1|||
160673588|NCT00835666|580183806|FG001|Washout|Protocol Violation|0|||
160673589|NCT00835666|580183805|FG000|Washout|Withdrawal by Subject|1|||
160673590|NCT00835666|580183806|FG001|Washout|Withdrawal by Subject|0|||
160673591|NCT03827395|580183807|FG000|Overall Study|Lost to Follow-up|1|||
160673592|NCT03827395|580183808|FG001|Overall Study|Lost to Follow-up|0|||
160673593|NCT03827395|580183807|FG000|Overall Study|Protocol Violation|1|||
160673594|NCT03827395|580183808|FG001|Overall Study|Protocol Violation|0|||
160673595|NCT03827395|580183807|FG000|Overall Study|Became ineligible after enrollment|1|||
160673596|NCT03827395|580183808|FG001|Overall Study|Became ineligible after enrollment|2|||
160673597|NCT01370083|580183809|FG000|Overall Study|Lost to Follow-up|2|||
160673598|NCT01370083|580183810|FG001|Overall Study|Lost to Follow-up|0|||
160673599|NCT01370083|580183809|FG000|Overall Study|Adverse Event|0|||
160673600|NCT01370083|580183810|FG001|Overall Study|Adverse Event|1|||
160673601|NCT02450539|580183813|FG000|Overall Study|Withdrawal by Subject|12|||
160673602|NCT02450539|580183814|FG001|Overall Study|Withdrawal by Subject|6|||
160673603|NCT02450539|580183813|FG000|Overall Study|Lost to Follow-up|4|||
160673604|NCT02450539|580183814|FG001|Overall Study|Lost to Follow-up|1|||
160673605|NCT00585286|580183815|FG000|Overall Study|Lost to Follow-up|1|||
160673606|NCT03358147|580183817|FG000|Overall Study|Withdrawal by Subject|13|||
160673607|NCT03358147|580183818|FG001|Overall Study|Withdrawal by Subject|19|||
160673608|NCT03358147|580183819|FG002|Overall Study|Withdrawal by Subject|16|||
160673609|NCT03358147|580183820|FG003|Overall Study|Withdrawal by Subject|10|||
160673610|NCT03358147|580183821|FG004|Overall Study|Withdrawal by Subject|5|||
160673611|NCT03358147|580183817|FG000|Overall Study|Adverse Event|3|||
160673612|NCT03358147|580183818|FG001|Overall Study|Adverse Event|9|||
160673613|NCT03358147|580183819|FG002|Overall Study|Adverse Event|7|||
160673614|NCT03358147|580183820|FG003|Overall Study|Adverse Event|5|||
160673615|NCT03358147|580183821|FG004|Overall Study|Adverse Event|2|||
160673616|NCT03358147|580183817|FG000|Overall Study|Lost to Follow-up|4|||
160673617|NCT03358147|580183818|FG001|Overall Study|Lost to Follow-up|3|||
160673618|NCT03358147|580183819|FG002|Overall Study|Lost to Follow-up|7|||
160630062|NCT00471237|580026749|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
160630063|NCT00471237|580026750|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
160630064|NCT00471237|580026751|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
160630065|NCT00471237|580026752|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
160630066|NCT00471237|580026753|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
160630067|NCT00471237|580026754|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
160630068|NCT00471237|580026748|FG000|Overall Study|Early stopping due to non-efficacy|1|||
160630069|NCT00471237|580026749|FG001|Overall Study|Early stopping due to non-efficacy|0|||
160630070|NCT00471237|580026750|FG002|Overall Study|Early stopping due to non-efficacy|0|||
160630071|NCT00471237|580026751|FG003|Overall Study|Early stopping due to non-efficacy|0|||
160630072|NCT00471237|580026752|FG004|Overall Study|Early stopping due to non-efficacy|1|||
160630073|NCT00471237|580026753|FG005|Overall Study|Early stopping due to non-efficacy|0|||
160630074|NCT00471237|580026754|FG006|Overall Study|Early stopping due to non-efficacy|0|||
160630075|NCT00471237|580026748|FG000|Overall Study|Participant planned to travel to abraod|1|||
160630076|NCT00471237|580026749|FG001|Overall Study|Participant planned to travel to abraod|0|||
160630077|NCT00471237|580026750|FG002|Overall Study|Participant planned to travel to abraod|0|||
160630078|NCT00471237|580026751|FG003|Overall Study|Participant planned to travel to abraod|0|||
160630079|NCT00471237|580026752|FG004|Overall Study|Participant planned to travel to abraod|0|||
160630080|NCT00471237|580026753|FG005|Overall Study|Participant planned to travel to abraod|1|||
160630081|NCT00471237|580026754|FG006|Overall Study|Participant planned to travel to abraod|0|||
160630082|NCT00471237|580026748|FG000|Overall Study|High parathyroid hormone|0|||
160630083|NCT00471237|580026749|FG001|Overall Study|High parathyroid hormone|0|||
160630084|NCT00471237|580026750|FG002|Overall Study|High parathyroid hormone|1|||
160630085|NCT00471237|580026751|FG003|Overall Study|High parathyroid hormone|0|||
160630086|NCT00471237|580026752|FG004|Overall Study|High parathyroid hormone|0|||
160630087|NCT00471237|580026753|FG005|Overall Study|High parathyroid hormone|0|||
160630088|NCT00471237|580026754|FG006|Overall Study|High parathyroid hormone|0|||
160630089|NCT00471237|580026748|FG000|Overall Study|Participant lost medication|0|||
160630090|NCT00471237|580026749|FG001|Overall Study|Participant lost medication|0|||
160630091|NCT00471237|580026750|FG002|Overall Study|Participant lost medication|0|||
160630092|NCT00471237|580026751|FG003|Overall Study|Participant lost medication|0|||
160630093|NCT00471237|580026752|FG004|Overall Study|Participant lost medication|1|||
160630094|NCT00471237|580026753|FG005|Overall Study|Participant lost medication|0|||
160630095|NCT00471237|580026754|FG006|Overall Study|Participant lost medication|0|||
160630096|NCT00471237|580026748|FG000|Overall Study|Administration of prohibited medicine|0|||
160630097|NCT00471237|580026749|FG001|Overall Study|Administration of prohibited medicine|0|||
160630098|NCT00471237|580026750|FG002|Overall Study|Administration of prohibited medicine|0|||
160630099|NCT00471237|580026751|FG003|Overall Study|Administration of prohibited medicine|0|||
160630100|NCT00471237|580026752|FG004|Overall Study|Administration of prohibited medicine|1|||
160630101|NCT00471237|580026753|FG005|Overall Study|Administration of prohibited medicine|0|||
160630102|NCT00471237|580026754|FG006|Overall Study|Administration of prohibited medicine|0|||
160630103|NCT00471237|580026748|FG000|Overall Study|Participant shifted residence|0|||
160630104|NCT00471237|580026749|FG001|Overall Study|Participant shifted residence|0|||
160630105|NCT00471237|580026750|FG002|Overall Study|Participant shifted residence|0|||
160630106|NCT00471237|580026751|FG003|Overall Study|Participant shifted residence|0|||
160630107|NCT00471237|580026752|FG004|Overall Study|Participant shifted residence|1|||
160630108|NCT00471237|580026753|FG005|Overall Study|Participant shifted residence|0|||
160630109|NCT00471237|580026754|FG006|Overall Study|Participant shifted residence|0|||
160630110|NCT00471237|580026748|FG000|Overall Study|Participant's decision|0|||
160630111|NCT00471237|580026749|FG001|Overall Study|Participant's decision|0|||
160630112|NCT00471237|580026750|FG002|Overall Study|Participant's decision|0|||
160630113|NCT00471237|580026751|FG003|Overall Study|Participant's decision|0|||
160630114|NCT00471237|580026752|FG004|Overall Study|Participant's decision|0|||
160630115|NCT00471237|580026753|FG005|Overall Study|Participant's decision|1|||
160630116|NCT00471237|580026754|FG006|Overall Study|Participant's decision|0|||
160630117|NCT00348348|580026755|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
160630118|NCT00348348|580026756|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
160630119|NCT00348348|580026755|FG000|Overall Study|Lack of Efficacy|1|||
160630120|NCT00348348|580026756|FG001|Overall Study|Lack of Efficacy|1|||
160630121|NCT00348348|580026755|FG000|Overall Study|Lost to Follow-up|8|||
160630122|NCT00348348|580026756|FG001|Overall Study|Lost to Follow-up|10|||
160630123|NCT00348348|580026755|FG000|Overall Study|Withdrawal by Subject|4|||
160630124|NCT00348348|580026756|FG001|Overall Study|Withdrawal by Subject|1|||
160630125|NCT00348348|580026755|FG000|Overall Study|Other|7|||
160630126|NCT00348348|580026756|FG001|Overall Study|Other|4|||
160630127|NCT00348348|580026755|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
160630128|NCT00348348|580026756|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
160630129|NCT00348348|580026755|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
160630130|NCT00348348|580026756|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
160673619|NCT03358147|580183820|FG003|Overall Study|Lost to Follow-up|6|||
160673620|NCT03358147|580183821|FG004|Overall Study|Lost to Follow-up|4|||
160630131|NCT00348348|580026755|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
160630132|NCT00348348|580026756|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
160630133|NCT00348348|580026755|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
160630134|NCT00348348|580026756|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
160630135|NCT00348348|580026755|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
160630136|NCT00348348|580026756|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
160630137|NCT00348348|580026755|FG000|Overall Study|Adverse event probably related to study|1|||
160630138|NCT00348348|580026756|FG001|Overall Study|Adverse event probably related to study|0|||
160630139|NCT03237325|580026757|FG000|Overall Study|Lost to Follow-up|3|||
160630140|NCT03237325|580026758|FG001|Overall Study|Lost to Follow-up|5|||
160630141|NCT03237325|580026757|FG000|Overall Study|Physician Decision|2|||
160630142|NCT03237325|580026758|FG001|Overall Study|Physician Decision|4|||
160630143|NCT03237325|580026757|FG000|Overall Study|Withdrawal by Subject|9|||
160630144|NCT03237325|580026758|FG001|Overall Study|Withdrawal by Subject|12|||
160630145|NCT03237325|580026757|FG000|Overall Study|Noncompliance with Study Procedures|1|||
160630146|NCT03237325|580026758|FG001|Overall Study|Noncompliance with Study Procedures|1|||
160630147|NCT03237325|580026757|FG000|Overall Study|Termination by Sponsor|0|||
160630148|NCT03237325|580026758|FG001|Overall Study|Termination by Sponsor|1|||
160630149|NCT03237325|580026757|FG000|Overall Study|Reason other than described|0|||
160630150|NCT03237325|580026758|FG001|Overall Study|Reason other than described|2|||
160630151|NCT02684370|580026759|FG000|Part A|Adverse Event|2|||
160630152|NCT02684370|580026760|FG001|Part A|Adverse Event|0|||
160630153|NCT02684370|580026761|FG002|Part A|Adverse Event|1|||
160630154|NCT02684370|580026762|FG003|Part A|Adverse Event|0|||
160630155|NCT02684370|580026763|FG004|Part A|Adverse Event|0|||
160630156|NCT02684370|580026764|FG005|Part A|Adverse Event|0|||
160630157|NCT02684370|580026759|FG000|Part A|Lost to Follow-up|1|||
160630158|NCT02684370|580026760|FG001|Part A|Lost to Follow-up|1|||
160630159|NCT02684370|580026761|FG002|Part A|Lost to Follow-up|0|||
160630160|NCT02684370|580026762|FG003|Part A|Lost to Follow-up|0|||
160630161|NCT02684370|580026763|FG004|Part A|Lost to Follow-up|0|||
160630162|NCT02684370|580026764|FG005|Part A|Lost to Follow-up|0|||
160630163|NCT02684370|580026759|FG000|Part A|Subject Withdrawal|1|||
160630164|NCT02684370|580026760|FG001|Part A|Subject Withdrawal|0|||
160630165|NCT02684370|580026761|FG002|Part A|Subject Withdrawal|3|||
160630166|NCT02684370|580026762|FG003|Part A|Subject Withdrawal|0|||
160630167|NCT02684370|580026763|FG004|Part A|Subject Withdrawal|0|||
160630168|NCT02684370|580026764|FG005|Part A|Subject Withdrawal|0|||
160630169|NCT02684370|580026759|FG000|Part A|Other|0|||
160630170|NCT02684370|580026760|FG001|Part A|Other|0|||
160630171|NCT02684370|580026761|FG002|Part A|Other|1|||
160630172|NCT02684370|580026762|FG003|Part A|Other|0|||
160630173|NCT02684370|580026763|FG004|Part A|Other|0|||
160630174|NCT02684370|580026764|FG005|Part A|Other|0|||
160630175|NCT02684370|580026759|FG000|Part B|Adverse Event|0|||
160630176|NCT02684370|580026760|FG001|Part B|Adverse Event|0|||
160630177|NCT02684370|580026761|FG002|Part B|Adverse Event|0|||
160630178|NCT02684370|580026762|FG003|Part B|Adverse Event|0|||
160630179|NCT02684370|580026763|FG004|Part B|Adverse Event|2|||
160630180|NCT02684370|580026764|FG005|Part B|Adverse Event|1|||
160630181|NCT02684370|580026759|FG000|Part B|Lost to Follow-up|0|||
160630182|NCT02684370|580026760|FG001|Part B|Lost to Follow-up|0|||
160630183|NCT02684370|580026761|FG002|Part B|Lost to Follow-up|0|||
160630184|NCT02684370|580026762|FG003|Part B|Lost to Follow-up|1|||
160630185|NCT02684370|580026763|FG004|Part B|Lost to Follow-up|2|||
160630186|NCT02684370|580026764|FG005|Part B|Lost to Follow-up|5|||
160630187|NCT02684370|580026759|FG000|Part B|Subject Withdrawal|0|||
160630188|NCT02684370|580026760|FG001|Part B|Subject Withdrawal|0|||
160630189|NCT02684370|580026761|FG002|Part B|Subject Withdrawal|0|||
160630190|NCT02684370|580026762|FG003|Part B|Subject Withdrawal|1|||
160630191|NCT02684370|580026763|FG004|Part B|Subject Withdrawal|1|||
160630192|NCT02684370|580026764|FG005|Part B|Subject Withdrawal|2|||
160630193|NCT00627094|580026770|FG000|Overall Study|Adverse Event|8|||
160630194|NCT00627094|580026771|FG001|Overall Study|Adverse Event|7|||
160630195|NCT00627094|580026770|FG000|Overall Study|Lost to Follow-up|1|||
160630196|NCT00627094|580026771|FG001|Overall Study|Lost to Follow-up|0|||
160630197|NCT00627094|580026770|FG000|Overall Study|Withdrawal by Subject|1|||
160630198|NCT00627094|580026771|FG001|Overall Study|Withdrawal by Subject|1|||
160630199|NCT00627094|580026770|FG000|Overall Study|ulcer healed|1|||
160630200|NCT00627094|580026771|FG001|Overall Study|ulcer healed|7|||
160630201|NCT00627094|580026770|FG000|Overall Study|Other reason|1|||
160630202|NCT00627094|580026771|FG001|Overall Study|Other reason|0|||
160630203|NCT01165424|580026778|FG000|Overall Study|Clinical adverse experiences|1|||
160630204|NCT01165424|580026778|FG000|Overall Study|Laboratory adverse experiences|1|||
160630205|NCT01165424|580026778|FG000|Overall Study|Did not meet entry criteria|1|||
160630206|NCT01165424|580026778|FG000|Overall Study|Participant moved (relocated)|1|||
160630207|NCT04139642|580026779|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
160630208|NCT04139642|580026780|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
160630209|NCT02050373|580026788|FG000|Overall Study|Adverse Event|4|||
160630210|NCT02050373|580026789|FG001|Overall Study|Adverse Event|7|||
160630211|NCT02050373|580026788|FG000|Overall Study|Death|3|||
160630212|NCT02050373|580026789|FG001|Overall Study|Death|3|||
160630213|NCT01179191|580026793|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
160630214|NCT01179191|580026793|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
160630215|NCT01179191|580026793|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
160630216|NCT01179191|580026793|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
160630217|NCT01179191|580026793|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
160630218|NCT01179191|580026793|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
160630219|NCT01179191|580026793|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
160630220|NCT01179191|580026793|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
160630221|NCT01179191|580026793|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
160630222|NCT01179191|580026793|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
160630223|NCT01179191|580026793|FG000|Maintenance Phase (8 Weeks)|Other|66|||
160630224|NCT01833897|580026802|FG000|Overall Study|Lack of Efficacy|1|||
160630225|NCT00669110|580026803|FG000|Overall Study|Adverse Event|4|||
160630226|NCT00669110|580026804|FG001|Overall Study|Adverse Event|3|||
160630227|NCT00669110|580026803|FG000|Overall Study|Caregiver request|3|||
160630228|NCT00669110|580026804|FG001|Overall Study|Caregiver request|2|||
160630229|NCT00669110|580026803|FG000|Overall Study|Physician Decision|0|||
160630230|NCT00669110|580026804|FG001|Overall Study|Physician Decision|1|||
160630231|NCT00669110|580026803|FG000|Overall Study|Lost to Follow-up|1|||
160630232|NCT00669110|580026804|FG001|Overall Study|Lost to Follow-up|0|||
160630233|NCT00669110|580026803|FG000|Overall Study|Protocol Violation|0|||
160630234|NCT00669110|580026804|FG001|Overall Study|Protocol Violation|5|||
160630235|NCT00669110|580026803|FG000|Overall Study|Withdrawal by Subject|0|||
160630236|NCT00669110|580026804|FG001|Overall Study|Withdrawal by Subject|2|||
160630237|NCT00530621|580026809|FG000|Overall Study|Adverse Event|11|||
160630238|NCT00530621|580026810|FG001|Overall Study|Adverse Event|8|||
160630239|NCT00530621|580026809|FG000|Overall Study|Physician Decision|2|||
160630240|NCT00530621|580026810|FG001|Overall Study|Physician Decision|4|||
160630241|NCT00530621|580026809|FG000|Overall Study|Progressive Disease (PD)|47|||
160630242|NCT00530621|580026810|FG001|Overall Study|Progressive Disease (PD)|40|||
160630243|NCT00530621|580026809|FG000|Overall Study|Sponsor Decision|12|||
160630244|NCT00530621|580026810|FG001|Overall Study|Sponsor Decision|15|||
160630245|NCT00530621|580026809|FG000|Overall Study|Subject Decision|4|||
160630246|NCT00530621|580026810|FG001|Overall Study|Subject Decision|7|||
160630247|NCT00530621|580026809|FG000|Overall Study|Death|3|||
160630248|NCT00530621|580026810|FG001|Overall Study|Death|6|||
160630249|NCT00530621|580026809|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
160630250|NCT00530621|580026810|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
160630251|NCT04611152|580026811|FG000|Overall Study|Adverse Event|9|||
160630252|NCT04611152|580026812|FG001|Overall Study|Adverse Event|8|||
160630253|NCT04611152|580026811|FG000|Overall Study|Non-compliance with study schedule|1|||
160630254|NCT04611152|580026812|FG001|Overall Study|Non-compliance with study schedule|3|||
160630255|NCT04611152|580026811|FG000|Overall Study|Withdrawal by Subject|5|||
160630256|NCT04611152|580026812|FG001|Overall Study|Withdrawal by Subject|6|||
160630257|NCT04611152|580026811|FG000|Overall Study|Lost to Follow-up|11|||
160630258|NCT04611152|580026812|FG001|Overall Study|Lost to Follow-up|2|||
160630259|NCT03917654|580026824|FG000|Year 1|Withdrawal by Subject|1|||
160630260|NCT03917654|580026825|FG001|Year 1|Withdrawal by Subject|0|||
160630261|NCT03917654|580026826|FG002|Year 1|Withdrawal by Subject|0|||
160630262|NCT03917654|580026827|FG003|Year 1|Withdrawal by Subject|0|||
160630263|NCT03917654|580026828|FG004|Year 1|Withdrawal by Subject|0|||
160630264|NCT03917654|580026829|FG005|Year 1|Withdrawal by Subject|1|||
160630265|NCT03917654|580026830|FG006|Year 1|Withdrawal by Subject|6|||
160630266|NCT03917654|580026831|FG007|Year 1|Withdrawal by Subject|2|||
160630267|NCT03917654|580026832|FG008|Year 1|Withdrawal by Subject|5|||
160630268|NCT03917654|580026833|FG009|Year 1|Withdrawal by Subject|3|||
160630269|NCT03917654|580026834|FG010|Year 1|Withdrawal by Subject|1|||
160630270|NCT03917654|580026835|FG011|Year 1|Withdrawal by Subject|0|||
160630271|NCT03917654|580026824|FG000|Year 1|Travel|0|||
160630272|NCT03917654|580026825|FG001|Year 1|Travel|1|||
160630273|NCT03917654|580026826|FG002|Year 1|Travel|1|||
160630274|NCT03917654|580026827|FG003|Year 1|Travel|0|||
160630275|NCT03917654|580026828|FG004|Year 1|Travel|4|||
160630276|NCT03917654|580026829|FG005|Year 1|Travel|4|||
160630277|NCT03917654|580026830|FG006|Year 1|Travel|10|||
160630278|NCT03917654|580026831|FG007|Year 1|Travel|8|||
160630279|NCT03917654|580026832|FG008|Year 1|Travel|2|||
160630280|NCT03917654|580026833|FG009|Year 1|Travel|5|||
160630281|NCT03917654|580026834|FG010|Year 1|Travel|3|||
160630282|NCT03917654|580026835|FG011|Year 1|Travel|3|||
160630283|NCT03917654|580026824|FG000|Year 1|Subject moved away from site|0|||
160630284|NCT03917654|580026825|FG001|Year 1|Subject moved away from site|1|||
160630285|NCT03917654|580026826|FG002|Year 1|Subject moved away from site|0|||
160630286|NCT03917654|580026827|FG003|Year 1|Subject moved away from site|0|||
160630287|NCT03917654|580026828|FG004|Year 1|Subject moved away from site|0|||
160630288|NCT03917654|580026829|FG005|Year 1|Subject moved away from site|0|||
160630289|NCT03917654|580026830|FG006|Year 1|Subject moved away from site|1|||
160630290|NCT03917654|580026831|FG007|Year 1|Subject moved away from site|2|||
160630291|NCT03917654|580026832|FG008|Year 1|Subject moved away from site|1|||
160630292|NCT03917654|580026833|FG009|Year 1|Subject moved away from site|0|||
160630293|NCT03917654|580026834|FG010|Year 1|Subject moved away from site|0|||
160630294|NCT03917654|580026835|FG011|Year 1|Subject moved away from site|3|||
160630295|NCT03917654|580026824|FG000|Year 1|Spouse/Family member request|0|||
160630296|NCT03917654|580026825|FG001|Year 1|Spouse/Family member request|0|||
160630297|NCT03917654|580026826|FG002|Year 1|Spouse/Family member request|1|||
160630298|NCT03917654|580026827|FG003|Year 1|Spouse/Family member request|0|||
160630299|NCT03917654|580026828|FG004|Year 1|Spouse/Family member request|1|||
160630300|NCT03917654|580026829|FG005|Year 1|Spouse/Family member request|0|||
160630301|NCT03917654|580026830|FG006|Year 1|Spouse/Family member request|0|||
160630302|NCT03917654|580026831|FG007|Year 1|Spouse/Family member request|2|||
160630303|NCT03917654|580026832|FG008|Year 1|Spouse/Family member request|0|||
160630304|NCT03917654|580026833|FG009|Year 1|Spouse/Family member request|0|||
160630305|NCT03917654|580026834|FG010|Year 1|Spouse/Family member request|0|||
160630306|NCT03917654|580026835|FG011|Year 1|Spouse/Family member request|1|||
160630307|NCT03917654|580026824|FG000|Year 1|Death|0|||
160630308|NCT03917654|580026825|FG001|Year 1|Death|0|||
160630309|NCT03917654|580026826|FG002|Year 1|Death|0|||
160630310|NCT03917654|580026827|FG003|Year 1|Death|0|||
160630311|NCT03917654|580026828|FG004|Year 1|Death|0|||
160630312|NCT03917654|580026829|FG005|Year 1|Death|0|||
160630313|NCT03917654|580026830|FG006|Year 1|Death|0|||
160630314|NCT03917654|580026831|FG007|Year 1|Death|0|||
160630315|NCT03917654|580026832|FG008|Year 1|Death|1|||
160630316|NCT03917654|580026833|FG009|Year 1|Death|1|||
160630317|NCT03917654|580026834|FG010|Year 1|Death|0|||
160630318|NCT03917654|580026835|FG011|Year 1|Death|0|||
160630319|NCT03917654|580026824|FG000|Year 1|Lost to Follow-up|0|||
160630320|NCT03917654|580026825|FG001|Year 1|Lost to Follow-up|0|||
160630321|NCT03917654|580026826|FG002|Year 1|Lost to Follow-up|0|||
160630322|NCT03917654|580026827|FG003|Year 1|Lost to Follow-up|0|||
160630323|NCT03917654|580026828|FG004|Year 1|Lost to Follow-up|0|||
160630324|NCT03917654|580026829|FG005|Year 1|Lost to Follow-up|0|||
160630325|NCT03917654|580026830|FG006|Year 1|Lost to Follow-up|2|||
160630326|NCT03917654|580026831|FG007|Year 1|Lost to Follow-up|0|||
160630327|NCT03917654|580026832|FG008|Year 1|Lost to Follow-up|0|||
160630328|NCT03917654|580026833|FG009|Year 1|Lost to Follow-up|0|||
160630329|NCT03917654|580026834|FG010|Year 1|Lost to Follow-up|0|||
160630330|NCT03917654|580026835|FG011|Year 1|Lost to Follow-up|0|||
160630331|NCT03917654|580026824|FG000|Year 1|Missed visits|0|||
160630332|NCT03917654|580026825|FG001|Year 1|Missed visits|0|||
160630333|NCT03917654|580026826|FG002|Year 1|Missed visits|0|||
160630334|NCT03917654|580026827|FG003|Year 1|Missed visits|0|||
160630335|NCT03917654|580026828|FG004|Year 1|Missed visits|0|||
160630336|NCT03917654|580026829|FG005|Year 1|Missed visits|0|||
160630337|NCT03917654|580026830|FG006|Year 1|Missed visits|0|||
160630338|NCT03917654|580026831|FG007|Year 1|Missed visits|0|||
160630339|NCT03917654|580026832|FG008|Year 1|Missed visits|0|||
160630340|NCT03917654|580026833|FG009|Year 1|Missed visits|0|||
160630341|NCT03917654|580026834|FG010|Year 1|Missed visits|1|||
160630342|NCT03917654|580026835|FG011|Year 1|Missed visits|1|||
160630343|NCT03917654|580026824|FG000|Year 1|Pregnancy|0|||
160630344|NCT03917654|580026825|FG001|Year 1|Pregnancy|0|||
160630345|NCT03917654|580026826|FG002|Year 1|Pregnancy|0|||
160673621|NCT03358147|580183817|FG000|Overall Study|Major Protocol Deviation|11|||
160630346|NCT03917654|580026827|FG003|Year 1|Pregnancy|0|||
160630347|NCT03917654|580026828|FG004|Year 1|Pregnancy|0|||
160630348|NCT03917654|580026829|FG005|Year 1|Pregnancy|0|||
160630349|NCT03917654|580026830|FG006|Year 1|Pregnancy|0|||
160630350|NCT03917654|580026831|FG007|Year 1|Pregnancy|1|||
160630351|NCT03917654|580026832|FG008|Year 1|Pregnancy|0|||
160630352|NCT03917654|580026833|FG009|Year 1|Pregnancy|1|||
160630353|NCT03917654|580026834|FG010|Year 1|Pregnancy|0|||
160630354|NCT03917654|580026835|FG011|Year 1|Pregnancy|0|||
160630355|NCT03917654|580026824|FG000|Year 2|Travel|1|||
160630356|NCT03917654|580026825|FG001|Year 2|Travel|0|||
160630357|NCT03917654|580026826|FG002|Year 2|Travel|0|||
160630358|NCT03917654|580026827|FG003|Year 2|Travel|0|||
160630359|NCT03917654|580026828|FG004|Year 2|Travel|1|||
160630360|NCT03917654|580026829|FG005|Year 2|Travel|1|||
160630361|NCT03917654|580026830|FG006|Year 2|Travel|2|||
160630362|NCT03917654|580026831|FG007|Year 2|Travel|1|||
160630363|NCT03917654|580026832|FG008|Year 2|Travel|0|||
160630364|NCT03917654|580026833|FG009|Year 2|Travel|1|||
160630365|NCT03917654|580026834|FG010|Year 2|Travel|0|||
160630366|NCT03917654|580026835|FG011|Year 2|Travel|1|||
160630367|NCT03917654|580026824|FG000|Year 2|Married|1|||
160630368|NCT03917654|580026825|FG001|Year 2|Married|0|||
160630369|NCT03917654|580026826|FG002|Year 2|Married|0|||
160630370|NCT03917654|580026827|FG003|Year 2|Married|0|||
160630371|NCT03917654|580026828|FG004|Year 2|Married|0|||
160630372|NCT03917654|580026829|FG005|Year 2|Married|0|||
160630373|NCT03917654|580026830|FG006|Year 2|Married|1|||
160630374|NCT03917654|580026831|FG007|Year 2|Married|1|||
160630375|NCT03917654|580026832|FG008|Year 2|Married|0|||
160630376|NCT03917654|580026833|FG009|Year 2|Married|0|||
160630377|NCT03917654|580026834|FG010|Year 2|Married|0|||
160630378|NCT03917654|580026835|FG011|Year 2|Married|0|||
160630379|NCT03917654|580026824|FG000|Year 2|Subject moved away from site|1|||
160673622|NCT03358147|580183818|FG001|Overall Study|Major Protocol Deviation|3|||
160673623|NCT03358147|580183819|FG002|Overall Study|Major Protocol Deviation|2|||
160673624|NCT03358147|580183820|FG003|Overall Study|Major Protocol Deviation|3|||
160673625|NCT03358147|580183821|FG004|Overall Study|Major Protocol Deviation|1|||
160673626|NCT03358147|580183817|FG000|Overall Study|Protocol specified criteria|2|||
160673627|NCT03358147|580183818|FG001|Overall Study|Protocol specified criteria|3|||
160673628|NCT03358147|580183819|FG002|Overall Study|Protocol specified criteria|0|||
160673629|NCT03358147|580183820|FG003|Overall Study|Protocol specified criteria|3|||
160673630|NCT03358147|580183821|FG004|Overall Study|Protocol specified criteria|1|||
160673631|NCT03358147|580183817|FG000|Overall Study|Physician Decision|1|||
160673632|NCT03358147|580183818|FG001|Overall Study|Physician Decision|0|||
160673633|NCT03358147|580183819|FG002|Overall Study|Physician Decision|1|||
160673634|NCT03358147|580183820|FG003|Overall Study|Physician Decision|6|||
160673635|NCT03358147|580183821|FG004|Overall Study|Physician Decision|1|||
160673636|NCT03358147|580183817|FG000|Overall Study|Administrative reasons|0|||
160673637|NCT03358147|580183818|FG001|Overall Study|Administrative reasons|1|||
160673638|NCT03358147|580183819|FG002|Overall Study|Administrative reasons|0|||
160673639|NCT03358147|580183820|FG003|Overall Study|Administrative reasons|3|||
160673640|NCT03358147|580183821|FG004|Overall Study|Administrative reasons|0|||
160673641|NCT03358147|580183817|FG000|Overall Study|Lack of Efficacy|0|||
160673642|NCT03358147|580183818|FG001|Overall Study|Lack of Efficacy|1|||
160673643|NCT03358147|580183819|FG002|Overall Study|Lack of Efficacy|1|||
160673644|NCT03358147|580183820|FG003|Overall Study|Lack of Efficacy|0|||
160673645|NCT03358147|580183821|FG004|Overall Study|Lack of Efficacy|0|||
160673646|NCT03158727|580183824|FG000|Overall Study|Withdrawal by Subject|2|||
160673647|NCT03158727|580183825|FG001|Overall Study|Withdrawal by Subject|6|||
160673648|NCT03158727|580183824|FG000|Overall Study|Death|11|||
160673649|NCT03158727|580183825|FG001|Overall Study|Death|12|||
160673650|NCT03158727|580183824|FG000|Overall Study|Lost to Follow-up|1|||
160673651|NCT03158727|580183825|FG001|Overall Study|Lost to Follow-up|0|||
160673652|NCT03158727|580183824|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
160673653|NCT03158727|580183825|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
160673654|NCT03158727|580183824|FG000|Overall Study|Visit 11 not done by mistake|0|||
160673655|NCT03158727|580183825|FG001|Overall Study|Visit 11 not done by mistake|1|||
160673656|NCT03158727|580183824|FG000|Overall Study|Enrolled, not treated|1|||
160673657|NCT03158727|580183825|FG001|Overall Study|Enrolled, not treated|0|||
160673658|NCT03236311|580183826|FG000|Overall Study|Study terminated by sponsor|0|||
160673659|NCT03236311|580183827|FG001|Overall Study|Study terminated by sponsor|2|||
160673660|NCT03236311|580183826|FG000|Overall Study|Adverse Event|0|||
160673661|NCT03236311|580183827|FG001|Overall Study|Adverse Event|1|||
160673662|NCT00669162|580183828|FG000|Overall Study|Withdrawal by Subject|1|||
160673663|NCT02704091|580183829|FG000|Overall Study|Adverse Event|4|||
160673664|NCT02704091|580183830|FG001|Overall Study|Adverse Event|3|||
160673665|NCT02704091|580183829|FG000|Overall Study|Protocol Violation|5|||
160673666|NCT02704091|580183830|FG001|Overall Study|Protocol Violation|3|||
160673667|NCT02704091|580183829|FG000|Overall Study|Consent withdrawn|4|||
160673668|NCT02704091|580183830|FG001|Overall Study|Consent withdrawn|4|||
160673669|NCT02704091|580183829|FG000|Overall Study|Lost to Follow-up|13|||
160673670|NCT02704091|580183830|FG001|Overall Study|Lost to Follow-up|5|||
160673671|NCT02704091|580183829|FG000|Overall Study|Other|2|||
160673672|NCT02704091|580183830|FG001|Overall Study|Other|8|||
160673673|NCT02412852|580183831|FG000|Overall Study|Withdrawal by Subject|0|||
160673674|NCT02412852|580183832|FG001|Overall Study|Withdrawal by Subject|1|||
160673675|NCT02412852|580183833|FG002|Overall Study|Withdrawal by Subject|0|||
160673676|NCT02412852|580183834|FG003|Overall Study|Withdrawal by Subject|0|||
160673677|NCT02412852|580183831|FG000|Overall Study|Physician Decision|0|||
160673678|NCT02412852|580183832|FG001|Overall Study|Physician Decision|0|||
160673679|NCT02412852|580183833|FG002|Overall Study|Physician Decision|0|||
160673680|NCT02412852|580183834|FG003|Overall Study|Physician Decision|1|||
160673681|NCT01051349|580183835|FG000|Overall Study|Adverse Event|88|||
160673682|NCT01051349|580183835|FG000|Overall Study|Consent Withdrawn|54|||
160673683|NCT01051349|580183835|FG000|Overall Study|Investigator Decision|6|||
160673684|NCT01051349|580183835|FG000|Overall Study|Lost to Follow-up|6|||
160673685|NCT01051349|580183835|FG000|Overall Study|Subject non-compliance|7|||
160673686|NCT01051349|580183835|FG000|Overall Study|Reason not Specified|12|||
160673687|NCT00840203|580183841|FG000|First Intervention|Protocol Violation|1|||
160673688|NCT00840203|580183842|FG001|First Intervention|Protocol Violation|1|||
160673689|NCT00840203|580183841|FG000|Washout|Protocol Violation|1|||
160673690|NCT00840203|580183842|FG001|Washout|Protocol Violation|0|||
160673691|NCT00101439|580183850|FG000|Period 2|Withdrawal by Subject|0|||
160673692|NCT00101439|580183851|FG001|Period 2|Withdrawal by Subject|2|||
160673693|NCT02615249|580183855|FG000|Overall Study|Withdrawal by Subject|1|||
160673694|NCT00957021|580183856|FG000|Overall Study|Death|5|||
160673695|NCT00957021|580183856|FG000|Overall Study|Lost to Follow-up|8|||
160673696|NCT00957021|580183856|FG000|Overall Study|Withdrawal by Subject|34|||
160673697|NCT00957021|580183856|FG000|Overall Study|No 2 yr ROM data|35|||
160673698|NCT00957021|580183856|FG000|Overall Study|Revised study component by 2 yr visit|8|||
160630380|NCT03917654|580026825|FG001|Year 2|Subject moved away from site|0|||
160630381|NCT03917654|580026826|FG002|Year 2|Subject moved away from site|0|||
160630382|NCT03917654|580026827|FG003|Year 2|Subject moved away from site|0|||
160630383|NCT03917654|580026828|FG004|Year 2|Subject moved away from site|1|||
160630384|NCT03917654|580026829|FG005|Year 2|Subject moved away from site|0|||
160630385|NCT03917654|580026830|FG006|Year 2|Subject moved away from site|2|||
160630386|NCT03917654|580026831|FG007|Year 2|Subject moved away from site|3|||
160630387|NCT03917654|580026832|FG008|Year 2|Subject moved away from site|0|||
160630388|NCT03917654|580026833|FG009|Year 2|Subject moved away from site|2|||
160630389|NCT03917654|580026834|FG010|Year 2|Subject moved away from site|0|||
160630390|NCT03917654|580026835|FG011|Year 2|Subject moved away from site|1|||
160630391|NCT03917654|580026824|FG000|Year 2|Year 2 Screening failure|0|||
160630392|NCT03917654|580026825|FG001|Year 2|Year 2 Screening failure|1|||
160630393|NCT03917654|580026826|FG002|Year 2|Year 2 Screening failure|0|||
160630394|NCT03917654|580026827|FG003|Year 2|Year 2 Screening failure|0|||
160630395|NCT03917654|580026828|FG004|Year 2|Year 2 Screening failure|2|||
160630396|NCT03917654|580026829|FG005|Year 2|Year 2 Screening failure|0|||
160630397|NCT03917654|580026830|FG006|Year 2|Year 2 Screening failure|4|||
160630398|NCT03917654|580026831|FG007|Year 2|Year 2 Screening failure|3|||
160630399|NCT03917654|580026832|FG008|Year 2|Year 2 Screening failure|10|||
160630400|NCT03917654|580026833|FG009|Year 2|Year 2 Screening failure|2|||
160630401|NCT03917654|580026834|FG010|Year 2|Year 2 Screening failure|1|||
160630402|NCT03917654|580026835|FG011|Year 2|Year 2 Screening failure|1|||
160630403|NCT03917654|580026824|FG000|Year 2|Death|0|||
160630404|NCT03917654|580026825|FG001|Year 2|Death|0|||
160630405|NCT03917654|580026826|FG002|Year 2|Death|0|||
160630406|NCT03917654|580026827|FG003|Year 2|Death|0|||
160630407|NCT03917654|580026828|FG004|Year 2|Death|0|||
160630408|NCT03917654|580026829|FG005|Year 2|Death|1|||
160630409|NCT03917654|580026830|FG006|Year 2|Death|0|||
160630410|NCT03917654|580026831|FG007|Year 2|Death|0|||
160630411|NCT03917654|580026832|FG008|Year 2|Death|1|||
160630412|NCT03917654|580026833|FG009|Year 2|Death|1|||
160630413|NCT03917654|580026834|FG010|Year 2|Death|0|||
160630414|NCT03917654|580026835|FG011|Year 2|Death|0|||
160630415|NCT03917654|580026824|FG000|Year 2|Withdrawal by Subject|0|||
160630416|NCT03917654|580026825|FG001|Year 2|Withdrawal by Subject|0|||
160630417|NCT03917654|580026826|FG002|Year 2|Withdrawal by Subject|0|||
160630418|NCT03917654|580026827|FG003|Year 2|Withdrawal by Subject|0|||
160630419|NCT03917654|580026828|FG004|Year 2|Withdrawal by Subject|0|||
160630420|NCT03917654|580026829|FG005|Year 2|Withdrawal by Subject|0|||
160630421|NCT03917654|580026830|FG006|Year 2|Withdrawal by Subject|3|||
160630422|NCT03917654|580026831|FG007|Year 2|Withdrawal by Subject|0|||
160630423|NCT03917654|580026832|FG008|Year 2|Withdrawal by Subject|2|||
160630424|NCT03917654|580026833|FG009|Year 2|Withdrawal by Subject|5|||
160630425|NCT03917654|580026834|FG010|Year 2|Withdrawal by Subject|0|||
160630426|NCT03917654|580026835|FG011|Year 2|Withdrawal by Subject|0|||
160630427|NCT03917654|580026824|FG000|Year 2|Spouse/family member request|0|||
160630428|NCT03917654|580026825|FG001|Year 2|Spouse/family member request|0|||
160630429|NCT03917654|580026826|FG002|Year 2|Spouse/family member request|0|||
160630430|NCT03917654|580026827|FG003|Year 2|Spouse/family member request|0|||
160630431|NCT03917654|580026828|FG004|Year 2|Spouse/family member request|0|||
160630432|NCT03917654|580026829|FG005|Year 2|Spouse/family member request|0|||
160630433|NCT03917654|580026830|FG006|Year 2|Spouse/family member request|1|||
160630434|NCT03917654|580026831|FG007|Year 2|Spouse/family member request|0|||
160630435|NCT03917654|580026832|FG008|Year 2|Spouse/family member request|0|||
160630436|NCT03917654|580026833|FG009|Year 2|Spouse/family member request|0|||
160630437|NCT03917654|580026834|FG010|Year 2|Spouse/family member request|0|||
160630438|NCT03917654|580026835|FG011|Year 2|Spouse/family member request|0|||
160630439|NCT03917654|580026824|FG000|Year 2|Lost to Follow-up|0|||
160630440|NCT03917654|580026825|FG001|Year 2|Lost to Follow-up|0|||
160630441|NCT03917654|580026826|FG002|Year 2|Lost to Follow-up|0|||
160630442|NCT03917654|580026827|FG003|Year 2|Lost to Follow-up|0|||
160630443|NCT03917654|580026828|FG004|Year 2|Lost to Follow-up|0|||
160630444|NCT03917654|580026829|FG005|Year 2|Lost to Follow-up|0|||
160630445|NCT03917654|580026830|FG006|Year 2|Lost to Follow-up|1|||
160630446|NCT03917654|580026831|FG007|Year 2|Lost to Follow-up|0|||
160630447|NCT03917654|580026832|FG008|Year 2|Lost to Follow-up|1|||
160630448|NCT03917654|580026833|FG009|Year 2|Lost to Follow-up|0|||
160630449|NCT03917654|580026834|FG010|Year 2|Lost to Follow-up|0|||
160630450|NCT03917654|580026835|FG011|Year 2|Lost to Follow-up|1|||
160630451|NCT03917654|580026824|FG000|Year 2|Adverse Event|0|||
160630452|NCT03917654|580026825|FG001|Year 2|Adverse Event|0|||
160630453|NCT03917654|580026826|FG002|Year 2|Adverse Event|0|||
160630454|NCT03917654|580026827|FG003|Year 2|Adverse Event|0|||
160630455|NCT03917654|580026828|FG004|Year 2|Adverse Event|0|||
160630456|NCT03917654|580026829|FG005|Year 2|Adverse Event|0|||
160630457|NCT03917654|580026830|FG006|Year 2|Adverse Event|0|||
160630458|NCT03917654|580026831|FG007|Year 2|Adverse Event|0|||
160630459|NCT03917654|580026832|FG008|Year 2|Adverse Event|0|||
160630460|NCT03917654|580026833|FG009|Year 2|Adverse Event|1|||
160630461|NCT03917654|580026834|FG010|Year 2|Adverse Event|0|||
160630462|NCT03917654|580026835|FG011|Year 2|Adverse Event|0|||
160630463|NCT05012943|580026836|FG000|Overall Study|Adverse Event|2|||
160630464|NCT05012943|580026837|FG001|Overall Study|Adverse Event|1|||
160630465|NCT05012943|580026838|FG002|Overall Study|Adverse Event|0|||
160630466|NCT05012943|580026836|FG000|Overall Study|Withdrawal by Subject|1052|||
160630467|NCT05012943|580026837|FG001|Overall Study|Withdrawal by Subject|1006|||
160630468|NCT05012943|580026838|FG002|Overall Study|Withdrawal by Subject|20|||
160630469|NCT05012943|580026836|FG000|Overall Study|Death|25|||
160630470|NCT05012943|580026837|FG001|Overall Study|Death|17|||
160630471|NCT05012943|580026838|FG002|Overall Study|Death|4|||
160630472|NCT05012943|580026836|FG000|Overall Study|Lost to Follow-up|11|||
160630473|NCT05012943|580026837|FG001|Overall Study|Lost to Follow-up|24|||
160630474|NCT05012943|580026838|FG002|Overall Study|Lost to Follow-up|3|||
160630475|NCT05012943|580026836|FG000|Overall Study|Physician Decision|1|||
160630476|NCT05012943|580026837|FG001|Overall Study|Physician Decision|1|||
160630477|NCT05012943|580026838|FG002|Overall Study|Physician Decision|0|||
160630478|NCT05012943|580026836|FG000|Overall Study|Other than Specified|2|||
160630479|NCT05012943|580026837|FG001|Overall Study|Other than Specified|1|||
160630480|NCT05012943|580026838|FG002|Overall Study|Other than Specified|0|||
160630481|NCT00400985|580026840|FG000|Overall Study|Withdrawal by Subject|5|||
160630482|NCT00400985|580026840|FG000|Overall Study|system modification|8|||
160630483|NCT00400985|580026840|FG000|Overall Study|Death|30|||
160630484|NCT00400985|580026840|FG000|Overall Study|Lost to Follow-up|9|||
160630485|NCT05048875|580026842|FG000|Overall Study|Withdrawal by Subject|1|||
160630486|NCT05048875|580026843|FG001|Overall Study|Withdrawal by Subject|0|||
160630487|NCT05048875|580026844|FG002|Overall Study|Withdrawal by Subject|0|||
160630488|NCT05048875|580026845|FG003|Overall Study|Withdrawal by Subject|0|||
160630489|NCT05048875|580026846|FG004|Overall Study|Withdrawal by Subject|0|||
160630490|NCT05048875|580026847|FG005|Overall Study|Withdrawal by Subject|0|||
160630491|NCT05048875|580026848|FG006|Overall Study|Withdrawal by Subject|0|||
160630492|NCT05048875|580026849|FG007|Overall Study|Withdrawal by Subject|0|||
160630493|NCT05048875|580026842|FG000|Overall Study|Adverse Event|0|||
160630494|NCT05048875|580026843|FG001|Overall Study|Adverse Event|0|||
160630495|NCT05048875|580026844|FG002|Overall Study|Adverse Event|0|||
160630496|NCT05048875|580026845|FG003|Overall Study|Adverse Event|1|||
160630497|NCT05048875|580026846|FG004|Overall Study|Adverse Event|0|||
160630498|NCT05048875|580026847|FG005|Overall Study|Adverse Event|0|||
160630499|NCT05048875|580026848|FG006|Overall Study|Adverse Event|0|||
160630500|NCT05048875|580026849|FG007|Overall Study|Adverse Event|0|||
160630501|NCT02255422|580026851|FG000|Overall Study|Withdrawal by Subject|0|||
160630502|NCT02255422|580026852|FG001|Overall Study|Withdrawal by Subject|0|||
160630503|NCT02255422|580026853|FG002|Overall Study|Withdrawal by Subject|0|||
160630504|NCT02255422|580026854|FG003|Overall Study|Withdrawal by Subject|0|||
160630505|NCT02255422|580026855|FG004|Overall Study|Withdrawal by Subject|0|||
160630506|NCT02255422|580026856|FG005|Overall Study|Withdrawal by Subject|0|||
160630507|NCT02255422|580026857|FG006|Overall Study|Withdrawal by Subject|2|||
160630508|NCT02255422|580026851|FG000|Overall Study|Lost to Follow-up|0|||
160630509|NCT02255422|580026852|FG001|Overall Study|Lost to Follow-up|0|||
160630510|NCT02255422|580026853|FG002|Overall Study|Lost to Follow-up|1|||
160630511|NCT02255422|580026854|FG003|Overall Study|Lost to Follow-up|0|||
160630512|NCT02255422|580026855|FG004|Overall Study|Lost to Follow-up|0|||
160630513|NCT02255422|580026856|FG005|Overall Study|Lost to Follow-up|0|||
160630514|NCT02255422|580026857|FG006|Overall Study|Lost to Follow-up|0|||
160673699|NCT00957021|580183856|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
160630539|NCT00972309|580026873|FG000|Overall Study|Switched to alternative treatment|0|||
160630540|NCT00972309|580026874|FG001|Overall Study|Switched to alternative treatment|2|||
160630541|NCT00972309|580026873|FG000|Overall Study|Refused further treatment|0|||
160630542|NCT00972309|580026874|FG001|Overall Study|Refused further treatment|1|||
160630543|NCT00972309|580026873|FG000|Overall Study|Late determination of ineligibility|0|||
160630544|NCT00972309|580026874|FG001|Overall Study|Late determination of ineligibility|1|||
160630545|NCT00972309|580026873|FG000|Overall Study|Second malignancy|1|||
160630546|NCT00972309|580026874|FG001|Overall Study|Second malignancy|1|||
160630547|NCT00972309|580026873|FG000|Overall Study|Visa issues|0|||
160630548|NCT00972309|580026874|FG001|Overall Study|Visa issues|1|||
160630549|NCT00972309|580026873|FG000|Overall Study|Secondary cancer (SCC)|0|||
160630550|NCT00972309|580026874|FG001|Overall Study|Secondary cancer (SCC)|1|||
160630551|NCT00972309|580026873|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
160630552|NCT00972309|580026874|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
160630553|NCT00972309|580026873|FG000|Overall Study|Lost to Follow-up|1|||
160630554|NCT00972309|580026874|FG001|Overall Study|Lost to Follow-up|1|||
160630555|NCT00972309|580026873|FG000|Overall Study|Disease progression on study|10|||
160630556|NCT00972309|580026874|FG001|Overall Study|Disease progression on study|4|||
160630557|NCT00167414|580026877|FG000|Overall Study|Death|10|||
160630558|NCT01593761|580026878|FG000|Overall Study|Lost to Follow-up|1|||
160630559|NCT01593761|580026878|FG000|Overall Study|culture negative for MRSA at baseline|5|||
160630560|NCT01593761|580026878|FG000|Overall Study|positive for hepatitis C virus|1|||
160630561|NCT01593761|580026878|FG000|Overall Study|secondary cellulitis|1|||
160630562|NCT02576951|580026879|FG000|Overall Study|Lost to Follow-up|0|||
160630563|NCT02576951|580026880|FG001|Overall Study|Lost to Follow-up|0|||
160630564|NCT02576951|580026881|FG002|Overall Study|Lost to Follow-up|2|||
160630565|NCT02576951|580026882|FG003|Overall Study|Lost to Follow-up|2|||
160630566|NCT02576951|580026879|FG000|Overall Study|Withdrawal by Subject|1|||
160630567|NCT02576951|580026880|FG001|Overall Study|Withdrawal by Subject|0|||
160630568|NCT02576951|580026881|FG002|Overall Study|Withdrawal by Subject|0|||
160630569|NCT02576951|580026882|FG003|Overall Study|Withdrawal by Subject|2|||
160630570|NCT02576951|580026879|FG000|Overall Study|Protocol Violation|0|||
160630571|NCT02576951|580026880|FG001|Overall Study|Protocol Violation|0|||
160630572|NCT02576951|580026881|FG002|Overall Study|Protocol Violation|0|||
160630573|NCT02576951|580026882|FG003|Overall Study|Protocol Violation|1|||
160630574|NCT00223990|580026883|FG000|Overall Study|Moved from area|2|||
160630575|NCT00223990|580026884|FG001|Overall Study|Moved from area|1|||
160630576|NCT00223990|580026883|FG000|Overall Study|Withdrawal by Subject|4|||
160630577|NCT00223990|580026884|FG001|Overall Study|Withdrawal by Subject|8|||
160630578|NCT00223990|580026883|FG000|Overall Study|Lost to Follow-up|1|||
160630579|NCT00223990|580026884|FG001|Overall Study|Lost to Follow-up|0|||
160630580|NCT01319994|580028929|FG000|Overall Study|Protocol Violation|7|||
160630581|NCT01319994|580028930|FG001|Overall Study|Protocol Violation|6|||
160630582|NCT01340794|580028931|FG000|Overall Study|Withdrawal by Subject|0|||
160630583|NCT01340794|580028932|FG001|Overall Study|Withdrawal by Subject|1|||
160630584|NCT02674568|580028941|FG000|Overall Study|Withdrawal by Subject|5|||
160630585|NCT02674568|580028941|FG000|Overall Study|Death|303|||
160630586|NCT02674568|580028941|FG000|Overall Study|Physician Decision|2|||
160630587|NCT02674568|580028941|FG000|Overall Study|Lost to Follow-up|9|||
160630588|NCT02674568|580028941|FG000|Overall Study|Other, Not Specified|20|||
160630589|NCT01808508|580028944|FG000|Overall Study|Lost to Follow-up|1|||
160630590|NCT01808508|580028945|FG001|Overall Study|Lost to Follow-up|0|||
160630591|NCT01808508|580028946|FG002|Overall Study|Lost to Follow-up|0|||
160630592|NCT01118949|580028947|FG000|Overall Study|Adverse Event|5|||
160630593|NCT01118949|580028947|FG000|Overall Study|Withdrawal by Subject|4|||
160630594|NCT00648739|580028948|FG000|Overall Study|Adverse Event|1|||
160630595|NCT00648739|580028949|FG001|Overall Study|Adverse Event|0|||
160630596|NCT00648739|580028950|FG002|Overall Study|Adverse Event|1|||
160630597|NCT00648739|580028951|FG003|Overall Study|Adverse Event|2|||
160630598|NCT00648739|580028952|FG004|Overall Study|Adverse Event|1|||
160630599|NCT00648739|580028953|FG005|Overall Study|Adverse Event|0|||
160630600|NCT00648739|580028954|FG006|Overall Study|Adverse Event|0|||
160630601|NCT00648739|580028948|FG000|Overall Study|Withdrawal by Subject|1|||
160630602|NCT00648739|580028949|FG001|Overall Study|Withdrawal by Subject|0|||
160630603|NCT00648739|580028950|FG002|Overall Study|Withdrawal by Subject|1|||
160630604|NCT00648739|580028951|FG003|Overall Study|Withdrawal by Subject|0|||
160630605|NCT00648739|580028952|FG004|Overall Study|Withdrawal by Subject|0|||
160630606|NCT00648739|580028953|FG005|Overall Study|Withdrawal by Subject|2|||
160630607|NCT00648739|580028954|FG006|Overall Study|Withdrawal by Subject|0|||
160630608|NCT00648739|580028948|FG000|Overall Study|Lack of Efficacy|0|||
160630609|NCT00648739|580028949|FG001|Overall Study|Lack of Efficacy|0|||
160630610|NCT00648739|580028950|FG002|Overall Study|Lack of Efficacy|0|||
160630611|NCT00648739|580028951|FG003|Overall Study|Lack of Efficacy|0|||
160630612|NCT00648739|580028952|FG004|Overall Study|Lack of Efficacy|1|||
160630613|NCT00648739|580028953|FG005|Overall Study|Lack of Efficacy|2|||
160630614|NCT00648739|580028954|FG006|Overall Study|Lack of Efficacy|0|||
160630615|NCT00648739|580028948|FG000|Overall Study|Investigator Considered it Advisable|0|||
160630616|NCT00648739|580028949|FG001|Overall Study|Investigator Considered it Advisable|0|||
160630617|NCT00648739|580028950|FG002|Overall Study|Investigator Considered it Advisable|0|||
160630618|NCT00648739|580028951|FG003|Overall Study|Investigator Considered it Advisable|0|||
160630619|NCT00648739|580028952|FG004|Overall Study|Investigator Considered it Advisable|0|||
160630620|NCT00648739|580028953|FG005|Overall Study|Investigator Considered it Advisable|1|||
160630621|NCT00648739|580028954|FG006|Overall Study|Investigator Considered it Advisable|1|||
160630622|NCT00648739|580028948|FG000|Overall Study|Death|0|||
160630623|NCT00648739|580028949|FG001|Overall Study|Death|1|||
160630624|NCT00648739|580028950|FG002|Overall Study|Death|0|||
160630625|NCT00648739|580028951|FG003|Overall Study|Death|0|||
160630626|NCT00648739|580028952|FG004|Overall Study|Death|0|||
160630627|NCT00648739|580028953|FG005|Overall Study|Death|0|||
160630628|NCT00648739|580028954|FG006|Overall Study|Death|0|||
160630629|NCT00648739|580028948|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
160630630|NCT00648739|580028949|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
160630631|NCT00648739|580028950|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
160630632|NCT00648739|580028951|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
160630633|NCT00648739|580028952|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
160630634|NCT00648739|580028953|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
160630635|NCT00648739|580028954|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
160630636|NCT00648739|580028948|FG000|Overall Study|Follow-up Visits Not Completed|0|||
160630637|NCT00648739|580028949|FG001|Overall Study|Follow-up Visits Not Completed|1|||
160630638|NCT00648739|580028950|FG002|Overall Study|Follow-up Visits Not Completed|0|||
160630639|NCT00648739|580028951|FG003|Overall Study|Follow-up Visits Not Completed|0|||
160630640|NCT00648739|580028952|FG004|Overall Study|Follow-up Visits Not Completed|0|||
160630641|NCT00648739|580028953|FG005|Overall Study|Follow-up Visits Not Completed|0|||
160630642|NCT00648739|580028954|FG006|Overall Study|Follow-up Visits Not Completed|0|||
160630643|NCT03387423|580028959|FG000|Overall Study|Lost to Follow-up|16|||
160630644|NCT03387423|580028960|FG001|Overall Study|Lost to Follow-up|12|||
160630645|NCT03387423|580028961|FG002|Overall Study|Lost to Follow-up|1|||
160630646|NCT03387423|580028962|FG003|Overall Study|Lost to Follow-up|0|||
160630647|NCT03387423|580028959|FG000|Overall Study|Other|0|||
160630648|NCT03387423|580028960|FG001|Overall Study|Other|3|||
160630649|NCT03387423|580028961|FG002|Overall Study|Other|0|||
160630650|NCT03387423|580028962|FG003|Overall Study|Other|0|||
160630651|NCT03387423|580028959|FG000|Overall Study|Administrative Reason|166|||
160630652|NCT03387423|580028960|FG001|Overall Study|Administrative Reason|89|||
160630653|NCT03387423|580028961|FG002|Overall Study|Administrative Reason|17|||
160630654|NCT03387423|580028962|FG003|Overall Study|Administrative Reason|19|||
160630655|NCT03387423|580028959|FG000|Overall Study|Revocation Consent|76|||
160630656|NCT03387423|580028960|FG001|Overall Study|Revocation Consent|32|||
160630657|NCT03387423|580028961|FG002|Overall Study|Revocation Consent|3|||
160630658|NCT03387423|580028962|FG003|Overall Study|Revocation Consent|5|||
160630659|NCT04362761|580028969|FG000|Part A (48 Weeks)|Adverse Event|2|||
160630660|NCT04362761|580028969|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
160630661|NCT04362761|580028969|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
160630662|NCT04362761|580028969|FG000|Part A (48 Weeks)|Other|5|||
160630663|NCT04362761|580028969|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
160630664|NCT04362761|580028969|FG000|Part B (86 Weeks)|Other|4|||
160630665|NCT01473589|580028977|FG000|Overall Study|Adverse Event|1|||
160630666|NCT01473589|580028978|FG001|Overall Study|Adverse Event|1|||
160630667|NCT01473589|580028977|FG000|Overall Study|Death|2|||
160630668|NCT01473589|580028978|FG001|Overall Study|Death|0|||
160630669|NCT01473589|580028977|FG000|Overall Study|Lost to Follow-up|2|||
160630670|NCT01473589|580028978|FG001|Overall Study|Lost to Follow-up|2|||
160630671|NCT01473589|580028977|FG000|Overall Study|Protocol Violation|1|||
160630672|NCT01473589|580028978|FG001|Overall Study|Protocol Violation|0|||
160630673|NCT01473589|580028977|FG000|Overall Study|Withdrawal by Subject|5|||
160630674|NCT01473589|580028978|FG001|Overall Study|Withdrawal by Subject|11|||
160630675|NCT01473589|580028977|FG000|Overall Study|Physician Decision|0|||
160630676|NCT01473589|580028978|FG001|Overall Study|Physician Decision|1|||
160630677|NCT01473589|580028977|FG000|Overall Study|Entry criteria not met|0|||
160630678|NCT01473589|580028978|FG001|Overall Study|Entry criteria not met|1|||
160673700|NCT00957021|580183856|FG000|Overall Study|Surgery Cancelled|9|||
160630679|NCT01721200|580028981|FG000|Overall Study|Lost to Follow-up|3|||
160630680|NCT01721200|580028982|FG001|Overall Study|Lost to Follow-up|5|||
160630681|NCT01513759|580028983|FG000|Overall Study|Protocol Violation|4|||
160630682|NCT01513759|580028983|FG000|Overall Study|Death during catheter placement|1|||
160630683|NCT03606109|580028984|FG000|Overall Study|Lost to Follow-up|2|||
160630684|NCT03606109|580028985|FG001|Overall Study|Lost to Follow-up|1|||
160630685|NCT03926728|580028986|FG000|Overall Study|Withdrawal by Subject|0|||
160630686|NCT03926728|580028987|FG001|Overall Study|Withdrawal by Subject|1|||
160630687|NCT03926728|580028988|FG002|Overall Study|Withdrawal by Subject|1|||
160630688|NCT03926728|580028989|FG003|Overall Study|Withdrawal by Subject|0|||
160630689|NCT03926728|580028990|FG004|Overall Study|Withdrawal by Subject|0|||
160630690|NCT03926728|580028991|FG005|Overall Study|Withdrawal by Subject|1|||
160630691|NCT03926728|580028992|FG006|Overall Study|Withdrawal by Subject|1|||
160630692|NCT03926728|580028993|FG007|Overall Study|Withdrawal by Subject|0|||
160630693|NCT03926728|580028994|FG008|Overall Study|Withdrawal by Subject|0|||
160630694|NCT03926728|580028995|FG009|Overall Study|Withdrawal by Subject|1|||
160630695|NCT03926728|580028996|FG010|Overall Study|Withdrawal by Subject|0|||
160630696|NCT03926728|580028997|FG011|Overall Study|Withdrawal by Subject|0|||
160630697|NCT03669640|580029002|FG000|Overall Study|Study Terminated by Sponsor|0|||
160630698|NCT03669640|580029003|FG001|Overall Study|Study Terminated by Sponsor|0|||
160630699|NCT03669640|580029004|FG002|Overall Study|Study Terminated by Sponsor|0|||
160630700|NCT03669640|580029005|FG003|Overall Study|Study Terminated by Sponsor|0|||
160630701|NCT03669640|580029006|FG004|Overall Study|Study Terminated by Sponsor|1|||
160630702|NCT03669640|580029007|FG005|Overall Study|Study Terminated by Sponsor|0|||
160630703|NCT03669640|580029002|FG000|Overall Study|Lost to Follow-up|0|||
160630704|NCT03669640|580029003|FG001|Overall Study|Lost to Follow-up|0|||
160630705|NCT03669640|580029004|FG002|Overall Study|Lost to Follow-up|2|||
160630706|NCT03669640|580029005|FG003|Overall Study|Lost to Follow-up|0|||
160630707|NCT03669640|580029006|FG004|Overall Study|Lost to Follow-up|0|||
160630708|NCT03669640|580029007|FG005|Overall Study|Lost to Follow-up|0|||
160630709|NCT03669640|580029002|FG000|Overall Study|Death|0|||
160630710|NCT03669640|580029003|FG001|Overall Study|Death|0|||
160630711|NCT03669640|580029004|FG002|Overall Study|Death|1|||
160630712|NCT03669640|580029005|FG003|Overall Study|Death|0|||
160630713|NCT03669640|580029006|FG004|Overall Study|Death|0|||
160630714|NCT03669640|580029007|FG005|Overall Study|Death|0|||
160630715|NCT03669640|580029002|FG000|Overall Study|Withdrawal by Subject|1|||
160630716|NCT03669640|580029003|FG001|Overall Study|Withdrawal by Subject|2|||
160630717|NCT03669640|580029004|FG002|Overall Study|Withdrawal by Subject|1|||
160630718|NCT03669640|580029005|FG003|Overall Study|Withdrawal by Subject|0|||
160630719|NCT03669640|580029006|FG004|Overall Study|Withdrawal by Subject|1|||
160630720|NCT03669640|580029007|FG005|Overall Study|Withdrawal by Subject|3|||
160630721|NCT03669640|580029002|FG000|Overall Study|Protocol Violation|1|||
160630722|NCT03669640|580029003|FG001|Overall Study|Protocol Violation|0|||
160630723|NCT03669640|580029004|FG002|Overall Study|Protocol Violation|0|||
160630724|NCT03669640|580029005|FG003|Overall Study|Protocol Violation|0|||
160630725|NCT03669640|580029006|FG004|Overall Study|Protocol Violation|0|||
160630726|NCT03669640|580029007|FG005|Overall Study|Protocol Violation|0|||
160630727|NCT03669640|580029002|FG000|Overall Study|Physician Decision|0|||
160630728|NCT03669640|580029003|FG001|Overall Study|Physician Decision|2|||
160630729|NCT03669640|580029004|FG002|Overall Study|Physician Decision|0|||
160630730|NCT03669640|580029005|FG003|Overall Study|Physician Decision|0|||
160630731|NCT03669640|580029006|FG004|Overall Study|Physician Decision|0|||
160630732|NCT03669640|580029007|FG005|Overall Study|Physician Decision|0|||
160630733|NCT03669640|580029002|FG000|Overall Study|Disease Relapse|1|||
160630734|NCT03669640|580029003|FG001|Overall Study|Disease Relapse|0|||
160630735|NCT03669640|580029004|FG002|Overall Study|Disease Relapse|0|||
160630736|NCT03669640|580029005|FG003|Overall Study|Disease Relapse|0|||
160630737|NCT03669640|580029006|FG004|Overall Study|Disease Relapse|0|||
160630738|NCT03669640|580029007|FG005|Overall Study|Disease Relapse|0|||
160630739|NCT03669640|580029002|FG000|Overall Study|Adverse Event|2|||
160630740|NCT03669640|580029003|FG001|Overall Study|Adverse Event|1|||
160630741|NCT03669640|580029004|FG002|Overall Study|Adverse Event|0|||
160630742|NCT03669640|580029005|FG003|Overall Study|Adverse Event|0|||
160630743|NCT03669640|580029006|FG004|Overall Study|Adverse Event|1|||
160630744|NCT03669640|580029007|FG005|Overall Study|Adverse Event|0|||
160630745|NCT03722849|580029010|FG000|Overall Study|Withdrawal by Subject|1|||
160630746|NCT03722849|580029011|FG001|Overall Study|Withdrawal by Subject|1|||
160630747|NCT03993288|580029012|FG000|Overall Study|Lost to Follow-up|2|||
160630748|NCT03993288|580029013|FG001|Overall Study|Lost to Follow-up|1|||
160630749|NCT03993288|580029012|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
160630750|NCT03993288|580029013|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
160630751|NCT03993288|580029012|FG000|Overall Study|wrong randomization|0|||
160630752|NCT03993288|580029013|FG001|Overall Study|wrong randomization|1|||
160630753|NCT03993288|580029012|FG000|Overall Study|improper enrollment|0|||
160630754|NCT03993288|580029013|FG001|Overall Study|improper enrollment|1|||
160630755|NCT03993288|580029012|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
160630756|NCT03993288|580029013|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
160630757|NCT03993288|580029012|FG000|Overall Study|developed SAE|2|||
160630758|NCT03993288|580029013|FG001|Overall Study|developed SAE|0|||
160630759|NCT03993288|580029012|FG000|Overall Study|consent withdrawal|1|||
160630760|NCT03993288|580029013|FG001|Overall Study|consent withdrawal|0|||
160630761|NCT03993288|580029012|FG000|Overall Study|did not follow the treatment schedule|1|||
160630762|NCT03993288|580029013|FG001|Overall Study|did not follow the treatment schedule|0|||
160630763|NCT03993288|580029012|FG000|Overall Study|did not follow the treatment regimen|1|||
160630764|NCT03993288|580029013|FG001|Overall Study|did not follow the treatment regimen|0|||
160630765|NCT03993288|580029012|FG000|Overall Study|Adverse Event|1|||
160630766|NCT03993288|580029013|FG001|Overall Study|Adverse Event|0|||
160630767|NCT03993288|580029012|FG000|Overall Study|Withdrawal by Subject|1|||
160630768|NCT03993288|580029013|FG001|Overall Study|Withdrawal by Subject|1|||
160630769|NCT02729545|580029014|FG000|Overall Study|Pregnancy|1|||
160630770|NCT02729545|580029015|FG001|Overall Study|Pregnancy|1|||
160630771|NCT02729545|580029014|FG000|Overall Study|Lost to Follow-up|0|||
160673701|NCT00957021|580183856|FG000|Overall Study|Termination due to language issue|2|||
160673702|NCT01087502|580183869|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
160673703|NCT01087502|580183870|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
160673704|NCT01087502|580183869|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
160673705|NCT01087502|580183870|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
160673706|NCT01087502|580183869|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
160673707|NCT01087502|580183870|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
160673708|NCT01087502|580183869|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
160673709|NCT01087502|580183870|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
160673710|NCT01087502|580183869|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
160673711|NCT01087502|580183870|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
160673712|NCT01087502|580183869|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
160673713|NCT01087502|580183870|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
160673714|NCT01087502|580183869|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
160673715|NCT01087502|580183870|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
160673716|NCT01087502|580183869|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
160673717|NCT01087502|580183870|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
160673718|NCT01087502|580183869|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
160673719|NCT01087502|580183870|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
160673720|NCT01087502|580183869|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
160673721|NCT01087502|580183870|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
160673722|NCT01087502|580183869|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
160673723|NCT01087502|580183870|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
160673724|NCT01087502|580183869|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
160673725|NCT01087502|580183870|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
160673726|NCT02705716|580183871|FG000|Overall Study|Adverse Event|0|||
160673727|NCT02705716|580183872|FG001|Overall Study|Adverse Event|1|||
160673728|NCT02705716|580183871|FG000|Overall Study|Protocol Violation|3|||
160673729|NCT02705716|580183872|FG001|Overall Study|Protocol Violation|0|||
160673730|NCT02705716|580183871|FG000|Overall Study|Withdrawal of Consent|1|||
160673731|NCT02705716|580183872|FG001|Overall Study|Withdrawal of Consent|1|||
160673732|NCT01151618|580183873|FG000|Overall Study|Adverse Event|2|||
160673733|NCT01151618|580183873|FG000|Overall Study|Withdrawal by Subject|7|||
160673734|NCT00562718|580183874|FG000|Overall Study|Death|1|||
160673735|NCT00562718|580183874|FG000|Overall Study|Withdrawal by Subject|3|||
160673736|NCT00562718|580183874|FG000|Overall Study|Adverse Event|4|||
160673737|NCT00562718|580183874|FG000|Overall Study|Lack of Efficacy|2|||
160673738|NCT00562718|580183874|FG000|Overall Study|not stated|1|||
160673739|NCT04025021|580183875|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
160673740|NCT04025021|580183876|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
160673741|NCT01663896|580183879|FG000|Overall Study|Various reasons|43|||
160673742|NCT05412121|580183883|FG000|Overall Study|Withdrawal by Subject|4|||
160673743|NCT05412121|580183883|FG000|Overall Study|Physician Decision|1|||
160673744|NCT05412121|580183883|FG000|Overall Study|Lost to Follow-up|5|||
160673745|NCT03727139|580183884|FG000|Overall Study|Protocol Violation|60|||
160673746|NCT00566722|580183885|FG000|Overall Study|Adverse Event|0|||
160673747|NCT00566722|580183886|FG001|Overall Study|Adverse Event|1|||
160673748|NCT00566722|580183887|FG002|Overall Study|Adverse Event|0|||
160673749|NCT00566722|580183885|FG000|Overall Study|Withdrawal by Subject|0|||
160673750|NCT00566722|580183886|FG001|Overall Study|Withdrawal by Subject|0|||
160673751|NCT00566722|580183887|FG002|Overall Study|Withdrawal by Subject|1|||
160673752|NCT00566722|580183885|FG000|Overall Study|Lost to Follow-up|1|||
160630772|NCT02729545|580029015|FG001|Overall Study|Lost to Follow-up|1|||
160630773|NCT02729545|580029014|FG000|Overall Study|Withdrawal by Subject|2|||
160630774|NCT02729545|580029015|FG001|Overall Study|Withdrawal by Subject|3|||
160630775|NCT03533608|580029016|FG000|Overall Study|Withdrawal by Subject|3|||
160630776|NCT03533608|580029016|FG000|Overall Study|Physician Decision|2|||
160630777|NCT00915473|580029017|FG000|Screening|Withdrawal by Subject|1|||
160630778|NCT00915473|580029018|FG001|Screening|Withdrawal by Subject|0|||
160673753|NCT00566722|580183886|FG001|Overall Study|Lost to Follow-up|1|||
160673754|NCT00566722|580183887|FG002|Overall Study|Lost to Follow-up|1|||
160673755|NCT00566722|580183885|FG000|Overall Study|Lack of Efficacy|1|||
160673756|NCT00566722|580183886|FG001|Overall Study|Lack of Efficacy|2|||
160673757|NCT00566722|580183887|FG002|Overall Study|Lack of Efficacy|4|||
160673758|NCT00566722|580183885|FG000|Overall Study|Did not meet exclusion criteria|0|||
160673759|NCT00566722|580183886|FG001|Overall Study|Did not meet exclusion criteria|0|||
160673760|NCT00566722|580183887|FG002|Overall Study|Did not meet exclusion criteria|2|||
160673761|NCT00566722|580183885|FG000|Overall Study|Serious adverse event|0|||
160673762|NCT00566722|580183886|FG001|Overall Study|Serious adverse event|1|||
160673763|NCT00566722|580183887|FG002|Overall Study|Serious adverse event|0|||
160673764|NCT00566722|580183885|FG000|Overall Study|Noncompliant with drug administration|0|||
160673765|NCT00566722|580183886|FG001|Overall Study|Noncompliant with drug administration|0|||
160630779|NCT00915473|580029017|FG000|4-week Follow Up|Lost to Follow-up|1|||
160673766|NCT00566722|580183887|FG002|Overall Study|Noncompliant with drug administration|1|||
160673767|NCT00858403|580183888|FG000|Overall Study|Withdrawal by Subject|1|||
160673768|NCT00858403|580183888|FG000|Overall Study|Death|3|||
160673769|NCT00858403|580183888|FG000|Overall Study|Disease Progression|1|||
160673770|NCT02264977|580183889|FG000|Overall Study|Death|3|||
160673771|NCT02264977|580183889|FG000|Overall Study|Physician Decision|1|||
160673772|NCT02264977|580183889|FG000|Overall Study|Refuse to return|1|||
160673773|NCT03573544|580183890|FG000|Overall Study|Adverse Event|0|||
160673774|NCT03573544|580183891|FG001|Overall Study|Adverse Event|0|||
160673775|NCT03573544|580183892|FG002|Overall Study|Adverse Event|0|||
160673776|NCT03573544|580183893|FG003|Overall Study|Adverse Event|3|||
160673777|NCT03573544|580183894|FG004|Overall Study|Adverse Event|1|||
160673778|NCT03573544|580183895|FG005|Overall Study|Adverse Event|0|||
160673779|NCT03573544|580183896|FG006|Overall Study|Adverse Event|2|||
160673780|NCT03573544|580183897|FG007|Overall Study|Adverse Event|0|||
160673781|NCT03573544|580183890|FG000|Overall Study|Physician Decision|0|||
160673782|NCT03573544|580183891|FG001|Overall Study|Physician Decision|0|||
160673783|NCT03573544|580183892|FG002|Overall Study|Physician Decision|0|||
160673784|NCT03573544|580183893|FG003|Overall Study|Physician Decision|0|||
160673785|NCT03573544|580183894|FG004|Overall Study|Physician Decision|0|||
160673786|NCT03573544|580183895|FG005|Overall Study|Physician Decision|0|||
160673787|NCT03573544|580183896|FG006|Overall Study|Physician Decision|1|||
160673788|NCT03573544|580183897|FG007|Overall Study|Physician Decision|0|||
160673789|NCT03573544|580183890|FG000|Overall Study|Withdrawal by Subject|2|||
160673790|NCT03573544|580183891|FG001|Overall Study|Withdrawal by Subject|0|||
160673791|NCT03573544|580183892|FG002|Overall Study|Withdrawal by Subject|0|||
160673792|NCT03573544|580183893|FG003|Overall Study|Withdrawal by Subject|1|||
160673793|NCT03573544|580183894|FG004|Overall Study|Withdrawal by Subject|1|||
160673794|NCT03573544|580183895|FG005|Overall Study|Withdrawal by Subject|1|||
160673795|NCT03573544|580183896|FG006|Overall Study|Withdrawal by Subject|0|||
160673796|NCT03573544|580183897|FG007|Overall Study|Withdrawal by Subject|1|||
160673797|NCT03573544|580183890|FG000|Overall Study|Disease progression|3|||
160673798|NCT03573544|580183891|FG001|Overall Study|Disease progression|3|||
160673799|NCT03573544|580183892|FG002|Overall Study|Disease progression|6|||
160673800|NCT03573544|580183893|FG003|Overall Study|Disease progression|4|||
160673801|NCT03573544|580183894|FG004|Overall Study|Disease progression|5|||
160673802|NCT03573544|580183895|FG005|Overall Study|Disease progression|7|||
160673803|NCT03573544|580183896|FG006|Overall Study|Disease progression|6|||
160673804|NCT03573544|580183897|FG007|Overall Study|Disease progression|7|||
160673805|NCT01073631|580183898|FG000|Overall Study|Death|82|||
160673806|NCT01073631|580183898|FG000|Overall Study|Adverse Event|24|||
160673807|NCT01073631|580183898|FG000|Overall Study|Other|63|||
160673808|NCT00849797|580183901|FG000|First Intervention|bad veins|1|||
160673809|NCT00849797|580183902|FG001|First Intervention|bad veins|0|||
160673810|NCT00849797|580183901|FG000|First Intervention|Adverse Event|0|||
160673811|NCT00849797|580183902|FG001|First Intervention|Adverse Event|1|||
160673812|NCT00849797|580183901|FG000|Washout: One Week|Withdrawal by Subject|0|||
160673813|NCT00849797|580183902|FG001|Washout: One Week|Withdrawal by Subject|2|||
160673814|NCT01018862|580183912|FG000|Overall Study|Adverse Event|2|||
160673815|NCT01018862|580183913|FG001|Overall Study|Adverse Event|0|||
160673816|NCT01018862|580183914|FG002|Overall Study|Adverse Event|6|||
160673817|NCT01018862|580183912|FG000|Overall Study|Lack of Efficacy|1|||
160673818|NCT01018862|580183913|FG001|Overall Study|Lack of Efficacy|0|||
160673819|NCT01018862|580183914|FG002|Overall Study|Lack of Efficacy|2|||
160673820|NCT01018862|580183912|FG000|Overall Study|Lost to Follow-up|3|||
160673821|NCT01018862|580183913|FG001|Overall Study|Lost to Follow-up|1|||
160673822|NCT01018862|580183914|FG002|Overall Study|Lost to Follow-up|0|||
160673823|NCT01018862|580183912|FG000|Overall Study|Protocol Violation|1|||
160673824|NCT01018862|580183913|FG001|Overall Study|Protocol Violation|3|||
160673825|NCT01018862|580183914|FG002|Overall Study|Protocol Violation|3|||
160673826|NCT01018862|580183912|FG000|Overall Study|Withdrawal by Subject|1|||
160673827|NCT01018862|580183913|FG001|Overall Study|Withdrawal by Subject|2|||
160673828|NCT01018862|580183914|FG002|Overall Study|Withdrawal by Subject|1|||
160673829|NCT01018862|580183912|FG000|Overall Study|administrative problems|5|||
160673830|NCT01018862|580183913|FG001|Overall Study|administrative problems|4|||
160673831|NCT01018862|580183914|FG002|Overall Study|administrative problems|4|||
160673832|NCT01968031|580183918|FG000|Overall Study|Adverse Event|13|||
160673833|NCT01968031|580183919|FG001|Overall Study|Adverse Event|10|||
160673834|NCT01968031|580183920|FG002|Overall Study|Adverse Event|22|||
160673835|NCT01968031|580183918|FG000|Overall Study|Withdrawal by Subject|3|||
160673836|NCT01968031|580183919|FG001|Overall Study|Withdrawal by Subject|7|||
160673837|NCT01968031|580183920|FG002|Overall Study|Withdrawal by Subject|3|||
160673838|NCT01968031|580183918|FG000|Overall Study|Did not meet entry criteria|1|||
160673839|NCT01968031|580183919|FG001|Overall Study|Did not meet entry criteria|1|||
160673840|NCT01968031|580183920|FG002|Overall Study|Did not meet entry criteria|1|||
160673841|NCT01968031|580183918|FG000|Overall Study|Noncompliance|0|||
160673842|NCT01968031|580183919|FG001|Overall Study|Noncompliance|0|||
160673843|NCT01968031|580183920|FG002|Overall Study|Noncompliance|2|||
160673844|NCT01968031|580183918|FG000|Overall Study|Failed inclusion criteria|0|||
160673845|NCT01968031|580183919|FG001|Overall Study|Failed inclusion criteria|2|||
160673846|NCT01968031|580183920|FG002|Overall Study|Failed inclusion criteria|0|||
160673847|NCT01968031|580183918|FG000|Overall Study|Death|0|||
160673848|NCT01968031|580183919|FG001|Overall Study|Death|0|||
160673849|NCT01968031|580183920|FG002|Overall Study|Death|1|||
160673850|NCT01968031|580183918|FG000|Overall Study|Prohibited concomitant medication|1|||
160673851|NCT01968031|580183919|FG001|Overall Study|Prohibited concomitant medication|0|||
160673852|NCT01968031|580183920|FG002|Overall Study|Prohibited concomitant medication|0|||
160673853|NCT00477594|580183921|FG000|Year 1 and Year 2|Adverse Event|4|||
160673854|NCT00477594|580183922|FG001|Year 1 and Year 2|Adverse Event|2|||
160673855|NCT00477594|580183921|FG000|Year 1 and Year 2|Physician Decision|2|||
160673856|NCT00477594|580183922|FG001|Year 1 and Year 2|Physician Decision|1|||
160673857|NCT00477594|580183921|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
160673858|NCT00477594|580183922|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
160673859|NCT00477594|580183921|FG000|Year 1 and Year 2|Other|1|||
160673860|NCT00477594|580183922|FG001|Year 1 and Year 2|Other|0|||
160673861|NCT00477594|580183921|FG000|Year 3|Adverse Event|1|||
160673862|NCT00477594|580183922|FG001|Year 3|Adverse Event|0|||
160673863|NCT00477594|580183921|FG000|Year 3|Withdrawal by Subject|1|||
160673864|NCT00477594|580183922|FG001|Year 3|Withdrawal by Subject|0|||
160673865|NCT00477594|580183921|FG000|Follow-up Period|Withdrawal by Subject|2|||
160673866|NCT00477594|580183922|FG001|Follow-up Period|Withdrawal by Subject|1|||
160673867|NCT00477594|580183921|FG000|Follow-up Period|Other|1|||
160673868|NCT00477594|580183922|FG001|Follow-up Period|Other|0|||
160673869|NCT04573309|580185808|FG000|Overall Study|Protocol Violation|1|||
160673870|NCT04573309|580185809|FG001|Overall Study|Protocol Violation|0|||
160673871|NCT01691430|580185811|FG000|Overall Study|Death|17|||
160673872|NCT01691430|580185812|FG001|Overall Study|Death|16|||
160673873|NCT01691430|580185811|FG000|Overall Study|Withdrawal by Subject|5|||
160673874|NCT01691430|580185812|FG001|Overall Study|Withdrawal by Subject|1|||
160673875|NCT01691430|580185811|FG000|Overall Study|Lost to Follow-up|0|||
160673876|NCT01691430|580185812|FG001|Overall Study|Lost to Follow-up|3|||
160673877|NCT02998541|580185816|FG000|Overall Study|Adverse Event|4|||
160673878|NCT02998541|580185817|FG001|Overall Study|Adverse Event|5|||
160673879|NCT02998541|580185818|FG002|Overall Study|Adverse Event|1|||
160673880|NCT02998541|580185816|FG000|Overall Study|Protocol Violation|1|||
160673881|NCT02998541|580185817|FG001|Overall Study|Protocol Violation|0|||
160673882|NCT02998541|580185818|FG002|Overall Study|Protocol Violation|0|||
160673883|NCT02998541|580185816|FG000|Overall Study|Withdrawal by Subject|3|||
160673884|NCT02998541|580185817|FG001|Overall Study|Withdrawal by Subject|1|||
160673885|NCT02998541|580185818|FG002|Overall Study|Withdrawal by Subject|0|||
160673886|NCT02998541|580185816|FG000|Overall Study|Lost to Follow-up|0|||
160673887|NCT02998541|580185817|FG001|Overall Study|Lost to Follow-up|3|||
160673888|NCT02998541|580185818|FG002|Overall Study|Lost to Follow-up|1|||
160673889|NCT02998541|580185816|FG000|Overall Study|Physician Decision|0|||
160673890|NCT02998541|580185817|FG001|Overall Study|Physician Decision|0|||
160673891|NCT02998541|580185818|FG002|Overall Study|Physician Decision|3|||
160673892|NCT02998541|580185816|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160673893|NCT02998541|580185817|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160673894|NCT02998541|580185818|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
160673895|NCT03540160|580185822|FG000|Overall Study|Protocol Violation|1|||
160673896|NCT03540160|580185822|FG000|Overall Study|Physician Decision|8|||
160673897|NCT03540160|580185822|FG000|Overall Study|Lack of Efficacy|60|||
160673898|NCT03540160|580185822|FG000|Overall Study|Pregnancy|1|||
160673899|NCT03540160|580185822|FG000|Overall Study|Adverse Event|20|||
160673900|NCT03540160|580185822|FG000|Overall Study|Withdrawal by Subject|68|||
160673901|NCT03540160|580185822|FG000|Overall Study|COVID-19|2|||
160673902|NCT03540160|580185822|FG000|Overall Study|Study Closure|10|||
160673903|NCT03540160|580185822|FG000|Overall Study|Lost to Follow-up|18|||
160673904|NCT03540160|580185822|FG000|Overall Study|Sponsor decision|191|||
160673905|NCT01944722|580185823|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
160673906|NCT01944722|580185823|FG000|Overall Study|Specimen Shipping Issues|34|||
160673907|NCT01944722|580185823|FG000|Overall Study|Improper Storage/Transport|5|||
160673908|NCT01944722|580185823|FG000|Overall Study|Insufficient Volume for Test|1|||
160673909|NCT01944722|580185823|FG000|Overall Study|Missing Specimens|3|||
160673910|NCT01944722|580185823|FG000|Overall Study|Specimens Mislabeled|2|||
160673911|NCT01944722|580185823|FG000|Overall Study|Withdrawal by Subject|8|||
160673912|NCT01944722|580185823|FG000|Overall Study|NILM Subjects <30 years old|8106|||
160673913|NCT01944722|580185823|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
160673914|NCT01944722|580185823|FG000|Overall Study|>ASCUS Cytology|1122|||
160673915|NCT02906917|580185826|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
160673916|NCT02906917|580185827|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
160673917|NCT02906917|580185826|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
160673918|NCT02906917|580185827|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
160673919|NCT02906917|580185826|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
160673920|NCT02906917|580185827|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
160673921|NCT02906917|580185826|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
160673922|NCT02906917|580185827|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
160630780|NCT00915473|580029018|FG001|4-week Follow Up|Lost to Follow-up|5|||
160630781|NCT01389024|580029019|FG000|Overall Study|Withdrawal by Subject|0|||
160630782|NCT01389024|580029020|FG001|Overall Study|Withdrawal by Subject|1|||
160630783|NCT01389024|580029019|FG000|Overall Study|Lost to Follow-up|1|||
160630784|NCT01389024|580029020|FG001|Overall Study|Lost to Follow-up|0|||
160630785|NCT03286426|580029022|FG000|Overall Study|Physician Decision|3|||
160630786|NCT01817764|580029023|FG000|Overall Study|Adverse Event|7|||
160630787|NCT01817764|580029024|FG001|Overall Study|Adverse Event|10|||
160630788|NCT01817764|580029023|FG000|Overall Study|Lack of Efficacy|9|||
160630789|NCT01817764|580029024|FG001|Overall Study|Lack of Efficacy|7|||
160630790|NCT01817764|580029023|FG000|Overall Study|Protocol Violation|7|||
160630791|NCT01817764|580029024|FG001|Overall Study|Protocol Violation|5|||
160630792|NCT01817764|580029023|FG000|Overall Study|Lost to Follow-up|1|||
160630793|NCT01817764|580029024|FG001|Overall Study|Lost to Follow-up|4|||
160630794|NCT01817764|580029023|FG000|Overall Study|Withdrawal by Subject|10|||
160630795|NCT01817764|580029024|FG001|Overall Study|Withdrawal by Subject|12|||
160630796|NCT03443973|580029025|FG000|Double-blind Treatment Period|Adverse Event|5|||
160630797|NCT03443973|580029026|FG001|Double-blind Treatment Period|Adverse Event|19|||
160630798|NCT03443973|580029027|FG002|Double-blind Treatment Period|Adverse Event|0|||
160630799|NCT03443973|580029028|FG003|Double-blind Treatment Period|Adverse Event|0|||
160630800|NCT03443973|580029025|FG000|Double-blind Treatment Period|Death|5|||
160630801|NCT03443973|580029026|FG001|Double-blind Treatment Period|Death|7|||
160630802|NCT03443973|580029027|FG002|Double-blind Treatment Period|Death|0|||
160630803|NCT03443973|580029028|FG003|Double-blind Treatment Period|Death|0|||
160630804|NCT03443973|580029025|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
160630805|NCT03443973|580029026|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
160630806|NCT03443973|580029027|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
160630807|NCT03443973|580029028|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
160630808|NCT03443973|580029025|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
160630809|NCT03443973|580029026|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
160630810|NCT03443973|580029027|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
160630811|NCT03443973|580029028|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
160630812|NCT03443973|580029025|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
160630813|NCT03443973|580029026|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
160630814|NCT03443973|580029027|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
160630815|NCT03443973|580029028|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
160630816|NCT03443973|580029025|FG000|Double-blind Treatment Period|Physician Decision|5|||
160630817|NCT03443973|580029026|FG001|Double-blind Treatment Period|Physician Decision|6|||
160630818|NCT03443973|580029027|FG002|Double-blind Treatment Period|Physician Decision|0|||
160630819|NCT03443973|580029028|FG003|Double-blind Treatment Period|Physician Decision|0|||
160630820|NCT03443973|580029025|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
160630821|NCT03443973|580029026|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
160630822|NCT03443973|580029027|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
160630823|NCT03443973|580029028|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
160630824|NCT03443973|580029025|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
160630825|NCT03443973|580029026|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
160630826|NCT03443973|580029027|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160630827|NCT03443973|580029028|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
160630828|NCT03443973|580029025|FG000|Open-label Extension Period|Reason Not Specified|0|||
160630829|NCT03443973|580029026|FG001|Open-label Extension Period|Reason Not Specified|0|||
160630830|NCT03443973|580029027|FG002|Open-label Extension Period|Reason Not Specified|3|||
160630831|NCT03443973|580029028|FG003|Open-label Extension Period|Reason Not Specified|0|||
160630832|NCT03443973|580029025|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
160630833|NCT03443973|580029026|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
160630834|NCT03443973|580029027|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
160630835|NCT03443973|580029028|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
160630836|NCT01956123|580029029|FG000|COS Cycle 2|Protocol Violation|8|||
160630837|NCT01956123|580029030|FG001|COS Cycle 2|Protocol Violation|3|||
160630838|NCT01956123|580029031|FG002|COS Cycle 2|Protocol Violation|0|||
160630839|NCT01956123|580029032|FG003|COS Cycle 2|Protocol Violation|0|||
160630840|NCT01956123|580029029|FG000|COS Cycle 2|Adverse Event|3|||
160630841|NCT01956123|580029030|FG001|COS Cycle 2|Adverse Event|4|||
160630842|NCT01956123|580029031|FG002|COS Cycle 2|Adverse Event|0|||
160630843|NCT01956123|580029032|FG003|COS Cycle 2|Adverse Event|0|||
160630844|NCT01956123|580029029|FG000|COS Cycle 2|Personal Reasons|2|||
160630845|NCT01956123|580029030|FG001|COS Cycle 2|Personal Reasons|0|||
160630846|NCT01956123|580029031|FG002|COS Cycle 2|Personal Reasons|0|||
160630847|NCT01956123|580029032|FG003|COS Cycle 2|Personal Reasons|0|||
160630848|NCT01956123|580029029|FG000|COS Cycle 2|Withdrawal by Subject|1|||
160630849|NCT01956123|580029030|FG001|COS Cycle 2|Withdrawal by Subject|0|||
160630850|NCT01956123|580029031|FG002|COS Cycle 2|Withdrawal by Subject|0|||
160630851|NCT01956123|580029032|FG003|COS Cycle 2|Withdrawal by Subject|0|||
160630852|NCT01956123|580029029|FG000|COS Cycle 3|Protocol Violation|0|||
160630853|NCT01956123|580029030|FG001|COS Cycle 3|Protocol Violation|0|||
160673923|NCT02906917|580185826|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
160673924|NCT02906917|580185827|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
160673925|NCT02906917|580185826|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
160673926|NCT02906917|580185827|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
160673927|NCT02906917|580185826|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
160673928|NCT02906917|580185827|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
160673929|NCT02906917|580185826|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
160673930|NCT02906917|580185827|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
160673931|NCT00687739|580185828|FG000|Overall Study|Lost to Follow-up|2|||
160673932|NCT00687739|580185829|FG001|Overall Study|Lost to Follow-up|2|||
160673933|NCT00687739|580185830|FG002|Overall Study|Lost to Follow-up|1|||
160673934|NCT00687739|580185831|FG003|Overall Study|Lost to Follow-up|2|||
160673935|NCT00687739|580185828|FG000|Overall Study|Adverse Event|0|||
160673936|NCT00687739|580185829|FG001|Overall Study|Adverse Event|1|||
160673937|NCT00687739|580185830|FG002|Overall Study|Adverse Event|1|||
160673938|NCT00687739|580185831|FG003|Overall Study|Adverse Event|0|||
160673939|NCT02554877|580185832|FG000|Overall Study|Adverse Event|2|||
160673940|NCT02554877|580185833|FG001|Overall Study|Adverse Event|0|||
160673941|NCT02554877|580185834|FG002|Overall Study|Adverse Event|0|||
160673942|NCT02554877|580185835|FG003|Overall Study|Adverse Event|1|||
160673943|NCT02554877|580185832|FG000|Overall Study|Lost to Follow-up|1|||
160673944|NCT02554877|580185833|FG001|Overall Study|Lost to Follow-up|1|||
160673945|NCT02554877|580185834|FG002|Overall Study|Lost to Follow-up|1|||
160673946|NCT02554877|580185835|FG003|Overall Study|Lost to Follow-up|2|||
160673947|NCT02554877|580185832|FG000|Overall Study|Did not meet entrance criteria|0|||
160673948|NCT02554877|580185833|FG001|Overall Study|Did not meet entrance criteria|0|||
160673949|NCT02554877|580185834|FG002|Overall Study|Did not meet entrance criteria|1|||
160673950|NCT02554877|580185835|FG003|Overall Study|Did not meet entrance criteria|0|||
160673951|NCT02554877|580185832|FG000|Overall Study|No longer met eligibility criteria|1|||
160673952|NCT02554877|580185833|FG001|Overall Study|No longer met eligibility criteria|0|||
160673953|NCT02554877|580185834|FG002|Overall Study|No longer met eligibility criteria|1|||
160673954|NCT02554877|580185835|FG003|Overall Study|No longer met eligibility criteria|1|||
160630854|NCT01956123|580029031|FG002|COS Cycle 3|Protocol Violation|2|||
160630855|NCT01956123|580029032|FG003|COS Cycle 3|Protocol Violation|1|||
160630856|NCT01956123|580029029|FG000|COS Cycle 3|Adverse Event|0|||
160630857|NCT01956123|580029030|FG001|COS Cycle 3|Adverse Event|0|||
160630858|NCT01956123|580029031|FG002|COS Cycle 3|Adverse Event|3|||
160630859|NCT01956123|580029032|FG003|COS Cycle 3|Adverse Event|0|||
160630860|NCT01956123|580029029|FG000|COS Cycle 3|Personal Reasons|0|||
160630861|NCT01956123|580029030|FG001|COS Cycle 3|Personal Reasons|0|||
160630862|NCT01956123|580029031|FG002|COS Cycle 3|Personal Reasons|1|||
160630863|NCT01956123|580029032|FG003|COS Cycle 3|Personal Reasons|0|||
160630864|NCT01956123|580029029|FG000|COS Cycle 3|Withdrawal by Subject|0|||
160630865|NCT01956123|580029030|FG001|COS Cycle 3|Withdrawal by Subject|0|||
160630866|NCT01956123|580029031|FG002|COS Cycle 3|Withdrawal by Subject|0|||
160630867|NCT01956123|580029032|FG003|COS Cycle 3|Withdrawal by Subject|1|||
160630868|NCT04930536|580029033|FG000|Overall Study|Adverse Event|1|||
160630869|NCT04930536|580029034|FG001|Overall Study|Adverse Event|0|||
160630870|NCT04930536|580029033|FG000|Overall Study|Disease Progression|2|||
160630871|NCT04930536|580029034|FG001|Overall Study|Disease Progression|0|||
160630872|NCT04930536|580029033|FG000|Overall Study|Patient Decision|4|||
160630873|NCT04930536|580029034|FG001|Overall Study|Patient Decision|2|||
160630874|NCT04930536|580029033|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
160630875|NCT04930536|580029034|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
160630876|NCT01432600|580029035|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
160630877|NCT01432600|580029036|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
160630878|NCT01432600|580029037|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
160630879|NCT00398632|580029038|FG000|Overall Study|Withdrawal by Subject|1|||
160630880|NCT00398632|580029038|FG000|Overall Study|Lack of Efficacy|1|||
160630881|NCT00267020|580029039|FG000|Overall Study|Adverse Event|22|||
160630882|NCT00267020|580029040|FG001|Overall Study|Adverse Event|5|||
160630883|NCT00267020|580029039|FG000|Overall Study|Death|2|||
160630884|NCT00267020|580029040|FG001|Overall Study|Death|1|||
160630885|NCT00267020|580029039|FG000|Overall Study|Withdrawal by Subject|17|||
160630886|NCT00267020|580029040|FG001|Overall Study|Withdrawal by Subject|7|||
160630887|NCT00267020|580029039|FG000|Overall Study|Physician Decision|3|||
160630888|NCT00267020|580029040|FG001|Overall Study|Physician Decision|2|||
160630889|NCT00267020|580029039|FG000|Overall Study|Disease Progression|39|||
160630890|NCT00267020|580029040|FG001|Overall Study|Disease Progression|25|||
160673955|NCT02554877|580185832|FG000|Overall Study|Protocol Violation|3|||
160673956|NCT02554877|580185833|FG001|Overall Study|Protocol Violation|1|||
160673957|NCT02554877|580185834|FG002|Overall Study|Protocol Violation|1|||
160673958|NCT02554877|580185835|FG003|Overall Study|Protocol Violation|0|||
160630891|NCT00267020|580029039|FG000|Overall Study|Unrelated Complication|1|||
160630892|NCT00267020|580029040|FG001|Overall Study|Unrelated Complication|1|||
160630893|NCT00267020|580029039|FG000|Overall Study|Sponsor Request|1|||
160630894|NCT00267020|580029040|FG001|Overall Study|Sponsor Request|0|||
160673959|NCT02554877|580185832|FG000|Overall Study|Other|1|||
160673960|NCT02554877|580185833|FG001|Overall Study|Other|3|||
160673961|NCT02554877|580185834|FG002|Overall Study|Other|0|||
160673962|NCT02554877|580185835|FG003|Overall Study|Other|3|||
160673963|NCT02554877|580185832|FG000|Overall Study|Insufficient clinical response|4|||
160673964|NCT02554877|580185833|FG001|Overall Study|Insufficient clinical response|0|||
160673965|NCT02554877|580185834|FG002|Overall Study|Insufficient clinical response|0|||
160673966|NCT02554877|580185835|FG003|Overall Study|Insufficient clinical response|0|||
160673967|NCT02554877|580185832|FG000|Overall Study|No longer willing to participate|0|||
160673968|NCT02554877|580185833|FG001|Overall Study|No longer willing to participate|2|||
160673969|NCT02554877|580185834|FG002|Overall Study|No longer willing to participate|2|||
160673970|NCT02554877|580185835|FG003|Overall Study|No longer willing to participate|0|||
160673971|NCT01537887|580185836|FG000|Period 1|Physician Decision|0|||
160673972|NCT01537887|580185837|FG001|Period 1|Physician Decision|0|||
160673973|NCT01537887|580185838|FG002|Period 1|Physician Decision|0|||
160673974|NCT01537887|580185839|FG003|Period 1|Physician Decision|0|||
160673975|NCT01537887|580185840|FG004|Period 1|Physician Decision|1|||
160673976|NCT01537887|580185841|FG005|Period 1|Physician Decision|1|||
160673977|NCT01537887|580185836|FG000|Period 1|Did not receive treatment|0|||
160673978|NCT01537887|580185837|FG001|Period 1|Did not receive treatment|0|||
160673979|NCT01537887|580185838|FG002|Period 1|Did not receive treatment|1|||
160673980|NCT01537887|580185839|FG003|Period 1|Did not receive treatment|0|||
160673981|NCT01537887|580185840|FG004|Period 1|Did not receive treatment|0|||
160673982|NCT01537887|580185841|FG005|Period 1|Did not receive treatment|0|||
160673983|NCT01537887|580185836|FG000|Period 2|Withdrawal by Subject|0|||
160673984|NCT01537887|580185837|FG001|Period 2|Withdrawal by Subject|1|||
160673985|NCT01537887|580185838|FG002|Period 2|Withdrawal by Subject|0|||
160673986|NCT01537887|580185839|FG003|Period 2|Withdrawal by Subject|0|||
160673987|NCT01537887|580185840|FG004|Period 2|Withdrawal by Subject|0|||
160673988|NCT01537887|580185841|FG005|Period 2|Withdrawal by Subject|0|||
160673989|NCT01537887|580185836|FG000|Period 3|Adverse Event|0|||
160673990|NCT01537887|580185837|FG001|Period 3|Adverse Event|0|||
160673991|NCT01537887|580185838|FG002|Period 3|Adverse Event|1|||
160673992|NCT01537887|580185839|FG003|Period 3|Adverse Event|0|||
160673993|NCT01537887|580185840|FG004|Period 3|Adverse Event|0|||
160673994|NCT01537887|580185841|FG005|Period 3|Adverse Event|0|||
160673995|NCT01537887|580185836|FG000|Period 3|Withdrawal by Subject|0|||
160673996|NCT01537887|580185837|FG001|Period 3|Withdrawal by Subject|1|||
160673997|NCT01537887|580185838|FG002|Period 3|Withdrawal by Subject|0|||
160673998|NCT01537887|580185839|FG003|Period 3|Withdrawal by Subject|0|||
160673999|NCT01537887|580185840|FG004|Period 3|Withdrawal by Subject|0|||
160674000|NCT01537887|580185841|FG005|Period 3|Withdrawal by Subject|0|||
160674001|NCT02072096|580185844|FG000|Overall Study|Lack of Efficacy|18|||
160674002|NCT02072096|580185845|FG001|Overall Study|Lack of Efficacy|29|||
160674003|NCT02072096|580185844|FG000|Overall Study|Protocol Violation|7|||
160674004|NCT02072096|580185845|FG001|Overall Study|Protocol Violation|7|||
160674005|NCT02072096|580185844|FG000|Overall Study|Withdrawal by Subject|5|||
160674006|NCT02072096|580185845|FG001|Overall Study|Withdrawal by Subject|7|||
160674007|NCT02072096|580185844|FG000|Overall Study|Adverse Event|5|||
160674008|NCT02072096|580185845|FG001|Overall Study|Adverse Event|2|||
160674009|NCT02072096|580185844|FG000|Overall Study|No Reason Provided|4|||
160674010|NCT02072096|580185845|FG001|Overall Study|No Reason Provided|2|||
160674011|NCT02072096|580185844|FG000|Overall Study|Death|2|||
160674012|NCT02072096|580185845|FG001|Overall Study|Death|0|||
160674013|NCT02072096|580185844|FG000|Overall Study|Physician Decision|0|||
160674014|NCT02072096|580185845|FG001|Overall Study|Physician Decision|1|||
160674015|NCT02072096|580185844|FG000|Overall Study|Study Terminated by Sponsor|43|||
160674016|NCT02072096|580185845|FG001|Overall Study|Study Terminated by Sponsor|30|||
160674017|NCT02072096|580185844|FG000|Overall Study|Lost to Follow-up|1|||
160674018|NCT02072096|580185845|FG001|Overall Study|Lost to Follow-up|0|||
160674019|NCT05604014|580185846|FG000|Overall Study|Lost to Follow-up|13|||
160674020|NCT04567329|580185866|FG000|Overall Study|Withdrawal by Subject|5|||
160674021|NCT04567329|580185867|FG001|Overall Study|Withdrawal by Subject|6|||
160674022|NCT04567329|580185866|FG000|Overall Study|Protocol Violation|2|||
160674023|NCT04567329|580185867|FG001|Overall Study|Protocol Violation|3|||
160674024|NCT04567329|580185866|FG000|Overall Study|Discontinued|2|||
160674025|NCT04567329|580185867|FG001|Overall Study|Discontinued|2|||
160674026|NCT04567329|580185866|FG000|Overall Study|Lost to Follow-up|0|||
160674027|NCT04567329|580185867|FG001|Overall Study|Lost to Follow-up|1|||
160674028|NCT04567329|580185866|FG000|Overall Study|Lack of Efficacy|0|||
160674029|NCT04567329|580185867|FG001|Overall Study|Lack of Efficacy|1|||
160674030|NCT02933060|580185868|FG000|Overall Study|Withdrawal by Subject|0|||
160674031|NCT02933060|580185869|FG001|Overall Study|Withdrawal by Subject|1|||
160674032|NCT01945580|580185870|FG000|Overall Study|Withdrawal by Subject|13|||
160674033|NCT01945580|580185871|FG001|Overall Study|Withdrawal by Subject|35|||
160674034|NCT01945580|580185870|FG000|Overall Study|Physician Decision|3|||
160674035|NCT01945580|580185871|FG001|Overall Study|Physician Decision|2|||
160674036|NCT01945580|580185870|FG000|Overall Study|Lost to Follow-up|26|||
160674037|NCT01945580|580185871|FG001|Overall Study|Lost to Follow-up|39|||
160674038|NCT01945580|580185870|FG000|Overall Study|Death|7|||
160674039|NCT01945580|580185871|FG001|Overall Study|Death|2|||
160674040|NCT01945580|580185870|FG000|Overall Study|Patient moved out of state|0|||
160674041|NCT01945580|580185871|FG001|Overall Study|Patient moved out of state|1|||
160674042|NCT01945580|580185870|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
160674043|NCT01945580|580185871|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
160674044|NCT01945580|580185870|FG000|Overall Study|Family illness - unable to return|0|||
160674045|NCT01945580|580185871|FG001|Overall Study|Family illness - unable to return|1|||
160674046|NCT01945580|580185870|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
160674047|NCT01945580|580185871|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
160674048|NCT01945580|580185870|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
160674049|NCT01945580|580185871|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
160674050|NCT01945580|580185870|FG000|Overall Study|Noncompliance with 36 month visit|1|||
160674051|NCT01945580|580185871|FG001|Overall Study|Noncompliance with 36 month visit|0|||
160674052|NCT01945580|580185870|FG000|Overall Study|The patient moved.|1|||
160674053|NCT01945580|580185871|FG001|Overall Study|The patient moved.|0|||
160674054|NCT01945580|580185870|FG000|Overall Study|No data available|0|||
160674055|NCT01945580|580185871|FG001|Overall Study|No data available|2|||
160674056|NCT00073307|580185879|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
160674057|NCT00073307|580185880|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
160674058|NCT00073307|580185881|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
160674059|NCT00073307|580185879|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
160674060|NCT00073307|580185880|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
160674061|NCT00073307|580185881|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
160674062|NCT00073307|580185879|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
160674063|NCT00073307|580185880|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
160674064|NCT00073307|580185881|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
160674065|NCT00073307|580185879|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
160674066|NCT00073307|580185880|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
160674067|NCT00073307|580185881|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
160674068|NCT00073307|580185879|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
160674069|NCT00073307|580185880|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
160674070|NCT00073307|580185881|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
160674071|NCT00073307|580185879|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
160674072|NCT00073307|580185880|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
160674073|NCT00073307|580185881|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
160674074|NCT00073307|580185879|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
160674075|NCT00073307|580185880|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
160674076|NCT00073307|580185881|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
160674077|NCT00073307|580185879|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
160674078|NCT00073307|580185880|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
160674079|NCT00073307|580185881|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
160674080|NCT00073307|580185879|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
160674081|NCT00073307|580185880|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
160674082|NCT00073307|580185881|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
160674083|NCT00073307|580185879|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
160674084|NCT00073307|580185880|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
160674085|NCT00073307|580185881|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
160674086|NCT00073307|580185879|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
160674087|NCT00073307|580185880|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
160674088|NCT00073307|580185881|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
160674089|NCT00073307|580185879|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
160674090|NCT00073307|580185880|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
160674091|NCT00073307|580185881|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
160674092|NCT00073307|580185879|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
160674093|NCT00073307|580185880|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
160674094|NCT00073307|580185881|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
160674095|NCT00073307|580185879|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
160674096|NCT00073307|580185880|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
160674097|NCT00073307|580185881|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
160674098|NCT00073307|580185879|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
160674099|NCT00073307|580185880|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
160674100|NCT00073307|580185881|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
160630895|NCT00267020|580029039|FG000|Overall Study|Other|1|||
160630896|NCT00267020|580029040|FG001|Overall Study|Other|2|||
160630897|NCT00640614|580029044|FG000|Overall Study|Lost to Follow-up|1|||
160630898|NCT00640614|580029045|FG001|Overall Study|Lost to Follow-up|0|||
160630899|NCT00529802|580029046|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
160630900|NCT00529802|580029046|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
160630901|NCT00529802|580029046|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
160630902|NCT00529802|580029046|FG000|Evaluable for Primary Endpoint|Death|1|||
160630903|NCT00529802|580029046|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
160630904|NCT00529802|580029046|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
160630905|NCT00529802|580029046|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
160630906|NCT02209454|580029050|FG000|Second Period|Adverse Event|1|||
160630907|NCT02209454|580029051|FG001|Second Period|Adverse Event|0|||
160630908|NCT00366678|580029052|FG000|Infant Series|Withdrawal by Subject|8|||
160630909|NCT00366678|580029053|FG001|Infant Series|Withdrawal by Subject|6|||
160630910|NCT00366678|580029054|FG002|Infant Series|Withdrawal by Subject|0|||
160630911|NCT00366678|580029052|FG000|Infant Series|Protocol Violation|4|||
160630912|NCT00366678|580029053|FG001|Infant Series|Protocol Violation|3|||
160630913|NCT00366678|580029054|FG002|Infant Series|Protocol Violation|0|||
160630914|NCT00366678|580029052|FG000|Infant Series|Failed to return|1|||
160630915|NCT00366678|580029053|FG001|Infant Series|Failed to return|1|||
160630916|NCT00366678|580029054|FG002|Infant Series|Failed to return|0|||
160630917|NCT00366678|580029052|FG000|Infant Series|Adverse Event|1|||
160630918|NCT00366678|580029053|FG001|Infant Series|Adverse Event|0|||
160630919|NCT00366678|580029054|FG002|Infant Series|Adverse Event|0|||
160630920|NCT00366678|580029052|FG000|After Infant|Withdrawal by Subject|8|||
160630921|NCT00366678|580029053|FG001|After Infant|Withdrawal by Subject|4|||
160630922|NCT00366678|580029054|FG002|After Infant|Withdrawal by Subject|0|||
160630923|NCT00366678|580029052|FG000|After Infant|Lost to Follow-up|2|||
160630924|NCT00366678|580029053|FG001|After Infant|Lost to Follow-up|1|||
160630925|NCT00366678|580029054|FG002|After Infant|Lost to Follow-up|0|||
160630926|NCT00366678|580029052|FG000|After Infant|Failed to return|5|||
160630927|NCT00366678|580029053|FG001|After Infant|Failed to return|5|||
160630928|NCT00366678|580029054|FG002|After Infant|Failed to return|0|||
160630929|NCT00366678|580029052|FG000|After Infant|Adverse Event|1|||
160630930|NCT00366678|580029053|FG001|After Infant|Adverse Event|0|||
160630931|NCT00366678|580029054|FG002|After Infant|Adverse Event|0|||
160630932|NCT00366678|580029052|FG000|After Infant|Protocol Violation|1|||
160630933|NCT00366678|580029053|FG001|After Infant|Protocol Violation|0|||
160630934|NCT00366678|580029054|FG002|After Infant|Protocol Violation|0|||
160630935|NCT00366678|580029052|FG000|Toddler Dose|Protocol Violation|2|||
160630936|NCT00366678|580029053|FG001|Toddler Dose|Protocol Violation|1|||
160630937|NCT00366678|580029054|FG002|Toddler Dose|Protocol Violation|0|||
160630938|NCT00366678|580029052|FG000|Toddler Dose|Failed to return|1|||
160630939|NCT00366678|580029053|FG001|Toddler Dose|Failed to return|0|||
160630940|NCT00366678|580029054|FG002|Toddler Dose|Failed to return|0|||
160630941|NCT00366678|580029052|FG000|Toddler Dose|Withdrawal by Subject|1|||
160630942|NCT00366678|580029053|FG001|Toddler Dose|Withdrawal by Subject|0|||
160630943|NCT00366678|580029054|FG002|Toddler Dose|Withdrawal by Subject|0|||
160630944|NCT00366678|580029052|FG000|Toddler Dose|protocol deviation|1|||
160630945|NCT00366678|580029053|FG001|Toddler Dose|protocol deviation|0|||
160630946|NCT00366678|580029054|FG002|Toddler Dose|protocol deviation|0|||
160630947|NCT04465916|580029058|FG000|Overall Study|Withdrawal by Subject|0|||
160630948|NCT04465916|580029059|FG001|Overall Study|Withdrawal by Subject|1|||
160630949|NCT00297882|580029068|FG000|Day 14|Lack of Efficacy|12|||
160630950|NCT00297882|580029069|FG001|Day 14|Lack of Efficacy|49|||
160630951|NCT00297882|580029068|FG000|Day 28|Lost to Follow-up|13|||
160630952|NCT00297882|580029069|FG001|Day 28|Lost to Follow-up|23|||
160630953|NCT00297882|580029068|FG000|Day 28|Lack of Efficacy|3|||
160630954|NCT00297882|580029069|FG001|Day 28|Lack of Efficacy|0|||
160630955|NCT04242264|580029070|FG000|Overall Study|Lost to Follow-up|2|||
160630956|NCT04242264|580029071|FG001|Overall Study|Lost to Follow-up|2|||
160630957|NCT04242264|580029072|FG002|Overall Study|Lost to Follow-up|1|||
160630958|NCT04242264|580029073|FG003|Overall Study|Lost to Follow-up|1|||
160630959|NCT04242264|580029070|FG000|Overall Study|Withdrawal by Subject|1|||
160630960|NCT04242264|580029071|FG001|Overall Study|Withdrawal by Subject|0|||
160630961|NCT04242264|580029072|FG002|Overall Study|Withdrawal by Subject|0|||
160630962|NCT04242264|580029073|FG003|Overall Study|Withdrawal by Subject|0|||
160630963|NCT04221373|580029074|FG000|Overall Study|Physician Decision|4|||
160630964|NCT04221373|580029075|FG001|Overall Study|Physician Decision|0|||
160630965|NCT00577031|580029079|FG000|Overall Study|Adverse Event|52|||
160630966|NCT00577031|580029079|FG000|Overall Study|Progression of disease|93|||
160630967|NCT00577031|580029079|FG000|Overall Study|Protocol Violation|5|||
160677545|NCT01567527|580198880|FG001|Conversion Phase.|Lost to Follow-up|0|||
160630968|NCT00577031|580029079|FG000|Overall Study|Participant withdrew consent|13|||
160630969|NCT00577031|580029079|FG000|Overall Study|Participant non-compliance|5|||
160630970|NCT00577031|580029079|FG000|Overall Study|Need for surgery|17|||
160630971|NCT00577031|580029079|FG000|Overall Study|Medical decision|14|||
160630972|NCT00577031|580029079|FG000|Overall Study|Death|6|||
160630973|NCT00557830|580029080|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
160630974|NCT00557830|580029081|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
160630975|NCT00557830|580029082|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
160630976|NCT00557830|580029080|FG000|Screening Treatment Phase|Adverse Event|2|||
160630977|NCT00557830|580029081|FG001|Screening Treatment Phase|Adverse Event|0|||
160630978|NCT00557830|580029082|FG002|Screening Treatment Phase|Adverse Event|0|||
160630979|NCT00557830|580029080|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
160630980|NCT00557830|580029081|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
160630981|NCT00557830|580029082|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
160630982|NCT00538473|580029083|FG000|Overall Study|Adverse Event|1|||
160630983|NCT00538473|580029084|FG001|Overall Study|Adverse Event|0|||
160630984|NCT01569074|580029085|FG000|Overall Study|Study stopped|6|||
160630985|NCT01569074|580029086|FG001|Overall Study|Study stopped|6|||
160630986|NCT01569074|580029087|FG002|Overall Study|Study stopped|8|||
160630987|NCT01569074|580029088|FG003|Overall Study|Study stopped|7|||
160630988|NCT01569074|580029089|FG004|Overall Study|Study stopped|7|||
160630989|NCT01569074|580029085|FG000|Overall Study|Study-specific discontinuation criteria|0|||
160630990|NCT01569074|580029086|FG001|Overall Study|Study-specific discontinuation criteria|1|||
160630991|NCT01569074|580029087|FG002|Overall Study|Study-specific discontinuation criteria|0|||
160630992|NCT01569074|580029088|FG003|Overall Study|Study-specific discontinuation criteria|0|||
160630993|NCT01569074|580029089|FG004|Overall Study|Study-specific discontinuation criteria|0|||
160630994|NCT01569074|580029085|FG000|Overall Study|Severe non-compliance to protocol|0|||
160630995|NCT01569074|580029086|FG001|Overall Study|Severe non-compliance to protocol|0|||
160630996|NCT01569074|580029087|FG002|Overall Study|Severe non-compliance to protocol|1|||
160630997|NCT01569074|580029088|FG003|Overall Study|Severe non-compliance to protocol|0|||
160630998|NCT01569074|580029089|FG004|Overall Study|Severe non-compliance to protocol|0|||
160630999|NCT01569074|580029085|FG000|Overall Study|eg change in circumstances|0|||
160631000|NCT01569074|580029086|FG001|Overall Study|eg change in circumstances|2|||
160631001|NCT01569074|580029087|FG002|Overall Study|eg change in circumstances|0|||
160631002|NCT01569074|580029088|FG003|Overall Study|eg change in circumstances|1|||
160631003|NCT01569074|580029089|FG004|Overall Study|eg change in circumstances|1|||
160631004|NCT01569074|580029085|FG000|Overall Study|Adverse Event|1|||
160631005|NCT01569074|580029086|FG001|Overall Study|Adverse Event|0|||
160631006|NCT01569074|580029087|FG002|Overall Study|Adverse Event|3|||
160631007|NCT01569074|580029088|FG003|Overall Study|Adverse Event|0|||
160631008|NCT01569074|580029089|FG004|Overall Study|Adverse Event|0|||
160631009|NCT05168657|580029090|FG000|Overall Study|Adverse Event|0|||
160631010|NCT05168657|580029091|FG001|Overall Study|Adverse Event|0|||
160631011|NCT05168657|580029092|FG002|Overall Study|Adverse Event|1|||
160631012|NCT05168657|580029093|FG003|Overall Study|Adverse Event|0|||
160631013|NCT05168657|580029094|FG004|Overall Study|Adverse Event|0|||
160631014|NCT05168657|580029095|FG005|Overall Study|Adverse Event|0|||
160631015|NCT05168657|580029096|FG006|Overall Study|Adverse Event|0|||
160631016|NCT05168657|580029097|FG007|Overall Study|Adverse Event|0|||
160631017|NCT00962013|580029098|FG000|Overall Study|Did not have surgery|1|||
160631018|NCT00962013|580029098|FG000|Overall Study|Death|8|||
160631019|NCT00962013|580029098|FG000|Overall Study|Lost to Follow-up|12|||
160631020|NCT00962013|580029098|FG000|Overall Study|Unable/Unwilling to return|6|||
160631021|NCT00962013|580029098|FG000|Overall Study|Withdrawal by Subject|8|||
160631022|NCT00962013|580029098|FG000|Overall Study|Removal of study device|3|||
160631023|NCT00962013|580029098|FG000|Overall Study|Site Termination|24|||
160631024|NCT00962013|580029098|FG000|Overall Study|No 5 year evaluation|6|||
160631025|NCT03843775|580029101|FG000|Overall Study|Adverse Event|1|||
160631026|NCT03843775|580029102|FG001|Overall Study|Adverse Event|1|||
160631027|NCT03843775|580029101|FG000|Overall Study|Lack of Efficacy|2|||
160631028|NCT03843775|580029102|FG001|Overall Study|Lack of Efficacy|6|||
160631029|NCT03843775|580029101|FG000|Overall Study|Withdrawal by Subject|0|||
160631030|NCT03843775|580029102|FG001|Overall Study|Withdrawal by Subject|1|||
160631031|NCT02851069|580029103|FG000|Overall Study|Failure to Return|3|||
160631032|NCT02851069|580029103|FG000|Overall Study|Other|3|||
160631033|NCT03743571|580029104|FG000|Overall Study|Withdrawal by Subject|1|||
160631034|NCT03743571|580029105|FG001|Overall Study|Withdrawal by Subject|1|||
160631035|NCT03743571|580029104|FG000|Overall Study|Lost to Follow-up|1|||
160631036|NCT03743571|580029105|FG001|Overall Study|Lost to Follow-up|2|||
160631037|NCT01489865|580029106|FG000|Overall Study|Progression of Disease|4|||
160631038|NCT01489865|580029107|FG001|Overall Study|Progression of Disease|2|||
160631039|NCT01489865|580029108|FG002|Overall Study|Progression of Disease|2|||
160631040|NCT01489865|580029109|FG003|Overall Study|Progression of Disease|3|||
160631041|NCT01489865|580029110|FG004|Overall Study|Progression of Disease|1|||
160631042|NCT01489865|580029111|FG005|Overall Study|Progression of Disease|6|||
160631043|NCT01489865|580029112|FG006|Overall Study|Progression of Disease|3|||
160631044|NCT01489865|580029113|FG007|Overall Study|Progression of Disease|0|||
160631045|NCT01489865|580029114|FG008|Overall Study|Progression of Disease|23|||
160631046|NCT01489865|580029106|FG000|Overall Study|Adverse Event|2|||
160631047|NCT01489865|580029107|FG001|Overall Study|Adverse Event|0|||
160631048|NCT01489865|580029108|FG002|Overall Study|Adverse Event|0|||
160674101|NCT00073307|580185879|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
160674102|NCT00073307|580185880|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
160674103|NCT00073307|580185881|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
160674104|NCT00073307|580185879|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
160674105|NCT00073307|580185880|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
160674106|NCT00073307|580185881|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
160674107|NCT00073307|580185879|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
160674108|NCT00073307|580185880|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
160674109|NCT00073307|580185881|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
160674110|NCT00073307|580185879|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
160674111|NCT00073307|580185880|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
160674112|NCT00073307|580185881|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
160674113|NCT01438060|580185882|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
160674114|NCT01438060|580185883|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
160674115|NCT01438060|580185882|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
160674116|NCT01438060|580185883|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
160674117|NCT01438060|580185882|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
160674118|NCT01438060|580185883|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
160674119|NCT01438060|580185882|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
160674120|NCT01438060|580185883|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
160674121|NCT01438060|580185882|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
160674122|NCT01438060|580185883|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
160674123|NCT01438060|580185882|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
160674124|NCT01438060|580185883|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
160674125|NCT01438060|580185882|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
160674126|NCT01438060|580185883|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
160674127|NCT01438060|580185882|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
160674128|NCT01438060|580185883|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
160674129|NCT01438060|580185882|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
160674130|NCT01438060|580185883|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
160674131|NCT01438060|580185882|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
160674132|NCT01438060|580185883|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
160674133|NCT01438060|580185882|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
160674134|NCT01438060|580185883|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
160674135|NCT01438060|580185882|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
160674136|NCT01438060|580185883|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
160674137|NCT01438060|580185882|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
160674138|NCT01438060|580185883|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
160674139|NCT01438060|580185882|FG000|On Study Beyond Week 140|Adverse Event|0|||
160674140|NCT01438060|580185883|FG001|On Study Beyond Week 140|Adverse Event|2|||
160674141|NCT01438060|580185882|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
160674142|NCT01438060|580185883|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
160674143|NCT01438060|580185882|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
160674144|NCT01438060|580185883|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
160674145|NCT01438060|580185882|FG000|On Study Beyond Week 140|Death|0|||
160674146|NCT01438060|580185883|FG001|On Study Beyond Week 140|Death|1|||
160674147|NCT01438060|580185882|FG000|On Study Beyond Week 140|Other Reason|0|||
160674148|NCT01438060|580185883|FG001|On Study Beyond Week 140|Other Reason|3|||
160674149|NCT03602339|580185884|FG000|Overall Study|Withdrawal by Subject|9|||
160674150|NCT03602339|580185884|FG000|Overall Study|Physician Decision|2|||
160674151|NCT03602339|580185884|FG000|Overall Study|Other reason|4|||
160674152|NCT01190865|580185896|FG000|Overall Study|Withdrawal by Subject|1|||
160674153|NCT01190865|580185896|FG000|Overall Study|Non-compliance|2|||
160674154|NCT00875524|580185897|FG000|Overall Study|Serious adverse event|0|||
160674155|NCT00875524|580185898|FG001|Overall Study|Serious adverse event|1|||
160674156|NCT00875524|580185897|FG000|Overall Study|Protocol Violation|4|||
160674157|NCT00875524|580185898|FG001|Overall Study|Protocol Violation|0|||
160674158|NCT00875524|580185897|FG000|Overall Study|Lost to Follow-up|1|||
160674159|NCT00875524|580185898|FG001|Overall Study|Lost to Follow-up|0|||
160674160|NCT00875524|580185897|FG000|Overall Study|Withdrawal by Subject|3|||
160674161|NCT00875524|580185898|FG001|Overall Study|Withdrawal by Subject|5|||
160674162|NCT00829452|580185900|FG000|First Intervention|Withdrawal by Subject|0|||
160674163|NCT00829452|580185901|FG001|First Intervention|Withdrawal by Subject|1|||
160674164|NCT00829452|580185900|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
160674165|NCT00829452|580185901|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
160674166|NCT00829452|580185900|FG000|Second Intervention|Physician Decision|0|||
160674167|NCT00829452|580185901|FG001|Second Intervention|Physician Decision|1|||
160674168|NCT00574847|580185911|FG000|Overall Study|Adverse Event|2|||
160674169|NCT00574847|580185912|FG001|Overall Study|Adverse Event|0|||
160631049|NCT01489865|580029109|FG003|Overall Study|Adverse Event|0|||
160631050|NCT01489865|580029110|FG004|Overall Study|Adverse Event|1|||
160631051|NCT01489865|580029111|FG005|Overall Study|Adverse Event|0|||
160631052|NCT01489865|580029112|FG006|Overall Study|Adverse Event|2|||
160631053|NCT01489865|580029113|FG007|Overall Study|Adverse Event|0|||
160631054|NCT01489865|580029114|FG008|Overall Study|Adverse Event|5|||
160631055|NCT01489865|580029106|FG000|Overall Study|Death|0|||
160631056|NCT01489865|580029107|FG001|Overall Study|Death|1|||
160631057|NCT01489865|580029108|FG002|Overall Study|Death|0|||
160631058|NCT01489865|580029109|FG003|Overall Study|Death|0|||
160631059|NCT01489865|580029110|FG004|Overall Study|Death|1|||
160631060|NCT01489865|580029111|FG005|Overall Study|Death|0|||
160631061|NCT01489865|580029112|FG006|Overall Study|Death|0|||
160631062|NCT01489865|580029113|FG007|Overall Study|Death|0|||
160631063|NCT01489865|580029114|FG008|Overall Study|Death|2|||
160631064|NCT01489865|580029106|FG000|Overall Study|Withdrawal by Subject|0|||
160631065|NCT01489865|580029107|FG001|Overall Study|Withdrawal by Subject|0|||
160631066|NCT01489865|580029108|FG002|Overall Study|Withdrawal by Subject|0|||
160631067|NCT01489865|580029109|FG003|Overall Study|Withdrawal by Subject|0|||
160631068|NCT01489865|580029110|FG004|Overall Study|Withdrawal by Subject|0|||
160631069|NCT01489865|580029111|FG005|Overall Study|Withdrawal by Subject|1|||
160631070|NCT01489865|580029112|FG006|Overall Study|Withdrawal by Subject|1|||
160631071|NCT01489865|580029113|FG007|Overall Study|Withdrawal by Subject|0|||
160631072|NCT01489865|580029114|FG008|Overall Study|Withdrawal by Subject|2|||
160631073|NCT01489865|580029106|FG000|Overall Study|Shifted|0|||
160631074|NCT01489865|580029107|FG001|Overall Study|Shifted|0|||
160631075|NCT01489865|580029108|FG002|Overall Study|Shifted|1|||
160631076|NCT01489865|580029109|FG003|Overall Study|Shifted|0|||
160631077|NCT01489865|580029110|FG004|Overall Study|Shifted|0|||
160631078|NCT01489865|580029111|FG005|Overall Study|Shifted|0|||
160631079|NCT01489865|580029112|FG006|Overall Study|Shifted|0|||
160631080|NCT01489865|580029113|FG007|Overall Study|Shifted|0|||
160631081|NCT01489865|580029114|FG008|Overall Study|Shifted|0|||
160631082|NCT04115488|580029115|FG000|Overall Study|Adverse Event|8|||
160631083|NCT04115488|580029116|FG001|Overall Study|Adverse Event|4|||
160631084|NCT04115488|580029115|FG000|Overall Study|Withdrawal by Subject|3|||
160631085|NCT04115488|580029116|FG001|Overall Study|Withdrawal by Subject|6|||
160631086|NCT04115488|580029115|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
160631087|NCT04115488|580029116|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
160631088|NCT04115488|580029115|FG000|Overall Study|Patient 's location change|1|||
160631089|NCT04115488|580029116|FG001|Overall Study|Patient 's location change|0|||
160631090|NCT04115488|580029115|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
160631091|NCT04115488|580029116|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
160631092|NCT00885677|580029117|FG000|Overall Study|Death|40|||
160631093|NCT00885677|580029118|FG001|Overall Study|Death|34|||
160631094|NCT00885677|580029117|FG000|Overall Study|Lost to Follow-up|15|||
160631095|NCT00885677|580029118|FG001|Overall Study|Lost to Follow-up|13|||
160631096|NCT00885677|580029117|FG000|Overall Study|Protocol Violation|54|||
160631097|NCT00885677|580029118|FG001|Overall Study|Protocol Violation|54|||
160631098|NCT00885677|580029117|FG000|Overall Study|premature study closure|41|||
160631099|NCT00885677|580029118|FG001|Overall Study|premature study closure|44|||
160631100|NCT00885677|580029117|FG000|Overall Study|device/lead revision or replacement|7|||
160631101|NCT00885677|580029118|FG001|Overall Study|device/lead revision or replacement|6|||
160631102|NCT00885677|580029117|FG000|Overall Study|Heart transplantation|1|||
160631103|NCT00885677|580029118|FG001|Overall Study|Heart transplantation|0|||
160631104|NCT00885677|580029117|FG000|Overall Study|Inclusion/exclusion not met|25|||
160631105|NCT00885677|580029118|FG001|Overall Study|Inclusion/exclusion not met|27|||
160631106|NCT01875731|580029131|FG000|Overall Study|Fail to obtain lab sample|1|||
160631107|NCT01875731|580029132|FG001|Overall Study|Fail to obtain lab sample|0|||
160631108|NCT03417102|580029133|FG000|Overall Study|Adverse Event|0|||
160631109|NCT03417102|580029134|FG001|Overall Study|Adverse Event|1|||
160631110|NCT03417102|580029133|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
160631111|NCT03417102|580029134|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
160631112|NCT03417102|580029133|FG000|Overall Study|Other|0|||
160631113|NCT03417102|580029134|FG001|Overall Study|Other|1|||
160631114|NCT02062385|580029138|FG000|Overall Study|Adverse Event|19|||
160631115|NCT02062385|580029139|FG001|Overall Study|Adverse Event|13|||
160631116|NCT02062385|580029140|FG002|Overall Study|Adverse Event|1|||
160631117|NCT02062385|580029141|FG003|Overall Study|Adverse Event|0|||
160631118|NCT02062385|580029138|FG000|Overall Study|Protocol Violation|1|||
160631119|NCT02062385|580029139|FG001|Overall Study|Protocol Violation|0|||
160631120|NCT02062385|580029140|FG002|Overall Study|Protocol Violation|0|||
160631121|NCT02062385|580029141|FG003|Overall Study|Protocol Violation|0|||
160631122|NCT02062385|580029138|FG000|Overall Study|Incomplete EPI by database lock|2|||
160631123|NCT02062385|580029139|FG001|Overall Study|Incomplete EPI by database lock|0|||
160631124|NCT02062385|580029140|FG002|Overall Study|Incomplete EPI by database lock|0|||
160631125|NCT02062385|580029141|FG003|Overall Study|Incomplete EPI by database lock|0|||
160631126|NCT02062385|580029138|FG000|Overall Study|Moved|10|||
160631127|NCT02062385|580029139|FG001|Overall Study|Moved|11|||
160631128|NCT02062385|580029140|FG002|Overall Study|Moved|1|||
160631129|NCT02062385|580029141|FG003|Overall Study|Moved|0|||
160631130|NCT02062385|580029138|FG000|Overall Study|Withdrawn by parent/guardian|46|||
160631131|NCT02062385|580029139|FG001|Overall Study|Withdrawn by parent/guardian|41|||
160631132|NCT02062385|580029140|FG002|Overall Study|Withdrawn by parent/guardian|9|||
160631133|NCT02062385|580029141|FG003|Overall Study|Withdrawn by parent/guardian|8|||
160631134|NCT02062385|580029138|FG000|Overall Study|Death|0|||
160631135|NCT02062385|580029139|FG001|Overall Study|Death|0|||
160631136|NCT02062385|580029140|FG002|Overall Study|Death|0|||
160631137|NCT02062385|580029141|FG003|Overall Study|Death|1|||
160631138|NCT02062385|580029138|FG000|Overall Study|Lost to Follow-up|0|||
160631139|NCT02062385|580029139|FG001|Overall Study|Lost to Follow-up|0|||
160631140|NCT02062385|580029140|FG002|Overall Study|Lost to Follow-up|1|||
160631141|NCT02062385|580029141|FG003|Overall Study|Lost to Follow-up|0|||
160631142|NCT03188991|580029142|FG000|Overall Study|Withdrawal by Subject|0|||
160631143|NCT03188991|580029143|FG001|Overall Study|Withdrawal by Subject|0|||
160631144|NCT03188991|580029144|FG002|Overall Study|Withdrawal by Subject|0|||
160631145|NCT03188991|580029145|FG003|Overall Study|Withdrawal by Subject|1|||
160631146|NCT03255226|580030988|FG000|Overall Study|Adverse Event|2|||
160631147|NCT03255226|580030988|FG000|Overall Study|Physician Decision|3|||
160631148|NCT03255226|580030988|FG000|Overall Study|Withdrawal by Subject|1|||
160631149|NCT03255226|580030988|FG000|Overall Study|Serum or blood sodium increased|4|||
160631150|NCT03255226|580030988|FG000|Overall Study|Serum or blood potassium increased|4|||
160631151|NCT01017731|580030989|FG000|Overall Study|Lost to Follow-up|2|||
160631152|NCT01017731|580030989|FG000|Overall Study|Withdrawal by Subject|3|||
160631153|NCT01017731|580030989|FG000|Overall Study|Physician Decision|2|||
160631154|NCT01017731|580030989|FG000|Overall Study|Adverse Event|1|||
160631155|NCT01035229|580030990|FG000|Overall Study|Adverse Event|61|||
160631156|NCT01035229|580030991|FG001|Overall Study|Adverse Event|14|||
160631157|NCT01035229|580030990|FG000|Overall Study|Withdrawal by Subject|20|||
160631158|NCT01035229|580030991|FG001|Overall Study|Withdrawal by Subject|7|||
160631159|NCT01035229|580030990|FG000|Overall Study|Lost to Follow-up|1|||
160631160|NCT01035229|580030991|FG001|Overall Study|Lost to Follow-up|0|||
160631161|NCT01035229|580030990|FG000|Overall Study|Administrative problems|1|||
160631162|NCT01035229|580030991|FG001|Overall Study|Administrative problems|1|||
160631163|NCT01035229|580030990|FG000|Overall Study|Death|13|||
160631164|NCT01035229|580030991|FG001|Overall Study|Death|5|||
160631165|NCT01035229|580030990|FG000|Overall Study|New cancer therapy|2|||
160631166|NCT01035229|580030991|FG001|Overall Study|New cancer therapy|0|||
160631167|NCT01035229|580030990|FG000|Overall Study|Protocol Violation|0|||
160631168|NCT01035229|580030991|FG001|Overall Study|Protocol Violation|2|||
160631169|NCT01035229|580030990|FG000|Overall Study|Sponsor's decision to end study|3|||
160631170|NCT01035229|580030991|FG001|Overall Study|Sponsor's decision to end study|3|||
160631171|NCT01035229|580030990|FG000|Overall Study|Disease Progression|261|||
160631172|NCT01035229|580030991|FG001|Overall Study|Disease Progression|152|||
160631173|NCT00685763|580030993|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
160631174|NCT00685763|580030993|FG000|Overall Study|Protocol Violation|1|||
160631175|NCT00698009|580030997|FG000|Overall Study|Withdrawal by Subject|1|||
160631176|NCT00564486|580031001|FG000|Overall Study|Adverse Event|0|||
160631177|NCT00564486|580031002|FG001|Overall Study|Adverse Event|1|||
160631178|NCT00564486|580031003|FG002|Overall Study|Adverse Event|0|||
160631179|NCT00564486|580031004|FG003|Overall Study|Adverse Event|0|||
160631180|NCT00564486|580031001|FG000|Overall Study|Withdrawal by Subject|4|||
160631181|NCT00564486|580031002|FG001|Overall Study|Withdrawal by Subject|0|||
160631182|NCT00564486|580031003|FG002|Overall Study|Withdrawal by Subject|0|||
160631183|NCT00564486|580031004|FG003|Overall Study|Withdrawal by Subject|5|||
160631184|NCT00564486|580031001|FG000|Overall Study|Subject refused to have blood drawn|0|||
160631185|NCT00564486|580031002|FG001|Overall Study|Subject refused to have blood drawn|0|||
160631186|NCT00564486|580031003|FG002|Overall Study|Subject refused to have blood drawn|1|||
160631187|NCT00564486|580031004|FG003|Overall Study|Subject refused to have blood drawn|0|||
160631188|NCT00564486|580031001|FG000|Overall Study|Lost to Follow-up|3|||
160631189|NCT00564486|580031002|FG001|Overall Study|Lost to Follow-up|0|||
160631190|NCT00564486|580031003|FG002|Overall Study|Lost to Follow-up|2|||
160631191|NCT00564486|580031004|FG003|Overall Study|Lost to Follow-up|2|||
160631192|NCT03862807|580031005|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
160631193|NCT00798707|580031006|FG000|Overall Study|Adverse Event|6|||
160631194|NCT00798707|580031007|FG001|Overall Study|Adverse Event|8|||
160631195|NCT00798707|580031008|FG002|Overall Study|Adverse Event|8|||
160631196|NCT00798707|580031006|FG000|Overall Study|Failed to return|2|||
160631197|NCT00798707|580031007|FG001|Overall Study|Failed to return|2|||
160631198|NCT00798707|580031008|FG002|Overall Study|Failed to return|0|||
160674170|NCT00574847|580185911|FG000|Overall Study|Death|1|||
160631199|NCT00798707|580031006|FG000|Overall Study|Investigator|0|||
160631200|NCT00798707|580031007|FG001|Overall Study|Investigator|1|||
160631201|NCT00798707|580031008|FG002|Overall Study|Investigator|2|||
160631202|NCT00798707|580031006|FG000|Overall Study|Lack of Efficacy|2|||
160631203|NCT00798707|580031007|FG001|Overall Study|Lack of Efficacy|2|||
160631204|NCT00798707|580031008|FG002|Overall Study|Lack of Efficacy|1|||
160631205|NCT00798707|580031006|FG000|Overall Study|Lost to Follow-up|5|||
160631206|NCT00798707|580031007|FG001|Overall Study|Lost to Follow-up|6|||
160631207|NCT00798707|580031008|FG002|Overall Study|Lost to Follow-up|6|||
160631208|NCT00798707|580031006|FG000|Overall Study|Other|0|||
160631209|NCT00798707|580031007|FG001|Overall Study|Other|1|||
160631210|NCT00798707|580031008|FG002|Overall Study|Other|0|||
160631211|NCT00798707|580031006|FG000|Overall Study|Protocol Violation|4|||
160631212|NCT00798707|580031007|FG001|Overall Study|Protocol Violation|0|||
160631213|NCT00798707|580031008|FG002|Overall Study|Protocol Violation|2|||
160631214|NCT00798707|580031006|FG000|Overall Study|Withdrawal by Subject|3|||
160631215|NCT00798707|580031007|FG001|Overall Study|Withdrawal by Subject|8|||
160631216|NCT00798707|580031008|FG002|Overall Study|Withdrawal by Subject|2|||
160631217|NCT00798707|580031006|FG000|Overall Study|Randomized not treated|4|||
160631218|NCT00798707|580031007|FG001|Overall Study|Randomized not treated|5|||
160631219|NCT00798707|580031008|FG002|Overall Study|Randomized not treated|1|||
160631220|NCT03457727|580031010|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
160631221|NCT03457727|580031011|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
160631222|NCT03457727|580031012|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
160631223|NCT03457727|580031013|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
160631224|NCT00929201|580031014|FG000|Period 1|Withdrawal by Subject|0|||
160631225|NCT00929201|580031015|FG001|Period 1|Withdrawal by Subject|1|||
160631226|NCT01299272|580031021|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
160631227|NCT01299272|580031022|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
160631228|NCT01299272|580031023|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
160631229|NCT01299272|580031024|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
160631230|NCT01299272|580031021|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
160631231|NCT01299272|580031022|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
160631232|NCT01299272|580031023|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
160631233|NCT01299272|580031024|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
160631234|NCT01299272|580031021|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
160631235|NCT01299272|580031022|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
160631236|NCT01299272|580031023|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
160631237|NCT01299272|580031024|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
160631238|NCT01299272|580031021|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
160631239|NCT01299272|580031022|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
160631240|NCT01299272|580031023|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
160631241|NCT01299272|580031024|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
160631242|NCT01299272|580031021|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
160631243|NCT01299272|580031022|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
160631244|NCT01299272|580031023|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
160631245|NCT01299272|580031024|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
160631246|NCT01299272|580031021|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
160631247|NCT01299272|580031022|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
160631248|NCT01299272|580031023|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
160631249|NCT01299272|580031024|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
160631250|NCT01299272|580031021|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
160631251|NCT01299272|580031022|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
160631252|NCT01299272|580031023|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
160631253|NCT01299272|580031024|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
160631254|NCT01299272|580031021|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
160631255|NCT01299272|580031022|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
160631256|NCT01299272|580031023|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
160631257|NCT01299272|580031024|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
160631258|NCT01299272|580031021|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
160631259|NCT01299272|580031022|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
160631260|NCT01299272|580031023|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
160631261|NCT01299272|580031024|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
160631262|NCT01299272|580031021|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
160631263|NCT01299272|580031022|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
160631264|NCT01299272|580031023|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
160631265|NCT01299272|580031024|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
160631266|NCT01299272|580031021|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
160631267|NCT01299272|580031022|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
160631268|NCT01299272|580031023|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
160631269|NCT01299272|580031024|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
160631270|NCT01299272|580031021|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
160631271|NCT01299272|580031022|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
160631272|NCT01299272|580031023|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
160631273|NCT01299272|580031024|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
160631274|NCT01299272|580031021|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
160674171|NCT00574847|580185912|FG001|Overall Study|Death|0|||
160674172|NCT00574847|580185911|FG000|Overall Study|Withdrawal by Subject|2|||
160674173|NCT00574847|580185912|FG001|Overall Study|Withdrawal by Subject|2|||
160674174|NCT00574847|580185911|FG000|Overall Study|Physician Decision|1|||
160674175|NCT00574847|580185912|FG001|Overall Study|Physician Decision|0|||
160674176|NCT00574847|580185911|FG000|Overall Study|Did not receive medication (declined)|2|||
160674177|NCT00574847|580185912|FG001|Overall Study|Did not receive medication (declined)|5|||
160674178|NCT04060251|580185920|FG000|Overall Study|Study terminated due to low enrollment.|7|||
160674179|NCT04060251|580185921|FG001|Overall Study|Study terminated due to low enrollment.|5|||
160674180|NCT04060251|580185922|FG002|Overall Study|Study terminated due to low enrollment.|7|||
160674181|NCT04060251|580185920|FG000|Overall Study|Adverse Event|1|||
160674182|NCT04060251|580185921|FG001|Overall Study|Adverse Event|1|||
160674183|NCT04060251|580185922|FG002|Overall Study|Adverse Event|0|||
160674184|NCT00487435|580185923|FG000|Overall Study|Adverse Event|146|||
160674185|NCT00487435|580185923|FG000|Overall Study|Death|2|||
160674186|NCT00487435|580185923|FG000|Overall Study|Lack of Efficacy|33|||
160674187|NCT00487435|580185923|FG000|Overall Study|Lost to Follow-up|54|||
160674188|NCT00487435|580185923|FG000|Overall Study|Pregnancy|2|||
160674189|NCT00487435|580185923|FG000|Overall Study|Withdrawal by Subject|132|||
160674190|NCT00487435|580185923|FG000|Overall Study|Resolution Of Pain|1|||
160674191|NCT00487435|580185923|FG000|Overall Study|Study Medication Non-Compliant|32|||
160674192|NCT00487435|580185923|FG000|Overall Study|Other|83|||
160674193|NCT01155531|580185924|FG000|Overall Study|Adverse Event|0|||
160674194|NCT01155531|580185925|FG001|Overall Study|Adverse Event|0|||
160674195|NCT01155531|580185926|FG002|Overall Study|Adverse Event|1|||
160674196|NCT01155531|580185927|FG003|Overall Study|Adverse Event|0|||
160674197|NCT01155531|580185924|FG000|Overall Study|Lost to Follow-up|0|||
160674198|NCT01155531|580185925|FG001|Overall Study|Lost to Follow-up|0|||
160674199|NCT01155531|580185926|FG002|Overall Study|Lost to Follow-up|0|||
160631275|NCT01299272|580031022|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
160631276|NCT01299272|580031023|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
160674200|NCT01155531|580185927|FG003|Overall Study|Lost to Follow-up|1|||
160674201|NCT01155531|580185924|FG000|Overall Study|Withdrawal by Subject|1|||
160674202|NCT01155531|580185925|FG001|Overall Study|Withdrawal by Subject|0|||
160674203|NCT01155531|580185926|FG002|Overall Study|Withdrawal by Subject|1|||
160674204|NCT01155531|580185927|FG003|Overall Study|Withdrawal by Subject|0|||
160674205|NCT02227238|580185928|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
160674206|NCT02227238|580185929|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
160674207|NCT02227238|580185930|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
160674208|NCT02227238|580185928|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
160674209|NCT02227238|580185929|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
160674210|NCT02227238|580185930|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
160674211|NCT02227238|580185928|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
160674212|NCT02227238|580185929|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
160674213|NCT02227238|580185930|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
160674214|NCT02227238|580185928|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
160674215|NCT02227238|580185929|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
160674216|NCT02227238|580185930|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
160674217|NCT02227238|580185928|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
160674218|NCT02227238|580185929|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
160631277|NCT01299272|580031024|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
160631278|NCT01299272|580031021|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
160631279|NCT01299272|580031022|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
160631280|NCT01299272|580031023|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
160631281|NCT01299272|580031024|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
160631282|NCT01299272|580031021|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
160631283|NCT01299272|580031022|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
160631284|NCT01299272|580031023|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
160631285|NCT01299272|580031024|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
160631286|NCT01299272|580031021|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
160631287|NCT01299272|580031022|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
160674219|NCT02227238|580185930|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
160674220|NCT02227238|580185928|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
160674221|NCT02227238|580185929|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
160674222|NCT02227238|580185930|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
160674223|NCT02227238|580185928|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
160674224|NCT02227238|580185929|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
160674225|NCT02227238|580185930|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
160674226|NCT02227238|580185928|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
160674227|NCT02227238|580185929|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
160631288|NCT01299272|580031023|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
160631289|NCT01299272|580031024|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
160631290|NCT01299272|580031021|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
160631291|NCT01299272|580031022|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
160631292|NCT01299272|580031023|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
160631293|NCT01299272|580031024|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
160631294|NCT01299272|580031021|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
160631295|NCT01299272|580031022|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
160631296|NCT01299272|580031023|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
160631297|NCT01299272|580031024|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
160631298|NCT01299272|580031021|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
160631299|NCT01299272|580031022|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
160631300|NCT01299272|580031023|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
160631301|NCT01299272|580031024|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
160631302|NCT01299272|580031021|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
160631303|NCT01299272|580031022|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
160631304|NCT01299272|580031023|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
160631305|NCT01299272|580031024|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
160631306|NCT01299272|580031021|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
160631307|NCT01299272|580031022|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
160631308|NCT01299272|580031023|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
160631309|NCT01299272|580031024|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
160631310|NCT01299272|580031021|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
160631311|NCT01299272|580031022|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
160631312|NCT01299272|580031023|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
160631313|NCT01299272|580031024|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
160674228|NCT02227238|580185930|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
160674229|NCT02227238|580185928|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
160674230|NCT02227238|580185929|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
160674231|NCT02227238|580185930|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
160674232|NCT02227238|580185928|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
160674233|NCT02227238|580185929|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
160674234|NCT02227238|580185930|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
160674235|NCT02227238|580185928|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
160674236|NCT02227238|580185929|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
160674237|NCT02227238|580185930|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
160674238|NCT02227238|580185928|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
160631314|NCT01299272|580031021|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
160631315|NCT01299272|580031022|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
160631316|NCT01299272|580031023|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
160631317|NCT01299272|580031024|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
160631318|NCT01299272|580031021|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
160631319|NCT01299272|580031022|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
160631320|NCT01299272|580031023|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
160631321|NCT01299272|580031024|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
160631322|NCT01299272|580031021|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
160631323|NCT01299272|580031022|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
160631324|NCT01299272|580031023|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
160631325|NCT01299272|580031024|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
160631326|NCT00464308|580031025|FG000|Overall Study|Adverse Event|22|||
160631327|NCT00464308|580031026|FG001|Overall Study|Adverse Event|27|||
160631328|NCT00464308|580031027|FG002|Overall Study|Adverse Event|16|||
160631329|NCT00464308|580031025|FG000|Overall Study|Lost to Follow-up|29|||
160631330|NCT00464308|580031026|FG001|Overall Study|Lost to Follow-up|19|||
160631331|NCT00464308|580031027|FG002|Overall Study|Lost to Follow-up|20|||
160631332|NCT00464308|580031025|FG000|Overall Study|Patient discontinued and other reasons|17|||
160631333|NCT00464308|580031026|FG001|Overall Study|Patient discontinued and other reasons|17|||
160631334|NCT00464308|580031027|FG002|Overall Study|Patient discontinued and other reasons|23|||
160631335|NCT00464308|580031025|FG000|Overall Study|Physician Decision|1|||
160631336|NCT00464308|580031026|FG001|Overall Study|Physician Decision|0|||
160631337|NCT00464308|580031027|FG002|Overall Study|Physician Decision|0|||
160631338|NCT00826176|580031040|FG000|Overall Study|Lost to Follow-up|1|||
160631339|NCT00826176|580031041|FG001|Overall Study|Lost to Follow-up|0|||
160631340|NCT00826176|580031040|FG000|Overall Study|Subject Withdrew Consent|3|||
160631341|NCT00826176|580031041|FG001|Overall Study|Subject Withdrew Consent|0|||
160631342|NCT00826176|580031040|FG000|Overall Study|Administrative|9|||
160674239|NCT02227238|580185929|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
160631343|NCT00826176|580031041|FG001|Overall Study|Administrative|0|||
160631344|NCT00740480|580031042|FG000|Overall Study|Adverse Event|1|||
160631345|NCT00740480|580031042|FG000|Overall Study|Physician Decision|1|||
160631346|NCT03079869|580031045|FG000|Overall Study|Adverse Event|6|||
160631347|NCT03079869|580031046|FG001|Overall Study|Adverse Event|8|||
160631348|NCT03079869|580031045|FG000|Overall Study|Withdrawal by Subject|4|||
160631349|NCT03079869|580031046|FG001|Overall Study|Withdrawal by Subject|1|||
160631350|NCT03079869|580031045|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
160631351|NCT03079869|580031046|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
160631352|NCT01325701|580031047|FG000|Overall Study|Adverse Event|12|||
160631353|NCT01325701|580031048|FG001|Overall Study|Adverse Event|0|||
160631354|NCT01325701|580031047|FG000|Overall Study|Protocol Violation|1|||
160631355|NCT01325701|580031048|FG001|Overall Study|Protocol Violation|0|||
160631356|NCT01325701|580031047|FG000|Overall Study|Physician Decision|2|||
160631357|NCT01325701|580031048|FG001|Overall Study|Physician Decision|2|||
160631358|NCT01325701|580031047|FG000|Overall Study|Withdrawal by Subject|2|||
160631359|NCT01325701|580031048|FG001|Overall Study|Withdrawal by Subject|1|||
160631360|NCT01325701|580031047|FG000|Overall Study|Rollerover Extension Study|4|||
160631361|NCT01325701|580031048|FG001|Overall Study|Rollerover Extension Study|0|||
160631362|NCT01005680|580031054|FG000|Overall Study|Lost to Follow-up|4|||
160631363|NCT01005680|580031055|FG001|Overall Study|Lost to Follow-up|6|||
160631364|NCT01005680|580031054|FG000|Overall Study|Withdrawal by Subject|1|||
160631365|NCT01005680|580031055|FG001|Overall Study|Withdrawal by Subject|4|||
160631366|NCT01005680|580031054|FG000|Overall Study|Physician Decision|1|||
160631367|NCT01005680|580031055|FG001|Overall Study|Physician Decision|1|||
160631368|NCT04484805|580031058|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
160631369|NCT04484805|580031059|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
160631370|NCT04484805|580031058|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
160631371|NCT04484805|580031059|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
160631372|NCT02118896|580031060|FG000|Overall Study|Death|4|||
160631373|NCT02118896|580031061|FG001|Overall Study|Death|0|||
160631374|NCT02118896|580031062|FG002|Overall Study|Death|4|||
160631375|NCT02118896|580031063|FG003|Overall Study|Death|6|||
160631376|NCT02118896|580031064|FG004|Overall Study|Death|3|||
160631377|NCT02118896|580031065|FG005|Overall Study|Death|1|||
160631378|NCT02118896|580031066|FG006|Overall Study|Death|0|||
160631379|NCT02118896|580031067|FG007|Overall Study|Death|0|||
160631380|NCT02118896|580031068|FG008|Overall Study|Death|0|||
160631381|NCT02118896|580031069|FG009|Overall Study|Death|0|||
160631382|NCT02118896|580031060|FG000|Overall Study|Adverse Event|5|||
160631383|NCT02118896|580031061|FG001|Overall Study|Adverse Event|4|||
160631384|NCT02118896|580031062|FG002|Overall Study|Adverse Event|4|||
160631385|NCT02118896|580031063|FG003|Overall Study|Adverse Event|5|||
160631386|NCT02118896|580031064|FG004|Overall Study|Adverse Event|5|||
160631387|NCT02118896|580031065|FG005|Overall Study|Adverse Event|9|||
160631388|NCT02118896|580031066|FG006|Overall Study|Adverse Event|1|||
160631389|NCT02118896|580031067|FG007|Overall Study|Adverse Event|1|||
160631390|NCT02118896|580031068|FG008|Overall Study|Adverse Event|4|||
160631391|NCT02118896|580031069|FG009|Overall Study|Adverse Event|0|||
160631392|NCT02118896|580031060|FG000|Overall Study|Consent withdrawn|2|||
160631393|NCT02118896|580031061|FG001|Overall Study|Consent withdrawn|0|||
160631394|NCT02118896|580031062|FG002|Overall Study|Consent withdrawn|3|||
160631395|NCT02118896|580031063|FG003|Overall Study|Consent withdrawn|4|||
160631396|NCT02118896|580031064|FG004|Overall Study|Consent withdrawn|1|||
160631397|NCT02118896|580031065|FG005|Overall Study|Consent withdrawn|4|||
160631398|NCT02118896|580031066|FG006|Overall Study|Consent withdrawn|0|||
160631399|NCT02118896|580031067|FG007|Overall Study|Consent withdrawn|0|||
160631400|NCT02118896|580031068|FG008|Overall Study|Consent withdrawn|0|||
160631401|NCT02118896|580031069|FG009|Overall Study|Consent withdrawn|0|||
160631402|NCT02118896|580031060|FG000|Overall Study|Non-compliance|2|||
160631403|NCT02118896|580031061|FG001|Overall Study|Non-compliance|1|||
160631404|NCT02118896|580031062|FG002|Overall Study|Non-compliance|1|||
160631405|NCT02118896|580031063|FG003|Overall Study|Non-compliance|5|||
160631406|NCT02118896|580031064|FG004|Overall Study|Non-compliance|0|||
160631407|NCT02118896|580031065|FG005|Overall Study|Non-compliance|1|||
160631408|NCT02118896|580031066|FG006|Overall Study|Non-compliance|0|||
160631409|NCT02118896|580031067|FG007|Overall Study|Non-compliance|1|||
160631410|NCT02118896|580031068|FG008|Overall Study|Non-compliance|0|||
160631411|NCT02118896|580031069|FG009|Overall Study|Non-compliance|0|||
160631412|NCT02118896|580031060|FG000|Overall Study|Pregnancy|1|||
160631413|NCT02118896|580031061|FG001|Overall Study|Pregnancy|1|||
160631414|NCT02118896|580031062|FG002|Overall Study|Pregnancy|0|||
160631415|NCT02118896|580031063|FG003|Overall Study|Pregnancy|0|||
160631416|NCT02118896|580031064|FG004|Overall Study|Pregnancy|1|||
160631417|NCT02118896|580031065|FG005|Overall Study|Pregnancy|3|||
160631418|NCT02118896|580031066|FG006|Overall Study|Pregnancy|1|||
160631419|NCT02118896|580031067|FG007|Overall Study|Pregnancy|0|||
160631420|NCT02118896|580031068|FG008|Overall Study|Pregnancy|0|||
160631421|NCT02118896|580031069|FG009|Overall Study|Pregnancy|0|||
160631422|NCT02118896|580031060|FG000|Overall Study|Lost to Follow-up|1|||
160631423|NCT02118896|580031061|FG001|Overall Study|Lost to Follow-up|2|||
160631424|NCT02118896|580031062|FG002|Overall Study|Lost to Follow-up|1|||
160631425|NCT02118896|580031063|FG003|Overall Study|Lost to Follow-up|0|||
160631426|NCT02118896|580031064|FG004|Overall Study|Lost to Follow-up|2|||
160631427|NCT02118896|580031065|FG005|Overall Study|Lost to Follow-up|1|||
160631428|NCT02118896|580031066|FG006|Overall Study|Lost to Follow-up|0|||
160631429|NCT02118896|580031067|FG007|Overall Study|Lost to Follow-up|0|||
160631430|NCT02118896|580031068|FG008|Overall Study|Lost to Follow-up|0|||
160631431|NCT02118896|580031069|FG009|Overall Study|Lost to Follow-up|0|||
160631432|NCT02118896|580031060|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
160631433|NCT02118896|580031061|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
160631434|NCT02118896|580031062|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
160631435|NCT02118896|580031063|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
160631436|NCT02118896|580031064|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
160631437|NCT02118896|580031065|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
160631438|NCT02118896|580031066|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
160631439|NCT02118896|580031067|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
160631440|NCT02118896|580031068|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
160631441|NCT02118896|580031069|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
160631442|NCT02118896|580031060|FG000|Overall Study|Prohibited medication|0|||
160631443|NCT02118896|580031061|FG001|Overall Study|Prohibited medication|0|||
160631444|NCT02118896|580031062|FG002|Overall Study|Prohibited medication|0|||
160631445|NCT02118896|580031063|FG003|Overall Study|Prohibited medication|0|||
160631446|NCT02118896|580031064|FG004|Overall Study|Prohibited medication|1|||
160631447|NCT02118896|580031065|FG005|Overall Study|Prohibited medication|3|||
160631448|NCT02118896|580031066|FG006|Overall Study|Prohibited medication|0|||
160631449|NCT02118896|580031067|FG007|Overall Study|Prohibited medication|0|||
160631450|NCT02118896|580031068|FG008|Overall Study|Prohibited medication|0|||
160631451|NCT02118896|580031069|FG009|Overall Study|Prohibited medication|0|||
160631452|NCT02118896|580031060|FG000|Overall Study|Miscellaneous|1|||
160631453|NCT02118896|580031061|FG001|Overall Study|Miscellaneous|2|||
160631454|NCT02118896|580031062|FG002|Overall Study|Miscellaneous|0|||
160631455|NCT02118896|580031063|FG003|Overall Study|Miscellaneous|2|||
160631456|NCT02118896|580031064|FG004|Overall Study|Miscellaneous|0|||
160631457|NCT02118896|580031065|FG005|Overall Study|Miscellaneous|4|||
160631458|NCT02118896|580031066|FG006|Overall Study|Miscellaneous|0|||
160631459|NCT02118896|580031067|FG007|Overall Study|Miscellaneous|0|||
160631460|NCT02118896|580031068|FG008|Overall Study|Miscellaneous|0|||
160631461|NCT02118896|580031069|FG009|Overall Study|Miscellaneous|0|||
160631462|NCT00539006|580031073|FG000|Pre-treatment|Other|0|||
160631463|NCT00539006|580031074|FG001|Pre-treatment|Other|1|||
160631464|NCT00539006|580031075|FG002|Pre-treatment|Other|0|||
160631465|NCT00539006|580031076|FG003|Pre-treatment|Other|0|||
160631466|NCT00539006|580031073|FG000|Treatment Period 1|Lost to Follow-up|0|||
160631467|NCT00539006|580031074|FG001|Treatment Period 1|Lost to Follow-up|0|||
160631468|NCT00539006|580031075|FG002|Treatment Period 1|Lost to Follow-up|1|||
160674240|NCT02227238|580185930|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
160674241|NCT02227238|580185928|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
160674242|NCT02227238|580185929|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
160674243|NCT02227238|580185930|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
160674244|NCT02227238|580185928|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
160674245|NCT02227238|580185929|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
160674246|NCT02227238|580185930|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
160674247|NCT00380588|580185931|FG000|Overall Study|Unequivocal Disease Progression|25|||
160674248|NCT00380588|580185932|FG001|Overall Study|Unequivocal Disease Progression|34|||
160674249|NCT00380588|580185931|FG000|Overall Study|Next Cycle Not Started|4|||
160674250|NCT00380588|580185932|FG001|Overall Study|Next Cycle Not Started|0|||
160674251|NCT00380588|580185931|FG000|Overall Study|Adverse Event|7|||
160674252|NCT00380588|580185932|FG001|Overall Study|Adverse Event|3|||
160674253|NCT00380588|580185931|FG000|Overall Study|Withdrawal by Subject|1|||
160674254|NCT00380588|580185932|FG001|Overall Study|Withdrawal by Subject|3|||
160674255|NCT00380588|580185931|FG000|Overall Study|Physician Decision|2|||
160674256|NCT00380588|580185932|FG001|Overall Study|Physician Decision|0|||
160674257|NCT02096705|580185933|FG000|Treatment|Adverse Event|6|||
160631469|NCT00539006|580031076|FG003|Treatment Period 1|Lost to Follow-up|0|||
160631470|NCT00539006|580031073|FG000|Treatment Period 1|Protocol Violation|0|||
160631471|NCT00539006|580031074|FG001|Treatment Period 1|Protocol Violation|0|||
160631472|NCT00539006|580031075|FG002|Treatment Period 1|Protocol Violation|1|||
160631473|NCT00539006|580031076|FG003|Treatment Period 1|Protocol Violation|0|||
160631474|NCT00539006|580031073|FG000|Treatment Period 1|Lack of Efficacy|0|||
160674258|NCT02096705|580185934|FG001|Treatment|Adverse Event|3|||
160674259|NCT02096705|580185933|FG000|Treatment|Subject request to discontinue treatment|1|||
160674260|NCT02096705|580185934|FG001|Treatment|Subject request to discontinue treatment|1|||
160631475|NCT00539006|580031074|FG001|Treatment Period 1|Lack of Efficacy|0|||
160631476|NCT00539006|580031075|FG002|Treatment Period 1|Lack of Efficacy|0|||
160631477|NCT00539006|580031076|FG003|Treatment Period 1|Lack of Efficacy|1|||
160631478|NCT00539006|580031073|FG000|Washout|Adverse Event|2|||
160631479|NCT00539006|580031074|FG001|Washout|Adverse Event|1|||
160631480|NCT00539006|580031075|FG002|Washout|Adverse Event|0|||
160631481|NCT00539006|580031076|FG003|Washout|Adverse Event|0|||
160631482|NCT00539006|580031073|FG000|Washout|Protocol Violation|1|||
160631483|NCT00539006|580031074|FG001|Washout|Protocol Violation|1|||
160631484|NCT00539006|580031075|FG002|Washout|Protocol Violation|0|||
160631485|NCT00539006|580031076|FG003|Washout|Protocol Violation|0|||
160631486|NCT00539006|580031073|FG000|Washout|Withdrawal by Subject|0|||
160631487|NCT00539006|580031074|FG001|Washout|Withdrawal by Subject|2|||
160631488|NCT00539006|580031075|FG002|Washout|Withdrawal by Subject|0|||
160631489|NCT00539006|580031076|FG003|Washout|Withdrawal by Subject|0|||
160631490|NCT00539006|580031073|FG000|Washout|Failed to meet continuation criteria|16|||
160631491|NCT00539006|580031074|FG001|Washout|Failed to meet continuation criteria|5|||
160631492|NCT00539006|580031075|FG002|Washout|Failed to meet continuation criteria|14|||
160631493|NCT00539006|580031076|FG003|Washout|Failed to meet continuation criteria|6|||
160631494|NCT00539006|580031073|FG000|Washout|Other|1|||
160631495|NCT00539006|580031074|FG001|Washout|Other|1|||
160631496|NCT00539006|580031075|FG002|Washout|Other|2|||
160631497|NCT00539006|580031076|FG003|Washout|Other|3|||
160631498|NCT00539006|580031073|FG000|Treatment Period 2|Protocol Violation|1|||
160631499|NCT00539006|580031074|FG001|Treatment Period 2|Protocol Violation|0|||
160631500|NCT00539006|580031075|FG002|Treatment Period 2|Protocol Violation|0|||
160631501|NCT00539006|580031076|FG003|Treatment Period 2|Protocol Violation|0|||
160631502|NCT00539006|580031073|FG000|Treatment Period 2|Other|0|||
160631503|NCT00539006|580031074|FG001|Treatment Period 2|Other|1|||
160631504|NCT00539006|580031075|FG002|Treatment Period 2|Other|0|||
160631505|NCT00539006|580031076|FG003|Treatment Period 2|Other|0|||
160631506|NCT03733301|580031077|FG000|Overall Study|Screen Fail|1|||
160631507|NCT03733301|580031078|FG001|Overall Study|Screen Fail|0|||
160631508|NCT03733301|580031079|FG002|Overall Study|Screen Fail|0|||
160631509|NCT03733301|580031077|FG000|Overall Study|Non-compliance|1|||
160631510|NCT03733301|580031078|FG001|Overall Study|Non-compliance|0|||
160631511|NCT03733301|580031079|FG002|Overall Study|Non-compliance|0|||
160631512|NCT03733301|580031077|FG000|Overall Study|Lack of Efficacy|2|||
160631513|NCT03733301|580031078|FG001|Overall Study|Lack of Efficacy|3|||
160631514|NCT03733301|580031079|FG002|Overall Study|Lack of Efficacy|0|||
160631515|NCT03733301|580031077|FG000|Overall Study|Adverse Event|0|||
160631516|NCT03733301|580031078|FG001|Overall Study|Adverse Event|1|||
160631517|NCT03733301|580031079|FG002|Overall Study|Adverse Event|3|||
160631518|NCT03733301|580031077|FG000|Overall Study|Withdrawal by Subject|3|||
160631519|NCT03733301|580031078|FG001|Overall Study|Withdrawal by Subject|5|||
160631520|NCT03733301|580031079|FG002|Overall Study|Withdrawal by Subject|1|||
160631521|NCT01965431|580031080|FG000|Overall Study|Adverse Event|0|||
160631522|NCT01965431|580031081|FG001|Overall Study|Adverse Event|1|||
160631523|NCT01965431|580031082|FG002|Overall Study|Adverse Event|0|||
160631524|NCT01965431|580031083|FG003|Overall Study|Adverse Event|0|||
160631525|NCT01965431|580031084|FG004|Overall Study|Adverse Event|0|||
160631526|NCT01965431|580031085|FG005|Overall Study|Adverse Event|0|||
160631527|NCT01965431|580031080|FG000|Overall Study|Other than stated above|6|||
160631528|NCT01965431|580031081|FG001|Overall Study|Other than stated above|5|||
160631529|NCT01965431|580031082|FG002|Overall Study|Other than stated above|6|||
160631530|NCT01965431|580031083|FG003|Overall Study|Other than stated above|6|||
160631531|NCT01965431|580031084|FG004|Overall Study|Other than stated above|6|||
160631532|NCT01965431|580031085|FG005|Overall Study|Other than stated above|6|||
160631533|NCT04635631|580031086|FG000|Overall Study|Adverse Event|1|||
160631534|NCT04635631|580031086|FG000|Overall Study|Progressive disease|13|||
160631535|NCT04635631|580031086|FG000|Overall Study|Withdrawal by Subject|1|||
160631536|NCT00943826|580031087|FG000|Concurrent Phase|Adverse Event|50|||
160631537|NCT00943826|580031088|FG001|Concurrent Phase|Adverse Event|27|||
160631538|NCT00943826|580031087|FG000|Concurrent Phase|Withdrew consent|3|||
160631539|NCT00943826|580031088|FG001|Concurrent Phase|Withdrew consent|7|||
160631540|NCT00943826|580031087|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
160631541|NCT00943826|580031088|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
160631542|NCT00943826|580031087|FG000|Concurrent Phase|Administrative reasons|2|||
160631543|NCT00943826|580031088|FG001|Concurrent Phase|Administrative reasons|1|||
160631544|NCT00943826|580031087|FG000|Concurrent Phase|Protocol Violation|1|||
160631545|NCT00943826|580031088|FG001|Concurrent Phase|Protocol Violation|0|||
160631546|NCT00943826|580031087|FG000|Maintenance Phase|Adverse Event|31|||
160631547|NCT00943826|580031088|FG001|Maintenance Phase|Adverse Event|30|||
160631548|NCT00943826|580031087|FG000|Maintenance Phase|Withdrew consent|2|||
160631549|NCT00943826|580031088|FG001|Maintenance Phase|Withdrew consent|4|||
160631550|NCT00943826|580031087|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
160631551|NCT00943826|580031088|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
160631552|NCT00943826|580031087|FG000|Maintenance Phase|Administrative reasons|4|||
160631553|NCT00943826|580031088|FG001|Maintenance Phase|Administrative reasons|1|||
160631554|NCT00943826|580031087|FG000|Maintenance Phase|Failure to return|0|||
160631555|NCT00943826|580031088|FG001|Maintenance Phase|Failure to return|1|||
160631556|NCT00943826|580031087|FG000|Monotherapy Phase|Adverse Event|42|||
160631557|NCT00943826|580031088|FG001|Monotherapy Phase|Adverse Event|5|||
160631558|NCT00943826|580031087|FG000|Monotherapy Phase|Administrative reasons|11|||
160631559|NCT00943826|580031088|FG001|Monotherapy Phase|Administrative reasons|5|||
160631560|NCT00943826|580031087|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
160631561|NCT00943826|580031088|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
160631562|NCT00943826|580031087|FG000|Monotherapy Phase|Withdrew Consent|2|||
160631563|NCT00943826|580031088|FG001|Monotherapy Phase|Withdrew Consent|3|||
160631564|NCT00943826|580031087|FG000|Monotherapy Phase|Failure to return|2|||
160631565|NCT00943826|580031088|FG001|Monotherapy Phase|Failure to return|1|||
160631566|NCT00943826|580031087|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
160631567|NCT00943826|580031088|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
160631568|NCT00943826|580031087|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
160631569|NCT00943826|580031088|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
160631570|NCT00943826|580031087|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
160631571|NCT00943826|580031088|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
160631572|NCT00943826|580031087|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
160631573|NCT00943826|580031088|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
160631574|NCT04764669|580031089|FG000|Overall Study|Adverse Event|1|||
160631575|NCT04764669|580031090|FG001|Overall Study|Adverse Event|0|||
160631576|NCT04764669|580031091|FG002|Overall Study|Adverse Event|1|||
160631577|NCT04764669|580031092|FG003|Overall Study|Adverse Event|0|||
160631578|NCT04764669|580031089|FG000|Overall Study|Subject Choice|0|||
160631579|NCT04764669|580031090|FG001|Overall Study|Subject Choice|0|||
160631580|NCT04764669|580031091|FG002|Overall Study|Subject Choice|1|||
160631581|NCT04764669|580031092|FG003|Overall Study|Subject Choice|0|||
160631582|NCT04764669|580031089|FG000|Overall Study|Withdrawal by Subject|2|||
160631583|NCT04764669|580031090|FG001|Overall Study|Withdrawal by Subject|0|||
160631584|NCT04764669|580031091|FG002|Overall Study|Withdrawal by Subject|0|||
160631585|NCT04764669|580031092|FG003|Overall Study|Withdrawal by Subject|0|||
160631586|NCT00877799|580031094|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
160631587|NCT00877799|580031095|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
160631588|NCT00877799|580031096|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
160631589|NCT00877799|580031097|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
160631590|NCT00877799|580031098|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
160631591|NCT00877799|580031094|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
160631592|NCT00877799|580031095|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
160631593|NCT00877799|580031096|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
160631594|NCT00877799|580031097|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
160631595|NCT00877799|580031098|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
160631596|NCT00877799|580031094|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
160631597|NCT00877799|580031095|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
160631598|NCT00877799|580031096|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
160631599|NCT00877799|580031097|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
160631600|NCT00877799|580031098|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
160631601|NCT00877799|580031094|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
160631602|NCT00877799|580031095|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
160631603|NCT00877799|580031096|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
160631604|NCT00877799|580031097|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
160631605|NCT00877799|580031098|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
160631606|NCT00877799|580031094|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
160631607|NCT00877799|580031095|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
160631608|NCT00877799|580031096|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
160631609|NCT00877799|580031097|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
160631610|NCT00877799|580031098|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
160631611|NCT00566631|580031099|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
160631612|NCT00566631|580031099|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
160631613|NCT00566631|580031099|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
160631614|NCT00566631|580031099|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
160631615|NCT00566631|580031099|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
160631616|NCT00566631|580031099|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
160631617|NCT00566631|580031099|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
160631618|NCT00566631|580031099|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
160631619|NCT00566631|580031099|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
160631620|NCT00566631|580031099|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
160631621|NCT00566631|580031099|FG000|Part 2: Extension Phase|Adverse Event|11|||
160631622|NCT00566631|580031099|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
160674261|NCT02096705|580185933|FG000|Treatment|Withdrawal by Subject|1|||
160674262|NCT02096705|580185934|FG001|Treatment|Withdrawal by Subject|0|||
160674263|NCT02096705|580185933|FG000|Treatment|Other|1|||
160674264|NCT02096705|580185934|FG001|Treatment|Other|1|||
160674265|NCT02096705|580185933|FG000|Follow-up|Withdrawal by Subject|1|||
160674266|NCT02096705|580185934|FG001|Follow-up|Withdrawal by Subject|0|||
160674267|NCT02096705|580185933|FG000|Follow-up|Adverse Event|2|||
160674268|NCT02096705|580185934|FG001|Follow-up|Adverse Event|2|||
160674269|NCT02096705|580185933|FG000|Follow-up|Subjects not reporting status|1|||
160674270|NCT02096705|580185934|FG001|Follow-up|Subjects not reporting status|2|||
160674271|NCT02905435|580185935|FG000|Overall Study|Death|2|||
160674272|NCT02905435|580185935|FG000|Overall Study|Physician Decision|1|||
160674273|NCT02905435|580185935|FG000|Overall Study|Lost to Follow-up|4|||
160674274|NCT00999687|580185947|FG000|First Intervention|Withdrawal by Subject|1|||
160674275|NCT00999687|580185947|FG000|Second Intervention|Withdrawal by Subject|2|||
160674276|NCT00999687|580185947|FG000|Second Intervention|Lack of Efficacy|1|||
160674277|NCT03614728|580185950|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
160674278|NCT03614728|580185951|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
160674279|NCT03614728|580185952|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
160674280|NCT03614728|580185953|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
160674281|NCT03614728|580185950|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
160674282|NCT03614728|580185951|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
160674283|NCT03614728|580185952|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
160674284|NCT03614728|580185953|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
160674285|NCT00842309|580185956|FG000|Overall Study|Withdrawal by Subject|3|||
160674286|NCT00842309|580185957|FG001|Overall Study|Withdrawal by Subject|1|||
160674287|NCT02670551|580185958|FG000|Overall Study|Adverse Event|4|||
160674288|NCT02670551|580185959|FG001|Overall Study|Adverse Event|7|||
160674289|NCT02670551|580185960|FG002|Overall Study|Adverse Event|9|||
160674290|NCT02670551|580185958|FG000|Overall Study|Lack of Efficacy|2|||
160674291|NCT02670551|580185959|FG001|Overall Study|Lack of Efficacy|0|||
160674292|NCT02670551|580185960|FG002|Overall Study|Lack of Efficacy|3|||
160674293|NCT02670551|580185958|FG000|Overall Study|Withdrawal of Consent|6|||
160674294|NCT02670551|580185959|FG001|Overall Study|Withdrawal of Consent|3|||
160674295|NCT02670551|580185960|FG002|Overall Study|Withdrawal of Consent|8|||
160674296|NCT02670551|580185958|FG000|Overall Study|Lost to Follow-up|5|||
160674297|NCT02670551|580185959|FG001|Overall Study|Lost to Follow-up|7|||
160674298|NCT02670551|580185960|FG002|Overall Study|Lost to Follow-up|6|||
160674299|NCT02670551|580185958|FG000|Overall Study|Protocol Violation|1|||
160631623|NCT00566631|580031099|FG000|Part 2: Extension Phase|Death|1|||
160631624|NCT00566631|580031099|FG000|Part 2: Extension Phase|Other|5|||
160631625|NCT00592007|580031100|FG000|Overall Study|Withdrawal by Subject|1|||
160631626|NCT00592007|580031100|FG000|Overall Study|patient ineligible (out of lab range)|1|||
160631627|NCT04054011|580031101|FG000|Overall Study|COVID|3|||
160631628|NCT00595127|580031102|FG000|Overall Study|Death|6|||
160631629|NCT00595127|580031102|FG000|Overall Study|Relapsed|3|||
160631630|NCT00595127|580031102|FG000|Overall Study|joined another trial|1|||
160631631|NCT01785472|580031103|FG000|Overall Study|Adverse Event|5|||
160631632|NCT01785472|580031104|FG001|Overall Study|Adverse Event|4|||
160631633|NCT01785472|580031105|FG002|Overall Study|Adverse Event|6|||
160631634|NCT01785472|580031103|FG000|Overall Study|Lack of Efficacy|2|||
160631635|NCT01785472|580031104|FG001|Overall Study|Lack of Efficacy|0|||
160631636|NCT01785472|580031105|FG002|Overall Study|Lack of Efficacy|1|||
160631637|NCT01785472|580031103|FG000|Overall Study|Lost to Follow-up|1|||
160631638|NCT01785472|580031104|FG001|Overall Study|Lost to Follow-up|2|||
160631639|NCT01785472|580031105|FG002|Overall Study|Lost to Follow-up|0|||
160631640|NCT01785472|580031103|FG000|Overall Study|Physician Decision|1|||
160631641|NCT01785472|580031104|FG001|Overall Study|Physician Decision|1|||
160631642|NCT01785472|580031105|FG002|Overall Study|Physician Decision|1|||
160631643|NCT01785472|580031103|FG000|Overall Study|Protocol deviation|0|||
160631644|NCT01785472|580031104|FG001|Overall Study|Protocol deviation|2|||
160631645|NCT01785472|580031105|FG002|Overall Study|Protocol deviation|2|||
160631646|NCT01785472|580031103|FG000|Overall Study|Subject/guardian decision|15|||
160631647|NCT01785472|580031104|FG001|Overall Study|Subject/guardian decision|10|||
160631648|NCT01785472|580031105|FG002|Overall Study|Subject/guardian decision|11|||
160631649|NCT01785472|580031103|FG000|Overall Study|Technical problems|0|||
160631650|NCT01785472|580031104|FG001|Overall Study|Technical problems|0|||
160674300|NCT02670551|580185959|FG001|Overall Study|Protocol Violation|0|||
160674301|NCT02670551|580185960|FG002|Overall Study|Protocol Violation|0|||
160674302|NCT02670551|580185958|FG000|Overall Study|Noncompliance with study drug|3|||
160674303|NCT02670551|580185959|FG001|Overall Study|Noncompliance with study drug|3|||
160674304|NCT02670551|580185960|FG002|Overall Study|Noncompliance with study drug|2|||
160674305|NCT02670551|580185958|FG000|Overall Study|Other Miscellaneous Reasons|2|||
160674306|NCT02670551|580185959|FG001|Overall Study|Other Miscellaneous Reasons|3|||
160674307|NCT02670551|580185960|FG002|Overall Study|Other Miscellaneous Reasons|3|||
160674308|NCT02670551|580185958|FG000|Overall Study|Did Not Receive Treatment|5|||
160674309|NCT02670551|580185959|FG001|Overall Study|Did Not Receive Treatment|3|||
160631651|NCT01785472|580031105|FG002|Overall Study|Technical problems|1|||
160631652|NCT01803464|580031107|FG000|Overall Study|Incomplete data|0|||
160631653|NCT01803464|580031108|FG001|Overall Study|Incomplete data|0|||
160631654|NCT01803464|580031109|FG002|Overall Study|Incomplete data|4|||
160631655|NCT01803464|580031110|FG003|Overall Study|Incomplete data|0|||
160631656|NCT01803464|580031107|FG000|Overall Study|Withdrawal by Subject|1|||
160631657|NCT01803464|580031108|FG001|Overall Study|Withdrawal by Subject|0|||
160631658|NCT01803464|580031109|FG002|Overall Study|Withdrawal by Subject|0|||
160631659|NCT01803464|580031110|FG003|Overall Study|Withdrawal by Subject|0|||
160631660|NCT01275170|580031121|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
160631661|NCT01275170|580031122|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
160631662|NCT01275170|580031123|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
160631663|NCT01275170|580031124|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
160631664|NCT01275170|580031125|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
160631665|NCT01275170|580031126|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
160631666|NCT01275170|580031127|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
160631667|NCT01275170|580031128|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
160631668|NCT00605839|580031129|FG000|Overall Study|Protocol Violation|1|||
160631669|NCT00605839|580031130|FG001|Overall Study|Protocol Violation|0|||
160631670|NCT00605839|580031131|FG002|Overall Study|Protocol Violation|0|||
160631671|NCT04636437|580031135|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
160631672|NCT04636437|580031136|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
160631673|NCT04636437|580031137|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
160631674|NCT04636437|580031135|FG000|Overall Study|Started weight loss drug/program|2|||
160631675|NCT04636437|580031136|FG001|Overall Study|Started weight loss drug/program|1|||
160631676|NCT04636437|580031137|FG002|Overall Study|Started weight loss drug/program|1|||
160631677|NCT04636437|580031135|FG000|Overall Study|Lost to Follow-up|3|||
160631678|NCT04636437|580031136|FG001|Overall Study|Lost to Follow-up|1|||
160631679|NCT04636437|580031137|FG002|Overall Study|Lost to Follow-up|4|||
160631680|NCT04636437|580031135|FG000|Overall Study|Participant or physician decision|3|||
160631681|NCT04636437|580031136|FG001|Overall Study|Participant or physician decision|1|||
160631682|NCT04636437|580031137|FG002|Overall Study|Participant or physician decision|1|||
160631683|NCT00816166|580031138|FG000|Overall Study|Lost to Follow-up|6|||
160631684|NCT00816166|580031139|FG001|Overall Study|Lost to Follow-up|10|||
160631685|NCT00816166|580031138|FG000|Overall Study|Death|4|||
160631686|NCT00816166|580031139|FG001|Overall Study|Death|2|||
160631687|NCT01071278|580031140|FG000|Overall Study|Premature Discontinuation|254|||
160631688|NCT01071278|580031140|FG000|Overall Study|Completion Status Unknown|459|||
160631689|NCT00352664|580031141|FG000|Overall Study|Withdrawal by Subject|7|||
160631690|NCT00352664|580031142|FG001|Overall Study|Withdrawal by Subject|0|||
160631691|NCT01821391|580031143|FG000|Overall Study|Adverse Event|1|||
160631692|NCT01821391|580031144|FG001|Overall Study|Adverse Event|0|||
160631693|NCT01608321|580031145|FG000|Overall Study|Withdrawal by Subject|1|||
160631694|NCT01608321|580031146|FG001|Overall Study|Withdrawal by Subject|0|||
160631695|NCT03222856|580031149|FG000|Overall Study|Adverse Event|6|||
160631696|NCT03222856|580031149|FG000|Overall Study|Death|1|||
160631697|NCT03514121|580032649|FG000|Overall Study|Withdrawal by Subject|0|||
160631698|NCT03514121|580032650|FG001|Overall Study|Withdrawal by Subject|0|||
160631699|NCT03514121|580032651|FG002|Overall Study|Withdrawal by Subject|0|||
160631700|NCT03514121|580032652|FG003|Overall Study|Withdrawal by Subject|0|||
160631701|NCT03514121|580032653|FG004|Overall Study|Withdrawal by Subject|1|||
160631702|NCT03514121|580032654|FG005|Overall Study|Withdrawal by Subject|2|||
160631703|NCT03514121|580032655|FG006|Overall Study|Withdrawal by Subject|1|||
160631704|NCT03514121|580032656|FG007|Overall Study|Withdrawal by Subject|1|||
160631705|NCT03514121|580032657|FG008|Overall Study|Withdrawal by Subject|7|||
160631706|NCT03514121|580032658|FG009|Overall Study|Withdrawal by Subject|2|||
160631707|NCT03514121|580032649|FG000|Overall Study|Death|0|||
160631708|NCT03514121|580032650|FG001|Overall Study|Death|0|||
160631709|NCT03514121|580032651|FG002|Overall Study|Death|0|||
160631710|NCT03514121|580032652|FG003|Overall Study|Death|0|||
160631711|NCT03514121|580032653|FG004|Overall Study|Death|0|||
160631712|NCT03514121|580032654|FG005|Overall Study|Death|3|||
160631713|NCT03514121|580032655|FG006|Overall Study|Death|2|||
160631714|NCT03514121|580032656|FG007|Overall Study|Death|1|||
160631715|NCT03514121|580032657|FG008|Overall Study|Death|26|||
160631716|NCT03514121|580032658|FG009|Overall Study|Death|3|||
160631717|NCT03514121|580032649|FG000|Overall Study|Lost to Follow-up|0|||
160631718|NCT03514121|580032650|FG001|Overall Study|Lost to Follow-up|0|||
160631719|NCT03514121|580032651|FG002|Overall Study|Lost to Follow-up|1|||
160631720|NCT03514121|580032652|FG003|Overall Study|Lost to Follow-up|0|||
160631721|NCT03514121|580032653|FG004|Overall Study|Lost to Follow-up|0|||
160631722|NCT03514121|580032654|FG005|Overall Study|Lost to Follow-up|0|||
160631723|NCT03514121|580032655|FG006|Overall Study|Lost to Follow-up|0|||
160631724|NCT03514121|580032656|FG007|Overall Study|Lost to Follow-up|0|||
160631725|NCT03514121|580032657|FG008|Overall Study|Lost to Follow-up|1|||
160631726|NCT03514121|580032658|FG009|Overall Study|Lost to Follow-up|0|||
160631727|NCT03514121|580032649|FG000|Overall Study|Adverse Event|0|||
160674310|NCT02670551|580185960|FG002|Overall Study|Did Not Receive Treatment|0|||
160674311|NCT01962298|580185961|FG000|Overall Study|Protocol Violation|1|||
160674312|NCT01962298|580185962|FG001|Overall Study|Protocol Violation|0|||
160674313|NCT01962298|580185963|FG002|Overall Study|Protocol Violation|1|||
160674314|NCT01962298|580185964|FG003|Overall Study|Protocol Violation|1|||
160674315|NCT01962298|580185965|FG004|Overall Study|Protocol Violation|0|||
160674316|NCT01962298|580185961|FG000|Overall Study|Data quality insufficient|2|||
160674317|NCT01962298|580185962|FG001|Overall Study|Data quality insufficient|0|||
160674318|NCT01962298|580185963|FG002|Overall Study|Data quality insufficient|3|||
160674319|NCT01962298|580185964|FG003|Overall Study|Data quality insufficient|1|||
160674320|NCT01962298|580185965|FG004|Overall Study|Data quality insufficient|4|||
160674321|NCT01962298|580185961|FG000|Overall Study|Insufficient data|0|||
160674322|NCT01962298|580185962|FG001|Overall Study|Insufficient data|2|||
160674323|NCT01962298|580185963|FG002|Overall Study|Insufficient data|1|||
160674324|NCT01962298|580185964|FG003|Overall Study|Insufficient data|0|||
160674325|NCT01962298|580185965|FG004|Overall Study|Insufficient data|1|||
160674326|NCT01962298|580185961|FG000|Overall Study|Incorrect data recorded|0|||
160674327|NCT01962298|580185962|FG001|Overall Study|Incorrect data recorded|1|||
160674328|NCT01962298|580185963|FG002|Overall Study|Incorrect data recorded|0|||
160674329|NCT01962298|580185964|FG003|Overall Study|Incorrect data recorded|0|||
160674330|NCT01962298|580185965|FG004|Overall Study|Incorrect data recorded|0|||
160674331|NCT01962298|580185961|FG000|Overall Study|Physician Decision|0|||
160674332|NCT01962298|580185962|FG001|Overall Study|Physician Decision|1|||
160674333|NCT01962298|580185963|FG002|Overall Study|Physician Decision|0|||
160674334|NCT01962298|580185964|FG003|Overall Study|Physician Decision|0|||
160674335|NCT01962298|580185965|FG004|Overall Study|Physician Decision|1|||
160674336|NCT04476277|580185966|FG000|Overall Study|Withdrawal by Subject|0|||
160674337|NCT04476277|580185967|FG001|Overall Study|Withdrawal by Subject|0|||
160674338|NCT04476277|580185968|FG002|Overall Study|Withdrawal by Subject|1|||
160674339|NCT04476277|580185969|FG003|Overall Study|Withdrawal by Subject|0|||
160674340|NCT03105297|580185970|FG000|Baseline Phase (Day 1)|Other|21|||
160674341|NCT03105297|580185970|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
160674342|NCT03105297|580185970|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
160674343|NCT00714051|580185971|FG000|Overall Study|Withdrawal by Subject|1|||
160674344|NCT00714051|580185972|FG001|Overall Study|Withdrawal by Subject|0|||
160674345|NCT00714051|580185971|FG000|Overall Study|Death|0|||
160674346|NCT00714051|580185972|FG001|Overall Study|Death|1|||
160674347|NCT01390948|580185973|FG000|Overall Study|End of Study|1|||
160631728|NCT03514121|580032650|FG001|Overall Study|Adverse Event|0|||
160631729|NCT03514121|580032651|FG002|Overall Study|Adverse Event|0|||
160631730|NCT03514121|580032652|FG003|Overall Study|Adverse Event|0|||
160631731|NCT03514121|580032653|FG004|Overall Study|Adverse Event|0|||
160631732|NCT03514121|580032654|FG005|Overall Study|Adverse Event|0|||
160631733|NCT03514121|580032655|FG006|Overall Study|Adverse Event|1|||
160631734|NCT03514121|580032656|FG007|Overall Study|Adverse Event|0|||
160631735|NCT03514121|580032657|FG008|Overall Study|Adverse Event|0|||
160631736|NCT03514121|580032658|FG009|Overall Study|Adverse Event|0|||
160631737|NCT03514121|580032649|FG000|Overall Study|Other|0|||
160631738|NCT03514121|580032650|FG001|Overall Study|Other|1|||
160631739|NCT03514121|580032651|FG002|Overall Study|Other|1|||
160631740|NCT03514121|580032652|FG003|Overall Study|Other|0|||
160631741|NCT03514121|580032653|FG004|Overall Study|Other|1|||
160631742|NCT03514121|580032654|FG005|Overall Study|Other|2|||
160631743|NCT03514121|580032655|FG006|Overall Study|Other|3|||
160631744|NCT03514121|580032656|FG007|Overall Study|Other|2|||
160631745|NCT03514121|580032657|FG008|Overall Study|Other|7|||
160631746|NCT03514121|580032658|FG009|Overall Study|Other|3|||
160631747|NCT03514121|580032649|FG000|Overall Study|Study termination by Sponsor|0|||
160631748|NCT03514121|580032650|FG001|Overall Study|Study termination by Sponsor|0|||
160631749|NCT03514121|580032651|FG002|Overall Study|Study termination by Sponsor|0|||
160631750|NCT03514121|580032652|FG003|Overall Study|Study termination by Sponsor|0|||
160631751|NCT03514121|580032653|FG004|Overall Study|Study termination by Sponsor|0|||
160631752|NCT03514121|580032654|FG005|Overall Study|Study termination by Sponsor|0|||
160631753|NCT03514121|580032655|FG006|Overall Study|Study termination by Sponsor|0|||
160631754|NCT03514121|580032656|FG007|Overall Study|Study termination by Sponsor|0|||
160631755|NCT03514121|580032657|FG008|Overall Study|Study termination by Sponsor|11|||
160674348|NCT01390948|580185974|FG001|Overall Study|End of Study|0|||
160674349|NCT01390948|580185975|FG002|Overall Study|End of Study|0|||
160674350|NCT01390948|580185973|FG000|Overall Study|Withdrew consent|2|||
160674351|NCT01390948|580185974|FG001|Overall Study|Withdrew consent|2|||
160674352|NCT01390948|580185975|FG002|Overall Study|Withdrew consent|0|||
160674353|NCT01390948|580185973|FG000|Overall Study|Progressive Disease|2|||
160674354|NCT01390948|580185974|FG001|Overall Study|Progressive Disease|5|||
160674355|NCT01390948|580185975|FG002|Overall Study|Progressive Disease|0|||
160674356|NCT01390948|580185973|FG000|Overall Study|Death during follow-up|10|||
160674357|NCT01390948|580185974|FG001|Overall Study|Death during follow-up|11|||
160631756|NCT03514121|580032658|FG009|Overall Study|Study termination by Sponsor|3|||
160631757|NCT03514121|580032649|FG000|Overall Study|Investigator decision|0|||
160631758|NCT03514121|580032650|FG001|Overall Study|Investigator decision|0|||
160631759|NCT03514121|580032651|FG002|Overall Study|Investigator decision|0|||
160631760|NCT03514121|580032652|FG003|Overall Study|Investigator decision|0|||
160631761|NCT03514121|580032653|FG004|Overall Study|Investigator decision|0|||
160631762|NCT03514121|580032654|FG005|Overall Study|Investigator decision|0|||
160631763|NCT03514121|580032655|FG006|Overall Study|Investigator decision|0|||
160631764|NCT03514121|580032656|FG007|Overall Study|Investigator decision|0|||
160631765|NCT03514121|580032657|FG008|Overall Study|Investigator decision|1|||
160631766|NCT03514121|580032658|FG009|Overall Study|Investigator decision|0|||
160631767|NCT00388674|580032663|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
160631768|NCT00388674|580032664|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
160631769|NCT00388674|580032663|FG000|Initial Treatment|Adverse Event|22|||
160631770|NCT00388674|580032664|FG001|Initial Treatment|Adverse Event|87|||
160631771|NCT00388674|580032663|FG000|Initial Treatment|Death|215|||
160631772|NCT00388674|580032664|FG001|Initial Treatment|Death|216|||
160631773|NCT00388674|580032663|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
160631774|NCT00388674|580032664|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
160631775|NCT00388674|580032663|FG000|Initial Treatment|HCC|12|||
160631776|NCT00388674|580032664|FG001|Initial Treatment|HCC|20|||
160631777|NCT00388674|580032663|FG000|Initial Treatment|Lost to Follow-up|526|||
160631778|NCT00388674|580032664|FG001|Initial Treatment|Lost to Follow-up|624|||
160631779|NCT00388674|580032663|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
160631780|NCT00388674|580032664|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
160631781|NCT00388674|580032663|FG000|Initial Treatment|Never Treated with Study Medication|1|||
160631782|NCT00388674|580032664|FG001|Initial Treatment|Never Treated with Study Medication|7|||
160631783|NCT00388674|580032663|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
160631784|NCT00388674|580032664|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
160631785|NCT00388674|580032663|FG000|Initial Treatment|Not Defined|125|||
160631786|NCT00388674|580032664|FG001|Initial Treatment|Not Defined|172|||
160631787|NCT00388674|580032663|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
160631788|NCT00388674|580032664|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
160631789|NCT00388674|580032663|FG000|Initial Treatment|Pregnancy|26|||
160631790|NCT00388674|580032664|FG001|Initial Treatment|Pregnancy|16|||
160631791|NCT00388674|580032663|FG000|Initial Treatment|Study Drug Toxicity|5|||
160631792|NCT00388674|580032664|FG001|Initial Treatment|Study Drug Toxicity|92|||
160631793|NCT00388674|580032663|FG000|Initial Treatment|Participant Request|501|||
160631794|NCT00388674|580032664|FG001|Initial Treatment|Participant Request|673|||
160631795|NCT00388674|580032663|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
160631796|NCT00388674|580032664|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
160631797|NCT00388674|580032663|FG000|Initial Treatment|Not Reported|10|||
160674358|NCT01390948|580185975|FG002|Overall Study|Death during follow-up|1|||
160674359|NCT05740098|580185978|FG000|Overall Study|Lost to Follow-up|26|||
160674360|NCT05740098|580185979|FG001|Overall Study|Lost to Follow-up|17|||
160674361|NCT05740098|580185980|FG002|Overall Study|Lost to Follow-up|21|||
160674362|NCT01401062|580185985|FG000|Overall Study|Death|9|||
160674363|NCT01401062|580185986|FG001|Overall Study|Death|7|||
160674364|NCT01401062|580185985|FG000|Overall Study|Physician Decision|1|||
160674365|NCT01401062|580185986|FG001|Overall Study|Physician Decision|0|||
160674366|NCT01401062|580185985|FG000|Overall Study|Withdrawal by Subject|1|||
160674367|NCT01401062|580185986|FG001|Overall Study|Withdrawal by Subject|1|||
160674368|NCT00840879|580185989|FG000|Second Intervention|Withdrawal by Subject|1|||
160674369|NCT00840879|580185990|FG001|Second Intervention|Withdrawal by Subject|0|||
160674370|NCT02259348|580187535|FG000|Overall Study|Donors|6|||
160674371|NCT02259348|580187535|FG000|Overall Study|Death|4|||
160674372|NCT01622660|580187536|FG000|Overall Study|Adverse Event|1|||
160674373|NCT04211766|580187537|FG000|Overall Study|Withdrawal by Subject|5|||
160674374|NCT04211766|580187538|FG001|Overall Study|Withdrawal by Subject|1|||
160674375|NCT02664415|580187539|FG000|Overall Study|Adverse Event|1|||
160674376|NCT02664415|580187540|FG001|Overall Study|Adverse Event|0|||
160674377|NCT00642993|580187541|FG000|Overall Study|Adverse Event|85|||
160674378|NCT00642993|580187542|FG001|Overall Study|Adverse Event|4|||
160674379|NCT00642993|580187541|FG000|Overall Study|Lost to Follow-up|8|||
160674380|NCT00642993|580187542|FG001|Overall Study|Lost to Follow-up|4|||
160674381|NCT00642993|580187541|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
160674382|NCT00642993|580187542|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
160674383|NCT00642993|580187541|FG000|Overall Study|Protocol Violation|1|||
160631798|NCT00388674|580032664|FG001|Initial Treatment|Not Reported|12|||
160631799|NCT00388674|580032663|FG000|End of Study|Administrative Reason By Sponsor|299|||
160631800|NCT00388674|580032664|FG001|End of Study|Administrative Reason By Sponsor|253|||
160631801|NCT00388674|580032663|FG000|End of Study|Death|239|||
160631802|NCT00388674|580032664|FG001|End of Study|Death|262|||
160674384|NCT00642993|580187542|FG001|Overall Study|Protocol Violation|4|||
160674385|NCT00642993|580187541|FG000|Overall Study|Did not meet protocol eligibility|0|||
160674386|NCT00642993|580187542|FG001|Overall Study|Did not meet protocol eligibility|1|||
160674387|NCT00642993|580187541|FG000|Overall Study|Administrative|1|||
160674388|NCT00642993|580187542|FG001|Overall Study|Administrative|0|||
160674389|NCT02034513|580187543|FG000|Overall Study|Adverse Event|11|||
160631803|NCT00388674|580032663|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
160631804|NCT00388674|580032664|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
160631805|NCT00388674|580032663|FG000|End of Study|HCC|8|||
160631806|NCT00388674|580032664|FG001|End of Study|HCC|7|||
160631807|NCT00388674|580032663|FG000|End of Study|Lost to Follow-up|587|||
160631808|NCT00388674|580032664|FG001|End of Study|Lost to Follow-up|715|||
160631809|NCT00388674|580032663|FG000|End of Study|Malignancy (Non-HCC)|1|||
160631810|NCT00388674|580032664|FG001|End of Study|Malignancy (Non-HCC)|1|||
160631811|NCT00388674|580032663|FG000|End of Study|Non-Study Related Comorbidities|3|||
160631812|NCT00388674|580032664|FG001|End of Study|Non-Study Related Comorbidities|4|||
160631813|NCT00388674|580032663|FG000|End of Study|Not Defined|135|||
160631814|NCT00388674|580032664|FG001|End of Study|Not Defined|214|||
160631815|NCT00388674|580032663|FG000|End of Study|Participant Withdrew Consent|437|||
160631816|NCT00388674|580032664|FG001|End of Study|Participant Withdrew Consent|673|||
160631817|NCT00388674|580032663|FG000|End of Study|No Off-Treatment Status Data|22|||
160631818|NCT00388674|580032664|FG001|End of Study|No Off-Treatment Status Data|30|||
160631819|NCT00388674|580032663|FG000|End of Study|Not Reported|0|||
160631820|NCT00388674|580032664|FG001|End of Study|Not Reported|1|||
160631821|NCT00568776|580032667|FG000|Overall Study|Adverse Event|8|||
160631822|NCT00568776|580032668|FG001|Overall Study|Adverse Event|8|||
160631823|NCT00568776|580032669|FG002|Overall Study|Adverse Event|10|||
160631824|NCT00568776|580032670|FG003|Overall Study|Adverse Event|8|||
160631825|NCT00568776|580032667|FG000|Overall Study|Death|0|||
160631826|NCT00568776|580032668|FG001|Overall Study|Death|1|||
160631827|NCT00568776|580032669|FG002|Overall Study|Death|4|||
160631828|NCT00568776|580032670|FG003|Overall Study|Death|3|||
160631829|NCT00568776|580032667|FG000|Overall Study|Physician Decision|0|||
160631830|NCT00568776|580032668|FG001|Overall Study|Physician Decision|2|||
160631831|NCT00568776|580032669|FG002|Overall Study|Physician Decision|0|||
160631832|NCT00568776|580032670|FG003|Overall Study|Physician Decision|0|||
160631833|NCT00568776|580032667|FG000|Overall Study|Lack of Efficacy|2|||
160631834|NCT00568776|580032668|FG001|Overall Study|Lack of Efficacy|2|||
160631835|NCT00568776|580032669|FG002|Overall Study|Lack of Efficacy|2|||
160631836|NCT00568776|580032670|FG003|Overall Study|Lack of Efficacy|4|||
160631837|NCT00568776|580032667|FG000|Overall Study|Lost to Follow-up|1|||
160631838|NCT00568776|580032668|FG001|Overall Study|Lost to Follow-up|1|||
160631839|NCT00568776|580032669|FG002|Overall Study|Lost to Follow-up|1|||
160631840|NCT00568776|580032670|FG003|Overall Study|Lost to Follow-up|1|||
160631841|NCT00568776|580032667|FG000|Overall Study|Protocol Violation|1|||
160631842|NCT00568776|580032668|FG001|Overall Study|Protocol Violation|0|||
160631843|NCT00568776|580032669|FG002|Overall Study|Protocol Violation|1|||
160631844|NCT00568776|580032670|FG003|Overall Study|Protocol Violation|1|||
160631845|NCT00568776|580032667|FG000|Overall Study|Withdrawal by Subject|13|||
160631846|NCT00568776|580032668|FG001|Overall Study|Withdrawal by Subject|15|||
160631847|NCT00568776|580032669|FG002|Overall Study|Withdrawal by Subject|13|||
160631848|NCT00568776|580032670|FG003|Overall Study|Withdrawal by Subject|7|||
160631849|NCT00568776|580032667|FG000|Overall Study|Loss of Caregiver|0|||
160631850|NCT00568776|580032668|FG001|Overall Study|Loss of Caregiver|2|||
160631851|NCT00568776|580032669|FG002|Overall Study|Loss of Caregiver|1|||
160631852|NCT00568776|580032670|FG003|Overall Study|Loss of Caregiver|2|||
160631853|NCT00568776|580032667|FG000|Overall Study|Sponsor Decision|2|||
160631854|NCT00568776|580032668|FG001|Overall Study|Sponsor Decision|2|||
160631855|NCT00568776|580032669|FG002|Overall Study|Sponsor Decision|41|||
160631856|NCT00568776|580032670|FG003|Overall Study|Sponsor Decision|42|||
160631857|NCT00568776|580032667|FG000|Overall Study|Miscellaeneous|3|||
160631858|NCT00568776|580032668|FG001|Overall Study|Miscellaeneous|3|||
160631859|NCT00568776|580032669|FG002|Overall Study|Miscellaeneous|1|||
160674390|NCT02034513|580187544|FG001|Overall Study|Adverse Event|10|||
160674391|NCT02034513|580187543|FG000|Overall Study|Lack of Efficacy|0|||
160674392|NCT02034513|580187544|FG001|Overall Study|Lack of Efficacy|1|||
160674393|NCT02034513|580187543|FG000|Overall Study|Lost to Follow-up|6|||
160674394|NCT02034513|580187544|FG001|Overall Study|Lost to Follow-up|7|||
160674395|NCT02034513|580187543|FG000|Overall Study|Pregnancy|0|||
160674396|NCT02034513|580187544|FG001|Overall Study|Pregnancy|3|||
160674397|NCT02034513|580187543|FG000|Overall Study|Protocol Violation|7|||
160631860|NCT00568776|580032670|FG003|Overall Study|Miscellaeneous|4|||
160631861|NCT03576131|580032671|FG000|Overall Study|Investigator decision|0|||
160631862|NCT03576131|580032672|FG001|Overall Study|Investigator decision|0|||
160631863|NCT03576131|580032673|FG002|Overall Study|Investigator decision|0|||
160631864|NCT03576131|580032674|FG003|Overall Study|Investigator decision|1|||
160631865|NCT03576131|580032675|FG004|Overall Study|Investigator decision|0|||
160631866|NCT03576131|580032676|FG005|Overall Study|Investigator decision|1|||
160631867|NCT03576131|580032677|FG006|Overall Study|Investigator decision|0|||
160631868|NCT03576131|580032678|FG007|Overall Study|Investigator decision|0|||
160674398|NCT02034513|580187544|FG001|Overall Study|Protocol Violation|10|||
160631869|NCT03576131|580032671|FG000|Overall Study|Withdrawal by Subject|1|||
160631870|NCT03576131|580032672|FG001|Overall Study|Withdrawal by Subject|1|||
160631871|NCT03576131|580032673|FG002|Overall Study|Withdrawal by Subject|0|||
160674399|NCT02034513|580187543|FG000|Overall Study|Withdrawal by Subject|25|||
160674400|NCT02034513|580187544|FG001|Overall Study|Withdrawal by Subject|25|||
160631872|NCT03576131|580032674|FG003|Overall Study|Withdrawal by Subject|1|||
160631873|NCT03576131|580032675|FG004|Overall Study|Withdrawal by Subject|2|||
160631874|NCT03576131|580032676|FG005|Overall Study|Withdrawal by Subject|3|||
160631875|NCT03576131|580032677|FG006|Overall Study|Withdrawal by Subject|1|||
160631876|NCT03576131|580032678|FG007|Overall Study|Withdrawal by Subject|0|||
160631877|NCT03576131|580032671|FG000|Overall Study|Death|3|||
160631878|NCT03576131|580032672|FG001|Overall Study|Death|3|||
160631879|NCT03576131|580032673|FG002|Overall Study|Death|1|||
160631880|NCT03576131|580032674|FG003|Overall Study|Death|5|||
160631881|NCT03576131|580032675|FG004|Overall Study|Death|4|||
160631882|NCT03576131|580032676|FG005|Overall Study|Death|1|||
160631883|NCT03576131|580032677|FG006|Overall Study|Death|0|||
160631884|NCT03576131|580032678|FG007|Overall Study|Death|1|||
160631885|NCT03576131|580032671|FG000|Overall Study|New anti-cancer treatment|5|||
160631886|NCT03576131|580032672|FG001|Overall Study|New anti-cancer treatment|1|||
160631887|NCT03576131|580032673|FG002|Overall Study|New anti-cancer treatment|2|||
160631888|NCT03576131|580032674|FG003|Overall Study|New anti-cancer treatment|3|||
160631889|NCT03576131|580032675|FG004|Overall Study|New anti-cancer treatment|0|||
160631890|NCT03576131|580032676|FG005|Overall Study|New anti-cancer treatment|0|||
160631891|NCT03576131|580032677|FG006|Overall Study|New anti-cancer treatment|0|||
160631892|NCT03576131|580032678|FG007|Overall Study|New anti-cancer treatment|0|||
160631893|NCT03576131|580032671|FG000|Overall Study|Unspecified reason|0|||
160631894|NCT03576131|580032672|FG001|Overall Study|Unspecified reason|0|||
160631895|NCT03576131|580032673|FG002|Overall Study|Unspecified reason|1|||
160631896|NCT03576131|580032674|FG003|Overall Study|Unspecified reason|1|||
160631897|NCT03576131|580032675|FG004|Overall Study|Unspecified reason|1|||
160631898|NCT03576131|580032676|FG005|Overall Study|Unspecified reason|1|||
160631899|NCT03576131|580032677|FG006|Overall Study|Unspecified reason|0|||
160631900|NCT03576131|580032678|FG007|Overall Study|Unspecified reason|0|||
160631901|NCT03576131|580032671|FG000|Overall Study|Subject non-compliance|0|||
160631902|NCT03576131|580032672|FG001|Overall Study|Subject non-compliance|0|||
160631903|NCT03576131|580032673|FG002|Overall Study|Subject non-compliance|0|||
160631904|NCT03576131|580032674|FG003|Overall Study|Subject non-compliance|0|||
160631905|NCT03576131|580032675|FG004|Overall Study|Subject non-compliance|0|||
160631906|NCT03576131|580032676|FG005|Overall Study|Subject non-compliance|1|||
160631907|NCT03576131|580032677|FG006|Overall Study|Subject non-compliance|0|||
160631908|NCT03576131|580032678|FG007|Overall Study|Subject non-compliance|0|||
160631909|NCT01563029|580032683|FG000|Overall Study|Adverse Event|1|||
160631910|NCT01563029|580032684|FG001|Overall Study|Adverse Event|0|||
160631911|NCT01563029|580032685|FG002|Overall Study|Adverse Event|1|||
160631912|NCT01563029|580032686|FG003|Overall Study|Adverse Event|2|||
160631913|NCT01563029|580032687|FG004|Overall Study|Adverse Event|1|||
160631914|NCT01563029|580032683|FG000|Overall Study|Lack of Efficacy|42|||
160631915|NCT01563029|580032684|FG001|Overall Study|Lack of Efficacy|16|||
160631916|NCT01563029|580032685|FG002|Overall Study|Lack of Efficacy|23|||
160631917|NCT01563029|580032686|FG003|Overall Study|Lack of Efficacy|21|||
160631918|NCT01563029|580032687|FG004|Overall Study|Lack of Efficacy|19|||
160631919|NCT01563029|580032683|FG000|Overall Study|Protocol Violation|1|||
160631920|NCT01563029|580032684|FG001|Overall Study|Protocol Violation|2|||
160631921|NCT01563029|580032685|FG002|Overall Study|Protocol Violation|3|||
160631922|NCT01563029|580032686|FG003|Overall Study|Protocol Violation|1|||
160631923|NCT01563029|580032687|FG004|Overall Study|Protocol Violation|3|||
160631924|NCT01563029|580032683|FG000|Overall Study|Protocol defined stopping criteria|1|||
160631925|NCT01563029|580032684|FG001|Overall Study|Protocol defined stopping criteria|0|||
160631926|NCT01563029|580032685|FG002|Overall Study|Protocol defined stopping criteria|0|||
160631927|NCT01563029|580032686|FG003|Overall Study|Protocol defined stopping criteria|0|||
160631928|NCT01563029|580032687|FG004|Overall Study|Protocol defined stopping criteria|0|||
160631929|NCT01563029|580032683|FG000|Overall Study|Lost to Follow-up|1|||
160631930|NCT01563029|580032684|FG001|Overall Study|Lost to Follow-up|0|||
160631931|NCT01563029|580032685|FG002|Overall Study|Lost to Follow-up|1|||
160631932|NCT01563029|580032686|FG003|Overall Study|Lost to Follow-up|1|||
160631933|NCT01563029|580032687|FG004|Overall Study|Lost to Follow-up|1|||
160631934|NCT01563029|580032683|FG000|Overall Study|Physician Decision|3|||
160631935|NCT01563029|580032684|FG001|Overall Study|Physician Decision|5|||
160631936|NCT01563029|580032685|FG002|Overall Study|Physician Decision|2|||
160631937|NCT01563029|580032686|FG003|Overall Study|Physician Decision|4|||
160631938|NCT01563029|580032687|FG004|Overall Study|Physician Decision|2|||
160631939|NCT01563029|580032683|FG000|Overall Study|Withdrawal by Subject|4|||
160631940|NCT01563029|580032684|FG001|Overall Study|Withdrawal by Subject|1|||
160631941|NCT01563029|580032685|FG002|Overall Study|Withdrawal by Subject|3|||
160631942|NCT01563029|580032686|FG003|Overall Study|Withdrawal by Subject|4|||
160631943|NCT01563029|580032687|FG004|Overall Study|Withdrawal by Subject|3|||
160631944|NCT01569594|580032688|FG000|Overall Study|Physician Decision|4|||
160631945|NCT01569594|580032688|FG000|Overall Study|Death|13|||
160631946|NCT01569594|580032688|FG000|Overall Study|Lost to Follow-up|22|||
160631947|NCT01569594|580032688|FG000|Overall Study|Adverse Event|2|||
160631948|NCT01569594|580032688|FG000|Overall Study|Withdrawal by Subject|13|||
160631949|NCT01569594|580032688|FG000|Overall Study|Other|4|||
160631950|NCT01569594|580032688|FG000|Overall Study|No ECM used|9|||
160631951|NCT03069365|580032689|FG000|Overall Study|Adverse Event|1|||
160631952|NCT02860039|580032694|FG000|Overall Study|Death|4|||
160631953|NCT02860039|580032695|FG001|Overall Study|Death|0|||
160631954|NCT02860039|580032694|FG000|Overall Study|Lost to Follow-up|2|||
160631955|NCT02860039|580032695|FG001|Overall Study|Lost to Follow-up|2|||
160631956|NCT02860039|580032694|FG000|Overall Study|Protocol Violation|3|||
160631957|NCT02860039|580032695|FG001|Overall Study|Protocol Violation|1|||
160631958|NCT02860039|580032694|FG000|Overall Study|Withdrawal by Subject|1|||
160631959|NCT02860039|580032695|FG001|Overall Study|Withdrawal by Subject|0|||
160631960|NCT02860039|580032694|FG000|Overall Study|Not otherwise eligible|1|||
160631961|NCT02860039|580032695|FG001|Overall Study|Not otherwise eligible|1|||
160631962|NCT02723786|580032698|FG000|Overall Study|Lost to Follow-up|1|||
160631963|NCT03170271|580032701|FG000|Overall Study|Adverse Event|7|||
160631964|NCT03170271|580032702|FG001|Overall Study|Adverse Event|2|||
160631965|NCT03170271|580032701|FG000|Overall Study|Lost to Follow-up|0|||
160631966|NCT03170271|580032702|FG001|Overall Study|Lost to Follow-up|1|||
160631967|NCT03170271|580032701|FG000|Overall Study|Physician Decision|1|||
160631968|NCT03170271|580032702|FG001|Overall Study|Physician Decision|0|||
160631969|NCT03170271|580032701|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
160631970|NCT03170271|580032702|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
160631971|NCT03170271|580032701|FG000|Overall Study|Withdrawal by Subject|17|||
160631972|NCT03170271|580032702|FG001|Overall Study|Withdrawal by Subject|5|||
160631973|NCT03170271|580032701|FG000|Overall Study|Other|2|||
160631974|NCT03170271|580032702|FG001|Overall Study|Other|2|||
160631975|NCT03170271|580032701|FG000|Overall Study|Randomized in error|4|||
160631976|NCT03170271|580032702|FG001|Overall Study|Randomized in error|0|||
160631977|NCT01036594|580032714|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
160631978|NCT01036594|580032715|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
160631979|NCT01036594|580032714|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
160631980|NCT01036594|580032715|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
160631981|NCT01036594|580032714|FG000|Week 12 Evaluation|Adverse Event|5|||
160631982|NCT01036594|580032715|FG001|Week 12 Evaluation|Adverse Event|0|||
160631983|NCT01036594|580032714|FG000|Week 12 Evaluation|Physician Decision|1|||
160631984|NCT01036594|580032715|FG001|Week 12 Evaluation|Physician Decision|0|||
160631985|NCT01036594|580032714|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
160631986|NCT01036594|580032715|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
160631987|NCT01036594|580032714|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
160631988|NCT01036594|580032715|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
160674401|NCT02034513|580187543|FG000|Overall Study|Unclassified|0|||
160674402|NCT02034513|580187544|FG001|Overall Study|Unclassified|1|||
160674403|NCT00960154|580187545|FG000|Overall Study|Study termination|25|||
160674404|NCT00960154|580187546|FG001|Overall Study|Study termination|25|||
160674405|NCT00757705|580187547|FG000|Overall Study|Adverse Event|19|||
160674406|NCT00757705|580187547|FG000|Overall Study|Lost to Follow-up|16|||
160674407|NCT00757705|580187547|FG000|Overall Study|Withdrawal by Subject|25|||
160674408|NCT00757705|580187547|FG000|Overall Study|Insufficient Response|26|||
160674409|NCT00757705|580187547|FG000|Overall Study|Ineligible to continue|8|||
160674410|NCT00757705|580187547|FG000|Overall Study|Non-compliant|9|||
160674411|NCT00757705|580187547|FG000|Overall Study|Other|18|||
160674412|NCT00856349|580187551|FG000|Overall Study|Death|418|||
160674413|NCT00856349|580187551|FG000|Overall Study|Withdrawal by Subject|116|||
160674414|NCT00856349|580187551|FG000|Overall Study|Lost to Follow-up|91|||
160674415|NCT00856349|580187551|FG000|Overall Study|Protocol Violation|38|||
160674416|NCT00856349|580187551|FG000|Overall Study|Physician Decision|13|||
160674417|NCT00856349|580187551|FG000|Overall Study|Subject relocation|104|||
160674418|NCT00856349|580187551|FG000|Overall Study|Device explant|33|||
160674419|NCT00856349|580187551|FG000|Overall Study|Site closure|78|||
160674420|NCT00856349|580187551|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
160674421|NCT01923740|580187552|FG000|Overall Study|Lost to Follow-up|4|||
160674422|NCT01923740|580187553|FG001|Overall Study|Lost to Follow-up|9|||
160631989|NCT01036594|580032714|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
160631990|NCT01036594|580032715|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
160631991|NCT01036594|580032714|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
160674423|NCT01923740|580187552|FG000|Overall Study|Withdrawal by Subject|2|||
160674424|NCT01923740|580187553|FG001|Overall Study|Withdrawal by Subject|0|||
160631992|NCT01036594|580032715|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
160631993|NCT01036594|580032714|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
160631994|NCT01036594|580032715|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
160631995|NCT03345485|580032718|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
160631996|NCT03345485|580032719|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
160631997|NCT03345485|580032720|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
160674425|NCT03345420|580187556|FG000|Overall Study|Withdrawal by Subject|1|||
160674426|NCT00834444|580187557|FG000|First Intervention|Adverse Event|1|||
160674427|NCT00834444|580187558|FG001|First Intervention|Adverse Event|0|||
160674428|NCT00834444|580187557|FG000|First Intervention|Intolerance to Venopuncture|0|||
160674429|NCT00834444|580187558|FG001|First Intervention|Intolerance to Venopuncture|1|||
160631998|NCT03345485|580032721|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
160631999|NCT03345485|580032722|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
160632000|NCT03345485|580032723|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
160632001|NCT03345485|580032724|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
160632002|NCT03345485|580032725|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
160632003|NCT03345485|580032726|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
160632004|NCT03345485|580032727|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
160632005|NCT03345485|580032728|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
160632006|NCT03345485|580032729|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
160632007|NCT03345485|580032730|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
160632008|NCT03020966|580032731|FG000|Overall Study|Withdrawal by Subject|2|||
160632009|NCT03020966|580032732|FG001|Overall Study|Withdrawal by Subject|0|||
160632010|NCT01856257|580032733|FG000|Overall Study|Death|2|||
160632011|NCT01856257|580032734|FG001|Overall Study|Death|0|||
160632012|NCT01856257|580032735|FG002|Overall Study|Death|0|||
160632013|NCT01856257|580032736|FG003|Overall Study|Death|0|||
160632014|NCT01856257|580032733|FG000|Overall Study|Physician Decision|0|||
160632015|NCT01856257|580032734|FG001|Overall Study|Physician Decision|0|||
160632016|NCT01856257|580032735|FG002|Overall Study|Physician Decision|0|||
160632017|NCT01856257|580032736|FG003|Overall Study|Physician Decision|1|||
160632018|NCT01856257|580032733|FG000|Overall Study|Withdrawal by Subject|1|||
160632019|NCT01856257|580032734|FG001|Overall Study|Withdrawal by Subject|1|||
160632020|NCT01856257|580032735|FG002|Overall Study|Withdrawal by Subject|0|||
160632021|NCT01856257|580032736|FG003|Overall Study|Withdrawal by Subject|0|||
160632022|NCT01856257|580032733|FG000|Overall Study|Donor complication|0|||
160632023|NCT01856257|580032734|FG001|Overall Study|Donor complication|0|||
160632024|NCT01856257|580032735|FG002|Overall Study|Donor complication|0|||
160632025|NCT01856257|580032736|FG003|Overall Study|Donor complication|1|||
160632026|NCT01125358|580032740|FG000|Overall Study|Adverse Event|3|||
160632027|NCT01125358|580032741|FG001|Overall Study|Adverse Event|0|||
160632028|NCT01125358|580032742|FG002|Overall Study|Adverse Event|0|||
160632029|NCT01125358|580032743|FG003|Overall Study|Adverse Event|2|||
160632030|NCT01125358|580032740|FG000|Overall Study|Perceived Lack of Efficacy|6|||
160632031|NCT01125358|580032741|FG001|Overall Study|Perceived Lack of Efficacy|3|||
160632032|NCT01125358|580032742|FG002|Overall Study|Perceived Lack of Efficacy|7|||
160632033|NCT01125358|580032743|FG003|Overall Study|Perceived Lack of Efficacy|4|||
160632034|NCT01125358|580032740|FG000|Overall Study|Protocol Violation|1|||
160632035|NCT01125358|580032741|FG001|Overall Study|Protocol Violation|0|||
160632036|NCT01125358|580032742|FG002|Overall Study|Protocol Violation|0|||
160632037|NCT01125358|580032743|FG003|Overall Study|Protocol Violation|0|||
160632038|NCT01125358|580032740|FG000|Overall Study|Sponsor Decision|0|||
160632039|NCT01125358|580032741|FG001|Overall Study|Sponsor Decision|0|||
160632040|NCT01125358|580032742|FG002|Overall Study|Sponsor Decision|1|||
160632041|NCT01125358|580032743|FG003|Overall Study|Sponsor Decision|1|||
160632042|NCT01125358|580032740|FG000|Overall Study|Withdrawal by Subject|2|||
160632043|NCT01125358|580032741|FG001|Overall Study|Withdrawal by Subject|1|||
160632044|NCT01125358|580032742|FG002|Overall Study|Withdrawal by Subject|1|||
160632045|NCT01125358|580032743|FG003|Overall Study|Withdrawal by Subject|1|||
160632046|NCT01060007|580032744|FG000|Overall Study|Withdrawal by Subject|1|||
160632047|NCT01060007|580032744|FG000|Overall Study|Inevaluable for response at surgery|3|||
160632048|NCT04935931|580032748|FG000|Overall Study|Withdrawal by Subject|1|||
160632049|NCT00424632|580032749|FG000|Overall Study|Death|0|||
160632050|NCT00424632|580032750|FG001|Overall Study|Death|0|||
160632051|NCT00424632|580032751|FG002|Overall Study|Death|0|||
160632052|NCT00424632|580032752|FG003|Overall Study|Death|0|||
160632053|NCT00424632|580032753|FG004|Overall Study|Death|0|||
160632054|NCT00424632|580032754|FG005|Overall Study|Death|2|||
160632055|NCT00424632|580032755|FG006|Overall Study|Death|0|||
160632056|NCT00424632|580032756|FG007|Overall Study|Death|0|||
160632057|NCT00424632|580032757|FG008|Overall Study|Death|0|||
160632058|NCT00424632|580032758|FG009|Overall Study|Death|0|||
160632059|NCT00424632|580032749|FG000|Overall Study|Adverse Event|0|||
160632060|NCT00424632|580032750|FG001|Overall Study|Adverse Event|0|||
160632061|NCT00424632|580032751|FG002|Overall Study|Adverse Event|0|||
160632062|NCT00424632|580032752|FG003|Overall Study|Adverse Event|0|||
160632063|NCT00424632|580032753|FG004|Overall Study|Adverse Event|0|||
160632064|NCT00424632|580032754|FG005|Overall Study|Adverse Event|0|||
160632065|NCT00424632|580032755|FG006|Overall Study|Adverse Event|0|||
160632066|NCT00424632|580032756|FG007|Overall Study|Adverse Event|0|||
160632067|NCT00424632|580032757|FG008|Overall Study|Adverse Event|3|||
160632068|NCT00424632|580032758|FG009|Overall Study|Adverse Event|2|||
160632069|NCT00424632|580032749|FG000|Overall Study|Global deterioration of health status|0|||
160632070|NCT00424632|580032750|FG001|Overall Study|Global deterioration of health status|0|||
160632071|NCT00424632|580032751|FG002|Overall Study|Global deterioration of health status|0|||
160632072|NCT00424632|580032752|FG003|Overall Study|Global deterioration of health status|1|||
160632073|NCT00424632|580032753|FG004|Overall Study|Global deterioration of health status|1|||
160632074|NCT00424632|580032754|FG005|Overall Study|Global deterioration of health status|0|||
160632075|NCT00424632|580032755|FG006|Overall Study|Global deterioration of health status|0|||
160632076|NCT00424632|580032756|FG007|Overall Study|Global deterioration of health status|0|||
160632077|NCT00424632|580032757|FG008|Overall Study|Global deterioration of health status|0|||
160632078|NCT00424632|580032758|FG009|Overall Study|Global deterioration of health status|0|||
160632079|NCT00424632|580032749|FG000|Overall Study|Objective progression or relapse|1|||
160632080|NCT00424632|580032750|FG001|Overall Study|Objective progression or relapse|1|||
160632081|NCT00424632|580032751|FG002|Overall Study|Objective progression or relapse|1|||
160632082|NCT00424632|580032752|FG003|Overall Study|Objective progression or relapse|2|||
160632083|NCT00424632|580032753|FG004|Overall Study|Objective progression or relapse|2|||
160632084|NCT00424632|580032754|FG005|Overall Study|Objective progression or relapse|13|||
160632085|NCT00424632|580032755|FG006|Overall Study|Objective progression or relapse|7|||
160632086|NCT00424632|580032756|FG007|Overall Study|Objective progression or relapse|3|||
160632087|NCT00424632|580032757|FG008|Overall Study|Objective progression or relapse|12|||
160632088|NCT00424632|580032758|FG009|Overall Study|Objective progression or relapse|4|||
160632089|NCT00424632|580032749|FG000|Overall Study|Other|0|||
160632090|NCT00424632|580032750|FG001|Overall Study|Other|0|||
160632091|NCT00424632|580032751|FG002|Overall Study|Other|0|||
160632092|NCT00424632|580032752|FG003|Overall Study|Other|1|||
160632093|NCT00424632|580032753|FG004|Overall Study|Other|0|||
160632094|NCT00424632|580032754|FG005|Overall Study|Other|0|||
160632095|NCT00424632|580032755|FG006|Overall Study|Other|0|||
160632096|NCT00424632|580032756|FG007|Overall Study|Other|0|||
160632097|NCT00424632|580032757|FG008|Overall Study|Other|1|||
160632098|NCT00424632|580032758|FG009|Overall Study|Other|0|||
160632099|NCT02628418|580032759|FG000|Overall Study|Lost to Follow-up|1|||
160632100|NCT02628418|580032760|FG001|Overall Study|Lost to Follow-up|2|||
160632101|NCT03159611|580032764|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
160632102|NCT03159611|580032765|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
160632103|NCT03159611|580032764|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
160632104|NCT03159611|580032765|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
160632105|NCT03159611|580032764|FG000|Overall Study|Protocol Violation|7|||
160632106|NCT03159611|580032765|FG001|Overall Study|Protocol Violation|4|||
160632107|NCT03159611|580032764|FG000|Overall Study|Adverse Event|1|||
160632108|NCT03159611|580032765|FG001|Overall Study|Adverse Event|0|||
160632109|NCT03159611|580032764|FG000|Overall Study|Withdrawal by Subject|1|||
160632110|NCT03159611|580032765|FG001|Overall Study|Withdrawal by Subject|1|||
160632111|NCT03159611|580032764|FG000|Overall Study|Non-compliance with protocol requirement|3|||
160632112|NCT03159611|580032765|FG001|Overall Study|Non-compliance with protocol requirement|2|||
160632113|NCT03159611|580032764|FG000|Overall Study|Inability to perform procedures|1|||
160632114|NCT03159611|580032765|FG001|Overall Study|Inability to perform procedures|0|||
160632115|NCT01984229|580032766|FG000|Safety Follow-up Period|Adverse Event|1|||
160632116|NCT01984229|580032767|FG001|Safety Follow-up Period|Adverse Event|1|||
160632117|NCT01984229|580032766|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
160632118|NCT01984229|580032767|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
160632119|NCT02072174|580032768|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
160632120|NCT02072174|580032769|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
160632121|NCT02072174|580032768|FG000|Overall Study|Protocol Violation|16|||
160632122|NCT02072174|580032769|FG001|Overall Study|Protocol Violation|23|||
160632123|NCT02072174|580032768|FG000|Overall Study|Physician Decision|0|||
160632124|NCT02072174|580032769|FG001|Overall Study|Physician Decision|1|||
160632125|NCT02072174|580032768|FG000|Overall Study|Non-compliance with protocol requirement|2|||
160632126|NCT02072174|580032769|FG001|Overall Study|Non-compliance with protocol requirement|0|||
160632127|NCT05674721|580032771|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
160632128|NCT05674721|580032772|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
160632129|NCT05674721|580032771|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
160632130|NCT05674721|580032772|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
160632131|NCT02057549|580032780|FG000|Overall Study|Lost to Follow-up|1|||
160632132|NCT02057549|580032781|FG001|Overall Study|Lost to Follow-up|0|||
160632133|NCT02057549|580032780|FG000|Overall Study|Physician Decision|1|||
160632134|NCT02057549|580032781|FG001|Overall Study|Physician Decision|0|||
160632135|NCT02057549|580032780|FG000|Overall Study|Withdrawal by Subject|1|||
160632136|NCT02057549|580032781|FG001|Overall Study|Withdrawal by Subject|0|||
160632137|NCT01418365|580032782|FG000|First Intervention|Withdrawal by Subject|0|||
160632138|NCT01418365|580032783|FG001|First Intervention|Withdrawal by Subject|1|||
160632139|NCT01418365|580032782|FG000|First Intervention|Non-compliance|1|||
160632140|NCT01418365|580032783|FG001|First Intervention|Non-compliance|0|||
160632141|NCT01418365|580032782|FG000|Second Intervention|Withdrawal by Subject|0|||
160632142|NCT01418365|580032783|FG001|Second Intervention|Withdrawal by Subject|1|||
160632143|NCT03319368|580032784|FG000|Overall Study|Discharge swabs not collected from resident|57|||
160632144|NCT03319368|580032785|FG001|Overall Study|Discharge swabs not collected from resident|46|||
160632145|NCT04150107|580032788|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
160632146|NCT04150107|580032789|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
160632147|NCT04150107|580032788|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
160632148|NCT04150107|580032789|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
160674430|NCT00834444|580187557|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
160674431|NCT00834444|580187558|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
160674432|NCT00834444|580187557|FG000|Second Intervention|Adverse Event|1|||
160674433|NCT00834444|580187558|FG001|Second Intervention|Adverse Event|0|||
160632149|NCT00440193|580032794|FG000|Treatment Period|Adverse Event|74|||
160632150|NCT00440193|580032795|FG001|Treatment Period|Adverse Event|67|||
160632151|NCT00440193|580032794|FG000|Treatment Period|Death|19|||
160632152|NCT00440193|580032795|FG001|Treatment Period|Death|22|||
160632153|NCT00440193|580032794|FG000|Treatment Period|Lack of Efficacy|0|||
160632154|NCT00440193|580032795|FG001|Treatment Period|Lack of Efficacy|1|||
160632155|NCT00440193|580032794|FG000|Treatment Period|Lost to Follow-up|12|||
160632156|NCT00440193|580032795|FG001|Treatment Period|Lost to Follow-up|18|||
160632157|NCT00440193|580032794|FG000|Treatment Period|Physician Decision|3|||
160632158|NCT00440193|580032795|FG001|Treatment Period|Physician Decision|6|||
160632159|NCT00440193|580032794|FG000|Treatment Period|Protocol Violation|16|||
160632160|NCT00440193|580032795|FG001|Treatment Period|Protocol Violation|19|||
160632161|NCT00440193|580032794|FG000|Treatment Period|Withdrawal by Subject|36|||
160632162|NCT00440193|580032795|FG001|Treatment Period|Withdrawal by Subject|77|||
160632163|NCT00440193|580032794|FG000|Treatment Period|Clinical endpoint reached|28|||
160632164|NCT00440193|580032795|FG001|Treatment Period|Clinical endpoint reached|25|||
160632165|NCT00440193|580032794|FG000|Treatment Period|Study terminated by sponsor|102|||
160632166|NCT00440193|580032795|FG001|Treatment Period|Study terminated by sponsor|94|||
160632167|NCT00440193|580032794|FG000|Treatment Period|Protocol driven decision point|2|||
160632168|NCT00440193|580032795|FG001|Treatment Period|Protocol driven decision point|2|||
160632169|NCT00440193|580032794|FG000|Treatment Period|Switch to commercial drug|0|||
160632170|NCT00440193|580032795|FG001|Treatment Period|Switch to commercial drug|2|||
160632171|NCT00440193|580032794|FG000|Treatment Period|Technical problems|1|||
160632172|NCT00440193|580032795|FG001|Treatment Period|Technical problems|1|||
160632173|NCT00440193|580032794|FG000|Treatment Period|Participant convenience|5|||
160632174|NCT00440193|580032795|FG001|Treatment Period|Participant convenience|2|||
160632175|NCT00440193|580032794|FG000|Treatment Period|Participant did not receive treatment|7|||
160632176|NCT00440193|580032795|FG001|Treatment Period|Participant did not receive treatment|13|||
160632177|NCT00440193|580032794|FG000|Treatment Period|Site closed by investigator|0|||
160632178|NCT00440193|580032795|FG001|Treatment Period|Site closed by investigator|2|||
160632179|NCT00440193|580032794|FG000|Observational Period|Adverse Event|2|||
160632180|NCT00440193|580032795|FG001|Observational Period|Adverse Event|2|||
160632181|NCT00440193|580032794|FG000|Observational Period|Death|15|||
160632182|NCT00440193|580032795|FG001|Observational Period|Death|20|||
160632183|NCT00440193|580032794|FG000|Observational Period|Lost to Follow-up|12|||
160632184|NCT00440193|580032795|FG001|Observational Period|Lost to Follow-up|8|||
160632185|NCT00440193|580032794|FG000|Observational Period|Protocol Violation|1|||
160632186|NCT00440193|580032795|FG001|Observational Period|Protocol Violation|0|||
160632187|NCT00440193|580032794|FG000|Observational Period|Withdrawal by Subject|11|||
160632188|NCT00440193|580032795|FG001|Observational Period|Withdrawal by Subject|8|||
160632189|NCT00440193|580032794|FG000|Observational Period|Physician Decision|1|||
160632190|NCT00440193|580032795|FG001|Observational Period|Physician Decision|0|||
160632191|NCT00440193|580032794|FG000|Observational Period|Clinical endpoint reached|1|||
160632192|NCT00440193|580032795|FG001|Observational Period|Clinical endpoint reached|0|||
160632193|NCT00440193|580032794|FG000|Observational Period|Participant convenience|2|||
160632194|NCT00440193|580032795|FG001|Observational Period|Participant convenience|0|||
160632195|NCT00824993|580032796|FG000|Overall Study|Withdrawal by Subject|1|||
160632196|NCT00824993|580032797|FG001|Overall Study|Withdrawal by Subject|1|||
160632197|NCT00824993|580032796|FG000|Overall Study|Malignancy Relapse|9|||
160632198|NCT00824993|580032797|FG001|Overall Study|Malignancy Relapse|10|||
160632199|NCT00824993|580032796|FG000|Overall Study|Rapid Bone Loss|0|||
160632200|NCT00824993|580032797|FG001|Overall Study|Rapid Bone Loss|1|||
160632201|NCT00824993|580032796|FG000|Overall Study|Non-Compliant|2|||
160632202|NCT00824993|580032797|FG001|Overall Study|Non-Compliant|1|||
160632203|NCT00824993|580032796|FG000|Overall Study|Insurance Issue|2|||
160632204|NCT00824993|580032797|FG001|Overall Study|Insurance Issue|1|||
160632205|NCT00824993|580032796|FG000|Overall Study|Death|0|||
160632206|NCT00824993|580032797|FG001|Overall Study|Death|3|||
160632207|NCT00834366|580032798|FG000|Treatment Period 1|Adverse Event|1|||
160674434|NCT02890992|580187562|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
160632208|NCT00834366|580032799|FG001|Treatment Period 1|Adverse Event|1|||
160674435|NCT02890992|580187563|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
160674436|NCT02890992|580187564|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
160632209|NCT01819467|580034197|FG000|Overall Study|Physician Decision|20|||
160632210|NCT01819467|580034198|FG001|Overall Study|Physician Decision|9|||
160632211|NCT02545868|580034199|FG000|Overall Study|Lack of Efficacy|1|||
160632212|NCT02545868|580034200|FG001|Overall Study|Lack of Efficacy|1|||
160632213|NCT02545868|580034201|FG002|Overall Study|Lack of Efficacy|0|||
160632214|NCT02545868|580034199|FG000|Overall Study|Lost to Follow-up|1|||
160632215|NCT02545868|580034200|FG001|Overall Study|Lost to Follow-up|5|||
160632216|NCT02545868|580034201|FG002|Overall Study|Lost to Follow-up|1|||
160632217|NCT02545868|580034199|FG000|Overall Study|Non-compliance|1|||
160674437|NCT02890992|580187565|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
160674438|NCT02890992|580187566|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
160674439|NCT02890992|580187567|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
160674440|NCT02890992|580187568|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
160674441|NCT02890992|580187569|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
160674442|NCT02890992|580187562|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
160674443|NCT02890992|580187563|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
160674444|NCT02890992|580187564|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
160674445|NCT02890992|580187565|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
160674446|NCT02890992|580187566|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
160674447|NCT02890992|580187567|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
160674448|NCT02890992|580187568|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
160674449|NCT02890992|580187569|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
160674450|NCT02890992|580187562|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
160674451|NCT02890992|580187563|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
160674452|NCT02890992|580187564|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
160674453|NCT02890992|580187565|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
160674454|NCT02890992|580187566|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
160674455|NCT02890992|580187567|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
160674456|NCT02890992|580187568|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
160674457|NCT02890992|580187569|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
160674458|NCT02336074|580187576|FG000|Overall Study|Adverse Event|0|||
160674459|NCT02336074|580187577|FG001|Overall Study|Adverse Event|2|||
160674460|NCT00958724|580187580|FG000|Overall Study|Disease Progression|6|||
160674461|NCT01266902|580187582|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
160674462|NCT01266902|580187583|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
160674463|NCT01266902|580187584|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
160674464|NCT01266902|580187582|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
160674465|NCT01266902|580187583|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
160674466|NCT01266902|580187584|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
160674467|NCT01266902|580187582|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
160674468|NCT01266902|580187583|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
160674469|NCT01266902|580187584|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
160674470|NCT01266902|580187582|FG000|Period 1 (Main Study)|Adverse Event|3|||
160674471|NCT01266902|580187583|FG001|Period 1 (Main Study)|Adverse Event|11|||
160674472|NCT01266902|580187584|FG002|Period 1 (Main Study)|Adverse Event|0|||
160674473|NCT01266902|580187582|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
160674474|NCT01266902|580187583|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
160674475|NCT01266902|580187584|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
160674476|NCT01266902|580187582|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
160674477|NCT01266902|580187583|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
160674478|NCT01266902|580187584|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
160674479|NCT01266902|580187582|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
160674480|NCT01266902|580187583|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
160674481|NCT01266902|580187584|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
160674482|NCT01266902|580187582|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
160674483|NCT01266902|580187583|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
160674484|NCT01266902|580187584|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
160674485|NCT01266902|580187582|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
160674486|NCT01266902|580187583|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
160674487|NCT01266902|580187584|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
160674488|NCT01266902|580187582|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
160674489|NCT01266902|580187583|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
160674490|NCT01266902|580187584|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
160674491|NCT02121184|580187585|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
160674492|NCT02121184|580187586|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
160674493|NCT02121184|580187585|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
160674494|NCT02121184|580187586|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
160674495|NCT02121184|580187585|FG000|Overall Study|Emergency cesarean section required|0|||
160674496|NCT02121184|580187586|FG001|Overall Study|Emergency cesarean section required|2|||
160674497|NCT02121184|580187585|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
160674498|NCT02121184|580187586|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
160674499|NCT00858780|580187587|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
160674500|NCT00858780|580187588|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
160674501|NCT00858780|580187589|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
160674502|NCT00858780|580187590|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
160674503|NCT00858780|580187591|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
160674504|NCT00858780|580187587|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
160674505|NCT00858780|580187588|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
160674506|NCT00858780|580187589|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
160674507|NCT00858780|580187590|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
160674508|NCT00858780|580187591|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
160674509|NCT00858780|580187587|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
160674510|NCT00858780|580187588|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
160674511|NCT00858780|580187589|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
160674512|NCT00858780|580187590|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
160632218|NCT02545868|580034200|FG001|Overall Study|Non-compliance|1|||
160632219|NCT02545868|580034201|FG002|Overall Study|Non-compliance|1|||
160632220|NCT02545868|580034199|FG000|Overall Study|Treatment change|21|||
160632221|NCT02545868|580034200|FG001|Overall Study|Treatment change|19|||
160632222|NCT02545868|580034201|FG002|Overall Study|Treatment change|22|||
160632223|NCT02545868|580034199|FG000|Overall Study|Physician Decision|1|||
160632224|NCT02545868|580034200|FG001|Overall Study|Physician Decision|1|||
160632225|NCT02545868|580034201|FG002|Overall Study|Physician Decision|1|||
160632226|NCT02545868|580034199|FG000|Overall Study|Withdrawal by Subject|6|||
160632227|NCT02545868|580034200|FG001|Overall Study|Withdrawal by Subject|7|||
160632228|NCT02545868|580034201|FG002|Overall Study|Withdrawal by Subject|9|||
160632229|NCT01777191|580034202|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
160632230|NCT01777191|580034203|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
160632231|NCT01777191|580034202|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
160632232|NCT01777191|580034203|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
160632233|NCT01777191|580034202|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
160632234|NCT01777191|580034203|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
160632235|NCT01777191|580034202|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
160632236|NCT01777191|580034203|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
160632237|NCT01777191|580034202|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
160632238|NCT01777191|580034203|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
160632239|NCT01777191|580034202|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
160632240|NCT01777191|580034203|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
160632241|NCT01777191|580034202|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
160632242|NCT01777191|580034203|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
160632243|NCT01777191|580034202|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
160632244|NCT01777191|580034203|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
160632245|NCT01777191|580034202|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
160632246|NCT01777191|580034203|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
160632247|NCT01777191|580034202|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
160632248|NCT01777191|580034203|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
160632249|NCT01777191|580034202|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
160632250|NCT01777191|580034203|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
160632251|NCT03286400|580034208|FG000|Overall Study|Death|10|||
160632252|NCT03286400|580034208|FG000|Overall Study|Lost to Follow-up|10|||
160632253|NCT03286400|580034208|FG000|Overall Study|Physician Decision|1|||
160632254|NCT03286400|580034208|FG000|Overall Study|Scheduling difficulty|4|||
160632255|NCT01856686|580034209|FG000|Overall Study|Lost to Follow-up|5|||
160632256|NCT01856686|580034210|FG001|Overall Study|Lost to Follow-up|11|||
160632257|NCT01461369|580034213|FG000|Overall Study|Lack of Efficacy|2|||
160632258|NCT01461369|580034214|FG001|Overall Study|Lack of Efficacy|0|||
160632259|NCT01461369|580034215|FG002|Overall Study|Lack of Efficacy|6|||
160632260|NCT01461369|580034213|FG000|Overall Study|Lost to Follow-up|0|||
160632261|NCT01461369|580034214|FG001|Overall Study|Lost to Follow-up|0|||
160632262|NCT01461369|580034215|FG002|Overall Study|Lost to Follow-up|3|||
160632263|NCT01461369|580034213|FG000|Overall Study|Adverse Event|9|||
160632264|NCT01461369|580034214|FG001|Overall Study|Adverse Event|12|||
160632265|NCT01461369|580034215|FG002|Overall Study|Adverse Event|4|||
160632266|NCT01461369|580034213|FG000|Overall Study|Protocol Violation|1|||
160632267|NCT01461369|580034214|FG001|Overall Study|Protocol Violation|2|||
160632268|NCT01461369|580034215|FG002|Overall Study|Protocol Violation|2|||
160632269|NCT01461369|580034213|FG000|Overall Study|Withdrawal by Subject|1|||
160632270|NCT01461369|580034214|FG001|Overall Study|Withdrawal by Subject|3|||
160632271|NCT01461369|580034215|FG002|Overall Study|Withdrawal by Subject|2|||
160632272|NCT00734617|580034220|FG000|Overall Study|Adverse Event|4|||
160632273|NCT00734617|580034221|FG001|Overall Study|Adverse Event|7|||
160632274|NCT00734617|580034220|FG000|Overall Study|Withdrawal by Subject|103|||
160632275|NCT00734617|580034221|FG001|Overall Study|Withdrawal by Subject|95|||
160632276|NCT00996632|580034230|FG000|Overall Study|Physician Decision|0|||
160632277|NCT00996632|580034231|FG001|Overall Study|Physician Decision|0|||
160632278|NCT02780115|580034232|FG000|Overall Study|Withdrawal by Subject|0|||
160632279|NCT02780115|580034233|FG001|Overall Study|Withdrawal by Subject|1|||
160632280|NCT02780115|580034234|FG002|Overall Study|Withdrawal by Subject|1|||
160632281|NCT02780115|580034235|FG003|Overall Study|Withdrawal by Subject|0|||
160632282|NCT02780115|580034236|FG004|Overall Study|Withdrawal by Subject|0|||
160632283|NCT02780115|580034232|FG000|Overall Study|Adverse Event|0|||
160632284|NCT02780115|580034233|FG001|Overall Study|Adverse Event|0|||
160632285|NCT02780115|580034234|FG002|Overall Study|Adverse Event|0|||
160632286|NCT02780115|580034235|FG003|Overall Study|Adverse Event|1|||
160632287|NCT02780115|580034236|FG004|Overall Study|Adverse Event|1|||
160632288|NCT00769132|580034237|FG000|Period 1|Adverse Event|1|||
160632289|NCT00769132|580034238|FG001|Period 1|Adverse Event|0|||
160632290|NCT00769132|580034239|FG002|Period 1|Adverse Event|0|||
160632291|NCT00769132|580034240|FG003|Period 1|Adverse Event|1|||
160632292|NCT00769132|580034237|FG000|Period 2|Withdrawal by Subject|0|||
160632293|NCT00769132|580034238|FG001|Period 2|Withdrawal by Subject|0|||
160632294|NCT00769132|580034239|FG002|Period 2|Withdrawal by Subject|0|||
160632295|NCT00769132|580034240|FG003|Period 2|Withdrawal by Subject|1|||
160632296|NCT00769132|580034237|FG000|Period 3|Withdrawal by Subject|1|||
160632297|NCT00769132|580034238|FG001|Period 3|Withdrawal by Subject|0|||
160632298|NCT00769132|580034239|FG002|Period 3|Withdrawal by Subject|0|||
160632299|NCT00769132|580034240|FG003|Period 3|Withdrawal by Subject|0|||
160632300|NCT00769132|580034237|FG000|Period 4|Withdrawal by Subject|0|||
160632301|NCT00769132|580034238|FG001|Period 4|Withdrawal by Subject|1|||
160632302|NCT00769132|580034239|FG002|Period 4|Withdrawal by Subject|0|||
160632303|NCT00769132|580034240|FG003|Period 4|Withdrawal by Subject|0|||
160632304|NCT00499252|580034241|FG000|Overall Study|Adverse Event|3|||
160632305|NCT00499252|580034241|FG000|Overall Study|Refused further treatment|2|||
160632306|NCT00499252|580034241|FG000|Overall Study|Ineligible|4|||
160632307|NCT00499252|580034241|FG000|Overall Study|<no further label>|3|||
160632308|NCT02230332|580034242|FG000|Overall Study|Adverse Event|2|||
160632309|NCT02230332|580034243|FG001|Overall Study|Adverse Event|1|||
160632310|NCT02230332|580034242|FG000|Overall Study|Lost to Follow-up|1|||
160632311|NCT02230332|580034243|FG001|Overall Study|Lost to Follow-up|0|||
160632312|NCT02230332|580034242|FG000|Overall Study|Protocol Violation|1|||
160632313|NCT02230332|580034243|FG001|Overall Study|Protocol Violation|0|||
160632314|NCT01260194|580034246|FG000|Overall Study|Withdrawal of Consent|1|||
160632315|NCT00537056|580034250|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
160632316|NCT01257737|580034251|FG000|Overall Study|Lost to Follow-up|1|||
160632317|NCT01257737|580034252|FG001|Overall Study|Lost to Follow-up|2|||
160632318|NCT01257737|580034251|FG000|Overall Study|Liver transplant|1|||
160632319|NCT01257737|580034252|FG001|Overall Study|Liver transplant|0|||
160632320|NCT01257737|580034251|FG000|Overall Study|Relocation out of the country|0|||
160632321|NCT01257737|580034252|FG001|Overall Study|Relocation out of the country|1|||
160632322|NCT01257737|580034251|FG000|Overall Study|Withdrew from study|0|||
160632323|NCT01257737|580034252|FG001|Overall Study|Withdrew from study|1|||
160632324|NCT00127192|580034260|FG000|Overall Study|Adverse Event|0|||
160632325|NCT00127192|580034261|FG001|Overall Study|Adverse Event|1|||
160632326|NCT00127192|580034262|FG002|Overall Study|Adverse Event|1|||
160632327|NCT00127192|580034263|FG003|Overall Study|Adverse Event|1|||
160632328|NCT00127192|580034264|FG004|Overall Study|Adverse Event|0|||
160632329|NCT00127192|580034260|FG000|Overall Study|Lack of Efficacy|2|||
160632330|NCT00127192|580034261|FG001|Overall Study|Lack of Efficacy|0|||
160632331|NCT00127192|580034262|FG002|Overall Study|Lack of Efficacy|0|||
160632332|NCT00127192|580034263|FG003|Overall Study|Lack of Efficacy|0|||
160632333|NCT00127192|580034264|FG004|Overall Study|Lack of Efficacy|2|||
160632334|NCT00127192|580034260|FG000|Overall Study|Withdrawal by Subject|0|||
160632335|NCT00127192|580034261|FG001|Overall Study|Withdrawal by Subject|0|||
160632336|NCT00127192|580034262|FG002|Overall Study|Withdrawal by Subject|1|||
160632337|NCT00127192|580034263|FG003|Overall Study|Withdrawal by Subject|0|||
160632338|NCT00127192|580034264|FG004|Overall Study|Withdrawal by Subject|3|||
160632339|NCT00127192|580034260|FG000|Overall Study|Adverse event in pre-treatment period|1|||
160632340|NCT00127192|580034261|FG001|Overall Study|Adverse event in pre-treatment period|0|||
160632341|NCT00127192|580034262|FG002|Overall Study|Adverse event in pre-treatment period|0|||
160632342|NCT00127192|580034263|FG003|Overall Study|Adverse event in pre-treatment period|0|||
160632343|NCT00127192|580034264|FG004|Overall Study|Adverse event in pre-treatment period|0|||
160632344|NCT03466060|580034270|FG000|Period 1|Test Lens Damage|0|||
160632345|NCT03466060|580034271|FG001|Period 1|Test Lens Damage|2|||
160632346|NCT03466060|580034272|FG002|Period 1|Test Lens Damage|0|||
160632347|NCT03466060|580034273|FG003|Period 1|Test Lens Damage|0|||
160632348|NCT03466060|580034274|FG004|Period 1|Test Lens Damage|0|||
160632349|NCT03466060|580034275|FG005|Period 1|Test Lens Damage|0|||
160632350|NCT03466060|580034270|FG000|Period 1|Withdrawal by Subject|0|||
160632351|NCT03466060|580034271|FG001|Period 1|Withdrawal by Subject|0|||
160632352|NCT03466060|580034272|FG002|Period 1|Withdrawal by Subject|2|||
160632353|NCT03466060|580034273|FG003|Period 1|Withdrawal by Subject|0|||
160632354|NCT03466060|580034274|FG004|Period 1|Withdrawal by Subject|0|||
160674513|NCT00858780|580187591|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
160674514|NCT00858780|580187587|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
160674515|NCT00858780|580187588|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
160674516|NCT00858780|580187589|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
160674517|NCT00858780|580187590|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
160674518|NCT00858780|580187591|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
160674519|NCT00858780|580187587|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
160674520|NCT00858780|580187588|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
160674521|NCT00858780|580187589|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
160674522|NCT00858780|580187590|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
160674523|NCT00858780|580187591|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
160674524|NCT00858780|580187587|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
160674525|NCT00858780|580187588|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
160674526|NCT00858780|580187589|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
160674527|NCT00858780|580187590|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
160674528|NCT00858780|580187591|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
160632355|NCT03466060|580034275|FG005|Period 1|Withdrawal by Subject|0|||
160632356|NCT03466060|580034270|FG000|Period 1|Lost to Follow-up|0|||
160632357|NCT03466060|580034271|FG001|Period 1|Lost to Follow-up|0|||
160632358|NCT03466060|580034272|FG002|Period 1|Lost to Follow-up|0|||
160632359|NCT03466060|580034273|FG003|Period 1|Lost to Follow-up|1|||
160632360|NCT03466060|580034274|FG004|Period 1|Lost to Follow-up|0|||
160632361|NCT03466060|580034275|FG005|Period 1|Lost to Follow-up|0|||
160632362|NCT03466060|580034270|FG000|Period 1|Grade 2 Conjunctivitis|0|||
160632363|NCT03466060|580034271|FG001|Period 1|Grade 2 Conjunctivitis|0|||
160632364|NCT03466060|580034272|FG002|Period 1|Grade 2 Conjunctivitis|1|||
160632365|NCT03466060|580034273|FG003|Period 1|Grade 2 Conjunctivitis|0|||
160632366|NCT03466060|580034274|FG004|Period 1|Grade 2 Conjunctivitis|0|||
160632367|NCT03466060|580034275|FG005|Period 1|Grade 2 Conjunctivitis|0|||
160632368|NCT03466060|580034270|FG000|Period 2|Lens Handling Difficulties|0|||
160632369|NCT03466060|580034271|FG001|Period 2|Lens Handling Difficulties|0|||
160632370|NCT03466060|580034272|FG002|Period 2|Lens Handling Difficulties|1|||
160632371|NCT03466060|580034273|FG003|Period 2|Lens Handling Difficulties|0|||
160632372|NCT03466060|580034274|FG004|Period 2|Lens Handling Difficulties|0|||
160632373|NCT03466060|580034275|FG005|Period 2|Lens Handling Difficulties|0|||
160632374|NCT01612780|580034276|FG000|Overall Study|Treatment not completed|1|||
160632375|NCT01612780|580034276|FG000|Overall Study|Withdrawal by Subject|5|||
160632376|NCT02985515|580034280|FG000|Olfaction Testing|Lost to Follow-up|0|||
160632377|NCT02985515|580034281|FG001|Olfaction Testing|Lost to Follow-up|5|||
160632378|NCT02985515|580034280|FG000|Olfaction Testing|Protocol Violation|0|||
160632379|NCT02985515|580034281|FG001|Olfaction Testing|Protocol Violation|3|||
160632380|NCT01610284|580034282|FG000|Randomization Phase|Adverse Event|1|||
160632381|NCT01610284|580034283|FG001|Randomization Phase|Adverse Event|0|||
160632382|NCT01610284|580034282|FG000|Randomization Phase|Physician Decision|1|||
160632383|NCT01610284|580034283|FG001|Randomization Phase|Physician Decision|1|||
160632384|NCT01610284|580034282|FG000|Randomization Phase|Death|0|||
160632385|NCT01610284|580034283|FG001|Randomization Phase|Death|1|||
160632386|NCT01610284|580034282|FG000|Treatment Phase|Adverse Event|80|||
160632387|NCT01610284|580034283|FG001|Treatment Phase|Adverse Event|12|||
160632388|NCT01610284|580034282|FG000|Treatment Phase|Lost to Follow-up|1|||
160632389|NCT01610284|580034283|FG001|Treatment Phase|Lost to Follow-up|0|||
160632390|NCT01610284|580034282|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
160632391|NCT01610284|580034283|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
160632392|NCT01610284|580034282|FG000|Treatment Phase|Physician Decision|27|||
160632393|NCT01610284|580034283|FG001|Treatment Phase|Physician Decision|24|||
160632394|NCT01610284|580034282|FG000|Treatment Phase|Progressive Disease|377|||
160632395|NCT01610284|580034283|FG001|Treatment Phase|Progressive Disease|486|||
160632396|NCT01610284|580034282|FG000|Treatment Phase|Protocol Deviation|2|||
160632397|NCT01610284|580034283|FG001|Treatment Phase|Protocol Deviation|3|||
160632398|NCT01610284|580034282|FG000|Treatment Phase|Study terminated by Sponsor|18|||
160632399|NCT01610284|580034283|FG001|Treatment Phase|Study terminated by Sponsor|15|||
160632400|NCT01610284|580034282|FG000|Treatment Phase|Subject/Guardian Decision|55|||
160632401|NCT01610284|580034283|FG001|Treatment Phase|Subject/Guardian Decision|23|||
160632402|NCT01610284|580034282|FG000|Treatment Phase|Death|6|||
160674529|NCT01964950|580187592|FG000|Overall Study|Protocol Violation|25|||
160632403|NCT01610284|580034283|FG001|Treatment Phase|Death|5|||
160632404|NCT01610284|580034282|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
160632405|NCT01610284|580034283|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160632406|NCT01610284|580034282|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
160632407|NCT01610284|580034283|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
160632408|NCT01610284|580034282|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
160632409|NCT01610284|580034283|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
160632410|NCT01610284|580034282|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
160674530|NCT01149057|580187593|FG000|Overall Study|Lack of Efficacy|16|||
160632411|NCT01610284|580034283|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
160632412|NCT01610284|580034282|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
160632413|NCT01610284|580034283|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
160632414|NCT01610284|580034282|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
160674531|NCT01149057|580187593|FG000|Overall Study|Adverse Event|13|||
160674532|NCT01149057|580187593|FG000|Overall Study|Withdrawal by Subject|9|||
160674533|NCT01149057|580187593|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
160674534|NCT01149057|580187593|FG000|Overall Study|B Cell Depletion|4|||
160674535|NCT01149057|580187593|FG000|Overall Study|Participant Non-Compliance|2|||
160674536|NCT01149057|580187593|FG000|Overall Study|Lost to Follow-up|1|||
160674537|NCT01149057|580187593|FG000|Overall Study|High Parathyroid Hormone Value|1|||
160674538|NCT01149057|580187593|FG000|Overall Study|Other|6|||
160674539|NCT03499873|580187594|FG000|Overall Study|Withdrawal by Subject|4|||
160674540|NCT03499873|580187595|FG001|Overall Study|Withdrawal by Subject|6|||
160674541|NCT03499873|580187596|FG002|Overall Study|Withdrawal by Subject|1|||
160674542|NCT03499873|580187594|FG000|Overall Study|Subjects condition worsened|0|||
160674543|NCT03499873|580187595|FG001|Overall Study|Subjects condition worsened|3|||
160674544|NCT03499873|580187596|FG002|Overall Study|Subjects condition worsened|11|||
160674545|NCT03499873|580187594|FG000|Overall Study|Adverse Event|8|||
160674546|NCT03499873|580187595|FG001|Overall Study|Adverse Event|3|||
160674547|NCT03499873|580187596|FG002|Overall Study|Adverse Event|6|||
160674548|NCT03499873|580187594|FG000|Overall Study|Physician Decision|1|||
160674549|NCT03499873|580187595|FG001|Overall Study|Physician Decision|0|||
160674550|NCT03499873|580187596|FG002|Overall Study|Physician Decision|0|||
160674551|NCT03499873|580187594|FG000|Overall Study|Administrative reasons|0|||
160674552|NCT03499873|580187595|FG001|Overall Study|Administrative reasons|1|||
160674553|NCT03499873|580187596|FG002|Overall Study|Administrative reasons|0|||
160674554|NCT03499873|580187594|FG000|Overall Study|Concomitant therapy|5|||
160674555|NCT03499873|580187595|FG001|Overall Study|Concomitant therapy|4|||
160674556|NCT03499873|580187596|FG002|Overall Study|Concomitant therapy|7|||
160674557|NCT03499873|580187594|FG000|Overall Study|Miscellaneous|1|||
160674558|NCT03499873|580187595|FG001|Overall Study|Miscellaneous|2|||
160674559|NCT03499873|580187596|FG002|Overall Study|Miscellaneous|2|||
160674560|NCT03499873|580187594|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
160632415|NCT01610284|580034283|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
160632416|NCT00445458|580034284|FG000|Overall Study|Disease Progression|3|||
160632417|NCT00445458|580034285|FG001|Overall Study|Disease Progression|4|||
160632418|NCT00445458|580034286|FG002|Overall Study|Disease Progression|54|||
160632419|NCT00445458|580034287|FG003|Overall Study|Disease Progression|27|||
160632420|NCT00445458|580034284|FG000|Overall Study|Withdrawal by Subject|0|||
160632421|NCT00445458|580034285|FG001|Overall Study|Withdrawal by Subject|0|||
160632422|NCT00445458|580034286|FG002|Overall Study|Withdrawal by Subject|7|||
160632423|NCT00445458|580034287|FG003|Overall Study|Withdrawal by Subject|0|||
160674561|NCT03499873|580187595|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
160674562|NCT03499873|580187596|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
160674563|NCT01297504|580187597|FG000|Overall Study|Invalid Consent|1|||
160674564|NCT01297504|580187597|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
160674565|NCT01297504|580187597|FG000|Overall Study|No Study Visits|4|||
160674566|NCT01297504|580187597|FG000|Overall Study|Death|3|||
160674567|NCT01297504|580187597|FG000|Overall Study|Lost to Follow-up|43|||
160674568|NCT01297504|580187597|FG000|Overall Study|Withdrawal by Subject|9|||
160674569|NCT01297504|580187597|FG000|Overall Study|Site Closure|3|||
160674570|NCT01297504|580187597|FG000|Overall Study|Protocol Violation|3|||
160674571|NCT03306277|580187598|FG000|Overall Study|Death|1|||
160674572|NCT03306277|580187598|FG000|Overall Study|Adverse Event|1|||
160674573|NCT03306277|580187598|FG000|Overall Study|Withdrawal by Subject|1|||
160674574|NCT01370863|580187602|FG000|Overall Study|Adverse Event|1|||
160674575|NCT01370863|580187603|FG001|Overall Study|Adverse Event|1|||
160674576|NCT01370863|580187602|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
160674577|NCT01370863|580187603|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
160674578|NCT01370863|580187602|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
160674579|NCT01370863|580187603|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
160674580|NCT00881751|580187604|FG000|Overall Study|Physician Decision|0|||
160674581|NCT00881751|580187605|FG001|Overall Study|Physician Decision|1|||
160674582|NCT00881751|580187604|FG000|Overall Study|Adverse Event|0|||
160674583|NCT00881751|580187605|FG001|Overall Study|Adverse Event|2|||
160674584|NCT00881751|580187604|FG000|Overall Study|Withdrawal by Subject|0|||
160674585|NCT00881751|580187605|FG001|Overall Study|Withdrawal by Subject|2|||
160674586|NCT01926119|580187606|FG000|Overall Study|Withdrawal by Subject|1|||
160674587|NCT01968551|580187607|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
160674588|NCT01968551|580187608|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
160674589|NCT01968551|580187609|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
160674590|NCT01968551|580187607|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
160674591|NCT01968551|580187608|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
160674592|NCT01968551|580187609|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
160674593|NCT01968551|580187607|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
160674594|NCT01968551|580187608|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
160674595|NCT01968551|580187609|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
160674596|NCT01968551|580187607|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
160674597|NCT01968551|580187608|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
160674598|NCT01968551|580187609|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
160674599|NCT01968551|580187607|FG000|Extension Phase|Adverse Event|0|||
160674600|NCT01968551|580187608|FG001|Extension Phase|Adverse Event|0|||
160674601|NCT01968551|580187609|FG002|Extension Phase|Adverse Event|2|||
160674602|NCT01968551|580187607|FG000|Extension Phase|Death|0|||
160674603|NCT01968551|580187608|FG001|Extension Phase|Death|1|||
160674604|NCT01968551|580187609|FG002|Extension Phase|Death|0|||
160674605|NCT01968551|580187607|FG000|Extension Phase|Withdrew Consent|0|||
160674606|NCT01968551|580187608|FG001|Extension Phase|Withdrew Consent|0|||
160674607|NCT01968551|580187609|FG002|Extension Phase|Withdrew Consent|1|||
160674608|NCT01968551|580187607|FG000|Extension Phase|Lost to Follow-up|1|||
160674609|NCT01968551|580187608|FG001|Extension Phase|Lost to Follow-up|0|||
160674610|NCT01968551|580187609|FG002|Extension Phase|Lost to Follow-up|1|||
160674611|NCT00645853|580187610|FG000|Overall Study|Adverse Event|18|||
160674612|NCT00645853|580187611|FG001|Overall Study|Adverse Event|7|||
160674613|NCT00645853|580187610|FG000|Overall Study|AZ study closure in Hungary|60|||
160674614|NCT00645853|580187611|FG001|Overall Study|AZ study closure in Hungary|40|||
160674615|NCT00645853|580187610|FG000|Overall Study|Withdrawal by Subject|5|||
160674616|NCT00645853|580187611|FG001|Overall Study|Withdrawal by Subject|2|||
160674617|NCT00645853|580187610|FG000|Overall Study|Protocol Violation|0|||
160674618|NCT00645853|580187611|FG001|Overall Study|Protocol Violation|2|||
160674619|NCT00645853|580187610|FG000|Overall Study|Discontinuation criteria|2|||
160674620|NCT00645853|580187611|FG001|Overall Study|Discontinuation criteria|2|||
160674621|NCT00645853|580187610|FG000|Overall Study|recall of ICF, planned operation, death|7|||
160674622|NCT00645853|580187611|FG001|Overall Study|recall of ICF, planned operation, death|4|||
160674623|NCT00819169|580187612|FG000|Overall Study|Withdrawal by Subject|2|||
160674624|NCT00819169|580187613|FG001|Overall Study|Withdrawal by Subject|0|||
160674625|NCT00819169|580187614|FG002|Overall Study|Withdrawal by Subject|0|||
160674626|NCT00819169|580187615|FG003|Overall Study|Withdrawal by Subject|1|||
160674627|NCT00819169|580187616|FG004|Overall Study|Withdrawal by Subject|1|||
160674628|NCT00819169|580187617|FG005|Overall Study|Withdrawal by Subject|1|||
160674629|NCT00819169|580187618|FG006|Overall Study|Withdrawal by Subject|5|||
160674630|NCT00819169|580187619|FG007|Overall Study|Withdrawal by Subject|1|||
160674631|NCT00819169|580187620|FG008|Overall Study|Withdrawal by Subject|4|||
160674632|NCT00819169|580187612|FG000|Overall Study|Lost to Follow-up|0|||
160674633|NCT00819169|580187613|FG001|Overall Study|Lost to Follow-up|2|||
160674634|NCT00819169|580187614|FG002|Overall Study|Lost to Follow-up|0|||
160674635|NCT00819169|580187615|FG003|Overall Study|Lost to Follow-up|1|||
160674636|NCT00819169|580187616|FG004|Overall Study|Lost to Follow-up|0|||
160674637|NCT00819169|580187617|FG005|Overall Study|Lost to Follow-up|6|||
160674638|NCT00819169|580187618|FG006|Overall Study|Lost to Follow-up|2|||
160674639|NCT00819169|580187619|FG007|Overall Study|Lost to Follow-up|2|||
160674640|NCT00819169|580187620|FG008|Overall Study|Lost to Follow-up|1|||
160674641|NCT00819169|580187612|FG000|Overall Study|Death|1|||
160674642|NCT00819169|580187613|FG001|Overall Study|Death|1|||
160674643|NCT00819169|580187614|FG002|Overall Study|Death|3|||
160674644|NCT00819169|580187615|FG003|Overall Study|Death|8|||
160674645|NCT00819169|580187616|FG004|Overall Study|Death|5|||
160674646|NCT00819169|580187617|FG005|Overall Study|Death|7|||
160674647|NCT00819169|580187618|FG006|Overall Study|Death|9|||
160674648|NCT00819169|580187619|FG007|Overall Study|Death|4|||
160674649|NCT00819169|580187620|FG008|Overall Study|Death|7|||
160674650|NCT00819169|580187612|FG000|Overall Study|Ineligibility determined|0|||
160674651|NCT00819169|580187613|FG001|Overall Study|Ineligibility determined|0|||
160674652|NCT00819169|580187614|FG002|Overall Study|Ineligibility determined|0|||
160674653|NCT00819169|580187615|FG003|Overall Study|Ineligibility determined|2|||
160674654|NCT00819169|580187616|FG004|Overall Study|Ineligibility determined|0|||
160674655|NCT00819169|580187617|FG005|Overall Study|Ineligibility determined|0|||
160674656|NCT00819169|580187618|FG006|Overall Study|Ineligibility determined|0|||
160674657|NCT00819169|580187619|FG007|Overall Study|Ineligibility determined|0|||
160674658|NCT00819169|580187620|FG008|Overall Study|Ineligibility determined|1|||
160674659|NCT00819169|580187612|FG000|Overall Study|Adverse Event|0|||
160674660|NCT00819169|580187613|FG001|Overall Study|Adverse Event|0|||
160674661|NCT00819169|580187614|FG002|Overall Study|Adverse Event|0|||
160674662|NCT00819169|580187615|FG003|Overall Study|Adverse Event|0|||
160674663|NCT00819169|580187616|FG004|Overall Study|Adverse Event|1|||
160674664|NCT00819169|580187617|FG005|Overall Study|Adverse Event|0|||
160674665|NCT00819169|580187618|FG006|Overall Study|Adverse Event|0|||
160674666|NCT00819169|580187619|FG007|Overall Study|Adverse Event|0|||
160674667|NCT00819169|580187620|FG008|Overall Study|Adverse Event|0|||
160674668|NCT00819169|580187612|FG000|Overall Study|Administrative Decision|0|||
160674669|NCT00819169|580187613|FG001|Overall Study|Administrative Decision|0|||
160674670|NCT00819169|580187614|FG002|Overall Study|Administrative Decision|0|||
160674671|NCT00819169|580187615|FG003|Overall Study|Administrative Decision|0|||
160674672|NCT00819169|580187616|FG004|Overall Study|Administrative Decision|1|||
160674673|NCT00819169|580187617|FG005|Overall Study|Administrative Decision|2|||
160674674|NCT00819169|580187618|FG006|Overall Study|Administrative Decision|0|||
160674675|NCT00819169|580187619|FG007|Overall Study|Administrative Decision|2|||
160674676|NCT00819169|580187620|FG008|Overall Study|Administrative Decision|0|||
160674677|NCT02637141|580187624|FG000|Overall Study|Adverse Event|1|||
160674678|NCT02637141|580187625|FG001|Overall Study|Adverse Event|1|||
160674679|NCT02637141|580187626|FG002|Overall Study|Adverse Event|0|||
160674680|NCT02637141|580187624|FG000|Overall Study|Withdrawal by Subject|1|||
160674681|NCT02637141|580187625|FG001|Overall Study|Withdrawal by Subject|1|||
160674682|NCT02637141|580187626|FG002|Overall Study|Withdrawal by Subject|1|||
160674683|NCT00406393|580187630|FG000|Overall Study|Did not undergo transplantation|2|||
160674684|NCT00406393|580187631|FG001|Overall Study|Did not undergo transplantation|1|||
160674685|NCT03885934|580187632|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
160674686|NCT03885934|580187633|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
160674687|NCT03885934|580187634|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
160674688|NCT03885934|580187635|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
160674689|NCT03885934|580187636|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
160674690|NCT03885934|580187637|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
160674691|NCT02377349|580187638|FG000|Overall Study|Serious Adverse Event|1|||
160674692|NCT02377349|580187639|FG001|Overall Study|Serious Adverse Event|0|||
160674693|NCT02377349|580187638|FG000|Overall Study|Protocol Violation|3|||
160674694|NCT02377349|580187639|FG001|Overall Study|Protocol Violation|2|||
160674695|NCT02377349|580187638|FG000|Overall Study|Withdrawal by Subject|5|||
160674696|NCT02377349|580187639|FG001|Overall Study|Withdrawal by Subject|3|||
160674697|NCT02377349|580187638|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
160674698|NCT02377349|580187639|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
160674699|NCT02377349|580187638|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
160674700|NCT02377349|580187639|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
160674701|NCT02377349|580187638|FG000|Overall Study|Other|0|||
160674702|NCT02377349|580187639|FG001|Overall Study|Other|1|||
160674703|NCT01507662|580187644|FG000|Overall Study|Death|26|||
160674704|NCT01507662|580187645|FG001|Overall Study|Death|18|||
160674705|NCT01507662|580187644|FG000|Overall Study|Withdrawal by Subject|290|||
160674706|NCT01507662|580187645|FG001|Overall Study|Withdrawal by Subject|287|||
160674707|NCT01507662|580187644|FG000|Overall Study|Lost to Follow-up|498|||
160674708|NCT01507662|580187645|FG001|Overall Study|Lost to Follow-up|523|||
160674709|NCT01507662|580187644|FG000|Overall Study|Proxy interview done|2|||
160674710|NCT01507662|580187645|FG001|Overall Study|Proxy interview done|3|||
160674711|NCT01395017|580187646|FG000|Overall Study|Lost to Follow-up|1|||
160674712|NCT01395017|580187647|FG001|Overall Study|Lost to Follow-up|0|||
160674713|NCT01395017|580187646|FG000|Overall Study|Adverse Event|26|||
160674714|NCT01395017|580187647|FG001|Overall Study|Adverse Event|12|||
160674715|NCT01395017|580187646|FG000|Overall Study|Physician Decision|11|||
160674716|NCT01395017|580187647|FG001|Overall Study|Physician Decision|15|||
160674717|NCT01395017|580187646|FG000|Overall Study|Withdrawal by Subject|14|||
160674718|NCT01395017|580187647|FG001|Overall Study|Withdrawal by Subject|8|||
160674719|NCT01395017|580187646|FG000|Overall Study|Protocol deviation|1|||
160674720|NCT01395017|580187647|FG001|Overall Study|Protocol deviation|2|||
160674721|NCT01395017|580187646|FG000|Overall Study|Death|4|||
160674722|NCT01395017|580187647|FG001|Overall Study|Death|3|||
160674723|NCT01395017|580187646|FG000|Overall Study|Disease progression|42|||
160674724|NCT01395017|580187647|FG001|Overall Study|Disease progression|58|||
160674725|NCT01395017|580187646|FG000|Overall Study|Sponsor discontinued study|1|||
160674726|NCT01395017|580187647|FG001|Overall Study|Sponsor discontinued study|4|||
160674727|NCT03366428|580187648|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
160674728|NCT03366428|580187648|FG000|Overall Study|Adverse Event|12|||
160674729|NCT03366428|580187648|FG000|Overall Study|Clinical progression|2|||
160674730|NCT03366428|580187648|FG000|Overall Study|Withdrawal by Subject|4|||
160674731|NCT01971645|580187649|FG000|Overall Study|Adverse Event|1|||
160674732|NCT01971645|580187650|FG001|Overall Study|Adverse Event|0|||
160674733|NCT01971645|580187651|FG002|Overall Study|Adverse Event|0|||
160674734|NCT01971645|580187649|FG000|Overall Study|Lost to Follow-up|1|||
160674735|NCT01971645|580187650|FG001|Overall Study|Lost to Follow-up|0|||
160674736|NCT01971645|580187651|FG002|Overall Study|Lost to Follow-up|1|||
160674737|NCT01971645|580187649|FG000|Overall Study|Protocol Violation|0|||
160674738|NCT01971645|580187650|FG001|Overall Study|Protocol Violation|0|||
160674739|NCT01971645|580187651|FG002|Overall Study|Protocol Violation|1|||
160674740|NCT03867760|580187656|FG000|Overall Study|Lost to Follow-up|2|||
160674741|NCT03867760|580187657|FG001|Overall Study|Lost to Follow-up|3|||
160674742|NCT03867760|580187656|FG000|Overall Study|Withdrawal by Subject|1|||
160674743|NCT03867760|580187657|FG001|Overall Study|Withdrawal by Subject|2|||
160674744|NCT03867760|580187656|FG000|Overall Study|subject could not meet study logistics|3|||
160674745|NCT03867760|580187657|FG001|Overall Study|subject could not meet study logistics|3|||
160674746|NCT04203823|580187659|FG000|Overall Study|Withdrawal by Subject|2|||
160674747|NCT04203823|580187660|FG001|Overall Study|Withdrawal by Subject|2|||
160674748|NCT04203823|580187659|FG000|Overall Study|Adverse Event|1|||
160674749|NCT04203823|580187660|FG001|Overall Study|Adverse Event|1|||
160674750|NCT04203823|580187659|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160674751|NCT04203823|580187660|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
160674752|NCT03684928|580187661|FG000|First Intervention|Lost to Follow-up|0|||
160674753|NCT03684928|580187662|FG001|First Intervention|Lost to Follow-up|1|||
160674754|NCT03684928|580187661|FG000|First Intervention|Withdrawal by Subject|0|||
160674755|NCT03684928|580187662|FG001|First Intervention|Withdrawal by Subject|2|||
160674756|NCT03684928|580187661|FG000|Second Intervention|Soft Tissue Injury|1|||
160674757|NCT03684928|580187662|FG001|Second Intervention|Soft Tissue Injury|0|||
160674758|NCT03193021|580187663|FG000|Overall Study|Lost to Follow-up|1|||
160674759|NCT03193021|580187664|FG001|Overall Study|Lost to Follow-up|1|||
160674760|NCT02286466|580187665|FG000|Overall Study|Death|1|||
160674761|NCT02286466|580187666|FG001|Overall Study|Death|3|||
160674762|NCT02286466|580187665|FG000|Overall Study|Withdrawal by Subject|5|||
160674763|NCT02286466|580187666|FG001|Overall Study|Withdrawal by Subject|2|||
160674764|NCT02286466|580187665|FG000|Overall Study|Lost to Follow-up|1|||
160674765|NCT02286466|580187666|FG001|Overall Study|Lost to Follow-up|4|||
160674766|NCT02286466|580187665|FG000|Overall Study|Declined Clinician Assessment|0|||
160674767|NCT02286466|580187666|FG001|Overall Study|Declined Clinician Assessment|1|||
160674768|NCT00835081|580187667|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
160674769|NCT00835081|580187668|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
160674770|NCT01675596|580187669|FG000|Overall Study|Death|6|||
160674771|NCT01675596|580187669|FG000|Overall Study|Exit with other reason|1|||
160674772|NCT01675596|580187669|FG000|Overall Study|Missed Visit|1|||
160674773|NCT01139762|580187670|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
160674774|NCT01139762|580187671|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
160674775|NCT01139762|580187672|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
160674776|NCT01139762|580187670|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
160674777|NCT01139762|580187671|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
160674778|NCT01139762|580187672|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
160674779|NCT01139762|580187670|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
160674780|NCT01139762|580187671|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
160674781|NCT01139762|580187672|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
160674782|NCT01139762|580187670|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
160674783|NCT01139762|580187671|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
160674784|NCT01139762|580187672|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
160674785|NCT01139762|580187670|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
160674786|NCT01139762|580187671|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
160674787|NCT01139762|580187672|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
160674788|NCT01139762|580187670|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
160674789|NCT01139762|580187671|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
160674790|NCT01139762|580187672|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
160674791|NCT01139762|580187670|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
160674792|NCT01139762|580187671|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
160674793|NCT01139762|580187672|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
160674794|NCT01139762|580187670|FG000|Double-Blind Randomized Active Treatment|Death|0|||
160674795|NCT01139762|580187671|FG001|Double-Blind Randomized Active Treatment|Death|1|||
160674796|NCT01139762|580187672|FG002|Double-Blind Randomized Active Treatment|Death|1|||
160674797|NCT01139762|580187670|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
160674798|NCT01139762|580187671|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
160674799|NCT01139762|580187672|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
160674800|NCT01139762|580187670|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
160674801|NCT01139762|580187671|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
160674802|NCT01139762|580187672|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
160674803|NCT01139762|580187670|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
160674804|NCT01139762|580187671|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
160674805|NCT01139762|580187672|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
160674806|NCT01139762|580187670|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
160674807|NCT01139762|580187671|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
160674808|NCT01139762|580187672|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
160674809|NCT01139762|580187670|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
160674810|NCT01139762|580187671|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
160674811|NCT01139762|580187672|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
160674812|NCT01139762|580187670|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
160674813|NCT01139762|580187671|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
160674814|NCT01139762|580187672|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
160674815|NCT01139762|580187670|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
160632424|NCT00445458|580034284|FG000|Overall Study|Adverse Event|0|||
160632425|NCT00445458|580034285|FG001|Overall Study|Adverse Event|0|||
160632426|NCT00445458|580034286|FG002|Overall Study|Adverse Event|3|||
160632427|NCT00445458|580034287|FG003|Overall Study|Adverse Event|0|||
160632428|NCT00445458|580034284|FG000|Overall Study|Death|0|||
160632429|NCT00445458|580034285|FG001|Overall Study|Death|1|||
160632430|NCT00445458|580034286|FG002|Overall Study|Death|2|||
160632431|NCT00445458|580034287|FG003|Overall Study|Death|0|||
160632432|NCT00445458|580034284|FG000|Overall Study|Physician Decision|0|||
160632433|NCT00445458|580034285|FG001|Overall Study|Physician Decision|0|||
160632434|NCT00445458|580034286|FG002|Overall Study|Physician Decision|1|||
160632435|NCT00445458|580034287|FG003|Overall Study|Physician Decision|1|||
160632436|NCT00445458|580034284|FG000|Overall Study|Surgery|0|||
160632437|NCT00445458|580034285|FG001|Overall Study|Surgery|0|||
160632438|NCT00445458|580034286|FG002|Overall Study|Surgery|1|||
160632439|NCT00445458|580034287|FG003|Overall Study|Surgery|0|||
160632440|NCT03506425|580034295|FG000|Overall Study|Adverse Event|1|||
160632441|NCT03506425|580034296|FG001|Overall Study|Adverse Event|3|||
160632442|NCT03506425|580034297|FG002|Overall Study|Adverse Event|0|||
160632443|NCT03506425|580034295|FG000|Overall Study|Death|1|||
160632444|NCT03506425|580034296|FG001|Overall Study|Death|0|||
160632445|NCT03506425|580034297|FG002|Overall Study|Death|0|||
160632446|NCT03506425|580034295|FG000|Overall Study|Withdrawal by Subject|0|||
160632447|NCT03506425|580034296|FG001|Overall Study|Withdrawal by Subject|0|||
160632448|NCT03506425|580034297|FG002|Overall Study|Withdrawal by Subject|1|||
160632449|NCT00077766|580034298|FG000|Overall Study|Adverse Event|1|||
160632450|NCT00077766|580034299|FG001|Overall Study|Adverse Event|1|||
160632451|NCT00077766|580034298|FG000|Overall Study|Withdrawal by Subject|4|||
160632452|NCT00077766|580034299|FG001|Overall Study|Withdrawal by Subject|3|||
160632453|NCT00077766|580034298|FG000|Overall Study|Death|12|||
160632454|NCT00077766|580034299|FG001|Overall Study|Death|10|||
160632455|NCT00077766|580034298|FG000|Overall Study|Lost to Follow-up|2|||
160632456|NCT00077766|580034299|FG001|Overall Study|Lost to Follow-up|0|||
160632457|NCT00077766|580034298|FG000|Overall Study|Protocol Violation|1|||
160632458|NCT00077766|580034299|FG001|Overall Study|Protocol Violation|0|||
160632459|NCT00077766|580034298|FG000|Overall Study|Kidney Transplantation|9|||
160632460|NCT00077766|580034299|FG001|Overall Study|Kidney Transplantation|5|||
160632461|NCT00077766|580034298|FG000|Overall Study|Transplantation|5|||
160632462|NCT00077766|580034299|FG001|Overall Study|Transplantation|1|||
160632463|NCT00077766|580034298|FG000|Overall Study|Investigators Discretion|1|||
160632464|NCT00077766|580034299|FG001|Overall Study|Investigators Discretion|0|||
160632465|NCT00077766|580034298|FG000|Overall Study|Participant's decision|1|||
160632466|NCT00077766|580034299|FG001|Overall Study|Participant's decision|0|||
160632467|NCT00077766|580034298|FG000|Overall Study|Dialysis Discontinued|1|||
160632468|NCT00077766|580034299|FG001|Overall Study|Dialysis Discontinued|0|||
160632469|NCT00077766|580034298|FG000|Overall Study|Dialysis|0|||
160632470|NCT00077766|580034299|FG001|Overall Study|Dialysis|1|||
160632471|NCT00077766|580034298|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
160632472|NCT00077766|580034299|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
160632473|NCT00077766|580034298|FG000|Overall Study|Started Nocturnal Dialysis|0|||
160632474|NCT00077766|580034299|FG001|Overall Study|Started Nocturnal Dialysis|1|||
160632475|NCT00077766|580034298|FG000|Overall Study|Stop Dialysis|0|||
160632476|NCT00077766|580034299|FG001|Overall Study|Stop Dialysis|1|||
160632477|NCT00077766|580034298|FG000|Overall Study|Participants Vacation|2|||
160632478|NCT00077766|580034299|FG001|Overall Study|Participants Vacation|1|||
160632479|NCT01154673|580034307|FG000|Overall Study|Lost to Follow-up|1|||
160632480|NCT01154673|580034308|FG001|Overall Study|Lost to Follow-up|0|||
160632481|NCT01154673|580034307|FG000|Overall Study|moved out of province|1|||
160632482|NCT01154673|580034308|FG001|Overall Study|moved out of province|0|||
160632483|NCT03409328|580034314|FG000|Overall Study|Lost to Follow-up|6|||
160632484|NCT03409328|580034315|FG001|Overall Study|Lost to Follow-up|3|||
160632485|NCT02998645|580034316|FG000|Treatment Period 1|Adverse Event|6|||
160632486|NCT02998645|580034316|FG000|Treatment Period 1|Death|5|||
160632487|NCT02998645|580034316|FG000|Treatment Period 1|Technical Problems|4|||
160632488|NCT02998645|580034316|FG000|Treatment Period 1|Lack of Efficacy|2|||
160632489|NCT02998645|580034316|FG000|Treatment Period 1|Progressive disease|1|||
160632490|NCT02998645|580034316|FG000|Treatment Period 1|Subject/guardian decision|1|||
160632491|NCT02998645|580034316|FG000|Treatment Period 2|Lack of Efficacy|5|||
160632492|NCT02998645|580034316|FG000|Treatment Period 2|Adverse Event|2|||
160632493|NCT02998645|580034316|FG000|Treatment Period 2|Progressive disease|2|||
160632494|NCT02998645|580034316|FG000|Treatment Period 2|Physician Decision|1|||
160632495|NCT00478673|580034317|FG000|30-Days Post-Procedure|Death|2|||
160632496|NCT00478673|580034317|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
160632497|NCT00478673|580034317|FG000|30-Days Post-Procedure|Missed Visit|7|||
160632498|NCT00478673|580034317|FG000|12-Months Post-Procedure|Death|23|||
160632499|NCT00478673|580034317|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
160632500|NCT00478673|580034317|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
160632501|NCT00478673|580034317|FG000|12-Months Post-Procedure|Missed Visit|25|||
160632502|NCT00478673|580034317|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
160674816|NCT01139762|580187671|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
160674817|NCT01139762|580187672|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
160674818|NCT00874276|580187673|FG000|Overall Study|Withdrawal by Subject|1|||
160674819|NCT00874276|580187674|FG001|Overall Study|Withdrawal by Subject|1|||
160674820|NCT04236596|580187675|FG000|Overall Study|Withdrawal by Subject|1|||
160674821|NCT04236596|580187675|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
160674822|NCT04236596|580187675|FG000|Overall Study|Participants did not receive implant at all|4|||
160674823|NCT01894230|580188989|FG000|Overall Study|Lost to Follow-up|2|||
160674824|NCT01894230|580188990|FG001|Overall Study|Lost to Follow-up|2|||
160674825|NCT01894230|580188989|FG000|Overall Study|Withdrawal by Subject|4|||
160674826|NCT01894230|580188990|FG001|Overall Study|Withdrawal by Subject|4|||
160674827|NCT01894230|580188989|FG000|Overall Study|Non-adherent|0|||
160674828|NCT01894230|580188990|FG001|Overall Study|Non-adherent|1|||
160674829|NCT01894230|580188989|FG000|Overall Study|Death|1|||
160674830|NCT01894230|580188990|FG001|Overall Study|Death|0|||
160674831|NCT02300987|580188991|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
160674832|NCT02300987|580188992|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
160674833|NCT02300987|580188991|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
160674834|NCT02300987|580188992|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
160674835|NCT02300987|580188991|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
160674836|NCT02300987|580188992|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
160674837|NCT02300987|580188991|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
160674838|NCT02300987|580188992|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
160674839|NCT02300987|580188991|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
160674840|NCT02300987|580188992|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
160674841|NCT02219009|580188993|FG000|Overall Study|Withdrawal by Subject|5|||
160674842|NCT02219009|580188994|FG001|Overall Study|Withdrawal by Subject|1|||
160674843|NCT02219009|580188993|FG000|Overall Study|Adverse Event|2|||
160674844|NCT02219009|580188994|FG001|Overall Study|Adverse Event|4|||
160674845|NCT02219009|580188993|FG000|Overall Study|Lost to Follow-up|2|||
160674846|NCT02219009|580188994|FG001|Overall Study|Lost to Follow-up|2|||
160674847|NCT02219009|580188993|FG000|Overall Study|Protocol deviation|1|||
160674848|NCT02219009|580188994|FG001|Overall Study|Protocol deviation|0|||
160674849|NCT02219009|580188993|FG000|Overall Study|Physician Decision|0|||
160674850|NCT02219009|580188994|FG001|Overall Study|Physician Decision|1|||
160674851|NCT04408924|580188995|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
160674852|NCT04408924|580188995|FG000|Overall Study|Lost to Follow-up|3|||
160674853|NCT04408924|580188995|FG000|Overall Study|Withdrawal by Subject|5|||
160674854|NCT04408924|580188995|FG000|Overall Study|Sponsor Decision|2|||
160674855|NCT00486434|580188996|FG000|Overall Study|Withdrawal by Subject|34|||
160674856|NCT00486434|580188997|FG001|Overall Study|Withdrawal by Subject|39|||
160674857|NCT00486434|580188996|FG000|Overall Study|Adverse Event|118|||
160674858|NCT00486434|580188997|FG001|Overall Study|Adverse Event|44|||
160674859|NCT00486434|580188996|FG000|Overall Study|Protocol Violation|22|||
160674860|NCT00486434|580188997|FG001|Overall Study|Protocol Violation|21|||
160674861|NCT00486434|580188996|FG000|Overall Study|Lack of Efficacy|12|||
160674862|NCT00486434|580188997|FG001|Overall Study|Lack of Efficacy|19|||
160674863|NCT00486434|580188996|FG000|Overall Study|Lost to Follow-up|2|||
160674864|NCT00486434|580188997|FG001|Overall Study|Lost to Follow-up|3|||
160674865|NCT00486434|580188996|FG000|Overall Study|Death|1|||
160674866|NCT00486434|580188997|FG001|Overall Study|Death|2|||
160674867|NCT00486434|580188996|FG000|Overall Study|Personal reasons|5|||
160674868|NCT00486434|580188997|FG001|Overall Study|Personal reasons|6|||
160674869|NCT02218541|580188998|FG000|Overall Study|Lost to Follow-up|2|||
160674870|NCT02218541|580188999|FG001|Overall Study|Lost to Follow-up|1|||
160674871|NCT02218541|580188998|FG000|Overall Study|Implant Failure|4|||
160674872|NCT02218541|580188999|FG001|Overall Study|Implant Failure|1|||
160674873|NCT04165824|580189002|FG000|Overall Study|Adverse Event|23|||
160674874|NCT04165824|580189002|FG000|Overall Study|Physician Decision|1|||
160674875|NCT04165824|580189002|FG000|Overall Study|Withdrawal by Subject|17|||
160674876|NCT04165824|580189002|FG000|Overall Study|Other|5|||
160674877|NCT03036930|580189003|FG000|Overall Study|Lost to Follow-up|7|||
160674878|NCT03036930|580189003|FG000|Overall Study|Withdrawal by Subject|3|||
160674879|NCT03036930|580189003|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
160674880|NCT01513239|580189005|FG000|Period 1: Main Phase|Adverse Event|1|||
160674881|NCT01513239|580189006|FG001|Period 1: Main Phase|Adverse Event|1|||
160674882|NCT01513239|580189007|FG002|Period 1: Main Phase|Adverse Event|2|||
160674883|NCT01513239|580189008|FG003|Period 1: Main Phase|Adverse Event|0|||
160674884|NCT01513239|580189009|FG004|Period 1: Main Phase|Adverse Event|0|||
160674885|NCT01513239|580189010|FG005|Period 1: Main Phase|Adverse Event|0|||
160674886|NCT01513239|580189005|FG000|Period 1: Main Phase|Death|29|||
160674887|NCT01513239|580189006|FG001|Period 1: Main Phase|Death|22|||
160674888|NCT01513239|580189007|FG002|Period 1: Main Phase|Death|32|||
160674889|NCT01513239|580189008|FG003|Period 1: Main Phase|Death|0|||
160674890|NCT01513239|580189009|FG004|Period 1: Main Phase|Death|0|||
160674891|NCT01513239|580189010|FG005|Period 1: Main Phase|Death|0|||
160674892|NCT01513239|580189005|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
160674893|NCT01513239|580189006|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
160674894|NCT01513239|580189007|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
160674895|NCT01513239|580189008|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
160674896|NCT01513239|580189009|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
160674897|NCT01513239|580189010|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
160674898|NCT01513239|580189005|FG000|Period 1: Main Phase|Physician Decision|4|||
160674899|NCT01513239|580189006|FG001|Period 1: Main Phase|Physician Decision|4|||
160674900|NCT01513239|580189007|FG002|Period 1: Main Phase|Physician Decision|4|||
160674901|NCT01513239|580189008|FG003|Period 1: Main Phase|Physician Decision|0|||
160674902|NCT01513239|580189009|FG004|Period 1: Main Phase|Physician Decision|0|||
160674903|NCT01513239|580189010|FG005|Period 1: Main Phase|Physician Decision|0|||
160674904|NCT01513239|580189005|FG000|Period 1: Main Phase|Protocol Violation|2|||
160674905|NCT01513239|580189006|FG001|Period 1: Main Phase|Protocol Violation|2|||
160674906|NCT01513239|580189007|FG002|Period 1: Main Phase|Protocol Violation|2|||
160674907|NCT01513239|580189008|FG003|Period 1: Main Phase|Protocol Violation|0|||
160674908|NCT01513239|580189009|FG004|Period 1: Main Phase|Protocol Violation|0|||
160674909|NCT01513239|580189010|FG005|Period 1: Main Phase|Protocol Violation|0|||
160674910|NCT01513239|580189005|FG000|Period 1: Main Phase|Technical Problems|1|||
160674911|NCT01513239|580189006|FG001|Period 1: Main Phase|Technical Problems|2|||
160674912|NCT01513239|580189007|FG002|Period 1: Main Phase|Technical Problems|0|||
160674913|NCT01513239|580189008|FG003|Period 1: Main Phase|Technical Problems|0|||
160674914|NCT01513239|580189009|FG004|Period 1: Main Phase|Technical Problems|0|||
160674915|NCT01513239|580189010|FG005|Period 1: Main Phase|Technical Problems|0|||
160674916|NCT01513239|580189005|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
160674917|NCT01513239|580189006|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
160674918|NCT01513239|580189007|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
160674919|NCT01513239|580189008|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
160674920|NCT01513239|580189009|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
160674921|NCT01513239|580189010|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
160674922|NCT01513239|580189005|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
160674923|NCT01513239|580189006|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
160674924|NCT01513239|580189007|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
160674925|NCT01513239|580189008|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
160674926|NCT01513239|580189009|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
160674927|NCT01513239|580189010|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
160674928|NCT01513239|580189005|FG000|Period 2: 9 Month Extension Phase|Death|0|||
160674929|NCT01513239|580189006|FG001|Period 2: 9 Month Extension Phase|Death|0|||
160674930|NCT01513239|580189007|FG002|Period 2: 9 Month Extension Phase|Death|0|||
160674931|NCT01513239|580189008|FG003|Period 2: 9 Month Extension Phase|Death|2|||
160674932|NCT01513239|580189009|FG004|Period 2: 9 Month Extension Phase|Death|5|||
160674933|NCT01513239|580189010|FG005|Period 2: 9 Month Extension Phase|Death|2|||
160674934|NCT01513239|580189005|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
160674935|NCT01513239|580189006|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
160674936|NCT01513239|580189007|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
160674937|NCT01513239|580189008|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
160674938|NCT01513239|580189009|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
160674939|NCT01513239|580189010|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
160674940|NCT01513239|580189005|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
160674941|NCT01513239|580189006|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
160674942|NCT01513239|580189007|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
160674943|NCT01513239|580189008|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
160674944|NCT01513239|580189009|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
160674945|NCT01513239|580189010|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
160674946|NCT01513239|580189005|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
160674947|NCT01513239|580189006|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
160674948|NCT01513239|580189007|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
160674949|NCT01513239|580189008|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
160674950|NCT01513239|580189009|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
160674951|NCT01513239|580189010|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
160674952|NCT00396162|580189011|FG000|Overall Study|Withdrawal by Subject|2|||
160674953|NCT00396162|580189012|FG001|Overall Study|Withdrawal by Subject|3|||
160674954|NCT02694536|580189013|FG000|Overall Study|Progressive Disease|40|||
160674955|NCT02694536|580189013|FG000|Overall Study|Lost to Follow-up|1|||
160674956|NCT02694536|580189013|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
160674957|NCT02694536|580189013|FG000|Overall Study|Withdrawal by Subject|8|||
160674958|NCT02694536|580189013|FG000|Overall Study|Death|8|||
160674959|NCT02694536|580189013|FG000|Overall Study|Other|22|||
160674960|NCT01911429|580189014|FG000|Overall Study|Adverse Event|5|||
160674961|NCT01911429|580189015|FG001|Overall Study|Adverse Event|3|||
160674962|NCT01911429|580189016|FG002|Overall Study|Adverse Event|9|||
160674963|NCT01911429|580189014|FG000|Overall Study|Lack of Efficacy|1|||
160632503|NCT03701516|580034318|FG000|Period 1|Lost to Follow-up|0|||
160632504|NCT03701516|580034319|FG001|Period 1|Lost to Follow-up|1|||
160632505|NCT03701516|580034318|FG000|Period 1|Adverse Event|0|||
160632506|NCT03701516|580034319|FG001|Period 1|Adverse Event|2|||
160632507|NCT03701516|580034318|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
160632508|NCT03701516|580034319|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
160632509|NCT03701516|580034318|FG000|Period 1|Non Compliance to Protocol|2|||
160632510|NCT03701516|580034319|FG001|Period 1|Non Compliance to Protocol|1|||
160632511|NCT03701516|580034318|FG000|Period 1|Withdrawal by Subject|0|||
160632512|NCT03701516|580034319|FG001|Period 1|Withdrawal by Subject|1|||
160632513|NCT03701516|580034318|FG000|Period 2|failed to meet all eligibility creiteria|1|||
160632514|NCT03701516|580034319|FG001|Period 2|failed to meet all eligibility creiteria|0|||
160632515|NCT03701516|580034318|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
160632516|NCT03701516|580034319|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
160632517|NCT03930615|580034320|FG000|Overall Study|Death|9|||
160632518|NCT03930615|580034321|FG001|Overall Study|Death|3|||
160632519|NCT03930615|580034320|FG000|Overall Study|Lost to Follow-up|1|||
160632520|NCT03930615|580034321|FG001|Overall Study|Lost to Follow-up|2|||
160632521|NCT03930615|580034320|FG000|Overall Study|Physician Decision|3|||
160632522|NCT03930615|580034321|FG001|Overall Study|Physician Decision|4|||
160632523|NCT03930615|580034320|FG000|Overall Study|Withdrawal by Subject|13|||
160632524|NCT03930615|580034321|FG001|Overall Study|Withdrawal by Subject|2|||
160632525|NCT03930615|580034320|FG000|Overall Study|Not treated|1|||
160632526|NCT03930615|580034321|FG001|Overall Study|Not treated|1|||
160632527|NCT03644927|580034322|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
160632528|NCT03644927|580034323|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
160632529|NCT00956813|580034324|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
160632530|NCT00956813|580034325|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
160632531|NCT00956813|580034324|FG000|Flaxseed and Placebo|Ineligible|3|||
160632532|NCT00956813|580034325|FG001|Flaxseed and Placebo|Ineligible|1|||
160632533|NCT02380248|580034326|FG000|Overall Study|Lost to Follow-up|11|||
160632534|NCT02380248|580034326|FG000|Overall Study|Withdrawal by Subject|3|||
160632535|NCT02864953|580034327|FG000|Overall Study|Adverse Event|22|||
160632536|NCT02864953|580034328|FG001|Overall Study|Adverse Event|19|||
160632537|NCT02864953|580034327|FG000|Overall Study|Withdrawal by Subject|1|||
160632538|NCT02864953|580034328|FG001|Overall Study|Withdrawal by Subject|0|||
160632539|NCT02864953|580034327|FG000|Overall Study|Physician Decision|4|||
160632540|NCT02864953|580034328|FG001|Overall Study|Physician Decision|2|||
160632541|NCT02864953|580034327|FG000|Overall Study|Death|3|||
160632542|NCT02864953|580034328|FG001|Overall Study|Death|13|||
160632543|NCT02864953|580034327|FG000|Overall Study|Reason not specified|14|||
160632544|NCT02864953|580034328|FG001|Overall Study|Reason not specified|12|||
160632545|NCT02864953|580034327|FG000|Overall Study|Withdrew Prior to Dosing|9|||
160632546|NCT02864953|580034328|FG001|Overall Study|Withdrew Prior to Dosing|8|||
160632547|NCT00981019|580034329|FG000|Overall Study|Did not respond|65|||
160632548|NCT00981019|580034329|FG000|Overall Study|Did not match target population|94|||
160632549|NCT00981019|580034329|FG000|Overall Study|Inadvertent exclusion|239|||
160632550|NCT00981019|580034329|FG000|Overall Study|Hit the survey after closure|79|||
160632551|NCT00358670|580034330|FG000|Overall Study|Adverse Event|26|||
160632552|NCT00358670|580034331|FG001|Overall Study|Adverse Event|29|||
160632553|NCT00358670|580034330|FG000|Overall Study|Lack of Efficacy|20|||
160632554|NCT00358670|580034331|FG001|Overall Study|Lack of Efficacy|23|||
160632555|NCT00358670|580034330|FG000|Overall Study|Protocol Violation|6|||
160632556|NCT00358670|580034331|FG001|Overall Study|Protocol Violation|9|||
160632557|NCT00358670|580034330|FG000|Overall Study|Lost to Follow-up|4|||
160632558|NCT00358670|580034331|FG001|Overall Study|Lost to Follow-up|5|||
160632559|NCT00358670|580034330|FG000|Overall Study|Withdrawal by Subject|13|||
160632560|NCT00358670|580034331|FG001|Overall Study|Withdrawal by Subject|24|||
160632561|NCT00358670|580034330|FG000|Overall Study|Protocol Defined Clinical Event|0|||
160632562|NCT00358670|580034331|FG001|Overall Study|Protocol Defined Clinical Event|1|||
160632563|NCT00358670|580034330|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
160632564|NCT00358670|580034331|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
160632565|NCT00358670|580034330|FG000|Overall Study|Administrative|153|||
160632566|NCT00358670|580034331|FG001|Overall Study|Administrative|125|||
160632567|NCT00865306|580034332|FG000|Controlled Trial|Lost to Follow-up|1|||
160632568|NCT00865306|580034333|FG001|Controlled Trial|Lost to Follow-up|1|||
160632569|NCT00865306|580034332|FG000|Controlled Trial|Difficulty commuting|2|||
160632570|NCT00865306|580034333|FG001|Controlled Trial|Difficulty commuting|0|||
160632571|NCT00865306|580034332|FG000|Controlled Trial|Improved btw baseline and first session|1|||
160632572|NCT00865306|580034333|FG001|Controlled Trial|Improved btw baseline and first session|0|||
160632573|NCT00865306|580034332|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
160632574|NCT00865306|580034333|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
160632575|NCT00865306|580034332|FG000|Controlled Trial|Withdrawal by Subject|0|||
160632576|NCT00865306|580034333|FG001|Controlled Trial|Withdrawal by Subject|1|||
160632577|NCT05083559|580034334|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
160674964|NCT01911429|580189015|FG001|Overall Study|Lack of Efficacy|2|||
160674965|NCT01911429|580189016|FG002|Overall Study|Lack of Efficacy|4|||
160674966|NCT01911429|580189014|FG000|Overall Study|Lost to Follow-up|0|||
160674967|NCT01911429|580189015|FG001|Overall Study|Lost to Follow-up|0|||
160674968|NCT01911429|580189016|FG002|Overall Study|Lost to Follow-up|1|||
160674969|NCT01911429|580189014|FG000|Overall Study|Protocol Violation|0|||
160674970|NCT01911429|580189015|FG001|Overall Study|Protocol Violation|0|||
160674971|NCT01911429|580189016|FG002|Overall Study|Protocol Violation|1|||
160674972|NCT01911429|580189014|FG000|Overall Study|Withdrawal by Subject|5|||
160674973|NCT01911429|580189015|FG001|Overall Study|Withdrawal by Subject|5|||
160674974|NCT01911429|580189016|FG002|Overall Study|Withdrawal by Subject|4|||
160674975|NCT01911429|580189014|FG000|Overall Study|Accidental randomization|0|||
160674976|NCT01911429|580189015|FG001|Overall Study|Accidental randomization|0|||
160674977|NCT01911429|580189016|FG002|Overall Study|Accidental randomization|1|||
160674978|NCT01911429|580189014|FG000|Overall Study|subject left study|1|||
160674979|NCT01911429|580189015|FG001|Overall Study|subject left study|0|||
160674980|NCT01911429|580189016|FG002|Overall Study|subject left study|0|||
160674981|NCT03599362|580189018|FG000|Overall Study|Screen Failure|3|||
160674982|NCT03707587|580189019|FG000|Overall Study|Death|0|||
160674983|NCT03707587|580189020|FG001|Overall Study|Death|1|||
160674984|NCT01634139|580189022|FG000|Overall Study|Non compliant with protocol|1|||
160674985|NCT01634139|580189023|FG001|Overall Study|Non compliant with protocol|0|||
160674986|NCT01634139|580189024|FG002|Overall Study|Non compliant with protocol|0|||
160674987|NCT01634139|580189022|FG000|Overall Study|Consent withdrawn not due to AE|4|||
160674988|NCT01634139|580189023|FG001|Overall Study|Consent withdrawn not due to AE|3|||
160674989|NCT01634139|580189024|FG002|Overall Study|Consent withdrawn not due to AE|2|||
160674990|NCT01634139|580189022|FG000|Overall Study|Other|4|||
160674991|NCT01634139|580189023|FG001|Overall Study|Other|0|||
160674992|NCT01634139|580189024|FG002|Overall Study|Other|3|||
160674993|NCT01634139|580189022|FG000|Overall Study|Lost to Follow-up|0|||
160674994|NCT01634139|580189023|FG001|Overall Study|Lost to Follow-up|2|||
160674995|NCT01634139|580189024|FG002|Overall Study|Lost to Follow-up|0|||
160674996|NCT01634139|580189022|FG000|Overall Study|Not treated|1|||
160674997|NCT01634139|580189023|FG001|Overall Study|Not treated|1|||
160674998|NCT01634139|580189024|FG002|Overall Study|Not treated|0|||
160674999|NCT05562011|580189034|FG000|Overall Study|Withdrawal by Subject|3|||
160675000|NCT05562011|580189034|FG000|Overall Study|Lost to Follow-up|1|||
160675001|NCT05562011|580189034|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
160675002|NCT05562011|580189034|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
160675003|NCT05562011|580189034|FG000|Overall Study|Device malfunction|13|||
160675004|NCT04411680|580189035|FG000|Treatment Period|Adverse Event|3|||
160675005|NCT04411680|580189036|FG001|Treatment Period|Adverse Event|0|||
160675006|NCT04411680|580189035|FG000|Treatment Period|Discharged from hospital|18|||
160675007|NCT04411680|580189036|FG001|Treatment Period|Discharged from hospital|7|||
160675008|NCT04411680|580189035|FG000|Treatment Period|Missed 1 or more doses|8|||
160675009|NCT04411680|580189036|FG001|Treatment Period|Missed 1 or more doses|0|||
160675010|NCT04411680|580189035|FG000|Treatment Period|Transferred to another hospital|0|||
160675011|NCT04411680|580189036|FG001|Treatment Period|Transferred to another hospital|1|||
160675012|NCT04411680|580189035|FG000|Follow up Period|Withdrawal by Subject|2|||
160675013|NCT04411680|580189036|FG001|Follow up Period|Withdrawal by Subject|0|||
160675014|NCT04411680|580189035|FG000|Follow up Period|Lost to Follow-up|5|||
160675015|NCT04411680|580189036|FG001|Follow up Period|Lost to Follow-up|6|||
160675016|NCT04411680|580189035|FG000|Follow up Period|Death|11|||
160675017|NCT04411680|580189036|FG001|Follow up Period|Death|8|||
160675018|NCT05034874|580189037|FG000|Overall Study|Withdrawal by Subject|6|||
160675019|NCT05034874|580189038|FG001|Overall Study|Withdrawal by Subject|6|||
160675020|NCT05034874|580189037|FG000|Overall Study|Lost to Follow-up|18|||
160675021|NCT05034874|580189038|FG001|Overall Study|Lost to Follow-up|8|||
160675022|NCT05034874|580189037|FG000|Overall Study|Physician Decision|0|||
160675023|NCT05034874|580189038|FG001|Overall Study|Physician Decision|1|||
160675024|NCT05034874|580189037|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
160675025|NCT05034874|580189038|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
160675026|NCT01867658|580189039|FG000|Overall Study|Withdrawal by Subject|6|||
160675027|NCT01867658|580189039|FG000|Overall Study|Death|2|||
160675028|NCT01867658|580189039|FG000|Overall Study|Subject could not be contacted|1|||
160675029|NCT03101358|580189040|FG000|Overall Study|Non-compliance with study schedule|1|||
160675030|NCT03101358|580189041|FG001|Overall Study|Non-compliance with study schedule|0|||
160675031|NCT03101358|580189042|FG002|Overall Study|Non-compliance with study schedule|0|||
160675032|NCT03101358|580189043|FG003|Overall Study|Non-compliance with study schedule|1|||
160675033|NCT03101358|580189040|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
160675034|NCT03101358|580189041|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
160675035|NCT03101358|580189042|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
160675036|NCT03101358|580189043|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
160675037|NCT03101358|580189040|FG000|Overall Study|Physician Decision|1|||
160675038|NCT03101358|580189041|FG001|Overall Study|Physician Decision|0|||
160675039|NCT03101358|580189042|FG002|Overall Study|Physician Decision|0|||
160675040|NCT03101358|580189043|FG003|Overall Study|Physician Decision|3|||
160675041|NCT03101358|580189040|FG000|Overall Study|Adverse Event|0|||
160675042|NCT03101358|580189041|FG001|Overall Study|Adverse Event|0|||
160675043|NCT03101358|580189042|FG002|Overall Study|Adverse Event|1|||
160675044|NCT03101358|580189043|FG003|Overall Study|Adverse Event|0|||
160675045|NCT03101358|580189040|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
160675046|NCT03101358|580189041|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
160675047|NCT03101358|580189042|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
160675048|NCT03101358|580189043|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
160675049|NCT03101358|580189040|FG000|Overall Study|Lost to Follow-up|1|||
160675050|NCT03101358|580189041|FG001|Overall Study|Lost to Follow-up|0|||
160675051|NCT03101358|580189042|FG002|Overall Study|Lost to Follow-up|0|||
160675052|NCT03101358|580189043|FG003|Overall Study|Lost to Follow-up|1|||
160675053|NCT02640235|580189044|FG000|Overall Study|Withdrawal by Subject|7|||
160675054|NCT02640235|580189045|FG001|Overall Study|Withdrawal by Subject|6|||
160675055|NCT02640235|580189044|FG000|Overall Study|Lost to Follow-up|4|||
160675056|NCT02640235|580189045|FG001|Overall Study|Lost to Follow-up|3|||
160675057|NCT02640235|580189044|FG000|Overall Study|Death|2|||
160675058|NCT02640235|580189045|FG001|Overall Study|Death|3|||
160675059|NCT02640235|580189044|FG000|Overall Study|Other|1|||
160675060|NCT02640235|580189045|FG001|Overall Study|Other|2|||
160675061|NCT02426918|580189046|FG000|Overall Study|Adverse Event|2|||
160675062|NCT02426918|580189047|FG001|Overall Study|Adverse Event|2|||
160675063|NCT02426918|580189048|FG002|Overall Study|Adverse Event|0|||
160675064|NCT02426918|580189046|FG000|Overall Study|Physician Decision|1|||
160675065|NCT02426918|580189047|FG001|Overall Study|Physician Decision|1|||
160675066|NCT02426918|580189048|FG002|Overall Study|Physician Decision|1|||
160675067|NCT02426918|580189046|FG000|Overall Study|Withdrawal by Subject|5|||
160675068|NCT02426918|580189047|FG001|Overall Study|Withdrawal by Subject|5|||
160675069|NCT02426918|580189048|FG002|Overall Study|Withdrawal by Subject|4|||
160675070|NCT02426918|580189046|FG000|Overall Study|Other|9|||
160675071|NCT02426918|580189047|FG001|Overall Study|Other|11|||
160675072|NCT02426918|580189048|FG002|Overall Study|Other|9|||
160675073|NCT01496118|580189049|FG000|Overall Study|Disease progression|3|||
160675074|NCT01496118|580189050|FG001|Overall Study|Disease progression|2|||
160675075|NCT01496118|580189051|FG002|Overall Study|Disease progression|3|||
160675076|NCT01496118|580189052|FG003|Overall Study|Disease progression|1|||
160675077|NCT01496118|580189053|FG004|Overall Study|Disease progression|2|||
160675078|NCT01496118|580189054|FG005|Overall Study|Disease progression|2|||
160675079|NCT01496118|580189055|FG006|Overall Study|Disease progression|14|||
160675080|NCT01496118|580189056|FG007|Overall Study|Disease progression|10|||
160675081|NCT01496118|580189049|FG000|Overall Study|Physician Decision|0|||
160675082|NCT01496118|580189050|FG001|Overall Study|Physician Decision|0|||
160675083|NCT01496118|580189051|FG002|Overall Study|Physician Decision|0|||
160675084|NCT01496118|580189052|FG003|Overall Study|Physician Decision|0|||
160675085|NCT01496118|580189053|FG004|Overall Study|Physician Decision|1|||
160675086|NCT01496118|580189054|FG005|Overall Study|Physician Decision|0|||
160675087|NCT01496118|580189055|FG006|Overall Study|Physician Decision|3|||
160675088|NCT01496118|580189056|FG007|Overall Study|Physician Decision|6|||
160675089|NCT01496118|580189049|FG000|Overall Study|Adverse Event|1|||
160675090|NCT01496118|580189050|FG001|Overall Study|Adverse Event|1|||
160675091|NCT01496118|580189051|FG002|Overall Study|Adverse Event|0|||
160675092|NCT01496118|580189052|FG003|Overall Study|Adverse Event|0|||
160675093|NCT01496118|580189053|FG004|Overall Study|Adverse Event|0|||
160675094|NCT01496118|580189054|FG005|Overall Study|Adverse Event|0|||
160675095|NCT01496118|580189055|FG006|Overall Study|Adverse Event|6|||
160675096|NCT01496118|580189056|FG007|Overall Study|Adverse Event|10|||
160675097|NCT01496118|580189049|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
160675098|NCT01496118|580189050|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
160675099|NCT01496118|580189051|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
160675100|NCT01496118|580189052|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
160675101|NCT01496118|580189053|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
160675102|NCT01496118|580189054|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
160675103|NCT01496118|580189055|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
160675104|NCT01496118|580189056|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
160675105|NCT01496118|580189049|FG000|Overall Study|Death|0|||
160675106|NCT01496118|580189050|FG001|Overall Study|Death|0|||
160675107|NCT01496118|580189051|FG002|Overall Study|Death|0|||
160675108|NCT01496118|580189052|FG003|Overall Study|Death|0|||
160675109|NCT01496118|580189053|FG004|Overall Study|Death|0|||
160675110|NCT01496118|580189054|FG005|Overall Study|Death|0|||
160675111|NCT01496118|580189055|FG006|Overall Study|Death|1|||
160675112|NCT01496118|580189056|FG007|Overall Study|Death|1|||
160675113|NCT01496118|580189049|FG000|Overall Study|Withdrawal by Subject|0|||
160675114|NCT01496118|580189050|FG001|Overall Study|Withdrawal by Subject|0|||
160675115|NCT01496118|580189051|FG002|Overall Study|Withdrawal by Subject|0|||
160675116|NCT01496118|580189052|FG003|Overall Study|Withdrawal by Subject|2|||
160675117|NCT01496118|580189053|FG004|Overall Study|Withdrawal by Subject|0|||
160675118|NCT01496118|580189054|FG005|Overall Study|Withdrawal by Subject|1|||
160675119|NCT01496118|580189055|FG006|Overall Study|Withdrawal by Subject|6|||
160675120|NCT01496118|580189056|FG007|Overall Study|Withdrawal by Subject|3|||
160675121|NCT00841659|580189057|FG000|Washout: 2 Weeks|Protocol Violation|1|||
160675122|NCT00841659|580189058|FG001|Washout: 2 Weeks|Protocol Violation|0|||
160675123|NCT02420353|580189059|FG000|Overall Study|Withdrawal by Subject|0|||
160675124|NCT02420353|580189060|FG001|Overall Study|Withdrawal by Subject|1|||
160675125|NCT00503867|580189064|FG000|Overall Study|Lost to Follow-up|1|||
160675126|NCT00503867|580189064|FG000|Overall Study|Adverse Event|1|||
160675127|NCT04608448|580189065|FG000|Overall Study|Withdrawal by Subject|1|||
160675128|NCT04608448|580189065|FG000|Overall Study|Adverse Event|1|||
160675129|NCT00654186|580189066|FG000|Overall Study|Withdrawal by Subject|5|||
160675130|NCT05616728|580189067|FG000|Overall Study|Lost to Follow-up|0|||
160675131|NCT05616728|580189068|FG001|Overall Study|Lost to Follow-up|0|||
160675132|NCT05616728|580189069|FG002|Overall Study|Lost to Follow-up|1|||
160675133|NCT05616728|580189067|FG000|Overall Study|Withdrawal by Subject|1|||
160675134|NCT05616728|580189068|FG001|Overall Study|Withdrawal by Subject|1|||
160675135|NCT05616728|580189069|FG002|Overall Study|Withdrawal by Subject|0|||
160675136|NCT05616728|580189067|FG000|Overall Study|Physician Decision|1|||
160675137|NCT05616728|580189068|FG001|Overall Study|Physician Decision|1|||
160675138|NCT05616728|580189069|FG002|Overall Study|Physician Decision|1|||
160675139|NCT05616728|580189067|FG000|Overall Study|Other|0|||
160675140|NCT05616728|580189068|FG001|Overall Study|Other|2|||
160675141|NCT05616728|580189069|FG002|Overall Study|Other|0|||
160675142|NCT01024855|580189072|FG000|Overall Study|Inclusion/exclusion criteria|1|||
160675143|NCT00577655|580189073|FG000|Overall Study|Patient Request|0|||
160675144|NCT00577655|580189074|FG001|Overall Study|Patient Request|2|||
160675145|NCT00577655|580189073|FG000|Overall Study|Protocol Violation|0|||
160675146|NCT00577655|580189074|FG001|Overall Study|Protocol Violation|1|||
160675147|NCT00577655|580189073|FG000|Overall Study|Lost to Follow-up|1|||
160675148|NCT00577655|580189074|FG001|Overall Study|Lost to Follow-up|1|||
160675149|NCT05004649|580189084|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
160675150|NCT05004649|580189084|FG000|Overall Study|Lost to Follow-up|1|||
160675151|NCT05004649|580189084|FG000|Overall Study|Withdrawal by Subject|2|||
160675152|NCT05004649|580189084|FG000|Overall Study|COVID-19|1|||
160675153|NCT00301964|580189085|FG000|Overall Study|Second primary|2|||
160675154|NCT00301964|580189085|FG000|Overall Study|Wrong primary|1|||
160675155|NCT00301964|580189085|FG000|Overall Study|Inadequate pathology|1|||
160675156|NCT02385708|580189086|FG000|Overall Study|Withdrawal by Subject|0|||
160675157|NCT02385708|580189087|FG001|Overall Study|Withdrawal by Subject|2|||
160675158|NCT02385708|580189086|FG000|Overall Study|Withdrawn - surgery canceled|2|||
160675159|NCT02385708|580189087|FG001|Overall Study|Withdrawn - surgery canceled|5|||
160675160|NCT02385708|580189086|FG000|Overall Study|Investigator decision|5|||
160675161|NCT02385708|580189087|FG001|Overall Study|Investigator decision|7|||
160675162|NCT02385708|580189086|FG000|Overall Study|Protocol Violation|1|||
160675163|NCT02385708|580189087|FG001|Overall Study|Protocol Violation|1|||
160675164|NCT02761915|580189089|FG000|Overall Study|Death|3|||
160675165|NCT02761915|580189090|FG001|Overall Study|Death|1|||
160675166|NCT02761915|580189091|FG002|Overall Study|Death|1|||
160675167|NCT02761915|580189092|FG003|Overall Study|Death|1|||
160675168|NCT02761915|580189093|FG004|Overall Study|Death|0|||
160675169|NCT02761915|580189094|FG005|Overall Study|Death|1|||
160675170|NCT02761915|580189089|FG000|Overall Study|Withdrawal by Subject|1|||
160675171|NCT02761915|580189090|FG001|Overall Study|Withdrawal by Subject|0|||
160675172|NCT02761915|580189091|FG002|Overall Study|Withdrawal by Subject|0|||
160675173|NCT02761915|580189092|FG003|Overall Study|Withdrawal by Subject|0|||
160675174|NCT02761915|580189093|FG004|Overall Study|Withdrawal by Subject|1|||
160675175|NCT02761915|580189094|FG005|Overall Study|Withdrawal by Subject|2|||
160675176|NCT02761915|580189089|FG000|Overall Study|Disease Progression|0|||
160675177|NCT02761915|580189090|FG001|Overall Study|Disease Progression|0|||
160675178|NCT02761915|580189091|FG002|Overall Study|Disease Progression|0|||
160675179|NCT02761915|580189092|FG003|Overall Study|Disease Progression|2|||
160675180|NCT02761915|580189093|FG004|Overall Study|Disease Progression|2|||
160675181|NCT02761915|580189094|FG005|Overall Study|Disease Progression|2|||
160675182|NCT02436200|580189095|FG000|Overall Study|Significant outlier|1|||
160675183|NCT02654145|580189102|FG000|Overall Study|Lack of Efficacy|1|||
160675184|NCT02654145|580189102|FG000|Overall Study|Protocol Violation|1|||
160675185|NCT02654145|580189102|FG000|Overall Study|Withdrawal by Subject|5|||
160675186|NCT00354835|580189103|FG000|Overall Study|Death|1|||
160675187|NCT00354835|580189104|FG001|Overall Study|Death|1|||
160675188|NCT00354835|580189103|FG000|Overall Study|Physician Decision|8|||
160675189|NCT00354835|580189104|FG001|Overall Study|Physician Decision|13|||
160675190|NCT00354835|580189103|FG000|Overall Study|Withdrawal by Subject|2|||
160675191|NCT00354835|580189104|FG001|Overall Study|Withdrawal by Subject|1|||
160675192|NCT00354835|580189103|FG000|Overall Study|Ineligible|17|||
160675193|NCT00354835|580189104|FG001|Overall Study|Ineligible|16|||
160675194|NCT00354835|580189103|FG000|Overall Study|Disease progression or relapse|15|||
160675195|NCT00354835|580189104|FG001|Overall Study|Disease progression or relapse|22|||
160675196|NCT00354835|580189103|FG000|Overall Study|Adverse Event|6|||
160675197|NCT00354835|580189104|FG001|Overall Study|Adverse Event|0|||
160675198|NCT00354835|580189103|FG000|Overall Study|Refusal of further therapy|3|||
160675199|NCT00354835|580189104|FG001|Overall Study|Refusal of further therapy|8|||
160675200|NCT06475729|580189105|FG000|Overall Study|Withdrawal by Subject|2|||
160675201|NCT06475729|580189106|FG001|Overall Study|Withdrawal by Subject|1|||
160675202|NCT06475729|580189105|FG000|Overall Study|Randomized but did not receive any dose|3|||
160675203|NCT06475729|580189106|FG001|Overall Study|Randomized but did not receive any dose|2|||
160675204|NCT06475729|580189105|FG000|Overall Study|Lost to Follow-up|1|||
160675205|NCT06475729|580189106|FG001|Overall Study|Lost to Follow-up|2|||
160675206|NCT06475729|580189105|FG000|Overall Study|Physician Decision|5|||
160675207|NCT06475729|580189106|FG001|Overall Study|Physician Decision|2|||
160675208|NCT06475729|580189105|FG000|Overall Study|Adverse Event|1|||
160675209|NCT06475729|580189106|FG001|Overall Study|Adverse Event|1|||
160675210|NCT01046084|580189110|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
160675211|NCT01046084|580189111|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
160675212|NCT02166606|580189112|FG000|Overall Study|Adverse Event|3|||
160675213|NCT02166606|580189112|FG000|Overall Study|Death|31|||
160675214|NCT02166606|580189112|FG000|Overall Study|Protocol Violation|7|||
160675215|NCT02166606|580189112|FG000|Overall Study|Lost to Follow-up|30|||
160675216|NCT02166606|580189112|FG000|Overall Study|Withdrawal by Subject|1|||
160675217|NCT02166606|580189112|FG000|Overall Study|Physician Decision|1|||
160675218|NCT02166606|580189112|FG000|Overall Study|Device upgrade|1|||
160675219|NCT02166606|580189112|FG000|Overall Study|Enrolled after End of Enrollment|4|||
160675220|NCT01958476|580189113|FG000|Overall Study|Parent requested exclusion from analysis|1|||
160675221|NCT01958476|580189114|FG001|Overall Study|Parent requested exclusion from analysis|0|||
160675222|NCT02943096|580189117|FG000|Overall Study|Lack of Efficacy|0|||
160675223|NCT02943096|580189118|FG001|Overall Study|Lack of Efficacy|1|||
160675224|NCT03868631|580189120|FG000|Baseline to Week 6|Adverse Event|0|||
160675225|NCT03868631|580189121|FG001|Baseline to Week 6|Adverse Event|3|||
160675226|NCT03868631|580189120|FG000|Baseline to Week 6|Protocol Violation|1|||
160675227|NCT03868631|580189121|FG001|Baseline to Week 6|Protocol Violation|1|||
160675228|NCT03868631|580189120|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
160675229|NCT03868631|580189121|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
160675230|NCT03868631|580189120|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
160675231|NCT03868631|580189121|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
160675232|NCT03868631|580189120|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
160675233|NCT03868631|580189121|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
160675234|NCT03868631|580189120|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
160675235|NCT03868631|580189121|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
160675236|NCT02957331|580189124|FG000|Overall Study|Protocol Violation|1|||
160675237|NCT02957331|580189125|FG001|Overall Study|Protocol Violation|0|||
160675238|NCT02588339|580189127|FG000|Overall Study|Withdrawal by Subject|1|||
160675239|NCT02588339|580189127|FG000|Overall Study|GVHD Progression prior to treatment|2|||
160675240|NCT05568615|580190436|FG000|Overall Study|Death|1|||
160675241|NCT05568615|580190436|FG000|Overall Study|Physician Decision|1|||
160675242|NCT00565851|580190437|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
160675243|NCT00565851|580190438|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
160675244|NCT00565851|580190439|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
160675245|NCT00565851|580190440|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
160675246|NCT00565851|580190441|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
160675247|NCT00565851|580190442|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
160675248|NCT00565851|580190443|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
160675249|NCT00565851|580190444|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
160675250|NCT00565851|580190437|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
160675251|NCT00565851|580190438|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
160675252|NCT00565851|580190439|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
160675253|NCT00565851|580190440|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
160675254|NCT00565851|580190441|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
160675255|NCT00565851|580190442|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
160675256|NCT00565851|580190443|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
160675257|NCT00565851|580190444|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
160675258|NCT03291067|580190445|FG000|Overall Study|Adverse Event|0|||
160675259|NCT03291067|580190446|FG001|Overall Study|Adverse Event|2|||
160675260|NCT03291067|580190447|FG002|Overall Study|Adverse Event|17|||
160675261|NCT03291067|580190448|FG003|Overall Study|Adverse Event|3|||
160675262|NCT03291067|580190445|FG000|Overall Study|Lost to Follow-up|2|||
160675263|NCT03291067|580190446|FG001|Overall Study|Lost to Follow-up|1|||
160675264|NCT03291067|580190447|FG002|Overall Study|Lost to Follow-up|0|||
160675265|NCT03291067|580190448|FG003|Overall Study|Lost to Follow-up|1|||
160675266|NCT03291067|580190445|FG000|Overall Study|Physician Decision|0|||
160675267|NCT03291067|580190446|FG001|Overall Study|Physician Decision|0|||
160675268|NCT03291067|580190447|FG002|Overall Study|Physician Decision|1|||
160675269|NCT03291067|580190448|FG003|Overall Study|Physician Decision|0|||
160675270|NCT03291067|580190445|FG000|Overall Study|Protocol Violation|5|||
160675271|NCT03291067|580190446|FG001|Overall Study|Protocol Violation|3|||
160675272|NCT03291067|580190447|FG002|Overall Study|Protocol Violation|4|||
160675273|NCT03291067|580190448|FG003|Overall Study|Protocol Violation|2|||
160675274|NCT03291067|580190445|FG000|Overall Study|Withdrawal by Subject|3|||
160675275|NCT03291067|580190446|FG001|Overall Study|Withdrawal by Subject|4|||
160675276|NCT03291067|580190447|FG002|Overall Study|Withdrawal by Subject|7|||
160675277|NCT03291067|580190448|FG003|Overall Study|Withdrawal by Subject|5|||
160675278|NCT03291067|580190445|FG000|Overall Study|Other|0|||
160675279|NCT03291067|580190446|FG001|Overall Study|Other|4|||
160675280|NCT03291067|580190447|FG002|Overall Study|Other|4|||
160675281|NCT03291067|580190448|FG003|Overall Study|Other|6|||
160675282|NCT01520987|580190456|FG000|Overall Study|Withdrawal by Subject|1|||
160675283|NCT01520987|580190457|FG001|Overall Study|Withdrawal by Subject|0|||
160675284|NCT01520987|580190458|FG002|Overall Study|Withdrawal by Subject|0|||
160675285|NCT01520987|580190459|FG003|Overall Study|Withdrawal by Subject|0|||
160675286|NCT01520987|580190460|FG004|Overall Study|Withdrawal by Subject|0|||
160675287|NCT01520987|580190461|FG005|Overall Study|Withdrawal by Subject|1|||
160675288|NCT01520987|580190462|FG006|Overall Study|Withdrawal by Subject|0|||
160675289|NCT01520987|580190463|FG007|Overall Study|Withdrawal by Subject|0|||
160675290|NCT02005562|580190464|FG000|Overall Study|Death|2|||
160675291|NCT02005562|580190465|FG001|Overall Study|Death|2|||
160675292|NCT02005562|580190464|FG000|Overall Study|Graft loss|7|||
160675293|NCT02005562|580190465|FG001|Overall Study|Graft loss|6|||
160675294|NCT02005562|580190464|FG000|Overall Study|Withdrawal by Subject|2|||
160675295|NCT02005562|580190465|FG001|Overall Study|Withdrawal by Subject|2|||
160675296|NCT02005562|580190464|FG000|Overall Study|No transplant|1|||
160675297|NCT02005562|580190465|FG001|Overall Study|No transplant|4|||
160675298|NCT02005562|580190464|FG000|Overall Study|Physician Decision|0|||
160675299|NCT02005562|580190465|FG001|Overall Study|Physician Decision|1|||
160675300|NCT00660387|580190466|FG000|Overall Study|Adverse Event|1|||
160675301|NCT00660387|580190467|FG001|Overall Study|Adverse Event|2|||
160675302|NCT00660387|580190466|FG000|Overall Study|Lack of Efficacy|0|||
160675303|NCT00660387|580190467|FG001|Overall Study|Lack of Efficacy|1|||
160675304|NCT00660387|580190466|FG000|Overall Study|Protocol Violation|1|||
160675305|NCT00660387|580190467|FG001|Overall Study|Protocol Violation|0|||
160675306|NCT03086135|580190468|FG000|Overall Study|Adverse Event|1|||
160675307|NCT03086135|580190468|FG000|Overall Study|Lost to Follow-up|2|||
160675308|NCT01023061|580190469|FG000|Overall Study|Withdrawal prior to treatment|2|||
160675309|NCT02966340|580190470|FG000|Overall Study|Adverse Event|0|||
160675310|NCT02966340|580190471|FG001|Overall Study|Adverse Event|1|||
160675311|NCT02966340|580190470|FG000|Overall Study|Lost to Follow-up|0|||
160675312|NCT02966340|580190471|FG001|Overall Study|Lost to Follow-up|1|||
160675313|NCT02966340|580190470|FG000|Overall Study|Withdrawal by Subject|1|||
160675314|NCT02966340|580190471|FG001|Overall Study|Withdrawal by Subject|0|||
160675315|NCT02966340|580190470|FG000|Overall Study|data acquisition error|1|||
160675316|NCT02966340|580190471|FG001|Overall Study|data acquisition error|0|||
160675317|NCT02966340|580190470|FG000|Overall Study|startle non-responder|1|||
160675318|NCT02966340|580190471|FG001|Overall Study|startle non-responder|1|||
160675319|NCT00255346|580190479|FG000|Overall Study|Adverse Event|1|||
160675320|NCT00255346|580190480|FG001|Overall Study|Adverse Event|0|||
160675321|NCT00255346|580190481|FG002|Overall Study|Adverse Event|0|||
160675322|NCT00255346|580190482|FG003|Overall Study|Adverse Event|0|||
160675323|NCT00255346|580190483|FG004|Overall Study|Adverse Event|0|||
160675324|NCT04402489|580190485|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
160675325|NCT04402489|580190486|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
160675326|NCT04402489|580190487|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
160675327|NCT04402489|580190488|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
160675328|NCT04402489|580190489|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
160675329|NCT04402489|580190485|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
160675330|NCT04402489|580190486|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
160675331|NCT04402489|580190487|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
160675332|NCT04402489|580190488|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
160675333|NCT04402489|580190489|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
160675334|NCT04402489|580190485|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
160675335|NCT04402489|580190486|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
160675336|NCT04402489|580190487|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
160675337|NCT04402489|580190488|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
160675338|NCT04402489|580190489|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
160675339|NCT04402489|580190485|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
160675340|NCT04402489|580190486|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
160675341|NCT04402489|580190487|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
160675342|NCT04402489|580190488|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
160675343|NCT04402489|580190489|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
160675344|NCT04402489|580190485|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
160675345|NCT04402489|580190486|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
160675346|NCT04402489|580190487|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
160675347|NCT04402489|580190488|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
160675348|NCT04402489|580190489|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
160675349|NCT04402489|580190485|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
160675350|NCT04402489|580190486|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
160675351|NCT04402489|580190487|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
160675352|NCT04402489|580190488|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
160675353|NCT04402489|580190489|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
160675354|NCT05223868|580190490|FG000|Overall Study|Lost to Follow-up|1|||
160675355|NCT05223868|580190491|FG001|Overall Study|Lost to Follow-up|3|||
160675356|NCT05223868|580190492|FG002|Overall Study|Lost to Follow-up|0|||
160675357|NCT05223868|580190493|FG003|Overall Study|Lost to Follow-up|0|||
160675358|NCT05223868|580190494|FG004|Overall Study|Lost to Follow-up|0|||
160675359|NCT05223868|580190495|FG005|Overall Study|Lost to Follow-up|1|||
160675360|NCT05223868|580190490|FG000|Overall Study|Withdrawal by Subject|6|||
160675361|NCT05223868|580190491|FG001|Overall Study|Withdrawal by Subject|2|||
160675362|NCT05223868|580190492|FG002|Overall Study|Withdrawal by Subject|3|||
160675363|NCT05223868|580190493|FG003|Overall Study|Withdrawal by Subject|1|||
160675364|NCT05223868|580190494|FG004|Overall Study|Withdrawal by Subject|1|||
160675365|NCT05223868|580190495|FG005|Overall Study|Withdrawal by Subject|2|||
160675366|NCT05223868|580190490|FG000|Overall Study|Other|0|||
160675367|NCT05223868|580190491|FG001|Overall Study|Other|2|||
160675368|NCT05223868|580190492|FG002|Overall Study|Other|0|||
160675369|NCT05223868|580190493|FG003|Overall Study|Other|0|||
160675370|NCT05223868|580190494|FG004|Overall Study|Other|1|||
160675371|NCT05223868|580190495|FG005|Overall Study|Other|1|||
160675372|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
160675373|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
160675374|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
160675375|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
160675376|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
160675377|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
160675378|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
160675379|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
160675380|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
160675381|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
160675382|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
160675383|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
160675384|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
160675385|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
160675386|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
160675387|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
160675388|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
160675389|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
160675390|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
160675391|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
160675392|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
160675393|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
160675394|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
160675395|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
160675396|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
160675397|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
160675398|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
160675399|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
160675400|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
160675401|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
160675402|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
160675403|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
160675404|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
160675405|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
160675406|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
160675407|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
160675408|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
160675409|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
160675410|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
160675411|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
160675412|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
160675413|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
160675414|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
160675415|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
160675416|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
160675417|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
160675418|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
160675419|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
160675420|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
160675421|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
160675422|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
160675423|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
160675424|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
160675425|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
160675426|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
160675427|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
160675428|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
160675429|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
160675430|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
160675431|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
160675432|NCT03395197|580190496|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
160675433|NCT03395197|580190497|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
160675434|NCT03395197|580190498|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
160675435|NCT03395197|580190499|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
160675436|NCT03395197|580190500|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
160675437|NCT03395197|580190501|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
160675438|NCT03395197|580190496|FG000|Analysis for DDR-Deficient Participants|Death|0|||
160675439|NCT03395197|580190497|FG001|Analysis for DDR-Deficient Participants|Death|0|||
160675440|NCT03395197|580190498|FG002|Analysis for DDR-Deficient Participants|Death|0|||
160675441|NCT03395197|580190499|FG003|Analysis for DDR-Deficient Participants|Death|0|||
160675442|NCT03395197|580190500|FG004|Analysis for DDR-Deficient Participants|Death|1|||
160675443|NCT03395197|580190501|FG005|Analysis for DDR-Deficient Participants|Death|4|||
160675444|NCT03395197|580190496|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
160675445|NCT03395197|580190497|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
160675446|NCT03395197|580190498|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
160675447|NCT03395197|580190499|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
160675448|NCT03395197|580190500|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
160675449|NCT03395197|580190501|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
160675450|NCT03395197|580190496|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
160675451|NCT03395197|580190497|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
160675452|NCT03395197|580190498|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
160675453|NCT03395197|580190499|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
160675454|NCT03395197|580190500|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
160675455|NCT03395197|580190501|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
160675456|NCT03395197|580190496|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
160675457|NCT03395197|580190497|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
160675458|NCT03395197|580190498|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
160675459|NCT03395197|580190499|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
160675460|NCT03395197|580190500|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
160675461|NCT03395197|580190501|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
160675462|NCT03395197|580190496|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
160675463|NCT03395197|580190497|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
160675464|NCT03395197|580190498|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
160675465|NCT03395197|580190499|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
160675466|NCT03395197|580190500|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
160675467|NCT03395197|580190501|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
160675468|NCT03395197|580190496|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
160675469|NCT03395197|580190497|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
160675470|NCT03395197|580190498|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
160675471|NCT03395197|580190499|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
160675472|NCT03395197|580190500|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
160675473|NCT03395197|580190501|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
160675474|NCT03395197|580190496|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
160675475|NCT03395197|580190497|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
160675476|NCT03395197|580190498|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
160675477|NCT03395197|580190499|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
160675478|NCT03395197|580190500|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
160675479|NCT03395197|580190501|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
160675480|NCT03395197|580190496|FG000|Analysis for DDR-Deficient Participants|Other|0|||
160675481|NCT03395197|580190497|FG001|Analysis for DDR-Deficient Participants|Other|0|||
160675482|NCT03395197|580190498|FG002|Analysis for DDR-Deficient Participants|Other|0|||
160675483|NCT03395197|580190499|FG003|Analysis for DDR-Deficient Participants|Other|0|||
160675484|NCT03395197|580190500|FG004|Analysis for DDR-Deficient Participants|Other|3|||
160675485|NCT03395197|580190501|FG005|Analysis for DDR-Deficient Participants|Other|3|||
160675486|NCT03395197|580190496|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
160675487|NCT03395197|580190497|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
160675488|NCT03395197|580190498|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
160675489|NCT03395197|580190499|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
160675490|NCT03395197|580190500|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
160675491|NCT03395197|580190501|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
160675492|NCT02308241|580190505|FG000|Overall Study|Withdrawal by Subject|3|||
160675493|NCT03609944|580190506|FG000|Overall Study|Lost to Follow-up|1|||
160675494|NCT03609944|580190507|FG001|Overall Study|Lost to Follow-up|5|||
160675495|NCT03609944|580190506|FG000|Overall Study|Withdrawal by Subject|1|||
160675496|NCT03609944|580190507|FG001|Overall Study|Withdrawal by Subject|1|||
160675497|NCT00659815|580190508|FG000|Overall Study|Study related symptoms and complaints|2|||
160675498|NCT00659815|580190509|FG001|Overall Study|Study related symptoms and complaints|1|||
160675499|NCT00659815|580190508|FG000|Overall Study|Inability to maintain wearing schedule|1|||
160675500|NCT00659815|580190509|FG001|Overall Study|Inability to maintain wearing schedule|2|||
160675501|NCT00659815|580190508|FG000|Overall Study|Withdrawal by Subject|1|||
160675502|NCT00659815|580190509|FG001|Overall Study|Withdrawal by Subject|1|||
160675503|NCT02578641|580190510|FG000|Overall Study|Adverse Event|5|||
160675504|NCT02578641|580190511|FG001|Overall Study|Adverse Event|15|||
160675505|NCT02578641|580190510|FG000|Overall Study|Death|16|||
160675506|NCT02578641|580190511|FG001|Overall Study|Death|8|||
160675507|NCT02578641|580190510|FG000|Overall Study|Lost to Follow-up|0|||
160675508|NCT02578641|580190511|FG001|Overall Study|Lost to Follow-up|1|||
160675509|NCT02578641|580190510|FG000|Overall Study|Withdrawal by Subject|14|||
160675510|NCT02578641|580190511|FG001|Overall Study|Withdrawal by Subject|7|||
160675511|NCT02578641|580190510|FG000|Overall Study|Progressive Disease|69|||
160675512|NCT02578641|580190511|FG001|Overall Study|Progressive Disease|21|||
160675513|NCT02578641|580190510|FG000|Overall Study|No Study Drug|2|||
160675514|NCT02578641|580190511|FG001|Overall Study|No Study Drug|0|||
160675515|NCT02578641|580190510|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
160675516|NCT02578641|580190511|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
160675517|NCT02578641|580190510|FG000|Overall Study|Non-compliance with Study Schedule|1|||
160675518|NCT02578641|580190511|FG001|Overall Study|Non-compliance with Study Schedule|0|||
160675519|NCT02578641|580190510|FG000|Overall Study|Other|1|||
160675520|NCT02578641|580190511|FG001|Overall Study|Other|10|||
160675521|NCT02578641|580190510|FG000|Overall Study|Not treated|1|||
160675522|NCT02578641|580190511|FG001|Overall Study|Not treated|4|||
160675523|NCT05330975|580190512|FG000|Primary|Lost to Follow-up|12|||
160675524|NCT05330975|580190513|FG001|Primary|Lost to Follow-up|21|||
160675525|NCT05330975|580190514|FG002|Primary|Lost to Follow-up|38|||
160675526|NCT05330975|580190515|FG003|Primary|Lost to Follow-up|30|||
160675527|NCT05330975|580190516|FG004|Primary|Lost to Follow-up|25|||
160675528|NCT05330975|580190517|FG005|Primary|Lost to Follow-up|28|||
160675529|NCT05330975|580190518|FG006|Primary|Lost to Follow-up|0|||
160675530|NCT05330975|580190512|FG000|Primary|Withdrawal by Subject|4|||
160675531|NCT05330975|580190513|FG001|Primary|Withdrawal by Subject|11|||
160675532|NCT05330975|580190514|FG002|Primary|Withdrawal by Subject|8|||
160675533|NCT05330975|580190515|FG003|Primary|Withdrawal by Subject|23|||
160675534|NCT05330975|580190516|FG004|Primary|Withdrawal by Subject|20|||
160675535|NCT05330975|580190517|FG005|Primary|Withdrawal by Subject|19|||
160675536|NCT05330975|580190518|FG006|Primary|Withdrawal by Subject|0|||
160675537|NCT05330975|580190512|FG000|Primary|Protocol Violation|0|||
160675538|NCT05330975|580190513|FG001|Primary|Protocol Violation|2|||
160675539|NCT05330975|580190514|FG002|Primary|Protocol Violation|0|||
160675540|NCT05330975|580190515|FG003|Primary|Protocol Violation|4|||
160675541|NCT05330975|580190516|FG004|Primary|Protocol Violation|0|||
160675542|NCT05330975|580190517|FG005|Primary|Protocol Violation|3|||
160675543|NCT05330975|580190518|FG006|Primary|Protocol Violation|0|||
160675544|NCT05330975|580190512|FG000|Primary|Death|0|||
160675545|NCT05330975|580190513|FG001|Primary|Death|3|||
160675546|NCT05330975|580190514|FG002|Primary|Death|1|||
160675547|NCT05330975|580190515|FG003|Primary|Death|1|||
160675548|NCT05330975|580190516|FG004|Primary|Death|0|||
160675549|NCT05330975|580190517|FG005|Primary|Death|0|||
160675550|NCT05330975|580190518|FG006|Primary|Death|0|||
160675551|NCT05330975|580190512|FG000|Primary|Other Than Specified|0|||
160675552|NCT05330975|580190513|FG001|Primary|Other Than Specified|1|||
160675553|NCT05330975|580190514|FG002|Primary|Other Than Specified|2|||
160675554|NCT05330975|580190515|FG003|Primary|Other Than Specified|1|||
160675555|NCT05330975|580190516|FG004|Primary|Other Than Specified|2|||
160675556|NCT05330975|580190517|FG005|Primary|Other Than Specified|2|||
160675557|NCT05330975|580190518|FG006|Primary|Other Than Specified|0|||
160675558|NCT05330975|580190512|FG000|Primary|Adverse Event|0|||
160675559|NCT05330975|580190513|FG001|Primary|Adverse Event|0|||
160675560|NCT05330975|580190514|FG002|Primary|Adverse Event|0|||
160675561|NCT05330975|580190515|FG003|Primary|Adverse Event|1|||
160675562|NCT05330975|580190516|FG004|Primary|Adverse Event|0|||
160675563|NCT05330975|580190517|FG005|Primary|Adverse Event|0|||
160675564|NCT05330975|580190518|FG006|Primary|Adverse Event|0|||
160675565|NCT05330975|580190512|FG000|Primary|Physician Decision|0|||
160675566|NCT05330975|580190513|FG001|Primary|Physician Decision|0|||
160675567|NCT05330975|580190514|FG002|Primary|Physician Decision|0|||
160675568|NCT05330975|580190515|FG003|Primary|Physician Decision|0|||
160675569|NCT05330975|580190516|FG004|Primary|Physician Decision|1|||
160675570|NCT05330975|580190517|FG005|Primary|Physician Decision|0|||
160675571|NCT05330975|580190518|FG006|Primary|Physician Decision|0|||
160675572|NCT05330975|580190512|FG000|Revaccination|Adverse Event|0|||
160675573|NCT05330975|580190513|FG001|Revaccination|Adverse Event|0|||
160675574|NCT05330975|580190514|FG002|Revaccination|Adverse Event|0|||
160675575|NCT05330975|580190515|FG003|Revaccination|Adverse Event|0|||
160675576|NCT05330975|580190516|FG004|Revaccination|Adverse Event|0|||
160675577|NCT05330975|580190517|FG005|Revaccination|Adverse Event|0|||
160675578|NCT05330975|580190518|FG006|Revaccination|Adverse Event|3|||
160675579|NCT05330975|580190512|FG000|Revaccination|Lost to Follow-up|0|||
160675580|NCT05330975|580190513|FG001|Revaccination|Lost to Follow-up|0|||
160675581|NCT05330975|580190514|FG002|Revaccination|Lost to Follow-up|0|||
160675582|NCT05330975|580190515|FG003|Revaccination|Lost to Follow-up|0|||
160675583|NCT05330975|580190516|FG004|Revaccination|Lost to Follow-up|0|||
160675584|NCT05330975|580190517|FG005|Revaccination|Lost to Follow-up|0|||
160675585|NCT05330975|580190518|FG006|Revaccination|Lost to Follow-up|10|||
160675586|NCT05330975|580190512|FG000|Revaccination|Withdrawal by Subject|0|||
160675587|NCT05330975|580190513|FG001|Revaccination|Withdrawal by Subject|0|||
160675588|NCT05330975|580190514|FG002|Revaccination|Withdrawal by Subject|0|||
160675589|NCT05330975|580190515|FG003|Revaccination|Withdrawal by Subject|0|||
160675590|NCT05330975|580190516|FG004|Revaccination|Withdrawal by Subject|0|||
160675591|NCT05330975|580190517|FG005|Revaccination|Withdrawal by Subject|0|||
160675592|NCT05330975|580190518|FG006|Revaccination|Withdrawal by Subject|2|||
160675593|NCT05330975|580190512|FG000|Revaccination|Death|0|||
160675594|NCT05330975|580190513|FG001|Revaccination|Death|0|||
160675595|NCT05330975|580190514|FG002|Revaccination|Death|0|||
160675596|NCT05330975|580190515|FG003|Revaccination|Death|0|||
160675597|NCT05330975|580190516|FG004|Revaccination|Death|0|||
160675598|NCT05330975|580190517|FG005|Revaccination|Death|0|||
160675599|NCT05330975|580190518|FG006|Revaccination|Death|3|||
160675600|NCT05267106|580190519|FG000|Overall Study|Death|50|||
160675601|NCT05267106|580190520|FG001|Overall Study|Death|2|||
160675602|NCT05267106|580190519|FG000|Overall Study|Study terminated by Sponsor|24|||
160675603|NCT05267106|580190520|FG001|Overall Study|Study terminated by Sponsor|6|||
160675604|NCT05267106|580190519|FG000|Overall Study|Withdrawal by Subject|0|||
160675605|NCT05267106|580190520|FG001|Overall Study|Withdrawal by Subject|1|||
160675606|NCT04227899|580190531|FG000|Overall Study|Withdrawal by Subject|6|||
160675607|NCT04227899|580190532|FG001|Overall Study|Withdrawal by Subject|3|||
160675608|NCT04227899|580190531|FG000|Overall Study|Death|12|||
160675609|NCT04227899|580190532|FG001|Overall Study|Death|6|||
160675610|NCT04227899|580190531|FG000|Overall Study|Lost to Follow-up|2|||
160675611|NCT04227899|580190532|FG001|Overall Study|Lost to Follow-up|1|||
160675612|NCT03292458|580190539|FG000|Period 1|Adverse Event|2|||
160675613|NCT03292458|580190540|FG001|Period 1|Adverse Event|0|||
160675614|NCT01664039|580190543|FG000|Overall Study|Adverse Event|3|||
160675615|NCT01664039|580190544|FG001|Overall Study|Adverse Event|4|||
160675616|NCT01664039|580190543|FG000|Overall Study|Lost to Follow-up|1|||
160675617|NCT01664039|580190544|FG001|Overall Study|Lost to Follow-up|1|||
160675618|NCT01664039|580190543|FG000|Overall Study|Withdrawal by Subject|1|||
160675619|NCT01664039|580190544|FG001|Overall Study|Withdrawal by Subject|3|||
160675620|NCT01664039|580190543|FG000|Overall Study|Noncompliance|1|||
160675621|NCT01664039|580190544|FG001|Overall Study|Noncompliance|1|||
160675622|NCT01853176|580190545|FG000|Overall Study|Study terminated|4|||
160675623|NCT01853176|580190546|FG001|Overall Study|Study terminated|0|||
160675624|NCT02276885|580190547|FG000|Overall Study|Withdrawal by Subject|2|||
160675625|NCT02276885|580190548|FG001|Overall Study|Withdrawal by Subject|0|||
160675626|NCT02276885|580190547|FG000|Overall Study|Lost to Follow-up|5|||
160675627|NCT02276885|580190548|FG001|Overall Study|Lost to Follow-up|2|||
160675628|NCT04569032|580190549|FG000|Overall Study|Death|10|||
160675629|NCT04569032|580190550|FG001|Overall Study|Death|13|||
160675630|NCT04569032|580190549|FG000|Overall Study|Withdrawal by Subject|2|||
160675631|NCT04569032|580190550|FG001|Overall Study|Withdrawal by Subject|0|||
160675632|NCT04569032|580190549|FG000|Overall Study|Lost to Follow-up|0|||
160675633|NCT04569032|580190550|FG001|Overall Study|Lost to Follow-up|1|||
160675634|NCT04569032|580190549|FG000|Overall Study|In long term follow up|22|||
160675635|NCT04569032|580190550|FG001|Overall Study|In long term follow up|34|||
160675636|NCT03837626|580190556|FG000|Overall Study|Adverse Event|3|||
160675637|NCT03837626|580190557|FG001|Overall Study|Adverse Event|3|||
160675638|NCT03837626|580190556|FG000|Overall Study|Withdrawal by Subject|2|||
160675639|NCT03837626|580190557|FG001|Overall Study|Withdrawal by Subject|4|||
160675640|NCT03837626|580190556|FG000|Overall Study|Physician Decision|2|||
160675641|NCT03837626|580190557|FG001|Overall Study|Physician Decision|3|||
160675642|NCT03837626|580190556|FG000|Overall Study|Lost to Follow-up|3|||
160675643|NCT03837626|580190557|FG001|Overall Study|Lost to Follow-up|1|||
160675644|NCT00874822|580190558|FG000|Overall Study|excluded by criteria|8|||
160675645|NCT01168856|580190559|FG000|Overall Study|Lost to Follow-up|4|||
160675646|NCT01168856|580190560|FG001|Overall Study|Lost to Follow-up|34|||
160675647|NCT01168856|580190559|FG000|Overall Study|Withdrawal by Subject|6|||
160675648|NCT01168856|580190560|FG001|Overall Study|Withdrawal by Subject|8|||
160675649|NCT01168856|580190559|FG000|Overall Study|Physician Decision|2|||
160675650|NCT01168856|580190560|FG001|Overall Study|Physician Decision|1|||
160675651|NCT01168856|580190559|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
160675652|NCT01168856|580190560|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
160675653|NCT01168856|580190559|FG000|Overall Study|Participant received anti-HCV treatment|1|||
160675654|NCT01168856|580190560|FG001|Overall Study|Participant received anti-HCV treatment|0|||
160675655|NCT01168856|580190559|FG000|Overall Study|Death|0|||
160675656|NCT01168856|580190560|FG001|Overall Study|Death|2|||
160675657|NCT01168856|580190559|FG000|Overall Study|Other|1|||
160675658|NCT01168856|580190560|FG001|Overall Study|Other|291|||
160675659|NCT01168856|580190559|FG000|Overall Study|Protocol Violation|4|||
160675660|NCT01168856|580190560|FG001|Overall Study|Protocol Violation|6|||
160675661|NCT04442503|580190561|FG000|Overall Study|Adverse Event|1|||
160675662|NCT04442503|580190562|FG001|Overall Study|Adverse Event|1|||
160675663|NCT04442503|580190561|FG000|Overall Study|Lost to Follow-up|8|||
160675664|NCT04442503|580190562|FG001|Overall Study|Lost to Follow-up|6|||
160675665|NCT04442503|580190561|FG000|Overall Study|Physician Decision|0|||
160675666|NCT04442503|580190562|FG001|Overall Study|Physician Decision|2|||
160675667|NCT04442503|580190561|FG000|Overall Study|Withdrawal by Subject|3|||
160675668|NCT04442503|580190562|FG001|Overall Study|Withdrawal by Subject|4|||
160675669|NCT04442503|580190561|FG000|Overall Study|Reason not Specified|0|||
160675670|NCT04442503|580190562|FG001|Overall Study|Reason not Specified|1|||
160675671|NCT04442503|580190561|FG000|Overall Study|Randomized but not Treated|3|||
160675672|NCT04442503|580190562|FG001|Overall Study|Randomized but not Treated|1|||
160675673|NCT00387153|580190569|FG000|Overall Study|Adverse Event|1|||
160675674|NCT00387153|580190569|FG000|Overall Study|Disease Progression|3|||
160675675|NCT00387153|580190569|FG000|Overall Study|Lack of Response|4|||
160675676|NCT00474058|580190570|FG000|Overall Study|Adverse Event|11|||
160675677|NCT00474058|580190571|FG001|Overall Study|Adverse Event|6|||
160675678|NCT00474058|580190570|FG000|Overall Study|Lack of Efficacy|0|||
160675679|NCT00474058|580190571|FG001|Overall Study|Lack of Efficacy|4|||
160675680|NCT00474058|580190570|FG000|Overall Study|Withdrawal by Subject|11|||
160675681|NCT00474058|580190571|FG001|Overall Study|Withdrawal by Subject|7|||
160675682|NCT00474058|580190570|FG000|Overall Study|Other|2|||
160675683|NCT00474058|580190571|FG001|Overall Study|Other|0|||
160675684|NCT03922750|580190578|FG000|Overall Study|Unclassified|0|||
160675685|NCT03922750|580190579|FG001|Overall Study|Unclassified|0|||
160675686|NCT03922750|580190580|FG002|Overall Study|Unclassified|1|||
160675687|NCT03922750|580190578|FG000|Overall Study|Adverse Event|0|||
160675688|NCT03922750|580190579|FG001|Overall Study|Adverse Event|1|||
160675689|NCT03922750|580190580|FG002|Overall Study|Adverse Event|0|||
160675690|NCT01717040|580190582|FG000|Overall Study|Lost to Follow-up|2|||
160675691|NCT01717040|580190583|FG001|Overall Study|Lost to Follow-up|3|||
160675692|NCT01717040|580190582|FG000|Overall Study|Lack of Efficacy|1|||
160675693|NCT01717040|580190583|FG001|Overall Study|Lack of Efficacy|1|||
160675694|NCT01717040|580190582|FG000|Overall Study|Adverse Event|1|||
160675695|NCT01717040|580190583|FG001|Overall Study|Adverse Event|0|||
160675696|NCT01717040|580190582|FG000|Overall Study|Required Medication Change|0|||
160675697|NCT01717040|580190583|FG001|Overall Study|Required Medication Change|1|||
160675698|NCT01717040|580190582|FG000|Overall Study|New Substance Use Disorder|1|||
160675699|NCT01717040|580190583|FG001|Overall Study|New Substance Use Disorder|0|||
160675700|NCT04577404|580190584|FG000|Overall Study|Adverse Event|31|||
160675701|NCT04577404|580190584|FG000|Overall Study|Death|1|||
160675702|NCT04577404|580190584|FG000|Overall Study|Lack of Efficacy|3|||
160675703|NCT04577404|580190584|FG000|Overall Study|Physician Decision|7|||
160675704|NCT04577404|580190584|FG000|Overall Study|Withdrawal by Subject|21|||
160675705|NCT04577404|580190584|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
160675706|NCT03921554|580190585|FG000|Overall Study|Adverse Event|2|||
160675707|NCT03921554|580190585|FG000|Overall Study|Withdrawal by Subject|1|||
160675708|NCT03921554|580190585|FG000|Overall Study|Death|3|||
160675709|NCT04440592|580190586|FG000|Overall Study|Adverse Event|8|||
160675710|NCT04440592|580190587|FG001|Overall Study|Adverse Event|0|||
160675711|NCT04440592|580190586|FG000|Overall Study|Lost to Follow-up|1|||
160675712|NCT04440592|580190587|FG001|Overall Study|Lost to Follow-up|0|||
160675713|NCT04440592|580190586|FG000|Overall Study|Withdrawal by Subject|1|||
160675714|NCT04440592|580190587|FG001|Overall Study|Withdrawal by Subject|1|||
160675715|NCT04440592|580190586|FG000|Overall Study|Other therapy needed|0|||
160675716|NCT04440592|580190587|FG001|Overall Study|Other therapy needed|1|||
160675717|NCT00762411|580192070|FG000|Initial Treatment|Death|7|||
160675718|NCT00762411|580192071|FG001|Initial Treatment|Death|6|||
160675719|NCT00762411|580192070|FG000|Initial Treatment|Adverse Event|132|||
160675720|NCT00762411|580192071|FG001|Initial Treatment|Adverse Event|40|||
160675721|NCT00762411|580192070|FG000|Initial Treatment|Protocol Violation|4|||
160675722|NCT00762411|580192071|FG001|Initial Treatment|Protocol Violation|1|||
160675723|NCT00762411|580192070|FG000|Initial Treatment|Withdrawal by Subject|65|||
160675724|NCT00762411|580192071|FG001|Initial Treatment|Withdrawal by Subject|52|||
160675725|NCT00762411|580192070|FG000|Initial Treatment|Physician Decision|1|||
160675726|NCT00762411|580192071|FG001|Initial Treatment|Physician Decision|0|||
160675727|NCT00762411|580192070|FG000|Initial Treatment|Sponsor Decision|293|||
160675728|NCT00762411|580192071|FG001|Initial Treatment|Sponsor Decision|401|||
160675729|NCT00762411|580192070|FG000|Initial Treatment|Lost to Follow-up|5|||
160675730|NCT00762411|580192071|FG001|Initial Treatment|Lost to Follow-up|0|||
160675731|NCT00762411|580192070|FG000|Initial Treatment|Caregiver Decision|21|||
160675732|NCT00762411|580192071|FG001|Initial Treatment|Caregiver Decision|16|||
160675733|NCT00762411|580192070|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
160675734|NCT00762411|580192071|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
160675735|NCT00762411|580192070|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
160675736|NCT00762411|580192071|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
160675737|NCT00762411|580192070|FG000|Delayed Start|Adverse Event|0|||
160675738|NCT00762411|580192071|FG001|Delayed Start|Adverse Event|4|||
160675739|NCT00762411|580192070|FG000|Delayed Start|Protocol Violation|0|||
160675740|NCT00762411|580192071|FG001|Delayed Start|Protocol Violation|1|||
160675741|NCT00762411|580192070|FG000|Delayed Start|Sponsor Decision|16|||
160675742|NCT00762411|580192071|FG001|Delayed Start|Sponsor Decision|20|||
160675743|NCT00762411|580192070|FG000|Delayed Start|Caregiver Decision|1|||
160675744|NCT00762411|580192071|FG001|Delayed Start|Caregiver Decision|1|||
160675745|NCT00762411|580192070|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
160675746|NCT00762411|580192071|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
160675747|NCT00762411|580192070|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
160675748|NCT00762411|580192071|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
160675749|NCT00762411|580192070|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
160675750|NCT00762411|580192071|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
160675751|NCT00762411|580192070|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
160675752|NCT00762411|580192071|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
160675753|NCT00762411|580192070|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
160675754|NCT00762411|580192071|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
160675755|NCT00762411|580192070|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
160675756|NCT00762411|580192071|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
160675757|NCT02710214|580192075|FG000|Overall Study|Lost to Follow-up|1|||
160675758|NCT02710214|580192076|FG001|Overall Study|Lost to Follow-up|0|||
160675759|NCT02710214|580192075|FG000|Overall Study|Lack of Efficacy|0|||
160675760|NCT02710214|580192076|FG001|Overall Study|Lack of Efficacy|1|||
160675761|NCT02710214|580192075|FG000|Overall Study|Death|0|||
160675762|NCT02710214|580192076|FG001|Overall Study|Death|1|||
160675763|NCT02832167|580192077|FG000|Treatment Period 1|Disease progression|90|||
160675764|NCT02832167|580192077|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
160675765|NCT02832167|580192077|FG000|Treatment Period 1|Death|2|||
160675766|NCT02832167|580192077|FG000|Treatment Period 1|Study Drug Toxicity|6|||
160675767|NCT02832167|580192077|FG000|Treatment Period 1|Participant request to discontinue|9|||
160675768|NCT02832167|580192077|FG000|Treatment Period 1|No longer meet study criteria|1|||
160675769|NCT02832167|580192077|FG000|Treatment Period 1|Participant withdrew consent|3|||
160675770|NCT02832167|580192077|FG000|Treatment Period 1|Other reasons|6|||
160675771|NCT02832167|580192077|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
160675772|NCT02832167|580192077|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
160675773|NCT02832167|580192077|FG000|Transition From Period 1 to Period 2|Death|2|||
160675774|NCT02832167|580192077|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
160675775|NCT02832167|580192077|FG000|Treatment Period 2|Disease progression|69|||
160675776|NCT02832167|580192077|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
160675777|NCT02832167|580192077|FG000|Treatment Period 2|Maximum clinical benefit|1|||
160675778|NCT02832167|580192077|FG000|Treatment Period 2|Study Drug Toxicity|5|||
160675779|NCT02832167|580192077|FG000|Treatment Period 2|Participant request to discontinue|2|||
160675780|NCT02832167|580192077|FG000|Treatment Period 2|Participant withdrew consent|3|||
160675781|NCT02832167|580192077|FG000|Treatment Period 2|Other reasons|3|||
160675782|NCT01754376|580192078|FG000|Overall Study|Adverse Event|1|||
160675783|NCT01754376|580192078|FG000|Overall Study|Lack of Efficacy|2|||
160675784|NCT04590781|580192079|FG000|Overall Study|Death|0|||
160675785|NCT04590781|580192080|FG001|Overall Study|Death|2|||
160675786|NCT04590781|580192079|FG000|Overall Study|Withdrawal by Subject|2|||
160675787|NCT04590781|580192080|FG001|Overall Study|Withdrawal by Subject|0|||
160675788|NCT04768296|580192082|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
160675789|NCT04768296|580192083|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
160675790|NCT03192891|580192088|FG000|Overall Study|Lost to Follow-up|55|||
160675791|NCT02655224|580192095|FG000|Overall Study|Adverse Event|1|||
160675792|NCT02655224|580192096|FG001|Overall Study|Adverse Event|1|||
160675793|NCT05151471|580192097|FG000|Overall Study|Adverse Event|21|||
160675794|NCT05151471|580192098|FG001|Overall Study|Adverse Event|16|||
160675795|NCT05151471|580192097|FG000|Overall Study|Death|1|||
160675796|NCT05151471|580192098|FG001|Overall Study|Death|0|||
160675797|NCT05151471|580192097|FG000|Overall Study|Lost to Follow-up|0|||
160675798|NCT05151471|580192098|FG001|Overall Study|Lost to Follow-up|1|||
160675799|NCT05151471|580192097|FG000|Overall Study|Withdrawal by Subject|7|||
160675800|NCT05151471|580192098|FG001|Overall Study|Withdrawal by Subject|9|||
160675801|NCT05151471|580192097|FG000|Overall Study|Study terminated by sponsor|49|||
160675802|NCT05151471|580192098|FG001|Overall Study|Study terminated by sponsor|47|||
160675803|NCT05151471|580192097|FG000|Overall Study|Other|2|||
160675804|NCT05151471|580192098|FG001|Overall Study|Other|1|||
160675805|NCT03988608|580192099|FG000|Overall Study|Adverse Event|1|||
160675806|NCT03988608|580192099|FG000|Overall Study|Lost to Follow-up|1|||
160675807|NCT03988608|580192099|FG000|Overall Study|Withdrawal by Subject|3|||
160675808|NCT03988608|580192099|FG000|Overall Study|Death|1|||
160675809|NCT01741545|580192107|FG000|Treatment Period|Lack of Efficacy|0|||
160675810|NCT01741545|580192108|FG001|Treatment Period|Lack of Efficacy|1|||
160675811|NCT01741545|580192107|FG000|Treatment Period|Adverse event, non-fatal|1|||
160675812|NCT01741545|580192108|FG001|Treatment Period|Adverse event, non-fatal|3|||
160675813|NCT01741545|580192107|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
160675814|NCT01741545|580192108|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
160675815|NCT01741545|580192107|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
160675816|NCT01741545|580192108|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
160675817|NCT01456962|580192109|FG000|Overall Study|Lost to Follow-up|2|||
160675818|NCT01456962|580192110|FG001|Overall Study|Lost to Follow-up|1|||
160675819|NCT03387462|580192111|FG000|Overall Study|Lost to Follow-up|1|||
160675820|NCT01460628|580192112|FG000|Overall Study|Adverse Event|3|||
160675821|NCT01460628|580192112|FG000|Overall Study|Withdrawal by Subject|2|||
160675822|NCT05029687|580192128|FG000|Overall Study|Withdrawal by Subject|4|||
160675823|NCT05029687|580192129|FG001|Overall Study|Withdrawal by Subject|0|||
160675824|NCT05029687|580192130|FG002|Overall Study|Withdrawal by Subject|2|||
160675825|NCT05029687|580192128|FG000|Overall Study|Lost to Follow-up|4|||
160675826|NCT05029687|580192129|FG001|Overall Study|Lost to Follow-up|0|||
160675827|NCT05029687|580192130|FG002|Overall Study|Lost to Follow-up|2|||
160675828|NCT05740371|580192133|FG000|Overall Study|Death|1|||
160675829|NCT02627963|580192134|FG000|Overall Study|Randomized but not treated|2|||
160675830|NCT02627963|580192135|FG001|Overall Study|Randomized but not treated|6|||
160675831|NCT03073798|580192136|FG000|Overall Study|Adverse Event|1|||
160675832|NCT03073798|580192136|FG000|Overall Study|Withdrawal by Subject|1|||
160675833|NCT00840658|580192141|FG000|Overall Study|Death|2|||
160675834|NCT00840658|580192142|FG001|Overall Study|Death|2|||
160675835|NCT00840658|580192143|FG002|Overall Study|Death|3|||
160675836|NCT00840658|580192144|FG003|Overall Study|Death|3|||
160675837|NCT00840658|580192141|FG000|Overall Study|Lost to Follow-up|3|||
160675838|NCT00840658|580192142|FG001|Overall Study|Lost to Follow-up|1|||
160675839|NCT00840658|580192143|FG002|Overall Study|Lost to Follow-up|2|||
160675840|NCT00840658|580192144|FG003|Overall Study|Lost to Follow-up|1|||
160675841|NCT05278858|580192145|FG000|Overall Study|Withdrawal by Subject|1|||
160675842|NCT02372006|580192149|FG000|Overall Study|Progressive disease|8|||
160675843|NCT02372006|580192150|FG001|Overall Study|Progressive disease|7|||
160675844|NCT02372006|580192151|FG002|Overall Study|Progressive disease|34|||
160675845|NCT02372006|580192149|FG000|Overall Study|Dose limiting toxicity|0|||
160675846|NCT02372006|580192150|FG001|Overall Study|Dose limiting toxicity|1|||
160675847|NCT02372006|580192151|FG002|Overall Study|Dose limiting toxicity|0|||
160675848|NCT02372006|580192149|FG000|Overall Study|Adverse Event|0|||
160675849|NCT02372006|580192150|FG001|Overall Study|Adverse Event|0|||
160675850|NCT02372006|580192151|FG002|Overall Study|Adverse Event|3|||
160675851|NCT02372006|580192149|FG000|Overall Study|Withdrawal by Subject|0|||
160675852|NCT02372006|580192150|FG001|Overall Study|Withdrawal by Subject|1|||
160675853|NCT02372006|580192151|FG002|Overall Study|Withdrawal by Subject|1|||
160675854|NCT02372006|580192149|FG000|Overall Study|Other reason for not completing|0|||
160675855|NCT02372006|580192150|FG001|Overall Study|Other reason for not completing|0|||
160675856|NCT02372006|580192151|FG002|Overall Study|Other reason for not completing|1|||
160675857|NCT00728754|580192154|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
160675858|NCT00728754|580192155|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
160675859|NCT00728754|580192154|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
160675860|NCT00728754|580192155|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
160675861|NCT00728754|580192154|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
160675862|NCT00728754|580192155|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
160675863|NCT00573313|580192160|FG000|Overall Study|Protocol Violation|5|||
160675864|NCT00573313|580192161|FG001|Overall Study|Protocol Violation|0|||
160675865|NCT00573313|580192162|FG002|Overall Study|Protocol Violation|6|||
160675866|NCT00573313|580192163|FG003|Overall Study|Protocol Violation|0|||
160675867|NCT00295490|580192166|FG000|Overall Study|Protocol Violation|0|||
160675868|NCT00295490|580192167|FG001|Overall Study|Protocol Violation|0|||
160675869|NCT00295490|580192168|FG002|Overall Study|Protocol Violation|3|||
160675870|NCT00295490|580192169|FG003|Overall Study|Protocol Violation|3|||
160675871|NCT00295490|580192166|FG000|Overall Study|Withdrawal by Subject|0|||
160675872|NCT00295490|580192167|FG001|Overall Study|Withdrawal by Subject|2|||
160675873|NCT00295490|580192168|FG002|Overall Study|Withdrawal by Subject|0|||
160675874|NCT00295490|580192169|FG003|Overall Study|Withdrawal by Subject|1|||
160675875|NCT00295490|580192166|FG000|Overall Study|Lost to Follow-up|0|||
160675876|NCT00295490|580192167|FG001|Overall Study|Lost to Follow-up|0|||
160675877|NCT00295490|580192168|FG002|Overall Study|Lost to Follow-up|1|||
160675878|NCT00295490|580192169|FG003|Overall Study|Lost to Follow-up|0|||
160675879|NCT00295490|580192166|FG000|Overall Study|Adverse Event|1|||
160675880|NCT00295490|580192167|FG001|Overall Study|Adverse Event|0|||
160675881|NCT00295490|580192168|FG002|Overall Study|Adverse Event|0|||
160675882|NCT00295490|580192169|FG003|Overall Study|Adverse Event|0|||
160675883|NCT00295490|580192166|FG000|Overall Study|Other|0|||
160675884|NCT00295490|580192167|FG001|Overall Study|Other|2|||
160675885|NCT00295490|580192168|FG002|Overall Study|Other|0|||
160675886|NCT00295490|580192169|FG003|Overall Study|Other|1|||
160675887|NCT03255980|580192170|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
160675888|NCT03255980|580192171|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
160675889|NCT03255980|580192172|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
160675890|NCT03255980|580192173|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
160675891|NCT03255980|580192170|FG000|Overall Study|Adverse Event|1|||
160675892|NCT03255980|580192171|FG001|Overall Study|Adverse Event|1|||
160675893|NCT03255980|580192172|FG002|Overall Study|Adverse Event|0|||
160675894|NCT03255980|580192173|FG003|Overall Study|Adverse Event|1|||
160675895|NCT03255980|580192170|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
160675896|NCT03255980|580192171|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
160675897|NCT03255980|580192172|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
160675898|NCT03255980|580192173|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
160675899|NCT03255980|580192170|FG000|Overall Study|Lost to Follow-up|1|||
160675900|NCT03255980|580192171|FG001|Overall Study|Lost to Follow-up|1|||
160675901|NCT03255980|580192172|FG002|Overall Study|Lost to Follow-up|0|||
160675902|NCT03255980|580192173|FG003|Overall Study|Lost to Follow-up|3|||
160675903|NCT03255980|580192170|FG000|Overall Study|Withdrawal by Subject|0|||
160675904|NCT03255980|580192171|FG001|Overall Study|Withdrawal by Subject|1|||
160675905|NCT03255980|580192172|FG002|Overall Study|Withdrawal by Subject|0|||
160675906|NCT03255980|580192173|FG003|Overall Study|Withdrawal by Subject|3|||
160675907|NCT02611362|580192174|FG000|Overall Study|Withdrawal by Subject|7|||
160675908|NCT02611362|580192175|FG001|Overall Study|Withdrawal by Subject|2|||
160675909|NCT02611362|580192174|FG000|Overall Study|Lost to Follow-up|2|||
160675910|NCT02611362|580192175|FG001|Overall Study|Lost to Follow-up|4|||
160675911|NCT00354159|580192176|FG000|Randomized Study Period|Withdrawal by Subject|5|||
160675912|NCT00354159|580192177|FG001|Randomized Study Period|Withdrawal by Subject|3|||
160675913|NCT00354159|580192176|FG000|Randomized Study Period|Physician Decision|6|||
160675914|NCT00354159|580192177|FG001|Randomized Study Period|Physician Decision|10|||
160675915|NCT00354159|580192176|FG000|Randomized Study Period|Lost to Follow-up|4|||
160675916|NCT00354159|580192177|FG001|Randomized Study Period|Lost to Follow-up|0|||
160675917|NCT00354159|580192176|FG000|Randomized Study Period|Death|7|||
160675918|NCT00354159|580192177|FG001|Randomized Study Period|Death|9|||
160675919|NCT00354159|580192176|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
160675920|NCT00354159|580192177|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
160675921|NCT00354159|580192176|FG000|Long-term Follow-up|Physician Decision|127|||
160675922|NCT00354159|580192177|FG001|Long-term Follow-up|Physician Decision|122|||
160675923|NCT00354159|580192176|FG000|Long-term Follow-up|Lost to Follow-up|1|||
160675924|NCT00354159|580192177|FG001|Long-term Follow-up|Lost to Follow-up|0|||
160675925|NCT00354159|580192176|FG000|Long-term Follow-up|Death|14|||
160675926|NCT00354159|580192177|FG001|Long-term Follow-up|Death|11|||
160675927|NCT00354159|580192176|FG000|Long-term Follow-up|Study Closed|29|||
160675928|NCT00354159|580192177|FG001|Long-term Follow-up|Study Closed|34|||
160675929|NCT02229084|580192179|FG000|Overall Study|Adverse Event|1|||
160675930|NCT02229084|580192180|FG001|Overall Study|Adverse Event|0|||
160675931|NCT02229084|580192181|FG002|Overall Study|Adverse Event|0|||
160675932|NCT02229084|580192182|FG003|Overall Study|Adverse Event|0|||
160675933|NCT02229084|580192183|FG004|Overall Study|Adverse Event|0|||
160675934|NCT02229084|580192184|FG005|Overall Study|Adverse Event|0|||
160675935|NCT02229084|580192185|FG006|Overall Study|Adverse Event|0|||
160675936|NCT02229084|580192179|FG000|Overall Study|Lost to Follow-up|0|||
160675937|NCT02229084|580192180|FG001|Overall Study|Lost to Follow-up|0|||
160675938|NCT02229084|580192181|FG002|Overall Study|Lost to Follow-up|1|||
160675939|NCT02229084|580192182|FG003|Overall Study|Lost to Follow-up|1|||
160675940|NCT02229084|580192183|FG004|Overall Study|Lost to Follow-up|0|||
160675941|NCT02229084|580192184|FG005|Overall Study|Lost to Follow-up|0|||
160675942|NCT02229084|580192185|FG006|Overall Study|Lost to Follow-up|1|||
160675943|NCT02229084|580192179|FG000|Overall Study|Physician Decision|0|||
160675944|NCT02229084|580192180|FG001|Overall Study|Physician Decision|0|||
160675945|NCT02229084|580192181|FG002|Overall Study|Physician Decision|0|||
160675946|NCT02229084|580192182|FG003|Overall Study|Physician Decision|1|||
160675947|NCT02229084|580192183|FG004|Overall Study|Physician Decision|3|||
160675948|NCT02229084|580192184|FG005|Overall Study|Physician Decision|0|||
160675949|NCT02229084|580192185|FG006|Overall Study|Physician Decision|1|||
160675950|NCT02229084|580192179|FG000|Overall Study|Withdrawal by Subject|0|||
160675951|NCT02229084|580192180|FG001|Overall Study|Withdrawal by Subject|0|||
160675952|NCT02229084|580192181|FG002|Overall Study|Withdrawal by Subject|1|||
160675953|NCT02229084|580192182|FG003|Overall Study|Withdrawal by Subject|0|||
160675954|NCT02229084|580192183|FG004|Overall Study|Withdrawal by Subject|1|||
160675955|NCT02229084|580192184|FG005|Overall Study|Withdrawal by Subject|1|||
160675956|NCT02229084|580192185|FG006|Overall Study|Withdrawal by Subject|1|||
160675957|NCT02229084|580192179|FG000|Overall Study|Death|0|||
160675958|NCT02229084|580192180|FG001|Overall Study|Death|0|||
160675959|NCT02229084|580192181|FG002|Overall Study|Death|0|||
160675960|NCT02229084|580192182|FG003|Overall Study|Death|0|||
160675961|NCT02229084|580192183|FG004|Overall Study|Death|0|||
160675962|NCT02229084|580192184|FG005|Overall Study|Death|0|||
160675963|NCT02229084|580192185|FG006|Overall Study|Death|1|||
160675964|NCT01728116|580192188|FG000|Overall Study|Sponsor Terminated Study|106|||
160675965|NCT01728116|580192189|FG001|Overall Study|Sponsor Terminated Study|35|||
160675966|NCT01728116|580192188|FG000|Overall Study|Withdrawal by Subject|16|||
160675967|NCT01728116|580192189|FG001|Overall Study|Withdrawal by Subject|9|||
160675968|NCT01728116|580192188|FG000|Overall Study|Adverse Event|13|||
160675969|NCT01728116|580192189|FG001|Overall Study|Adverse Event|0|||
160675970|NCT01728116|580192188|FG000|Overall Study|Procedure/device failure|7|||
160675971|NCT01728116|580192189|FG001|Overall Study|Procedure/device failure|0|||
160675972|NCT01728116|580192188|FG000|Overall Study|Lost to Follow-up|9|||
160675973|NCT01728116|580192189|FG001|Overall Study|Lost to Follow-up|2|||
160675974|NCT01728116|580192188|FG000|Overall Study|Physician Decision|2|||
160675975|NCT01728116|580192189|FG001|Overall Study|Physician Decision|0|||
160675976|NCT01728116|580192188|FG000|Overall Study|Subject Non-Compliance|2|||
160675977|NCT01728116|580192189|FG001|Overall Study|Subject Non-Compliance|0|||
160675978|NCT01728116|580192188|FG000|Overall Study|Inter-current finding at procedure|1|||
160675979|NCT01728116|580192189|FG001|Overall Study|Inter-current finding at procedure|0|||
160675980|NCT01728116|580192188|FG000|Overall Study|Incorrectly enrolled in Study|0|||
160675981|NCT01728116|580192189|FG001|Overall Study|Incorrectly enrolled in Study|1|||
160675982|NCT01728116|580192188|FG000|Overall Study|various not noted previously|5|||
160675983|NCT01728116|580192189|FG001|Overall Study|various not noted previously|0|||
160675984|NCT01559116|580192200|FG000|Overall Study|Adverse Event|10|||
160675985|NCT01559116|580192200|FG000|Overall Study|Lack of Efficacy|1|||
160675986|NCT01559116|580192200|FG000|Overall Study|Lost to Follow-up|1|||
160675987|NCT01559116|580192200|FG000|Overall Study|Protocol Violation|1|||
160675988|NCT01559116|580192200|FG000|Overall Study|Withdrawal by Subject|4|||
160675989|NCT01559116|580192200|FG000|Overall Study|other than stated above|9|||
160675990|NCT01451541|580192202|FG000|Overall Study|Adverse Event|4|||
160675991|NCT01451541|580192203|FG001|Overall Study|Adverse Event|3|||
160675992|NCT01451541|580192204|FG002|Overall Study|Adverse Event|6|||
160675993|NCT01451541|580192202|FG000|Overall Study|Lack of Efficacy|2|||
160675994|NCT01451541|580192203|FG001|Overall Study|Lack of Efficacy|0|||
160675995|NCT01451541|580192204|FG002|Overall Study|Lack of Efficacy|0|||
160675996|NCT01451541|580192202|FG000|Overall Study|Lost to Follow-up|4|||
160675997|NCT01451541|580192203|FG001|Overall Study|Lost to Follow-up|4|||
160675998|NCT01451541|580192204|FG002|Overall Study|Lost to Follow-up|7|||
160675999|NCT01451541|580192202|FG000|Overall Study|Withdrawal by Subject|15|||
160676000|NCT01451541|580192203|FG001|Overall Study|Withdrawal by Subject|8|||
160676001|NCT01451541|580192204|FG002|Overall Study|Withdrawal by Subject|6|||
160676002|NCT01451541|580192202|FG000|Overall Study|randomization error, noncompliance|11|||
160676003|NCT01451541|580192203|FG001|Overall Study|randomization error, noncompliance|10|||
160676004|NCT01451541|580192204|FG002|Overall Study|randomization error, noncompliance|8|||
160676005|NCT00006436|580192207|FG000|Overall Study|Refused further treatment|2|||
160676006|NCT00006436|580192207|FG000|Overall Study|Declined to participate (before treatment started)|1|||
160676007|NCT00939523|580192208|FG000|Overall Study|Lack of Efficacy|1|||
160676008|NCT00939523|580192208|FG000|Overall Study|Physician Decision|2|||
160676009|NCT01499043|580192213|FG000|Overall Study|Progressive disease (radiographic)|2|||
160676010|NCT01499043|580192213|FG000|Overall Study|Progressive disease (clinical)|1|||
160676011|NCT01499043|580192213|FG000|Overall Study|Withdrawal by Subject|2|||
160676012|NCT01499043|580192213|FG000|Overall Study|Adverse Event|1|||
160676013|NCT01596127|580192216|FG000|Overall Study|Patient Ineligible|1|||
160676014|NCT05468320|580192217|FG000|Overall Study|Other|1|||
160676015|NCT05468320|580192217|FG000|Overall Study|Adverse Event|1|||
160676016|NCT00820599|580193603|FG000|Overall Study|Death|129|||
160676017|NCT00820599|580193603|FG000|Overall Study|Withdrawal by Subject|2|||
160676018|NCT03686215|580193604|FG000|Overall Study|Adverse Event|0|||
160676019|NCT03686215|580193605|FG001|Overall Study|Adverse Event|0|||
160676020|NCT03686215|580193606|FG002|Overall Study|Adverse Event|7|||
160676021|NCT03686215|580193604|FG000|Overall Study|Physician Decision|0|||
160676022|NCT03686215|580193605|FG001|Overall Study|Physician Decision|0|||
160676023|NCT03686215|580193606|FG002|Overall Study|Physician Decision|1|||
160676024|NCT03686215|580193604|FG000|Overall Study|Protocol Violation|0|||
160676025|NCT03686215|580193605|FG001|Overall Study|Protocol Violation|0|||
160676026|NCT03686215|580193606|FG002|Overall Study|Protocol Violation|4|||
160676027|NCT03686215|580193604|FG000|Overall Study|Device issue|1|||
160676028|NCT03686215|580193605|FG001|Overall Study|Device issue|0|||
160676029|NCT03686215|580193606|FG002|Overall Study|Device issue|2|||
160676030|NCT00202839|580193609|FG000|Overall Study|Adverse Event|1|||
160676031|NCT00202839|580193610|FG001|Overall Study|Adverse Event|5|||
160676032|NCT00202839|580193609|FG000|Overall Study|Physician Decision|12|||
160676033|NCT00202839|580193610|FG001|Overall Study|Physician Decision|0|||
160676034|NCT00202839|580193609|FG000|Overall Study|Withdrawal by Subject|6|||
160676035|NCT00202839|580193610|FG001|Overall Study|Withdrawal by Subject|2|||
160676036|NCT00202839|580193609|FG000|Overall Study|Protocol Violation|2|||
160676037|NCT00202839|580193610|FG001|Overall Study|Protocol Violation|1|||
160676038|NCT00202839|580193609|FG000|Overall Study|Lost to Follow-up|3|||
160676039|NCT00202839|580193610|FG001|Overall Study|Lost to Follow-up|2|||
160676040|NCT01490190|580193612|FG000|Overall Study|Withdrawal by Subject|9|||
160676041|NCT01490190|580193612|FG000|Overall Study|Adverse Event|17|||
160676042|NCT01490190|580193612|FG000|Overall Study|Protocol Violation|5|||
160676043|NCT01490190|580193612|FG000|Overall Study|Lost to Follow-up|13|||
160676044|NCT01490190|580193612|FG000|Overall Study|Relocation|1|||
160676045|NCT01490190|580193612|FG000|Overall Study|Inconvenience|1|||
160676046|NCT01490190|580193612|FG000|Overall Study|Ring expulsion|2|||
160676047|NCT00063258|580193613|FG000|Overall Study|Physician Decision|2|||
160676048|NCT00063258|580193614|FG001|Overall Study|Physician Decision|0|||
160676049|NCT00063258|580193613|FG000|Overall Study|Lack of Efficacy|2|||
160676050|NCT00063258|580193614|FG001|Overall Study|Lack of Efficacy|0|||
160676051|NCT02483416|580193617|FG000|Overall Study|Other reason|0|||
160676052|NCT02483416|580193618|FG001|Overall Study|Other reason|1|||
160676053|NCT02483416|580193617|FG000|Overall Study|Treatment stop|3|||
160676054|NCT02483416|580193618|FG001|Overall Study|Treatment stop|0|||
160676055|NCT02854800|580193626|FG000|Overall Study|Protocol Violation|16|||
160676056|NCT02854800|580193627|FG001|Overall Study|Protocol Violation|11|||
160676057|NCT02854800|580193628|FG002|Overall Study|Protocol Violation|3|||
160676058|NCT02854800|580193626|FG000|Overall Study|Withdrawal by Subject|4|||
160676059|NCT02854800|580193627|FG001|Overall Study|Withdrawal by Subject|2|||
160676060|NCT02854800|580193628|FG002|Overall Study|Withdrawal by Subject|3|||
160676061|NCT04697173|580193639|FG000|Overall Study|Withdrawal by Subject|34|||
160676062|NCT04697173|580193640|FG001|Overall Study|Withdrawal by Subject|38|||
160676063|NCT03504085|580193641|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
160676064|NCT03504085|580193642|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
160676065|NCT03504085|580193641|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
160676066|NCT03504085|580193642|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
160676067|NCT04133311|580193644|FG000|Period 1 Double Masked Treatment Period|Death|1|||
160676068|NCT04133311|580193645|FG001|Period 1 Double Masked Treatment Period|Death|0|||
160676069|NCT04133311|580193646|FG002|Period 1 Double Masked Treatment Period|Death|0|||
160676070|NCT04133311|580193647|FG003|Period 1 Double Masked Treatment Period|Death|0|||
160676071|NCT04133311|580193644|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
160676072|NCT04133311|580193645|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
160676073|NCT04133311|580193646|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
160676074|NCT04133311|580193647|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
160676075|NCT04133311|580193644|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
160676076|NCT04133311|580193645|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
160676077|NCT04133311|580193646|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
160676078|NCT04133311|580193647|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
160676079|NCT04133311|580193644|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
160676080|NCT04133311|580193645|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
160676081|NCT04133311|580193646|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
160676082|NCT04133311|580193647|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
160676083|NCT04133311|580193644|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
160676084|NCT04133311|580193645|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
160676085|NCT04133311|580193646|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
160676086|NCT04133311|580193647|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
160676087|NCT04133311|580193644|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
160676088|NCT04133311|580193645|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
160676089|NCT04133311|580193646|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
160676090|NCT04133311|580193647|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
160676091|NCT04133311|580193644|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
160676092|NCT04133311|580193645|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
160676093|NCT04133311|580193646|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
160676094|NCT04133311|580193647|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
160676095|NCT04133311|580193644|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
160676096|NCT04133311|580193645|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
160676097|NCT04133311|580193646|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
160676098|NCT04133311|580193647|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
160676099|NCT01859598|580193654|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
160676100|NCT00009945|580193655|FG000|Overall Study|no follow up data|7|||
160676101|NCT00009945|580193656|FG001|Overall Study|no follow up data|5|||
160676102|NCT00672984|580193657|FG000|First Intervention|Adverse Event|5|||
160676103|NCT00672984|580193658|FG001|First Intervention|Adverse Event|0|||
160676104|NCT00672984|580193659|FG002|First Intervention|Adverse Event|0|||
160676105|NCT00672984|580193657|FG000|First Intervention|Withdrawal by Subject|1|||
160676106|NCT00672984|580193658|FG001|First Intervention|Withdrawal by Subject|2|||
160676107|NCT00672984|580193659|FG002|First Intervention|Withdrawal by Subject|2|||
160676108|NCT00672984|580193657|FG000|First Intervention|Sponsor decision|3|||
160676109|NCT00672984|580193658|FG001|First Intervention|Sponsor decision|0|||
160676110|NCT00672984|580193659|FG002|First Intervention|Sponsor decision|0|||
160676111|NCT00672984|580193657|FG000|Second Intervention|Non-compliance with facility policies|0|||
160676112|NCT00672984|580193658|FG001|Second Intervention|Non-compliance with facility policies|2|||
160676113|NCT00672984|580193659|FG002|Second Intervention|Non-compliance with facility policies|0|||
160676114|NCT00672984|580193657|FG000|Second Intervention|Withdrawal by Subject|0|||
160676115|NCT00672984|580193658|FG001|Second Intervention|Withdrawal by Subject|3|||
160676116|NCT00672984|580193659|FG002|Second Intervention|Withdrawal by Subject|0|||
160676117|NCT00672984|580193657|FG000|Second Intervention|Protocol Violation|0|||
160676118|NCT00672984|580193658|FG001|Second Intervention|Protocol Violation|1|||
160676119|NCT00672984|580193659|FG002|Second Intervention|Protocol Violation|1|||
160676120|NCT00672984|580193657|FG000|Third Intervention|Adverse Event|1|||
160676121|NCT00672984|580193658|FG001|Third Intervention|Adverse Event|0|||
160676122|NCT00672984|580193659|FG002|Third Intervention|Adverse Event|1|||
160676123|NCT01597791|580193660|FG000|Overall Study|Physician Decision|2|||
160676124|NCT01597791|580193661|FG001|Overall Study|Physician Decision|1|||
160676125|NCT01597791|580193660|FG000|Overall Study|Cesarean Section|6|||
160676126|NCT01597791|580193661|FG001|Overall Study|Cesarean Section|7|||
160676127|NCT01597791|580193660|FG000|Overall Study|Subject withdrawal|0|||
160676128|NCT01597791|580193661|FG001|Overall Study|Subject withdrawal|1|||
160676129|NCT01597791|580193660|FG000|Overall Study|Protocol Violation|0|||
160676130|NCT01597791|580193661|FG001|Overall Study|Protocol Violation|1|||
160676131|NCT01868243|580193662|FG000|Overall Study|Death|0|||
160676132|NCT01868243|580193663|FG001|Overall Study|Death|1|||
160676133|NCT01745094|580193665|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
160676134|NCT01745094|580193666|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
160676135|NCT01745094|580193667|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
160676136|NCT01745094|580193668|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
160676137|NCT01745094|580193665|FG000|Overall Study|Adverse Event|0|||
160676138|NCT01745094|580193666|FG001|Overall Study|Adverse Event|0|||
160676139|NCT01745094|580193667|FG002|Overall Study|Adverse Event|3|||
160676140|NCT01745094|580193668|FG003|Overall Study|Adverse Event|0|||
160676141|NCT01745094|580193665|FG000|Overall Study|Withdrawal by Subject|2|||
160676142|NCT01745094|580193666|FG001|Overall Study|Withdrawal by Subject|0|||
160676143|NCT01745094|580193667|FG002|Overall Study|Withdrawal by Subject|1|||
160676144|NCT01745094|580193668|FG003|Overall Study|Withdrawal by Subject|2|||
160676145|NCT01745094|580193665|FG000|Overall Study|Protocol Violation|1|||
160676146|NCT01745094|580193666|FG001|Overall Study|Protocol Violation|0|||
160676147|NCT01745094|580193667|FG002|Overall Study|Protocol Violation|3|||
160676148|NCT01745094|580193668|FG003|Overall Study|Protocol Violation|1|||
160676149|NCT01745094|580193665|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
160676150|NCT01745094|580193666|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
160676151|NCT01745094|580193667|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
160676152|NCT01745094|580193668|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
160676153|NCT01745094|580193665|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
160676154|NCT01745094|580193666|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
160676155|NCT01745094|580193667|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
160676156|NCT01745094|580193668|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
160676157|NCT01745094|580193665|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
160676158|NCT01745094|580193666|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
160676159|NCT01745094|580193667|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
160676160|NCT01745094|580193668|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
160676161|NCT04610580|580193669|FG000|Two-way Crossover Period|Adverse Event|1|||
160676162|NCT04610580|580193670|FG001|Two-way Crossover Period|Adverse Event|0|||
160676163|NCT04610580|580193671|FG002|Two-way Crossover Period|Adverse Event|0|||
160676164|NCT04610580|580193672|FG003|Two-way Crossover Period|Adverse Event|0|||
160676165|NCT04610580|580193673|FG004|Two-way Crossover Period|Adverse Event|0|||
160676166|NCT04610580|580193674|FG005|Two-way Crossover Period|Adverse Event|0|||
160676167|NCT04610580|580193669|FG000|Two-way Crossover Period|Physician Decision|1|||
160676168|NCT04610580|580193670|FG001|Two-way Crossover Period|Physician Decision|0|||
160676169|NCT04610580|580193671|FG002|Two-way Crossover Period|Physician Decision|0|||
160676170|NCT04610580|580193672|FG003|Two-way Crossover Period|Physician Decision|0|||
160676171|NCT04610580|580193673|FG004|Two-way Crossover Period|Physician Decision|0|||
160676172|NCT04610580|580193674|FG005|Two-way Crossover Period|Physician Decision|0|||
160676173|NCT04610580|580193669|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
160676174|NCT04610580|580193670|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
160676175|NCT04610580|580193671|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
160676176|NCT04610580|580193672|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
160676177|NCT04610580|580193673|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
160676178|NCT04610580|580193674|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
160676179|NCT04610580|580193669|FG000|Two-way Crossover Period|Other than specified|0|||
160676180|NCT04610580|580193670|FG001|Two-way Crossover Period|Other than specified|1|||
160676181|NCT04610580|580193671|FG002|Two-way Crossover Period|Other than specified|0|||
160676182|NCT04610580|580193672|FG003|Two-way Crossover Period|Other than specified|0|||
160676183|NCT04610580|580193673|FG004|Two-way Crossover Period|Other than specified|0|||
160676184|NCT04610580|580193674|FG005|Two-way Crossover Period|Other than specified|0|||
160676185|NCT04610580|580193669|FG000|Washout Before Extension Period|Other than specified|0|||
160676186|NCT04610580|580193670|FG001|Washout Before Extension Period|Other than specified|1|||
160676187|NCT04610580|580193671|FG002|Washout Before Extension Period|Other than specified|0|||
160676188|NCT04610580|580193672|FG003|Washout Before Extension Period|Other than specified|0|||
160676189|NCT04610580|580193673|FG004|Washout Before Extension Period|Other than specified|0|||
160676190|NCT04610580|580193674|FG005|Washout Before Extension Period|Other than specified|0|||
160676191|NCT04610580|580193669|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
160676192|NCT04610580|580193670|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
160676193|NCT04610580|580193671|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
160676194|NCT04610580|580193672|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
160676195|NCT04610580|580193673|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
160676196|NCT04610580|580193674|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
160676197|NCT04610580|580193669|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
160676198|NCT04610580|580193670|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
160676199|NCT04610580|580193671|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
160676200|NCT04610580|580193672|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
160676201|NCT04610580|580193673|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
160676202|NCT04610580|580193674|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
160676203|NCT03277248|580193675|FG000|Overall Study|Adverse Event|3|||
160676204|NCT03277248|580193676|FG001|Overall Study|Adverse Event|1|||
160676205|NCT03277248|580193675|FG000|Overall Study|Subject Withdrawal of Consent|6|||
160676206|NCT03277248|580193676|FG001|Overall Study|Subject Withdrawal of Consent|23|||
160676207|NCT03277248|580193675|FG000|Overall Study|Investigator/Sponsor Decision|2|||
160676208|NCT03277248|580193676|FG001|Overall Study|Investigator/Sponsor Decision|2|||
160676209|NCT03277248|580193675|FG000|Overall Study|Pregnancy|4|||
160676210|NCT03277248|580193676|FG001|Overall Study|Pregnancy|1|||
160676211|NCT03277248|580193675|FG000|Overall Study|Lost to Follow-up|0|||
160676212|NCT03277248|580193676|FG001|Overall Study|Lost to Follow-up|2|||
160676213|NCT03277248|580193675|FG000|Overall Study|Lack of Efficacy|0|||
160676214|NCT03277248|580193676|FG001|Overall Study|Lack of Efficacy|2|||
160676215|NCT03277248|580193675|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
160676216|NCT03277248|580193676|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
160676217|NCT01993940|580193677|FG000|Overall Study|Adverse Event|16|||
160676218|NCT01993940|580193678|FG001|Overall Study|Adverse Event|11|||
160676219|NCT01993940|580193677|FG000|Overall Study|Withdrawal by Subject|15|||
160676220|NCT01993940|580193678|FG001|Overall Study|Withdrawal by Subject|19|||
160676221|NCT01993940|580193677|FG000|Overall Study|Lost to Follow-up|2|||
160676222|NCT01993940|580193678|FG001|Overall Study|Lost to Follow-up|5|||
160676223|NCT01993940|580193677|FG000|Overall Study|Protocol Violation|5|||
160676224|NCT01993940|580193678|FG001|Overall Study|Protocol Violation|8|||
160676225|NCT01993940|580193677|FG000|Overall Study|Death|1|||
160676226|NCT01993940|580193678|FG001|Overall Study|Death|0|||
160676227|NCT01993940|580193677|FG000|Overall Study|Other - Miscellaneous|1|||
160676228|NCT01993940|580193678|FG001|Overall Study|Other - Miscellaneous|1|||
160676229|NCT00379353|580193679|FG000|Overall Study|Hospitalization|3|||
160676230|NCT00379353|580193680|FG001|Overall Study|Hospitalization|3|||
160676231|NCT00379353|580193679|FG000|Overall Study|Withdrawal by Subject|5|||
160676232|NCT00379353|580193680|FG001|Overall Study|Withdrawal by Subject|2|||
160676233|NCT00379353|580193679|FG000|Overall Study|Death|1|||
160676234|NCT00379353|580193680|FG001|Overall Study|Death|0|||
160676235|NCT00379353|580193679|FG000|Overall Study|Cardiac Tamponade|1|||
160676236|NCT00379353|580193680|FG001|Overall Study|Cardiac Tamponade|0|||
160676237|NCT00379353|580193679|FG000|Overall Study|Non-compliance|1|||
160676238|NCT00379353|580193680|FG001|Overall Study|Non-compliance|0|||
160676239|NCT00379353|580193679|FG000|Overall Study|Conflicting drug treatment|0|||
160676240|NCT00379353|580193680|FG001|Overall Study|Conflicting drug treatment|1|||
160676241|NCT05665387|580193681|FG000|Overall Study|Withdrawal by Subject|1|||
160676242|NCT05665387|580193682|FG001|Overall Study|Withdrawal by Subject|0|||
160676243|NCT05665387|580193683|FG002|Overall Study|Withdrawal by Subject|1|||
160676244|NCT01824498|580193684|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
160676245|NCT01824498|580193685|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
160676246|NCT01824498|580193686|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
160676247|NCT01824498|580193687|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
160676248|NCT01824498|580193688|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
160676249|NCT01824498|580193689|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
160676250|NCT00884390|580193691|FG000|Overall Study|Adverse Event|0|||
160676251|NCT00884390|580193692|FG001|Overall Study|Adverse Event|1|||
160676252|NCT00884390|580193691|FG000|Overall Study|Lost to Follow-up|0|||
160676253|NCT00884390|580193692|FG001|Overall Study|Lost to Follow-up|1|||
160676254|NCT00884390|580193691|FG000|Overall Study|Physician Decision|2|||
160676255|NCT00884390|580193692|FG001|Overall Study|Physician Decision|1|||
160676256|NCT00884390|580193691|FG000|Overall Study|Protocol Violation|4|||
160676257|NCT00884390|580193692|FG001|Overall Study|Protocol Violation|1|||
160676258|NCT00884390|580193691|FG000|Overall Study|Withdrawal by Subject|4|||
160676259|NCT00884390|580193692|FG001|Overall Study|Withdrawal by Subject|1|||
160676260|NCT00884390|580193691|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
160676261|NCT00884390|580193692|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
160676262|NCT00884390|580193691|FG000|Overall Study|Other|11|||
160676263|NCT00884390|580193692|FG001|Overall Study|Other|1|||
160676264|NCT00570128|580193695|FG000|Overall Study|Adverse Event|1|||
160676265|NCT00570128|580193696|FG001|Overall Study|Adverse Event|0|||
160676266|NCT00570128|580193695|FG000|Overall Study|Lost to Follow-up|1|||
160676267|NCT00570128|580193696|FG001|Overall Study|Lost to Follow-up|0|||
160676268|NCT00570128|580193695|FG000|Overall Study|Withdrawal by Subject|2|||
160676269|NCT00570128|580193696|FG001|Overall Study|Withdrawal by Subject|0|||
160676270|NCT01528735|580193699|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
160676271|NCT01528735|580193700|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
160676272|NCT01528735|580193699|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
160676273|NCT01528735|580193700|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
160676274|NCT01426854|580193701|FG000|Overall Study|Adverse Event|1|||
160676275|NCT01426854|580193702|FG001|Overall Study|Adverse Event|5|||
160676276|NCT01426854|580193701|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
160676277|NCT01426854|580193702|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
160676278|NCT01426854|580193701|FG000|Overall Study|Lost to Follow-up|3|||
160676279|NCT01426854|580193702|FG001|Overall Study|Lost to Follow-up|0|||
160676280|NCT01426854|580193701|FG000|Overall Study|Noncompliance|0|||
160676281|NCT01426854|580193702|FG001|Overall Study|Noncompliance|1|||
160676282|NCT01426854|580193701|FG000|Overall Study|Treatment Failure|0|||
160676283|NCT01426854|580193702|FG001|Overall Study|Treatment Failure|16|||
160676284|NCT01426854|580193701|FG000|Overall Study|Protocol Deviation|0|||
160676285|NCT01426854|580193702|FG001|Overall Study|Protocol Deviation|1|||
160676286|NCT01426854|580193701|FG000|Overall Study|Other|3|||
160676287|NCT01426854|580193702|FG001|Overall Study|Other|2|||
160676288|NCT00757172|580193703|FG000|Overall Study|Withdrawal by Subject|4|||
160676289|NCT00757172|580193703|FG000|Overall Study|Physician Decision|3|||
160676290|NCT00757172|580193703|FG000|Overall Study|Progression|4|||
160676291|NCT03555695|580193704|FG000|Overall Study|Withdrawal by Subject|1|||
160676292|NCT03555695|580193704|FG000|Overall Study|Lost to Follow-up|1|||
160676293|NCT03555695|580193704|FG000|Overall Study|appendicitis (unrelated)|1|||
160676294|NCT03555695|580193704|FG000|Overall Study|pre-existing sciatica|1|||
160676295|NCT01942135|580193709|FG000|Overall Study|Adverse Event|21|||
160676296|NCT01942135|580193710|FG001|Overall Study|Adverse Event|7|||
160676297|NCT01942135|580193709|FG000|Overall Study|Global Deterioration of Health Status|9|||
160676298|NCT01942135|580193710|FG001|Overall Study|Global Deterioration of Health Status|6|||
160676299|NCT01942135|580193709|FG000|Overall Study|Randomized Not Treated|2|||
160676300|NCT01942135|580193710|FG001|Overall Study|Randomized Not Treated|2|||
160676301|NCT01942135|580193709|FG000|Overall Study|Death|2|||
160676302|NCT01942135|580193710|FG001|Overall Study|Death|1|||
160676303|NCT01942135|580193709|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
160676304|NCT01942135|580193710|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
160676305|NCT01942135|580193709|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
160676306|NCT01942135|580193710|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
160676307|NCT01942135|580193709|FG000|Overall Study|Withdrawal by Subject|4|||
160676308|NCT01942135|580193710|FG001|Overall Study|Withdrawal by Subject|3|||
160676309|NCT01942135|580193709|FG000|Overall Study|Protocol Violation|1|||
160676310|NCT01942135|580193710|FG001|Overall Study|Protocol Violation|0|||
160676311|NCT01942135|580193709|FG000|Overall Study|Other|19|||
160676312|NCT01942135|580193710|FG001|Overall Study|Other|4|||
160676313|NCT01566435|580193712|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
160676314|NCT00438633|580193713|FG000|Overall Study|Withdrawal by Subject|1|||
160676315|NCT00438633|580193714|FG001|Overall Study|Withdrawal by Subject|0|||
160676316|NCT00438633|580193713|FG000|Overall Study|Lost to Follow-up|15|||
160676317|NCT00438633|580193714|FG001|Overall Study|Lost to Follow-up|17|||
160676318|NCT04569084|580193715|FG000|Overall Study|Adverse Event|10|||
160676319|NCT04569084|580193716|FG001|Overall Study|Adverse Event|14|||
160676320|NCT04569084|580193715|FG000|Overall Study|Death|2|||
160676321|NCT04569084|580193716|FG001|Overall Study|Death|3|||
160676322|NCT04569084|580193715|FG000|Overall Study|Lost to Follow-up|1|||
160676323|NCT04569084|580193716|FG001|Overall Study|Lost to Follow-up|1|||
160676324|NCT04569084|580193715|FG000|Overall Study|Physician Decision|3|||
160676325|NCT04569084|580193716|FG001|Overall Study|Physician Decision|3|||
160676326|NCT04569084|580193715|FG000|Overall Study|Protocol Violation|2|||
160676327|NCT04569084|580193716|FG001|Overall Study|Protocol Violation|1|||
160676328|NCT04569084|580193715|FG000|Overall Study|Withdrawal by Subject|20|||
160676329|NCT04569084|580193716|FG001|Overall Study|Withdrawal by Subject|21|||
160676330|NCT04569084|580193715|FG000|Overall Study|Study terminated by sponsor|26|||
160676331|NCT04569084|580193716|FG001|Overall Study|Study terminated by sponsor|23|||
160676332|NCT04569084|580193715|FG000|Overall Study|Other|3|||
160676333|NCT04569084|580193716|FG001|Overall Study|Other|5|||
160676334|NCT03196284|580193717|FG000|Main Part|Withdrawal by Subject|0|||
160676335|NCT03196284|580193718|FG001|Main Part|Withdrawal by Subject|1|||
160676336|NCT03196284|580193719|FG002|Main Part|Withdrawal by Subject|0|||
160676337|NCT03196284|580193717|FG000|Extension Part|Lack of Efficacy|0|||
160676338|NCT03196284|580193718|FG001|Extension Part|Lack of Efficacy|0|||
160676339|NCT03196284|580193719|FG002|Extension Part|Lack of Efficacy|1|||
160676340|NCT03196284|580193717|FG000|Extension Part|Withdrawal by Subject|0|||
160676341|NCT03196284|580193718|FG001|Extension Part|Withdrawal by Subject|0|||
160676342|NCT03196284|580193719|FG002|Extension Part|Withdrawal by Subject|1|||
160676343|NCT03196284|580193717|FG000|Extension Part|Physician Decision|0|||
160676344|NCT03196284|580193718|FG001|Extension Part|Physician Decision|0|||
160676345|NCT03196284|580193719|FG002|Extension Part|Physician Decision|1|||
160676346|NCT00685334|580193725|FG000|Overall Study|Withdrawal by Subject|5|||
160676347|NCT00685334|580193726|FG001|Overall Study|Withdrawal by Subject|6|||
160676348|NCT00685334|580193725|FG000|Overall Study|Lost to Follow-up|4|||
160676349|NCT00685334|580193726|FG001|Overall Study|Lost to Follow-up|0|||
160676350|NCT00685334|580193725|FG000|Overall Study|Chose to enter hospital|1|||
160676351|NCT00685334|580193726|FG001|Overall Study|Chose to enter hospital|1|||
160676352|NCT03820947|580193727|FG000|Overall Study|Physician Decision|0|||
160676353|NCT03820947|580193728|FG001|Overall Study|Physician Decision|1|||
160676354|NCT03820947|580193729|FG002|Overall Study|Physician Decision|1|||
160676355|NCT03820947|580193730|FG003|Overall Study|Physician Decision|0|||
160676356|NCT03820947|580193731|FG004|Overall Study|Physician Decision|3|||
160676357|NCT03820947|580193727|FG000|Overall Study|Withdrawal by Subject|6|||
160676358|NCT03820947|580193728|FG001|Overall Study|Withdrawal by Subject|10|||
160676359|NCT03820947|580193729|FG002|Overall Study|Withdrawal by Subject|3|||
160676360|NCT03820947|580193730|FG003|Overall Study|Withdrawal by Subject|8|||
160676361|NCT03820947|580193731|FG004|Overall Study|Withdrawal by Subject|5|||
160676362|NCT03820947|580193727|FG000|Overall Study|Procedure Not Attempted|0|||
160676363|NCT03820947|580193728|FG001|Overall Study|Procedure Not Attempted|2|||
160676364|NCT03820947|580193729|FG002|Overall Study|Procedure Not Attempted|1|||
160676365|NCT03820947|580193730|FG003|Overall Study|Procedure Not Attempted|0|||
160676366|NCT03820947|580193731|FG004|Overall Study|Procedure Not Attempted|0|||
160676367|NCT03820947|580193727|FG000|Overall Study|Other Exit|1|||
160676368|NCT03820947|580193728|FG001|Overall Study|Other Exit|3|||
160676369|NCT03820947|580193729|FG002|Overall Study|Other Exit|3|||
160676370|NCT03820947|580193730|FG003|Overall Study|Other Exit|3|||
160676371|NCT03820947|580193731|FG004|Overall Study|Other Exit|0|||
160676372|NCT03820947|580193727|FG000|Overall Study|Follow-up Not Done|10|||
160676373|NCT03820947|580193728|FG001|Overall Study|Follow-up Not Done|13|||
160676374|NCT03820947|580193729|FG002|Overall Study|Follow-up Not Done|2|||
160676375|NCT03820947|580193730|FG003|Overall Study|Follow-up Not Done|3|||
160676376|NCT03820947|580193731|FG004|Overall Study|Follow-up Not Done|12|||
160676377|NCT03820947|580193727|FG000|Overall Study|Death|0|||
160676378|NCT03820947|580193728|FG001|Overall Study|Death|0|||
160676379|NCT03820947|580193729|FG002|Overall Study|Death|0|||
160676380|NCT03820947|580193730|FG003|Overall Study|Death|0|||
160676381|NCT03820947|580193731|FG004|Overall Study|Death|9|||
160676382|NCT03820947|580193727|FG000|Overall Study|Lost to Follow-up|4|||
160676383|NCT03820947|580193728|FG001|Overall Study|Lost to Follow-up|6|||
160676384|NCT03820947|580193729|FG002|Overall Study|Lost to Follow-up|0|||
160676385|NCT03820947|580193730|FG003|Overall Study|Lost to Follow-up|0|||
160676386|NCT03820947|580193731|FG004|Overall Study|Lost to Follow-up|9|||
160676387|NCT04729101|580194957|FG000|Overall Study|Adverse Event|1|||
160676388|NCT04729101|580194958|FG001|Overall Study|Adverse Event|0|||
160676389|NCT04729101|580194957|FG000|Overall Study|Physician Decision|1|||
160676390|NCT04729101|580194958|FG001|Overall Study|Physician Decision|0|||
160676391|NCT04729101|580194957|FG000|Overall Study|Withdrawal by Subject|1|||
160676392|NCT04729101|580194958|FG001|Overall Study|Withdrawal by Subject|0|||
160676393|NCT04556734|580194961|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
160676394|NCT04556734|580194962|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
160676395|NCT04556734|580194963|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
160676396|NCT04556734|580194964|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160676397|NCT04556734|580194965|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160676398|NCT04556734|580194966|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160676399|NCT04556734|580194967|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160676400|NCT04556734|580194968|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160676401|NCT04556734|580194961|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
160676402|NCT04556734|580194962|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
160676403|NCT04556734|580194963|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
160676404|NCT04556734|580194964|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
160676405|NCT04556734|580194965|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
160676406|NCT04556734|580194966|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
160676407|NCT04556734|580194967|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
160676408|NCT04556734|580194968|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
160676409|NCT04556734|580194961|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
160676410|NCT04556734|580194962|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160676411|NCT04556734|580194963|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
160676412|NCT04556734|580194964|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160676413|NCT04556734|580194965|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160676414|NCT04556734|580194966|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160676415|NCT04556734|580194967|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160676416|NCT04556734|580194968|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160676417|NCT04556734|580194961|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
160676418|NCT04556734|580194962|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160676419|NCT04556734|580194963|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160676420|NCT04556734|580194964|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160676421|NCT04556734|580194965|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160676422|NCT04556734|580194966|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160676423|NCT04556734|580194967|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160676424|NCT04556734|580194968|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160676425|NCT04556734|580194961|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
160676426|NCT04556734|580194962|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
160676427|NCT04556734|580194963|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
160676428|NCT04556734|580194964|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
160676429|NCT04556734|580194965|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
160676430|NCT04556734|580194966|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
160676431|NCT04556734|580194967|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
160676432|NCT04556734|580194968|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
160676433|NCT04556734|580194961|FG000|OLE Period (28 Weeks)|Not reported|0|||
160676434|NCT04556734|580194962|FG001|OLE Period (28 Weeks)|Not reported|0|||
160676435|NCT04556734|580194963|FG002|OLE Period (28 Weeks)|Not reported|0|||
160676436|NCT04556734|580194964|FG003|OLE Period (28 Weeks)|Not reported|0|||
160676437|NCT04556734|580194965|FG004|OLE Period (28 Weeks)|Not reported|0|||
160676438|NCT04556734|580194966|FG005|OLE Period (28 Weeks)|Not reported|1|||
160676439|NCT04556734|580194967|FG006|OLE Period (28 Weeks)|Not reported|0|||
160676440|NCT04556734|580194968|FG007|OLE Period (28 Weeks)|Not reported|0|||
160676441|NCT04556734|580194961|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
160676442|NCT04556734|580194962|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
160676443|NCT04556734|580194963|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
160676444|NCT04556734|580194964|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
160676445|NCT04556734|580194965|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
160676446|NCT04556734|580194966|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
160676447|NCT04556734|580194967|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
160676448|NCT04556734|580194968|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
160676449|NCT04556734|580194961|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
160676450|NCT04556734|580194962|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
160676451|NCT04556734|580194963|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
160676452|NCT04556734|580194964|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
160676453|NCT04556734|580194965|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
160676454|NCT04556734|580194966|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
160676455|NCT04556734|580194967|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
160676456|NCT04556734|580194968|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
160676457|NCT04556734|580194961|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
160676458|NCT04556734|580194962|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
160676459|NCT04556734|580194963|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
160676460|NCT04556734|580194964|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
160676461|NCT04556734|580194965|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
160676462|NCT04556734|580194966|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
160676463|NCT04556734|580194967|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
160676464|NCT04556734|580194968|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
160676465|NCT01662024|580194972|FG000|Overall Study|Pregnancy|2|||
160676466|NCT01662024|580194972|FG000|Overall Study|Withdrawal by Subject|3|||
160676467|NCT00927251|580194975|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
160676468|NCT01120899|580194982|FG000|Overall Study|Withdrawal by Subject|3|||
160676469|NCT00452348|580194983|FG000|Overall Study|Adverse Event|6|||
160676470|NCT00452348|580194984|FG001|Overall Study|Adverse Event|9|||
160676471|NCT00452348|580194983|FG000|Overall Study|Lack of Efficacy|10|||
160676472|NCT00452348|580194984|FG001|Overall Study|Lack of Efficacy|9|||
160676473|NCT00452348|580194983|FG000|Overall Study|Lost to Follow-up|14|||
160676474|NCT00452348|580194984|FG001|Overall Study|Lost to Follow-up|8|||
160676475|NCT00452348|580194983|FG000|Overall Study|Protocol Violation|22|||
160676476|NCT00452348|580194984|FG001|Overall Study|Protocol Violation|28|||
160676477|NCT00452348|580194983|FG000|Overall Study|Withdrawal by Subject|18|||
160676478|NCT00452348|580194984|FG001|Overall Study|Withdrawal by Subject|21|||
160676479|NCT00452348|580194983|FG000|Overall Study|Other|9|||
160676480|NCT00452348|580194984|FG001|Overall Study|Other|9|||
160676481|NCT03119662|580194987|FG000|Overall Study|Withdrawal by Subject|0|||
160676482|NCT03119662|580194988|FG001|Overall Study|Withdrawal by Subject|1|||
160676483|NCT02817828|580194989|FG000|Overall Study|Lost to Follow-up|41|||
160676484|NCT02817828|580194989|FG000|Overall Study|Adverse event not related to bleeding|104|||
160676485|NCT02817828|580194989|FG000|Overall Study|Adverse event related to bleeding|53|||
160676486|NCT02817828|580194989|FG000|Overall Study|Protocol Violation|11|||
160676487|NCT02817828|580194989|FG000|Overall Study|Pregnancy|7|||
160676488|NCT02817828|580194989|FG000|Overall Study|Pregnancy wish|15|||
160676489|NCT02817828|580194989|FG000|Overall Study|Withdrawal by Subject|78|||
160676490|NCT02817828|580194989|FG000|Overall Study|Other|26|||
160676491|NCT00522041|580194991|FG000|Overall Study|Adverse Event|9|||
160676492|NCT00522041|580194992|FG001|Overall Study|Adverse Event|3|||
160676493|NCT00522041|580194991|FG000|Overall Study|Protocol Violation|2|||
160676494|NCT00522041|580194992|FG001|Overall Study|Protocol Violation|0|||
160676495|NCT00522041|580194991|FG000|Overall Study|Lost to Follow-up|1|||
160676496|NCT00522041|580194992|FG001|Overall Study|Lost to Follow-up|4|||
160676497|NCT00522041|580194991|FG000|Overall Study|Voluntary withdrawal|5|||
160676498|NCT00522041|580194992|FG001|Overall Study|Voluntary withdrawal|4|||
160676499|NCT00522041|580194991|FG000|Overall Study|Did not receive treatment|0|||
160676500|NCT00522041|580194992|FG001|Overall Study|Did not receive treatment|1|||
160676501|NCT00544167|580194993|FG000|Overall Study|Adverse Event|21|||
160676502|NCT00544167|580194993|FG000|Overall Study|Physician Decision|8|||
160676503|NCT00874549|580194994|FG000|Overall Study|Adverse Event|0|||
160676504|NCT00874549|580194995|FG001|Overall Study|Adverse Event|0|||
160676505|NCT00874549|580194996|FG002|Overall Study|Adverse Event|1|||
160676506|NCT00874549|580194997|FG003|Overall Study|Adverse Event|0|||
160676507|NCT00874549|580194994|FG000|Overall Study|Protocol Violation|1|||
160676508|NCT00874549|580194995|FG001|Overall Study|Protocol Violation|0|||
160676509|NCT00874549|580194996|FG002|Overall Study|Protocol Violation|2|||
160676510|NCT00874549|580194997|FG003|Overall Study|Protocol Violation|1|||
160676511|NCT00874549|580194994|FG000|Overall Study|Lost to Follow-up|0|||
160676512|NCT00874549|580194995|FG001|Overall Study|Lost to Follow-up|0|||
160676513|NCT00874549|580194996|FG002|Overall Study|Lost to Follow-up|1|||
160676514|NCT00874549|580194997|FG003|Overall Study|Lost to Follow-up|0|||
160676515|NCT00874549|580194994|FG000|Overall Study|Withdrawal by Subject|0|||
160676516|NCT00874549|580194995|FG001|Overall Study|Withdrawal by Subject|1|||
160676517|NCT00874549|580194996|FG002|Overall Study|Withdrawal by Subject|0|||
160676518|NCT00874549|580194997|FG003|Overall Study|Withdrawal by Subject|1|||
160676519|NCT03343639|580194998|FG000|Overall Study|Withdrawal by Subject|10|||
160676520|NCT03343639|580194999|FG001|Overall Study|Withdrawal by Subject|6|||
160676521|NCT03343639|580194998|FG000|Overall Study|Lost to Follow-up|4|||
160676522|NCT03343639|580194999|FG001|Overall Study|Lost to Follow-up|5|||
160676523|NCT03343639|580194998|FG000|Overall Study|Protocol Violation|0|||
160676524|NCT03343639|580194999|FG001|Overall Study|Protocol Violation|1|||
160676525|NCT00735696|580195004|FG000|Overall Study|Withdrawal by Subject|1|||
160676526|NCT00735696|580195004|FG000|Overall Study|Enrolled but never Treated|1|||
160676527|NCT00084864|580195005|FG000|Overall Study|Adverse Event|1|||
160676528|NCT00084864|580195006|FG001|Overall Study|Adverse Event|0|||
160676529|NCT00084864|580195007|FG002|Overall Study|Adverse Event|0|||
160676530|NCT00084864|580195008|FG003|Overall Study|Adverse Event|0|||
160676531|NCT02460835|580195013|FG000|Overall Study|Disease progression prior to treatment|3|||
160676532|NCT02460835|580195013|FG000|Overall Study|Unable to complete planning scans|2|||
160676533|NCT02460835|580195013|FG000|Overall Study|Decrease in performance status|1|||
160676534|NCT02460835|580195013|FG000|Overall Study|Withdrawal by Subject|3|||
160676535|NCT02460835|580195013|FG000|Overall Study|Underwent fractionated RT|10|||
160676536|NCT02460835|580195013|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
160676537|NCT00969124|580195028|FG000|Overall Study|Protocol Violation|2|||
160676538|NCT00969124|580195028|FG000|Overall Study|Inadequate bowel preparation|15|||
160676539|NCT00969124|580195028|FG000|Overall Study|Inability to reach cecum|9|||
160676540|NCT00969124|580195028|FG000|Overall Study|Previously unrecognized disease|3|||
160676541|NCT00969124|580195028|FG000|Overall Study|Technical error|1|||
160676542|NCT00210639|580195029|FG000|Overall Study|Lost to Follow-up|37|||
160676543|NCT00210639|580195030|FG001|Overall Study|Lost to Follow-up|29|||
160676544|NCT00210639|580195029|FG000|Overall Study|Withdrawal by Subject|8|||
160676545|NCT00210639|580195030|FG001|Overall Study|Withdrawal by Subject|1|||
160676546|NCT00210639|580195029|FG000|Overall Study|Other|18|||
160676547|NCT00210639|580195030|FG001|Overall Study|Other|12|||
160676548|NCT02786953|580195033|FG000|Overall Study|Withdrawal by Subject|3|||
160676549|NCT02786953|580195034|FG001|Overall Study|Withdrawal by Subject|0|||
160676550|NCT02786953|580195033|FG000|Overall Study|Physician Decision|0|||
160676551|NCT02786953|580195034|FG001|Overall Study|Physician Decision|1|||
160676552|NCT01186458|580195040|FG000|Overall Study|Adverse Event|1|||
160676553|NCT04281472|580195041|FG000|Stage A|Lack of Efficacy|8|||
160676554|NCT04281472|580195042|FG001|Stage A|Lack of Efficacy|0|||
160676555|NCT04281472|580195043|FG002|Stage A|Lack of Efficacy|0|||
160676556|NCT04281472|580195041|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
160676557|NCT04281472|580195042|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
160676558|NCT04281472|580195043|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
160676559|NCT04281472|580195041|FG000|Stage A|Adverse Event|20|||
160676560|NCT04281472|580195042|FG001|Stage A|Adverse Event|0|||
160676561|NCT04281472|580195043|FG002|Stage A|Adverse Event|0|||
160676562|NCT04281472|580195041|FG000|Stage A|Death|1|||
160676563|NCT04281472|580195042|FG001|Stage A|Death|0|||
160676564|NCT04281472|580195043|FG002|Stage A|Death|0|||
160676565|NCT04281472|580195041|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
160676566|NCT04281472|580195042|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
160676567|NCT04281472|580195043|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
160676568|NCT04281472|580195041|FG000|Stage A|Lost to Follow-up|2|||
160676569|NCT04281472|580195042|FG001|Stage A|Lost to Follow-up|0|||
160676570|NCT04281472|580195043|FG002|Stage A|Lost to Follow-up|0|||
160676571|NCT04281472|580195041|FG000|Stage A|Non-compliance with study drug|1|||
160676572|NCT04281472|580195042|FG001|Stage A|Non-compliance with study drug|0|||
160676573|NCT04281472|580195043|FG002|Stage A|Non-compliance with study drug|0|||
160676574|NCT04281472|580195041|FG000|Stage A|Physician Decision|1|||
160676575|NCT04281472|580195042|FG001|Stage A|Physician Decision|0|||
160676576|NCT04281472|580195043|FG002|Stage A|Physician Decision|0|||
160676577|NCT04281472|580195041|FG000|Stage A|Prohibited medications|2|||
160676578|NCT04281472|580195042|FG001|Stage A|Prohibited medications|0|||
160676579|NCT04281472|580195043|FG002|Stage A|Prohibited medications|0|||
160676580|NCT04281472|580195041|FG000|Stage A|Withdrawal by Subject|11|||
160676581|NCT04281472|580195042|FG001|Stage A|Withdrawal by Subject|0|||
160676582|NCT04281472|580195043|FG002|Stage A|Withdrawal by Subject|0|||
160676583|NCT04281472|580195041|FG000|Stage A|Other|5|||
160676584|NCT04281472|580195042|FG001|Stage A|Other|0|||
160676585|NCT04281472|580195043|FG002|Stage A|Other|0|||
160676586|NCT04281472|580195041|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
160676587|NCT04281472|580195042|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
160676588|NCT04281472|580195043|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
160676589|NCT04281472|580195041|FG000|Stage B|Adverse Event|0|||
160676590|NCT04281472|580195042|FG001|Stage B|Adverse Event|3|||
160676591|NCT04281472|580195043|FG002|Stage B|Adverse Event|0|||
160676592|NCT04281472|580195041|FG000|Stage B|Death|0|||
160676593|NCT04281472|580195042|FG001|Stage B|Death|0|||
160676594|NCT04281472|580195043|FG002|Stage B|Death|1|||
160676595|NCT04281472|580195041|FG000|Stage B|Lack of Efficacy|0|||
160676596|NCT04281472|580195042|FG001|Stage B|Lack of Efficacy|0|||
160676597|NCT04281472|580195043|FG002|Stage B|Lack of Efficacy|1|||
160676598|NCT04281472|580195041|FG000|Stage B|Lost to Follow-up|0|||
160676599|NCT04281472|580195042|FG001|Stage B|Lost to Follow-up|0|||
160676600|NCT04281472|580195043|FG002|Stage B|Lost to Follow-up|2|||
160676601|NCT04281472|580195041|FG000|Stage B|Prohibited medications|0|||
160676602|NCT04281472|580195042|FG001|Stage B|Prohibited medications|2|||
160676603|NCT04281472|580195043|FG002|Stage B|Prohibited medications|1|||
160676604|NCT04281472|580195041|FG000|Stage B|Protocol Violation|0|||
160676605|NCT04281472|580195042|FG001|Stage B|Protocol Violation|1|||
160676606|NCT04281472|580195043|FG002|Stage B|Protocol Violation|1|||
160676607|NCT04281472|580195041|FG000|Stage B|Sponsor decision|0|||
160676608|NCT04281472|580195042|FG001|Stage B|Sponsor decision|0|||
160676609|NCT04281472|580195043|FG002|Stage B|Sponsor decision|1|||
160676610|NCT04281472|580195041|FG000|Stage B|Withdrawal by Subject|0|||
160676611|NCT04281472|580195042|FG001|Stage B|Withdrawal by Subject|3|||
160676612|NCT04281472|580195043|FG002|Stage B|Withdrawal by Subject|3|||
160676613|NCT04281472|580195041|FG000|Stage B|Other|0|||
160676614|NCT04281472|580195042|FG001|Stage B|Other|3|||
160676615|NCT04281472|580195043|FG002|Stage B|Other|0|||
160676616|NCT01055834|580195050|FG000|Treatment Period I|Adverse Event|1|||
160676617|NCT01055834|580195051|FG001|Treatment Period I|Adverse Event|0|||
160676618|NCT01670097|580195056|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
160676619|NCT01670097|580195057|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
160676620|NCT01670097|580195056|FG000|Overall Study|Study burden|1|||
160676621|NCT01670097|580195057|FG001|Overall Study|Study burden|0|||
160676622|NCT01670097|580195056|FG000|Overall Study|COPD exacerbation|0|||
160676623|NCT01670097|580195057|FG001|Overall Study|COPD exacerbation|1|||
160676624|NCT01670097|580195056|FG000|Overall Study|Neutropenia|0|||
160676625|NCT01670097|580195057|FG001|Overall Study|Neutropenia|1|||
160676626|NCT01670097|580195056|FG000|Overall Study|Clinical deterioration|0|||
160676627|NCT01670097|580195057|FG001|Overall Study|Clinical deterioration|1|||
160676628|NCT01670097|580195056|FG000|Overall Study|Disease progression|0|||
160676629|NCT01670097|580195057|FG001|Overall Study|Disease progression|1|||
160676630|NCT01949532|580195058|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
160676631|NCT01949532|580195059|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
160676632|NCT02311894|580195060|FG000|Overall Study|Discontinued in error|1|||
160676633|NCT02311894|580195060|FG000|Overall Study|Lost to Follow-up|1|||
160676634|NCT02311894|580195060|FG000|Overall Study|Adverse Event|1|||
160676635|NCT02311894|580195060|FG000|Overall Study|Withdrawal by Subject|1|||
160676636|NCT01691612|580195063|FG000|Overall Study|deemed ineligible after 1st visit|6|||
160676637|NCT01691612|580195063|FG000|Overall Study|Adverse Event|1|||
160676638|NCT01211262|580195067|FG000|Overall Study|Progressive Disease|18|||
160676639|NCT01211262|580195068|FG001|Overall Study|Progressive Disease|9|||
160676640|NCT01211262|580195067|FG000|Overall Study|Adverse Event|4|||
160676641|NCT01211262|580195068|FG001|Overall Study|Adverse Event|0|||
160676642|NCT01211262|580195067|FG000|Overall Study|Withdrawal of Consent|1|||
160676643|NCT01211262|580195068|FG001|Overall Study|Withdrawal of Consent|0|||
160676644|NCT01211262|580195067|FG000|Overall Study|Other|0|||
160676645|NCT01211262|580195068|FG001|Overall Study|Other|1|||
160676646|NCT01277510|580195069|FG000|Double-blind Phase|Non-compliance|0|||
160676647|NCT01277510|580195070|FG001|Double-blind Phase|Non-compliance|1|||
160676648|NCT01277510|580195069|FG000|Double-blind Phase|Adverse Event|1|||
160676649|NCT01277510|580195070|FG001|Double-blind Phase|Adverse Event|0|||
160676650|NCT01277510|580195069|FG000|Double-blind Phase|Withdrawal by Subject|2|||
160676651|NCT01277510|580195070|FG001|Double-blind Phase|Withdrawal by Subject|0|||
160676652|NCT01277510|580195069|FG000|Double-blind Phase|Administrative decision|7|||
160676653|NCT01277510|580195070|FG001|Double-blind Phase|Administrative decision|9|||
160676654|NCT01277510|580195069|FG000|Double-blind Phase|Death|0|||
160676655|NCT01277510|580195070|FG001|Double-blind Phase|Death|1|||
160676656|NCT01277510|580195069|FG000|Double-blind Phase|Protocol-specified criteria|2|||
160676657|NCT01277510|580195070|FG001|Double-blind Phase|Protocol-specified criteria|6|||
160676658|NCT01277510|580195069|FG000|Double-blind Phase|Other|1|||
160676659|NCT01277510|580195070|FG001|Double-blind Phase|Other|1|||
160676660|NCT01277510|580195069|FG000|Open-label Phase|Administrative decision|4|||
160676661|NCT01277510|580195070|FG001|Open-label Phase|Administrative decision|3|||
160676662|NCT01277510|580195069|FG000|Open-label Phase|Protocol-specified criteria|1|||
160676663|NCT01277510|580195070|FG001|Open-label Phase|Protocol-specified criteria|0|||
160676664|NCT01277510|580195069|FG000|Open-label Phase|Never received investigational product|2|||
160676665|NCT01277510|580195070|FG001|Open-label Phase|Never received investigational product|0|||
160676666|NCT00533507|580195071|FG000|Overall Study|Withdrawal by Subject|1|||
160676667|NCT00021541|580195072|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
160676668|NCT00021541|580195073|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
160676669|NCT00021541|580195072|FG000|Period 1-First Treatment|Adverse Event|2|||
160676670|NCT00021541|580195073|FG001|Period 1-First Treatment|Adverse Event|1|||
160676671|NCT00021541|580195072|FG000|Period 1-First Treatment|non-adherence|3|||
160676672|NCT00021541|580195073|FG001|Period 1-First Treatment|non-adherence|0|||
160676673|NCT00021541|580195072|FG000|Period 1-First Treatment|Death|1|||
160676674|NCT00021541|580195073|FG001|Period 1-First Treatment|Death|0|||
160676675|NCT00021541|580195072|FG000|Period 1-First Treatment|Pts that did not progress|2|||
160676676|NCT00021541|580195073|FG001|Period 1-First Treatment|Pts that did not progress|2|||
160676677|NCT00021541|580195072|FG000|Period 1-First Treatment|Ineligible|0|||
160632578|NCT05083559|580034335|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
160632579|NCT05083559|580034334|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
160632580|NCT05083559|580034335|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
160632581|NCT05083559|580034334|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
160632582|NCT05083559|580034335|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
160632583|NCT02704130|580034337|FG000|Overall Study|Physician Decision|5|||
160632584|NCT02704130|580034338|FG001|Overall Study|Physician Decision|3|||
160632585|NCT01023022|580034341|FG000|Overall Study|Death|5|||
160676678|NCT00021541|580195073|FG001|Period 1-First Treatment|Ineligible|2|||
160676679|NCT00021541|580195072|FG000|Period 2-crossover|refused phase B|2|||
160676680|NCT00021541|580195073|FG001|Period 2-crossover|refused phase B|2|||
160676681|NCT00021541|580195072|FG000|Period 2-crossover|Withdrawal by Subject|3|||
160676682|NCT00021541|580195073|FG001|Period 2-crossover|Withdrawal by Subject|4|||
160676683|NCT00021541|580195072|FG000|Period 2-crossover|Adverse Event|2|||
160676684|NCT00021541|580195073|FG001|Period 2-crossover|Adverse Event|2|||
160676685|NCT00021541|580195072|FG000|Period 2-crossover|non-adherence|1|||
160676686|NCT00021541|580195073|FG001|Period 2-crossover|non-adherence|0|||
160676687|NCT00021541|580195072|FG000|Period 2-crossover|Pts that did not progress|2|||
160676688|NCT00021541|580195073|FG001|Period 2-crossover|Pts that did not progress|3|||
160676689|NCT01874535|580195074|FG000|Overall Study|Lost to Follow-up|10|||
160676690|NCT01874535|580195075|FG001|Overall Study|Lost to Follow-up|9|||
160676691|NCT01874535|580195074|FG000|Overall Study|incomplete symptom resolution|45|||
160676692|NCT01874535|580195075|FG001|Overall Study|incomplete symptom resolution|35|||
160676693|NCT05263505|580195076|FG000|Overall Study|Adverse Event|0|||
160676694|NCT05263505|580195077|FG001|Overall Study|Adverse Event|1|||
160676695|NCT02616380|580195078|FG000|Overall Study|Lost to Follow-up|1|||
160676696|NCT02616380|580195078|FG000|Overall Study|Other|2|||
160676697|NCT05065619|580195079|FG000|Up to Day 42|Lost to Follow-up|1|||
160676698|NCT05065619|580195080|FG001|Up to Day 42|Lost to Follow-up|0|||
160676699|NCT05065619|580195079|FG000|Up to Day 42|Withdrawal by Subject|1|||
160676700|NCT05065619|580195080|FG001|Up to Day 42|Withdrawal by Subject|0|||
160676701|NCT05065619|580195079|FG000|After Day 43|Lost to Follow-up|1|||
160676702|NCT05065619|580195080|FG001|After Day 43|Lost to Follow-up|0|||
160676703|NCT05065619|580195079|FG000|After Day 43|Physician Decision|3|||
160676704|NCT05065619|580195080|FG001|After Day 43|Physician Decision|0|||
160676705|NCT05065619|580195079|FG000|After Day 43|Withdrawal by Subject|1|||
160676706|NCT05065619|580195080|FG001|After Day 43|Withdrawal by Subject|2|||
160676707|NCT05065619|580195079|FG000|After Day 43|Public vaccination|6|||
160676708|NCT05065619|580195080|FG001|After Day 43|Public vaccination|8|||
160676709|NCT05065619|580195079|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
160676710|NCT05065619|580195080|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
160676711|NCT05065619|580195079|FG000|After Day 43|Study Terminated by Sponsor|88|||
160676712|NCT05065619|580195080|FG001|After Day 43|Study Terminated by Sponsor|16|||
160676713|NCT01050764|580195081|FG000|Overall Study|Death, before HSCT|1|||
160676714|NCT01050764|580195081|FG000|Overall Study|Donor mobilization failure, death|1|||
160676715|NCT01050764|580195081|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
160676716|NCT02119936|580195094|FG000|Overall Study|Lost to Follow-up|10|||
160676717|NCT00274625|580196793|FG000|Overall Study|Lost to Follow-up|46|||
160676718|NCT00274625|580196794|FG001|Overall Study|Lost to Follow-up|54|||
160676719|NCT00274625|580196793|FG000|Overall Study|Excluded from analysis|14|||
160676720|NCT00274625|580196794|FG001|Overall Study|Excluded from analysis|8|||
160676721|NCT04264819|580196800|FG000|Overall Study|Physician Decision|19|||
160676722|NCT04264819|580196800|FG000|Overall Study|Adverse Event|12|||
160676723|NCT04264819|580196800|FG000|Overall Study|Withdrawal by Subject|11|||
160676724|NCT04264819|580196800|FG000|Overall Study|Lost to Follow-up|2|||
160676725|NCT04264819|580196800|FG000|Overall Study|Death|2|||
160676726|NCT01680016|580196801|FG000|Overall Study|Adverse Event|0|||
160676727|NCT01680016|580196802|FG001|Overall Study|Adverse Event|0|||
160676728|NCT01680016|580196803|FG002|Overall Study|Adverse Event|1|||
160676729|NCT01680016|580196804|FG003|Overall Study|Adverse Event|4|||
160676730|NCT01680016|580196801|FG000|Overall Study|The Subject went out of The Trial|1|||
160676731|NCT01680016|580196802|FG001|Overall Study|The Subject went out of The Trial|0|||
160676732|NCT01680016|580196803|FG002|Overall Study|The Subject went out of The Trial|3|||
160676733|NCT01680016|580196804|FG003|Overall Study|The Subject went out of The Trial|0|||
160676734|NCT01680016|580196801|FG000|Overall Study|Protocol Violation|0|||
160676735|NCT01680016|580196802|FG001|Overall Study|Protocol Violation|1|||
160676736|NCT01680016|580196803|FG002|Overall Study|Protocol Violation|0|||
160676737|NCT01680016|580196804|FG003|Overall Study|Protocol Violation|0|||
160676738|NCT01680016|580196801|FG000|Overall Study|Withdrawal by Subject|5|||
160676739|NCT01680016|580196802|FG001|Overall Study|Withdrawal by Subject|7|||
160676740|NCT01680016|580196803|FG002|Overall Study|Withdrawal by Subject|1|||
160676741|NCT01680016|580196804|FG003|Overall Study|Withdrawal by Subject|1|||
160676742|NCT01958060|580196808|FG000|Overall Study|Not treated|2|||
160676743|NCT01958060|580196809|FG001|Overall Study|Not treated|0|||
160676744|NCT01958060|580196810|FG002|Overall Study|Not treated|0|||
160676745|NCT01958060|580196811|FG003|Overall Study|Not treated|0|||
160676746|NCT01958060|580196812|FG004|Overall Study|Not treated|1|||
160676747|NCT01958060|580196813|FG005|Overall Study|Not treated|0|||
160676748|NCT02846883|580196816|FG000|Overall Study|Death|0|||
160676749|NCT02846883|580196817|FG001|Overall Study|Death|1|||
160676750|NCT02846883|580196818|FG002|Overall Study|Death|1|||
160676751|NCT02846883|580196816|FG000|Overall Study|Lost to Follow-up|0|||
160676752|NCT02846883|580196817|FG001|Overall Study|Lost to Follow-up|0|||
160676753|NCT02846883|580196818|FG002|Overall Study|Lost to Follow-up|1|||
160676754|NCT02846883|580196816|FG000|Overall Study|Withdrawal by Subject|1|||
160676755|NCT02846883|580196817|FG001|Overall Study|Withdrawal by Subject|0|||
160676756|NCT02846883|580196818|FG002|Overall Study|Withdrawal by Subject|0|||
160676757|NCT02846883|580196816|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
160676758|NCT02846883|580196817|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
160676759|NCT02846883|580196818|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
160676760|NCT02846883|580196816|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
160676761|NCT02846883|580196817|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
160676762|NCT02846883|580196818|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
160676763|NCT00500318|580196822|FG000|Overall Study|Adverse Event|3|||
160676764|NCT00500318|580196823|FG001|Overall Study|Adverse Event|8|||
160676765|NCT00500318|580196822|FG000|Overall Study|Protocol Violation|1|||
160676766|NCT00500318|580196823|FG001|Overall Study|Protocol Violation|3|||
160676767|NCT00500318|580196822|FG000|Overall Study|Withdrawal by Subject|1|||
160676768|NCT00500318|580196823|FG001|Overall Study|Withdrawal by Subject|2|||
160676769|NCT00500318|580196822|FG000|Overall Study|Lack of Efficacy|0|||
160676770|NCT00500318|580196823|FG001|Overall Study|Lack of Efficacy|3|||
160676771|NCT00500318|580196822|FG000|Overall Study|Other Reason|0|||
160676772|NCT00500318|580196823|FG001|Overall Study|Other Reason|1|||
160676773|NCT01813435|580196826|FG000|Overall Study|did not finish experimental regimen|1902|||
160676774|NCT01813435|580196827|FG001|Overall Study|did not finish experimental regimen|770|||
160676775|NCT01813435|580196826|FG000|Overall Study|Lost to Follow-up|268|||
160676776|NCT01813435|580196827|FG001|Overall Study|Lost to Follow-up|237|||
160676777|NCT01011335|580196828|FG000|Overall Study|Lost to Follow-up|0|||
160676778|NCT01011335|580196829|FG001|Overall Study|Lost to Follow-up|0|||
160676779|NCT01011335|580196830|FG002|Overall Study|Lost to Follow-up|1|||
160676780|NCT01011335|580196831|FG003|Overall Study|Lost to Follow-up|1|||
160676781|NCT01011335|580196832|FG004|Overall Study|Lost to Follow-up|1|||
160676782|NCT01011335|580196833|FG005|Overall Study|Lost to Follow-up|1|||
160676783|NCT01011335|580196834|FG006|Overall Study|Lost to Follow-up|2|||
160676784|NCT01011335|580196835|FG007|Overall Study|Lost to Follow-up|2|||
160676785|NCT01011335|580196836|FG008|Overall Study|Lost to Follow-up|1|||
160676786|NCT01011335|580196837|FG009|Overall Study|Lost to Follow-up|0|||
160676787|NCT01011335|580196838|FG010|Overall Study|Lost to Follow-up|0|||
160676788|NCT01011335|580196839|FG011|Overall Study|Lost to Follow-up|1|||
160676789|NCT01011335|580196840|FG012|Overall Study|Lost to Follow-up|2|||
160676790|NCT01011335|580196828|FG000|Overall Study|Protocol Violation|0|||
160676791|NCT01011335|580196829|FG001|Overall Study|Protocol Violation|1|||
160676792|NCT01011335|580196830|FG002|Overall Study|Protocol Violation|0|||
160676793|NCT01011335|580196831|FG003|Overall Study|Protocol Violation|0|||
160676794|NCT01011335|580196832|FG004|Overall Study|Protocol Violation|0|||
160676795|NCT01011335|580196833|FG005|Overall Study|Protocol Violation|0|||
160676796|NCT01011335|580196834|FG006|Overall Study|Protocol Violation|0|||
160676797|NCT01011335|580196835|FG007|Overall Study|Protocol Violation|0|||
160676798|NCT01011335|580196836|FG008|Overall Study|Protocol Violation|0|||
160676799|NCT01011335|580196837|FG009|Overall Study|Protocol Violation|0|||
160676800|NCT01011335|580196838|FG010|Overall Study|Protocol Violation|0|||
160676801|NCT01011335|580196839|FG011|Overall Study|Protocol Violation|0|||
160676802|NCT01011335|580196840|FG012|Overall Study|Protocol Violation|0|||
160676803|NCT01011335|580196828|FG000|Overall Study|Moved/deployed or no booster|1|||
160676804|NCT01011335|580196829|FG001|Overall Study|Moved/deployed or no booster|0|||
160676805|NCT01011335|580196830|FG002|Overall Study|Moved/deployed or no booster|0|||
160676806|NCT01011335|580196831|FG003|Overall Study|Moved/deployed or no booster|1|||
160676807|NCT01011335|580196832|FG004|Overall Study|Moved/deployed or no booster|0|||
160676808|NCT01011335|580196833|FG005|Overall Study|Moved/deployed or no booster|0|||
160676809|NCT01011335|580196834|FG006|Overall Study|Moved/deployed or no booster|1|||
160676810|NCT01011335|580196835|FG007|Overall Study|Moved/deployed or no booster|0|||
160676811|NCT01011335|580196836|FG008|Overall Study|Moved/deployed or no booster|1|||
160676812|NCT01011335|580196837|FG009|Overall Study|Moved/deployed or no booster|0|||
160676813|NCT01011335|580196838|FG010|Overall Study|Moved/deployed or no booster|2|||
160676814|NCT01011335|580196839|FG011|Overall Study|Moved/deployed or no booster|0|||
160676815|NCT01011335|580196840|FG012|Overall Study|Moved/deployed or no booster|0|||
160676816|NCT01011335|580196828|FG000|Overall Study|Adverse Event|0|||
160676817|NCT01011335|580196829|FG001|Overall Study|Adverse Event|0|||
160676818|NCT01011335|580196830|FG002|Overall Study|Adverse Event|0|||
160676819|NCT01011335|580196831|FG003|Overall Study|Adverse Event|0|||
160676820|NCT01011335|580196832|FG004|Overall Study|Adverse Event|0|||
160676821|NCT01011335|580196833|FG005|Overall Study|Adverse Event|0|||
160676822|NCT01011335|580196834|FG006|Overall Study|Adverse Event|0|||
160676823|NCT01011335|580196835|FG007|Overall Study|Adverse Event|0|||
160676824|NCT01011335|580196836|FG008|Overall Study|Adverse Event|0|||
160676825|NCT01011335|580196837|FG009|Overall Study|Adverse Event|0|||
160676826|NCT01011335|580196838|FG010|Overall Study|Adverse Event|4|||
160676827|NCT01011335|580196839|FG011|Overall Study|Adverse Event|0|||
160676828|NCT01011335|580196840|FG012|Overall Study|Adverse Event|1|||
160676829|NCT01765751|580196841|FG000|Overall Study|Lost to Follow-up|0|||
160676830|NCT01765751|580196842|FG001|Overall Study|Lost to Follow-up|2|||
160676831|NCT01765751|580196843|FG002|Overall Study|Lost to Follow-up|1|||
160676832|NCT02435433|580196844|FG000|Overall Study|Withdrawal by Subject|2|||
160676833|NCT02435433|580196845|FG001|Overall Study|Withdrawal by Subject|3|||
160676834|NCT02435433|580196846|FG002|Overall Study|Withdrawal by Subject|1|||
160676835|NCT02435433|580196847|FG003|Overall Study|Withdrawal by Subject|0|||
160676836|NCT02435433|580196848|FG004|Overall Study|Withdrawal by Subject|0|||
160676837|NCT02435433|580196844|FG000|Overall Study|Lost to Follow-up|2|||
160676838|NCT02435433|580196845|FG001|Overall Study|Lost to Follow-up|2|||
160676839|NCT02435433|580196846|FG002|Overall Study|Lost to Follow-up|4|||
160676840|NCT02435433|580196847|FG003|Overall Study|Lost to Follow-up|1|||
160676841|NCT02435433|580196848|FG004|Overall Study|Lost to Follow-up|0|||
160676842|NCT01243151|580196849|FG000|Overall Study|Adverse Event|0|||
160676843|NCT01243151|580196850|FG001|Overall Study|Adverse Event|1|||
160676844|NCT01243151|580196851|FG002|Overall Study|Adverse Event|0|||
160676845|NCT01243151|580196852|FG003|Overall Study|Adverse Event|0|||
160676846|NCT01243151|580196853|FG004|Overall Study|Adverse Event|0|||
160676847|NCT01243151|580196849|FG000|Overall Study|Protocol Violation|0|||
160676848|NCT01243151|580196850|FG001|Overall Study|Protocol Violation|0|||
160676849|NCT01243151|580196851|FG002|Overall Study|Protocol Violation|1|||
160676850|NCT01243151|580196852|FG003|Overall Study|Protocol Violation|0|||
160676851|NCT01243151|580196853|FG004|Overall Study|Protocol Violation|0|||
160676852|NCT01243151|580196849|FG000|Overall Study|Other|0|||
160676853|NCT01243151|580196850|FG001|Overall Study|Other|0|||
160676854|NCT01243151|580196851|FG002|Overall Study|Other|0|||
160676855|NCT01243151|580196852|FG003|Overall Study|Other|1|||
160676856|NCT01243151|580196853|FG004|Overall Study|Other|0|||
160676857|NCT01243151|580196849|FG000|Overall Study|Randomized but not treated|0|||
160676858|NCT01243151|580196850|FG001|Overall Study|Randomized but not treated|0|||
160676859|NCT01243151|580196851|FG002|Overall Study|Randomized but not treated|0|||
160676860|NCT01243151|580196852|FG003|Overall Study|Randomized but not treated|1|||
160676861|NCT01243151|580196853|FG004|Overall Study|Randomized but not treated|0|||
160676862|NCT01710358|580196856|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
160676863|NCT01710358|580196857|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
160676864|NCT01710358|580196858|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
160676865|NCT01710358|580196856|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
160676866|NCT01710358|580196857|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
160676867|NCT01710358|580196858|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
160676868|NCT01710358|580196856|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
160676869|NCT01710358|580196857|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
160676870|NCT01710358|580196858|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
160676871|NCT01710358|580196856|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
160676872|NCT01710358|580196857|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
160676873|NCT01710358|580196858|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
160676874|NCT01710358|580196856|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
160676875|NCT01710358|580196857|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
160676876|NCT01710358|580196858|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
160676877|NCT01710358|580196856|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
160676878|NCT01710358|580196857|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
160676879|NCT01710358|580196858|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
160676880|NCT01710358|580196856|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
160676881|NCT01710358|580196857|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
160676882|NCT01710358|580196858|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
160676883|NCT01710358|580196856|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
160676884|NCT01710358|580196857|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
160676885|NCT01710358|580196858|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
160676886|NCT01710358|580196856|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
160676887|NCT01710358|580196857|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
160676888|NCT01710358|580196858|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
160676889|NCT01710358|580196856|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
160676890|NCT01710358|580196857|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
160676891|NCT01710358|580196858|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
160676892|NCT01710358|580196856|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
160676893|NCT01710358|580196857|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
160676894|NCT01710358|580196858|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
160676895|NCT01710358|580196856|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
160676896|NCT01710358|580196857|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
160676897|NCT01710358|580196858|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
160676898|NCT01710358|580196856|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
160676899|NCT01710358|580196857|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
160676900|NCT01710358|580196858|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
160676901|NCT01710358|580196856|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
160676902|NCT01710358|580196857|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
160676903|NCT01710358|580196858|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
160676904|NCT01710358|580196856|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
160676905|NCT01710358|580196857|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
160676906|NCT01710358|580196858|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
160676907|NCT01710358|580196856|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
160676908|NCT01710358|580196857|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
160676909|NCT01710358|580196858|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
160676910|NCT01710358|580196856|FG000|Rescue Period|Adverse Event|0|||
160676911|NCT01710358|580196857|FG001|Rescue Period|Adverse Event|15|||
160676912|NCT01710358|580196858|FG002|Rescue Period|Adverse Event|0|||
160676913|NCT01710358|580196856|FG000|Rescue Period|Death|0|||
160676914|NCT01710358|580196857|FG001|Rescue Period|Death|1|||
160676915|NCT01710358|580196858|FG002|Rescue Period|Death|0|||
160676916|NCT01710358|580196856|FG000|Rescue Period|Lack of Efficacy|0|||
160676917|NCT01710358|580196857|FG001|Rescue Period|Lack of Efficacy|7|||
160676918|NCT01710358|580196858|FG002|Rescue Period|Lack of Efficacy|0|||
160676919|NCT01710358|580196856|FG000|Rescue Period|Withdrawal by Subject|0|||
160676920|NCT01710358|580196857|FG001|Rescue Period|Withdrawal by Subject|8|||
160676921|NCT01710358|580196858|FG002|Rescue Period|Withdrawal by Subject|0|||
160676922|NCT00799708|580196861|FG000|Overall Study|non-compliance|1|||
160676923|NCT00799708|580196862|FG001|Overall Study|non-compliance|0|||
160676924|NCT00799708|580196863|FG002|Overall Study|non-compliance|0|||
160676925|NCT00880334|580196864|FG000|Randomized Phase|Physician Decision|1|||
160676926|NCT00880334|580196865|FG001|Randomized Phase|Physician Decision|0|||
160676927|NCT00880334|580196864|FG000|Randomized Phase|Withdrawal by Subject|2|||
160676928|NCT00880334|580196865|FG001|Randomized Phase|Withdrawal by Subject|1|||
160676929|NCT00880334|580196864|FG000|Randomized Phase|Inadequate Labs|1|||
160676930|NCT00880334|580196865|FG001|Randomized Phase|Inadequate Labs|1|||
160676931|NCT00880334|580196864|FG000|Randomized Phase|Brain Metastasis|0|||
160676932|NCT00880334|580196865|FG001|Randomized Phase|Brain Metastasis|1|||
160676933|NCT00880334|580196864|FG000|Randomized Phase|Crossover Participants|0|||
160676934|NCT00880334|580196865|FG001|Randomized Phase|Crossover Participants|37|||
160676935|NCT01717313|580196869|FG000|Phase A (Weeks 0 to 24)|Death|0|||
160676936|NCT01717313|580196870|FG001|Phase A (Weeks 0 to 24)|Death|1|||
160676937|NCT01717313|580196869|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
160676938|NCT01717313|580196870|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
160676939|NCT01717313|580196869|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
160676940|NCT01717313|580196870|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
160676941|NCT01717313|580196869|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
160676942|NCT01717313|580196870|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
160676943|NCT01717313|580196869|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
160676944|NCT01717313|580196870|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
160676945|NCT01717313|580196869|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
160676946|NCT01717313|580196870|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
160676947|NCT01717313|580196869|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
160676948|NCT01717313|580196870|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
160676949|NCT01717313|580196869|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
160676950|NCT01717313|580196870|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
160676951|NCT01717313|580196869|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
160676952|NCT01717313|580196870|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
160676953|NCT01617096|580196871|FG000|Overall Study|Withdrawal by Subject|96|||
160676954|NCT01617096|580196872|FG001|Overall Study|Withdrawal by Subject|81|||
160676955|NCT01617096|580196871|FG000|Overall Study|Lost to Follow-up|37|||
160676956|NCT01617096|580196872|FG001|Overall Study|Lost to Follow-up|32|||
160676957|NCT01617096|580196871|FG000|Overall Study|Physician Decision|10|||
160676958|NCT01617096|580196872|FG001|Overall Study|Physician Decision|18|||
160676959|NCT01617096|580196871|FG000|Overall Study|Death|4|||
160676960|NCT01617096|580196872|FG001|Overall Study|Death|3|||
160676961|NCT01617096|580196871|FG000|Overall Study|Other|1|||
160676962|NCT01617096|580196872|FG001|Overall Study|Other|3|||
160676963|NCT01532908|580196877|FG000|Overall Study|Not Transplanted|1|||
160676964|NCT01532908|580196878|FG001|Overall Study|Not Transplanted|0|||
160676965|NCT01632306|580196879|FG000|Overall Study|Protocol Violation|1|||
160676966|NCT01632306|580196880|FG001|Overall Study|Protocol Violation|0|||
160676967|NCT01632306|580196881|FG002|Overall Study|Protocol Violation|0|||
160676968|NCT00467597|580196886|FG000|Overall Study|Withdrawal by Subject|2|||
160676969|NCT00467597|580196887|FG001|Overall Study|Withdrawal by Subject|0|||
160676970|NCT03141151|580196888|FG000|Overall Study|Lost to Follow-up|3|||
160676971|NCT03141151|580196889|FG001|Overall Study|Lost to Follow-up|2|||
160676972|NCT03141151|580196888|FG000|Overall Study|Withdrawal by Subject|3|||
160676973|NCT03141151|580196889|FG001|Overall Study|Withdrawal by Subject|2|||
160676974|NCT04561115|580196896|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
160676975|NCT04561115|580196897|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
160676976|NCT04561115|580196896|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
160676977|NCT04561115|580196897|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
160676978|NCT04561115|580196896|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
160676979|NCT04561115|580196897|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
160676980|NCT00743145|580196898|FG000|Overall Study|Withdrawal by Subject|1|||
160676981|NCT00743145|580196898|FG000|Overall Study|Adverse Event|2|||
160676982|NCT00743145|580196898|FG000|Overall Study|Pregnancy|1|||
160676983|NCT02179190|580196899|FG000|Enrollment|Exit Prior to Device Attempt|11|||
160676984|NCT02179190|580196899|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
160676985|NCT02179190|580196899|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
160676986|NCT02179190|580196899|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
160676987|NCT02179190|580196899|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
160676988|NCT02179190|580196899|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
160676989|NCT00881569|580196900|FG000|Overall Study|Disease progression|1|||
160676990|NCT00881569|580196901|FG001|Overall Study|Disease progression|1|||
160676991|NCT03480022|580196902|FG000|Overall Study|Pregnancy|2|||
160676992|NCT03480022|580196903|FG001|Overall Study|Pregnancy|0|||
160676993|NCT03480022|580196902|FG000|Overall Study|Adverse Event|6|||
160676994|NCT03480022|580196903|FG001|Overall Study|Adverse Event|0|||
160676995|NCT03480022|580196902|FG000|Overall Study|Lack of Efficacy|0|||
160676996|NCT03480022|580196903|FG001|Overall Study|Lack of Efficacy|2|||
160676997|NCT03480022|580196902|FG000|Overall Study|Physician Decision|0|||
160676998|NCT03480022|580196903|FG001|Overall Study|Physician Decision|1|||
160676999|NCT03480022|580196902|FG000|Overall Study|Withdrawal by Subject|2|||
160677000|NCT03480022|580196903|FG001|Overall Study|Withdrawal by Subject|0|||
160677001|NCT03480022|580196902|FG000|Overall Study|Medication concerns|1|||
160677002|NCT03480022|580196903|FG001|Overall Study|Medication concerns|0|||
160677003|NCT03480022|580196902|FG000|Overall Study|Family member COVID exposure|0|||
160677004|NCT03480022|580196903|FG001|Overall Study|Family member COVID exposure|1|||
160677005|NCT02623218|580196904|FG000|Overall Study|Lost to Follow-up|0|||
160677006|NCT02623218|580196905|FG001|Overall Study|Lost to Follow-up|1|||
160677007|NCT02623218|580196906|FG002|Overall Study|Lost to Follow-up|0|||
160677008|NCT02623218|580196907|FG003|Overall Study|Lost to Follow-up|0|||
160677009|NCT02623218|580196908|FG004|Overall Study|Lost to Follow-up|0|||
160677010|NCT04049097|580196911|FG000|Overall Study|Adverse Event|18|||
160677011|NCT04049097|580196911|FG000|Overall Study|Death|2|||
160677012|NCT04049097|580196911|FG000|Overall Study|Lost to Follow-up|1|||
160677013|NCT04049097|580196911|FG000|Overall Study|Physician Decision|2|||
160677014|NCT04049097|580196911|FG000|Overall Study|Withdrawal by Subject|9|||
160677015|NCT04049097|580196911|FG000|Overall Study|Protocol Violation|2|||
160677016|NCT04049097|580196911|FG000|Overall Study|Other|1|||
160677017|NCT04049097|580196911|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
160677018|NCT00537095|580196912|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
160677019|NCT00537095|580196913|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
160677020|NCT00537095|580196912|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
160677021|NCT00537095|580196913|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
160677022|NCT00537095|580196912|FG000|Randomized Treatment Period (433 Days)|Death|3|||
160677023|NCT00537095|580196913|FG001|Randomized Treatment Period (433 Days)|Death|1|||
160677024|NCT00537095|580196912|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
160677025|NCT00537095|580196913|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
160677026|NCT00537095|580196912|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
160677027|NCT00537095|580196913|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
160677028|NCT00537095|580196912|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
160677029|NCT00537095|580196913|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
160677030|NCT00537095|580196912|FG000|Open-label Period (590 Days)|Adverse Event|2|||
160677031|NCT00537095|580196913|FG001|Open-label Period (590 Days)|Adverse Event|11|||
160677032|NCT00537095|580196912|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
160677033|NCT00537095|580196913|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
160677034|NCT00537095|580196912|FG000|Open-label Period (590 Days)|Death|2|||
160677035|NCT00537095|580196913|FG001|Open-label Period (590 Days)|Death|2|||
160677036|NCT00537095|580196912|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
160677037|NCT00537095|580196913|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
160677038|NCT00537095|580196912|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
160677039|NCT00537095|580196913|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
160677040|NCT01970592|580196914|FG000|Overall Study|Withdrawal by Subject|4|||
160677041|NCT01970592|580196914|FG000|Overall Study|Physician Decision|1|||
160677042|NCT01970592|580196914|FG000|Overall Study|Adverse Event|1|||
160677043|NCT01320722|580196917|FG000|Overall Study|Did not Receive Intervention|3|||
160677044|NCT01320722|580196918|FG001|Overall Study|Did not Receive Intervention|2|||
160677045|NCT01320722|580196919|FG002|Overall Study|Did not Receive Intervention|1|||
160677046|NCT01320722|580196920|FG003|Overall Study|Did not Receive Intervention|1|||
160677047|NCT01320722|580196921|FG004|Overall Study|Did not Receive Intervention|2|||
160677048|NCT01320722|580196917|FG000|Overall Study|Lost to Follow-up|0|||
160677049|NCT01320722|580196918|FG001|Overall Study|Lost to Follow-up|1|||
160677050|NCT01320722|580196919|FG002|Overall Study|Lost to Follow-up|0|||
160677051|NCT01320722|580196920|FG003|Overall Study|Lost to Follow-up|1|||
160677052|NCT01320722|580196921|FG004|Overall Study|Lost to Follow-up|3|||
160519912|NCT01275131|579632917|FG003|Period 2 (Crossover)|Adverse Event|0|||
160519913|NCT01275131|579632914|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
160677053|NCT01320722|580196917|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
160677054|NCT01320722|580196918|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
160677055|NCT01320722|580196919|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
160677056|NCT01320722|580196920|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
160677057|NCT01320722|580196921|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
160677058|NCT01320722|580196917|FG000|Overall Study|Participant Developed a Rash|0|||
160677059|NCT01320722|580196918|FG001|Overall Study|Participant Developed a Rash|0|||
160677060|NCT01320722|580196919|FG002|Overall Study|Participant Developed a Rash|2|||
160677061|NCT01320722|580196920|FG003|Overall Study|Participant Developed a Rash|1|||
160677062|NCT01320722|580196921|FG004|Overall Study|Participant Developed a Rash|1|||
160677063|NCT01320722|580196917|FG000|Overall Study|Non-compliant with Medication|0|||
160677064|NCT01320722|580196918|FG001|Overall Study|Non-compliant with Medication|0|||
160677065|NCT01320722|580196919|FG002|Overall Study|Non-compliant with Medication|1|||
160677066|NCT01320722|580196920|FG003|Overall Study|Non-compliant with Medication|0|||
160677067|NCT01320722|580196921|FG004|Overall Study|Non-compliant with Medication|0|||
160677068|NCT01320722|580196917|FG000|Overall Study|Adverse Event|0|||
160677069|NCT01320722|580196918|FG001|Overall Study|Adverse Event|0|||
160677070|NCT01320722|580196919|FG002|Overall Study|Adverse Event|3|||
160677071|NCT01320722|580196920|FG003|Overall Study|Adverse Event|6|||
160677072|NCT01320722|580196921|FG004|Overall Study|Adverse Event|0|||
160677073|NCT01320722|580196917|FG000|Overall Study|Not Compliant with Study Procedures|0|||
160677074|NCT01320722|580196918|FG001|Overall Study|Not Compliant with Study Procedures|0|||
160677075|NCT01320722|580196919|FG002|Overall Study|Not Compliant with Study Procedures|0|||
160677076|NCT01320722|580196920|FG003|Overall Study|Not Compliant with Study Procedures|4|||
160677077|NCT01320722|580196921|FG004|Overall Study|Not Compliant with Study Procedures|0|||
160677078|NCT01320722|580196917|FG000|Overall Study|Pregnancy|0|||
160677079|NCT01320722|580196918|FG001|Overall Study|Pregnancy|0|||
160677080|NCT01320722|580196919|FG002|Overall Study|Pregnancy|0|||
160677081|NCT01320722|580196920|FG003|Overall Study|Pregnancy|1|||
160677082|NCT01320722|580196921|FG004|Overall Study|Pregnancy|0|||
160677083|NCT01320722|580196917|FG000|Overall Study|Started an Exclusionary Medication|0|||
160677084|NCT01320722|580196918|FG001|Overall Study|Started an Exclusionary Medication|0|||
160677085|NCT01320722|580196919|FG002|Overall Study|Started an Exclusionary Medication|0|||
160677086|NCT01320722|580196920|FG003|Overall Study|Started an Exclusionary Medication|0|||
160677087|NCT01320722|580196921|FG004|Overall Study|Started an Exclusionary Medication|1|||
160677088|NCT01320722|580196917|FG000|Overall Study|Withdrew due to Health Condition|0|||
160677089|NCT01320722|580196918|FG001|Overall Study|Withdrew due to Health Condition|0|||
160677090|NCT01320722|580196919|FG002|Overall Study|Withdrew due to Health Condition|0|||
160677091|NCT01320722|580196920|FG003|Overall Study|Withdrew due to Health Condition|0|||
160677092|NCT01320722|580196921|FG004|Overall Study|Withdrew due to Health Condition|1|||
160677093|NCT03980522|580196922|FG000|Treatment Period|Adverse Event|1|||
160677094|NCT03980522|580196923|FG001|Treatment Period|Adverse Event|0|||
160677095|NCT03980522|580196924|FG002|Treatment Period|Adverse Event|0|||
160677096|NCT03980522|580196925|FG003|Treatment Period|Adverse Event|0|||
160677097|NCT03980522|580196926|FG004|Treatment Period|Adverse Event|0|||
160677098|NCT01091363|580196927|FG000|Overall Study|Withdrawal by Subject|11|||
160677099|NCT01091363|580196928|FG001|Overall Study|Withdrawal by Subject|15|||
160677100|NCT01091363|580196927|FG000|Overall Study|Lost to Follow-up|2|||
160677101|NCT01091363|580196928|FG001|Overall Study|Lost to Follow-up|2|||
160677102|NCT00160524|580196929|FG000|Overall Study|Adverse Event|119|||
160677103|NCT00160524|580196929|FG000|Overall Study|Adverse Event and Other|94|||
160677104|NCT00160524|580196929|FG000|Overall Study|Protocol Violation|16|||
160677105|NCT00160524|580196929|FG000|Overall Study|Protocol Violation and Other|2|||
160677106|NCT00160524|580196929|FG000|Overall Study|Withdrawal by Subject|141|||
160677107|NCT00160524|580196929|FG000|Overall Study|Withdrawal by Subject and Other|17|||
160677108|NCT00160524|580196929|FG000|Overall Study|Physician Decision|27|||
160677109|NCT00160524|580196929|FG000|Overall Study|Physician Decision and Other|6|||
160677110|NCT00160524|580196929|FG000|Overall Study|Lost to Follow-up|13|||
160677111|NCT00160524|580196929|FG000|Overall Study|Lost to Follow-up and Other|1|||
160677112|NCT00160524|580196929|FG000|Overall Study|Lack of Efficacy|21|||
160677113|NCT00160524|580196929|FG000|Overall Study|Lack of Efficacy and Other|1|||
160677114|NCT00160524|580196929|FG000|Overall Study|Other|20|||
160677115|NCT04892147|580196930|FG000|Overall Study|Withdrawal by Subject|2|||
160519914|NCT01275131|579632915|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
160519915|NCT01275131|579632916|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
160677116|NCT04892147|580196931|FG001|Overall Study|Withdrawal by Subject|0|||
160677117|NCT01929681|580196937|FG000|Overall Study|Withdrawal by Subject|1|||
160677118|NCT01929681|580196938|FG001|Overall Study|Withdrawal by Subject|0|||
160677119|NCT01929681|580196937|FG000|Overall Study|Physician Decision|1|||
160677120|NCT01929681|580196938|FG001|Overall Study|Physician Decision|1|||
160677121|NCT05315713|580196939|FG000|Overall Study|Death|5|||
160677122|NCT05315713|580196939|FG000|Overall Study|Progressive disease|1|||
160677123|NCT05315713|580196939|FG000|Overall Study|Withdrawal by Subject|1|||
160677124|NCT05315713|580196939|FG000|Overall Study|Study terminated by sponsor|1|||
160677125|NCT00556673|580196941|FG000|Overall Study|Protocol deviation|3|||
160632586|NCT01023022|580034341|FG000|Overall Study|Lost to Follow-up|7|||
160632587|NCT01023022|580034341|FG000|Overall Study|due to technical issues|2|||
160632588|NCT00903409|580034342|FG000|Overall Study|Adverse Event|11|||
160632589|NCT00903409|580034343|FG001|Overall Study|Adverse Event|9|||
160632590|NCT00903409|580034342|FG000|Overall Study|Non-compliance with Protocol|1|||
160632591|NCT00903409|580034343|FG001|Overall Study|Non-compliance with Protocol|1|||
160632592|NCT00903409|580034342|FG000|Overall Study|Laboratory Abnormality|2|||
160632593|NCT00903409|580034343|FG001|Overall Study|Laboratory Abnormality|0|||
160632594|NCT00903409|580034342|FG000|Overall Study|Withdrawal by Subject|8|||
160632595|NCT00903409|580034343|FG001|Overall Study|Withdrawal by Subject|8|||
160632596|NCT00903409|580034342|FG000|Overall Study|Other|2|||
160632597|NCT00903409|580034343|FG001|Overall Study|Other|3|||
160632598|NCT00903409|580034342|FG000|Overall Study|Lost to Follow-up|2|||
160632599|NCT00903409|580034343|FG001|Overall Study|Lost to Follow-up|6|||
160632600|NCT00797316|580034344|FG000|Overall Study|Administrative problems|1|||
160632601|NCT00797316|580034345|FG001|Overall Study|Administrative problems|0|||
160632602|NCT00797316|580034344|FG000|Overall Study|Adverse Event|5|||
160632603|NCT00797316|580034345|FG001|Overall Study|Adverse Event|3|||
160632604|NCT00797316|580034344|FG000|Overall Study|Lost to Follow-up|4|||
160632605|NCT00797316|580034345|FG001|Overall Study|Lost to Follow-up|8|||
160632606|NCT00797316|580034344|FG000|Overall Study|Protocol Deviation|1|||
160632607|NCT00797316|580034345|FG001|Overall Study|Protocol Deviation|2|||
160632608|NCT00797316|580034344|FG000|Overall Study|Patient withdrew consent|12|||
160632609|NCT00797316|580034345|FG001|Overall Study|Patient withdrew consent|6|||
160632610|NCT00797316|580034344|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160632611|NCT00797316|580034345|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
160632612|NCT00402779|580034348|FG000|Overall Study|Screen Failure|77|||
160632613|NCT00402779|580034349|FG001|Overall Study|Screen Failure|76|||
160632614|NCT03539952|580034350|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
160632615|NCT03539952|580034351|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
160632616|NCT03539952|580034350|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
160632617|NCT03539952|580034351|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
160632618|NCT03539952|580034350|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
160632619|NCT03539952|580034351|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
160632620|NCT03539952|580034350|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
160632621|NCT03539952|580034351|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
160632622|NCT03539952|580034350|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
160632623|NCT03539952|580034351|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
160632624|NCT03539952|580034350|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
160632625|NCT03539952|580034351|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
160632626|NCT03539952|580034350|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
160632627|NCT03539952|580034351|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
160632628|NCT02184988|580034352|FG000|Overall Study|Pregnancy|2|||
160632629|NCT02184988|580034352|FG000|Overall Study|Adverse Event|2|||
160632630|NCT02184988|580034352|FG000|Overall Study|moving away/travelling/unable to complet|6|||
160632631|NCT02184988|580034352|FG000|Overall Study|work scheduling issues|4|||
160632632|NCT02184988|580034352|FG000|Overall Study|various other reasons|9|||
160632633|NCT02184988|580034352|FG000|Overall Study|Lost to Follow-up|32|||
160632634|NCT03075215|580034353|FG000|12-Month Primary Endpoint|Death|152|||
160632635|NCT03075215|580034353|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
160632636|NCT03075215|580034353|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
160632637|NCT03075215|580034353|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
160632638|NCT02146365|580034354|FG000|Overall Study|Lost to Follow-up|2|||
160632639|NCT02146365|580034355|FG001|Overall Study|Lost to Follow-up|1|||
160632640|NCT02146365|580034356|FG002|Overall Study|Lost to Follow-up|3|||
160632641|NCT02146365|580034357|FG003|Overall Study|Lost to Follow-up|3|||
160632642|NCT02146365|580034358|FG004|Overall Study|Lost to Follow-up|1|||
160632643|NCT02146365|580034359|FG005|Overall Study|Lost to Follow-up|1|||
160632644|NCT02146365|580034360|FG006|Overall Study|Lost to Follow-up|0|||
160632645|NCT02146365|580034361|FG007|Overall Study|Lost to Follow-up|1|||
160632646|NCT02146365|580034354|FG000|Overall Study|Withdrawal by Subject|1|||
160632647|NCT02146365|580034355|FG001|Overall Study|Withdrawal by Subject|2|||
160632648|NCT02146365|580034356|FG002|Overall Study|Withdrawal by Subject|1|||
160632649|NCT02146365|580034357|FG003|Overall Study|Withdrawal by Subject|5|||
160632650|NCT02146365|580034358|FG004|Overall Study|Withdrawal by Subject|1|||
160632651|NCT02146365|580034359|FG005|Overall Study|Withdrawal by Subject|0|||
160632652|NCT02146365|580034360|FG006|Overall Study|Withdrawal by Subject|0|||
160632653|NCT02146365|580034361|FG007|Overall Study|Withdrawal by Subject|0|||
160632654|NCT02146365|580034354|FG000|Overall Study|Unable to Comply with Protocol|0|||
160632655|NCT02146365|580034355|FG001|Overall Study|Unable to Comply with Protocol|1|||
160632656|NCT02146365|580034356|FG002|Overall Study|Unable to Comply with Protocol|1|||
160632657|NCT02146365|580034357|FG003|Overall Study|Unable to Comply with Protocol|0|||
160677126|NCT00556673|580196942|FG001|Overall Study|Protocol deviation|2|||
160677127|NCT01971554|580196943|FG000|Overall Study|Lost to Follow-up|1|||
160677128|NCT01971554|580196944|FG001|Overall Study|Lost to Follow-up|0|||
160677129|NCT01971554|580196945|FG002|Overall Study|Lost to Follow-up|0|||
160677130|NCT01971554|580196946|FG003|Overall Study|Lost to Follow-up|0|||
160677131|NCT04194151|580196948|FG000|Overall Study|Physician Decision|1|||
160677132|NCT04194151|580196949|FG001|Overall Study|Physician Decision|1|||
160677133|NCT04194151|580196950|FG002|Overall Study|Physician Decision|1|||
160677134|NCT04194151|580196951|FG003|Overall Study|Physician Decision|1|||
160677135|NCT04194151|580196952|FG004|Overall Study|Physician Decision|0|||
160677136|NCT04194151|580196953|FG005|Overall Study|Physician Decision|1|||
160677137|NCT04194151|580196948|FG000|Overall Study|Monitorization problem|0|||
160677138|NCT04194151|580196949|FG001|Overall Study|Monitorization problem|1|||
160677139|NCT04194151|580196950|FG002|Overall Study|Monitorization problem|0|||
160677140|NCT04194151|580196951|FG003|Overall Study|Monitorization problem|0|||
160677141|NCT04194151|580196952|FG004|Overall Study|Monitorization problem|0|||
160677142|NCT04194151|580196953|FG005|Overall Study|Monitorization problem|0|||
160677143|NCT00421304|580196954|FG000|Overall Study|Lost to Follow-up|5|||
160677144|NCT00421304|580196955|FG001|Overall Study|Lost to Follow-up|2|||
160677145|NCT00421304|580196956|FG002|Overall Study|Lost to Follow-up|5|||
160677146|NCT00421304|580196954|FG000|Overall Study|Withdrawal by Subject|2|||
160677147|NCT00421304|580196955|FG001|Overall Study|Withdrawal by Subject|2|||
160677148|NCT00421304|580196956|FG002|Overall Study|Withdrawal by Subject|2|||
160677149|NCT00421304|580196954|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
160677150|NCT00421304|580196955|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
160677151|NCT00421304|580196956|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
160677152|NCT00421304|580196954|FG000|Overall Study|Did not attend Day 360 visit|0|||
160677153|NCT00421304|580196955|FG001|Overall Study|Did not attend Day 360 visit|0|||
160677154|NCT00421304|580196956|FG002|Overall Study|Did not attend Day 360 visit|1|||
160677155|NCT00919711|580196957|FG000|Overall Study|Withdrawal by Subject|15|||
160677156|NCT00919711|580196958|FG001|Overall Study|Withdrawal by Subject|7|||
160677157|NCT00919711|580196957|FG000|Overall Study|Adverse Event|13|||
160677158|NCT00919711|580196958|FG001|Overall Study|Adverse Event|3|||
160677159|NCT00919711|580196957|FG000|Overall Study|Other|1|||
160677160|NCT00919711|580196958|FG001|Overall Study|Other|2|||
160677161|NCT00919711|580196957|FG000|Overall Study|Administrative Decision|0|||
160677162|NCT00919711|580196958|FG001|Overall Study|Administrative Decision|1|||
160677163|NCT00919711|580196957|FG000|Overall Study|Lost to Follow-up|2|||
160677164|NCT00919711|580196958|FG001|Overall Study|Lost to Follow-up|0|||
160677165|NCT00919711|580196957|FG000|Overall Study|Death|1|||
160677166|NCT00919711|580196958|FG001|Overall Study|Death|0|||
160677167|NCT00919711|580196957|FG000|Overall Study|Noncompliance|1|||
160677168|NCT00919711|580196958|FG001|Overall Study|Noncompliance|0|||
160677169|NCT00903877|580196959|FG000|Overall Study|Did not meet study criteria|33|||
160677170|NCT00903877|580196959|FG000|Overall Study|Withdrawal by Subject|3|||
160677171|NCT00903877|580196959|FG000|Overall Study|Adverse Event|2|||
160677172|NCT00903877|580196959|FG000|Overall Study|Lost to Follow-up|1|||
160677173|NCT00903877|580196959|FG000|Overall Study|Participation put on hold|4|||
160677174|NCT00087529|580196961|FG000|Overall Study|Death|1|||
160677175|NCT00087529|580196962|FG001|Overall Study|Death|0|||
160519916|NCT01275131|579632917|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
160519917|NCT01740323|579632918|FG000|Overall Study|Adverse Event|1|||
160519918|NCT01740323|579632919|FG001|Overall Study|Adverse Event|0|||
160519919|NCT01740323|579632918|FG000|Overall Study|Randomized but did not take study drug|1|||
160519920|NCT01740323|579632919|FG001|Overall Study|Randomized but did not take study drug|0|||
160519921|NCT06338462|579632920|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
160519922|NCT02112708|579632926|FG000|Baseline|Physician Decision|16|||
160519923|NCT02112708|579632927|FG001|Baseline|Physician Decision|11|||
160519924|NCT02112708|579632926|FG000|Baseline|Lost to Follow-up|12|||
160519925|NCT02112708|579632927|FG001|Baseline|Lost to Follow-up|0|||
160519926|NCT02112708|579632926|FG000|4 Month|Death|0|||
160519927|NCT02112708|579632927|FG001|4 Month|Death|1|||
160677176|NCT00087529|580196961|FG000|Overall Study|Adverse Event|0|||
160677177|NCT00087529|580196962|FG001|Overall Study|Adverse Event|8|||
160677178|NCT00087529|580196961|FG000|Overall Study|Pregnancy|0|||
160677179|NCT00087529|580196962|FG001|Overall Study|Pregnancy|1|||
160519928|NCT02112708|579632926|FG000|4 Month|Withdrawal by Subject|12|||
160519929|NCT02112708|579632927|FG001|4 Month|Withdrawal by Subject|0|||
160677180|NCT00087529|580196961|FG000|Overall Study|Lost to Follow-up|2|||
160677181|NCT00087529|580196962|FG001|Overall Study|Lost to Follow-up|3|||
160677182|NCT00087529|580196961|FG000|Overall Study|Participant Decision|14|||
160677183|NCT00087529|580196962|FG001|Overall Study|Participant Decision|37|||
160677184|NCT00087529|580196961|FG000|Overall Study|Physician Decision|4|||
160677185|NCT00087529|580196962|FG001|Overall Study|Physician Decision|8|||
160677186|NCT00087529|580196961|FG000|Overall Study|Initiation of Excluded Therapy|0|||
160677187|NCT00087529|580196962|FG001|Overall Study|Initiation of Excluded Therapy|1|||
160677188|NCT00087529|580196961|FG000|Overall Study|Participant Noncompliance|0|||
160677189|NCT00087529|580196962|FG001|Overall Study|Participant Noncompliance|1|||
160677190|NCT00087529|580196961|FG000|Overall Study|Disease Progression|5|||
160677191|NCT00087529|580196962|FG001|Overall Study|Disease Progression|4|||
160677192|NCT00087529|580196961|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
160677193|NCT00087529|580196962|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
160677194|NCT02535923|580196963|FG000|Overall Study|Lost to Follow-up|5|||
160677195|NCT02535923|580196964|FG001|Overall Study|Lost to Follow-up|5|||
160677196|NCT02535923|580196963|FG000|Overall Study|Withdrawal by Subject|4|||
160677197|NCT02535923|580196964|FG001|Overall Study|Withdrawal by Subject|3|||
160677198|NCT04388787|580196965|FG000|Blinded Period|Patient could not follow instructions|1|||
160677199|NCT04388787|580196965|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
160677200|NCT03694197|580196968|FG000|Overall Study|Adverse Event|9|||
160677201|NCT03694197|580196968|FG000|Overall Study|Protocol became inconvenient to participate|1|||
160677202|NCT03694197|580196968|FG000|Overall Study|Physician Decision|4|||
160677203|NCT03694197|580196968|FG000|Overall Study|Study terminated by sponsor|1350|||
160677204|NCT03694197|580196968|FG000|Overall Study|Participant moved|5|||
160677205|NCT03694197|580196968|FG000|Overall Study|Participant withdrew consent|10|||
160677206|NCT03694197|580196968|FG000|Overall Study|Related to IMP administration|1|||
160677207|NCT03694197|580196968|FG000|Overall Study|Not disclosed|5|||
160677208|NCT02940522|580198712|FG000|Overall Study|Lost to Follow-up|1|||
160677209|NCT02940522|580198713|FG001|Overall Study|Lost to Follow-up|2|||
160677210|NCT02940522|580198712|FG000|Overall Study|Withdrawal by Subject|1|||
160677211|NCT02940522|580198713|FG001|Overall Study|Withdrawal by Subject|0|||
160677212|NCT05135273|580198714|FG000|Overall Study|Recruited into the army|0|||
160677213|NCT05135273|580198715|FG001|Overall Study|Recruited into the army|0|||
160677214|NCT05135273|580198716|FG002|Overall Study|Recruited into the army|0|||
160677215|NCT05135273|580198717|FG003|Overall Study|Recruited into the army|0|||
160677216|NCT05135273|580198718|FG004|Overall Study|Recruited into the army|1|||
160677217|NCT05135273|580198719|FG005|Overall Study|Recruited into the army|0|||
160677218|NCT05135273|580198720|FG006|Overall Study|Recruited into the army|0|||
160677219|NCT05135273|580198721|FG007|Overall Study|Recruited into the army|0|||
160677220|NCT05135273|580198714|FG000|Overall Study|Moved away from study site|0|||
160677221|NCT05135273|580198715|FG001|Overall Study|Moved away from study site|0|||
160677222|NCT05135273|580198716|FG002|Overall Study|Moved away from study site|0|||
160677223|NCT05135273|580198717|FG003|Overall Study|Moved away from study site|0|||
160677224|NCT05135273|580198718|FG004|Overall Study|Moved away from study site|0|||
160677225|NCT05135273|580198719|FG005|Overall Study|Moved away from study site|1|||
160677226|NCT05135273|580198720|FG006|Overall Study|Moved away from study site|1|||
160677227|NCT05135273|580198721|FG007|Overall Study|Moved away from study site|0|||
160677228|NCT05135273|580198714|FG000|Overall Study|Travel|0|||
160677229|NCT05135273|580198715|FG001|Overall Study|Travel|0|||
160677230|NCT05135273|580198716|FG002|Overall Study|Travel|0|||
160677231|NCT05135273|580198717|FG003|Overall Study|Travel|0|||
160677232|NCT05135273|580198718|FG004|Overall Study|Travel|0|||
160677233|NCT05135273|580198719|FG005|Overall Study|Travel|0|||
160677234|NCT05135273|580198720|FG006|Overall Study|Travel|0|||
160677235|NCT05135273|580198721|FG007|Overall Study|Travel|1|||
160677236|NCT01188226|580198727|FG000|Overall Study|Withdrawal by Subject|4|||
160677237|NCT04980456|580198728|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
160677238|NCT04980456|580198729|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
160677239|NCT04980456|580198728|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
160677240|NCT04980456|580198729|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
160677241|NCT04980456|580198728|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
160677242|NCT04980456|580198729|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
160677243|NCT04980456|580198728|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
160677244|NCT04980456|580198729|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
160677245|NCT00442351|580198730|FG000|Overall Study|Administrative|6|||
160677246|NCT00442351|580198731|FG001|Overall Study|Administrative|5|||
160677247|NCT00442351|580198730|FG000|Overall Study|Did not meet protocol eligibility|1|||
160677248|NCT00442351|580198731|FG001|Overall Study|Did not meet protocol eligibility|0|||
160677249|NCT00442351|580198730|FG000|Overall Study|Other|0|||
160677250|NCT00442351|580198731|FG001|Overall Study|Other|1|||
160677251|NCT01579006|580198761|FG000|Overall Study|Lack of Efficacy|10|||
160519930|NCT00953745|579632928|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
160677252|NCT01579006|580198761|FG000|Overall Study|Adverse Event|13|||
160677253|NCT01579006|580198761|FG000|Overall Study|Withdrawal by Subject|5|||
160677254|NCT01579006|580198761|FG000|Overall Study|Non-compliance|3|||
160677255|NCT01579006|580198761|FG000|Overall Study|Due to participant's health fund|1|||
160677256|NCT01579006|580198761|FG000|Overall Study|Scheduled surgery|1|||
160677257|NCT02274558|580198767|FG000|Overall Study|Adverse Event|2|||
160677258|NCT02274558|580198768|FG001|Overall Study|Adverse Event|4|||
160677259|NCT02274558|580198769|FG002|Overall Study|Adverse Event|2|||
160677260|NCT02274558|580198767|FG000|Overall Study|Non-compliance|2|||
160677261|NCT02274558|580198768|FG001|Overall Study|Non-compliance|1|||
160677262|NCT02274558|580198769|FG002|Overall Study|Non-compliance|0|||
160677263|NCT02274558|580198767|FG000|Overall Study|Withdrawal by Subject|1|||
160677264|NCT02274558|580198768|FG001|Overall Study|Withdrawal by Subject|5|||
160677265|NCT02274558|580198769|FG002|Overall Study|Withdrawal by Subject|4|||
160677266|NCT02274558|580198767|FG000|Overall Study|Death|0|||
160677267|NCT02274558|580198768|FG001|Overall Study|Death|0|||
160677268|NCT02274558|580198769|FG002|Overall Study|Death|1|||
160677269|NCT02274558|580198767|FG000|Overall Study|Lost to Follow-up|2|||
160677270|NCT02274558|580198768|FG001|Overall Study|Lost to Follow-up|1|||
160677271|NCT02274558|580198769|FG002|Overall Study|Lost to Follow-up|1|||
160677272|NCT02274558|580198767|FG000|Overall Study|Physician Decision|0|||
160677273|NCT02274558|580198768|FG001|Overall Study|Physician Decision|2|||
160677274|NCT02274558|580198769|FG002|Overall Study|Physician Decision|1|||
160677275|NCT02733627|580198770|FG000|Overall Study|Adverse Event|0|||
160677276|NCT02733627|580198771|FG001|Overall Study|Adverse Event|1|||
160677277|NCT02733627|580198772|FG002|Overall Study|Adverse Event|1|||
160677278|NCT02733627|580198773|FG003|Overall Study|Adverse Event|0|||
160677279|NCT02733627|580198770|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
160677280|NCT02733627|580198771|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
160677281|NCT02733627|580198772|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
160677282|NCT02733627|580198773|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
160677283|NCT05393271|580198774|FG000|Overall Study|Physician Decision|0|||
160677284|NCT05393271|580198775|FG001|Overall Study|Physician Decision|0|||
160677285|NCT05393271|580198776|FG002|Overall Study|Physician Decision|0|||
160677286|NCT05393271|580198777|FG003|Overall Study|Physician Decision|0|||
160677287|NCT05393271|580198778|FG004|Overall Study|Physician Decision|0|||
160677288|NCT05393271|580198779|FG005|Overall Study|Physician Decision|0|||
160677289|NCT05393271|580198780|FG006|Overall Study|Physician Decision|1|||
160677290|NCT05393271|580198781|FG007|Overall Study|Physician Decision|0|||
160677291|NCT05393271|580198782|FG008|Overall Study|Physician Decision|0|||
160677292|NCT05393271|580198783|FG009|Overall Study|Physician Decision|0|||
160677293|NCT05393271|580198784|FG010|Overall Study|Physician Decision|0|||
160677294|NCT01708954|580198785|FG000|Step 1|Disease progression|26|||
160677295|NCT01708954|580198786|FG001|Step 1|Disease progression|17|||
160677296|NCT01708954|580198787|FG002|Step 1|Disease progression|14|||
160677297|NCT01708954|580198785|FG000|Step 1|Adverse Event|3|||
160677298|NCT01708954|580198786|FG001|Step 1|Adverse Event|11|||
160677299|NCT01708954|580198787|FG002|Step 1|Adverse Event|13|||
160677300|NCT01708954|580198785|FG000|Step 1|Death|3|||
160677301|NCT01708954|580198786|FG001|Step 1|Death|2|||
160677302|NCT01708954|580198787|FG002|Step 1|Death|3|||
160677303|NCT01708954|580198785|FG000|Step 1|Withdrawal by Subject|2|||
160677304|NCT01708954|580198786|FG001|Step 1|Withdrawal by Subject|5|||
160677305|NCT01708954|580198787|FG002|Step 1|Withdrawal by Subject|3|||
160677306|NCT01708954|580198785|FG000|Step 1|Other complicating disease|0|||
160677307|NCT01708954|580198786|FG001|Step 1|Other complicating disease|2|||
160677308|NCT01708954|580198787|FG002|Step 1|Other complicating disease|0|||
160677309|NCT01708954|580198785|FG000|Step 1|Crossed over to Step 2|2|||
160677310|NCT01708954|580198786|FG001|Step 1|Crossed over to Step 2|0|||
160677311|NCT01708954|580198787|FG002|Step 1|Crossed over to Step 2|0|||
160677312|NCT01708954|580198785|FG000|Step 1|Symptomatic deterioration|1|||
160677313|NCT01708954|580198786|FG001|Step 1|Symptomatic deterioration|0|||
160677314|NCT01708954|580198787|FG002|Step 1|Symptomatic deterioration|1|||
160677315|NCT01708954|580198785|FG000|Step 1|Off-treatment reason not submitted|1|||
160677316|NCT01708954|580198786|FG001|Step 1|Off-treatment reason not submitted|1|||
160677317|NCT01708954|580198787|FG002|Step 1|Off-treatment reason not submitted|1|||
160677318|NCT01708954|580198785|FG000|Step 1|Ineligible or never received treatment|4|||
160677319|NCT01708954|580198786|FG001|Step 1|Ineligible or never received treatment|2|||
160677320|NCT01708954|580198787|FG002|Step 1|Ineligible or never received treatment|8|||
160677321|NCT01708954|580198785|FG000|Step 2|Disease progression|9|||
160677322|NCT01708954|580198786|FG001|Step 2|Disease progression|4|||
160677323|NCT01708954|580198787|FG002|Step 2|Disease progression|0|||
160519931|NCT00953745|579632929|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
160519932|NCT00953745|579632928|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
160519933|NCT00953745|579632929|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
160519934|NCT00953745|579632928|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
160519935|NCT00953745|579632929|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
160677324|NCT01708954|580198785|FG000|Step 2|Adverse Event|3|||
160677325|NCT01708954|580198786|FG001|Step 2|Adverse Event|2|||
160677326|NCT01708954|580198787|FG002|Step 2|Adverse Event|0|||
160677327|NCT01708954|580198785|FG000|Step 2|Withdrawal by Subject|1|||
160677328|NCT01708954|580198786|FG001|Step 2|Withdrawal by Subject|1|||
160677329|NCT01708954|580198787|FG002|Step 2|Withdrawal by Subject|0|||
160519936|NCT00953745|579632928|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
160519937|NCT00953745|579632929|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
160632658|NCT02146365|580034358|FG004|Overall Study|Unable to Comply with Protocol|0|||
160632659|NCT02146365|580034359|FG005|Overall Study|Unable to Comply with Protocol|0|||
160519938|NCT00953745|579632928|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
160519939|NCT00953745|579632929|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
160519940|NCT00953745|579632928|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
160519941|NCT00953745|579632929|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
160519942|NCT03110185|579632931|FG000|Overall Study|Death|0|||
160519943|NCT03110185|579632932|FG001|Overall Study|Death|1|||
160519944|NCT03110185|579632931|FG000|Overall Study|Withdrawal by Subject|2|||
160519945|NCT03110185|579632932|FG001|Overall Study|Withdrawal by Subject|7|||
160519946|NCT03110185|579632931|FG000|Overall Study|Time Constraints|0|||
160519947|NCT03110185|579632932|FG001|Overall Study|Time Constraints|6|||
160519948|NCT03110185|579632931|FG000|Overall Study|Conflict with care|5|||
160519949|NCT03110185|579632932|FG001|Overall Study|Conflict with care|12|||
160519950|NCT03110185|579632931|FG000|Overall Study|Protocol Violation|1|||
160519951|NCT03110185|579632932|FG001|Overall Study|Protocol Violation|4|||
160519952|NCT03110185|579632931|FG000|Overall Study|MRI Incompatible|2|||
160519953|NCT03110185|579632932|FG001|Overall Study|MRI Incompatible|0|||
160519954|NCT03110185|579632931|FG000|Overall Study|Patient Refusal|0|||
160519955|NCT03110185|579632932|FG001|Overall Study|Patient Refusal|1|||
160519956|NCT02053792|579632933|FG000|Overall Study|Physician Decision|0|||
160519957|NCT02053792|579632934|FG001|Overall Study|Physician Decision|1|||
160519958|NCT02053792|579632933|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
160519959|NCT02053792|579632934|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
160519960|NCT02053792|579632933|FG000|Overall Study|Lack of Efficacy|1|||
160519961|NCT02053792|579632934|FG001|Overall Study|Lack of Efficacy|0|||
160519962|NCT02053792|579632933|FG000|Overall Study|Adverse Event|1|||
160519963|NCT02053792|579632934|FG001|Overall Study|Adverse Event|0|||
160519964|NCT02053792|579632933|FG000|Overall Study|Withdrawal by Subject|2|||
160519965|NCT02053792|579632934|FG001|Overall Study|Withdrawal by Subject|2|||
160519966|NCT02053792|579632933|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
160519967|NCT02053792|579632934|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
160519968|NCT02053792|579632933|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
160632660|NCT02146365|580034360|FG006|Overall Study|Unable to Comply with Protocol|0|||
160632661|NCT02146365|580034361|FG007|Overall Study|Unable to Comply with Protocol|0|||
160632662|NCT02146365|580034354|FG000|Overall Study|Other|1|||
160632663|NCT02146365|580034355|FG001|Overall Study|Other|0|||
160632664|NCT02146365|580034356|FG002|Overall Study|Other|2|||
160632665|NCT02146365|580034357|FG003|Overall Study|Other|1|||
160632666|NCT02146365|580034358|FG004|Overall Study|Other|0|||
160632667|NCT02146365|580034359|FG005|Overall Study|Other|0|||
160632668|NCT02146365|580034360|FG006|Overall Study|Other|0|||
160632669|NCT02146365|580034361|FG007|Overall Study|Other|0|||
160632670|NCT00359073|580036022|FG000|Overall Study|Withdrawal by Subject|1|||
160632671|NCT00359073|580036023|FG001|Overall Study|Withdrawal by Subject|1|||
160632672|NCT00359073|580036022|FG000|Overall Study|Eligibility criteria no longer met|3|||
160632673|NCT00359073|580036023|FG001|Overall Study|Eligibility criteria no longer met|0|||
160632674|NCT00359073|580036022|FG000|Overall Study|developed RV16 antibody|0|||
160632675|NCT00359073|580036023|FG001|Overall Study|developed RV16 antibody|1|||
160632676|NCT01371006|580036024|FG000|Overall Study|Adverse Event|1|||
160632677|NCT01371006|580036025|FG001|Overall Study|Adverse Event|0|||
160632678|NCT00684645|580036026|FG000|Overall Study|Death|2|||
160632679|NCT00684645|580036026|FG000|Overall Study|Progressive disease|67|||
160632680|NCT00684645|580036026|FG000|Overall Study|Adverse Event|27|||
160632681|NCT00684645|580036026|FG000|Overall Study|Lost to Follow-up|3|||
160632682|NCT00684645|580036026|FG000|Overall Study|Other|15|||
160632683|NCT03515837|580036028|FG000|Overall Study|Death|219|||
160632684|NCT03515837|580036029|FG001|Overall Study|Death|227|||
160632685|NCT03515837|580036028|FG000|Overall Study|Lost to Follow-up|0|||
160632686|NCT03515837|580036029|FG001|Overall Study|Lost to Follow-up|1|||
160632687|NCT03515837|580036028|FG000|Overall Study|Withdrawal by Subject|0|||
160632688|NCT03515837|580036029|FG001|Overall Study|Withdrawal by Subject|4|||
160632689|NCT03515837|580036028|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
160632690|NCT03515837|580036029|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
160632691|NCT02325401|580036030|FG000|Overall Study|Withdrawal by Subject|0|||
160632692|NCT02325401|580036031|FG001|Overall Study|Withdrawal by Subject|1|||
160632693|NCT02325401|580036032|FG002|Overall Study|Withdrawal by Subject|1|||
160632694|NCT00391092|580036033|FG000|Overall Study|Death|78|||
160632695|NCT00391092|580036034|FG001|Overall Study|Death|81|||
160632696|NCT00391092|580036033|FG000|Overall Study|Lost to Follow-up|13|||
160632697|NCT00391092|580036034|FG001|Overall Study|Lost to Follow-up|18|||
160632698|NCT00391092|580036033|FG000|Overall Study|Alive on treatment|29|||
160632699|NCT00391092|580036034|FG001|Overall Study|Alive on treatment|33|||
160519969|NCT02053792|579632934|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
160519970|NCT01427751|579632935|FG000|Overall Study|Adverse Event|18|||
160519971|NCT01427751|579632936|FG001|Overall Study|Adverse Event|2|||
160519972|NCT01427751|579632935|FG000|Overall Study|No further treatment benefit expected|5|||
160519973|NCT01427751|579632936|FG001|Overall Study|No further treatment benefit expected|1|||
160519974|NCT01427751|579632935|FG000|Overall Study|Lost to Follow-up|3|||
160519975|NCT01427751|579632936|FG001|Overall Study|Lost to Follow-up|1|||
160519976|NCT01427751|579632935|FG000|Overall Study|Withdrawal of consent|2|||
160519977|NCT01427751|579632936|FG001|Overall Study|Withdrawal of consent|2|||
160519978|NCT01427751|579632935|FG000|Overall Study|Protocol Violation|6|||
160519979|NCT01427751|579632936|FG001|Overall Study|Protocol Violation|4|||
160519980|NCT01427751|579632935|FG000|Overall Study|Death|2|||
160519981|NCT01427751|579632936|FG001|Overall Study|Death|0|||
160519982|NCT01427751|579632935|FG000|Overall Study|Other miscellaneous reasons|6|||
160519983|NCT01427751|579632936|FG001|Overall Study|Other miscellaneous reasons|4|||
160519984|NCT00368992|579632945|FG000|Overall Study|Ineligible|5|||
160519985|NCT00368992|579632945|FG000|Overall Study|Refused treatment|3|||
160519986|NCT00368992|579632945|FG000|Overall Study|Lack of Efficacy|63|||
160519987|NCT00368992|579632945|FG000|Overall Study|Adverse Event|26|||
160519988|NCT00368992|579632945|FG000|Overall Study|Death|4|||
160519989|NCT00368992|579632945|FG000|Overall Study|Other|9|||
160519990|NCT00790751|579632952|FG000|Overall Study|Protocol non-compliance|16|||
160519991|NCT00790751|579632953|FG001|Overall Study|Protocol non-compliance|16|||
160519992|NCT00790751|579632954|FG002|Overall Study|Protocol non-compliance|10|||
160519993|NCT00790751|579632955|FG003|Overall Study|Protocol non-compliance|11|||
160519994|NCT00790751|579632952|FG000|Overall Study|Lost to Follow-up|4|||
160519995|NCT00790751|579632953|FG001|Overall Study|Lost to Follow-up|9|||
160519996|NCT00790751|579632954|FG002|Overall Study|Lost to Follow-up|4|||
160519997|NCT00790751|579632955|FG003|Overall Study|Lost to Follow-up|5|||
160519998|NCT00790751|579632952|FG000|Overall Study|Adverse Event|5|||
160519999|NCT00790751|579632953|FG001|Overall Study|Adverse Event|3|||
160520000|NCT00790751|579632954|FG002|Overall Study|Adverse Event|5|||
160520001|NCT00790751|579632955|FG003|Overall Study|Adverse Event|4|||
160520002|NCT00790751|579632952|FG000|Overall Study|Requirement for restricted medication|0|||
160520003|NCT00790751|579632953|FG001|Overall Study|Requirement for restricted medication|2|||
160520004|NCT00790751|579632954|FG002|Overall Study|Requirement for restricted medication|0|||
160520005|NCT00790751|579632955|FG003|Overall Study|Requirement for restricted medication|0|||
160520006|NCT00790751|579632952|FG000|Overall Study|Death|0|||
160520007|NCT00790751|579632953|FG001|Overall Study|Death|0|||
160520008|NCT00790751|579632954|FG002|Overall Study|Death|1|||
160520009|NCT00790751|579632955|FG003|Overall Study|Death|0|||
160520010|NCT00790751|579632952|FG000|Overall Study|Physician Decision|0|||
160520011|NCT00790751|579632953|FG001|Overall Study|Physician Decision|0|||
160520012|NCT00790751|579632954|FG002|Overall Study|Physician Decision|0|||
160520013|NCT00790751|579632955|FG003|Overall Study|Physician Decision|1|||
160520014|NCT02427464|579632958|FG000|Overall Study|Adverse Event|6|||
160520015|NCT02427464|579632959|FG001|Overall Study|Adverse Event|1|||
160520016|NCT02427464|579632958|FG000|Overall Study|Lost to Follow-up|16|||
160520017|NCT02427464|579632959|FG001|Overall Study|Lost to Follow-up|5|||
160520018|NCT02427464|579632958|FG000|Overall Study|Physician Decision|2|||
160520019|NCT02427464|579632959|FG001|Overall Study|Physician Decision|0|||
160520020|NCT02427464|579632958|FG000|Overall Study|Withdrawal by Subject|10|||
160520021|NCT02427464|579632959|FG001|Overall Study|Withdrawal by Subject|8|||
160520022|NCT02427464|579632958|FG000|Overall Study|Noncompliance|16|||
160632700|NCT00391092|580036033|FG000|Overall Study|Alive in follow-up|88|||
160632701|NCT00391092|580036034|FG001|Overall Study|Alive in follow-up|84|||
160632702|NCT00602979|580036037|FG000|Overall Study|Lost to Follow-up|3|||
160632703|NCT00602979|580036038|FG001|Overall Study|Lost to Follow-up|2|||
160632704|NCT00602979|580036039|FG002|Overall Study|Lost to Follow-up|3|||
160632705|NCT00602979|580036040|FG003|Overall Study|Lost to Follow-up|2|||
160632706|NCT00602979|580036041|FG004|Overall Study|Lost to Follow-up|3|||
160632707|NCT00602979|580036037|FG000|Overall Study|Failed Intubation|0|||
160632708|NCT00602979|580036038|FG001|Overall Study|Failed Intubation|1|||
160632709|NCT00602979|580036039|FG002|Overall Study|Failed Intubation|0|||
160632710|NCT00602979|580036040|FG003|Overall Study|Failed Intubation|1|||
160677330|NCT01192776|580198788|FG000|Overall Study|Death|8|||
160677331|NCT01192776|580198789|FG001|Overall Study|Death|15|||
160677332|NCT01192776|580198790|FG002|Overall Study|Death|18|||
160677333|NCT01192776|580198791|FG003|Overall Study|Death|15|||
160520023|NCT02427464|579632959|FG001|Overall Study|Noncompliance|10|||
160632711|NCT00602979|580036041|FG004|Overall Study|Failed Intubation|0|||
160632712|NCT03692078|580036042|FG000|Overall Study|Adverse Event|0|||
160632713|NCT03692078|580036043|FG001|Overall Study|Adverse Event|0|||
160632714|NCT03692078|580036044|FG002|Overall Study|Adverse Event|0|||
160632715|NCT03692078|580036045|FG003|Overall Study|Adverse Event|0|||
160632716|NCT03692078|580036046|FG004|Overall Study|Adverse Event|0|||
160632717|NCT03692078|580036047|FG005|Overall Study|Adverse Event|1|||
160632718|NCT03692078|580036048|FG006|Overall Study|Adverse Event|0|||
160632719|NCT03692078|580036042|FG000|Overall Study|Enrollment Closed|5|||
160632720|NCT03692078|580036043|FG001|Overall Study|Enrollment Closed|0|||
160632721|NCT03692078|580036044|FG002|Overall Study|Enrollment Closed|0|||
160632722|NCT03692078|580036045|FG003|Overall Study|Enrollment Closed|0|||
160632723|NCT03692078|580036046|FG004|Overall Study|Enrollment Closed|0|||
160632724|NCT03692078|580036047|FG005|Overall Study|Enrollment Closed|0|||
160632725|NCT03692078|580036048|FG006|Overall Study|Enrollment Closed|0|||
160632726|NCT03692078|580036042|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
160632727|NCT03692078|580036043|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
160632728|NCT03692078|580036044|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
160632729|NCT03692078|580036045|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
160632730|NCT03692078|580036046|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
160632731|NCT03692078|580036047|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
160632732|NCT03692078|580036048|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
160632733|NCT03692078|580036042|FG000|Overall Study|Withdrawal by Subject|0|||
160632734|NCT03692078|580036043|FG001|Overall Study|Withdrawal by Subject|2|||
160632735|NCT03692078|580036044|FG002|Overall Study|Withdrawal by Subject|0|||
160632736|NCT03692078|580036045|FG003|Overall Study|Withdrawal by Subject|1|||
160632737|NCT03692078|580036046|FG004|Overall Study|Withdrawal by Subject|5|||
160632738|NCT03692078|580036047|FG005|Overall Study|Withdrawal by Subject|3|||
160632739|NCT03692078|580036048|FG006|Overall Study|Withdrawal by Subject|3|||
160632740|NCT01615822|580036052|FG000|Period 1|Withdrawal by Subject|0|||
160632741|NCT01615822|580036053|FG001|Period 1|Withdrawal by Subject|1|||
160632742|NCT01615822|580036054|FG002|Period 1|Withdrawal by Subject|0|||
160632743|NCT01615822|580036052|FG000|Period 1|Adverse Event|1|||
160632744|NCT01615822|580036053|FG001|Period 1|Adverse Event|1|||
160632745|NCT01615822|580036054|FG002|Period 1|Adverse Event|0|||
160632746|NCT01615822|580036052|FG000|Period 2|Lost to Follow-up|0|||
160632747|NCT01615822|580036053|FG001|Period 2|Lost to Follow-up|1|||
160632748|NCT01615822|580036054|FG002|Period 2|Lost to Follow-up|2|||
160632749|NCT02861534|580036055|FG000|Overall Study|Death|541|||
160632750|NCT02861534|580036056|FG001|Overall Study|Death|552|||
160632751|NCT02861534|580036055|FG000|Overall Study|Lost to Follow-up|14|||
160632752|NCT02861534|580036056|FG001|Overall Study|Lost to Follow-up|14|||
160632753|NCT02861534|580036055|FG000|Overall Study|Site Terminated by Sponsor|4|||
160632754|NCT02861534|580036056|FG001|Overall Study|Site Terminated by Sponsor|3|||
160632755|NCT02861534|580036055|FG000|Overall Study|Withdrawal by Subject|15|||
160632756|NCT02861534|580036056|FG001|Overall Study|Withdrawal by Subject|18|||
160632757|NCT02886494|580036057|FG000|Overall Study|Adverse Event|1|||
160632758|NCT02886494|580036058|FG001|Overall Study|Adverse Event|0|||
160632759|NCT02886494|580036057|FG000|Overall Study|Withdrawal by Subject|12|||
160632760|NCT02886494|580036058|FG001|Overall Study|Withdrawal by Subject|3|||
160632761|NCT02886494|580036057|FG000|Overall Study|Protocol Violation|4|||
160632762|NCT02886494|580036058|FG001|Overall Study|Protocol Violation|1|||
160632763|NCT00916617|580036064|FG000|Overall Study|Adverse Event|3|||
160632764|NCT00916617|580036065|FG001|Overall Study|Adverse Event|2|||
160632765|NCT00916617|580036066|FG002|Overall Study|Adverse Event|6|||
160632766|NCT00916617|580036067|FG003|Overall Study|Adverse Event|3|||
160632767|NCT00916617|580036064|FG000|Overall Study|Withdrawal by Subject|3|||
160632768|NCT00916617|580036065|FG001|Overall Study|Withdrawal by Subject|2|||
160632769|NCT00916617|580036066|FG002|Overall Study|Withdrawal by Subject|0|||
160632770|NCT00916617|580036067|FG003|Overall Study|Withdrawal by Subject|1|||
160632771|NCT00916617|580036064|FG000|Overall Study|Caregiver Request|3|||
160632772|NCT00916617|580036065|FG001|Overall Study|Caregiver Request|2|||
160632773|NCT00916617|580036066|FG002|Overall Study|Caregiver Request|1|||
160632774|NCT00916617|580036067|FG003|Overall Study|Caregiver Request|0|||
160632775|NCT00916617|580036064|FG000|Overall Study|Physician Decision|1|||
160632776|NCT00916617|580036065|FG001|Overall Study|Physician Decision|1|||
160632777|NCT00916617|580036066|FG002|Overall Study|Physician Decision|0|||
160632778|NCT00916617|580036067|FG003|Overall Study|Physician Decision|0|||
160632779|NCT00916617|580036064|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
160632780|NCT00916617|580036065|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
160632781|NCT00916617|580036066|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
160632782|NCT00916617|580036067|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
160632783|NCT00916617|580036064|FG000|Overall Study|Lost to Follow-up|2|||
160632784|NCT00916617|580036065|FG001|Overall Study|Lost to Follow-up|1|||
160632785|NCT00916617|580036066|FG002|Overall Study|Lost to Follow-up|0|||
160632786|NCT00916617|580036067|FG003|Overall Study|Lost to Follow-up|0|||
160632787|NCT00916617|580036064|FG000|Overall Study|Lack of Efficacy|1|||
160632788|NCT00916617|580036065|FG001|Overall Study|Lack of Efficacy|0|||
160632789|NCT00916617|580036066|FG002|Overall Study|Lack of Efficacy|0|||
160632790|NCT00916617|580036067|FG003|Overall Study|Lack of Efficacy|0|||
160632791|NCT00916617|580036064|FG000|Overall Study|Other|2|||
160632792|NCT00916617|580036065|FG001|Overall Study|Other|0|||
160632793|NCT00916617|580036066|FG002|Overall Study|Other|0|||
160632794|NCT00916617|580036067|FG003|Overall Study|Other|2|||
160632795|NCT02086968|580036072|FG000|Overall Study|Adverse Event|1|||
160677334|NCT01192776|580198788|FG000|Overall Study|Lost to Follow-up|3|||
160677335|NCT01192776|580198789|FG001|Overall Study|Lost to Follow-up|6|||
160677336|NCT01192776|580198790|FG002|Overall Study|Lost to Follow-up|3|||
160677337|NCT01192776|580198791|FG003|Overall Study|Lost to Follow-up|5|||
160677338|NCT02587143|580198792|FG000|Overall Study|Adverse Event|1|||
160677339|NCT02587143|580198793|FG001|Overall Study|Adverse Event|0|||
160677340|NCT03314857|580198794|FG000|Overall Study|Death|4|||
160677341|NCT03314857|580198794|FG000|Overall Study|Physician Decision|1|||
160677342|NCT01119625|580198795|FG000|Overall Study|Lost to Follow-up|1|||
160677343|NCT01119625|580198796|FG001|Overall Study|Lost to Follow-up|2|||
160677344|NCT01119625|580198795|FG000|Overall Study|Withdrawal by Subject|2|||
160677345|NCT01119625|580198796|FG001|Overall Study|Withdrawal by Subject|1|||
160677346|NCT01119625|580198795|FG000|Overall Study|Other|0|||
160677347|NCT01119625|580198796|FG001|Overall Study|Other|1|||
160677348|NCT01721772|580198801|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
160677349|NCT01721772|580198802|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
160677350|NCT01721772|580198801|FG000|Pre-Treatment|Poor/non-compliance|0|||
160677351|NCT01721772|580198802|FG001|Pre-Treatment|Poor/non-compliance|1|||
160677352|NCT01721772|580198801|FG000|Pre-Treatment|Participant withdrew consent|0|||
160677353|NCT01721772|580198802|FG001|Pre-Treatment|Participant withdrew consent|1|||
160677354|NCT01721772|580198801|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
160677355|NCT01721772|580198802|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
160677356|NCT01721772|580198801|FG000|Treatment|Disease progression|119|||
160677357|NCT01721772|580198802|FG001|Treatment|Disease progression|168|||
160677358|NCT01721772|580198801|FG000|Treatment|Study drug toxicity|19|||
160677359|NCT01721772|580198802|FG001|Treatment|Study drug toxicity|10|||
160677360|NCT01721772|580198801|FG000|Treatment|Adverse event unrelated to study drug|7|||
160677361|NCT01721772|580198802|FG001|Treatment|Adverse event unrelated to study drug|7|||
160677362|NCT01721772|580198801|FG000|Treatment|Maximum clinical benefit|16|||
160677363|NCT01721772|580198802|FG001|Treatment|Maximum clinical benefit|4|||
160677364|NCT01721772|580198801|FG000|Treatment|Other|19|||
160677365|NCT01721772|580198802|FG001|Treatment|Other|2|||
160677366|NCT01721772|580198801|FG000|Treatment|Participant withdrew consent|2|||
160677367|NCT01721772|580198802|FG001|Treatment|Participant withdrew consent|5|||
160677368|NCT01721772|580198801|FG000|Treatment|Participant request to discontinue study treatment|21|||
160677369|NCT01721772|580198802|FG001|Treatment|Participant request to discontinue study treatment|8|||
160677370|NCT01721772|580198801|FG000|Treatment|Death|1|||
160677371|NCT01721772|580198802|FG001|Treatment|Death|0|||
160677372|NCT01721772|580198801|FG000|Treatment|Not reported|1|||
160677373|NCT01721772|580198802|FG001|Treatment|Not reported|0|||
160677374|NCT01721772|580198801|FG000|Treatment|Poor/non-compliance|1|||
160677375|NCT01721772|580198802|FG001|Treatment|Poor/non-compliance|0|||
160677376|NCT01721772|580198801|FG000|Treatment|Lost to Follow-up|0|||
160677377|NCT01721772|580198802|FG001|Treatment|Lost to Follow-up|1|||
160677378|NCT02754492|580198803|FG000|Overall Study|Protocol Violation|2|||
160677379|NCT02754492|580198804|FG001|Overall Study|Protocol Violation|2|||
160677380|NCT02754492|580198805|FG002|Overall Study|Protocol Violation|0|||
160677381|NCT02754492|580198806|FG003|Overall Study|Protocol Violation|1|||
160677382|NCT02754492|580198803|FG000|Overall Study|Withdrawal by Subject|2|||
160677383|NCT02754492|580198804|FG001|Overall Study|Withdrawal by Subject|0|||
160677384|NCT02754492|580198805|FG002|Overall Study|Withdrawal by Subject|0|||
160677385|NCT02754492|580198806|FG003|Overall Study|Withdrawal by Subject|0|||
160677386|NCT02754492|580198803|FG000|Overall Study|Equipment malfuntion|0|||
160677387|NCT02754492|580198804|FG001|Overall Study|Equipment malfuntion|0|||
160677388|NCT02754492|580198805|FG002|Overall Study|Equipment malfuntion|2|||
160677389|NCT02754492|580198806|FG003|Overall Study|Equipment malfuntion|5|||
160677390|NCT02754492|580198803|FG000|Overall Study|Adverse Event|0|||
160677391|NCT02754492|580198804|FG001|Overall Study|Adverse Event|0|||
160677392|NCT02754492|580198805|FG002|Overall Study|Adverse Event|0|||
160677393|NCT02754492|580198806|FG003|Overall Study|Adverse Event|13|||
160677394|NCT02754492|580198803|FG000|Overall Study|Venous access issues not resulting in AE|0|||
160677395|NCT02754492|580198804|FG001|Overall Study|Venous access issues not resulting in AE|0|||
160677396|NCT02754492|580198805|FG002|Overall Study|Venous access issues not resulting in AE|0|||
160677397|NCT02754492|580198806|FG003|Overall Study|Venous access issues not resulting in AE|4|||
160677398|NCT01408888|580198807|FG000|First Intervention|Adverse Event|0|||
160677399|NCT01408888|580198808|FG001|First Intervention|Adverse Event|1|||
160677400|NCT01408888|580198807|FG000|First Intervention|Withdrawal by Subject|0|||
160677401|NCT01408888|580198808|FG001|First Intervention|Withdrawal by Subject|2|||
160677402|NCT01408888|580198807|FG000|Second Intervention|Withdrawal by Subject|1|||
160677403|NCT01408888|580198808|FG001|Second Intervention|Withdrawal by Subject|0|||
160677404|NCT01408888|580198807|FG000|Second Intervention|Adverse Event|1|||
160677405|NCT01408888|580198808|FG001|Second Intervention|Adverse Event|0|||
160677406|NCT04542694|580198809|FG000|Overall Study|The need for prohibited therapy|2|||
160677407|NCT04542694|580198810|FG001|Overall Study|The need for prohibited therapy|0|||
160677408|NCT04542694|580198809|FG000|Overall Study|Adverse Event|1|||
160677409|NCT04542694|580198810|FG001|Overall Study|Adverse Event|0|||
160677410|NCT04542694|580198809|FG000|Overall Study|Protocol Violation|1|||
160677411|NCT04542694|580198810|FG001|Overall Study|Protocol Violation|0|||
160677412|NCT04633642|580198813|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
160677413|NCT04633642|580198814|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
160677414|NCT00611884|580198815|FG000|Overall Study|Adverse Event|1|||
160677415|NCT00611884|580198816|FG001|Overall Study|Adverse Event|0|||
160677416|NCT00611884|580198817|FG002|Overall Study|Adverse Event|0|||
160677417|NCT00611884|580198818|FG003|Overall Study|Adverse Event|1|||
160677418|NCT00611884|580198815|FG000|Overall Study|Non-Compliance|1|||
160677419|NCT00611884|580198816|FG001|Overall Study|Non-Compliance|4|||
160677420|NCT00611884|580198817|FG002|Overall Study|Non-Compliance|2|||
160677421|NCT00611884|580198818|FG003|Overall Study|Non-Compliance|2|||
160677422|NCT00611884|580198815|FG000|Overall Study|Lack of Efficacy|0|||
160677423|NCT00611884|580198816|FG001|Overall Study|Lack of Efficacy|1|||
160677424|NCT00611884|580198817|FG002|Overall Study|Lack of Efficacy|0|||
160677425|NCT00611884|580198818|FG003|Overall Study|Lack of Efficacy|0|||
160677426|NCT00611884|580198815|FG000|Overall Study|Unclassified|7|||
160677427|NCT00611884|580198816|FG001|Overall Study|Unclassified|4|||
160677428|NCT00611884|580198817|FG002|Overall Study|Unclassified|2|||
160677429|NCT00611884|580198818|FG003|Overall Study|Unclassified|3|||
160677430|NCT00981799|580198819|FG000|Overall Study|Adverse Event|1|||
160677431|NCT00981799|580198820|FG001|Overall Study|Adverse Event|1|||
160677432|NCT00981799|580198821|FG002|Overall Study|Adverse Event|0|||
160677433|NCT00981799|580198822|FG003|Overall Study|Adverse Event|0|||
160677434|NCT05387408|580198823|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
160677435|NCT00397254|580198824|FG000|Overall Study|Lost to Follow-up|2|||
160677436|NCT00397254|580198825|FG001|Overall Study|Lost to Follow-up|2|||
160677437|NCT00152451|580198831|FG000|Overall Study|Adverse Event|4|||
160677438|NCT00323258|580198834|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
160677439|NCT00323258|580198835|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
160677440|NCT00323258|580198834|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
160677441|NCT00323258|580198835|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
160677442|NCT00323258|580198834|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
160677443|NCT00323258|580198835|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
160677444|NCT00323258|580198834|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
160677445|NCT00323258|580198835|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
160677446|NCT00323258|580198834|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
160677447|NCT00323258|580198835|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
160677448|NCT00323258|580198834|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
160677449|NCT00323258|580198835|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
160677450|NCT00323258|580198834|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
160677451|NCT00323258|580198835|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
160677452|NCT01943435|580198842|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
160677453|NCT01943435|580198843|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
160677454|NCT01943435|580198844|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
160677455|NCT01943435|580198842|FG000|Intervention Period|Withdrawal by Subject|3|||
160677456|NCT01943435|580198843|FG001|Intervention Period|Withdrawal by Subject|3|||
160677457|NCT01943435|580198844|FG002|Intervention Period|Withdrawal by Subject|4|||
160677458|NCT01943435|580198842|FG000|2 Month Follow up|Lost to Follow-up|2|||
160677459|NCT01943435|580198843|FG001|2 Month Follow up|Lost to Follow-up|3|||
160677460|NCT01943435|580198844|FG002|2 Month Follow up|Lost to Follow-up|0|||
160677461|NCT01943435|580198842|FG000|6 Month Follow up|Lost to Follow-up|12|||
160677462|NCT01943435|580198843|FG001|6 Month Follow up|Lost to Follow-up|7|||
160677463|NCT01943435|580198844|FG002|6 Month Follow up|Lost to Follow-up|15|||
160677464|NCT04473326|580198853|FG000|Overall Study|Death|0|||
160677465|NCT04473326|580198854|FG001|Overall Study|Death|1|||
160677466|NCT04473326|580198853|FG000|Overall Study|Withdrawal by Subject|1|||
160677467|NCT04473326|580198854|FG001|Overall Study|Withdrawal by Subject|2|||
160677468|NCT02046122|580198855|FG000|Overall Study|Physician Decision|8|||
160677469|NCT02046122|580198855|FG000|Overall Study|Withdrawal by Subject|1|||
160677470|NCT04535986|580198860|FG000|Overall Study|Death|4|||
160677471|NCT04535986|580198861|FG001|Overall Study|Death|5|||
160677472|NCT04535986|580198860|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
160677473|NCT04535986|580198861|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
160677474|NCT04535986|580198860|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
160677475|NCT04535986|580198861|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
160677476|NCT04535986|580198860|FG000|Overall Study|Adverse Event|10|||
160677477|NCT04535986|580198861|FG001|Overall Study|Adverse Event|1|||
160677478|NCT04535986|580198860|FG000|Overall Study|Lack of Efficacy|3|||
160677479|NCT04535986|580198861|FG001|Overall Study|Lack of Efficacy|2|||
160677480|NCT04535986|580198860|FG000|Overall Study|Investigator discretion|3|||
160677481|NCT04535986|580198861|FG001|Overall Study|Investigator discretion|0|||
160677482|NCT04535986|580198860|FG000|Overall Study|Withdrawal by Subject|32|||
160677483|NCT04535986|580198861|FG001|Overall Study|Withdrawal by Subject|14|||
160677484|NCT04535986|580198860|FG000|Overall Study|Lost to Follow-up|5|||
160677485|NCT04535986|580198861|FG001|Overall Study|Lost to Follow-up|3|||
160677486|NCT04535986|580198860|FG000|Overall Study|Other|7|||
160677487|NCT04535986|580198861|FG001|Overall Study|Other|3|||
160677488|NCT01196390|580198862|FG000|Overall Study|Protocol Violation|4|||
160677489|NCT01196390|580198863|FG001|Overall Study|Protocol Violation|5|||
160677490|NCT00252564|580198864|FG000|Overall Study|Adverse Event|17|||
160677491|NCT00252564|580198865|FG001|Overall Study|Adverse Event|13|||
160677492|NCT00252564|580198864|FG000|Overall Study|Unrelated Complication|2|||
160677493|NCT00252564|580198865|FG001|Overall Study|Unrelated Complication|1|||
160677494|NCT00252564|580198864|FG000|Overall Study|Disease Progression|14|||
160677495|NCT00252564|580198865|FG001|Overall Study|Disease Progression|20|||
160677496|NCT00252564|580198864|FG000|Overall Study|Death|0|||
160677497|NCT00252564|580198865|FG001|Overall Study|Death|3|||
160677498|NCT00252564|580198864|FG000|Overall Study|Physician Decision|1|||
160677499|NCT00252564|580198865|FG001|Overall Study|Physician Decision|0|||
160677500|NCT00252564|580198864|FG000|Overall Study|Lost to Follow-up|1|||
160677501|NCT00252564|580198865|FG001|Overall Study|Lost to Follow-up|0|||
160677502|NCT00252564|580198864|FG000|Overall Study|Patient Request|4|||
160677503|NCT00252564|580198865|FG001|Overall Study|Patient Request|5|||
160677504|NCT00252564|580198864|FG000|Overall Study|Withdrawal by Subject|0|||
160677505|NCT00252564|580198865|FG001|Overall Study|Withdrawal by Subject|2|||
160677506|NCT01097694|580198866|FG000|Overall Study|Adverse Event|5|||
160677507|NCT01097694|580198867|FG001|Overall Study|Adverse Event|0|||
160677508|NCT01097694|580198866|FG000|Overall Study|Lost to Follow-up|0|||
160677509|NCT01097694|580198867|FG001|Overall Study|Lost to Follow-up|3|||
160677510|NCT01097694|580198866|FG000|Overall Study|Withdrawal by Subject|3|||
160677511|NCT01097694|580198867|FG001|Overall Study|Withdrawal by Subject|1|||
160677512|NCT00668395|580198869|FG000|Overall Study|Withdrawal by Subject|4|||
160677513|NCT00668395|580198870|FG001|Overall Study|Withdrawal by Subject|4|||
160677514|NCT00668395|580198871|FG002|Overall Study|Withdrawal by Subject|1|||
160677515|NCT00668395|580198869|FG000|Overall Study|Adverse Event|1|||
160677516|NCT00668395|580198870|FG001|Overall Study|Adverse Event|1|||
160677517|NCT00668395|580198871|FG002|Overall Study|Adverse Event|0|||
160677518|NCT00668395|580198869|FG000|Overall Study|Physician Decision|1|||
160677519|NCT00668395|580198870|FG001|Overall Study|Physician Decision|1|||
160677520|NCT00668395|580198871|FG002|Overall Study|Physician Decision|0|||
160677521|NCT04164758|580198872|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
160677522|NCT04164758|580198873|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
160677523|NCT04164758|580198874|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
160677524|NCT04164758|580198872|FG000|Overall Study|Adverse Event|0|||
160677525|NCT04164758|580198873|FG001|Overall Study|Adverse Event|1|||
160677526|NCT04164758|580198874|FG002|Overall Study|Adverse Event|0|||
160677527|NCT03259165|580198875|FG000|Overall Study|COVID 19 pandemic|1|||
160677528|NCT03259165|580198876|FG001|Overall Study|COVID 19 pandemic|1|||
160677529|NCT01567527|580198879|FG000|Conversion Phase.|Protocol deviation|3|||
160632796|NCT02086968|580036073|FG001|Overall Study|Adverse Event|5|||
160632797|NCT02086968|580036072|FG000|Overall Study|Lost to Follow-up|2|||
160632798|NCT02086968|580036073|FG001|Overall Study|Lost to Follow-up|3|||
160632799|NCT02086968|580036072|FG000|Overall Study|Study drug received outside protocol|0|||
160632800|NCT02086968|580036073|FG001|Overall Study|Study drug received outside protocol|1|||
160520024|NCT02572843|579632963|FG000|Accrual|Brain metastasis retrospectively detected|1|||
160520025|NCT02572843|579632963|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
160520026|NCT02572843|579632963|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
160520027|NCT02572843|579632963|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
160520028|NCT02572843|579632963|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
160520029|NCT02572843|579632963|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
160520030|NCT02572843|579632963|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
160520031|NCT02572843|579632963|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
160520032|NCT02572843|579632963|FG000|Surgery|lost to follow up|7|||
160520033|NCT02572843|579632963|FG000|Surgery|Death|1|||
160520034|NCT01078454|579632966|FG000|Overall Study|Adverse Event|1|||
160520035|NCT01078454|579632967|FG001|Overall Study|Adverse Event|1|||
160632801|NCT02086968|580036072|FG000|Overall Study|Physician Decision|4|||
160632802|NCT02086968|580036073|FG001|Overall Study|Physician Decision|0|||
160632803|NCT02086968|580036072|FG000|Overall Study|Withdrawal by Subject|1|||
160632804|NCT02086968|580036073|FG001|Overall Study|Withdrawal by Subject|4|||
160632805|NCT00203892|580036075|FG000|Overall Study|Physician Decision|1|||
160632806|NCT00203892|580036076|FG001|Overall Study|Physician Decision|2|||
160632807|NCT00203892|580036077|FG002|Overall Study|Physician Decision|0|||
160677530|NCT01567527|580198880|FG001|Conversion Phase.|Protocol deviation|0|||
160677531|NCT01567527|580198881|FG002|Conversion Phase.|Protocol deviation|0|||
160677532|NCT01567527|580198882|FG003|Conversion Phase.|Protocol deviation|0|||
160677533|NCT01567527|580198883|FG004|Conversion Phase.|Protocol deviation|0|||
160520036|NCT01078454|579632966|FG000|Overall Study|Death|0|||
160677534|NCT01567527|580198879|FG000|Conversion Phase.|Met withdrawal criteria|10|||
160677535|NCT01567527|580198880|FG001|Conversion Phase.|Met withdrawal criteria|0|||
160632916|NCT02575807|580036108|FG004|Overall Study|Study terminated by Sponsor|1|||
160632917|NCT02575807|580036104|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
160632918|NCT02575807|580036105|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
160632919|NCT02575807|580036106|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
160632920|NCT02575807|580036107|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
160632921|NCT02575807|580036108|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
160632922|NCT02575807|580036104|FG000|Overall Study|Terminated due to physician decision|0|||
160632923|NCT02575807|580036105|FG001|Overall Study|Terminated due to physician decision|0|||
160632924|NCT02575807|580036106|FG002|Overall Study|Terminated due to physician decision|1|||
160632925|NCT02575807|580036107|FG003|Overall Study|Terminated due to physician decision|0|||
160632926|NCT02575807|580036108|FG004|Overall Study|Terminated due to physician decision|0|||
160632927|NCT02575807|580036104|FG000|Overall Study|Subject ineligible - medical implant|0|||
160632928|NCT02575807|580036105|FG001|Overall Study|Subject ineligible - medical implant|0|||
160632929|NCT02575807|580036106|FG002|Overall Study|Subject ineligible - medical implant|0|||
160632930|NCT02575807|580036107|FG003|Overall Study|Subject ineligible - medical implant|1|||
160632931|NCT02575807|580036108|FG004|Overall Study|Subject ineligible - medical implant|0|||
160632932|NCT02575807|580036104|FG000|Overall Study|Withdrawal by Subject|0|||
160632933|NCT02575807|580036105|FG001|Overall Study|Withdrawal by Subject|0|||
160632934|NCT02575807|580036106|FG002|Overall Study|Withdrawal by Subject|1|||
160632935|NCT02575807|580036107|FG003|Overall Study|Withdrawal by Subject|1|||
160632936|NCT02575807|580036108|FG004|Overall Study|Withdrawal by Subject|2|||
160632937|NCT02180659|580036109|FG000|Overall Study|Adverse Event|1|||
160632938|NCT02180659|580036110|FG001|Overall Study|Adverse Event|0|||
160632939|NCT02180659|580036109|FG000|Overall Study|Lost to Follow-up|4|||
160632940|NCT02180659|580036110|FG001|Overall Study|Lost to Follow-up|2|||
160632941|NCT02180659|580036109|FG000|Overall Study|Subject incarcerated during conduct|1|||
160632942|NCT02180659|580036110|FG001|Overall Study|Subject incarcerated during conduct|0|||
160677546|NCT01567527|580198881|FG002|Conversion Phase.|Lost to Follow-up|0|||
160677547|NCT01567527|580198882|FG003|Conversion Phase.|Lost to Follow-up|0|||
160677548|NCT01567527|580198883|FG004|Conversion Phase.|Lost to Follow-up|0|||
160677549|NCT01567527|580198879|FG000|Conversion Phase.|Lack of Efficacy|2|||
160677550|NCT01567527|580198880|FG001|Conversion Phase.|Lack of Efficacy|0|||
160677551|NCT01567527|580198881|FG002|Conversion Phase.|Lack of Efficacy|0|||
160677552|NCT01567527|580198882|FG003|Conversion Phase.|Lack of Efficacy|0|||
160677553|NCT01567527|580198883|FG004|Conversion Phase.|Lack of Efficacy|0|||
160677554|NCT01567527|580198879|FG000|Conversion Phase.|Adverse Event|33|||
160677555|NCT01567527|580198880|FG001|Conversion Phase.|Adverse Event|0|||
160632943|NCT02180659|580036109|FG000|Overall Study|Withdrawal by Subject|0|||
160632944|NCT02180659|580036110|FG001|Overall Study|Withdrawal by Subject|2|||
160632945|NCT02180659|580036109|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
160632946|NCT02180659|580036110|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
160632947|NCT03000075|580036111|FG000|Part A|Adverse Event|4|||
160632948|NCT03000075|580036112|FG001|Part A|Adverse Event|0|||
160632949|NCT03000075|580036113|FG002|Part A|Adverse Event|0|||
160632950|NCT03000075|580036114|FG003|Part A|Adverse Event|0|||
160632951|NCT03000075|580036115|FG004|Part A|Adverse Event|0|||
160632952|NCT03000075|580036116|FG005|Part A|Adverse Event|0|||
160632953|NCT03000075|580036117|FG006|Part A|Adverse Event|0|||
160632954|NCT03000075|580036111|FG000|Part B|Not dosed due to AE|0|||
160632955|NCT03000075|580036112|FG001|Part B|Not dosed due to AE|0|||
160632956|NCT03000075|580036113|FG002|Part B|Not dosed due to AE|0|||
160632957|NCT03000075|580036114|FG003|Part B|Not dosed due to AE|0|||
160632958|NCT03000075|580036115|FG004|Part B|Not dosed due to AE|0|||
160632959|NCT03000075|580036116|FG005|Part B|Not dosed due to AE|2|||
160632960|NCT03000075|580036117|FG006|Part B|Not dosed due to AE|1|||
160632961|NCT03000075|580036111|FG000|Part B|Adverse Event|0|||
160632962|NCT03000075|580036112|FG001|Part B|Adverse Event|0|||
160632963|NCT03000075|580036113|FG002|Part B|Adverse Event|0|||
160632964|NCT03000075|580036114|FG003|Part B|Adverse Event|0|||
160677556|NCT01567527|580198881|FG002|Conversion Phase.|Adverse Event|0|||
160677557|NCT01567527|580198882|FG003|Conversion Phase.|Adverse Event|0|||
160632965|NCT03000075|580036115|FG004|Part B|Adverse Event|1|||
160632966|NCT03000075|580036116|FG005|Part B|Adverse Event|0|||
160632967|NCT03000075|580036117|FG006|Part B|Adverse Event|0|||
160632968|NCT00518011|580036118|FG000|Overall Study|Death|1|||
160632969|NCT00518011|580036119|FG001|Overall Study|Death|1|||
160632970|NCT00518011|580036118|FG000|Overall Study|Adverse Event|2|||
160632971|NCT00518011|580036119|FG001|Overall Study|Adverse Event|3|||
160632972|NCT00518011|580036118|FG000|Overall Study|Disease Progression|2|||
160632973|NCT00518011|580036119|FG001|Overall Study|Disease Progression|2|||
160632974|NCT00518011|580036118|FG000|Overall Study|Other Reasons|3|||
160632975|NCT00518011|580036119|FG001|Overall Study|Other Reasons|2|||
160632976|NCT00518011|580036118|FG000|Overall Study|Withdrawal by Subject|1|||
160632977|NCT00518011|580036119|FG001|Overall Study|Withdrawal by Subject|0|||
160632978|NCT01216319|580036127|FG000|Overall Study|Lost to Follow-up|2|||
160677558|NCT01567527|580198883|FG004|Conversion Phase.|Adverse Event|0|||
160677559|NCT01567527|580198879|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
160632979|NCT01216319|580036127|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
160632980|NCT03128931|580036129|FG000|Overall Study|Physician Decision|1|||
160677560|NCT01567527|580198880|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
160677561|NCT01567527|580198881|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
160677562|NCT01567527|580198882|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
160677563|NCT01567527|580198883|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
160677564|NCT01567527|580198879|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
160677565|NCT01567527|580198880|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
160677566|NCT01567527|580198881|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
160677567|NCT01567527|580198882|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
160677568|NCT01567527|580198883|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
160677569|NCT01567527|580198879|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
160677570|NCT01567527|580198880|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
160677571|NCT01567527|580198881|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
160677572|NCT01567527|580198882|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
160677573|NCT01567527|580198883|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
160677574|NCT01567527|580198879|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
160677575|NCT01567527|580198880|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
160677576|NCT01567527|580198881|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
160677577|NCT01567527|580198882|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
160677578|NCT01567527|580198883|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
160677579|NCT01567527|580198879|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
160677580|NCT01567527|580198880|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
160677581|NCT01567527|580198881|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
160632981|NCT03128931|580036129|FG000|Overall Study|Equipment Issues|3|||
160632982|NCT04993339|580036130|FG000|Overall Study|Lost to Follow-up|0|||
160632983|NCT04993339|580036131|FG001|Overall Study|Lost to Follow-up|1|||
160632984|NCT04993339|580036130|FG000|Overall Study|no MRI scan|3|||
160632985|NCT04993339|580036131|FG001|Overall Study|no MRI scan|1|||
160632986|NCT03151226|580036132|FG000|Overall Study|Withdrawal by Subject|2|||
160632987|NCT03151226|580036132|FG000|Overall Study|not wear device correctly|1|||
160632988|NCT03239340|580036133|FG000|Overall Study|Other|26|||
160632989|NCT03239340|580036133|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
160632990|NCT03239340|580036133|FG000|Overall Study|Death|40|||
160632991|NCT03239340|580036133|FG000|Overall Study|Lost to Follow-up|2|||
160632992|NCT03239340|580036133|FG000|Overall Study|Physician Decision|16|||
160632993|NCT03239340|580036133|FG000|Overall Study|Withdrawal by Subject|27|||
160632994|NCT00690573|580036143|FG000|Overall Study|Lack of Efficacy|8|||
160632995|NCT00690573|580036143|FG000|Overall Study|Withdrawal by Subject|1|||
160632996|NCT00777920|580036144|FG000|Overall Study|Adverse Event|39|||
160632997|NCT00777920|580036144|FG000|Overall Study|Withdrawal of Consent|4|||
160632998|NCT00777920|580036144|FG000|Overall Study|Lost to Follow-up|1|||
160632999|NCT00777920|580036144|FG000|Overall Study|Investigator's discretion|1|||
160633000|NCT00777920|580036144|FG000|Overall Study|Clinical status did not improve|1|||
160633001|NCT00777920|580036144|FG000|Overall Study|Other, not specified|4|||
160633002|NCT02332655|580036145|FG000|Overall Study|Lack of Efficacy|1|||
160677582|NCT01567527|580198882|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
160633003|NCT01843660|580036146|FG000|Overall Study|Other|30|||
160677583|NCT01567527|580198883|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
160677584|NCT01567527|580198879|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
160677585|NCT01567527|580198880|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
160677586|NCT01567527|580198881|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
160677587|NCT01567527|580198882|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
160677588|NCT01567527|580198883|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
160677589|NCT01567527|580198879|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
160677590|NCT01567527|580198880|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
160677591|NCT01567527|580198881|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
160677592|NCT01567527|580198882|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
160677593|NCT01567527|580198883|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
160677594|NCT01567527|580198879|FG000|IM Depot Stabilization.|Protocol deviation|0|||
160677595|NCT01567527|580198880|FG001|IM Depot Stabilization.|Protocol deviation|0|||
160677596|NCT01567527|580198881|FG002|IM Depot Stabilization.|Protocol deviation|5|||
160677597|NCT01567527|580198882|FG003|IM Depot Stabilization.|Protocol deviation|0|||
160677598|NCT01567527|580198883|FG004|IM Depot Stabilization.|Protocol deviation|0|||
160677599|NCT01567527|580198879|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
160633004|NCT01977482|580036147|FG000|Overall Study|Adverse Event|0|||
160633005|NCT01977482|580036148|FG001|Overall Study|Adverse Event|1|||
160633006|NCT01977482|580036149|FG002|Overall Study|Adverse Event|1|||
160633007|NCT01977482|580036150|FG003|Overall Study|Adverse Event|0|||
160633008|NCT01977482|580036151|FG004|Overall Study|Adverse Event|2|||
160677600|NCT01567527|580198880|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
160677601|NCT01567527|580198881|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
160677602|NCT01567527|580198882|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
160677603|NCT01567527|580198883|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
160677604|NCT01567527|580198879|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
160677605|NCT01567527|580198880|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
160677606|NCT01567527|580198881|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
160677607|NCT01567527|580198882|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
160677608|NCT01567527|580198883|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
160677609|NCT01567527|580198879|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
160677610|NCT01567527|580198880|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
160677611|NCT01567527|580198881|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
160677612|NCT01567527|580198882|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
160677613|NCT01567527|580198883|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
160677614|NCT01567527|580198879|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
160677615|NCT01567527|580198880|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
160677616|NCT01567527|580198881|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
160677617|NCT01567527|580198882|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
160677618|NCT01567527|580198883|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
160677619|NCT01567527|580198879|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
160677620|NCT01567527|580198880|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
160677621|NCT01567527|580198881|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
160677622|NCT01567527|580198882|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
160677623|NCT01567527|580198883|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
160677624|NCT01567527|580198879|FG000|IM Depot Stabilization.|Adverse Event|0|||
160677625|NCT01567527|580198880|FG001|IM Depot Stabilization.|Adverse Event|0|||
160677626|NCT01567527|580198881|FG002|IM Depot Stabilization.|Adverse Event|37|||
160677627|NCT01567527|580198882|FG003|IM Depot Stabilization.|Adverse Event|0|||
160677628|NCT01567527|580198883|FG004|IM Depot Stabilization.|Adverse Event|0|||
160677629|NCT01567527|580198879|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
160677630|NCT01567527|580198880|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
160677631|NCT01567527|580198881|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
160677632|NCT01567527|580198882|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
160677633|NCT01567527|580198883|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
160677634|NCT01567527|580198879|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
160677635|NCT01567527|580198880|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
160677636|NCT01567527|580198881|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
160677637|NCT01567527|580198882|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
160677638|NCT01567527|580198883|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
160677639|NCT01567527|580198879|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
160677640|NCT01567527|580198880|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
160677641|NCT01567527|580198881|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
160677642|NCT01567527|580198882|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
160677643|NCT01567527|580198883|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
160677644|NCT01567527|580198879|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
160677645|NCT01567527|580198880|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
160677646|NCT01567527|580198881|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
160677647|NCT01567527|580198882|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
160677648|NCT01567527|580198883|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
160677649|NCT01567527|580198879|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
160677650|NCT01567527|580198880|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
160677651|NCT01567527|580198881|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
160677652|NCT01567527|580198882|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
160677653|NCT01567527|580198883|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
160677654|NCT01567527|580198879|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160677655|NCT01567527|580198880|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160677656|NCT01567527|580198881|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160677657|NCT01567527|580198882|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
160677658|NCT01567527|580198883|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
160677659|NCT01567527|580198879|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
160677660|NCT01567527|580198880|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
160677661|NCT01567527|580198881|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
160677662|NCT01567527|580198882|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
160677663|NCT01567527|580198883|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
160677664|NCT01567527|580198879|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
160677665|NCT01567527|580198880|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
160677666|NCT01567527|580198881|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
160677667|NCT01567527|580198882|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
160677668|NCT01567527|580198883|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
160677669|NCT01567527|580198879|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160677670|NCT01567527|580198880|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160677671|NCT01567527|580198881|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160677672|NCT01567527|580198882|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
160677673|NCT01567527|580198883|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
160677674|NCT02004691|580198884|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
160677675|NCT02004691|580198885|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
160677676|NCT02004691|580198884|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
160677677|NCT02004691|580198885|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
160677678|NCT02004691|580198884|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
160677679|NCT02004691|580198885|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
160677680|NCT02004691|580198884|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
160677681|NCT02004691|580198885|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
160677682|NCT02004691|580198884|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
160677683|NCT02004691|580198885|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
160677684|NCT02004691|580198884|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
160677685|NCT02004691|580198885|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
160677686|NCT01726803|580198886|FG000|Overall Study|Lost to Follow-up|6|||
160677687|NCT01726803|580198887|FG001|Overall Study|Lost to Follow-up|1|||
160677688|NCT01726803|580198886|FG000|Overall Study|Withdrawal by Subject|1|||
160677689|NCT01726803|580198887|FG001|Overall Study|Withdrawal by Subject|0|||
160677690|NCT01215721|580198891|FG000|Overall Study|Adverse Event|2|||
160677691|NCT00045162|580198892|FG000|Overall Study|Ineligible|12|||
160677692|NCT00045162|580198893|FG001|Overall Study|Ineligible|8|||
160677693|NCT00045162|580198892|FG000|Overall Study|Not treated|7|||
160677694|NCT00045162|580198893|FG001|Overall Study|Not treated|2|||
160677695|NCT00045162|580198892|FG000|Overall Study|Adverse Event|55|||
160677696|NCT00045162|580198893|FG001|Overall Study|Adverse Event|50|||
160677697|NCT00045162|580198892|FG000|Overall Study|Lack of Efficacy|32|||
160677698|NCT00045162|580198893|FG001|Overall Study|Lack of Efficacy|29|||
160677699|NCT00045162|580198892|FG000|Overall Study|Death|10|||
160677700|NCT00045162|580198893|FG001|Overall Study|Death|10|||
160677701|NCT00045162|580198892|FG000|Overall Study|Withdrawal by Subject|5|||
160677702|NCT00045162|580198893|FG001|Overall Study|Withdrawal by Subject|3|||
160677703|NCT00045162|580198892|FG000|Overall Study|Other|21|||
160677704|NCT00045162|580198893|FG001|Overall Study|Other|16|||
160677705|NCT01044433|580198894|FG000|Overall Study|Lost to Follow-up|3|||
160677706|NCT01044433|580198894|FG000|Overall Study|Withdrawal by Subject|3|||
160677707|NCT00826241|580198895|FG000|Overall Study|Withdrawal from Follow-up|1|||
160677708|NCT00826241|580198895|FG000|Overall Study|Withdrew consent|2|||
160677709|NCT00826241|580198895|FG000|Overall Study|Death|4|||
160677710|NCT00826241|580198895|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
160677711|NCT00826241|580198895|FG000|Overall Study|Non-compliance|1|||
160677712|NCT00826241|580198895|FG000|Overall Study|Progression of disease|1|||
160677713|NCT00826241|580198895|FG000|Overall Study|Patient refused follow-up|3|||
160677714|NCT00826241|580198895|FG000|Overall Study|Lost to Follow-up|9|||
160677715|NCT00826241|580198895|FG000|Overall Study|Could not obtain records|1|||
160677716|NCT00826241|580198895|FG000|Overall Study|Screen failure|2|||
160677717|NCT00826241|580198895|FG000|Overall Study|Pt unable to proceed to registration|1|||
160677718|NCT00826241|580198895|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
160677719|NCT03407729|580198896|FG000|Overall Study|Lost to Follow-up|2|||
160677720|NCT03407729|580198897|FG001|Overall Study|Lost to Follow-up|0|||
160677721|NCT03407729|580198896|FG000|Overall Study|Unable to schedule|0|||
160677722|NCT03407729|580198897|FG001|Overall Study|Unable to schedule|3|||
160677723|NCT01912807|580198898|FG000|Overall Study|Did not meet elegibility criteria|6|||
160677724|NCT01912807|580198899|FG001|Overall Study|Did not meet elegibility criteria|4|||
160677725|NCT01912807|580198898|FG000|Overall Study|Lost to Follow-up|36|||
160677726|NCT01912807|580198899|FG001|Overall Study|Lost to Follow-up|37|||
160677727|NCT04750239|580198900|FG000|Overall Study|Withdrawal by Subject|2|||
160677728|NCT04750239|580198900|FG000|Overall Study|Trial terminated by sponsor|1|||
160677729|NCT02614196|580198901|FG000|Double Blind Treatment Phase|Adverse Event|8|||
160677730|NCT02614196|580198902|FG001|Double Blind Treatment Phase|Adverse Event|5|||
160677731|NCT02614196|580198903|FG002|Double Blind Treatment Phase|Adverse Event|9|||
160677732|NCT02614196|580198904|FG003|Double Blind Treatment Phase|Adverse Event|0|||
160677733|NCT02614196|580198905|FG004|Double Blind Treatment Phase|Adverse Event|0|||
160677734|NCT02614196|580198906|FG005|Double Blind Treatment Phase|Adverse Event|0|||
160677735|NCT02614196|580198901|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
160677736|NCT02614196|580198902|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
160677737|NCT02614196|580198903|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
160677738|NCT02614196|580198904|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
160677739|NCT02614196|580198905|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
160677740|NCT02614196|580198906|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
160677741|NCT02614196|580198901|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
160677742|NCT02614196|580198902|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
160677743|NCT02614196|580198903|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
160677744|NCT02614196|580198904|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
160677745|NCT02614196|580198905|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
160677746|NCT02614196|580198906|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
160677747|NCT02614196|580198901|FG000|Double Blind Treatment Phase|Physician Decision|4|||
160677748|NCT02614196|580198902|FG001|Double Blind Treatment Phase|Physician Decision|0|||
160677749|NCT02614196|580198903|FG002|Double Blind Treatment Phase|Physician Decision|2|||
160677750|NCT02614196|580198904|FG003|Double Blind Treatment Phase|Physician Decision|0|||
160677751|NCT02614196|580198905|FG004|Double Blind Treatment Phase|Physician Decision|0|||
160677752|NCT02614196|580198906|FG005|Double Blind Treatment Phase|Physician Decision|0|||
160677753|NCT02614196|580198901|FG000|Double Blind Treatment Phase|Pregnancy|1|||
160677754|NCT02614196|580198902|FG001|Double Blind Treatment Phase|Pregnancy|2|||
160677755|NCT02614196|580198903|FG002|Double Blind Treatment Phase|Pregnancy|0|||
160677756|NCT02614196|580198904|FG003|Double Blind Treatment Phase|Pregnancy|0|||
160677757|NCT02614196|580198905|FG004|Double Blind Treatment Phase|Pregnancy|0|||
160677758|NCT02614196|580198906|FG005|Double Blind Treatment Phase|Pregnancy|0|||
160677759|NCT02614196|580198901|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
160677760|NCT02614196|580198902|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
160677761|NCT02614196|580198903|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
160677762|NCT02614196|580198904|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
160677763|NCT02614196|580198905|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
160677764|NCT02614196|580198906|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
160677765|NCT02614196|580198901|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
160677766|NCT02614196|580198902|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
160677767|NCT02614196|580198903|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
160677768|NCT02614196|580198904|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
160677769|NCT02614196|580198905|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
160677770|NCT02614196|580198906|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
160677771|NCT02614196|580198901|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
160677772|NCT02614196|580198902|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
160677773|NCT02614196|580198903|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
160677774|NCT02614196|580198904|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
160677775|NCT02614196|580198905|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
160677776|NCT02614196|580198906|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
160677777|NCT02614196|580198901|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
160677778|NCT02614196|580198902|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
160677779|NCT02614196|580198903|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
160677780|NCT02614196|580198904|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
160677781|NCT02614196|580198905|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
160677782|NCT02614196|580198906|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
160677783|NCT02614196|580198901|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
160677784|NCT02614196|580198902|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
160677785|NCT02614196|580198903|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
160677786|NCT02614196|580198904|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
160677787|NCT02614196|580198905|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
160677788|NCT02614196|580198906|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
160677789|NCT02614196|580198901|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
160677790|NCT02614196|580198902|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
160677791|NCT02614196|580198903|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
160677792|NCT02614196|580198904|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
160677793|NCT02614196|580198905|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
160677794|NCT02614196|580198906|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
160677795|NCT02614196|580198901|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
160677796|NCT02614196|580198902|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
160677797|NCT02614196|580198903|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
160677798|NCT02614196|580198904|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
160677799|NCT02614196|580198905|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
160677800|NCT02614196|580198906|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
160677801|NCT02614196|580198901|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
160677802|NCT02614196|580198902|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
160677803|NCT02614196|580198903|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
160677804|NCT02614196|580198904|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
160677805|NCT02614196|580198905|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
160677806|NCT02614196|580198906|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
160677807|NCT01562613|580198907|FG000|Overall Study|Lost to Follow-up|2|||
160677808|NCT01562613|580198907|FG000|Overall Study|Withdrawal by Subject|2|||
160677809|NCT00633022|580198910|FG000|Overall Study|Adverse Event|1|||
160677810|NCT00633022|580198911|FG001|Overall Study|Adverse Event|0|||
160677811|NCT00633022|580198912|FG002|Overall Study|Adverse Event|5|||
160677812|NCT00633022|580198910|FG000|Overall Study|Physician Decision|0|||
160677813|NCT00633022|580198911|FG001|Overall Study|Physician Decision|1|||
160677814|NCT00633022|580198912|FG002|Overall Study|Physician Decision|0|||
160677815|NCT00663234|580198913|FG000|Overall Study|Not willing to adhere to requirements|1|||
160677816|NCT00224484|580200317|FG000|Overall Study|Serious Adverse Event|1|||
160677817|NCT00224484|580200318|FG001|Overall Study|Serious Adverse Event|1|||
160677818|NCT00224484|580200319|FG002|Overall Study|Serious Adverse Event|0|||
160677819|NCT00224484|580200317|FG000|Overall Study|Non-Serious Adverse Event|5|||
160677820|NCT00224484|580200318|FG001|Overall Study|Non-Serious Adverse Event|7|||
160677821|NCT00224484|580200319|FG002|Overall Study|Non-Serious Adverse Event|3|||
160677822|NCT00224484|580200317|FG000|Overall Study|Protocol Violation|2|||
160677823|NCT00224484|580200318|FG001|Overall Study|Protocol Violation|2|||
160677824|NCT00224484|580200319|FG002|Overall Study|Protocol Violation|0|||
160677825|NCT00224484|580200317|FG000|Overall Study|Withdrawal by Subject|49|||
160677826|NCT00224484|580200318|FG001|Overall Study|Withdrawal by Subject|18|||
160677827|NCT00224484|580200319|FG002|Overall Study|Withdrawal by Subject|16|||
160677828|NCT00224484|580200317|FG000|Overall Study|Migrated/moved from study area|18|||
160677829|NCT00224484|580200318|FG001|Overall Study|Migrated/moved from study area|5|||
160677830|NCT00224484|580200319|FG002|Overall Study|Migrated/moved from study area|5|||
160677831|NCT00224484|580200317|FG000|Overall Study|Lost to Follow-up|66|||
160677832|NCT00224484|580200318|FG001|Overall Study|Lost to Follow-up|28|||
160677833|NCT00224484|580200319|FG002|Overall Study|Lost to Follow-up|36|||
160677834|NCT00224484|580200317|FG000|Overall Study|Reason not specified|5|||
160677835|NCT00224484|580200318|FG001|Overall Study|Reason not specified|4|||
160677836|NCT00224484|580200319|FG002|Overall Study|Reason not specified|2|||
160677837|NCT00108628|580200322|FG000|Overall Study|Withdrawal by Subject|17|||
160677838|NCT00108628|580200323|FG001|Overall Study|Withdrawal by Subject|9|||
160677839|NCT00108628|580200322|FG000|Overall Study|Lack of Efficacy|2|||
160677840|NCT00108628|580200323|FG001|Overall Study|Lack of Efficacy|1|||
160677841|NCT00108628|580200322|FG000|Overall Study|Death|1|||
160677842|NCT00108628|580200323|FG001|Overall Study|Death|0|||
160677843|NCT01453153|580200324|FG000|Overall Study|Physician Decision|0|||
160677844|NCT01453153|580200325|FG001|Overall Study|Physician Decision|0|||
160677845|NCT01453153|580200326|FG002|Overall Study|Physician Decision|1|||
160677846|NCT01453153|580200324|FG000|Overall Study|Progressive Disease|3|||
160677847|NCT01453153|580200325|FG001|Overall Study|Progressive Disease|2|||
160677848|NCT01453153|580200326|FG002|Overall Study|Progressive Disease|16|||
160677849|NCT01453153|580200324|FG000|Overall Study|Withdrawal by Subject|0|||
160677850|NCT01453153|580200325|FG001|Overall Study|Withdrawal by Subject|1|||
160677851|NCT01453153|580200326|FG002|Overall Study|Withdrawal by Subject|2|||
160677852|NCT01453153|580200324|FG000|Overall Study|Adverse Event|1|||
160677853|NCT01453153|580200325|FG001|Overall Study|Adverse Event|1|||
160677854|NCT01453153|580200326|FG002|Overall Study|Adverse Event|1|||
160677855|NCT01350934|580200329|FG000|Base Study|Adverse Event|6|||
160677856|NCT01350934|580200330|FG001|Base Study|Adverse Event|0|||
160677857|NCT01350934|580200329|FG000|Base Study|Lost to Follow-up|1|||
160677858|NCT01350934|580200330|FG001|Base Study|Lost to Follow-up|0|||
160677859|NCT01350934|580200329|FG000|Base Study|Protocol Violation|1|||
160677860|NCT01350934|580200330|FG001|Base Study|Protocol Violation|1|||
160677861|NCT01350934|580200329|FG000|Base Study|Withdrawal by Subject|1|||
160677862|NCT01350934|580200330|FG001|Base Study|Withdrawal by Subject|2|||
160677863|NCT01350934|580200329|FG000|Base Study|Non-Compliance With Study Drug|2|||
160677864|NCT01350934|580200330|FG001|Base Study|Non-Compliance With Study Drug|0|||
160677865|NCT01350934|580200329|FG000|Extension Study|Adverse Event|2|||
160677866|NCT01350934|580200330|FG001|Extension Study|Adverse Event|1|||
160677867|NCT01350934|580200329|FG000|Extension Study|Lost to Follow-up|2|||
160677868|NCT01350934|580200330|FG001|Extension Study|Lost to Follow-up|0|||
160677869|NCT01350934|580200329|FG000|Extension Study|Protocol Violation|1|||
160677870|NCT01350934|580200330|FG001|Extension Study|Protocol Violation|1|||
160677871|NCT01350934|580200329|FG000|Extension Study|Lack of Efficacy|0|||
160677872|NCT01350934|580200330|FG001|Extension Study|Lack of Efficacy|1|||
160677873|NCT01350934|580200329|FG000|Extension Study|Withdrawal by Subject|0|||
160677874|NCT01350934|580200330|FG001|Extension Study|Withdrawal by Subject|1|||
160677875|NCT03547635|580200331|FG000|Overall Study|Adverse Event|5|||
160677876|NCT03547635|580200332|FG001|Overall Study|Adverse Event|2|||
160677877|NCT03547635|580200333|FG002|Overall Study|Adverse Event|3|||
160677878|NCT03547635|580200331|FG000|Overall Study|Lost to Follow-up|1|||
160677879|NCT03547635|580200332|FG001|Overall Study|Lost to Follow-up|3|||
160677880|NCT03547635|580200333|FG002|Overall Study|Lost to Follow-up|4|||
160677881|NCT03547635|580200331|FG000|Overall Study|Withdrawal by Subject|1|||
160677882|NCT03547635|580200332|FG001|Overall Study|Withdrawal by Subject|0|||
160677883|NCT03547635|580200333|FG002|Overall Study|Withdrawal by Subject|0|||
160677884|NCT03547635|580200331|FG000|Overall Study|Withdrawal By PI|0|||
160677885|NCT03547635|580200332|FG001|Overall Study|Withdrawal By PI|1|||
160677886|NCT03547635|580200333|FG002|Overall Study|Withdrawal By PI|0|||
160677887|NCT03547635|580200331|FG000|Overall Study|Withdrawal by Sponsor|0|||
160677888|NCT03547635|580200332|FG001|Overall Study|Withdrawal by Sponsor|0|||
160677889|NCT03547635|580200333|FG002|Overall Study|Withdrawal by Sponsor|1|||
160677890|NCT03547635|580200331|FG000|Overall Study|Errant Randomization before Treatment|0|||
160677891|NCT03547635|580200332|FG001|Overall Study|Errant Randomization before Treatment|1|||
160677892|NCT03547635|580200333|FG002|Overall Study|Errant Randomization before Treatment|0|||
160677893|NCT03547635|580200331|FG000|Overall Study|Withdrawal by Subject|1|||
160677894|NCT03547635|580200332|FG001|Overall Study|Withdrawal by Subject|0|||
160677895|NCT03547635|580200333|FG002|Overall Study|Withdrawal by Subject|0|||
160677896|NCT02415387|580200334|FG000|Overall Study|Withdrawal by Subject|6|||
160677897|NCT02415387|580200335|FG001|Overall Study|Withdrawal by Subject|1|||
160677898|NCT02415387|580200334|FG000|Overall Study|blood draw problem|0|||
160677899|NCT02415387|580200335|FG001|Overall Study|blood draw problem|1|||
160677900|NCT02415387|580200334|FG000|Overall Study|Protocol Violation|1|||
160677901|NCT02415387|580200335|FG001|Overall Study|Protocol Violation|0|||
160677902|NCT03243396|580200336|FG000|Overall Study|Lost to Follow-up|2|||
160677903|NCT03243396|580200337|FG001|Overall Study|Lost to Follow-up|3|||
160677904|NCT03243396|580200338|FG002|Overall Study|Lost to Follow-up|15|||
160677905|NCT03243396|580200339|FG003|Overall Study|Lost to Follow-up|8|||
160677906|NCT03243396|580200340|FG004|Overall Study|Lost to Follow-up|1|||
160677907|NCT03243396|580200341|FG005|Overall Study|Lost to Follow-up|4|||
160677908|NCT03243396|580200342|FG006|Overall Study|Lost to Follow-up|9|||
160677909|NCT03687242|580200343|FG000|Overall Study|Adverse Event|1|||
160677910|NCT01151280|580200344|FG000|Overall Study|Adverse Event|1|||
160677911|NCT01151280|580200344|FG000|Overall Study|Lack of Efficacy|3|||
160677912|NCT02473393|580200349|FG000|Overall Study|Adverse Event|0|||
160677913|NCT02473393|580200350|FG001|Overall Study|Adverse Event|0|||
160677914|NCT02473393|580200351|FG002|Overall Study|Adverse Event|1|||
160677915|NCT02473393|580200352|FG003|Overall Study|Adverse Event|0|||
160677916|NCT02473393|580200349|FG000|Overall Study|Withdrawal by Subject|0|||
160677917|NCT02473393|580200350|FG001|Overall Study|Withdrawal by Subject|0|||
160677918|NCT02473393|580200351|FG002|Overall Study|Withdrawal by Subject|1|||
160677919|NCT02473393|580200352|FG003|Overall Study|Withdrawal by Subject|1|||
160677920|NCT01257581|580200354|FG000|Overall Study|Early Termination|3|||
160677921|NCT01257581|580200355|FG001|Overall Study|Early Termination|1|||
160677922|NCT01257581|580200356|FG002|Overall Study|Early Termination|2|||
160677923|NCT01257581|580200354|FG000|Overall Study|Death|2|||
160677924|NCT01257581|580200355|FG001|Overall Study|Death|2|||
160677925|NCT01257581|580200356|FG002|Overall Study|Death|4|||
160677926|NCT01157234|580200359|FG000|Overall Study|Withdrawal by Subject|1|||
160677927|NCT01157234|580200360|FG001|Overall Study|Withdrawal by Subject|0|||
160677928|NCT02246764|580200363|FG000|Overall Study|Adverse Event|15|||
160677929|NCT02246764|580200364|FG001|Overall Study|Adverse Event|29|||
160677930|NCT02246764|580200365|FG002|Overall Study|Adverse Event|1|||
160677931|NCT02246764|580200363|FG000|Overall Study|Withdrawal by Subject|0|||
160677932|NCT02246764|580200364|FG001|Overall Study|Withdrawal by Subject|0|||
160677933|NCT02246764|580200365|FG002|Overall Study|Withdrawal by Subject|1|||
160677934|NCT02246764|580200363|FG000|Overall Study|Disallowed Concomitant Medication|1|||
160677935|NCT02246764|580200364|FG001|Overall Study|Disallowed Concomitant Medication|0|||
160677936|NCT02246764|580200365|FG002|Overall Study|Disallowed Concomitant Medication|0|||
160677937|NCT02246764|580200363|FG000|Overall Study|Physician Decision|0|||
160677938|NCT02246764|580200364|FG001|Overall Study|Physician Decision|2|||
160677939|NCT02246764|580200365|FG002|Overall Study|Physician Decision|1|||
160677940|NCT02246764|580200363|FG000|Overall Study|Protocol Violation|2|||
160677941|NCT02246764|580200364|FG001|Overall Study|Protocol Violation|1|||
160677942|NCT02246764|580200365|FG002|Overall Study|Protocol Violation|1|||
160677943|NCT02048813|580200366|FG000|Overall Study|Still on treatment|279|||
160677944|NCT02048813|580200367|FG001|Overall Study|Still on treatment|0|||
160677945|NCT02048813|580200366|FG000|Overall Study|Adverse Event|40|||
160677946|NCT02048813|580200367|FG001|Overall Study|Adverse Event|38|||
160677947|NCT02048813|580200366|FG000|Overall Study|Disease progression|13|||
160677948|NCT02048813|580200367|FG001|Overall Study|Disease progression|3|||
160677949|NCT02048813|580200366|FG000|Overall Study|Withdrawal by Subject|7|||
160677950|NCT02048813|580200367|FG001|Overall Study|Withdrawal by Subject|8|||
160677951|NCT02048813|580200366|FG000|Overall Study|Death|2|||
160677952|NCT02048813|580200367|FG001|Overall Study|Death|1|||
160677953|NCT02048813|580200366|FG000|Overall Study|Complication|2|||
160677954|NCT02048813|580200367|FG001|Overall Study|Complication|2|||
160677955|NCT02048813|580200366|FG000|Overall Study|Non-protocol therapy|0|||
160677956|NCT02048813|580200367|FG001|Overall Study|Non-protocol therapy|1|||
160677957|NCT02048813|580200366|FG000|Overall Study|Second primary cancer|2|||
160677958|NCT02048813|580200367|FG001|Overall Study|Second primary cancer|0|||
160677959|NCT02048813|580200366|FG000|Overall Study|Insurance|2|||
160677960|NCT02048813|580200367|FG001|Overall Study|Insurance|0|||
160677961|NCT02048813|580200366|FG000|Overall Study|Wound infection/healing|2|||
160677962|NCT02048813|580200367|FG001|Overall Study|Wound infection/healing|0|||
160677963|NCT02048813|580200366|FG000|Overall Study|Missed appointment|3|||
160677964|NCT02048813|580200367|FG001|Overall Study|Missed appointment|0|||
160677965|NCT02048813|580200366|FG000|Overall Study|Never started treatment|2|||
160677966|NCT02048813|580200367|FG001|Overall Study|Never started treatment|17|||
160677967|NCT05996198|580200368|FG000|Overall Study|Withdrawal by Subject|1|||
160677968|NCT05996198|580200369|FG001|Overall Study|Withdrawal by Subject|0|||
160677969|NCT00487695|580200370|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
160677970|NCT00487695|580200371|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
160677971|NCT00487695|580200370|FG000|First Procedure|active wheezing (did not have procedure)|1|||
160677972|NCT00487695|580200371|FG001|First Procedure|active wheezing (did not have procedure)|0|||
160677973|NCT00487695|580200370|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
160677974|NCT00487695|580200371|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
160677975|NCT00487695|580200370|FG000|Second Procedure|active wheezing|0|||
160677976|NCT00487695|580200371|FG001|Second Procedure|active wheezing|1|||
160677977|NCT00487695|580200370|FG000|Second Procedure|Withdrawal by Subject|1|||
160677978|NCT00487695|580200371|FG001|Second Procedure|Withdrawal by Subject|2|||
160677979|NCT01698554|580200377|FG000|Overall Study|Adverse Event|2|||
160677980|NCT01698554|580200378|FG001|Overall Study|Adverse Event|5|||
160677981|NCT01698554|580200379|FG002|Overall Study|Adverse Event|0|||
160677982|NCT01698554|580200380|FG003|Overall Study|Adverse Event|1|||
160677983|NCT01698554|580200377|FG000|Overall Study|Lost to Follow-up|1|||
160677984|NCT01698554|580200378|FG001|Overall Study|Lost to Follow-up|0|||
160677985|NCT01698554|580200379|FG002|Overall Study|Lost to Follow-up|0|||
160677986|NCT01698554|580200380|FG003|Overall Study|Lost to Follow-up|0|||
160677987|NCT01698554|580200377|FG000|Overall Study|Personal Reasons|0|||
160677988|NCT01698554|580200378|FG001|Overall Study|Personal Reasons|5|||
160677989|NCT01698554|580200379|FG002|Overall Study|Personal Reasons|1|||
160677990|NCT01698554|580200380|FG003|Overall Study|Personal Reasons|1|||
160677991|NCT01698554|580200377|FG000|Overall Study|Protocol Violation|2|||
160677992|NCT01698554|580200378|FG001|Overall Study|Protocol Violation|0|||
160677993|NCT01698554|580200379|FG002|Overall Study|Protocol Violation|1|||
160677994|NCT01698554|580200380|FG003|Overall Study|Protocol Violation|0|||
160677995|NCT01698554|580200377|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160677996|NCT01698554|580200378|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160677997|NCT01698554|580200379|FG002|Overall Study|Other Miscellaneous Reasons|0|||
160677998|NCT01698554|580200380|FG003|Overall Study|Other Miscellaneous Reasons|0|||
160677999|NCT03732833|580200383|FG000|Overall Study|Adverse Event|0|||
160678000|NCT03732833|580200384|FG001|Overall Study|Adverse Event|3|||
160678001|NCT03732833|580200385|FG002|Overall Study|Adverse Event|1|||
160678002|NCT03732833|580200383|FG000|Overall Study|Withdrawal by Subject|11|||
160678003|NCT03732833|580200384|FG001|Overall Study|Withdrawal by Subject|13|||
160678004|NCT03732833|580200385|FG002|Overall Study|Withdrawal by Subject|8|||
160678005|NCT03732833|580200383|FG000|Overall Study|Lost to Follow-up|3|||
160678006|NCT03732833|580200384|FG001|Overall Study|Lost to Follow-up|5|||
160678007|NCT03732833|580200385|FG002|Overall Study|Lost to Follow-up|4|||
160678008|NCT03732833|580200383|FG000|Overall Study|Pregnancy|0|||
160678009|NCT03732833|580200384|FG001|Overall Study|Pregnancy|2|||
160678010|NCT03732833|580200385|FG002|Overall Study|Pregnancy|0|||
160678011|NCT03732833|580200383|FG000|Overall Study|Physician Decision|2|||
160678012|NCT03732833|580200384|FG001|Overall Study|Physician Decision|3|||
160678013|NCT03732833|580200385|FG002|Overall Study|Physician Decision|1|||
160678014|NCT03732833|580200383|FG000|Overall Study|Covid-19 related and other reasons|2|||
160678015|NCT03732833|580200384|FG001|Overall Study|Covid-19 related and other reasons|7|||
160678016|NCT03732833|580200385|FG002|Overall Study|Covid-19 related and other reasons|3|||
160678017|NCT00024258|580200388|FG000|Overall Study|Withdrawal by Subject|1|||
160678018|NCT00024258|580200388|FG000|Overall Study|Disease Progression|8|||
160678019|NCT01863433|580200389|FG000|Overall Study|Protocol Violation|1|||
160678020|NCT00830167|580200392|FG000|Overall Study|Lack of Efficacy|26|||
160678021|NCT00830167|580200393|FG001|Overall Study|Lack of Efficacy|10|||
160678022|NCT00830167|580200392|FG000|Overall Study|Adverse Event|8|||
160678023|NCT00830167|580200393|FG001|Overall Study|Adverse Event|24|||
160678024|NCT00830167|580200392|FG000|Overall Study|Not meeting entrance criteria|2|||
160678025|NCT00830167|580200393|FG001|Overall Study|Not meeting entrance criteria|5|||
160678026|NCT00830167|580200392|FG000|Overall Study|Withdrawal by Subject|2|||
160678027|NCT00830167|580200393|FG001|Overall Study|Withdrawal by Subject|0|||
160678028|NCT00830167|580200392|FG000|Overall Study|Lost to Follow-up|0|||
160678029|NCT00830167|580200393|FG001|Overall Study|Lost to Follow-up|1|||
160678030|NCT00830167|580200392|FG000|Overall Study|Protocol Violation|0|||
160678031|NCT00830167|580200393|FG001|Overall Study|Protocol Violation|1|||
160678032|NCT00830167|580200392|FG000|Overall Study|Other|2|||
160678033|NCT00830167|580200393|FG001|Overall Study|Other|2|||
160678034|NCT03428945|580200394|FG000|Overall Study|Lost to Follow-up|5|||
160678035|NCT03428945|580200395|FG001|Overall Study|Lost to Follow-up|3|||
160678036|NCT03428945|580200394|FG000|Overall Study|Withdrawal by Subject|10|||
160678037|NCT03428945|580200395|FG001|Overall Study|Withdrawal by Subject|10|||
160678038|NCT00982228|580200396|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
160678039|NCT00982228|580200397|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
160678040|NCT00982228|580200396|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
160678041|NCT00982228|580200397|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
160678042|NCT00982228|580200396|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
160678043|NCT00982228|580200397|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
160678044|NCT00982228|580200396|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
160678045|NCT00982228|580200397|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
160678046|NCT00982228|580200396|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
160678047|NCT00982228|580200397|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
160678048|NCT00982228|580200396|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
160678049|NCT00982228|580200397|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
160678050|NCT00982228|580200396|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
160678051|NCT00982228|580200397|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
160678052|NCT00982228|580200396|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
160678053|NCT00982228|580200397|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
160678054|NCT00982228|580200396|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
160678055|NCT00982228|580200397|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
160678056|NCT00982228|580200396|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
160678057|NCT00982228|580200397|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
160678058|NCT00360490|580200401|FG000|Overall Study|Adverse Event|4|||
160678059|NCT00360490|580200402|FG001|Overall Study|Adverse Event|2|||
160678060|NCT00360490|580200401|FG000|Overall Study|Lost to Follow-up|2|||
160678061|NCT00360490|580200402|FG001|Overall Study|Lost to Follow-up|1|||
160678062|NCT00360490|580200401|FG000|Overall Study|Physician Decision|2|||
160678063|NCT00360490|580200402|FG001|Overall Study|Physician Decision|1|||
160678064|NCT00360490|580200401|FG000|Overall Study|Protocol Violation|0|||
160678065|NCT00360490|580200402|FG001|Overall Study|Protocol Violation|4|||
160678066|NCT00360490|580200401|FG000|Overall Study|Withdrawal by Subject|1|||
160678067|NCT00360490|580200402|FG001|Overall Study|Withdrawal by Subject|3|||
160678068|NCT02289820|580200403|FG000|Overall Study|Withdrawal by Subject|2|||
160678069|NCT02289820|580200404|FG001|Overall Study|Withdrawal by Subject|1|||
160678070|NCT02289820|580200405|FG002|Overall Study|Withdrawal by Subject|2|||
160678071|NCT02289820|580200406|FG003|Overall Study|Withdrawal by Subject|1|||
160678072|NCT02289820|580200407|FG004|Overall Study|Withdrawal by Subject|0|||
160678073|NCT02289820|580200408|FG005|Overall Study|Withdrawal by Subject|0|||
160678074|NCT02289820|580200409|FG006|Overall Study|Withdrawal by Subject|1|||
160678075|NCT02289820|580200403|FG000|Overall Study|Death|0|||
160678076|NCT02289820|580200404|FG001|Overall Study|Death|0|||
160678077|NCT02289820|580200405|FG002|Overall Study|Death|1|||
160678078|NCT02289820|580200406|FG003|Overall Study|Death|0|||
160678079|NCT02289820|580200407|FG004|Overall Study|Death|0|||
160678080|NCT02289820|580200408|FG005|Overall Study|Death|0|||
160678081|NCT02289820|580200409|FG006|Overall Study|Death|0|||
160678082|NCT02289820|580200403|FG000|Overall Study|Lost to Follow-up|0|||
160678083|NCT02289820|580200404|FG001|Overall Study|Lost to Follow-up|0|||
160678084|NCT02289820|580200405|FG002|Overall Study|Lost to Follow-up|3|||
160678085|NCT02289820|580200406|FG003|Overall Study|Lost to Follow-up|1|||
160678086|NCT02289820|580200407|FG004|Overall Study|Lost to Follow-up|0|||
160678087|NCT02289820|580200408|FG005|Overall Study|Lost to Follow-up|1|||
160678088|NCT02289820|580200409|FG006|Overall Study|Lost to Follow-up|1|||
160678089|NCT02289820|580200403|FG000|Overall Study|withdrawal of consent|0|||
160678090|NCT02289820|580200404|FG001|Overall Study|withdrawal of consent|1|||
160678091|NCT02289820|580200405|FG002|Overall Study|withdrawal of consent|0|||
160678092|NCT02289820|580200406|FG003|Overall Study|withdrawal of consent|0|||
160678093|NCT02289820|580200407|FG004|Overall Study|withdrawal of consent|0|||
160678094|NCT02289820|580200408|FG005|Overall Study|withdrawal of consent|0|||
160678095|NCT02289820|580200409|FG006|Overall Study|withdrawal of consent|0|||
160678096|NCT02005276|580200410|FG000|Overall Study|No longer interested|5|||
160678097|NCT02005276|580200411|FG001|Overall Study|No longer interested|2|||
160678098|NCT02005276|580200412|FG002|Overall Study|No longer interested|3|||
160678099|NCT02005276|580200413|FG003|Overall Study|No longer interested|3|||
160678100|NCT01688882|580200420|FG000|Overall Study|Adverse Event|1|||
160678101|NCT01688882|580200421|FG001|Overall Study|Adverse Event|0|||
160678102|NCT01688882|580200420|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160678103|NCT01688882|580200421|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160678104|NCT01688882|580200420|FG000|Overall Study|Administrative problems|1|||
160678105|NCT01688882|580200421|FG001|Overall Study|Administrative problems|0|||
160678106|NCT00950300|580200422|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
160678107|NCT00950300|580200423|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
160678108|NCT00950300|580200422|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
160678109|NCT00950300|580200423|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
160678110|NCT00950300|580200422|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
160678111|NCT00950300|580200423|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
160678112|NCT00950300|580200422|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
160678113|NCT00950300|580200423|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
160678114|NCT00950300|580200422|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
160678115|NCT00950300|580200423|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
160678116|NCT00950300|580200422|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
160678117|NCT00950300|580200423|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
160678118|NCT00950300|580200422|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
160678119|NCT00950300|580200423|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
160678120|NCT00950300|580200422|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
160678121|NCT00950300|580200423|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
160678122|NCT00950300|580200422|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
160678123|NCT00950300|580200423|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
160678124|NCT00950300|580200422|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
160678125|NCT00950300|580200423|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
160678126|NCT00950300|580200422|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
160678127|NCT00950300|580200423|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
160678128|NCT00950300|580200422|FG000|TFFU Period|Death|4|||
160678129|NCT00950300|580200423|FG001|TFFU Period|Death|1|||
160678130|NCT00950300|580200422|FG000|TFFU Period|Refused Treatment|10|||
160678131|NCT00950300|580200423|FG001|TFFU Period|Refused Treatment|11|||
160678132|NCT00950300|580200422|FG000|TFFU Period|Failure to Return|16|||
160678133|NCT00950300|580200423|FG001|TFFU Period|Failure to Return|16|||
160678134|NCT00950300|580200422|FG000|TFFU Period|Recurrence of Disease|63|||
160678135|NCT00950300|580200423|FG001|TFFU Period|Recurrence of Disease|72|||
160678136|NCT00950300|580200422|FG000|TFFU Period|Other|4|||
160678137|NCT00950300|580200423|FG001|TFFU Period|Other|3|||
160678138|NCT00950300|580200422|FG000|SFU Period|Death|44|||
160678139|NCT00950300|580200423|FG001|SFU Period|Death|42|||
160678140|NCT00950300|580200422|FG000|SFU Period|Lost to Follow-up|30|||
160678141|NCT00950300|580200423|FG001|SFU Period|Lost to Follow-up|28|||
160678142|NCT00950300|580200422|FG000|SFU Period|Withdrawal by Subject|4|||
160678143|NCT00950300|580200423|FG001|SFU Period|Withdrawal by Subject|8|||
160678144|NCT00124618|580200424|FG000|Overall Study|Ineligible|1|||
160678145|NCT00494013|580200428|FG000|Overall Study|Adverse Event|0|||
160678146|NCT00494013|580200429|FG001|Overall Study|Adverse Event|1|||
160678147|NCT00494013|580200428|FG000|Overall Study|Entry Criteria Not Met|1|||
160678148|NCT00494013|580200429|FG001|Overall Study|Entry Criteria Not Met|4|||
160678149|NCT00494013|580200428|FG000|Overall Study|Lost to Follow-up|5|||
160678150|NCT00494013|580200429|FG001|Overall Study|Lost to Follow-up|6|||
160678151|NCT00494013|580200428|FG000|Overall Study|Physician Decision|3|||
160678152|NCT00494013|580200429|FG001|Overall Study|Physician Decision|5|||
160678153|NCT00494013|580200428|FG000|Overall Study|Protocol Violation|8|||
160678154|NCT00494013|580200429|FG001|Overall Study|Protocol Violation|5|||
160678155|NCT00494013|580200428|FG000|Overall Study|Withdrawal by Subject|13|||
160678156|NCT00494013|580200429|FG001|Overall Study|Withdrawal by Subject|14|||
160678157|NCT00494013|580200428|FG000|Overall Study|Sponsor Decision|0|||
160678158|NCT00494013|580200429|FG001|Overall Study|Sponsor Decision|1|||
160678159|NCT01539239|580200431|FG000|Overall Study|Death|5|||
160678160|NCT01539239|580200432|FG001|Overall Study|Death|5|||
160678161|NCT01539239|580200431|FG000|Overall Study|Lost to Follow-up|7|||
160678162|NCT01539239|580200432|FG001|Overall Study|Lost to Follow-up|12|||
160678163|NCT01253564|580200438|FG000|Overall Study|Disease Progression|22|||
160678164|NCT01253564|580200438|FG000|Overall Study|Withdrawal by Subject|1|||
160678165|NCT01253564|580200438|FG000|Overall Study|Serious Adverse Event|1|||
160678166|NCT02129062|580201728|FG000|Overall Study|Death|1|||
160678167|NCT02129062|580201728|FG000|Overall Study|Disease Progression|2|||
160678168|NCT04662710|580201729|FG000|Overall Study|Death|14|||
160678169|NCT04662710|580201730|FG001|Overall Study|Death|331|||
160678170|NCT04662710|580201731|FG002|Overall Study|Death|367|||
160678171|NCT04662710|580201729|FG000|Overall Study|Ongoing|1|||
160678172|NCT04662710|580201730|FG001|Overall Study|Ongoing|109|||
160678173|NCT04662710|580201731|FG002|Overall Study|Ongoing|56|||
160678174|NCT04662710|580201729|FG000|Overall Study|Withdrawal by Subject|0|||
160678175|NCT04662710|580201730|FG001|Overall Study|Withdrawal by Subject|3|||
160678176|NCT04662710|580201731|FG002|Overall Study|Withdrawal by Subject|14|||
160678177|NCT02722616|580201733|FG000|Overall Study|Sponsor closed study after one month|2|||
160678178|NCT02722616|580201734|FG001|Overall Study|Sponsor closed study after one month|0|||
160678179|NCT02722616|580201735|FG002|Overall Study|Sponsor closed study after one month|0|||
160678180|NCT01636934|580201737|FG000|Overall Study|Withdrawal by Subject|3|||
160678181|NCT01636934|580201738|FG001|Overall Study|Withdrawal by Subject|2|||
160678182|NCT01636934|580201737|FG000|Overall Study|Chemo cancel|1|||
160678183|NCT01636934|580201738|FG001|Overall Study|Chemo cancel|0|||
160678184|NCT01636934|580201737|FG000|Overall Study|Too ill to continue|1|||
160678185|NCT01636934|580201738|FG001|Overall Study|Too ill to continue|0|||
160678186|NCT01636934|580201737|FG000|Overall Study|Never started study medication|1|||
160678187|NCT01636934|580201738|FG001|Overall Study|Never started study medication|1|||
160678188|NCT03035890|580201746|FG000|Overall Study|Death|1|||
160678189|NCT00288704|580201748|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
160678190|NCT00288704|580201749|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
160678191|NCT00288704|580201750|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
160678192|NCT00288704|580201748|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
160678193|NCT00288704|580201749|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
160678194|NCT00288704|580201750|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
160678195|NCT00288704|580201748|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
160678196|NCT00288704|580201749|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
160678197|NCT00288704|580201750|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
160678198|NCT00288704|580201748|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
160678199|NCT00288704|580201749|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
160678200|NCT00288704|580201750|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
160678201|NCT00288704|580201748|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
160678202|NCT00288704|580201749|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
160678203|NCT00288704|580201750|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
160678204|NCT00288704|580201748|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
160678205|NCT00288704|580201749|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
160678206|NCT00288704|580201750|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
160678207|NCT00288704|580201748|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
160678208|NCT00288704|580201749|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
160678209|NCT00288704|580201750|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
160678210|NCT00676650|580201753|FG000|Overall Study|Death|45|||
160678211|NCT00676650|580201754|FG001|Overall Study|Death|14|||
160678212|NCT00676650|580201753|FG000|Overall Study|Adverse Event|159|||
160678213|NCT00676650|580201754|FG001|Overall Study|Adverse Event|21|||
160678214|NCT00676650|580201753|FG000|Overall Study|Global deterioration of health status|66|||
160678215|NCT00676650|580201754|FG001|Overall Study|Global deterioration of health status|31|||
160678216|NCT00676650|580201753|FG000|Overall Study|Lost to Follow-up|0|||
160678217|NCT00676650|580201754|FG001|Overall Study|Lost to Follow-up|1|||
160678218|NCT00676650|580201753|FG000|Overall Study|Objective progression or relapse|189|||
160678219|NCT00676650|580201754|FG001|Overall Study|Objective progression or relapse|140|||
160678220|NCT00676650|580201753|FG000|Overall Study|Other|14|||
160678221|NCT00676650|580201754|FG001|Overall Study|Other|10|||
160678222|NCT00676650|580201753|FG000|Overall Study|Protocol Violation|3|||
160678223|NCT00676650|580201754|FG001|Overall Study|Protocol Violation|1|||
160678224|NCT00676650|580201753|FG000|Overall Study|Study terminated by sponsor|57|||
160678225|NCT00676650|580201754|FG001|Overall Study|Study terminated by sponsor|43|||
160678226|NCT00676650|580201753|FG000|Overall Study|Withdrawal by Subject|48|||
160678227|NCT00676650|580201754|FG001|Overall Study|Withdrawal by Subject|24|||
160678228|NCT00676650|580201753|FG000|Overall Study|Randomized but not treated|3|||
160678229|NCT00676650|580201754|FG001|Overall Study|Randomized but not treated|4|||
160678230|NCT02297841|580201755|FG000|Overall Study|Withdrawal by Subject|1|||
160678231|NCT02297841|580201755|FG000|Overall Study|Protocol Violation|7|||
160678232|NCT05061992|580201756|FG000|Overall Study|Excess bowel movements|1|||
160678233|NCT05061992|580201757|FG001|Overall Study|Excess bowel movements|0|||
160678234|NCT05061992|580201756|FG000|Overall Study|Complications of Medical Care|1|||
160678235|NCT05061992|580201757|FG001|Overall Study|Complications of Medical Care|0|||
160678236|NCT05061992|580201756|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
160678237|NCT05061992|580201757|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
160678238|NCT05061992|580201756|FG000|Overall Study|Withdrawal by Subject|0|||
160678239|NCT05061992|580201757|FG001|Overall Study|Withdrawal by Subject|1|||
160678240|NCT03167606|580201772|FG000|Overall Study|Lost to Follow-up|73|||
160678241|NCT03167606|580201773|FG001|Overall Study|Lost to Follow-up|64|||
160678242|NCT03167606|580201772|FG000|Overall Study|Withdrawal by Subject|6|||
160678243|NCT03167606|580201773|FG001|Overall Study|Withdrawal by Subject|5|||
160678244|NCT03167606|580201772|FG000|Overall Study|Withdrawal by Investigator|0|||
160678245|NCT03167606|580201773|FG001|Overall Study|Withdrawal by Investigator|2|||
160678246|NCT00059332|580201774|FG000|Overall Study|Withdrawal by Subject|2|||
160678247|NCT00059332|580201775|FG001|Overall Study|Withdrawal by Subject|1|||
160678248|NCT00059332|580201774|FG000|Overall Study|Lost to Follow-up|1|||
160678249|NCT00059332|580201775|FG001|Overall Study|Lost to Follow-up|1|||
160678250|NCT00413049|580201776|FG000|Overall Study|Adverse Event|10|||
160678251|NCT00413049|580201777|FG001|Overall Study|Adverse Event|8|||
160678252|NCT00413049|580201776|FG000|Overall Study|Withdrawal by Subject|7|||
160678253|NCT00413049|580201777|FG001|Overall Study|Withdrawal by Subject|5|||
160678254|NCT00413049|580201776|FG000|Overall Study|Lost to Follow-up|2|||
160678255|NCT00413049|580201777|FG001|Overall Study|Lost to Follow-up|3|||
160678256|NCT00413049|580201776|FG000|Overall Study|Protocol Violation|3|||
160678257|NCT00413049|580201777|FG001|Overall Study|Protocol Violation|1|||
160678258|NCT00413049|580201776|FG000|Overall Study|Subject no longer requires study drug|0|||
160678259|NCT00413049|580201777|FG001|Overall Study|Subject no longer requires study drug|1|||
160678260|NCT00413049|580201776|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160678261|NCT00413049|580201777|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160678262|NCT00413049|580201776|FG000|Overall Study|Lack of Efficacy|1|||
160678263|NCT00413049|580201777|FG001|Overall Study|Lack of Efficacy|0|||
160678264|NCT00640926|580201786|FG000|Overall Study|Adverse Event|2|||
160678265|NCT00640926|580201787|FG001|Overall Study|Adverse Event|3|||
160678266|NCT00640926|580201788|FG002|Overall Study|Adverse Event|2|||
160678267|NCT00640926|580201786|FG000|Overall Study|Lack of Efficacy|0|||
160678268|NCT00640926|580201787|FG001|Overall Study|Lack of Efficacy|2|||
160678269|NCT00640926|580201788|FG002|Overall Study|Lack of Efficacy|1|||
160678270|NCT00640926|580201786|FG000|Overall Study|Protocol Violation|2|||
160678271|NCT00640926|580201787|FG001|Overall Study|Protocol Violation|0|||
160678272|NCT00640926|580201788|FG002|Overall Study|Protocol Violation|2|||
160678273|NCT00640926|580201786|FG000|Overall Study|Lost to Follow-up|3|||
160678274|NCT00640926|580201787|FG001|Overall Study|Lost to Follow-up|1|||
160678275|NCT00640926|580201788|FG002|Overall Study|Lost to Follow-up|2|||
160678276|NCT00640926|580201786|FG000|Overall Study|Withdrawal by Subject|1|||
160678277|NCT00640926|580201787|FG001|Overall Study|Withdrawal by Subject|0|||
160678278|NCT00640926|580201788|FG002|Overall Study|Withdrawal by Subject|1|||
160678279|NCT02985398|580201789|FG000|Overall Study|Adverse Event|1|||
160678280|NCT02985398|580201789|FG000|Overall Study|Lost to Follow-up|4|||
160678281|NCT02985398|580201789|FG000|Overall Study|Withdrawal by Subject|8|||
160678282|NCT02985398|580201789|FG000|Overall Study|Study Burden|9|||
160678283|NCT01841073|580201790|FG000|Overall Study|Adverse Event|1|||
160678284|NCT01841073|580201791|FG001|Overall Study|Adverse Event|1|||
160678285|NCT01841073|580201790|FG000|Overall Study|Physician Decision|1|||
160678286|NCT01841073|580201791|FG001|Overall Study|Physician Decision|0|||
160678287|NCT01841073|580201790|FG000|Overall Study|Lost to Follow-up|0|||
160678288|NCT01841073|580201791|FG001|Overall Study|Lost to Follow-up|2|||
160678289|NCT00697827|580201792|FG000|Overall Study|enrolled but not treated|2|||
160678290|NCT00697827|580201793|FG001|Overall Study|enrolled but not treated|1|||
160678291|NCT00283842|580201798|FG000|Overall Study|Adverse Event|8|||
160678292|NCT00283842|580201799|FG001|Overall Study|Adverse Event|7|||
160678293|NCT00283842|580201800|FG002|Overall Study|Adverse Event|21|||
160678294|NCT00283842|580201801|FG003|Overall Study|Adverse Event|21|||
160678295|NCT00283842|580201802|FG004|Overall Study|Adverse Event|5|||
160678296|NCT00283842|580201798|FG000|Overall Study|Protocol Violation|1|||
160678297|NCT00283842|580201799|FG001|Overall Study|Protocol Violation|5|||
160678298|NCT00283842|580201800|FG002|Overall Study|Protocol Violation|4|||
160678299|NCT00283842|580201801|FG003|Overall Study|Protocol Violation|0|||
160678300|NCT00283842|580201802|FG004|Overall Study|Protocol Violation|0|||
160678301|NCT00283842|580201798|FG000|Overall Study|Protocol deviation|0|||
160678302|NCT00283842|580201799|FG001|Overall Study|Protocol deviation|0|||
160678303|NCT00283842|580201800|FG002|Overall Study|Protocol deviation|0|||
160678304|NCT00283842|580201801|FG003|Overall Study|Protocol deviation|0|||
160678305|NCT00283842|580201802|FG004|Overall Study|Protocol deviation|2|||
160678306|NCT00283842|580201798|FG000|Overall Study|Withdrawal by Subject|2|||
160678307|NCT00283842|580201799|FG001|Overall Study|Withdrawal by Subject|1|||
160678308|NCT00283842|580201800|FG002|Overall Study|Withdrawal by Subject|1|||
160678309|NCT00283842|580201801|FG003|Overall Study|Withdrawal by Subject|5|||
160678310|NCT00283842|580201802|FG004|Overall Study|Withdrawal by Subject|4|||
160678311|NCT00283842|580201798|FG000|Overall Study|Lack of Efficacy|1|||
160678312|NCT00283842|580201799|FG001|Overall Study|Lack of Efficacy|3|||
160678313|NCT00283842|580201800|FG002|Overall Study|Lack of Efficacy|1|||
160678314|NCT00283842|580201801|FG003|Overall Study|Lack of Efficacy|0|||
160678315|NCT00283842|580201802|FG004|Overall Study|Lack of Efficacy|3|||
160678316|NCT00283842|580201798|FG000|Overall Study|Lost to Follow-up|0|||
160678317|NCT00283842|580201799|FG001|Overall Study|Lost to Follow-up|2|||
160678318|NCT00283842|580201800|FG002|Overall Study|Lost to Follow-up|4|||
160678319|NCT00283842|580201801|FG003|Overall Study|Lost to Follow-up|1|||
160678320|NCT00283842|580201802|FG004|Overall Study|Lost to Follow-up|1|||
160678321|NCT00046839|580201803|FG000|Overall Study|Ineligible / No protocol treatment|0|||
160678322|NCT00046839|580201804|FG001|Overall Study|Ineligible / No protocol treatment|2|||
160678323|NCT00046839|580201803|FG000|Overall Study|Withdrawal of consent|1|||
160678324|NCT00046839|580201804|FG001|Overall Study|Withdrawal of consent|0|||
160678325|NCT02472639|580201806|FG000|Overall Study|Physician Decision|4|||
160678326|NCT02472639|580201807|FG001|Overall Study|Physician Decision|3|||
160678327|NCT00751023|580201808|FG000|Overall Study|Lost to Follow-up|11|||
160678328|NCT00751023|580201809|FG001|Overall Study|Lost to Follow-up|7|||
160678329|NCT02760433|580201810|FG000|Overall Study|Lost to Follow-up|1|||
160678330|NCT02760433|580201811|FG001|Overall Study|Lost to Follow-up|0|||
160678331|NCT02760433|580201812|FG002|Overall Study|Lost to Follow-up|1|||
160678332|NCT02760433|580201813|FG003|Overall Study|Lost to Follow-up|0|||
160678333|NCT02760433|580201814|FG004|Overall Study|Lost to Follow-up|0|||
160678334|NCT02760433|580201810|FG000|Overall Study|Withdrawal by Subject|23|||
160678335|NCT02760433|580201811|FG001|Overall Study|Withdrawal by Subject|9|||
160678336|NCT02760433|580201812|FG002|Overall Study|Withdrawal by Subject|0|||
160678337|NCT02760433|580201813|FG003|Overall Study|Withdrawal by Subject|2|||
160678338|NCT02760433|580201814|FG004|Overall Study|Withdrawal by Subject|9|||
160678339|NCT02760433|580201810|FG000|Overall Study|Lack of Response At Week 14|0|||
160678340|NCT02760433|580201811|FG001|Overall Study|Lack of Response At Week 14|0|||
160678341|NCT02760433|580201812|FG002|Overall Study|Lack of Response At Week 14|0|||
160678342|NCT02760433|580201813|FG003|Overall Study|Lack of Response At Week 14|0|||
160678343|NCT02760433|580201814|FG004|Overall Study|Lack of Response At Week 14|1|||
160678344|NCT02760433|580201810|FG000|Overall Study|Subject refused to continue the study|1|||
160678345|NCT02760433|580201811|FG001|Overall Study|Subject refused to continue the study|0|||
160678346|NCT02760433|580201812|FG002|Overall Study|Subject refused to continue the study|0|||
160678347|NCT02760433|580201813|FG003|Overall Study|Subject refused to continue the study|0|||
160678348|NCT02760433|580201814|FG004|Overall Study|Subject refused to continue the study|0|||
160678349|NCT02760433|580201810|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
160678350|NCT02760433|580201811|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
160678351|NCT02760433|580201812|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
160678352|NCT02760433|580201813|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
160678353|NCT02760433|580201814|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
160678354|NCT02760433|580201810|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
160678355|NCT02760433|580201811|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
160678356|NCT02760433|580201812|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
160678357|NCT02760433|580201813|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
160678358|NCT02760433|580201814|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
160678359|NCT00766493|580201815|FG000|30 Days Post-Procedure|Discontinued|7|||
160678360|NCT00766493|580201815|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
160678361|NCT00766493|580201815|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
160678362|NCT01849458|580201816|FG000|Overall Study|Lost to Follow-up|4|||
160678363|NCT03950674|580201817|FG000|Overall Study|Death|16|||
160678364|NCT03950674|580201818|FG001|Overall Study|Death|15|||
160678365|NCT03950674|580201817|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
160678366|NCT03950674|580201818|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
160678367|NCT03448692|580201823|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
160678368|NCT03448692|580201824|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
160678369|NCT03448692|580201823|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
160678370|NCT03448692|580201824|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
160678371|NCT03448692|580201823|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
160678372|NCT03448692|580201824|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
160678373|NCT03448692|580201823|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
160678374|NCT03448692|580201824|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
160678375|NCT03448692|580201823|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
160678376|NCT03448692|580201824|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
160678377|NCT02786927|580201827|FG000|Overall Study|Adverse Event|1|||
160678378|NCT02786927|580201827|FG000|Overall Study|Protocol Violation|4|||
160678379|NCT01801917|580201828|FG000|Period 1 - Randomized|Adverse Event|1|||
160678380|NCT01801917|580201829|FG001|Period 1 - Randomized|Adverse Event|0|||
160678381|NCT01801917|580201830|FG002|Period 1 - Randomized|Adverse Event|1|||
160678382|NCT01801917|580201831|FG003|Period 1 - Randomized|Adverse Event|0|||
160678383|NCT01924364|580201832|FG000|Overall Study|Physician Decision|3|||
160678384|NCT00265785|580201833|FG000|Overall Study|Adverse Event|4|||
160678385|NCT00265785|580201833|FG000|Overall Study|Withdrawal by Subject|3|||
160678386|NCT00265785|580201833|FG000|Overall Study|Progression/Relapse|15|||
160678387|NCT00265785|580201833|FG000|Overall Study|Not protocol specified|2|||
160678388|NCT00265785|580201833|FG000|Overall Study|Ineligible|1|||
160678389|NCT00265785|580201833|FG000|Overall Study|Did not receive protocol treatment|2|||
160678390|NCT03919695|580201834|FG000|3-month Follow-up|Death|1|||
160678391|NCT03919695|580201835|FG001|3-month Follow-up|Death|1|||
160678392|NCT03919695|580201834|FG000|3-month Follow-up|unable to contact|0|||
160678393|NCT03919695|580201835|FG001|3-month Follow-up|unable to contact|3|||
160678394|NCT03919695|580201834|FG000|3-month Follow-up|in prison|0|||
160678395|NCT03919695|580201835|FG001|3-month Follow-up|in prison|1|||
160678396|NCT03919695|580201834|FG000|6-month Follow-up|Death|0|||
160678397|NCT03919695|580201835|FG001|6-month Follow-up|Death|1|||
160678398|NCT03919695|580201834|FG000|6-month Follow-up|Lost to Follow-up|1|||
160678399|NCT03919695|580201835|FG001|6-month Follow-up|Lost to Follow-up|2|||
160678400|NCT03919695|580201834|FG000|6-month Follow-up|in prison|0|||
160678401|NCT03919695|580201835|FG001|6-month Follow-up|in prison|2|||
160678402|NCT03919695|580201834|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
160678403|NCT03919695|580201835|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
160678404|NCT03919695|580201834|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
160678405|NCT03919695|580201835|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
160678406|NCT02416934|580201837|FG000|Overall Study|given steroids|1|||
160678407|NCT02416934|580201838|FG001|Overall Study|given steroids|2|||
160678408|NCT02416934|580201837|FG000|Overall Study|Lost to Follow-up|0|||
160678409|NCT02416934|580201838|FG001|Overall Study|Lost to Follow-up|2|||
160678410|NCT02416934|580201837|FG000|Overall Study|Withdrawal by Subject|1|||
160678411|NCT02416934|580201838|FG001|Overall Study|Withdrawal by Subject|0|||
160678412|NCT02416934|580201837|FG000|Overall Study|recruited during continuing renewal proc|0|||
160678413|NCT02416934|580201838|FG001|Overall Study|recruited during continuing renewal proc|1|||
160678414|NCT02416934|580201837|FG000|Overall Study|Protocol Violation|0|||
160678415|NCT02416934|580201838|FG001|Overall Study|Protocol Violation|1|||
160678416|NCT02416934|580201837|FG000|Overall Study|surgery started late|0|||
160678417|NCT02416934|580201838|FG001|Overall Study|surgery started late|1|||
160678418|NCT02416934|580201837|FG000|Overall Study|re-operation|1|||
160678419|NCT02416934|580201838|FG001|Overall Study|re-operation|0|||
160678420|NCT05467540|580201841|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
160678421|NCT05467540|580201841|FG000|3-Month Follow-up|Lost to Follow-up|4|||
160678422|NCT05467540|580201841|FG000|3-Month Follow-up|Death|5|||
160678423|NCT05467540|580201841|FG000|12-Month Follow-up|Lost to Follow-up|6|||
160678424|NCT05467540|580201841|FG000|12-Month Follow-up|Death|8|||
160678425|NCT05467540|580201841|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
160678426|NCT03382041|580201865|FG000|Overall Study|Consent Form Lost|2|||
160678427|NCT03382041|580201866|FG001|Overall Study|Consent Form Lost|1|||
160678428|NCT03382041|580201865|FG000|Overall Study|Withdrawal by Subject|1|||
160678429|NCT03382041|580201866|FG001|Overall Study|Withdrawal by Subject|4|||
160678430|NCT03382041|580201865|FG000|Overall Study|Lost to Follow-up|1|||
160678431|NCT03382041|580201866|FG001|Overall Study|Lost to Follow-up|4|||
160678432|NCT01374451|580201869|FG000|Overall Study|Administrative problems|1|||
160678433|NCT01374451|580201870|FG001|Overall Study|Administrative problems|0|||
160678434|NCT01337596|580201871|FG000|Overall Study|Withdrawal by Subject|0|||
160678435|NCT01337596|580201872|FG001|Overall Study|Withdrawal by Subject|0|||
160678436|NCT01337596|580201873|FG002|Overall Study|Withdrawal by Subject|0|||
160678437|NCT01337596|580201874|FG003|Overall Study|Withdrawal by Subject|0|||
160678438|NCT01337596|580201875|FG004|Overall Study|Withdrawal by Subject|2|||
160678439|NCT01337596|580201876|FG005|Overall Study|Withdrawal by Subject|0|||
160678440|NCT01337596|580201877|FG006|Overall Study|Withdrawal by Subject|0|||
160678441|NCT01337596|580201878|FG007|Overall Study|Withdrawal by Subject|0|||
160678442|NCT01337596|580201879|FG008|Overall Study|Withdrawal by Subject|0|||
160678443|NCT04640194|580201880|FG000|Overall Study|Adverse Event|3|||
160678444|NCT04640194|580201881|FG001|Overall Study|Adverse Event|7|||
160678445|NCT04640194|580201882|FG002|Overall Study|Adverse Event|0|||
160678446|NCT04640194|580201883|FG003|Overall Study|Adverse Event|5|||
160678447|NCT04640194|580201884|FG004|Overall Study|Adverse Event|0|||
160678448|NCT04640194|580201885|FG005|Overall Study|Adverse Event|4|||
160678449|NCT04640194|580201886|FG006|Overall Study|Adverse Event|0|||
160678450|NCT04640194|580201880|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
160678451|NCT04640194|580201881|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
160678452|NCT04640194|580201882|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
160678453|NCT04640194|580201883|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
160678454|NCT04640194|580201884|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
160678455|NCT04640194|580201885|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
160678456|NCT04640194|580201886|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
160678457|NCT04640194|580201880|FG000|Overall Study|fibrinogen level too low|0|||
160678458|NCT04640194|580201881|FG001|Overall Study|fibrinogen level too low|0|||
160678459|NCT04640194|580201882|FG002|Overall Study|fibrinogen level too low|0|||
160678460|NCT04640194|580201883|FG003|Overall Study|fibrinogen level too low|1|||
160678461|NCT04640194|580201884|FG004|Overall Study|fibrinogen level too low|0|||
160678462|NCT04640194|580201885|FG005|Overall Study|fibrinogen level too low|0|||
160678463|NCT04640194|580201886|FG006|Overall Study|fibrinogen level too low|0|||
160678464|NCT04640194|580201880|FG000|Overall Study|mild bleeding|0|||
160678465|NCT04640194|580201881|FG001|Overall Study|mild bleeding|0|||
160678466|NCT04640194|580201882|FG002|Overall Study|mild bleeding|0|||
160678467|NCT04640194|580201883|FG003|Overall Study|mild bleeding|1|||
160678468|NCT04640194|580201884|FG004|Overall Study|mild bleeding|0|||
160678469|NCT04640194|580201885|FG005|Overall Study|mild bleeding|0|||
160678470|NCT04640194|580201886|FG006|Overall Study|mild bleeding|0|||
160678471|NCT04640194|580201880|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
160678472|NCT04640194|580201881|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
160678473|NCT04640194|580201882|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
160678474|NCT04640194|580201883|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
160678475|NCT04640194|580201884|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
160678476|NCT04640194|580201885|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
160678477|NCT04640194|580201886|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
160678478|NCT03201003|580201890|FG000|Overall Study|Adverse Event|14|||
160678479|NCT03201003|580201891|FG001|Overall Study|Adverse Event|1|||
160678480|NCT03201003|580201890|FG000|Overall Study|Other reasons|5|||
160678481|NCT03201003|580201891|FG001|Overall Study|Other reasons|1|||
160678482|NCT03201003|580201890|FG000|Overall Study|Withdrawal by Subject|4|||
160678483|NCT03201003|580201891|FG001|Overall Study|Withdrawal by Subject|1|||
160678484|NCT03201003|580201890|FG000|Overall Study|Lost to Follow-up|2|||
160678485|NCT03201003|580201891|FG001|Overall Study|Lost to Follow-up|0|||
160678486|NCT03201003|580201890|FG000|Overall Study|Protocol Violation|1|||
160678487|NCT03201003|580201891|FG001|Overall Study|Protocol Violation|0|||
160678488|NCT00834613|580201892|FG000|First Intervention|Protocol Violation|1|||
160678489|NCT00834613|580201893|FG001|First Intervention|Protocol Violation|0|||
160678490|NCT01751087|580201900|FG000|Overall Study|Withdrawal by Subject|1|||
160678491|NCT01751087|580201901|FG001|Overall Study|Withdrawal by Subject|0|||
160678492|NCT01751087|580201902|FG002|Overall Study|Withdrawal by Subject|0|||
160678493|NCT01751087|580201900|FG000|Overall Study|Physician Decision|0|||
160678494|NCT01751087|580201901|FG001|Overall Study|Physician Decision|0|||
160678495|NCT01751087|580201902|FG002|Overall Study|Physician Decision|1|||
160678496|NCT04584983|580201903|FG000|Overall Study|Parental request for withdraw|2|||
160678497|NCT04584983|580201904|FG001|Overall Study|Parental request for withdraw|0|||
160678498|NCT05377489|580201905|FG000|Overall Study|Withdrawal by Subject|122|||
160678499|NCT05377489|580201905|FG000|Overall Study|Lost to Follow-up|21|||
160678500|NCT05377489|580201905|FG000|Overall Study|Lack of Efficacy|10|||
160678501|NCT05377489|580201905|FG000|Overall Study|Adverse Event|5|||
160678502|NCT05377489|580201905|FG000|Overall Study|Death|4|||
160678503|NCT05377489|580201905|FG000|Overall Study|Physician Decision|3|||
160678504|NCT05377489|580201905|FG000|Overall Study|Protocol Violation|1|||
160678505|NCT05377489|580201905|FG000|Overall Study|Other|9|||
160678506|NCT00724958|580201906|FG000|Overall Study|Adverse Event|28|||
160678507|NCT00724958|580201906|FG000|Overall Study|Loss of Response|40|||
160678508|NCT00724958|580201906|FG000|Overall Study|No Response|18|||
160678509|NCT00724958|580201906|FG000|Overall Study|Remission|7|||
160678510|NCT00724958|580201906|FG000|Overall Study|Other Reason|76|||
160678511|NCT00724958|580201906|FG000|Overall Study|No documentation for end of therapy|13|||
160678512|NCT00697619|580201907|FG000|Overall Study|Lack of Efficacy|2|||
160678513|NCT00697619|580201908|FG001|Overall Study|Lack of Efficacy|2|||
160678514|NCT00697619|580201907|FG000|Overall Study|Adverse Event|4|||
160678515|NCT00697619|580201908|FG001|Overall Study|Adverse Event|6|||
160678516|NCT00559637|580203734|FG000|Overall Study|Adverse Event|22|||
160678517|NCT00559637|580203734|FG000|Overall Study|Withdrawal by Subject|4|||
160678518|NCT00559637|580203734|FG000|Overall Study|Protocol Violation|6|||
160678519|NCT00559637|580203734|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
160678520|NCT00559637|580203734|FG000|Overall Study|Failure to return|6|||
160678521|NCT00559637|580203734|FG000|Overall Study|Insufficient response|3|||
160678522|NCT00559637|580203734|FG000|Overall Study|Started requiring dialysis after month 7|2|||
160678523|NCT00559637|580203734|FG000|Overall Study|Suspected lung cancer|1|||
160678524|NCT00559637|580203734|FG000|Overall Study|Participation in another study|1|||
160678525|NCT00559637|580203734|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
160678526|NCT00559637|580203734|FG000|Overall Study|Change of center|1|||
160678527|NCT00559637|580203734|FG000|Overall Study|Change of home|1|||
160678528|NCT00559637|580203734|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
160678529|NCT01705717|580203736|FG000|Overall Study|Adverse Event|2|||
160678530|NCT01705717|580203737|FG001|Overall Study|Adverse Event|2|||
160678531|NCT01705717|580203736|FG000|Overall Study|Lack of Efficacy|0|||
160678532|NCT01705717|580203737|FG001|Overall Study|Lack of Efficacy|1|||
160678533|NCT01705717|580203736|FG000|Overall Study|Other|0|||
160678534|NCT01705717|580203737|FG001|Overall Study|Other|2|||
160678535|NCT02031237|580203738|FG000|Overall Study|Death|1|||
160678536|NCT02031237|580203739|FG001|Overall Study|Death|5|||
160678537|NCT02031237|580203740|FG002|Overall Study|Death|0|||
160678538|NCT02031237|580203738|FG000|Overall Study|Physician Decision|0|||
160678539|NCT02031237|580203739|FG001|Overall Study|Physician Decision|1|||
160678540|NCT02031237|580203740|FG002|Overall Study|Physician Decision|0|||
160678541|NCT02031237|580203738|FG000|Overall Study|Withdrawal by Subject|2|||
160678542|NCT02031237|580203739|FG001|Overall Study|Withdrawal by Subject|2|||
160678543|NCT02031237|580203740|FG002|Overall Study|Withdrawal by Subject|0|||
160678544|NCT02031237|580203738|FG000|Overall Study|Protocol Violation|2|||
160678545|NCT02031237|580203739|FG001|Overall Study|Protocol Violation|6|||
160678546|NCT02031237|580203740|FG002|Overall Study|Protocol Violation|0|||
160678547|NCT02031237|580203738|FG000|Overall Study|Alternate Treatment Given|0|||
160678548|NCT02031237|580203739|FG001|Overall Study|Alternate Treatment Given|0|||
160678549|NCT02031237|580203740|FG002|Overall Study|Alternate Treatment Given|3|||
160678550|NCT02293460|580203741|FG000|Overall Study|Protocol Violation|1|||
160678551|NCT02293460|580203741|FG000|Overall Study|Lack of Efficacy|2|||
160678552|NCT02293460|580203741|FG000|Overall Study|Adverse Event|2|||
160678553|NCT02293460|580203741|FG000|Overall Study|Withdrawal by Subject|1|||
160678554|NCT01074008|580203747|FG000|Overall Study|Adverse Event|0|||
160678555|NCT01074008|580203748|FG001|Overall Study|Adverse Event|1|||
160678556|NCT01074008|580203749|FG002|Overall Study|Adverse Event|0|||
160678557|NCT01074008|580203750|FG003|Overall Study|Adverse Event|0|||
160678558|NCT01074008|580203751|FG004|Overall Study|Adverse Event|0|||
160678559|NCT01074008|580203752|FG005|Overall Study|Adverse Event|0|||
160678560|NCT01074008|580203753|FG006|Overall Study|Adverse Event|0|||
160678561|NCT01074008|580203754|FG007|Overall Study|Adverse Event|0|||
160678562|NCT01074008|580203755|FG008|Overall Study|Adverse Event|0|||
160678563|NCT01074008|580203747|FG000|Overall Study|Withdrawal by Subject|1|||
160678564|NCT01074008|580203748|FG001|Overall Study|Withdrawal by Subject|1|||
160678565|NCT01074008|580203749|FG002|Overall Study|Withdrawal by Subject|1|||
160678566|NCT01074008|580203750|FG003|Overall Study|Withdrawal by Subject|0|||
160678567|NCT01074008|580203751|FG004|Overall Study|Withdrawal by Subject|1|||
160678568|NCT01074008|580203752|FG005|Overall Study|Withdrawal by Subject|0|||
160678569|NCT01074008|580203753|FG006|Overall Study|Withdrawal by Subject|0|||
160678570|NCT01074008|580203754|FG007|Overall Study|Withdrawal by Subject|0|||
160678571|NCT01074008|580203755|FG008|Overall Study|Withdrawal by Subject|0|||
160678572|NCT01074008|580203747|FG000|Overall Study|Lost to Follow-up|0|||
160678573|NCT01074008|580203748|FG001|Overall Study|Lost to Follow-up|1|||
160678574|NCT01074008|580203749|FG002|Overall Study|Lost to Follow-up|1|||
160678575|NCT01074008|580203750|FG003|Overall Study|Lost to Follow-up|1|||
160678576|NCT01074008|580203751|FG004|Overall Study|Lost to Follow-up|1|||
160678577|NCT01074008|580203752|FG005|Overall Study|Lost to Follow-up|0|||
160678578|NCT01074008|580203753|FG006|Overall Study|Lost to Follow-up|1|||
160678579|NCT01074008|580203754|FG007|Overall Study|Lost to Follow-up|0|||
160678580|NCT01074008|580203755|FG008|Overall Study|Lost to Follow-up|4|||
160678581|NCT02805309|580203756|FG000|Overall Study|Lost to Follow-up|2|||
160678582|NCT02805309|580203757|FG001|Overall Study|Lost to Follow-up|2|||
160678583|NCT02805309|580203758|FG002|Overall Study|Lost to Follow-up|2|||
160678584|NCT02805309|580203756|FG000|Overall Study|Post-Randomization Exclusion|0|||
160678585|NCT02805309|580203757|FG001|Overall Study|Post-Randomization Exclusion|2|||
160678586|NCT02805309|580203758|FG002|Overall Study|Post-Randomization Exclusion|1|||
160678587|NCT05480800|580203767|FG000|Overall Study|Withdrawal by Subject|0|||
160678588|NCT05480800|580203768|FG001|Overall Study|Withdrawal by Subject|0|||
160678589|NCT05480800|580203769|FG002|Overall Study|Withdrawal by Subject|2|||
160678590|NCT05480800|580203770|FG003|Overall Study|Withdrawal by Subject|1|||
160678591|NCT05480800|580203771|FG004|Overall Study|Withdrawal by Subject|0|||
160678592|NCT05480800|580203772|FG005|Overall Study|Withdrawal by Subject|0|||
160678593|NCT05480800|580203773|FG006|Overall Study|Withdrawal by Subject|1|||
160678594|NCT05480800|580203774|FG007|Overall Study|Withdrawal by Subject|0|||
160678595|NCT05480800|580203767|FG000|Overall Study|Other|0|||
160678596|NCT05480800|580203768|FG001|Overall Study|Other|0|||
160678597|NCT05480800|580203769|FG002|Overall Study|Other|0|||
160678598|NCT05480800|580203770|FG003|Overall Study|Other|0|||
160678599|NCT05480800|580203771|FG004|Overall Study|Other|0|||
160678600|NCT05480800|580203772|FG005|Overall Study|Other|0|||
160678601|NCT05480800|580203773|FG006|Overall Study|Other|1|||
160678602|NCT05480800|580203774|FG007|Overall Study|Other|0|||
160678603|NCT00377156|580203779|FG000|Overall Study|Death|23|||
160678604|NCT00377156|580203780|FG001|Overall Study|Death|19|||
160678605|NCT00377156|580203779|FG000|Overall Study|Withdrawal by Subject|16|||
160678606|NCT00377156|580203780|FG001|Overall Study|Withdrawal by Subject|24|||
160678607|NCT00377156|580203779|FG000|Overall Study|Had follow-up <90 d|3|||
160678608|NCT00377156|580203780|FG001|Overall Study|Had follow-up <90 d|6|||
160678609|NCT00377156|580203779|FG000|Overall Study|Cancellation|1|||
160678610|NCT00377156|580203780|FG001|Overall Study|Cancellation|0|||
160678611|NCT00377156|580203779|FG000|Overall Study|Refused testing|0|||
160678612|NCT00377156|580203780|FG001|Overall Study|Refused testing|1|||
160678613|NCT00377156|580203779|FG000|Overall Study|Ineligible|0|||
160678614|NCT00377156|580203780|FG001|Overall Study|Ineligible|1|||
160678615|NCT00377156|580203779|FG000|Overall Study|Disability or language problem|0|||
160678616|NCT00377156|580203780|FG001|Overall Study|Disability or language problem|1|||
160678617|NCT00377156|580203779|FG000|Overall Study|Other|5|||
160678618|NCT00377156|580203780|FG001|Overall Study|Other|2|||
160678619|NCT01802216|580203781|FG000|4 Month Visit|Participant did not show to visit|3|||
160678620|NCT01802216|580203782|FG001|4 Month Visit|Participant did not show to visit|4|||
160678621|NCT01802216|580203781|FG000|8 Month Visit|Participant did not show to visit|3|||
160678622|NCT01802216|580203782|FG001|8 Month Visit|Participant did not show to visit|5|||
160678623|NCT01802216|580203781|FG000|12 Month Visit|Participant did not show to visit|3|||
160678624|NCT01802216|580203782|FG001|12 Month Visit|Participant did not show to visit|4|||
160678625|NCT02459418|580203783|FG000|Overall Study|Exclusion Criteria|4|||
160678626|NCT02459418|580203784|FG001|Overall Study|Exclusion Criteria|0|||
160678627|NCT02459418|580203783|FG000|Overall Study|Protocol Violation|0|||
160678628|NCT02459418|580203784|FG001|Overall Study|Protocol Violation|2|||
160678629|NCT02459418|580203783|FG000|Overall Study|Physician Decision|0|||
160678630|NCT02459418|580203784|FG001|Overall Study|Physician Decision|2|||
160678631|NCT02459418|580203783|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
160678632|NCT02459418|580203784|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
160678633|NCT02459418|580203783|FG000|Overall Study|Adverse Event|0|||
160678634|NCT02459418|580203784|FG001|Overall Study|Adverse Event|1|||
160678635|NCT02459418|580203783|FG000|Overall Study|Withdrawal by Subject|1|||
160678636|NCT02459418|580203784|FG001|Overall Study|Withdrawal by Subject|1|||
160678637|NCT02459418|580203783|FG000|Overall Study|Elevated Creatine Kinase|1|||
160678638|NCT02459418|580203784|FG001|Overall Study|Elevated Creatine Kinase|0|||
160678639|NCT02459418|580203783|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
160678640|NCT02459418|580203784|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
160678641|NCT00683592|580203787|FG000|Overall Study|Adverse Event|12|||
160678642|NCT00683592|580203788|FG001|Overall Study|Adverse Event|4|||
160678643|NCT00683592|580203787|FG000|Overall Study|Withdrawal by Subject|11|||
160678644|NCT00683592|580203788|FG001|Overall Study|Withdrawal by Subject|11|||
160678645|NCT00683592|580203787|FG000|Overall Study|Lost to Follow-up|17|||
160678646|NCT00683592|580203788|FG001|Overall Study|Lost to Follow-up|17|||
160678647|NCT00683592|580203787|FG000|Overall Study|Lack of Efficacy|3|||
160678648|NCT00683592|580203788|FG001|Overall Study|Lack of Efficacy|7|||
160678649|NCT00683592|580203787|FG000|Overall Study|Physician Decision|0|||
160678650|NCT00683592|580203788|FG001|Overall Study|Physician Decision|1|||
160678651|NCT00683592|580203787|FG000|Overall Study|Non-compliance|3|||
160678652|NCT00683592|580203788|FG001|Overall Study|Non-compliance|5|||
160678653|NCT00683592|580203787|FG000|Overall Study|Other|1|||
160678654|NCT00683592|580203788|FG001|Overall Study|Other|1|||
160678655|NCT02697617|580203796|FG000|Overall Study|Withdrawal by Subject|0|||
160678656|NCT02697617|580203797|FG001|Overall Study|Withdrawal by Subject|2|||
160678657|NCT02697617|580203796|FG000|Overall Study|Pregnancy|1|||
160678658|NCT02697617|580203797|FG001|Overall Study|Pregnancy|0|||
160678659|NCT03303417|580203799|FG000|Overall Study|Withdrawal by Subject|1|||
160678660|NCT03303417|580203800|FG001|Overall Study|Withdrawal by Subject|1|||
160678661|NCT00329160|580203803|FG000|Overall Study|Adverse Event|27|||
160678662|NCT00329160|580203803|FG000|Overall Study|Withdrawal by Subject|13|||
160678663|NCT00329160|580203803|FG000|Overall Study|Protocol Violation|2|||
160678664|NCT00329160|580203803|FG000|Overall Study|Did not Receive Study Drug|1|||
160678665|NCT00329160|580203803|FG000|Overall Study|Incomplete IVUS|45|||
160678666|NCT05212948|580203808|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
160678667|NCT05212948|580203809|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
160678668|NCT05212948|580203808|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
160678669|NCT05212948|580203809|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
160678670|NCT05212948|580203808|FG000|Initial Vaccination Period|Pregnancy|20|||
160678671|NCT05212948|580203809|FG001|Initial Vaccination Period|Pregnancy|14|||
160678672|NCT05212948|580203808|FG000|Initial Vaccination Period|Physician Decision|686|||
160678673|NCT05212948|580203809|FG001|Initial Vaccination Period|Physician Decision|401|||
160678674|NCT05212948|580203808|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
160678675|NCT05212948|580203809|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
160678676|NCT05212948|580203808|FG000|Initial Vaccination Period|Death|23|||
160678677|NCT05212948|580203809|FG001|Initial Vaccination Period|Death|18|||
160678678|NCT05212948|580203808|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
160678679|NCT05212948|580203809|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
160678680|NCT05212948|580203808|FG000|Initial Vaccination Period|Adverse Event|36|||
160678681|NCT05212948|580203809|FG001|Initial Vaccination Period|Adverse Event|23|||
160678682|NCT05212948|580203808|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
160678683|NCT05212948|580203809|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
160678684|NCT05212948|580203808|FG000|Crossover Vaccination Period|Pregnancy|6|||
160678685|NCT05212948|580203809|FG001|Crossover Vaccination Period|Pregnancy|1|||
160678686|NCT05212948|580203808|FG000|Crossover Vaccination Period|Physician Decision|49|||
160678687|NCT05212948|580203809|FG001|Crossover Vaccination Period|Physician Decision|24|||
160678688|NCT05212948|580203808|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
160678689|NCT05212948|580203809|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
160678690|NCT05212948|580203808|FG000|Crossover Vaccination Period|Death|10|||
160678691|NCT05212948|580203809|FG001|Crossover Vaccination Period|Death|5|||
160678692|NCT05212948|580203808|FG000|Crossover Vaccination Period|Adverse Event|9|||
160678693|NCT05212948|580203809|FG001|Crossover Vaccination Period|Adverse Event|4|||
160678694|NCT05347693|580203810|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
160678695|NCT05347693|580203811|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
160678696|NCT05347693|580203812|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
160678697|NCT05347693|580203810|FG000|Inpatient Period|Withdrawal of consent|10|||
160678698|NCT05347693|580203811|FG001|Inpatient Period|Withdrawal of consent|0|||
160678699|NCT05347693|580203812|FG002|Inpatient Period|Withdrawal of consent|0|||
160678700|NCT05347693|580203810|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
160678701|NCT05347693|580203811|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
160678702|NCT05347693|580203812|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
160678703|NCT05347693|580203810|FG000|Inpatient Period|Screening Failure|8|||
160678704|NCT05347693|580203811|FG001|Inpatient Period|Screening Failure|0|||
160678705|NCT05347693|580203812|FG002|Inpatient Period|Screening Failure|0|||
160678706|NCT05347693|580203810|FG000|Inpatient Period|Death|2|||
160678707|NCT05347693|580203811|FG001|Inpatient Period|Death|0|||
160678708|NCT05347693|580203812|FG002|Inpatient Period|Death|0|||
160678709|NCT05347693|580203810|FG000|Inpatient Period|Physician Decision|5|||
160678710|NCT05347693|580203811|FG001|Inpatient Period|Physician Decision|0|||
160678711|NCT05347693|580203812|FG002|Inpatient Period|Physician Decision|0|||
160678712|NCT05347693|580203810|FG000|Inpatient Period|Adverse Event|3|||
160678713|NCT05347693|580203811|FG001|Inpatient Period|Adverse Event|0|||
160678714|NCT05347693|580203812|FG002|Inpatient Period|Adverse Event|0|||
160678715|NCT05347693|580203810|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
160678716|NCT05347693|580203811|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
160678717|NCT05347693|580203812|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
160678718|NCT05347693|580203810|FG000|Outpatient Period|Adverse Event|0|||
160678719|NCT05347693|580203811|FG001|Outpatient Period|Adverse Event|9|||
160678720|NCT05347693|580203812|FG002|Outpatient Period|Adverse Event|0|||
160678721|NCT05347693|580203810|FG000|Outpatient Period|Death|0|||
160678722|NCT05347693|580203811|FG001|Outpatient Period|Death|6|||
160678723|NCT05347693|580203812|FG002|Outpatient Period|Death|2|||
160678724|NCT05347693|580203810|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
160678725|NCT05347693|580203811|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
160678726|NCT05347693|580203812|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
160678727|NCT05347693|580203810|FG000|Outpatient Period|Lost to Follow-up|0|||
160678728|NCT05347693|580203811|FG001|Outpatient Period|Lost to Follow-up|0|||
160678729|NCT05347693|580203812|FG002|Outpatient Period|Lost to Follow-up|1|||
160678730|NCT05347693|580203810|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
160678731|NCT05347693|580203811|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
160678732|NCT05347693|580203812|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
160678733|NCT05347693|580203810|FG000|Outpatient Period|Scheduled hemodialysis|0|||
160678734|NCT05347693|580203811|FG001|Outpatient Period|Scheduled hemodialysis|1|||
160678735|NCT05347693|580203812|FG002|Outpatient Period|Scheduled hemodialysis|0|||
160678736|NCT05347693|580203810|FG000|Outpatient Period|Severe HK|0|||
160678737|NCT05347693|580203811|FG001|Outpatient Period|Severe HK|0|||
160678738|NCT05347693|580203812|FG002|Outpatient Period|Severe HK|1|||
160678739|NCT05347693|580203810|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
160678740|NCT05347693|580203811|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
160678741|NCT05347693|580203812|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
160678742|NCT05347693|580203810|FG000|Outpatient Period|Start of dialysis|0|||
160678743|NCT05347693|580203811|FG001|Outpatient Period|Start of dialysis|0|||
160678744|NCT05347693|580203812|FG002|Outpatient Period|Start of dialysis|1|||
160678745|NCT05347693|580203810|FG000|Outpatient Period|The participant entered hemodialysis|0|||
160678746|NCT05347693|580203811|FG001|Outpatient Period|The participant entered hemodialysis|0|||
160678747|NCT05347693|580203812|FG002|Outpatient Period|The participant entered hemodialysis|1|||
160678748|NCT05347693|580203810|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
160678749|NCT05347693|580203811|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
160678750|NCT05347693|580203812|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
160678751|NCT05347693|580203810|FG000|Outpatient Period|Withdrawal by Subject|0|||
160678752|NCT05347693|580203811|FG001|Outpatient Period|Withdrawal by Subject|8|||
160678753|NCT05347693|580203812|FG002|Outpatient Period|Withdrawal by Subject|5|||
160678754|NCT01755975|580203813|FG000|Overall Study|Adverse Event|0|||
160678755|NCT01755975|580203814|FG001|Overall Study|Adverse Event|0|||
160678756|NCT01755975|580203815|FG002|Overall Study|Adverse Event|1|||
160678757|NCT01755975|580203816|FG003|Overall Study|Adverse Event|0|||
160678758|NCT01755975|580203817|FG004|Overall Study|Adverse Event|2|||
160678759|NCT03653026|580203818|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
160678760|NCT03653026|580203819|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
160678761|NCT03653026|580203820|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
160678762|NCT03653026|580203821|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
160678763|NCT03653026|580203818|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
160678764|NCT03653026|580203819|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
160678765|NCT03653026|580203820|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160678766|NCT03653026|580203821|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160678767|NCT03653026|580203818|FG000|Part 1: Placebo-controlled Period|Other|0|||
160678768|NCT03653026|580203819|FG001|Part 1: Placebo-controlled Period|Other|3|||
160678769|NCT03653026|580203820|FG002|Part 1: Placebo-controlled Period|Other|0|||
160678770|NCT03653026|580203821|FG003|Part 1: Placebo-controlled Period|Other|0|||
160678771|NCT03653026|580203818|FG000|Part 2: Open-label Extension|Adverse Event|0|||
160678772|NCT03653026|580203819|FG001|Part 2: Open-label Extension|Adverse Event|0|||
160678773|NCT03653026|580203820|FG002|Part 2: Open-label Extension|Adverse Event|1|||
160678774|NCT03653026|580203821|FG003|Part 2: Open-label Extension|Adverse Event|1|||
160678775|NCT03653026|580203818|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
160678776|NCT03653026|580203819|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
160678777|NCT03653026|580203820|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
160678778|NCT03653026|580203821|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
160678779|NCT03653026|580203818|FG000|Part 2: Open-label Extension|Other|0|||
160678780|NCT03653026|580203819|FG001|Part 2: Open-label Extension|Other|0|||
160678781|NCT03653026|580203820|FG002|Part 2: Open-label Extension|Other|1|||
160678782|NCT03653026|580203821|FG003|Part 2: Open-label Extension|Other|2|||
160678783|NCT02104817|580203822|FG000|Overall Study|Death|363|||
160678784|NCT02104817|580203823|FG001|Overall Study|Death|330|||
160678785|NCT02104817|580203822|FG000|Overall Study|Lost to Follow-up|3|||
160678786|NCT02104817|580203823|FG001|Overall Study|Lost to Follow-up|2|||
160678787|NCT02104817|580203822|FG000|Overall Study|Protocol Violation|0|||
160678788|NCT02104817|580203823|FG001|Overall Study|Protocol Violation|1|||
160678789|NCT02104817|580203822|FG000|Overall Study|Study terminated by sponsor|5854|||
160678790|NCT02104817|580203823|FG001|Overall Study|Study terminated by sponsor|5901|||
160678791|NCT02104817|580203822|FG000|Overall Study|Withdrawal by Subject|111|||
160678792|NCT02104817|580203823|FG001|Overall Study|Withdrawal by Subject|78|||
160678793|NCT02104817|580203822|FG000|Overall Study|Other reasons|128|||
160678794|NCT02104817|580203823|FG001|Overall Study|Other reasons|135|||
160678795|NCT00852917|580203826|FG000|Overall Study|Adverse Event|13|||
160678796|NCT00852917|580203827|FG001|Overall Study|Adverse Event|20|||
160678797|NCT00852917|580203828|FG002|Overall Study|Adverse Event|35|||
160678798|NCT00852917|580203829|FG003|Overall Study|Adverse Event|17|||
160678799|NCT00852917|580203826|FG000|Overall Study|Lack of Efficacy|21|||
160678800|NCT00852917|580203827|FG001|Overall Study|Lack of Efficacy|11|||
160678801|NCT00852917|580203828|FG002|Overall Study|Lack of Efficacy|11|||
160678802|NCT00852917|580203829|FG003|Overall Study|Lack of Efficacy|47|||
160678803|NCT00852917|580203826|FG000|Overall Study|Withdrawal by Subject|4|||
160678804|NCT00852917|580203827|FG001|Overall Study|Withdrawal by Subject|8|||
160678805|NCT00852917|580203828|FG002|Overall Study|Withdrawal by Subject|10|||
160678806|NCT00852917|580203829|FG003|Overall Study|Withdrawal by Subject|9|||
160678807|NCT00852917|580203826|FG000|Overall Study|Physician Decision|6|||
160678808|NCT00852917|580203827|FG001|Overall Study|Physician Decision|7|||
160678809|NCT00852917|580203828|FG002|Overall Study|Physician Decision|2|||
160678810|NCT00852917|580203829|FG003|Overall Study|Physician Decision|19|||
160678811|NCT00852917|580203826|FG000|Overall Study|Death|0|||
160678812|NCT00852917|580203827|FG001|Overall Study|Death|0|||
160678813|NCT00852917|580203828|FG002|Overall Study|Death|0|||
160678814|NCT00852917|580203829|FG003|Overall Study|Death|1|||
160678815|NCT01358877|580203830|FG000|Overall Study|Withdrawal by Subject|475|||
160678816|NCT01358877|580203831|FG001|Overall Study|Withdrawal by Subject|466|||
160678817|NCT01358877|580203830|FG000|Overall Study|Recurrence of disease|181|||
160678818|NCT01358877|580203831|FG001|Overall Study|Recurrence of disease|269|||
160678819|NCT01358877|580203830|FG000|Overall Study|Lost to Follow-up|181|||
160678820|NCT01358877|580203831|FG001|Overall Study|Lost to Follow-up|176|||
160678821|NCT01358877|580203830|FG000|Overall Study|Death|41|||
160678822|NCT01358877|580203831|FG001|Overall Study|Death|46|||
160678823|NCT01358877|580203830|FG000|Overall Study|Adverse Event|39|||
160678824|NCT01358877|580203831|FG001|Overall Study|Adverse Event|42|||
160678825|NCT01358877|580203830|FG000|Overall Study|Physician Decision|43|||
160678826|NCT01358877|580203831|FG001|Overall Study|Physician Decision|32|||
160678827|NCT01358877|580203830|FG000|Overall Study|Contralateral breast cancer|42|||
160678828|NCT01358877|580203831|FG001|Overall Study|Contralateral breast cancer|28|||
160678829|NCT01358877|580203830|FG000|Overall Study|Reason not specified|37|||
160678830|NCT01358877|580203831|FG001|Overall Study|Reason not specified|29|||
160678831|NCT01597479|580203835|FG000|Overall Study|Protocol Violation|1|||
160678832|NCT01597479|580203836|FG001|Overall Study|Protocol Violation|0|||
160678833|NCT01597479|580203835|FG000|Overall Study|Lost to Follow-up|1|||
160678834|NCT01597479|580203836|FG001|Overall Study|Lost to Follow-up|0|||
160678835|NCT02167594|580203837|FG000|Overall Study|Withdrawal by Subject|2|||
160678836|NCT02167594|580203838|FG001|Overall Study|Withdrawal by Subject|0|||
160678837|NCT02167594|580203839|FG002|Overall Study|Withdrawal by Subject|0|||
160678838|NCT02167594|580203837|FG000|Overall Study|Death|0|||
160678839|NCT02167594|580203838|FG001|Overall Study|Death|1|||
160678840|NCT02167594|580203839|FG002|Overall Study|Death|0|||
160678841|NCT02161549|580203840|FG000|Overall Study|Physician Decision|6|||
160678842|NCT02161549|580203841|FG001|Overall Study|Physician Decision|2|||
160678843|NCT02340780|580203842|FG000|Overall Study|Ineligible|1|||
160678844|NCT03433703|580203843|FG000|Overall Study|Study terminated by Sponsor|2|||
160678845|NCT03422068|580203846|FG000|Overall Study|Adverse Event|0|||
160678846|NCT03422068|580203847|FG001|Overall Study|Adverse Event|1|||
160678847|NCT03422068|580203846|FG000|Overall Study|Inconvenience to frequent study visits|0|||
160678848|NCT03422068|580203847|FG001|Overall Study|Inconvenience to frequent study visits|1|||
160678849|NCT01583530|580203848|FG000|Overall Study|Adverse Event|0|||
160678850|NCT01583530|580203849|FG001|Overall Study|Adverse Event|0|||
160678851|NCT01583530|580203850|FG002|Overall Study|Adverse Event|0|||
160678852|NCT01583530|580203851|FG003|Overall Study|Adverse Event|0|||
160678853|NCT01583530|580203852|FG004|Overall Study|Adverse Event|0|||
160678854|NCT01583530|580203853|FG005|Overall Study|Adverse Event|1|||
160678855|NCT01583530|580203848|FG000|Overall Study|Withdrawal by Subject|0|||
160678856|NCT01583530|580203849|FG001|Overall Study|Withdrawal by Subject|3|||
160678857|NCT01583530|580203850|FG002|Overall Study|Withdrawal by Subject|0|||
160678858|NCT01583530|580203851|FG003|Overall Study|Withdrawal by Subject|1|||
160678859|NCT01583530|580203852|FG004|Overall Study|Withdrawal by Subject|1|||
160678860|NCT01583530|580203853|FG005|Overall Study|Withdrawal by Subject|2|||
160678861|NCT01583530|580203848|FG000|Overall Study|Lost to Follow-up|0|||
160678862|NCT01583530|580203849|FG001|Overall Study|Lost to Follow-up|0|||
160678863|NCT01583530|580203850|FG002|Overall Study|Lost to Follow-up|0|||
160678864|NCT01583530|580203851|FG003|Overall Study|Lost to Follow-up|0|||
160678865|NCT01583530|580203852|FG004|Overall Study|Lost to Follow-up|3|||
160678866|NCT01583530|580203853|FG005|Overall Study|Lost to Follow-up|0|||
160678867|NCT01583530|580203848|FG000|Overall Study|Lack of compliance|0|||
160678868|NCT01583530|580203849|FG001|Overall Study|Lack of compliance|0|||
160678869|NCT01583530|580203850|FG002|Overall Study|Lack of compliance|0|||
160678870|NCT01583530|580203851|FG003|Overall Study|Lack of compliance|0|||
160678871|NCT01583530|580203852|FG004|Overall Study|Lack of compliance|1|||
160678872|NCT01583530|580203853|FG005|Overall Study|Lack of compliance|0|||
160678873|NCT02416180|580203854|FG000|Overall Study|Withdrawal by Subject|1|||
160678874|NCT02858037|580203857|FG000|Overall Study|Death|1|||
160678875|NCT02858037|580203857|FG000|Overall Study|Withdrawal by Subject|18|||
160678876|NCT02858037|580203857|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
160678877|NCT02858037|580203857|FG000|Overall Study|Lost to Follow-up|3|||
160678878|NCT02858037|580203857|FG000|Overall Study|Other|4|||
160678879|NCT00550147|580203860|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
160678880|NCT00550147|580203860|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
160678881|NCT00550147|580203860|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
160678882|NCT00550147|580203860|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
160678883|NCT00550147|580203860|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
160678884|NCT04320745|580203861|FG000|Overall Study|Adverse Event|26|||
160678885|NCT04320745|580203861|FG000|Overall Study|Withdrawal by Subject|4|||
160678886|NCT04320745|580203861|FG000|Overall Study|Lost to Follow-up|12|||
160678887|NCT04320745|580203861|FG000|Overall Study|Protocol Deviation|2|||
160678888|NCT04320745|580203861|FG000|Overall Study|Non-compliance With Study Drug|2|||
160678889|NCT04320745|580203861|FG000|Overall Study|Reason Not Specified|1|||
160678890|NCT02050321|580203862|FG000|Overall Study|Withdrawal by Subject|1|||
160678891|NCT02050321|580203862|FG000|Overall Study|Adverse Event|1|||
160678892|NCT04768114|580203863|FG000|Overall Study|Lost to Follow-up|5|||
160678893|NCT04768114|580203864|FG001|Overall Study|Lost to Follow-up|10|||
160678894|NCT04768114|580203863|FG000|Overall Study|Withdrawal by Subject|0|||
160678895|NCT04768114|580203864|FG001|Overall Study|Withdrawal by Subject|1|||
160678896|NCT01685008|580203865|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
160678897|NCT01685008|580203866|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
160678898|NCT01685008|580203867|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
160678899|NCT01685008|580203868|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
160678900|NCT01685008|580203865|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
160678901|NCT01685008|580203866|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
160678902|NCT01685008|580203867|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
160678903|NCT01685008|580203868|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
160678904|NCT01685008|580203865|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
160678905|NCT01685008|580203866|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
160678906|NCT01685008|580203867|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
160678907|NCT01685008|580203868|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
160678908|NCT01685008|580203865|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
160678909|NCT01685008|580203866|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
160678910|NCT01685008|580203867|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
160678911|NCT01685008|580203868|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
160678912|NCT01685008|580203865|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
160678913|NCT01685008|580203866|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
160678914|NCT01685008|580203867|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
160678915|NCT01685008|580203868|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
160678916|NCT00715676|580203880|FG000|Overall Study|Adverse Event|3|||
160678917|NCT00715676|580203881|FG001|Overall Study|Adverse Event|5|||
160678918|NCT00715676|580203882|FG002|Overall Study|Adverse Event|21|||
160678919|NCT00715676|580203880|FG000|Overall Study|Withdrawal by Subject|1|||
160678920|NCT00715676|580203881|FG001|Overall Study|Withdrawal by Subject|3|||
160678921|NCT00715676|580203882|FG002|Overall Study|Withdrawal by Subject|8|||
160678922|NCT00715676|580203880|FG000|Overall Study|Lost to Follow-up|1|||
160678923|NCT00715676|580203881|FG001|Overall Study|Lost to Follow-up|2|||
160678924|NCT00715676|580203882|FG002|Overall Study|Lost to Follow-up|1|||
160678925|NCT00715676|580203880|FG000|Overall Study|Terminated by Sponsor|1|||
160678926|NCT00715676|580203881|FG001|Overall Study|Terminated by Sponsor|0|||
160678927|NCT00715676|580203882|FG002|Overall Study|Terminated by Sponsor|0|||
160678928|NCT00715676|580203880|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
160678929|NCT00715676|580203881|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
160678930|NCT00715676|580203882|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
160678931|NCT00715676|580203880|FG000|Overall Study|Use of Exclusionary Medication|0|||
160678932|NCT00715676|580203881|FG001|Overall Study|Use of Exclusionary Medication|0|||
160678933|NCT00715676|580203882|FG002|Overall Study|Use of Exclusionary Medication|1|||
160678934|NCT00715676|580203880|FG000|Overall Study|Elevated Blood Glucose|0|||
160678935|NCT00715676|580203881|FG001|Overall Study|Elevated Blood Glucose|1|||
160678936|NCT00715676|580203882|FG002|Overall Study|Elevated Blood Glucose|0|||
160678937|NCT01963260|580203883|FG000|Overall Study|Withdrawal by Subject|2|||
160678938|NCT01963260|580203884|FG001|Overall Study|Withdrawal by Subject|0|||
160678939|NCT01963260|580203885|FG002|Overall Study|Withdrawal by Subject|0|||
160678940|NCT01963260|580203886|FG003|Overall Study|Withdrawal by Subject|1|||
160678941|NCT01963260|580203887|FG004|Overall Study|Withdrawal by Subject|2|||
160678942|NCT01963260|580203888|FG005|Overall Study|Withdrawal by Subject|0|||
160678943|NCT01963260|580203889|FG006|Overall Study|Withdrawal by Subject|0|||
160678944|NCT01963260|580203890|FG007|Overall Study|Withdrawal by Subject|0|||
160678945|NCT01963260|580203891|FG008|Overall Study|Withdrawal by Subject|0|||
160678946|NCT01963260|580203892|FG009|Overall Study|Withdrawal by Subject|0|||
160678947|NCT01547728|580203894|FG000|Overall Study|Change in procedure and equipment|1|||
160678948|NCT01547728|580203894|FG000|Overall Study|Drug not ready for subject|1|||
160678949|NCT01547728|580203894|FG000|Overall Study|Screen failure|39|||
160678950|NCT03828539|580203895|FG000|Overall Study|Adverse Event|3|||
160678951|NCT03828539|580203896|FG001|Overall Study|Adverse Event|12|||
160678952|NCT03828539|580203895|FG000|Overall Study|Patient's/guardian's decision|3|||
160678953|NCT03828539|580203896|FG001|Overall Study|Patient's/guardian's decision|5|||
160678954|NCT03828539|580203895|FG000|Overall Study|Lost to Follow-up|4|||
160678955|NCT03828539|580203896|FG001|Overall Study|Lost to Follow-up|2|||
160678956|NCT03828539|580203895|FG000|Overall Study|Protocol Violation|3|||
160678957|NCT03828539|580203896|FG001|Overall Study|Protocol Violation|2|||
160678958|NCT03828539|580203895|FG000|Overall Study|Withdrawal of informed consent|2|||
160678959|NCT03828539|580203896|FG001|Overall Study|Withdrawal of informed consent|1|||
160678960|NCT03828539|580203895|FG000|Overall Study|New therapy for study indication|1|||
160678961|NCT03828539|580203896|FG001|Overall Study|New therapy for study indication|0|||
160678962|NCT01341405|580203897|FG000|Overall Study|Adverse Event|0|||
160678963|NCT01341405|580203898|FG001|Overall Study|Adverse Event|1|||
160678964|NCT01341405|580203899|FG002|Overall Study|Adverse Event|1|||
160678965|NCT01341405|580203897|FG000|Overall Study|Withdrawal by Subject|3|||
160678966|NCT01341405|580203898|FG001|Overall Study|Withdrawal by Subject|2|||
160678967|NCT01341405|580203899|FG002|Overall Study|Withdrawal by Subject|1|||
160678968|NCT02224053|580203901|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
160678969|NCT02224053|580203901|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
160678970|NCT02224053|580203901|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
160678971|NCT02224053|580203901|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
160678972|NCT02224053|580203901|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
160678973|NCT01898598|580203902|FG000|Overall Study|Adverse Event|1|||
160678974|NCT01898598|580203903|FG001|Overall Study|Adverse Event|0|||
160678975|NCT01898598|580203902|FG000|Overall Study|Withdrawal by Subject|3|||
160678976|NCT01898598|580203903|FG001|Overall Study|Withdrawal by Subject|0|||
160678977|NCT01898598|580203902|FG000|Overall Study|Lost to Follow-up|0|||
160678978|NCT01898598|580203903|FG001|Overall Study|Lost to Follow-up|1|||
160678979|NCT01898598|580203902|FG000|Overall Study|Other|0|||
160678980|NCT01898598|580203903|FG001|Overall Study|Other|1|||
160678981|NCT03833427|580203904|FG000|Overall Study|Death|4|||
160678982|NCT03833427|580203905|FG001|Overall Study|Death|2|||
160678983|NCT03833427|580203906|FG002|Overall Study|Death|9|||
160678984|NCT03833427|580203907|FG003|Overall Study|Death|11|||
160678985|NCT03833427|580203908|FG004|Overall Study|Death|0|||
160678986|NCT03833427|580203909|FG005|Overall Study|Death|0|||
160678987|NCT03833427|580203910|FG006|Overall Study|Death|0|||
160678988|NCT03833427|580203904|FG000|Overall Study|Withdrawal by Subject|0|||
160678989|NCT03833427|580203905|FG001|Overall Study|Withdrawal by Subject|1|||
160678990|NCT03833427|580203906|FG002|Overall Study|Withdrawal by Subject|1|||
160678991|NCT03833427|580203907|FG003|Overall Study|Withdrawal by Subject|0|||
160678992|NCT03833427|580203908|FG004|Overall Study|Withdrawal by Subject|0|||
160678993|NCT03833427|580203909|FG005|Overall Study|Withdrawal by Subject|0|||
160678994|NCT03833427|580203910|FG006|Overall Study|Withdrawal by Subject|0|||
160678995|NCT03833427|580203904|FG000|Overall Study|Sponsor Decision|0|||
160678996|NCT03833427|580203905|FG001|Overall Study|Sponsor Decision|0|||
160678997|NCT03833427|580203906|FG002|Overall Study|Sponsor Decision|1|||
160678998|NCT03833427|580203907|FG003|Overall Study|Sponsor Decision|3|||
160678999|NCT03833427|580203908|FG004|Overall Study|Sponsor Decision|0|||
160679000|NCT03833427|580203909|FG005|Overall Study|Sponsor Decision|0|||
160679001|NCT03833427|580203910|FG006|Overall Study|Sponsor Decision|0|||
160679002|NCT01709903|580203912|FG000|Overall Study|administrative problems|2|||
160679003|NCT01709903|580203913|FG001|Overall Study|administrative problems|6|||
160679004|NCT01709903|580203912|FG000|Overall Study|Abnormal test procedure results|1|||
160679005|NCT01709903|580203913|FG001|Overall Study|Abnormal test procedure results|0|||
160679006|NCT01709903|580203912|FG000|Overall Study|In ability to use device|1|||
160679007|NCT01709903|580203913|FG001|Overall Study|In ability to use device|1|||
160679008|NCT01709903|580203912|FG000|Overall Study|no longer needed study drug|0|||
160679009|NCT01709903|580203913|FG001|Overall Study|no longer needed study drug|1|||
160679010|NCT01709903|580203912|FG000|Overall Study|Lost to Follow-up|0|||
160679011|NCT01709903|580203913|FG001|Overall Study|Lost to Follow-up|2|||
160679012|NCT01709903|580203912|FG000|Overall Study|Death|2|||
160679013|NCT01709903|580203913|FG001|Overall Study|Death|0|||
160679014|NCT01709903|580203912|FG000|Overall Study|Protocol Violation|3|||
160679015|NCT01709903|580203913|FG001|Overall Study|Protocol Violation|2|||
160679016|NCT01709903|580203912|FG000|Overall Study|Lack of Efficacy|3|||
160679017|NCT01709903|580203913|FG001|Overall Study|Lack of Efficacy|3|||
160679018|NCT01709903|580203912|FG000|Overall Study|Withdrawal by Subject|6|||
160679019|NCT01709903|580203913|FG001|Overall Study|Withdrawal by Subject|6|||
160679020|NCT01709903|580203912|FG000|Overall Study|Adverse Event|11|||
160679021|NCT01709903|580203913|FG001|Overall Study|Adverse Event|18|||
160679022|NCT00653159|580205498|FG000|Overall Study|Adverse Event|4|||
160679023|NCT00653159|580205499|FG001|Overall Study|Adverse Event|1|||
160679024|NCT00653159|580205498|FG000|Overall Study|Lost to Follow-up|1|||
160679025|NCT00653159|580205499|FG001|Overall Study|Lost to Follow-up|2|||
160679026|NCT01872715|580205500|FG000|Overall Study|Adverse Event|1|||
160679027|NCT01872715|580205500|FG000|Overall Study|Protocol Violation|1|||
160679028|NCT01872715|580205500|FG000|Overall Study|Withdrawal by Subject|2|||
160679029|NCT00381849|580205501|FG000|Wash Out|Withdrawal by Subject|0|||
160679030|NCT00381849|580205502|FG001|Wash Out|Withdrawal by Subject|1|||
160679031|NCT01765270|580205506|FG000|Overall Study|Physician Decision|1|||
160679032|NCT01765270|580205507|FG001|Overall Study|Physician Decision|0|||
160679033|NCT01765270|580205506|FG000|Overall Study|Withdrawal by Subject|0|||
160679034|NCT01765270|580205507|FG001|Overall Study|Withdrawal by Subject|1|||
160679035|NCT00517192|580205508|FG000|Overall Study|Adverse Event|1|||
160679036|NCT00517192|580205509|FG001|Overall Study|Adverse Event|1|||
160679037|NCT00517192|580205508|FG000|Overall Study|Lost to Follow-up|1|||
160679038|NCT00517192|580205509|FG001|Overall Study|Lost to Follow-up|1|||
160679039|NCT00517192|580205508|FG000|Overall Study|Withdrawal by Subject|1|||
160679040|NCT00517192|580205509|FG001|Overall Study|Withdrawal by Subject|0|||
160679041|NCT00517192|580205508|FG000|Overall Study|Early termination of the trial|16|||
160679042|NCT00517192|580205509|FG001|Overall Study|Early termination of the trial|18|||
160679043|NCT04501094|580205511|FG000|Overall Study|Death (unrelated to research)|1|||
160679044|NCT04501094|580205512|FG001|Overall Study|Death (unrelated to research)|0|||
160679045|NCT05693805|580205515|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
160679046|NCT05693805|580205516|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
160679047|NCT02943993|580205519|FG000|Overall Study|Withdrawal by Subject|52|||
160679048|NCT02943993|580205519|FG000|Overall Study|Transfer to another institution|6|||
160679049|NCT02943993|580205519|FG000|Overall Study|Lost to Follow-up|135|||
160679050|NCT02943993|580205519|FG000|Overall Study|Death|98|||
160679051|NCT02943993|580205519|FG000|Overall Study|Other reason for premature termination|32|||
160679052|NCT02943993|580205519|FG000|Overall Study|Missing reason for termination|7|||
160679053|NCT02152982|580205521|FG000|Overall Study|Withdrawal by Subject|17|||
160679054|NCT02152982|580205522|FG001|Overall Study|Withdrawal by Subject|16|||
160679055|NCT02152982|580205521|FG000|Overall Study|Did not start treatment|11|||
160679056|NCT02152982|580205522|FG001|Overall Study|Did not start treatment|5|||
160679057|NCT02152982|580205521|FG000|Overall Study|Disease progression|41|||
160679058|NCT02152982|580205522|FG001|Overall Study|Disease progression|52|||
160679059|NCT02152982|580205521|FG000|Overall Study|Adverse Event|7|||
160679060|NCT02152982|580205522|FG001|Overall Study|Adverse Event|12|||
160679061|NCT02152982|580205521|FG000|Overall Study|Complicating disease|1|||
160679062|NCT02152982|580205522|FG001|Overall Study|Complicating disease|1|||
160679063|NCT02152982|580205521|FG000|Overall Study|Death|0|||
160679064|NCT02152982|580205522|FG001|Overall Study|Death|3|||
160679065|NCT02152982|580205521|FG000|Overall Study|Physician Decision|3|||
160679066|NCT02152982|580205522|FG001|Overall Study|Physician Decision|0|||
160679067|NCT02510261|580205523|FG000|Overall Study|Adverse Event|5|||
160679068|NCT02510261|580205524|FG001|Overall Study|Adverse Event|8|||
160679069|NCT02510261|580205525|FG002|Overall Study|Adverse Event|0|||
160679070|NCT02510261|580205523|FG000|Overall Study|Physician Decision|1|||
160679071|NCT02510261|580205524|FG001|Overall Study|Physician Decision|5|||
160679072|NCT02510261|580205525|FG002|Overall Study|Physician Decision|0|||
160679073|NCT02510261|580205523|FG000|Overall Study|Death|19|||
160679074|NCT02510261|580205524|FG001|Overall Study|Death|19|||
160679075|NCT02510261|580205525|FG002|Overall Study|Death|0|||
160679076|NCT02510261|580205523|FG000|Overall Study|Withdrawal by Subject|3|||
160679077|NCT02510261|580205524|FG001|Overall Study|Withdrawal by Subject|10|||
160679078|NCT02510261|580205525|FG002|Overall Study|Withdrawal by Subject|3|||
160679079|NCT02003222|580205527|FG000|Induction|Never started treatment|0|||
160679080|NCT02003222|580205528|FG001|Induction|Never started treatment|0|||
160679081|NCT02003222|580205529|FG002|Induction|Never started treatment|0|||
160679082|NCT02003222|580205530|FG003|Induction|Never started treatment|0|||
160679083|NCT02003222|580205531|FG004|Induction|Never started treatment|8|||
160679084|NCT02003222|580205527|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
160679085|NCT02003222|580205528|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
160679086|NCT02003222|580205529|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
160679087|NCT02003222|580205530|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
160679088|NCT02003222|580205531|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
160679089|NCT02003222|580205527|FG000|Induction|Adverse Event|0|||
160679090|NCT02003222|580205528|FG001|Induction|Adverse Event|0|||
160679091|NCT02003222|580205529|FG002|Induction|Adverse Event|0|||
160679092|NCT02003222|580205530|FG003|Induction|Adverse Event|0|||
160679093|NCT02003222|580205531|FG004|Induction|Adverse Event|13|||
160679094|NCT02003222|580205527|FG000|Induction|Alternative therapy|0|||
160679095|NCT02003222|580205528|FG001|Induction|Alternative therapy|0|||
160679096|NCT02003222|580205529|FG002|Induction|Alternative therapy|0|||
160679097|NCT02003222|580205530|FG003|Induction|Alternative therapy|0|||
160679098|NCT02003222|580205531|FG004|Induction|Alternative therapy|12|||
160679099|NCT02003222|580205527|FG000|Induction|Disease progression|0|||
160679100|NCT02003222|580205528|FG001|Induction|Disease progression|0|||
160679101|NCT02003222|580205529|FG002|Induction|Disease progression|0|||
160679102|NCT02003222|580205530|FG003|Induction|Disease progression|0|||
160679103|NCT02003222|580205531|FG004|Induction|Disease progression|22|||
160679104|NCT02003222|580205527|FG000|Induction|Death|0|||
160679105|NCT02003222|580205528|FG001|Induction|Death|0|||
160679106|NCT02003222|580205529|FG002|Induction|Death|0|||
160679107|NCT02003222|580205530|FG003|Induction|Death|0|||
160679108|NCT02003222|580205531|FG004|Induction|Death|3|||
160679109|NCT02003222|580205527|FG000|Induction|Withdrawal by Subject|0|||
160679110|NCT02003222|580205528|FG001|Induction|Withdrawal by Subject|0|||
160679111|NCT02003222|580205529|FG002|Induction|Withdrawal by Subject|0|||
160679112|NCT02003222|580205530|FG003|Induction|Withdrawal by Subject|0|||
160679113|NCT02003222|580205531|FG004|Induction|Withdrawal by Subject|8|||
160679114|NCT02003222|580205527|FG000|Induction|Other reasons|0|||
160679115|NCT02003222|580205528|FG001|Induction|Other reasons|0|||
160679116|NCT02003222|580205529|FG002|Induction|Other reasons|0|||
160679117|NCT02003222|580205530|FG003|Induction|Other reasons|0|||
160679118|NCT02003222|580205531|FG004|Induction|Other reasons|22|||
160679119|NCT02003222|580205527|FG000|Intensification|Never started treatment|0|||
160679120|NCT02003222|580205528|FG001|Intensification|Never started treatment|0|||
160679121|NCT02003222|580205529|FG002|Intensification|Never started treatment|0|||
160679122|NCT02003222|580205530|FG003|Intensification|Never started treatment|0|||
160679123|NCT02003222|580205531|FG004|Intensification|Never started treatment|2|||
160679124|NCT02003222|580205527|FG000|Intensification|Adverse Event|0|||
160679125|NCT02003222|580205528|FG001|Intensification|Adverse Event|0|||
160679126|NCT02003222|580205529|FG002|Intensification|Adverse Event|0|||
160679127|NCT02003222|580205530|FG003|Intensification|Adverse Event|0|||
160679128|NCT02003222|580205531|FG004|Intensification|Adverse Event|6|||
160679129|NCT02003222|580205527|FG000|Intensification|Alternative therapy|0|||
160679130|NCT02003222|580205528|FG001|Intensification|Alternative therapy|0|||
160679131|NCT02003222|580205529|FG002|Intensification|Alternative therapy|0|||
160679132|NCT02003222|580205530|FG003|Intensification|Alternative therapy|0|||
160679133|NCT02003222|580205531|FG004|Intensification|Alternative therapy|8|||
160679134|NCT02003222|580205527|FG000|Intensification|Disease progression|0|||
160679135|NCT02003222|580205528|FG001|Intensification|Disease progression|0|||
160679136|NCT02003222|580205529|FG002|Intensification|Disease progression|0|||
160679137|NCT02003222|580205530|FG003|Intensification|Disease progression|0|||
160679138|NCT02003222|580205531|FG004|Intensification|Disease progression|18|||
160679139|NCT02003222|580205527|FG000|Intensification|Withdrawal by Subject|0|||
160679140|NCT02003222|580205528|FG001|Intensification|Withdrawal by Subject|0|||
160679141|NCT02003222|580205529|FG002|Intensification|Withdrawal by Subject|0|||
160679142|NCT02003222|580205530|FG003|Intensification|Withdrawal by Subject|0|||
160679143|NCT02003222|580205531|FG004|Intensification|Withdrawal by Subject|5|||
160679144|NCT02003222|580205527|FG000|Intensification|Other reasons|0|||
160679145|NCT02003222|580205528|FG001|Intensification|Other reasons|0|||
160679146|NCT02003222|580205529|FG002|Intensification|Other reasons|0|||
160679147|NCT02003222|580205530|FG003|Intensification|Other reasons|0|||
160679148|NCT02003222|580205531|FG004|Intensification|Other reasons|8|||
160679149|NCT04941768|580205536|FG000|Overall Study|Lost to Follow-up|10|||
160679150|NCT04941768|580205536|FG000|Overall Study|Death|24|||
160679151|NCT04941768|580205536|FG000|Overall Study|Progressive Disease|4|||
160679152|NCT04941768|580205536|FG000|Overall Study|Withdrawal by Subject|4|||
160679153|NCT04941768|580205536|FG000|Overall Study|Other|3|||
160679154|NCT04941768|580205536|FG000|Overall Study|Treatment ongoing|21|||
160679155|NCT04941768|580205536|FG000|Overall Study|Off treatment and in follow-up|21|||
160679156|NCT03302078|580205538|FG000|Washout Period|Adverse Event|0|||
160679157|NCT03302078|580205539|FG001|Washout Period|Adverse Event|1|||
160679158|NCT01886872|580205540|FG000|Overall Study|Ineligible|7|||
160679159|NCT01886872|580205541|FG001|Overall Study|Ineligible|4|||
160679160|NCT01886872|580205542|FG002|Overall Study|Ineligible|12|||
160679161|NCT05148299|580205543|FG000|Treatment Period|Adverse Event|1|||
160679162|NCT05148299|580205543|FG000|Treatment Period|Physician Decision|1|||
160679163|NCT05148299|580205543|FG000|Treatment Period|Death|1|||
160679164|NCT05148299|580205543|FG000|Follow-up Period|Death|3|||
160679165|NCT01957150|580205544|FG000|Overall Study|Adverse Event|23|||
160679166|NCT01957150|580205545|FG001|Overall Study|Adverse Event|20|||
160679167|NCT01957150|580205544|FG000|Overall Study|Withdrawal by Subject|13|||
160679168|NCT01957150|580205545|FG001|Overall Study|Withdrawal by Subject|17|||
160679169|NCT01957150|580205544|FG000|Overall Study|Physician Decision|3|||
160679170|NCT01957150|580205545|FG001|Overall Study|Physician Decision|6|||
160679171|NCT01957150|580205544|FG000|Overall Study|Lost to Follow-up|4|||
160679172|NCT01957150|580205545|FG001|Overall Study|Lost to Follow-up|4|||
160679173|NCT01957150|580205544|FG000|Overall Study|Protocol Violation|1|||
160679174|NCT01957150|580205545|FG001|Overall Study|Protocol Violation|0|||
160679175|NCT01957150|580205544|FG000|Overall Study|Lack of Efficacy|11|||
160679176|NCT01957150|580205545|FG001|Overall Study|Lack of Efficacy|11|||
160679177|NCT01856192|580205546|FG000|Overall Study|Adverse Event|12|||
160679178|NCT01856192|580205547|FG001|Overall Study|Adverse Event|4|||
160679179|NCT01856192|580205546|FG000|Overall Study|Alternative therapy|0|||
160679180|NCT01856192|580205547|FG001|Overall Study|Alternative therapy|3|||
160679181|NCT01856192|580205546|FG000|Overall Study|Death|3|||
160679182|NCT01856192|580205547|FG001|Overall Study|Death|5|||
160679183|NCT01856192|580205546|FG000|Overall Study|Lack of Efficacy|0|||
160679184|NCT01856192|580205547|FG001|Overall Study|Lack of Efficacy|5|||
160679185|NCT01856192|580205546|FG000|Overall Study|Withdrawal by Subject|1|||
160679186|NCT01856192|580205547|FG001|Overall Study|Withdrawal by Subject|1|||
160679187|NCT01856192|580205546|FG000|Overall Study|Other diseases|1|||
160679188|NCT01856192|580205547|FG001|Overall Study|Other diseases|0|||
160679189|NCT01856192|580205546|FG000|Overall Study|Never started treatment|7|||
160679190|NCT01856192|580205547|FG001|Overall Study|Never started treatment|5|||
160679191|NCT01856192|580205546|FG000|Overall Study|Path ineligible|20|||
160679192|NCT01856192|580205547|FG001|Overall Study|Path ineligible|34|||
160679193|NCT01856192|580205546|FG000|Overall Study|Non-path ineligible|2|||
160679194|NCT01856192|580205547|FG001|Overall Study|Non-path ineligible|2|||
160679195|NCT01856192|580205546|FG000|Overall Study|Physician Decision|1|||
160679196|NCT01856192|580205547|FG001|Overall Study|Physician Decision|1|||
160679197|NCT01856192|580205546|FG000|Overall Study|Suspicion of progressive disease|1|||
160679198|NCT01856192|580205547|FG001|Overall Study|Suspicion of progressive disease|0|||
160679199|NCT01856192|580205546|FG000|Overall Study|Non-compliance|1|||
160679200|NCT01856192|580205547|FG001|Overall Study|Non-compliance|0|||
160679201|NCT00098475|580205548|FG000|Step 1|Progressive disease|33|||
160679202|NCT00098475|580205549|FG001|Step 1|Progressive disease|35|||
160679203|NCT00098475|580205550|FG002|Step 1|Progressive disease|2|||
160679204|NCT00098475|580205551|FG003|Step 1|Progressive disease|1|||
160679205|NCT00098475|580205548|FG000|Step 1|Adverse Event|56|||
160679206|NCT00098475|580205549|FG001|Step 1|Adverse Event|37|||
160679207|NCT00098475|580205550|FG002|Step 1|Adverse Event|0|||
160679208|NCT00098475|580205551|FG003|Step 1|Adverse Event|1|||
160679209|NCT00098475|580205548|FG000|Step 1|Death|8|||
160679210|NCT00098475|580205549|FG001|Step 1|Death|5|||
160679211|NCT00098475|580205550|FG002|Step 1|Death|0|||
160679212|NCT00098475|580205551|FG003|Step 1|Death|1|||
160679213|NCT00098475|580205548|FG000|Step 1|Withdrawal by Subject|14|||
160679214|NCT00098475|580205549|FG001|Step 1|Withdrawal by Subject|11|||
160679215|NCT00098475|580205550|FG002|Step 1|Withdrawal by Subject|0|||
160679216|NCT00098475|580205551|FG003|Step 1|Withdrawal by Subject|0|||
160679217|NCT00098475|580205548|FG000|Step 1|Physician Decision|5|||
160679218|NCT00098475|580205549|FG001|Step 1|Physician Decision|2|||
160679219|NCT00098475|580205550|FG002|Step 1|Physician Decision|0|||
160679220|NCT00098475|580205551|FG003|Step 1|Physician Decision|0|||
160679221|NCT00098475|580205548|FG000|Step 1|Alternative therapy|31|||
160679222|NCT00098475|580205549|FG001|Step 1|Alternative therapy|43|||
160679223|NCT00098475|580205550|FG002|Step 1|Alternative therapy|1|||
160679224|NCT00098475|580205551|FG003|Step 1|Alternative therapy|0|||
160679225|NCT00098475|580205548|FG000|Step 1|Other disease|2|||
160679226|NCT00098475|580205549|FG001|Step 1|Other disease|1|||
160679227|NCT00098475|580205550|FG002|Step 1|Other disease|1|||
160679228|NCT00098475|580205551|FG003|Step 1|Other disease|0|||
160679229|NCT00098475|580205548|FG000|Step 1|Never started treatment|0|||
160679230|NCT00098475|580205549|FG001|Step 1|Never started treatment|2|||
160679231|NCT00098475|580205550|FG002|Step 1|Never started treatment|0|||
160679232|NCT00098475|580205551|FG003|Step 1|Never started treatment|0|||
160679233|NCT00098475|580205548|FG000|Step 1|Still on treatment as of this analysis|14|||
160679234|NCT00098475|580205549|FG001|Step 1|Still on treatment as of this analysis|27|||
160679235|NCT00098475|580205550|FG002|Step 1|Still on treatment as of this analysis|0|||
160679236|NCT00098475|580205551|FG003|Step 1|Still on treatment as of this analysis|0|||
160679237|NCT00098475|580205548|FG000|Step 1|Knee surgery|1|||
160679238|NCT00098475|580205549|FG001|Step 1|Knee surgery|0|||
160679239|NCT00098475|580205550|FG002|Step 1|Knee surgery|0|||
160679240|NCT00098475|580205551|FG003|Step 1|Knee surgery|0|||
160679241|NCT00098475|580205548|FG000|Step 1|Complications|1|||
160679242|NCT00098475|580205549|FG001|Step 1|Complications|0|||
160679243|NCT00098475|580205550|FG002|Step 1|Complications|0|||
160679244|NCT00098475|580205551|FG003|Step 1|Complications|0|||
160679245|NCT00098475|580205548|FG000|Step 1|Cannot comply due to other tx|0|||
160679246|NCT00098475|580205549|FG001|Step 1|Cannot comply due to other tx|1|||
160679247|NCT00098475|580205550|FG002|Step 1|Cannot comply due to other tx|0|||
160679248|NCT00098475|580205551|FG003|Step 1|Cannot comply due to other tx|0|||
160679249|NCT00098475|580205548|FG000|Step 1|Both patient and physician's decision|2|||
160679250|NCT00098475|580205549|FG001|Step 1|Both patient and physician's decision|1|||
160679251|NCT00098475|580205550|FG002|Step 1|Both patient and physician's decision|0|||
160679252|NCT00098475|580205551|FG003|Step 1|Both patient and physician's decision|0|||
160679253|NCT00098475|580205548|FG000|Step 1|Incorrect disease assessment|2|||
160679254|NCT00098475|580205549|FG001|Step 1|Incorrect disease assessment|0|||
160679255|NCT00098475|580205550|FG002|Step 1|Incorrect disease assessment|0|||
160679256|NCT00098475|580205551|FG003|Step 1|Incorrect disease assessment|0|||
160679257|NCT00098475|580205548|FG000|Step 1|Off treatment for > specified timeframe|1|||
160679258|NCT00098475|580205549|FG001|Step 1|Off treatment for > specified timeframe|1|||
160679259|NCT00098475|580205550|FG002|Step 1|Off treatment for > specified timeframe|0|||
160679260|NCT00098475|580205551|FG003|Step 1|Off treatment for > specified timeframe|0|||
160679261|NCT00098475|580205548|FG000|Step 1|Declining performance status|0|||
160679262|NCT00098475|580205549|FG001|Step 1|Declining performance status|1|||
160679263|NCT00098475|580205550|FG002|Step 1|Declining performance status|0|||
160679264|NCT00098475|580205551|FG003|Step 1|Declining performance status|0|||
160679265|NCT00098475|580205548|FG000|Step 1|Insurance issue|0|||
160679266|NCT00098475|580205549|FG001|Step 1|Insurance issue|1|||
160679267|NCT00098475|580205550|FG002|Step 1|Insurance issue|0|||
160679268|NCT00098475|580205551|FG003|Step 1|Insurance issue|0|||
160679269|NCT00098475|580205548|FG000|Step 1|Rising paraprotein|0|||
160679270|NCT00098475|580205549|FG001|Step 1|Rising paraprotein|1|||
160679271|NCT00098475|580205550|FG002|Step 1|Rising paraprotein|0|||
160679272|NCT00098475|580205551|FG003|Step 1|Rising paraprotein|0|||
160679273|NCT00098475|580205548|FG000|Step 1|Referred to other physicians|0|||
160679274|NCT00098475|580205549|FG001|Step 1|Referred to other physicians|1|||
160679275|NCT00098475|580205550|FG002|Step 1|Referred to other physicians|0|||
160679276|NCT00098475|580205551|FG003|Step 1|Referred to other physicians|0|||
160679277|NCT00098475|580205548|FG000|Step 1|Criteria to continue treatment not met|0|||
160679278|NCT00098475|580205549|FG001|Step 1|Criteria to continue treatment not met|1|||
160679279|NCT00098475|580205550|FG002|Step 1|Criteria to continue treatment not met|0|||
160679280|NCT00098475|580205551|FG003|Step 1|Criteria to continue treatment not met|0|||
160679281|NCT00098475|580205548|FG000|Step 1|Misinterpretation of lab data|0|||
160679282|NCT00098475|580205549|FG001|Step 1|Misinterpretation of lab data|1|||
160679283|NCT00098475|580205550|FG002|Step 1|Misinterpretation of lab data|0|||
160679284|NCT00098475|580205551|FG003|Step 1|Misinterpretation of lab data|0|||
160679285|NCT00098475|580205548|FG000|Step 1|Patient fell with fracture|1|||
160679286|NCT00098475|580205549|FG001|Step 1|Patient fell with fracture|0|||
160679287|NCT00098475|580205550|FG002|Step 1|Patient fell with fracture|0|||
160679288|NCT00098475|580205551|FG003|Step 1|Patient fell with fracture|0|||
160679289|NCT00098475|580205548|FG000|Step 1|Not documented|0|||
160679290|NCT00098475|580205549|FG001|Step 1|Not documented|1|||
160679291|NCT00098475|580205550|FG002|Step 1|Not documented|0|||
160679292|NCT00098475|580205551|FG003|Step 1|Not documented|0|||
160679293|NCT00098475|580205548|FG000|Step 2|Disease progression|1|||
160679294|NCT00098475|580205549|FG001|Step 2|Disease progression|4|||
160679295|NCT00098475|580205550|FG002|Step 2|Disease progression|0|||
160679296|NCT00098475|580205551|FG003|Step 2|Disease progression|0|||
160679297|NCT00098475|580205548|FG000|Step 2|Adverse Event|2|||
160679298|NCT00098475|580205549|FG001|Step 2|Adverse Event|0|||
160679299|NCT00098475|580205550|FG002|Step 2|Adverse Event|0|||
160679300|NCT00098475|580205551|FG003|Step 2|Adverse Event|0|||
160679301|NCT00098475|580205548|FG000|Step 2|Withdrawal by Subject|0|||
160679302|NCT00098475|580205549|FG001|Step 2|Withdrawal by Subject|2|||
160679303|NCT00098475|580205550|FG002|Step 2|Withdrawal by Subject|0|||
160679304|NCT00098475|580205551|FG003|Step 2|Withdrawal by Subject|0|||
160679305|NCT00098475|580205548|FG000|Step 2|Physician Decision|0|||
160679306|NCT00098475|580205549|FG001|Step 2|Physician Decision|1|||
160679307|NCT00098475|580205550|FG002|Step 2|Physician Decision|0|||
160679308|NCT00098475|580205551|FG003|Step 2|Physician Decision|0|||
160679309|NCT00098475|580205548|FG000|Step 2|Alternative therapy|1|||
160679310|NCT00098475|580205549|FG001|Step 2|Alternative therapy|2|||
160679311|NCT00098475|580205550|FG002|Step 2|Alternative therapy|0|||
160679312|NCT00098475|580205551|FG003|Step 2|Alternative therapy|0|||
160679313|NCT00098475|580205548|FG000|Step 2|Never started treatment|1|||
160679314|NCT00098475|580205549|FG001|Step 2|Never started treatment|1|||
160679315|NCT00098475|580205550|FG002|Step 2|Never started treatment|0|||
160679316|NCT00098475|580205551|FG003|Step 2|Never started treatment|0|||
160679317|NCT02340962|580205556|FG000|Overall Study|Lost to Follow-up|1|||
160679318|NCT02340962|580205557|FG001|Overall Study|Lost to Follow-up|0|||
160679319|NCT04994431|580205558|FG000|Overall Study|Adverse Event|1|||
160679320|NCT04994431|580205559|FG001|Overall Study|Adverse Event|0|||
160679321|NCT01067521|580205560|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
160679322|NCT01067521|580205561|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
160679323|NCT01067521|580205560|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
160679324|NCT01067521|580205561|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
160679325|NCT01067521|580205560|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
160679326|NCT01067521|580205561|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
160679327|NCT01067521|580205560|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
160679328|NCT01067521|580205561|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
160679329|NCT01067521|580205560|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
160679330|NCT01067521|580205561|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
160679331|NCT01067521|580205560|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
160679332|NCT01067521|580205561|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
160679333|NCT01067521|580205560|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
160679334|NCT01067521|580205561|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
160679335|NCT01067521|580205560|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
160679336|NCT01067521|580205561|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
160679337|NCT01067521|580205560|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
160679338|NCT01067521|580205561|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
160679339|NCT01067521|580205560|FG000|Open-Label Period|Death|3|||
160679340|NCT01067521|580205561|FG001|Open-Label Period|Death|1|||
160679341|NCT01067521|580205560|FG000|Open-Label Period|Adverse Event|30|||
160679342|NCT01067521|580205561|FG001|Open-Label Period|Adverse Event|28|||
160679343|NCT01067521|580205560|FG000|Open-Label Period|Withdrawal by Subject|160|||
160679344|NCT01067521|580205561|FG001|Open-Label Period|Withdrawal by Subject|88|||
160679345|NCT01067521|580205560|FG000|Open-Label Period|Physician Decision|13|||
160679346|NCT01067521|580205561|FG001|Open-Label Period|Physician Decision|11|||
160679347|NCT01067521|580205560|FG000|Open-Label Period|Non-compliance with study drug|5|||
160679348|NCT01067521|580205561|FG001|Open-Label Period|Non-compliance with study drug|0|||
160679349|NCT01067521|580205560|FG000|Open-Label Period|Protocol Violation|3|||
160679350|NCT01067521|580205561|FG001|Open-Label Period|Protocol Violation|0|||
160679351|NCT01067521|580205560|FG000|Open-Label Period|Pregnancy|14|||
160679352|NCT01067521|580205561|FG001|Open-Label Period|Pregnancy|8|||
160679353|NCT01067521|580205560|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
160679354|NCT01067521|580205561|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
160679355|NCT01067521|580205560|FG000|Open-Label Period|Lost to Follow-up|21|||
160679356|NCT01067521|580205561|FG001|Open-Label Period|Lost to Follow-up|20|||
160679357|NCT00057941|580205567|FG000|Overall Study|Death|1|||
160679358|NCT00057941|580205568|FG001|Overall Study|Death|2|||
160679359|NCT00057941|580205567|FG000|Overall Study|Adverse Event|7|||
160679360|NCT00057941|580205568|FG001|Overall Study|Adverse Event|9|||
160679361|NCT00057941|580205567|FG000|Overall Study|Lack of Efficacy|54|||
160679362|NCT00057941|580205568|FG001|Overall Study|Lack of Efficacy|53|||
160679363|NCT00057941|580205567|FG000|Overall Study|Withdrawal by Subject|6|||
160679364|NCT00057941|580205568|FG001|Overall Study|Withdrawal by Subject|1|||
160679365|NCT00057941|580205567|FG000|Overall Study|still on treatment|3|||
160679366|NCT00057941|580205568|FG001|Overall Study|still on treatment|1|||
160679367|NCT00057941|580205567|FG000|Overall Study|insurance, symptomatic deterioration|1|||
160679368|NCT00057941|580205568|FG001|Overall Study|insurance, symptomatic deterioration|3|||
160679369|NCT00057941|580205567|FG000|Overall Study|Ineligible|2|||
160679370|NCT00057941|580205568|FG001|Overall Study|Ineligible|5|||
160679371|NCT02151149|580205569|FG000|Treatment Period|Death|2|||
160679372|NCT02151149|580205570|FG001|Treatment Period|Death|3|||
160679373|NCT02151149|580205569|FG000|Treatment Period|Adverse Event|17|||
160679374|NCT02151149|580205570|FG001|Treatment Period|Adverse Event|14|||
160679375|NCT02151149|580205569|FG000|Treatment Period|Progressive Disease|25|||
160679376|NCT02151149|580205570|FG001|Treatment Period|Progressive Disease|24|||
160679377|NCT02151149|580205569|FG000|Treatment Period|Symptomatic Deterioration|2|||
160679378|NCT02151149|580205570|FG001|Treatment Period|Symptomatic Deterioration|10|||
160679379|NCT02151149|580205569|FG000|Treatment Period|Withdrawal by Subject|13|||
160679380|NCT02151149|580205570|FG001|Treatment Period|Withdrawal by Subject|11|||
160679381|NCT02151149|580205569|FG000|Treatment Period|Miscellaneous|8|||
160679382|NCT02151149|580205570|FG001|Treatment Period|Miscellaneous|7|||
160679383|NCT02151149|580205569|FG000|Treatment Period|Participants randomized but not treated|3|||
160679384|NCT02151149|580205570|FG001|Treatment Period|Participants randomized but not treated|2|||
160679385|NCT02151149|580205569|FG000|Follow-Up Period|Lost to Follow-up|2|||
160679386|NCT02151149|580205570|FG001|Follow-Up Period|Lost to Follow-up|3|||
160679387|NCT02151149|580205569|FG000|Follow-Up Period|Death|37|||
160679388|NCT02151149|580205570|FG001|Follow-Up Period|Death|34|||
160679389|NCT03419962|580205571|FG000|Overall Study|Change to other medication|1|||
160679390|NCT03419962|580205571|FG000|Overall Study|Refusal of continuing with trial drug|1|||
160679391|NCT03419962|580205571|FG000|Overall Study|Lost to Follow-up|3|||
160679392|NCT03419962|580205571|FG000|Overall Study|Difficulty in inhaling the doses|1|||
160679393|NCT03419962|580205571|FG000|Overall Study|Missing completion data|31|||
160679394|NCT03439085|580205574|FG000|Overall Study|Death|2|||
160679395|NCT03439085|580205574|FG000|Overall Study|Screen Failure|20|||
160679396|NCT01499160|580205578|FG000|Overall Study|Adverse Event|1|||
160679397|NCT01499160|580205578|FG000|Overall Study|Withdrawal by Subject|1|||
160679398|NCT01438476|580205582|FG000|Overall Study|Protocol Violation|1|||
160679399|NCT01438476|580205583|FG001|Overall Study|Protocol Violation|0|||
160679400|NCT01438476|580205582|FG000|Overall Study|Withdrawal by Subject|1|||
160679401|NCT01438476|580205583|FG001|Overall Study|Withdrawal by Subject|0|||
160679402|NCT01438476|580205582|FG000|Overall Study|No Surgery- Disease|8|||
160679403|NCT01438476|580205583|FG001|Overall Study|No Surgery- Disease|10|||
160679404|NCT01438476|580205582|FG000|Overall Study|Communication barrier|0|||
160679405|NCT01438476|580205583|FG001|Overall Study|Communication barrier|1|||
160679406|NCT03294317|580205589|FG000|Overall Study|Physician Decision|1|||
160679407|NCT03294317|580205589|FG000|Overall Study|Withdrawal by Subject|6|||
160679408|NCT03294317|580205589|FG000|Overall Study|Lost to Follow-up|1|||
160679409|NCT03294317|580205589|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
160679410|NCT03294317|580205589|FG000|Overall Study|Failed HB lead implant|8|||
160679411|NCT03294317|580205589|FG000|Overall Study|Received CRT instead|1|||
160679412|NCT03294317|580205589|FG000|Overall Study|Exited after lead revision|2|||
160679413|NCT03847974|580205590|FG000|Overall Study|relocated out of region|3|||
160679414|NCT03847974|580205590|FG000|Overall Study|Withdrawal by Subject|2|||
160679415|NCT03847974|580205590|FG000|Overall Study|Adverse Event|1|||
160679416|NCT02911935|580205591|FG000|Overall Study|Lost to Follow-up|5|||
160679417|NCT02911935|580205592|FG001|Overall Study|Lost to Follow-up|7|||
160679418|NCT01294449|580205593|FG000|Overall Study|Death|11|||
160679419|NCT01294449|580205594|FG001|Overall Study|Death|12|||
160679420|NCT01294449|580205593|FG000|Overall Study|Withdrawal by Subject|1|||
160679421|NCT01294449|580205594|FG001|Overall Study|Withdrawal by Subject|3|||
160679422|NCT01685216|580205595|FG000|Overall Study|Did not receive study drug|1|||
160679423|NCT00603512|580205596|FG000|Overall Study|Adverse Event|0|||
160679424|NCT00603512|580205597|FG001|Overall Study|Adverse Event|2|||
160679425|NCT00603512|580205598|FG002|Overall Study|Adverse Event|4|||
160679426|NCT00603512|580205599|FG003|Overall Study|Adverse Event|4|||
160679427|NCT00603512|580205600|FG004|Overall Study|Adverse Event|2|||
160679428|NCT00603512|580205596|FG000|Overall Study|Lack of Efficacy|0|||
160679429|NCT00603512|580205597|FG001|Overall Study|Lack of Efficacy|1|||
160679430|NCT00603512|580205598|FG002|Overall Study|Lack of Efficacy|0|||
160679431|NCT00603512|580205599|FG003|Overall Study|Lack of Efficacy|0|||
160679432|NCT00603512|580205600|FG004|Overall Study|Lack of Efficacy|1|||
160679433|NCT00603512|580205596|FG000|Overall Study|Other|2|||
160679434|NCT00603512|580205597|FG001|Overall Study|Other|1|||
160679435|NCT00603512|580205598|FG002|Overall Study|Other|0|||
160679436|NCT00603512|580205599|FG003|Overall Study|Other|1|||
160679437|NCT00603512|580205600|FG004|Overall Study|Other|1|||
160679438|NCT00603512|580205596|FG000|Overall Study|Withdrawal by Subject|0|||
160679439|NCT00603512|580205597|FG001|Overall Study|Withdrawal by Subject|0|||
160679440|NCT00603512|580205598|FG002|Overall Study|Withdrawal by Subject|0|||
160679441|NCT00603512|580205599|FG003|Overall Study|Withdrawal by Subject|0|||
160679442|NCT00603512|580205600|FG004|Overall Study|Withdrawal by Subject|1|||
160679443|NCT00603512|580205596|FG000|Overall Study|Randomized but not treated|0|||
160679444|NCT00603512|580205597|FG001|Overall Study|Randomized but not treated|1|||
160679445|NCT00603512|580205598|FG002|Overall Study|Randomized but not treated|1|||
160679446|NCT00603512|580205599|FG003|Overall Study|Randomized but not treated|2|||
160679447|NCT00603512|580205600|FG004|Overall Study|Randomized but not treated|0|||
160679448|NCT04979858|580205601|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
160679449|NCT04979858|580205602|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
160679450|NCT04253236|580205603|FG000|Overall Study|Adverse Event|1|||
160679451|NCT04253236|580205604|FG001|Overall Study|Adverse Event|0|||
160679452|NCT04253236|580205603|FG000|Overall Study|Safety Concerns|1|||
160679453|NCT04253236|580205604|FG001|Overall Study|Safety Concerns|0|||
160679454|NCT04253236|580205603|FG000|Overall Study|Study Terminated by Sponsor|1|||
160679455|NCT04253236|580205604|FG001|Overall Study|Study Terminated by Sponsor|0|||
160679456|NCT01896505|580205605|FG000|Overall Study|Adverse Event|1|||
160679457|NCT01896505|580205606|FG001|Overall Study|Adverse Event|0|||
160679458|NCT01896505|580205607|FG002|Overall Study|Adverse Event|2|||
160679459|NCT01896505|580205608|FG003|Overall Study|Adverse Event|1|||
160679460|NCT01896505|580205609|FG004|Overall Study|Adverse Event|1|||
160679461|NCT01896505|580205610|FG005|Overall Study|Adverse Event|0|||
160679462|NCT01896505|580205605|FG000|Overall Study|Physician Decision|1|||
160679463|NCT01896505|580205606|FG001|Overall Study|Physician Decision|3|||
160679464|NCT01896505|580205607|FG002|Overall Study|Physician Decision|2|||
160679465|NCT01896505|580205608|FG003|Overall Study|Physician Decision|0|||
160679466|NCT01896505|580205609|FG004|Overall Study|Physician Decision|0|||
160679467|NCT01896505|580205610|FG005|Overall Study|Physician Decision|1|||
160679468|NCT01896505|580205605|FG000|Overall Study|Withdrawal by Subject|1|||
160679469|NCT01896505|580205606|FG001|Overall Study|Withdrawal by Subject|0|||
160679470|NCT01896505|580205607|FG002|Overall Study|Withdrawal by Subject|3|||
160679471|NCT01896505|580205608|FG003|Overall Study|Withdrawal by Subject|1|||
160679472|NCT01896505|580205609|FG004|Overall Study|Withdrawal by Subject|0|||
160679473|NCT01896505|580205610|FG005|Overall Study|Withdrawal by Subject|0|||
160679474|NCT01896505|580205605|FG000|Overall Study|Disease Progression|7|||
160679475|NCT01896505|580205606|FG001|Overall Study|Disease Progression|5|||
160679476|NCT01896505|580205607|FG002|Overall Study|Disease Progression|8|||
160679477|NCT01896505|580205608|FG003|Overall Study|Disease Progression|4|||
160679478|NCT01896505|580205609|FG004|Overall Study|Disease Progression|4|||
160679479|NCT01896505|580205610|FG005|Overall Study|Disease Progression|4|||
160679480|NCT01896505|580205605|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
160679481|NCT01896505|580205606|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
160679482|NCT01896505|580205607|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
160679483|NCT01896505|580205608|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
160679484|NCT01896505|580205609|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
160679485|NCT01896505|580205610|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
160679486|NCT01896505|580205605|FG000|Overall Study|Intercurrent illness|0|||
160679487|NCT01896505|580205606|FG001|Overall Study|Intercurrent illness|1|||
160679488|NCT01896505|580205607|FG002|Overall Study|Intercurrent illness|0|||
160679489|NCT01896505|580205608|FG003|Overall Study|Intercurrent illness|0|||
160679490|NCT01896505|580205609|FG004|Overall Study|Intercurrent illness|0|||
160679491|NCT01896505|580205610|FG005|Overall Study|Intercurrent illness|0|||
160679492|NCT01896505|580205605|FG000|Overall Study|Death|0|||
160679493|NCT01896505|580205606|FG001|Overall Study|Death|0|||
160679494|NCT01896505|580205607|FG002|Overall Study|Death|1|||
160679495|NCT01896505|580205608|FG003|Overall Study|Death|1|||
160679496|NCT01896505|580205609|FG004|Overall Study|Death|0|||
160679497|NCT01896505|580205610|FG005|Overall Study|Death|1|||
160679498|NCT02063217|580205611|FG000|Overall Study|Withdrawal by Subject|1|||
160679499|NCT02063217|580205612|FG001|Overall Study|Withdrawal by Subject|0|||
160679500|NCT02063217|580205613|FG002|Overall Study|Withdrawal by Subject|0|||
160679501|NCT00889252|580205614|FG000|Overall Study|Adverse Event|2|||
160679502|NCT00889252|580205615|FG001|Overall Study|Adverse Event|4|||
160679503|NCT00889252|580205614|FG000|Overall Study|Withdrawal by Subject|3|||
160679504|NCT00889252|580205615|FG001|Overall Study|Withdrawal by Subject|0|||
160679505|NCT00889252|580205614|FG000|Overall Study|Protocol Violation|2|||
160679506|NCT00889252|580205615|FG001|Overall Study|Protocol Violation|0|||
160679507|NCT04291508|580205616|FG000|Overall Study|Withdrawal by Subject|1|||
160679508|NCT04291508|580205617|FG001|Overall Study|Withdrawal by Subject|0|||
160679509|NCT04291508|580205618|FG002|Overall Study|Withdrawal by Subject|1|||
160679510|NCT04291508|580205619|FG003|Overall Study|Withdrawal by Subject|0|||
160679511|NCT04291508|580205616|FG000|Overall Study|lost to follow up|4|||
160679512|NCT04291508|580205617|FG001|Overall Study|lost to follow up|0|||
160679513|NCT04291508|580205618|FG002|Overall Study|lost to follow up|1|||
160679514|NCT04291508|580205619|FG003|Overall Study|lost to follow up|0|||
160679515|NCT03566238|580205620|FG000|Overall Study|Adverse Event|0|||
160679516|NCT03566238|580205621|FG001|Overall Study|Adverse Event|0|||
160679517|NCT03566238|580205622|FG002|Overall Study|Adverse Event|1|||
160679518|NCT03566238|580205620|FG000|Overall Study|Lack of Efficacy|5|||
160679519|NCT03566238|580205621|FG001|Overall Study|Lack of Efficacy|4|||
160679520|NCT03566238|580205622|FG002|Overall Study|Lack of Efficacy|2|||
160679521|NCT03566238|580205620|FG000|Overall Study|Other|0|||
160679522|NCT03566238|580205621|FG001|Overall Study|Other|1|||
160679523|NCT03566238|580205622|FG002|Overall Study|Other|0|||
160679524|NCT00593827|580205629|FG000|Overall Study|On Active Treatment/Pending|0|||
160679525|NCT00593827|580205630|FG001|Overall Study|On Active Treatment/Pending|2|||
160679526|NCT00089973|580205631|FG000|Overall Study|Adverse Event|3|||
160679527|NCT00089973|580205631|FG000|Overall Study|Withdrawal by Subject|1|||
160679528|NCT00089973|580205631|FG000|Overall Study|Disease progression|45|||
160679529|NCT00089973|580205631|FG000|Overall Study|Death|1|||
160679530|NCT01049581|580205635|FG000|Overall Study|Lost to Follow-up|2|||
160679531|NCT01049581|580205636|FG001|Overall Study|Lost to Follow-up|1|||
160679532|NCT01841060|580207090|FG000|Overall Study|Protocol Violation|10|||
160679533|NCT01848210|580207091|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
160679534|NCT01848210|580207092|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
160679535|NCT01848210|580207091|FG000|Overall Study|Lost to Follow-up|24|||
160679536|NCT01848210|580207092|FG001|Overall Study|Lost to Follow-up|12|||
160679537|NCT01848210|580207091|FG000|Overall Study|Protocol Violation|3|||
160679538|NCT01848210|580207092|FG001|Overall Study|Protocol Violation|5|||
160679539|NCT01848210|580207091|FG000|Overall Study|Use of Forbidden Drugs|9|||
160679540|NCT01848210|580207092|FG001|Overall Study|Use of Forbidden Drugs|10|||
160679541|NCT01848210|580207091|FG000|Overall Study|Impedition Condition|5|||
160679542|NCT01848210|580207092|FG001|Overall Study|Impedition Condition|9|||
160679543|NCT01848210|580207091|FG000|Overall Study|Adverse Event|7|||
160679544|NCT01848210|580207092|FG001|Overall Study|Adverse Event|9|||
160679545|NCT01848210|580207091|FG000|Overall Study|Discontinuation Criterion|5|||
160679546|NCT01848210|580207092|FG001|Overall Study|Discontinuation Criterion|7|||
160679547|NCT01848210|580207091|FG000|Overall Study|Hypesensitivity|1|||
160679548|NCT01848210|580207092|FG001|Overall Study|Hypesensitivity|0|||
160679549|NCT01848210|580207091|FG000|Overall Study|Hepatic Function Alteration|4|||
160679550|NCT01848210|580207092|FG001|Overall Study|Hepatic Function Alteration|0|||
160679551|NCT01848210|580207091|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
160679552|NCT01848210|580207092|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
160679553|NCT01848210|580207091|FG000|Overall Study|Administrative|1|||
160679554|NCT01848210|580207092|FG001|Overall Study|Administrative|0|||
160679555|NCT04592419|580207093|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
160679556|NCT04592419|580207094|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
160679557|NCT04592419|580207093|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
160679558|NCT04592419|580207094|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
160679559|NCT04592419|580207093|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
160679560|NCT04592419|580207094|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
160679561|NCT04592419|580207093|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
160679562|NCT04592419|580207094|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
160679563|NCT04592419|580207093|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
160679564|NCT04592419|580207094|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
160679565|NCT04592419|580207093|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
160679566|NCT04592419|580207094|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
160679567|NCT04592419|580207093|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
160679568|NCT04592419|580207094|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
160679569|NCT04592419|580207093|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
160679570|NCT04592419|580207094|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
160679571|NCT04592419|580207093|FG000|Open-Label Extension Period|Adverse Event|1|||
160679572|NCT04592419|580207094|FG001|Open-Label Extension Period|Adverse Event|2|||
160679573|NCT04592419|580207093|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
160679574|NCT04592419|580207094|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
160679575|NCT04592419|580207093|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
160679576|NCT04592419|580207094|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
160679577|NCT04592419|580207093|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
160679578|NCT04592419|580207094|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
160679579|NCT04592419|580207093|FG000|Open-Label Extension Period|Sponsor Request|73|||
160679580|NCT04592419|580207094|FG001|Open-Label Extension Period|Sponsor Request|84|||
160679581|NCT02419573|580207097|FG000|Overall Study|Lost to Follow-up|3|||
160679582|NCT02419573|580207098|FG001|Overall Study|Lost to Follow-up|0|||
160679583|NCT02419573|580207097|FG000|Overall Study|Withdrawal by Subject|1|||
160679584|NCT02419573|580207098|FG001|Overall Study|Withdrawal by Subject|0|||
160679585|NCT00493792|580207099|FG000|Overall Study|Death|55|||
160679586|NCT00493792|580207100|FG001|Overall Study|Death|50|||
160679587|NCT00493792|580207099|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
160679588|NCT00493792|580207100|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
160679589|NCT00685035|580207105|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
160679590|NCT00685035|580207106|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
160679591|NCT02426541|580207109|FG000|Overall Study|Protocol Violation|1|||
160679592|NCT02426541|580207110|FG001|Overall Study|Protocol Violation|0|||
160679593|NCT00784979|580207111|FG000|Overall Study|incomplete data|6|||
160679594|NCT04241133|580207112|FG000|Overall Study|COVID19 Precautions|14|||
160679595|NCT04241133|580207113|FG001|Overall Study|COVID19 Precautions|34|||
160679596|NCT01933919|580207123|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
160679597|NCT01933919|580207124|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
160679598|NCT01933919|580207123|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
160679599|NCT01933919|580207124|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
160679600|NCT01933919|580207123|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
160679601|NCT01933919|580207124|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
160679602|NCT01933919|580207123|FG000|Open-label Long-term Phase|Adverse Event|2|||
160679603|NCT01933919|580207124|FG001|Open-label Long-term Phase|Adverse Event|0|||
160679604|NCT01933919|580207123|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
160679605|NCT01933919|580207124|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
160679606|NCT01933919|580207123|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
160679607|NCT01933919|580207124|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
160679608|NCT01933919|580207123|FG000|Open-label Long-term Phase|Other|1|||
160679609|NCT01933919|580207124|FG001|Open-label Long-term Phase|Other|2|||
160679610|NCT02575339|580207125|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
160679611|NCT02575339|580207126|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
160679612|NCT02575339|580207127|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
160679613|NCT02575339|580207125|FG000|Study Treatment|Disease Progression|5|||
160679614|NCT02575339|580207126|FG001|Study Treatment|Disease Progression|2|||
160679615|NCT02575339|580207127|FG002|Study Treatment|Disease Progression|0|||
160679616|NCT02575339|580207125|FG000|Study Treatment|Adverse Event|1|||
160679617|NCT02575339|580207126|FG001|Study Treatment|Adverse Event|2|||
160679618|NCT02575339|580207127|FG002|Study Treatment|Adverse Event|0|||
160679619|NCT02575339|580207125|FG000|Follow up|Death|6|||
160679620|NCT02575339|580207126|FG001|Follow up|Death|2|||
160679621|NCT02575339|580207127|FG002|Follow up|Death|0|||
160679622|NCT02575339|580207125|FG000|Follow up|Study Terminated|0|||
160679623|NCT02575339|580207126|FG001|Follow up|Study Terminated|2|||
160679624|NCT02575339|580207127|FG002|Follow up|Study Terminated|0|||
160679625|NCT02575339|580207125|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
160679626|NCT02575339|580207126|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
160679627|NCT02575339|580207127|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
160679628|NCT04675775|580207128|FG000|Overall Study|Withdrawal by Subject|7|||
160679629|NCT00348816|580207131|FG000|Overall Study|Noncompliance with radiation treatment|1|||
160679630|NCT04142658|580207132|FG000|Overall Study|Death|2|||
160679631|NCT04142658|580207133|FG001|Overall Study|Death|1|||
160679632|NCT04142658|580207132|FG000|Overall Study|Lost to Follow-up|4|||
160679633|NCT04142658|580207133|FG001|Overall Study|Lost to Follow-up|13|||
160679634|NCT04142658|580207132|FG000|Overall Study|Withdrawal by Subject|9|||
160679635|NCT04142658|580207133|FG001|Overall Study|Withdrawal by Subject|16|||
160679636|NCT01781234|580207134|FG000|Overall Study|Adverse Event|2|||
160679637|NCT01781234|580207135|FG001|Overall Study|Adverse Event|0|||
160679638|NCT01781234|580207134|FG000|Overall Study|Protocol Violation|3|||
160679639|NCT01781234|580207135|FG001|Overall Study|Protocol Violation|0|||
160679640|NCT01781234|580207134|FG000|Overall Study|Withdrawal by Subject|4|||
160679641|NCT01781234|580207135|FG001|Overall Study|Withdrawal by Subject|3|||
160679642|NCT02466386|580207138|FG000|Overall Study|Adverse Event|5|||
160679643|NCT02466386|580207138|FG000|Overall Study|Protocol Violation|2|||
160679644|NCT02466386|580207138|FG000|Overall Study|Withdrawal by Subject|14|||
160679645|NCT02466386|580207138|FG000|Overall Study|Lost to Follow-up|5|||
160679646|NCT02466386|580207138|FG000|Overall Study|Lack of Efficacy|8|||
160679647|NCT02466386|580207138|FG000|Overall Study|Other|10|||
160679648|NCT05317195|580207139|FG000|Randomization|Withdrawal by Subject|1|||
160679649|NCT05317195|580207139|FG000|Randomization|Discontinued|6|||
160679650|NCT05317195|580207139|FG000|Admission|Withdrawal by Subject|2|||
160679651|NCT03259789|580207140|FG000|Overall Study|Adverse Event|3|||
160679652|NCT03259789|580207141|FG001|Overall Study|Adverse Event|2|||
160679653|NCT03259789|580207142|FG002|Overall Study|Adverse Event|1|||
160679654|NCT03259789|580207140|FG000|Overall Study|Withdrawal by Subject|9|||
160679655|NCT03259789|580207141|FG001|Overall Study|Withdrawal by Subject|5|||
160679656|NCT03259789|580207142|FG002|Overall Study|Withdrawal by Subject|1|||
160679657|NCT03259789|580207140|FG000|Overall Study|Lost to Follow-up|5|||
160679658|NCT03259789|580207141|FG001|Overall Study|Lost to Follow-up|9|||
160679659|NCT03259789|580207142|FG002|Overall Study|Lost to Follow-up|4|||
160679660|NCT03259789|580207140|FG000|Overall Study|Physician Decision|0|||
160679661|NCT03259789|580207141|FG001|Overall Study|Physician Decision|1|||
160679662|NCT03259789|580207142|FG002|Overall Study|Physician Decision|0|||
160679663|NCT00860262|580207146|FG000|Overall Study|Adverse Event|9|||
160679664|NCT00860262|580207147|FG001|Overall Study|Adverse Event|6|||
160679665|NCT00860262|580207148|FG002|Overall Study|Adverse Event|7|||
160679666|NCT00860262|580207146|FG000|Overall Study|Protocol Violation|0|||
160679667|NCT00860262|580207147|FG001|Overall Study|Protocol Violation|1|||
160679668|NCT00860262|580207148|FG002|Overall Study|Protocol Violation|0|||
160679669|NCT00860262|580207146|FG000|Overall Study|Lost to Follow-up|2|||
160679670|NCT00860262|580207147|FG001|Overall Study|Lost to Follow-up|0|||
160679671|NCT00860262|580207148|FG002|Overall Study|Lost to Follow-up|1|||
160679672|NCT00860262|580207146|FG000|Overall Study|Withdrawal by Subject|4|||
160679673|NCT00860262|580207147|FG001|Overall Study|Withdrawal by Subject|8|||
160679674|NCT00860262|580207148|FG002|Overall Study|Withdrawal by Subject|6|||
160679675|NCT00860262|580207146|FG000|Overall Study|Lack of Efficacy|0|||
160679676|NCT00860262|580207147|FG001|Overall Study|Lack of Efficacy|4|||
160679677|NCT00860262|580207148|FG002|Overall Study|Lack of Efficacy|3|||
160679678|NCT00860262|580207146|FG000|Overall Study|Other|5|||
160679679|NCT00860262|580207147|FG001|Overall Study|Other|3|||
160679680|NCT00860262|580207148|FG002|Overall Study|Other|1|||
160679681|NCT01833169|580207152|FG000|Overall Study|Disease Progression|99|||
160679682|NCT01833169|580207152|FG000|Overall Study|Adverse Event|33|||
160679683|NCT01833169|580207152|FG000|Overall Study|Withdrawal by Subject|9|||
160679684|NCT01833169|580207152|FG000|Overall Study|Death|3|||
160679685|NCT01833169|580207152|FG000|Overall Study|Physician Decision|2|||
160679686|NCT01183884|580207153|FG000|Overall Study|Progressive Disease|26|||
160679687|NCT01183884|580207153|FG000|Overall Study|Adverse Event|3|||
160679688|NCT01183884|580207153|FG000|Overall Study|Withdrawal by Subject|1|||
160679689|NCT01183884|580207153|FG000|Overall Study|Other Complicating Disease|3|||
160679690|NCT01183884|580207153|FG000|Overall Study|Not Treated|1|||
160679691|NCT01183884|580207153|FG000|Overall Study|Other|4|||
160679692|NCT02169336|580207158|FG000|Overall Study|Lack of Efficacy|1|||
160679693|NCT02169336|580207159|FG001|Overall Study|Lack of Efficacy|1|||
160679694|NCT02169336|580207160|FG002|Overall Study|Lack of Efficacy|0|||
160679695|NCT02169336|580207158|FG000|Overall Study|Adverse Event|2|||
160679696|NCT02169336|580207159|FG001|Overall Study|Adverse Event|3|||
160679697|NCT02169336|580207160|FG002|Overall Study|Adverse Event|1|||
160679698|NCT02169336|580207158|FG000|Overall Study|Withdrawal by Subject|1|||
160679699|NCT02169336|580207159|FG001|Overall Study|Withdrawal by Subject|0|||
160679700|NCT02169336|580207160|FG002|Overall Study|Withdrawal by Subject|0|||
160679701|NCT02169336|580207158|FG000|Overall Study|Physician Decision|0|||
160679702|NCT02169336|580207159|FG001|Overall Study|Physician Decision|0|||
160679703|NCT02169336|580207160|FG002|Overall Study|Physician Decision|1|||
160679704|NCT02169336|580207158|FG000|Overall Study|Subject declined to continue dosing|0|||
160679705|NCT02169336|580207159|FG001|Overall Study|Subject declined to continue dosing|0|||
160679706|NCT02169336|580207160|FG002|Overall Study|Subject declined to continue dosing|1|||
160679707|NCT04718129|580207161|FG000|Overall Study|Lost to Follow-up|6|||
160679708|NCT04718129|580207162|FG001|Overall Study|Lost to Follow-up|7|||
160679709|NCT02212457|580207163|FG000|Overall Study|Adverse Event|1|||
160679710|NCT02212457|580207164|FG001|Overall Study|Adverse Event|2|||
160679711|NCT02212457|580207165|FG002|Overall Study|Adverse Event|2|||
160679712|NCT02212457|580207166|FG003|Overall Study|Adverse Event|2|||
160679713|NCT02212457|580207167|FG004|Overall Study|Adverse Event|0|||
160679714|NCT02212457|580207168|FG005|Overall Study|Adverse Event|1|||
160679715|NCT02212457|580207163|FG000|Overall Study|Withdrawal by Subject|8|||
160679716|NCT02212457|580207164|FG001|Overall Study|Withdrawal by Subject|10|||
160679717|NCT02212457|580207165|FG002|Overall Study|Withdrawal by Subject|8|||
160679718|NCT02212457|580207166|FG003|Overall Study|Withdrawal by Subject|6|||
160679719|NCT02212457|580207167|FG004|Overall Study|Withdrawal by Subject|5|||
160679720|NCT02212457|580207168|FG005|Overall Study|Withdrawal by Subject|4|||
160679721|NCT02212457|580207163|FG000|Overall Study|Lost to Follow-up|6|||
160679722|NCT02212457|580207164|FG001|Overall Study|Lost to Follow-up|7|||
160679723|NCT02212457|580207165|FG002|Overall Study|Lost to Follow-up|4|||
160679724|NCT02212457|580207166|FG003|Overall Study|Lost to Follow-up|1|||
160679725|NCT02212457|580207167|FG004|Overall Study|Lost to Follow-up|8|||
160679726|NCT02212457|580207168|FG005|Overall Study|Lost to Follow-up|4|||
160679727|NCT02212457|580207163|FG000|Overall Study|Protocol Violation|2|||
160679728|NCT02212457|580207164|FG001|Overall Study|Protocol Violation|1|||
160679729|NCT02212457|580207165|FG002|Overall Study|Protocol Violation|0|||
160679730|NCT02212457|580207166|FG003|Overall Study|Protocol Violation|1|||
160679731|NCT02212457|580207167|FG004|Overall Study|Protocol Violation|2|||
160679732|NCT02212457|580207168|FG005|Overall Study|Protocol Violation|3|||
160679733|NCT02212457|580207163|FG000|Overall Study|Other|2|||
160679734|NCT02212457|580207164|FG001|Overall Study|Other|1|||
160679735|NCT02212457|580207165|FG002|Overall Study|Other|2|||
160679736|NCT02212457|580207166|FG003|Overall Study|Other|1|||
160679737|NCT02212457|580207167|FG004|Overall Study|Other|0|||
160679738|NCT02212457|580207168|FG005|Overall Study|Other|1|||
160679739|NCT01598896|580207169|FG000|Overall Study|Withdrawal by Subject|0|||
160679740|NCT01598896|580207170|FG001|Overall Study|Withdrawal by Subject|1|||
160679741|NCT01598896|580207169|FG000|Overall Study|Lack of Efficacy|0|||
160679742|NCT01598896|580207170|FG001|Overall Study|Lack of Efficacy|1|||
160679743|NCT00420095|580207171|FG000|Overall Study|Adverse Event|1|||
160679744|NCT00420095|580207172|FG001|Overall Study|Adverse Event|0|||
160679745|NCT00420095|580207171|FG000|Overall Study|Protocol Violation|1|||
160679746|NCT00420095|580207172|FG001|Overall Study|Protocol Violation|1|||
160679747|NCT00420095|580207171|FG000|Overall Study|Lost to Follow-up|1|||
160679748|NCT00420095|580207172|FG001|Overall Study|Lost to Follow-up|0|||
160679749|NCT00393705|580207173|FG000|Overall Study|Adverse Event|0|||
160679750|NCT00393705|580207174|FG001|Overall Study|Adverse Event|2|||
160679751|NCT00393705|580207173|FG000|Overall Study|Death|0|||
160679752|NCT00393705|580207174|FG001|Overall Study|Death|1|||
160679753|NCT00393705|580207173|FG000|Overall Study|Lost to Follow-up|2|||
160679754|NCT00393705|580207174|FG001|Overall Study|Lost to Follow-up|2|||
160679755|NCT00393705|580207173|FG000|Overall Study|Entry Criteria Not Met|10|||
160679756|NCT00393705|580207174|FG001|Overall Study|Entry Criteria Not Met|10|||
160679757|NCT00393705|580207173|FG000|Overall Study|Protocol Violation|4|||
160679758|NCT00393705|580207174|FG001|Overall Study|Protocol Violation|3|||
160679759|NCT00393705|580207173|FG000|Overall Study|Withdrawal by Subject|5|||
160679760|NCT00393705|580207174|FG001|Overall Study|Withdrawal by Subject|3|||
160679761|NCT00393705|580207173|FG000|Overall Study|Physician Decision|2|||
160679762|NCT00393705|580207174|FG001|Overall Study|Physician Decision|2|||
160679763|NCT01120691|580207177|FG000|Overall Study|Adverse Event|59|||
160679764|NCT01120691|580207178|FG001|Overall Study|Adverse Event|67|||
160679765|NCT01120691|580207179|FG002|Overall Study|Adverse Event|47|||
160679766|NCT01120691|580207177|FG000|Overall Study|Subject withdrew consent|33|||
160679767|NCT01120691|580207178|FG001|Overall Study|Subject withdrew consent|50|||
160679768|NCT01120691|580207179|FG002|Overall Study|Subject withdrew consent|44|||
160679769|NCT01120691|580207177|FG000|Overall Study|Death|21|||
160679770|NCT01120691|580207178|FG001|Overall Study|Death|22|||
160679771|NCT01120691|580207179|FG002|Overall Study|Death|24|||
160679772|NCT01120691|580207177|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
160679773|NCT01120691|580207178|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
160679774|NCT01120691|580207179|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
160679775|NCT01120691|580207177|FG000|Overall Study|Administrative problems|15|||
160679776|NCT01120691|580207178|FG001|Overall Study|Administrative problems|8|||
160679777|NCT01120691|580207179|FG002|Overall Study|Administrative problems|9|||
160679778|NCT01120691|580207177|FG000|Overall Study|Protocol deviation|13|||
160679779|NCT01120691|580207178|FG001|Overall Study|Protocol deviation|12|||
160679780|NCT01120691|580207179|FG002|Overall Study|Protocol deviation|12|||
160679781|NCT01120691|580207177|FG000|Overall Study|Lost to Follow-up|5|||
160679782|NCT01120691|580207178|FG001|Overall Study|Lost to Follow-up|6|||
160679783|NCT01120691|580207179|FG002|Overall Study|Lost to Follow-up|4|||
160679784|NCT01120691|580207177|FG000|Overall Study|Abnormal test procedure result(s)|3|||
160679785|NCT01120691|580207178|FG001|Overall Study|Abnormal test procedure result(s)|2|||
160679786|NCT01120691|580207179|FG002|Overall Study|Abnormal test procedure result(s)|1|||
160679787|NCT01120691|580207177|FG000|Overall Study|Patient's inability to use the device|3|||
160679788|NCT01120691|580207178|FG001|Overall Study|Patient's inability to use the device|1|||
160679789|NCT01120691|580207179|FG002|Overall Study|Patient's inability to use the device|0|||
160679790|NCT01120691|580207177|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160679791|NCT01120691|580207178|FG001|Overall Study|Abnormal laboratory value(s)|3|||
160679792|NCT01120691|580207179|FG002|Overall Study|Abnormal laboratory value(s)|4|||
160679793|NCT04553406|580207183|FG000|Overall Study|Study Discontinuation|0|||
160679794|NCT04553406|580207184|FG001|Overall Study|Study Discontinuation|1|||
160679795|NCT03370510|580207185|FG000|Overall Study|COVID-19|2|||
160679796|NCT03370510|580207186|FG001|Overall Study|COVID-19|0|||
160679797|NCT00772148|580207187|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
160679798|NCT00772148|580207188|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
160679799|NCT00772148|580207187|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
160679800|NCT00772148|580207188|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
160679801|NCT00772148|580207187|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
160679802|NCT00772148|580207188|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
160679803|NCT00772148|580207187|FG000|Maintenance Phase (Week 52)|Death|2|||
160679804|NCT00772148|580207188|FG001|Maintenance Phase (Week 52)|Death|2|||
160679805|NCT00772148|580207187|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
160679806|NCT00772148|580207188|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
160679807|NCT00772148|580207187|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
160679808|NCT00772148|580207188|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
160679809|NCT00772148|580207187|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
160679810|NCT00772148|580207188|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
160679811|NCT00688844|580207189|FG000|Overall Study|Lost to Follow-up|10|||
160679812|NCT01321697|580207194|FG000|Overall Study|Study Terminated|7|||
160679813|NCT00857818|580207195|FG000|Overall Study|Lack of Efficacy|1|||
160679814|NCT00857818|580207196|FG001|Overall Study|Lack of Efficacy|0|||
160679815|NCT00857818|580207195|FG000|Overall Study|Adverse Event|3|||
160679816|NCT00857818|580207196|FG001|Overall Study|Adverse Event|0|||
160679817|NCT00857818|580207195|FG000|Overall Study|Withdrawal by Subject|0|||
160679818|NCT00857818|580207196|FG001|Overall Study|Withdrawal by Subject|4|||
160679819|NCT00857818|580207195|FG000|Overall Study|Sponsor terminated study|6|||
160679820|NCT00857818|580207196|FG001|Overall Study|Sponsor terminated study|4|||
160679821|NCT00857818|580207195|FG000|Overall Study|Investigator decision|1|||
160679822|NCT00857818|580207196|FG001|Overall Study|Investigator decision|0|||
160679823|NCT02061280|580207200|FG000|Overall Study|Protocol Violation|12|||
160679824|NCT02061280|580207201|FG001|Overall Study|Protocol Violation|8|||
160679825|NCT02061280|580207200|FG000|Overall Study|moved out of state|0|||
160679826|NCT02061280|580207201|FG001|Overall Study|moved out of state|1|||
160679827|NCT02061280|580207200|FG000|Overall Study|Withdrawal by Subject|1|||
160679828|NCT02061280|580207201|FG001|Overall Study|Withdrawal by Subject|2|||
160679829|NCT02061280|580207200|FG000|Overall Study|Lost to Follow-up|5|||
160679830|NCT02061280|580207201|FG001|Overall Study|Lost to Follow-up|1|||
160679831|NCT01977456|580207202|FG000|Overall Study|Death|5|||
160679832|NCT05258630|580209335|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
160679833|NCT05258630|580209336|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
160679834|NCT05258630|580209335|FG000|Overall Study|Lost to Follow-up|0|||
160679835|NCT05258630|580209336|FG001|Overall Study|Lost to Follow-up|2|||
160679836|NCT03431337|580209337|FG000|Overall Study|Lost to Follow-up|21|||
160679837|NCT03431337|580209338|FG001|Overall Study|Lost to Follow-up|19|||
160679838|NCT03431337|580209337|FG000|Overall Study|Withdrawal by Subject|8|||
160679839|NCT03431337|580209338|FG001|Overall Study|Withdrawal by Subject|3|||
160679840|NCT00894933|580209345|FG000|Overall Study|Lost to Follow-up|2|||
160679841|NCT00894933|580209345|FG000|Overall Study|Cancelled Procedure|1|||
160679842|NCT00894933|580209345|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
160679843|NCT00631007|580209348|FG000|Overall Study|Adverse Event|0|||
160679844|NCT00631007|580209349|FG001|Overall Study|Adverse Event|2|||
160679845|NCT00631007|580209350|FG002|Overall Study|Adverse Event|0|||
160679846|NCT00631007|580209351|FG003|Overall Study|Adverse Event|2|||
160679847|NCT00631007|580209352|FG004|Overall Study|Adverse Event|3|||
160679848|NCT00631007|580209353|FG005|Overall Study|Adverse Event|2|||
160679849|NCT00631007|580209348|FG000|Overall Study|Lost to Follow-up|2|||
160679850|NCT00631007|580209349|FG001|Overall Study|Lost to Follow-up|1|||
160679851|NCT00631007|580209350|FG002|Overall Study|Lost to Follow-up|2|||
160679852|NCT00631007|580209351|FG003|Overall Study|Lost to Follow-up|4|||
160679853|NCT00631007|580209352|FG004|Overall Study|Lost to Follow-up|5|||
160679854|NCT00631007|580209353|FG005|Overall Study|Lost to Follow-up|3|||
160679855|NCT00631007|580209348|FG000|Overall Study|Physician Decision|1|||
160679856|NCT00631007|580209349|FG001|Overall Study|Physician Decision|0|||
160679857|NCT00631007|580209350|FG002|Overall Study|Physician Decision|1|||
160679858|NCT00631007|580209351|FG003|Overall Study|Physician Decision|0|||
160679859|NCT00631007|580209352|FG004|Overall Study|Physician Decision|0|||
160679860|NCT00631007|580209353|FG005|Overall Study|Physician Decision|2|||
160679861|NCT00631007|580209348|FG000|Overall Study|Persistent Hyperglycemia|2|||
160679862|NCT00631007|580209349|FG001|Overall Study|Persistent Hyperglycemia|2|||
160679863|NCT00631007|580209350|FG002|Overall Study|Persistent Hyperglycemia|5|||
160679864|NCT00631007|580209351|FG003|Overall Study|Persistent Hyperglycemia|1|||
160679865|NCT00631007|580209352|FG004|Overall Study|Persistent Hyperglycemia|2|||
160679866|NCT00631007|580209353|FG005|Overall Study|Persistent Hyperglycemia|5|||
160679867|NCT00631007|580209348|FG000|Overall Study|Withdrawal by Subject|4|||
160679868|NCT00631007|580209349|FG001|Overall Study|Withdrawal by Subject|5|||
160679869|NCT00631007|580209350|FG002|Overall Study|Withdrawal by Subject|2|||
160679870|NCT00631007|580209351|FG003|Overall Study|Withdrawal by Subject|2|||
160679871|NCT00631007|580209352|FG004|Overall Study|Withdrawal by Subject|1|||
160679872|NCT00631007|580209353|FG005|Overall Study|Withdrawal by Subject|3|||
160679873|NCT00631007|580209348|FG000|Overall Study|Other|2|||
160679874|NCT00631007|580209349|FG001|Overall Study|Other|1|||
160679875|NCT00631007|580209350|FG002|Overall Study|Other|0|||
160679876|NCT00631007|580209351|FG003|Overall Study|Other|0|||
160679877|NCT00631007|580209352|FG004|Overall Study|Other|1|||
160679878|NCT00631007|580209353|FG005|Overall Study|Other|0|||
160679879|NCT00683787|580209354|FG000|Overall Study|Progression|3|||
160679880|NCT00683787|580209355|FG001|Overall Study|Progression|3|||
160679881|NCT00683787|580209356|FG002|Overall Study|Progression|0|||
160679882|NCT00683787|580209354|FG000|Overall Study|Adverse Event|0|||
160679883|NCT00683787|580209355|FG001|Overall Study|Adverse Event|0|||
160679884|NCT00683787|580209356|FG002|Overall Study|Adverse Event|2|||
160679885|NCT02674633|580209357|FG000|Overall Study|Lost to Follow-up|3|||
160679886|NCT02674633|580209358|FG001|Overall Study|Lost to Follow-up|2|||
160679887|NCT02674633|580209357|FG000|Overall Study|Physician Decision|1|||
160679888|NCT02674633|580209358|FG001|Overall Study|Physician Decision|0|||
160679889|NCT02674633|580209357|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160679890|NCT02674633|580209358|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
160679891|NCT00460109|580209359|FG000|Overall Study|Death|1|||
160679892|NCT04167618|580209360|FG000|Overall Study|Trial terminated by sponsor|1|||
160679893|NCT04167618|580209361|FG001|Overall Study|Trial terminated by sponsor|1|||
160679894|NCT01235715|580209362|FG000|Overall Study|Physician Decision|0|||
160679895|NCT01235715|580209363|FG001|Overall Study|Physician Decision|2|||
160679896|NCT02994394|580209364|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
160679897|NCT02994394|580209365|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
160679898|NCT02994394|580209366|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
160679899|NCT02994394|580209367|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
160679900|NCT02994394|580209368|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
160679901|NCT02994394|580209369|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
160679902|NCT02994394|580209364|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
160679903|NCT02994394|580209365|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
160679904|NCT02994394|580209366|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
160679905|NCT02994394|580209367|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
160679906|NCT02994394|580209368|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
160679907|NCT02994394|580209369|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
160679908|NCT03619876|580209370|FG000|Overall Study|Withdrawal by Subject|1|||
160679909|NCT03619876|580209371|FG001|Overall Study|Withdrawal by Subject|2|||
160679910|NCT03619876|580209370|FG000|Overall Study|Withdrawal due to incidental finding|0|||
160679911|NCT03619876|580209371|FG001|Overall Study|Withdrawal due to incidental finding|2|||
160679912|NCT02344745|580209372|FG000|Overall Study|Data collection sheets were lost|2|||
160679913|NCT02344745|580209373|FG001|Overall Study|Data collection sheets were lost|0|||
160679914|NCT02788513|580209374|FG000|Overall Study|Withdrawal by Subject|3|||
160679915|NCT02788513|580209375|FG001|Overall Study|Withdrawal by Subject|0|||
160679916|NCT02788513|580209376|FG002|Overall Study|Withdrawal by Subject|2|||
160679917|NCT02788513|580209377|FG003|Overall Study|Withdrawal by Subject|3|||
160679918|NCT02788513|580209378|FG004|Overall Study|Withdrawal by Subject|1|||
160679919|NCT02788513|580209374|FG000|Overall Study|Lost to Follow-up|1|||
160679920|NCT02788513|580209375|FG001|Overall Study|Lost to Follow-up|0|||
160679921|NCT02788513|580209376|FG002|Overall Study|Lost to Follow-up|0|||
160679922|NCT02788513|580209377|FG003|Overall Study|Lost to Follow-up|0|||
160679923|NCT02788513|580209378|FG004|Overall Study|Lost to Follow-up|1|||
160679924|NCT02788513|580209374|FG000|Overall Study|Adverse Event|5|||
160679925|NCT02788513|580209375|FG001|Overall Study|Adverse Event|8|||
160679926|NCT02788513|580209376|FG002|Overall Study|Adverse Event|4|||
160679927|NCT02788513|580209377|FG003|Overall Study|Adverse Event|2|||
160679928|NCT02788513|580209378|FG004|Overall Study|Adverse Event|2|||
160679929|NCT02788513|580209374|FG000|Overall Study|Protocol Violation|0|||
160679930|NCT02788513|580209375|FG001|Overall Study|Protocol Violation|0|||
160679931|NCT02788513|580209376|FG002|Overall Study|Protocol Violation|1|||
160679932|NCT02788513|580209377|FG003|Overall Study|Protocol Violation|1|||
160679933|NCT02788513|580209378|FG004|Overall Study|Protocol Violation|0|||
160679934|NCT02788513|580209374|FG000|Overall Study|Subject decided to stop taking treatment|0|||
160679935|NCT02788513|580209375|FG001|Overall Study|Subject decided to stop taking treatment|0|||
160679936|NCT02788513|580209376|FG002|Overall Study|Subject decided to stop taking treatment|1|||
160679937|NCT02788513|580209377|FG003|Overall Study|Subject decided to stop taking treatment|0|||
160679938|NCT02788513|580209378|FG004|Overall Study|Subject decided to stop taking treatment|0|||
160679939|NCT02788513|580209374|FG000|Overall Study|Decision by the study team|0|||
160679940|NCT02788513|580209375|FG001|Overall Study|Decision by the study team|0|||
160679941|NCT02788513|580209376|FG002|Overall Study|Decision by the study team|0|||
160679942|NCT02788513|580209377|FG003|Overall Study|Decision by the study team|0|||
160679943|NCT02788513|580209378|FG004|Overall Study|Decision by the study team|1|||
160679944|NCT04982445|580209380|FG000|Overall Study|Protocol Violation|1|||
160679945|NCT04982445|580209380|FG000|Overall Study|Withdrawal by Subject|4|||
160679946|NCT04982445|580209380|FG000|Overall Study|Lost to Follow-up|1|||
160679947|NCT03230487|580209384|FG000|Overall Study|Adverse Event|0|||
160679948|NCT03230487|580209385|FG001|Overall Study|Adverse Event|0|||
160679949|NCT03230487|580209386|FG002|Overall Study|Adverse Event|0|||
160679950|NCT03230487|580209387|FG003|Overall Study|Adverse Event|1|||
160679951|NCT03230487|580209388|FG004|Overall Study|Adverse Event|0|||
160679952|NCT03230487|580209389|FG005|Overall Study|Adverse Event|0|||
160679953|NCT04968925|580209392|FG000|Phase I- Period 1|COVID-19 related|0|||
160679954|NCT04968925|580209393|FG001|Phase I- Period 1|COVID-19 related|1|||
160679955|NCT04968925|580209394|FG002|Phase I- Period 1|COVID-19 related|0|||
160679956|NCT04968925|580209395|FG003|Phase I- Period 1|COVID-19 related|0|||
160679957|NCT04968925|580209392|FG000|Phase I- Period 1|Subject enrolled in error|1|||
160679958|NCT04968925|580209393|FG001|Phase I- Period 1|Subject enrolled in error|1|||
160679959|NCT04968925|580209394|FG002|Phase I- Period 1|Subject enrolled in error|0|||
160679960|NCT04968925|580209395|FG003|Phase I- Period 1|Subject enrolled in error|0|||
160679961|NCT04968925|580209392|FG000|Phase II- Period 1|COVID-19 Related|0|||
160679962|NCT04968925|580209393|FG001|Phase II- Period 1|COVID-19 Related|0|||
160679963|NCT04968925|580209394|FG002|Phase II- Period 1|COVID-19 Related|6|||
160679964|NCT04968925|580209395|FG003|Phase II- Period 1|COVID-19 Related|6|||
160679965|NCT04968925|580209392|FG000|Phase II- Period 1|Subject enrolled in error|0|||
160679966|NCT04968925|580209393|FG001|Phase II- Period 1|Subject enrolled in error|0|||
160679967|NCT04968925|580209394|FG002|Phase II- Period 1|Subject enrolled in error|1|||
160679968|NCT04968925|580209395|FG003|Phase II- Period 1|Subject enrolled in error|0|||
160679969|NCT04968925|580209392|FG000|Phase II -Period 2|COVID-19 related|0|||
160679970|NCT04968925|580209393|FG001|Phase II -Period 2|COVID-19 related|0|||
160679971|NCT04968925|580209394|FG002|Phase II -Period 2|COVID-19 related|4|||
160679972|NCT04968925|580209395|FG003|Phase II -Period 2|COVID-19 related|3|||
160679973|NCT04968925|580209392|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
160679974|NCT04968925|580209393|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
160679975|NCT04968925|580209394|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
160679976|NCT04968925|580209395|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
160679977|NCT00835796|580209401|FG000|First Intervention|Withdrawal by Subject|0|||
160679978|NCT00835796|580209402|FG001|First Intervention|Withdrawal by Subject|1|||
160679979|NCT00396630|580209403|FG000|Overall Study|Lost to Follow-up|1|||
160679980|NCT00396630|580209404|FG001|Overall Study|Lost to Follow-up|1|||
160679981|NCT00396630|580209403|FG000|Overall Study|Withdrawal by Subject|1|||
160679982|NCT00396630|580209404|FG001|Overall Study|Withdrawal by Subject|1|||
160679983|NCT00396630|580209403|FG000|Overall Study|Not vaccinated at Visit 3|3|||
160679984|NCT00396630|580209404|FG001|Overall Study|Not vaccinated at Visit 3|3|||
160679985|NCT00876265|580209405|FG000|Overall Study|Miscellaneous reasons|4|||
160679986|NCT00876265|580209405|FG000|Overall Study|Lost to Follow-up|6|||
160679987|NCT00876265|580209405|FG000|Overall Study|Withdrawal by Subject|2|||
160679988|NCT02327325|580209406|FG000|Overall Study|Withdrawal by Subject|1|||
160679989|NCT02327325|580209407|FG001|Overall Study|Withdrawal by Subject|4|||
160679990|NCT02327325|580209408|FG002|Overall Study|Withdrawal by Subject|4|||
160679991|NCT02327325|580209406|FG000|Overall Study|Excluded by Study Team|0|||
160679992|NCT02327325|580209407|FG001|Overall Study|Excluded by Study Team|0|||
160679993|NCT02327325|580209408|FG002|Overall Study|Excluded by Study Team|1|||
160679994|NCT00651183|580209413|FG000|Overall Study|Lack of Efficacy|1|||
160679995|NCT00651183|580209414|FG001|Overall Study|Lack of Efficacy|0|||
160679996|NCT00651183|580209413|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
160679997|NCT00651183|580209414|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
160679998|NCT00651183|580209413|FG000|Overall Study|Tolerability insufficient|5|||
160679999|NCT00651183|580209414|FG001|Overall Study|Tolerability insufficient|2|||
160680000|NCT00651183|580209413|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
160680001|NCT00651183|580209414|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
160680002|NCT00651183|580209413|FG000|Overall Study|Withdrawal by Subject|6|||
160680003|NCT00651183|580209414|FG001|Overall Study|Withdrawal by Subject|3|||
160680004|NCT00651183|580209413|FG000|Overall Study|Lost to Follow-up|3|||
160680005|NCT00651183|580209414|FG001|Overall Study|Lost to Follow-up|1|||
160680006|NCT00651183|580209413|FG000|Overall Study|Other reasons|4|||
160680007|NCT00651183|580209414|FG001|Overall Study|Other reasons|2|||
160680008|NCT00651183|580209413|FG000|Overall Study|missing|1|||
160680009|NCT00651183|580209414|FG001|Overall Study|missing|0|||
160680010|NCT00695110|580209417|FG000|Treatment Period 1|Adverse Event|1|||
160680011|NCT00695110|580209417|FG000|Treatment Period 1|Withdrawal by Subject|2|||
160680012|NCT00695110|580209417|FG000|Treatment Period 3|Withdrawal by Subject|1|||
160680013|NCT00695110|580209417|FG000|Treatment Period 4|Adverse Event|1|||
160680014|NCT00108082|580209426|FG000|Overall Study|Adverse Event|14|||
160680015|NCT00108082|580209427|FG001|Overall Study|Adverse Event|12|||
160680016|NCT00108082|580209428|FG002|Overall Study|Adverse Event|17|||
160680017|NCT00108082|580209426|FG000|Overall Study|Lost to Follow-up|6|||
160680018|NCT00108082|580209427|FG001|Overall Study|Lost to Follow-up|3|||
160680019|NCT00108082|580209428|FG002|Overall Study|Lost to Follow-up|7|||
160680020|NCT00108082|580209426|FG000|Overall Study|Consent Withdrawn|3|||
160680021|NCT00108082|580209427|FG001|Overall Study|Consent Withdrawn|3|||
160680022|NCT00108082|580209428|FG002|Overall Study|Consent Withdrawn|5|||
160680023|NCT00108082|580209426|FG000|Overall Study|Protocol Violation|1|||
160680024|NCT00108082|580209427|FG001|Overall Study|Protocol Violation|2|||
160680025|NCT00108082|580209428|FG002|Overall Study|Protocol Violation|0|||
160680026|NCT00108082|580209426|FG000|Overall Study|Lack of Efficacy|3|||
160680027|NCT00108082|580209427|FG001|Overall Study|Lack of Efficacy|1|||
160680028|NCT00108082|580209428|FG002|Overall Study|Lack of Efficacy|2|||
160680029|NCT00108082|580209426|FG000|Overall Study|Amendment 4: > Month 12|5|||
160680030|NCT00108082|580209427|FG001|Overall Study|Amendment 4: > Month 12|7|||
160680031|NCT00108082|580209428|FG002|Overall Study|Amendment 4: > Month 12|5|||
160680032|NCT00108082|580209426|FG000|Overall Study|Woman of Child-bearing Potential|2|||
160680033|NCT00108082|580209427|FG001|Overall Study|Woman of Child-bearing Potential|0|||
160680034|NCT00108082|580209428|FG002|Overall Study|Woman of Child-bearing Potential|2|||
160680035|NCT00108082|580209426|FG000|Overall Study|Incorrectly Randomized|0|||
160680036|NCT00108082|580209427|FG001|Overall Study|Incorrectly Randomized|0|||
160680037|NCT00108082|580209428|FG002|Overall Study|Incorrectly Randomized|2|||
160680038|NCT00108082|580209426|FG000|Overall Study|Non-compliance|1|||
160680039|NCT00108082|580209427|FG001|Overall Study|Non-compliance|0|||
160680040|NCT00108082|580209428|FG002|Overall Study|Non-compliance|2|||
160680041|NCT00108082|580209426|FG000|Overall Study|Stopped Study Medication|0|||
160680042|NCT00108082|580209427|FG001|Overall Study|Stopped Study Medication|0|||
160680043|NCT00108082|580209428|FG002|Overall Study|Stopped Study Medication|1|||
160680044|NCT00108082|580209426|FG000|Overall Study|Site Closed Study|0|||
160680045|NCT00108082|580209427|FG001|Overall Study|Site Closed Study|2|||
160680046|NCT00108082|580209428|FG002|Overall Study|Site Closed Study|0|||
160680047|NCT00108082|580209426|FG000|Overall Study|Protocol Amendment|0|||
160680048|NCT00108082|580209427|FG001|Overall Study|Protocol Amendment|1|||
160680049|NCT00108082|580209428|FG002|Overall Study|Protocol Amendment|0|||
160680050|NCT00108082|580209426|FG000|Overall Study|Study Medication Not Tapered|0|||
160680051|NCT00108082|580209427|FG001|Overall Study|Study Medication Not Tapered|1|||
160680052|NCT00108082|580209428|FG002|Overall Study|Study Medication Not Tapered|0|||
160680053|NCT00108082|580209426|FG000|Overall Study|Subject Left Site Location|1|||
160680054|NCT00108082|580209427|FG001|Overall Study|Subject Left Site Location|0|||
160680055|NCT00108082|580209428|FG002|Overall Study|Subject Left Site Location|0|||
160680056|NCT00108082|580209426|FG000|Overall Study|Investigator Not at Site|1|||
160680057|NCT00108082|580209427|FG001|Overall Study|Investigator Not at Site|0|||
160680058|NCT00108082|580209428|FG002|Overall Study|Investigator Not at Site|0|||
160680059|NCT00108082|580209426|FG000|Overall Study|Blood Pressure Not Controlled|1|||
160680060|NCT00108082|580209427|FG001|Overall Study|Blood Pressure Not Controlled|0|||
160680061|NCT00108082|580209428|FG002|Overall Study|Blood Pressure Not Controlled|0|||
160680062|NCT01091103|580209430|FG000|Overall Study|Adverse Event|1|||
160680063|NCT01091103|580209430|FG000|Overall Study|Progressive Disease|3|||
160680064|NCT01270620|580209431|FG000|Overall Study|Withdrawal by Subject|1|||
160680065|NCT01270620|580209432|FG001|Overall Study|Withdrawal by Subject|3|||
160680066|NCT01045707|580209433|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
160680067|NCT01045707|580209434|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
160680068|NCT01045707|580209433|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
160680069|NCT01045707|580209434|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
160680070|NCT01045707|580209433|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
160680071|NCT01045707|580209434|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
160680072|NCT01045707|580209433|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
160680073|NCT01045707|580209434|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
160680074|NCT01045707|580209433|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
160680075|NCT01045707|580209434|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
160680076|NCT01045707|580209433|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
160680077|NCT01045707|580209434|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
160680078|NCT01045707|580209433|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
160680079|NCT01045707|580209434|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
160680080|NCT01045707|580209433|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
160680081|NCT01045707|580209434|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
160680082|NCT01045707|580209433|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
160680083|NCT01045707|580209434|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
160680084|NCT00809965|580209435|FG000|Overall Study|Death|194|||
160680085|NCT00809965|580209436|FG001|Overall Study|Death|147|||
160680086|NCT00809965|580209437|FG002|Overall Study|Death|196|||
160680087|NCT00809965|580209435|FG000|Overall Study|Lost to Follow-up|17|||
160680088|NCT00809965|580209436|FG001|Overall Study|Lost to Follow-up|10|||
160680089|NCT00809965|580209437|FG002|Overall Study|Lost to Follow-up|18|||
160680090|NCT00809965|580209435|FG000|Overall Study|Withdrawal by Subject|405|||
160680091|NCT00809965|580209436|FG001|Overall Study|Withdrawal by Subject|448|||
160680092|NCT00809965|580209437|FG002|Overall Study|Withdrawal by Subject|441|||
160680093|NCT00809965|580209435|FG000|Overall Study|Other Reason|167|||
160680094|NCT00809965|580209436|FG001|Overall Study|Other Reason|170|||
160680095|NCT00809965|580209437|FG002|Overall Study|Other Reason|189|||
160680096|NCT02780167|580209438|FG000|Overall Study|Adverse Event|9|||
160680097|NCT02780167|580209439|FG001|Overall Study|Adverse Event|8|||
160680098|NCT02780167|580209440|FG002|Overall Study|Adverse Event|8|||
160680099|NCT02780167|580209441|FG003|Overall Study|Adverse Event|12|||
160680100|NCT02780167|580209442|FG004|Overall Study|Adverse Event|8|||
160680101|NCT02780167|580209438|FG000|Overall Study|Lack of Efficacy|6|||
160680102|NCT02780167|580209439|FG001|Overall Study|Lack of Efficacy|5|||
160680103|NCT02780167|580209440|FG002|Overall Study|Lack of Efficacy|6|||
160680104|NCT02780167|580209441|FG003|Overall Study|Lack of Efficacy|1|||
160680105|NCT02780167|580209442|FG004|Overall Study|Lack of Efficacy|0|||
160680106|NCT02780167|580209438|FG000|Overall Study|Lost to Follow-up|2|||
160680107|NCT02780167|580209439|FG001|Overall Study|Lost to Follow-up|0|||
160680108|NCT02780167|580209440|FG002|Overall Study|Lost to Follow-up|1|||
160680109|NCT02780167|580209441|FG003|Overall Study|Lost to Follow-up|0|||
160680110|NCT02780167|580209442|FG004|Overall Study|Lost to Follow-up|0|||
160680111|NCT02780167|580209438|FG000|Overall Study|Does not meet entrance criteria|0|||
160680112|NCT02780167|580209439|FG001|Overall Study|Does not meet entrance criteria|0|||
160680113|NCT02780167|580209440|FG002|Overall Study|Does not meet entrance criteria|1|||
160680114|NCT02780167|580209441|FG003|Overall Study|Does not meet entrance criteria|0|||
160680115|NCT02780167|580209442|FG004|Overall Study|Does not meet entrance criteria|0|||
160680116|NCT02780167|580209438|FG000|Overall Study|No longer meets eligibility criteria|0|||
160680117|NCT02780167|580209439|FG001|Overall Study|No longer meets eligibility criteria|0|||
160680118|NCT02780167|580209440|FG002|Overall Study|No longer meets eligibility criteria|0|||
160680119|NCT02780167|580209441|FG003|Overall Study|No longer meets eligibility criteria|1|||
160680120|NCT02780167|580209442|FG004|Overall Study|No longer meets eligibility criteria|1|||
160680121|NCT02780167|580209438|FG000|Overall Study|Protocol Violation|5|||
160680122|NCT02780167|580209439|FG001|Overall Study|Protocol Violation|5|||
160680123|NCT02780167|580209440|FG002|Overall Study|Protocol Violation|1|||
160680124|NCT02780167|580209441|FG003|Overall Study|Protocol Violation|1|||
160680125|NCT02780167|580209442|FG004|Overall Study|Protocol Violation|2|||
160680126|NCT02780167|580209438|FG000|Overall Study|Withdrawal by Subject|6|||
160680127|NCT02780167|580209439|FG001|Overall Study|Withdrawal by Subject|4|||
160680128|NCT02780167|580209440|FG002|Overall Study|Withdrawal by Subject|4|||
160680129|NCT02780167|580209441|FG003|Overall Study|Withdrawal by Subject|3|||
160680130|NCT02780167|580209442|FG004|Overall Study|Withdrawal by Subject|4|||
160680131|NCT02780167|580209438|FG000|Overall Study|Other|0|||
160680132|NCT02780167|580209439|FG001|Overall Study|Other|0|||
160680133|NCT02780167|580209440|FG002|Overall Study|Other|3|||
160680134|NCT02780167|580209441|FG003|Overall Study|Other|1|||
160680135|NCT02780167|580209442|FG004|Overall Study|Other|2|||
160680136|NCT05552261|580209444|FG000|Overall Study|Withdrawal by Subject|1|||
160680137|NCT05552261|580209444|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
160680138|NCT02315066|580209445|FG000|Overall Study|Lost to Follow-up|0|||
160680139|NCT02315066|580209446|FG001|Overall Study|Lost to Follow-up|1|||
160680140|NCT02315066|580209447|FG002|Overall Study|Lost to Follow-up|1|||
160680141|NCT02315066|580209448|FG003|Overall Study|Lost to Follow-up|0|||
160680142|NCT02315066|580209449|FG004|Overall Study|Lost to Follow-up|1|||
160680143|NCT02315066|580209450|FG005|Overall Study|Lost to Follow-up|0|||
160680144|NCT02315066|580209451|FG006|Overall Study|Lost to Follow-up|2|||
160680145|NCT02315066|580209452|FG007|Overall Study|Lost to Follow-up|1|||
160680146|NCT02315066|580209453|FG008|Overall Study|Lost to Follow-up|0|||
160680147|NCT02315066|580209454|FG009|Overall Study|Lost to Follow-up|0|||
160680148|NCT02315066|580209455|FG010|Overall Study|Lost to Follow-up|1|||
160680149|NCT02315066|580209456|FG011|Overall Study|Lost to Follow-up|2|||
160680150|NCT02315066|580209457|FG012|Overall Study|Lost to Follow-up|0|||
160680151|NCT02315066|580209458|FG013|Overall Study|Lost to Follow-up|4|||
160680152|NCT02315066|580209445|FG000|Overall Study|Death|2|||
160680153|NCT02315066|580209446|FG001|Overall Study|Death|7|||
160680154|NCT02315066|580209447|FG002|Overall Study|Death|6|||
160680155|NCT02315066|580209448|FG003|Overall Study|Death|11|||
160680156|NCT02315066|580209449|FG004|Overall Study|Death|10|||
160680157|NCT02315066|580209450|FG005|Overall Study|Death|3|||
160680158|NCT02315066|580209451|FG006|Overall Study|Death|9|||
160680159|NCT02315066|580209452|FG007|Overall Study|Death|9|||
160680160|NCT02315066|580209453|FG008|Overall Study|Death|10|||
160680161|NCT02315066|580209454|FG009|Overall Study|Death|8|||
160680162|NCT02315066|580209455|FG010|Overall Study|Death|10|||
160680163|NCT02315066|580209456|FG011|Overall Study|Death|7|||
160680164|NCT02315066|580209457|FG012|Overall Study|Death|8|||
160680165|NCT02315066|580209458|FG013|Overall Study|Death|21|||
160680166|NCT02315066|580209445|FG000|Overall Study|Other|0|||
160680167|NCT02315066|580209446|FG001|Overall Study|Other|0|||
160680168|NCT02315066|580209447|FG002|Overall Study|Other|0|||
160680169|NCT02315066|580209448|FG003|Overall Study|Other|0|||
160680170|NCT02315066|580209449|FG004|Overall Study|Other|0|||
160680171|NCT02315066|580209450|FG005|Overall Study|Other|0|||
160680172|NCT02315066|580209451|FG006|Overall Study|Other|0|||
160680173|NCT02315066|580209452|FG007|Overall Study|Other|1|||
160680174|NCT02315066|580209453|FG008|Overall Study|Other|1|||
160680175|NCT02315066|580209454|FG009|Overall Study|Other|2|||
160680176|NCT02315066|580209455|FG010|Overall Study|Other|0|||
160680177|NCT02315066|580209456|FG011|Overall Study|Other|0|||
160680178|NCT02315066|580209457|FG012|Overall Study|Other|0|||
160680179|NCT02315066|580209458|FG013|Overall Study|Other|0|||
160680180|NCT02315066|580209445|FG000|Overall Study|Subject refused further follow-up|0|||
160680181|NCT02315066|580209446|FG001|Overall Study|Subject refused further follow-up|2|||
160680182|NCT02315066|580209447|FG002|Overall Study|Subject refused further follow-up|2|||
160680183|NCT02315066|580209448|FG003|Overall Study|Subject refused further follow-up|0|||
160680184|NCT02315066|580209449|FG004|Overall Study|Subject refused further follow-up|0|||
160680185|NCT02315066|580209450|FG005|Overall Study|Subject refused further follow-up|0|||
160680186|NCT02315066|580209451|FG006|Overall Study|Subject refused further follow-up|2|||
160680187|NCT02315066|580209452|FG007|Overall Study|Subject refused further follow-up|3|||
160680188|NCT02315066|580209453|FG008|Overall Study|Subject refused further follow-up|0|||
160680189|NCT02315066|580209454|FG009|Overall Study|Subject refused further follow-up|1|||
160680190|NCT02315066|580209455|FG010|Overall Study|Subject refused further follow-up|1|||
160680191|NCT02315066|580209456|FG011|Overall Study|Subject refused further follow-up|2|||
160680192|NCT02315066|580209457|FG012|Overall Study|Subject refused further follow-up|2|||
160680193|NCT02315066|580209458|FG013|Overall Study|Subject refused further follow-up|4|||
160680194|NCT02315066|580209445|FG000|Overall Study|Study ongoing at date of cut-off|0|||
160680195|NCT02315066|580209446|FG001|Overall Study|Study ongoing at date of cut-off|0|||
160680196|NCT02315066|580209447|FG002|Overall Study|Study ongoing at date of cut-off|0|||
160680197|NCT02315066|580209448|FG003|Overall Study|Study ongoing at date of cut-off|0|||
160680198|NCT02315066|580209449|FG004|Overall Study|Study ongoing at date of cut-off|0|||
160680199|NCT02315066|580209450|FG005|Overall Study|Study ongoing at date of cut-off|0|||
160680200|NCT02315066|580209451|FG006|Overall Study|Study ongoing at date of cut-off|0|||
160680201|NCT02315066|580209452|FG007|Overall Study|Study ongoing at date of cut-off|0|||
160680202|NCT02315066|580209453|FG008|Overall Study|Study ongoing at date of cut-off|0|||
160680203|NCT02315066|580209454|FG009|Overall Study|Study ongoing at date of cut-off|0|||
160680204|NCT02315066|580209455|FG010|Overall Study|Study ongoing at date of cut-off|0|||
160680205|NCT02315066|580209456|FG011|Overall Study|Study ongoing at date of cut-off|0|||
160680206|NCT02315066|580209457|FG012|Overall Study|Study ongoing at date of cut-off|0|||
160680207|NCT02315066|580209458|FG013|Overall Study|Study ongoing at date of cut-off|1|||
160680208|NCT02916693|580209459|FG000|Overall Study|Lost to Follow-up|7|||
160680209|NCT00979212|580209463|FG000|Overall Study|Protocol Violation|1|||
160680210|NCT00979212|580209464|FG001|Overall Study|Protocol Violation|8|||
160680211|NCT00979212|580209463|FG000|Overall Study|No protocol therapy received|1|||
160680212|NCT00979212|580209464|FG001|Overall Study|No protocol therapy received|0|||
160680213|NCT03223909|580209465|FG000|Overall Study|Protocol Violation|48|||
160680214|NCT03223909|580209466|FG001|Overall Study|Protocol Violation|45|||
160680215|NCT03223909|580209467|FG002|Overall Study|Protocol Violation|16|||
160680216|NCT04886063|580209474|FG000|Overall Study|Adverse Event|50|||
160680217|NCT04886063|580209474|FG000|Overall Study|Lack of Efficacy|31|||
160680218|NCT04886063|580209474|FG000|Overall Study|Withdrawal by Subject|45|||
160680219|NCT04886063|580209474|FG000|Overall Study|Physician Decision|3|||
160680220|NCT04886063|580209474|FG000|Overall Study|Protocol Violation|3|||
160680221|NCT04886063|580209474|FG000|Overall Study|Site closure|4|||
160680222|NCT04886063|580209474|FG000|Overall Study|Nursing home replacement|3|||
160680223|NCT04886063|580209474|FG000|Overall Study|Lost to Follow-up|5|||
160680224|NCT04886063|580209474|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
160680225|NCT04886063|580209474|FG000|Overall Study|>1 reason|20|||
160680226|NCT01628549|580209475|FG000|Overall Study|Adverse Event|1|||
160680227|NCT01628549|580209476|FG001|Overall Study|Adverse Event|1|||
160680228|NCT01628549|580209477|FG002|Overall Study|Adverse Event|0|||
160680229|NCT01628549|580209478|FG003|Overall Study|Adverse Event|4|||
160680230|NCT01628549|580209475|FG000|Overall Study|Lost to Follow-up|3|||
160680231|NCT01628549|580209476|FG001|Overall Study|Lost to Follow-up|4|||
160680232|NCT01628549|580209477|FG002|Overall Study|Lost to Follow-up|3|||
160680233|NCT01628549|580209478|FG003|Overall Study|Lost to Follow-up|3|||
160680234|NCT01628549|580209475|FG000|Overall Study|Withdrawal by Subject|3|||
160680235|NCT01628549|580209476|FG001|Overall Study|Withdrawal by Subject|4|||
160680236|NCT01628549|580209477|FG002|Overall Study|Withdrawal by Subject|4|||
160680237|NCT01628549|580209478|FG003|Overall Study|Withdrawal by Subject|1|||
160680238|NCT01628549|580209475|FG000|Overall Study|Protocol Violation|2|||
160680239|NCT01628549|580209476|FG001|Overall Study|Protocol Violation|1|||
160680240|NCT01628549|580209477|FG002|Overall Study|Protocol Violation|1|||
160680241|NCT01628549|580209478|FG003|Overall Study|Protocol Violation|0|||
160680242|NCT01628549|580209475|FG000|Overall Study|withdrawn for noncompliance|0|||
160680243|NCT01628549|580209476|FG001|Overall Study|withdrawn for noncompliance|2|||
160680244|NCT01628549|580209477|FG002|Overall Study|withdrawn for noncompliance|1|||
160680245|NCT01628549|580209478|FG003|Overall Study|withdrawn for noncompliance|0|||
160680246|NCT01628549|580209475|FG000|Overall Study|abnormal laboratory test results|0|||
160680247|NCT01628549|580209476|FG001|Overall Study|abnormal laboratory test results|0|||
160680248|NCT01628549|580209477|FG002|Overall Study|abnormal laboratory test results|1|||
160680249|NCT01628549|580209478|FG003|Overall Study|abnormal laboratory test results|0|||
160680250|NCT01628549|580209475|FG000|Overall Study|positive pregnancy test|0|||
160680251|NCT01628549|580209476|FG001|Overall Study|positive pregnancy test|0|||
160680252|NCT01628549|580209477|FG002|Overall Study|positive pregnancy test|0|||
160680253|NCT01628549|580209478|FG003|Overall Study|positive pregnancy test|1|||
160680254|NCT03807440|580209479|FG000|Overall Study|No documentation of index date 2|320|||
160680255|NCT03807440|580209479|FG000|Overall Study|No informed consent for index date 2|117|||
160680256|NCT06128525|580209480|FG000|Overall Study|Patient withdrew consent|1|||
160680257|NCT02448563|580209481|FG000|Overall Study|Lost to Follow-up|16|||
160680258|NCT02448563|580209482|FG001|Overall Study|Lost to Follow-up|10|||
160680259|NCT02448563|580209481|FG000|Overall Study|Withdrawal by Subject|0|||
160680260|NCT02448563|580209482|FG001|Overall Study|Withdrawal by Subject|1|||
160680261|NCT00702507|580209483|FG000|Initial Treatment Phase|Adverse Event|2|||
160680262|NCT00702507|580209483|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
160680263|NCT00702507|580209483|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
160680264|NCT00702507|580209483|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
160680265|NCT00702507|580209483|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
160680266|NCT00702507|580209483|FG000|Follow-up Phase|Protocol Violation|2|||
160680267|NCT00702507|580209483|FG000|Follow-up Phase|Lost to Follow-up|23|||
160680268|NCT00702507|580209483|FG000|Follow-up Phase|Late Enrollment|1|||
160680269|NCT04194008|580209488|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
160680270|NCT04194008|580209488|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
160680271|NCT04194008|580209488|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
160680272|NCT04194008|580209488|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
160680273|NCT04194008|580209488|FG000|Treatment Phase With Nerivio|Missing data|4|||
160680274|NCT04194008|580209488|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
160680275|NCT01785615|580209489|FG000|Dietary Phase|Lost to Follow-up|0|||
160680276|NCT01785615|580209490|FG001|Dietary Phase|Lost to Follow-up|0|||
160680277|NCT01785615|580209491|FG002|Dietary Phase|Lost to Follow-up|0|||
160680278|NCT01785615|580209492|FG003|Dietary Phase|Lost to Follow-up|24|||
160680279|NCT02522780|580209493|FG000|Overall Study|Consent withdrawn by subject|5|||
160680280|NCT02522780|580209494|FG001|Overall Study|Consent withdrawn by subject|7|||
160680281|NCT02522780|580209493|FG000|Overall Study|Protocol deviation|1|||
160680282|NCT02522780|580209494|FG001|Overall Study|Protocol deviation|3|||
160680283|NCT02522780|580209493|FG000|Overall Study|Subject refused endoscopic procedure|0|||
160680284|NCT02522780|580209494|FG001|Overall Study|Subject refused endoscopic procedure|1|||
160680285|NCT02522780|580209493|FG000|Overall Study|Adverse event, non-fatal|11|||
160680286|NCT02522780|580209494|FG001|Overall Study|Adverse event, non-fatal|16|||
160680287|NCT00926367|580209495|FG000|Overall Study|Withdrawal by Subject|0|||
160680288|NCT00926367|580209496|FG001|Overall Study|Withdrawal by Subject|1|||
160680289|NCT00926367|580209495|FG000|Overall Study|Lost to Follow-up|1|||
160680290|NCT00926367|580209496|FG001|Overall Study|Lost to Follow-up|0|||
160680291|NCT00926367|580209495|FG000|Overall Study|Skin Irritation|1|||
160680292|NCT00926367|580209496|FG001|Overall Study|Skin Irritation|2|||
160680293|NCT01517867|580209497|FG000|Overall Study|never started treatment|29|||
160680294|NCT01517867|580209498|FG001|Overall Study|never started treatment|32|||
160680295|NCT01517867|580209497|FG000|Overall Study|Withdrawal by Subject|34|||
160680296|NCT01517867|580209498|FG001|Overall Study|Withdrawal by Subject|30|||
160680297|NCT01517867|580209497|FG000|Overall Study|Still in treatment at study end|0|||
160680298|NCT01517867|580209498|FG001|Overall Study|Still in treatment at study end|3|||
160680299|NCT01223027|580209503|FG000|Overall Study|Adverse Event|20|||
160680300|NCT01223027|580209504|FG001|Overall Study|Adverse Event|10|||
160680301|NCT01223027|580209503|FG000|Overall Study|Death|42|||
160680302|NCT01223027|580209504|FG001|Overall Study|Death|42|||
160680303|NCT01223027|580209503|FG000|Overall Study|Lost to Follow-up|2|||
160680304|NCT01223027|580209504|FG001|Overall Study|Lost to Follow-up|1|||
160680305|NCT01223027|580209503|FG000|Overall Study|Physician Decision|4|||
160680306|NCT01223027|580209504|FG001|Overall Study|Physician Decision|8|||
160680307|NCT01223027|580209503|FG000|Overall Study|Progressive Disease|167|||
160680308|NCT01223027|580209504|FG001|Overall Study|Progressive Disease|183|||
160680309|NCT01223027|580209503|FG000|Overall Study|Protocol Violation|2|||
160680310|NCT01223027|580209504|FG001|Overall Study|Protocol Violation|1|||
160680311|NCT01223027|580209503|FG000|Overall Study|Subject/guardian decicion|18|||
160680312|NCT01223027|580209504|FG001|Overall Study|Subject/guardian decicion|16|||
160680313|NCT01223027|580209503|FG000|Overall Study|New therapy for study indication|17|||
160680314|NCT01223027|580209504|FG001|Overall Study|New therapy for study indication|8|||
160680315|NCT01223027|580209503|FG000|Overall Study|Study terminated by sponsor|2|||
160680316|NCT01223027|580209504|FG001|Overall Study|Study terminated by sponsor|8|||
160680317|NCT03493919|580209505|FG000|Overall Study|Other|2|||
160680318|NCT03493919|580209506|FG001|Overall Study|Other|0|||
160680319|NCT03493919|580209507|FG002|Overall Study|Other|1|||
160680320|NCT03493919|580209508|FG003|Overall Study|Other|0|||
160680321|NCT03493919|580209505|FG000|Overall Study|Withdrawal by Subject|9|||
160680322|NCT03493919|580209506|FG001|Overall Study|Withdrawal by Subject|3|||
160680323|NCT03493919|580209507|FG002|Overall Study|Withdrawal by Subject|1|||
160680324|NCT03493919|580209508|FG003|Overall Study|Withdrawal by Subject|1|||
160680325|NCT03493919|580209505|FG000|Overall Study|Lost to Follow-up|5|||
160680326|NCT03493919|580209506|FG001|Overall Study|Lost to Follow-up|0|||
160680327|NCT03493919|580209507|FG002|Overall Study|Lost to Follow-up|0|||
160680328|NCT03493919|580209508|FG003|Overall Study|Lost to Follow-up|3|||
160680329|NCT03493919|580209505|FG000|Overall Study|Adverse Event|0|||
160680330|NCT03493919|580209506|FG001|Overall Study|Adverse Event|1|||
160680331|NCT03493919|580209507|FG002|Overall Study|Adverse Event|0|||
160680332|NCT03493919|580209508|FG003|Overall Study|Adverse Event|0|||
160680333|NCT01475487|580209509|FG000|Overall Study|had to leave early for personal reasons|2|||
160680334|NCT01475487|580209510|FG001|Overall Study|had to leave early for personal reasons|1|||
160680335|NCT04428645|580209511|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
160680336|NCT02014441|580211008|FG000|Overall Study|Withdrawal by Subject|12|||
160680337|NCT01363011|580211010|FG000|Main Study|Adverse Event|2|||
160680338|NCT01363011|580211011|FG001|Main Study|Adverse Event|3|||
160680339|NCT01363011|580211010|FG000|Main Study|Investigator's Discretion|1|||
160680340|NCT01363011|580211011|FG001|Main Study|Investigator's Discretion|1|||
160680341|NCT01363011|580211010|FG000|Main Study|Withdrew Consent|1|||
160680342|NCT01363011|580211011|FG001|Main Study|Withdrew Consent|4|||
160680343|NCT01363011|580211010|FG000|Main Study|Protocol Violation|0|||
160680344|NCT01363011|580211011|FG001|Main Study|Protocol Violation|1|||
160680345|NCT01363011|580211010|FG000|Extension Phase|Adverse Event|1|||
160680346|NCT01363011|580211011|FG001|Extension Phase|Adverse Event|1|||
160680347|NCT01363011|580211010|FG000|Extension Phase|Lack of Efficacy|0|||
160680348|NCT01363011|580211011|FG001|Extension Phase|Lack of Efficacy|1|||
160680349|NCT01363011|580211010|FG000|Extension Phase|Investigator's Discretion|2|||
160680350|NCT01363011|580211011|FG001|Extension Phase|Investigator's Discretion|2|||
160680351|NCT01363011|580211010|FG000|Extension Phase|Withdrew Consent|0|||
160680352|NCT01363011|580211011|FG001|Extension Phase|Withdrew Consent|1|||
160680353|NCT01363011|580211010|FG000|Extension Phase|Lost to Follow-up|0|||
160680354|NCT01363011|580211011|FG001|Extension Phase|Lost to Follow-up|2|||
160680355|NCT01363011|580211010|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
160680356|NCT01363011|580211011|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
160680357|NCT04412057|580211012|FG000|Overall Study|Death|3|||
160680358|NCT04412057|580211013|FG001|Overall Study|Death|7|||
160680359|NCT04412057|580211012|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
160680360|NCT04412057|580211013|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
160680361|NCT02457819|580211014|FG000|Overall Study|reason not given|8|||
160680362|NCT02457819|580211014|FG000|Overall Study|Withdrawal by Subject|24|||
160680363|NCT02457819|580211014|FG000|Overall Study|Protocol Violation|1|||
160680364|NCT02457819|580211014|FG000|Overall Study|non compliance with study drug|4|||
160680365|NCT02457819|580211014|FG000|Overall Study|Lost to Follow-up|10|||
160680366|NCT02457819|580211014|FG000|Overall Study|Lack of Efficacy|19|||
160680367|NCT02457819|580211014|FG000|Overall Study|Adverse Event|33|||
160680368|NCT03330236|580211016|FG000|Overall Study|Death|2|||
160680369|NCT03330236|580211017|FG001|Overall Study|Death|1|||
160680370|NCT03330236|580211016|FG000|Overall Study|Withdrawal by Subject|2|||
160680371|NCT03330236|580211017|FG001|Overall Study|Withdrawal by Subject|4|||
160680372|NCT03330236|580211016|FG000|Overall Study|Lost to Follow-up|0|||
160680373|NCT03330236|580211017|FG001|Overall Study|Lost to Follow-up|2|||
160680374|NCT03330236|580211016|FG000|Overall Study|Physician Decision|2|||
160680375|NCT03330236|580211017|FG001|Overall Study|Physician Decision|0|||
160680376|NCT03330236|580211016|FG000|Overall Study|Protocol Violation|4|||
160680377|NCT03330236|580211017|FG001|Overall Study|Protocol Violation|3|||
160680378|NCT03330236|580211016|FG000|Overall Study|SedLine malfunction/blinding|19|||
160680379|NCT03330236|580211017|FG001|Overall Study|SedLine malfunction/blinding|14|||
160680380|NCT03330236|580211016|FG000|Overall Study|Volatile anesthetics used|11|||
160680381|NCT03330236|580211017|FG001|Overall Study|Volatile anesthetics used|8|||
160680382|NCT03330236|580211016|FG000|Overall Study|Surgery aborted/converted to open|60|||
160680383|NCT03330236|580211017|FG001|Overall Study|Surgery aborted/converted to open|52|||
160680384|NCT01961882|580211018|FG000|Overall Study|Adverse Event|3|||
160680385|NCT01961882|580211019|FG001|Overall Study|Adverse Event|2|||
160680386|NCT01961882|580211018|FG000|Overall Study|Physician Decision|1|||
160680387|NCT01961882|580211019|FG001|Overall Study|Physician Decision|0|||
160680388|NCT01961882|580211018|FG000|Overall Study|Withdrawal by Subject|4|||
160680389|NCT01961882|580211019|FG001|Overall Study|Withdrawal by Subject|1|||
160680390|NCT01961882|580211018|FG000|Overall Study|Relapse of AML|39|||
160680391|NCT01961882|580211019|FG001|Overall Study|Relapse of AML|37|||
160680392|NCT01961882|580211018|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
160680393|NCT01961882|580211019|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
160680394|NCT01961882|580211018|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
160680395|NCT01961882|580211019|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
160680396|NCT01901848|580211023|FG000|Randomized and Treated|Lost to Follow-up|3|||
160680397|NCT01901848|580211024|FG001|Randomized and Treated|Lost to Follow-up|6|||
160680398|NCT01901848|580211023|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
160680399|NCT01901848|580211024|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
160680400|NCT00763555|580211025|FG000|Overall Study|Adverse Event|2|||
160680401|NCT00763555|580211026|FG001|Overall Study|Adverse Event|1|||
160680402|NCT00763555|580211025|FG000|Overall Study|Withdrawal by Subject|2|||
160680403|NCT00763555|580211026|FG001|Overall Study|Withdrawal by Subject|6|||
160680404|NCT00763555|580211025|FG000|Overall Study|Lost to Follow-up|0|||
160680405|NCT00763555|580211026|FG001|Overall Study|Lost to Follow-up|3|||
160680406|NCT01729026|580211027|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
160680407|NCT01729026|580211028|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
160680408|NCT01729026|580211027|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
160680409|NCT01729026|580211028|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
160680410|NCT01190930|580211031|FG000|Induction|Adverse Event|17|||
160680411|NCT01190930|580211032|FG001|Induction|Adverse Event|0|||
160680412|NCT01190930|580211033|FG002|Induction|Adverse Event|0|||
160680413|NCT01190930|580211034|FG003|Induction|Adverse Event|0|||
160680414|NCT01190930|580211035|FG004|Induction|Adverse Event|0|||
160680415|NCT01190930|580211036|FG005|Induction|Adverse Event|0|||
160680416|NCT01190930|580211037|FG006|Induction|Adverse Event|0|||
160680417|NCT01190930|580211038|FG007|Induction|Adverse Event|0|||
160680418|NCT01190930|580211039|FG008|Induction|Adverse Event|0|||
160680419|NCT01190930|580211040|FG009|Induction|Adverse Event|0|||
160680420|NCT01190930|580211031|FG000|Induction|Death|34|||
160680421|NCT01190930|580211032|FG001|Induction|Death|0|||
160680422|NCT01190930|580211033|FG002|Induction|Death|0|||
160680423|NCT01190930|580211034|FG003|Induction|Death|0|||
160680424|NCT01190930|580211035|FG004|Induction|Death|0|||
160680425|NCT01190930|580211036|FG005|Induction|Death|0|||
160680426|NCT01190930|580211037|FG006|Induction|Death|0|||
160680427|NCT01190930|580211038|FG007|Induction|Death|0|||
160680428|NCT01190930|580211039|FG008|Induction|Death|0|||
160680429|NCT01190930|580211040|FG009|Induction|Death|0|||
160680430|NCT01190930|580211031|FG000|Induction|Lost to Follow-up|1|||
160680431|NCT01190930|580211032|FG001|Induction|Lost to Follow-up|0|||
160680432|NCT01190930|580211033|FG002|Induction|Lost to Follow-up|0|||
160680433|NCT01190930|580211034|FG003|Induction|Lost to Follow-up|0|||
160680434|NCT01190930|580211035|FG004|Induction|Lost to Follow-up|0|||
160680435|NCT01190930|580211036|FG005|Induction|Lost to Follow-up|0|||
160680436|NCT01190930|580211037|FG006|Induction|Lost to Follow-up|0|||
160680437|NCT01190930|580211038|FG007|Induction|Lost to Follow-up|0|||
160680438|NCT01190930|580211039|FG008|Induction|Lost to Follow-up|0|||
160680439|NCT01190930|580211040|FG009|Induction|Lost to Follow-up|0|||
160680440|NCT01190930|580211031|FG000|Induction|Physician Decision|125|||
160680441|NCT01190930|580211032|FG001|Induction|Physician Decision|3|||
160680442|NCT01190930|580211033|FG002|Induction|Physician Decision|0|||
160680443|NCT01190930|580211034|FG003|Induction|Physician Decision|0|||
160680444|NCT01190930|580211035|FG004|Induction|Physician Decision|0|||
160680445|NCT01190930|580211036|FG005|Induction|Physician Decision|0|||
160680446|NCT01190930|580211037|FG006|Induction|Physician Decision|0|||
160680447|NCT01190930|580211038|FG007|Induction|Physician Decision|0|||
160680448|NCT01190930|580211039|FG008|Induction|Physician Decision|0|||
160680449|NCT01190930|580211040|FG009|Induction|Physician Decision|0|||
160680450|NCT01190930|580211031|FG000|Induction|Withdrawal by Subject|9|||
160680451|NCT01190930|580211032|FG001|Induction|Withdrawal by Subject|0|||
160680452|NCT01190930|580211033|FG002|Induction|Withdrawal by Subject|0|||
160680453|NCT01190930|580211034|FG003|Induction|Withdrawal by Subject|0|||
160680454|NCT01190930|580211035|FG004|Induction|Withdrawal by Subject|0|||
160680455|NCT01190930|580211036|FG005|Induction|Withdrawal by Subject|0|||
160680456|NCT01190930|580211037|FG006|Induction|Withdrawal by Subject|0|||
160680457|NCT01190930|580211038|FG007|Induction|Withdrawal by Subject|0|||
160680458|NCT01190930|580211039|FG008|Induction|Withdrawal by Subject|0|||
160680459|NCT01190930|580211040|FG009|Induction|Withdrawal by Subject|0|||
160680460|NCT01190930|580211031|FG000|Induction|Refusal|235|||
160680461|NCT01190930|580211032|FG001|Induction|Refusal|0|||
160680462|NCT01190930|580211033|FG002|Induction|Refusal|0|||
160680463|NCT01190930|580211034|FG003|Induction|Refusal|0|||
160680464|NCT01190930|580211035|FG004|Induction|Refusal|0|||
160680465|NCT01190930|580211036|FG005|Induction|Refusal|0|||
160680466|NCT01190930|580211037|FG006|Induction|Refusal|0|||
160680467|NCT01190930|580211038|FG007|Induction|Refusal|0|||
160680468|NCT01190930|580211039|FG008|Induction|Refusal|0|||
160680469|NCT01190930|580211040|FG009|Induction|Refusal|0|||
160680470|NCT01190930|580211031|FG000|Induction|Inevaluable|23|||
160680471|NCT01190930|580211032|FG001|Induction|Inevaluable|1|||
160680472|NCT01190930|580211033|FG002|Induction|Inevaluable|0|||
160680473|NCT01190930|580211034|FG003|Induction|Inevaluable|0|||
160680474|NCT01190930|580211035|FG004|Induction|Inevaluable|0|||
160680475|NCT01190930|580211036|FG005|Induction|Inevaluable|0|||
160680476|NCT01190930|580211037|FG006|Induction|Inevaluable|0|||
160680477|NCT01190930|580211038|FG007|Induction|Inevaluable|0|||
160680478|NCT01190930|580211039|FG008|Induction|Inevaluable|0|||
160680479|NCT01190930|580211040|FG009|Induction|Inevaluable|0|||
160680480|NCT01190930|580211031|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
160680481|NCT01190930|580211032|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160680482|NCT01190930|580211033|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160680483|NCT01190930|580211034|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160680484|NCT01190930|580211035|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160680485|NCT01190930|580211036|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160680486|NCT01190930|580211037|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160680487|NCT01190930|580211038|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160680488|NCT01190930|580211039|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160680489|NCT01190930|580211040|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160680490|NCT01190930|580211031|FG000|Induction|High Risk Downs|80|||
160680491|NCT01190930|580211032|FG001|Induction|High Risk Downs|0|||
160680492|NCT01190930|580211033|FG002|Induction|High Risk Downs|0|||
160680493|NCT01190930|580211034|FG003|Induction|High Risk Downs|0|||
160680494|NCT01190930|580211035|FG004|Induction|High Risk Downs|0|||
160680495|NCT01190930|580211036|FG005|Induction|High Risk Downs|0|||
160680496|NCT01190930|580211037|FG006|Induction|High Risk Downs|0|||
160680497|NCT01190930|580211038|FG007|Induction|High Risk Downs|0|||
160680498|NCT01190930|580211039|FG008|Induction|High Risk Downs|0|||
160680499|NCT01190930|580211040|FG009|Induction|High Risk Downs|0|||
160680500|NCT01190930|580211031|FG000|Induction|Enrollment onto another COG Protocol|1|||
160680501|NCT01190930|580211032|FG001|Induction|Enrollment onto another COG Protocol|0|||
160680502|NCT01190930|580211033|FG002|Induction|Enrollment onto another COG Protocol|0|||
160680503|NCT01190930|580211034|FG003|Induction|Enrollment onto another COG Protocol|0|||
160680504|NCT01190930|580211035|FG004|Induction|Enrollment onto another COG Protocol|0|||
160680505|NCT01190930|580211036|FG005|Induction|Enrollment onto another COG Protocol|0|||
160680506|NCT01190930|580211037|FG006|Induction|Enrollment onto another COG Protocol|0|||
160680507|NCT01190930|580211038|FG007|Induction|Enrollment onto another COG Protocol|0|||
160680508|NCT01190930|580211039|FG008|Induction|Enrollment onto another COG Protocol|0|||
160680509|NCT01190930|580211040|FG009|Induction|Enrollment onto another COG Protocol|0|||
160680510|NCT01190930|580211031|FG000|Induction|Average Risk|1847|||
160680511|NCT01190930|580211032|FG001|Induction|Average Risk|0|||
160680512|NCT01190930|580211033|FG002|Induction|Average Risk|0|||
160680513|NCT01190930|580211034|FG003|Induction|Average Risk|0|||
160680514|NCT01190930|580211035|FG004|Induction|Average Risk|0|||
160680515|NCT01190930|580211036|FG005|Induction|Average Risk|0|||
160680516|NCT01190930|580211037|FG006|Induction|Average Risk|0|||
160680517|NCT01190930|580211038|FG007|Induction|Average Risk|0|||
160680518|NCT01190930|580211039|FG008|Induction|Average Risk|0|||
160680519|NCT01190930|580211040|FG009|Induction|Average Risk|0|||
160680520|NCT01190930|580211031|FG000|Induction|High Risk|1227|||
160680521|NCT01190930|580211032|FG001|Induction|High Risk|0|||
160680522|NCT01190930|580211033|FG002|Induction|High Risk|0|||
160680523|NCT01190930|580211034|FG003|Induction|High Risk|0|||
160680524|NCT01190930|580211035|FG004|Induction|High Risk|0|||
160680525|NCT01190930|580211036|FG005|Induction|High Risk|0|||
160680526|NCT01190930|580211037|FG006|Induction|High Risk|0|||
160680527|NCT01190930|580211038|FG007|Induction|High Risk|0|||
160680528|NCT01190930|580211039|FG008|Induction|High Risk|0|||
160680529|NCT01190930|580211040|FG009|Induction|High Risk|0|||
160680530|NCT01190930|580211031|FG000|Induction|Low Risk|443|||
160680531|NCT01190930|580211032|FG001|Induction|Low Risk|0|||
160680532|NCT01190930|580211033|FG002|Induction|Low Risk|0|||
160680533|NCT01190930|580211034|FG003|Induction|Low Risk|0|||
160680534|NCT01190930|580211035|FG004|Induction|Low Risk|0|||
160680535|NCT01190930|580211036|FG005|Induction|Low Risk|0|||
160680536|NCT01190930|580211037|FG006|Induction|Low Risk|0|||
160680537|NCT01190930|580211038|FG007|Induction|Low Risk|0|||
160680538|NCT01190930|580211039|FG008|Induction|Low Risk|0|||
160680539|NCT01190930|580211040|FG009|Induction|Low Risk|0|||
160680540|NCT01190930|580211031|FG000|Induction|Very High Risk|1012|||
160680541|NCT01190930|580211032|FG001|Induction|Very High Risk|0|||
160680542|NCT01190930|580211033|FG002|Induction|Very High Risk|0|||
160680543|NCT01190930|580211034|FG003|Induction|Very High Risk|0|||
160680544|NCT01190930|580211035|FG004|Induction|Very High Risk|0|||
160680545|NCT01190930|580211036|FG005|Induction|Very High Risk|0|||
160680546|NCT01190930|580211037|FG006|Induction|Very High Risk|0|||
160680547|NCT01190930|580211038|FG007|Induction|Very High Risk|0|||
160680548|NCT01190930|580211039|FG008|Induction|Very High Risk|0|||
160680549|NCT01190930|580211040|FG009|Induction|Very High Risk|0|||
160680550|NCT01190930|580211031|FG000|Induction|Philadelphia chromosome-positive|99|||
160680551|NCT01190930|580211032|FG001|Induction|Philadelphia chromosome-positive|0|||
160680552|NCT01190930|580211033|FG002|Induction|Philadelphia chromosome-positive|0|||
160680553|NCT01190930|580211034|FG003|Induction|Philadelphia chromosome-positive|0|||
160680554|NCT01190930|580211035|FG004|Induction|Philadelphia chromosome-positive|0|||
160680555|NCT01190930|580211036|FG005|Induction|Philadelphia chromosome-positive|0|||
160680556|NCT01190930|580211037|FG006|Induction|Philadelphia chromosome-positive|0|||
160680557|NCT01190930|580211038|FG007|Induction|Philadelphia chromosome-positive|0|||
160680558|NCT01190930|580211039|FG008|Induction|Philadelphia chromosome-positive|0|||
160680559|NCT01190930|580211040|FG009|Induction|Philadelphia chromosome-positive|0|||
160680560|NCT01190930|580211031|FG000|Induction|Incomplete Induction data|63|||
160680561|NCT01190930|580211032|FG001|Induction|Incomplete Induction data|0|||
160680562|NCT01190930|580211033|FG002|Induction|Incomplete Induction data|0|||
160680563|NCT01190930|580211034|FG003|Induction|Incomplete Induction data|0|||
160680564|NCT01190930|580211035|FG004|Induction|Incomplete Induction data|0|||
160680565|NCT01190930|580211036|FG005|Induction|Incomplete Induction data|0|||
160680566|NCT01190930|580211037|FG006|Induction|Incomplete Induction data|0|||
160680567|NCT01190930|580211038|FG007|Induction|Incomplete Induction data|0|||
160680568|NCT01190930|580211039|FG008|Induction|Incomplete Induction data|0|||
160680569|NCT01190930|580211040|FG009|Induction|Incomplete Induction data|0|||
160680570|NCT01190930|580211031|FG000|Induction|Progressive disease|0|||
160680571|NCT01190930|580211032|FG001|Induction|Progressive disease|1|||
160680572|NCT01190930|580211033|FG002|Induction|Progressive disease|0|||
160680573|NCT01190930|580211034|FG003|Induction|Progressive disease|0|||
160680574|NCT01190930|580211035|FG004|Induction|Progressive disease|0|||
160680575|NCT01190930|580211036|FG005|Induction|Progressive disease|0|||
160680576|NCT01190930|580211037|FG006|Induction|Progressive disease|0|||
160680577|NCT01190930|580211038|FG007|Induction|Progressive disease|0|||
160680578|NCT01190930|580211039|FG008|Induction|Progressive disease|0|||
160680579|NCT01190930|580211040|FG009|Induction|Progressive disease|0|||
160680580|NCT01190930|580211031|FG000|Induction|No treatment|3|||
160680581|NCT01190930|580211032|FG001|Induction|No treatment|0|||
160680582|NCT01190930|580211033|FG002|Induction|No treatment|0|||
160680583|NCT01190930|580211034|FG003|Induction|No treatment|0|||
160680584|NCT01190930|580211035|FG004|Induction|No treatment|0|||
160680585|NCT01190930|580211036|FG005|Induction|No treatment|0|||
160680586|NCT01190930|580211037|FG006|Induction|No treatment|0|||
160680587|NCT01190930|580211038|FG007|Induction|No treatment|0|||
160680588|NCT01190930|580211039|FG008|Induction|No treatment|0|||
160680589|NCT01190930|580211040|FG009|Induction|No treatment|0|||
160680590|NCT01190930|580211031|FG000|Induction|Ineligible|69|||
160680591|NCT01190930|580211032|FG001|Induction|Ineligible|4|||
160680592|NCT01190930|580211033|FG002|Induction|Ineligible|0|||
160680593|NCT01190930|580211034|FG003|Induction|Ineligible|0|||
160680594|NCT01190930|580211035|FG004|Induction|Ineligible|0|||
160680595|NCT01190930|580211036|FG005|Induction|Ineligible|0|||
160680596|NCT01190930|580211037|FG006|Induction|Ineligible|0|||
160680597|NCT01190930|580211038|FG007|Induction|Ineligible|0|||
160680598|NCT01190930|580211039|FG008|Induction|Ineligible|0|||
160680599|NCT01190930|580211040|FG009|Induction|Ineligible|0|||
160680600|NCT01190930|580211031|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
160680601|NCT01190930|580211032|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
160680602|NCT01190930|580211033|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
160680603|NCT01190930|580211034|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
160680604|NCT01190930|580211035|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
160680605|NCT01190930|580211036|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
160680606|NCT01190930|580211037|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
160680607|NCT01190930|580211038|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
160680608|NCT01190930|580211039|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
160680609|NCT01190930|580211040|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
160680610|NCT01190930|580211031|FG000|Post Induction Pre-Maintenance|Death|0|||
160680611|NCT01190930|580211032|FG001|Post Induction Pre-Maintenance|Death|0|||
160680612|NCT01190930|580211033|FG002|Post Induction Pre-Maintenance|Death|8|||
160680613|NCT01190930|580211034|FG003|Post Induction Pre-Maintenance|Death|4|||
160680614|NCT01190930|580211035|FG004|Post Induction Pre-Maintenance|Death|0|||
160680615|NCT01190930|580211036|FG005|Post Induction Pre-Maintenance|Death|0|||
160680616|NCT01190930|580211037|FG006|Post Induction Pre-Maintenance|Death|0|||
160680617|NCT01190930|580211038|FG007|Post Induction Pre-Maintenance|Death|0|||
160680618|NCT01190930|580211039|FG008|Post Induction Pre-Maintenance|Death|0|||
160680619|NCT01190930|580211040|FG009|Post Induction Pre-Maintenance|Death|0|||
160680620|NCT01190930|580211031|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
160680621|NCT01190930|580211032|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
160680622|NCT01190930|580211033|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
160680623|NCT01190930|580211034|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
160680624|NCT01190930|580211035|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
160680625|NCT01190930|580211036|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
160680626|NCT01190930|580211037|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
160680627|NCT01190930|580211038|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
160680628|NCT01190930|580211039|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
160680629|NCT01190930|580211040|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
160680630|NCT01190930|580211031|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
160680631|NCT01190930|580211032|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
160680632|NCT01190930|580211033|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
160680633|NCT01190930|580211034|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
160680634|NCT01190930|580211035|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
160680635|NCT01190930|580211036|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
160680636|NCT01190930|580211037|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
160680637|NCT01190930|580211038|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
160680638|NCT01190930|580211039|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
160680639|NCT01190930|580211040|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
160680640|NCT01190930|580211031|FG000|Post Induction Pre-Maintenance|Refusal|0|||
160680641|NCT01190930|580211032|FG001|Post Induction Pre-Maintenance|Refusal|2|||
160680642|NCT01190930|580211033|FG002|Post Induction Pre-Maintenance|Refusal|694|||
160680643|NCT01190930|580211034|FG003|Post Induction Pre-Maintenance|Refusal|4|||
160680644|NCT01190930|580211035|FG004|Post Induction Pre-Maintenance|Refusal|0|||
160680645|NCT01190930|580211036|FG005|Post Induction Pre-Maintenance|Refusal|3|||
160680646|NCT01190930|580211037|FG006|Post Induction Pre-Maintenance|Refusal|0|||
160680647|NCT01190930|580211038|FG007|Post Induction Pre-Maintenance|Refusal|0|||
160680648|NCT01190930|580211039|FG008|Post Induction Pre-Maintenance|Refusal|0|||
160680649|NCT01190930|580211040|FG009|Post Induction Pre-Maintenance|Refusal|0|||
160680650|NCT01190930|580211031|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
160680651|NCT01190930|580211032|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
160680652|NCT01190930|580211033|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
160680653|NCT01190930|580211034|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
160680654|NCT01190930|580211035|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
160680655|NCT01190930|580211036|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
160680656|NCT01190930|580211037|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
160680657|NCT01190930|580211038|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
160680658|NCT01190930|580211039|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
160680659|NCT01190930|580211040|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
160680660|NCT01190930|580211031|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
160680661|NCT01190930|580211032|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
160680662|NCT01190930|580211033|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
160680663|NCT01190930|580211034|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
160680664|NCT01190930|580211035|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
160680665|NCT01190930|580211036|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
160680666|NCT01190930|580211037|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
160680667|NCT01190930|580211038|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
160680668|NCT01190930|580211039|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
160680669|NCT01190930|580211040|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
160680670|NCT01190930|580211031|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
160680671|NCT01190930|580211032|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
160680672|NCT01190930|580211033|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
160680673|NCT01190930|580211034|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
160680674|NCT01190930|580211035|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
160680675|NCT01190930|580211036|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
160680676|NCT01190930|580211037|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
160680677|NCT01190930|580211038|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
160680678|NCT01190930|580211039|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
160680679|NCT01190930|580211040|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
160680680|NCT01190930|580211031|FG000|Post Induction Pre-Maintenance|Relapse|0|||
160680681|NCT01190930|580211032|FG001|Post Induction Pre-Maintenance|Relapse|0|||
160680682|NCT01190930|580211033|FG002|Post Induction Pre-Maintenance|Relapse|1|||
160680683|NCT01190930|580211034|FG003|Post Induction Pre-Maintenance|Relapse|0|||
160680684|NCT01190930|580211035|FG004|Post Induction Pre-Maintenance|Relapse|0|||
160680685|NCT01190930|580211036|FG005|Post Induction Pre-Maintenance|Relapse|0|||
160680686|NCT01190930|580211037|FG006|Post Induction Pre-Maintenance|Relapse|0|||
160680687|NCT01190930|580211038|FG007|Post Induction Pre-Maintenance|Relapse|0|||
160680688|NCT01190930|580211039|FG008|Post Induction Pre-Maintenance|Relapse|0|||
160680689|NCT01190930|580211040|FG009|Post Induction Pre-Maintenance|Relapse|0|||
160680690|NCT01190930|580211031|FG000|Maintenance|Adverse Event|0|||
160680691|NCT01190930|580211032|FG001|Maintenance|Adverse Event|0|||
160680692|NCT01190930|580211033|FG002|Maintenance|Adverse Event|0|||
160680693|NCT01190930|580211034|FG003|Maintenance|Adverse Event|0|||
160680694|NCT01190930|580211035|FG004|Maintenance|Adverse Event|0|||
160680695|NCT01190930|580211036|FG005|Maintenance|Adverse Event|1|||
160680696|NCT01190930|580211037|FG006|Maintenance|Adverse Event|1|||
160680697|NCT01190930|580211038|FG007|Maintenance|Adverse Event|3|||
160680698|NCT01190930|580211039|FG008|Maintenance|Adverse Event|3|||
160680699|NCT01190930|580211040|FG009|Maintenance|Adverse Event|0|||
160680700|NCT01190930|580211031|FG000|Maintenance|Death|0|||
160680701|NCT01190930|580211032|FG001|Maintenance|Death|0|||
160680702|NCT01190930|580211033|FG002|Maintenance|Death|0|||
160680703|NCT01190930|580211034|FG003|Maintenance|Death|1|||
160680704|NCT01190930|580211035|FG004|Maintenance|Death|0|||
160680705|NCT01190930|580211036|FG005|Maintenance|Death|0|||
160680706|NCT01190930|580211037|FG006|Maintenance|Death|2|||
160680707|NCT01190930|580211038|FG007|Maintenance|Death|2|||
160680708|NCT01190930|580211039|FG008|Maintenance|Death|2|||
160680709|NCT01190930|580211040|FG009|Maintenance|Death|2|||
160680710|NCT01190930|580211031|FG000|Maintenance|Lost to Follow-up|0|||
160680711|NCT01190930|580211032|FG001|Maintenance|Lost to Follow-up|0|||
160680712|NCT01190930|580211033|FG002|Maintenance|Lost to Follow-up|0|||
160680713|NCT01190930|580211034|FG003|Maintenance|Lost to Follow-up|0|||
160680714|NCT01190930|580211035|FG004|Maintenance|Lost to Follow-up|0|||
160680715|NCT01190930|580211036|FG005|Maintenance|Lost to Follow-up|0|||
160680716|NCT01190930|580211037|FG006|Maintenance|Lost to Follow-up|1|||
160680717|NCT01190930|580211038|FG007|Maintenance|Lost to Follow-up|1|||
160680718|NCT01190930|580211039|FG008|Maintenance|Lost to Follow-up|1|||
160680719|NCT01190930|580211040|FG009|Maintenance|Lost to Follow-up|0|||
160680720|NCT01190930|580211031|FG000|Maintenance|Physician Decision|0|||
160680721|NCT01190930|580211032|FG001|Maintenance|Physician Decision|1|||
160680722|NCT01190930|580211033|FG002|Maintenance|Physician Decision|0|||
160680723|NCT01190930|580211034|FG003|Maintenance|Physician Decision|5|||
160680724|NCT01190930|580211035|FG004|Maintenance|Physician Decision|9|||
160680725|NCT01190930|580211036|FG005|Maintenance|Physician Decision|4|||
160680726|NCT01190930|580211037|FG006|Maintenance|Physician Decision|8|||
160680727|NCT01190930|580211038|FG007|Maintenance|Physician Decision|8|||
160680728|NCT01190930|580211039|FG008|Maintenance|Physician Decision|10|||
160680729|NCT01190930|580211040|FG009|Maintenance|Physician Decision|17|||
160680730|NCT01190930|580211031|FG000|Maintenance|Withdrawal by Subject|0|||
160680731|NCT01190930|580211032|FG001|Maintenance|Withdrawal by Subject|0|||
160680732|NCT01190930|580211033|FG002|Maintenance|Withdrawal by Subject|0|||
160680733|NCT01190930|580211034|FG003|Maintenance|Withdrawal by Subject|0|||
160680734|NCT01190930|580211035|FG004|Maintenance|Withdrawal by Subject|0|||
160680735|NCT01190930|580211036|FG005|Maintenance|Withdrawal by Subject|0|||
160680736|NCT01190930|580211037|FG006|Maintenance|Withdrawal by Subject|2|||
160680737|NCT01190930|580211038|FG007|Maintenance|Withdrawal by Subject|1|||
160680738|NCT01190930|580211039|FG008|Maintenance|Withdrawal by Subject|4|||
160680739|NCT01190930|580211040|FG009|Maintenance|Withdrawal by Subject|1|||
160680740|NCT01190930|580211031|FG000|Maintenance|Refusal|0|||
160680741|NCT01190930|580211032|FG001|Maintenance|Refusal|1|||
160680742|NCT01190930|580211033|FG002|Maintenance|Refusal|0|||
160680743|NCT01190930|580211034|FG003|Maintenance|Refusal|2|||
160680744|NCT01190930|580211035|FG004|Maintenance|Refusal|0|||
160680745|NCT01190930|580211036|FG005|Maintenance|Refusal|4|||
160680746|NCT01190930|580211037|FG006|Maintenance|Refusal|5|||
160680747|NCT01190930|580211038|FG007|Maintenance|Refusal|17|||
160680748|NCT01190930|580211039|FG008|Maintenance|Refusal|13|||
160680749|NCT01190930|580211040|FG009|Maintenance|Refusal|6|||
160680750|NCT01190930|580211031|FG000|Maintenance|second malignant neoplasm|0|||
160680751|NCT01190930|580211032|FG001|Maintenance|second malignant neoplasm|0|||
160680752|NCT01190930|580211033|FG002|Maintenance|second malignant neoplasm|0|||
160680753|NCT01190930|580211034|FG003|Maintenance|second malignant neoplasm|1|||
160680754|NCT01190930|580211035|FG004|Maintenance|second malignant neoplasm|0|||
160680755|NCT01190930|580211036|FG005|Maintenance|second malignant neoplasm|1|||
160680756|NCT01190930|580211037|FG006|Maintenance|second malignant neoplasm|0|||
160680757|NCT01190930|580211038|FG007|Maintenance|second malignant neoplasm|0|||
160680758|NCT01190930|580211039|FG008|Maintenance|second malignant neoplasm|1|||
160680759|NCT01190930|580211040|FG009|Maintenance|second malignant neoplasm|0|||
160680760|NCT01190930|580211031|FG000|Maintenance|Inevaluable|0|||
160680761|NCT01190930|580211032|FG001|Maintenance|Inevaluable|0|||
160680762|NCT01190930|580211033|FG002|Maintenance|Inevaluable|0|||
160680763|NCT01190930|580211034|FG003|Maintenance|Inevaluable|0|||
160680764|NCT01190930|580211035|FG004|Maintenance|Inevaluable|0|||
160680765|NCT01190930|580211036|FG005|Maintenance|Inevaluable|1|||
160680766|NCT01190930|580211037|FG006|Maintenance|Inevaluable|1|||
160680767|NCT01190930|580211038|FG007|Maintenance|Inevaluable|1|||
160680768|NCT01190930|580211039|FG008|Maintenance|Inevaluable|0|||
160680769|NCT01190930|580211040|FG009|Maintenance|Inevaluable|0|||
160680770|NCT01190930|580211031|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
160680771|NCT01190930|580211032|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
160680772|NCT01190930|580211033|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
160680773|NCT01190930|580211034|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
160680774|NCT01190930|580211035|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
160680775|NCT01190930|580211036|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
160680776|NCT01190930|580211037|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
160680777|NCT01190930|580211038|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
160680778|NCT01190930|580211039|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
160680779|NCT01190930|580211040|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
160680780|NCT01190930|580211031|FG000|Maintenance|Relapse|0|||
160680781|NCT01190930|580211032|FG001|Maintenance|Relapse|0|||
160680782|NCT01190930|580211033|FG002|Maintenance|Relapse|0|||
160680783|NCT01190930|580211034|FG003|Maintenance|Relapse|2|||
160680784|NCT01190930|580211035|FG004|Maintenance|Relapse|0|||
160680785|NCT01190930|580211036|FG005|Maintenance|Relapse|1|||
160680786|NCT01190930|580211037|FG006|Maintenance|Relapse|6|||
160680787|NCT01190930|580211038|FG007|Maintenance|Relapse|13|||
160680788|NCT01190930|580211039|FG008|Maintenance|Relapse|11|||
160680789|NCT01190930|580211040|FG009|Maintenance|Relapse|11|||
160680790|NCT01190930|580211031|FG000|Maintenance|Still on therapy|0|||
160680791|NCT01190930|580211032|FG001|Maintenance|Still on therapy|8|||
160680792|NCT01190930|580211033|FG002|Maintenance|Still on therapy|0|||
160680793|NCT01190930|580211034|FG003|Maintenance|Still on therapy|29|||
160680794|NCT01190930|580211035|FG004|Maintenance|Still on therapy|0|||
160680795|NCT01190930|580211036|FG005|Maintenance|Still on therapy|0|||
160680796|NCT01190930|580211037|FG006|Maintenance|Still on therapy|0|||
160680797|NCT01190930|580211038|FG007|Maintenance|Still on therapy|0|||
160680798|NCT01190930|580211039|FG008|Maintenance|Still on therapy|0|||
160680799|NCT01190930|580211040|FG009|Maintenance|Still on therapy|0|||
160680800|NCT00035555|580211041|FG000|Overall Study|Adverse Event|5|||
160680801|NCT00035555|580211042|FG001|Overall Study|Adverse Event|8|||
160680802|NCT00035555|580211043|FG002|Overall Study|Adverse Event|9|||
160680803|NCT00035555|580211041|FG000|Overall Study|Allograft loss|1|||
160680804|NCT00035555|580211042|FG001|Overall Study|Allograft loss|1|||
160680805|NCT00035555|580211043|FG002|Overall Study|Allograft loss|2|||
160680806|NCT00035555|580211041|FG000|Overall Study|Death|0|||
160680807|NCT00035555|580211042|FG001|Overall Study|Death|0|||
160680808|NCT00035555|580211043|FG002|Overall Study|Death|2|||
160680809|NCT00035555|580211041|FG000|Overall Study|Lost to Follow-up|0|||
160680810|NCT00035555|580211042|FG001|Overall Study|Lost to Follow-up|0|||
160680811|NCT00035555|580211043|FG002|Overall Study|Lost to Follow-up|1|||
160680812|NCT00035555|580211041|FG000|Overall Study|Noncompliance|0|||
160680813|NCT00035555|580211042|FG001|Overall Study|Noncompliance|1|||
160680814|NCT00035555|580211043|FG002|Overall Study|Noncompliance|1|||
160680815|NCT00035555|580211041|FG000|Overall Study|Prohibited medication|1|||
160680816|NCT00035555|580211042|FG001|Overall Study|Prohibited medication|1|||
160680817|NCT00035555|580211043|FG002|Overall Study|Prohibited medication|0|||
160680818|NCT00035555|580211041|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
160680819|NCT00035555|580211042|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
160680820|NCT00035555|580211043|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
160680821|NCT00035555|580211041|FG000|Overall Study|Withdrawal by Subject|2|||
160680822|NCT00035555|580211042|FG001|Overall Study|Withdrawal by Subject|0|||
160680823|NCT00035555|580211043|FG002|Overall Study|Withdrawal by Subject|2|||
160680824|NCT00035555|580211041|FG000|Overall Study|Investigator deemed not a good candidate|0|||
160680825|NCT00035555|580211042|FG001|Overall Study|Investigator deemed not a good candidate|0|||
160680826|NCT00035555|580211043|FG002|Overall Study|Investigator deemed not a good candidate|1|||
160680827|NCT00035555|580211041|FG000|Overall Study|Received cyclosporin in error|0|||
160680828|NCT00035555|580211042|FG001|Overall Study|Received cyclosporin in error|0|||
160680829|NCT00035555|580211043|FG002|Overall Study|Received cyclosporin in error|1|||
160680830|NCT00337428|580211044|FG000|Overall Study|Withdrawal by Subject|1|||
160680831|NCT00337428|580211045|FG001|Overall Study|Withdrawal by Subject|2|||
160680832|NCT00337428|580211044|FG000|Overall Study|Lack of Time|1|||
160680833|NCT00337428|580211045|FG001|Overall Study|Lack of Time|1|||
160680834|NCT00337428|580211044|FG000|Overall Study|Unwilling to Continue|1|||
160680835|NCT00337428|580211045|FG001|Overall Study|Unwilling to Continue|0|||
160680836|NCT00337428|580211044|FG000|Overall Study|Anorexia|1|||
160680837|NCT00337428|580211045|FG001|Overall Study|Anorexia|0|||
160680838|NCT02618382|580211046|FG000|Overall Study|Physician Decision|1|||
160680839|NCT02618382|580211046|FG000|Overall Study|Withdrawal by Subject|1|||
160680840|NCT02618382|580211046|FG000|Overall Study|Protocol Violation|1|||
160680841|NCT00177164|580211054|FG000|Overall Study|Protocol Violation|0|||
160680842|NCT00177164|580211055|FG001|Overall Study|Protocol Violation|7|||
160680843|NCT00177164|580211054|FG000|Overall Study|Lost to Follow-up|4|||
160680844|NCT00177164|580211055|FG001|Overall Study|Lost to Follow-up|5|||
160680845|NCT00177164|580211054|FG000|Overall Study|increase in alcohol and drug use|1|||
160680846|NCT00177164|580211055|FG001|Overall Study|increase in alcohol and drug use|2|||
160680847|NCT00177164|580211054|FG000|Overall Study|Adverse Event|1|||
160680848|NCT00177164|580211055|FG001|Overall Study|Adverse Event|0|||
160680849|NCT00177164|580211054|FG000|Overall Study|discharge from hospital|1|||
160680850|NCT00177164|580211055|FG001|Overall Study|discharge from hospital|0|||
160680851|NCT00177164|580211054|FG000|Overall Study|Lack of Efficacy|2|||
160680852|NCT00177164|580211055|FG001|Overall Study|Lack of Efficacy|1|||
160680853|NCT00177164|580211054|FG000|Overall Study|Pregnancy|0|||
160680854|NCT00177164|580211055|FG001|Overall Study|Pregnancy|1|||
160680855|NCT02451358|580211058|FG000|Overall Study|Withdrawal by Subject|1|||
160680856|NCT02451358|580211059|FG001|Overall Study|Withdrawal by Subject|1|||
160680857|NCT02451358|580211060|FG002|Overall Study|Withdrawal by Subject|0|||
160680858|NCT02451358|580211061|FG003|Overall Study|Withdrawal by Subject|0|||
160680859|NCT02451358|580211058|FG000|Overall Study|Protocol Violation|0|||
160680860|NCT02451358|580211059|FG001|Overall Study|Protocol Violation|1|||
160680861|NCT02451358|580211060|FG002|Overall Study|Protocol Violation|1|||
160680862|NCT02451358|580211061|FG003|Overall Study|Protocol Violation|0|||
160680863|NCT03414034|580211066|FG000|Overall Study|Adverse Event|6|||
160680864|NCT03414034|580211067|FG001|Overall Study|Adverse Event|1|||
160680865|NCT03414034|580211068|FG002|Overall Study|Adverse Event|1|||
160680866|NCT03414034|580211066|FG000|Overall Study|Death|0|||
160680867|NCT03414034|580211067|FG001|Overall Study|Death|0|||
160680868|NCT03414034|580211068|FG002|Overall Study|Death|1|||
160680869|NCT03414034|580211066|FG000|Overall Study|Non-compliance With Study Drug|0|||
160680870|NCT03414034|580211067|FG001|Overall Study|Non-compliance With Study Drug|0|||
160680871|NCT03414034|580211068|FG002|Overall Study|Non-compliance With Study Drug|1|||
160680872|NCT03414034|580211066|FG000|Overall Study|Physician Decision|1|||
160680873|NCT03414034|580211067|FG001|Overall Study|Physician Decision|3|||
160680874|NCT03414034|580211068|FG002|Overall Study|Physician Decision|2|||
160680875|NCT03414034|580211066|FG000|Overall Study|Withdrawal of Informed Consent|2|||
160680876|NCT03414034|580211067|FG001|Overall Study|Withdrawal of Informed Consent|1|||
160680877|NCT03414034|580211068|FG002|Overall Study|Withdrawal of Informed Consent|4|||
160680878|NCT03414034|580211066|FG000|Overall Study|Progressive Disease|15|||
160680879|NCT03414034|580211067|FG001|Overall Study|Progressive Disease|15|||
160680880|NCT03414034|580211068|FG002|Overall Study|Progressive Disease|17|||
160680881|NCT03414034|580211066|FG000|Overall Study|Miscellaneous|0|||
160680882|NCT03414034|580211067|FG001|Overall Study|Miscellaneous|0|||
160680883|NCT03414034|580211068|FG002|Overall Study|Miscellaneous|2|||
160680884|NCT02351167|580211070|FG000|Overall Study|Withdrawal by Subject|19|||
160680885|NCT02351167|580211071|FG001|Overall Study|Withdrawal by Subject|18|||
160680886|NCT02351167|580211072|FG002|Overall Study|Withdrawal by Subject|21|||
160680887|NCT01332968|580211073|FG000|Induction Period|Adverse Event|23|||
160680888|NCT01332968|580211074|FG001|Induction Period|Adverse Event|26|||
160680889|NCT01332968|580211075|FG002|Induction Period|Adverse Event|0|||
160680890|NCT01332968|580211076|FG003|Induction Period|Adverse Event|0|||
160680891|NCT01332968|580211077|FG004|Induction Period|Adverse Event|0|||
160680892|NCT01332968|580211078|FG005|Induction Period|Adverse Event|0|||
160680893|NCT01332968|580211079|FG006|Induction Period|Adverse Event|0|||
160680894|NCT01332968|580211080|FG007|Induction Period|Adverse Event|0|||
160680895|NCT01332968|580211073|FG000|Induction Period|Death|1|||
160680896|NCT01332968|580211074|FG001|Induction Period|Death|4|||
160680897|NCT01332968|580211075|FG002|Induction Period|Death|0|||
160680898|NCT01332968|580211076|FG003|Induction Period|Death|0|||
160680899|NCT01332968|580211077|FG004|Induction Period|Death|0|||
160680900|NCT01332968|580211078|FG005|Induction Period|Death|0|||
160680901|NCT01332968|580211079|FG006|Induction Period|Death|0|||
160680902|NCT01332968|580211080|FG007|Induction Period|Death|0|||
160680903|NCT01332968|580211073|FG000|Induction Period|Non-compliance|1|||
160680904|NCT01332968|580211074|FG001|Induction Period|Non-compliance|0|||
160680905|NCT01332968|580211075|FG002|Induction Period|Non-compliance|0|||
160680906|NCT01332968|580211076|FG003|Induction Period|Non-compliance|0|||
160680907|NCT01332968|580211077|FG004|Induction Period|Non-compliance|0|||
160680908|NCT01332968|580211078|FG005|Induction Period|Non-compliance|0|||
160680909|NCT01332968|580211079|FG006|Induction Period|Non-compliance|0|||
160680910|NCT01332968|580211080|FG007|Induction Period|Non-compliance|0|||
160680911|NCT01332968|580211073|FG000|Induction Period|Other|2|||
160680912|NCT01332968|580211074|FG001|Induction Period|Other|2|||
160680913|NCT01332968|580211075|FG002|Induction Period|Other|0|||
160680914|NCT01332968|580211076|FG003|Induction Period|Other|0|||
160680915|NCT01332968|580211077|FG004|Induction Period|Other|0|||
160680916|NCT01332968|580211078|FG005|Induction Period|Other|0|||
160680917|NCT01332968|580211079|FG006|Induction Period|Other|0|||
160680918|NCT01332968|580211080|FG007|Induction Period|Other|0|||
160680919|NCT01332968|580211073|FG000|Induction Period|Physician Decision|6|||
160680920|NCT01332968|580211074|FG001|Induction Period|Physician Decision|1|||
160680921|NCT01332968|580211075|FG002|Induction Period|Physician Decision|0|||
160680922|NCT01332968|580211076|FG003|Induction Period|Physician Decision|0|||
160680923|NCT01332968|580211077|FG004|Induction Period|Physician Decision|0|||
160680924|NCT01332968|580211078|FG005|Induction Period|Physician Decision|0|||
160680925|NCT01332968|580211079|FG006|Induction Period|Physician Decision|0|||
160680926|NCT01332968|580211080|FG007|Induction Period|Physician Decision|0|||
160680927|NCT01332968|580211073|FG000|Induction Period|Progressive Disease|15|||
160680928|NCT01332968|580211074|FG001|Induction Period|Progressive Disease|7|||
160680929|NCT01332968|580211075|FG002|Induction Period|Progressive Disease|0|||
160680930|NCT01332968|580211076|FG003|Induction Period|Progressive Disease|0|||
160680931|NCT01332968|580211077|FG004|Induction Period|Progressive Disease|0|||
160680932|NCT01332968|580211078|FG005|Induction Period|Progressive Disease|0|||
160680933|NCT01332968|580211079|FG006|Induction Period|Progressive Disease|0|||
160680934|NCT01332968|580211080|FG007|Induction Period|Progressive Disease|0|||
160680935|NCT01332968|580211073|FG000|Induction Period|Protocol Violation|3|||
160680936|NCT01332968|580211074|FG001|Induction Period|Protocol Violation|4|||
160680937|NCT01332968|580211075|FG002|Induction Period|Protocol Violation|0|||
160680938|NCT01332968|580211076|FG003|Induction Period|Protocol Violation|0|||
160680939|NCT01332968|580211077|FG004|Induction Period|Protocol Violation|0|||
160680940|NCT01332968|580211078|FG005|Induction Period|Protocol Violation|0|||
160680941|NCT01332968|580211079|FG006|Induction Period|Protocol Violation|0|||
160680942|NCT01332968|580211080|FG007|Induction Period|Protocol Violation|0|||
160680943|NCT01332968|580211073|FG000|Induction Period|Withdrawal by Subject|3|||
160680944|NCT01332968|580211074|FG001|Induction Period|Withdrawal by Subject|5|||
160680945|NCT01332968|580211075|FG002|Induction Period|Withdrawal by Subject|0|||
160680946|NCT01332968|580211076|FG003|Induction Period|Withdrawal by Subject|0|||
160680947|NCT01332968|580211077|FG004|Induction Period|Withdrawal by Subject|0|||
160680948|NCT01332968|580211078|FG005|Induction Period|Withdrawal by Subject|0|||
160680949|NCT01332968|580211079|FG006|Induction Period|Withdrawal by Subject|0|||
160680950|NCT01332968|580211080|FG007|Induction Period|Withdrawal by Subject|0|||
160680951|NCT01332968|580211073|FG000|Induction Period|Randomised but not treated|4|||
160680952|NCT01332968|580211074|FG001|Induction Period|Randomised but not treated|7|||
160680953|NCT01332968|580211075|FG002|Induction Period|Randomised but not treated|0|||
160680954|NCT01332968|580211076|FG003|Induction Period|Randomised but not treated|0|||
160680955|NCT01332968|580211077|FG004|Induction Period|Randomised but not treated|0|||
160680956|NCT01332968|580211078|FG005|Induction Period|Randomised but not treated|0|||
160680957|NCT01332968|580211079|FG006|Induction Period|Randomised but not treated|0|||
160680958|NCT01332968|580211080|FG007|Induction Period|Randomised but not treated|0|||
160680959|NCT01332968|580211073|FG000|Maintenance/Observation Period|Adverse Event|0|||
160680960|NCT01332968|580211074|FG001|Maintenance/Observation Period|Adverse Event|0|||
160680961|NCT01332968|580211075|FG002|Maintenance/Observation Period|Adverse Event|53|||
160680962|NCT01332968|580211076|FG003|Maintenance/Observation Period|Adverse Event|66|||
160680963|NCT01332968|580211077|FG004|Maintenance/Observation Period|Adverse Event|0|||
160680964|NCT01332968|580211078|FG005|Maintenance/Observation Period|Adverse Event|0|||
160680965|NCT01332968|580211079|FG006|Maintenance/Observation Period|Adverse Event|0|||
160680966|NCT01332968|580211080|FG007|Maintenance/Observation Period|Adverse Event|0|||
160680967|NCT01332968|580211073|FG000|Maintenance/Observation Period|Death|0|||
160680968|NCT01332968|580211074|FG001|Maintenance/Observation Period|Death|0|||
160680969|NCT01332968|580211075|FG002|Maintenance/Observation Period|Death|5|||
160680970|NCT01332968|580211076|FG003|Maintenance/Observation Period|Death|6|||
160680971|NCT01332968|580211077|FG004|Maintenance/Observation Period|Death|0|||
160680972|NCT01332968|580211078|FG005|Maintenance/Observation Period|Death|0|||
160680973|NCT01332968|580211079|FG006|Maintenance/Observation Period|Death|0|||
160680974|NCT01332968|580211080|FG007|Maintenance/Observation Period|Death|0|||
160680975|NCT01332968|580211073|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
160680976|NCT01332968|580211074|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
160680977|NCT01332968|580211075|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
160680978|NCT01332968|580211076|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
160680979|NCT01332968|580211077|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
160680980|NCT01332968|580211078|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
160680981|NCT01332968|580211079|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
160680982|NCT01332968|580211080|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
160680983|NCT01332968|580211073|FG000|Maintenance/Observation Period|Non-compliance|0|||
160680984|NCT01332968|580211074|FG001|Maintenance/Observation Period|Non-compliance|0|||
160680985|NCT01332968|580211075|FG002|Maintenance/Observation Period|Non-compliance|4|||
160680986|NCT01332968|580211076|FG003|Maintenance/Observation Period|Non-compliance|3|||
160680987|NCT01332968|580211077|FG004|Maintenance/Observation Period|Non-compliance|0|||
160680988|NCT01332968|580211078|FG005|Maintenance/Observation Period|Non-compliance|0|||
160680989|NCT01332968|580211079|FG006|Maintenance/Observation Period|Non-compliance|0|||
160680990|NCT01332968|580211080|FG007|Maintenance/Observation Period|Non-compliance|0|||
160680991|NCT01332968|580211073|FG000|Maintenance/Observation Period|Other|0|||
160680992|NCT01332968|580211074|FG001|Maintenance/Observation Period|Other|0|||
160680993|NCT01332968|580211075|FG002|Maintenance/Observation Period|Other|4|||
160680994|NCT01332968|580211076|FG003|Maintenance/Observation Period|Other|7|||
160680995|NCT01332968|580211077|FG004|Maintenance/Observation Period|Other|0|||
160680996|NCT01332968|580211078|FG005|Maintenance/Observation Period|Other|0|||
160680997|NCT01332968|580211079|FG006|Maintenance/Observation Period|Other|0|||
160680998|NCT01332968|580211080|FG007|Maintenance/Observation Period|Other|0|||
160680999|NCT01332968|580211073|FG000|Maintenance/Observation Period|Physician Decision|0|||
160681000|NCT01332968|580211074|FG001|Maintenance/Observation Period|Physician Decision|0|||
160681001|NCT01332968|580211075|FG002|Maintenance/Observation Period|Physician Decision|14|||
160681002|NCT01332968|580211076|FG003|Maintenance/Observation Period|Physician Decision|19|||
160681003|NCT01332968|580211077|FG004|Maintenance/Observation Period|Physician Decision|0|||
160681004|NCT01332968|580211078|FG005|Maintenance/Observation Period|Physician Decision|1|||
160681005|NCT01332968|580211079|FG006|Maintenance/Observation Period|Physician Decision|0|||
160681006|NCT01332968|580211080|FG007|Maintenance/Observation Period|Physician Decision|0|||
160681007|NCT01332968|580211073|FG000|Maintenance/Observation Period|Progressive Disease|0|||
160681008|NCT01332968|580211074|FG001|Maintenance/Observation Period|Progressive Disease|0|||
160681009|NCT01332968|580211075|FG002|Maintenance/Observation Period|Progressive Disease|72|||
160681010|NCT01332968|580211076|FG003|Maintenance/Observation Period|Progressive Disease|40|||
160681011|NCT01332968|580211077|FG004|Maintenance/Observation Period|Progressive Disease|0|||
160681012|NCT01332968|580211078|FG005|Maintenance/Observation Period|Progressive Disease|0|||
160681013|NCT01332968|580211079|FG006|Maintenance/Observation Period|Progressive Disease|0|||
160681014|NCT01332968|580211080|FG007|Maintenance/Observation Period|Progressive Disease|0|||
160681015|NCT01332968|580211073|FG000|Maintenance/Observation Period|Protocol Violation|0|||
160681016|NCT01332968|580211074|FG001|Maintenance/Observation Period|Protocol Violation|0|||
160681017|NCT01332968|580211075|FG002|Maintenance/Observation Period|Protocol Violation|1|||
160681018|NCT01332968|580211076|FG003|Maintenance/Observation Period|Protocol Violation|1|||
160681019|NCT01332968|580211077|FG004|Maintenance/Observation Period|Protocol Violation|0|||
160681020|NCT01332968|580211078|FG005|Maintenance/Observation Period|Protocol Violation|0|||
160681021|NCT01332968|580211079|FG006|Maintenance/Observation Period|Protocol Violation|0|||
160681022|NCT01332968|580211080|FG007|Maintenance/Observation Period|Protocol Violation|0|||
160681023|NCT01332968|580211073|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
160681024|NCT01332968|580211074|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
160681025|NCT01332968|580211075|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
160681026|NCT01332968|580211076|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
160681027|NCT01332968|580211077|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
160681028|NCT01332968|580211078|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
160681029|NCT01332968|580211079|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
160681030|NCT01332968|580211080|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
160681031|NCT01332968|580211073|FG000|Follow-Up Period|Adverse Event|0|||
160681032|NCT01332968|580211074|FG001|Follow-Up Period|Adverse Event|0|||
160681033|NCT01332968|580211075|FG002|Follow-Up Period|Adverse Event|0|||
160681034|NCT01332968|580211076|FG003|Follow-Up Period|Adverse Event|0|||
160681035|NCT01332968|580211077|FG004|Follow-Up Period|Adverse Event|0|||
160681036|NCT01332968|580211078|FG005|Follow-Up Period|Adverse Event|0|||
160681037|NCT01332968|580211079|FG006|Follow-Up Period|Adverse Event|0|||
160681038|NCT01332968|580211080|FG007|Follow-Up Period|Adverse Event|4|||
160681039|NCT01332968|580211073|FG000|Follow-Up Period|Death|0|||
160681040|NCT01332968|580211074|FG001|Follow-Up Period|Death|0|||
160681041|NCT01332968|580211075|FG002|Follow-Up Period|Death|0|||
160681042|NCT01332968|580211076|FG003|Follow-Up Period|Death|0|||
160681043|NCT01332968|580211077|FG004|Follow-Up Period|Death|0|||
160681044|NCT01332968|580211078|FG005|Follow-Up Period|Death|0|||
160681045|NCT01332968|580211079|FG006|Follow-Up Period|Death|27|||
160681046|NCT01332968|580211080|FG007|Follow-Up Period|Death|30|||
160681047|NCT01332968|580211073|FG000|Follow-Up Period|Lost to Follow-up|0|||
160681048|NCT01332968|580211074|FG001|Follow-Up Period|Lost to Follow-up|0|||
160681049|NCT01332968|580211075|FG002|Follow-Up Period|Lost to Follow-up|0|||
160681050|NCT01332968|580211076|FG003|Follow-Up Period|Lost to Follow-up|0|||
160681051|NCT01332968|580211077|FG004|Follow-Up Period|Lost to Follow-up|0|||
160681052|NCT01332968|580211078|FG005|Follow-Up Period|Lost to Follow-up|0|||
160681053|NCT01332968|580211079|FG006|Follow-Up Period|Lost to Follow-up|11|||
160681054|NCT01332968|580211080|FG007|Follow-Up Period|Lost to Follow-up|15|||
160681055|NCT01332968|580211073|FG000|Follow-Up Period|Non-compliance|0|||
160681056|NCT01332968|580211074|FG001|Follow-Up Period|Non-compliance|0|||
160681057|NCT01332968|580211075|FG002|Follow-Up Period|Non-compliance|0|||
160681058|NCT01332968|580211076|FG003|Follow-Up Period|Non-compliance|0|||
160681059|NCT01332968|580211077|FG004|Follow-Up Period|Non-compliance|0|||
160681060|NCT01332968|580211078|FG005|Follow-Up Period|Non-compliance|0|||
160681061|NCT01332968|580211079|FG006|Follow-Up Period|Non-compliance|4|||
160681062|NCT01332968|580211080|FG007|Follow-Up Period|Non-compliance|9|||
160681063|NCT01332968|580211073|FG000|Follow-Up Period|Other|0|||
160681064|NCT01332968|580211074|FG001|Follow-Up Period|Other|0|||
160681065|NCT01332968|580211075|FG002|Follow-Up Period|Other|0|||
160681066|NCT01332968|580211076|FG003|Follow-Up Period|Other|0|||
160681067|NCT01332968|580211077|FG004|Follow-Up Period|Other|0|||
160681068|NCT01332968|580211078|FG005|Follow-Up Period|Other|0|||
160681069|NCT01332968|580211079|FG006|Follow-Up Period|Other|18|||
160681070|NCT01332968|580211080|FG007|Follow-Up Period|Other|21|||
160681071|NCT01332968|580211073|FG000|Follow-Up Period|Physician Decision|0|||
160681072|NCT01332968|580211074|FG001|Follow-Up Period|Physician Decision|0|||
160681073|NCT01332968|580211075|FG002|Follow-Up Period|Physician Decision|0|||
160681074|NCT01332968|580211076|FG003|Follow-Up Period|Physician Decision|0|||
160681075|NCT01332968|580211077|FG004|Follow-Up Period|Physician Decision|0|||
160681076|NCT01332968|580211078|FG005|Follow-Up Period|Physician Decision|0|||
160681077|NCT01332968|580211079|FG006|Follow-Up Period|Physician Decision|12|||
160681078|NCT01332968|580211080|FG007|Follow-Up Period|Physician Decision|15|||
160681079|NCT01332968|580211073|FG000|Follow-Up Period|Progressive Disease|0|||
160681080|NCT01332968|580211074|FG001|Follow-Up Period|Progressive Disease|0|||
160681081|NCT01332968|580211075|FG002|Follow-Up Period|Progressive Disease|0|||
160681082|NCT01332968|580211076|FG003|Follow-Up Period|Progressive Disease|0|||
160681083|NCT01332968|580211077|FG004|Follow-Up Period|Progressive Disease|0|||
160681084|NCT01332968|580211078|FG005|Follow-Up Period|Progressive Disease|0|||
160681085|NCT01332968|580211079|FG006|Follow-Up Period|Progressive Disease|126|||
160681086|NCT01332968|580211080|FG007|Follow-Up Period|Progressive Disease|106|||
160681087|NCT01332968|580211073|FG000|Follow-Up Period|Protocol Violation|0|||
160681088|NCT01332968|580211074|FG001|Follow-Up Period|Protocol Violation|0|||
160681089|NCT01332968|580211075|FG002|Follow-Up Period|Protocol Violation|0|||
160681090|NCT01332968|580211076|FG003|Follow-Up Period|Protocol Violation|0|||
160681091|NCT01332968|580211077|FG004|Follow-Up Period|Protocol Violation|0|||
160681092|NCT01332968|580211078|FG005|Follow-Up Period|Protocol Violation|0|||
160681093|NCT01332968|580211079|FG006|Follow-Up Period|Protocol Violation|1|||
160681094|NCT01332968|580211080|FG007|Follow-Up Period|Protocol Violation|0|||
160681095|NCT01332968|580211073|FG000|Follow-Up Period|Withdrawal by Subject|0|||
160681096|NCT01332968|580211074|FG001|Follow-Up Period|Withdrawal by Subject|0|||
160681097|NCT01332968|580211075|FG002|Follow-Up Period|Withdrawal by Subject|0|||
160681098|NCT01332968|580211076|FG003|Follow-Up Period|Withdrawal by Subject|0|||
160681099|NCT01332968|580211077|FG004|Follow-Up Period|Withdrawal by Subject|0|||
160681100|NCT01332968|580211078|FG005|Follow-Up Period|Withdrawal by Subject|0|||
160681101|NCT01332968|580211079|FG006|Follow-Up Period|Withdrawal by Subject|29|||
160681102|NCT01332968|580211080|FG007|Follow-Up Period|Withdrawal by Subject|32|||
160633009|NCT01977482|580036152|FG005|Overall Study|Adverse Event|0|||
160633010|NCT01977482|580036147|FG000|Overall Study|Lost to Follow-up|1|||
160633011|NCT01977482|580036148|FG001|Overall Study|Lost to Follow-up|0|||
160633012|NCT01977482|580036149|FG002|Overall Study|Lost to Follow-up|0|||
160633013|NCT01977482|580036150|FG003|Overall Study|Lost to Follow-up|0|||
160633014|NCT01977482|580036151|FG004|Overall Study|Lost to Follow-up|0|||
160633015|NCT01977482|580036152|FG005|Overall Study|Lost to Follow-up|0|||
160633016|NCT01977482|580036147|FG000|Overall Study|Physician Decision|0|||
160633017|NCT01977482|580036148|FG001|Overall Study|Physician Decision|1|||
160633018|NCT01977482|580036149|FG002|Overall Study|Physician Decision|0|||
160633019|NCT01977482|580036150|FG003|Overall Study|Physician Decision|0|||
160633020|NCT01977482|580036151|FG004|Overall Study|Physician Decision|0|||
160633021|NCT01977482|580036152|FG005|Overall Study|Physician Decision|0|||
160633022|NCT01977482|580036147|FG000|Overall Study|Protocol Violation|0|||
160633023|NCT01977482|580036148|FG001|Overall Study|Protocol Violation|0|||
160633024|NCT01977482|580036149|FG002|Overall Study|Protocol Violation|1|||
160633025|NCT01977482|580036150|FG003|Overall Study|Protocol Violation|0|||
160633026|NCT01977482|580036151|FG004|Overall Study|Protocol Violation|0|||
160633027|NCT01977482|580036152|FG005|Overall Study|Protocol Violation|0|||
160633028|NCT01977482|580036147|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
160633029|NCT01977482|580036148|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
160633030|NCT01977482|580036149|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
160633031|NCT01977482|580036150|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
160633032|NCT01977482|580036151|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
160633033|NCT01977482|580036152|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
160633034|NCT01977482|580036147|FG000|Overall Study|Withdrawal by Subject|2|||
160633035|NCT01977482|580036148|FG001|Overall Study|Withdrawal by Subject|4|||
160633036|NCT01977482|580036149|FG002|Overall Study|Withdrawal by Subject|1|||
160633037|NCT01977482|580036150|FG003|Overall Study|Withdrawal by Subject|3|||
160633038|NCT01977482|580036151|FG004|Overall Study|Withdrawal by Subject|1|||
160633039|NCT01977482|580036152|FG005|Overall Study|Withdrawal by Subject|5|||
160633040|NCT01525407|580036159|FG000|Overall Study|Change in recipient treatment plan|2|||
160633041|NCT01525407|580036160|FG001|Overall Study|Change in recipient treatment plan|2|||
160633042|NCT01525407|580036159|FG000|Overall Study|Withdrawal by Subject|0|||
160633043|NCT01525407|580036160|FG001|Overall Study|Withdrawal by Subject|1|||
160633044|NCT01525407|580036159|FG000|Overall Study|Transplant was delayed|0|||
160633045|NCT01525407|580036160|FG001|Overall Study|Transplant was delayed|1|||
160633046|NCT01525407|580036159|FG000|Overall Study|Delay in Transplant|1|||
160633047|NCT01525407|580036160|FG001|Overall Study|Delay in Transplant|0|||
160633048|NCT01721369|580036161|FG000|Overall Study|Not initial etiological diagnosis|12|||
160633049|NCT05378269|580037972|FG000|Overall Study|Protocol Violation|1|||
160633050|NCT05378269|580037973|FG001|Overall Study|Protocol Violation|0|||
160633051|NCT05378269|580037974|FG002|Overall Study|Protocol Violation|2|||
160633052|NCT05378269|580037975|FG003|Overall Study|Protocol Violation|0|||
160633053|NCT05378269|580037976|FG004|Overall Study|Protocol Violation|0|||
160633054|NCT03256526|580037977|FG000|Overall Study|Adverse Event|1|||
160633055|NCT03256526|580037978|FG001|Overall Study|Adverse Event|0|||
160633056|NCT03256526|580037979|FG002|Overall Study|Adverse Event|1|||
160633057|NCT03256526|580037977|FG000|Overall Study|Lost to Follow-up|1|||
160633058|NCT03256526|580037978|FG001|Overall Study|Lost to Follow-up|0|||
160633059|NCT03256526|580037979|FG002|Overall Study|Lost to Follow-up|2|||
160633060|NCT00891527|580037980|FG000|Overall Study|Withdrawal by Subject|2|||
160633061|NCT01186744|580037981|FG000|Overall Study|Lack of Efficacy|156|||
160633062|NCT01186744|580037982|FG001|Overall Study|Lack of Efficacy|99|||
160633063|NCT01186744|580037983|FG002|Overall Study|Lack of Efficacy|0|||
160633064|NCT01186744|580037984|FG003|Overall Study|Lack of Efficacy|2|||
160633065|NCT01186744|580037985|FG004|Overall Study|Lack of Efficacy|2|||
160633066|NCT01186744|580037986|FG005|Overall Study|Lack of Efficacy|5|||
160633067|NCT01186744|580037981|FG000|Overall Study|Protocol Violation|1|||
160633068|NCT01186744|580037982|FG001|Overall Study|Protocol Violation|2|||
160633069|NCT01186744|580037983|FG002|Overall Study|Protocol Violation|0|||
160633070|NCT01186744|580037984|FG003|Overall Study|Protocol Violation|1|||
160633071|NCT01186744|580037985|FG004|Overall Study|Protocol Violation|1|||
160633072|NCT01186744|580037986|FG005|Overall Study|Protocol Violation|2|||
160633073|NCT01186744|580037981|FG000|Overall Study|Lost to Follow-up|15|||
160633074|NCT01186744|580037982|FG001|Overall Study|Lost to Follow-up|16|||
160633075|NCT01186744|580037983|FG002|Overall Study|Lost to Follow-up|2|||
160633076|NCT01186744|580037984|FG003|Overall Study|Lost to Follow-up|1|||
160633077|NCT01186744|580037985|FG004|Overall Study|Lost to Follow-up|1|||
160633078|NCT01186744|580037986|FG005|Overall Study|Lost to Follow-up|4|||
160633079|NCT01186744|580037981|FG000|Overall Study|Screen failure|1|||
160633080|NCT01186744|580037982|FG001|Overall Study|Screen failure|1|||
160633081|NCT01186744|580037983|FG002|Overall Study|Screen failure|0|||
160633082|NCT01186744|580037984|FG003|Overall Study|Screen failure|1|||
160633083|NCT01186744|580037985|FG004|Overall Study|Screen failure|0|||
160633084|NCT01186744|580037986|FG005|Overall Study|Screen failure|0|||
160633085|NCT01186744|580037981|FG000|Overall Study|Withdrawal by Subject|14|||
160633086|NCT01186744|580037982|FG001|Overall Study|Withdrawal by Subject|10|||
160681103|NCT01332968|580211073|FG000|Follow-Up Period|No reason provided|0|||
160681104|NCT01332968|580211074|FG001|Follow-Up Period|No reason provided|0|||
160681105|NCT01332968|580211075|FG002|Follow-Up Period|No reason provided|0|||
160681106|NCT01332968|580211076|FG003|Follow-Up Period|No reason provided|0|||
160681107|NCT01332968|580211077|FG004|Follow-Up Period|No reason provided|0|||
160681108|NCT01332968|580211078|FG005|Follow-Up Period|No reason provided|0|||
160681109|NCT01332968|580211079|FG006|Follow-Up Period|No reason provided|2|||
160681110|NCT01332968|580211080|FG007|Follow-Up Period|No reason provided|3|||
160681111|NCT00194792|580211081|FG000|Overall Study|Withdrawal by Subject|1|||
160681112|NCT00113919|580211083|FG000|Overall Study|Physician Decision|8|||
160681113|NCT00113919|580211083|FG000|Overall Study|Death|6|||
160681114|NCT00721955|580211091|FG000|Overall Study|Adverse Event|0|||
160681115|NCT00721955|580211092|FG001|Overall Study|Adverse Event|0|||
160681116|NCT00721955|580211093|FG002|Overall Study|Adverse Event|2|||
160681117|NCT01055886|580211094|FG000|Overall Study|Withdrawal by Subject|4|||
160681118|NCT01055886|580211095|FG001|Overall Study|Withdrawal by Subject|9|||
160681119|NCT01055886|580211094|FG000|Overall Study|Lost to Follow-up|1|||
160681120|NCT01055886|580211095|FG001|Overall Study|Lost to Follow-up|1|||
160681121|NCT01055886|580211094|FG000|Overall Study|Withdrawal by PI|0|||
160681122|NCT01055886|580211095|FG001|Overall Study|Withdrawal by PI|1|||
160681123|NCT01077258|580211101|FG000|Overall Study|Lost to Follow-up|1390|||
160681124|NCT01077258|580211101|FG000|Overall Study|Adverse drug reaction|218|||
160681125|NCT01077258|580211101|FG000|Overall Study|Lack of Efficacy|663|||
160681126|NCT01077258|580211101|FG000|Overall Study|Clinical remission|37|||
160681127|NCT01077258|580211101|FG000|Overall Study|Other reasons|260|||
160681128|NCT00726895|580211102|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
160681129|NCT00726895|580211103|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
160681130|NCT01881737|580211107|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
160681131|NCT01881737|580211107|FG000|Overall Study|Withdrawal by Subject|1|||
160681132|NCT01881737|580211107|FG000|Overall Study|Worsening of baseline behavior|1|||
160681133|NCT04106817|580211110|FG000|Overall Study|Lost to Follow-up|1|||
160681134|NCT04106817|580211111|FG001|Overall Study|Lost to Follow-up|0|||
160681135|NCT04106817|580211112|FG002|Overall Study|Lost to Follow-up|0|||
160681136|NCT02260635|580211113|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
160681137|NCT02260635|580211114|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
160681138|NCT02260635|580211113|FG000|Open-Label Extension|Study Termination|25|||
160681139|NCT02260635|580211114|FG001|Open-Label Extension|Study Termination|25|||
160681140|NCT02260635|580211113|FG000|Open-Label Extension|Withdrawal by Subject|1|||
160681141|NCT02260635|580211114|FG001|Open-Label Extension|Withdrawal by Subject|0|||
160681142|NCT01266603|580211117|FG000|Overall Study|Adverse Event|1|||
160681143|NCT01266603|580211117|FG000|Overall Study|Lack of Efficacy|14|||
160681144|NCT01266603|580211117|FG000|Overall Study|Withdrawal by Subject|1|||
160681145|NCT01266603|580211117|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
160681146|NCT04307849|580211118|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
160681147|NCT04307849|580211119|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
160681148|NCT04307849|580211120|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
160681149|NCT04307849|580211121|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
160681150|NCT04307849|580211122|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
160681151|NCT04307849|580211123|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
160681152|NCT04307849|580211118|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
160681153|NCT04307849|580211119|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
160681154|NCT04307849|580211120|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
160681155|NCT04307849|580211121|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
160681156|NCT04307849|580211122|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
160681157|NCT04307849|580211123|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
160681158|NCT04307849|580211118|FG000|Overall Study|Family member did not want them to continue|0|||
160681159|NCT04307849|580211119|FG001|Overall Study|Family member did not want them to continue|0|||
160681160|NCT04307849|580211120|FG002|Overall Study|Family member did not want them to continue|1|||
160681161|NCT04307849|580211121|FG003|Overall Study|Family member did not want them to continue|0|||
160681162|NCT04307849|580211122|FG004|Overall Study|Family member did not want them to continue|0|||
160681163|NCT04307849|580211123|FG005|Overall Study|Family member did not want them to continue|0|||
160681164|NCT04307849|580211118|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
160681165|NCT04307849|580211119|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
160681166|NCT04307849|580211120|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
160681167|NCT04307849|580211121|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
160681168|NCT04307849|580211122|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
160681169|NCT04307849|580211123|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
160681170|NCT00756717|580211124|FG000|Overall Study|Withdrawal by Subject|2|||
160681171|NCT02654015|580211125|FG000|Overall Study|Death|12|||
160681172|NCT02654015|580211125|FG000|Overall Study|Lost to Follow-up|3|||
160681173|NCT02418754|580211128|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
160681174|NCT02418754|580211129|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
160681175|NCT02418754|580211130|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
160681176|NCT02418754|580211131|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
160681177|NCT02418754|580211132|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
160681178|NCT02418754|580211128|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
160681179|NCT02418754|580211129|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
160681180|NCT02418754|580211130|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
160681181|NCT02418754|580211131|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
160681182|NCT02418754|580211132|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
160681183|NCT02418754|580211128|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
160681184|NCT02418754|580211129|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
160681185|NCT02418754|580211130|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
160681186|NCT02418754|580211131|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
160681187|NCT02418754|580211132|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
160681188|NCT02418754|580211128|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
160681189|NCT02418754|580211129|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
160681190|NCT02418754|580211130|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
160681191|NCT02418754|580211131|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
160681192|NCT02418754|580211132|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
160681193|NCT02418754|580211128|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
160681194|NCT02418754|580211129|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
160681195|NCT02418754|580211130|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
160681196|NCT02418754|580211131|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
160681197|NCT02418754|580211132|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
160681198|NCT02418754|580211128|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
160681199|NCT02418754|580211129|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
160681200|NCT02418754|580211130|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
160681201|NCT02418754|580211131|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
160681202|NCT02418754|580211132|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
160681203|NCT02418754|580211128|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
160681204|NCT02418754|580211129|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
160681205|NCT02418754|580211130|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
160681206|NCT02418754|580211131|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
160681207|NCT02418754|580211132|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
160681208|NCT02418754|580211128|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
160681209|NCT02418754|580211129|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
160681210|NCT02418754|580211130|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
160681211|NCT02418754|580211131|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
160681212|NCT02418754|580211132|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
160681213|NCT02418754|580211128|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
160681214|NCT02418754|580211129|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
160681215|NCT02418754|580211130|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
160681216|NCT02418754|580211131|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
160681217|NCT02418754|580211132|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
160681218|NCT02418754|580211128|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
160681219|NCT02418754|580211129|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
160681220|NCT02418754|580211130|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
160681221|NCT02418754|580211131|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
160681222|NCT02418754|580211132|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
160681223|NCT02418754|580211128|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
160681224|NCT02418754|580211129|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
160681225|NCT02418754|580211130|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
160681226|NCT02418754|580211131|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
160681227|NCT02418754|580211132|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
160681228|NCT00761176|580211135|FG000|Overall Study|Death|1|||
160681229|NCT00761176|580211136|FG001|Overall Study|Death|0|||
160681230|NCT00761176|580211135|FG000|Overall Study|Withdrawal by Subject|1|||
160681231|NCT00761176|580211136|FG001|Overall Study|Withdrawal by Subject|1|||
160681232|NCT02762994|580211137|FG000|Overall Study|Withdrawal by Subject|0|||
160681233|NCT02762994|580211138|FG001|Overall Study|Withdrawal by Subject|1|||
160681234|NCT02762994|580211139|FG002|Overall Study|Withdrawal by Subject|2|||
160681235|NCT02762994|580211140|FG003|Overall Study|Withdrawal by Subject|0|||
160681236|NCT02762994|580211137|FG000|Overall Study|Protocol Violation|1|||
160681237|NCT02762994|580211138|FG001|Overall Study|Protocol Violation|0|||
160681238|NCT02762994|580211139|FG002|Overall Study|Protocol Violation|0|||
160681239|NCT02762994|580211140|FG003|Overall Study|Protocol Violation|2|||
160681240|NCT05103657|580211143|FG000|Overall Study|Other reasons than listed|9|||
160681241|NCT05103657|580211144|FG001|Overall Study|Other reasons than listed|8|||
160681242|NCT05103657|580211143|FG000|Overall Study|Protocol deviation|2|||
160633087|NCT01186744|580037983|FG002|Overall Study|Withdrawal by Subject|2|||
160633088|NCT01186744|580037984|FG003|Overall Study|Withdrawal by Subject|5|||
160633089|NCT01186744|580037985|FG004|Overall Study|Withdrawal by Subject|0|||
160633090|NCT01186744|580037986|FG005|Overall Study|Withdrawal by Subject|6|||
160633091|NCT01186744|580037981|FG000|Overall Study|Study terminated by Sponsor|1|||
160633092|NCT01186744|580037982|FG001|Overall Study|Study terminated by Sponsor|0|||
160633093|NCT01186744|580037983|FG002|Overall Study|Study terminated by Sponsor|0|||
160633094|NCT01186744|580037984|FG003|Overall Study|Study terminated by Sponsor|0|||
160633095|NCT01186744|580037985|FG004|Overall Study|Study terminated by Sponsor|0|||
160633096|NCT01186744|580037986|FG005|Overall Study|Study terminated by Sponsor|0|||
160633097|NCT01186744|580037981|FG000|Overall Study|Other|9|||
160633098|NCT01186744|580037982|FG001|Overall Study|Other|10|||
160633099|NCT01186744|580037983|FG002|Overall Study|Other|1|||
160633100|NCT01186744|580037984|FG003|Overall Study|Other|2|||
160633101|NCT01186744|580037985|FG004|Overall Study|Other|1|||
160633102|NCT01186744|580037986|FG005|Overall Study|Other|5|||
160633103|NCT01186744|580037981|FG000|Overall Study|Adverse Event|10|||
160633104|NCT01186744|580037982|FG001|Overall Study|Adverse Event|14|||
160633105|NCT01186744|580037983|FG002|Overall Study|Adverse Event|1|||
160633106|NCT01186744|580037984|FG003|Overall Study|Adverse Event|0|||
160633107|NCT01186744|580037985|FG004|Overall Study|Adverse Event|1|||
160633108|NCT01186744|580037986|FG005|Overall Study|Adverse Event|4|||
160633109|NCT01186744|580037981|FG000|Overall Study|Death|1|||
160633110|NCT01186744|580037982|FG001|Overall Study|Death|0|||
160633111|NCT01186744|580037983|FG002|Overall Study|Death|0|||
160633112|NCT01186744|580037984|FG003|Overall Study|Death|0|||
160633113|NCT01186744|580037985|FG004|Overall Study|Death|0|||
160633114|NCT01186744|580037986|FG005|Overall Study|Death|0|||
160633115|NCT02406742|580037990|FG000|Overall Study|Progression of Disease|5|||
160633116|NCT02406742|580037991|FG001|Overall Study|Progression of Disease|1|||
160633117|NCT02406742|580037992|FG002|Overall Study|Progression of Disease|6|||
160633118|NCT02406742|580037990|FG000|Overall Study|Adverse Event|3|||
160633119|NCT02406742|580037991|FG001|Overall Study|Adverse Event|0|||
160633120|NCT02406742|580037992|FG002|Overall Study|Adverse Event|2|||
160633121|NCT02406742|580037990|FG000|Overall Study|Death|1|||
160633122|NCT02406742|580037991|FG001|Overall Study|Death|0|||
160633123|NCT02406742|580037992|FG002|Overall Study|Death|0|||
160633124|NCT02406742|580037990|FG000|Overall Study|Lack of Efficacy|0|||
160633125|NCT02406742|580037991|FG001|Overall Study|Lack of Efficacy|0|||
160633126|NCT02406742|580037992|FG002|Overall Study|Lack of Efficacy|1|||
160633127|NCT02406742|580037990|FG000|Overall Study|Withdrawal by Participant|1|||
160633128|NCT02406742|580037991|FG001|Overall Study|Withdrawal by Participant|2|||
160633129|NCT02406742|580037992|FG002|Overall Study|Withdrawal by Participant|0|||
160633130|NCT02406742|580037990|FG000|Overall Study|Physician Decision|1|||
160633131|NCT02406742|580037991|FG001|Overall Study|Physician Decision|2|||
160633132|NCT02406742|580037992|FG002|Overall Study|Physician Decision|1|||
160633133|NCT02406742|580037990|FG000|Overall Study|Transition to other treatment|2|||
160633134|NCT02406742|580037991|FG001|Overall Study|Transition to other treatment|0|||
160633135|NCT02406742|580037992|FG002|Overall Study|Transition to other treatment|1|||
160633136|NCT02406742|580037990|FG000|Overall Study|Other Reasons|1|||
160633137|NCT02406742|580037991|FG001|Overall Study|Other Reasons|11|||
160633138|NCT02406742|580037992|FG002|Overall Study|Other Reasons|5|||
160633139|NCT00765999|580037993|FG000|Overall Study|Adverse Event|203|||
160633140|NCT00765999|580037993|FG000|Overall Study|Insufficient Therapeutic Response|100|||
160633141|NCT00765999|580037993|FG000|Overall Study|Protocol Violation|95|||
160633142|NCT00765999|580037993|FG000|Overall Study|Consent Withdrawn|202|||
160633143|NCT00765999|580037993|FG000|Overall Study|Lost to Follow-up|131|||
160633144|NCT00765999|580037993|FG000|Overall Study|Study Terminated by Sponsor|2|||
160633145|NCT00765999|580037993|FG000|Overall Study|Other Miscellaneous Reasons|51|||
160633146|NCT02367729|580037996|FG000|Overall Study|Organic disorder diagnosed|2|||
160633147|NCT02367729|580037997|FG001|Overall Study|Organic disorder diagnosed|1|||
160633148|NCT02367729|580037996|FG000|Overall Study|Adverse Event|1|||
160633149|NCT02367729|580037997|FG001|Overall Study|Adverse Event|2|||
160633150|NCT02367729|580037996|FG000|Overall Study|Withdrawal by Subject|0|||
160633151|NCT02367729|580037997|FG001|Overall Study|Withdrawal by Subject|5|||
160633152|NCT00759174|580037998|FG000|Overall Study|Other|0|||
160633153|NCT00759174|580037999|FG001|Overall Study|Other|2|||
160633154|NCT01890109|580038000|FG000|Overall Study|Withdrawal by Subject|0|||
160633155|NCT01890109|580038001|FG001|Overall Study|Withdrawal by Subject|3|||
160633156|NCT01890109|580038000|FG000|Overall Study|Lost to Follow-up|1|||
160633157|NCT01890109|580038001|FG001|Overall Study|Lost to Follow-up|2|||
160633158|NCT01643928|580038002|FG000|Overall Study|Lost to Follow-up|1|||
160633159|NCT01643928|580038003|FG001|Overall Study|Lost to Follow-up|0|||
160633160|NCT01643928|580038004|FG002|Overall Study|Lost to Follow-up|2|||
160633161|NCT01643928|580038005|FG003|Overall Study|Lost to Follow-up|0|||
160633162|NCT01643928|580038006|FG004|Overall Study|Lost to Follow-up|0|||
160633163|NCT01643928|580038002|FG000|Overall Study|Withdrawal by Subject|2|||
160633164|NCT01643928|580038003|FG001|Overall Study|Withdrawal by Subject|0|||
160633165|NCT01643928|580038004|FG002|Overall Study|Withdrawal by Subject|0|||
160633166|NCT01643928|580038005|FG003|Overall Study|Withdrawal by Subject|1|||
160681243|NCT05103657|580211144|FG001|Overall Study|Protocol deviation|2|||
160681244|NCT05103657|580211143|FG000|Overall Study|No reason available|5|||
160681245|NCT05103657|580211144|FG001|Overall Study|No reason available|4|||
160681246|NCT05103657|580211143|FG000|Overall Study|Burden of study procedures|3|||
160681247|NCT05103657|580211144|FG001|Overall Study|Burden of study procedures|1|||
160681248|NCT05103657|580211143|FG000|Overall Study|Perceived lack of efficacy|1|||
160681249|NCT05103657|580211144|FG001|Overall Study|Perceived lack of efficacy|1|||
160681250|NCT05103657|580211143|FG000|Overall Study|Adverse Event|6|||
160681251|NCT05103657|580211144|FG001|Overall Study|Adverse Event|14|||
160681252|NCT05103657|580211143|FG000|Overall Study|Not Treated|1|||
160681253|NCT05103657|580211144|FG001|Overall Study|Not Treated|1|||
160681254|NCT02020967|580211145|FG000|Overall Study|Withdrawal by Subject|51|||
160681255|NCT02387762|580211148|FG000|Overall Study|Withdrawal by Subject|1|||
160681256|NCT02387762|580211149|FG001|Overall Study|Withdrawal by Subject|0|||
160681257|NCT04203667|580211150|FG000|Overall Study|Withdrawal by Subject|1|||
160681258|NCT04203667|580211150|FG000|Overall Study|Lost to Follow-up|1|||
160681259|NCT04203667|580211150|FG000|Overall Study|Death|1|||
160681260|NCT04203667|580211150|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
160681261|NCT01160640|580211151|FG000|Overall Study|Physician Decision|3|||
160681262|NCT01160640|580211152|FG001|Overall Study|Physician Decision|3|||
160681263|NCT01160640|580211151|FG000|Overall Study|Incarceration|1|||
160681264|NCT01160640|580211152|FG001|Overall Study|Incarceration|0|||
160681265|NCT01160640|580211151|FG000|Overall Study|Withdrawal by Subject|0|||
160681266|NCT01160640|580211152|FG001|Overall Study|Withdrawal by Subject|3|||
160681267|NCT00642811|580211155|FG000|Overall Study|Adverse Event|2|||
160681268|NCT00642811|580211156|FG001|Overall Study|Adverse Event|3|||
160681269|NCT00642811|580211157|FG002|Overall Study|Adverse Event|0|||
160681270|NCT00642811|580211158|FG003|Overall Study|Adverse Event|0|||
160681271|NCT00642811|580211159|FG004|Overall Study|Adverse Event|0|||
160681272|NCT00642811|580211160|FG005|Overall Study|Adverse Event|1|||
160681273|NCT00642811|580211155|FG000|Overall Study|Developement of discontinuation criteria|0|||
160681274|NCT00642811|580211156|FG001|Overall Study|Developement of discontinuation criteria|0|||
160681275|NCT00642811|580211157|FG002|Overall Study|Developement of discontinuation criteria|0|||
160681276|NCT00642811|580211158|FG003|Overall Study|Developement of discontinuation criteria|0|||
160681277|NCT00642811|580211159|FG004|Overall Study|Developement of discontinuation criteria|1|||
160681278|NCT00642811|580211160|FG005|Overall Study|Developement of discontinuation criteria|0|||
160681279|NCT00642811|580211155|FG000|Overall Study|Severe Non-compliance to protocol|1|||
160681280|NCT00642811|580211156|FG001|Overall Study|Severe Non-compliance to protocol|0|||
160681281|NCT00642811|580211157|FG002|Overall Study|Severe Non-compliance to protocol|0|||
160681282|NCT00642811|580211158|FG003|Overall Study|Severe Non-compliance to protocol|0|||
160681283|NCT00642811|580211159|FG004|Overall Study|Severe Non-compliance to protocol|0|||
160681284|NCT00642811|580211160|FG005|Overall Study|Severe Non-compliance to protocol|0|||
160681285|NCT00642811|580211155|FG000|Overall Study|Other|0|||
160681286|NCT00642811|580211156|FG001|Overall Study|Other|1|||
160681287|NCT00642811|580211157|FG002|Overall Study|Other|0|||
160681288|NCT00642811|580211158|FG003|Overall Study|Other|1|||
160681289|NCT00642811|580211159|FG004|Overall Study|Other|0|||
160681290|NCT00642811|580211160|FG005|Overall Study|Other|0|||
160681291|NCT01525628|580211161|FG000|Overall Study|Adverse Event|1|||
160681292|NCT01525628|580211162|FG001|Overall Study|Adverse Event|1|||
160681293|NCT01525628|580211163|FG002|Overall Study|Adverse Event|2|||
160681294|NCT01525628|580211164|FG003|Overall Study|Adverse Event|0|||
160681295|NCT01525628|580211165|FG004|Overall Study|Adverse Event|1|||
160681296|NCT01525628|580211161|FG000|Overall Study|Lack of Efficacy|0|||
160681297|NCT01525628|580211162|FG001|Overall Study|Lack of Efficacy|2|||
160681298|NCT01525628|580211163|FG002|Overall Study|Lack of Efficacy|2|||
160681299|NCT01525628|580211164|FG003|Overall Study|Lack of Efficacy|1|||
160681300|NCT01525628|580211165|FG004|Overall Study|Lack of Efficacy|2|||
160681301|NCT01525628|580211161|FG000|Overall Study|Protocol Violation|0|||
160681302|NCT01525628|580211162|FG001|Overall Study|Protocol Violation|0|||
160681303|NCT01525628|580211163|FG002|Overall Study|Protocol Violation|1|||
160681304|NCT01525628|580211164|FG003|Overall Study|Protocol Violation|0|||
160681305|NCT01525628|580211165|FG004|Overall Study|Protocol Violation|0|||
160681306|NCT01525628|580211161|FG000|Overall Study|Lost to Follow-up|1|||
160681307|NCT01525628|580211162|FG001|Overall Study|Lost to Follow-up|1|||
160681308|NCT01525628|580211163|FG002|Overall Study|Lost to Follow-up|0|||
160681309|NCT01525628|580211164|FG003|Overall Study|Lost to Follow-up|0|||
160681310|NCT01525628|580211165|FG004|Overall Study|Lost to Follow-up|0|||
160681311|NCT01525628|580211161|FG000|Overall Study|Withdrawal by Subject|0|||
160681312|NCT01525628|580211162|FG001|Overall Study|Withdrawal by Subject|1|||
160681313|NCT01525628|580211163|FG002|Overall Study|Withdrawal by Subject|0|||
160681314|NCT01525628|580211164|FG003|Overall Study|Withdrawal by Subject|0|||
160681315|NCT01525628|580211165|FG004|Overall Study|Withdrawal by Subject|0|||
160681316|NCT01525628|580211161|FG000|Overall Study|Other reason not defined above|0|||
160681317|NCT01525628|580211162|FG001|Overall Study|Other reason not defined above|0|||
160681318|NCT01525628|580211163|FG002|Overall Study|Other reason not defined above|0|||
160681319|NCT01525628|580211164|FG003|Overall Study|Other reason not defined above|3|||
160681320|NCT01525628|580211165|FG004|Overall Study|Other reason not defined above|0|||
160681321|NCT02614898|580211166|FG000|Overall Study|Participated until study termination|10|||
160681322|NCT02614898|580211167|FG001|Overall Study|Participated until study termination|26|||
160681323|NCT02614898|580211166|FG000|Overall Study|Lost to Follow-up|0|||
160681324|NCT02614898|580211167|FG001|Overall Study|Lost to Follow-up|2|||
160681325|NCT02614898|580211166|FG000|Overall Study|Physician Decision|1|||
160681326|NCT02614898|580211167|FG001|Overall Study|Physician Decision|8|||
160681327|NCT02614898|580211166|FG000|Overall Study|Study Terminated by Sponsor|3|||
160681328|NCT02614898|580211167|FG001|Overall Study|Study Terminated by Sponsor|0|||
160681329|NCT02614898|580211166|FG000|Overall Study|Withdrawal by Subject|0|||
160681330|NCT02614898|580211167|FG001|Overall Study|Withdrawal by Subject|2|||
160681331|NCT02614898|580211166|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160681332|NCT02614898|580211167|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160681333|NCT02614898|580211166|FG000|Overall Study|Other-Additional Information Unavailable|0|||
160681334|NCT02614898|580211167|FG001|Overall Study|Other-Additional Information Unavailable|11|||
160681335|NCT02614898|580211166|FG000|Overall Study|Missing|0|||
160681336|NCT02614898|580211167|FG001|Overall Study|Missing|1|||
160681337|NCT00787605|580211168|FG000|Overall Study|Administrative Problems|3|||
160681338|NCT00787605|580211169|FG001|Overall Study|Administrative Problems|0|||
160681339|NCT00787605|580211168|FG000|Overall Study|Adverse Event|14|||
160681340|NCT00787605|580211169|FG001|Overall Study|Adverse Event|25|||
160681341|NCT00787605|580211168|FG000|Overall Study|Lost to Follow-up|3|||
160681342|NCT00787605|580211169|FG001|Overall Study|Lost to Follow-up|6|||
160681343|NCT00787605|580211168|FG000|Overall Study|Protocol Violation|7|||
160681344|NCT00787605|580211169|FG001|Overall Study|Protocol Violation|3|||
160681345|NCT00787605|580211168|FG000|Overall Study|Withdrawal by Subject|6|||
160681346|NCT00787605|580211169|FG001|Overall Study|Withdrawal by Subject|13|||
160681347|NCT00787605|580211168|FG000|Overall Study|Lack of Efficacy|13|||
160681348|NCT00787605|580211169|FG001|Overall Study|Lack of Efficacy|9|||
160681349|NCT00810602|580211174|FG000|Overall Study|Withdrawal by Subject|8|||
160681350|NCT00810602|580211175|FG001|Overall Study|Withdrawal by Subject|3|||
160681351|NCT00401245|580213407|FG000|Double Blind Titration Phase|Adverse Event|3|||
160681352|NCT00401245|580213408|FG001|Double Blind Titration Phase|Adverse Event|2|||
160681353|NCT00401245|580213409|FG002|Double Blind Titration Phase|Adverse Event|5|||
160681354|NCT00401245|580213410|FG003|Double Blind Titration Phase|Adverse Event|12|||
160681355|NCT00401245|580213411|FG004|Double Blind Titration Phase|Adverse Event|0|||
160681356|NCT00401245|580213412|FG005|Double Blind Titration Phase|Adverse Event|0|||
160681357|NCT00401245|580213413|FG006|Double Blind Titration Phase|Adverse Event|0|||
160681358|NCT00401245|580213414|FG007|Double Blind Titration Phase|Adverse Event|0|||
160681359|NCT00401245|580213407|FG000|Double Blind Titration Phase|Other|0|||
160681360|NCT00401245|580213408|FG001|Double Blind Titration Phase|Other|0|||
160681361|NCT00401245|580213409|FG002|Double Blind Titration Phase|Other|1|||
160681362|NCT00401245|580213410|FG003|Double Blind Titration Phase|Other|0|||
160681363|NCT00401245|580213411|FG004|Double Blind Titration Phase|Other|0|||
160681364|NCT00401245|580213412|FG005|Double Blind Titration Phase|Other|0|||
160681365|NCT00401245|580213413|FG006|Double Blind Titration Phase|Other|0|||
160681366|NCT00401245|580213414|FG007|Double Blind Titration Phase|Other|0|||
160681367|NCT00401245|580213407|FG000|Double Blind Titration Phase|Protocol Violation|0|||
160681368|NCT00401245|580213408|FG001|Double Blind Titration Phase|Protocol Violation|0|||
160681369|NCT00401245|580213409|FG002|Double Blind Titration Phase|Protocol Violation|0|||
160681370|NCT00401245|580213410|FG003|Double Blind Titration Phase|Protocol Violation|1|||
160681371|NCT00401245|580213411|FG004|Double Blind Titration Phase|Protocol Violation|0|||
160681372|NCT00401245|580213412|FG005|Double Blind Titration Phase|Protocol Violation|0|||
160681373|NCT00401245|580213413|FG006|Double Blind Titration Phase|Protocol Violation|0|||
160681374|NCT00401245|580213414|FG007|Double Blind Titration Phase|Protocol Violation|0|||
160681375|NCT00401245|580213407|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
160681376|NCT00401245|580213408|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
160681377|NCT00401245|580213409|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
160681378|NCT00401245|580213410|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
160681379|NCT00401245|580213411|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
160681380|NCT00401245|580213412|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
160681381|NCT00401245|580213413|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
160681382|NCT00401245|580213414|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
160681383|NCT00401245|580213407|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
160681384|NCT00401245|580213408|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
160681385|NCT00401245|580213409|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
160681386|NCT00401245|580213410|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
160681387|NCT00401245|580213411|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
160681388|NCT00401245|580213412|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
160681389|NCT00401245|580213413|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
160681390|NCT00401245|580213414|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
160681391|NCT00401245|580213407|FG000|Open Label Phase|Adverse Event|5|||
160681392|NCT00401245|580213408|FG001|Open Label Phase|Adverse Event|14|||
160681393|NCT00401245|580213409|FG002|Open Label Phase|Adverse Event|6|||
160681394|NCT00401245|580213410|FG003|Open Label Phase|Adverse Event|7|||
160681395|NCT00401245|580213411|FG004|Open Label Phase|Adverse Event|0|||
160681396|NCT00401245|580213412|FG005|Open Label Phase|Adverse Event|0|||
160681397|NCT00401245|580213413|FG006|Open Label Phase|Adverse Event|0|||
160681398|NCT00401245|580213414|FG007|Open Label Phase|Adverse Event|0|||
160681399|NCT00401245|580213407|FG000|Open Label Phase|Lost to Follow-up|5|||
160681400|NCT00401245|580213408|FG001|Open Label Phase|Lost to Follow-up|7|||
160681401|NCT00401245|580213409|FG002|Open Label Phase|Lost to Follow-up|5|||
160681402|NCT00401245|580213410|FG003|Open Label Phase|Lost to Follow-up|4|||
160681403|NCT00401245|580213411|FG004|Open Label Phase|Lost to Follow-up|0|||
160681404|NCT00401245|580213412|FG005|Open Label Phase|Lost to Follow-up|0|||
160681405|NCT00401245|580213413|FG006|Open Label Phase|Lost to Follow-up|0|||
160681406|NCT00401245|580213414|FG007|Open Label Phase|Lost to Follow-up|0|||
160681407|NCT00401245|580213407|FG000|Open Label Phase|Other|4|||
160681408|NCT00401245|580213408|FG001|Open Label Phase|Other|8|||
160681409|NCT00401245|580213409|FG002|Open Label Phase|Other|7|||
160681410|NCT00401245|580213410|FG003|Open Label Phase|Other|8|||
160681411|NCT00401245|580213411|FG004|Open Label Phase|Other|0|||
160681412|NCT00401245|580213412|FG005|Open Label Phase|Other|0|||
160681413|NCT00401245|580213413|FG006|Open Label Phase|Other|0|||
160681414|NCT00401245|580213414|FG007|Open Label Phase|Other|0|||
160681415|NCT00401245|580213407|FG000|Open Label Phase|Protocol Violation|0|||
160681416|NCT00401245|580213408|FG001|Open Label Phase|Protocol Violation|1|||
160681417|NCT00401245|580213409|FG002|Open Label Phase|Protocol Violation|0|||
160681418|NCT00401245|580213410|FG003|Open Label Phase|Protocol Violation|1|||
160681419|NCT00401245|580213411|FG004|Open Label Phase|Protocol Violation|0|||
160681420|NCT00401245|580213412|FG005|Open Label Phase|Protocol Violation|0|||
160681421|NCT00401245|580213413|FG006|Open Label Phase|Protocol Violation|0|||
160681422|NCT00401245|580213414|FG007|Open Label Phase|Protocol Violation|0|||
160681423|NCT00401245|580213407|FG000|Open Label Phase|Withdrawal by Subject|3|||
160681424|NCT00401245|580213408|FG001|Open Label Phase|Withdrawal by Subject|3|||
160681425|NCT00401245|580213409|FG002|Open Label Phase|Withdrawal by Subject|2|||
160681426|NCT00401245|580213410|FG003|Open Label Phase|Withdrawal by Subject|1|||
160681427|NCT00401245|580213411|FG004|Open Label Phase|Withdrawal by Subject|0|||
160681428|NCT00401245|580213412|FG005|Open Label Phase|Withdrawal by Subject|0|||
160681429|NCT00401245|580213413|FG006|Open Label Phase|Withdrawal by Subject|0|||
160681430|NCT00401245|580213414|FG007|Open Label Phase|Withdrawal by Subject|0|||
160681431|NCT00401245|580213407|FG000|Open Label Phase|Lack of Efficacy|4|||
160681432|NCT00401245|580213408|FG001|Open Label Phase|Lack of Efficacy|2|||
160681433|NCT00401245|580213409|FG002|Open Label Phase|Lack of Efficacy|3|||
160681434|NCT00401245|580213410|FG003|Open Label Phase|Lack of Efficacy|0|||
160681435|NCT00401245|580213411|FG004|Open Label Phase|Lack of Efficacy|0|||
160681436|NCT00401245|580213412|FG005|Open Label Phase|Lack of Efficacy|0|||
160681437|NCT00401245|580213413|FG006|Open Label Phase|Lack of Efficacy|0|||
160681438|NCT00401245|580213414|FG007|Open Label Phase|Lack of Efficacy|0|||
160681439|NCT00401245|580213407|FG000|Double Blind Tapering Phase|Adverse Event|0|||
160681440|NCT00401245|580213408|FG001|Double Blind Tapering Phase|Adverse Event|0|||
160681441|NCT00401245|580213409|FG002|Double Blind Tapering Phase|Adverse Event|0|||
160681442|NCT00401245|580213410|FG003|Double Blind Tapering Phase|Adverse Event|0|||
160681443|NCT00401245|580213411|FG004|Double Blind Tapering Phase|Adverse Event|1|||
160681444|NCT00401245|580213412|FG005|Double Blind Tapering Phase|Adverse Event|1|||
160681445|NCT00401245|580213413|FG006|Double Blind Tapering Phase|Adverse Event|2|||
160681446|NCT00401245|580213414|FG007|Double Blind Tapering Phase|Adverse Event|4|||
160681447|NCT00401245|580213407|FG000|Double Blind Tapering Phase|Investigator request|0|||
160681448|NCT00401245|580213408|FG001|Double Blind Tapering Phase|Investigator request|0|||
160681449|NCT00401245|580213409|FG002|Double Blind Tapering Phase|Investigator request|0|||
160681450|NCT00401245|580213410|FG003|Double Blind Tapering Phase|Investigator request|0|||
160681451|NCT00401245|580213411|FG004|Double Blind Tapering Phase|Investigator request|0|||
160681452|NCT00401245|580213412|FG005|Double Blind Tapering Phase|Investigator request|0|||
160681453|NCT00401245|580213413|FG006|Double Blind Tapering Phase|Investigator request|0|||
160681454|NCT00401245|580213414|FG007|Double Blind Tapering Phase|Investigator request|1|||
160681455|NCT00401245|580213407|FG000|Double Blind Tapering Phase|Other|0|||
160681456|NCT00401245|580213408|FG001|Double Blind Tapering Phase|Other|0|||
160681457|NCT00401245|580213409|FG002|Double Blind Tapering Phase|Other|0|||
160681458|NCT00401245|580213410|FG003|Double Blind Tapering Phase|Other|0|||
160681459|NCT00401245|580213411|FG004|Double Blind Tapering Phase|Other|1|||
160681460|NCT00401245|580213412|FG005|Double Blind Tapering Phase|Other|0|||
160681461|NCT00401245|580213413|FG006|Double Blind Tapering Phase|Other|2|||
160681462|NCT00401245|580213414|FG007|Double Blind Tapering Phase|Other|2|||
160681463|NCT00401245|580213407|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
160681464|NCT00401245|580213408|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
160681465|NCT00401245|580213409|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
160681466|NCT00401245|580213410|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
160681467|NCT00401245|580213411|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
160681468|NCT00401245|580213412|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
160681469|NCT00401245|580213413|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
160681470|NCT00401245|580213414|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
160681471|NCT00401245|580213407|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
160681472|NCT00401245|580213408|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
160681473|NCT00401245|580213409|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
160681474|NCT00401245|580213410|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
160681475|NCT00401245|580213411|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
160681476|NCT00401245|580213412|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
160681477|NCT00401245|580213413|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
160681478|NCT00401245|580213414|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
160681479|NCT00996437|580213415|FG000|Overall Study|Death|1|||
160681480|NCT00996437|580213416|FG001|Overall Study|Death|0|||
160681481|NCT00996437|580213415|FG000|Overall Study|Dropped|2|||
160681482|NCT00996437|580213416|FG001|Overall Study|Dropped|2|||
160681483|NCT00996437|580213415|FG000|Overall Study|Missed|2|||
160681484|NCT00996437|580213416|FG001|Overall Study|Missed|5|||
160681485|NCT02576717|580213417|FG000|Overall Study|Other Reasons|16|||
160681486|NCT02576717|580213418|FG001|Overall Study|Other Reasons|18|||
160681487|NCT02576717|580213419|FG002|Overall Study|Other Reasons|15|||
160681488|NCT02576717|580213417|FG000|Overall Study|Covid-19 Pandemic|0|||
160681489|NCT02576717|580213418|FG001|Overall Study|Covid-19 Pandemic|1|||
160681490|NCT02576717|580213419|FG002|Overall Study|Covid-19 Pandemic|1|||
160681491|NCT02576717|580213417|FG000|Overall Study|Sponsor Decision|0|||
160681492|NCT02576717|580213418|FG001|Overall Study|Sponsor Decision|0|||
160681493|NCT02576717|580213419|FG002|Overall Study|Sponsor Decision|1|||
160681494|NCT02576717|580213417|FG000|Overall Study|Physician Decision|3|||
160681495|NCT02576717|580213418|FG001|Overall Study|Physician Decision|8|||
160681496|NCT02576717|580213419|FG002|Overall Study|Physician Decision|9|||
160681497|NCT02576717|580213417|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
160681498|NCT02576717|580213418|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
160681499|NCT02576717|580213419|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
160681500|NCT02576717|580213417|FG000|Overall Study|Death|3|||
160681501|NCT02576717|580213418|FG001|Overall Study|Death|5|||
160681502|NCT02576717|580213419|FG002|Overall Study|Death|3|||
160681503|NCT02576717|580213417|FG000|Overall Study|Lost to Follow-up|9|||
160681504|NCT02576717|580213418|FG001|Overall Study|Lost to Follow-up|10|||
160681505|NCT02576717|580213419|FG002|Overall Study|Lost to Follow-up|19|||
160681506|NCT02576717|580213417|FG000|Overall Study|Protocol Violation|4|||
160681507|NCT02576717|580213418|FG001|Overall Study|Protocol Violation|0|||
160681508|NCT02576717|580213419|FG002|Overall Study|Protocol Violation|5|||
160681509|NCT02576717|580213417|FG000|Overall Study|Lack of Efficacy|24|||
160681510|NCT02576717|580213418|FG001|Overall Study|Lack of Efficacy|28|||
160681511|NCT02576717|580213419|FG002|Overall Study|Lack of Efficacy|20|||
160681512|NCT02576717|580213417|FG000|Overall Study|Adverse Event|26|||
160681513|NCT02576717|580213418|FG001|Overall Study|Adverse Event|32|||
160681514|NCT02576717|580213419|FG002|Overall Study|Adverse Event|26|||
160681515|NCT00399893|580213420|FG000|Overall Study|Withdrawal by Subject|1|||
160681516|NCT00399893|580213421|FG001|Overall Study|Withdrawal by Subject|0|||
160681517|NCT00114231|580213422|FG000|Overall Study|No consent|2|||
160681518|NCT00114231|580213423|FG001|Overall Study|No consent|0|||
160681519|NCT00114231|580213422|FG000|Overall Study|QARC requirement not met|1|||
160681520|NCT00114231|580213423|FG001|Overall Study|QARC requirement not met|0|||
160681521|NCT00114231|580213422|FG000|Overall Study|Suspected metastatic disease|1|||
160681522|NCT00114231|580213423|FG001|Overall Study|Suspected metastatic disease|0|||
160681523|NCT00114231|580213422|FG000|Overall Study|No adenocarcinoma|1|||
160681524|NCT00114231|580213423|FG001|Overall Study|No adenocarcinoma|0|||
160681525|NCT00114231|580213422|FG000|Overall Study|Low creatinine clearance|0|||
160681526|NCT00114231|580213423|FG001|Overall Study|Low creatinine clearance|1|||
160681527|NCT00114231|580213422|FG000|Overall Study|Tumor size > 4cm|1|||
160681528|NCT00114231|580213423|FG001|Overall Study|Tumor size > 4cm|0|||
160681529|NCT00114231|580213422|FG000|Overall Study|Tumor fixed on digital exam|0|||
160681530|NCT00114231|580213423|FG001|Overall Study|Tumor fixed on digital exam|1|||
160681531|NCT00114231|580213422|FG000|Overall Study|No Absolute Neutrophil Count|2|||
160681532|NCT00114231|580213423|FG001|Overall Study|No Absolute Neutrophil Count|0|||
160681533|NCT00114231|580213422|FG000|Overall Study|Biopsy done after registration|1|||
160681534|NCT00114231|580213423|FG001|Overall Study|Biopsy done after registration|0|||
160681535|NCT00407745|580213436|FG000|Overall Study|Lack of Efficacy|1|||
160681536|NCT00407745|580213437|FG001|Overall Study|Lack of Efficacy|2|||
160681537|NCT00407745|580213436|FG000|Overall Study|Withdrawal by Subject|3|||
160681538|NCT00407745|580213437|FG001|Overall Study|Withdrawal by Subject|3|||
160681539|NCT00407745|580213436|FG000|Overall Study|Protocol Violation|5|||
160681540|NCT00407745|580213437|FG001|Overall Study|Protocol Violation|3|||
160681541|NCT00407745|580213436|FG000|Overall Study|Adverse Event|8|||
160681542|NCT00407745|580213437|FG001|Overall Study|Adverse Event|8|||
160681543|NCT00407745|580213436|FG000|Overall Study|Other|2|||
160681544|NCT00407745|580213437|FG001|Overall Study|Other|0|||
160681545|NCT00407745|580213436|FG000|Overall Study|Randomized, unknown if treated|0|||
160681546|NCT00407745|580213437|FG001|Overall Study|Randomized, unknown if treated|1|||
160681547|NCT02940730|580213440|FG000|Intervention 2|Physician Decision|7|||
160681548|NCT02940730|580213441|FG001|Intervention 2|Physician Decision|0|||
160681549|NCT02960438|580213442|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
160681550|NCT02960438|580213443|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
160681551|NCT02960438|580213444|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
160681552|NCT02960438|580213445|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
160681553|NCT02960438|580213442|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
160681554|NCT02960438|580213443|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
160681555|NCT02960438|580213444|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
160681556|NCT02960438|580213445|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
160681557|NCT02960438|580213442|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
160681558|NCT02960438|580213443|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
160681559|NCT02960438|580213444|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
160681560|NCT02960438|580213445|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
160681561|NCT02960438|580213442|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
160681562|NCT02960438|580213443|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
160681563|NCT02960438|580213444|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
160681564|NCT02960438|580213445|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
160681565|NCT02960438|580213442|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
160681566|NCT02960438|580213443|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
160681567|NCT02960438|580213444|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
160681568|NCT02960438|580213445|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
160681569|NCT02960438|580213442|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
160681570|NCT02960438|580213443|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
160681571|NCT02960438|580213444|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
160681572|NCT02960438|580213445|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
160681573|NCT02960438|580213442|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
160681574|NCT02960438|580213443|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
160681575|NCT02960438|580213444|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
160681576|NCT02960438|580213445|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
160681577|NCT02960438|580213442|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
160681578|NCT02960438|580213443|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
160681579|NCT02960438|580213444|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
160681580|NCT02960438|580213445|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
160681581|NCT02960438|580213442|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
160681582|NCT02960438|580213443|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
160681583|NCT02960438|580213444|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
160681584|NCT02960438|580213445|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
160681585|NCT02960438|580213442|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
160681586|NCT02960438|580213443|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
160681587|NCT02960438|580213444|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
160681588|NCT02960438|580213445|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
160681589|NCT02960438|580213442|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
160681590|NCT02960438|580213443|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
160681591|NCT02960438|580213444|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
160681592|NCT02960438|580213445|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
160681593|NCT02960438|580213442|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
160681594|NCT02960438|580213443|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
160681595|NCT02960438|580213444|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
160681596|NCT02960438|580213445|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
160681597|NCT00298740|580213448|FG000|Overall Study|Lack of Efficacy|6|||
160681598|NCT00298740|580213448|FG000|Overall Study|Withdrawal by Subject|3|||
160681599|NCT00684567|580213449|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
160681600|NCT00684567|580213449|FG000|Monotherapy Period|Adverse Event|2|||
160681601|NCT00684567|580213449|FG000|Monotherapy Period|Death|1|||
160681602|NCT00684567|580213449|FG000|Monotherapy Period|Progression of primary disease|11|||
160681603|NCT01201759|580213450|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
160681604|NCT01201759|580213451|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
160681605|NCT01201759|580213450|FG000|Visit 3 - Washout|Adverse Event|0|||
160681606|NCT01201759|580213451|FG001|Visit 3 - Washout|Adverse Event|3|||
160681607|NCT01201759|580213450|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
160681608|NCT01201759|580213451|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
160681609|NCT01201759|580213450|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
160681610|NCT01201759|580213451|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
160681611|NCT00906373|580213452|FG000|Overall Study|Withdrawal by Subject|0|||
160681612|NCT00906373|580213453|FG001|Overall Study|Withdrawal by Subject|5|||
160681613|NCT00906373|580213452|FG000|Overall Study|Other|0|||
160681614|NCT00906373|580213453|FG001|Overall Study|Other|1|||
160681615|NCT00906373|580213452|FG000|Overall Study|Still on treatment at cutoff date|0|||
160681616|NCT00906373|580213453|FG001|Overall Study|Still on treatment at cutoff date|2|||
160681617|NCT00848042|580213454|FG000|Overall Study|Death|1|||
160681618|NCT00848042|580213455|FG001|Overall Study|Death|2|||
160681619|NCT00848042|580213456|FG002|Overall Study|Death|0|||
160681620|NCT00848042|580213454|FG000|Overall Study|Other Therapy|3|||
160681621|NCT00848042|580213455|FG001|Overall Study|Other Therapy|0|||
160681622|NCT00848042|580213456|FG002|Overall Study|Other Therapy|0|||
160681623|NCT02744755|580213457|FG000|Study Period 1|Protocol Violation|2|||
160681624|NCT02744755|580213458|FG001|Study Period 1|Protocol Violation|1|||
160681625|NCT02744755|580213457|FG000|Study Period 1|not defined|0|||
160681626|NCT02744755|580213458|FG001|Study Period 1|not defined|1|||
160681627|NCT02744755|580213457|FG000|Study Period 1|Pregnancy|1|||
160681628|NCT02744755|580213458|FG001|Study Period 1|Pregnancy|0|||
160681629|NCT02744755|580213457|FG000|Study Period 1|Adverse Event|1|||
160681630|NCT02744755|580213458|FG001|Study Period 1|Adverse Event|1|||
160681631|NCT02744755|580213457|FG000|Study Period 1|Lost to Follow-up|1|||
160681632|NCT02744755|580213458|FG001|Study Period 1|Lost to Follow-up|1|||
160681633|NCT02744755|580213457|FG000|Study Period 1|Lack of Efficacy|1|||
160681634|NCT02744755|580213458|FG001|Study Period 1|Lack of Efficacy|0|||
160681635|NCT02744755|580213457|FG000|Study Period 1|Withdrawal by Subject|8|||
160681636|NCT02744755|580213458|FG001|Study Period 1|Withdrawal by Subject|4|||
160681637|NCT02744755|580213457|FG000|Study Period 2|Adverse Event|5|||
160681638|NCT02744755|580213458|FG001|Study Period 2|Adverse Event|0|||
160681639|NCT02744755|580213457|FG000|Study Period 2|Protocol Violation|1|||
160681640|NCT02744755|580213458|FG001|Study Period 2|Protocol Violation|0|||
160681641|NCT02744755|580213457|FG000|Study Period 2|not defined|3|||
160681642|NCT02744755|580213458|FG001|Study Period 2|not defined|2|||
160681643|NCT02744755|580213457|FG000|Study Period 2|Lost to Follow-up|0|||
160681644|NCT02744755|580213458|FG001|Study Period 2|Lost to Follow-up|2|||
160681645|NCT02744755|580213457|FG000|Study Period 2|Withdrawal by Subject|2|||
160681646|NCT02744755|580213458|FG001|Study Period 2|Withdrawal by Subject|2|||
160681647|NCT02744755|580213457|FG000|Study Period 2|Lack of Efficacy|3|||
160681648|NCT02744755|580213458|FG001|Study Period 2|Lack of Efficacy|2|||
160681649|NCT00965757|580213459|FG000|Double-blind Phase|Progression of concomitant disease|1|||
160681650|NCT00965757|580213460|FG001|Double-blind Phase|Progression of concomitant disease|2|||
160681651|NCT00965757|580213461|FG002|Double-blind Phase|Progression of concomitant disease|0|||
160681652|NCT00965757|580213462|FG003|Double-blind Phase|Progression of concomitant disease|0|||
160681653|NCT00965757|580213459|FG000|Double-blind Phase|Adverse drug reaction|2|||
160681654|NCT00965757|580213460|FG001|Double-blind Phase|Adverse drug reaction|1|||
160681655|NCT00965757|580213461|FG002|Double-blind Phase|Adverse drug reaction|0|||
160681656|NCT00965757|580213462|FG003|Double-blind Phase|Adverse drug reaction|0|||
160681657|NCT00965757|580213459|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
160681658|NCT00965757|580213460|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
160681659|NCT00965757|580213461|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
160681660|NCT00965757|580213462|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
160681661|NCT00965757|580213459|FG000|Double-blind Phase|Lack of Efficacy|7|||
160681662|NCT00965757|580213460|FG001|Double-blind Phase|Lack of Efficacy|11|||
160681663|NCT00965757|580213461|FG002|Double-blind Phase|Lack of Efficacy|0|||
160681664|NCT00965757|580213462|FG003|Double-blind Phase|Lack of Efficacy|0|||
160681665|NCT00965757|580213459|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
160681666|NCT00965757|580213460|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
160681667|NCT00965757|580213461|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
160681668|NCT00965757|580213462|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
160681669|NCT00965757|580213459|FG000|Double-blind Phase|Lost to Follow-up|0|||
160681670|NCT00965757|580213460|FG001|Double-blind Phase|Lost to Follow-up|1|||
160681671|NCT00965757|580213461|FG002|Double-blind Phase|Lost to Follow-up|0|||
160681672|NCT00965757|580213462|FG003|Double-blind Phase|Lost to Follow-up|0|||
160681673|NCT00965757|580213459|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
160681674|NCT00965757|580213460|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
160681675|NCT00965757|580213461|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
160681676|NCT00965757|580213462|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
160681677|NCT00965757|580213459|FG000|Double-blind Phase|Other|1|||
160681678|NCT00965757|580213460|FG001|Double-blind Phase|Other|0|||
160681679|NCT00965757|580213461|FG002|Double-blind Phase|Other|0|||
160681680|NCT00965757|580213462|FG003|Double-blind Phase|Other|0|||
160681681|NCT00965757|580213459|FG000|Extension Phase|Progression of concomitant disease|0|||
160681682|NCT00965757|580213460|FG001|Extension Phase|Progression of concomitant disease|0|||
160681683|NCT00965757|580213461|FG002|Extension Phase|Progression of concomitant disease|4|||
160681684|NCT00965757|580213462|FG003|Extension Phase|Progression of concomitant disease|2|||
160681685|NCT00965757|580213459|FG000|Extension Phase|Adverse drug reaction|0|||
160681686|NCT00965757|580213460|FG001|Extension Phase|Adverse drug reaction|0|||
160681687|NCT00965757|580213461|FG002|Extension Phase|Adverse drug reaction|6|||
160681688|NCT00965757|580213462|FG003|Extension Phase|Adverse drug reaction|3|||
160681689|NCT00965757|580213459|FG000|Extension Phase|Abnormal Laboratory Value|0|||
160681690|NCT00965757|580213460|FG001|Extension Phase|Abnormal Laboratory Value|0|||
160681691|NCT00965757|580213461|FG002|Extension Phase|Abnormal Laboratory Value|6|||
160681692|NCT00965757|580213462|FG003|Extension Phase|Abnormal Laboratory Value|1|||
160681693|NCT00965757|580213459|FG000|Extension Phase|Lack of Efficacy|0|||
160681694|NCT00965757|580213460|FG001|Extension Phase|Lack of Efficacy|0|||
160681695|NCT00965757|580213461|FG002|Extension Phase|Lack of Efficacy|8|||
160681696|NCT00965757|580213462|FG003|Extension Phase|Lack of Efficacy|12|||
160681697|NCT00965757|580213459|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
160681698|NCT00965757|580213460|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
160681699|NCT00965757|580213461|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
160681700|NCT00965757|580213462|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
160681701|NCT00965757|580213459|FG000|Extension Phase|Lost to Follow-up|0|||
160681702|NCT00965757|580213460|FG001|Extension Phase|Lost to Follow-up|0|||
160681703|NCT00965757|580213461|FG002|Extension Phase|Lost to Follow-up|0|||
160681704|NCT00965757|580213462|FG003|Extension Phase|Lost to Follow-up|1|||
160681705|NCT00965757|580213459|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
160681706|NCT00965757|580213460|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
160681707|NCT00965757|580213461|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
160681708|NCT00965757|580213462|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
160681709|NCT00965757|580213459|FG000|Extension Phase|Protocol Violation|0|||
160681710|NCT00965757|580213460|FG001|Extension Phase|Protocol Violation|0|||
160681711|NCT00965757|580213461|FG002|Extension Phase|Protocol Violation|0|||
160681712|NCT00965757|580213462|FG003|Extension Phase|Protocol Violation|1|||
160681713|NCT00965757|580213459|FG000|Extension Phase|Other|0|||
160681714|NCT00965757|580213460|FG001|Extension Phase|Other|0|||
160681715|NCT00965757|580213461|FG002|Extension Phase|Other|2|||
160681716|NCT00965757|580213462|FG003|Extension Phase|Other|1|||
160681717|NCT01344018|580213466|FG000|Overall Study|Death|22|||
160681718|NCT01344018|580213467|FG001|Overall Study|Death|25|||
160681719|NCT01344018|580213466|FG000|Overall Study|Lost to Follow-up|4|||
160681720|NCT01344018|580213467|FG001|Overall Study|Lost to Follow-up|7|||
160681721|NCT04010227|580213468|FG000|Overall Study|Death|1|||
160681722|NCT04010227|580213469|FG001|Overall Study|Death|2|||
160681723|NCT04010227|580213468|FG000|Overall Study|Medical Reasons|4|||
160681724|NCT04010227|580213469|FG001|Overall Study|Medical Reasons|3|||
160681725|NCT04010227|580213468|FG000|Overall Study|Withdrawal by Subject|2|||
160681726|NCT04010227|580213469|FG001|Overall Study|Withdrawal by Subject|0|||
160681727|NCT04010227|580213468|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
160681728|NCT04010227|580213469|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
160681729|NCT02308696|580213470|FG000|Overall Study|Lost to Follow-up|28|||
160681730|NCT02308696|580213471|FG001|Overall Study|Lost to Follow-up|21|||
160681731|NCT02308696|580213470|FG000|Overall Study|Death|8|||
160681732|NCT02308696|580213471|FG001|Overall Study|Death|4|||
160681733|NCT02308696|580213470|FG000|Overall Study|Moved to a Higher Level of Care|17|||
160681734|NCT02308696|580213471|FG001|Overall Study|Moved to a Higher Level of Care|6|||
160681735|NCT02914457|580213472|FG000|Overall Study|Withdrawal by Subject|1|||
160681736|NCT02914457|580213472|FG000|Overall Study|Physician Decision|1|||
160681737|NCT02914457|580213472|FG000|Overall Study|No veins available for lead placement|1|||
160681738|NCT02914457|580213472|FG000|Overall Study|Electrical instability of patient|1|||
160681739|NCT02914457|580213472|FG000|Overall Study|ECG acquisition error due to sweating|1|||
160681740|NCT02914457|580213472|FG000|Overall Study|Protocol Violation|1|||
160681741|NCT03843125|580213473|FG000|Overall Study|Adverse Event|17|||
160681742|NCT03843125|580213474|FG001|Overall Study|Adverse Event|13|||
160681743|NCT03843125|580213475|FG002|Overall Study|Adverse Event|5|||
160681744|NCT03843125|580213476|FG003|Overall Study|Adverse Event|9|||
160681745|NCT03843125|580213473|FG000|Overall Study|Death|0|||
160681746|NCT03843125|580213474|FG001|Overall Study|Death|6|||
160681747|NCT03843125|580213475|FG002|Overall Study|Death|2|||
160681748|NCT03843125|580213476|FG003|Overall Study|Death|0|||
160681749|NCT03843125|580213473|FG000|Overall Study|Lack of Efficacy|14|||
160681750|NCT03843125|580213474|FG001|Overall Study|Lack of Efficacy|11|||
160681751|NCT03843125|580213475|FG002|Overall Study|Lack of Efficacy|9|||
160681752|NCT03843125|580213476|FG003|Overall Study|Lack of Efficacy|4|||
160681753|NCT03843125|580213473|FG000|Overall Study|Lost to Follow-up|3|||
160681754|NCT03843125|580213474|FG001|Overall Study|Lost to Follow-up|4|||
160681755|NCT03843125|580213475|FG002|Overall Study|Lost to Follow-up|0|||
160681756|NCT03843125|580213476|FG003|Overall Study|Lost to Follow-up|2|||
160681757|NCT03843125|580213473|FG000|Overall Study|Other|12|||
160681758|NCT03843125|580213474|FG001|Overall Study|Other|14|||
160681759|NCT03843125|580213475|FG002|Overall Study|Other|3|||
160681760|NCT03843125|580213476|FG003|Overall Study|Other|4|||
160681761|NCT03843125|580213473|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
160681762|NCT03843125|580213474|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
160681763|NCT03843125|580213475|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
160681764|NCT03843125|580213476|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
160681765|NCT03843125|580213473|FG000|Overall Study|Study Terminated by Sponsor|318|||
160681766|NCT03843125|580213474|FG001|Overall Study|Study Terminated by Sponsor|318|||
160681767|NCT03843125|580213475|FG002|Overall Study|Study Terminated by Sponsor|163|||
160681768|NCT03843125|580213476|FG003|Overall Study|Study Terminated by Sponsor|163|||
160681769|NCT03843125|580213473|FG000|Overall Study|Withdrawal by Subject|23|||
160681770|NCT03843125|580213474|FG001|Overall Study|Withdrawal by Subject|12|||
160681771|NCT03843125|580213475|FG002|Overall Study|Withdrawal by Subject|6|||
160681772|NCT03843125|580213476|FG003|Overall Study|Withdrawal by Subject|9|||
160681773|NCT03843125|580213473|FG000|Overall Study|Missing data|0|||
160681774|NCT03843125|580213474|FG001|Overall Study|Missing data|1|||
160681775|NCT03843125|580213475|FG002|Overall Study|Missing data|1|||
160681776|NCT03843125|580213476|FG003|Overall Study|Missing data|0|||
160681777|NCT04254809|580213479|FG000|Overall Study|Lost to Follow-up|5|||
160681778|NCT04254809|580213480|FG001|Overall Study|Lost to Follow-up|10|||
160681779|NCT01928615|580213481|FG000|Overall Study|Study Terminated by Sponsor|2|||
160681780|NCT02972515|580213482|FG000|Overall Study|Lost to Follow-up|78|||
160681781|NCT04531527|580213483|FG000|Overall Study|Found to be Ineligible|3|||
160681782|NCT03496298|580213486|FG000|Overall Study|Adverse Event|49|||
160681783|NCT03496298|580213487|FG001|Overall Study|Adverse Event|68|||
160681784|NCT03496298|580213488|FG002|Overall Study|Adverse Event|79|||
160681785|NCT03496298|580213486|FG000|Overall Study|Study terminated by Sponsor|1050|||
160681786|NCT03496298|580213487|FG001|Overall Study|Study terminated by Sponsor|1063|||
160681787|NCT03496298|580213488|FG002|Overall Study|Study terminated by Sponsor|1071|||
160681788|NCT03496298|580213486|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
160681789|NCT03496298|580213487|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
160681790|NCT03496298|580213488|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
160681791|NCT03496298|580213486|FG000|Overall Study|Withdrawal by Subject|176|||
160681792|NCT03496298|580213487|FG001|Overall Study|Withdrawal by Subject|154|||
160681793|NCT03496298|580213488|FG002|Overall Study|Withdrawal by Subject|151|||
160681794|NCT03496298|580213486|FG000|Overall Study|Other|29|||
160681795|NCT03496298|580213487|FG001|Overall Study|Other|20|||
160681796|NCT03496298|580213488|FG002|Overall Study|Other|23|||
160681797|NCT03496298|580213486|FG000|Overall Study|Randomized and not treated|1|||
160681798|NCT03496298|580213487|FG001|Overall Study|Randomized and not treated|1|||
160681799|NCT03496298|580213488|FG002|Overall Study|Randomized and not treated|1|||
160681800|NCT02608476|580213489|FG000|Overall Study|Withdrawal by Subject|30|||
160681801|NCT02608476|580213490|FG001|Overall Study|Withdrawal by Subject|37|||
160681802|NCT02608476|580213489|FG000|Overall Study|Lost to Follow-up|24|||
160681803|NCT02608476|580213490|FG001|Overall Study|Lost to Follow-up|24|||
160681804|NCT02608476|580213489|FG000|Overall Study|Adverse Event|2|||
160681805|NCT02608476|580213490|FG001|Overall Study|Adverse Event|8|||
160681806|NCT02608476|580213489|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
160681807|NCT02608476|580213490|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
160681808|NCT02608476|580213489|FG000|Overall Study|Noncompliance with treatment|1|||
160681809|NCT02608476|580213490|FG001|Overall Study|Noncompliance with treatment|5|||
160681810|NCT02608476|580213489|FG000|Overall Study|Lack of Efficacy|3|||
160681811|NCT02608476|580213490|FG001|Overall Study|Lack of Efficacy|1|||
160681812|NCT02608476|580213489|FG000|Overall Study|Other|0|||
160681813|NCT02608476|580213490|FG001|Overall Study|Other|1|||
160681814|NCT02608476|580213489|FG000|Overall Study|Physician Decision|1|||
160681815|NCT02608476|580213490|FG001|Overall Study|Physician Decision|0|||
160681816|NCT02608476|580213489|FG000|Overall Study|Pregnancy|0|||
160681817|NCT02608476|580213490|FG001|Overall Study|Pregnancy|1|||
160681818|NCT02608476|580213489|FG000|Overall Study|Progressive disease|1|||
160681819|NCT02608476|580213490|FG001|Overall Study|Progressive disease|0|||
160681820|NCT00676494|580213491|FG000|Overall Study|Missed Visit|8|||
160681821|NCT00676494|580213491|FG000|Overall Study|Withdrawal by Subject|6|||
160681822|NCT02058160|580213492|FG000|Overall Study|Randomized but not treated|2|||
160681823|NCT02058160|580213493|FG001|Overall Study|Randomized but not treated|4|||
160681824|NCT02058160|580213492|FG000|Overall Study|Poor compliance to protocol|4|||
160681825|NCT02058160|580213493|FG001|Overall Study|Poor compliance to protocol|1|||
160681826|NCT02058160|580213492|FG000|Overall Study|Adverse Event|12|||
160681827|NCT02058160|580213493|FG001|Overall Study|Adverse Event|3|||
160681828|NCT02058160|580213492|FG000|Overall Study|Lost to Follow-up|1|||
160681829|NCT02058160|580213493|FG001|Overall Study|Lost to Follow-up|0|||
160681830|NCT02058160|580213492|FG000|Overall Study|Other than specified above|12|||
160681831|NCT02058160|580213493|FG001|Overall Study|Other than specified above|6|||
160681832|NCT01203917|580213495|FG000|Overall Study|Death|29|||
160681833|NCT01203917|580213495|FG000|Overall Study|Lost to Follow-up|2|||
160681834|NCT01203917|580213495|FG000|Overall Study|Withdrawal by Subject|3|||
160681835|NCT01203917|580213495|FG000|Overall Study|Due to objective disease progression|1|||
160681836|NCT01203917|580213495|FG000|Overall Study|Due to EGFR M+I patient|1|||
160681837|NCT03310619|580213496|FG000|Pre-Treatment Period|Death|1|||
160681838|NCT03310619|580213497|FG001|Pre-Treatment Period|Death|0|||
160681839|NCT03310619|580213498|FG002|Pre-Treatment Period|Death|0|||
160681840|NCT03310619|580213499|FG003|Pre-Treatment Period|Death|0|||
160681841|NCT03310619|580213500|FG004|Pre-Treatment Period|Death|1|||
160681842|NCT03310619|580213501|FG005|Pre-Treatment Period|Death|0|||
160681843|NCT03310619|580213502|FG006|Pre-Treatment Period|Death|0|||
160681844|NCT03310619|580213503|FG007|Pre-Treatment Period|Death|0|||
160681845|NCT03310619|580213496|FG000|Pre-Treatment Period|Other reasons|2|||
160681846|NCT03310619|580213497|FG001|Pre-Treatment Period|Other reasons|1|||
160681847|NCT03310619|580213498|FG002|Pre-Treatment Period|Other reasons|2|||
160681848|NCT03310619|580213499|FG003|Pre-Treatment Period|Other reasons|0|||
160681849|NCT03310619|580213500|FG004|Pre-Treatment Period|Other reasons|0|||
160681850|NCT03310619|580213501|FG005|Pre-Treatment Period|Other reasons|0|||
160681851|NCT03310619|580213502|FG006|Pre-Treatment Period|Other reasons|2|||
160681852|NCT03310619|580213503|FG007|Pre-Treatment Period|Other reasons|0|||
160681853|NCT03310619|580213496|FG000|Treatment Period|Death|1|||
160681854|NCT03310619|580213497|FG001|Treatment Period|Death|2|||
160681855|NCT03310619|580213498|FG002|Treatment Period|Death|0|||
160681856|NCT03310619|580213499|FG003|Treatment Period|Death|0|||
160681857|NCT03310619|580213500|FG004|Treatment Period|Death|1|||
160681858|NCT03310619|580213501|FG005|Treatment Period|Death|0|||
160681859|NCT03310619|580213502|FG006|Treatment Period|Death|2|||
160681860|NCT03310619|580213503|FG007|Treatment Period|Death|0|||
160681861|NCT03310619|580213496|FG000|Treatment Period|Adverse Event|0|||
160681862|NCT03310619|580213497|FG001|Treatment Period|Adverse Event|1|||
160681863|NCT03310619|580213498|FG002|Treatment Period|Adverse Event|4|||
160681864|NCT03310619|580213499|FG003|Treatment Period|Adverse Event|1|||
160681865|NCT03310619|580213500|FG004|Treatment Period|Adverse Event|0|||
160681866|NCT03310619|580213501|FG005|Treatment Period|Adverse Event|0|||
160681867|NCT03310619|580213502|FG006|Treatment Period|Adverse Event|0|||
160681868|NCT03310619|580213503|FG007|Treatment Period|Adverse Event|0|||
160681869|NCT03310619|580213496|FG000|Treatment Period|Withdrawal by participant|0|||
160681870|NCT03310619|580213497|FG001|Treatment Period|Withdrawal by participant|0|||
160681871|NCT03310619|580213498|FG002|Treatment Period|Withdrawal by participant|1|||
160681872|NCT03310619|580213499|FG003|Treatment Period|Withdrawal by participant|0|||
160681873|NCT03310619|580213500|FG004|Treatment Period|Withdrawal by participant|0|||
160681874|NCT03310619|580213501|FG005|Treatment Period|Withdrawal by participant|0|||
160681875|NCT03310619|580213502|FG006|Treatment Period|Withdrawal by participant|0|||
160681876|NCT03310619|580213503|FG007|Treatment Period|Withdrawal by participant|0|||
160681877|NCT03310619|580213496|FG000|Treatment Period|Lost to Follow-up|0|||
160681878|NCT03310619|580213497|FG001|Treatment Period|Lost to Follow-up|0|||
160681879|NCT03310619|580213498|FG002|Treatment Period|Lost to Follow-up|0|||
160681880|NCT03310619|580213499|FG003|Treatment Period|Lost to Follow-up|0|||
160681881|NCT03310619|580213500|FG004|Treatment Period|Lost to Follow-up|0|||
160681882|NCT03310619|580213501|FG005|Treatment Period|Lost to Follow-up|0|||
160681883|NCT03310619|580213502|FG006|Treatment Period|Lost to Follow-up|0|||
160681884|NCT03310619|580213503|FG007|Treatment Period|Lost to Follow-up|1|||
160681885|NCT03310619|580213496|FG000|Treatment Period|Study terminated by sponsor|0|||
160681886|NCT03310619|580213497|FG001|Treatment Period|Study terminated by sponsor|0|||
160681887|NCT03310619|580213498|FG002|Treatment Period|Study terminated by sponsor|0|||
160681888|NCT03310619|580213499|FG003|Treatment Period|Study terminated by sponsor|0|||
160681889|NCT03310619|580213500|FG004|Treatment Period|Study terminated by sponsor|0|||
160681890|NCT03310619|580213501|FG005|Treatment Period|Study terminated by sponsor|0|||
160681891|NCT03310619|580213502|FG006|Treatment Period|Study terminated by sponsor|0|||
160681892|NCT03310619|580213503|FG007|Treatment Period|Study terminated by sponsor|1|||
160681893|NCT03310619|580213496|FG000|Treatment Period|Physician Decision|0|||
160681894|NCT03310619|580213497|FG001|Treatment Period|Physician Decision|0|||
160681895|NCT03310619|580213498|FG002|Treatment Period|Physician Decision|0|||
160681896|NCT03310619|580213499|FG003|Treatment Period|Physician Decision|0|||
160681897|NCT03310619|580213500|FG004|Treatment Period|Physician Decision|3|||
160681898|NCT03310619|580213501|FG005|Treatment Period|Physician Decision|0|||
160681899|NCT03310619|580213502|FG006|Treatment Period|Physician Decision|0|||
160681900|NCT03310619|580213503|FG007|Treatment Period|Physician Decision|0|||
160681901|NCT03310619|580213496|FG000|Treatment Period|Other reasons|1|||
160681902|NCT03310619|580213497|FG001|Treatment Period|Other reasons|0|||
160681903|NCT03310619|580213498|FG002|Treatment Period|Other reasons|2|||
160681904|NCT03310619|580213499|FG003|Treatment Period|Other reasons|0|||
160681905|NCT03310619|580213500|FG004|Treatment Period|Other reasons|0|||
160681906|NCT03310619|580213501|FG005|Treatment Period|Other reasons|0|||
160681907|NCT03310619|580213502|FG006|Treatment Period|Other reasons|0|||
160681908|NCT03310619|580213503|FG007|Treatment Period|Other reasons|0|||
160681909|NCT00152516|580213508|FG000|Overall Study|Adverse Event|18|||
160681910|NCT00152516|580213508|FG000|Overall Study|Lack and Loss of Efficacy|30|||
160681911|NCT00152516|580213508|FG000|Overall Study|Lost to Follow-up|5|||
160681912|NCT00152516|580213508|FG000|Overall Study|Withdrawal by Subject|8|||
160681913|NCT00152516|580213508|FG000|Overall Study|Protocol Violation|3|||
160681914|NCT00152516|580213508|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
160681915|NCT00152516|580213508|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
160681916|NCT00152516|580213508|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
160681917|NCT00152516|580213508|FG000|Overall Study|Other: Non-Compliance|2|||
160681918|NCT00152516|580213508|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
160681919|NCT00152516|580213508|FG000|Overall Study|Other: Moved Out Of State|1|||
160681920|NCT00152516|580213508|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
160681921|NCT00152516|580213508|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
160681922|NCT04660032|580213511|FG000|Overall Study|Protocol Violation|1|||
160681923|NCT04660032|580213512|FG001|Overall Study|Protocol Violation|1|||
160681924|NCT00090753|580213513|FG000|First Treatment Period|Adverse Event|20|||
160681925|NCT00090753|580213514|FG001|First Treatment Period|Adverse Event|8|||
160681926|NCT00090753|580213513|FG000|First Treatment Period|Death|88|||
160681927|NCT00090753|580213514|FG001|First Treatment Period|Death|62|||
160681928|NCT00090753|580213513|FG000|First Treatment Period|Lack of Efficacy|2|||
160681929|NCT00090753|580213514|FG001|First Treatment Period|Lack of Efficacy|1|||
160681930|NCT00090753|580213513|FG000|First Treatment Period|Refused Treatment|32|||
160681931|NCT00090753|580213514|FG001|First Treatment Period|Refused Treatment|25|||
160681932|NCT00090753|580213513|FG000|First Treatment Period|Lost to Follow-up|4|||
160681933|NCT00090753|580213514|FG001|First Treatment Period|Lost to Follow-up|4|||
160681934|NCT00090753|580213513|FG000|First Treatment Period|Renal Transplant|70|||
160681935|NCT00090753|580213514|FG001|First Treatment Period|Renal Transplant|50|||
160681936|NCT00090753|580213513|FG000|First Treatment Period|Mircera Commercialization|1|||
160681937|NCT00090753|580213514|FG001|First Treatment Period|Mircera Commercialization|0|||
160681938|NCT00090753|580213513|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
160681939|NCT00090753|580213514|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
160681940|NCT00090753|580213513|FG000|Extended Treatment Period|Adverse Event|11|||
160681941|NCT00090753|580213514|FG001|Extended Treatment Period|Adverse Event|0|||
160681942|NCT00090753|580213513|FG000|Extended Treatment Period|Death|58|||
160681943|NCT00090753|580213514|FG001|Extended Treatment Period|Death|30|||
160681944|NCT00090753|580213513|FG000|Extended Treatment Period|Lack of Efficacy|1|||
160681945|NCT00090753|580213514|FG001|Extended Treatment Period|Lack of Efficacy|0|||
160681946|NCT00090753|580213513|FG000|Extended Treatment Period|Refused Treatment|18|||
160681947|NCT00090753|580213514|FG001|Extended Treatment Period|Refused Treatment|12|||
160681948|NCT00090753|580213513|FG000|Extended Treatment Period|Lost to Follow-up|3|||
160681949|NCT00090753|580213514|FG001|Extended Treatment Period|Lost to Follow-up|1|||
160681950|NCT00090753|580213513|FG000|Extended Treatment Period|Renal Transplant|15|||
160681951|NCT00090753|580213514|FG001|Extended Treatment Period|Renal Transplant|12|||
160681952|NCT00090753|580213513|FG000|Extended Treatment Period|Mircera Commercialization|188|||
160681953|NCT00090753|580213514|FG001|Extended Treatment Period|Mircera Commercialization|93|||
160681954|NCT00090753|580213513|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
160681955|NCT00090753|580213514|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
160681956|NCT02725411|580213523|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
160681957|NCT02725411|580213524|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
160681958|NCT02725411|580213525|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
160681959|NCT02725411|580213523|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
160681960|NCT02725411|580213524|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
160681961|NCT02725411|580213525|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
160681962|NCT02725411|580213523|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
160681963|NCT02725411|580213524|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
160681964|NCT02725411|580213525|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
160681965|NCT02725411|580213523|FG000|Treatment Period (56 Weeks)|Other|1|||
160681966|NCT02725411|580213524|FG001|Treatment Period (56 Weeks)|Other|4|||
160681967|NCT02725411|580213525|FG002|Treatment Period (56 Weeks)|Other|5|||
160681968|NCT02725411|580213523|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
160681969|NCT02725411|580213524|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
160681970|NCT02725411|580213525|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
160681971|NCT02725411|580213523|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
160681972|NCT02725411|580213524|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
160681973|NCT02725411|580213525|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
160681974|NCT02725411|580213523|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
160681975|NCT02725411|580213524|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
160681976|NCT02725411|580213525|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
160681977|NCT02725411|580213523|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
160681978|NCT02725411|580213524|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
160681979|NCT02725411|580213525|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
160681980|NCT02725411|580213523|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
160681981|NCT02725411|580213524|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
160681982|NCT02725411|580213525|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
160681983|NCT02725411|580213523|FG000|Follow-up Period (24 Weeks)|Other|1|||
160681984|NCT02725411|580213524|FG001|Follow-up Period (24 Weeks)|Other|4|||
160681985|NCT02725411|580213525|FG002|Follow-up Period (24 Weeks)|Other|2|||
160681986|NCT02725411|580213523|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
160681987|NCT02725411|580213524|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
160681988|NCT02725411|580213525|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
160681989|NCT00250705|580213526|FG000|Overall Study|Lack of Efficacy|2|||
160681990|NCT00587431|580213527|FG000|Overall Study|Adverse Event|1|||
160681991|NCT00587431|580213528|FG001|Overall Study|Adverse Event|0|||
160681992|NCT00587431|580213527|FG000|Overall Study|Withdrawal by Subject|0|||
160681993|NCT00587431|580213528|FG001|Overall Study|Withdrawal by Subject|1|||
160681994|NCT05467982|580213529|FG000|Overall Study|Death|0|||
160681995|NCT05467982|580213530|FG001|Overall Study|Death|1|||
160681996|NCT05467982|580213529|FG000|Overall Study|Lost to Follow-up|3|||
160681997|NCT05467982|580213530|FG001|Overall Study|Lost to Follow-up|1|||
160681998|NCT03507686|580213539|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
160681999|NCT03507686|580213540|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
160682000|NCT03507686|580213539|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
160682001|NCT03507686|580213540|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
160682002|NCT03507686|580213539|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
160682003|NCT03507686|580213540|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
160682004|NCT03507686|580213539|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
160682005|NCT03507686|580213540|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
160682006|NCT03507686|580213539|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
160682007|NCT03507686|580213540|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
160682008|NCT03507686|580213539|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
160682009|NCT03507686|580213540|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
160682010|NCT00585312|580213541|FG000|Overall Study|Adverse Event|3|||
160682011|NCT00585312|580213542|FG001|Overall Study|Adverse Event|0|||
160682012|NCT00585312|580213541|FG000|Overall Study|Lack of Efficacy|6|||
160682013|NCT00585312|580213542|FG001|Overall Study|Lack of Efficacy|11|||
160682014|NCT00585312|580213541|FG000|Overall Study|Lost to Follow-up|1|||
160682015|NCT00585312|580213542|FG001|Overall Study|Lost to Follow-up|1|||
160682016|NCT00585312|580213541|FG000|Overall Study|Reason not specified|2|||
160682017|NCT00585312|580213542|FG001|Overall Study|Reason not specified|0|||
160682018|NCT00585312|580213541|FG000|Overall Study|Withdrawal by Subject|5|||
160682019|NCT00585312|580213542|FG001|Overall Study|Withdrawal by Subject|1|||
160682020|NCT00585312|580213541|FG000|Overall Study|Study terminated by the sponsor|34|||
160682021|NCT00585312|580213542|FG001|Overall Study|Study terminated by the sponsor|31|||
160682022|NCT01263561|580213543|FG000|Overall Study|Death|1|||
160682023|NCT01263561|580213544|FG001|Overall Study|Death|2|||
160682024|NCT00879684|580213545|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
160682025|NCT00879684|580213546|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
160682026|NCT00879684|580213547|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
160682027|NCT00879684|580213548|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
160682028|NCT00879684|580213549|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
160682029|NCT00879684|580213550|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
160682030|NCT00879684|580213551|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
160682031|NCT00879684|580213545|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
160682032|NCT00879684|580213546|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
160682033|NCT00879684|580213547|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
160682034|NCT00879684|580213548|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
160682035|NCT00879684|580213549|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
160682036|NCT00879684|580213550|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
160682037|NCT00879684|580213551|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
160682038|NCT00879684|580213545|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
160682039|NCT00879684|580213546|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
160682040|NCT00879684|580213547|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
160682041|NCT00879684|580213548|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
160682042|NCT00879684|580213549|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
160682043|NCT00879684|580213550|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
160682044|NCT00879684|580213551|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
160682045|NCT00879684|580213545|FG000|Stage 1: Dose Escalation|Death|0|||
160682046|NCT00879684|580213546|FG001|Stage 1: Dose Escalation|Death|0|||
160682047|NCT00879684|580213547|FG002|Stage 1: Dose Escalation|Death|1|||
160682048|NCT00879684|580213548|FG003|Stage 1: Dose Escalation|Death|0|||
160682049|NCT00879684|580213549|FG004|Stage 1: Dose Escalation|Death|0|||
160682050|NCT00879684|580213550|FG005|Stage 1: Dose Escalation|Death|0|||
160682051|NCT00879684|580213551|FG006|Stage 1: Dose Escalation|Death|0|||
160682052|NCT00879684|580213545|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
160682053|NCT00879684|580213546|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
160682054|NCT00879684|580213547|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
160682055|NCT00879684|580213548|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
160682056|NCT00879684|580213549|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
160682057|NCT00879684|580213550|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
160682058|NCT00879684|580213551|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
160682059|NCT00879684|580213545|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
160682060|NCT00879684|580213546|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
160682061|NCT00879684|580213547|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
160682062|NCT00879684|580213548|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
160682063|NCT00879684|580213549|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
160682064|NCT00879684|580213550|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
160682065|NCT00879684|580213551|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
160682066|NCT00879684|580213545|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
160682067|NCT00879684|580213546|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
160682068|NCT00879684|580213547|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
160682069|NCT00879684|580213548|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
160682070|NCT00879684|580213549|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
160682071|NCT00879684|580213550|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
160682072|NCT00879684|580213551|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
160682073|NCT03185741|580213556|FG000|Baseline|Withdrawal by Subject|1|||
160682074|NCT03185741|580213557|FG001|Baseline|Withdrawal by Subject|3|||
160682075|NCT03185741|580213558|FG002|Baseline|Withdrawal by Subject|2|||
160682076|NCT03185741|580213556|FG000|Baseline|Lost to Follow-up|1|||
160682077|NCT03185741|580213557|FG001|Baseline|Lost to Follow-up|2|||
160682078|NCT03185741|580213558|FG002|Baseline|Lost to Follow-up|3|||
160682079|NCT03185741|580213556|FG000|3Month|Death|1|||
160682080|NCT03185741|580213557|FG001|3Month|Death|1|||
160682081|NCT03185741|580213558|FG002|3Month|Death|2|||
160682082|NCT03185741|580213556|FG000|3Month|Withdrawal by Subject|1|||
160682083|NCT03185741|580213557|FG001|3Month|Withdrawal by Subject|5|||
160682084|NCT03185741|580213558|FG002|3Month|Withdrawal by Subject|1|||
160682085|NCT03185741|580213556|FG000|3Month|Lost to Follow-up|7|||
160682086|NCT03185741|580213557|FG001|3Month|Lost to Follow-up|9|||
160682087|NCT03185741|580213558|FG002|3Month|Lost to Follow-up|8|||
160682088|NCT03185741|580213556|FG000|3Month|Unavailable for 3Month|11|||
160682089|NCT03185741|580213557|FG001|3Month|Unavailable for 3Month|10|||
160682090|NCT03185741|580213558|FG002|3Month|Unavailable for 3Month|11|||
160682091|NCT03185741|580213556|FG000|3Month|Protocol Violation|0|||
160682092|NCT03185741|580213557|FG001|3Month|Protocol Violation|0|||
160682093|NCT03185741|580213558|FG002|3Month|Protocol Violation|3|||
160682094|NCT03185741|580213556|FG000|6Month|Death|1|||
160682095|NCT03185741|580213557|FG001|6Month|Death|1|||
160682096|NCT03185741|580213558|FG002|6Month|Death|2|||
160682097|NCT03185741|580213556|FG000|6Month|Withdrawal by Subject|2|||
160682098|NCT03185741|580213557|FG001|6Month|Withdrawal by Subject|3|||
160682099|NCT03185741|580213558|FG002|6Month|Withdrawal by Subject|1|||
160682100|NCT03185741|580213556|FG000|6Month|Lost to Follow-up|16|||
160682101|NCT03185741|580213557|FG001|6Month|Lost to Follow-up|15|||
160682102|NCT03185741|580213558|FG002|6Month|Lost to Follow-up|16|||
160682103|NCT03573336|580213561|FG000|Overall Study|Study terminated|2|||
160682104|NCT03573336|580213562|FG001|Overall Study|Study terminated|4|||
160682105|NCT03573336|580213563|FG002|Overall Study|Study terminated|2|||
160682106|NCT03108820|580213564|FG000|Overall Study|Lost to Follow-up|30|||
160682107|NCT03108820|580213565|FG001|Overall Study|Lost to Follow-up|28|||
160682108|NCT03108820|580213564|FG000|Overall Study|Withdrawal by Subject|32|||
160682109|NCT03108820|580213565|FG001|Overall Study|Withdrawal by Subject|24|||
160682110|NCT03108820|580213564|FG000|Overall Study|Death|6|||
160682111|NCT03108820|580213565|FG001|Overall Study|Death|11|||
160682112|NCT01488448|580213571|FG000|Overall Study|Withdrawal by Subject|3|||
160682113|NCT01488448|580213572|FG001|Overall Study|Withdrawal by Subject|1|||
160682114|NCT01488448|580213571|FG000|Overall Study|Adverse Event|9|||
160682115|NCT01488448|580213572|FG001|Overall Study|Adverse Event|4|||
160682116|NCT01488448|580213571|FG000|Overall Study|Physician Decision|4|||
160682117|NCT01488448|580213572|FG001|Overall Study|Physician Decision|9|||
160682118|NCT01488448|580213571|FG000|Overall Study|Protocol Violation|4|||
160682119|NCT01488448|580213572|FG001|Overall Study|Protocol Violation|3|||
160682120|NCT00654641|580213573|FG000|Overall Study|Lost to Follow-up|2|||
160682121|NCT00654641|580213574|FG001|Overall Study|Lost to Follow-up|3|||
160682122|NCT01992094|580213575|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
160682123|NCT01992094|580213576|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
160682124|NCT01992094|580213577|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
160682125|NCT01992094|580213575|FG000|Overall Study|Adverse Event|1|||
160682126|NCT01992094|580213576|FG001|Overall Study|Adverse Event|0|||
160682127|NCT01992094|580213577|FG002|Overall Study|Adverse Event|0|||
160682128|NCT01992094|580213575|FG000|Overall Study|Death|5|||
160682129|NCT01992094|580213576|FG001|Overall Study|Death|5|||
160682130|NCT01992094|580213577|FG002|Overall Study|Death|2|||
160682131|NCT01992094|580213575|FG000|Overall Study|Lost to Follow-up|26|||
160682132|NCT01992094|580213576|FG001|Overall Study|Lost to Follow-up|9|||
160682133|NCT01992094|580213577|FG002|Overall Study|Lost to Follow-up|13|||
160682134|NCT01992094|580213575|FG000|Overall Study|OTHER|4|||
160682135|NCT01992094|580213576|FG001|Overall Study|OTHER|0|||
160682136|NCT01992094|580213577|FG002|Overall Study|OTHER|0|||
160682137|NCT01992094|580213575|FG000|Overall Study|Protocol Violation|1|||
160682138|NCT01992094|580213576|FG001|Overall Study|Protocol Violation|0|||
160682139|NCT01992094|580213577|FG002|Overall Study|Protocol Violation|1|||
160682140|NCT01992094|580213575|FG000|Overall Study|Withdrawal by Subject|7|||
160682141|NCT01992094|580213576|FG001|Overall Study|Withdrawal by Subject|3|||
160682142|NCT01992094|580213577|FG002|Overall Study|Withdrawal by Subject|4|||
160682143|NCT03168906|580213578|FG000|Overall Study|Lack of Efficacy|6|||
160682144|NCT03168906|580213579|FG001|Overall Study|Lack of Efficacy|6|||
160682145|NCT01214239|580213580|FG000|Overall Study|Adverse Event|3|||
160682146|NCT01214239|580213581|FG001|Overall Study|Adverse Event|4|||
160682147|NCT01214239|580213580|FG000|Overall Study|Protocol Violation|2|||
160682148|NCT01214239|580213581|FG001|Overall Study|Protocol Violation|1|||
160682149|NCT01214239|580213580|FG000|Overall Study|Lost to Follow-up|1|||
160682150|NCT01214239|580213581|FG001|Overall Study|Lost to Follow-up|1|||
160682151|NCT01214239|580213580|FG000|Overall Study|Withdrawal by Subject|4|||
160682152|NCT01214239|580213581|FG001|Overall Study|Withdrawal by Subject|9|||
160682153|NCT01214239|580213580|FG000|Overall Study|Lack of Efficacy|1|||
160682154|NCT01214239|580213581|FG001|Overall Study|Lack of Efficacy|2|||
160682155|NCT01214239|580213580|FG000|Overall Study|patient's private reason|1|||
160682156|NCT01214239|580213581|FG001|Overall Study|patient's private reason|1|||
160682157|NCT03840382|580213582|FG000|Overall Study|Lost to Follow-up|11|||
160682158|NCT01142661|580213583|FG000|Overall Study|Adverse Event|2|||
160682159|NCT01142661|580213583|FG000|Overall Study|Withdrawal by Subject|1|||
160682160|NCT01142661|580213583|FG000|Overall Study|Physician Decision|1|||
160682161|NCT00434590|580213584|FG000|Overall Study|Administrative problems|5|||
160682162|NCT00434590|580213585|FG001|Overall Study|Administrative problems|5|||
160682163|NCT01522950|580215702|FG000|Overall Study|Withdrawal by Subject|3|||
160682164|NCT01522950|580215703|FG001|Overall Study|Withdrawal by Subject|2|||
160682165|NCT01522950|580215704|FG002|Overall Study|Withdrawal by Subject|1|||
160682166|NCT01522950|580215702|FG000|Overall Study|Adverse Event|3|||
160682167|NCT01522950|580215703|FG001|Overall Study|Adverse Event|1|||
160682168|NCT01522950|580215704|FG002|Overall Study|Adverse Event|1|||
160682169|NCT01522950|580215702|FG000|Overall Study|Protocol Violation|0|||
160682170|NCT01522950|580215703|FG001|Overall Study|Protocol Violation|0|||
160682171|NCT01522950|580215704|FG002|Overall Study|Protocol Violation|2|||
160682172|NCT01522950|580215702|FG000|Overall Study|Death|0|||
160682173|NCT01522950|580215703|FG001|Overall Study|Death|1|||
160682174|NCT01522950|580215704|FG002|Overall Study|Death|1|||
160682175|NCT01522950|580215702|FG000|Overall Study|Study Medication Sensitivity|0|||
160682176|NCT01522950|580215703|FG001|Overall Study|Study Medication Sensitivity|1|||
160682177|NCT01522950|580215704|FG002|Overall Study|Study Medication Sensitivity|0|||
160682178|NCT01064531|580215707|FG000|Overall Study|Lost to Follow-up|0|||
160682179|NCT01064531|580215708|FG001|Overall Study|Lost to Follow-up|2|||
160682180|NCT01064531|580215707|FG000|Overall Study|Physician Decision|0|||
160682181|NCT01064531|580215708|FG001|Overall Study|Physician Decision|1|||
160682182|NCT01064531|580215707|FG000|Overall Study|Withdrawal by Subject|2|||
160682183|NCT01064531|580215708|FG001|Overall Study|Withdrawal by Subject|2|||
160682184|NCT01064531|580215707|FG000|Overall Study|Revision due to femoral stem loosening|1|||
160682185|NCT01064531|580215708|FG001|Overall Study|Revision due to femoral stem loosening|0|||
160682186|NCT01064531|580215707|FG000|Overall Study|Revision due to dislocation|0|||
160682187|NCT01064531|580215708|FG001|Overall Study|Revision due to dislocation|1|||
160682188|NCT01064531|580215707|FG000|Overall Study|Death|0|||
160682189|NCT01064531|580215708|FG001|Overall Study|Death|1|||
160682190|NCT03449199|580215713|FG000|Overall Study|Lost to Follow-up|1|||
160682191|NCT03449199|580215714|FG001|Overall Study|Lost to Follow-up|1|||
160682192|NCT03449199|580215715|FG002|Overall Study|Lost to Follow-up|0|||
160682193|NCT03449199|580215713|FG000|Overall Study|Protocol Deviation|0|||
160682194|NCT03449199|580215714|FG001|Overall Study|Protocol Deviation|0|||
160682195|NCT03449199|580215715|FG002|Overall Study|Protocol Deviation|1|||
160682196|NCT03449199|580215713|FG000|Overall Study|Withdrawal by Subject|0|||
160682197|NCT03449199|580215714|FG001|Overall Study|Withdrawal by Subject|0|||
160682198|NCT03449199|580215715|FG002|Overall Study|Withdrawal by Subject|1|||
160682199|NCT03136406|580215716|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
160682200|NCT01652729|580215717|FG000|Overall Study|Withdrawal by Subject|14|||
160682201|NCT01652729|580215718|FG001|Overall Study|Withdrawal by Subject|7|||
160682202|NCT01652729|580215719|FG002|Overall Study|Withdrawal by Subject|7|||
160682203|NCT01652729|580215717|FG000|Overall Study|Adverse Event|4|||
160682204|NCT01652729|580215718|FG001|Overall Study|Adverse Event|0|||
160682205|NCT01652729|580215719|FG002|Overall Study|Adverse Event|3|||
160682206|NCT01652729|580215717|FG000|Overall Study|Physician Decision|1|||
160682207|NCT01652729|580215718|FG001|Overall Study|Physician Decision|0|||
160682208|NCT01652729|580215719|FG002|Overall Study|Physician Decision|1|||
160682209|NCT01652729|580215717|FG000|Overall Study|Protocol Violation|1|||
160682210|NCT01652729|580215718|FG001|Overall Study|Protocol Violation|0|||
160682211|NCT01652729|580215719|FG002|Overall Study|Protocol Violation|0|||
160682212|NCT01652729|580215717|FG000|Overall Study|Lost to Follow-up|6|||
160682213|NCT01652729|580215718|FG001|Overall Study|Lost to Follow-up|6|||
160682214|NCT01652729|580215719|FG002|Overall Study|Lost to Follow-up|3|||
160682215|NCT01652729|580215717|FG000|Overall Study|Administrative|1|||
160682216|NCT01652729|580215718|FG001|Overall Study|Administrative|0|||
160682217|NCT01652729|580215719|FG002|Overall Study|Administrative|0|||
160682218|NCT00483548|580215720|FG000|Overall Study|Randomized; not treated with study drug|1|||
160682219|NCT00483548|580215721|FG001|Overall Study|Randomized; not treated with study drug|3|||
160682220|NCT00483548|580215720|FG000|Overall Study|Adverse Event|25|||
160682221|NCT00483548|580215721|FG001|Overall Study|Adverse Event|14|||
160682222|NCT00483548|580215720|FG000|Overall Study|Laboratory abnormality|1|||
160682223|NCT00483548|580215721|FG001|Overall Study|Laboratory abnormality|2|||
160682224|NCT00483548|580215720|FG000|Overall Study|Lack of Efficacy|4|||
160682225|NCT00483548|580215721|FG001|Overall Study|Lack of Efficacy|8|||
160682226|NCT00483548|580215720|FG000|Overall Study|Protocol Violation|11|||
160682227|NCT00483548|580215721|FG001|Overall Study|Protocol Violation|7|||
160682228|NCT00483548|580215720|FG000|Overall Study|Pregnancy|1|||
160682229|NCT00483548|580215721|FG001|Overall Study|Pregnancy|0|||
160682230|NCT00483548|580215720|FG000|Overall Study|Protocol required discontinuation|6|||
160682231|NCT00483548|580215721|FG001|Overall Study|Protocol required discontinuation|6|||
160682232|NCT00483548|580215720|FG000|Overall Study|Unable to comply with protocol schedule|1|||
160682233|NCT00483548|580215721|FG001|Overall Study|Unable to comply with protocol schedule|0|||
160682234|NCT00483548|580215720|FG000|Overall Study|Non-compliance with medication|2|||
160682235|NCT00483548|580215721|FG001|Overall Study|Non-compliance with medication|0|||
160682236|NCT00483548|580215720|FG000|Overall Study|Lost to Follow-up|3|||
160682237|NCT00483548|580215721|FG001|Overall Study|Lost to Follow-up|4|||
160682238|NCT00483548|580215720|FG000|Overall Study|Withdrawal by Subject|5|||
160682239|NCT00483548|580215721|FG001|Overall Study|Withdrawal by Subject|2|||
160682240|NCT04364737|580215725|FG000|Overall Study|Withdrawal by Subject|4|||
160682241|NCT04364737|580215726|FG001|Overall Study|Withdrawal by Subject|9|||
160682242|NCT04364737|580215725|FG000|Overall Study|Lost to Follow-up|1|||
160682243|NCT04364737|580215726|FG001|Overall Study|Lost to Follow-up|1|||
160682244|NCT01220609|580215727|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
160682245|NCT01220609|580215727|FG000|Overall Study|Ineligible- Wrong cell type|1|||
160682246|NCT01220609|580215727|FG000|Overall Study|Ineligible-Never treated|1|||
160682247|NCT00112294|580215728|FG000|Overall Study|Still on study|5|||
160682248|NCT00112294|580215729|FG001|Overall Study|Still on study|0|||
160682249|NCT05070754|580215739|FG000|Overall Study|Withdrawal by Subject|0|||
160682250|NCT05070754|580215740|FG001|Overall Study|Withdrawal by Subject|0|||
160682251|NCT05070754|580215741|FG002|Overall Study|Withdrawal by Subject|0|||
160682252|NCT05070754|580215742|FG003|Overall Study|Withdrawal by Subject|1|||
160682253|NCT05070754|580215739|FG000|Overall Study|Protocol Violation|0|||
160682254|NCT05070754|580215740|FG001|Overall Study|Protocol Violation|0|||
160682255|NCT05070754|580215741|FG002|Overall Study|Protocol Violation|0|||
160682256|NCT05070754|580215742|FG003|Overall Study|Protocol Violation|1|||
160682257|NCT01398787|580215743|FG000|Overall Study|Adverse Event|1|||
160682258|NCT00529217|580215746|FG000|Overall Study|Lack of Efficacy|2|||
160682259|NCT00529217|580215746|FG000|Overall Study|Unable to adhere to study schedule|2|||
160682260|NCT00372996|580215749|FG000|Overall Study|Death|11|||
160682261|NCT00372996|580215750|FG001|Overall Study|Death|4|||
160682262|NCT00372996|580215751|FG002|Overall Study|Death|8|||
160682263|NCT00372996|580215752|FG003|Overall Study|Death|7|||
160682264|NCT00372996|580215749|FG000|Overall Study|Lost to Follow-up|0|||
160682265|NCT00372996|580215750|FG001|Overall Study|Lost to Follow-up|2|||
160682266|NCT00372996|580215751|FG002|Overall Study|Lost to Follow-up|0|||
160682267|NCT00372996|580215752|FG003|Overall Study|Lost to Follow-up|1|||
160682268|NCT00372996|580215749|FG000|Overall Study|Withdrawal by Subject|12|||
160682269|NCT00372996|580215750|FG001|Overall Study|Withdrawal by Subject|6|||
160682270|NCT00372996|580215751|FG002|Overall Study|Withdrawal by Subject|9|||
160682271|NCT00372996|580215752|FG003|Overall Study|Withdrawal by Subject|5|||
160682272|NCT00372996|580215749|FG000|Overall Study|Study Terminated by Sponsor|4|||
160682273|NCT00372996|580215750|FG001|Overall Study|Study Terminated by Sponsor|0|||
160682274|NCT00372996|580215751|FG002|Overall Study|Study Terminated by Sponsor|4|||
160682275|NCT00372996|580215752|FG003|Overall Study|Study Terminated by Sponsor|0|||
160682276|NCT00372996|580215749|FG000|Overall Study|Other|10|||
160682277|NCT00372996|580215750|FG001|Overall Study|Other|2|||
160682278|NCT00372996|580215751|FG002|Overall Study|Other|7|||
160682279|NCT00372996|580215752|FG003|Overall Study|Other|7|||
160682280|NCT01098539|580215753|FG000|Overall Study|Adverse Event|26|||
160682281|NCT01098539|580215754|FG001|Overall Study|Adverse Event|26|||
160682282|NCT01098539|580215753|FG000|Overall Study|Protocol Violation|1|||
160682283|NCT01098539|580215754|FG001|Overall Study|Protocol Violation|4|||
160682284|NCT01098539|580215753|FG000|Overall Study|Noncompliance|3|||
160682285|NCT01098539|580215754|FG001|Overall Study|Noncompliance|5|||
160682286|NCT01098539|580215753|FG000|Overall Study|Lost to Follow-up|4|||
160682287|NCT01098539|580215754|FG001|Overall Study|Lost to Follow-up|4|||
160682288|NCT01098539|580215753|FG000|Overall Study|Withdrawal by Subject|12|||
160682289|NCT01098539|580215754|FG001|Overall Study|Withdrawal by Subject|26|||
160682290|NCT01098539|580215753|FG000|Overall Study|Physician Decision|5|||
160682291|NCT01098539|580215754|FG001|Overall Study|Physician Decision|3|||
160682292|NCT01386125|580215755|FG000|Overall Study|Lost to Follow-up|3|||
160682293|NCT01386125|580215756|FG001|Overall Study|Lost to Follow-up|9|||
160682294|NCT01386125|580215755|FG000|Overall Study|Physician Decision|0|||
160682295|NCT01386125|580215756|FG001|Overall Study|Physician Decision|1|||
160682296|NCT01386125|580215755|FG000|Overall Study|Protocol Violation|5|||
160682297|NCT01386125|580215756|FG001|Overall Study|Protocol Violation|7|||
160682298|NCT01386125|580215755|FG000|Overall Study|Disease Progress|1|||
160682299|NCT01386125|580215756|FG001|Overall Study|Disease Progress|2|||
160682300|NCT01386125|580215755|FG000|Overall Study|Withdrawal by Subject|13|||
160682301|NCT01386125|580215756|FG001|Overall Study|Withdrawal by Subject|12|||
160682302|NCT01386125|580215755|FG000|Overall Study|Adverse Event|2|||
160682303|NCT01386125|580215756|FG001|Overall Study|Adverse Event|5|||
160682304|NCT01386125|580215755|FG000|Overall Study|Lack of Efficacy|0|||
160682305|NCT01386125|580215756|FG001|Overall Study|Lack of Efficacy|1|||
160682306|NCT01386125|580215755|FG000|Overall Study|Participant Leaving Country|1|||
160682307|NCT01386125|580215756|FG001|Overall Study|Participant Leaving Country|0|||
160682308|NCT03173560|580215757|FG000|Overall Study|Death|70|||
160682309|NCT03173560|580215758|FG001|Overall Study|Death|60|||
160682310|NCT03173560|580215757|FG000|Overall Study|Lost to Follow-up|1|||
160682311|NCT03173560|580215758|FG001|Overall Study|Lost to Follow-up|4|||
160682312|NCT03173560|580215757|FG000|Overall Study|Withdrawal by Subject|10|||
160682313|NCT03173560|580215758|FG001|Overall Study|Withdrawal by Subject|5|||
160682314|NCT03173560|580215757|FG000|Overall Study|Other|0|||
160682315|NCT03173560|580215758|FG001|Overall Study|Other|1|||
160682316|NCT01292837|580215759|FG000|Overall Study|Adverse Event|1|||
160682317|NCT01292837|580215759|FG000|Overall Study|Further treatment determined|1|||
160682318|NCT02174276|580215762|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
160682319|NCT02174276|580215763|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
160682320|NCT02174276|580215764|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
160682321|NCT02174276|580215765|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
160682322|NCT02174276|580215762|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
160682323|NCT02174276|580215763|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
160682324|NCT02174276|580215764|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
160682325|NCT02174276|580215765|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
160682326|NCT02174276|580215762|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
160682327|NCT02174276|580215763|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
160682328|NCT02174276|580215764|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
160682329|NCT02174276|580215765|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
160682330|NCT02174276|580215762|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
160682331|NCT02174276|580215763|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
160682332|NCT02174276|580215764|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
160682333|NCT02174276|580215765|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
160682334|NCT02174276|580215762|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
160682335|NCT02174276|580215763|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
160682336|NCT02174276|580215764|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
160682337|NCT02174276|580215765|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
160682338|NCT02174276|580215762|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
160682339|NCT02174276|580215763|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
160682340|NCT02174276|580215764|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
160682341|NCT02174276|580215765|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
160682342|NCT02661022|580215766|FG000|Overall Study|Withdrawal by Subject|3|||
160682343|NCT02661022|580215767|FG001|Overall Study|Withdrawal by Subject|0|||
160682344|NCT02661022|580215766|FG000|Overall Study|Adverse Event|1|||
160682345|NCT02661022|580215767|FG001|Overall Study|Adverse Event|1|||
160682346|NCT02661022|580215766|FG000|Overall Study|Physician Decision|1|||
160682347|NCT02661022|580215767|FG001|Overall Study|Physician Decision|0|||
160682348|NCT02661022|580215766|FG000|Overall Study|Progressive Disease|2|||
160682349|NCT02661022|580215767|FG001|Overall Study|Progressive Disease|1|||
160682350|NCT02359864|580215769|FG000|Overall Study|Withdrawal by Subject|1|||
160682351|NCT02359864|580215770|FG001|Overall Study|Withdrawal by Subject|0|||
160682352|NCT00725764|580215771|FG000|Overall Study|Withdrawal by Subject|2|||
160682353|NCT00725764|580215771|FG000|Overall Study|Physician Decision|1|||
160682354|NCT00725764|580215771|FG000|Overall Study|Progressive Disease|7|||
160682355|NCT00725764|580215771|FG000|Overall Study|Lost to Follow-up|1|||
160682356|NCT00725764|580215771|FG000|Overall Study|Death|1|||
160682357|NCT00725764|580215771|FG000|Overall Study|Participant non compliant with protocol|1|||
160682358|NCT00725764|580215771|FG000|Overall Study|Decline in performance status|1|||
160682359|NCT04480307|580215773|FG000|Overall Study|Withdrawal by Subject|0|||
160682360|NCT04480307|580215774|FG001|Overall Study|Withdrawal by Subject|1|||
160682361|NCT04480307|580215775|FG002|Overall Study|Withdrawal by Subject|0|||
160682362|NCT04480307|580215776|FG003|Overall Study|Withdrawal by Subject|0|||
160682363|NCT04480307|580215773|FG000|Overall Study|Adverse Event|0|||
160682364|NCT04480307|580215774|FG001|Overall Study|Adverse Event|0|||
160682365|NCT04480307|580215775|FG002|Overall Study|Adverse Event|0|||
160682366|NCT04480307|580215776|FG003|Overall Study|Adverse Event|1|||
160682367|NCT00609154|580215777|FG000|Overall Study|Protocol Violation|1|||
160682368|NCT00609154|580215778|FG001|Overall Study|Protocol Violation|2|||
160682369|NCT00609154|580215777|FG000|Overall Study|Unable to establish IV access|0|||
160682370|NCT00609154|580215778|FG001|Overall Study|Unable to establish IV access|4|||
160682371|NCT00609154|580215777|FG000|Overall Study|Adverse Event|0|||
160682372|NCT00609154|580215778|FG001|Overall Study|Adverse Event|2|||
160682373|NCT00434837|580215781|FG000|Overall Study|Lost to Follow-up|20|||
160682374|NCT00434837|580215782|FG001|Overall Study|Lost to Follow-up|23|||
160682375|NCT00434837|580215783|FG002|Overall Study|Lost to Follow-up|30|||
160682376|NCT00515216|580215784|FG000|Overall Study|Withdrawal by Subject|1|||
160682377|NCT01450800|580215786|FG000|Overall Study|Protocol Violation|1|||
160682378|NCT01450800|580215787|FG001|Overall Study|Protocol Violation|3|||
160682379|NCT03023137|580215798|FG000|Overall Study|Multiple pregnancy|2|||
160682380|NCT03023137|580215799|FG001|Overall Study|Multiple pregnancy|4|||
160682381|NCT03023137|580215798|FG000|Overall Study|Lost to Follow-up|1|||
160682382|NCT03023137|580215799|FG001|Overall Study|Lost to Follow-up|1|||
160682383|NCT03023137|580215798|FG000|Overall Study|Protocol Violation|0|||
160682384|NCT03023137|580215799|FG001|Overall Study|Protocol Violation|4|||
160682385|NCT03023137|580215798|FG000|Overall Study|Lost the baby in a car accident|1|||
160682386|NCT03023137|580215799|FG001|Overall Study|Lost the baby in a car accident|0|||
160682387|NCT02795676|580215807|FG000|Overall Study|Adverse Event|2|||
160682388|NCT02795676|580215808|FG001|Overall Study|Adverse Event|0|||
160682389|NCT02795676|580215807|FG000|Overall Study|Withdrawal by Subject|3|||
160682390|NCT02795676|580215808|FG001|Overall Study|Withdrawal by Subject|1|||
160682391|NCT00732160|580215809|FG000|Overall Study|Adverse Event|1|||
160682392|NCT00732160|580215810|FG001|Overall Study|Adverse Event|0|||
160682393|NCT00732160|580215811|FG002|Overall Study|Adverse Event|1|||
160682394|NCT00732160|580215812|FG003|Overall Study|Adverse Event|1|||
160682395|NCT00732160|580215809|FG000|Overall Study|scheduling|4|||
160682396|NCT00732160|580215810|FG001|Overall Study|scheduling|4|||
160682397|NCT00732160|580215811|FG002|Overall Study|scheduling|2|||
160682398|NCT00732160|580215812|FG003|Overall Study|scheduling|1|||
160682399|NCT01115933|580215815|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
160682400|NCT02427399|580215816|FG000|Overall Study|Protocol Violation|14|||
160682401|NCT02427399|580215817|FG001|Overall Study|Protocol Violation|16|||
160682402|NCT02427399|580215818|FG002|Overall Study|Protocol Violation|12|||
160682403|NCT02427399|580215819|FG003|Overall Study|Protocol Violation|18|||
160682404|NCT02427399|580215820|FG004|Overall Study|Protocol Violation|15|||
160682405|NCT00605176|580215823|FG000|Overall Study|Adverse Event|2|||
160682406|NCT00605176|580215824|FG001|Overall Study|Adverse Event|1|||
160682407|NCT00605176|580215825|FG002|Overall Study|Adverse Event|3|||
160682408|NCT00605176|580215823|FG000|Overall Study|Withdrawal by Subject|4|||
160682409|NCT00605176|580215824|FG001|Overall Study|Withdrawal by Subject|2|||
160682410|NCT00605176|580215825|FG002|Overall Study|Withdrawal by Subject|4|||
160682411|NCT00605176|580215823|FG000|Overall Study|Lost to Follow-up|2|||
160682412|NCT00605176|580215824|FG001|Overall Study|Lost to Follow-up|2|||
160682413|NCT00605176|580215825|FG002|Overall Study|Lost to Follow-up|1|||
160682414|NCT00605176|580215823|FG000|Overall Study|Non-complicance with study procedures|1|||
160682415|NCT00605176|580215824|FG001|Overall Study|Non-complicance with study procedures|0|||
160682416|NCT00605176|580215825|FG002|Overall Study|Non-complicance with study procedures|0|||
160682417|NCT00605176|580215823|FG000|Overall Study|Use of concomitant therapy|1|||
160682418|NCT00605176|580215824|FG001|Overall Study|Use of concomitant therapy|0|||
160682419|NCT00605176|580215825|FG002|Overall Study|Use of concomitant therapy|1|||
160682420|NCT00605176|580215823|FG000|Overall Study|Other (not due to AE)|1|||
160682421|NCT00605176|580215824|FG001|Overall Study|Other (not due to AE)|1|||
160682422|NCT00605176|580215825|FG002|Overall Study|Other (not due to AE)|0|||
160682423|NCT01086969|580215826|FG000|Overall Study|Withdrawal by Subject|1|||
160682424|NCT01086969|580215827|FG001|Overall Study|Withdrawal by Subject|2|||
160682425|NCT01086969|580215828|FG002|Overall Study|Withdrawal by Subject|0|||
160682426|NCT01609582|580215833|FG000|Overall Study|Adverse Event|20|||
160682427|NCT01609582|580215834|FG001|Overall Study|Adverse Event|18|||
160682428|NCT01609582|580215833|FG000|Overall Study|Lost to Follow-up|10|||
160682429|NCT01609582|580215834|FG001|Overall Study|Lost to Follow-up|10|||
160682430|NCT01609582|580215833|FG000|Overall Study|Withdrawal by Subject|21|||
160682431|NCT01609582|580215834|FG001|Overall Study|Withdrawal by Subject|15|||
160682432|NCT01609582|580215833|FG000|Overall Study|Study Terminated by Sponsor|1543|||
160682433|NCT01609582|580215834|FG001|Overall Study|Study Terminated by Sponsor|1548|||
160682434|NCT01609582|580215833|FG000|Overall Study|Other|9|||
160682435|NCT01609582|580215834|FG001|Overall Study|Other|10|||
160682436|NCT01609582|580215833|FG000|Overall Study|Randomized, but not treated|0|||
160682437|NCT01609582|580215834|FG001|Overall Study|Randomized, but not treated|3|||
160682438|NCT00819767|580215835|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160682439|NCT00819767|580215836|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160682440|NCT00685750|580215837|FG000|Overall Study|Tumor sampling failure|0|||
160682441|NCT00685750|580215838|FG001|Overall Study|Tumor sampling failure|0|||
160682442|NCT00685750|580215839|FG002|Overall Study|Tumor sampling failure|1|||
160682443|NCT00685750|580215840|FG003|Overall Study|Tumor sampling failure|0|||
160682444|NCT00685750|580215841|FG004|Overall Study|Tumor sampling failure|0|||
160682445|NCT00685750|580215842|FG005|Overall Study|Tumor sampling failure|0|||
160682446|NCT00685750|580215843|FG006|Overall Study|Tumor sampling failure|0|||
160682447|NCT00685750|580215837|FG000|Overall Study|Patient didn't receive the treatment|0|||
160682448|NCT00685750|580215838|FG001|Overall Study|Patient didn't receive the treatment|0|||
160682449|NCT00685750|580215839|FG002|Overall Study|Patient didn't receive the treatment|0|||
160682450|NCT00685750|580215840|FG003|Overall Study|Patient didn't receive the treatment|0|||
160682451|NCT00685750|580215841|FG004|Overall Study|Patient didn't receive the treatment|0|||
160682452|NCT00685750|580215842|FG005|Overall Study|Patient didn't receive the treatment|0|||
160682453|NCT00685750|580215843|FG006|Overall Study|Patient didn't receive the treatment|1|||
160682454|NCT00685750|580215837|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160682455|NCT00685750|580215838|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160682456|NCT00685750|580215839|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
160682457|NCT00685750|580215840|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
160682458|NCT00685750|580215841|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
160682459|NCT00685750|580215842|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
160682460|NCT00685750|580215843|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
160682461|NCT00129116|580215846|FG000|Primary Phase|Lost to Follow-up|1|||
160682462|NCT00129116|580215847|FG001|Primary Phase|Lost to Follow-up|1|||
160682463|NCT00129116|580215848|FG002|Primary Phase|Lost to Follow-up|0|||
160682464|NCT00129116|580215849|FG003|Primary Phase|Lost to Follow-up|1|||
160682465|NCT00129116|580215850|FG004|Primary Phase|Lost to Follow-up|1|||
160682466|NCT00129116|580215846|FG000|Primary Phase|Protocol Violation|0|||
160682467|NCT00129116|580215847|FG001|Primary Phase|Protocol Violation|1|||
160682468|NCT00129116|580215848|FG002|Primary Phase|Protocol Violation|0|||
160682469|NCT00129116|580215849|FG003|Primary Phase|Protocol Violation|0|||
160682470|NCT00129116|580215850|FG004|Primary Phase|Protocol Violation|0|||
160682471|NCT00129116|580215846|FG000|Primary Phase|Adverse Event|1|||
160682472|NCT00129116|580215847|FG001|Primary Phase|Adverse Event|1|||
160682473|NCT00129116|580215848|FG002|Primary Phase|Adverse Event|0|||
160682474|NCT00129116|580215849|FG003|Primary Phase|Adverse Event|0|||
160682475|NCT00129116|580215850|FG004|Primary Phase|Adverse Event|0|||
160682476|NCT00129116|580215846|FG000|Primary Phase|Withdrawal by Subject|0|||
160682477|NCT00129116|580215847|FG001|Primary Phase|Withdrawal by Subject|1|||
160682478|NCT00129116|580215848|FG002|Primary Phase|Withdrawal by Subject|0|||
160682479|NCT00129116|580215849|FG003|Primary Phase|Withdrawal by Subject|0|||
160682480|NCT00129116|580215850|FG004|Primary Phase|Withdrawal by Subject|0|||
160682481|NCT00129116|580215846|FG000|Primary Phase|Other|0|||
160682482|NCT00129116|580215847|FG001|Primary Phase|Other|0|||
160682483|NCT00129116|580215848|FG002|Primary Phase|Other|1|||
160682484|NCT00129116|580215849|FG003|Primary Phase|Other|0|||
160682485|NCT00129116|580215850|FG004|Primary Phase|Other|0|||
160682486|NCT00129116|580215846|FG000|Booster Phase|Lost to Follow-up|2|||
160682487|NCT00129116|580215847|FG001|Booster Phase|Lost to Follow-up|0|||
160682488|NCT00129116|580215848|FG002|Booster Phase|Lost to Follow-up|0|||
160682489|NCT00129116|580215849|FG003|Booster Phase|Lost to Follow-up|0|||
160682490|NCT00129116|580215850|FG004|Booster Phase|Lost to Follow-up|1|||
160682491|NCT02539368|580215851|FG000|Overall Study|Death|4|||
160682492|NCT02539368|580215852|FG001|Overall Study|Death|2|||
160682493|NCT02539368|580215853|FG002|Overall Study|Death|1|||
160682494|NCT02539368|580215854|FG003|Overall Study|Death|0|||
160682495|NCT02539368|580215855|FG004|Overall Study|Death|0|||
160682496|NCT02539368|580215851|FG000|Overall Study|Withdrawal by Subject|44|||
160682497|NCT02539368|580215852|FG001|Overall Study|Withdrawal by Subject|35|||
160682498|NCT02539368|580215853|FG002|Overall Study|Withdrawal by Subject|9|||
160682499|NCT02539368|580215854|FG003|Overall Study|Withdrawal by Subject|1|||
160682500|NCT02539368|580215855|FG004|Overall Study|Withdrawal by Subject|3|||
160682501|NCT02539368|580215851|FG000|Overall Study|Physician Decision|49|||
160682502|NCT02539368|580215852|FG001|Overall Study|Physician Decision|15|||
160682503|NCT02539368|580215853|FG002|Overall Study|Physician Decision|7|||
160682504|NCT02539368|580215854|FG003|Overall Study|Physician Decision|0|||
160682505|NCT02539368|580215855|FG004|Overall Study|Physician Decision|2|||
160682506|NCT02539368|580215851|FG000|Overall Study|Lost to Follow-up|96|||
160682507|NCT02539368|580215852|FG001|Overall Study|Lost to Follow-up|21|||
160682508|NCT02539368|580215853|FG002|Overall Study|Lost to Follow-up|16|||
160682509|NCT02539368|580215854|FG003|Overall Study|Lost to Follow-up|4|||
160682510|NCT02539368|580215855|FG004|Overall Study|Lost to Follow-up|3|||
160682511|NCT02539368|580215851|FG000|Overall Study|Adverse Event|44|||
160682512|NCT02539368|580215852|FG001|Overall Study|Adverse Event|5|||
160682513|NCT02539368|580215853|FG002|Overall Study|Adverse Event|9|||
160682514|NCT02539368|580215854|FG003|Overall Study|Adverse Event|0|||
160682515|NCT02539368|580215855|FG004|Overall Study|Adverse Event|3|||
160682516|NCT02539368|580215851|FG000|Overall Study|Participant Non-compliant|13|||
160682517|NCT02539368|580215852|FG001|Overall Study|Participant Non-compliant|2|||
160682518|NCT02539368|580215853|FG002|Overall Study|Participant Non-compliant|1|||
160682519|NCT02539368|580215854|FG003|Overall Study|Participant Non-compliant|1|||
160682520|NCT02539368|580215855|FG004|Overall Study|Participant Non-compliant|0|||
160682521|NCT02539368|580215851|FG000|Overall Study|Other|145|||
160682522|NCT02539368|580215852|FG001|Overall Study|Other|18|||
160682523|NCT02539368|580215853|FG002|Overall Study|Other|24|||
160682524|NCT02539368|580215854|FG003|Overall Study|Other|1|||
160682525|NCT02539368|580215855|FG004|Overall Study|Other|3|||
160682526|NCT02539368|580215851|FG000|Overall Study|Missing|10|||
160682527|NCT02539368|580215852|FG001|Overall Study|Missing|3|||
160682528|NCT02539368|580215853|FG002|Overall Study|Missing|0|||
160682529|NCT02539368|580215854|FG003|Overall Study|Missing|0|||
160682530|NCT02539368|580215855|FG004|Overall Study|Missing|0|||
160682531|NCT00251316|580215858|FG000|Overall Study|Physician Decision|2|||
160682532|NCT00251316|580215859|FG001|Overall Study|Physician Decision|3|||
160682533|NCT00398073|580215860|FG000|Overall Study|Withdrawal by Subject|1|||
160682534|NCT00398073|580215861|FG001|Overall Study|Withdrawal by Subject|0|||
160682535|NCT00708682|580215862|FG000|Infant Series|Adverse Event|1|||
160682536|NCT00708682|580215862|FG000|Infant Series|Lost to Follow-up|4|||
160682537|NCT00708682|580215862|FG000|Infant Series|Protocol Violation|1|||
160682538|NCT00708682|580215862|FG000|Infant Series|Parent/legal guardian request|6|||
160682539|NCT00708682|580215862|FG000|Infant Series|Failed to return|2|||
160682540|NCT00708682|580215862|FG000|Infant Series|Other|19|||
160682541|NCT00708682|580215862|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
160682542|NCT00708682|580215862|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
160682543|NCT00708682|580215862|FG000|Toddler Dose|Lost to Follow-up|3|||
160682544|NCT00708682|580215862|FG000|Toddler Dose|Failed to Return|4|||
160682545|NCT00569777|580215865|FG000|Overall Study|Withdrawal by Subject|4|||
160682546|NCT00569777|580215866|FG001|Overall Study|Withdrawal by Subject|0|||
160682547|NCT00569777|580215865|FG000|Overall Study|Adverse Event|3|||
160682548|NCT00569777|580215866|FG001|Overall Study|Adverse Event|0|||
160682549|NCT00569777|580215865|FG000|Overall Study|Lost to Follow-up|1|||
160682550|NCT00569777|580215866|FG001|Overall Study|Lost to Follow-up|0|||
160682551|NCT00569777|580215865|FG000|Overall Study|scheduled eye surgery|0|||
160682552|NCT00569777|580215866|FG001|Overall Study|scheduled eye surgery|1|||
160682553|NCT00569777|580215865|FG000|Overall Study|did not meet exclusion criteria|1|||
160682554|NCT00569777|580215866|FG001|Overall Study|did not meet exclusion criteria|2|||
160682555|NCT00569777|580215865|FG000|Overall Study|pregnant|1|||
160682556|NCT00569777|580215866|FG001|Overall Study|pregnant|0|||
160682557|NCT00987831|580215867|FG000|Overall Study|Never flared in 12 months|1|||
160682558|NCT00987831|580215868|FG001|Overall Study|Never flared in 12 months|0|||
160682559|NCT00987831|580215869|FG002|Overall Study|Never flared in 12 months|0|||
160682560|NCT00987831|580215867|FG000|Overall Study|Lost to Follow-up|0|||
160682561|NCT00987831|580215868|FG001|Overall Study|Lost to Follow-up|3|||
160682562|NCT00987831|580215869|FG002|Overall Study|Lost to Follow-up|0|||
160682563|NCT03253094|580215870|FG000|Overall Study|Adverse Event|2|||
160682564|NCT03253094|580215871|FG001|Overall Study|Adverse Event|0|||
160682565|NCT03253094|580215872|FG002|Overall Study|Adverse Event|0|||
160682566|NCT03253094|580215873|FG003|Overall Study|Adverse Event|0|||
160682567|NCT03253094|580215874|FG004|Overall Study|Adverse Event|0|||
160682568|NCT03253094|580215875|FG005|Overall Study|Adverse Event|0|||
160682569|NCT03253094|580215870|FG000|Overall Study|Lack of Efficacy|0|||
160682570|NCT03253094|580215871|FG001|Overall Study|Lack of Efficacy|0|||
160682571|NCT03253094|580215872|FG002|Overall Study|Lack of Efficacy|2|||
160682572|NCT03253094|580215873|FG003|Overall Study|Lack of Efficacy|1|||
160682573|NCT03253094|580215874|FG004|Overall Study|Lack of Efficacy|2|||
160682574|NCT03253094|580215875|FG005|Overall Study|Lack of Efficacy|1|||
160682575|NCT03253094|580215870|FG000|Overall Study|Lost to Follow-up|0|||
160682576|NCT03253094|580215871|FG001|Overall Study|Lost to Follow-up|0|||
160682577|NCT03253094|580215872|FG002|Overall Study|Lost to Follow-up|1|||
160682578|NCT03253094|580215873|FG003|Overall Study|Lost to Follow-up|1|||
160682579|NCT03253094|580215874|FG004|Overall Study|Lost to Follow-up|0|||
160682580|NCT03253094|580215875|FG005|Overall Study|Lost to Follow-up|1|||
160682581|NCT03253094|580215870|FG000|Overall Study|Physician Decision|1|||
160682582|NCT03253094|580215871|FG001|Overall Study|Physician Decision|0|||
160682583|NCT03253094|580215872|FG002|Overall Study|Physician Decision|0|||
160682584|NCT03253094|580215873|FG003|Overall Study|Physician Decision|1|||
160682585|NCT03253094|580215874|FG004|Overall Study|Physician Decision|0|||
160682586|NCT03253094|580215875|FG005|Overall Study|Physician Decision|2|||
160682587|NCT03253094|580215870|FG000|Overall Study|Withdrawal by Subject|1|||
160682588|NCT03253094|580215871|FG001|Overall Study|Withdrawal by Subject|2|||
160682589|NCT03253094|580215872|FG002|Overall Study|Withdrawal by Subject|1|||
160682590|NCT03253094|580215873|FG003|Overall Study|Withdrawal by Subject|0|||
160682591|NCT03253094|580215874|FG004|Overall Study|Withdrawal by Subject|3|||
160682592|NCT03253094|580215875|FG005|Overall Study|Withdrawal by Subject|0|||
160682593|NCT03253094|580215870|FG000|Overall Study|Other|0|||
160682594|NCT03253094|580215871|FG001|Overall Study|Other|1|||
160682595|NCT03253094|580215872|FG002|Overall Study|Other|2|||
160682596|NCT03253094|580215873|FG003|Overall Study|Other|1|||
160682597|NCT03253094|580215874|FG004|Overall Study|Other|0|||
160682598|NCT03253094|580215875|FG005|Overall Study|Other|0|||
160682599|NCT02625974|580215876|FG000|Part 1|Lost to Follow-up|9|||
160682600|NCT02625974|580215877|FG001|Part 1|Lost to Follow-up|3|||
160682601|NCT02625974|580215876|FG000|Part 2|Lost to Follow-up|4|||
160682602|NCT02625974|580215877|FG001|Part 2|Lost to Follow-up|6|||
160682603|NCT02625974|580215876|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
160682604|NCT02625974|580215877|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
160682605|NCT00965731|580215880|FG000|Overall Study|Death|0|||
160682606|NCT00965731|580215881|FG001|Overall Study|Death|4|||
160682607|NCT00965731|580215880|FG000|Overall Study|Withdrawal by Subject|0|||
160682608|NCT00965731|580215881|FG001|Overall Study|Withdrawal by Subject|1|||
160682609|NCT00965731|580215880|FG000|Overall Study|Other|7|||
160682610|NCT00965731|580215881|FG001|Overall Study|Other|15|||
160682611|NCT04773600|580215882|FG000|Overall Study|Withdrawal by Subject|15|||
160682612|NCT04773600|580215883|FG001|Overall Study|Withdrawal by Subject|9|||
160682613|NCT04773600|580215882|FG000|Overall Study|Lost to Follow-up|10|||
160682614|NCT04773600|580215883|FG001|Overall Study|Lost to Follow-up|6|||
160682615|NCT04773600|580215882|FG000|Overall Study|Adverse Event|8|||
160682616|NCT04773600|580215883|FG001|Overall Study|Adverse Event|2|||
160682617|NCT04773600|580215882|FG000|Overall Study|Lack of Efficacy|2|||
160682618|NCT04773600|580215883|FG001|Overall Study|Lack of Efficacy|3|||
160682619|NCT04773600|580215882|FG000|Overall Study|Noncompliance|2|||
160682620|NCT04773600|580215883|FG001|Overall Study|Noncompliance|0|||
160682621|NCT04773600|580215882|FG000|Overall Study|Protocol Violation|2|||
160682622|NCT04773600|580215883|FG001|Overall Study|Protocol Violation|0|||
160682623|NCT04773600|580215882|FG000|Overall Study|Physician Decision|0|||
160682624|NCT04773600|580215883|FG001|Overall Study|Physician Decision|1|||
160682625|NCT04773600|580215882|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
160682626|NCT04773600|580215883|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
160682627|NCT04773600|580215882|FG000|Overall Study|Emergency Travel Out of Country|1|||
160682628|NCT04773600|580215883|FG001|Overall Study|Emergency Travel Out of Country|0|||
160682629|NCT01923311|580217012|FG000|Overall Study|Pregnancy|1|||
160682630|NCT01923311|580217013|FG001|Overall Study|Pregnancy|0|||
160682631|NCT01923311|580217012|FG000|Overall Study|Investigator's Discretion|1|||
160682632|NCT01923311|580217013|FG001|Overall Study|Investigator's Discretion|0|||
160682633|NCT01923311|580217012|FG000|Overall Study|Non-Compliance with Study Drug|2|||
160682634|NCT01923311|580217013|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160682635|NCT01923311|580217012|FG000|Overall Study|Withdrew Consent|1|||
160682636|NCT01923311|580217013|FG001|Overall Study|Withdrew Consent|0|||
160682637|NCT01923311|580217012|FG000|Overall Study|Study Terminated by Sponsor|12|||
160682638|NCT01923311|580217013|FG001|Overall Study|Study Terminated by Sponsor|0|||
160682639|NCT02839798|580217019|FG000|Overall Study|Withdrawal by Subject|2|||
160682640|NCT03180528|580217020|FG000|Overall Study|Adverse Event|1|||
160682641|NCT03180528|580217020|FG000|Overall Study|Withdrawal by Subject|1|||
160682642|NCT03180528|580217020|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
160682643|NCT02447887|580217021|FG000|Overall Study|Study was terminated|3|||
160682644|NCT03429049|580217022|FG000|Overall Study|Adverse Event|2|||
160682645|NCT03429049|580217023|FG001|Overall Study|Adverse Event|3|||
160682646|NCT03429049|580217022|FG000|Overall Study|Death|0|||
160682647|NCT03429049|580217023|FG001|Overall Study|Death|1|||
160682648|NCT03429049|580217022|FG000|Overall Study|Lack of Efficacy|4|||
160682649|NCT03429049|580217023|FG001|Overall Study|Lack of Efficacy|2|||
160682650|NCT03429049|580217022|FG000|Overall Study|Lost to Follow-up|9|||
160682651|NCT03429049|580217023|FG001|Overall Study|Lost to Follow-up|8|||
160682652|NCT03429049|580217022|FG000|Overall Study|Physician Decision|1|||
160682653|NCT03429049|580217023|FG001|Overall Study|Physician Decision|0|||
160682654|NCT03429049|580217022|FG000|Overall Study|Protocol Violation|3|||
160682655|NCT03429049|580217023|FG001|Overall Study|Protocol Violation|0|||
160682656|NCT03429049|580217022|FG000|Overall Study|Sponsor Decision|2|||
160682657|NCT03429049|580217023|FG001|Overall Study|Sponsor Decision|0|||
160682658|NCT03429049|580217022|FG000|Overall Study|Withdrawal by Subject|4|||
160682659|NCT03429049|580217023|FG001|Overall Study|Withdrawal by Subject|20|||
160682660|NCT03429049|580217022|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
160682661|NCT03429049|580217023|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
160682662|NCT04703855|580217024|FG000|Overall Study|Heart Transplant|1|||
160682663|NCT04129944|580217026|FG000|Overall Study|Death|0|||
160682664|NCT04129944|580217027|FG001|Overall Study|Death|0|||
160682665|NCT04129944|580217028|FG002|Overall Study|Death|0|||
160682666|NCT04129944|580217029|FG003|Overall Study|Death|1|||
160682667|NCT04129944|580217026|FG000|Overall Study|Lost to Follow-up|1|||
160682668|NCT04129944|580217027|FG001|Overall Study|Lost to Follow-up|0|||
160682669|NCT04129944|580217028|FG002|Overall Study|Lost to Follow-up|0|||
160682670|NCT04129944|580217029|FG003|Overall Study|Lost to Follow-up|0|||
160682671|NCT04129944|580217026|FG000|Overall Study|Withdrawal by Subject|1|||
160682672|NCT04129944|580217027|FG001|Overall Study|Withdrawal by Subject|0|||
160682673|NCT04129944|580217028|FG002|Overall Study|Withdrawal by Subject|1|||
160682674|NCT04129944|580217029|FG003|Overall Study|Withdrawal by Subject|2|||
160682675|NCT03941834|580217030|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
160682676|NCT03941834|580217031|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
160682677|NCT03941834|580217032|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
160682678|NCT03941834|580217030|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
160682679|NCT03941834|580217031|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
160682680|NCT03941834|580217032|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
160682681|NCT03941834|580217030|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
160682682|NCT03941834|580217031|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
160682683|NCT03941834|580217032|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
160682684|NCT03941834|580217030|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
160682685|NCT03941834|580217031|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
160682686|NCT03941834|580217032|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
160682687|NCT03941834|580217030|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
160682688|NCT03941834|580217031|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
160682689|NCT03941834|580217032|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
160682690|NCT03941834|580217030|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
160682691|NCT03941834|580217031|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
160682692|NCT03941834|580217032|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
160682693|NCT02356211|580217033|FG000|Overall Study|Withdrawal by Subject|2|||
160682694|NCT02356211|580217034|FG001|Overall Study|Withdrawal by Subject|2|||
160682695|NCT02356211|580217033|FG000|Overall Study|ineligible|1|||
160682696|NCT02356211|580217034|FG001|Overall Study|ineligible|8|||
160682697|NCT01124695|580217039|FG000|Overall Study|Disease progression|77|||
160682698|NCT01124695|580217039|FG000|Overall Study|Adverse Event|11|||
160682699|NCT01124695|580217039|FG000|Overall Study|Death|1|||
160682700|NCT01124695|580217039|FG000|Overall Study|Withdrawal by Subject|7|||
160682701|NCT01124695|580217039|FG000|Overall Study|Physician Decision|3|||
160682702|NCT01124695|580217039|FG000|Overall Study|Alternative therapy|9|||
160682703|NCT01124695|580217039|FG000|Overall Study|No documentation that patient went off treatment|4|||
160682704|NCT01124695|580217039|FG000|Overall Study|Ineligible|9|||
160682705|NCT01124695|580217039|FG000|Overall Study|Ineligible and never start treatment|2|||
160682706|NCT02668822|580217040|FG000|Overall Study|Protocol Violation|2|||
160682707|NCT02668822|580217041|FG001|Overall Study|Protocol Violation|0|||
160682708|NCT02668822|580217040|FG000|Overall Study|Study Terminated by Sponsor|7|||
160682709|NCT02668822|580217041|FG001|Overall Study|Study Terminated by Sponsor|9|||
160682710|NCT03036839|580217043|FG000|Overall Study|Adverse Event|0|||
160682711|NCT03036839|580217044|FG001|Overall Study|Adverse Event|0|||
160682712|NCT03036839|580217045|FG002|Overall Study|Adverse Event|1|||
160682713|NCT03036839|580217043|FG000|Overall Study|Death|3|||
160682714|NCT03036839|580217044|FG001|Overall Study|Death|0|||
160682715|NCT03036839|580217045|FG002|Overall Study|Death|3|||
160682716|NCT03036839|580217043|FG000|Overall Study|Withdrew Consent|0|||
160682717|NCT03036839|580217044|FG001|Overall Study|Withdrew Consent|0|||
160682718|NCT03036839|580217045|FG002|Overall Study|Withdrew Consent|1|||
160682719|NCT00412737|580217046|FG000|Overall Study|Death|1|||
160682720|NCT00412737|580217047|FG001|Overall Study|Death|0|||
160682721|NCT00412737|580217046|FG000|Overall Study|Adverse Event|3|||
160682722|NCT00412737|580217047|FG001|Overall Study|Adverse Event|2|||
160682723|NCT00412737|580217046|FG000|Overall Study|Refused Treatment|6|||
160682724|NCT00412737|580217047|FG001|Overall Study|Refused Treatment|2|||
160682725|NCT00412737|580217046|FG000|Overall Study|Failure to Return|6|||
160682726|NCT00412737|580217047|FG001|Overall Study|Failure to Return|2|||
160682727|NCT03180801|580217048|FG000|Overall Study|Physician Decision|3|||
160682728|NCT03180801|580217049|FG001|Overall Study|Physician Decision|3|||
160682729|NCT03180801|580217050|FG002|Overall Study|Physician Decision|1|||
160682730|NCT03180801|580217048|FG000|Overall Study|Non-compliance|1|||
160682731|NCT03180801|580217049|FG001|Overall Study|Non-compliance|4|||
160682732|NCT03180801|580217050|FG002|Overall Study|Non-compliance|0|||
160682733|NCT03180801|580217048|FG000|Overall Study|Inoculation Target Reached|1|||
160682734|NCT03180801|580217049|FG001|Overall Study|Inoculation Target Reached|1|||
160682735|NCT03180801|580217050|FG002|Overall Study|Inoculation Target Reached|3|||
160682736|NCT03180801|580217048|FG000|Overall Study|Adverse Event|1|||
160682737|NCT03180801|580217049|FG001|Overall Study|Adverse Event|0|||
160682738|NCT03180801|580217050|FG002|Overall Study|Adverse Event|2|||
160682739|NCT03180801|580217048|FG000|Overall Study|Withdrawal by Subject|2|||
160682740|NCT03180801|580217049|FG001|Overall Study|Withdrawal by Subject|2|||
160682741|NCT03180801|580217050|FG002|Overall Study|Withdrawal by Subject|1|||
160682742|NCT03180801|580217048|FG000|Overall Study|Lost to Follow-up|0|||
160682743|NCT03180801|580217049|FG001|Overall Study|Lost to Follow-up|2|||
160682744|NCT03180801|580217050|FG002|Overall Study|Lost to Follow-up|3|||
160682745|NCT00868296|580217052|FG000|Overall Study|Adverse Event|0|||
160682746|NCT00868296|580217053|FG001|Overall Study|Adverse Event|2|||
160682747|NCT00868296|580217052|FG000|Overall Study|Withdrawal by Subject|0|||
160682748|NCT00868296|580217053|FG001|Overall Study|Withdrawal by Subject|1|||
160682749|NCT02418455|580217056|FG000|48-Week Treatment Period|Other- Not Specified|1|||
160682750|NCT02418455|580217056|FG000|Continuation Period|Sponsor Decision|7|||
160682751|NCT03235479|580217059|FG000|Overall Study|Lost to Follow-up|8|||
160682752|NCT03235479|580217060|FG001|Overall Study|Lost to Follow-up|11|||
160682753|NCT03235479|580217059|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
160682754|NCT03235479|580217060|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
160682755|NCT03235479|580217059|FG000|Overall Study|Pregnancy|1|||
160682756|NCT03235479|580217060|FG001|Overall Study|Pregnancy|0|||
160682757|NCT03235479|580217059|FG000|Overall Study|Protocol Deviation|1|||
160682758|NCT03235479|580217060|FG001|Overall Study|Protocol Deviation|3|||
160682759|NCT03235479|580217059|FG000|Overall Study|Technical Problems|3|||
160682760|NCT03235479|580217060|FG001|Overall Study|Technical Problems|2|||
160682761|NCT03235479|580217059|FG000|Overall Study|Withdrawal by Subject|2|||
160682762|NCT03235479|580217060|FG001|Overall Study|Withdrawal by Subject|2|||
160682763|NCT03235479|580217059|FG000|Overall Study|Other Reasons|3|||
160682764|NCT03235479|580217060|FG001|Overall Study|Other Reasons|5|||
160682765|NCT02001051|580217061|FG000|Overall Study|Deemed not eligible following enrollment|0|||
160682766|NCT02001051|580217062|FG001|Overall Study|Deemed not eligible following enrollment|1|||
160682767|NCT04205162|580217072|FG000|Overall Study|Lost to Follow-up|1|||
160682768|NCT04205162|580217073|FG001|Overall Study|Lost to Follow-up|0|||
160682769|NCT04205162|580217072|FG000|Overall Study|Withdrawal by Subject|2|||
160682770|NCT04205162|580217073|FG001|Overall Study|Withdrawal by Subject|0|||
160682771|NCT04205162|580217072|FG000|Overall Study|University closure due to COVID-19|1|||
160682772|NCT04205162|580217073|FG001|Overall Study|University closure due to COVID-19|0|||
160682773|NCT01999894|580217074|FG000|Overall Study|Adverse Event|9|||
160682774|NCT01999894|580217074|FG000|Overall Study|Lack of Efficacy|5|||
160682775|NCT01999894|580217074|FG000|Overall Study|Protocol Violation|1|||
160682776|NCT01999894|580217074|FG000|Overall Study|Withdrawal by Subject|7|||
160682777|NCT01999894|580217074|FG000|Overall Study|Lost to Follow-up|10|||
160682778|NCT01999894|580217074|FG000|Overall Study|Other Reason|3|||
160682779|NCT01999894|580217074|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
160682780|NCT01546519|580217076|FG000|Overall Study|Adverse Event|0|||
160682781|NCT01546519|580217077|FG001|Overall Study|Adverse Event|0|||
160682782|NCT01546519|580217078|FG002|Overall Study|Adverse Event|1|||
160682783|NCT01546519|580217079|FG003|Overall Study|Adverse Event|1|||
160682784|NCT01546519|580217076|FG000|Overall Study|Death|0|||
160682785|NCT01546519|580217077|FG001|Overall Study|Death|1|||
160682786|NCT01546519|580217078|FG002|Overall Study|Death|3|||
160682787|NCT01546519|580217079|FG003|Overall Study|Death|1|||
160682788|NCT01546519|580217076|FG000|Overall Study|related to disease progression|2|||
160682789|NCT01546519|580217077|FG001|Overall Study|related to disease progression|2|||
160682790|NCT01546519|580217078|FG002|Overall Study|related to disease progression|2|||
160682791|NCT01546519|580217079|FG003|Overall Study|related to disease progression|1|||
160682792|NCT01546519|580217076|FG000|Overall Study|Physician Decision|6|||
160682793|NCT01546519|580217077|FG001|Overall Study|Physician Decision|5|||
160682794|NCT01546519|580217078|FG002|Overall Study|Physician Decision|2|||
160682795|NCT01546519|580217079|FG003|Overall Study|Physician Decision|3|||
160682796|NCT01546519|580217076|FG000|Overall Study|Withdrawal by Subject|1|||
160682797|NCT01546519|580217077|FG001|Overall Study|Withdrawal by Subject|0|||
160682798|NCT01546519|580217078|FG002|Overall Study|Withdrawal by Subject|0|||
160682799|NCT01546519|580217079|FG003|Overall Study|Withdrawal by Subject|0|||
160682800|NCT00779402|580217080|FG000|Treatment Phase 1|Disease Progression|1|||
160682801|NCT00779402|580217081|FG001|Treatment Phase 1|Disease Progression|0|||
160682802|NCT00779402|580217080|FG000|Treatment Phase 1|Adverse Event|2|||
160682803|NCT00779402|580217081|FG001|Treatment Phase 1|Adverse Event|0|||
160682804|NCT00779402|580217080|FG000|Treatment Phase 1|Protocol Violation|1|||
160682805|NCT00779402|580217081|FG001|Treatment Phase 1|Protocol Violation|0|||
160682806|NCT00779402|580217080|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
160682807|NCT00779402|580217081|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
160682808|NCT00779402|580217080|FG000|Treatment Phase 1|Lost to Follow-up|0|||
160682809|NCT00779402|580217081|FG001|Treatment Phase 1|Lost to Follow-up|1|||
160682810|NCT00779402|580217080|FG000|Treatment Phase 1|Death|0|||
160682811|NCT00779402|580217081|FG001|Treatment Phase 1|Death|1|||
160682812|NCT00779402|580217080|FG000|Treatment Phase 1|Intercurrent Illness|1|||
160682813|NCT00779402|580217081|FG001|Treatment Phase 1|Intercurrent Illness|1|||
160682814|NCT00779402|580217080|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
160682815|NCT00779402|580217081|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
160682816|NCT00779402|580217080|FG000|Treatment Phase 1|Other|4|||
160682817|NCT00779402|580217081|FG001|Treatment Phase 1|Other|2|||
160682818|NCT00779402|580217080|FG000|Treatment Phase 1|Closure of Study|3|||
160682819|NCT00779402|580217081|FG001|Treatment Phase 1|Closure of Study|2|||
160682820|NCT00779402|580217080|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
160682821|NCT00779402|580217081|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
160682822|NCT00779402|580217080|FG000|Surveillance Phase|Protocol Violation|0|||
160682823|NCT00779402|580217081|FG001|Surveillance Phase|Protocol Violation|1|||
160682824|NCT00779402|580217080|FG000|Surveillance Phase|Patient refused to continue|22|||
160682825|NCT00779402|580217081|FG001|Surveillance Phase|Patient refused to continue|14|||
160682826|NCT00779402|580217080|FG000|Surveillance Phase|Lost to Follow-up|2|||
160682827|NCT00779402|580217081|FG001|Surveillance Phase|Lost to Follow-up|1|||
160682828|NCT00779402|580217080|FG000|Surveillance Phase|Death|0|||
160682829|NCT00779402|580217081|FG001|Surveillance Phase|Death|1|||
160682830|NCT00779402|580217080|FG000|Surveillance Phase|Intercurrent Illness|2|||
160682831|NCT00779402|580217081|FG001|Surveillance Phase|Intercurrent Illness|0|||
160682832|NCT00779402|580217080|FG000|Surveillance Phase|Other|5|||
160682833|NCT00779402|580217081|FG001|Surveillance Phase|Other|5|||
160682834|NCT00779402|580217080|FG000|Surveillance Phase|Withdrawal by Subject|4|||
160682835|NCT00779402|580217081|FG001|Surveillance Phase|Withdrawal by Subject|1|||
160682836|NCT00779402|580217080|FG000|Surveillance Phase|Closure of study|5|||
160682837|NCT00779402|580217081|FG001|Surveillance Phase|Closure of study|6|||
160682838|NCT00779402|580217080|FG000|Surveillance Phase|Completed Protocol Visits|3|||
160682839|NCT00779402|580217081|FG001|Surveillance Phase|Completed Protocol Visits|2|||
160682840|NCT00779402|580217080|FG000|Long-term Follow-up|Patient refused to continue|2|||
160682841|NCT00779402|580217081|FG001|Long-term Follow-up|Patient refused to continue|0|||
160682842|NCT00779402|580217080|FG000|Long-term Follow-up|Other|5|||
160682843|NCT00779402|580217081|FG001|Long-term Follow-up|Other|0|||
160682844|NCT00779402|580217080|FG000|Long-term Follow-up|Closure of Study|8|||
160682845|NCT00779402|580217081|FG001|Long-term Follow-up|Closure of Study|4|||
160682846|NCT00779402|580217080|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
160682847|NCT00779402|580217081|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
160682848|NCT01519947|580217082|FG000|Overall Study|Death|0|||
160682849|NCT01519947|580217083|FG001|Overall Study|Death|0|||
160682850|NCT01519947|580217084|FG002|Overall Study|Death|0|||
160682851|NCT01519947|580217085|FG003|Overall Study|Death|1|||
160682852|NCT01519947|580217082|FG000|Overall Study|Protocol Violation|0|||
160682853|NCT01519947|580217083|FG001|Overall Study|Protocol Violation|0|||
160682854|NCT01519947|580217084|FG002|Overall Study|Protocol Violation|2|||
160682855|NCT01519947|580217085|FG003|Overall Study|Protocol Violation|1|||
160682856|NCT01519947|580217082|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
160682857|NCT01519947|580217083|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
160682858|NCT01519947|580217084|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
160682859|NCT01519947|580217085|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
160682860|NCT01519947|580217082|FG000|Overall Study|Development of Anemia|0|||
160682861|NCT01519947|580217083|FG001|Overall Study|Development of Anemia|1|||
160682862|NCT01519947|580217084|FG002|Overall Study|Development of Anemia|0|||
160682863|NCT01519947|580217085|FG003|Overall Study|Development of Anemia|1|||
160682864|NCT01519947|580217082|FG000|Overall Study|Blood Transfusion|0|||
160682865|NCT01519947|580217083|FG001|Overall Study|Blood Transfusion|1|||
160682866|NCT01519947|580217084|FG002|Overall Study|Blood Transfusion|1|||
160682867|NCT01519947|580217085|FG003|Overall Study|Blood Transfusion|0|||
160682868|NCT01519947|580217082|FG000|Overall Study|Withdrawal by Subject|0|||
160682869|NCT01519947|580217083|FG001|Overall Study|Withdrawal by Subject|1|||
160682870|NCT01519947|580217084|FG002|Overall Study|Withdrawal by Subject|0|||
160682871|NCT01519947|580217085|FG003|Overall Study|Withdrawal by Subject|1|||
160682872|NCT01519947|580217082|FG000|Overall Study|Lost to Follow-up|0|||
160682873|NCT01519947|580217083|FG001|Overall Study|Lost to Follow-up|0|||
160682874|NCT01519947|580217084|FG002|Overall Study|Lost to Follow-up|3|||
160682875|NCT01519947|580217085|FG003|Overall Study|Lost to Follow-up|2|||
160682876|NCT01519947|580217082|FG000|Overall Study|Poor Response|1|||
160682877|NCT01519947|580217083|FG001|Overall Study|Poor Response|0|||
160682878|NCT01519947|580217084|FG002|Overall Study|Poor Response|0|||
160682879|NCT01519947|580217085|FG003|Overall Study|Poor Response|1|||
160682880|NCT01519947|580217082|FG000|Overall Study|Adverse Event|1|||
160682881|NCT01519947|580217083|FG001|Overall Study|Adverse Event|0|||
160682882|NCT01519947|580217084|FG002|Overall Study|Adverse Event|1|||
160682883|NCT01519947|580217085|FG003|Overall Study|Adverse Event|1|||
160682884|NCT00693225|580217086|FG000|Overall Study|Lost to Follow-up|1|||
160682885|NCT00693225|580217087|FG001|Overall Study|Lost to Follow-up|2|||
160682886|NCT00693225|580217086|FG000|Overall Study|Adverse Event|1|||
160682887|NCT00693225|580217087|FG001|Overall Study|Adverse Event|3|||
160682888|NCT03585959|580217092|FG000|Overall Study|Physician Decision|1|||
160682889|NCT03585959|580217092|FG000|Overall Study|Unsuccessful Procedure|2|||
160682890|NCT01186016|580217094|FG000|Overall Study|Withdrawal by Subject|46|||
160682891|NCT01186016|580217095|FG001|Overall Study|Withdrawal by Subject|29|||
160682892|NCT03750695|580217097|FG000|Overall Study|Lost to Follow-up|0|||
160682893|NCT03750695|580217098|FG001|Overall Study|Lost to Follow-up|1|||
160682894|NCT01206439|580217101|FG000|Overall Study|subject did not meet inclusion criteria|1|||
160682895|NCT05889039|580217103|FG000|Overall Study|error in completing survey|0|||
160682896|NCT05889039|580217104|FG001|Overall Study|error in completing survey|2|||
160682897|NCT05889039|580217105|FG002|Overall Study|error in completing survey|0|||
160682898|NCT05889039|580217106|FG003|Overall Study|error in completing survey|0|||
160682899|NCT05889039|580217103|FG000|Overall Study|Lost to Follow-up|4|||
160682900|NCT05889039|580217104|FG001|Overall Study|Lost to Follow-up|0|||
160682901|NCT05889039|580217105|FG002|Overall Study|Lost to Follow-up|0|||
160682902|NCT05889039|580217106|FG003|Overall Study|Lost to Follow-up|0|||
160682903|NCT01808248|580217109|FG000|Overall Study|Lack of Efficacy|3|||
160682904|NCT01808248|580217109|FG000|Overall Study|Withdrawal by Subject|1|||
160682905|NCT01808248|580217109|FG000|Overall Study|Lost to Follow-up|1|||
160682906|NCT04974580|580217112|FG000|Overall Study|Lost to Follow-up|33|||
160682907|NCT04974580|580217113|FG001|Overall Study|Lost to Follow-up|39|||
160682908|NCT04974580|580217114|FG002|Overall Study|Lost to Follow-up|30|||
160682909|NCT04974580|580217115|FG003|Overall Study|Lost to Follow-up|29|||
160682910|NCT02941523|580217119|FG000|Monotherapy|Withdrawal by Subject|0|||
160682911|NCT02941523|580217120|FG001|Monotherapy|Withdrawal by Subject|1|||
160682912|NCT02941523|580217119|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
160682913|NCT02941523|580217120|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
160682914|NCT02941523|580217119|FG000|Carboplatin Combination Therapy|Death|1|||
160682915|NCT02941523|580217120|FG001|Carboplatin Combination Therapy|Death|2|||
160682916|NCT02941523|580217119|FG000|Carboplatin Combination Therapy|Disease progression|2|||
160682917|NCT02941523|580217120|FG001|Carboplatin Combination Therapy|Disease progression|0|||
160682918|NCT02941523|580217119|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
160682919|NCT02941523|580217120|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
160682920|NCT04330157|580217121|FG000|Overall Study|Protocol Violation|4|||
160682921|NCT04330157|580217121|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
160682922|NCT03558139|580217122|FG000|Overall Study|Consent Withdrawn|1|||
160682923|NCT03558139|580217123|FG001|Overall Study|Consent Withdrawn|1|||
160682924|NCT03558139|580217124|FG002|Overall Study|Consent Withdrawn|4|||
160682925|NCT03558139|580217122|FG000|Overall Study|Death|5|||
160682926|NCT03558139|580217123|FG001|Overall Study|Death|3|||
160682927|NCT03558139|580217124|FG002|Overall Study|Death|8|||
160682928|NCT03558139|580217122|FG000|Overall Study|Lost to Follow-up|0|||
160682929|NCT03558139|580217123|FG001|Overall Study|Lost to Follow-up|0|||
160682930|NCT03558139|580217124|FG002|Overall Study|Lost to Follow-up|3|||
160682931|NCT03558139|580217122|FG000|Overall Study|Study Ended Per Protocol|0|||
160682932|NCT03558139|580217123|FG001|Overall Study|Study Ended Per Protocol|3|||
160682933|NCT03558139|580217124|FG002|Overall Study|Study Ended Per Protocol|6|||
160682934|NCT02752802|580217125|FG000|Overall Study|Contrast Volume Not Collected|1|||
160682935|NCT02752802|580217126|FG001|Overall Study|Contrast Volume Not Collected|0|||
160682936|NCT03689894|580217127|FG000|Overall Study|Adverse Event|1|||
160682937|NCT01378962|580217133|FG000|Overall Study|Death|14|||
160682938|NCT01378962|580217133|FG000|Overall Study|Lost to Follow-up|1|||
160682939|NCT01378962|580217133|FG000|Overall Study|Other|2|||
160682940|NCT02056652|580217134|FG000|Overall Study|Withdrawal by Subject|1|||
160682941|NCT02056652|580217135|FG001|Overall Study|Withdrawal by Subject|0|||
160682942|NCT02056652|580217134|FG000|Overall Study|Lost to Follow-up|0|||
160682943|NCT02056652|580217135|FG001|Overall Study|Lost to Follow-up|3|||
160682944|NCT00239005|580217140|FG000|Overall Study|Adverse Event|6|||
160682945|NCT00239005|580217141|FG001|Overall Study|Adverse Event|6|||
160682946|NCT00239005|580217140|FG000|Overall Study|Withdrawal by Subject|3|||
160682947|NCT00239005|580217141|FG001|Overall Study|Withdrawal by Subject|4|||
160682948|NCT00239005|580217140|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
160682949|NCT00239005|580217141|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
160682950|NCT00239005|580217140|FG000|Overall Study|Protocol Violation|1|||
160682951|NCT00239005|580217141|FG001|Overall Study|Protocol Violation|0|||
160682952|NCT00239005|580217140|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
160682953|NCT00239005|580217141|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
160682954|NCT00239005|580217140|FG000|Overall Study|Lost to Follow-up|0|||
160682955|NCT00239005|580217141|FG001|Overall Study|Lost to Follow-up|1|||
160682956|NCT00824369|580217143|FG000|Overall Study|Nolonger willing to participate in study|1|||
160682957|NCT00824369|580217144|FG001|Overall Study|Nolonger willing to participate in study|0|||
160682958|NCT00824369|580217145|FG002|Overall Study|Nolonger willing to participate in study|1|||
160682959|NCT00824369|580217146|FG003|Overall Study|Nolonger willing to participate in study|2|||
160682960|NCT00824369|580217147|FG004|Overall Study|Nolonger willing to participate in study|0|||
160682961|NCT00824369|580217148|FG005|Overall Study|Nolonger willing to participate in study|1|||
160682962|NCT00824369|580217143|FG000|Overall Study|Lost to Follow-up|0|||
160682963|NCT00824369|580217144|FG001|Overall Study|Lost to Follow-up|0|||
160682964|NCT00824369|580217145|FG002|Overall Study|Lost to Follow-up|0|||
160682965|NCT00824369|580217146|FG003|Overall Study|Lost to Follow-up|0|||
160682966|NCT00824369|580217147|FG004|Overall Study|Lost to Follow-up|1|||
160682967|NCT00824369|580217148|FG005|Overall Study|Lost to Follow-up|0|||
160682968|NCT02413294|580217149|FG000|Overall Study|Withdrawal by Subject|1|||
160682969|NCT01560819|580218511|FG000|Overall Study|Physician Decision|1|||
160682970|NCT01560819|580218512|FG001|Overall Study|Physician Decision|0|||
160682971|NCT02012452|580218515|FG000|Overall Study|Lost to Follow-up|2|||
160682972|NCT02012452|580218516|FG001|Overall Study|Lost to Follow-up|1|||
160682973|NCT02012452|580218515|FG000|Overall Study|Withdrawal by Subject|4|||
160682974|NCT02012452|580218516|FG001|Overall Study|Withdrawal by Subject|0|||
160682975|NCT04403399|580218519|FG000|Period 2|Physician Decision|0|||
160682976|NCT04403399|580218520|FG001|Period 2|Physician Decision|1|||
160682977|NCT00831233|580218523|FG000|Overall Study|Adverse Event|0|||
160682978|NCT00831233|580218524|FG001|Overall Study|Adverse Event|1|||
160682979|NCT00831233|580218523|FG000|Overall Study|Protocol Violation|1|||
160682980|NCT00831233|580218524|FG001|Overall Study|Protocol Violation|0|||
160682981|NCT00831233|580218523|FG000|Overall Study|Selection Criteria Not Met|2|||
160682982|NCT00831233|580218524|FG001|Overall Study|Selection Criteria Not Met|0|||
160682983|NCT00991510|580218525|FG000|Period I (Days 1-14)|Adverse Event|1|||
160682984|NCT00991510|580218526|FG001|Period I (Days 1-14)|Adverse Event|0|||
160682985|NCT00991510|580218525|FG000|Period III (Days 29-112)|Adverse Event|1|||
160682986|NCT00991510|580218526|FG001|Period III (Days 29-112)|Adverse Event|1|||
160682987|NCT03710590|580218527|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
160682988|NCT03710590|580218528|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
160682989|NCT02488824|580218529|FG000|Overall Study|Adverse Event|1|||
160682990|NCT02488824|580218530|FG001|Overall Study|Adverse Event|1|||
160682991|NCT01976728|580218531|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
160682992|NCT01976728|580218532|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
160682993|NCT01976728|580218533|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
160682994|NCT01976728|580218534|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
160682995|NCT01563237|580218535|FG000|Overall Study|Lost to Follow-up|6|||
160682996|NCT01563237|580218536|FG001|Overall Study|Lost to Follow-up|0|||
160682997|NCT01563237|580218535|FG000|Overall Study|Withdrawal by Subject|1|||
160682998|NCT01563237|580218536|FG001|Overall Study|Withdrawal by Subject|0|||
160682999|NCT01563237|580218535|FG000|Overall Study|Adverse Event|1|||
160683000|NCT01563237|580218536|FG001|Overall Study|Adverse Event|0|||
160683001|NCT01563237|580218535|FG000|Overall Study|Medical Reasons|1|||
160683002|NCT01563237|580218536|FG001|Overall Study|Medical Reasons|0|||
160683003|NCT01563237|580218535|FG000|Overall Study|Death|1|||
160683004|NCT01563237|580218536|FG001|Overall Study|Death|0|||
160683005|NCT02211014|580218537|FG000|Overall Study|Adverse Event|0|||
160683006|NCT02211014|580218538|FG001|Overall Study|Adverse Event|2|||
160683007|NCT02211014|580218537|FG000|Overall Study|Physician Decision|1|||
160683008|NCT02211014|580218538|FG001|Overall Study|Physician Decision|2|||
160683009|NCT02211014|580218537|FG000|Overall Study|Started another cancer therapy|1|||
160683010|NCT02211014|580218538|FG001|Overall Study|Started another cancer therapy|0|||
160683011|NCT02211014|580218537|FG000|Overall Study|Withdrawal by Subject|0|||
160683012|NCT02211014|580218538|FG001|Overall Study|Withdrawal by Subject|1|||
160683013|NCT02211014|580218537|FG000|Overall Study|In agreement with patient, no benefit|0|||
160683014|NCT02211014|580218538|FG001|Overall Study|In agreement with patient, no benefit|1|||
160683015|NCT00097786|580218539|FG000|Overall Study|lost to follow-up for all-cause death|296|||
160683016|NCT00097786|580218540|FG001|Overall Study|lost to follow-up for all-cause death|292|||
160683017|NCT00097786|580218541|FG002|Overall Study|lost to follow-up for all-cause death|313|||
160683018|NCT00097786|580218542|FG003|Overall Study|lost to follow-up for all-cause death|310|||
160683019|NCT01647711|580218544|FG000|Overall Study|Progressive disease|6|||
160683020|NCT01647711|580218545|FG001|Overall Study|Progressive disease|2|||
160683021|NCT01647711|580218546|FG002|Overall Study|Progressive disease|6|||
160683022|NCT01647711|580218547|FG003|Overall Study|Progressive disease|8|||
160683023|NCT01647711|580218548|FG004|Overall Study|Progressive disease|2|||
160683024|NCT01647711|580218544|FG000|Overall Study|Other adverse event|0|||
160683025|NCT01647711|580218545|FG001|Overall Study|Other adverse event|0|||
160683026|NCT01647711|580218546|FG002|Overall Study|Other adverse event|2|||
160683027|NCT01647711|580218547|FG003|Overall Study|Other adverse event|0|||
160683028|NCT01647711|580218548|FG004|Overall Study|Other adverse event|2|||
160683029|NCT01647711|580218544|FG000|Overall Study|Protocol Violation|0|||
160683030|NCT01647711|580218545|FG001|Overall Study|Protocol Violation|0|||
160683031|NCT01647711|580218546|FG002|Overall Study|Protocol Violation|0|||
160683032|NCT01647711|580218547|FG003|Overall Study|Protocol Violation|0|||
160683033|NCT01647711|580218548|FG004|Overall Study|Protocol Violation|1|||
160683034|NCT01647711|580218544|FG000|Overall Study|Refused to continue taking medication|0|||
160683035|NCT01647711|580218545|FG001|Overall Study|Refused to continue taking medication|0|||
160683036|NCT01647711|580218546|FG002|Overall Study|Refused to continue taking medication|0|||
160683037|NCT01647711|580218547|FG003|Overall Study|Refused to continue taking medication|2|||
160683038|NCT01647711|580218548|FG004|Overall Study|Refused to continue taking medication|1|||
160683039|NCT01647711|580218544|FG000|Overall Study|Other reason not defined|0|||
160683040|NCT01647711|580218545|FG001|Overall Study|Other reason not defined|1|||
160683041|NCT01647711|580218546|FG002|Overall Study|Other reason not defined|1|||
160683042|NCT01647711|580218547|FG003|Overall Study|Other reason not defined|1|||
160683043|NCT01647711|580218548|FG004|Overall Study|Other reason not defined|0|||
160683044|NCT01316419|580218549|FG000|Overall Study|Not treated|103|||
160683045|NCT01316419|580218549|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
160683046|NCT01316419|580218549|FG000|Overall Study|Lost to Follow-up|19|||
160683047|NCT01345318|580218563|FG000|Overall Study|Adverse Event|16|||
160683048|NCT01345318|580218563|FG000|Overall Study|Lack of Efficacy|17|||
160683049|NCT01345318|580218563|FG000|Overall Study|Lost to Follow-up|2|||
160683050|NCT01345318|580218563|FG000|Overall Study|Protocol Violation|1|||
160683051|NCT01345318|580218563|FG000|Overall Study|Withdrawal by Subject|41|||
160683052|NCT01345318|580218563|FG000|Overall Study|Other|3|||
160683053|NCT01685073|580218564|FG000|Overall Study|Lost to Follow-up|6|||
160683054|NCT01685073|580218565|FG001|Overall Study|Lost to Follow-up|8|||
160683055|NCT01685073|580218564|FG000|Overall Study|Withdrawal by Subject|24|||
160683056|NCT01685073|580218565|FG001|Overall Study|Withdrawal by Subject|24|||
160683057|NCT01239472|580218568|FG000|Overall Study|Withdrawal by Subject|5|||
160683058|NCT01239472|580218569|FG001|Overall Study|Withdrawal by Subject|1|||
160683059|NCT01239472|580218568|FG000|Overall Study|Adverse Event|0|||
160683060|NCT01239472|580218569|FG001|Overall Study|Adverse Event|1|||
160683061|NCT01239472|580218568|FG000|Overall Study|Lack of Efficacy|0|||
160683062|NCT01239472|580218569|FG001|Overall Study|Lack of Efficacy|1|||
160683063|NCT02695719|580218573|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
160683064|NCT02695719|580218574|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
160683065|NCT02695719|580218573|FG000|Overall Study|Significant Protocol Deviation|0|||
160683066|NCT02695719|580218574|FG001|Overall Study|Significant Protocol Deviation|1|||
160683067|NCT02695719|580218573|FG000|Overall Study|Voluntary Withdrawal|1|||
160683068|NCT02695719|580218574|FG001|Overall Study|Voluntary Withdrawal|0|||
160683069|NCT01049412|580218577|FG000|Period I|Withdrawal by Subject|4|||
160683070|NCT01049412|580218578|FG001|Period I|Withdrawal by Subject|6|||
160683071|NCT01049412|580218577|FG000|Period I|Lost to Follow-up|2|||
160683072|NCT01049412|580218578|FG001|Period I|Lost to Follow-up|2|||
160683073|NCT01049412|580218577|FG000|Period I|Physician Decision|0|||
160683074|NCT01049412|580218578|FG001|Period I|Physician Decision|3|||
160683075|NCT01049412|580218577|FG000|Period I|Protocol Violation|1|||
160683076|NCT01049412|580218578|FG001|Period I|Protocol Violation|2|||
160683077|NCT01049412|580218577|FG000|Period I|Adverse Event|1|||
160683078|NCT01049412|580218578|FG001|Period I|Adverse Event|0|||
160683079|NCT01049412|580218577|FG000|Period II|Withdrawal by Subject|2|||
160683080|NCT01049412|580218578|FG001|Period II|Withdrawal by Subject|3|||
160683081|NCT01049412|580218577|FG000|Period II|Adverse Event|1|||
160683082|NCT01049412|580218578|FG001|Period II|Adverse Event|0|||
160683083|NCT01049412|580218577|FG000|Period II|Lost to Follow-up|1|||
160683084|NCT01049412|580218578|FG001|Period II|Lost to Follow-up|0|||
160683085|NCT00573170|580218580|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
160683086|NCT00573170|580218581|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
160683087|NCT00573170|580218582|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
160683088|NCT00573170|580218583|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
160683089|NCT00573170|580218584|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
160683090|NCT00573170|580218585|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
160683091|NCT00573170|580218580|FG000|First Washout Period|Adverse Event|1|||
160683092|NCT00573170|580218581|FG001|First Washout Period|Adverse Event|1|||
160683093|NCT00573170|580218582|FG002|First Washout Period|Adverse Event|0|||
160683094|NCT00573170|580218583|FG003|First Washout Period|Adverse Event|0|||
160683095|NCT00573170|580218584|FG004|First Washout Period|Adverse Event|0|||
160683096|NCT00573170|580218585|FG005|First Washout Period|Adverse Event|1|||
160683097|NCT00573170|580218580|FG000|First Washout Period|Lack of Efficacy|0|||
160683098|NCT00573170|580218581|FG001|First Washout Period|Lack of Efficacy|0|||
160683099|NCT00573170|580218582|FG002|First Washout Period|Lack of Efficacy|0|||
160683100|NCT00573170|580218583|FG003|First Washout Period|Lack of Efficacy|0|||
160683101|NCT00573170|580218584|FG004|First Washout Period|Lack of Efficacy|0|||
160683102|NCT00573170|580218585|FG005|First Washout Period|Lack of Efficacy|1|||
160683103|NCT00573170|580218580|FG000|First Washout Period|Lost to Follow-up|1|||
160683104|NCT00573170|580218581|FG001|First Washout Period|Lost to Follow-up|1|||
160683105|NCT00573170|580218582|FG002|First Washout Period|Lost to Follow-up|0|||
160683106|NCT00573170|580218583|FG003|First Washout Period|Lost to Follow-up|2|||
160683107|NCT00573170|580218584|FG004|First Washout Period|Lost to Follow-up|0|||
160683108|NCT00573170|580218585|FG005|First Washout Period|Lost to Follow-up|2|||
160683109|NCT00573170|580218580|FG000|First Washout Period|Withdrawal by Subject|2|||
160683110|NCT00573170|580218581|FG001|First Washout Period|Withdrawal by Subject|0|||
160683111|NCT00573170|580218582|FG002|First Washout Period|Withdrawal by Subject|0|||
160683112|NCT00573170|580218583|FG003|First Washout Period|Withdrawal by Subject|2|||
160683113|NCT00573170|580218584|FG004|First Washout Period|Withdrawal by Subject|3|||
160683114|NCT00573170|580218585|FG005|First Washout Period|Withdrawal by Subject|3|||
160683115|NCT00573170|580218580|FG000|First Washout Period|Other|4|||
160683116|NCT00573170|580218581|FG001|First Washout Period|Other|0|||
160683117|NCT00573170|580218582|FG002|First Washout Period|Other|1|||
160683118|NCT00573170|580218583|FG003|First Washout Period|Other|1|||
160683119|NCT00573170|580218584|FG004|First Washout Period|Other|0|||
160683120|NCT00573170|580218585|FG005|First Washout Period|Other|0|||
160683121|NCT00573170|580218580|FG000|Second Washout Period|Adverse Event|1|||
160683122|NCT00573170|580218581|FG001|Second Washout Period|Adverse Event|0|||
160683123|NCT00573170|580218582|FG002|Second Washout Period|Adverse Event|0|||
160683124|NCT00573170|580218583|FG003|Second Washout Period|Adverse Event|0|||
160683125|NCT00573170|580218584|FG004|Second Washout Period|Adverse Event|1|||
160683126|NCT00573170|580218585|FG005|Second Washout Period|Adverse Event|0|||
160683127|NCT00573170|580218580|FG000|Second Washout Period|Protocol Violation|2|||
160683128|NCT00573170|580218581|FG001|Second Washout Period|Protocol Violation|1|||
160683129|NCT00573170|580218582|FG002|Second Washout Period|Protocol Violation|1|||
160683130|NCT00573170|580218583|FG003|Second Washout Period|Protocol Violation|0|||
160683131|NCT00573170|580218584|FG004|Second Washout Period|Protocol Violation|0|||
160683132|NCT00573170|580218585|FG005|Second Washout Period|Protocol Violation|0|||
160683133|NCT00573170|580218580|FG000|Second Washout Period|Withdrawal by Subject|1|||
160683134|NCT00573170|580218581|FG001|Second Washout Period|Withdrawal by Subject|1|||
160683135|NCT00573170|580218582|FG002|Second Washout Period|Withdrawal by Subject|2|||
160683136|NCT00573170|580218583|FG003|Second Washout Period|Withdrawal by Subject|0|||
160683137|NCT00573170|580218584|FG004|Second Washout Period|Withdrawal by Subject|1|||
160683138|NCT00573170|580218585|FG005|Second Washout Period|Withdrawal by Subject|0|||
160683139|NCT00573170|580218580|FG000|Second Washout Period|Lost to Follow-up|0|||
160683140|NCT00573170|580218581|FG001|Second Washout Period|Lost to Follow-up|0|||
160683141|NCT00573170|580218582|FG002|Second Washout Period|Lost to Follow-up|0|||
160683142|NCT00573170|580218583|FG003|Second Washout Period|Lost to Follow-up|1|||
160683143|NCT00573170|580218584|FG004|Second Washout Period|Lost to Follow-up|0|||
160683144|NCT00573170|580218585|FG005|Second Washout Period|Lost to Follow-up|0|||
160683145|NCT00573170|580218580|FG000|Second Washout Period|Other|1|||
160683146|NCT00573170|580218581|FG001|Second Washout Period|Other|2|||
160683147|NCT00573170|580218582|FG002|Second Washout Period|Other|1|||
160683148|NCT00573170|580218583|FG003|Second Washout Period|Other|4|||
160683149|NCT00573170|580218584|FG004|Second Washout Period|Other|6|||
160683150|NCT00573170|580218585|FG005|Second Washout Period|Other|2|||
160683151|NCT00573170|580218580|FG000|Third Treatment Period|Withdrawal by Subject|1|||
160683152|NCT00573170|580218581|FG001|Third Treatment Period|Withdrawal by Subject|0|||
160683153|NCT00573170|580218582|FG002|Third Treatment Period|Withdrawal by Subject|0|||
160683154|NCT00573170|580218583|FG003|Third Treatment Period|Withdrawal by Subject|0|||
160683155|NCT00573170|580218584|FG004|Third Treatment Period|Withdrawal by Subject|0|||
160683156|NCT00573170|580218585|FG005|Third Treatment Period|Withdrawal by Subject|0|||
160683157|NCT00573170|580218580|FG000|Third Treatment Period|Lost to Follow-up|0|||
160683158|NCT00573170|580218581|FG001|Third Treatment Period|Lost to Follow-up|0|||
160683159|NCT00573170|580218582|FG002|Third Treatment Period|Lost to Follow-up|0|||
160683160|NCT00573170|580218583|FG003|Third Treatment Period|Lost to Follow-up|0|||
160683161|NCT00573170|580218584|FG004|Third Treatment Period|Lost to Follow-up|0|||
160683162|NCT00573170|580218585|FG005|Third Treatment Period|Lost to Follow-up|2|||
160683163|NCT05966090|580218586|FG000|Overall Study|Lost to Follow-up|6|||
160683164|NCT05966090|580218587|FG001|Overall Study|Lost to Follow-up|6|||
160683165|NCT05966090|580218586|FG000|Overall Study|Adverse Event|1|||
160683166|NCT05966090|580218587|FG001|Overall Study|Adverse Event|1|||
160683167|NCT05966090|580218586|FG000|Overall Study|Withdrawal by Subject|1|||
160683168|NCT05966090|580218587|FG001|Overall Study|Withdrawal by Subject|1|||
160683169|NCT05966090|580218586|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160683170|NCT05966090|580218587|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
160683171|NCT05966090|580218586|FG000|Overall Study|Other|1|||
160683172|NCT05966090|580218587|FG001|Overall Study|Other|1|||
160683173|NCT00804141|580218588|FG000|Overall Study|Adverse Event|157|||
160683174|NCT00804141|580218588|FG000|Overall Study|Death|4|||
160683175|NCT00804141|580218588|FG000|Overall Study|Failed to return|96|||
160683176|NCT00804141|580218588|FG000|Overall Study|Investigator request|8|||
160683177|NCT00804141|580218588|FG000|Overall Study|Protocol Violation|85|||
160683178|NCT00804141|580218588|FG000|Overall Study|Withdrawal by Subject|131|||
160683179|NCT00804141|580218588|FG000|Overall Study|Lack of Efficacy|46|||
160683180|NCT00804141|580218588|FG000|Overall Study|Other than specified|30|||
160683181|NCT00804141|580218588|FG000|Overall Study|Enrolled but not treated|6|||
160683182|NCT01142908|580218589|FG000|Overall Study|Lost to Follow-up|19|||
160683183|NCT01142908|580218590|FG001|Overall Study|Lost to Follow-up|13|||
160683184|NCT01142908|580218589|FG000|Overall Study|Death|1|||
160683185|NCT01142908|580218590|FG001|Overall Study|Death|4|||
160683186|NCT01142908|580218589|FG000|Overall Study|Excluded - did not meet criteria|9|||
160683187|NCT01142908|580218590|FG001|Overall Study|Excluded - did not meet criteria|5|||
160683188|NCT01142908|580218589|FG000|Overall Study|Withdrawal by Subject|3|||
160683189|NCT01142908|580218590|FG001|Overall Study|Withdrawal by Subject|0|||
160683190|NCT03110380|580218601|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
160683191|NCT03110380|580218602|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
160683192|NCT03110380|580218603|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
160683193|NCT03110380|580218604|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
160683194|NCT03110380|580218601|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
160683195|NCT03110380|580218602|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
160683196|NCT03110380|580218603|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160683197|NCT03110380|580218604|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160683198|NCT03110380|580218601|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
160683199|NCT03110380|580218602|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
160683200|NCT03110380|580218603|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
160683201|NCT03110380|580218604|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
160683202|NCT03110380|580218601|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
160683203|NCT03110380|580218602|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
160683204|NCT03110380|580218603|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
160683205|NCT03110380|580218604|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
160683206|NCT03110380|580218601|FG000|Double-Blind Treatment Phase|Death|2|||
160683207|NCT03110380|580218602|FG001|Double-Blind Treatment Phase|Death|1|||
160683208|NCT03110380|580218603|FG002|Double-Blind Treatment Phase|Death|0|||
160683209|NCT03110380|580218604|FG003|Double-Blind Treatment Phase|Death|0|||
160683210|NCT03110380|580218601|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
160683211|NCT03110380|580218602|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
160683212|NCT03110380|580218603|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
160683213|NCT03110380|580218604|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
160683214|NCT03110380|580218601|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
160683215|NCT03110380|580218602|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
160683216|NCT03110380|580218603|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
160683217|NCT03110380|580218604|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
160683218|NCT03110380|580218601|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
160683219|NCT03110380|580218602|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
160683220|NCT03110380|580218603|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
160683221|NCT03110380|580218604|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
160683222|NCT03110380|580218601|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
160683223|NCT03110380|580218602|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
160683224|NCT03110380|580218603|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
160683225|NCT03110380|580218604|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
160683226|NCT03110380|580218601|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
160683227|NCT03110380|580218602|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
160683228|NCT03110380|580218603|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
160683229|NCT03110380|580218604|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
160683230|NCT03110380|580218601|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
160683231|NCT03110380|580218602|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
160683232|NCT03110380|580218603|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
160683233|NCT03110380|580218604|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
160683234|NCT02250651|580218605|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
160683235|NCT02250651|580218606|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
160683236|NCT02250651|580218607|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
160683237|NCT02250651|580218605|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
160683238|NCT02250651|580218606|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
160683239|NCT02250651|580218607|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
160683240|NCT02250651|580218605|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
160683241|NCT02250651|580218606|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
160683242|NCT02250651|580218607|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
160683243|NCT02250651|580218605|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
160683244|NCT02250651|580218606|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
160683245|NCT02250651|580218607|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
160683246|NCT02250651|580218605|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
160683247|NCT02250651|580218606|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
160683248|NCT02250651|580218607|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
160683249|NCT02250651|580218605|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
160683250|NCT02250651|580218606|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
160683251|NCT02250651|580218607|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
160683252|NCT02250651|580218605|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
160683253|NCT02250651|580218606|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
160683254|NCT02250651|580218607|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
160683255|NCT02250651|580218605|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
160683256|NCT02250651|580218606|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
160683257|NCT02250651|580218607|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
160683258|NCT02250651|580218605|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
160683259|NCT02250651|580218606|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
160683260|NCT02250651|580218607|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
160683261|NCT02250651|580218605|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
160683262|NCT02250651|580218606|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
160683263|NCT02250651|580218607|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
160683264|NCT02250651|580218605|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
160683265|NCT02250651|580218606|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
160683266|NCT02250651|580218607|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
160683267|NCT02250651|580218605|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
160683268|NCT02250651|580218606|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
160683269|NCT02250651|580218607|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
160683270|NCT02250651|580218605|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
160683271|NCT02250651|580218606|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
160683272|NCT02250651|580218607|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
160683273|NCT02250651|580218605|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
160683274|NCT02250651|580218606|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
160683275|NCT02250651|580218607|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
160683276|NCT02250651|580218605|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
160683277|NCT02250651|580218606|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
160683278|NCT02250651|580218607|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
160683279|NCT01264835|580218608|FG000|Overall Study|Lost to Follow-up|1|||
160683280|NCT01557920|580218611|FG000|Overall Study|Withdrawal by Subject|2|||
160683281|NCT01557920|580218612|FG001|Overall Study|Withdrawal by Subject|3|||
160683282|NCT01557920|580218611|FG000|Overall Study|Lack of Efficacy|1|||
160683283|NCT01557920|580218612|FG001|Overall Study|Lack of Efficacy|0|||
160683284|NCT01466036|580218615|FG000|Overall Study|Death|1|||
160683285|NCT01466036|580218616|FG001|Overall Study|Death|1|||
160683286|NCT01466036|580218615|FG000|Overall Study|Physician Decision|0|||
160683287|NCT01466036|580218616|FG001|Overall Study|Physician Decision|4|||
160683288|NCT01466036|580218615|FG000|Overall Study|Adverse Event|2|||
160683289|NCT01466036|580218616|FG001|Overall Study|Adverse Event|6|||
160683290|NCT01466036|580218615|FG000|Overall Study|Withdrawal by Subject|2|||
160683291|NCT01466036|580218616|FG001|Overall Study|Withdrawal by Subject|8|||
160683292|NCT01466036|580218615|FG000|Overall Study|progression/relapse|14|||
160683293|NCT01466036|580218616|FG001|Overall Study|progression/relapse|21|||
160683294|NCT01466036|580218615|FG000|Overall Study|prolonged treatment delay|1|||
160683295|NCT01466036|580218616|FG001|Overall Study|prolonged treatment delay|1|||
160683296|NCT00220727|580218643|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
160683297|NCT00220727|580218644|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
160683298|NCT02508116|580218645|FG000|Overall Study|Lost to Follow-up|2|||
160683299|NCT02508116|580218646|FG001|Overall Study|Lost to Follow-up|3|||
160683300|NCT02508116|580218645|FG000|Overall Study|Withdrawal by Subject|3|||
160683301|NCT02508116|580218646|FG001|Overall Study|Withdrawal by Subject|2|||
160683302|NCT02508116|580218645|FG000|Overall Study|Protocol Violation|1|||
160683303|NCT02508116|580218646|FG001|Overall Study|Protocol Violation|2|||
160683304|NCT02508116|580218645|FG000|Overall Study|Physician Decision|2|||
160683305|NCT02508116|580218646|FG001|Overall Study|Physician Decision|0|||
160683306|NCT00109850|580218652|FG000|Overall Study|Adverse Event|1|||
160683307|NCT00109850|580218652|FG000|Overall Study|Death|2|||
160683308|NCT00109850|580218652|FG000|Overall Study|Ineligible|1|||
160683309|NCT00476593|580218653|FG000|Overall Study|Lost to Follow-up|10|||
160683310|NCT00476593|580218654|FG001|Overall Study|Lost to Follow-up|2|||
160683311|NCT00476593|580218655|FG002|Overall Study|Lost to Follow-up|8|||
160683312|NCT00476593|580218656|FG003|Overall Study|Lost to Follow-up|22|||
160683313|NCT03430011|580218657|FG000|Pre-Treatment|Death|1|||
160683314|NCT03430011|580218658|FG001|Pre-Treatment|Death|0|||
160683315|NCT03430011|580218659|FG002|Pre-Treatment|Death|0|||
160683316|NCT03430011|580218660|FG003|Pre-Treatment|Death|0|||
160683317|NCT03430011|580218661|FG004|Pre-Treatment|Death|1|||
160683318|NCT03430011|580218662|FG005|Pre-Treatment|Death|0|||
160683319|NCT03430011|580218663|FG006|Pre-Treatment|Death|1|||
160683320|NCT03430011|580218664|FG007|Pre-Treatment|Death|0|||
160683321|NCT03430011|580218657|FG000|Pre-Treatment|Screen Fail|0|||
160683322|NCT03430011|580218658|FG001|Pre-Treatment|Screen Fail|0|||
160683323|NCT03430011|580218659|FG002|Pre-Treatment|Screen Fail|0|||
160683324|NCT03430011|580218660|FG003|Pre-Treatment|Screen Fail|0|||
160683325|NCT03430011|580218661|FG004|Pre-Treatment|Screen Fail|1|||
160683326|NCT03430011|580218662|FG005|Pre-Treatment|Screen Fail|0|||
160683327|NCT03430011|580218663|FG006|Pre-Treatment|Screen Fail|0|||
160683328|NCT03430011|580218664|FG007|Pre-Treatment|Screen Fail|0|||
160683329|NCT03430011|580218657|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
160683330|NCT03430011|580218658|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
160683331|NCT03430011|580218659|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
160683332|NCT03430011|580218660|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
160683333|NCT03430011|580218661|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
160683334|NCT03430011|580218662|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
160683335|NCT03430011|580218663|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
160683336|NCT03430011|580218664|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
160683337|NCT03430011|580218657|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
160683338|NCT03430011|580218658|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
160683339|NCT03430011|580218659|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
160683340|NCT03430011|580218660|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
160683341|NCT03430011|580218661|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
160683342|NCT03430011|580218662|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
160683343|NCT03430011|580218663|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
160683344|NCT03430011|580218664|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
160683345|NCT03430011|580218657|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
160683346|NCT03430011|580218658|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
160683347|NCT03430011|580218659|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
160683348|NCT03430011|580218660|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
160683349|NCT03430011|580218661|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
160683350|NCT03430011|580218662|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
160683351|NCT03430011|580218663|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
160683352|NCT03430011|580218664|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
160683353|NCT03430011|580218657|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
160683354|NCT03430011|580218658|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
160683355|NCT03430011|580218659|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
160683356|NCT03430011|580218660|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
160683357|NCT03430011|580218661|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
160683358|NCT03430011|580218662|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
160683359|NCT03430011|580218663|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
160683360|NCT03430011|580218664|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
160683361|NCT03430011|580218657|FG000|JCARH125 Treatment|Death|4|||
160683362|NCT03430011|580218658|FG001|JCARH125 Treatment|Death|19|||
160683363|NCT03430011|580218659|FG002|JCARH125 Treatment|Death|10|||
160683364|NCT03430011|580218660|FG003|JCARH125 Treatment|Death|8|||
160683365|NCT03430011|580218661|FG004|JCARH125 Treatment|Death|5|||
160683366|NCT03430011|580218662|FG005|JCARH125 Treatment|Death|3|||
160683367|NCT03430011|580218663|FG006|JCARH125 Treatment|Death|4|||
160683368|NCT03430011|580218664|FG007|JCARH125 Treatment|Death|2|||
160683369|NCT03430011|580218657|FG000|JCARH125 Treatment|Other reasons|1|||
160683370|NCT03430011|580218658|FG001|JCARH125 Treatment|Other reasons|0|||
160683371|NCT03430011|580218659|FG002|JCARH125 Treatment|Other reasons|4|||
160683372|NCT03430011|580218660|FG003|JCARH125 Treatment|Other reasons|2|||
160683373|NCT03430011|580218661|FG004|JCARH125 Treatment|Other reasons|2|||
160683374|NCT03430011|580218662|FG005|JCARH125 Treatment|Other reasons|1|||
160683375|NCT03430011|580218663|FG006|JCARH125 Treatment|Other reasons|3|||
160683376|NCT03430011|580218664|FG007|JCARH125 Treatment|Other reasons|2|||
160683377|NCT00559364|580218666|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
160683378|NCT00559364|580218667|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
160683379|NCT00330460|580218670|FG000|Overall Study|Physician Decision|1|||
160683380|NCT00330460|580218671|FG001|Overall Study|Physician Decision|0|||
160683381|NCT00330460|580218670|FG000|Overall Study|Adverse Event|10|||
160683382|NCT00330460|580218671|FG001|Overall Study|Adverse Event|8|||
160683383|NCT00330460|580218670|FG000|Overall Study|Withdrawal by Subject|18|||
160683384|NCT00330460|580218671|FG001|Overall Study|Withdrawal by Subject|17|||
160683385|NCT00330460|580218670|FG000|Overall Study|Death|1|||
160683386|NCT00330460|580218671|FG001|Overall Study|Death|1|||
160683387|NCT00330460|580218670|FG000|Overall Study|Ineligibility determined|1|||
160683388|NCT00330460|580218671|FG001|Overall Study|Ineligibility determined|3|||
160683389|NCT00330460|580218670|FG000|Overall Study|Lost to Follow-up|8|||
160683390|NCT00330460|580218671|FG001|Overall Study|Lost to Follow-up|3|||
160683391|NCT00330460|580218670|FG000|Overall Study|Noncompliance|2|||
160683392|NCT00330460|580218671|FG001|Overall Study|Noncompliance|1|||
160683393|NCT00330460|580218670|FG000|Overall Study|Other|1|||
160683394|NCT00330460|580218671|FG001|Overall Study|Other|0|||
160683395|NCT00869440|580218672|FG000|Overall Study|Withdrawal by Subject|1|||
160683396|NCT00869440|580218673|FG001|Overall Study|Withdrawal by Subject|0|||
160683397|NCT00869440|580218674|FG002|Overall Study|Withdrawal by Subject|0|||
160683398|NCT00869440|580218675|FG003|Overall Study|Withdrawal by Subject|0|||
160683399|NCT00869440|580218672|FG000|Overall Study|Physician Decision|1|||
160683400|NCT00869440|580218673|FG001|Overall Study|Physician Decision|1|||
160683401|NCT00869440|580218674|FG002|Overall Study|Physician Decision|0|||
160683402|NCT00869440|580218675|FG003|Overall Study|Physician Decision|0|||
160683403|NCT02030535|580218676|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
160683404|NCT02219308|580218677|FG000|Overall Study|Withdrawal by Subject|1|||
160683405|NCT02219308|580218678|FG001|Overall Study|Withdrawal by Subject|2|||
160683406|NCT02443324|580220581|FG000|Overall Study|Death|4|||
160683407|NCT02443324|580220582|FG001|Overall Study|Death|1|||
160683408|NCT02443324|580220583|FG002|Overall Study|Death|0|||
160683409|NCT02443324|580220584|FG003|Overall Study|Death|3|||
160683410|NCT02443324|580220585|FG004|Overall Study|Death|1|||
160683411|NCT02443324|580220586|FG005|Overall Study|Death|3|||
160683412|NCT02443324|580220587|FG006|Overall Study|Death|2|||
160683413|NCT02443324|580220581|FG000|Overall Study|Lost to Follow-up|0|||
160683414|NCT02443324|580220582|FG001|Overall Study|Lost to Follow-up|0|||
160683415|NCT02443324|580220583|FG002|Overall Study|Lost to Follow-up|0|||
160683416|NCT02443324|580220584|FG003|Overall Study|Lost to Follow-up|1|||
160683417|NCT02443324|580220585|FG004|Overall Study|Lost to Follow-up|0|||
160683418|NCT02443324|580220586|FG005|Overall Study|Lost to Follow-up|1|||
160683419|NCT02443324|580220587|FG006|Overall Study|Lost to Follow-up|0|||
160683420|NCT02443324|580220581|FG000|Overall Study|Physician Decision|0|||
160683421|NCT02443324|580220582|FG001|Overall Study|Physician Decision|3|||
160683422|NCT02443324|580220583|FG002|Overall Study|Physician Decision|5|||
160683423|NCT02443324|580220584|FG003|Overall Study|Physician Decision|1|||
160683424|NCT02443324|580220585|FG004|Overall Study|Physician Decision|1|||
160683425|NCT02443324|580220586|FG005|Overall Study|Physician Decision|0|||
160683426|NCT02443324|580220587|FG006|Overall Study|Physician Decision|2|||
160683427|NCT02443324|580220581|FG000|Overall Study|Progressive Disease|20|||
160683428|NCT02443324|580220582|FG001|Overall Study|Progressive Disease|20|||
160683429|NCT02443324|580220583|FG002|Overall Study|Progressive Disease|13|||
160683430|NCT02443324|580220584|FG003|Overall Study|Progressive Disease|10|||
160683431|NCT02443324|580220585|FG004|Overall Study|Progressive Disease|13|||
160683432|NCT02443324|580220586|FG005|Overall Study|Progressive Disease|17|||
160683433|NCT02443324|580220587|FG006|Overall Study|Progressive Disease|10|||
160683434|NCT02443324|580220581|FG000|Overall Study|Withdrawal by Subject|0|||
160683435|NCT02443324|580220582|FG001|Overall Study|Withdrawal by Subject|0|||
160683436|NCT02443324|580220583|FG002|Overall Study|Withdrawal by Subject|3|||
160683437|NCT02443324|580220584|FG003|Overall Study|Withdrawal by Subject|1|||
160683438|NCT02443324|580220585|FG004|Overall Study|Withdrawal by Subject|1|||
160683439|NCT02443324|580220586|FG005|Overall Study|Withdrawal by Subject|0|||
160683440|NCT02443324|580220587|FG006|Overall Study|Withdrawal by Subject|1|||
160683441|NCT02443324|580220581|FG000|Overall Study|Adverse Event|0|||
160683442|NCT02443324|580220582|FG001|Overall Study|Adverse Event|1|||
160683443|NCT02443324|580220583|FG002|Overall Study|Adverse Event|3|||
160683444|NCT02443324|580220584|FG003|Overall Study|Adverse Event|0|||
160683445|NCT02443324|580220585|FG004|Overall Study|Adverse Event|4|||
160683446|NCT02443324|580220586|FG005|Overall Study|Adverse Event|3|||
160683447|NCT02443324|580220587|FG006|Overall Study|Adverse Event|3|||
160683448|NCT02443324|580220581|FG000|Overall Study|Enrolled but Never Treated|0|||
160683449|NCT02443324|580220582|FG001|Overall Study|Enrolled but Never Treated|0|||
160683450|NCT02443324|580220583|FG002|Overall Study|Enrolled but Never Treated|1|||
160683451|NCT02443324|580220584|FG003|Overall Study|Enrolled but Never Treated|0|||
160683452|NCT02443324|580220585|FG004|Overall Study|Enrolled but Never Treated|1|||
160683453|NCT02443324|580220586|FG005|Overall Study|Enrolled but Never Treated|0|||
160683454|NCT02443324|580220587|FG006|Overall Study|Enrolled but Never Treated|1|||
160683455|NCT00983918|580220590|FG000|Overall Study|conversion to open cholecystectomy|0|||
160683456|NCT00983918|580220591|FG001|Overall Study|conversion to open cholecystectomy|2|||
160683457|NCT00983918|580220592|FG002|Overall Study|conversion to open cholecystectomy|2|||
160683458|NCT00983918|580220593|FG003|Overall Study|conversion to open cholecystectomy|2|||
160683459|NCT01796964|580220599|FG000|Overall Study|Adverse Event|1|||
160683460|NCT01796964|580220600|FG001|Overall Study|Adverse Event|1|||
160683461|NCT01796964|580220599|FG000|Overall Study|Death|1|||
160683462|NCT01796964|580220600|FG001|Overall Study|Death|0|||
160683463|NCT01796964|580220599|FG000|Overall Study|Protocol Violation|0|||
160683464|NCT01796964|580220600|FG001|Overall Study|Protocol Violation|1|||
160683465|NCT01796964|580220599|FG000|Overall Study|Withdrawal by Subject|1|||
160683466|NCT01796964|580220600|FG001|Overall Study|Withdrawal by Subject|1|||
160683467|NCT01844531|580220601|FG000|Overall Study|Withdrawal by Subject|0|||
160683468|NCT01844531|580220602|FG001|Overall Study|Withdrawal by Subject|1|||
160683469|NCT01844531|580220603|FG002|Overall Study|Withdrawal by Subject|0|||
160683470|NCT01844531|580220604|FG003|Overall Study|Withdrawal by Subject|0|||
160683471|NCT01546922|580220613|FG000|First Period of 10 Weeks|Protocol Violation|3|||
160683472|NCT01546922|580220614|FG001|First Period of 10 Weeks|Protocol Violation|1|||
160683473|NCT01546922|580220613|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
160683474|NCT01546922|580220614|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
160683475|NCT01546922|580220613|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
160683476|NCT01546922|580220614|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
160683477|NCT01546922|580220613|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
160683478|NCT01546922|580220614|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
160683479|NCT01546922|580220613|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
160683480|NCT01546922|580220614|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
160683481|NCT00418522|580220619|FG000|Overall Study|Adverse Event|7|||
160683482|NCT00418522|580220620|FG001|Overall Study|Adverse Event|1|||
160683483|NCT00418522|580220619|FG000|Overall Study|Lack of Efficacy|1|||
160683484|NCT00418522|580220620|FG001|Overall Study|Lack of Efficacy|3|||
160683485|NCT00418522|580220619|FG000|Overall Study|Lost to Follow-up|10|||
160683486|NCT00418522|580220620|FG001|Overall Study|Lost to Follow-up|4|||
160683487|NCT00418522|580220619|FG000|Overall Study|Withdrawal by Subject|31|||
160683488|NCT00418522|580220620|FG001|Overall Study|Withdrawal by Subject|7|||
160683489|NCT00418522|580220619|FG000|Overall Study|Other|27|||
160683490|NCT00418522|580220620|FG001|Overall Study|Other|23|||
160683491|NCT00418522|580220619|FG000|Overall Study|Randomized but did not receive treatment|7|||
160683492|NCT00418522|580220620|FG001|Overall Study|Randomized but did not receive treatment|4|||
160683493|NCT01005329|580220621|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
160683494|NCT02147587|580220622|FG000|Overall Study|Adverse Event|9|||
160683495|NCT02147587|580220623|FG001|Overall Study|Adverse Event|4|||
160683496|NCT02147587|580220622|FG000|Overall Study|Lack of Efficacy|2|||
160683497|NCT02147587|580220623|FG001|Overall Study|Lack of Efficacy|1|||
160683498|NCT01315028|580220628|FG000|Overall Study|Lost to Follow-up|1|||
160683499|NCT01315028|580220629|FG001|Overall Study|Lost to Follow-up|0|||
160683500|NCT01315028|580220628|FG000|Overall Study|Death|0|||
160683501|NCT01315028|580220629|FG001|Overall Study|Death|1|||
160683502|NCT01714739|580220630|FG000|Overall Study|Disease progression|3|||
160683503|NCT01714739|580220631|FG001|Overall Study|Disease progression|5|||
160683504|NCT01714739|580220632|FG002|Overall Study|Disease progression|5|||
160683505|NCT01714739|580220633|FG003|Overall Study|Disease progression|204|||
160683506|NCT01714739|580220634|FG004|Overall Study|Disease progression|1|||
160683507|NCT01714739|580220635|FG005|Overall Study|Disease progression|3|||
160683508|NCT01714739|580220636|FG006|Overall Study|Disease progression|5|||
160683509|NCT01714739|580220630|FG000|Overall Study|Study drug toxicity|1|||
160683510|NCT01714739|580220631|FG001|Overall Study|Study drug toxicity|1|||
160683511|NCT01714739|580220632|FG002|Overall Study|Study drug toxicity|1|||
160683512|NCT01714739|580220633|FG003|Overall Study|Study drug toxicity|15|||
160683513|NCT01714739|580220634|FG004|Overall Study|Study drug toxicity|0|||
160683514|NCT01714739|580220635|FG005|Overall Study|Study drug toxicity|0|||
160683515|NCT01714739|580220636|FG006|Overall Study|Study drug toxicity|5|||
160683516|NCT01714739|580220630|FG000|Overall Study|Death|0|||
160683517|NCT01714739|580220631|FG001|Overall Study|Death|0|||
160683518|NCT01714739|580220632|FG002|Overall Study|Death|0|||
160683519|NCT01714739|580220633|FG003|Overall Study|Death|1|||
160683520|NCT01714739|580220634|FG004|Overall Study|Death|0|||
160683521|NCT01714739|580220635|FG005|Overall Study|Death|0|||
160683522|NCT01714739|580220636|FG006|Overall Study|Death|0|||
160683523|NCT01714739|580220630|FG000|Overall Study|Adverse Event unrelated to drug|0|||
160683524|NCT01714739|580220631|FG001|Overall Study|Adverse Event unrelated to drug|0|||
160683525|NCT01714739|580220632|FG002|Overall Study|Adverse Event unrelated to drug|3|||
160683526|NCT01714739|580220633|FG003|Overall Study|Adverse Event unrelated to drug|21|||
160683527|NCT01714739|580220634|FG004|Overall Study|Adverse Event unrelated to drug|0|||
160683528|NCT01714739|580220635|FG005|Overall Study|Adverse Event unrelated to drug|0|||
160683529|NCT01714739|580220636|FG006|Overall Study|Adverse Event unrelated to drug|0|||
160683530|NCT01714739|580220630|FG000|Overall Study|Participant request to stop therapy|0|||
160683531|NCT01714739|580220631|FG001|Overall Study|Participant request to stop therapy|1|||
160683532|NCT01714739|580220632|FG002|Overall Study|Participant request to stop therapy|0|||
160683533|NCT01714739|580220633|FG003|Overall Study|Participant request to stop therapy|6|||
160683534|NCT01714739|580220634|FG004|Overall Study|Participant request to stop therapy|0|||
160683535|NCT01714739|580220635|FG005|Overall Study|Participant request to stop therapy|0|||
160683536|NCT01714739|580220636|FG006|Overall Study|Participant request to stop therapy|0|||
160683537|NCT01714739|580220630|FG000|Overall Study|Participant withdrew consent|0|||
160683538|NCT01714739|580220631|FG001|Overall Study|Participant withdrew consent|1|||
160683539|NCT01714739|580220632|FG002|Overall Study|Participant withdrew consent|0|||
160683540|NCT01714739|580220633|FG003|Overall Study|Participant withdrew consent|8|||
160683541|NCT01714739|580220634|FG004|Overall Study|Participant withdrew consent|0|||
160683542|NCT01714739|580220635|FG005|Overall Study|Participant withdrew consent|0|||
160683543|NCT01714739|580220636|FG006|Overall Study|Participant withdrew consent|0|||
160683544|NCT01714739|580220630|FG000|Overall Study|Lost to Follow-up|0|||
160683545|NCT01714739|580220631|FG001|Overall Study|Lost to Follow-up|0|||
160683546|NCT01714739|580220632|FG002|Overall Study|Lost to Follow-up|0|||
160683547|NCT01714739|580220633|FG003|Overall Study|Lost to Follow-up|1|||
160683548|NCT01714739|580220634|FG004|Overall Study|Lost to Follow-up|0|||
160683549|NCT01714739|580220635|FG005|Overall Study|Lost to Follow-up|0|||
160683550|NCT01714739|580220636|FG006|Overall Study|Lost to Follow-up|0|||
160683551|NCT01714739|580220630|FG000|Overall Study|Maximum clinical benefit|0|||
160683552|NCT01714739|580220631|FG001|Overall Study|Maximum clinical benefit|1|||
160683553|NCT01714739|580220632|FG002|Overall Study|Maximum clinical benefit|1|||
160683554|NCT01714739|580220633|FG003|Overall Study|Maximum clinical benefit|3|||
160683555|NCT01714739|580220634|FG004|Overall Study|Maximum clinical benefit|0|||
160683556|NCT01714739|580220635|FG005|Overall Study|Maximum clinical benefit|0|||
160683557|NCT01714739|580220636|FG006|Overall Study|Maximum clinical benefit|0|||
160683558|NCT01714739|580220630|FG000|Overall Study|Poor/non-comliance|0|||
160683559|NCT01714739|580220631|FG001|Overall Study|Poor/non-comliance|1|||
160683560|NCT01714739|580220632|FG002|Overall Study|Poor/non-comliance|0|||
160683561|NCT01714739|580220633|FG003|Overall Study|Poor/non-comliance|1|||
160683562|NCT01714739|580220634|FG004|Overall Study|Poor/non-comliance|0|||
160683563|NCT01714739|580220635|FG005|Overall Study|Poor/non-comliance|0|||
160683564|NCT01714739|580220636|FG006|Overall Study|Poor/non-comliance|0|||
160683565|NCT01714739|580220630|FG000|Overall Study|No longer meets study criteria|0|||
160683566|NCT01714739|580220631|FG001|Overall Study|No longer meets study criteria|0|||
160683567|NCT01714739|580220632|FG002|Overall Study|No longer meets study criteria|0|||
160683568|NCT01714739|580220633|FG003|Overall Study|No longer meets study criteria|1|||
160683569|NCT01714739|580220634|FG004|Overall Study|No longer meets study criteria|0|||
160683570|NCT01714739|580220635|FG005|Overall Study|No longer meets study criteria|0|||
160683571|NCT01714739|580220636|FG006|Overall Study|No longer meets study criteria|0|||
160683572|NCT01714739|580220630|FG000|Overall Study|Other reason|0|||
160683573|NCT01714739|580220631|FG001|Overall Study|Other reason|0|||
160683574|NCT01714739|580220632|FG002|Overall Study|Other reason|0|||
160683575|NCT01714739|580220633|FG003|Overall Study|Other reason|3|||
160683576|NCT01714739|580220634|FG004|Overall Study|Other reason|1|||
160683577|NCT01714739|580220635|FG005|Overall Study|Other reason|0|||
160683578|NCT01714739|580220636|FG006|Overall Study|Other reason|0|||
160683579|NCT02531594|580220637|FG000|Overall Study|Withdrawal by Subject|7|||
160683580|NCT02531594|580220638|FG001|Overall Study|Withdrawal by Subject|8|||
160683581|NCT01175473|580220654|FG000|Overall Study|Adverse Event|2|||
160683582|NCT01175473|580220655|FG001|Overall Study|Adverse Event|2|||
160683583|NCT04234464|580220658|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
160683584|NCT04234464|580220659|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
160683585|NCT00983528|580220660|FG000|Overall Study|Death|4|||
160683586|NCT00983528|580220660|FG000|Overall Study|Lost to Follow-up|1|||
160683587|NCT00983528|580220660|FG000|Overall Study|Study Terminated|1|||
160683588|NCT03635983|580220661|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
160683589|NCT03635983|580220662|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
160683590|NCT03635983|580220661|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
160683591|NCT03635983|580220662|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160683592|NCT03635983|580220661|FG000|Pre-Treatment Period|Other reasons|0|||
160683593|NCT03635983|580220662|FG001|Pre-Treatment Period|Other reasons|1|||
160683594|NCT03635983|580220661|FG000|Pre-Treatment Period|Disease Progression|0|||
160683595|NCT03635983|580220662|FG001|Pre-Treatment Period|Disease Progression|1|||
160683596|NCT03635983|580220661|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
160683597|NCT03635983|580220662|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
160683598|NCT03635983|580220661|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
160683599|NCT03635983|580220662|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
160683600|NCT03635983|580220661|FG000|Treatment Period|Withdrawal by Subject|3|||
160683601|NCT03635983|580220662|FG001|Treatment Period|Withdrawal by Subject|5|||
160683602|NCT03635983|580220661|FG000|Treatment Period|Death|3|||
160683603|NCT03635983|580220662|FG001|Treatment Period|Death|5|||
160683604|NCT03635983|580220661|FG000|Treatment Period|Poor/Non-compliance|2|||
160683605|NCT03635983|580220662|FG001|Treatment Period|Poor/Non-compliance|1|||
160683606|NCT03635983|580220661|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
160683607|NCT03635983|580220662|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
160683608|NCT03635983|580220661|FG000|Treatment Period|Other reasons|7|||
160683609|NCT03635983|580220662|FG001|Treatment Period|Other reasons|4|||
160683610|NCT03635983|580220661|FG000|Treatment Period|Disease progression|230|||
160683611|NCT03635983|580220662|FG001|Treatment Period|Disease progression|201|||
160683612|NCT03635983|580220661|FG000|Treatment Period|Study drug toxicity|35|||
160683613|NCT03635983|580220662|FG001|Treatment Period|Study drug toxicity|36|||
160683614|NCT03635983|580220661|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
160683615|NCT03635983|580220662|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
160683616|NCT03635983|580220661|FG000|Treatment Period|Maximum clinical benefit|3|||
160683617|NCT03635983|580220662|FG001|Treatment Period|Maximum clinical benefit|5|||
160683618|NCT03635983|580220661|FG000|Treatment Period|Administrative reason by the sponsor|1|||
160683619|NCT03635983|580220662|FG001|Treatment Period|Administrative reason by the sponsor|2|||
160683620|NCT03635983|580220661|FG000|Treatment Period|Lost to Follow-up|0|||
160683621|NCT03635983|580220662|FG001|Treatment Period|Lost to Follow-up|1|||
160683622|NCT04126343|580220664|FG000|Overall Study|Adverse Event|0|||
160683623|NCT04126343|580220665|FG001|Overall Study|Adverse Event|0|||
160683624|NCT04126343|580220666|FG002|Overall Study|Adverse Event|0|||
160683625|NCT04126343|580220667|FG003|Overall Study|Adverse Event|0|||
160683626|NCT04126343|580220668|FG004|Overall Study|Adverse Event|0|||
160683627|NCT04126343|580220669|FG005|Overall Study|Adverse Event|1|||
160683628|NCT04126343|580220664|FG000|Overall Study|Withdrawal by Subject|0|||
160683629|NCT04126343|580220665|FG001|Overall Study|Withdrawal by Subject|0|||
160683630|NCT04126343|580220666|FG002|Overall Study|Withdrawal by Subject|0|||
160683631|NCT04126343|580220667|FG003|Overall Study|Withdrawal by Subject|1|||
160683632|NCT04126343|580220668|FG004|Overall Study|Withdrawal by Subject|0|||
160683633|NCT04126343|580220669|FG005|Overall Study|Withdrawal by Subject|0|||
160683634|NCT04126343|580220664|FG000|Overall Study|Related to COVID-19 pandemic|3|||
160683635|NCT04126343|580220665|FG001|Overall Study|Related to COVID-19 pandemic|4|||
160683636|NCT04126343|580220666|FG002|Overall Study|Related to COVID-19 pandemic|3|||
160683637|NCT04126343|580220667|FG003|Overall Study|Related to COVID-19 pandemic|3|||
160683638|NCT04126343|580220668|FG004|Overall Study|Related to COVID-19 pandemic|3|||
160683639|NCT04126343|580220669|FG005|Overall Study|Related to COVID-19 pandemic|3|||
160683640|NCT01235442|580220670|FG000|Overall Study|Lost to Follow-up|12|||
160683641|NCT01235442|580220671|FG001|Overall Study|Lost to Follow-up|10|||
160683642|NCT01235442|580220670|FG000|Overall Study|Death|0|||
160683643|NCT01235442|580220671|FG001|Overall Study|Death|2|||
160683644|NCT01235442|580220670|FG000|Overall Study|Pregnancy|1|||
160683645|NCT01235442|580220671|FG001|Overall Study|Pregnancy|1|||
160683646|NCT01235442|580220670|FG000|Overall Study|Ineligibility determined|5|||
160683647|NCT01235442|580220671|FG001|Overall Study|Ineligibility determined|4|||
160683648|NCT01235442|580220670|FG000|Overall Study|Protocol Violation|3|||
160683649|NCT01235442|580220671|FG001|Overall Study|Protocol Violation|3|||
160683650|NCT01235442|580220670|FG000|Overall Study|Adverse Event|4|||
160683651|NCT01235442|580220671|FG001|Overall Study|Adverse Event|6|||
160683652|NCT01235442|580220670|FG000|Overall Study|Withdrawal by Subject|15|||
160683653|NCT01235442|580220671|FG001|Overall Study|Withdrawal by Subject|9|||
160683654|NCT01235442|580220670|FG000|Overall Study|Lack of Efficacy|1|||
160683655|NCT01235442|580220671|FG001|Overall Study|Lack of Efficacy|3|||
160683656|NCT01235442|580220670|FG000|Overall Study|Noncompliance|1|||
160683657|NCT01235442|580220671|FG001|Overall Study|Noncompliance|2|||
160683658|NCT01235442|580220670|FG000|Overall Study|Administrative decision|1|||
160683659|NCT01235442|580220671|FG001|Overall Study|Administrative decision|2|||
160683660|NCT01235442|580220670|FG000|Overall Study|Other unspecified|1|||
160683661|NCT01235442|580220671|FG001|Overall Study|Other unspecified|2|||
160683662|NCT01857973|580220678|FG000|Overall Study|Subject did not meet required BG range|3|||
160683663|NCT01857973|580220678|FG000|Overall Study|drop out after 3 failed attempts|1|||
160683664|NCT01857973|580220678|FG000|Overall Study|Physician Decision|1|||
160683665|NCT01701973|580220681|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
160683666|NCT01701973|580220682|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
160683667|NCT01701973|580220683|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
160683668|NCT01701973|580220684|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
160683669|NCT01701973|580220685|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
160683670|NCT01701973|580220686|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
160683671|NCT01701973|580220687|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
160683672|NCT01701973|580220688|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
160683673|NCT02663882|580220689|FG000|Overall Study|Lost to Follow-up|4|||
160683674|NCT02663882|580220690|FG001|Overall Study|Lost to Follow-up|2|||
160683675|NCT03712124|580220693|FG000|Overall Study|Protocol Violation|1|||
160683676|NCT03712124|580220694|FG001|Overall Study|Protocol Violation|0|||
160683677|NCT00388037|580220696|FG000|Overall Study|Protocol Violation|1|||
160683678|NCT00602537|580220699|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
160683679|NCT00602537|580220700|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
160683680|NCT00602537|580220699|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
160683681|NCT00602537|580220700|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
160683682|NCT00602537|580220699|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
160683683|NCT00602537|580220700|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
160683684|NCT00602537|580220699|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
160683685|NCT00602537|580220700|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
160683686|NCT00602537|580220699|FG000|Follow Up Study Comparison|Adverse Event|1|||
160683687|NCT00602537|580220700|FG001|Follow Up Study Comparison|Adverse Event|0|||
160683688|NCT00602537|580220699|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
160683689|NCT00602537|580220700|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
160683690|NCT00602537|580220699|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
160683691|NCT00602537|580220700|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
160683692|NCT04314843|580220701|FG000|Overall Study|Death|2|||
160683693|NCT04314843|580220702|FG001|Overall Study|Death|2|||
160683694|NCT04314843|580220701|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
160683695|NCT04314843|580220702|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
160683696|NCT01899326|580220704|FG000|Overall Study|Withdrawal by Subject|1|||
160683697|NCT01899326|580220704|FG000|Overall Study|Adverse Event|2|||
160683698|NCT01899326|580220704|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
160683699|NCT01435031|580220705|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
160683700|NCT01435031|580220705|FG000|ITT at 1 Month|Death|1|||
160683701|NCT01435031|580220705|FG000|ITT at 1 Month|Lost to Follow-up|4|||
160683702|NCT01435031|580220705|FG000|ITT at 6 Months|Death|2|||
160683703|NCT01435031|580220705|FG000|ITT at 6 Months|Lost to Follow-up|3|||
160683704|NCT01435031|580220705|FG000|ITT at 1 Year|Death|1|||
160683705|NCT01435031|580220705|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
160683706|NCT01435031|580220705|FG000|ITT at 1 Year|Lost to Follow-up|6|||
160683707|NCT01435031|580220705|FG000|ITT at 2 Years|Death|7|||
160683708|NCT01435031|580220705|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
160683709|NCT01435031|580220705|FG000|ITT at 2 Years|Lost to Follow-up|4|||
160683710|NCT01435031|580220705|FG000|ITT at 3 Years|Death|5|||
160683711|NCT01435031|580220705|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
160683712|NCT01435031|580220705|FG000|ITT at 3 Years|Lost to Follow-up|4|||
160683713|NCT01435031|580220705|FG000|ITT at 4 Years|Death|4|||
160683714|NCT01435031|580220705|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
160683715|NCT01435031|580220705|FG000|ITT at 4 Years|Lost to Follow-up|1|||
160683716|NCT00104247|580220706|FG000|Overall Study|Withdrawal by Subject|1|||
160683717|NCT00104247|580220707|FG001|Overall Study|Withdrawal by Subject|0|||
160683718|NCT00104247|580220706|FG000|Overall Study|Noncompliant with dosing|0|||
160683719|NCT00104247|580220707|FG001|Overall Study|Noncompliant with dosing|1|||
160683720|NCT03718117|580220709|FG000|Overall Study|Death|12|||
160683721|NCT03718117|580220710|FG001|Overall Study|Death|11|||
160683722|NCT03718117|580220711|FG002|Overall Study|Death|0|||
160683723|NCT03718117|580220709|FG000|Overall Study|Other|0|||
160683724|NCT03718117|580220710|FG001|Overall Study|Other|1|||
160683725|NCT03718117|580220711|FG002|Overall Study|Other|0|||
160683726|NCT03718117|580220709|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
160683727|NCT03718117|580220710|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
160683728|NCT03718117|580220711|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
160683729|NCT03718117|580220709|FG000|Overall Study|Participant not met eligibility criteria|0|||
160683730|NCT03718117|580220710|FG001|Overall Study|Participant not met eligibility criteria|0|||
160683731|NCT03718117|580220711|FG002|Overall Study|Participant not met eligibility criteria|2|||
160683732|NCT01588548|580220712|FG000|Overall Study|Withdrawal by Subject|0|||
160683733|NCT01588548|580220713|FG001|Overall Study|Withdrawal by Subject|1|||
160683734|NCT01588548|580220714|FG002|Overall Study|Withdrawal by Subject|1|||
160683735|NCT01588548|580220715|FG003|Overall Study|Withdrawal by Subject|1|||
160683736|NCT01588548|580220716|FG004|Overall Study|Withdrawal by Subject|2|||
160683737|NCT01588548|580220717|FG005|Overall Study|Withdrawal by Subject|3|||
160683738|NCT01588548|580220712|FG000|Overall Study|Adverse Event|0|||
160683739|NCT01588548|580220713|FG001|Overall Study|Adverse Event|0|||
160683740|NCT01588548|580220714|FG002|Overall Study|Adverse Event|1|||
160683741|NCT01588548|580220715|FG003|Overall Study|Adverse Event|2|||
160683742|NCT01588548|580220716|FG004|Overall Study|Adverse Event|1|||
160683743|NCT01588548|580220717|FG005|Overall Study|Adverse Event|0|||
160683744|NCT01588548|580220712|FG000|Overall Study|Condition Under Investigation Worsened|3|||
160683745|NCT01588548|580220713|FG001|Overall Study|Condition Under Investigation Worsened|6|||
160683746|NCT01588548|580220714|FG002|Overall Study|Condition Under Investigation Worsened|4|||
160683747|NCT01588548|580220715|FG003|Overall Study|Condition Under Investigation Worsened|4|||
160683748|NCT01588548|580220716|FG004|Overall Study|Condition Under Investigation Worsened|3|||
160683749|NCT01588548|580220717|FG005|Overall Study|Condition Under Investigation Worsened|3|||
160683750|NCT01835548|580220720|FG000|Dose Optimization Period|Adverse Event|0|||
160683751|NCT01835548|580220721|FG001|Dose Optimization Period|Adverse Event|0|||
160683752|NCT01835548|580220722|FG002|Dose Optimization Period|Adverse Event|1|||
160683753|NCT01835548|580220720|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
160683754|NCT01835548|580220721|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
160683755|NCT01835548|580220722|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
160683756|NCT01835548|580220720|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160683757|NCT01835548|580220721|FG001|Double-Blind Treatment Period|Adverse Event|1|||
160683758|NCT01835548|580220722|FG002|Double-Blind Treatment Period|Adverse Event|0|||
160683759|NCT01835548|580220720|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160683760|NCT01835548|580220721|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160683761|NCT01835548|580220722|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160683762|NCT01169038|580220723|FG000|Overall Study|Death|1|||
160683763|NCT01169038|580220723|FG000|Overall Study|Adverse Event|5|||
160683764|NCT01169038|580220723|FG000|Overall Study|Required antibiotic administration|1|||
160683765|NCT02490800|580220724|FG000|Overall Study|Adverse Event|0|||
160683766|NCT02490800|580220725|FG001|Overall Study|Adverse Event|0|||
160683767|NCT02490800|580220726|FG002|Overall Study|Adverse Event|0|||
160683768|NCT02490800|580220727|FG003|Overall Study|Adverse Event|2|||
160683769|NCT02490800|580220728|FG004|Overall Study|Adverse Event|3|||
160683770|NCT02490800|580220729|FG005|Overall Study|Adverse Event|2|||
160683771|NCT02490800|580220730|FG006|Overall Study|Adverse Event|0|||
160683772|NCT02490800|580220731|FG007|Overall Study|Adverse Event|0|||
160683773|NCT02490800|580220732|FG008|Overall Study|Adverse Event|0|||
160683774|NCT02490800|580220733|FG009|Overall Study|Adverse Event|0|||
160683775|NCT02490800|580220734|FG010|Overall Study|Adverse Event|0|||
160683776|NCT02490800|580220735|FG011|Overall Study|Adverse Event|2|||
160683777|NCT02490800|580220736|FG012|Overall Study|Adverse Event|2|||
160683778|NCT02490800|580220724|FG000|Overall Study|Withdrawal by Subject|0|||
160683779|NCT02490800|580220725|FG001|Overall Study|Withdrawal by Subject|0|||
160683780|NCT02490800|580220726|FG002|Overall Study|Withdrawal by Subject|0|||
160683781|NCT02490800|580220727|FG003|Overall Study|Withdrawal by Subject|1|||
160683782|NCT02490800|580220728|FG004|Overall Study|Withdrawal by Subject|0|||
160683783|NCT02490800|580220729|FG005|Overall Study|Withdrawal by Subject|0|||
160683784|NCT02490800|580220730|FG006|Overall Study|Withdrawal by Subject|0|||
160683785|NCT02490800|580220731|FG007|Overall Study|Withdrawal by Subject|0|||
160683786|NCT02490800|580220732|FG008|Overall Study|Withdrawal by Subject|1|||
160683787|NCT02490800|580220733|FG009|Overall Study|Withdrawal by Subject|0|||
160683788|NCT02490800|580220734|FG010|Overall Study|Withdrawal by Subject|0|||
160683789|NCT02490800|580220735|FG011|Overall Study|Withdrawal by Subject|0|||
160683790|NCT02490800|580220736|FG012|Overall Study|Withdrawal by Subject|0|||
160683791|NCT02490800|580220724|FG000|Overall Study|Progressive disease|3|||
160683792|NCT02490800|580220725|FG001|Overall Study|Progressive disease|3|||
160683793|NCT02490800|580220726|FG002|Overall Study|Progressive disease|3|||
160683794|NCT02490800|580220727|FG003|Overall Study|Progressive disease|4|||
160683795|NCT02490800|580220728|FG004|Overall Study|Progressive disease|4|||
160683796|NCT02490800|580220729|FG005|Overall Study|Progressive disease|1|||
160683797|NCT02490800|580220730|FG006|Overall Study|Progressive disease|4|||
160683798|NCT02490800|580220731|FG007|Overall Study|Progressive disease|3|||
160683799|NCT02490800|580220732|FG008|Overall Study|Progressive disease|6|||
160683800|NCT02490800|580220733|FG009|Overall Study|Progressive disease|2|||
160683801|NCT02490800|580220734|FG010|Overall Study|Progressive disease|7|||
160683802|NCT02490800|580220735|FG011|Overall Study|Progressive disease|1|||
160683803|NCT02490800|580220736|FG012|Overall Study|Progressive disease|10|||
160683804|NCT02490800|580220724|FG000|Overall Study|Patient enrolled in post-trial access|0|||
160683805|NCT02490800|580220725|FG001|Overall Study|Patient enrolled in post-trial access|0|||
160683806|NCT02490800|580220726|FG002|Overall Study|Patient enrolled in post-trial access|0|||
160683807|NCT02490800|580220727|FG003|Overall Study|Patient enrolled in post-trial access|0|||
160683808|NCT02490800|580220728|FG004|Overall Study|Patient enrolled in post-trial access|0|||
160683809|NCT02490800|580220729|FG005|Overall Study|Patient enrolled in post-trial access|0|||
160683810|NCT02490800|580220730|FG006|Overall Study|Patient enrolled in post-trial access|0|||
160683811|NCT02490800|580220731|FG007|Overall Study|Patient enrolled in post-trial access|0|||
160683812|NCT02490800|580220732|FG008|Overall Study|Patient enrolled in post-trial access|0|||
160683813|NCT02490800|580220733|FG009|Overall Study|Patient enrolled in post-trial access|1|||
160683814|NCT02490800|580220734|FG010|Overall Study|Patient enrolled in post-trial access|1|||
160683815|NCT02490800|580220735|FG011|Overall Study|Patient enrolled in post-trial access|0|||
160683816|NCT02490800|580220736|FG012|Overall Study|Patient enrolled in post-trial access|6|||
160683817|NCT01634854|580220737|FG000|Overall Study|Cesarean delivery|2|||
160683818|NCT01634854|580220738|FG001|Overall Study|Cesarean delivery|7|||
160683819|NCT03257254|580220739|FG000|Overall Study|Withdrawal by Subject|7|||
160683820|NCT03257254|580220739|FG000|Overall Study|Lost to Follow-up|9|||
160683821|NCT03257254|580220739|FG000|Overall Study|Study discontinued by sponsor|5|||
160683822|NCT03365791|580220740|FG000|Overall Study|Adverse Event|5|||
160683823|NCT03365791|580220740|FG000|Overall Study|Death|1|||
160683824|NCT03365791|580220740|FG000|Overall Study|Lost to Follow-up|1|||
160683825|NCT03365791|580220740|FG000|Overall Study|Physician Decision|9|||
160683826|NCT03365791|580220740|FG000|Overall Study|Progressive disease|51|||
160683827|NCT03365791|580220740|FG000|Overall Study|Subject/guardian decision|5|||
160683828|NCT00739973|580220741|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
160683829|NCT00739973|580220742|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
160683830|NCT00739973|580220743|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
160683831|NCT00739973|580220744|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
160683832|NCT00739973|580220745|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
160683833|NCT00739973|580220746|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
160683834|NCT00739973|580220747|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
160683835|NCT00739973|580220748|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
160683836|NCT00739973|580220749|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
160683837|NCT00739973|580220741|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
160683838|NCT00739973|580220742|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
160683839|NCT00739973|580220743|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
160683840|NCT00739973|580220744|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
160683841|NCT00739973|580220745|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
160683842|NCT00739973|580220746|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
160683843|NCT00739973|580220747|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
160683844|NCT00739973|580220748|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
160683845|NCT00739973|580220749|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
160683846|NCT00739973|580220741|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
160683847|NCT00739973|580220742|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
160683848|NCT00739973|580220743|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
160683849|NCT00739973|580220744|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
160683850|NCT00739973|580220745|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
160683851|NCT00739973|580220746|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
160683852|NCT00739973|580220747|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
160683853|NCT00739973|580220748|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
160683854|NCT00739973|580220749|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
160683855|NCT00739973|580220741|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
160683856|NCT00739973|580220742|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160683857|NCT00739973|580220743|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160683858|NCT00739973|580220744|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160683859|NCT00739973|580220745|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160683860|NCT00739973|580220746|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160683861|NCT00739973|580220747|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160683862|NCT00739973|580220748|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160683863|NCT00739973|580220749|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160683864|NCT00739973|580220741|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
160683865|NCT00739973|580220742|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
160683866|NCT00739973|580220743|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
160683867|NCT00739973|580220744|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
160683868|NCT00739973|580220745|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
160683869|NCT00739973|580220746|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
160683870|NCT00739973|580220747|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
160683871|NCT00739973|580220748|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
160683872|NCT00739973|580220749|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
160683873|NCT00739973|580220741|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
160683874|NCT00739973|580220742|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
160683875|NCT00739973|580220743|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
160683876|NCT00739973|580220744|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
160683877|NCT00739973|580220745|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
160683878|NCT00739973|580220746|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
160683879|NCT00739973|580220747|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
160683880|NCT00739973|580220748|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
160683881|NCT00739973|580220749|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
160683882|NCT00739973|580220741|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
160683883|NCT00739973|580220742|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
160683884|NCT00739973|580220743|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
160683885|NCT00739973|580220744|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
160683886|NCT00739973|580220745|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
160683887|NCT00739973|580220746|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
160683888|NCT00739973|580220747|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
160683889|NCT00739973|580220748|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
160683890|NCT00739973|580220749|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
160683891|NCT00739973|580220741|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
160683892|NCT00739973|580220742|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
160683893|NCT00739973|580220743|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
160683894|NCT00739973|580220744|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
160683895|NCT00739973|580220745|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
160683896|NCT00739973|580220746|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
160683897|NCT00739973|580220747|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
160683898|NCT00739973|580220748|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
160683899|NCT00739973|580220749|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
160683900|NCT00739973|580220741|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
160683901|NCT00739973|580220742|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
160683902|NCT00739973|580220743|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
160683903|NCT00739973|580220744|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
160683904|NCT00739973|580220745|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
160683905|NCT00739973|580220746|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
160683906|NCT00739973|580220747|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
160683907|NCT00739973|580220748|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
160683908|NCT00739973|580220749|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
160683909|NCT00739973|580220741|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
160683910|NCT00739973|580220742|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
160683911|NCT00739973|580220743|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
160683912|NCT00739973|580220744|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
160683913|NCT00739973|580220745|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
160683914|NCT00739973|580220746|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
160683915|NCT00739973|580220747|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
160683916|NCT00739973|580220748|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
160683917|NCT00739973|580220749|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
160683918|NCT00739973|580220741|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
160683919|NCT00739973|580220742|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
160683920|NCT00739973|580220743|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
160683921|NCT00739973|580220744|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
160683922|NCT00739973|580220745|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
160683923|NCT00739973|580220746|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
160683924|NCT00739973|580220747|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
160683925|NCT00739973|580220748|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
160683926|NCT00739973|580220749|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
160683927|NCT00739973|580220741|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
160683928|NCT00739973|580220742|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
160683929|NCT00739973|580220743|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
160683930|NCT00739973|580220744|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
160683931|NCT00739973|580220745|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
160683932|NCT00739973|580220746|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
160683933|NCT00739973|580220747|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
160683934|NCT00739973|580220748|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
160683935|NCT00739973|580220749|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
160683936|NCT00739973|580220741|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
160683937|NCT00739973|580220742|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
160683938|NCT00739973|580220743|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
160683939|NCT00739973|580220744|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
160683940|NCT00739973|580220745|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
160683941|NCT00739973|580220746|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
160683942|NCT00739973|580220747|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
160683943|NCT00739973|580220748|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
160683944|NCT00739973|580220749|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
160683945|NCT00739973|580220741|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
160683946|NCT00739973|580220742|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
160683947|NCT00739973|580220743|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
160683948|NCT00739973|580220744|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
160683949|NCT00739973|580220745|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
160683950|NCT00739973|580220746|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
160683951|NCT00739973|580220747|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
160683952|NCT00739973|580220748|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
160683953|NCT00739973|580220749|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
160683954|NCT00739973|580220741|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
160683955|NCT00739973|580220742|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
160683956|NCT00739973|580220743|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
160683957|NCT00739973|580220744|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
160683958|NCT00739973|580220745|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
160683959|NCT00739973|580220746|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
160683960|NCT00739973|580220747|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
160683961|NCT00739973|580220748|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
160683962|NCT00739973|580220749|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
160683963|NCT00739973|580220741|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
160683964|NCT00739973|580220742|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
160683965|NCT00739973|580220743|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
160683966|NCT00739973|580220744|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
160683967|NCT00739973|580220745|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
160683968|NCT00739973|580220746|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
160683969|NCT00739973|580220747|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
160683970|NCT00739973|580220748|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
160683971|NCT00739973|580220749|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
160683972|NCT00739973|580220741|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
160683973|NCT00739973|580220742|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
160683974|NCT00739973|580220743|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
160683975|NCT00739973|580220744|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
160683976|NCT00739973|580220745|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
160683977|NCT00739973|580220746|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
160683978|NCT00739973|580220747|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
160683979|NCT00739973|580220748|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
160683980|NCT00739973|580220749|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
160683981|NCT04149535|580220753|FG000|Overall Study|Death|11|||
160683982|NCT04149535|580220754|FG001|Overall Study|Death|7|||
160683983|NCT04149535|580220753|FG000|Overall Study|Physician Decision|10|||
160683984|NCT04149535|580220754|FG001|Overall Study|Physician Decision|4|||
160683985|NCT04149535|580220753|FG000|Overall Study|Withdrawal by Subject|6|||
160683986|NCT04149535|580220754|FG001|Overall Study|Withdrawal by Subject|7|||
160683987|NCT04149535|580220753|FG000|Overall Study|Not described|2|||
160683988|NCT04149535|580220754|FG001|Overall Study|Not described|0|||
160683989|NCT02175368|580220755|FG000|Overall Study|Lost to Follow-up|1|||
160683990|NCT02875028|580220756|FG000|Washout Period|Withdrawal by Subject|0|||
160683991|NCT02875028|580220757|FG001|Washout Period|Withdrawal by Subject|1|||
160683992|NCT05068284|580220758|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
160683993|NCT05068284|580220759|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
160683994|NCT05068284|580220760|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
160683995|NCT05068284|580220761|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
160683996|NCT05068284|580220762|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
160683997|NCT05068284|580220763|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
160683998|NCT05068284|580220764|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
160683999|NCT05068284|580220765|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
160684000|NCT05068284|580220758|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
160684001|NCT05068284|580220759|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
160684002|NCT05068284|580220760|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
160684003|NCT05068284|580220761|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
160684004|NCT05068284|580220762|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
160684005|NCT05068284|580220763|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
160684006|NCT05068284|580220764|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
160684007|NCT05068284|580220765|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
160684008|NCT05068284|580220758|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
160684009|NCT05068284|580220759|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
160684010|NCT05068284|580220760|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
160684011|NCT05068284|580220761|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
160684012|NCT05068284|580220762|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
160684013|NCT05068284|580220763|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
160684014|NCT05068284|580220764|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
160684015|NCT05068284|580220765|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
160684016|NCT05068284|580220758|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
160684017|NCT05068284|580220759|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
160684018|NCT05068284|580220760|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
160684019|NCT05068284|580220761|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
160684020|NCT05068284|580220762|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
160684021|NCT05068284|580220763|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
160684022|NCT05068284|580220764|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
160684023|NCT05068284|580220765|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
160684024|NCT05068284|580220758|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
160684025|NCT05068284|580220759|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
160684026|NCT05068284|580220760|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
160684027|NCT05068284|580220761|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
160684028|NCT05068284|580220762|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
160684029|NCT05068284|580220763|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
160684030|NCT05068284|580220764|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
160684031|NCT05068284|580220765|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
160684032|NCT05068284|580220758|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
160684033|NCT05068284|580220759|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
160684034|NCT05068284|580220760|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
160684035|NCT05068284|580220761|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
160684036|NCT05068284|580220762|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
160684037|NCT05068284|580220763|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
160684038|NCT05068284|580220764|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
160684039|NCT05068284|580220765|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
160684040|NCT05068284|580220758|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
160684041|NCT05068284|580220759|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
160684042|NCT05068284|580220760|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
160684043|NCT05068284|580220761|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
160684044|NCT05068284|580220762|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
160684045|NCT05068284|580220763|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
160684046|NCT05068284|580220764|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
160684047|NCT05068284|580220765|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
160684048|NCT05068284|580220758|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
160684049|NCT05068284|580220759|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
160684050|NCT05068284|580220760|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
160684051|NCT05068284|580220761|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
160684052|NCT05068284|580220762|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
160684053|NCT05068284|580220763|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
160684054|NCT05068284|580220764|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
160684055|NCT05068284|580220765|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
160684056|NCT05068284|580220758|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
160684057|NCT05068284|580220759|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
160684058|NCT05068284|580220760|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
160684059|NCT05068284|580220761|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
160684060|NCT05068284|580220762|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
160684061|NCT05068284|580220763|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
160684062|NCT05068284|580220764|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
160684063|NCT05068284|580220765|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
160684064|NCT05068284|580220758|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
160684065|NCT05068284|580220759|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
160684066|NCT05068284|580220760|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
160684067|NCT05068284|580220761|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
160684068|NCT05068284|580220762|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
160684069|NCT05068284|580220763|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
160684070|NCT05068284|580220764|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
160684071|NCT05068284|580220765|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
160684072|NCT05068284|580220758|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
160684073|NCT05068284|580220759|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
160684074|NCT05068284|580220760|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
160684075|NCT05068284|580220761|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
160684076|NCT05068284|580220762|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
160684077|NCT05068284|580220763|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
160684078|NCT05068284|580220764|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
160684079|NCT05068284|580220765|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
160748704|NCT00303472|580465932|FG006|Treatment Extension (Optional)|Adverse Event|0|||
160684080|NCT05068284|580220758|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
160684081|NCT05068284|580220759|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
160684082|NCT05068284|580220760|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
160684083|NCT05068284|580220761|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
160684084|NCT05068284|580220762|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
160684085|NCT05068284|580220763|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
160684086|NCT05068284|580220764|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
160684087|NCT05068284|580220765|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
160684088|NCT05068284|580220758|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
160684089|NCT05068284|580220759|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
160684090|NCT05068284|580220760|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
160684091|NCT05068284|580220761|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
160684092|NCT05068284|580220762|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
160684093|NCT05068284|580220763|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
160684094|NCT05068284|580220764|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
160684095|NCT05068284|580220765|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
160684096|NCT05068284|580220758|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
160684097|NCT05068284|580220759|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
160684098|NCT05068284|580220760|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
160684099|NCT05068284|580220761|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
160684100|NCT05068284|580220762|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
160684101|NCT05068284|580220763|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
160684102|NCT05068284|580220764|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
160684103|NCT05068284|580220765|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
160684104|NCT03581188|580223254|FG000|Overall Study|Inclusion criteria not met|3|||
160684105|NCT03581188|580223255|FG001|Overall Study|Inclusion criteria not met|2|||
160684106|NCT03581188|580223254|FG000|Overall Study|Lost to Follow-up|5|||
160684107|NCT03581188|580223255|FG001|Overall Study|Lost to Follow-up|5|||
160684108|NCT03581188|580223254|FG000|Overall Study|Discontinued intervention|11|||
160684109|NCT03581188|580223255|FG001|Overall Study|Discontinued intervention|8|||
160684110|NCT00109837|580223258|FG000|Overall Study|Adverse Event|2|||
160684111|NCT00109837|580223258|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
160684112|NCT00109837|580223258|FG000|Overall Study|Death|1|||
160684113|NCT00109837|580223258|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
160684114|NCT00109837|580223258|FG000|Overall Study|Not treated|1|||
160684115|NCT00109837|580223258|FG000|Overall Study|Ineligible|1|||
160684116|NCT01989676|580223259|FG000|Overall Study|Death|52|||
160684117|NCT01989676|580223260|FG001|Overall Study|Death|60|||
160684118|NCT01989676|580223259|FG000|Overall Study|Protocol Violation|2|||
160684119|NCT01989676|580223260|FG001|Overall Study|Protocol Violation|1|||
160684120|NCT01989676|580223259|FG000|Overall Study|Lost to Follow-up|8|||
160684121|NCT01989676|580223260|FG001|Overall Study|Lost to Follow-up|18|||
160684122|NCT01989676|580223259|FG000|Overall Study|No longer willing to participate in study|26|||
160684123|NCT01989676|580223260|FG001|Overall Study|No longer willing to participate in study|26|||
160684124|NCT01989676|580223259|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
160684125|NCT01989676|580223260|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
160684126|NCT01989676|580223259|FG000|Overall Study|Other|4|||
160684127|NCT01989676|580223260|FG001|Overall Study|Other|3|||
160684128|NCT01619579|580223261|FG000|Overall Study|Withdrawal by Subject|0|||
160684129|NCT01619579|580223262|FG001|Overall Study|Withdrawal by Subject|3|||
160684130|NCT02190279|580223264|FG000|Overall Study|Withdrawal consent|1|||
160684131|NCT02190279|580223265|FG001|Overall Study|Withdrawal consent|0|||
160684132|NCT02190279|580223266|FG002|Overall Study|Withdrawal consent|1|||
160684133|NCT02190279|580223264|FG000|Overall Study|Lost to Follow-up|2|||
160684134|NCT02190279|580223265|FG001|Overall Study|Lost to Follow-up|0|||
160684135|NCT02190279|580223266|FG002|Overall Study|Lost to Follow-up|0|||
160684136|NCT02190279|580223264|FG000|Overall Study|Refused further treatment|0|||
160684137|NCT02190279|580223265|FG001|Overall Study|Refused further treatment|0|||
160684138|NCT02190279|580223266|FG002|Overall Study|Refused further treatment|1|||
160684139|NCT02190279|580223264|FG000|Overall Study|Screening failure|0|||
160684140|NCT02190279|580223265|FG001|Overall Study|Screening failure|0|||
160684141|NCT02190279|580223266|FG002|Overall Study|Screening failure|1|||
160684142|NCT02688387|580223267|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684143|NCT02688387|580223268|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684144|NCT02688387|580223269|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
160684145|NCT02688387|580223270|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684146|NCT02688387|580223271|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684147|NCT02688387|580223272|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684148|NCT02688387|580223273|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684149|NCT02688387|580223274|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684150|NCT02688387|580223275|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684151|NCT02688387|580223276|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684152|NCT02688387|580223277|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684153|NCT02688387|580223278|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684154|NCT02688387|580223279|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684155|NCT02688387|580223280|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684156|NCT02688387|580223281|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684157|NCT02688387|580223282|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684158|NCT02688387|580223283|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684159|NCT02688387|580223284|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684160|NCT02688387|580223285|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684161|NCT02688387|580223286|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684162|NCT02688387|580223287|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684163|NCT02688387|580223288|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160684164|NCT02688387|580223267|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684165|NCT02688387|580223268|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684166|NCT02688387|580223269|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684167|NCT02688387|580223270|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
160684168|NCT02688387|580223271|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684169|NCT02688387|580223272|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684170|NCT02688387|580223273|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684171|NCT02688387|580223274|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684172|NCT02688387|580223275|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684173|NCT02688387|580223276|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684174|NCT02688387|580223277|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684175|NCT02688387|580223278|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684176|NCT02688387|580223279|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684177|NCT02688387|580223280|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684178|NCT02688387|580223281|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684179|NCT02688387|580223282|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684180|NCT02688387|580223283|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684181|NCT02688387|580223284|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684182|NCT02688387|580223285|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684183|NCT02688387|580223286|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684184|NCT02688387|580223287|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684185|NCT02688387|580223288|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684186|NCT02688387|580223267|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684187|NCT02688387|580223268|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
160684188|NCT02688387|580223269|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684189|NCT02688387|580223270|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684190|NCT02688387|580223271|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684191|NCT02688387|580223272|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684192|NCT02688387|580223273|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684193|NCT02688387|580223274|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684194|NCT02688387|580223275|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684195|NCT02688387|580223276|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684196|NCT02688387|580223277|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684197|NCT02688387|580223278|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684198|NCT02688387|580223279|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684199|NCT02688387|580223280|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684200|NCT02688387|580223281|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684201|NCT02688387|580223282|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684202|NCT02688387|580223283|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684203|NCT02688387|580223284|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684204|NCT02688387|580223285|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684205|NCT02688387|580223286|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684206|NCT02688387|580223287|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684207|NCT02688387|580223288|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160684208|NCT02688387|580223267|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684209|NCT02688387|580223268|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684210|NCT02688387|580223269|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
160684211|NCT02688387|580223270|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684212|NCT02688387|580223271|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
160684213|NCT02688387|580223272|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684214|NCT02688387|580223273|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684215|NCT02688387|580223274|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684216|NCT02688387|580223275|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684217|NCT02688387|580223276|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684218|NCT02688387|580223277|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684219|NCT02688387|580223278|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684220|NCT02688387|580223279|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684221|NCT02688387|580223280|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684222|NCT02688387|580223281|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684223|NCT02688387|580223282|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684224|NCT02688387|580223283|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684225|NCT02688387|580223284|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684226|NCT02688387|580223285|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684227|NCT02688387|580223286|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684228|NCT02688387|580223287|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684229|NCT02688387|580223288|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160684230|NCT02688387|580223267|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
160684231|NCT02688387|580223268|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684232|NCT02688387|580223269|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684233|NCT02688387|580223270|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684234|NCT02688387|580223271|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684235|NCT02688387|580223272|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684236|NCT02688387|580223273|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684237|NCT02688387|580223274|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684238|NCT02688387|580223275|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684239|NCT02688387|580223276|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684240|NCT02688387|580223277|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684241|NCT02688387|580223278|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684242|NCT02688387|580223279|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684243|NCT02688387|580223280|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684244|NCT02688387|580223281|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684245|NCT02688387|580223282|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684246|NCT02688387|580223283|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684247|NCT02688387|580223284|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684248|NCT02688387|580223285|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684249|NCT02688387|580223286|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684250|NCT02688387|580223287|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684251|NCT02688387|580223288|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160684252|NCT02688387|580223267|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684253|NCT02688387|580223268|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684254|NCT02688387|580223269|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684255|NCT02688387|580223270|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684256|NCT02688387|580223271|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684257|NCT02688387|580223272|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684258|NCT02688387|580223273|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684259|NCT02688387|580223274|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684260|NCT02688387|580223275|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684261|NCT02688387|580223276|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684262|NCT02688387|580223277|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
160684263|NCT02688387|580223278|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684264|NCT02688387|580223279|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684265|NCT02688387|580223280|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684266|NCT02688387|580223281|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684267|NCT02688387|580223282|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684268|NCT02688387|580223283|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684269|NCT02688387|580223284|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684270|NCT02688387|580223285|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684271|NCT02688387|580223286|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684272|NCT02688387|580223287|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684273|NCT02688387|580223288|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160684274|NCT02688387|580223267|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684275|NCT02688387|580223268|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684276|NCT02688387|580223269|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684277|NCT02688387|580223270|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684278|NCT02688387|580223271|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684279|NCT02688387|580223272|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684280|NCT02688387|580223273|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684281|NCT02688387|580223274|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684282|NCT02688387|580223275|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684283|NCT02688387|580223276|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684284|NCT02688387|580223277|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684285|NCT02688387|580223278|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684286|NCT02688387|580223279|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684287|NCT02688387|580223280|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684288|NCT02688387|580223281|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
160684289|NCT02688387|580223282|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684290|NCT02688387|580223283|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684291|NCT02688387|580223284|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684292|NCT02688387|580223285|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684293|NCT02688387|580223286|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684294|NCT02688387|580223287|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684295|NCT02688387|580223288|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160684296|NCT02688387|580223267|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684297|NCT02688387|580223268|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684298|NCT02688387|580223269|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684299|NCT02688387|580223270|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684300|NCT02688387|580223271|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684301|NCT02688387|580223272|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684302|NCT02688387|580223273|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684303|NCT02688387|580223274|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684304|NCT02688387|580223275|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684305|NCT02688387|580223276|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684306|NCT02688387|580223277|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684307|NCT02688387|580223278|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684308|NCT02688387|580223279|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684309|NCT02688387|580223280|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684310|NCT02688387|580223281|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684311|NCT02688387|580223282|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684312|NCT02688387|580223283|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684313|NCT02688387|580223284|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684314|NCT02688387|580223285|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684315|NCT02688387|580223286|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684316|NCT02688387|580223287|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
160684317|NCT02688387|580223288|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160684318|NCT02688387|580223267|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684319|NCT02688387|580223268|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684320|NCT02688387|580223269|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684321|NCT02688387|580223270|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684322|NCT02688387|580223271|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684323|NCT02688387|580223272|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684324|NCT02688387|580223273|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684325|NCT02688387|580223274|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684326|NCT02688387|580223275|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684327|NCT02688387|580223276|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684328|NCT02688387|580223277|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684329|NCT02688387|580223278|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684330|NCT02688387|580223279|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684331|NCT02688387|580223280|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684332|NCT02688387|580223281|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684333|NCT02688387|580223282|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684334|NCT02688387|580223283|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684335|NCT02688387|580223284|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684336|NCT02688387|580223285|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
160684337|NCT02688387|580223286|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684338|NCT02688387|580223287|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
160684339|NCT02688387|580223288|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160684340|NCT02688387|580223267|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684341|NCT02688387|580223268|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684342|NCT02688387|580223269|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684343|NCT02688387|580223270|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684344|NCT02688387|580223271|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684345|NCT02688387|580223272|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684346|NCT02688387|580223273|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684347|NCT02688387|580223274|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684348|NCT02688387|580223275|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684349|NCT02688387|580223276|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684350|NCT02688387|580223277|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684351|NCT02688387|580223278|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684352|NCT02688387|580223279|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684353|NCT02688387|580223280|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684354|NCT02688387|580223281|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684355|NCT02688387|580223282|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684356|NCT02688387|580223283|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684357|NCT02688387|580223284|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684358|NCT02688387|580223285|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684359|NCT02688387|580223286|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
160684360|NCT02688387|580223287|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684361|NCT02688387|580223288|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160684362|NCT02938442|580223289|FG000|Overall Study|Death|0|||
160684363|NCT02938442|580223290|FG001|Overall Study|Death|1|||
160684364|NCT02938442|580223289|FG000|Overall Study|Lost to Follow-up|0|||
160684365|NCT02938442|580223290|FG001|Overall Study|Lost to Follow-up|1|||
160684366|NCT02938442|580223289|FG000|Overall Study|Physician Decision|0|||
160684367|NCT02938442|580223290|FG001|Overall Study|Physician Decision|1|||
160684368|NCT02938442|580223289|FG000|Overall Study|Withdrawal by Subject|2|||
160684369|NCT02938442|580223290|FG001|Overall Study|Withdrawal by Subject|0|||
160684370|NCT00802178|580223291|FG000|Overall Study|Lack of Efficacy|36|||
160684371|NCT00802178|580223291|FG000|Overall Study|Insufficient tolerability (IT)|17|||
160684372|NCT00802178|580223291|FG000|Overall Study|Withdrawal by Subject|18|||
160684373|NCT00802178|580223291|FG000|Overall Study|Other|32|||
160684374|NCT00802178|580223291|FG000|Overall Study|Lack of efficacy and patient wish|1|||
160684375|NCT00802178|580223291|FG000|Overall Study|IT and patient wish|8|||
160684376|NCT00802178|580223291|FG000|Overall Study|Patients wish and other reason|1|||
160684377|NCT01606228|580223292|FG000|Overall Study|Lost to Follow-up|20|||
160684378|NCT01606228|580223292|FG000|Overall Study|Withdrawal by Subject|3|||
160684379|NCT01606228|580223292|FG000|Overall Study|Non-compliant|3|||
160684380|NCT01606228|580223292|FG000|Overall Study|Lack of Efficacy|2|||
160684381|NCT01606228|580223292|FG000|Overall Study|Adverse Event|1|||
160684382|NCT01115855|580223293|FG000|Overall Study|Adverse Event|16|||
160684383|NCT01115855|580223294|FG001|Overall Study|Adverse Event|18|||
160684384|NCT01115855|580223293|FG000|Overall Study|Death|6|||
160684385|NCT01115855|580223294|FG001|Overall Study|Death|5|||
160684386|NCT01115855|580223293|FG000|Overall Study|Lab Abnormality|1|||
160684387|NCT01115855|580223294|FG001|Overall Study|Lab Abnormality|1|||
160684388|NCT01115855|580223293|FG000|Overall Study|Protocol Violation|0|||
160684389|NCT01115855|580223294|FG001|Overall Study|Protocol Violation|1|||
160684390|NCT01115855|580223293|FG000|Overall Study|Withdrawal by Subject|5|||
160684391|NCT01115855|580223294|FG001|Overall Study|Withdrawal by Subject|5|||
160684392|NCT01115855|580223293|FG000|Overall Study|Other|8|||
160684393|NCT01115855|580223294|FG001|Overall Study|Other|6|||
160684394|NCT04100096|580223295|FG000|Overall Study|Adverse Event|19|||
160684395|NCT04100096|580223296|FG001|Overall Study|Adverse Event|7|||
160684396|NCT04100096|580223295|FG000|Overall Study|Lack of Efficacy|0|||
160684397|NCT04100096|580223296|FG001|Overall Study|Lack of Efficacy|1|||
160684398|NCT04100096|580223295|FG000|Overall Study|Lost to Follow-up|13|||
160684399|NCT04100096|580223296|FG001|Overall Study|Lost to Follow-up|11|||
160684400|NCT04100096|580223295|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160684401|NCT04100096|580223296|FG001|Overall Study|Non-Compliance With Study Drug|3|||
160684402|NCT04100096|580223295|FG000|Overall Study|Protocol Deviation|1|||
160684403|NCT04100096|580223296|FG001|Overall Study|Protocol Deviation|1|||
160684404|NCT04100096|580223295|FG000|Overall Study|Withdrawal by Participant|13|||
160684405|NCT04100096|580223296|FG001|Overall Study|Withdrawal by Participant|15|||
160684406|NCT01684215|580223297|FG000|Phase 1, Part 1|Adverse Event|1|||
160684407|NCT01684215|580223298|FG001|Phase 1, Part 1|Adverse Event|0|||
160684408|NCT01684215|580223299|FG002|Phase 1, Part 1|Adverse Event|0|||
160684409|NCT01684215|580223300|FG003|Phase 1, Part 1|Adverse Event|0|||
160684410|NCT01684215|580223297|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
160684411|NCT01684215|580223298|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
160684412|NCT01684215|580223299|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
160684413|NCT01684215|580223300|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
160684414|NCT01684215|580223297|FG000|Phase 1, Part 2|Adverse Event|0|||
160684415|NCT01684215|580223298|FG001|Phase 1, Part 2|Adverse Event|0|||
160684416|NCT01684215|580223299|FG002|Phase 1, Part 2|Adverse Event|1|||
160684417|NCT01684215|580223300|FG003|Phase 1, Part 2|Adverse Event|0|||
160684418|NCT01684215|580223297|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
160684419|NCT01684215|580223298|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
160684420|NCT01684215|580223299|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
160684421|NCT01684215|580223300|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
160684422|NCT01684215|580223297|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
160684423|NCT01684215|580223298|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
160684424|NCT01684215|580223299|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
160684425|NCT01684215|580223300|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
160684426|NCT01684215|580223297|FG000|Phase 2|Death|0|||
160684427|NCT01684215|580223298|FG001|Phase 2|Death|0|||
160684428|NCT01684215|580223299|FG002|Phase 2|Death|0|||
160684429|NCT01684215|580223300|FG003|Phase 2|Death|8|||
160684430|NCT01684215|580223297|FG000|Phase 2|Study terminated by sponsor|0|||
160684431|NCT01684215|580223298|FG001|Phase 2|Study terminated by sponsor|0|||
160684432|NCT01684215|580223299|FG002|Phase 2|Study terminated by sponsor|0|||
160684433|NCT01684215|580223300|FG003|Phase 2|Study terminated by sponsor|30|||
160684434|NCT01684215|580223297|FG000|Phase 2|Enrolled but not treated|0|||
160684435|NCT01684215|580223298|FG001|Phase 2|Enrolled but not treated|0|||
160684436|NCT01684215|580223299|FG002|Phase 2|Enrolled but not treated|0|||
160684437|NCT01684215|580223300|FG003|Phase 2|Enrolled but not treated|1|||
160684438|NCT01684215|580223297|FG000|Phase 2|Lost to Follow-up|0|||
160684439|NCT01684215|580223298|FG001|Phase 2|Lost to Follow-up|0|||
160684440|NCT01684215|580223299|FG002|Phase 2|Lost to Follow-up|0|||
160684441|NCT01684215|580223300|FG003|Phase 2|Lost to Follow-up|4|||
160684442|NCT00480324|580223301|FG000|Overall Study|Adverse Event|1|||
160684443|NCT00480324|580223302|FG001|Overall Study|Adverse Event|1|||
160684444|NCT00480324|580223301|FG000|Overall Study|Protocol Violation|0|||
160684445|NCT00480324|580223302|FG001|Overall Study|Protocol Violation|1|||
160684446|NCT00480324|580223301|FG000|Overall Study|Withdrawal by Subject|14|||
160684447|NCT00480324|580223302|FG001|Overall Study|Withdrawal by Subject|5|||
160684448|NCT00480324|580223301|FG000|Overall Study|Lost to Follow-up|17|||
160684449|NCT00480324|580223302|FG001|Overall Study|Lost to Follow-up|8|||
160684450|NCT00480324|580223301|FG000|Overall Study|Subject's mother pregnant|0|||
160684451|NCT00480324|580223302|FG001|Overall Study|Subject's mother pregnant|1|||
160684452|NCT00784134|580223303|FG000|Overall Study|Lost to Follow-up|3|||
160684453|NCT00784134|580223304|FG001|Overall Study|Lost to Follow-up|6|||
160684454|NCT03785145|580223305|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
160684455|NCT03785145|580223306|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
160684456|NCT03785145|580223305|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
160684457|NCT03785145|580223306|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
160684458|NCT03785145|580223305|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
160684459|NCT03785145|580223306|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
160684460|NCT03785145|580223305|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
160684461|NCT03785145|580223306|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
160684462|NCT03785145|580223305|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
160684463|NCT03785145|580223306|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
160684464|NCT03785145|580223305|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
160684465|NCT03785145|580223306|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
160684466|NCT03785145|580223305|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
160684467|NCT03785145|580223306|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
160684468|NCT03785145|580223305|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
160684469|NCT03785145|580223306|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
160684470|NCT03785145|580223305|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
160684471|NCT03785145|580223306|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
160684472|NCT03785145|580223305|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
160684473|NCT03785145|580223306|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
160684474|NCT03785145|580223305|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
160684475|NCT03785145|580223306|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
160684476|NCT00966381|580223307|FG000|Overall Study|Withdrawal by Subject|2|||
160684477|NCT00966381|580223308|FG001|Overall Study|Withdrawal by Subject|2|||
160684478|NCT01915940|580223309|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
160684479|NCT01915940|580223310|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
160684480|NCT01915940|580223311|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
160684481|NCT01915940|580223309|FG000|Treatment Period|Decision of Participant|0|||
160684482|NCT01915940|580223310|FG001|Treatment Period|Decision of Participant|1|||
160684483|NCT01915940|580223311|FG002|Treatment Period|Decision of Participant|3|||
160684484|NCT01915940|580223309|FG000|Treatment Period|Adverse Event|0|||
160684485|NCT01915940|580223310|FG001|Treatment Period|Adverse Event|9|||
160684486|NCT01915940|580223311|FG002|Treatment Period|Adverse Event|1|||
160684487|NCT01915940|580223309|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
160684488|NCT01915940|580223310|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
160684489|NCT01915940|580223311|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
160684490|NCT03686150|580223312|FG000|Overall Study|Withdrawal by Subject|1|||
160684491|NCT03686150|580223313|FG001|Overall Study|Withdrawal by Subject|1|||
160684492|NCT03686150|580223314|FG002|Overall Study|Withdrawal by Subject|1|||
160684493|NCT03686150|580223315|FG003|Overall Study|Withdrawal by Subject|0|||
160684494|NCT03686150|580223316|FG004|Overall Study|Withdrawal by Subject|1|||
160684495|NCT03686150|580223317|FG005|Overall Study|Withdrawal by Subject|2|||
160684496|NCT03686150|580223312|FG000|Overall Study|Physician Decision|1|||
160684497|NCT03686150|580223313|FG001|Overall Study|Physician Decision|0|||
160684498|NCT03686150|580223314|FG002|Overall Study|Physician Decision|0|||
160684499|NCT03686150|580223315|FG003|Overall Study|Physician Decision|0|||
160684500|NCT03686150|580223316|FG004|Overall Study|Physician Decision|0|||
160684501|NCT03686150|580223317|FG005|Overall Study|Physician Decision|1|||
160684502|NCT03686150|580223312|FG000|Overall Study|Lost to Follow-up|0|||
160684503|NCT03686150|580223313|FG001|Overall Study|Lost to Follow-up|1|||
160684504|NCT03686150|580223314|FG002|Overall Study|Lost to Follow-up|0|||
160684505|NCT03686150|580223315|FG003|Overall Study|Lost to Follow-up|0|||
160684506|NCT03686150|580223316|FG004|Overall Study|Lost to Follow-up|0|||
160684507|NCT03686150|580223317|FG005|Overall Study|Lost to Follow-up|0|||
160684508|NCT04025684|580223324|FG000|Overall Study|Withdrawal by Subject|1|||
160684509|NCT04025684|580223325|FG001|Overall Study|Withdrawal by Subject|1|||
160684510|NCT04025684|580223326|FG002|Overall Study|Withdrawal by Subject|0|||
160684511|NCT04025684|580223327|FG003|Overall Study|Withdrawal by Subject|0|||
160684512|NCT04025684|580223324|FG000|Overall Study|Multiple reasons|1|||
160684513|NCT04025684|580223325|FG001|Overall Study|Multiple reasons|3|||
160684514|NCT04025684|580223326|FG002|Overall Study|Multiple reasons|0|||
160684515|NCT04025684|580223327|FG003|Overall Study|Multiple reasons|1|||
160684516|NCT01613378|580223334|FG000|Overall Study|Lack of Efficacy|13|||
160684517|NCT01613378|580223334|FG000|Overall Study|Adverse Event|11|||
160684518|NCT01613378|580223334|FG000|Overall Study|Withdrawal by Subject|8|||
160684519|NCT01613378|580223334|FG000|Overall Study|Death|2|||
160684520|NCT01613378|580223334|FG000|Overall Study|Lost to Follow-up|1|||
160684521|NCT01613378|580223334|FG000|Overall Study|Other Reason|4|||
160684522|NCT02000531|580223335|FG000|Overall Study|Lost to Follow-up|1|||
160684523|NCT02000531|580223336|FG001|Overall Study|Lost to Follow-up|0|||
160684524|NCT02000531|580223335|FG000|Overall Study|Discontinued due to data cut-off|3|||
160684525|NCT02000531|580223336|FG001|Overall Study|Discontinued due to data cut-off|8|||
160684526|NCT00794417|580223337|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
160684527|NCT00794417|580223338|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
160684528|NCT00794417|580223339|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
160684529|NCT00794417|580223340|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
160684530|NCT00794417|580223337|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
160684531|NCT00794417|580223338|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
160684532|NCT00794417|580223339|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
160684533|NCT00794417|580223340|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
160684534|NCT00794417|580223337|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
160684535|NCT00794417|580223338|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
160684536|NCT00794417|580223339|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
160684537|NCT00794417|580223340|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
160684538|NCT00794417|580223337|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
160684539|NCT00794417|580223338|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
160684540|NCT00794417|580223339|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
160684541|NCT00794417|580223340|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
160684542|NCT00794417|580223337|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
160684543|NCT00794417|580223338|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
160684544|NCT00794417|580223339|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
160684545|NCT00794417|580223340|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
160684546|NCT00794417|580223337|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
160684547|NCT00794417|580223338|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
160684548|NCT00794417|580223339|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
160684549|NCT00794417|580223340|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
160684550|NCT00317642|580223341|FG000|Overall Study|Not Received Either Study Drug|1|||
160684551|NCT00317642|580223342|FG001|Overall Study|Not Received Either Study Drug|3|||
160684552|NCT00317642|580223341|FG000|Overall Study|Physician Decision|15|||
160684553|NCT00317642|580223342|FG001|Overall Study|Physician Decision|7|||
160684554|NCT00317642|580223341|FG000|Overall Study|Participant declined treatment|14|||
160684555|NCT00317642|580223342|FG001|Overall Study|Participant declined treatment|3|||
160684556|NCT00317642|580223341|FG000|Overall Study|Adverse Event|17|||
160684557|NCT00317642|580223342|FG001|Overall Study|Adverse Event|5|||
160684558|NCT00317642|580223341|FG000|Overall Study|Treatment Failure|56|||
160684559|NCT00317642|580223342|FG001|Overall Study|Treatment Failure|102|||
160684560|NCT00317642|580223341|FG000|Overall Study|Disease Recurrence|1|||
160684561|NCT00317642|580223342|FG001|Overall Study|Disease Recurrence|2|||
160684562|NCT00317642|580223341|FG000|Overall Study|Death|14|||
160684563|NCT00317642|580223342|FG001|Overall Study|Death|7|||
160684564|NCT00317642|580223341|FG000|Overall Study|Not Continue to Consolidation|2|||
160684565|NCT00317642|580223342|FG001|Overall Study|Not Continue to Consolidation|0|||
160684566|NCT00317642|580223341|FG000|Overall Study|Withdrawal by Subject|0|||
160684567|NCT00317642|580223342|FG001|Overall Study|Withdrawal by Subject|1|||
160684568|NCT00317642|580223341|FG000|Overall Study|Referred For Transplantation|1|||
160684569|NCT00317642|580223342|FG001|Overall Study|Referred For Transplantation|0|||
160684570|NCT00317642|580223341|FG000|Overall Study|AML Not Centrally Confirmed|1|||
160684571|NCT00317642|580223342|FG001|Overall Study|AML Not Centrally Confirmed|5|||
160684572|NCT00880087|580223345|FG000|Overall Study|Lost to Follow-up|0|||
160684573|NCT00880087|580223346|FG001|Overall Study|Lost to Follow-up|2|||
160684574|NCT00743509|580223347|FG000|Overall Study|Withdrawal by Subject|2|||
160684575|NCT01280617|580223355|FG000|Overall Study|Adverse Event|0|||
160684576|NCT01280617|580223356|FG001|Overall Study|Adverse Event|1|||
160684577|NCT01098110|580223360|FG000|Overall Study|Withdrawal by Subject|14|||
160684578|NCT01098110|580223361|FG001|Overall Study|Withdrawal by Subject|24|||
160684579|NCT01098110|580223362|FG002|Overall Study|Withdrawal by Subject|19|||
160684580|NCT01098110|580223360|FG000|Overall Study|Adverse Event|30|||
160684581|NCT01098110|580223361|FG001|Overall Study|Adverse Event|32|||
160684582|NCT01098110|580223362|FG002|Overall Study|Adverse Event|43|||
160684583|NCT01098110|580223360|FG000|Overall Study|Lack of Efficacy|13|||
160684584|NCT01098110|580223361|FG001|Overall Study|Lack of Efficacy|9|||
160684585|NCT01098110|580223362|FG002|Overall Study|Lack of Efficacy|27|||
160684586|NCT01098110|580223360|FG000|Overall Study|Other|4|||
160684587|NCT01098110|580223361|FG001|Overall Study|Other|7|||
160684588|NCT01098110|580223362|FG002|Overall Study|Other|5|||
160684589|NCT01098110|580223360|FG000|Overall Study|Untreated|1|||
160684590|NCT01098110|580223361|FG001|Overall Study|Untreated|1|||
160684591|NCT01098110|580223362|FG002|Overall Study|Untreated|0|||
160684592|NCT00373425|580223369|FG000|Overall Study|Relapse of NSCLC|116|||
160684593|NCT00373425|580223370|FG001|Overall Study|Relapse of NSCLC|104|||
160684594|NCT00373425|580223371|FG002|Overall Study|Relapse of NSCLC|19|||
160684595|NCT00373425|580223372|FG003|Overall Study|Relapse of NSCLC|2|||
160684596|NCT00373425|580223373|FG004|Overall Study|Relapse of NSCLC|26|||
160684597|NCT00373425|580223369|FG000|Overall Study|Adverse Event|191|||
160684598|NCT00373425|580223370|FG001|Overall Study|Adverse Event|22|||
160684599|NCT00373425|580223371|FG002|Overall Study|Adverse Event|59|||
160684600|NCT00373425|580223372|FG003|Overall Study|Adverse Event|0|||
160684601|NCT00373425|580223373|FG004|Overall Study|Adverse Event|34|||
160684602|NCT00373425|580223369|FG000|Overall Study|Patient request|35|||
160684603|NCT00373425|580223370|FG001|Overall Study|Patient request|18|||
160684604|NCT00373425|580223371|FG002|Overall Study|Patient request|43|||
160684605|NCT00373425|580223372|FG003|Overall Study|Patient request|6|||
160684606|NCT00373425|580223373|FG004|Overall Study|Patient request|7|||
160684607|NCT00373425|580223369|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
160684608|NCT00373425|580223370|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
160684609|NCT00373425|580223371|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
160684610|NCT00373425|580223372|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
160684611|NCT00373425|580223373|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
160684612|NCT00373425|580223369|FG000|Overall Study|Death|7|||
160684613|NCT00373425|580223370|FG001|Overall Study|Death|0|||
160684614|NCT00373425|580223371|FG002|Overall Study|Death|3|||
160684615|NCT00373425|580223372|FG003|Overall Study|Death|1|||
160684616|NCT00373425|580223373|FG004|Overall Study|Death|0|||
160684617|NCT00551616|580223376|FG000|Overall Study|Lost to Follow-up|48|||
160684618|NCT00551616|580223377|FG001|Overall Study|Lost to Follow-up|40|||
160684619|NCT02808819|580223378|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
160684620|NCT02808819|580223379|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
160684621|NCT02808819|580223378|FG000|Overall Study|Withdrawal by Subject|10|||
160684622|NCT02808819|580223379|FG001|Overall Study|Withdrawal by Subject|13|||
160684623|NCT02808819|580223378|FG000|Overall Study|Site terminated by sponsor|2|||
160684624|NCT02808819|580223379|FG001|Overall Study|Site terminated by sponsor|0|||
160684625|NCT02808819|580223378|FG000|Overall Study|Pregnancy|1|||
160684626|NCT02808819|580223379|FG001|Overall Study|Pregnancy|0|||
160684627|NCT02808819|580223378|FG000|Overall Study|Lost to Follow-up|1|||
160684628|NCT02808819|580223379|FG001|Overall Study|Lost to Follow-up|6|||
160684629|NCT02808819|580223378|FG000|Overall Study|Protocol Violation|0|||
160684630|NCT02808819|580223379|FG001|Overall Study|Protocol Violation|1|||
160684631|NCT02808819|580223378|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
160684632|NCT02808819|580223379|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
160684633|NCT02808819|580223378|FG000|Overall Study|Death|1|||
160684634|NCT02808819|580223379|FG001|Overall Study|Death|0|||
160684635|NCT02808819|580223378|FG000|Overall Study|Adverse Event|3|||
160684636|NCT02808819|580223379|FG001|Overall Study|Adverse Event|4|||
160684637|NCT03297294|580223380|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
160684638|NCT03297294|580223381|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
160684639|NCT03297294|580223382|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
160684640|NCT03297294|580223383|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
160684641|NCT03297294|580223384|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
160684642|NCT03297294|580223380|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
160684643|NCT03297294|580223381|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
160684644|NCT03297294|580223382|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160684645|NCT03297294|580223383|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160684646|NCT03297294|580223384|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160684647|NCT03297294|580223380|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
160684648|NCT03297294|580223381|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
160684649|NCT03297294|580223382|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160684650|NCT03297294|580223383|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160684651|NCT03297294|580223384|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160684652|NCT03297294|580223380|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
160684653|NCT03297294|580223381|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
160684654|NCT03297294|580223382|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
160684655|NCT03297294|580223383|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
160684656|NCT03297294|580223384|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
160684657|NCT03297294|580223380|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
160684658|NCT03297294|580223381|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
160684659|NCT03297294|580223382|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
160684660|NCT03297294|580223383|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
160684661|NCT03297294|580223384|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
160684662|NCT02692482|580223385|FG000|Overall Study|Death|2|||
160684663|NCT02692482|580223386|FG001|Overall Study|Death|2|||
160684664|NCT02692482|580223385|FG000|Overall Study|Withdrawal by Subject|1|||
160684665|NCT02692482|580223386|FG001|Overall Study|Withdrawal by Subject|2|||
160684666|NCT00127166|580223389|FG000|Period I|Protocol Violation|0|||
160684667|NCT00127166|580223390|FG001|Period I|Protocol Violation|2|||
160684668|NCT00127166|580223389|FG000|Period I|Withdrawal by Subject|2|||
160684669|NCT00127166|580223390|FG001|Period I|Withdrawal by Subject|0|||
160684670|NCT00127166|580223389|FG000|Period I|Patient did not meet inclusion criteria|1|||
160684671|NCT00127166|580223390|FG001|Period I|Patient did not meet inclusion criteria|0|||
160684672|NCT00127166|580223389|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
160684673|NCT00127166|580223390|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
160684674|NCT00127166|580223389|FG000|Period II|Withdrawal by Subject|2|||
160684675|NCT00127166|580223390|FG001|Period II|Withdrawal by Subject|0|||
160684676|NCT00127166|580223389|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
160684677|NCT00127166|580223390|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
160684678|NCT00105157|580223391|FG000|Double-Blind (DB)|Never Treated|1|||
160684679|NCT00105157|580223392|FG001|Double-Blind (DB)|Never Treated|0|||
160684680|NCT00105157|580223393|FG002|Double-Blind (DB)|Never Treated|0|||
160684681|NCT00105157|580223394|FG003|Double-Blind (DB)|Never Treated|0|||
160684682|NCT00105157|580223391|FG000|Double-Blind (DB)|Adverse Event|2|||
160684683|NCT00105157|580223392|FG001|Double-Blind (DB)|Adverse Event|0|||
160684684|NCT00105157|580223393|FG002|Double-Blind (DB)|Adverse Event|1|||
160684685|NCT00105157|580223394|FG003|Double-Blind (DB)|Adverse Event|1|||
160684686|NCT00105157|580223391|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
160684687|NCT00105157|580223392|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
160684688|NCT00105157|580223393|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
160684689|NCT00105157|580223394|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
160684690|NCT00105157|580223391|FG000|Open-Label Continuation of DB|Adverse Event|3|||
160684691|NCT00105157|580223392|FG001|Open-Label Continuation of DB|Adverse Event|1|||
160684692|NCT00105157|580223393|FG002|Open-Label Continuation of DB|Adverse Event|0|||
160684693|NCT00105157|580223394|FG003|Open-Label Continuation of DB|Adverse Event|0|||
160684694|NCT00105157|580223391|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
160684695|NCT00105157|580223392|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
160684696|NCT00105157|580223393|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
160684697|NCT00105157|580223394|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
160684698|NCT00105157|580223391|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
160684699|NCT00105157|580223392|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
160684700|NCT00105157|580223393|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
160684701|NCT00105157|580223394|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
160684702|NCT00105157|580223391|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
160684703|NCT00105157|580223392|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
160684704|NCT00105157|580223393|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
160684705|NCT00105157|580223394|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
160684706|NCT00105157|580223391|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
160684707|NCT00105157|580223392|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
160684708|NCT00105157|580223393|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
160684709|NCT00105157|580223394|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
160684710|NCT00105157|580223391|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
160684711|NCT00105157|580223392|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
160684712|NCT00105157|580223393|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
160684713|NCT00105157|580223394|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
160684714|NCT00105157|580223391|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
160684715|NCT00105157|580223392|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
160684716|NCT00105157|580223393|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
160684717|NCT00105157|580223394|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
160684718|NCT00105157|580223391|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
160684719|NCT00105157|580223392|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
160684720|NCT00105157|580223393|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
160684721|NCT00105157|580223394|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
160684722|NCT00105157|580223391|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
160684723|NCT00105157|580223392|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
160684724|NCT00105157|580223393|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
160684725|NCT00105157|580223394|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
160684726|NCT00105157|580223391|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
160684727|NCT00105157|580223392|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
160684728|NCT00105157|580223393|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
160684729|NCT00105157|580223394|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
160684730|NCT00105157|580223391|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
160684731|NCT00105157|580223392|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
160684732|NCT00105157|580223393|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
160684733|NCT00105157|580223394|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
160684734|NCT01396421|580223395|FG000|Overall Study|Lost to Follow-up|0|||
160684735|NCT01396421|580223396|FG001|Overall Study|Lost to Follow-up|0|||
160684736|NCT01396421|580223397|FG002|Overall Study|Lost to Follow-up|0|||
160684737|NCT01396421|580223398|FG003|Overall Study|Lost to Follow-up|1|||
160684738|NCT01396421|580223395|FG000|Overall Study|Adverse Event|17|||
160684739|NCT01396421|580223396|FG001|Overall Study|Adverse Event|15|||
160684740|NCT01396421|580223397|FG002|Overall Study|Adverse Event|12|||
160684741|NCT01396421|580223398|FG003|Overall Study|Adverse Event|32|||
160684742|NCT01396421|580223395|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
160684743|NCT01396421|580223396|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
160684744|NCT01396421|580223397|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
160684745|NCT01396421|580223398|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
160684746|NCT01396421|580223395|FG000|Overall Study|Physician Decision|1|||
160684747|NCT01396421|580223396|FG001|Overall Study|Physician Decision|1|||
160684748|NCT01396421|580223397|FG002|Overall Study|Physician Decision|0|||
160684749|NCT01396421|580223398|FG003|Overall Study|Physician Decision|3|||
160684750|NCT01396421|580223395|FG000|Overall Study|Withdrawal by Subject|31|||
160684751|NCT01396421|580223396|FG001|Overall Study|Withdrawal by Subject|24|||
160684752|NCT01396421|580223397|FG002|Overall Study|Withdrawal by Subject|13|||
160684753|NCT01396421|580223398|FG003|Overall Study|Withdrawal by Subject|21|||
160684754|NCT01396421|580223395|FG000|Overall Study|Protocol Deviation|2|||
160684755|NCT01396421|580223396|FG001|Overall Study|Protocol Deviation|1|||
160684756|NCT01396421|580223397|FG002|Overall Study|Protocol Deviation|1|||
160684757|NCT01396421|580223398|FG003|Overall Study|Protocol Deviation|0|||
160684758|NCT01396421|580223395|FG000|Overall Study|Lack of Efficacy|7|||
160684759|NCT01396421|580223396|FG001|Overall Study|Lack of Efficacy|17|||
160684760|NCT01396421|580223397|FG002|Overall Study|Lack of Efficacy|7|||
160684761|NCT01396421|580223398|FG003|Overall Study|Lack of Efficacy|18|||
160684762|NCT01610063|580223403|FG000|Overall Study|Lost to Follow-up|42|||
160684763|NCT01610063|580223404|FG001|Overall Study|Lost to Follow-up|20|||
160684764|NCT03314662|580223411|FG000|Overall Study|Withdrawal by Subject|1|||
160684765|NCT03314662|580223412|FG001|Overall Study|Withdrawal by Subject|1|||
160684766|NCT03314662|580223413|FG002|Overall Study|Withdrawal by Subject|1|||
160684767|NCT03314662|580223411|FG000|Overall Study|Lost to Follow-up|5|||
160684768|NCT03314662|580223412|FG001|Overall Study|Lost to Follow-up|4|||
160684769|NCT03314662|580223413|FG002|Overall Study|Lost to Follow-up|4|||
160684770|NCT03314662|580223411|FG000|Overall Study|Death|2|||
160684771|NCT03314662|580223412|FG001|Overall Study|Death|0|||
160684772|NCT03314662|580223413|FG002|Overall Study|Death|0|||
160684773|NCT01117766|580223418|FG000|First Intervention|Adverse Event|0|||
160684774|NCT01117766|580223419|FG001|First Intervention|Adverse Event|1|||
160684775|NCT01117766|580223418|FG000|First Intervention|Protocol Violation|1|||
160684776|NCT01117766|580223419|FG001|First Intervention|Protocol Violation|0|||
160684777|NCT01117766|580223418|FG000|Washout Period|Protocol Violation|0|||
160684778|NCT01117766|580223419|FG001|Washout Period|Protocol Violation|2|||
160684779|NCT01117766|580223418|FG000|Second Intervention|Lost to Follow-up|1|||
160684780|NCT01117766|580223419|FG001|Second Intervention|Lost to Follow-up|0|||
160684781|NCT01117766|580223418|FG000|Second Intervention|Other|1|||
160684782|NCT01117766|580223419|FG001|Second Intervention|Other|2|||
160684783|NCT01117766|580223418|FG000|Second Intervention|Adverse Event|0|||
160684784|NCT01117766|580223419|FG001|Second Intervention|Adverse Event|2|||
160684785|NCT01117766|580223418|FG000|Second Intervention|Withdrawal by Subject|0|||
160684786|NCT01117766|580223419|FG001|Second Intervention|Withdrawal by Subject|1|||
160684787|NCT04405739|580223420|FG000|Overall Study|Adverse Event|0|||
160684788|NCT04405739|580223421|FG001|Overall Study|Adverse Event|1|||
160684789|NCT04405739|580223422|FG002|Overall Study|Adverse Event|0|||
160684790|NCT04405739|580223423|FG003|Overall Study|Adverse Event|0|||
160684791|NCT04405739|580223420|FG000|Overall Study|Lost to Follow-up|0|||
160684792|NCT04405739|580223421|FG001|Overall Study|Lost to Follow-up|2|||
160684793|NCT04405739|580223422|FG002|Overall Study|Lost to Follow-up|1|||
160684794|NCT04405739|580223423|FG003|Overall Study|Lost to Follow-up|3|||
160684795|NCT04405739|580223420|FG000|Overall Study|Withdrawal by Subject|0|||
160684796|NCT04405739|580223421|FG001|Overall Study|Withdrawal by Subject|2|||
160684797|NCT04405739|580223422|FG002|Overall Study|Withdrawal by Subject|1|||
160684798|NCT04405739|580223423|FG003|Overall Study|Withdrawal by Subject|1|||
160684799|NCT04405739|580223420|FG000|Overall Study|Death|0|||
160684800|NCT04405739|580223421|FG001|Overall Study|Death|0|||
160684801|NCT04405739|580223422|FG002|Overall Study|Death|1|||
160684802|NCT04405739|580223423|FG003|Overall Study|Death|0|||
160684803|NCT04405739|580223420|FG000|Overall Study|Transferred to rehab|0|||
160684804|NCT04405739|580223421|FG001|Overall Study|Transferred to rehab|0|||
160684805|NCT04405739|580223422|FG002|Overall Study|Transferred to rehab|0|||
160684806|NCT04405739|580223423|FG003|Overall Study|Transferred to rehab|1|||
160684807|NCT04405739|580223420|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
160684808|NCT04405739|580223421|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
160684809|NCT04405739|580223422|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
160684810|NCT04405739|580223423|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
160684811|NCT00438659|580223424|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
160684812|NCT00438659|580223425|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
160684813|NCT00438659|580223424|FG000|Overall Study|Cancel|5|||
160684814|NCT00438659|580223425|FG001|Overall Study|Cancel|2|||
160684815|NCT05766787|580223426|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
160684816|NCT05766787|580223427|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
160684817|NCT05766787|580223426|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
160684818|NCT05766787|580223427|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
160684819|NCT05766787|580223426|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
160684820|NCT05766787|580223427|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
160684821|NCT01867606|580223428|FG000|Overall Study|Withdrawal by Subject|10|||
160684822|NCT01867606|580223429|FG001|Overall Study|Withdrawal by Subject|14|||
160684823|NCT01867606|580223428|FG000|Overall Study|Protocol Violation|0|||
160684824|NCT01867606|580223429|FG001|Overall Study|Protocol Violation|1|||
160684825|NCT00206102|580223430|FG000|Overall Study|Adverse Event|119|||
160684826|NCT00206102|580223431|FG001|Overall Study|Adverse Event|82|||
160684827|NCT00206102|580223430|FG000|Overall Study|Protocol Violation|0|||
160684828|NCT00206102|580223431|FG001|Overall Study|Protocol Violation|2|||
160684829|NCT00206102|580223430|FG000|Overall Study|Lack of therapeutic response|16|||
160684830|NCT00206102|580223431|FG001|Overall Study|Lack of therapeutic response|11|||
160684831|NCT00206102|580223430|FG000|Overall Study|Lost to Follow-up|95|||
160684832|NCT00206102|580223431|FG001|Overall Study|Lost to Follow-up|66|||
160684833|NCT00206102|580223430|FG000|Overall Study|Withdrawal by Subject|118|||
160684834|NCT00206102|580223431|FG001|Overall Study|Withdrawal by Subject|101|||
160684835|NCT00206102|580223430|FG000|Overall Study|Study-specific discontinuation criteria|18|||
160684836|NCT00206102|580223431|FG001|Overall Study|Study-specific discontinuation criteria|17|||
160684837|NCT00206102|580223430|FG000|Overall Study|None of those categories|42|||
160684838|NCT00206102|580223431|FG001|Overall Study|None of those categories|36|||
160684839|NCT01917968|580223432|FG000|Overall Study|Death|3|||
160684840|NCT01917968|580223433|FG001|Overall Study|Death|2|||
160684841|NCT01917968|580223432|FG000|Overall Study|Lost to Follow-up|21|||
160684842|NCT01917968|580223433|FG001|Overall Study|Lost to Follow-up|39|||
160684843|NCT01917968|580223432|FG000|Overall Study|Physician Decision|1|||
160684844|NCT01917968|580223433|FG001|Overall Study|Physician Decision|2|||
160684845|NCT01917968|580223432|FG000|Overall Study|Withdrawal by Subject|20|||
160684846|NCT01917968|580223433|FG001|Overall Study|Withdrawal by Subject|35|||
160684847|NCT01917968|580223432|FG000|Overall Study|Subject Relocation|5|||
160684848|NCT01917968|580223433|FG001|Overall Study|Subject Relocation|1|||
160684849|NCT01917968|580223432|FG000|Overall Study|36M Missed Visit|3|||
160684850|NCT01917968|580223433|FG001|Overall Study|36M Missed Visit|2|||
160684851|NCT01917968|580223432|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
160684852|NCT01917968|580223433|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
160684853|NCT01917968|580223432|FG000|Overall Study|Change in Family Circumstances|0|||
160684854|NCT01917968|580223433|FG001|Overall Study|Change in Family Circumstances|1|||
160684855|NCT01917968|580223432|FG000|Overall Study|No Data Available|0|||
160684856|NCT01917968|580223433|FG001|Overall Study|No Data Available|2|||
160684857|NCT01435928|580223435|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
160684858|NCT01435928|580223436|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
160684859|NCT01435928|580223437|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
160684860|NCT01435928|580223435|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
160684861|NCT01435928|580223436|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
160684862|NCT01435928|580223437|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
160684863|NCT01435928|580223435|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
160684864|NCT01435928|580223436|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
160684865|NCT01435928|580223437|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
160684866|NCT01435928|580223435|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
160684867|NCT01435928|580223436|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
160684868|NCT01435928|580223437|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
160684869|NCT01435928|580223435|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
160684870|NCT01435928|580223436|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
160684871|NCT01435928|580223437|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
160684872|NCT01435928|580223435|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
160684873|NCT01435928|580223436|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
160684874|NCT01435928|580223437|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
160684875|NCT01435928|580223435|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
160684876|NCT01435928|580223436|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
160684877|NCT01435928|580223437|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
160684878|NCT01435928|580223435|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
160684879|NCT01435928|580223436|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
160684880|NCT01435928|580223437|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
160684881|NCT01435928|580223435|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
160684882|NCT01435928|580223436|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
160684883|NCT01435928|580223437|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
160684884|NCT01435928|580223435|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
160684885|NCT01435928|580223436|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
160684886|NCT01435928|580223437|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
160684887|NCT01435928|580223435|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
160684888|NCT01435928|580223436|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
160684889|NCT01435928|580223437|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
160684890|NCT01435928|580223435|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
160684891|NCT01435928|580223436|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
160684892|NCT01435928|580223437|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
160684893|NCT01435928|580223435|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
160684894|NCT01435928|580223436|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
160684895|NCT01435928|580223437|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
160684896|NCT01435928|580223435|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
160684897|NCT01435928|580223436|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
160684898|NCT01435928|580223437|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
160684899|NCT01435928|580223435|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
160684900|NCT01435928|580223436|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
160684901|NCT01435928|580223437|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
160684902|NCT01435928|580223435|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
160684903|NCT01435928|580223436|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
160684904|NCT01435928|580223437|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
160684905|NCT00576303|580223441|FG000|Dose Titration Period|Early withdrawal|17|||
160684906|NCT00576303|580223441|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
160684907|NCT00576303|580223441|FG000|Long Term Safety Period|Early withdrawal|16|||
160684908|NCT02843659|580223445|FG000|Overall Study|Subject Withdrew Consent|0|||
160684909|NCT02843659|580223446|FG001|Overall Study|Subject Withdrew Consent|0|||
160684910|NCT02843659|580223447|FG002|Overall Study|Subject Withdrew Consent|1|||
160684911|NCT02843659|580223445|FG000|Overall Study|Administrative Reason by Sponsor|4|||
160684912|NCT02843659|580223446|FG001|Overall Study|Administrative Reason by Sponsor|5|||
160684913|NCT02843659|580223447|FG002|Overall Study|Administrative Reason by Sponsor|4|||
160684914|NCT02843659|580223445|FG000|Overall Study|Adverse Event|0|||
160684915|NCT02843659|580223446|FG001|Overall Study|Adverse Event|1|||
160684916|NCT02843659|580223447|FG002|Overall Study|Adverse Event|0|||
160684917|NCT03203642|580223448|FG000|Overall Study|Adverse Event|3|||
160684918|NCT03203642|580223449|FG001|Overall Study|Adverse Event|1|||
160684919|NCT03203642|580223448|FG000|Overall Study|Withdrawal by Subject|6|||
160684920|NCT03203642|580223449|FG001|Overall Study|Withdrawal by Subject|6|||
160684921|NCT03203642|580223448|FG000|Overall Study|Lost to Follow-up|2|||
160684922|NCT03203642|580223449|FG001|Overall Study|Lost to Follow-up|1|||
160684923|NCT03203642|580223448|FG000|Overall Study|Termination of the study by sponsor|1|||
160684924|NCT03203642|580223449|FG001|Overall Study|Termination of the study by sponsor|1|||
160684925|NCT03203642|580223448|FG000|Overall Study|Participant moved|0|||
160684926|NCT03203642|580223449|FG001|Overall Study|Participant moved|1|||
160684927|NCT03203642|580223448|FG000|Overall Study|Investigator's decision|3|||
160684928|NCT03203642|580223449|FG001|Overall Study|Investigator's decision|0|||
160684929|NCT03203642|580223448|FG000|Overall Study|Other than above specified|0|||
160684930|NCT03203642|580223449|FG001|Overall Study|Other than above specified|1|||
160684931|NCT04039919|580225048|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160684932|NCT04039919|580225049|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160684933|NCT04039919|580225050|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160684934|NCT04039919|580225051|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160684935|NCT04039919|580225052|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160684936|NCT04039919|580225048|FG000|Treatment Period 1|Sponsor's decision|0|||
160684937|NCT04039919|580225049|FG001|Treatment Period 1|Sponsor's decision|0|||
160684938|NCT04039919|580225050|FG002|Treatment Period 1|Sponsor's decision|0|||
160684939|NCT04039919|580225051|FG003|Treatment Period 1|Sponsor's decision|0|||
160684940|NCT04039919|580225052|FG004|Treatment Period 1|Sponsor's decision|16|||
160684941|NCT04039919|580225048|FG000|Treatment Period 5|Withdrawal by Subject|1|||
160684942|NCT04039919|580225049|FG001|Treatment Period 5|Withdrawal by Subject|0|||
160684943|NCT04039919|580225050|FG002|Treatment Period 5|Withdrawal by Subject|0|||
160684944|NCT04039919|580225051|FG003|Treatment Period 5|Withdrawal by Subject|0|||
160684945|NCT04039919|580225052|FG004|Treatment Period 5|Withdrawal by Subject|0|||
160684946|NCT03250299|580225060|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
160684947|NCT03250299|580225061|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
160684948|NCT03250299|580225062|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
160684949|NCT03250299|580225063|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
160684950|NCT03250299|580225064|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
160684951|NCT03250299|580225060|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
160684952|NCT03250299|580225061|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
160684953|NCT03250299|580225062|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
160684954|NCT03250299|580225063|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
160684955|NCT03250299|580225064|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
160684956|NCT03250299|580225060|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
160684957|NCT03250299|580225061|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
160684958|NCT03250299|580225062|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
160684959|NCT03250299|580225063|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
160684960|NCT03250299|580225064|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
160684961|NCT03250299|580225060|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
160684962|NCT03250299|580225061|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
160684963|NCT03250299|580225062|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
160684964|NCT03250299|580225063|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
160684965|NCT03250299|580225064|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
160684966|NCT03346070|580225065|FG000|Overall Study|Death|0|||
160684967|NCT03346070|580225066|FG001|Overall Study|Death|0|||
160684968|NCT03346070|580225067|FG002|Overall Study|Death|0|||
160684969|NCT03346070|580225068|FG003|Overall Study|Death|0|||
160684970|NCT03346070|580225069|FG004|Overall Study|Death|1|||
160684971|NCT03346070|580225065|FG000|Overall Study|Lost to Follow-up|0|||
160684972|NCT03346070|580225066|FG001|Overall Study|Lost to Follow-up|1|||
160684973|NCT03346070|580225067|FG002|Overall Study|Lost to Follow-up|2|||
160684974|NCT03346070|580225068|FG003|Overall Study|Lost to Follow-up|0|||
160684975|NCT03346070|580225069|FG004|Overall Study|Lost to Follow-up|0|||
160684976|NCT03346070|580225065|FG000|Overall Study|Physician Decision|0|||
160684977|NCT03346070|580225066|FG001|Overall Study|Physician Decision|0|||
160684978|NCT03346070|580225067|FG002|Overall Study|Physician Decision|0|||
160684979|NCT03346070|580225068|FG003|Overall Study|Physician Decision|1|||
160684980|NCT03346070|580225069|FG004|Overall Study|Physician Decision|1|||
160684981|NCT03346070|580225065|FG000|Overall Study|Withdrawal by Subject|1|||
160684982|NCT03346070|580225066|FG001|Overall Study|Withdrawal by Subject|0|||
160684983|NCT03346070|580225067|FG002|Overall Study|Withdrawal by Subject|0|||
160684984|NCT03346070|580225068|FG003|Overall Study|Withdrawal by Subject|1|||
160684985|NCT03346070|580225069|FG004|Overall Study|Withdrawal by Subject|0|||
160684986|NCT03346070|580225065|FG000|Overall Study|Study medication not received as planned|2|||
160684987|NCT03346070|580225066|FG001|Overall Study|Study medication not received as planned|3|||
160684988|NCT03346070|580225067|FG002|Overall Study|Study medication not received as planned|2|||
160684989|NCT03346070|580225068|FG003|Overall Study|Study medication not received as planned|3|||
160684990|NCT03346070|580225069|FG004|Overall Study|Study medication not received as planned|2|||
160684991|NCT03346070|580225065|FG000|Overall Study|Screen Failure|0|||
160684992|NCT03346070|580225066|FG001|Overall Study|Screen Failure|0|||
160684993|NCT03346070|580225067|FG002|Overall Study|Screen Failure|0|||
160684994|NCT03346070|580225068|FG003|Overall Study|Screen Failure|1|||
160684995|NCT03346070|580225069|FG004|Overall Study|Screen Failure|1|||
160684996|NCT00977548|580225070|FG000|Overall Study|Ineligible|4|||
160684997|NCT00977548|580225070|FG000|Overall Study|Adverse Event|8|||
160684998|NCT00977548|580225070|FG000|Overall Study|Withdrawal by Subject|1|||
160684999|NCT00988208|580225072|FG000|Overall Study|Adverse Event|71|||
160685000|NCT00988208|580225073|FG001|Overall Study|Adverse Event|122|||
160685001|NCT00988208|580225072|FG000|Overall Study|Disease Progression|103|||
160685002|NCT00988208|580225073|FG001|Overall Study|Disease Progression|89|||
160685003|NCT00988208|580225072|FG000|Overall Study|Withdrawal by Subject|50|||
160685004|NCT00988208|580225073|FG001|Overall Study|Withdrawal by Subject|57|||
160685005|NCT00988208|580225072|FG000|Overall Study|Death|9|||
160685006|NCT00988208|580225073|FG001|Overall Study|Death|15|||
160685007|NCT00988208|580225072|FG000|Overall Study|Lost to Follow-up|2|||
160685008|NCT00988208|580225073|FG001|Overall Study|Lost to Follow-up|3|||
160685009|NCT00988208|580225072|FG000|Overall Study|Protocol Violation|9|||
160685010|NCT00988208|580225073|FG001|Overall Study|Protocol Violation|2|||
160685011|NCT00988208|580225072|FG000|Overall Study|Sponsor Decision|102|||
160685012|NCT00988208|580225073|FG001|Overall Study|Sponsor Decision|78|||
160685013|NCT00988208|580225072|FG000|Overall Study|Clinical Progression|17|||
160685014|NCT00988208|580225073|FG001|Overall Study|Clinical Progression|16|||
160685015|NCT00988208|580225072|FG000|Overall Study|Biochemical Progression|21|||
160685016|NCT00988208|580225073|FG001|Overall Study|Biochemical Progression|7|||
160685017|NCT00988208|580225072|FG000|Overall Study|Clinical Deterioration|7|||
160685018|NCT00988208|580225073|FG001|Overall Study|Clinical Deterioration|14|||
160685019|NCT00988208|580225072|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
160685020|NCT00988208|580225073|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
160685021|NCT00988208|580225072|FG000|Overall Study|Other|8|||
160685022|NCT00988208|580225073|FG001|Overall Study|Other|3|||
160685023|NCT00255151|580225080|FG000|Overall Study|Adverse Event|10|||
160685024|NCT00255151|580225081|FG001|Overall Study|Adverse Event|6|||
160685025|NCT00255151|580225082|FG002|Overall Study|Adverse Event|9|||
160685026|NCT00255151|580225080|FG000|Overall Study|Lost to Follow-up|4|||
160685027|NCT00255151|580225081|FG001|Overall Study|Lost to Follow-up|3|||
160685028|NCT00255151|580225082|FG002|Overall Study|Lost to Follow-up|4|||
160685029|NCT00255151|580225080|FG000|Overall Study|Withdrawal by Subject|18|||
160685030|NCT00255151|580225081|FG001|Overall Study|Withdrawal by Subject|17|||
160685031|NCT00255151|580225082|FG002|Overall Study|Withdrawal by Subject|8|||
160685032|NCT00255151|580225080|FG000|Overall Study|Noncompliance|0|||
160685033|NCT00255151|580225081|FG001|Overall Study|Noncompliance|1|||
160685034|NCT00255151|580225082|FG002|Overall Study|Noncompliance|2|||
160685035|NCT00255151|580225080|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
160685036|NCT00255151|580225081|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
160685037|NCT00255151|580225082|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
160685038|NCT00255151|580225080|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
160685039|NCT00255151|580225081|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
160685040|NCT00255151|580225082|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
160685041|NCT00255151|580225080|FG000|Overall Study|Possible Barrett's Esophagus|1|||
160685042|NCT00255151|580225081|FG001|Overall Study|Possible Barrett's Esophagus|3|||
160685043|NCT00255151|580225082|FG002|Overall Study|Possible Barrett's Esophagus|8|||
160685044|NCT00255151|580225080|FG000|Overall Study|Esophageal Stricture|0|||
160685045|NCT00255151|580225081|FG001|Overall Study|Esophageal Stricture|0|||
160685046|NCT00255151|580225082|FG002|Overall Study|Esophageal Stricture|1|||
160685047|NCT00255151|580225080|FG000|Overall Study|Therapeutic Failure|11|||
160685048|NCT00255151|580225081|FG001|Overall Study|Therapeutic Failure|2|||
160685049|NCT00255151|580225082|FG002|Overall Study|Therapeutic Failure|3|||
160685050|NCT00792623|580225083|FG000|Overall Study|Adverse Event|2|||
160685051|NCT00792623|580225083|FG000|Overall Study|Withdrawal by Subject|5|||
160685052|NCT00892281|580225091|FG000|Overall Study|Adverse Event|65|||
160685053|NCT00892281|580225092|FG001|Overall Study|Adverse Event|8|||
160685054|NCT00892281|580225091|FG000|Overall Study|Lost to Follow-up|81|||
160685055|NCT00892281|580225092|FG001|Overall Study|Lost to Follow-up|8|||
160685056|NCT00892281|580225091|FG000|Overall Study|Pregnancy|1|||
160685057|NCT00892281|580225092|FG001|Overall Study|Pregnancy|0|||
160685058|NCT00892281|580225091|FG000|Overall Study|Protocol Violation|7|||
160685059|NCT00892281|580225092|FG001|Overall Study|Protocol Violation|2|||
160685060|NCT00892281|580225091|FG000|Overall Study|Withdrawal by Subject|86|||
160685061|NCT00892281|580225092|FG001|Overall Study|Withdrawal by Subject|14|||
160685062|NCT00892281|580225091|FG000|Overall Study|Subject failed to return for final visit|2|||
160685063|NCT00892281|580225092|FG001|Overall Study|Subject failed to return for final visit|0|||
160685064|NCT00892281|580225091|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
160685065|NCT00892281|580225092|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
160685066|NCT00892281|580225091|FG000|Overall Study|Final visit completed 4 weeks late|0|||
160685067|NCT00892281|580225092|FG001|Overall Study|Final visit completed 4 weeks late|1|||
160685068|NCT00892281|580225091|FG000|Overall Study|Subject completed day after study closed|1|||
160685069|NCT00892281|580225092|FG001|Overall Study|Subject completed day after study closed|0|||
160685070|NCT00892281|580225091|FG000|Overall Study|Family emergency|1|||
160685071|NCT00892281|580225092|FG001|Overall Study|Family emergency|0|||
160685072|NCT00892281|580225091|FG000|Overall Study|Last visit not done - death in family|1|||
160685073|NCT00892281|580225092|FG001|Overall Study|Last visit not done - death in family|0|||
160685074|NCT00892281|580225091|FG000|Overall Study|Did not meet incl/excl criteria|1|||
160685075|NCT00892281|580225092|FG001|Overall Study|Did not meet incl/excl criteria|0|||
160685076|NCT00892281|580225091|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
160685077|NCT00892281|580225092|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
160685078|NCT00892281|580225091|FG000|Overall Study|Unable to redeem the drug voucher|1|||
160685079|NCT00892281|580225092|FG001|Overall Study|Unable to redeem the drug voucher|0|||
160685080|NCT00892281|580225091|FG000|Overall Study|Subject not good candidate for study|1|||
160685081|NCT00892281|580225092|FG001|Overall Study|Subject not good candidate for study|0|||
160685082|NCT00892281|580225091|FG000|Overall Study|Subject did not return for any visits|1|||
160685083|NCT00892281|580225092|FG001|Overall Study|Subject did not return for any visits|0|||
160685084|NCT00892281|580225091|FG000|Overall Study|Subject missed several visits/lost meds|1|||
160685085|NCT00892281|580225092|FG001|Overall Study|Subject missed several visits/lost meds|0|||
160685086|NCT00892281|580225091|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
160685087|NCT00892281|580225092|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
160685088|NCT00892281|580225091|FG000|Overall Study|Scheduled for knee replacement|0|||
160685089|NCT00892281|580225092|FG001|Overall Study|Scheduled for knee replacement|1|||
160685090|NCT00892281|580225091|FG000|Overall Study|PI complained of inadequate compensation|3|||
160685091|NCT00892281|580225092|FG001|Overall Study|PI complained of inadequate compensation|0|||
160685092|NCT00892281|580225091|FG000|Overall Study|Subject lost interest in program|0|||
160685093|NCT00892281|580225092|FG001|Overall Study|Subject lost interest in program|1|||
160685094|NCT00892281|580225091|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
160685095|NCT00892281|580225092|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
160685096|NCT00892281|580225091|FG000|Overall Study|Death in family|1|||
160685097|NCT00892281|580225092|FG001|Overall Study|Death in family|0|||
160685098|NCT00892281|580225091|FG000|Overall Study|Lack of efficacy of study product|2|||
160685099|NCT00892281|580225092|FG001|Overall Study|Lack of efficacy of study product|0|||
160685100|NCT00892281|580225091|FG000|Overall Study|Subject not seen by PI at final visit|1|||
160685101|NCT00892281|580225092|FG001|Overall Study|Subject not seen by PI at final visit|0|||
160685102|NCT00892281|580225091|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
160685103|NCT00892281|580225092|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
160685104|NCT00892281|580225091|FG000|Overall Study|Missed multiple visits|1|||
160685105|NCT00892281|580225092|FG001|Overall Study|Missed multiple visits|0|||
160685106|NCT00892281|580225091|FG000|Overall Study|Missed visits rescheduled out of window|1|||
160685107|NCT00892281|580225092|FG001|Overall Study|Missed visits rescheduled out of window|0|||
160685108|NCT00892281|580225091|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
160685109|NCT00892281|580225092|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
160685110|NCT00892281|580225091|FG000|Overall Study|Subject had history of drug abuse|1|||
160685111|NCT00892281|580225092|FG001|Overall Study|Subject had history of drug abuse|0|||
160685112|NCT00892281|580225091|FG000|Overall Study|Rash on hand|1|||
160685113|NCT00892281|580225092|FG001|Overall Study|Rash on hand|0|||
160685114|NCT00892281|580225091|FG000|Overall Study|Visit 4 date out of window|1|||
160685115|NCT00892281|580225092|FG001|Overall Study|Visit 4 date out of window|0|||
160685116|NCT01534078|580225093|FG000|Overall Study|Death|1|||
160685117|NCT01534078|580225093|FG000|Overall Study|Withdrawal by Subject|1|||
160685118|NCT00986570|580225094|FG000|Overall Study|Lost to Follow-up|6|||
160685119|NCT00986570|580225094|FG000|Overall Study|Potential bias for objective assessment|1|||
160685120|NCT02225665|580225095|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
160685121|NCT02225665|580225096|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
160685122|NCT02225665|580225095|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
160685123|NCT02225665|580225096|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
160685124|NCT01311557|580225097|FG000|Overall Study|Serious adverse event|0|||
160685125|NCT01311557|580225098|FG001|Overall Study|Serious adverse event|1|||
160685126|NCT01311557|580225097|FG000|Overall Study|Protocol Violation|4|||
160685127|NCT01311557|580225098|FG001|Overall Study|Protocol Violation|2|||
160685128|NCT01311557|580225097|FG000|Overall Study|Lost to Follow-up|0|||
160685129|NCT01311557|580225098|FG001|Overall Study|Lost to Follow-up|1|||
160685130|NCT01311557|580225097|FG000|Overall Study|Withdrawal by Subject|1|||
160685131|NCT01311557|580225098|FG001|Overall Study|Withdrawal by Subject|2|||
160685132|NCT00608517|580225099|FG000|Overall Study|Death|1|||
160685133|NCT00608517|580225100|FG001|Overall Study|Death|0|||
160685134|NCT00608517|580225101|FG002|Overall Study|Death|0|||
160685135|NCT00572039|580225102|FG000|Overall Study|Withdrawal by Subject|9|||
160685136|NCT00572039|580225103|FG001|Overall Study|Withdrawal by Subject|6|||
160685137|NCT00572039|580225102|FG000|Overall Study|Death|2|||
160685138|NCT00572039|580225103|FG001|Overall Study|Death|3|||
160685139|NCT00572039|580225102|FG000|Overall Study|Ill|5|||
160685140|NCT00572039|580225103|FG001|Overall Study|Ill|1|||
160685141|NCT01470417|580225106|FG000|Overall Study|Disease progression|0|||
160685142|NCT01470417|580225107|FG001|Overall Study|Disease progression|2|||
160685143|NCT02973321|580225108|FG000|Overall Study|Other than specified|0|||
160685144|NCT02973321|580225109|FG001|Overall Study|Other than specified|5|||
160685145|NCT02973321|580225110|FG002|Overall Study|Other than specified|3|||
160685146|NCT02973321|580225111|FG003|Overall Study|Other than specified|3|||
160685147|NCT02973321|580225112|FG004|Overall Study|Other than specified|1|||
160685148|NCT02973321|580225108|FG000|Overall Study|Lack of Efficacy|0|||
160685149|NCT02973321|580225109|FG001|Overall Study|Lack of Efficacy|0|||
160685150|NCT02973321|580225110|FG002|Overall Study|Lack of Efficacy|0|||
160685151|NCT02973321|580225111|FG003|Overall Study|Lack of Efficacy|0|||
160685152|NCT02973321|580225112|FG004|Overall Study|Lack of Efficacy|1|||
160685153|NCT02973321|580225108|FG000|Overall Study|Adverse Event|1|||
160685154|NCT02973321|580225109|FG001|Overall Study|Adverse Event|10|||
160685155|NCT02973321|580225110|FG002|Overall Study|Adverse Event|11|||
160685156|NCT02973321|580225111|FG003|Overall Study|Adverse Event|13|||
160685157|NCT02973321|580225112|FG004|Overall Study|Adverse Event|3|||
160685158|NCT01355302|580225116|FG000|Phase 1b|Death|4|||
160685159|NCT01355302|580225117|FG001|Phase 1b|Death|0|||
160685160|NCT01355302|580225118|FG002|Phase 1b|Death|0|||
160685161|NCT01355302|580225116|FG000|Phase 1b|Study terminated by sponsor|2|||
160685162|NCT01355302|580225117|FG001|Phase 1b|Study terminated by sponsor|0|||
160685163|NCT01355302|580225118|FG002|Phase 1b|Study terminated by sponsor|0|||
160685164|NCT00263887|580225119|FG000|Overall Study|Withdrawal by Subject|1|||
160685165|NCT00263887|580225120|FG001|Overall Study|Withdrawal by Subject|1|||
160685166|NCT00263887|580225119|FG000|Overall Study|Lung transplantation|1|||
160685167|NCT00263887|580225120|FG001|Overall Study|Lung transplantation|2|||
160685168|NCT00263887|580225119|FG000|Overall Study|Too ill to attend visit|1|||
160685169|NCT00263887|580225120|FG001|Overall Study|Too ill to attend visit|0|||
160685170|NCT00263887|580225119|FG000|Overall Study|Adverse Event|0|||
160685171|NCT00263887|580225120|FG001|Overall Study|Adverse Event|2|||
160685172|NCT00263887|580225119|FG000|Overall Study|Disease progression|0|||
160685173|NCT00263887|580225120|FG001|Overall Study|Disease progression|1|||
160685174|NCT00263887|580225119|FG000|Overall Study|Lack of Efficacy|0|||
160685175|NCT00263887|580225120|FG001|Overall Study|Lack of Efficacy|1|||
160685176|NCT02274948|580225123|FG000|Overall Study|Lost to Follow-up|28|||
160685177|NCT02274948|580225124|FG001|Overall Study|Lost to Follow-up|25|||
160685178|NCT02274948|580225123|FG000|Overall Study|Withdrawal by Subject|64|||
160685179|NCT02274948|580225124|FG001|Overall Study|Withdrawal by Subject|58|||
160685180|NCT02274948|580225123|FG000|Overall Study|Stopped on family Practitioner advice|2|||
160685181|NCT02274948|580225124|FG001|Overall Study|Stopped on family Practitioner advice|5|||
160685182|NCT02274948|580225123|FG000|Overall Study|Left the area|4|||
160685183|NCT02274948|580225124|FG001|Overall Study|Left the area|3|||
160685184|NCT00707434|580225125|FG000|Overall Study|Adverse Event|1|||
160685185|NCT00614822|580225126|FG000|Overall Study|Adverse Event|3|||
160685186|NCT00865514|580225132|FG000|Overall Study|Infusion cost exceeded funding|2|||
160685187|NCT03649412|580225133|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
160685188|NCT03649412|580225134|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
160685189|NCT03649412|580225133|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
160685190|NCT03649412|580225134|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
160685191|NCT03649412|580225133|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
160685192|NCT03649412|580225134|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
160685193|NCT03649412|580225133|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
160685194|NCT03649412|580225134|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
160685195|NCT03649412|580225133|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
160685196|NCT03649412|580225134|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
160685197|NCT03649412|580225133|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
160685198|NCT03649412|580225134|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
160685199|NCT00530348|580225135|FG000|Overall Study|Adverse Event|5|||
160685200|NCT00530348|580225136|FG001|Overall Study|Adverse Event|1|||
160685201|NCT00530348|580225135|FG000|Overall Study|Death|0|||
160685202|NCT00530348|580225136|FG001|Overall Study|Death|1|||
160685203|NCT00530348|580225135|FG000|Overall Study|Lack of Efficacy|2|||
160685204|NCT00530348|580225136|FG001|Overall Study|Lack of Efficacy|0|||
160685205|NCT00530348|580225135|FG000|Overall Study|Lost to Follow-up|0|||
160685206|NCT00530348|580225136|FG001|Overall Study|Lost to Follow-up|2|||
160685207|NCT00530348|580225135|FG000|Overall Study|Physician Decision|1|||
160685208|NCT00530348|580225136|FG001|Overall Study|Physician Decision|2|||
160685209|NCT00530348|580225135|FG000|Overall Study|Pregnancy|1|||
160685210|NCT00530348|580225136|FG001|Overall Study|Pregnancy|0|||
160685211|NCT00530348|580225135|FG000|Overall Study|Withdrawal by Subject|12|||
160685212|NCT00530348|580225136|FG001|Overall Study|Withdrawal by Subject|12|||
160685213|NCT00530348|580225135|FG000|Overall Study|Randomised in error|1|||
160685214|NCT00530348|580225136|FG001|Overall Study|Randomised in error|0|||
160685215|NCT00530348|580225135|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
160685216|NCT00530348|580225136|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
160685217|NCT04364763|580225137|FG000|Overall Study|Death|1|||
160685218|NCT04364763|580225138|FG001|Overall Study|Death|2|||
160685219|NCT04364763|580225137|FG000|Overall Study|Lost to Follow-up|1|||
160685220|NCT04364763|580225138|FG001|Overall Study|Lost to Follow-up|0|||
160685221|NCT01256060|580225140|FG000|Overall Study|Lost to Follow-up|0|||
160685222|NCT01256060|580225141|FG001|Overall Study|Lost to Follow-up|1|||
160685223|NCT01256060|580225142|FG002|Overall Study|Lost to Follow-up|0|||
160685224|NCT01256060|580225143|FG003|Overall Study|Lost to Follow-up|0|||
160685225|NCT00985231|580225146|FG000|Overall Study|ineligible|1|||
160685226|NCT00985231|580225147|FG001|Overall Study|ineligible|0|||
160685227|NCT00985231|580225146|FG000|Overall Study|Protocol Violation|1|||
160685228|NCT00985231|580225147|FG001|Overall Study|Protocol Violation|0|||
160685229|NCT00985231|580225146|FG000|Overall Study|Withdrawal by Subject|1|||
160685230|NCT00985231|580225147|FG001|Overall Study|Withdrawal by Subject|0|||
160685231|NCT00985231|580225146|FG000|Overall Study|Lost to Follow-up|0|||
160685232|NCT00985231|580225147|FG001|Overall Study|Lost to Follow-up|1|||
160685233|NCT00985231|580225146|FG000|Overall Study|Study related symptoms & complaints|0|||
160685234|NCT00985231|580225147|FG001|Overall Study|Study related symptoms & complaints|2|||
160685235|NCT00089076|580225148|FG000|Overall Study|Alternate Therapy|1|||
160685236|NCT00089076|580225148|FG000|Overall Study|Withdrawal by Subject|2|||
160685237|NCT00089076|580225148|FG000|Overall Study|Progression|7|||
160685238|NCT00931463|580225149|FG000|Overall Study|Death|8|||
160685239|NCT00931463|580225150|FG001|Overall Study|Death|4|||
160685240|NCT00931463|580225149|FG000|Overall Study|Withdrawal by Subject|5|||
160685241|NCT00931463|580225150|FG001|Overall Study|Withdrawal by Subject|0|||
160685242|NCT00931463|580225149|FG000|Overall Study|Lost to Follow-up|4|||
160685243|NCT00931463|580225150|FG001|Overall Study|Lost to Follow-up|1|||
160685244|NCT00808509|580225151|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
160685245|NCT00808509|580225152|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
160685246|NCT00808509|580225151|FG000|Randomized Phase|Reduced methotrexate dose|1|||
160685247|NCT00808509|580225152|FG001|Randomized Phase|Reduced methotrexate dose|2|||
160685248|NCT00808509|580225151|FG000|Randomized Phase|Patient refused rescue therapy|0|||
160685249|NCT00808509|580225152|FG001|Randomized Phase|Patient refused rescue therapy|3|||
160685250|NCT00436917|580225153|FG000|Overall Study|Withdrawal by Subject|13|||
160685251|NCT00436917|580225153|FG000|Overall Study|Adverse Event|2|||
160685252|NCT00436917|580225153|FG000|Overall Study|Physician Decision|1|||
160685253|NCT00436917|580225153|FG000|Overall Study|Death|1|||
160685254|NCT00436917|580225153|FG000|Overall Study|Lost to Follow-up|1|||
160685255|NCT00436917|580225153|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
160685256|NCT00436917|580225153|FG000|Overall Study|Increased creatinine|1|||
160685257|NCT00436917|580225153|FG000|Overall Study|Personal conflicts of patient|1|||
160685258|NCT02169791|580225156|FG000|Overall Study|Death|6|||
160685259|NCT02169791|580225156|FG000|Overall Study|patient withdrew consent|1|||
160685260|NCT03170869|580225157|FG000|Overall Study|Protocol Violation|5|||
160685261|NCT03170869|580225157|FG000|Overall Study|Early study termination|3|||
160685262|NCT01009515|580225162|FG000|Overall Study|Withdrawal by Subject|3|||
160685263|NCT01501110|580225164|FG000|Overall Study|Death|0|||
160685264|NCT01501110|580225165|FG001|Overall Study|Death|1|||
160685265|NCT02075606|580225166|FG000|Overall Study|Adverse Event|5|||
160685266|NCT02075606|580225166|FG000|Overall Study|Withdrawal by Subject|1|||
160685267|NCT02075606|580225166|FG000|Overall Study|Death|1|||
160685268|NCT02075606|580225166|FG000|Overall Study|Investigator's decision|1|||
160685269|NCT02075606|580225166|FG000|Overall Study|Symptom management|1|||
160685270|NCT02075606|580225166|FG000|Overall Study|Increasing Symptoms|1|||
160685271|NCT00983476|580225170|FG000|Overall Study|Did not receive intervention|17|||
160685272|NCT00983476|580225171|FG001|Overall Study|Did not receive intervention|22|||
160685273|NCT00983476|580225172|FG002|Overall Study|Did not receive intervention|0|||
160685274|NCT01439724|580225174|FG000|Overall Study|missing consultation|9|||
160685275|NCT01439724|580225175|FG001|Overall Study|missing consultation|8|||
160685276|NCT00575380|580225180|FG000|Overall Study|Withdrawal by Subject|1|||
160685277|NCT00575380|580225181|FG001|Overall Study|Withdrawal by Subject|0|||
160685278|NCT00575380|580225180|FG000|Overall Study|Adverse Event|0|||
160685279|NCT00575380|580225181|FG001|Overall Study|Adverse Event|1|||
160685280|NCT00575380|580225180|FG000|Overall Study|Various|0|||
160685281|NCT00575380|580225181|FG001|Overall Study|Various|2|||
160685282|NCT02412722|580225182|FG000|Overall Study|Adverse Event|0|||
160685283|NCT02412722|580225183|FG001|Overall Study|Adverse Event|2|||
160685284|NCT02412722|580225184|FG002|Overall Study|Adverse Event|0|||
160685285|NCT02412722|580225185|FG003|Overall Study|Adverse Event|3|||
160685286|NCT02412722|580225186|FG004|Overall Study|Adverse Event|0|||
160685287|NCT02412722|580225187|FG005|Overall Study|Adverse Event|3|||
160685288|NCT02412722|580225182|FG000|Overall Study|Progressive Disease|6|||
160685289|NCT02412722|580225183|FG001|Overall Study|Progressive Disease|4|||
160685290|NCT02412722|580225184|FG002|Overall Study|Progressive Disease|4|||
160685291|NCT02412722|580225185|FG003|Overall Study|Progressive Disease|9|||
160685292|NCT02412722|580225186|FG004|Overall Study|Progressive Disease|3|||
160685293|NCT02412722|580225187|FG005|Overall Study|Progressive Disease|3|||
160685294|NCT02412722|580225182|FG000|Overall Study|Withdrawal by Subject|2|||
160685295|NCT02412722|580225183|FG001|Overall Study|Withdrawal by Subject|0|||
160685296|NCT02412722|580225184|FG002|Overall Study|Withdrawal by Subject|1|||
160685297|NCT02412722|580225185|FG003|Overall Study|Withdrawal by Subject|2|||
160685298|NCT02412722|580225186|FG004|Overall Study|Withdrawal by Subject|1|||
160685299|NCT02412722|580225187|FG005|Overall Study|Withdrawal by Subject|1|||
160685300|NCT02412722|580225182|FG000|Overall Study|Lost to Follow-up|0|||
160685301|NCT02412722|580225183|FG001|Overall Study|Lost to Follow-up|0|||
160685302|NCT02412722|580225184|FG002|Overall Study|Lost to Follow-up|0|||
160685303|NCT02412722|580225185|FG003|Overall Study|Lost to Follow-up|0|||
160685304|NCT02412722|580225186|FG004|Overall Study|Lost to Follow-up|1|||
160685305|NCT02412722|580225187|FG005|Overall Study|Lost to Follow-up|0|||
160685306|NCT02412722|580225182|FG000|Overall Study|Received drug in run-in and discontinued|0|||
160685307|NCT02412722|580225183|FG001|Overall Study|Received drug in run-in and discontinued|2|||
160685308|NCT02412722|580225184|FG002|Overall Study|Received drug in run-in and discontinued|0|||
160685309|NCT02412722|580225185|FG003|Overall Study|Received drug in run-in and discontinued|0|||
160685310|NCT02412722|580225186|FG004|Overall Study|Received drug in run-in and discontinued|0|||
160685311|NCT02412722|580225187|FG005|Overall Study|Received drug in run-in and discontinued|0|||
160685312|NCT02412722|580225182|FG000|Overall Study|Reason not Specified|3|||
160685313|NCT02412722|580225183|FG001|Overall Study|Reason not Specified|0|||
160685314|NCT02412722|580225184|FG002|Overall Study|Reason not Specified|2|||
160685315|NCT02412722|580225185|FG003|Overall Study|Reason not Specified|1|||
160685316|NCT02412722|580225186|FG004|Overall Study|Reason not Specified|2|||
160685317|NCT02412722|580225187|FG005|Overall Study|Reason not Specified|6|||
160685318|NCT00442546|580225188|FG000|Overall Study|Adverse Event|11|||
160685319|NCT00442546|580225189|FG001|Overall Study|Adverse Event|17|||
160685320|NCT00442546|580225190|FG002|Overall Study|Adverse Event|13|||
160685321|NCT00442546|580225188|FG000|Overall Study|Lost to Follow-up|1|||
160685322|NCT00442546|580225189|FG001|Overall Study|Lost to Follow-up|2|||
160685323|NCT00442546|580225190|FG002|Overall Study|Lost to Follow-up|1|||
160685324|NCT00442546|580225188|FG000|Overall Study|Other|4|||
160685325|NCT00442546|580225189|FG001|Overall Study|Other|9|||
160685326|NCT00442546|580225190|FG002|Overall Study|Other|6|||
160685327|NCT00442546|580225188|FG000|Overall Study|Withdrawal by Subject|5|||
160685328|NCT00442546|580225189|FG001|Overall Study|Withdrawal by Subject|5|||
160685329|NCT00442546|580225190|FG002|Overall Study|Withdrawal by Subject|7|||
160685330|NCT00442546|580225188|FG000|Overall Study|Randomized But Not Treated|5|||
160685331|NCT00442546|580225189|FG001|Overall Study|Randomized But Not Treated|4|||
160685332|NCT00442546|580225190|FG002|Overall Study|Randomized But Not Treated|6|||
160685333|NCT01557582|580225192|FG000|Overall Study|Protocol Violation|4|||
160685334|NCT01557582|580225192|FG000|Overall Study|Operator error|2|||
160685335|NCT01546142|580227621|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
160685336|NCT01546142|580227622|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
160685337|NCT01546142|580227621|FG000|Overall Study|Subject Noncompliance|1|||
160685338|NCT01546142|580227622|FG001|Overall Study|Subject Noncompliance|1|||
160685339|NCT01546142|580227621|FG000|Overall Study|Adverse Event|6|||
160685340|NCT01546142|580227622|FG001|Overall Study|Adverse Event|3|||
160685341|NCT01546142|580227621|FG000|Overall Study|Lost to Follow-up|20|||
160685342|NCT01546142|580227622|FG001|Overall Study|Lost to Follow-up|15|||
160685343|NCT01546142|580227621|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
160685344|NCT01546142|580227622|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
160685345|NCT01546142|580227621|FG000|Overall Study|Subject Randomized but Not Treated|1|||
160685346|NCT01546142|580227622|FG001|Overall Study|Subject Randomized but Not Treated|0|||
160685347|NCT01213836|580227623|FG000|Period 1, First Intervention|Adverse Event|2|||
160685348|NCT01213836|580227624|FG001|Period 1, First Intervention|Adverse Event|1|||
160685349|NCT01213836|580227623|FG000|Period 1, First Intervention|Protocol Violation|0|||
160685350|NCT01213836|580227624|FG001|Period 1, First Intervention|Protocol Violation|1|||
160685351|NCT01213836|580227623|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
160685352|NCT01213836|580227624|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
160685353|NCT00706095|580227625|FG000|Overall Study|Progressive Disease|4|||
160685354|NCT00706095|580227626|FG001|Overall Study|Progressive Disease|5|||
160685355|NCT00706095|580227627|FG002|Overall Study|Progressive Disease|3|||
160685356|NCT00706095|580227625|FG000|Overall Study|Clinical Progression|1|||
160685357|NCT00706095|580227626|FG001|Overall Study|Clinical Progression|2|||
160685358|NCT00706095|580227627|FG002|Overall Study|Clinical Progression|2|||
160685359|NCT00706095|580227625|FG000|Overall Study|Withdrawal by Subject|1|||
160685360|NCT00706095|580227626|FG001|Overall Study|Withdrawal by Subject|0|||
160685361|NCT00706095|580227627|FG002|Overall Study|Withdrawal by Subject|0|||
160685362|NCT01011556|580227633|FG000|Overall Study|Adverse Event|1|||
160685363|NCT01011556|580227634|FG001|Overall Study|Adverse Event|3|||
160685364|NCT01011556|580227635|FG002|Overall Study|Adverse Event|2|||
160685365|NCT01011556|580227636|FG003|Overall Study|Adverse Event|1|||
160685366|NCT01011556|580227633|FG000|Overall Study|Lost to Follow-up|1|||
160685367|NCT01011556|580227634|FG001|Overall Study|Lost to Follow-up|0|||
160685368|NCT01011556|580227635|FG002|Overall Study|Lost to Follow-up|0|||
160685369|NCT01011556|580227636|FG003|Overall Study|Lost to Follow-up|0|||
160685370|NCT01011556|580227633|FG000|Overall Study|Physician Decision|1|||
160685371|NCT01011556|580227634|FG001|Overall Study|Physician Decision|0|||
160685372|NCT01011556|580227635|FG002|Overall Study|Physician Decision|0|||
160685373|NCT01011556|580227636|FG003|Overall Study|Physician Decision|1|||
160685374|NCT01011556|580227633|FG000|Overall Study|Protocol Violation|0|||
160685375|NCT01011556|580227634|FG001|Overall Study|Protocol Violation|1|||
160685376|NCT01011556|580227635|FG002|Overall Study|Protocol Violation|0|||
160685377|NCT01011556|580227636|FG003|Overall Study|Protocol Violation|0|||
160685378|NCT01011556|580227633|FG000|Overall Study|Withdrawal by Subject|1|||
160685379|NCT01011556|580227634|FG001|Overall Study|Withdrawal by Subject|2|||
160685380|NCT01011556|580227635|FG002|Overall Study|Withdrawal by Subject|4|||
160685381|NCT01011556|580227636|FG003|Overall Study|Withdrawal by Subject|4|||
160685382|NCT01011556|580227633|FG000|Overall Study|Sponsor decision|0|||
160685383|NCT01011556|580227634|FG001|Overall Study|Sponsor decision|1|||
160685384|NCT01011556|580227635|FG002|Overall Study|Sponsor decision|1|||
160685385|NCT01011556|580227636|FG003|Overall Study|Sponsor decision|2|||
160685386|NCT01011556|580227633|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
160685387|NCT01011556|580227634|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
160685388|NCT01011556|580227635|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
160685389|NCT01011556|580227636|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
160685390|NCT05212883|580227637|FG000|Overall Study|Invalid test result|125|||
160685391|NCT02502734|580227638|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
160685392|NCT02502734|580227639|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
160685393|NCT02502734|580227638|FG000|Washout Period|Adverse Event|1|||
160685394|NCT02502734|580227639|FG001|Washout Period|Adverse Event|0|||
160685395|NCT03095118|580227643|FG000|Overall Study|Adverse Event|1|||
160685396|NCT03095118|580227643|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
160685397|NCT02865395|580227644|FG000|Overall Study|Physician Decision|6|||
160685398|NCT02865395|580227645|FG001|Overall Study|Physician Decision|10|||
160685399|NCT02865395|580227646|FG002|Overall Study|Physician Decision|7|||
160685400|NCT03920280|580227647|FG000|Overall Study|Adverse Event|2|||
160685401|NCT03920280|580227648|FG001|Overall Study|Adverse Event|3|||
160685402|NCT03920280|580227647|FG000|Overall Study|Lost to Follow-up|0|||
160685403|NCT03920280|580227648|FG001|Overall Study|Lost to Follow-up|1|||
160685404|NCT03920280|580227647|FG000|Overall Study|Withdrawal by Subject|1|||
160685405|NCT03920280|580227648|FG001|Overall Study|Withdrawal by Subject|1|||
160685406|NCT03920280|580227647|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
160685407|NCT03920280|580227648|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
160685408|NCT04019054|580227655|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
160685409|NCT04019054|580227656|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
160685410|NCT04019054|580227655|FG000|Overall Study|Withdrawal by Subject|3|||
160685411|NCT04019054|580227656|FG001|Overall Study|Withdrawal by Subject|1|||
160685412|NCT01040793|580227657|FG000|Overall Study|Adverse Event|5|||
160685413|NCT01040793|580227658|FG001|Overall Study|Adverse Event|3|||
160685414|NCT01040793|580227659|FG002|Overall Study|Adverse Event|0|||
160685415|NCT01040793|580227660|FG003|Overall Study|Adverse Event|2|||
160685416|NCT01040793|580227661|FG004|Overall Study|Adverse Event|2|||
160685417|NCT01040793|580227662|FG005|Overall Study|Adverse Event|1|||
160685418|NCT01040793|580227657|FG000|Overall Study|Protocol Violation|1|||
160685419|NCT01040793|580227658|FG001|Overall Study|Protocol Violation|1|||
160685420|NCT01040793|580227659|FG002|Overall Study|Protocol Violation|1|||
160685421|NCT01040793|580227660|FG003|Overall Study|Protocol Violation|0|||
160685422|NCT01040793|580227661|FG004|Overall Study|Protocol Violation|1|||
160685423|NCT01040793|580227662|FG005|Overall Study|Protocol Violation|0|||
160685424|NCT01040793|580227657|FG000|Overall Study|Lost to Follow-up|0|||
160685425|NCT01040793|580227658|FG001|Overall Study|Lost to Follow-up|1|||
160685426|NCT01040793|580227659|FG002|Overall Study|Lost to Follow-up|1|||
160685427|NCT01040793|580227660|FG003|Overall Study|Lost to Follow-up|0|||
160685428|NCT01040793|580227661|FG004|Overall Study|Lost to Follow-up|0|||
160685429|NCT01040793|580227662|FG005|Overall Study|Lost to Follow-up|0|||
160685430|NCT01040793|580227657|FG000|Overall Study|Withdrawal by Subject|0|||
160685431|NCT01040793|580227658|FG001|Overall Study|Withdrawal by Subject|0|||
160685432|NCT01040793|580227659|FG002|Overall Study|Withdrawal by Subject|0|||
160685433|NCT01040793|580227660|FG003|Overall Study|Withdrawal by Subject|2|||
160685434|NCT01040793|580227661|FG004|Overall Study|Withdrawal by Subject|0|||
160685435|NCT01040793|580227662|FG005|Overall Study|Withdrawal by Subject|0|||
160685436|NCT01040793|580227657|FG000|Overall Study|Other reasons not listed above|0|||
160685437|NCT01040793|580227658|FG001|Overall Study|Other reasons not listed above|0|||
160685438|NCT01040793|580227659|FG002|Overall Study|Other reasons not listed above|1|||
160685439|NCT01040793|580227660|FG003|Overall Study|Other reasons not listed above|0|||
160685440|NCT01040793|580227661|FG004|Overall Study|Other reasons not listed above|1|||
160685441|NCT01040793|580227662|FG005|Overall Study|Other reasons not listed above|0|||
160685442|NCT04449341|580227667|FG000|Overall Study|Protocol Violation|1|||
160685443|NCT04449341|580227668|FG001|Overall Study|Protocol Violation|0|||
160685444|NCT04499482|580227669|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
160685445|NCT01020526|580227670|FG000|Overall Study|Withdrawal by Subject|5|||
160685446|NCT01020526|580227670|FG000|Overall Study|Other reasons|3|||
160685447|NCT01020526|580227670|FG000|Overall Study|Insufficient clinical response|3|||
160685448|NCT01020526|580227670|FG000|Overall Study|Lost to Follow-up|1|||
160685449|NCT01020526|580227670|FG000|Overall Study|Adverse Event|2|||
160685450|NCT01083680|580227677|FG000|Overall Study|Lost to Follow-up|2758|||
160685451|NCT01083680|580227677|FG000|Overall Study|Withdrawal by Subject|1086|||
160685452|NCT03877926|580227678|FG000|Overall Study|Adverse Event|1|||
160685453|NCT03877926|580227679|FG001|Overall Study|Adverse Event|0|||
160685454|NCT03877926|580227680|FG002|Overall Study|Adverse Event|0|||
160685455|NCT03877926|580227681|FG003|Overall Study|Adverse Event|0|||
160685456|NCT03877926|580227678|FG000|Overall Study|Death|2|||
160685457|NCT03877926|580227679|FG001|Overall Study|Death|2|||
160685458|NCT03877926|580227680|FG002|Overall Study|Death|2|||
160685459|NCT03877926|580227681|FG003|Overall Study|Death|0|||
160685460|NCT03877926|580227678|FG000|Overall Study|Lost to Follow-up|41|||
160685461|NCT03877926|580227679|FG001|Overall Study|Lost to Follow-up|52|||
160685462|NCT03877926|580227680|FG002|Overall Study|Lost to Follow-up|45|||
160685463|NCT03877926|580227681|FG003|Overall Study|Lost to Follow-up|17|||
160685464|NCT03877926|580227678|FG000|Overall Study|Physician Decision|2|||
160685465|NCT03877926|580227679|FG001|Overall Study|Physician Decision|0|||
160685466|NCT03877926|580227680|FG002|Overall Study|Physician Decision|2|||
160685467|NCT03877926|580227681|FG003|Overall Study|Physician Decision|0|||
160685468|NCT03877926|580227678|FG000|Overall Study|Withdrawal by Subject|18|||
160685469|NCT03877926|580227679|FG001|Overall Study|Withdrawal by Subject|21|||
160685470|NCT03877926|580227680|FG002|Overall Study|Withdrawal by Subject|12|||
160685471|NCT03877926|580227681|FG003|Overall Study|Withdrawal by Subject|4|||
160685472|NCT03877926|580227678|FG000|Overall Study|Other - Various|4|||
160685473|NCT03877926|580227679|FG001|Overall Study|Other - Various|1|||
160685474|NCT03877926|580227680|FG002|Overall Study|Other - Various|1|||
160685475|NCT03877926|580227681|FG003|Overall Study|Other - Various|0|||
160685476|NCT03877926|580227678|FG000|Overall Study|Not Treated|3|||
160685477|NCT03877926|580227679|FG001|Overall Study|Not Treated|1|||
160685478|NCT03877926|580227680|FG002|Overall Study|Not Treated|1|||
160685479|NCT03877926|580227681|FG003|Overall Study|Not Treated|0|||
160685480|NCT03546647|580227682|FG000|Overall Study|Adverse Event|1|||
160685481|NCT03546647|580227683|FG001|Overall Study|Adverse Event|0|||
160685482|NCT00124462|580227684|FG000|Overall Study|Lost to Follow-up|3|||
160685483|NCT00124462|580227685|FG001|Overall Study|Lost to Follow-up|3|||
160685484|NCT00124462|580227684|FG000|Overall Study|Physician Decision|3|||
160685485|NCT00124462|580227685|FG001|Overall Study|Physician Decision|4|||
160685486|NCT00124462|580227684|FG000|Overall Study|Withdrawal by Subject|4|||
160685487|NCT00124462|580227685|FG001|Overall Study|Withdrawal by Subject|5|||
160685488|NCT00124462|580227684|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
160685489|NCT00124462|580227685|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
160685490|NCT02400476|580227686|FG000|Overall Study|Adverse Event|57|||
160685491|NCT02400476|580227687|FG001|Overall Study|Adverse Event|10|||
160685492|NCT02400476|580227688|FG002|Overall Study|Adverse Event|22|||
160685493|NCT02400476|580227689|FG003|Overall Study|Adverse Event|19|||
160685494|NCT02400476|580227690|FG004|Overall Study|Adverse Event|5|||
160685495|NCT02400476|580227691|FG005|Overall Study|Adverse Event|8|||
160685496|NCT02400476|580227686|FG000|Overall Study|Withdrawal by Subject|4|||
160685497|NCT02400476|580227687|FG001|Overall Study|Withdrawal by Subject|1|||
160685498|NCT02400476|580227688|FG002|Overall Study|Withdrawal by Subject|12|||
160685499|NCT02400476|580227689|FG003|Overall Study|Withdrawal by Subject|7|||
160685500|NCT02400476|580227690|FG004|Overall Study|Withdrawal by Subject|5|||
160685501|NCT02400476|580227691|FG005|Overall Study|Withdrawal by Subject|5|||
160685502|NCT02400476|580227686|FG000|Overall Study|Lost to Follow-up|0|||
160685503|NCT02400476|580227687|FG001|Overall Study|Lost to Follow-up|0|||
160685504|NCT02400476|580227688|FG002|Overall Study|Lost to Follow-up|0|||
160685505|NCT02400476|580227689|FG003|Overall Study|Lost to Follow-up|1|||
160685506|NCT02400476|580227690|FG004|Overall Study|Lost to Follow-up|3|||
160685507|NCT02400476|580227691|FG005|Overall Study|Lost to Follow-up|1|||
160685508|NCT02400476|580227686|FG000|Overall Study|Physician Decision|0|||
160685509|NCT02400476|580227687|FG001|Overall Study|Physician Decision|0|||
160685510|NCT02400476|580227688|FG002|Overall Study|Physician Decision|1|||
160685511|NCT02400476|580227689|FG003|Overall Study|Physician Decision|1|||
160685512|NCT02400476|580227690|FG004|Overall Study|Physician Decision|0|||
160685513|NCT02400476|580227691|FG005|Overall Study|Physician Decision|1|||
160685514|NCT02400476|580227686|FG000|Overall Study|Other, Disease Progression|0|||
160685515|NCT02400476|580227687|FG001|Overall Study|Other, Disease Progression|1|||
160685516|NCT02400476|580227688|FG002|Overall Study|Other, Disease Progression|2|||
160685517|NCT02400476|580227689|FG003|Overall Study|Other, Disease Progression|1|||
160685518|NCT02400476|580227690|FG004|Overall Study|Other, Disease Progression|2|||
160685519|NCT02400476|580227691|FG005|Overall Study|Other, Disease Progression|1|||
160685520|NCT02400476|580227686|FG000|Overall Study|Other, Decreased Quality of Life|0|||
160685521|NCT02400476|580227687|FG001|Overall Study|Other, Decreased Quality of Life|0|||
160685522|NCT02400476|580227688|FG002|Overall Study|Other, Decreased Quality of Life|2|||
160685523|NCT02400476|580227689|FG003|Overall Study|Other, Decreased Quality of Life|0|||
160685524|NCT02400476|580227690|FG004|Overall Study|Other, Decreased Quality of Life|0|||
160685525|NCT02400476|580227691|FG005|Overall Study|Other, Decreased Quality of Life|0|||
160685526|NCT02400476|580227686|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
160685527|NCT02400476|580227687|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
160685528|NCT02400476|580227688|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
160685529|NCT02400476|580227689|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
160685530|NCT02400476|580227690|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
160685531|NCT02400476|580227691|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
160685532|NCT02487082|580227692|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
160685533|NCT02487082|580227693|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
160685534|NCT02487082|580227692|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
160685535|NCT02487082|580227693|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
160685536|NCT00003531|580227694|FG000|Overall Study|Not evaluable|10|||
160685537|NCT00588731|580227695|FG000|Overall Study|Withdrawal by Subject|3|||
160685538|NCT00588731|580227696|FG001|Overall Study|Withdrawal by Subject|2|||
160685539|NCT00346164|580227697|FG000|Overall Study|Adverse Event|0|||
160685540|NCT00346164|580227698|FG001|Overall Study|Adverse Event|0|||
160685541|NCT00346164|580227699|FG002|Overall Study|Adverse Event|0|||
160685542|NCT00346164|580227700|FG003|Overall Study|Adverse Event|1|||
160685543|NCT00346164|580227697|FG000|Overall Study|Lack of Efficacy|0|||
160685544|NCT00346164|580227698|FG001|Overall Study|Lack of Efficacy|1|||
160685545|NCT00346164|580227699|FG002|Overall Study|Lack of Efficacy|7|||
160685546|NCT00346164|580227700|FG003|Overall Study|Lack of Efficacy|25|||
160685547|NCT00346164|580227697|FG000|Overall Study|Physician Decision|0|||
160685548|NCT00346164|580227698|FG001|Overall Study|Physician Decision|1|||
160685549|NCT00346164|580227699|FG002|Overall Study|Physician Decision|2|||
160685550|NCT00346164|580227700|FG003|Overall Study|Physician Decision|27|||
160685551|NCT00346164|580227697|FG000|Overall Study|Protocol Violation|6|||
160685552|NCT00346164|580227698|FG001|Overall Study|Protocol Violation|2|||
160685553|NCT00346164|580227699|FG002|Overall Study|Protocol Violation|10|||
160685554|NCT00346164|580227700|FG003|Overall Study|Protocol Violation|4|||
160685555|NCT00346164|580227697|FG000|Overall Study|Withdrawal by Subject|0|||
160685556|NCT00346164|580227698|FG001|Overall Study|Withdrawal by Subject|0|||
160685557|NCT00346164|580227699|FG002|Overall Study|Withdrawal by Subject|2|||
160685558|NCT00346164|580227700|FG003|Overall Study|Withdrawal by Subject|0|||
160685559|NCT00346164|580227697|FG000|Overall Study|Ineligible|11|||
160685560|NCT00346164|580227698|FG001|Overall Study|Ineligible|2|||
160685561|NCT00346164|580227699|FG002|Overall Study|Ineligible|2|||
160685562|NCT00346164|580227700|FG003|Overall Study|Ineligible|23|||
160685563|NCT00346164|580227697|FG000|Overall Study|Refusal of further protocol therapy|0|||
160685564|NCT00346164|580227698|FG001|Overall Study|Refusal of further protocol therapy|1|||
160685565|NCT00346164|580227699|FG002|Overall Study|Refusal of further protocol therapy|3|||
160685566|NCT00346164|580227700|FG003|Overall Study|Refusal of further protocol therapy|15|||
160685567|NCT00346164|580227697|FG000|Overall Study|Inability to start week 16 tx on time|0|||
160685568|NCT00346164|580227698|FG001|Overall Study|Inability to start week 16 tx on time|0|||
160685569|NCT00346164|580227699|FG002|Overall Study|Inability to start week 16 tx on time|0|||
160685570|NCT00346164|580227700|FG003|Overall Study|Inability to start week 16 tx on time|11|||
160685571|NCT00268892|580227702|FG000|Overall Study|Adverse Event|14|||
160685572|NCT00268892|580227703|FG001|Overall Study|Adverse Event|17|||
160685573|NCT00268892|580227704|FG002|Overall Study|Adverse Event|20|||
160685574|NCT00268892|580227702|FG000|Overall Study|Lack of Efficacy|1|||
160685575|NCT00268892|580227703|FG001|Overall Study|Lack of Efficacy|3|||
160685576|NCT00268892|580227704|FG002|Overall Study|Lack of Efficacy|0|||
160685577|NCT00268892|580227702|FG000|Overall Study|Withdrawal by Subject|14|||
160685578|NCT00268892|580227703|FG001|Overall Study|Withdrawal by Subject|15|||
160685579|NCT00268892|580227704|FG002|Overall Study|Withdrawal by Subject|13|||
160685580|NCT00268892|580227702|FG000|Overall Study|Physician Decision|0|||
160685581|NCT00268892|580227703|FG001|Overall Study|Physician Decision|1|||
160685582|NCT00268892|580227704|FG002|Overall Study|Physician Decision|0|||
160685583|NCT00268892|580227702|FG000|Overall Study|Lost to Follow-up|5|||
160685584|NCT00268892|580227703|FG001|Overall Study|Lost to Follow-up|2|||
160685585|NCT00268892|580227704|FG002|Overall Study|Lost to Follow-up|4|||
160685586|NCT00268892|580227702|FG000|Overall Study|Protocol Violation|0|||
160685587|NCT00268892|580227703|FG001|Overall Study|Protocol Violation|1|||
160685588|NCT00268892|580227704|FG002|Overall Study|Protocol Violation|0|||
160685589|NCT00268892|580227702|FG000|Overall Study|Disease Progression|1|||
160685590|NCT00268892|580227703|FG001|Overall Study|Disease Progression|1|||
160685591|NCT00268892|580227704|FG002|Overall Study|Disease Progression|0|||
160685592|NCT00268892|580227702|FG000|Overall Study|Trial Site Closed|4|||
160685593|NCT00268892|580227703|FG001|Overall Study|Trial Site Closed|2|||
160685594|NCT00268892|580227704|FG002|Overall Study|Trial Site Closed|2|||
160685595|NCT04569786|580227714|FG000|Overall Study|Lost to Follow-up|1|||
160685596|NCT04569786|580227715|FG001|Overall Study|Lost to Follow-up|0|||
160685597|NCT04569786|580227716|FG002|Overall Study|Lost to Follow-up|4|||
160685598|NCT04569786|580227717|FG003|Overall Study|Lost to Follow-up|1|||
160685599|NCT04569786|580227718|FG004|Overall Study|Lost to Follow-up|0|||
160685600|NCT04569786|580227714|FG000|Overall Study|Withdrawal by Subject|0|||
160685601|NCT04569786|580227715|FG001|Overall Study|Withdrawal by Subject|0|||
160685602|NCT04569786|580227716|FG002|Overall Study|Withdrawal by Subject|0|||
160685603|NCT04569786|580227717|FG003|Overall Study|Withdrawal by Subject|5|||
160685604|NCT04569786|580227718|FG004|Overall Study|Withdrawal by Subject|1|||
160685605|NCT04569786|580227714|FG000|Overall Study|Physician Decision|0|||
160685606|NCT04569786|580227715|FG001|Overall Study|Physician Decision|0|||
160685607|NCT04569786|580227716|FG002|Overall Study|Physician Decision|0|||
160685608|NCT04569786|580227717|FG003|Overall Study|Physician Decision|1|||
160685609|NCT04569786|580227718|FG004|Overall Study|Physician Decision|0|||
160685610|NCT01640184|580227721|FG000|Overall Study|Death|1|||
160685611|NCT01640184|580227722|FG001|Overall Study|Death|0|||
160685612|NCT01640184|580227723|FG002|Overall Study|Death|0|||
160685613|NCT01640184|580227721|FG000|Overall Study|Lost to Follow-up|4|||
160685614|NCT01640184|580227722|FG001|Overall Study|Lost to Follow-up|1|||
160685615|NCT01640184|580227723|FG002|Overall Study|Lost to Follow-up|0|||
160685616|NCT01640184|580227721|FG000|Overall Study|Physician Decision|3|||
160685617|NCT01640184|580227722|FG001|Overall Study|Physician Decision|0|||
160685618|NCT01640184|580227723|FG002|Overall Study|Physician Decision|0|||
160685619|NCT01640184|580227721|FG000|Overall Study|Withdrawal by Subject|0|||
160685620|NCT01640184|580227722|FG001|Overall Study|Withdrawal by Subject|1|||
160685621|NCT01640184|580227723|FG002|Overall Study|Withdrawal by Subject|1|||
160685622|NCT01640184|580227721|FG000|Overall Study|Protocol Violation|0|||
160685623|NCT01640184|580227722|FG001|Overall Study|Protocol Violation|0|||
160685624|NCT01640184|580227723|FG002|Overall Study|Protocol Violation|1|||
160685625|NCT01684878|580227724|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
160685626|NCT01684878|580227725|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
160685627|NCT01684878|580227726|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
160685628|NCT01684878|580227727|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
160685629|NCT01684878|580227724|FG000|Part 1: Safety Run in Phase|Death|15|||
160685630|NCT01684878|580227725|FG001|Part 1: Safety Run in Phase|Death|20|||
160685631|NCT01684878|580227726|FG002|Part 1: Safety Run in Phase|Death|0|||
160685632|NCT01684878|580227727|FG003|Part 1: Safety Run in Phase|Death|0|||
160685633|NCT01684878|580227724|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
160685634|NCT01684878|580227725|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
160685635|NCT01684878|580227726|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
160685636|NCT01684878|580227727|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
160685637|NCT01684878|580227724|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
160685638|NCT01684878|580227725|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
160685639|NCT01684878|580227726|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
160685640|NCT01684878|580227727|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
160685641|NCT01684878|580227724|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
160685642|NCT01684878|580227725|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
160685643|NCT01684878|580227726|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
160685644|NCT01684878|580227727|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
160685645|NCT01684878|580227724|FG000|Part 2: Randomized Phase|Death|0|||
160685646|NCT01684878|580227725|FG001|Part 2: Randomized Phase|Death|0|||
160685647|NCT01684878|580227726|FG002|Part 2: Randomized Phase|Death|62|||
160685648|NCT01684878|580227727|FG003|Part 2: Randomized Phase|Death|68|||
160685649|NCT01684878|580227724|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
160685650|NCT01684878|580227725|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
160685651|NCT01684878|580227726|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
160685652|NCT01684878|580227727|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
160685653|NCT01684878|580227724|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
160685654|NCT01684878|580227725|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
160685655|NCT01684878|580227726|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
160685656|NCT01684878|580227727|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
160685657|NCT02087176|580227731|FG000|Overall Study|Withdrawal by Subject|1|||
160685658|NCT02087176|580227731|FG000|Overall Study|Death|10|||
160685659|NCT02087176|580227731|FG000|Overall Study|Censored|19|||
160685660|NCT02087176|580227731|FG000|Overall Study|Study Terminated by Sponsor|2|||
160685661|NCT02927834|580227732|FG000|Overall Study|Lost to Follow-up|1|||
160685662|NCT02927834|580227733|FG001|Overall Study|Lost to Follow-up|2|||
160685663|NCT02927834|580227734|FG002|Overall Study|Lost to Follow-up|2|||
160685664|NCT03812991|580227736|FG000|Overall Study|Lost to Follow-up|3|||
160685665|NCT03812991|580227737|FG001|Overall Study|Lost to Follow-up|1|||
160685666|NCT03942211|580227738|FG000|Overall Study|Death|1|||
160685667|NCT03942211|580227739|FG001|Overall Study|Death|0|||
160685668|NCT03942211|580227738|FG000|Overall Study|Study terminated by sponsor|5|||
160685669|NCT03942211|580227739|FG001|Overall Study|Study terminated by sponsor|3|||
160685670|NCT03942211|580227738|FG000|Overall Study|Adverse Event|0|||
160685671|NCT03942211|580227739|FG001|Overall Study|Adverse Event|1|||
160685672|NCT01955044|580227740|FG000|Overall Study|Death|1|||
160685673|NCT01955044|580227741|FG001|Overall Study|Death|1|||
160685674|NCT01955044|580227742|FG002|Overall Study|Death|0|||
160685675|NCT01148225|580227743|FG000|Overall Study|Other|185|||
160685676|NCT02260258|580227747|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
160685677|NCT02260258|580227748|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
160685678|NCT01644149|580227749|FG000|Overall Study|Withdrawal by Subject|1|||
160685679|NCT01644149|580227750|FG001|Overall Study|Withdrawal by Subject|0|||
160685680|NCT01644149|580227749|FG000|Overall Study|Lost to Follow-up|3|||
160685681|NCT01644149|580227750|FG001|Overall Study|Lost to Follow-up|1|||
160685682|NCT04798482|580227751|FG000|Overall Study|Physician Decision|1|||
160685683|NCT04798482|580227751|FG000|Overall Study|Lost eligibility|1|||
160685684|NCT00690482|580227756|FG000|Overall Study|Adverse Event|2|||
160685685|NCT00690482|580227757|FG001|Overall Study|Adverse Event|1|||
160685686|NCT00690482|580227756|FG000|Overall Study|Incorrect enrolment|0|||
160685687|NCT00690482|580227757|FG001|Overall Study|Incorrect enrolment|1|||
160685688|NCT00690482|580227756|FG000|Overall Study|Study-specific discontinuation criteria|1|||
160685689|NCT00690482|580227757|FG001|Overall Study|Study-specific discontinuation criteria|0|||
160685690|NCT00690482|580227756|FG000|Overall Study|Intake of prohibited medicine|1|||
160685691|NCT00690482|580227757|FG001|Overall Study|Intake of prohibited medicine|0|||
160685692|NCT00690482|580227756|FG000|Overall Study|withdrew consent at rand.day|0|||
160685693|NCT00690482|580227757|FG001|Overall Study|withdrew consent at rand.day|1|||
160685694|NCT00605917|580227758|FG000|Overall Study|Protocol Violation|79|||
160685695|NCT01506908|580227759|FG000|Overall Study|Adverse Event|1|||
160685696|NCT01506908|580227760|FG001|Overall Study|Adverse Event|0|||
160685697|NCT00925301|580227763|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
160685698|NCT00925301|580227764|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
160685699|NCT00925301|580227765|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
160685700|NCT00925301|580227766|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
160685701|NCT00925301|580227763|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
160685702|NCT00925301|580227764|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
160685703|NCT00925301|580227765|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
160685704|NCT00925301|580227766|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
160685705|NCT00925301|580227763|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
160685706|NCT00925301|580227764|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
160685707|NCT00925301|580227765|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
160685708|NCT00925301|580227766|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
160685709|NCT00925301|580227763|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
160685710|NCT00925301|580227764|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
160685711|NCT00925301|580227765|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
160685712|NCT00925301|580227766|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
160685713|NCT00925301|580227763|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
160685714|NCT00925301|580227764|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
160685715|NCT00925301|580227765|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
160685716|NCT00925301|580227766|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
160685717|NCT00925301|580227763|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
160685718|NCT00925301|580227764|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
160685719|NCT00925301|580227765|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
160685720|NCT00925301|580227766|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
160685721|NCT00925301|580227763|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
160685722|NCT00925301|580227764|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
160685723|NCT00925301|580227765|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
160685724|NCT00925301|580227766|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
160685725|NCT03043560|580227767|FG000|Overall Study|Discontinued Intervention|1|||
160685726|NCT03043560|580227768|FG001|Overall Study|Discontinued Intervention|2|||
160685727|NCT03043560|580227767|FG000|Overall Study|Lost to Follow-up|0|||
160685728|NCT03043560|580227768|FG001|Overall Study|Lost to Follow-up|1|||
160685729|NCT00292227|580227769|FG000|Patch Period|Adverse Event|1|||
160685730|NCT00292227|580227770|FG001|Patch Period|Adverse Event|0|||
160685731|NCT00292227|580227771|FG002|Patch Period|Adverse Event|2|||
160685732|NCT00292227|580227769|FG000|Patch Period|Withdrawal by Subject|0|||
160685733|NCT00292227|580227770|FG001|Patch Period|Withdrawal by Subject|0|||
160685734|NCT00292227|580227771|FG002|Patch Period|Withdrawal by Subject|1|||
160685735|NCT04232540|580227775|FG000|Overall Study|Lost to Follow-up|1|||
160685736|NCT04232540|580227776|FG001|Overall Study|Lost to Follow-up|0|||
160685737|NCT00537017|580227777|FG000|Treatment Phase|Adverse Event|19|||
160685738|NCT00537017|580227777|FG000|Treatment Phase|Withdrawal by Subject|13|||
160685739|NCT00537017|580227777|FG000|Treatment Phase|Protocol Violation|2|||
160685740|NCT00537017|580227777|FG000|Follow-up Phase|Withdrawal by Subject|9|||
160685741|NCT02105701|580227779|FG000|Overall Study|Lost to Follow-up|1|||
160685742|NCT02105701|580227780|FG001|Overall Study|Lost to Follow-up|0|||
160685743|NCT02105701|580227781|FG002|Overall Study|Lost to Follow-up|2|||
160685744|NCT02105701|580227782|FG003|Overall Study|Lost to Follow-up|1|||
160685745|NCT02105701|580227779|FG000|Overall Study|Protocol Violation|0|||
160685746|NCT02105701|580227780|FG001|Overall Study|Protocol Violation|0|||
160685747|NCT02105701|580227781|FG002|Overall Study|Protocol Violation|1|||
160685748|NCT02105701|580227782|FG003|Overall Study|Protocol Violation|0|||
160685749|NCT02105701|580227779|FG000|Overall Study|Withdrawal by Subject|2|||
160685750|NCT02105701|580227780|FG001|Overall Study|Withdrawal by Subject|1|||
160685751|NCT02105701|580227781|FG002|Overall Study|Withdrawal by Subject|0|||
160685752|NCT02105701|580227782|FG003|Overall Study|Withdrawal by Subject|1|||
160685753|NCT02105701|580227779|FG000|Overall Study|Death|1|||
160685754|NCT02105701|580227780|FG001|Overall Study|Death|0|||
160685755|NCT02105701|580227781|FG002|Overall Study|Death|0|||
160685756|NCT02105701|580227782|FG003|Overall Study|Death|0|||
160685757|NCT03234608|580227783|FG000|Overall Study|Lost to Follow-up|23|||
160685758|NCT03234608|580227784|FG001|Overall Study|Lost to Follow-up|21|||
160685759|NCT02329431|580227785|FG000|Overall Study|Lost to Follow-up|20|||
160685760|NCT02329431|580227786|FG001|Overall Study|Lost to Follow-up|13|||
160685761|NCT01362296|580227787|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
160685762|NCT01362296|580227788|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
160685763|NCT01362296|580227789|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
160685764|NCT01362296|580227790|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
160685765|NCT01362296|580227787|FG000|Randomized Phase (RP)|Physician Decision|1|||
160685766|NCT01362296|580227788|FG001|Randomized Phase (RP)|Physician Decision|9|||
160685767|NCT01362296|580227789|FG002|Randomized Phase (RP)|Physician Decision|0|||
160685768|NCT01362296|580227790|FG003|Randomized Phase (RP)|Physician Decision|0|||
160685769|NCT01362296|580227787|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
160685770|NCT01362296|580227788|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
160685771|NCT01362296|580227789|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
160685772|NCT01362296|580227790|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
160685773|NCT01362296|580227787|FG000|Randomized Phase (RP)|Adverse Event|20|||
160685774|NCT01362296|580227788|FG001|Randomized Phase (RP)|Adverse Event|4|||
160685775|NCT01362296|580227789|FG002|Randomized Phase (RP)|Adverse Event|0|||
160685776|NCT01362296|580227790|FG003|Randomized Phase (RP)|Adverse Event|0|||
160685777|NCT01362296|580227787|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
160685778|NCT01362296|580227788|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
160685779|NCT01362296|580227789|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
160685780|NCT01362296|580227790|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
160685781|NCT01362296|580227787|FG000|Crossover Phase|PD including Death due to PD|0|||
160685782|NCT01362296|580227788|FG001|Crossover Phase|PD including Death due to PD|0|||
160685783|NCT01362296|580227789|FG002|Crossover Phase|PD including Death due to PD|16|||
160685784|NCT01362296|580227790|FG003|Crossover Phase|PD including Death due to PD|1|||
160685785|NCT01362296|580227787|FG000|Crossover Phase|Withdrawal by Subject|0|||
160685786|NCT01362296|580227788|FG001|Crossover Phase|Withdrawal by Subject|0|||
160685787|NCT01362296|580227789|FG002|Crossover Phase|Withdrawal by Subject|2|||
160685788|NCT01362296|580227790|FG003|Crossover Phase|Withdrawal by Subject|1|||
160685789|NCT01362296|580227787|FG000|Crossover Phase|Adverse Event|0|||
160685790|NCT01362296|580227788|FG001|Crossover Phase|Adverse Event|0|||
160685791|NCT01362296|580227789|FG002|Crossover Phase|Adverse Event|4|||
160685792|NCT01362296|580227790|FG003|Crossover Phase|Adverse Event|0|||
160685793|NCT01362296|580227787|FG000|Crossover Phase|Study Closed/Terminated|0|||
160685794|NCT01362296|580227788|FG001|Crossover Phase|Study Closed/Terminated|0|||
160685795|NCT01362296|580227789|FG002|Crossover Phase|Study Closed/Terminated|1|||
160685796|NCT01362296|580227790|FG003|Crossover Phase|Study Closed/Terminated|0|||
160685797|NCT03693950|580227791|FG000|Overall Study|Withdrawal by Subject|1|||
160685798|NCT03693950|580227792|FG001|Overall Study|Withdrawal by Subject|0|||
160685799|NCT04230876|580227794|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
160685800|NCT04230876|580227795|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
160685801|NCT01662362|580227796|FG000|Overall Study|Lost to Follow-up|38|||
160685802|NCT00545688|580227798|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
160685803|NCT00545688|580227799|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
160685804|NCT00545688|580227800|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
160685805|NCT00545688|580227801|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
160685806|NCT00545688|580227798|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
160685807|NCT00545688|580227799|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
160685808|NCT00545688|580227800|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
160685809|NCT00545688|580227801|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
160685810|NCT00545688|580227798|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
160685811|NCT00545688|580227799|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
160685812|NCT00545688|580227800|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
160685813|NCT00545688|580227801|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
160685814|NCT00545688|580227798|FG000|Neo-Adjuvant Treatment Period|Death|0|||
160685815|NCT00545688|580227799|FG001|Neo-Adjuvant Treatment Period|Death|1|||
160685816|NCT00545688|580227800|FG002|Neo-Adjuvant Treatment Period|Death|0|||
160685817|NCT00545688|580227801|FG003|Neo-Adjuvant Treatment Period|Death|0|||
160685818|NCT00545688|580227798|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
160685819|NCT00545688|580227799|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
160685820|NCT00545688|580227800|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
160685821|NCT00545688|580227801|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
160685822|NCT00545688|580227798|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
160685823|NCT00545688|580227799|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
160685824|NCT00545688|580227800|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
160685825|NCT00545688|580227801|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
160685826|NCT00545688|580227798|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
160685827|NCT00545688|580227799|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
160685828|NCT00545688|580227800|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
160685829|NCT00545688|580227801|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
160685830|NCT00545688|580227798|FG000|Adjuvant Treatment Period|Disease Progression|3|||
160685831|NCT00545688|580227799|FG001|Adjuvant Treatment Period|Disease Progression|3|||
160685832|NCT00545688|580227800|FG002|Adjuvant Treatment Period|Disease Progression|0|||
160685833|NCT00545688|580227801|FG003|Adjuvant Treatment Period|Disease Progression|7|||
160685834|NCT00545688|580227798|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
160685835|NCT00545688|580227799|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
160685836|NCT00545688|580227800|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
160685837|NCT00545688|580227801|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
160685838|NCT00545688|580227798|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
160685839|NCT00545688|580227799|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
160685840|NCT00545688|580227800|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
160685841|NCT00545688|580227801|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
160685842|NCT00545688|580227798|FG000|Adjuvant Treatment Period|Adverse Event|0|||
160685843|NCT00545688|580227799|FG001|Adjuvant Treatment Period|Adverse Event|3|||
160685844|NCT00545688|580227800|FG002|Adjuvant Treatment Period|Adverse Event|2|||
160685845|NCT00545688|580227801|FG003|Adjuvant Treatment Period|Adverse Event|2|||
160685846|NCT00545688|580227798|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
160685847|NCT00545688|580227799|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
160685848|NCT00545688|580227800|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
160685849|NCT00545688|580227801|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
160685850|NCT00545688|580227798|FG000|Follow-Up Period|Death|4|||
160685851|NCT00545688|580227799|FG001|Follow-Up Period|Death|2|||
160685852|NCT00545688|580227800|FG002|Follow-Up Period|Death|2|||
160685853|NCT00545688|580227801|FG003|Follow-Up Period|Death|6|||
160685854|NCT00545688|580227798|FG000|Follow-Up Period|Disease Progression|6|||
160685855|NCT00545688|580227799|FG001|Follow-Up Period|Disease Progression|5|||
160685856|NCT00545688|580227800|FG002|Follow-Up Period|Disease Progression|9|||
160685857|NCT00545688|580227801|FG003|Follow-Up Period|Disease Progression|9|||
160685858|NCT00545688|580227798|FG000|Follow-Up Period|Refused Treatment|6|||
160685859|NCT00545688|580227799|FG001|Follow-Up Period|Refused Treatment|2|||
160685860|NCT00545688|580227800|FG002|Follow-Up Period|Refused Treatment|0|||
160685861|NCT00545688|580227801|FG003|Follow-Up Period|Refused Treatment|2|||
160685862|NCT00545688|580227798|FG000|Follow-Up Period|Lost to Follow-up|3|||
160685863|NCT00545688|580227799|FG001|Follow-Up Period|Lost to Follow-up|3|||
160685864|NCT00545688|580227800|FG002|Follow-Up Period|Lost to Follow-up|3|||
160685865|NCT00545688|580227801|FG003|Follow-Up Period|Lost to Follow-up|1|||
160685866|NCT00545688|580227798|FG000|Follow-Up Period|Unspecified Reason|2|||
160685867|NCT00545688|580227799|FG001|Follow-Up Period|Unspecified Reason|5|||
160685868|NCT00545688|580227800|FG002|Follow-Up Period|Unspecified Reason|6|||
160685869|NCT00545688|580227801|FG003|Follow-Up Period|Unspecified Reason|8|||
160685870|NCT00545688|580227798|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
160685871|NCT00545688|580227799|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
160685872|NCT00545688|580227800|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
160685873|NCT00545688|580227801|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
160685874|NCT02339090|580227802|FG000|Overall Study|Adverse Event|1|||
160685875|NCT02339090|580227803|FG001|Overall Study|Adverse Event|0|||
160685876|NCT02339090|580227802|FG000|Overall Study|Lost to Follow-up|0|||
160685877|NCT02339090|580227803|FG001|Overall Study|Lost to Follow-up|1|||
160685878|NCT02339090|580227802|FG000|Overall Study|Non-compliance With Study Drug|0|||
160685879|NCT02339090|580227803|FG001|Overall Study|Non-compliance With Study Drug|1|||
160685880|NCT02339090|580227802|FG000|Overall Study|Withdrawal by Subject|2|||
160685881|NCT02339090|580227803|FG001|Overall Study|Withdrawal by Subject|1|||
160685882|NCT02339090|580227802|FG000|Overall Study|Poor Growth|3|||
160685883|NCT02339090|580227803|FG001|Overall Study|Poor Growth|0|||
160685884|NCT02339090|580227802|FG000|Overall Study|Randomized but not treated|0|||
160685885|NCT02339090|580227803|FG001|Overall Study|Randomized but not treated|2|||
160685886|NCT03183141|580227807|FG000|Overall Study|Withdrawal by Subject|2|||
160685887|NCT03183141|580227808|FG001|Overall Study|Withdrawal by Subject|4|||
160685888|NCT03183141|580227807|FG000|Overall Study|Death|0|||
160685889|NCT03183141|580227808|FG001|Overall Study|Death|8|||
160685890|NCT01507090|580227810|FG000|Overall Study|incomplete dataset|18|||
160685891|NCT02953678|580227829|FG000|Overall Study|Adverse Event|20|||
160685892|NCT02953678|580227829|FG000|Overall Study|Death|7|||
160685893|NCT02953678|580227829|FG000|Overall Study|Physician Decision|23|||
160685894|NCT02953678|580227829|FG000|Overall Study|Progressive Disease of GVHD|7|||
160685895|NCT02953678|580227829|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
160685896|NCT02953678|580227829|FG000|Overall Study|Withdrawal by participant|3|||
160685897|NCT02953678|580227829|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
160685898|NCT02953678|580227829|FG000|Overall Study|Participants were transferred to commercial product.|3|||
160685899|NCT00546910|580229088|FG000|Overall Study|Adverse Event|2|||
160685900|NCT00546910|580229089|FG001|Overall Study|Adverse Event|3|||
160685901|NCT00546910|580229088|FG000|Overall Study|Lack of Efficacy|5|||
160685902|NCT00546910|580229089|FG001|Overall Study|Lack of Efficacy|7|||
160685903|NCT00546910|580229088|FG000|Overall Study|Physician Decision|0|||
160685904|NCT00546910|580229089|FG001|Overall Study|Physician Decision|1|||
160685905|NCT00546910|580229088|FG000|Overall Study|Withdrawal by Subject|2|||
160685906|NCT00546910|580229089|FG001|Overall Study|Withdrawal by Subject|0|||
160685907|NCT01301482|580229090|FG000|Overall Study|Withdrawal by Subject|1|||
160685908|NCT02070757|580229098|FG000|Overall Study|Adverse Event|107|||
160685909|NCT02070757|580229099|FG001|Overall Study|Adverse Event|99|||
160685910|NCT02070757|580229098|FG000|Overall Study|Lost to Follow-up|7|||
160685911|NCT02070757|580229099|FG001|Overall Study|Lost to Follow-up|4|||
160685912|NCT02070757|580229098|FG000|Overall Study|Protocol Violation|0|||
160685913|NCT02070757|580229099|FG001|Overall Study|Protocol Violation|4|||
160685914|NCT02070757|580229098|FG000|Overall Study|Withdrawal by Subject|1|||
160685915|NCT02070757|580229099|FG001|Overall Study|Withdrawal by Subject|3|||
160685916|NCT02070757|580229098|FG000|Overall Study|Investigator Decision|0|||
160685917|NCT02070757|580229099|FG001|Overall Study|Investigator Decision|2|||
160685918|NCT02070757|580229098|FG000|Overall Study|Discharged from Study Hospital|2|||
160685919|NCT02070757|580229099|FG001|Overall Study|Discharged from Study Hospital|2|||
160685920|NCT04086641|580229100|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
160685921|NCT04086641|580229101|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
160685922|NCT00126126|580229105|FG000|Overall Study|Lost to Follow-up|0|||
160685923|NCT00126126|580229106|FG001|Overall Study|Lost to Follow-up|2|||
160685924|NCT01570283|580229110|FG000|Cohort 1: Dose Level 1|Death|0|||
160685925|NCT01570283|580229111|FG001|Cohort 1: Dose Level 1|Death|1|||
160685926|NCT01570283|580229112|FG002|Cohort 1: Dose Level 1|Death|0|||
160685927|NCT01570283|580229113|FG003|Cohort 1: Dose Level 1|Death|0|||
160685928|NCT01570283|580229114|FG004|Cohort 1: Dose Level 1|Death|0|||
160685929|NCT01570283|580229115|FG005|Cohort 1: Dose Level 1|Death|0|||
160685930|NCT01570283|580229110|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
160685931|NCT01570283|580229111|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
160685932|NCT01570283|580229112|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
160685933|NCT01570283|580229113|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
160685934|NCT01570283|580229114|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
160685935|NCT01570283|580229115|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
160685936|NCT01570283|580229110|FG000|Cohort 2: Dose Level 2|Death|0|||
160685937|NCT01570283|580229111|FG001|Cohort 2: Dose Level 2|Death|0|||
160685938|NCT01570283|580229112|FG002|Cohort 2: Dose Level 2|Death|1|||
160685939|NCT01570283|580229113|FG003|Cohort 2: Dose Level 2|Death|0|||
160685940|NCT01570283|580229114|FG004|Cohort 2: Dose Level 2|Death|0|||
160685941|NCT01570283|580229115|FG005|Cohort 2: Dose Level 2|Death|0|||
160685942|NCT01570283|580229110|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
160685943|NCT01570283|580229111|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
160685944|NCT01570283|580229112|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
160685945|NCT01570283|580229113|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
160685946|NCT01570283|580229114|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
160685947|NCT01570283|580229115|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
160685948|NCT01570283|580229110|FG000|Cohort 3: Dose Level 3|Death|0|||
160685949|NCT01570283|580229111|FG001|Cohort 3: Dose Level 3|Death|0|||
160685950|NCT01570283|580229112|FG002|Cohort 3: Dose Level 3|Death|0|||
160685951|NCT01570283|580229113|FG003|Cohort 3: Dose Level 3|Death|0|||
160685952|NCT01570283|580229114|FG004|Cohort 3: Dose Level 3|Death|0|||
160685953|NCT01570283|580229115|FG005|Cohort 3: Dose Level 3|Death|1|||
160685954|NCT01570283|580229110|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
160685955|NCT01570283|580229111|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
160685956|NCT01570283|580229112|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
160685957|NCT01570283|580229113|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
160685958|NCT01570283|580229114|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
160685959|NCT01570283|580229115|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
160685960|NCT01048502|580229116|FG000|Overall Study|Lost to Follow-up|2|||
160685961|NCT01048502|580229117|FG001|Overall Study|Lost to Follow-up|0|||
160685962|NCT01048502|580229118|FG002|Overall Study|Lost to Follow-up|0|||
160685963|NCT01048502|580229119|FG003|Overall Study|Lost to Follow-up|0|||
160685964|NCT01048502|580229116|FG000|Overall Study|Adverse Event|1|||
160685965|NCT01048502|580229117|FG001|Overall Study|Adverse Event|0|||
160685966|NCT01048502|580229118|FG002|Overall Study|Adverse Event|0|||
160685967|NCT01048502|580229119|FG003|Overall Study|Adverse Event|0|||
160685968|NCT01048502|580229116|FG000|Overall Study|Withdrawal by Subject|1|||
160685969|NCT01048502|580229117|FG001|Overall Study|Withdrawal by Subject|4|||
160685970|NCT01048502|580229118|FG002|Overall Study|Withdrawal by Subject|5|||
160685971|NCT01048502|580229119|FG003|Overall Study|Withdrawal by Subject|3|||
160685972|NCT01048502|580229116|FG000|Overall Study|Physician Decision|0|||
160685973|NCT01048502|580229117|FG001|Overall Study|Physician Decision|3|||
160685974|NCT01048502|580229118|FG002|Overall Study|Physician Decision|0|||
160685975|NCT01048502|580229119|FG003|Overall Study|Physician Decision|1|||
160685976|NCT04220775|580229120|FG000|Overall Study|Adverse Event|1|||
160685977|NCT04220775|580229121|FG001|Overall Study|Adverse Event|0|||
160685978|NCT04220775|580229120|FG000|Overall Study|Disease Progression|1|||
160685979|NCT04220775|580229121|FG001|Overall Study|Disease Progression|0|||
160685980|NCT01857206|580229123|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
160685981|NCT01857206|580229124|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
160685982|NCT01857206|580229123|FG000|Overall Study|Lost to Follow-up|9|||
160685983|NCT01857206|580229124|FG001|Overall Study|Lost to Follow-up|6|||
160685984|NCT01857206|580229123|FG000|Overall Study|Unclassified|3|||
160685985|NCT01857206|580229124|FG001|Overall Study|Unclassified|3|||
160685986|NCT01857206|580229123|FG000|Overall Study|Withdrawal by Subject|1|||
160685987|NCT01857206|580229124|FG001|Overall Study|Withdrawal by Subject|0|||
160685988|NCT01483625|580229127|FG000|Overall Study|Adverse Event|1|||
160685989|NCT01483625|580229128|FG001|Overall Study|Adverse Event|1|||
160685990|NCT01483625|580229127|FG000|Overall Study|Refused to continue medication|2|||
160685991|NCT01483625|580229128|FG001|Overall Study|Refused to continue medication|1|||
160685992|NCT01483625|580229127|FG000|Overall Study|Due to other reason|1|||
160685993|NCT01483625|580229128|FG001|Overall Study|Due to other reason|0|||
160685994|NCT00084799|580229129|FG000|Overall Study|Disease Progression|1|||
160685995|NCT00084799|580229130|FG001|Overall Study|Disease Progression|0|||
160685996|NCT00271024|580229135|FG000|Overall Study|Lost Interest|3|||
160685997|NCT00271024|580229136|FG001|Overall Study|Lost Interest|4|||
160685998|NCT00271024|580229137|FG002|Overall Study|Lost Interest|2|||
160685999|NCT00271024|580229138|FG003|Overall Study|Lost Interest|3|||
160686000|NCT00271024|580229135|FG000|Overall Study|Unknown/Unspecified|11|||
160686001|NCT00271024|580229136|FG001|Overall Study|Unknown/Unspecified|11|||
160686002|NCT00271024|580229137|FG002|Overall Study|Unknown/Unspecified|8|||
160686003|NCT00271024|580229138|FG003|Overall Study|Unknown/Unspecified|4|||
160686004|NCT00271024|580229135|FG000|Overall Study|Protocol Violation|1|||
160686005|NCT00271024|580229136|FG001|Overall Study|Protocol Violation|6|||
160686006|NCT00271024|580229137|FG002|Overall Study|Protocol Violation|5|||
160686007|NCT00271024|580229138|FG003|Overall Study|Protocol Violation|11|||
160686008|NCT00271024|580229135|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
160686009|NCT00271024|580229136|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
160686010|NCT00271024|580229137|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
160686011|NCT00271024|580229138|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
160686012|NCT00271024|580229135|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
160686013|NCT00271024|580229136|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
160686014|NCT00271024|580229137|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
160686015|NCT00271024|580229138|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
160686016|NCT01261624|580229139|FG000|Week 0 to Week 12|Disease Progression|1|||
160686017|NCT01261624|580229140|FG001|Week 0 to Week 12|Disease Progression|1|||
160686018|NCT01261624|580229139|FG000|Week 0 to Week 12|Insufficient Response|0|||
160686019|NCT01261624|580229140|FG001|Week 0 to Week 12|Insufficient Response|2|||
160686020|NCT01261624|580229139|FG000|Week 13 to Week 24|Insufficient Response|0|||
160686021|NCT01261624|580229140|FG001|Week 13 to Week 24|Insufficient Response|1|||
160686022|NCT02094261|580229144|FG000|Overall Study|Death|24|||
160686023|NCT02094261|580229144|FG000|Overall Study|Lost to Follow-up|1|||
160686024|NCT02094261|580229144|FG000|Overall Study|Withdrawal by Subject|4|||
160686025|NCT02094261|580229144|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
160686026|NCT03573817|580229146|FG000|Overall Study|Adverse Event|0|||
160686027|NCT03573817|580229147|FG001|Overall Study|Adverse Event|2|||
160686028|NCT03573817|580229146|FG000|Overall Study|Protocol Violation|0|||
160686029|NCT03573817|580229147|FG001|Overall Study|Protocol Violation|1|||
160686030|NCT03573817|580229146|FG000|Overall Study|Withdrawal by Subject|1|||
160686031|NCT03573817|580229147|FG001|Overall Study|Withdrawal by Subject|1|||
160686032|NCT01719562|580229150|FG000|Overall Study|Lost to Follow-up|1|||
160686033|NCT01719562|580229151|FG001|Overall Study|Lost to Follow-up|0|||
160686034|NCT01719562|580229150|FG000|Overall Study|Death|1|||
160686035|NCT01719562|580229151|FG001|Overall Study|Death|0|||
160686036|NCT01719562|580229150|FG000|Overall Study|New cancer diagnosis|1|||
160686037|NCT01719562|580229151|FG001|Overall Study|New cancer diagnosis|0|||
160686038|NCT00508027|580229152|FG000|Dose Level 1|Lost to Follow-up|4|||
160686039|NCT00508027|580229152|FG000|Dose Level 1|Withdrawal by Subject|2|||
160686040|NCT00508027|580229152|FG000|Dose Level 1|Physician Decision|2|||
160686041|NCT00508027|580229152|FG000|Dose Level 2|Lost to Follow-up|2|||
160686042|NCT00508027|580229152|FG000|Dose Level 2|Withdrawal by Subject|2|||
160686043|NCT00537199|580229153|FG000|Overall Study|Study Terminated|1|||
160686044|NCT00612677|580229155|FG000|Overall Study|study closed before treatment started|1|||
160686045|NCT03139240|580229156|FG000|Overall Study|Lost to Follow-up|0|||
160686046|NCT03139240|580229157|FG001|Overall Study|Lost to Follow-up|1|||
160686047|NCT03139240|580229158|FG002|Overall Study|Lost to Follow-up|1|||
160686048|NCT03139240|580229159|FG003|Overall Study|Lost to Follow-up|0|||
160686049|NCT00860743|580229160|FG000|Overall Study|Withdrawal by Subject|3|||
160686050|NCT00860743|580229161|FG001|Overall Study|Withdrawal by Subject|0|||
160686051|NCT00941720|580229162|FG000|Overall Study|Withdrawal by Subject|1|||
160686052|NCT00941720|580229162|FG000|Overall Study|Insurance denied participation|11|||
160686053|NCT00941720|580229162|FG000|Overall Study|ineligible|2|||
160686054|NCT01876368|580229169|FG000|Overall Study|Adverse Event|2|||
160686055|NCT01876368|580229170|FG001|Overall Study|Adverse Event|5|||
160686056|NCT01876368|580229169|FG000|Overall Study|Lack of Efficacy|1|||
160686057|NCT01876368|580229170|FG001|Overall Study|Lack of Efficacy|0|||
160686058|NCT01876368|580229169|FG000|Overall Study|Lost to Follow-up|0|||
160686059|NCT01876368|580229170|FG001|Overall Study|Lost to Follow-up|1|||
160686060|NCT01876368|580229169|FG000|Overall Study|Non-compliance with study treatment|0|||
160686061|NCT01876368|580229170|FG001|Overall Study|Non-compliance with study treatment|1|||
160686062|NCT01876368|580229169|FG000|Overall Study|Physician Decision|0|||
160686063|NCT01876368|580229170|FG001|Overall Study|Physician Decision|2|||
160686064|NCT01876368|580229169|FG000|Overall Study|Protocol deviation|3|||
160686065|NCT01876368|580229170|FG001|Overall Study|Protocol deviation|3|||
160686066|NCT01876368|580229169|FG000|Overall Study|Subject/guardian decision|3|||
160686067|NCT01876368|580229170|FG001|Overall Study|Subject/guardian decision|1|||
160686068|NCT03903159|580229172|FG000|Overall Study|Discharged with Staff Approval|2|||
160686069|NCT03903159|580229172|FG000|Overall Study|Discharged at Staff Request|2|||
160686070|NCT03903159|580229172|FG000|Overall Study|Discharged Against Staff Advice|1|||
160686071|NCT01382251|580229175|FG000|Overall Study|Surgeries cancelled or delayed|16|||
160686072|NCT01382251|580229176|FG001|Overall Study|Surgeries cancelled or delayed|16|||
160686073|NCT01382251|580229175|FG000|Overall Study|Lost to Follow-up|4|||
160686074|NCT01382251|580229176|FG001|Overall Study|Lost to Follow-up|4|||
160686075|NCT01382251|580229175|FG000|Overall Study|Contacted after study closed|1|||
160686076|NCT01382251|580229176|FG001|Overall Study|Contacted after study closed|1|||
160686077|NCT00562120|580229177|FG000|First Intervention Period|Adverse Event|1|||
160686078|NCT00562120|580229178|FG001|First Intervention Period|Adverse Event|0|||
160686079|NCT00562120|580229179|FG002|First Intervention Period|Adverse Event|0|||
160686080|NCT00562120|580229180|FG003|First Intervention Period|Adverse Event|0|||
160686081|NCT00562120|580229177|FG000|First Intervention Period|Randomized but not Treated|1|||
160686082|NCT00562120|580229178|FG001|First Intervention Period|Randomized but not Treated|0|||
160686083|NCT00562120|580229179|FG002|First Intervention Period|Randomized but not Treated|0|||
160686084|NCT00562120|580229180|FG003|First Intervention Period|Randomized but not Treated|0|||
160686085|NCT02148445|580229181|FG000|Overall Study|Death|1|||
160686086|NCT02148445|580229182|FG001|Overall Study|Death|3|||
160686087|NCT03450629|580229183|FG000|Overall Study|Adverse Event|15|||
160686088|NCT03450629|580229184|FG001|Overall Study|Adverse Event|14|||
160686089|NCT03450629|580229183|FG000|Overall Study|Physician Decision|2|||
160686090|NCT03450629|580229184|FG001|Overall Study|Physician Decision|2|||
160686091|NCT03450629|580229183|FG000|Overall Study|Lack of Efficacy|2|||
160686092|NCT03450629|580229184|FG001|Overall Study|Lack of Efficacy|0|||
160686093|NCT03450629|580229183|FG000|Overall Study|Lost to Follow-up|4|||
160686094|NCT03450629|580229184|FG001|Overall Study|Lost to Follow-up|2|||
160686095|NCT03450629|580229183|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160686096|NCT03450629|580229184|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
160686097|NCT03450629|580229183|FG000|Overall Study|Non-Compliance With Study Drug|2|||
160686098|NCT03450629|580229184|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160686099|NCT03450629|580229183|FG000|Overall Study|Protocol Violation|11|||
160686100|NCT03450629|580229184|FG001|Overall Study|Protocol Violation|8|||
160686101|NCT03450629|580229183|FG000|Overall Study|Withdrawal by Subject|12|||
160686102|NCT03450629|580229184|FG001|Overall Study|Withdrawal by Subject|6|||
160686103|NCT03366194|580229185|FG000|Overall Study|Lost to Follow-up|2|||
160686104|NCT02093923|580229186|FG000|Overall Study|Lost to Follow-up|0|||
160686105|NCT02093923|580229187|FG001|Overall Study|Lost to Follow-up|0|||
160686106|NCT02093923|580229188|FG002|Overall Study|Lost to Follow-up|0|||
160686107|NCT02093923|580229189|FG003|Overall Study|Lost to Follow-up|1|||
160686108|NCT02093923|580229190|FG004|Overall Study|Lost to Follow-up|0|||
160686109|NCT02093923|580229186|FG000|Overall Study|Screen failure after randomization|0|||
160686110|NCT02093923|580229187|FG001|Overall Study|Screen failure after randomization|0|||
160686111|NCT02093923|580229188|FG002|Overall Study|Screen failure after randomization|0|||
160686112|NCT02093923|580229189|FG003|Overall Study|Screen failure after randomization|1|||
160686113|NCT02093923|580229190|FG004|Overall Study|Screen failure after randomization|0|||
160686114|NCT02737592|580229191|FG000|Overall Study|Withdrawal by Subject|1|||
160686115|NCT02792218|580229192|FG000|Overall Study|Patient/guardian decision|15|||
160686116|NCT02792218|580229193|FG001|Overall Study|Patient/guardian decision|42|||
160686117|NCT02792218|580229192|FG000|Overall Study|Adverse Event|15|||
160686118|NCT02792218|580229193|FG001|Overall Study|Adverse Event|14|||
160686119|NCT02792218|580229192|FG000|Overall Study|Lost to Follow-up|10|||
160686120|NCT02792218|580229193|FG001|Overall Study|Lost to Follow-up|5|||
160686121|NCT02792218|580229192|FG000|Overall Study|Lack of Efficacy|1|||
160686122|NCT02792218|580229193|FG001|Overall Study|Lack of Efficacy|12|||
160686123|NCT02792218|580229192|FG000|Overall Study|Physician Decision|4|||
160686124|NCT02792218|580229193|FG001|Overall Study|Physician Decision|4|||
160686125|NCT02792218|580229192|FG000|Overall Study|Protocol deviation|3|||
160686126|NCT02792218|580229193|FG001|Overall Study|Protocol deviation|2|||
160686127|NCT02792218|580229192|FG000|Overall Study|New therapy for study indication|0|||
160686128|NCT02792218|580229193|FG001|Overall Study|New therapy for study indication|1|||
160686129|NCT02792218|580229192|FG000|Overall Study|Non-compliance with study treatment|0|||
160686130|NCT02792218|580229193|FG001|Overall Study|Non-compliance with study treatment|1|||
160686131|NCT02792218|580229192|FG000|Overall Study|Pregnancy|1|||
160686132|NCT02792218|580229193|FG001|Overall Study|Pregnancy|0|||
160686133|NCT00248170|580229194|FG000|Overall Study|Withdrawal by Subject|71|||
160686134|NCT00248170|580229195|FG001|Overall Study|Withdrawal by Subject|79|||
160686135|NCT00248170|580229194|FG000|Overall Study|Protocol Violation|35|||
160686136|NCT00248170|580229195|FG001|Overall Study|Protocol Violation|30|||
160686137|NCT00248170|580229194|FG000|Overall Study|Lost to Follow-up|28|||
160686138|NCT00248170|580229195|FG001|Overall Study|Lost to Follow-up|35|||
160686139|NCT00248170|580229194|FG000|Overall Study|Disease progression|196|||
160686140|NCT00248170|580229195|FG001|Overall Study|Disease progression|216|||
160686141|NCT00248170|580229194|FG000|Overall Study|Death|28|||
160686142|NCT00248170|580229195|FG001|Overall Study|Death|47|||
160686143|NCT00248170|580229194|FG000|Overall Study|Adverse Event|311|||
160686144|NCT00248170|580229195|FG001|Overall Study|Adverse Event|296|||
160686145|NCT00248170|580229194|FG000|Overall Study|Administrative problems|22|||
160686146|NCT00248170|580229195|FG001|Overall Study|Administrative problems|25|||
160686147|NCT00248170|580229194|FG000|Overall Study|Abnormal test procedure(s) result|49|||
160686148|NCT00248170|580229195|FG001|Overall Study|Abnormal test procedure(s) result|61|||
160686149|NCT00248170|580229194|FG000|Overall Study|Abnormal laboratory values|4|||
160686150|NCT00248170|580229195|FG001|Overall Study|Abnormal laboratory values|0|||
160686151|NCT00248170|580229194|FG000|Overall Study|Protocol deviation|17|||
160686152|NCT00248170|580229195|FG001|Overall Study|Protocol deviation|19|||
160686153|NCT03123783|580229196|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
160686154|NCT03123783|580229197|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
160686155|NCT03123783|580229198|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
160686156|NCT03123783|580229199|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
160686157|NCT03123783|580229200|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
160686158|NCT03123783|580229201|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
160686159|NCT03123783|580229202|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
160686160|NCT03123783|580229196|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
160686161|NCT03123783|580229197|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
160686162|NCT03123783|580229198|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
160686163|NCT03123783|580229199|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
160686164|NCT03123783|580229200|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
160686165|NCT03123783|580229201|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
160686166|NCT03123783|580229202|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
160686167|NCT03123783|580229196|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
160686168|NCT03123783|580229197|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
160686169|NCT03123783|580229198|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
160686170|NCT03123783|580229199|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
160686171|NCT03123783|580229200|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
160686172|NCT03123783|580229201|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
160686173|NCT03123783|580229202|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
160686174|NCT03123783|580229196|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
160686175|NCT03123783|580229197|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
160686176|NCT03123783|580229198|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
160686177|NCT03123783|580229199|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
160686178|NCT03123783|580229200|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
160686179|NCT03123783|580229201|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
160686180|NCT03123783|580229202|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
160686181|NCT01253317|580229212|FG000|Overall Study|Adverse Event|2|||
160686182|NCT00749411|580229215|FG000|Overall Study|Adverse Event|0|||
160686183|NCT00749411|580229216|FG001|Overall Study|Adverse Event|2|||
160686184|NCT00749411|580229215|FG000|Overall Study|Lack of Efficacy|0|||
160686185|NCT00749411|580229216|FG001|Overall Study|Lack of Efficacy|1|||
160686186|NCT00749411|580229215|FG000|Overall Study|Protocol Violation|1|||
160686187|NCT00749411|580229216|FG001|Overall Study|Protocol Violation|1|||
160686188|NCT00749411|580229215|FG000|Overall Study|Protocol-defined stopping criteria|0|||
160686189|NCT00749411|580229216|FG001|Overall Study|Protocol-defined stopping criteria|1|||
160686190|NCT04678817|580230800|FG000|Overall Study|Lost to Follow-up|28|||
160686191|NCT04678817|580230801|FG001|Overall Study|Lost to Follow-up|0|||
160686192|NCT04678817|580230802|FG002|Overall Study|Lost to Follow-up|0|||
160686193|NCT02129647|580230805|FG000|Overall Study|Adverse Event|2|||
160686194|NCT02129647|580230805|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
160686195|NCT01833533|580230806|FG000|Overall Study|Adverse Event|0|||
160686196|NCT01833533|580230807|FG001|Overall Study|Adverse Event|1|||
160686197|NCT01833533|580230806|FG000|Overall Study|Lost to Follow-up|4|||
160686198|NCT01833533|580230807|FG001|Overall Study|Lost to Follow-up|9|||
160686199|NCT01833533|580230806|FG000|Overall Study|To Enter an Extension Study|0|||
160686200|NCT01833533|580230807|FG001|Overall Study|To Enter an Extension Study|4|||
160686201|NCT01833533|580230806|FG000|Overall Study|Other|2|||
160686202|NCT01833533|580230807|FG001|Overall Study|Other|7|||
160686203|NCT02017860|580230808|FG000|Overall Study|Adverse Event|1|||
160686204|NCT02017860|580230808|FG000|Overall Study|Withdrawal by Subject|1|||
160686205|NCT02772562|580230809|FG000|Overall Study|Withdrawal by Subject|1|||
160686206|NCT02772562|580230809|FG000|Overall Study|Protocol Violation|1|||
160686207|NCT03756883|580230810|FG000|Overall Study|Adverse Event|2|||
160686208|NCT03756883|580230811|FG001|Overall Study|Adverse Event|2|||
160686209|NCT03756883|580230812|FG002|Overall Study|Adverse Event|2|||
160686210|NCT03756883|580230810|FG000|Overall Study|Lack of Efficacy|0|||
160686211|NCT03756883|580230811|FG001|Overall Study|Lack of Efficacy|1|||
160686212|NCT03756883|580230812|FG002|Overall Study|Lack of Efficacy|2|||
160686213|NCT03756883|580230810|FG000|Overall Study|Lost to Follow-up|3|||
160686214|NCT03756883|580230811|FG001|Overall Study|Lost to Follow-up|3|||
160686215|NCT03756883|580230812|FG002|Overall Study|Lost to Follow-up|0|||
160686216|NCT03756883|580230810|FG000|Overall Study|Protocol Violation|2|||
160686217|NCT03756883|580230811|FG001|Overall Study|Protocol Violation|0|||
160686218|NCT03756883|580230812|FG002|Overall Study|Protocol Violation|1|||
160686219|NCT03756883|580230810|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
160686220|NCT03756883|580230811|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
160686221|NCT03756883|580230812|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
160686222|NCT03756883|580230810|FG000|Overall Study|Withdrawal by Subject|4|||
160686223|NCT03756883|580230811|FG001|Overall Study|Withdrawal by Subject|1|||
160686224|NCT03756883|580230812|FG002|Overall Study|Withdrawal by Subject|0|||
160686225|NCT03756883|580230810|FG000|Overall Study|Other Reasons|2|||
160686226|NCT03756883|580230811|FG001|Overall Study|Other Reasons|4|||
160686227|NCT03756883|580230812|FG002|Overall Study|Other Reasons|0|||
160686228|NCT01333072|580230816|FG000|Overall Study|Lost to Follow-up|3|||
160686229|NCT01333072|580230817|FG001|Overall Study|Lost to Follow-up|0|||
160686230|NCT01333072|580230816|FG000|Overall Study|Adverse Event|2|||
160686231|NCT01333072|580230817|FG001|Overall Study|Adverse Event|4|||
160686232|NCT01333072|580230816|FG000|Overall Study|Physician Decision|1|||
160686233|NCT01333072|580230817|FG001|Overall Study|Physician Decision|0|||
160686234|NCT02457611|580230818|FG000|Overall Study|Lost to Follow-up|3|||
160686235|NCT00493454|580230819|FG000|Overall Study|Withdrawal by Subject|1|||
160686236|NCT04668274|580230820|FG000|Part 1 Study Period 1|Adverse Event|3|||
160686237|NCT04668274|580230821|FG001|Part 1 Study Period 1|Adverse Event|0|||
160686238|NCT04668274|580230822|FG002|Part 1 Study Period 1|Adverse Event|0|||
160686239|NCT04668274|580230823|FG003|Part 1 Study Period 1|Adverse Event|0|||
160686240|NCT04668274|580230820|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
160686241|NCT04668274|580230821|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
160686242|NCT04668274|580230822|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
160686243|NCT04668274|580230823|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
160686244|NCT04668274|580230820|FG000|Part 1 Study Period 2|Other|0|||
160686245|NCT04668274|580230821|FG001|Part 1 Study Period 2|Other|1|||
160686246|NCT04668274|580230822|FG002|Part 1 Study Period 2|Other|0|||
160686247|NCT04668274|580230823|FG003|Part 1 Study Period 2|Other|0|||
160686248|NCT04668274|580230820|FG000|Part 1 Study Period 3|Adverse Event|0|||
160686249|NCT04668274|580230821|FG001|Part 1 Study Period 3|Adverse Event|0|||
160686250|NCT04668274|580230822|FG002|Part 1 Study Period 3|Adverse Event|1|||
160686251|NCT04668274|580230823|FG003|Part 1 Study Period 3|Adverse Event|0|||
160686252|NCT04668274|580230820|FG000|Part 1 Study Period 3|Other|0|||
160686253|NCT04668274|580230821|FG001|Part 1 Study Period 3|Other|0|||
160686254|NCT04668274|580230822|FG002|Part 1 Study Period 3|Other|2|||
160686255|NCT04668274|580230823|FG003|Part 1 Study Period 3|Other|0|||
160686256|NCT04668274|580230820|FG000|Part 2 Study Period 4|Other|0|||
160686257|NCT04668274|580230821|FG001|Part 2 Study Period 4|Other|0|||
160686258|NCT04668274|580230822|FG002|Part 2 Study Period 4|Other|0|||
160686259|NCT04668274|580230823|FG003|Part 2 Study Period 4|Other|1|||
160686260|NCT02363439|580230828|FG000|Overall Study|Lack of Efficacy|4|||
160686261|NCT02010255|580230833|FG000|Overall Study|Death|0|||
160686262|NCT02010255|580230834|FG001|Overall Study|Death|1|||
160686263|NCT02010255|580230835|FG002|Overall Study|Death|4|||
160686264|NCT02010255|580230836|FG003|Overall Study|Death|4|||
160686265|NCT02010255|580230837|FG004|Overall Study|Death|2|||
160686266|NCT02010255|580230838|FG005|Overall Study|Death|0|||
160686267|NCT02010255|580230839|FG006|Overall Study|Death|1|||
160686268|NCT02010255|580230840|FG007|Overall Study|Death|1|||
160686269|NCT02010255|580230841|FG008|Overall Study|Death|1|||
160686270|NCT02010255|580230842|FG009|Overall Study|Death|0|||
160686271|NCT02010255|580230843|FG010|Overall Study|Death|1|||
160686272|NCT02010255|580230844|FG011|Overall Study|Death|1|||
160686273|NCT02010255|580230845|FG012|Overall Study|Death|0|||
160686274|NCT02010255|580230846|FG013|Overall Study|Death|0|||
160686275|NCT02010255|580230833|FG000|Overall Study|Lack of Efficacy|4|||
160686276|NCT02010255|580230834|FG001|Overall Study|Lack of Efficacy|1|||
160686277|NCT02010255|580230835|FG002|Overall Study|Lack of Efficacy|2|||
160686278|NCT02010255|580230836|FG003|Overall Study|Lack of Efficacy|1|||
160686279|NCT02010255|580230837|FG004|Overall Study|Lack of Efficacy|1|||
160686280|NCT02010255|580230838|FG005|Overall Study|Lack of Efficacy|0|||
160686281|NCT02010255|580230839|FG006|Overall Study|Lack of Efficacy|0|||
160686282|NCT02010255|580230840|FG007|Overall Study|Lack of Efficacy|0|||
160686283|NCT02010255|580230841|FG008|Overall Study|Lack of Efficacy|0|||
160686284|NCT02010255|580230842|FG009|Overall Study|Lack of Efficacy|0|||
160686285|NCT02010255|580230843|FG010|Overall Study|Lack of Efficacy|1|||
160686286|NCT02010255|580230844|FG011|Overall Study|Lack of Efficacy|0|||
160686287|NCT02010255|580230845|FG012|Overall Study|Lack of Efficacy|0|||
160686288|NCT02010255|580230846|FG013|Overall Study|Lack of Efficacy|0|||
160686289|NCT02010255|580230833|FG000|Overall Study|Withdrew Consent|1|||
160686290|NCT02010255|580230834|FG001|Overall Study|Withdrew Consent|0|||
160686291|NCT02010255|580230835|FG002|Overall Study|Withdrew Consent|0|||
160686292|NCT02010255|580230836|FG003|Overall Study|Withdrew Consent|1|||
160686293|NCT02010255|580230837|FG004|Overall Study|Withdrew Consent|0|||
160686294|NCT02010255|580230838|FG005|Overall Study|Withdrew Consent|0|||
160686295|NCT02010255|580230839|FG006|Overall Study|Withdrew Consent|0|||
160686296|NCT02010255|580230840|FG007|Overall Study|Withdrew Consent|0|||
160686297|NCT02010255|580230841|FG008|Overall Study|Withdrew Consent|0|||
160686298|NCT02010255|580230842|FG009|Overall Study|Withdrew Consent|0|||
160686299|NCT02010255|580230843|FG010|Overall Study|Withdrew Consent|0|||
160686300|NCT02010255|580230844|FG011|Overall Study|Withdrew Consent|0|||
160686301|NCT02010255|580230845|FG012|Overall Study|Withdrew Consent|0|||
160686302|NCT02010255|580230846|FG013|Overall Study|Withdrew Consent|0|||
160686303|NCT02010255|580230833|FG000|Overall Study|Adverse Event|1|||
160686304|NCT02010255|580230834|FG001|Overall Study|Adverse Event|0|||
160686305|NCT02010255|580230835|FG002|Overall Study|Adverse Event|0|||
160686306|NCT02010255|580230836|FG003|Overall Study|Adverse Event|0|||
160686307|NCT02010255|580230837|FG004|Overall Study|Adverse Event|0|||
160686308|NCT02010255|580230838|FG005|Overall Study|Adverse Event|0|||
160686309|NCT02010255|580230839|FG006|Overall Study|Adverse Event|0|||
160686310|NCT02010255|580230840|FG007|Overall Study|Adverse Event|0|||
160686311|NCT02010255|580230841|FG008|Overall Study|Adverse Event|0|||
160686312|NCT02010255|580230842|FG009|Overall Study|Adverse Event|0|||
160686313|NCT02010255|580230843|FG010|Overall Study|Adverse Event|0|||
160686314|NCT02010255|580230844|FG011|Overall Study|Adverse Event|0|||
160686315|NCT02010255|580230845|FG012|Overall Study|Adverse Event|0|||
160686316|NCT02010255|580230846|FG013|Overall Study|Adverse Event|0|||
160686317|NCT02010255|580230833|FG000|Overall Study|Lost to Follow-up|0|||
160686318|NCT02010255|580230834|FG001|Overall Study|Lost to Follow-up|0|||
160686319|NCT02010255|580230835|FG002|Overall Study|Lost to Follow-up|1|||
160686320|NCT02010255|580230836|FG003|Overall Study|Lost to Follow-up|0|||
160686321|NCT02010255|580230837|FG004|Overall Study|Lost to Follow-up|1|||
160686322|NCT02010255|580230838|FG005|Overall Study|Lost to Follow-up|0|||
160686323|NCT02010255|580230839|FG006|Overall Study|Lost to Follow-up|0|||
160686324|NCT02010255|580230840|FG007|Overall Study|Lost to Follow-up|0|||
160686325|NCT02010255|580230841|FG008|Overall Study|Lost to Follow-up|0|||
160686326|NCT02010255|580230842|FG009|Overall Study|Lost to Follow-up|0|||
160686327|NCT02010255|580230843|FG010|Overall Study|Lost to Follow-up|0|||
160686328|NCT02010255|580230844|FG011|Overall Study|Lost to Follow-up|0|||
160686329|NCT02010255|580230845|FG012|Overall Study|Lost to Follow-up|0|||
160686330|NCT02010255|580230846|FG013|Overall Study|Lost to Follow-up|0|||
160686331|NCT02010255|580230833|FG000|Overall Study|Randomized but Not Treated|0|||
160686332|NCT02010255|580230834|FG001|Overall Study|Randomized but Not Treated|0|||
160686333|NCT02010255|580230835|FG002|Overall Study|Randomized but Not Treated|0|||
160686334|NCT02010255|580230836|FG003|Overall Study|Randomized but Not Treated|0|||
160686335|NCT02010255|580230837|FG004|Overall Study|Randomized but Not Treated|0|||
160686336|NCT02010255|580230838|FG005|Overall Study|Randomized but Not Treated|0|||
160686337|NCT02010255|580230839|FG006|Overall Study|Randomized but Not Treated|0|||
160686338|NCT02010255|580230840|FG007|Overall Study|Randomized but Not Treated|0|||
160686339|NCT02010255|580230841|FG008|Overall Study|Randomized but Not Treated|0|||
160686340|NCT02010255|580230842|FG009|Overall Study|Randomized but Not Treated|0|||
160686341|NCT02010255|580230843|FG010|Overall Study|Randomized but Not Treated|0|||
160686342|NCT02010255|580230844|FG011|Overall Study|Randomized but Not Treated|0|||
160686343|NCT02010255|580230845|FG012|Overall Study|Randomized but Not Treated|0|||
160686344|NCT02010255|580230846|FG013|Overall Study|Randomized but Not Treated|1|||
160686345|NCT02013531|580230849|FG000|Overall Study|Lost to Follow-up|3|||
160686346|NCT02013531|580230849|FG000|Overall Study|Met Withdrawal Criteria|1|||
160686347|NCT02013531|580230849|FG000|Overall Study|Withdrawal by Subject|1|||
160686348|NCT03554317|580230853|FG000|Overall Study|Withdrawal by Subject|1|||
160686349|NCT03554317|580230853|FG000|Overall Study|PSA Progression|3|||
160686350|NCT03554317|580230853|FG000|Overall Study|Radiographic Progression|4|||
160686351|NCT00939627|580230856|FG000|Overall Study|Disease Progression|16|||
160686352|NCT00939627|580230857|FG001|Overall Study|Disease Progression|12|||
160686353|NCT00939627|580230858|FG002|Overall Study|Disease Progression|0|||
160686354|NCT00939627|580230856|FG000|Overall Study|Adverse Event|6|||
160686355|NCT00939627|580230857|FG001|Overall Study|Adverse Event|7|||
160686356|NCT00939627|580230858|FG002|Overall Study|Adverse Event|0|||
160686357|NCT00939627|580230856|FG000|Overall Study|Death|0|||
160686358|NCT00939627|580230857|FG001|Overall Study|Death|2|||
160686359|NCT00939627|580230858|FG002|Overall Study|Death|0|||
160686360|NCT00939627|580230856|FG000|Overall Study|Withdrawal by Subject|2|||
160686361|NCT00939627|580230857|FG001|Overall Study|Withdrawal by Subject|4|||
160686362|NCT00939627|580230858|FG002|Overall Study|Withdrawal by Subject|0|||
160686363|NCT00939627|580230856|FG000|Overall Study|Other complicating disease|1|||
160686364|NCT00939627|580230857|FG001|Overall Study|Other complicating disease|1|||
160686365|NCT00939627|580230858|FG002|Overall Study|Other complicating disease|0|||
160686366|NCT00939627|580230856|FG000|Overall Study|Not compliant|2|||
160686367|NCT00939627|580230857|FG001|Overall Study|Not compliant|0|||
160686368|NCT00939627|580230858|FG002|Overall Study|Not compliant|0|||
160686369|NCT00939627|580230856|FG000|Overall Study|No off-tx reason given|0|||
160686370|NCT00939627|580230857|FG001|Overall Study|No off-tx reason given|2|||
160686371|NCT00939627|580230858|FG002|Overall Study|No off-tx reason given|0|||
160686372|NCT02039063|580230861|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
160686373|NCT02039063|580230862|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
160686374|NCT02039063|580230863|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
160686375|NCT02039063|580230864|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
160686376|NCT02039063|580230861|FG000|Treatment Phase|Progression of disease|0|||
160686377|NCT02039063|580230862|FG001|Treatment Phase|Progression of disease|0|||
160686378|NCT02039063|580230863|FG002|Treatment Phase|Progression of disease|1|||
160686379|NCT02039063|580230864|FG003|Treatment Phase|Progression of disease|1|||
160686380|NCT02039063|580230861|FG000|Extension Phase|Inadequate therapeutic effect|0|||
160686381|NCT02039063|580230862|FG001|Extension Phase|Inadequate therapeutic effect|1|||
160686382|NCT02039063|580230863|FG002|Extension Phase|Inadequate therapeutic effect|2|||
160686383|NCT02039063|580230864|FG003|Extension Phase|Inadequate therapeutic effect|0|||
160686384|NCT02039063|580230861|FG000|Extension Phase|Progression of disease|0|||
160686385|NCT02039063|580230862|FG001|Extension Phase|Progression of disease|0|||
160686386|NCT02039063|580230863|FG002|Extension Phase|Progression of disease|0|||
160686387|NCT02039063|580230864|FG003|Extension Phase|Progression of disease|1|||
160686388|NCT02039063|580230861|FG000|Extension Phase|Adverse Event|0|||
160686389|NCT02039063|580230862|FG001|Extension Phase|Adverse Event|0|||
160686390|NCT02039063|580230863|FG002|Extension Phase|Adverse Event|1|||
160686391|NCT02039063|580230864|FG003|Extension Phase|Adverse Event|0|||
160686392|NCT00467831|580230867|FG000|Overall Study|Death|2|||
160686393|NCT00467831|580230867|FG000|Overall Study|Withdrawal by Subject|1|||
160686394|NCT01832402|580230870|FG000|Overall Study|Lost to Follow-up|2|||
160686395|NCT01832402|580230871|FG001|Overall Study|Lost to Follow-up|0|||
160686396|NCT01832402|580230870|FG000|Overall Study|Withdrawal by Subject|3|||
160686397|NCT01832402|580230871|FG001|Overall Study|Withdrawal by Subject|3|||
160686398|NCT01832402|580230870|FG000|Overall Study|Declining Performance status|2|||
160686399|NCT01832402|580230871|FG001|Overall Study|Declining Performance status|1|||
160686400|NCT01198873|580230872|FG000|Overall Study|Adverse Event|4|||
160686401|NCT01198873|580230873|FG001|Overall Study|Adverse Event|7|||
160686402|NCT01198873|580230872|FG000|Overall Study|Study closure|29|||
160686403|NCT01198873|580230873|FG001|Overall Study|Study closure|23|||
160686404|NCT01198873|580230872|FG000|Overall Study|Other than above|4|||
160686405|NCT01198873|580230873|FG001|Overall Study|Other than above|2|||
160686406|NCT00823199|580230875|FG000|Overall Study|Withdrawal by Subject|2|||
160686407|NCT02776553|580230879|FG000|Overall Study|Lost to Follow-up|1|||
160686408|NCT02776553|580230880|FG001|Overall Study|Lost to Follow-up|0|||
160686409|NCT02776553|580230879|FG000|Overall Study|got liver transplant|1|||
160686410|NCT02776553|580230880|FG001|Overall Study|got liver transplant|2|||
160686411|NCT02776553|580230879|FG000|Overall Study|had other surgery|1|||
160686412|NCT02776553|580230880|FG001|Overall Study|had other surgery|0|||
160686413|NCT02776553|580230879|FG000|Overall Study|Protocol Violation|0|||
160686414|NCT02776553|580230880|FG001|Overall Study|Protocol Violation|1|||
160686415|NCT00171340|580230881|FG000|Overall Study|Adverse Event|46|||
160686416|NCT00171340|580230882|FG001|Overall Study|Adverse Event|42|||
160686417|NCT00171340|580230881|FG000|Overall Study|Lack of Efficacy|29|||
160686418|NCT00171340|580230882|FG001|Overall Study|Lack of Efficacy|41|||
160686419|NCT00171340|580230881|FG000|Overall Study|Protocol Violation|7|||
160686420|NCT00171340|580230882|FG001|Overall Study|Protocol Violation|8|||
160686421|NCT00171340|580230881|FG000|Overall Study|Withdrawal by Subject|22|||
160686422|NCT00171340|580230882|FG001|Overall Study|Withdrawal by Subject|19|||
160686423|NCT00171340|580230881|FG000|Overall Study|Lost to Follow-up|0|||
160686424|NCT00171340|580230882|FG001|Overall Study|Lost to Follow-up|5|||
160686425|NCT00171340|580230881|FG000|Overall Study|Abnormal Laboratory Results|2|||
160686426|NCT00171340|580230882|FG001|Overall Study|Abnormal Laboratory Results|0|||
160686427|NCT00171340|580230881|FG000|Overall Study|Abnormal Test Procedure Results|6|||
160686428|NCT00171340|580230882|FG001|Overall Study|Abnormal Test Procedure Results|11|||
160686429|NCT00171340|580230881|FG000|Overall Study|No Longer Required Study Drug|1|||
160686430|NCT00171340|580230882|FG001|Overall Study|No Longer Required Study Drug|1|||
160686431|NCT00171340|580230881|FG000|Overall Study|Administrative Problems|5|||
160686432|NCT00171340|580230882|FG001|Overall Study|Administrative Problems|2|||
160686433|NCT00171340|580230881|FG000|Overall Study|Death|6|||
160686434|NCT00171340|580230882|FG001|Overall Study|Death|6|||
160686435|NCT03827018|580230885|FG000|Overall Study|Adverse Event|1|||
160686436|NCT03827018|580230886|FG001|Overall Study|Adverse Event|0|||
160686437|NCT03827018|580230885|FG000|Overall Study|Withdrawal by Subject|2|||
160686438|NCT03827018|580230886|FG001|Overall Study|Withdrawal by Subject|2|||
160686439|NCT03827018|580230885|FG000|Overall Study|Lack of Efficacy|0|||
160686440|NCT03827018|580230886|FG001|Overall Study|Lack of Efficacy|1|||
160686441|NCT01998243|580230887|FG000|Overall Study|Pregnancy|0|||
160686442|NCT01998243|580230888|FG001|Overall Study|Pregnancy|1|||
160686443|NCT01998243|580230887|FG000|Overall Study|Protocol Violation|5|||
160686444|NCT01998243|580230888|FG001|Overall Study|Protocol Violation|2|||
160686445|NCT01998243|580230887|FG000|Overall Study|Withdrawal by Subject|3|||
160686446|NCT01998243|580230888|FG001|Overall Study|Withdrawal by Subject|4|||
160686447|NCT00680186|580230889|FG000|Overall Study|Adverse Event|47|||
160686448|NCT00680186|580230890|FG001|Overall Study|Adverse Event|44|||
160686449|NCT00680186|580230889|FG000|Overall Study|Protocol Violation|31|||
160686450|NCT00680186|580230890|FG001|Overall Study|Protocol Violation|26|||
160686451|NCT00680186|580230889|FG000|Overall Study|Lost to Follow-up|11|||
160686452|NCT00680186|580230890|FG001|Overall Study|Lost to Follow-up|6|||
160686453|NCT00680186|580230889|FG000|Overall Study|Withdrawal by Subject|32|||
160686454|NCT00680186|580230890|FG001|Overall Study|Withdrawal by Subject|39|||
160686455|NCT00680186|580230889|FG000|Overall Study|Other|4|||
160686456|NCT00680186|580230890|FG001|Overall Study|Other|1|||
160686457|NCT01351350|580230891|FG000|Overall Study|Disease Progression|5|||
160686458|NCT01351350|580230892|FG001|Overall Study|Disease Progression|13|||
160686459|NCT01351350|580230893|FG002|Overall Study|Disease Progression|6|||
160686460|NCT01351350|580230894|FG003|Overall Study|Disease Progression|8|||
160686461|NCT01351350|580230895|FG004|Overall Study|Disease Progression|5|||
160686462|NCT01351350|580230891|FG000|Overall Study|Adverse Event|1|||
160686463|NCT01351350|580230892|FG001|Overall Study|Adverse Event|10|||
160686464|NCT01351350|580230893|FG002|Overall Study|Adverse Event|1|||
160686465|NCT01351350|580230894|FG003|Overall Study|Adverse Event|2|||
160686466|NCT01351350|580230895|FG004|Overall Study|Adverse Event|0|||
160686467|NCT01351350|580230891|FG000|Overall Study|Participant Decision|2|||
160686468|NCT01351350|580230892|FG001|Overall Study|Participant Decision|6|||
160686469|NCT01351350|580230893|FG002|Overall Study|Participant Decision|3|||
160686470|NCT01351350|580230894|FG003|Overall Study|Participant Decision|3|||
160686471|NCT01351350|580230895|FG004|Overall Study|Participant Decision|2|||
160686472|NCT01351350|580230891|FG000|Overall Study|Enrolled but not Treated|0|||
160686473|NCT01351350|580230892|FG001|Overall Study|Enrolled but not Treated|0|||
160686474|NCT01351350|580230893|FG002|Overall Study|Enrolled but not Treated|1|||
160686475|NCT01351350|580230894|FG003|Overall Study|Enrolled but not Treated|0|||
160686476|NCT01351350|580230895|FG004|Overall Study|Enrolled but not Treated|0|||
160686477|NCT00775528|580230900|FG000|Overall Study|Protocol Violation|1|||
160686478|NCT04647383|580230901|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
160686479|NCT04647383|580230902|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
160686480|NCT04647383|580230903|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
160686481|NCT04647383|580230904|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
160686482|NCT02492841|580230905|FG000|Overall Study|Lost to Follow-up|34|||
160686483|NCT02492841|580230906|FG001|Overall Study|Lost to Follow-up|31|||
160686484|NCT02492841|580230907|FG002|Overall Study|Lost to Follow-up|35|||
160686485|NCT00613730|580230912|FG000|Overall Study|Disease progression|2|||
160686486|NCT00613730|580230912|FG000|Overall Study|Administrative decision|1|||
160686487|NCT00479388|580230913|FG000|Overall Study|Adverse Event|90|||
160686488|NCT00479388|580230914|FG001|Overall Study|Adverse Event|45|||
160686489|NCT00479388|580230913|FG000|Overall Study|Lost to Follow-up|0|||
160686490|NCT00479388|580230914|FG001|Overall Study|Lost to Follow-up|2|||
160686491|NCT00479388|580230913|FG000|Overall Study|Protocol Violation|10|||
160686492|NCT00479388|580230914|FG001|Overall Study|Protocol Violation|9|||
160686493|NCT00479388|580230913|FG000|Overall Study|Withdrawal by Subject|32|||
160686494|NCT00479388|580230914|FG001|Overall Study|Withdrawal by Subject|17|||
160686495|NCT00895037|580230920|FG000|Overall Study|Death|0|||
160686496|NCT00895037|580230921|FG001|Overall Study|Death|2|||
160686497|NCT00895037|580230922|FG002|Overall Study|Death|1|||
160686498|NCT01930175|580230927|FG000|Core Study|Lost to Follow-up|0|||
160686499|NCT01930175|580230928|FG001|Core Study|Lost to Follow-up|1|||
160686500|NCT01930175|580230929|FG002|Core Study|Lost to Follow-up|0|||
160686501|NCT01930175|580230927|FG000|Core Study|Adverse Event|0|||
160686502|NCT01930175|580230928|FG001|Core Study|Adverse Event|0|||
160686503|NCT01930175|580230929|FG002|Core Study|Adverse Event|1|||
160686504|NCT02820740|580230930|FG000|Overall Study|Did not have procedure|2|||
160686505|NCT00890552|580230931|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
160686506|NCT00890552|580230931|FG000|On-treatment|Early prog disease/ death|10|||
160686507|NCT04965389|580230932|FG000|Overall Study|Other reasons|1|||
160686508|NCT04965389|580230933|FG001|Overall Study|Other reasons|0|||
160686509|NCT04965389|580230934|FG002|Overall Study|Other reasons|0|||
160686510|NCT04965389|580230935|FG003|Overall Study|Other reasons|0|||
160686511|NCT04965389|580230932|FG000|Overall Study|Participant withdrew consent|0|||
160686512|NCT04965389|580230933|FG001|Overall Study|Participant withdrew consent|1|||
160686513|NCT04965389|580230934|FG002|Overall Study|Participant withdrew consent|0|||
160686514|NCT04965389|580230935|FG003|Overall Study|Participant withdrew consent|0|||
160686515|NCT04965389|580230932|FG000|Overall Study|Poor/Non-compliance|0|||
160686516|NCT04965389|580230933|FG001|Overall Study|Poor/Non-compliance|1|||
160686517|NCT04965389|580230934|FG002|Overall Study|Poor/Non-compliance|0|||
160686518|NCT04965389|580230935|FG003|Overall Study|Poor/Non-compliance|0|||
160686519|NCT01117987|580230938|FG000|Overall Study|Protocol deviation|0|||
160686520|NCT01117987|580230939|FG001|Overall Study|Protocol deviation|1|||
160686521|NCT01117987|580230938|FG000|Overall Study|Subject no longer requires study drug|1|||
160686522|NCT01117987|580230939|FG001|Overall Study|Subject no longer requires study drug|0|||
160686523|NCT01117987|580230938|FG000|Overall Study|Lost to Follow-up|1|||
160686524|NCT01117987|580230939|FG001|Overall Study|Lost to Follow-up|1|||
160686525|NCT01117987|580230938|FG000|Overall Study|Abnormal test procedure result|2|||
160686526|NCT01117987|580230939|FG001|Overall Study|Abnormal test procedure result|0|||
160686527|NCT01117987|580230938|FG000|Overall Study|Lack of Efficacy|3|||
160686528|NCT01117987|580230939|FG001|Overall Study|Lack of Efficacy|4|||
160686529|NCT01117987|580230938|FG000|Overall Study|Death|5|||
160686530|NCT01117987|580230939|FG001|Overall Study|Death|10|||
160686531|NCT01117987|580230938|FG000|Overall Study|Withdrawal by Subject|5|||
160686532|NCT01117987|580230939|FG001|Overall Study|Withdrawal by Subject|10|||
160686533|NCT01117987|580230938|FG000|Overall Study|Adverse Event|19|||
160686534|NCT01117987|580230939|FG001|Overall Study|Adverse Event|26|||
160686535|NCT01117987|580230938|FG000|Overall Study|Administrative problems|25|||
160686536|NCT01117987|580230939|FG001|Overall Study|Administrative problems|22|||
160686537|NCT02244424|580230940|FG000|Overall Study|Lost to Follow-up|20|||
160686538|NCT02244424|580230941|FG001|Overall Study|Lost to Follow-up|10|||
160686539|NCT04117945|580230944|FG000|Overall Study|Death|1|||
160686540|NCT04117945|580230945|FG001|Overall Study|Death|0|||
160686541|NCT04117945|580230944|FG000|Overall Study|Withdrawal by Subject|3|||
160686542|NCT04117945|580230945|FG001|Overall Study|Withdrawal by Subject|1|||
160686543|NCT04117945|580230944|FG000|Overall Study|Disease Progression|0|||
160686544|NCT04117945|580230945|FG001|Overall Study|Disease Progression|2|||
160686545|NCT04117945|580230944|FG000|Overall Study|Ineligible|8|||
160686546|NCT04117945|580230945|FG001|Overall Study|Ineligible|7|||
160686547|NCT00702208|580230949|FG000|Overall Study|Lost to Follow-up|28|||
160686548|NCT00702208|580230949|FG000|Overall Study|Did not self-lavage|1|||
160686549|NCT00702208|580230949|FG000|Overall Study|Unsatisfactory colposcopy|2|||
160686550|NCT03438006|580230950|FG000|Overall Study|Adverse Event|1|||
160686551|NCT03438006|580230950|FG000|Overall Study|Lost to Follow-up|67|||
160686552|NCT03438006|580230950|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
160686553|NCT03438006|580230950|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
160686554|NCT04034355|580230960|FG000|Overall Study|Study terminated by Sponsor|10|||
160686555|NCT04034355|580230961|FG001|Overall Study|Study terminated by Sponsor|17|||
160686556|NCT04034355|580230960|FG000|Overall Study|Withdrawal by Subject|12|||
160686557|NCT04034355|580230961|FG001|Overall Study|Withdrawal by Subject|11|||
160686558|NCT04034355|580230960|FG000|Overall Study|Site terminated by Sponsor|4|||
160686559|NCT04034355|580230961|FG001|Overall Study|Site terminated by Sponsor|5|||
160686560|NCT04034355|580230960|FG000|Overall Study|Adverse Event|2|||
160686561|NCT04034355|580230961|FG001|Overall Study|Adverse Event|0|||
160686562|NCT04034355|580230960|FG000|Overall Study|Death|1|||
160686563|NCT04034355|580230961|FG001|Overall Study|Death|1|||
160686564|NCT04034355|580230960|FG000|Overall Study|Not reported|2|||
160686565|NCT04034355|580230961|FG001|Overall Study|Not reported|0|||
160686566|NCT04034355|580230960|FG000|Overall Study|Lost to Follow-up|1|||
160686567|NCT04034355|580230961|FG001|Overall Study|Lost to Follow-up|0|||
160686568|NCT04034355|580230960|FG000|Overall Study|Physician Decision|1|||
160686569|NCT04034355|580230961|FG001|Overall Study|Physician Decision|0|||
160686570|NCT04034355|580230960|FG000|Overall Study|Protocol Violation|0|||
160686571|NCT04034355|580230961|FG001|Overall Study|Protocol Violation|1|||
160686572|NCT04034355|580230960|FG000|Overall Study|Progressive disease|1|||
160686573|NCT04034355|580230961|FG001|Overall Study|Progressive disease|0|||
160686574|NCT03064438|580232356|FG000|Overall Study|Lost to Follow-up|1|||
160686575|NCT03064438|580232357|FG001|Overall Study|Lost to Follow-up|0|||
160686576|NCT03064438|580232356|FG000|Overall Study|Withdrawal by Subject|0|||
160686577|NCT03064438|580232357|FG001|Overall Study|Withdrawal by Subject|1|||
160686578|NCT02124902|580232358|FG000|Overall Study|Adverse Event|7|||
160686579|NCT02124902|580232359|FG001|Overall Study|Adverse Event|2|||
160686580|NCT02124902|580232358|FG000|Overall Study|Went to alternative treatment|4|||
160686581|NCT02124902|580232359|FG001|Overall Study|Went to alternative treatment|0|||
160686582|NCT02124902|580232358|FG000|Overall Study|Withdrawal by Subject|2|||
160686583|NCT02124902|580232359|FG001|Overall Study|Withdrawal by Subject|1|||
160686584|NCT02124902|580232358|FG000|Overall Study|Physician Decision|2|||
160686585|NCT02124902|580232359|FG001|Overall Study|Physician Decision|0|||
160686586|NCT02124902|580232358|FG000|Overall Study|Not eligible|1|||
160686587|NCT02124902|580232359|FG001|Overall Study|Not eligible|0|||
160686588|NCT02124902|580232358|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
160686589|NCT02124902|580232359|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
160686590|NCT01937351|580232360|FG000|Overall Study|Withdrawal by Subject|4|||
160686591|NCT01937351|580232361|FG001|Overall Study|Withdrawal by Subject|2|||
160686592|NCT01937351|580232360|FG000|Overall Study|Death|1|||
160686593|NCT01937351|580232361|FG001|Overall Study|Death|0|||
160686594|NCT01937351|580232360|FG000|Overall Study|Not treated w device, per protocol fail|4|||
160686595|NCT01937351|580232361|FG001|Overall Study|Not treated w device, per protocol fail|0|||
160686596|NCT01961687|580232362|FG000|Overall Study|Lost to Follow-up|19|||
160686597|NCT01961687|580232362|FG000|Overall Study|Re-operation|17|||
160686598|NCT01961687|580232362|FG000|Overall Study|Death|7|||
160686599|NCT01961687|580232362|FG000|Overall Study|Withdrawal by Subject|6|||
160686600|NCT01961687|580232362|FG000|Overall Study|Adverse Event|6|||
160686601|NCT01961687|580232362|FG000|Overall Study|Moved to area without study site|2|||
160686602|NCT01961687|580232362|FG000|Overall Study|Sponsor decision|2|||
160686603|NCT01961687|580232362|FG000|Overall Study|Physician Decision|1|||
160686604|NCT01961687|580232362|FG000|Overall Study|Unable to meet follow-up requirements|1|||
160686605|NCT01314118|580232363|FG000|Overall Study|Adverse Event|10|||
160686606|NCT01314118|580232363|FG000|Overall Study|Progressive disease|3|||
160686607|NCT01314118|580232363|FG000|Overall Study|Death|8|||
160686608|NCT01314118|580232363|FG000|Overall Study|Physician Decision|13|||
160686609|NCT01314118|580232363|FG000|Overall Study|Sponsor Decision|1|||
160686610|NCT01314118|580232363|FG000|Overall Study|Protocol Violation|2|||
160686611|NCT01314118|580232363|FG000|Overall Study|Withdrawal by Subject|26|||
160686612|NCT01314118|580232363|FG000|Overall Study|Other|21|||
160686637|NCT04079712|580232366|FG000|Overall Study|Disease progression before starting treatment|1|||
160686638|NCT01467479|580232367|FG000|Overall Study|No Study Medication|1|||
160686639|NCT01467479|580232368|FG001|Overall Study|No Study Medication|0|||
160686640|NCT01467479|580232369|FG002|Overall Study|No Study Medication|2|||
160686641|NCT01467479|580232367|FG000|Overall Study|Adverse Event|1|||
160686642|NCT01467479|580232368|FG001|Overall Study|Adverse Event|2|||
160686643|NCT01467479|580232369|FG002|Overall Study|Adverse Event|0|||
160686644|NCT01467479|580232367|FG000|Overall Study|Death|0|||
160686645|NCT01467479|580232368|FG001|Overall Study|Death|0|||
160686646|NCT01467479|580232369|FG002|Overall Study|Death|1|||
160686647|NCT01467479|580232367|FG000|Overall Study|Lost to Follow-up|2|||
160686648|NCT01467479|580232368|FG001|Overall Study|Lost to Follow-up|5|||
160686649|NCT01467479|580232369|FG002|Overall Study|Lost to Follow-up|3|||
160686650|NCT01467479|580232367|FG000|Overall Study|Withdrawal of Consent|3|||
160686651|NCT01467479|580232368|FG001|Overall Study|Withdrawal of Consent|7|||
160686652|NCT01467479|580232369|FG002|Overall Study|Withdrawal of Consent|7|||
160686653|NCT01467479|580232367|FG000|Overall Study|Study Terminated by Sponsor|1|||
160686654|NCT01467479|580232368|FG001|Overall Study|Study Terminated by Sponsor|3|||
160686655|NCT01467479|580232369|FG002|Overall Study|Study Terminated by Sponsor|3|||
160686656|NCT01467479|580232367|FG000|Overall Study|Other|1|||
160686657|NCT01467479|580232368|FG001|Overall Study|Other|0|||
160686658|NCT01467479|580232369|FG002|Overall Study|Other|0|||
160686659|NCT02284347|580232380|FG000|Overall Study|Lost to Follow-up|2|||
160686660|NCT02284347|580232380|FG000|Overall Study|Withdrawn prior to treatment|1|||
160686661|NCT01730040|580232382|FG000|Overall Study|Randomized but not treated|0|||
160686662|NCT01730040|580232383|FG001|Overall Study|Randomized but not treated|0|||
160686663|NCT01730040|580232384|FG002|Overall Study|Randomized but not treated|0|||
160686664|NCT01730040|580232385|FG003|Overall Study|Randomized but not treated|0|||
160686665|NCT01730040|580232386|FG004|Overall Study|Randomized but not treated|0|||
160686666|NCT01730040|580232387|FG005|Overall Study|Randomized but not treated|1|||
160686667|NCT01730040|580232388|FG006|Overall Study|Randomized but not treated|0|||
160686668|NCT01730040|580232382|FG000|Overall Study|Subject moved|0|||
160686669|NCT01730040|580232383|FG001|Overall Study|Subject moved|0|||
160686670|NCT01730040|580232384|FG002|Overall Study|Subject moved|1|||
160686671|NCT01730040|580232385|FG003|Overall Study|Subject moved|0|||
160686672|NCT01730040|580232386|FG004|Overall Study|Subject moved|0|||
160686673|NCT01730040|580232387|FG005|Overall Study|Subject moved|0|||
160686674|NCT01730040|580232388|FG006|Overall Study|Subject moved|1|||
160686675|NCT01730040|580232382|FG000|Overall Study|Physician Decision|0|||
160686676|NCT01730040|580232383|FG001|Overall Study|Physician Decision|0|||
160686677|NCT01730040|580232384|FG002|Overall Study|Physician Decision|0|||
160686678|NCT01730040|580232385|FG003|Overall Study|Physician Decision|0|||
160686679|NCT01730040|580232386|FG004|Overall Study|Physician Decision|0|||
160686680|NCT01730040|580232387|FG005|Overall Study|Physician Decision|1|||
160686681|NCT01730040|580232388|FG006|Overall Study|Physician Decision|1|||
160686682|NCT01730040|580232382|FG000|Overall Study|Other than specified|7|||
160686683|NCT01730040|580232383|FG001|Overall Study|Other than specified|8|||
160686684|NCT01730040|580232384|FG002|Overall Study|Other than specified|5|||
160686685|NCT01730040|580232385|FG003|Overall Study|Other than specified|5|||
160686686|NCT01730040|580232386|FG004|Overall Study|Other than specified|5|||
160686687|NCT01730040|580232387|FG005|Overall Study|Other than specified|4|||
160686688|NCT01730040|580232388|FG006|Overall Study|Other than specified|4|||
160686689|NCT01730040|580232382|FG000|Overall Study|Adverse Event|4|||
160686690|NCT01730040|580232383|FG001|Overall Study|Adverse Event|3|||
160686691|NCT01730040|580232384|FG002|Overall Study|Adverse Event|5|||
160686692|NCT01730040|580232385|FG003|Overall Study|Adverse Event|3|||
160686693|NCT01730040|580232386|FG004|Overall Study|Adverse Event|1|||
160686694|NCT01730040|580232387|FG005|Overall Study|Adverse Event|1|||
160686695|NCT01730040|580232388|FG006|Overall Study|Adverse Event|2|||
160686696|NCT01730040|580232382|FG000|Overall Study|Poor compliance to protocol|2|||
160686697|NCT01730040|580232383|FG001|Overall Study|Poor compliance to protocol|4|||
160686698|NCT01730040|580232384|FG002|Overall Study|Poor compliance to protocol|0|||
160686699|NCT01730040|580232385|FG003|Overall Study|Poor compliance to protocol|0|||
160686700|NCT01730040|580232386|FG004|Overall Study|Poor compliance to protocol|0|||
160686701|NCT01730040|580232387|FG005|Overall Study|Poor compliance to protocol|0|||
160686702|NCT01730040|580232388|FG006|Overall Study|Poor compliance to protocol|1|||
160686703|NCT00544817|580232391|FG000|Combined Modality|Lack of Efficacy|2|||
160686704|NCT00544817|580232391|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
160686705|NCT00544817|580232391|FG000|Combined Modality|Adverse Event|2|||
160686706|NCT00544817|580232391|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
160686707|NCT00544817|580232391|FG000|No Treatment Interval|Lack of Efficacy|8|||
160686708|NCT00544817|580232391|FG000|No Treatment Interval|Physician Decision|3|||
160686709|NCT00544817|580232391|FG000|No Treatment Interval|Adverse Event|1|||
160686710|NCT00544817|580232391|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
160686711|NCT00544817|580232391|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
160686712|NCT00544817|580232391|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
160686713|NCT01552369|580232392|FG000|Overall Study|Did not consent to extended follow up|8|||
160686714|NCT01552369|580232393|FG001|Overall Study|Did not consent to extended follow up|9|||
160686715|NCT00614926|580232394|FG000|Overall Study|Burden of travel|1|||
160686716|NCT00614926|580232395|FG001|Overall Study|Burden of travel|0|||
160686717|NCT00614926|580232394|FG000|Overall Study|Adverse Event|3|||
160686718|NCT00614926|580232395|FG001|Overall Study|Adverse Event|0|||
160686719|NCT02999984|580232400|FG000|Overall Study|Treatment Failure|1|||
160686720|NCT00754013|580232404|FG000|Overall Study|Lost to Follow-up|1|||
160686721|NCT00754013|580232405|FG001|Overall Study|Lost to Follow-up|1|||
160686722|NCT00754013|580232404|FG000|Overall Study|didn't return after study termed|3|||
160686723|NCT00754013|580232405|FG001|Overall Study|didn't return after study termed|4|||
160686724|NCT02310789|580232406|FG000|Overall Study|Adverse Event|1|||
160686725|NCT01197417|580232407|FG000|Overall Study|Physician Decision|3|||
160686726|NCT01197417|580232408|FG001|Overall Study|Physician Decision|2|||
160686727|NCT01197417|580232407|FG000|Overall Study|Withdrawal by Subject|2|||
160686728|NCT01197417|580232408|FG001|Overall Study|Withdrawal by Subject|4|||
160686729|NCT01197417|580232407|FG000|Overall Study|Site miscommunication|0|||
160686730|NCT01197417|580232408|FG001|Overall Study|Site miscommunication|1|||
160686731|NCT01197417|580232407|FG000|Overall Study|Subject transferred to intensive care|0|||
160686732|NCT01197417|580232408|FG001|Overall Study|Subject transferred to intensive care|1|||
160686733|NCT01197417|580232407|FG000|Overall Study|Not consented in time to receive drug|0|||
160686734|NCT01197417|580232408|FG001|Overall Study|Not consented in time to receive drug|1|||
160686735|NCT01197417|580232407|FG000|Overall Study|Hypotension|1|||
160686736|NCT01197417|580232408|FG001|Overall Study|Hypotension|2|||
160686737|NCT01197417|580232407|FG000|Overall Study|Found to be ineligible|2|||
160686738|NCT01197417|580232408|FG001|Overall Study|Found to be ineligible|5|||
160686739|NCT01197417|580232407|FG000|Overall Study|No 25-hour magnesium level|0|||
160686740|NCT01197417|580232408|FG001|Overall Study|No 25-hour magnesium level|2|||
160686741|NCT02813421|580232409|FG000|Overall Study|Withdrawal by Subject|1|||
160686742|NCT02813421|580232410|FG001|Overall Study|Withdrawal by Subject|2|||
160686743|NCT02813421|580232409|FG000|Overall Study|Lost to Follow-up|1|||
160686744|NCT02813421|580232410|FG001|Overall Study|Lost to Follow-up|1|||
160686745|NCT00685802|580232423|FG000|Washout Period of 7 Days|Protocol Violation|2|||
160686746|NCT00685802|580232424|FG001|Washout Period of 7 Days|Protocol Violation|0|||
160686747|NCT00685802|580232423|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
160686748|NCT00685802|580232424|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
160686749|NCT03336242|580232425|FG000|Overall Study|Adverse Event|0|||
160686750|NCT03336242|580232426|FG001|Overall Study|Adverse Event|1|||
160686751|NCT00384293|580232427|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
160686752|NCT00384293|580232428|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
160686753|NCT00384293|580232429|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
160686754|NCT00384293|580232427|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
160686755|NCT00384293|580232428|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
160686756|NCT00384293|580232429|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
160686757|NCT00384293|580232427|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
160686758|NCT00384293|580232428|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
160686759|NCT00384293|580232429|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
160686760|NCT00384293|580232427|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
160686761|NCT00384293|580232428|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
160686762|NCT00384293|580232429|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
160686763|NCT00384293|580232427|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
160686764|NCT00384293|580232428|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
160686765|NCT00384293|580232429|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
160686766|NCT00384293|580232427|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
160686767|NCT00384293|580232428|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
160686768|NCT00384293|580232429|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
160686769|NCT00384293|580232427|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
160686770|NCT00384293|580232428|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
160686771|NCT00384293|580232429|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
160686772|NCT00384293|580232427|FG000|Post-randomization Period|Adverse Event|0|||
160686773|NCT00384293|580232428|FG001|Post-randomization Period|Adverse Event|23|||
160686774|NCT00384293|580232429|FG002|Post-randomization Period|Adverse Event|7|||
160686775|NCT00384293|580232427|FG000|Post-randomization Period|Lost to Follow-up|0|||
160686776|NCT00384293|580232428|FG001|Post-randomization Period|Lost to Follow-up|2|||
160686777|NCT00384293|580232429|FG002|Post-randomization Period|Lost to Follow-up|1|||
160686778|NCT00384293|580232427|FG000|Post-randomization Period|Protocol Violation|0|||
160686779|NCT00384293|580232428|FG001|Post-randomization Period|Protocol Violation|1|||
160686780|NCT00384293|580232429|FG002|Post-randomization Period|Protocol Violation|0|||
160686781|NCT00384293|580232427|FG000|Post-randomization Period|Withdrawal by Subject|0|||
160686782|NCT00384293|580232428|FG001|Post-randomization Period|Withdrawal by Subject|8|||
160686783|NCT00384293|580232429|FG002|Post-randomization Period|Withdrawal by Subject|6|||
160686784|NCT00384293|580232427|FG000|Post-randomization Period|Trial Termination|0|||
160686785|NCT00384293|580232428|FG001|Post-randomization Period|Trial Termination|180|||
160686786|NCT00384293|580232429|FG002|Post-randomization Period|Trial Termination|204|||
160686787|NCT00384293|580232427|FG000|Post-randomization Period|Patient Randomized in Error|0|||
160686788|NCT00384293|580232428|FG001|Post-randomization Period|Patient Randomized in Error|0|||
160686789|NCT00384293|580232429|FG002|Post-randomization Period|Patient Randomized in Error|1|||
160686790|NCT00103038|580232434|FG000|Overall Study|Withdrawal by Subject|8|||
160686791|NCT00103038|580232434|FG000|Overall Study|Screen failure|3|||
160686792|NCT00103038|580232434|FG000|Overall Study|Death|1|||
160686793|NCT00103038|580232434|FG000|Overall Study|Physician Decision|1|||
160686794|NCT01463982|580232435|FG000|Overall Study|Withdrawal by Subject|0|||
160686795|NCT01463982|580232436|FG001|Overall Study|Withdrawal by Subject|1|||
160686796|NCT01463982|580232437|FG002|Overall Study|Withdrawal by Subject|1|||
160686797|NCT01463982|580232438|FG003|Overall Study|Withdrawal by Subject|0|||
160686798|NCT01463982|580232435|FG000|Overall Study|Treatment delay over 5 week|0|||
160686799|NCT01463982|580232436|FG001|Overall Study|Treatment delay over 5 week|0|||
160686800|NCT01463982|580232437|FG002|Overall Study|Treatment delay over 5 week|1|||
160686801|NCT01463982|580232438|FG003|Overall Study|Treatment delay over 5 week|0|||
160686802|NCT02310763|580232439|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
160686803|NCT02310763|580232440|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
160686804|NCT02310763|580232441|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
160686805|NCT02310763|580232439|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
160686806|NCT02310763|580232440|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
160686807|NCT02310763|580232441|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
160686808|NCT02310763|580232439|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
160686809|NCT02310763|580232440|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
160686810|NCT02310763|580232441|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
160686811|NCT02310763|580232439|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
160686812|NCT02310763|580232440|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
160686813|NCT02310763|580232441|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
160686814|NCT02310763|580232439|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
160686815|NCT02310763|580232440|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
160686816|NCT02310763|580232441|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
160686817|NCT01731886|580232443|FG000|Overall Study|Death|1|||
160686818|NCT01731886|580232444|FG001|Overall Study|Death|0|||
160686819|NCT01731886|580232443|FG000|Overall Study|Never started treatment|0|||
160686820|NCT01731886|580232444|FG001|Overall Study|Never started treatment|1|||
160686821|NCT01731886|580232443|FG000|Overall Study|Non-compliant|1|||
160686822|NCT01731886|580232444|FG001|Overall Study|Non-compliant|0|||
160686823|NCT02280187|580232445|FG000|Overall Study|Lost to Follow-up|218|||
160686824|NCT03417830|580232448|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
160686825|NCT03417830|580232449|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
160686826|NCT02563769|580232453|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
160686827|NCT02563769|580232454|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
160686828|NCT02563769|580232455|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
160686829|NCT01192399|580232473|FG000|Overall Study|Lack of Efficacy|2|||
160686830|NCT00724373|580232475|FG000|Overall Study|Adverse Event|41|||
160686831|NCT00724373|580232475|FG000|Overall Study|Lack of Efficacy|82|||
160686832|NCT00724373|580232475|FG000|Overall Study|Lost to Follow-up|7|||
160686833|NCT00724373|580232475|FG000|Overall Study|Non-compliance|2|||
160686834|NCT00724373|580232475|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
160686835|NCT00724373|580232475|FG000|Overall Study|Participant moved away|1|||
160686836|NCT00724373|580232475|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
160686837|NCT00724373|580232475|FG000|Overall Study|Only to have 24 week regimen|1|||
160686838|NCT00724373|580232475|FG000|Overall Study|Viral Relapse|1|||
160686839|NCT00724373|580232475|FG000|Overall Study|Acute HCV infection|1|||
160686840|NCT00724373|580232475|FG000|Overall Study|Drug Relapse|1|||
160686841|NCT00724373|580232475|FG000|Overall Study|Tolerability|23|||
160686842|NCT02083926|580232476|FG000|Overall Study|Withdrawal by Subject|1|||
160686843|NCT02083926|580232477|FG001|Overall Study|Withdrawal by Subject|0|||
160686844|NCT01436643|580232478|FG000|2-week Pre-treatment|Abnormal test result|0|||
160686845|NCT01436643|580232479|FG001|2-week Pre-treatment|Abnormal test result|0|||
160686846|NCT01436643|580232480|FG002|2-week Pre-treatment|Abnormal test result|0|||
160686847|NCT01436643|580232481|FG003|2-week Pre-treatment|Abnormal test result|1|||
160686848|NCT01436643|580232478|FG000|2-week Pre-treatment|Adverse Event|0|||
160686849|NCT01436643|580232479|FG001|2-week Pre-treatment|Adverse Event|0|||
160686850|NCT01436643|580232480|FG002|2-week Pre-treatment|Adverse Event|0|||
160686851|NCT01436643|580232481|FG003|2-week Pre-treatment|Adverse Event|5|||
160686852|NCT01436643|580232478|FG000|2-week Pre-treatment|Protocol Violation|0|||
160686853|NCT01436643|580232479|FG001|2-week Pre-treatment|Protocol Violation|0|||
160686854|NCT01436643|580232480|FG002|2-week Pre-treatment|Protocol Violation|0|||
160686855|NCT01436643|580232481|FG003|2-week Pre-treatment|Protocol Violation|4|||
160686856|NCT01436643|580232478|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
160686857|NCT01436643|580232479|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
160686858|NCT01436643|580232480|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
160686859|NCT01436643|580232481|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
160686860|NCT01436643|580232478|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
160686861|NCT01436643|580232479|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
160686862|NCT01436643|580232480|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
160686863|NCT01436643|580232481|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
160686864|NCT01436643|580232478|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
160686865|NCT01436643|580232479|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
160686866|NCT01436643|580232480|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
160686867|NCT01436643|580232481|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
160686868|NCT02377063|580232482|FG000|Overall Study|Non-compliance|5|||
160686869|NCT01524913|580232483|FG000|Overall Study|Lost to Follow-up|4|||
160686870|NCT01524913|580232484|FG001|Overall Study|Lost to Follow-up|0|||
160686871|NCT01524913|580232485|FG002|Overall Study|Lost to Follow-up|0|||
160686872|NCT01181531|580232486|FG000|Overall Study|Other|17|||
160686873|NCT01181531|580232487|FG001|Overall Study|Other|12|||
160686874|NCT01181531|580232486|FG000|Overall Study|Partial consent by subject withdrawn|0|||
160686875|NCT01181531|580232487|FG001|Overall Study|Partial consent by subject withdrawn|1|||
160686876|NCT01181531|580232486|FG000|Overall Study|Physician Decision|3|||
160686877|NCT01181531|580232487|FG001|Overall Study|Physician Decision|1|||
160686878|NCT01181531|580232486|FG000|Overall Study|Noncompliance|2|||
160686879|NCT01181531|580232487|FG001|Overall Study|Noncompliance|2|||
160686880|NCT01181531|580232486|FG000|Overall Study|Ineligibility determined|1|||
160686881|NCT01181531|580232487|FG001|Overall Study|Ineligibility determined|2|||
160686882|NCT01181531|580232486|FG000|Overall Study|Protocol Specified Criteria|15|||
160686883|NCT01181531|580232487|FG001|Overall Study|Protocol Specified Criteria|8|||
160686884|NCT01181531|580232486|FG000|Overall Study|Pregnancy|0|||
160686885|NCT01181531|580232487|FG001|Overall Study|Pregnancy|1|||
160686886|NCT01181531|580232486|FG000|Overall Study|Withdrawal by Subject|8|||
160686887|NCT01181531|580232487|FG001|Overall Study|Withdrawal by Subject|7|||
160686888|NCT01181531|580232486|FG000|Overall Study|Protocol Violation|6|||
160686889|NCT01181531|580232487|FG001|Overall Study|Protocol Violation|6|||
160686890|NCT01181531|580232486|FG000|Overall Study|Death|9|||
160686891|NCT01181531|580232487|FG001|Overall Study|Death|12|||
160686892|NCT01181531|580232486|FG000|Overall Study|Adverse Event|0|||
160686893|NCT01181531|580232487|FG001|Overall Study|Adverse Event|1|||
160686894|NCT00955721|580232488|FG000|Overall Study|Physician Decision|1|||
160686895|NCT00955721|580232489|FG001|Overall Study|Physician Decision|0|||
160686896|NCT00955721|580232488|FG000|Overall Study|Death|1|||
160686897|NCT00955721|580232489|FG001|Overall Study|Death|0|||
160686898|NCT00955721|580232488|FG000|Overall Study|Withdrawal by Subject|1|||
160686899|NCT00955721|580232489|FG001|Overall Study|Withdrawal by Subject|0|||
160686900|NCT02723773|580233948|FG000|Overall Study|Adverse Event|934|||
160686901|NCT02723773|580233949|FG001|Overall Study|Adverse Event|3|||
160686902|NCT02723773|580233950|FG002|Overall Study|Adverse Event|1|||
160686903|NCT02723773|580233951|FG003|Overall Study|Adverse Event|9|||
160686904|NCT02723773|580233948|FG000|Overall Study|Protocol Violation|1|||
160686905|NCT02723773|580233949|FG001|Overall Study|Protocol Violation|0|||
160686906|NCT02723773|580233950|FG002|Overall Study|Protocol Violation|0|||
160686907|NCT02723773|580233951|FG003|Overall Study|Protocol Violation|0|||
160686908|NCT02723773|580233948|FG000|Overall Study|Withdrawal by Subject|360|||
160686909|NCT02723773|580233949|FG001|Overall Study|Withdrawal by Subject|5|||
160686910|NCT02723773|580233950|FG002|Overall Study|Withdrawal by Subject|6|||
160686911|NCT02723773|580233951|FG003|Overall Study|Withdrawal by Subject|10|||
160686912|NCT02723773|580233948|FG000|Overall Study|Migrated/moved from study area|37|||
160686913|NCT02723773|580233949|FG001|Overall Study|Migrated/moved from study area|0|||
160686914|NCT02723773|580233950|FG002|Overall Study|Migrated/moved from study area|0|||
160686915|NCT02723773|580233951|FG003|Overall Study|Migrated/moved from study area|1|||
160686916|NCT02723773|580233948|FG000|Overall Study|Lost to Follow-up|198|||
160686917|NCT02723773|580233949|FG001|Overall Study|Lost to Follow-up|0|||
160686918|NCT02723773|580233950|FG002|Overall Study|Lost to Follow-up|0|||
160686919|NCT02723773|580233951|FG003|Overall Study|Lost to Follow-up|0|||
160686920|NCT02723773|580233948|FG000|Overall Study|Other|189|||
160686921|NCT02723773|580233949|FG001|Overall Study|Other|1|||
160686922|NCT02723773|580233950|FG002|Overall Study|Other|2|||
160686923|NCT02723773|580233951|FG003|Overall Study|Other|2|||
160686924|NCT05168774|580233952|FG000|Overall Study|Lack of Efficacy|1|||
160686925|NCT05168774|580233953|FG001|Overall Study|Lack of Efficacy|2|||
160686926|NCT05168774|580233952|FG000|Overall Study|Withdrawal by Subject|1|||
160686927|NCT05168774|580233953|FG001|Overall Study|Withdrawal by Subject|2|||
160686928|NCT05168774|580233952|FG000|Overall Study|Adverse Event|2|||
160686929|NCT05168774|580233953|FG001|Overall Study|Adverse Event|0|||
160686930|NCT01432574|580233968|FG000|Overall Study|Moved|2|||
160686931|NCT01432574|580233968|FG000|Overall Study|Not interested|1|||
160686932|NCT03135899|580233975|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
160686933|NCT03135899|580233976|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
160686934|NCT03135899|580233977|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
160686935|NCT03135899|580233978|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
160686936|NCT03135899|580233979|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
160686937|NCT03135899|580233980|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
160686938|NCT03135899|580233981|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
160686939|NCT03135899|580233982|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
160686940|NCT03135899|580233975|FG000|Overall Study|Withdrawal by Subject|0|||
160686941|NCT03135899|580233976|FG001|Overall Study|Withdrawal by Subject|0|||
160686942|NCT03135899|580233977|FG002|Overall Study|Withdrawal by Subject|0|||
160686943|NCT03135899|580233978|FG003|Overall Study|Withdrawal by Subject|0|||
160686944|NCT03135899|580233979|FG004|Overall Study|Withdrawal by Subject|0|||
160686945|NCT03135899|580233980|FG005|Overall Study|Withdrawal by Subject|2|||
160686946|NCT03135899|580233981|FG006|Overall Study|Withdrawal by Subject|0|||
160686947|NCT03135899|580233982|FG007|Overall Study|Withdrawal by Subject|0|||
160686948|NCT04373551|580233983|FG000|Overall Study|Lost to Follow-up|15|||
160686949|NCT04373551|580233983|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
160686950|NCT02914236|580233984|FG000|Overall Study|Lost to Follow-up|1|||
160686951|NCT01042535|580233985|FG000|Overall Study|disease progression prior to treatment|3|||
160686952|NCT01042535|580233985|FG000|Overall Study|disease progression during treatment|3|||
160686953|NCT01042535|580233985|FG000|Overall Study|complications from other disease|2|||
160686954|NCT03438539|580233992|FG000|Overall Study|Lost to Follow-up|8|||
160686955|NCT03438539|580233993|FG001|Overall Study|Lost to Follow-up|4|||
160686956|NCT03438539|580233994|FG002|Overall Study|Lost to Follow-up|10|||
160686957|NCT03438539|580233995|FG003|Overall Study|Lost to Follow-up|9|||
160686958|NCT03438539|580233996|FG004|Overall Study|Lost to Follow-up|3|||
160686959|NCT03438539|580233997|FG005|Overall Study|Lost to Follow-up|8|||
160686960|NCT04213209|580233998|FG000|Overall Study|Protocol Violation|1|||
160686961|NCT04213209|580233999|FG001|Overall Study|Protocol Violation|0|||
160686962|NCT04213209|580234000|FG002|Overall Study|Protocol Violation|0|||
160686963|NCT04213209|580234001|FG003|Overall Study|Protocol Violation|0|||
160686964|NCT04213209|580234002|FG004|Overall Study|Protocol Violation|0|||
160686965|NCT04213209|580234003|FG005|Overall Study|Protocol Violation|0|||
160686966|NCT00440466|580234005|FG000|Overall Study|Death|3|||
160686967|NCT00440466|580234006|FG001|Overall Study|Death|2|||
160686968|NCT00440466|580234007|FG002|Overall Study|Death|9|||
160686969|NCT00440466|580234005|FG000|Overall Study|Adverse Event|3|||
160686970|NCT00440466|580234006|FG001|Overall Study|Adverse Event|4|||
160686971|NCT00440466|580234007|FG002|Overall Study|Adverse Event|11|||
160686972|NCT00440466|580234005|FG000|Overall Study|Lost to Follow-up|1|||
160686973|NCT00440466|580234006|FG001|Overall Study|Lost to Follow-up|0|||
160686974|NCT00440466|580234007|FG002|Overall Study|Lost to Follow-up|2|||
160686975|NCT00440466|580234005|FG000|Overall Study|Physician Decision|2|||
160686976|NCT00440466|580234006|FG001|Overall Study|Physician Decision|0|||
160686977|NCT00440466|580234007|FG002|Overall Study|Physician Decision|1|||
160686978|NCT00440466|580234005|FG000|Overall Study|Protocol Violation|2|||
160686979|NCT00440466|580234006|FG001|Overall Study|Protocol Violation|0|||
160686980|NCT00440466|580234007|FG002|Overall Study|Protocol Violation|4|||
160686981|NCT00440466|580234005|FG000|Overall Study|Withdrawal by Subject|2|||
160686982|NCT00440466|580234006|FG001|Overall Study|Withdrawal by Subject|5|||
160686983|NCT00440466|580234007|FG002|Overall Study|Withdrawal by Subject|9|||
160686984|NCT00440466|580234005|FG000|Overall Study|Began Dialysis|0|||
160686985|NCT00440466|580234006|FG001|Overall Study|Began Dialysis|0|||
160686986|NCT00440466|580234007|FG002|Overall Study|Began Dialysis|1|||
160686987|NCT00440466|580234005|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
160686988|NCT00440466|580234006|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
160686989|NCT00440466|580234007|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
160686990|NCT02065713|580234008|FG000|Overall Study|Adverse Event|0|||
160686991|NCT02065713|580234009|FG001|Overall Study|Adverse Event|1|||
160686992|NCT02065713|580234008|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160686993|NCT02065713|580234009|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160686994|NCT00655850|580234012|FG000|Overall Study|Death|2|||
160686995|NCT00655850|580234012|FG000|Overall Study|Withdrawal by Subject|1|||
160686996|NCT00918463|580234013|FG000|Overall Study|Death|1|||
160686997|NCT00918463|580234013|FG000|Overall Study|Lack of Efficacy|1|||
160686998|NCT01014624|580234014|FG000|Overall Study|Adverse Event|0|||
160686999|NCT01014624|580234015|FG001|Overall Study|Adverse Event|1|||
160687000|NCT01014624|580234014|FG000|Overall Study|Protocol Violation|1|||
160687001|NCT01014624|580234015|FG001|Overall Study|Protocol Violation|0|||
160687002|NCT01014624|580234014|FG000|Overall Study|Withdrawal by Subject|1|||
160687003|NCT01014624|580234015|FG001|Overall Study|Withdrawal by Subject|0|||
160687004|NCT01715896|580234016|FG000|Overall Study|Lost to Follow-up|0|||
160687005|NCT01715896|580234017|FG001|Overall Study|Lost to Follow-up|2|||
160687006|NCT01715896|580234016|FG000|Overall Study|Withdrawal by Subject|1|||
160687007|NCT01715896|580234017|FG001|Overall Study|Withdrawal by Subject|4|||
160687008|NCT01715896|580234016|FG000|Overall Study|Other|2|||
160687009|NCT01715896|580234017|FG001|Overall Study|Other|5|||
160687010|NCT01045993|580234019|FG000|Overall Study|Treated-later found eligibility not met|0|||
160687011|NCT01045993|580234020|FG001|Overall Study|Treated-later found eligibility not met|1|||
160687012|NCT01045993|580234021|FG002|Overall Study|Treated-later found eligibility not met|0|||
160687013|NCT01045993|580234022|FG003|Overall Study|Treated-later found eligibility not met|0|||
160687014|NCT01659736|580234023|FG000|Treatment Period|Adverse Event|1|||
160687015|NCT01659736|580234024|FG001|Treatment Period|Adverse Event|1|||
160687016|NCT01659736|580234023|FG000|Treatment Period|Protocol Violation|3|||
160687017|NCT01659736|580234024|FG001|Treatment Period|Protocol Violation|1|||
160687018|NCT01659736|580234023|FG000|Treatment Period|Withdrawal by Subject|1|||
160687019|NCT01659736|580234024|FG001|Treatment Period|Withdrawal by Subject|0|||
160687020|NCT01659736|580234023|FG000|3-month Follow-up|Lost to Follow-up|0|||
160687021|NCT01659736|580234024|FG001|3-month Follow-up|Lost to Follow-up|1|||
160687022|NCT03005067|580234027|FG000|Overall Study|Withdrawal by Subject|3|||
160687023|NCT03005067|580234028|FG001|Overall Study|Withdrawal by Subject|2|||
160687024|NCT03005067|580234027|FG000|Overall Study|Adverse Event|4|||
160687025|NCT03005067|580234028|FG001|Overall Study|Adverse Event|3|||
160687026|NCT03005067|580234027|FG000|Overall Study|Other (reason not specified)|3|||
160687027|NCT03005067|580234028|FG001|Overall Study|Other (reason not specified)|1|||
160687028|NCT03005067|580234027|FG000|Overall Study|Protocol Violation|0|||
160687029|NCT03005067|580234028|FG001|Overall Study|Protocol Violation|1|||
160687030|NCT00355472|580234033|FG000|Overall Study|Physician Decision|1|||
160687031|NCT05445843|580234034|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
160687032|NCT05445843|580234035|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
160687033|NCT05445843|580234034|FG000|Overall Study|Progressive disease|17|||
160687034|NCT05445843|580234035|FG001|Overall Study|Progressive disease|9|||
160687035|NCT05445843|580234034|FG000|Overall Study|Physician Decision|16|||
160687036|NCT05445843|580234035|FG001|Overall Study|Physician Decision|4|||
160687037|NCT05445843|580234034|FG000|Overall Study|Death|6|||
160687038|NCT05445843|580234035|FG001|Overall Study|Death|3|||
160687039|NCT05445843|580234034|FG000|Overall Study|Subject decision|6|||
160687040|NCT05445843|580234035|FG001|Overall Study|Subject decision|2|||
160687041|NCT05445843|580234034|FG000|Overall Study|Adverse Event|2|||
160687042|NCT05445843|580234035|FG001|Overall Study|Adverse Event|0|||
160687043|NCT05307679|580234040|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
160687044|NCT05307679|580234041|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
160687045|NCT02674386|580234046|FG000|Overall Study|Lost to Follow-up|0|||
160687046|NCT02674386|580234047|FG001|Overall Study|Lost to Follow-up|1|||
160687047|NCT02674386|580234048|FG002|Overall Study|Lost to Follow-up|1|||
160687048|NCT02674386|580234046|FG000|Overall Study|Withdrawal by Subject|0|||
160687049|NCT02674386|580234047|FG001|Overall Study|Withdrawal by Subject|4|||
160687050|NCT02674386|580234048|FG002|Overall Study|Withdrawal by Subject|0|||
160687051|NCT02674386|580234046|FG000|Overall Study|Other|0|||
160687052|NCT02674386|580234047|FG001|Overall Study|Other|1|||
160687053|NCT02674386|580234048|FG002|Overall Study|Other|0|||
160687054|NCT02674386|580234046|FG000|Overall Study|Enrolled but not evaluated|0|||
160687055|NCT02674386|580234047|FG001|Overall Study|Enrolled but not evaluated|4|||
160687056|NCT02674386|580234048|FG002|Overall Study|Enrolled but not evaluated|0|||
160687057|NCT02462486|580234049|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
160687058|NCT02462486|580234050|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
160687059|NCT02462486|580234051|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
160687060|NCT02462486|580234049|FG000|Overall Study|Adverse Event|53|||
160687061|NCT02462486|580234050|FG001|Overall Study|Adverse Event|48|||
160687062|NCT02462486|580234051|FG002|Overall Study|Adverse Event|21|||
160687063|NCT02462486|580234049|FG000|Overall Study|Lack of Efficacy|6|||
160687064|NCT02462486|580234050|FG001|Overall Study|Lack of Efficacy|12|||
160687065|NCT02462486|580234051|FG002|Overall Study|Lack of Efficacy|3|||
160687066|NCT02462486|580234049|FG000|Overall Study|Lost to Follow-up|3|||
160687067|NCT02462486|580234050|FG001|Overall Study|Lost to Follow-up|4|||
160687068|NCT02462486|580234051|FG002|Overall Study|Lost to Follow-up|2|||
160687069|NCT02462486|580234049|FG000|Overall Study|Withdrawal by Subject|25|||
160687070|NCT02462486|580234050|FG001|Overall Study|Withdrawal by Subject|22|||
160687071|NCT02462486|580234051|FG002|Overall Study|Withdrawal by Subject|19|||
160687072|NCT02462486|580234049|FG000|Overall Study|Protocol Violation|3|||
160687073|NCT02462486|580234050|FG001|Overall Study|Protocol Violation|1|||
160687074|NCT02462486|580234051|FG002|Overall Study|Protocol Violation|1|||
160687075|NCT02462486|580234049|FG000|Overall Study|Reason not Specified|3|||
160687076|NCT02462486|580234050|FG001|Overall Study|Reason not Specified|4|||
160687077|NCT02462486|580234051|FG002|Overall Study|Reason not Specified|3|||
160687078|NCT04099641|580234057|FG000|Overall Study|Death|46|||
160687079|NCT04099641|580234058|FG001|Overall Study|Death|12|||
160687080|NCT04099641|580234057|FG000|Overall Study|Lost to Follow-up|1|||
160687081|NCT04099641|580234058|FG001|Overall Study|Lost to Follow-up|0|||
160687082|NCT04099641|580234057|FG000|Overall Study|Withdrawal by Subject|2|||
160687083|NCT04099641|580234058|FG001|Overall Study|Withdrawal by Subject|0|||
160687084|NCT02470091|580234059|FG000|Overall Study|Withdrawal by Subject|1|||
160687085|NCT02470091|580234060|FG001|Overall Study|Withdrawal by Subject|0|||
160687086|NCT02470091|580234059|FG000|Overall Study|Ineligible|0|||
160687087|NCT02470091|580234060|FG001|Overall Study|Ineligible|2|||
160687088|NCT00303667|580234062|FG000|Overall Study|Death|0|||
160687089|NCT00303667|580234063|FG001|Overall Study|Death|4|||
160687090|NCT01029392|580234065|FG000|Overall Study|Withdrawal by Subject|18|||
160687091|NCT01029392|580234066|FG001|Overall Study|Withdrawal by Subject|11|||
160687092|NCT01029392|580234065|FG000|Overall Study|Physician Decision|2|||
160687093|NCT01029392|580234066|FG001|Overall Study|Physician Decision|0|||
160687094|NCT01103479|580234067|FG000|Overall Study|Up to date with CRC screening|1|||
160687095|NCT01103479|580234068|FG001|Overall Study|Up to date with CRC screening|9|||
160687096|NCT01103479|580234069|FG002|Overall Study|Up to date with CRC screening|12|||
160687097|NCT01103479|580234067|FG000|Overall Study|Family history of CRC|1|||
160687098|NCT01103479|580234068|FG001|Overall Study|Family history of CRC|0|||
160687099|NCT01103479|580234069|FG002|Overall Study|Family history of CRC|2|||
160687100|NCT01103479|580234067|FG000|Overall Study|Active cancer|1|||
160687101|NCT01103479|580234068|FG001|Overall Study|Active cancer|0|||
160687102|NCT01103479|580234069|FG002|Overall Study|Active cancer|0|||
160687103|NCT01103479|580234067|FG000|Overall Study|Saw non-study physician|2|||
160687104|NCT01103479|580234068|FG001|Overall Study|Saw non-study physician|0|||
160687105|NCT01103479|580234069|FG002|Overall Study|Saw non-study physician|0|||
160687106|NCT01523587|580234070|FG000|Overall Study|Other than listed|5|||
160687107|NCT01523587|580234071|FG001|Overall Study|Other than listed|5|||
160687108|NCT01523587|580234070|FG000|Overall Study|Worsening of underlying cancer disease|19|||
160687109|NCT01523587|580234071|FG001|Overall Study|Worsening of underlying cancer disease|34|||
160687110|NCT01523587|580234070|FG000|Overall Study|Adverse Event|68|||
160687111|NCT01523587|580234071|FG001|Overall Study|Adverse Event|52|||
160687112|NCT01523587|580234070|FG000|Overall Study|Protocol Violation|5|||
160687113|NCT01523587|580234071|FG001|Overall Study|Protocol Violation|3|||
160687114|NCT01523587|580234070|FG000|Overall Study|Lost to Follow-up|2|||
160687115|NCT01523587|580234071|FG001|Overall Study|Lost to Follow-up|2|||
160687116|NCT01523587|580234070|FG000|Overall Study|Withdrawal by Subject|28|||
160687117|NCT01523587|580234071|FG001|Overall Study|Withdrawal by Subject|20|||
160687118|NCT01523587|580234070|FG000|Overall Study|Withdrew due to Progressive disease|265|||
160687119|NCT01523587|580234071|FG001|Overall Study|Withdrew due to Progressive disease|279|||
160687120|NCT01523587|580234070|FG000|Overall Study|Randomised but bot treated|6|||
160687121|NCT01523587|580234071|FG001|Overall Study|Randomised but bot treated|2|||
160687122|NCT01298778|580234072|FG000|Overall Study|Lost to Follow-up|2|||
160687123|NCT01298778|580234073|FG001|Overall Study|Lost to Follow-up|3|||
160687124|NCT01298778|580234072|FG000|Overall Study|Incorrect use of VAS|1|||
160687125|NCT01298778|580234073|FG001|Overall Study|Incorrect use of VAS|0|||
160687126|NCT01298778|580234072|FG000|Overall Study|Withdrawal by Subject|0|||
160687127|NCT01298778|580234073|FG001|Overall Study|Withdrawal by Subject|1|||
160687128|NCT01298778|580234072|FG000|Overall Study|Protocol Violation|0|||
160687129|NCT01298778|580234073|FG001|Overall Study|Protocol Violation|1|||
160687130|NCT01298778|580234072|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
160687131|NCT01298778|580234073|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
160687132|NCT00384176|580234076|FG000|Overall Study|Death|239|||
160687133|NCT00384176|580234077|FG001|Overall Study|Death|247|||
160687134|NCT00384176|580234078|FG002|Overall Study|Death|105|||
160687135|NCT00384176|580234076|FG000|Overall Study|Withdrawal by Subject|52|||
160687136|NCT00384176|580234077|FG001|Overall Study|Withdrawal by Subject|48|||
160687137|NCT00384176|580234078|FG002|Overall Study|Withdrawal by Subject|22|||
160687138|NCT00384176|580234076|FG000|Overall Study|Lost to Follow-up|16|||
160687139|NCT00384176|580234077|FG001|Overall Study|Lost to Follow-up|18|||
160687140|NCT00384176|580234078|FG002|Overall Study|Lost to Follow-up|4|||
160687141|NCT00384176|580234076|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
160687142|NCT00384176|580234077|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
160687143|NCT00384176|580234078|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
160687144|NCT00384176|580234076|FG000|Overall Study|Longer QTC as Visit 1|1|||
160687145|NCT00384176|580234077|FG001|Overall Study|Longer QTC as Visit 1|0|||
160687146|NCT00384176|580234078|FG002|Overall Study|Longer QTC as Visit 1|0|||
160687147|NCT00384176|580234076|FG000|Overall Study|Toxicity of treatment|1|||
160687148|NCT00384176|580234077|FG001|Overall Study|Toxicity of treatment|0|||
160687149|NCT00384176|580234078|FG002|Overall Study|Toxicity of treatment|0|||
160687150|NCT00384176|580234076|FG000|Overall Study|Did not receive study treatment|0|||
160687151|NCT00384176|580234077|FG001|Overall Study|Did not receive study treatment|1|||
160687152|NCT00384176|580234078|FG002|Overall Study|Did not receive study treatment|1|||
160687153|NCT00384176|580234076|FG000|Overall Study|Physician Decision|0|||
160687154|NCT00384176|580234077|FG001|Overall Study|Physician Decision|2|||
160687155|NCT00384176|580234078|FG002|Overall Study|Physician Decision|0|||
160687156|NCT00384176|580234076|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
160687157|NCT00384176|580234077|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
160687158|NCT00384176|580234078|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
160687159|NCT00842530|580234079|FG000|Overall Study|Serious adverse event|0|||
160687160|NCT00842530|580234080|FG001|Overall Study|Serious adverse event|6|||
160687161|NCT00842530|580234079|FG000|Overall Study|Other adverse event|6|||
160687162|NCT00842530|580234080|FG001|Overall Study|Other adverse event|1|||
160687163|NCT00842530|580234079|FG000|Overall Study|Protocol Violation|32|||
160687164|NCT00842530|580234080|FG001|Overall Study|Protocol Violation|14|||
160687165|NCT00842530|580234079|FG000|Overall Study|Lost to Follow-up|6|||
160687166|NCT00842530|580234080|FG001|Overall Study|Lost to Follow-up|8|||
160687167|NCT00842530|580234079|FG000|Overall Study|Withdrawal by Subject|73|||
160687168|NCT00842530|580234080|FG001|Overall Study|Withdrawal by Subject|28|||
160687169|NCT02939950|580234081|FG000|Overall Study|Lost to Follow-up|13|||
160687170|NCT02939950|580234082|FG001|Overall Study|Lost to Follow-up|16|||
160687171|NCT02939950|580234081|FG000|Overall Study|Positive slit lamp findings|0|||
160687172|NCT02939950|580234082|FG001|Overall Study|Positive slit lamp findings|1|||
160687173|NCT02939950|580234081|FG000|Overall Study|Chalazion upper lid|0|||
160687174|NCT02939950|580234082|FG001|Overall Study|Chalazion upper lid|1|||
160687175|NCT02939950|580234081|FG000|Overall Study|Lack of motivation|0|||
160687176|NCT02939950|580234082|FG001|Overall Study|Lack of motivation|2|||
160687177|NCT02939950|580234081|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
160687178|NCT02939950|580234082|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
160687179|NCT02939950|580234081|FG000|Overall Study|Military orders|1|||
160687180|NCT02939950|580234082|FG001|Overall Study|Military orders|0|||
160687181|NCT02939950|580234081|FG000|Overall Study|Participant Relocated|5|||
160687182|NCT02939950|580234082|FG001|Overall Study|Participant Relocated|3|||
160687183|NCT02939950|580234081|FG000|Overall Study|Study related symptoms|8|||
160687184|NCT02939950|580234082|FG001|Overall Study|Study related symptoms|8|||
160687185|NCT02939950|580234081|FG000|Overall Study|Unacceptable lens movement|2|||
160687186|NCT02939950|580234082|FG001|Overall Study|Unacceptable lens movement|0|||
160687187|NCT02939950|580234081|FG000|Overall Study|Protocol Violation|6|||
160687188|NCT02939950|580234082|FG001|Overall Study|Protocol Violation|3|||
160687189|NCT02939950|580234081|FG000|Overall Study|Physician Decision|2|||
160687190|NCT02939950|580234082|FG001|Overall Study|Physician Decision|0|||
160687191|NCT02939950|580234081|FG000|Overall Study|Pregnancy|6|||
160687192|NCT02939950|580234082|FG001|Overall Study|Pregnancy|7|||
160687193|NCT02939950|580234081|FG000|Overall Study|Withdrawal by Subject|12|||
160687194|NCT02939950|580234082|FG001|Overall Study|Withdrawal by Subject|28|||
160687195|NCT02939950|580234081|FG000|Overall Study|Adverse Event|7|||
160687196|NCT02939950|580234082|FG001|Overall Study|Adverse Event|3|||
160687197|NCT02939950|580234081|FG000|Overall Study|Randomized, not dispensed|1|||
160687198|NCT02939950|580234082|FG001|Overall Study|Randomized, not dispensed|0|||
160687199|NCT02939950|580234081|FG000|Overall Study|Ineligible at Baseline|2|||
160687200|NCT02939950|580234082|FG001|Overall Study|Ineligible at Baseline|8|||
160687201|NCT00402025|580234083|FG000|Overall Study|Adverse Event|0|||
160687202|NCT00402025|580234084|FG001|Overall Study|Adverse Event|0|||
160687203|NCT00402025|580234085|FG002|Overall Study|Adverse Event|2|||
160687204|NCT00402025|580234083|FG000|Overall Study|Death|0|||
160687205|NCT00402025|580234084|FG001|Overall Study|Death|1|||
160687206|NCT00402025|580234085|FG002|Overall Study|Death|5|||
160687207|NCT00402025|580234083|FG000|Overall Study|Disease Progression|1|||
160687208|NCT00402025|580234084|FG001|Overall Study|Disease Progression|1|||
160687209|NCT00402025|580234085|FG002|Overall Study|Disease Progression|2|||
160687210|NCT00402025|580234083|FG000|Overall Study|Physician Decision|1|||
160687211|NCT00402025|580234084|FG001|Overall Study|Physician Decision|1|||
160687212|NCT00402025|580234085|FG002|Overall Study|Physician Decision|0|||
160687213|NCT00402025|580234083|FG000|Overall Study|Participant Decision|0|||
160687214|NCT00402025|580234084|FG001|Overall Study|Participant Decision|0|||
160687215|NCT00402025|580234085|FG002|Overall Study|Participant Decision|1|||
160687216|NCT01221090|580235935|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
160687217|NCT01221090|580235936|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
160687218|NCT01221090|580235937|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
160687219|NCT01221090|580235938|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
160687220|NCT01221090|580235935|FG000|Overall Study|Withdrawal by Subject|0|||
160687221|NCT01221090|580235936|FG001|Overall Study|Withdrawal by Subject|22|||
160687222|NCT01221090|580235937|FG002|Overall Study|Withdrawal by Subject|27|||
160687223|NCT01221090|580235938|FG003|Overall Study|Withdrawal by Subject|2|||
160687224|NCT04507126|580235939|FG000|Overall Study|Withdrawal by Subject|3|||
160687225|NCT04507126|580235939|FG000|Overall Study|Protocol Violation|4|||
160687226|NCT00140413|580235940|FG000|Overall Study|Lost to Follow-up|1|||
160687227|NCT00140413|580235941|FG001|Overall Study|Lost to Follow-up|0|||
160687228|NCT00140413|580235940|FG000|Overall Study|Withdrawal by Subject|2|||
160687229|NCT00140413|580235941|FG001|Overall Study|Withdrawal by Subject|0|||
160687230|NCT02459665|580235942|FG000|Overall Study|Withdrawal by Subject|0|||
160687231|NCT02459665|580235943|FG001|Overall Study|Withdrawal by Subject|1|||
160687232|NCT02459665|580235944|FG002|Overall Study|Withdrawal by Subject|1|||
160687233|NCT02459665|580235945|FG003|Overall Study|Withdrawal by Subject|2|||
160687234|NCT01223235|580235946|FG000|Overall Study|Withdrawal by Subject|1|||
160687235|NCT05444556|580235954|FG000|Overall Study|Withdrawal by Subject|0|||
160687236|NCT05444556|580235955|FG001|Overall Study|Withdrawal by Subject|0|||
160687237|NCT05444556|580235956|FG002|Overall Study|Withdrawal by Subject|2|||
160687238|NCT05444556|580235957|FG003|Overall Study|Withdrawal by Subject|1|||
160687239|NCT00754442|580235963|FG000|Overall Study|Withdrawal by Subject|5|||
160687240|NCT00754442|580235964|FG001|Overall Study|Withdrawal by Subject|3|||
160687241|NCT05560763|580235969|FG000|Overall Study|Withdrawal by Subject|4|||
160687242|NCT00296491|580235970|FG000|Overall Study|Low Pollen Counts|18|||
160687243|NCT00296491|580235971|FG001|Overall Study|Low Pollen Counts|26|||
160687244|NCT00296491|580235972|FG002|Overall Study|Low Pollen Counts|25|||
160687245|NCT00296491|580235973|FG003|Overall Study|Low Pollen Counts|16|||
160687246|NCT00296491|580235970|FG000|Overall Study|Protocol Violation|4|||
160687247|NCT00296491|580235971|FG001|Overall Study|Protocol Violation|6|||
160687248|NCT00296491|580235972|FG002|Overall Study|Protocol Violation|2|||
160687249|NCT00296491|580235973|FG003|Overall Study|Protocol Violation|3|||
160687250|NCT00296491|580235970|FG000|Overall Study|Adverse Event|1|||
160687251|NCT00296491|580235971|FG001|Overall Study|Adverse Event|3|||
160687252|NCT00296491|580235972|FG002|Overall Study|Adverse Event|1|||
160687253|NCT00296491|580235973|FG003|Overall Study|Adverse Event|4|||
160687254|NCT00296491|580235970|FG000|Overall Study|Withdrawn due to Asthma|0|||
160687255|NCT00296491|580235971|FG001|Overall Study|Withdrawn due to Asthma|0|||
160687256|NCT00296491|580235972|FG002|Overall Study|Withdrawn due to Asthma|0|||
160687257|NCT00296491|580235973|FG003|Overall Study|Withdrawn due to Asthma|4|||
160687258|NCT00296491|580235970|FG000|Overall Study|Withdrawal by Subject|7|||
160687259|NCT00296491|580235971|FG001|Overall Study|Withdrawal by Subject|3|||
160687260|NCT00296491|580235972|FG002|Overall Study|Withdrawal by Subject|3|||
160687261|NCT00296491|580235973|FG003|Overall Study|Withdrawal by Subject|2|||
160687262|NCT00296491|580235970|FG000|Overall Study|Non-Compliance|12|||
160687263|NCT00296491|580235971|FG001|Overall Study|Non-Compliance|13|||
160687264|NCT00296491|580235972|FG002|Overall Study|Non-Compliance|10|||
160687265|NCT00296491|580235973|FG003|Overall Study|Non-Compliance|14|||
160687266|NCT00296491|580235970|FG000|Overall Study|Lost to Follow-up|0|||
160687267|NCT00296491|580235971|FG001|Overall Study|Lost to Follow-up|2|||
160687268|NCT00296491|580235972|FG002|Overall Study|Lost to Follow-up|2|||
160687269|NCT00296491|580235973|FG003|Overall Study|Lost to Follow-up|0|||
160687270|NCT00949988|580235982|FG000|Overall Study|Withdrawal by Subject|3|||
160687271|NCT01929395|580235984|FG000|Overall Study|Did not complete - non-related toxicity|1|||
160687272|NCT01929395|580235985|FG001|Overall Study|Did not complete - non-related toxicity|0|||
160687273|NCT01929395|580235986|FG002|Overall Study|Did not complete - non-related toxicity|0|||
160687274|NCT01929395|580235984|FG000|Overall Study|Withdrawal by Subject|0|||
160687275|NCT01929395|580235985|FG001|Overall Study|Withdrawal by Subject|1|||
160687276|NCT01929395|580235986|FG002|Overall Study|Withdrawal by Subject|0|||
160687277|NCT01929395|580235984|FG000|Overall Study|Screen Fail|0|||
160687278|NCT01929395|580235985|FG001|Overall Study|Screen Fail|0|||
160687279|NCT01929395|580235986|FG002|Overall Study|Screen Fail|1|||
160687280|NCT00484419|580235987|FG000|Overall Study|Adverse Event|3|||
160687281|NCT00484419|580235988|FG001|Overall Study|Adverse Event|0|||
160687282|NCT00484419|580235989|FG002|Overall Study|Adverse Event|0|||
160687283|NCT00484419|580235987|FG000|Overall Study|Lost to Follow-up|1|||
160687284|NCT00484419|580235988|FG001|Overall Study|Lost to Follow-up|0|||
160687285|NCT00484419|580235989|FG002|Overall Study|Lost to Follow-up|2|||
160687286|NCT00484419|580235987|FG000|Overall Study|Withdrawal by Subject|3|||
160687287|NCT00484419|580235988|FG001|Overall Study|Withdrawal by Subject|1|||
160687288|NCT00484419|580235989|FG002|Overall Study|Withdrawal by Subject|1|||
160687289|NCT00484419|580235987|FG000|Overall Study|subject met discontinuation criteria|2|||
160687290|NCT00484419|580235988|FG001|Overall Study|subject met discontinuation criteria|2|||
160687291|NCT00484419|580235989|FG002|Overall Study|subject met discontinuation criteria|4|||
160687292|NCT00484419|580235987|FG000|Overall Study|required restricted medication|1|||
160687293|NCT00484419|580235988|FG001|Overall Study|required restricted medication|0|||
160687294|NCT00484419|580235989|FG002|Overall Study|required restricted medication|1|||
160687295|NCT00484419|580235987|FG000|Overall Study|Physician Decision|1|||
160687296|NCT00484419|580235988|FG001|Overall Study|Physician Decision|1|||
160687297|NCT00484419|580235989|FG002|Overall Study|Physician Decision|1|||
160687298|NCT00484419|580235987|FG000|Overall Study|subject unable to receive medication|1|||
160687299|NCT00484419|580235988|FG001|Overall Study|subject unable to receive medication|0|||
160687300|NCT00484419|580235989|FG002|Overall Study|subject unable to receive medication|0|||
160687301|NCT00484419|580235987|FG000|Overall Study|subject relocated|0|||
160687302|NCT00484419|580235988|FG001|Overall Study|subject relocated|1|||
160687303|NCT00484419|580235989|FG002|Overall Study|subject relocated|0|||
160687304|NCT00484419|580235987|FG000|Overall Study|sponsor decision, randomized in error|0|||
160687305|NCT00484419|580235988|FG001|Overall Study|sponsor decision, randomized in error|0|||
160687306|NCT00484419|580235989|FG002|Overall Study|sponsor decision, randomized in error|2|||
160687307|NCT03604341|580235990|FG000|Overall Study|Withdrawal by Subject|1|||
160687308|NCT03604341|580235991|FG001|Overall Study|Withdrawal by Subject|1|||
160687309|NCT03604341|580235990|FG000|Overall Study|Adverse Event|1|||
160687310|NCT03604341|580235991|FG001|Overall Study|Adverse Event|0|||
160687311|NCT03604341|580235990|FG000|Overall Study|Protocol Violation|0|||
160687312|NCT03604341|580235991|FG001|Overall Study|Protocol Violation|1|||
160687313|NCT01829113|580235992|FG000|Overall Study|Disease Progression|37|||
160687314|NCT01829113|580235993|FG001|Overall Study|Disease Progression|48|||
160687315|NCT01829113|580235992|FG000|Overall Study|Adverse Event|14|||
160687316|NCT01829113|580235993|FG001|Overall Study|Adverse Event|10|||
160687317|NCT01829113|580235992|FG000|Overall Study|Withdrawal by Subject|17|||
160687318|NCT01829113|580235993|FG001|Overall Study|Withdrawal by Subject|10|||
160687319|NCT01829113|580235992|FG000|Overall Study|Death|4|||
160687320|NCT01829113|580235993|FG001|Overall Study|Death|6|||
160687321|NCT01829113|580235992|FG000|Overall Study|Sponsor Decision|1|||
160687322|NCT01829113|580235993|FG001|Overall Study|Sponsor Decision|1|||
160687323|NCT01829113|580235992|FG000|Overall Study|No Study Treatment Received|3|||
160687324|NCT01829113|580235993|FG001|Overall Study|No Study Treatment Received|2|||
160687325|NCT01829113|580235992|FG000|Overall Study|Physician Decision|1|||
160687326|NCT01829113|580235993|FG001|Overall Study|Physician Decision|1|||
160687327|NCT01740791|580235994|FG000|Overall Study|Randomized but never treated|5|||
160687328|NCT01740791|580235995|FG001|Overall Study|Randomized but never treated|3|||
160687329|NCT01740791|580235996|FG002|Overall Study|Randomized but never treated|2|||
160687330|NCT01740791|580235997|FG003|Overall Study|Randomized but never treated|2|||
160687331|NCT01740791|580235998|FG004|Overall Study|Randomized but never treated|1|||
160687332|NCT01740791|580235999|FG005|Overall Study|Randomized but never treated|3|||
160687333|NCT01740791|580235994|FG000|Overall Study|Lost to Follow-up|2|||
160687334|NCT01740791|580235995|FG001|Overall Study|Lost to Follow-up|0|||
160687335|NCT01740791|580235996|FG002|Overall Study|Lost to Follow-up|2|||
160687336|NCT01740791|580235997|FG003|Overall Study|Lost to Follow-up|3|||
160687337|NCT01740791|580235998|FG004|Overall Study|Lost to Follow-up|2|||
160687338|NCT01740791|580235999|FG005|Overall Study|Lost to Follow-up|3|||
160687339|NCT01740791|580235994|FG000|Overall Study|Withdrew Consent|4|||
160687340|NCT01740791|580235995|FG001|Overall Study|Withdrew Consent|0|||
160687341|NCT01740791|580235996|FG002|Overall Study|Withdrew Consent|1|||
160687342|NCT01740791|580235997|FG003|Overall Study|Withdrew Consent|2|||
160687343|NCT01740791|580235998|FG004|Overall Study|Withdrew Consent|0|||
160687344|NCT01740791|580235999|FG005|Overall Study|Withdrew Consent|3|||
160687345|NCT01740791|580235994|FG000|Overall Study|Investigator's discretion|1|||
160687346|NCT01740791|580235995|FG001|Overall Study|Investigator's discretion|0|||
160687347|NCT01740791|580235996|FG002|Overall Study|Investigator's discretion|1|||
160687348|NCT01740791|580235997|FG003|Overall Study|Investigator's discretion|0|||
160687349|NCT01740791|580235998|FG004|Overall Study|Investigator's discretion|0|||
160687350|NCT01740791|580235999|FG005|Overall Study|Investigator's discretion|1|||
160687351|NCT01740791|580235994|FG000|Overall Study|Adverse Event|0|||
160687352|NCT01740791|580235995|FG001|Overall Study|Adverse Event|0|||
160687353|NCT01740791|580235996|FG002|Overall Study|Adverse Event|0|||
160687354|NCT01740791|580235997|FG003|Overall Study|Adverse Event|0|||
160687355|NCT01740791|580235998|FG004|Overall Study|Adverse Event|0|||
160687356|NCT01740791|580235999|FG005|Overall Study|Adverse Event|1|||
160687357|NCT04706507|580236000|FG000|Overall Study|Death|45|||
160687358|NCT04706507|580236001|FG001|Overall Study|Death|22|||
160687359|NCT04706507|580236000|FG000|Overall Study|Unable to adhere|0|||
160687360|NCT04706507|580236001|FG001|Overall Study|Unable to adhere|2|||
160687361|NCT04706507|580236000|FG000|Overall Study|Lost to Follow-up|13|||
160687362|NCT04706507|580236001|FG001|Overall Study|Lost to Follow-up|12|||
160687363|NCT04706507|580236000|FG000|Overall Study|Withdrawal of consent|1|||
160687364|NCT04706507|580236001|FG001|Overall Study|Withdrawal of consent|1|||
160687365|NCT04706507|580236000|FG000|Overall Study|Patient or LAR refuses further participation|0|||
160687366|NCT04706507|580236001|FG001|Overall Study|Patient or LAR refuses further participation|3|||
160687367|NCT00396331|580236007|FG000|Overall Study|Failed to mobilize - no transplant|8|||
160687368|NCT00396331|580236007|FG000|Overall Study|Did not go on to transplant|5|||
160687369|NCT00396331|580236007|FG000|Overall Study|Lost to Follow-up|3|||
160687370|NCT00396331|580236007|FG000|Overall Study|Death|16|||
160687371|NCT00873119|580236014|FG000|Overall Study|Patient request|4|||
160687372|NCT00873119|580236015|FG001|Overall Study|Patient request|2|||
160687373|NCT00873119|580236014|FG000|Overall Study|Adverse Event|8|||
160687374|NCT00873119|580236015|FG001|Overall Study|Adverse Event|0|||
160687375|NCT00873119|580236014|FG000|Overall Study|Progressive disease|26|||
160687376|NCT00873119|580236015|FG001|Overall Study|Progressive disease|18|||
160687377|NCT00873119|580236014|FG000|Overall Study|Death|2|||
160687378|NCT00873119|580236015|FG001|Overall Study|Death|1|||
160687379|NCT00873119|580236014|FG000|Overall Study|Other|2|||
160687380|NCT00873119|580236015|FG001|Overall Study|Other|5|||
160687381|NCT00873119|580236014|FG000|Overall Study|Not treated|2|||
160687382|NCT00873119|580236015|FG001|Overall Study|Not treated|0|||
160687383|NCT03648879|580236016|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
160687384|NCT00285584|580236017|FG000|Month 3|Lost to Follow-up|3|||
160687385|NCT00285584|580236018|FG001|Month 3|Lost to Follow-up|3|||
160687386|NCT00285584|580236017|FG000|Month 3|Withdrawal by Subject|1|||
160687387|NCT00285584|580236018|FG001|Month 3|Withdrawal by Subject|0|||
160687388|NCT00285584|580236017|FG000|Month 6|Lost to Follow-up|0|||
160687389|NCT00285584|580236018|FG001|Month 6|Lost to Follow-up|1|||
160687390|NCT01884688|580236019|FG000|Overall Study|Screen Failure|2|||
160687391|NCT02709486|580236020|FG000|Overall Study|Adverse Event|2|||
160687392|NCT02709486|580236021|FG001|Overall Study|Adverse Event|5|||
160687393|NCT02709486|580236022|FG002|Overall Study|Adverse Event|3|||
160687394|NCT02709486|580236020|FG000|Overall Study|Death|0|||
160687395|NCT02709486|580236021|FG001|Overall Study|Death|0|||
160687396|NCT02709486|580236022|FG002|Overall Study|Death|2|||
160687397|NCT02709486|580236020|FG000|Overall Study|Insufficient clinical response|7|||
160687398|NCT02709486|580236021|FG001|Overall Study|Insufficient clinical response|3|||
160687399|NCT02709486|580236022|FG002|Overall Study|Insufficient clinical response|3|||
160687400|NCT02709486|580236020|FG000|Overall Study|Lost to Follow-up|3|||
160687401|NCT02709486|580236021|FG001|Overall Study|Lost to Follow-up|2|||
160687402|NCT02709486|580236022|FG002|Overall Study|Lost to Follow-up|2|||
160687403|NCT02709486|580236020|FG000|Overall Study|Other|0|||
160687404|NCT02709486|580236021|FG001|Overall Study|Other|2|||
160687405|NCT02709486|580236022|FG002|Overall Study|Other|3|||
160687406|NCT02709486|580236020|FG000|Overall Study|Withdrawal by Subject|32|||
160687407|NCT02709486|580236021|FG001|Overall Study|Withdrawal by Subject|22|||
160687408|NCT02709486|580236022|FG002|Overall Study|Withdrawal by Subject|32|||
160687409|NCT00536484|580236027|FG000|Overall Study|Adverse Event|21|||
160687410|NCT00536484|580236028|FG001|Overall Study|Adverse Event|34|||
160687411|NCT00536484|580236027|FG000|Overall Study|Withdrawal by Subject|11|||
160687412|NCT00536484|580236028|FG001|Overall Study|Withdrawal by Subject|11|||
160687413|NCT00536484|580236027|FG000|Overall Study|Lost to Follow-up|8|||
160687414|NCT00536484|580236028|FG001|Overall Study|Lost to Follow-up|6|||
160687415|NCT00536484|580236027|FG000|Overall Study|Lack of Efficacy|16|||
160687416|NCT00536484|580236028|FG001|Overall Study|Lack of Efficacy|5|||
160687417|NCT00536484|580236027|FG000|Overall Study|Other|4|||
160687418|NCT00536484|580236028|FG001|Overall Study|Other|0|||
160687419|NCT00706355|580236029|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
160687420|NCT00706355|580236030|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
160687421|NCT00706355|580236031|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
160687422|NCT00706355|580236032|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
160687423|NCT00706355|580236029|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
160687424|NCT00706355|580236030|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
160687425|NCT00706355|580236031|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
160687426|NCT00706355|580236032|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
160687427|NCT00706355|580236029|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
160687428|NCT00706355|580236030|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
160687429|NCT00706355|580236031|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
160687430|NCT00706355|580236032|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
160687431|NCT00706355|580236029|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
160687432|NCT00706355|580236030|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
160687433|NCT00706355|580236031|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
160687434|NCT00706355|580236032|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
160687435|NCT00706355|580236029|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
160687436|NCT00706355|580236030|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
160687437|NCT00706355|580236031|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
160687438|NCT00706355|580236032|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
160687439|NCT00706355|580236029|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
160687440|NCT00706355|580236030|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
160687441|NCT00706355|580236031|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
160687442|NCT00706355|580236032|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
160687443|NCT00706355|580236029|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
160687444|NCT00706355|580236030|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
160687445|NCT00706355|580236031|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
160687446|NCT00706355|580236032|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
160687447|NCT00706355|580236029|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
160687448|NCT00706355|580236030|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
160687449|NCT00706355|580236031|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
160687450|NCT00706355|580236032|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
160687451|NCT00706355|580236029|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
160687452|NCT00706355|580236030|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
160687453|NCT00706355|580236031|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
160687454|NCT00706355|580236032|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
160687455|NCT02549573|580236035|FG000|Overall Study|Withdrawal by Subject|0|||
160687456|NCT02549573|580236036|FG001|Overall Study|Withdrawal by Subject|2|||
160687457|NCT02549573|580236035|FG000|Overall Study|Protocol Violation|0|||
160687458|NCT02549573|580236036|FG001|Overall Study|Protocol Violation|1|||
160687459|NCT02610816|580236039|FG000|Phase 1|Withdrawal by Subject|2|||
160687460|NCT02610816|580236040|FG001|Phase 1|Withdrawal by Subject|6|||
160687461|NCT02610816|580236041|FG002|Phase 1|Withdrawal by Subject|0|||
160687462|NCT02610816|580236042|FG003|Phase 1|Withdrawal by Subject|0|||
160687463|NCT02610816|580236039|FG000|Phase 1|Lost to Follow-up|2|||
160687464|NCT02610816|580236040|FG001|Phase 1|Lost to Follow-up|1|||
160687465|NCT02610816|580236041|FG002|Phase 1|Lost to Follow-up|0|||
160687466|NCT02610816|580236042|FG003|Phase 1|Lost to Follow-up|0|||
160687467|NCT02610816|580236039|FG000|Phase 1|Physician Decision|0|||
160687468|NCT02610816|580236040|FG001|Phase 1|Physician Decision|1|||
160687469|NCT02610816|580236041|FG002|Phase 1|Physician Decision|0|||
160687470|NCT02610816|580236042|FG003|Phase 1|Physician Decision|0|||
160687471|NCT02610816|580236039|FG000|Phase 2|Withdrawal by Subject|0|||
160687472|NCT02610816|580236040|FG001|Phase 2|Withdrawal by Subject|0|||
160687473|NCT02610816|580236041|FG002|Phase 2|Withdrawal by Subject|9|||
160687474|NCT02610816|580236042|FG003|Phase 2|Withdrawal by Subject|3|||
160687475|NCT02610816|580236039|FG000|Phase 2|Lost to Follow-up|0|||
160687476|NCT02610816|580236040|FG001|Phase 2|Lost to Follow-up|0|||
160687477|NCT02610816|580236041|FG002|Phase 2|Lost to Follow-up|2|||
160687478|NCT02610816|580236042|FG003|Phase 2|Lost to Follow-up|0|||
160687479|NCT02610816|580236039|FG000|Phase 2|Physician Decision|0|||
160687480|NCT02610816|580236040|FG001|Phase 2|Physician Decision|0|||
160687481|NCT02610816|580236041|FG002|Phase 2|Physician Decision|0|||
160687482|NCT02610816|580236042|FG003|Phase 2|Physician Decision|2|||
160687483|NCT02610816|580236039|FG000|Phase 2|Pregnancy|0|||
160687484|NCT02610816|580236040|FG001|Phase 2|Pregnancy|0|||
160687485|NCT02610816|580236041|FG002|Phase 2|Pregnancy|0|||
160687486|NCT02610816|580236042|FG003|Phase 2|Pregnancy|1|||
160687487|NCT02691741|580236043|FG000|Overall Study|Adverse Event|0|||
160687488|NCT02691741|580236044|FG001|Overall Study|Adverse Event|2|||
160687489|NCT02691741|580236043|FG000|Overall Study|Lost to Follow-up|1|||
160687490|NCT02691741|580236044|FG001|Overall Study|Lost to Follow-up|0|||
160687491|NCT02691741|580236043|FG000|Overall Study|Physician Decision|0|||
160687492|NCT02691741|580236044|FG001|Overall Study|Physician Decision|1|||
160687493|NCT02691741|580236043|FG000|Overall Study|Withdrawal by Subject|0|||
160687494|NCT02691741|580236044|FG001|Overall Study|Withdrawal by Subject|4|||
160687495|NCT03465436|580236045|FG000|Period 1|Protocol Violation|0|||
160687496|NCT03465436|580236046|FG001|Period 1|Protocol Violation|0|||
160687497|NCT03465436|580236047|FG002|Period 1|Protocol Violation|1|||
160687498|NCT03465436|580236048|FG003|Period 1|Protocol Violation|0|||
160687499|NCT03465436|580236045|FG000|Period 2|Protocol Violation|0|||
160687500|NCT03465436|580236046|FG001|Period 2|Protocol Violation|1|||
160687501|NCT03465436|580236047|FG002|Period 2|Protocol Violation|0|||
160687502|NCT03465436|580236048|FG003|Period 2|Protocol Violation|0|||
160687503|NCT03465436|580236045|FG000|Period 3|Protocol Violation|1|||
160687504|NCT03465436|580236046|FG001|Period 3|Protocol Violation|1|||
160687505|NCT03465436|580236047|FG002|Period 3|Protocol Violation|0|||
160687506|NCT03465436|580236048|FG003|Period 3|Protocol Violation|0|||
160687507|NCT03465436|580236045|FG000|Period 4|Protocol Violation|0|||
160687508|NCT03465436|580236046|FG001|Period 4|Protocol Violation|0|||
160687509|NCT03465436|580236047|FG002|Period 4|Protocol Violation|1|||
160687510|NCT03465436|580236048|FG003|Period 4|Protocol Violation|0|||
160687511|NCT01425528|580236049|FG000|Overall Study|Withdrawal by Subject|1|||
160687512|NCT01425528|580236050|FG001|Overall Study|Withdrawal by Subject|1|||
160687513|NCT02697773|580236051|FG000|Overall Study|Adverse Event|2|||
160687514|NCT02697773|580236052|FG001|Overall Study|Adverse Event|1|||
160687515|NCT02697773|580236053|FG002|Overall Study|Adverse Event|2|||
160687516|NCT02697773|580236051|FG000|Overall Study|Death|0|||
160687517|NCT02697773|580236052|FG001|Overall Study|Death|0|||
160687518|NCT02697773|580236053|FG002|Overall Study|Death|2|||
160687519|NCT02697773|580236051|FG000|Overall Study|Lack of Efficacy|4|||
160687520|NCT02697773|580236052|FG001|Overall Study|Lack of Efficacy|6|||
160687521|NCT02697773|580236053|FG002|Overall Study|Lack of Efficacy|6|||
160687522|NCT02697773|580236051|FG000|Overall Study|Lost to Follow-up|5|||
160687523|NCT02697773|580236052|FG001|Overall Study|Lost to Follow-up|5|||
160687524|NCT02697773|580236053|FG002|Overall Study|Lost to Follow-up|7|||
160687525|NCT02697773|580236051|FG000|Overall Study|Other|15|||
160687526|NCT02697773|580236052|FG001|Overall Study|Other|11|||
160687527|NCT02697773|580236053|FG002|Overall Study|Other|10|||
160687528|NCT02697773|580236051|FG000|Overall Study|Protocol Violation|1|||
160687529|NCT02697773|580236052|FG001|Overall Study|Protocol Violation|1|||
160687530|NCT02697773|580236053|FG002|Overall Study|Protocol Violation|0|||
160687531|NCT02697773|580236051|FG000|Overall Study|Withdrawal by Subject|10|||
160687532|NCT02697773|580236052|FG001|Overall Study|Withdrawal by Subject|13|||
160687533|NCT02697773|580236053|FG002|Overall Study|Withdrawal by Subject|13|||
160687534|NCT02697773|580236051|FG000|Overall Study|Randomized but not treated|1|||
160687535|NCT02697773|580236052|FG001|Overall Study|Randomized but not treated|1|||
160687536|NCT02697773|580236053|FG002|Overall Study|Randomized but not treated|0|||
160687537|NCT02243293|580236054|FG000|Overall Study|Adverse Event|1|||
160687538|NCT02243293|580236055|FG001|Overall Study|Adverse Event|0|||
160687539|NCT02243293|580236056|FG002|Overall Study|Adverse Event|0|||
160687540|NCT02243293|580236057|FG003|Overall Study|Adverse Event|0|||
160687541|NCT02243293|580236058|FG004|Overall Study|Adverse Event|0|||
160687542|NCT02243293|580236059|FG005|Overall Study|Adverse Event|0|||
160687543|NCT02243293|580236060|FG006|Overall Study|Adverse Event|0|||
160687544|NCT02243293|580236061|FG007|Overall Study|Adverse Event|0|||
160687545|NCT02243293|580236062|FG008|Overall Study|Adverse Event|0|||
160687546|NCT02243293|580236063|FG009|Overall Study|Adverse Event|0|||
160687547|NCT02243293|580236064|FG010|Overall Study|Adverse Event|0|||
160687548|NCT02243293|580236065|FG011|Overall Study|Adverse Event|0|||
160687549|NCT02243293|580236066|FG012|Overall Study|Adverse Event|0|||
160687550|NCT02243293|580236067|FG013|Overall Study|Adverse Event|0|||
160687551|NCT02243293|580236068|FG014|Overall Study|Adverse Event|0|||
160687552|NCT02243293|580236069|FG015|Overall Study|Adverse Event|1|||
160687553|NCT02243293|580236070|FG016|Overall Study|Adverse Event|0|||
160687554|NCT02243293|580236071|FG017|Overall Study|Adverse Event|0|||
160687555|NCT02243293|580236072|FG018|Overall Study|Adverse Event|0|||
160687556|NCT02243293|580236073|FG019|Overall Study|Adverse Event|0|||
160687557|NCT02243293|580236074|FG020|Overall Study|Adverse Event|1|||
160687558|NCT02243293|580236075|FG021|Overall Study|Adverse Event|0|||
160687559|NCT02243293|580236054|FG000|Overall Study|Withdrawal by Subject|1|||
160687560|NCT02243293|580236055|FG001|Overall Study|Withdrawal by Subject|0|||
160687561|NCT02243293|580236056|FG002|Overall Study|Withdrawal by Subject|0|||
160687562|NCT02243293|580236057|FG003|Overall Study|Withdrawal by Subject|0|||
160687563|NCT02243293|580236058|FG004|Overall Study|Withdrawal by Subject|0|||
160687564|NCT02243293|580236059|FG005|Overall Study|Withdrawal by Subject|0|||
160687565|NCT02243293|580236060|FG006|Overall Study|Withdrawal by Subject|0|||
160687566|NCT02243293|580236061|FG007|Overall Study|Withdrawal by Subject|0|||
160687567|NCT02243293|580236062|FG008|Overall Study|Withdrawal by Subject|0|||
160687568|NCT02243293|580236063|FG009|Overall Study|Withdrawal by Subject|1|||
160687569|NCT02243293|580236064|FG010|Overall Study|Withdrawal by Subject|0|||
160687570|NCT02243293|580236065|FG011|Overall Study|Withdrawal by Subject|1|||
160687571|NCT02243293|580236066|FG012|Overall Study|Withdrawal by Subject|0|||
160687572|NCT02243293|580236067|FG013|Overall Study|Withdrawal by Subject|0|||
160687573|NCT02243293|580236068|FG014|Overall Study|Withdrawal by Subject|0|||
160687574|NCT02243293|580236069|FG015|Overall Study|Withdrawal by Subject|0|||
160687575|NCT02243293|580236070|FG016|Overall Study|Withdrawal by Subject|0|||
160687576|NCT02243293|580236071|FG017|Overall Study|Withdrawal by Subject|0|||
160687577|NCT02243293|580236072|FG018|Overall Study|Withdrawal by Subject|0|||
160687578|NCT02243293|580236073|FG019|Overall Study|Withdrawal by Subject|0|||
160687579|NCT02243293|580236074|FG020|Overall Study|Withdrawal by Subject|0|||
160687580|NCT02243293|580236075|FG021|Overall Study|Withdrawal by Subject|1|||
160687581|NCT02243293|580236054|FG000|Overall Study|Lost to Follow-up|0|||
160687582|NCT02243293|580236055|FG001|Overall Study|Lost to Follow-up|1|||
160687583|NCT02243293|580236056|FG002|Overall Study|Lost to Follow-up|1|||
160687584|NCT02243293|580236057|FG003|Overall Study|Lost to Follow-up|1|||
160687585|NCT02243293|580236058|FG004|Overall Study|Lost to Follow-up|0|||
160687586|NCT02243293|580236059|FG005|Overall Study|Lost to Follow-up|0|||
160687587|NCT02243293|580236060|FG006|Overall Study|Lost to Follow-up|3|||
160687588|NCT02243293|580236061|FG007|Overall Study|Lost to Follow-up|0|||
160687589|NCT02243293|580236062|FG008|Overall Study|Lost to Follow-up|0|||
160687590|NCT02243293|580236063|FG009|Overall Study|Lost to Follow-up|0|||
160687591|NCT02243293|580236064|FG010|Overall Study|Lost to Follow-up|0|||
160687592|NCT02243293|580236065|FG011|Overall Study|Lost to Follow-up|2|||
160687593|NCT02243293|580236066|FG012|Overall Study|Lost to Follow-up|0|||
160687594|NCT02243293|580236067|FG013|Overall Study|Lost to Follow-up|0|||
160687595|NCT02243293|580236068|FG014|Overall Study|Lost to Follow-up|0|||
160687596|NCT02243293|580236069|FG015|Overall Study|Lost to Follow-up|0|||
160687597|NCT02243293|580236070|FG016|Overall Study|Lost to Follow-up|3|||
160687598|NCT02243293|580236071|FG017|Overall Study|Lost to Follow-up|1|||
160687599|NCT02243293|580236072|FG018|Overall Study|Lost to Follow-up|0|||
160687600|NCT02243293|580236073|FG019|Overall Study|Lost to Follow-up|0|||
160687601|NCT02243293|580236074|FG020|Overall Study|Lost to Follow-up|1|||
160687602|NCT02243293|580236075|FG021|Overall Study|Lost to Follow-up|2|||
160687603|NCT02243293|580236054|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
160687604|NCT02243293|580236055|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
160687605|NCT02243293|580236056|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
160687606|NCT02243293|580236057|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
160687607|NCT02243293|580236058|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
160687608|NCT02243293|580236059|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
160687609|NCT02243293|580236060|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
160687610|NCT02243293|580236061|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
160687611|NCT02243293|580236062|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
160687612|NCT02243293|580236063|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
160687613|NCT02243293|580236064|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
160687614|NCT02243293|580236065|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
160687615|NCT02243293|580236066|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
160687616|NCT02243293|580236067|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
160687617|NCT02243293|580236068|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
160687618|NCT02243293|580236069|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
160687619|NCT02243293|580236070|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
160687620|NCT02243293|580236071|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
160687621|NCT02243293|580236072|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
160687622|NCT02243293|580236073|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
160687623|NCT02243293|580236074|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
160687624|NCT02243293|580236075|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
160687625|NCT02243293|580236054|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
160687626|NCT02243293|580236055|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
160687627|NCT02243293|580236056|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
160687628|NCT02243293|580236057|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
160687629|NCT02243293|580236058|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
160687630|NCT02243293|580236059|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
160687631|NCT02243293|580236060|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
160687632|NCT02243293|580236061|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
160687633|NCT02243293|580236062|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
160687634|NCT02243293|580236063|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
160687635|NCT02243293|580236064|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
160687636|NCT02243293|580236065|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
160687637|NCT02243293|580236066|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
160687638|NCT02243293|580236067|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
160687639|NCT02243293|580236068|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
160687640|NCT02243293|580236069|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
160687641|NCT02243293|580236070|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
160687642|NCT02243293|580236071|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
160687643|NCT02243293|580236072|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
160687644|NCT02243293|580236073|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
160687645|NCT02243293|580236074|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
160687646|NCT02243293|580236075|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
160687647|NCT01172821|580236081|FG000|Overall Study|Adverse Event|5|||
160687648|NCT01172821|580236082|FG001|Overall Study|Adverse Event|2|||
160687649|NCT01172821|580236083|FG002|Overall Study|Adverse Event|2|||
160687650|NCT01172821|580236084|FG003|Overall Study|Adverse Event|7|||
160687651|NCT01172821|580236081|FG000|Overall Study|Protocol Violation|0|||
160687652|NCT01172821|580236082|FG001|Overall Study|Protocol Violation|2|||
160687653|NCT01172821|580236083|FG002|Overall Study|Protocol Violation|1|||
160687654|NCT01172821|580236084|FG003|Overall Study|Protocol Violation|2|||
160687655|NCT01172821|580236081|FG000|Overall Study|Lost to Follow-up|4|||
160687656|NCT01172821|580236082|FG001|Overall Study|Lost to Follow-up|1|||
160687657|NCT01172821|580236083|FG002|Overall Study|Lost to Follow-up|2|||
160687658|NCT01172821|580236084|FG003|Overall Study|Lost to Follow-up|2|||
160687659|NCT01172821|580236081|FG000|Overall Study|Withdrawal by Subject|2|||
160687660|NCT01172821|580236082|FG001|Overall Study|Withdrawal by Subject|3|||
160687661|NCT01172821|580236083|FG002|Overall Study|Withdrawal by Subject|3|||
160687662|NCT01172821|580236084|FG003|Overall Study|Withdrawal by Subject|3|||
160687663|NCT01172821|580236081|FG000|Overall Study|Other|3|||
160687664|NCT01172821|580236082|FG001|Overall Study|Other|4|||
160687665|NCT01172821|580236083|FG002|Overall Study|Other|5|||
160687666|NCT01172821|580236084|FG003|Overall Study|Other|3|||
160687667|NCT02756637|580236087|FG000|Overall Study|Not eligible for initial SWOG study|10|||
160687668|NCT02756637|580236088|FG001|Overall Study|Not eligible for initial SWOG study|10|||
160687669|NCT02756637|580236087|FG000|Overall Study|No available NLR value|44|||
160687670|NCT02756637|580236088|FG001|Overall Study|No available NLR value|44|||
160687671|NCT02756637|580236087|FG000|Overall Study|Did not complete curative therapy|33|||
160687672|NCT02756637|580236088|FG001|Overall Study|Did not complete curative therapy|0|||
160687673|NCT02985879|580236089|FG000|Overall Study|Adverse Event|7|||
160687674|NCT02985879|580236090|FG001|Overall Study|Adverse Event|9|||
160687675|NCT02985879|580236091|FG002|Overall Study|Adverse Event|7|||
160687676|NCT02985879|580236089|FG000|Overall Study|Withdrew consent|6|||
160687677|NCT02985879|580236090|FG001|Overall Study|Withdrew consent|8|||
160687678|NCT02985879|580236091|FG002|Overall Study|Withdrew consent|10|||
160687679|NCT02985879|580236089|FG000|Overall Study|Lost to Follow-up|1|||
160687680|NCT02985879|580236090|FG001|Overall Study|Lost to Follow-up|0|||
160687681|NCT02985879|580236091|FG002|Overall Study|Lost to Follow-up|2|||
160687682|NCT02985879|580236089|FG000|Overall Study|Other, not specified|62|||
160687683|NCT02985879|580236090|FG001|Overall Study|Other, not specified|58|||
160687684|NCT02985879|580236091|FG002|Overall Study|Other, not specified|58|||
160687685|NCT03940703|580237452|FG000|Overall Study|Still under treatment|31|||
160687686|NCT03940703|580237453|FG001|Overall Study|Still under treatment|0|||
160687687|NCT02658487|580237454|FG000|Overall Study|Death|2|||
160687688|NCT02658487|580237454|FG000|Overall Study|Disease progression|10|||
160687689|NCT02658487|580237454|FG000|Overall Study|Alternative therapy|1|||
160687690|NCT02658487|580237454|FG000|Overall Study|Adverse Event|1|||
160687691|NCT02658487|580237454|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
160687692|NCT02658487|580237454|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
160687693|NCT01885182|580237455|FG000|Overall Study|Adverse Event|11|||
160687694|NCT01885182|580237456|FG001|Overall Study|Adverse Event|13|||
160687695|NCT01885182|580237455|FG000|Overall Study|Withdrawal by Subject|13|||
160687696|NCT01885182|580237456|FG001|Overall Study|Withdrawal by Subject|6|||
160687697|NCT01885182|580237455|FG000|Overall Study|Lost to Follow-up|2|||
160687698|NCT01885182|580237456|FG001|Overall Study|Lost to Follow-up|2|||
160687699|NCT01885182|580237455|FG000|Overall Study|Lack of Efficacy|8|||
160687700|NCT01885182|580237456|FG001|Overall Study|Lack of Efficacy|1|||
160687701|NCT04146363|580237457|FG000|Induction Period|Adverse Event|1|||
160687702|NCT04146363|580237458|FG001|Induction Period|Adverse Event|2|||
160687703|NCT04146363|580237459|FG002|Induction Period|Adverse Event|0|||
160687704|NCT04146363|580237460|FG003|Induction Period|Adverse Event|0|||
160687705|NCT04146363|580237461|FG004|Induction Period|Adverse Event|0|||
160687706|NCT04146363|580237462|FG005|Induction Period|Adverse Event|0|||
160687707|NCT04146363|580237463|FG006|Induction Period|Adverse Event|0|||
160687708|NCT04146363|580237464|FG007|Induction Period|Adverse Event|0|||
160687709|NCT04146363|580237465|FG008|Induction Period|Adverse Event|0|||
160687710|NCT04146363|580237466|FG009|Induction Period|Adverse Event|0|||
160687711|NCT04146363|580237467|FG010|Induction Period|Adverse Event|0|||
160687712|NCT04146363|580237457|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
160687713|NCT04146363|580237458|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
160687714|NCT04146363|580237459|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
160687715|NCT04146363|580237460|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
160687716|NCT04146363|580237461|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
160687717|NCT04146363|580237462|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
160687718|NCT04146363|580237463|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
160687719|NCT04146363|580237464|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
160687720|NCT04146363|580237465|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
160687721|NCT04146363|580237466|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
160687722|NCT04146363|580237467|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
160687723|NCT04146363|580237457|FG000|Induction Period|Lack of Efficacy|7|||
160687724|NCT04146363|580237458|FG001|Induction Period|Lack of Efficacy|2|||
160687725|NCT04146363|580237459|FG002|Induction Period|Lack of Efficacy|0|||
160687726|NCT04146363|580237460|FG003|Induction Period|Lack of Efficacy|0|||
160687727|NCT04146363|580237461|FG004|Induction Period|Lack of Efficacy|0|||
160687728|NCT04146363|580237462|FG005|Induction Period|Lack of Efficacy|0|||
160687729|NCT04146363|580237463|FG006|Induction Period|Lack of Efficacy|0|||
160687730|NCT04146363|580237464|FG007|Induction Period|Lack of Efficacy|0|||
160687731|NCT04146363|580237465|FG008|Induction Period|Lack of Efficacy|0|||
160687732|NCT04146363|580237466|FG009|Induction Period|Lack of Efficacy|0|||
160687733|NCT04146363|580237467|FG010|Induction Period|Lack of Efficacy|0|||
160687734|NCT04146363|580237457|FG000|Induction Period|Lost to Follow-up|1|||
160687735|NCT04146363|580237458|FG001|Induction Period|Lost to Follow-up|4|||
160687736|NCT04146363|580237459|FG002|Induction Period|Lost to Follow-up|0|||
160687737|NCT04146363|580237460|FG003|Induction Period|Lost to Follow-up|0|||
160687738|NCT04146363|580237461|FG004|Induction Period|Lost to Follow-up|0|||
160687739|NCT04146363|580237462|FG005|Induction Period|Lost to Follow-up|0|||
160687740|NCT04146363|580237463|FG006|Induction Period|Lost to Follow-up|0|||
160687741|NCT04146363|580237464|FG007|Induction Period|Lost to Follow-up|0|||
160687742|NCT04146363|580237465|FG008|Induction Period|Lost to Follow-up|0|||
160687743|NCT04146363|580237466|FG009|Induction Period|Lost to Follow-up|0|||
160687744|NCT04146363|580237467|FG010|Induction Period|Lost to Follow-up|0|||
160687745|NCT04146363|580237457|FG000|Induction Period|Positive quantiferon test|0|||
160687746|NCT04146363|580237458|FG001|Induction Period|Positive quantiferon test|1|||
160687747|NCT04146363|580237459|FG002|Induction Period|Positive quantiferon test|0|||
160687748|NCT04146363|580237460|FG003|Induction Period|Positive quantiferon test|0|||
160687749|NCT04146363|580237461|FG004|Induction Period|Positive quantiferon test|0|||
160687750|NCT04146363|580237462|FG005|Induction Period|Positive quantiferon test|0|||
160687751|NCT04146363|580237463|FG006|Induction Period|Positive quantiferon test|0|||
160687752|NCT04146363|580237464|FG007|Induction Period|Positive quantiferon test|0|||
160687753|NCT04146363|580237465|FG008|Induction Period|Positive quantiferon test|0|||
160687754|NCT04146363|580237466|FG009|Induction Period|Positive quantiferon test|0|||
160687755|NCT04146363|580237467|FG010|Induction Period|Positive quantiferon test|0|||
160687756|NCT04146363|580237457|FG000|Induction Period|Protocol Deviation|5|||
160687757|NCT04146363|580237458|FG001|Induction Period|Protocol Deviation|6|||
160687758|NCT04146363|580237459|FG002|Induction Period|Protocol Deviation|0|||
160687759|NCT04146363|580237460|FG003|Induction Period|Protocol Deviation|0|||
160687760|NCT04146363|580237461|FG004|Induction Period|Protocol Deviation|0|||
160687761|NCT04146363|580237462|FG005|Induction Period|Protocol Deviation|0|||
160687762|NCT04146363|580237463|FG006|Induction Period|Protocol Deviation|0|||
160687763|NCT04146363|580237464|FG007|Induction Period|Protocol Deviation|0|||
160687764|NCT04146363|580237465|FG008|Induction Period|Protocol Deviation|0|||
160687765|NCT04146363|580237466|FG009|Induction Period|Protocol Deviation|0|||
160687766|NCT04146363|580237467|FG010|Induction Period|Protocol Deviation|0|||
160687767|NCT04146363|580237457|FG000|Induction Period|Withdrawal by Subject|6|||
160687768|NCT04146363|580237458|FG001|Induction Period|Withdrawal by Subject|3|||
160687769|NCT04146363|580237459|FG002|Induction Period|Withdrawal by Subject|0|||
160687770|NCT04146363|580237460|FG003|Induction Period|Withdrawal by Subject|0|||
160687771|NCT04146363|580237461|FG004|Induction Period|Withdrawal by Subject|0|||
160687772|NCT04146363|580237462|FG005|Induction Period|Withdrawal by Subject|0|||
160687773|NCT04146363|580237463|FG006|Induction Period|Withdrawal by Subject|0|||
160687774|NCT04146363|580237464|FG007|Induction Period|Withdrawal by Subject|0|||
160687775|NCT04146363|580237465|FG008|Induction Period|Withdrawal by Subject|0|||
160687776|NCT04146363|580237466|FG009|Induction Period|Withdrawal by Subject|0|||
160687777|NCT04146363|580237467|FG010|Induction Period|Withdrawal by Subject|0|||
160687778|NCT04146363|580237457|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
160687779|NCT04146363|580237458|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
160687780|NCT04146363|580237459|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
160687781|NCT04146363|580237460|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
160687782|NCT04146363|580237461|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
160687783|NCT04146363|580237462|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
160687784|NCT04146363|580237463|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
160687785|NCT04146363|580237464|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
160687786|NCT04146363|580237465|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
160687787|NCT04146363|580237466|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
160687788|NCT04146363|580237467|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
160687789|NCT04146363|580237457|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160687790|NCT04146363|580237458|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160687791|NCT04146363|580237459|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160687792|NCT04146363|580237460|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160687793|NCT04146363|580237461|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160687794|NCT04146363|580237462|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160687795|NCT04146363|580237463|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160687796|NCT04146363|580237464|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
160687797|NCT04146363|580237465|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160687798|NCT04146363|580237466|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160687799|NCT04146363|580237467|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
160687800|NCT04146363|580237457|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160687801|NCT04146363|580237458|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160687802|NCT04146363|580237459|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160687803|NCT04146363|580237460|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160687804|NCT04146363|580237461|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160687805|NCT04146363|580237462|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160687806|NCT04146363|580237463|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
160687807|NCT04146363|580237464|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
160687808|NCT04146363|580237465|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160687809|NCT04146363|580237466|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160687810|NCT04146363|580237467|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
160687811|NCT04146363|580237457|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
160687812|NCT04146363|580237458|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
160687813|NCT04146363|580237459|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
160687814|NCT04146363|580237460|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
160687815|NCT04146363|580237461|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
160687816|NCT04146363|580237462|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
160687817|NCT04146363|580237463|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
160687818|NCT04146363|580237464|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
160687819|NCT04146363|580237465|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
160687820|NCT04146363|580237466|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
160687821|NCT04146363|580237467|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
160687822|NCT04146363|580237457|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160687823|NCT04146363|580237458|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160687824|NCT04146363|580237459|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160687825|NCT04146363|580237460|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160687826|NCT04146363|580237461|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
160687827|NCT04146363|580237462|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
160687828|NCT04146363|580237463|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
160687829|NCT04146363|580237464|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
160687830|NCT04146363|580237465|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160687831|NCT04146363|580237466|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160687832|NCT04146363|580237467|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
160687833|NCT04146363|580237457|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160687834|NCT04146363|580237458|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160687835|NCT04146363|580237459|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
160687836|NCT04146363|580237460|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160687837|NCT04146363|580237461|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160687838|NCT04146363|580237462|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
160687839|NCT04146363|580237463|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
160687840|NCT04146363|580237464|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
160687841|NCT04146363|580237465|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160687842|NCT04146363|580237466|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160687843|NCT04146363|580237467|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
160687844|NCT04146363|580237457|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
160687845|NCT04146363|580237458|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
160687846|NCT04146363|580237459|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
160687847|NCT04146363|580237460|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
160687848|NCT04146363|580237461|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
160687849|NCT04146363|580237462|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
160687850|NCT04146363|580237463|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
160687851|NCT04146363|580237464|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
160687852|NCT04146363|580237465|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
160687853|NCT04146363|580237466|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
160687854|NCT04146363|580237467|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
160687855|NCT04146363|580237457|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160687856|NCT04146363|580237458|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160687857|NCT04146363|580237459|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160687858|NCT04146363|580237460|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160687859|NCT04146363|580237461|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160687860|NCT04146363|580237462|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160687861|NCT04146363|580237463|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160687862|NCT04146363|580237464|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
160687863|NCT04146363|580237465|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
160687864|NCT04146363|580237466|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
160687865|NCT04146363|580237467|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
160687866|NCT04146363|580237457|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160687867|NCT04146363|580237458|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160687868|NCT04146363|580237459|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160687869|NCT04146363|580237460|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160687870|NCT04146363|580237461|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160687871|NCT04146363|580237462|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160687872|NCT04146363|580237463|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160687873|NCT04146363|580237464|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160687874|NCT04146363|580237465|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
160687875|NCT04146363|580237466|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
160687876|NCT04146363|580237467|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160687877|NCT04146363|580237457|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
160687878|NCT04146363|580237458|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
160687879|NCT04146363|580237459|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
160687880|NCT04146363|580237460|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
160687881|NCT04146363|580237461|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
160687882|NCT04146363|580237462|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
160687883|NCT04146363|580237463|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
160687884|NCT04146363|580237464|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
160687885|NCT04146363|580237465|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
160687886|NCT04146363|580237466|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
160687887|NCT04146363|580237467|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
160687888|NCT04146363|580237457|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160687889|NCT04146363|580237458|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160687890|NCT04146363|580237459|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160687891|NCT04146363|580237460|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160687892|NCT04146363|580237461|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160687893|NCT04146363|580237462|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160687894|NCT04146363|580237463|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160687895|NCT04146363|580237464|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
160687896|NCT04146363|580237465|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
160687897|NCT04146363|580237466|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
160687898|NCT04146363|580237467|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
160687899|NCT04146363|580237457|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
160687900|NCT04146363|580237458|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
160687901|NCT04146363|580237459|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
160687902|NCT04146363|580237460|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
160687903|NCT04146363|580237461|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
160687904|NCT04146363|580237462|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
160687905|NCT04146363|580237463|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
160687906|NCT04146363|580237464|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
160687907|NCT04146363|580237465|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
160687908|NCT04146363|580237466|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
160687909|NCT04146363|580237467|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
160687910|NCT04146363|580237457|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
160687911|NCT04146363|580237458|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
160687912|NCT04146363|580237459|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
160687913|NCT04146363|580237460|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
160687914|NCT04146363|580237461|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
160687915|NCT04146363|580237462|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
160687916|NCT04146363|580237463|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
160687917|NCT04146363|580237464|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
160687918|NCT04146363|580237465|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
160687919|NCT04146363|580237466|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
160687920|NCT04146363|580237467|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
160687921|NCT00380692|580237474|FG000|Study Period II - Double Blind|Adverse Event|1|||
160687922|NCT00380692|580237475|FG001|Study Period II - Double Blind|Adverse Event|0|||
160687923|NCT00380692|580237474|FG000|Study Period II - Double Blind|Protocol Violation|2|||
160687924|NCT00380692|580237475|FG001|Study Period II - Double Blind|Protocol Violation|2|||
160687925|NCT00380692|580237474|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
160687926|NCT00380692|580237475|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
160687927|NCT00380692|580237474|FG000|Study Period II - Double Blind|Physician Decision|0|||
160687928|NCT00380692|580237475|FG001|Study Period II - Double Blind|Physician Decision|1|||
160687929|NCT00380692|580237474|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
160687930|NCT00380692|580237475|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
160687931|NCT00380692|580237474|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
160687932|NCT00380692|580237475|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
160687933|NCT00380692|580237474|FG000|Study Period III - Open Label|Adverse Event|5|||
160687934|NCT00380692|580237475|FG001|Study Period III - Open Label|Adverse Event|3|||
160687935|NCT00380692|580237474|FG000|Study Period III - Open Label|Protocol Violation|0|||
160687936|NCT00380692|580237475|FG001|Study Period III - Open Label|Protocol Violation|0|||
160687937|NCT00380692|580237474|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
160687938|NCT00380692|580237475|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
160687939|NCT00380692|580237474|FG000|Study Period III - Open Label|Physician Decision|0|||
160687940|NCT00380692|580237475|FG001|Study Period III - Open Label|Physician Decision|3|||
160687941|NCT00380692|580237474|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
160687942|NCT00380692|580237475|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
160687943|NCT00380692|580237474|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
160687944|NCT00380692|580237475|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
160687945|NCT02676284|580237476|FG000|Overall Study|Withdrawal by Subject|1|||
160687946|NCT00107042|580237477|FG000|Overall Study|Lost to Follow-up|9|||
160687947|NCT00107042|580237478|FG001|Overall Study|Lost to Follow-up|7|||
160687948|NCT00107042|580237477|FG000|Overall Study|Withdrawal by Subject|6|||
160687949|NCT00107042|580237478|FG001|Overall Study|Withdrawal by Subject|1|||
160687950|NCT00107042|580237477|FG000|Overall Study|Moved out of area|5|||
160687951|NCT00107042|580237478|FG001|Overall Study|Moved out of area|3|||
160687952|NCT00107042|580237477|FG000|Overall Study|Pregnancy|1|||
160687953|NCT00107042|580237478|FG001|Overall Study|Pregnancy|1|||
160687954|NCT00107042|580237477|FG000|Overall Study|Inadvertent enrollment|0|||
160687955|NCT00107042|580237478|FG001|Overall Study|Inadvertent enrollment|1|||
160687956|NCT00107042|580237477|FG000|Overall Study|vaccinated outside window|1|||
160687957|NCT00107042|580237478|FG001|Overall Study|vaccinated outside window|1|||
160687958|NCT00107042|580237477|FG000|Overall Study|Disallowed medications|0|||
160687959|NCT00107042|580237478|FG001|Overall Study|Disallowed medications|2|||
160687960|NCT03919448|580237480|FG000|Overall Study|Withdrawal by Subject|1|||
160687961|NCT03919448|580237481|FG001|Overall Study|Withdrawal by Subject|0|||
160687962|NCT03919448|580237482|FG002|Overall Study|Withdrawal by Subject|0|||
160687963|NCT00708708|580237483|FG000|Overall Study|Another therapy instead of Enbrel|141|||
160687964|NCT00708708|580237483|FG000|Overall Study|Lost to Follow-up|52|||
160687965|NCT00708708|580237483|FG000|Overall Study|Withdrawal by Subject|51|||
160687966|NCT00708708|580237483|FG000|Overall Study|Intolerance|42|||
160687967|NCT00708708|580237483|FG000|Overall Study|Another therapy along with Enbrel|15|||
160687968|NCT00708708|580237483|FG000|Overall Study|Other unspecified|11|||
160687969|NCT00708708|580237483|FG000|Overall Study|Good effectiveness|9|||
160687970|NCT00708708|580237483|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
160687971|NCT00708708|580237483|FG000|Overall Study|Administrative reasons|7|||
160687972|NCT00708708|580237483|FG000|Overall Study|Lack of effectiveness|4|||
160687973|NCT00708708|580237483|FG000|Overall Study|Lack of compliance|3|||
160687974|NCT00708708|580237483|FG000|Overall Study|Pregnancy|3|||
160687975|NCT00708708|580237483|FG000|Overall Study|Adverse Event|3|||
160687976|NCT00708708|580237483|FG000|Overall Study|Missing values|392|||
160687977|NCT00865098|580237486|FG000|Overall Study|Progressive disease|1|||
160687978|NCT01117337|580237499|FG000|Overall Study|Lost to Follow-up|4|||
160687979|NCT01117337|580237500|FG001|Overall Study|Lost to Follow-up|0|||
160687980|NCT02791893|580237501|FG000|Blinded Phase|Lost to Follow-up|2|||
160687981|NCT02791893|580237502|FG001|Blinded Phase|Lost to Follow-up|2|||
160687982|NCT02791893|580237501|FG000|Blinded Phase|Withdrawal by Subject|1|||
160687983|NCT02791893|580237502|FG001|Blinded Phase|Withdrawal by Subject|2|||
160687984|NCT02791893|580237501|FG000|Open Label Phase|Lost to Follow-up|3|||
160687985|NCT02791893|580237502|FG001|Open Label Phase|Lost to Follow-up|0|||
160687986|NCT02791893|580237501|FG000|Open Label Phase|Withdrawal by Subject|0|||
160687987|NCT02791893|580237502|FG001|Open Label Phase|Withdrawal by Subject|2|||
160687988|NCT04319159|580237506|FG000|Overall Study|Screening failure|13|||
160687989|NCT04319159|580237506|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
160687990|NCT04319159|580237506|FG000|Overall Study|Withdrawal by Subject|1|||
160687991|NCT04976621|580237514|FG000|Overall Study|Lost to Follow-up|2|||
160687992|NCT04976621|580237515|FG001|Overall Study|Lost to Follow-up|2|||
160687993|NCT04976621|580237514|FG000|Overall Study|Withdrawal by Subject|1|||
160687994|NCT04976621|580237515|FG001|Overall Study|Withdrawal by Subject|1|||
160687995|NCT05611996|580237516|FG000|Overall Study|Ineligible|1|||
160687996|NCT05611996|580237516|FG000|Overall Study|Withdrawal by Subject|9|||
160687997|NCT00619359|580237519|FG000|Overall Study|Adverse Event|32|||
160687998|NCT00619359|580237520|FG001|Overall Study|Adverse Event|36|||
160687999|NCT00619359|580237519|FG000|Overall Study|Lost to Follow-up|12|||
160688000|NCT00619359|580237520|FG001|Overall Study|Lost to Follow-up|16|||
160688001|NCT00619359|580237519|FG000|Overall Study|Physician Decision|0|||
160688002|NCT00619359|580237520|FG001|Overall Study|Physician Decision|7|||
160688003|NCT00619359|580237519|FG000|Overall Study|Protocol Violation|1|||
160688004|NCT00619359|580237520|FG001|Overall Study|Protocol Violation|1|||
160688005|NCT00619359|580237519|FG000|Overall Study|Withdrawal by Subject|19|||
160688006|NCT00619359|580237520|FG001|Overall Study|Withdrawal by Subject|20|||
160688007|NCT00619359|580237519|FG000|Overall Study|Progressive Disease|3|||
160688008|NCT00619359|580237520|FG001|Overall Study|Progressive Disease|1|||
160688009|NCT06972251|580237521|FG000|Overall Study|Withdrawal by Subject|1|||
160688010|NCT06972251|580237522|FG001|Overall Study|Withdrawal by Subject|0|||
160688011|NCT06972251|580237521|FG000|Overall Study|Lost to Follow-up|10|||
160688012|NCT06972251|580237522|FG001|Overall Study|Lost to Follow-up|2|||
160688013|NCT05575063|580237523|FG000|Overall Study|Withdrawal by Subject|1|||
160688014|NCT00351351|580237525|FG000|Overall Study|surgical access pbs; device issues|9|||
160688015|NCT00351351|580237526|FG001|Overall Study|surgical access pbs; device issues|4|||
160688016|NCT03891329|580237527|FG000|Overall Study|Death|5|||
160688017|NCT03891329|580237527|FG000|Overall Study|Lost to Follow-up|4|||
160688018|NCT03891329|580237527|FG000|Overall Study|Physician Decision|4|||
160688019|NCT03891329|580237527|FG000|Overall Study|Device explanted|3|||
160688020|NCT03891329|580237527|FG000|Overall Study|No study device implanted|3|||
160688021|NCT03176784|580237528|FG000|Overall Study|Lost to Follow-up|77|||
160688022|NCT03176784|580237529|FG001|Overall Study|Lost to Follow-up|79|||
160688023|NCT03176784|580237530|FG002|Overall Study|Lost to Follow-up|79|||
160688024|NCT03176784|580237531|FG003|Overall Study|Lost to Follow-up|49|||
160688025|NCT03176784|580237528|FG000|Overall Study|Withdrawal by Subject|28|||
160688026|NCT03176784|580237529|FG001|Overall Study|Withdrawal by Subject|34|||
160688027|NCT03176784|580237530|FG002|Overall Study|Withdrawal by Subject|34|||
160688028|NCT03176784|580237531|FG003|Overall Study|Withdrawal by Subject|21|||
160688029|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
160688030|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
160688031|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
160688032|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
160688033|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
160688034|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
160688035|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
160688036|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
160688037|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
160688038|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
160688039|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
160688040|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
160688041|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
160688042|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
160688043|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
160688044|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
160688045|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
160688046|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
160688047|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
160688048|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
160688049|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
160688050|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
160688051|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
160688052|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
160688053|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
160688054|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
160688055|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
160688056|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
160688057|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Death|0|||
160688058|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Death|1|||
160688059|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Death|0|||
160688060|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Death|0|||
160688061|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
160688062|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
160688063|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
160688064|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
160688065|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
160688066|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
160688067|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
160688068|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
160688069|NCT02990806|580237532|FG000|Stage 1 (22 Weeks)|Other|1|||
160688070|NCT02990806|580237533|FG001|Stage 1 (22 Weeks)|Other|3|||
160688071|NCT02990806|580237534|FG002|Stage 1 (22 Weeks)|Other|0|||
160688072|NCT02990806|580237535|FG003|Stage 1 (22 Weeks)|Other|0|||
160688073|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
160688074|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
160688075|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
160688076|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
160688077|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Death|1|||
160688078|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Death|0|||
160688079|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Death|0|||
160688080|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Death|0|||
160688081|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
160688082|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
160688083|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
160688084|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
160688085|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
160688086|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
160688087|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
160688088|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
160688089|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
160688090|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
160688091|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
160688092|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
160688093|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
160688094|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
160688095|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
160688096|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
160688097|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
160688098|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
160688099|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
160688100|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
160688101|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
160688102|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
160688103|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
160688104|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
160688105|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
160688106|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
160688107|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
160688108|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
160688109|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
160688110|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
160688111|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
160688112|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
160688113|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
160688114|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
160688115|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
160688116|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
160688117|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Other|3|||
160688118|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Other|0|||
160688119|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Other|4|||
160688120|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Other|1|||
160688121|NCT02990806|580237532|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
160688122|NCT02990806|580237533|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
160688123|NCT02990806|580237534|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
160688124|NCT02990806|580237535|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
160688125|NCT02990806|580237532|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
160688126|NCT02990806|580237533|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
160688127|NCT02990806|580237534|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
160688128|NCT02990806|580237535|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
160688129|NCT02990806|580237532|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
160688130|NCT02990806|580237533|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
160688131|NCT02990806|580237534|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
160688132|NCT02990806|580237535|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
160688133|NCT02990806|580237532|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
160688134|NCT02990806|580237533|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
160688135|NCT02990806|580237534|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
160688136|NCT02990806|580237535|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
160688137|NCT02990806|580237532|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
160688138|NCT02990806|580237533|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
160688139|NCT02990806|580237534|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
160688140|NCT02990806|580237535|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
160688141|NCT02990806|580237532|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
160688142|NCT02990806|580237533|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
160688143|NCT02990806|580237534|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
160688144|NCT02990806|580237535|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
160688145|NCT02990806|580237532|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
160688146|NCT02990806|580237533|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
160688147|NCT02990806|580237534|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
160688148|NCT02990806|580237535|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
160688149|NCT02990806|580237532|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
160688150|NCT02990806|580237533|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
160688151|NCT02990806|580237534|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
160688152|NCT02990806|580237535|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
160688153|NCT02990806|580237532|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
160688154|NCT02990806|580237533|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
160688155|NCT02990806|580237534|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
160688156|NCT02990806|580237535|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
160688157|NCT02654587|580237536|FG000|Overall Study|patient alive at end of study|22|||
160688158|NCT02654587|580237537|FG001|Overall Study|patient alive at end of study|8|||
160688159|NCT02654587|580237536|FG000|Overall Study|Withdrawal by Subject|1|||
160688160|NCT02654587|580237537|FG001|Overall Study|Withdrawal by Subject|7|||
160688161|NCT01825837|580237538|FG000|PART I|Withdrawal by Subject|0|||
160688162|NCT01825837|580237539|FG001|PART I|Withdrawal by Subject|0|||
160688163|NCT01825837|580237540|FG002|PART I|Withdrawal by Subject|0|||
160688164|NCT01825837|580237541|FG003|PART I|Withdrawal by Subject|6|||
160688165|NCT01825837|580237538|FG000|PART I|Patient non-compliance|0|||
160688166|NCT01825837|580237539|FG001|PART I|Patient non-compliance|0|||
160688167|NCT01825837|580237540|FG002|PART I|Patient non-compliance|0|||
160688168|NCT01825837|580237541|FG003|PART I|Patient non-compliance|1|||
160688169|NCT01825837|580237538|FG000|PART I|Treatment failure|0|||
160688170|NCT01825837|580237539|FG001|PART I|Treatment failure|0|||
160688171|NCT01825837|580237540|FG002|PART I|Treatment failure|0|||
160688172|NCT01825837|580237541|FG003|PART I|Treatment failure|7|||
160688173|NCT01825837|580237538|FG000|PART I|reason unspecified|0|||
160688174|NCT01825837|580237539|FG001|PART I|reason unspecified|0|||
160688175|NCT01825837|580237540|FG002|PART I|reason unspecified|0|||
160688176|NCT01825837|580237541|FG003|PART I|reason unspecified|3|||
160688177|NCT01825837|580237538|FG000|PART II|Withdrawal by Subject|3|||
160688178|NCT01825837|580237539|FG001|PART II|Withdrawal by Subject|3|||
160688179|NCT01825837|580237540|FG002|PART II|Withdrawal by Subject|7|||
160688180|NCT01825837|580237541|FG003|PART II|Withdrawal by Subject|0|||
160688181|NCT01825837|580237538|FG000|PART II|Patient non-compliance|5|||
160688182|NCT01825837|580237539|FG001|PART II|Patient non-compliance|2|||
160688183|NCT01825837|580237540|FG002|PART II|Patient non-compliance|4|||
160688184|NCT01825837|580237541|FG003|PART II|Patient non-compliance|0|||
160688185|NCT01825837|580237538|FG000|PART II|Adverse Event|3|||
160688186|NCT01825837|580237539|FG001|PART II|Adverse Event|3|||
160688187|NCT01825837|580237540|FG002|PART II|Adverse Event|1|||
160688188|NCT01825837|580237541|FG003|PART II|Adverse Event|0|||
160688189|NCT01825837|580237538|FG000|PART II|Treatment failure|6|||
160688190|NCT01825837|580237539|FG001|PART II|Treatment failure|4|||
160688191|NCT01825837|580237540|FG002|PART II|Treatment failure|5|||
160688192|NCT01825837|580237541|FG003|PART II|Treatment failure|0|||
160688193|NCT01825837|580237538|FG000|PART II|reason unspecified|2|||
160688194|NCT01825837|580237539|FG001|PART II|reason unspecified|2|||
160688195|NCT01825837|580237540|FG002|PART II|reason unspecified|2|||
160688196|NCT01825837|580237541|FG003|PART II|reason unspecified|0|||
160688197|NCT00904748|580237544|FG000|Overall Study|Withdrawal by Subject|1|||
160688198|NCT00904748|580237545|FG001|Overall Study|Withdrawal by Subject|1|||
160688199|NCT00904748|580237546|FG002|Overall Study|Withdrawal by Subject|1|||
160688200|NCT00904748|580237547|FG003|Overall Study|Withdrawal by Subject|2|||
160688201|NCT00904748|580237548|FG004|Overall Study|Withdrawal by Subject|0|||
160688202|NCT00904748|580237549|FG005|Overall Study|Withdrawal by Subject|0|||
160688203|NCT00904748|580237544|FG000|Overall Study|Adverse Event|0|||
160688204|NCT00904748|580237545|FG001|Overall Study|Adverse Event|0|||
160688205|NCT00904748|580237546|FG002|Overall Study|Adverse Event|0|||
160688206|NCT00904748|580237547|FG003|Overall Study|Adverse Event|0|||
160688207|NCT00904748|580237548|FG004|Overall Study|Adverse Event|1|||
160688208|NCT00904748|580237549|FG005|Overall Study|Adverse Event|0|||
160688209|NCT01682148|580237550|FG000|Overall Study|Withdrawal by Subject|2|||
160688210|NCT01682148|580237551|FG001|Overall Study|Withdrawal by Subject|0|||
160688211|NCT01682148|580237550|FG000|Overall Study|Lost to Follow-up|1|||
160688212|NCT01682148|580237551|FG001|Overall Study|Lost to Follow-up|2|||
160688213|NCT01682148|580237550|FG000|Overall Study|Protocol Violation|1|||
160688214|NCT01682148|580237551|FG001|Overall Study|Protocol Violation|1|||
160688215|NCT01202877|580237552|FG000|Overall Study|Disease Progression|0|||
160688216|NCT01202877|580237553|FG001|Overall Study|Disease Progression|1|||
160688217|NCT01202877|580237554|FG002|Overall Study|Disease Progression|2|||
160688218|NCT01202877|580237552|FG000|Overall Study|Adverse Event|0|||
160688219|NCT01202877|580237553|FG001|Overall Study|Adverse Event|0|||
160688220|NCT01202877|580237554|FG002|Overall Study|Adverse Event|2|||
160688221|NCT01202877|580237552|FG000|Overall Study|Withdrawal by Subject|0|||
160688222|NCT01202877|580237553|FG001|Overall Study|Withdrawal by Subject|0|||
160688223|NCT01202877|580237554|FG002|Overall Study|Withdrawal by Subject|1|||
160688224|NCT01202877|580237552|FG000|Overall Study|Death|0|||
160688225|NCT01202877|580237553|FG001|Overall Study|Death|0|||
160688226|NCT01202877|580237554|FG002|Overall Study|Death|1|||
160688227|NCT04403763|580237555|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
160688228|NCT04403763|580237556|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
160688229|NCT04403763|580237557|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
160688230|NCT04403763|580237558|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
160688231|NCT04403763|580237559|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
160688232|NCT04403763|580237560|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
160688233|NCT04403763|580237561|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
160688234|NCT04403763|580237555|FG000|Stage 1|Early termination due to PK tube failure|0|||
160688235|NCT04403763|580237556|FG001|Stage 1|Early termination due to PK tube failure|0|||
160688236|NCT04403763|580237557|FG002|Stage 1|Early termination due to PK tube failure|1|||
160688237|NCT04403763|580237558|FG003|Stage 1|Early termination due to PK tube failure|0|||
160688238|NCT04403763|580237559|FG004|Stage 1|Early termination due to PK tube failure|0|||
160688239|NCT04403763|580237560|FG005|Stage 1|Early termination due to PK tube failure|0|||
160688240|NCT04403763|580237561|FG006|Stage 1|Early termination due to PK tube failure|0|||
160688241|NCT04403763|580237555|FG000|Stage 2A|Adverse Event|0|||
160688242|NCT04403763|580237556|FG001|Stage 2A|Adverse Event|0|||
160688243|NCT04403763|580237557|FG002|Stage 2A|Adverse Event|0|||
160688244|NCT04403763|580237558|FG003|Stage 2A|Adverse Event|0|||
160688245|NCT04403763|580237559|FG004|Stage 2A|Adverse Event|0|||
160688246|NCT04403763|580237560|FG005|Stage 2A|Adverse Event|0|||
160688247|NCT04403763|580237561|FG006|Stage 2A|Adverse Event|1|||
160688248|NCT00350402|580237562|FG000|Overall Study|Lost to Follow-up|1|||
160688249|NCT00350402|580237563|FG001|Overall Study|Lost to Follow-up|1|||
160688250|NCT01376310|580237564|FG000|Overall Study|Study closed/terminated|1|||
160688251|NCT01376310|580237565|FG001|Overall Study|Study closed/terminated|2|||
160688252|NCT01376310|580237564|FG000|Overall Study|Withdrawal by Subject|8|||
160688253|NCT01376310|580237565|FG001|Overall Study|Withdrawal by Subject|2|||
160688254|NCT01376310|580237564|FG000|Overall Study|Physician Decision|26|||
160688255|NCT01376310|580237565|FG001|Overall Study|Physician Decision|7|||
160688256|NCT01376310|580237564|FG000|Overall Study|Lost to Follow-up|1|||
160688257|NCT01376310|580237565|FG001|Overall Study|Lost to Follow-up|0|||
160688258|NCT01534637|580237568|FG000|Overall Study|Physician Decision|3|||
160688259|NCT01534637|580237568|FG000|Overall Study|Lack of Efficacy|3|||
160688260|NCT01534637|580237568|FG000|Overall Study|Withdrawal by Subject|1|||
160688261|NCT01534637|580237568|FG000|Overall Study|Adverse Event|1|||
160688262|NCT01534637|580237568|FG000|Overall Study|Liver Mets before treatment|1|||
160688263|NCT00834899|580237569|FG000|Overall Study|Withdrawal by Subject|1|||
160688264|NCT00834899|580237570|FG001|Overall Study|Withdrawal by Subject|1|||
160688265|NCT00606502|580237571|FG000|Randomization|Randomized but not treated|3|||
160688266|NCT00606502|580237572|FG001|Randomization|Randomized but not treated|0|||
160688267|NCT00606502|580237571|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
160688268|NCT00606502|580237572|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
160688269|NCT02377921|580237575|FG000|Overall Study|Subject non-compliance|1|||
160688270|NCT02377921|580237576|FG001|Overall Study|Subject non-compliance|1|||
160688271|NCT02443545|580237579|FG000|Overall Study|Adverse Event|1|||
160688272|NCT02443545|580237580|FG001|Overall Study|Adverse Event|1|||
160688273|NCT02443545|580237579|FG000|Overall Study|Lost to Follow-up|0|||
160688274|NCT02443545|580237580|FG001|Overall Study|Lost to Follow-up|2|||
160688275|NCT02443545|580237579|FG000|Overall Study|Physician Decision|3|||
160688276|NCT02443545|580237580|FG001|Overall Study|Physician Decision|0|||
160688277|NCT02443545|580237579|FG000|Overall Study|Protocol Violation|8|||
160688278|NCT02443545|580237580|FG001|Overall Study|Protocol Violation|1|||
160688279|NCT02443545|580237579|FG000|Overall Study|Pregnancy|1|||
160688280|NCT02443545|580237580|FG001|Overall Study|Pregnancy|1|||
160688281|NCT02443545|580237579|FG000|Overall Study|Withdrawal by Subject|6|||
160688282|NCT02443545|580237580|FG001|Overall Study|Withdrawal by Subject|3|||
160688283|NCT02443545|580237579|FG000|Overall Study|Termination of study|20|||
160688284|NCT02443545|580237580|FG001|Overall Study|Termination of study|11|||
160688285|NCT04179019|580237584|FG000|Overall Study|Lost to Follow-up|2|||
160688286|NCT04179019|580237584|FG000|Overall Study|Physician Decision|2|||
160688287|NCT04179019|580237584|FG000|Overall Study|Withdrawal by Subject|5|||
160688288|NCT04179019|580237584|FG000|Overall Study|Adverse Event|4|||
160688289|NCT02139124|580237585|FG000|Overall Study|Adverse Event|2|||
160688290|NCT02139124|580237586|FG001|Overall Study|Adverse Event|0|||
160688291|NCT02139124|580237587|FG002|Overall Study|Adverse Event|1|||
160688292|NCT02139124|580237588|FG003|Overall Study|Adverse Event|2|||
160688293|NCT02139124|580237589|FG004|Overall Study|Adverse Event|5|||
160688294|NCT02139124|580237585|FG000|Overall Study|Withdrawal by Subject|2|||
160688295|NCT02139124|580237586|FG001|Overall Study|Withdrawal by Subject|2|||
160688296|NCT02139124|580237587|FG002|Overall Study|Withdrawal by Subject|2|||
160688297|NCT02139124|580237588|FG003|Overall Study|Withdrawal by Subject|2|||
160688298|NCT02139124|580237589|FG004|Overall Study|Withdrawal by Subject|3|||
160688299|NCT02139124|580237585|FG000|Overall Study|Protocol Violation|0|||
160688300|NCT02139124|580237586|FG001|Overall Study|Protocol Violation|0|||
160688301|NCT02139124|580237587|FG002|Overall Study|Protocol Violation|0|||
160688302|NCT02139124|580237588|FG003|Overall Study|Protocol Violation|1|||
160688303|NCT02139124|580237589|FG004|Overall Study|Protocol Violation|1|||
160688304|NCT02139124|580237585|FG000|Overall Study|non-compliant|1|||
160688305|NCT02139124|580237586|FG001|Overall Study|non-compliant|0|||
160688306|NCT02139124|580237587|FG002|Overall Study|non-compliant|0|||
160688307|NCT02139124|580237588|FG003|Overall Study|non-compliant|2|||
160688308|NCT02139124|580237589|FG004|Overall Study|non-compliant|0|||
160688309|NCT02139124|580237585|FG000|Overall Study|incarceration|0|||
160688310|NCT02139124|580237586|FG001|Overall Study|incarceration|0|||
160688311|NCT02139124|580237587|FG002|Overall Study|incarceration|1|||
160688312|NCT02139124|580237588|FG003|Overall Study|incarceration|0|||
160688313|NCT02139124|580237589|FG004|Overall Study|incarceration|0|||
160688314|NCT02139124|580237585|FG000|Overall Study|subject moved|1|||
160688315|NCT02139124|580237586|FG001|Overall Study|subject moved|0|||
160688316|NCT02139124|580237587|FG002|Overall Study|subject moved|0|||
160688317|NCT02139124|580237588|FG003|Overall Study|subject moved|0|||
160688318|NCT02139124|580237589|FG004|Overall Study|subject moved|0|||
160688319|NCT02139124|580237585|FG000|Overall Study|Lost to Follow-up|3|||
160688320|NCT02139124|580237586|FG001|Overall Study|Lost to Follow-up|2|||
160688321|NCT02139124|580237587|FG002|Overall Study|Lost to Follow-up|0|||
160688322|NCT02139124|580237588|FG003|Overall Study|Lost to Follow-up|5|||
160688323|NCT02139124|580237589|FG004|Overall Study|Lost to Follow-up|4|||
160688324|NCT00613834|580237590|FG000|Overall Study|Withdrawal by Subject|0|||
160688325|NCT00613834|580237591|FG001|Overall Study|Withdrawal by Subject|3|||
160688326|NCT00440115|580237592|FG000|Overall Study|Death|7|||
160688327|NCT00440115|580237593|FG001|Overall Study|Death|9|||
160688328|NCT00440115|580237594|FG002|Overall Study|Death|5|||
160688329|NCT00440115|580237592|FG000|Overall Study|Incarceration|0|||
160688330|NCT00440115|580237593|FG001|Overall Study|Incarceration|2|||
160688331|NCT00440115|580237594|FG002|Overall Study|Incarceration|1|||
160688332|NCT03078478|580237595|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
160688333|NCT03078478|580237596|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
160688334|NCT03078478|580237595|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
160688335|NCT03078478|580237596|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
160688336|NCT03078478|580237595|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
160688337|NCT03078478|580237596|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
160688338|NCT03078478|580237595|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
160688339|NCT03078478|580237596|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
160688340|NCT03078478|580237595|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
160688341|NCT03078478|580237596|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
160688342|NCT03078478|580237595|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
160688343|NCT03078478|580237596|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
160688344|NCT03078478|580237595|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
160688345|NCT03078478|580237596|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
160688346|NCT03078478|580237595|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
160688347|NCT03078478|580237596|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
160688348|NCT03310957|580238919|FG000|Overall Study|Withdrawal by Subject|1|||
160688349|NCT03310957|580238920|FG001|Overall Study|Withdrawal by Subject|1|||
160688350|NCT03310957|580238921|FG002|Overall Study|Withdrawal by Subject|1|||
160688351|NCT03310957|580238922|FG003|Overall Study|Withdrawal by Subject|5|||
160688352|NCT03310957|580238923|FG004|Overall Study|Withdrawal by Subject|0|||
160688353|NCT03310957|580238924|FG005|Overall Study|Withdrawal by Subject|4|||
160688354|NCT03310957|580238925|FG006|Overall Study|Withdrawal by Subject|3|||
160688355|NCT03310957|580238919|FG000|Overall Study|Site Terminated|0|||
160688356|NCT03310957|580238920|FG001|Overall Study|Site Terminated|1|||
160688357|NCT03310957|580238921|FG002|Overall Study|Site Terminated|1|||
160688358|NCT03310957|580238922|FG003|Overall Study|Site Terminated|1|||
160688359|NCT03310957|580238923|FG004|Overall Study|Site Terminated|0|||
160688360|NCT03310957|580238924|FG005|Overall Study|Site Terminated|2|||
160688361|NCT03310957|580238925|FG006|Overall Study|Site Terminated|8|||
160688362|NCT03310957|580238919|FG000|Overall Study|Lost to Follow-up|1|||
160688363|NCT03310957|580238920|FG001|Overall Study|Lost to Follow-up|1|||
160688364|NCT03310957|580238921|FG002|Overall Study|Lost to Follow-up|1|||
160688365|NCT03310957|580238922|FG003|Overall Study|Lost to Follow-up|4|||
160688366|NCT03310957|580238923|FG004|Overall Study|Lost to Follow-up|0|||
160688367|NCT03310957|580238924|FG005|Overall Study|Lost to Follow-up|4|||
160688368|NCT03310957|580238925|FG006|Overall Study|Lost to Follow-up|2|||
160688369|NCT03310957|580238919|FG000|Overall Study|Death|5|||
160688370|NCT03310957|580238920|FG001|Overall Study|Death|8|||
160688371|NCT03310957|580238921|FG002|Overall Study|Death|18|||
160688372|NCT03310957|580238922|FG003|Overall Study|Death|31|||
160688373|NCT03310957|580238923|FG004|Overall Study|Death|1|||
160688374|NCT03310957|580238924|FG005|Overall Study|Death|29|||
160688375|NCT03310957|580238925|FG006|Overall Study|Death|7|||
160688376|NCT03310957|580238919|FG000|Overall Study|Discontinuation per sponsor|0|||
160688377|NCT03310957|580238920|FG001|Overall Study|Discontinuation per sponsor|1|||
160688378|NCT03310957|580238921|FG002|Overall Study|Discontinuation per sponsor|2|||
160688379|NCT03310957|580238922|FG003|Overall Study|Discontinuation per sponsor|4|||
160688380|NCT03310957|580238923|FG004|Overall Study|Discontinuation per sponsor|1|||
160688381|NCT03310957|580238924|FG005|Overall Study|Discontinuation per sponsor|9|||
160688382|NCT03310957|580238925|FG006|Overall Study|Discontinuation per sponsor|12|||
160688383|NCT03310957|580238919|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
160688384|NCT03310957|580238920|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
160688385|NCT03310957|580238921|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
160688386|NCT03310957|580238922|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
160688387|NCT03310957|580238923|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
160688388|NCT03310957|580238924|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
160688389|NCT03310957|580238925|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
160688390|NCT03310957|580238919|FG000|Overall Study|Treatment landscape|0|||
160688391|NCT03310957|580238920|FG001|Overall Study|Treatment landscape|0|||
160688392|NCT03310957|580238921|FG002|Overall Study|Treatment landscape|1|||
160688393|NCT03310957|580238922|FG003|Overall Study|Treatment landscape|1|||
160688394|NCT03310957|580238923|FG004|Overall Study|Treatment landscape|0|||
160688395|NCT03310957|580238924|FG005|Overall Study|Treatment landscape|1|||
160688396|NCT03310957|580238925|FG006|Overall Study|Treatment landscape|0|||
160688397|NCT03310957|580238919|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
160688398|NCT03310957|580238920|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
160688399|NCT03310957|580238921|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
160688400|NCT03310957|580238922|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
160688401|NCT03310957|580238923|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
160688402|NCT03310957|580238924|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
160688403|NCT03310957|580238925|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
160688404|NCT03310957|580238919|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
160688405|NCT03310957|580238920|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
160688406|NCT03310957|580238921|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
160688407|NCT03310957|580238922|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
160688408|NCT03310957|580238923|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
160688409|NCT03310957|580238924|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
160688410|NCT03310957|580238925|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
160688411|NCT03310957|580238919|FG000|Overall Study|Hospice|0|||
160688412|NCT03310957|580238920|FG001|Overall Study|Hospice|0|||
160688413|NCT03310957|580238921|FG002|Overall Study|Hospice|0|||
160688414|NCT03310957|580238922|FG003|Overall Study|Hospice|0|||
160688415|NCT03310957|580238923|FG004|Overall Study|Hospice|0|||
160688416|NCT03310957|580238924|FG005|Overall Study|Hospice|1|||
160688417|NCT03310957|580238925|FG006|Overall Study|Hospice|0|||
160688418|NCT03310957|580238919|FG000|Overall Study|Progressive|0|||
160688419|NCT03310957|580238920|FG001|Overall Study|Progressive|0|||
160688420|NCT03310957|580238921|FG002|Overall Study|Progressive|1|||
160688421|NCT03310957|580238922|FG003|Overall Study|Progressive|0|||
160688422|NCT03310957|580238923|FG004|Overall Study|Progressive|0|||
160688423|NCT03310957|580238924|FG005|Overall Study|Progressive|0|||
160688424|NCT03310957|580238925|FG006|Overall Study|Progressive|0|||
160688425|NCT01475253|580238930|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
160688426|NCT01475253|580238931|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
160688427|NCT01475253|580238932|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
160688428|NCT01475253|580238933|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
160688429|NCT01475253|580238930|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
160688430|NCT01475253|580238931|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
160688431|NCT01475253|580238932|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
160688432|NCT01475253|580238933|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
160688433|NCT04776746|580238935|FG000|Overall Study|Study terminated by sponsor|61|||
160688434|NCT04776746|580238935|FG000|Overall Study|Adverse Event|5|||
160688435|NCT04776746|580238935|FG000|Overall Study|Death|4|||
160688436|NCT04776746|580238935|FG000|Overall Study|Lack of Efficacy|3|||
160688437|NCT04776746|580238935|FG000|Overall Study|Noncompliance with study drug|2|||
160688438|NCT04776746|580238935|FG000|Overall Study|Not related to COVID-19|2|||
160688439|NCT01286558|580238944|FG000|Overall Study|Adverse Event|1|||
160688440|NCT01286558|580238945|FG001|Overall Study|Adverse Event|1|||
160688441|NCT01286558|580238944|FG000|Overall Study|Withdrawal by Subject|0|||
160688442|NCT01286558|580238945|FG001|Overall Study|Withdrawal by Subject|1|||
160688443|NCT01220297|580238946|FG000|Overall Study|Death|2|||
160688444|NCT01220297|580238946|FG000|Overall Study|Lost to Follow-up|1|||
160688445|NCT01787279|580238948|FG000|Overall Study|Lost to Follow-up|2|||
160688446|NCT01787279|580238948|FG000|Overall Study|Lack of Efficacy|1|||
160688447|NCT02148913|580238949|FG000|Overall Study|Death|0|||
160688448|NCT02148913|580238950|FG001|Overall Study|Death|1|||
160688449|NCT02148913|580238951|FG002|Overall Study|Death|0|||
160688450|NCT02148913|580238952|FG003|Overall Study|Death|0|||
160688451|NCT01287039|580238954|FG000|Overall Study|Noncompliance with study procedures|0|||
160688452|NCT01287039|580238955|FG001|Overall Study|Noncompliance with study procedures|1|||
160688453|NCT01287039|580238954|FG000|Overall Study|Change of location/residence|0|||
160688454|NCT01287039|580238955|FG001|Overall Study|Change of location/residence|3|||
160688455|NCT01287039|580238954|FG000|Overall Study|Elective surgery|0|||
160688456|NCT01287039|580238955|FG001|Overall Study|Elective surgery|1|||
160688457|NCT01287039|580238954|FG000|Overall Study|Protocol Violation|2|||
160688458|NCT01287039|580238955|FG001|Overall Study|Protocol Violation|3|||
160688459|NCT01287039|580238954|FG000|Overall Study|Excluded medication taken|1|||
160688460|NCT01287039|580238955|FG001|Overall Study|Excluded medication taken|0|||
160688461|NCT01287039|580238954|FG000|Overall Study|Noncompliance with study medication|0|||
160688462|NCT01287039|580238955|FG001|Overall Study|Noncompliance with study medication|1|||
160688463|NCT01287039|580238954|FG000|Overall Study|Problem with travel|0|||
160688464|NCT01287039|580238955|FG001|Overall Study|Problem with travel|1|||
160688465|NCT01287039|580238954|FG000|Overall Study|Death|1|||
160688466|NCT01287039|580238955|FG001|Overall Study|Death|0|||
160688467|NCT01287039|580238954|FG000|Overall Study|Change of residence|1|||
160688468|NCT01287039|580238955|FG001|Overall Study|Change of residence|0|||
160688469|NCT01287039|580238954|FG000|Overall Study|Adverse Event|7|||
160688470|NCT01287039|580238955|FG001|Overall Study|Adverse Event|4|||
160688471|NCT01287039|580238954|FG000|Overall Study|Withdrawal by Subject|14|||
160688472|NCT01287039|580238955|FG001|Overall Study|Withdrawal by Subject|11|||
160688473|NCT01287039|580238954|FG000|Overall Study|Lost to Follow-up|3|||
160688474|NCT01287039|580238955|FG001|Overall Study|Lost to Follow-up|2|||
160688475|NCT01567826|580238956|FG000|Overall Study|Lost to Follow-up|3|||
160688476|NCT01567826|580238957|FG001|Overall Study|Lost to Follow-up|2|||
160688477|NCT03265288|580238960|FG000|Overall Study|Adverse Event|0|||
160688478|NCT03265288|580238961|FG001|Overall Study|Adverse Event|1|||
160688479|NCT03265288|580238960|FG000|Overall Study|Withdrawal by Subject|13|||
160688480|NCT03265288|580238961|FG001|Overall Study|Withdrawal by Subject|5|||
160688481|NCT03265288|580238960|FG000|Overall Study|Drug Withdrawn|3|||
160688482|NCT03265288|580238961|FG001|Overall Study|Drug Withdrawn|3|||
160688483|NCT03265288|580238960|FG000|Overall Study|Any Other Reason|7|||
160688484|NCT03265288|580238961|FG001|Overall Study|Any Other Reason|3|||
160688485|NCT01360866|580238962|FG000|Overall Study|Lost to Follow-up|11|||
160688486|NCT01360866|580238963|FG001|Overall Study|Lost to Follow-up|28|||
160688487|NCT01360866|580238964|FG002|Overall Study|Lost to Follow-up|41|||
160688488|NCT01360866|580238965|FG003|Overall Study|Lost to Follow-up|0|||
160688489|NCT01360866|580238962|FG000|Overall Study|Adverse Event|56|||
160688490|NCT01360866|580238963|FG001|Overall Study|Adverse Event|61|||
160688491|NCT01360866|580238964|FG002|Overall Study|Adverse Event|134|||
160688492|NCT01360866|580238965|FG003|Overall Study|Adverse Event|6|||
160688493|NCT01360866|580238962|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
160688494|NCT01360866|580238963|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
160688495|NCT01360866|580238964|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
160688496|NCT01360866|580238965|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
160688497|NCT01360866|580238962|FG000|Overall Study|Withdrawn by Investigator|9|||
160688498|NCT01360866|580238963|FG001|Overall Study|Withdrawn by Investigator|8|||
160688499|NCT01360866|580238964|FG002|Overall Study|Withdrawn by Investigator|31|||
160688500|NCT01360866|580238965|FG003|Overall Study|Withdrawn by Investigator|2|||
160688501|NCT01360866|580238962|FG000|Overall Study|Withdrawal by participant|79|||
160688502|NCT01360866|580238963|FG001|Overall Study|Withdrawal by participant|89|||
160688503|NCT01360866|580238964|FG002|Overall Study|Withdrawal by participant|168|||
160688504|NCT01360866|580238965|FG003|Overall Study|Withdrawal by participant|8|||
160688505|NCT01360866|580238962|FG000|Overall Study|Protocol Deviation|25|||
160688506|NCT01360866|580238963|FG001|Overall Study|Protocol Deviation|33|||
160688507|NCT01360866|580238964|FG002|Overall Study|Protocol Deviation|61|||
160688508|NCT01360866|580238965|FG003|Overall Study|Protocol Deviation|2|||
160688509|NCT01360866|580238962|FG000|Overall Study|Lack of Efficacy|30|||
160688510|NCT01360866|580238963|FG001|Overall Study|Lack of Efficacy|40|||
160688511|NCT01360866|580238964|FG002|Overall Study|Lack of Efficacy|30|||
160688512|NCT01360866|580238965|FG003|Overall Study|Lack of Efficacy|4|||
160688513|NCT05016622|580238966|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
160688514|NCT05016622|580238966|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
160688515|NCT03575871|580238973|FG000|Overall Study|Adverse Event|5|||
160688516|NCT03575871|580238974|FG001|Overall Study|Adverse Event|5|||
160688517|NCT03575871|580238975|FG002|Overall Study|Adverse Event|8|||
160688518|NCT03575871|580238973|FG000|Overall Study|Death|1|||
160688519|NCT03575871|580238974|FG001|Overall Study|Death|0|||
160688520|NCT03575871|580238975|FG002|Overall Study|Death|0|||
160688521|NCT03575871|580238973|FG000|Overall Study|Lack of Efficacy|5|||
160688522|NCT03575871|580238974|FG001|Overall Study|Lack of Efficacy|4|||
160688523|NCT03575871|580238975|FG002|Overall Study|Lack of Efficacy|7|||
160688524|NCT03575871|580238973|FG000|Overall Study|Lost to Follow-up|1|||
160688525|NCT03575871|580238974|FG001|Overall Study|Lost to Follow-up|1|||
160688526|NCT03575871|580238975|FG002|Overall Study|Lost to Follow-up|1|||
160688527|NCT03575871|580238973|FG000|Overall Study|Protocol Deviation|1|||
160688528|NCT03575871|580238974|FG001|Overall Study|Protocol Deviation|1|||
160688529|NCT03575871|580238975|FG002|Overall Study|Protocol Deviation|1|||
160688530|NCT03575871|580238973|FG000|Overall Study|Withdrawal by Subject|6|||
160688531|NCT03575871|580238974|FG001|Overall Study|Withdrawal by Subject|1|||
160688532|NCT03575871|580238975|FG002|Overall Study|Withdrawal by Subject|9|||
160688533|NCT03575871|580238973|FG000|Overall Study|Other than specified|2|||
160688534|NCT03575871|580238974|FG001|Overall Study|Other than specified|2|||
160688535|NCT03575871|580238975|FG002|Overall Study|Other than specified|0|||
160688536|NCT05506358|580238976|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
160688537|NCT05506358|580238977|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
160688538|NCT05506358|580238978|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
160688539|NCT05506358|580238979|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
160688540|NCT05506358|580238980|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
160688541|NCT05506358|580238976|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
160688542|NCT05506358|580238977|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
160688543|NCT05506358|580238978|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
160688544|NCT05506358|580238979|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
160688545|NCT05506358|580238980|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
160688546|NCT05506358|580238976|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
160688547|NCT05506358|580238977|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
160688548|NCT05506358|580238978|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
160688549|NCT05506358|580238979|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
160688550|NCT05506358|580238980|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
160688551|NCT05506358|580238976|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
160688552|NCT05506358|580238977|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
160688553|NCT05506358|580238978|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
160688554|NCT05506358|580238979|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
160688555|NCT05506358|580238980|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
160688556|NCT05506358|580238976|FG000|Overall Study|HbE trait|0|||
160688557|NCT05506358|580238977|FG001|Overall Study|HbE trait|0|||
160688558|NCT05506358|580238978|FG002|Overall Study|HbE trait|0|||
160688559|NCT05506358|580238979|FG003|Overall Study|HbE trait|1|||
160688560|NCT05506358|580238980|FG004|Overall Study|HbE trait|0|||
160688561|NCT00584844|580238982|FG000|Overall Study|Withdrawal by Subject|59|||
160688562|NCT00584844|580238982|FG000|Overall Study|Screen Failure|20|||
160688563|NCT00171301|580238983|FG000|Overall Study|Death|1|||
160688564|NCT00171301|580238984|FG001|Overall Study|Death|2|||
160688565|NCT00171301|580238983|FG000|Overall Study|Adverse Event|1|||
160688566|NCT00171301|580238984|FG001|Overall Study|Adverse Event|2|||
160688567|NCT00171301|580238983|FG000|Overall Study|Lost to Follow-up|6|||
160688568|NCT00171301|580238984|FG001|Overall Study|Lost to Follow-up|2|||
160688569|NCT00171301|580238983|FG000|Overall Study|Protocol Violation|0|||
160688570|NCT00171301|580238984|FG001|Overall Study|Protocol Violation|2|||
160688571|NCT00171301|580238983|FG000|Overall Study|Withdrawal by Subject|0|||
160688572|NCT00171301|580238984|FG001|Overall Study|Withdrawal by Subject|1|||
160688573|NCT02100319|580238987|FG000|Overall Study|Case Report Forms Uncollected|11|||
160688574|NCT02100319|580238987|FG000|Overall Study|Protocol Deviation|5|||
160688575|NCT02589522|580238988|FG000|Overall Study|Physician Decision|1|||
160688576|NCT02589522|580238989|FG001|Overall Study|Physician Decision|2|||
160688577|NCT02589522|580238990|FG002|Overall Study|Physician Decision|0|||
160688578|NCT02589522|580238988|FG000|Overall Study|Did not start treatment|1|||
160688579|NCT02589522|580238989|FG001|Overall Study|Did not start treatment|0|||
160688580|NCT02589522|580238990|FG002|Overall Study|Did not start treatment|0|||
160688581|NCT01478828|580238991|FG000|Overall Study|Adverse Event|1|||
160688582|NCT01557842|580238992|FG000|Overall Study|Lost to Follow-up|0|||
160688583|NCT01557842|580238993|FG001|Overall Study|Lost to Follow-up|1|||
160688584|NCT01557842|580238992|FG000|Overall Study|Death|1|||
160688585|NCT01557842|580238993|FG001|Overall Study|Death|0|||
160688586|NCT01557842|580238992|FG000|Overall Study|Lack of Efficacy|0|||
160688587|NCT01557842|580238993|FG001|Overall Study|Lack of Efficacy|1|||
160688588|NCT01557842|580238992|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
160688589|NCT01557842|580238993|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
160688590|NCT01557842|580238992|FG000|Overall Study|Study Terminated by Sponsor|3|||
160688591|NCT01557842|580238993|FG001|Overall Study|Study Terminated by Sponsor|4|||
160688592|NCT01557842|580238992|FG000|Overall Study|Not Ablated|2|||
160688593|NCT01557842|580238993|FG001|Overall Study|Not Ablated|0|||
160688594|NCT04479475|580238997|FG000|Overall Study|Withdrawal by Subject|7|||
160688595|NCT01560507|580239001|FG000|Overall Study|Lost to Follow-up|3|||
160688596|NCT01560507|580239002|FG001|Overall Study|Lost to Follow-up|1|||
160688597|NCT01560507|580239003|FG002|Overall Study|Lost to Follow-up|2|||
160688598|NCT01560507|580239001|FG000|Overall Study|Withdrawal by Subject|1|||
160688599|NCT01560507|580239002|FG001|Overall Study|Withdrawal by Subject|1|||
160688600|NCT01560507|580239003|FG002|Overall Study|Withdrawal by Subject|0|||
160688601|NCT02080832|580239007|FG000|Overall Study|Excluded from analysis by MRI|9|||
160688602|NCT02080832|580239008|FG001|Overall Study|Excluded from analysis by MRI|10|||
160688603|NCT02080832|580239009|FG002|Overall Study|Excluded from analysis by MRI|14|||
160688604|NCT02080832|580239007|FG000|Overall Study|Lost to Follow-up|0|||
160688605|NCT02080832|580239008|FG001|Overall Study|Lost to Follow-up|2|||
160688606|NCT02080832|580239009|FG002|Overall Study|Lost to Follow-up|2|||
160688607|NCT00560937|580239010|FG000|Overall Study|Withdrawal by Subject|0|||
160688608|NCT00560937|580239011|FG001|Overall Study|Withdrawal by Subject|1|||
160688609|NCT00560937|580239010|FG000|Overall Study|Physician Decision|1|||
160688610|NCT00560937|580239011|FG001|Overall Study|Physician Decision|1|||
160688611|NCT03069417|580239012|FG000|Overall Study|Lost to Follow-up|2|||
160688612|NCT03069417|580239013|FG001|Overall Study|Lost to Follow-up|0|||
160688613|NCT03069417|580239012|FG000|Overall Study|Reason Unknown|4|||
160688614|NCT03069417|580239013|FG001|Overall Study|Reason Unknown|7|||
160688615|NCT01660022|580239014|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
160688616|NCT01660022|580239015|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
160688617|NCT01660022|580239016|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
160688618|NCT01660022|580239017|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
160688619|NCT01660022|580239018|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
160688620|NCT01660022|580239019|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
160688621|NCT01660022|580239014|FG000|First Sequence (7 Days)|Adverse Event|0|||
160688622|NCT01660022|580239015|FG001|First Sequence (7 Days)|Adverse Event|0|||
160688623|NCT01660022|580239016|FG002|First Sequence (7 Days)|Adverse Event|0|||
160688624|NCT01660022|580239017|FG003|First Sequence (7 Days)|Adverse Event|0|||
160688625|NCT01660022|580239018|FG004|First Sequence (7 Days)|Adverse Event|1|||
160688626|NCT01660022|580239019|FG005|First Sequence (7 Days)|Adverse Event|3|||
160688627|NCT01660022|580239014|FG000|First Sequence (7 Days)|Protocol Violation|0|||
160688628|NCT01660022|580239015|FG001|First Sequence (7 Days)|Protocol Violation|0|||
160688629|NCT01660022|580239016|FG002|First Sequence (7 Days)|Protocol Violation|0|||
160688630|NCT01660022|580239017|FG003|First Sequence (7 Days)|Protocol Violation|0|||
160688631|NCT01660022|580239018|FG004|First Sequence (7 Days)|Protocol Violation|0|||
160688632|NCT01660022|580239019|FG005|First Sequence (7 Days)|Protocol Violation|1|||
160688633|NCT03545191|580239022|FG000|Overall Study|Death|1|||
160688634|NCT03545191|580239023|FG001|Overall Study|Death|0|||
160688635|NCT03545191|580239024|FG002|Overall Study|Death|0|||
160688636|NCT03545191|580239022|FG000|Overall Study|Adverse Event|4|||
160688637|NCT03545191|580239023|FG001|Overall Study|Adverse Event|2|||
160688638|NCT03545191|580239024|FG002|Overall Study|Adverse Event|7|||
160688639|NCT03545191|580239022|FG000|Overall Study|Other reasons|3|||
160688640|NCT03545191|580239023|FG001|Overall Study|Other reasons|11|||
160688641|NCT03545191|580239024|FG002|Overall Study|Other reasons|8|||
160688642|NCT03545191|580239022|FG000|Overall Study|Withdrawal by Subject|13|||
160688643|NCT03545191|580239023|FG001|Overall Study|Withdrawal by Subject|10|||
160688644|NCT03545191|580239024|FG002|Overall Study|Withdrawal by Subject|12|||
160688645|NCT03545191|580239022|FG000|Overall Study|Lost to Follow-up|1|||
160688646|NCT03545191|580239023|FG001|Overall Study|Lost to Follow-up|2|||
160688647|NCT03545191|580239024|FG002|Overall Study|Lost to Follow-up|3|||
160688648|NCT01277718|580239027|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
160688649|NCT01277718|580239028|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
160688650|NCT01277718|580239027|FG000|Period 2 - Second Intervention|Physician Decision|0|||
160688651|NCT01277718|580239028|FG001|Period 2 - Second Intervention|Physician Decision|2|||
160688652|NCT03919162|580239031|FG000|Overall Study|Adverse Event|3|||
160688653|NCT03919162|580239032|FG001|Overall Study|Adverse Event|2|||
160688654|NCT03919162|580239031|FG000|Overall Study|Death|2|||
160688655|NCT03919162|580239032|FG001|Overall Study|Death|0|||
160688656|NCT03919162|580239031|FG000|Overall Study|Lost to Follow-up|1|||
160688657|NCT03919162|580239032|FG001|Overall Study|Lost to Follow-up|0|||
160688658|NCT03919162|580239031|FG000|Overall Study|Withdrawal by Subject|12|||
160688659|NCT03919162|580239032|FG001|Overall Study|Withdrawal by Subject|12|||
160688660|NCT03919162|580239031|FG000|Overall Study|Study terminated by Sponsor|20|||
160688661|NCT03919162|580239032|FG001|Overall Study|Study terminated by Sponsor|24|||
160688662|NCT03919162|580239031|FG000|Overall Study|Screen failure|1|||
160688663|NCT03919162|580239032|FG001|Overall Study|Screen failure|0|||
160688664|NCT03919162|580239031|FG000|Overall Study|Missing|1|||
160688665|NCT03919162|580239032|FG001|Overall Study|Missing|1|||
160688666|NCT02746627|580239033|FG000|Overall Study|Withdrawal by Subject|1|||
160688667|NCT02746627|580239034|FG001|Overall Study|Withdrawal by Subject|1|||
160688668|NCT02746627|580239035|FG002|Overall Study|Withdrawal by Subject|1|||
160688669|NCT01688726|580239040|FG000|Overall Study|Adverse Event|1|||
160688670|NCT01688726|580239041|FG001|Overall Study|Adverse Event|0|||
160688671|NCT01688726|580239040|FG000|Overall Study|Relocated abroad|0|||
160688672|NCT01688726|580239041|FG001|Overall Study|Relocated abroad|1|||
160688673|NCT04846881|580239043|FG000|Overall Study|Adverse Event|14|||
160688674|NCT04846881|580239044|FG001|Overall Study|Adverse Event|15|||
160688675|NCT04846881|580239043|FG000|Overall Study|Burden of study procedures|7|||
160688676|NCT04846881|580239044|FG001|Overall Study|Burden of study procedures|3|||
160688677|NCT04846881|580239043|FG000|Overall Study|Protocol deviation|6|||
160688678|NCT04846881|580239044|FG001|Overall Study|Protocol deviation|4|||
160688679|NCT04846881|580239043|FG000|Overall Study|Perceived lack of efficacy|5|||
160688680|NCT04846881|580239044|FG001|Overall Study|Perceived lack of efficacy|2|||
160688681|NCT04846881|580239043|FG000|Overall Study|Change of residence|2|||
160688682|NCT04846881|580239044|FG001|Overall Study|Change of residence|0|||
160688683|NCT04846881|580239043|FG000|Overall Study|Technical problems|0|||
160688684|NCT04846881|580239044|FG001|Overall Study|Technical problems|1|||
160688685|NCT04846881|580239043|FG000|Overall Study|Other than listed|3|||
160688686|NCT04846881|580239044|FG001|Overall Study|Other than listed|10|||
160688687|NCT04846881|580239043|FG000|Overall Study|No reason available|1|||
160688688|NCT04846881|580239044|FG001|Overall Study|No reason available|3|||
160688689|NCT04846881|580239043|FG000|Overall Study|Patient randomised in error|1|||
160688690|NCT04846881|580239044|FG001|Overall Study|Patient randomised in error|0|||
160688691|NCT03821272|580240100|FG000|Overall Study|Death|1|||
160688692|NCT03821272|580240101|FG001|Overall Study|Death|0|||
160688693|NCT03821272|580240100|FG000|Overall Study|Physician Decision|1|||
160688694|NCT03821272|580240101|FG001|Overall Study|Physician Decision|0|||
160688695|NCT03821272|580240100|FG000|Overall Study|Withdrawal by Subject|1|||
160688696|NCT03821272|580240101|FG001|Overall Study|Withdrawal by Subject|0|||
160688697|NCT05904769|580240102|FG000|Overall Study|Physician Decision|0|||
160688698|NCT05904769|580240103|FG001|Overall Study|Physician Decision|6|||
160688699|NCT05626803|580240109|FG000|Overall Study|Lost to Follow-up|0|||
160688700|NCT05626803|580240110|FG001|Overall Study|Lost to Follow-up|1|||
160688701|NCT05626803|580240111|FG002|Overall Study|Lost to Follow-up|0|||
160688702|NCT05626803|580240112|FG003|Overall Study|Lost to Follow-up|0|||
160688703|NCT04974619|580240113|FG000|Overall Study|Lost to Follow-up|0|||
160688704|NCT04974619|580240114|FG001|Overall Study|Lost to Follow-up|0|||
160688705|NCT04974619|580240115|FG002|Overall Study|Lost to Follow-up|1|||
160688706|NCT04974619|580240113|FG000|Overall Study|Withdrawal by Subject|0|||
160688707|NCT04974619|580240114|FG001|Overall Study|Withdrawal by Subject|0|||
160688708|NCT04974619|580240115|FG002|Overall Study|Withdrawal by Subject|1|||
160688709|NCT04974619|580240113|FG000|Overall Study|Protocol Violation|0|||
160688710|NCT04974619|580240114|FG001|Overall Study|Protocol Violation|1|||
160688711|NCT04974619|580240115|FG002|Overall Study|Protocol Violation|0|||
160688712|NCT01688466|580240117|FG000|Overall Study|Withdrawal by Subject|2|||
160688713|NCT01688466|580240118|FG001|Overall Study|Withdrawal by Subject|1|||
160688714|NCT01688466|580240117|FG000|Overall Study|Death|0|||
160688715|NCT01688466|580240118|FG001|Overall Study|Death|1|||
160688716|NCT01688466|580240117|FG000|Overall Study|Adverse Event|0|||
160688717|NCT01688466|580240118|FG001|Overall Study|Adverse Event|4|||
160688718|NCT01688466|580240117|FG000|Overall Study|Not evaluable|0|||
160688719|NCT01688466|580240118|FG001|Overall Study|Not evaluable|1|||
160688720|NCT01000610|580240119|FG000|Overall Study|Adverse Event|1|||
160688721|NCT01000610|580240119|FG000|Overall Study|Lost to Follow-up|4|||
160688722|NCT01000610|580240119|FG000|Overall Study|Treatment failure|1|||
160688723|NCT01010126|580240120|FG000|Overall Study|Withdrawal by Subject|1|||
160688724|NCT01010126|580240121|FG001|Overall Study|Withdrawal by Subject|0|||
160688725|NCT01010126|580240122|FG002|Overall Study|Withdrawal by Subject|1|||
160688726|NCT01010126|580240123|FG003|Overall Study|Withdrawal by Subject|0|||
160688727|NCT01010126|580240124|FG004|Overall Study|Withdrawal by Subject|3|||
160688728|NCT01010126|580240125|FG005|Overall Study|Withdrawal by Subject|0|||
160688729|NCT04495283|580240128|FG000|Overall Study|Physician Decision|0|||
160688730|NCT04495283|580240129|FG001|Overall Study|Physician Decision|0|||
160688731|NCT04495283|580240130|FG002|Overall Study|Physician Decision|1|||
160688732|NCT04495283|580240128|FG000|Overall Study|Withdrawal by Subject|0|||
160688733|NCT04495283|580240129|FG001|Overall Study|Withdrawal by Subject|1|||
160688734|NCT04495283|580240130|FG002|Overall Study|Withdrawal by Subject|1|||
160688735|NCT04495283|580240128|FG000|Overall Study|Other|1|||
160688736|NCT04495283|580240129|FG001|Overall Study|Other|0|||
160688737|NCT04495283|580240130|FG002|Overall Study|Other|1|||
160688738|NCT03341000|580240148|FG000|Overall Study|Adverse Event|1|||
160688739|NCT02516410|580240149|FG000|Overall Study|Adverse Event|0|||
160688740|NCT02516410|580240150|FG001|Overall Study|Adverse Event|1|||
160688741|NCT02516410|580240149|FG000|Overall Study|Withdrawal by Subject|0|||
160688742|NCT02516410|580240150|FG001|Overall Study|Withdrawal by Subject|1|||
160688743|NCT01173471|580240158|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160688744|NCT01173471|580240159|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160688745|NCT01173471|580240160|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
160688746|NCT01173471|580240161|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
160688747|NCT01173471|580240158|FG000|Overall Study|Condition under investigation worsened|2|||
160688748|NCT01173471|580240159|FG001|Overall Study|Condition under investigation worsened|0|||
160688749|NCT01173471|580240160|FG002|Overall Study|Condition under investigation worsened|0|||
160688750|NCT01173471|580240161|FG003|Overall Study|Condition under investigation worsened|0|||
160688751|NCT01173471|580240158|FG000|Overall Study|Lost to Follow-up|0|||
160688752|NCT01173471|580240159|FG001|Overall Study|Lost to Follow-up|0|||
160688753|NCT01173471|580240160|FG002|Overall Study|Lost to Follow-up|1|||
160688754|NCT01173471|580240161|FG003|Overall Study|Lost to Follow-up|0|||
160688755|NCT01173471|580240158|FG000|Overall Study|Reason given as Other|0|||
160688756|NCT01173471|580240159|FG001|Overall Study|Reason given as Other|0|||
160688757|NCT01173471|580240160|FG002|Overall Study|Reason given as Other|1|||
160688758|NCT01173471|580240161|FG003|Overall Study|Reason given as Other|0|||
160688759|NCT03028740|580240162|FG000|Overall Study|Did not Receive Study Drug|4|||
160688760|NCT03028740|580240163|FG001|Overall Study|Did not Receive Study Drug|5|||
160688761|NCT03028740|580240162|FG000|Overall Study|Adverse Event|8|||
160688762|NCT03028740|580240163|FG001|Overall Study|Adverse Event|26|||
160688763|NCT03028740|580240162|FG000|Overall Study|Lack of Efficacy|0|||
160688764|NCT03028740|580240163|FG001|Overall Study|Lack of Efficacy|1|||
160688765|NCT03028740|580240162|FG000|Overall Study|Withdrawal by Subject|48|||
160688766|NCT03028740|580240163|FG001|Overall Study|Withdrawal by Subject|101|||
160688767|NCT03028740|580240162|FG000|Overall Study|Lost to Follow-up|30|||
160688768|NCT03028740|580240163|FG001|Overall Study|Lost to Follow-up|54|||
160688769|NCT03028740|580240162|FG000|Overall Study|Physician Decision|4|||
160688770|NCT03028740|580240163|FG001|Overall Study|Physician Decision|11|||
160688771|NCT03028740|580240162|FG000|Overall Study|Protocol Violation|4|||
160688772|NCT03028740|580240163|FG001|Overall Study|Protocol Violation|8|||
160688773|NCT03028740|580240162|FG000|Overall Study|Non-compliance with Study Drug|0|||
160688774|NCT03028740|580240163|FG001|Overall Study|Non-compliance with Study Drug|2|||
160688775|NCT03028740|580240162|FG000|Overall Study|Study Terminated by Sponsor|467|||
160688776|NCT03028740|580240163|FG001|Overall Study|Study Terminated by Sponsor|917|||
160688777|NCT03028740|580240162|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
160688778|NCT03028740|580240163|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
160688779|NCT03028740|580240162|FG000|Overall Study|Reason not Specified|1|||
160688780|NCT03028740|580240163|FG001|Overall Study|Reason not Specified|5|||
160688781|NCT01138826|580240167|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
160688782|NCT01138826|580240168|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
160688783|NCT01138826|580240169|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
160688784|NCT01138826|580240170|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
160688785|NCT01138826|580240171|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
160688786|NCT01138826|580240172|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
160688787|NCT02566993|580240173|FG000|Overall Study|Randomized but not treated|5|||
160688788|NCT02566993|580240174|FG001|Overall Study|Randomized but not treated|16|||
160688789|NCT02566993|580240173|FG000|Overall Study|Progressive disease|213|||
160688790|NCT02566993|580240174|FG001|Overall Study|Progressive disease|152|||
160688791|NCT02566993|580240173|FG000|Overall Study|Withdrawal by Subject|12|||
160688792|NCT02566993|580240174|FG001|Overall Study|Withdrawal by Subject|28|||
160688793|NCT02566993|580240173|FG000|Overall Study|Death|17|||
160688794|NCT02566993|580240174|FG001|Overall Study|Death|23|||
160688795|NCT02566993|580240173|FG000|Overall Study|Physician Decision|10|||
160688796|NCT02566993|580240174|FG001|Overall Study|Physician Decision|17|||
160688797|NCT02566993|580240173|FG000|Overall Study|Study drug-related adverse event|20|||
160688798|NCT02566993|580240174|FG001|Overall Study|Study drug-related adverse event|41|||
160688799|NCT02566993|580240173|FG000|Overall Study|Non study drug-related adverse event|9|||
160688800|NCT02566993|580240174|FG001|Overall Study|Non study drug-related adverse event|9|||
160688801|NCT02566993|580240173|FG000|Overall Study|Symptomatic deterioration|9|||
160688802|NCT02566993|580240174|FG001|Overall Study|Symptomatic deterioration|16|||
160688803|NCT02566993|580240173|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
160688804|NCT02566993|580240174|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
160688805|NCT02566993|580240173|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
160688806|NCT02566993|580240174|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
160688807|NCT02566993|580240173|FG000|Overall Study|Screening failure|2|||
160688808|NCT02566993|580240174|FG001|Overall Study|Screening failure|0|||
160688809|NCT02566993|580240173|FG000|Overall Study|Lost to Follow-up|0|||
160688810|NCT02566993|580240174|FG001|Overall Study|Lost to Follow-up|1|||
160688811|NCT02566993|580240173|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
160688812|NCT02566993|580240174|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
160688813|NCT05206448|580240175|FG000|Overall Study|Lost to Follow-up|2|||
160688814|NCT05206448|580240176|FG001|Overall Study|Lost to Follow-up|2|||
160688815|NCT05206448|580240175|FG000|Overall Study|Withdrawal by Subject|2|||
160688816|NCT05206448|580240176|FG001|Overall Study|Withdrawal by Subject|0|||
160688817|NCT05206448|580240175|FG000|Overall Study|found ineligible after randomization|1|||
160688818|NCT05206448|580240176|FG001|Overall Study|found ineligible after randomization|1|||
160688819|NCT05206448|580240175|FG000|Overall Study|unable to complete study due to personal constraints|1|||
160688820|NCT05206448|580240176|FG001|Overall Study|unable to complete study due to personal constraints|0|||
160688821|NCT05206448|580240175|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
160688822|NCT05206448|580240176|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
160688823|NCT04440449|580240177|FG000|Overall Study|Lost to Follow-up|2|||
160688824|NCT04440449|580240178|FG001|Overall Study|Lost to Follow-up|0|||
160688825|NCT02547766|580240179|FG000|Overall Study|Withdrawal by Subject|1|||
160688826|NCT03253744|580240184|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
160688827|NCT03253744|580240185|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
160688828|NCT03253744|580240186|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
160688829|NCT03253744|580240187|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
160688830|NCT05224544|580240188|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
160688831|NCT05224544|580240189|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
160688832|NCT06279871|580240190|FG000|Overall Study|Death|0|||
160688833|NCT06279871|580240191|FG001|Overall Study|Death|0|||
160688834|NCT06279871|580240192|FG002|Overall Study|Death|0|||
160688835|NCT06279871|580240193|FG003|Overall Study|Death|0|||
160688836|NCT06279871|580240194|FG004|Overall Study|Death|0|||
160688837|NCT06279871|580240195|FG005|Overall Study|Death|1|||
160688838|NCT06279871|580240196|FG006|Overall Study|Death|0|||
160688839|NCT06279871|580240190|FG000|Overall Study|Other than Specified|1|||
160688840|NCT06279871|580240191|FG001|Overall Study|Other than Specified|0|||
160688841|NCT06279871|580240192|FG002|Overall Study|Other than Specified|4|||
160688842|NCT06279871|580240193|FG003|Overall Study|Other than Specified|0|||
160688843|NCT06279871|580240194|FG004|Overall Study|Other than Specified|0|||
160688844|NCT06279871|580240195|FG005|Overall Study|Other than Specified|0|||
160688845|NCT06279871|580240196|FG006|Overall Study|Other than Specified|0|||
160688846|NCT06279871|580240190|FG000|Overall Study|Withdrawal by Subject|4|||
160688847|NCT06279871|580240191|FG001|Overall Study|Withdrawal by Subject|8|||
160688848|NCT06279871|580240192|FG002|Overall Study|Withdrawal by Subject|4|||
160688849|NCT06279871|580240193|FG003|Overall Study|Withdrawal by Subject|2|||
160688850|NCT06279871|580240194|FG004|Overall Study|Withdrawal by Subject|0|||
160688851|NCT06279871|580240195|FG005|Overall Study|Withdrawal by Subject|0|||
160688852|NCT06279871|580240196|FG006|Overall Study|Withdrawal by Subject|0|||
160688853|NCT06279871|580240190|FG000|Overall Study|Lost to Follow-up|11|||
160688854|NCT06279871|580240191|FG001|Overall Study|Lost to Follow-up|10|||
160688855|NCT06279871|580240192|FG002|Overall Study|Lost to Follow-up|8|||
160688856|NCT06279871|580240193|FG003|Overall Study|Lost to Follow-up|0|||
160688857|NCT06279871|580240194|FG004|Overall Study|Lost to Follow-up|0|||
160688858|NCT06279871|580240195|FG005|Overall Study|Lost to Follow-up|0|||
160688859|NCT06279871|580240196|FG006|Overall Study|Lost to Follow-up|0|||
160688860|NCT06279871|580240190|FG000|Overall Study|Adverse Event|0|||
160688861|NCT06279871|580240191|FG001|Overall Study|Adverse Event|1|||
160688862|NCT06279871|580240192|FG002|Overall Study|Adverse Event|0|||
160688863|NCT06279871|580240193|FG003|Overall Study|Adverse Event|0|||
160688864|NCT06279871|580240194|FG004|Overall Study|Adverse Event|0|||
160688865|NCT06279871|580240195|FG005|Overall Study|Adverse Event|0|||
160688866|NCT06279871|580240196|FG006|Overall Study|Adverse Event|0|||
160688867|NCT01341587|580240199|FG000|Overall Study|Lost to Follow-up|2|||
160688868|NCT01341587|580240200|FG001|Overall Study|Lost to Follow-up|0|||
160688869|NCT01341587|580240199|FG000|Overall Study|stopped using the meters|2|||
160688870|NCT01341587|580240200|FG001|Overall Study|stopped using the meters|10|||
160688871|NCT00645944|580240203|FG000|Randomized|Withdrawal by Subject|1|||
160688872|NCT00645944|580240204|FG001|Randomized|Withdrawal by Subject|2|||
160688873|NCT00645944|580240203|FG000|Received Medication|Adverse Event|2|||
160688874|NCT00645944|580240204|FG001|Received Medication|Adverse Event|1|||
160688875|NCT00645944|580240203|FG000|Received Medication|Withdrawal by Subject|1|||
160688876|NCT00645944|580240204|FG001|Received Medication|Withdrawal by Subject|1|||
160688877|NCT00645944|580240203|FG000|Received Medication|Lost to Follow-up|1|||
160688878|NCT00645944|580240204|FG001|Received Medication|Lost to Follow-up|0|||
160688879|NCT00645944|580240203|FG000|Received Medication|Protocol Violation|2|||
160688880|NCT00645944|580240204|FG001|Received Medication|Protocol Violation|1|||
160688881|NCT01807117|580240205|FG000|Overall Study|Physician Decision|2|||
160688882|NCT01807117|580240205|FG000|Overall Study|Disease diagnosis not a study disease|1|||
160688883|NCT05486065|580240206|FG000|Overall Study|Withdrawal by Subject|1|||
160688884|NCT05486065|580240207|FG001|Overall Study|Withdrawal by Subject|5|||
160688885|NCT05486065|580240208|FG002|Overall Study|Withdrawal by Subject|4|||
160688886|NCT05486065|580240209|FG003|Overall Study|Withdrawal by Subject|3|||
160688887|NCT05486065|580240206|FG000|Overall Study|Lost to Follow-up|4|||
160688888|NCT05486065|580240207|FG001|Overall Study|Lost to Follow-up|2|||
160688889|NCT05486065|580240208|FG002|Overall Study|Lost to Follow-up|2|||
160688890|NCT05486065|580240209|FG003|Overall Study|Lost to Follow-up|2|||
160688891|NCT05486065|580240206|FG000|Overall Study|Physician Decision|0|||
160688892|NCT05486065|580240207|FG001|Overall Study|Physician Decision|1|||
160688893|NCT05486065|580240208|FG002|Overall Study|Physician Decision|1|||
160688894|NCT05486065|580240209|FG003|Overall Study|Physician Decision|0|||
160688895|NCT05486065|580240206|FG000|Overall Study|Failure to meet randomization criteria|0|||
160688896|NCT05486065|580240207|FG001|Overall Study|Failure to meet randomization criteria|0|||
160688897|NCT05486065|580240208|FG002|Overall Study|Failure to meet randomization criteria|0|||
160688898|NCT05486065|580240209|FG003|Overall Study|Failure to meet randomization criteria|1|||
160688899|NCT02858726|580240219|FG000|Overall Study|Adverse Event|4|||
160688900|NCT02858726|580240220|FG001|Overall Study|Adverse Event|4|||
160688901|NCT02858726|580240221|FG002|Overall Study|Adverse Event|9|||
160688902|NCT02858726|580240222|FG003|Overall Study|Adverse Event|1|||
160688903|NCT02858726|580240219|FG000|Overall Study|Physician Decision|0|||
160688904|NCT02858726|580240220|FG001|Overall Study|Physician Decision|0|||
160688905|NCT02858726|580240221|FG002|Overall Study|Physician Decision|1|||
160688906|NCT02858726|580240222|FG003|Overall Study|Physician Decision|0|||
160688907|NCT02858726|580240219|FG000|Overall Study|Protocol Violation|0|||
160688908|NCT02858726|580240220|FG001|Overall Study|Protocol Violation|0|||
160688909|NCT02858726|580240221|FG002|Overall Study|Protocol Violation|0|||
160688910|NCT02858726|580240222|FG003|Overall Study|Protocol Violation|1|||
160688911|NCT02858726|580240219|FG000|Overall Study|Study Terminated by Sponsor|0|||
160688912|NCT02858726|580240220|FG001|Overall Study|Study Terminated by Sponsor|0|||
160688913|NCT02858726|580240221|FG002|Overall Study|Study Terminated by Sponsor|0|||
160688914|NCT02858726|580240222|FG003|Overall Study|Study Terminated by Sponsor|1|||
160688915|NCT02858726|580240219|FG000|Overall Study|Withdrawal by Subject|1|||
160688916|NCT02858726|580240220|FG001|Overall Study|Withdrawal by Subject|2|||
160688917|NCT02858726|580240221|FG002|Overall Study|Withdrawal by Subject|1|||
160688918|NCT02858726|580240222|FG003|Overall Study|Withdrawal by Subject|0|||
160688919|NCT02858726|580240219|FG000|Overall Study|Noncompliance|0|||
160688920|NCT02858726|580240220|FG001|Overall Study|Noncompliance|1|||
160688921|NCT02858726|580240221|FG002|Overall Study|Noncompliance|0|||
160688922|NCT02858726|580240222|FG003|Overall Study|Noncompliance|0|||
160688923|NCT00233987|580240225|FG000|Overall Study|Withdrawal by Subject|1|||
160688924|NCT00233987|580240225|FG000|Overall Study|Lack of Efficacy|2|||
160688925|NCT00233987|580240225|FG000|Overall Study|Reason Under Review|1|||
160688926|NCT00233987|580240225|FG000|Overall Study|Other - Not Protocol Specified|5|||
160688927|NCT00233987|580240225|FG000|Overall Study|Eligible but No Treatment Received|2|||
160688928|NCT00233987|580240225|FG000|Overall Study|Ineligible|4|||
160688929|NCT04553913|580240226|FG000|Overall Study|patient's block resolved prior to PACU|1|||
160688930|NCT04553913|580240226|FG000|Overall Study|did not use the device properly|5|||
160688931|NCT01481324|580240228|FG000|Overall Study|Missing Data|0|||
160688932|NCT01481324|580240229|FG001|Overall Study|Missing Data|2|||
160688933|NCT01481324|580240230|FG002|Overall Study|Missing Data|2|||
160688934|NCT00710749|580240232|FG000|First Intervention|Withdrawal by Subject|1|||
160688935|NCT00710749|580240233|FG001|First Intervention|Withdrawal by Subject|0|||
160688936|NCT05478252|580240234|FG000|Overall Study|Withdrawal by Subject|2|||
160688937|NCT05478252|580240235|FG001|Overall Study|Withdrawal by Subject|3|||
160688938|NCT05478252|580240234|FG000|Overall Study|Lost to Follow-up|4|||
160688939|NCT05478252|580240235|FG001|Overall Study|Lost to Follow-up|2|||
160688940|NCT05478252|580240234|FG000|Overall Study|Physician Decision|1|||
160688941|NCT05478252|580240235|FG001|Overall Study|Physician Decision|1|||
160688942|NCT05478252|580240234|FG000|Overall Study|Death|1|||
160688943|NCT05478252|580240235|FG001|Overall Study|Death|0|||
160688944|NCT04560998|580240236|FG000|Overall Study|Withdrawal by Subject|18|||
160688945|NCT04560998|580240237|FG001|Overall Study|Withdrawal by Subject|12|||
160688946|NCT04560998|580240236|FG000|Overall Study|Lost to Follow-up|8|||
160688947|NCT04560998|580240237|FG001|Overall Study|Lost to Follow-up|5|||
160688948|NCT04560998|580240236|FG000|Overall Study|Physician Decision|4|||
160688949|NCT04560998|580240237|FG001|Overall Study|Physician Decision|0|||
160688950|NCT01647958|580243045|FG000|Initial Study|Lost to Follow-up|2|||
160688951|NCT01647958|580243046|FG001|Initial Study|Lost to Follow-up|3|||
160688952|NCT01647958|580243045|FG000|Continuation Phase|treatment received during Overall Study|39|||
160688953|NCT01647958|580243046|FG001|Continuation Phase|treatment received during Overall Study|0|||
160688954|NCT01647958|580243045|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
160688955|NCT01647958|580243046|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
160688956|NCT01131299|580243047|FG000|Overall Study|Withdrawal by Subject|4|||
160688957|NCT01131299|580243048|FG001|Overall Study|Withdrawal by Subject|7|||
160688958|NCT01207440|580243056|FG000|Overall Study|Adverse Event|46|||
160688959|NCT01207440|580243057|FG001|Overall Study|Adverse Event|11|||
160688960|NCT01207440|580243058|FG002|Overall Study|Adverse Event|7|||
160688961|NCT01207440|580243059|FG003|Overall Study|Adverse Event|2|||
160688962|NCT01207440|580243060|FG004|Overall Study|Adverse Event|6|||
160688963|NCT01207440|580243061|FG005|Overall Study|Adverse Event|6|||
160688964|NCT01207440|580243062|FG006|Overall Study|Adverse Event|2|||
160688965|NCT01207440|580243056|FG000|Overall Study|Death|6|||
160688966|NCT01207440|580243057|FG001|Overall Study|Death|3|||
160688967|NCT01207440|580243058|FG002|Overall Study|Death|2|||
160688968|NCT01207440|580243059|FG003|Overall Study|Death|2|||
160688969|NCT01207440|580243060|FG004|Overall Study|Death|7|||
160688970|NCT01207440|580243061|FG005|Overall Study|Death|5|||
160688971|NCT01207440|580243062|FG006|Overall Study|Death|1|||
160688972|NCT01207440|580243056|FG000|Overall Study|Lack of Efficacy|13|||
160688973|NCT01207440|580243057|FG001|Overall Study|Lack of Efficacy|2|||
160688974|NCT01207440|580243058|FG002|Overall Study|Lack of Efficacy|5|||
160688975|NCT01207440|580243059|FG003|Overall Study|Lack of Efficacy|1|||
160688976|NCT01207440|580243060|FG004|Overall Study|Lack of Efficacy|2|||
160688977|NCT01207440|580243061|FG005|Overall Study|Lack of Efficacy|3|||
160688978|NCT01207440|580243062|FG006|Overall Study|Lack of Efficacy|0|||
160688979|NCT01207440|580243056|FG000|Overall Study|Lost to Follow-up|0|||
160688980|NCT01207440|580243057|FG001|Overall Study|Lost to Follow-up|0|||
160688981|NCT01207440|580243058|FG002|Overall Study|Lost to Follow-up|2|||
160688982|NCT01207440|580243059|FG003|Overall Study|Lost to Follow-up|1|||
160688983|NCT01207440|580243060|FG004|Overall Study|Lost to Follow-up|0|||
160688984|NCT01207440|580243061|FG005|Overall Study|Lost to Follow-up|0|||
160688985|NCT01207440|580243062|FG006|Overall Study|Lost to Follow-up|0|||
160688986|NCT01207440|580243056|FG000|Overall Study|Non-compliance with Study Drug|3|||
160688987|NCT01207440|580243057|FG001|Overall Study|Non-compliance with Study Drug|0|||
160688988|NCT01207440|580243058|FG002|Overall Study|Non-compliance with Study Drug|1|||
160688989|NCT01207440|580243059|FG003|Overall Study|Non-compliance with Study Drug|0|||
160688990|NCT01207440|580243060|FG004|Overall Study|Non-compliance with Study Drug|0|||
160688991|NCT01207440|580243061|FG005|Overall Study|Non-compliance with Study Drug|0|||
160688992|NCT01207440|580243062|FG006|Overall Study|Non-compliance with Study Drug|0|||
160688993|NCT01207440|580243056|FG000|Overall Study|Physician Decision|6|||
160688994|NCT01207440|580243057|FG001|Overall Study|Physician Decision|5|||
160688995|NCT01207440|580243058|FG002|Overall Study|Physician Decision|5|||
160688996|NCT01207440|580243059|FG003|Overall Study|Physician Decision|0|||
160688997|NCT01207440|580243060|FG004|Overall Study|Physician Decision|1|||
160688998|NCT01207440|580243061|FG005|Overall Study|Physician Decision|0|||
160688999|NCT01207440|580243062|FG006|Overall Study|Physician Decision|0|||
160689000|NCT01207440|580243056|FG000|Overall Study|Progressive Disease|19|||
160689001|NCT01207440|580243057|FG001|Overall Study|Progressive Disease|10|||
160689002|NCT01207440|580243058|FG002|Overall Study|Progressive Disease|19|||
160689003|NCT01207440|580243059|FG003|Overall Study|Progressive Disease|7|||
160689004|NCT01207440|580243060|FG004|Overall Study|Progressive Disease|23|||
160689005|NCT01207440|580243061|FG005|Overall Study|Progressive Disease|27|||
160689006|NCT01207440|580243062|FG006|Overall Study|Progressive Disease|0|||
160689007|NCT01207440|580243056|FG000|Overall Study|Protocol Violation|2|||
160689008|NCT01207440|580243057|FG001|Overall Study|Protocol Violation|0|||
160689009|NCT01207440|580243058|FG002|Overall Study|Protocol Violation|0|||
160689010|NCT01207440|580243059|FG003|Overall Study|Protocol Violation|0|||
160689011|NCT01207440|580243060|FG004|Overall Study|Protocol Violation|0|||
160689012|NCT01207440|580243061|FG005|Overall Study|Protocol Violation|0|||
160689013|NCT01207440|580243062|FG006|Overall Study|Protocol Violation|0|||
160689014|NCT01207440|580243056|FG000|Overall Study|Site Terminated by Sponsor|69|||
160689015|NCT01207440|580243057|FG001|Overall Study|Site Terminated by Sponsor|19|||
160689016|NCT01207440|580243058|FG002|Overall Study|Site Terminated by Sponsor|12|||
160689017|NCT01207440|580243059|FG003|Overall Study|Site Terminated by Sponsor|2|||
160689018|NCT01207440|580243060|FG004|Overall Study|Site Terminated by Sponsor|3|||
160689019|NCT01207440|580243061|FG005|Overall Study|Site Terminated by Sponsor|0|||
160689020|NCT01207440|580243062|FG006|Overall Study|Site Terminated by Sponsor|2|||
160689021|NCT01207440|580243056|FG000|Overall Study|Withdrawal by Subject|29|||
160689022|NCT01207440|580243057|FG001|Overall Study|Withdrawal by Subject|4|||
160689023|NCT01207440|580243058|FG002|Overall Study|Withdrawal by Subject|5|||
160689024|NCT01207440|580243059|FG003|Overall Study|Withdrawal by Subject|3|||
160689025|NCT01207440|580243060|FG004|Overall Study|Withdrawal by Subject|2|||
160689026|NCT01207440|580243061|FG005|Overall Study|Withdrawal by Subject|2|||
160689027|NCT01207440|580243062|FG006|Overall Study|Withdrawal by Subject|0|||
160689028|NCT01207440|580243056|FG000|Overall Study|Reason Not Specified|10|||
160689029|NCT01207440|580243057|FG001|Overall Study|Reason Not Specified|10|||
160689030|NCT01207440|580243058|FG002|Overall Study|Reason Not Specified|7|||
160689031|NCT01207440|580243059|FG003|Overall Study|Reason Not Specified|0|||
160689032|NCT01207440|580243060|FG004|Overall Study|Reason Not Specified|4|||
160689033|NCT01207440|580243061|FG005|Overall Study|Reason Not Specified|3|||
160689034|NCT01207440|580243062|FG006|Overall Study|Reason Not Specified|0|||
160689035|NCT01592721|580243063|FG000|Long-term Follow-up|Death|1|||
160689036|NCT04718194|580243066|FG000|Overall Study|Withdrawal by Subject|3|||
160689037|NCT04718194|580243067|FG001|Overall Study|Withdrawal by Subject|0|||
160689038|NCT04718194|580243066|FG000|Overall Study|Lost to Follow-up|3|||
160689039|NCT04718194|580243067|FG001|Overall Study|Lost to Follow-up|0|||
160689040|NCT01215513|580243068|FG000|Overall Study|Not completed CS42|9|||
160689041|NCT01215513|580243068|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
160689042|NCT01215513|580243068|FG000|Overall Study|Adverse event (CS42A)|2|||
160689043|NCT01215513|580243068|FG000|Overall Study|Physician decision (CS42A)|6|||
160689044|NCT01215513|580243068|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
160689045|NCT01215513|580243068|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
160689046|NCT00821873|580243069|FG000|Overall Study|Lost to Follow-up|4|||
160689047|NCT02698865|580243070|FG000|Overall Study|Other|11|||
160689048|NCT02698865|580243071|FG001|Overall Study|Other|11|||
160689049|NCT02698865|580243070|FG000|Overall Study|Withdrawal by Subject|20|||
160689050|NCT02698865|580243071|FG001|Overall Study|Withdrawal by Subject|16|||
160689051|NCT02698865|580243070|FG000|Overall Study|Physician Decision|0|||
160689052|NCT02698865|580243071|FG001|Overall Study|Physician Decision|4|||
160689053|NCT02698865|580243070|FG000|Overall Study|Lost to Follow-up|4|||
160689054|NCT02698865|580243071|FG001|Overall Study|Lost to Follow-up|2|||
160689055|NCT03861481|580243073|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
160689056|NCT03861481|580243074|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
160689057|NCT03861481|580243073|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
160689058|NCT03861481|580243074|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
160689059|NCT03861481|580243073|FG000|Overall Study|Relapse|1|||
160689060|NCT03861481|580243074|FG001|Overall Study|Relapse|0|||
160689061|NCT03861481|580243073|FG000|Overall Study|Withdrawal by Subject|0|||
160689062|NCT03861481|580243074|FG001|Overall Study|Withdrawal by Subject|1|||
160689063|NCT03861481|580243073|FG000|Overall Study|Lack of Efficacy|4|||
160689064|NCT03861481|580243074|FG001|Overall Study|Lack of Efficacy|5|||
160689065|NCT00773734|580243075|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
160689066|NCT00773734|580243076|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
160689067|NCT00773734|580243077|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
160689068|NCT00773734|580243078|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
160689069|NCT00773734|580243079|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
160689070|NCT00773734|580243080|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
160689071|NCT00773734|580243075|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
160689072|NCT00773734|580243076|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
160689073|NCT00773734|580243077|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
160689074|NCT00773734|580243078|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
160689075|NCT00773734|580243079|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
160689076|NCT00773734|580243080|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
160689077|NCT00773734|580243075|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
160689078|NCT00773734|580243076|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
160689079|NCT00773734|580243077|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
160689080|NCT00773734|580243078|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
160689081|NCT00773734|580243079|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
160689082|NCT00773734|580243080|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
160689083|NCT00773734|580243075|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
160689084|NCT00773734|580243076|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
160689085|NCT00773734|580243077|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
160689086|NCT00773734|580243078|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
160689087|NCT00773734|580243079|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
160689088|NCT00773734|580243080|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
160689089|NCT00773734|580243075|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
160689090|NCT00773734|580243076|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
160689091|NCT00773734|580243077|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
160689092|NCT00773734|580243078|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
160689093|NCT00773734|580243079|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
160689094|NCT00773734|580243080|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
160689095|NCT00773734|580243075|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
160689096|NCT00773734|580243076|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
160689097|NCT00773734|580243077|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
160689098|NCT00773734|580243078|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
160689099|NCT00773734|580243079|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
160689100|NCT00773734|580243080|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
160689101|NCT00773734|580243075|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
160689102|NCT00773734|580243076|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
160689103|NCT00773734|580243077|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
160689104|NCT00773734|580243078|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
160689105|NCT00773734|580243079|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
160689106|NCT00773734|580243080|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
160689107|NCT00773734|580243075|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
160689108|NCT00773734|580243076|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
160689109|NCT00773734|580243077|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
160689110|NCT00773734|580243078|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
160689111|NCT00773734|580243079|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
160689112|NCT00773734|580243080|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
160689113|NCT00773734|580243075|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
160689114|NCT00773734|580243076|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
160689115|NCT00773734|580243077|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
160689116|NCT00773734|580243078|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
160689117|NCT00773734|580243079|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
160689118|NCT00773734|580243080|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
160689119|NCT00773734|580243075|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
160689120|NCT00773734|580243076|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
160689121|NCT00773734|580243077|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
160689122|NCT00773734|580243078|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
160689123|NCT00773734|580243079|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
160689124|NCT00773734|580243080|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
160689125|NCT00773734|580243075|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
160689126|NCT00773734|580243076|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
160689127|NCT00773734|580243077|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
160689128|NCT00773734|580243078|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
160689129|NCT00773734|580243079|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
160689130|NCT00773734|580243080|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
160689131|NCT00773734|580243075|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
160689132|NCT00773734|580243076|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
160689133|NCT00773734|580243077|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
160689134|NCT00773734|580243078|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
160689135|NCT00773734|580243079|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
160689136|NCT00773734|580243080|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
160689137|NCT00773734|580243075|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
160689138|NCT00773734|580243076|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
160689139|NCT00773734|580243077|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
160689140|NCT00773734|580243078|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
160689141|NCT00773734|580243079|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
160689142|NCT00773734|580243080|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
160689143|NCT00773734|580243075|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
160689144|NCT00773734|580243076|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
160689145|NCT00773734|580243077|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
160689146|NCT00773734|580243078|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
160689147|NCT00773734|580243079|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
160689148|NCT00773734|580243080|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
160689149|NCT00773734|580243075|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
160689150|NCT00773734|580243076|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
160689151|NCT00773734|580243077|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
160689152|NCT00773734|580243078|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
160689153|NCT00773734|580243079|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
160689154|NCT00773734|580243080|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
160689155|NCT00773734|580243075|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
160689156|NCT00773734|580243076|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
160689157|NCT00773734|580243077|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
160689158|NCT00773734|580243078|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
160689159|NCT00773734|580243079|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
160689160|NCT00773734|580243080|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
160689161|NCT00773734|580243075|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
160689162|NCT00773734|580243076|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
160689163|NCT00773734|580243077|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
160689164|NCT00773734|580243078|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
160689165|NCT00773734|580243079|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
160689166|NCT00773734|580243080|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
160689167|NCT00773734|580243075|FG000|Extension: Active Treatment Week 24-52|Other|0|||
160689168|NCT00773734|580243076|FG001|Extension: Active Treatment Week 24-52|Other|0|||
160689169|NCT00773734|580243077|FG002|Extension: Active Treatment Week 24-52|Other|1|||
160689170|NCT00773734|580243078|FG003|Extension: Active Treatment Week 24-52|Other|2|||
160689171|NCT00773734|580243079|FG004|Extension: Active Treatment Week 24-52|Other|0|||
160689172|NCT00773734|580243080|FG005|Extension: Active Treatment Week 24-52|Other|1|||
160689173|NCT00773734|580243075|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
160689174|NCT00773734|580243076|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
160689175|NCT00773734|580243077|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
160689176|NCT00773734|580243078|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
160689177|NCT00773734|580243079|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
160689178|NCT00773734|580243080|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
160689179|NCT00773734|580243075|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
160689180|NCT00773734|580243076|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
160689181|NCT00773734|580243077|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
160689182|NCT00773734|580243078|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
160689183|NCT00773734|580243079|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
160689184|NCT00773734|580243080|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
160689185|NCT00773734|580243075|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
160689186|NCT00773734|580243076|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
160689187|NCT00773734|580243077|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
160689188|NCT00773734|580243078|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
160689189|NCT00773734|580243079|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
160689190|NCT00773734|580243080|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
160689191|NCT00773734|580243075|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
160689192|NCT00773734|580243076|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
160689193|NCT00773734|580243077|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
160689194|NCT00773734|580243078|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
160689195|NCT00773734|580243079|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
160689196|NCT00773734|580243080|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
160689197|NCT00856830|580243084|FG000|Irinotecan & Bendamustine|Death|0|||
160689198|NCT00856830|580243085|FG001|Irinotecan & Bendamustine|Death|0|||
160689199|NCT00856830|580243086|FG002|Irinotecan & Bendamustine|Death|0|||
160689200|NCT00856830|580243087|FG003|Irinotecan & Bendamustine|Death|2|||
160689201|NCT00856830|580243084|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
160689202|NCT00856830|580243085|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
160689203|NCT00856830|580243086|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
160689204|NCT00856830|580243087|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
160689205|NCT03768726|580243088|FG000|Treatment Phase|Adverse Event|2|||
160689206|NCT03768726|580243089|FG001|Treatment Phase|Adverse Event|2|||
160689207|NCT03768726|580243088|FG000|Treatment Phase|Lost to Follow-up|1|||
160689208|NCT03768726|580243089|FG001|Treatment Phase|Lost to Follow-up|0|||
160689209|NCT03768726|580243088|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
160689210|NCT03768726|580243089|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
160689211|NCT03768726|580243088|FG000|Treatment Phase|Withdrawal by Subject|3|||
160689212|NCT03768726|580243089|FG001|Treatment Phase|Withdrawal by Subject|1|||
160689213|NCT03768726|580243088|FG000|Follow-Up|Adverse Event|2|||
160689214|NCT03768726|580243089|FG001|Follow-Up|Adverse Event|2|||
160689215|NCT03768726|580243088|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
160689216|NCT03768726|580243089|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
160689217|NCT03768726|580243088|FG000|Follow-Up|Withdrawal by Subject|2|||
160689218|NCT03768726|580243089|FG001|Follow-Up|Withdrawal by Subject|0|||
160689219|NCT03768726|580243088|FG000|Follow-Up|Other|1|||
160689220|NCT03768726|580243089|FG001|Follow-Up|Other|0|||
160689221|NCT00099268|580243090|FG000|Overall Study|Withdrawal by Subject|46|||
160689222|NCT00099268|580243091|FG001|Overall Study|Withdrawal by Subject|28|||
160689223|NCT00099268|580243090|FG000|Overall Study|Adverse Event|19|||
160689224|NCT00099268|580243091|FG001|Overall Study|Adverse Event|19|||
160689225|NCT00099268|580243090|FG000|Overall Study|Protocol Violation|9|||
160689226|NCT00099268|580243091|FG001|Overall Study|Protocol Violation|8|||
160689227|NCT00099268|580243090|FG000|Overall Study|Lost to Follow-up|6|||
160689228|NCT00099268|580243091|FG001|Overall Study|Lost to Follow-up|4|||
160689229|NCT00099268|580243090|FG000|Overall Study|Lack of Efficacy|5|||
160689230|NCT00099268|580243091|FG001|Overall Study|Lack of Efficacy|18|||
160689231|NCT00099268|580243090|FG000|Overall Study|Administrative problems|4|||
160689232|NCT00099268|580243091|FG001|Overall Study|Administrative problems|4|||
160689233|NCT00099268|580243090|FG000|Overall Study|Death|3|||
160689234|NCT00099268|580243091|FG001|Overall Study|Death|1|||
160689235|NCT03702049|580243092|FG000|Overall Study|Lost to Follow-up|4|||
160689236|NCT03702049|580243092|FG000|Overall Study|Physician Decision|1|||
160689237|NCT03438396|580243094|FG000|Overall Study|Reason Not Specified|9|||
160689238|NCT03438396|580243094|FG000|Overall Study|Withdrawal by Subject|5|||
160689239|NCT03438396|580243094|FG000|Overall Study|Lost to Follow-up|2|||
160689240|NCT03438396|580243094|FG000|Overall Study|Death|85|||
160689241|NCT03438396|580243094|FG000|Overall Study|Not treated|1|||
160689242|NCT01744093|580243095|FG000|Overall Study|Withdrawal by Subject|6|||
160689243|NCT01744093|580243096|FG001|Overall Study|Withdrawal by Subject|1|||
160689244|NCT02006628|580243097|FG000|Overall Study|Adverse Event|1|||
160689245|NCT02006628|580243098|FG001|Overall Study|Adverse Event|1|||
160689246|NCT02006628|580243097|FG000|Overall Study|Withdrawal by Subject|2|||
160689247|NCT02006628|580243098|FG001|Overall Study|Withdrawal by Subject|1|||
160689248|NCT00262041|580243099|FG000|Overall Study|Withdrawal by Subject|0|||
160689249|NCT00262041|580243100|FG001|Overall Study|Withdrawal by Subject|3|||
160689250|NCT00262041|580243101|FG002|Overall Study|Withdrawal by Subject|1|||
160689251|NCT00262041|580243099|FG000|Overall Study|Lost to Follow-up|1|||
160689252|NCT00262041|580243100|FG001|Overall Study|Lost to Follow-up|1|||
160689253|NCT00262041|580243101|FG002|Overall Study|Lost to Follow-up|5|||
160689254|NCT00262041|580243099|FG000|Overall Study|Unable to classify|1|||
160689255|NCT00262041|580243100|FG001|Overall Study|Unable to classify|0|||
160689256|NCT00262041|580243101|FG002|Overall Study|Unable to classify|0|||
160689257|NCT03578237|580243104|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
160689258|NCT03578237|580243105|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
160689259|NCT04132336|580243106|FG000|Overall Study|Investigator Decision|0|||
160689260|NCT04132336|580243107|FG001|Overall Study|Investigator Decision|1|||
160689261|NCT04132336|580243108|FG002|Overall Study|Investigator Decision|0|||
160689262|NCT04132336|580243109|FG003|Overall Study|Investigator Decision|0|||
160689263|NCT04132336|580243110|FG004|Overall Study|Investigator Decision|0|||
160689264|NCT04132336|580243111|FG005|Overall Study|Investigator Decision|0|||
160689265|NCT04132336|580243112|FG006|Overall Study|Investigator Decision|0|||
160689266|NCT02488330|580243113|FG000|Overall Study|Adverse Event|1|||
160689267|NCT02488330|580243113|FG000|Overall Study|Physician Decision|2|||
160689268|NCT02488330|580243113|FG000|Overall Study|Death|2|||
160689269|NCT02488330|580243113|FG000|Overall Study|Disease Progression|3|||
160689270|NCT02488330|580243113|FG000|Overall Study|Study Termination by Sponsor|4|||
160689271|NCT02384941|580243118|FG000|Overall Study|Adverse Event|11|||
160689272|NCT02384941|580243119|FG001|Overall Study|Adverse Event|13|||
160689273|NCT02384941|580243120|FG002|Overall Study|Adverse Event|17|||
160689274|NCT02384941|580243118|FG000|Overall Study|Lost to Follow-up|3|||
160689275|NCT02384941|580243119|FG001|Overall Study|Lost to Follow-up|2|||
160689276|NCT02384941|580243120|FG002|Overall Study|Lost to Follow-up|1|||
160689277|NCT02384941|580243118|FG000|Overall Study|Non-Compliance With Study Drug|2|||
160689278|NCT02384941|580243119|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160689279|NCT02384941|580243120|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160689280|NCT02384941|580243118|FG000|Overall Study|Physician Decision|1|||
160689281|NCT02384941|580243119|FG001|Overall Study|Physician Decision|1|||
160689282|NCT02384941|580243120|FG002|Overall Study|Physician Decision|0|||
160689283|NCT02384941|580243118|FG000|Overall Study|Protocol Violation|3|||
160689284|NCT02384941|580243119|FG001|Overall Study|Protocol Violation|0|||
160689285|NCT02384941|580243120|FG002|Overall Study|Protocol Violation|0|||
160689286|NCT02384941|580243118|FG000|Overall Study|Withdrawal by Subject|26|||
160689287|NCT02384941|580243119|FG001|Overall Study|Withdrawal by Subject|19|||
160689288|NCT02384941|580243120|FG002|Overall Study|Withdrawal by Subject|20|||
160689289|NCT02384941|580243118|FG000|Overall Study|Pregnancy|0|||
160689290|NCT02384941|580243119|FG001|Overall Study|Pregnancy|0|||
160689291|NCT02384941|580243120|FG002|Overall Study|Pregnancy|1|||
160689292|NCT02384941|580243118|FG000|Overall Study|Other than specified above|4|||
160689293|NCT02384941|580243119|FG001|Overall Study|Other than specified above|0|||
160689294|NCT02384941|580243120|FG002|Overall Study|Other than specified above|1|||
160689295|NCT02493777|580243121|FG000|Overall Study|Lost to Follow-up|0|||
160689296|NCT02493777|580243122|FG001|Overall Study|Lost to Follow-up|1|||
160689297|NCT00468728|580243123|FG000|Treatment|criteria for mITT population|4|||
160689298|NCT00468728|580243124|FG001|Treatment|criteria for mITT population|11|||
160689299|NCT00468728|580243123|FG000|Follow-up|mITT failure|34|||
160689300|NCT00468728|580243124|FG001|Follow-up|mITT failure|31|||
160689301|NCT01705236|580243125|FG000|Overall Study|Lost to Follow-up|1|||
160689302|NCT01705236|580243125|FG000|Overall Study|Administrative problems|2|||
160689303|NCT01705236|580243125|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
160689304|NCT01705236|580243125|FG000|Overall Study|Protocol Violation|3|||
160689305|NCT01705236|580243125|FG000|Overall Study|Abnormal test procedure result(s)|4|||
160689306|NCT01705236|580243125|FG000|Overall Study|Abnormal laboratory value(s)|4|||
160689307|NCT01705236|580243125|FG000|Overall Study|Withdrawal by Subject|5|||
160689308|NCT01705236|580243125|FG000|Overall Study|Adverse Event|5|||
160689309|NCT06005597|580243126|FG000|Overall Study|Lost to Follow-up|1|||
160689310|NCT06005597|580243127|FG001|Overall Study|Lost to Follow-up|2|||
160689311|NCT06005597|580243128|FG002|Overall Study|Lost to Follow-up|1|||
160689312|NCT06005597|580243129|FG003|Overall Study|Lost to Follow-up|2|||
160689313|NCT06005597|580243126|FG000|Overall Study|Death|1|||
160689314|NCT06005597|580243127|FG001|Overall Study|Death|1|||
160689315|NCT06005597|580243128|FG002|Overall Study|Death|1|||
160689316|NCT06005597|580243129|FG003|Overall Study|Death|0|||
160689317|NCT02370914|580243130|FG000|Overall Study|Protocol Violation|2|||
160689318|NCT02224573|580243131|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
160689319|NCT02224573|580243132|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
160689320|NCT02224573|580243131|FG000|Treatment Phase|Started on Other IMP|1|||
160689321|NCT02224573|580243132|FG001|Treatment Phase|Started on Other IMP|0|||
160689322|NCT02224573|580243131|FG000|Treatment Phase|Participant Discontinued IMP|0|||
160689323|NCT02224573|580243132|FG001|Treatment Phase|Participant Discontinued IMP|1|||
160689324|NCT02224573|580243131|FG000|Treatment Phase|Lack of Efficacy|15|||
160689325|NCT02224573|580243132|FG001|Treatment Phase|Lack of Efficacy|8|||
160689326|NCT02224573|580243131|FG000|Treatment Phase|Began Commercial Product|1|||
160689327|NCT02224573|580243132|FG001|Treatment Phase|Began Commercial Product|0|||
160689328|NCT02224573|580243131|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
160689329|NCT02224573|580243132|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
160689330|NCT02224573|580243131|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
160689331|NCT02224573|580243132|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
160689332|NCT02224573|580243131|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
160689333|NCT02224573|580243132|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
160689334|NCT02224573|580243131|FG000|Treatment Phase|Continued Compassionate Use|1|||
160689335|NCT02224573|580243132|FG001|Treatment Phase|Continued Compassionate Use|0|||
160689336|NCT02224573|580243131|FG000|Treatment Phase|Lack of Efficiency|2|||
160689337|NCT02224573|580243132|FG001|Treatment Phase|Lack of Efficiency|1|||
160689338|NCT02224573|580243131|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
160689339|NCT02224573|580243132|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
160689340|NCT02224573|580243131|FG000|Treatment Phase|Participant Moved|2|||
160689341|NCT02224573|580243132|FG001|Treatment Phase|Participant Moved|0|||
160689342|NCT02224573|580243131|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
160689343|NCT02224573|580243132|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
160689344|NCT02224573|580243131|FG000|Treatment Phase|Refused Medication|1|||
160689345|NCT02224573|580243132|FG001|Treatment Phase|Refused Medication|1|||
160689346|NCT02224573|580243131|FG000|Treatment Phase|Adverse Event|26|||
160689347|NCT02224573|580243132|FG001|Treatment Phase|Adverse Event|38|||
160689348|NCT02224573|580243131|FG000|Treatment Phase|Placed in Group Home|0|||
160689349|NCT02224573|580243132|FG001|Treatment Phase|Placed in Group Home|1|||
160689350|NCT02224573|580243131|FG000|Treatment Phase|Pursued Other Trials|1|||
160689351|NCT02224573|580243132|FG001|Treatment Phase|Pursued Other Trials|0|||
160689352|NCT02224573|580243131|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
160689353|NCT02224573|580243132|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
160689354|NCT02224573|580243131|FG000|Treatment Phase|Lost to Follow-up|2|||
160689355|NCT02224573|580243132|FG001|Treatment Phase|Lost to Follow-up|1|||
160689356|NCT02224573|580243131|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
160689357|NCT02224573|580243132|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
160689358|NCT02224573|580243131|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
160689359|NCT02224573|580243132|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
160689360|NCT02224573|580243131|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
160689361|NCT02224573|580243132|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
160689362|NCT02224573|580243131|FG000|Taper Phase|Adverse Event|1|||
160689363|NCT02224573|580243132|FG001|Taper Phase|Adverse Event|1|||
160689364|NCT00252174|580243133|FG000|Overall Study|Withdrawal by Subject|0|||
160689365|NCT00252174|580243134|FG001|Overall Study|Withdrawal by Subject|1|||
160689366|NCT00252174|580243135|FG002|Overall Study|Withdrawal by Subject|0|||
160689367|NCT02546362|580243136|FG000|4-week Treatment Period|Lost to Follow-up|1|||
160689368|NCT02546362|580243136|FG000|4-week Treatment Period|Change in medication|2|||
160689369|NCT02546362|580243136|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
160689370|NCT02546362|580243136|FG000|12-week Treatment Period|Lost to Follow-up|2|||
160689371|NCT02546362|580243136|FG000|12-week Treatment Period|Change in medication|1|||
160689372|NCT02025010|580243138|FG000|Overall Study|Symptomatic or radiographic progression|36|||
160689373|NCT02025010|580243138|FG000|Overall Study|Adverse Event|6|||
160689374|NCT02025010|580243138|FG000|Overall Study|Physician Decision|7|||
160689375|NCT02025010|580243138|FG000|Overall Study|Withdrawal by Subject|3|||
160689376|NCT02025010|580243138|FG000|Overall Study|Intercurrent illness|3|||
160689377|NCT02025010|580243138|FG000|Overall Study|Patients still on treatment|3|||
160689378|NCT02025010|580243138|FG000|Overall Study|Never initiate the treatment|2|||
160689379|NCT04572243|580243140|FG000|Core Study: 14 Weeks|Adverse Event|1|||
160689380|NCT04572243|580243141|FG001|Core Study: 14 Weeks|Adverse Event|2|||
160689381|NCT04572243|580243142|FG002|Core Study: 14 Weeks|Adverse Event|0|||
160689382|NCT04572243|580243143|FG003|Core Study: 14 Weeks|Adverse Event|0|||
160689383|NCT04572243|580243140|FG000|Core Study: 14 Weeks|Subject choice|0|||
160689384|NCT04572243|580243141|FG001|Core Study: 14 Weeks|Subject choice|2|||
160689385|NCT04572243|580243142|FG002|Core Study: 14 Weeks|Subject choice|0|||
160689386|NCT04572243|580243143|FG003|Core Study: 14 Weeks|Subject choice|0|||
160689387|NCT04572243|580243140|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
160689388|NCT04572243|580243141|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
160689389|NCT04572243|580243142|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
160689390|NCT04572243|580243143|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
160689391|NCT04572243|580243140|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
160689392|NCT04572243|580243141|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
160689393|NCT04572243|580243142|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
160689394|NCT04572243|580243143|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
160689395|NCT01661881|580243144|FG000|Overall Study|Disease Progression|1|||
160689396|NCT01790113|580243145|FG000|Overall Study|Adverse Event|2|||
160689397|NCT01790113|580243146|FG001|Overall Study|Adverse Event|7|||
160689398|NCT01790113|580243145|FG000|Overall Study|Study ended due to FDA clearance|1|||
160689399|NCT01790113|580243146|FG001|Overall Study|Study ended due to FDA clearance|68|||
160689400|NCT03451006|580243147|FG000|Overall Study|Withdrawal by Subject|2|||
160689401|NCT03451006|580243148|FG001|Overall Study|Withdrawal by Subject|2|||
160689402|NCT00775606|580243153|FG000|Overall Study|Study sponsor terminated funding|3|||
160689403|NCT00775606|580243154|FG001|Overall Study|Study sponsor terminated funding|0|||
160689404|NCT02278718|580243155|FG000|Overall Study|Adverse Event|1|||
160689405|NCT02278718|580243156|FG001|Overall Study|Adverse Event|0|||
160689406|NCT02278718|580243155|FG000|Overall Study|Lost to Follow-up|2|||
160689407|NCT02278718|580243156|FG001|Overall Study|Lost to Follow-up|4|||
160689408|NCT02278718|580243155|FG000|Overall Study|Withdrawal by Subject|1|||
160689409|NCT02278718|580243156|FG001|Overall Study|Withdrawal by Subject|4|||
160689410|NCT02278718|580243155|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
160689411|NCT02278718|580243156|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
160689412|NCT02278718|580243155|FG000|Overall Study|Missing|0|||
160689413|NCT02278718|580243156|FG001|Overall Study|Missing|1|||
160689414|NCT03212794|580243157|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
160689415|NCT03212794|580243158|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
160689416|NCT03212794|580243157|FG000|Overall Study|Lost to Follow-up|5|||
160689417|NCT03212794|580243158|FG001|Overall Study|Lost to Follow-up|6|||
160689418|NCT03212794|580243157|FG000|Overall Study|Incarcerated; unable to participate|2|||
160689419|NCT03212794|580243158|FG001|Overall Study|Incarcerated; unable to participate|0|||
160689420|NCT03212794|580243157|FG000|Overall Study|Withdrawal by Subject|1|||
160689421|NCT03212794|580243158|FG001|Overall Study|Withdrawal by Subject|0|||
160689422|NCT03212794|580243157|FG000|Overall Study|Death|0|||
160689423|NCT03212794|580243158|FG001|Overall Study|Death|1|||
160689424|NCT03212794|580243157|FG000|Overall Study|Found to be ineligible after allocation|0|||
160689425|NCT03212794|580243158|FG001|Overall Study|Found to be ineligible after allocation|1|||
160689426|NCT03212794|580243157|FG000|Overall Study|Relocated out of area|2|||
160689427|NCT03212794|580243158|FG001|Overall Study|Relocated out of area|0|||
160689428|NCT01763918|580243161|FG000|Overall Study|Withdrawal by Subject|2|||
160689429|NCT01763918|580243162|FG001|Overall Study|Withdrawal by Subject|1|||
160689430|NCT01763918|580243163|FG002|Overall Study|Withdrawal by Subject|1|||
160689431|NCT01763918|580243164|FG003|Overall Study|Withdrawal by Subject|2|||
160689432|NCT01763918|580243161|FG000|Overall Study|Sponsor Decision|4|||
160689433|NCT01763918|580243162|FG001|Overall Study|Sponsor Decision|0|||
160689434|NCT01763918|580243163|FG002|Overall Study|Sponsor Decision|9|||
160689435|NCT01763918|580243164|FG003|Overall Study|Sponsor Decision|0|||
160689436|NCT00897949|580243165|FG000|Overall Study|Adverse Event|1|||
160689437|NCT00897949|580243166|FG001|Overall Study|Adverse Event|1|||
160689438|NCT00897949|580243167|FG002|Overall Study|Adverse Event|0|||
160689439|NCT00897949|580243165|FG000|Overall Study|Lost to Follow-up|0|||
160689440|NCT00897949|580243166|FG001|Overall Study|Lost to Follow-up|2|||
160689441|NCT00897949|580243167|FG002|Overall Study|Lost to Follow-up|1|||
160689442|NCT00897949|580243165|FG000|Overall Study|Protocol Violation|6|||
160689443|NCT00897949|580243166|FG001|Overall Study|Protocol Violation|3|||
160689444|NCT00897949|580243167|FG002|Overall Study|Protocol Violation|1|||
160689445|NCT00897949|580243165|FG000|Overall Study|Withdrawal by Subject|1|||
160689446|NCT00897949|580243166|FG001|Overall Study|Withdrawal by Subject|2|||
160689447|NCT00897949|580243167|FG002|Overall Study|Withdrawal by Subject|0|||
160689448|NCT00897949|580243165|FG000|Overall Study|Patient Uncoorperative|0|||
160689449|NCT00897949|580243166|FG001|Overall Study|Patient Uncoorperative|2|||
160689450|NCT00897949|580243167|FG002|Overall Study|Patient Uncoorperative|1|||
160689451|NCT00897949|580243165|FG000|Overall Study|Lost to Follow-up|30|||
160689452|NCT00897949|580243166|FG001|Overall Study|Lost to Follow-up|23|||
160689453|NCT00897949|580243167|FG002|Overall Study|Lost to Follow-up|17|||
160689454|NCT00897949|580243165|FG000|Overall Study|Withdrawal by Subject|24|||
160689455|NCT00897949|580243166|FG001|Overall Study|Withdrawal by Subject|31|||
160689456|NCT00897949|580243167|FG002|Overall Study|Withdrawal by Subject|17|||
160689457|NCT00897949|580243165|FG000|Overall Study|Abnormal Prestudy Labs|2|||
160689458|NCT00897949|580243166|FG001|Overall Study|Abnormal Prestudy Labs|3|||
160689459|NCT00897949|580243167|FG002|Overall Study|Abnormal Prestudy Labs|4|||
160689460|NCT00897949|580243165|FG000|Overall Study|Abnormal Baseline ECG|2|||
160689461|NCT00897949|580243166|FG001|Overall Study|Abnormal Baseline ECG|2|||
160689462|NCT00897949|580243167|FG002|Overall Study|Abnormal Baseline ECG|4|||
160689463|NCT00897949|580243165|FG000|Overall Study|Need for Concom. Med.|0|||
160689464|NCT00897949|580243166|FG001|Overall Study|Need for Concom. Med.|1|||
160689465|NCT00897949|580243167|FG002|Overall Study|Need for Concom. Med.|1|||
160689466|NCT00897949|580243165|FG000|Overall Study|Lack of Migraine Attack|29|||
160689467|NCT00897949|580243166|FG001|Overall Study|Lack of Migraine Attack|30|||
160689468|NCT00897949|580243167|FG002|Overall Study|Lack of Migraine Attack|19|||
160689469|NCT00897949|580243165|FG000|Overall Study|Did not take study drug|9|||
160689470|NCT00897949|580243166|FG001|Overall Study|Did not take study drug|3|||
160689471|NCT00897949|580243167|FG002|Overall Study|Did not take study drug|4|||
160689472|NCT01553747|580243168|FG000|Overall Study|Protocol Violation|0|||
160689473|NCT01553747|580243169|FG001|Overall Study|Protocol Violation|2|||
160689474|NCT01553747|580243170|FG002|Overall Study|Protocol Violation|0|||
160689475|NCT01553747|580243168|FG000|Overall Study|Voluntarily withdrew|70|||
160689476|NCT01553747|580243169|FG001|Overall Study|Voluntarily withdrew|66|||
160689477|NCT01553747|580243170|FG002|Overall Study|Voluntarily withdrew|74|||
160689478|NCT01553747|580243168|FG000|Overall Study|Adverse event or SAE|32|||
160689479|NCT01553747|580243169|FG001|Overall Study|Adverse event or SAE|28|||
160689480|NCT01553747|580243170|FG002|Overall Study|Adverse event or SAE|19|||
160689481|NCT01553747|580243168|FG000|Overall Study|Physician decision: other|10|||
160689482|NCT01553747|580243169|FG001|Overall Study|Physician decision: other|8|||
160689483|NCT01553747|580243170|FG002|Overall Study|Physician decision: other|7|||
160689484|NCT01553747|580243168|FG000|Overall Study|Lost to Follow-up|11|||
160689485|NCT01553747|580243169|FG001|Overall Study|Lost to Follow-up|5|||
160689486|NCT01553747|580243170|FG002|Overall Study|Lost to Follow-up|6|||
160689487|NCT01553747|580243168|FG000|Overall Study|Sponsor decision, specify|7|||
160689488|NCT01553747|580243169|FG001|Overall Study|Sponsor decision, specify|5|||
160689489|NCT01553747|580243170|FG002|Overall Study|Sponsor decision, specify|0|||
160689490|NCT01553747|580243168|FG000|Overall Study|Physician decision: lack of efficacy|1|||
160689491|NCT01553747|580243169|FG001|Overall Study|Physician decision: lack of efficacy|5|||
160689492|NCT01553747|580243170|FG002|Overall Study|Physician decision: lack of efficacy|3|||
160689493|NCT00102687|580243171|FG000|Initial Period|Withdrawal by Subject|6|||
160689494|NCT00102687|580243172|FG001|Initial Period|Withdrawal by Subject|3|||
160689495|NCT00102687|580243173|FG002|Initial Period|Withdrawal by Subject|5|||
160689496|NCT00102687|580243174|FG003|Initial Period|Withdrawal by Subject|0|||
160689497|NCT00102687|580243175|FG004|Initial Period|Withdrawal by Subject|0|||
160689498|NCT00102687|580243171|FG000|Initial Period|Adverse Event|4|||
160689499|NCT00102687|580243172|FG001|Initial Period|Adverse Event|7|||
160689500|NCT00102687|580243173|FG002|Initial Period|Adverse Event|9|||
160689501|NCT00102687|580243174|FG003|Initial Period|Adverse Event|0|||
160689502|NCT00102687|580243175|FG004|Initial Period|Adverse Event|0|||
160689503|NCT00102687|580243171|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
160689504|NCT00102687|580243172|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
160689505|NCT00102687|580243173|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
160689506|NCT00102687|580243174|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
160689507|NCT00102687|580243175|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
160689508|NCT00102687|580243171|FG000|Initial Period|Protocol Violation|0|||
160689509|NCT00102687|580243172|FG001|Initial Period|Protocol Violation|0|||
160689510|NCT00102687|580243173|FG002|Initial Period|Protocol Violation|2|||
160689511|NCT00102687|580243174|FG003|Initial Period|Protocol Violation|0|||
160689512|NCT00102687|580243175|FG004|Initial Period|Protocol Violation|0|||
160689513|NCT00102687|580243171|FG000|Initial Period|Physician Decision|2|||
160689514|NCT00102687|580243172|FG001|Initial Period|Physician Decision|9|||
160689515|NCT00102687|580243173|FG002|Initial Period|Physician Decision|6|||
160689516|NCT00102687|580243174|FG003|Initial Period|Physician Decision|0|||
160689517|NCT00102687|580243175|FG004|Initial Period|Physician Decision|0|||
160689518|NCT00102687|580243171|FG000|Initial Period|Sponsor's decision|0|||
160689519|NCT00102687|580243172|FG001|Initial Period|Sponsor's decision|1|||
160689520|NCT00102687|580243173|FG002|Initial Period|Sponsor's decision|1|||
160689521|NCT00102687|580243174|FG003|Initial Period|Sponsor's decision|0|||
160689522|NCT00102687|580243175|FG004|Initial Period|Sponsor's decision|0|||
160689523|NCT00102687|580243171|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
160689524|NCT00102687|580243172|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
160689525|NCT00102687|580243173|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
160689526|NCT00102687|580243174|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
160689527|NCT00102687|580243175|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
160689528|NCT00102687|580243171|FG000|Initial Period|Death|1|||
160689529|NCT00102687|580243172|FG001|Initial Period|Death|1|||
160689530|NCT00102687|580243173|FG002|Initial Period|Death|1|||
160689531|NCT00102687|580243174|FG003|Initial Period|Death|0|||
160689532|NCT00102687|580243175|FG004|Initial Period|Death|0|||
160689533|NCT00102687|580243171|FG000|Maintenance Period|Withdrawal by Subject|4|||
160689534|NCT00102687|580243172|FG001|Maintenance Period|Withdrawal by Subject|0|||
160689535|NCT00102687|580243173|FG002|Maintenance Period|Withdrawal by Subject|2|||
160689536|NCT00102687|580243174|FG003|Maintenance Period|Withdrawal by Subject|3|||
160689537|NCT00102687|580243175|FG004|Maintenance Period|Withdrawal by Subject|1|||
160689538|NCT00102687|580243171|FG000|Maintenance Period|Adverse Event|1|||
160689539|NCT00102687|580243172|FG001|Maintenance Period|Adverse Event|0|||
160689540|NCT00102687|580243173|FG002|Maintenance Period|Adverse Event|0|||
160689541|NCT00102687|580243174|FG003|Maintenance Period|Adverse Event|1|||
160689542|NCT00102687|580243175|FG004|Maintenance Period|Adverse Event|3|||
160689543|NCT00102687|580243171|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
160689544|NCT00102687|580243172|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
160689545|NCT00102687|580243173|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
160689546|NCT00102687|580243174|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
160689547|NCT00102687|580243175|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
160689548|NCT00102687|580243171|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
160689549|NCT00102687|580243172|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
160689550|NCT00102687|580243173|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
160689551|NCT00102687|580243174|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
160689552|NCT00102687|580243175|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
160689553|NCT00102687|580243171|FG000|Maintenance Period|Death|0|||
160689554|NCT00102687|580243172|FG001|Maintenance Period|Death|0|||
160689555|NCT00102687|580243173|FG002|Maintenance Period|Death|0|||
160689556|NCT00102687|580243174|FG003|Maintenance Period|Death|1|||
160689557|NCT00102687|580243175|FG004|Maintenance Period|Death|1|||
160689558|NCT00102687|580243171|FG000|Maintenance Period|Physician Decision|1|||
160689559|NCT00102687|580243172|FG001|Maintenance Period|Physician Decision|2|||
160689560|NCT00102687|580243173|FG002|Maintenance Period|Physician Decision|3|||
160689561|NCT00102687|580243174|FG003|Maintenance Period|Physician Decision|0|||
160689562|NCT00102687|580243175|FG004|Maintenance Period|Physician Decision|4|||
160689563|NCT03847194|580243177|FG000|Overall Study|Lost to Follow-up|2|||
160689564|NCT03847194|580243178|FG001|Overall Study|Lost to Follow-up|5|||
160689565|NCT03847194|580243177|FG000|Overall Study|Withdrawal by Subject|1|||
160689566|NCT03847194|580243178|FG001|Overall Study|Withdrawal by Subject|2|||
160689567|NCT03847194|580243177|FG000|Overall Study|Death|0|||
160689568|NCT03847194|580243178|FG001|Overall Study|Death|1|||
160689569|NCT01134627|580243179|FG000|Overall Study|Adverse Event|47|||
160689570|NCT01134627|580243180|FG001|Overall Study|Adverse Event|31|||
160689571|NCT01134627|580243179|FG000|Overall Study|Lost to Follow-up|1|||
160689572|NCT01134627|580243180|FG001|Overall Study|Lost to Follow-up|2|||
160689573|NCT01134627|580243179|FG000|Overall Study|Protocol Violation|3|||
160689574|NCT01134627|580243180|FG001|Overall Study|Protocol Violation|5|||
160689575|NCT01134627|580243179|FG000|Overall Study|Lack of Efficacy|2|||
160689576|NCT01134627|580243180|FG001|Overall Study|Lack of Efficacy|12|||
160689577|NCT01134627|580243179|FG000|Overall Study|Withdrawal by Subject|4|||
160689578|NCT01134627|580243180|FG001|Overall Study|Withdrawal by Subject|3|||
160689579|NCT01134627|580243179|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
160689580|NCT01134627|580243180|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
160689581|NCT01134627|580243179|FG000|Overall Study|Other|11|||
160689582|NCT01134627|580243180|FG001|Overall Study|Other|14|||
160689583|NCT01144403|580243184|FG000|Overall Study|Lost to Follow-up|3|||
160689584|NCT01144403|580243184|FG000|Overall Study|Death|1|||
160689585|NCT01144403|580243184|FG000|Overall Study|Adverse Event|1|||
160689586|NCT01010750|580243185|FG000|Second Intervention|Adverse Event|0|||
160689587|NCT01010750|580243186|FG001|Second Intervention|Adverse Event|1|||
160689588|NCT01010750|580243187|FG002|Second Intervention|Adverse Event|0|||
160689589|NCT01010750|580243188|FG003|Second Intervention|Adverse Event|0|||
160689590|NCT01010750|580243189|FG004|Second Intervention|Adverse Event|0|||
160689591|NCT01010750|580243190|FG005|Second Intervention|Adverse Event|0|||
160689592|NCT01056640|580243191|FG000|Overall Study|Withdrawal by Subject|11|||
160689593|NCT01056640|580243192|FG001|Overall Study|Withdrawal by Subject|8|||
160689594|NCT01056640|580243191|FG000|Overall Study|Death|15|||
160689595|NCT01056640|580243192|FG001|Overall Study|Death|4|||
160689596|NCT01803269|580243193|FG000|Overall Study|Withdrawal by Subject|3|||
160689597|NCT01803269|580243194|FG001|Overall Study|Withdrawal by Subject|0|||
160689598|NCT01803269|580243195|FG002|Overall Study|Withdrawal by Subject|0|||
160689599|NCT00466726|580243198|FG000|Overall Study|Not evaluable for response|14|||
160689600|NCT02339740|580243199|FG000|Overall Study|Death|1|||
160689601|NCT02339740|580243200|FG001|Overall Study|Death|0|||
160689602|NCT02339740|580243199|FG000|Overall Study|Physician Decision|0|||
160689603|NCT02339740|580243200|FG001|Overall Study|Physician Decision|2|||
160689604|NCT02339740|580243199|FG000|Overall Study|Withdrawal by Subject|5|||
160689605|NCT02339740|580243200|FG001|Overall Study|Withdrawal by Subject|1|||
160689606|NCT02339740|580243199|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
160689607|NCT02339740|580243200|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
160689608|NCT02777918|580243207|FG000|Overall Study|Medical reasons|1|||
160689609|NCT02777918|580243208|FG001|Overall Study|Medical reasons|2|||
160689610|NCT02777918|580243207|FG000|Overall Study|Too busy / stressed|1|||
160689611|NCT02777918|580243208|FG001|Overall Study|Too busy / stressed|1|||
160689612|NCT02777918|580243207|FG000|Overall Study|Withdrawal by Subject|1|||
160689613|NCT02777918|580243208|FG001|Overall Study|Withdrawal by Subject|1|||
160689614|NCT02510014|580243214|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
160689615|NCT02510014|580243215|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
160689616|NCT02510014|580243214|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
160689617|NCT02510014|580243215|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
160689618|NCT02510014|580243214|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
160689619|NCT02510014|580243215|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
160689620|NCT02510014|580243214|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
160689621|NCT02510014|580243215|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
160689622|NCT02510014|580243214|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
160689623|NCT02510014|580243215|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
160689624|NCT02510014|580243214|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
160689625|NCT02510014|580243215|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
160689626|NCT02510014|580243214|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
160689627|NCT02510014|580243215|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
160689628|NCT02510014|580243214|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
160689629|NCT02510014|580243215|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
160689630|NCT02510014|580243214|FG000|Treatment Period|Adverse Event|11|||
160689631|NCT02510014|580243215|FG001|Treatment Period|Adverse Event|4|||
160689632|NCT02510014|580243214|FG000|Treatment Period|Withdrawal symptoms|3|||
160689633|NCT02510014|580243215|FG001|Treatment Period|Withdrawal symptoms|0|||
160689634|NCT02510014|580243214|FG000|Treatment Period|Lost to Follow-up|80|||
160689635|NCT02510014|580243215|FG001|Treatment Period|Lost to Follow-up|19|||
160689636|NCT02510014|580243214|FG000|Treatment Period|Physician Decision|5|||
160689637|NCT02510014|580243215|FG001|Treatment Period|Physician Decision|0|||
160689638|NCT02510014|580243214|FG000|Treatment Period|Withdrawal by Subject|67|||
160689639|NCT02510014|580243215|FG001|Treatment Period|Withdrawal by Subject|24|||
160689640|NCT02510014|580243214|FG000|Treatment Period|Withdrawn by the investigator|7|||
160689641|NCT02510014|580243215|FG001|Treatment Period|Withdrawn by the investigator|1|||
160689642|NCT02510014|580243214|FG000|Treatment Period|Protocol Violation|4|||
160689643|NCT02510014|580243215|FG001|Treatment Period|Protocol Violation|4|||
160689644|NCT02510014|580243214|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
160689645|NCT02510014|580243215|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
160689646|NCT01949116|580243217|FG000|Overall Study|Death|2|||
160689647|NCT01949116|580243218|FG001|Overall Study|Death|0|||
160689648|NCT01949116|580243217|FG000|Overall Study|Lost to Follow-up|1|||
160689649|NCT01949116|580243218|FG001|Overall Study|Lost to Follow-up|3|||
160689650|NCT01949116|580243217|FG000|Overall Study|Withdrawal by Subject|5|||
160689651|NCT01949116|580243218|FG001|Overall Study|Withdrawal by Subject|3|||
160689652|NCT01855048|580243229|FG000|Overall Study|Withdrawal by Subject|0|||
160689653|NCT01855048|580243230|FG001|Overall Study|Withdrawal by Subject|1|||
160689654|NCT01855048|580243231|FG002|Overall Study|Withdrawal by Subject|0|||
160689655|NCT01855048|580243232|FG003|Overall Study|Withdrawal by Subject|0|||
160689656|NCT01855048|580243233|FG004|Overall Study|Withdrawal by Subject|1|||
160689657|NCT01855048|580243234|FG005|Overall Study|Withdrawal by Subject|0|||
160689658|NCT03832738|580243235|FG000|Overall Study|Withdrawal by Subject|6|||
160689659|NCT03832738|580243236|FG001|Overall Study|Withdrawal by Subject|7|||
160689660|NCT03832738|580243237|FG002|Overall Study|Withdrawal by Subject|16|||
160689661|NCT03832738|580243235|FG000|Overall Study|Physician Decision|0|||
160689662|NCT03832738|580243236|FG001|Overall Study|Physician Decision|1|||
160689663|NCT03832738|580243237|FG002|Overall Study|Physician Decision|2|||
160689664|NCT03832738|580243235|FG000|Overall Study|Adverse Event|2|||
160689665|NCT03832738|580243236|FG001|Overall Study|Adverse Event|3|||
160689666|NCT03832738|580243237|FG002|Overall Study|Adverse Event|1|||
160689667|NCT03832738|580243235|FG000|Overall Study|Pregnancy|0|||
160689668|NCT03832738|580243236|FG001|Overall Study|Pregnancy|1|||
160689669|NCT03832738|580243237|FG002|Overall Study|Pregnancy|0|||
160689670|NCT01813071|580243238|FG000|Overall Study|Protocol Violation|0|||
160689671|NCT01813071|580243239|FG001|Overall Study|Protocol Violation|0|||
160689672|NCT01813071|580243240|FG002|Overall Study|Protocol Violation|0|||
160689673|NCT01813071|580243241|FG003|Overall Study|Protocol Violation|0|||
160689674|NCT01813071|580243242|FG004|Overall Study|Protocol Violation|1|||
160689675|NCT01813071|580243243|FG005|Overall Study|Protocol Violation|4|||
160689676|NCT01813071|580243244|FG006|Overall Study|Protocol Violation|2|||
160689677|NCT01813071|580243245|FG007|Overall Study|Protocol Violation|4|||
160689678|NCT01813071|580243246|FG008|Overall Study|Protocol Violation|2|||
160689679|NCT01813071|580243238|FG000|Overall Study|Withdrawal by Subject|0|||
160689680|NCT01813071|580243239|FG001|Overall Study|Withdrawal by Subject|0|||
160689681|NCT01813071|580243240|FG002|Overall Study|Withdrawal by Subject|0|||
160689682|NCT01813071|580243241|FG003|Overall Study|Withdrawal by Subject|0|||
160689683|NCT01813071|580243242|FG004|Overall Study|Withdrawal by Subject|0|||
160689684|NCT01813071|580243243|FG005|Overall Study|Withdrawal by Subject|1|||
160689685|NCT01813071|580243244|FG006|Overall Study|Withdrawal by Subject|0|||
160689686|NCT01813071|580243245|FG007|Overall Study|Withdrawal by Subject|0|||
160689687|NCT01813071|580243246|FG008|Overall Study|Withdrawal by Subject|0|||
160689688|NCT01813071|580243238|FG000|Overall Study|Adverse Event|0|||
160689689|NCT01813071|580243239|FG001|Overall Study|Adverse Event|0|||
160689690|NCT01813071|580243240|FG002|Overall Study|Adverse Event|0|||
160689691|NCT01813071|580243241|FG003|Overall Study|Adverse Event|0|||
160689692|NCT01813071|580243242|FG004|Overall Study|Adverse Event|0|||
160689693|NCT01813071|580243243|FG005|Overall Study|Adverse Event|1|||
160689694|NCT01813071|580243244|FG006|Overall Study|Adverse Event|0|||
160689695|NCT01813071|580243245|FG007|Overall Study|Adverse Event|0|||
160689696|NCT01813071|580243246|FG008|Overall Study|Adverse Event|0|||
160689697|NCT01813071|580243238|FG000|Overall Study|Physician Decision|0|||
160689698|NCT01813071|580243239|FG001|Overall Study|Physician Decision|0|||
160689699|NCT01813071|580243240|FG002|Overall Study|Physician Decision|0|||
160689700|NCT01813071|580243241|FG003|Overall Study|Physician Decision|0|||
160689701|NCT01813071|580243242|FG004|Overall Study|Physician Decision|0|||
160689702|NCT01813071|580243243|FG005|Overall Study|Physician Decision|0|||
160689703|NCT01813071|580243244|FG006|Overall Study|Physician Decision|1|||
160689704|NCT01813071|580243245|FG007|Overall Study|Physician Decision|0|||
160689705|NCT01813071|580243246|FG008|Overall Study|Physician Decision|0|||
160689706|NCT01813071|580243238|FG000|Overall Study|Met inc/exc criteria|0|||
160689707|NCT01813071|580243239|FG001|Overall Study|Met inc/exc criteria|0|||
160689708|NCT01813071|580243240|FG002|Overall Study|Met inc/exc criteria|0|||
160689709|NCT01813071|580243241|FG003|Overall Study|Met inc/exc criteria|0|||
160689710|NCT01813071|580243242|FG004|Overall Study|Met inc/exc criteria|0|||
160689711|NCT01813071|580243243|FG005|Overall Study|Met inc/exc criteria|1|||
160689712|NCT01813071|580243244|FG006|Overall Study|Met inc/exc criteria|0|||
160689713|NCT01813071|580243245|FG007|Overall Study|Met inc/exc criteria|1|||
160689714|NCT01813071|580243246|FG008|Overall Study|Met inc/exc criteria|1|||
160689715|NCT00307931|580243247|FG000|Overall Study|Adverse Event|1|||
160689716|NCT02442271|580243250|FG000|Overall Study|Adverse Event|1|||
160689717|NCT02442271|580243250|FG000|Overall Study|Withdrew Consent|1|||
160689718|NCT02442271|580243250|FG000|Overall Study|Lost to Follow-up|1|||
160689719|NCT02442271|580243250|FG000|Overall Study|Other|1|||
160689720|NCT00831623|580243252|FG000|Overall Study|Withdrawal by Subject|9|||
160689721|NCT00831623|580243252|FG000|Overall Study|Lost to Follow-up|1|||
160689722|NCT00831623|580243252|FG000|Overall Study|Not 2 years post-treatment|12|||
160689723|NCT00493246|580244941|FG000|Overall Study|Withdrawal by Subject|0|||
160689724|NCT00493246|580244942|FG001|Overall Study|Withdrawal by Subject|0|||
160689725|NCT00493246|580244943|FG002|Overall Study|Withdrawal by Subject|0|||
160689726|NCT00493246|580244944|FG003|Overall Study|Withdrawal by Subject|0|||
160689727|NCT00493246|580244945|FG004|Overall Study|Withdrawal by Subject|1|||
160689728|NCT00493246|580244946|FG005|Overall Study|Withdrawal by Subject|0|||
160689729|NCT00493246|580244947|FG006|Overall Study|Withdrawal by Subject|0|||
160689730|NCT00493246|580244948|FG007|Overall Study|Withdrawal by Subject|0|||
160689731|NCT00493246|580244941|FG000|Overall Study|No access to draw blood|0|||
160689732|NCT00493246|580244942|FG001|Overall Study|No access to draw blood|0|||
160689733|NCT00493246|580244943|FG002|Overall Study|No access to draw blood|0|||
160689734|NCT00493246|580244944|FG003|Overall Study|No access to draw blood|0|||
160689735|NCT00493246|580244945|FG004|Overall Study|No access to draw blood|0|||
160689736|NCT00493246|580244946|FG005|Overall Study|No access to draw blood|1|||
160689737|NCT00493246|580244947|FG006|Overall Study|No access to draw blood|0|||
160689738|NCT00493246|580244948|FG007|Overall Study|No access to draw blood|0|||
160689739|NCT00493246|580244941|FG000|Overall Study|Lost to Follow-up|0|||
160689740|NCT00493246|580244942|FG001|Overall Study|Lost to Follow-up|0|||
160689741|NCT00493246|580244943|FG002|Overall Study|Lost to Follow-up|0|||
160689742|NCT00493246|580244944|FG003|Overall Study|Lost to Follow-up|0|||
160689743|NCT00493246|580244945|FG004|Overall Study|Lost to Follow-up|0|||
160689744|NCT00493246|580244946|FG005|Overall Study|Lost to Follow-up|0|||
160689745|NCT00493246|580244947|FG006|Overall Study|Lost to Follow-up|1|||
160689746|NCT00493246|580244948|FG007|Overall Study|Lost to Follow-up|0|||
160689747|NCT00595335|580244949|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
160689748|NCT00595335|580244950|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
160689749|NCT00595335|580244949|FG000|Baseline to Six Months|Disease Progression|1|||
160689750|NCT00595335|580244950|FG001|Baseline to Six Months|Disease Progression|1|||
160689751|NCT00595335|580244949|FG000|Baseline to Six Months|Adverse Event|1|||
160689752|NCT00595335|580244950|FG001|Baseline to Six Months|Adverse Event|0|||
160689753|NCT00595335|580244949|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
160689754|NCT00595335|580244950|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
160689755|NCT00595335|580244949|FG000|Six Months to Twelve Months|Disease Progression|1|||
160689756|NCT00595335|580244950|FG001|Six Months to Twelve Months|Disease Progression|0|||
160689757|NCT01013649|580244953|FG000|First Step|Withdrawal by Subject|36|||
160689758|NCT01013649|580244954|FG001|First Step|Withdrawal by Subject|19|||
160689759|NCT01013649|580244955|FG002|First Step|Withdrawal by Subject|0|||
160689760|NCT01013649|580244956|FG003|First Step|Withdrawal by Subject|0|||
160689761|NCT01013649|580244953|FG000|First Step|Progression|58|||
160689762|NCT01013649|580244954|FG001|First Step|Progression|23|||
160689763|NCT01013649|580244955|FG002|First Step|Progression|0|||
160689764|NCT01013649|580244956|FG003|First Step|Progression|0|||
160689765|NCT01013649|580244953|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
160689766|NCT01013649|580244954|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
160689767|NCT01013649|580244955|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
160689768|NCT01013649|580244956|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
160689769|NCT01013649|580244953|FG000|First Step|Death|3|||
160689770|NCT01013649|580244954|FG001|First Step|Death|4|||
160689771|NCT01013649|580244955|FG002|First Step|Death|0|||
160689772|NCT01013649|580244956|FG003|First Step|Death|0|||
160689773|NCT01013649|580244953|FG000|First Step|Adverse Event|9|||
160689774|NCT01013649|580244954|FG001|First Step|Adverse Event|5|||
160689775|NCT01013649|580244955|FG002|First Step|Adverse Event|0|||
160689776|NCT01013649|580244956|FG003|First Step|Adverse Event|0|||
160689777|NCT01013649|580244953|FG000|First Step|Other|4|||
160689778|NCT01013649|580244954|FG001|First Step|Other|6|||
160689779|NCT01013649|580244955|FG002|First Step|Other|0|||
160689780|NCT01013649|580244956|FG003|First Step|Other|0|||
160689781|NCT01386684|580244968|FG000|Overall Study|Lost to Follow-up|51|||
160689782|NCT01386684|580244968|FG000|Overall Study|Other|51|||
160689783|NCT01386684|580244968|FG000|Overall Study|Death|47|||
160689784|NCT01386684|580244968|FG000|Overall Study|Withdrawal of Consent|44|||
160689785|NCT01386684|580244968|FG000|Overall Study|Alternative Therapy Required|37|||
160689786|NCT01386684|580244968|FG000|Overall Study|Disease Progression|28|||
160689787|NCT01386684|580244968|FG000|Overall Study|Adverse Event|20|||
160689788|NCT01386684|580244968|FG000|Overall Study|Noncompliance|8|||
160689789|NCT01386684|580244968|FG000|Overall Study|Protocol Violation|4|||
160689790|NCT01386684|580244968|FG000|Overall Study|Missing|3|||
160689791|NCT02119286|580244971|FG000|Overall Study|Adverse Event|9|||
160689792|NCT02119286|580244972|FG001|Overall Study|Adverse Event|7|||
160689793|NCT02119286|580244973|FG002|Overall Study|Adverse Event|2|||
160689794|NCT02119286|580244971|FG000|Overall Study|Lack of Efficacy|11|||
160689795|NCT02119286|580244972|FG001|Overall Study|Lack of Efficacy|3|||
160689796|NCT02119286|580244973|FG002|Overall Study|Lack of Efficacy|4|||
160689797|NCT02119286|580244971|FG000|Overall Study|Lost to Follow-up|2|||
160689798|NCT02119286|580244972|FG001|Overall Study|Lost to Follow-up|0|||
160689799|NCT02119286|580244973|FG002|Overall Study|Lost to Follow-up|1|||
160689800|NCT02119286|580244971|FG000|Overall Study|Withdrawal by Subject|4|||
160689801|NCT02119286|580244972|FG001|Overall Study|Withdrawal by Subject|1|||
160689802|NCT02119286|580244973|FG002|Overall Study|Withdrawal by Subject|0|||
160689803|NCT04109313|580244974|FG000|Overall Study|Pregnancy|1|||
160689804|NCT04109313|580244974|FG000|Overall Study|Adverse Event|11|||
160689805|NCT04109313|580244974|FG000|Overall Study|Lack of Efficacy|11|||
160689806|NCT04109313|580244974|FG000|Overall Study|Lost to Follow-up|1|||
160689807|NCT04109313|580244974|FG000|Overall Study|Physician Decision|2|||
160689808|NCT04109313|580244974|FG000|Overall Study|Subject Decision|13|||
160689809|NCT04109313|580244974|FG000|Overall Study|Covid-19 situation|2|||
160689810|NCT01272921|580244975|FG000|Overall Study|Protocol Violation|2|||
160689811|NCT01272921|580244976|FG001|Overall Study|Protocol Violation|1|||
160689812|NCT01132664|580244977|FG000|Phase lb|Adverse Event|0|||
160689813|NCT01132664|580244978|FG001|Phase lb|Adverse Event|1|||
160689814|NCT01132664|580244979|FG002|Phase lb|Adverse Event|0|||
160689815|NCT01132664|580244980|FG003|Phase lb|Adverse Event|0|||
160689816|NCT01132664|580244981|FG004|Phase lb|Adverse Event|0|||
160689817|NCT01132664|580244977|FG000|Phase lb|Withdrawal by Subject|1|||
160689818|NCT01132664|580244978|FG001|Phase lb|Withdrawal by Subject|2|||
160689819|NCT01132664|580244979|FG002|Phase lb|Withdrawal by Subject|0|||
160689820|NCT01132664|580244980|FG003|Phase lb|Withdrawal by Subject|0|||
160689821|NCT01132664|580244981|FG004|Phase lb|Withdrawal by Subject|0|||
160689822|NCT01132664|580244977|FG000|Phase lb|Disease Progression|4|||
160689823|NCT01132664|580244978|FG001|Phase lb|Disease Progression|9|||
160689824|NCT01132664|580244979|FG002|Phase lb|Disease Progression|0|||
160689825|NCT01132664|580244980|FG003|Phase lb|Disease Progression|0|||
160689826|NCT01132664|580244981|FG004|Phase lb|Disease Progression|0|||
160689827|NCT01132664|580244977|FG000|Phase ll|Death|0|||
160689828|NCT01132664|580244978|FG001|Phase ll|Death|0|||
160689829|NCT01132664|580244979|FG002|Phase ll|Death|2|||
160689830|NCT01132664|580244980|FG003|Phase ll|Death|0|||
160689831|NCT01132664|580244981|FG004|Phase ll|Death|0|||
160689832|NCT01132664|580244977|FG000|Phase ll|Adverse Event|0|||
160689833|NCT01132664|580244978|FG001|Phase ll|Adverse Event|0|||
160689834|NCT01132664|580244979|FG002|Phase ll|Adverse Event|10|||
160689835|NCT01132664|580244980|FG003|Phase ll|Adverse Event|0|||
160689836|NCT01132664|580244981|FG004|Phase ll|Adverse Event|0|||
160689837|NCT01132664|580244977|FG000|Phase ll|Withdrawal by Subject|0|||
160689838|NCT01132664|580244978|FG001|Phase ll|Withdrawal by Subject|0|||
160689839|NCT01132664|580244979|FG002|Phase ll|Withdrawal by Subject|3|||
160689840|NCT01132664|580244980|FG003|Phase ll|Withdrawal by Subject|0|||
160689841|NCT01132664|580244981|FG004|Phase ll|Withdrawal by Subject|0|||
160689842|NCT01132664|580244977|FG000|Phase ll|Disease progression|0|||
160689843|NCT01132664|580244978|FG001|Phase ll|Disease progression|0|||
160689844|NCT01132664|580244979|FG002|Phase ll|Disease progression|35|||
160689845|NCT01132664|580244980|FG003|Phase ll|Disease progression|0|||
160689846|NCT01132664|580244981|FG004|Phase ll|Disease progression|0|||
160689847|NCT01132664|580244977|FG000|BM Cohort|Disease progression|0|||
160689848|NCT01132664|580244978|FG001|BM Cohort|Disease progression|0|||
160689849|NCT01132664|580244979|FG002|BM Cohort|Disease progression|0|||
160689850|NCT01132664|580244980|FG003|BM Cohort|Disease progression|3|||
160689851|NCT01132664|580244981|FG004|BM Cohort|Disease progression|4|||
160689852|NCT01132664|580244977|FG000|BM Cohort|Adverse Event|0|||
160689853|NCT01132664|580244978|FG001|BM Cohort|Adverse Event|0|||
160689854|NCT01132664|580244979|FG002|BM Cohort|Adverse Event|0|||
160689855|NCT01132664|580244980|FG003|BM Cohort|Adverse Event|0|||
160689856|NCT01132664|580244981|FG004|BM Cohort|Adverse Event|1|||
160689857|NCT01132664|580244977|FG000|BM Cohort|Withdrawal by Subject|0|||
160689858|NCT01132664|580244978|FG001|BM Cohort|Withdrawal by Subject|0|||
160689859|NCT01132664|580244979|FG002|BM Cohort|Withdrawal by Subject|0|||
160689860|NCT01132664|580244980|FG003|BM Cohort|Withdrawal by Subject|0|||
160689861|NCT01132664|580244981|FG004|BM Cohort|Withdrawal by Subject|1|||
160689862|NCT02694549|580244985|FG000|Overall Study|screen failures|2|||
160689863|NCT01996332|580244986|FG000|Overall Study|Adverse Event|117|||
160689864|NCT01996332|580244986|FG000|Overall Study|Lack of Efficacy|1245|||
160689865|NCT01996332|580244986|FG000|Overall Study|Death|264|||
160689866|NCT01996332|580244986|FG000|Overall Study|Protocol Violation|9|||
160689867|NCT01996332|580244986|FG000|Overall Study|Withdrawal by Subject|71|||
160689868|NCT01996332|580244986|FG000|Overall Study|Other|20|||
160689869|NCT01996332|580244986|FG000|Overall Study|Clinical Deterioration|28|||
160689870|NCT01996332|580244986|FG000|Overall Study|Physician Decision|17|||
160689871|NCT01996332|580244986|FG000|Overall Study|Lost to Follow-up|34|||
160689872|NCT02113189|580244987|FG000|Overall Study|Lost to follow up|2|||
160689873|NCT02113189|580244988|FG001|Overall Study|Lost to follow up|1|||
160689874|NCT02113189|580244989|FG002|Overall Study|Lost to follow up|3|||
160689875|NCT02954159|580244992|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
160689876|NCT02954159|580244993|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
160689877|NCT02954159|580244992|FG000|Overall Study|Withdrawal by Subject|0|||
160689878|NCT02954159|580244993|FG001|Overall Study|Withdrawal by Subject|1|||
160689879|NCT03739138|580244999|FG000|Overall Study|Death|0|||
160689880|NCT03739138|580245000|FG001|Overall Study|Death|7|||
160689881|NCT03739138|580245001|FG002|Overall Study|Death|4|||
160689882|NCT03739138|580245002|FG003|Overall Study|Death|13|||
160689883|NCT03739138|580245003|FG004|Overall Study|Death|0|||
160689884|NCT03739138|580244999|FG000|Overall Study|Lost to Follow-up|0|||
160689885|NCT03739138|580245000|FG001|Overall Study|Lost to Follow-up|0|||
160689886|NCT03739138|580245001|FG002|Overall Study|Lost to Follow-up|1|||
160689887|NCT03739138|580245002|FG003|Overall Study|Lost to Follow-up|0|||
160689888|NCT03739138|580245003|FG004|Overall Study|Lost to Follow-up|0|||
160689889|NCT03739138|580244999|FG000|Overall Study|Study Terminated By Sponsor|0|||
160689890|NCT03739138|580245000|FG001|Overall Study|Study Terminated By Sponsor|0|||
160689891|NCT03739138|580245001|FG002|Overall Study|Study Terminated By Sponsor|0|||
160689892|NCT03739138|580245002|FG003|Overall Study|Study Terminated By Sponsor|4|||
160689893|NCT03739138|580245003|FG004|Overall Study|Study Terminated By Sponsor|0|||
160689894|NCT03739138|580244999|FG000|Overall Study|Withdrawal by Subject|0|||
160689895|NCT03739138|580245000|FG001|Overall Study|Withdrawal by Subject|0|||
160689896|NCT03739138|580245001|FG002|Overall Study|Withdrawal by Subject|0|||
160689897|NCT03739138|580245002|FG003|Overall Study|Withdrawal by Subject|1|||
160689898|NCT03739138|580245003|FG004|Overall Study|Withdrawal by Subject|0|||
160689899|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
160689900|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
160689901|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
160689902|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
160689903|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
160689904|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
160689905|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
160689906|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
160689907|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
160689908|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
160689909|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Subject decision|1|||
160689910|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Subject decision|1|||
160689911|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
160689912|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
160689913|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
160689914|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
160689915|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
160689916|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
160689917|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
160689918|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
160689919|NCT00518882|580245006|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
160689920|NCT00518882|580245007|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
160689921|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
160689922|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
160689923|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
160689924|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
160689925|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
160689926|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
160689927|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
160689928|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
160689929|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
160689930|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
160689931|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
160689932|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
160689933|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
160689934|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
160689935|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
160689936|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
160689937|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
160689938|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
160689939|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
160689940|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
160689941|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
160689942|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
160689943|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
160689944|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
160689945|NCT00518882|580245006|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
160689946|NCT00518882|580245007|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
160689947|NCT04740931|580245009|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
160689948|NCT04740931|580245010|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
160689949|NCT04740931|580245009|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
160689950|NCT04740931|580245010|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
160689951|NCT04740931|580245009|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
160689952|NCT04740931|580245010|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
160689953|NCT04740931|580245009|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
160689954|NCT04740931|580245010|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
160689955|NCT04740931|580245009|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
160689956|NCT04740931|580245010|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
160689957|NCT04740931|580245009|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
160689958|NCT04740931|580245010|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
160689959|NCT04740931|580245009|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
160689960|NCT04740931|580245010|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
160689961|NCT04740931|580245009|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
160689962|NCT04740931|580245010|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
160689963|NCT04740931|580245009|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
160689964|NCT04740931|580245010|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
160689965|NCT04740931|580245009|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
160689966|NCT04740931|580245010|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
160689967|NCT04740931|580245009|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
160689968|NCT04740931|580245010|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
160689969|NCT04740931|580245009|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
160689970|NCT04740931|580245010|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
160689971|NCT04740931|580245009|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
160689972|NCT04740931|580245010|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
160689973|NCT04740931|580245009|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
160689974|NCT04740931|580245010|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
160689975|NCT04740931|580245009|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
160689976|NCT04740931|580245010|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
160689977|NCT02696031|580245012|FG000|Up to Week 24|Adverse Event|2|||
160689978|NCT02696031|580245013|FG001|Up to Week 24|Adverse Event|4|||
160689979|NCT02696031|580245014|FG002|Up to Week 24|Adverse Event|2|||
160689980|NCT02696031|580245015|FG003|Up to Week 24|Adverse Event|0|||
160689981|NCT02696031|580245016|FG004|Up to Week 24|Adverse Event|0|||
160689982|NCT02696031|580245017|FG005|Up to Week 24|Adverse Event|0|||
160689983|NCT02696031|580245012|FG000|Up to Week 24|Lack of Efficacy|2|||
160689984|NCT02696031|580245013|FG001|Up to Week 24|Lack of Efficacy|1|||
160689985|NCT02696031|580245014|FG002|Up to Week 24|Lack of Efficacy|2|||
160689986|NCT02696031|580245015|FG003|Up to Week 24|Lack of Efficacy|0|||
160689987|NCT02696031|580245016|FG004|Up to Week 24|Lack of Efficacy|0|||
160689988|NCT02696031|580245017|FG005|Up to Week 24|Lack of Efficacy|0|||
160689989|NCT02696031|580245012|FG000|Up to Week 24|Lost to Follow-up|0|||
160689990|NCT02696031|580245013|FG001|Up to Week 24|Lost to Follow-up|1|||
160689991|NCT02696031|580245014|FG002|Up to Week 24|Lost to Follow-up|1|||
160689992|NCT02696031|580245015|FG003|Up to Week 24|Lost to Follow-up|0|||
160689993|NCT02696031|580245016|FG004|Up to Week 24|Lost to Follow-up|0|||
160689994|NCT02696031|580245017|FG005|Up to Week 24|Lost to Follow-up|0|||
160689995|NCT02696031|580245012|FG000|Up to Week 24|Physician Decision|1|||
160689996|NCT02696031|580245013|FG001|Up to Week 24|Physician Decision|0|||
160689997|NCT02696031|580245014|FG002|Up to Week 24|Physician Decision|1|||
160689998|NCT02696031|580245015|FG003|Up to Week 24|Physician Decision|0|||
160689999|NCT02696031|580245016|FG004|Up to Week 24|Physician Decision|0|||
160690000|NCT02696031|580245017|FG005|Up to Week 24|Physician Decision|0|||
160690001|NCT02696031|580245012|FG000|Up to Week 24|Protocol Violation|1|||
160690002|NCT02696031|580245013|FG001|Up to Week 24|Protocol Violation|0|||
160690003|NCT02696031|580245014|FG002|Up to Week 24|Protocol Violation|0|||
160690004|NCT02696031|580245015|FG003|Up to Week 24|Protocol Violation|0|||
160690005|NCT02696031|580245016|FG004|Up to Week 24|Protocol Violation|0|||
160690006|NCT02696031|580245017|FG005|Up to Week 24|Protocol Violation|0|||
160690007|NCT02696031|580245012|FG000|Up to Week 24|Withdrawal by Subject|4|||
160690008|NCT02696031|580245013|FG001|Up to Week 24|Withdrawal by Subject|1|||
160690009|NCT02696031|580245014|FG002|Up to Week 24|Withdrawal by Subject|5|||
160690010|NCT02696031|580245015|FG003|Up to Week 24|Withdrawal by Subject|0|||
160690011|NCT02696031|580245016|FG004|Up to Week 24|Withdrawal by Subject|0|||
160690012|NCT02696031|580245017|FG005|Up to Week 24|Withdrawal by Subject|0|||
160690013|NCT02696031|580245012|FG000|Up to Week 52|Adverse Event|4|||
160690014|NCT02696031|580245013|FG001|Up to Week 52|Adverse Event|5|||
160690015|NCT02696031|580245014|FG002|Up to Week 52|Adverse Event|3|||
160690016|NCT02696031|580245015|FG003|Up to Week 52|Adverse Event|0|||
160690017|NCT02696031|580245016|FG004|Up to Week 52|Adverse Event|0|||
160690018|NCT02696031|580245017|FG005|Up to Week 52|Adverse Event|0|||
160690019|NCT02696031|580245012|FG000|Up to Week 52|Lack of Efficacy|10|||
160690020|NCT02696031|580245013|FG001|Up to Week 52|Lack of Efficacy|7|||
160690021|NCT02696031|580245014|FG002|Up to Week 52|Lack of Efficacy|11|||
160690022|NCT02696031|580245015|FG003|Up to Week 52|Lack of Efficacy|0|||
160690023|NCT02696031|580245016|FG004|Up to Week 52|Lack of Efficacy|0|||
160690024|NCT02696031|580245017|FG005|Up to Week 52|Lack of Efficacy|0|||
160690025|NCT02696031|580245012|FG000|Up to Week 52|Lost to Follow-up|1|||
160690026|NCT02696031|580245013|FG001|Up to Week 52|Lost to Follow-up|1|||
160690027|NCT02696031|580245014|FG002|Up to Week 52|Lost to Follow-up|1|||
160690028|NCT02696031|580245015|FG003|Up to Week 52|Lost to Follow-up|0|||
160690029|NCT02696031|580245016|FG004|Up to Week 52|Lost to Follow-up|0|||
160690030|NCT02696031|580245017|FG005|Up to Week 52|Lost to Follow-up|0|||
160690031|NCT02696031|580245012|FG000|Up to Week 52|Physician Decision|1|||
160690032|NCT02696031|580245013|FG001|Up to Week 52|Physician Decision|1|||
160690033|NCT02696031|580245014|FG002|Up to Week 52|Physician Decision|2|||
160690034|NCT02696031|580245015|FG003|Up to Week 52|Physician Decision|0|||
160690035|NCT02696031|580245016|FG004|Up to Week 52|Physician Decision|0|||
160690036|NCT02696031|580245017|FG005|Up to Week 52|Physician Decision|0|||
160690037|NCT02696031|580245012|FG000|Up to Week 52|Pregnancy|0|||
160690038|NCT02696031|580245013|FG001|Up to Week 52|Pregnancy|2|||
160690039|NCT02696031|580245014|FG002|Up to Week 52|Pregnancy|0|||
160690040|NCT02696031|580245015|FG003|Up to Week 52|Pregnancy|0|||
160690041|NCT02696031|580245016|FG004|Up to Week 52|Pregnancy|0|||
160690042|NCT02696031|580245017|FG005|Up to Week 52|Pregnancy|0|||
160690043|NCT02696031|580245012|FG000|Up to Week 52|Protocol Violation|1|||
160690044|NCT02696031|580245013|FG001|Up to Week 52|Protocol Violation|0|||
160690045|NCT02696031|580245014|FG002|Up to Week 52|Protocol Violation|0|||
160690046|NCT02696031|580245015|FG003|Up to Week 52|Protocol Violation|0|||
160690047|NCT02696031|580245016|FG004|Up to Week 52|Protocol Violation|0|||
160690048|NCT02696031|580245017|FG005|Up to Week 52|Protocol Violation|0|||
160690049|NCT02696031|580245012|FG000|Up to Week 52|Withdrawal by Subject|12|||
160690050|NCT02696031|580245013|FG001|Up to Week 52|Withdrawal by Subject|3|||
160690051|NCT02696031|580245014|FG002|Up to Week 52|Withdrawal by Subject|9|||
160690052|NCT02696031|580245015|FG003|Up to Week 52|Withdrawal by Subject|0|||
160690053|NCT02696031|580245016|FG004|Up to Week 52|Withdrawal by Subject|0|||
160690054|NCT02696031|580245017|FG005|Up to Week 52|Withdrawal by Subject|0|||
160690055|NCT02696031|580245012|FG000|Up to Week 104|Pregnancy|0|||
160690056|NCT02696031|580245013|FG001|Up to Week 104|Pregnancy|2|||
160690057|NCT02696031|580245014|FG002|Up to Week 104|Pregnancy|1|||
160690058|NCT02696031|580245015|FG003|Up to Week 104|Pregnancy|0|||
160690059|NCT02696031|580245016|FG004|Up to Week 104|Pregnancy|0|||
160690060|NCT02696031|580245017|FG005|Up to Week 104|Pregnancy|0|||
160690061|NCT02696031|580245012|FG000|Up to Week 104|Withdrawal by Subject|15|||
160690062|NCT02696031|580245013|FG001|Up to Week 104|Withdrawal by Subject|10|||
160690063|NCT02696031|580245014|FG002|Up to Week 104|Withdrawal by Subject|16|||
160690064|NCT02696031|580245015|FG003|Up to Week 104|Withdrawal by Subject|0|||
160690065|NCT02696031|580245016|FG004|Up to Week 104|Withdrawal by Subject|0|||
160690066|NCT02696031|580245017|FG005|Up to Week 104|Withdrawal by Subject|0|||
160690067|NCT02696031|580245012|FG000|Up to Week 104|Protocol Violation|1|||
160690068|NCT02696031|580245013|FG001|Up to Week 104|Protocol Violation|0|||
160690069|NCT02696031|580245014|FG002|Up to Week 104|Protocol Violation|0|||
160690070|NCT02696031|580245015|FG003|Up to Week 104|Protocol Violation|0|||
160690071|NCT02696031|580245016|FG004|Up to Week 104|Protocol Violation|0|||
160690072|NCT02696031|580245017|FG005|Up to Week 104|Protocol Violation|0|||
160690073|NCT02696031|580245012|FG000|Up to Week 104|Physician Decision|1|||
160690074|NCT02696031|580245013|FG001|Up to Week 104|Physician Decision|2|||
160690075|NCT02696031|580245014|FG002|Up to Week 104|Physician Decision|3|||
160690076|NCT02696031|580245015|FG003|Up to Week 104|Physician Decision|0|||
160690077|NCT02696031|580245016|FG004|Up to Week 104|Physician Decision|0|||
160690078|NCT02696031|580245017|FG005|Up to Week 104|Physician Decision|0|||
160690079|NCT02696031|580245012|FG000|Up to Week 104|Lost to Follow-up|2|||
160690080|NCT02696031|580245013|FG001|Up to Week 104|Lost to Follow-up|3|||
160690081|NCT02696031|580245014|FG002|Up to Week 104|Lost to Follow-up|1|||
160690082|NCT02696031|580245015|FG003|Up to Week 104|Lost to Follow-up|0|||
160690083|NCT02696031|580245016|FG004|Up to Week 104|Lost to Follow-up|0|||
160690084|NCT02696031|580245017|FG005|Up to Week 104|Lost to Follow-up|0|||
160690085|NCT02696031|580245012|FG000|Up to Week 104|Lack of Efficacy|13|||
160690086|NCT02696031|580245013|FG001|Up to Week 104|Lack of Efficacy|12|||
160690087|NCT02696031|580245014|FG002|Up to Week 104|Lack of Efficacy|11|||
160690088|NCT02696031|580245015|FG003|Up to Week 104|Lack of Efficacy|0|||
160690089|NCT02696031|580245016|FG004|Up to Week 104|Lack of Efficacy|0|||
160690090|NCT02696031|580245017|FG005|Up to Week 104|Lack of Efficacy|0|||
160690091|NCT02696031|580245012|FG000|Up to Week 104|Adverse Event|7|||
160690092|NCT02696031|580245013|FG001|Up to Week 104|Adverse Event|11|||
160690093|NCT02696031|580245014|FG002|Up to Week 104|Adverse Event|5|||
160690094|NCT02696031|580245015|FG003|Up to Week 104|Adverse Event|0|||
160690095|NCT02696031|580245016|FG004|Up to Week 104|Adverse Event|0|||
160690096|NCT02696031|580245017|FG005|Up to Week 104|Adverse Event|0|||
160690097|NCT02696031|580245012|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
160690098|NCT02696031|580245013|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
160690099|NCT02696031|580245014|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
160690100|NCT02696031|580245015|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
160690101|NCT02696031|580245016|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
160690102|NCT02696031|580245017|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
160690103|NCT02696031|580245012|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
160690104|NCT02696031|580245013|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
160690105|NCT02696031|580245014|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
160690106|NCT02696031|580245015|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
160690107|NCT02696031|580245016|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
160690108|NCT02696031|580245017|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
160690109|NCT02696031|580245012|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
160690110|NCT02696031|580245013|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
160690111|NCT02696031|580245014|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
160690112|NCT02696031|580245015|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
160690113|NCT02696031|580245016|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
160690114|NCT02696031|580245017|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
160690115|NCT02696031|580245012|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
160690116|NCT02696031|580245013|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
160690117|NCT02696031|580245014|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
160690118|NCT02696031|580245015|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
160690119|NCT02696031|580245016|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
160690120|NCT02696031|580245017|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
160690121|NCT02696031|580245012|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
160690122|NCT02696031|580245013|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
160690123|NCT02696031|580245014|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
160690124|NCT02696031|580245015|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
160690125|NCT02696031|580245016|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
160690126|NCT02696031|580245017|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
160690127|NCT02696031|580245012|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
160690128|NCT02696031|580245013|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
160690129|NCT02696031|580245014|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
160690130|NCT02696031|580245015|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
160690131|NCT02696031|580245016|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
160690132|NCT02696031|580245017|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
160690133|NCT02696031|580245012|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
160690134|NCT02696031|580245013|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
160690135|NCT02696031|580245014|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
160690136|NCT02696031|580245015|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
160690137|NCT02696031|580245016|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
160690138|NCT02696031|580245017|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
160690139|NCT00597116|580245018|FG000|Overall Study|Adverse Event|2|||
160690140|NCT00597116|580245019|FG001|Overall Study|Adverse Event|1|||
160690141|NCT00597116|580245018|FG000|Overall Study|Withdrawal by Subject|0|||
160690142|NCT00597116|580245019|FG001|Overall Study|Withdrawal by Subject|2|||
160690143|NCT00597116|580245018|FG000|Overall Study|Physician Decision|0|||
160690144|NCT00597116|580245019|FG001|Overall Study|Physician Decision|1|||
160690145|NCT00597116|580245018|FG000|Overall Study|Death|0|||
160690146|NCT00597116|580245019|FG001|Overall Study|Death|1|||
160690147|NCT00597116|580245018|FG000|Overall Study|Lost to Follow-up|1|||
160690148|NCT00597116|580245019|FG001|Overall Study|Lost to Follow-up|0|||
160690149|NCT00597116|580245018|FG000|Overall Study|Progressive disease|11|||
160690150|NCT00597116|580245019|FG001|Overall Study|Progressive disease|6|||
160690151|NCT02096588|580245020|FG000|Overall Study|Lack of Efficacy|2|||
160690152|NCT02096588|580245021|FG001|Overall Study|Lack of Efficacy|0|||
160690153|NCT02096588|580245020|FG000|Overall Study|Withdrawal by Subject|0|||
160690154|NCT02096588|580245021|FG001|Overall Study|Withdrawal by Subject|1|||
160690155|NCT01258101|580245022|FG000|Overall Study|Adverse Event|5|||
160690156|NCT01258101|580245023|FG001|Overall Study|Adverse Event|6|||
160690157|NCT01258101|580245024|FG002|Overall Study|Adverse Event|0|||
160690158|NCT01258101|580245025|FG003|Overall Study|Adverse Event|0|||
160690159|NCT01258101|580245022|FG000|Overall Study|Extra exclusion criterion amended|2|||
160690160|NCT01258101|580245023|FG001|Overall Study|Extra exclusion criterion amended|1|||
160690161|NCT01258101|580245024|FG002|Overall Study|Extra exclusion criterion amended|1|||
160690162|NCT01258101|580245025|FG003|Overall Study|Extra exclusion criterion amended|1|||
160690163|NCT01258101|580245022|FG000|Overall Study|Informed consent has been withdrawn|2|||
160690164|NCT01258101|580245023|FG001|Overall Study|Informed consent has been withdrawn|2|||
160690165|NCT01258101|580245024|FG002|Overall Study|Informed consent has been withdrawn|1|||
160690166|NCT01258101|580245025|FG003|Overall Study|Informed consent has been withdrawn|1|||
160690167|NCT01258101|580245022|FG000|Overall Study|Patient is not able to attend visits|8|||
160690168|NCT01258101|580245023|FG001|Overall Study|Patient is not able to attend visits|9|||
160690169|NCT01258101|580245024|FG002|Overall Study|Patient is not able to attend visits|7|||
160690170|NCT01258101|580245025|FG003|Overall Study|Patient is not able to attend visits|6|||
160690171|NCT01258101|580245022|FG000|Overall Study|Patient´s compliance|4|||
160690172|NCT01258101|580245023|FG001|Overall Study|Patient´s compliance|3|||
160690173|NCT01258101|580245024|FG002|Overall Study|Patient´s compliance|1|||
160690174|NCT01258101|580245025|FG003|Overall Study|Patient´s compliance|2|||
160690175|NCT01258101|580245022|FG000|Overall Study|Lost to Follow-up|5|||
160690176|NCT01258101|580245023|FG001|Overall Study|Lost to Follow-up|5|||
160690177|NCT01258101|580245024|FG002|Overall Study|Lost to Follow-up|0|||
160690178|NCT01258101|580245025|FG003|Overall Study|Lost to Follow-up|6|||
160690179|NCT01258101|580245022|FG000|Overall Study|PCR positive at week 24|0|||
160690180|NCT01258101|580245023|FG001|Overall Study|PCR positive at week 24|0|||
160690181|NCT01258101|580245024|FG002|Overall Study|PCR positive at week 24|0|||
160690182|NCT01258101|580245025|FG003|Overall Study|PCR positive at week 24|1|||
160690183|NCT01258101|580245022|FG000|Overall Study|Other reason|7|||
160690184|NCT01258101|580245023|FG001|Overall Study|Other reason|8|||
160690185|NCT01258101|580245024|FG002|Overall Study|Other reason|1|||
160690186|NCT01258101|580245025|FG003|Overall Study|Other reason|8|||
160690187|NCT00063882|580245028|FG000|Overall Study|Protocol Violation|3|||
160690188|NCT00063882|580245029|FG001|Overall Study|Protocol Violation|3|||
160690189|NCT00063882|580245028|FG000|Overall Study|Withdrawal by Subject|2|||
160690190|NCT00063882|580245029|FG001|Overall Study|Withdrawal by Subject|1|||
160690191|NCT02903238|580245030|FG000|Overall Study|Lost to Follow-up|4|||
160690192|NCT01020799|580245032|FG000|Overall Study|Adverse Event|4|||
160690193|NCT01020799|580245033|FG001|Overall Study|Adverse Event|3|||
160690194|NCT01020799|580245034|FG002|Overall Study|Adverse Event|2|||
160690195|NCT01020799|580245032|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
160690196|NCT01020799|580245033|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
160690197|NCT01020799|580245034|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
160690198|NCT01020799|580245032|FG000|Overall Study|Protocol Violation|3|||
160690199|NCT01020799|580245033|FG001|Overall Study|Protocol Violation|2|||
160690200|NCT01020799|580245034|FG002|Overall Study|Protocol Violation|0|||
160690201|NCT01020799|580245032|FG000|Overall Study|Withdrawal by Subject|2|||
160690202|NCT01020799|580245033|FG001|Overall Study|Withdrawal by Subject|2|||
160690203|NCT01020799|580245034|FG002|Overall Study|Withdrawal by Subject|3|||
160690204|NCT01020799|580245032|FG000|Overall Study|Lost to Follow-up|6|||
160690205|NCT01020799|580245033|FG001|Overall Study|Lost to Follow-up|4|||
160690206|NCT01020799|580245034|FG002|Overall Study|Lost to Follow-up|2|||
160690207|NCT02556307|580245037|FG000|Overall Study|Premature treatment interruption|11|||
160690208|NCT02556307|580245037|FG000|Overall Study|Lost to Follow-up|36|||
160690209|NCT02556307|580245037|FG000|Overall Study|Change to triple therapy|4|||
160690210|NCT02556307|580245037|FG000|Overall Study|Enrolled but not treated|2|||
160690211|NCT03438227|580245038|FG000|Overall Study|Withdrawal by Subject|10|||
160690212|NCT03438227|580245039|FG001|Overall Study|Withdrawal by Subject|5|||
160690213|NCT02972502|580245044|FG000|Overall Study|Lost to Follow-up|3|||
160690214|NCT02972502|580245045|FG001|Overall Study|Lost to Follow-up|1|||
160690215|NCT02972502|580245044|FG000|Overall Study|Withdrawal by Subject|1|||
160690216|NCT02972502|580245045|FG001|Overall Study|Withdrawal by Subject|1|||
160690217|NCT03852459|580245046|FG000|Overall Study|Adverse Event|2|||
160690218|NCT03852459|580245047|FG001|Overall Study|Adverse Event|2|||
160690219|NCT03852459|580245046|FG000|Overall Study|Withdrawal by Subject|1|||
160690220|NCT03852459|580245047|FG001|Overall Study|Withdrawal by Subject|1|||
160690221|NCT00049842|580245048|FG000|Treatment Phase|Adverse Event|47|||
160690222|NCT00049842|580245049|FG001|Treatment Phase|Adverse Event|12|||
160690223|NCT00049842|580245048|FG000|Treatment Phase|Withdrawal by Subject|35|||
160690224|NCT00049842|580245049|FG001|Treatment Phase|Withdrawal by Subject|46|||
160690225|NCT00049842|580245048|FG000|Treatment Phase|Non-compliance with protocol|7|||
160690226|NCT00049842|580245049|FG001|Treatment Phase|Non-compliance with protocol|8|||
160690227|NCT00049842|580245048|FG000|Treatment Phase|Lost to Follow-up|4|||
160690228|NCT00049842|580245049|FG001|Treatment Phase|Lost to Follow-up|8|||
160690229|NCT00049842|580245048|FG000|Treatment Phase|Administrative|0|||
160690230|NCT00049842|580245049|FG001|Treatment Phase|Administrative|3|||
160690231|NCT00049842|580245048|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
160690232|NCT00049842|580245049|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
160690233|NCT00049842|580245048|FG000|Follow-up Phase|Adverse Event|6|||
160690234|NCT00049842|580245049|FG001|Follow-up Phase|Adverse Event|1|||
160690235|NCT00049842|580245048|FG000|Follow-up Phase|Other|1|||
160690236|NCT00049842|580245049|FG001|Follow-up Phase|Other|4|||
160690237|NCT01138111|580245058|FG000|Overall Study|Withdrawal by Subject|5|||
160690238|NCT01138111|580245058|FG000|Overall Study|Adverse Event|1|||
160690239|NCT01138111|580245058|FG000|Overall Study|Death|1|||
160690240|NCT01138111|580245058|FG000|Overall Study|Lost to Follow-up|2|||
160690241|NCT01118117|580245059|FG000|Overall Study|Death|8|||
160690242|NCT01118117|580245060|FG001|Overall Study|Death|0|||
160690243|NCT01118117|580245059|FG000|Overall Study|Lost to Follow-up|6|||
160690244|NCT01118117|580245060|FG001|Overall Study|Lost to Follow-up|0|||
160690245|NCT01118117|580245059|FG000|Overall Study|Missed 12 Month Visit|7|||
160690246|NCT01118117|580245060|FG001|Overall Study|Missed 12 Month Visit|0|||
160690247|NCT00706992|580245061|FG000|Overall Study|Study termination|5|||
160690248|NCT00706992|580245062|FG001|Overall Study|Study termination|5|||
160690249|NCT00706992|580245063|FG002|Overall Study|Study termination|6|||
160690250|NCT00706992|580245064|FG003|Overall Study|Study termination|2|||
160690251|NCT00706992|580245065|FG004|Overall Study|Study termination|3|||
160690252|NCT00706992|580245066|FG005|Overall Study|Study termination|2|||
160690253|NCT00706992|580245067|FG006|Overall Study|Study termination|3|||
160690254|NCT00706992|580245061|FG000|Overall Study|Disease progression before treatment|0|||
160690255|NCT00706992|580245062|FG001|Overall Study|Disease progression before treatment|0|||
160690256|NCT00706992|580245063|FG002|Overall Study|Disease progression before treatment|0|||
160690257|NCT00706992|580245064|FG003|Overall Study|Disease progression before treatment|0|||
160690258|NCT00706992|580245065|FG004|Overall Study|Disease progression before treatment|1|||
160690259|NCT00706992|580245066|FG005|Overall Study|Disease progression before treatment|0|||
160690260|NCT00706992|580245067|FG006|Overall Study|Disease progression before treatment|0|||
160690261|NCT02149121|580245070|FG000|Main Study Period|Lack of Efficacy|2|||
160690262|NCT02149121|580245071|FG001|Main Study Period|Lack of Efficacy|2|||
160690263|NCT02149121|580245072|FG002|Main Study Period|Lack of Efficacy|1|||
160690264|NCT02149121|580245073|FG003|Main Study Period|Lack of Efficacy|0|||
160690265|NCT02149121|580245074|FG004|Main Study Period|Lack of Efficacy|0|||
160690266|NCT02149121|580245075|FG005|Main Study Period|Lack of Efficacy|0|||
160690267|NCT02149121|580245076|FG006|Main Study Period|Lack of Efficacy|0|||
160690268|NCT02149121|580245070|FG000|Main Study Period|Withdrawal by Subject|9|||
160690269|NCT02149121|580245071|FG001|Main Study Period|Withdrawal by Subject|5|||
160690270|NCT02149121|580245072|FG002|Main Study Period|Withdrawal by Subject|1|||
160690271|NCT02149121|580245073|FG003|Main Study Period|Withdrawal by Subject|0|||
160690272|NCT02149121|580245074|FG004|Main Study Period|Withdrawal by Subject|0|||
160690273|NCT02149121|580245075|FG005|Main Study Period|Withdrawal by Subject|0|||
160690274|NCT02149121|580245076|FG006|Main Study Period|Withdrawal by Subject|0|||
160690275|NCT02149121|580245070|FG000|Main Study Period|Adverse Event|2|||
160690276|NCT02149121|580245071|FG001|Main Study Period|Adverse Event|5|||
160690277|NCT02149121|580245072|FG002|Main Study Period|Adverse Event|1|||
160690278|NCT02149121|580245073|FG003|Main Study Period|Adverse Event|0|||
160690279|NCT02149121|580245074|FG004|Main Study Period|Adverse Event|0|||
160690280|NCT02149121|580245075|FG005|Main Study Period|Adverse Event|0|||
160690281|NCT02149121|580245076|FG006|Main Study Period|Adverse Event|0|||
160690282|NCT02149121|580245070|FG000|Main Study Period|Protocol Violation|2|||
160690283|NCT02149121|580245071|FG001|Main Study Period|Protocol Violation|0|||
160690284|NCT02149121|580245072|FG002|Main Study Period|Protocol Violation|0|||
160690285|NCT02149121|580245073|FG003|Main Study Period|Protocol Violation|0|||
160690286|NCT02149121|580245074|FG004|Main Study Period|Protocol Violation|0|||
160690287|NCT02149121|580245075|FG005|Main Study Period|Protocol Violation|0|||
160690288|NCT02149121|580245076|FG006|Main Study Period|Protocol Violation|0|||
160690289|NCT02149121|580245070|FG000|Main Study Period|Lost to Follow-up|2|||
160690290|NCT02149121|580245071|FG001|Main Study Period|Lost to Follow-up|1|||
160690291|NCT02149121|580245072|FG002|Main Study Period|Lost to Follow-up|0|||
160690292|NCT02149121|580245073|FG003|Main Study Period|Lost to Follow-up|0|||
160690293|NCT02149121|580245074|FG004|Main Study Period|Lost to Follow-up|0|||
160690294|NCT02149121|580245075|FG005|Main Study Period|Lost to Follow-up|0|||
160690295|NCT02149121|580245076|FG006|Main Study Period|Lost to Follow-up|0|||
160690296|NCT02149121|580245070|FG000|Main Study Period|Death|1|||
160690297|NCT02149121|580245071|FG001|Main Study Period|Death|0|||
160690298|NCT02149121|580245072|FG002|Main Study Period|Death|0|||
160690299|NCT02149121|580245073|FG003|Main Study Period|Death|0|||
160690300|NCT02149121|580245074|FG004|Main Study Period|Death|0|||
160690301|NCT02149121|580245075|FG005|Main Study Period|Death|0|||
160690302|NCT02149121|580245076|FG006|Main Study Period|Death|0|||
160690303|NCT02149121|580245070|FG000|Main Study Period|Physician Decision|1|||
160690304|NCT02149121|580245071|FG001|Main Study Period|Physician Decision|0|||
160690305|NCT02149121|580245072|FG002|Main Study Period|Physician Decision|0|||
160690306|NCT02149121|580245073|FG003|Main Study Period|Physician Decision|0|||
160690307|NCT02149121|580245074|FG004|Main Study Period|Physician Decision|0|||
160690308|NCT02149121|580245075|FG005|Main Study Period|Physician Decision|0|||
160690309|NCT02149121|580245076|FG006|Main Study Period|Physician Decision|0|||
160690310|NCT02149121|580245070|FG000|Main Study Period|Developed any malignancy|0|||
160690311|NCT02149121|580245071|FG001|Main Study Period|Developed any malignancy|1|||
160690312|NCT02149121|580245072|FG002|Main Study Period|Developed any malignancy|1|||
160690313|NCT02149121|580245073|FG003|Main Study Period|Developed any malignancy|0|||
160690314|NCT02149121|580245074|FG004|Main Study Period|Developed any malignancy|0|||
160690315|NCT02149121|580245075|FG005|Main Study Period|Developed any malignancy|0|||
160690316|NCT02149121|580245076|FG006|Main Study Period|Developed any malignancy|0|||
160690317|NCT02149121|580245070|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
160690318|NCT02149121|580245071|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
160690319|NCT02149121|580245072|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
160690320|NCT02149121|580245073|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
160690321|NCT02149121|580245074|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
160690322|NCT02149121|580245075|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
160690323|NCT02149121|580245076|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
160690324|NCT02149121|580245070|FG000|Main Study Period|Disease progression|0|||
160690325|NCT02149121|580245071|FG001|Main Study Period|Disease progression|1|||
160690326|NCT02149121|580245072|FG002|Main Study Period|Disease progression|0|||
160690327|NCT02149121|580245073|FG003|Main Study Period|Disease progression|0|||
160690328|NCT02149121|580245074|FG004|Main Study Period|Disease progression|0|||
160690329|NCT02149121|580245075|FG005|Main Study Period|Disease progression|0|||
160690330|NCT02149121|580245076|FG006|Main Study Period|Disease progression|0|||
160690331|NCT02149121|580245070|FG000|Extension Study Period|Withdrawal by Subject|0|||
160690332|NCT02149121|580245071|FG001|Extension Study Period|Withdrawal by Subject|0|||
160690333|NCT02149121|580245072|FG002|Extension Study Period|Withdrawal by Subject|0|||
160690334|NCT02149121|580245073|FG003|Extension Study Period|Withdrawal by Subject|1|||
160690335|NCT02149121|580245074|FG004|Extension Study Period|Withdrawal by Subject|0|||
160690336|NCT02149121|580245075|FG005|Extension Study Period|Withdrawal by Subject|2|||
160690337|NCT02149121|580245076|FG006|Extension Study Period|Withdrawal by Subject|0|||
160690338|NCT01244061|580245085|FG000|Overall Study|Death|1|||
160690339|NCT01244061|580245086|FG001|Overall Study|Death|0|||
160690340|NCT01244061|580245085|FG000|Overall Study|Did not meet entrance criteria|1|||
160690341|NCT01244061|580245086|FG001|Overall Study|Did not meet entrance criteria|0|||
160690342|NCT01244061|580245085|FG000|Overall Study|Lack of Efficacy|1|||
160690343|NCT01244061|580245086|FG001|Overall Study|Lack of Efficacy|3|||
160690344|NCT01244061|580245085|FG000|Overall Study|Lost to Follow-up|34|||
160690345|NCT01244061|580245086|FG001|Overall Study|Lost to Follow-up|30|||
160690346|NCT01244061|580245085|FG000|Overall Study|Withdrawal by Subject|29|||
160690347|NCT01244061|580245086|FG001|Overall Study|Withdrawal by Subject|46|||
160690348|NCT01244061|580245085|FG000|Overall Study|Other|8|||
160690349|NCT01244061|580245086|FG001|Overall Study|Other|19|||
160690350|NCT01244061|580245085|FG000|Overall Study|Protocol Violation|1|||
160690351|NCT01244061|580245086|FG001|Overall Study|Protocol Violation|1|||
160690352|NCT01244061|580245085|FG000|Overall Study|Adverse Event|5|||
160690353|NCT01244061|580245086|FG001|Overall Study|Adverse Event|2|||
160690354|NCT01244061|580245085|FG000|Overall Study|Randomized but not treated|2|||
160690355|NCT01244061|580245086|FG001|Overall Study|Randomized but not treated|2|||
160690356|NCT03166124|580245087|FG000|Treatment Period 1|Adverse Event|0|||
160690357|NCT03166124|580245088|FG001|Treatment Period 1|Adverse Event|0|||
160690358|NCT03166124|580245089|FG002|Treatment Period 1|Adverse Event|1|||
160690359|NCT03166124|580245090|FG003|Treatment Period 1|Adverse Event|0|||
160690360|NCT03166124|580245087|FG000|Wash-out Period|Withdrawal by Subject|0|||
160690361|NCT03166124|580245088|FG001|Wash-out Period|Withdrawal by Subject|1|||
160690362|NCT03166124|580245089|FG002|Wash-out Period|Withdrawal by Subject|0|||
160690363|NCT03166124|580245090|FG003|Wash-out Period|Withdrawal by Subject|1|||
160690364|NCT03166124|580245087|FG000|Wash-out Period|Adverse Event|0|||
160690365|NCT03166124|580245088|FG001|Wash-out Period|Adverse Event|1|||
160690366|NCT03166124|580245089|FG002|Wash-out Period|Adverse Event|1|||
160690367|NCT03166124|580245090|FG003|Wash-out Period|Adverse Event|0|||
160690368|NCT00788593|580245091|FG000|Placebo Run-in Phase|Adverse Event|2|||
160690369|NCT00788593|580245092|FG001|Placebo Run-in Phase|Adverse Event|0|||
160690370|NCT00788593|580245093|FG002|Placebo Run-in Phase|Adverse Event|0|||
160690371|NCT00788593|580245091|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
160690372|NCT00788593|580245092|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
160690373|NCT00788593|580245093|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
160690374|NCT00788593|580245091|FG000|Placebo Run-in Phase|Protocol Violation|2|||
160690375|NCT00788593|580245092|FG001|Placebo Run-in Phase|Protocol Violation|0|||
160690376|NCT00788593|580245093|FG002|Placebo Run-in Phase|Protocol Violation|0|||
160690377|NCT00788593|580245091|FG000|First Intervention Period|Adverse Event|0|||
160690378|NCT00788593|580245092|FG001|First Intervention Period|Adverse Event|1|||
160690379|NCT00788593|580245093|FG002|First Intervention Period|Adverse Event|0|||
160690380|NCT00788593|580245091|FG000|Second Intervention Period|Lost to Follow-up|0|||
160690381|NCT00788593|580245092|FG001|Second Intervention Period|Lost to Follow-up|1|||
160690382|NCT00788593|580245093|FG002|Second Intervention Period|Lost to Follow-up|0|||
160690383|NCT00788593|580245091|FG000|Second Intervention Period|Other|0|||
160690384|NCT00788593|580245092|FG001|Second Intervention Period|Other|0|||
160690385|NCT00788593|580245093|FG002|Second Intervention Period|Other|1|||
160690386|NCT01392326|580245094|FG000|Overall Study|Death|2|||
160690387|NCT01392326|580245095|FG001|Overall Study|Death|0|||
160690388|NCT01392326|580245096|FG002|Overall Study|Death|0|||
160690389|NCT01392326|580245094|FG000|Overall Study|Withdrawal by Subject|12|||
160690390|NCT01392326|580245095|FG001|Overall Study|Withdrawal by Subject|11|||
160690391|NCT01392326|580245096|FG002|Overall Study|Withdrawal by Subject|15|||
160690392|NCT01392326|580245094|FG000|Overall Study|Protocol Violation|2|||
160690393|NCT01392326|580245095|FG001|Overall Study|Protocol Violation|0|||
160690394|NCT01392326|580245096|FG002|Overall Study|Protocol Violation|0|||
160690395|NCT01392326|580245094|FG000|Overall Study|Pregnancy|0|||
160690396|NCT01392326|580245095|FG001|Overall Study|Pregnancy|0|||
160690397|NCT01392326|580245096|FG002|Overall Study|Pregnancy|1|||
160690398|NCT01392326|580245094|FG000|Overall Study|Physician Decision|7|||
160690399|NCT01392326|580245095|FG001|Overall Study|Physician Decision|5|||
160690400|NCT01392326|580245096|FG002|Overall Study|Physician Decision|2|||
160690401|NCT01392326|580245094|FG000|Overall Study|Lost to Follow-up|1|||
160690402|NCT01392326|580245095|FG001|Overall Study|Lost to Follow-up|3|||
160690403|NCT01392326|580245096|FG002|Overall Study|Lost to Follow-up|4|||
160690404|NCT01392326|580245094|FG000|Overall Study|Lack of Efficacy|14|||
160690405|NCT01392326|580245095|FG001|Overall Study|Lack of Efficacy|10|||
160690406|NCT01392326|580245096|FG002|Overall Study|Lack of Efficacy|15|||
160690407|NCT01392326|580245094|FG000|Overall Study|Adverse Event|9|||
160690408|NCT01392326|580245095|FG001|Overall Study|Adverse Event|6|||
160690409|NCT01392326|580245096|FG002|Overall Study|Adverse Event|11|||
160690410|NCT03487848|580245099|FG000|Overall Study|Lost to Follow-up|1|||
160690411|NCT00123955|580245102|FG000|Overall Study|Adverse Event|1|||
160690412|NCT00123955|580245103|FG001|Overall Study|Adverse Event|0|||
160690413|NCT00123955|580245102|FG000|Overall Study|Withdrawal by Subject|4|||
160690414|NCT00123955|580245103|FG001|Overall Study|Withdrawal by Subject|3|||
160690415|NCT00123955|580245102|FG000|Overall Study|Death|0|||
160690416|NCT00123955|580245103|FG001|Overall Study|Death|1|||
160690417|NCT00094094|580245104|FG000|Overall Study|Death|2|||
160690418|NCT00094094|580245104|FG000|Overall Study|Lack of Efficacy|23|||
160690419|NCT00094094|580245104|FG000|Overall Study|Adverse Event|7|||
160690420|NCT04459715|580245109|FG000|Overall Study|Adverse Event|3|||
160690421|NCT04459715|580245110|FG001|Overall Study|Adverse Event|3|||
160690422|NCT04459715|580245109|FG000|Overall Study|Death|111|||
160690423|NCT04459715|580245110|FG001|Overall Study|Death|93|||
160690424|NCT04459715|580245109|FG000|Overall Study|Lost to Follow-up|10|||
160690425|NCT04459715|580245110|FG001|Overall Study|Lost to Follow-up|9|||
160690426|NCT04459715|580245109|FG000|Overall Study|Other Reasons|4|||
160690427|NCT04459715|580245110|FG001|Overall Study|Other Reasons|5|||
160690428|NCT04459715|580245109|FG000|Overall Study|PROTOCOL DEVIATION|0|||
160690429|NCT04459715|580245110|FG001|Overall Study|PROTOCOL DEVIATION|1|||
160690430|NCT04459715|580245109|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
160690431|NCT04459715|580245110|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
160690432|NCT04459715|580245109|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
160690433|NCT04459715|580245110|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
160690434|NCT04459715|580245109|FG000|Overall Study|Withdrawal by Subject|22|||
160690435|NCT04459715|580245110|FG001|Overall Study|Withdrawal by Subject|22|||
160690436|NCT01408563|580246627|FG000|Overall Study|Ineligible after consent/ registration|2|||
160690437|NCT02177136|580246630|FG000|DB Phase|Withdrawal by Subject|2|||
160690438|NCT02177136|580246631|FG001|DB Phase|Withdrawal by Subject|0|||
160690439|NCT02177136|580246632|FG002|DB Phase|Withdrawal by Subject|0|||
160690440|NCT02177136|580246633|FG003|DB Phase|Withdrawal by Subject|0|||
160690441|NCT02177136|580246630|FG000|DB Phase|Discontinued Due to Pruritus|1|||
160690442|NCT02177136|580246631|FG001|DB Phase|Discontinued Due to Pruritus|3|||
160690443|NCT02177136|580246632|FG002|DB Phase|Discontinued Due to Pruritus|0|||
160690444|NCT02177136|580246633|FG003|DB Phase|Discontinued Due to Pruritus|0|||
160690445|NCT02177136|580246630|FG000|DB Phase|Adverse Event|3|||
160690446|NCT02177136|580246631|FG001|DB Phase|Adverse Event|2|||
160690447|NCT02177136|580246632|FG002|DB Phase|Adverse Event|3|||
160690448|NCT02177136|580246633|FG003|DB Phase|Adverse Event|0|||
160690449|NCT02177136|580246630|FG000|DB Phase|Protocol Violation|0|||
160690450|NCT02177136|580246631|FG001|DB Phase|Protocol Violation|0|||
160690451|NCT02177136|580246632|FG002|DB Phase|Protocol Violation|1|||
160690452|NCT02177136|580246633|FG003|DB Phase|Protocol Violation|0|||
160690453|NCT02177136|580246630|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
160690454|NCT02177136|580246631|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
160690455|NCT02177136|580246632|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
160690456|NCT02177136|580246633|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
160690457|NCT02177136|580246630|FG000|LTSE Phase|Withdrawal by Subject|0|||
160690458|NCT02177136|580246631|FG001|LTSE Phase|Withdrawal by Subject|0|||
160690459|NCT02177136|580246632|FG002|LTSE Phase|Withdrawal by Subject|0|||
160690460|NCT02177136|580246633|FG003|LTSE Phase|Withdrawal by Subject|6|||
160690461|NCT02177136|580246630|FG000|LTSE Phase|Adverse Event|0|||
160690462|NCT02177136|580246631|FG001|LTSE Phase|Adverse Event|0|||
160690463|NCT02177136|580246632|FG002|LTSE Phase|Adverse Event|0|||
160690464|NCT02177136|580246633|FG003|LTSE Phase|Adverse Event|10|||
160690465|NCT02177136|580246630|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
160690466|NCT02177136|580246631|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
160690467|NCT02177136|580246632|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
160690468|NCT02177136|580246633|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
160690469|NCT02177136|580246630|FG000|LTSE Phase|Physician Decision|0|||
160690470|NCT02177136|580246631|FG001|LTSE Phase|Physician Decision|0|||
160690471|NCT02177136|580246632|FG002|LTSE Phase|Physician Decision|0|||
160690472|NCT02177136|580246633|FG003|LTSE Phase|Physician Decision|2|||
160690473|NCT02177136|580246630|FG000|LTSE Phase|Lost to Follow-up|0|||
160690474|NCT02177136|580246631|FG001|LTSE Phase|Lost to Follow-up|0|||
160690475|NCT02177136|580246632|FG002|LTSE Phase|Lost to Follow-up|0|||
160690476|NCT02177136|580246633|FG003|LTSE Phase|Lost to Follow-up|1|||
160690477|NCT02177136|580246630|FG000|LTSE Phase|Participant Moved|0|||
160690478|NCT02177136|580246631|FG001|LTSE Phase|Participant Moved|0|||
160690479|NCT02177136|580246632|FG002|LTSE Phase|Participant Moved|0|||
160690480|NCT02177136|580246633|FG003|LTSE Phase|Participant Moved|1|||
160690481|NCT02054130|580246634|FG000|Overall Study|Withdrawal by Subject|4|||
160690482|NCT02054130|580246635|FG001|Overall Study|Withdrawal by Subject|4|||
160690483|NCT02054130|580246636|FG002|Overall Study|Withdrawal by Subject|7|||
160690484|NCT02054130|580246637|FG003|Overall Study|Withdrawal by Subject|10|||
160690485|NCT02054130|580246634|FG000|Overall Study|Death|0|||
160690486|NCT02054130|580246635|FG001|Overall Study|Death|1|||
160690487|NCT02054130|580246636|FG002|Overall Study|Death|0|||
160690488|NCT02054130|580246637|FG003|Overall Study|Death|0|||
160690489|NCT02054130|580246634|FG000|Overall Study|Lost to Follow-up|0|||
160690490|NCT02054130|580246635|FG001|Overall Study|Lost to Follow-up|0|||
160690491|NCT02054130|580246636|FG002|Overall Study|Lost to Follow-up|1|||
160690492|NCT02054130|580246637|FG003|Overall Study|Lost to Follow-up|2|||
160690493|NCT02054130|580246634|FG000|Overall Study|Missed dose|4|||
160690494|NCT02054130|580246635|FG001|Overall Study|Missed dose|6|||
160690495|NCT02054130|580246636|FG002|Overall Study|Missed dose|7|||
160690496|NCT02054130|580246637|FG003|Overall Study|Missed dose|10|||
160690497|NCT04271735|580246641|FG000|Overall Study|Physician Decision|2|||
160690498|NCT04271735|580246642|FG001|Overall Study|Physician Decision|0|||
160690499|NCT04268316|580246643|FG000|Overall Study|Withdrawal by Subject|2|||
160690500|NCT04268316|580246644|FG001|Overall Study|Withdrawal by Subject|1|||
160690501|NCT04268316|580246645|FG002|Overall Study|Withdrawal by Subject|0|||
160690502|NCT02040779|580246647|FG000|Overall Study|Adverse Event|1|||
160690503|NCT02040779|580246648|FG001|Overall Study|Adverse Event|0|||
160690504|NCT02040779|580246649|FG002|Overall Study|Adverse Event|0|||
160690505|NCT02040779|580246647|FG000|Overall Study|Withdrawal by Subject|4|||
160690506|NCT02040779|580246648|FG001|Overall Study|Withdrawal by Subject|1|||
160690507|NCT02040779|580246649|FG002|Overall Study|Withdrawal by Subject|3|||
160690508|NCT02040779|580246647|FG000|Overall Study|Non-compliance|0|||
160690509|NCT02040779|580246648|FG001|Overall Study|Non-compliance|1|||
160690510|NCT02040779|580246649|FG002|Overall Study|Non-compliance|0|||
160690511|NCT02040779|580246647|FG000|Overall Study|Protocol Violation|2|||
160690512|NCT02040779|580246648|FG001|Overall Study|Protocol Violation|1|||
160690513|NCT02040779|580246649|FG002|Overall Study|Protocol Violation|0|||
160690514|NCT02040779|580246647|FG000|Overall Study|Lost to Follow-up|1|||
160690515|NCT02040779|580246648|FG001|Overall Study|Lost to Follow-up|2|||
160690516|NCT02040779|580246649|FG002|Overall Study|Lost to Follow-up|1|||
160690517|NCT02040779|580246647|FG000|Overall Study|Lack of Efficacy|4|||
160690518|NCT02040779|580246648|FG001|Overall Study|Lack of Efficacy|2|||
160690519|NCT02040779|580246649|FG002|Overall Study|Lack of Efficacy|0|||
160690520|NCT02132637|580246650|FG000|Study Period 1|Withdrawal by Subject|0|||
160690521|NCT02132637|580246651|FG001|Study Period 1|Withdrawal by Subject|4|||
160690522|NCT02132637|580246650|FG000|Study Period 1|Physician Decision|1|||
160690523|NCT02132637|580246651|FG001|Study Period 1|Physician Decision|0|||
160690524|NCT02132637|580246650|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
160690525|NCT02132637|580246651|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
160690526|NCT02132637|580246650|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
160690527|NCT02132637|580246651|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
160690528|NCT00922272|580246654|FG000|Open-label Phase|Adverse Event|5|||
160690529|NCT00922272|580246655|FG001|Open-label Phase|Adverse Event|0|||
160690530|NCT00922272|580246654|FG000|Open-label Phase|Protocol Violation|1|||
160690531|NCT00922272|580246655|FG001|Open-label Phase|Protocol Violation|0|||
160690532|NCT00922272|580246654|FG000|Open-label Phase|Withdrawal by Subject|11|||
160690533|NCT00922272|580246655|FG001|Open-label Phase|Withdrawal by Subject|0|||
160690534|NCT00922272|580246654|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
160690535|NCT00922272|580246655|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
160690536|NCT00922272|580246654|FG000|Open-label Phase|Withdrawal criteria met|5|||
160690537|NCT00922272|580246655|FG001|Open-label Phase|Withdrawal criteria met|0|||
160690538|NCT00922272|580246654|FG000|Double-blind Phase|Adverse Event|1|||
160690539|NCT00922272|580246655|FG001|Double-blind Phase|Adverse Event|1|||
160690540|NCT00922272|580246654|FG000|Double-blind Phase|Withdrawal by Subject|1|||
160690541|NCT00922272|580246655|FG001|Double-blind Phase|Withdrawal by Subject|1|||
160690542|NCT00922272|580246654|FG000|Double-blind Phase|Lost to Follow-up|2|||
160690543|NCT00922272|580246655|FG001|Double-blind Phase|Lost to Follow-up|1|||
160690544|NCT00922272|580246654|FG000|Double-blind Phase|Withdrawal criteria met|1|||
160690545|NCT00922272|580246655|FG001|Double-blind Phase|Withdrawal criteria met|1|||
160690546|NCT00922272|580246654|FG000|Double-blind Phase|Noncompliance|1|||
160690547|NCT00922272|580246655|FG001|Double-blind Phase|Noncompliance|1|||
160690548|NCT00922272|580246654|FG000|Double-blind Phase|Positive urine drug screen|1|||
160690549|NCT00922272|580246655|FG001|Double-blind Phase|Positive urine drug screen|1|||
160690550|NCT03197558|580246662|FG000|Overall Study|Tubes not placed|1|||
160690551|NCT01304693|580246671|FG000|Overall Study|Adverse Event|0|||
160690552|NCT01304693|580246672|FG001|Overall Study|Adverse Event|0|||
160690553|NCT01304693|580246673|FG002|Overall Study|Adverse Event|0|||
160690554|NCT01304693|580246674|FG003|Overall Study|Adverse Event|0|||
160690555|NCT01304693|580246675|FG004|Overall Study|Adverse Event|1|||
160690556|NCT01304693|580246671|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
160690557|NCT01304693|580246672|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
160690558|NCT01304693|580246673|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
160690559|NCT01304693|580246674|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
160690560|NCT01304693|580246675|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
160690561|NCT02581163|580246676|FG000|Overall Study|Failure to return|15|||
160690562|NCT02581163|580246676|FG000|Overall Study|Insufficient virological response|3|||
160690563|NCT02581163|580246676|FG000|Overall Study|Withdrew consent|1|||
160690564|NCT02581163|580246676|FG000|Overall Study|Death|1|||
160690565|NCT02581163|580246676|FG000|Overall Study|Other, not specified|9|||
160690566|NCT00931268|580246677|FG000|Overall Study|Lost to Follow-up|6|||
160690567|NCT02072148|580246683|FG000|Overall Study|withdrew prior to surgery|23|||
160690568|NCT02072148|580246684|FG001|Overall Study|withdrew prior to surgery|0|||
160690569|NCT02072148|580246685|FG002|Overall Study|withdrew prior to surgery|0|||
160690570|NCT02072148|580246683|FG000|Overall Study|Death|0|||
160690571|NCT02072148|580246684|FG001|Overall Study|Death|0|||
160690572|NCT02072148|580246685|FG002|Overall Study|Death|1|||
160690573|NCT02072148|580246683|FG000|Overall Study|Withdrawal by Subject|0|||
160690574|NCT02072148|580246684|FG001|Overall Study|Withdrawal by Subject|13|||
160690575|NCT02072148|580246685|FG002|Overall Study|Withdrawal by Subject|12|||
160690576|NCT03656874|580246688|FG000|Overall Study|Lost to Follow-up|3|||
160690577|NCT03656874|580246689|FG001|Overall Study|Lost to Follow-up|17|||
160690578|NCT01206816|580246690|FG000|Overall Study|Protocol Violation|0|||
160690579|NCT01206816|580246691|FG001|Overall Study|Protocol Violation|0|||
160690580|NCT01206816|580246692|FG002|Overall Study|Protocol Violation|1|||
160690581|NCT01206816|580246693|FG003|Overall Study|Protocol Violation|0|||
160690582|NCT01206816|580246694|FG004|Overall Study|Protocol Violation|0|||
160690583|NCT01206816|580246695|FG005|Overall Study|Protocol Violation|0|||
160690584|NCT01206816|580246696|FG006|Overall Study|Protocol Violation|0|||
160690585|NCT01206816|580246690|FG000|Overall Study|Withdrawal by Subject|0|||
160690586|NCT01206816|580246691|FG001|Overall Study|Withdrawal by Subject|0|||
160690587|NCT01206816|580246692|FG002|Overall Study|Withdrawal by Subject|1|||
160690588|NCT01206816|580246693|FG003|Overall Study|Withdrawal by Subject|0|||
160690589|NCT01206816|580246694|FG004|Overall Study|Withdrawal by Subject|0|||
160690590|NCT01206816|580246695|FG005|Overall Study|Withdrawal by Subject|0|||
160690591|NCT01206816|580246696|FG006|Overall Study|Withdrawal by Subject|0|||
160690592|NCT01206816|580246690|FG000|Overall Study|Progressive disease|3|||
160690593|NCT01206816|580246691|FG001|Overall Study|Progressive disease|3|||
160690594|NCT01206816|580246692|FG002|Overall Study|Progressive disease|13|||
160690595|NCT01206816|580246693|FG003|Overall Study|Progressive disease|3|||
160690596|NCT01206816|580246694|FG004|Overall Study|Progressive disease|3|||
160690597|NCT01206816|580246695|FG005|Overall Study|Progressive disease|16|||
160690598|NCT01206816|580246696|FG006|Overall Study|Progressive disease|3|||
160690599|NCT01206816|580246690|FG000|Overall Study|Other AE|0|||
160690600|NCT01206816|580246691|FG001|Overall Study|Other AE|0|||
160690601|NCT01206816|580246692|FG002|Overall Study|Other AE|4|||
160690602|NCT01206816|580246693|FG003|Overall Study|Other AE|0|||
160690603|NCT01206816|580246694|FG004|Overall Study|Other AE|0|||
160690604|NCT01206816|580246695|FG005|Overall Study|Other AE|3|||
160690605|NCT01206816|580246696|FG006|Overall Study|Other AE|2|||
160690606|NCT01206816|580246690|FG000|Overall Study|other than stated above|0|||
160690607|NCT01206816|580246691|FG001|Overall Study|other than stated above|0|||
160690608|NCT01206816|580246692|FG002|Overall Study|other than stated above|1|||
160690609|NCT01206816|580246693|FG003|Overall Study|other than stated above|0|||
160690610|NCT01206816|580246694|FG004|Overall Study|other than stated above|0|||
160690611|NCT01206816|580246695|FG005|Overall Study|other than stated above|0|||
160690612|NCT01206816|580246696|FG006|Overall Study|other than stated above|1|||
160690613|NCT00506129|580246698|FG000|Overall Study|Disease Progression/Relapse|15|||
160690614|NCT00506129|580246698|FG000|Overall Study|Death|7|||
160690615|NCT01642914|580246699|FG000|Overall Study|Adverse Event|11|||
160690616|NCT01642914|580246700|FG001|Overall Study|Adverse Event|7|||
160690617|NCT01642914|580246701|FG002|Overall Study|Adverse Event|15|||
160690618|NCT01642914|580246699|FG000|Overall Study|Lack of Efficacy|9|||
160690619|NCT01642914|580246700|FG001|Overall Study|Lack of Efficacy|4|||
160690620|NCT01642914|580246701|FG002|Overall Study|Lack of Efficacy|2|||
160690621|NCT01642914|580246699|FG000|Overall Study|Protocol Violation|15|||
160690622|NCT01642914|580246700|FG001|Overall Study|Protocol Violation|13|||
160690623|NCT01642914|580246701|FG002|Overall Study|Protocol Violation|6|||
160690624|NCT01642914|580246699|FG000|Overall Study|Withdrawal by Subject|5|||
160690625|NCT01642914|580246700|FG001|Overall Study|Withdrawal by Subject|5|||
160690626|NCT01642914|580246701|FG002|Overall Study|Withdrawal by Subject|10|||
160690627|NCT01642914|580246699|FG000|Overall Study|Lost to Follow-up|5|||
160690628|NCT01642914|580246700|FG001|Overall Study|Lost to Follow-up|3|||
160690629|NCT01642914|580246701|FG002|Overall Study|Lost to Follow-up|7|||
160690630|NCT01642914|580246699|FG000|Overall Study|Other Reason|1|||
160690631|NCT01642914|580246700|FG001|Overall Study|Other Reason|0|||
160690632|NCT01642914|580246701|FG002|Overall Study|Other Reason|0|||
160690633|NCT02923674|580246702|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
160690634|NCT02923674|580246703|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
160690635|NCT02923674|580246704|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
160690636|NCT02923674|580246702|FG000|Overall Study|Lost to Follow-up|7|||
160690637|NCT02923674|580246703|FG001|Overall Study|Lost to Follow-up|12|||
160690638|NCT02923674|580246704|FG002|Overall Study|Lost to Follow-up|7|||
160690639|NCT02923674|580246702|FG000|Overall Study|Problem with intervention|2|||
160690640|NCT02923674|580246703|FG001|Overall Study|Problem with intervention|2|||
160690641|NCT02923674|580246704|FG002|Overall Study|Problem with intervention|1|||
160690642|NCT02923674|580246702|FG000|Overall Study|Adverse Event|3|||
160690643|NCT02923674|580246703|FG001|Overall Study|Adverse Event|1|||
160690644|NCT02923674|580246704|FG002|Overall Study|Adverse Event|1|||
160690645|NCT02923674|580246702|FG000|Overall Study|Withdrawal by Subject|2|||
160690646|NCT02923674|580246703|FG001|Overall Study|Withdrawal by Subject|2|||
160690647|NCT02923674|580246704|FG002|Overall Study|Withdrawal by Subject|2|||
160690648|NCT02712333|580246708|FG000|First Period|Withdrawal by Subject|3|||
160690649|NCT02712333|580246709|FG001|First Period|Withdrawal by Subject|2|||
160690650|NCT03463993|580246710|FG000|Overall Study|Lost to Follow-up|7|||
160690651|NCT03463993|580246711|FG001|Overall Study|Lost to Follow-up|8|||
160690652|NCT03463993|580246710|FG000|Overall Study|Withdrawal by Subject|2|||
160690653|NCT03463993|580246711|FG001|Overall Study|Withdrawal by Subject|0|||
160690654|NCT03463993|580246710|FG000|Overall Study|Protocol Violation|4|||
160690655|NCT03463993|580246711|FG001|Overall Study|Protocol Violation|1|||
160690656|NCT03463993|580246710|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
160690657|NCT03463993|580246711|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
160690658|NCT03463993|580246710|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
160690659|NCT03463993|580246711|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
160690660|NCT01231373|580246716|FG000|Overall Study|Withdrew consent prior to randomization|2|||
160690661|NCT01231373|580246717|FG001|Overall Study|Withdrew consent prior to randomization|1|||
160690662|NCT01231373|580246718|FG002|Overall Study|Withdrew consent prior to randomization|0|||
160690663|NCT01231373|580246719|FG003|Overall Study|Withdrew consent prior to randomization|0|||
160690664|NCT01231373|580246716|FG000|Overall Study|Lost to Follow-up|0|||
160690665|NCT01231373|580246717|FG001|Overall Study|Lost to Follow-up|0|||
160690666|NCT01231373|580246718|FG002|Overall Study|Lost to Follow-up|0|||
160690667|NCT01231373|580246719|FG003|Overall Study|Lost to Follow-up|1|||
160690668|NCT01231373|580246716|FG000|Overall Study|Withdrew Consent|1|||
160690669|NCT01231373|580246717|FG001|Overall Study|Withdrew Consent|0|||
160690670|NCT01231373|580246718|FG002|Overall Study|Withdrew Consent|0|||
160690671|NCT01231373|580246719|FG003|Overall Study|Withdrew Consent|0|||
160690672|NCT05444543|580246723|FG000|Overall Study|Withdrawal by Subject|1|||
160690673|NCT05444543|580246724|FG001|Overall Study|Withdrawal by Subject|0|||
160690674|NCT05444543|580246723|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
160690675|NCT05444543|580246724|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
160690676|NCT05444543|580246723|FG000|Overall Study|Adverse Event|0|||
160690677|NCT05444543|580246724|FG001|Overall Study|Adverse Event|1|||
160690678|NCT05444543|580246723|FG000|Overall Study|Family relocating at a distance from study site|0|||
160690679|NCT05444543|580246724|FG001|Overall Study|Family relocating at a distance from study site|1|||
160690680|NCT02408120|580246725|FG000|Overall Study|Withdrawal by Subject|0|||
160690681|NCT02408120|580246726|FG001|Overall Study|Withdrawal by Subject|1|||
160690682|NCT02408120|580246725|FG000|Overall Study|Treatment Refusal|1|||
160690683|NCT02408120|580246726|FG001|Overall Study|Treatment Refusal|0|||
160690684|NCT02408120|580246725|FG000|Overall Study|Received Steroids|1|||
160690685|NCT02408120|580246726|FG001|Overall Study|Received Steroids|1|||
160690686|NCT02408120|580246725|FG000|Overall Study|Discharged same day|1|||
160690687|NCT02408120|580246726|FG001|Overall Study|Discharged same day|1|||
160690688|NCT02408120|580246725|FG000|Overall Study|Did not receive insulin|1|||
160690689|NCT02408120|580246726|FG001|Overall Study|Did not receive insulin|2|||
160690690|NCT00977431|580246727|FG000|Overall Study|Other than listed|1|||
160690691|NCT00977431|580246728|FG001|Overall Study|Other than listed|0|||
160690692|NCT00977431|580246729|FG002|Overall Study|Other than listed|0|||
160690693|NCT00977431|580246730|FG003|Overall Study|Other than listed|0|||
160690694|NCT00977431|580246731|FG004|Overall Study|Other than listed|2|||
160690695|NCT00977431|580246727|FG000|Overall Study|Protocol Violation|0|||
160690696|NCT00977431|580246728|FG001|Overall Study|Protocol Violation|0|||
160690697|NCT00977431|580246729|FG002|Overall Study|Protocol Violation|1|||
160690698|NCT00977431|580246730|FG003|Overall Study|Protocol Violation|0|||
160690699|NCT00977431|580246731|FG004|Overall Study|Protocol Violation|0|||
160690700|NCT00977431|580246727|FG000|Overall Study|Adverse Event|3|||
160690701|NCT00977431|580246728|FG001|Overall Study|Adverse Event|0|||
160690702|NCT00977431|580246729|FG002|Overall Study|Adverse Event|4|||
160690703|NCT00977431|580246730|FG003|Overall Study|Adverse Event|0|||
160690704|NCT00977431|580246731|FG004|Overall Study|Adverse Event|6|||
160690705|NCT00977431|580246727|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
160690706|NCT00977431|580246728|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
160690707|NCT00977431|580246729|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
160690708|NCT00977431|580246730|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
160690709|NCT00977431|580246731|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
160690710|NCT00977431|580246727|FG000|Overall Study|Progressive disease|2|||
160690711|NCT00977431|580246728|FG001|Overall Study|Progressive disease|6|||
160690712|NCT00977431|580246729|FG002|Overall Study|Progressive disease|1|||
160690713|NCT00977431|580246730|FG003|Overall Study|Progressive disease|3|||
160690714|NCT00977431|580246731|FG004|Overall Study|Progressive disease|5|||
160690715|NCT00720226|580246739|FG000|Overall Study|Withdrawal by Subject|7|||
160690716|NCT00720226|580246740|FG001|Overall Study|Withdrawal by Subject|4|||
160690717|NCT00958126|580246741|FG000|Overall Study|Serious Adverse Event|0|||
160690718|NCT00958126|580246742|FG001|Overall Study|Serious Adverse Event|2|||
160690719|NCT00958126|580246743|FG002|Overall Study|Serious Adverse Event|0|||
160690720|NCT00958126|580246744|FG003|Overall Study|Serious Adverse Event|0|||
160690721|NCT00958126|580246745|FG004|Overall Study|Serious Adverse Event|0|||
160690722|NCT00958126|580246746|FG005|Overall Study|Serious Adverse Event|0|||
160690723|NCT00958126|580246747|FG006|Overall Study|Serious Adverse Event|1|||
160690724|NCT00958126|580246748|FG007|Overall Study|Serious Adverse Event|0|||
160690725|NCT00958126|580246741|FG000|Overall Study|Withdrawal by Subject|0|||
160690726|NCT00958126|580246742|FG001|Overall Study|Withdrawal by Subject|2|||
160690727|NCT00958126|580246743|FG002|Overall Study|Withdrawal by Subject|0|||
160690728|NCT00958126|580246744|FG003|Overall Study|Withdrawal by Subject|0|||
160690729|NCT00958126|580246745|FG004|Overall Study|Withdrawal by Subject|0|||
160690730|NCT00958126|580246746|FG005|Overall Study|Withdrawal by Subject|0|||
160690731|NCT00958126|580246747|FG006|Overall Study|Withdrawal by Subject|0|||
160690732|NCT00958126|580246748|FG007|Overall Study|Withdrawal by Subject|0|||
160690733|NCT00958126|580246741|FG000|Overall Study|Moved away from study area|0|||
160690734|NCT00958126|580246742|FG001|Overall Study|Moved away from study area|0|||
160690735|NCT00958126|580246743|FG002|Overall Study|Moved away from study area|1|||
160690736|NCT00958126|580246744|FG003|Overall Study|Moved away from study area|1|||
160690737|NCT00958126|580246745|FG004|Overall Study|Moved away from study area|0|||
160690738|NCT00958126|580246746|FG005|Overall Study|Moved away from study area|0|||
160690739|NCT00958126|580246747|FG006|Overall Study|Moved away from study area|0|||
160690740|NCT00958126|580246748|FG007|Overall Study|Moved away from study area|0|||
160690741|NCT00958126|580246741|FG000|Overall Study|Lost to Follow-up|1|||
160690742|NCT00958126|580246742|FG001|Overall Study|Lost to Follow-up|5|||
160690743|NCT00958126|580246743|FG002|Overall Study|Lost to Follow-up|9|||
160690744|NCT00958126|580246744|FG003|Overall Study|Lost to Follow-up|8|||
160690745|NCT00958126|580246745|FG004|Overall Study|Lost to Follow-up|0|||
160690746|NCT00958126|580246746|FG005|Overall Study|Lost to Follow-up|0|||
160690747|NCT00958126|580246747|FG006|Overall Study|Lost to Follow-up|0|||
160690748|NCT00958126|580246748|FG007|Overall Study|Lost to Follow-up|0|||
160690749|NCT00958126|580246741|FG000|Overall Study|Sponsor/Investigator decision|0|||
160690750|NCT00958126|580246742|FG001|Overall Study|Sponsor/Investigator decision|0|||
160690751|NCT00958126|580246743|FG002|Overall Study|Sponsor/Investigator decision|0|||
160690752|NCT00958126|580246744|FG003|Overall Study|Sponsor/Investigator decision|1|||
160690753|NCT00958126|580246745|FG004|Overall Study|Sponsor/Investigator decision|0|||
160690754|NCT00958126|580246746|FG005|Overall Study|Sponsor/Investigator decision|0|||
160690755|NCT00958126|580246747|FG006|Overall Study|Sponsor/Investigator decision|0|||
160690756|NCT00958126|580246748|FG007|Overall Study|Sponsor/Investigator decision|0|||
160690757|NCT00958126|580246741|FG000|Overall Study|Other Reason|0|||
160690758|NCT00958126|580246742|FG001|Overall Study|Other Reason|0|||
160690759|NCT00958126|580246743|FG002|Overall Study|Other Reason|0|||
160690760|NCT00958126|580246744|FG003|Overall Study|Other Reason|1|||
160690761|NCT00958126|580246745|FG004|Overall Study|Other Reason|0|||
160690762|NCT00958126|580246746|FG005|Overall Study|Other Reason|1|||
160690763|NCT00958126|580246747|FG006|Overall Study|Other Reason|0|||
160690764|NCT00958126|580246748|FG007|Overall Study|Other Reason|0|||
160690765|NCT00733369|580246749|FG000|Overall Study|Lost to Follow-up|2|||
160690766|NCT00733369|580246750|FG001|Overall Study|Lost to Follow-up|1|||
160690767|NCT00733369|580246749|FG000|Overall Study|Adverse Event|4|||
160690768|NCT00733369|580246750|FG001|Overall Study|Adverse Event|4|||
160690769|NCT00733369|580246749|FG000|Overall Study|Protocol Violation|4|||
160690770|NCT00733369|580246750|FG001|Overall Study|Protocol Violation|4|||
160690771|NCT03401073|580246751|FG000|Overall Study|Lost to Follow-up|1|||
160690772|NCT03401073|580246752|FG001|Overall Study|Lost to Follow-up|2|||
160690773|NCT01470612|580246755|FG000|Overall Study|Adverse Event|20|||
160690774|NCT01470612|580246756|FG001|Overall Study|Adverse Event|80|||
160690775|NCT01470612|580246755|FG000|Overall Study|Death|0|||
160690776|NCT01470612|580246756|FG001|Overall Study|Death|1|||
160690777|NCT01470612|580246755|FG000|Overall Study|Lack of Efficacy|20|||
160690778|NCT01470612|580246756|FG001|Overall Study|Lack of Efficacy|326|||
160690779|NCT01470612|580246755|FG000|Overall Study|Lost to Follow-up|2|||
160690780|NCT01470612|580246756|FG001|Overall Study|Lost to Follow-up|5|||
160690781|NCT01470612|580246755|FG000|Overall Study|Did not meet entrance criteria|0|||
160690782|NCT01470612|580246756|FG001|Overall Study|Did not meet entrance criteria|1|||
160690783|NCT01470612|580246755|FG000|Overall Study|Pregnancy|2|||
160690784|NCT01470612|580246756|FG001|Overall Study|Pregnancy|10|||
160690785|NCT01470612|580246755|FG000|Overall Study|Protocol Violation|2|||
160690786|NCT01470612|580246756|FG001|Overall Study|Protocol Violation|7|||
160690787|NCT01470612|580246755|FG000|Overall Study|Withdrawal by Subject|24|||
160690788|NCT01470612|580246756|FG001|Overall Study|Withdrawal by Subject|79|||
160690789|NCT01470612|580246755|FG000|Overall Study|Other|14|||
160690790|NCT01470612|580246756|FG001|Overall Study|Other|156|||
160690791|NCT03959527|580248250|FG000|Overall Study|Withdrawal by Subject|8|||
160690792|NCT03959527|580248251|FG001|Overall Study|Withdrawal by Subject|3|||
160690793|NCT03959527|580248250|FG000|Overall Study|Lost to Follow-up|31|||
160690794|NCT03959527|580248251|FG001|Overall Study|Lost to Follow-up|15|||
160690795|NCT03959527|580248250|FG000|Overall Study|Did not meet eligibility criteria|1|||
160690796|NCT03959527|580248251|FG001|Overall Study|Did not meet eligibility criteria|1|||
160690797|NCT03959527|580248250|FG000|Overall Study|Protocol Violation|10|||
160690798|NCT03959527|580248251|FG001|Overall Study|Protocol Violation|5|||
160690799|NCT06029959|580248252|FG000|Overall Study|Physician Decision|6|||
160690800|NCT02960893|580248258|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
160690801|NCT02960893|580248259|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
160690802|NCT02960893|580248260|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
160690803|NCT02960893|580248261|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
160690804|NCT02960893|580248258|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
160690805|NCT02960893|580248259|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
160690806|NCT02960893|580248260|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
160690807|NCT02960893|580248261|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
160690808|NCT02960893|580248258|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
160690809|NCT02960893|580248259|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
160690810|NCT02960893|580248260|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
160690811|NCT02960893|580248261|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
160690812|NCT02960893|580248258|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
160690813|NCT02960893|580248259|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
160690814|NCT02960893|580248260|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
160690815|NCT02960893|580248261|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
160690816|NCT02960893|580248258|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
160690817|NCT02960893|580248259|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
160690818|NCT02960893|580248260|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
160690819|NCT02960893|580248261|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
160690820|NCT02960893|580248258|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
160690821|NCT02960893|580248259|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
160690822|NCT02960893|580248260|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
160690823|NCT02960893|580248261|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
160690824|NCT02960893|580248258|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
160690825|NCT02960893|580248259|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
160690826|NCT02960893|580248260|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
160690827|NCT02960893|580248261|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
160690828|NCT02960893|580248258|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
160690829|NCT02960893|580248259|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
160690830|NCT02960893|580248260|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
160690831|NCT02960893|580248261|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
160690832|NCT02960893|580248258|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
160690833|NCT02960893|580248259|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
160690834|NCT02960893|580248260|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
160690835|NCT02960893|580248261|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
160690836|NCT02960893|580248258|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
160690837|NCT02960893|580248259|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
160690838|NCT02960893|580248260|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
160690839|NCT02960893|580248261|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
160690840|NCT02631876|580248264|FG000|Overall Study|Death|96|||
160690841|NCT02631876|580248265|FG001|Overall Study|Death|50|||
160690842|NCT02631876|580248264|FG000|Overall Study|Investigator's discretion|1|||
160690843|NCT02631876|580248265|FG001|Overall Study|Investigator's discretion|0|||
160690844|NCT02631876|580248264|FG000|Overall Study|Lost to Follow-up|2|||
160690845|NCT02631876|580248265|FG001|Overall Study|Lost to Follow-up|0|||
160690846|NCT02631876|580248264|FG000|Overall Study|Withdrawal by Subject|16|||
160690847|NCT02631876|580248265|FG001|Overall Study|Withdrawal by Subject|9|||
160690848|NCT02631876|580248264|FG000|Overall Study|Other than specified|4|||
160690849|NCT02631876|580248265|FG001|Overall Study|Other than specified|4|||
160690850|NCT04285567|580248266|FG000|Overall Study|Death|3|||
160690851|NCT04285567|580248267|FG001|Overall Study|Death|3|||
160690852|NCT04285567|580248266|FG000|Overall Study|Lost to Follow-up|1|||
160690853|NCT04285567|580248267|FG001|Overall Study|Lost to Follow-up|1|||
160690854|NCT04285567|580248266|FG000|Overall Study|Reason Not Specified|1|||
160690855|NCT04285567|580248267|FG001|Overall Study|Reason Not Specified|1|||
160690856|NCT04285567|580248266|FG000|Overall Study|Physician Decision|2|||
160690857|NCT04285567|580248267|FG001|Overall Study|Physician Decision|1|||
160690858|NCT04285567|580248266|FG000|Overall Study|Withdrawal by Subject|2|||
160690859|NCT04285567|580248267|FG001|Overall Study|Withdrawal by Subject|6|||
160690860|NCT04285567|580248266|FG000|Overall Study|Adverse Event|1|||
160690861|NCT04285567|580248267|FG001|Overall Study|Adverse Event|0|||
160690862|NCT04285567|580248266|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
160690863|NCT04285567|580248267|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
160690864|NCT00493779|580248268|FG000|Overall Study|Logistical issue at site|1|||
160690865|NCT02091141|580248270|FG000|Overall Study|Death|280|||
160690866|NCT02091141|580248271|FG001|Overall Study|Death|118|||
160690867|NCT02091141|580248272|FG002|Overall Study|Death|46|||
160690868|NCT02091141|580248273|FG003|Overall Study|Death|13|||
160690869|NCT02091141|580248274|FG004|Overall Study|Death|31|||
160690870|NCT02091141|580248275|FG005|Overall Study|Death|16|||
160690871|NCT02091141|580248276|FG006|Overall Study|Death|12|||
160690872|NCT02091141|580248270|FG000|Overall Study|Withdrawal by Subject|21|||
160690873|NCT02091141|580248271|FG001|Overall Study|Withdrawal by Subject|13|||
160690874|NCT02091141|580248272|FG002|Overall Study|Withdrawal by Subject|3|||
160690875|NCT02091141|580248273|FG003|Overall Study|Withdrawal by Subject|2|||
160690876|NCT02091141|580248274|FG004|Overall Study|Withdrawal by Subject|2|||
160690877|NCT02091141|580248275|FG005|Overall Study|Withdrawal by Subject|3|||
160690878|NCT02091141|580248276|FG006|Overall Study|Withdrawal by Subject|0|||
160690879|NCT02091141|580248270|FG000|Overall Study|Lost to Follow-up|21|||
160690880|NCT02091141|580248271|FG001|Overall Study|Lost to Follow-up|5|||
160690881|NCT02091141|580248272|FG002|Overall Study|Lost to Follow-up|1|||
160690882|NCT02091141|580248273|FG003|Overall Study|Lost to Follow-up|0|||
160690883|NCT02091141|580248274|FG004|Overall Study|Lost to Follow-up|1|||
160690884|NCT02091141|580248275|FG005|Overall Study|Lost to Follow-up|2|||
160690885|NCT02091141|580248276|FG006|Overall Study|Lost to Follow-up|0|||
160690886|NCT02091141|580248270|FG000|Overall Study|Reason Not Specified|6|||
160690887|NCT02091141|580248271|FG001|Overall Study|Reason Not Specified|5|||
160690888|NCT02091141|580248272|FG002|Overall Study|Reason Not Specified|2|||
160690889|NCT02091141|580248273|FG003|Overall Study|Reason Not Specified|0|||
160690890|NCT02091141|580248274|FG004|Overall Study|Reason Not Specified|0|||
160690891|NCT02091141|580248275|FG005|Overall Study|Reason Not Specified|0|||
160690892|NCT02091141|580248276|FG006|Overall Study|Reason Not Specified|1|||
160690893|NCT02091141|580248270|FG000|Overall Study|Study Ended by Sponsor|1|||
160690894|NCT02091141|580248271|FG001|Overall Study|Study Ended by Sponsor|9|||
160690895|NCT02091141|580248272|FG002|Overall Study|Study Ended by Sponsor|0|||
160690896|NCT02091141|580248273|FG003|Overall Study|Study Ended by Sponsor|0|||
160690897|NCT02091141|580248274|FG004|Overall Study|Study Ended by Sponsor|0|||
160690898|NCT02091141|580248275|FG005|Overall Study|Study Ended by Sponsor|0|||
160690899|NCT02091141|580248276|FG006|Overall Study|Study Ended by Sponsor|0|||
160690900|NCT02091141|580248270|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
160690901|NCT02091141|580248271|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
160690902|NCT02091141|580248272|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
160690903|NCT02091141|580248273|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
160690904|NCT02091141|580248274|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
160690905|NCT02091141|580248275|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
160690906|NCT02091141|580248276|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
160690907|NCT02246439|580248277|FG000|Overall Study|Adverse Event|3|||
160690908|NCT02246439|580248278|FG001|Overall Study|Adverse Event|0|||
160690909|NCT02246439|580248277|FG000|Overall Study|Lost to Follow-up|7|||
160690910|NCT02246439|580248278|FG001|Overall Study|Lost to Follow-up|5|||
160690911|NCT02246439|580248277|FG000|Overall Study|Protocol Violation|0|||
160690912|NCT02246439|580248278|FG001|Overall Study|Protocol Violation|2|||
160690913|NCT02246439|580248277|FG000|Overall Study|Physician Decision|0|||
160690914|NCT02246439|580248278|FG001|Overall Study|Physician Decision|1|||
160690915|NCT02246439|580248277|FG000|Overall Study|Unkonwn|1|||
160690916|NCT02246439|580248278|FG001|Overall Study|Unkonwn|3|||
160690917|NCT02246439|580248277|FG000|Overall Study|Withdrawal by Subject|1|||
160690918|NCT02246439|580248278|FG001|Overall Study|Withdrawal by Subject|0|||
160690919|NCT03439852|580248281|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
160690920|NCT03439852|580248282|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
160690921|NCT03439852|580248281|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
160690922|NCT03439852|580248282|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
160690923|NCT03439852|580248281|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
160690924|NCT03439852|580248282|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
160690925|NCT04551911|580248283|FG000|Overall Study|Lost to Follow-up|2|||
160690926|NCT04551911|580248284|FG001|Overall Study|Lost to Follow-up|1|||
160690927|NCT04551911|580248283|FG000|Overall Study|Withdrawal by Subject|10|||
160690928|NCT04551911|580248284|FG001|Overall Study|Withdrawal by Subject|10|||
160690929|NCT04551911|580248283|FG000|Overall Study|Did not receive the study drug|3|||
160690930|NCT04551911|580248284|FG001|Overall Study|Did not receive the study drug|4|||
160690931|NCT00866658|580248295|FG000|Overall Study|Adverse Event|5|||
160690932|NCT00866658|580248296|FG001|Overall Study|Adverse Event|14|||
160690933|NCT00866658|580248295|FG000|Overall Study|Lack of Efficacy|2|||
160690934|NCT00866658|580248296|FG001|Overall Study|Lack of Efficacy|1|||
160690935|NCT00866658|580248295|FG000|Overall Study|Withdrawal by Subject|1|||
160690936|NCT00866658|580248296|FG001|Overall Study|Withdrawal by Subject|0|||
160690937|NCT00866658|580248295|FG000|Overall Study|Protocol Violation|1|||
160690938|NCT00866658|580248296|FG001|Overall Study|Protocol Violation|1|||
160690939|NCT00866658|580248295|FG000|Overall Study|Familial and Personal Reasons|4|||
160690940|NCT00866658|580248296|FG001|Overall Study|Familial and Personal Reasons|5|||
160690941|NCT00430495|580248298|FG000|Overall Study|Adverse Event|2|||
160690942|NCT00430495|580248299|FG001|Overall Study|Adverse Event|3|||
160690943|NCT00430495|580248300|FG002|Overall Study|Adverse Event|2|||
160690944|NCT00430495|580248301|FG003|Overall Study|Adverse Event|0|||
160690945|NCT00430495|580248298|FG000|Overall Study|Death|0|||
160690946|NCT00430495|580248299|FG001|Overall Study|Death|0|||
160690947|NCT00430495|580248300|FG002|Overall Study|Death|1|||
160690948|NCT00430495|580248301|FG003|Overall Study|Death|0|||
160690949|NCT00430495|580248298|FG000|Overall Study|Lost to Follow-up|0|||
160690950|NCT00430495|580248299|FG001|Overall Study|Lost to Follow-up|1|||
160690951|NCT00430495|580248300|FG002|Overall Study|Lost to Follow-up|4|||
160690952|NCT00430495|580248301|FG003|Overall Study|Lost to Follow-up|0|||
160690953|NCT00430495|580248298|FG000|Overall Study|Protocol Violation|1|||
160690954|NCT00430495|580248299|FG001|Overall Study|Protocol Violation|0|||
160690955|NCT00430495|580248300|FG002|Overall Study|Protocol Violation|1|||
160690956|NCT00430495|580248301|FG003|Overall Study|Protocol Violation|0|||
160690957|NCT00430495|580248298|FG000|Overall Study|Disease Progression|1|||
160690958|NCT00430495|580248299|FG001|Overall Study|Disease Progression|1|||
160690959|NCT00430495|580248300|FG002|Overall Study|Disease Progression|0|||
160690960|NCT00430495|580248301|FG003|Overall Study|Disease Progression|0|||
160690961|NCT00430495|580248298|FG000|Overall Study|Other|8|||
160690962|NCT00430495|580248299|FG001|Overall Study|Other|2|||
160690963|NCT00430495|580248300|FG002|Overall Study|Other|5|||
160690964|NCT00430495|580248301|FG003|Overall Study|Other|4|||
160690965|NCT00430495|580248298|FG000|Overall Study|Randomized but not Treated|2|||
160690966|NCT00430495|580248299|FG001|Overall Study|Randomized but not Treated|0|||
160690967|NCT00430495|580248300|FG002|Overall Study|Randomized but not Treated|0|||
160690968|NCT00430495|580248301|FG003|Overall Study|Randomized but not Treated|0|||
160690969|NCT00158756|580248302|FG000|Overall Study|Withdrawal by Subject|5|||
160690970|NCT00158756|580248303|FG001|Overall Study|Withdrawal by Subject|0|||
160690971|NCT00158756|580248304|FG002|Overall Study|Withdrawal by Subject|6|||
160690972|NCT00158756|580248305|FG003|Overall Study|Withdrawal by Subject|1|||
160690973|NCT00158756|580248306|FG004|Overall Study|Withdrawal by Subject|3|||
160690974|NCT00158756|580248302|FG000|Overall Study|Adverse Event|0|||
160690975|NCT00158756|580248303|FG001|Overall Study|Adverse Event|0|||
160690976|NCT00158756|580248304|FG002|Overall Study|Adverse Event|1|||
160690977|NCT00158756|580248305|FG003|Overall Study|Adverse Event|0|||
160690978|NCT00158756|580248306|FG004|Overall Study|Adverse Event|0|||
160690979|NCT00158756|580248302|FG000|Overall Study|Serious adverse event|0|||
160690980|NCT00158756|580248303|FG001|Overall Study|Serious adverse event|0|||
160690981|NCT00158756|580248304|FG002|Overall Study|Serious adverse event|1|||
160690982|NCT00158756|580248305|FG003|Overall Study|Serious adverse event|0|||
160690983|NCT00158756|580248306|FG004|Overall Study|Serious adverse event|0|||
160690984|NCT01421342|580248307|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
160690985|NCT01421342|580248308|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
160690986|NCT01421342|580248309|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
160690987|NCT01421342|580248307|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
160690988|NCT01421342|580248308|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
160690989|NCT01421342|580248309|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
160690990|NCT01421342|580248307|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
160690991|NCT01421342|580248308|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
160690992|NCT01421342|580248309|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
160690993|NCT01421342|580248307|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
160690994|NCT01421342|580248308|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
160690995|NCT01421342|580248309|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
160690996|NCT01421342|580248307|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
160690997|NCT01421342|580248308|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
160690998|NCT01421342|580248309|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
160690999|NCT01421342|580248307|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
160691000|NCT01421342|580248308|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
160691001|NCT01421342|580248309|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
160691002|NCT01421342|580248307|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
160691003|NCT01421342|580248308|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
160691004|NCT01421342|580248309|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
160691005|NCT01421342|580248307|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
160691006|NCT01421342|580248308|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
160691007|NCT01421342|580248309|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
160691008|NCT01421342|580248307|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
160691009|NCT01421342|580248308|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
160691010|NCT01421342|580248309|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
160691011|NCT01421342|580248307|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
160691012|NCT01421342|580248308|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
160691013|NCT01421342|580248309|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
160691014|NCT01421342|580248307|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
160691015|NCT01421342|580248308|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
160691016|NCT01421342|580248309|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
160691017|NCT01421342|580248307|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
160691018|NCT01421342|580248308|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
160691019|NCT01421342|580248309|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
160691020|NCT01421342|580248307|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
160691021|NCT01421342|580248308|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
160691022|NCT01421342|580248309|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
160691023|NCT01421342|580248307|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
160691024|NCT01421342|580248308|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
160691025|NCT01421342|580248309|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
160691026|NCT01421342|580248307|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
160691027|NCT01421342|580248308|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
160691028|NCT01421342|580248309|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
160691029|NCT01421342|580248307|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
160691030|NCT01421342|580248308|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
160691031|NCT01421342|580248309|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
160691032|NCT01421342|580248307|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
160691033|NCT01421342|580248308|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
160691034|NCT01421342|580248309|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
160691035|NCT01421342|580248307|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
160691036|NCT01421342|580248308|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
160691037|NCT01421342|580248309|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
160691038|NCT01421342|580248307|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
160691039|NCT01421342|580248308|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
160691040|NCT01421342|580248309|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
160691041|NCT01421342|580248307|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
160691042|NCT01421342|580248308|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
160691043|NCT01421342|580248309|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
160691044|NCT01421342|580248307|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
160691045|NCT01421342|580248308|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
160691046|NCT01421342|580248309|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
160691047|NCT01421342|580248307|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
160691048|NCT01421342|580248308|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
160691049|NCT01421342|580248309|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
160691050|NCT01421342|580248307|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
160691051|NCT01421342|580248308|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
160691052|NCT01421342|580248309|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
160691053|NCT01421342|580248307|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
160691054|NCT01421342|580248308|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
160691055|NCT01421342|580248309|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
160691056|NCT01421342|580248307|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
160691057|NCT01421342|580248308|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
160691058|NCT01421342|580248309|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
160691059|NCT01421342|580248307|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
160691060|NCT01421342|580248308|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
160691061|NCT01421342|580248309|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
160691062|NCT01421342|580248307|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
160691063|NCT01421342|580248308|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
160691064|NCT01421342|580248309|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
160691065|NCT01421342|580248307|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
160691066|NCT01421342|580248308|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
160691067|NCT01421342|580248309|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
160691068|NCT02528123|580248310|FG000|Overall Study|Lost to Follow-up|1|||
160691069|NCT01939496|580248311|FG000|Overall Study|Adverse Event|2|||
160691070|NCT01939496|580248312|FG001|Overall Study|Adverse Event|0|||
160691071|NCT01939496|580248313|FG002|Overall Study|Adverse Event|0|||
160691072|NCT01939496|580248311|FG000|Overall Study|Lost to Follow-up|1|||
160691073|NCT01939496|580248312|FG001|Overall Study|Lost to Follow-up|1|||
160691074|NCT01939496|580248313|FG002|Overall Study|Lost to Follow-up|0|||
160691075|NCT01939496|580248311|FG000|Overall Study|Physician Decision|1|||
160691076|NCT01939496|580248312|FG001|Overall Study|Physician Decision|0|||
160691077|NCT01939496|580248313|FG002|Overall Study|Physician Decision|0|||
160691078|NCT01939496|580248311|FG000|Overall Study|Protocol Violation|3|||
160691079|NCT01939496|580248312|FG001|Overall Study|Protocol Violation|0|||
160691080|NCT01939496|580248313|FG002|Overall Study|Protocol Violation|0|||
160691081|NCT01939496|580248311|FG000|Overall Study|Withdrawal by Subject|0|||
160691082|NCT01939496|580248312|FG001|Overall Study|Withdrawal by Subject|1|||
160691083|NCT01939496|580248313|FG002|Overall Study|Withdrawal by Subject|1|||
160691084|NCT01939496|580248311|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
160691085|NCT01939496|580248312|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
160691086|NCT01939496|580248313|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
160691087|NCT01939496|580248311|FG000|Overall Study|Other|2|||
160691088|NCT01939496|580248312|FG001|Overall Study|Other|0|||
160691089|NCT01939496|580248313|FG002|Overall Study|Other|1|||
160691090|NCT04505293|580248316|FG000|Overall Study|Lost to Follow-up|2|||
160691091|NCT04505293|580248316|FG000|Overall Study|Withdrawal by Subject|6|||
160691092|NCT04505293|580248316|FG000|Overall Study|CT scan unreadable|277|||
160691093|NCT04295135|580248317|FG000|Overall Study|Withdrawal by Subject|2|||
160691094|NCT04295135|580248318|FG001|Overall Study|Withdrawal by Subject|1|||
160691095|NCT04295135|580248317|FG000|Overall Study|Subject left organization|8|||
160691096|NCT04295135|580248318|FG001|Overall Study|Subject left organization|4|||
160691097|NCT01300052|580248321|FG000|Overall Study|Adverse Event|3|||
160691098|NCT01300052|580248322|FG001|Overall Study|Adverse Event|0|||
160691099|NCT01300052|580248321|FG000|Overall Study|Withdrawal by Subject|2|||
160691100|NCT01300052|580248322|FG001|Overall Study|Withdrawal by Subject|2|||
160691101|NCT01300052|580248321|FG000|Overall Study|Protocol Violation|1|||
160691102|NCT01300052|580248322|FG001|Overall Study|Protocol Violation|1|||
160691103|NCT01621191|580248324|FG000|Overall Study|Adverse Event|9|||
160691104|NCT01621191|580248324|FG000|Overall Study|Withdrawal by Subject|8|||
160691105|NCT01621191|580248324|FG000|Overall Study|Lack of Efficacy|6|||
160691106|NCT01621191|580248324|FG000|Overall Study|Lost to Follow-up|1|||
160691107|NCT01621191|580248324|FG000|Overall Study|Site Removed From Study|1|||
160691108|NCT04355663|580248326|FG000|Overall Study|Physician Decision|2|||
160691109|NCT04355663|580248327|FG001|Overall Study|Physician Decision|7|||
160691110|NCT04355663|580248328|FG002|Overall Study|Physician Decision|0|||
160691111|NCT04355663|580248326|FG000|Overall Study|Adverse Event|0|||
160691112|NCT04355663|580248327|FG001|Overall Study|Adverse Event|0|||
160691113|NCT04355663|580248328|FG002|Overall Study|Adverse Event|1|||
160691114|NCT04355663|580248326|FG000|Overall Study|Withdrawal by Subject|0|||
160691115|NCT04355663|580248327|FG001|Overall Study|Withdrawal by Subject|8|||
160691116|NCT04355663|580248328|FG002|Overall Study|Withdrawal by Subject|3|||
160691117|NCT02787408|580248334|FG000|Overall Study|Death|16|||
160691118|NCT02787408|580248334|FG000|Overall Study|Withdrawal by Subject|1|||
160691119|NCT02787408|580248334|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
160691120|NCT01782482|580248337|FG000|Overall Study|Adverse Event|2|||
160691121|NCT01782482|580248338|FG001|Overall Study|Adverse Event|1|||
160691122|NCT01782482|580248337|FG000|Overall Study|Lost to Follow-up|2|||
160691123|NCT01782482|580248338|FG001|Overall Study|Lost to Follow-up|3|||
160691124|NCT01782482|580248337|FG000|Overall Study|Physician Decision|1|||
160691125|NCT01782482|580248338|FG001|Overall Study|Physician Decision|0|||
160691126|NCT01782482|580248337|FG000|Overall Study|Protocol Violation|1|||
160691127|NCT01782482|580248338|FG001|Overall Study|Protocol Violation|0|||
160691128|NCT01782482|580248337|FG000|Overall Study|Withdrawal by Subject|2|||
160691129|NCT01782482|580248338|FG001|Overall Study|Withdrawal by Subject|3|||
160691130|NCT01782482|580248337|FG000|Overall Study|Randomized in Error|2|||
160691131|NCT01782482|580248338|FG001|Overall Study|Randomized in Error|2|||
160691132|NCT01782482|580248337|FG000|Overall Study|Habitually wearing toric lens OS|0|||
160691133|NCT01782482|580248338|FG001|Overall Study|Habitually wearing toric lens OS|1|||
160691134|NCT00767520|580248341|FG000|Overall Study|Participants still on treatment|11|||
160691135|NCT00767520|580248342|FG001|Overall Study|Participants still on treatment|15|||
160691136|NCT00767520|580248341|FG000|Overall Study|Randomized in error and Never treated|0|||
160691137|NCT00767520|580248342|FG001|Overall Study|Randomized in error and Never treated|2|||
160691138|NCT01901874|580248352|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
160691139|NCT01901874|580248352|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
160691140|NCT01901874|580248352|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
160691141|NCT01901874|580248352|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
160691142|NCT01901874|580248352|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
160691143|NCT01901874|580248352|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
160691144|NCT03078582|580248353|FG000|Overall Study|Adverse Event|0|||
160691145|NCT03078582|580248354|FG001|Overall Study|Adverse Event|8|||
160691146|NCT02039414|580248357|FG000|Overall Study|Delivered|1|||
160691147|NCT02039414|580248358|FG001|Overall Study|Delivered|1|||
160691148|NCT02039414|580248357|FG000|Overall Study|Lost to Follow-up|2|||
160691149|NCT02039414|580248358|FG001|Overall Study|Lost to Follow-up|0|||
160691150|NCT02039414|580248357|FG000|Overall Study|Protocol Violation|3|||
160691151|NCT02039414|580248358|FG001|Overall Study|Protocol Violation|1|||
160691152|NCT03977701|580248359|FG000|Overall Study|COVID-19 pandemic|0|||
160691153|NCT03977701|580248360|FG001|Overall Study|COVID-19 pandemic|0|||
160691154|NCT03977701|580248361|FG002|Overall Study|COVID-19 pandemic|0|||
160691155|NCT03977701|580248362|FG003|Overall Study|COVID-19 pandemic|0|||
160691156|NCT03977701|580248363|FG004|Overall Study|COVID-19 pandemic|0|||
160691157|NCT03977701|580248364|FG005|Overall Study|COVID-19 pandemic|1|||
160691158|NCT03977701|580248365|FG006|Overall Study|COVID-19 pandemic|0|||
160691159|NCT03977701|580248366|FG007|Overall Study|COVID-19 pandemic|1|||
160691160|NCT03977701|580248367|FG008|Overall Study|COVID-19 pandemic|0|||
160691161|NCT03977701|580248368|FG009|Overall Study|COVID-19 pandemic|0|||
160691162|NCT00430950|580248370|FG000|Overall Study|Adverse Event|7|||
160691163|NCT00430950|580248371|FG001|Overall Study|Adverse Event|6|||
160691164|NCT00430950|580248370|FG000|Overall Study|Withdrawal by Subject|1|||
160691165|NCT00430950|580248371|FG001|Overall Study|Withdrawal by Subject|0|||
160691166|NCT00430950|580248370|FG000|Overall Study|concomitant medication,etc.|5|||
160691167|NCT00430950|580248371|FG001|Overall Study|concomitant medication,etc.|7|||
160691168|NCT02429934|580248372|FG000|Overall Study|Withdrawal by Subject|0|||
160691169|NCT02429934|580248373|FG001|Overall Study|Withdrawal by Subject|2|||
160691170|NCT02429934|580248372|FG000|Overall Study|Adverse Event|2|||
160691171|NCT02429934|580248373|FG001|Overall Study|Adverse Event|0|||
160691172|NCT02429934|580248372|FG000|Overall Study|Lost to Follow-up|1|||
160691173|NCT02429934|580248373|FG001|Overall Study|Lost to Follow-up|1|||
160691174|NCT02429934|580248372|FG000|Overall Study|Physician Decision|1|||
160691175|NCT02429934|580248373|FG001|Overall Study|Physician Decision|0|||
160691176|NCT00869024|580248374|FG000|Overall Study|Death|2|||
160691177|NCT00869024|580248375|FG001|Overall Study|Death|3|||
160691178|NCT00869024|580248374|FG000|Overall Study|Lost to Follow-up|0|||
160691179|NCT00869024|580248375|FG001|Overall Study|Lost to Follow-up|1|||
160691180|NCT00869024|580248374|FG000|Overall Study|Protocol Violation|0|||
160691181|NCT00869024|580248375|FG001|Overall Study|Protocol Violation|1|||
160691182|NCT00293202|580248376|FG000|Overall Study|Withdrawal by Subject|1|||
160691183|NCT00293202|580248377|FG001|Overall Study|Withdrawal by Subject|2|||
160691184|NCT00293202|580248376|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
160691185|NCT00293202|580248377|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
160691186|NCT00293202|580248376|FG000|Overall Study|on-hold due to fistula maturation time|1|||
160691187|NCT00293202|580248377|FG001|Overall Study|on-hold due to fistula maturation time|0|||
160691188|NCT01564459|580248378|FG000|Run-In|Adverse Event|7|||
160691189|NCT01564459|580248379|FG001|Run-In|Adverse Event|0|||
160691190|NCT01564459|580248380|FG002|Run-In|Adverse Event|0|||
160691191|NCT01564459|580248378|FG000|Run-In|Lost to Follow-up|1|||
160691192|NCT01564459|580248379|FG001|Run-In|Lost to Follow-up|0|||
160691193|NCT01564459|580248380|FG002|Run-In|Lost to Follow-up|0|||
160691194|NCT01564459|580248378|FG000|Run-In|Non-compliance with study drug|2|||
160691195|NCT01564459|580248379|FG001|Run-In|Non-compliance with study drug|0|||
160691196|NCT01564459|580248380|FG002|Run-In|Non-compliance with study drug|0|||
160691197|NCT01564459|580248378|FG000|Run-In|Protocol Violation|1|||
160691198|NCT01564459|580248379|FG001|Run-In|Protocol Violation|0|||
160691199|NCT01564459|580248380|FG002|Run-In|Protocol Violation|0|||
160691200|NCT01564459|580248378|FG000|Run-In|Withdrawal by Subject|1|||
160691201|NCT01564459|580248379|FG001|Run-In|Withdrawal by Subject|0|||
160691202|NCT01564459|580248380|FG002|Run-In|Withdrawal by Subject|0|||
160691203|NCT01564459|580248378|FG000|Double-blind Treatment|Adverse Event|0|||
160691204|NCT01564459|580248379|FG001|Double-blind Treatment|Adverse Event|0|||
160691205|NCT01564459|580248380|FG002|Double-blind Treatment|Adverse Event|1|||
160691206|NCT00653991|580248386|FG000|3 Month Follow-up|Participant would not respond|150|||
160691207|NCT00653991|580248387|FG001|3 Month Follow-up|Participant would not respond|157|||
160691208|NCT00653991|580248386|FG000|6 Month Follow-up|Participant would not respond|133|||
160691209|NCT00653991|580248387|FG001|6 Month Follow-up|Participant would not respond|141|||
160691210|NCT00515034|580248390|FG000|Overall Study|Adverse Event|2|||
160691211|NCT00515034|580248391|FG001|Overall Study|Adverse Event|0|||
160691212|NCT00515034|580248392|FG002|Overall Study|Adverse Event|1|||
160691213|NCT00515034|580248393|FG003|Overall Study|Adverse Event|0|||
160691214|NCT00515034|580248390|FG000|Overall Study|Death|4|||
160691215|NCT00515034|580248391|FG001|Overall Study|Death|2|||
160691216|NCT00515034|580248392|FG002|Overall Study|Death|1|||
160691217|NCT00515034|580248393|FG003|Overall Study|Death|3|||
160691218|NCT00515034|580248390|FG000|Overall Study|Withdrawal by Subject|1|||
160691219|NCT00515034|580248391|FG001|Overall Study|Withdrawal by Subject|0|||
160691220|NCT00515034|580248392|FG002|Overall Study|Withdrawal by Subject|3|||
160691221|NCT00515034|580248393|FG003|Overall Study|Withdrawal by Subject|0|||
160691222|NCT00515034|580248390|FG000|Overall Study|Physician Decision|0|||
160691223|NCT00515034|580248391|FG001|Overall Study|Physician Decision|0|||
160691224|NCT00515034|580248392|FG002|Overall Study|Physician Decision|1|||
160691225|NCT00515034|580248393|FG003|Overall Study|Physician Decision|1|||
160691226|NCT00515034|580248390|FG000|Overall Study|Other|1|||
160691227|NCT00515034|580248391|FG001|Overall Study|Other|0|||
160691228|NCT00515034|580248392|FG002|Overall Study|Other|2|||
160691229|NCT00515034|580248393|FG003|Overall Study|Other|1|||
160691230|NCT00518622|580248396|FG000|Overall Study|Lost to Follow-up|0|||
160691231|NCT00518622|580248397|FG001|Overall Study|Lost to Follow-up|0|||
160691232|NCT00518622|580248398|FG002|Overall Study|Lost to Follow-up|1|||
160691233|NCT00518622|580248399|FG003|Overall Study|Lost to Follow-up|0|||
160691234|NCT00518622|580248400|FG004|Overall Study|Lost to Follow-up|0|||
160691235|NCT00518622|580248401|FG005|Overall Study|Lost to Follow-up|0|||
160691236|NCT00518622|580248402|FG006|Overall Study|Lost to Follow-up|0|||
160691237|NCT00518622|580248403|FG007|Overall Study|Lost to Follow-up|0|||
160691238|NCT00518622|580248396|FG000|Overall Study|Study medication taken incorrectly|0|||
160691239|NCT00518622|580248397|FG001|Overall Study|Study medication taken incorrectly|1|||
160691240|NCT00518622|580248398|FG002|Overall Study|Study medication taken incorrectly|0|||
160691241|NCT00518622|580248399|FG003|Overall Study|Study medication taken incorrectly|0|||
160691242|NCT00518622|580248400|FG004|Overall Study|Study medication taken incorrectly|0|||
160691243|NCT00518622|580248401|FG005|Overall Study|Study medication taken incorrectly|0|||
160691244|NCT00518622|580248402|FG006|Overall Study|Study medication taken incorrectly|0|||
160691245|NCT00518622|580248403|FG007|Overall Study|Study medication taken incorrectly|0|||
160691246|NCT03499119|580248404|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
160691247|NCT03499119|580248405|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
160691248|NCT03499119|580248406|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
160691249|NCT03499119|580248407|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
160691250|NCT03499119|580248404|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
160691251|NCT03499119|580248405|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
160691252|NCT03499119|580248406|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
160691253|NCT03499119|580248407|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
160691254|NCT03499119|580248404|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
160691255|NCT03499119|580248405|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
160691256|NCT03499119|580248406|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
160691257|NCT03499119|580248407|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
160691258|NCT03499119|580248404|FG000|Optional Extension Phase|Lost to Follow-up|0|||
160691259|NCT03499119|580248405|FG001|Optional Extension Phase|Lost to Follow-up|0|||
160691260|NCT03499119|580248406|FG002|Optional Extension Phase|Lost to Follow-up|0|||
160691261|NCT03499119|580248407|FG003|Optional Extension Phase|Lost to Follow-up|1|||
160691262|NCT03499119|580248404|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
160691263|NCT03499119|580248405|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
160691264|NCT03499119|580248406|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
160691265|NCT03499119|580248407|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
160691266|NCT03499119|580248404|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
160691267|NCT03499119|580248405|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
160691268|NCT03499119|580248406|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
160691269|NCT03499119|580248407|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
160691270|NCT01558297|580248408|FG000|Overall Study|Withdrawal by Subject|2|||
160691271|NCT01558297|580248409|FG001|Overall Study|Withdrawal by Subject|2|||
160691272|NCT01558297|580248410|FG002|Overall Study|Withdrawal by Subject|1|||
160691273|NCT02655016|580248411|FG000|Overall Study|Disease progression|6|||
160691274|NCT02655016|580248412|FG001|Overall Study|Disease progression|4|||
160691275|NCT02655016|580248411|FG000|Overall Study|Site closed|0|||
160691276|NCT02655016|580248412|FG001|Overall Study|Site closed|1|||
160691277|NCT02655016|580248411|FG000|Overall Study|Death|30|||
160691278|NCT02655016|580248412|FG001|Overall Study|Death|48|||
160691279|NCT02655016|580248411|FG000|Overall Study|Lost to Follow-up|1|||
160691280|NCT02655016|580248412|FG001|Overall Study|Lost to Follow-up|1|||
160691281|NCT02655016|580248411|FG000|Overall Study|Withdrawal by Subject|18|||
160691282|NCT02655016|580248412|FG001|Overall Study|Withdrawal by Subject|36|||
160691283|NCT04189445|580250821|FG000|Overall Study|Withdrawal of consent|8|||
160691284|NCT04189445|580250822|FG001|Overall Study|Withdrawal of consent|1|||
160691285|NCT04189445|580250823|FG002|Overall Study|Withdrawal of consent|0|||
160691286|NCT04189445|580250821|FG000|Overall Study|Study Terminated by Sponsor|25|||
160691287|NCT04189445|580250822|FG001|Overall Study|Study Terminated by Sponsor|3|||
160691288|NCT04189445|580250823|FG002|Overall Study|Study Terminated by Sponsor|0|||
160691289|NCT04189445|580250821|FG000|Overall Study|Death|54|||
160691290|NCT04189445|580250822|FG001|Overall Study|Death|24|||
160691291|NCT04189445|580250823|FG002|Overall Study|Death|0|||
160691292|NCT00003138|580250824|FG000|Step 1|Reasons off treatment not documented|60|||
160691293|NCT00003138|580250825|FG001|Step 1|Reasons off treatment not documented|57|||
160691294|NCT00003138|580250824|FG000|Step 1|Never started treatment|1|||
160691295|NCT00003138|580250825|FG001|Step 1|Never started treatment|0|||
160691296|NCT00003138|580250824|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
160691297|NCT00003138|580250825|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
160691298|NCT00003138|580250824|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
160691299|NCT00003138|580250825|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
160691300|NCT00003138|580250824|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
160691301|NCT00003138|580250825|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
160691302|NCT00003138|580250824|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
160691303|NCT00003138|580250825|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
160691304|NCT02522403|580250826|FG000|Overall Study|Lost to Follow-up|2|||
160691305|NCT02522403|580250827|FG001|Overall Study|Lost to Follow-up|2|||
160691306|NCT02522403|580250826|FG000|Overall Study|Withdrawal by Subject|2|||
160691307|NCT02522403|580250827|FG001|Overall Study|Withdrawal by Subject|4|||
160691308|NCT05142566|580250828|FG000|Overall Study|Protocol Violation|1|||
160691309|NCT04556552|580250829|FG000|Overall Study|Lost to Follow-up|1|||
160691310|NCT04556552|580250830|FG001|Overall Study|Lost to Follow-up|0|||
160691311|NCT04556552|580250829|FG000|Overall Study|Claustrophobia|0|||
160691312|NCT04556552|580250830|FG001|Overall Study|Claustrophobia|1|||
160691313|NCT04556552|580250829|FG000|Overall Study|Inability to continue|0|||
160691314|NCT04556552|580250830|FG001|Overall Study|Inability to continue|1|||
160691315|NCT01553279|580250831|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
160691316|NCT01553279|580250832|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
160691317|NCT01553279|580250831|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
160691318|NCT01553279|580250832|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
160691319|NCT01553279|580250831|FG000|Interim Period|Withdrawal by Subject|2|||
160691320|NCT01553279|580250832|FG001|Interim Period|Withdrawal by Subject|2|||
160691321|NCT01553279|580250831|FG000|Interim Period|Lost to Follow-up|1|||
160691322|NCT01553279|580250832|FG001|Interim Period|Lost to Follow-up|0|||
160691323|NCT01553279|580250831|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
160691324|NCT01553279|580250832|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
160691325|NCT01553279|580250831|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
160691326|NCT01553279|580250832|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
160691327|NCT00605865|580250833|FG000|Overall Study|Protocol Violation|115|||
160691328|NCT02856880|580250839|FG000|Overall Study|Withdrawal of consent|1|||
160691329|NCT00094458|580250840|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
160691330|NCT00094458|580250841|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
160691331|NCT00094458|580250842|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
160691332|NCT00094458|580250843|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
160691333|NCT00094458|580250844|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
160691334|NCT00094458|580250845|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
160691335|NCT00094458|580250840|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
160691336|NCT00094458|580250841|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
160691337|NCT00094458|580250842|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
160691338|NCT00094458|580250843|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
160691339|NCT00094458|580250844|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
160691340|NCT00094458|580250845|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
160691341|NCT00094458|580250840|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
160691342|NCT00094458|580250841|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
160691343|NCT00094458|580250842|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
160691344|NCT00094458|580250843|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
160691345|NCT00094458|580250844|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
160691346|NCT00094458|580250845|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
160691347|NCT00094458|580250840|FG000|Main Study: Through Week 30|Adverse Event|38|||
160691348|NCT00094458|580250841|FG001|Main Study: Through Week 30|Adverse Event|20|||
160691349|NCT00094458|580250842|FG002|Main Study: Through Week 30|Adverse Event|28|||
160691350|NCT00094458|580250843|FG003|Main Study: Through Week 30|Adverse Event|0|||
160691351|NCT00094458|580250844|FG004|Main Study: Through Week 30|Adverse Event|0|||
160691352|NCT00094458|580250845|FG005|Main Study: Through Week 30|Adverse Event|0|||
160691353|NCT00094458|580250840|FG000|Main Study: Through Week 30|Death|1|||
160691354|NCT00094458|580250841|FG001|Main Study: Through Week 30|Death|0|||
160691355|NCT00094458|580250842|FG002|Main Study: Through Week 30|Death|0|||
160691356|NCT00094458|580250843|FG003|Main Study: Through Week 30|Death|0|||
160691357|NCT00094458|580250844|FG004|Main Study: Through Week 30|Death|0|||
160691358|NCT00094458|580250845|FG005|Main Study: Through Week 30|Death|0|||
160691359|NCT00094458|580250840|FG000|Main Study: Through Week 30|Other|19|||
160691360|NCT00094458|580250841|FG001|Main Study: Through Week 30|Other|16|||
160691361|NCT00094458|580250842|FG002|Main Study: Through Week 30|Other|9|||
160691362|NCT00094458|580250843|FG003|Main Study: Through Week 30|Other|0|||
160691363|NCT00094458|580250844|FG004|Main Study: Through Week 30|Other|0|||
160691364|NCT00094458|580250845|FG005|Main Study: Through Week 30|Other|0|||
160691365|NCT00094458|580250840|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
160691366|NCT00094458|580250841|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
160691367|NCT00094458|580250842|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
160691368|NCT00094458|580250843|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
160691369|NCT00094458|580250844|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
160691370|NCT00094458|580250845|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
160691371|NCT00094458|580250840|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
160691372|NCT00094458|580250841|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
160691373|NCT00094458|580250842|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
160691374|NCT00094458|580250843|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
160691375|NCT00094458|580250844|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
160691376|NCT00094458|580250845|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
160691377|NCT00094458|580250840|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
160691378|NCT00094458|580250841|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
160691379|NCT00094458|580250842|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
160691380|NCT00094458|580250843|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
160691381|NCT00094458|580250844|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
160691382|NCT00094458|580250845|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
160691383|NCT00094458|580250840|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
160691384|NCT00094458|580250841|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
160691385|NCT00094458|580250842|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
160691386|NCT00094458|580250843|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
160691387|NCT00094458|580250844|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
160691388|NCT00094458|580250845|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
160691389|NCT00094458|580250840|FG000|OLE: Open-Label Extension|Adverse Event|0|||
160691390|NCT00094458|580250841|FG001|OLE: Open-Label Extension|Adverse Event|0|||
160691391|NCT00094458|580250842|FG002|OLE: Open-Label Extension|Adverse Event|0|||
160691392|NCT00094458|580250843|FG003|OLE: Open-Label Extension|Adverse Event|0|||
160691393|NCT00094458|580250844|FG004|OLE: Open-Label Extension|Adverse Event|3|||
160691394|NCT00094458|580250845|FG005|OLE: Open-Label Extension|Adverse Event|4|||
160691395|NCT00094458|580250840|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
160691396|NCT00094458|580250841|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
160691397|NCT00094458|580250842|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
160691398|NCT00094458|580250843|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
160691399|NCT00094458|580250844|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
160691400|NCT00094458|580250845|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
160691401|NCT00094458|580250840|FG000|OLE: Open-Label Extension|Patient decision|0|||
160691402|NCT00094458|580250841|FG001|OLE: Open-Label Extension|Patient decision|0|||
160691403|NCT00094458|580250842|FG002|OLE: Open-Label Extension|Patient decision|0|||
160691404|NCT00094458|580250843|FG003|OLE: Open-Label Extension|Patient decision|0|||
160691405|NCT00094458|580250844|FG004|OLE: Open-Label Extension|Patient decision|1|||
160691406|NCT00094458|580250845|FG005|OLE: Open-Label Extension|Patient decision|0|||
160691407|NCT03247517|580250846|FG000|Overall Study|Adverse Event|0|||
160691408|NCT03247517|580250847|FG001|Overall Study|Adverse Event|4|||
160691409|NCT03247517|580250848|FG002|Overall Study|Adverse Event|2|||
160691410|NCT03247517|580250846|FG000|Overall Study|Lost to Follow-up|2|||
160691411|NCT03247517|580250847|FG001|Overall Study|Lost to Follow-up|6|||
160691412|NCT03247517|580250848|FG002|Overall Study|Lost to Follow-up|4|||
160691413|NCT03247517|580250846|FG000|Overall Study|Consent withdrawn by caregiver|1|||
160691414|NCT03247517|580250847|FG001|Overall Study|Consent withdrawn by caregiver|4|||
160691415|NCT03247517|580250848|FG002|Overall Study|Consent withdrawn by caregiver|7|||
160691416|NCT03247517|580250846|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
160691417|NCT03247517|580250847|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
160691418|NCT03247517|580250848|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
160691419|NCT03247517|580250846|FG000|Overall Study|Protocol Violation|0|||
160691420|NCT03247517|580250847|FG001|Overall Study|Protocol Violation|2|||
160691421|NCT03247517|580250848|FG002|Overall Study|Protocol Violation|0|||
160691422|NCT03247517|580250846|FG000|Overall Study|Multiple reasons|3|||
160691423|NCT03247517|580250847|FG001|Overall Study|Multiple reasons|1|||
160691424|NCT03247517|580250848|FG002|Overall Study|Multiple reasons|0|||
160691425|NCT03310411|580250849|FG000|Period 1|Adverse Event|0|||
160691426|NCT03310411|580250850|FG001|Period 1|Adverse Event|0|||
160691427|NCT03310411|580250851|FG002|Period 1|Adverse Event|0|||
160691428|NCT03310411|580250852|FG003|Period 1|Adverse Event|1|||
160691429|NCT00619112|580250853|FG000|Overall Study|Adverse Event|1|||
160691430|NCT00619112|580250854|FG001|Overall Study|Adverse Event|2|||
160691431|NCT00729248|580250855|FG000|Overall Study|Physician Decision|2|||
160691432|NCT02145026|580250856|FG000|Overall Study|Adverse Event|2|||
160691433|NCT02145026|580250856|FG000|Overall Study|Death|4|||
160691434|NCT02145026|580250856|FG000|Overall Study|Withdrawal by Subject|2|||
160691435|NCT02145026|580250856|FG000|Overall Study|Physician Decision|4|||
160691436|NCT03052322|580250857|FG000|Overall Study|Other un-specified|1|||
160691437|NCT03052322|580250858|FG001|Overall Study|Other un-specified|2|||
160691438|NCT03052322|580250857|FG000|Overall Study|Withdrawal by Subject|10|||
160691439|NCT03052322|580250858|FG001|Overall Study|Withdrawal by Subject|9|||
160691440|NCT03052322|580250857|FG000|Overall Study|Death|0|||
160691441|NCT03052322|580250858|FG001|Overall Study|Death|2|||
160691442|NCT03052322|580250857|FG000|Overall Study|Lack of Efficacy|1|||
160691443|NCT03052322|580250858|FG001|Overall Study|Lack of Efficacy|2|||
160691444|NCT03052322|580250857|FG000|Overall Study|Protocol Violation|1|||
160691445|NCT03052322|580250858|FG001|Overall Study|Protocol Violation|0|||
160691446|NCT03052322|580250857|FG000|Overall Study|Lost to Follow-up|2|||
160691447|NCT03052322|580250858|FG001|Overall Study|Lost to Follow-up|4|||
160691448|NCT03052322|580250857|FG000|Overall Study|Adverse Event|6|||
160691449|NCT03052322|580250858|FG001|Overall Study|Adverse Event|13|||
160691450|NCT01546649|580250859|FG000|Overall Study|Adverse Event|4|||
160691451|NCT01546649|580250860|FG001|Overall Study|Adverse Event|5|||
160691452|NCT01546649|580250859|FG000|Overall Study|Protocol Violation|1|||
160691453|NCT01546649|580250860|FG001|Overall Study|Protocol Violation|0|||
160691454|NCT01546649|580250859|FG000|Overall Study|Lack of Efficacy|1|||
160691455|NCT01546649|580250860|FG001|Overall Study|Lack of Efficacy|0|||
160691456|NCT01546649|580250859|FG000|Overall Study|Recurrence|1|||
160691457|NCT01546649|580250860|FG001|Overall Study|Recurrence|1|||
160691458|NCT01546649|580250859|FG000|Overall Study|Discovery of secondary cancer|0|||
160691459|NCT01546649|580250860|FG001|Overall Study|Discovery of secondary cancer|1|||
160691460|NCT01546649|580250859|FG000|Overall Study|Withdrawal by Subject|1|||
160691461|NCT01546649|580250860|FG001|Overall Study|Withdrawal by Subject|2|||
160691462|NCT00706381|580250863|FG000|Overall Study|Lost to Follow-up|0|||
160691463|NCT00706381|580250864|FG001|Overall Study|Lost to Follow-up|1|||
160691464|NCT00706381|580250865|FG002|Overall Study|Lost to Follow-up|1|||
160691465|NCT00706381|580250866|FG003|Overall Study|Lost to Follow-up|0|||
160691466|NCT05420012|580250867|FG000|Overall Study|Lost to Follow-up|0|||
160691467|NCT05420012|580250868|FG001|Overall Study|Lost to Follow-up|1|||
160691468|NCT00700817|580250877|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
160691469|NCT00700817|580250878|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
160691470|NCT00700817|580250879|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
160691471|NCT00700817|580250880|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
160691472|NCT00700817|580250881|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
160691473|NCT00700817|580250877|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
160691474|NCT00700817|580250878|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
160691475|NCT00700817|580250879|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
160691476|NCT00700817|580250880|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
160691477|NCT00700817|580250881|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
160691478|NCT00700817|580250877|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
160691479|NCT00700817|580250878|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
160691480|NCT00700817|580250879|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
160691481|NCT00700817|580250880|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
160691482|NCT00700817|580250881|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
160691483|NCT00700817|580250877|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
160691484|NCT00700817|580250878|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
160691485|NCT00700817|580250879|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
160691486|NCT00700817|580250880|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
160691487|NCT00700817|580250881|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
160691488|NCT00700817|580250877|FG000|Week 0-26 (Main Period)|Unclassified|14|||
160691489|NCT00700817|580250878|FG001|Week 0-26 (Main Period)|Unclassified|4|||
160691490|NCT00700817|580250879|FG002|Week 0-26 (Main Period)|Unclassified|8|||
160691491|NCT00700817|580250880|FG003|Week 0-26 (Main Period)|Unclassified|0|||
160691492|NCT00700817|580250881|FG004|Week 0-26 (Main Period)|Unclassified|0|||
160691493|NCT00700817|580250877|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
160691494|NCT00700817|580250878|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
160691495|NCT00700817|580250879|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
160691496|NCT00700817|580250880|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
160691497|NCT00700817|580250881|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
160691498|NCT00700817|580250877|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
160691499|NCT00700817|580250878|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
160691500|NCT00700817|580250879|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
160691501|NCT00700817|580250880|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
160691502|NCT00700817|580250881|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
160691503|NCT00700817|580250877|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
160691504|NCT00700817|580250878|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
160691505|NCT00700817|580250879|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
160691506|NCT00700817|580250880|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
160691507|NCT00700817|580250881|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
160691508|NCT00700817|580250877|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
160691509|NCT00700817|580250878|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
160691510|NCT00700817|580250879|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
160691511|NCT00700817|580250880|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
160691512|NCT00700817|580250881|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
160691513|NCT00700817|580250877|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
160691514|NCT00700817|580250878|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
160691515|NCT00700817|580250879|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
160691516|NCT00700817|580250880|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
160691517|NCT00700817|580250881|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
160691518|NCT00700817|580250877|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
160691519|NCT00700817|580250878|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
160691520|NCT00700817|580250879|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
160691521|NCT00700817|580250880|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
160691522|NCT00700817|580250881|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
160691523|NCT00700817|580250877|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
160691524|NCT00700817|580250878|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
160691525|NCT00700817|580250879|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
160691526|NCT00700817|580250880|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
160691527|NCT00700817|580250881|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
160691528|NCT00700817|580250877|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
160691529|NCT00700817|580250878|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
160691530|NCT00700817|580250879|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
160691531|NCT00700817|580250880|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
160691532|NCT00700817|580250881|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
160691533|NCT00700817|580250877|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
160691534|NCT00700817|580250878|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
160691535|NCT00700817|580250879|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
160691536|NCT00700817|580250880|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
160691537|NCT00700817|580250881|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
160691538|NCT00700817|580250877|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
160691539|NCT00700817|580250878|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
160691540|NCT00700817|580250879|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
160691541|NCT00700817|580250880|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
160691542|NCT00700817|580250881|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
160691543|NCT01194973|580250882|FG000|Screening Period|Screen Failure|3|||
160691544|NCT01194973|580250882|FG000|26 Week Treatment Period|Adverse Event|1|||
160691545|NCT01194973|580250882|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
160691546|NCT01194973|580250882|FG000|26 Week Treatment Period|Pregnancy|1|||
160691547|NCT01338987|580250883|FG000|Overall Study|enrolled on new protocol|0|||
160691548|NCT01338987|580250884|FG001|Overall Study|enrolled on new protocol|0|||
160691549|NCT01338987|580250885|FG002|Overall Study|enrolled on new protocol|1|||
160691550|NCT01338987|580250886|FG003|Overall Study|enrolled on new protocol|0|||
160691551|NCT01338987|580250887|FG004|Overall Study|enrolled on new protocol|0|||
160691552|NCT01338987|580250883|FG000|Overall Study|Disease progression on study|2|||
160691553|NCT01338987|580250884|FG001|Overall Study|Disease progression on study|1|||
160691554|NCT01338987|580250885|FG002|Overall Study|Disease progression on study|1|||
160691555|NCT01338987|580250886|FG003|Overall Study|Disease progression on study|0|||
160691556|NCT01338987|580250887|FG004|Overall Study|Disease progression on study|0|||
160691557|NCT00757848|580250888|FG000|Overall Study|Voluntary discontinuation|1|||
160691558|NCT00757848|580250889|FG001|Overall Study|Voluntary discontinuation|0|||
160691559|NCT00757848|580250888|FG000|Overall Study|Adverse Event|1|||
160691560|NCT00757848|580250889|FG001|Overall Study|Adverse Event|2|||
160691561|NCT00757848|580250888|FG000|Overall Study|Incorrect enrolment|1|||
160691562|NCT00757848|580250889|FG001|Overall Study|Incorrect enrolment|0|||
160691563|NCT00058214|580250892|FG000|Overall Study|Adverse Event|1|||
160691564|NCT01347866|580250899|FG000|Overall Study|Death|0|||
160691565|NCT01347866|580250900|FG001|Overall Study|Death|0|||
160691566|NCT01347866|580250901|FG002|Overall Study|Death|0|||
160691567|NCT01347866|580250902|FG003|Overall Study|Death|1|||
160691568|NCT01347866|580250903|FG004|Overall Study|Death|2|||
160691569|NCT01347866|580250904|FG005|Overall Study|Death|2|||
160691570|NCT01347866|580250905|FG006|Overall Study|Death|1|||
160691571|NCT01347866|580250906|FG007|Overall Study|Death|0|||
160691572|NCT01347866|580250907|FG008|Overall Study|Death|4|||
160691573|NCT01347866|580250908|FG009|Overall Study|Death|1|||
160691574|NCT01347866|580250909|FG010|Overall Study|Death|3|||
160691575|NCT01347866|580250910|FG011|Overall Study|Death|1|||
160691576|NCT01347866|580250911|FG012|Overall Study|Death|2|||
160691577|NCT01347866|580250912|FG013|Overall Study|Death|0|||
160691578|NCT01347866|580250913|FG014|Overall Study|Death|0|||
160691579|NCT01347866|580250914|FG015|Overall Study|Death|1|||
160691580|NCT01347866|580250915|FG016|Overall Study|Death|0|||
160691581|NCT01347866|580250899|FG000|Overall Study|Lost to Follow-up|0|||
160691582|NCT01347866|580250900|FG001|Overall Study|Lost to Follow-up|0|||
160691583|NCT01347866|580250901|FG002|Overall Study|Lost to Follow-up|0|||
160691584|NCT01347866|580250902|FG003|Overall Study|Lost to Follow-up|0|||
160691585|NCT01347866|580250903|FG004|Overall Study|Lost to Follow-up|0|||
160691586|NCT01347866|580250904|FG005|Overall Study|Lost to Follow-up|0|||
160691587|NCT01347866|580250905|FG006|Overall Study|Lost to Follow-up|0|||
160691588|NCT01347866|580250906|FG007|Overall Study|Lost to Follow-up|1|||
160691589|NCT01347866|580250907|FG008|Overall Study|Lost to Follow-up|1|||
160691590|NCT01347866|580250908|FG009|Overall Study|Lost to Follow-up|0|||
160691591|NCT01347866|580250909|FG010|Overall Study|Lost to Follow-up|0|||
160691592|NCT01347866|580250910|FG011|Overall Study|Lost to Follow-up|0|||
160691593|NCT01347866|580250911|FG012|Overall Study|Lost to Follow-up|0|||
160691594|NCT01347866|580250912|FG013|Overall Study|Lost to Follow-up|0|||
160691595|NCT01347866|580250913|FG014|Overall Study|Lost to Follow-up|0|||
160691596|NCT01347866|580250914|FG015|Overall Study|Lost to Follow-up|0|||
160691597|NCT01347866|580250915|FG016|Overall Study|Lost to Follow-up|0|||
160691598|NCT01347866|580250899|FG000|Overall Study|Other|3|||
160691599|NCT01347866|580250900|FG001|Overall Study|Other|1|||
160691600|NCT01347866|580250901|FG002|Overall Study|Other|1|||
160691601|NCT01347866|580250902|FG003|Overall Study|Other|4|||
160691602|NCT01347866|580250903|FG004|Overall Study|Other|5|||
160691603|NCT01347866|580250904|FG005|Overall Study|Other|0|||
160691604|NCT01347866|580250905|FG006|Overall Study|Other|5|||
160691605|NCT01347866|580250906|FG007|Overall Study|Other|3|||
160691606|NCT01347866|580250907|FG008|Overall Study|Other|22|||
160691607|NCT01347866|580250908|FG009|Overall Study|Other|5|||
160691608|NCT01347866|580250909|FG010|Overall Study|Other|0|||
160691609|NCT01347866|580250910|FG011|Overall Study|Other|3|||
160691610|NCT01347866|580250911|FG012|Overall Study|Other|4|||
160691611|NCT01347866|580250912|FG013|Overall Study|Other|4|||
160691612|NCT01347866|580250913|FG014|Overall Study|Other|2|||
160691613|NCT01347866|580250914|FG015|Overall Study|Other|3|||
160691614|NCT01347866|580250915|FG016|Overall Study|Other|0|||
160691615|NCT01347866|580250899|FG000|Overall Study|Subject refused further follow-up|2|||
160691616|NCT01347866|580250900|FG001|Overall Study|Subject refused further follow-up|0|||
160691617|NCT01347866|580250901|FG002|Overall Study|Subject refused further follow-up|0|||
160691618|NCT01347866|580250902|FG003|Overall Study|Subject refused further follow-up|2|||
160691619|NCT01347866|580250903|FG004|Overall Study|Subject refused further follow-up|0|||
160691620|NCT01347866|580250904|FG005|Overall Study|Subject refused further follow-up|1|||
160691621|NCT01347866|580250905|FG006|Overall Study|Subject refused further follow-up|0|||
160691622|NCT01347866|580250906|FG007|Overall Study|Subject refused further follow-up|0|||
160691623|NCT01347866|580250907|FG008|Overall Study|Subject refused further follow-up|4|||
160691624|NCT01347866|580250908|FG009|Overall Study|Subject refused further follow-up|1|||
160691625|NCT01347866|580250909|FG010|Overall Study|Subject refused further follow-up|0|||
160691626|NCT01347866|580250910|FG011|Overall Study|Subject refused further follow-up|0|||
160691627|NCT01347866|580250911|FG012|Overall Study|Subject refused further follow-up|1|||
160691628|NCT01347866|580250912|FG013|Overall Study|Subject refused further follow-up|3|||
160691629|NCT01347866|580250913|FG014|Overall Study|Subject refused further follow-up|1|||
160691630|NCT01347866|580250914|FG015|Overall Study|Subject refused further follow-up|0|||
160691631|NCT01347866|580250915|FG016|Overall Study|Subject refused further follow-up|2|||
160691632|NCT01491035|580250927|FG000|Overall Study|Lost to Follow-up|0|||
160691633|NCT01491035|580250928|FG001|Overall Study|Lost to Follow-up|0|||
160691634|NCT01491035|580250929|FG002|Overall Study|Lost to Follow-up|0|||
160691635|NCT01491035|580250930|FG003|Overall Study|Lost to Follow-up|0|||
160691636|NCT01491035|580250931|FG004|Overall Study|Lost to Follow-up|1|||
160691637|NCT01491035|580250932|FG005|Overall Study|Lost to Follow-up|0|||
160691638|NCT01491035|580250933|FG006|Overall Study|Lost to Follow-up|0|||
160691639|NCT01491035|580250934|FG007|Overall Study|Lost to Follow-up|0|||
160691640|NCT02025751|580250935|FG000|Overall Study|Lost to Follow-up|1|||
160691641|NCT02025751|580250936|FG001|Overall Study|Lost to Follow-up|0|||
160691642|NCT02025751|580250935|FG000|Overall Study|Adverse Event|0|||
160691643|NCT02025751|580250936|FG001|Overall Study|Adverse Event|1|||
160691644|NCT02025751|580250935|FG000|Overall Study|Physician Decision|0|||
160691645|NCT02025751|580250936|FG001|Overall Study|Physician Decision|1|||
160691646|NCT02025751|580250935|FG000|Overall Study|Withdrawal by Subject|0|||
160691647|NCT02025751|580250936|FG001|Overall Study|Withdrawal by Subject|1|||
160691648|NCT02687360|580250939|FG000|Overall Study|Withdrawal by Subject|3|||
160691649|NCT02687360|580250940|FG001|Overall Study|Withdrawal by Subject|0|||
160691650|NCT02181296|580250942|FG000|Overall Study|Lost to Follow-up|7|||
160691651|NCT02181296|580250943|FG001|Overall Study|Lost to Follow-up|6|||
160691652|NCT01568866|580250944|FG000|Overall Study|Disease Progression|208|||
160691653|NCT01568866|580250945|FG001|Overall Study|Disease Progression|183|||
160691654|NCT01568866|580250944|FG000|Overall Study|Adverse Event|94|||
160691655|NCT01568866|580250945|FG001|Overall Study|Adverse Event|96|||
160691656|NCT01568866|580250944|FG000|Overall Study|Patient Request|55|||
160691657|NCT01568866|580250945|FG001|Overall Study|Patient Request|71|||
160691658|NCT01568866|580250944|FG000|Overall Study|Physician Decision|40|||
160691659|NCT01568866|580250945|FG001|Overall Study|Physician Decision|32|||
160691660|NCT01568866|580250944|FG000|Overall Study|Withdrawal by Subject|19|||
160691661|NCT01568866|580250945|FG001|Overall Study|Withdrawal by Subject|11|||
160691662|NCT01568866|580250944|FG000|Overall Study|Death|10|||
160691663|NCT01568866|580250945|FG001|Overall Study|Death|18|||
160691664|NCT01568866|580250944|FG000|Overall Study|Protocol Non-compliance|2|||
160691665|NCT01568866|580250945|FG001|Overall Study|Protocol Non-compliance|4|||
160691666|NCT01568866|580250944|FG000|Overall Study|Lost to Follow-up|1|||
160691667|NCT01568866|580250945|FG001|Overall Study|Lost to Follow-up|0|||
160691668|NCT01568866|580250944|FG000|Overall Study|Randomized but Not Dosed|9|||
160691669|NCT01568866|580250945|FG001|Overall Study|Randomized but Not Dosed|1|||
160691670|NCT01698775|580250946|FG000|Phase A|Adverse Event|2|||
160691671|NCT01698775|580250947|FG001|Phase A|Adverse Event|1|||
160691672|NCT01698775|580250946|FG000|Phase A|Death|1|||
160691673|NCT01698775|580250947|FG001|Phase A|Death|1|||
160691674|NCT01698775|580250946|FG000|Phase A|Lack of Efficacy|1|||
160691675|NCT01698775|580250947|FG001|Phase A|Lack of Efficacy|0|||
160691676|NCT01698775|580250946|FG000|Phase A|Lost to Follow-up|1|||
160691677|NCT01698775|580250947|FG001|Phase A|Lost to Follow-up|2|||
160691678|NCT01698775|580250946|FG000|Phase A|Protocol Violation|1|||
160691679|NCT01698775|580250947|FG001|Phase A|Protocol Violation|0|||
160691680|NCT01698775|580250946|FG000|Phase A|Withdrawal by Subject|3|||
160691681|NCT01698775|580250947|FG001|Phase A|Withdrawal by Subject|4|||
160691682|NCT01698775|580250946|FG000|Phase A|Kidney [transplant]|0|||
160691683|NCT01698775|580250947|FG001|Phase A|Kidney [transplant]|1|||
160691684|NCT01698775|580250946|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
160691685|NCT01698775|580250947|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
160691686|NCT01698775|580250946|FG000|Phase B|Adverse Event|6|||
160691687|NCT01698775|580250947|FG001|Phase B|Adverse Event|3|||
160691688|NCT01698775|580250946|FG000|Phase B|Death|0|||
160691689|NCT01698775|580250947|FG001|Phase B|Death|1|||
160691690|NCT01698775|580250946|FG000|Phase B|Lack of Efficacy|0|||
160691691|NCT01698775|580250947|FG001|Phase B|Lack of Efficacy|1|||
160691692|NCT01698775|580250946|FG000|Phase B|Lost to Follow-up|0|||
160691693|NCT01698775|580250947|FG001|Phase B|Lost to Follow-up|1|||
160691694|NCT01698775|580250946|FG000|Phase B|Physician Decision|1|||
160691695|NCT01698775|580250947|FG001|Phase B|Physician Decision|1|||
160691696|NCT01698775|580250946|FG000|Phase B|Protocol Violation|1|||
160691697|NCT01698775|580250947|FG001|Phase B|Protocol Violation|1|||
160691698|NCT01698775|580250946|FG000|Phase B|Withdrawal by Subject|6|||
160691699|NCT01698775|580250947|FG001|Phase B|Withdrawal by Subject|2|||
160691700|NCT03864042|580250948|FG000|DDI Phase|Adverse Event|2|||
160691701|NCT03864042|580250949|FG001|DDI Phase|Adverse Event|0|||
160691702|NCT03864042|580250950|FG002|DDI Phase|Adverse Event|0|||
160691703|NCT03864042|580250948|FG000|DDI Phase|Physician Decision|1|||
160691704|NCT03864042|580250949|FG001|DDI Phase|Physician Decision|0|||
160691705|NCT03864042|580250950|FG002|DDI Phase|Physician Decision|0|||
160691706|NCT03864042|580250948|FG000|DDI Phase|Progressive Disease|1|||
160691707|NCT03864042|580250949|FG001|DDI Phase|Progressive Disease|0|||
160691708|NCT03864042|580250950|FG002|DDI Phase|Progressive Disease|0|||
160691709|NCT03864042|580250948|FG000|Post-DDI Phase|Adverse Event|5|||
160691710|NCT03864042|580250949|FG001|Post-DDI Phase|Adverse Event|3|||
160691711|NCT03864042|580250950|FG002|Post-DDI Phase|Adverse Event|2|||
160691712|NCT03864042|580250948|FG000|Post-DDI Phase|Progressive Disease|11|||
160691713|NCT03864042|580250949|FG001|Post-DDI Phase|Progressive Disease|6|||
160691714|NCT03864042|580250950|FG002|Post-DDI Phase|Progressive Disease|13|||
160691715|NCT03864042|580250948|FG000|Post-DDI Phase|Discretion of investigator|1|||
160691716|NCT03864042|580250949|FG001|Post-DDI Phase|Discretion of investigator|1|||
160691717|NCT03864042|580250950|FG002|Post-DDI Phase|Discretion of investigator|0|||
160691718|NCT03864042|580250948|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
160691719|NCT03864042|580250949|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
160691720|NCT03864042|580250950|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
160691721|NCT03864042|580250948|FG000|Post-DDI Phase|Withdrawal of consent|1|||
160691722|NCT03864042|580250949|FG001|Post-DDI Phase|Withdrawal of consent|2|||
160691723|NCT03864042|580250950|FG002|Post-DDI Phase|Withdrawal of consent|0|||
160691724|NCT02143583|580250957|FG000|Overall Study|Withdrawal by Subject|1|||
160691725|NCT02143583|580250958|FG001|Overall Study|Withdrawal by Subject|0|||
160691726|NCT02143583|580250959|FG002|Overall Study|Withdrawal by Subject|1|||
160691727|NCT02143583|580250957|FG000|Overall Study|husband illness|0|||
160691728|NCT02143583|580250958|FG001|Overall Study|husband illness|0|||
160691729|NCT02143583|580250959|FG002|Overall Study|husband illness|1|||
160691730|NCT00766831|580250960|FG000|Overall Study|Withdrawal by Subject|4|||
160691731|NCT00766831|580250960|FG000|Overall Study|Lost to Follow-up|3|||
160691732|NCT00766831|580250960|FG000|Overall Study|Adverse Event|20|||
160691733|NCT00766831|580250960|FG000|Overall Study|Protocol Violation|15|||
160691734|NCT00766831|580250960|FG000|Overall Study|Physician Decision|5|||
160691735|NCT00766831|580250960|FG000|Overall Study|Withdrawal of consent|26|||
160691736|NCT00766831|580250960|FG000|Overall Study|Non cooperation by participants|14|||
160691737|NCT00766831|580250960|FG000|Overall Study|Other|28|||
160691738|NCT02340221|580250963|FG000|Overall Study|Death|100|||
160691739|NCT02340221|580250964|FG001|Overall Study|Death|197|||
160691740|NCT02340221|580250963|FG000|Overall Study|Withdrawal by Participant|24|||
160691741|NCT02340221|580250964|FG001|Overall Study|Withdrawal by Participant|37|||
160691742|NCT02340221|580250963|FG000|Overall Study|Lost to Follow-up|4|||
160691743|NCT02340221|580250964|FG001|Overall Study|Lost to Follow-up|15|||
160691744|NCT02340221|580250963|FG000|Overall Study|Reason Not Specified|85|||
160691745|NCT02340221|580250964|FG001|Overall Study|Reason Not Specified|165|||
160691746|NCT02340221|580250963|FG000|Overall Study|Study Terminated by Sponsor|1|||
160691747|NCT02340221|580250964|FG001|Overall Study|Study Terminated by Sponsor|3|||
160691748|NCT00952276|580250967|FG000|Overall Study|Withdrawal by Subject|1|||
160691749|NCT00952276|580250968|FG001|Overall Study|Withdrawal by Subject|0|||
160691750|NCT00952276|580250969|FG002|Overall Study|Withdrawal by Subject|0|||
160691751|NCT00952276|580250970|FG003|Overall Study|Withdrawal by Subject|1|||
160691752|NCT00952276|580250971|FG004|Overall Study|Withdrawal by Subject|0|||
160691753|NCT02427984|580250972|FG000|Overall Study|Lost to Follow-up|13|||
160691754|NCT02427984|580250973|FG001|Overall Study|Lost to Follow-up|5|||
160691755|NCT02427984|580250974|FG002|Overall Study|Lost to Follow-up|18|||
160691756|NCT03303625|580252077|FG000|Overall Study|Withdrawal by Subject|2|||
160691757|NCT03303625|580252078|FG001|Overall Study|Withdrawal by Subject|0|||
160691758|NCT03303625|580252079|FG002|Overall Study|Withdrawal by Subject|0|||
160691759|NCT03303625|580252080|FG003|Overall Study|Withdrawal by Subject|0|||
160691760|NCT03573505|580252084|FG000|Overall Study|Adverse Event|1|||
160691761|NCT03573505|580252085|FG001|Overall Study|Adverse Event|1|||
160691762|NCT03573505|580252084|FG000|Overall Study|Consent withdrawn|0|||
160691763|NCT03573505|580252085|FG001|Overall Study|Consent withdrawn|1|||
160691764|NCT03573505|580252084|FG000|Overall Study|Disease progression|0|||
160691765|NCT03573505|580252085|FG001|Overall Study|Disease progression|1|||
160691766|NCT03573505|580252084|FG000|Overall Study|Site Terminated by Sponsor|1|||
160691767|NCT03573505|580252085|FG001|Overall Study|Site Terminated by Sponsor|1|||
160691768|NCT03573505|580252084|FG000|Overall Study|Study terminated by sponsor|50|||
160691769|NCT03573505|580252085|FG001|Overall Study|Study terminated by sponsor|45|||
160691770|NCT03573505|580252084|FG000|Overall Study|Reason not specified|0|||
160691771|NCT03573505|580252085|FG001|Overall Study|Reason not specified|1|||
160691772|NCT03573505|580252084|FG000|Overall Study|Death|0|||
160691773|NCT03573505|580252085|FG001|Overall Study|Death|4|||
160691774|NCT00515541|580252086|FG000|Overall Study|Physician Decision|0|||
160691775|NCT00515541|580252087|FG001|Overall Study|Physician Decision|2|||
160691776|NCT00515541|580252088|FG002|Overall Study|Physician Decision|0|||
160691777|NCT00515541|580252089|FG003|Overall Study|Physician Decision|1|||
160691778|NCT00515541|580252086|FG000|Overall Study|No show for appointments|0|||
160691779|NCT00515541|580252087|FG001|Overall Study|No show for appointments|1|||
160691780|NCT00515541|580252088|FG002|Overall Study|No show for appointments|0|||
160691781|NCT00515541|580252089|FG003|Overall Study|No show for appointments|2|||
160691782|NCT00515541|580252086|FG000|Overall Study|Withdrawal by Subject|0|||
160691783|NCT00515541|580252087|FG001|Overall Study|Withdrawal by Subject|2|||
160691784|NCT00515541|580252088|FG002|Overall Study|Withdrawal by Subject|0|||
160691785|NCT00515541|580252089|FG003|Overall Study|Withdrawal by Subject|2|||
160691786|NCT02588950|580252090|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
160691787|NCT02588950|580252091|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
160691788|NCT02588950|580252092|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
160691789|NCT02588950|580252093|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
160691790|NCT02588950|580252090|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
160691791|NCT02588950|580252091|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
160691792|NCT02588950|580252092|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
160691793|NCT02588950|580252093|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
160691794|NCT00652028|580252096|FG000|Overall Study|Adverse Event|1|||
160691795|NCT00652028|580252097|FG001|Overall Study|Adverse Event|0|||
160691796|NCT00652028|580252098|FG002|Overall Study|Adverse Event|0|||
160691797|NCT00652028|580252099|FG003|Overall Study|Adverse Event|0|||
160691798|NCT00652028|580252096|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
160691799|NCT00652028|580252097|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
160691800|NCT00652028|580252098|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
160691801|NCT00652028|580252099|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
160691802|NCT00652028|580252096|FG000|Overall Study|Physician Decision|0|||
160691803|NCT00652028|580252097|FG001|Overall Study|Physician Decision|0|||
160691804|NCT00652028|580252098|FG002|Overall Study|Physician Decision|1|||
160691805|NCT00652028|580252099|FG003|Overall Study|Physician Decision|0|||
160691806|NCT02072824|580252101|FG000|Overall Study|Insufficient clinical response|1|||
160691807|NCT02072824|580252102|FG001|Overall Study|Insufficient clinical response|0|||
160691808|NCT02072824|580252103|FG002|Overall Study|Insufficient clinical response|1|||
160691809|NCT02072824|580252101|FG000|Overall Study|No longer willing to participate|1|||
160691810|NCT02072824|580252102|FG001|Overall Study|No longer willing to participate|0|||
160691811|NCT02072824|580252103|FG002|Overall Study|No longer willing to participate|1|||
160691812|NCT02072824|580252101|FG000|Overall Study|Medication error|0|||
160691813|NCT02072824|580252102|FG001|Overall Study|Medication error|1|||
160691814|NCT02072824|580252103|FG002|Overall Study|Medication error|0|||
160691815|NCT02072824|580252101|FG000|Overall Study|Adverse Event|0|||
160691816|NCT02072824|580252102|FG001|Overall Study|Adverse Event|0|||
160691817|NCT02072824|580252103|FG002|Overall Study|Adverse Event|1|||
160691818|NCT00127036|580252107|FG000|Overall Study|Insufficient Data for Analysis|6|||
160691819|NCT00127036|580252108|FG001|Overall Study|Insufficient Data for Analysis|11|||
160691820|NCT00127036|580252107|FG000|Overall Study|Screen Failure|2|||
160691821|NCT00127036|580252108|FG001|Overall Study|Screen Failure|0|||
160691822|NCT03921151|580252111|FG000|Overall Study|Withdrawal by Subject|11|||
160691823|NCT03921151|580252112|FG001|Overall Study|Withdrawal by Subject|16|||
160691824|NCT01797835|580252120|FG000|Overall Study|Lost to Follow-up|31|||
160691825|NCT01797835|580252121|FG001|Overall Study|Lost to Follow-up|27|||
160691826|NCT03001219|580252122|FG000|Proof of Concept|Study Termination by Sponsor|0|||
160691827|NCT03001219|580252123|FG001|Proof of Concept|Study Termination by Sponsor|1|||
160691828|NCT03001219|580252122|FG000|Proof of Concept|Withdrawal by Subject|0|||
160691829|NCT03001219|580252123|FG001|Proof of Concept|Withdrawal by Subject|4|||
160691830|NCT03001219|580252122|FG000|Proof of Concept|Protocol Deviation|0|||
160691831|NCT03001219|580252123|FG001|Proof of Concept|Protocol Deviation|1|||
160691832|NCT03001219|580252122|FG000|Proof of Concept|Adverse Event|1|||
160691833|NCT03001219|580252123|FG001|Proof of Concept|Adverse Event|1|||
160691834|NCT03001219|580252122|FG000|Proof of Concept|Physician Decision|1|||
160691835|NCT03001219|580252123|FG001|Proof of Concept|Physician Decision|0|||
160691836|NCT03001219|580252122|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
160691837|NCT03001219|580252123|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
160691838|NCT03001219|580252122|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
160691839|NCT03001219|580252123|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
160691840|NCT03001219|580252122|FG000|Extension Period Analysis|Physician Decision|0|||
160691841|NCT03001219|580252123|FG001|Extension Period Analysis|Physician Decision|1|||
160691842|NCT03001219|580252122|FG000|Extension Period Analysis|Adverse Event|1|||
160691843|NCT03001219|580252123|FG001|Extension Period Analysis|Adverse Event|1|||
160691844|NCT03001219|580252122|FG000|Extension Period Analysis|Protocol Deviation|0|||
160691845|NCT03001219|580252123|FG001|Extension Period Analysis|Protocol Deviation|1|||
160691846|NCT03001219|580252122|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
160691847|NCT03001219|580252123|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
160691848|NCT01403064|580252124|FG000|Overall Study|Death|0|||
160691849|NCT01403064|580252125|FG001|Overall Study|Death|0|||
160691850|NCT01403064|580252126|FG002|Overall Study|Death|1|||
160691851|NCT01403064|580252127|FG003|Overall Study|Death|1|||
160691852|NCT01403064|580252124|FG000|Overall Study|Withdrawal by Subject|0|||
160691853|NCT01403064|580252125|FG001|Overall Study|Withdrawal by Subject|0|||
160691854|NCT01403064|580252126|FG002|Overall Study|Withdrawal by Subject|1|||
160691855|NCT01403064|580252127|FG003|Overall Study|Withdrawal by Subject|1|||
160691856|NCT01403064|580252124|FG000|Overall Study|Other|1|||
160691857|NCT01403064|580252125|FG001|Overall Study|Other|0|||
160691858|NCT01403064|580252126|FG002|Overall Study|Other|2|||
160691859|NCT01403064|580252127|FG003|Overall Study|Other|1|||
160691860|NCT00973765|580252128|FG000|Overall Study|Lost to Follow-up|8|||
160691861|NCT00973765|580252129|FG001|Overall Study|Lost to Follow-up|14|||
160691862|NCT02669940|580252130|FG000|Overall Study|Failure to return|0|||
160691863|NCT02669940|580252131|FG001|Overall Study|Failure to return|3|||
160691864|NCT02669940|580252130|FG000|Overall Study|Insufficient follow-up data|1|||
160691865|NCT02669940|580252131|FG001|Overall Study|Insufficient follow-up data|0|||
160691866|NCT01892657|580252132|FG000|Overall Study|Withdrawal by Subject|6|||
160691867|NCT01892657|580252132|FG000|Overall Study|Protocol Violation|12|||
160691868|NCT05065983|580252133|FG000|Overall Study|Lost to Follow-up|2|||
160691869|NCT00986180|580252134|FG000|Overall Study|Adverse Event|21|||
160691870|NCT00986180|580252135|FG001|Overall Study|Adverse Event|23|||
160691871|NCT00986180|580252134|FG000|Overall Study|Lack of Efficacy|4|||
160691872|NCT00986180|580252135|FG001|Overall Study|Lack of Efficacy|3|||
160691873|NCT00986180|580252134|FG000|Overall Study|Lost to Follow-up|5|||
160691874|NCT00986180|580252135|FG001|Overall Study|Lost to Follow-up|7|||
160691875|NCT00986180|580252134|FG000|Overall Study|Physician Decision|1|||
160691876|NCT00986180|580252135|FG001|Overall Study|Physician Decision|3|||
160691877|NCT00986180|580252134|FG000|Overall Study|Protocol Violation|2|||
160691878|NCT00986180|580252135|FG001|Overall Study|Protocol Violation|0|||
160691879|NCT00986180|580252134|FG000|Overall Study|Withdrawal by Subject|1|||
160691880|NCT00986180|580252135|FG001|Overall Study|Withdrawal by Subject|9|||
160691881|NCT00986180|580252134|FG000|Overall Study|Miscellanies|10|||
160691882|NCT00986180|580252135|FG001|Overall Study|Miscellanies|11|||
160691883|NCT00003875|580252138|FG000|Overall Study|Screen Failed|1|||
160691884|NCT01070771|580252139|FG000|Overall Study|Adverse Event|2|||
160691885|NCT01070771|580252139|FG000|Overall Study|Protocol Violation|1|||
160691886|NCT03835325|580252140|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
160691887|NCT03835325|580252140|FG000|Overall Study|Selection failure|1|||
160691888|NCT01370213|580252143|FG000|Overall Study|Early Death|1|||
160691889|NCT01370213|580252144|FG001|Overall Study|Early Death|0|||
160691890|NCT01370213|580252145|FG002|Overall Study|Early Death|0|||
160691891|NCT01370213|580252143|FG000|Overall Study|Not evaluable|0|||
160691892|NCT01370213|580252144|FG001|Overall Study|Not evaluable|2|||
160691893|NCT01370213|580252145|FG002|Overall Study|Not evaluable|0|||
160691894|NCT01550744|580252151|FG000|Open-Label|Lost to Follow-up|7|||
160691895|NCT01550744|580252152|FG001|Open-Label|Lost to Follow-up|0|||
160691896|NCT01550744|580252153|FG002|Open-Label|Lost to Follow-up|0|||
160691897|NCT01550744|580252151|FG000|Open-Label|Withdrawal by Subject|13|||
160691898|NCT01550744|580252152|FG001|Open-Label|Withdrawal by Subject|0|||
160691899|NCT01550744|580252153|FG002|Open-Label|Withdrawal by Subject|0|||
160691900|NCT01550744|580252151|FG000|Open-Label|Adverse Event|11|||
160691901|NCT01550744|580252152|FG001|Open-Label|Adverse Event|0|||
160691902|NCT01550744|580252153|FG002|Open-Label|Adverse Event|0|||
160691903|NCT01550744|580252151|FG000|Open-Label|Lack of Efficacy|4|||
160691904|NCT01550744|580252152|FG001|Open-Label|Lack of Efficacy|0|||
160691905|NCT01550744|580252153|FG002|Open-Label|Lack of Efficacy|0|||
160691906|NCT01550744|580252151|FG000|Open-Label|Protocol Violation|4|||
160691907|NCT01550744|580252152|FG001|Open-Label|Protocol Violation|0|||
160691908|NCT01550744|580252153|FG002|Open-Label|Protocol Violation|0|||
160691909|NCT01550744|580252151|FG000|Open-Label|Not all 3 study drug injections received|2|||
160691910|NCT01550744|580252152|FG001|Open-Label|Not all 3 study drug injections received|0|||
160691911|NCT01550744|580252153|FG002|Open-Label|Not all 3 study drug injections received|0|||
160691912|NCT01550744|580252151|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
160691913|NCT01550744|580252152|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
160691914|NCT01550744|580252153|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
160691915|NCT01550744|580252151|FG000|Open-Label|Other|1|||
160691916|NCT01550744|580252152|FG001|Open-Label|Other|0|||
160691917|NCT01550744|580252153|FG002|Open-Label|Other|0|||
160691918|NCT01550744|580252151|FG000|Double-Blind|Lost to Follow-up|0|||
160691919|NCT01550744|580252152|FG001|Double-Blind|Lost to Follow-up|6|||
160691920|NCT01550744|580252153|FG002|Double-Blind|Lost to Follow-up|12|||
160691921|NCT01550744|580252151|FG000|Double-Blind|Withdrawal by Subject|0|||
160691922|NCT01550744|580252152|FG001|Double-Blind|Withdrawal by Subject|2|||
160691923|NCT01550744|580252153|FG002|Double-Blind|Withdrawal by Subject|15|||
160691924|NCT01550744|580252151|FG000|Double-Blind|Adverse Event|0|||
160691925|NCT01550744|580252152|FG001|Double-Blind|Adverse Event|4|||
160691926|NCT01550744|580252153|FG002|Double-Blind|Adverse Event|15|||
160691927|NCT01550744|580252151|FG000|Double-Blind|Death|0|||
160691928|NCT01550744|580252152|FG001|Double-Blind|Death|1|||
160691929|NCT01550744|580252153|FG002|Double-Blind|Death|0|||
160691930|NCT01550744|580252151|FG000|Double-Blind|Lack of Efficacy|0|||
160691931|NCT01550744|580252152|FG001|Double-Blind|Lack of Efficacy|2|||
160691932|NCT01550744|580252153|FG002|Double-Blind|Lack of Efficacy|8|||
160691933|NCT01550744|580252151|FG000|Double-Blind|Protocol Violation|0|||
160691934|NCT01550744|580252152|FG001|Double-Blind|Protocol Violation|0|||
160691935|NCT01550744|580252153|FG002|Double-Blind|Protocol Violation|4|||
160691936|NCT01550744|580252151|FG000|Double-Blind|Pregnancy|0|||
160691937|NCT01550744|580252152|FG001|Double-Blind|Pregnancy|0|||
160691938|NCT01550744|580252153|FG002|Double-Blind|Pregnancy|3|||
160691939|NCT01550744|580252151|FG000|Double-Blind|Other|0|||
160691940|NCT01550744|580252152|FG001|Double-Blind|Other|2|||
160691941|NCT01550744|580252153|FG002|Double-Blind|Other|10|||
160691942|NCT00038649|580252154|FG000|Overall Study|Adverse Event|9|||
160691943|NCT03395639|580252155|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
160691944|NCT03395639|580252156|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
160691945|NCT03395639|580252157|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
160691946|NCT03395639|580252155|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
160691947|NCT03395639|580252156|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
160691948|NCT03395639|580252157|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
160691949|NCT03395639|580252155|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
160691950|NCT03395639|580252156|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
160691951|NCT03395639|580252157|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
160691952|NCT03395639|580252155|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
160691953|NCT03395639|580252156|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
160691954|NCT03395639|580252157|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
160691955|NCT03395639|580252155|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
160691956|NCT03395639|580252156|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
160691957|NCT03395639|580252157|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
160691958|NCT00942331|580252158|FG000|Overall Study|Did not start treatment|15|||
160691959|NCT00942331|580252159|FG001|Overall Study|Did not start treatment|22|||
160691960|NCT00567476|580252160|FG000|Overall Study|Adverse Event|2|||
160691961|NCT00567476|580252161|FG001|Overall Study|Adverse Event|0|||
160691962|NCT00567476|580252160|FG000|Overall Study|Pregnancy|1|||
160691963|NCT00567476|580252161|FG001|Overall Study|Pregnancy|0|||
160691964|NCT00567476|580252160|FG000|Overall Study|Protocol Violation|4|||
160691965|NCT00567476|580252161|FG001|Overall Study|Protocol Violation|1|||
160691966|NCT00567476|580252160|FG000|Overall Study|Lost to Follow-up|0|||
160691967|NCT00567476|580252161|FG001|Overall Study|Lost to Follow-up|1|||
160691968|NCT00567476|580252160|FG000|Overall Study|Administrative issues|1|||
160691969|NCT00567476|580252161|FG001|Overall Study|Administrative issues|0|||
160691970|NCT00567476|580252160|FG000|Overall Study|Medical Decision|0|||
160691971|NCT00567476|580252161|FG001|Overall Study|Medical Decision|1|||
160691972|NCT00567476|580252160|FG000|Overall Study|Non-adherence to protocol|0|||
160691973|NCT00567476|580252161|FG001|Overall Study|Non-adherence to protocol|1|||
160691974|NCT00995085|580252162|FG000|Overall Study|Withdrawal by Subject|5|||
160691975|NCT03856593|580252167|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
160691976|NCT03856593|580252168|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
160691977|NCT02595008|580252169|FG000|Overall Study|Enrolled In Error|1|||
160691978|NCT02595008|580252170|FG001|Overall Study|Enrolled In Error|0|||
160691979|NCT03407118|580252171|FG000|Period 2|Withdrawal by Subject|1|||
160691980|NCT03407118|580252172|FG001|Period 2|Withdrawal by Subject|0|||
160691981|NCT02939014|580252185|FG000|Overall Study|Lost to Follow-up|1|||
160691982|NCT02939014|580252186|FG001|Overall Study|Lost to Follow-up|0|||
160691983|NCT02939014|580252185|FG000|Overall Study|Death|4|||
160691984|NCT02939014|580252186|FG001|Overall Study|Death|3|||
160691985|NCT02333487|580252187|FG000|Overall Study|Adverse Event|0|||
160691986|NCT02333487|580252188|FG001|Overall Study|Adverse Event|2|||
160691987|NCT02333487|580252189|FG002|Overall Study|Adverse Event|0|||
160691988|NCT04385277|580253995|FG000|Overall Study|Physician Decision|2|||
160691989|NCT04385277|580253995|FG000|Overall Study|Ineligible|1|||
160691990|NCT04385277|580253995|FG000|Overall Study|Patient/Parent Refusal|2|||
160691991|NCT04905290|580253996|FG000|Overall Study|Adverse Event|4|||
160691992|NCT04905290|580253996|FG000|Overall Study|Death|2|||
160691993|NCT04905290|580253996|FG000|Overall Study|Withdrawal by Subject|4|||
160691994|NCT04905290|580253996|FG000|Overall Study|Physician Decision|2|||
160691995|NCT04905290|580253996|FG000|Overall Study|Lost to Follow-up|2|||
160691996|NCT04905290|580253996|FG000|Overall Study|Screen Failure|2|||
160691997|NCT04905290|580253996|FG000|Overall Study|Unsuccessful Procedure|2|||
160691998|NCT03340064|580254000|FG000|First Period|Adverse Event, non-fatal|2|||
160691999|NCT03340064|580254001|FG001|First Period|Adverse Event, non-fatal|0|||
160692000|NCT03340064|580254000|FG000|First Period|Lack of Efficacy|3|||
160692001|NCT03340064|580254001|FG001|First Period|Lack of Efficacy|0|||
160692002|NCT03340064|580254000|FG000|Second Period|Adverse Event, non-fatal|1|||
160692003|NCT03340064|580254001|FG001|Second Period|Adverse Event, non-fatal|1|||
160692004|NCT03340064|580254000|FG000|Second Period|Lack of Efficacy|11|||
160692005|NCT03340064|580254001|FG001|Second Period|Lack of Efficacy|0|||
160692006|NCT03340064|580254000|FG000|Second Period|Physician Decision|3|||
160692007|NCT03340064|580254001|FG001|Second Period|Physician Decision|0|||
160692008|NCT03340064|580254000|FG000|Second Period|Withdrawal by Subject|2|||
160692009|NCT03340064|580254001|FG001|Second Period|Withdrawal by Subject|1|||
160692010|NCT03340064|580254000|FG000|Second Period|Approved Drug Available For Indication|1|||
160692011|NCT03340064|580254001|FG001|Second Period|Approved Drug Available For Indication|0|||
160692012|NCT03340064|580254000|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
160692013|NCT03340064|580254001|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
160692014|NCT01045421|580254002|FG000|Phase 1|Progressive Disease|0|||
160692015|NCT01045421|580254003|FG001|Phase 1|Progressive Disease|0|||
160692016|NCT01045421|580254004|FG002|Phase 1|Progressive Disease|0|||
160692017|NCT01045421|580254005|FG003|Phase 1|Progressive Disease|0|||
160692018|NCT01045421|580254006|FG004|Phase 1|Progressive Disease|1|||
160692019|NCT01045421|580254007|FG005|Phase 1|Progressive Disease|0|||
160692020|NCT01045421|580254008|FG006|Phase 1|Progressive Disease|0|||
160692021|NCT01045421|580254009|FG007|Phase 1|Progressive Disease|0|||
160692022|NCT01045421|580254010|FG008|Phase 1|Progressive Disease|0|||
160692023|NCT01045421|580254011|FG009|Phase 1|Progressive Disease|0|||
160692024|NCT01045421|580254012|FG010|Phase 1|Progressive Disease|0|||
160692025|NCT01045421|580254002|FG000|Phase 1|Withdrawal by Subject|0|||
160692026|NCT01045421|580254003|FG001|Phase 1|Withdrawal by Subject|0|||
160692027|NCT01045421|580254004|FG002|Phase 1|Withdrawal by Subject|0|||
160692028|NCT01045421|580254005|FG003|Phase 1|Withdrawal by Subject|1|||
160692029|NCT01045421|580254006|FG004|Phase 1|Withdrawal by Subject|0|||
160692030|NCT01045421|580254007|FG005|Phase 1|Withdrawal by Subject|0|||
160692031|NCT01045421|580254008|FG006|Phase 1|Withdrawal by Subject|0|||
160692032|NCT01045421|580254009|FG007|Phase 1|Withdrawal by Subject|0|||
160692033|NCT01045421|580254010|FG008|Phase 1|Withdrawal by Subject|0|||
160692034|NCT01045421|580254011|FG009|Phase 1|Withdrawal by Subject|0|||
160692035|NCT01045421|580254012|FG010|Phase 1|Withdrawal by Subject|0|||
160692036|NCT01045421|580254002|FG000|Phase 2|Progressive Disease|0|||
160692037|NCT01045421|580254003|FG001|Phase 2|Progressive Disease|0|||
160692038|NCT01045421|580254004|FG002|Phase 2|Progressive Disease|0|||
160692039|NCT01045421|580254005|FG003|Phase 2|Progressive Disease|0|||
160692040|NCT01045421|580254006|FG004|Phase 2|Progressive Disease|0|||
160692041|NCT01045421|580254007|FG005|Phase 2|Progressive Disease|0|||
160692042|NCT01045421|580254008|FG006|Phase 2|Progressive Disease|0|||
160692043|NCT01045421|580254009|FG007|Phase 2|Progressive Disease|1|||
160692044|NCT01045421|580254010|FG008|Phase 2|Progressive Disease|1|||
160692045|NCT01045421|580254011|FG009|Phase 2|Progressive Disease|1|||
160692046|NCT01045421|580254012|FG010|Phase 2|Progressive Disease|1|||
160692047|NCT01045421|580254002|FG000|Phase 2|Death|0|||
160692048|NCT01045421|580254003|FG001|Phase 2|Death|0|||
160692049|NCT01045421|580254004|FG002|Phase 2|Death|0|||
160692050|NCT01045421|580254005|FG003|Phase 2|Death|0|||
160692051|NCT01045421|580254006|FG004|Phase 2|Death|0|||
160692052|NCT01045421|580254007|FG005|Phase 2|Death|0|||
160692053|NCT01045421|580254008|FG006|Phase 2|Death|0|||
160692054|NCT01045421|580254009|FG007|Phase 2|Death|1|||
160692055|NCT01045421|580254010|FG008|Phase 2|Death|1|||
160692056|NCT01045421|580254011|FG009|Phase 2|Death|2|||
160692057|NCT01045421|580254012|FG010|Phase 2|Death|0|||
160692058|NCT01045421|580254002|FG000|Phase 2|Other|0|||
160692059|NCT01045421|580254003|FG001|Phase 2|Other|0|||
160692060|NCT01045421|580254004|FG002|Phase 2|Other|0|||
160692061|NCT01045421|580254005|FG003|Phase 2|Other|0|||
160692062|NCT01045421|580254006|FG004|Phase 2|Other|0|||
160692063|NCT01045421|580254007|FG005|Phase 2|Other|0|||
160692064|NCT01045421|580254008|FG006|Phase 2|Other|0|||
160692065|NCT01045421|580254009|FG007|Phase 2|Other|3|||
160692066|NCT01045421|580254010|FG008|Phase 2|Other|0|||
160692067|NCT01045421|580254011|FG009|Phase 2|Other|0|||
160692068|NCT01045421|580254012|FG010|Phase 2|Other|1|||
160692069|NCT00856973|580254013|FG000|Overall Study|Adverse Event|5|||
160692070|NCT00856973|580254014|FG001|Overall Study|Adverse Event|5|||
160692071|NCT00856973|580254015|FG002|Overall Study|Adverse Event|3|||
160692072|NCT00856973|580254013|FG000|Overall Study|Lost to Follow-up|6|||
160692073|NCT00856973|580254014|FG001|Overall Study|Lost to Follow-up|3|||
160692074|NCT00856973|580254015|FG002|Overall Study|Lost to Follow-up|5|||
160692075|NCT00856973|580254013|FG000|Overall Study|Physician Decision|0|||
160692076|NCT00856973|580254014|FG001|Overall Study|Physician Decision|3|||
160692077|NCT00856973|580254015|FG002|Overall Study|Physician Decision|1|||
160692078|NCT00856973|580254013|FG000|Overall Study|Protocol Violation|1|||
160692079|NCT00856973|580254014|FG001|Overall Study|Protocol Violation|2|||
160692080|NCT00856973|580254015|FG002|Overall Study|Protocol Violation|1|||
160692081|NCT00856973|580254013|FG000|Overall Study|Withdrawal by Subject|13|||
160692082|NCT00856973|580254014|FG001|Overall Study|Withdrawal by Subject|16|||
160692083|NCT00856973|580254015|FG002|Overall Study|Withdrawal by Subject|15|||
160692084|NCT00856973|580254013|FG000|Overall Study|Other|11|||
160692085|NCT00856973|580254014|FG001|Overall Study|Other|12|||
160692086|NCT00856973|580254015|FG002|Overall Study|Other|13|||
160692087|NCT01030341|580254017|FG000|Overall Study|Withdrawal by Subject|1|||
160692088|NCT01030341|580254017|FG000|Overall Study|Lost to Follow-up|2|||
160692089|NCT03623386|580254018|FG000|Overall Study|Protocol Violation|3|||
160692090|NCT03623386|580254019|FG001|Overall Study|Protocol Violation|2|||
160692091|NCT03623386|580254020|FG002|Overall Study|Protocol Violation|0|||
160692092|NCT03623386|580254018|FG000|Overall Study|Physician Decision|1|||
160692093|NCT03623386|580254019|FG001|Overall Study|Physician Decision|1|||
160692094|NCT03623386|580254020|FG002|Overall Study|Physician Decision|0|||
160692095|NCT03623386|580254018|FG000|Overall Study|Lost to Follow-up|0|||
160692096|NCT03623386|580254019|FG001|Overall Study|Lost to Follow-up|2|||
160692097|NCT03623386|580254020|FG002|Overall Study|Lost to Follow-up|0|||
160692098|NCT03623386|580254018|FG000|Overall Study|COVID-19|0|||
160692099|NCT03623386|580254019|FG001|Overall Study|COVID-19|1|||
160692100|NCT03623386|580254020|FG002|Overall Study|COVID-19|0|||
160692101|NCT01859130|580254021|FG000|Overall Study|Death|4|||
160692102|NCT01859130|580254021|FG000|Overall Study|Lost to Follow-up|16|||
160692103|NCT01859130|580254021|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
160692104|NCT01859130|580254021|FG000|Overall Study|Physician Decision|6|||
160692105|NCT01859130|580254021|FG000|Overall Study|Withdrawal by Subject|17|||
160692106|NCT01859130|580254021|FG000|Overall Study|Adverse Event|11|||
160692107|NCT01388166|580254022|FG000|Overall Study|Adverse Event|16|||
160692108|NCT01388166|580254022|FG000|Overall Study|Lost to Follow-up|30|||
160692109|NCT01388166|580254022|FG000|Overall Study|Others than specified above|13|||
160692110|NCT02751359|580254024|FG000|Overall Study|Lost to Follow-up|1|||
160692111|NCT02667288|580254025|FG000|Overall Study|Protocol Violation|5|||
160692112|NCT02667288|580254025|FG000|Overall Study|Lost to Follow-up|3|||
160692113|NCT02667288|580254025|FG000|Overall Study|Withdrawal by Subject|5|||
160692114|NCT01196078|580254026|FG000|Overall Study|Withdrawal by Subject|3|||
160692115|NCT01196078|580254027|FG001|Overall Study|Withdrawal by Subject|5|||
160692116|NCT01196078|580254026|FG000|Overall Study|Adverse Event|4|||
160692117|NCT01196078|580254027|FG001|Overall Study|Adverse Event|4|||
160692118|NCT01196078|580254026|FG000|Overall Study|Protocol Violation|2|||
160692119|NCT01196078|580254027|FG001|Overall Study|Protocol Violation|1|||
160692120|NCT01196078|580254026|FG000|Overall Study|Lack of Efficacy|17|||
160692121|NCT01196078|580254027|FG001|Overall Study|Lack of Efficacy|23|||
160692122|NCT01196078|580254026|FG000|Overall Study|Lost to Follow-up|1|||
160692123|NCT01196078|580254027|FG001|Overall Study|Lost to Follow-up|0|||
160692124|NCT01196078|580254026|FG000|Overall Study|Death|6|||
160692125|NCT01196078|580254027|FG001|Overall Study|Death|4|||
160692126|NCT02400671|580254028|FG000|Overall Study|Death|5|||
160692127|NCT02400671|580254029|FG001|Overall Study|Death|3|||
160692128|NCT02400671|580254030|FG002|Overall Study|Death|4|||
160692129|NCT02400671|580254028|FG000|Overall Study|Lost to Follow-up|20|||
160692130|NCT02400671|580254029|FG001|Overall Study|Lost to Follow-up|27|||
160692131|NCT02400671|580254030|FG002|Overall Study|Lost to Follow-up|24|||
160692132|NCT02400671|580254028|FG000|Overall Study|Withdrawal by Subject|2|||
160692133|NCT02400671|580254029|FG001|Overall Study|Withdrawal by Subject|2|||
160692134|NCT02400671|580254030|FG002|Overall Study|Withdrawal by Subject|0|||
160692135|NCT00857792|580254032|FG000|Overall Study|inadequate image quality for analysis|12|||
160692136|NCT03760250|580254034|FG000|Overall Study|Withdrawal by Subject|1|||
160692137|NCT03760250|580254034|FG000|Overall Study|Physician Decision|1|||
160692138|NCT03733210|580254035|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
160692139|NCT03733210|580254036|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
160692140|NCT04421586|580254037|FG000|Overall Study|Death|0|||
160692141|NCT04421586|580254038|FG001|Overall Study|Death|1|||
160692142|NCT04421586|580254037|FG000|Overall Study|Lost to Follow-up|2|||
160692143|NCT04421586|580254038|FG001|Overall Study|Lost to Follow-up|2|||
160692144|NCT04421586|580254037|FG000|Overall Study|Withdrawn by PI|1|||
160692145|NCT04421586|580254038|FG001|Overall Study|Withdrawn by PI|0|||
160692146|NCT04421586|580254037|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
160692147|NCT04421586|580254038|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
160692148|NCT04920916|580254039|FG000|Phase IIa 60 Day Study|Death|2|||
160692149|NCT04920916|580254040|FG001|Phase IIa 60 Day Study|Death|5|||
160692150|NCT04920916|580254039|FG000|1 Year Follow up (Phone Call)|Death|1|||
160692151|NCT04920916|580254040|FG001|1 Year Follow up (Phone Call)|Death|3|||
160692152|NCT04920916|580254039|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
160692153|NCT04920916|580254040|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
160692154|NCT02963441|580254041|FG000|Overall Study|Protocol violation or withdrawn|8|||
160692155|NCT02963441|580254041|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
160692156|NCT02963441|580254041|FG000|Overall Study|IDx-DR insufficient quality|33|||
160692157|NCT02011113|580254042|FG000|Overall Study|Adverse Event|4|||
160692158|NCT02011113|580254042|FG000|Overall Study|Disease Progression (DP)|16|||
160692159|NCT02011113|580254042|FG000|Overall Study|Death|1|||
160692160|NCT02011113|580254042|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
160692161|NCT02011113|580254042|FG000|Overall Study|Investigator's judgement- DP|3|||
160692162|NCT02011113|580254042|FG000|Overall Study|Study terminated by sponsor|11|||
160692163|NCT04688931|580254045|FG000|Overall Study|Adverse Event|4|||
160692164|NCT04688931|580254046|FG001|Overall Study|Adverse Event|1|||
160692165|NCT04688931|580254045|FG000|Overall Study|Withdrawal by Subject|5|||
160692166|NCT04688931|580254046|FG001|Overall Study|Withdrawal by Subject|16|||
160692167|NCT04688931|580254045|FG000|Overall Study|Physician Decision|3|||
160692168|NCT04688931|580254046|FG001|Overall Study|Physician Decision|5|||
160692169|NCT04688931|580254045|FG000|Overall Study|Noncompliance|0|||
160692170|NCT04688931|580254046|FG001|Overall Study|Noncompliance|1|||
160692171|NCT04688931|580254045|FG000|Overall Study|Lost to Follow-up|1|||
160692172|NCT04688931|580254046|FG001|Overall Study|Lost to Follow-up|3|||
160692173|NCT04688931|580254045|FG000|Overall Study|Randomization Error|3|||
160692174|NCT04688931|580254046|FG001|Overall Study|Randomization Error|0|||
160692175|NCT04688931|580254045|FG000|Overall Study|Not Eligible|1|||
160692176|NCT04688931|580254046|FG001|Overall Study|Not Eligible|3|||
160692177|NCT04688931|580254045|FG000|Overall Study|Disease Progression|0|||
160692178|NCT04688931|580254046|FG001|Overall Study|Disease Progression|2|||
160692179|NCT04688931|580254045|FG000|Overall Study|Sponsor Requirement|1|||
160692180|NCT04688931|580254046|FG001|Overall Study|Sponsor Requirement|1|||
160692181|NCT04688931|580254045|FG000|Overall Study|Other Reason|1|||
160692182|NCT04688931|580254046|FG001|Overall Study|Other Reason|2|||
160692183|NCT00361335|580254049|FG000|IV Period: Baseline to E0|Adverse Event|9|||
160692184|NCT00361335|580254050|FG001|IV Period: Baseline to E0|Adverse Event|4|||
160692185|NCT00361335|580254051|FG002|IV Period: Baseline to E0|Adverse Event|5|||
160692186|NCT00361335|580254052|FG003|IV Period: Baseline to E0|Adverse Event|9|||
160692187|NCT00361335|580254053|FG004|IV Period: Baseline to E0|Adverse Event|8|||
160692188|NCT00361335|580254054|FG005|IV Period: Baseline to E0|Adverse Event|0|||
160692189|NCT00361335|580254055|FG006|IV Period: Baseline to E0|Adverse Event|0|||
160692190|NCT00361335|580254049|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
160692191|NCT00361335|580254050|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
160692192|NCT00361335|580254051|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
160692193|NCT00361335|580254052|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
160692194|NCT00361335|580254053|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
160692195|NCT00361335|580254054|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
160692196|NCT00361335|580254055|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
160692197|NCT00361335|580254049|FG000|IV Period: Baseline to E0|Death|1|||
160692198|NCT00361335|580254050|FG001|IV Period: Baseline to E0|Death|1|||
160692199|NCT00361335|580254051|FG002|IV Period: Baseline to E0|Death|1|||
160692200|NCT00361335|580254052|FG003|IV Period: Baseline to E0|Death|1|||
160692201|NCT00361335|580254053|FG004|IV Period: Baseline to E0|Death|0|||
160692202|NCT00361335|580254054|FG005|IV Period: Baseline to E0|Death|0|||
160692203|NCT00361335|580254055|FG006|IV Period: Baseline to E0|Death|0|||
160692204|NCT00361335|580254049|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
160692205|NCT00361335|580254050|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
160692206|NCT00361335|580254051|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
160692207|NCT00361335|580254052|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
160692208|NCT00361335|580254053|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
160692209|NCT00361335|580254054|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
160692210|NCT00361335|580254055|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
160692211|NCT00361335|580254049|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
160692212|NCT00361335|580254050|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
160692213|NCT00361335|580254051|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
160692214|NCT00361335|580254052|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
160692215|NCT00361335|580254053|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
160692216|NCT00361335|580254054|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
160692217|NCT00361335|580254055|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
160692218|NCT00361335|580254049|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
160692219|NCT00361335|580254050|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
160692220|NCT00361335|580254051|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
160692221|NCT00361335|580254052|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
160692222|NCT00361335|580254053|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
160692223|NCT00361335|580254054|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
160692224|NCT00361335|580254055|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
160692225|NCT00361335|580254049|FG000|IV Period: Baseline to E0|Other|2|||
160692226|NCT00361335|580254050|FG001|IV Period: Baseline to E0|Other|9|||
160692227|NCT00361335|580254051|FG002|IV Period: Baseline to E0|Other|9|||
160692228|NCT00361335|580254052|FG003|IV Period: Baseline to E0|Other|3|||
160692229|NCT00361335|580254053|FG004|IV Period: Baseline to E0|Other|2|||
160692230|NCT00361335|580254054|FG005|IV Period: Baseline to E0|Other|0|||
160692231|NCT00361335|580254055|FG006|IV Period: Baseline to E0|Other|0|||
160692232|NCT00361335|580254049|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
160692233|NCT00361335|580254050|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
160692234|NCT00361335|580254051|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
160692235|NCT00361335|580254052|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
160692236|NCT00361335|580254053|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
160692237|NCT00361335|580254054|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
160692238|NCT00361335|580254055|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
160692239|NCT00361335|580254049|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
160692240|NCT00361335|580254050|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
160692241|NCT00361335|580254051|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
160692242|NCT00361335|580254052|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
160692243|NCT00361335|580254053|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
160692244|NCT00361335|580254054|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
160692245|NCT00361335|580254055|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
160692246|NCT00361335|580254049|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
160692247|NCT00361335|580254050|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
160692248|NCT00361335|580254051|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
160692249|NCT00361335|580254052|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
160692250|NCT00361335|580254053|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
160692251|NCT00361335|580254054|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
160692252|NCT00361335|580254055|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
160692253|NCT00361335|580254049|FG000|SC Period: Week E0 to Week E24|Death|0|||
160692254|NCT00361335|580254050|FG001|SC Period: Week E0 to Week E24|Death|0|||
160692255|NCT00361335|580254051|FG002|SC Period: Week E0 to Week E24|Death|0|||
160692256|NCT00361335|580254052|FG003|SC Period: Week E0 to Week E24|Death|0|||
160692257|NCT00361335|580254053|FG004|SC Period: Week E0 to Week E24|Death|0|||
160692258|NCT00361335|580254054|FG005|SC Period: Week E0 to Week E24|Death|0|||
160692259|NCT00361335|580254055|FG006|SC Period: Week E0 to Week E24|Death|1|||
160692260|NCT00361335|580254049|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
160692261|NCT00361335|580254050|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
160692262|NCT00361335|580254051|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
160692263|NCT00361335|580254052|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
160692264|NCT00361335|580254053|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
160692265|NCT00361335|580254054|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
160692266|NCT00361335|580254055|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
160692267|NCT00361335|580254049|FG000|SC Period: Week E0 to Week E24|Other|1|||
160692268|NCT00361335|580254050|FG001|SC Period: Week E0 to Week E24|Other|0|||
160692269|NCT00361335|580254051|FG002|SC Period: Week E0 to Week E24|Other|0|||
160692270|NCT00361335|580254052|FG003|SC Period: Week E0 to Week E24|Other|1|||
160692271|NCT00361335|580254053|FG004|SC Period: Week E0 to Week E24|Other|0|||
160692272|NCT00361335|580254054|FG005|SC Period: Week E0 to Week E24|Other|1|||
160692273|NCT00361335|580254055|FG006|SC Period: Week E0 to Week E24|Other|2|||
160692274|NCT00361335|580254049|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
160692275|NCT00361335|580254050|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
160692276|NCT00361335|580254051|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
160692277|NCT00361335|580254052|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
160692278|NCT00361335|580254053|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
160692279|NCT00361335|580254054|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
160692280|NCT00361335|580254055|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
160692281|NCT01765582|580254064|FG000|Overall Study|Other|3|||
160692282|NCT01765582|580254065|FG001|Overall Study|Other|6|||
160692283|NCT01765582|580254066|FG002|Overall Study|Other|9|||
160692284|NCT01765582|580254064|FG000|Overall Study|Lost to Follow-up|2|||
160692285|NCT01765582|580254065|FG001|Overall Study|Lost to Follow-up|2|||
160692286|NCT01765582|580254066|FG002|Overall Study|Lost to Follow-up|1|||
160692287|NCT01765582|580254064|FG000|Overall Study|Death|31|||
160692288|NCT01765582|580254065|FG001|Overall Study|Death|36|||
160692289|NCT01765582|580254066|FG002|Overall Study|Death|33|||
160692290|NCT01765582|580254064|FG000|Overall Study|Sponsor Decision|46|||
160692291|NCT01765582|580254065|FG001|Overall Study|Sponsor Decision|42|||
160692292|NCT01765582|580254066|FG002|Overall Study|Sponsor Decision|42|||
160692293|NCT01765582|580254064|FG000|Overall Study|Withdrawal of Consent|11|||
160692294|NCT01765582|580254065|FG001|Overall Study|Withdrawal of Consent|6|||
160692295|NCT01765582|580254066|FG002|Overall Study|Withdrawal of Consent|10|||
160692296|NCT03251963|580254069|FG000|Overall Study|inappropriate Xa level timing|6|||
160692297|NCT03251963|580254070|FG001|Overall Study|inappropriate Xa level timing|3|||
160692298|NCT03251963|580254069|FG000|Overall Study|no peak Xa level drawn|2|||
160692299|NCT03251963|580254070|FG001|Overall Study|no peak Xa level drawn|0|||
160692300|NCT03251963|580254069|FG000|Overall Study|bled prior to Xa level|1|||
160692301|NCT03251963|580254070|FG001|Overall Study|bled prior to Xa level|2|||
160692302|NCT00354341|580254078|FG000|Overall Study|Adverse Event|1|||
160692303|NCT00354341|580254079|FG001|Overall Study|Adverse Event|0|||
160692304|NCT00354341|580254078|FG000|Overall Study|Death|0|||
160692305|NCT00354341|580254079|FG001|Overall Study|Death|2|||
160692306|NCT00354341|580254078|FG000|Overall Study|Refused treatment|1|||
160692307|NCT00354341|580254079|FG001|Overall Study|Refused treatment|2|||
160692308|NCT00354341|580254078|FG000|Overall Study|Failure to return|0|||
160692309|NCT00354341|580254079|FG001|Overall Study|Failure to return|1|||
160692310|NCT00354341|580254078|FG000|Overall Study|Other|1|||
160692311|NCT00354341|580254079|FG001|Overall Study|Other|2|||
160692312|NCT00251719|580254080|FG000|Overall Study|Adverse Event|14|||
160692313|NCT00251719|580254081|FG001|Overall Study|Adverse Event|8|||
160692314|NCT00251719|580254082|FG002|Overall Study|Adverse Event|7|||
160692315|NCT00251719|580254080|FG000|Overall Study|Protocol Violation|1|||
160692316|NCT00251719|580254081|FG001|Overall Study|Protocol Violation|1|||
160692317|NCT00251719|580254082|FG002|Overall Study|Protocol Violation|1|||
160692318|NCT00251719|580254080|FG000|Overall Study|Lost to Follow-up|5|||
160692319|NCT00251719|580254081|FG001|Overall Study|Lost to Follow-up|11|||
160692320|NCT00251719|580254082|FG002|Overall Study|Lost to Follow-up|8|||
160692321|NCT00251719|580254080|FG000|Overall Study|Withdrawal by Subject|14|||
160692322|NCT00251719|580254081|FG001|Overall Study|Withdrawal by Subject|12|||
160692323|NCT00251719|580254082|FG002|Overall Study|Withdrawal by Subject|11|||
160692324|NCT00251719|580254080|FG000|Overall Study|Lack of Efficacy|2|||
160692325|NCT00251719|580254081|FG001|Overall Study|Lack of Efficacy|1|||
160692326|NCT00251719|580254082|FG002|Overall Study|Lack of Efficacy|0|||
160692327|NCT00251719|580254080|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
160692328|NCT00251719|580254081|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
160692329|NCT00251719|580254082|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
160692330|NCT00251719|580254080|FG000|Overall Study|Investigator decision|1|||
160692331|NCT00251719|580254081|FG001|Overall Study|Investigator decision|1|||
160692332|NCT00251719|580254082|FG002|Overall Study|Investigator decision|0|||
160692333|NCT00251719|580254080|FG000|Overall Study|Noncompliance|2|||
160692334|NCT00251719|580254081|FG001|Overall Study|Noncompliance|3|||
160692335|NCT00251719|580254082|FG002|Overall Study|Noncompliance|1|||
160692336|NCT00251719|580254080|FG000|Overall Study|Barrett's esophagus|2|||
160692337|NCT00251719|580254081|FG001|Overall Study|Barrett's esophagus|2|||
160692338|NCT00251719|580254082|FG002|Overall Study|Barrett's esophagus|0|||
160692339|NCT02792959|580254086|FG000|Overall Study|Protocol Violation|1|||
160692340|NCT02408068|580254087|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
160692341|NCT02408068|580254088|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
160692342|NCT02408068|580254089|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
160692343|NCT02408068|580254090|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
160692344|NCT02408068|580254091|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
160692345|NCT02408068|580254092|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
160692346|NCT03484117|580254093|FG000|Overall Study|Lost to Follow-up|1|||
160692347|NCT03484117|580254094|FG001|Overall Study|Lost to Follow-up|3|||
160692348|NCT03484117|580254093|FG000|Overall Study|Declined participation in exit assess|1|||
160692349|NCT03484117|580254094|FG001|Overall Study|Declined participation in exit assess|1|||
160692350|NCT02999477|580254100|FG000|Overall Study|found ineligible after first dose|0|||
160692351|NCT02999477|580254101|FG001|Overall Study|found ineligible after first dose|1|||
160692352|NCT02999477|580254100|FG000|Overall Study|Withdrawal by Subject|1|||
160692353|NCT02999477|580254101|FG001|Overall Study|Withdrawal by Subject|1|||
160692354|NCT01846273|580254102|FG000|Overall Study|Adverse Event|9|||
160692355|NCT01846273|580254103|FG001|Overall Study|Adverse Event|7|||
160692356|NCT01846273|580254104|FG002|Overall Study|Adverse Event|0|||
160692357|NCT01846273|580254102|FG000|Overall Study|Subject withdrew consent|5|||
160692358|NCT01846273|580254103|FG001|Overall Study|Subject withdrew consent|8|||
160692359|NCT01846273|580254104|FG002|Overall Study|Subject withdrew consent|0|||
160692360|NCT01846273|580254102|FG000|Overall Study|Lost to Follow-up|2|||
160692361|NCT01846273|580254103|FG001|Overall Study|Lost to Follow-up|1|||
160692362|NCT01846273|580254104|FG002|Overall Study|Lost to Follow-up|0|||
160692363|NCT01846273|580254102|FG000|Overall Study|Administrative problems|1|||
160692364|NCT01846273|580254103|FG001|Overall Study|Administrative problems|0|||
160692365|NCT01846273|580254104|FG002|Overall Study|Administrative problems|0|||
160692366|NCT01846273|580254102|FG000|Overall Study|Death|2|||
160692367|NCT01846273|580254103|FG001|Overall Study|Death|1|||
160692368|NCT01846273|580254104|FG002|Overall Study|Death|0|||
160692369|NCT01846273|580254102|FG000|Overall Study|Disease Progression|0|||
160692370|NCT01846273|580254103|FG001|Overall Study|Disease Progression|4|||
160692371|NCT01846273|580254104|FG002|Overall Study|Disease Progression|0|||
160692372|NCT01846273|580254102|FG000|Overall Study|Protocol Deviation|2|||
160692373|NCT01846273|580254103|FG001|Overall Study|Protocol Deviation|3|||
160692374|NCT01846273|580254104|FG002|Overall Study|Protocol Deviation|0|||
160692375|NCT01846273|580254102|FG000|Overall Study|Physician Decision|1|||
160692376|NCT01846273|580254103|FG001|Overall Study|Physician Decision|2|||
160692377|NCT01846273|580254104|FG002|Overall Study|Physician Decision|0|||
160692378|NCT00891839|580254105|FG000|Overall Study|Adverse Event|2|||
160692379|NCT00891839|580254105|FG000|Overall Study|Withdrawal by Subject|2|||
160692380|NCT00891839|580254105|FG000|Overall Study|Disease progression|3|||
160692381|NCT00851643|580254106|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
160692382|NCT00851643|580254107|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
160692383|NCT00851643|580254108|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
160692384|NCT00851643|580254109|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
160692385|NCT00851643|580254110|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
160692386|NCT00851643|580254111|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
160692387|NCT00851643|580254106|FG000|Base Study (Up to 12 Months)|Other|0|||
160692388|NCT00851643|580254107|FG001|Base Study (Up to 12 Months)|Other|0|||
160692389|NCT00851643|580254108|FG002|Base Study (Up to 12 Months)|Other|0|||
160692390|NCT00851643|580254109|FG003|Base Study (Up to 12 Months)|Other|0|||
160692391|NCT00851643|580254110|FG004|Base Study (Up to 12 Months)|Other|0|||
160692392|NCT00851643|580254111|FG005|Base Study (Up to 12 Months)|Other|1|||
160692393|NCT00851643|580254106|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
160692394|NCT00851643|580254107|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
160692395|NCT00851643|580254108|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
160692396|NCT00851643|580254109|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
160692397|NCT00851643|580254110|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
160692398|NCT00851643|580254111|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
160692399|NCT00851643|580254106|FG000|Extension Study (Up to 36 Months)|Moved|0|||
160692400|NCT00851643|580254107|FG001|Extension Study (Up to 36 Months)|Moved|2|||
160692401|NCT00851643|580254108|FG002|Extension Study (Up to 36 Months)|Moved|1|||
160692402|NCT00851643|580254109|FG003|Extension Study (Up to 36 Months)|Moved|1|||
160692403|NCT00851643|580254110|FG004|Extension Study (Up to 36 Months)|Moved|0|||
160692404|NCT00851643|580254111|FG005|Extension Study (Up to 36 Months)|Moved|1|||
160692405|NCT00359788|580254112|FG000|Overall Study|Adverse Event|11|||
160692406|NCT00359788|580254113|FG001|Overall Study|Adverse Event|10|||
160692407|NCT00359788|580254112|FG000|Overall Study|Lack of Efficacy|1|||
160692408|NCT00359788|580254113|FG001|Overall Study|Lack of Efficacy|2|||
160692409|NCT00359788|580254112|FG000|Overall Study|Lost to Follow-up|3|||
160692410|NCT00359788|580254113|FG001|Overall Study|Lost to Follow-up|2|||
160692411|NCT00359788|580254112|FG000|Overall Study|Withdrawal by Subject|4|||
160692412|NCT00359788|580254113|FG001|Overall Study|Withdrawal by Subject|1|||
160692413|NCT00359788|580254112|FG000|Overall Study|Protocol Violation|4|||
160692414|NCT00359788|580254113|FG001|Overall Study|Protocol Violation|2|||
160692415|NCT01641133|580254114|FG000|Overall Study|Protocol Violation|0|||
160692416|NCT01641133|580254115|FG001|Overall Study|Protocol Violation|1|||
160692417|NCT01641133|580254116|FG002|Overall Study|Protocol Violation|1|||
160692418|NCT01641133|580254114|FG000|Overall Study|Migrated/moved from study area|5|||
160692419|NCT01641133|580254115|FG001|Overall Study|Migrated/moved from study area|3|||
160692420|NCT01641133|580254116|FG002|Overall Study|Migrated/moved from study area|1|||
160692421|NCT01641133|580254114|FG000|Overall Study|Adverse Event|0|||
160692422|NCT01641133|580254115|FG001|Overall Study|Adverse Event|0|||
160692423|NCT01641133|580254116|FG002|Overall Study|Adverse Event|1|||
160692424|NCT01641133|580254114|FG000|Overall Study|Withdrawal by Subject|5|||
160692425|NCT01641133|580254115|FG001|Overall Study|Withdrawal by Subject|3|||
160692426|NCT01641133|580254116|FG002|Overall Study|Withdrawal by Subject|3|||
160692427|NCT01641133|580254114|FG000|Overall Study|Lost to Follow-up|0|||
160692428|NCT01641133|580254115|FG001|Overall Study|Lost to Follow-up|2|||
160692429|NCT01641133|580254116|FG002|Overall Study|Lost to Follow-up|2|||
160692430|NCT02220725|580254117|FG000|Overall Study|Lost to Follow-up|0|||
160692431|NCT02220725|580254118|FG001|Overall Study|Lost to Follow-up|0|||
160692432|NCT02220725|580254119|FG002|Overall Study|Lost to Follow-up|0|||
160692433|NCT02220725|580254120|FG003|Overall Study|Lost to Follow-up|1|||
160692434|NCT02220725|580254117|FG000|Overall Study|Withdrawal by Subject|0|||
160692435|NCT02220725|580254118|FG001|Overall Study|Withdrawal by Subject|0|||
160692436|NCT02220725|580254119|FG002|Overall Study|Withdrawal by Subject|0|||
160692437|NCT02220725|580254120|FG003|Overall Study|Withdrawal by Subject|1|||
160692438|NCT03351231|580254123|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
160692439|NCT03351231|580254123|FG000|Combination Therapy Period|Disease progression|2|||
160692440|NCT03351231|580254123|FG000|Combination Therapy Period|Study drug toxicity|1|||
160692441|NCT03351231|580254123|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
160692442|NCT03351231|580254123|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
160692443|NCT03351231|580254123|FG000|Safety Follow-Up Period|Other reason|2|||
160692444|NCT00103402|580254124|FG000|Overall Study|Adverse Event|3|||
160692445|NCT00103402|580254125|FG001|Overall Study|Adverse Event|4|||
160692446|NCT00103402|580254124|FG000|Overall Study|Lost to Follow-up|8|||
160692447|NCT00103402|580254125|FG001|Overall Study|Lost to Follow-up|7|||
160692448|NCT00103402|580254124|FG000|Overall Study|Dissatisfied/No longer interested|6|||
160692449|NCT00103402|580254125|FG001|Overall Study|Dissatisfied/No longer interested|6|||
160692450|NCT00103402|580254124|FG000|Overall Study|Personal constraints/Other|5|||
160692451|NCT00103402|580254125|FG001|Overall Study|Personal constraints/Other|0|||
160692452|NCT01673698|580254126|FG000|Overall Study|Lost to Follow-up|51|||
160692453|NCT01673698|580254127|FG001|Overall Study|Lost to Follow-up|13|||
160692454|NCT01297322|580254128|FG000|Overall Study|Lost to Follow-up|1|||
160692455|NCT01297322|580254129|FG001|Overall Study|Lost to Follow-up|0|||
160692456|NCT01297322|580254128|FG000|Overall Study|Withdrawal by Subject|0|||
160692457|NCT01297322|580254129|FG001|Overall Study|Withdrawal by Subject|1|||
160692458|NCT01297322|580254128|FG000|Overall Study|Protocol Violation|0|||
160692459|NCT01297322|580254129|FG001|Overall Study|Protocol Violation|3|||
160692460|NCT01111019|580254130|FG000|Overall Study|Withdrew Prematurely|2|||
160692461|NCT01111019|580254130|FG000|Overall Study|Other|1|||
160692462|NCT01583218|580254131|FG000|Overall Study|Withdrawal by Subject|43|||
160692463|NCT01583218|580254132|FG001|Overall Study|Withdrawal by Subject|29|||
160692464|NCT01583218|580254131|FG000|Overall Study|Death|206|||
160692465|NCT01583218|580254132|FG001|Overall Study|Death|211|||
160692466|NCT01583218|580254131|FG000|Overall Study|Lost to Follow-up|11|||
160692467|NCT01583218|580254132|FG001|Overall Study|Lost to Follow-up|17|||
160692468|NCT01583218|580254131|FG000|Overall Study|Adverse event or serious adverse event|3|||
160692469|NCT01583218|580254132|FG001|Overall Study|Adverse event or serious adverse event|3|||
160692470|NCT01583218|580254131|FG000|Overall Study|Patient /Family decision|3|||
160692471|NCT01583218|580254132|FG001|Overall Study|Patient /Family decision|0|||
160692472|NCT01583218|580254131|FG000|Overall Study|Cannot contact patient directly|1|||
160692473|NCT01583218|580254132|FG001|Overall Study|Cannot contact patient directly|2|||
160692474|NCT01583218|580254131|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
160692475|NCT01583218|580254132|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
160692476|NCT01583218|580254131|FG000|Overall Study|Patient did not wish to attend visits|0|||
160692477|NCT01583218|580254132|FG001|Overall Study|Patient did not wish to attend visits|1|||
160692478|NCT01583218|580254131|FG000|Overall Study|Patient randomized but not dosed|17|||
160692479|NCT01583218|580254132|FG001|Overall Study|Patient randomized but not dosed|16|||
160692480|NCT01583218|580254131|FG000|Overall Study|Patient was assessed via phone in person|1|||
160692481|NCT01583218|580254132|FG001|Overall Study|Patient was assessed via phone in person|0|||
160692482|NCT01583218|580254131|FG000|Overall Study|Patient deemed ineligible after random|2|||
160692483|NCT01583218|580254132|FG001|Overall Study|Patient deemed ineligible after random|0|||
160692484|NCT01583218|580254131|FG000|Overall Study|Patient was early terminated from study|0|||
160692485|NCT01583218|580254132|FG001|Overall Study|Patient was early terminated from study|1|||
160692486|NCT01583218|580254131|FG000|Overall Study|Patient was randomized due to mistake|1|||
160692487|NCT01583218|580254132|FG001|Overall Study|Patient was randomized due to mistake|0|||
160692488|NCT01583218|580254131|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
160692489|NCT01583218|580254132|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
160692490|NCT01583218|580254131|FG000|Overall Study|Withdraw of consent on day of random|1|||
160692491|NCT01583218|580254132|FG001|Overall Study|Withdraw of consent on day of random|0|||
160692492|NCT02013375|580254135|FG000|Overall Study|Did not engraft|1|||
160692493|NCT02013375|580254135|FG000|Overall Study|Did not engraft|1|||
160692494|NCT00712985|580254136|FG000|Overall Study|1 withdrew prior to start of drug|1|||
160692495|NCT00712985|580254136|FG000|Overall Study|1 patient moved out of state|1|||
160692496|NCT00712985|580254136|FG000|Overall Study|Lack of Efficacy|3|||
160692497|NCT02674061|580254137|FG000|Overall Study|Death|229|||
160692498|NCT02674061|580254138|FG001|Overall Study|Death|77|||
160692499|NCT02674061|580254137|FG000|Overall Study|Lost to Follow-up|3|||
160692500|NCT02674061|580254138|FG001|Overall Study|Lost to Follow-up|3|||
160692501|NCT02674061|580254137|FG000|Overall Study|Withdrawal by Subject|9|||
160692502|NCT02674061|580254138|FG001|Overall Study|Withdrawal by Subject|1|||
160692503|NCT02674061|580254137|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
160692504|NCT02674061|580254138|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
160692505|NCT03334721|580254141|FG000|Overall Study|Withdrawal by Subject|1|||
160692506|NCT03334721|580254142|FG001|Overall Study|Withdrawal by Subject|0|||
160692507|NCT03334721|580254141|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
160692508|NCT03334721|580254142|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
160692509|NCT01663727|580254144|FG000|Overall Study|Death|161|||
160692510|NCT01663727|580254145|FG001|Overall Study|Death|155|||
160692511|NCT01663727|580254144|FG000|Overall Study|Lost to Follow-up|10|||
160692512|NCT01663727|580254145|FG001|Overall Study|Lost to Follow-up|8|||
160692513|NCT01663727|580254144|FG000|Overall Study|Withdrawal by Subject|18|||
160692514|NCT01663727|580254145|FG001|Overall Study|Withdrawal by Subject|25|||
160692515|NCT01663727|580254144|FG000|Overall Study|Study Terminated|51|||
160692516|NCT01663727|580254145|FG001|Overall Study|Study Terminated|50|||
160692517|NCT01663727|580254144|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
160692518|NCT01663727|580254145|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
160692519|NCT01663727|580254144|FG000|Overall Study|Withdrawal prior to dosing.|1|||
160692520|NCT01663727|580254145|FG001|Overall Study|Withdrawal prior to dosing.|0|||
160692521|NCT01902628|580254146|FG000|Overall Study|Withdrawal of participant's consent|7|||
160692522|NCT01902628|580254146|FG000|Overall Study|Adverse Event|41|||
160692523|NCT01902628|580254146|FG000|Overall Study|Lost to Follow-up|35|||
160692524|NCT01232491|580254147|FG000|Overall Study|Adverse Event|13|||
160692525|NCT01232491|580254148|FG001|Overall Study|Adverse Event|8|||
160692526|NCT01232491|580254147|FG000|Overall Study|Lack of Efficacy|1|||
160692527|NCT01232491|580254148|FG001|Overall Study|Lack of Efficacy|5|||
160692528|NCT01232491|580254147|FG000|Overall Study|Protocol Violation|13|||
160692529|NCT01232491|580254148|FG001|Overall Study|Protocol Violation|11|||
160692530|NCT01232491|580254147|FG000|Overall Study|Withdrawal Criteria|12|||
160692531|NCT01232491|580254148|FG001|Overall Study|Withdrawal Criteria|21|||
160692532|NCT01232491|580254147|FG000|Overall Study|Other|21|||
160692533|NCT01232491|580254148|FG001|Overall Study|Other|18|||
160692534|NCT02932228|580254149|FG000|Overall Study|Death|8|||
160692535|NCT02932228|580254150|FG001|Overall Study|Death|23|||
160692536|NCT02932228|580254149|FG000|Overall Study|not eligible upon chart review|2|||
160692537|NCT02932228|580254150|FG001|Overall Study|not eligible upon chart review|5|||
160692538|NCT04062448|580256126|FG000|Overall Study|Lost to Follow-up|1|||
160692539|NCT04062448|580256126|FG000|Overall Study|Withdrawal by Subject|2|||
160692540|NCT04319718|580256127|FG000|Overall Study|Adverse Event|0|||
160692541|NCT04319718|580256128|FG001|Overall Study|Adverse Event|2|||
160692542|NCT04319718|580256127|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
160692543|NCT04319718|580256128|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
160692544|NCT02221037|580256129|FG000|Overall Study|Physician Decision|0|||
160692545|NCT02221037|580256130|FG001|Overall Study|Physician Decision|0|||
160692546|NCT02221037|580256131|FG002|Overall Study|Physician Decision|1|||
160692547|NCT02221037|580256132|FG003|Overall Study|Physician Decision|0|||
160692548|NCT03955471|580256134|FG000|Overall Study|Death|22|||
160692549|NCT03955471|580256134|FG000|Overall Study|Lost to Follow-up|1|||
160692550|NCT03955471|580256134|FG000|Overall Study|Withdrawal by Subject|6|||
160692551|NCT03955471|580256134|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
160692552|NCT01884311|580256135|FG000|Overall Study|Withdrawal by Subject|3|||
160692553|NCT01884311|580256135|FG000|Overall Study|withdrew consent due to AEs|1|||
160692554|NCT01884311|580256135|FG000|Overall Study|Precautionary measure|1|||
160692555|NCT02858492|580256136|FG000|Overall Study|Withdrawal by Subject|0|||
160692556|NCT02858492|580256137|FG001|Overall Study|Withdrawal by Subject|1|||
160692557|NCT02858492|580256138|FG002|Overall Study|Withdrawal by Subject|0|||
160692558|NCT02858492|580256139|FG003|Overall Study|Withdrawal by Subject|1|||
160692559|NCT02858492|580256136|FG000|Overall Study|Adverse Event|0|||
160692560|NCT02858492|580256137|FG001|Overall Study|Adverse Event|0|||
160692561|NCT02858492|580256138|FG002|Overall Study|Adverse Event|0|||
160692562|NCT02858492|580256139|FG003|Overall Study|Adverse Event|3|||
160692563|NCT02858492|580256136|FG000|Overall Study|Lack of Efficacy|0|||
160692564|NCT02858492|580256137|FG001|Overall Study|Lack of Efficacy|0|||
160692565|NCT02858492|580256138|FG002|Overall Study|Lack of Efficacy|0|||
160692566|NCT02858492|580256139|FG003|Overall Study|Lack of Efficacy|1|||
160692567|NCT02858492|580256136|FG000|Overall Study|Protocol defined stopping criteria|0|||
160692568|NCT02858492|580256137|FG001|Overall Study|Protocol defined stopping criteria|0|||
160692569|NCT02858492|580256138|FG002|Overall Study|Protocol defined stopping criteria|0|||
160692570|NCT02858492|580256139|FG003|Overall Study|Protocol defined stopping criteria|1|||
160692571|NCT02944383|580256140|FG000|Overall Study|Lost to Follow-up|0|||
160692572|NCT02944383|580256141|FG001|Overall Study|Lost to Follow-up|0|||
160692573|NCT02944383|580256142|FG002|Overall Study|Lost to Follow-up|1|||
160692574|NCT02944383|580256140|FG000|Overall Study|Withdrawal by Subject|1|||
160692575|NCT02944383|580256141|FG001|Overall Study|Withdrawal by Subject|0|||
160692576|NCT02944383|580256142|FG002|Overall Study|Withdrawal by Subject|0|||
160692577|NCT01995266|580256144|FG000|Overall Study|Death|1|||
160692578|NCT01995266|580256144|FG000|Overall Study|Lack of Efficacy|6|||
160692579|NCT01995266|580256144|FG000|Overall Study|Adverse Event|2|||
160692580|NCT03853148|580256145|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
160692581|NCT03853148|580256146|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
160692582|NCT03853148|580256147|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
160692583|NCT03853148|580256148|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
160692584|NCT00090610|580256149|FG000|Overall Study|Withdrawal by Subject|1|||
160692585|NCT00090610|580256150|FG001|Overall Study|Withdrawal by Subject|1|||
160692586|NCT00599521|580256155|FG000|Overall Study|Lack of Efficacy|4|||
160692587|NCT00599521|580256156|FG001|Overall Study|Lack of Efficacy|8|||
160692588|NCT00599521|580256155|FG000|Overall Study|Adverse Event|4|||
160692589|NCT00599521|580256156|FG001|Overall Study|Adverse Event|1|||
160692590|NCT00599521|580256155|FG000|Overall Study|Withdrawal by Subject|28|||
160692591|NCT00599521|580256156|FG001|Overall Study|Withdrawal by Subject|34|||
160692592|NCT00599521|580256155|FG000|Overall Study|Protocol Violation|1|||
160692593|NCT00599521|580256156|FG001|Overall Study|Protocol Violation|1|||
160692594|NCT00599521|580256155|FG000|Overall Study|Lost to Follow-up|23|||
160692595|NCT00599521|580256156|FG001|Overall Study|Lost to Follow-up|23|||
160692596|NCT00599521|580256155|FG000|Overall Study|Pregnancy|0|||
160692597|NCT00599521|580256156|FG001|Overall Study|Pregnancy|2|||
160692598|NCT01293539|580256158|FG000|Overall Study|Physician Decision|1|||
160692599|NCT00609518|580256160|FG000|Overall Study|Death from Study Disease|32|||
160692600|NCT00609518|580256161|FG001|Overall Study|Death from Study Disease|32|||
160692601|NCT00609518|580256160|FG000|Overall Study|Withdrawal by Subject|5|||
160692602|NCT00609518|580256161|FG001|Overall Study|Withdrawal by Subject|3|||
160692603|NCT00609518|580256160|FG000|Overall Study|Lost to Follow-up|3|||
160692604|NCT00609518|580256161|FG001|Overall Study|Lost to Follow-up|0|||
160692605|NCT00609518|580256160|FG000|Overall Study|Physician Decision|1|||
160692606|NCT00609518|580256161|FG001|Overall Study|Physician Decision|3|||
160692607|NCT00609518|580256160|FG000|Overall Study|Death from Adverse Event|2|||
160692608|NCT00609518|580256161|FG001|Overall Study|Death from Adverse Event|2|||
160692609|NCT05855616|580256162|FG000|Overall Study|Lost to Follow-up|1|||
160692610|NCT05855616|580256163|FG001|Overall Study|Lost to Follow-up|2|||
160692611|NCT04032158|580256164|FG000|Overall Study|Study Termination|2|||
160692612|NCT04032158|580256165|FG001|Overall Study|Study Termination|1|||
160692613|NCT00059787|580256166|FG000|Overall Study|Adverse Event|13|||
160692614|NCT00059787|580256166|FG000|Overall Study|disease progression|2|||
160692615|NCT00059787|580256166|FG000|Overall Study|ineligible|1|||
160692616|NCT00059787|580256166|FG000|Overall Study|Other|4|||
160692617|NCT01248013|580256169|FG000|Overall Study|Withdrawal by Subject|14|||
160692618|NCT04325204|580256172|FG000|Overall Study|Death|0|||
160692619|NCT04325204|580256173|FG001|Overall Study|Death|1|||
160692620|NCT04325204|580256172|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
160692621|NCT04325204|580256173|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
160692622|NCT04325204|580256172|FG000|Overall Study|Lost to Follow-up|8|||
160692623|NCT04325204|580256173|FG001|Overall Study|Lost to Follow-up|8|||
160692624|NCT04325204|580256172|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
160748705|NCT00303472|580465926|FG000|Treatment Extension (Optional)|Death|2|||
160692625|NCT04325204|580256173|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
160692626|NCT00841906|580256174|FG000|Overall Study|Withdrawal by Subject|2|||
160692627|NCT00841906|580256175|FG001|Overall Study|Withdrawal by Subject|0|||
160692628|NCT04397445|580256185|FG000|Overall Study|Withdrawal by Subject|1|||
160692629|NCT04397445|580256186|FG001|Overall Study|Withdrawal by Subject|0|||
160692630|NCT04397445|580256187|FG002|Overall Study|Withdrawal by Subject|0|||
160692631|NCT04397445|580256188|FG003|Overall Study|Withdrawal by Subject|0|||
160692632|NCT01429051|580256189|FG000|Titration Phase|Death|1|||
160692633|NCT01429051|580256189|FG000|Titration Phase|Withdrawal by Subject|7|||
160692634|NCT01429051|580256189|FG000|Titration Phase|Physician Decision|1|||
160692635|NCT01429051|580256189|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
160692636|NCT01429051|580256189|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
160692637|NCT01429051|580256189|FG000|Efficacy Phase|Adverse Event|1|||
160692638|NCT01429051|580256189|FG000|Efficacy Phase|Death|1|||
160692639|NCT01429051|580256189|FG000|Tolerability Phase|Death|5|||
160692640|NCT01429051|580256189|FG000|Tolerability Phase|Adverse Event|2|||
160692641|NCT01429051|580256189|FG000|Tolerability Phase|Withdrawal by Subject|5|||
160692642|NCT01429051|580256189|FG000|Tolerability Phase|Physician Decision|1|||
160692643|NCT01429051|580256189|FG000|Tolerability Phase|Other|2|||
160692644|NCT00891371|580256190|FG000|Pre-assignment|Inclusion/exclusion|5|||
160692645|NCT00891371|580256190|FG000|Pre-assignment|Consent withdrawal|1|||
160692646|NCT00891371|580256190|FG000|Treatment|Lack of Efficacy|5|||
160692647|NCT00891371|580256190|FG000|Treatment|Adverse Event|2|||
160692648|NCT00891371|580256190|FG000|Treatment|Death|1|||
160692649|NCT00891371|580256190|FG000|Treatment|Lost to Follow-up|1|||
160692650|NCT00307034|580256191|FG000|Overall Study|Adverse Event|1|||
160692651|NCT00307034|580256192|FG001|Overall Study|Adverse Event|2|||
160692652|NCT00307034|580256191|FG000|Overall Study|Withdrawal by Subject|1|||
160692653|NCT00307034|580256192|FG001|Overall Study|Withdrawal by Subject|2|||
160692654|NCT00307034|580256191|FG000|Overall Study|Lost to Follow-up|0|||
160692655|NCT00307034|580256192|FG001|Overall Study|Lost to Follow-up|3|||
160692656|NCT02034058|580256201|FG000|Overall Study|Death|3|||
160692657|NCT00616941|580256202|FG000|Overall Study|Progressive Disease|1|||
160692658|NCT00616941|580256203|FG001|Overall Study|Progressive Disease|2|||
160692659|NCT00616941|580256204|FG002|Overall Study|Progressive Disease|1|||
160692660|NCT00616941|580256202|FG000|Overall Study|Adverse Event|0|||
160692661|NCT00616941|580256203|FG001|Overall Study|Adverse Event|1|||
160692662|NCT00616941|580256204|FG002|Overall Study|Adverse Event|1|||
160692663|NCT00616941|580256202|FG000|Overall Study|Subject Non-compliance|0|||
160692664|NCT00616941|580256203|FG001|Overall Study|Subject Non-compliance|0|||
160692665|NCT00616941|580256204|FG002|Overall Study|Subject Non-compliance|1|||
160692666|NCT00616941|580256202|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
160692667|NCT00616941|580256203|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
160692668|NCT00616941|580256204|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
160692669|NCT00616941|580256202|FG000|Overall Study|Vaccination Suspended|0|||
160692670|NCT00616941|580256203|FG001|Overall Study|Vaccination Suspended|0|||
160692671|NCT00616941|580256204|FG002|Overall Study|Vaccination Suspended|3|||
160692672|NCT00714493|580256205|FG000|Overall Study|Adverse Event|11|||
160692673|NCT00714493|580256205|FG000|Overall Study|Death|3|||
160692674|NCT00714493|580256205|FG000|Overall Study|Lack of Efficacy|10|||
160692675|NCT00714493|580256205|FG000|Overall Study|Lost to Follow-up|3|||
160692676|NCT00714493|580256205|FG000|Overall Study|Protocol Violation|12|||
160692677|NCT00714493|580256205|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
160692678|NCT00714493|580256205|FG000|Overall Study|OTHER|2|||
160692679|NCT00076804|580256206|FG000|Overall Study|Death|9|||
160692680|NCT00076804|580256207|FG001|Overall Study|Death|20|||
160692681|NCT00076804|580256206|FG000|Overall Study|Lost to Follow-up|9|||
160692682|NCT00076804|580256207|FG001|Overall Study|Lost to Follow-up|9|||
160692683|NCT00076804|580256206|FG000|Overall Study|Withdrawal by Subject|10|||
160692684|NCT00076804|580256207|FG001|Overall Study|Withdrawal by Subject|8|||
160692685|NCT00076804|580256206|FG000|Overall Study|Early study Closure|32|||
160692686|NCT00076804|580256207|FG001|Overall Study|Early study Closure|32|||
160692687|NCT01449279|580256210|FG000|Overall Study|Lack of Efficacy|5|||
160692688|NCT01449279|580256210|FG000|Overall Study|Toxicity|2|||
160692689|NCT01732874|580256211|FG000|Overall Study|Withdrawal by Subject|5|||
160692690|NCT01732874|580256212|FG001|Overall Study|Withdrawal by Subject|1|||
160692691|NCT01732874|580256211|FG000|Overall Study|Death of Infant|3|||
160692692|NCT01732874|580256212|FG001|Overall Study|Death of Infant|2|||
160692693|NCT00688376|580256213|FG000|Double-Blind Phase|Adverse Event|4|||
160692694|NCT00688376|580256214|FG001|Double-Blind Phase|Adverse Event|4|||
160692695|NCT00688376|580256213|FG000|Double-Blind Phase|Protocol Violation|1|||
160692696|NCT00688376|580256214|FG001|Double-Blind Phase|Protocol Violation|2|||
160692697|NCT00688376|580256213|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
160692698|NCT00688376|580256214|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
160692699|NCT00688376|580256213|FG000|Double-Blind Phase|Not treated|0|||
160692700|NCT00688376|580256214|FG001|Double-Blind Phase|Not treated|1|||
160692701|NCT00688376|580256213|FG000|Blinded Extension Phase|Adverse Event|3|||
160692702|NCT00688376|580256214|FG001|Blinded Extension Phase|Adverse Event|4|||
160692703|NCT00688376|580256213|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
160692704|NCT00688376|580256214|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
160692705|NCT00688376|580256213|FG000|Blinded Extension Phase|Physician Decision|1|||
160692706|NCT00688376|580256214|FG001|Blinded Extension Phase|Physician Decision|0|||
160692707|NCT00688376|580256213|FG000|Blinded Extension Phase|Other|1|||
160692708|NCT00688376|580256214|FG001|Blinded Extension Phase|Other|0|||
160692709|NCT00557076|580256215|FG000|Overall Study|Unblinding|0|||
160692710|NCT00557076|580256216|FG001|Overall Study|Unblinding|1|||
160692711|NCT03201250|580256218|FG000|Overall Study|screen failures|3|||
160692712|NCT03201250|580256219|FG001|Overall Study|screen failures|0|||
160692713|NCT03201250|580256220|FG002|Overall Study|screen failures|0|||
160692714|NCT02575911|580256223|FG000|Overall Study|Lost to Follow-up|1|||
160692715|NCT03579966|580256224|FG000|Overall Study|Adverse Event|6|||
160692716|NCT03579966|580256224|FG000|Overall Study|Lost to Follow-up|4|||
160692717|NCT03579966|580256224|FG000|Overall Study|Physician Decision|10|||
160692718|NCT03579966|580256224|FG000|Overall Study|Pregnancy|1|||
160692719|NCT03579966|580256224|FG000|Overall Study|Withdrawal by Subject|16|||
160692720|NCT03579966|580256224|FG000|Overall Study|Study terminated by Sponsor|22|||
160692721|NCT03579966|580256224|FG000|Overall Study|Protocol Violation|1|||
160692722|NCT01249365|580256225|FG000|Overall Study|Lost to Follow-up|1|||
160692723|NCT03551496|580256226|FG000|Overall Study|Death|11|||
160692724|NCT03551496|580256227|FG001|Overall Study|Death|7|||
160692725|NCT03551496|580256226|FG000|Overall Study|Withdrawal by Subject|4|||
160692726|NCT03551496|580256227|FG001|Overall Study|Withdrawal by Subject|3|||
160692727|NCT03551496|580256226|FG000|Overall Study|Other Reasons|1|||
160692728|NCT03551496|580256227|FG001|Overall Study|Other Reasons|0|||
160692729|NCT02303041|580256230|FG000|Overall Study|Adverse Event|1|||
160692730|NCT02303041|580256231|FG001|Overall Study|Adverse Event|2|||
160692731|NCT00886288|580256232|FG000|Overall Study|no respect of the 12 weeks period|657|||
160692732|NCT00886288|580256233|FG001|Overall Study|no respect of the 12 weeks period|227|||
160692733|NCT00886288|580256232|FG000|Overall Study|Lost to Follow-up|86|||
160692734|NCT00886288|580256233|FG001|Overall Study|Lost to Follow-up|0|||
160692735|NCT02335983|580256234|FG000|Overall Study|Sponsor Decision|0|||
160692736|NCT02335983|580256235|FG001|Overall Study|Sponsor Decision|0|||
160692737|NCT02335983|580256236|FG002|Overall Study|Sponsor Decision|1|||
160692738|NCT02335983|580256237|FG003|Overall Study|Sponsor Decision|1|||
160692739|NCT02335983|580256238|FG004|Overall Study|Sponsor Decision|0|||
160692740|NCT02335983|580256239|FG005|Overall Study|Sponsor Decision|1|||
160692741|NCT02335983|580256234|FG000|Overall Study|Withdrawal by Subject|3|||
160692742|NCT02335983|580256235|FG001|Overall Study|Withdrawal by Subject|2|||
160692743|NCT02335983|580256236|FG002|Overall Study|Withdrawal by Subject|2|||
160692744|NCT02335983|580256237|FG003|Overall Study|Withdrawal by Subject|1|||
160692745|NCT02335983|580256238|FG004|Overall Study|Withdrawal by Subject|3|||
160692746|NCT02335983|580256239|FG005|Overall Study|Withdrawal by Subject|9|||
160692747|NCT02335983|580256234|FG000|Overall Study|Death|0|||
160692748|NCT02335983|580256235|FG001|Overall Study|Death|0|||
160692749|NCT02335983|580256236|FG002|Overall Study|Death|2|||
160692750|NCT02335983|580256237|FG003|Overall Study|Death|0|||
160692751|NCT02335983|580256238|FG004|Overall Study|Death|0|||
160692752|NCT02335983|580256239|FG005|Overall Study|Death|0|||
160692753|NCT02335983|580256234|FG000|Overall Study|Lost to Follow-up|0|||
160692754|NCT02335983|580256235|FG001|Overall Study|Lost to Follow-up|0|||
160692755|NCT02335983|580256236|FG002|Overall Study|Lost to Follow-up|0|||
160692756|NCT02335983|580256237|FG003|Overall Study|Lost to Follow-up|0|||
160692757|NCT02335983|580256238|FG004|Overall Study|Lost to Follow-up|0|||
160692758|NCT02335983|580256239|FG005|Overall Study|Lost to Follow-up|1|||
160692759|NCT02335983|580256234|FG000|Overall Study|Protocol Specified Criteria|5|||
160692760|NCT02335983|580256235|FG001|Overall Study|Protocol Specified Criteria|7|||
160692761|NCT02335983|580256236|FG002|Overall Study|Protocol Specified Criteria|27|||
160692762|NCT02335983|580256237|FG003|Overall Study|Protocol Specified Criteria|7|||
160692763|NCT02335983|580256238|FG004|Overall Study|Protocol Specified Criteria|5|||
160692764|NCT02335983|580256239|FG005|Overall Study|Protocol Specified Criteria|21|||
160692765|NCT05070546|580256240|FG000|Overall Study|Death|0|||
160692766|NCT05070546|580256241|FG001|Overall Study|Death|0|||
160692767|NCT05070546|580256242|FG002|Overall Study|Death|0|||
160692768|NCT05070546|580256243|FG003|Overall Study|Death|0|||
160692769|NCT05070546|580256244|FG004|Overall Study|Death|0|||
160692770|NCT05070546|580256245|FG005|Overall Study|Death|1|||
160692771|NCT05070546|580256240|FG000|Overall Study|Lost to Follow-up|8|||
160692772|NCT05070546|580256241|FG001|Overall Study|Lost to Follow-up|2|||
160692773|NCT05070546|580256242|FG002|Overall Study|Lost to Follow-up|7|||
160692774|NCT05070546|580256243|FG003|Overall Study|Lost to Follow-up|1|||
160692775|NCT05070546|580256244|FG004|Overall Study|Lost to Follow-up|2|||
160692776|NCT05070546|580256245|FG005|Overall Study|Lost to Follow-up|0|||
160692777|NCT05070546|580256240|FG000|Overall Study|Withdrawal by Subject|1|||
160692778|NCT05070546|580256241|FG001|Overall Study|Withdrawal by Subject|1|||
160692779|NCT05070546|580256242|FG002|Overall Study|Withdrawal by Subject|3|||
160692780|NCT05070546|580256243|FG003|Overall Study|Withdrawal by Subject|0|||
160692781|NCT05070546|580256244|FG004|Overall Study|Withdrawal by Subject|0|||
160692782|NCT05070546|580256245|FG005|Overall Study|Withdrawal by Subject|0|||
160692783|NCT05070546|580256240|FG000|Overall Study|Other|0|||
160692784|NCT05070546|580256241|FG001|Overall Study|Other|0|||
160692785|NCT05070546|580256242|FG002|Overall Study|Other|0|||
160692786|NCT05070546|580256243|FG003|Overall Study|Other|0|||
160692787|NCT05070546|580256244|FG004|Overall Study|Other|3|||
160692788|NCT05070546|580256245|FG005|Overall Study|Other|0|||
160692789|NCT05070546|580256240|FG000|Overall Study|Randomized but not vaccinated|1|||
160692790|NCT05070546|580256241|FG001|Overall Study|Randomized but not vaccinated|0|||
160692791|NCT05070546|580256242|FG002|Overall Study|Randomized but not vaccinated|1|||
160692792|NCT05070546|580256243|FG003|Overall Study|Randomized but not vaccinated|1|||
160692793|NCT05070546|580256244|FG004|Overall Study|Randomized but not vaccinated|3|||
160692794|NCT05070546|580256245|FG005|Overall Study|Randomized but not vaccinated|0|||
160692795|NCT03096847|580256257|FG000|Overall Study|Other|2|||
160692796|NCT03096847|580256258|FG001|Overall Study|Other|1|||
160692797|NCT03096847|580256259|FG002|Overall Study|Other|2|||
160692798|NCT03096847|580256257|FG000|Overall Study|Lost to Follow-up|1|||
160692799|NCT03096847|580256258|FG001|Overall Study|Lost to Follow-up|0|||
160692800|NCT03096847|580256259|FG002|Overall Study|Lost to Follow-up|1|||
160692801|NCT03096847|580256257|FG000|Overall Study|Death|6|||
160692802|NCT03096847|580256258|FG001|Overall Study|Death|0|||
160692803|NCT03096847|580256259|FG002|Overall Study|Death|2|||
160692804|NCT03096847|580256257|FG000|Overall Study|Protocol Violation|3|||
160692805|NCT03096847|580256258|FG001|Overall Study|Protocol Violation|0|||
160692806|NCT03096847|580256259|FG002|Overall Study|Protocol Violation|6|||
160692807|NCT03096847|580256257|FG000|Overall Study|Physician Decision|12|||
160692808|NCT03096847|580256258|FG001|Overall Study|Physician Decision|2|||
160692809|NCT03096847|580256259|FG002|Overall Study|Physician Decision|8|||
160692810|NCT03096847|580256257|FG000|Overall Study|Withdrawal by Subject|24|||
160692811|NCT03096847|580256258|FG001|Overall Study|Withdrawal by Subject|1|||
160692812|NCT03096847|580256259|FG002|Overall Study|Withdrawal by Subject|12|||
160692813|NCT03096847|580256257|FG000|Overall Study|Adverse Event|72|||
160692814|NCT03096847|580256258|FG001|Overall Study|Adverse Event|6|||
160692815|NCT03096847|580256259|FG002|Overall Study|Adverse Event|28|||
160692816|NCT03096847|580256257|FG000|Overall Study|Progressive disease|97|||
160692817|NCT03096847|580256258|FG001|Overall Study|Progressive disease|10|||
160692818|NCT03096847|580256259|FG002|Overall Study|Progressive disease|78|||
160692819|NCT03096847|580256257|FG000|Overall Study|Non-compliance with study medication|1|||
160692820|NCT03096847|580256258|FG001|Overall Study|Non-compliance with study medication|0|||
160692821|NCT03096847|580256259|FG002|Overall Study|Non-compliance with study medication|0|||
160692822|NCT03096847|580256257|FG000|Overall Study|New therapy for study indication|1|||
160692823|NCT03096847|580256258|FG001|Overall Study|New therapy for study indication|0|||
160692824|NCT03096847|580256259|FG002|Overall Study|New therapy for study indication|1|||
160692825|NCT00359632|580256263|FG000|Overall Study|Death|2|||
160692826|NCT00359632|580256264|FG001|Overall Study|Death|0|||
160692827|NCT00359632|580256263|FG000|Overall Study|Adverse Event|1|||
160692828|NCT00359632|580256264|FG001|Overall Study|Adverse Event|0|||
160692829|NCT00359632|580256263|FG000|Overall Study|Non-compliance with visit schedule|1|||
160692830|NCT00359632|580256264|FG001|Overall Study|Non-compliance with visit schedule|0|||
160692831|NCT03978091|580256265|FG000|Overall Study|Lost to Follow-up|0|||
160692832|NCT03978091|580256266|FG001|Overall Study|Lost to Follow-up|0|||
160692833|NCT03978091|580256267|FG002|Overall Study|Lost to Follow-up|1|||
160692834|NCT03978091|580256268|FG003|Overall Study|Lost to Follow-up|0|||
160692835|NCT03978091|580256269|FG004|Overall Study|Lost to Follow-up|0|||
160692836|NCT03978091|580256270|FG005|Overall Study|Lost to Follow-up|0|||
160692837|NCT03978091|580256265|FG000|Overall Study|Withdrawal by Subject|0|||
160692838|NCT03978091|580256266|FG001|Overall Study|Withdrawal by Subject|0|||
160692839|NCT03978091|580256267|FG002|Overall Study|Withdrawal by Subject|0|||
160692840|NCT03978091|580256268|FG003|Overall Study|Withdrawal by Subject|1|||
160692841|NCT03978091|580256269|FG004|Overall Study|Withdrawal by Subject|1|||
160692842|NCT03978091|580256270|FG005|Overall Study|Withdrawal by Subject|0|||
160692843|NCT02093221|580256278|FG000|Overall Study|Adverse Event|1|||
160692844|NCT02093221|580256279|FG001|Overall Study|Adverse Event|0|||
160692845|NCT02093221|580256280|FG002|Overall Study|Adverse Event|0|||
160692846|NCT02093221|580256281|FG003|Overall Study|Adverse Event|0|||
160692847|NCT02093221|580256282|FG004|Overall Study|Adverse Event|0|||
160692848|NCT02093221|580256278|FG000|Overall Study|Withdrawal by Subject|1|||
160692849|NCT02093221|580256279|FG001|Overall Study|Withdrawal by Subject|1|||
160692850|NCT02093221|580256280|FG002|Overall Study|Withdrawal by Subject|4|||
160692851|NCT02093221|580256281|FG003|Overall Study|Withdrawal by Subject|1|||
160692852|NCT02093221|580256282|FG004|Overall Study|Withdrawal by Subject|1|||
160692853|NCT02093221|580256278|FG000|Overall Study|Lost to Follow-up|2|||
160692854|NCT02093221|580256279|FG001|Overall Study|Lost to Follow-up|0|||
160692855|NCT02093221|580256280|FG002|Overall Study|Lost to Follow-up|1|||
160692856|NCT02093221|580256281|FG003|Overall Study|Lost to Follow-up|1|||
160692857|NCT02093221|580256282|FG004|Overall Study|Lost to Follow-up|0|||
160692858|NCT02093221|580256278|FG000|Overall Study|Death|0|||
160692859|NCT02093221|580256279|FG001|Overall Study|Death|1|||
160692860|NCT02093221|580256280|FG002|Overall Study|Death|0|||
160692861|NCT02093221|580256281|FG003|Overall Study|Death|0|||
160692862|NCT02093221|580256282|FG004|Overall Study|Death|0|||
160692863|NCT02093221|580256278|FG000|Overall Study|Protocol Violation|0|||
160692864|NCT02093221|580256279|FG001|Overall Study|Protocol Violation|1|||
160692865|NCT02093221|580256280|FG002|Overall Study|Protocol Violation|0|||
160692866|NCT02093221|580256281|FG003|Overall Study|Protocol Violation|0|||
160692867|NCT02093221|580256282|FG004|Overall Study|Protocol Violation|0|||
160692868|NCT02093221|580256278|FG000|Overall Study|Study termination|6|||
160692869|NCT02093221|580256279|FG001|Overall Study|Study termination|5|||
160692870|NCT02093221|580256280|FG002|Overall Study|Study termination|4|||
160692871|NCT02093221|580256281|FG003|Overall Study|Study termination|6|||
160692872|NCT02093221|580256282|FG004|Overall Study|Study termination|7|||
160692873|NCT01189500|580256283|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
160692874|NCT01189500|580256283|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
160748706|NCT00303472|580465927|FG001|Treatment Extension (Optional)|Death|0|||
160748707|NCT00303472|580465928|FG002|Treatment Extension (Optional)|Death|1|||
160748708|NCT00303472|580465929|FG003|Treatment Extension (Optional)|Death|0|||
160748709|NCT00303472|580465930|FG004|Treatment Extension (Optional)|Death|0|||
160748710|NCT00303472|580465931|FG005|Treatment Extension (Optional)|Death|0|||
160748711|NCT00303472|580465932|FG006|Treatment Extension (Optional)|Death|0|||
160692875|NCT04710979|580257796|FG000|Overall Study|Lost to Follow-up|2|||
160692876|NCT04710979|580257797|FG001|Overall Study|Lost to Follow-up|4|||
160692877|NCT04710979|580257796|FG000|Overall Study|Withdrawal by Subject|1|||
160692878|NCT04710979|580257797|FG001|Overall Study|Withdrawal by Subject|0|||
160692879|NCT03709823|580257812|FG000|Overall Study|Adverse Event|0|||
160692880|NCT03709823|580257813|FG001|Overall Study|Adverse Event|0|||
160692881|NCT03709823|580257814|FG002|Overall Study|Adverse Event|1|||
160692882|NCT03709823|580257815|FG003|Overall Study|Adverse Event|0|||
160692883|NCT03709823|580257816|FG004|Overall Study|Adverse Event|0|||
160692884|NCT03709823|580257817|FG005|Overall Study|Adverse Event|0|||
160692885|NCT03709823|580257812|FG000|Overall Study|Lost to Follow-up|2|||
160692886|NCT03709823|580257813|FG001|Overall Study|Lost to Follow-up|2|||
160692887|NCT03709823|580257814|FG002|Overall Study|Lost to Follow-up|2|||
160692888|NCT03709823|580257815|FG003|Overall Study|Lost to Follow-up|1|||
160692889|NCT03709823|580257816|FG004|Overall Study|Lost to Follow-up|1|||
160692890|NCT03709823|580257817|FG005|Overall Study|Lost to Follow-up|0|||
160692891|NCT03709823|580257812|FG000|Overall Study|Withdrawal by Subject|1|||
160692892|NCT03709823|580257813|FG001|Overall Study|Withdrawal by Subject|3|||
160692893|NCT03709823|580257814|FG002|Overall Study|Withdrawal by Subject|0|||
160692894|NCT03709823|580257815|FG003|Overall Study|Withdrawal by Subject|0|||
160692895|NCT03709823|580257816|FG004|Overall Study|Withdrawal by Subject|0|||
160692896|NCT03709823|580257817|FG005|Overall Study|Withdrawal by Subject|0|||
160692897|NCT03709823|580257812|FG000|Overall Study|Other, Not Specified|0|||
160692898|NCT03709823|580257813|FG001|Overall Study|Other, Not Specified|0|||
160692899|NCT03709823|580257814|FG002|Overall Study|Other, Not Specified|0|||
160692900|NCT03709823|580257815|FG003|Overall Study|Other, Not Specified|1|||
160692901|NCT03709823|580257816|FG004|Overall Study|Other, Not Specified|0|||
160692902|NCT03709823|580257817|FG005|Overall Study|Other, Not Specified|0|||
160692903|NCT00846521|580257818|FG000|Overall Study|Withdrawal by Subject|5|||
160692904|NCT00846521|580257818|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
160692905|NCT00846521|580257818|FG000|Overall Study|Protocol Violation|1|||
160692906|NCT01246011|580257819|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
160692907|NCT01246011|580257820|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
160692908|NCT01246011|580257821|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
160692909|NCT01246011|580257819|FG000|Overall Study|Withdrawal by Subject|0|||
160692910|NCT01246011|580257820|FG001|Overall Study|Withdrawal by Subject|0|||
160692911|NCT01246011|580257821|FG002|Overall Study|Withdrawal by Subject|1|||
160692912|NCT04392583|580257822|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
160692913|NCT01340768|580257825|FG000|Overall Study|Lost to Follow-up|10|||
160692914|NCT01340768|580257826|FG001|Overall Study|Lost to Follow-up|4|||
160692915|NCT01340768|580257825|FG000|Overall Study|Withdrawal by Subject|5|||
160692916|NCT01340768|580257826|FG001|Overall Study|Withdrawal by Subject|1|||
160692917|NCT01340768|580257825|FG000|Overall Study|Other|2|||
160692918|NCT01340768|580257826|FG001|Overall Study|Other|0|||
160692919|NCT03052959|580257829|FG000|Overall Study|Lost to Follow-up|4|||
160692920|NCT03052959|580257830|FG001|Overall Study|Lost to Follow-up|5|||
160692921|NCT01683838|580257831|FG000|Overall Study|Adverse Event|12|||
160692922|NCT01683838|580257832|FG001|Overall Study|Adverse Event|2|||
160692923|NCT01683838|580257831|FG000|Overall Study|Protocol Violation|3|||
160692924|NCT01683838|580257832|FG001|Overall Study|Protocol Violation|1|||
160692925|NCT01683838|580257831|FG000|Overall Study|Withdrawal by Subject|6|||
160692926|NCT01683838|580257832|FG001|Overall Study|Withdrawal by Subject|5|||
160692927|NCT01683838|580257831|FG000|Overall Study|Lost to Follow-up|1|||
160692928|NCT01683838|580257832|FG001|Overall Study|Lost to Follow-up|1|||
160692929|NCT01683838|580257831|FG000|Overall Study|Other|4|||
160692930|NCT01683838|580257832|FG001|Overall Study|Other|3|||
160692931|NCT04049617|580257833|FG000|Overall Study|Adverse Event|0|||
160692932|NCT04049617|580257834|FG001|Overall Study|Adverse Event|0|||
160692933|NCT04049617|580257835|FG002|Overall Study|Adverse Event|0|||
160692934|NCT04049617|580257836|FG003|Overall Study|Adverse Event|1|||
160692935|NCT04049617|580257837|FG004|Overall Study|Adverse Event|0|||
160692936|NCT04049617|580257838|FG005|Overall Study|Adverse Event|0|||
160692937|NCT04049617|580257833|FG000|Overall Study|Death|0|||
160692938|NCT04049617|580257834|FG001|Overall Study|Death|0|||
160692939|NCT04049617|580257835|FG002|Overall Study|Death|0|||
160692940|NCT04049617|580257836|FG003|Overall Study|Death|0|||
160692941|NCT04049617|580257837|FG004|Overall Study|Death|0|||
160692942|NCT04049617|580257838|FG005|Overall Study|Death|1|||
160692943|NCT04049617|580257833|FG000|Overall Study|Lost to Follow-up|0|||
160692944|NCT04049617|580257834|FG001|Overall Study|Lost to Follow-up|0|||
160692945|NCT04049617|580257835|FG002|Overall Study|Lost to Follow-up|0|||
160692946|NCT04049617|580257836|FG003|Overall Study|Lost to Follow-up|1|||
160692947|NCT04049617|580257837|FG004|Overall Study|Lost to Follow-up|0|||
160692948|NCT04049617|580257838|FG005|Overall Study|Lost to Follow-up|0|||
160692949|NCT04049617|580257833|FG000|Overall Study|Withdrew consent|0|||
160692950|NCT04049617|580257834|FG001|Overall Study|Withdrew consent|0|||
160692951|NCT04049617|580257835|FG002|Overall Study|Withdrew consent|1|||
160692952|NCT04049617|580257836|FG003|Overall Study|Withdrew consent|0|||
160692953|NCT04049617|580257837|FG004|Overall Study|Withdrew consent|0|||
160692954|NCT04049617|580257838|FG005|Overall Study|Withdrew consent|0|||
160692955|NCT01524679|580257839|FG000|Overall Study|Lost to Follow-up|1|||
160692956|NCT01524679|580257840|FG001|Overall Study|Lost to Follow-up|4|||
160692957|NCT01524679|580257839|FG000|Overall Study|Withdrawal by Subject|4|||
160692958|NCT01524679|580257840|FG001|Overall Study|Withdrawal by Subject|4|||
160692959|NCT01524679|580257839|FG000|Overall Study|Adverse Event|9|||
160692960|NCT01524679|580257840|FG001|Overall Study|Adverse Event|0|||
160692961|NCT01524679|580257839|FG000|Overall Study|Protocol Violation|1|||
160692962|NCT01524679|580257840|FG001|Overall Study|Protocol Violation|0|||
160692963|NCT01524679|580257839|FG000|Overall Study|Lack of Efficacy|2|||
160692964|NCT01524679|580257840|FG001|Overall Study|Lack of Efficacy|0|||
160692965|NCT01524679|580257839|FG000|Overall Study|e.g.wish for children, relocation|6|||
160692966|NCT01524679|580257840|FG001|Overall Study|e.g.wish for children, relocation|1|||
160692967|NCT04168190|580257841|FG000|Overall Study|Lost to Follow-up|0|||
160692968|NCT04168190|580257842|FG001|Overall Study|Lost to Follow-up|1|||
160692969|NCT04168190|580257843|FG002|Overall Study|Lost to Follow-up|0|||
160692970|NCT04168190|580257844|FG003|Overall Study|Lost to Follow-up|7|||
160692971|NCT04168190|580257845|FG004|Overall Study|Lost to Follow-up|5|||
160692972|NCT04168190|580257841|FG000|Overall Study|Withdrawal by Subject|1|||
160692973|NCT04168190|580257842|FG001|Overall Study|Withdrawal by Subject|0|||
160692974|NCT04168190|580257843|FG002|Overall Study|Withdrawal by Subject|0|||
160692975|NCT04168190|580257844|FG003|Overall Study|Withdrawal by Subject|2|||
160692976|NCT04168190|580257845|FG004|Overall Study|Withdrawal by Subject|4|||
160692977|NCT04168190|580257841|FG000|Overall Study|Death|0|||
160692978|NCT04168190|580257842|FG001|Overall Study|Death|0|||
160692979|NCT04168190|580257843|FG002|Overall Study|Death|0|||
160692980|NCT04168190|580257844|FG003|Overall Study|Death|1|||
160692981|NCT04168190|580257845|FG004|Overall Study|Death|0|||
160692982|NCT03246126|580257850|FG000|Overall Study|Withdrawal by Subject|0|||
160692983|NCT03246126|580257851|FG001|Overall Study|Withdrawal by Subject|1|||
160692984|NCT00629265|580257854|FG000|Overall Study|Lost to Follow-up|4|||
160692985|NCT00629265|580257855|FG001|Overall Study|Lost to Follow-up|5|||
160692986|NCT00629265|580257854|FG000|Overall Study|Withdrawal by Subject|11|||
160692987|NCT00629265|580257855|FG001|Overall Study|Withdrawal by Subject|8|||
160692988|NCT00629265|580257854|FG000|Overall Study|Death|1|||
160692989|NCT00629265|580257855|FG001|Overall Study|Death|0|||
160692990|NCT00629265|580257854|FG000|Overall Study|Adverse Event|2|||
160692991|NCT00629265|580257855|FG001|Overall Study|Adverse Event|0|||
160692992|NCT00629265|580257854|FG000|Overall Study|HNC Recurrence|4|||
160692993|NCT00629265|580257855|FG001|Overall Study|HNC Recurrence|0|||
160692994|NCT00629265|580257854|FG000|Overall Study|Other CA Requiring Treatment|1|||
160692995|NCT00629265|580257855|FG001|Overall Study|Other CA Requiring Treatment|3|||
160692996|NCT00629265|580257854|FG000|Overall Study|Needed Esophageal Dilation|4|||
160692997|NCT00629265|580257855|FG001|Overall Study|Needed Esophageal Dilation|1|||
160692998|NCT00629265|580257854|FG000|Overall Study|Unrelated Medical Complications|3|||
160692999|NCT00629265|580257855|FG001|Overall Study|Unrelated Medical Complications|1|||
160693000|NCT00629265|580257854|FG000|Overall Study|Unknown Reason|2|||
160693001|NCT00629265|580257855|FG001|Overall Study|Unknown Reason|2|||
160693002|NCT04465630|580257856|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
160693003|NCT04465630|580257856|FG000|Overall Study|Screen failure|8|||
160693004|NCT04465630|580257856|FG000|Overall Study|Baseline failure|16|||
160693005|NCT01006135|580257857|FG000|Overall Study|Adverse Event|22|||
160693006|NCT01006135|580257857|FG000|Overall Study|Protocol Violation|14|||
160693007|NCT01006135|580257857|FG000|Overall Study|Lost to Follow-up|32|||
160693008|NCT01006135|580257857|FG000|Overall Study|Other|72|||
160693009|NCT01732484|580257861|FG000|Overall Study|Death|7|||
160693010|NCT01732484|580257861|FG000|Overall Study|Lost to Follow-up|14|||
160693011|NCT01732484|580257861|FG000|Overall Study|chronical illness|5|||
160693012|NCT05297578|580257862|FG000|Overall Study|Lost to Follow-up|1|||
160693013|NCT05297578|580257863|FG001|Overall Study|Lost to Follow-up|1|||
160693014|NCT05297578|580257864|FG002|Overall Study|Lost to Follow-up|2|||
160693015|NCT05297578|580257865|FG003|Overall Study|Lost to Follow-up|1|||
160693016|NCT05297578|580257862|FG000|Overall Study|Death|0|||
160693017|NCT05297578|580257863|FG001|Overall Study|Death|1|||
160693018|NCT05297578|580257864|FG002|Overall Study|Death|0|||
160693019|NCT05297578|580257865|FG003|Overall Study|Death|0|||
160693020|NCT05297578|580257862|FG000|Overall Study|Withdrawal by Subject|0|||
160693021|NCT05297578|580257863|FG001|Overall Study|Withdrawal by Subject|0|||
160693022|NCT05297578|580257864|FG002|Overall Study|Withdrawal by Subject|1|||
160693023|NCT05297578|580257865|FG003|Overall Study|Withdrawal by Subject|0|||
160693024|NCT00289874|580257866|FG000|Overall Study|Adverse Event|1|||
160693025|NCT00289874|580257867|FG001|Overall Study|Adverse Event|5|||
160693026|NCT00289874|580257866|FG000|Overall Study|Lost to Follow-up|1|||
160693027|NCT00289874|580257867|FG001|Overall Study|Lost to Follow-up|1|||
160693028|NCT00289874|580257866|FG000|Overall Study|Protocol Violation|3|||
160693029|NCT00289874|580257867|FG001|Overall Study|Protocol Violation|2|||
160693030|NCT00289874|580257866|FG000|Overall Study|Did not meet eligibility|1|||
160693031|NCT00289874|580257867|FG001|Overall Study|Did not meet eligibility|0|||
160693032|NCT01087489|580257868|FG000|Overall Study|enrolled in another VA study|0|||
160693033|NCT01087489|580257869|FG001|Overall Study|enrolled in another VA study|1|||
160693034|NCT01087489|580257868|FG000|Overall Study|Death|0|||
160693035|NCT01087489|580257869|FG001|Overall Study|Death|1|||
160693036|NCT01087489|580257868|FG000|Overall Study|unable to survey by telephone|0|||
160693037|NCT01087489|580257869|FG001|Overall Study|unable to survey by telephone|1|||
160693038|NCT03127644|580257877|FG000|Overall Study|Study-specific withdrawal criteria|0|||
160693039|NCT03127644|580257878|FG001|Overall Study|Study-specific withdrawal criteria|0|||
160693040|NCT03127644|580257879|FG002|Overall Study|Study-specific withdrawal criteria|2|||
160693041|NCT02032706|580257880|FG000|Overall Study|Did not qualify|5|||
160693042|NCT02032706|580257880|FG000|Overall Study|Protocol Violation|1|||
160693043|NCT00893737|580257883|FG000|Overall Study|Adverse Event|4|||
160693044|NCT00893737|580257883|FG000|Overall Study|Withdrawal by Subject|2|||
160693045|NCT00893737|580257883|FG000|Overall Study|Lost to Follow-up|6|||
160693046|NCT01156142|580257884|FG000|Overall Study|Withdrawal by Subject|8|||
160693047|NCT01156142|580257885|FG001|Overall Study|Withdrawal by Subject|6|||
160693048|NCT01156142|580257884|FG000|Overall Study|Ineligible|0|||
160693049|NCT01156142|580257885|FG001|Overall Study|Ineligible|1|||
160693050|NCT00928707|580257886|FG000|Overall Study|Protocol Violation|1|||
160693051|NCT00928707|580257887|FG001|Overall Study|Protocol Violation|0|||
160693052|NCT00132028|580257888|FG000|Overall Study|Adverse Event|7|||
160693053|NCT00132028|580257888|FG000|Overall Study|Death|2|||
160693054|NCT00132028|580257888|FG000|Overall Study|Lack of Efficacy|11|||
160693055|NCT00132028|580257888|FG000|Overall Study|Withdrawal by Subject|2|||
160693056|NCT00132028|580257888|FG000|Overall Study|not eligible|2|||
160693057|NCT00132028|580257888|FG000|Overall Study|Physician Decision|3|||
160693058|NCT02140411|580257889|FG000|Overall Study|Adverse Event|1|||
160693059|NCT03981419|580257892|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
160693060|NCT03981419|580257893|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
160693061|NCT01330459|580257894|FG000|Overall Study|Physician Decision|0|||
160693062|NCT01330459|580257895|FG001|Overall Study|Physician Decision|2|||
160693063|NCT00136318|580257902|FG000|Overall Study|Adverse Event|5|||
160693064|NCT00136318|580257903|FG001|Overall Study|Adverse Event|5|||
160693065|NCT00136318|580257902|FG000|Overall Study|Withdrawal by Subject|2|||
160693066|NCT00136318|580257903|FG001|Overall Study|Withdrawal by Subject|2|||
160693067|NCT02005887|580257904|FG000|Overall Study|Protocol Violation|0|||
160693068|NCT02005887|580257905|FG001|Overall Study|Protocol Violation|2|||
160693069|NCT01615263|580257914|FG000|Overall Study|Post-randomization exclusion|0|||
160693070|NCT01615263|580257915|FG001|Overall Study|Post-randomization exclusion|2|||
160693071|NCT00988065|580257916|FG000|Overall Study|Adverse Event|4|||
160693072|NCT00988065|580257917|FG001|Overall Study|Adverse Event|10|||
160693073|NCT00988065|580257918|FG002|Overall Study|Adverse Event|2|||
160693074|NCT00988065|580257916|FG000|Overall Study|Lost to Follow-up|1|||
160693075|NCT00988065|580257917|FG001|Overall Study|Lost to Follow-up|2|||
160693076|NCT00988065|580257918|FG002|Overall Study|Lost to Follow-up|2|||
160693077|NCT00988065|580257916|FG000|Overall Study|Subject withdrew consent|3|||
160693078|NCT00988065|580257917|FG001|Overall Study|Subject withdrew consent|5|||
160693079|NCT00988065|580257918|FG002|Overall Study|Subject withdrew consent|2|||
160693080|NCT00988065|580257916|FG000|Overall Study|Noncompliance with protocol|5|||
160693081|NCT00988065|580257917|FG001|Overall Study|Noncompliance with protocol|6|||
160693082|NCT00988065|580257918|FG002|Overall Study|Noncompliance with protocol|9|||
160693083|NCT00160641|580257921|FG000|Overall Study|Adverse Event|102|||
160693084|NCT00160641|580257921|FG000|Overall Study|Withdrawal by Subject|87|||
160693085|NCT00160641|580257921|FG000|Overall Study|Lost to Follow-up|8|||
160693086|NCT00160641|580257921|FG000|Overall Study|Lack of Efficacy|12|||
160693087|NCT00160641|580257921|FG000|Overall Study|Protocol Violation|3|||
160693088|NCT00160641|580257921|FG000|Overall Study|Other|9|||
160693089|NCT04700280|580257923|FG000|Overall Study|Adverse Event|4|||
160693090|NCT04700280|580257924|FG001|Overall Study|Adverse Event|0|||
160693091|NCT04700280|580257923|FG000|Overall Study|Lack of Efficacy|1|||
160693092|NCT04700280|580257924|FG001|Overall Study|Lack of Efficacy|0|||
160693093|NCT04700280|580257923|FG000|Overall Study|Study terminated by sponsor|5|||
160693094|NCT04700280|580257924|FG001|Overall Study|Study terminated by sponsor|3|||
160693095|NCT04700280|580257923|FG000|Overall Study|Other than specified|1|||
160693096|NCT04700280|580257924|FG001|Overall Study|Other than specified|0|||
160693097|NCT00257920|580257925|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
160693098|NCT00257920|580257926|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
160693099|NCT00257920|580257925|FG000|Period: Second Intervention|Other|2|||
160693100|NCT00257920|580257926|FG001|Period: Second Intervention|Other|1|||
160693101|NCT00770692|580257927|FG000|Overall Study|Withdrawal by Subject|7|||
160693102|NCT00770692|580257928|FG001|Overall Study|Withdrawal by Subject|9|||
160693103|NCT00770692|580257929|FG002|Overall Study|Withdrawal by Subject|9|||
160693104|NCT00770692|580257930|FG003|Overall Study|Withdrawal by Subject|6|||
160693105|NCT00770692|580257927|FG000|Overall Study|Adverse Event|3|||
160693106|NCT00770692|580257928|FG001|Overall Study|Adverse Event|0|||
160693107|NCT00770692|580257929|FG002|Overall Study|Adverse Event|4|||
160693108|NCT00770692|580257930|FG003|Overall Study|Adverse Event|4|||
160693109|NCT00770692|580257927|FG000|Overall Study|Investigator judgment|2|||
160693110|NCT00770692|580257928|FG001|Overall Study|Investigator judgment|0|||
160693111|NCT00770692|580257929|FG002|Overall Study|Investigator judgment|1|||
160693112|NCT00770692|580257930|FG003|Overall Study|Investigator judgment|1|||
160693113|NCT01230892|580257931|FG000|Overall Study|Withdrawal by Subject|1|||
160693114|NCT01230892|580257932|FG001|Overall Study|Withdrawal by Subject|1|||
160693115|NCT01230892|580257931|FG000|Overall Study|Lost to Follow-up|2|||
160693116|NCT01230892|580257932|FG001|Overall Study|Lost to Follow-up|0|||
160693117|NCT00725621|580257933|FG000|Overall Study|Adverse Event|25|||
160693118|NCT00725621|580257933|FG000|Overall Study|Lack of Efficacy|46|||
160693119|NCT00725621|580257933|FG000|Overall Study|Withdrawal by Subject|57|||
160693120|NCT00725621|580257933|FG000|Overall Study|Physician Decision|19|||
160693121|NCT00725621|580257933|FG000|Overall Study|Lost to Follow-up|52|||
160693122|NCT00725621|580257933|FG000|Overall Study|Non-compliance|8|||
160693123|NCT00725621|580257933|FG000|Overall Study|Continued treatment by other physician|6|||
160693124|NCT00725621|580257933|FG000|Overall Study|Switched to other study|1|||
160693125|NCT00725621|580257933|FG000|Overall Study|Switched to other drug|1|||
160693126|NCT00725621|580257933|FG000|Overall Study|Prepared for elective surgery|1|||
160693127|NCT00725621|580257933|FG000|Overall Study|Reason not specified|55|||
160693128|NCT00062751|580257934|FG000|Overall Study|Disease progression|24|||
160693129|NCT00062751|580257935|FG001|Overall Study|Disease progression|17|||
160693130|NCT00062751|580257936|FG002|Overall Study|Disease progression|24|||
160693131|NCT00062751|580257937|FG003|Overall Study|Disease progression|2|||
160693132|NCT00062751|580257938|FG004|Overall Study|Disease progression|2|||
160693133|NCT00062751|580257934|FG000|Overall Study|Adverse Event|4|||
160693134|NCT00062751|580257935|FG001|Overall Study|Adverse Event|7|||
160693135|NCT00062751|580257936|FG002|Overall Study|Adverse Event|2|||
160693136|NCT00062751|580257937|FG003|Overall Study|Adverse Event|2|||
160693137|NCT00062751|580257938|FG004|Overall Study|Adverse Event|2|||
160693138|NCT00062751|580257934|FG000|Overall Study|Other|2|||
160693139|NCT00062751|580257935|FG001|Overall Study|Other|3|||
160693140|NCT00062751|580257936|FG002|Overall Study|Other|1|||
160693141|NCT00062751|580257937|FG003|Overall Study|Other|0|||
160693142|NCT00062751|580257938|FG004|Overall Study|Other|1|||
160693143|NCT00062751|580257934|FG000|Overall Study|Withdrawal by Subject|1|||
160693144|NCT00062751|580257935|FG001|Overall Study|Withdrawal by Subject|2|||
160693145|NCT00062751|580257936|FG002|Overall Study|Withdrawal by Subject|2|||
160693146|NCT00062751|580257937|FG003|Overall Study|Withdrawal by Subject|1|||
160693147|NCT00062751|580257938|FG004|Overall Study|Withdrawal by Subject|0|||
160693148|NCT00062751|580257934|FG000|Overall Study|Symptomatic deterioration|1|||
160693149|NCT00062751|580257935|FG001|Overall Study|Symptomatic deterioration|1|||
160693150|NCT00062751|580257936|FG002|Overall Study|Symptomatic deterioration|0|||
160693151|NCT00062751|580257937|FG003|Overall Study|Symptomatic deterioration|0|||
160693152|NCT00062751|580257938|FG004|Overall Study|Symptomatic deterioration|1|||
160693153|NCT00062751|580257934|FG000|Overall Study|Death|1|||
160693154|NCT00062751|580257935|FG001|Overall Study|Death|0|||
160693155|NCT00062751|580257936|FG002|Overall Study|Death|1|||
160693156|NCT00062751|580257937|FG003|Overall Study|Death|0|||
160693157|NCT00062751|580257938|FG004|Overall Study|Death|0|||
160693158|NCT03097588|580257945|FG000|Overall Study|Adverse Event|1|||
160693159|NCT01144364|580257946|FG000|Induction Phase|Disease progression|14|||
160693160|NCT01144364|580257947|FG001|Induction Phase|Disease progression|0|||
160693161|NCT01144364|580257948|FG002|Induction Phase|Disease progression|0|||
160693162|NCT01144364|580257946|FG000|Induction Phase|Adverse Event|9|||
160693163|NCT01144364|580257947|FG001|Induction Phase|Adverse Event|0|||
160693164|NCT01144364|580257948|FG002|Induction Phase|Adverse Event|0|||
160693165|NCT01144364|580257946|FG000|Induction Phase|Death|1|||
160693166|NCT01144364|580257947|FG001|Induction Phase|Death|0|||
160693167|NCT01144364|580257948|FG002|Induction Phase|Death|0|||
160693168|NCT01144364|580257946|FG000|Induction Phase|Withdrawal by Subject|1|||
160693169|NCT01144364|580257947|FG001|Induction Phase|Withdrawal by Subject|0|||
160693170|NCT01144364|580257948|FG002|Induction Phase|Withdrawal by Subject|0|||
160693171|NCT01144364|580257946|FG000|Induction Phase|Lost to Follow-up|2|||
160693172|NCT01144364|580257947|FG001|Induction Phase|Lost to Follow-up|0|||
160693173|NCT01144364|580257948|FG002|Induction Phase|Lost to Follow-up|0|||
160693174|NCT01144364|580257946|FG000|Induction Phase|Physician Decision|1|||
160693175|NCT01144364|580257947|FG001|Induction Phase|Physician Decision|0|||
160693176|NCT01144364|580257948|FG002|Induction Phase|Physician Decision|0|||
160693177|NCT01144364|580257946|FG000|Induction Phase|Stable disease|2|||
160693178|NCT01144364|580257947|FG001|Induction Phase|Stable disease|0|||
160693179|NCT01144364|580257948|FG002|Induction Phase|Stable disease|0|||
160693180|NCT01144364|580257946|FG000|Induction Phase|Secondary neoplasia|1|||
160693181|NCT01144364|580257947|FG001|Induction Phase|Secondary neoplasia|0|||
160693182|NCT01144364|580257948|FG002|Induction Phase|Secondary neoplasia|0|||
160693183|NCT01144364|580257946|FG000|Induction Phase|Protocol Violation|1|||
160693184|NCT01144364|580257947|FG001|Induction Phase|Protocol Violation|0|||
160693185|NCT01144364|580257948|FG002|Induction Phase|Protocol Violation|0|||
160693186|NCT01144364|580257946|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
160693187|NCT01144364|580257947|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
160693188|NCT01144364|580257948|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
160693189|NCT01144364|580257946|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
160693190|NCT01144364|580257947|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
160693191|NCT01144364|580257948|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
160693192|NCT01144364|580257946|FG000|Follow-Up/Maintenance Phase|Death|0|||
160693193|NCT01144364|580257947|FG001|Follow-Up/Maintenance Phase|Death|2|||
160693194|NCT01144364|580257948|FG002|Follow-Up/Maintenance Phase|Death|0|||
160693195|NCT01144364|580257946|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
160693196|NCT01144364|580257947|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
160693197|NCT01144364|580257948|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
160693198|NCT01144364|580257946|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
160693199|NCT01144364|580257947|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
160693200|NCT01144364|580257948|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
160693201|NCT01144364|580257946|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
160693202|NCT01144364|580257947|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
160693203|NCT01144364|580257948|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
160693204|NCT01144364|580257946|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
160693205|NCT01144364|580257947|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
160693206|NCT01144364|580257948|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
160693207|NCT02037165|580257949|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
160693208|NCT02037165|580257950|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
160693209|NCT02037165|580257951|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
160693210|NCT02037165|580257952|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
160693211|NCT02037165|580257953|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
160693212|NCT00673933|580257954|FG000|Overall Study|Withdrawal by Subject|2|||
160693213|NCT00673933|580257954|FG000|Overall Study|Lost to Follow-up|1|||
160693214|NCT04932941|580257955|FG000|Overall Study|Lost to Follow-up|3|||
160693215|NCT04932941|580257956|FG001|Overall Study|Lost to Follow-up|1|||
160693216|NCT04932941|580257955|FG000|Overall Study|Withdrawal by Subject|7|||
160693217|NCT04932941|580257956|FG001|Overall Study|Withdrawal by Subject|4|||
160693218|NCT04932941|580257955|FG000|Overall Study|Other|4|||
160693219|NCT04932941|580257956|FG001|Overall Study|Other|2|||
160693220|NCT02206620|580257957|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
160693221|NCT02206620|580257958|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
160693222|NCT02206620|580257957|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
160693223|NCT02206620|580257958|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
160693224|NCT05816200|580257959|FG000|Overall Study|Lost to Follow-up|2|||
160693225|NCT05816200|580257960|FG001|Overall Study|Lost to Follow-up|1|||
160693226|NCT02394730|580257961|FG000|Overall Study|Lost to Follow-up|1|||
160693227|NCT02394730|580257962|FG001|Overall Study|Lost to Follow-up|0|||
160693228|NCT02394730|580257961|FG000|Overall Study|Withdrawal by Subject|0|||
160693229|NCT02394730|580257962|FG001|Overall Study|Withdrawal by Subject|1|||
160693230|NCT00588640|580257963|FG000|Overall Study|Physician Decision|1|||
160693231|NCT00588640|580257963|FG000|Overall Study|Ineligible Patient|1|||
160693232|NCT01393730|580257964|FG000|Overall Study|Withdrawal by Subject|3|||
160693233|NCT01393730|580257964|FG000|Overall Study|Other|2|||
160693234|NCT01393730|580257964|FG000|Overall Study|Adverse Event|1|||
160693235|NCT03510182|580257969|FG000|Overall Study|Withdrawal by Subject|2|||
160693236|NCT00375492|580257970|FG000|Overall Study|Adverse Event|4|||
160693237|NCT00375492|580257971|FG001|Overall Study|Adverse Event|5|||
160693238|NCT00375492|580257970|FG000|Overall Study|Entry Criteria Not Met|0|||
160693239|NCT00375492|580257971|FG001|Overall Study|Entry Criteria Not Met|1|||
160693240|NCT00375492|580257970|FG000|Overall Study|Loss of Glucose Control|0|||
160693241|NCT00375492|580257971|FG001|Overall Study|Loss of Glucose Control|1|||
160693242|NCT00375492|580257970|FG000|Overall Study|Lost to Follow-up|10|||
160693243|NCT00375492|580257971|FG001|Overall Study|Lost to Follow-up|5|||
160693244|NCT00375492|580257970|FG000|Overall Study|Physician Decision|0|||
160693245|NCT00375492|580257971|FG001|Overall Study|Physician Decision|4|||
160693246|NCT00375492|580257970|FG000|Overall Study|Protocol Violation|6|||
160693247|NCT00375492|580257971|FG001|Overall Study|Protocol Violation|3|||
160693248|NCT00375492|580257970|FG000|Overall Study|Sponsor Decision|0|||
160693249|NCT00375492|580257971|FG001|Overall Study|Sponsor Decision|1|||
160693250|NCT00375492|580257970|FG000|Overall Study|Withdrawal by Subject|6|||
160693251|NCT00375492|580257971|FG001|Overall Study|Withdrawal by Subject|6|||
160693252|NCT03295318|580259324|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
160693253|NCT03295318|580259325|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
160693254|NCT03295318|580259326|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
160693255|NCT03295318|580259324|FG000|Overall Study|Death|1|||
160693256|NCT03295318|580259325|FG001|Overall Study|Death|1|||
160693257|NCT03295318|580259326|FG002|Overall Study|Death|1|||
160693258|NCT03295318|580259324|FG000|Overall Study|Protocol Violation|4|||
160693259|NCT03295318|580259325|FG001|Overall Study|Protocol Violation|3|||
160693260|NCT03295318|580259326|FG002|Overall Study|Protocol Violation|3|||
160693261|NCT03295318|580259324|FG000|Overall Study|Withdrawal by Subject|0|||
160693262|NCT03295318|580259325|FG001|Overall Study|Withdrawal by Subject|0|||
160693263|NCT03295318|580259326|FG002|Overall Study|Withdrawal by Subject|1|||
160693264|NCT03295318|580259324|FG000|Overall Study|Subject discontinued due to travel|0|||
160693265|NCT03295318|580259325|FG001|Overall Study|Subject discontinued due to travel|1|||
160693266|NCT03295318|580259326|FG002|Overall Study|Subject discontinued due to travel|0|||
160693267|NCT03747601|580259327|FG000|Overall Study|COVID halt to visits|4|||
160693268|NCT00321828|580259328|FG000|Overall Study|Ineligible|3|||
160693269|NCT00321828|580259328|FG000|Overall Study|No follow up data|1|||
160693270|NCT02307266|580259331|FG000|Overall Study|Adverse Event|3|||
160693271|NCT02307266|580259332|FG001|Overall Study|Adverse Event|1|||
160693272|NCT02307266|580259333|FG002|Overall Study|Adverse Event|5|||
160693273|NCT02307266|580259331|FG000|Overall Study|Withdrawal by Subject|2|||
160693274|NCT02307266|580259332|FG001|Overall Study|Withdrawal by Subject|0|||
160693275|NCT02307266|580259333|FG002|Overall Study|Withdrawal by Subject|1|||
160693276|NCT02307266|580259331|FG000|Overall Study|Lost to Follow-up|3|||
160693277|NCT02307266|580259332|FG001|Overall Study|Lost to Follow-up|0|||
160693278|NCT02307266|580259333|FG002|Overall Study|Lost to Follow-up|0|||
160693279|NCT00793780|580259334|FG000|Overall Study|Withdrawal by Subject|2|||
160693280|NCT00793780|580259335|FG001|Overall Study|Withdrawal by Subject|1|||
160693281|NCT00573157|580259336|FG000|Overall Study|Adverse Event|3|||
160693282|NCT00573157|580259337|FG001|Overall Study|Adverse Event|1|||
160693283|NCT00573157|580259336|FG000|Overall Study|Other|1|||
160693284|NCT00573157|580259337|FG001|Overall Study|Other|1|||
160693285|NCT01032018|580259340|FG000|Overall Study|Lost to Follow-up|6|||
160693286|NCT01032018|580259341|FG001|Overall Study|Lost to Follow-up|5|||
160693287|NCT01032018|580259340|FG000|Overall Study|Death|0|||
160693288|NCT01032018|580259341|FG001|Overall Study|Death|1|||
160693289|NCT00858143|580259344|FG000|Overall Study|Adverse Event|16|||
160693290|NCT00858143|580259344|FG000|Overall Study|Lack of Efficacy|4|||
160693291|NCT00858143|580259344|FG000|Overall Study|Death|7|||
160693292|NCT00858143|580259344|FG000|Overall Study|Other|23|||
160693293|NCT00577395|580259350|FG000|Overall Study|Study was terminated early by Sponsor|7|||
160693294|NCT00577395|580259351|FG001|Overall Study|Study was terminated early by Sponsor|6|||
160693295|NCT03084367|580259352|FG000|Overall Study|Lost to Follow-up|32|||
160693296|NCT03084367|580259352|FG000|Overall Study|Withdrawal by Subject|4|||
160693297|NCT03084367|580259352|FG000|Overall Study|Other|1|||
160693298|NCT00103311|580259355|FG000|Overall Study|Lost to Follow-up|1|||
160693299|NCT00103311|580259356|FG001|Overall Study|Lost to Follow-up|0|||
160693300|NCT00103311|580259355|FG000|Overall Study|Withdrawal by Subject|2|||
160693301|NCT00103311|580259356|FG001|Overall Study|Withdrawal by Subject|1|||
160693302|NCT00103311|580259355|FG000|Overall Study|Adverse Event|1|||
160693303|NCT00103311|580259356|FG001|Overall Study|Adverse Event|0|||
160693304|NCT03827564|580259359|FG000|Overall Study|Discontinued due to Study Termination|1|||
160693305|NCT03827564|580259360|FG001|Overall Study|Discontinued due to Study Termination|0|||
160693306|NCT02621034|580259364|FG000|Overall Study|Lost to Follow-up|3|||
160693307|NCT02621034|580259365|FG001|Overall Study|Lost to Follow-up|2|||
160693308|NCT02621034|580259366|FG002|Overall Study|Lost to Follow-up|5|||
160693309|NCT00974974|580259375|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
160693310|NCT00974974|580259376|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
160693311|NCT00974974|580259375|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
160693312|NCT00974974|580259376|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
160693313|NCT00974974|580259375|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
160693314|NCT00974974|580259376|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
160693315|NCT00974974|580259375|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
160693316|NCT00974974|580259376|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
160693317|NCT00974974|580259375|FG000|IR CD-LD Dose Adjustment|Various|0|||
160693318|NCT00974974|580259376|FG001|IR CD-LD Dose Adjustment|Various|9|||
160693319|NCT00974974|580259375|FG000|IPX066 Dose Conversion|Adverse Event|23|||
160693320|NCT00974974|580259376|FG001|IPX066 Dose Conversion|Adverse Event|0|||
160693321|NCT00974974|580259375|FG000|IPX066 Dose Conversion|Death|2|||
160693322|NCT00974974|580259376|FG001|IPX066 Dose Conversion|Death|0|||
160693323|NCT00974974|580259375|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
160693324|NCT00974974|580259376|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
160693325|NCT00974974|580259375|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
160693326|NCT00974974|580259376|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
160693327|NCT00974974|580259375|FG000|IPX066 Dose Conversion|Various|3|||
160693328|NCT00974974|580259376|FG001|IPX066 Dose Conversion|Various|0|||
160693329|NCT00974974|580259375|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
160693330|NCT00974974|580259376|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
160693331|NCT00974974|580259375|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
160693332|NCT00974974|580259376|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
160693333|NCT00974974|580259375|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
160693334|NCT00974974|580259376|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
160693335|NCT00974974|580259375|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
160693336|NCT00974974|580259376|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
160693337|NCT00974974|580259375|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
160693338|NCT00974974|580259376|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
160693339|NCT00974974|580259375|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
160693340|NCT00974974|580259376|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
160693341|NCT00974974|580259375|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
160693342|NCT00974974|580259376|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
160693343|NCT00974974|580259375|FG000|Maintenance - Double Blind Treatment|Various|4|||
160693344|NCT00974974|580259376|FG001|Maintenance - Double Blind Treatment|Various|0|||
160693345|NCT01959035|580259377|FG000|Overall Study|Adverse Event|5|||
160693346|NCT01959035|580259377|FG000|Overall Study|Withdrawal by Subject|4|||
160693347|NCT01959035|580259377|FG000|Overall Study|Lost to Follow-up|1|||
160693348|NCT01959035|580259377|FG000|Overall Study|Other (no primary reason given)|1|||
160693349|NCT03254602|580259378|FG000|Overall Study|Lost to Follow-up|4|||
160693350|NCT01691820|580259381|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
160693351|NCT01691820|580259382|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
160693352|NCT01691820|580259381|FG000|Overall Study|Migrated/moved from study area|7|||
160693353|NCT01691820|580259382|FG001|Overall Study|Migrated/moved from study area|4|||
160693354|NCT01691820|580259381|FG000|Overall Study|Lost to Follow-up|6|||
160693355|NCT01691820|580259382|FG001|Overall Study|Lost to Follow-up|17|||
160693356|NCT01691820|580259381|FG000|Overall Study|Other (unspecified)|4|||
160693357|NCT01691820|580259382|FG001|Overall Study|Other (unspecified)|1|||
160693358|NCT04442490|580259384|FG000|Overall Study|Withdrawal by Subject|18|||
160693359|NCT04442490|580259385|FG001|Overall Study|Withdrawal by Subject|10|||
160693360|NCT04442490|580259384|FG000|Overall Study|Lost to Follow-up|7|||
160693361|NCT04442490|580259385|FG001|Overall Study|Lost to Follow-up|7|||
160693362|NCT04442490|580259384|FG000|Overall Study|Adverse Event|2|||
160693363|NCT04442490|580259385|FG001|Overall Study|Adverse Event|6|||
160693364|NCT04442490|580259384|FG000|Overall Study|Noncompliance|3|||
160693365|NCT04442490|580259385|FG001|Overall Study|Noncompliance|1|||
160693366|NCT04442490|580259384|FG000|Overall Study|Physician Decision|2|||
160693367|NCT04442490|580259385|FG001|Overall Study|Physician Decision|1|||
160693368|NCT04442490|580259384|FG000|Overall Study|Reason not Specified|2|||
160693369|NCT04442490|580259385|FG001|Overall Study|Reason not Specified|1|||
160693370|NCT04442490|580259384|FG000|Overall Study|Randomized but not Treated|3|||
160693371|NCT04442490|580259385|FG001|Overall Study|Randomized but not Treated|3|||
160693372|NCT01968694|580259386|FG000|Washout (1 Month)|Lost to Follow-up|0|||
160693373|NCT01968694|580259387|FG001|Washout (1 Month)|Lost to Follow-up|1|||
160693374|NCT02836496|580259388|FG000|Overall Study|Adverse Event|2|||
160693375|NCT02836496|580259389|FG001|Overall Study|Adverse Event|1|||
160693376|NCT02836496|580259388|FG000|Overall Study|Withdrawal by Subject|0|||
160693377|NCT02836496|580259389|FG001|Overall Study|Withdrawal by Subject|1|||
160693378|NCT01400919|580259390|FG000|Overall Study|Withdrawal by Subject|4|||
160693379|NCT01400919|580259390|FG000|Overall Study|Lost to Follow-up|2|||
160693380|NCT01400919|580259390|FG000|Overall Study|Missed visit|2|||
160693381|NCT00415194|580259394|FG000|Overall Study|Adverse Event|37|||
160693382|NCT00415194|580259395|FG001|Overall Study|Adverse Event|32|||
160693383|NCT00415194|580259394|FG000|Overall Study|Entry Criteria Not Met|4|||
160693384|NCT00415194|580259395|FG001|Overall Study|Entry Criteria Not Met|8|||
160693385|NCT00415194|580259394|FG000|Overall Study|Lost to Follow-up|1|||
160693386|NCT00415194|580259395|FG001|Overall Study|Lost to Follow-up|0|||
160693387|NCT00415194|580259394|FG000|Overall Study|Physician Decision|10|||
160693388|NCT00415194|580259395|FG001|Overall Study|Physician Decision|16|||
160693389|NCT00415194|580259394|FG000|Overall Study|Progressive Disease|180|||
160693390|NCT00415194|580259395|FG001|Overall Study|Progressive Disease|217|||
160693391|NCT00415194|580259394|FG000|Overall Study|Protocol Violation|4|||
160693392|NCT00415194|580259395|FG001|Overall Study|Protocol Violation|2|||
160693393|NCT00415194|580259394|FG000|Overall Study|Withdrawal by Subject|28|||
160693394|NCT00415194|580259395|FG001|Overall Study|Withdrawal by Subject|21|||
160693395|NCT00415194|580259394|FG000|Overall Study|Death Due to Study Disease|26|||
160693396|NCT00415194|580259395|FG001|Overall Study|Death Due to Study Disease|29|||
160693397|NCT00415194|580259394|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
160693398|NCT00415194|580259395|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
160693399|NCT00415194|580259394|FG000|Overall Study|Death Due to Procedural Related AE|0|||
160693400|NCT00415194|580259395|FG001|Overall Study|Death Due to Procedural Related AE|1|||
160693401|NCT00415194|580259394|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
160693402|NCT00415194|580259395|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
160693403|NCT01297465|580259396|FG000|Overall Study|Lack of Ovarian Response|1|||
160693404|NCT01297465|580259397|FG001|Overall Study|Lack of Ovarian Response|1|||
160693405|NCT01297465|580259396|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
160693406|NCT01297465|580259397|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
160693407|NCT01297465|580259396|FG000|Overall Study|No Oocytes Retrieved|1|||
160693408|NCT01297465|580259397|FG001|Overall Study|No Oocytes Retrieved|1|||
160693409|NCT01297465|580259396|FG000|Overall Study|Poor oocyte quality|0|||
160693410|NCT01297465|580259397|FG001|Overall Study|Poor oocyte quality|1|||
160693411|NCT01297465|580259396|FG000|Overall Study|No Fertilization|6|||
160693412|NCT01297465|580259397|FG001|Overall Study|No Fertilization|4|||
160693413|NCT01297465|580259396|FG000|Overall Study|All Embryos Discarded|0|||
160693414|NCT01297465|580259397|FG001|Overall Study|All Embryos Discarded|1|||
160693415|NCT01297465|580259396|FG000|Overall Study|Intention to Freeze all Embryos|0|||
160693416|NCT01297465|580259397|FG001|Overall Study|Intention to Freeze all Embryos|1|||
160693417|NCT00969540|580259398|FG000|Overall Study|Lost to Follow-up|1|||
160693418|NCT00969540|580259399|FG001|Overall Study|Lost to Follow-up|1|||
160693419|NCT02397408|580259400|FG000|Overall Study|Physician Decision|4|||
160693420|NCT02397408|580259400|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
160693421|NCT01646138|580259401|FG000|Overall Study|Lost to Follow-up|0|||
160693422|NCT01646138|580259402|FG001|Overall Study|Lost to Follow-up|0|||
160693423|NCT01646138|580259403|FG002|Overall Study|Lost to Follow-up|0|||
160693424|NCT01646138|580259404|FG003|Overall Study|Lost to Follow-up|0|||
160693425|NCT01646138|580259405|FG004|Overall Study|Lost to Follow-up|2|||
160693426|NCT00801099|580259406|FG000|Overall Study|Lost to Follow-up|101|||
160693427|NCT01780987|580259407|FG000|Overall Study|Adverse Event|0|||
160693428|NCT01780987|580259408|FG001|Overall Study|Adverse Event|4|||
160693429|NCT01780987|580259407|FG000|Overall Study|Withdrawal by Subject|2|||
160693430|NCT01780987|580259408|FG001|Overall Study|Withdrawal by Subject|0|||
160693431|NCT01780987|580259407|FG000|Overall Study|Request of Changing Hospital|0|||
160693432|NCT01780987|580259408|FG001|Overall Study|Request of Changing Hospital|1|||
160693433|NCT01780987|580259407|FG000|Overall Study|Changing Residence|1|||
160693434|NCT01780987|580259408|FG001|Overall Study|Changing Residence|0|||
160693435|NCT01780987|580259407|FG000|Overall Study|Not Receiving any Study Medication|0|||
160693436|NCT01780987|580259408|FG001|Overall Study|Not Receiving any Study Medication|1|||
160693437|NCT04078126|580259411|FG000|Washout|Study put on hold due to COVID-19|0|||
160693438|NCT04078126|580259412|FG001|Washout|Study put on hold due to COVID-19|2|||
160693439|NCT04078126|580259411|FG000|Period 2|Study put on hold due to COVID-19|1|||
160693440|NCT04078126|580259412|FG001|Period 2|Study put on hold due to COVID-19|1|||
160693441|NCT03321630|580259415|FG000|Overall Study|Adverse Event|1|||
160693442|NCT03321630|580259415|FG000|Overall Study|Investigator Discretion|2|||
160693443|NCT03321630|580259415|FG000|Overall Study|Withdrawal by Subject|1|||
160693444|NCT00140426|580259416|FG000|Overall Study|Withdrawal by Subject|0|||
160693445|NCT00140426|580259417|FG001|Overall Study|Withdrawal by Subject|3|||
160693446|NCT00950963|580259418|FG000|Overall Study|Lost to Follow-up|29|||
160693447|NCT00950963|580259419|FG001|Overall Study|Lost to Follow-up|24|||
160693448|NCT02325518|580259420|FG000|Overall Study|Adverse Event|4|||
160693449|NCT02325518|580259421|FG001|Overall Study|Adverse Event|1|||
160693450|NCT02325518|580259420|FG000|Overall Study|Physician Decision|0|||
160693451|NCT02325518|580259421|FG001|Overall Study|Physician Decision|1|||
160693452|NCT02325518|580259420|FG000|Overall Study|Withdrawal by Subject|0|||
160693453|NCT02325518|580259421|FG001|Overall Study|Withdrawal by Subject|1|||
160693454|NCT01675661|580259422|FG000|Overall Study|Lost to Follow-up|22|||
160693455|NCT01675661|580259423|FG001|Overall Study|Lost to Follow-up|23|||
160693456|NCT01675661|580259422|FG000|Overall Study|Practical problems|9|||
160693457|NCT01675661|580259423|FG001|Overall Study|Practical problems|5|||
160693458|NCT01675661|580259422|FG000|Overall Study|Moved away|5|||
160693459|NCT01675661|580259423|FG001|Overall Study|Moved away|6|||
160693460|NCT01675661|580259422|FG000|Overall Study|Withdrawal by Subject|3|||
160693461|NCT01675661|580259423|FG001|Overall Study|Withdrawal by Subject|7|||
160693462|NCT01675661|580259422|FG000|Overall Study|Physician Decision|0|||
160693463|NCT01675661|580259423|FG001|Overall Study|Physician Decision|2|||
160693464|NCT01675661|580259422|FG000|Overall Study|Death|0|||
160693465|NCT01675661|580259423|FG001|Overall Study|Death|1|||
160693466|NCT01675661|580259422|FG000|Overall Study|Other reason|1|||
160693467|NCT01675661|580259423|FG001|Overall Study|Other reason|2|||
160693468|NCT04765384|580259424|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
160693469|NCT04765384|580259425|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
160693470|NCT04765384|580259426|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
160693471|NCT04765384|580259427|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
160693472|NCT04765384|580259428|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
160693473|NCT04765384|580259429|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
160693474|NCT04765384|580259424|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
160693475|NCT04765384|580259425|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
160693476|NCT04765384|580259426|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
160693477|NCT04765384|580259427|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
160693478|NCT04765384|580259428|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
160693479|NCT04765384|580259429|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
160693480|NCT04765384|580259424|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
160693481|NCT04765384|580259425|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
160693482|NCT04765384|580259426|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
160693483|NCT04765384|580259427|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
160693484|NCT04765384|580259428|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
160693485|NCT04765384|580259429|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
160693486|NCT04765384|580259424|FG000|Post-natal: Neonates and Infants|Death|0|||
160693487|NCT04765384|580259425|FG001|Post-natal: Neonates and Infants|Death|0|||
160693488|NCT04765384|580259426|FG002|Post-natal: Neonates and Infants|Death|0|||
160693489|NCT04765384|580259427|FG003|Post-natal: Neonates and Infants|Death|1|||
160693490|NCT04765384|580259428|FG004|Post-natal: Neonates and Infants|Death|0|||
160693491|NCT04765384|580259429|FG005|Post-natal: Neonates and Infants|Death|0|||
160693492|NCT04765384|580259424|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
160693493|NCT04765384|580259425|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
160693494|NCT04765384|580259426|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
160693495|NCT04765384|580259427|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
160693496|NCT04765384|580259428|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
160693497|NCT04765384|580259429|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
160693498|NCT00987389|580259430|FG000|Overall Study|Ineligible|0|||
160693499|NCT00987389|580259431|FG001|Overall Study|Ineligible|3|||
160693500|NCT00987389|580259432|FG002|Overall Study|Ineligible|0|||
160693501|NCT00987389|580259433|FG003|Overall Study|Ineligible|0|||
160693502|NCT00987389|580259430|FG000|Overall Study|Lost to Follow-up|4|||
160693503|NCT00987389|580259431|FG001|Overall Study|Lost to Follow-up|1|||
160693504|NCT00987389|580259432|FG002|Overall Study|Lost to Follow-up|3|||
160693505|NCT00987389|580259433|FG003|Overall Study|Lost to Follow-up|1|||
160693506|NCT00987389|580259430|FG000|Overall Study|Withdrawal by Subject|4|||
160693507|NCT00987389|580259431|FG001|Overall Study|Withdrawal by Subject|3|||
160693508|NCT00987389|580259432|FG002|Overall Study|Withdrawal by Subject|2|||
160693509|NCT00987389|580259433|FG003|Overall Study|Withdrawal by Subject|1|||
160693510|NCT00987389|580259430|FG000|Overall Study|Withdrawn from Treatment|0|||
160693511|NCT00987389|580259431|FG001|Overall Study|Withdrawn from Treatment|1|||
160693512|NCT00987389|580259432|FG002|Overall Study|Withdrawn from Treatment|0|||
160693513|NCT00987389|580259433|FG003|Overall Study|Withdrawn from Treatment|0|||
160693514|NCT00987389|580259430|FG000|Overall Study|Multiple different reasons|1|||
160693515|NCT00987389|580259431|FG001|Overall Study|Multiple different reasons|0|||
160693516|NCT00987389|580259432|FG002|Overall Study|Multiple different reasons|3|||
160693517|NCT00987389|580259433|FG003|Overall Study|Multiple different reasons|1|||
160693518|NCT02992418|580259436|FG000|Overall Study|Withdrawal by Subject|11|||
160693519|NCT02992418|580259437|FG001|Overall Study|Withdrawal by Subject|12|||
160693520|NCT02992418|580259436|FG000|Overall Study|Non-compliance with the protocol|308|||
160693521|NCT02992418|580259437|FG001|Overall Study|Non-compliance with the protocol|308|||
160693522|NCT02992418|580259436|FG000|Overall Study|Lost to Follow-up|27|||
160693523|NCT02992418|580259437|FG001|Overall Study|Lost to Follow-up|22|||
160693524|NCT00289536|580259438|FG000|Period 3|Lost to Follow-up|0|||
160693525|NCT00289536|580259439|FG001|Period 3|Lost to Follow-up|0|||
160693526|NCT00289536|580259440|FG002|Period 3|Lost to Follow-up|1|||
160693527|NCT02272634|580259443|FG000|Overall Study|Adverse Event|1|||
160693528|NCT02272634|580259444|FG001|Overall Study|Adverse Event|0|||
160693529|NCT02272634|580259445|FG002|Overall Study|Adverse Event|0|||
160693530|NCT02272634|580259443|FG000|Overall Study|Protocol Violation|0|||
160693531|NCT02272634|580259444|FG001|Overall Study|Protocol Violation|0|||
160693532|NCT02272634|580259445|FG002|Overall Study|Protocol Violation|1|||
160693533|NCT02272634|580259443|FG000|Overall Study|Withdrawal by Subject|0|||
160693534|NCT02272634|580259444|FG001|Overall Study|Withdrawal by Subject|1|||
160693535|NCT02272634|580259445|FG002|Overall Study|Withdrawal by Subject|0|||
160693536|NCT01437943|580259446|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
160693537|NCT01437943|580259447|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
160693538|NCT01437943|580259446|FG000|Overall Study|Subject expressed pregnancy plans|1|||
160693539|NCT01437943|580259447|FG001|Overall Study|Subject expressed pregnancy plans|0|||
160693540|NCT01437943|580259446|FG000|Overall Study|Adverse Event|2|||
160693541|NCT01437943|580259447|FG001|Overall Study|Adverse Event|0|||
160693542|NCT04647721|580259448|FG000|Overall Study|Withdrawal by Subject|0|||
160693543|NCT04647721|580259449|FG001|Overall Study|Withdrawal by Subject|2|||
160693544|NCT04647721|580259448|FG000|Overall Study|Lost to Follow-up|2|||
160693545|NCT04647721|580259449|FG001|Overall Study|Lost to Follow-up|0|||
160693546|NCT02643355|580259450|FG000|Overall Study|Withdrawal by Subject|1|||
160693547|NCT02643355|580259451|FG001|Overall Study|Withdrawal by Subject|3|||
160693548|NCT02643355|580259450|FG000|Overall Study|Protocol Violation|0|||
160693549|NCT02643355|580259451|FG001|Overall Study|Protocol Violation|2|||
160693550|NCT00985712|580259454|FG000|Overall Study|Adverse Event|0|||
160693551|NCT00985712|580259455|FG001|Overall Study|Adverse Event|1|||
160693552|NCT00985712|580259454|FG000|Overall Study|Lost to Follow-up|2|||
160693553|NCT00985712|580259455|FG001|Overall Study|Lost to Follow-up|2|||
160693554|NCT00985712|580259454|FG000|Overall Study|Protocol Violation|0|||
160693555|NCT00985712|580259455|FG001|Overall Study|Protocol Violation|1|||
160693556|NCT00985712|580259454|FG000|Overall Study|Withdrawal by Subject|4|||
160693557|NCT00985712|580259455|FG001|Overall Study|Withdrawal by Subject|1|||
160693558|NCT00985712|580259454|FG000|Overall Study|Sponsor decision|0|||
160693559|NCT00985712|580259455|FG001|Overall Study|Sponsor decision|2|||
160693560|NCT01843348|580259458|FG000|Overall Study|Withdrawal by Subject|4|||
160693561|NCT01843348|580259459|FG001|Overall Study|Withdrawal by Subject|16|||
160693562|NCT01843348|580259460|FG002|Overall Study|Withdrawal by Subject|18|||
160693563|NCT01843348|580259458|FG000|Overall Study|Lost to Follow-up|5|||
160693564|NCT01843348|580259459|FG001|Overall Study|Lost to Follow-up|4|||
160693565|NCT01843348|580259460|FG002|Overall Study|Lost to Follow-up|2|||
160693566|NCT01843348|580259458|FG000|Overall Study|Death|5|||
160693567|NCT01843348|580259459|FG001|Overall Study|Death|3|||
160693568|NCT01843348|580259460|FG002|Overall Study|Death|4|||
160693569|NCT01843348|580259458|FG000|Overall Study|Graft loss/retransplantation|5|||
160693570|NCT01843348|580259459|FG001|Overall Study|Graft loss/retransplantation|8|||
160693571|NCT01843348|580259460|FG002|Overall Study|Graft loss/retransplantation|11|||
160693572|NCT01843348|580259458|FG000|Overall Study|Various reasons|4|||
160693573|NCT01843348|580259459|FG001|Overall Study|Various reasons|9|||
160693574|NCT01843348|580259460|FG002|Overall Study|Various reasons|6|||
160693575|NCT00251641|580259461|FG000|Overall Study|Adverse Event|80|||
160693576|NCT00251641|580259462|FG001|Overall Study|Adverse Event|8|||
160693577|NCT00251641|580259461|FG000|Overall Study|Lack of Efficacy|2|||
160693578|NCT00251641|580259462|FG001|Overall Study|Lack of Efficacy|1|||
160693579|NCT00251641|580259461|FG000|Overall Study|Progression of Disease|0|||
160693580|NCT00251641|580259462|FG001|Overall Study|Progression of Disease|2|||
160693581|NCT00251641|580259461|FG000|Overall Study|Lost to Follow-up|3|||
160693582|NCT00251641|580259462|FG001|Overall Study|Lost to Follow-up|3|||
160693583|NCT00251641|580259461|FG000|Overall Study|Withdrawal by Subject|6|||
160693584|NCT00251641|580259462|FG001|Overall Study|Withdrawal by Subject|8|||
160693585|NCT00251641|580259461|FG000|Overall Study|Protocol Violation|10|||
160693586|NCT00251641|580259462|FG001|Overall Study|Protocol Violation|2|||
160693587|NCT00251641|580259461|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
160693588|NCT00251641|580259462|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
160693589|NCT00251641|580259461|FG000|Overall Study|Switched Treatment|9|||
160693590|NCT00251641|580259462|FG001|Overall Study|Switched Treatment|63|||
160693591|NCT03828448|580259464|FG000|Overall Study|Sponsor's Discretion|34|||
160693592|NCT02192164|580259470|FG000|Overall Study|Other|8|||
160693593|NCT02192164|580259470|FG000|Overall Study|Withdrawal by Subject|1|||
160693594|NCT02192164|580259470|FG000|Overall Study|Physician Decision|4|||
160693595|NCT02192164|580259470|FG000|Overall Study|Did not meet the exclusion criteria|1|||
160693596|NCT05069155|580259471|FG000|Overall Study|Withdrawal by Subject|1|||
160693597|NCT05069155|580259472|FG001|Overall Study|Withdrawal by Subject|3|||
160693598|NCT01929031|580259473|FG000|Overall Study|Adverse Event|3|||
160693599|NCT01929031|580259474|FG001|Overall Study|Adverse Event|1|||
160693600|NCT01929031|580259475|FG002|Overall Study|Adverse Event|1|||
160693601|NCT01929031|580259476|FG003|Overall Study|Adverse Event|0|||
160693602|NCT01929031|580259477|FG004|Overall Study|Adverse Event|0|||
160693603|NCT01929031|580259478|FG005|Overall Study|Adverse Event|0|||
160693604|NCT01929031|580259473|FG000|Overall Study|Protocol Violation|1|||
160693605|NCT01929031|580259474|FG001|Overall Study|Protocol Violation|0|||
160693606|NCT01929031|580259475|FG002|Overall Study|Protocol Violation|0|||
160693607|NCT01929031|580259476|FG003|Overall Study|Protocol Violation|0|||
160693608|NCT01929031|580259477|FG004|Overall Study|Protocol Violation|0|||
160693609|NCT01929031|580259478|FG005|Overall Study|Protocol Violation|1|||
160693610|NCT01929031|580259473|FG000|Overall Study|Reason other than specified above|0|||
160693611|NCT01929031|580259474|FG001|Overall Study|Reason other than specified above|1|||
160693612|NCT01929031|580259475|FG002|Overall Study|Reason other than specified above|0|||
160693613|NCT01929031|580259476|FG003|Overall Study|Reason other than specified above|0|||
160693614|NCT01929031|580259477|FG004|Overall Study|Reason other than specified above|1|||
160693615|NCT01929031|580259478|FG005|Overall Study|Reason other than specified above|0|||
160693616|NCT01366443|580259479|FG000|Overall Study|Lost to Follow-up|2|||
160693617|NCT01366443|580259479|FG000|Overall Study|Under 18 yo|1|||
160693618|NCT00731549|580259480|FG000|Overall Study|Lost to Follow-up|19|||
160693619|NCT00731549|580259480|FG000|Overall Study|Met withdrawal criteria|24|||
160693620|NCT00731549|580259480|FG000|Overall Study|Physician Decision|16|||
160693621|NCT00731549|580259480|FG000|Overall Study|Withdrawal by Subject|89|||
160693622|NCT00731549|580259480|FG000|Overall Study|Protocol deviation|1|||
160693623|NCT00731549|580259480|FG000|Overall Study|Adverse Event|31|||
160693624|NCT00731549|580259480|FG000|Overall Study|Lack of efficacy with AE|37|||
160693625|NCT00731549|580259480|FG000|Overall Study|Lack of efficacy without AE|6|||
160693626|NCT00678041|580260905|FG000|Overall Study|Physician Decision|5|||
160693627|NCT00678041|580260906|FG001|Overall Study|Physician Decision|5|||
160693628|NCT02358343|580260907|FG000|Screening Intervention|Death|0|||
160693629|NCT02358343|580260908|FG001|Screening Intervention|Death|2|||
160693630|NCT02358343|580260909|FG002|Screening Intervention|Death|0|||
160693631|NCT02358343|580260910|FG003|Screening Intervention|Death|0|||
160693632|NCT02358343|580260911|FG004|Screening Intervention|Death|0|||
160693633|NCT02358343|580260907|FG000|Screening Intervention|Withdrawal by Subject|1|||
160693634|NCT02358343|580260908|FG001|Screening Intervention|Withdrawal by Subject|0|||
160693635|NCT02358343|580260909|FG002|Screening Intervention|Withdrawal by Subject|0|||
160693636|NCT02358343|580260910|FG003|Screening Intervention|Withdrawal by Subject|0|||
160693637|NCT02358343|580260911|FG004|Screening Intervention|Withdrawal by Subject|0|||
160693638|NCT02358343|580260907|FG000|Screening Intervention|Determined Ineligible|5|||
160693639|NCT02358343|580260908|FG001|Screening Intervention|Determined Ineligible|6|||
160693640|NCT02358343|580260909|FG002|Screening Intervention|Determined Ineligible|0|||
160693641|NCT02358343|580260910|FG003|Screening Intervention|Determined Ineligible|0|||
160693642|NCT02358343|580260911|FG004|Screening Intervention|Determined Ineligible|0|||
160693643|NCT02358343|580260907|FG000|Comparative Efficacy Trial / Observation|Death|0|||
160693644|NCT02358343|580260908|FG001|Comparative Efficacy Trial / Observation|Death|0|||
160693645|NCT02358343|580260909|FG002|Comparative Efficacy Trial / Observation|Death|2|||
160693646|NCT02358343|580260910|FG003|Comparative Efficacy Trial / Observation|Death|0|||
160693647|NCT02358343|580260911|FG004|Comparative Efficacy Trial / Observation|Death|0|||
160693648|NCT02358343|580260907|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
160693649|NCT02358343|580260908|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
160693650|NCT02358343|580260909|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
160693651|NCT02358343|580260910|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
160693652|NCT02358343|580260911|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
160693653|NCT02358343|580260907|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
160693654|NCT02358343|580260908|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
160693655|NCT02358343|580260909|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
160693656|NCT02358343|580260910|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
160693657|NCT02358343|580260911|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
160693658|NCT01951885|580260912|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
160693659|NCT01951885|580260913|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
160693660|NCT01951885|580260912|FG000|Overall Study|Adverse Event|1|||
160693661|NCT01951885|580260913|FG001|Overall Study|Adverse Event|0|||
160693662|NCT01951885|580260912|FG000|Overall Study|Withdrawal by Subject|0|||
160693663|NCT01951885|580260913|FG001|Overall Study|Withdrawal by Subject|1|||
160693664|NCT01951885|580260912|FG000|Overall Study|ineligible due to a change in donor|0|||
160693665|NCT01951885|580260913|FG001|Overall Study|ineligible due to a change in donor|1|||
160693666|NCT01951885|580260912|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
160693667|NCT01951885|580260913|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
160693668|NCT03188718|580260914|FG000|Overall Study|Participant noncompliance|4|||
160693669|NCT03188718|580260914|FG000|Overall Study|Withdrawal by Subject|1|||
160693670|NCT03188718|580260914|FG000|Overall Study|Device failure|3|||
160693671|NCT04322149|580260915|FG000|Overall Study|Adverse Event|1|||
160693672|NCT04322149|580260916|FG001|Overall Study|Adverse Event|1|||
160693673|NCT04322149|580260917|FG002|Overall Study|Adverse Event|0|||
160693674|NCT04322149|580260918|FG003|Overall Study|Adverse Event|0|||
160693675|NCT04322149|580260915|FG000|Overall Study|Withdrawal by Subject|0|||
160693676|NCT04322149|580260916|FG001|Overall Study|Withdrawal by Subject|0|||
160693677|NCT04322149|580260917|FG002|Overall Study|Withdrawal by Subject|0|||
160693678|NCT04322149|580260918|FG003|Overall Study|Withdrawal by Subject|2|||
160693679|NCT04322149|580260915|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
160693680|NCT04322149|580260916|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
160693681|NCT04322149|580260917|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
160693682|NCT04322149|580260918|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
160693683|NCT01700049|580260925|FG000|Overall Study|Withdrawal by Subject|1|||
160693684|NCT01206101|580260929|FG000|Overall Study|Adverse Event|1|||
160693685|NCT01206101|580260930|FG001|Overall Study|Adverse Event|0|||
160693686|NCT01206101|580260929|FG000|Overall Study|Physician Decision|0|||
160693687|NCT01206101|580260930|FG001|Overall Study|Physician Decision|1|||
160693688|NCT01206101|580260929|FG000|Overall Study|Unclassified|1|||
160693689|NCT01206101|580260930|FG001|Overall Study|Unclassified|0|||
160693690|NCT00368979|580260934|FG000|Overall Study|Adverse Event|9|||
160693691|NCT00368979|580260935|FG001|Overall Study|Adverse Event|16|||
160693692|NCT00368979|580260934|FG000|Overall Study|Lack of Efficacy|5|||
160693693|NCT00368979|580260935|FG001|Overall Study|Lack of Efficacy|3|||
160693694|NCT00368979|580260934|FG000|Overall Study|Other|3|||
160693695|NCT00368979|580260935|FG001|Overall Study|Other|1|||
160693696|NCT00368979|580260934|FG000|Overall Study|Lost to Follow-up|1|||
160693697|NCT00368979|580260935|FG001|Overall Study|Lost to Follow-up|0|||
160693698|NCT00368979|580260934|FG000|Overall Study|Protocol Violation|2|||
160693699|NCT00368979|580260935|FG001|Overall Study|Protocol Violation|1|||
160693700|NCT00368979|580260934|FG000|Overall Study|Withdrawal by Subject|5|||
160693701|NCT00368979|580260935|FG001|Overall Study|Withdrawal by Subject|9|||
160693702|NCT00912093|580260936|FG000|The Controlled Phase|Death|0|||
160693703|NCT00912093|580260937|FG001|The Controlled Phase|Death|1|||
160693704|NCT00912093|580260938|FG002|The Controlled Phase|Death|0|||
160693705|NCT00912093|580260939|FG003|The Controlled Phase|Death|0|||
160693706|NCT00912093|580260940|FG004|The Controlled Phase|Death|0|||
160693707|NCT00912093|580260936|FG000|The Controlled Phase|Medical Condition|0|||
160693708|NCT00912093|580260937|FG001|The Controlled Phase|Medical Condition|1|||
160693709|NCT00912093|580260938|FG002|The Controlled Phase|Medical Condition|0|||
160693710|NCT00912093|580260939|FG003|The Controlled Phase|Medical Condition|0|||
160693711|NCT00912093|580260940|FG004|The Controlled Phase|Medical Condition|0|||
160693712|NCT00912093|580260936|FG000|The Controlled Phase|Lost to Follow-up|0|||
160693713|NCT00912093|580260937|FG001|The Controlled Phase|Lost to Follow-up|0|||
160693714|NCT00912093|580260938|FG002|The Controlled Phase|Lost to Follow-up|0|||
160693715|NCT00912093|580260939|FG003|The Controlled Phase|Lost to Follow-up|0|||
160693716|NCT00912093|580260940|FG004|The Controlled Phase|Lost to Follow-up|1|||
160693717|NCT00394524|580260941|FG000|Overall Study|Protocol Violation|2|||
160693718|NCT00394524|580260942|FG001|Overall Study|Protocol Violation|3|||
160693719|NCT00394524|580260941|FG000|Overall Study|Death|1|||
160693720|NCT00394524|580260942|FG001|Overall Study|Death|0|||
160693721|NCT00394524|580260941|FG000|Overall Study|Withdrawal by Subject|0|||
160693722|NCT00394524|580260942|FG001|Overall Study|Withdrawal by Subject|1|||
160693723|NCT01462318|580260943|FG000|Main Study / TP-DI Study|Other|2|||
160693724|NCT01462318|580260944|FG001|Main Study / TP-DI Study|Other|0|||
160693725|NCT01462318|580260945|FG002|Main Study / TP-DI Study|Other|0|||
160693726|NCT01462318|580260943|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
160693727|NCT01462318|580260944|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
160693728|NCT01462318|580260945|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
160693729|NCT01462318|580260943|FG000|Main Study / TP-DI Study|Adverse Event|4|||
160693730|NCT01462318|580260944|FG001|Main Study / TP-DI Study|Adverse Event|0|||
160693731|NCT01462318|580260945|FG002|Main Study / TP-DI Study|Adverse Event|0|||
160693732|NCT01462318|580260943|FG000|Extension Phase|Lost to Follow-up|0|||
160693733|NCT01462318|580260944|FG001|Extension Phase|Lost to Follow-up|0|||
160693734|NCT01462318|580260945|FG002|Extension Phase|Lost to Follow-up|1|||
160693735|NCT01462318|580260943|FG000|Extension Phase|Other|0|||
160693736|NCT01462318|580260944|FG001|Extension Phase|Other|0|||
160693737|NCT01462318|580260945|FG002|Extension Phase|Other|1|||
160693738|NCT01462318|580260943|FG000|Extension Phase|Disease Progression|0|||
160693739|NCT01462318|580260944|FG001|Extension Phase|Disease Progression|0|||
160693740|NCT01462318|580260945|FG002|Extension Phase|Disease Progression|1|||
160693741|NCT01462318|580260943|FG000|Extension Phase|Withdrawal by Subject|0|||
160693742|NCT01462318|580260944|FG001|Extension Phase|Withdrawal by Subject|0|||
160693743|NCT01462318|580260945|FG002|Extension Phase|Withdrawal by Subject|15|||
160693744|NCT01462318|580260943|FG000|Extension Phase|Investigator Decision|0|||
160693745|NCT01462318|580260944|FG001|Extension Phase|Investigator Decision|0|||
160693746|NCT01462318|580260945|FG002|Extension Phase|Investigator Decision|5|||
160693747|NCT01462318|580260943|FG000|Extension Phase|Adverse Event|0|||
160693748|NCT01462318|580260944|FG001|Extension Phase|Adverse Event|0|||
160693749|NCT01462318|580260945|FG002|Extension Phase|Adverse Event|22|||
160693750|NCT02238626|580260946|FG000|Overall Study|Adverse Event|3|||
160693751|NCT02238626|580260947|FG001|Overall Study|Adverse Event|5|||
160693752|NCT02238626|580260948|FG002|Overall Study|Adverse Event|0|||
160693753|NCT02238626|580260949|FG003|Overall Study|Adverse Event|3|||
160693754|NCT02238626|580260946|FG000|Overall Study|Lost to Follow-up|2|||
160693755|NCT02238626|580260947|FG001|Overall Study|Lost to Follow-up|4|||
160693756|NCT02238626|580260948|FG002|Overall Study|Lost to Follow-up|2|||
160693757|NCT02238626|580260949|FG003|Overall Study|Lost to Follow-up|2|||
160693758|NCT02238626|580260946|FG000|Overall Study|Withdrawal by Subject|0|||
160693759|NCT02238626|580260947|FG001|Overall Study|Withdrawal by Subject|3|||
160693760|NCT02238626|580260948|FG002|Overall Study|Withdrawal by Subject|0|||
160693761|NCT02238626|580260949|FG003|Overall Study|Withdrawal by Subject|1|||
160693762|NCT02238626|580260946|FG000|Overall Study|Death|0|||
160693763|NCT02238626|580260947|FG001|Overall Study|Death|0|||
160693764|NCT02238626|580260948|FG002|Overall Study|Death|1|||
160693765|NCT02238626|580260949|FG003|Overall Study|Death|1|||
160693766|NCT02238626|580260946|FG000|Overall Study|Other|0|||
160693767|NCT02238626|580260947|FG001|Overall Study|Other|2|||
160693768|NCT02238626|580260948|FG002|Overall Study|Other|0|||
160693769|NCT02238626|580260949|FG003|Overall Study|Other|0|||
160693770|NCT00270257|580260950|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
160693771|NCT00270257|580260951|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
160693772|NCT01195103|580260954|FG000|Overall Study|Withdrawal by Subject|1|||
160693773|NCT01195103|580260955|FG001|Overall Study|Withdrawal by Subject|0|||
160693774|NCT01195103|580260956|FG002|Overall Study|Withdrawal by Subject|0|||
160693775|NCT00450619|580260963|FG000|Overall Study|refused treatment after randomization|2|||
160693776|NCT00450619|580260964|FG001|Overall Study|refused treatment after randomization|0|||
160693777|NCT00450619|580260963|FG000|Overall Study|did not progress; refused further trmt|1|||
160693778|NCT00450619|580260964|FG001|Overall Study|did not progress; refused further trmt|1|||
160693779|NCT00450619|580260963|FG000|Overall Study|Adverse Event|1|||
160693780|NCT00450619|580260964|FG001|Overall Study|Adverse Event|0|||
160693781|NCT02963311|580260965|FG000|Overall Study|Withdrawal by Subject|1|||
160693782|NCT02963311|580260965|FG000|Overall Study|Screen Failure|4|||
160693783|NCT02149108|580260968|FG000|Overall Study|Not treated|1|||
160693784|NCT02149108|580260969|FG001|Overall Study|Not treated|2|||
160693785|NCT02149108|580260968|FG000|Overall Study|Progressive Disease (PD)|324|||
160693786|NCT02149108|580260969|FG001|Overall Study|Progressive Disease (PD)|318|||
160693787|NCT02149108|580260968|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
160693788|NCT02149108|580260969|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
160693789|NCT02149108|580260968|FG000|Overall Study|Other Adverse Event (AE)|8|||
160693790|NCT02149108|580260969|FG001|Overall Study|Other Adverse Event (AE)|18|||
160693791|NCT02149108|580260968|FG000|Overall Study|Other not defined above|0|||
160693792|NCT02149108|580260969|FG001|Overall Study|Other not defined above|2|||
160693793|NCT02149108|580260968|FG000|Overall Study|Refusal to continue trial medication|15|||
160693794|NCT02149108|580260969|FG001|Overall Study|Refusal to continue trial medication|11|||
160693795|NCT02149108|580260968|FG000|Overall Study|Lost to Follow-up|1|||
160693796|NCT02149108|580260969|FG001|Overall Study|Lost to Follow-up|0|||
160693797|NCT01974440|580260970|FG000|Overall Study|Lost to Follow-up|7|||
160693798|NCT01974440|580260971|FG001|Overall Study|Lost to Follow-up|7|||
160693799|NCT01974440|580260970|FG000|Overall Study|Withdrawal by Subject|24|||
160693800|NCT01974440|580260971|FG001|Overall Study|Withdrawal by Subject|20|||
160693801|NCT01974440|580260970|FG000|Overall Study|Sponsor decision|109|||
160693802|NCT01974440|580260971|FG001|Overall Study|Sponsor decision|110|||
160693803|NCT04771403|580260975|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
160693804|NCT04771403|580260976|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
160693805|NCT04771403|580260975|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
160693806|NCT04771403|580260976|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
160693807|NCT04771403|580260975|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
160693808|NCT04771403|580260976|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
160693809|NCT04771403|580260975|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
160693810|NCT04771403|580260976|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
160693811|NCT04771403|580260975|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
160693812|NCT04771403|580260976|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
160693813|NCT04771403|580260975|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
160693814|NCT04771403|580260976|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
160693815|NCT04771403|580260975|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
160748712|NCT00303472|580465926|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
160693816|NCT04771403|580260976|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
160693817|NCT04771403|580260975|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
160693818|NCT04771403|580260976|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
160693819|NCT00857259|580260977|FG000|Overall Study|Protocol Violation|1|||
160693820|NCT00857259|580260978|FG001|Overall Study|Protocol Violation|0|||
160693821|NCT00857259|580260979|FG002|Overall Study|Protocol Violation|1|||
160693822|NCT02701413|580260980|FG000|Overall Study|Withdrawal by Subject|7|||
160693823|NCT02701413|580260981|FG001|Overall Study|Withdrawal by Subject|11|||
160693824|NCT02138136|580260982|FG000|Overall Study|Protocol Violation|4|||
160693825|NCT02138136|580260982|FG000|Overall Study|Physician Decision|7|||
160693826|NCT02138136|580260982|FG000|Overall Study|Lack of Efficacy|35|||
160693827|NCT02138136|580260982|FG000|Overall Study|Pregnancy|2|||
160693828|NCT02138136|580260982|FG000|Overall Study|Adverse Event|18|||
160693829|NCT02138136|580260982|FG000|Overall Study|Withdrawal by Subject|36|||
160693830|NCT02138136|580260982|FG000|Overall Study|Lost to Follow-up|32|||
160693831|NCT02138136|580260982|FG000|Overall Study|Withdrawn by Sponsor|5|||
160693832|NCT01660334|580260987|FG000|Overall Study|Lost to Follow-up|1|||
160693833|NCT00536263|580260988|FG000|Overall Study|Adverse Event|5|||
160693834|NCT00536263|580260989|FG001|Overall Study|Adverse Event|5|||
160693835|NCT00536263|580260990|FG002|Overall Study|Adverse Event|7|||
160693836|NCT00536263|580260988|FG000|Overall Study|Lost to Follow-up|3|||
160693837|NCT00536263|580260989|FG001|Overall Study|Lost to Follow-up|4|||
160693838|NCT00536263|580260990|FG002|Overall Study|Lost to Follow-up|4|||
160693839|NCT00536263|580260988|FG000|Overall Study|Subject withdrew - not treatment related|2|||
160693840|NCT00536263|580260989|FG001|Overall Study|Subject withdrew - not treatment related|0|||
160693841|NCT00536263|580260990|FG002|Overall Study|Subject withdrew - not treatment related|5|||
160693842|NCT00536263|580260988|FG000|Overall Study|Subject withdrew - treatment related|0|||
160693843|NCT00536263|580260989|FG001|Overall Study|Subject withdrew - treatment related|3|||
160693844|NCT00536263|580260990|FG002|Overall Study|Subject withdrew - treatment related|2|||
160693845|NCT00536263|580260988|FG000|Overall Study|Noncompliance with protocol|0|||
160693846|NCT00536263|580260989|FG001|Overall Study|Noncompliance with protocol|0|||
160693847|NCT00536263|580260990|FG002|Overall Study|Noncompliance with protocol|1|||
160693848|NCT00536263|580260988|FG000|Overall Study|Did not meet protocol eligibility|1|||
160693849|NCT00536263|580260989|FG001|Overall Study|Did not meet protocol eligibility|2|||
160693850|NCT00536263|580260990|FG002|Overall Study|Did not meet protocol eligibility|2|||
160693851|NCT00826449|580260993|FG000|Overall Study|Disease Progression|4|||
160693852|NCT00826449|580260993|FG000|Overall Study|Withdrawal by Subject|1|||
160693853|NCT01640873|580261008|FG000|Overall Study|Protocol Violation|2|||
160693854|NCT01640873|580261009|FG001|Overall Study|Protocol Violation|1|||
160693855|NCT01875471|580261010|FG000|Overall Study|Adverse Event|0|||
160693856|NCT01875471|580261011|FG001|Overall Study|Adverse Event|1|||
160693857|NCT01875471|580261010|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
160693858|NCT01875471|580261011|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
160693859|NCT01321008|580261012|FG000|Overall Study|Early Study Termination|1|||
160693860|NCT02749292|580261013|FG000|Overall Study|Physician Decision|1|||
160693861|NCT02749292|580261014|FG001|Overall Study|Physician Decision|0|||
160693862|NCT02749292|580261013|FG000|Overall Study|Withdrawal by Subject|5|||
160693863|NCT02749292|580261014|FG001|Overall Study|Withdrawal by Subject|7|||
160693864|NCT02749292|580261013|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
160693865|NCT02749292|580261014|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
160693866|NCT02749292|580261013|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
160693867|NCT02749292|580261014|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
160693868|NCT02749292|580261013|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
160693869|NCT02749292|580261014|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
160693870|NCT02749292|580261013|FG000|Overall Study|Adverse Event|4|||
160693871|NCT02749292|580261014|FG001|Overall Study|Adverse Event|1|||
160693872|NCT02749292|580261013|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
160693873|NCT02749292|580261014|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
160693874|NCT02749292|580261013|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
160693875|NCT02749292|580261014|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
160693876|NCT02749292|580261013|FG000|Overall Study|Requiring glucocorticoids|0|||
160693877|NCT02749292|580261014|FG001|Overall Study|Requiring glucocorticoids|3|||
160693878|NCT02749292|580261013|FG000|Overall Study|Cancer|1|||
160693879|NCT02749292|580261014|FG001|Overall Study|Cancer|0|||
160693880|NCT02458092|580261015|FG000|Overall Study|Withdrawal by Subject|1|||
160693881|NCT02458092|580261016|FG001|Overall Study|Withdrawal by Subject|0|||
160693882|NCT00876018|580261017|FG000|Overall Study|Lost to Follow-up|0|||
160693883|NCT00876018|580261018|FG001|Overall Study|Lost to Follow-up|1|||
160693884|NCT00876018|580261019|FG002|Overall Study|Lost to Follow-up|1|||
160693885|NCT00876018|580261017|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
160693886|NCT00876018|580261018|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
160693887|NCT00876018|580261019|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
160693888|NCT03629028|580261022|FG000|Overall Study|Lost to Follow-up|26|||
160693889|NCT03629028|580261023|FG001|Overall Study|Lost to Follow-up|23|||
160693890|NCT03629028|580261022|FG000|Overall Study|Pregnancy|4|||
160693891|NCT03629028|580261023|FG001|Overall Study|Pregnancy|2|||
160693892|NCT03629028|580261022|FG000|Overall Study|intolerance to examination|2|||
160693893|NCT03629028|580261023|FG001|Overall Study|intolerance to examination|0|||
160693894|NCT00456495|580261026|FG000|Overall Study|Physician Decision|2|||
160693895|NCT01301508|580261027|FG000|Overall Study|Withdrawal by Subject|1|||
160693896|NCT01301508|580261028|FG001|Overall Study|Withdrawal by Subject|2|||
160693897|NCT01301508|580261027|FG000|Overall Study|Lost to Follow-up|0|||
160693898|NCT01301508|580261028|FG001|Overall Study|Lost to Follow-up|1|||
160693899|NCT01300923|580261029|FG000|Overall Study|Physician Decision|0|||
160693900|NCT01300923|580261030|FG001|Overall Study|Physician Decision|2|||
160693901|NCT02707861|580261033|FG000|Overall Study|Went onto commercial drug|30|||
160693902|NCT02707861|580261034|FG001|Overall Study|Went onto commercial drug|23|||
160693903|NCT02707861|580261033|FG000|Overall Study|Adverse Event|2|||
160693904|NCT02707861|580261034|FG001|Overall Study|Adverse Event|3|||
160693905|NCT02707861|580261033|FG000|Overall Study|Death|5|||
160693906|NCT02707861|580261034|FG001|Overall Study|Death|2|||
160693907|NCT02707861|580261033|FG000|Overall Study|Lack of Efficacy|0|||
160693908|NCT02707861|580261034|FG001|Overall Study|Lack of Efficacy|2|||
160693909|NCT02707861|580261033|FG000|Overall Study|Physician Decision|1|||
160693910|NCT02707861|580261034|FG001|Overall Study|Physician Decision|4|||
160693911|NCT02707861|580261033|FG000|Overall Study|Withdrawal by Subject|2|||
160693912|NCT02707861|580261034|FG001|Overall Study|Withdrawal by Subject|1|||
160693913|NCT02707861|580261033|FG000|Overall Study|Lost to Follow-up|1|||
160693914|NCT02707861|580261034|FG001|Overall Study|Lost to Follow-up|3|||
160693915|NCT03123861|580261035|FG000|Overall Study|Protocol Violation|1|||
160693916|NCT03123861|580261036|FG001|Overall Study|Protocol Violation|1|||
160693917|NCT03123861|580261035|FG000|Overall Study|Withdrawal by Subject|2|||
160693918|NCT03123861|580261036|FG001|Overall Study|Withdrawal by Subject|2|||
160693919|NCT01346774|580261039|FG000|Overall Study|Did not take a single dose|6|||
160693920|NCT01346774|580261040|FG001|Overall Study|Did not take a single dose|4|||
160693921|NCT01346774|580261039|FG000|Overall Study|Lost to Follow-up|3|||
160693922|NCT01346774|580261040|FG001|Overall Study|Lost to Follow-up|4|||
160693923|NCT01346774|580261039|FG000|Overall Study|Withdrawal by Subject|1|||
160693924|NCT01346774|580261040|FG001|Overall Study|Withdrawal by Subject|4|||
160693925|NCT01346774|580261039|FG000|Overall Study|Protocol Violation|2|||
160693926|NCT01346774|580261040|FG001|Overall Study|Protocol Violation|3|||
160693927|NCT01346774|580261039|FG000|Overall Study|Adverse Event|1|||
160693928|NCT01346774|580261040|FG001|Overall Study|Adverse Event|2|||
160693929|NCT00448136|580261045|FG000|Overall Study|Death|3|||
160693930|NCT00448136|580261046|FG001|Overall Study|Death|8|||
160693931|NCT00448136|580261045|FG000|Overall Study|Investigator's decision (progression)|1|||
160693932|NCT00448136|580261046|FG001|Overall Study|Investigator's decision (progression)|0|||
160693933|NCT00609466|580261047|FG000|Overall Study|Withdrawal by Subject|0|||
160693934|NCT00609466|580261048|FG001|Overall Study|Withdrawal by Subject|1|||
160693935|NCT00609466|580261049|FG002|Overall Study|Withdrawal by Subject|1|||
160693936|NCT00609466|580261047|FG000|Overall Study|Adverse Event|2|||
160693937|NCT00609466|580261048|FG001|Overall Study|Adverse Event|3|||
160693938|NCT00609466|580261049|FG002|Overall Study|Adverse Event|1|||
160693939|NCT00609466|580261047|FG000|Overall Study|Lack of Efficacy|0|||
160693940|NCT00609466|580261048|FG001|Overall Study|Lack of Efficacy|2|||
160693941|NCT00609466|580261049|FG002|Overall Study|Lack of Efficacy|2|||
160693942|NCT03512262|580261050|FG000|Overall Study|Adverse Event|8|||
160693943|NCT03512262|580261051|FG001|Overall Study|Adverse Event|3|||
160693944|NCT03512262|580261050|FG000|Overall Study|Death (non-treatment emergent)|1|||
160693945|NCT03512262|580261051|FG001|Overall Study|Death (non-treatment emergent)|0|||
160693946|NCT03512262|580261050|FG000|Overall Study|Withdrawal by Subject|17|||
160693947|NCT03512262|580261051|FG001|Overall Study|Withdrawal by Subject|9|||
160693948|NCT03512262|580261050|FG000|Overall Study|Lost to Follow-up|7|||
160693949|NCT03512262|580261051|FG001|Overall Study|Lost to Follow-up|1|||
160693950|NCT03512262|580261050|FG000|Overall Study|Other than Specified|2|||
160693951|NCT03512262|580261051|FG001|Overall Study|Other than Specified|2|||
160693952|NCT01299805|580261054|FG000|Overall Study|Adverse Event|2|||
160693953|NCT01299805|580261055|FG001|Overall Study|Adverse Event|0|||
160693954|NCT03407430|580261056|FG000|Washout|Protocol Violation|1|||
160693955|NCT03407430|580261057|FG001|Washout|Protocol Violation|0|||
160693956|NCT00922987|580261059|FG000|Overall Study|Insufficient clinical response|1|||
160693957|NCT00922987|580261059|FG000|Overall Study|Protocol Violation|2|||
160693958|NCT00922987|580261059|FG000|Overall Study|Adverse Event|1|||
160693959|NCT01334710|580261066|FG000|Overall Study|Trial was terminated|3|||
160693960|NCT05011123|580262693|FG000|Overall Study|Withdrawal by Subject|4|||
160693961|NCT05011123|580262694|FG001|Overall Study|Withdrawal by Subject|2|||
160693962|NCT05011123|580262693|FG000|Overall Study|Lost to Follow-up|7|||
160693963|NCT05011123|580262694|FG001|Overall Study|Lost to Follow-up|6|||
160693964|NCT05011123|580262693|FG000|Overall Study|Ongoing at the time of DBL date|36|||
160693965|NCT05011123|580262694|FG001|Overall Study|Ongoing at the time of DBL date|10|||
160693966|NCT05011123|580262693|FG000|Overall Study|Randomized but did not receive vaccination|1|||
160693967|NCT05011123|580262694|FG001|Overall Study|Randomized but did not receive vaccination|0|||
160693968|NCT04221789|580262696|FG000|Overall Study|deviation from protoco|22|||
160693969|NCT04221789|580262697|FG001|Overall Study|deviation from protoco|8|||
160693970|NCT04394351|580262708|FG000|Part A (16 Weeks)|Adverse Event|1|||
160693971|NCT04394351|580262709|FG001|Part A (16 Weeks)|Adverse Event|0|||
160693972|NCT04394351|580262710|FG002|Part A (16 Weeks)|Adverse Event|0|||
160693973|NCT04394351|580262711|FG003|Part A (16 Weeks)|Adverse Event|0|||
160693974|NCT04394351|580262712|FG004|Part A (16 Weeks)|Adverse Event|0|||
160693975|NCT04394351|580262713|FG005|Part A (16 Weeks)|Adverse Event|0|||
160693976|NCT04394351|580262714|FG006|Part A (16 Weeks)|Adverse Event|0|||
160693977|NCT04394351|580262715|FG007|Part A (16 Weeks)|Adverse Event|0|||
160693978|NCT04394351|580262708|FG000|Part A (16 Weeks)|Physician Decision|0|||
160693979|NCT04394351|580262709|FG001|Part A (16 Weeks)|Physician Decision|1|||
160693980|NCT04394351|580262710|FG002|Part A (16 Weeks)|Physician Decision|0|||
160693981|NCT04394351|580262711|FG003|Part A (16 Weeks)|Physician Decision|0|||
160693982|NCT04394351|580262712|FG004|Part A (16 Weeks)|Physician Decision|0|||
160693983|NCT04394351|580262713|FG005|Part A (16 Weeks)|Physician Decision|0|||
160693984|NCT04394351|580262714|FG006|Part A (16 Weeks)|Physician Decision|0|||
160693985|NCT04394351|580262715|FG007|Part A (16 Weeks)|Physician Decision|0|||
160693986|NCT04394351|580262708|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
160693987|NCT04394351|580262709|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
160693988|NCT04394351|580262710|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
160693989|NCT04394351|580262711|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
160693990|NCT04394351|580262712|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
160693991|NCT04394351|580262713|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
160693992|NCT04394351|580262714|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
160693993|NCT04394351|580262715|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
160693994|NCT04394351|580262708|FG000|Part B (36 Weeks)|Adverse Event|0|||
160693995|NCT04394351|580262709|FG001|Part B (36 Weeks)|Adverse Event|0|||
160693996|NCT04394351|580262710|FG002|Part B (36 Weeks)|Adverse Event|0|||
160693997|NCT04394351|580262711|FG003|Part B (36 Weeks)|Adverse Event|0|||
160693998|NCT04394351|580262712|FG004|Part B (36 Weeks)|Adverse Event|0|||
160693999|NCT04394351|580262713|FG005|Part B (36 Weeks)|Adverse Event|0|||
160694000|NCT04394351|580262714|FG006|Part B (36 Weeks)|Adverse Event|1|||
160694001|NCT04394351|580262715|FG007|Part B (36 Weeks)|Adverse Event|0|||
160694002|NCT04394351|580262708|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160694003|NCT04394351|580262709|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160694004|NCT04394351|580262710|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160694005|NCT04394351|580262711|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160694006|NCT04394351|580262712|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160694007|NCT04394351|580262713|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160694008|NCT04394351|580262714|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160694009|NCT04394351|580262715|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
160694010|NCT04394351|580262708|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
160694011|NCT04394351|580262709|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
160694012|NCT04394351|580262710|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
160694013|NCT04394351|580262711|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
160694014|NCT04394351|580262712|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
160694015|NCT04394351|580262713|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
160694016|NCT04394351|580262714|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
160694017|NCT04394351|580262715|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
160694018|NCT04394351|580262708|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
160694019|NCT04394351|580262709|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
160694020|NCT04394351|580262710|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
160694021|NCT04394351|580262711|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
160694022|NCT04394351|580262712|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
160694023|NCT04394351|580262713|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
160694024|NCT04394351|580262714|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
160694025|NCT04394351|580262715|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
160694026|NCT04394351|580262708|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
160694027|NCT04394351|580262709|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
160694028|NCT04394351|580262710|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
160694029|NCT04394351|580262711|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
160694030|NCT04394351|580262712|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
160694031|NCT04394351|580262713|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
160694032|NCT04394351|580262714|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
160694033|NCT04394351|580262715|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
160694034|NCT03653507|580262716|FG000|Overall Study|Miscellaneous|28|||
160694035|NCT03653507|580262717|FG001|Overall Study|Miscellaneous|19|||
160694036|NCT03653507|580262716|FG000|Overall Study|Withdrawal by Subject|37|||
160694037|NCT03653507|580262717|FG001|Overall Study|Withdrawal by Subject|22|||
160694038|NCT03653507|580262716|FG000|Overall Study|Protocol Deviation|2|||
160694039|NCT03653507|580262717|FG001|Overall Study|Protocol Deviation|1|||
160694040|NCT03653507|580262716|FG000|Overall Study|Progressive disease|117|||
160694041|NCT03653507|580262717|FG001|Overall Study|Progressive disease|168|||
160694042|NCT03653507|580262716|FG000|Overall Study|Lost to Follow-up|1|||
160694043|NCT03653507|580262717|FG001|Overall Study|Lost to Follow-up|1|||
160694044|NCT03653507|580262716|FG000|Overall Study|Death|25|||
160694045|NCT03653507|580262717|FG001|Overall Study|Death|22|||
160694046|NCT03653507|580262716|FG000|Overall Study|Adverse Event|35|||
160694047|NCT03653507|580262717|FG001|Overall Study|Adverse Event|14|||
160694048|NCT01288053|580262724|FG000|Overall Study|Death|1|||
160694049|NCT03188666|580262725|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
160694050|NCT03188666|580262726|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
160694051|NCT03188666|580262727|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
160694052|NCT03188666|580262728|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
160694053|NCT03188666|580262725|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
160694054|NCT03188666|580262726|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
160694055|NCT03188666|580262727|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
160694056|NCT03188666|580262728|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
160694057|NCT03188666|580262725|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
160694058|NCT03188666|580262726|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
160694059|NCT03188666|580262727|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
160694060|NCT03188666|580262728|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
160694061|NCT03188666|580262725|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
160694062|NCT03188666|580262726|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
160694063|NCT03188666|580262727|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
160694064|NCT03188666|580262728|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
160694065|NCT00144781|580262729|FG000|Overall Study|Adverse Event|0|||
160694066|NCT00144781|580262730|FG001|Overall Study|Adverse Event|1|||
160694067|NCT00144781|580262731|FG002|Overall Study|Adverse Event|0|||
160694068|NCT00144781|580262732|FG003|Overall Study|Adverse Event|0|||
160694069|NCT00144781|580262729|FG000|Overall Study|Non-compliant|0|||
160694070|NCT00144781|580262730|FG001|Overall Study|Non-compliant|1|||
160694071|NCT00144781|580262731|FG002|Overall Study|Non-compliant|0|||
160694072|NCT00144781|580262732|FG003|Overall Study|Non-compliant|0|||
160694073|NCT03696953|580262733|FG000|Overall Study|Withdrawal by Subject|6|||
160694074|NCT03696953|580262734|FG001|Overall Study|Withdrawal by Subject|1|||
160694075|NCT03696953|580262733|FG000|Overall Study|missed GBS swabs|2|||
160694076|NCT03696953|580262734|FG001|Overall Study|missed GBS swabs|2|||
160694077|NCT03696953|580262733|FG000|Overall Study|lost study bottle containing capsules|2|||
160694078|NCT03696953|580262734|FG001|Overall Study|lost study bottle containing capsules|0|||
160694079|NCT03696953|580262733|FG000|Overall Study|Premature birth|1|||
160694080|NCT03696953|580262734|FG001|Overall Study|Premature birth|4|||
160694081|NCT03696953|580262733|FG000|Overall Study|Gestational hypertension|1|||
160694082|NCT03696953|580262734|FG001|Overall Study|Gestational hypertension|1|||
160694083|NCT03696953|580262733|FG000|Overall Study|Gestational diabetes|2|||
160694084|NCT03696953|580262734|FG001|Overall Study|Gestational diabetes|1|||
160694085|NCT03696953|580262733|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
160694086|NCT03696953|580262734|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
160694087|NCT03696953|580262733|FG000|Overall Study|Changed prenatal provider|1|||
160694088|NCT03696953|580262734|FG001|Overall Study|Changed prenatal provider|1|||
160694089|NCT02068092|580262735|FG000|Overall Study|Physician Decision|2|||
160694090|NCT02068092|580262735|FG000|Overall Study|Adverse Event|2|||
160694091|NCT02068092|580262735|FG000|Overall Study|Lost to Follow-up|4|||
160694092|NCT02068092|580262735|FG000|Overall Study|Withdrawal by Subject|2|||
160694093|NCT03502707|580262736|FG000|Overall Study|Adverse Event|0|||
160694094|NCT03502707|580262737|FG001|Overall Study|Adverse Event|0|||
160694095|NCT03502707|580262738|FG002|Overall Study|Adverse Event|0|||
160694096|NCT03502707|580262739|FG003|Overall Study|Adverse Event|0|||
160694097|NCT03502707|580262740|FG004|Overall Study|Adverse Event|0|||
160694098|NCT03502707|580262741|FG005|Overall Study|Adverse Event|0|||
160694099|NCT03502707|580262742|FG006|Overall Study|Adverse Event|0|||
160694100|NCT03502707|580262743|FG007|Overall Study|Adverse Event|0|||
160694101|NCT03502707|580262744|FG008|Overall Study|Adverse Event|0|||
160694102|NCT03502707|580262745|FG009|Overall Study|Adverse Event|0|||
160694103|NCT03502707|580262746|FG010|Overall Study|Adverse Event|0|||
160694104|NCT03502707|580262747|FG011|Overall Study|Adverse Event|0|||
160694105|NCT03502707|580262748|FG012|Overall Study|Adverse Event|0|||
160694106|NCT03502707|580262749|FG013|Overall Study|Adverse Event|0|||
160694107|NCT03502707|580262750|FG014|Overall Study|Adverse Event|0|||
160694108|NCT03502707|580262751|FG015|Overall Study|Adverse Event|1|||
160694109|NCT03502707|580262752|FG016|Overall Study|Adverse Event|5|||
160694110|NCT03502707|580262753|FG017|Overall Study|Adverse Event|0|||
160694111|NCT03502707|580262736|FG000|Overall Study|Death|0|||
160694112|NCT03502707|580262737|FG001|Overall Study|Death|0|||
160694113|NCT03502707|580262738|FG002|Overall Study|Death|0|||
160694114|NCT03502707|580262739|FG003|Overall Study|Death|1|||
160694115|NCT03502707|580262740|FG004|Overall Study|Death|0|||
160694116|NCT03502707|580262741|FG005|Overall Study|Death|0|||
160694117|NCT03502707|580262742|FG006|Overall Study|Death|0|||
160694118|NCT03502707|580262743|FG007|Overall Study|Death|0|||
160694119|NCT03502707|580262744|FG008|Overall Study|Death|1|||
160694120|NCT03502707|580262745|FG009|Overall Study|Death|1|||
160694121|NCT03502707|580262746|FG010|Overall Study|Death|0|||
160694122|NCT03502707|580262747|FG011|Overall Study|Death|0|||
160694123|NCT03502707|580262748|FG012|Overall Study|Death|1|||
160694124|NCT03502707|580262749|FG013|Overall Study|Death|0|||
160694125|NCT03502707|580262750|FG014|Overall Study|Death|0|||
160694126|NCT03502707|580262751|FG015|Overall Study|Death|1|||
160694127|NCT03502707|580262752|FG016|Overall Study|Death|0|||
160694128|NCT03502707|580262753|FG017|Overall Study|Death|0|||
160694129|NCT03502707|580262736|FG000|Overall Study|Lost to Follow-up|0|||
160694130|NCT03502707|580262737|FG001|Overall Study|Lost to Follow-up|0|||
160694131|NCT03502707|580262738|FG002|Overall Study|Lost to Follow-up|0|||
160694132|NCT03502707|580262739|FG003|Overall Study|Lost to Follow-up|0|||
160694133|NCT03502707|580262740|FG004|Overall Study|Lost to Follow-up|0|||
160694134|NCT03502707|580262741|FG005|Overall Study|Lost to Follow-up|0|||
160694135|NCT03502707|580262742|FG006|Overall Study|Lost to Follow-up|0|||
160694136|NCT03502707|580262743|FG007|Overall Study|Lost to Follow-up|5|||
160694137|NCT03502707|580262744|FG008|Overall Study|Lost to Follow-up|0|||
160694138|NCT03502707|580262745|FG009|Overall Study|Lost to Follow-up|2|||
160694139|NCT03502707|580262746|FG010|Overall Study|Lost to Follow-up|1|||
160694140|NCT03502707|580262747|FG011|Overall Study|Lost to Follow-up|2|||
160694141|NCT03502707|580262748|FG012|Overall Study|Lost to Follow-up|1|||
160694142|NCT03502707|580262749|FG013|Overall Study|Lost to Follow-up|1|||
160694143|NCT03502707|580262750|FG014|Overall Study|Lost to Follow-up|0|||
160694144|NCT03502707|580262751|FG015|Overall Study|Lost to Follow-up|4|||
160694145|NCT03502707|580262752|FG016|Overall Study|Lost to Follow-up|9|||
160694146|NCT03502707|580262753|FG017|Overall Study|Lost to Follow-up|2|||
160694147|NCT03502707|580262736|FG000|Overall Study|Physician Decision|0|||
160694148|NCT03502707|580262737|FG001|Overall Study|Physician Decision|0|||
160694149|NCT03502707|580262738|FG002|Overall Study|Physician Decision|0|||
160694150|NCT03502707|580262739|FG003|Overall Study|Physician Decision|0|||
160694151|NCT03502707|580262740|FG004|Overall Study|Physician Decision|0|||
160694152|NCT03502707|580262741|FG005|Overall Study|Physician Decision|0|||
160694153|NCT03502707|580262742|FG006|Overall Study|Physician Decision|0|||
160694154|NCT03502707|580262743|FG007|Overall Study|Physician Decision|0|||
160694155|NCT03502707|580262744|FG008|Overall Study|Physician Decision|2|||
160694156|NCT03502707|580262745|FG009|Overall Study|Physician Decision|1|||
160694157|NCT03502707|580262746|FG010|Overall Study|Physician Decision|0|||
160694158|NCT03502707|580262747|FG011|Overall Study|Physician Decision|0|||
160694159|NCT03502707|580262748|FG012|Overall Study|Physician Decision|0|||
160694160|NCT03502707|580262749|FG013|Overall Study|Physician Decision|0|||
160694161|NCT03502707|580262750|FG014|Overall Study|Physician Decision|1|||
160694162|NCT03502707|580262751|FG015|Overall Study|Physician Decision|3|||
160694163|NCT03502707|580262752|FG016|Overall Study|Physician Decision|0|||
160694164|NCT03502707|580262753|FG017|Overall Study|Physician Decision|0|||
160694165|NCT03502707|580262736|FG000|Overall Study|Protocol Violation|0|||
160694166|NCT03502707|580262737|FG001|Overall Study|Protocol Violation|0|||
160694167|NCT03502707|580262738|FG002|Overall Study|Protocol Violation|0|||
160694168|NCT03502707|580262739|FG003|Overall Study|Protocol Violation|0|||
160694169|NCT03502707|580262740|FG004|Overall Study|Protocol Violation|0|||
160694170|NCT03502707|580262741|FG005|Overall Study|Protocol Violation|0|||
160694171|NCT03502707|580262742|FG006|Overall Study|Protocol Violation|0|||
160694172|NCT03502707|580262743|FG007|Overall Study|Protocol Violation|0|||
160694173|NCT03502707|580262744|FG008|Overall Study|Protocol Violation|0|||
160694174|NCT03502707|580262745|FG009|Overall Study|Protocol Violation|0|||
160694175|NCT03502707|580262746|FG010|Overall Study|Protocol Violation|0|||
160694176|NCT03502707|580262747|FG011|Overall Study|Protocol Violation|0|||
160694177|NCT03502707|580262748|FG012|Overall Study|Protocol Violation|0|||
160694178|NCT03502707|580262749|FG013|Overall Study|Protocol Violation|0|||
160694179|NCT03502707|580262750|FG014|Overall Study|Protocol Violation|0|||
160694180|NCT03502707|580262751|FG015|Overall Study|Protocol Violation|1|||
160694181|NCT03502707|580262752|FG016|Overall Study|Protocol Violation|0|||
160694182|NCT03502707|580262753|FG017|Overall Study|Protocol Violation|0|||
160694183|NCT03502707|580262736|FG000|Overall Study|Withdrawal by Subject|1|||
160694184|NCT03502707|580262737|FG001|Overall Study|Withdrawal by Subject|1|||
160694185|NCT03502707|580262738|FG002|Overall Study|Withdrawal by Subject|0|||
160694186|NCT03502707|580262739|FG003|Overall Study|Withdrawal by Subject|0|||
160694187|NCT03502707|580262740|FG004|Overall Study|Withdrawal by Subject|0|||
160694188|NCT03502707|580262741|FG005|Overall Study|Withdrawal by Subject|2|||
160694189|NCT03502707|580262742|FG006|Overall Study|Withdrawal by Subject|0|||
160694190|NCT03502707|580262743|FG007|Overall Study|Withdrawal by Subject|3|||
160694191|NCT03502707|580262744|FG008|Overall Study|Withdrawal by Subject|1|||
160694192|NCT03502707|580262745|FG009|Overall Study|Withdrawal by Subject|2|||
160694193|NCT03502707|580262746|FG010|Overall Study|Withdrawal by Subject|12|||
160694194|NCT03502707|580262747|FG011|Overall Study|Withdrawal by Subject|23|||
160694195|NCT03502707|580262748|FG012|Overall Study|Withdrawal by Subject|5|||
160694196|NCT03502707|580262749|FG013|Overall Study|Withdrawal by Subject|3|||
160694197|NCT03502707|580262750|FG014|Overall Study|Withdrawal by Subject|3|||
160694198|NCT03502707|580262751|FG015|Overall Study|Withdrawal by Subject|43|||
160694199|NCT03502707|580262752|FG016|Overall Study|Withdrawal by Subject|44|||
160694200|NCT03502707|580262753|FG017|Overall Study|Withdrawal by Subject|18|||
160694201|NCT03502707|580262736|FG000|Overall Study|Sponsor's Decision|1|||
160694202|NCT03502707|580262737|FG001|Overall Study|Sponsor's Decision|0|||
160694203|NCT03502707|580262738|FG002|Overall Study|Sponsor's Decision|0|||
160694204|NCT03502707|580262739|FG003|Overall Study|Sponsor's Decision|0|||
160694205|NCT03502707|580262740|FG004|Overall Study|Sponsor's Decision|0|||
160694206|NCT03502707|580262741|FG005|Overall Study|Sponsor's Decision|0|||
160694207|NCT03502707|580262742|FG006|Overall Study|Sponsor's Decision|0|||
160694208|NCT03502707|580262743|FG007|Overall Study|Sponsor's Decision|0|||
160694209|NCT03502707|580262744|FG008|Overall Study|Sponsor's Decision|0|||
160694210|NCT03502707|580262745|FG009|Overall Study|Sponsor's Decision|1|||
160694211|NCT03502707|580262746|FG010|Overall Study|Sponsor's Decision|0|||
160694212|NCT03502707|580262747|FG011|Overall Study|Sponsor's Decision|0|||
160694213|NCT03502707|580262748|FG012|Overall Study|Sponsor's Decision|0|||
160694214|NCT03502707|580262749|FG013|Overall Study|Sponsor's Decision|0|||
160694215|NCT03502707|580262750|FG014|Overall Study|Sponsor's Decision|0|||
160694216|NCT03502707|580262751|FG015|Overall Study|Sponsor's Decision|2|||
160694217|NCT03502707|580262752|FG016|Overall Study|Sponsor's Decision|1|||
160694218|NCT03502707|580262753|FG017|Overall Study|Sponsor's Decision|0|||
160694219|NCT03502707|580262736|FG000|Overall Study|Initiated Prohibited Medication|0|||
160694220|NCT03502707|580262737|FG001|Overall Study|Initiated Prohibited Medication|0|||
160694221|NCT03502707|580262738|FG002|Overall Study|Initiated Prohibited Medication|0|||
160694222|NCT03502707|580262739|FG003|Overall Study|Initiated Prohibited Medication|0|||
160694223|NCT03502707|580262740|FG004|Overall Study|Initiated Prohibited Medication|0|||
160694224|NCT03502707|580262741|FG005|Overall Study|Initiated Prohibited Medication|0|||
160694225|NCT03502707|580262742|FG006|Overall Study|Initiated Prohibited Medication|0|||
160694226|NCT03502707|580262743|FG007|Overall Study|Initiated Prohibited Medication|0|||
160694227|NCT03502707|580262744|FG008|Overall Study|Initiated Prohibited Medication|0|||
160694228|NCT03502707|580262745|FG009|Overall Study|Initiated Prohibited Medication|0|||
160694229|NCT03502707|580262746|FG010|Overall Study|Initiated Prohibited Medication|0|||
160694230|NCT03502707|580262747|FG011|Overall Study|Initiated Prohibited Medication|0|||
160694231|NCT03502707|580262748|FG012|Overall Study|Initiated Prohibited Medication|0|||
160694232|NCT03502707|580262749|FG013|Overall Study|Initiated Prohibited Medication|0|||
160694233|NCT03502707|580262750|FG014|Overall Study|Initiated Prohibited Medication|0|||
160694234|NCT03502707|580262751|FG015|Overall Study|Initiated Prohibited Medication|0|||
160694235|NCT03502707|580262752|FG016|Overall Study|Initiated Prohibited Medication|1|||
160694236|NCT03502707|580262753|FG017|Overall Study|Initiated Prohibited Medication|0|||
160694237|NCT03502707|580262736|FG000|Overall Study|Other|0|||
160694238|NCT03502707|580262737|FG001|Overall Study|Other|0|||
160694239|NCT03502707|580262738|FG002|Overall Study|Other|0|||
160694240|NCT03502707|580262739|FG003|Overall Study|Other|0|||
160694241|NCT03502707|580262740|FG004|Overall Study|Other|0|||
160694242|NCT03502707|580262741|FG005|Overall Study|Other|0|||
160694243|NCT03502707|580262742|FG006|Overall Study|Other|0|||
160694244|NCT03502707|580262743|FG007|Overall Study|Other|0|||
160694245|NCT03502707|580262744|FG008|Overall Study|Other|1|||
160694246|NCT03502707|580262745|FG009|Overall Study|Other|1|||
160694247|NCT03502707|580262746|FG010|Overall Study|Other|2|||
160694248|NCT03502707|580262747|FG011|Overall Study|Other|0|||
160694249|NCT03502707|580262748|FG012|Overall Study|Other|0|||
160694250|NCT03502707|580262749|FG013|Overall Study|Other|0|||
160694251|NCT03502707|580262750|FG014|Overall Study|Other|0|||
160694252|NCT03502707|580262751|FG015|Overall Study|Other|4|||
160694253|NCT03502707|580262752|FG016|Overall Study|Other|1|||
160694254|NCT03502707|580262753|FG017|Overall Study|Other|0|||
160694255|NCT03502707|580262736|FG000|Overall Study|Randomized but not vaccinated|0|||
160694256|NCT03502707|580262737|FG001|Overall Study|Randomized but not vaccinated|0|||
160694257|NCT03502707|580262738|FG002|Overall Study|Randomized but not vaccinated|0|||
160694258|NCT03502707|580262739|FG003|Overall Study|Randomized but not vaccinated|0|||
160694259|NCT03502707|580262740|FG004|Overall Study|Randomized but not vaccinated|0|||
160694260|NCT03502707|580262741|FG005|Overall Study|Randomized but not vaccinated|0|||
160694261|NCT03502707|580262742|FG006|Overall Study|Randomized but not vaccinated|0|||
160694262|NCT03502707|580262743|FG007|Overall Study|Randomized but not vaccinated|0|||
160694263|NCT03502707|580262744|FG008|Overall Study|Randomized but not vaccinated|0|||
160694264|NCT03502707|580262745|FG009|Overall Study|Randomized but not vaccinated|0|||
160694265|NCT03502707|580262746|FG010|Overall Study|Randomized but not vaccinated|0|||
160694266|NCT03502707|580262747|FG011|Overall Study|Randomized but not vaccinated|1|||
160694267|NCT03502707|580262748|FG012|Overall Study|Randomized but not vaccinated|0|||
160694268|NCT03502707|580262749|FG013|Overall Study|Randomized but not vaccinated|0|||
160694269|NCT03502707|580262750|FG014|Overall Study|Randomized but not vaccinated|0|||
160694270|NCT03502707|580262751|FG015|Overall Study|Randomized but not vaccinated|0|||
160694271|NCT03502707|580262752|FG016|Overall Study|Randomized but not vaccinated|0|||
160694272|NCT03502707|580262753|FG017|Overall Study|Randomized but not vaccinated|1|||
160694273|NCT00461253|580262754|FG000|Overall Study|Death|985|||
160694274|NCT00461253|580262755|FG001|Overall Study|Death|0|||
160694275|NCT00461253|580262754|FG000|Overall Study|Protocol Violation|613|||
160694276|NCT00461253|580262755|FG001|Overall Study|Protocol Violation|236|||
160694277|NCT00461253|580262754|FG000|Overall Study|no response|2609|||
160694278|NCT00461253|580262755|FG001|Overall Study|no response|11789|||
160694279|NCT00461253|580262754|FG000|Overall Study|administrative|773|||
160694280|NCT00461253|580262755|FG001|Overall Study|administrative|7773|||
160694281|NCT01933113|580262756|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
160694282|NCT02297438|580262757|FG000|Overall Study|Death|79|||
160694283|NCT02297438|580262758|FG001|Overall Study|Death|86|||
160694284|NCT02297438|580262757|FG000|Overall Study|Lost to Follow-up|9|||
160694285|NCT02297438|580262758|FG001|Overall Study|Lost to Follow-up|7|||
160694286|NCT02297438|580262757|FG000|Overall Study|Withdrawal by Subject|7|||
160694287|NCT02297438|580262758|FG001|Overall Study|Withdrawal by Subject|0|||
160694288|NCT02297438|580262757|FG000|Overall Study|Other|9|||
160694289|NCT02297438|580262758|FG001|Overall Study|Other|5|||
160694290|NCT02297438|580262757|FG000|Overall Study|Ongoing|65|||
160694291|NCT02297438|580262758|FG001|Overall Study|Ongoing|73|||
160694292|NCT01687478|580262762|FG000|Overall Study|Adverse Event|3|||
160694293|NCT01687478|580262763|FG001|Overall Study|Adverse Event|10|||
160694294|NCT01687478|580262762|FG000|Overall Study|Lost to Follow-up|1|||
160694295|NCT01687478|580262763|FG001|Overall Study|Lost to Follow-up|3|||
160694296|NCT01687478|580262762|FG000|Overall Study|Protocol Violation|0|||
160694297|NCT01687478|580262763|FG001|Overall Study|Protocol Violation|2|||
160694298|NCT01687478|580262762|FG000|Overall Study|Withdrawal by Subject|21|||
160694299|NCT01687478|580262763|FG001|Overall Study|Withdrawal by Subject|19|||
160694300|NCT01687478|580262762|FG000|Overall Study|Physician Decision|1|||
160694301|NCT01687478|580262763|FG001|Overall Study|Physician Decision|3|||
160694302|NCT01687478|580262762|FG000|Overall Study|Entry Criteria Not Met|6|||
160694303|NCT01687478|580262763|FG001|Overall Study|Entry Criteria Not Met|2|||
160694304|NCT00792935|580262764|FG000|Overall Study|Adverse Event|2|||
160694305|NCT00792935|580262765|FG001|Overall Study|Adverse Event|1|||
160694306|NCT00792935|580262764|FG000|Overall Study|Lost to Follow-up|0|||
160694307|NCT00792935|580262765|FG001|Overall Study|Lost to Follow-up|1|||
160694308|NCT00792935|580262764|FG000|Overall Study|Protocol Violation|2|||
160694309|NCT00792935|580262765|FG001|Overall Study|Protocol Violation|0|||
160694310|NCT00792935|580262764|FG000|Overall Study|Withdrawal by Subject|0|||
160694311|NCT00792935|580262765|FG001|Overall Study|Withdrawal by Subject|1|||
160694312|NCT00622466|580262768|FG000|Overall Study|Death|1|||
160694313|NCT00622466|580262768|FG000|Overall Study|Adverse Event|1|||
160694314|NCT00622466|580262768|FG000|Overall Study|Withdrawal by Subject|2|||
160694315|NCT01155024|580262774|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
160694316|NCT01155024|580262775|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
160694317|NCT01155024|580262774|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
160694318|NCT01155024|580262775|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
160694319|NCT01155024|580262774|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
160694320|NCT01155024|580262775|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
160694321|NCT01593696|580262776|FG000|Dose Escalation|Progressive Disease|2|||
160694322|NCT01593696|580262777|FG001|Dose Escalation|Progressive Disease|0|||
160694323|NCT01593696|580262778|FG002|Dose Escalation|Progressive Disease|0|||
160694324|NCT01593696|580262779|FG003|Dose Escalation|Progressive Disease|0|||
160694325|NCT01593696|580262776|FG000|Dose Expansion|Fungal infection|0|||
160694326|NCT01593696|580262777|FG001|Dose Expansion|Fungal infection|0|||
160694327|NCT01593696|580262778|FG002|Dose Expansion|Fungal infection|1|||
160694328|NCT01593696|580262779|FG003|Dose Expansion|Fungal infection|0|||
160694329|NCT01936623|580262790|FG000|Overall Study|Lost to Follow-up|0|||
160694330|NCT01936623|580262791|FG001|Overall Study|Lost to Follow-up|5|||
160694331|NCT00369655|580262794|FG000|Overall Study|Refusal of further treatment|2|||
160694332|NCT03402750|580262795|FG000|Overall Study|Lost to Follow-up|2|||
160694333|NCT03402750|580262796|FG001|Overall Study|Lost to Follow-up|1|||
160694334|NCT02981303|580262797|FG000|Overall Study|Progressive Disease|17|||
160694335|NCT02981303|580262798|FG001|Overall Study|Progressive Disease|37|||
160694336|NCT02981303|580262797|FG000|Overall Study|Adverse Event|1|||
160694337|NCT02981303|580262798|FG001|Overall Study|Adverse Event|4|||
160694338|NCT02981303|580262797|FG000|Overall Study|Withdrawal by Subject|0|||
160694339|NCT02981303|580262798|FG001|Overall Study|Withdrawal by Subject|1|||
160694340|NCT00848107|580262799|FG000|Overall Study|Lost to Follow-up|2|||
160694341|NCT00848107|580262799|FG000|Overall Study|Withdrawal by Subject|8|||
160694342|NCT00848107|580262799|FG000|Overall Study|Adverse Event|9|||
160694343|NCT00848107|580262799|FG000|Overall Study|Death|1|||
160694344|NCT00848107|580262799|FG000|Overall Study|Pregnancy|1|||
160694345|NCT01169532|580262804|FG000|Overall Study|Withdrawal by Subject|1|||
160694346|NCT00117325|580262805|FG000|Overall Study|Adverse Event|3|||
160694347|NCT00117325|580262806|FG001|Overall Study|Adverse Event|3|||
160694348|NCT00117325|580262805|FG000|Overall Study|Lost to Follow-up|1|||
160694349|NCT00117325|580262806|FG001|Overall Study|Lost to Follow-up|1|||
160694350|NCT00117325|580262805|FG000|Overall Study|Protocol Violation|2|||
160694351|NCT00117325|580262806|FG001|Overall Study|Protocol Violation|3|||
160694352|NCT00117325|580262805|FG000|Overall Study|Withdrawal by Subject|3|||
160694353|NCT00117325|580262806|FG001|Overall Study|Withdrawal by Subject|2|||
160694354|NCT00117325|580262805|FG000|Overall Study|Lack of Efficacy|1|||
160694355|NCT00117325|580262806|FG001|Overall Study|Lack of Efficacy|0|||
160694356|NCT00117325|580262805|FG000|Overall Study|Use of prohibited medicine|1|||
160694357|NCT00117325|580262806|FG001|Overall Study|Use of prohibited medicine|2|||
160694358|NCT00117325|580262805|FG000|Overall Study|Early termination|1|||
160694359|NCT00117325|580262806|FG001|Overall Study|Early termination|1|||
160694360|NCT00117325|580262805|FG000|Overall Study|Admisnitrative|1|||
160694361|NCT00117325|580262806|FG001|Overall Study|Admisnitrative|0|||
160694362|NCT01468818|580262810|FG000|Overall Study|Death during treatment|2|||
160694363|NCT02266134|580262811|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
160694364|NCT02266134|580262812|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
160694365|NCT02266134|580262813|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
160694366|NCT02266134|580262814|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
160694367|NCT02266134|580262811|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
160694368|NCT02266134|580262812|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
160694369|NCT02266134|580262813|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
160694370|NCT02266134|580262814|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
160694371|NCT02266134|580262811|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
160694372|NCT02266134|580262812|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
160694373|NCT02266134|580262813|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
160694374|NCT02266134|580262814|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
160694375|NCT02266134|580262811|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
160694376|NCT02266134|580262812|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
160694377|NCT02266134|580262813|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
160694378|NCT02266134|580262814|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
160694379|NCT02266134|580262811|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
160694380|NCT02266134|580262812|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
160694381|NCT02266134|580262813|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
160694382|NCT02266134|580262814|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
160694383|NCT02266134|580262811|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
160694384|NCT02266134|580262812|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
160694385|NCT02266134|580262813|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
160694386|NCT02266134|580262814|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
160694387|NCT04620135|580262815|FG000|Study Completion|Adverse Event|2|||
160694388|NCT04620135|580262816|FG001|Study Completion|Adverse Event|3|||
160694389|NCT04620135|580262815|FG000|Study Completion|Withdrawal by Subject|2|||
160694390|NCT04620135|580262816|FG001|Study Completion|Withdrawal by Subject|0|||
160694391|NCT01442688|580262818|FG000|First Intervention|Withdrawal by Subject|1|||
160694392|NCT01442688|580262819|FG001|First Intervention|Withdrawal by Subject|0|||
160694393|NCT01442688|580262818|FG000|First Intervention|subject incarcerated|1|||
160694394|NCT01442688|580262819|FG001|First Intervention|subject incarcerated|0|||
160694395|NCT01442688|580262818|FG000|Second Intervention|Adverse Event|1|||
160694396|NCT01442688|580262819|FG001|Second Intervention|Adverse Event|0|||
160694397|NCT00762437|580262820|FG000|Overall Study|Lost to Follow-up|7|||
160694398|NCT00762437|580262820|FG000|Overall Study|Missed final study visit|11|||
160694399|NCT00762437|580262820|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
160694400|NCT00302081|580262821|FG000|Overall Study|Adverse Event|6|||
160694401|NCT00302081|580262822|FG001|Overall Study|Adverse Event|5|||
160694402|NCT00302081|580262823|FG002|Overall Study|Adverse Event|4|||
160694403|NCT00302081|580262821|FG000|Overall Study|Lost to Follow-up|21|||
160694404|NCT00302081|580262822|FG001|Overall Study|Lost to Follow-up|18|||
160694405|NCT00302081|580262823|FG002|Overall Study|Lost to Follow-up|28|||
160694406|NCT00302081|580262821|FG000|Overall Study|Withdrawal by Subject|8|||
160694407|NCT00302081|580262822|FG001|Overall Study|Withdrawal by Subject|12|||
160694408|NCT00302081|580262823|FG002|Overall Study|Withdrawal by Subject|8|||
160694409|NCT00302081|580262821|FG000|Overall Study|Protocol Violation|5|||
160694410|NCT00302081|580262822|FG001|Overall Study|Protocol Violation|1|||
160694411|NCT00302081|580262823|FG002|Overall Study|Protocol Violation|2|||
160694412|NCT00302081|580262821|FG000|Overall Study|Lack of Efficacy|1|||
160694413|NCT00302081|580262822|FG001|Overall Study|Lack of Efficacy|0|||
160694414|NCT00302081|580262823|FG002|Overall Study|Lack of Efficacy|5|||
160694415|NCT00302081|580262821|FG000|Overall Study|Death|2|||
160694416|NCT00302081|580262822|FG001|Overall Study|Death|1|||
160694417|NCT00302081|580262823|FG002|Overall Study|Death|0|||
160694418|NCT00302081|580262821|FG000|Overall Study|Other|13|||
160694419|NCT00302081|580262822|FG001|Overall Study|Other|6|||
160694420|NCT00302081|580262823|FG002|Overall Study|Other|5|||
160694421|NCT01359644|580262824|FG000|Treatment Period|Lack of Efficacy|0|||
160694422|NCT01359644|580262825|FG001|Treatment Period|Lack of Efficacy|1|||
160694423|NCT01359644|580262826|FG002|Treatment Period|Lack of Efficacy|0|||
160694424|NCT01359644|580262827|FG003|Treatment Period|Lack of Efficacy|0|||
160694425|NCT01359644|580262828|FG004|Treatment Period|Lack of Efficacy|0|||
160694426|NCT01359644|580262829|FG005|Treatment Period|Lack of Efficacy|0|||
160694427|NCT01359644|580262830|FG006|Treatment Period|Lack of Efficacy|0|||
160694428|NCT01359644|580262831|FG007|Treatment Period|Lack of Efficacy|0|||
160694429|NCT01359644|580262832|FG008|Treatment Period|Lack of Efficacy|0|||
160694430|NCT01359644|580262833|FG009|Treatment Period|Lack of Efficacy|0|||
160694431|NCT01359644|580262824|FG000|Treatment Period|Adverse Event|0|||
160694432|NCT01359644|580262825|FG001|Treatment Period|Adverse Event|0|||
160694433|NCT01359644|580262826|FG002|Treatment Period|Adverse Event|1|||
160694434|NCT01359644|580262827|FG003|Treatment Period|Adverse Event|0|||
160694435|NCT01359644|580262828|FG004|Treatment Period|Adverse Event|0|||
160694436|NCT01359644|580262829|FG005|Treatment Period|Adverse Event|1|||
160694437|NCT01359644|580262830|FG006|Treatment Period|Adverse Event|0|||
160694438|NCT01359644|580262831|FG007|Treatment Period|Adverse Event|0|||
160694439|NCT01359644|580262832|FG008|Treatment Period|Adverse Event|0|||
160694440|NCT01359644|580262833|FG009|Treatment Period|Adverse Event|0|||
160694441|NCT01359644|580262824|FG000|Treatment Period|Lost to Follow-up|0|||
160694442|NCT01359644|580262825|FG001|Treatment Period|Lost to Follow-up|0|||
160694443|NCT01359644|580262826|FG002|Treatment Period|Lost to Follow-up|0|||
160694444|NCT01359644|580262827|FG003|Treatment Period|Lost to Follow-up|0|||
160694445|NCT01359644|580262828|FG004|Treatment Period|Lost to Follow-up|0|||
160694446|NCT01359644|580262829|FG005|Treatment Period|Lost to Follow-up|1|||
160694447|NCT01359644|580262830|FG006|Treatment Period|Lost to Follow-up|0|||
160694448|NCT01359644|580262831|FG007|Treatment Period|Lost to Follow-up|0|||
160694449|NCT01359644|580262832|FG008|Treatment Period|Lost to Follow-up|0|||
160694450|NCT01359644|580262833|FG009|Treatment Period|Lost to Follow-up|0|||
160694451|NCT01359644|580262824|FG000|Follow-up Period|Withdrawal by Subject|0|||
160694452|NCT01359644|580262825|FG001|Follow-up Period|Withdrawal by Subject|0|||
160694453|NCT01359644|580262826|FG002|Follow-up Period|Withdrawal by Subject|0|||
160694454|NCT01359644|580262827|FG003|Follow-up Period|Withdrawal by Subject|0|||
160694455|NCT01359644|580262828|FG004|Follow-up Period|Withdrawal by Subject|0|||
160694456|NCT01359644|580262829|FG005|Follow-up Period|Withdrawal by Subject|1|||
160694457|NCT01359644|580262830|FG006|Follow-up Period|Withdrawal by Subject|0|||
160694458|NCT01359644|580262831|FG007|Follow-up Period|Withdrawal by Subject|0|||
160694459|NCT01359644|580262832|FG008|Follow-up Period|Withdrawal by Subject|0|||
160694460|NCT01359644|580262833|FG009|Follow-up Period|Withdrawal by Subject|0|||
160694461|NCT01359644|580262824|FG000|Follow-up Period|Lost to Follow-up|0|||
160694462|NCT01359644|580262825|FG001|Follow-up Period|Lost to Follow-up|0|||
160694463|NCT01359644|580262826|FG002|Follow-up Period|Lost to Follow-up|0|||
160694464|NCT01359644|580262827|FG003|Follow-up Period|Lost to Follow-up|0|||
160694465|NCT01359644|580262828|FG004|Follow-up Period|Lost to Follow-up|0|||
160694466|NCT01359644|580262829|FG005|Follow-up Period|Lost to Follow-up|0|||
160694467|NCT01359644|580262830|FG006|Follow-up Period|Lost to Follow-up|1|||
160694468|NCT01359644|580262831|FG007|Follow-up Period|Lost to Follow-up|2|||
160694469|NCT01359644|580262832|FG008|Follow-up Period|Lost to Follow-up|0|||
160694470|NCT01359644|580262833|FG009|Follow-up Period|Lost to Follow-up|0|||
160694471|NCT00311311|580262835|FG000|Overall Study|Adverse Event|3|||
160694472|NCT00311311|580262836|FG001|Overall Study|Adverse Event|2|||
160694473|NCT00311311|580262835|FG000|Overall Study|Withdrawal by Subject|1|||
160694474|NCT00311311|580262836|FG001|Overall Study|Withdrawal by Subject|1|||
160694475|NCT00311311|580262835|FG000|Overall Study|Noncompliance|0|||
160694476|NCT00311311|580262836|FG001|Overall Study|Noncompliance|1|||
160694477|NCT00311311|580262835|FG000|Overall Study|Study Termination by Sponsor|3|||
160694478|NCT00311311|580262836|FG001|Overall Study|Study Termination by Sponsor|4|||
160694479|NCT00311311|580262835|FG000|Overall Study|Death|1|||
160694480|NCT00311311|580262836|FG001|Overall Study|Death|0|||
160694481|NCT00311311|580262835|FG000|Overall Study|Lack of ancillary assistance|0|||
160694482|NCT00311311|580262836|FG001|Overall Study|Lack of ancillary assistance|1|||
160694483|NCT00546572|580262837|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
160694484|NCT00546572|580262838|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
160694485|NCT00546572|580262837|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
160694486|NCT00546572|580262838|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
160694487|NCT00546572|580262837|FG000|Vax 1 / Year 0|Protocol Violation|3|||
160694488|NCT00546572|580262838|FG001|Vax 1 / Year 0|Protocol Violation|4|||
160694489|NCT00546572|580262837|FG000|Vax 1 / Year 0|Death|2|||
160694490|NCT00546572|580262838|FG001|Vax 1 / Year 0|Death|2|||
160694491|NCT00546572|580262837|FG000|Vax 1 / Year 0|Adverse Event|0|||
160694492|NCT00546572|580262838|FG001|Vax 1 / Year 0|Adverse Event|1|||
160694493|NCT00546572|580262837|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
160694494|NCT00546572|580262838|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
160694495|NCT00546572|580262837|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
160694496|NCT00546572|580262838|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
160694497|NCT00546572|580262837|FG000|Vax 2 / Year 1|Other|1|||
160694498|NCT00546572|580262838|FG001|Vax 2 / Year 1|Other|1|||
160694499|NCT00546572|580262837|FG000|Vax 2 / Year 1|Adverse Event|1|||
160694500|NCT00546572|580262838|FG001|Vax 2 / Year 1|Adverse Event|0|||
160694501|NCT00546572|580262837|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
160694502|NCT00546572|580262838|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
160694503|NCT03979820|580262839|FG000|Overall Study|Protocol Violation|1|||
160694504|NCT03979820|580262840|FG001|Overall Study|Protocol Violation|0|||
160694505|NCT03979820|580262841|FG002|Overall Study|Protocol Violation|0|||
160694506|NCT03979820|580262842|FG003|Overall Study|Protocol Violation|0|||
160694507|NCT03979820|580262839|FG000|Overall Study|Withdrawal by Subject|0|||
160694508|NCT03979820|580262840|FG001|Overall Study|Withdrawal by Subject|0|||
160694509|NCT03979820|580262841|FG002|Overall Study|Withdrawal by Subject|1|||
160694510|NCT03979820|580262842|FG003|Overall Study|Withdrawal by Subject|0|||
160694511|NCT03979820|580262839|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
160694512|NCT03979820|580262840|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
160694513|NCT03979820|580262841|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
160694514|NCT03979820|580262842|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
160694515|NCT01229735|580262843|FG000|Overall Study|Lack of Efficacy|8|||
160694516|NCT01229735|580262844|FG001|Overall Study|Lack of Efficacy|8|||
160694517|NCT01229735|580262843|FG000|Overall Study|Protocol Violation|13|||
160694518|NCT01229735|580262844|FG001|Overall Study|Protocol Violation|8|||
160694519|NCT01229735|580262843|FG000|Overall Study|Lost to Follow-up|0|||
160694520|NCT01229735|580262844|FG001|Overall Study|Lost to Follow-up|2|||
160694521|NCT01229735|580262843|FG000|Overall Study|Withdrawal by Subject|18|||
160694522|NCT01229735|580262844|FG001|Overall Study|Withdrawal by Subject|17|||
160694523|NCT01229735|580262843|FG000|Overall Study|Other Reason|13|||
160694524|NCT01229735|580262844|FG001|Overall Study|Other Reason|10|||
160694525|NCT01229735|580262843|FG000|Overall Study|SAE, non-fatal|0|||
160694526|NCT01229735|580262844|FG001|Overall Study|SAE, non-fatal|4|||
160694527|NCT01229735|580262843|FG000|Overall Study|AE, non-serious non-fatal|13|||
160694528|NCT01229735|580262844|FG001|Overall Study|AE, non-serious non-fatal|17|||
160694529|NCT01229735|580262843|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160694530|NCT01229735|580262844|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
160694531|NCT02685202|580262845|FG000|Overall Study|Lost to Follow-up|9|||
160694532|NCT02130882|580262846|FG000|Overall Study|Withdrawal by Subject|0|||
160694533|NCT02130882|580262847|FG001|Overall Study|Withdrawal by Subject|1|||
160694534|NCT02331368|580262852|FG000|Overall Study|Withdrawal by Subject|3|||
160694535|NCT02302859|580262853|FG000|Overall Study|Lost Phone|1|||
160694536|NCT02302859|580262854|FG001|Overall Study|Lost Phone|1|||
160694537|NCT02302859|580262853|FG000|Overall Study|Withdrawal by Subject|0|||
160694538|NCT02302859|580262854|FG001|Overall Study|Withdrawal by Subject|1|||
160694539|NCT00679913|580262859|FG000|Overall Study|Protocol Violation|18|||
160694540|NCT00679913|580262860|FG001|Overall Study|Protocol Violation|13|||
160694541|NCT01000493|580262864|FG000|Overall Study|Adverse Event|3|||
160694542|NCT01000493|580262865|FG001|Overall Study|Adverse Event|6|||
160694543|NCT01000493|580262864|FG000|Overall Study|Lack of Efficacy|1|||
160694544|NCT01000493|580262865|FG001|Overall Study|Lack of Efficacy|1|||
160694545|NCT01000493|580262864|FG000|Overall Study|Protocol Violation|1|||
160694546|NCT01000493|580262865|FG001|Overall Study|Protocol Violation|8|||
160694547|NCT01000493|580262864|FG000|Overall Study|Study closed/terminated|25|||
160694548|NCT01000493|580262865|FG001|Overall Study|Study closed/terminated|23|||
160694549|NCT01000493|580262864|FG000|Overall Study|Lost to Follow-up|5|||
160694550|NCT01000493|580262865|FG001|Overall Study|Lost to Follow-up|9|||
160694551|NCT01000493|580262864|FG000|Overall Study|Physician Decision|1|||
160694552|NCT01000493|580262865|FG001|Overall Study|Physician Decision|1|||
160694553|NCT01000493|580262864|FG000|Overall Study|Withdrawal by Subject|3|||
160694554|NCT01000493|580262865|FG001|Overall Study|Withdrawal by Subject|7|||
160694555|NCT00369382|580262876|FG000|Overall Study|Death|0|||
160694556|NCT00369382|580262877|FG001|Overall Study|Death|2|||
160694557|NCT00369382|580262876|FG000|Overall Study|Physician Decision|2|||
160694558|NCT00369382|580262877|FG001|Overall Study|Physician Decision|1|||
160694559|NCT00369382|580262876|FG000|Overall Study|Withdrawal by Subject|5|||
160694560|NCT00369382|580262877|FG001|Overall Study|Withdrawal by Subject|0|||
160694561|NCT00369382|580262876|FG000|Overall Study|Randomized, not treated|2|||
160694562|NCT00369382|580262877|FG001|Overall Study|Randomized, not treated|0|||
160694563|NCT00369382|580262876|FG000|Overall Study|Other|1|||
160694564|NCT00369382|580262877|FG001|Overall Study|Other|0|||
160694565|NCT02384850|580262881|FG000|Overall Study|Withdrawal by Subject|2|||
160694566|NCT02384850|580262882|FG001|Overall Study|Withdrawal by Subject|2|||
160694567|NCT00507546|580262883|FG000|Overall Study|Withdrawal by Subject|1|||
160694568|NCT00507546|580262884|FG001|Overall Study|Withdrawal by Subject|0|||
160694569|NCT00507546|580262883|FG000|Overall Study|Protocol Violation|1|||
160694570|NCT00507546|580262884|FG001|Overall Study|Protocol Violation|0|||
160694571|NCT00507546|580262883|FG000|Overall Study|Physician Decision|0|||
160694572|NCT00507546|580262884|FG001|Overall Study|Physician Decision|1|||
160694573|NCT03548064|580265094|FG000|Overall Study|Withdrawal by Subject|0|||
160694574|NCT03548064|580265095|FG001|Overall Study|Withdrawal by Subject|0|||
160694575|NCT03548064|580265096|FG002|Overall Study|Withdrawal by Subject|0|||
160694576|NCT03548064|580265097|FG003|Overall Study|Withdrawal by Subject|1|||
160694577|NCT03548064|580265098|FG004|Overall Study|Withdrawal by Subject|0|||
160694578|NCT03548064|580265099|FG005|Overall Study|Withdrawal by Subject|0|||
160694579|NCT03548064|580265100|FG006|Overall Study|Withdrawal by Subject|0|||
160694580|NCT03548064|580265101|FG007|Overall Study|Withdrawal by Subject|0|||
160694581|NCT03548064|580265094|FG000|Overall Study|Lost to Follow-up|0|||
160694582|NCT03548064|580265095|FG001|Overall Study|Lost to Follow-up|0|||
160694583|NCT03548064|580265096|FG002|Overall Study|Lost to Follow-up|0|||
160694584|NCT03548064|580265097|FG003|Overall Study|Lost to Follow-up|0|||
160694585|NCT03548064|580265098|FG004|Overall Study|Lost to Follow-up|2|||
160694586|NCT03548064|580265099|FG005|Overall Study|Lost to Follow-up|0|||
160694587|NCT03548064|580265100|FG006|Overall Study|Lost to Follow-up|0|||
160694588|NCT03548064|580265101|FG007|Overall Study|Lost to Follow-up|0|||
160694589|NCT03548064|580265094|FG000|Overall Study|Covid-19 Pandemic|0|||
160694590|NCT03548064|580265095|FG001|Overall Study|Covid-19 Pandemic|0|||
160694591|NCT03548064|580265096|FG002|Overall Study|Covid-19 Pandemic|0|||
160694592|NCT03548064|580265097|FG003|Overall Study|Covid-19 Pandemic|0|||
160694593|NCT03548064|580265098|FG004|Overall Study|Covid-19 Pandemic|10|||
160694594|NCT03548064|580265099|FG005|Overall Study|Covid-19 Pandemic|3|||
160694595|NCT03548064|580265100|FG006|Overall Study|Covid-19 Pandemic|0|||
160694596|NCT03548064|580265101|FG007|Overall Study|Covid-19 Pandemic|0|||
160694597|NCT04092894|580265104|FG000|Overall Study|Withdrawal by Subject|2|||
160694598|NCT04092894|580265105|FG001|Overall Study|Withdrawal by Subject|4|||
160694599|NCT04092894|580265104|FG000|Overall Study|Discontinued EEG after randomization|10|||
160694600|NCT04092894|580265105|FG001|Overall Study|Discontinued EEG after randomization|6|||
160694601|NCT01106014|580265106|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
160694602|NCT01106014|580265107|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
160694603|NCT01106014|580265106|FG000|Overall Study|Adverse Event|78|||
160694604|NCT01106014|580265107|FG001|Overall Study|Adverse Event|42|||
160694605|NCT01106014|580265106|FG000|Overall Study|Withdrawal by Subject|43|||
160694606|NCT01106014|580265107|FG001|Overall Study|Withdrawal by Subject|37|||
160694607|NCT01106014|580265106|FG000|Overall Study|Administrative reason|7|||
160694608|NCT01106014|580265107|FG001|Overall Study|Administrative reason|6|||
160694609|NCT01106014|580265106|FG000|Overall Study|Lost to Follow-up|2|||
160694610|NCT01106014|580265107|FG001|Overall Study|Lost to Follow-up|3|||
160694611|NCT02935686|580265108|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
160694612|NCT02935686|580265109|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
160694613|NCT02935686|580265110|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
160694614|NCT02935686|580265111|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
160694615|NCT02935686|580265112|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
160694616|NCT02935686|580265108|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
160694617|NCT02935686|580265109|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
160694618|NCT02935686|580265110|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
160694619|NCT02935686|580265111|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
160694620|NCT02935686|580265112|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
160694621|NCT02935686|580265108|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
160694622|NCT02935686|580265109|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
160694623|NCT02935686|580265110|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
160694624|NCT02935686|580265111|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
160694625|NCT02935686|580265112|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
160694626|NCT02935686|580265108|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
160694627|NCT02935686|580265109|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
160694628|NCT02935686|580265110|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
160694629|NCT02935686|580265111|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
160694630|NCT02935686|580265112|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
160694631|NCT02935686|580265108|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
160694632|NCT02935686|580265109|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
160694633|NCT02935686|580265110|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
160694634|NCT02935686|580265111|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
160694635|NCT02935686|580265112|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
160694636|NCT02935686|580265108|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
160694637|NCT02935686|580265109|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
160694638|NCT02935686|580265110|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
160694639|NCT02935686|580265111|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
160694640|NCT02935686|580265112|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
160694641|NCT02935686|580265108|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
160694642|NCT02935686|580265109|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
160694643|NCT02935686|580265110|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
160694644|NCT02935686|580265111|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
160694645|NCT02935686|580265112|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
160694646|NCT02935686|580265108|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
160694647|NCT02935686|580265109|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
160694648|NCT02935686|580265110|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
160694649|NCT02935686|580265111|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
160694650|NCT02935686|580265112|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
160694651|NCT02935686|580265108|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
160694652|NCT02935686|580265109|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
160694653|NCT02935686|580265110|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
160694654|NCT02935686|580265111|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
160694655|NCT02935686|580265112|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
160694656|NCT02935686|580265108|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
160694657|NCT02935686|580265109|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
160694658|NCT02935686|580265110|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
160694659|NCT02935686|580265111|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
160694660|NCT02935686|580265112|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
160694661|NCT02935686|580265108|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
160694662|NCT02935686|580265109|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
160694663|NCT02935686|580265110|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
160694664|NCT02935686|580265111|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
160694665|NCT02935686|580265112|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
160694666|NCT00062010|580265115|FG000|Overall Study|Ineligible|3|||
160694667|NCT01183221|580265116|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
160694668|NCT01183221|580265117|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
160694669|NCT00852969|580265120|FG000|Overall Study|Adverse Event|0|||
160694670|NCT00852969|580265121|FG001|Overall Study|Adverse Event|1|||
160694671|NCT00852969|580265120|FG000|Overall Study|Lost to Follow-up|0|||
160694672|NCT00852969|580265121|FG001|Overall Study|Lost to Follow-up|1|||
160694673|NCT03596151|580265122|FG000|Overall Study|Withdrawal by Subject|1|||
160694674|NCT00807248|580265124|FG000|Overall Study|Adverse Event|1|||
160694675|NCT00807248|580265125|FG001|Overall Study|Adverse Event|2|||
160694676|NCT00807248|580265126|FG002|Overall Study|Adverse Event|2|||
160694677|NCT00807248|580265127|FG003|Overall Study|Adverse Event|6|||
160694678|NCT00807248|580265124|FG000|Overall Study|Lack of Efficacy|14|||
160694679|NCT00807248|580265125|FG001|Overall Study|Lack of Efficacy|4|||
160694680|NCT00807248|580265126|FG002|Overall Study|Lack of Efficacy|8|||
160694681|NCT00807248|580265127|FG003|Overall Study|Lack of Efficacy|3|||
160694682|NCT00807248|580265124|FG000|Overall Study|Protocol Violation|0|||
160694683|NCT00807248|580265125|FG001|Overall Study|Protocol Violation|1|||
160694684|NCT00807248|580265126|FG002|Overall Study|Protocol Violation|1|||
160694685|NCT00807248|580265127|FG003|Overall Study|Protocol Violation|0|||
160694686|NCT00807248|580265124|FG000|Overall Study|Withdrawal of Consent|5|||
160694687|NCT00807248|580265125|FG001|Overall Study|Withdrawal of Consent|5|||
160694688|NCT00807248|580265126|FG002|Overall Study|Withdrawal of Consent|5|||
160694689|NCT00807248|580265127|FG003|Overall Study|Withdrawal of Consent|5|||
160694690|NCT00807248|580265124|FG000|Overall Study|Lost to Follow-up|1|||
160694691|NCT00807248|580265125|FG001|Overall Study|Lost to Follow-up|0|||
160694692|NCT00807248|580265126|FG002|Overall Study|Lost to Follow-up|0|||
160694693|NCT00807248|580265127|FG003|Overall Study|Lost to Follow-up|0|||
160694694|NCT00807248|580265124|FG000|Overall Study|Other Reason|0|||
160694695|NCT00807248|580265125|FG001|Overall Study|Other Reason|0|||
160694696|NCT00807248|580265126|FG002|Overall Study|Other Reason|2|||
160694697|NCT00807248|580265127|FG003|Overall Study|Other Reason|0|||
160694698|NCT02444793|580265128|FG000|Overall Study|Lost to Follow-up|2|||
160694699|NCT02444793|580265129|FG001|Overall Study|Lost to Follow-up|2|||
160694700|NCT02444793|580265130|FG002|Overall Study|Lost to Follow-up|0|||
160694701|NCT02444793|580265131|FG003|Overall Study|Lost to Follow-up|0|||
160694702|NCT02444793|580265128|FG000|Overall Study|Death|0|||
160694703|NCT02444793|580265129|FG001|Overall Study|Death|3|||
160694704|NCT02444793|580265130|FG002|Overall Study|Death|0|||
160694705|NCT02444793|580265131|FG003|Overall Study|Death|0|||
160694706|NCT02444793|580265128|FG000|Overall Study|Other|0|||
160694707|NCT02444793|580265129|FG001|Overall Study|Other|0|||
160694708|NCT02444793|580265130|FG002|Overall Study|Other|2|||
160694709|NCT02444793|580265131|FG003|Overall Study|Other|0|||
160694710|NCT02444793|580265128|FG000|Overall Study|Objective progression or relapse|9|||
160694711|NCT02444793|580265129|FG001|Overall Study|Objective progression or relapse|1|||
160694712|NCT02444793|580265130|FG002|Overall Study|Objective progression or relapse|2|||
160694713|NCT02444793|580265131|FG003|Overall Study|Objective progression or relapse|3|||
160694714|NCT02504671|580265136|FG000|Overall Study|Withdrawal by Subject|1|||
160694715|NCT02504671|580265137|FG001|Overall Study|Withdrawal by Subject|5|||
160694716|NCT02504671|580265138|FG002|Overall Study|Withdrawal by Subject|4|||
160694717|NCT02504671|580265139|FG003|Overall Study|Withdrawal by Subject|4|||
160694718|NCT02504671|580265140|FG004|Overall Study|Withdrawal by Subject|5|||
160694719|NCT02504671|580265141|FG005|Overall Study|Withdrawal by Subject|3|||
160694720|NCT02504671|580265136|FG000|Overall Study|Lack of Efficacy|1|||
160694721|NCT02504671|580265137|FG001|Overall Study|Lack of Efficacy|3|||
160694722|NCT02504671|580265138|FG002|Overall Study|Lack of Efficacy|1|||
160694723|NCT02504671|580265139|FG003|Overall Study|Lack of Efficacy|0|||
160694724|NCT02504671|580265140|FG004|Overall Study|Lack of Efficacy|4|||
160694725|NCT02504671|580265141|FG005|Overall Study|Lack of Efficacy|4|||
160694726|NCT02504671|580265136|FG000|Overall Study|Adverse Event|1|||
160694727|NCT02504671|580265137|FG001|Overall Study|Adverse Event|1|||
160694728|NCT02504671|580265138|FG002|Overall Study|Adverse Event|0|||
160694729|NCT02504671|580265139|FG003|Overall Study|Adverse Event|1|||
160694730|NCT02504671|580265140|FG004|Overall Study|Adverse Event|0|||
160694731|NCT02504671|580265141|FG005|Overall Study|Adverse Event|2|||
160694732|NCT02504671|580265136|FG000|Overall Study|Protocol Violation|2|||
160694733|NCT02504671|580265137|FG001|Overall Study|Protocol Violation|1|||
160694734|NCT02504671|580265138|FG002|Overall Study|Protocol Violation|0|||
160694735|NCT02504671|580265139|FG003|Overall Study|Protocol Violation|0|||
160694736|NCT02504671|580265140|FG004|Overall Study|Protocol Violation|0|||
160694737|NCT02504671|580265141|FG005|Overall Study|Protocol Violation|1|||
160694738|NCT02504671|580265136|FG000|Overall Study|Lost to Follow-up|0|||
160694739|NCT02504671|580265137|FG001|Overall Study|Lost to Follow-up|0|||
160694740|NCT02504671|580265138|FG002|Overall Study|Lost to Follow-up|2|||
160694741|NCT02504671|580265139|FG003|Overall Study|Lost to Follow-up|0|||
160694742|NCT02504671|580265140|FG004|Overall Study|Lost to Follow-up|0|||
160694743|NCT02504671|580265141|FG005|Overall Study|Lost to Follow-up|1|||
160694744|NCT02504671|580265136|FG000|Overall Study|Protocol defined stopping criteria|7|||
160694745|NCT02504671|580265137|FG001|Overall Study|Protocol defined stopping criteria|4|||
160694746|NCT02504671|580265138|FG002|Overall Study|Protocol defined stopping criteria|3|||
160694747|NCT02504671|580265139|FG003|Overall Study|Protocol defined stopping criteria|5|||
160694748|NCT02504671|580265140|FG004|Overall Study|Protocol defined stopping criteria|3|||
160694749|NCT02504671|580265141|FG005|Overall Study|Protocol defined stopping criteria|3|||
160694750|NCT02518919|580265144|FG000|Overall Study|Protocol Violation|1|||
160694751|NCT02518919|580265145|FG001|Overall Study|Protocol Violation|1|||
160694752|NCT02518919|580265146|FG002|Overall Study|Protocol Violation|2|||
160694753|NCT04498403|580265147|FG000|Overall Study|Adverse Event|1|||
160694754|NCT04498403|580265148|FG001|Overall Study|Adverse Event|0|||
160694755|NCT04498403|580265147|FG000|Overall Study|Study Terminated By Sponsor|29|||
160694756|NCT04498403|580265148|FG001|Overall Study|Study Terminated By Sponsor|10|||
160694757|NCT03986138|580265149|FG000|First MRI Examination|Physician Decision|0|||
160694758|NCT03986138|580265150|FG001|First MRI Examination|Physician Decision|1|||
160694759|NCT03986138|580265149|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
160694760|NCT03986138|580265150|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
160694761|NCT03986138|580265149|FG000|Washout|Withdrawal by Subject|4|||
160694762|NCT03986138|580265150|FG001|Washout|Withdrawal by Subject|5|||
160694763|NCT03986138|580265149|FG000|Washout|Lost to Follow-up|0|||
160694764|NCT03986138|580265150|FG001|Washout|Lost to Follow-up|2|||
160694765|NCT03986138|580265149|FG000|Washout|Adverse Event|1|||
160694766|NCT03986138|580265150|FG001|Washout|Adverse Event|1|||
160694767|NCT03986138|580265149|FG000|Washout|Other reason|5|||
160694768|NCT03986138|580265150|FG001|Washout|Other reason|5|||
160694769|NCT03986138|580265149|FG000|Second MRI Examination|Withdrawal by Subject|0|||
160694770|NCT03986138|580265150|FG001|Second MRI Examination|Withdrawal by Subject|2|||
160694771|NCT03182244|580265154|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
160694772|NCT03182244|580265155|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
160694773|NCT03182244|580265154|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
160694774|NCT03182244|580265155|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
160694775|NCT03182244|580265154|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
160694776|NCT03182244|580265155|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
160694777|NCT03182244|580265154|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
160694778|NCT03182244|580265155|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
160694779|NCT03182244|580265154|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
160694780|NCT03182244|580265155|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
160694781|NCT03182244|580265154|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
160694782|NCT03182244|580265155|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
160694783|NCT03182244|580265154|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
160694784|NCT03182244|580265155|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
160694785|NCT03182244|580265154|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
160694786|NCT03182244|580265155|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
160694787|NCT03182244|580265154|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
160694788|NCT03182244|580265155|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
160694789|NCT03182244|580265154|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
160694790|NCT03182244|580265155|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
160694791|NCT03182244|580265154|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
160694792|NCT03182244|580265155|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
160694793|NCT03182244|580265154|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
160694794|NCT03182244|580265155|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
160694795|NCT03182244|580265154|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
160694796|NCT03182244|580265155|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
160694797|NCT02049450|580265156|FG000|Overall Study|Adverse Event|2|||
160694798|NCT02049450|580265156|FG000|Overall Study|Withdrawal by Subject|1|||
160694799|NCT02049450|580265156|FG000|Overall Study|Patients/guardian decision|1|||
160694800|NCT03186781|580265157|FG000|Overall Study|Lost to Follow-up|0|||
160694801|NCT03186781|580265158|FG001|Overall Study|Lost to Follow-up|0|||
160694802|NCT03186781|580265159|FG002|Overall Study|Lost to Follow-up|1|||
160694803|NCT03186781|580265160|FG003|Overall Study|Lost to Follow-up|0|||
160694804|NCT03186781|580265161|FG004|Overall Study|Lost to Follow-up|1|||
160694805|NCT03186781|580265162|FG005|Overall Study|Lost to Follow-up|0|||
160694806|NCT03186781|580265157|FG000|Overall Study|Moved from Area|0|||
160694807|NCT03186781|580265158|FG001|Overall Study|Moved from Area|0|||
160694808|NCT03186781|580265159|FG002|Overall Study|Moved from Area|0|||
160694809|NCT03186781|580265160|FG003|Overall Study|Moved from Area|0|||
160694810|NCT03186781|580265161|FG004|Overall Study|Moved from Area|1|||
160694811|NCT03186781|580265162|FG005|Overall Study|Moved from Area|0|||
160694812|NCT03186781|580265157|FG000|Overall Study|Withdrawal by Subject|0|||
160694813|NCT03186781|580265158|FG001|Overall Study|Withdrawal by Subject|0|||
160694814|NCT03186781|580265159|FG002|Overall Study|Withdrawal by Subject|0|||
160694815|NCT03186781|580265160|FG003|Overall Study|Withdrawal by Subject|0|||
160694816|NCT03186781|580265161|FG004|Overall Study|Withdrawal by Subject|1|||
160694817|NCT03186781|580265162|FG005|Overall Study|Withdrawal by Subject|0|||
160694818|NCT04709835|580265163|FG000|Overall Study|Withdrawal by Subject|0|||
160694819|NCT04709835|580265164|FG001|Overall Study|Withdrawal by Subject|1|||
160694820|NCT04709835|580265165|FG002|Overall Study|Withdrawal by Subject|0|||
160694821|NCT02372071|580265166|FG000|Overall Study|Protocol Violation|18|||
160694822|NCT03347422|580265170|FG000|Part A (26 Weeks)|Adverse Event|3|||
160694823|NCT03347422|580265171|FG001|Part A (26 Weeks)|Adverse Event|0|||
160694824|NCT03347422|580265170|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
160694825|NCT03347422|580265171|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
160694826|NCT03347422|580265170|FG000|Part B (149 Weeks)|Adverse Event|0|||
160694827|NCT03347422|580265171|FG001|Part B (149 Weeks)|Adverse Event|1|||
160694828|NCT03347422|580265170|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
160694829|NCT03347422|580265171|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
160694830|NCT03347422|580265170|FG000|Part B (149 Weeks)|Other|1|||
160694831|NCT03347422|580265171|FG001|Part B (149 Weeks)|Other|0|||
160694832|NCT02618408|580265178|FG000|Overall Study|Withdrawal by Subject|1|||
160694833|NCT02618408|580265179|FG001|Overall Study|Withdrawal by Subject|0|||
160694834|NCT02618408|580265180|FG002|Overall Study|Withdrawal by Subject|4|||
160694835|NCT02618408|580265178|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
160694836|NCT02618408|580265179|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
160694837|NCT02618408|580265180|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
160694838|NCT02618408|580265178|FG000|Overall Study|Lost to Follow-up|4|||
160694839|NCT02618408|580265179|FG001|Overall Study|Lost to Follow-up|2|||
160694840|NCT02618408|580265180|FG002|Overall Study|Lost to Follow-up|6|||
160694841|NCT02618408|580265178|FG000|Overall Study|Adverse Event|4|||
160694842|NCT02618408|580265179|FG001|Overall Study|Adverse Event|0|||
160694843|NCT02618408|580265180|FG002|Overall Study|Adverse Event|10|||
160694844|NCT02618408|580265178|FG000|Overall Study|Physician Decision|1|||
160694845|NCT02618408|580265179|FG001|Overall Study|Physician Decision|1|||
160694846|NCT02618408|580265180|FG002|Overall Study|Physician Decision|2|||
160694847|NCT02618408|580265178|FG000|Overall Study|Protocol Violation|1|||
160694848|NCT02618408|580265179|FG001|Overall Study|Protocol Violation|1|||
160694849|NCT02618408|580265180|FG002|Overall Study|Protocol Violation|2|||
160694850|NCT02618408|580265178|FG000|Overall Study|Other, Multiple Categories|0|||
160694851|NCT02618408|580265179|FG001|Overall Study|Other, Multiple Categories|0|||
160694852|NCT02618408|580265180|FG002|Overall Study|Other, Multiple Categories|4|||
160694853|NCT03914950|580265185|FG000|Overall Study|Physician Decision|54|||
160694854|NCT01383135|580265191|FG000|Overall Study|Not Scanned / Imaged|1|||
160694855|NCT01383135|580265192|FG001|Overall Study|Not Scanned / Imaged|0|||
160694856|NCT01383135|580265193|FG002|Overall Study|Not Scanned / Imaged|1|||
160694857|NCT01383135|580265194|FG003|Overall Study|Not Scanned / Imaged|0|||
160694858|NCT03167723|580265197|FG000|Overall Study|Protocol Violation|4|||
160694859|NCT03167723|580265198|FG001|Overall Study|Protocol Violation|6|||
160694860|NCT03397771|580265199|FG000|Overall Study|2 erroneously randomized, never treated|3|||
160694861|NCT03397771|580265200|FG001|Overall Study|2 erroneously randomized, never treated|1|||
160694862|NCT03397771|580265199|FG000|Overall Study|Withdrawal by Subject|1|||
160694863|NCT03397771|580265200|FG001|Overall Study|Withdrawal by Subject|3|||
160694864|NCT03397771|580265199|FG000|Overall Study|Protocol Violation|2|||
160694865|NCT03397771|580265200|FG001|Overall Study|Protocol Violation|2|||
160694866|NCT03397771|580265199|FG000|Overall Study|Adverse Event|2|||
160694867|NCT03397771|580265200|FG001|Overall Study|Adverse Event|1|||
160694868|NCT02669758|580265203|FG000|Overall Study|Withdrawal by Subject|43|||
160694869|NCT02669758|580265203|FG000|Overall Study|Lost to Follow-up|19|||
160694870|NCT02669758|580265203|FG000|Overall Study|Adverse Event|16|||
160694871|NCT02669758|580265203|FG000|Overall Study|Non-Compliance with Study Drug|8|||
160694872|NCT02669758|580265203|FG000|Overall Study|Lack of Efficacy|5|||
160694873|NCT02669758|580265203|FG000|Overall Study|Pregnancy|1|||
160694874|NCT02669758|580265203|FG000|Overall Study|Study noncompliance|1|||
160694875|NCT02669758|580265203|FG000|Overall Study|Protocol Violation|1|||
160694876|NCT02455050|580265204|FG000|Treatment Period 1|Lost to Follow-up|1|||
160694877|NCT02455050|580265205|FG001|Treatment Period 1|Lost to Follow-up|1|||
160694878|NCT02455050|580265206|FG002|Treatment Period 1|Lost to Follow-up|1|||
160694879|NCT02455050|580265207|FG003|Treatment Period 1|Lost to Follow-up|2|||
160694880|NCT02455050|580265204|FG000|Treatment Period 2|Lost to Follow-up|1|||
160694881|NCT02455050|580265205|FG001|Treatment Period 2|Lost to Follow-up|0|||
160694882|NCT02455050|580265206|FG002|Treatment Period 2|Lost to Follow-up|2|||
160694883|NCT02455050|580265207|FG003|Treatment Period 2|Lost to Follow-up|1|||
160694884|NCT03393806|580265210|FG000|Overall Study|Physician Decision|1|||
160694885|NCT03393806|580265211|FG001|Overall Study|Physician Decision|0|||
160694886|NCT01259115|580265212|FG000|Period 1|Adverse Event|1|||
160694887|NCT01259115|580265213|FG001|Period 1|Adverse Event|0|||
160694888|NCT01259115|580265212|FG000|Period 1|Protocol Violation|2|||
160694889|NCT01259115|580265213|FG001|Period 1|Protocol Violation|0|||
160694890|NCT01259115|580265212|FG000|Period 1|Lost to Follow-up|0|||
160694891|NCT01259115|580265213|FG001|Period 1|Lost to Follow-up|1|||
160694892|NCT01259115|580265212|FG000|Period 2|Adverse Event|1|||
160694893|NCT01259115|580265213|FG001|Period 2|Adverse Event|0|||
160694894|NCT02534844|580265214|FG000|Part B|Withdrawal by Subject|0|||
160694895|NCT02534844|580265215|FG001|Part B|Withdrawal by Subject|0|||
160694896|NCT02534844|580265216|FG002|Part B|Withdrawal by Subject|0|||
160694897|NCT02534844|580265217|FG003|Part B|Withdrawal by Subject|0|||
160694898|NCT02534844|580265218|FG004|Part B|Withdrawal by Subject|2|||
160694899|NCT02534844|580265219|FG005|Part B|Withdrawal by Subject|1|||
160694900|NCT01971970|580265220|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
160694901|NCT01971970|580265221|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
160694902|NCT01971970|580265220|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
160694903|NCT01971970|580265221|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
160694904|NCT01971970|580265220|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
160694905|NCT01971970|580265221|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
160694906|NCT01971970|580265220|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
160694907|NCT01971970|580265221|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
160694908|NCT01971970|580265220|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
160694909|NCT01971970|580265221|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
160694910|NCT01971970|580265220|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
160694911|NCT01971970|580265221|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
160694912|NCT01971970|580265220|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
160694913|NCT01971970|580265221|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
160694914|NCT01831765|580265222|FG000|Overall Study|Lack of Efficacy|1|||
160694915|NCT01831765|580265223|FG001|Overall Study|Lack of Efficacy|0|||
160694916|NCT01831765|580265224|FG002|Overall Study|Lack of Efficacy|0|||
160694917|NCT01831765|580265222|FG000|Overall Study|Other, sponsor withdrew subject|0|||
160694918|NCT01831765|580265223|FG001|Overall Study|Other, sponsor withdrew subject|1|||
160694919|NCT01831765|580265224|FG002|Overall Study|Other, sponsor withdrew subject|0|||
160694920|NCT01831765|580265222|FG000|Overall Study|Pregnancy|1|||
160694921|NCT01831765|580265223|FG001|Overall Study|Pregnancy|1|||
160694922|NCT01831765|580265224|FG002|Overall Study|Pregnancy|2|||
160694923|NCT01831765|580265222|FG000|Overall Study|Death|0|||
160694924|NCT01831765|580265223|FG001|Overall Study|Death|1|||
160694925|NCT01831765|580265224|FG002|Overall Study|Death|1|||
160694926|NCT01831765|580265222|FG000|Overall Study|Other, site closed|1|||
160694927|NCT01831765|580265223|FG001|Overall Study|Other, site closed|1|||
160694928|NCT01831765|580265224|FG002|Overall Study|Other, site closed|0|||
160694929|NCT01831765|580265222|FG000|Overall Study|Adverse Event|5|||
160694930|NCT01831765|580265223|FG001|Overall Study|Adverse Event|3|||
160694931|NCT01831765|580265224|FG002|Overall Study|Adverse Event|3|||
160694932|NCT01831765|580265222|FG000|Overall Study|Withdrawal by Subject|22|||
160694933|NCT01831765|580265223|FG001|Overall Study|Withdrawal by Subject|7|||
160694934|NCT01831765|580265224|FG002|Overall Study|Withdrawal by Subject|17|||
160694935|NCT01831765|580265222|FG000|Overall Study|Withdrawal criteria|12|||
160694936|NCT01831765|580265223|FG001|Overall Study|Withdrawal criteria|10|||
160694937|NCT01831765|580265224|FG002|Overall Study|Withdrawal criteria|16|||
160694938|NCT01831765|580265222|FG000|Overall Study|Lost to Follow-up|2|||
160694939|NCT01831765|580265223|FG001|Overall Study|Lost to Follow-up|3|||
160694940|NCT01831765|580265224|FG002|Overall Study|Lost to Follow-up|3|||
160694941|NCT00859586|580265225|FG000|Overall Study|Donors|4|||
160694942|NCT00080938|580265226|FG000|Overall Study|Adverse Event|3|||
160694943|NCT00080938|580265226|FG000|Overall Study|Withdrawal by Subject|6|||
160694944|NCT00080938|580265226|FG000|Overall Study|Death|2|||
160694945|NCT00080938|580265226|FG000|Overall Study|Lack of Efficacy|7|||
160694946|NCT00080938|580265226|FG000|Overall Study|other disease|1|||
160694947|NCT00080938|580265226|FG000|Overall Study|Not started protocol therapy|1|||
160694948|NCT00080938|580265226|FG000|Overall Study|Ineligible|4|||
160694949|NCT00706511|580265229|FG000|Overall Study|Withdrawal by Subject|1|||
160694950|NCT00706511|580265230|FG001|Overall Study|Withdrawal by Subject|0|||
160694951|NCT00706511|580265231|FG002|Overall Study|Withdrawal by Subject|0|||
160694952|NCT00706511|580265232|FG003|Overall Study|Withdrawal by Subject|0|||
160694953|NCT02605993|580265233|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
160694954|NCT02605993|580265234|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
160694955|NCT02605993|580265235|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
160694956|NCT02605993|580265236|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
160694957|NCT03493386|580265239|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160694958|NCT03493386|580265240|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
160694959|NCT03493386|580265241|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160694960|NCT03493386|580265242|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
160694961|NCT02116608|580265248|FG000|Overall Study|Lost to Follow-up|0|||
160694962|NCT02116608|580265249|FG001|Overall Study|Lost to Follow-up|0|||
160694963|NCT02116608|580265250|FG002|Overall Study|Lost to Follow-up|1|||
160694964|NCT02116608|580265248|FG000|Overall Study|Physician Decision|0|||
160694965|NCT02116608|580265249|FG001|Overall Study|Physician Decision|1|||
160694966|NCT02116608|580265250|FG002|Overall Study|Physician Decision|0|||
160694967|NCT02116608|580265248|FG000|Overall Study|Death|0|||
160694968|NCT02116608|580265249|FG001|Overall Study|Death|1|||
160694969|NCT02116608|580265250|FG002|Overall Study|Death|0|||
160694970|NCT00988442|580265252|FG000|Overall Study|Death|1|||
160694971|NCT00988442|580265253|FG001|Overall Study|Death|2|||
160694972|NCT00988442|580265252|FG000|Overall Study|Lost to Follow-up|0|||
160694973|NCT00988442|580265253|FG001|Overall Study|Lost to Follow-up|1|||
160694974|NCT00988442|580265252|FG000|Overall Study|Early Study Closure|29|||
160694975|NCT00988442|580265253|FG001|Overall Study|Early Study Closure|25|||
160694976|NCT02731326|580265257|FG000|Overall Study|Withdrawal by Subject|4|||
160694977|NCT02731326|580265258|FG001|Overall Study|Withdrawal by Subject|1|||
160694978|NCT02731326|580265257|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
160694979|NCT02731326|580265258|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
160694980|NCT02731326|580265257|FG000|Overall Study|Discharged without AliveCor|10|||
160694981|NCT02731326|580265258|FG001|Overall Study|Discharged without AliveCor|0|||
160694982|NCT02731326|580265257|FG000|Overall Study|Duplicate Participant|1|||
160694983|NCT02731326|580265258|FG001|Overall Study|Duplicate Participant|1|||
160694984|NCT04480021|580265259|FG000|Overall Study|Lost to Follow-up|3|||
160694985|NCT04480021|580265260|FG001|Overall Study|Lost to Follow-up|4|||
160694986|NCT02615171|580265261|FG000|Overall Study|Lost to Follow-up|2|||
160694987|NCT02615171|580265262|FG001|Overall Study|Lost to Follow-up|1|||
160694988|NCT02989168|580265269|FG000|Overall Study|Withdrawal by Subject|2|||
160694989|NCT02989168|580265270|FG001|Overall Study|Withdrawal by Subject|0|||
160694990|NCT02989168|580265269|FG000|Overall Study|Physician Decision|0|||
160694991|NCT02989168|580265270|FG001|Overall Study|Physician Decision|1|||
160694992|NCT02989168|580265269|FG000|Overall Study|Adverse Event|1|||
160694993|NCT02989168|580265270|FG001|Overall Study|Adverse Event|2|||
160694994|NCT02989168|580265269|FG000|Overall Study|Sponsor stopped study.|1|||
160694995|NCT02989168|580265270|FG001|Overall Study|Sponsor stopped study.|0|||
160694996|NCT03456960|580265271|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
160694997|NCT03456960|580265272|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
160694998|NCT03456960|580265273|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
160694999|NCT03456960|580265274|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
160695000|NCT03456960|580265275|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
160695001|NCT03456960|580265276|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
160695002|NCT03456960|580265271|FG000|Period 2 (1 Day)|Adverse Event|1|||
160695003|NCT03456960|580265272|FG001|Period 2 (1 Day)|Adverse Event|0|||
160695004|NCT03456960|580265273|FG002|Period 2 (1 Day)|Adverse Event|0|||
160695005|NCT03456960|580265274|FG003|Period 2 (1 Day)|Adverse Event|1|||
160695006|NCT03456960|580265275|FG004|Period 2 (1 Day)|Adverse Event|0|||
160695007|NCT03456960|580265276|FG005|Period 2 (1 Day)|Adverse Event|0|||
160695008|NCT01940497|580265277|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
160695009|NCT01940497|580265278|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
160695010|NCT01940497|580265277|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
160695011|NCT01940497|580265278|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
160695012|NCT01940497|580265277|FG000|Overall Study|Violation of Entry Criteria|1|||
160695013|NCT01940497|580265278|FG001|Overall Study|Violation of Entry Criteria|1|||
160695014|NCT01940497|580265277|FG000|Overall Study|Refused Treatment|1|||
160695015|NCT01940497|580265278|FG001|Overall Study|Refused Treatment|3|||
160695016|NCT01940497|580265277|FG000|Overall Study|Withdrew Consent|6|||
160695017|NCT01940497|580265278|FG001|Overall Study|Withdrew Consent|2|||
160695018|NCT01940497|580265277|FG000|Overall Study|Administrative/Other|1|||
160695019|NCT01940497|580265278|FG001|Overall Study|Administrative/Other|1|||
160695020|NCT00502801|580265279|FG000|Treatment Period|Withdrawal by Subject|3|||
160695021|NCT00502801|580265279|FG000|Treatment Period|Adverse Event|7|||
160695022|NCT00502801|580265279|FG000|Treatment Period|Death|14|||
160695023|NCT00502801|580265279|FG000|Treatment Period|OTHER|30|||
160695024|NCT00502801|580265279|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
160695025|NCT00502801|580265279|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
160695026|NCT00502801|580265279|FG000|End of Therapy to Test of Cure|Death|3|||
160695027|NCT00502801|580265279|FG000|End of Therapy to Test of Cure|OTHER|2|||
160695028|NCT01195272|580265280|FG000|Overall Study|Adverse Event|1|||
160695029|NCT01195272|580265280|FG000|Overall Study|Lack of Efficacy|3|||
160695030|NCT01769339|580265281|FG000|Overall Study|Lost to Follow-up|42|||
160695031|NCT01769339|580265281|FG000|Overall Study|Adverse Event|1|||
160695032|NCT06218823|580267723|FG000|Overall Study|Death|3|||
160695033|NCT06218823|580267724|FG001|Overall Study|Death|0|||
160695034|NCT06218823|580267723|FG000|Overall Study|Lost to Follow-up|0|||
160695035|NCT06218823|580267724|FG001|Overall Study|Lost to Follow-up|2|||
160695036|NCT06077487|580267725|FG000|Overall Study|Withdrawal by Subject|0|||
160695037|NCT06077487|580267726|FG001|Overall Study|Withdrawal by Subject|1|||
160695038|NCT05101486|580267727|FG000|Overall Study|Death|1|||
160695039|NCT05101486|580267728|FG001|Overall Study|Death|0|||
160695040|NCT05101486|580267729|FG002|Overall Study|Death|1|||
160695041|NCT05101486|580267727|FG000|Overall Study|Lost to Follow-up|12|||
160695042|NCT05101486|580267728|FG001|Overall Study|Lost to Follow-up|8|||
160695043|NCT05101486|580267729|FG002|Overall Study|Lost to Follow-up|17|||
160695044|NCT05101486|580267727|FG000|Overall Study|Physician Decision|1|||
160695045|NCT05101486|580267728|FG001|Overall Study|Physician Decision|0|||
160695046|NCT05101486|580267729|FG002|Overall Study|Physician Decision|0|||
160695047|NCT05101486|580267727|FG000|Overall Study|Protocol Violation|0|||
160695048|NCT05101486|580267728|FG001|Overall Study|Protocol Violation|0|||
160695049|NCT05101486|580267729|FG002|Overall Study|Protocol Violation|1|||
160695050|NCT05101486|580267727|FG000|Overall Study|Withdrawal by Subject|5|||
160695051|NCT05101486|580267728|FG001|Overall Study|Withdrawal by Subject|2|||
160695052|NCT05101486|580267729|FG002|Overall Study|Withdrawal by Subject|4|||
160695053|NCT05101486|580267727|FG000|Overall Study|Randomized but not vaccinated|1|||
160695054|NCT05101486|580267728|FG001|Overall Study|Randomized but not vaccinated|1|||
160695055|NCT05101486|580267729|FG002|Overall Study|Randomized but not vaccinated|1|||
160695056|NCT02788045|580267730|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
160695057|NCT02788045|580267731|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
160695058|NCT02788045|580267732|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
160695059|NCT02788045|580267730|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
160695060|NCT02788045|580267731|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
160695061|NCT02788045|580267732|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
160695062|NCT02788045|580267730|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
160695063|NCT02788045|580267731|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
160695064|NCT02788045|580267732|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
160695065|NCT02788045|580267730|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
160695066|NCT02788045|580267731|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
160695067|NCT02788045|580267732|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
160695068|NCT02788045|580267730|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
160695069|NCT02788045|580267731|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
160695070|NCT02788045|580267732|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
160695071|NCT02788045|580267730|FG000|Main Study (Up to Week 72)|Other|3|||
160695072|NCT02788045|580267731|FG001|Main Study (Up to Week 72)|Other|0|||
160695073|NCT02788045|580267732|FG002|Main Study (Up to Week 72)|Other|0|||
160695074|NCT02788045|580267730|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
160695075|NCT02788045|580267731|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
160695076|NCT02788045|580267732|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
160695077|NCT02788045|580267730|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
160695078|NCT02788045|580267731|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
160695079|NCT02788045|580267732|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
160695080|NCT02788045|580267730|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
160695081|NCT02788045|580267731|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
160695082|NCT02788045|580267732|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
160695083|NCT02128217|580267743|FG000|Overall Study|Lost to Follow-up|0|||
160695084|NCT02128217|580267744|FG001|Overall Study|Lost to Follow-up|1|||
160695085|NCT05071313|580267745|FG000|Overall Study|Lost to Follow-up|17|||
160695086|NCT05071313|580267746|FG001|Overall Study|Lost to Follow-up|10|||
160695087|NCT05071313|580267745|FG000|Overall Study|Physician Decision|1|||
160695088|NCT05071313|580267746|FG001|Overall Study|Physician Decision|6|||
160695089|NCT05071313|580267745|FG000|Overall Study|Death|1|||
160695090|NCT05071313|580267746|FG001|Overall Study|Death|0|||
160695091|NCT05071313|580267745|FG000|Overall Study|Withdrawal by Subject|10|||
160695092|NCT05071313|580267746|FG001|Overall Study|Withdrawal by Subject|15|||
160695093|NCT05071313|580267745|FG000|Overall Study|Other|1|||
160695094|NCT05071313|580267746|FG001|Overall Study|Other|0|||
160695095|NCT05071313|580267745|FG000|Overall Study|Randomized but not vaccinated|4|||
160695096|NCT05071313|580267746|FG001|Overall Study|Randomized but not vaccinated|2|||
160695097|NCT00541970|580267747|FG000|Month 7|Protocol Violation|9|||
160695098|NCT00541970|580267748|FG001|Month 7|Protocol Violation|13|||
160695099|NCT00541970|580267749|FG002|Month 7|Protocol Violation|11|||
160695100|NCT00541970|580267750|FG003|Month 7|Protocol Violation|5|||
160695101|NCT00541970|580267747|FG000|Month 12|Adverse Event|0|||
160695102|NCT00541970|580267748|FG001|Month 12|Adverse Event|1|||
160695103|NCT00541970|580267749|FG002|Month 12|Adverse Event|1|||
160695104|NCT00541970|580267750|FG003|Month 12|Adverse Event|1|||
160695105|NCT00541970|580267747|FG000|Month 12|Protocol Violation|12|||
160695106|NCT00541970|580267748|FG001|Month 12|Protocol Violation|21|||
160695107|NCT00541970|580267749|FG002|Month 12|Protocol Violation|20|||
160695108|NCT00541970|580267750|FG003|Month 12|Protocol Violation|15|||
160695109|NCT00541970|580267747|FG000|Month 18|Adverse Event|0|||
160695110|NCT00541970|580267748|FG001|Month 18|Adverse Event|1|||
160695111|NCT00541970|580267749|FG002|Month 18|Adverse Event|1|||
160695112|NCT00541970|580267750|FG003|Month 18|Adverse Event|1|||
160695113|NCT00541970|580267747|FG000|Month 18|Protocol Violation|14|||
160695114|NCT00541970|580267748|FG001|Month 18|Protocol Violation|23|||
160695115|NCT00541970|580267749|FG002|Month 18|Protocol Violation|24|||
160695116|NCT00541970|580267750|FG003|Month 18|Protocol Violation|16|||
160695117|NCT00541970|580267747|FG000|Month 24|Adverse Event|0|||
160695118|NCT00541970|580267748|FG001|Month 24|Adverse Event|1|||
160695119|NCT00541970|580267749|FG002|Month 24|Adverse Event|1|||
160695120|NCT00541970|580267750|FG003|Month 24|Adverse Event|1|||
160695121|NCT00541970|580267747|FG000|Month 24|Protocol Violation|29|||
160695122|NCT00541970|580267748|FG001|Month 24|Protocol Violation|31|||
160695123|NCT00541970|580267749|FG002|Month 24|Protocol Violation|31|||
160695124|NCT00541970|580267750|FG003|Month 24|Protocol Violation|21|||
160695125|NCT00541970|580267747|FG000|Month 36|Protocol Violation|61|||
160695126|NCT00541970|580267748|FG001|Month 36|Protocol Violation|66|||
160695127|NCT00541970|580267749|FG002|Month 36|Protocol Violation|66|||
160695128|NCT00541970|580267750|FG003|Month 36|Protocol Violation|60|||
160695129|NCT00541970|580267747|FG000|Month 48|Withdrawal by Subject|2|||
160695130|NCT00541970|580267748|FG001|Month 48|Withdrawal by Subject|4|||
160695131|NCT00541970|580267749|FG002|Month 48|Withdrawal by Subject|4|||
160695132|NCT00541970|580267750|FG003|Month 48|Withdrawal by Subject|2|||
160695133|NCT00541970|580267747|FG000|Month 48|Other|3|||
160695134|NCT00541970|580267748|FG001|Month 48|Other|1|||
160695135|NCT00541970|580267749|FG002|Month 48|Other|1|||
160695136|NCT00541970|580267750|FG003|Month 48|Other|0|||
160695137|NCT00541970|580267747|FG000|Month 48|Lost to Follow-up|66|||
160695138|NCT00541970|580267748|FG001|Month 48|Lost to Follow-up|68|||
160695139|NCT00541970|580267749|FG002|Month 48|Lost to Follow-up|68|||
160695140|NCT00541970|580267750|FG003|Month 48|Lost to Follow-up|73|||
160695141|NCT00541970|580267747|FG000|Month 60|Protocol Violation|78|||
160695142|NCT00541970|580267748|FG001|Month 60|Protocol Violation|77|||
160695143|NCT00541970|580267749|FG002|Month 60|Protocol Violation|82|||
160695144|NCT00541970|580267750|FG003|Month 60|Protocol Violation|72|||
160695145|NCT03107026|580267751|FG000|Overall Study|Adverse Event|2|||
160695146|NCT03107026|580267752|FG001|Overall Study|Adverse Event|14|||
160695147|NCT03107026|580267753|FG002|Overall Study|Adverse Event|23|||
160695148|NCT03107026|580267751|FG000|Overall Study|Lost to Follow-up|12|||
160695149|NCT03107026|580267752|FG001|Overall Study|Lost to Follow-up|12|||
160695150|NCT03107026|580267753|FG002|Overall Study|Lost to Follow-up|13|||
160695151|NCT03107026|580267751|FG000|Overall Study|Protocol Violation|1|||
160695152|NCT03107026|580267752|FG001|Overall Study|Protocol Violation|2|||
160695153|NCT03107026|580267753|FG002|Overall Study|Protocol Violation|0|||
160695154|NCT03107026|580267751|FG000|Overall Study|Pregnancy|1|||
160695155|NCT03107026|580267752|FG001|Overall Study|Pregnancy|0|||
160695156|NCT03107026|580267753|FG002|Overall Study|Pregnancy|0|||
160695157|NCT03107026|580267751|FG000|Overall Study|Withdrawal by Subject|13|||
160695158|NCT03107026|580267752|FG001|Overall Study|Withdrawal by Subject|5|||
160695159|NCT03107026|580267753|FG002|Overall Study|Withdrawal by Subject|17|||
160695160|NCT03107026|580267751|FG000|Overall Study|non compliance with study visits|1|||
160695161|NCT03107026|580267752|FG001|Overall Study|non compliance with study visits|2|||
160695162|NCT03107026|580267753|FG002|Overall Study|non compliance with study visits|0|||
160695163|NCT03107026|580267751|FG000|Overall Study|non-compliance with study drug|2|||
160695164|NCT03107026|580267752|FG001|Overall Study|non-compliance with study drug|2|||
160695165|NCT03107026|580267753|FG002|Overall Study|non-compliance with study drug|3|||
160695166|NCT03107026|580267751|FG000|Overall Study|Physician Decision|0|||
160695167|NCT03107026|580267752|FG001|Overall Study|Physician Decision|1|||
160695168|NCT03107026|580267753|FG002|Overall Study|Physician Decision|0|||
160695169|NCT00210249|580267756|FG000|Overall Study|Lost to Follow-up|5|||
160695170|NCT00210249|580267756|FG000|Overall Study|Protocol Violation|11|||
160695171|NCT04280705|580267757|FG000|Overall Study|Enrolled but not treated|4|||
160695172|NCT04280705|580267758|FG001|Overall Study|Enrolled but not treated|10|||
160695173|NCT04280705|580267757|FG000|Overall Study|Physician Decision|1|||
160695174|NCT04280705|580267758|FG001|Overall Study|Physician Decision|0|||
160695175|NCT04280705|580267757|FG000|Overall Study|Withdrawal by Subject|7|||
160695176|NCT04280705|580267758|FG001|Overall Study|Withdrawal by Subject|9|||
160695177|NCT04280705|580267757|FG000|Overall Study|Adverse Event|0|||
160695178|NCT04280705|580267758|FG001|Overall Study|Adverse Event|4|||
160695179|NCT04280705|580267757|FG000|Overall Study|Transferred to another hospital|1|||
160695180|NCT04280705|580267758|FG001|Overall Study|Transferred to another hospital|1|||
160695181|NCT03222583|580267759|FG000|Overall Study|Withdrawal by Subject|3|||
160695182|NCT03222583|580267760|FG001|Overall Study|Withdrawal by Subject|3|||
160695183|NCT03222583|580267759|FG000|Overall Study|Lost to Follow-up|1|||
160695184|NCT03222583|580267760|FG001|Overall Study|Lost to Follow-up|0|||
160695185|NCT03222583|580267759|FG000|Overall Study|Other|1|||
160695186|NCT03222583|580267760|FG001|Overall Study|Other|3|||
160695187|NCT02492880|580267761|FG000|Overall Study|Lost to Follow-up|1|||
160695188|NCT02492880|580267761|FG000|Overall Study|Protocol Violation|1|||
160695189|NCT01200992|580267762|FG000|Overall Study|Study terminated early|35|||
160695190|NCT01200992|580267763|FG001|Overall Study|Study terminated early|41|||
160695191|NCT01200992|580267762|FG000|Overall Study|Randomized but not treated|2|||
160695192|NCT01200992|580267763|FG001|Overall Study|Randomized but not treated|0|||
160695193|NCT00667810|580267764|FG000|Overall Study|Adverse Event|13|||
160695194|NCT00667810|580267765|FG001|Overall Study|Adverse Event|14|||
160695195|NCT00667810|580267766|FG002|Overall Study|Adverse Event|19|||
160695196|NCT00667810|580267767|FG003|Overall Study|Adverse Event|1|||
160695197|NCT00667810|580267764|FG000|Overall Study|Death|1|||
160695198|NCT00667810|580267765|FG001|Overall Study|Death|1|||
160695199|NCT00667810|580267766|FG002|Overall Study|Death|3|||
160695200|NCT00667810|580267767|FG003|Overall Study|Death|0|||
160695201|NCT00667810|580267764|FG000|Overall Study|Lack of Efficacy|1|||
160695202|NCT00667810|580267765|FG001|Overall Study|Lack of Efficacy|0|||
160695203|NCT00667810|580267766|FG002|Overall Study|Lack of Efficacy|2|||
160695204|NCT00667810|580267767|FG003|Overall Study|Lack of Efficacy|0|||
160695205|NCT00667810|580267764|FG000|Overall Study|Lost to Follow-up|1|||
160695206|NCT00667810|580267765|FG001|Overall Study|Lost to Follow-up|4|||
160695207|NCT00667810|580267766|FG002|Overall Study|Lost to Follow-up|2|||
160695208|NCT00667810|580267767|FG003|Overall Study|Lost to Follow-up|0|||
160695209|NCT00667810|580267764|FG000|Overall Study|Physician Decision|1|||
160695210|NCT00667810|580267765|FG001|Overall Study|Physician Decision|1|||
160695211|NCT00667810|580267766|FG002|Overall Study|Physician Decision|2|||
160695212|NCT00667810|580267767|FG003|Overall Study|Physician Decision|0|||
160695213|NCT00667810|580267764|FG000|Overall Study|Protocol Violation|0|||
160695214|NCT00667810|580267765|FG001|Overall Study|Protocol Violation|2|||
160695215|NCT00667810|580267766|FG002|Overall Study|Protocol Violation|0|||
160695216|NCT00667810|580267767|FG003|Overall Study|Protocol Violation|0|||
160695217|NCT00667810|580267764|FG000|Overall Study|Withdrawal by Subject|14|||
160695218|NCT00667810|580267765|FG001|Overall Study|Withdrawal by Subject|20|||
160695219|NCT00667810|580267766|FG002|Overall Study|Withdrawal by Subject|29|||
160695220|NCT00667810|580267767|FG003|Overall Study|Withdrawal by Subject|1|||
160695221|NCT00667810|580267764|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
160695222|NCT00667810|580267765|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
160695223|NCT00667810|580267766|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
160695224|NCT00667810|580267767|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
160695225|NCT00667810|580267764|FG000|Overall Study|Failed to Return|0|||
160695226|NCT00667810|580267765|FG001|Overall Study|Failed to Return|0|||
160695227|NCT00667810|580267766|FG002|Overall Study|Failed to Return|2|||
160695228|NCT00667810|580267767|FG003|Overall Study|Failed to Return|0|||
160695229|NCT00667810|580267764|FG000|Overall Study|Loss of Caregiver|0|||
160695230|NCT00667810|580267765|FG001|Overall Study|Loss of Caregiver|1|||
160695231|NCT00667810|580267766|FG002|Overall Study|Loss of Caregiver|3|||
160695232|NCT00667810|580267767|FG003|Overall Study|Loss of Caregiver|0|||
160695233|NCT00667810|580267764|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
160695234|NCT00667810|580267765|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
160695235|NCT00667810|580267766|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
160695236|NCT00667810|580267767|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
160695237|NCT00667810|580267764|FG000|Overall Study|Other|6|||
160695238|NCT00667810|580267765|FG001|Overall Study|Other|6|||
160695239|NCT00667810|580267766|FG002|Overall Study|Other|5|||
160695240|NCT00667810|580267767|FG003|Overall Study|Other|0|||
160695241|NCT01570686|580267770|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160695242|NCT01570686|580267771|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160695243|NCT01570686|580267770|FG000|Overall Study|Administrative problems|0|||
160695244|NCT01570686|580267771|FG001|Overall Study|Administrative problems|1|||
160695245|NCT01570686|580267770|FG000|Overall Study|Adverse Event|8|||
160695246|NCT01570686|580267771|FG001|Overall Study|Adverse Event|6|||
160695247|NCT01570686|580267770|FG000|Overall Study|Lost to Follow-up|4|||
160695248|NCT01570686|580267771|FG001|Overall Study|Lost to Follow-up|3|||
160695249|NCT01570686|580267770|FG000|Overall Study|Protocol Deviation|3|||
160695250|NCT01570686|580267771|FG001|Overall Study|Protocol Deviation|0|||
160695251|NCT01570686|580267770|FG000|Overall Study|Withdrawal by Subject|4|||
160695252|NCT01570686|580267771|FG001|Overall Study|Withdrawal by Subject|4|||
160695253|NCT01570686|580267770|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160695254|NCT01570686|580267771|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160695255|NCT00754650|580267772|FG000|Overall Study|Disease Progression|2|||
160695256|NCT02227147|580267779|FG000|Controlled Treatment Period|Adverse Event|4|||
160695257|NCT02227147|580267780|FG001|Controlled Treatment Period|Adverse Event|3|||
160695258|NCT02227147|580267779|FG000|Controlled Treatment Period|Other|2|||
160695259|NCT02227147|580267780|FG001|Controlled Treatment Period|Other|0|||
160695260|NCT02227147|580267779|FG000|Follow-up Period|Other|3|||
160695261|NCT02227147|580267780|FG001|Follow-up Period|Other|5|||
160695262|NCT04234984|580267793|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
160695263|NCT04234984|580267793|FG000|Follow-up at the Second Time Point|Death|1|||
160695264|NCT04234984|580267793|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
160695265|NCT01055132|580267794|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
160695266|NCT01055132|580267795|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
160695267|NCT01055132|580267794|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
160695268|NCT01055132|580267795|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
160695269|NCT00158600|580267796|FG000|Overall Study|unable to commit time to study|0|||
160695270|NCT00158600|580267797|FG001|Overall Study|unable to commit time to study|1|||
160695271|NCT00158600|580267796|FG000|Overall Study|Adverse Event|2|||
160695272|NCT00158600|580267797|FG001|Overall Study|Adverse Event|1|||
160695273|NCT00158600|580267796|FG000|Overall Study|Death|1|||
160695274|NCT00158600|580267797|FG001|Overall Study|Death|0|||
160695275|NCT00158600|580267796|FG000|Overall Study|Withdrawal by Subject|2|||
160695276|NCT00158600|580267797|FG001|Overall Study|Withdrawal by Subject|2|||
160695277|NCT02570113|580267798|FG000|Overall Study|Withdrawal by Subject|3|||
160695278|NCT02038907|580267799|FG000|Overall Study|Protocol Violation|0|||
160695279|NCT02038907|580267800|FG001|Overall Study|Protocol Violation|0|||
160695280|NCT02038907|580267801|FG002|Overall Study|Protocol Violation|0|||
160695281|NCT02038907|580267802|FG003|Overall Study|Protocol Violation|0|||
160695282|NCT02038907|580267803|FG004|Overall Study|Protocol Violation|0|||
160695283|NCT02038907|580267804|FG005|Overall Study|Protocol Violation|0|||
160695284|NCT02038907|580267805|FG006|Overall Study|Protocol Violation|0|||
160695285|NCT02038907|580267806|FG007|Overall Study|Protocol Violation|0|||
160695286|NCT02038907|580267807|FG008|Overall Study|Protocol Violation|0|||
160695287|NCT02038907|580267808|FG009|Overall Study|Protocol Violation|0|||
160695288|NCT02038907|580267809|FG010|Overall Study|Protocol Violation|1|||
160695289|NCT02038907|580267810|FG011|Overall Study|Protocol Violation|0|||
160695290|NCT02038907|580267811|FG012|Overall Study|Protocol Violation|0|||
160695291|NCT02038907|580267812|FG013|Overall Study|Protocol Violation|0|||
160695292|NCT02038907|580267799|FG000|Overall Study|Withdrawal by Subject|0|||
160695293|NCT02038907|580267800|FG001|Overall Study|Withdrawal by Subject|0|||
160695294|NCT02038907|580267801|FG002|Overall Study|Withdrawal by Subject|0|||
160695295|NCT02038907|580267802|FG003|Overall Study|Withdrawal by Subject|0|||
160695296|NCT02038907|580267803|FG004|Overall Study|Withdrawal by Subject|0|||
160695297|NCT02038907|580267804|FG005|Overall Study|Withdrawal by Subject|0|||
160695298|NCT02038907|580267805|FG006|Overall Study|Withdrawal by Subject|0|||
160695299|NCT02038907|580267806|FG007|Overall Study|Withdrawal by Subject|0|||
160695300|NCT02038907|580267807|FG008|Overall Study|Withdrawal by Subject|0|||
160695301|NCT02038907|580267808|FG009|Overall Study|Withdrawal by Subject|0|||
160695302|NCT02038907|580267809|FG010|Overall Study|Withdrawal by Subject|1|||
160695303|NCT02038907|580267810|FG011|Overall Study|Withdrawal by Subject|0|||
160695304|NCT02038907|580267811|FG012|Overall Study|Withdrawal by Subject|0|||
160695305|NCT02038907|580267812|FG013|Overall Study|Withdrawal by Subject|0|||
160695306|NCT02746471|580267813|FG000|Overall Study|Death|43|||
160695307|NCT02746471|580267813|FG000|Overall Study|Exited before 36 months|1119|||
160695308|NCT02564211|580267814|FG000|Overall Study|Adverse Event|4|||
160695309|NCT00910091|580267816|FG000|Pre-assignment|Withdrawal by Subject|0|||
160695310|NCT00910091|580267817|FG001|Pre-assignment|Withdrawal by Subject|2|||
160695311|NCT00910091|580267816|FG000|Treatment and Survival|Withdrawal by Subject|3|||
160695312|NCT00910091|580267817|FG001|Treatment and Survival|Withdrawal by Subject|4|||
160695313|NCT00910091|580267816|FG000|Treatment and Survival|Adverse Event|1|||
160695314|NCT00910091|580267817|FG001|Treatment and Survival|Adverse Event|0|||
160695315|NCT01908816|580267820|FG000|Overall Study|Subject's no longer requires study drug|0|||
160695316|NCT01908816|580267821|FG001|Overall Study|Subject's no longer requires study drug|0|||
160695317|NCT01908816|580267822|FG002|Overall Study|Subject's no longer requires study drug|0|||
160695318|NCT01908816|580267823|FG003|Overall Study|Subject's no longer requires study drug|1|||
160695319|NCT01908816|580267820|FG000|Overall Study|Protocol deviation|1|||
160695320|NCT01908816|580267821|FG001|Overall Study|Protocol deviation|2|||
160695321|NCT01908816|580267822|FG002|Overall Study|Protocol deviation|1|||
160695322|NCT01908816|580267823|FG003|Overall Study|Protocol deviation|1|||
160695323|NCT01908816|580267820|FG000|Overall Study|Withdrawal by Subject|0|||
160695324|NCT01908816|580267821|FG001|Overall Study|Withdrawal by Subject|4|||
160695325|NCT01908816|580267822|FG002|Overall Study|Withdrawal by Subject|2|||
160695326|NCT01908816|580267823|FG003|Overall Study|Withdrawal by Subject|2|||
160695327|NCT01908816|580267820|FG000|Overall Study|Lost to Follow-up|3|||
160695328|NCT01908816|580267821|FG001|Overall Study|Lost to Follow-up|5|||
160695329|NCT01908816|580267822|FG002|Overall Study|Lost to Follow-up|4|||
160695330|NCT01908816|580267823|FG003|Overall Study|Lost to Follow-up|2|||
160695331|NCT01908816|580267820|FG000|Overall Study|Death|1|||
160695332|NCT01908816|580267821|FG001|Overall Study|Death|0|||
160695333|NCT01908816|580267822|FG002|Overall Study|Death|7|||
160695334|NCT01908816|580267823|FG003|Overall Study|Death|1|||
160695335|NCT01908816|580267820|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160695336|NCT01908816|580267821|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
160695337|NCT01908816|580267822|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
160695338|NCT01908816|580267823|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
160695339|NCT01908816|580267820|FG000|Overall Study|Early termination|87|||
160695340|NCT01908816|580267821|FG001|Overall Study|Early termination|60|||
160695341|NCT01908816|580267822|FG002|Overall Study|Early termination|43|||
160695342|NCT01908816|580267823|FG003|Overall Study|Early termination|28|||
160695343|NCT05183217|580267824|FG000|Overall Study|Withdrawal by Subject|1|||
160695344|NCT05183217|580267825|FG001|Overall Study|Withdrawal by Subject|1|||
160695345|NCT02524730|580267826|FG000|Overall Study|Lost to Follow-up|5|||
160695346|NCT02524730|580267826|FG000|Overall Study|Withdrawal by Subject|18|||
160695347|NCT02524730|580267826|FG000|Overall Study|Death|10|||
160695348|NCT02524730|580267826|FG000|Overall Study|Adverse Event|8|||
160695349|NCT02524730|580267826|FG000|Overall Study|Protocol Violation|1|||
160695350|NCT02524730|580267826|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
160695351|NCT00507130|580267827|FG000|Overall Study|Lost to Follow-up|0|||
160695352|NCT00507130|580267828|FG001|Overall Study|Lost to Follow-up|0|||
160695353|NCT00507130|580267829|FG002|Overall Study|Lost to Follow-up|1|||
160695354|NCT00507130|580267830|FG003|Overall Study|Lost to Follow-up|1|||
160695355|NCT00507130|580267827|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
160695356|NCT00507130|580267828|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
160695357|NCT00507130|580267829|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
160695358|NCT00507130|580267830|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
160695359|NCT03283761|580267844|FG000|Study Treatment|Patient Non-Compliance|1|||
160695360|NCT03283761|580267844|FG000|Study Treatment|Alternative Cancer Therapy|7|||
160695361|NCT03283761|580267844|FG000|Study Treatment|Disease progression|21|||
160695362|NCT03283761|580267844|FG000|Study Treatment|Adverse Event|3|||
160695363|NCT03283761|580267844|FG000|Study Treatment|Withdrawal by Subject|4|||
160695364|NCT03283761|580267844|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
160695365|NCT03283761|580267844|FG000|Study Treatment|Symptomatic Deterioration|1|||
160695366|NCT03283761|580267844|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
160695367|NCT03283761|580267844|FG000|Follow up|Lost to Follow-up|1|||
160695368|NCT03283761|580267844|FG000|Follow up|Symptomatic Deterioration|1|||
160695369|NCT03283761|580267844|FG000|Follow up|Death|29|||
160695370|NCT03283761|580267844|FG000|Follow up|study terminated|4|||
160695371|NCT03283761|580267844|FG000|Follow up|Primary Investigator Withdrawal|1|||
160695372|NCT03283761|580267844|FG000|Follow up|Switched to alternative therapy|1|||
160695373|NCT03283761|580267844|FG000|Follow up|Subject is now in Hospice|1|||
160695374|NCT04453202|580267849|FG000|Overall Study|Adverse Event|0|||
160695375|NCT04453202|580267850|FG001|Overall Study|Adverse Event|0|||
160695376|NCT04453202|580267851|FG002|Overall Study|Adverse Event|0|||
160695377|NCT04453202|580267852|FG003|Overall Study|Adverse Event|0|||
160695378|NCT04453202|580267853|FG004|Overall Study|Adverse Event|0|||
160695379|NCT04453202|580267854|FG005|Overall Study|Adverse Event|0|||
160695380|NCT04453202|580267855|FG006|Overall Study|Adverse Event|1|||
160695381|NCT04453202|580267856|FG007|Overall Study|Adverse Event|0|||
160695382|NCT04453202|580267857|FG008|Overall Study|Adverse Event|0|||
160695383|NCT04453202|580267858|FG009|Overall Study|Adverse Event|0|||
160695384|NCT04453202|580267859|FG010|Overall Study|Adverse Event|0|||
160695385|NCT04453202|580267849|FG000|Overall Study|Death|0|||
160695386|NCT04453202|580267850|FG001|Overall Study|Death|0|||
160695387|NCT04453202|580267851|FG002|Overall Study|Death|0|||
160695388|NCT04453202|580267852|FG003|Overall Study|Death|0|||
160695389|NCT04453202|580267853|FG004|Overall Study|Death|0|||
160695390|NCT04453202|580267854|FG005|Overall Study|Death|0|||
160695391|NCT04453202|580267855|FG006|Overall Study|Death|0|||
160695392|NCT04453202|580267856|FG007|Overall Study|Death|0|||
160695393|NCT04453202|580267857|FG008|Overall Study|Death|0|||
160695394|NCT04453202|580267858|FG009|Overall Study|Death|1|||
160695395|NCT04453202|580267859|FG010|Overall Study|Death|0|||
160695396|NCT04453202|580267849|FG000|Overall Study|Lost to Follow-up|0|||
160695397|NCT04453202|580267850|FG001|Overall Study|Lost to Follow-up|1|||
160695398|NCT04453202|580267851|FG002|Overall Study|Lost to Follow-up|0|||
160695399|NCT04453202|580267852|FG003|Overall Study|Lost to Follow-up|1|||
160695400|NCT04453202|580267853|FG004|Overall Study|Lost to Follow-up|0|||
160695401|NCT04453202|580267854|FG005|Overall Study|Lost to Follow-up|0|||
160695402|NCT04453202|580267855|FG006|Overall Study|Lost to Follow-up|0|||
160695403|NCT04453202|580267856|FG007|Overall Study|Lost to Follow-up|0|||
160695404|NCT04453202|580267857|FG008|Overall Study|Lost to Follow-up|0|||
160695405|NCT04453202|580267858|FG009|Overall Study|Lost to Follow-up|1|||
160695406|NCT04453202|580267859|FG010|Overall Study|Lost to Follow-up|1|||
160695407|NCT04453202|580267849|FG000|Overall Study|Withdrawal by Subject|1|||
160695408|NCT04453202|580267850|FG001|Overall Study|Withdrawal by Subject|2|||
160695409|NCT04453202|580267851|FG002|Overall Study|Withdrawal by Subject|1|||
160695410|NCT04453202|580267852|FG003|Overall Study|Withdrawal by Subject|2|||
160695411|NCT04453202|580267853|FG004|Overall Study|Withdrawal by Subject|1|||
160695412|NCT04453202|580267854|FG005|Overall Study|Withdrawal by Subject|1|||
160695413|NCT04453202|580267855|FG006|Overall Study|Withdrawal by Subject|0|||
160695414|NCT04453202|580267856|FG007|Overall Study|Withdrawal by Subject|0|||
160695415|NCT04453202|580267857|FG008|Overall Study|Withdrawal by Subject|0|||
160695416|NCT04453202|580267858|FG009|Overall Study|Withdrawal by Subject|1|||
160695417|NCT04453202|580267859|FG010|Overall Study|Withdrawal by Subject|0|||
160695418|NCT04453202|580267849|FG000|Overall Study|Adverse Event|0|||
160695419|NCT04453202|580267850|FG001|Overall Study|Adverse Event|0|||
160695420|NCT04453202|580267851|FG002|Overall Study|Adverse Event|0|||
160695421|NCT04453202|580267852|FG003|Overall Study|Adverse Event|0|||
160695422|NCT04453202|580267853|FG004|Overall Study|Adverse Event|0|||
160695423|NCT04453202|580267854|FG005|Overall Study|Adverse Event|1|||
160695424|NCT04453202|580267855|FG006|Overall Study|Adverse Event|0|||
160695425|NCT04453202|580267856|FG007|Overall Study|Adverse Event|0|||
160695426|NCT04453202|580267857|FG008|Overall Study|Adverse Event|0|||
160695427|NCT04453202|580267858|FG009|Overall Study|Adverse Event|0|||
160695428|NCT04453202|580267859|FG010|Overall Study|Adverse Event|0|||
160695429|NCT01355159|580267864|FG000|Overall Study|Withdrew consent|39|||
160695430|NCT01355159|580267865|FG001|Overall Study|Withdrew consent|47|||
160695431|NCT01355159|580267864|FG000|Overall Study|No primary outcome data|17|||
160695432|NCT01355159|580267865|FG001|Overall Study|No primary outcome data|11|||
160695433|NCT01355159|580267864|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
160695434|NCT01355159|580267865|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
160695435|NCT01355159|580267864|FG000|Overall Study|Early intrauterine fetal death|6|||
160695436|NCT01355159|580267865|FG001|Overall Study|Early intrauterine fetal death|6|||
160695437|NCT03276221|580267866|FG000|Overall Study|Lost to Follow-up|6|||
160695438|NCT03276221|580267867|FG001|Overall Study|Lost to Follow-up|2|||
160695439|NCT03276221|580267868|FG002|Overall Study|Lost to Follow-up|0|||
160695440|NCT03276221|580267866|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
160695441|NCT03276221|580267867|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
160695442|NCT03276221|580267868|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
160695443|NCT00424775|580267869|FG000|Overall Study|Adverse Event|2|||
160695444|NCT00424775|580267870|FG001|Overall Study|Adverse Event|0|||
160695445|NCT00424775|580267869|FG000|Overall Study|Lack of Efficacy|1|||
160695446|NCT00424775|580267870|FG001|Overall Study|Lack of Efficacy|0|||
160695447|NCT00975286|580267873|FG000|Overall Study|Adverse Event|9|||
160695448|NCT00975286|580267874|FG001|Overall Study|Adverse Event|19|||
160695449|NCT00975286|580267873|FG000|Overall Study|Protocol Violation|1|||
160695450|NCT00975286|580267874|FG001|Overall Study|Protocol Violation|2|||
160695451|NCT00975286|580267873|FG000|Overall Study|Withdrawal by Subject|0|||
160695452|NCT00975286|580267874|FG001|Overall Study|Withdrawal by Subject|2|||
160695453|NCT00975286|580267873|FG000|Overall Study|Familial and Personal Reasons|2|||
160695454|NCT00975286|580267874|FG001|Overall Study|Familial and Personal Reasons|2|||
160695455|NCT00975286|580267873|FG000|Overall Study|Poor Compliance to Protocol|0|||
160695456|NCT00975286|580267874|FG001|Overall Study|Poor Compliance to Protocol|2|||
160695457|NCT00975286|580267873|FG000|Overall Study|Sponsor Decision|0|||
160695458|NCT00975286|580267874|FG001|Overall Study|Sponsor Decision|2|||
160695459|NCT00741936|580267876|FG000|Overall Study|Lost to Follow-up|1|||
160695460|NCT00741936|580267877|FG001|Overall Study|Lost to Follow-up|1|||
160695461|NCT00741936|580267876|FG000|Overall Study|Adverse Event|3|||
160695462|NCT00741936|580267877|FG001|Overall Study|Adverse Event|4|||
160695463|NCT00741936|580267876|FG000|Overall Study|Pregnancy|0|||
160695464|NCT00741936|580267877|FG001|Overall Study|Pregnancy|1|||
160695465|NCT00741936|580267876|FG000|Overall Study|Protocol Violation|2|||
160695466|NCT00741936|580267877|FG001|Overall Study|Protocol Violation|0|||
160695467|NCT00741936|580267876|FG000|Overall Study|Lack of Efficacy|0|||
160695468|NCT00741936|580267877|FG001|Overall Study|Lack of Efficacy|2|||
160695469|NCT00741936|580267876|FG000|Overall Study|Low compliance|3|||
160695470|NCT00741936|580267877|FG001|Overall Study|Low compliance|0|||
160695471|NCT01941940|580267878|FG000|Overall Study|Adverse Event|11|||
160695472|NCT01941940|580267878|FG000|Overall Study|Lost to Follow-up|2|||
160695473|NCT01941940|580267878|FG000|Overall Study|Physician Decision|2|||
160695474|NCT01941940|580267878|FG000|Overall Study|Withdrawal by Subject|15|||
160695475|NCT01941940|580267878|FG000|Overall Study|Death|1|||
160695476|NCT01941940|580267878|FG000|Overall Study|Other|1|||
160695477|NCT01941940|580267878|FG000|Overall Study|Other|1|||
160695478|NCT00532935|580267879|FG000|Overall Study|Adverse Event|11|||
160695479|NCT00532935|580267880|FG001|Overall Study|Adverse Event|12|||
160695480|NCT00532935|580267879|FG000|Overall Study|Lack of Efficacy|0|||
160695481|NCT00532935|580267880|FG001|Overall Study|Lack of Efficacy|3|||
160695482|NCT00532935|580267879|FG000|Overall Study|Lost to Follow-up|10|||
160695483|NCT00532935|580267880|FG001|Overall Study|Lost to Follow-up|6|||
160695484|NCT00532935|580267879|FG000|Overall Study|Physician Decision|4|||
160695485|NCT00532935|580267880|FG001|Overall Study|Physician Decision|5|||
160695486|NCT00532935|580267879|FG000|Overall Study|Pregnancy|1|||
160695487|NCT00532935|580267880|FG001|Overall Study|Pregnancy|0|||
160695488|NCT00532935|580267879|FG000|Overall Study|Protocol Violation|4|||
160695489|NCT00532935|580267880|FG001|Overall Study|Protocol Violation|2|||
160695490|NCT00532935|580267879|FG000|Overall Study|Withdrawal by Subject|10|||
160695491|NCT00532935|580267880|FG001|Overall Study|Withdrawal by Subject|9|||
160695492|NCT00532935|580267879|FG000|Overall Study|Protocol Specific Criteria|11|||
160695493|NCT00532935|580267880|FG001|Overall Study|Protocol Specific Criteria|15|||
160695494|NCT03212521|580267883|FG000|Overall Study|Adverse Event|1|||
160695495|NCT03212521|580267883|FG000|Overall Study|Lost to Follow-up|4|||
160695496|NCT03212521|580267883|FG000|Overall Study|Withdrawal by Subject|1|||
160695497|NCT03212521|580267883|FG000|Overall Study|Other|1|||
160695498|NCT00914459|580267886|FG000|Overall Study|Protocol Violation|0|||
160695499|NCT00914459|580267887|FG001|Overall Study|Protocol Violation|1|||
160695500|NCT00914459|580267886|FG000|Overall Study|Parent/Legal guardian request|1|||
160695501|NCT00914459|580267887|FG001|Overall Study|Parent/Legal guardian request|0|||
160695502|NCT03176459|580267888|FG000|Overall Study|Lost to Follow-up|5|||
160695503|NCT03176459|580267889|FG001|Overall Study|Lost to Follow-up|7|||
160695504|NCT01661179|580267890|FG000|Overall Study|Death|1|||
160695505|NCT01661179|580267890|FG000|Overall Study|Withdrawal by Subject|1|||
160695506|NCT01661179|580267890|FG000|Overall Study|Other Eligibility criteria|4|||
160695507|NCT01083810|580267891|FG000|Overall Study|Lost to Follow-up|23|||
160695508|NCT01083810|580267892|FG001|Overall Study|Lost to Follow-up|11|||
160695509|NCT01083810|580267893|FG002|Overall Study|Lost to Follow-up|4|||
160695510|NCT01083810|580267891|FG000|Overall Study|Adverse Event|15|||
160695511|NCT01083810|580267892|FG001|Overall Study|Adverse Event|11|||
160695512|NCT01083810|580267893|FG002|Overall Study|Adverse Event|4|||
160695513|NCT01083810|580267891|FG000|Overall Study|Withdrawal by Subject|7|||
160695514|NCT01083810|580267892|FG001|Overall Study|Withdrawal by Subject|2|||
160695515|NCT01083810|580267893|FG002|Overall Study|Withdrawal by Subject|4|||
160695516|NCT01083810|580267891|FG000|Overall Study|Reason not reported|6|||
160695517|NCT01083810|580267892|FG001|Overall Study|Reason not reported|1|||
160695518|NCT01083810|580267893|FG002|Overall Study|Reason not reported|1|||
160695519|NCT01083810|580267891|FG000|Overall Study|Non-compliance|4|||
160695520|NCT01083810|580267892|FG001|Overall Study|Non-compliance|7|||
160695521|NCT01083810|580267893|FG002|Overall Study|Non-compliance|2|||
160695522|NCT01083810|580267891|FG000|Overall Study|Simplification|4|||
160695523|NCT01083810|580267892|FG001|Overall Study|Simplification|1|||
160695524|NCT01083810|580267893|FG002|Overall Study|Simplification|0|||
160695525|NCT01083810|580267891|FG000|Overall Study|Death|2|||
160695526|NCT01083810|580267892|FG001|Overall Study|Death|2|||
160695527|NCT01083810|580267893|FG002|Overall Study|Death|3|||
160695528|NCT01083810|580267891|FG000|Overall Study|Co-morbidities|1|||
160695529|NCT01083810|580267892|FG001|Overall Study|Co-morbidities|0|||
160695530|NCT01083810|580267893|FG002|Overall Study|Co-morbidities|0|||
160695531|NCT01083810|580267891|FG000|Overall Study|Participation in study|1|||
160695532|NCT01083810|580267892|FG001|Overall Study|Participation in study|0|||
160695533|NCT01083810|580267893|FG002|Overall Study|Participation in study|0|||
160695534|NCT01083810|580267891|FG000|Overall Study|Therapy break|1|||
160695535|NCT01083810|580267892|FG001|Overall Study|Therapy break|2|||
160695536|NCT01083810|580267893|FG002|Overall Study|Therapy break|2|||
160695537|NCT01083810|580267891|FG000|Overall Study|Virologic failure|1|||
160695538|NCT01083810|580267892|FG001|Overall Study|Virologic failure|8|||
160695539|NCT01083810|580267893|FG002|Overall Study|Virologic failure|0|||
160695540|NCT01602965|580267894|FG000|Overall Study|Lost to Follow-up|4|||
160695541|NCT01602965|580267895|FG001|Overall Study|Lost to Follow-up|2|||
160695542|NCT00446199|580267898|FG000|Overall Study|Adverse Event|7|||
160695543|NCT00446199|580267899|FG001|Overall Study|Adverse Event|4|||
160695544|NCT00446199|580267900|FG002|Overall Study|Adverse Event|6|||
160695545|NCT00446199|580267901|FG003|Overall Study|Adverse Event|4|||
160695546|NCT00446199|580267898|FG000|Overall Study|Lost to Follow-up|4|||
160695547|NCT00446199|580267899|FG001|Overall Study|Lost to Follow-up|5|||
160695548|NCT00446199|580267900|FG002|Overall Study|Lost to Follow-up|2|||
160695549|NCT00446199|580267901|FG003|Overall Study|Lost to Follow-up|6|||
160695550|NCT00446199|580267898|FG000|Overall Study|Protocol Violation|1|||
160695551|NCT00446199|580267899|FG001|Overall Study|Protocol Violation|2|||
160695552|NCT00446199|580267900|FG002|Overall Study|Protocol Violation|1|||
160695553|NCT00446199|580267901|FG003|Overall Study|Protocol Violation|3|||
160695554|NCT00446199|580267898|FG000|Overall Study|Withdrawal by Subject|2|||
160695555|NCT00446199|580267899|FG001|Overall Study|Withdrawal by Subject|5|||
160695556|NCT00446199|580267900|FG002|Overall Study|Withdrawal by Subject|9|||
160695557|NCT00446199|580267901|FG003|Overall Study|Withdrawal by Subject|10|||
160695558|NCT00446199|580267898|FG000|Overall Study|Site termination|2|||
160695559|NCT00446199|580267899|FG001|Overall Study|Site termination|0|||
160695560|NCT00446199|580267900|FG002|Overall Study|Site termination|0|||
160695561|NCT00446199|580267901|FG003|Overall Study|Site termination|1|||
160695562|NCT00446199|580267898|FG000|Overall Study|Randomization in Error|2|||
160695563|NCT00446199|580267899|FG001|Overall Study|Randomization in Error|0|||
160695564|NCT00446199|580267900|FG002|Overall Study|Randomization in Error|1|||
160695565|NCT00446199|580267901|FG003|Overall Study|Randomization in Error|1|||
160695566|NCT00446199|580267898|FG000|Overall Study|Lack of Efficacy|1|||
160695567|NCT00446199|580267899|FG001|Overall Study|Lack of Efficacy|0|||
160695568|NCT00446199|580267900|FG002|Overall Study|Lack of Efficacy|0|||
160695569|NCT00446199|580267901|FG003|Overall Study|Lack of Efficacy|1|||
160695570|NCT00446199|580267898|FG000|Overall Study|Non-compliant with study drug|1|||
160695571|NCT00446199|580267899|FG001|Overall Study|Non-compliant with study drug|0|||
160695572|NCT00446199|580267900|FG002|Overall Study|Non-compliant with study drug|5|||
160695573|NCT00446199|580267901|FG003|Overall Study|Non-compliant with study drug|0|||
160695574|NCT00446199|580267898|FG000|Overall Study|Non-compliant with visit schedule|1|||
160695575|NCT00446199|580267899|FG001|Overall Study|Non-compliant with visit schedule|1|||
160695576|NCT00446199|580267900|FG002|Overall Study|Non-compliant with visit schedule|1|||
160695577|NCT00446199|580267901|FG003|Overall Study|Non-compliant with visit schedule|2|||
160695578|NCT00446199|580267898|FG000|Overall Study|Hormone fear|0|||
160695579|NCT00446199|580267899|FG001|Overall Study|Hormone fear|0|||
160695580|NCT00446199|580267900|FG002|Overall Study|Hormone fear|0|||
160695581|NCT00446199|580267901|FG003|Overall Study|Hormone fear|1|||
160695582|NCT00446199|580267898|FG000|Overall Study|Lost interest in study participation|0|||
160695583|NCT00446199|580267899|FG001|Overall Study|Lost interest in study participation|1|||
160695584|NCT00446199|580267900|FG002|Overall Study|Lost interest in study participation|0|||
160695585|NCT00446199|580267901|FG003|Overall Study|Lost interest in study participation|0|||
160695586|NCT00446199|580267898|FG000|Overall Study|In-/Exclusion criterion violated|2|||
160695587|NCT00446199|580267899|FG001|Overall Study|In-/Exclusion criterion violated|1|||
160695588|NCT00446199|580267900|FG002|Overall Study|In-/Exclusion criterion violated|2|||
160695589|NCT00446199|580267901|FG003|Overall Study|In-/Exclusion criterion violated|1|||
160695590|NCT00446199|580267898|FG000|Overall Study|Move|0|||
160695591|NCT00446199|580267899|FG001|Overall Study|Move|1|||
160695592|NCT00446199|580267900|FG002|Overall Study|Move|0|||
160695593|NCT00446199|580267901|FG003|Overall Study|Move|0|||
160695594|NCT03071094|580267905|FG000|Overall Study|Death|1|||
160695595|NCT03071094|580267906|FG001|Overall Study|Death|1|||
160695596|NCT03071094|580267905|FG000|Overall Study|Adverse Event|1|||
160695597|NCT03071094|580267906|FG001|Overall Study|Adverse Event|0|||
160695598|NCT02312063|580267907|FG000|Overall Study|Withdrawal by Subject|0|||
160695599|NCT02312063|580267908|FG001|Overall Study|Withdrawal by Subject|1|||
160695600|NCT04969861|580267914|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
160695601|NCT04969861|580267915|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
160695602|NCT04941729|580269931|FG000|Overall Study|Death|0|||
160695603|NCT04941729|580269932|FG001|Overall Study|Death|1|||
160695604|NCT04941729|580269931|FG000|Overall Study|Study terminated by sponsor|11|||
160695605|NCT04941729|580269932|FG001|Overall Study|Study terminated by sponsor|10|||
160695606|NCT00006721|580269933|FG000|Overall Study|Adverse Event|0|||
160695607|NCT00006721|580269934|FG001|Overall Study|Adverse Event|4|||
160695608|NCT00006721|580269935|FG002|Overall Study|Adverse Event|4|||
160695609|NCT00006721|580269933|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
160695610|NCT00006721|580269934|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
160695611|NCT00006721|580269935|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
160695612|NCT00006721|580269933|FG000|Overall Study|Progression/Relapse|0|||
160695613|NCT00006721|580269934|FG001|Overall Study|Progression/Relapse|1|||
160695614|NCT00006721|580269935|FG002|Overall Study|Progression/Relapse|2|||
160695615|NCT00006721|580269933|FG000|Overall Study|Death|0|||
160695616|NCT00006721|580269934|FG001|Overall Study|Death|1|||
160695617|NCT00006721|580269935|FG002|Overall Study|Death|2|||
160695618|NCT00006721|580269933|FG000|Overall Study|Other - Not Protocol Specified|0|||
160695619|NCT00006721|580269934|FG001|Overall Study|Other - Not Protocol Specified|7|||
160695620|NCT00006721|580269935|FG002|Overall Study|Other - Not Protocol Specified|7|||
160695621|NCT00006721|580269933|FG000|Overall Study|Ineligible|2|||
160695622|NCT00006721|580269934|FG001|Overall Study|Ineligible|12|||
160695623|NCT00006721|580269935|FG002|Overall Study|Ineligible|10|||
160695624|NCT00006721|580269933|FG000|Overall Study|Eligible but no Treatment Received|1|||
160695625|NCT00006721|580269934|FG001|Overall Study|Eligible but no Treatment Received|0|||
160695626|NCT00006721|580269935|FG002|Overall Study|Eligible but no Treatment Received|0|||
160695627|NCT03845296|580269936|FG000|Overall Study|On Treatment|2|||
160695628|NCT03845296|580269937|FG001|Overall Study|On Treatment|1|||
160695629|NCT03845296|580269936|FG000|Overall Study|Adverse Event|4|||
160695630|NCT03845296|580269937|FG001|Overall Study|Adverse Event|11|||
160695631|NCT03845296|580269936|FG000|Overall Study|Refusal unrelated to adverse event|0|||
160695632|NCT03845296|580269937|FG001|Overall Study|Refusal unrelated to adverse event|1|||
160695633|NCT03845296|580269936|FG000|Overall Study|Progression/relapse|14|||
160695634|NCT03845296|580269937|FG001|Overall Study|Progression/relapse|18|||
160695635|NCT03845296|580269936|FG000|Overall Study|Death|4|||
160695636|NCT03845296|580269937|FG001|Overall Study|Death|0|||
160695637|NCT03845296|580269936|FG000|Overall Study|Other - not protocol specified|1|||
160695638|NCT03845296|580269937|FG001|Overall Study|Other - not protocol specified|3|||
160695639|NCT05424042|580269938|FG000|Overall Study|Withdrawal by Subject|2|||
160695640|NCT05424042|580269939|FG001|Overall Study|Withdrawal by Subject|0|||
160695641|NCT05424042|580269940|FG002|Overall Study|Withdrawal by Subject|4|||
160695642|NCT05424042|580269938|FG000|Overall Study|Lost to Follow-up|0|||
160695643|NCT05424042|580269939|FG001|Overall Study|Lost to Follow-up|0|||
160695644|NCT05424042|580269940|FG002|Overall Study|Lost to Follow-up|1|||
160695645|NCT05091307|580269941|FG000|Overall Study|Death|0|||
160695646|NCT05091307|580269942|FG001|Overall Study|Death|0|||
160695647|NCT05091307|580269943|FG002|Overall Study|Death|1|||
160695648|NCT05091307|580269944|FG003|Overall Study|Death|0|||
160695649|NCT05091307|580269941|FG000|Overall Study|Lost to Follow-up|33|||
160695650|NCT05091307|580269942|FG001|Overall Study|Lost to Follow-up|33|||
160695651|NCT05091307|580269943|FG002|Overall Study|Lost to Follow-up|2|||
160695652|NCT05091307|580269944|FG003|Overall Study|Lost to Follow-up|0|||
160695653|NCT05091307|580269941|FG000|Overall Study|Physician Decision|1|||
160695654|NCT05091307|580269942|FG001|Overall Study|Physician Decision|0|||
160695655|NCT05091307|580269943|FG002|Overall Study|Physician Decision|0|||
160695656|NCT05091307|580269944|FG003|Overall Study|Physician Decision|0|||
160695657|NCT05091307|580269941|FG000|Overall Study|Protocol Violation|1|||
160695658|NCT05091307|580269942|FG001|Overall Study|Protocol Violation|0|||
160695659|NCT05091307|580269943|FG002|Overall Study|Protocol Violation|0|||
160695660|NCT05091307|580269944|FG003|Overall Study|Protocol Violation|0|||
160695661|NCT05091307|580269941|FG000|Overall Study|Withdrawal by Subject|16|||
160695662|NCT05091307|580269942|FG001|Overall Study|Withdrawal by Subject|16|||
160695663|NCT05091307|580269943|FG002|Overall Study|Withdrawal by Subject|0|||
160695664|NCT05091307|580269944|FG003|Overall Study|Withdrawal by Subject|1|||
160695665|NCT05091307|580269941|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
160695666|NCT05091307|580269942|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
160695667|NCT05091307|580269943|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
160695668|NCT05091307|580269944|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
160695669|NCT05091307|580269941|FG000|Overall Study|Initiated Prohibited Medication|1|||
160695670|NCT05091307|580269942|FG001|Overall Study|Initiated Prohibited Medication|0|||
160695671|NCT05091307|580269943|FG002|Overall Study|Initiated Prohibited Medication|0|||
160695672|NCT05091307|580269944|FG003|Overall Study|Initiated Prohibited Medication|0|||
160695673|NCT05091307|580269941|FG000|Overall Study|Other|4|||
160695674|NCT05091307|580269942|FG001|Overall Study|Other|4|||
160695675|NCT05091307|580269943|FG002|Overall Study|Other|0|||
160695676|NCT05091307|580269944|FG003|Overall Study|Other|0|||
160695677|NCT05091307|580269941|FG000|Overall Study|Randomized but not vaccinated|0|||
160695678|NCT05091307|580269942|FG001|Overall Study|Randomized but not vaccinated|2|||
160695679|NCT05091307|580269943|FG002|Overall Study|Randomized but not vaccinated|0|||
160695680|NCT05091307|580269944|FG003|Overall Study|Randomized but not vaccinated|0|||
160695681|NCT02031458|580269947|FG000|May 8, 2015 to January 11, 2019|Death|89|||
160695682|NCT02031458|580269948|FG001|May 8, 2015 to January 11, 2019|Death|193|||
160695683|NCT02031458|580269949|FG002|May 8, 2015 to January 11, 2019|Death|198|||
160695684|NCT02031458|580269947|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
160695685|NCT02031458|580269948|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
160695686|NCT02031458|580269949|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
160695687|NCT02031458|580269947|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
160695688|NCT02031458|580269948|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
160695689|NCT02031458|580269949|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
160695690|NCT02031458|580269947|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
160695691|NCT02031458|580269948|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
160695692|NCT02031458|580269949|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
160695693|NCT02031458|580269947|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
160695694|NCT02031458|580269948|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
160695695|NCT02031458|580269949|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
160695696|NCT02031458|580269947|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
160695697|NCT02031458|580269948|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
160695698|NCT02031458|580269949|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
160695699|NCT02031458|580269947|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
160695700|NCT02031458|580269948|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
160695701|NCT02031458|580269949|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
160695702|NCT02031458|580269947|FG000|Baseline to May 8, 2015|Death|36|||
160695703|NCT02031458|580269948|FG001|Baseline to May 8, 2015|Death|87|||
160695704|NCT02031458|580269949|FG002|Baseline to May 8, 2015|Death|100|||
160695705|NCT02031458|580269947|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
160695706|NCT02031458|580269948|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
160695707|NCT02031458|580269949|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
160695708|NCT02031458|580269947|FG000|Baseline to May 8, 2015|Physician Decision|0|||
160695709|NCT02031458|580269948|FG001|Baseline to May 8, 2015|Physician Decision|1|||
160695710|NCT02031458|580269949|FG002|Baseline to May 8, 2015|Physician Decision|0|||
160695711|NCT02031458|580269947|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
160695712|NCT02031458|580269948|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
160695713|NCT02031458|580269949|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
160695714|NCT02031458|580269947|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
160695715|NCT02031458|580269948|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
160695716|NCT02031458|580269949|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
160695717|NCT02031458|580269947|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
160695718|NCT02031458|580269948|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
160695719|NCT02031458|580269949|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
160695720|NCT02031458|580269947|FG000|Baseline to May 8, 2015|On Treatment|43|||
160695721|NCT02031458|580269948|FG001|Baseline to May 8, 2015|On Treatment|81|||
160695722|NCT02031458|580269949|FG002|Baseline to May 8, 2015|On Treatment|73|||
160695723|NCT02031458|580269947|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
160695724|NCT02031458|580269948|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
160695725|NCT02031458|580269949|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
160695726|NCT04305587|580269950|FG000|Overall Study|Withdrawal by Subject|0|||
160695727|NCT04305587|580269951|FG001|Overall Study|Withdrawal by Subject|0|||
160695728|NCT04305587|580269952|FG002|Overall Study|Withdrawal by Subject|0|||
160695729|NCT04305587|580269953|FG003|Overall Study|Withdrawal by Subject|1|||
160695730|NCT04305587|580269954|FG004|Overall Study|Withdrawal by Subject|0|||
160695731|NCT04305587|580269955|FG005|Overall Study|Withdrawal by Subject|0|||
160695732|NCT04305587|580269956|FG006|Overall Study|Withdrawal by Subject|0|||
160695733|NCT04305587|580269957|FG007|Overall Study|Withdrawal by Subject|0|||
160695734|NCT04305587|580269958|FG008|Overall Study|Withdrawal by Subject|0|||
160695735|NCT02752906|580269959|FG000|Overall Study|Protocol Violation|2|||
160695736|NCT02752906|580269960|FG001|Overall Study|Protocol Violation|1|||
160695737|NCT02752906|580269959|FG000|Overall Study|Withdrawal by Subject|2|||
160695738|NCT02752906|580269960|FG001|Overall Study|Withdrawal by Subject|2|||
160695739|NCT02752906|580269959|FG000|Overall Study|Lost to Follow-up|3|||
160695740|NCT02752906|580269960|FG001|Overall Study|Lost to Follow-up|2|||
160695741|NCT00292188|580269964|FG000|Single-Blind|Adverse Event|14|||
160695742|NCT00292188|580269965|FG001|Single-Blind|Adverse Event|0|||
160695743|NCT00292188|580269966|FG002|Single-Blind|Adverse Event|0|||
160695744|NCT00292188|580269964|FG000|Single-Blind|Lack of Efficacy|2|||
160695745|NCT00292188|580269965|FG001|Single-Blind|Lack of Efficacy|0|||
160695746|NCT00292188|580269966|FG002|Single-Blind|Lack of Efficacy|0|||
160695747|NCT00292188|580269964|FG000|Single-Blind|Laboratory Abnormality|5|||
160695748|NCT00292188|580269965|FG001|Single-Blind|Laboratory Abnormality|0|||
160695749|NCT00292188|580269966|FG002|Single-Blind|Laboratory Abnormality|0|||
160695750|NCT00292188|580269964|FG000|Single-Blind|Lost to Follow-up|3|||
160695751|NCT00292188|580269965|FG001|Single-Blind|Lost to Follow-up|0|||
160695752|NCT00292188|580269966|FG002|Single-Blind|Lost to Follow-up|0|||
160695753|NCT00292188|580269964|FG000|Single-Blind|Other|77|||
160695754|NCT00292188|580269965|FG001|Single-Blind|Other|0|||
160695755|NCT00292188|580269966|FG002|Single-Blind|Other|0|||
160695756|NCT00292188|580269964|FG000|Single-Blind|Withdrawal by Subject|12|||
160695757|NCT00292188|580269965|FG001|Single-Blind|Withdrawal by Subject|0|||
160695758|NCT00292188|580269966|FG002|Single-Blind|Withdrawal by Subject|0|||
160695759|NCT00292188|580269964|FG000|Single-Blind|Did not receive treatment|1|||
160695760|NCT00292188|580269965|FG001|Single-Blind|Did not receive treatment|0|||
160695761|NCT00292188|580269966|FG002|Single-Blind|Did not receive treatment|0|||
160695762|NCT00292188|580269964|FG000|Double-Blind|Adverse Event|0|||
160695763|NCT00292188|580269965|FG001|Double-Blind|Adverse Event|25|||
160695764|NCT00292188|580269966|FG002|Double-Blind|Adverse Event|9|||
160695765|NCT00292188|580269964|FG000|Double-Blind|Lack of Efficacy|0|||
160695766|NCT00292188|580269965|FG001|Double-Blind|Lack of Efficacy|2|||
160695767|NCT00292188|580269966|FG002|Double-Blind|Lack of Efficacy|12|||
160695768|NCT00292188|580269964|FG000|Double-Blind|Lost to Follow-up|0|||
160695769|NCT00292188|580269965|FG001|Double-Blind|Lost to Follow-up|1|||
160695770|NCT00292188|580269966|FG002|Double-Blind|Lost to Follow-up|0|||
160695771|NCT00292188|580269964|FG000|Double-Blind|Other|0|||
160695772|NCT00292188|580269965|FG001|Double-Blind|Other|3|||
160695773|NCT00292188|580269966|FG002|Double-Blind|Other|4|||
160695774|NCT00292188|580269964|FG000|Double-Blind|Withdrawal by Subject|0|||
160695775|NCT00292188|580269965|FG001|Double-Blind|Withdrawal by Subject|0|||
160695776|NCT00292188|580269966|FG002|Double-Blind|Withdrawal by Subject|3|||
160695777|NCT00292188|580269964|FG000|Double-Blind|Laboratory Abnormality|0|||
160695778|NCT00292188|580269965|FG001|Double-Blind|Laboratory Abnormality|0|||
160695779|NCT00292188|580269966|FG002|Double-Blind|Laboratory Abnormality|1|||
160695780|NCT00824616|580269967|FG000|Overall Study|Adverse Event|2|||
160695781|NCT00824616|580269968|FG001|Overall Study|Adverse Event|1|||
160695782|NCT00824616|580269967|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
160695783|NCT00824616|580269968|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
160695784|NCT00824616|580269967|FG000|Overall Study|Hyperglycemia|1|||
160695785|NCT00824616|580269968|FG001|Overall Study|Hyperglycemia|1|||
160695786|NCT00824616|580269967|FG000|Overall Study|Lack of Efficacy|2|||
160695787|NCT00824616|580269968|FG001|Overall Study|Lack of Efficacy|1|||
160695788|NCT00824616|580269967|FG000|Overall Study|Lost to Follow-up|0|||
160695789|NCT00824616|580269968|FG001|Overall Study|Lost to Follow-up|1|||
160695790|NCT00824616|580269967|FG000|Overall Study|Withdrawal by Subject|1|||
160695791|NCT00824616|580269968|FG001|Overall Study|Withdrawal by Subject|1|||
160695792|NCT00721630|580269969|FG000|Overall Study|Participant found to be ineligible|1|||
160695793|NCT04711902|580269973|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
160695794|NCT04711902|580269974|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
160695795|NCT04711902|580269975|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
160695796|NCT04711902|580269976|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
160695797|NCT04711902|580269977|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
160695798|NCT04711902|580269978|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
160695799|NCT03786718|580269979|FG000|Overall Study|Lost to Follow-up|3|||
160695800|NCT03786718|580269979|FG000|Overall Study|Withdrawal by Subject|1|||
160695801|NCT03786718|580269979|FG000|Overall Study|Did not use the intervention|2|||
160695802|NCT03786718|580269979|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
160695803|NCT00372411|580269986|FG000|Overall Study|Withdrawal by Subject|3|||
160695804|NCT00372411|580269987|FG001|Overall Study|Withdrawal by Subject|4|||
160695805|NCT00372411|580269988|FG002|Overall Study|Withdrawal by Subject|1|||
160695806|NCT00372411|580269986|FG000|Overall Study|Death|0|||
160695807|NCT00372411|580269987|FG001|Overall Study|Death|2|||
160695808|NCT00372411|580269988|FG002|Overall Study|Death|1|||
160695809|NCT00372411|580269986|FG000|Overall Study|Lost to Follow-up|1|||
160695810|NCT00372411|580269987|FG001|Overall Study|Lost to Follow-up|1|||
160695811|NCT00372411|580269988|FG002|Overall Study|Lost to Follow-up|1|||
160695812|NCT00372411|580269986|FG000|Overall Study|Adverse Event|1|||
160695813|NCT00372411|580269987|FG001|Overall Study|Adverse Event|1|||
160695814|NCT00372411|580269988|FG002|Overall Study|Adverse Event|0|||
160695815|NCT01398514|580269989|FG000|Overall Study|Adverse Event|1|||
160695816|NCT01398514|580269990|FG001|Overall Study|Adverse Event|0|||
160695817|NCT01398514|580269989|FG000|Overall Study|Non-compliance with study procedures|2|||
160695818|NCT01398514|580269990|FG001|Overall Study|Non-compliance with study procedures|0|||
160695819|NCT01398514|580269989|FG000|Overall Study|Physiologic non-responsiveness|1|||
160695820|NCT01398514|580269990|FG001|Overall Study|Physiologic non-responsiveness|3|||
160695821|NCT01398514|580269989|FG000|Overall Study|Failure to show a conditioned response|4|||
160695822|NCT01398514|580269990|FG001|Overall Study|Failure to show a conditioned response|3|||
160695823|NCT03514641|580269994|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
160695824|NCT03514641|580269995|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
160695825|NCT03514641|580269996|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
160695826|NCT03514641|580269997|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
160695827|NCT03514641|580269994|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
160695828|NCT03514641|580269995|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
160695829|NCT03514641|580269996|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
160695830|NCT03514641|580269997|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
160695831|NCT03514641|580269994|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
160695832|NCT03514641|580269995|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
160695833|NCT03514641|580269996|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
160695834|NCT03514641|580269997|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
160695835|NCT03514641|580269994|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
160695836|NCT03514641|580269995|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
160695837|NCT03514641|580269996|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
160695838|NCT03514641|580269997|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
160695839|NCT03514641|580269994|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
160695840|NCT03514641|580269995|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
160695841|NCT03514641|580269996|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
160695842|NCT03514641|580269997|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
160695843|NCT03514641|580269994|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
160695844|NCT03514641|580269995|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
160695845|NCT03514641|580269996|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
160695846|NCT03514641|580269997|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
160695847|NCT03514641|580269994|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
160695848|NCT03514641|580269995|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
160695849|NCT03514641|580269996|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
160695850|NCT03514641|580269997|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
160695851|NCT03514641|580269994|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
160695852|NCT03514641|580269995|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
160695853|NCT03514641|580269996|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
160695854|NCT03514641|580269997|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
160695855|NCT03514641|580269994|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
160695856|NCT03514641|580269995|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
160695857|NCT03514641|580269996|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
160695858|NCT03514641|580269997|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
160695859|NCT03514641|580269994|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
160695860|NCT03514641|580269995|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
160695861|NCT03514641|580269996|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
160695862|NCT03514641|580269997|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
160695863|NCT03514641|580269994|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
160695864|NCT03514641|580269995|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
160695865|NCT03514641|580269996|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
160695866|NCT03514641|580269997|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
160695867|NCT03514641|580269994|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
160695868|NCT03514641|580269995|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
160695869|NCT03514641|580269996|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
160695870|NCT03514641|580269997|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
160695871|NCT01345175|580269998|FG000|Overall Study|Physician Decision|0|||
160695872|NCT01345175|580269999|FG001|Overall Study|Physician Decision|1|||
160695873|NCT01345175|580269998|FG000|Overall Study|Withdrawal by Subject|1|||
160695874|NCT01345175|580269999|FG001|Overall Study|Withdrawal by Subject|1|||
160695875|NCT01345175|580269998|FG000|Overall Study|Failed to complete BFI|3|||
160695876|NCT01345175|580269999|FG001|Overall Study|Failed to complete BFI|2|||
160695877|NCT01345175|580269998|FG000|Overall Study|Stopped taking medication|2|||
160695878|NCT01345175|580269999|FG001|Overall Study|Stopped taking medication|2|||
160695879|NCT01561430|580270001|FG000|Overall Study|Adverse Event|0|||
160695880|NCT01561430|580270002|FG001|Overall Study|Adverse Event|0|||
160695881|NCT01561430|580270003|FG002|Overall Study|Adverse Event|3|||
160695882|NCT01561430|580270004|FG003|Overall Study|Adverse Event|1|||
160695883|NCT01561430|580270001|FG000|Overall Study|Withdrawal by Subject|0|||
160695884|NCT01561430|580270002|FG001|Overall Study|Withdrawal by Subject|0|||
160695885|NCT01561430|580270003|FG002|Overall Study|Withdrawal by Subject|1|||
160695886|NCT01561430|580270004|FG003|Overall Study|Withdrawal by Subject|0|||
160695887|NCT01561430|580270001|FG000|Overall Study|Physician Decision|0|||
160695888|NCT01561430|580270002|FG001|Overall Study|Physician Decision|1|||
160695889|NCT01561430|580270003|FG002|Overall Study|Physician Decision|0|||
160695890|NCT01561430|580270004|FG003|Overall Study|Physician Decision|0|||
160695891|NCT01561430|580270001|FG000|Overall Study|Sponsor Decision|1|||
160695892|NCT01561430|580270002|FG001|Overall Study|Sponsor Decision|14|||
160695893|NCT01561430|580270003|FG002|Overall Study|Sponsor Decision|13|||
160695894|NCT01561430|580270004|FG003|Overall Study|Sponsor Decision|12|||
160695895|NCT04112173|580270005|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
160695896|NCT01007942|580270007|FG000|Overall Study|Adverse Event|29|||
160695897|NCT01007942|580270008|FG001|Overall Study|Adverse Event|14|||
160695898|NCT01007942|580270007|FG000|Overall Study|Abnormal test procedure|0|||
160695899|NCT01007942|580270008|FG001|Overall Study|Abnormal test procedure|1|||
160695900|NCT01007942|580270007|FG000|Overall Study|Disease progression|217|||
160695901|NCT01007942|580270008|FG001|Overall Study|Disease progression|242|||
160695902|NCT01007942|580270007|FG000|Overall Study|New cancer therapy|5|||
160695903|NCT01007942|580270008|FG001|Overall Study|New cancer therapy|1|||
160695904|NCT01007942|580270007|FG000|Overall Study|Protocol Violation|1|||
160695905|NCT01007942|580270008|FG001|Overall Study|Protocol Violation|1|||
160695906|NCT01007942|580270007|FG000|Overall Study|Withdrawal by Subject|19|||
160695907|NCT01007942|580270008|FG001|Overall Study|Withdrawal by Subject|14|||
160695908|NCT01007942|580270007|FG000|Overall Study|Lost to Follow-up|1|||
160695909|NCT01007942|580270008|FG001|Overall Study|Lost to Follow-up|0|||
160695910|NCT01007942|580270007|FG000|Overall Study|Administrative problems|2|||
160695911|NCT01007942|580270008|FG001|Overall Study|Administrative problems|0|||
160695912|NCT01007942|580270007|FG000|Overall Study|Death|3|||
160695913|NCT01007942|580270008|FG001|Overall Study|Death|2|||
160695914|NCT01007942|580270007|FG000|Overall Study|Patients untreated|4|||
160695915|NCT01007942|580270008|FG001|Overall Study|Patients untreated|3|||
160695916|NCT03412396|580270009|FG000|Overall Study|Withdrawal by Subject|2|||
160695917|NCT03412396|580270009|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
160695918|NCT03412396|580270009|FG000|Overall Study|Did not undergo RP|2|||
160695919|NCT00655876|580270010|FG000|Overall Study|Protocol Violation|9|||
160695920|NCT00655876|580270011|FG001|Overall Study|Protocol Violation|7|||
160695921|NCT00470067|580270014|FG000|Overall Study|Death|1|||
160695922|NCT00470067|580270014|FG000|Overall Study|Disease Progression|6|||
160695923|NCT01460901|580270015|FG000|Overall Study|Withdrawal by Subject|2|||
160695924|NCT01059539|580270018|FG000|Overall Study|Adverse Event|66|||
160695925|NCT01059539|580270018|FG000|Overall Study|Insufficient Therapeutic Response|26|||
160695926|NCT01059539|580270018|FG000|Overall Study|Protocol Violation|55|||
160695927|NCT01059539|580270018|FG000|Overall Study|Withdrawal of Consent|80|||
160695928|NCT01059539|580270018|FG000|Overall Study|Lost to Follow-up|42|||
160695929|NCT01059539|580270018|FG000|Overall Study|Reason Not Specified|2|||
160695930|NCT04091659|580270021|FG000|Overall Study|Protocol Violation|3|||
160695931|NCT04091659|580270022|FG001|Overall Study|Protocol Violation|0|||
160695932|NCT04091659|580270021|FG000|Overall Study|Lost to Follow-up|0|||
160695933|NCT04091659|580270022|FG001|Overall Study|Lost to Follow-up|1|||
160695934|NCT00895947|580270023|FG000|Overall Study|Adverse Event|3|||
160695935|NCT00895947|580270024|FG001|Overall Study|Adverse Event|4|||
160695936|NCT00895947|580270023|FG000|Overall Study|Lost to Follow-up|3|||
160695937|NCT00895947|580270024|FG001|Overall Study|Lost to Follow-up|4|||
160695938|NCT00895947|580270023|FG000|Overall Study|Protocol Violation|4|||
160695939|NCT00895947|580270024|FG001|Overall Study|Protocol Violation|2|||
160695940|NCT00895947|580270023|FG000|Overall Study|Withdrawal by Subject|2|||
160695941|NCT00895947|580270024|FG001|Overall Study|Withdrawal by Subject|0|||
160695942|NCT03678285|580270028|FG000|Overall Study|Adverse Event|2|||
160695943|NCT03678285|580270028|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
160695944|NCT03678285|580270028|FG000|Overall Study|Dehydrated prior to start of workout|1|||
160695945|NCT00123474|580270029|FG000|Randomized to Treatment|Randomized, never treated|1|||
160695946|NCT00123474|580270030|FG001|Randomized to Treatment|Randomized, never treated|4|||
160695947|NCT00123474|580270031|FG002|Randomized to Treatment|Randomized, never treated|2|||
160695948|NCT00123474|580270032|FG003|Randomized to Treatment|Randomized, never treated|1|||
160695949|NCT00123474|580270029|FG000|As Treated at Study Closure|not reported when site closed|1|||
160695950|NCT00123474|580270030|FG001|As Treated at Study Closure|not reported when site closed|0|||
160695951|NCT00123474|580270031|FG002|As Treated at Study Closure|not reported when site closed|1|||
160695952|NCT00123474|580270032|FG003|As Treated at Study Closure|not reported when site closed|0|||
160695953|NCT00123474|580270029|FG000|As Treated at Study Closure|Adverse Event|10|||
160695954|NCT00123474|580270030|FG001|As Treated at Study Closure|Adverse Event|4|||
160695955|NCT00123474|580270031|FG002|As Treated at Study Closure|Adverse Event|10|||
160695956|NCT00123474|580270032|FG003|As Treated at Study Closure|Adverse Event|8|||
160695957|NCT00123474|580270029|FG000|As Treated at Study Closure|Disease Progression|35|||
160695958|NCT00123474|580270030|FG001|As Treated at Study Closure|Disease Progression|42|||
160695959|NCT00123474|580270031|FG002|As Treated at Study Closure|Disease Progression|29|||
160695960|NCT00123474|580270032|FG003|As Treated at Study Closure|Disease Progression|27|||
160695961|NCT00123474|580270029|FG000|As Treated at Study Closure|Investigator Request|12|||
160695962|NCT00123474|580270030|FG001|As Treated at Study Closure|Investigator Request|6|||
160695963|NCT00123474|580270031|FG002|As Treated at Study Closure|Investigator Request|7|||
160695964|NCT00123474|580270032|FG003|As Treated at Study Closure|Investigator Request|5|||
160695965|NCT00123474|580270029|FG000|As Treated at Study Closure|non-specified|54|||
160695966|NCT00123474|580270030|FG001|As Treated at Study Closure|non-specified|47|||
160695967|NCT00123474|580270031|FG002|As Treated at Study Closure|non-specified|57|||
160695968|NCT00123474|580270032|FG003|As Treated at Study Closure|non-specified|60|||
160695969|NCT00123474|580270029|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
160695970|NCT00123474|580270030|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
160695971|NCT00123474|580270031|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
160695972|NCT00123474|580270032|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
160695973|NCT00123474|580270029|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
160695974|NCT00123474|580270030|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
160695975|NCT00123474|580270031|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
160695976|NCT00123474|580270032|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
160695977|NCT00616629|580270033|FG000|Overall Study|Protocol Violation|1|||
160695978|NCT00616629|580270034|FG001|Overall Study|Protocol Violation|2|||
160695979|NCT00616629|580270035|FG002|Overall Study|Protocol Violation|1|||
160695980|NCT00616629|580270036|FG003|Overall Study|Protocol Violation|0|||
160695981|NCT00616629|580270037|FG004|Overall Study|Protocol Violation|0|||
160695982|NCT00616629|580270033|FG000|Overall Study|AV-block|1|||
160695983|NCT00616629|580270034|FG001|Overall Study|AV-block|0|||
160695984|NCT00616629|580270035|FG002|Overall Study|AV-block|0|||
160695985|NCT00616629|580270036|FG003|Overall Study|AV-block|0|||
160695986|NCT00616629|580270037|FG004|Overall Study|AV-block|0|||
160695987|NCT01059344|580270038|FG000|Overall Study|Adverse Event|12|||
160695988|NCT01059344|580270039|FG001|Overall Study|Adverse Event|30|||
160695989|NCT01059344|580270038|FG000|Overall Study|Withdrawal by Subject|6|||
160695990|NCT01059344|580270039|FG001|Overall Study|Withdrawal by Subject|9|||
160695991|NCT01059344|580270038|FG000|Overall Study|Lost to Follow-up|1|||
160695992|NCT01059344|580270039|FG001|Overall Study|Lost to Follow-up|1|||
160695993|NCT01059344|580270038|FG000|Overall Study|Other|3|||
160695994|NCT01059344|580270039|FG001|Overall Study|Other|6|||
160695995|NCT04480710|580270040|FG000|Overall Study|Adverse Event|0|||
160695996|NCT04480710|580270041|FG001|Overall Study|Adverse Event|2|||
160695997|NCT04480710|580270042|FG002|Overall Study|Adverse Event|0|||
160695998|NCT04480710|580270043|FG003|Overall Study|Adverse Event|0|||
160695999|NCT04480710|580270040|FG000|Overall Study|Withdrawal by Subject|0|||
160696000|NCT04480710|580270041|FG001|Overall Study|Withdrawal by Subject|1|||
160696001|NCT04480710|580270042|FG002|Overall Study|Withdrawal by Subject|0|||
160696002|NCT04480710|580270043|FG003|Overall Study|Withdrawal by Subject|0|||
160696003|NCT04480710|580270040|FG000|Overall Study|Physician Decision|0|||
160696004|NCT04480710|580270041|FG001|Overall Study|Physician Decision|0|||
160696005|NCT04480710|580270042|FG002|Overall Study|Physician Decision|1|||
160696006|NCT04480710|580270043|FG003|Overall Study|Physician Decision|0|||
160696007|NCT02994940|580270049|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
160696008|NCT02994940|580270050|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
160696009|NCT02994940|580270049|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
160696010|NCT02994940|580270050|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
160696011|NCT02994940|580270049|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
160696012|NCT02994940|580270050|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
160696013|NCT01103466|580270053|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
160696014|NCT01103466|580270054|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
160696015|NCT01103466|580270055|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
160696016|NCT01103466|580270053|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
160696017|NCT01103466|580270054|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
160696018|NCT01103466|580270055|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
160696019|NCT01103466|580270053|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
160696020|NCT01103466|580270054|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
160696021|NCT01103466|580270055|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
160696022|NCT01103466|580270053|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
160696023|NCT01103466|580270054|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
160696024|NCT01103466|580270055|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
160696025|NCT01103466|580270053|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
160696026|NCT01103466|580270054|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
160696027|NCT01103466|580270055|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
160696028|NCT01103466|580270053|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
160696029|NCT01103466|580270054|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
160696030|NCT01103466|580270055|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
160696031|NCT02987959|580270060|FG000|Overall Study|Grantor stopped supply of drugs|6|||
160696032|NCT04126213|580270063|FG000|Overall Study|Lost to Follow-up|9|||
160696033|NCT04126213|580270064|FG001|Overall Study|Lost to Follow-up|1|||
160696034|NCT04126213|580270065|FG002|Overall Study|Lost to Follow-up|5|||
160696035|NCT04126213|580270066|FG003|Overall Study|Lost to Follow-up|10|||
160696036|NCT04126213|580270067|FG004|Overall Study|Lost to Follow-up|4|||
160696037|NCT04126213|580270068|FG005|Overall Study|Lost to Follow-up|7|||
160696038|NCT04126213|580270063|FG000|Overall Study|Withdrawal by Subject|3|||
160696039|NCT04126213|580270064|FG001|Overall Study|Withdrawal by Subject|2|||
160696040|NCT04126213|580270065|FG002|Overall Study|Withdrawal by Subject|1|||
160696041|NCT04126213|580270066|FG003|Overall Study|Withdrawal by Subject|1|||
160696042|NCT04126213|580270067|FG004|Overall Study|Withdrawal by Subject|1|||
160696043|NCT04126213|580270068|FG005|Overall Study|Withdrawal by Subject|1|||
160696044|NCT04126213|580270063|FG000|Overall Study|Other|0|||
160696045|NCT04126213|580270064|FG001|Overall Study|Other|0|||
160696046|NCT04126213|580270065|FG002|Overall Study|Other|2|||
160696047|NCT04126213|580270066|FG003|Overall Study|Other|2|||
160696048|NCT04126213|580270067|FG004|Overall Study|Other|0|||
160696049|NCT04126213|580270068|FG005|Overall Study|Other|1|||
160696050|NCT04126213|580270063|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160696051|NCT04126213|580270064|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
160696052|NCT04126213|580270065|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160696053|NCT04126213|580270066|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160696054|NCT04126213|580270067|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160696055|NCT04126213|580270068|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
160696056|NCT02853370|580270070|FG000|Overall Study|Physician Decision|1|||
160696057|NCT02853370|580270070|FG000|Overall Study|Lack of Efficacy|2|||
160696058|NCT02853370|580270070|FG000|Overall Study|Death|1|||
160696059|NCT02853370|580270070|FG000|Overall Study|Adverse Event|4|||
160696060|NCT02853370|580270070|FG000|Overall Study|Withdrawal by Subject|3|||
160696061|NCT02317614|580270072|FG000|Overall Study|Lost to Follow-up|1|||
160696062|NCT02317614|580270073|FG001|Overall Study|Lost to Follow-up|1|||
160696063|NCT02317614|580270072|FG000|Overall Study|Withdrawal by Subject|1|||
160696064|NCT02317614|580270073|FG001|Overall Study|Withdrawal by Subject|0|||
160696065|NCT02317614|580270072|FG000|Overall Study|Death|1|||
160696066|NCT02317614|580270073|FG001|Overall Study|Death|1|||
160696067|NCT03285308|580270074|FG000|Overall Study|Adverse Event|3|||
160696068|NCT03285308|580270075|FG001|Overall Study|Adverse Event|7|||
160696069|NCT03285308|580270074|FG000|Overall Study|Withdrawal by Subject|8|||
160696070|NCT03285308|580270075|FG001|Overall Study|Withdrawal by Subject|9|||
160696071|NCT03285308|580270074|FG000|Overall Study|Lost to Follow-up|3|||
160696072|NCT03285308|580270075|FG001|Overall Study|Lost to Follow-up|1|||
160696073|NCT03285308|580270074|FG000|Overall Study|Protocol Deviation|6|||
160696074|NCT03285308|580270075|FG001|Overall Study|Protocol Deviation|5|||
160696075|NCT03285308|580270074|FG000|Overall Study|Reason not Specified|0|||
160696076|NCT03285308|580270075|FG001|Overall Study|Reason not Specified|1|||
160696077|NCT03734666|580270076|FG000|Overall Study|Other|7|||
160696078|NCT03734666|580270077|FG001|Overall Study|Other|4|||
160696079|NCT03734666|580270076|FG000|Overall Study|Lost to Follow-up|12|||
160696080|NCT03734666|580270077|FG001|Overall Study|Lost to Follow-up|12|||
160696081|NCT01898650|580270079|FG000|Overall Study|the subject would not lie still for imaging|1|||
160696082|NCT02912650|580270080|FG000|Overall Study|Withdrawal by Subject|1|||
160696083|NCT02912650|580270081|FG001|Overall Study|Withdrawal by Subject|0|||
160696084|NCT02912650|580270082|FG002|Overall Study|Withdrawal by Subject|1|||
160696085|NCT02912650|580270083|FG003|Overall Study|Withdrawal by Subject|5|||
160696086|NCT02912650|580270080|FG000|Overall Study|Adverse Event|0|||
160696087|NCT02912650|580270081|FG001|Overall Study|Adverse Event|0|||
160696088|NCT02912650|580270082|FG002|Overall Study|Adverse Event|1|||
160696089|NCT02912650|580270083|FG003|Overall Study|Adverse Event|0|||
160696090|NCT01674647|580270084|FG000|Treatment Period|Death|4|||
160696091|NCT01674647|580270085|FG001|Treatment Period|Death|1|||
160696092|NCT01674647|580270084|FG000|Treatment Period|Efficacy outcome reached|0|||
160696093|NCT01674647|580270085|FG001|Treatment Period|Efficacy outcome reached|1|||
160696094|NCT01674647|580270084|FG000|Treatment Period|Physician Decision|3|||
160696095|NCT01674647|580270085|FG001|Treatment Period|Physician Decision|1|||
160696096|NCT01674647|580270084|FG000|Treatment Period|Adverse Event|60|||
160696097|NCT01674647|580270085|FG001|Treatment Period|Adverse Event|22|||
160696098|NCT01674647|580270084|FG000|Treatment Period|Non-compliance with study drug|3|||
160696099|NCT01674647|580270085|FG001|Treatment Period|Non-compliance with study drug|0|||
160696100|NCT01674647|580270084|FG000|Treatment Period|Lost to Follow-up|1|||
160696101|NCT01674647|580270085|FG001|Treatment Period|Lost to Follow-up|1|||
160696102|NCT01674647|580270084|FG000|Treatment Period|Withdrawal by Subject|19|||
160696103|NCT01674647|580270085|FG001|Treatment Period|Withdrawal by Subject|16|||
160696104|NCT01674647|580270084|FG000|Treatment Period|Switching to other therapy|5|||
160696105|NCT01674647|580270085|FG001|Treatment Period|Switching to other therapy|2|||
160696106|NCT01674647|580270084|FG000|Treatment Period|Logistical difficulties|5|||
160696107|NCT01674647|580270085|FG001|Treatment Period|Logistical difficulties|8|||
160696108|NCT01674647|580270084|FG000|Treatment Period|Treatment failure|0|||
160696109|NCT01674647|580270085|FG001|Treatment Period|Treatment failure|14|||
160696110|NCT01674647|580270084|FG000|Treatment Period|Protocol Violation|56|||
160696111|NCT01674647|580270085|FG001|Treatment Period|Protocol Violation|36|||
160696112|NCT01674647|580270084|FG000|30-day Safety Follow-up Period|Death|3|||
160696113|NCT01674647|580270085|FG001|30-day Safety Follow-up Period|Death|2|||
160696114|NCT01674647|580270084|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
160696115|NCT01674647|580270085|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
160696116|NCT01674647|580270084|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
160696117|NCT01674647|580270085|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
160696118|NCT01674647|580270084|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
160696119|NCT01674647|580270085|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
160696120|NCT01674647|580270084|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
160696121|NCT01674647|580270085|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
160696122|NCT01674647|580270084|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
160696123|NCT01674647|580270085|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
160696124|NCT04135196|580270087|FG000|Overall Study|Lost to Follow-up|8|||
160696125|NCT04135196|580270088|FG001|Overall Study|Lost to Follow-up|7|||
160696126|NCT04135196|580270089|FG002|Overall Study|Lost to Follow-up|8|||
160696127|NCT04135196|580270090|FG003|Overall Study|Lost to Follow-up|9|||
160696128|NCT04135196|580270091|FG004|Overall Study|Lost to Follow-up|1|||
160696129|NCT04135196|580270087|FG000|Overall Study|Pregnancy|0|||
160696130|NCT04135196|580270088|FG001|Overall Study|Pregnancy|0|||
160696131|NCT04135196|580270089|FG002|Overall Study|Pregnancy|1|||
160696132|NCT04135196|580270090|FG003|Overall Study|Pregnancy|0|||
160696133|NCT04135196|580270091|FG004|Overall Study|Pregnancy|0|||
160696134|NCT04135196|580270087|FG000|Overall Study|Withdrawal by Subject|0|||
160696135|NCT04135196|580270088|FG001|Overall Study|Withdrawal by Subject|0|||
160696136|NCT04135196|580270089|FG002|Overall Study|Withdrawal by Subject|0|||
160696137|NCT04135196|580270090|FG003|Overall Study|Withdrawal by Subject|0|||
160696138|NCT04135196|580270091|FG004|Overall Study|Withdrawal by Subject|1|||
160696139|NCT00444457|580270093|FG000|Infant Series|Other|0|||
160696140|NCT00444457|580270094|FG001|Infant Series|Other|1|||
160696141|NCT00444457|580270095|FG002|Infant Series|Other|0|||
160696142|NCT00444457|580270096|FG003|Infant Series|Other|0|||
160696143|NCT00444457|580270093|FG000|Infant Series|Parent or legal guardian request|18|||
160696144|NCT00444457|580270094|FG001|Infant Series|Parent or legal guardian request|29|||
160696145|NCT00444457|580270095|FG002|Infant Series|Parent or legal guardian request|34|||
160696146|NCT00444457|580270096|FG003|Infant Series|Parent or legal guardian request|14|||
160696147|NCT00444457|580270093|FG000|Infant Series|Lost to Follow-up|10|||
160696148|NCT00444457|580270094|FG001|Infant Series|Lost to Follow-up|11|||
160696149|NCT00444457|580270095|FG002|Infant Series|Lost to Follow-up|7|||
160696150|NCT00444457|580270096|FG003|Infant Series|Lost to Follow-up|6|||
160696151|NCT00444457|580270093|FG000|Infant Series|Protocol Violation|16|||
160696152|NCT00444457|580270094|FG001|Infant Series|Protocol Violation|8|||
160696153|NCT00444457|580270095|FG002|Infant Series|Protocol Violation|6|||
160696154|NCT00444457|580270096|FG003|Infant Series|Protocol Violation|3|||
160696155|NCT00444457|580270093|FG000|Infant Series|Failed to return|5|||
160696156|NCT00444457|580270094|FG001|Infant Series|Failed to return|4|||
160696157|NCT00444457|580270095|FG002|Infant Series|Failed to return|4|||
160696158|NCT00444457|580270096|FG003|Infant Series|Failed to return|2|||
160696159|NCT00444457|580270093|FG000|Infant Series|Investigator request|4|||
160696160|NCT00444457|580270094|FG001|Infant Series|Investigator request|3|||
160696161|NCT00444457|580270095|FG002|Infant Series|Investigator request|3|||
160696162|NCT00444457|580270096|FG003|Infant Series|Investigator request|2|||
160696163|NCT00444457|580270093|FG000|Infant Series|Other|0|||
160696164|NCT00444457|580270094|FG001|Infant Series|Other|2|||
160696165|NCT00444457|580270095|FG002|Infant Series|Other|4|||
160696166|NCT00444457|580270096|FG003|Infant Series|Other|0|||
160696167|NCT00444457|580270093|FG000|Infant Series|Adverse Event|1|||
160696168|NCT00444457|580270094|FG001|Infant Series|Adverse Event|2|||
160696169|NCT00444457|580270095|FG002|Infant Series|Adverse Event|2|||
160696170|NCT00444457|580270096|FG003|Infant Series|Adverse Event|0|||
160696171|NCT00444457|580270093|FG000|Infant Series|Death|0|||
160696172|NCT00444457|580270094|FG001|Infant Series|Death|1|||
160696173|NCT00444457|580270095|FG002|Infant Series|Death|1|||
160696174|NCT00444457|580270096|FG003|Infant Series|Death|1|||
160696175|NCT00444457|580270093|FG000|After Infant Series|Other|0|||
160696176|NCT00444457|580270094|FG001|After Infant Series|Other|1|||
160696177|NCT00444457|580270095|FG002|After Infant Series|Other|1|||
160696178|NCT00444457|580270096|FG003|After Infant Series|Other|1|||
160696179|NCT00444457|580270093|FG000|After Infant Series|Parent or legal guardian request|4|||
160696180|NCT00444457|580270094|FG001|After Infant Series|Parent or legal guardian request|11|||
160696181|NCT00444457|580270095|FG002|After Infant Series|Parent or legal guardian request|6|||
160696182|NCT00444457|580270096|FG003|After Infant Series|Parent or legal guardian request|3|||
160696183|NCT00444457|580270093|FG000|After Infant Series|Failed to return|7|||
160696184|NCT00444457|580270094|FG001|After Infant Series|Failed to return|6|||
160696185|NCT00444457|580270095|FG002|After Infant Series|Failed to return|5|||
160696186|NCT00444457|580270096|FG003|After Infant Series|Failed to return|1|||
160696187|NCT00444457|580270093|FG000|After Infant Series|Lost to Follow-up|5|||
160696188|NCT00444457|580270094|FG001|After Infant Series|Lost to Follow-up|5|||
160696189|NCT00444457|580270095|FG002|After Infant Series|Lost to Follow-up|5|||
160696190|NCT00444457|580270096|FG003|After Infant Series|Lost to Follow-up|2|||
160696191|NCT00444457|580270093|FG000|After Infant Series|Protocol Violation|2|||
160696192|NCT00444457|580270094|FG001|After Infant Series|Protocol Violation|4|||
160696193|NCT00444457|580270095|FG002|After Infant Series|Protocol Violation|2|||
160696194|NCT00444457|580270096|FG003|After Infant Series|Protocol Violation|2|||
160696195|NCT00444457|580270093|FG000|After Infant Series|Adverse Event|2|||
160696196|NCT00444457|580270094|FG001|After Infant Series|Adverse Event|2|||
160696197|NCT00444457|580270095|FG002|After Infant Series|Adverse Event|0|||
160696198|NCT00444457|580270096|FG003|After Infant Series|Adverse Event|0|||
160696199|NCT00444457|580270093|FG000|After Infant Series|Investigator request|0|||
160696200|NCT00444457|580270094|FG001|After Infant Series|Investigator request|0|||
160696201|NCT00444457|580270095|FG002|After Infant Series|Investigator request|0|||
160696202|NCT00444457|580270096|FG003|After Infant Series|Investigator request|1|||
160696203|NCT00444457|580270093|FG000|After Infant Series|Other|0|||
160696204|NCT00444457|580270094|FG001|After Infant Series|Other|1|||
160696205|NCT00444457|580270095|FG002|After Infant Series|Other|0|||
160696206|NCT00444457|580270096|FG003|After Infant Series|Other|0|||
160696207|NCT00444457|580270093|FG000|Toddler Dose|Lost to Follow-up|4|||
160696208|NCT00444457|580270094|FG001|Toddler Dose|Lost to Follow-up|1|||
160696209|NCT00444457|580270095|FG002|Toddler Dose|Lost to Follow-up|1|||
160696210|NCT00444457|580270096|FG003|Toddler Dose|Lost to Follow-up|3|||
160696211|NCT00444457|580270093|FG000|Toddler Dose|Failed to return|2|||
160696212|NCT00444457|580270094|FG001|Toddler Dose|Failed to return|2|||
160696213|NCT00444457|580270095|FG002|Toddler Dose|Failed to return|1|||
160696214|NCT00444457|580270096|FG003|Toddler Dose|Failed to return|3|||
160696215|NCT00444457|580270093|FG000|Toddler Dose|Parent or legal guardian request|0|||
160696216|NCT00444457|580270094|FG001|Toddler Dose|Parent or legal guardian request|3|||
160696217|NCT00444457|580270095|FG002|Toddler Dose|Parent or legal guardian request|2|||
160696218|NCT00444457|580270096|FG003|Toddler Dose|Parent or legal guardian request|1|||
160696219|NCT00444457|580270093|FG000|Toddler Dose|Protocol Violation|1|||
160696220|NCT00444457|580270094|FG001|Toddler Dose|Protocol Violation|0|||
160696221|NCT00444457|580270095|FG002|Toddler Dose|Protocol Violation|0|||
160696222|NCT00444457|580270096|FG003|Toddler Dose|Protocol Violation|1|||
160696223|NCT01946191|580270097|FG000|Allocation|Did not complete orientation|1|||
160696224|NCT01946191|580270098|FG001|Allocation|Did not complete orientation|1|||
160696225|NCT01946191|580270097|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
160696226|NCT01946191|580270098|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
160696227|NCT01946191|580270097|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
160696228|NCT01946191|580270098|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
160696229|NCT01946191|580270097|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
160696230|NCT01946191|580270098|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
160696231|NCT01079832|580270099|FG000|Overall Study|Withdrawal by Subject|1|||
160696232|NCT00290251|580270100|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
160696233|NCT00290251|580270101|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
160696234|NCT00290251|580270102|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
160696235|NCT00290251|580270103|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
160696236|NCT00290251|580270104|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
160696237|NCT00290251|580270105|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
160696238|NCT00290251|580270100|FG000|Treatment 1 (Months 2-4)|headache|0|||
160696239|NCT00290251|580270101|FG001|Treatment 1 (Months 2-4)|headache|0|||
160696240|NCT00290251|580270102|FG002|Treatment 1 (Months 2-4)|headache|0|||
160696241|NCT00290251|580270103|FG003|Treatment 1 (Months 2-4)|headache|0|||
160696242|NCT00290251|580270104|FG004|Treatment 1 (Months 2-4)|headache|1|||
160696243|NCT00290251|580270105|FG005|Treatment 1 (Months 2-4)|headache|0|||
160696244|NCT00290251|580270100|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
160696245|NCT00290251|580270101|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
160696246|NCT00290251|580270102|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
160696247|NCT00290251|580270103|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
160696248|NCT00290251|580270104|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
160696249|NCT00290251|580270105|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
160696250|NCT04732221|580273319|FG000|Base Period|Death|2|||
160696251|NCT04732221|580273320|FG001|Base Period|Death|0|||
160696252|NCT04732221|580273321|FG002|Base Period|Death|0|||
160696253|NCT04732221|580273322|FG003|Base Period|Death|0|||
160696254|NCT04732221|580273323|FG004|Base Period|Death|0|||
160696255|NCT04732221|580273324|FG005|Base Period|Death|0|||
160696256|NCT04732221|580273325|FG006|Base Period|Death|0|||
160696257|NCT04732221|580273319|FG000|Base Period|Withdrawal by Subject|0|||
160696258|NCT04732221|580273320|FG001|Base Period|Withdrawal by Subject|1|||
160696259|NCT04732221|580273321|FG002|Base Period|Withdrawal by Subject|1|||
160696260|NCT04732221|580273322|FG003|Base Period|Withdrawal by Subject|0|||
160696261|NCT04732221|580273323|FG004|Base Period|Withdrawal by Subject|0|||
160696262|NCT04732221|580273324|FG005|Base Period|Withdrawal by Subject|0|||
160696263|NCT04732221|580273325|FG006|Base Period|Withdrawal by Subject|0|||
160696264|NCT04732221|580273319|FG000|Extension Period|Adverse Event|0|||
160696265|NCT04732221|580273320|FG001|Extension Period|Adverse Event|0|||
160696266|NCT04732221|580273321|FG002|Extension Period|Adverse Event|0|||
160696267|NCT04732221|580273322|FG003|Extension Period|Adverse Event|0|||
160696268|NCT04732221|580273323|FG004|Extension Period|Adverse Event|0|||
160696269|NCT04732221|580273324|FG005|Extension Period|Adverse Event|1|||
160696270|NCT04732221|580273325|FG006|Extension Period|Adverse Event|0|||
160696271|NCT04732221|580273319|FG000|Extension Period|Death|0|||
160696272|NCT04732221|580273320|FG001|Extension Period|Death|0|||
160696273|NCT04732221|580273321|FG002|Extension Period|Death|0|||
160696274|NCT04732221|580273322|FG003|Extension Period|Death|0|||
160696275|NCT04732221|580273323|FG004|Extension Period|Death|1|||
160696276|NCT04732221|580273324|FG005|Extension Period|Death|0|||
160696277|NCT04732221|580273325|FG006|Extension Period|Death|2|||
160696278|NCT04732221|580273319|FG000|Extension Period|Pregnancy|0|||
160696279|NCT04732221|580273320|FG001|Extension Period|Pregnancy|0|||
160696280|NCT04732221|580273321|FG002|Extension Period|Pregnancy|0|||
160696281|NCT04732221|580273322|FG003|Extension Period|Pregnancy|0|||
160696282|NCT04732221|580273323|FG004|Extension Period|Pregnancy|1|||
160696283|NCT04732221|580273324|FG005|Extension Period|Pregnancy|0|||
160696284|NCT04732221|580273325|FG006|Extension Period|Pregnancy|0|||
160696285|NCT04732221|580273319|FG000|Extension Period|Sponsors Decision|0|||
160696286|NCT04732221|580273320|FG001|Extension Period|Sponsors Decision|0|||
160696287|NCT04732221|580273321|FG002|Extension Period|Sponsors Decision|0|||
160696288|NCT04732221|580273322|FG003|Extension Period|Sponsors Decision|0|||
160696289|NCT04732221|580273323|FG004|Extension Period|Sponsors Decision|41|||
160696290|NCT04732221|580273324|FG005|Extension Period|Sponsors Decision|40|||
160696291|NCT04732221|580273325|FG006|Extension Period|Sponsors Decision|40|||
160696292|NCT04732221|580273319|FG000|Extension Period|Withdrawal by Subject|0|||
160696293|NCT04732221|580273320|FG001|Extension Period|Withdrawal by Subject|0|||
160696294|NCT04732221|580273321|FG002|Extension Period|Withdrawal by Subject|0|||
160696295|NCT04732221|580273322|FG003|Extension Period|Withdrawal by Subject|0|||
160696296|NCT04732221|580273323|FG004|Extension Period|Withdrawal by Subject|1|||
160696297|NCT04732221|580273324|FG005|Extension Period|Withdrawal by Subject|5|||
160696298|NCT04732221|580273325|FG006|Extension Period|Withdrawal by Subject|2|||
160696299|NCT03611543|580273326|FG000|Overall Study|Withdrawal by Subject|4|||
160696300|NCT03611543|580273327|FG001|Overall Study|Withdrawal by Subject|4|||
160696301|NCT03611543|580273326|FG000|Overall Study|Physician Decision|1|||
160696302|NCT03611543|580273327|FG001|Overall Study|Physician Decision|1|||
160696303|NCT03611543|580273326|FG000|Overall Study|Protocol Violation|2|||
160696304|NCT03611543|580273327|FG001|Overall Study|Protocol Violation|2|||
160696305|NCT03611543|580273326|FG000|Overall Study|Device failure|2|||
160696306|NCT03611543|580273327|FG001|Overall Study|Device failure|2|||
160696307|NCT03611543|580273326|FG000|Overall Study|Missing information|5|||
160696308|NCT03611543|580273327|FG001|Overall Study|Missing information|5|||
160696309|NCT00379340|580273332|FG000|Overall Study|Death|0|||
160696310|NCT00379340|580273333|FG001|Overall Study|Death|0|||
160696311|NCT00379340|580273334|FG002|Overall Study|Death|0|||
160696312|NCT00379340|580273335|FG003|Overall Study|Death|2|||
160696313|NCT00379340|580273336|FG004|Overall Study|Death|0|||
160696314|NCT00379340|580273332|FG000|Overall Study|Lack of Efficacy|6|||
160696315|NCT00379340|580273333|FG001|Overall Study|Lack of Efficacy|1|||
160696316|NCT00379340|580273334|FG002|Overall Study|Lack of Efficacy|0|||
160696317|NCT00379340|580273335|FG003|Overall Study|Lack of Efficacy|4|||
160696318|NCT00379340|580273336|FG004|Overall Study|Lack of Efficacy|3|||
160696319|NCT00379340|580273332|FG000|Overall Study|Physician Decision|6|||
160696320|NCT00379340|580273333|FG001|Overall Study|Physician Decision|2|||
160696321|NCT00379340|580273334|FG002|Overall Study|Physician Decision|1|||
160696322|NCT00379340|580273335|FG003|Overall Study|Physician Decision|2|||
160696323|NCT00379340|580273336|FG004|Overall Study|Physician Decision|3|||
160696324|NCT00379340|580273332|FG000|Overall Study|Withdrawal by Subject|0|||
160696325|NCT00379340|580273333|FG001|Overall Study|Withdrawal by Subject|0|||
160696326|NCT00379340|580273334|FG002|Overall Study|Withdrawal by Subject|0|||
160696327|NCT00379340|580273335|FG003|Overall Study|Withdrawal by Subject|1|||
160696328|NCT00379340|580273336|FG004|Overall Study|Withdrawal by Subject|0|||
160696329|NCT00379340|580273332|FG000|Overall Study|Refusal of further protocol therapy|1|||
160696330|NCT00379340|580273333|FG001|Overall Study|Refusal of further protocol therapy|0|||
160696331|NCT00379340|580273334|FG002|Overall Study|Refusal of further protocol therapy|1|||
160696332|NCT00379340|580273335|FG003|Overall Study|Refusal of further protocol therapy|1|||
160696333|NCT00379340|580273336|FG004|Overall Study|Refusal of further protocol therapy|7|||
160696334|NCT00379340|580273332|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
160696335|NCT00379340|580273333|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
160696336|NCT00379340|580273334|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
160696337|NCT00379340|580273335|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
160696338|NCT00379340|580273336|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
160696339|NCT00379340|580273332|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
160696340|NCT00379340|580273333|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
160696341|NCT00379340|580273334|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
160696342|NCT00379340|580273335|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
160696343|NCT00379340|580273336|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
160696344|NCT02799095|580273337|FG000|Part A|Adverse Event|1|||
160696345|NCT02799095|580273338|FG001|Part A|Adverse Event|0|||
160696346|NCT02799095|580273339|FG002|Part A|Adverse Event|1|||
160696347|NCT02799095|580273340|FG003|Part A|Adverse Event|4|||
160696348|NCT02799095|580273341|FG004|Part A|Adverse Event|1|||
160696349|NCT02799095|580273342|FG005|Part A|Adverse Event|0|||
160696350|NCT02799095|580273343|FG006|Part A|Adverse Event|0|||
160696351|NCT02799095|580273344|FG007|Part A|Adverse Event|0|||
160696352|NCT02799095|580273345|FG008|Part A|Adverse Event|0|||
160696353|NCT02799095|580273346|FG009|Part A|Adverse Event|0|||
160696354|NCT02799095|580273347|FG010|Part A|Adverse Event|0|||
160696355|NCT02799095|580273348|FG011|Part A|Adverse Event|0|||
160696356|NCT02799095|580273349|FG012|Part A|Adverse Event|0|||
160696357|NCT02799095|580273350|FG013|Part A|Adverse Event|0|||
160696358|NCT02799095|580273351|FG014|Part A|Adverse Event|0|||
160696359|NCT02799095|580273352|FG015|Part A|Adverse Event|0|||
160696360|NCT02799095|580273353|FG016|Part A|Adverse Event|0|||
160696361|NCT02799095|580273337|FG000|Part A|Death|0|||
160696362|NCT02799095|580273338|FG001|Part A|Death|0|||
160696363|NCT02799095|580273339|FG002|Part A|Death|0|||
160696364|NCT02799095|580273340|FG003|Part A|Death|0|||
160696365|NCT02799095|580273341|FG004|Part A|Death|0|||
160696366|NCT02799095|580273342|FG005|Part A|Death|0|||
160696367|NCT02799095|580273343|FG006|Part A|Death|3|||
160696368|NCT02799095|580273344|FG007|Part A|Death|0|||
160696369|NCT02799095|580273345|FG008|Part A|Death|0|||
160696370|NCT02799095|580273346|FG009|Part A|Death|0|||
160696371|NCT02799095|580273347|FG010|Part A|Death|0|||
160696372|NCT02799095|580273348|FG011|Part A|Death|0|||
160696373|NCT02799095|580273349|FG012|Part A|Death|0|||
160696374|NCT02799095|580273350|FG013|Part A|Death|0|||
160696375|NCT02799095|580273351|FG014|Part A|Death|0|||
160696376|NCT02799095|580273352|FG015|Part A|Death|0|||
160696377|NCT02799095|580273353|FG016|Part A|Death|0|||
160696378|NCT02799095|580273337|FG000|Part A|Lost to Follow-up|0|||
160696379|NCT02799095|580273338|FG001|Part A|Lost to Follow-up|1|||
160696380|NCT02799095|580273339|FG002|Part A|Lost to Follow-up|0|||
160696381|NCT02799095|580273340|FG003|Part A|Lost to Follow-up|0|||
160696382|NCT02799095|580273341|FG004|Part A|Lost to Follow-up|0|||
160696383|NCT02799095|580273342|FG005|Part A|Lost to Follow-up|0|||
160696384|NCT02799095|580273343|FG006|Part A|Lost to Follow-up|1|||
160696385|NCT02799095|580273344|FG007|Part A|Lost to Follow-up|0|||
160696386|NCT02799095|580273345|FG008|Part A|Lost to Follow-up|0|||
160696387|NCT02799095|580273346|FG009|Part A|Lost to Follow-up|0|||
160696388|NCT02799095|580273347|FG010|Part A|Lost to Follow-up|0|||
160696389|NCT02799095|580273348|FG011|Part A|Lost to Follow-up|0|||
160696390|NCT02799095|580273349|FG012|Part A|Lost to Follow-up|0|||
160696391|NCT02799095|580273350|FG013|Part A|Lost to Follow-up|0|||
160696392|NCT02799095|580273351|FG014|Part A|Lost to Follow-up|0|||
160696393|NCT02799095|580273352|FG015|Part A|Lost to Follow-up|0|||
160696394|NCT02799095|580273353|FG016|Part A|Lost to Follow-up|0|||
160696395|NCT02799095|580273337|FG000|Part A|Progressive Disease|3|||
160696396|NCT02799095|580273338|FG001|Part A|Progressive Disease|3|||
160696397|NCT02799095|580273339|FG002|Part A|Progressive Disease|3|||
160696398|NCT02799095|580273340|FG003|Part A|Progressive Disease|2|||
160696399|NCT02799095|580273341|FG004|Part A|Progressive Disease|2|||
160696400|NCT02799095|580273342|FG005|Part A|Progressive Disease|0|||
160696401|NCT02799095|580273343|FG006|Part A|Progressive Disease|0|||
160696402|NCT02799095|580273344|FG007|Part A|Progressive Disease|0|||
160696403|NCT02799095|580273345|FG008|Part A|Progressive Disease|0|||
160696404|NCT02799095|580273346|FG009|Part A|Progressive Disease|0|||
160696405|NCT02799095|580273347|FG010|Part A|Progressive Disease|0|||
160696406|NCT02799095|580273348|FG011|Part A|Progressive Disease|0|||
160696407|NCT02799095|580273349|FG012|Part A|Progressive Disease|0|||
160696408|NCT02799095|580273350|FG013|Part A|Progressive Disease|0|||
160696409|NCT02799095|580273351|FG014|Part A|Progressive Disease|0|||
160696410|NCT02799095|580273352|FG015|Part A|Progressive Disease|0|||
160696411|NCT02799095|580273353|FG016|Part A|Progressive Disease|0|||
160696412|NCT02799095|580273337|FG000|Part A|Clinical Progression|1|||
160696413|NCT02799095|580273338|FG001|Part A|Clinical Progression|0|||
160696414|NCT02799095|580273339|FG002|Part A|Clinical Progression|2|||
160696415|NCT02799095|580273340|FG003|Part A|Clinical Progression|1|||
160696416|NCT02799095|580273341|FG004|Part A|Clinical Progression|5|||
160696417|NCT02799095|580273342|FG005|Part A|Clinical Progression|0|||
160696418|NCT02799095|580273343|FG006|Part A|Clinical Progression|0|||
160696419|NCT02799095|580273344|FG007|Part A|Clinical Progression|0|||
160696420|NCT02799095|580273345|FG008|Part A|Clinical Progression|0|||
160696421|NCT02799095|580273346|FG009|Part A|Clinical Progression|0|||
160696422|NCT02799095|580273347|FG010|Part A|Clinical Progression|0|||
160696423|NCT02799095|580273348|FG011|Part A|Clinical Progression|0|||
160696424|NCT02799095|580273349|FG012|Part A|Clinical Progression|0|||
160696425|NCT02799095|580273350|FG013|Part A|Clinical Progression|0|||
160696426|NCT02799095|580273351|FG014|Part A|Clinical Progression|0|||
160696427|NCT02799095|580273352|FG015|Part A|Clinical Progression|0|||
160696428|NCT02799095|580273353|FG016|Part A|Clinical Progression|0|||
160696429|NCT02799095|580273337|FG000|Part A|Protocol Deviation|0|||
160696430|NCT02799095|580273338|FG001|Part A|Protocol Deviation|0|||
160696431|NCT02799095|580273339|FG002|Part A|Protocol Deviation|1|||
160696432|NCT02799095|580273340|FG003|Part A|Protocol Deviation|0|||
160696433|NCT02799095|580273341|FG004|Part A|Protocol Deviation|0|||
160696434|NCT02799095|580273342|FG005|Part A|Protocol Deviation|0|||
160696435|NCT02799095|580273343|FG006|Part A|Protocol Deviation|0|||
160696436|NCT02799095|580273344|FG007|Part A|Protocol Deviation|0|||
160696437|NCT02799095|580273345|FG008|Part A|Protocol Deviation|0|||
160696438|NCT02799095|580273346|FG009|Part A|Protocol Deviation|0|||
160696439|NCT02799095|580273347|FG010|Part A|Protocol Deviation|0|||
160696440|NCT02799095|580273348|FG011|Part A|Protocol Deviation|0|||
160696441|NCT02799095|580273349|FG012|Part A|Protocol Deviation|0|||
160696442|NCT02799095|580273350|FG013|Part A|Protocol Deviation|0|||
160696443|NCT02799095|580273351|FG014|Part A|Protocol Deviation|0|||
160696444|NCT02799095|580273352|FG015|Part A|Protocol Deviation|0|||
160696445|NCT02799095|580273353|FG016|Part A|Protocol Deviation|0|||
160696446|NCT02799095|580273337|FG000|Part A|Withdrawal by Subject|0|||
160696447|NCT02799095|580273338|FG001|Part A|Withdrawal by Subject|0|||
160696448|NCT02799095|580273339|FG002|Part A|Withdrawal by Subject|0|||
160696449|NCT02799095|580273340|FG003|Part A|Withdrawal by Subject|1|||
160696450|NCT02799095|580273341|FG004|Part A|Withdrawal by Subject|3|||
160696451|NCT02799095|580273342|FG005|Part A|Withdrawal by Subject|1|||
160696452|NCT02799095|580273343|FG006|Part A|Withdrawal by Subject|1|||
160696453|NCT02799095|580273344|FG007|Part A|Withdrawal by Subject|0|||
160696454|NCT02799095|580273345|FG008|Part A|Withdrawal by Subject|0|||
160696455|NCT02799095|580273346|FG009|Part A|Withdrawal by Subject|0|||
160696456|NCT02799095|580273347|FG010|Part A|Withdrawal by Subject|0|||
160696457|NCT02799095|580273348|FG011|Part A|Withdrawal by Subject|0|||
160696458|NCT02799095|580273349|FG012|Part A|Withdrawal by Subject|0|||
160696459|NCT02799095|580273350|FG013|Part A|Withdrawal by Subject|0|||
160696460|NCT02799095|580273351|FG014|Part A|Withdrawal by Subject|0|||
160696461|NCT02799095|580273352|FG015|Part A|Withdrawal by Subject|0|||
160696462|NCT02799095|580273353|FG016|Part A|Withdrawal by Subject|0|||
160696463|NCT02799095|580273337|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
160696464|NCT02799095|580273338|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
160696465|NCT02799095|580273339|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
160696466|NCT02799095|580273340|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
160696467|NCT02799095|580273341|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
160696468|NCT02799095|580273342|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
160696469|NCT02799095|580273343|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
160696470|NCT02799095|580273344|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
160696471|NCT02799095|580273345|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
160696472|NCT02799095|580273346|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
160696473|NCT02799095|580273347|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
160696474|NCT02799095|580273348|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
160696475|NCT02799095|580273349|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
160696476|NCT02799095|580273350|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
160696477|NCT02799095|580273351|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
160696478|NCT02799095|580273352|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
160696479|NCT02799095|580273353|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
160696480|NCT02799095|580273337|FG000|Part B|Death|0|||
160696481|NCT02799095|580273338|FG001|Part B|Death|0|||
160696482|NCT02799095|580273339|FG002|Part B|Death|0|||
160696483|NCT02799095|580273340|FG003|Part B|Death|0|||
160696484|NCT02799095|580273341|FG004|Part B|Death|0|||
160696485|NCT02799095|580273342|FG005|Part B|Death|0|||
160696486|NCT02799095|580273343|FG006|Part B|Death|0|||
160696487|NCT02799095|580273344|FG007|Part B|Death|7|||
160696488|NCT02799095|580273345|FG008|Part B|Death|7|||
160696489|NCT02799095|580273346|FG009|Part B|Death|0|||
160696490|NCT02799095|580273347|FG010|Part B|Death|0|||
160696491|NCT02799095|580273348|FG011|Part B|Death|0|||
160696492|NCT02799095|580273349|FG012|Part B|Death|0|||
160696493|NCT02799095|580273350|FG013|Part B|Death|0|||
160696494|NCT02799095|580273351|FG014|Part B|Death|0|||
160696495|NCT02799095|580273352|FG015|Part B|Death|0|||
160696496|NCT02799095|580273353|FG016|Part B|Death|0|||
160696497|NCT02799095|580273337|FG000|Part B|Progressive Disease|0|||
160696498|NCT02799095|580273338|FG001|Part B|Progressive Disease|0|||
160696499|NCT02799095|580273339|FG002|Part B|Progressive Disease|0|||
160696500|NCT02799095|580273340|FG003|Part B|Progressive Disease|0|||
160696501|NCT02799095|580273341|FG004|Part B|Progressive Disease|0|||
160696502|NCT02799095|580273342|FG005|Part B|Progressive Disease|0|||
160696503|NCT02799095|580273343|FG006|Part B|Progressive Disease|0|||
160696504|NCT02799095|580273344|FG007|Part B|Progressive Disease|1|||
160696505|NCT02799095|580273345|FG008|Part B|Progressive Disease|0|||
160696506|NCT02799095|580273346|FG009|Part B|Progressive Disease|0|||
160696507|NCT02799095|580273347|FG010|Part B|Progressive Disease|0|||
160696508|NCT02799095|580273348|FG011|Part B|Progressive Disease|0|||
160696509|NCT02799095|580273349|FG012|Part B|Progressive Disease|0|||
160696510|NCT02799095|580273350|FG013|Part B|Progressive Disease|0|||
160696511|NCT02799095|580273351|FG014|Part B|Progressive Disease|0|||
160696512|NCT02799095|580273352|FG015|Part B|Progressive Disease|0|||
160696513|NCT02799095|580273353|FG016|Part B|Progressive Disease|0|||
160696514|NCT02799095|580273337|FG000|Part B|Withdrawal by Subject|0|||
160696515|NCT02799095|580273338|FG001|Part B|Withdrawal by Subject|0|||
160696516|NCT02799095|580273339|FG002|Part B|Withdrawal by Subject|0|||
160696517|NCT02799095|580273340|FG003|Part B|Withdrawal by Subject|0|||
160696518|NCT02799095|580273341|FG004|Part B|Withdrawal by Subject|0|||
160696519|NCT02799095|580273342|FG005|Part B|Withdrawal by Subject|0|||
160696520|NCT02799095|580273343|FG006|Part B|Withdrawal by Subject|0|||
160696521|NCT02799095|580273344|FG007|Part B|Withdrawal by Subject|10|||
160696522|NCT02799095|580273345|FG008|Part B|Withdrawal by Subject|7|||
160696523|NCT02799095|580273346|FG009|Part B|Withdrawal by Subject|0|||
160696524|NCT02799095|580273347|FG010|Part B|Withdrawal by Subject|0|||
160696525|NCT02799095|580273348|FG011|Part B|Withdrawal by Subject|0|||
160696526|NCT02799095|580273349|FG012|Part B|Withdrawal by Subject|0|||
160696527|NCT02799095|580273350|FG013|Part B|Withdrawal by Subject|0|||
160696528|NCT02799095|580273351|FG014|Part B|Withdrawal by Subject|0|||
160696529|NCT02799095|580273352|FG015|Part B|Withdrawal by Subject|0|||
160696530|NCT02799095|580273353|FG016|Part B|Withdrawal by Subject|0|||
160696531|NCT02799095|580273337|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
160696532|NCT02799095|580273338|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
160696533|NCT02799095|580273339|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
160696534|NCT02799095|580273340|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
160696535|NCT02799095|580273341|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
160696536|NCT02799095|580273342|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
160696537|NCT02799095|580273343|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
160696538|NCT02799095|580273344|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
160696539|NCT02799095|580273345|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
160696540|NCT02799095|580273346|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
160696541|NCT02799095|580273347|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
160696542|NCT02799095|580273348|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
160696543|NCT02799095|580273349|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
160696544|NCT02799095|580273350|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
160696545|NCT02799095|580273351|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
160696546|NCT02799095|580273352|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
160696547|NCT02799095|580273353|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
160696548|NCT02799095|580273337|FG000|Part C|Adverse Event|0|||
160696549|NCT02799095|580273338|FG001|Part C|Adverse Event|0|||
160696550|NCT02799095|580273339|FG002|Part C|Adverse Event|0|||
160696551|NCT02799095|580273340|FG003|Part C|Adverse Event|0|||
160696552|NCT02799095|580273341|FG004|Part C|Adverse Event|0|||
160696553|NCT02799095|580273342|FG005|Part C|Adverse Event|0|||
160696554|NCT02799095|580273343|FG006|Part C|Adverse Event|0|||
160696555|NCT02799095|580273344|FG007|Part C|Adverse Event|0|||
160696556|NCT02799095|580273345|FG008|Part C|Adverse Event|0|||
160696557|NCT02799095|580273346|FG009|Part C|Adverse Event|0|||
160696558|NCT02799095|580273347|FG010|Part C|Adverse Event|3|||
160696559|NCT02799095|580273348|FG011|Part C|Adverse Event|1|||
160696560|NCT02799095|580273349|FG012|Part C|Adverse Event|0|||
160696561|NCT02799095|580273350|FG013|Part C|Adverse Event|1|||
160696562|NCT02799095|580273351|FG014|Part C|Adverse Event|0|||
160696563|NCT02799095|580273352|FG015|Part C|Adverse Event|0|||
160696564|NCT02799095|580273353|FG016|Part C|Adverse Event|0|||
160696565|NCT02799095|580273337|FG000|Part C|Death|0|||
160696566|NCT02799095|580273338|FG001|Part C|Death|0|||
160696567|NCT02799095|580273339|FG002|Part C|Death|0|||
160696568|NCT02799095|580273340|FG003|Part C|Death|0|||
160696569|NCT02799095|580273341|FG004|Part C|Death|0|||
160696570|NCT02799095|580273342|FG005|Part C|Death|0|||
160696571|NCT02799095|580273343|FG006|Part C|Death|0|||
160696572|NCT02799095|580273344|FG007|Part C|Death|0|||
160696573|NCT02799095|580273345|FG008|Part C|Death|0|||
160696574|NCT02799095|580273346|FG009|Part C|Death|0|||
160696575|NCT02799095|580273347|FG010|Part C|Death|7|||
160696576|NCT02799095|580273348|FG011|Part C|Death|5|||
160696577|NCT02799095|580273349|FG012|Part C|Death|6|||
160696578|NCT02799095|580273350|FG013|Part C|Death|8|||
160696579|NCT02799095|580273351|FG014|Part C|Death|1|||
160696580|NCT02799095|580273352|FG015|Part C|Death|8|||
160696581|NCT02799095|580273353|FG016|Part C|Death|1|||
160696582|NCT02799095|580273337|FG000|Part C|Lost to Follow-up|0|||
160696583|NCT02799095|580273338|FG001|Part C|Lost to Follow-up|0|||
160696584|NCT02799095|580273339|FG002|Part C|Lost to Follow-up|0|||
160696585|NCT02799095|580273340|FG003|Part C|Lost to Follow-up|0|||
160696586|NCT02799095|580273341|FG004|Part C|Lost to Follow-up|0|||
160696587|NCT02799095|580273342|FG005|Part C|Lost to Follow-up|0|||
160696588|NCT02799095|580273343|FG006|Part C|Lost to Follow-up|0|||
160696589|NCT02799095|580273344|FG007|Part C|Lost to Follow-up|0|||
160696590|NCT02799095|580273345|FG008|Part C|Lost to Follow-up|0|||
160696591|NCT02799095|580273346|FG009|Part C|Lost to Follow-up|0|||
160696592|NCT02799095|580273347|FG010|Part C|Lost to Follow-up|1|||
160696593|NCT02799095|580273348|FG011|Part C|Lost to Follow-up|1|||
160696594|NCT02799095|580273349|FG012|Part C|Lost to Follow-up|1|||
160696595|NCT02799095|580273350|FG013|Part C|Lost to Follow-up|3|||
160696596|NCT02799095|580273351|FG014|Part C|Lost to Follow-up|0|||
160696597|NCT02799095|580273352|FG015|Part C|Lost to Follow-up|0|||
160696598|NCT02799095|580273353|FG016|Part C|Lost to Follow-up|0|||
160696599|NCT02799095|580273337|FG000|Part C|Progressive Disease|0|||
160696600|NCT02799095|580273338|FG001|Part C|Progressive Disease|0|||
160696601|NCT02799095|580273339|FG002|Part C|Progressive Disease|0|||
160696602|NCT02799095|580273340|FG003|Part C|Progressive Disease|0|||
160696603|NCT02799095|580273341|FG004|Part C|Progressive Disease|0|||
160696604|NCT02799095|580273342|FG005|Part C|Progressive Disease|0|||
160696605|NCT02799095|580273343|FG006|Part C|Progressive Disease|0|||
160696606|NCT02799095|580273344|FG007|Part C|Progressive Disease|0|||
160696607|NCT02799095|580273345|FG008|Part C|Progressive Disease|0|||
160696608|NCT02799095|580273346|FG009|Part C|Progressive Disease|2|||
160696609|NCT02799095|580273347|FG010|Part C|Progressive Disease|13|||
160696610|NCT02799095|580273348|FG011|Part C|Progressive Disease|2|||
160696611|NCT02799095|580273349|FG012|Part C|Progressive Disease|0|||
160696612|NCT02799095|580273350|FG013|Part C|Progressive Disease|1|||
160696613|NCT02799095|580273351|FG014|Part C|Progressive Disease|0|||
160696614|NCT02799095|580273352|FG015|Part C|Progressive Disease|0|||
160696615|NCT02799095|580273353|FG016|Part C|Progressive Disease|0|||
160696616|NCT02799095|580273337|FG000|Part C|Clinical Progression|0|||
160696617|NCT02799095|580273338|FG001|Part C|Clinical Progression|0|||
160696618|NCT02799095|580273339|FG002|Part C|Clinical Progression|0|||
160696619|NCT02799095|580273340|FG003|Part C|Clinical Progression|0|||
160696620|NCT02799095|580273341|FG004|Part C|Clinical Progression|0|||
160696621|NCT02799095|580273342|FG005|Part C|Clinical Progression|0|||
160696622|NCT02799095|580273343|FG006|Part C|Clinical Progression|0|||
160696623|NCT02799095|580273344|FG007|Part C|Clinical Progression|0|||
160696624|NCT02799095|580273345|FG008|Part C|Clinical Progression|0|||
160696625|NCT02799095|580273346|FG009|Part C|Clinical Progression|1|||
160696626|NCT02799095|580273347|FG010|Part C|Clinical Progression|3|||
160696627|NCT02799095|580273348|FG011|Part C|Clinical Progression|0|||
160696628|NCT02799095|580273349|FG012|Part C|Clinical Progression|0|||
160696629|NCT02799095|580273350|FG013|Part C|Clinical Progression|1|||
160696630|NCT02799095|580273351|FG014|Part C|Clinical Progression|0|||
160696631|NCT02799095|580273352|FG015|Part C|Clinical Progression|0|||
160696632|NCT02799095|580273353|FG016|Part C|Clinical Progression|0|||
160696633|NCT02799095|580273337|FG000|Part C|Withdrawal by Subject|0|||
160696634|NCT02799095|580273338|FG001|Part C|Withdrawal by Subject|0|||
160696635|NCT02799095|580273339|FG002|Part C|Withdrawal by Subject|0|||
160696636|NCT02799095|580273340|FG003|Part C|Withdrawal by Subject|0|||
160696637|NCT02799095|580273341|FG004|Part C|Withdrawal by Subject|0|||
160696638|NCT02799095|580273342|FG005|Part C|Withdrawal by Subject|0|||
160696639|NCT02799095|580273343|FG006|Part C|Withdrawal by Subject|0|||
160696640|NCT02799095|580273344|FG007|Part C|Withdrawal by Subject|0|||
160696641|NCT02799095|580273345|FG008|Part C|Withdrawal by Subject|0|||
160696642|NCT02799095|580273346|FG009|Part C|Withdrawal by Subject|0|||
160696643|NCT02799095|580273347|FG010|Part C|Withdrawal by Subject|13|||
160696644|NCT02799095|580273348|FG011|Part C|Withdrawal by Subject|15|||
160696645|NCT02799095|580273349|FG012|Part C|Withdrawal by Subject|13|||
160696646|NCT02799095|580273350|FG013|Part C|Withdrawal by Subject|21|||
160696647|NCT02799095|580273351|FG014|Part C|Withdrawal by Subject|0|||
160696648|NCT02799095|580273352|FG015|Part C|Withdrawal by Subject|12|||
160696649|NCT02799095|580273353|FG016|Part C|Withdrawal by Subject|1|||
160696650|NCT02799095|580273337|FG000|Part C|Physician Decision|0|||
160696651|NCT02799095|580273338|FG001|Part C|Physician Decision|0|||
160696652|NCT02799095|580273339|FG002|Part C|Physician Decision|0|||
160696653|NCT02799095|580273340|FG003|Part C|Physician Decision|0|||
160696654|NCT02799095|580273341|FG004|Part C|Physician Decision|0|||
160696655|NCT02799095|580273342|FG005|Part C|Physician Decision|0|||
160696656|NCT02799095|580273343|FG006|Part C|Physician Decision|0|||
160696657|NCT02799095|580273344|FG007|Part C|Physician Decision|0|||
160696658|NCT02799095|580273345|FG008|Part C|Physician Decision|0|||
160696659|NCT02799095|580273346|FG009|Part C|Physician Decision|0|||
160696660|NCT02799095|580273347|FG010|Part C|Physician Decision|1|||
160696661|NCT02799095|580273348|FG011|Part C|Physician Decision|0|||
160696662|NCT02799095|580273349|FG012|Part C|Physician Decision|0|||
160696663|NCT02799095|580273350|FG013|Part C|Physician Decision|0|||
160696664|NCT02799095|580273351|FG014|Part C|Physician Decision|0|||
160696665|NCT02799095|580273352|FG015|Part C|Physician Decision|0|||
160696666|NCT02799095|580273353|FG016|Part C|Physician Decision|0|||
160696667|NCT02799095|580273337|FG000|Part C|Other|0|||
160696668|NCT02799095|580273338|FG001|Part C|Other|0|||
160696669|NCT02799095|580273339|FG002|Part C|Other|0|||
160696670|NCT02799095|580273340|FG003|Part C|Other|0|||
160696671|NCT02799095|580273341|FG004|Part C|Other|0|||
160696672|NCT02799095|580273342|FG005|Part C|Other|0|||
160696673|NCT02799095|580273343|FG006|Part C|Other|0|||
160696674|NCT02799095|580273344|FG007|Part C|Other|0|||
160696675|NCT02799095|580273345|FG008|Part C|Other|0|||
160696676|NCT02799095|580273346|FG009|Part C|Other|0|||
160696677|NCT02799095|580273347|FG010|Part C|Other|0|||
160696678|NCT02799095|580273348|FG011|Part C|Other|2|||
160696679|NCT02799095|580273349|FG012|Part C|Other|2|||
160696680|NCT02799095|580273350|FG013|Part C|Other|0|||
160696681|NCT02799095|580273351|FG014|Part C|Other|0|||
160696682|NCT02799095|580273352|FG015|Part C|Other|0|||
160696683|NCT02799095|580273353|FG016|Part C|Other|0|||
160696684|NCT03047473|580273358|FG000|Overall Study|Lost to Follow-up|2|||
160696685|NCT05327816|580273359|FG000|Overall Study|Lost to Follow-up|1|||
160696686|NCT05327816|580273360|FG001|Overall Study|Lost to Follow-up|0|||
160696687|NCT05327816|580273361|FG002|Overall Study|Lost to Follow-up|0|||
160696688|NCT05327816|580273362|FG003|Overall Study|Lost to Follow-up|0|||
160696689|NCT05327816|580273363|FG004|Overall Study|Lost to Follow-up|0|||
160696690|NCT05327816|580273364|FG005|Overall Study|Lost to Follow-up|0|||
160696691|NCT05327816|580273365|FG006|Overall Study|Lost to Follow-up|0|||
160696692|NCT05327816|580273366|FG007|Overall Study|Lost to Follow-up|0|||
160696693|NCT05327816|580273367|FG008|Overall Study|Lost to Follow-up|0|||
160696694|NCT05327816|580273368|FG009|Overall Study|Lost to Follow-up|1|||
160696695|NCT05327816|580273369|FG010|Overall Study|Lost to Follow-up|0|||
160696696|NCT05327816|580273359|FG000|Overall Study|Withdrawal by Subject|0|||
160696697|NCT05327816|580273360|FG001|Overall Study|Withdrawal by Subject|0|||
160696698|NCT05327816|580273361|FG002|Overall Study|Withdrawal by Subject|0|||
160696699|NCT05327816|580273362|FG003|Overall Study|Withdrawal by Subject|0|||
160696700|NCT05327816|580273363|FG004|Overall Study|Withdrawal by Subject|1|||
160696701|NCT05327816|580273364|FG005|Overall Study|Withdrawal by Subject|1|||
160696702|NCT05327816|580273365|FG006|Overall Study|Withdrawal by Subject|0|||
160696703|NCT05327816|580273366|FG007|Overall Study|Withdrawal by Subject|0|||
160696704|NCT05327816|580273367|FG008|Overall Study|Withdrawal by Subject|0|||
160696705|NCT05327816|580273368|FG009|Overall Study|Withdrawal by Subject|0|||
160696706|NCT05327816|580273369|FG010|Overall Study|Withdrawal by Subject|0|||
160696707|NCT05327816|580273359|FG000|Overall Study|Study Terminated by Sponsor|11|||
160696708|NCT05327816|580273360|FG001|Overall Study|Study Terminated by Sponsor|12|||
160696709|NCT05327816|580273361|FG002|Overall Study|Study Terminated by Sponsor|12|||
160696710|NCT05327816|580273362|FG003|Overall Study|Study Terminated by Sponsor|12|||
160696711|NCT05327816|580273363|FG004|Overall Study|Study Terminated by Sponsor|11|||
160696712|NCT05327816|580273364|FG005|Overall Study|Study Terminated by Sponsor|11|||
160696713|NCT05327816|580273365|FG006|Overall Study|Study Terminated by Sponsor|11|||
160696714|NCT05327816|580273366|FG007|Overall Study|Study Terminated by Sponsor|11|||
160696715|NCT05327816|580273367|FG008|Overall Study|Study Terminated by Sponsor|11|||
160696716|NCT05327816|580273368|FG009|Overall Study|Study Terminated by Sponsor|11|||
160696717|NCT05327816|580273369|FG010|Overall Study|Study Terminated by Sponsor|12|||
160696718|NCT05327816|580273359|FG000|Overall Study|Randomized but not treated|0|||
160696719|NCT05327816|580273360|FG001|Overall Study|Randomized but not treated|0|||
160696720|NCT05327816|580273361|FG002|Overall Study|Randomized but not treated|0|||
160696721|NCT05327816|580273362|FG003|Overall Study|Randomized but not treated|0|||
160696722|NCT05327816|580273363|FG004|Overall Study|Randomized but not treated|0|||
160696723|NCT05327816|580273364|FG005|Overall Study|Randomized but not treated|0|||
160696724|NCT05327816|580273365|FG006|Overall Study|Randomized but not treated|1|||
160696725|NCT05327816|580273366|FG007|Overall Study|Randomized but not treated|1|||
160696726|NCT05327816|580273367|FG008|Overall Study|Randomized but not treated|1|||
160696727|NCT05327816|580273368|FG009|Overall Study|Randomized but not treated|0|||
160696728|NCT05327816|580273369|FG010|Overall Study|Randomized but not treated|0|||
160696729|NCT00759902|580273370|FG000|Overall Study|Adverse Event|0|||
160696730|NCT00759902|580273371|FG001|Overall Study|Adverse Event|1|||
160696731|NCT00658658|580273376|FG000|Overall Study|Withdrawal by Subject|0|||
160696732|NCT00658658|580273377|FG001|Overall Study|Withdrawal by Subject|1|||
160696733|NCT00658658|580273378|FG002|Overall Study|Withdrawal by Subject|0|||
160696734|NCT00658658|580273379|FG003|Overall Study|Withdrawal by Subject|0|||
160696735|NCT00658658|580273380|FG004|Overall Study|Withdrawal by Subject|0|||
160696736|NCT00658658|580273376|FG000|Overall Study|Death|4|||
160696737|NCT00658658|580273377|FG001|Overall Study|Death|0|||
160696738|NCT00658658|580273378|FG002|Overall Study|Death|0|||
160696739|NCT00658658|580273379|FG003|Overall Study|Death|1|||
160696740|NCT00658658|580273380|FG004|Overall Study|Death|1|||
160696741|NCT00658658|580273376|FG000|Overall Study|Disease Progression|0|||
160696742|NCT00658658|580273377|FG001|Overall Study|Disease Progression|1|||
160696743|NCT00658658|580273378|FG002|Overall Study|Disease Progression|0|||
160696744|NCT00658658|580273379|FG003|Overall Study|Disease Progression|1|||
160696745|NCT00658658|580273380|FG004|Overall Study|Disease Progression|3|||
160696746|NCT00658658|580273376|FG000|Overall Study|Protocol-specified Criteria|1|||
160696747|NCT00658658|580273377|FG001|Overall Study|Protocol-specified Criteria|0|||
160696748|NCT00658658|580273378|FG002|Overall Study|Protocol-specified Criteria|0|||
160696749|NCT00658658|580273379|FG003|Overall Study|Protocol-specified Criteria|0|||
160696750|NCT00658658|580273380|FG004|Overall Study|Protocol-specified Criteria|0|||
160696751|NCT00658658|580273376|FG000|Overall Study|Other|0|||
160696752|NCT00658658|580273377|FG001|Overall Study|Other|0|||
160696753|NCT00658658|580273378|FG002|Overall Study|Other|0|||
160696754|NCT00658658|580273379|FG003|Overall Study|Other|0|||
160696755|NCT00658658|580273380|FG004|Overall Study|Other|1|||
160696756|NCT01167257|580273381|FG000|Overall Study|Lost to Follow-up|2|||
160696757|NCT01167257|580273382|FG001|Overall Study|Lost to Follow-up|2|||
160696758|NCT01167257|580273381|FG000|Overall Study|Withdrew consent|1|||
160696759|NCT01167257|580273382|FG001|Overall Study|Withdrew consent|1|||
160696760|NCT01175811|580273386|FG000|Overall Study|Adverse Event|1|||
160696761|NCT01175811|580273387|FG001|Overall Study|Adverse Event|1|||
160696762|NCT01175811|580273386|FG000|Overall Study|Entry criteria not met|3|||
160696763|NCT01175811|580273387|FG001|Overall Study|Entry criteria not met|1|||
160696764|NCT01175811|580273386|FG000|Overall Study|Lack of Efficacy|1|||
160696765|NCT01175811|580273387|FG001|Overall Study|Lack of Efficacy|0|||
160696766|NCT01175811|580273386|FG000|Overall Study|Lost to Follow-up|3|||
160696767|NCT01175811|580273387|FG001|Overall Study|Lost to Follow-up|2|||
160696768|NCT01175811|580273386|FG000|Overall Study|Physician Decision|1|||
160696769|NCT01175811|580273387|FG001|Overall Study|Physician Decision|1|||
160696770|NCT01175811|580273386|FG000|Overall Study|Protocol Violation|1|||
160696771|NCT01175811|580273387|FG001|Overall Study|Protocol Violation|2|||
160696772|NCT01175811|580273386|FG000|Overall Study|Withdrawal by Subject|6|||
160696773|NCT01175811|580273387|FG001|Overall Study|Withdrawal by Subject|7|||
160696774|NCT02628743|580273390|FG000|Overall Study|Other|3|||
160696775|NCT02628743|580273390|FG000|Overall Study|Withdrawal by Subject|50|||
160696776|NCT02628743|580273390|FG000|Overall Study|Study Terminated by Sponsor|76|||
160696777|NCT02628743|580273390|FG000|Overall Study|Physician Decision|2|||
160696778|NCT04715932|580273391|FG000|Overall Study|Lost to Follow-up|1|||
160696779|NCT04715932|580273392|FG001|Overall Study|Lost to Follow-up|0|||
160696780|NCT03560986|580273393|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
160696781|NCT03560986|580273394|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
160696782|NCT03560986|580273393|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
160696783|NCT03560986|580273394|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
160696784|NCT03560986|580273393|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
160696785|NCT03560986|580273394|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
160696786|NCT03560986|580273393|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
160696787|NCT03560986|580273394|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
160696788|NCT03560986|580273393|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
160696789|NCT03560986|580273394|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
160696790|NCT03560986|580273393|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
160696791|NCT03560986|580273394|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
160696792|NCT03560986|580273393|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
160696793|NCT03560986|580273394|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
160696794|NCT00326963|580273395|FG000|Overall Study|Adverse Event|2|||
160696795|NCT00326963|580273395|FG000|Overall Study|Injection site reaction|1|||
160696796|NCT00326963|580273395|FG000|Overall Study|Death|1|||
160696797|NCT00326963|580273395|FG000|Overall Study|Failure to return|10|||
160696798|NCT00326963|580273395|FG000|Overall Study|Withdrawal by Subject|10|||
160696799|NCT00326963|580273395|FG000|Overall Study|Refused treatment / did not cooperate|5|||
160696800|NCT00326963|580273395|FG000|Overall Study|Violation of selection criteria at entry|2|||
160696801|NCT00326963|580273395|FG000|Overall Study|Other protocol violation|1|||
160696802|NCT00326963|580273395|FG000|Overall Study|Administrative / other|1|||
160696803|NCT04645966|580273396|FG000|Vaccination Phase|Adverse Event|1|||
160696804|NCT04645966|580273397|FG001|Vaccination Phase|Adverse Event|0|||
160696805|NCT04645966|580273398|FG002|Vaccination Phase|Adverse Event|0|||
160696806|NCT04645966|580273399|FG003|Vaccination Phase|Adverse Event|0|||
160696807|NCT04645966|580273400|FG004|Vaccination Phase|Adverse Event|0|||
160696808|NCT04645966|580273401|FG005|Vaccination Phase|Adverse Event|0|||
160696809|NCT04645966|580273402|FG006|Vaccination Phase|Adverse Event|1|||
160696810|NCT04645966|580273403|FG007|Vaccination Phase|Adverse Event|0|||
160696811|NCT04645966|580273404|FG008|Vaccination Phase|Adverse Event|0|||
160696812|NCT04645966|580273396|FG000|Vaccination Phase|Death|0|||
160696813|NCT04645966|580273397|FG001|Vaccination Phase|Death|0|||
160696814|NCT04645966|580273398|FG002|Vaccination Phase|Death|0|||
160696815|NCT04645966|580273399|FG003|Vaccination Phase|Death|0|||
160696816|NCT04645966|580273400|FG004|Vaccination Phase|Death|0|||
160696817|NCT04645966|580273401|FG005|Vaccination Phase|Death|1|||
160696818|NCT04645966|580273402|FG006|Vaccination Phase|Death|0|||
160696819|NCT04645966|580273403|FG007|Vaccination Phase|Death|0|||
160696820|NCT04645966|580273404|FG008|Vaccination Phase|Death|0|||
160696821|NCT04645966|580273396|FG000|Vaccination Phase|Protocol Violation|0|||
160696822|NCT04645966|580273397|FG001|Vaccination Phase|Protocol Violation|0|||
160696823|NCT04645966|580273398|FG002|Vaccination Phase|Protocol Violation|0|||
160696824|NCT04645966|580273399|FG003|Vaccination Phase|Protocol Violation|0|||
160696825|NCT04645966|580273400|FG004|Vaccination Phase|Protocol Violation|1|||
160696826|NCT04645966|580273401|FG005|Vaccination Phase|Protocol Violation|0|||
160696827|NCT04645966|580273402|FG006|Vaccination Phase|Protocol Violation|0|||
160696828|NCT04645966|580273403|FG007|Vaccination Phase|Protocol Violation|0|||
160696829|NCT04645966|580273404|FG008|Vaccination Phase|Protocol Violation|0|||
160696830|NCT04645966|580273396|FG000|Vaccination Phase|Study terminated by sponsor|0|||
160696831|NCT04645966|580273397|FG001|Vaccination Phase|Study terminated by sponsor|0|||
160696832|NCT04645966|580273398|FG002|Vaccination Phase|Study terminated by sponsor|14|||
160696833|NCT04645966|580273399|FG003|Vaccination Phase|Study terminated by sponsor|15|||
160696834|NCT04645966|580273400|FG004|Vaccination Phase|Study terminated by sponsor|47|||
160696835|NCT04645966|580273401|FG005|Vaccination Phase|Study terminated by sponsor|43|||
160696836|NCT04645966|580273402|FG006|Vaccination Phase|Study terminated by sponsor|29|||
160696837|NCT04645966|580273403|FG007|Vaccination Phase|Study terminated by sponsor|29|||
160696838|NCT04645966|580273404|FG008|Vaccination Phase|Study terminated by sponsor|12|||
160696839|NCT04645966|580273396|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
160696840|NCT04645966|580273397|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
160696841|NCT04645966|580273398|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
160696842|NCT04645966|580273399|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
160696843|NCT04645966|580273400|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
160696844|NCT04645966|580273401|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
160696845|NCT04645966|580273402|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
160696846|NCT04645966|580273403|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
160696847|NCT04645966|580273404|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
160696848|NCT04645966|580273396|FG000|Vaccination Phase|Other|0|||
160696849|NCT04645966|580273397|FG001|Vaccination Phase|Other|0|||
160696850|NCT04645966|580273398|FG002|Vaccination Phase|Other|0|||
160696851|NCT04645966|580273399|FG003|Vaccination Phase|Other|0|||
160696852|NCT04645966|580273400|FG004|Vaccination Phase|Other|0|||
160696853|NCT04645966|580273401|FG005|Vaccination Phase|Other|2|||
160696854|NCT04645966|580273402|FG006|Vaccination Phase|Other|0|||
160696855|NCT04645966|580273403|FG007|Vaccination Phase|Other|0|||
160696856|NCT04645966|580273404|FG008|Vaccination Phase|Other|0|||
160696857|NCT04645966|580273396|FG000|Vaccination Phase|Lost to Follow-up|0|||
160696858|NCT04645966|580273397|FG001|Vaccination Phase|Lost to Follow-up|0|||
160696859|NCT04645966|580273398|FG002|Vaccination Phase|Lost to Follow-up|0|||
160696860|NCT04645966|580273399|FG003|Vaccination Phase|Lost to Follow-up|0|||
160696861|NCT04645966|580273400|FG004|Vaccination Phase|Lost to Follow-up|0|||
160696862|NCT04645966|580273401|FG005|Vaccination Phase|Lost to Follow-up|0|||
160696863|NCT04645966|580273402|FG006|Vaccination Phase|Lost to Follow-up|0|||
160696864|NCT04645966|580273403|FG007|Vaccination Phase|Lost to Follow-up|1|||
160696865|NCT04645966|580273404|FG008|Vaccination Phase|Lost to Follow-up|0|||
160696866|NCT04645966|580273396|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
160696867|NCT04645966|580273397|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
160696868|NCT04645966|580273398|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
160696869|NCT04645966|580273399|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
160696870|NCT04645966|580273400|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
160696871|NCT04645966|580273401|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
160696872|NCT04645966|580273402|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
160696873|NCT04645966|580273403|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
160696874|NCT04645966|580273404|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
160696875|NCT04645966|580273396|FG000|Follow-up Phase|Lost to Follow-up|0|||
160696876|NCT04645966|580273397|FG001|Follow-up Phase|Lost to Follow-up|0|||
160696877|NCT04645966|580273398|FG002|Follow-up Phase|Lost to Follow-up|0|||
160696878|NCT04645966|580273399|FG003|Follow-up Phase|Lost to Follow-up|0|||
160696879|NCT04645966|580273400|FG004|Follow-up Phase|Lost to Follow-up|0|||
160696880|NCT04645966|580273401|FG005|Follow-up Phase|Lost to Follow-up|0|||
160696881|NCT04645966|580273402|FG006|Follow-up Phase|Lost to Follow-up|0|||
160696882|NCT04645966|580273403|FG007|Follow-up Phase|Lost to Follow-up|1|||
160696883|NCT04645966|580273404|FG008|Follow-up Phase|Lost to Follow-up|0|||
160696884|NCT00552578|580273408|FG000|Overall Study|Lost to Follow-up|1|||
160696885|NCT00552578|580273409|FG001|Overall Study|Lost to Follow-up|1|||
160696886|NCT01739348|580273416|FG000|Part I (Base Study)|Adverse Event|41|||
160696887|NCT01739348|580273417|FG001|Part I (Base Study)|Adverse Event|52|||
160696888|NCT01739348|580273418|FG002|Part I (Base Study)|Adverse Event|8|||
160696889|NCT01739348|580273419|FG003|Part I (Base Study)|Adverse Event|33|||
160696890|NCT01739348|580273416|FG000|Part I (Base Study)|Death|10|||
160696891|NCT01739348|580273417|FG001|Part I (Base Study)|Death|7|||
160696892|NCT01739348|580273418|FG002|Part I (Base Study)|Death|2|||
160696893|NCT01739348|580273419|FG003|Part I (Base Study)|Death|8|||
160696894|NCT01739348|580273416|FG000|Part I (Base Study)|Lack of Efficacy|3|||
160696895|NCT01739348|580273417|FG001|Part I (Base Study)|Lack of Efficacy|8|||
160696896|NCT01739348|580273418|FG002|Part I (Base Study)|Lack of Efficacy|0|||
160696897|NCT01739348|580273419|FG003|Part I (Base Study)|Lack of Efficacy|7|||
160696898|NCT01739348|580273416|FG000|Part I (Base Study)|Lost to Follow-up|4|||
160696899|NCT01739348|580273417|FG001|Part I (Base Study)|Lost to Follow-up|2|||
160696900|NCT01739348|580273418|FG002|Part I (Base Study)|Lost to Follow-up|4|||
160696901|NCT01739348|580273419|FG003|Part I (Base Study)|Lost to Follow-up|4|||
160696902|NCT01739348|580273416|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
160696903|NCT01739348|580273417|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
160696904|NCT01739348|580273418|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
160696905|NCT01739348|580273419|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
160696906|NCT01739348|580273416|FG000|Part I (Base Study)|Physician Decision|10|||
160696907|NCT01739348|580273417|FG001|Part I (Base Study)|Physician Decision|7|||
160696908|NCT01739348|580273418|FG002|Part I (Base Study)|Physician Decision|1|||
160696909|NCT01739348|580273419|FG003|Part I (Base Study)|Physician Decision|4|||
160696910|NCT01739348|580273416|FG000|Part I (Base Study)|Protocol Violation|2|||
160696911|NCT01739348|580273417|FG001|Part I (Base Study)|Protocol Violation|0|||
160696912|NCT01739348|580273418|FG002|Part I (Base Study)|Protocol Violation|1|||
160696913|NCT01739348|580273419|FG003|Part I (Base Study)|Protocol Violation|2|||
160696914|NCT01739348|580273416|FG000|Part I (Base Study)|Screen Failure|2|||
160696915|NCT01739348|580273417|FG001|Part I (Base Study)|Screen Failure|0|||
160696916|NCT01739348|580273418|FG002|Part I (Base Study)|Screen Failure|0|||
160696917|NCT01739348|580273419|FG003|Part I (Base Study)|Screen Failure|0|||
160696918|NCT01739348|580273416|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
160696919|NCT01739348|580273417|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
160696920|NCT01739348|580273418|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
160696921|NCT01739348|580273419|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
160696922|NCT01739348|580273416|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
160696923|NCT01739348|580273417|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
160696924|NCT01739348|580273418|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
160696925|NCT01739348|580273419|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
160696926|NCT01739348|580273416|FG000|Part I (Base Study)|Participant Moved|4|||
160696927|NCT01739348|580273417|FG001|Part I (Base Study)|Participant Moved|3|||
160696928|NCT01739348|580273418|FG002|Part I (Base Study)|Participant Moved|1|||
160696929|NCT01739348|580273419|FG003|Part I (Base Study)|Participant Moved|7|||
160696930|NCT01739348|580273416|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
160696931|NCT01739348|580273417|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
160696932|NCT01739348|580273418|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
160696933|NCT01739348|580273419|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
160696934|NCT01739348|580273416|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
160696935|NCT01739348|580273417|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
160696936|NCT01739348|580273418|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
160696937|NCT01739348|580273419|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
160696938|NCT01739348|580273416|FG000|Part II (Extension Study)|Adverse Event|10|||
160696939|NCT01739348|580273417|FG001|Part II (Extension Study)|Adverse Event|11|||
160696940|NCT01739348|580273418|FG002|Part II (Extension Study)|Adverse Event|7|||
160696941|NCT01739348|580273419|FG003|Part II (Extension Study)|Adverse Event|26|||
160696942|NCT01739348|580273416|FG000|Part II (Extension Study)|Death|3|||
160696943|NCT01739348|580273417|FG001|Part II (Extension Study)|Death|3|||
160696944|NCT01739348|580273418|FG002|Part II (Extension Study)|Death|2|||
160696945|NCT01739348|580273419|FG003|Part II (Extension Study)|Death|6|||
160696946|NCT01739348|580273416|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
160696947|NCT01739348|580273417|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
160696948|NCT01739348|580273418|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
160696949|NCT01739348|580273419|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
160696950|NCT01739348|580273416|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
160696951|NCT01739348|580273417|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
160696952|NCT01739348|580273418|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
160696953|NCT01739348|580273419|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
160696954|NCT01739348|580273416|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
160696955|NCT01739348|580273417|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
160696956|NCT01739348|580273418|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
160696957|NCT01739348|580273419|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
160696958|NCT01739348|580273416|FG000|Part II (Extension Study)|Physician Decision|7|||
160696959|NCT01739348|580273417|FG001|Part II (Extension Study)|Physician Decision|11|||
160696960|NCT01739348|580273418|FG002|Part II (Extension Study)|Physician Decision|6|||
160696961|NCT01739348|580273419|FG003|Part II (Extension Study)|Physician Decision|12|||
160696962|NCT01739348|580273416|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
160696963|NCT01739348|580273417|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
160696964|NCT01739348|580273418|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
160696965|NCT01739348|580273419|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
160696966|NCT01739348|580273416|FG000|Part II (Extension Study)|Participant Moved|3|||
160696967|NCT01739348|580273417|FG001|Part II (Extension Study)|Participant Moved|3|||
160696968|NCT01739348|580273418|FG002|Part II (Extension Study)|Participant Moved|0|||
160696969|NCT01739348|580273419|FG003|Part II (Extension Study)|Participant Moved|3|||
160696970|NCT01739348|580273416|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
160696971|NCT01739348|580273417|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
160696972|NCT01739348|580273418|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
160696973|NCT01739348|580273419|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
160696974|NCT01739348|580273416|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
160696975|NCT01739348|580273417|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
160696976|NCT01739348|580273418|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
160696977|NCT01739348|580273419|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
160696978|NCT01447420|580273426|FG000|Overall Study|Adverse Event|2|||
160696979|NCT01447420|580273427|FG001|Overall Study|Adverse Event|4|||
160696980|NCT01447420|580273428|FG002|Overall Study|Adverse Event|2|||
160696981|NCT01447420|580273426|FG000|Overall Study|Protocol Violation|3|||
160696982|NCT01447420|580273427|FG001|Overall Study|Protocol Violation|3|||
160696983|NCT01447420|580273428|FG002|Overall Study|Protocol Violation|0|||
160696984|NCT01447420|580273426|FG000|Overall Study|Withdrawal by Subject|4|||
160696985|NCT01447420|580273427|FG001|Overall Study|Withdrawal by Subject|1|||
160696986|NCT01447420|580273428|FG002|Overall Study|Withdrawal by Subject|0|||
160696987|NCT01447420|580273426|FG000|Overall Study|Lack of Efficacy|1|||
160696988|NCT01447420|580273427|FG001|Overall Study|Lack of Efficacy|19|||
160696989|NCT01447420|580273428|FG002|Overall Study|Lack of Efficacy|8|||
160696990|NCT01085201|580273435|FG000|Overall Study|Scheduling conflict|1|||
160696991|NCT01085201|580273436|FG001|Overall Study|Scheduling conflict|0|||
160696992|NCT01085201|580273437|FG002|Overall Study|Scheduling conflict|1|||
160696993|NCT01085201|580273438|FG003|Overall Study|Scheduling conflict|0|||
160696994|NCT01085201|580273439|FG004|Overall Study|Scheduling conflict|0|||
160696995|NCT01085201|580273435|FG000|Overall Study|Unknown- no study drug|2|||
160696996|NCT01085201|580273436|FG001|Overall Study|Unknown- no study drug|0|||
160696997|NCT01085201|580273437|FG002|Overall Study|Unknown- no study drug|0|||
160696998|NCT01085201|580273438|FG003|Overall Study|Unknown- no study drug|0|||
160696999|NCT01085201|580273439|FG004|Overall Study|Unknown- no study drug|0|||
160697000|NCT01085201|580273435|FG000|Overall Study|Fond ineligible after consent|0|||
160697001|NCT01085201|580273436|FG001|Overall Study|Fond ineligible after consent|1|||
160697002|NCT01085201|580273437|FG002|Overall Study|Fond ineligible after consent|1|||
160697003|NCT01085201|580273438|FG003|Overall Study|Fond ineligible after consent|0|||
160697004|NCT01085201|580273439|FG004|Overall Study|Fond ineligible after consent|0|||
160697005|NCT00528411|580273440|FG000|Overall Study|Adverse Event|4|||
160697006|NCT00528411|580273441|FG001|Overall Study|Adverse Event|0|||
160697007|NCT00528411|580273442|FG002|Overall Study|Adverse Event|1|||
160697008|NCT00528411|580273440|FG000|Overall Study|Incorrect Enrolment|1|||
160697009|NCT00528411|580273441|FG001|Overall Study|Incorrect Enrolment|1|||
160697010|NCT00528411|580273442|FG002|Overall Study|Incorrect Enrolment|0|||
160697011|NCT00528411|580273440|FG000|Overall Study|Severe non-compliance to protocol|0|||
160697012|NCT00528411|580273441|FG001|Overall Study|Severe non-compliance to protocol|1|||
160697013|NCT00528411|580273442|FG002|Overall Study|Severe non-compliance to protocol|0|||
160697014|NCT00528411|580273440|FG000|Overall Study|Prior commitment medication|0|||
160697015|NCT00528411|580273441|FG001|Overall Study|Prior commitment medication|1|||
160697016|NCT00528411|580273442|FG002|Overall Study|Prior commitment medication|0|||
160697017|NCT03893565|580273443|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
160697018|NCT03893565|580273444|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
160697019|NCT03893565|580273445|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
160697020|NCT03893565|580273446|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
160697021|NCT03893565|580273447|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
160697022|NCT03893565|580273448|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
160697023|NCT03893565|580273449|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
160697024|NCT03893565|580273450|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
160697025|NCT03893565|580273451|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
160697026|NCT03893565|580273443|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
160697027|NCT03893565|580273444|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
160697028|NCT03893565|580273445|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
160697029|NCT03893565|580273446|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
160697030|NCT03893565|580273447|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
160697031|NCT03893565|580273448|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
160697032|NCT03893565|580273449|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
160697033|NCT03893565|580273450|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
160697034|NCT03893565|580273451|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
160697035|NCT03893565|580273443|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697036|NCT03893565|580273444|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
160697037|NCT03893565|580273445|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697038|NCT03893565|580273446|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
160697039|NCT03893565|580273447|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697040|NCT03893565|580273448|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697041|NCT03893565|580273449|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697042|NCT03893565|580273450|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697043|NCT03893565|580273451|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697044|NCT03893565|580273443|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
160697045|NCT03893565|580273444|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
160697046|NCT03893565|580273445|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
160697047|NCT03893565|580273446|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
160697048|NCT03893565|580273447|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
160697049|NCT03893565|580273448|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
160697050|NCT03893565|580273449|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
160697051|NCT03893565|580273450|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
160697052|NCT03893565|580273451|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
160697053|NCT03893565|580273443|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
160697054|NCT03893565|580273444|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
160697055|NCT03893565|580273445|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
160697056|NCT03893565|580273446|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697057|NCT03893565|580273447|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
160697058|NCT03893565|580273448|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697059|NCT03893565|580273449|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697060|NCT03893565|580273450|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697061|NCT03893565|580273451|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697062|NCT03893565|580273443|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
160697063|NCT03893565|580273444|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
160697064|NCT03893565|580273445|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
160697065|NCT03893565|580273446|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
160697066|NCT03893565|580273447|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
160697067|NCT03893565|580273448|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
160697068|NCT03893565|580273449|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
160697069|NCT03893565|580273450|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
160697070|NCT03893565|580273451|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
160697071|NCT03893565|580273443|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697072|NCT03893565|580273444|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697073|NCT03893565|580273445|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697074|NCT03893565|580273446|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
160697075|NCT03893565|580273447|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697076|NCT03893565|580273448|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697077|NCT03893565|580273449|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697078|NCT03893565|580273450|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697079|NCT03893565|580273451|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697080|NCT03893565|580273443|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
160697081|NCT03893565|580273444|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
160697082|NCT03893565|580273445|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
160697083|NCT03893565|580273446|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
160697084|NCT03893565|580273447|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
160697085|NCT03893565|580273448|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
160697086|NCT03893565|580273449|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
160697087|NCT03893565|580273450|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
160697088|NCT03893565|580273451|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
160697089|NCT03893565|580273443|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
160697090|NCT03893565|580273444|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
160697091|NCT03893565|580273445|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
160697092|NCT03893565|580273446|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
160697093|NCT03893565|580273447|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
160697094|NCT03893565|580273448|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
160697095|NCT03893565|580273449|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
160697096|NCT03893565|580273450|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
160697097|NCT03893565|580273451|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
160697098|NCT03893565|580273443|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
160697099|NCT03893565|580273444|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
160697100|NCT03893565|580273445|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
160697101|NCT03893565|580273446|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
160697102|NCT03893565|580273447|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
160697103|NCT03893565|580273448|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
160697104|NCT03893565|580273449|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
160697105|NCT03893565|580273450|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
160697106|NCT03893565|580273451|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
160697107|NCT03893565|580273443|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
160697108|NCT03893565|580273444|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
160697109|NCT03893565|580273445|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
160697110|NCT03893565|580273446|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
160697111|NCT03893565|580273447|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
160697112|NCT03893565|580273448|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
160697113|NCT03893565|580273449|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
160697114|NCT03893565|580273450|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
160697115|NCT03893565|580273451|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
160697116|NCT03893565|580273443|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
160697117|NCT03893565|580273444|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
160697118|NCT03893565|580273445|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
160697119|NCT03893565|580273446|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
160697120|NCT03893565|580273447|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
160697121|NCT03893565|580273448|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
160697122|NCT03893565|580273449|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
160697123|NCT03893565|580273450|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
160697124|NCT03893565|580273451|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
160697125|NCT03893565|580273443|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697126|NCT03893565|580273444|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697127|NCT03893565|580273445|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697128|NCT03893565|580273446|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697129|NCT03893565|580273447|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697130|NCT03893565|580273448|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697131|NCT03893565|580273449|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697132|NCT03893565|580273450|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
160697133|NCT03893565|580273451|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160697134|NCT03893565|580273443|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697135|NCT03893565|580273444|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697136|NCT03893565|580273445|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697137|NCT03893565|580273446|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697138|NCT03893565|580273447|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697139|NCT03893565|580273448|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697140|NCT03893565|580273449|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697141|NCT03893565|580273450|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
160697142|NCT03893565|580273451|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160697143|NCT03893565|580273443|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697144|NCT03893565|580273444|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697145|NCT03893565|580273445|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697146|NCT03893565|580273446|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697147|NCT03893565|580273447|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697148|NCT03893565|580273448|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697149|NCT03893565|580273449|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697150|NCT03893565|580273450|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
160697151|NCT03893565|580273451|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
160697152|NCT03893565|580273443|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
160697153|NCT03893565|580273444|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
160697154|NCT03893565|580273445|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
160697155|NCT03893565|580273446|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
160697156|NCT03893565|580273447|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
160697157|NCT03893565|580273448|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
160697158|NCT03893565|580273449|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
160697159|NCT03893565|580273450|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
160697160|NCT03893565|580273451|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
160697161|NCT02695537|580273452|FG000|Overall Study|Adverse Event|3|||
160697162|NCT02695537|580273452|FG000|Overall Study|Lack of Efficacy|28|||
160697163|NCT02695537|580273452|FG000|Overall Study|Withdrawal by Subject|4|||
160697164|NCT02695537|580273452|FG000|Overall Study|Protocol Violation|3|||
160697165|NCT02792699|580273453|FG000|Overall Study|Adverse Event|1|||
160697166|NCT02792699|580273454|FG001|Overall Study|Adverse Event|2|||
160697167|NCT02792699|580273455|FG002|Overall Study|Adverse Event|4|||
160697168|NCT02792699|580273453|FG000|Overall Study|Withdrawal by Subject|4|||
160697169|NCT02792699|580273454|FG001|Overall Study|Withdrawal by Subject|4|||
160697170|NCT02792699|580273455|FG002|Overall Study|Withdrawal by Subject|3|||
160697171|NCT02792699|580273453|FG000|Overall Study|Lost to Follow-up|0|||
160697172|NCT02792699|580273454|FG001|Overall Study|Lost to Follow-up|1|||
160697173|NCT02792699|580273455|FG002|Overall Study|Lost to Follow-up|2|||
160697174|NCT02792699|580273453|FG000|Overall Study|Physician Decision|2|||
160697175|NCT02792699|580273454|FG001|Overall Study|Physician Decision|0|||
160697176|NCT02792699|580273455|FG002|Overall Study|Physician Decision|0|||
160697177|NCT02792699|580273453|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
160697178|NCT02792699|580273454|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
160697179|NCT02792699|580273455|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
160697180|NCT02792699|580273453|FG000|Overall Study|Other|1|||
160697181|NCT02792699|580273454|FG001|Overall Study|Other|0|||
160697182|NCT02792699|580273455|FG002|Overall Study|Other|0|||
160697183|NCT01715571|580273458|FG000|Overall Study|Lost to Follow-up|8|||
160697184|NCT03870477|580273463|FG000|Overall Study|Early Study Termination|1|||
160697185|NCT02256436|580273472|FG000|Overall Study|Adverse Event|9|||
160697186|NCT02256436|580273473|FG001|Overall Study|Adverse Event|14|||
160697187|NCT02256436|580273472|FG000|Overall Study|Death|216|||
160697188|NCT02256436|580273473|FG001|Overall Study|Death|208|||
160697189|NCT02256436|580273472|FG000|Overall Study|Lost to Follow-up|1|||
160697190|NCT02256436|580273473|FG001|Overall Study|Lost to Follow-up|2|||
160697191|NCT02256436|580273472|FG000|Overall Study|Physician Decision|1|||
160697192|NCT02256436|580273473|FG001|Overall Study|Physician Decision|0|||
160697193|NCT02256436|580273472|FG000|Overall Study|Protocol Violation|0|||
160697194|NCT02256436|580273473|FG001|Overall Study|Protocol Violation|1|||
160697195|NCT02256436|580273472|FG000|Overall Study|Withdrawal by Subject|26|||
160697196|NCT02256436|580273473|FG001|Overall Study|Withdrawal by Subject|10|||
160697197|NCT02256436|580273472|FG000|Overall Study|Transferred to Extension Study|11|||
160697198|NCT02256436|580273473|FG001|Overall Study|Transferred to Extension Study|23|||
160697199|NCT02256436|580273472|FG000|Overall Study|Did Not Continue on Extension Study|8|||
160697200|NCT02256436|580273473|FG001|Overall Study|Did Not Continue on Extension Study|12|||
160697201|NCT05961215|580273474|FG000|Overall Study|Withdrawal by Subject|1|||
160697202|NCT00077857|580273477|FG000|Overall Study|Adverse Event|30|||
160697203|NCT00077857|580273478|FG001|Overall Study|Adverse Event|32|||
160697204|NCT00077857|580273477|FG000|Overall Study|Death|7|||
160697205|NCT00077857|580273478|FG001|Overall Study|Death|3|||
160697206|NCT00077857|580273477|FG000|Overall Study|Insufficient therapeutic response|112|||
160697207|NCT00077857|580273478|FG001|Overall Study|Insufficient therapeutic response|128|||
160697208|NCT00077857|580273477|FG000|Overall Study|Violation of selection criteria at entry|3|||
160697209|NCT00077857|580273478|FG001|Overall Study|Violation of selection criteria at entry|1|||
160697210|NCT00077857|580273477|FG000|Overall Study|Other protocol violation|0|||
160697211|NCT00077857|580273478|FG001|Overall Study|Other protocol violation|1|||
160697212|NCT00077857|580273477|FG000|Overall Study|Refused treatment|29|||
160697213|NCT00077857|580273478|FG001|Overall Study|Refused treatment|21|||
160697214|NCT00077857|580273477|FG000|Overall Study|Failure to return|5|||
160697215|NCT00077857|580273478|FG001|Overall Study|Failure to return|5|||
160697216|NCT00077857|580273477|FG000|Overall Study|Other|15|||
160697217|NCT00077857|580273478|FG001|Overall Study|Other|13|||
160697218|NCT05084963|580273482|FG000|Overall Study|Withdrawal by Subject|0|||
160697219|NCT05084963|580273483|FG001|Overall Study|Withdrawal by Subject|0|||
160697220|NCT05084963|580273484|FG002|Overall Study|Withdrawal by Subject|1|||
160697221|NCT06187909|580273485|FG000|Overall Study|Withdrawal by Subject|2|||
160697222|NCT06187909|580273486|FG001|Overall Study|Withdrawal by Subject|2|||
160697223|NCT03569228|580273487|FG000|Overall Study|Withdrawal by PI|0|||
160697224|NCT03569228|580273488|FG001|Overall Study|Withdrawal by PI|0|||
160697225|NCT03569228|580273489|FG002|Overall Study|Withdrawal by PI|2|||
160697226|NCT03569228|580273490|FG003|Overall Study|Withdrawal by PI|2|||
160697227|NCT03569228|580273491|FG004|Overall Study|Withdrawal by PI|1|||
160697228|NCT03569228|580273492|FG005|Overall Study|Withdrawal by PI|0|||
160697229|NCT03569228|580273493|FG006|Overall Study|Withdrawal by PI|0|||
160697230|NCT03569228|580273494|FG007|Overall Study|Withdrawal by PI|0|||
160697231|NCT03569228|580273495|FG008|Overall Study|Withdrawal by PI|0|||
160697232|NCT03569228|580273487|FG000|Overall Study|Lost to Follow-up|0|||
160697233|NCT03569228|580273488|FG001|Overall Study|Lost to Follow-up|0|||
160697234|NCT03569228|580273489|FG002|Overall Study|Lost to Follow-up|0|||
160697235|NCT03569228|580273490|FG003|Overall Study|Lost to Follow-up|0|||
160697236|NCT03569228|580273491|FG004|Overall Study|Lost to Follow-up|0|||
160697237|NCT03569228|580273492|FG005|Overall Study|Lost to Follow-up|0|||
160697238|NCT03569228|580273493|FG006|Overall Study|Lost to Follow-up|0|||
160697239|NCT03569228|580273494|FG007|Overall Study|Lost to Follow-up|0|||
160697240|NCT03569228|580273495|FG008|Overall Study|Lost to Follow-up|1|||
160697241|NCT03569228|580273487|FG000|Overall Study|Screen Fail|2|||
160697242|NCT03569228|580273488|FG001|Overall Study|Screen Fail|2|||
160697243|NCT03569228|580273489|FG002|Overall Study|Screen Fail|1|||
160697244|NCT03569228|580273490|FG003|Overall Study|Screen Fail|1|||
160697245|NCT03569228|580273491|FG004|Overall Study|Screen Fail|1|||
160697246|NCT03569228|580273492|FG005|Overall Study|Screen Fail|3|||
160697247|NCT03569228|580273493|FG006|Overall Study|Screen Fail|1|||
160697248|NCT03569228|580273494|FG007|Overall Study|Screen Fail|5|||
160697249|NCT03569228|580273495|FG008|Overall Study|Screen Fail|2|||
160697250|NCT06354998|580273496|FG000|Overall Study|Withdrawal by Subject|3|||
160697251|NCT06354998|580273497|FG001|Overall Study|Withdrawal by Subject|0|||
160697252|NCT05442866|580273498|FG000|Overall Study|Death|1|||
160697253|NCT05442866|580273498|FG000|Overall Study|Lost to Follow-up|9|||
160697254|NCT05442866|580273498|FG000|Overall Study|Protocol Violation|1|||
160697255|NCT03819049|580273499|FG000|Overall Study|Lost to Follow-up|1|||
160697256|NCT03819049|580273500|FG001|Overall Study|Lost to Follow-up|2|||
160697257|NCT03819049|580273501|FG002|Overall Study|Lost to Follow-up|9|||
160697258|NCT03819049|580273502|FG003|Overall Study|Lost to Follow-up|0|||
160697259|NCT03819049|580273503|FG004|Overall Study|Lost to Follow-up|3|||
160697260|NCT03819049|580273504|FG005|Overall Study|Lost to Follow-up|1|||
160697261|NCT03819049|580273505|FG006|Overall Study|Lost to Follow-up|0|||
160697262|NCT03819049|580273499|FG000|Overall Study|Withdrawal by Subject|0|||
160697263|NCT03819049|580273500|FG001|Overall Study|Withdrawal by Subject|0|||
160697264|NCT03819049|580273501|FG002|Overall Study|Withdrawal by Subject|18|||
160697265|NCT03819049|580273502|FG003|Overall Study|Withdrawal by Subject|0|||
160697266|NCT03819049|580273503|FG004|Overall Study|Withdrawal by Subject|10|||
160697267|NCT03819049|580273504|FG005|Overall Study|Withdrawal by Subject|9|||
160697268|NCT03819049|580273505|FG006|Overall Study|Withdrawal by Subject|1|||
160697269|NCT03819049|580273499|FG000|Overall Study|Ongoing|0|||
160697270|NCT03819049|580273500|FG001|Overall Study|Ongoing|0|||
160697271|NCT03819049|580273501|FG002|Overall Study|Ongoing|75|||
160697272|NCT03819049|580273502|FG003|Overall Study|Ongoing|0|||
160697273|NCT03819049|580273503|FG004|Overall Study|Ongoing|41|||
160697274|NCT03819049|580273504|FG005|Overall Study|Ongoing|0|||
160697275|NCT03819049|580273505|FG006|Overall Study|Ongoing|0|||
160697276|NCT03819049|580273499|FG000|Overall Study|Other|0|||
160697277|NCT03819049|580273500|FG001|Overall Study|Other|0|||
160697278|NCT03819049|580273501|FG002|Overall Study|Other|2|||
160697279|NCT03819049|580273502|FG003|Overall Study|Other|0|||
160697280|NCT03819049|580273503|FG004|Overall Study|Other|0|||
160697281|NCT03819049|580273504|FG005|Overall Study|Other|0|||
160697282|NCT03819049|580273505|FG006|Overall Study|Other|0|||
160697283|NCT03819049|580273499|FG000|Overall Study|Randomized but not vaccinated|0|||
160697284|NCT03819049|580273500|FG001|Overall Study|Randomized but not vaccinated|0|||
160697285|NCT03819049|580273501|FG002|Overall Study|Randomized but not vaccinated|0|||
160697286|NCT03819049|580273502|FG003|Overall Study|Randomized but not vaccinated|1|||
160697287|NCT03819049|580273503|FG004|Overall Study|Randomized but not vaccinated|0|||
160697288|NCT03819049|580273504|FG005|Overall Study|Randomized but not vaccinated|2|||
160697289|NCT03819049|580273505|FG006|Overall Study|Randomized but not vaccinated|1|||
160697290|NCT03819049|580273499|FG000|Overall Study|Physician Decision|0|||
160697291|NCT03819049|580273500|FG001|Overall Study|Physician Decision|0|||
160697292|NCT03819049|580273501|FG002|Overall Study|Physician Decision|0|||
160697293|NCT03819049|580273502|FG003|Overall Study|Physician Decision|0|||
160697294|NCT03819049|580273503|FG004|Overall Study|Physician Decision|0|||
160697295|NCT03819049|580273504|FG005|Overall Study|Physician Decision|0|||
160697296|NCT03819049|580273505|FG006|Overall Study|Physician Decision|1|||
160697297|NCT01394952|580273506|FG000|Overall Study|Lost to Follow-up|0|||
160697298|NCT01394952|580273507|FG001|Overall Study|Lost to Follow-up|5|||
160697299|NCT01394952|580273506|FG000|Overall Study|Withdrawal by Subject|10|||
160697300|NCT01394952|580273507|FG001|Overall Study|Withdrawal by Subject|5|||
160697301|NCT01394952|580273506|FG000|Overall Study|Physician Decision|2|||
160697302|NCT01394952|580273507|FG001|Overall Study|Physician Decision|0|||
160697303|NCT01394952|580273506|FG000|Overall Study|Sponsor Decision|5|||
160697304|NCT01394952|580273507|FG001|Overall Study|Sponsor Decision|7|||
160697305|NCT01986010|580273508|FG000|Overall Study|Adverse Event|0|||
160697306|NCT01986010|580273509|FG001|Overall Study|Adverse Event|1|||
160697307|NCT01986010|580273510|FG002|Overall Study|Adverse Event|0|||
160697308|NCT01986010|580273511|FG003|Overall Study|Adverse Event|0|||
160697309|NCT01986010|580273512|FG004|Overall Study|Adverse Event|0|||
160697310|NCT01986010|580273513|FG005|Overall Study|Adverse Event|0|||
160697311|NCT01986010|580273514|FG006|Overall Study|Adverse Event|0|||
160697312|NCT01986010|580273515|FG007|Overall Study|Adverse Event|0|||
160697313|NCT01986010|580273516|FG008|Overall Study|Adverse Event|0|||
160697314|NCT01986010|580273517|FG009|Overall Study|Adverse Event|0|||
160697315|NCT01986010|580273518|FG010|Overall Study|Adverse Event|0|||
160697316|NCT01986010|580273519|FG011|Overall Study|Adverse Event|0|||
160697317|NCT01986010|580273520|FG012|Overall Study|Adverse Event|0|||
160697318|NCT01986010|580273521|FG013|Overall Study|Adverse Event|0|||
160697319|NCT01986010|580273522|FG014|Overall Study|Adverse Event|0|||
160697320|NCT01986010|580273523|FG015|Overall Study|Adverse Event|1|||
160697321|NCT01986010|580273524|FG016|Overall Study|Adverse Event|0|||
160697322|NCT01986010|580273508|FG000|Overall Study|Lost to Follow-up|2|||
160697323|NCT01986010|580273509|FG001|Overall Study|Lost to Follow-up|1|||
160697324|NCT01986010|580273510|FG002|Overall Study|Lost to Follow-up|2|||
160697325|NCT01986010|580273511|FG003|Overall Study|Lost to Follow-up|2|||
160697326|NCT01986010|580273512|FG004|Overall Study|Lost to Follow-up|2|||
160697327|NCT01986010|580273513|FG005|Overall Study|Lost to Follow-up|2|||
160697328|NCT01986010|580273514|FG006|Overall Study|Lost to Follow-up|0|||
160697329|NCT01986010|580273515|FG007|Overall Study|Lost to Follow-up|0|||
160697330|NCT01986010|580273516|FG008|Overall Study|Lost to Follow-up|4|||
160697331|NCT01986010|580273517|FG009|Overall Study|Lost to Follow-up|2|||
160697332|NCT01986010|580273518|FG010|Overall Study|Lost to Follow-up|0|||
160697333|NCT01986010|580273519|FG011|Overall Study|Lost to Follow-up|1|||
160697334|NCT01986010|580273520|FG012|Overall Study|Lost to Follow-up|1|||
160697335|NCT01986010|580273521|FG013|Overall Study|Lost to Follow-up|1|||
160697336|NCT01986010|580273522|FG014|Overall Study|Lost to Follow-up|2|||
160697337|NCT01986010|580273523|FG015|Overall Study|Lost to Follow-up|0|||
160697338|NCT01986010|580273524|FG016|Overall Study|Lost to Follow-up|0|||
160697339|NCT01986010|580273508|FG000|Overall Study|Physician Decision|0|||
160697340|NCT01986010|580273509|FG001|Overall Study|Physician Decision|0|||
160697341|NCT01986010|580273510|FG002|Overall Study|Physician Decision|0|||
160697342|NCT01986010|580273511|FG003|Overall Study|Physician Decision|0|||
160697343|NCT01986010|580273512|FG004|Overall Study|Physician Decision|0|||
160697344|NCT01986010|580273513|FG005|Overall Study|Physician Decision|0|||
160697345|NCT01986010|580273514|FG006|Overall Study|Physician Decision|0|||
160697346|NCT01986010|580273515|FG007|Overall Study|Physician Decision|0|||
160697347|NCT01986010|580273516|FG008|Overall Study|Physician Decision|0|||
160697348|NCT01986010|580273517|FG009|Overall Study|Physician Decision|0|||
160697349|NCT01986010|580273518|FG010|Overall Study|Physician Decision|0|||
160697350|NCT01986010|580273519|FG011|Overall Study|Physician Decision|0|||
160697351|NCT01986010|580273520|FG012|Overall Study|Physician Decision|0|||
160697352|NCT01986010|580273521|FG013|Overall Study|Physician Decision|0|||
160697353|NCT01986010|580273522|FG014|Overall Study|Physician Decision|1|||
160697354|NCT01986010|580273523|FG015|Overall Study|Physician Decision|0|||
160697355|NCT01986010|580273524|FG016|Overall Study|Physician Decision|0|||
160697356|NCT01986010|580273508|FG000|Overall Study|Withdrawal by Subject|2|||
160697357|NCT01986010|580273509|FG001|Overall Study|Withdrawal by Subject|2|||
160697358|NCT01986010|580273510|FG002|Overall Study|Withdrawal by Subject|3|||
160697359|NCT01986010|580273511|FG003|Overall Study|Withdrawal by Subject|0|||
160697360|NCT01986010|580273512|FG004|Overall Study|Withdrawal by Subject|2|||
160697361|NCT01986010|580273513|FG005|Overall Study|Withdrawal by Subject|4|||
160697362|NCT01986010|580273514|FG006|Overall Study|Withdrawal by Subject|0|||
160697363|NCT01986010|580273515|FG007|Overall Study|Withdrawal by Subject|0|||
160697364|NCT01986010|580273516|FG008|Overall Study|Withdrawal by Subject|0|||
160697365|NCT01986010|580273517|FG009|Overall Study|Withdrawal by Subject|0|||
160697366|NCT01986010|580273518|FG010|Overall Study|Withdrawal by Subject|0|||
160697367|NCT01986010|580273519|FG011|Overall Study|Withdrawal by Subject|2|||
160697368|NCT01986010|580273520|FG012|Overall Study|Withdrawal by Subject|0|||
160697369|NCT01986010|580273521|FG013|Overall Study|Withdrawal by Subject|1|||
160697370|NCT01986010|580273522|FG014|Overall Study|Withdrawal by Subject|2|||
160697371|NCT01986010|580273523|FG015|Overall Study|Withdrawal by Subject|0|||
160697372|NCT01986010|580273524|FG016|Overall Study|Withdrawal by Subject|0|||
160697373|NCT01986010|580273508|FG000|Overall Study|Status Not Recorded|2|||
160697374|NCT01986010|580273509|FG001|Overall Study|Status Not Recorded|4|||
160697375|NCT01986010|580273510|FG002|Overall Study|Status Not Recorded|2|||
160697376|NCT01986010|580273511|FG003|Overall Study|Status Not Recorded|0|||
160697377|NCT01986010|580273512|FG004|Overall Study|Status Not Recorded|1|||
160697378|NCT01986010|580273513|FG005|Overall Study|Status Not Recorded|2|||
160697379|NCT01986010|580273514|FG006|Overall Study|Status Not Recorded|0|||
160697380|NCT01986010|580273515|FG007|Overall Study|Status Not Recorded|0|||
160697381|NCT01986010|580273516|FG008|Overall Study|Status Not Recorded|2|||
160697382|NCT01986010|580273517|FG009|Overall Study|Status Not Recorded|1|||
160697383|NCT01986010|580273518|FG010|Overall Study|Status Not Recorded|7|||
160697384|NCT01986010|580273519|FG011|Overall Study|Status Not Recorded|7|||
160697385|NCT01986010|580273520|FG012|Overall Study|Status Not Recorded|9|||
160697386|NCT01986010|580273521|FG013|Overall Study|Status Not Recorded|9|||
160697387|NCT01986010|580273522|FG014|Overall Study|Status Not Recorded|5|||
160697388|NCT01986010|580273523|FG015|Overall Study|Status Not Recorded|10|||
160697389|NCT01986010|580273524|FG016|Overall Study|Status Not Recorded|4|||
160697390|NCT01335997|580273525|FG000|Period I and II|Adverse Event|63|||
160697391|NCT01335997|580273526|FG001|Period I and II|Adverse Event|43|||
160697392|NCT01335997|580273525|FG000|Period I and II|Noncompliance with Study Drug|1|||
160697393|NCT01335997|580273526|FG001|Period I and II|Noncompliance with Study Drug|1|||
160697394|NCT01335997|580273525|FG000|Period I and II|Lost to Follow-up|3|||
160697395|NCT01335997|580273526|FG001|Period I and II|Lost to Follow-up|5|||
160697396|NCT01335997|580273525|FG000|Period I and II|Withdrawal by Subject|9|||
160697397|NCT01335997|580273526|FG001|Period I and II|Withdrawal by Subject|4|||
160697398|NCT01335997|580273525|FG000|Period I and II|Study Terminated by Sponsor|406|||
160697399|NCT01335997|580273526|FG001|Period I and II|Study Terminated by Sponsor|415|||
160697400|NCT01335997|580273525|FG000|Period I and II|Protocol Violation|9|||
160697401|NCT01335997|580273526|FG001|Period I and II|Protocol Violation|10|||
160697402|NCT01335997|580273525|FG000|Period I and II|Physician Decision|2|||
160697403|NCT01335997|580273526|FG001|Period I and II|Physician Decision|1|||
160697404|NCT01335997|580273525|FG000|Period III|Adverse Event|0|||
160697405|NCT01335997|580273526|FG001|Period III|Adverse Event|2|||
160697406|NCT01335997|580273525|FG000|Period III|Study Terminated by Sponsor|77|||
160697407|NCT01335997|580273526|FG001|Period III|Study Terminated by Sponsor|76|||
160697408|NCT01335997|580273525|FG000|Period III|Protocol Violation|0|||
160697409|NCT01335997|580273526|FG001|Period III|Protocol Violation|1|||
160697410|NCT01335997|580273525|FG000|Period III|Lost to Follow-up|1|||
160697411|NCT01335997|580273526|FG001|Period III|Lost to Follow-up|0|||
160697412|NCT00085423|580273529|FG000|Overall Study|Withdrawal by Subject|1|||
160697413|NCT00085423|580273529|FG000|Overall Study|screen failure|1|||
160697414|NCT04740814|580273530|FG000|Overall Study|Adverse Event|3|||
160697415|NCT04740814|580273530|FG000|Overall Study|Protocol Violation|2|||
160697416|NCT04740814|580273530|FG000|Overall Study|Lost to Follow-up|2|||
160697417|NCT04740814|580273530|FG000|Overall Study|Withdrawal by Subject|3|||
160697418|NCT02440568|580273535|FG000|Overall Study|Death|1|||
160697419|NCT02440568|580273536|FG001|Overall Study|Death|3|||
160697420|NCT02440568|580273537|FG002|Overall Study|Death|4|||
160697421|NCT02440568|580273538|FG003|Overall Study|Death|2|||
160697422|NCT02440568|580273535|FG000|Overall Study|Lack of Efficacy|2|||
160697423|NCT02440568|580273536|FG001|Overall Study|Lack of Efficacy|0|||
160697424|NCT02440568|580273537|FG002|Overall Study|Lack of Efficacy|1|||
160697425|NCT02440568|580273538|FG003|Overall Study|Lack of Efficacy|0|||
160697426|NCT02440568|580273535|FG000|Overall Study|Lost to Follow-up|1|||
160697427|NCT02440568|580273536|FG001|Overall Study|Lost to Follow-up|0|||
160697428|NCT02440568|580273537|FG002|Overall Study|Lost to Follow-up|0|||
160697429|NCT02440568|580273538|FG003|Overall Study|Lost to Follow-up|0|||
160697430|NCT00643565|580273539|FG000|Overall Study|Death|12|||
160697431|NCT00643565|580273540|FG001|Overall Study|Death|11|||
160697432|NCT00643565|580273539|FG000|Overall Study|Withdrawal by Subject|4|||
160697433|NCT00643565|580273540|FG001|Overall Study|Withdrawal by Subject|1|||
160697434|NCT00643565|580273539|FG000|Overall Study|Lost to Follow-up|0|||
160697435|NCT00643565|580273540|FG001|Overall Study|Lost to Follow-up|6|||
160697436|NCT00643565|580273539|FG000|Overall Study|Other|7|||
160697437|NCT00643565|580273540|FG001|Overall Study|Other|8|||
160697438|NCT00643565|580273539|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
160697439|NCT00643565|580273540|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
160697440|NCT00643565|580273539|FG000|Overall Study|Recurrence of Disease|2|||
160697441|NCT00643565|580273540|FG001|Overall Study|Recurrence of Disease|1|||
160697442|NCT00643565|580273539|FG000|Overall Study|Progression of Disease|18|||
160697443|NCT00643565|580273540|FG001|Overall Study|Progression of Disease|14|||
160697444|NCT00643565|580273539|FG000|Overall Study|Protocol Violation|3|||
160697445|NCT00643565|580273540|FG001|Overall Study|Protocol Violation|0|||
160697446|NCT00643565|580273539|FG000|Overall Study|Did Not Cooperate|0|||
160697447|NCT00643565|580273540|FG001|Overall Study|Did Not Cooperate|1|||
160697448|NCT00643565|580273539|FG000|Overall Study|Administrative|22|||
160697449|NCT00643565|580273540|FG001|Overall Study|Administrative|16|||
160697450|NCT00643565|580273539|FG000|Overall Study|Adverse Event|5|||
160697451|NCT00643565|580273540|FG001|Overall Study|Adverse Event|8|||
160697452|NCT00669071|580273541|FG000|Overall Study|Lost to Follow-up|3|||
160697453|NCT00669071|580273541|FG000|Overall Study|Final visit 40 days out of window|1|||
160697454|NCT01910389|580273542|FG000|Overall Study|Withdrawal by Subject|2|||
160697455|NCT01910389|580273543|FG001|Overall Study|Withdrawal by Subject|0|||
160697456|NCT01910389|580273542|FG000|Overall Study|Study Closed|13|||
160697457|NCT01910389|580273543|FG001|Overall Study|Study Closed|8|||
160697458|NCT02357342|580273545|FG000|First 6 Months|Death|2|||
160697459|NCT02357342|580273546|FG001|First 6 Months|Death|0|||
160697460|NCT01490866|580273547|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
160697461|NCT01490866|580273547|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
160697462|NCT01490866|580273547|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
160697463|NCT01490866|580273547|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
160697464|NCT01490866|580273547|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
160697465|NCT01490866|580273547|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
160697466|NCT01490866|580273547|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
160697467|NCT01490866|580273547|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
160697468|NCT01490866|580273547|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
160697469|NCT01490866|580273547|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
160697470|NCT01490866|580273547|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
160697471|NCT03923530|580273548|FG000|Overall Study|Withdrawal by Subject|1|||
160697472|NCT03923530|580273548|FG000|Overall Study|screen failure|3|||
160697473|NCT02435836|580273549|FG000|Overall Study|Lost to Follow-up|21|||
160697474|NCT02435836|580273549|FG000|Overall Study|Lack of Efficacy|1|||
160697475|NCT02435836|580273549|FG000|Overall Study|Withdrawal by Subject|236|||
160697476|NCT02435836|580273549|FG000|Overall Study|Insufficient Clinical Response|26|||
160697477|NCT02435836|580273549|FG000|Overall Study|Adverse Event|44|||
160697478|NCT02435836|580273549|FG000|Overall Study|Sponsor discontinued trial|167|||
160697479|NCT02435836|580273549|FG000|Overall Study|Noncompliance|27|||
160697480|NCT02435836|580273549|FG000|Overall Study|Protocol Violation|6|||
160697481|NCT02435836|580273549|FG000|Overall Study|Met Withdrawal Criteria|7|||
160697482|NCT02435836|580273549|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
160697483|NCT03970837|580273551|FG000|Overall Study|Adverse Event|23|||
160697484|NCT03970837|580273552|FG001|Overall Study|Adverse Event|20|||
160697485|NCT03970837|580273553|FG002|Overall Study|Adverse Event|16|||
160697486|NCT03970837|580273554|FG003|Overall Study|Adverse Event|6|||
160697487|NCT03970837|580273555|FG004|Overall Study|Adverse Event|4|||
160697488|NCT03970837|580273556|FG005|Overall Study|Adverse Event|5|||
160697489|NCT03970837|580273557|FG006|Overall Study|Adverse Event|1|||
160697490|NCT03970837|580273558|FG007|Overall Study|Adverse Event|5|||
160697491|NCT03970837|580273559|FG008|Overall Study|Adverse Event|0|||
160697492|NCT03970837|580273560|FG009|Overall Study|Adverse Event|0|||
160697493|NCT03970837|580273561|FG010|Overall Study|Adverse Event|1|||
160697494|NCT03970837|580273562|FG011|Overall Study|Adverse Event|1|||
160697495|NCT03970837|580273551|FG000|Overall Study|Lack of Efficacy|14|||
160697496|NCT03970837|580273552|FG001|Overall Study|Lack of Efficacy|12|||
160697497|NCT03970837|580273553|FG002|Overall Study|Lack of Efficacy|1|||
160697498|NCT03970837|580273554|FG003|Overall Study|Lack of Efficacy|2|||
160697499|NCT03970837|580273555|FG004|Overall Study|Lack of Efficacy|3|||
160697500|NCT03970837|580273556|FG005|Overall Study|Lack of Efficacy|4|||
160697501|NCT03970837|580273557|FG006|Overall Study|Lack of Efficacy|6|||
160697502|NCT03970837|580273558|FG007|Overall Study|Lack of Efficacy|1|||
160697503|NCT03970837|580273559|FG008|Overall Study|Lack of Efficacy|1|||
160697504|NCT03970837|580273560|FG009|Overall Study|Lack of Efficacy|0|||
160697505|NCT03970837|580273561|FG010|Overall Study|Lack of Efficacy|0|||
160697506|NCT03970837|580273562|FG011|Overall Study|Lack of Efficacy|0|||
160697507|NCT03970837|580273551|FG000|Overall Study|Lost to Follow-up|6|||
160697508|NCT03970837|580273552|FG001|Overall Study|Lost to Follow-up|5|||
160697509|NCT03970837|580273553|FG002|Overall Study|Lost to Follow-up|5|||
160697510|NCT03970837|580273554|FG003|Overall Study|Lost to Follow-up|1|||
160697511|NCT03970837|580273555|FG004|Overall Study|Lost to Follow-up|0|||
160697512|NCT03970837|580273556|FG005|Overall Study|Lost to Follow-up|2|||
160697513|NCT03970837|580273557|FG006|Overall Study|Lost to Follow-up|0|||
160697514|NCT03970837|580273558|FG007|Overall Study|Lost to Follow-up|0|||
160697515|NCT03970837|580273559|FG008|Overall Study|Lost to Follow-up|0|||
160697516|NCT03970837|580273560|FG009|Overall Study|Lost to Follow-up|0|||
160697517|NCT03970837|580273561|FG010|Overall Study|Lost to Follow-up|0|||
160697518|NCT03970837|580273562|FG011|Overall Study|Lost to Follow-up|0|||
160697519|NCT03970837|580273551|FG000|Overall Study|Protocol Violation|1|||
160697520|NCT03970837|580273552|FG001|Overall Study|Protocol Violation|0|||
160697521|NCT03970837|580273553|FG002|Overall Study|Protocol Violation|0|||
160697522|NCT03970837|580273554|FG003|Overall Study|Protocol Violation|0|||
160697523|NCT03970837|580273555|FG004|Overall Study|Protocol Violation|0|||
160697524|NCT03970837|580273556|FG005|Overall Study|Protocol Violation|0|||
160697525|NCT03970837|580273557|FG006|Overall Study|Protocol Violation|0|||
160697526|NCT03970837|580273558|FG007|Overall Study|Protocol Violation|0|||
160697527|NCT03970837|580273559|FG008|Overall Study|Protocol Violation|0|||
160697528|NCT03970837|580273560|FG009|Overall Study|Protocol Violation|0|||
160697529|NCT03970837|580273561|FG010|Overall Study|Protocol Violation|0|||
160697530|NCT03970837|580273562|FG011|Overall Study|Protocol Violation|0|||
160697531|NCT03970837|580273551|FG000|Overall Study|Physician Decision|5|||
160697532|NCT03970837|580273552|FG001|Overall Study|Physician Decision|8|||
160697533|NCT03970837|580273553|FG002|Overall Study|Physician Decision|4|||
160697534|NCT03970837|580273554|FG003|Overall Study|Physician Decision|1|||
160697535|NCT03970837|580273555|FG004|Overall Study|Physician Decision|5|||
160697536|NCT03970837|580273556|FG005|Overall Study|Physician Decision|2|||
160697537|NCT03970837|580273557|FG006|Overall Study|Physician Decision|4|||
160697538|NCT03970837|580273558|FG007|Overall Study|Physician Decision|5|||
160697539|NCT03970837|580273559|FG008|Overall Study|Physician Decision|0|||
160697540|NCT03970837|580273560|FG009|Overall Study|Physician Decision|1|||
160697541|NCT03970837|580273561|FG010|Overall Study|Physician Decision|0|||
160697542|NCT03970837|580273562|FG011|Overall Study|Physician Decision|0|||
160697543|NCT03970837|580273551|FG000|Overall Study|Withdrawal by Subject|32|||
160697544|NCT03970837|580273552|FG001|Overall Study|Withdrawal by Subject|35|||
160697545|NCT03970837|580273553|FG002|Overall Study|Withdrawal by Subject|12|||
160697546|NCT03970837|580273554|FG003|Overall Study|Withdrawal by Subject|8|||
160697547|NCT03970837|580273555|FG004|Overall Study|Withdrawal by Subject|6|||
160697548|NCT03970837|580273556|FG005|Overall Study|Withdrawal by Subject|8|||
160697549|NCT03970837|580273557|FG006|Overall Study|Withdrawal by Subject|2|||
160697550|NCT03970837|580273558|FG007|Overall Study|Withdrawal by Subject|3|||
160697551|NCT03970837|580273559|FG008|Overall Study|Withdrawal by Subject|0|||
160697552|NCT03970837|580273560|FG009|Overall Study|Withdrawal by Subject|0|||
160697553|NCT03970837|580273561|FG010|Overall Study|Withdrawal by Subject|0|||
160697554|NCT03970837|580273562|FG011|Overall Study|Withdrawal by Subject|1|||
160697555|NCT03970837|580273551|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
160697556|NCT03970837|580273552|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
160697557|NCT03970837|580273553|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
160697558|NCT03970837|580273554|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
160697559|NCT03970837|580273555|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
160697560|NCT03970837|580273556|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
160697561|NCT03970837|580273557|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
160697562|NCT03970837|580273558|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
160697563|NCT03970837|580273559|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
160697564|NCT03970837|580273560|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
160697565|NCT03970837|580273561|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
160697566|NCT03970837|580273562|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
160697567|NCT03970837|580273551|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
160697568|NCT03970837|580273552|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
160697569|NCT03970837|580273553|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
160697570|NCT03970837|580273554|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
160697571|NCT03970837|580273555|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
160697572|NCT03970837|580273556|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
160697573|NCT03970837|580273557|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
160697574|NCT03970837|580273558|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
160697575|NCT03970837|580273559|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
160697576|NCT03970837|580273560|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
160697577|NCT03970837|580273561|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
160697578|NCT03970837|580273562|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
160697579|NCT02370329|580275974|FG000|Overall Study|Alternate treatment|1|||
160697580|NCT02370329|580275974|FG000|Overall Study|Adverse Event|1|||
160697581|NCT02370329|580275974|FG000|Overall Study|Disease progression|3|||
160697582|NCT02370329|580275974|FG000|Overall Study|Physician Decision|2|||
160697583|NCT02370329|580275974|FG000|Overall Study|Study closure|4|||
160697584|NCT02022748|580275975|FG000|Overall Study|Adverse Event|1|||
160697585|NCT02022748|580275976|FG001|Overall Study|Adverse Event|1|||
160697586|NCT02022748|580275977|FG002|Overall Study|Adverse Event|0|||
160697587|NCT02022748|580275975|FG000|Overall Study|Withdrawal by Subject|0|||
160697588|NCT02022748|580275976|FG001|Overall Study|Withdrawal by Subject|1|||
160697589|NCT02022748|580275977|FG002|Overall Study|Withdrawal by Subject|0|||
160697590|NCT04347122|580275979|FG000|Overall Study|Physician Decision|0|||
160697591|NCT04347122|580275980|FG001|Overall Study|Physician Decision|3|||
160697592|NCT04347122|580275981|FG002|Overall Study|Physician Decision|3|||
160697593|NCT04347122|580275982|FG003|Overall Study|Physician Decision|6|||
160697594|NCT03510598|580275983|FG000|Overall Study|Withdrawal by Subject|1|||
160697595|NCT01523457|580275984|FG000|Overall Study|Withdrawal by Subject|7|||
160697596|NCT01523457|580275985|FG001|Overall Study|Withdrawal by Subject|2|||
160697597|NCT01367665|580275986|FG000|Overall Study|Death|102|||
160697598|NCT01367665|580275987|FG001|Overall Study|Death|19|||
160697599|NCT01367665|580275986|FG000|Overall Study|Lost to Follow-up|222|||
160697600|NCT01367665|580275987|FG001|Overall Study|Lost to Follow-up|22|||
160697601|NCT01367665|580275986|FG000|Overall Study|Not Done|118|||
160697602|NCT01367665|580275987|FG001|Overall Study|Not Done|14|||
160697603|NCT03283319|580275988|FG000|Overall Study|Lost to Follow-up|5|||
160697604|NCT03283319|580275989|FG001|Overall Study|Lost to Follow-up|4|||
160697605|NCT03283319|580275990|FG002|Overall Study|Lost to Follow-up|5|||
160697606|NCT03283319|580275991|FG003|Overall Study|Lost to Follow-up|5|||
160697607|NCT03283319|580275992|FG004|Overall Study|Lost to Follow-up|4|||
160697608|NCT03283319|580275993|FG005|Overall Study|Lost to Follow-up|3|||
160697609|NCT03283319|580275988|FG000|Overall Study|Withdrawal by Subject|2|||
160697610|NCT03283319|580275989|FG001|Overall Study|Withdrawal by Subject|2|||
160697611|NCT03283319|580275990|FG002|Overall Study|Withdrawal by Subject|2|||
160697612|NCT03283319|580275991|FG003|Overall Study|Withdrawal by Subject|1|||
160697613|NCT03283319|580275992|FG004|Overall Study|Withdrawal by Subject|0|||
160697614|NCT03283319|580275993|FG005|Overall Study|Withdrawal by Subject|1|||
160697615|NCT03283319|580275988|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
160697616|NCT03283319|580275989|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
160697617|NCT03283319|580275990|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
160697618|NCT03283319|580275991|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
160697619|NCT03283319|580275992|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
160697620|NCT03283319|580275993|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
160697621|NCT03954834|580275995|FG000|Overall Study|Adverse Event|1|||
160697622|NCT03954834|580275996|FG001|Overall Study|Adverse Event|3|||
160697623|NCT03954834|580275997|FG002|Overall Study|Adverse Event|1|||
160697624|NCT03954834|580275998|FG003|Overall Study|Adverse Event|1|||
160697625|NCT03954834|580275995|FG000|Overall Study|Death|0|||
160697626|NCT03954834|580275996|FG001|Overall Study|Death|0|||
160697627|NCT03954834|580275997|FG002|Overall Study|Death|0|||
160697628|NCT03954834|580275998|FG003|Overall Study|Death|1|||
160697629|NCT03954834|580275995|FG000|Overall Study|Physician Decision|0|||
160697630|NCT03954834|580275996|FG001|Overall Study|Physician Decision|1|||
160697631|NCT03954834|580275997|FG002|Overall Study|Physician Decision|0|||
160697632|NCT03954834|580275998|FG003|Overall Study|Physician Decision|2|||
160697633|NCT03954834|580275995|FG000|Overall Study|Protocol Violation|1|||
160697634|NCT03954834|580275996|FG001|Overall Study|Protocol Violation|0|||
160697635|NCT03954834|580275997|FG002|Overall Study|Protocol Violation|0|||
160697636|NCT03954834|580275998|FG003|Overall Study|Protocol Violation|1|||
160697637|NCT03954834|580275995|FG000|Overall Study|Withdrawal by Subject|2|||
160697638|NCT03954834|580275996|FG001|Overall Study|Withdrawal by Subject|3|||
160697639|NCT03954834|580275997|FG002|Overall Study|Withdrawal by Subject|13|||
160697640|NCT03954834|580275998|FG003|Overall Study|Withdrawal by Subject|6|||
160697641|NCT03954834|580275995|FG000|Overall Study|Participant left the country|0|||
160697642|NCT03954834|580275996|FG001|Overall Study|Participant left the country|0|||
160697643|NCT03954834|580275997|FG002|Overall Study|Participant left the country|1|||
160697644|NCT03954834|580275998|FG003|Overall Study|Participant left the country|0|||
160697645|NCT03954834|580275995|FG000|Overall Study|Lost to Follow-up|3|||
160697646|NCT03954834|580275996|FG001|Overall Study|Lost to Follow-up|2|||
160697647|NCT03954834|580275997|FG002|Overall Study|Lost to Follow-up|3|||
160697648|NCT03954834|580275998|FG003|Overall Study|Lost to Follow-up|5|||
160697649|NCT01284361|580276002|FG000|Overall Study|Withdrawal by Subject|1|||
160697650|NCT01284361|580276002|FG000|Overall Study|Protocol Violation|5|||
160697651|NCT01284361|580276002|FG000|Overall Study|Adverse Event|1|||
160697652|NCT01284361|580276002|FG000|Overall Study|Lost to Follow-up|2|||
160697653|NCT00505375|580276003|FG000|Overall Study|Death|1|||
160697654|NCT00505375|580276004|FG001|Overall Study|Death|0|||
160697655|NCT00505375|580276003|FG000|Overall Study|Withdrawal by Subject|2|||
160697656|NCT00505375|580276004|FG001|Overall Study|Withdrawal by Subject|2|||
160697657|NCT00505375|580276003|FG000|Overall Study|Lost to Follow-up|0|||
160697658|NCT00505375|580276004|FG001|Overall Study|Lost to Follow-up|2|||
160697659|NCT00505375|580276003|FG000|Overall Study|Pregnancy|1|||
160697660|NCT00505375|580276004|FG001|Overall Study|Pregnancy|0|||
160697661|NCT00505375|580276003|FG000|Overall Study|Travel issues|0|||
160697662|NCT00505375|580276004|FG001|Overall Study|Travel issues|1|||
160697663|NCT02906930|580276005|FG000|Overall Study|Withdrawal by Subject|0|||
160697664|NCT02906930|580276006|FG001|Overall Study|Withdrawal by Subject|5|||
160697665|NCT02906930|580276007|FG002|Overall Study|Withdrawal by Subject|5|||
160697666|NCT02906930|580276008|FG003|Overall Study|Withdrawal by Subject|4|||
160697667|NCT02906930|580276005|FG000|Overall Study|Lost to Follow-up|5|||
160697668|NCT02906930|580276006|FG001|Overall Study|Lost to Follow-up|7|||
160697669|NCT02906930|580276007|FG002|Overall Study|Lost to Follow-up|5|||
160697670|NCT02906930|580276008|FG003|Overall Study|Lost to Follow-up|2|||
160697671|NCT02906930|580276005|FG000|Overall Study|Death|0|||
160697672|NCT02906930|580276006|FG001|Overall Study|Death|0|||
160697673|NCT02906930|580276007|FG002|Overall Study|Death|1|||
160697674|NCT02906930|580276008|FG003|Overall Study|Death|0|||
160697675|NCT02906930|580276005|FG000|Overall Study|Other|1|||
160697676|NCT02906930|580276006|FG001|Overall Study|Other|2|||
160697677|NCT02906930|580276007|FG002|Overall Study|Other|1|||
160697678|NCT02906930|580276008|FG003|Overall Study|Other|2|||
160697679|NCT00540293|580276009|FG000|Overall Study|Adverse event related to study drug|10|||
160697680|NCT00540293|580276009|FG000|Overall Study|Adverse event not related to study drug|7|||
160697681|NCT00540293|580276009|FG000|Overall Study|Withdrawal by Subject|6|||
160697682|NCT00540293|580276009|FG000|Overall Study|Protocol violation, & subject schedule|12|||
160697683|NCT04492020|580276012|FG000|Overall Study|Adverse Event|1|||
160697684|NCT04492020|580276013|FG001|Overall Study|Adverse Event|3|||
160697685|NCT04492020|580276012|FG000|Overall Study|Withdrawal by Subject|4|||
160697686|NCT04492020|580276013|FG001|Overall Study|Withdrawal by Subject|3|||
160697687|NCT04492020|580276012|FG000|Overall Study|Lost to Follow-up|4|||
160697688|NCT04492020|580276013|FG001|Overall Study|Lost to Follow-up|3|||
160697689|NCT04492020|580276012|FG000|Overall Study|Protocol Violation|5|||
160697690|NCT04492020|580276013|FG001|Overall Study|Protocol Violation|2|||
160697691|NCT04492020|580276012|FG000|Overall Study|Lack of Qualifying Event|25|||
160697692|NCT04492020|580276013|FG001|Overall Study|Lack of Qualifying Event|27|||
160697693|NCT04492020|580276012|FG000|Overall Study|Non-compliance with Study Drug|2|||
160697694|NCT04492020|580276013|FG001|Overall Study|Non-compliance with Study Drug|1|||
160697695|NCT00325195|580276014|FG000|Randomized|Not dosed|5|||
160697696|NCT00325195|580276015|FG001|Randomized|Not dosed|5|||
160697697|NCT00325195|580276016|FG002|Randomized|Not dosed|3|||
160697698|NCT00325195|580276014|FG000|Received Intervention: ITT Population|Adverse Event|15|||
160697699|NCT00325195|580276015|FG001|Received Intervention: ITT Population|Adverse Event|17|||
160697700|NCT00325195|580276016|FG002|Received Intervention: ITT Population|Adverse Event|1|||
160697701|NCT00325195|580276014|FG000|Received Intervention: ITT Population|Death|3|||
160697702|NCT00325195|580276015|FG001|Received Intervention: ITT Population|Death|1|||
160697703|NCT00325195|580276016|FG002|Received Intervention: ITT Population|Death|0|||
160697704|NCT00325195|580276014|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
160697705|NCT00325195|580276015|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
160697706|NCT00325195|580276016|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
160697707|NCT00325195|580276014|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
160697708|NCT00325195|580276015|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
160697709|NCT00325195|580276016|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
160697710|NCT00325195|580276014|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
160697711|NCT00325195|580276015|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
160697712|NCT00325195|580276016|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
160697713|NCT04594707|580276017|FG000|Overall Study|Adverse Event|0|||
160697714|NCT04594707|580276018|FG001|Overall Study|Adverse Event|0|||
160697715|NCT04594707|580276019|FG002|Overall Study|Adverse Event|1|||
160697716|NCT04594707|580276017|FG000|Overall Study|Death|0|||
160697717|NCT04594707|580276018|FG001|Overall Study|Death|2|||
160697718|NCT04594707|580276019|FG002|Overall Study|Death|2|||
160697719|NCT04594707|580276017|FG000|Overall Study|Lung Transplant|0|||
160697720|NCT04594707|580276018|FG001|Overall Study|Lung Transplant|0|||
160697721|NCT04594707|580276019|FG002|Overall Study|Lung Transplant|1|||
160697722|NCT04594707|580276017|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
160697723|NCT04594707|580276018|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
160697724|NCT04594707|580276019|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
160697725|NCT04594707|580276017|FG000|Overall Study|Study Terminated By Sponsor|19|||
160697726|NCT04594707|580276018|FG001|Overall Study|Study Terminated By Sponsor|47|||
160697727|NCT04594707|580276019|FG002|Overall Study|Study Terminated By Sponsor|41|||
160697728|NCT04594707|580276017|FG000|Overall Study|Withdrawal by Subject|1|||
160697729|NCT04594707|580276018|FG001|Overall Study|Withdrawal by Subject|0|||
160697730|NCT04594707|580276019|FG002|Overall Study|Withdrawal by Subject|2|||
160697731|NCT04585789|580276020|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
160697732|NCT04585789|580276021|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
160697733|NCT04585789|580276022|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
160697734|NCT04585789|580276020|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
160697735|NCT04585789|580276021|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
160697736|NCT04585789|580276022|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
160697737|NCT05083585|580276023|FG000|Overall Study|Death|1|||
160697738|NCT05083585|580276024|FG001|Overall Study|Death|1|||
160697739|NCT05083585|580276023|FG000|Overall Study|Lost to Follow-up|1|||
160697740|NCT05083585|580276024|FG001|Overall Study|Lost to Follow-up|1|||
160697741|NCT05083585|580276023|FG000|Overall Study|Withdrawal by Subject|2|||
160697742|NCT05083585|580276024|FG001|Overall Study|Withdrawal by Subject|0|||
160697743|NCT05083585|580276023|FG000|Overall Study|Randomized but not vaccinated|2|||
160697744|NCT05083585|580276024|FG001|Overall Study|Randomized but not vaccinated|0|||
160697745|NCT03469336|580276025|FG000|Overall Study|Adverse Event|1|||
160697746|NCT02740699|580276028|FG000|Overall Study|Lost to Follow-up|5|||
160697747|NCT02740699|580276028|FG000|Overall Study|Withdrawal by Subject|14|||
160697748|NCT02740699|580276028|FG000|Overall Study|Physician Decision|5|||
160697749|NCT00699374|580276041|FG000|Overall Study|Death|93|||
160697750|NCT00699374|580276042|FG001|Overall Study|Death|83|||
160697751|NCT00699374|580276041|FG000|Overall Study|Adverse Event|70|||
160697752|NCT00699374|580276042|FG001|Overall Study|Adverse Event|67|||
160697753|NCT00699374|580276041|FG000|Overall Study|Global deterioration of health status|7|||
160697754|NCT00699374|580276042|FG001|Overall Study|Global deterioration of health status|8|||
160697755|NCT00699374|580276041|FG000|Overall Study|Lost to Follow-up|3|||
160697756|NCT00699374|580276042|FG001|Overall Study|Lost to Follow-up|5|||
160697757|NCT00699374|580276041|FG000|Overall Study|Withdrawal by Subject|34|||
160697758|NCT00699374|580276042|FG001|Overall Study|Withdrawal by Subject|44|||
160697759|NCT00699374|580276041|FG000|Overall Study|Objective progression or relapse|281|||
160697760|NCT00699374|580276042|FG001|Overall Study|Objective progression or relapse|277|||
160697761|NCT00699374|580276041|FG000|Overall Study|Other|18|||
160697762|NCT00699374|580276042|FG001|Overall Study|Other|15|||
160697763|NCT00699374|580276041|FG000|Overall Study|Protocol Violation|2|||
160697764|NCT00699374|580276042|FG001|Overall Study|Protocol Violation|6|||
160697765|NCT00699374|580276041|FG000|Overall Study|Study terminated by sponsor|13|||
160697766|NCT00699374|580276042|FG001|Overall Study|Study terminated by sponsor|28|||
160697767|NCT00699374|580276041|FG000|Overall Study|Randomized but not treated|4|||
160697768|NCT00699374|580276042|FG001|Overall Study|Randomized but not treated|2|||
160697769|NCT00699374|580276041|FG000|Overall Study|Died 28 days after last dose|5|||
160697770|NCT00699374|580276042|FG001|Overall Study|Died 28 days after last dose|9|||
160697771|NCT01359969|580276043|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
160697772|NCT00593736|580276050|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
160697773|NCT00593736|580276051|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
160697774|NCT00593736|580276052|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
160697775|NCT00593736|580276053|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
160697776|NCT00593736|580276050|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
160697777|NCT00593736|580276051|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
160697778|NCT00593736|580276052|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
160697779|NCT00593736|580276053|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
160697780|NCT00593736|580276050|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
160697781|NCT00593736|580276051|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
160697782|NCT00593736|580276052|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
160697783|NCT00593736|580276053|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
160697784|NCT00593736|580276050|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
160697785|NCT00593736|580276051|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
160697786|NCT00593736|580276052|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
160697787|NCT00593736|580276053|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
160697788|NCT00593736|580276050|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
160697789|NCT00593736|580276051|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
160697790|NCT00593736|580276052|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
160697791|NCT00593736|580276053|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
160697792|NCT00593736|580276050|FG000|Screening Period and Placebo Run-in|Various|0|||
160697793|NCT00593736|580276051|FG001|Screening Period and Placebo Run-in|Various|0|||
160697794|NCT00593736|580276052|FG002|Screening Period and Placebo Run-in|Various|0|||
160697795|NCT00593736|580276053|FG003|Screening Period and Placebo Run-in|Various|25|||
160697796|NCT00593736|580276050|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
160697797|NCT00593736|580276051|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
160697798|NCT00593736|580276052|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
160697799|NCT00593736|580276053|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
160697800|NCT00593736|580276050|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
160697801|NCT00593736|580276051|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
160697802|NCT00593736|580276052|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
160697803|NCT00593736|580276053|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
160697804|NCT00593736|580276050|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
160697805|NCT00593736|580276051|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
160697806|NCT00593736|580276052|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
160697807|NCT00593736|580276053|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
160697808|NCT00593736|580276050|FG000|Treatment Period and Placebo Run-out|Various|1|||
160697809|NCT00593736|580276051|FG001|Treatment Period and Placebo Run-out|Various|1|||
160697810|NCT00593736|580276052|FG002|Treatment Period and Placebo Run-out|Various|1|||
160697811|NCT00593736|580276053|FG003|Treatment Period and Placebo Run-out|Various|0|||
160697812|NCT01868893|580276054|FG000|Overall Study|Adverse Event|2|||
160697813|NCT01868893|580276054|FG000|Overall Study|Commercial availability of study drug|17|||
160697814|NCT01868893|580276054|FG000|Overall Study|Neutropenia|1|||
160697815|NCT01857271|580276055|FG000|Overall Study|Lost to Follow-up|1|||
160697816|NCT01783548|580276056|FG000|Overall Study|Adverse Event|8|||
160697817|NCT01783548|580276057|FG001|Overall Study|Adverse Event|4|||
160697818|NCT01783548|580276056|FG000|Overall Study|Withdrawal by Subject|11|||
160697819|NCT01783548|580276057|FG001|Overall Study|Withdrawal by Subject|8|||
160697820|NCT01783548|580276056|FG000|Overall Study|Non-compliance|4|||
160697821|NCT01783548|580276057|FG001|Overall Study|Non-compliance|0|||
160697822|NCT01783548|580276056|FG000|Overall Study|Protocol Violation|2|||
160697823|NCT01783548|580276057|FG001|Overall Study|Protocol Violation|2|||
160697824|NCT01783548|580276056|FG000|Overall Study|Lost to Follow-up|8|||
160697825|NCT01783548|580276057|FG001|Overall Study|Lost to Follow-up|3|||
160697826|NCT01783548|580276056|FG000|Overall Study|Lack of Efficacy|1|||
160697827|NCT01783548|580276057|FG001|Overall Study|Lack of Efficacy|1|||
160697828|NCT03825341|580276060|FG000|Overall Study|Withdrawal by Subject|0|||
160697829|NCT03825341|580276061|FG001|Overall Study|Withdrawal by Subject|1|||
160697830|NCT04283500|580276064|FG000|Overall Study|Lost to Follow-up|8|||
160697831|NCT04283500|580276064|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
160697832|NCT04729309|580276072|FG000|Period 1|Subject unable to return for Period 2|3|||
160697833|NCT04729309|580276073|FG001|Period 1|Subject unable to return for Period 2|0|||
160697834|NCT04729309|580276072|FG000|Period 1|Lost to Follow-up|1|||
160697835|NCT04729309|580276073|FG001|Period 1|Lost to Follow-up|0|||
160697836|NCT00338455|580276076|FG000|Overall Study|Death|2|||
160697837|NCT00338455|580276077|FG001|Overall Study|Death|1|||
160697838|NCT00338455|580276076|FG000|Overall Study|Physician Decision|1|||
160697839|NCT00338455|580276077|FG001|Overall Study|Physician Decision|0|||
160697840|NCT01517373|580276078|FG000|Run-in Period|Death|1|||
160697841|NCT01517373|580276079|FG001|Run-in Period|Death|0|||
160697842|NCT01517373|580276080|FG002|Run-in Period|Death|0|||
160697843|NCT01517373|580276081|FG003|Run-in Period|Death|0|||
160697844|NCT01517373|580276082|FG004|Run-in Period|Death|0|||
160697845|NCT01517373|580276083|FG005|Run-in Period|Death|0|||
160697846|NCT01517373|580276078|FG000|Run-in Period|Adverse Event|5|||
160697847|NCT01517373|580276079|FG001|Run-in Period|Adverse Event|0|||
160697848|NCT01517373|580276080|FG002|Run-in Period|Adverse Event|0|||
160697849|NCT01517373|580276081|FG003|Run-in Period|Adverse Event|0|||
160697850|NCT01517373|580276082|FG004|Run-in Period|Adverse Event|0|||
160697851|NCT01517373|580276083|FG005|Run-in Period|Adverse Event|0|||
160697852|NCT01517373|580276078|FG000|Run-in Period|Did not meet eligibility criteria|34|||
160697853|NCT01517373|580276079|FG001|Run-in Period|Did not meet eligibility criteria|0|||
160697854|NCT01517373|580276080|FG002|Run-in Period|Did not meet eligibility criteria|0|||
160697855|NCT01517373|580276081|FG003|Run-in Period|Did not meet eligibility criteria|0|||
160697856|NCT01517373|580276082|FG004|Run-in Period|Did not meet eligibility criteria|0|||
160697857|NCT01517373|580276083|FG005|Run-in Period|Did not meet eligibility criteria|0|||
160697858|NCT01517373|580276078|FG000|Run-in Period|Lost to Follow-up|1|||
160697859|NCT01517373|580276079|FG001|Run-in Period|Lost to Follow-up|0|||
160697860|NCT01517373|580276080|FG002|Run-in Period|Lost to Follow-up|0|||
160697861|NCT01517373|580276081|FG003|Run-in Period|Lost to Follow-up|0|||
160697862|NCT01517373|580276082|FG004|Run-in Period|Lost to Follow-up|0|||
160697863|NCT01517373|580276083|FG005|Run-in Period|Lost to Follow-up|0|||
160697864|NCT01517373|580276078|FG000|Run-in Period|Withdrawal by Subject|12|||
160697865|NCT01517373|580276079|FG001|Run-in Period|Withdrawal by Subject|0|||
160697866|NCT01517373|580276080|FG002|Run-in Period|Withdrawal by Subject|0|||
160697867|NCT01517373|580276081|FG003|Run-in Period|Withdrawal by Subject|0|||
160697868|NCT01517373|580276082|FG004|Run-in Period|Withdrawal by Subject|0|||
160697869|NCT01517373|580276083|FG005|Run-in Period|Withdrawal by Subject|0|||
160697870|NCT01517373|580276078|FG000|Run-in Period|Sponsor Decision|3|||
160697871|NCT01517373|580276079|FG001|Run-in Period|Sponsor Decision|0|||
160697872|NCT01517373|580276080|FG002|Run-in Period|Sponsor Decision|0|||
160697873|NCT01517373|580276081|FG003|Run-in Period|Sponsor Decision|0|||
160697874|NCT01517373|580276082|FG004|Run-in Period|Sponsor Decision|0|||
160697875|NCT01517373|580276083|FG005|Run-in Period|Sponsor Decision|0|||
160697876|NCT01517373|580276078|FG000|Run-in Period|Other|1|||
160697877|NCT01517373|580276079|FG001|Run-in Period|Other|0|||
160697878|NCT01517373|580276080|FG002|Run-in Period|Other|0|||
160697879|NCT01517373|580276081|FG003|Run-in Period|Other|0|||
160697880|NCT01517373|580276082|FG004|Run-in Period|Other|0|||
160697881|NCT01517373|580276083|FG005|Run-in Period|Other|0|||
160697882|NCT01517373|580276078|FG000|Treatment Period|Adverse Event|0|||
160697883|NCT01517373|580276079|FG001|Treatment Period|Adverse Event|0|||
160697884|NCT01517373|580276080|FG002|Treatment Period|Adverse Event|0|||
160697885|NCT01517373|580276081|FG003|Treatment Period|Adverse Event|0|||
160697886|NCT01517373|580276082|FG004|Treatment Period|Adverse Event|0|||
160697887|NCT01517373|580276083|FG005|Treatment Period|Adverse Event|2|||
160697888|NCT01517373|580276078|FG000|Treatment Period|Lost to Follow-up|0|||
160697889|NCT01517373|580276079|FG001|Treatment Period|Lost to Follow-up|0|||
160697890|NCT01517373|580276080|FG002|Treatment Period|Lost to Follow-up|1|||
160697891|NCT01517373|580276081|FG003|Treatment Period|Lost to Follow-up|1|||
160697892|NCT01517373|580276082|FG004|Treatment Period|Lost to Follow-up|0|||
160697893|NCT01517373|580276083|FG005|Treatment Period|Lost to Follow-up|0|||
160697894|NCT01517373|580276078|FG000|Treatment Period|Withdrawal by Subject|0|||
160697895|NCT01517373|580276079|FG001|Treatment Period|Withdrawal by Subject|3|||
160697896|NCT01517373|580276080|FG002|Treatment Period|Withdrawal by Subject|2|||
160697897|NCT01517373|580276081|FG003|Treatment Period|Withdrawal by Subject|2|||
160697898|NCT01517373|580276082|FG004|Treatment Period|Withdrawal by Subject|2|||
160697899|NCT01517373|580276083|FG005|Treatment Period|Withdrawal by Subject|3|||
160697900|NCT01517373|580276078|FG000|Treatment Period|Other|0|||
160697901|NCT01517373|580276079|FG001|Treatment Period|Other|0|||
160697902|NCT01517373|580276080|FG002|Treatment Period|Other|0|||
160697903|NCT01517373|580276081|FG003|Treatment Period|Other|0|||
160697904|NCT01517373|580276082|FG004|Treatment Period|Other|1|||
160697905|NCT01517373|580276083|FG005|Treatment Period|Other|0|||
160697906|NCT01517373|580276078|FG000|Treatment Period|Protocol Violation|0|||
160697907|NCT01517373|580276079|FG001|Treatment Period|Protocol Violation|0|||
160697908|NCT01517373|580276080|FG002|Treatment Period|Protocol Violation|0|||
160697909|NCT01517373|580276081|FG003|Treatment Period|Protocol Violation|0|||
160697910|NCT01517373|580276082|FG004|Treatment Period|Protocol Violation|1|||
160697911|NCT01517373|580276083|FG005|Treatment Period|Protocol Violation|0|||
160697912|NCT01517373|580276078|FG000|Treatment Period|Lack of Efficacy|0|||
160697913|NCT01517373|580276079|FG001|Treatment Period|Lack of Efficacy|1|||
160697914|NCT01517373|580276080|FG002|Treatment Period|Lack of Efficacy|1|||
160697915|NCT01517373|580276081|FG003|Treatment Period|Lack of Efficacy|3|||
160697916|NCT01517373|580276082|FG004|Treatment Period|Lack of Efficacy|2|||
160697917|NCT01517373|580276083|FG005|Treatment Period|Lack of Efficacy|0|||
160697918|NCT01517373|580276078|FG000|Treatment Period|Medication error without AEs|0|||
160697919|NCT01517373|580276079|FG001|Treatment Period|Medication error without AEs|0|||
160697920|NCT01517373|580276080|FG002|Treatment Period|Medication error without AEs|2|||
160697921|NCT01517373|580276081|FG003|Treatment Period|Medication error without AEs|1|||
160697922|NCT01517373|580276082|FG004|Treatment Period|Medication error without AEs|0|||
160697923|NCT01517373|580276083|FG005|Treatment Period|Medication error without AEs|2|||
160697924|NCT05005312|580276090|FG000|Overall Study|Enrolled, but not treated|0|||
160697925|NCT05005312|580276091|FG001|Overall Study|Enrolled, but not treated|1|||
160697926|NCT00851318|580276092|FG000|Overall Study|Withdrawal by Subject|7|||
160697927|NCT00851318|580276093|FG001|Overall Study|Withdrawal by Subject|1|||
160697928|NCT00851318|580276094|FG002|Overall Study|Withdrawal by Subject|5|||
160697929|NCT00851318|580276095|FG003|Overall Study|Withdrawal by Subject|3|||
160697930|NCT00851318|580276092|FG000|Overall Study|Adverse Event|13|||
160697931|NCT00851318|580276093|FG001|Overall Study|Adverse Event|2|||
160697932|NCT00851318|580276094|FG002|Overall Study|Adverse Event|9|||
160697933|NCT00851318|580276095|FG003|Overall Study|Adverse Event|12|||
160697934|NCT00851318|580276092|FG000|Overall Study|Pregnancy|0|||
160697935|NCT00851318|580276093|FG001|Overall Study|Pregnancy|0|||
160697936|NCT00851318|580276094|FG002|Overall Study|Pregnancy|1|||
160697937|NCT00851318|580276095|FG003|Overall Study|Pregnancy|1|||
160697938|NCT00851318|580276092|FG000|Overall Study|Lack of Efficacy|8|||
160697939|NCT00851318|580276093|FG001|Overall Study|Lack of Efficacy|2|||
160697940|NCT00851318|580276094|FG002|Overall Study|Lack of Efficacy|4|||
160697941|NCT00851318|580276095|FG003|Overall Study|Lack of Efficacy|2|||
160697942|NCT00851318|580276092|FG000|Overall Study|Non-compliance with Study Procedures|2|||
160697943|NCT00851318|580276093|FG001|Overall Study|Non-compliance with Study Procedures|0|||
160697944|NCT00851318|580276094|FG002|Overall Study|Non-compliance with Study Procedures|1|||
160697945|NCT00851318|580276095|FG003|Overall Study|Non-compliance with Study Procedures|0|||
160697946|NCT00851318|580276092|FG000|Overall Study|Physician Decision|0|||
160697947|NCT00851318|580276093|FG001|Overall Study|Physician Decision|0|||
160697948|NCT00851318|580276094|FG002|Overall Study|Physician Decision|1|||
160697949|NCT00851318|580276095|FG003|Overall Study|Physician Decision|1|||
160697950|NCT04015908|580276105|FG000|Overall Study|Lost to Follow-up|0|||
160697951|NCT04015908|580276106|FG001|Overall Study|Lost to Follow-up|1|||
160697952|NCT01584843|580276110|FG000|First Treatment Period|Adverse Event|0|||
160697953|NCT01584843|580276111|FG001|First Treatment Period|Adverse Event|0|||
160697954|NCT01584843|580276112|FG002|First Treatment Period|Adverse Event|1|||
160697955|NCT01584843|580276113|FG003|First Treatment Period|Adverse Event|0|||
160697956|NCT01584843|580276114|FG004|First Treatment Period|Adverse Event|0|||
160697957|NCT01584843|580276115|FG005|First Treatment Period|Adverse Event|0|||
160697958|NCT01584843|580276110|FG000|First Treatment Period|Protocol Violation|0|||
160697959|NCT01584843|580276111|FG001|First Treatment Period|Protocol Violation|0|||
160697960|NCT01584843|580276112|FG002|First Treatment Period|Protocol Violation|0|||
160697961|NCT01584843|580276113|FG003|First Treatment Period|Protocol Violation|0|||
160697962|NCT01584843|580276114|FG004|First Treatment Period|Protocol Violation|0|||
160697963|NCT01584843|580276115|FG005|First Treatment Period|Protocol Violation|1|||
160697964|NCT01584843|580276110|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
160697965|NCT01584843|580276111|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
160697966|NCT01584843|580276112|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
160697967|NCT01584843|580276113|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
160697968|NCT01584843|580276114|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
160697969|NCT01584843|580276115|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
160697970|NCT01584843|580276110|FG000|Second Treatment Period|Withdrawal by Subject|0|||
160697971|NCT01584843|580276111|FG001|Second Treatment Period|Withdrawal by Subject|0|||
160697972|NCT01584843|580276112|FG002|Second Treatment Period|Withdrawal by Subject|0|||
160697973|NCT01584843|580276113|FG003|Second Treatment Period|Withdrawal by Subject|0|||
160697974|NCT01584843|580276114|FG004|Second Treatment Period|Withdrawal by Subject|0|||
160697975|NCT01584843|580276115|FG005|Second Treatment Period|Withdrawal by Subject|1|||
160697976|NCT01763684|580276116|FG000|Overall Study|Study terminated early due to low enrollment|126|||
160697977|NCT01763684|580276117|FG001|Overall Study|Study terminated early due to low enrollment|127|||
160697978|NCT01763684|580276116|FG000|Overall Study|Study surgery not performed|7|||
160697979|NCT01763684|580276117|FG001|Overall Study|Study surgery not performed|6|||
160697980|NCT02196701|580276118|FG000|Overall Study|Adverse Event|1|||
160697981|NCT02196701|580276118|FG000|Overall Study|Lost to Follow-up|1|||
160697982|NCT02196701|580276118|FG000|Overall Study|Non-adherence to Protocol|1|||
160697983|NCT02283983|580276121|FG000|Overall Study|Inclusion criteria not met|0|||
160697984|NCT02283983|580276122|FG001|Overall Study|Inclusion criteria not met|1|||
160697985|NCT02283983|580276121|FG000|Overall Study|Withdrawal by Subject|4|||
160697986|NCT02283983|580276122|FG001|Overall Study|Withdrawal by Subject|2|||
160697987|NCT02283983|580276121|FG000|Overall Study|Protocol Violation|0|||
160697988|NCT02283983|580276122|FG001|Overall Study|Protocol Violation|4|||
160697989|NCT02283983|580276121|FG000|Overall Study|Physician Decision|2|||
160697990|NCT02283983|580276122|FG001|Overall Study|Physician Decision|4|||
160697991|NCT02283983|580276121|FG000|Overall Study|Death|1|||
160697992|NCT02283983|580276122|FG001|Overall Study|Death|0|||
160697993|NCT02283983|580276121|FG000|Overall Study|Adverse Event|1|||
160697994|NCT02283983|580276122|FG001|Overall Study|Adverse Event|0|||
160697995|NCT02283983|580276121|FG000|Overall Study|Lost to Follow-up|9|||
160697996|NCT02283983|580276122|FG001|Overall Study|Lost to Follow-up|8|||
160697997|NCT02283983|580276121|FG000|Overall Study|Relapse|1|||
160697998|NCT02283983|580276122|FG001|Overall Study|Relapse|0|||
160697999|NCT03275064|580276123|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
160698000|NCT03275064|580276124|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
160698001|NCT03275064|580276125|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
160698002|NCT03275064|580276126|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
160698003|NCT03275064|580276127|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
160698004|NCT03275064|580276123|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
160698005|NCT03275064|580276124|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
160698006|NCT03275064|580276125|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
160698007|NCT03275064|580276126|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
160698008|NCT03275064|580276127|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
160698009|NCT03275064|580276123|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
160698010|NCT03275064|580276124|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
160698011|NCT03275064|580276125|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
160698012|NCT03275064|580276126|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
160698013|NCT03275064|580276127|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
160698014|NCT03275064|580276123|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
160698015|NCT03275064|580276124|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
160698016|NCT03275064|580276125|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
160698017|NCT03275064|580276126|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
160698018|NCT03275064|580276127|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
160698019|NCT03275064|580276123|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
160698020|NCT03275064|580276124|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
160698021|NCT03275064|580276125|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
160698022|NCT03275064|580276126|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
160698023|NCT03275064|580276127|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
160698024|NCT00620555|580276130|FG000|Overall Study|Adverse Event|4|||
160698025|NCT00620555|580276130|FG000|Overall Study|Protocol Violation|2|||
160698026|NCT00620555|580276130|FG000|Overall Study|Lack of Efficacy|12|||
160698027|NCT00620555|580276130|FG000|Overall Study|Withdrawal by Subject|1|||
160698028|NCT00620555|580276130|FG000|Overall Study|Choice of other treatment|1|||
160698029|NCT00620555|580276130|FG000|Overall Study|Visit failure against planned|1|||
160698030|NCT03796039|580276131|FG000|Overall Study|Death|2|||
160698031|NCT03796039|580276132|FG001|Overall Study|Death|1|||
160698032|NCT03796039|580276131|FG000|Overall Study|Withdrawal by Subject|7|||
160698033|NCT03796039|580276132|FG001|Overall Study|Withdrawal by Subject|4|||
160698034|NCT01140503|580276133|FG000|Overall Study|Withdrawal by Subject|1|||
160698035|NCT04305496|580276135|FG000|Global Cohort|Withdrawal by Subject|13|||
160698036|NCT04305496|580276136|FG001|Global Cohort|Withdrawal by Subject|6|||
160698037|NCT04305496|580276135|FG000|Global Cohort|Physician Decision|1|||
160698038|NCT04305496|580276136|FG001|Global Cohort|Physician Decision|1|||
160698039|NCT04305496|580276135|FG000|Global Cohort|Subjective disease progression|16|||
160698040|NCT04305496|580276136|FG001|Global Cohort|Subjective disease progression|17|||
160698041|NCT04305496|580276135|FG000|Global Cohort|Condition under investigation worsened|209|||
160698042|NCT04305496|580276136|FG001|Global Cohort|Condition under investigation worsened|273|||
160698043|NCT04305496|580276135|FG000|Global Cohort|Protocol Violation|2|||
160698044|NCT04305496|580276136|FG001|Global Cohort|Protocol Violation|0|||
160698045|NCT04305496|580276135|FG000|Global Cohort|Adverse Event|44|||
160698046|NCT04305496|580276136|FG001|Global Cohort|Adverse Event|6|||
160698047|NCT04305496|580276135|FG000|Global Cohort|Death|3|||
160698048|NCT04305496|580276136|FG001|Global Cohort|Death|2|||
160698049|NCT04305496|580276135|FG000|Global Cohort|Any reason not specifically recorded|4|||
160698050|NCT04305496|580276136|FG001|Global Cohort|Any reason not specifically recorded|5|||
160698051|NCT04305496|580276135|FG000|China Cohort|Any reason not specifically recorded|1|||
160698052|NCT04305496|580276136|FG001|China Cohort|Any reason not specifically recorded|1|||
160698053|NCT04305496|580276135|FG000|China Cohort|Adverse Event|8|||
160698054|NCT04305496|580276136|FG001|China Cohort|Adverse Event|2|||
160698055|NCT04305496|580276135|FG000|China Cohort|Condition under investigation worsened|40|||
160698056|NCT04305496|580276136|FG001|China Cohort|Condition under investigation worsened|47|||
160698057|NCT04305496|580276135|FG000|China Cohort|Subjective disease progression|2|||
160698058|NCT04305496|580276136|FG001|China Cohort|Subjective disease progression|2|||
160698059|NCT04305496|580276135|FG000|China Cohort|Withdrawal by Subject|2|||
160698060|NCT04305496|580276136|FG001|China Cohort|Withdrawal by Subject|1|||
160698061|NCT01157897|580276138|FG000|Overall Study|Lost to Follow-up|2|||
160698062|NCT01157897|580276139|FG001|Overall Study|Lost to Follow-up|0|||
160698063|NCT01157897|580276140|FG002|Overall Study|Lost to Follow-up|0|||
160698064|NCT01157897|580276141|FG003|Overall Study|Lost to Follow-up|1|||
160698065|NCT01157897|580276138|FG000|Overall Study|Relocated|0|||
160698066|NCT01157897|580276139|FG001|Overall Study|Relocated|2|||
160698067|NCT01157897|580276140|FG002|Overall Study|Relocated|0|||
160698068|NCT01157897|580276141|FG003|Overall Study|Relocated|0|||
160698069|NCT00681590|580276143|FG000|Overall Study|Withdrawal by Subject|2|||
160698070|NCT00681590|580276144|FG001|Overall Study|Withdrawal by Subject|12|||
160698071|NCT01791153|580276146|FG000|Part 1: Blinded Period|Adverse Event|7|||
160698072|NCT01791153|580276147|FG001|Part 1: Blinded Period|Adverse Event|3|||
160698073|NCT01791153|580276148|FG002|Part 1: Blinded Period|Adverse Event|2|||
160698074|NCT01791153|580276149|FG003|Part 1: Blinded Period|Adverse Event|0|||
160698075|NCT01791153|580276150|FG004|Part 1: Blinded Period|Adverse Event|0|||
160698076|NCT01791153|580276151|FG005|Part 1: Blinded Period|Adverse Event|0|||
160698077|NCT01791153|580276152|FG006|Part 1: Blinded Period|Adverse Event|0|||
160698078|NCT01791153|580276153|FG007|Part 1: Blinded Period|Adverse Event|0|||
160698079|NCT01791153|580276146|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
160698080|NCT01791153|580276147|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
160698081|NCT01791153|580276148|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
160698082|NCT01791153|580276149|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
160698083|NCT01791153|580276150|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
160698084|NCT01791153|580276151|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
160698085|NCT01791153|580276152|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
160698086|NCT01791153|580276153|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
160698087|NCT01791153|580276146|FG000|Part 1: Blinded Period|Non-Compliance|1|||
160698088|NCT01791153|580276147|FG001|Part 1: Blinded Period|Non-Compliance|0|||
160698089|NCT01791153|580276148|FG002|Part 1: Blinded Period|Non-Compliance|0|||
160698090|NCT01791153|580276149|FG003|Part 1: Blinded Period|Non-Compliance|0|||
160698091|NCT01791153|580276150|FG004|Part 1: Blinded Period|Non-Compliance|0|||
160698092|NCT01791153|580276151|FG005|Part 1: Blinded Period|Non-Compliance|0|||
160698093|NCT01791153|580276152|FG006|Part 1: Blinded Period|Non-Compliance|0|||
160698094|NCT01791153|580276153|FG007|Part 1: Blinded Period|Non-Compliance|0|||
160698095|NCT01791153|580276146|FG000|Part 1: Blinded Period|Physician Decision|0|||
160698096|NCT01791153|580276147|FG001|Part 1: Blinded Period|Physician Decision|0|||
160698097|NCT01791153|580276148|FG002|Part 1: Blinded Period|Physician Decision|0|||
160698098|NCT01791153|580276149|FG003|Part 1: Blinded Period|Physician Decision|1|||
160698099|NCT01791153|580276150|FG004|Part 1: Blinded Period|Physician Decision|0|||
160698100|NCT01791153|580276151|FG005|Part 1: Blinded Period|Physician Decision|0|||
160698101|NCT01791153|580276152|FG006|Part 1: Blinded Period|Physician Decision|0|||
160698102|NCT01791153|580276153|FG007|Part 1: Blinded Period|Physician Decision|0|||
160698103|NCT01791153|580276146|FG000|Part 1: Blinded Period|Protocol Violation|0|||
160698104|NCT01791153|580276147|FG001|Part 1: Blinded Period|Protocol Violation|0|||
160698105|NCT01791153|580276148|FG002|Part 1: Blinded Period|Protocol Violation|0|||
160698106|NCT01791153|580276149|FG003|Part 1: Blinded Period|Protocol Violation|1|||
160698107|NCT01791153|580276150|FG004|Part 1: Blinded Period|Protocol Violation|0|||
160698108|NCT01791153|580276151|FG005|Part 1: Blinded Period|Protocol Violation|0|||
160698109|NCT01791153|580276152|FG006|Part 1: Blinded Period|Protocol Violation|0|||
160698110|NCT01791153|580276153|FG007|Part 1: Blinded Period|Protocol Violation|0|||
160698111|NCT01791153|580276146|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
160698112|NCT01791153|580276147|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
160698113|NCT01791153|580276148|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
160698114|NCT01791153|580276149|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
160698115|NCT01791153|580276150|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
160698116|NCT01791153|580276151|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
160698117|NCT01791153|580276152|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
160698118|NCT01791153|580276153|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
160698119|NCT01791153|580276146|FG000|Part 2: Open-label Period|Adverse Event|0|||
160698120|NCT01791153|580276147|FG001|Part 2: Open-label Period|Adverse Event|0|||
160698121|NCT01791153|580276148|FG002|Part 2: Open-label Period|Adverse Event|0|||
160698122|NCT01791153|580276149|FG003|Part 2: Open-label Period|Adverse Event|0|||
160698123|NCT01791153|580276150|FG004|Part 2: Open-label Period|Adverse Event|0|||
160698124|NCT01791153|580276151|FG005|Part 2: Open-label Period|Adverse Event|1|||
160698125|NCT01791153|580276152|FG006|Part 2: Open-label Period|Adverse Event|1|||
160698126|NCT01791153|580276153|FG007|Part 2: Open-label Period|Adverse Event|2|||
160698127|NCT01791153|580276146|FG000|Part 2: Open-label Period|Death|0|||
160698128|NCT01791153|580276147|FG001|Part 2: Open-label Period|Death|0|||
160698129|NCT01791153|580276148|FG002|Part 2: Open-label Period|Death|0|||
160698130|NCT01791153|580276149|FG003|Part 2: Open-label Period|Death|0|||
160698131|NCT01791153|580276150|FG004|Part 2: Open-label Period|Death|0|||
160698132|NCT01791153|580276151|FG005|Part 2: Open-label Period|Death|1|||
160698133|NCT01791153|580276152|FG006|Part 2: Open-label Period|Death|1|||
160698134|NCT01791153|580276153|FG007|Part 2: Open-label Period|Death|1|||
160698135|NCT01791153|580276146|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
160698136|NCT01791153|580276147|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
160698137|NCT01791153|580276148|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
160698138|NCT01791153|580276149|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
160698139|NCT01791153|580276150|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
160698140|NCT01791153|580276151|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
160698141|NCT01791153|580276152|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
160698142|NCT01791153|580276153|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
160698143|NCT01791153|580276146|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
160698144|NCT01791153|580276147|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
160698145|NCT01791153|580276148|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
160698146|NCT01791153|580276149|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
160698147|NCT01791153|580276150|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
160698148|NCT01791153|580276151|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
160698149|NCT01791153|580276152|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
160698150|NCT01791153|580276153|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
160698151|NCT01791153|580276146|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
160698152|NCT01791153|580276147|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
160698153|NCT01791153|580276148|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
160698154|NCT01791153|580276149|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
160698155|NCT01791153|580276150|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
160698156|NCT01791153|580276151|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
160698157|NCT01791153|580276152|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
160698158|NCT01791153|580276153|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
160698159|NCT01791153|580276146|FG000|Part 2: Open-label Period|Physician Decision|0|||
160698160|NCT01791153|580276147|FG001|Part 2: Open-label Period|Physician Decision|0|||
160698161|NCT01791153|580276148|FG002|Part 2: Open-label Period|Physician Decision|0|||
160698162|NCT01791153|580276149|FG003|Part 2: Open-label Period|Physician Decision|0|||
160698163|NCT01791153|580276150|FG004|Part 2: Open-label Period|Physician Decision|1|||
160698164|NCT01791153|580276151|FG005|Part 2: Open-label Period|Physician Decision|1|||
160698165|NCT01791153|580276152|FG006|Part 2: Open-label Period|Physician Decision|0|||
160698166|NCT01791153|580276153|FG007|Part 2: Open-label Period|Physician Decision|0|||
160698167|NCT02562482|580276154|FG000|Overall Study|Enrolled, but did not receive product|4|||
160698168|NCT02562482|580276155|FG001|Overall Study|Enrolled, but did not receive product|0|||
160698169|NCT02562482|580276154|FG000|Overall Study|Lost to Follow-up|9|||
160698170|NCT02562482|580276155|FG001|Overall Study|Lost to Follow-up|6|||
160698171|NCT02562482|580276154|FG000|Overall Study|Moved from area|2|||
160698172|NCT02562482|580276155|FG001|Overall Study|Moved from area|3|||
160698173|NCT02562482|580276154|FG000|Overall Study|Withdrawal by Subject|5|||
160698174|NCT02562482|580276155|FG001|Overall Study|Withdrawal by Subject|3|||
160698175|NCT02562482|580276154|FG000|Overall Study|Physician Decision|1|||
160698176|NCT02562482|580276155|FG001|Overall Study|Physician Decision|3|||
160698177|NCT02562482|580276154|FG000|Overall Study|Illness/Injury unrelated to product|0|||
160698178|NCT02562482|580276155|FG001|Overall Study|Illness/Injury unrelated to product|1|||
160698179|NCT05896202|580276158|FG000|Overall Study|Lost to Follow-up|2|||
160698180|NCT05896202|580276159|FG001|Overall Study|Lost to Follow-up|2|||
160698181|NCT01181271|580276162|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
160698182|NCT01181271|580276162|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
160698183|NCT01181271|580276162|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
160698184|NCT01181271|580276162|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
160698185|NCT02041091|580276163|FG000|Treatment|Adverse Event|3|||
160698186|NCT02041091|580276164|FG001|Treatment|Adverse Event|3|||
160698187|NCT02041091|580276163|FG000|Treatment|Withdrawal by Subject|2|||
160698188|NCT02041091|580276164|FG001|Treatment|Withdrawal by Subject|4|||
160698189|NCT02041091|580276163|FG000|Treatment|Physician Decision|1|||
160698190|NCT02041091|580276164|FG001|Treatment|Physician Decision|0|||
160698191|NCT02041091|580276163|FG000|Treatment|Sponsor Decision|15|||
160698192|NCT02041091|580276164|FG001|Treatment|Sponsor Decision|16|||
160698193|NCT02041091|580276163|FG000|Treatment|Lost to Follow-up|1|||
160698194|NCT02041091|580276164|FG001|Treatment|Lost to Follow-up|0|||
160698195|NCT02041091|580276163|FG000|Optional Safety Extension Period|Adverse Event|4|||
160698196|NCT02041091|580276164|FG001|Optional Safety Extension Period|Adverse Event|2|||
160698197|NCT02041091|580276163|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
160698198|NCT02041091|580276164|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
160698199|NCT02041091|580276163|FG000|Optional Safety Extension Period|Protocol Violation|2|||
160698200|NCT02041091|580276164|FG001|Optional Safety Extension Period|Protocol Violation|0|||
160698201|NCT02041091|580276163|FG000|Optional Safety Extension Period|Physician Decision|2|||
160698202|NCT02041091|580276164|FG001|Optional Safety Extension Period|Physician Decision|1|||
160698203|NCT02041091|580276163|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
160698204|NCT02041091|580276164|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
160698205|NCT02041091|580276163|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
160698206|NCT02041091|580276164|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
160698207|NCT03190330|580279621|FG000|Overall Study|Adverse Event|2|||
160698208|NCT03190330|580279621|FG000|Overall Study|Death|10|||
160698209|NCT03190330|580279621|FG000|Overall Study|Lost to Follow-up|1|||
160698210|NCT03190330|580279621|FG000|Overall Study|Withdrawal by Subject|6|||
160698211|NCT03190330|580279621|FG000|Overall Study|Progressive Disease|1|||
160698212|NCT02081209|580279622|FG000|Overall Study|Withdrawal by Subject|1|||
160698213|NCT04994483|580279623|FG000|Overall Study|Adverse Event|26|||
160698214|NCT04994483|580279624|FG001|Overall Study|Adverse Event|17|||
160698215|NCT04994483|580279623|FG000|Overall Study|Lost to Follow-up|6|||
160698216|NCT04994483|580279624|FG001|Overall Study|Lost to Follow-up|10|||
160698217|NCT04994483|580279623|FG000|Overall Study|Noncompliance with study drug|8|||
160698218|NCT04994483|580279624|FG001|Overall Study|Noncompliance with study drug|5|||
160698219|NCT04994483|580279623|FG000|Overall Study|Physician Decision|5|||
160698220|NCT04994483|580279624|FG001|Overall Study|Physician Decision|0|||
160698221|NCT04994483|580279623|FG000|Overall Study|Withdrawal by Subject|41|||
160698222|NCT04994483|580279624|FG001|Overall Study|Withdrawal by Subject|38|||
160698223|NCT04994483|580279623|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
160698224|NCT04994483|580279624|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
160698225|NCT04994483|580279623|FG000|Overall Study|Met stopping criteria|1|||
160698226|NCT04994483|580279624|FG001|Overall Study|Met stopping criteria|0|||
160698227|NCT04994483|580279623|FG000|Overall Study|Randomized in error, not treated|4|||
160698228|NCT04994483|580279624|FG001|Overall Study|Randomized in error, not treated|3|||
160698229|NCT04994483|580279623|FG000|Overall Study|Lack of a reliable study partner|0|||
160698230|NCT04994483|580279624|FG001|Overall Study|Lack of a reliable study partner|1|||
160698231|NCT04994483|580279623|FG000|Overall Study|Met MRI exclusion criteria|0|||
160698232|NCT04994483|580279624|FG001|Overall Study|Met MRI exclusion criteria|1|||
160698233|NCT00112866|580279625|FG000|Overall Study|Protocol Violation|1|||
160698234|NCT00112866|580279626|FG001|Overall Study|Protocol Violation|0|||
160698235|NCT00112866|580279625|FG000|Overall Study|did not start treatment post-op|1|||
160698236|NCT00112866|580279626|FG001|Overall Study|did not start treatment post-op|2|||
160698237|NCT04663295|580279627|FG000|Run-in Period|Withdrawal by Subject|3|||
160698238|NCT04663295|580279627|FG000|Overall Study Period|Pregnancy|1|||
160698239|NCT04663295|580279627|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
160698240|NCT00554190|580279628|FG000|Overall Study|Termination forms not completed|10|||
160698241|NCT02213510|580279629|FG000|Overall Study|Death|0|||
160698242|NCT02213510|580279630|FG001|Overall Study|Death|1|||
160698243|NCT02213510|580279629|FG000|Overall Study|Lost to Follow-up|1|||
160698244|NCT02213510|580279630|FG001|Overall Study|Lost to Follow-up|0|||
160698245|NCT02903030|580279631|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
160698246|NCT02903030|580279632|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
160698247|NCT01502410|580279633|FG000|Overall Study|Adverse Event|1|||
160698248|NCT01502410|580279634|FG001|Overall Study|Adverse Event|2|||
160698249|NCT01502410|580279635|FG002|Overall Study|Adverse Event|0|||
160698250|NCT01502410|580279636|FG003|Overall Study|Adverse Event|0|||
160698251|NCT01502410|580279633|FG000|Overall Study|Lack of Efficacy|7|||
160698252|NCT01502410|580279634|FG001|Overall Study|Lack of Efficacy|7|||
160698253|NCT01502410|580279635|FG002|Overall Study|Lack of Efficacy|0|||
160698254|NCT01502410|580279636|FG003|Overall Study|Lack of Efficacy|0|||
160698255|NCT01502410|580279633|FG000|Overall Study|Physician Decision|0|||
160698256|NCT01502410|580279634|FG001|Overall Study|Physician Decision|1|||
160698257|NCT01502410|580279635|FG002|Overall Study|Physician Decision|0|||
160698258|NCT01502410|580279636|FG003|Overall Study|Physician Decision|0|||
160698259|NCT01502410|580279633|FG000|Overall Study|Withdrawal by Subject|2|||
160698260|NCT01502410|580279634|FG001|Overall Study|Withdrawal by Subject|0|||
160698261|NCT01502410|580279635|FG002|Overall Study|Withdrawal by Subject|0|||
160698262|NCT01502410|580279636|FG003|Overall Study|Withdrawal by Subject|0|||
160698263|NCT03700385|580279642|FG000|Overall Study|Lost to Follow-up|1|||
160698264|NCT00699283|580279643|FG000|Overall Study|Lack of Efficacy|15|||
160698265|NCT00699283|580279644|FG001|Overall Study|Lack of Efficacy|5|||
160698266|NCT00699283|580279643|FG000|Overall Study|Lost to Follow-up|2|||
160698267|NCT00699283|580279644|FG001|Overall Study|Lost to Follow-up|0|||
160698268|NCT00699283|580279643|FG000|Overall Study|Withdrawal by Subject|1|||
160698269|NCT00699283|580279644|FG001|Overall Study|Withdrawal by Subject|0|||
160698270|NCT00699283|580279643|FG000|Overall Study|Other Reason|5|||
160698271|NCT00699283|580279644|FG001|Overall Study|Other Reason|1|||
160698272|NCT00699283|580279643|FG000|Overall Study|SAE, non-fatal|1|||
160698273|NCT00699283|580279644|FG001|Overall Study|SAE, non-fatal|1|||
160698274|NCT00699283|580279643|FG000|Overall Study|AE, non-serious non-fatal|8|||
160698275|NCT00699283|580279644|FG001|Overall Study|AE, non-serious non-fatal|1|||
160698276|NCT00699283|580279643|FG000|Overall Study|AE of unknown type|1|||
160698277|NCT00699283|580279644|FG001|Overall Study|AE of unknown type|0|||
160698278|NCT04590040|580279650|FG000|Treatment Period|Lost to Follow-up|2|||
160698279|NCT04590040|580279651|FG001|Treatment Period|Lost to Follow-up|5|||
160698280|NCT04590040|580279652|FG002|Treatment Period|Lost to Follow-up|0|||
160698281|NCT04590040|580279650|FG000|Treatment Period|Physician Decision|0|||
160698282|NCT04590040|580279651|FG001|Treatment Period|Physician Decision|0|||
160698283|NCT04590040|580279652|FG002|Treatment Period|Physician Decision|2|||
160698284|NCT00000378|580279655|FG000|Overall Study|Lack of Efficacy|16|||
160698285|NCT00000378|580279656|FG001|Overall Study|Lack of Efficacy|14|||
160698286|NCT00805675|580279664|FG000|Overall Study|Adverse Event|0|||
160698287|NCT00805675|580279665|FG001|Overall Study|Adverse Event|0|||
160698288|NCT00805675|580279666|FG002|Overall Study|Adverse Event|1|||
160698289|NCT02771795|580279667|FG000|Overall Study|Withdrawal by Subject|47|||
160698290|NCT02771795|580279668|FG001|Overall Study|Withdrawal by Subject|37|||
160698291|NCT02771795|580279667|FG000|Overall Study|Termination by premature discontinuation of study|168|||
160698292|NCT02771795|580279668|FG001|Overall Study|Termination by premature discontinuation of study|185|||
160698293|NCT01957397|580279670|FG000|Test Period 1|sudden leakage/small bag|1|||
160698294|NCT01957397|580279671|FG001|Test Period 1|sudden leakage/small bag|1|||
160698295|NCT01957397|580279670|FG000|Test Period 1|Withdrawal by Subject|1|||
160698296|NCT01957397|580279671|FG001|Test Period 1|Withdrawal by Subject|0|||
160698297|NCT01957397|580279670|FG000|Test Period 2|Adverse Event|0|||
160698298|NCT01957397|580279671|FG001|Test Period 2|Adverse Event|1|||
160698299|NCT01957397|580279670|FG000|Test Period 3|Adverse Event|1|||
160698300|NCT01957397|580279671|FG001|Test Period 3|Adverse Event|2|||
160698301|NCT01957397|580279670|FG000|Test Period 3|the adhesive did not work|1|||
160698302|NCT01957397|580279671|FG001|Test Period 3|the adhesive did not work|0|||
160698303|NCT03537599|580279672|FG000|Overall Study|Disease Progression|2|||
160698304|NCT03537599|580279673|FG001|Overall Study|Disease Progression|1|||
160698305|NCT03537599|580279672|FG000|Overall Study|Death|0|||
160698306|NCT03537599|580279673|FG001|Overall Study|Death|1|||
160698307|NCT00114166|580279674|FG000|Overall Study|Wrong primary|0|||
160698308|NCT00114166|580279675|FG001|Overall Study|Wrong primary|1|||
160698309|NCT02393248|580279676|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698310|NCT02393248|580279677|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
160698311|NCT02393248|580279678|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698312|NCT02393248|580279679|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698313|NCT02393248|580279680|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698314|NCT02393248|580279681|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
160698315|NCT02393248|580279682|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
160698316|NCT02393248|580279683|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698317|NCT02393248|580279684|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698318|NCT02393248|580279685|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698319|NCT02393248|580279686|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698320|NCT02393248|580279687|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698321|NCT02393248|580279688|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698322|NCT02393248|580279689|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698323|NCT02393248|580279690|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698324|NCT02393248|580279691|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698325|NCT02393248|580279692|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698326|NCT02393248|580279693|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698327|NCT02393248|580279694|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698328|NCT02393248|580279695|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698329|NCT02393248|580279696|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698330|NCT02393248|580279697|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698331|NCT02393248|580279698|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698332|NCT02393248|580279699|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698333|NCT02393248|580279700|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
160698334|NCT02393248|580279676|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698335|NCT02393248|580279677|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
160698336|NCT02393248|580279678|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698337|NCT02393248|580279679|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698338|NCT02393248|580279680|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698339|NCT02393248|580279681|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698340|NCT02393248|580279682|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698341|NCT02393248|580279683|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698342|NCT02393248|580279684|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698343|NCT02393248|580279685|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698344|NCT02393248|580279686|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698345|NCT02393248|580279687|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698346|NCT02393248|580279688|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698347|NCT02393248|580279689|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698348|NCT02393248|580279690|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698349|NCT02393248|580279691|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698350|NCT02393248|580279692|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698351|NCT02393248|580279693|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698352|NCT02393248|580279694|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698353|NCT02393248|580279695|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698354|NCT02393248|580279696|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698355|NCT02393248|580279697|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698356|NCT02393248|580279698|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698357|NCT02393248|580279699|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698358|NCT02393248|580279700|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
160698359|NCT02393248|580279676|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
160698360|NCT02393248|580279677|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
160698361|NCT02393248|580279678|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
160698362|NCT02393248|580279679|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
160698363|NCT02393248|580279680|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
160698364|NCT02393248|580279681|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
160698365|NCT02393248|580279682|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
160698366|NCT02393248|580279683|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
160698367|NCT02393248|580279684|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
160698368|NCT02393248|580279685|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
160698369|NCT02393248|580279686|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
160698370|NCT02393248|580279687|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
160698371|NCT02393248|580279688|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
160698372|NCT02393248|580279689|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
160698373|NCT02393248|580279690|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
160698374|NCT02393248|580279691|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
160698375|NCT02393248|580279692|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
160698376|NCT02393248|580279693|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
160698377|NCT02393248|580279694|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
160698378|NCT02393248|580279695|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
160698379|NCT02393248|580279696|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
160698380|NCT02393248|580279697|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
160698381|NCT02393248|580279698|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
160698382|NCT02393248|580279699|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
160698383|NCT02393248|580279700|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
160698384|NCT02393248|580279676|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
160698385|NCT02393248|580279677|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698386|NCT02393248|580279678|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698387|NCT02393248|580279679|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698388|NCT02393248|580279680|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698389|NCT02393248|580279681|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698390|NCT02393248|580279682|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698391|NCT02393248|580279683|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698392|NCT02393248|580279684|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698393|NCT02393248|580279685|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698394|NCT02393248|580279686|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698395|NCT02393248|580279687|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698396|NCT02393248|580279688|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698397|NCT02393248|580279689|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698398|NCT02393248|580279690|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698399|NCT02393248|580279691|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698400|NCT02393248|580279692|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698401|NCT02393248|580279693|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698402|NCT02393248|580279694|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698403|NCT02393248|580279695|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698404|NCT02393248|580279696|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698405|NCT02393248|580279697|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698406|NCT02393248|580279698|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698407|NCT02393248|580279699|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698408|NCT02393248|580279700|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
160698409|NCT02393248|580279676|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698410|NCT02393248|580279677|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698411|NCT02393248|580279678|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698412|NCT02393248|580279679|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698413|NCT02393248|580279680|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698414|NCT02393248|580279681|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
160698415|NCT02393248|580279682|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
160698416|NCT02393248|580279683|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698417|NCT02393248|580279684|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698418|NCT02393248|580279685|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
160698419|NCT02393248|580279686|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698420|NCT02393248|580279687|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698421|NCT02393248|580279688|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698422|NCT02393248|580279689|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698423|NCT02393248|580279690|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698424|NCT02393248|580279691|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698425|NCT02393248|580279692|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698426|NCT02393248|580279693|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698427|NCT02393248|580279694|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698428|NCT02393248|580279695|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698429|NCT02393248|580279696|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698430|NCT02393248|580279697|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698431|NCT02393248|580279698|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698432|NCT02393248|580279699|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698433|NCT02393248|580279700|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160698434|NCT02393248|580279676|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698435|NCT02393248|580279677|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698436|NCT02393248|580279678|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698437|NCT02393248|580279679|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698438|NCT02393248|580279680|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698439|NCT02393248|580279681|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698440|NCT02393248|580279682|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
160698441|NCT02393248|580279683|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698442|NCT02393248|580279684|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698443|NCT02393248|580279685|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698444|NCT02393248|580279686|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698445|NCT02393248|580279687|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698446|NCT02393248|580279688|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698447|NCT02393248|580279689|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698448|NCT02393248|580279690|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698449|NCT02393248|580279691|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698450|NCT02393248|580279692|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698451|NCT02393248|580279693|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698452|NCT02393248|580279694|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698453|NCT02393248|580279695|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698454|NCT02393248|580279696|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698455|NCT02393248|580279697|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698456|NCT02393248|580279698|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698457|NCT02393248|580279699|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698458|NCT02393248|580279700|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160698459|NCT02393248|580279676|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698460|NCT02393248|580279677|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698461|NCT02393248|580279678|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698462|NCT02393248|580279679|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698463|NCT02393248|580279680|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698464|NCT02393248|580279681|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698465|NCT02393248|580279682|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698466|NCT02393248|580279683|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698467|NCT02393248|580279684|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698468|NCT02393248|580279685|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698469|NCT02393248|580279686|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698470|NCT02393248|580279687|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
160698471|NCT02393248|580279688|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
160698472|NCT02393248|580279689|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
160698473|NCT02393248|580279690|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
160698474|NCT02393248|580279691|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698475|NCT02393248|580279692|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698476|NCT02393248|580279693|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698477|NCT02393248|580279694|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698478|NCT02393248|580279695|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698479|NCT02393248|580279696|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698480|NCT02393248|580279697|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698481|NCT02393248|580279698|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698482|NCT02393248|580279699|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698483|NCT02393248|580279700|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
160698484|NCT02393248|580279676|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698485|NCT02393248|580279677|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698486|NCT02393248|580279678|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698487|NCT02393248|580279679|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698488|NCT02393248|580279680|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698489|NCT02393248|580279681|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698490|NCT02393248|580279682|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698491|NCT02393248|580279683|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698492|NCT02393248|580279684|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698493|NCT02393248|580279685|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698494|NCT02393248|580279686|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
160698495|NCT02393248|580279687|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
160698496|NCT02393248|580279688|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698497|NCT02393248|580279689|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698498|NCT02393248|580279690|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698499|NCT02393248|580279691|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698500|NCT02393248|580279692|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698501|NCT02393248|580279693|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698502|NCT02393248|580279694|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698503|NCT02393248|580279695|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698504|NCT02393248|580279696|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698505|NCT02393248|580279697|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698506|NCT02393248|580279698|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698507|NCT02393248|580279699|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698508|NCT02393248|580279700|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
160698509|NCT02393248|580279676|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
160698510|NCT02393248|580279677|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
160698511|NCT02393248|580279678|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
160698512|NCT02393248|580279679|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
160698513|NCT02393248|580279680|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
160698514|NCT02393248|580279681|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
160698515|NCT02393248|580279682|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
160698516|NCT02393248|580279683|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
160698517|NCT02393248|580279684|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
160698518|NCT02393248|580279685|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
160698519|NCT02393248|580279686|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
160698520|NCT02393248|580279687|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
160698521|NCT02393248|580279688|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
160698522|NCT02393248|580279689|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
160698523|NCT02393248|580279690|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
160698524|NCT02393248|580279691|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
160698525|NCT02393248|580279692|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
160698526|NCT02393248|580279693|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
160698527|NCT02393248|580279694|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
160698528|NCT02393248|580279695|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
160698529|NCT02393248|580279696|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
160698530|NCT02393248|580279697|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
160698531|NCT02393248|580279698|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
160698532|NCT02393248|580279699|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
160698533|NCT02393248|580279700|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
160698534|NCT02393248|580279676|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698535|NCT02393248|580279677|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698536|NCT02393248|580279678|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698537|NCT02393248|580279679|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698538|NCT02393248|580279680|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698539|NCT02393248|580279681|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698540|NCT02393248|580279682|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698541|NCT02393248|580279683|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698542|NCT02393248|580279684|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698543|NCT02393248|580279685|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698544|NCT02393248|580279686|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698545|NCT02393248|580279687|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
160698546|NCT02393248|580279688|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698547|NCT02393248|580279689|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
160698548|NCT02393248|580279690|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698549|NCT02393248|580279691|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698550|NCT02393248|580279692|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698551|NCT02393248|580279693|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698552|NCT02393248|580279694|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698553|NCT02393248|580279695|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698554|NCT02393248|580279696|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698555|NCT02393248|580279697|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698556|NCT02393248|580279698|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698557|NCT02393248|580279699|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698558|NCT02393248|580279700|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
160698559|NCT02393248|580279676|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698560|NCT02393248|580279677|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698561|NCT02393248|580279678|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698562|NCT02393248|580279679|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698563|NCT02393248|580279680|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698564|NCT02393248|580279681|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698565|NCT02393248|580279682|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698566|NCT02393248|580279683|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698567|NCT02393248|580279684|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698568|NCT02393248|580279685|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698569|NCT02393248|580279686|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698570|NCT02393248|580279687|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698571|NCT02393248|580279688|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698572|NCT02393248|580279689|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698573|NCT02393248|580279690|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698574|NCT02393248|580279691|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698575|NCT02393248|580279692|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698576|NCT02393248|580279693|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698577|NCT02393248|580279694|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
160698578|NCT02393248|580279695|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698579|NCT02393248|580279696|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
160698580|NCT02393248|580279697|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
160698581|NCT02393248|580279698|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698582|NCT02393248|580279699|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
160698583|NCT02393248|580279700|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
160698584|NCT02393248|580279676|FG000|Part 3: Combination Therapy|Death|0|||
160698585|NCT02393248|580279677|FG001|Part 3: Combination Therapy|Death|0|||
160698586|NCT02393248|580279678|FG002|Part 3: Combination Therapy|Death|0|||
160698587|NCT02393248|580279679|FG003|Part 3: Combination Therapy|Death|0|||
160698588|NCT02393248|580279680|FG004|Part 3: Combination Therapy|Death|0|||
160698589|NCT02393248|580279681|FG005|Part 3: Combination Therapy|Death|0|||
160698590|NCT02393248|580279682|FG006|Part 3: Combination Therapy|Death|0|||
160698591|NCT02393248|580279683|FG007|Part 3: Combination Therapy|Death|0|||
160698592|NCT02393248|580279684|FG008|Part 3: Combination Therapy|Death|0|||
160698593|NCT02393248|580279685|FG009|Part 3: Combination Therapy|Death|0|||
160698594|NCT02393248|580279686|FG010|Part 3: Combination Therapy|Death|0|||
160698595|NCT02393248|580279687|FG011|Part 3: Combination Therapy|Death|0|||
160698596|NCT02393248|580279688|FG012|Part 3: Combination Therapy|Death|0|||
160698597|NCT02393248|580279689|FG013|Part 3: Combination Therapy|Death|0|||
160698598|NCT02393248|580279690|FG014|Part 3: Combination Therapy|Death|0|||
160698599|NCT02393248|580279691|FG015|Part 3: Combination Therapy|Death|1|||
160698600|NCT02393248|580279692|FG016|Part 3: Combination Therapy|Death|7|||
160698601|NCT02393248|580279693|FG017|Part 3: Combination Therapy|Death|5|||
160698602|NCT02393248|580279694|FG018|Part 3: Combination Therapy|Death|5|||
160698603|NCT02393248|580279695|FG019|Part 3: Combination Therapy|Death|3|||
160698604|NCT02393248|580279696|FG020|Part 3: Combination Therapy|Death|7|||
160698605|NCT02393248|580279697|FG021|Part 3: Combination Therapy|Death|5|||
160698606|NCT02393248|580279698|FG022|Part 3: Combination Therapy|Death|6|||
160698607|NCT02393248|580279699|FG023|Part 3: Combination Therapy|Death|3|||
160698608|NCT02393248|580279700|FG024|Part 3: Combination Therapy|Death|0|||
160698609|NCT02393248|580279676|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698610|NCT02393248|580279677|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698611|NCT02393248|580279678|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698612|NCT02393248|580279679|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698613|NCT02393248|580279680|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698614|NCT02393248|580279681|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698615|NCT02393248|580279682|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698616|NCT02393248|580279683|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698617|NCT02393248|580279684|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698618|NCT02393248|580279685|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698619|NCT02393248|580279686|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698620|NCT02393248|580279687|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698621|NCT02393248|580279688|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698622|NCT02393248|580279689|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698623|NCT02393248|580279690|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698624|NCT02393248|580279691|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698625|NCT02393248|580279692|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698626|NCT02393248|580279693|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
160698627|NCT02393248|580279694|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
160698628|NCT02393248|580279695|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
160698629|NCT02393248|580279696|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
160698630|NCT02393248|580279697|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
160698631|NCT02393248|580279698|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
160698632|NCT02393248|580279699|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
160698633|NCT02393248|580279700|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
160698634|NCT02393248|580279676|FG000|Part 3: Combination Therapy|Disease Progression|0|||
160698635|NCT02393248|580279677|FG001|Part 3: Combination Therapy|Disease Progression|0|||
160698636|NCT02393248|580279678|FG002|Part 3: Combination Therapy|Disease Progression|0|||
160698637|NCT02393248|580279679|FG003|Part 3: Combination Therapy|Disease Progression|0|||
160698638|NCT02393248|580279680|FG004|Part 3: Combination Therapy|Disease Progression|0|||
160698639|NCT02393248|580279681|FG005|Part 3: Combination Therapy|Disease Progression|0|||
160698640|NCT02393248|580279682|FG006|Part 3: Combination Therapy|Disease Progression|0|||
160698641|NCT02393248|580279683|FG007|Part 3: Combination Therapy|Disease Progression|0|||
160698642|NCT02393248|580279684|FG008|Part 3: Combination Therapy|Disease Progression|0|||
160698643|NCT02393248|580279685|FG009|Part 3: Combination Therapy|Disease Progression|0|||
160698644|NCT02393248|580279686|FG010|Part 3: Combination Therapy|Disease Progression|0|||
160698645|NCT02393248|580279687|FG011|Part 3: Combination Therapy|Disease Progression|0|||
160698646|NCT02393248|580279688|FG012|Part 3: Combination Therapy|Disease Progression|0|||
160698647|NCT02393248|580279689|FG013|Part 3: Combination Therapy|Disease Progression|0|||
160698648|NCT02393248|580279690|FG014|Part 3: Combination Therapy|Disease Progression|0|||
160698649|NCT02393248|580279691|FG015|Part 3: Combination Therapy|Disease Progression|0|||
160698650|NCT02393248|580279692|FG016|Part 3: Combination Therapy|Disease Progression|0|||
160698651|NCT02393248|580279693|FG017|Part 3: Combination Therapy|Disease Progression|0|||
160698652|NCT02393248|580279694|FG018|Part 3: Combination Therapy|Disease Progression|0|||
160698653|NCT02393248|580279695|FG019|Part 3: Combination Therapy|Disease Progression|0|||
160698654|NCT02393248|580279696|FG020|Part 3: Combination Therapy|Disease Progression|2|||
160698655|NCT02393248|580279697|FG021|Part 3: Combination Therapy|Disease Progression|1|||
160698656|NCT02393248|580279698|FG022|Part 3: Combination Therapy|Disease Progression|0|||
160698657|NCT02393248|580279699|FG023|Part 3: Combination Therapy|Disease Progression|0|||
160698658|NCT02393248|580279700|FG024|Part 3: Combination Therapy|Disease Progression|0|||
160698659|NCT02393248|580279676|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698660|NCT02393248|580279677|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698661|NCT02393248|580279678|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698662|NCT02393248|580279679|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698663|NCT02393248|580279680|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698664|NCT02393248|580279681|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698665|NCT02393248|580279682|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698666|NCT02393248|580279683|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698667|NCT02393248|580279684|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698668|NCT02393248|580279685|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698669|NCT02393248|580279686|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698670|NCT02393248|580279687|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698671|NCT02393248|580279688|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698672|NCT02393248|580279689|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698673|NCT02393248|580279690|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698674|NCT02393248|580279691|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698675|NCT02393248|580279692|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698676|NCT02393248|580279693|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698677|NCT02393248|580279694|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698678|NCT02393248|580279695|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698679|NCT02393248|580279696|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
160698680|NCT02393248|580279697|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
160698681|NCT02393248|580279698|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698682|NCT02393248|580279699|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698683|NCT02393248|580279700|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
160698684|NCT02393248|580279676|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698685|NCT02393248|580279677|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698686|NCT02393248|580279678|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698687|NCT02393248|580279679|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698688|NCT02393248|580279680|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698689|NCT02393248|580279681|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698690|NCT02393248|580279682|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698691|NCT02393248|580279683|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698692|NCT02393248|580279684|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698693|NCT02393248|580279685|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698694|NCT02393248|580279686|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698695|NCT02393248|580279687|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698696|NCT02393248|580279688|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698697|NCT02393248|580279689|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698698|NCT02393248|580279690|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698699|NCT02393248|580279691|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698700|NCT02393248|580279692|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698701|NCT02393248|580279693|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698702|NCT02393248|580279694|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698703|NCT02393248|580279695|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698704|NCT02393248|580279696|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
160698705|NCT02393248|580279697|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698706|NCT02393248|580279698|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698707|NCT02393248|580279699|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698708|NCT02393248|580279700|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160698709|NCT02393248|580279676|FG000|Part 3: Combination Therapy|Adverse Event|0|||
160698710|NCT02393248|580279677|FG001|Part 3: Combination Therapy|Adverse Event|0|||
160698711|NCT02393248|580279678|FG002|Part 3: Combination Therapy|Adverse Event|0|||
160698712|NCT02393248|580279679|FG003|Part 3: Combination Therapy|Adverse Event|0|||
160698713|NCT02393248|580279680|FG004|Part 3: Combination Therapy|Adverse Event|0|||
160698714|NCT02393248|580279681|FG005|Part 3: Combination Therapy|Adverse Event|0|||
160698715|NCT02393248|580279682|FG006|Part 3: Combination Therapy|Adverse Event|0|||
160698716|NCT02393248|580279683|FG007|Part 3: Combination Therapy|Adverse Event|0|||
160698717|NCT02393248|580279684|FG008|Part 3: Combination Therapy|Adverse Event|0|||
160698718|NCT02393248|580279685|FG009|Part 3: Combination Therapy|Adverse Event|0|||
160698719|NCT02393248|580279686|FG010|Part 3: Combination Therapy|Adverse Event|0|||
160698720|NCT02393248|580279687|FG011|Part 3: Combination Therapy|Adverse Event|0|||
160698721|NCT02393248|580279688|FG012|Part 3: Combination Therapy|Adverse Event|0|||
160698722|NCT02393248|580279689|FG013|Part 3: Combination Therapy|Adverse Event|0|||
160698723|NCT02393248|580279690|FG014|Part 3: Combination Therapy|Adverse Event|0|||
160698724|NCT02393248|580279691|FG015|Part 3: Combination Therapy|Adverse Event|0|||
160698725|NCT02393248|580279692|FG016|Part 3: Combination Therapy|Adverse Event|0|||
160698726|NCT02393248|580279693|FG017|Part 3: Combination Therapy|Adverse Event|0|||
160698727|NCT02393248|580279694|FG018|Part 3: Combination Therapy|Adverse Event|0|||
160698728|NCT02393248|580279695|FG019|Part 3: Combination Therapy|Adverse Event|0|||
160698729|NCT02393248|580279696|FG020|Part 3: Combination Therapy|Adverse Event|0|||
160698730|NCT02393248|580279697|FG021|Part 3: Combination Therapy|Adverse Event|0|||
160698731|NCT02393248|580279698|FG022|Part 3: Combination Therapy|Adverse Event|0|||
160698732|NCT02393248|580279699|FG023|Part 3: Combination Therapy|Adverse Event|1|||
160698733|NCT02393248|580279700|FG024|Part 3: Combination Therapy|Adverse Event|0|||
160698734|NCT02393248|580279676|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698735|NCT02393248|580279677|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698736|NCT02393248|580279678|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698737|NCT02393248|580279679|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698738|NCT02393248|580279680|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698739|NCT02393248|580279681|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698740|NCT02393248|580279682|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698741|NCT02393248|580279683|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698742|NCT02393248|580279684|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698743|NCT02393248|580279685|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698744|NCT02393248|580279686|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698745|NCT02393248|580279687|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698746|NCT02393248|580279688|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698747|NCT02393248|580279689|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698748|NCT02393248|580279690|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698749|NCT02393248|580279691|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698750|NCT02393248|580279692|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698751|NCT02393248|580279693|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698752|NCT02393248|580279694|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698753|NCT02393248|580279695|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698754|NCT02393248|580279696|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698755|NCT02393248|580279697|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698756|NCT02393248|580279698|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698757|NCT02393248|580279699|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
160698758|NCT02393248|580279700|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
160698759|NCT02585934|580279701|FG000|Overall Study|Lost to Follow-up|2|||
160698760|NCT02585934|580279702|FG001|Overall Study|Lost to Follow-up|2|||
160698761|NCT02585934|580279701|FG000|Overall Study|Protocol Violation|14|||
160698762|NCT02585934|580279702|FG001|Overall Study|Protocol Violation|11|||
160698763|NCT02585934|580279701|FG000|Overall Study|Adverse Event|21|||
160698764|NCT02585934|580279702|FG001|Overall Study|Adverse Event|22|||
160698765|NCT02585934|580279701|FG000|Overall Study|Physician Decision|3|||
160698766|NCT02585934|580279702|FG001|Overall Study|Physician Decision|2|||
160698767|NCT02585934|580279701|FG000|Overall Study|Withdrawal by Subject|7|||
160698768|NCT02585934|580279702|FG001|Overall Study|Withdrawal by Subject|21|||
160698769|NCT02585934|580279701|FG000|Overall Study|Lack of Efficacy|2|||
160698770|NCT02585934|580279702|FG001|Overall Study|Lack of Efficacy|1|||
160698771|NCT02585934|580279701|FG000|Overall Study|Death|2|||
160698772|NCT02585934|580279702|FG001|Overall Study|Death|0|||
160698773|NCT02585934|580279701|FG000|Overall Study|Caregiver Withdrew Consent|7|||
160698774|NCT02585934|580279702|FG001|Overall Study|Caregiver Withdrew Consent|7|||
160698775|NCT02585934|580279701|FG000|Overall Study|Sponsor Termination|1|||
160698776|NCT02585934|580279702|FG001|Overall Study|Sponsor Termination|2|||
160698777|NCT02585934|580279701|FG000|Overall Study|Another Reason|10|||
160698778|NCT02585934|580279702|FG001|Overall Study|Another Reason|5|||
160698779|NCT02603393|580279704|FG000|Overall Study|Patient/guardian decision|32|||
160698780|NCT02603393|580279705|FG001|Overall Study|Patient/guardian decision|18|||
160698781|NCT02603393|580279704|FG000|Overall Study|Adverse Event|17|||
160698782|NCT02603393|580279705|FG001|Overall Study|Adverse Event|15|||
160698783|NCT02603393|580279704|FG000|Overall Study|Technical problems|4|||
160698784|NCT02603393|580279705|FG001|Overall Study|Technical problems|7|||
160698785|NCT02603393|580279704|FG000|Overall Study|Lack of Efficacy|7|||
160698786|NCT02603393|580279705|FG001|Overall Study|Lack of Efficacy|2|||
160698787|NCT02603393|580279704|FG000|Overall Study|Death|3|||
160698788|NCT02603393|580279705|FG001|Overall Study|Death|4|||
160698789|NCT02603393|580279704|FG000|Overall Study|Physician Decision|3|||
160698790|NCT02603393|580279705|FG001|Overall Study|Physician Decision|3|||
160698791|NCT02603393|580279704|FG000|Overall Study|Protocol deviation|2|||
160698792|NCT02603393|580279705|FG001|Overall Study|Protocol deviation|3|||
160698793|NCT02603393|580279704|FG000|Overall Study|Lost to Follow-up|1|||
160698794|NCT02603393|580279705|FG001|Overall Study|Lost to Follow-up|2|||
160698795|NCT02603393|580279704|FG000|Overall Study|Non-compliance with study treatment|1|||
160698796|NCT02603393|580279705|FG001|Overall Study|Non-compliance with study treatment|0|||
160698797|NCT02603393|580279704|FG000|Overall Study|Sponsor decision|1|||
160698798|NCT02603393|580279705|FG001|Overall Study|Sponsor decision|0|||
160698799|NCT04053465|580279707|FG000|Overall Study|Withdrawal by Subject|4|||
160698800|NCT04053465|580279708|FG001|Overall Study|Withdrawal by Subject|4|||
160698801|NCT02085135|580279709|FG000|Overall Study|Adverse Event|4|||
160698802|NCT02085135|580279710|FG001|Overall Study|Adverse Event|7|||
160698803|NCT02085135|580279709|FG000|Overall Study|Lost to Follow-up|2|||
160698804|NCT02085135|580279710|FG001|Overall Study|Lost to Follow-up|2|||
160698805|NCT02085135|580279709|FG000|Overall Study|Withdrawal by Subject|3|||
160698806|NCT02085135|580279710|FG001|Overall Study|Withdrawal by Subject|0|||
160698807|NCT02085135|580279709|FG000|Overall Study|Lack of Efficacy|2|||
160698808|NCT02085135|580279710|FG001|Overall Study|Lack of Efficacy|0|||
160698809|NCT01755767|580279713|FG000|Overall Study|Progressive Disease|8|||
160698810|NCT01755767|580279714|FG001|Overall Study|Progressive Disease|7|||
160698811|NCT01755767|580279715|FG002|Overall Study|Progressive Disease|91|||
160698812|NCT01755767|580279716|FG003|Overall Study|Progressive Disease|43|||
160698813|NCT01755767|580279713|FG000|Overall Study|Clinical Disease Progression|4|||
160698814|NCT01755767|580279714|FG001|Overall Study|Clinical Disease Progression|2|||
160698815|NCT01755767|580279715|FG002|Overall Study|Clinical Disease Progression|29|||
160698816|NCT01755767|580279716|FG003|Overall Study|Clinical Disease Progression|20|||
160698817|NCT01755767|580279713|FG000|Overall Study|Radiographic Disease Progression|9|||
160698818|NCT01755767|580279714|FG001|Overall Study|Radiographic Disease Progression|4|||
160698819|NCT01755767|580279715|FG002|Overall Study|Radiographic Disease Progression|44|||
160698820|NCT01755767|580279716|FG003|Overall Study|Radiographic Disease Progression|27|||
160698821|NCT01755767|580279713|FG000|Overall Study|Adverse Event|6|||
160698822|NCT01755767|580279714|FG001|Overall Study|Adverse Event|0|||
160698823|NCT01755767|580279715|FG002|Overall Study|Adverse Event|28|||
160698824|NCT01755767|580279716|FG003|Overall Study|Adverse Event|11|||
160698825|NCT01755767|580279713|FG000|Overall Study|Death|1|||
160698826|NCT01755767|580279714|FG001|Overall Study|Death|2|||
160698827|NCT01755767|580279715|FG002|Overall Study|Death|15|||
160698828|NCT01755767|580279716|FG003|Overall Study|Death|4|||
160698829|NCT01755767|580279713|FG000|Overall Study|Subject Decision|0|||
160698830|NCT01755767|580279714|FG001|Overall Study|Subject Decision|0|||
160698831|NCT01755767|580279715|FG002|Overall Study|Subject Decision|10|||
160698832|NCT01755767|580279716|FG003|Overall Study|Subject Decision|3|||
160698833|NCT01755767|580279713|FG000|Overall Study|Withdrawal by Subject|0|||
160698834|NCT01755767|580279714|FG001|Overall Study|Withdrawal by Subject|0|||
160698835|NCT01755767|580279715|FG002|Overall Study|Withdrawal by Subject|2|||
160698836|NCT01755767|580279716|FG003|Overall Study|Withdrawal by Subject|1|||
160698837|NCT01755767|580279713|FG000|Overall Study|Other|0|||
160698838|NCT01755767|580279714|FG001|Overall Study|Other|0|||
160698839|NCT01755767|580279715|FG002|Overall Study|Other|2|||
160698840|NCT01755767|580279716|FG003|Overall Study|Other|3|||
160698841|NCT01755767|580279713|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
160698842|NCT01755767|580279714|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
160698843|NCT01755767|580279715|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
160698844|NCT01755767|580279716|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
160698845|NCT02865460|580279717|FG000|Overall Study|Adverse Event|1|||
160698846|NCT02865460|580279718|FG001|Overall Study|Adverse Event|0|||
160698847|NCT02865460|580279717|FG000|Overall Study|Withdrawal by Subject|1|||
160698848|NCT02865460|580279718|FG001|Overall Study|Withdrawal by Subject|1|||
160698849|NCT02865460|580279717|FG000|Overall Study|Lost to Follow-up|7|||
160698850|NCT02865460|580279718|FG001|Overall Study|Lost to Follow-up|4|||
160698851|NCT02865460|580279717|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
160698852|NCT02865460|580279718|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
160698853|NCT00901576|580279719|FG000|Second Intervention|Withdrawal by Subject|0|||
160698854|NCT00901576|580279720|FG001|Second Intervention|Withdrawal by Subject|0|||
160698855|NCT00901576|580279721|FG002|Second Intervention|Withdrawal by Subject|0|||
160698856|NCT00901576|580279722|FG003|Second Intervention|Withdrawal by Subject|1|||
160698857|NCT00901576|580279723|FG004|Second Intervention|Withdrawal by Subject|0|||
160698858|NCT00901576|580279724|FG005|Second Intervention|Withdrawal by Subject|1|||
160698859|NCT00901576|580279719|FG000|Second Intervention|Physician Decision|1|||
160698860|NCT00901576|580279720|FG001|Second Intervention|Physician Decision|0|||
160698861|NCT00901576|580279721|FG002|Second Intervention|Physician Decision|0|||
160698862|NCT00901576|580279722|FG003|Second Intervention|Physician Decision|0|||
160698863|NCT00901576|580279723|FG004|Second Intervention|Physician Decision|0|||
160698864|NCT00901576|580279724|FG005|Second Intervention|Physician Decision|0|||
160698865|NCT01696279|580279725|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
160698866|NCT01696279|580279726|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
160698867|NCT01696279|580279727|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
160698868|NCT01696279|580279728|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
160698869|NCT01696279|580279725|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
160698870|NCT01696279|580279726|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
160698871|NCT01696279|580279727|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
160698872|NCT01696279|580279728|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
160698873|NCT01696279|580279725|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
160698874|NCT01696279|580279726|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
160698875|NCT01696279|580279727|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
160698876|NCT01696279|580279728|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
160698877|NCT01696279|580279725|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
160698878|NCT01696279|580279726|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
160698879|NCT01696279|580279727|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
160698880|NCT01696279|580279728|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
160698881|NCT01696279|580279725|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
160698882|NCT01696279|580279726|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
160698883|NCT01696279|580279727|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
160698884|NCT01696279|580279728|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
160698885|NCT01696279|580279725|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
160698886|NCT01696279|580279726|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
160698887|NCT01696279|580279727|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
160698888|NCT01696279|580279728|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
160698889|NCT01696279|580279725|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
160698890|NCT01696279|580279726|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
160698891|NCT01696279|580279727|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
160698892|NCT01696279|580279728|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
160698893|NCT01696279|580279725|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
160698894|NCT01696279|580279726|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
160698895|NCT01696279|580279727|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
160698896|NCT01696279|580279728|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
160698897|NCT01696279|580279725|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
160698898|NCT01696279|580279726|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
160698899|NCT01696279|580279727|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
160698900|NCT01696279|580279728|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
160698901|NCT01696279|580279725|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
160698902|NCT01696279|580279726|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
160698903|NCT01696279|580279727|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
160698904|NCT01696279|580279728|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
160698905|NCT01696279|580279725|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
160698906|NCT01696279|580279726|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
160698907|NCT01696279|580279727|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
160698908|NCT01696279|580279728|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
160698909|NCT00171951|580279729|FG000|Overall Study|Adverse Event|1|||
160698910|NCT00171951|580279729|FG000|Overall Study|Abnormal Laboratory Values|2|||
160698911|NCT00171951|580279729|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160698912|NCT00171951|580279729|FG000|Overall Study|Participants Withdrew Consent|3|||
160698913|NCT00171951|580279729|FG000|Overall Study|New Cancer Therapy|5|||
160698914|NCT00171951|580279729|FG000|Overall Study|Reason not Specified|2|||
160698915|NCT06077149|580279730|FG000|Overall Study|Death|1|||
160698916|NCT06077149|580279731|FG001|Overall Study|Death|0|||
160698917|NCT06077149|580279730|FG000|Overall Study|Withdrawal by Subject|2|||
160698918|NCT06077149|580279731|FG001|Overall Study|Withdrawal by Subject|0|||
160698919|NCT06077149|580279730|FG000|Overall Study|RSV infection before vaccination|3|||
160698920|NCT06077149|580279731|FG001|Overall Study|RSV infection before vaccination|0|||
160698921|NCT04658095|580279732|FG000|Overall Study|Study terminated|5|||
160698922|NCT04658095|580279733|FG001|Overall Study|Study terminated|1|||
160698923|NCT04658095|580279734|FG002|Overall Study|Study terminated|4|||
160698924|NCT04154631|580279735|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
160698925|NCT04154631|580279736|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
160698926|NCT01441947|580279737|FG000|Overall Study|Withdrawal by Subject|3|||
160698927|NCT01441947|580279738|FG001|Overall Study|Withdrawal by Subject|0|||
160698928|NCT02970318|580279740|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
160698929|NCT02970318|580279741|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
160698930|NCT02970318|580279742|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
160698931|NCT02970318|580279743|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
160698932|NCT02970318|580279740|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
160698933|NCT02970318|580279741|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
160698934|NCT02970318|580279742|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
160698935|NCT02970318|580279743|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
160698936|NCT02970318|580279740|FG000|Overall for Arm A & Main for Arm B|Death|41|||
160698937|NCT02970318|580279741|FG001|Overall for Arm A & Main for Arm B|Death|33|||
160698938|NCT02970318|580279742|FG002|Overall for Arm A & Main for Arm B|Death|0|||
160698939|NCT02970318|580279743|FG003|Overall for Arm A & Main for Arm B|Death|0|||
160698940|NCT02970318|580279740|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
160698941|NCT02970318|580279741|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
160698942|NCT02970318|580279742|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
160698943|NCT02970318|580279743|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
160698944|NCT02970318|580279740|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
160698945|NCT02970318|580279741|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
160698946|NCT02970318|580279742|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
160698947|NCT02970318|580279743|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
160698948|NCT02970318|580279740|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
160698949|NCT02970318|580279741|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
160698950|NCT02970318|580279742|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
160698951|NCT02970318|580279743|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
160698952|NCT02970318|580279740|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
160698953|NCT02970318|580279741|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
160698954|NCT02970318|580279742|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
160698955|NCT02970318|580279743|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
160698956|NCT03384654|580279744|FG000|Overall Study|Withdrawal by Subject|0|||
160698957|NCT03384654|580279745|FG001|Overall Study|Withdrawal by Subject|0|||
160698958|NCT03384654|580279746|FG002|Overall Study|Withdrawal by Subject|1|||
160698959|NCT03384654|580279747|FG003|Overall Study|Withdrawal by Subject|0|||
160698960|NCT01616953|580279748|FG000|Overall Study|Lost to Follow-up|1|||
160698961|NCT01616953|580279749|FG001|Overall Study|Lost to Follow-up|0|||
160698962|NCT01616953|580279748|FG000|Overall Study|lack of bone and soft tissue|1|||
160698963|NCT01616953|580279749|FG001|Overall Study|lack of bone and soft tissue|0|||
160698964|NCT00816361|580279751|FG000|Overall Study|Withdrawal by Subject|0|||
160698965|NCT00816361|580279752|FG001|Overall Study|Withdrawal by Subject|0|||
160698966|NCT00816361|580279753|FG002|Overall Study|Withdrawal by Subject|0|||
160698967|NCT00816361|580279754|FG003|Overall Study|Withdrawal by Subject|0|||
160698968|NCT00816361|580279755|FG004|Overall Study|Withdrawal by Subject|1|||
160698969|NCT00816361|580279756|FG005|Overall Study|Withdrawal by Subject|2|||
160698970|NCT00816361|580279757|FG006|Overall Study|Withdrawal by Subject|0|||
160698971|NCT00816361|580279758|FG007|Overall Study|Withdrawal by Subject|2|||
160698972|NCT00816361|580279759|FG008|Overall Study|Withdrawal by Subject|1|||
160698973|NCT00816361|580279751|FG000|Overall Study|Death|4|||
160698974|NCT00816361|580279752|FG001|Overall Study|Death|3|||
160698975|NCT00816361|580279753|FG002|Overall Study|Death|3|||
160698976|NCT00816361|580279754|FG003|Overall Study|Death|3|||
160698977|NCT00816361|580279755|FG004|Overall Study|Death|1|||
160698978|NCT00816361|580279756|FG005|Overall Study|Death|1|||
160698979|NCT00816361|580279757|FG006|Overall Study|Death|3|||
160698980|NCT00816361|580279758|FG007|Overall Study|Death|7|||
160698981|NCT00816361|580279759|FG008|Overall Study|Death|8|||
160698982|NCT00816361|580279751|FG000|Overall Study|Other|0|||
160698983|NCT00816361|580279752|FG001|Overall Study|Other|0|||
160698984|NCT00816361|580279753|FG002|Overall Study|Other|0|||
160698985|NCT00816361|580279754|FG003|Overall Study|Other|0|||
160698986|NCT00816361|580279755|FG004|Overall Study|Other|0|||
160698987|NCT00816361|580279756|FG005|Overall Study|Other|0|||
160698988|NCT00816361|580279757|FG006|Overall Study|Other|0|||
160698989|NCT00816361|580279758|FG007|Overall Study|Other|0|||
160698990|NCT00816361|580279759|FG008|Overall Study|Other|1|||
160698991|NCT02500641|580279760|FG000|Overall Study|Adverse Event|0|||
160698992|NCT02500641|580279761|FG001|Overall Study|Adverse Event|2|||
160698993|NCT02500641|580279760|FG000|Overall Study|Withdrawal by Subject|4|||
160698994|NCT02500641|580279761|FG001|Overall Study|Withdrawal by Subject|5|||
160698995|NCT02500641|580279760|FG000|Overall Study|Unable to follow study procedures|3|||
160698996|NCT02500641|580279761|FG001|Overall Study|Unable to follow study procedures|2|||
160698997|NCT02500641|580279760|FG000|Overall Study|Protocol Violation|1|||
160698998|NCT02500641|580279761|FG001|Overall Study|Protocol Violation|2|||
160698999|NCT02500641|580279760|FG000|Overall Study|Lost to Follow-up|1|||
160699000|NCT02500641|580279761|FG001|Overall Study|Lost to Follow-up|0|||
160699001|NCT02500641|580279760|FG000|Overall Study|Sponsor decision|1|||
160699002|NCT02500641|580279761|FG001|Overall Study|Sponsor decision|0|||
160699003|NCT02500641|580279760|FG000|Overall Study|Non compliance to study drug|0|||
160699004|NCT02500641|580279761|FG001|Overall Study|Non compliance to study drug|1|||
160699005|NCT01408628|580279765|FG000|Consented|Withdrawal by Subject|12|||
160699006|NCT01408628|580279765|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
160699007|NCT01408628|580279765|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
160699008|NCT01408628|580279765|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
160699009|NCT04156620|580279766|FG000|Overall Study|Adverse event - TP 1|5|||
160699010|NCT04156620|580279767|FG001|Overall Study|Adverse event - TP 1|2|||
160699011|NCT04156620|580279766|FG000|Overall Study|Lost to follow-up TP 1|1|||
160699012|NCT04156620|580279767|FG001|Overall Study|Lost to follow-up TP 1|1|||
160699013|NCT04156620|580279766|FG000|Overall Study|Progressive disease - TP 1|0|||
160699014|NCT04156620|580279767|FG001|Overall Study|Progressive disease - TP 1|1|||
160699015|NCT04156620|580279766|FG000|Overall Study|Subject decision - TP 1|3|||
160699016|NCT04156620|580279767|FG001|Overall Study|Subject decision - TP 1|5|||
160699017|NCT04156620|580279766|FG000|Overall Study|Adverse event - TP 2|5|||
160699018|NCT04156620|580279767|FG001|Overall Study|Adverse event - TP 2|6|||
160699019|NCT04156620|580279766|FG000|Overall Study|Death - TP 2|1|||
160699020|NCT04156620|580279767|FG001|Overall Study|Death - TP 2|0|||
160699021|NCT04156620|580279766|FG000|Overall Study|Lost to follow-up - TP 2|5|||
160699022|NCT04156620|580279767|FG001|Overall Study|Lost to follow-up - TP 2|2|||
160699023|NCT04156620|580279766|FG000|Overall Study|Physician decision - TP 2|4|||
160699024|NCT04156620|580279767|FG001|Overall Study|Physician decision - TP 2|2|||
160699025|NCT04156620|580279766|FG000|Overall Study|Pregnancy - TP 2|1|||
160699026|NCT04156620|580279767|FG001|Overall Study|Pregnancy - TP 2|1|||
160699027|NCT04156620|580279766|FG000|Overall Study|Subject decision - TP 2|11|||
160699028|NCT04156620|580279767|FG001|Overall Study|Subject decision - TP 2|9|||
160699029|NCT04156620|580279766|FG000|Overall Study|New therapy for study indication - TP 2|1|||
160699030|NCT04156620|580279767|FG001|Overall Study|New therapy for study indication - TP 2|0|||
160699031|NCT01753336|580279768|FG000|Overall Study|Patient decision|12|||
160699032|NCT01753336|580279768|FG000|Overall Study|Lost to Follow-up|3|||
160699033|NCT01753336|580279768|FG000|Overall Study|Physician Decision|2|||
160699034|NCT01753336|580279768|FG000|Overall Study|Sponsor's decision|2|||
160699035|NCT01753336|580279768|FG000|Overall Study|Withdrawal by Subject|1|||
160699036|NCT01121666|580279769|FG000|Overall Study|Protocol Violation|29|||
160699037|NCT01121666|580279770|FG001|Overall Study|Protocol Violation|10|||
160699038|NCT03201211|580279773|FG000|Overall Study|Adverse Event|1|||
160699039|NCT03201211|580279774|FG001|Overall Study|Adverse Event|0|||
160699040|NCT03201211|580279775|FG002|Overall Study|Adverse Event|0|||
160699041|NCT03201211|580279773|FG000|Overall Study|Protocol Violation|1|||
160699042|NCT03201211|580279774|FG001|Overall Study|Protocol Violation|0|||
160699043|NCT03201211|580279775|FG002|Overall Study|Protocol Violation|0|||
160699044|NCT03201211|580279773|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160699045|NCT03201211|580279774|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160699046|NCT03201211|580279775|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
160699047|NCT03201211|580279773|FG000|Overall Study|OTHER unknown reasons|0|||
160699048|NCT03201211|580279774|FG001|Overall Study|OTHER unknown reasons|1|||
160699049|NCT03201211|580279775|FG002|Overall Study|OTHER unknown reasons|0|||
160699050|NCT01970865|580279776|FG000|Overall Study|Death|3|||
160699051|NCT01970865|580279777|FG001|Overall Study|Death|2|||
160699052|NCT01970865|580279778|FG002|Overall Study|Death|3|||
160699053|NCT01970865|580279779|FG003|Overall Study|Death|6|||
160699054|NCT01970865|580279780|FG004|Overall Study|Death|9|||
160699055|NCT01970865|580279781|FG005|Overall Study|Death|3|||
160699056|NCT01970865|580279782|FG006|Overall Study|Death|2|||
160699057|NCT01970865|580279783|FG007|Overall Study|Death|3|||
160699058|NCT01970865|580279784|FG008|Overall Study|Death|2|||
160699059|NCT01970865|580279785|FG009|Overall Study|Death|2|||
160699060|NCT01970865|580279786|FG010|Overall Study|Death|8|||
160699061|NCT01970865|580279787|FG011|Overall Study|Death|13|||
160699062|NCT01970865|580279788|FG012|Overall Study|Death|25|||
160699063|NCT01970865|580279789|FG013|Overall Study|Death|46|||
160699064|NCT01970865|580279790|FG014|Overall Study|Death|37|||
160699065|NCT01970865|580279791|FG015|Overall Study|Death|22|||
160699066|NCT01970865|580279792|FG016|Overall Study|Death|1|||
160699067|NCT01970865|580279793|FG017|Overall Study|Death|17|||
160699068|NCT01970865|580279776|FG000|Overall Study|Lost to Follow-up|0|||
160699069|NCT01970865|580279777|FG001|Overall Study|Lost to Follow-up|0|||
160699070|NCT01970865|580279778|FG002|Overall Study|Lost to Follow-up|0|||
160699071|NCT01970865|580279779|FG003|Overall Study|Lost to Follow-up|1|||
160699072|NCT01970865|580279780|FG004|Overall Study|Lost to Follow-up|1|||
160699073|NCT01970865|580279781|FG005|Overall Study|Lost to Follow-up|0|||
160699074|NCT01970865|580279782|FG006|Overall Study|Lost to Follow-up|0|||
160699075|NCT01970865|580279783|FG007|Overall Study|Lost to Follow-up|0|||
160699076|NCT01970865|580279784|FG008|Overall Study|Lost to Follow-up|0|||
160699077|NCT01970865|580279785|FG009|Overall Study|Lost to Follow-up|0|||
160699078|NCT01970865|580279786|FG010|Overall Study|Lost to Follow-up|1|||
160699079|NCT01970865|580279787|FG011|Overall Study|Lost to Follow-up|0|||
160699080|NCT01970865|580279788|FG012|Overall Study|Lost to Follow-up|2|||
160699081|NCT01970865|580279789|FG013|Overall Study|Lost to Follow-up|0|||
160699082|NCT01970865|580279790|FG014|Overall Study|Lost to Follow-up|1|||
160699083|NCT01970865|580279791|FG015|Overall Study|Lost to Follow-up|4|||
160699084|NCT01970865|580279792|FG016|Overall Study|Lost to Follow-up|0|||
160699085|NCT01970865|580279793|FG017|Overall Study|Lost to Follow-up|1|||
160699086|NCT01970865|580279776|FG000|Overall Study|Other|0|||
160699087|NCT01970865|580279777|FG001|Overall Study|Other|1|||
160699088|NCT01970865|580279778|FG002|Overall Study|Other|0|||
160699089|NCT01970865|580279779|FG003|Overall Study|Other|1|||
160699090|NCT01970865|580279780|FG004|Overall Study|Other|1|||
160699091|NCT01970865|580279781|FG005|Overall Study|Other|0|||
160699092|NCT01970865|580279782|FG006|Overall Study|Other|1|||
160699093|NCT01970865|580279783|FG007|Overall Study|Other|0|||
160699094|NCT01970865|580279784|FG008|Overall Study|Other|0|||
160699095|NCT01970865|580279785|FG009|Overall Study|Other|0|||
160699096|NCT01970865|580279786|FG010|Overall Study|Other|2|||
160699097|NCT01970865|580279787|FG011|Overall Study|Other|3|||
160699098|NCT01970865|580279788|FG012|Overall Study|Other|8|||
160699099|NCT01970865|580279789|FG013|Overall Study|Other|3|||
160699100|NCT01970865|580279790|FG014|Overall Study|Other|2|||
160699101|NCT01970865|580279791|FG015|Overall Study|Other|3|||
160699102|NCT01970865|580279792|FG016|Overall Study|Other|0|||
160699103|NCT01970865|580279793|FG017|Overall Study|Other|2|||
160699104|NCT01970865|580279776|FG000|Overall Study|Participant refused further follow-up|0|||
160699105|NCT01970865|580279777|FG001|Overall Study|Participant refused further follow-up|0|||
160699106|NCT01970865|580279778|FG002|Overall Study|Participant refused further follow-up|0|||
160699107|NCT01970865|580279779|FG003|Overall Study|Participant refused further follow-up|2|||
160699108|NCT01970865|580279780|FG004|Overall Study|Participant refused further follow-up|3|||
160699109|NCT01970865|580279781|FG005|Overall Study|Participant refused further follow-up|0|||
160699110|NCT01970865|580279782|FG006|Overall Study|Participant refused further follow-up|0|||
160699111|NCT01970865|580279783|FG007|Overall Study|Participant refused further follow-up|0|||
160699112|NCT01970865|580279784|FG008|Overall Study|Participant refused further follow-up|0|||
160699113|NCT01970865|580279785|FG009|Overall Study|Participant refused further follow-up|0|||
160699114|NCT01970865|580279786|FG010|Overall Study|Participant refused further follow-up|1|||
160699115|NCT01970865|580279787|FG011|Overall Study|Participant refused further follow-up|4|||
160699116|NCT01970865|580279788|FG012|Overall Study|Participant refused further follow-up|7|||
160699117|NCT01970865|580279789|FG013|Overall Study|Participant refused further follow-up|8|||
160699118|NCT01970865|580279790|FG014|Overall Study|Participant refused further follow-up|3|||
160699119|NCT01970865|580279791|FG015|Overall Study|Participant refused further follow-up|11|||
160699120|NCT01970865|580279792|FG016|Overall Study|Participant refused further follow-up|0|||
160699121|NCT01970865|580279793|FG017|Overall Study|Participant refused further follow-up|6|||
160699122|NCT01855074|580279794|FG000|Overall Study|Adverse Event|1|||
160699123|NCT01855074|580279794|FG000|Overall Study|Lost to Follow-up|4|||
160699124|NCT01855074|580279794|FG000|Overall Study|Withdrawal by Subject|8|||
160699125|NCT01855074|580279794|FG000|Overall Study|Started but not treated|1|||
160699126|NCT01629966|580279795|FG000|Overall Study|Pregnancy|0|||
160699127|NCT01629966|580279796|FG001|Overall Study|Pregnancy|1|||
160699128|NCT01629966|580279797|FG002|Overall Study|Pregnancy|0|||
160699129|NCT01629966|580279795|FG000|Overall Study|Lost to Follow-up|10|||
160699130|NCT01629966|580279796|FG001|Overall Study|Lost to Follow-up|13|||
160699131|NCT01629966|580279797|FG002|Overall Study|Lost to Follow-up|9|||
160699132|NCT01629966|580279795|FG000|Overall Study|Withdrawal by Subject|8|||
160699133|NCT01629966|580279796|FG001|Overall Study|Withdrawal by Subject|9|||
160699134|NCT01629966|580279797|FG002|Overall Study|Withdrawal by Subject|16|||
160699135|NCT01629966|580279795|FG000|Overall Study|Protocol Violation|7|||
160699136|NCT01629966|580279796|FG001|Overall Study|Protocol Violation|9|||
160699137|NCT01629966|580279797|FG002|Overall Study|Protocol Violation|7|||
160699138|NCT01629966|580279795|FG000|Overall Study|Lack of Efficacy|5|||
160699139|NCT01629966|580279796|FG001|Overall Study|Lack of Efficacy|2|||
160699140|NCT01629966|580279797|FG002|Overall Study|Lack of Efficacy|4|||
160699141|NCT01629966|580279795|FG000|Overall Study|Adverse Event|11|||
160699142|NCT01629966|580279796|FG001|Overall Study|Adverse Event|18|||
160699143|NCT01629966|580279797|FG002|Overall Study|Adverse Event|30|||
160699144|NCT02991430|580279798|FG000|Treatment Period 1|Adverse Event|1|||
160699145|NCT02991430|580279799|FG001|Treatment Period 1|Adverse Event|0|||
160699146|NCT02991430|580279800|FG002|Treatment Period 1|Adverse Event|2|||
160699147|NCT02991430|580279798|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160699148|NCT02991430|580279799|FG001|Treatment Period 1|Withdrawal by Subject|4|||
160699149|NCT02991430|580279800|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160699150|NCT02991430|580279798|FG000|Treatment Period 2|Study Termination|6|||
160699151|NCT02991430|580279799|FG001|Treatment Period 2|Study Termination|3|||
160699152|NCT02991430|580279800|FG002|Treatment Period 2|Study Termination|3|||
160699153|NCT02991430|580279798|FG000|Treatment Period 2|Lost to Follow-up|0|||
160699154|NCT02991430|580279799|FG001|Treatment Period 2|Lost to Follow-up|0|||
160699155|NCT02991430|580279800|FG002|Treatment Period 2|Lost to Follow-up|1|||
160699156|NCT02991430|580279798|FG000|Post-treatment Observation Period|Study Termination|3|||
160699157|NCT02991430|580279799|FG001|Post-treatment Observation Period|Study Termination|6|||
160699158|NCT02991430|580279800|FG002|Post-treatment Observation Period|Study Termination|5|||
160699159|NCT01150890|580279801|FG000|Overall Study|Other|0|||
160699160|NCT01150890|580279802|FG001|Overall Study|Other|1|||
160699161|NCT01150890|580279803|FG002|Overall Study|Other|0|||
160699162|NCT01150890|580279804|FG003|Overall Study|Other|2|||
160699163|NCT01150890|580279801|FG000|Overall Study|Pregnancy|0|||
160699164|NCT01150890|580279802|FG001|Overall Study|Pregnancy|0|||
160699165|NCT01150890|580279803|FG002|Overall Study|Pregnancy|0|||
160699166|NCT01150890|580279804|FG003|Overall Study|Pregnancy|1|||
160699167|NCT01150890|580279801|FG000|Overall Study|Administrative Decision|4|||
160699168|NCT01150890|580279802|FG001|Overall Study|Administrative Decision|4|||
160699169|NCT01150890|580279803|FG002|Overall Study|Administrative Decision|5|||
160699170|NCT01150890|580279804|FG003|Overall Study|Administrative Decision|6|||
160699171|NCT01150890|580279801|FG000|Overall Study|Ineligibility determined|0|||
160699172|NCT01150890|580279802|FG001|Overall Study|Ineligibility determined|1|||
160699173|NCT01150890|580279803|FG002|Overall Study|Ineligibility determined|0|||
160699174|NCT01150890|580279804|FG003|Overall Study|Ineligibility determined|0|||
160699175|NCT01150890|580279801|FG000|Overall Study|Adverse Event|0|||
160699176|NCT01150890|580279802|FG001|Overall Study|Adverse Event|0|||
160699177|NCT01150890|580279803|FG002|Overall Study|Adverse Event|2|||
160699178|NCT01150890|580279804|FG003|Overall Study|Adverse Event|0|||
160699179|NCT01150890|580279801|FG000|Overall Study|Withdrawal by Subject|0|||
160699180|NCT01150890|580279802|FG001|Overall Study|Withdrawal by Subject|0|||
160699181|NCT01150890|580279803|FG002|Overall Study|Withdrawal by Subject|2|||
160699182|NCT01150890|580279804|FG003|Overall Study|Withdrawal by Subject|1|||
160699183|NCT01150890|580279801|FG000|Overall Study|Disease progression|0|||
160699184|NCT01150890|580279802|FG001|Overall Study|Disease progression|7|||
160699185|NCT01150890|580279803|FG002|Overall Study|Disease progression|3|||
160699186|NCT01150890|580279804|FG003|Overall Study|Disease progression|7|||
160699187|NCT01672970|580279805|FG000|Overall Study|Lack of Efficacy|12|||
160699188|NCT01672970|580279805|FG000|Overall Study|Adverse Event|18|||
160699189|NCT01672970|580279805|FG000|Overall Study|Withdrawal by Subject|2|||
160699190|NCT01672970|580279805|FG000|Overall Study|Lost to Follow-up|5|||
160699191|NCT01672970|580279805|FG000|Overall Study|Other|9|||
160699192|NCT01672970|580279805|FG000|Overall Study|Enrolled but not treated|1|||
160699193|NCT03118570|580279806|FG000|Overall Study|Adverse Event|2|||
160699194|NCT03118570|580279807|FG001|Overall Study|Adverse Event|0|||
160699195|NCT03118570|580279808|FG002|Overall Study|Adverse Event|0|||
160699196|NCT03118570|580279809|FG003|Overall Study|Adverse Event|0|||
160699197|NCT03118570|580279810|FG004|Overall Study|Adverse Event|3|||
160699198|NCT03118570|580279806|FG000|Overall Study|Withdrawal by Subject|0|||
160699199|NCT03118570|580279807|FG001|Overall Study|Withdrawal by Subject|1|||
160699200|NCT03118570|580279808|FG002|Overall Study|Withdrawal by Subject|4|||
160699201|NCT03118570|580279809|FG003|Overall Study|Withdrawal by Subject|0|||
160699202|NCT03118570|580279810|FG004|Overall Study|Withdrawal by Subject|1|||
160699203|NCT03118570|580279806|FG000|Overall Study|Lost to Follow-up|2|||
160699204|NCT03118570|580279807|FG001|Overall Study|Lost to Follow-up|3|||
160699205|NCT03118570|580279808|FG002|Overall Study|Lost to Follow-up|1|||
160699206|NCT03118570|580279809|FG003|Overall Study|Lost to Follow-up|0|||
160699207|NCT03118570|580279810|FG004|Overall Study|Lost to Follow-up|1|||
160699208|NCT03118570|580279806|FG000|Overall Study|Other, Not Specified|1|||
160699209|NCT03118570|580279807|FG001|Overall Study|Other, Not Specified|3|||
160699210|NCT03118570|580279808|FG002|Overall Study|Other, Not Specified|0|||
160699211|NCT03118570|580279809|FG003|Overall Study|Other, Not Specified|0|||
160699212|NCT03118570|580279810|FG004|Overall Study|Other, Not Specified|0|||
160699213|NCT02132754|580279811|FG000|Overall Study|Adverse Event|0|||
160699214|NCT02132754|580279812|FG001|Overall Study|Adverse Event|0|||
160699215|NCT02132754|580279813|FG002|Overall Study|Adverse Event|0|||
160699216|NCT02132754|580279814|FG003|Overall Study|Adverse Event|0|||
160699217|NCT02132754|580279815|FG004|Overall Study|Adverse Event|0|||
160699218|NCT02132754|580279816|FG005|Overall Study|Adverse Event|0|||
160699219|NCT02132754|580279817|FG006|Overall Study|Adverse Event|0|||
160699220|NCT02132754|580279818|FG007|Overall Study|Adverse Event|0|||
160699221|NCT02132754|580279819|FG008|Overall Study|Adverse Event|0|||
160699222|NCT02132754|580279820|FG009|Overall Study|Adverse Event|0|||
160699223|NCT02132754|580279821|FG010|Overall Study|Adverse Event|0|||
160699224|NCT02132754|580279822|FG011|Overall Study|Adverse Event|0|||
160699225|NCT02132754|580279823|FG012|Overall Study|Adverse Event|0|||
160699226|NCT02132754|580279824|FG013|Overall Study|Adverse Event|0|||
160699227|NCT02132754|580279825|FG014|Overall Study|Adverse Event|0|||
160699228|NCT02132754|580279826|FG015|Overall Study|Adverse Event|0|||
160699229|NCT02132754|580279827|FG016|Overall Study|Adverse Event|0|||
160699230|NCT02132754|580279828|FG017|Overall Study|Adverse Event|1|||
160699231|NCT02132754|580279829|FG018|Overall Study|Adverse Event|0|||
160699232|NCT02132754|580279830|FG019|Overall Study|Adverse Event|0|||
160699233|NCT02132754|580279831|FG020|Overall Study|Adverse Event|0|||
160699234|NCT02132754|580279832|FG021|Overall Study|Adverse Event|0|||
160699235|NCT02132754|580279833|FG022|Overall Study|Adverse Event|0|||
160699236|NCT02132754|580279834|FG023|Overall Study|Adverse Event|0|||
160699237|NCT02132754|580279835|FG024|Overall Study|Adverse Event|0|||
160699238|NCT02132754|580279836|FG025|Overall Study|Adverse Event|1|||
160699239|NCT02132754|580279837|FG026|Overall Study|Adverse Event|1|||
160699240|NCT02132754|580279838|FG027|Overall Study|Adverse Event|0|||
160699241|NCT02132754|580279839|FG028|Overall Study|Adverse Event|0|||
160699242|NCT02132754|580279840|FG029|Overall Study|Adverse Event|0|||
160699243|NCT02132754|580279841|FG030|Overall Study|Adverse Event|1|||
160699244|NCT02132754|580279842|FG031|Overall Study|Adverse Event|0|||
160699245|NCT02132754|580279843|FG032|Overall Study|Adverse Event|1|||
160699246|NCT02132754|580279844|FG033|Overall Study|Adverse Event|1|||
160699247|NCT02132754|580279811|FG000|Overall Study|Clinical Progression|0|||
160699248|NCT02132754|580279812|FG001|Overall Study|Clinical Progression|0|||
160699249|NCT02132754|580279813|FG002|Overall Study|Clinical Progression|0|||
160699250|NCT02132754|580279814|FG003|Overall Study|Clinical Progression|0|||
160699251|NCT02132754|580279815|FG004|Overall Study|Clinical Progression|0|||
160699252|NCT02132754|580279816|FG005|Overall Study|Clinical Progression|0|||
160699253|NCT02132754|580279817|FG006|Overall Study|Clinical Progression|0|||
160699254|NCT02132754|580279818|FG007|Overall Study|Clinical Progression|0|||
160699255|NCT02132754|580279819|FG008|Overall Study|Clinical Progression|0|||
160699256|NCT02132754|580279820|FG009|Overall Study|Clinical Progression|1|||
160699257|NCT02132754|580279821|FG010|Overall Study|Clinical Progression|0|||
160699258|NCT02132754|580279822|FG011|Overall Study|Clinical Progression|0|||
160699259|NCT02132754|580279823|FG012|Overall Study|Clinical Progression|0|||
160699260|NCT02132754|580279824|FG013|Overall Study|Clinical Progression|0|||
160699261|NCT02132754|580279825|FG014|Overall Study|Clinical Progression|0|||
160699262|NCT02132754|580279826|FG015|Overall Study|Clinical Progression|0|||
160699263|NCT02132754|580279827|FG016|Overall Study|Clinical Progression|1|||
160699264|NCT02132754|580279828|FG017|Overall Study|Clinical Progression|1|||
160699265|NCT02132754|580279829|FG018|Overall Study|Clinical Progression|0|||
160699266|NCT02132754|580279830|FG019|Overall Study|Clinical Progression|1|||
160699267|NCT02132754|580279831|FG020|Overall Study|Clinical Progression|0|||
160699268|NCT02132754|580279832|FG021|Overall Study|Clinical Progression|0|||
160699269|NCT02132754|580279833|FG022|Overall Study|Clinical Progression|1|||
160699270|NCT02132754|580279834|FG023|Overall Study|Clinical Progression|0|||
160699271|NCT02132754|580279835|FG024|Overall Study|Clinical Progression|1|||
160699272|NCT02132754|580279836|FG025|Overall Study|Clinical Progression|1|||
160699273|NCT02132754|580279837|FG026|Overall Study|Clinical Progression|0|||
160699274|NCT02132754|580279838|FG027|Overall Study|Clinical Progression|1|||
160699275|NCT02132754|580279839|FG028|Overall Study|Clinical Progression|1|||
160699276|NCT02132754|580279840|FG029|Overall Study|Clinical Progression|0|||
160699277|NCT02132754|580279841|FG030|Overall Study|Clinical Progression|1|||
160699278|NCT02132754|580279842|FG031|Overall Study|Clinical Progression|0|||
160699279|NCT02132754|580279843|FG032|Overall Study|Clinical Progression|0|||
160699280|NCT02132754|580279844|FG033|Overall Study|Clinical Progression|2|||
160699281|NCT02132754|580279811|FG000|Overall Study|Death|0|||
160699282|NCT02132754|580279812|FG001|Overall Study|Death|0|||
160699283|NCT02132754|580279813|FG002|Overall Study|Death|0|||
160699284|NCT02132754|580279814|FG003|Overall Study|Death|0|||
160699285|NCT02132754|580279815|FG004|Overall Study|Death|0|||
160699286|NCT02132754|580279816|FG005|Overall Study|Death|0|||
160699287|NCT02132754|580279817|FG006|Overall Study|Death|0|||
160699288|NCT02132754|580279818|FG007|Overall Study|Death|0|||
160699289|NCT02132754|580279819|FG008|Overall Study|Death|0|||
160699290|NCT02132754|580279820|FG009|Overall Study|Death|0|||
160699291|NCT02132754|580279821|FG010|Overall Study|Death|0|||
160699292|NCT02132754|580279822|FG011|Overall Study|Death|0|||
160699293|NCT02132754|580279823|FG012|Overall Study|Death|0|||
160699294|NCT02132754|580279824|FG013|Overall Study|Death|0|||
160699295|NCT02132754|580279825|FG014|Overall Study|Death|0|||
160699296|NCT02132754|580279826|FG015|Overall Study|Death|1|||
160699297|NCT02132754|580279827|FG016|Overall Study|Death|0|||
160699298|NCT02132754|580279828|FG017|Overall Study|Death|0|||
160699299|NCT02132754|580279829|FG018|Overall Study|Death|0|||
160699300|NCT02132754|580279830|FG019|Overall Study|Death|1|||
160699301|NCT02132754|580279831|FG020|Overall Study|Death|0|||
160699302|NCT02132754|580279832|FG021|Overall Study|Death|1|||
160699303|NCT02132754|580279833|FG022|Overall Study|Death|0|||
160699304|NCT02132754|580279834|FG023|Overall Study|Death|0|||
160699305|NCT02132754|580279835|FG024|Overall Study|Death|0|||
160699306|NCT02132754|580279836|FG025|Overall Study|Death|0|||
160699307|NCT02132754|580279837|FG026|Overall Study|Death|1|||
160699308|NCT02132754|580279838|FG027|Overall Study|Death|0|||
160699309|NCT02132754|580279839|FG028|Overall Study|Death|0|||
160699310|NCT02132754|580279840|FG029|Overall Study|Death|0|||
160699311|NCT02132754|580279841|FG030|Overall Study|Death|0|||
160699312|NCT02132754|580279842|FG031|Overall Study|Death|0|||
160699313|NCT02132754|580279843|FG032|Overall Study|Death|0|||
160699314|NCT02132754|580279844|FG033|Overall Study|Death|2|||
160699315|NCT02132754|580279811|FG000|Overall Study|Excluded Medication|0|||
160699316|NCT02132754|580279812|FG001|Overall Study|Excluded Medication|0|||
160699317|NCT02132754|580279813|FG002|Overall Study|Excluded Medication|0|||
160699318|NCT02132754|580279814|FG003|Overall Study|Excluded Medication|0|||
160699319|NCT02132754|580279815|FG004|Overall Study|Excluded Medication|0|||
160699320|NCT02132754|580279816|FG005|Overall Study|Excluded Medication|0|||
160699321|NCT02132754|580279817|FG006|Overall Study|Excluded Medication|0|||
160699322|NCT02132754|580279818|FG007|Overall Study|Excluded Medication|0|||
160699323|NCT02132754|580279819|FG008|Overall Study|Excluded Medication|0|||
160699324|NCT02132754|580279820|FG009|Overall Study|Excluded Medication|0|||
160699325|NCT02132754|580279821|FG010|Overall Study|Excluded Medication|0|||
160699326|NCT02132754|580279822|FG011|Overall Study|Excluded Medication|0|||
160699327|NCT02132754|580279823|FG012|Overall Study|Excluded Medication|0|||
160699328|NCT02132754|580279824|FG013|Overall Study|Excluded Medication|0|||
160699329|NCT02132754|580279825|FG014|Overall Study|Excluded Medication|0|||
160699330|NCT02132754|580279826|FG015|Overall Study|Excluded Medication|0|||
160699331|NCT02132754|580279827|FG016|Overall Study|Excluded Medication|0|||
160699332|NCT02132754|580279828|FG017|Overall Study|Excluded Medication|0|||
160699333|NCT02132754|580279829|FG018|Overall Study|Excluded Medication|0|||
160699334|NCT02132754|580279830|FG019|Overall Study|Excluded Medication|0|||
160699335|NCT02132754|580279831|FG020|Overall Study|Excluded Medication|1|||
160699336|NCT02132754|580279832|FG021|Overall Study|Excluded Medication|0|||
160699337|NCT02132754|580279833|FG022|Overall Study|Excluded Medication|0|||
160699338|NCT02132754|580279834|FG023|Overall Study|Excluded Medication|0|||
160699339|NCT02132754|580279835|FG024|Overall Study|Excluded Medication|0|||
160699340|NCT02132754|580279836|FG025|Overall Study|Excluded Medication|0|||
160699341|NCT02132754|580279837|FG026|Overall Study|Excluded Medication|0|||
160699342|NCT02132754|580279838|FG027|Overall Study|Excluded Medication|0|||
160699343|NCT02132754|580279839|FG028|Overall Study|Excluded Medication|0|||
160699344|NCT02132754|580279840|FG029|Overall Study|Excluded Medication|0|||
160699345|NCT02132754|580279841|FG030|Overall Study|Excluded Medication|0|||
160699346|NCT02132754|580279842|FG031|Overall Study|Excluded Medication|0|||
160699347|NCT02132754|580279843|FG032|Overall Study|Excluded Medication|0|||
160699348|NCT02132754|580279844|FG033|Overall Study|Excluded Medication|1|||
160699349|NCT02132754|580279811|FG000|Overall Study|Physician Decision|0|||
160699350|NCT02132754|580279812|FG001|Overall Study|Physician Decision|0|||
160699351|NCT02132754|580279813|FG002|Overall Study|Physician Decision|0|||
160699352|NCT02132754|580279814|FG003|Overall Study|Physician Decision|0|||
160699353|NCT02132754|580279815|FG004|Overall Study|Physician Decision|0|||
160699354|NCT02132754|580279816|FG005|Overall Study|Physician Decision|0|||
160699355|NCT02132754|580279817|FG006|Overall Study|Physician Decision|0|||
160699356|NCT02132754|580279818|FG007|Overall Study|Physician Decision|0|||
160699357|NCT02132754|580279819|FG008|Overall Study|Physician Decision|0|||
160699358|NCT02132754|580279820|FG009|Overall Study|Physician Decision|1|||
160699359|NCT02132754|580279821|FG010|Overall Study|Physician Decision|0|||
160699360|NCT02132754|580279822|FG011|Overall Study|Physician Decision|1|||
160699361|NCT02132754|580279823|FG012|Overall Study|Physician Decision|1|||
160699362|NCT02132754|580279824|FG013|Overall Study|Physician Decision|0|||
160699363|NCT02132754|580279825|FG014|Overall Study|Physician Decision|0|||
160699364|NCT02132754|580279826|FG015|Overall Study|Physician Decision|1|||
160699365|NCT02132754|580279827|FG016|Overall Study|Physician Decision|0|||
160699366|NCT02132754|580279828|FG017|Overall Study|Physician Decision|0|||
160699367|NCT02132754|580279829|FG018|Overall Study|Physician Decision|0|||
160699368|NCT02132754|580279830|FG019|Overall Study|Physician Decision|0|||
160699369|NCT02132754|580279831|FG020|Overall Study|Physician Decision|0|||
160699370|NCT02132754|580279832|FG021|Overall Study|Physician Decision|0|||
160699371|NCT02132754|580279833|FG022|Overall Study|Physician Decision|0|||
160699372|NCT02132754|580279834|FG023|Overall Study|Physician Decision|0|||
160699373|NCT02132754|580279835|FG024|Overall Study|Physician Decision|1|||
160699374|NCT02132754|580279836|FG025|Overall Study|Physician Decision|0|||
160699375|NCT02132754|580279837|FG026|Overall Study|Physician Decision|0|||
160699376|NCT02132754|580279838|FG027|Overall Study|Physician Decision|0|||
160699377|NCT02132754|580279839|FG028|Overall Study|Physician Decision|0|||
160699378|NCT02132754|580279840|FG029|Overall Study|Physician Decision|0|||
160699379|NCT02132754|580279841|FG030|Overall Study|Physician Decision|0|||
160699380|NCT02132754|580279842|FG031|Overall Study|Physician Decision|1|||
160699381|NCT02132754|580279843|FG032|Overall Study|Physician Decision|0|||
160699382|NCT02132754|580279844|FG033|Overall Study|Physician Decision|3|||
160699383|NCT02132754|580279811|FG000|Overall Study|Progressive Disease|1|||
160699384|NCT02132754|580279812|FG001|Overall Study|Progressive Disease|1|||
160699385|NCT02132754|580279813|FG002|Overall Study|Progressive Disease|1|||
160699386|NCT02132754|580279814|FG003|Overall Study|Progressive Disease|1|||
160699387|NCT02132754|580279815|FG004|Overall Study|Progressive Disease|1|||
160699388|NCT02132754|580279816|FG005|Overall Study|Progressive Disease|1|||
160699389|NCT02132754|580279817|FG006|Overall Study|Progressive Disease|1|||
160699390|NCT02132754|580279818|FG007|Overall Study|Progressive Disease|1|||
160699391|NCT02132754|580279819|FG008|Overall Study|Progressive Disease|1|||
160699392|NCT02132754|580279820|FG009|Overall Study|Progressive Disease|3|||
160699393|NCT02132754|580279821|FG010|Overall Study|Progressive Disease|3|||
160699394|NCT02132754|580279822|FG011|Overall Study|Progressive Disease|2|||
160699395|NCT02132754|580279823|FG012|Overall Study|Progressive Disease|2|||
160699396|NCT02132754|580279824|FG013|Overall Study|Progressive Disease|3|||
160699397|NCT02132754|580279825|FG014|Overall Study|Progressive Disease|2|||
160699398|NCT02132754|580279826|FG015|Overall Study|Progressive Disease|1|||
160699399|NCT02132754|580279827|FG016|Overall Study|Progressive Disease|2|||
160699400|NCT02132754|580279828|FG017|Overall Study|Progressive Disease|1|||
160699401|NCT02132754|580279829|FG018|Overall Study|Progressive Disease|3|||
160699402|NCT02132754|580279830|FG019|Overall Study|Progressive Disease|1|||
160699403|NCT02132754|580279831|FG020|Overall Study|Progressive Disease|1|||
160699404|NCT02132754|580279832|FG021|Overall Study|Progressive Disease|3|||
160699405|NCT02132754|580279833|FG022|Overall Study|Progressive Disease|2|||
160699406|NCT02132754|580279834|FG023|Overall Study|Progressive Disease|3|||
160699407|NCT02132754|580279835|FG024|Overall Study|Progressive Disease|0|||
160699408|NCT02132754|580279836|FG025|Overall Study|Progressive Disease|1|||
160699409|NCT02132754|580279837|FG026|Overall Study|Progressive Disease|2|||
160699410|NCT02132754|580279838|FG027|Overall Study|Progressive Disease|1|||
160699411|NCT02132754|580279839|FG028|Overall Study|Progressive Disease|2|||
160699412|NCT02132754|580279840|FG029|Overall Study|Progressive Disease|3|||
160699413|NCT02132754|580279841|FG030|Overall Study|Progressive Disease|1|||
160699414|NCT02132754|580279842|FG031|Overall Study|Progressive Disease|1|||
160699415|NCT02132754|580279843|FG032|Overall Study|Progressive Disease|3|||
160699416|NCT02132754|580279844|FG033|Overall Study|Progressive Disease|6|||
160699417|NCT02132754|580279811|FG000|Overall Study|Screen Failure|0|||
160699418|NCT02132754|580279812|FG001|Overall Study|Screen Failure|0|||
160699419|NCT02132754|580279813|FG002|Overall Study|Screen Failure|0|||
160699420|NCT02132754|580279814|FG003|Overall Study|Screen Failure|0|||
160699421|NCT02132754|580279815|FG004|Overall Study|Screen Failure|0|||
160699422|NCT02132754|580279816|FG005|Overall Study|Screen Failure|0|||
160699423|NCT02132754|580279817|FG006|Overall Study|Screen Failure|0|||
160699424|NCT02132754|580279818|FG007|Overall Study|Screen Failure|0|||
160699425|NCT02132754|580279819|FG008|Overall Study|Screen Failure|0|||
160699426|NCT02132754|580279820|FG009|Overall Study|Screen Failure|0|||
160699427|NCT02132754|580279821|FG010|Overall Study|Screen Failure|0|||
160699428|NCT02132754|580279822|FG011|Overall Study|Screen Failure|0|||
160699429|NCT02132754|580279823|FG012|Overall Study|Screen Failure|0|||
160699430|NCT02132754|580279824|FG013|Overall Study|Screen Failure|0|||
160699431|NCT02132754|580279825|FG014|Overall Study|Screen Failure|0|||
160699432|NCT02132754|580279826|FG015|Overall Study|Screen Failure|0|||
160699433|NCT02132754|580279827|FG016|Overall Study|Screen Failure|0|||
160699434|NCT02132754|580279828|FG017|Overall Study|Screen Failure|0|||
160699435|NCT02132754|580279829|FG018|Overall Study|Screen Failure|0|||
160699436|NCT02132754|580279830|FG019|Overall Study|Screen Failure|1|||
160699437|NCT02132754|580279831|FG020|Overall Study|Screen Failure|0|||
160699438|NCT02132754|580279832|FG021|Overall Study|Screen Failure|1|||
160699439|NCT02132754|580279833|FG022|Overall Study|Screen Failure|0|||
160699440|NCT02132754|580279834|FG023|Overall Study|Screen Failure|0|||
160699441|NCT02132754|580279835|FG024|Overall Study|Screen Failure|0|||
160699442|NCT02132754|580279836|FG025|Overall Study|Screen Failure|0|||
160699443|NCT02132754|580279837|FG026|Overall Study|Screen Failure|0|||
160699444|NCT02132754|580279838|FG027|Overall Study|Screen Failure|0|||
160699445|NCT02132754|580279839|FG028|Overall Study|Screen Failure|0|||
160699446|NCT02132754|580279840|FG029|Overall Study|Screen Failure|0|||
160699447|NCT02132754|580279841|FG030|Overall Study|Screen Failure|0|||
160699448|NCT02132754|580279842|FG031|Overall Study|Screen Failure|0|||
160699449|NCT02132754|580279843|FG032|Overall Study|Screen Failure|0|||
160699450|NCT02132754|580279844|FG033|Overall Study|Screen Failure|0|||
160699451|NCT02132754|580279811|FG000|Overall Study|Transferred to Extension Study|0|||
160699452|NCT02132754|580279812|FG001|Overall Study|Transferred to Extension Study|0|||
160699453|NCT02132754|580279813|FG002|Overall Study|Transferred to Extension Study|0|||
160699454|NCT02132754|580279814|FG003|Overall Study|Transferred to Extension Study|0|||
160699455|NCT02132754|580279815|FG004|Overall Study|Transferred to Extension Study|0|||
160699456|NCT02132754|580279816|FG005|Overall Study|Transferred to Extension Study|0|||
160699457|NCT02132754|580279817|FG006|Overall Study|Transferred to Extension Study|0|||
160699458|NCT02132754|580279818|FG007|Overall Study|Transferred to Extension Study|0|||
160699459|NCT02132754|580279819|FG008|Overall Study|Transferred to Extension Study|0|||
160699460|NCT02132754|580279820|FG009|Overall Study|Transferred to Extension Study|0|||
160699461|NCT02132754|580279821|FG010|Overall Study|Transferred to Extension Study|0|||
160699462|NCT02132754|580279822|FG011|Overall Study|Transferred to Extension Study|0|||
160699463|NCT02132754|580279823|FG012|Overall Study|Transferred to Extension Study|0|||
160699464|NCT02132754|580279824|FG013|Overall Study|Transferred to Extension Study|0|||
160699465|NCT02132754|580279825|FG014|Overall Study|Transferred to Extension Study|0|||
160699466|NCT02132754|580279826|FG015|Overall Study|Transferred to Extension Study|0|||
160699467|NCT02132754|580279827|FG016|Overall Study|Transferred to Extension Study|0|||
160699468|NCT02132754|580279828|FG017|Overall Study|Transferred to Extension Study|0|||
160699469|NCT02132754|580279829|FG018|Overall Study|Transferred to Extension Study|0|||
160699470|NCT02132754|580279830|FG019|Overall Study|Transferred to Extension Study|0|||
160699471|NCT02132754|580279831|FG020|Overall Study|Transferred to Extension Study|0|||
160699472|NCT02132754|580279832|FG021|Overall Study|Transferred to Extension Study|0|||
160699473|NCT02132754|580279833|FG022|Overall Study|Transferred to Extension Study|0|||
160699474|NCT02132754|580279834|FG023|Overall Study|Transferred to Extension Study|0|||
160699475|NCT02132754|580279835|FG024|Overall Study|Transferred to Extension Study|0|||
160699476|NCT02132754|580279836|FG025|Overall Study|Transferred to Extension Study|0|||
160699477|NCT02132754|580279837|FG026|Overall Study|Transferred to Extension Study|0|||
160699478|NCT02132754|580279838|FG027|Overall Study|Transferred to Extension Study|0|||
160699479|NCT02132754|580279839|FG028|Overall Study|Transferred to Extension Study|0|||
160699480|NCT02132754|580279840|FG029|Overall Study|Transferred to Extension Study|0|||
160699481|NCT02132754|580279841|FG030|Overall Study|Transferred to Extension Study|0|||
160699482|NCT02132754|580279842|FG031|Overall Study|Transferred to Extension Study|0|||
160699483|NCT02132754|580279843|FG032|Overall Study|Transferred to Extension Study|0|||
160699484|NCT02132754|580279844|FG033|Overall Study|Transferred to Extension Study|6|||
160699485|NCT02132754|580279811|FG000|Overall Study|Withdrawal by Subject|0|||
160699486|NCT02132754|580279812|FG001|Overall Study|Withdrawal by Subject|0|||
160699487|NCT02132754|580279813|FG002|Overall Study|Withdrawal by Subject|0|||
160699488|NCT02132754|580279814|FG003|Overall Study|Withdrawal by Subject|0|||
160699489|NCT02132754|580279815|FG004|Overall Study|Withdrawal by Subject|0|||
160699490|NCT02132754|580279816|FG005|Overall Study|Withdrawal by Subject|0|||
160699491|NCT02132754|580279817|FG006|Overall Study|Withdrawal by Subject|0|||
160699492|NCT02132754|580279818|FG007|Overall Study|Withdrawal by Subject|0|||
160699493|NCT02132754|580279819|FG008|Overall Study|Withdrawal by Subject|0|||
160699494|NCT02132754|580279820|FG009|Overall Study|Withdrawal by Subject|1|||
160699495|NCT02132754|580279821|FG010|Overall Study|Withdrawal by Subject|0|||
160699496|NCT02132754|580279822|FG011|Overall Study|Withdrawal by Subject|0|||
160699497|NCT02132754|580279823|FG012|Overall Study|Withdrawal by Subject|1|||
160699498|NCT02132754|580279824|FG013|Overall Study|Withdrawal by Subject|0|||
160699499|NCT02132754|580279825|FG014|Overall Study|Withdrawal by Subject|1|||
160699500|NCT02132754|580279826|FG015|Overall Study|Withdrawal by Subject|2|||
160699501|NCT02132754|580279827|FG016|Overall Study|Withdrawal by Subject|1|||
160699502|NCT02132754|580279828|FG017|Overall Study|Withdrawal by Subject|0|||
160699503|NCT02132754|580279829|FG018|Overall Study|Withdrawal by Subject|0|||
160699504|NCT02132754|580279830|FG019|Overall Study|Withdrawal by Subject|0|||
160699505|NCT02132754|580279831|FG020|Overall Study|Withdrawal by Subject|1|||
160699506|NCT02132754|580279832|FG021|Overall Study|Withdrawal by Subject|0|||
160699507|NCT02132754|580279833|FG022|Overall Study|Withdrawal by Subject|0|||
160699508|NCT02132754|580279834|FG023|Overall Study|Withdrawal by Subject|0|||
160699509|NCT02132754|580279835|FG024|Overall Study|Withdrawal by Subject|1|||
160699510|NCT02132754|580279836|FG025|Overall Study|Withdrawal by Subject|0|||
160699511|NCT02132754|580279837|FG026|Overall Study|Withdrawal by Subject|0|||
160699512|NCT02132754|580279838|FG027|Overall Study|Withdrawal by Subject|1|||
160699513|NCT02132754|580279839|FG028|Overall Study|Withdrawal by Subject|0|||
160699514|NCT02132754|580279840|FG029|Overall Study|Withdrawal by Subject|0|||
160699515|NCT02132754|580279841|FG030|Overall Study|Withdrawal by Subject|0|||
160699516|NCT02132754|580279842|FG031|Overall Study|Withdrawal by Subject|1|||
160699517|NCT02132754|580279843|FG032|Overall Study|Withdrawal by Subject|0|||
160699518|NCT02132754|580279844|FG033|Overall Study|Withdrawal by Subject|2|||
160699519|NCT01770392|580279852|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
160699520|NCT03401450|580279853|FG000|Overall Study|Lost to Follow-up|4|||
160699521|NCT03401450|580279854|FG001|Overall Study|Lost to Follow-up|6|||
160699522|NCT03401450|580279853|FG000|Overall Study|Anesthesia plan changed|2|||
160699523|NCT03401450|580279854|FG001|Overall Study|Anesthesia plan changed|2|||
160699524|NCT03401450|580279853|FG000|Overall Study|Did not complete medication diary|4|||
160699525|NCT03401450|580279854|FG001|Overall Study|Did not complete medication diary|2|||
160699526|NCT03401450|580279853|FG000|Overall Study|post surgery medication change|2|||
160699527|NCT03401450|580279854|FG001|Overall Study|post surgery medication change|1|||
160699528|NCT03401450|580279853|FG000|Overall Study|Cancelled surgery|0|||
160699529|NCT03401450|580279854|FG001|Overall Study|Cancelled surgery|2|||
160699530|NCT00390221|580279855|FG000|Overall Study|Lost to Follow-up|0|||
160699531|NCT00390221|580279856|FG001|Overall Study|Lost to Follow-up|3|||
160699532|NCT00390221|580279857|FG002|Overall Study|Lost to Follow-up|0|||
160699533|NCT00390221|580279855|FG000|Overall Study|Adverse Event|1|||
160699534|NCT00390221|580279856|FG001|Overall Study|Adverse Event|4|||
160699535|NCT00390221|580279857|FG002|Overall Study|Adverse Event|3|||
160699536|NCT00390221|580279855|FG000|Overall Study|Investigator Decision|0|||
160699537|NCT00390221|580279856|FG001|Overall Study|Investigator Decision|0|||
160699538|NCT00390221|580279857|FG002|Overall Study|Investigator Decision|1|||
160699539|NCT00390221|580279855|FG000|Overall Study|Withdrawal by Subject|13|||
160699540|NCT00390221|580279856|FG001|Overall Study|Withdrawal by Subject|9|||
160699541|NCT00390221|580279857|FG002|Overall Study|Withdrawal by Subject|7|||
160699542|NCT00390221|580279855|FG000|Overall Study|Subject Non-compliance|1|||
160699543|NCT00390221|580279856|FG001|Overall Study|Subject Non-compliance|0|||
160699544|NCT00390221|580279857|FG002|Overall Study|Subject Non-compliance|2|||
160699545|NCT00390221|580279855|FG000|Overall Study|Other|3|||
160699546|NCT00390221|580279856|FG001|Overall Study|Other|4|||
160699547|NCT00390221|580279857|FG002|Overall Study|Other|2|||
160699548|NCT02011386|580279874|FG000|Overall Study|Non-compliance|2|||
160699549|NCT02011386|580279874|FG000|Overall Study|Lack of Efficacy|3|||
160699550|NCT01193127|580279875|FG000|Randomized|Surgery Cancelled|0|||
160699551|NCT01193127|580279876|FG001|Randomized|Surgery Cancelled|0|||
160699552|NCT01193127|580279877|FG002|Randomized|Surgery Cancelled|0|||
160699553|NCT01193127|580279878|FG003|Randomized|Surgery Cancelled|1|||
160699554|NCT01193127|580279875|FG000|Treated|Withdrawal by Subject|0|||
160699555|NCT01193127|580279876|FG001|Treated|Withdrawal by Subject|0|||
160699556|NCT01193127|580279877|FG002|Treated|Withdrawal by Subject|0|||
160699557|NCT01193127|580279878|FG003|Treated|Withdrawal by Subject|1|||
160699558|NCT02352779|580279882|FG000|Overall Study|Personal Issues|1|||
160699559|NCT02352779|580279883|FG001|Overall Study|Personal Issues|1|||
160699560|NCT02352779|580279884|FG002|Overall Study|Personal Issues|0|||
160699561|NCT02352779|580279882|FG000|Overall Study|Too Many Forms|2|||
160699562|NCT02352779|580279883|FG001|Overall Study|Too Many Forms|0|||
160699563|NCT02352779|580279884|FG002|Overall Study|Too Many Forms|0|||
160699564|NCT02352779|580279882|FG000|Overall Study|Feeling Overwhelmed|1|||
160699565|NCT02352779|580279883|FG001|Overall Study|Feeling Overwhelmed|0|||
160699566|NCT02352779|580279884|FG002|Overall Study|Feeling Overwhelmed|0|||
160699567|NCT02352779|580279882|FG000|Overall Study|Disliked Intervention|1|||
160699568|NCT02352779|580279883|FG001|Overall Study|Disliked Intervention|0|||
160699569|NCT02352779|580279884|FG002|Overall Study|Disliked Intervention|0|||
160699570|NCT02352779|580279882|FG000|Overall Study|Changed Mind|1|||
160699571|NCT02352779|580279883|FG001|Overall Study|Changed Mind|0|||
160699572|NCT02352779|580279884|FG002|Overall Study|Changed Mind|0|||
160699573|NCT02352779|580279882|FG000|Overall Study|Study Related Symptoms|1|||
160699574|NCT02352779|580279883|FG001|Overall Study|Study Related Symptoms|0|||
160699575|NCT02352779|580279884|FG002|Overall Study|Study Related Symptoms|0|||
160699576|NCT02352779|580279882|FG000|Overall Study|Absence of Symptoms|1|||
160699577|NCT02352779|580279883|FG001|Overall Study|Absence of Symptoms|0|||
160699578|NCT02352779|580279884|FG002|Overall Study|Absence of Symptoms|0|||
160699579|NCT02352779|580279882|FG000|Overall Study|Other Medical Reason|0|||
160699580|NCT02352779|580279883|FG001|Overall Study|Other Medical Reason|0|||
160699581|NCT02352779|580279884|FG002|Overall Study|Other Medical Reason|1|||
160699582|NCT02352779|580279882|FG000|Overall Study|No Reason|0|||
160699583|NCT02352779|580279883|FG001|Overall Study|No Reason|0|||
160699584|NCT02352779|580279884|FG002|Overall Study|No Reason|1|||
160699585|NCT00761865|580279885|FG000|Overall Study|Lost to Follow-up|8|||
160699586|NCT00761865|580279886|FG001|Overall Study|Lost to Follow-up|7|||
160699587|NCT04555720|580279887|FG000|Overall Study|Lost to Follow-up|2|||
160699588|NCT04555720|580279888|FG001|Overall Study|Lost to Follow-up|0|||
160699589|NCT04555720|580279889|FG002|Overall Study|Lost to Follow-up|0|||
160699590|NCT04555720|580279890|FG003|Overall Study|Lost to Follow-up|0|||
160699591|NCT04555720|580279887|FG000|Overall Study|Withdrawal by Subject|4|||
160699592|NCT04555720|580279888|FG001|Overall Study|Withdrawal by Subject|6|||
160699593|NCT04555720|580279889|FG002|Overall Study|Withdrawal by Subject|0|||
160699594|NCT04555720|580279890|FG003|Overall Study|Withdrawal by Subject|0|||
160699595|NCT00719849|580279891|FG000|Overall Study|Death|0|||
160699596|NCT00719849|580279892|FG001|Overall Study|Death|1|||
160699597|NCT00321737|580279893|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
160699598|NCT00321737|580279894|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
160699599|NCT00321737|580279895|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
160699600|NCT00321737|580279893|FG000|Overall Study|Adverse Event|11|||
160699601|NCT00321737|580279894|FG001|Overall Study|Adverse Event|3|||
160699602|NCT00321737|580279895|FG002|Overall Study|Adverse Event|6|||
160699603|NCT00321737|580279893|FG000|Overall Study|Lost to Follow-up|5|||
160699604|NCT00321737|580279894|FG001|Overall Study|Lost to Follow-up|5|||
160699605|NCT00321737|580279895|FG002|Overall Study|Lost to Follow-up|6|||
160699606|NCT00321737|580279893|FG000|Overall Study|Withdrawal by Subject|19|||
160699607|NCT00321737|580279894|FG001|Overall Study|Withdrawal by Subject|12|||
160699608|NCT00321737|580279895|FG002|Overall Study|Withdrawal by Subject|17|||
160699609|NCT00321737|580279893|FG000|Overall Study|Protocol Violation|0|||
160699610|NCT00321737|580279894|FG001|Overall Study|Protocol Violation|0|||
160699611|NCT00321737|580279895|FG002|Overall Study|Protocol Violation|1|||
160699612|NCT00321737|580279893|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
160699613|NCT00321737|580279894|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
160699614|NCT00321737|580279895|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
160699615|NCT00321737|580279893|FG000|Overall Study|Possible Barrett's Esophagus|2|||
160699616|NCT00321737|580279894|FG001|Overall Study|Possible Barrett's Esophagus|1|||
160699617|NCT00321737|580279895|FG002|Overall Study|Possible Barrett's Esophagus|1|||
160699618|NCT00321737|580279893|FG000|Overall Study|Therapeutic Failure|6|||
160699619|NCT00321737|580279894|FG001|Overall Study|Therapeutic Failure|0|||
160699620|NCT00321737|580279895|FG002|Overall Study|Therapeutic Failure|2|||
160699621|NCT00321737|580279893|FG000|Overall Study|Pregnancy|0|||
160699622|NCT00321737|580279894|FG001|Overall Study|Pregnancy|2|||
160699623|NCT00321737|580279895|FG002|Overall Study|Pregnancy|0|||
160699624|NCT00321737|580279893|FG000|Overall Study|Noncompliance|2|||
160699625|NCT00321737|580279894|FG001|Overall Study|Noncompliance|0|||
160699626|NCT00321737|580279895|FG002|Overall Study|Noncompliance|0|||
160699627|NCT00321737|580279893|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
160699628|NCT00321737|580279894|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
160699629|NCT00321737|580279895|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
160699630|NCT02283294|580279896|FG000|Overall Study|Lost to Follow-up|1|||
160699631|NCT02283294|580279897|FG001|Overall Study|Lost to Follow-up|1|||
160699632|NCT02283294|580279896|FG000|Overall Study|Withdrawal by Subject|1|||
160699633|NCT02283294|580279897|FG001|Overall Study|Withdrawal by Subject|6|||
160699634|NCT02283294|580279896|FG000|Overall Study|Protocol Violation|1|||
160699635|NCT02283294|580279897|FG001|Overall Study|Protocol Violation|0|||
160699636|NCT02283294|580279896|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
160699637|NCT02283294|580279897|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
160699638|NCT01212588|580281646|FG000|Overall Study|Physician Decision|0|||
160699639|NCT01212588|580281647|FG001|Overall Study|Physician Decision|1|||
160699640|NCT01212588|580281646|FG000|Overall Study|Protocol Violation|1|||
160699641|NCT01212588|580281647|FG001|Overall Study|Protocol Violation|1|||
160699642|NCT02885181|580281648|FG000|Overall Study|Investigator's Discretion|0|||
160699643|NCT02885181|580281649|FG001|Overall Study|Investigator's Discretion|1|||
160699644|NCT02885181|580281650|FG002|Overall Study|Investigator's Discretion|0|||
160699645|NCT02885181|580281651|FG003|Overall Study|Investigator's Discretion|1|||
160699646|NCT02885181|580281648|FG000|Overall Study|Adverse Event|0|||
160699647|NCT02885181|580281649|FG001|Overall Study|Adverse Event|0|||
160699648|NCT02885181|580281650|FG002|Overall Study|Adverse Event|0|||
160699649|NCT02885181|580281651|FG003|Overall Study|Adverse Event|1|||
160699650|NCT02885181|580281648|FG000|Overall Study|Withdrawal by Subject|0|||
160699651|NCT02885181|580281649|FG001|Overall Study|Withdrawal by Subject|0|||
160699652|NCT02885181|580281650|FG002|Overall Study|Withdrawal by Subject|0|||
160699653|NCT02885181|580281651|FG003|Overall Study|Withdrawal by Subject|1|||
160699654|NCT01085734|580281652|FG000|Overall Study|Adverse Event|0|||
160699655|NCT01085734|580281653|FG001|Overall Study|Adverse Event|2|||
160699656|NCT01085734|580281652|FG000|Overall Study|Death|1|||
160699657|NCT01085734|580281653|FG001|Overall Study|Death|0|||
160699658|NCT01085734|580281652|FG000|Overall Study|Lost to Follow-up|0|||
160699659|NCT01085734|580281653|FG001|Overall Study|Lost to Follow-up|1|||
160699660|NCT01085734|580281652|FG000|Overall Study|Withdrawal by Subject|0|||
160699661|NCT01085734|580281653|FG001|Overall Study|Withdrawal by Subject|1|||
160699662|NCT00742924|580281656|FG000|Overall Study|Adverse Event|0|||
160699663|NCT00742924|580281657|FG001|Overall Study|Adverse Event|0|||
160699664|NCT00742924|580281658|FG002|Overall Study|Adverse Event|1|||
160699665|NCT00742924|580281659|FG003|Overall Study|Adverse Event|1|||
160699666|NCT00742924|580281656|FG000|Overall Study|Lack of Efficacy|5|||
160699667|NCT00742924|580281657|FG001|Overall Study|Lack of Efficacy|1|||
160699668|NCT00742924|580281658|FG002|Overall Study|Lack of Efficacy|2|||
160699669|NCT00742924|580281659|FG003|Overall Study|Lack of Efficacy|4|||
160699670|NCT00742924|580281656|FG000|Overall Study|Physician Decision|0|||
160699671|NCT00742924|580281657|FG001|Overall Study|Physician Decision|0|||
160699672|NCT00742924|580281658|FG002|Overall Study|Physician Decision|0|||
160699673|NCT00742924|580281659|FG003|Overall Study|Physician Decision|1|||
160699674|NCT00742924|580281656|FG000|Overall Study|Withdrawal by Subject|0|||
160699675|NCT00742924|580281657|FG001|Overall Study|Withdrawal by Subject|1|||
160699676|NCT00742924|580281658|FG002|Overall Study|Withdrawal by Subject|1|||
160699677|NCT00742924|580281659|FG003|Overall Study|Withdrawal by Subject|0|||
160699678|NCT00660400|580281660|FG000|Overall Study|Lack of insurance approval|1|||
160699679|NCT00660400|580281660|FG000|Overall Study|Suboptimal organ function|1|||
160699680|NCT00660400|580281660|FG000|Overall Study|Intracranial hemorrhage|1|||
160699681|NCT00660400|580281660|FG000|Overall Study|Withdrawal by Subject|1|||
160699682|NCT01161407|580281661|FG000|Overall Study|Protocol Violation|3|||
160699683|NCT01161407|580281662|FG001|Overall Study|Protocol Violation|1|||
160699684|NCT01777620|580281663|FG000|Overall Study|Subject Withdrawal|1|||
160699685|NCT01777620|580281664|FG001|Overall Study|Subject Withdrawal|0|||
160699686|NCT04562155|580281667|FG000|Overall Study|COVID-19 pandemic|0|||
160699687|NCT04562155|580281668|FG001|Overall Study|COVID-19 pandemic|0|||
160699688|NCT04562155|580281669|FG002|Overall Study|COVID-19 pandemic|0|||
160699689|NCT04562155|580281670|FG003|Overall Study|COVID-19 pandemic|1|||
160699690|NCT04562155|580281667|FG000|Overall Study|Adverse Event|7|||
160699691|NCT04562155|580281668|FG001|Overall Study|Adverse Event|3|||
160699692|NCT04562155|580281669|FG002|Overall Study|Adverse Event|8|||
160699693|NCT04562155|580281670|FG003|Overall Study|Adverse Event|1|||
160699694|NCT04562155|580281667|FG000|Overall Study|Withdrawal by Subject|3|||
160699695|NCT04562155|580281668|FG001|Overall Study|Withdrawal by Subject|6|||
160699696|NCT04562155|580281669|FG002|Overall Study|Withdrawal by Subject|3|||
160699697|NCT04562155|580281670|FG003|Overall Study|Withdrawal by Subject|3|||
160699698|NCT04562155|580281667|FG000|Overall Study|Participant personal reason|1|||
160699699|NCT04562155|580281668|FG001|Overall Study|Participant personal reason|0|||
160699700|NCT04562155|580281669|FG002|Overall Study|Participant personal reason|2|||
160699701|NCT04562155|580281670|FG003|Overall Study|Participant personal reason|1|||
160699702|NCT01283035|580281691|FG000|Overall Study|Subject later found ineligible|1|||
160699703|NCT03597529|580281696|FG000|Overall Study|Lost to Follow-up|10|||
160699704|NCT03597529|580281697|FG001|Overall Study|Lost to Follow-up|12|||
160699705|NCT03597529|580281696|FG000|Overall Study|Physician Decision|3|||
160699706|NCT03597529|580281697|FG001|Overall Study|Physician Decision|1|||
160699707|NCT03597529|580281696|FG000|Overall Study|Withdrawal by Subject|6|||
160699708|NCT03597529|580281697|FG001|Overall Study|Withdrawal by Subject|3|||
160699709|NCT03597529|580281696|FG000|Overall Study|Non-compliant with study activities|1|||
160699710|NCT03597529|580281697|FG001|Overall Study|Non-compliant with study activities|2|||
160699711|NCT00191165|580281698|FG000|Overall Study|Adverse Event|2|||
160699712|NCT00191165|580281699|FG001|Overall Study|Adverse Event|0|||
160699713|NCT00191165|580281698|FG000|Overall Study|Protocol Violation|0|||
160699714|NCT00191165|580281699|FG001|Overall Study|Protocol Violation|1|||
160699715|NCT00191165|580281698|FG000|Overall Study|Participant Moved Away|0|||
160699716|NCT00191165|580281699|FG001|Overall Study|Participant Moved Away|1|||
160699717|NCT03200912|580281700|FG000|Overall Study|Adverse Event|3|||
160699718|NCT03200912|580281701|FG001|Overall Study|Adverse Event|0|||
160699719|NCT03200912|580281702|FG002|Overall Study|Adverse Event|0|||
160699720|NCT03200912|580281700|FG000|Overall Study|Withdrawal by Subject|1|||
160699721|NCT03200912|580281701|FG001|Overall Study|Withdrawal by Subject|2|||
160699722|NCT03200912|580281702|FG002|Overall Study|Withdrawal by Subject|4|||
160699723|NCT03200912|580281700|FG000|Overall Study|Non-compliance with study drug|0|||
160699724|NCT03200912|580281701|FG001|Overall Study|Non-compliance with study drug|1|||
160699725|NCT03200912|580281702|FG002|Overall Study|Non-compliance with study drug|0|||
160699726|NCT03196635|580281703|FG000|Overall Study|Withdrawal by Subject|1|||
160699727|NCT00998309|580281706|FG000|Overall Study|Protocol Violation|4|||
160699728|NCT05788289|580281707|FG000|Overall Study|Death|3|||
160699729|NCT02238795|580281709|FG000|Overall Study|Patient without purpura fulminans|1|||
160699730|NCT05187013|580281710|FG000|Overall Study|Withdrawal by Subject|1|||
160699731|NCT05187013|580281711|FG001|Overall Study|Withdrawal by Subject|1|||
160699732|NCT05187013|580281712|FG002|Overall Study|Withdrawal by Subject|0|||
160699733|NCT05187013|580281710|FG000|Overall Study|Death|0|||
160699734|NCT05187013|580281711|FG001|Overall Study|Death|1|||
160699735|NCT05187013|580281712|FG002|Overall Study|Death|0|||
160699736|NCT05187013|580281710|FG000|Overall Study|Lost to Follow-up|20|||
160699737|NCT05187013|580281711|FG001|Overall Study|Lost to Follow-up|17|||
160699738|NCT05187013|580281712|FG002|Overall Study|Lost to Follow-up|0|||
160699739|NCT05187013|580281710|FG000|Overall Study|Ongoing Participants|3|||
160699740|NCT05187013|580281711|FG001|Overall Study|Ongoing Participants|5|||
160699741|NCT05187013|580281712|FG002|Overall Study|Ongoing Participants|0|||
160699742|NCT01096368|580281714|FG000|Overall Study|Death|0|||
160699743|NCT01096368|580281715|FG001|Overall Study|Death|1|||
160699744|NCT01096368|580281716|FG002|Overall Study|Death|0|||
160699745|NCT01096368|580281717|FG003|Overall Study|Death|0|||
160699746|NCT01096368|580281718|FG004|Overall Study|Death|0|||
160699747|NCT01096368|580281714|FG000|Overall Study|Physician Decision|0|||
160699748|NCT01096368|580281715|FG001|Overall Study|Physician Decision|13|||
160699749|NCT01096368|580281716|FG002|Overall Study|Physician Decision|2|||
160699750|NCT01096368|580281717|FG003|Overall Study|Physician Decision|4|||
160699751|NCT01096368|580281718|FG004|Overall Study|Physician Decision|6|||
160699752|NCT01096368|580281714|FG000|Overall Study|Withdrawal by Subject|0|||
160699753|NCT01096368|580281715|FG001|Overall Study|Withdrawal by Subject|52|||
160699754|NCT01096368|580281716|FG002|Overall Study|Withdrawal by Subject|0|||
160699755|NCT01096368|580281717|FG003|Overall Study|Withdrawal by Subject|10|||
160699756|NCT01096368|580281718|FG004|Overall Study|Withdrawal by Subject|14|||
160699757|NCT01096368|580281714|FG000|Overall Study|Ineligible|0|||
160699758|NCT01096368|580281715|FG001|Overall Study|Ineligible|3|||
160699759|NCT01096368|580281716|FG002|Overall Study|Ineligible|2|||
160699760|NCT01096368|580281717|FG003|Overall Study|Ineligible|0|||
160699761|NCT01096368|580281718|FG004|Overall Study|Ineligible|25|||
160699762|NCT01096368|580281714|FG000|Overall Study|Did not start treatment|0|||
160699763|NCT01096368|580281715|FG001|Overall Study|Did not start treatment|4|||
160699764|NCT01096368|580281716|FG002|Overall Study|Did not start treatment|4|||
160699765|NCT01096368|580281717|FG003|Overall Study|Did not start treatment|0|||
160699766|NCT01096368|580281718|FG004|Overall Study|Did not start treatment|0|||
160699767|NCT01096368|580281714|FG000|Overall Study|Progressive disease|0|||
160699768|NCT01096368|580281715|FG001|Overall Study|Progressive disease|6|||
160699769|NCT01096368|580281716|FG002|Overall Study|Progressive disease|0|||
160699770|NCT01096368|580281717|FG003|Overall Study|Progressive disease|10|||
160699771|NCT01096368|580281718|FG004|Overall Study|Progressive disease|3|||
160699772|NCT01096368|580281714|FG000|Overall Study|Other|0|||
160699773|NCT01096368|580281715|FG001|Overall Study|Other|0|||
160699774|NCT01096368|580281716|FG002|Overall Study|Other|1|||
160699775|NCT01096368|580281717|FG003|Overall Study|Other|0|||
160699776|NCT01096368|580281718|FG004|Overall Study|Other|0|||
160699777|NCT01096368|580281714|FG000|Overall Study|Treated with institutional review|0|||
160699778|NCT01096368|580281715|FG001|Overall Study|Treated with institutional review|0|||
160699779|NCT01096368|580281716|FG002|Overall Study|Treated with institutional review|0|||
160699780|NCT01096368|580281717|FG003|Overall Study|Treated with institutional review|0|||
160699781|NCT01096368|580281718|FG004|Overall Study|Treated with institutional review|1|||
160699782|NCT01568320|580281720|FG000|Overall Study|Death|20|||
160699783|NCT01568320|580281720|FG000|Overall Study|Lost to Follow-up|9|||
160699784|NCT01568320|580281720|FG000|Overall Study|Withdrawal by Subject|10|||
160699785|NCT01568320|580281720|FG000|Overall Study|Conversion to open repair|1|||
160699786|NCT01568320|580281720|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
160699787|NCT03233230|580281721|FG000|Overall Study|Adverse Event|6|||
160699788|NCT03233230|580281722|FG001|Overall Study|Adverse Event|3|||
160699789|NCT03233230|580281723|FG002|Overall Study|Adverse Event|6|||
160699790|NCT03233230|580281724|FG003|Overall Study|Adverse Event|3|||
160699791|NCT03233230|580281721|FG000|Overall Study|Protocol Violation|1|||
160699792|NCT03233230|580281722|FG001|Overall Study|Protocol Violation|2|||
160699793|NCT03233230|580281723|FG002|Overall Study|Protocol Violation|1|||
160699794|NCT03233230|580281724|FG003|Overall Study|Protocol Violation|1|||
160699795|NCT03233230|580281721|FG000|Overall Study|Lack of Efficacy|1|||
160699796|NCT03233230|580281722|FG001|Overall Study|Lack of Efficacy|0|||
160699797|NCT03233230|580281723|FG002|Overall Study|Lack of Efficacy|0|||
160699798|NCT03233230|580281724|FG003|Overall Study|Lack of Efficacy|0|||
160699799|NCT03233230|580281721|FG000|Overall Study|Other|5|||
160699800|NCT03233230|580281722|FG001|Overall Study|Other|5|||
160699801|NCT03233230|580281723|FG002|Overall Study|Other|5|||
160699802|NCT03233230|580281724|FG003|Overall Study|Other|3|||
160699803|NCT03233230|580281721|FG000|Overall Study|Withdrawal by Subject|2|||
160699804|NCT03233230|580281722|FG001|Overall Study|Withdrawal by Subject|2|||
160699805|NCT03233230|580281723|FG002|Overall Study|Withdrawal by Subject|0|||
160699806|NCT03233230|580281724|FG003|Overall Study|Withdrawal by Subject|1|||
160699807|NCT03233230|580281721|FG000|Overall Study|Lost to Follow-up|0|||
160699808|NCT03233230|580281722|FG001|Overall Study|Lost to Follow-up|3|||
160699809|NCT03233230|580281723|FG002|Overall Study|Lost to Follow-up|0|||
160699810|NCT03233230|580281724|FG003|Overall Study|Lost to Follow-up|0|||
160699811|NCT04159935|580281725|FG000|Overall Study|Study terminated due to COVID-19|1|||
160699812|NCT04159935|580281726|FG001|Overall Study|Study terminated due to COVID-19|3|||
160699813|NCT01341782|580281727|FG000|Overall Study|Adverse Event|1|||
160699814|NCT01341782|580281728|FG001|Overall Study|Adverse Event|1|||
160699815|NCT01341782|580281727|FG000|Overall Study|Withdrawal by Subject|6|||
160699816|NCT01341782|580281728|FG001|Overall Study|Withdrawal by Subject|5|||
160699817|NCT01341782|580281727|FG000|Overall Study|Missed 3 consecutive doses|0|||
160699818|NCT01341782|580281728|FG001|Overall Study|Missed 3 consecutive doses|4|||
160699819|NCT01341782|580281727|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
160699820|NCT01341782|580281728|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
160699821|NCT01341782|580281727|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
160699822|NCT01341782|580281728|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
160699823|NCT01341782|580281727|FG000|Overall Study|Other|5|||
160699824|NCT01341782|580281728|FG001|Overall Study|Other|0|||
160699825|NCT02036775|580281729|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
160699826|NCT02036775|580281730|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
160699827|NCT02036775|580281731|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
160699828|NCT02036775|580281732|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
160699829|NCT02036775|580281733|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
160699830|NCT02036775|580281734|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
160699831|NCT02927366|580281736|FG000|Overall Study|Adverse Event|1|||
160699832|NCT02927366|580281737|FG001|Overall Study|Adverse Event|0|||
160699833|NCT02927366|580281736|FG000|Overall Study|Patient schedule|1|||
160699834|NCT02927366|580281737|FG001|Overall Study|Patient schedule|0|||
160699835|NCT00206323|580281742|FG000|Overall Study|Lack of Efficacy|4|||
160699836|NCT00206323|580281743|FG001|Overall Study|Lack of Efficacy|1|||
160699837|NCT00206323|580281742|FG000|Overall Study|Adverse Event|1|||
160699838|NCT00206323|580281743|FG001|Overall Study|Adverse Event|1|||
160699839|NCT00206323|580281742|FG000|Overall Study|Lost to Follow-up|1|||
160699840|NCT00206323|580281743|FG001|Overall Study|Lost to Follow-up|1|||
160699841|NCT02910063|580281744|FG000|Phase 2|Withdrawal by Subject|3|||
160699842|NCT02910063|580281745|FG001|Phase 2|Withdrawal by Subject|0|||
160699843|NCT02910063|580281746|FG002|Phase 2|Withdrawal by Subject|0|||
160699844|NCT02910063|580281744|FG000|Phase 2|Lost to Follow-up|1|||
160699845|NCT02910063|580281745|FG001|Phase 2|Lost to Follow-up|0|||
160699846|NCT02910063|580281746|FG002|Phase 2|Lost to Follow-up|0|||
160699847|NCT02910063|580281744|FG000|Phase 2|Death|24|||
160699848|NCT02910063|580281745|FG001|Phase 2|Death|0|||
160699849|NCT02910063|580281746|FG002|Phase 2|Death|0|||
160699850|NCT03496610|580281747|FG000|Overall Study|Lost to Follow-up|3|||
160699851|NCT03496610|580281748|FG001|Overall Study|Lost to Follow-up|2|||
160699852|NCT03496610|580281747|FG000|Overall Study|Physician Decision|1|||
160699853|NCT03496610|580281748|FG001|Overall Study|Physician Decision|0|||
160699854|NCT03496610|580281747|FG000|Overall Study|Withdrawal by Subject|1|||
160699855|NCT03496610|580281748|FG001|Overall Study|Withdrawal by Subject|0|||
160699856|NCT00426361|580281751|FG000|Overall Study|Lost to Follow-up|3|||
160699857|NCT00426361|580281752|FG001|Overall Study|Lost to Follow-up|2|||
160699858|NCT00426361|580281753|FG002|Overall Study|Lost to Follow-up|5|||
160699859|NCT00426361|580281751|FG000|Overall Study|Withdrawal by Subject|1|||
160699860|NCT00426361|580281752|FG001|Overall Study|Withdrawal by Subject|3|||
160699861|NCT00426361|580281753|FG002|Overall Study|Withdrawal by Subject|0|||
160699862|NCT04568031|580281757|FG000|Overall Study|Lost to Follow-up|1|||
160699863|NCT04568031|580281758|FG001|Overall Study|Lost to Follow-up|0|||
160699864|NCT04568031|580281759|FG002|Overall Study|Lost to Follow-up|0|||
160699865|NCT04568031|580281760|FG003|Overall Study|Lost to Follow-up|0|||
160699866|NCT04568031|580281757|FG000|Overall Study|Physician Decision|1|||
160699867|NCT04568031|580281758|FG001|Overall Study|Physician Decision|0|||
160699868|NCT04568031|580281759|FG002|Overall Study|Physician Decision|1|||
160699869|NCT04568031|580281760|FG003|Overall Study|Physician Decision|0|||
160699870|NCT04568031|580281757|FG000|Overall Study|Withdrawal by Subject|1|||
160699871|NCT04568031|580281758|FG001|Overall Study|Withdrawal by Subject|0|||
160699872|NCT04568031|580281759|FG002|Overall Study|Withdrawal by Subject|4|||
160699873|NCT04568031|580281760|FG003|Overall Study|Withdrawal by Subject|1|||
160699874|NCT02304458|580281761|FG000|Overall Study|Adverse Event|0|||
160699875|NCT02304458|580281762|FG001|Overall Study|Adverse Event|0|||
160699876|NCT02304458|580281763|FG002|Overall Study|Adverse Event|7|||
160699877|NCT02304458|580281764|FG003|Overall Study|Adverse Event|0|||
160699878|NCT02304458|580281765|FG004|Overall Study|Adverse Event|0|||
160699879|NCT02304458|580281766|FG005|Overall Study|Adverse Event|0|||
160699880|NCT02304458|580281767|FG006|Overall Study|Adverse Event|3|||
160699881|NCT02304458|580281768|FG007|Overall Study|Adverse Event|4|||
160699882|NCT02304458|580281761|FG000|Overall Study|Death|0|||
160699883|NCT02304458|580281762|FG001|Overall Study|Death|0|||
160699884|NCT02304458|580281763|FG002|Overall Study|Death|2|||
160699885|NCT02304458|580281764|FG003|Overall Study|Death|0|||
160699886|NCT02304458|580281765|FG004|Overall Study|Death|0|||
160699887|NCT02304458|580281766|FG005|Overall Study|Death|0|||
160699888|NCT02304458|580281767|FG006|Overall Study|Death|1|||
160699889|NCT02304458|580281768|FG007|Overall Study|Death|0|||
160699890|NCT02304458|580281761|FG000|Overall Study|Lack of Efficacy|4|||
160699891|NCT02304458|580281762|FG001|Overall Study|Lack of Efficacy|6|||
160699892|NCT02304458|580281763|FG002|Overall Study|Lack of Efficacy|38|||
160699893|NCT02304458|580281764|FG003|Overall Study|Lack of Efficacy|5|||
160699894|NCT02304458|580281765|FG004|Overall Study|Lack of Efficacy|6|||
160699895|NCT02304458|580281766|FG005|Overall Study|Lack of Efficacy|6|||
160699896|NCT02304458|580281767|FG006|Overall Study|Lack of Efficacy|21|||
160699897|NCT02304458|580281768|FG007|Overall Study|Lack of Efficacy|4|||
160699898|NCT02304458|580281761|FG000|Overall Study|Physician Decision|2|||
160699899|NCT02304458|580281762|FG001|Overall Study|Physician Decision|0|||
160699900|NCT02304458|580281763|FG002|Overall Study|Physician Decision|16|||
160699901|NCT02304458|580281764|FG003|Overall Study|Physician Decision|1|||
160699902|NCT02304458|580281765|FG004|Overall Study|Physician Decision|0|||
160699903|NCT02304458|580281766|FG005|Overall Study|Physician Decision|0|||
160699904|NCT02304458|580281767|FG006|Overall Study|Physician Decision|3|||
160699905|NCT02304458|580281768|FG007|Overall Study|Physician Decision|0|||
160699906|NCT02304458|580281761|FG000|Overall Study|Protocol Violation|0|||
160699907|NCT02304458|580281762|FG001|Overall Study|Protocol Violation|0|||
160699908|NCT02304458|580281763|FG002|Overall Study|Protocol Violation|1|||
160699909|NCT02304458|580281764|FG003|Overall Study|Protocol Violation|0|||
160699910|NCT02304458|580281765|FG004|Overall Study|Protocol Violation|0|||
160699911|NCT02304458|580281766|FG005|Overall Study|Protocol Violation|0|||
160699912|NCT02304458|580281767|FG006|Overall Study|Protocol Violation|0|||
160699913|NCT02304458|580281768|FG007|Overall Study|Protocol Violation|0|||
160699914|NCT02304458|580281761|FG000|Overall Study|Withdrawal by Subject|1|||
160699915|NCT02304458|580281762|FG001|Overall Study|Withdrawal by Subject|0|||
160699916|NCT02304458|580281763|FG002|Overall Study|Withdrawal by Subject|7|||
160699917|NCT02304458|580281764|FG003|Overall Study|Withdrawal by Subject|0|||
160699918|NCT02304458|580281765|FG004|Overall Study|Withdrawal by Subject|0|||
160699919|NCT02304458|580281766|FG005|Overall Study|Withdrawal by Subject|0|||
160699920|NCT02304458|580281767|FG006|Overall Study|Withdrawal by Subject|1|||
160699921|NCT02304458|580281768|FG007|Overall Study|Withdrawal by Subject|0|||
160699922|NCT04430855|580281769|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
160699923|NCT04430855|580281770|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
160699924|NCT04430855|580281769|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
160699925|NCT04430855|580281770|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
160699926|NCT04430855|580281769|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
160699927|NCT04430855|580281770|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
160699928|NCT04430855|580281769|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
160699929|NCT04430855|580281770|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
160699930|NCT04430855|580281769|FG000|Period 1 (Weeks 1-12)|Other|0|||
160699931|NCT04430855|580281770|FG001|Period 1 (Weeks 1-12)|Other|1|||
160699932|NCT04430855|580281769|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
160699933|NCT04430855|580281770|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
160699934|NCT04430855|580281769|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
160699935|NCT04430855|580281770|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
160699936|NCT04430855|580281769|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
160699937|NCT04430855|580281770|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
160699938|NCT04874636|580281771|FG000|Overall Study|Adverse Event|17|||
160699939|NCT04874636|580281772|FG001|Overall Study|Adverse Event|7|||
160699940|NCT04874636|580281771|FG000|Overall Study|Lost to Follow-up|1|||
160699941|NCT04874636|580281772|FG001|Overall Study|Lost to Follow-up|0|||
160699942|NCT04874636|580281771|FG000|Overall Study|Non-Compliance with Study Drug|2|||
160699943|NCT04874636|580281772|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160699944|NCT04874636|580281771|FG000|Overall Study|Physician Decision|1|||
160699945|NCT04874636|580281772|FG001|Overall Study|Physician Decision|0|||
160699946|NCT04874636|580281771|FG000|Overall Study|Withdrawal by Subject|6|||
160699947|NCT04874636|580281772|FG001|Overall Study|Withdrawal by Subject|5|||
160699948|NCT02582866|580281779|FG000|Overall Study|Death|1|||
160699949|NCT02582866|580281779|FG000|Overall Study|Lack of Efficacy|2|||
160699950|NCT02582866|580281779|FG000|Overall Study|Lost to Follow-up|2|||
160699951|NCT02582866|580281779|FG000|Overall Study|Withdrawal by Subject|7|||
160699952|NCT02582866|580281779|FG000|Overall Study|Investigator decision|5|||
160699953|NCT02582866|580281779|FG000|Overall Study|Participant wants to get pregnant|1|||
160699954|NCT02582866|580281779|FG000|Overall Study|Pregnancy|2|||
160699955|NCT02582866|580281779|FG000|Overall Study|Sponsor decision|1|||
160699956|NCT02582866|580281779|FG000|Overall Study|Withdrawal due to personal reasons|1|||
160699957|NCT03567382|580281780|FG000|Overall Study|Lost to Follow-up|1|||
160699958|NCT03567382|580281781|FG001|Overall Study|Lost to Follow-up|21|||
160699959|NCT03567382|580281782|FG002|Overall Study|Lost to Follow-up|1|||
160699960|NCT03567382|580281783|FG003|Overall Study|Lost to Follow-up|21|||
160699961|NCT03567382|580281780|FG000|Overall Study|Withdrawal by Subject|2|||
160699962|NCT03567382|580281781|FG001|Overall Study|Withdrawal by Subject|14|||
160699963|NCT03567382|580281782|FG002|Overall Study|Withdrawal by Subject|1|||
160699964|NCT03567382|580281783|FG003|Overall Study|Withdrawal by Subject|12|||
160699965|NCT00620659|580281784|FG000|Treatment Period 1|Adverse Event|1|||
160699966|NCT00620659|580281785|FG001|Treatment Period 1|Adverse Event|0|||
160699967|NCT00620659|580281786|FG002|Treatment Period 1|Adverse Event|0|||
160699968|NCT00620659|580281787|FG003|Treatment Period 1|Adverse Event|3|||
160699969|NCT00620659|580281788|FG004|Treatment Period 1|Adverse Event|0|||
160699970|NCT00620659|580281789|FG005|Treatment Period 1|Adverse Event|0|||
160699971|NCT00620659|580281784|FG000|Treatment Period 1|Protocol Violation|1|||
160699972|NCT00620659|580281785|FG001|Treatment Period 1|Protocol Violation|0|||
160699973|NCT00620659|580281786|FG002|Treatment Period 1|Protocol Violation|0|||
160699974|NCT00620659|580281787|FG003|Treatment Period 1|Protocol Violation|0|||
160699975|NCT00620659|580281788|FG004|Treatment Period 1|Protocol Violation|0|||
160699976|NCT00620659|580281789|FG005|Treatment Period 1|Protocol Violation|0|||
160699977|NCT00620659|580281784|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160699978|NCT00620659|580281785|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160699979|NCT00620659|580281786|FG002|Treatment Period 1|Withdrawal by Subject|1|||
160699980|NCT00620659|580281787|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160699981|NCT00620659|580281788|FG004|Treatment Period 1|Withdrawal by Subject|1|||
160699982|NCT00620659|580281789|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160699983|NCT00620659|580281784|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
160699984|NCT00620659|580281785|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
160699985|NCT00620659|580281786|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
160699986|NCT00620659|580281787|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
160699987|NCT00620659|580281788|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
160699988|NCT00620659|580281789|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
160699989|NCT00620659|580281784|FG000|Treatment Period 2|Adverse Event|0|||
160699990|NCT00620659|580281785|FG001|Treatment Period 2|Adverse Event|3|||
160699991|NCT00620659|580281786|FG002|Treatment Period 2|Adverse Event|0|||
160699992|NCT00620659|580281787|FG003|Treatment Period 2|Adverse Event|0|||
160699993|NCT00620659|580281788|FG004|Treatment Period 2|Adverse Event|2|||
160699994|NCT00620659|580281789|FG005|Treatment Period 2|Adverse Event|0|||
160699995|NCT00620659|580281784|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160699996|NCT00620659|580281785|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160699997|NCT00620659|580281786|FG002|Treatment Period 2|Withdrawal by Subject|1|||
160699998|NCT00620659|580281787|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160699999|NCT00620659|580281788|FG004|Treatment Period 2|Withdrawal by Subject|3|||
160700000|NCT00620659|580281789|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160700001|NCT00620659|580281784|FG000|Placebo Washout Period 2|Adverse Event|2|||
160700002|NCT00620659|580281785|FG001|Placebo Washout Period 2|Adverse Event|0|||
160700003|NCT00620659|580281786|FG002|Placebo Washout Period 2|Adverse Event|0|||
160700004|NCT00620659|580281787|FG003|Placebo Washout Period 2|Adverse Event|0|||
160700005|NCT00620659|580281788|FG004|Placebo Washout Period 2|Adverse Event|0|||
160700006|NCT00620659|580281789|FG005|Placebo Washout Period 2|Adverse Event|0|||
160700007|NCT00620659|580281784|FG000|Treatment Period 3|Adverse Event|0|||
160700008|NCT00620659|580281785|FG001|Treatment Period 3|Adverse Event|2|||
160700009|NCT00620659|580281786|FG002|Treatment Period 3|Adverse Event|0|||
160700010|NCT00620659|580281787|FG003|Treatment Period 3|Adverse Event|0|||
160700011|NCT00620659|580281788|FG004|Treatment Period 3|Adverse Event|0|||
160700012|NCT00620659|580281789|FG005|Treatment Period 3|Adverse Event|0|||
160700013|NCT00620659|580281784|FG000|Treatment Period 3|Withdrawal by Subject|0|||
160700014|NCT00620659|580281785|FG001|Treatment Period 3|Withdrawal by Subject|0|||
160700015|NCT00620659|580281786|FG002|Treatment Period 3|Withdrawal by Subject|0|||
160700016|NCT00620659|580281787|FG003|Treatment Period 3|Withdrawal by Subject|1|||
160700017|NCT00620659|580281788|FG004|Treatment Period 3|Withdrawal by Subject|0|||
160700018|NCT00620659|580281789|FG005|Treatment Period 3|Withdrawal by Subject|0|||
160700019|NCT01709838|580281790|FG000|Overall Study|Withdrawal by Subject|21|||
160700020|NCT01709838|580281790|FG000|Overall Study|Lost to Follow-up|16|||
160700021|NCT01709838|580281790|FG000|Overall Study|Pregnancy|10|||
160700022|NCT01709838|580281790|FG000|Overall Study|Subject/guardian decision|8|||
160700023|NCT01709838|580281790|FG000|Overall Study|Adverse Event|4|||
160700024|NCT01709838|580281790|FG000|Overall Study|Physician Decision|4|||
160700025|NCT01709838|580281790|FG000|Overall Study|Death|3|||
160700026|NCT01709838|580281790|FG000|Overall Study|Protocol Violation|1|||
160700027|NCT03246646|580281793|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
160700028|NCT03246646|580281794|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
160700029|NCT03246646|580281793|FG000|Overall Study|Withdrawal by Subject|3|||
160700030|NCT03246646|580281794|FG001|Overall Study|Withdrawal by Subject|0|||
160700031|NCT03246646|580281793|FG000|Overall Study|Lost to Follow-up|7|||
160700032|NCT03246646|580281794|FG001|Overall Study|Lost to Follow-up|0|||
160700033|NCT00968799|580281797|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
160700034|NCT00389831|580281803|FG000|Overall Study|Lack of Efficacy|0|||
160700035|NCT00389831|580281804|FG001|Overall Study|Lack of Efficacy|2|||
160700036|NCT00389831|580281803|FG000|Overall Study|Did not receive treatment.|0|||
160700037|NCT00389831|580281804|FG001|Overall Study|Did not receive treatment.|2|||
160700038|NCT00389831|580281803|FG000|Overall Study|Other reasons|0|||
160700039|NCT00389831|580281804|FG001|Overall Study|Other reasons|2|||
160700040|NCT00389831|580281803|FG000|Overall Study|Lost to Follow-up|0|||
160700041|NCT00389831|580281804|FG001|Overall Study|Lost to Follow-up|1|||
160700042|NCT02201290|580281809|FG000|Overall Study|Withdrawal by Subject|2|||
160700043|NCT02201290|580281809|FG000|Overall Study|Lack of Efficacy|2|||
160700044|NCT02201290|580281809|FG000|Overall Study|Adverse Event|1|||
160700045|NCT00594646|580281810|FG000|Overall Study|Withdrawal by Subject|1|||
160700046|NCT00594646|580281810|FG000|Overall Study|Lost to Follow-up|15|||
160700047|NCT03907462|580281811|FG000|Overall Study|Physician Decision|1|||
160700048|NCT03907462|580281812|FG001|Overall Study|Physician Decision|3|||
160700049|NCT03907462|580281813|FG002|Overall Study|Physician Decision|1|||
160700050|NCT03907462|580281811|FG000|Overall Study|Withdrawal by Subject|6|||
160700051|NCT03907462|580281812|FG001|Overall Study|Withdrawal by Subject|3|||
160700052|NCT03907462|580281813|FG002|Overall Study|Withdrawal by Subject|3|||
160700053|NCT03907462|580281811|FG000|Overall Study|Pregnancy|4|||
160700054|NCT03907462|580281812|FG001|Overall Study|Pregnancy|2|||
160700055|NCT03907462|580281813|FG002|Overall Study|Pregnancy|6|||
160700056|NCT03907462|580281811|FG000|Overall Study|Lost to Follow-up|16|||
160700057|NCT03907462|580281812|FG001|Overall Study|Lost to Follow-up|18|||
160700058|NCT03907462|580281813|FG002|Overall Study|Lost to Follow-up|22|||
160700059|NCT04639713|580281815|FG000|Overall Study|Protocol Noncompliance|2|||
160700060|NCT04639713|580281815|FG000|Overall Study|Withdrawal by Subject|1|||
160700061|NCT00633243|580284103|FG000|Overall Study|Withdrawal by Subject|0|||
160700062|NCT00633243|580284104|FG001|Overall Study|Withdrawal by Subject|1|||
160700063|NCT00633243|580284103|FG000|Overall Study|incarceration|0|||
160700064|NCT00633243|580284104|FG001|Overall Study|incarceration|2|||
160700065|NCT00633243|580284103|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
160700066|NCT00633243|580284104|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
160700067|NCT00633243|580284103|FG000|Overall Study|Not comfortable with self-injecting|0|||
160700068|NCT00633243|580284104|FG001|Overall Study|Not comfortable with self-injecting|1|||
160700069|NCT00633243|580284103|FG000|Overall Study|Mental Health--Depression|0|||
160700070|NCT00633243|580284104|FG001|Overall Study|Mental Health--Depression|1|||
160700071|NCT00633243|580284103|FG000|Overall Study|Couldn't tolerate side-effects|1|||
160700072|NCT00633243|580284104|FG001|Overall Study|Couldn't tolerate side-effects|1|||
160700073|NCT03589768|580284105|FG000|Overall Study|Death|1|||
160700074|NCT03589768|580284106|FG001|Overall Study|Death|0|||
160700075|NCT03589768|580284107|FG002|Overall Study|Death|8|||
160700076|NCT03589768|580284108|FG003|Overall Study|Death|3|||
160700077|NCT03589768|580284105|FG000|Overall Study|Withdrawal by Subject|2|||
160700078|NCT03589768|580284106|FG001|Overall Study|Withdrawal by Subject|0|||
160700079|NCT03589768|580284107|FG002|Overall Study|Withdrawal by Subject|0|||
160700080|NCT03589768|580284108|FG003|Overall Study|Withdrawal by Subject|0|||
160700081|NCT03589768|580284105|FG000|Overall Study|Protocol Violation|1|||
160700082|NCT03589768|580284106|FG001|Overall Study|Protocol Violation|0|||
160700083|NCT03589768|580284107|FG002|Overall Study|Protocol Violation|0|||
160700084|NCT03589768|580284108|FG003|Overall Study|Protocol Violation|0|||
160700085|NCT00191113|580284111|FG000|Core Study|Withdrawal by Subject|25|||
160700086|NCT00191113|580284112|FG001|Core Study|Withdrawal by Subject|9|||
160700087|NCT00191113|580284111|FG000|Core Study|Protocol Violation|6|||
160700088|NCT00191113|580284112|FG001|Core Study|Protocol Violation|2|||
160700089|NCT00191113|580284111|FG000|Core Study|Lost to Follow-up|3|||
160700090|NCT00191113|580284112|FG001|Core Study|Lost to Follow-up|0|||
160700091|NCT00191113|580284111|FG000|Core Study|Adverse Event|0|||
160700092|NCT00191113|580284112|FG001|Core Study|Adverse Event|2|||
160700093|NCT00191113|580284111|FG000|Core Study|Lack of Efficacy|0|||
160700094|NCT00191113|580284112|FG001|Core Study|Lack of Efficacy|2|||
160700095|NCT00191113|580284111|FG000|Core Study|Death|1|||
160700096|NCT00191113|580284112|FG001|Core Study|Death|0|||
160700097|NCT04003896|580284115|FG000|Overall Study|Withdrawal by Subject|3|||
160700098|NCT04003896|580284115|FG000|Overall Study|Physician Decision|1|||
160700099|NCT01154816|580284118|FG000|Overall Study|Withdrawal by Subject|1|||
160700100|NCT01154816|580284119|FG001|Overall Study|Withdrawal by Subject|0|||
160700101|NCT01154816|580284120|FG002|Overall Study|Withdrawal by Subject|0|||
160700102|NCT01154816|580284121|FG003|Overall Study|Withdrawal by Subject|1|||
160700103|NCT01154816|580284122|FG004|Overall Study|Withdrawal by Subject|0|||
160700104|NCT01154816|580284123|FG005|Overall Study|Withdrawal by Subject|0|||
160700105|NCT01154816|580284124|FG006|Overall Study|Withdrawal by Subject|0|||
160700106|NCT01154816|580284125|FG007|Overall Study|Withdrawal by Subject|0|||
160700107|NCT01154816|580284126|FG008|Overall Study|Withdrawal by Subject|1|||
160700108|NCT01154816|580284127|FG009|Overall Study|Withdrawal by Subject|3|||
160700109|NCT01154816|580284128|FG010|Overall Study|Withdrawal by Subject|0|||
160700110|NCT01154816|580284129|FG011|Overall Study|Withdrawal by Subject|0|||
160700111|NCT01154816|580284118|FG000|Overall Study|Progressive Disease|13|||
160700112|NCT01154816|580284119|FG001|Overall Study|Progressive Disease|8|||
160700113|NCT01154816|580284120|FG002|Overall Study|Progressive Disease|9|||
160700114|NCT01154816|580284121|FG003|Overall Study|Progressive Disease|9|||
160700115|NCT01154816|580284122|FG004|Overall Study|Progressive Disease|8|||
160700116|NCT01154816|580284123|FG005|Overall Study|Progressive Disease|8|||
160700117|NCT01154816|580284124|FG006|Overall Study|Progressive Disease|5|||
160700118|NCT01154816|580284125|FG007|Overall Study|Progressive Disease|6|||
160700119|NCT01154816|580284126|FG008|Overall Study|Progressive Disease|8|||
160700120|NCT01154816|580284127|FG009|Overall Study|Progressive Disease|6|||
160700121|NCT01154816|580284128|FG010|Overall Study|Progressive Disease|10|||
160700122|NCT01154816|580284129|FG011|Overall Study|Progressive Disease|3|||
160700123|NCT01154816|580284118|FG000|Overall Study|Physician Decision|1|||
160700124|NCT01154816|580284119|FG001|Overall Study|Physician Decision|0|||
160700125|NCT01154816|580284120|FG002|Overall Study|Physician Decision|1|||
160700126|NCT01154816|580284121|FG003|Overall Study|Physician Decision|0|||
160700127|NCT01154816|580284122|FG004|Overall Study|Physician Decision|2|||
160700128|NCT01154816|580284123|FG005|Overall Study|Physician Decision|0|||
160700129|NCT01154816|580284124|FG006|Overall Study|Physician Decision|0|||
160700130|NCT01154816|580284125|FG007|Overall Study|Physician Decision|0|||
160700131|NCT01154816|580284126|FG008|Overall Study|Physician Decision|0|||
160700132|NCT01154816|580284127|FG009|Overall Study|Physician Decision|1|||
160700133|NCT01154816|580284128|FG010|Overall Study|Physician Decision|1|||
160700134|NCT01154816|580284129|FG011|Overall Study|Physician Decision|1|||
160700135|NCT01154816|580284118|FG000|Overall Study|Adverse Event|5|||
160700136|NCT01154816|580284119|FG001|Overall Study|Adverse Event|2|||
160700137|NCT01154816|580284120|FG002|Overall Study|Adverse Event|0|||
160700138|NCT01154816|580284121|FG003|Overall Study|Adverse Event|0|||
160700139|NCT01154816|580284122|FG004|Overall Study|Adverse Event|0|||
160700140|NCT01154816|580284123|FG005|Overall Study|Adverse Event|0|||
160700141|NCT01154816|580284124|FG006|Overall Study|Adverse Event|1|||
160700142|NCT01154816|580284125|FG007|Overall Study|Adverse Event|1|||
160700143|NCT01154816|580284126|FG008|Overall Study|Adverse Event|0|||
160700144|NCT01154816|580284127|FG009|Overall Study|Adverse Event|0|||
160700145|NCT01154816|580284128|FG010|Overall Study|Adverse Event|0|||
160700146|NCT01154816|580284129|FG011|Overall Study|Adverse Event|0|||
160700147|NCT00806286|580284130|FG000|Overall Study|Adverse Event|5|||
160700148|NCT00806286|580284131|FG001|Overall Study|Adverse Event|2|||
160700149|NCT00806286|580284132|FG002|Overall Study|Adverse Event|0|||
160700150|NCT00806286|580284130|FG000|Overall Study|Disease progression|31|||
160700151|NCT00806286|580284131|FG001|Overall Study|Disease progression|38|||
160700152|NCT00806286|580284132|FG002|Overall Study|Disease progression|1|||
160700153|NCT00806286|580284130|FG000|Overall Study|Death|1|||
160700154|NCT00806286|580284131|FG001|Overall Study|Death|6|||
160700155|NCT00806286|580284132|FG002|Overall Study|Death|0|||
160700156|NCT00806286|580284130|FG000|Overall Study|Lost to Follow-up|0|||
160700157|NCT00806286|580284131|FG001|Overall Study|Lost to Follow-up|1|||
160700158|NCT00806286|580284132|FG002|Overall Study|Lost to Follow-up|0|||
160700159|NCT00806286|580284130|FG000|Overall Study|Withdrawal by Subject|8|||
160700160|NCT00806286|580284131|FG001|Overall Study|Withdrawal by Subject|3|||
160700161|NCT00806286|580284132|FG002|Overall Study|Withdrawal by Subject|1|||
160700162|NCT00806286|580284130|FG000|Overall Study|Physician Decision|2|||
160700163|NCT00806286|580284131|FG001|Overall Study|Physician Decision|2|||
160700164|NCT00806286|580284132|FG002|Overall Study|Physician Decision|0|||
160700165|NCT00806286|580284130|FG000|Overall Study|Due to a variety of reasons|7|||
160700166|NCT00806286|580284131|FG001|Overall Study|Due to a variety of reasons|2|||
160700167|NCT00806286|580284132|FG002|Overall Study|Due to a variety of reasons|1|||
160700168|NCT01682863|580284133|FG000|Overall Study|Subject/guardian decision|19|||
160700169|NCT01682863|580284134|FG001|Overall Study|Subject/guardian decision|12|||
160700170|NCT01682863|580284135|FG002|Overall Study|Subject/guardian decision|10|||
160700171|NCT01682863|580284133|FG000|Overall Study|Lost to Follow-up|5|||
160700172|NCT01682863|580284134|FG001|Overall Study|Lost to Follow-up|1|||
160700173|NCT01682863|580284135|FG002|Overall Study|Lost to Follow-up|6|||
160700174|NCT01682863|580284133|FG000|Overall Study|Death|1|||
160700175|NCT01682863|580284134|FG001|Overall Study|Death|3|||
160700176|NCT01682863|580284135|FG002|Overall Study|Death|4|||
160700177|NCT01682863|580284133|FG000|Overall Study|Protocol deviation|1|||
160700178|NCT01682863|580284134|FG001|Overall Study|Protocol deviation|0|||
160700179|NCT01682863|580284135|FG002|Overall Study|Protocol deviation|1|||
160700180|NCT01682863|580284133|FG000|Overall Study|Technical problems|1|||
160700181|NCT01682863|580284134|FG001|Overall Study|Technical problems|0|||
160700182|NCT01682863|580284135|FG002|Overall Study|Technical problems|0|||
160700183|NCT01682863|580284133|FG000|Overall Study|Adverse Event|0|||
160700184|NCT01682863|580284134|FG001|Overall Study|Adverse Event|1|||
160700185|NCT01682863|580284135|FG002|Overall Study|Adverse Event|2|||
160700186|NCT01682863|580284133|FG000|Overall Study|Physician Decision|0|||
160700187|NCT01682863|580284134|FG001|Overall Study|Physician Decision|0|||
160700188|NCT01682863|580284135|FG002|Overall Study|Physician Decision|1|||
160700189|NCT00918138|580284136|FG000|Overall Study|Subject withdrew consent|1|||
160700190|NCT00918138|580284137|FG001|Overall Study|Subject withdrew consent|1|||
160700191|NCT00918138|580284136|FG000|Overall Study|Death|1|||
160700192|NCT00918138|580284137|FG001|Overall Study|Death|0|||
160700193|NCT00977379|580284138|FG000|Overall Study|Withdrawal by Subject|1|||
160700194|NCT00977379|580284139|FG001|Overall Study|Withdrawal by Subject|1|||
160700195|NCT00977379|580284138|FG000|Overall Study|Death|7|||
160700196|NCT00977379|580284139|FG001|Overall Study|Death|9|||
160700197|NCT00977379|580284138|FG000|Overall Study|Premature Study Termination|4|||
160700198|NCT00977379|580284139|FG001|Overall Study|Premature Study Termination|0|||
160700199|NCT00977379|580284138|FG000|Overall Study|Participant Moving House|0|||
160700200|NCT00977379|580284139|FG001|Overall Study|Participant Moving House|1|||
160700201|NCT00977379|580284138|FG000|Overall Study|Randomization Error|0|||
160700202|NCT00977379|580284139|FG001|Overall Study|Randomization Error|1|||
160700203|NCT03972163|580284140|FG000|Overall Study|Death|0|||
160700204|NCT03972163|580284141|FG001|Overall Study|Death|1|||
160700205|NCT01199471|580284142|FG000|Overall Study|Protocol Violation|4|||
160700206|NCT01199471|580284142|FG000|Overall Study|Withdrawal by Subject|1|||
160700207|NCT01199471|580284142|FG000|Overall Study|Physician Decision|1|||
160700208|NCT02006693|580284143|FG000|Overall Study|No Reason Specified|6|||
160700209|NCT02006693|580284144|FG001|Overall Study|No Reason Specified|8|||
160700210|NCT02006693|580284143|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
160700211|NCT02006693|580284144|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
160700212|NCT02006693|580284143|FG000|Overall Study|XEN Implant Explantation|0|||
160700213|NCT02006693|580284144|FG001|Overall Study|XEN Implant Explantation|1|||
160700214|NCT02006693|580284143|FG000|Overall Study|Death|2|||
160700215|NCT02006693|580284144|FG001|Overall Study|Death|2|||
160700216|NCT02006693|580284143|FG000|Overall Study|Lost to Follow-up|4|||
160700217|NCT02006693|580284144|FG001|Overall Study|Lost to Follow-up|1|||
160700218|NCT02006693|580284143|FG000|Overall Study|Patient Decision|4|||
160700219|NCT02006693|580284144|FG001|Overall Study|Patient Decision|0|||
160700220|NCT00265395|580284145|FG000|Overall Study|Adverse Event|3|||
160700221|NCT00265395|580284146|FG001|Overall Study|Adverse Event|6|||
160700222|NCT00265395|580284145|FG000|Overall Study|Lost to Follow-up|2|||
160700223|NCT00265395|580284146|FG001|Overall Study|Lost to Follow-up|1|||
160700224|NCT00265395|580284145|FG000|Overall Study|Withdrawal by Subject|1|||
160700225|NCT00265395|580284146|FG001|Overall Study|Withdrawal by Subject|6|||
160700226|NCT00265395|580284145|FG000|Overall Study|Protocol Violation|2|||
160700227|NCT00265395|580284146|FG001|Overall Study|Protocol Violation|2|||
160700228|NCT00265395|580284145|FG000|Overall Study|Lack of Efficacy|0|||
160700229|NCT00265395|580284146|FG001|Overall Study|Lack of Efficacy|1|||
160700230|NCT00265395|580284145|FG000|Overall Study|Administrative|0|||
160700231|NCT00265395|580284146|FG001|Overall Study|Administrative|1|||
160700232|NCT00837473|580284147|FG000|Overall Study|Lost to Follow-up|1|||
160700233|NCT00837473|580284147|FG000|Overall Study|Withdrawal by Subject|2|||
160700234|NCT03511326|580284156|FG000|Overall Study|Withdrawal by Subject|1|||
160700235|NCT04005352|580284159|FG000|Overall Study|Adverse Event|4|||
160700236|NCT04005352|580284160|FG001|Overall Study|Adverse Event|5|||
160700237|NCT04005352|580284159|FG000|Overall Study|Death|4|||
160700238|NCT04005352|580284160|FG001|Overall Study|Death|2|||
160700239|NCT04005352|580284159|FG000|Overall Study|Lost to Follow-up|6|||
160700240|NCT04005352|580284160|FG001|Overall Study|Lost to Follow-up|2|||
160700241|NCT04005352|580284159|FG000|Overall Study|Physician Decision|7|||
160700242|NCT04005352|580284160|FG001|Overall Study|Physician Decision|13|||
160700243|NCT04005352|580284159|FG000|Overall Study|Protocol Violation|0|||
160700244|NCT04005352|580284160|FG001|Overall Study|Protocol Violation|1|||
160700245|NCT04005352|580284159|FG000|Overall Study|Withdrawal by Subject|28|||
160700246|NCT04005352|580284160|FG001|Overall Study|Withdrawal by Subject|38|||
160700247|NCT00849186|580284161|FG000|Overall Study|Adverse Event|2|||
160700248|NCT00849186|580284161|FG000|Overall Study|Withdrawal by Subject|1|||
160700249|NCT00849186|580284161|FG000|Overall Study|not treated|6|||
160700250|NCT00849186|580284161|FG000|Overall Study|Other|1|||
160700251|NCT00936897|580284164|FG000|Overall Study|Withdrawal by Subject|9|||
160700252|NCT00936897|580284165|FG001|Overall Study|Withdrawal by Subject|19|||
160700253|NCT00936897|580284164|FG000|Overall Study|Adverse Event|4|||
160700254|NCT00936897|580284165|FG001|Overall Study|Adverse Event|13|||
160700255|NCT00936897|580284164|FG000|Overall Study|Other|3|||
160700256|NCT00936897|580284165|FG001|Overall Study|Other|9|||
160700257|NCT00936897|580284164|FG000|Overall Study|Lost to Follow-up|1|||
160700258|NCT00936897|580284165|FG001|Overall Study|Lost to Follow-up|10|||
160700259|NCT00936897|580284164|FG000|Overall Study|Administrative Decision|1|||
160700260|NCT00936897|580284165|FG001|Overall Study|Administrative Decision|2|||
160700261|NCT00936897|580284164|FG000|Overall Study|Protocol Violation|1|||
160700262|NCT00936897|580284165|FG001|Overall Study|Protocol Violation|1|||
160700263|NCT00936897|580284164|FG000|Overall Study|Ineligibility Determined|0|||
160700264|NCT00936897|580284165|FG001|Overall Study|Ineligibility Determined|3|||
160700265|NCT00936897|580284164|FG000|Overall Study|Noncompliance|0|||
160700266|NCT00936897|580284165|FG001|Overall Study|Noncompliance|2|||
160700267|NCT00936897|580284164|FG000|Overall Study|Death|0|||
160700268|NCT00936897|580284165|FG001|Overall Study|Death|1|||
160700269|NCT00417170|580284166|FG000|Overall Study|Adverse Event|1|||
160700270|NCT00417170|580284167|FG001|Overall Study|Adverse Event|1|||
160700271|NCT00417170|580284166|FG000|Overall Study|Withdrawal by Subject|1|||
160700272|NCT00417170|580284167|FG001|Overall Study|Withdrawal by Subject|1|||
160700273|NCT00417170|580284166|FG000|Overall Study|Lost to Follow-up|0|||
160700274|NCT00417170|580284167|FG001|Overall Study|Lost to Follow-up|1|||
160700275|NCT04058067|580284168|FG000|Overall Study|Adverse Event|2|||
160700276|NCT04058067|580284169|FG001|Overall Study|Adverse Event|0|||
160700277|NCT04058067|580284168|FG000|Overall Study|Death|0|||
160700278|NCT04058067|580284169|FG001|Overall Study|Death|1|||
160700279|NCT04058067|580284168|FG000|Overall Study|Physician Decision|3|||
160700280|NCT04058067|580284169|FG001|Overall Study|Physician Decision|1|||
160700281|NCT04058067|580284168|FG000|Overall Study|Protocol Violation|0|||
160700282|NCT04058067|580284169|FG001|Overall Study|Protocol Violation|1|||
160700283|NCT04058067|580284168|FG000|Overall Study|Withdrawal by Subject|7|||
160700284|NCT04058067|580284169|FG001|Overall Study|Withdrawal by Subject|8|||
160700285|NCT01844856|580284172|FG000|Overall Study|Lost to Follow-up|15|||
160700286|NCT01844856|580284173|FG001|Overall Study|Lost to Follow-up|3|||
160700287|NCT01844856|580284172|FG000|Overall Study|Adverse Event|3|||
160700288|NCT01844856|580284173|FG001|Overall Study|Adverse Event|6|||
160700289|NCT01844856|580284172|FG000|Overall Study|Withdrawal by Subject|3|||
160700290|NCT01844856|580284173|FG001|Overall Study|Withdrawal by Subject|2|||
160700291|NCT01844856|580284172|FG000|Overall Study|Noncompliance|2|||
160700292|NCT01844856|580284173|FG001|Overall Study|Noncompliance|3|||
160700293|NCT01844856|580284172|FG000|Overall Study|Enterococcus Resistant|0|||
160700294|NCT01844856|580284173|FG001|Overall Study|Enterococcus Resistant|1|||
160700295|NCT01844856|580284172|FG000|Overall Study|Inadvertently Not Scheduled|1|||
160700296|NCT01844856|580284173|FG001|Overall Study|Inadvertently Not Scheduled|0|||
160700297|NCT01844856|580284172|FG000|Overall Study|Randomized but was a Screen Failure|0|||
160700298|NCT01844856|580284173|FG001|Overall Study|Randomized but was a Screen Failure|1|||
160700299|NCT01001988|580284174|FG000|Overall Study|Protocol Violation|84|||
160700300|NCT01001988|580284174|FG000|Overall Study|Withdrawal by Subject|18|||
160700301|NCT01001988|580284174|FG000|Overall Study|Lost to Follow-up|15|||
160700302|NCT01221363|580284175|FG000|Overall Study|Pregnancy|1|||
160700303|NCT01221363|580284176|FG001|Overall Study|Pregnancy|0|||
160700304|NCT01221363|580284175|FG000|Overall Study|Withdrawal by Subject|11|||
160700305|NCT01221363|580284176|FG001|Overall Study|Withdrawal by Subject|5|||
160700306|NCT04628793|580284177|FG000|Overall Study|Study terminated by sponsor|0|||
160700307|NCT04628793|580284178|FG001|Overall Study|Study terminated by sponsor|0|||
160700308|NCT04628793|580284179|FG002|Overall Study|Study terminated by sponsor|8|||
160700309|NCT04628793|580284177|FG000|Overall Study|Withdrawal by Subject|2|||
160700310|NCT04628793|580284178|FG001|Overall Study|Withdrawal by Subject|3|||
160700311|NCT04628793|580284179|FG002|Overall Study|Withdrawal by Subject|0|||
160700312|NCT04628793|580284177|FG000|Overall Study|Lost to Follow-up|0|||
160700313|NCT04628793|580284178|FG001|Overall Study|Lost to Follow-up|1|||
160700314|NCT04628793|580284179|FG002|Overall Study|Lost to Follow-up|0|||
160700315|NCT01329549|580284186|FG000|Overall Study|Withdrawal by Subject|1|||
160700316|NCT01329549|580284186|FG000|Overall Study|Adverse Event|1|||
160700317|NCT01756079|580284187|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
160700318|NCT01756079|580284187|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
160700319|NCT01756079|580284187|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
160700320|NCT01756079|580284187|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
160700321|NCT01756079|580284187|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
160700322|NCT02677714|580284188|FG000|Overall Study|Withdrawal by Subject|2|||
160700323|NCT02677714|580284189|FG001|Overall Study|Withdrawal by Subject|0|||
160700324|NCT03421730|580284190|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700325|NCT03421730|580284191|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
160700326|NCT03421730|580284192|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700327|NCT03421730|580284193|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700328|NCT03421730|580284194|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700329|NCT03421730|580284195|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700330|NCT03421730|580284196|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700331|NCT03421730|580284197|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700332|NCT03421730|580284198|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700333|NCT03421730|580284199|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700334|NCT03421730|580284200|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700335|NCT03421730|580284201|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
160700336|NCT03421730|580284190|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700337|NCT03421730|580284191|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700338|NCT03421730|580284192|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700339|NCT03421730|580284193|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700340|NCT03421730|580284194|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
160700341|NCT03421730|580284195|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700342|NCT03421730|580284196|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700343|NCT03421730|580284197|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700344|NCT03421730|580284198|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700345|NCT03421730|580284199|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700346|NCT03421730|580284200|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700347|NCT03421730|580284201|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
160700348|NCT01661062|580284210|FG000|Overall Study|Completed Treatment Off Study|3|||
160700349|NCT01661062|580284210|FG000|Overall Study|Withdrawal by Subject|2|||
160700350|NCT02387983|580284212|FG000|Overall Study|Adverse Event|4|||
160700351|NCT02387983|580284212|FG000|Overall Study|Protocol Violation|1|||
160700352|NCT02387983|580284212|FG000|Overall Study|Withdrawal by Subject|2|||
160700353|NCT00587990|580284215|FG000|Overall Study|Death|0|||
160700354|NCT00587990|580284216|FG001|Overall Study|Death|0|||
160700355|NCT00587990|580284217|FG002|Overall Study|Death|1|||
160700356|NCT03334617|580284218|FG000|Overall Study|Adverse Event|0|||
160700357|NCT03334617|580284219|FG001|Overall Study|Adverse Event|0|||
160700358|NCT03334617|580284220|FG002|Overall Study|Adverse Event|0|||
160700359|NCT03334617|580284221|FG003|Overall Study|Adverse Event|0|||
160700360|NCT03334617|580284222|FG004|Overall Study|Adverse Event|0|||
160700361|NCT03334617|580284223|FG005|Overall Study|Adverse Event|0|||
160700362|NCT03334617|580284224|FG006|Overall Study|Adverse Event|0|||
160700363|NCT03334617|580284225|FG007|Overall Study|Adverse Event|0|||
160700364|NCT03334617|580284226|FG008|Overall Study|Adverse Event|1|||
160700365|NCT03334617|580284227|FG009|Overall Study|Adverse Event|0|||
160700366|NCT03334617|580284228|FG010|Overall Study|Adverse Event|0|||
160700367|NCT03334617|580284229|FG011|Overall Study|Adverse Event|0|||
160700368|NCT03334617|580284230|FG012|Overall Study|Adverse Event|1|||
160700369|NCT03334617|580284231|FG013|Overall Study|Adverse Event|0|||
160700370|NCT03334617|580284232|FG014|Overall Study|Adverse Event|0|||
160700371|NCT03334617|580284233|FG015|Overall Study|Adverse Event|0|||
160700372|NCT03334617|580284234|FG016|Overall Study|Adverse Event|0|||
160700373|NCT03334617|580284235|FG017|Overall Study|Adverse Event|0|||
160700374|NCT03334617|580284236|FG018|Overall Study|Adverse Event|0|||
160700375|NCT03334617|580284237|FG019|Overall Study|Adverse Event|0|||
160700376|NCT03334617|580284238|FG020|Overall Study|Adverse Event|0|||
160700377|NCT03334617|580284239|FG021|Overall Study|Adverse Event|0|||
160700378|NCT03334617|580284218|FG000|Overall Study|Death|18|||
160700379|NCT03334617|580284219|FG001|Overall Study|Death|18|||
160700380|NCT03334617|580284220|FG002|Overall Study|Death|20|||
160700381|NCT03334617|580284221|FG003|Overall Study|Death|21|||
160700382|NCT03334617|580284222|FG004|Overall Study|Death|20|||
160700383|NCT03334617|580284223|FG005|Overall Study|Death|16|||
160700384|NCT03334617|580284224|FG006|Overall Study|Death|28|||
160700385|NCT03334617|580284225|FG007|Overall Study|Death|35|||
160700386|NCT03334617|580284226|FG008|Overall Study|Death|47|||
160700387|NCT03334617|580284227|FG009|Overall Study|Death|0|||
160700388|NCT03334617|580284228|FG010|Overall Study|Death|19|||
160700389|NCT03334617|580284229|FG011|Overall Study|Death|6|||
160700390|NCT03334617|580284230|FG012|Overall Study|Death|20|||
160700391|NCT03334617|580284231|FG013|Overall Study|Death|22|||
160700392|NCT03334617|580284232|FG014|Overall Study|Death|17|||
160700393|NCT03334617|580284233|FG015|Overall Study|Death|18|||
160700394|NCT03334617|580284234|FG016|Overall Study|Death|12|||
160700395|NCT03334617|580284235|FG017|Overall Study|Death|15|||
160700396|NCT03334617|580284236|FG018|Overall Study|Death|16|||
160700397|NCT03334617|580284237|FG019|Overall Study|Death|27|||
160700398|NCT03334617|580284238|FG020|Overall Study|Death|14|||
160700399|NCT03334617|580284239|FG021|Overall Study|Death|27|||
160700400|NCT03334617|580284218|FG000|Overall Study|Lost to Follow-up|0|||
160700401|NCT03334617|580284219|FG001|Overall Study|Lost to Follow-up|0|||
160700402|NCT03334617|580284220|FG002|Overall Study|Lost to Follow-up|0|||
160700403|NCT03334617|580284221|FG003|Overall Study|Lost to Follow-up|1|||
160700404|NCT03334617|580284222|FG004|Overall Study|Lost to Follow-up|0|||
160700405|NCT03334617|580284223|FG005|Overall Study|Lost to Follow-up|1|||
160700406|NCT03334617|580284224|FG006|Overall Study|Lost to Follow-up|0|||
160700407|NCT03334617|580284225|FG007|Overall Study|Lost to Follow-up|0|||
160700408|NCT03334617|580284226|FG008|Overall Study|Lost to Follow-up|1|||
160700409|NCT03334617|580284227|FG009|Overall Study|Lost to Follow-up|0|||
160700410|NCT03334617|580284228|FG010|Overall Study|Lost to Follow-up|0|||
160700411|NCT03334617|580284229|FG011|Overall Study|Lost to Follow-up|0|||
160700412|NCT03334617|580284230|FG012|Overall Study|Lost to Follow-up|0|||
160700413|NCT03334617|580284231|FG013|Overall Study|Lost to Follow-up|0|||
160700414|NCT03334617|580284232|FG014|Overall Study|Lost to Follow-up|0|||
160700415|NCT03334617|580284233|FG015|Overall Study|Lost to Follow-up|0|||
160700416|NCT03334617|580284234|FG016|Overall Study|Lost to Follow-up|0|||
160700417|NCT03334617|580284235|FG017|Overall Study|Lost to Follow-up|0|||
160700418|NCT03334617|580284236|FG018|Overall Study|Lost to Follow-up|0|||
160700419|NCT03334617|580284237|FG019|Overall Study|Lost to Follow-up|0|||
160700420|NCT03334617|580284238|FG020|Overall Study|Lost to Follow-up|0|||
160700421|NCT03334617|580284239|FG021|Overall Study|Lost to Follow-up|0|||
160700422|NCT03334617|580284218|FG000|Overall Study|Withdrawal by Subject|0|||
160700423|NCT03334617|580284219|FG001|Overall Study|Withdrawal by Subject|1|||
160700424|NCT03334617|580284220|FG002|Overall Study|Withdrawal by Subject|0|||
160700425|NCT03334617|580284221|FG003|Overall Study|Withdrawal by Subject|0|||
160700426|NCT03334617|580284222|FG004|Overall Study|Withdrawal by Subject|1|||
160700427|NCT03334617|580284223|FG005|Overall Study|Withdrawal by Subject|1|||
160700428|NCT03334617|580284224|FG006|Overall Study|Withdrawal by Subject|1|||
160700429|NCT03334617|580284225|FG007|Overall Study|Withdrawal by Subject|2|||
160700430|NCT03334617|580284226|FG008|Overall Study|Withdrawal by Subject|0|||
160700431|NCT03334617|580284227|FG009|Overall Study|Withdrawal by Subject|0|||
160700432|NCT03334617|580284228|FG010|Overall Study|Withdrawal by Subject|0|||
160700433|NCT03334617|580284229|FG011|Overall Study|Withdrawal by Subject|1|||
160700434|NCT03334617|580284230|FG012|Overall Study|Withdrawal by Subject|1|||
160700435|NCT03334617|580284231|FG013|Overall Study|Withdrawal by Subject|0|||
160700436|NCT03334617|580284232|FG014|Overall Study|Withdrawal by Subject|2|||
160700437|NCT03334617|580284233|FG015|Overall Study|Withdrawal by Subject|1|||
160700438|NCT03334617|580284234|FG016|Overall Study|Withdrawal by Subject|0|||
160700439|NCT03334617|580284235|FG017|Overall Study|Withdrawal by Subject|1|||
160700440|NCT03334617|580284236|FG018|Overall Study|Withdrawal by Subject|1|||
160700441|NCT03334617|580284237|FG019|Overall Study|Withdrawal by Subject|1|||
160700442|NCT03334617|580284238|FG020|Overall Study|Withdrawal by Subject|0|||
160700443|NCT03334617|580284239|FG021|Overall Study|Withdrawal by Subject|1|||
160700444|NCT03334617|580284218|FG000|Overall Study|Other|1|||
160700445|NCT03334617|580284219|FG001|Overall Study|Other|2|||
160700446|NCT03334617|580284220|FG002|Overall Study|Other|0|||
160700447|NCT03334617|580284221|FG003|Overall Study|Other|1|||
160700448|NCT03334617|580284222|FG004|Overall Study|Other|1|||
160700449|NCT03334617|580284223|FG005|Overall Study|Other|0|||
160700450|NCT03334617|580284224|FG006|Overall Study|Other|2|||
160700451|NCT03334617|580284225|FG007|Overall Study|Other|1|||
160700452|NCT03334617|580284226|FG008|Overall Study|Other|8|||
160700453|NCT03334617|580284227|FG009|Overall Study|Other|0|||
160700454|NCT03334617|580284228|FG010|Overall Study|Other|3|||
160700455|NCT03334617|580284229|FG011|Overall Study|Other|1|||
160700456|NCT03334617|580284230|FG012|Overall Study|Other|3|||
160700457|NCT03334617|580284231|FG013|Overall Study|Other|1|||
160700458|NCT03334617|580284232|FG014|Overall Study|Other|1|||
160700459|NCT03334617|580284233|FG015|Overall Study|Other|3|||
160700460|NCT03334617|580284234|FG016|Overall Study|Other|3|||
160700461|NCT03334617|580284235|FG017|Overall Study|Other|3|||
160700462|NCT03334617|580284236|FG018|Overall Study|Other|7|||
160700463|NCT03334617|580284237|FG019|Overall Study|Other|4|||
160700464|NCT03334617|580284238|FG020|Overall Study|Other|1|||
160700465|NCT03334617|580284239|FG021|Overall Study|Other|4|||
160700466|NCT03334617|580284218|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
160700467|NCT03334617|580284219|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
160700468|NCT03334617|580284220|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
160700469|NCT03334617|580284221|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
160700470|NCT03334617|580284222|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
160700471|NCT03334617|580284223|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
160700472|NCT03334617|580284224|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
160700473|NCT03334617|580284225|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
160700474|NCT03334617|580284226|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
160700475|NCT03334617|580284227|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
160700476|NCT03334617|580284228|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
160700477|NCT03334617|580284229|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
160700478|NCT03334617|580284230|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
160700479|NCT03334617|580284231|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
160700480|NCT03334617|580284232|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
160700481|NCT03334617|580284233|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
160700482|NCT03334617|580284234|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
160700483|NCT03334617|580284235|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
160700484|NCT03334617|580284236|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
160700485|NCT03334617|580284237|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
160700486|NCT03334617|580284238|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
160700487|NCT03334617|580284239|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
160700488|NCT03657342|580284241|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
160700489|NCT03657342|580284242|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
160700490|NCT03657342|580284241|FG000|Overall Study|Withdrawal by Subject|4|||
160700491|NCT03657342|580284242|FG001|Overall Study|Withdrawal by Subject|4|||
160700492|NCT03657342|580284241|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
160700493|NCT03657342|580284242|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
160700494|NCT03657342|580284241|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
160700495|NCT03657342|580284242|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
160700496|NCT00827632|580284243|FG000|Overall Study|Lost to Follow-up|8|||
160700497|NCT00827632|580284244|FG001|Overall Study|Lost to Follow-up|12|||
160700498|NCT00827632|580284243|FG000|Overall Study|Early withdrawal|14|||
160700499|NCT00827632|580284244|FG001|Overall Study|Early withdrawal|11|||
160700500|NCT06281171|580284258|FG000|Timepoint 2|Lost to Follow-up|6|||
160700501|NCT06281171|580284259|FG001|Timepoint 2|Lost to Follow-up|4|||
160700502|NCT06281171|580284258|FG000|Timepoint 3|Lost to Follow-up|0|||
160700503|NCT06281171|580284259|FG001|Timepoint 3|Lost to Follow-up|5|||
160700504|NCT00407758|580284260|FG000|Overall Study|ineligible -improper prior treatment|1|||
160700505|NCT04669691|580284273|FG000|Overall Study|Death|0|||
160700506|NCT04669691|580284274|FG001|Overall Study|Death|1|||
160700507|NCT04669691|580284275|FG002|Overall Study|Death|0|||
160700508|NCT04669691|580284276|FG003|Overall Study|Death|0|||
160700509|NCT04669691|580284277|FG004|Overall Study|Death|0|||
160700510|NCT04669691|580284278|FG005|Overall Study|Death|0|||
160700511|NCT00750308|580284279|FG000|First Treatment|Adverse Event|0|||
160700512|NCT00750308|580284280|FG001|First Treatment|Adverse Event|1|||
160700513|NCT00750308|580284281|FG002|First Treatment|Adverse Event|0|||
160700514|NCT00750308|580284282|FG003|First Treatment|Adverse Event|0|||
160700515|NCT00750308|580284283|FG004|First Treatment|Adverse Event|0|||
160700516|NCT00750308|580284284|FG005|First Treatment|Adverse Event|0|||
160700517|NCT00750308|580284285|FG006|First Treatment|Adverse Event|0|||
160700518|NCT00750308|580284286|FG007|First Treatment|Adverse Event|0|||
160700519|NCT00750308|580284287|FG008|First Treatment|Adverse Event|0|||
160700520|NCT00750308|580284288|FG009|First Treatment|Adverse Event|0|||
160700521|NCT00750308|580284289|FG010|First Treatment|Adverse Event|1|||
160700522|NCT00750308|580284290|FG011|First Treatment|Adverse Event|1|||
160700523|NCT00750308|580284279|FG000|First Treatment|Withdrawal by Subject|0|||
160700524|NCT00750308|580284280|FG001|First Treatment|Withdrawal by Subject|0|||
160700525|NCT00750308|580284281|FG002|First Treatment|Withdrawal by Subject|0|||
160700526|NCT00750308|580284282|FG003|First Treatment|Withdrawal by Subject|1|||
160700527|NCT00750308|580284283|FG004|First Treatment|Withdrawal by Subject|0|||
160700528|NCT00750308|580284284|FG005|First Treatment|Withdrawal by Subject|0|||
160700529|NCT00750308|580284285|FG006|First Treatment|Withdrawal by Subject|0|||
160700530|NCT00750308|580284286|FG007|First Treatment|Withdrawal by Subject|1|||
160700531|NCT00750308|580284287|FG008|First Treatment|Withdrawal by Subject|0|||
160700532|NCT00750308|580284288|FG009|First Treatment|Withdrawal by Subject|0|||
160700533|NCT00750308|580284289|FG010|First Treatment|Withdrawal by Subject|0|||
160700534|NCT00750308|580284290|FG011|First Treatment|Withdrawal by Subject|0|||
160700535|NCT00750308|580284279|FG000|Second Treatment|Adverse Event|0|||
160700536|NCT00750308|580284280|FG001|Second Treatment|Adverse Event|0|||
160700537|NCT00750308|580284281|FG002|Second Treatment|Adverse Event|0|||
160700538|NCT00750308|580284282|FG003|Second Treatment|Adverse Event|0|||
160700539|NCT00750308|580284283|FG004|Second Treatment|Adverse Event|0|||
160700540|NCT00750308|580284284|FG005|Second Treatment|Adverse Event|1|||
160700541|NCT00750308|580284285|FG006|Second Treatment|Adverse Event|0|||
160700542|NCT00750308|580284286|FG007|Second Treatment|Adverse Event|0|||
160700543|NCT00750308|580284287|FG008|Second Treatment|Adverse Event|1|||
160700544|NCT00750308|580284288|FG009|Second Treatment|Adverse Event|0|||
160700545|NCT00750308|580284289|FG010|Second Treatment|Adverse Event|0|||
160700546|NCT00750308|580284290|FG011|Second Treatment|Adverse Event|0|||
160700547|NCT00750308|580284279|FG000|Second Treatment|Withdrawal by Subject|0|||
160700548|NCT00750308|580284280|FG001|Second Treatment|Withdrawal by Subject|0|||
160700549|NCT00750308|580284281|FG002|Second Treatment|Withdrawal by Subject|0|||
160700550|NCT00750308|580284282|FG003|Second Treatment|Withdrawal by Subject|0|||
160700551|NCT00750308|580284283|FG004|Second Treatment|Withdrawal by Subject|1|||
160700552|NCT00750308|580284284|FG005|Second Treatment|Withdrawal by Subject|0|||
160700553|NCT00750308|580284285|FG006|Second Treatment|Withdrawal by Subject|0|||
160700554|NCT00750308|580284286|FG007|Second Treatment|Withdrawal by Subject|0|||
160700555|NCT00750308|580284287|FG008|Second Treatment|Withdrawal by Subject|0|||
160700556|NCT00750308|580284288|FG009|Second Treatment|Withdrawal by Subject|0|||
160700557|NCT00750308|580284289|FG010|Second Treatment|Withdrawal by Subject|0|||
160700558|NCT00750308|580284290|FG011|Second Treatment|Withdrawal by Subject|0|||
160700559|NCT00750308|580284279|FG000|Third Treatment|Withdrawal by Subject|0|||
160700560|NCT00750308|580284280|FG001|Third Treatment|Withdrawal by Subject|1|||
160700561|NCT00750308|580284281|FG002|Third Treatment|Withdrawal by Subject|0|||
160700562|NCT00750308|580284282|FG003|Third Treatment|Withdrawal by Subject|0|||
160700563|NCT00750308|580284283|FG004|Third Treatment|Withdrawal by Subject|0|||
160700564|NCT00750308|580284284|FG005|Third Treatment|Withdrawal by Subject|0|||
160700565|NCT00750308|580284285|FG006|Third Treatment|Withdrawal by Subject|0|||
160700566|NCT00750308|580284286|FG007|Third Treatment|Withdrawal by Subject|0|||
160700567|NCT00750308|580284287|FG008|Third Treatment|Withdrawal by Subject|0|||
160700568|NCT00750308|580284288|FG009|Third Treatment|Withdrawal by Subject|0|||
160700569|NCT00750308|580284289|FG010|Third Treatment|Withdrawal by Subject|0|||
160700570|NCT00750308|580284290|FG011|Third Treatment|Withdrawal by Subject|0|||
160700571|NCT01822275|580284291|FG000|Overall Study|Withdrawal by Subject|3|||
160700572|NCT01822275|580284291|FG000|Overall Study|Adverse Event|3|||
160700573|NCT01822275|580284291|FG000|Overall Study|Progression|14|||
160700574|NCT01822275|580284291|FG000|Overall Study|Physician Decision|2|||
160700575|NCT00513682|580284292|FG000|Washout Phase|Adverse Event|2|||
160700576|NCT02980874|580284293|FG000|Overall Study|Adverse Event|2|||
160700577|NCT02980874|580284294|FG001|Overall Study|Adverse Event|7|||
160700578|NCT02980874|580284293|FG000|Overall Study|Withdrawal by Subject|7|||
160700579|NCT02980874|580284294|FG001|Overall Study|Withdrawal by Subject|2|||
160700580|NCT02980874|580284293|FG000|Overall Study|Lost to Follow-up|5|||
160700581|NCT02980874|580284294|FG001|Overall Study|Lost to Follow-up|5|||
160700582|NCT02980874|580284293|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
160700583|NCT02980874|580284294|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
160700584|NCT02980874|580284293|FG000|Overall Study|Unknown study completion status|1|||
160700585|NCT02980874|580284294|FG001|Overall Study|Unknown study completion status|0|||
160700586|NCT02450526|580284295|FG000|DB Period (Cycle 1)|Adverse Event|0|||
160700587|NCT02450526|580284296|FG001|DB Period (Cycle 1)|Adverse Event|0|||
160700588|NCT02450526|580284297|FG002|DB Period (Cycle 1)|Adverse Event|2|||
160700589|NCT02450526|580284298|FG003|DB Period (Cycle 1)|Adverse Event|0|||
160700590|NCT02450526|580284299|FG004|DB Period (Cycle 1)|Adverse Event|0|||
160700591|NCT02450526|580284295|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
160700592|NCT02450526|580284296|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
160700593|NCT02450526|580284297|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
160700594|NCT02450526|580284298|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
160700595|NCT02450526|580284299|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
160700596|NCT02450526|580284295|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
160700597|NCT02450526|580284296|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
160700598|NCT02450526|580284297|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
160700599|NCT02450526|580284298|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
160700600|NCT02450526|580284299|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
160700601|NCT02450526|580284295|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
160700602|NCT02450526|580284296|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
160700603|NCT02450526|580284297|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
160700604|NCT02450526|580284298|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
160700605|NCT02450526|580284299|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
160700606|NCT02450526|580284295|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
160700607|NCT02450526|580284296|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
160700608|NCT02450526|580284297|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
160700609|NCT02450526|580284298|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
160700610|NCT02450526|580284299|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
160700611|NCT02450526|580284295|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
160700612|NCT02450526|580284296|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
160700613|NCT02450526|580284297|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
160700614|NCT02450526|580284298|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
160700615|NCT02450526|580284299|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
160700616|NCT02450526|580284295|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
160700617|NCT02450526|580284296|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
160700618|NCT02450526|580284297|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
160700619|NCT02450526|580284298|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
160700620|NCT02450526|580284299|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
160700621|NCT02450526|580284295|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
160700622|NCT02450526|580284296|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
160700623|NCT02450526|580284297|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
160700624|NCT02450526|580284298|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
160700625|NCT02450526|580284299|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
160700626|NCT00911807|580284300|FG000|Overall Study|Adverse Event|2|||
160700627|NCT00911807|580284301|FG001|Overall Study|Adverse Event|1|||
160700628|NCT00911807|580284302|FG002|Overall Study|Adverse Event|5|||
160700629|NCT00911807|580284300|FG000|Overall Study|Death|0|||
160700630|NCT00911807|580284301|FG001|Overall Study|Death|0|||
160700631|NCT00911807|580284302|FG002|Overall Study|Death|1|||
160700632|NCT00911807|580284300|FG000|Overall Study|Protocol Violation|6|||
160700633|NCT00911807|580284301|FG001|Overall Study|Protocol Violation|4|||
160700634|NCT00911807|580284302|FG002|Overall Study|Protocol Violation|9|||
160700635|NCT00911807|580284300|FG000|Overall Study|Withdrawal by Subject|8|||
160700636|NCT00911807|580284301|FG001|Overall Study|Withdrawal by Subject|10|||
160700637|NCT00911807|580284302|FG002|Overall Study|Withdrawal by Subject|7|||
160700638|NCT00911807|580284300|FG000|Overall Study|Organizational reasons|1|||
160700639|NCT00911807|580284301|FG001|Overall Study|Organizational reasons|3|||
160700640|NCT00911807|580284302|FG002|Overall Study|Organizational reasons|1|||
160700641|NCT00855803|580284304|FG000|Overall Study|Death|2|||
160700642|NCT00855803|580284304|FG000|Overall Study|Lost to Follow-up|2|||
160700643|NCT00855803|580284304|FG000|Overall Study|Technical inability to undergo procedure|2|||
160700644|NCT00855803|580284304|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
160700645|NCT00855803|580284304|FG000|Overall Study|Withdrawal by Subject|3|||
160700646|NCT00855803|580284304|FG000|Overall Study|Physician Decision|3|||
160700647|NCT00809159|580284305|FG000|Part 1|Adverse Event|1|||
160700648|NCT00809159|580284306|FG001|Part 1|Adverse Event|1|||
160700649|NCT00809159|580284307|FG002|Part 1|Adverse Event|0|||
160700650|NCT00809159|580284308|FG003|Part 1|Adverse Event|0|||
160700651|NCT00809159|580284309|FG004|Part 1|Adverse Event|0|||
160700652|NCT00809159|580284310|FG005|Part 1|Adverse Event|0|||
160700653|NCT00809159|580284305|FG000|Part 1|Lost to Follow-up|1|||
160700654|NCT00809159|580284306|FG001|Part 1|Lost to Follow-up|0|||
160700655|NCT00809159|580284307|FG002|Part 1|Lost to Follow-up|0|||
160700656|NCT00809159|580284308|FG003|Part 1|Lost to Follow-up|0|||
160700657|NCT00809159|580284309|FG004|Part 1|Lost to Follow-up|0|||
160700658|NCT00809159|580284310|FG005|Part 1|Lost to Follow-up|0|||
160700659|NCT00809159|580284305|FG000|Part 1|Withdrawal by Subject|3|||
160700660|NCT00809159|580284306|FG001|Part 1|Withdrawal by Subject|1|||
160700661|NCT00809159|580284307|FG002|Part 1|Withdrawal by Subject|0|||
160700662|NCT00809159|580284308|FG003|Part 1|Withdrawal by Subject|0|||
160700663|NCT00809159|580284309|FG004|Part 1|Withdrawal by Subject|0|||
160700664|NCT00809159|580284310|FG005|Part 1|Withdrawal by Subject|0|||
160700665|NCT00809159|580284305|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
160700666|NCT00809159|580284306|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
160700667|NCT00809159|580284307|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
160700668|NCT00809159|580284308|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
160700669|NCT00809159|580284309|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
160700670|NCT00809159|580284310|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
160700671|NCT00809159|580284305|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
160700672|NCT00809159|580284306|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
160700673|NCT00809159|580284307|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
160700674|NCT00809159|580284308|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
160700675|NCT00809159|580284309|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
160700676|NCT00809159|580284310|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
160700677|NCT00809159|580284305|FG000|Part 1 and 2|Administrative problems|0|||
160700678|NCT00809159|580284306|FG001|Part 1 and 2|Administrative problems|0|||
160700679|NCT00809159|580284307|FG002|Part 1 and 2|Administrative problems|0|||
160700680|NCT00809159|580284308|FG003|Part 1 and 2|Administrative problems|1|||
160700681|NCT00809159|580284309|FG004|Part 1 and 2|Administrative problems|0|||
160700682|NCT00809159|580284310|FG005|Part 1 and 2|Administrative problems|0|||
160700683|NCT00809159|580284305|FG000|Part 1 and 2|Adverse Event|0|||
160700684|NCT00809159|580284306|FG001|Part 1 and 2|Adverse Event|0|||
160700685|NCT00809159|580284307|FG002|Part 1 and 2|Adverse Event|1|||
160700686|NCT00809159|580284308|FG003|Part 1 and 2|Adverse Event|0|||
160700687|NCT00809159|580284309|FG004|Part 1 and 2|Adverse Event|1|||
160700688|NCT00809159|580284310|FG005|Part 1 and 2|Adverse Event|1|||
160700689|NCT00809159|580284305|FG000|Part 1 and 2|Lost to Follow-up|0|||
160700690|NCT00809159|580284306|FG001|Part 1 and 2|Lost to Follow-up|0|||
160700691|NCT00809159|580284307|FG002|Part 1 and 2|Lost to Follow-up|1|||
160700692|NCT00809159|580284308|FG003|Part 1 and 2|Lost to Follow-up|1|||
160700693|NCT00809159|580284309|FG004|Part 1 and 2|Lost to Follow-up|0|||
160700694|NCT00809159|580284310|FG005|Part 1 and 2|Lost to Follow-up|0|||
160700695|NCT00809159|580284305|FG000|Part 1 and 2|Withdrawal by Subject|0|||
160700696|NCT00809159|580284306|FG001|Part 1 and 2|Withdrawal by Subject|0|||
160700697|NCT00809159|580284307|FG002|Part 1 and 2|Withdrawal by Subject|4|||
160700698|NCT00809159|580284308|FG003|Part 1 and 2|Withdrawal by Subject|0|||
160700699|NCT00809159|580284309|FG004|Part 1 and 2|Withdrawal by Subject|0|||
160700700|NCT00809159|580284310|FG005|Part 1 and 2|Withdrawal by Subject|1|||
160700701|NCT03918109|580284313|FG000|Overall Study|Withdrawal by Subject|0|||
160700702|NCT03918109|580284314|FG001|Overall Study|Withdrawal by Subject|0|||
160700703|NCT03918109|580284315|FG002|Overall Study|Withdrawal by Subject|2|||
160700704|NCT03918109|580284316|FG003|Overall Study|Withdrawal by Subject|1|||
160700705|NCT03918109|580284313|FG000|Overall Study|Lost to Follow-up|0|||
160700706|NCT03918109|580284314|FG001|Overall Study|Lost to Follow-up|0|||
160700707|NCT03918109|580284315|FG002|Overall Study|Lost to Follow-up|0|||
160700708|NCT03918109|580284316|FG003|Overall Study|Lost to Follow-up|1|||
160700709|NCT03050060|580284321|FG000|Overall Study|Adverse Event|7|||
160700710|NCT03050060|580284321|FG000|Overall Study|Withdrawal by Subject|1|||
160700711|NCT03050060|580284321|FG000|Overall Study|Progression|7|||
160700712|NCT00510289|580284322|FG000|Overall Study|Withdrawal by Subject|7|||
160700713|NCT00510289|580284322|FG000|Overall Study|Refused bone marrow biopsy|2|||
160700714|NCT00510289|580284322|FG000|Overall Study|Lost to Follow-up|1|||
160700715|NCT00510289|580284322|FG000|Overall Study|Progressed prior to starting drug|2|||
160700716|NCT00186043|580284323|FG000|Overall Study|Lack of Efficacy|1|||
160700717|NCT00186043|580284324|FG001|Overall Study|Lack of Efficacy|3|||
160700718|NCT00186043|580284323|FG000|Overall Study|Lost to Follow-up|4|||
160700719|NCT00186043|580284324|FG001|Overall Study|Lost to Follow-up|6|||
160700720|NCT00186043|580284323|FG000|Overall Study|Withdrawal by Subject|1|||
160700721|NCT00186043|580284324|FG001|Overall Study|Withdrawal by Subject|0|||
160700722|NCT00186043|580284323|FG000|Overall Study|Adverse Event|7|||
160700723|NCT00186043|580284324|FG001|Overall Study|Adverse Event|3|||
160700724|NCT00186043|580284323|FG000|Overall Study|Protocol Violation|2|||
160700725|NCT00186043|580284324|FG001|Overall Study|Protocol Violation|1|||
160700726|NCT04188301|580284327|FG000|Month 3|Lost to Follow-up|0|||
160700727|NCT04188301|580284328|FG001|Month 3|Lost to Follow-up|0|||
160700728|NCT04188301|580284329|FG002|Month 3|Lost to Follow-up|1|||
160700729|NCT04188301|580284327|FG000|Month 12|Lost to Follow-up|0|||
160700730|NCT04188301|580284328|FG001|Month 12|Lost to Follow-up|0|||
160700731|NCT04188301|580284329|FG002|Month 12|Lost to Follow-up|2|||
160700732|NCT04188301|580284327|FG000|Month 12|Death|1|||
160700733|NCT04188301|580284328|FG001|Month 12|Death|1|||
160700734|NCT04188301|580284329|FG002|Month 12|Death|0|||
160700735|NCT04188301|580284327|FG000|Month 18|Lost to Follow-up|6|||
160700736|NCT04188301|580284328|FG001|Month 18|Lost to Follow-up|0|||
160700737|NCT04188301|580284329|FG002|Month 18|Lost to Follow-up|0|||
160700738|NCT00228423|580284330|FG000|Overall Study|Adverse Event|2|||
160700739|NCT00228423|580284331|FG001|Overall Study|Adverse Event|5|||
160700740|NCT00228423|580284330|FG000|Overall Study|Withdrawal by Subject|7|||
160700741|NCT00228423|580284331|FG001|Overall Study|Withdrawal by Subject|3|||
160700742|NCT00228423|580284330|FG000|Overall Study|Protocol Violation|1|||
160700743|NCT00228423|580284331|FG001|Overall Study|Protocol Violation|3|||
160700744|NCT00228423|580284330|FG000|Overall Study|Physician Decision|0|||
160700745|NCT00228423|580284331|FG001|Overall Study|Physician Decision|1|||
160700746|NCT03258853|580284338|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
160700747|NCT03258853|580284339|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
160700748|NCT00319982|580284342|FG000|Overall Study|Withdrawal by Subject|1|||
160700749|NCT00319982|580284343|FG001|Overall Study|Withdrawal by Subject|0|||
160700750|NCT00758680|580284344|FG000|Overall Study|Adverse Event|0|||
160700751|NCT00758680|580284345|FG001|Overall Study|Adverse Event|0|||
160700752|NCT00758680|580284346|FG002|Overall Study|Adverse Event|0|||
160700753|NCT00758680|580284347|FG003|Overall Study|Adverse Event|0|||
160700754|NCT00758680|580284348|FG004|Overall Study|Adverse Event|0|||
160700755|NCT00758680|580284349|FG005|Overall Study|Adverse Event|0|||
160700756|NCT00758680|580284350|FG006|Overall Study|Adverse Event|0|||
160700757|NCT00758680|580284351|FG007|Overall Study|Adverse Event|1|||
160700758|NCT00758680|580284352|FG008|Overall Study|Adverse Event|0|||
160700759|NCT00758680|580284353|FG009|Overall Study|Adverse Event|1|||
160700760|NCT00758680|580284344|FG000|Overall Study|Laboratory Adverse Event|0|||
160700761|NCT00758680|580284345|FG001|Overall Study|Laboratory Adverse Event|0|||
160700762|NCT00758680|580284346|FG002|Overall Study|Laboratory Adverse Event|0|||
160700763|NCT00758680|580284347|FG003|Overall Study|Laboratory Adverse Event|0|||
160700764|NCT00758680|580284348|FG004|Overall Study|Laboratory Adverse Event|0|||
160700765|NCT00758680|580284349|FG005|Overall Study|Laboratory Adverse Event|0|||
160700766|NCT00758680|580284350|FG006|Overall Study|Laboratory Adverse Event|0|||
160700767|NCT00758680|580284351|FG007|Overall Study|Laboratory Adverse Event|0|||
160700768|NCT00758680|580284352|FG008|Overall Study|Laboratory Adverse Event|1|||
160700769|NCT00758680|580284353|FG009|Overall Study|Laboratory Adverse Event|0|||
160700770|NCT00758680|580284344|FG000|Overall Study|Withdrawal by Subject|0|||
160700771|NCT00758680|580284345|FG001|Overall Study|Withdrawal by Subject|0|||
160700772|NCT00758680|580284346|FG002|Overall Study|Withdrawal by Subject|0|||
160700773|NCT00758680|580284347|FG003|Overall Study|Withdrawal by Subject|0|||
160700774|NCT00758680|580284348|FG004|Overall Study|Withdrawal by Subject|0|||
160700775|NCT00758680|580284349|FG005|Overall Study|Withdrawal by Subject|0|||
160700776|NCT00758680|580284350|FG006|Overall Study|Withdrawal by Subject|1|||
160700777|NCT00758680|580284351|FG007|Overall Study|Withdrawal by Subject|0|||
160700778|NCT00758680|580284352|FG008|Overall Study|Withdrawal by Subject|1|||
160700779|NCT00758680|580284353|FG009|Overall Study|Withdrawal by Subject|0|||
160700780|NCT03480386|580284354|FG000|Overall Study|Did not complete measures at 3-months|17|||
160700781|NCT03480386|580284355|FG001|Overall Study|Did not complete measures at 3-months|14|||
160700782|NCT03480386|580284354|FG000|Overall Study|No baseline measures|11|||
160700783|NCT03480386|580284355|FG001|Overall Study|No baseline measures|14|||
160700784|NCT03480386|580284354|FG000|Overall Study|Death|0|||
160700785|NCT03480386|580284355|FG001|Overall Study|Death|5|||
160700786|NCT03480386|580284354|FG000|Overall Study|Withdrawal by Subject|12|||
160700787|NCT03480386|580284355|FG001|Overall Study|Withdrawal by Subject|8|||
160700788|NCT03480386|580284354|FG000|Overall Study|Lost to Follow-up|2|||
160700789|NCT03480386|580284355|FG001|Overall Study|Lost to Follow-up|1|||
160700790|NCT03480386|580284354|FG000|Overall Study|Complicating disease|0|||
160700791|NCT03480386|580284355|FG001|Overall Study|Complicating disease|1|||
160700792|NCT03480386|580284354|FG000|Overall Study|Disease progression|3|||
160700793|NCT03480386|580284355|FG001|Overall Study|Disease progression|0|||
160700794|NCT03480386|580284354|FG000|Overall Study|Became ineligible|0|||
160700795|NCT03480386|580284355|FG001|Overall Study|Became ineligible|2|||
160700796|NCT01555671|580286218|FG000|Overall Study|Physician Decision|20|||
160700797|NCT01555671|580286219|FG001|Overall Study|Physician Decision|25|||
160700798|NCT00631657|580286220|FG000|6-Month Treatment Period|Adverse Event|47|||
160700799|NCT00631657|580286221|FG001|6-Month Treatment Period|Adverse Event|0|||
160700800|NCT00631657|580286222|FG002|6-Month Treatment Period|Adverse Event|7|||
160700801|NCT00631657|580286220|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
160700802|NCT00631657|580286221|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
160700803|NCT00631657|580286222|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
160700804|NCT00631657|580286220|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
160700805|NCT00631657|580286221|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
160700806|NCT00631657|580286222|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
160700807|NCT00631657|580286220|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
160700808|NCT00631657|580286221|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
160700809|NCT00631657|580286222|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
160700810|NCT00631657|580286220|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
160700811|NCT00631657|580286221|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
160700812|NCT00631657|580286222|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
160700813|NCT00631657|580286220|FG000|6-Month Treatment Period|Other|16|||
160700814|NCT00631657|580286221|FG001|6-Month Treatment Period|Other|0|||
160700815|NCT00631657|580286222|FG002|6-Month Treatment Period|Other|4|||
160700816|NCT00631657|580286220|FG000|6-Month Treatment Period|Not Treated|2|||
160700817|NCT00631657|580286221|FG001|6-Month Treatment Period|Not Treated|0|||
160700818|NCT00631657|580286222|FG002|6-Month Treatment Period|Not Treated|1|||
160700819|NCT00631657|580286220|FG000|7-Day Discontinuation Period|Not Treated|1|||
160700820|NCT00631657|580286221|FG001|7-Day Discontinuation Period|Not Treated|1|||
160700821|NCT00631657|580286222|FG002|7-Day Discontinuation Period|Not Treated|1|||
160700822|NCT00631657|580286220|FG000|7-Day Discontinuation Period|Other|1|||
160700823|NCT00631657|580286221|FG001|7-Day Discontinuation Period|Other|0|||
160700824|NCT00631657|580286222|FG002|7-Day Discontinuation Period|Other|0|||
160700825|NCT03929757|580286223|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
160700826|NCT03929757|580286224|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
160700827|NCT03929757|580286225|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
160700828|NCT03929757|580286223|FG000|Main Study: Up to Day 365|Other|1|||
160700829|NCT03929757|580286224|FG001|Main Study: Up to Day 365|Other|0|||
160700830|NCT03929757|580286225|FG002|Main Study: Up to Day 365|Other|0|||
160700831|NCT03929757|580286223|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
160700832|NCT03929757|580286224|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
160700833|NCT03929757|580286225|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
160700834|NCT00686075|580286226|FG000|Overall Study|Withdrawal by Subject|4|||
160700835|NCT00686075|580286227|FG001|Overall Study|Withdrawal by Subject|3|||
160700836|NCT00686075|580286228|FG002|Overall Study|Withdrawal by Subject|3|||
160700837|NCT00686075|580286229|FG003|Overall Study|Withdrawal by Subject|7|||
160700838|NCT00686075|580286230|FG004|Overall Study|Withdrawal by Subject|1|||
160700839|NCT00686075|580286231|FG005|Overall Study|Withdrawal by Subject|0|||
160700840|NCT00686075|580286232|FG006|Overall Study|Withdrawal by Subject|0|||
160700841|NCT00686075|580286233|FG007|Overall Study|Withdrawal by Subject|2|||
160700842|NCT00686075|580286234|FG008|Overall Study|Withdrawal by Subject|4|||
160700843|NCT00686075|580286235|FG009|Overall Study|Withdrawal by Subject|6|||
160700844|NCT00686075|580286226|FG000|Overall Study|Lost to Follow-up|3|||
160700845|NCT00686075|580286227|FG001|Overall Study|Lost to Follow-up|6|||
160700846|NCT00686075|580286228|FG002|Overall Study|Lost to Follow-up|3|||
160700847|NCT00686075|580286229|FG003|Overall Study|Lost to Follow-up|2|||
160700848|NCT00686075|580286230|FG004|Overall Study|Lost to Follow-up|3|||
160700849|NCT00686075|580286231|FG005|Overall Study|Lost to Follow-up|3|||
160700850|NCT00686075|580286232|FG006|Overall Study|Lost to Follow-up|0|||
160700851|NCT00686075|580286233|FG007|Overall Study|Lost to Follow-up|0|||
160700852|NCT00686075|580286234|FG008|Overall Study|Lost to Follow-up|2|||
160700853|NCT00686075|580286235|FG009|Overall Study|Lost to Follow-up|3|||
160700854|NCT00686075|580286226|FG000|Overall Study|Other|1|||
160700855|NCT00686075|580286227|FG001|Overall Study|Other|1|||
160700856|NCT00686075|580286228|FG002|Overall Study|Other|0|||
160700857|NCT00686075|580286229|FG003|Overall Study|Other|0|||
160700858|NCT00686075|580286230|FG004|Overall Study|Other|0|||
160700859|NCT00686075|580286231|FG005|Overall Study|Other|0|||
160700860|NCT00686075|580286232|FG006|Overall Study|Other|0|||
160700861|NCT00686075|580286233|FG007|Overall Study|Other|0|||
160700862|NCT00686075|580286234|FG008|Overall Study|Other|0|||
160700863|NCT00686075|580286235|FG009|Overall Study|Other|1|||
160700864|NCT04713553|580286236|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
160700865|NCT04713553|580286237|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
160700866|NCT04713553|580286238|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
160700867|NCT04713553|580286239|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
160700868|NCT04713553|580286240|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
160700869|NCT04713553|580286241|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
160700870|NCT04713553|580286242|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
160700871|NCT04713553|580286236|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
160700872|NCT04713553|580286237|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
160700873|NCT04713553|580286238|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
160700874|NCT04713553|580286239|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
160700875|NCT04713553|580286240|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
160700876|NCT04713553|580286241|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
160700877|NCT04713553|580286242|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
160700878|NCT04713553|580286236|FG000|Primary Study (2 Months)|Other|1|||
160700879|NCT04713553|580286237|FG001|Primary Study (2 Months)|Other|2|||
160700880|NCT04713553|580286238|FG002|Primary Study (2 Months)|Other|0|||
160700881|NCT04713553|580286239|FG003|Primary Study (2 Months)|Other|0|||
160700882|NCT04713553|580286240|FG004|Primary Study (2 Months)|Other|1|||
160700883|NCT04713553|580286241|FG005|Primary Study (2 Months)|Other|0|||
160700884|NCT04713553|580286242|FG006|Primary Study (2 Months)|Other|0|||
160700885|NCT04713553|580286236|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
160700886|NCT04713553|580286237|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
160700887|NCT04713553|580286238|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
160700888|NCT04713553|580286239|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
160700889|NCT04713553|580286240|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
160700890|NCT04713553|580286241|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
160700891|NCT04713553|580286242|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
160700892|NCT04713553|580286236|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
160700893|NCT04713553|580286237|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
160700894|NCT04713553|580286238|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
160700895|NCT04713553|580286239|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
160700896|NCT04713553|580286240|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
160700897|NCT04713553|580286241|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
160700898|NCT04713553|580286242|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
160700899|NCT03783039|580286243|FG000|Overall Study|Death|2|||
160700900|NCT03783039|580286244|FG001|Overall Study|Death|1|||
160700901|NCT01119508|580286245|FG000|Overall Study|Adverse Event|56|||
160700902|NCT01119508|580286245|FG000|Overall Study|Withdrawal by Subject|2|||
160700903|NCT01119508|580286245|FG000|Overall Study|Died before tumor response evaluation|1|||
160700904|NCT03151408|580286246|FG000|Overall Study|Adverse Event|24|||
160700905|NCT03151408|580286247|FG001|Overall Study|Adverse Event|23|||
160700906|NCT03151408|580286246|FG000|Overall Study|Death|46|||
160700907|NCT03151408|580286247|FG001|Overall Study|Death|26|||
160700908|NCT03151408|580286246|FG000|Overall Study|Physician Decision|13|||
160700909|NCT03151408|580286247|FG001|Overall Study|Physician Decision|19|||
160700910|NCT03151408|580286246|FG000|Overall Study|Withdrawal by Subject|16|||
160700911|NCT03151408|580286247|FG001|Overall Study|Withdrawal by Subject|20|||
160700912|NCT03151408|580286246|FG000|Overall Study|Progressive disease|45|||
160700913|NCT03151408|580286247|FG001|Overall Study|Progressive disease|61|||
160700914|NCT03151408|580286246|FG000|Overall Study|non-compliance by patient|1|||
160700915|NCT03151408|580286247|FG001|Overall Study|non-compliance by patient|0|||
160700916|NCT03151408|580286246|FG000|Overall Study|other reasons|56|||
160700917|NCT03151408|580286247|FG001|Overall Study|other reasons|52|||
160700918|NCT03151408|580286246|FG000|Overall Study|randomized and not treated|2|||
160700919|NCT03151408|580286247|FG001|Overall Study|randomized and not treated|2|||
160700920|NCT03400943|580286250|FG000|Treatment Period 1|Adverse Event|0|||
160700921|NCT03400943|580286251|FG001|Treatment Period 1|Adverse Event|0|||
160700922|NCT03400943|580286252|FG002|Treatment Period 1|Adverse Event|0|||
160700923|NCT03400943|580286253|FG003|Treatment Period 1|Adverse Event|1|||
160700924|NCT03400943|580286250|FG000|Treatment Period 1|Lost to Follow-up|1|||
160700925|NCT03400943|580286251|FG001|Treatment Period 1|Lost to Follow-up|0|||
160700926|NCT03400943|580286252|FG002|Treatment Period 1|Lost to Follow-up|0|||
160700927|NCT03400943|580286253|FG003|Treatment Period 1|Lost to Follow-up|0|||
160700928|NCT03400943|580286250|FG000|Treatment Period 1|Protocol Violation|0|||
160700929|NCT03400943|580286251|FG001|Treatment Period 1|Protocol Violation|1|||
160700930|NCT03400943|580286252|FG002|Treatment Period 1|Protocol Violation|1|||
160700931|NCT03400943|580286253|FG003|Treatment Period 1|Protocol Violation|0|||
160700932|NCT03400943|580286250|FG000|Treatment Period 1|Study terminated by sponsor|2|||
160700933|NCT03400943|580286251|FG001|Treatment Period 1|Study terminated by sponsor|0|||
160700934|NCT03400943|580286252|FG002|Treatment Period 1|Study terminated by sponsor|0|||
160700935|NCT03400943|580286253|FG003|Treatment Period 1|Study terminated by sponsor|1|||
160700936|NCT03400943|580286250|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160700937|NCT03400943|580286251|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160700938|NCT03400943|580286252|FG002|Treatment Period 1|Withdrawal by Subject|3|||
160700939|NCT03400943|580286253|FG003|Treatment Period 1|Withdrawal by Subject|1|||
160700940|NCT03400943|580286250|FG000|Treatment Period 1|Other|2|||
160700941|NCT03400943|580286251|FG001|Treatment Period 1|Other|1|||
160700942|NCT03400943|580286252|FG002|Treatment Period 1|Other|2|||
160700943|NCT03400943|580286253|FG003|Treatment Period 1|Other|2|||
160700944|NCT03400943|580286250|FG000|Post-treatment Period 1|Adverse Event|2|||
160700945|NCT03400943|580286251|FG001|Post-treatment Period 1|Adverse Event|0|||
160700946|NCT03400943|580286252|FG002|Post-treatment Period 1|Adverse Event|0|||
160700947|NCT03400943|580286253|FG003|Post-treatment Period 1|Adverse Event|0|||
160700948|NCT03400943|580286250|FG000|Post-treatment Period 1|Protocol Violation|1|||
160700949|NCT03400943|580286251|FG001|Post-treatment Period 1|Protocol Violation|0|||
160700950|NCT03400943|580286252|FG002|Post-treatment Period 1|Protocol Violation|0|||
160700951|NCT03400943|580286253|FG003|Post-treatment Period 1|Protocol Violation|0|||
160700952|NCT03400943|580286250|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
160700953|NCT03400943|580286251|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
160700954|NCT03400943|580286252|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
160700955|NCT03400943|580286253|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
160700956|NCT03400943|580286250|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
160700957|NCT03400943|580286251|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
160700958|NCT03400943|580286252|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
160700959|NCT03400943|580286253|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
160700960|NCT03400943|580286250|FG000|Post-treatment Period 1|Other|2|||
160700961|NCT03400943|580286251|FG001|Post-treatment Period 1|Other|0|||
160700962|NCT03400943|580286252|FG002|Post-treatment Period 1|Other|4|||
160700963|NCT03400943|580286253|FG003|Post-treatment Period 1|Other|5|||
160700964|NCT03400943|580286250|FG000|Treatment Period 2|Study terminated by sponsor|0|||
160700965|NCT03400943|580286251|FG001|Treatment Period 2|Study terminated by sponsor|1|||
160700966|NCT03400943|580286252|FG002|Treatment Period 2|Study terminated by sponsor|0|||
160700967|NCT03400943|580286253|FG003|Treatment Period 2|Study terminated by sponsor|0|||
160700968|NCT03400943|580286250|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160700969|NCT03400943|580286251|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160700970|NCT03400943|580286252|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160700971|NCT03400943|580286253|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160700972|NCT03400943|580286250|FG000|Treatment Period 2|Other|1|||
160700973|NCT03400943|580286251|FG001|Treatment Period 2|Other|6|||
160700974|NCT03400943|580286252|FG002|Treatment Period 2|Other|0|||
160700975|NCT03400943|580286253|FG003|Treatment Period 2|Other|0|||
160700976|NCT03400943|580286250|FG000|Follow-up Period|Withdrawal by Subject|1|||
160700977|NCT03400943|580286251|FG001|Follow-up Period|Withdrawal by Subject|0|||
160700978|NCT03400943|580286252|FG002|Follow-up Period|Withdrawal by Subject|0|||
160700979|NCT03400943|580286253|FG003|Follow-up Period|Withdrawal by Subject|0|||
160700980|NCT02563106|580286254|FG000|Overall Study|Withdrawal by Subject|7|||
160700981|NCT02563106|580286255|FG001|Overall Study|Withdrawal by Subject|8|||
160700982|NCT02563106|580286254|FG000|Overall Study|Adverse Event|17|||
160700983|NCT02563106|580286255|FG001|Overall Study|Adverse Event|15|||
160700984|NCT02563106|580286254|FG000|Overall Study|Protocol Violation|1|||
160700985|NCT02563106|580286255|FG001|Overall Study|Protocol Violation|0|||
160700986|NCT02563106|580286254|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
160700987|NCT02563106|580286255|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
160700988|NCT02563106|580286254|FG000|Overall Study|Lost to Follow-up|3|||
160700989|NCT02563106|580286255|FG001|Overall Study|Lost to Follow-up|2|||
160700990|NCT02563106|580286254|FG000|Overall Study|Physician Decision|3|||
160700991|NCT02563106|580286255|FG001|Overall Study|Physician Decision|1|||
160700992|NCT02563106|580286254|FG000|Overall Study|Other reason - not specified|2|||
160700993|NCT02563106|580286255|FG001|Overall Study|Other reason - not specified|1|||
160700994|NCT02338193|580286256|FG000|Overall Study|Withdrawal by Subject|0|||
160700995|NCT02338193|580286257|FG001|Overall Study|Withdrawal by Subject|0|||
160700996|NCT02338193|580286258|FG002|Overall Study|Withdrawal by Subject|2|||
160700997|NCT02338193|580286256|FG000|Overall Study|Pregnancy|0|||
160700998|NCT02338193|580286257|FG001|Overall Study|Pregnancy|1|||
160700999|NCT02338193|580286258|FG002|Overall Study|Pregnancy|1|||
160701000|NCT02338193|580286256|FG000|Overall Study|Noncompliant with visits|2|||
160701001|NCT02338193|580286257|FG001|Overall Study|Noncompliant with visits|2|||
160701002|NCT02338193|580286258|FG002|Overall Study|Noncompliant with visits|7|||
160701003|NCT02338193|580286256|FG000|Overall Study|moved out of state|0|||
160701004|NCT02338193|580286257|FG001|Overall Study|moved out of state|1|||
160701005|NCT02338193|580286258|FG002|Overall Study|moved out of state|0|||
160701006|NCT02338193|580286256|FG000|Overall Study|intolerant of side effects|1|||
160701007|NCT02338193|580286257|FG001|Overall Study|intolerant of side effects|0|||
160701008|NCT02338193|580286258|FG002|Overall Study|intolerant of side effects|0|||
160701009|NCT01136967|580286262|FG000|Overall Study|Adverse Event|9|||
160701010|NCT01136967|580286263|FG001|Overall Study|Adverse Event|12|||
160701011|NCT01136967|580286262|FG000|Overall Study|Participant Choice|8|||
160701012|NCT01136967|580286263|FG001|Overall Study|Participant Choice|3|||
160701013|NCT01136967|580286262|FG000|Overall Study|Lost to Follow-up|0|||
160701014|NCT01136967|580286263|FG001|Overall Study|Lost to Follow-up|1|||
160701015|NCT01136967|580286262|FG000|Overall Study|Withdrawal by Subject|1|||
160701016|NCT01136967|580286263|FG001|Overall Study|Withdrawal by Subject|2|||
160701017|NCT01136967|580286262|FG000|Overall Study|Clinical Progression|3|||
160701018|NCT01136967|580286263|FG001|Overall Study|Clinical Progression|5|||
160701019|NCT01136967|580286262|FG000|Overall Study|Radiation|1|||
160701020|NCT01136967|580286263|FG001|Overall Study|Radiation|0|||
160701021|NCT01136967|580286262|FG000|Overall Study|Non-compliance|1|||
160701022|NCT01136967|580286263|FG001|Overall Study|Non-compliance|0|||
160701023|NCT01136967|580286262|FG000|Overall Study|Investigator's Choice|1|||
160701024|NCT01136967|580286263|FG001|Overall Study|Investigator's Choice|1|||
160701025|NCT01136967|580286262|FG000|Overall Study|Increase in Lesion Size|0|||
160701026|NCT01136967|580286263|FG001|Overall Study|Increase in Lesion Size|2|||
160701027|NCT01136967|580286262|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
160701028|NCT01136967|580286263|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
160701029|NCT03317834|580286265|FG000|Overall Study|Death|2|||
160701030|NCT03317834|580286265|FG000|Overall Study|Device Revision|5|||
160701031|NCT03317834|580286265|FG000|Overall Study|Withdrawal by Subject|13|||
160701032|NCT03317834|580286265|FG000|Overall Study|Lost to Follow-up|13|||
160701033|NCT03839823|580286269|FG000|Overall Study|Adverse Event|8|||
160701034|NCT03839823|580286270|FG001|Overall Study|Adverse Event|4|||
160701035|NCT03839823|580286269|FG000|Overall Study|Death|1|||
160701036|NCT03839823|580286270|FG001|Overall Study|Death|0|||
160701037|NCT03839823|580286269|FG000|Overall Study|Physician Decision|1|||
160701038|NCT03839823|580286270|FG001|Overall Study|Physician Decision|5|||
160701039|NCT03839823|580286269|FG000|Overall Study|Progressive Disease (PD)|65|||
160701040|NCT03839823|580286270|FG001|Overall Study|Progressive Disease (PD)|65|||
160701041|NCT03839823|580286269|FG000|Overall Study|Subject Decision|2|||
160701042|NCT03839823|580286270|FG001|Overall Study|Subject Decision|9|||
160701043|NCT03839823|580286269|FG000|Overall Study|Not Treated|0|||
160701044|NCT03839823|580286270|FG001|Overall Study|Not Treated|10|||
160701045|NCT01716715|580286271|FG000|Overall Study|Never Treated|2|||
160701046|NCT01716715|580286272|FG001|Overall Study|Never Treated|4|||
160701047|NCT04228783|580286273|FG000|Overall Study|Adverse Event|1|||
160701048|NCT04228783|580286274|FG001|Overall Study|Adverse Event|0|||
160701049|NCT04228783|580286275|FG002|Overall Study|Adverse Event|2|||
160701050|NCT04228783|580286276|FG003|Overall Study|Adverse Event|0|||
160701051|NCT04228783|580286277|FG004|Overall Study|Adverse Event|0|||
160701052|NCT04228783|580286278|FG005|Overall Study|Adverse Event|1|||
160701053|NCT04228783|580286273|FG000|Overall Study|Death|0|||
160701054|NCT04228783|580286274|FG001|Overall Study|Death|0|||
160701055|NCT04228783|580286275|FG002|Overall Study|Death|0|||
160701056|NCT04228783|580286276|FG003|Overall Study|Death|0|||
160701057|NCT04228783|580286277|FG004|Overall Study|Death|1|||
160701058|NCT04228783|580286278|FG005|Overall Study|Death|0|||
160701059|NCT04228783|580286273|FG000|Overall Study|Lost to Follow-up|36|||
160701060|NCT04228783|580286274|FG001|Overall Study|Lost to Follow-up|36|||
160701061|NCT04228783|580286275|FG002|Overall Study|Lost to Follow-up|28|||
160701062|NCT04228783|580286276|FG003|Overall Study|Lost to Follow-up|6|||
160701063|NCT04228783|580286277|FG004|Overall Study|Lost to Follow-up|14|||
160701064|NCT04228783|580286278|FG005|Overall Study|Lost to Follow-up|3|||
160701065|NCT04228783|580286273|FG000|Overall Study|Physician Decision|1|||
160701066|NCT04228783|580286274|FG001|Overall Study|Physician Decision|2|||
160701067|NCT04228783|580286275|FG002|Overall Study|Physician Decision|0|||
160701068|NCT04228783|580286276|FG003|Overall Study|Physician Decision|0|||
160701069|NCT04228783|580286277|FG004|Overall Study|Physician Decision|0|||
160701070|NCT04228783|580286278|FG005|Overall Study|Physician Decision|0|||
160701071|NCT04228783|580286273|FG000|Overall Study|Protocol Violation|0|||
160701072|NCT04228783|580286274|FG001|Overall Study|Protocol Violation|0|||
160701073|NCT04228783|580286275|FG002|Overall Study|Protocol Violation|0|||
160701074|NCT04228783|580286276|FG003|Overall Study|Protocol Violation|1|||
160701075|NCT04228783|580286277|FG004|Overall Study|Protocol Violation|0|||
160701076|NCT04228783|580286278|FG005|Overall Study|Protocol Violation|0|||
160701077|NCT04228783|580286273|FG000|Overall Study|Withdrawal by Subject|6|||
160701078|NCT04228783|580286274|FG001|Overall Study|Withdrawal by Subject|10|||
160701079|NCT04228783|580286275|FG002|Overall Study|Withdrawal by Subject|19|||
160701080|NCT04228783|580286276|FG003|Overall Study|Withdrawal by Subject|1|||
160701081|NCT04228783|580286277|FG004|Overall Study|Withdrawal by Subject|2|||
160701082|NCT04228783|580286278|FG005|Overall Study|Withdrawal by Subject|0|||
160701083|NCT04228783|580286273|FG000|Overall Study|Other|4|||
160701084|NCT04228783|580286274|FG001|Overall Study|Other|3|||
160701085|NCT04228783|580286275|FG002|Overall Study|Other|2|||
160701086|NCT04228783|580286276|FG003|Overall Study|Other|1|||
160701087|NCT04228783|580286277|FG004|Overall Study|Other|0|||
160701088|NCT04228783|580286278|FG005|Overall Study|Other|0|||
160701089|NCT03327792|580286279|FG000|Overall Study|Adverse Event|4|||
160701090|NCT03327792|580286280|FG001|Overall Study|Adverse Event|0|||
160701091|NCT03327792|580286279|FG000|Overall Study|Family/Personal issues|3|||
160701092|NCT03327792|580286280|FG001|Overall Study|Family/Personal issues|2|||
160701093|NCT03327792|580286279|FG000|Overall Study|Lost to Follow-up|0|||
160701094|NCT03327792|580286280|FG001|Overall Study|Lost to Follow-up|1|||
160701095|NCT00626392|580286281|FG000|Run-in Period|Adverse Event|0|||
160701096|NCT00626392|580286282|FG001|Run-in Period|Adverse Event|0|||
160701097|NCT00626392|580286283|FG002|Run-in Period|Adverse Event|1|||
160701098|NCT00626392|580286284|FG003|Run-in Period|Adverse Event|0|||
160701099|NCT00626392|580286285|FG004|Run-in Period|Adverse Event|1|||
160701100|NCT00626392|580286286|FG005|Run-in Period|Adverse Event|0|||
160701101|NCT00626392|580286281|FG000|Run-in Period|Withdrawal by Subject|0|||
160701102|NCT00626392|580286282|FG001|Run-in Period|Withdrawal by Subject|1|||
160701103|NCT00626392|580286283|FG002|Run-in Period|Withdrawal by Subject|1|||
160701104|NCT00626392|580286284|FG003|Run-in Period|Withdrawal by Subject|1|||
160701105|NCT00626392|580286285|FG004|Run-in Period|Withdrawal by Subject|3|||
160701106|NCT00626392|580286286|FG005|Run-in Period|Withdrawal by Subject|1|||
160701107|NCT00626392|580286281|FG000|Run-in Period|Noncompliance|1|||
160701108|NCT00626392|580286282|FG001|Run-in Period|Noncompliance|0|||
160701109|NCT00626392|580286283|FG002|Run-in Period|Noncompliance|1|||
160701110|NCT00626392|580286284|FG003|Run-in Period|Noncompliance|0|||
160701111|NCT00626392|580286285|FG004|Run-in Period|Noncompliance|0|||
160701112|NCT00626392|580286286|FG005|Run-in Period|Noncompliance|0|||
160701113|NCT00626392|580286281|FG000|Coadministration Period|Adverse Event|3|||
160701114|NCT00626392|580286282|FG001|Coadministration Period|Adverse Event|1|||
160701115|NCT00626392|580286283|FG002|Coadministration Period|Adverse Event|7|||
160701116|NCT00626392|580286284|FG003|Coadministration Period|Adverse Event|4|||
160701117|NCT00626392|580286285|FG004|Coadministration Period|Adverse Event|3|||
160701118|NCT00626392|580286286|FG005|Coadministration Period|Adverse Event|4|||
160701119|NCT00626392|580286281|FG000|Coadministration Period|Withdrawal by Subject|1|||
160701120|NCT00626392|580286282|FG001|Coadministration Period|Withdrawal by Subject|1|||
160701121|NCT00626392|580286283|FG002|Coadministration Period|Withdrawal by Subject|0|||
160701122|NCT00626392|580286284|FG003|Coadministration Period|Withdrawal by Subject|1|||
160701123|NCT00626392|580286285|FG004|Coadministration Period|Withdrawal by Subject|0|||
160701124|NCT00626392|580286286|FG005|Coadministration Period|Withdrawal by Subject|1|||
160701125|NCT00626392|580286281|FG000|Coadministration Period|Protocol Violation|0|||
160701126|NCT00626392|580286282|FG001|Coadministration Period|Protocol Violation|1|||
160701127|NCT00626392|580286283|FG002|Coadministration Period|Protocol Violation|0|||
160701128|NCT00626392|580286284|FG003|Coadministration Period|Protocol Violation|1|||
160701129|NCT00626392|580286285|FG004|Coadministration Period|Protocol Violation|1|||
160701130|NCT00626392|580286286|FG005|Coadministration Period|Protocol Violation|0|||
160701131|NCT00626392|580286281|FG000|Coadministration Period|Other|0|||
160701132|NCT00626392|580286282|FG001|Coadministration Period|Other|2|||
160701133|NCT00626392|580286283|FG002|Coadministration Period|Other|3|||
160701134|NCT00626392|580286284|FG003|Coadministration Period|Other|1|||
160701135|NCT00626392|580286285|FG004|Coadministration Period|Other|1|||
160701136|NCT00626392|580286286|FG005|Coadministration Period|Other|1|||
160701137|NCT04576923|580286287|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
160701138|NCT03151811|580286292|FG000|Overall Study|Randomized But Not Treated|18|||
160701139|NCT03151811|580286293|FG001|Overall Study|Randomized But Not Treated|3|||
160701140|NCT03151811|580286292|FG000|Overall Study|Progressive Disease|130|||
160701141|NCT03151811|580286293|FG001|Overall Study|Progressive Disease|170|||
160701142|NCT03151811|580286292|FG000|Overall Study|Adverse Event|49|||
160701143|NCT03151811|580286293|FG001|Overall Study|Adverse Event|40|||
160701144|NCT03151811|580286292|FG000|Overall Study|Lack of Efficacy|6|||
160701145|NCT03151811|580286293|FG001|Overall Study|Lack of Efficacy|8|||
160701146|NCT03151811|580286292|FG000|Overall Study|Physician Decision|21|||
160701147|NCT03151811|580286293|FG001|Overall Study|Physician Decision|9|||
160701148|NCT03151811|580286292|FG000|Overall Study|Withdrawal by Subject|17|||
160701149|NCT03151811|580286293|FG001|Overall Study|Withdrawal by Subject|7|||
160701150|NCT03151811|580286292|FG000|Overall Study|Lost to Follow-up|0|||
160701151|NCT03151811|580286293|FG001|Overall Study|Lost to Follow-up|1|||
160701152|NCT03151811|580286292|FG000|Overall Study|Study Terminated by Sponsor|5|||
160701153|NCT03151811|580286293|FG001|Overall Study|Study Terminated by Sponsor|11|||
160701154|NCT01081834|580286294|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
160701155|NCT01081834|580286295|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
160701156|NCT01081834|580286296|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
160701157|NCT01081834|580286297|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
160701158|NCT01081834|580286298|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
160701159|NCT01081834|580286294|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
160701160|NCT01081834|580286295|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
160701161|NCT01081834|580286296|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
160701162|NCT01081834|580286297|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
160701163|NCT01081834|580286298|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
160701164|NCT01081834|580286294|FG000|Core Period: Baseline to Week 26|Death|1|||
160701165|NCT01081834|580286295|FG001|Core Period: Baseline to Week 26|Death|0|||
160701166|NCT01081834|580286296|FG002|Core Period: Baseline to Week 26|Death|0|||
160701167|NCT01081834|580286297|FG003|Core Period: Baseline to Week 26|Death|0|||
160701168|NCT01081834|580286298|FG004|Core Period: Baseline to Week 26|Death|0|||
160701169|NCT01081834|580286294|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
160701170|NCT01081834|580286295|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
160701171|NCT01081834|580286296|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
160701172|NCT01081834|580286297|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
160701173|NCT01081834|580286298|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
160701174|NCT01081834|580286294|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
160701175|NCT01081834|580286295|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
160701176|NCT01081834|580286296|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
160701177|NCT01081834|580286297|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
160701178|NCT01081834|580286298|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
160701179|NCT01081834|580286294|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
160701180|NCT01081834|580286295|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
160701181|NCT01081834|580286296|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
160701182|NCT01081834|580286297|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
160701183|NCT01081834|580286298|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
160701184|NCT01081834|580286294|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
160701185|NCT01081834|580286295|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
160701186|NCT01081834|580286296|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
160701187|NCT01081834|580286297|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
160701188|NCT01081834|580286298|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
160701189|NCT01081834|580286294|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
160701190|NCT01081834|580286295|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
160701191|NCT01081834|580286296|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
160701192|NCT01081834|580286297|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
160701193|NCT01081834|580286298|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
160701194|NCT01081834|580286294|FG000|Core Period: Baseline to Week 26|Other|4|||
160701195|NCT01081834|580286295|FG001|Core Period: Baseline to Week 26|Other|4|||
160701196|NCT01081834|580286296|FG002|Core Period: Baseline to Week 26|Other|3|||
160701197|NCT01081834|580286297|FG003|Core Period: Baseline to Week 26|Other|1|||
160701198|NCT01081834|580286298|FG004|Core Period: Baseline to Week 26|Other|0|||
160701199|NCT01081834|580286294|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
160701200|NCT01081834|580286295|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
160701201|NCT01081834|580286296|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
160701202|NCT01081834|580286297|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
160701203|NCT01081834|580286298|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
160701204|NCT01081834|580286294|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
160701205|NCT01081834|580286295|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
160701206|NCT01081834|580286296|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
160701207|NCT01081834|580286297|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
160701208|NCT01081834|580286298|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
160701209|NCT01081834|580286294|FG000|Extension Period: Week 26 to Week 52|Death|1|||
160701210|NCT01081834|580286295|FG001|Extension Period: Week 26 to Week 52|Death|0|||
160701211|NCT01081834|580286296|FG002|Extension Period: Week 26 to Week 52|Death|0|||
160701212|NCT01081834|580286297|FG003|Extension Period: Week 26 to Week 52|Death|0|||
160701213|NCT01081834|580286298|FG004|Extension Period: Week 26 to Week 52|Death|0|||
160701214|NCT01081834|580286294|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
160701215|NCT01081834|580286295|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
160701216|NCT01081834|580286296|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
160701217|NCT01081834|580286297|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
160701218|NCT01081834|580286298|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
160701219|NCT01081834|580286294|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
160701220|NCT01081834|580286295|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
160701221|NCT01081834|580286296|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
160701222|NCT01081834|580286297|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
160701223|NCT01081834|580286298|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
160701224|NCT01081834|580286294|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
160701225|NCT01081834|580286295|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
160701226|NCT01081834|580286296|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
160701227|NCT01081834|580286297|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
160701228|NCT01081834|580286298|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
160701229|NCT01081834|580286294|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
160701230|NCT01081834|580286295|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
160701231|NCT01081834|580286296|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
160701232|NCT01081834|580286297|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
160701233|NCT01081834|580286298|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
160701234|NCT01081834|580286294|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
160701235|NCT01081834|580286295|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
160701236|NCT01081834|580286296|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
160701237|NCT01081834|580286297|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
160701238|NCT01081834|580286298|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
160701239|NCT01081834|580286294|FG000|Extension Period: Week 26 to Week 52|Other|4|||
160701240|NCT01081834|580286295|FG001|Extension Period: Week 26 to Week 52|Other|5|||
160701241|NCT01081834|580286296|FG002|Extension Period: Week 26 to Week 52|Other|4|||
160701242|NCT01081834|580286297|FG003|Extension Period: Week 26 to Week 52|Other|0|||
160701243|NCT01081834|580286298|FG004|Extension Period: Week 26 to Week 52|Other|0|||
160701244|NCT01081834|580286294|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
160701245|NCT01081834|580286295|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
160701246|NCT01081834|580286296|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
160701247|NCT01081834|580286297|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
160701248|NCT01081834|580286298|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
160701249|NCT01081834|580286294|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
160701250|NCT01081834|580286295|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
160701251|NCT01081834|580286296|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
160701252|NCT01081834|580286297|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
160701253|NCT01081834|580286298|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
160701254|NCT01475097|580286299|FG000|Overall Study|Protocol Violation|1|||
160701255|NCT01475097|580286300|FG001|Overall Study|Protocol Violation|1|||
160701256|NCT02045147|580286301|FG000|Overall Study|Withdrawal by Subject|2|||
160701257|NCT02045147|580286302|FG001|Overall Study|Withdrawal by Subject|0|||
160701258|NCT02045147|580286303|FG002|Overall Study|Withdrawal by Subject|0|||
160701259|NCT02045147|580286304|FG003|Overall Study|Withdrawal by Subject|0|||
160701260|NCT02045147|580286305|FG004|Overall Study|Withdrawal by Subject|0|||
160701261|NCT02045147|580286306|FG005|Overall Study|Withdrawal by Subject|0|||
160701262|NCT02045147|580286307|FG006|Overall Study|Withdrawal by Subject|0|||
160701263|NCT02045147|580286308|FG007|Overall Study|Withdrawal by Subject|1|||
160701264|NCT02045147|580286301|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
160701265|NCT02045147|580286302|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
160701266|NCT02045147|580286303|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
160701267|NCT02045147|580286304|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
160701268|NCT02045147|580286305|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
160701269|NCT02045147|580286306|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
160701270|NCT02045147|580286307|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
160701271|NCT02045147|580286308|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
160701272|NCT04839692|580286309|FG000|Overall Study|Withdrawal by Subject|0|||
160701273|NCT04839692|580286310|FG001|Overall Study|Withdrawal by Subject|3|||
160701274|NCT04839692|580286309|FG000|Overall Study|Physician Decision|1|||
160701275|NCT04839692|580286310|FG001|Overall Study|Physician Decision|0|||
160701276|NCT00049530|580286311|FG000|Overall Study|Lack of Efficacy|25|||
160701277|NCT00049530|580286311|FG000|Overall Study|Adverse Event|2|||
160701278|NCT00049530|580286311|FG000|Overall Study|Death|1|||
160701279|NCT00049530|580286311|FG000|Overall Study|symptomatic deterioration|1|||
160701280|NCT00049530|580286311|FG000|Overall Study|ineligible|3|||
160701281|NCT01305044|580286312|FG000|Overall Study|Withdrawal by Subject|3|||
160701282|NCT01305044|580286313|FG001|Overall Study|Withdrawal by Subject|6|||
160701283|NCT00492024|580286314|FG000|Treatment|Adverse Event|3|||
160701284|NCT00492024|580286315|FG001|Treatment|Adverse Event|1|||
160701285|NCT00492024|580286314|FG000|Treatment|Lack of Efficacy|21|||
160701286|NCT00492024|580286315|FG001|Treatment|Lack of Efficacy|20|||
160701287|NCT00492024|580286314|FG000|Treatment|Lost to Follow-up|3|||
160701288|NCT00492024|580286315|FG001|Treatment|Lost to Follow-up|1|||
160701289|NCT00492024|580286314|FG000|Treatment|Withdrawal by Subject|2|||
160701290|NCT00492024|580286315|FG001|Treatment|Withdrawal by Subject|0|||
160701291|NCT00492024|580286314|FG000|Follow up|Lack of Efficacy|0|||
160701292|NCT00492024|580286315|FG001|Follow up|Lack of Efficacy|1|||
160701293|NCT00492024|580286314|FG000|Follow up|Lost to Follow-up|1|||
160701294|NCT00492024|580286315|FG001|Follow up|Lost to Follow-up|1|||
160701295|NCT03247816|580286316|FG000|Overall Study|Adverse Event|12|||
160701296|NCT03247816|580286316|FG000|Overall Study|Physician Decision|3|||
160701297|NCT03247816|580286316|FG000|Overall Study|Lack of Efficacy|1|||
160701298|NCT03247816|580286316|FG000|Overall Study|Lost to Follow-up|10|||
160701299|NCT03247816|580286316|FG000|Overall Study|Missing Feraccru stop date|3|||
160701300|NCT02861014|580286319|FG000|Primary Analysis|Adverse Event|7|||
160701301|NCT02861014|580286319|FG000|Primary Analysis|Death|1|||
160701302|NCT02861014|580286319|FG000|Primary Analysis|Lack of Efficacy|3|||
160701303|NCT02861014|580286319|FG000|Primary Analysis|Physician Decision|2|||
160701304|NCT02861014|580286319|FG000|Primary Analysis|Pregnancy|4|||
160701305|NCT02861014|580286319|FG000|Primary Analysis|Protocol Violation|2|||
160701306|NCT02861014|580286319|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
160701307|NCT02861014|580286319|FG000|Primary Analysis|Withdrawal by Subject|14|||
160701308|NCT02861014|580286319|FG000|Primary Analysis|Commercial ocrelizumab|3|||
160701309|NCT02861014|580286319|FG000|Safety Follow-up|Adverse Event|1|||
160701310|NCT02861014|580286319|FG000|Safety Follow-up|Pregnancy|1|||
160701311|NCT02861014|580286319|FG000|Safety Follow-up|Withdrawal by Subject|9|||
160701312|NCT02861014|580286319|FG000|Safety Follow-up|Study terminated by sponsor|1|||
160701313|NCT02861014|580286319|FG000|Safety Follow-up|Physician Decision|1|||
160701314|NCT02861014|580286319|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
160701315|NCT02861014|580286319|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
160701316|NCT01439009|580286320|FG000|Overall Study|Physician Decision|5|||
160701317|NCT01439009|580286321|FG001|Overall Study|Physician Decision|3|||
160701318|NCT01439009|580286320|FG000|Overall Study|Protocol Violation|2|||
160701319|NCT01439009|580286321|FG001|Overall Study|Protocol Violation|0|||
160701320|NCT01439009|580286320|FG000|Overall Study|Deviation of exclusion criteria|1|||
160701321|NCT01439009|580286321|FG001|Overall Study|Deviation of exclusion criteria|0|||
160701322|NCT00926783|580286322|FG000|Overall Study|Incomplete CFAE Procedures|3|||
160701323|NCT00926783|580286323|FG001|Overall Study|Incomplete CFAE Procedures|3|||
160701324|NCT00696787|580286325|FG000|Overall Study|Adverse Event|1|||
160701325|NCT00696787|580286326|FG001|Overall Study|Adverse Event|0|||
160701326|NCT00696787|580286327|FG002|Overall Study|Adverse Event|6|||
160701327|NCT00696787|580286325|FG000|Overall Study|Discontinuation by Sponsor|9|||
160701328|NCT00696787|580286326|FG001|Overall Study|Discontinuation by Sponsor|13|||
160701329|NCT00696787|580286327|FG002|Overall Study|Discontinuation by Sponsor|14|||
160701330|NCT00696787|580286325|FG000|Overall Study|Lack of Efficacy|0|||
160701331|NCT00696787|580286326|FG001|Overall Study|Lack of Efficacy|1|||
160701332|NCT00696787|580286327|FG002|Overall Study|Lack of Efficacy|0|||
160701333|NCT00696787|580286325|FG000|Overall Study|Lost to Follow-up|4|||
160701334|NCT00696787|580286326|FG001|Overall Study|Lost to Follow-up|0|||
160701335|NCT00696787|580286327|FG002|Overall Study|Lost to Follow-up|3|||
160701336|NCT00696787|580286325|FG000|Overall Study|Withdrawal by Subject|0|||
160701337|NCT00696787|580286326|FG001|Overall Study|Withdrawal by Subject|3|||
160701338|NCT00696787|580286327|FG002|Overall Study|Withdrawal by Subject|2|||
160701339|NCT00696787|580286325|FG000|Overall Study|Failed to return|1|||
160701340|NCT00696787|580286326|FG001|Overall Study|Failed to return|3|||
160701341|NCT00696787|580286327|FG002|Overall Study|Failed to return|1|||
160701342|NCT00867503|580286329|FG000|Overall Study|Withdrawal by Subject|1|||
160701343|NCT02704403|580286330|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
160701344|NCT02704403|580286331|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
160701345|NCT02704403|580286330|FG000|Overall Study|Administrative reasons by sponsor|1251|||
160701346|NCT02704403|580286331|FG001|Overall Study|Administrative reasons by sponsor|616|||
160701347|NCT02704403|580286330|FG000|Overall Study|Death|4|||
160701348|NCT02704403|580286331|FG001|Overall Study|Death|3|||
160701349|NCT02704403|580286330|FG000|Overall Study|Endpoint event|52|||
160701350|NCT02704403|580286331|FG001|Overall Study|Endpoint event|24|||
160701351|NCT02704403|580286330|FG000|Overall Study|Lost to Follow-up|22|||
160701352|NCT02704403|580286331|FG001|Overall Study|Lost to Follow-up|11|||
160701353|NCT02704403|580286330|FG000|Overall Study|Protocol Violation|15|||
160701354|NCT02704403|580286331|FG001|Overall Study|Protocol Violation|15|||
160701355|NCT02704403|580286330|FG000|Overall Study|Adverse Event|2|||
160701356|NCT02704403|580286331|FG001|Overall Study|Adverse Event|0|||
160701357|NCT02704403|580286330|FG000|Overall Study|Withdrawal by Subject|85|||
160701358|NCT02704403|580286331|FG001|Overall Study|Withdrawal by Subject|45|||
160701359|NCT02704403|580286330|FG000|Overall Study|Investigator decision|1|||
160701360|NCT02704403|580286331|FG001|Overall Study|Investigator decision|1|||
160701361|NCT02704403|580286330|FG000|Overall Study|Follow-up not possible|1|||
160701362|NCT02704403|580286331|FG001|Overall Study|Follow-up not possible|2|||
160701363|NCT00927394|580286340|FG000|Overall Study|Adverse Event|14|||
160701364|NCT00927394|580286341|FG001|Overall Study|Adverse Event|9|||
160701365|NCT00927394|580286340|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
160701366|NCT00927394|580286341|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
160701367|NCT00927394|580286340|FG000|Overall Study|Withdrawal by Subject|20|||
160701368|NCT00927394|580286341|FG001|Overall Study|Withdrawal by Subject|24|||
160701369|NCT00927394|580286340|FG000|Overall Study|Lost to Follow-up|8|||
160701370|NCT00927394|580286341|FG001|Overall Study|Lost to Follow-up|14|||
160701371|NCT00927394|580286340|FG000|Overall Study|Administrative Problem|1|||
160701372|NCT00927394|580286341|FG001|Overall Study|Administrative Problem|0|||
160701373|NCT00927394|580286340|FG000|Overall Study|Death|1|||
160701374|NCT00927394|580286341|FG001|Overall Study|Death|1|||
160701375|NCT00927394|580286340|FG000|Overall Study|Protocol deviation|16|||
160701376|NCT00927394|580286341|FG001|Overall Study|Protocol deviation|13|||
160701377|NCT00927394|580286340|FG000|Overall Study|Randomized in error|0|||
160701378|NCT00927394|580286341|FG001|Overall Study|Randomized in error|1|||
160701379|NCT04623086|580286342|FG000|Overall Study|Withdrawal by Subject|0|||
160701380|NCT04623086|580286343|FG001|Overall Study|Withdrawal by Subject|0|||
160701381|NCT04623086|580286344|FG002|Overall Study|Withdrawal by Subject|10|||
160701382|NCT03464630|580286345|FG000|Overall Study|Lost to Follow-up|62|||
160701383|NCT03464630|580286346|FG001|Overall Study|Lost to Follow-up|52|||
160701384|NCT03464630|580286345|FG000|Overall Study|Withdrawal by Subject|16|||
160701385|NCT03464630|580286346|FG001|Overall Study|Withdrawal by Subject|10|||
160701386|NCT03464630|580286345|FG000|Overall Study|Passive Disengagement|8|||
160701387|NCT03464630|580286346|FG001|Overall Study|Passive Disengagement|4|||
160701388|NCT00715624|580286347|FG000|Overall Study|Adverse Event|12|||
160701389|NCT00715624|580286348|FG001|Overall Study|Adverse Event|37|||
160701390|NCT00715624|580286347|FG000|Overall Study|Lack of Efficacy|11|||
160701391|NCT00715624|580286348|FG001|Overall Study|Lack of Efficacy|11|||
160701392|NCT00715624|580286347|FG000|Overall Study|Lost to Follow-up|1|||
160701393|NCT00715624|580286348|FG001|Overall Study|Lost to Follow-up|2|||
160701394|NCT00715624|580286347|FG000|Overall Study|Protocol Violation|1|||
160701395|NCT00715624|580286348|FG001|Overall Study|Protocol Violation|0|||
160701396|NCT00715624|580286347|FG000|Overall Study|Withdrawal by Subject|11|||
160701397|NCT00715624|580286348|FG001|Overall Study|Withdrawal by Subject|25|||
160701398|NCT00715624|580286347|FG000|Overall Study|Familial and personal reasons|10|||
160701399|NCT00715624|580286348|FG001|Overall Study|Familial and personal reasons|22|||
160701400|NCT00715624|580286347|FG000|Overall Study|Poor compliance|6|||
160701401|NCT00715624|580286348|FG001|Overall Study|Poor compliance|13|||
160701402|NCT00715624|580286347|FG000|Overall Study|Sponsor decision|0|||
160701403|NCT00715624|580286348|FG001|Overall Study|Sponsor decision|4|||
160701404|NCT00715624|580286347|FG000|Overall Study|Incorrect randomization (not treated)|0|||
160701405|NCT00715624|580286348|FG001|Overall Study|Incorrect randomization (not treated)|1|||
160701406|NCT00715624|580286347|FG000|Overall Study|Other|0|||
160701407|NCT00715624|580286348|FG001|Overall Study|Other|1|||
160701408|NCT04524364|580286352|FG000|Overall Study|Physician Decision|3|||
160701409|NCT04524364|580286353|FG001|Overall Study|Physician Decision|6|||
160701410|NCT04524364|580286352|FG000|Overall Study|Adverse Event|0|||
160701411|NCT04524364|580286353|FG001|Overall Study|Adverse Event|1|||
160701412|NCT04524364|580286352|FG000|Overall Study|Investigational device deficiency|0|||
160701413|NCT04524364|580286353|FG001|Overall Study|Investigational device deficiency|1|||
160701414|NCT04524364|580286352|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
160701415|NCT04524364|580286353|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
160701416|NCT04524364|580286352|FG000|Overall Study|Device unavailability|0|||
160701417|NCT04524364|580286353|FG001|Overall Study|Device unavailability|2|||
160701418|NCT04524364|580286352|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
160701419|NCT04524364|580286353|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
160701420|NCT04524364|580286352|FG000|Overall Study|Low International normalized ratio (INR)|1|||
160701421|NCT04524364|580286353|FG001|Overall Study|Low International normalized ratio (INR)|0|||
160701422|NCT00229723|580286354|FG000|Concomitant Phase|Adverse Event|4|||
160701423|NCT00229723|580286355|FG001|Concomitant Phase|Adverse Event|2|||
160701424|NCT00229723|580286356|FG002|Concomitant Phase|Adverse Event|5|||
160701425|NCT00229723|580286357|FG003|Concomitant Phase|Adverse Event|2|||
160701426|NCT00229723|580286358|FG004|Concomitant Phase|Adverse Event|0|||
160701427|NCT00229723|580286359|FG005|Concomitant Phase|Adverse Event|1|||
160701428|NCT00229723|580286360|FG006|Concomitant Phase|Adverse Event|2|||
160701429|NCT00229723|580286354|FG000|Concomitant Phase|Objective disease progression|0|||
160701430|NCT00229723|580286355|FG001|Concomitant Phase|Objective disease progression|0|||
160701431|NCT00229723|580286356|FG002|Concomitant Phase|Objective disease progression|0|||
160701432|NCT00229723|580286357|FG003|Concomitant Phase|Objective disease progression|0|||
160701433|NCT00229723|580286358|FG004|Concomitant Phase|Objective disease progression|0|||
160701434|NCT00229723|580286359|FG005|Concomitant Phase|Objective disease progression|0|||
160701435|NCT00229723|580286360|FG006|Concomitant Phase|Objective disease progression|0|||
160701436|NCT00229723|580286354|FG000|Concomitant Phase|Clinical progression|0|||
160701437|NCT00229723|580286355|FG001|Concomitant Phase|Clinical progression|0|||
160701438|NCT00229723|580286356|FG002|Concomitant Phase|Clinical progression|0|||
160701439|NCT00229723|580286357|FG003|Concomitant Phase|Clinical progression|0|||
160701440|NCT00229723|580286358|FG004|Concomitant Phase|Clinical progression|0|||
160701441|NCT00229723|580286359|FG005|Concomitant Phase|Clinical progression|0|||
160701442|NCT00229723|580286360|FG006|Concomitant Phase|Clinical progression|1|||
160701443|NCT00229723|580286354|FG000|Concomitant Phase|Lost to Follow-up|0|||
160701444|NCT00229723|580286355|FG001|Concomitant Phase|Lost to Follow-up|0|||
160701445|NCT00229723|580286356|FG002|Concomitant Phase|Lost to Follow-up|0|||
160701446|NCT00229723|580286357|FG003|Concomitant Phase|Lost to Follow-up|0|||
160701447|NCT00229723|580286358|FG004|Concomitant Phase|Lost to Follow-up|1|||
160701448|NCT00229723|580286359|FG005|Concomitant Phase|Lost to Follow-up|0|||
160701449|NCT00229723|580286360|FG006|Concomitant Phase|Lost to Follow-up|0|||
160701450|NCT00229723|580286354|FG000|Concomitant Phase|Informed consent withdrawn|3|||
160701451|NCT00229723|580286355|FG001|Concomitant Phase|Informed consent withdrawn|2|||
160701452|NCT00229723|580286356|FG002|Concomitant Phase|Informed consent withdrawn|0|||
160701453|NCT00229723|580286357|FG003|Concomitant Phase|Informed consent withdrawn|2|||
160701454|NCT00229723|580286358|FG004|Concomitant Phase|Informed consent withdrawn|0|||
160701455|NCT00229723|580286359|FG005|Concomitant Phase|Informed consent withdrawn|0|||
160701456|NCT00229723|580286360|FG006|Concomitant Phase|Informed consent withdrawn|0|||
160701457|NCT00229723|580286354|FG000|Concomitant Phase|Severe non-compliance|0|||
160701458|NCT00229723|580286355|FG001|Concomitant Phase|Severe non-compliance|1|||
160701459|NCT00229723|580286356|FG002|Concomitant Phase|Severe non-compliance|0|||
160701460|NCT00229723|580286357|FG003|Concomitant Phase|Severe non-compliance|0|||
160701461|NCT00229723|580286358|FG004|Concomitant Phase|Severe non-compliance|1|||
160701462|NCT00229723|580286359|FG005|Concomitant Phase|Severe non-compliance|0|||
160701463|NCT00229723|580286360|FG006|Concomitant Phase|Severe non-compliance|0|||
160701464|NCT00229723|580286354|FG000|Concomitant Phase|Other|3|||
160701465|NCT00229723|580286355|FG001|Concomitant Phase|Other|0|||
160701466|NCT00229723|580286356|FG002|Concomitant Phase|Other|1|||
160701467|NCT00229723|580286357|FG003|Concomitant Phase|Other|1|||
160701468|NCT00229723|580286358|FG004|Concomitant Phase|Other|0|||
160701469|NCT00229723|580286359|FG005|Concomitant Phase|Other|2|||
160701470|NCT00229723|580286360|FG006|Concomitant Phase|Other|0|||
160701471|NCT00229723|580286354|FG000|Maintenance Phase|Adverse Event|7|||
160701472|NCT00229723|580286355|FG001|Maintenance Phase|Adverse Event|2|||
160701473|NCT00229723|580286356|FG002|Maintenance Phase|Adverse Event|1|||
160701474|NCT00229723|580286357|FG003|Maintenance Phase|Adverse Event|4|||
160701475|NCT00229723|580286358|FG004|Maintenance Phase|Adverse Event|7|||
160701476|NCT00229723|580286359|FG005|Maintenance Phase|Adverse Event|5|||
160701477|NCT00229723|580286360|FG006|Maintenance Phase|Adverse Event|2|||
160701478|NCT00229723|580286354|FG000|Maintenance Phase|Objective disease progression|5|||
160701479|NCT00229723|580286355|FG001|Maintenance Phase|Objective disease progression|5|||
160701480|NCT00229723|580286356|FG002|Maintenance Phase|Objective disease progression|3|||
160701481|NCT00229723|580286357|FG003|Maintenance Phase|Objective disease progression|6|||
160701482|NCT00229723|580286358|FG004|Maintenance Phase|Objective disease progression|2|||
160701483|NCT00229723|580286359|FG005|Maintenance Phase|Objective disease progression|9|||
160701484|NCT00229723|580286360|FG006|Maintenance Phase|Objective disease progression|5|||
160701485|NCT00229723|580286354|FG000|Maintenance Phase|Clinical progression|4|||
160701486|NCT00229723|580286355|FG001|Maintenance Phase|Clinical progression|1|||
160701487|NCT00229723|580286356|FG002|Maintenance Phase|Clinical progression|2|||
160701488|NCT00229723|580286357|FG003|Maintenance Phase|Clinical progression|2|||
160701489|NCT00229723|580286358|FG004|Maintenance Phase|Clinical progression|1|||
160701490|NCT00229723|580286359|FG005|Maintenance Phase|Clinical progression|1|||
160701491|NCT00229723|580286360|FG006|Maintenance Phase|Clinical progression|1|||
160701492|NCT00229723|580286354|FG000|Maintenance Phase|Lost to Follow-up|0|||
160701493|NCT00229723|580286355|FG001|Maintenance Phase|Lost to Follow-up|1|||
160701494|NCT00229723|580286356|FG002|Maintenance Phase|Lost to Follow-up|2|||
160701495|NCT00229723|580286357|FG003|Maintenance Phase|Lost to Follow-up|2|||
160701496|NCT00229723|580286358|FG004|Maintenance Phase|Lost to Follow-up|0|||
160701497|NCT00229723|580286359|FG005|Maintenance Phase|Lost to Follow-up|0|||
160701498|NCT00229723|580286360|FG006|Maintenance Phase|Lost to Follow-up|1|||
160701499|NCT00229723|580286354|FG000|Maintenance Phase|Informed consent withdrawn|1|||
160701500|NCT00229723|580286355|FG001|Maintenance Phase|Informed consent withdrawn|0|||
160701501|NCT00229723|580286356|FG002|Maintenance Phase|Informed consent withdrawn|0|||
160701502|NCT00229723|580286357|FG003|Maintenance Phase|Informed consent withdrawn|1|||
160701503|NCT00229723|580286358|FG004|Maintenance Phase|Informed consent withdrawn|1|||
160701504|NCT00229723|580286359|FG005|Maintenance Phase|Informed consent withdrawn|1|||
160701505|NCT00229723|580286360|FG006|Maintenance Phase|Informed consent withdrawn|0|||
160701506|NCT00229723|580286354|FG000|Maintenance Phase|Severe non-compliance|3|||
160701507|NCT00229723|580286355|FG001|Maintenance Phase|Severe non-compliance|1|||
160701508|NCT00229723|580286356|FG002|Maintenance Phase|Severe non-compliance|0|||
160701509|NCT00229723|580286357|FG003|Maintenance Phase|Severe non-compliance|0|||
160701510|NCT00229723|580286358|FG004|Maintenance Phase|Severe non-compliance|1|||
160701511|NCT00229723|580286359|FG005|Maintenance Phase|Severe non-compliance|0|||
160701512|NCT00229723|580286360|FG006|Maintenance Phase|Severe non-compliance|0|||
160701513|NCT00229723|580286354|FG000|Maintenance Phase|Other|5|||
160701514|NCT00229723|580286355|FG001|Maintenance Phase|Other|4|||
160701515|NCT00229723|580286356|FG002|Maintenance Phase|Other|1|||
160701516|NCT00229723|580286357|FG003|Maintenance Phase|Other|2|||
160701517|NCT00229723|580286358|FG004|Maintenance Phase|Other|3|||
160701518|NCT00229723|580286359|FG005|Maintenance Phase|Other|3|||
160701519|NCT00229723|580286360|FG006|Maintenance Phase|Other|1|||
160701520|NCT02309138|580286361|FG000|Overall Study|Withdrawal by Subject|44|||
160701521|NCT02309138|580286362|FG001|Overall Study|Withdrawal by Subject|15|||
160701522|NCT02309138|580286361|FG000|Overall Study|Protocol Violation|4|||
160701523|NCT02309138|580286362|FG001|Overall Study|Protocol Violation|2|||
160701524|NCT02309138|580286361|FG000|Overall Study|delivered before visit 2|0|||
160701525|NCT02309138|580286362|FG001|Overall Study|delivered before visit 2|1|||
160701526|NCT00735397|580286368|FG000|Overall Study|Adverse Event|194|||
160701527|NCT00735397|580286368|FG000|Overall Study|Lost to Follow-up|33|||
160701528|NCT00735397|580286368|FG000|Overall Study|Participant choice|252|||
160701529|NCT00735397|580286368|FG000|Overall Study|Inadequate therapeutic effect|202|||
160701530|NCT00735397|580286368|FG000|Overall Study|Administrative/Other|502|||
160701531|NCT00380744|580286369|FG000|Overall Study|Death|0|||
160701532|NCT00380744|580286370|FG001|Overall Study|Death|0|||
160701533|NCT00380744|580286371|FG002|Overall Study|Death|0|||
160701534|NCT00380744|580286372|FG003|Overall Study|Death|0|||
160701535|NCT00380744|580286373|FG004|Overall Study|Death|0|||
160701536|NCT00380744|580286374|FG005|Overall Study|Death|0|||
160701537|NCT00380744|580286375|FG006|Overall Study|Death|1|||
160701538|NCT00380744|580286369|FG000|Overall Study|Withdrawal by Subject|1|||
160701539|NCT00380744|580286370|FG001|Overall Study|Withdrawal by Subject|0|||
160701540|NCT00380744|580286371|FG002|Overall Study|Withdrawal by Subject|0|||
160701541|NCT00380744|580286372|FG003|Overall Study|Withdrawal by Subject|0|||
160701542|NCT00380744|580286373|FG004|Overall Study|Withdrawal by Subject|0|||
160701543|NCT00380744|580286374|FG005|Overall Study|Withdrawal by Subject|0|||
160701544|NCT00380744|580286375|FG006|Overall Study|Withdrawal by Subject|0|||
160701545|NCT04546724|580286376|FG000|Overall Study|Withdrawal by Subject|145|||
160701546|NCT04546724|580286377|FG001|Overall Study|Withdrawal by Subject|41|||
160701547|NCT04546724|580286376|FG000|Overall Study|Adverse Event|1|||
160701548|NCT04546724|580286377|FG001|Overall Study|Adverse Event|1|||
160701549|NCT04546724|580286376|FG000|Overall Study|Lost to Follow-up|186|||
160701550|NCT04546724|580286377|FG001|Overall Study|Lost to Follow-up|63|||
160701551|NCT04546724|580286376|FG000|Overall Study|Physician Decision|8|||
160701552|NCT04546724|580286377|FG001|Overall Study|Physician Decision|2|||
160701553|NCT04546724|580286376|FG000|Overall Study|Death|2|||
160701554|NCT04546724|580286377|FG001|Overall Study|Death|1|||
160701555|NCT04546724|580286376|FG000|Overall Study|subject has been out of town|1|||
160701556|NCT04546724|580286377|FG001|Overall Study|subject has been out of town|0|||
160701557|NCT04546724|580286376|FG000|Overall Study|subject is incarcerated|2|||
160701558|NCT04546724|580286377|FG001|Overall Study|subject is incarcerated|0|||
160701559|NCT04546724|580286376|FG000|Overall Study|subject is relocating|12|||
160701560|NCT04546724|580286377|FG001|Overall Study|subject is relocating|4|||
160701561|NCT04546724|580286376|FG000|Overall Study|Subject in another study|1|||
160701562|NCT04546724|580286377|FG001|Overall Study|Subject in another study|1|||
160701563|NCT01228019|580286378|FG000|Overall Study|Dose Violation|70|||
160701564|NCT01228019|580286378|FG000|Overall Study|Duplicate enrollment|1|||
160701565|NCT01228019|580286378|FG000|Overall Study|Missing pre-treatment data|72|||
160701566|NCT01228019|580286378|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
160701567|NCT01228019|580286378|FG000|Overall Study|Violation of Entry Criterion|9|||
160701568|NCT00128830|580286381|FG000|Overall Study|Adverse Event|10|||
160701569|NCT00128830|580286381|FG000|Overall Study|Withdrawal by Subject|14|||
160701570|NCT00128830|580286381|FG000|Overall Study|Lost to Follow-up|4|||
160701571|NCT00128830|580286381|FG000|Overall Study|Reached a virologic endpoint|29|||
160701572|NCT00128830|580286381|FG000|Overall Study|Non-compliant|4|||
160701573|NCT00128830|580286381|FG000|Overall Study|Discontinued or ineligible for study|2|||
160701574|NCT00128830|580286381|FG000|Overall Study|Other|9|||
160701575|NCT02730351|580286382|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
160701576|NCT02730351|580286383|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
160701577|NCT02730351|580286382|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
160701578|NCT02730351|580286383|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
160701579|NCT02730351|580286382|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
160701580|NCT02730351|580286383|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
160701581|NCT02730351|580286382|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
160701582|NCT02730351|580286383|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
160701583|NCT02730351|580286382|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
160701584|NCT02730351|580286383|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
160701585|NCT00311402|580286384|FG000|Overall Study|Adverse Event|118|||
160701586|NCT00311402|580286385|FG001|Overall Study|Adverse Event|105|||
160701587|NCT00311402|580286384|FG000|Overall Study|Lost to Follow-up|0|||
160701588|NCT00311402|580286385|FG001|Overall Study|Lost to Follow-up|3|||
160701589|NCT00311402|580286384|FG000|Overall Study|Withdrawal by Subject|17|||
160701590|NCT00311402|580286385|FG001|Overall Study|Withdrawal by Subject|18|||
160701591|NCT00311402|580286384|FG000|Overall Study|Lack of Efficacy|58|||
160701592|NCT00311402|580286385|FG001|Overall Study|Lack of Efficacy|42|||
160701593|NCT00311402|580286384|FG000|Overall Study|Protocol Violation|7|||
160701594|NCT00311402|580286385|FG001|Overall Study|Protocol Violation|6|||
160701595|NCT00311402|580286384|FG000|Overall Study|IRB's rejection etc.|10|||
160701596|NCT00311402|580286385|FG001|Overall Study|IRB's rejection etc.|3|||
160701597|NCT05330468|580286386|FG000|Overall Study|Death|6|||
160701598|NCT05330468|580286386|FG000|Overall Study|Withdrawal by Subject|4|||
160701599|NCT05330468|580286386|FG000|Overall Study|Lost to Follow-up|4|||
160701600|NCT02828241|580286391|FG000|Overall Study|Adverse Event|7|||
160701601|NCT02828241|580286392|FG001|Overall Study|Adverse Event|2|||
160701602|NCT02828241|580286391|FG000|Overall Study|Protocol Violation|1|||
160701603|NCT02828241|580286392|FG001|Overall Study|Protocol Violation|0|||
160701604|NCT01372774|580286400|FG000|Overall Study|Withdrawal prior to treatment|4|||
160701605|NCT01372774|580286401|FG001|Overall Study|Withdrawal prior to treatment|5|||
160701606|NCT04241315|580288016|FG000|Overall Study|Withdrawal by Subject|0|||
160701607|NCT04241315|580288017|FG001|Overall Study|Withdrawal by Subject|1|||
160701608|NCT03047330|580288019|FG000|Sleep Block 1|Withdrawal by Subject|3|||
160701609|NCT00663026|580288026|FG000|Overall Study|Lost to Follow-up|1|||
160701610|NCT00663026|580288027|FG001|Overall Study|Lost to Follow-up|0|||
160701611|NCT00663026|580288028|FG002|Overall Study|Lost to Follow-up|0|||
160701612|NCT00663026|580288026|FG000|Overall Study|Other|1|||
160701613|NCT00663026|580288027|FG001|Overall Study|Other|2|||
160701614|NCT00663026|580288028|FG002|Overall Study|Other|0|||
160701615|NCT00663026|580288026|FG000|Overall Study|Adverse Event|0|||
160701616|NCT00663026|580288027|FG001|Overall Study|Adverse Event|2|||
160701617|NCT00663026|580288028|FG002|Overall Study|Adverse Event|3|||
160701618|NCT00663026|580288026|FG000|Overall Study|Caregiver Request|0|||
160701619|NCT00663026|580288027|FG001|Overall Study|Caregiver Request|2|||
160701620|NCT00663026|580288028|FG002|Overall Study|Caregiver Request|0|||
160701621|NCT00663026|580288026|FG000|Overall Study|Withdrawal by Subject|0|||
160701622|NCT00663026|580288027|FG001|Overall Study|Withdrawal by Subject|0|||
160701623|NCT00663026|580288028|FG002|Overall Study|Withdrawal by Subject|1|||
160701624|NCT01392963|580288032|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
160701625|NCT01392963|580288033|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
160701626|NCT01392963|580288032|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
160701627|NCT01392963|580288033|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
160701628|NCT01392963|580288032|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
160701629|NCT01392963|580288033|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
160701630|NCT02152605|580288038|FG000|Overall Study|Adverse Event|6|||
160701631|NCT02152605|580288039|FG001|Overall Study|Adverse Event|8|||
160701632|NCT02152605|580288038|FG000|Overall Study|Lack of Efficacy|7|||
160701633|NCT02152605|580288039|FG001|Overall Study|Lack of Efficacy|4|||
160701634|NCT02152605|580288038|FG000|Overall Study|Protocol deviation|1|||
160701635|NCT02152605|580288039|FG001|Overall Study|Protocol deviation|4|||
160701636|NCT02152605|580288038|FG000|Overall Study|Lost to Follow-up|1|||
160701637|NCT02152605|580288039|FG001|Overall Study|Lost to Follow-up|0|||
160701638|NCT02152605|580288038|FG000|Overall Study|Withdrew consent|4|||
160701639|NCT02152605|580288039|FG001|Overall Study|Withdrew consent|2|||
160701640|NCT01735955|580288040|FG000|Overall Study|Administrative problems|1|||
160701641|NCT01735955|580288040|FG000|Overall Study|Patient/guardian decision|1|||
160701642|NCT01735955|580288040|FG000|Overall Study|Patient withdrew consent|2|||
160701643|NCT01735955|580288040|FG000|Overall Study|Physician Decision|4|||
160701644|NCT01735955|580288040|FG000|Overall Study|Disease progression|24|||
160701645|NCT01735955|580288040|FG000|Overall Study|Adverse Event|5|||
160701646|NCT01724489|580288041|FG000|Overall Study|Adverse Event|8|||
160701647|NCT01724489|580288042|FG001|Overall Study|Adverse Event|3|||
160701648|NCT01724489|580288041|FG000|Overall Study|Surgery, medication|1|||
160701649|NCT01724489|580288042|FG001|Overall Study|Surgery, medication|1|||
160701650|NCT01724489|580288041|FG000|Overall Study|Lost to Follow-up|1|||
160701651|NCT01724489|580288042|FG001|Overall Study|Lost to Follow-up|2|||
160701652|NCT01724489|580288041|FG000|Overall Study|Withdrawal by Subject|6|||
160701653|NCT01724489|580288042|FG001|Overall Study|Withdrawal by Subject|6|||
160701654|NCT01544179|580288043|FG000|Overall Study|Death|50|||
160701655|NCT01544179|580288044|FG001|Overall Study|Death|37|||
160701656|NCT01544179|580288043|FG000|Overall Study|Lost to Follow-up|0|||
160701657|NCT01544179|580288044|FG001|Overall Study|Lost to Follow-up|1|||
160701658|NCT01544179|580288043|FG000|Overall Study|Adverse Event|0|||
160701659|NCT01544179|580288044|FG001|Overall Study|Adverse Event|1|||
160701660|NCT01544179|580288043|FG000|Overall Study|Withdrawal by Subject|12|||
160701661|NCT01544179|580288044|FG001|Overall Study|Withdrawal by Subject|7|||
160701662|NCT01544179|580288043|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
160701663|NCT01544179|580288044|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160701664|NCT03146962|580288045|FG000|Overall Study|Lost to Follow-up|1|||
160701665|NCT03146962|580288046|FG001|Overall Study|Lost to Follow-up|1|||
160701666|NCT03146962|580288047|FG002|Overall Study|Lost to Follow-up|0|||
160701667|NCT03146962|580288048|FG003|Overall Study|Lost to Follow-up|0|||
160701668|NCT03146962|580288049|FG004|Overall Study|Lost to Follow-up|0|||
160701669|NCT03146962|580288050|FG005|Overall Study|Lost to Follow-up|0|||
160701670|NCT03146962|580288051|FG006|Overall Study|Lost to Follow-up|0|||
160701671|NCT03146962|580288052|FG007|Overall Study|Lost to Follow-up|0|||
160701672|NCT03146962|580288053|FG008|Overall Study|Lost to Follow-up|0|||
160701673|NCT03146962|580288054|FG009|Overall Study|Lost to Follow-up|0|||
160701674|NCT03146962|580288045|FG000|Overall Study|Adverse Event|0|||
160701675|NCT03146962|580288046|FG001|Overall Study|Adverse Event|3|||
160701676|NCT03146962|580288047|FG002|Overall Study|Adverse Event|0|||
160701677|NCT03146962|580288048|FG003|Overall Study|Adverse Event|0|||
160701678|NCT03146962|580288049|FG004|Overall Study|Adverse Event|0|||
160701679|NCT03146962|580288050|FG005|Overall Study|Adverse Event|0|||
160701680|NCT03146962|580288051|FG006|Overall Study|Adverse Event|0|||
160701681|NCT03146962|580288052|FG007|Overall Study|Adverse Event|1|||
160701682|NCT03146962|580288053|FG008|Overall Study|Adverse Event|0|||
160701683|NCT03146962|580288054|FG009|Overall Study|Adverse Event|0|||
160701684|NCT03146962|580288045|FG000|Overall Study|Withdrawal by Subject|0|||
160701685|NCT03146962|580288046|FG001|Overall Study|Withdrawal by Subject|0|||
160701686|NCT03146962|580288047|FG002|Overall Study|Withdrawal by Subject|0|||
160701687|NCT03146962|580288048|FG003|Overall Study|Withdrawal by Subject|0|||
160701688|NCT03146962|580288049|FG004|Overall Study|Withdrawal by Subject|1|||
160701689|NCT03146962|580288050|FG005|Overall Study|Withdrawal by Subject|0|||
160701690|NCT03146962|580288051|FG006|Overall Study|Withdrawal by Subject|0|||
160701691|NCT03146962|580288052|FG007|Overall Study|Withdrawal by Subject|0|||
160701692|NCT03146962|580288053|FG008|Overall Study|Withdrawal by Subject|0|||
160701693|NCT03146962|580288054|FG009|Overall Study|Withdrawal by Subject|0|||
160701694|NCT03146962|580288045|FG000|Overall Study|Death|0|||
160701695|NCT03146962|580288046|FG001|Overall Study|Death|1|||
160701696|NCT03146962|580288047|FG002|Overall Study|Death|0|||
160701697|NCT03146962|580288048|FG003|Overall Study|Death|0|||
160701698|NCT03146962|580288049|FG004|Overall Study|Death|0|||
160701699|NCT03146962|580288050|FG005|Overall Study|Death|0|||
160701700|NCT03146962|580288051|FG006|Overall Study|Death|0|||
160701701|NCT03146962|580288052|FG007|Overall Study|Death|0|||
160701702|NCT03146962|580288053|FG008|Overall Study|Death|0|||
160701703|NCT03146962|580288054|FG009|Overall Study|Death|0|||
160701704|NCT03146962|580288045|FG000|Overall Study|COVID Precautions|1|||
160701705|NCT03146962|580288046|FG001|Overall Study|COVID Precautions|0|||
160701706|NCT03146962|580288047|FG002|Overall Study|COVID Precautions|0|||
160701707|NCT03146962|580288048|FG003|Overall Study|COVID Precautions|0|||
160701708|NCT03146962|580288049|FG004|Overall Study|COVID Precautions|0|||
160701709|NCT03146962|580288050|FG005|Overall Study|COVID Precautions|0|||
160701710|NCT03146962|580288051|FG006|Overall Study|COVID Precautions|0|||
160701711|NCT03146962|580288052|FG007|Overall Study|COVID Precautions|0|||
160701712|NCT03146962|580288053|FG008|Overall Study|COVID Precautions|0|||
160701713|NCT03146962|580288054|FG009|Overall Study|COVID Precautions|0|||
160701714|NCT03146962|580288045|FG000|Overall Study|Physician Decision|0|||
160701715|NCT03146962|580288046|FG001|Overall Study|Physician Decision|0|||
160701716|NCT03146962|580288047|FG002|Overall Study|Physician Decision|0|||
160701717|NCT03146962|580288048|FG003|Overall Study|Physician Decision|0|||
160701718|NCT03146962|580288049|FG004|Overall Study|Physician Decision|0|||
160701719|NCT03146962|580288050|FG005|Overall Study|Physician Decision|0|||
160701720|NCT03146962|580288051|FG006|Overall Study|Physician Decision|0|||
160701721|NCT03146962|580288052|FG007|Overall Study|Physician Decision|0|||
160701722|NCT03146962|580288053|FG008|Overall Study|Physician Decision|0|||
160701723|NCT03146962|580288054|FG009|Overall Study|Physician Decision|1|||
160701724|NCT03146962|580288045|FG000|Overall Study|Started New Treatment|0|||
160701725|NCT03146962|580288046|FG001|Overall Study|Started New Treatment|1|||
160701726|NCT03146962|580288047|FG002|Overall Study|Started New Treatment|0|||
160701727|NCT03146962|580288048|FG003|Overall Study|Started New Treatment|0|||
160701728|NCT03146962|580288049|FG004|Overall Study|Started New Treatment|0|||
160701729|NCT03146962|580288050|FG005|Overall Study|Started New Treatment|0|||
160701730|NCT03146962|580288051|FG006|Overall Study|Started New Treatment|0|||
160701731|NCT03146962|580288052|FG007|Overall Study|Started New Treatment|0|||
160701732|NCT03146962|580288053|FG008|Overall Study|Started New Treatment|0|||
160701733|NCT03146962|580288054|FG009|Overall Study|Started New Treatment|0|||
160701734|NCT01635283|580288057|FG000|Overall Study|Tumor Progression|3|||
160701735|NCT01635283|580288057|FG000|Overall Study|Lost to Follow-up|1|||
160701736|NCT04516759|580288058|FG000|Overall Study|Withdrawal by Subject|1|||
160701737|NCT04516759|580288059|FG001|Overall Study|Withdrawal by Subject|1|||
160701738|NCT04516759|580288058|FG000|Overall Study|Other|0|||
160701739|NCT04516759|580288059|FG001|Overall Study|Other|1|||
160701740|NCT01338870|580288071|FG000|Overall Study|Lost to Follow-up|0|||
160701741|NCT01338870|580288072|FG001|Overall Study|Lost to Follow-up|0|||
160701742|NCT01338870|580288073|FG002|Overall Study|Lost to Follow-up|1|||
160701743|NCT01338870|580288074|FG003|Overall Study|Lost to Follow-up|0|||
160701744|NCT01338870|580288075|FG004|Overall Study|Lost to Follow-up|1|||
160701745|NCT01338870|580288076|FG005|Overall Study|Lost to Follow-up|0|||
160701746|NCT01338870|580288071|FG000|Overall Study|Withdrawal by Subject|2|||
160701747|NCT01338870|580288072|FG001|Overall Study|Withdrawal by Subject|3|||
160701748|NCT01338870|580288073|FG002|Overall Study|Withdrawal by Subject|4|||
160701749|NCT01338870|580288074|FG003|Overall Study|Withdrawal by Subject|0|||
160701750|NCT01338870|580288075|FG004|Overall Study|Withdrawal by Subject|0|||
160701751|NCT01338870|580288076|FG005|Overall Study|Withdrawal by Subject|2|||
160701752|NCT01338870|580288071|FG000|Overall Study|Other|3|||
160701753|NCT01338870|580288072|FG001|Overall Study|Other|3|||
160701754|NCT01338870|580288073|FG002|Overall Study|Other|3|||
160701755|NCT01338870|580288074|FG003|Overall Study|Other|2|||
160701756|NCT01338870|580288075|FG004|Overall Study|Other|0|||
160701757|NCT01338870|580288076|FG005|Overall Study|Other|2|||
160701758|NCT01338870|580288071|FG000|Overall Study|Protocol Violation|0|||
160701759|NCT01338870|580288072|FG001|Overall Study|Protocol Violation|2|||
160701760|NCT01338870|580288073|FG002|Overall Study|Protocol Violation|2|||
160701761|NCT01338870|580288074|FG003|Overall Study|Protocol Violation|2|||
160701762|NCT01338870|580288075|FG004|Overall Study|Protocol Violation|1|||
160701763|NCT01338870|580288076|FG005|Overall Study|Protocol Violation|1|||
160701764|NCT01338870|580288071|FG000|Overall Study|Adverse Event|4|||
160701765|NCT01338870|580288072|FG001|Overall Study|Adverse Event|4|||
160701766|NCT01338870|580288073|FG002|Overall Study|Adverse Event|1|||
160701767|NCT01338870|580288074|FG003|Overall Study|Adverse Event|5|||
160701768|NCT01338870|580288075|FG004|Overall Study|Adverse Event|4|||
160701769|NCT01338870|580288076|FG005|Overall Study|Adverse Event|1|||
160701770|NCT01955083|580288079|FG000|Overall Study|Lost to Follow-up|1|||
160701771|NCT01955083|580288080|FG001|Overall Study|Lost to Follow-up|1|||
160701772|NCT01559389|580288089|FG000|Overall Study|Withdrawal by Subject|20|||
160701773|NCT01559389|580288090|FG001|Overall Study|Withdrawal by Subject|20|||
160701774|NCT02871492|580288091|FG000|Overall Study|Lost to Follow-up|6|||
160701775|NCT02871492|580288092|FG001|Overall Study|Lost to Follow-up|3|||
160701776|NCT02871492|580288093|FG002|Overall Study|Lost to Follow-up|5|||
160701777|NCT02871492|580288091|FG000|Overall Study|Withdrawal by Subject|0|||
160701778|NCT02871492|580288092|FG001|Overall Study|Withdrawal by Subject|0|||
160701779|NCT02871492|580288093|FG002|Overall Study|Withdrawal by Subject|1|||
160701780|NCT03583086|580288094|FG000|Overall Study|Death|2|||
160701781|NCT03583086|580288095|FG001|Overall Study|Death|6|||
160701782|NCT03583086|580288096|FG002|Overall Study|Death|12|||
160701783|NCT03583086|580288097|FG003|Overall Study|Death|10|||
160701784|NCT03583086|580288098|FG004|Overall Study|Death|14|||
160701785|NCT03583086|580288099|FG005|Overall Study|Death|14|||
160701786|NCT03583086|580288100|FG006|Overall Study|Death|4|||
160701787|NCT03583086|580288094|FG000|Overall Study|Withdrawal by Subject|0|||
160701788|NCT03583086|580288095|FG001|Overall Study|Withdrawal by Subject|0|||
160701789|NCT03583086|580288096|FG002|Overall Study|Withdrawal by Subject|1|||
160701790|NCT03583086|580288097|FG003|Overall Study|Withdrawal by Subject|0|||
160701791|NCT03583086|580288098|FG004|Overall Study|Withdrawal by Subject|0|||
160701792|NCT03583086|580288099|FG005|Overall Study|Withdrawal by Subject|0|||
160701793|NCT03583086|580288100|FG006|Overall Study|Withdrawal by Subject|1|||
160701794|NCT03583086|580288094|FG000|Overall Study|Refused follow-up|0|||
160701795|NCT03583086|580288095|FG001|Overall Study|Refused follow-up|0|||
160701796|NCT03583086|580288096|FG002|Overall Study|Refused follow-up|1|||
160701797|NCT03583086|580288097|FG003|Overall Study|Refused follow-up|0|||
160701798|NCT03583086|580288098|FG004|Overall Study|Refused follow-up|1|||
160701799|NCT03583086|580288099|FG005|Overall Study|Refused follow-up|0|||
160701800|NCT03583086|580288100|FG006|Overall Study|Refused follow-up|0|||
160701801|NCT03583086|580288094|FG000|Overall Study|Declining Performance Status|0|||
160701802|NCT03583086|580288095|FG001|Overall Study|Declining Performance Status|0|||
160701803|NCT03583086|580288096|FG002|Overall Study|Declining Performance Status|1|||
160701804|NCT03583086|580288097|FG003|Overall Study|Declining Performance Status|0|||
160701805|NCT03583086|580288098|FG004|Overall Study|Declining Performance Status|0|||
160701806|NCT03583086|580288099|FG005|Overall Study|Declining Performance Status|0|||
160701807|NCT03583086|580288100|FG006|Overall Study|Declining Performance Status|0|||
160701808|NCT03583086|580288094|FG000|Overall Study|Still on study|0|||
160701809|NCT03583086|580288095|FG001|Overall Study|Still on study|0|||
160701810|NCT03583086|580288096|FG002|Overall Study|Still on study|0|||
160701811|NCT03583086|580288097|FG003|Overall Study|Still on study|1|||
160701812|NCT03583086|580288098|FG004|Overall Study|Still on study|0|||
160701813|NCT03583086|580288099|FG005|Overall Study|Still on study|0|||
160701814|NCT03583086|580288100|FG006|Overall Study|Still on study|1|||
160701815|NCT03583086|580288094|FG000|Overall Study|Disease progression|0|||
160701816|NCT03583086|580288095|FG001|Overall Study|Disease progression|0|||
160701817|NCT03583086|580288096|FG002|Overall Study|Disease progression|0|||
160701818|NCT03583086|580288097|FG003|Overall Study|Disease progression|0|||
160701819|NCT03583086|580288098|FG004|Overall Study|Disease progression|0|||
160701820|NCT03583086|580288099|FG005|Overall Study|Disease progression|0|||
160701821|NCT03583086|580288100|FG006|Overall Study|Disease progression|1|||
160701822|NCT03583086|580288094|FG000|Overall Study|Undergoing radiation therapy|0|||
160701823|NCT03583086|580288095|FG001|Overall Study|Undergoing radiation therapy|0|||
160701824|NCT03583086|580288096|FG002|Overall Study|Undergoing radiation therapy|0|||
160701825|NCT03583086|580288097|FG003|Overall Study|Undergoing radiation therapy|0|||
160701826|NCT03583086|580288098|FG004|Overall Study|Undergoing radiation therapy|0|||
160701827|NCT03583086|580288099|FG005|Overall Study|Undergoing radiation therapy|0|||
160701828|NCT03583086|580288100|FG006|Overall Study|Undergoing radiation therapy|1|||
160701829|NCT03583086|580288094|FG000|Overall Study|Lost to Follow-up|0|||
160701830|NCT03583086|580288095|FG001|Overall Study|Lost to Follow-up|0|||
160701831|NCT03583086|580288096|FG002|Overall Study|Lost to Follow-up|0|||
160701832|NCT03583086|580288097|FG003|Overall Study|Lost to Follow-up|0|||
160701833|NCT03583086|580288098|FG004|Overall Study|Lost to Follow-up|0|||
160701834|NCT03583086|580288099|FG005|Overall Study|Lost to Follow-up|1|||
160701835|NCT03583086|580288100|FG006|Overall Study|Lost to Follow-up|0|||
160701836|NCT03583086|580288094|FG000|Overall Study|Adverse Event|0|||
160701837|NCT03583086|580288095|FG001|Overall Study|Adverse Event|0|||
160701838|NCT03583086|580288096|FG002|Overall Study|Adverse Event|0|||
160701839|NCT03583086|580288097|FG003|Overall Study|Adverse Event|0|||
160701840|NCT03583086|580288098|FG004|Overall Study|Adverse Event|0|||
160701841|NCT03583086|580288099|FG005|Overall Study|Adverse Event|1|||
160701842|NCT03583086|580288100|FG006|Overall Study|Adverse Event|0|||
160701843|NCT00396812|580288102|FG000|Overall Study|Physician Decision|1|||
160701844|NCT03201445|580288106|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
160701845|NCT03201445|580288107|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
160701846|NCT03201445|580288106|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
160701847|NCT03201445|580288107|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
160701848|NCT03201445|580288106|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
160701849|NCT03201445|580288107|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
160701850|NCT03201445|580288106|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
160701851|NCT03201445|580288107|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
160701852|NCT03201445|580288106|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
160701853|NCT03201445|580288107|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
160701854|NCT03201445|580288106|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
160701855|NCT03201445|580288107|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
160701856|NCT03201445|580288106|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
160701857|NCT03201445|580288107|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
160701858|NCT03201445|580288106|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
160701859|NCT03201445|580288107|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
160701860|NCT03201445|580288106|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
160701861|NCT03201445|580288107|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
160701862|NCT03201445|580288106|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
160701863|NCT03201445|580288107|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
160701864|NCT03201445|580288106|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
160701865|NCT03201445|580288107|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
160701866|NCT03201445|580288106|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
160701867|NCT03201445|580288107|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
160701868|NCT03201445|580288106|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
160701869|NCT03201445|580288107|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
160701870|NCT03201445|580288106|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
160701871|NCT03201445|580288107|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
160701872|NCT03201445|580288106|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
160701873|NCT03201445|580288107|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
160701874|NCT03201445|580288106|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
160701875|NCT03201445|580288107|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
160701876|NCT03201445|580288106|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
160701877|NCT03201445|580288107|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
160701878|NCT03201445|580288106|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
160701879|NCT03201445|580288107|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
160701880|NCT03201445|580288106|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
160701881|NCT03201445|580288107|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
160701882|NCT03201445|580288106|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
160701883|NCT03201445|580288107|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
160701884|NCT03201445|580288106|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
160701885|NCT03201445|580288107|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
160701886|NCT01346293|580288108|FG000|Overall Study|Protocol Violation|30|||
160701887|NCT01346293|580288109|FG001|Overall Study|Protocol Violation|9|||
160701888|NCT01346293|580288108|FG000|Overall Study|Lost to Follow-up|21|||
160701889|NCT01346293|580288109|FG001|Overall Study|Lost to Follow-up|8|||
160701890|NCT01346293|580288108|FG000|Overall Study|Withdrawal by Subject|15|||
160701891|NCT01346293|580288109|FG001|Overall Study|Withdrawal by Subject|4|||
160701892|NCT01346293|580288108|FG000|Overall Study|Other|1|||
160701893|NCT01346293|580288109|FG001|Overall Study|Other|0|||
160701894|NCT01844505|580288113|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
160701895|NCT01844505|580288114|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
160701896|NCT01844505|580288115|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
160701897|NCT01844505|580288113|FG000|Treatment Period|Other Reasons|120|||
160701898|NCT01844505|580288114|FG001|Treatment Period|Other Reasons|136|||
160701899|NCT01844505|580288115|FG002|Treatment Period|Other Reasons|58|||
160701900|NCT01844505|580288113|FG000|Treatment Period|Lost to Follow-up|9|||
160701901|NCT01844505|580288114|FG001|Treatment Period|Lost to Follow-up|11|||
160701902|NCT01844505|580288115|FG002|Treatment Period|Lost to Follow-up|6|||
160701903|NCT01844505|580288113|FG000|Treatment Period|Death|175|||
160701904|NCT01844505|580288114|FG001|Treatment Period|Death|154|||
160701905|NCT01844505|580288115|FG002|Treatment Period|Death|228|||
160701906|NCT02640053|580288116|FG000|Overall Study|Withdrawal by Subject|2|||
160701907|NCT02640053|580288117|FG001|Overall Study|Withdrawal by Subject|1|||
160701908|NCT02640053|580288116|FG000|Overall Study|Adverse Event|1|||
160701909|NCT02640053|580288117|FG001|Overall Study|Adverse Event|1|||
160701910|NCT02640053|580288116|FG000|Overall Study|Alternative Therapy|1|||
160701911|NCT02640053|580288117|FG001|Overall Study|Alternative Therapy|1|||
160701912|NCT02640053|580288116|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
160701913|NCT02640053|580288117|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
160701914|NCT01268501|580288119|FG000|Overall Study|Lost to Follow-up|1|||
160701915|NCT01268501|580288119|FG000|Overall Study|Withdrawal by Subject|3|||
160701916|NCT01268501|580288119|FG000|Overall Study|Unacceptable Subjective Vision|3|||
160701917|NCT01268501|580288119|FG000|Overall Study|Handling Difficulties|2|||
160701918|NCT00724048|580288120|FG000|Overall Study|Adverse Event|1|||
160701919|NCT00724048|580288121|FG001|Overall Study|Adverse Event|1|||
160701920|NCT00724048|580288122|FG002|Overall Study|Adverse Event|1|||
160701921|NCT00724048|580288123|FG003|Overall Study|Adverse Event|0|||
160701922|NCT00724048|580288120|FG000|Overall Study|Lost to Follow-up|0|||
160701923|NCT00724048|580288121|FG001|Overall Study|Lost to Follow-up|1|||
160701924|NCT00724048|580288122|FG002|Overall Study|Lost to Follow-up|0|||
160701925|NCT00724048|580288123|FG003|Overall Study|Lost to Follow-up|0|||
160701926|NCT00724048|580288120|FG000|Overall Study|Withdrawal by Subject|1|||
160701927|NCT00724048|580288121|FG001|Overall Study|Withdrawal by Subject|2|||
160701928|NCT00724048|580288122|FG002|Overall Study|Withdrawal by Subject|1|||
160701929|NCT00724048|580288123|FG003|Overall Study|Withdrawal by Subject|2|||
160701930|NCT00724048|580288120|FG000|Overall Study|Investigator decision|0|||
160701931|NCT00724048|580288121|FG001|Overall Study|Investigator decision|0|||
160701932|NCT00724048|580288122|FG002|Overall Study|Investigator decision|1|||
160701933|NCT00724048|580288123|FG003|Overall Study|Investigator decision|0|||
160701934|NCT00724048|580288120|FG000|Overall Study|Did not tolerate study drug|0|||
160701935|NCT00724048|580288121|FG001|Overall Study|Did not tolerate study drug|0|||
160701936|NCT00724048|580288122|FG002|Overall Study|Did not tolerate study drug|0|||
160701937|NCT00724048|580288123|FG003|Overall Study|Did not tolerate study drug|1|||
160701938|NCT00724048|580288120|FG000|Overall Study|Other than specified|1|||
160701939|NCT00724048|580288121|FG001|Overall Study|Other than specified|1|||
160701940|NCT00724048|580288122|FG002|Overall Study|Other than specified|0|||
160701941|NCT00724048|580288123|FG003|Overall Study|Other than specified|0|||
160701942|NCT02754856|580288124|FG000|Overall Study|Withdrawal by Subject|1|||
160701943|NCT04874155|580288127|FG000|Overall Study|Lost to Follow-up|1|||
160701944|NCT04874155|580288128|FG001|Overall Study|Lost to Follow-up|1|||
160701945|NCT04874155|580288127|FG000|Overall Study|Withdrawal by Subject|2|||
160701946|NCT04874155|580288128|FG001|Overall Study|Withdrawal by Subject|2|||
160701947|NCT00530218|580288129|FG000|Overall Study|CMV Not Detected|13|||
160701948|NCT00530218|580288129|FG000|Overall Study|Death|12|||
160701949|NCT03477903|580288134|FG000|Overall Study|Study Terminated by Sponsor|1|||
160701950|NCT00474266|580288135|FG000|Overall Study|Withdrawal by Subject|7|||
160701951|NCT00474266|580288136|FG001|Overall Study|Withdrawal by Subject|20|||
160701952|NCT00474266|580288137|FG002|Overall Study|Withdrawal by Subject|4|||
160701953|NCT00474266|580288138|FG003|Overall Study|Withdrawal by Subject|7|||
160701954|NCT02774642|580288139|FG000|Overall Study|Lost to Follow-up|9|||
160701955|NCT02774642|580288140|FG001|Overall Study|Lost to Follow-up|7|||
160701956|NCT02329847|580288141|FG000|Overall Study|Death|4|||
160701957|NCT02329847|580288142|FG001|Overall Study|Death|4|||
160701958|NCT02329847|580288143|FG002|Overall Study|Death|22|||
160701959|NCT02329847|580288144|FG003|Overall Study|Death|12|||
160701960|NCT02329847|580288145|FG004|Overall Study|Death|20|||
160701961|NCT02329847|580288146|FG005|Overall Study|Death|13|||
160701962|NCT02329847|580288141|FG000|Overall Study|Lost to Follow-up|0|||
160701963|NCT02329847|580288142|FG001|Overall Study|Lost to Follow-up|0|||
160701964|NCT02329847|580288143|FG002|Overall Study|Lost to Follow-up|2|||
160701965|NCT02329847|580288144|FG003|Overall Study|Lost to Follow-up|3|||
160701966|NCT02329847|580288145|FG004|Overall Study|Lost to Follow-up|0|||
160701967|NCT02329847|580288146|FG005|Overall Study|Lost to Follow-up|1|||
160701968|NCT02329847|580288141|FG000|Overall Study|Physician Decision|0|||
160701969|NCT02329847|580288142|FG001|Overall Study|Physician Decision|0|||
160701970|NCT02329847|580288143|FG002|Overall Study|Physician Decision|0|||
160701971|NCT02329847|580288144|FG003|Overall Study|Physician Decision|0|||
160701972|NCT02329847|580288145|FG004|Overall Study|Physician Decision|1|||
160701973|NCT02329847|580288146|FG005|Overall Study|Physician Decision|0|||
160701974|NCT02329847|580288141|FG000|Overall Study|Withdrawal by Subject|2|||
160701975|NCT02329847|580288142|FG001|Overall Study|Withdrawal by Subject|1|||
160701976|NCT02329847|580288143|FG002|Overall Study|Withdrawal by Subject|5|||
160701977|NCT02329847|580288144|FG003|Overall Study|Withdrawal by Subject|7|||
160701978|NCT02329847|580288145|FG004|Overall Study|Withdrawal by Subject|8|||
160701979|NCT02329847|580288146|FG005|Overall Study|Withdrawal by Subject|3|||
160701980|NCT02329847|580288141|FG000|Overall Study|Other|1|||
160701981|NCT02329847|580288142|FG001|Overall Study|Other|2|||
160701982|NCT02329847|580288143|FG002|Overall Study|Other|6|||
160701983|NCT02329847|580288144|FG003|Overall Study|Other|13|||
160701984|NCT02329847|580288145|FG004|Overall Study|Other|10|||
160701985|NCT02329847|580288146|FG005|Overall Study|Other|3|||
160701986|NCT04572893|580288147|FG000|Part A|Adverse Event|1|||
160701987|NCT04572893|580288148|FG001|Part A|Adverse Event|0|||
160701988|NCT04572893|580288149|FG002|Part A|Adverse Event|0|||
160701989|NCT04572893|580288150|FG003|Part A|Adverse Event|0|||
160701990|NCT04572893|580288151|FG004|Part A|Adverse Event|0|||
160701991|NCT04572893|580288152|FG005|Part A|Adverse Event|0|||
160701992|NCT04572893|580288153|FG006|Part A|Adverse Event|0|||
160701993|NCT04572893|580288147|FG000|Part B|Withdrawal by Subject|0|||
160701994|NCT04572893|580288148|FG001|Part B|Withdrawal by Subject|0|||
160701995|NCT04572893|580288149|FG002|Part B|Withdrawal by Subject|0|||
160701996|NCT04572893|580288150|FG003|Part B|Withdrawal by Subject|0|||
160701997|NCT04572893|580288151|FG004|Part B|Withdrawal by Subject|0|||
160701998|NCT04572893|580288152|FG005|Part B|Withdrawal by Subject|1|||
160701999|NCT04572893|580288153|FG006|Part B|Withdrawal by Subject|0|||
160702000|NCT04572893|580288147|FG000|Part B|Study terminated by sponsor|0|||
160702001|NCT04572893|580288148|FG001|Part B|Study terminated by sponsor|0|||
160702002|NCT04572893|580288149|FG002|Part B|Study terminated by sponsor|0|||
160702003|NCT04572893|580288150|FG003|Part B|Study terminated by sponsor|0|||
160702004|NCT04572893|580288151|FG004|Part B|Study terminated by sponsor|7|||
160702005|NCT04572893|580288152|FG005|Part B|Study terminated by sponsor|5|||
160702006|NCT04572893|580288153|FG006|Part B|Study terminated by sponsor|3|||
160702007|NCT04572893|580288147|FG000|Part B|Lost to Follow-up|0|||
160702008|NCT04572893|580288148|FG001|Part B|Lost to Follow-up|0|||
160702009|NCT04572893|580288149|FG002|Part B|Lost to Follow-up|0|||
160702010|NCT04572893|580288150|FG003|Part B|Lost to Follow-up|0|||
160702011|NCT04572893|580288151|FG004|Part B|Lost to Follow-up|0|||
160702012|NCT04572893|580288152|FG005|Part B|Lost to Follow-up|0|||
160702013|NCT04572893|580288153|FG006|Part B|Lost to Follow-up|1|||
160702014|NCT04572893|580288147|FG000|Part B|Adverse Event|0|||
160702015|NCT04572893|580288148|FG001|Part B|Adverse Event|0|||
160702016|NCT04572893|580288149|FG002|Part B|Adverse Event|0|||
160702017|NCT04572893|580288150|FG003|Part B|Adverse Event|0|||
160702018|NCT04572893|580288151|FG004|Part B|Adverse Event|1|||
160702019|NCT04572893|580288152|FG005|Part B|Adverse Event|1|||
160702020|NCT04572893|580288153|FG006|Part B|Adverse Event|0|||
160702021|NCT03276780|580288154|FG000|Overall Study|Withdrawal by Subject|5|||
160702022|NCT03276780|580288155|FG001|Overall Study|Withdrawal by Subject|3|||
160702023|NCT03276780|580288154|FG000|Overall Study|Lost to Follow-up|3|||
160702024|NCT03276780|580288155|FG001|Overall Study|Lost to Follow-up|5|||
160702025|NCT03276780|580288154|FG000|Overall Study|Moved out of state|1|||
160702026|NCT03276780|580288155|FG001|Overall Study|Moved out of state|1|||
160702027|NCT03276780|580288154|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
160702028|NCT03276780|580288155|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
160702029|NCT03276780|580288154|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
160702030|NCT03276780|580288155|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
160702031|NCT00861198|580288156|FG000|Overall Study|SpyGlass Failed|5|||
160702032|NCT02288182|580288157|FG000|Overall Study|Adverse Event|0|||
160702033|NCT02288182|580288158|FG001|Overall Study|Adverse Event|1|||
160702034|NCT02288182|580288157|FG000|Overall Study|Lost to Follow-up|0|||
160702035|NCT02288182|580288158|FG001|Overall Study|Lost to Follow-up|1|||
160702036|NCT04619992|580288159|FG000|Overall Study|Withdrawal by Subject|1|||
160702037|NCT04619992|580288160|FG001|Overall Study|Withdrawal by Subject|0|||
160702038|NCT01197755|580288161|FG000|Overall Study|Adverse Event|8|||
160702039|NCT01197755|580288162|FG001|Overall Study|Adverse Event|10|||
160702040|NCT01197755|580288163|FG002|Overall Study|Adverse Event|10|||
160702041|NCT01197755|580288161|FG000|Overall Study|Study-specific discontinuation criteria|2|||
160702042|NCT01197755|580288162|FG001|Overall Study|Study-specific discontinuation criteria|1|||
160702043|NCT01197755|580288163|FG002|Overall Study|Study-specific discontinuation criteria|0|||
160702044|NCT01197755|580288161|FG000|Overall Study|Entered the long-term extension study|18|||
160702045|NCT01197755|580288162|FG001|Overall Study|Entered the long-term extension study|21|||
160702046|NCT01197755|580288163|FG002|Overall Study|Entered the long-term extension study|35|||
160702047|NCT01197755|580288161|FG000|Overall Study|Lack of therapeutic response|0|||
160702048|NCT01197755|580288162|FG001|Overall Study|Lack of therapeutic response|7|||
160702049|NCT01197755|580288163|FG002|Overall Study|Lack of therapeutic response|4|||
160702050|NCT01197755|580288161|FG000|Overall Study|Severe non-compliance to the protocol|2|||
160702051|NCT01197755|580288162|FG001|Overall Study|Severe non-compliance to the protocol|1|||
160702052|NCT01197755|580288163|FG002|Overall Study|Severe non-compliance to the protocol|2|||
160702053|NCT01197755|580288161|FG000|Overall Study|Withdrawal by Subject|1|||
160702054|NCT01197755|580288162|FG001|Overall Study|Withdrawal by Subject|0|||
160702055|NCT01197755|580288163|FG002|Overall Study|Withdrawal by Subject|0|||
160702056|NCT01197755|580288161|FG000|Overall Study|Lost to Follow-up|0|||
160702057|NCT01197755|580288162|FG001|Overall Study|Lost to Follow-up|0|||
160702058|NCT01197755|580288163|FG002|Overall Study|Lost to Follow-up|1|||
160702059|NCT01197755|580288161|FG000|Overall Study|eg, change in circumstances|7|||
160702060|NCT01197755|580288162|FG001|Overall Study|eg, change in circumstances|3|||
160702061|NCT01197755|580288163|FG002|Overall Study|eg, change in circumstances|2|||
160702062|NCT03365011|580288164|FG000|Overall Study|Withdrawal by Subject|1|||
160702063|NCT03365011|580288165|FG001|Overall Study|Withdrawal by Subject|2|||
160702064|NCT03582826|580288166|FG000|Overall Study|Lost to Follow-up|39|||
160702065|NCT03582826|580288167|FG001|Overall Study|Lost to Follow-up|0|||
160702066|NCT03582826|580288166|FG000|Overall Study|Withdrawal by Subject|2|||
160702067|NCT03582826|580288167|FG001|Overall Study|Withdrawal by Subject|0|||
160702068|NCT00499174|580288168|FG000|Overall Study|Physician Decision|78|||
160702069|NCT00499174|580288169|FG001|Overall Study|Physician Decision|9|||
160702070|NCT01214915|580288173|FG000|Overall Study|Adverse Event|8|||
160702071|NCT01214915|580288173|FG000|Overall Study|Lack of Efficacy|3|||
160702072|NCT00574912|580288174|FG000|Overall Study|Could not place IV lines.|3|||
160702073|NCT00574912|580288174|FG000|Overall Study|scheduling conflicts|3|||
160702074|NCT00574912|580288174|FG000|Overall Study|Physician Decision|2|||
160702075|NCT01104779|580288179|FG000|Overall Study|Protocol Violation|1|||
160702076|NCT01104779|580288180|FG001|Overall Study|Protocol Violation|2|||
160702077|NCT01104779|580288181|FG002|Overall Study|Protocol Violation|2|||
160702078|NCT01104779|580288179|FG000|Overall Study|Lack of Efficacy|26|||
160702079|NCT01104779|580288180|FG001|Overall Study|Lack of Efficacy|12|||
160702080|NCT01104779|580288181|FG002|Overall Study|Lack of Efficacy|13|||
160702081|NCT01104779|580288179|FG000|Overall Study|Adverse Event|13|||
160702082|NCT01104779|580288180|FG001|Overall Study|Adverse Event|14|||
160702083|NCT01104779|580288181|FG002|Overall Study|Adverse Event|13|||
160702084|NCT01104779|580288179|FG000|Overall Study|Did not meet inc/exc criteria|1|||
160702085|NCT01104779|580288180|FG001|Overall Study|Did not meet inc/exc criteria|1|||
160702086|NCT01104779|580288181|FG002|Overall Study|Did not meet inc/exc criteria|1|||
160702087|NCT01104779|580288179|FG000|Overall Study|Other reasons|0|||
160702088|NCT01104779|580288180|FG001|Overall Study|Other reasons|1|||
160702089|NCT01104779|580288181|FG002|Overall Study|Other reasons|0|||
160702090|NCT01104779|580288179|FG000|Overall Study|Lost to Follow-up|2|||
160702091|NCT01104779|580288180|FG001|Overall Study|Lost to Follow-up|0|||
160702092|NCT01104779|580288181|FG002|Overall Study|Lost to Follow-up|1|||
160702093|NCT01104779|580288179|FG000|Overall Study|Withdrawal by Subject|16|||
160702094|NCT01104779|580288180|FG001|Overall Study|Withdrawal by Subject|25|||
160702095|NCT01104779|580288181|FG002|Overall Study|Withdrawal by Subject|32|||
160702096|NCT03753763|580288182|FG000|Overall Study|Adverse Event|2|||
160702097|NCT03753763|580288183|FG001|Overall Study|Adverse Event|0|||
160702098|NCT03753763|580288182|FG000|Overall Study|Withdrawal by Subject|3|||
160702099|NCT03753763|580288183|FG001|Overall Study|Withdrawal by Subject|1|||
160702100|NCT03753763|580288182|FG000|Overall Study|clinical deterioration|1|||
160702101|NCT03753763|580288183|FG001|Overall Study|clinical deterioration|0|||
160702102|NCT02342639|580288190|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
160702103|NCT02342639|580288191|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
160702104|NCT02342639|580288190|FG000|Overall Study|Protocol Violation|0|||
160702105|NCT02342639|580288191|FG001|Overall Study|Protocol Violation|2|||
160702106|NCT00871741|580288196|FG000|Overall Study|Premature study termination|9|||
160702107|NCT00871741|580288197|FG001|Overall Study|Premature study termination|7|||
160702108|NCT03395405|580289528|FG000|Overall Study|Death|0|||
160702109|NCT03395405|580289529|FG001|Overall Study|Death|2|||
160702110|NCT03395405|580289528|FG000|Overall Study|Lost to Follow-up|0|||
160702111|NCT03395405|580289529|FG001|Overall Study|Lost to Follow-up|1|||
160702112|NCT03395405|580289528|FG000|Overall Study|Protocol Violation|0|||
160702113|NCT03395405|580289529|FG001|Overall Study|Protocol Violation|1|||
160702114|NCT03395405|580289528|FG000|Overall Study|Withdrawal by Subject|3|||
160702115|NCT03395405|580289529|FG001|Overall Study|Withdrawal by Subject|1|||
160702116|NCT03395405|580289528|FG000|Overall Study|COVID-19 Pandemic|1|||
160702117|NCT03395405|580289529|FG001|Overall Study|COVID-19 Pandemic|0|||
160702118|NCT04324073|580289530|FG000|Overall Study|withdrew consent|0|||
160702119|NCT04324073|580289531|FG001|Overall Study|withdrew consent|4|||
160702120|NCT04324073|580289532|FG002|Overall Study|withdrew consent|2|||
160702121|NCT04324073|580289533|FG003|Overall Study|withdrew consent|8|||
160702122|NCT01200069|580289539|FG000|Overall Study|Withdrawal by Subject|0|||
160702123|NCT01200069|580289540|FG001|Overall Study|Withdrawal by Subject|1|||
160702124|NCT04998851|580289541|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
160702125|NCT04998851|580289542|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
160702126|NCT04998851|580289541|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
160702127|NCT04998851|580289542|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
160702128|NCT00070499|580289543|FG000|Overall Study|Adverse Event|6|||
160702129|NCT00070499|580289544|FG001|Overall Study|Adverse Event|6|||
160702130|NCT00070499|580289545|FG002|Overall Study|Adverse Event|19|||
160702131|NCT00070499|580289546|FG003|Overall Study|Adverse Event|15|||
160702132|NCT00070499|580289543|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
160702133|NCT00070499|580289544|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
160702134|NCT00070499|580289545|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
160702135|NCT00070499|580289546|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
160702136|NCT00070499|580289543|FG000|Overall Study|Progression/relapse|4|||
160702137|NCT00070499|580289544|FG001|Overall Study|Progression/relapse|2|||
160702138|NCT00070499|580289545|FG002|Overall Study|Progression/relapse|1|||
160702139|NCT00070499|580289546|FG003|Overall Study|Progression/relapse|4|||
160702140|NCT00070499|580289543|FG000|Overall Study|Death|1|||
160702141|NCT00070499|580289544|FG001|Overall Study|Death|1|||
160702142|NCT00070499|580289545|FG002|Overall Study|Death|1|||
160702143|NCT00070499|580289546|FG003|Overall Study|Death|2|||
160702144|NCT00070499|580289543|FG000|Overall Study|Other - not protocol specified|7|||
160702145|NCT00070499|580289544|FG001|Overall Study|Other - not protocol specified|3|||
160702146|NCT00070499|580289545|FG002|Overall Study|Other - not protocol specified|12|||
160702147|NCT00070499|580289546|FG003|Overall Study|Other - not protocol specified|20|||
160702148|NCT00070499|580289543|FG000|Overall Study|Still on protocol treatment|10|||
160702149|NCT00070499|580289544|FG001|Overall Study|Still on protocol treatment|4|||
160702150|NCT00070499|580289545|FG002|Overall Study|Still on protocol treatment|79|||
160702151|NCT00070499|580289546|FG003|Overall Study|Still on protocol treatment|57|||
160702152|NCT00070499|580289543|FG000|Overall Study|Did not start treatment|1|||
160702153|NCT00070499|580289544|FG001|Overall Study|Did not start treatment|0|||
160702154|NCT00070499|580289545|FG002|Overall Study|Did not start treatment|0|||
160702155|NCT00070499|580289546|FG003|Overall Study|Did not start treatment|2|||
160702156|NCT00070499|580289543|FG000|Overall Study|Not eligible|2|||
160702157|NCT00070499|580289544|FG001|Overall Study|Not eligible|5|||
160702158|NCT00070499|580289545|FG002|Overall Study|Not eligible|3|||
160702159|NCT00070499|580289546|FG003|Overall Study|Not eligible|2|||
160702160|NCT00805467|580289547|FG000|Overall Study|Lack of Efficacy|0|||
160702161|NCT00805467|580289548|FG001|Overall Study|Lack of Efficacy|8|||
160702162|NCT00805467|580289549|FG002|Overall Study|Lack of Efficacy|13|||
160702163|NCT00805467|580289550|FG003|Overall Study|Lack of Efficacy|86|||
160702164|NCT00805467|580289547|FG000|Overall Study|Lost to Follow-up|0|||
160702165|NCT00805467|580289548|FG001|Overall Study|Lost to Follow-up|1|||
160702166|NCT00805467|580289549|FG002|Overall Study|Lost to Follow-up|7|||
160702167|NCT00805467|580289550|FG003|Overall Study|Lost to Follow-up|21|||
160702168|NCT00805467|580289547|FG000|Overall Study|Withdrawal by Subject|0|||
160702169|NCT00805467|580289548|FG001|Overall Study|Withdrawal by Subject|6|||
160702170|NCT00805467|580289549|FG002|Overall Study|Withdrawal by Subject|45|||
160702171|NCT00805467|580289550|FG003|Overall Study|Withdrawal by Subject|50|||
160702172|NCT00805467|580289547|FG000|Overall Study|Protocol Violation|0|||
160702173|NCT00805467|580289548|FG001|Overall Study|Protocol Violation|3|||
160702174|NCT00805467|580289549|FG002|Overall Study|Protocol Violation|0|||
160702175|NCT00805467|580289550|FG003|Overall Study|Protocol Violation|5|||
160702176|NCT00805467|580289547|FG000|Overall Study|Adverse Event|0|||
160702177|NCT00805467|580289548|FG001|Overall Study|Adverse Event|13|||
160702178|NCT00805467|580289549|FG002|Overall Study|Adverse Event|26|||
160702179|NCT00805467|580289550|FG003|Overall Study|Adverse Event|57|||
160702180|NCT00805467|580289547|FG000|Overall Study|Death|0|||
160702181|NCT00805467|580289548|FG001|Overall Study|Death|2|||
160702182|NCT00805467|580289549|FG002|Overall Study|Death|7|||
160702183|NCT00805467|580289550|FG003|Overall Study|Death|5|||
160702184|NCT00805467|580289547|FG000|Overall Study|Physician Decision|0|||
160702185|NCT00805467|580289548|FG001|Overall Study|Physician Decision|1|||
160702186|NCT00805467|580289549|FG002|Overall Study|Physician Decision|2|||
160702187|NCT00805467|580289550|FG003|Overall Study|Physician Decision|6|||
160702188|NCT00805467|580289547|FG000|Overall Study|Not reported|0|||
160702189|NCT00805467|580289548|FG001|Overall Study|Not reported|0|||
160702190|NCT00805467|580289549|FG002|Overall Study|Not reported|3|||
160702191|NCT00805467|580289550|FG003|Overall Study|Not reported|7|||
160702192|NCT04240392|580289552|FG000|Overall Study|Withdrawal by Subject|13|||
160702193|NCT04240392|580289553|FG001|Overall Study|Withdrawal by Subject|4|||
160702194|NCT04240392|580289552|FG000|Overall Study|Lost to Follow-up|11|||
160702195|NCT04240392|580289553|FG001|Overall Study|Lost to Follow-up|12|||
160702196|NCT04345601|580289566|FG000|Overall Study|Death|0|||
160702197|NCT04345601|580289567|FG001|Overall Study|Death|3|||
160702198|NCT04345601|580289568|FG002|Overall Study|Death|2|||
160702199|NCT04345601|580289566|FG000|Overall Study|Lost to Follow-up|0|||
160702200|NCT04345601|580289567|FG001|Overall Study|Lost to Follow-up|0|||
160702201|NCT04345601|580289568|FG002|Overall Study|Lost to Follow-up|2|||
160702202|NCT01396512|580289574|FG000|Overall Study|Withdrawal by Subject|0|||
160702203|NCT01396512|580289575|FG001|Overall Study|Withdrawal by Subject|1|||
160702204|NCT01564537|580289576|FG000|Overall Study|Site Terminated by Sponsor|1|||
160702205|NCT01564537|580289577|FG001|Overall Study|Site Terminated by Sponsor|0|||
160702206|NCT01564537|580289576|FG000|Overall Study|Withdrawal by Subject|12|||
160702207|NCT01564537|580289577|FG001|Overall Study|Withdrawal by Subject|14|||
160702208|NCT01564537|580289576|FG000|Overall Study|Lost to Follow-up|7|||
160702209|NCT01564537|580289577|FG001|Overall Study|Lost to Follow-up|3|||
160702210|NCT01564537|580289576|FG000|Overall Study|Reason not specified|81|||
160702211|NCT01564537|580289577|FG001|Overall Study|Reason not specified|82|||
160702212|NCT05776862|580289579|FG000|Overall Study|Adverse Event|0|||
160702213|NCT05776862|580289580|FG001|Overall Study|Adverse Event|1|||
160702214|NCT05776862|580289579|FG000|Overall Study|non-compliance|1|||
160702215|NCT05776862|580289580|FG001|Overall Study|non-compliance|0|||
160702216|NCT02448706|580289581|FG000|Overall Study|Withdrawal by Subject|4|||
160702217|NCT02448706|580289582|FG001|Overall Study|Withdrawal by Subject|3|||
160702218|NCT02448706|580289581|FG000|Overall Study|Protocol Violation|1|||
160702219|NCT02448706|580289582|FG001|Overall Study|Protocol Violation|1|||
160702220|NCT00537303|580289589|FG000|Overall Study|Adverse Event|1|||
160702221|NCT00537303|580289590|FG001|Overall Study|Adverse Event|4|||
160702222|NCT00537303|580289589|FG000|Overall Study|Lack of Efficacy|6|||
160702223|NCT00537303|580289590|FG001|Overall Study|Lack of Efficacy|7|||
160702224|NCT00537303|580289589|FG000|Overall Study|Protocol Violation|8|||
160702225|NCT00537303|580289590|FG001|Overall Study|Protocol Violation|4|||
160702226|NCT00537303|580289589|FG000|Overall Study|Withdrawal criteria|3|||
160702227|NCT00537303|580289590|FG001|Overall Study|Withdrawal criteria|3|||
160702228|NCT00537303|580289589|FG000|Overall Study|Unclassified|8|||
160702229|NCT00537303|580289590|FG001|Overall Study|Unclassified|7|||
160702230|NCT01473524|580289591|FG000|DB Phase|Adverse Event|4|||
160702231|NCT01473524|580289592|FG001|DB Phase|Adverse Event|8|||
160702232|NCT01473524|580289593|FG002|DB Phase|Adverse Event|2|||
160702233|NCT01473524|580289594|FG003|DB Phase|Adverse Event|0|||
160702234|NCT01473524|580289595|FG004|DB Phase|Adverse Event|0|||
160702235|NCT01473524|580289596|FG005|DB Phase|Adverse Event|0|||
160702236|NCT01473524|580289591|FG000|DB Phase|Death|1|||
160702237|NCT01473524|580289592|FG001|DB Phase|Death|0|||
160702238|NCT01473524|580289593|FG002|DB Phase|Death|0|||
160702239|NCT01473524|580289594|FG003|DB Phase|Death|0|||
160702240|NCT01473524|580289595|FG004|DB Phase|Death|0|||
160702241|NCT01473524|580289596|FG005|DB Phase|Death|0|||
160702242|NCT01473524|580289591|FG000|DB Phase|Withdrawal by Subject|2|||
160702243|NCT01473524|580289592|FG001|DB Phase|Withdrawal by Subject|1|||
160702244|NCT01473524|580289593|FG002|DB Phase|Withdrawal by Subject|1|||
160702245|NCT01473524|580289594|FG003|DB Phase|Withdrawal by Subject|0|||
160702246|NCT01473524|580289595|FG004|DB Phase|Withdrawal by Subject|0|||
160702247|NCT01473524|580289596|FG005|DB Phase|Withdrawal by Subject|0|||
160702248|NCT01473524|580289591|FG000|LTSE Phase|Withdrawal by Subject|0|||
160702249|NCT01473524|580289592|FG001|LTSE Phase|Withdrawal by Subject|0|||
160702250|NCT01473524|580289593|FG002|LTSE Phase|Withdrawal by Subject|0|||
160702251|NCT01473524|580289594|FG003|LTSE Phase|Withdrawal by Subject|3|||
160702252|NCT01473524|580289595|FG004|LTSE Phase|Withdrawal by Subject|3|||
160702253|NCT01473524|580289596|FG005|LTSE Phase|Withdrawal by Subject|6|||
160702254|NCT01473524|580289591|FG000|LTSE Phase|Death|0|||
160702255|NCT01473524|580289592|FG001|LTSE Phase|Death|0|||
160702256|NCT01473524|580289593|FG002|LTSE Phase|Death|0|||
160702257|NCT01473524|580289594|FG003|LTSE Phase|Death|0|||
160702258|NCT01473524|580289595|FG004|LTSE Phase|Death|1|||
160702259|NCT01473524|580289596|FG005|LTSE Phase|Death|0|||
160702260|NCT01473524|580289591|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
160702261|NCT01473524|580289592|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
160702262|NCT01473524|580289593|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
160702263|NCT01473524|580289594|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
160702264|NCT01473524|580289595|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
160702265|NCT01473524|580289596|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
160702266|NCT01473524|580289591|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
160702267|NCT01473524|580289592|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
160702268|NCT01473524|580289593|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
160702269|NCT01473524|580289594|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
160702270|NCT01473524|580289595|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
160702271|NCT01473524|580289596|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
160702272|NCT01473524|580289591|FG000|LTSE Phase|Lost to Follow-up|0|||
160702273|NCT01473524|580289592|FG001|LTSE Phase|Lost to Follow-up|0|||
160702274|NCT01473524|580289593|FG002|LTSE Phase|Lost to Follow-up|0|||
160702275|NCT01473524|580289594|FG003|LTSE Phase|Lost to Follow-up|1|||
160702276|NCT01473524|580289595|FG004|LTSE Phase|Lost to Follow-up|3|||
160702277|NCT01473524|580289596|FG005|LTSE Phase|Lost to Follow-up|2|||
160702278|NCT01473524|580289591|FG000|LTSE Phase|Principal Investigator Decision|0|||
160702279|NCT01473524|580289592|FG001|LTSE Phase|Principal Investigator Decision|0|||
160702280|NCT01473524|580289593|FG002|LTSE Phase|Principal Investigator Decision|0|||
160702281|NCT01473524|580289594|FG003|LTSE Phase|Principal Investigator Decision|1|||
160702282|NCT01473524|580289595|FG004|LTSE Phase|Principal Investigator Decision|1|||
160702283|NCT01473524|580289596|FG005|LTSE Phase|Principal Investigator Decision|3|||
160702284|NCT01473524|580289591|FG000|LTSE Phase|Liver Transplantation|0|||
160702285|NCT01473524|580289592|FG001|LTSE Phase|Liver Transplantation|0|||
160702286|NCT01473524|580289593|FG002|LTSE Phase|Liver Transplantation|0|||
160702287|NCT01473524|580289594|FG003|LTSE Phase|Liver Transplantation|0|||
160702288|NCT01473524|580289595|FG004|LTSE Phase|Liver Transplantation|0|||
160702289|NCT01473524|580289596|FG005|LTSE Phase|Liver Transplantation|1|||
160702290|NCT01473524|580289591|FG000|LTSE Phase|Pregnancy|0|||
160702291|NCT01473524|580289592|FG001|LTSE Phase|Pregnancy|0|||
160702292|NCT01473524|580289593|FG002|LTSE Phase|Pregnancy|0|||
160702293|NCT01473524|580289594|FG003|LTSE Phase|Pregnancy|1|||
160702294|NCT01473524|580289595|FG004|LTSE Phase|Pregnancy|0|||
160702295|NCT01473524|580289596|FG005|LTSE Phase|Pregnancy|0|||
160702296|NCT01473524|580289591|FG000|LTSE Phase|Protocol Violation|0|||
160702297|NCT01473524|580289592|FG001|LTSE Phase|Protocol Violation|0|||
160702298|NCT01473524|580289593|FG002|LTSE Phase|Protocol Violation|0|||
160702299|NCT01473524|580289594|FG003|LTSE Phase|Protocol Violation|0|||
160702300|NCT01473524|580289595|FG004|LTSE Phase|Protocol Violation|0|||
160702301|NCT01473524|580289596|FG005|LTSE Phase|Protocol Violation|1|||
160702302|NCT01147107|580289605|FG000|Overall Study|Lack of Efficacy|5|||
160702303|NCT01147107|580289606|FG001|Overall Study|Lack of Efficacy|0|||
160702304|NCT01147107|580289605|FG000|Overall Study|Withdrawal by Subject|1|||
160702305|NCT01147107|580289606|FG001|Overall Study|Withdrawal by Subject|1|||
160702306|NCT04435184|580289607|FG000|Overall Study|follow-up blood draws missing|3|||
160702307|NCT04435184|580289608|FG001|Overall Study|follow-up blood draws missing|5|||
160702308|NCT00369317|580289611|FG000|Overall Study|Adverse Event|3|||
160702309|NCT00369317|580289611|FG000|Overall Study|Death|1|||
160702310|NCT00369317|580289611|FG000|Overall Study|Lack of Efficacy|5|||
160702311|NCT00369317|580289611|FG000|Overall Study|Physician Decision|2|||
160702312|NCT00369317|580289611|FG000|Overall Study|Withdrawal by Subject|8|||
160702313|NCT00369317|580289611|FG000|Overall Study|Ineligible|1|||
160702314|NCT02365558|580289612|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
160702315|NCT02365558|580289613|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
160702316|NCT02365558|580289612|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
160702317|NCT02365558|580289613|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
160702318|NCT02722148|580289617|FG000|Overall Study|Lost to Follow-up|2|||
160702319|NCT02722148|580289617|FG000|Overall Study|Non compliant with treatment regimen|3|||
160702320|NCT00073021|580289618|FG000|Overall Study|Protocol Violation|2|||
160702321|NCT00073021|580289619|FG001|Overall Study|Protocol Violation|1|||
160702322|NCT00073021|580289618|FG000|Overall Study|Adverse Event|4|||
160702323|NCT00073021|580289619|FG001|Overall Study|Adverse Event|4|||
160702324|NCT00073021|580289618|FG000|Overall Study|Withdrawal by Subject|6|||
160702325|NCT00073021|580289619|FG001|Overall Study|Withdrawal by Subject|5|||
160702326|NCT00073021|580289618|FG000|Overall Study|Physician Decision|3|||
160702327|NCT00073021|580289619|FG001|Overall Study|Physician Decision|1|||
160702328|NCT00073021|580289618|FG000|Overall Study|Lack of Efficacy|11|||
160702329|NCT00073021|580289619|FG001|Overall Study|Lack of Efficacy|5|||
160702330|NCT00477295|580289620|FG000|Overall Study|Adverse Event|31|||
160702331|NCT00477295|580289621|FG001|Overall Study|Adverse Event|35|||
160702332|NCT00477295|580289620|FG000|Overall Study|Withdrawal by Subject|35|||
160702333|NCT00477295|580289621|FG001|Overall Study|Withdrawal by Subject|24|||
160702334|NCT00477295|580289620|FG000|Overall Study|Lack of Efficacy|23|||
160702335|NCT00477295|580289621|FG001|Overall Study|Lack of Efficacy|23|||
160702336|NCT00477295|580289620|FG000|Overall Study|Protocol Violation|3|||
160702337|NCT00477295|580289621|FG001|Overall Study|Protocol Violation|8|||
160702338|NCT00477295|580289620|FG000|Overall Study|Physician Decision|4|||
160702339|NCT00477295|580289621|FG001|Overall Study|Physician Decision|5|||
160702340|NCT00477295|580289620|FG000|Overall Study|Lost to Follow-up|21|||
160702341|NCT00477295|580289621|FG001|Overall Study|Lost to Follow-up|11|||
160702342|NCT00477295|580289620|FG000|Overall Study|Other|4|||
160702343|NCT00477295|580289621|FG001|Overall Study|Other|3|||
160702344|NCT01425723|580289624|FG000|Overall Study|Lack of Efficacy|0|||
160702345|NCT01425723|580289625|FG001|Overall Study|Lack of Efficacy|1|||
160702346|NCT01425723|580289624|FG000|Overall Study|Withdrawal by Subject|1|||
160702347|NCT01425723|580289625|FG001|Overall Study|Withdrawal by Subject|4|||
160702348|NCT01425723|580289624|FG000|Overall Study|Lost to Follow-up|0|||
160702349|NCT01425723|580289625|FG001|Overall Study|Lost to Follow-up|3|||
160702350|NCT01425723|580289624|FG000|Overall Study|Physician Decision|2|||
160702351|NCT01425723|580289625|FG001|Overall Study|Physician Decision|0|||
160702352|NCT01425723|580289624|FG000|Overall Study|Other|1|||
160702353|NCT01425723|580289625|FG001|Overall Study|Other|10|||
160702354|NCT03835221|580289626|FG000|Methafilcon A|Withdrawal by Subject|1|||
160702355|NCT04730349|580289632|FG000|Overall Study|Participant withdrew consent|1|||
160702356|NCT04730349|580289633|FG001|Overall Study|Participant withdrew consent|0|||
160702357|NCT04730349|580289632|FG000|Overall Study|Disease progression|6|||
160702358|NCT04730349|580289633|FG001|Overall Study|Disease progression|4|||
160702359|NCT04730349|580289632|FG000|Overall Study|Study drug toxicity|0|||
160702360|NCT04730349|580289633|FG001|Overall Study|Study drug toxicity|1|||
160702361|NCT00638027|580289634|FG000|Overall Study|Adverse Event|0|||
160702362|NCT00638027|580289635|FG001|Overall Study|Adverse Event|2|||
160702363|NCT00371397|580289636|FG000|Session 1|Withdrawal by Subject|1|||
160702364|NCT00371397|580289637|FG001|Session 1|Withdrawal by Subject|0|||
160702365|NCT00371397|580289638|FG002|Session 1|Withdrawal by Subject|0|||
160702366|NCT00371397|580289639|FG003|Session 1|Withdrawal by Subject|0|||
160702367|NCT00371397|580289640|FG004|Session 1|Withdrawal by Subject|0|||
160702368|NCT00371397|580289641|FG005|Session 1|Withdrawal by Subject|0|||
160702369|NCT00371397|580289642|FG006|Session 1|Withdrawal by Subject|0|||
160702370|NCT00371397|580289643|FG007|Session 1|Withdrawal by Subject|1|||
160702371|NCT00371397|580289644|FG008|Session 1|Withdrawal by Subject|0|||
160702372|NCT00371397|580289645|FG009|Session 1|Withdrawal by Subject|0|||
160702373|NCT00371397|580289646|FG010|Session 1|Withdrawal by Subject|0|||
160702374|NCT00371397|580289647|FG011|Session 1|Withdrawal by Subject|0|||
160702375|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
160702376|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
160702377|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702378|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702379|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702380|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702381|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702382|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702383|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702384|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702385|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702386|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702387|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702388|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
160702389|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
160702390|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
160702391|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702392|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702393|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702394|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702395|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702396|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702397|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702398|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702399|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702400|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702401|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702402|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160702403|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
160702404|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
160702405|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702406|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702407|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702408|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702409|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702410|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702411|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702412|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702413|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702414|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702415|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702416|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
160702417|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
160702418|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
160702419|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702420|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702421|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702422|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702423|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702424|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702425|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702426|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702427|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702428|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702429|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702430|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
160702431|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
160702432|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
160702433|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702434|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702435|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702436|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702437|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702438|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702439|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702440|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702441|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702442|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702443|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702444|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
160702445|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
160702446|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
160702447|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702448|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702449|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702450|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702451|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702452|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702453|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702454|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702455|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702456|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702457|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702458|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160702459|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
160702460|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
160702461|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702462|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702463|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702464|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702465|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702466|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702467|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702468|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702469|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702470|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702471|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702472|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160702473|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
160702474|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
160702475|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702476|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702477|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702478|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702479|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702480|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702481|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702482|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702483|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702484|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702485|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702486|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160702487|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
160702488|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
160702489|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702490|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702491|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702492|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702493|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702494|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702495|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702496|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702497|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702498|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702499|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702500|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
160702501|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
160702502|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
160702503|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702504|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702505|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702506|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702507|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702508|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702509|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702510|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702511|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702512|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702513|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702514|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
160702515|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
160702516|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
160702517|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702518|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702519|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702520|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702521|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702522|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702523|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702524|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702525|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702526|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702527|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702528|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
160702529|NCT03982199|580289648|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
160702530|NCT03982199|580289649|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
160702531|NCT03982199|580289650|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702532|NCT03982199|580289651|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702533|NCT03982199|580289652|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702534|NCT03982199|580289653|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702535|NCT03982199|580289654|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702536|NCT03982199|580289655|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702537|NCT03982199|580289656|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702538|NCT03982199|580289657|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702539|NCT03982199|580289658|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702540|NCT03982199|580289659|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702541|NCT03982199|580289660|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702542|NCT03982199|580289661|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
160702543|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702544|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702545|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702546|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
160702547|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702548|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702549|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702550|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702551|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702552|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702553|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702554|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702555|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702556|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
160702557|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702558|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702559|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
160702560|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702561|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702562|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702563|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702564|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702565|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160748713|NCT00303472|580465927|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
160702566|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702567|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702568|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702569|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702570|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160702571|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702572|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702573|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
160702574|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702575|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702576|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702577|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702578|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702579|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702580|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702581|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702582|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702583|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702584|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160702585|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702586|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702587|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
160702588|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
160702589|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702590|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702591|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702592|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702593|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702594|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702595|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702596|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702597|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702598|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
160702599|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702600|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702601|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702602|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
160702603|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702604|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702605|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702606|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702607|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702608|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702609|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702610|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702611|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702612|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
160702613|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702614|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702615|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
160702616|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
160702617|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702618|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702619|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702620|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702621|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702622|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702623|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702624|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702625|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702626|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160702627|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702628|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702629|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702630|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702631|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702632|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702633|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702634|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702635|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
160702636|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702637|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702638|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702639|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702640|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
160702641|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702642|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702643|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702644|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702645|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702646|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702647|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702648|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702649|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
160702650|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702651|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702652|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702653|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702654|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160702655|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702656|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702657|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702658|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702659|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702660|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702661|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702662|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702663|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
160702664|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702665|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702666|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702667|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702668|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
160702669|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702670|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702671|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702672|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702673|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702674|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702675|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702676|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702677|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
160702678|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702679|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702680|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702681|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702682|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
160702683|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702684|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702685|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702686|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702687|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702688|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702689|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702690|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702691|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
160702692|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702693|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702694|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702695|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702696|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
160702697|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702698|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702699|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702700|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702701|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702702|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
160702703|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702704|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
160702705|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
160702706|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702707|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702708|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702709|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702710|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
160702711|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702712|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702713|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702714|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702715|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702716|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702717|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702718|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702719|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
160702720|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702721|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702722|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702723|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702724|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
160702725|NCT03982199|580289648|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702726|NCT03982199|580289649|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702727|NCT03982199|580289650|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702728|NCT03982199|580289651|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702729|NCT03982199|580289652|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702730|NCT03982199|580289653|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
160702731|NCT03982199|580289654|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702732|NCT03982199|580289655|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
160702733|NCT03982199|580289656|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
160702734|NCT03982199|580289657|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702735|NCT03982199|580289658|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702736|NCT03982199|580289659|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702737|NCT03982199|580289660|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702738|NCT03982199|580289661|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
160702739|NCT03982199|580289648|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
160702740|NCT03982199|580289649|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
160702741|NCT03982199|580289650|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
160702742|NCT03982199|580289651|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
160702743|NCT03982199|580289652|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
160702744|NCT03982199|580289653|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
160702745|NCT03982199|580289654|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
160702746|NCT03982199|580289655|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
160702747|NCT03982199|580289656|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
160702748|NCT03982199|580289657|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
160702749|NCT03982199|580289658|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
160702750|NCT03982199|580289659|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
160702751|NCT03982199|580289660|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
160702752|NCT03982199|580289661|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
160702753|NCT03982199|580289648|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702754|NCT03982199|580289649|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702755|NCT03982199|580289650|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702756|NCT03982199|580289651|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702757|NCT03982199|580289652|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702758|NCT03982199|580289653|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702759|NCT03982199|580289654|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702760|NCT03982199|580289655|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702761|NCT03982199|580289656|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702762|NCT03982199|580289657|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
160702763|NCT03982199|580289658|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702764|NCT03982199|580289659|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702765|NCT03982199|580289660|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702766|NCT03982199|580289661|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160702767|NCT03982199|580289648|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702768|NCT03982199|580289649|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702769|NCT03982199|580289650|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702770|NCT03982199|580289651|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702771|NCT03982199|580289652|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702772|NCT03982199|580289653|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702773|NCT03982199|580289654|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702774|NCT03982199|580289655|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702775|NCT03982199|580289656|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702776|NCT03982199|580289657|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702777|NCT03982199|580289658|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702778|NCT03982199|580289659|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702779|NCT03982199|580289660|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
160702780|NCT03982199|580289661|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
160702781|NCT03982199|580289648|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702782|NCT03982199|580289649|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702783|NCT03982199|580289650|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702784|NCT03982199|580289651|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702785|NCT03982199|580289652|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702786|NCT03982199|580289653|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702787|NCT03982199|580289654|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702788|NCT03982199|580289655|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702789|NCT03982199|580289656|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702790|NCT03982199|580289657|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702791|NCT03982199|580289658|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
160702792|NCT03982199|580289659|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
160702793|NCT03982199|580289660|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
160702794|NCT03982199|580289661|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
160702795|NCT03982199|580289648|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702796|NCT03982199|580289649|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702797|NCT03982199|580289650|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702798|NCT03982199|580289651|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702799|NCT03982199|580289652|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702800|NCT03982199|580289653|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702801|NCT03982199|580289654|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702802|NCT03982199|580289655|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702803|NCT03982199|580289656|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702804|NCT03982199|580289657|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702805|NCT03982199|580289658|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702806|NCT03982199|580289659|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702807|NCT03982199|580289660|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
160702808|NCT03982199|580289661|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
160702809|NCT03982199|580289648|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702810|NCT03982199|580289649|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702811|NCT03982199|580289650|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702812|NCT03982199|580289651|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702813|NCT03982199|580289652|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702814|NCT03982199|580289653|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702815|NCT03982199|580289654|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702816|NCT03982199|580289655|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702817|NCT03982199|580289656|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702818|NCT03982199|580289657|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702819|NCT03982199|580289658|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702820|NCT03982199|580289659|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
160702821|NCT03982199|580289660|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
160702822|NCT03982199|580289661|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
160702823|NCT03982199|580289648|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702824|NCT03982199|580289649|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702825|NCT03982199|580289650|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702826|NCT03982199|580289651|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702827|NCT03982199|580289652|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702828|NCT03982199|580289653|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702829|NCT03982199|580289654|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702830|NCT03982199|580289655|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702831|NCT03982199|580289656|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702832|NCT03982199|580289657|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702833|NCT03982199|580289658|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702834|NCT03982199|580289659|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702835|NCT03982199|580289660|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
160702836|NCT03982199|580289661|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
160702837|NCT03433755|580289662|FG000|Overall Study|Lost to Follow-up|1|||
160702838|NCT03433755|580289663|FG001|Overall Study|Lost to Follow-up|0|||
160702839|NCT03433755|580289664|FG002|Overall Study|Lost to Follow-up|0|||
160702840|NCT03433755|580289665|FG003|Overall Study|Lost to Follow-up|0|||
160702841|NCT03433755|580289662|FG000|Overall Study|Decision by Sponsor|1|||
160702842|NCT03433755|580289663|FG001|Overall Study|Decision by Sponsor|0|||
160702843|NCT03433755|580289664|FG002|Overall Study|Decision by Sponsor|0|||
160702844|NCT03433755|580289665|FG003|Overall Study|Decision by Sponsor|0|||
160702845|NCT01565850|580289666|FG000|Overall Study|Adverse Event|0|||
160702846|NCT01565850|580289667|FG001|Overall Study|Adverse Event|1|||
160702847|NCT01565850|580289666|FG000|Overall Study|Lost to Follow-up|12|||
160702848|NCT01565850|580289667|FG001|Overall Study|Lost to Follow-up|4|||
160702849|NCT01565850|580289666|FG000|Overall Study|Investigator's Discretion|2|||
160702850|NCT01565850|580289667|FG001|Overall Study|Investigator's Discretion|1|||
160702851|NCT01565850|580289666|FG000|Overall Study|Participant noncompliance|2|||
160702852|NCT01565850|580289667|FG001|Overall Study|Participant noncompliance|0|||
160702853|NCT01565850|580289666|FG000|Overall Study|Withdrew Consent|4|||
160702854|NCT01565850|580289667|FG001|Overall Study|Withdrew Consent|2|||
160702855|NCT05065567|580289671|FG000|Overall Study|Lost to Follow-up|10|||
160702856|NCT05065567|580289672|FG001|Overall Study|Lost to Follow-up|9|||
160702857|NCT05065567|580289673|FG002|Overall Study|Lost to Follow-up|6|||
160702858|NCT05323123|580289674|FG000|Overall Study|Withdrawal by Subject|2|||
160702859|NCT05323123|580289675|FG001|Overall Study|Withdrawal by Subject|1|||
160702860|NCT05323123|580289674|FG000|Overall Study|Lost to Follow-up|4|||
160702861|NCT05323123|580289675|FG001|Overall Study|Lost to Follow-up|2|||
160702862|NCT05323123|580289674|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
160702863|NCT05323123|580289675|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
160702864|NCT05529472|580289676|FG000|Overall Study|Withdrawal by Subject|1|||
160702865|NCT05529472|580289677|FG001|Overall Study|Withdrawal by Subject|1|||
160702866|NCT03665441|580291482|FG000|Overall Study|survival follow up ongoing|23|||
160702867|NCT03665441|580291483|FG001|Overall Study|survival follow up ongoing|0|||
160702868|NCT03665441|580291482|FG000|Overall Study|Patients ongoing on treatment|9|||
160702869|NCT03665441|580291483|FG001|Overall Study|Patients ongoing on treatment|6|||
160702870|NCT03665441|580291482|FG000|Overall Study|Randomized but not treated|7|||
160702871|NCT03665441|580291483|FG001|Overall Study|Randomized but not treated|11|||
160702872|NCT05307510|580291484|FG000|Overall Study|Lost to Follow-up|3|||
160702873|NCT05307510|580291485|FG001|Overall Study|Lost to Follow-up|6|||
160702874|NCT05307510|580291484|FG000|Overall Study|Withdrawal by Subject|0|||
160702875|NCT05307510|580291485|FG001|Overall Study|Withdrawal by Subject|1|||
160702876|NCT03610516|580291486|FG000|Treatment Epoch|Adverse Event|3|||
160702877|NCT03610516|580291487|FG001|Treatment Epoch|Adverse Event|1|||
160702878|NCT03610516|580291486|FG000|Treatment Epoch|Death|1|||
160702879|NCT03610516|580291487|FG001|Treatment Epoch|Death|0|||
160702880|NCT03610516|580291486|FG000|Treatment Epoch|Lack of Efficacy|0|||
160702881|NCT03610516|580291487|FG001|Treatment Epoch|Lack of Efficacy|1|||
160702882|NCT03610516|580291486|FG000|Treatment Epoch|No longer requires treatment|1|||
160702883|NCT03610516|580291487|FG001|Treatment Epoch|No longer requires treatment|0|||
160702884|NCT03610516|580291486|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
160702885|NCT03610516|580291487|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
160702886|NCT03610516|580291486|FG000|Treatment Epoch|Physician Decision|8|||
160702887|NCT03610516|580291487|FG001|Treatment Epoch|Physician Decision|5|||
160702888|NCT03610516|580291486|FG000|Treatment Epoch|Protocol Deviation|1|||
160702889|NCT03610516|580291487|FG001|Treatment Epoch|Protocol Deviation|0|||
160702890|NCT03610516|580291486|FG000|Treatment Epoch|Withdrawal by Subject|3|||
160702891|NCT03610516|580291487|FG001|Treatment Epoch|Withdrawal by Subject|1|||
160702892|NCT03610516|580291486|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
160702893|NCT03610516|580291487|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
160702894|NCT03610516|580291486|FG000|Post-Treatment Follow-up|Death|1|||
160702895|NCT03610516|580291487|FG001|Post-Treatment Follow-up|Death|0|||
160702896|NCT00660907|580291488|FG000|Overall Study|Incorrect Enrollment|1|||
160702897|NCT00660907|580291489|FG001|Overall Study|Incorrect Enrollment|1|||
160702898|NCT00660907|580291488|FG000|Overall Study|Adverse Event|33|||
160702899|NCT00660907|580291489|FG001|Overall Study|Adverse Event|19|||
160702900|NCT00660907|580291488|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
160702901|NCT00660907|580291489|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
160702902|NCT00660907|580291488|FG000|Overall Study|Withdrawal by Subject|23|||
160702903|NCT00660907|580291489|FG001|Overall Study|Withdrawal by Subject|32|||
160702904|NCT00660907|580291488|FG000|Overall Study|Lost to Follow-up|3|||
160702905|NCT00660907|580291489|FG001|Overall Study|Lost to Follow-up|3|||
160702906|NCT00660907|580291488|FG000|Overall Study|Poor/Non-Compliance|5|||
160702907|NCT00660907|580291489|FG001|Overall Study|Poor/Non-Compliance|1|||
160702908|NCT00660907|580291488|FG000|Overall Study|Safety|1|||
160702909|NCT00660907|580291489|FG001|Overall Study|Safety|0|||
160702910|NCT00660907|580291488|FG000|Overall Study|Death|1|||
160702911|NCT00660907|580291489|FG001|Overall Study|Death|3|||
160702912|NCT00660907|580291488|FG000|Overall Study|Various|11|||
160702913|NCT00660907|580291489|FG001|Overall Study|Various|8|||
160702914|NCT01908907|580291490|FG000|Overall Study|Physician Decision|1|||
160702915|NCT01908907|580291491|FG001|Overall Study|Physician Decision|0|||
160702916|NCT01908907|580291490|FG000|Overall Study|Protocol Violation|1|||
160702917|NCT01908907|580291491|FG001|Overall Study|Protocol Violation|0|||
160702918|NCT04975191|580291492|FG000|Overall Study|Protocol Violation|1|||
160702919|NCT04975191|580291493|FG001|Overall Study|Protocol Violation|2|||
160702920|NCT04975191|580291494|FG002|Overall Study|Protocol Violation|2|||
160702921|NCT04975191|580291495|FG003|Overall Study|Protocol Violation|2|||
160702922|NCT04975191|580291492|FG000|Overall Study|Lost to Follow-up|13|||
160702923|NCT04975191|580291493|FG001|Overall Study|Lost to Follow-up|3|||
160702924|NCT04975191|580291494|FG002|Overall Study|Lost to Follow-up|8|||
160702925|NCT04975191|580291495|FG003|Overall Study|Lost to Follow-up|8|||
160702926|NCT00761657|580291498|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
160702927|NCT00761657|580291499|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
160702928|NCT00761657|580291500|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
160702929|NCT00761657|580291501|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
160702930|NCT00761657|580291502|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
160702931|NCT00761657|580291503|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
160702932|NCT00761657|580291504|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
160702933|NCT00761657|580291505|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
160702934|NCT00761657|580291506|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
160702935|NCT00761657|580291498|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
160702936|NCT00761657|580291499|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
160702937|NCT00761657|580291500|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
160702938|NCT00761657|580291501|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
160702939|NCT00761657|580291502|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
160702940|NCT00761657|580291503|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
160702941|NCT00761657|580291504|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
160702942|NCT00761657|580291505|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
160702943|NCT00761657|580291506|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
160702944|NCT00761657|580291498|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
160702945|NCT00761657|580291499|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
160702946|NCT00761657|580291500|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
160702947|NCT00761657|580291501|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
160702948|NCT00761657|580291502|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
160702949|NCT00761657|580291503|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
160702950|NCT00761657|580291504|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
160702951|NCT00761657|580291505|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
160702952|NCT00761657|580291506|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
160702953|NCT00761657|580291498|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
160702954|NCT00761657|580291499|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
160702955|NCT00761657|580291500|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
160702956|NCT00761657|580291501|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
160702957|NCT00761657|580291502|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
160702958|NCT00761657|580291503|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
160702959|NCT00761657|580291504|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
160702960|NCT00761657|580291505|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
160702961|NCT00761657|580291506|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
160702962|NCT00478244|580291512|FG000|Overall Study|Did not receive transplant|1|||
160702963|NCT02886624|580291513|FG000|12-week Post Treatment Follow-up|Death|1|||
160702964|NCT02886624|580291513|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
160702965|NCT00359801|580291518|FG000|Overall Study|Lost to Follow-up|72|||
160702966|NCT00359801|580291519|FG001|Overall Study|Lost to Follow-up|58|||
160702967|NCT00359801|580291518|FG000|Overall Study|Withdrawal by Subject|143|||
160702968|NCT00359801|580291519|FG001|Overall Study|Withdrawal by Subject|96|||
160702969|NCT00359801|580291518|FG000|Overall Study|Other|66|||
160702970|NCT00359801|580291519|FG001|Overall Study|Other|46|||
160702971|NCT00359801|580291518|FG000|Overall Study|Final Status Unknown: missing data|7|||
160702972|NCT00359801|580291519|FG001|Overall Study|Final Status Unknown: missing data|4|||
160702973|NCT00359801|580291518|FG000|Overall Study|Sponsor Decision|17|||
160702974|NCT00359801|580291519|FG001|Overall Study|Sponsor Decision|16|||
160702975|NCT02929056|580291523|FG000|Overall Study|Lost to Follow-up|0|||
160702976|NCT02929056|580291524|FG001|Overall Study|Lost to Follow-up|1|||
160702977|NCT00459043|580291527|FG000|Overall Study|Withdrawal by Subject|1|||
160702978|NCT00459043|580291528|FG001|Overall Study|Withdrawal by Subject|0|||
160702979|NCT00450801|580291531|FG000|Overall Study|Death|1|||
160702980|NCT00324649|580291532|FG000|Overall Study|Adverse Event|1|||
160702981|NCT00324649|580291533|FG001|Overall Study|Adverse Event|4|||
160702982|NCT00324649|580291532|FG000|Overall Study|Withdrawal by Subject|0|||
160702983|NCT00324649|580291533|FG001|Overall Study|Withdrawal by Subject|1|||
160702984|NCT00324649|580291532|FG000|Overall Study|Noncompliance|1|||
160702985|NCT00324649|580291533|FG001|Overall Study|Noncompliance|0|||
160702986|NCT02618759|580291534|FG000|Overall Study|Lost to Follow-up|0|||
160702987|NCT02618759|580291535|FG001|Overall Study|Lost to Follow-up|1|||
160702988|NCT02618759|580291534|FG000|Overall Study|Withdrawal by Subject|1|||
160702989|NCT02618759|580291535|FG001|Overall Study|Withdrawal by Subject|0|||
160702990|NCT02618759|580291534|FG000|Overall Study|Other Reasons|1|||
160702991|NCT02618759|580291535|FG001|Overall Study|Other Reasons|4|||
160702992|NCT02500043|580291542|FG000|Overall Study|Randomized, but not Treated|2|||
160702993|NCT02500043|580291543|FG001|Overall Study|Randomized, but not Treated|2|||
160702994|NCT02500043|580291542|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
160702995|NCT02500043|580291543|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
160702996|NCT02500043|580291542|FG000|Overall Study|Adverse Event|33|||
160702997|NCT02500043|580291543|FG001|Overall Study|Adverse Event|11|||
160702998|NCT02500043|580291542|FG000|Overall Study|Clinical Progression|54|||
160702999|NCT02500043|580291543|FG001|Overall Study|Clinical Progression|35|||
160703000|NCT02500043|580291542|FG000|Overall Study|Radiological Progression|192|||
160703001|NCT02500043|580291543|FG001|Overall Study|Radiological Progression|110|||
160703002|NCT02500043|580291542|FG000|Overall Study|Physician's Decision|11|||
160703003|NCT02500043|580291543|FG001|Overall Study|Physician's Decision|3|||
160703004|NCT02500043|580291542|FG000|Overall Study|Withdrawal by Subject|14|||
160703005|NCT02500043|580291543|FG001|Overall Study|Withdrawal by Subject|4|||
160703006|NCT02500043|580291542|FG000|Overall Study|Death|11|||
160703007|NCT02500043|580291543|FG001|Overall Study|Death|2|||
160703008|NCT02500043|580291542|FG000|Overall Study|Protocol Deviation|1|||
160703009|NCT02500043|580291543|FG001|Overall Study|Protocol Deviation|0|||
160703010|NCT00580788|580291544|FG000|Overall Study|Adverse Event|0|||
160703011|NCT00580788|580291545|FG001|Overall Study|Adverse Event|0|||
160703012|NCT00580788|580291546|FG002|Overall Study|Adverse Event|0|||
160703013|NCT00580788|580291547|FG003|Overall Study|Adverse Event|1|||
160703014|NCT02932306|580291560|FG000|Overall Study|Withdrawal by Subject|16|||
160703015|NCT02932306|580291561|FG001|Overall Study|Withdrawal by Subject|25|||
160703016|NCT02932306|580291560|FG000|Overall Study|Adverse Event|3|||
160703017|NCT02932306|580291561|FG001|Overall Study|Adverse Event|0|||
160703018|NCT02932306|580291560|FG000|Overall Study|Pregnancy|2|||
160703019|NCT02932306|580291561|FG001|Overall Study|Pregnancy|0|||
160703020|NCT02932306|580291560|FG000|Overall Study|Protocol Violation|1|||
160703021|NCT02932306|580291561|FG001|Overall Study|Protocol Violation|1|||
160703022|NCT02932306|580291560|FG000|Overall Study|Noncompliance with Study Drug|1|||
160703023|NCT02932306|580291561|FG001|Overall Study|Noncompliance with Study Drug|1|||
160703024|NCT02932306|580291560|FG000|Overall Study|Lost to Follow-up|36|||
160703025|NCT02932306|580291561|FG001|Overall Study|Lost to Follow-up|40|||
160703026|NCT02932306|580291560|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
160703027|NCT02932306|580291561|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
160703028|NCT02932306|580291560|FG000|Overall Study|Lack of Efficacy|0|||
160703029|NCT02932306|580291561|FG001|Overall Study|Lack of Efficacy|2|||
160703030|NCT02932306|580291560|FG000|Overall Study|Worsening condition|2|||
160703031|NCT02932306|580291561|FG001|Overall Study|Worsening condition|0|||
160703032|NCT02932306|580291560|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
160703033|NCT02932306|580291561|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
160703034|NCT02065700|580291572|FG000|Overall Study|Adverse Event|165|||
160703035|NCT02065700|580291573|FG001|Overall Study|Adverse Event|101|||
160703036|NCT02065700|580291572|FG000|Overall Study|Withdrawal by Subject|90|||
160703037|NCT02065700|580291573|FG001|Overall Study|Withdrawal by Subject|29|||
160703038|NCT02065700|580291572|FG000|Overall Study|Lost to Follow-up|12|||
160703039|NCT02065700|580291573|FG001|Overall Study|Lost to Follow-up|9|||
160703040|NCT02065700|580291572|FG000|Overall Study|Physician Decision|2|||
160703041|NCT02065700|580291573|FG001|Overall Study|Physician Decision|0|||
160703042|NCT02065700|580291572|FG000|Overall Study|Sponsor Request|38|||
160703043|NCT02065700|580291573|FG001|Overall Study|Sponsor Request|15|||
160703044|NCT02065700|580291572|FG000|Overall Study|Treatment Failure|3|||
160703045|NCT02065700|580291573|FG001|Overall Study|Treatment Failure|2|||
160703046|NCT02065700|580291572|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
160703047|NCT02065700|580291573|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
160703048|NCT02065700|580291572|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
160703049|NCT02065700|580291573|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
160703050|NCT02065700|580291572|FG000|Overall Study|Non-compliance with Study Procedures|2|||
160703051|NCT02065700|580291573|FG001|Overall Study|Non-compliance with Study Procedures|0|||
160703052|NCT02065700|580291572|FG000|Overall Study|Not Defined|21|||
160703053|NCT02065700|580291573|FG001|Overall Study|Not Defined|3|||
160703054|NCT02315196|580291574|FG000|Overall Study|Withdrew consent|9|||
160703055|NCT01635218|580291575|FG000|Overall Study|Lost to Follow-up|3|||
160703056|NCT01635218|580291576|FG001|Overall Study|Lost to Follow-up|7|||
160703057|NCT01635218|580291577|FG002|Overall Study|Lost to Follow-up|6|||
160703058|NCT03559400|580291578|FG000|Overall Study|Lost to Follow-up|9|||
160703059|NCT03559400|580291579|FG001|Overall Study|Lost to Follow-up|7|||
160703060|NCT03559400|580291578|FG000|Overall Study|Death|0|||
160703061|NCT03559400|580291579|FG001|Overall Study|Death|2|||
160703062|NCT03262038|580291584|FG000|Overall Study|Withdrawal by Subject|0|||
160703063|NCT03262038|580291585|FG001|Overall Study|Withdrawal by Subject|1|||
160703064|NCT04933968|580291586|FG000|Overall Study|Adverse Event|0|||
160703065|NCT04933968|580291587|FG001|Overall Study|Adverse Event|0|||
160703066|NCT04933968|580291588|FG002|Overall Study|Adverse Event|1|||
160703067|NCT04933968|580291589|FG003|Overall Study|Adverse Event|1|||
160703068|NCT04933968|580291590|FG004|Overall Study|Adverse Event|0|||
160703069|NCT04933968|580291591|FG005|Overall Study|Adverse Event|0|||
160703070|NCT04933968|580291586|FG000|Overall Study|Lost to Follow-up|1|||
160703071|NCT04933968|580291587|FG001|Overall Study|Lost to Follow-up|0|||
160703072|NCT04933968|580291588|FG002|Overall Study|Lost to Follow-up|1|||
160703073|NCT04933968|580291589|FG003|Overall Study|Lost to Follow-up|0|||
160703074|NCT04933968|580291590|FG004|Overall Study|Lost to Follow-up|0|||
160703075|NCT04933968|580291591|FG005|Overall Study|Lost to Follow-up|0|||
160703076|NCT04933968|580291586|FG000|Overall Study|Randomized not treated|1|||
160703077|NCT04933968|580291587|FG001|Overall Study|Randomized not treated|0|||
160703078|NCT04933968|580291588|FG002|Overall Study|Randomized not treated|0|||
160703079|NCT04933968|580291589|FG003|Overall Study|Randomized not treated|0|||
160703080|NCT04933968|580291590|FG004|Overall Study|Randomized not treated|0|||
160703081|NCT04933968|580291591|FG005|Overall Study|Randomized not treated|0|||
160703082|NCT04933968|580291586|FG000|Overall Study|Sponsor terminated study|0|||
160703083|NCT04933968|580291587|FG001|Overall Study|Sponsor terminated study|0|||
160703084|NCT04933968|580291588|FG002|Overall Study|Sponsor terminated study|0|||
160703085|NCT04933968|580291589|FG003|Overall Study|Sponsor terminated study|1|||
160703086|NCT04933968|580291590|FG004|Overall Study|Sponsor terminated study|2|||
160703087|NCT04933968|580291591|FG005|Overall Study|Sponsor terminated study|0|||
160703088|NCT04933968|580291586|FG000|Overall Study|Other|0|||
160703089|NCT04933968|580291587|FG001|Overall Study|Other|0|||
160703090|NCT04933968|580291588|FG002|Overall Study|Other|0|||
160703091|NCT04933968|580291589|FG003|Overall Study|Other|1|||
160703092|NCT04933968|580291590|FG004|Overall Study|Other|0|||
160703093|NCT04933968|580291591|FG005|Overall Study|Other|0|||
160703094|NCT04933968|580291586|FG000|Overall Study|Missing|1|||
160703095|NCT04933968|580291587|FG001|Overall Study|Missing|3|||
160703096|NCT04933968|580291588|FG002|Overall Study|Missing|2|||
160703097|NCT04933968|580291589|FG003|Overall Study|Missing|1|||
160703098|NCT04933968|580291590|FG004|Overall Study|Missing|1|||
160703099|NCT04933968|580291591|FG005|Overall Study|Missing|0|||
160703100|NCT01664130|580291594|FG000|Overall Study|competing secondary disease|2|||
160703101|NCT02679235|580291597|FG000|Overall Study|Withdrawal by Subject|3|||
160703102|NCT02679235|580291597|FG000|Overall Study|Adverse Event|1|||
160703103|NCT03323437|580291598|FG000|Overall Study|Withdrawal by Subject|0|||
160703104|NCT03323437|580291599|FG001|Overall Study|Withdrawal by Subject|4|||
160703105|NCT00923273|580291600|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
160703106|NCT00923273|580291601|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
160703107|NCT00923273|580291602|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
160703108|NCT00923273|580291603|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
160703109|NCT00923273|580291604|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
160703110|NCT00923273|580291600|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
160703111|NCT00923273|580291601|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
160703112|NCT00923273|580291602|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
160703113|NCT00923273|580291603|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
160703114|NCT00923273|580291604|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
160703115|NCT02383810|580291607|FG000|Overall Study|Physician Decision|1|||
160703116|NCT02383810|580291608|FG001|Overall Study|Physician Decision|1|||
160703117|NCT02383810|580291609|FG002|Overall Study|Physician Decision|0|||
160703118|NCT02383810|580291610|FG003|Overall Study|Physician Decision|0|||
160703119|NCT02383810|580291611|FG004|Overall Study|Physician Decision|0|||
160703120|NCT02383810|580291612|FG005|Overall Study|Physician Decision|0|||
160703121|NCT02383810|580291613|FG006|Overall Study|Physician Decision|0|||
160703122|NCT02383810|580291614|FG007|Overall Study|Physician Decision|0|||
160703123|NCT02383810|580291607|FG000|Overall Study|Withdrawal by Subject|2|||
160703124|NCT02383810|580291608|FG001|Overall Study|Withdrawal by Subject|3|||
160703125|NCT02383810|580291609|FG002|Overall Study|Withdrawal by Subject|3|||
160703126|NCT02383810|580291610|FG003|Overall Study|Withdrawal by Subject|3|||
160703127|NCT02383810|580291611|FG004|Overall Study|Withdrawal by Subject|0|||
160703128|NCT02383810|580291612|FG005|Overall Study|Withdrawal by Subject|0|||
160703129|NCT02383810|580291613|FG006|Overall Study|Withdrawal by Subject|0|||
160703130|NCT02383810|580291614|FG007|Overall Study|Withdrawal by Subject|0|||
160703131|NCT02383810|580291607|FG000|Overall Study|Adverse Event|0|||
160703132|NCT02383810|580291608|FG001|Overall Study|Adverse Event|2|||
160703133|NCT02383810|580291609|FG002|Overall Study|Adverse Event|4|||
160703134|NCT02383810|580291610|FG003|Overall Study|Adverse Event|5|||
160703135|NCT02383810|580291611|FG004|Overall Study|Adverse Event|0|||
160703136|NCT02383810|580291612|FG005|Overall Study|Adverse Event|1|||
160703137|NCT02383810|580291613|FG006|Overall Study|Adverse Event|1|||
160703138|NCT02383810|580291614|FG007|Overall Study|Adverse Event|0|||
160703139|NCT02383810|580291607|FG000|Overall Study|Lost to Follow-up|0|||
160703140|NCT02383810|580291608|FG001|Overall Study|Lost to Follow-up|1|||
160703141|NCT02383810|580291609|FG002|Overall Study|Lost to Follow-up|0|||
160703142|NCT02383810|580291610|FG003|Overall Study|Lost to Follow-up|1|||
160703143|NCT02383810|580291611|FG004|Overall Study|Lost to Follow-up|0|||
160703144|NCT02383810|580291612|FG005|Overall Study|Lost to Follow-up|0|||
160703145|NCT02383810|580291613|FG006|Overall Study|Lost to Follow-up|0|||
160703146|NCT02383810|580291614|FG007|Overall Study|Lost to Follow-up|0|||
160703147|NCT02383810|580291607|FG000|Overall Study|other|0|||
160703148|NCT02383810|580291608|FG001|Overall Study|other|0|||
160703149|NCT02383810|580291609|FG002|Overall Study|other|0|||
160703150|NCT02383810|580291610|FG003|Overall Study|other|2|||
160703151|NCT02383810|580291611|FG004|Overall Study|other|0|||
160703152|NCT02383810|580291612|FG005|Overall Study|other|0|||
160703153|NCT02383810|580291613|FG006|Overall Study|other|0|||
160703154|NCT02383810|580291614|FG007|Overall Study|other|0|||
160703155|NCT02383810|580291607|FG000|Overall Study|subject did not receive study treatment|0|||
160703156|NCT02383810|580291608|FG001|Overall Study|subject did not receive study treatment|1|||
160703157|NCT02383810|580291609|FG002|Overall Study|subject did not receive study treatment|0|||
160703158|NCT02383810|580291610|FG003|Overall Study|subject did not receive study treatment|0|||
160703159|NCT02383810|580291611|FG004|Overall Study|subject did not receive study treatment|0|||
160703160|NCT02383810|580291612|FG005|Overall Study|subject did not receive study treatment|0|||
160703161|NCT02383810|580291613|FG006|Overall Study|subject did not receive study treatment|0|||
160703162|NCT02383810|580291614|FG007|Overall Study|subject did not receive study treatment|0|||
160703163|NCT01438996|580291617|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
160703164|NCT01438996|580291618|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
160703165|NCT01438996|580291619|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
160703166|NCT02246114|580291620|FG000|Overall Study|miscarriage|1|||
160703167|NCT02246114|580291621|FG001|Overall Study|miscarriage|0|||
160703168|NCT02278055|580291624|FG000|Overall Study|Adverse Event|1|||
160703169|NCT02278055|580291624|FG000|Overall Study|Lost to Follow-up|1|||
160703170|NCT02278055|580291624|FG000|Overall Study|Withdrawal by Subject|2|||
160703171|NCT02278055|580291624|FG000|Overall Study|Progressive Disease|4|||
160703172|NCT01934335|580291625|FG000|Overall Study|Withdrawal by Subject|1|||
160703173|NCT01934335|580291626|FG001|Overall Study|Withdrawal by Subject|1|||
160703174|NCT01111825|580291627|FG000|Overall Study|Withdrawal by Subject|0|||
160703175|NCT01111825|580291628|FG001|Overall Study|Withdrawal by Subject|0|||
160703176|NCT01111825|580291629|FG002|Overall Study|Withdrawal by Subject|1|||
160703177|NCT01111825|580291630|FG003|Overall Study|Withdrawal by Subject|0|||
160703178|NCT01111825|580291627|FG000|Overall Study|Lost to Follow-up|0|||
160703179|NCT01111825|580291628|FG001|Overall Study|Lost to Follow-up|0|||
160703180|NCT01111825|580291629|FG002|Overall Study|Lost to Follow-up|3|||
160703181|NCT01111825|580291630|FG003|Overall Study|Lost to Follow-up|1|||
160703182|NCT01111825|580291627|FG000|Overall Study|Adverse Event|2|||
160703183|NCT01111825|580291628|FG001|Overall Study|Adverse Event|1|||
160703184|NCT01111825|580291629|FG002|Overall Study|Adverse Event|4|||
160703185|NCT01111825|580291630|FG003|Overall Study|Adverse Event|0|||
160703186|NCT01111825|580291627|FG000|Overall Study|Disease Progression|1|||
160703187|NCT01111825|580291628|FG001|Overall Study|Disease Progression|0|||
160703188|NCT01111825|580291629|FG002|Overall Study|Disease Progression|0|||
160703189|NCT01111825|580291630|FG003|Overall Study|Disease Progression|0|||
160703190|NCT01111825|580291627|FG000|Overall Study|Discontinuation by Sponsor|0|||
160703191|NCT01111825|580291628|FG001|Overall Study|Discontinuation by Sponsor|0|||
160703192|NCT01111825|580291629|FG002|Overall Study|Discontinuation by Sponsor|0|||
160703193|NCT01111825|580291630|FG003|Overall Study|Discontinuation by Sponsor|20|||
160703194|NCT00469144|580291631|FG000|Overall Study|Death|0|||
160703195|NCT00469144|580291632|FG001|Overall Study|Death|1|||
160703196|NCT00469144|580291631|FG000|Overall Study|No Response|5|||
160703197|NCT00469144|580291632|FG001|Overall Study|No Response|5|||
160703198|NCT00469144|580291631|FG000|Overall Study|Progressive Disease|1|||
160703199|NCT00469144|580291632|FG001|Overall Study|Progressive Disease|0|||
160703200|NCT01994291|580291633|FG000|Overall Study|Adverse Event|4|||
160703201|NCT01994291|580291634|FG001|Overall Study|Adverse Event|1|||
160703202|NCT01994291|580291635|FG002|Overall Study|Adverse Event|3|||
160703203|NCT01994291|580291633|FG000|Overall Study|Lost to Follow-up|1|||
160703204|NCT01994291|580291634|FG001|Overall Study|Lost to Follow-up|1|||
160703205|NCT01994291|580291635|FG002|Overall Study|Lost to Follow-up|0|||
160703206|NCT01994291|580291633|FG000|Overall Study|Does not meet entrance criteria|1|||
160703207|NCT01994291|580291634|FG001|Overall Study|Does not meet entrance criteria|0|||
160703208|NCT01994291|580291635|FG002|Overall Study|Does not meet entrance criteria|0|||
160703209|NCT01994291|580291633|FG000|Overall Study|Medication error without associated AE|1|||
160703210|NCT01994291|580291634|FG001|Overall Study|Medication error without associated AE|0|||
160703211|NCT01994291|580291635|FG002|Overall Study|Medication error without associated AE|1|||
160703212|NCT01994291|580291633|FG000|Overall Study|Protocol Violation|1|||
160703213|NCT01994291|580291634|FG001|Overall Study|Protocol Violation|0|||
160703214|NCT01994291|580291635|FG002|Overall Study|Protocol Violation|0|||
160703215|NCT01994291|580291633|FG000|Overall Study|Withdrawal by Subject|6|||
160703216|NCT01994291|580291634|FG001|Overall Study|Withdrawal by Subject|3|||
160703217|NCT01994291|580291635|FG002|Overall Study|Withdrawal by Subject|5|||
160703218|NCT01994291|580291633|FG000|Overall Study|Other|1|||
160703219|NCT01994291|580291634|FG001|Overall Study|Other|2|||
160703220|NCT01994291|580291635|FG002|Overall Study|Other|0|||
160703221|NCT03016975|580291645|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
160703222|NCT03016975|580291646|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
160703223|NCT03016975|580291647|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
160703224|NCT03016975|580291645|FG000|At 6 Months Follow-up|Death|2|||
160703225|NCT03016975|580291646|FG001|At 6 Months Follow-up|Death|0|||
160703226|NCT03016975|580291647|FG002|At 6 Months Follow-up|Death|0|||
160703227|NCT03016975|580291645|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
160703228|NCT03016975|580291646|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
160703229|NCT03016975|580291647|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
160703230|NCT03016975|580291645|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
160703231|NCT03016975|580291646|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
160703232|NCT03016975|580291647|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
160703233|NCT03016975|580291645|FG000|At 6 Months Follow-up|Aborted implant|1|||
160703234|NCT03016975|580291646|FG001|At 6 Months Follow-up|Aborted implant|0|||
160703235|NCT03016975|580291647|FG002|At 6 Months Follow-up|Aborted implant|0|||
160703236|NCT03016975|580291645|FG000|At 2 Year Follow-up|Death|1|||
160703237|NCT03016975|580291646|FG001|At 2 Year Follow-up|Death|0|||
160703238|NCT03016975|580291647|FG002|At 2 Year Follow-up|Death|0|||
160703239|NCT03016975|580291645|FG000|At 3 Year Follow-up|Death|1|||
160703240|NCT03016975|580291646|FG001|At 3 Year Follow-up|Death|0|||
160703241|NCT03016975|580291647|FG002|At 3 Year Follow-up|Death|0|||
160703242|NCT03016975|580291645|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
160703243|NCT03016975|580291646|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
160703244|NCT03016975|580291647|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
160703245|NCT03016975|580291645|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
160703246|NCT03016975|580291646|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
160703247|NCT03016975|580291647|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
160703248|NCT02901548|580291648|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
160703249|NCT00811928|580291649|FG000|Overall Study|AEs and SAEs Including Death|7|||
160703250|NCT00811928|580291650|FG001|Overall Study|AEs and SAEs Including Death|11|||
160703251|NCT00811928|580291649|FG000|Overall Study|Withdrawal by Subject|18|||
160703252|NCT00811928|580291650|FG001|Overall Study|Withdrawal by Subject|12|||
160703253|NCT00811928|580291649|FG000|Overall Study|Did Not Take Study Drug|3|||
160703254|NCT00811928|580291650|FG001|Overall Study|Did Not Take Study Drug|0|||
160703255|NCT00811928|580291649|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
160703256|NCT00811928|580291650|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
160703257|NCT00811928|580291649|FG000|Overall Study|Investigator Decision|2|||
160703258|NCT00811928|580291650|FG001|Overall Study|Investigator Decision|1|||
160703259|NCT00811928|580291649|FG000|Overall Study|Poor Compliance|2|||
160703260|NCT00811928|580291650|FG001|Overall Study|Poor Compliance|5|||
160703261|NCT00314951|580291651|FG000|Treatment|Didn't meet criteria for mITT population|16|||
160703262|NCT00314951|580291652|FG001|Treatment|Didn't meet criteria for mITT population|11|||
160703263|NCT00314951|580291651|FG000|Follow-up|mITT failure|44|||
160703264|NCT00314951|580291652|FG001|Follow-up|mITT failure|34|||
160703265|NCT00920790|580291653|FG000|Overall Study|aggravation of general condition|14|||
160703266|NCT00838435|580291654|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
160703267|NCT00838435|580291654|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
160703268|NCT00838435|580291654|FG000|Part 2 (7 Years)|Adverse Event|2|||
160703269|NCT00838435|580291654|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
160703270|NCT00838435|580291654|FG000|Part 2 (7 Years)|Physician Decision|1|||
160703271|NCT00838435|580291654|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
160703272|NCT00838435|580291654|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
160703273|NCT02348723|580291655|FG000|Overall Study|No ablation|21|||
160703274|NCT02348723|580291656|FG001|Overall Study|No ablation|20|||
160703275|NCT02348723|580291655|FG000|Overall Study|Non-compliant with Protocol|1|||
160703276|NCT02348723|580291656|FG001|Overall Study|Non-compliant with Protocol|0|||
160703277|NCT02348723|580291655|FG000|Overall Study|Lost to Follow-up|1|||
160703278|NCT02348723|580291656|FG001|Overall Study|Lost to Follow-up|1|||
160703279|NCT02348723|580291655|FG000|Overall Study|Consent withdrawn|1|||
160703280|NCT02348723|580291656|FG001|Overall Study|Consent withdrawn|3|||
160703281|NCT02348723|580291655|FG000|Overall Study|Reason other than specified|1|||
160703282|NCT02348723|580291656|FG001|Overall Study|Reason other than specified|1|||
160703283|NCT02348723|580291655|FG000|Overall Study|Adverse Event|3|||
160703284|NCT02348723|580291656|FG001|Overall Study|Adverse Event|1|||
160703285|NCT00678886|580291657|FG000|Overall Study|Withdrawal by Subject|0|||
160703286|NCT00678886|580291658|FG001|Overall Study|Withdrawal by Subject|0|||
160703287|NCT00678886|580291659|FG002|Overall Study|Withdrawal by Subject|4|||
160703288|NCT00678886|580291660|FG003|Overall Study|Withdrawal by Subject|6|||
160703289|NCT00678886|580291657|FG000|Overall Study|Physician Decision|0|||
160703290|NCT00678886|580291658|FG001|Overall Study|Physician Decision|0|||
160703291|NCT00678886|580291659|FG002|Overall Study|Physician Decision|1|||
160703292|NCT00678886|580291660|FG003|Overall Study|Physician Decision|1|||
160703293|NCT00678886|580291657|FG000|Overall Study|Lost to Follow-up|0|||
160703294|NCT00678886|580291658|FG001|Overall Study|Lost to Follow-up|0|||
160703295|NCT00678886|580291659|FG002|Overall Study|Lost to Follow-up|3|||
160703296|NCT00678886|580291660|FG003|Overall Study|Lost to Follow-up|2|||
160703297|NCT00678886|580291657|FG000|Overall Study|Other|0|||
160703298|NCT00678886|580291658|FG001|Overall Study|Other|0|||
160703299|NCT00678886|580291659|FG002|Overall Study|Other|1|||
160703300|NCT00678886|580291660|FG003|Overall Study|Other|0|||
160703301|NCT02245412|580293311|FG000|Treatment Period|Death|1|||
160703302|NCT02245412|580293312|FG001|Treatment Period|Death|1|||
160703303|NCT02245412|580293313|FG002|Treatment Period|Death|0|||
160703304|NCT02245412|580293311|FG000|Treatment Period|Physician Decision|1|||
160703305|NCT02245412|580293312|FG001|Treatment Period|Physician Decision|1|||
160703306|NCT02245412|580293313|FG002|Treatment Period|Physician Decision|0|||
160703307|NCT02245412|580293311|FG000|Treatment Period|Withdrawal by Subject|2|||
160703308|NCT02245412|580293312|FG001|Treatment Period|Withdrawal by Subject|1|||
160703309|NCT02245412|580293313|FG002|Treatment Period|Withdrawal by Subject|0|||
160703310|NCT02245412|580293311|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
160703311|NCT02245412|580293312|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
160703312|NCT02245412|580293313|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
160703313|NCT02245412|580293311|FG000|Follow-Up Period|Death|4|||
160703314|NCT02245412|580293312|FG001|Follow-Up Period|Death|2|||
160703315|NCT02245412|580293313|FG002|Follow-Up Period|Death|1|||
160703316|NCT02245412|580293311|FG000|Follow-Up Period|Physician Decision|1|||
160703317|NCT02245412|580293312|FG001|Follow-Up Period|Physician Decision|0|||
160703318|NCT02245412|580293313|FG002|Follow-Up Period|Physician Decision|0|||
160703319|NCT02245412|580293311|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
160703320|NCT02245412|580293312|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
160703321|NCT02245412|580293313|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
160703322|NCT01056289|580293317|FG000|Open-label Phase|Adverse Event|29|||
160703323|NCT01056289|580293318|FG001|Open-label Phase|Adverse Event|0|||
160703324|NCT01056289|580293319|FG002|Open-label Phase|Adverse Event|0|||
160703325|NCT01056289|580293320|FG003|Open-label Phase|Adverse Event|0|||
160703326|NCT01056289|580293317|FG000|Open-label Phase|Lost to Follow-up|30|||
160703327|NCT01056289|580293318|FG001|Open-label Phase|Lost to Follow-up|0|||
160703328|NCT01056289|580293319|FG002|Open-label Phase|Lost to Follow-up|0|||
160703329|NCT01056289|580293320|FG003|Open-label Phase|Lost to Follow-up|0|||
160703330|NCT01056289|580293317|FG000|Open-label Phase|Other|9|||
160703331|NCT01056289|580293318|FG001|Open-label Phase|Other|0|||
160703332|NCT01056289|580293319|FG002|Open-label Phase|Other|0|||
160703333|NCT01056289|580293320|FG003|Open-label Phase|Other|0|||
160703334|NCT01056289|580293317|FG000|Open-label Phase|Protocol Violation|6|||
160703335|NCT01056289|580293318|FG001|Open-label Phase|Protocol Violation|0|||
160703336|NCT01056289|580293319|FG002|Open-label Phase|Protocol Violation|0|||
160703337|NCT01056289|580293320|FG003|Open-label Phase|Protocol Violation|0|||
160703338|NCT01056289|580293317|FG000|Open-label Phase|Withdrawal by Subject|26|||
160703339|NCT01056289|580293318|FG001|Open-label Phase|Withdrawal by Subject|0|||
160703340|NCT01056289|580293319|FG002|Open-label Phase|Withdrawal by Subject|0|||
160703341|NCT01056289|580293320|FG003|Open-label Phase|Withdrawal by Subject|0|||
160703342|NCT01056289|580293317|FG000|Open-label Phase|Lack of Efficacy|18|||
160703343|NCT01056289|580293318|FG001|Open-label Phase|Lack of Efficacy|0|||
160703344|NCT01056289|580293319|FG002|Open-label Phase|Lack of Efficacy|0|||
160703345|NCT01056289|580293320|FG003|Open-label Phase|Lack of Efficacy|0|||
160703346|NCT01056289|580293317|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
160703347|NCT01056289|580293318|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
160703348|NCT01056289|580293319|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
160703349|NCT01056289|580293320|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
160703350|NCT01056289|580293317|FG000|Double-blind Phase|Adverse Event|0|||
160703351|NCT01056289|580293318|FG001|Double-blind Phase|Adverse Event|1|||
160703352|NCT01056289|580293319|FG002|Double-blind Phase|Adverse Event|2|||
160703353|NCT01056289|580293320|FG003|Double-blind Phase|Adverse Event|1|||
160703354|NCT01056289|580293317|FG000|Double-blind Phase|Lost to Follow-up|0|||
160703355|NCT01056289|580293318|FG001|Double-blind Phase|Lost to Follow-up|2|||
160703356|NCT01056289|580293319|FG002|Double-blind Phase|Lost to Follow-up|2|||
160703357|NCT01056289|580293320|FG003|Double-blind Phase|Lost to Follow-up|2|||
160703358|NCT01056289|580293317|FG000|Double-blind Phase|Other|0|||
160703359|NCT01056289|580293318|FG001|Double-blind Phase|Other|0|||
160703360|NCT01056289|580293319|FG002|Double-blind Phase|Other|1|||
160703361|NCT01056289|580293320|FG003|Double-blind Phase|Other|2|||
160703362|NCT01056289|580293317|FG000|Double-blind Phase|Protocol Violation|0|||
160703363|NCT01056289|580293318|FG001|Double-blind Phase|Protocol Violation|0|||
160703364|NCT01056289|580293319|FG002|Double-blind Phase|Protocol Violation|1|||
160703365|NCT01056289|580293320|FG003|Double-blind Phase|Protocol Violation|1|||
160703366|NCT01056289|580293317|FG000|Double-blind Phase|Withdrawal by Subject|0|||
160703367|NCT01056289|580293318|FG001|Double-blind Phase|Withdrawal by Subject|0|||
160703368|NCT01056289|580293319|FG002|Double-blind Phase|Withdrawal by Subject|4|||
160703369|NCT01056289|580293320|FG003|Double-blind Phase|Withdrawal by Subject|2|||
160703370|NCT01056289|580293317|FG000|Double-blind Phase|Discontinuation symptom|0|||
160703371|NCT01056289|580293318|FG001|Double-blind Phase|Discontinuation symptom|1|||
160703372|NCT01056289|580293319|FG002|Double-blind Phase|Discontinuation symptom|2|||
160703373|NCT01056289|580293320|FG003|Double-blind Phase|Discontinuation symptom|2|||
160703374|NCT01056289|580293317|FG000|Double-blind Phase|Physician Decision|0|||
160703375|NCT01056289|580293318|FG001|Double-blind Phase|Physician Decision|0|||
160703376|NCT01056289|580293319|FG002|Double-blind Phase|Physician Decision|1|||
160703377|NCT01056289|580293320|FG003|Double-blind Phase|Physician Decision|0|||
160703378|NCT00270855|580293329|FG000|Overall Study|Withdrawal by Subject|8|||
160703379|NCT00270855|580293330|FG001|Overall Study|Withdrawal by Subject|8|||
160703380|NCT03156504|580293334|FG000|Overall Study|Withdrawal by Subject|1|||
160703381|NCT05048329|580293335|FG000|Overall Study|Withdrawal by Subject|1|||
160703382|NCT05048329|580293335|FG000|Overall Study|Screenfail|1|||
160703383|NCT03301649|580293336|FG000|Overall Study|Need alternate therapy due to live lice|17|||
160703384|NCT03301649|580293337|FG001|Overall Study|Need alternate therapy due to live lice|25|||
160703385|NCT03301649|580293338|FG002|Overall Study|Need alternate therapy due to live lice|81|||
160703386|NCT03301649|580293336|FG000|Overall Study|Lost to Follow-up|11|||
160703387|NCT03301649|580293337|FG001|Overall Study|Lost to Follow-up|11|||
160703388|NCT03301649|580293338|FG002|Overall Study|Lost to Follow-up|3|||
160703389|NCT03301649|580293336|FG000|Overall Study|Protocol Violation|0|||
160703390|NCT03301649|580293337|FG001|Overall Study|Protocol Violation|1|||
160703391|NCT03301649|580293338|FG002|Overall Study|Protocol Violation|1|||
160703392|NCT03301649|580293336|FG000|Overall Study|Withdrawal by Subject|10|||
160703393|NCT03301649|580293337|FG001|Overall Study|Withdrawal by Subject|4|||
160703394|NCT03301649|580293338|FG002|Overall Study|Withdrawal by Subject|0|||
160703395|NCT03301649|580293336|FG000|Overall Study|Other than specified|5|||
160703396|NCT03301649|580293337|FG001|Overall Study|Other than specified|3|||
160703397|NCT03301649|580293338|FG002|Overall Study|Other than specified|0|||
160703398|NCT01403051|580293339|FG000|Overall Study|Protocol Violation|2|||
160703399|NCT01403051|580293340|FG001|Overall Study|Protocol Violation|0|||
160703400|NCT01403051|580293339|FG000|Overall Study|Death|1|||
160703401|NCT01403051|580293340|FG001|Overall Study|Death|0|||
160703402|NCT01403051|580293339|FG000|Overall Study|Withdrawal by Subject|2|||
160703403|NCT01403051|580293340|FG001|Overall Study|Withdrawal by Subject|1|||
160703404|NCT01403051|580293339|FG000|Overall Study|Lost to Follow-up|5|||
160703405|NCT01403051|580293340|FG001|Overall Study|Lost to Follow-up|5|||
160703406|NCT01377987|580293341|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
160703407|NCT01377987|580293342|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
160703408|NCT00168818|580293343|FG000|Overall Study|Adverse Event|23|||
160703409|NCT00168818|580293344|FG001|Overall Study|Adverse Event|29|||
160703410|NCT00168818|580293345|FG002|Overall Study|Adverse Event|31|||
160703411|NCT00168818|580293343|FG000|Overall Study|Protocol Violation|16|||
160703412|NCT00168818|580293344|FG001|Overall Study|Protocol Violation|11|||
160703413|NCT00168818|580293345|FG002|Overall Study|Protocol Violation|11|||
160703414|NCT00168818|580293343|FG000|Overall Study|Lost to Follow-up|13|||
160703415|NCT00168818|580293344|FG001|Overall Study|Lost to Follow-up|4|||
160703416|NCT00168818|580293345|FG002|Overall Study|Lost to Follow-up|15|||
160703417|NCT00168818|580293343|FG000|Overall Study|Withdrawal by Subject|43|||
160703418|NCT00168818|580293344|FG001|Overall Study|Withdrawal by Subject|41|||
160703419|NCT00168818|580293345|FG002|Overall Study|Withdrawal by Subject|37|||
160703420|NCT00168818|580293343|FG000|Overall Study|Other|22|||
160703421|NCT00168818|580293344|FG001|Overall Study|Other|24|||
160703422|NCT00168818|580293345|FG002|Overall Study|Other|30|||
160703423|NCT00168818|580293343|FG000|Treatment|Adverse Event|77|||
160703424|NCT00168818|580293344|FG001|Treatment|Adverse Event|89|||
160703425|NCT00168818|580293345|FG002|Treatment|Adverse Event|68|||
160703426|NCT00168818|580293343|FG000|Treatment|Protocol Violation|8|||
160703427|NCT00168818|580293344|FG001|Treatment|Protocol Violation|11|||
160703428|NCT00168818|580293345|FG002|Treatment|Protocol Violation|11|||
160703429|NCT00168818|580293343|FG000|Treatment|Lost to Follow-up|0|||
160703430|NCT00168818|580293344|FG001|Treatment|Lost to Follow-up|2|||
160703431|NCT00168818|580293345|FG002|Treatment|Lost to Follow-up|1|||
160703432|NCT00168818|580293343|FG000|Treatment|Withdrawal by Subject|25|||
160703433|NCT00168818|580293344|FG001|Treatment|Withdrawal by Subject|20|||
160703434|NCT00168818|580293345|FG002|Treatment|Withdrawal by Subject|22|||
160703435|NCT00168818|580293343|FG000|Treatment|Other|23|||
160703436|NCT00168818|580293344|FG001|Treatment|Other|29|||
160703437|NCT00168818|580293345|FG002|Treatment|Other|31|||
160703438|NCT01775189|580293346|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160703439|NCT01775189|580293347|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
160703440|NCT01775189|580293348|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160703441|NCT01775189|580293349|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160703442|NCT01775189|580293350|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160703443|NCT01775189|580293351|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160703444|NCT01775189|580293352|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160703445|NCT01775189|580293346|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160703446|NCT01775189|580293347|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
160703447|NCT01775189|580293348|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160703448|NCT01775189|580293349|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160703449|NCT01775189|580293350|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160703450|NCT01775189|580293351|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160703451|NCT01775189|580293352|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160703452|NCT01775189|580293346|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
160703453|NCT01775189|580293347|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
160703454|NCT01775189|580293348|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
160703455|NCT01775189|580293349|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
160703456|NCT01775189|580293350|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
160703457|NCT01775189|580293351|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
160703458|NCT01775189|580293352|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
160703459|NCT01775189|580293346|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
160703460|NCT01775189|580293347|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
160703461|NCT01775189|580293348|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
160703462|NCT01775189|580293349|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
160703463|NCT01775189|580293350|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
160703464|NCT01775189|580293351|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
160703465|NCT01775189|580293352|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
160703466|NCT01775189|580293346|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
160703467|NCT01775189|580293347|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
160703468|NCT01775189|580293348|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
160703469|NCT01775189|580293349|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
160703470|NCT01775189|580293350|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
160703471|NCT01775189|580293351|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
160703472|NCT01775189|580293352|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
160703473|NCT01775189|580293346|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
160703474|NCT01775189|580293347|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
160703475|NCT01775189|580293348|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
160703476|NCT01775189|580293349|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
160703477|NCT01775189|580293350|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
160703478|NCT01775189|580293351|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
160703479|NCT01775189|580293352|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
160703480|NCT02227446|580293353|FG000|Overall Study|not eligible post randomization|18|||
160703481|NCT02227446|580293354|FG001|Overall Study|not eligible post randomization|29|||
160703482|NCT02227446|580293353|FG000|Overall Study|Withdrawal by Subject|4|||
160703483|NCT02227446|580293354|FG001|Overall Study|Withdrawal by Subject|5|||
160703484|NCT04893018|580293362|FG000|Overall Study|Lost to Follow-up|1|||
160703485|NCT04893018|580293363|FG001|Overall Study|Lost to Follow-up|0|||
160703486|NCT04893018|580293362|FG000|Overall Study|Withdrawal by Subject|2|||
160703487|NCT04893018|580293363|FG001|Overall Study|Withdrawal by Subject|0|||
160703488|NCT04893018|580293362|FG000|Overall Study|Study Terminated|1|||
160703489|NCT04893018|580293363|FG001|Overall Study|Study Terminated|2|||
160703490|NCT03336528|580293364|FG000|Overall Study|Protocol Violation|1|||
160703491|NCT03336528|580293365|FG001|Overall Study|Protocol Violation|1|||
160703492|NCT03336528|580293364|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
160703493|NCT03336528|580293365|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
160703494|NCT03336528|580293364|FG000|Overall Study|Did not receive study medication|1|||
160703495|NCT03336528|580293365|FG001|Overall Study|Did not receive study medication|2|||
160703496|NCT01085357|580293366|FG000|Overall Study|Adverse Event|1|||
160703497|NCT01085357|580293367|FG001|Overall Study|Adverse Event|1|||
160703498|NCT01085357|580293366|FG000|Overall Study|Subject Decision|4|||
160703499|NCT01085357|580293367|FG001|Overall Study|Subject Decision|3|||
160703500|NCT01085357|580293366|FG000|Overall Study|Investigator Decision|1|||
160703501|NCT01085357|580293367|FG001|Overall Study|Investigator Decision|1|||
160703502|NCT01085357|580293366|FG000|Overall Study|Death|11|||
160703503|NCT01085357|580293367|FG001|Overall Study|Death|1|||
160703504|NCT01085357|580293366|FG000|Overall Study|Lost to Follow-up|2|||
160703505|NCT01085357|580293367|FG001|Overall Study|Lost to Follow-up|0|||
160703506|NCT02910011|580293370|FG000|Overall Study|Physician Decision|2|||
160703507|NCT04411914|580293371|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
160703508|NCT04411914|580293372|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
160703509|NCT00423319|580293376|FG000|Overall Study|Death|2|||
160703510|NCT00423319|580293377|FG001|Overall Study|Death|0|||
160703511|NCT00423319|580293376|FG000|Overall Study|Adverse Event|93|||
160703512|NCT00423319|580293377|FG001|Overall Study|Adverse Event|112|||
160703513|NCT00423319|580293376|FG000|Overall Study|Withdrawal by Subject|86|||
160703514|NCT00423319|580293377|FG001|Overall Study|Withdrawal by Subject|99|||
160703515|NCT00423319|580293376|FG000|Overall Study|Lost to Follow-up|4|||
160703516|NCT00423319|580293377|FG001|Overall Study|Lost to Follow-up|3|||
160703517|NCT00423319|580293376|FG000|Overall Study|Poor compliance or noncompliance|1|||
160703518|NCT00423319|580293377|FG001|Overall Study|Poor compliance or noncompliance|1|||
160703519|NCT00423319|580293376|FG000|Overall Study|No longer meets study criteria|15|||
160703520|NCT00423319|580293377|FG001|Overall Study|No longer meets study criteria|15|||
160703521|NCT00423319|580293376|FG000|Overall Study|Other|23|||
160703522|NCT00423319|580293377|FG001|Overall Study|Other|22|||
160703523|NCT02087189|580293379|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
160703524|NCT03136965|580293380|FG000|Overall Study|Lost to Follow-up|0|||
160703525|NCT03136965|580293381|FG001|Overall Study|Lost to Follow-up|1|||
160703526|NCT03136965|580293382|FG002|Overall Study|Lost to Follow-up|0|||
160703527|NCT01210612|580293385|FG000|Overall Study|Withdrawal by Subject|0|||
160703528|NCT01210612|580293386|FG001|Overall Study|Withdrawal by Subject|2|||
160703529|NCT02752087|580293387|FG000|Washout|Physician Decision|1|||
160703530|NCT02752087|580293388|FG001|Washout|Physician Decision|0|||
160703531|NCT02458287|580293389|FG000|Overall Study|Adverse Event|0|||
160703532|NCT02458287|580293390|FG001|Overall Study|Adverse Event|0|||
160703533|NCT02458287|580293391|FG002|Overall Study|Adverse Event|0|||
160703534|NCT02458287|580293392|FG003|Overall Study|Adverse Event|1|||
160703535|NCT02458287|580293389|FG000|Overall Study|Lost to Follow-up|0|||
160703536|NCT02458287|580293390|FG001|Overall Study|Lost to Follow-up|1|||
160703537|NCT02458287|580293391|FG002|Overall Study|Lost to Follow-up|1|||
160703538|NCT02458287|580293392|FG003|Overall Study|Lost to Follow-up|0|||
160703539|NCT02458287|580293389|FG000|Overall Study|Protocol Violation|0|||
160703540|NCT02458287|580293390|FG001|Overall Study|Protocol Violation|1|||
160703541|NCT02458287|580293391|FG002|Overall Study|Protocol Violation|0|||
160703542|NCT02458287|580293392|FG003|Overall Study|Protocol Violation|0|||
160703543|NCT02458287|580293389|FG000|Overall Study|Withdrawal by Subject|0|||
160703544|NCT02458287|580293390|FG001|Overall Study|Withdrawal by Subject|2|||
160703545|NCT02458287|580293391|FG002|Overall Study|Withdrawal by Subject|2|||
160703546|NCT02458287|580293392|FG003|Overall Study|Withdrawal by Subject|1|||
160703547|NCT02458287|580293389|FG000|Overall Study|Relocated Out of State|0|||
160703548|NCT02458287|580293390|FG001|Overall Study|Relocated Out of State|0|||
160703549|NCT02458287|580293391|FG002|Overall Study|Relocated Out of State|0|||
160703550|NCT02458287|580293392|FG003|Overall Study|Relocated Out of State|1|||
160703551|NCT00843635|580293393|FG000|Overall Study|Adverse Event|2|||
160703552|NCT00843635|580293394|FG001|Overall Study|Adverse Event|2|||
160703553|NCT00843635|580293395|FG002|Overall Study|Adverse Event|0|||
160703554|NCT04693416|580293396|FG000|Overall Study|Lost to Follow-up|13|||
160703555|NCT04693416|580293397|FG001|Overall Study|Lost to Follow-up|0|||
160703556|NCT02290223|580293398|FG000|6 Months|Lost to Follow-up|9|||
160703557|NCT02290223|580293399|FG001|6 Months|Lost to Follow-up|6|||
160703558|NCT02290223|580293398|FG000|6 Months|Withdrawal by Subject|5|||
160703559|NCT02290223|580293399|FG001|6 Months|Withdrawal by Subject|0|||
160703560|NCT02290223|580293398|FG000|6 Months|deceased (not related to study)|2|||
160703561|NCT02290223|580293399|FG001|6 Months|deceased (not related to study)|0|||
160703562|NCT02290223|580293398|FG000|12 Months|Lost to Follow-up|16|||
160703563|NCT02290223|580293399|FG001|12 Months|Lost to Follow-up|10|||
160703564|NCT02290223|580293398|FG000|12 Months|Refusal|0|||
160703565|NCT02290223|580293399|FG001|12 Months|Refusal|1|||
160703566|NCT05293639|580293400|FG000|Overall Study|Withdrawal by Subject|1|||
160703567|NCT05293639|580293401|FG001|Overall Study|Withdrawal by Subject|1|||
160703568|NCT05293639|580293402|FG002|Overall Study|Withdrawal by Subject|2|||
160703569|NCT05293639|580293400|FG000|Overall Study|Death|0|||
160703570|NCT05293639|580293401|FG001|Overall Study|Death|1|||
160703571|NCT05293639|580293402|FG002|Overall Study|Death|0|||
160703572|NCT05293639|580293400|FG000|Overall Study|Lost to Follow-up|0|||
160703573|NCT05293639|580293401|FG001|Overall Study|Lost to Follow-up|0|||
160703574|NCT05293639|580293402|FG002|Overall Study|Lost to Follow-up|5|||
160703575|NCT05293639|580293400|FG000|Overall Study|Other|0|||
160703576|NCT05293639|580293401|FG001|Overall Study|Other|0|||
160703577|NCT05293639|580293402|FG002|Overall Study|Other|1|||
160703578|NCT01671332|580293409|FG000|Overall Study|Withdrawal by Subject|1|||
160703579|NCT01671332|580293410|FG001|Overall Study|Withdrawal by Subject|1|||
160703580|NCT01458106|580293416|FG000|Overall Study|Withdrawal by Subject|2|||
160703581|NCT01458106|580293417|FG001|Overall Study|Withdrawal by Subject|0|||
160703582|NCT01458106|580293416|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
160703583|NCT01458106|580293417|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
160703584|NCT01458106|580293416|FG000|Overall Study|Withdrawn Per Protocol|0|||
160703585|NCT01458106|580293417|FG001|Overall Study|Withdrawn Per Protocol|1|||
160703586|NCT00418821|580293423|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
160703587|NCT02823652|580293424|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
160703588|NCT02823652|580293425|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
160703589|NCT02823652|580293426|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
160703590|NCT02823652|580293424|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
160703591|NCT02823652|580293425|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
160703592|NCT02823652|580293426|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
160703593|NCT02823652|580293424|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
160703594|NCT02823652|580293425|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
160703595|NCT02823652|580293426|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
160703596|NCT02823652|580293424|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
160703597|NCT02823652|580293425|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
160703598|NCT02823652|580293426|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
160703599|NCT04428333|580293427|FG000|Overall Study|Physician Decision|5|||
160703600|NCT04428333|580293428|FG001|Overall Study|Physician Decision|6|||
160703601|NCT04428333|580293427|FG000|Overall Study|Withdrawal by Subject|1|||
160703602|NCT04428333|580293428|FG001|Overall Study|Withdrawal by Subject|3|||
160703603|NCT04428333|580293427|FG000|Overall Study|Study Terminated By Sponsor|14|||
160703604|NCT04428333|580293428|FG001|Overall Study|Study Terminated By Sponsor|16|||
160703605|NCT04853992|580293429|FG000|Treatment Period A|Adverse Event|0|||
160703606|NCT04853992|580293430|FG001|Treatment Period A|Adverse Event|1|||
160703607|NCT04853992|580293429|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
160703608|NCT04853992|580293430|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
160703609|NCT02269163|580293431|FG000|Overall Study|Lost to Follow-up|1|||
160703610|NCT02269163|580293432|FG001|Overall Study|Lost to Follow-up|0|||
160703611|NCT02269163|580293431|FG000|Overall Study|Major protocol violation|0|||
160703612|NCT02269163|580293432|FG001|Overall Study|Major protocol violation|1|||
160703613|NCT02269163|580293431|FG000|Overall Study|Other|2|||
160703614|NCT02269163|580293432|FG001|Overall Study|Other|2|||
160703615|NCT02269163|580293431|FG000|Overall Study|Withdrawal by Subject|0|||
160703616|NCT02269163|580293432|FG001|Overall Study|Withdrawal by Subject|3|||
160703617|NCT02269163|580293431|FG000|Overall Study|Physician Decision|0|||
160703618|NCT02269163|580293432|FG001|Overall Study|Physician Decision|1|||
160703619|NCT02351960|580293433|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
160703620|NCT02351960|580293434|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
160703621|NCT02351960|580293433|FG000|Overall Study|Voluntary Withdrawal|5|||
160703622|NCT02351960|580293434|FG001|Overall Study|Voluntary Withdrawal|4|||
160703623|NCT02351960|580293433|FG000|Overall Study|Significant Protocol Deviation|0|||
160703624|NCT02351960|580293434|FG001|Overall Study|Significant Protocol Deviation|5|||
160703625|NCT03866902|580293437|FG000|Overall Study|Lost to Follow-up|98|||
160703626|NCT03866902|580293438|FG001|Overall Study|Lost to Follow-up|82|||
160703627|NCT03866902|580293437|FG000|Overall Study|Pregnancy|18|||
160703628|NCT03866902|580293438|FG001|Overall Study|Pregnancy|24|||
160703629|NCT02293863|580293441|FG000|Overall Study|Death|4|||
160703630|NCT02293863|580293442|FG001|Overall Study|Death|6|||
160703631|NCT02293863|580293443|FG002|Overall Study|Death|4|||
160703632|NCT02293863|580293441|FG000|Overall Study|Lost to Follow-up|2|||
160703633|NCT02293863|580293442|FG001|Overall Study|Lost to Follow-up|2|||
160703634|NCT02293863|580293443|FG002|Overall Study|Lost to Follow-up|2|||
160703635|NCT02293863|580293441|FG000|Overall Study|Withdrawal by Subject|3|||
160703636|NCT02293863|580293442|FG001|Overall Study|Withdrawal by Subject|3|||
160703637|NCT02293863|580293443|FG002|Overall Study|Withdrawal by Subject|1|||
160703638|NCT02293863|580293441|FG000|Overall Study|Reason Not Specified|0|||
160703639|NCT02293863|580293442|FG001|Overall Study|Reason Not Specified|2|||
160703640|NCT02293863|580293443|FG002|Overall Study|Reason Not Specified|2|||
160703641|NCT03155945|580293444|FG000|Overall Study|Lost to Follow-up|0|||
160703642|NCT03155945|580293445|FG001|Overall Study|Lost to Follow-up|1|||
160703643|NCT03155945|580293444|FG000|Overall Study|Withdrawal by Subject|0|||
160703644|NCT03155945|580293445|FG001|Overall Study|Withdrawal by Subject|1|||
160703645|NCT03155945|580293444|FG000|Overall Study|Other Reason|0|||
160703646|NCT03155945|580293445|FG001|Overall Study|Other Reason|1|||
160703647|NCT03408639|580295840|FG000|Overall Study|Death|5|||
160703648|NCT03408639|580295841|FG001|Overall Study|Death|5|||
160703649|NCT03408639|580295840|FG000|Overall Study|Lost to Follow-up|1|||
160703650|NCT03408639|580295841|FG001|Overall Study|Lost to Follow-up|4|||
160703651|NCT03408639|580295840|FG000|Overall Study|Withdrawal by Subject|2|||
160703652|NCT03408639|580295841|FG001|Overall Study|Withdrawal by Subject|7|||
160703653|NCT03408639|580295840|FG000|Overall Study|Physician Decision|3|||
160703654|NCT03408639|580295841|FG001|Overall Study|Physician Decision|6|||
160703655|NCT00213135|580295851|FG000|Overall Study|Adverse Event|9|||
160703656|NCT00213135|580295852|FG001|Overall Study|Adverse Event|5|||
160703657|NCT00213135|580295853|FG002|Overall Study|Adverse Event|5|||
160703658|NCT00213135|580295851|FG000|Overall Study|Lost to Follow-up|11|||
160703659|NCT00213135|580295852|FG001|Overall Study|Lost to Follow-up|8|||
160703660|NCT00213135|580295853|FG002|Overall Study|Lost to Follow-up|4|||
160703661|NCT00213135|580295851|FG000|Overall Study|Protocol Violation|4|||
160703662|NCT00213135|580295852|FG001|Overall Study|Protocol Violation|4|||
160703663|NCT00213135|580295853|FG002|Overall Study|Protocol Violation|10|||
160703664|NCT00213135|580295851|FG000|Overall Study|Death|1|||
160703665|NCT00213135|580295852|FG001|Overall Study|Death|1|||
160703666|NCT00213135|580295853|FG002|Overall Study|Death|2|||
160703667|NCT00213135|580295851|FG000|Overall Study|Disease progression|4|||
160703668|NCT00213135|580295852|FG001|Overall Study|Disease progression|5|||
160703669|NCT00213135|580295853|FG002|Overall Study|Disease progression|21|||
160703670|NCT00213135|580295851|FG000|Overall Study|Other|21|||
160703671|NCT00213135|580295852|FG001|Overall Study|Other|12|||
160703672|NCT00213135|580295853|FG002|Overall Study|Other|15|||
160703673|NCT01924754|580295858|FG000|Overall Study|Lost to Follow-up|1|||
160703674|NCT01924754|580295859|FG001|Overall Study|Lost to Follow-up|2|||
160703675|NCT01924754|580295860|FG002|Overall Study|Lost to Follow-up|1|||
160703676|NCT01924754|580295858|FG000|Overall Study|Pregnancy|0|||
160703677|NCT01924754|580295859|FG001|Overall Study|Pregnancy|1|||
160703678|NCT01924754|580295860|FG002|Overall Study|Pregnancy|2|||
160703679|NCT03132155|580295861|FG000|Overall Study|Lack of Efficacy|6|||
160703680|NCT03132155|580295861|FG000|Overall Study|Lost to Follow-up|1|||
160703681|NCT03132155|580295861|FG000|Overall Study|Withdrawal by Subject|1|||
160703682|NCT02925403|580295867|FG000|Overall Study|Lost to Follow-up|0|||
160703683|NCT02925403|580295868|FG001|Overall Study|Lost to Follow-up|1|||
160703684|NCT00402116|580295869|FG000|Overall Study|Jaw infection after surgery-other|1|||
160703685|NCT00402116|580295870|FG001|Overall Study|Jaw infection after surgery-other|0|||
160703686|NCT00402116|580295871|FG002|Overall Study|Jaw infection after surgery-other|0|||
160703687|NCT00402116|580295869|FG000|Overall Study|Withdrawal by Subject|1|||
160703688|NCT00402116|580295870|FG001|Overall Study|Withdrawal by Subject|0|||
160703689|NCT00402116|580295871|FG002|Overall Study|Withdrawal by Subject|5|||
160703690|NCT00402116|580295869|FG000|Overall Study|Treatment completed per protocol|1|||
160703691|NCT00402116|580295870|FG001|Overall Study|Treatment completed per protocol|1|||
160703692|NCT00402116|580295871|FG002|Overall Study|Treatment completed per protocol|2|||
160703693|NCT00402116|580295869|FG000|Overall Study|other complicating disease|0|||
160703694|NCT00402116|580295870|FG001|Overall Study|other complicating disease|0|||
160703695|NCT00402116|580295871|FG002|Overall Study|other complicating disease|2|||
160703696|NCT00402116|580295869|FG000|Overall Study|Disease Progression|0|||
160703697|NCT00402116|580295870|FG001|Overall Study|Disease Progression|4|||
160703698|NCT00402116|580295871|FG002|Overall Study|Disease Progression|38|||
160703699|NCT00402116|580295869|FG000|Overall Study|mistaken thrombocytopenia|0|||
160703700|NCT00402116|580295870|FG001|Overall Study|mistaken thrombocytopenia|0|||
160703701|NCT00402116|580295871|FG002|Overall Study|mistaken thrombocytopenia|1|||
160703702|NCT00402116|580295869|FG000|Overall Study|decline related hyponatremia/tumor|0|||
160703703|NCT00402116|580295870|FG001|Overall Study|decline related hyponatremia/tumor|0|||
160703704|NCT00402116|580295871|FG002|Overall Study|decline related hyponatremia/tumor|1|||
160703705|NCT00402116|580295869|FG000|Overall Study|Adverse Event|0|||
160703706|NCT00402116|580295870|FG001|Overall Study|Adverse Event|1|||
160703707|NCT00402116|580295871|FG002|Overall Study|Adverse Event|6|||
160703708|NCT02899195|580295872|FG000|Concurrent Durvalumab|Adverse Event|4|||
160703709|NCT02899195|580295872|FG000|Concurrent Durvalumab|Physician Decision|1|||
160703710|NCT02899195|580295872|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
160703711|NCT02899195|580295872|FG000|Concurrent Durvalumab|Progressive Disease|5|||
160703712|NCT02899195|580295872|FG000|Maintenance Durvalumab|Adverse Event|1|||
160703713|NCT02899195|580295872|FG000|Maintenance Durvalumab|Physician Decision|1|||
160703714|NCT02899195|580295872|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
160703715|NCT02899195|580295872|FG000|Maintenance Durvalumab|Progressive Disease|31|||
160703716|NCT04778904|580295873|FG000|Overall Study|Protocol Violation|1|||
160703717|NCT04778904|580295874|FG001|Overall Study|Protocol Violation|0|||
160703718|NCT04778904|580295875|FG002|Overall Study|Protocol Violation|0|||
160703719|NCT04778904|580295876|FG003|Overall Study|Protocol Violation|0|||
160703720|NCT04778904|580295873|FG000|Overall Study|Withdrawal by Subject|0|||
160703721|NCT04778904|580295874|FG001|Overall Study|Withdrawal by Subject|0|||
160703722|NCT04778904|580295875|FG002|Overall Study|Withdrawal by Subject|1|||
160703723|NCT04778904|580295876|FG003|Overall Study|Withdrawal by Subject|0|||
160703724|NCT03452137|580295877|FG000|Overall Study|Death|67|||
160703725|NCT03452137|580295878|FG001|Overall Study|Death|70|||
160703726|NCT03452137|580295877|FG000|Overall Study|Lost to Follow-up|4|||
160703727|NCT03452137|580295878|FG001|Overall Study|Lost to Follow-up|2|||
160703728|NCT03452137|580295877|FG000|Overall Study|Physician Decision|0|||
160703729|NCT03452137|580295878|FG001|Overall Study|Physician Decision|1|||
160703730|NCT03452137|580295877|FG000|Overall Study|Study Terminated by Sponsor|120|||
160703731|NCT03452137|580295878|FG001|Overall Study|Study Terminated by Sponsor|121|||
160703732|NCT03452137|580295877|FG000|Overall Study|Withdrawal by Subject|12|||
160703733|NCT03452137|580295878|FG001|Overall Study|Withdrawal by Subject|9|||
160703734|NCT04138043|580295879|FG000|Overall Study|Withdrawal by Subject|0|||
160703735|NCT04138043|580295880|FG001|Overall Study|Withdrawal by Subject|1|||
160703736|NCT02856802|580295881|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
160703737|NCT02856802|580295882|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
160703738|NCT02856802|580295881|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
160703739|NCT02856802|580295882|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
160703740|NCT02856802|580295881|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
160703741|NCT02856802|580295882|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
160703742|NCT02856802|580295881|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
160703743|NCT02856802|580295882|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
160703744|NCT02856802|580295881|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
160703745|NCT02856802|580295882|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
160703746|NCT02856802|580295881|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
160703747|NCT02856802|580295882|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
160703748|NCT03772717|580295883|FG000|Overall Study|Withdrawal by Subject|2|||
160703749|NCT00587860|580295884|FG000|Overall Study|Lost to Follow-up|2|||
160703750|NCT00587860|580295885|FG001|Overall Study|Lost to Follow-up|2|||
160703751|NCT00587860|580295884|FG000|Overall Study|Withdrawal by Subject|3|||
160703752|NCT00587860|580295885|FG001|Overall Study|Withdrawal by Subject|3|||
160703753|NCT01659125|580295886|FG000|Overall Study|Withdrawal by Subject|2|||
160703754|NCT01659125|580295886|FG000|Overall Study|Lost to Follow-up|7|||
160703755|NCT01659125|580295886|FG000|Overall Study|Technical Problem|1|||
160703756|NCT01659125|580295886|FG000|Overall Study|Time Constraints|2|||
160703757|NCT01659125|580295886|FG000|Overall Study|Failed to Start Treatment|2|||
160703758|NCT00261443|580295887|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
160703759|NCT00261443|580295888|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
160703760|NCT00261443|580295889|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
160703761|NCT00261443|580295887|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
160703762|NCT00261443|580295888|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
160703763|NCT00261443|580295889|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
160703764|NCT00261443|580295887|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
160703765|NCT00261443|580295888|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
160703766|NCT00261443|580295889|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
160703767|NCT00261443|580295887|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
160703768|NCT00261443|580295888|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
160703769|NCT00261443|580295889|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
160703770|NCT00261443|580295887|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
160703771|NCT00261443|580295888|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
160703772|NCT00261443|580295889|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
160703773|NCT00261443|580295887|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
160703774|NCT00261443|580295888|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
160703775|NCT00261443|580295889|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
160703776|NCT00261443|580295887|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
160703777|NCT00261443|580295888|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
160703778|NCT00261443|580295889|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
160703779|NCT00261443|580295887|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
160703780|NCT00261443|580295888|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
160703781|NCT00261443|580295889|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
160703782|NCT00261443|580295887|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
160703783|NCT00261443|580295888|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
160703784|NCT00261443|580295889|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
160703785|NCT00261443|580295887|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
160703786|NCT00261443|580295888|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
160703787|NCT00261443|580295889|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
160703788|NCT00261443|580295887|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
160703789|NCT00261443|580295888|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
160703790|NCT00261443|580295889|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
160703791|NCT00261443|580295887|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
160703792|NCT00261443|580295888|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
160703793|NCT00261443|580295889|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
160703794|NCT00261443|580295887|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
160703795|NCT00261443|580295888|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
160703796|NCT00261443|580295889|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
160703797|NCT00261443|580295887|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
160703798|NCT00261443|580295888|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
160703799|NCT00261443|580295889|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
160703800|NCT00261443|580295887|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
160703801|NCT00261443|580295888|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
160703802|NCT00261443|580295889|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
160703803|NCT00261443|580295887|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
160703804|NCT00261443|580295888|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
160703805|NCT00261443|580295889|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
160703806|NCT00261443|580295887|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
160703807|NCT00261443|580295888|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
160703808|NCT00261443|580295889|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
160703809|NCT00261443|580295887|FG000|3: Assessment of Relapse|Adverse Event|0|||
160703810|NCT00261443|580295888|FG001|3: Assessment of Relapse|Adverse Event|15|||
160703811|NCT00261443|580295889|FG002|3: Assessment of Relapse|Adverse Event|19|||
160703812|NCT00261443|580295887|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
160703813|NCT00261443|580295888|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
160703814|NCT00261443|580295889|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
160703815|NCT00261443|580295887|FG000|3: Assessment of Relapse|Death|0|||
160703816|NCT00261443|580295888|FG001|3: Assessment of Relapse|Death|0|||
160703817|NCT00261443|580295889|FG002|3: Assessment of Relapse|Death|1|||
160703818|NCT00261443|580295887|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
160703819|NCT00261443|580295888|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
160703820|NCT00261443|580295889|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
160703821|NCT00261443|580295887|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
160703822|NCT00261443|580295888|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
160703823|NCT00261443|580295889|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
160703824|NCT00261443|580295887|FG000|3: Assessment of Relapse|Pregnancy|0|||
160703825|NCT00261443|580295888|FG001|3: Assessment of Relapse|Pregnancy|2|||
160703826|NCT00261443|580295889|FG002|3: Assessment of Relapse|Pregnancy|1|||
160703827|NCT00261443|580295887|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
160703828|NCT00261443|580295888|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
160703829|NCT00261443|580295889|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
160703830|NCT00261443|580295887|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
160703831|NCT00261443|580295888|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
160703832|NCT00261443|580295889|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
160703833|NCT00261443|580295887|FG000|3: Assessment of Relapse|Other Reasons|0|||
160703834|NCT00261443|580295888|FG001|3: Assessment of Relapse|Other Reasons|4|||
160703835|NCT00261443|580295889|FG002|3: Assessment of Relapse|Other Reasons|3|||
160703836|NCT00261443|580295887|FG000|4: Extension Phase|Adverse Event|0|||
160703837|NCT00261443|580295888|FG001|4: Extension Phase|Adverse Event|1|||
160703838|NCT00261443|580295889|FG002|4: Extension Phase|Adverse Event|0|||
160703839|NCT00261443|580295887|FG000|4: Extension Phase|Withdrawal by Subject|0|||
160703840|NCT00261443|580295888|FG001|4: Extension Phase|Withdrawal by Subject|1|||
160703841|NCT00261443|580295889|FG002|4: Extension Phase|Withdrawal by Subject|2|||
160703842|NCT00261443|580295887|FG000|4: Extension Phase|Lost to Follow-up|0|||
160703843|NCT00261443|580295888|FG001|4: Extension Phase|Lost to Follow-up|1|||
160703844|NCT00261443|580295889|FG002|4: Extension Phase|Lost to Follow-up|0|||
160703845|NCT02755649|580295890|FG000|Overall Study|Transitioned into OLE study|99|||
160703846|NCT02755649|580295891|FG001|Overall Study|Transitioned into OLE study|98|||
160703847|NCT02755649|580295892|FG002|Overall Study|Transitioned into OLE study|100|||
160703848|NCT02755649|580295890|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
160703849|NCT02755649|580295891|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
160703850|NCT02755649|580295892|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
160703851|NCT02755649|580295890|FG000|Overall Study|Physician Decision|0|||
160703852|NCT02755649|580295891|FG001|Overall Study|Physician Decision|0|||
160703853|NCT02755649|580295892|FG002|Overall Study|Physician Decision|2|||
160703854|NCT02755649|580295890|FG000|Overall Study|Withdrawal by Subject|0|||
160703855|NCT02755649|580295891|FG001|Overall Study|Withdrawal by Subject|1|||
160703856|NCT02755649|580295892|FG002|Overall Study|Withdrawal by Subject|0|||
160703857|NCT02755649|580295890|FG000|Overall Study|Undecided|1|||
160703858|NCT02755649|580295891|FG001|Overall Study|Undecided|0|||
160703859|NCT02755649|580295892|FG002|Overall Study|Undecided|0|||
160703860|NCT01286753|580295893|FG000|Overall Study|Adverse Event|7|||
160703861|NCT01286753|580295894|FG001|Overall Study|Adverse Event|6|||
160703862|NCT01286753|580295893|FG000|Overall Study|Progression|11|||
160703863|NCT01286753|580295894|FG001|Overall Study|Progression|13|||
160703864|NCT01286753|580295893|FG000|Overall Study|Refused Treatment|1|||
160703865|NCT01286753|580295894|FG001|Overall Study|Refused Treatment|0|||
160703866|NCT01286753|580295893|FG000|Overall Study|Withdrawal of Consent|0|||
160703867|NCT01286753|580295894|FG001|Overall Study|Withdrawal of Consent|2|||
160703868|NCT01286753|580295893|FG000|Overall Study|Discontinued to Join Extension Study|6|||
160703869|NCT01286753|580295894|FG001|Overall Study|Discontinued to Join Extension Study|4|||
160703870|NCT01286753|580295893|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
160703871|NCT01286753|580295894|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
160703872|NCT00887289|580295895|FG000|Overall Study|Lack of Efficacy|14|||
160703873|NCT00887289|580295895|FG000|Overall Study|Adverse Event|27|||
160703874|NCT00887289|580295895|FG000|Overall Study|Withdrawal by Subject|26|||
160703875|NCT00887289|580295895|FG000|Overall Study|Lost to Follow-up|8|||
160703876|NCT00887289|580295895|FG000|Overall Study|Other|20|||
160703877|NCT00591773|580295896|FG000|Overall Study|Adverse Event|9|||
160703878|NCT00591773|580295897|FG001|Overall Study|Adverse Event|9|||
160703879|NCT00591773|580295898|FG002|Overall Study|Adverse Event|6|||
160703880|NCT00591773|580295896|FG000|Overall Study|Protocol Violation|2|||
160703881|NCT00591773|580295897|FG001|Overall Study|Protocol Violation|3|||
160703882|NCT00591773|580295898|FG002|Overall Study|Protocol Violation|0|||
160703883|NCT00591773|580295896|FG000|Overall Study|Lost to Follow-up|1|||
160703884|NCT00591773|580295897|FG001|Overall Study|Lost to Follow-up|4|||
160703885|NCT00591773|580295898|FG002|Overall Study|Lost to Follow-up|1|||
160703886|NCT00591773|580295896|FG000|Overall Study|Withdrawal by Subject|2|||
160703887|NCT00591773|580295897|FG001|Overall Study|Withdrawal by Subject|5|||
160703888|NCT00591773|580295898|FG002|Overall Study|Withdrawal by Subject|3|||
160703889|NCT00591773|580295896|FG000|Overall Study|Lack of Efficacy|1|||
160703890|NCT00591773|580295897|FG001|Overall Study|Lack of Efficacy|2|||
160703891|NCT00591773|580295898|FG002|Overall Study|Lack of Efficacy|2|||
160703892|NCT00591773|580295896|FG000|Overall Study|Other|1|||
160703893|NCT00591773|580295897|FG001|Overall Study|Other|1|||
160703894|NCT00591773|580295898|FG002|Overall Study|Other|4|||
160703895|NCT02135614|580295899|FG000|Overall Study|Randomized but Not Treated|2|||
160703896|NCT02135614|580295900|FG001|Overall Study|Randomized but Not Treated|1|||
160703897|NCT02135614|580295899|FG000|Overall Study|Adverse Event|0|||
160703898|NCT02135614|580295900|FG001|Overall Study|Adverse Event|1|||
160703899|NCT02135614|580295899|FG000|Overall Study|Death|1|||
160703900|NCT02135614|580295900|FG001|Overall Study|Death|0|||
160703901|NCT02135614|580295899|FG000|Overall Study|Investigator's Discretion|0|||
160703902|NCT02135614|580295900|FG001|Overall Study|Investigator's Discretion|1|||
160703903|NCT02135614|580295899|FG000|Overall Study|Withdrew Consent|2|||
160703904|NCT02135614|580295900|FG001|Overall Study|Withdrew Consent|2|||
160703905|NCT02135614|580295899|FG000|Overall Study|Lost to Follow-up|3|||
160703906|NCT02135614|580295900|FG001|Overall Study|Lost to Follow-up|0|||
160703907|NCT03022084|580295901|FG000|Overall Study|Lost to Follow-up|2|||
160703908|NCT03022084|580295902|FG001|Overall Study|Lost to Follow-up|3|||
160703909|NCT00554606|580295903|FG000|Overall Study|Adverse Event|3|||
160703910|NCT00554606|580295903|FG000|Overall Study|Abnormal laboratory values|1|||
160703911|NCT00554606|580295903|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
160703912|NCT00554606|580295903|FG000|Overall Study|Subject withdrew consent|2|||
160703913|NCT00554606|580295903|FG000|Overall Study|Lost to Follow-up|2|||
160703914|NCT00554606|580295903|FG000|Overall Study|Administrative problems|60|||
160703915|NCT00554606|580295903|FG000|Overall Study|Death|1|||
160703916|NCT00554606|580295903|FG000|Overall Study|Protocol deviation|2|||
160703917|NCT00605540|580295905|FG000|Overall Study|Death|15|||
160703918|NCT00605540|580295905|FG000|Overall Study|Lost to Follow-up|23|||
160703919|NCT00509366|580295906|FG000|Overall Study|Not Treated (Screen Failure)|1|||
160703920|NCT00509366|580295907|FG001|Overall Study|Not Treated (Screen Failure)|1|||
160703921|NCT00509366|580295908|FG002|Overall Study|Not Treated (Screen Failure)|1|||
160703922|NCT00509366|580295909|FG003|Overall Study|Not Treated (Screen Failure)|0|||
160703923|NCT00509366|580295910|FG004|Overall Study|Not Treated (Screen Failure)|0|||
160703924|NCT02119819|580295913|FG000|Overall Study|Adverse Event|3|||
160703925|NCT02119819|580295914|FG001|Overall Study|Adverse Event|1|||
160703926|NCT02119819|580295915|FG002|Overall Study|Adverse Event|2|||
160703927|NCT02119819|580295916|FG003|Overall Study|Adverse Event|3|||
160703928|NCT02119819|580295917|FG004|Overall Study|Adverse Event|0|||
160703929|NCT02119819|580295918|FG005|Overall Study|Adverse Event|1|||
160703930|NCT02119819|580295913|FG000|Overall Study|Lack of Efficacy|0|||
160703931|NCT02119819|580295914|FG001|Overall Study|Lack of Efficacy|0|||
160703932|NCT02119819|580295915|FG002|Overall Study|Lack of Efficacy|0|||
160703933|NCT02119819|580295916|FG003|Overall Study|Lack of Efficacy|0|||
160703934|NCT02119819|580295917|FG004|Overall Study|Lack of Efficacy|0|||
160703935|NCT02119819|580295918|FG005|Overall Study|Lack of Efficacy|1|||
160703936|NCT02119819|580295913|FG000|Overall Study|Lost to Follow-up|0|||
160703937|NCT02119819|580295914|FG001|Overall Study|Lost to Follow-up|0|||
160703938|NCT02119819|580295915|FG002|Overall Study|Lost to Follow-up|1|||
160703939|NCT02119819|580295916|FG003|Overall Study|Lost to Follow-up|2|||
160703940|NCT02119819|580295917|FG004|Overall Study|Lost to Follow-up|1|||
160703941|NCT02119819|580295918|FG005|Overall Study|Lost to Follow-up|2|||
160703942|NCT02119819|580295913|FG000|Overall Study|Physician Decision|1|||
160703943|NCT02119819|580295914|FG001|Overall Study|Physician Decision|1|||
160703944|NCT02119819|580295915|FG002|Overall Study|Physician Decision|0|||
160703945|NCT02119819|580295916|FG003|Overall Study|Physician Decision|0|||
160703946|NCT02119819|580295917|FG004|Overall Study|Physician Decision|0|||
160703947|NCT02119819|580295918|FG005|Overall Study|Physician Decision|1|||
160703948|NCT02119819|580295913|FG000|Overall Study|Withdrawal by Subject|5|||
160703949|NCT02119819|580295914|FG001|Overall Study|Withdrawal by Subject|3|||
160703950|NCT02119819|580295915|FG002|Overall Study|Withdrawal by Subject|0|||
160703951|NCT02119819|580295916|FG003|Overall Study|Withdrawal by Subject|0|||
160703952|NCT02119819|580295917|FG004|Overall Study|Withdrawal by Subject|6|||
160703953|NCT02119819|580295918|FG005|Overall Study|Withdrawal by Subject|10|||
160703954|NCT02119819|580295913|FG000|Overall Study|Jury Duty|0|||
160703955|NCT02119819|580295914|FG001|Overall Study|Jury Duty|0|||
160703956|NCT02119819|580295915|FG002|Overall Study|Jury Duty|1|||
160703957|NCT02119819|580295916|FG003|Overall Study|Jury Duty|0|||
160703958|NCT02119819|580295917|FG004|Overall Study|Jury Duty|0|||
160703959|NCT02119819|580295918|FG005|Overall Study|Jury Duty|0|||
160703960|NCT02119819|580295913|FG000|Overall Study|Protocol Violation|0|||
160703961|NCT02119819|580295914|FG001|Overall Study|Protocol Violation|0|||
160703962|NCT02119819|580295915|FG002|Overall Study|Protocol Violation|0|||
160703963|NCT02119819|580295916|FG003|Overall Study|Protocol Violation|1|||
160703964|NCT02119819|580295917|FG004|Overall Study|Protocol Violation|0|||
160703965|NCT02119819|580295918|FG005|Overall Study|Protocol Violation|0|||
160703966|NCT02119819|580295913|FG000|Overall Study|Left the city to get a job|0|||
160703967|NCT02119819|580295914|FG001|Overall Study|Left the city to get a job|0|||
160703968|NCT02119819|580295915|FG002|Overall Study|Left the city to get a job|0|||
160703969|NCT02119819|580295916|FG003|Overall Study|Left the city to get a job|1|||
160703970|NCT02119819|580295917|FG004|Overall Study|Left the city to get a job|0|||
160703971|NCT02119819|580295918|FG005|Overall Study|Left the city to get a job|0|||
160703972|NCT00282919|580295919|FG000|Overall Study|Lack of Efficacy|4|||
160703973|NCT00282919|580295919|FG000|Overall Study|Withdrawal by Subject|1|||
160703974|NCT00282919|580295919|FG000|Overall Study|Asymptomatic Parasitemia|2|||
160703975|NCT04497948|580295924|FG000|Overall Study|Death|2|||
160703976|NCT03257865|580295929|FG000|Overall Study|Adverse Event|4|||
160703977|NCT03257865|580295930|FG001|Overall Study|Adverse Event|8|||
160703978|NCT03257865|580295929|FG000|Overall Study|Lack of Efficacy|1|||
160703979|NCT03257865|580295930|FG001|Overall Study|Lack of Efficacy|2|||
160703980|NCT03257865|580295929|FG000|Overall Study|Non-compliance with Study Drug|0|||
160703981|NCT03257865|580295930|FG001|Overall Study|Non-compliance with Study Drug|2|||
160703982|NCT03257865|580295929|FG000|Overall Study|Withdrawal by Subject|23|||
160703983|NCT03257865|580295930|FG001|Overall Study|Withdrawal by Subject|17|||
160703984|NCT03257865|580295929|FG000|Overall Study|Physician Decision|3|||
160703985|NCT03257865|580295930|FG001|Overall Study|Physician Decision|1|||
160703986|NCT03257865|580295929|FG000|Overall Study|Other|0|||
160703987|NCT03257865|580295930|FG001|Overall Study|Other|1|||
160703988|NCT03257865|580295929|FG000|Overall Study|Lost to Follow-up|4|||
160703989|NCT03257865|580295930|FG001|Overall Study|Lost to Follow-up|4|||
160703990|NCT02549027|580295931|FG000|Washout After Period 4|Withdrawal by Subject|0|||
160703991|NCT02549027|580295932|FG001|Washout After Period 4|Withdrawal by Subject|1|||
160703992|NCT02549027|580295933|FG002|Washout After Period 4|Withdrawal by Subject|1|||
160703993|NCT02549027|580295934|FG003|Washout After Period 4|Withdrawal by Subject|1|||
160703994|NCT02549027|580295935|FG004|Washout After Period 4|Withdrawal by Subject|0|||
160703995|NCT02549027|580295936|FG005|Washout After Period 4|Withdrawal by Subject|0|||
160703996|NCT02549027|580295931|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
160703997|NCT02549027|580295932|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
160703998|NCT02549027|580295933|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
160703999|NCT02549027|580295934|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
160704000|NCT02549027|580295935|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
160704001|NCT02549027|580295936|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
160704002|NCT02242045|580295942|FG000|Overall Study|Investigator's Discretion|1|||
160704003|NCT02242045|580295942|FG000|Overall Study|Progressive Disease|2|||
160704004|NCT02242045|580295942|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
160704005|NCT02242045|580295942|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
160704006|NCT05384171|580295943|FG000|Overall Study|Lost to Follow-up|9|||
160704007|NCT05384171|580295944|FG001|Overall Study|Lost to Follow-up|9|||
160704008|NCT05384171|580295943|FG000|Overall Study|Withdrawal by Subject|3|||
160704009|NCT05384171|580295944|FG001|Overall Study|Withdrawal by Subject|0|||
160704010|NCT01421511|580295945|FG000|Overall Study|Lost to Follow-up|11|||
160704011|NCT01421511|580295946|FG001|Overall Study|Lost to Follow-up|14|||
160704012|NCT01421511|580295945|FG000|Overall Study|Randomized but didn't receive study drug|1|||
160704013|NCT01421511|580295946|FG001|Overall Study|Randomized but didn't receive study drug|7|||
160704014|NCT01421511|580295945|FG000|Overall Study|Physician Decision|0|||
160704015|NCT01421511|580295946|FG001|Overall Study|Physician Decision|1|||
160704016|NCT01421511|580295945|FG000|Overall Study|Withdrawal by Subject|6|||
160704017|NCT01421511|580295946|FG001|Overall Study|Withdrawal by Subject|5|||
160704018|NCT01421511|580295945|FG000|Overall Study|Death|1|||
160704019|NCT01421511|580295946|FG001|Overall Study|Death|1|||
160704020|NCT00749892|580295947|FG000|Overall Study|Withdrawal by Subject|3|||
160704021|NCT00106964|580295949|FG000|Overall Study|Lost to Follow-up|8|||
160704022|NCT00106964|580295950|FG001|Overall Study|Lost to Follow-up|6|||
160704023|NCT00106964|580295951|FG002|Overall Study|Lost to Follow-up|2|||
160704024|NCT00106964|580295949|FG000|Overall Study|Pregnancy|2|||
160704025|NCT00106964|580295950|FG001|Overall Study|Pregnancy|3|||
160704026|NCT00106964|580295951|FG002|Overall Study|Pregnancy|2|||
160704027|NCT00106964|580295949|FG000|Overall Study|Death|1|||
160704028|NCT00106964|580295950|FG001|Overall Study|Death|1|||
160704029|NCT00106964|580295951|FG002|Overall Study|Death|0|||
160704030|NCT00106964|580295949|FG000|Overall Study|Incarceration|0|||
160704031|NCT00106964|580295950|FG001|Overall Study|Incarceration|1|||
160704032|NCT00106964|580295951|FG002|Overall Study|Incarceration|0|||
160704033|NCT00106964|580295949|FG000|Overall Study|Site Funding Terminated|0|||
160704034|NCT00106964|580295950|FG001|Overall Study|Site Funding Terminated|1|||
160704035|NCT00106964|580295951|FG002|Overall Study|Site Funding Terminated|1|||
160704036|NCT00106964|580295949|FG000|Overall Study|Failure to adhere|2|||
160704037|NCT00106964|580295950|FG001|Overall Study|Failure to adhere|0|||
160704038|NCT00106964|580295951|FG002|Overall Study|Failure to adhere|0|||
160704039|NCT00106964|580295949|FG000|Overall Study|Did not meet eligibility criteria|0|||
160704040|NCT00106964|580295950|FG001|Overall Study|Did not meet eligibility criteria|2|||
160704041|NCT00106964|580295951|FG002|Overall Study|Did not meet eligibility criteria|2|||
160704042|NCT00106964|580295949|FG000|Overall Study|Required disallowed medication|0|||
160704043|NCT00106964|580295950|FG001|Overall Study|Required disallowed medication|1|||
160704044|NCT00106964|580295951|FG002|Overall Study|Required disallowed medication|0|||
160704045|NCT04040192|580295952|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
160704046|NCT04040192|580295953|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
160704047|NCT04040192|580295954|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
160704048|NCT04040192|580295952|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
160704049|NCT04040192|580295953|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
160704050|NCT04040192|580295954|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
160704051|NCT04040192|580295952|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
160704052|NCT04040192|580295953|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
160704053|NCT04040192|580295954|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
160704054|NCT04040192|580295952|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
160704055|NCT04040192|580295953|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
160704056|NCT04040192|580295954|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
160704057|NCT04040192|580295952|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
160704058|NCT04040192|580295953|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
160704059|NCT04040192|580295954|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
160704060|NCT04040192|580295952|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
160704061|NCT04040192|580295953|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
160704062|NCT04040192|580295954|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
160704063|NCT04040192|580295952|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
160704064|NCT04040192|580295953|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
160704065|NCT04040192|580295954|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
160704066|NCT04040192|580295952|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
160704067|NCT04040192|580295953|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
160704068|NCT04040192|580295954|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
160704069|NCT04040192|580295952|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
160704070|NCT04040192|580295953|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
160704071|NCT04040192|580295954|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
160704072|NCT04040192|580295952|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
160704073|NCT04040192|580295953|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
160704074|NCT04040192|580295954|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
160704075|NCT04040192|580295952|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
160704076|NCT04040192|580295953|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
160704077|NCT04040192|580295954|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
160704078|NCT04040192|580295952|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
160704079|NCT04040192|580295953|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
160704080|NCT04040192|580295954|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
160704081|NCT04040192|580295952|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
160704082|NCT04040192|580295953|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
160704083|NCT04040192|580295954|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
160704084|NCT04040192|580295952|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
160704085|NCT04040192|580295953|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
160704086|NCT04040192|580295954|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
160704087|NCT04040192|580295952|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
160704088|NCT04040192|580295953|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
160704089|NCT04040192|580295954|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
160704090|NCT04040192|580295952|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
160704091|NCT04040192|580295953|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
160704092|NCT04040192|580295954|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
160704093|NCT04040192|580295952|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
160704094|NCT04040192|580295953|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
160704095|NCT04040192|580295954|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
160704096|NCT03207243|580295955|FG000|Overall Study|Adverse Event|2|||
160704097|NCT03207243|580295956|FG001|Overall Study|Adverse Event|2|||
160704098|NCT03207243|580295955|FG000|Overall Study|Loss of Asthma Control|47|||
160704099|NCT03207243|580295956|FG001|Overall Study|Loss of Asthma Control|31|||
160704100|NCT03207243|580295955|FG000|Overall Study|Withdrawal by Subject|2|||
160704101|NCT03207243|580295956|FG001|Overall Study|Withdrawal by Subject|4|||
160704102|NCT03207243|580295955|FG000|Overall Study|Physician Decision|1|||
160704103|NCT03207243|580295956|FG001|Overall Study|Physician Decision|1|||
160704104|NCT03207243|580295955|FG000|Overall Study|Lost to Follow-up|0|||
160704105|NCT03207243|580295956|FG001|Overall Study|Lost to Follow-up|1|||
160704106|NCT03207243|580295955|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
160704107|NCT03207243|580295956|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
160704108|NCT03207243|580295955|FG000|Overall Study|Protocol Violation|0|||
160704109|NCT03207243|580295956|FG001|Overall Study|Protocol Violation|3|||
160704110|NCT02121392|580295965|FG000|Prior to Intervention|Protocol Violation|40|||
160704111|NCT02121392|580295966|FG001|Prior to Intervention|Protocol Violation|35|||
160704112|NCT02121392|580295965|FG000|Prior to Intervention|Withdrawal by Subject|8|||
160704113|NCT02121392|580295966|FG001|Prior to Intervention|Withdrawal by Subject|6|||
160704114|NCT02121392|580295965|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
160704115|NCT02121392|580295966|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
160704116|NCT02121392|580295965|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
160704117|NCT02121392|580295966|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
160704118|NCT01352416|580295967|FG000|Overall Study|Physician Decision|1|||
160704119|NCT01352416|580295968|FG001|Overall Study|Physician Decision|2|||
160704120|NCT01352416|580295969|FG002|Overall Study|Physician Decision|2|||
160704121|NCT01352416|580295970|FG003|Overall Study|Physician Decision|1|||
160704122|NCT00182325|580295972|FG000|Overall Study|Lost to Follow-up|7|||
160704123|NCT00182325|580295973|FG001|Overall Study|Lost to Follow-up|7|||
160704124|NCT00182325|580295972|FG000|Overall Study|Miscarriage|5|||
160704125|NCT00182325|580295973|FG001|Overall Study|Miscarriage|3|||
160704126|NCT00182325|580295972|FG000|Overall Study|Did not complete survey|22|||
160704127|NCT00182325|580295973|FG001|Overall Study|Did not complete survey|43|||
160704128|NCT02015065|580295977|FG000|Overall Study|Death on study|1|||
160704129|NCT02015065|580295978|FG001|Overall Study|Death on study|2|||
160704130|NCT02015065|580295979|FG002|Overall Study|Death on study|1|||
160704131|NCT01292226|580296016|FG000|Overall Study|Adverse Event|5|||
160704132|NCT01292226|580296016|FG000|Overall Study|Death|1|||
160704133|NCT01292226|580296016|FG000|Overall Study|Graft loss|1|||
160704134|NCT01292226|580296016|FG000|Overall Study|Protocol Violation|3|||
160704135|NCT01292226|580296016|FG000|Overall Study|Withdrawal by Subject|1|||
160704136|NCT01292226|580296016|FG000|Overall Study|Other|2|||
160704137|NCT04106661|580296017|FG000|Overall Study|Protocol Violation|3|||
160704138|NCT04106661|580296018|FG001|Overall Study|Protocol Violation|0|||
160704139|NCT04106661|580296017|FG000|Overall Study|Scheduling difficulties|1|||
160704140|NCT04106661|580296018|FG001|Overall Study|Scheduling difficulties|1|||
160704141|NCT00233402|580296019|FG000|Overall Study|No pathology data|12|||
160704142|NCT00233402|580296020|FG001|Overall Study|No pathology data|9|||
160704143|NCT00233402|580296019|FG000|Overall Study|No Ta/T1|89|||
160704144|NCT00233402|580296020|FG001|Overall Study|No Ta/T1|94|||
160704145|NCT00233402|580296019|FG000|Overall Study|Lost to follow up etc|3|||
160704146|NCT00233402|580296020|FG001|Overall Study|Lost to follow up etc|21|||
160704147|NCT03280381|580296021|FG000|Overall Study|Physician Decision|0|||
160704148|NCT03280381|580296022|FG001|Overall Study|Physician Decision|2|||
160704149|NCT03503864|580296023|FG000|Overall Study|Protocol Violation|6|||
160704150|NCT03503864|580296023|FG000|Overall Study|Withdrawal by Subject|7|||
160704151|NCT02639052|580296024|FG000|Overall Study|Lost to Follow-up|1|||
160704152|NCT02655666|580296026|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
160704153|NCT00895414|580296027|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
160704154|NCT00895414|580296028|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
160704155|NCT00895414|580296027|FG000|First Intervention (14 Days)|Physician Decision|0|||
160704156|NCT00895414|580296028|FG001|First Intervention (14 Days)|Physician Decision|1|||
160704157|NCT00478426|580296029|FG000|Overall Study|Withdrawal by Subject|1|||
160704158|NCT00789737|580296034|FG000|Overall Study|Withdrawal by Subject|13|||
160704159|NCT00789737|580296035|FG001|Overall Study|Withdrawal by Subject|22|||
160704160|NCT00789737|580296034|FG000|Overall Study|Lost to Follow-up|10|||
160704161|NCT00789737|580296035|FG001|Overall Study|Lost to Follow-up|14|||
160704162|NCT00789737|580296034|FG000|Overall Study|Adverse Event|8|||
160704163|NCT00789737|580296035|FG001|Overall Study|Adverse Event|8|||
160704164|NCT00789737|580296034|FG000|Overall Study|Protocol Violation|3|||
160704165|NCT00789737|580296035|FG001|Overall Study|Protocol Violation|0|||
160704166|NCT00789737|580296034|FG000|Overall Study|Lack of Efficacy|3|||
160704167|NCT00789737|580296035|FG001|Overall Study|Lack of Efficacy|0|||
160704168|NCT00789737|580296034|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
160704169|NCT00789737|580296035|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
160704170|NCT00789737|580296034|FG000|Overall Study|Other|11|||
160704171|NCT00789737|580296035|FG001|Overall Study|Other|7|||
160704172|NCT01189487|580296036|FG000|Overall Study|Lack of Efficacy|2|||
160704173|NCT01189487|580296036|FG000|Overall Study|Adverse Event|1|||
160704174|NCT04630158|580296037|FG000|Overall Study|Adverse Event|1|||
160704175|NCT04630158|580296038|FG001|Overall Study|Adverse Event|1|||
160704176|NCT04630158|580296039|FG002|Overall Study|Adverse Event|1|||
160704177|NCT04630158|580296037|FG000|Overall Study|Physician Decision|0|||
160704178|NCT04630158|580296038|FG001|Overall Study|Physician Decision|2|||
160704179|NCT04630158|580296039|FG002|Overall Study|Physician Decision|0|||
160704180|NCT04630158|580296037|FG000|Overall Study|Protocol Violation|1|||
160704181|NCT04630158|580296038|FG001|Overall Study|Protocol Violation|0|||
160704182|NCT04630158|580296039|FG002|Overall Study|Protocol Violation|1|||
160704183|NCT04630158|580296037|FG000|Overall Study|Withdrawal by Subject|2|||
160704184|NCT04630158|580296038|FG001|Overall Study|Withdrawal by Subject|1|||
160704185|NCT04630158|580296039|FG002|Overall Study|Withdrawal by Subject|2|||
160704186|NCT00813800|580296044|FG000|Overall Study|Screen Failure after Consent|2|||
160704187|NCT00813800|580296044|FG000|Overall Study|Adverse Event|1|||
160704188|NCT00813800|580296044|FG000|Overall Study|Worsening of depression|2|||
160704189|NCT00813800|580296044|FG000|Overall Study|Physician Decision|1|||
160704190|NCT01860677|580296045|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
160704191|NCT01860677|580296046|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
160704192|NCT02092467|580296049|FG000|Overall Study|Death|49|||
160704193|NCT02092467|580296050|FG001|Overall Study|Death|66|||
160704194|NCT02092467|580296051|FG002|Overall Study|Death|38|||
160704195|NCT02092467|580296049|FG000|Overall Study|Lost to Follow-up|38|||
160704196|NCT02092467|580296050|FG001|Overall Study|Lost to Follow-up|35|||
160704197|NCT02092467|580296051|FG002|Overall Study|Lost to Follow-up|40|||
160704198|NCT02092467|580296049|FG000|Overall Study|Global Deterioration of Health Status|1|||
160704199|NCT02092467|580296050|FG001|Overall Study|Global Deterioration of Health Status|0|||
160704200|NCT02092467|580296051|FG002|Overall Study|Global Deterioration of Health Status|0|||
160704201|NCT02092467|580296049|FG000|Overall Study|Other|32|||
160704202|NCT02092467|580296050|FG001|Overall Study|Other|30|||
160704203|NCT02092467|580296051|FG002|Overall Study|Other|24|||
160704204|NCT02092467|580296049|FG000|Overall Study|Withdrawal by Subject|282|||
160704205|NCT02092467|580296050|FG001|Overall Study|Withdrawal by Subject|327|||
160704206|NCT02092467|580296051|FG002|Overall Study|Withdrawal by Subject|289|||
160704207|NCT02092467|580296049|FG000|Overall Study|Randomized but not treated|2|||
160704208|NCT02092467|580296050|FG001|Overall Study|Randomized but not treated|1|||
160704209|NCT02092467|580296051|FG002|Overall Study|Randomized but not treated|7|||
160704210|NCT01284621|580296052|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
160704211|NCT01284621|580296053|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
160704212|NCT01284621|580296054|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
160704213|NCT01284621|580296055|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
160704214|NCT01284621|580296056|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
160704215|NCT01284621|580296057|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
160704216|NCT02377427|580296060|FG000|Part A (Up to Week 20)|Physician Decision|1|||
160704217|NCT02377427|580296061|FG001|Part A (Up to Week 20)|Physician Decision|0|||
160704218|NCT02377427|580296062|FG002|Part A (Up to Week 20)|Physician Decision|0|||
160704219|NCT02377427|580296063|FG003|Part A (Up to Week 20)|Physician Decision|0|||
160704220|NCT02377427|580296064|FG004|Part A (Up to Week 20)|Physician Decision|0|||
160704221|NCT02377427|580296060|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
160704222|NCT02377427|580296061|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
160704223|NCT02377427|580296062|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
160704224|NCT02377427|580296063|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
160704225|NCT02377427|580296064|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
160704226|NCT02377427|580296060|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
160704227|NCT02377427|580296061|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
160704228|NCT02377427|580296062|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
160704229|NCT02377427|580296063|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
160704230|NCT02377427|580296064|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
160704231|NCT02377427|580296060|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
160704232|NCT02377427|580296061|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
160704233|NCT02377427|580296062|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
160704234|NCT02377427|580296063|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
160704235|NCT02377427|580296064|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
160704236|NCT00416884|580296065|FG000|Overall Study|Study terminated due to low accrual|1|||
160704237|NCT02126826|580297732|FG000|Overall Study|Withdrawal by Subject|0|||
160704238|NCT02126826|580297733|FG001|Overall Study|Withdrawal by Subject|0|||
160704239|NCT02126826|580297734|FG002|Overall Study|Withdrawal by Subject|0|||
160704240|NCT02126826|580297735|FG003|Overall Study|Withdrawal by Subject|1|||
160704241|NCT02126826|580297736|FG004|Overall Study|Withdrawal by Subject|0|||
160704242|NCT02126826|580297737|FG005|Overall Study|Withdrawal by Subject|0|||
160704243|NCT02126826|580297738|FG006|Overall Study|Withdrawal by Subject|0|||
160704244|NCT02094417|580297739|FG000|Overall Study|Adverse Event|0|||
160704245|NCT02094417|580297740|FG001|Overall Study|Adverse Event|0|||
160704246|NCT02094417|580297741|FG002|Overall Study|Adverse Event|0|||
160704247|NCT02094417|580297742|FG003|Overall Study|Adverse Event|1|||
160704248|NCT02094417|580297739|FG000|Overall Study|Eligibility criteria|0|||
160704249|NCT02094417|580297740|FG001|Overall Study|Eligibility criteria|1|||
160704250|NCT02094417|580297741|FG002|Overall Study|Eligibility criteria|0|||
160704251|NCT02094417|580297742|FG003|Overall Study|Eligibility criteria|0|||
160704252|NCT02094417|580297739|FG000|Overall Study|No responder|4|||
160704253|NCT02094417|580297740|FG001|Overall Study|No responder|4|||
160704254|NCT02094417|580297741|FG002|Overall Study|No responder|4|||
160704255|NCT02094417|580297742|FG003|Overall Study|No responder|3|||
160704256|NCT02094417|580297739|FG000|Overall Study|Unable to conduct observations or assess|0|||
160704257|NCT02094417|580297740|FG001|Overall Study|Unable to conduct observations or assess|1|||
160704258|NCT02094417|580297741|FG002|Overall Study|Unable to conduct observations or assess|0|||
160704259|NCT02094417|580297742|FG003|Overall Study|Unable to conduct observations or assess|0|||
160704260|NCT02094417|580297739|FG000|Overall Study|Withdrawal by Subject|1|||
160704261|NCT02094417|580297740|FG001|Overall Study|Withdrawal by Subject|2|||
160704262|NCT02094417|580297741|FG002|Overall Study|Withdrawal by Subject|1|||
160704263|NCT02094417|580297742|FG003|Overall Study|Withdrawal by Subject|3|||
160704264|NCT01207583|580297743|FG000|Overall Study|Withdrawal by Subject|0|||
160704265|NCT01207583|580297744|FG001|Overall Study|Withdrawal by Subject|3|||
160704266|NCT01207583|580297745|FG002|Overall Study|Withdrawal by Subject|1|||
160704267|NCT01207583|580297743|FG000|Overall Study|Participant failed to return|1|||
160704268|NCT01207583|580297744|FG001|Overall Study|Participant failed to return|0|||
160704269|NCT01207583|580297745|FG002|Overall Study|Participant failed to return|0|||
160704270|NCT01207583|580297743|FG000|Overall Study|Lost to Follow-up|0|||
160704271|NCT01207583|580297744|FG001|Overall Study|Lost to Follow-up|2|||
160704272|NCT01207583|580297745|FG002|Overall Study|Lost to Follow-up|0|||
160704273|NCT01433549|580297747|FG000|Phase 2: Second Study Product|Adverse Event|0|||
160704274|NCT01433549|580297748|FG001|Phase 2: Second Study Product|Adverse Event|1|||
160704275|NCT01696058|580297750|FG000|Overall Study|Adverse Event|21|||
160704276|NCT01696058|580297751|FG001|Overall Study|Adverse Event|11|||
160704277|NCT01696058|580297750|FG000|Overall Study|Lack of Efficacy|2|||
160704278|NCT01696058|580297751|FG001|Overall Study|Lack of Efficacy|3|||
160704279|NCT01696058|580297750|FG000|Overall Study|Protocol Violation|9|||
160704280|NCT01696058|580297751|FG001|Overall Study|Protocol Violation|3|||
160704281|NCT01696058|580297750|FG000|Overall Study|Lost to Follow-up|2|||
160704282|NCT01696058|580297751|FG001|Overall Study|Lost to Follow-up|5|||
160704283|NCT01696058|580297750|FG000|Overall Study|Withdrawal by Subject|4|||
160704284|NCT01696058|580297751|FG001|Overall Study|Withdrawal by Subject|6|||
160704285|NCT01696058|580297750|FG000|Overall Study|Other reason prematurely discontinued|5|||
160704286|NCT01696058|580297751|FG001|Overall Study|Other reason prematurely discontinued|3|||
160704287|NCT00603837|580297753|FG000|Overall Study|Physician Decision|3|||
160704288|NCT00603837|580297754|FG001|Overall Study|Physician Decision|0|||
160704289|NCT04611529|580297755|FG000|2-day Follow up|Lost to Follow-up|5|||
160704290|NCT04611529|580297756|FG001|2-day Follow up|Lost to Follow-up|6|||
160704291|NCT04611529|580297757|FG002|2-day Follow up|Lost to Follow-up|3|||
160704292|NCT00856375|580297818|FG000|Overall Study|Other|0|||
160704293|NCT00856375|580297819|FG001|Overall Study|Other|1|||
160704294|NCT00856375|580297818|FG000|Overall Study|Death|32|||
160704295|NCT00856375|580297819|FG001|Overall Study|Death|30|||
160704296|NCT00856375|580297818|FG000|Overall Study|Sponsor Terminated Study|7|||
160704297|NCT00856375|580297819|FG001|Overall Study|Sponsor Terminated Study|7|||
160704298|NCT00856375|580297818|FG000|Overall Study|Withdrawal by Subject|2|||
160704299|NCT00856375|580297819|FG001|Overall Study|Withdrawal by Subject|1|||
160704300|NCT00856375|580297818|FG000|Overall Study|Lost to Follow-up|1|||
160704301|NCT00856375|580297819|FG001|Overall Study|Lost to Follow-up|2|||
160704302|NCT02538965|580297822|FG000|Treatment Period|Other = Death due to disease progression|1|||
160704303|NCT02538965|580297822|FG000|Treatment Period|Adverse Event|2|||
160704304|NCT02538965|580297822|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
160704305|NCT02538965|580297822|FG000|Treatment Period|Treatment Failure|9|||
160704306|NCT02538965|580297822|FG000|Treatment Period|Disease Progression|1|||
160704307|NCT02538965|580297822|FG000|Treatment Period|Physician Decision|2|||
160704308|NCT02538965|580297822|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
160704309|NCT02538965|580297822|FG000|Follow-Up Period|Withdrawal by Parent|4|||
160704310|NCT00875797|580297823|FG000|Overall Study|Protocol Violation|6|||
160704311|NCT00875797|580297824|FG001|Overall Study|Protocol Violation|3|||
160704312|NCT00253448|580297827|FG000|Overall Study|Withdrawal by Subject|1|||
160704313|NCT02564887|580297829|FG000|Overall Study|Lost to Follow-up|6|||
160704314|NCT02564887|580297830|FG001|Overall Study|Lost to Follow-up|0|||
160704315|NCT02052011|580297833|FG000|Overall Study|Lost to Follow-up|3|||
160704316|NCT02052011|580297834|FG001|Overall Study|Lost to Follow-up|0|||
160704317|NCT02052011|580297833|FG000|Overall Study|Withdrawal by Subject|1|||
160704318|NCT02052011|580297834|FG001|Overall Study|Withdrawal by Subject|2|||
160704319|NCT00000620|580297835|FG000|Overall Study|Death|86|||
160704320|NCT00000620|580297836|FG001|Overall Study|Death|67|||
160704321|NCT00000620|580297837|FG002|Overall Study|Death|112|||
160704322|NCT00000620|580297838|FG003|Overall Study|Death|126|||
160704323|NCT00000620|580297839|FG004|Overall Study|Death|64|||
160704324|NCT00000620|580297840|FG005|Overall Study|Death|77|||
160704325|NCT00000620|580297841|FG006|Overall Study|Death|91|||
160704326|NCT00000620|580297842|FG007|Overall Study|Death|95|||
160704327|NCT00000620|580297835|FG000|Overall Study|Lost to Follow-up|14|||
160704328|NCT00000620|580297836|FG001|Overall Study|Lost to Follow-up|14|||
160704329|NCT00000620|580297837|FG002|Overall Study|Lost to Follow-up|14|||
160704330|NCT00000620|580297838|FG003|Overall Study|Lost to Follow-up|14|||
160704331|NCT00000620|580297839|FG004|Overall Study|Lost to Follow-up|15|||
160704332|NCT00000620|580297840|FG005|Overall Study|Lost to Follow-up|15|||
160704333|NCT00000620|580297841|FG006|Overall Study|Lost to Follow-up|13|||
160704334|NCT00000620|580297842|FG007|Overall Study|Lost to Follow-up|14|||
160704335|NCT00000620|580297835|FG000|Overall Study|Withdrawal by Subject|40|||
160704336|NCT00000620|580297836|FG001|Overall Study|Withdrawal by Subject|27|||
160704337|NCT00000620|580297837|FG002|Overall Study|Withdrawal by Subject|28|||
160704338|NCT00000620|580297838|FG003|Overall Study|Withdrawal by Subject|27|||
160704339|NCT00000620|580297839|FG004|Overall Study|Withdrawal by Subject|30|||
160704340|NCT00000620|580297840|FG005|Overall Study|Withdrawal by Subject|32|||
160704341|NCT00000620|580297841|FG006|Overall Study|Withdrawal by Subject|32|||
160704342|NCT00000620|580297842|FG007|Overall Study|Withdrawal by Subject|21|||
160704343|NCT00000620|580297835|FG000|Overall Study|missed closeout visit|22|||
160704344|NCT00000620|580297836|FG001|Overall Study|missed closeout visit|28|||
160704345|NCT00000620|580297837|FG002|Overall Study|missed closeout visit|16|||
160704346|NCT00000620|580297838|FG003|Overall Study|missed closeout visit|11|||
160704347|NCT00000620|580297839|FG004|Overall Study|missed closeout visit|26|||
160704348|NCT00000620|580297840|FG005|Overall Study|missed closeout visit|28|||
160704349|NCT00000620|580297841|FG006|Overall Study|missed closeout visit|13|||
160704350|NCT00000620|580297842|FG007|Overall Study|missed closeout visit|16|||
160704351|NCT01851330|580297843|FG000|Overall Study|Lack of Efficacy|10|||
160704352|NCT01851330|580297844|FG001|Overall Study|Lack of Efficacy|9|||
160704353|NCT01851330|580297845|FG002|Overall Study|Lack of Efficacy|2|||
160704354|NCT01851330|580297843|FG000|Overall Study|Lost to Follow-up|1|||
160704355|NCT01851330|580297844|FG001|Overall Study|Lost to Follow-up|6|||
160704356|NCT01851330|580297845|FG002|Overall Study|Lost to Follow-up|9|||
160704357|NCT01851330|580297843|FG000|Overall Study|Withdrew Consent|2|||
160704358|NCT01851330|580297844|FG001|Overall Study|Withdrew Consent|1|||
160704359|NCT01851330|580297845|FG002|Overall Study|Withdrew Consent|0|||
160704360|NCT01851330|580297843|FG000|Overall Study|Investigator's Discretion|0|||
160704361|NCT01851330|580297844|FG001|Overall Study|Investigator's Discretion|0|||
160704362|NCT01851330|580297845|FG002|Overall Study|Investigator's Discretion|1|||
160704363|NCT02648932|580297846|FG000|Overall Study|No transplant|3|||
160704364|NCT02648932|580297847|FG001|Overall Study|No transplant|1|||
160704365|NCT01199016|580297848|FG000|Overall Study|No longer meets eligibility criteria|4|||
160704366|NCT01199016|580297848|FG000|Overall Study|Entrance criteria|5|||
160704367|NCT01199016|580297848|FG000|Overall Study|Protocol Violation|9|||
160704368|NCT01199016|580297848|FG000|Overall Study|Other|13|||
160704369|NCT01199016|580297848|FG000|Overall Study|Withdrawal by Subject|21|||
160704370|NCT01199016|580297848|FG000|Overall Study|Lost to Follow-up|25|||
160704371|NCT02960490|580297857|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
160704372|NCT02960490|580297858|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
160704373|NCT02960490|580297859|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
160704374|NCT02960490|580297860|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
160704375|NCT02960490|580297861|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
160704376|NCT02960490|580297862|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
160704377|NCT02960490|580297863|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
160704378|NCT02960490|580297864|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
160704379|NCT02960490|580297865|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
160704380|NCT02960490|580297866|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
160704381|NCT02960490|580297857|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
160704382|NCT02960490|580297858|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
160704383|NCT02960490|580297859|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
160704384|NCT02960490|580297860|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
160704385|NCT02960490|580297861|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
160704386|NCT02960490|580297862|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
160704387|NCT02960490|580297863|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
160704388|NCT02960490|580297864|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
160704389|NCT02960490|580297865|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
160704390|NCT02960490|580297866|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
160704391|NCT02960490|580297857|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
160704392|NCT02960490|580297858|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
160704393|NCT02960490|580297859|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
160704394|NCT02960490|580297860|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
160704395|NCT02960490|580297861|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
160704396|NCT02960490|580297862|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
160704397|NCT02960490|580297863|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
160704398|NCT02960490|580297864|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
160704399|NCT02960490|580297865|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
160704400|NCT02960490|580297866|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
160704401|NCT02960490|580297857|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
160704402|NCT02960490|580297858|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
160704403|NCT02960490|580297859|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
160704404|NCT02960490|580297860|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
160704405|NCT02960490|580297861|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
160704406|NCT02960490|580297862|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
160704407|NCT02960490|580297863|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
160704408|NCT02960490|580297864|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
160704409|NCT02960490|580297865|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
160704410|NCT02960490|580297866|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
160704411|NCT02960490|580297857|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
160704412|NCT02960490|580297858|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
160704413|NCT02960490|580297859|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
160704414|NCT02960490|580297860|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
160704415|NCT02960490|580297861|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
160704416|NCT02960490|580297862|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
160704417|NCT02960490|580297863|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
160704418|NCT02960490|580297864|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
160704419|NCT02960490|580297865|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
160704420|NCT02960490|580297866|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
160704421|NCT02960490|580297857|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
160704422|NCT02960490|580297858|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
160704423|NCT02960490|580297859|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
160704424|NCT02960490|580297860|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
160704425|NCT02960490|580297861|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
160704426|NCT02960490|580297862|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
160704427|NCT02960490|580297863|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
160704428|NCT02960490|580297864|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
160704429|NCT02960490|580297865|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
160704430|NCT02960490|580297866|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
160704431|NCT02960490|580297857|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
160704432|NCT02960490|580297858|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
160704433|NCT02960490|580297859|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
160704434|NCT02960490|580297860|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
160704435|NCT02960490|580297861|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
160704436|NCT02960490|580297862|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
160704437|NCT02960490|580297863|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
160704438|NCT02960490|580297864|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
160704439|NCT02960490|580297865|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
160704440|NCT02960490|580297866|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
160704441|NCT02960490|580297857|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
160704442|NCT02960490|580297858|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
160704443|NCT02960490|580297859|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
160704444|NCT02960490|580297860|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
160704445|NCT02960490|580297861|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
160704446|NCT02960490|580297862|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
160704447|NCT02960490|580297863|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
160704448|NCT02960490|580297864|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
160704449|NCT02960490|580297865|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
160704450|NCT02960490|580297866|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
160704451|NCT02960490|580297857|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
160704452|NCT02960490|580297858|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
160704453|NCT02960490|580297859|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
160704454|NCT02960490|580297860|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
160704455|NCT02960490|580297861|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
160704456|NCT02960490|580297862|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
160704457|NCT02960490|580297863|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
160704458|NCT02960490|580297864|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
160704459|NCT02960490|580297865|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
160704460|NCT02960490|580297866|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
160704461|NCT02960490|580297857|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
160704462|NCT02960490|580297858|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
160704463|NCT02960490|580297859|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
160704464|NCT02960490|580297860|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
160704465|NCT02960490|580297861|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
160704466|NCT02960490|580297862|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
160704467|NCT02960490|580297863|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
160704468|NCT02960490|580297864|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
160704469|NCT02960490|580297865|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
160704470|NCT02960490|580297866|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
160704471|NCT02960490|580297857|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
160704472|NCT02960490|580297858|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
160704473|NCT02960490|580297859|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
160704474|NCT02960490|580297860|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
160704475|NCT02960490|580297861|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
160704476|NCT02960490|580297862|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
160704477|NCT02960490|580297863|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
160704478|NCT02960490|580297864|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
160704479|NCT02960490|580297865|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
160704480|NCT02960490|580297866|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
160704481|NCT02960490|580297857|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
160704482|NCT02960490|580297858|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
160704483|NCT02960490|580297859|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
160704484|NCT02960490|580297860|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
160704485|NCT02960490|580297861|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
160704486|NCT02960490|580297862|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
160704487|NCT02960490|580297863|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
160704488|NCT02960490|580297864|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
160704489|NCT02960490|580297865|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
160704490|NCT02960490|580297866|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
160704491|NCT01590797|580297869|FG000|Overall Study|Adverse Event|4|||
160704492|NCT01590797|580297870|FG001|Overall Study|Adverse Event|3|||
160704493|NCT01590797|580297869|FG000|Overall Study|Lack of Efficacy|0|||
160704494|NCT01590797|580297870|FG001|Overall Study|Lack of Efficacy|2|||
160704495|NCT01590797|580297869|FG000|Overall Study|Lost to Follow-up|0|||
160704496|NCT01590797|580297870|FG001|Overall Study|Lost to Follow-up|1|||
160704497|NCT01590797|580297869|FG000|Overall Study|Protocol Violation|4|||
160704498|NCT01590797|580297870|FG001|Overall Study|Protocol Violation|1|||
160704499|NCT01590797|580297869|FG000|Overall Study|Withdrawal by Subject|7|||
160704500|NCT01590797|580297870|FG001|Overall Study|Withdrawal by Subject|5|||
160704501|NCT01590797|580297869|FG000|Overall Study|Other Protocol Specified Criteria|2|||
160704502|NCT01590797|580297870|FG001|Overall Study|Other Protocol Specified Criteria|4|||
160704503|NCT02368314|580297871|FG000|Overall Study|Withdrawal by Subject|2|||
160704504|NCT02368314|580297872|FG001|Overall Study|Withdrawal by Subject|1|||
160704505|NCT02368314|580297871|FG000|Overall Study|Adverse Event|1|||
160704506|NCT02368314|580297872|FG001|Overall Study|Adverse Event|2|||
160704507|NCT01266031|580297873|FG000|Overall Study|Not treated|0|||
160704508|NCT01266031|580297874|FG001|Overall Study|Not treated|3|||
160704509|NCT01266031|580297875|FG002|Overall Study|Not treated|2|||
160704510|NCT03106987|580297878|FG000|Overall Study|Death|37|||
160704511|NCT03106987|580297879|FG001|Overall Study|Death|22|||
160704512|NCT03106987|580297880|FG002|Overall Study|Death|12|||
160704513|NCT03106987|580297881|FG003|Overall Study|Death|8|||
160704514|NCT03106987|580297878|FG000|Overall Study|Lost to Follow-up|2|||
160704515|NCT03106987|580297879|FG001|Overall Study|Lost to Follow-up|0|||
160704516|NCT03106987|580297880|FG002|Overall Study|Lost to Follow-up|2|||
160704517|NCT03106987|580297881|FG003|Overall Study|Lost to Follow-up|2|||
160704518|NCT03106987|580297878|FG000|Overall Study|Withdrawal by Subject|5|||
160704519|NCT03106987|580297879|FG001|Overall Study|Withdrawal by Subject|1|||
160704520|NCT03106987|580297880|FG002|Overall Study|Withdrawal by Subject|4|||
160704521|NCT03106987|580297881|FG003|Overall Study|Withdrawal by Subject|1|||
160704522|NCT01307111|580297882|FG000|IUD Insertion|Lost to Follow-up|2|||
160704523|NCT01307111|580297883|FG001|IUD Insertion|Lost to Follow-up|0|||
160704524|NCT01307111|580297882|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
160704525|NCT01307111|580297883|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
160704526|NCT02114385|580297889|FG000|Overall Study|Withdrawal by Subject|3|||
160704527|NCT02114385|580297890|FG001|Overall Study|Withdrawal by Subject|2|||
160704528|NCT02114385|580297889|FG000|Overall Study|Lost to Follow-up|0|||
160704529|NCT02114385|580297890|FG001|Overall Study|Lost to Follow-up|6|||
160704530|NCT02842073|580297893|FG000|Overall Study|Withdrawal by Subject|1|||
160704531|NCT00195338|580297894|FG000|Overall Study|Lost to Follow-up|2|||
160704532|NCT00195338|580297894|FG000|Overall Study|Adverse Event|5|||
160704533|NCT00195338|580297894|FG000|Overall Study|Lack of Efficacy|1|||
160704534|NCT00195338|580297894|FG000|Overall Study|Early closure of the site|4|||
160704535|NCT02047734|580297897|FG000|Overall Study|Adverse Event|18|||
160704536|NCT02047734|580297898|FG001|Overall Study|Adverse Event|13|||
160704537|NCT02047734|580297899|FG002|Overall Study|Adverse Event|13|||
160704538|NCT02047734|580297897|FG000|Overall Study|Lack of Efficacy|4|||
160704539|NCT02047734|580297898|FG001|Overall Study|Lack of Efficacy|5|||
160704540|NCT02047734|580297899|FG002|Overall Study|Lack of Efficacy|1|||
160704541|NCT02047734|580297897|FG000|Overall Study|Protocol Violation|3|||
160704542|NCT02047734|580297898|FG001|Overall Study|Protocol Violation|1|||
160704543|NCT02047734|580297899|FG002|Overall Study|Protocol Violation|1|||
160704544|NCT02047734|580297897|FG000|Overall Study|Lost to Follow-up|1|||
160704545|NCT02047734|580297898|FG001|Overall Study|Lost to Follow-up|4|||
160704546|NCT02047734|580297899|FG002|Overall Study|Lost to Follow-up|0|||
160704547|NCT02047734|580297897|FG000|Overall Study|Death|0|||
160704548|NCT02047734|580297898|FG001|Overall Study|Death|1|||
160704549|NCT02047734|580297899|FG002|Overall Study|Death|0|||
160704550|NCT02047734|580297897|FG000|Overall Study|Withdrawal by Subject|30|||
160704551|NCT02047734|580297898|FG001|Overall Study|Withdrawal by Subject|31|||
160704552|NCT02047734|580297899|FG002|Overall Study|Withdrawal by Subject|19|||
160704553|NCT02047734|580297897|FG000|Overall Study|Physician Decision|7|||
160704554|NCT02047734|580297898|FG001|Overall Study|Physician Decision|6|||
160704555|NCT02047734|580297899|FG002|Overall Study|Physician Decision|5|||
160704556|NCT02047734|580297897|FG000|Overall Study|Miscellaneous|2|||
160704557|NCT02047734|580297898|FG001|Overall Study|Miscellaneous|4|||
160704558|NCT02047734|580297899|FG002|Overall Study|Miscellaneous|6|||
160704559|NCT02047734|580297897|FG000|Overall Study|Did Not Receive Study Drug|2|||
160704560|NCT02047734|580297898|FG001|Overall Study|Did Not Receive Study Drug|4|||
160704561|NCT02047734|580297899|FG002|Overall Study|Did Not Receive Study Drug|1|||
160704562|NCT01333397|580297900|FG000|Overall Study|Lost to Follow-up|1|||
160704563|NCT01333397|580297901|FG001|Overall Study|Lost to Follow-up|0|||
160704564|NCT01333397|580297902|FG002|Overall Study|Lost to Follow-up|0|||
160704565|NCT01333397|580297903|FG003|Overall Study|Lost to Follow-up|1|||
160704566|NCT01333397|580297904|FG004|Overall Study|Lost to Follow-up|0|||
160704567|NCT02460679|580297909|FG000|Overall Study|Investigator Decision|1|||
160704568|NCT02460679|580297909|FG000|Overall Study|Withdrawal by Subject|4|||
160704569|NCT01994850|580297919|FG000|Overall Study|Physician Decision|1|||
160704570|NCT01994850|580297919|FG000|Overall Study|Withdrawal by Subject|1|||
160704571|NCT01420965|580297924|FG000|Overall Study|Withdrawal by Subject|1|||
160704572|NCT01420965|580297925|FG001|Overall Study|Withdrawal by Subject|0|||
160704573|NCT01420965|580297926|FG002|Overall Study|Withdrawal by Subject|0|||
160704574|NCT01420965|580297924|FG000|Overall Study|Adverse Event|0|||
160704575|NCT01420965|580297925|FG001|Overall Study|Adverse Event|1|||
160704576|NCT01420965|580297926|FG002|Overall Study|Adverse Event|0|||
160704577|NCT00468650|580297929|FG000|Overall Study|Lost to Follow-up|4|||
160704578|NCT00468650|580297929|FG000|Overall Study|Withdrawal by Subject|2|||
160704579|NCT00468650|580297929|FG000|Overall Study|Protocol Violation|1|||
160704580|NCT00642278|580297934|FG000|Overall Study|Adverse Event|2|||
160704581|NCT00642278|580297935|FG001|Overall Study|Adverse Event|1|||
160704582|NCT00642278|580297936|FG002|Overall Study|Adverse Event|3|||
160704583|NCT00642278|580297937|FG003|Overall Study|Adverse Event|1|||
160704584|NCT00642278|580297938|FG004|Overall Study|Adverse Event|2|||
160704585|NCT00642278|580297939|FG005|Overall Study|Adverse Event|2|||
160704586|NCT00642278|580297940|FG006|Overall Study|Adverse Event|0|||
160704587|NCT00642278|580297934|FG000|Overall Study|Lack of Efficacy|0|||
160704588|NCT00642278|580297935|FG001|Overall Study|Lack of Efficacy|1|||
160704589|NCT00642278|580297936|FG002|Overall Study|Lack of Efficacy|0|||
160704590|NCT00642278|580297937|FG003|Overall Study|Lack of Efficacy|0|||
160704591|NCT00642278|580297938|FG004|Overall Study|Lack of Efficacy|0|||
160704592|NCT00642278|580297939|FG005|Overall Study|Lack of Efficacy|0|||
160704593|NCT00642278|580297940|FG006|Overall Study|Lack of Efficacy|0|||
160704594|NCT00642278|580297934|FG000|Overall Study|Lost to Follow-up|5|||
160704595|NCT00642278|580297935|FG001|Overall Study|Lost to Follow-up|1|||
160704596|NCT00642278|580297936|FG002|Overall Study|Lost to Follow-up|0|||
160704597|NCT00642278|580297937|FG003|Overall Study|Lost to Follow-up|1|||
160704598|NCT00642278|580297938|FG004|Overall Study|Lost to Follow-up|0|||
160704599|NCT00642278|580297939|FG005|Overall Study|Lost to Follow-up|1|||
160704600|NCT00642278|580297940|FG006|Overall Study|Lost to Follow-up|1|||
160704601|NCT00642278|580297934|FG000|Overall Study|Physician Decision|0|||
160704602|NCT00642278|580297935|FG001|Overall Study|Physician Decision|0|||
160704603|NCT00642278|580297936|FG002|Overall Study|Physician Decision|0|||
160704604|NCT00642278|580297937|FG003|Overall Study|Physician Decision|1|||
160704605|NCT00642278|580297938|FG004|Overall Study|Physician Decision|0|||
160704606|NCT00642278|580297939|FG005|Overall Study|Physician Decision|0|||
160704607|NCT00642278|580297940|FG006|Overall Study|Physician Decision|0|||
160704608|NCT00642278|580297934|FG000|Overall Study|Protocol Violation|0|||
160704609|NCT00642278|580297935|FG001|Overall Study|Protocol Violation|0|||
160704610|NCT00642278|580297936|FG002|Overall Study|Protocol Violation|1|||
160704611|NCT00642278|580297937|FG003|Overall Study|Protocol Violation|1|||
160704612|NCT00642278|580297938|FG004|Overall Study|Protocol Violation|0|||
160704613|NCT00642278|580297939|FG005|Overall Study|Protocol Violation|1|||
160704614|NCT00642278|580297940|FG006|Overall Study|Protocol Violation|2|||
160704615|NCT00642278|580297934|FG000|Overall Study|Withdrawal by Subject|1|||
160704616|NCT00642278|580297935|FG001|Overall Study|Withdrawal by Subject|1|||
160704617|NCT00642278|580297936|FG002|Overall Study|Withdrawal by Subject|1|||
160704618|NCT00642278|580297937|FG003|Overall Study|Withdrawal by Subject|3|||
160704619|NCT00642278|580297938|FG004|Overall Study|Withdrawal by Subject|6|||
160704620|NCT00642278|580297939|FG005|Overall Study|Withdrawal by Subject|2|||
160704621|NCT00642278|580297940|FG006|Overall Study|Withdrawal by Subject|2|||
160704622|NCT00642278|580297934|FG000|Overall Study|Noncompliance with study drug regimen|0|||
160704623|NCT00642278|580297935|FG001|Overall Study|Noncompliance with study drug regimen|0|||
160704624|NCT00642278|580297936|FG002|Overall Study|Noncompliance with study drug regimen|0|||
160704625|NCT00642278|580297937|FG003|Overall Study|Noncompliance with study drug regimen|1|||
160704626|NCT00642278|580297938|FG004|Overall Study|Noncompliance with study drug regimen|0|||
160704627|NCT00642278|580297939|FG005|Overall Study|Noncompliance with study drug regimen|0|||
160704628|NCT00642278|580297940|FG006|Overall Study|Noncompliance with study drug regimen|0|||
160704629|NCT00642278|580297934|FG000|Overall Study|Other|2|||
160704630|NCT00642278|580297935|FG001|Overall Study|Other|1|||
160704631|NCT00642278|580297936|FG002|Overall Study|Other|0|||
160704632|NCT00642278|580297937|FG003|Overall Study|Other|1|||
160704633|NCT00642278|580297938|FG004|Overall Study|Other|0|||
160704634|NCT00642278|580297939|FG005|Overall Study|Other|1|||
160704635|NCT00642278|580297940|FG006|Overall Study|Other|0|||
160704636|NCT03713619|580297943|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
160704637|NCT03713619|580297944|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
160704638|NCT03713619|580297945|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
160704639|NCT03713619|580297946|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
160704640|NCT03713619|580297947|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
160704641|NCT03713619|580297943|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
160704642|NCT03713619|580297944|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
160704643|NCT03713619|580297945|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
160704644|NCT03713619|580297946|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
160704645|NCT03713619|580297947|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
160704646|NCT03713619|580297943|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
160704647|NCT03713619|580297944|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
160704648|NCT03713619|580297945|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
160704649|NCT03713619|580297946|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
160704650|NCT03713619|580297947|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
160704651|NCT03713619|580297943|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
160704652|NCT03713619|580297944|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
160704653|NCT03713619|580297945|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
160704654|NCT03713619|580297946|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
160704655|NCT03713619|580297947|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
160704656|NCT03713619|580297943|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
160704657|NCT03713619|580297944|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
160704658|NCT03713619|580297945|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
160704659|NCT03713619|580297946|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
160704660|NCT03713619|580297947|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
160704661|NCT03713619|580297943|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
160704662|NCT03713619|580297944|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
160704663|NCT03713619|580297945|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
160704664|NCT03713619|580297946|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
160704665|NCT03713619|580297947|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
160704666|NCT03713619|580297943|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
160704667|NCT03713619|580297944|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
160704668|NCT03713619|580297945|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
160704669|NCT03713619|580297946|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
160704670|NCT03713619|580297947|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
160704671|NCT03713619|580297943|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
160704672|NCT03713619|580297944|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
160704673|NCT03713619|580297945|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
160704674|NCT03713619|580297946|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
160704675|NCT03713619|580297947|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
160704676|NCT03713619|580297943|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
160704677|NCT03713619|580297944|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
160704678|NCT03713619|580297945|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
160704679|NCT03713619|580297946|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
160704680|NCT03713619|580297947|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
160704681|NCT03713619|580297943|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
160704682|NCT03713619|580297944|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
160704683|NCT03713619|580297945|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
160704684|NCT03713619|580297946|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
160704685|NCT03713619|580297947|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
160704686|NCT03713619|580297943|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
160704687|NCT03713619|580297944|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
160704688|NCT03713619|580297945|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
160704689|NCT03713619|580297946|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
160704690|NCT03713619|580297947|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
160704691|NCT03713619|580297943|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
160704692|NCT03713619|580297944|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
160704693|NCT03713619|580297945|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
160704694|NCT03713619|580297946|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
160704695|NCT03713619|580297947|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
160704696|NCT03713619|580297943|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
160704697|NCT03713619|580297944|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
160704698|NCT03713619|580297945|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
160704699|NCT03713619|580297946|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
160704700|NCT03713619|580297947|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
160704701|NCT01144715|580297949|FG000|Overall Study|Lost to Follow-up|2|||
160704702|NCT01144715|580297950|FG001|Overall Study|Lost to Follow-up|1|||
160704703|NCT01144715|580297949|FG000|Overall Study|Withdrawal by Subject|2|||
160704704|NCT01144715|580297950|FG001|Overall Study|Withdrawal by Subject|1|||
160704705|NCT01144715|580297949|FG000|Overall Study|Adverse Event|0|||
160704706|NCT01144715|580297950|FG001|Overall Study|Adverse Event|1|||
160704707|NCT03553576|580297951|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
160704708|NCT03553576|580297952|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
160704709|NCT03553576|580297951|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
160704710|NCT03553576|580297952|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
160704711|NCT03553576|580297951|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
160704712|NCT03553576|580297952|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
160704713|NCT03553576|580297951|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
160704714|NCT03553576|580297952|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
160704715|NCT03553576|580297951|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
160704716|NCT03553576|580297952|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
160704717|NCT03553576|580297951|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
160704718|NCT03553576|580297952|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
160704719|NCT03553576|580297951|FG000|Overall Study|Physician Decision|2|||
160704720|NCT03553576|580297952|FG001|Overall Study|Physician Decision|5|||
160704721|NCT01094886|580297953|FG000|Overall Study|Adverse Event|2|||
160704722|NCT01094886|580297953|FG000|Overall Study|Withdrawal by Subject|5|||
160704723|NCT02013674|580297954|FG000|Overall Study|Death|0|||
160704724|NCT02013674|580297955|FG001|Overall Study|Death|1|||
160704725|NCT02013674|580297954|FG000|Overall Study|Lost to Follow-up|1|||
160704726|NCT02013674|580297955|FG001|Overall Study|Lost to Follow-up|0|||
160704727|NCT05833139|580300164|FG000|Study Period 2|Adverse Event|1|||
160704728|NCT03996447|580300165|FG000|First MRI Examination|Adverse Event|2|||
160704729|NCT03996447|580300166|FG001|First MRI Examination|Adverse Event|0|||
160704730|NCT03996447|580300165|FG000|First MRI Examination|Withdrawal by Subject|1|||
160704731|NCT03996447|580300166|FG001|First MRI Examination|Withdrawal by Subject|2|||
160704732|NCT03996447|580300165|FG000|First MRI Examination|Protocol Violation|0|||
160704733|NCT03996447|580300166|FG001|First MRI Examination|Protocol Violation|1|||
160704734|NCT03996447|580300165|FG000|Washout|Adverse Event|2|||
160704735|NCT03996447|580300166|FG001|Washout|Adverse Event|0|||
160704736|NCT03996447|580300165|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
160704737|NCT03996447|580300166|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
160704738|NCT03996447|580300165|FG000|Washout|Withdrawal by Subject|0|||
160704739|NCT03996447|580300166|FG001|Washout|Withdrawal by Subject|1|||
160704740|NCT03996447|580300165|FG000|Washout|Other reason|1|||
160704741|NCT03996447|580300166|FG001|Washout|Other reason|1|||
160704742|NCT01810302|580300173|FG000|Overall Study|Death|1|||
160704743|NCT01810302|580300174|FG001|Overall Study|Death|0|||
160704744|NCT01810302|580300173|FG000|Overall Study|Physician Decision|0|||
160704745|NCT01810302|580300174|FG001|Overall Study|Physician Decision|1|||
160704746|NCT01371747|580300175|FG000|Overall Study|Adverse Event|4|||
160704747|NCT01371747|580300176|FG001|Overall Study|Adverse Event|2|||
160704748|NCT01371747|580300177|FG002|Overall Study|Adverse Event|7|||
160704749|NCT01371747|580300178|FG003|Overall Study|Adverse Event|2|||
160704750|NCT01371747|580300179|FG004|Overall Study|Adverse Event|2|||
160704751|NCT01371747|580300180|FG005|Overall Study|Adverse Event|2|||
160704752|NCT01371747|580300175|FG000|Overall Study|Death|1|||
160704753|NCT01371747|580300176|FG001|Overall Study|Death|0|||
160704754|NCT01371747|580300177|FG002|Overall Study|Death|4|||
160704755|NCT01371747|580300178|FG003|Overall Study|Death|1|||
160704756|NCT01371747|580300179|FG004|Overall Study|Death|2|||
160704757|NCT01371747|580300180|FG005|Overall Study|Death|0|||
160704758|NCT01371747|580300175|FG000|Overall Study|Abnormal Renal Function|0|||
160704759|NCT01371747|580300176|FG001|Overall Study|Abnormal Renal Function|2|||
160704760|NCT01371747|580300177|FG002|Overall Study|Abnormal Renal Function|0|||
160704761|NCT01371747|580300178|FG003|Overall Study|Abnormal Renal Function|1|||
160704762|NCT01371747|580300179|FG004|Overall Study|Abnormal Renal Function|0|||
160704763|NCT01371747|580300180|FG005|Overall Study|Abnormal Renal Function|1|||
160704764|NCT01371747|580300175|FG000|Overall Study|High Serum Potassium Results|1|||
160704765|NCT01371747|580300176|FG001|Overall Study|High Serum Potassium Results|1|||
160704766|NCT01371747|580300177|FG002|Overall Study|High Serum Potassium Results|1|||
160704767|NCT01371747|580300178|FG003|Overall Study|High Serum Potassium Results|2|||
160704768|NCT01371747|580300179|FG004|Overall Study|High Serum Potassium Results|0|||
160704769|NCT01371747|580300180|FG005|Overall Study|High Serum Potassium Results|2|||
160704770|NCT01371747|580300175|FG000|Overall Study|Low Serum Potassium Results|1|||
160704771|NCT01371747|580300176|FG001|Overall Study|Low Serum Potassium Results|1|||
160704772|NCT01371747|580300177|FG002|Overall Study|Low Serum Potassium Results|1|||
160704773|NCT01371747|580300178|FG003|Overall Study|Low Serum Potassium Results|1|||
160704774|NCT01371747|580300179|FG004|Overall Study|Low Serum Potassium Results|0|||
160704775|NCT01371747|580300180|FG005|Overall Study|Low Serum Potassium Results|3|||
160704776|NCT01371747|580300175|FG000|Overall Study|Protocol Violation|0|||
160704777|NCT01371747|580300176|FG001|Overall Study|Protocol Violation|0|||
160704778|NCT01371747|580300177|FG002|Overall Study|Protocol Violation|1|||
160704779|NCT01371747|580300178|FG003|Overall Study|Protocol Violation|0|||
160704780|NCT01371747|580300179|FG004|Overall Study|Protocol Violation|0|||
160704781|NCT01371747|580300180|FG005|Overall Study|Protocol Violation|0|||
160704782|NCT01371747|580300175|FG000|Overall Study|Non-Compliance|3|||
160704783|NCT01371747|580300176|FG001|Overall Study|Non-Compliance|4|||
160704784|NCT01371747|580300177|FG002|Overall Study|Non-Compliance|3|||
160704785|NCT01371747|580300178|FG003|Overall Study|Non-Compliance|0|||
160704786|NCT01371747|580300179|FG004|Overall Study|Non-Compliance|0|||
160704787|NCT01371747|580300180|FG005|Overall Study|Non-Compliance|1|||
160704788|NCT01371747|580300175|FG000|Overall Study|Physician Decision|0|||
160704789|NCT01371747|580300176|FG001|Overall Study|Physician Decision|0|||
160704790|NCT01371747|580300177|FG002|Overall Study|Physician Decision|0|||
160704791|NCT01371747|580300178|FG003|Overall Study|Physician Decision|0|||
160704792|NCT01371747|580300179|FG004|Overall Study|Physician Decision|1|||
160704793|NCT01371747|580300180|FG005|Overall Study|Physician Decision|0|||
160704794|NCT01371747|580300175|FG000|Overall Study|Withdrawal by Subject|6|||
160704795|NCT01371747|580300176|FG001|Overall Study|Withdrawal by Subject|12|||
160704796|NCT01371747|580300177|FG002|Overall Study|Withdrawal by Subject|5|||
160704797|NCT01371747|580300178|FG003|Overall Study|Withdrawal by Subject|2|||
160704798|NCT01371747|580300179|FG004|Overall Study|Withdrawal by Subject|2|||
160704799|NCT01371747|580300180|FG005|Overall Study|Withdrawal by Subject|4|||
160704800|NCT01371747|580300175|FG000|Overall Study|Other Reasons|2|||
160704801|NCT01371747|580300176|FG001|Overall Study|Other Reasons|1|||
160704802|NCT01371747|580300177|FG002|Overall Study|Other Reasons|2|||
160704803|NCT01371747|580300178|FG003|Overall Study|Other Reasons|0|||
160704804|NCT01371747|580300179|FG004|Overall Study|Other Reasons|0|||
160704805|NCT01371747|580300180|FG005|Overall Study|Other Reasons|1|||
160704806|NCT03092219|580300181|FG000|Overall Study|Protocol Violation|7|||
160704807|NCT03092219|580300182|FG001|Overall Study|Protocol Violation|4|||
160704808|NCT03278626|580300185|FG000|Overall Study|Death|2|||
160704809|NCT03278626|580300185|FG000|Overall Study|Toxicity|1|||
160704810|NCT03278626|580300185|FG000|Overall Study|Disease Progression|2|||
160704811|NCT02856555|580300187|FG000|Overall Study|Adverse Event|1|||
160704812|NCT02856555|580300188|FG001|Overall Study|Adverse Event|0|||
160704813|NCT02856555|580300189|FG002|Overall Study|Adverse Event|0|||
160704814|NCT02856555|580300187|FG000|Overall Study|Lost to Follow-up|1|||
160704815|NCT02856555|580300188|FG001|Overall Study|Lost to Follow-up|3|||
160704816|NCT02856555|580300189|FG002|Overall Study|Lost to Follow-up|0|||
160704817|NCT02856555|580300187|FG000|Overall Study|Withdrawal by Subject|3|||
160704818|NCT02856555|580300188|FG001|Overall Study|Withdrawal by Subject|0|||
160704819|NCT02856555|580300189|FG002|Overall Study|Withdrawal by Subject|0|||
160704820|NCT02856555|580300187|FG000|Overall Study|Randomized but Never Treated|0|||
160704821|NCT02856555|580300188|FG001|Overall Study|Randomized but Never Treated|1|||
160704822|NCT02856555|580300189|FG002|Overall Study|Randomized but Never Treated|0|||
160704823|NCT05013008|580300190|FG000|Overall Study|Exclusion from mBFAS|5|||
160704824|NCT05013008|580300191|FG001|Overall Study|Exclusion from mBFAS|25|||
160704825|NCT03333941|580300195|FG000|Overall Study|Lost to Follow-up|10|||
160704826|NCT03333941|580300195|FG000|Overall Study|Death|2|||
160704827|NCT03333941|580300195|FG000|Overall Study|Adverse Event|1|||
160704828|NCT01443728|580300198|FG000|Overall Study|Lost to Follow-up|2|||
160704829|NCT01443728|580300199|FG001|Overall Study|Lost to Follow-up|0|||
160704830|NCT01443728|580300198|FG000|Overall Study|Withdrawal by Subject|1|||
160704831|NCT01443728|580300199|FG001|Overall Study|Withdrawal by Subject|1|||
160704832|NCT01443728|580300198|FG000|Overall Study|Adverse Event|0|||
160704833|NCT01443728|580300199|FG001|Overall Study|Adverse Event|2|||
160704834|NCT04971187|580300200|FG000|Overall Study|Screen failures|2|||
160704835|NCT04981717|580300206|FG000|Overall Study|Protocol Violation|0|||
160704836|NCT04981717|580300207|FG001|Overall Study|Protocol Violation|3|||
160704837|NCT04981717|580300206|FG000|Overall Study|Adverse Event|1|||
160704838|NCT04981717|580300207|FG001|Overall Study|Adverse Event|3|||
160704839|NCT04981717|580300206|FG000|Overall Study|Pregnancy|1|||
160704840|NCT04981717|580300207|FG001|Overall Study|Pregnancy|0|||
160704841|NCT04981717|580300206|FG000|Overall Study|Physician Decision|1|||
160704842|NCT04981717|580300207|FG001|Overall Study|Physician Decision|0|||
160704843|NCT04981717|580300206|FG000|Overall Study|Sponsor Request|157|||
160704844|NCT04981717|580300207|FG001|Overall Study|Sponsor Request|172|||
160704845|NCT04981717|580300206|FG000|Overall Study|Lost to Follow-up|4|||
160704846|NCT04981717|580300207|FG001|Overall Study|Lost to Follow-up|5|||
160704847|NCT04981717|580300206|FG000|Overall Study|Withdrawal by Subject|50|||
160704848|NCT04981717|580300207|FG001|Overall Study|Withdrawal by Subject|37|||
160704849|NCT02207634|580300208|FG000|Overall Study|Withdrawal by Subject|21|||
160704850|NCT02207634|580300209|FG001|Overall Study|Withdrawal by Subject|31|||
160704851|NCT02207634|580300208|FG000|Overall Study|Lost to Follow-up|1|||
160704852|NCT02207634|580300209|FG001|Overall Study|Lost to Follow-up|0|||
160704853|NCT00974922|580300212|FG000|Overall Study|study terminated|24|||
160704854|NCT02186834|580300213|FG000|Dose Escalation|Death|0|||
160704855|NCT02186834|580300214|FG001|Dose Escalation|Death|0|||
160704856|NCT02186834|580300215|FG002|Dose Escalation|Death|0|||
160704857|NCT02186834|580300216|FG003|Dose Escalation|Death|1|||
160704858|NCT02186834|580300217|FG004|Dose Escalation|Death|0|||
160704859|NCT02186834|580300218|FG005|Dose Escalation|Death|0|||
160704860|NCT02186834|580300213|FG000|Treatment at RP2D|Died prior to treatment|0|||
160704861|NCT02186834|580300214|FG001|Treatment at RP2D|Died prior to treatment|0|||
160704862|NCT02186834|580300215|FG002|Treatment at RP2D|Died prior to treatment|0|||
160704863|NCT02186834|580300216|FG003|Treatment at RP2D|Died prior to treatment|0|||
160704864|NCT02186834|580300217|FG004|Treatment at RP2D|Died prior to treatment|0|||
160704865|NCT02186834|580300218|FG005|Treatment at RP2D|Died prior to treatment|1|||
160704866|NCT04581369|580300219|FG000|Overall Study|Death|7|||
160704867|NCT04581369|580300220|FG001|Overall Study|Death|6|||
160704868|NCT04581369|580300221|FG002|Overall Study|Death|0|||
160704869|NCT04581369|580300219|FG000|Overall Study|Lost to Follow-up|7|||
160704870|NCT04581369|580300220|FG001|Overall Study|Lost to Follow-up|3|||
160704871|NCT04581369|580300221|FG002|Overall Study|Lost to Follow-up|0|||
160704872|NCT04581369|580300219|FG000|Overall Study|liver transplant|2|||
160704873|NCT04581369|580300220|FG001|Overall Study|liver transplant|2|||
160704874|NCT04581369|580300221|FG002|Overall Study|liver transplant|0|||
160704875|NCT04581369|580300219|FG000|Overall Study|transitioned to hospice care|0|||
160704876|NCT04581369|580300220|FG001|Overall Study|transitioned to hospice care|5|||
160704877|NCT04581369|580300221|FG002|Overall Study|transitioned to hospice care|0|||
160704878|NCT04746794|580300224|FG000|Overall Study|Did not complete any study assessment|50303|||
160704879|NCT04746794|580300225|FG001|Overall Study|Did not complete any study assessment|44997|||
160704880|NCT01422187|580300226|FG000|Overall Study|Personal reason|1|||
160704881|NCT01422187|580300227|FG001|Overall Study|Personal reason|0|||
160704882|NCT01422187|580300228|FG002|Overall Study|Personal reason|0|||
160704883|NCT01422187|580300226|FG000|Overall Study|Lost to Follow-up|0|||
160704884|NCT01422187|580300227|FG001|Overall Study|Lost to Follow-up|1|||
160704885|NCT01422187|580300228|FG002|Overall Study|Lost to Follow-up|0|||
160704886|NCT00741286|580300232|FG000|Overall Study|Lost to Follow-up|15|||
160704887|NCT00741286|580300233|FG001|Overall Study|Lost to Follow-up|10|||
160704888|NCT00741286|580300232|FG000|Overall Study|Adverse Event|1|||
160704889|NCT00741286|580300233|FG001|Overall Study|Adverse Event|6|||
160704890|NCT00741286|580300232|FG000|Overall Study|Protocol Violation|3|||
160704891|NCT00741286|580300233|FG001|Overall Study|Protocol Violation|2|||
160704892|NCT00741286|580300232|FG000|Overall Study|Primary Outcome|1|||
160704893|NCT00741286|580300233|FG001|Overall Study|Primary Outcome|1|||
160704894|NCT00582010|580300237|FG000|Overall Study|Death|0|||
160704895|NCT00582010|580300238|FG001|Overall Study|Death|1|||
160704896|NCT05320887|580300241|FG000|Overall Study|Lost to Follow-up|0|||
160704897|NCT05320887|580300242|FG001|Overall Study|Lost to Follow-up|3|||
160704898|NCT05320887|580300243|FG002|Overall Study|Lost to Follow-up|0|||
160704899|NCT05320887|580300244|FG003|Overall Study|Lost to Follow-up|0|||
160704900|NCT02463357|580300245|FG000|Overall Study|Withdrawal by Subject|1|||
160704901|NCT02463357|580300246|FG001|Overall Study|Withdrawal by Subject|0|||
160704902|NCT02463357|580300247|FG002|Overall Study|Withdrawal by Subject|0|||
160704903|NCT02463357|580300248|FG003|Overall Study|Withdrawal by Subject|0|||
160704904|NCT02463357|580300249|FG004|Overall Study|Withdrawal by Subject|0|||
160704905|NCT02463357|580300245|FG000|Overall Study|Withdrawal by Subject|0|||
160704906|NCT02463357|580300246|FG001|Overall Study|Withdrawal by Subject|0|||
160704907|NCT02463357|580300247|FG002|Overall Study|Withdrawal by Subject|0|||
160704908|NCT02463357|580300248|FG003|Overall Study|Withdrawal by Subject|0|||
160704909|NCT02463357|580300249|FG004|Overall Study|Withdrawal by Subject|1|||
160704910|NCT00378573|580300251|FG000|Treatment Period|Adverse Event|9|||
160704911|NCT00378573|580300251|FG000|Treatment Period|Physician Decision|1|||
160704912|NCT00378573|580300251|FG000|Treatment Period|Withdrawal by Subject|2|||
160704913|NCT00378573|580300251|FG000|Treatment Period|Disease Progression|4|||
160704914|NCT00378573|580300251|FG000|Treatment Period|Sponsor decision to close study|1|||
160704915|NCT00378573|580300251|FG000|Follow-up|Death|12|||
160704916|NCT00378573|580300251|FG000|Follow-up|Lost to Follow-up|1|||
160704917|NCT00378573|580300251|FG000|Follow-up|Withdrawal by Subject|1|||
160704918|NCT00339144|580300257|FG000|Overall Study|Disease progression|5|||
160704919|NCT00339144|580300258|FG001|Overall Study|Disease progression|2|||
160704920|NCT00339144|580300259|FG002|Overall Study|Disease progression|2|||
160704921|NCT00339144|580300257|FG000|Overall Study|Study drug toxicity|3|||
160704922|NCT00339144|580300258|FG001|Overall Study|Study drug toxicity|1|||
160704923|NCT00339144|580300259|FG002|Overall Study|Study drug toxicity|1|||
160704924|NCT00339144|580300257|FG000|Overall Study|Participant's request to discontinuation|1|||
160704925|NCT00339144|580300258|FG001|Overall Study|Participant's request to discontinuation|0|||
160704926|NCT00339144|580300259|FG002|Overall Study|Participant's request to discontinuation|1|||
160704927|NCT01267994|580300263|FG000|Overall Study|Adverse Event|2|||
160704928|NCT00252239|580300264|FG000|Overall Study|Withdrawal by Subject|1|||
160704929|NCT00252239|580300265|FG001|Overall Study|Withdrawal by Subject|0|||
160704930|NCT00252239|580300266|FG002|Overall Study|Withdrawal by Subject|0|||
160704931|NCT00252239|580300267|FG003|Overall Study|Withdrawal by Subject|1|||
160704932|NCT00252239|580300264|FG000|Overall Study|Lost to Follow-up|0|||
160704933|NCT00252239|580300265|FG001|Overall Study|Lost to Follow-up|0|||
160704934|NCT00252239|580300266|FG002|Overall Study|Lost to Follow-up|2|||
160704935|NCT00252239|580300267|FG003|Overall Study|Lost to Follow-up|0|||
160704936|NCT02181790|580300272|FG000|Overall Study|study terminated|2|||
160704937|NCT02181790|580300273|FG001|Overall Study|study terminated|0|||
160704938|NCT03276078|580300274|FG000|Overall Study|Adverse Event|1|||
160704939|NCT04642365|580300275|FG000|Overall Study|Death|3|||
160704940|NCT04642365|580300276|FG001|Overall Study|Death|2|||
160704941|NCT04642365|580300277|FG002|Overall Study|Death|4|||
160704942|NCT04642365|580300278|FG003|Overall Study|Death|5|||
160704943|NCT04642365|580300279|FG004|Overall Study|Death|5|||
160704944|NCT04642365|580300280|FG005|Overall Study|Death|3|||
160704945|NCT04642365|580300281|FG006|Overall Study|Death|2|||
160704946|NCT04642365|580300282|FG007|Overall Study|Death|1|||
160704947|NCT04642365|580300275|FG000|Overall Study|Physician Decision|1|||
160704948|NCT04642365|580300276|FG001|Overall Study|Physician Decision|0|||
160704949|NCT04642365|580300277|FG002|Overall Study|Physician Decision|0|||
160704950|NCT04642365|580300278|FG003|Overall Study|Physician Decision|0|||
160704951|NCT04642365|580300279|FG004|Overall Study|Physician Decision|0|||
160704952|NCT04642365|580300280|FG005|Overall Study|Physician Decision|0|||
160704953|NCT04642365|580300281|FG006|Overall Study|Physician Decision|0|||
160704954|NCT04642365|580300282|FG007|Overall Study|Physician Decision|0|||
160704955|NCT04642365|580300275|FG000|Overall Study|Progressive Disease|1|||
160704956|NCT04642365|580300276|FG001|Overall Study|Progressive Disease|1|||
160704957|NCT04642365|580300277|FG002|Overall Study|Progressive Disease|1|||
160704958|NCT04642365|580300278|FG003|Overall Study|Progressive Disease|0|||
160704959|NCT04642365|580300279|FG004|Overall Study|Progressive Disease|0|||
160704960|NCT04642365|580300280|FG005|Overall Study|Progressive Disease|0|||
160704961|NCT04642365|580300281|FG006|Overall Study|Progressive Disease|1|||
160704962|NCT04642365|580300282|FG007|Overall Study|Progressive Disease|0|||
160704963|NCT04642365|580300275|FG000|Overall Study|Study Terminated By Sponsor|0|||
160704964|NCT04642365|580300276|FG001|Overall Study|Study Terminated By Sponsor|2|||
160704965|NCT04642365|580300277|FG002|Overall Study|Study Terminated By Sponsor|1|||
160704966|NCT04642365|580300278|FG003|Overall Study|Study Terminated By Sponsor|1|||
160704967|NCT04642365|580300279|FG004|Overall Study|Study Terminated By Sponsor|1|||
160704968|NCT04642365|580300280|FG005|Overall Study|Study Terminated By Sponsor|2|||
160704969|NCT04642365|580300281|FG006|Overall Study|Study Terminated By Sponsor|2|||
160704970|NCT04642365|580300282|FG007|Overall Study|Study Terminated By Sponsor|1|||
160704971|NCT04642365|580300275|FG000|Overall Study|Symptomatic Deterioration|1|||
160704972|NCT04642365|580300276|FG001|Overall Study|Symptomatic Deterioration|1|||
160704973|NCT04642365|580300277|FG002|Overall Study|Symptomatic Deterioration|0|||
160704974|NCT04642365|580300278|FG003|Overall Study|Symptomatic Deterioration|0|||
160704975|NCT04642365|580300279|FG004|Overall Study|Symptomatic Deterioration|0|||
160704976|NCT04642365|580300280|FG005|Overall Study|Symptomatic Deterioration|1|||
160704977|NCT04642365|580300281|FG006|Overall Study|Symptomatic Deterioration|0|||
160704978|NCT04642365|580300282|FG007|Overall Study|Symptomatic Deterioration|0|||
160704979|NCT04642365|580300275|FG000|Overall Study|Withdrawal by Subject|0|||
160704980|NCT04642365|580300276|FG001|Overall Study|Withdrawal by Subject|0|||
160704981|NCT04642365|580300277|FG002|Overall Study|Withdrawal by Subject|1|||
160704982|NCT04642365|580300278|FG003|Overall Study|Withdrawal by Subject|1|||
160704983|NCT04642365|580300279|FG004|Overall Study|Withdrawal by Subject|0|||
160704984|NCT04642365|580300280|FG005|Overall Study|Withdrawal by Subject|0|||
160704985|NCT04642365|580300281|FG006|Overall Study|Withdrawal by Subject|2|||
160704986|NCT04642365|580300282|FG007|Overall Study|Withdrawal by Subject|0|||
160704987|NCT04642365|580300275|FG000|Overall Study|Adverse Event|0|||
160704988|NCT04642365|580300276|FG001|Overall Study|Adverse Event|0|||
160704989|NCT04642365|580300277|FG002|Overall Study|Adverse Event|0|||
160704990|NCT04642365|580300278|FG003|Overall Study|Adverse Event|0|||
160704991|NCT04642365|580300279|FG004|Overall Study|Adverse Event|0|||
160704992|NCT04642365|580300280|FG005|Overall Study|Adverse Event|0|||
160704993|NCT04642365|580300281|FG006|Overall Study|Adverse Event|0|||
160704994|NCT04642365|580300282|FG007|Overall Study|Adverse Event|1|||
160704995|NCT02552212|580300283|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
160704996|NCT02552212|580300284|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
160704997|NCT02552212|580300285|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
160704998|NCT02552212|580300283|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
160704999|NCT02552212|580300284|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
160705000|NCT02552212|580300285|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
160705001|NCT02552212|580300283|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
160705002|NCT02552212|580300284|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
160705003|NCT02552212|580300285|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
160705004|NCT02552212|580300283|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
160705005|NCT02552212|580300284|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
160705006|NCT02552212|580300285|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
160705007|NCT02552212|580300283|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
160705008|NCT02552212|580300284|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
160705009|NCT02552212|580300285|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
160705010|NCT02552212|580300283|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
160705011|NCT02552212|580300284|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
160705012|NCT02552212|580300285|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
160705013|NCT02552212|580300283|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
160705014|NCT02552212|580300284|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
160705015|NCT02552212|580300285|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
160705016|NCT02552212|580300283|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
160705017|NCT02552212|580300284|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
160705018|NCT02552212|580300285|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
160705019|NCT02552212|580300283|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
160705020|NCT02552212|580300284|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
160705021|NCT02552212|580300285|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
160705022|NCT02552212|580300283|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
160705023|NCT02552212|580300284|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
160705024|NCT02552212|580300285|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
160705025|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
160705026|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
160705027|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
160705028|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
160705029|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
160705030|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
160705031|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
160705032|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
160705033|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
160705034|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
160705035|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
160705036|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
160705037|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
160705038|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
160705039|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
160705040|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
160705041|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
160705042|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
160705043|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
160705044|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
160705045|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
160705046|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
160705047|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
160705048|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
160705049|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
160705050|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
160705051|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
160705052|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
160705053|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
160705054|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
160705055|NCT02552212|580300283|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
160705056|NCT02552212|580300284|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
160705057|NCT02552212|580300285|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
160705058|NCT02728843|580300286|FG000|Overall Study|Adverse Event|0|||
160705059|NCT02728843|580300287|FG001|Overall Study|Adverse Event|2|||
160705060|NCT02728843|580300288|FG002|Overall Study|Adverse Event|3|||
160705061|NCT02728843|580300289|FG003|Overall Study|Adverse Event|1|||
160705062|NCT02728843|580300290|FG004|Overall Study|Adverse Event|2|||
160705063|NCT02728843|580300286|FG000|Overall Study|Lack of Efficacy|0|||
160705064|NCT02728843|580300287|FG001|Overall Study|Lack of Efficacy|1|||
160705065|NCT02728843|580300288|FG002|Overall Study|Lack of Efficacy|1|||
160705066|NCT02728843|580300289|FG003|Overall Study|Lack of Efficacy|0|||
160705067|NCT02728843|580300290|FG004|Overall Study|Lack of Efficacy|0|||
160705068|NCT02728843|580300286|FG000|Overall Study|Protocol Violation|2|||
160705069|NCT02728843|580300287|FG001|Overall Study|Protocol Violation|0|||
160705070|NCT02728843|580300288|FG002|Overall Study|Protocol Violation|4|||
160705071|NCT02728843|580300289|FG003|Overall Study|Protocol Violation|2|||
160705072|NCT02728843|580300290|FG004|Overall Study|Protocol Violation|2|||
160705073|NCT02728843|580300286|FG000|Overall Study|Withdrawal by Subject|1|||
160705074|NCT02728843|580300287|FG001|Overall Study|Withdrawal by Subject|0|||
160705075|NCT02728843|580300288|FG002|Overall Study|Withdrawal by Subject|0|||
160705076|NCT02728843|580300289|FG003|Overall Study|Withdrawal by Subject|1|||
160705077|NCT02728843|580300290|FG004|Overall Study|Withdrawal by Subject|0|||
160705078|NCT02728843|580300286|FG000|Overall Study|Use of rescue medication|0|||
160705079|NCT02728843|580300287|FG001|Overall Study|Use of rescue medication|2|||
160705080|NCT02728843|580300288|FG002|Overall Study|Use of rescue medication|0|||
160705081|NCT02728843|580300289|FG003|Overall Study|Use of rescue medication|2|||
160705082|NCT02728843|580300290|FG004|Overall Study|Use of rescue medication|1|||
160705083|NCT00205803|580300295|FG000|Infant Series|Lost to Follow-up|10|||
160705084|NCT00205803|580300296|FG001|Infant Series|Lost to Follow-up|4|||
160705085|NCT00205803|580300295|FG000|Infant Series|Withdrawal by Subject|2|||
160705086|NCT00205803|580300296|FG001|Infant Series|Withdrawal by Subject|5|||
160705087|NCT00205803|580300295|FG000|Infant Series|Physician Decision|3|||
160705088|NCT00205803|580300296|FG001|Infant Series|Physician Decision|1|||
160705089|NCT00205803|580300295|FG000|Infant Series|Protocol Violation|1|||
160705090|NCT00205803|580300296|FG001|Infant Series|Protocol Violation|0|||
160705091|NCT00205803|580300295|FG000|Infant Series|Lost Kaiser coverage|0|||
160705092|NCT00205803|580300296|FG001|Infant Series|Lost Kaiser coverage|1|||
160705093|NCT00205803|580300295|FG000|Infant Series|Non-compliant|1|||
160705094|NCT00205803|580300296|FG001|Infant Series|Non-compliant|0|||
160705095|NCT00205803|580300295|FG000|Infant Series|Sponsor request|1|||
160705096|NCT00205803|580300296|FG001|Infant Series|Sponsor request|0|||
160705097|NCT00205803|580300295|FG000|After Infant Series|Adverse Event|1|||
160705098|NCT00205803|580300296|FG001|After Infant Series|Adverse Event|1|||
160705099|NCT00205803|580300295|FG000|After Infant Series|Protocol Violation|1|||
160705100|NCT00205803|580300296|FG001|After Infant Series|Protocol Violation|1|||
160705101|NCT00205803|580300295|FG000|After Infant Series|Lost to Follow-up|2|||
160705102|NCT00205803|580300296|FG001|After Infant Series|Lost to Follow-up|1|||
160705103|NCT00205803|580300295|FG000|After Infant Series|Physician Decision|3|||
160705104|NCT00205803|580300296|FG001|After Infant Series|Physician Decision|2|||
160705105|NCT00205803|580300295|FG000|After Infant Series|Withdrawal by Subject|1|||
160705106|NCT00205803|580300296|FG001|After Infant Series|Withdrawal by Subject|4|||
160705107|NCT00205803|580300295|FG000|After Infant Series|Other|10|||
160705108|NCT00205803|580300296|FG001|After Infant Series|Other|4|||
160705109|NCT00205803|580300295|FG000|Toddler Dose|Lost to Follow-up|2|||
160705110|NCT00205803|580300296|FG001|Toddler Dose|Lost to Follow-up|3|||
160705111|NCT05038800|580300298|FG000|Overall Study|Death|1|||
160705112|NCT05038800|580300299|FG001|Overall Study|Death|1|||
160705113|NCT05038800|580300300|FG002|Overall Study|Death|5|||
160705114|NCT05038800|580300301|FG003|Overall Study|Death|3|||
160705115|NCT05038800|580300302|FG004|Overall Study|Death|1|||
160705116|NCT05038800|580300298|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160705117|NCT05038800|580300299|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160705118|NCT05038800|580300300|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160705119|NCT05038800|580300301|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160705120|NCT05038800|580300302|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160705121|NCT05038800|580300298|FG000|Overall Study|Lack of Efficacy|0|||
160705122|NCT05038800|580300299|FG001|Overall Study|Lack of Efficacy|0|||
160705123|NCT05038800|580300300|FG002|Overall Study|Lack of Efficacy|0|||
160705124|NCT05038800|580300301|FG003|Overall Study|Lack of Efficacy|0|||
160705125|NCT05038800|580300302|FG004|Overall Study|Lack of Efficacy|1|||
160705126|NCT00121134|580300303|FG000|Overall Study|Progression of Disease|5|||
160705127|NCT00121134|580300304|FG001|Overall Study|Progression of Disease|3|||
160705128|NCT00121134|580300305|FG002|Overall Study|Progression of Disease|4|||
160705129|NCT00121134|580300306|FG003|Overall Study|Progression of Disease|2|||
160705130|NCT00121134|580300303|FG000|Overall Study|Toxicity|4|||
160705131|NCT00121134|580300304|FG001|Overall Study|Toxicity|7|||
160705132|NCT00121134|580300305|FG002|Overall Study|Toxicity|13|||
160705133|NCT00121134|580300306|FG003|Overall Study|Toxicity|5|||
160705134|NCT00121134|580300303|FG000|Overall Study|Physician Decision|6|||
160705135|NCT00121134|580300304|FG001|Overall Study|Physician Decision|4|||
160705136|NCT00121134|580300305|FG002|Overall Study|Physician Decision|4|||
160705137|NCT00121134|580300306|FG003|Overall Study|Physician Decision|1|||
160705138|NCT00121134|580300303|FG000|Overall Study|Treatment Delay|1|||
160705139|NCT00121134|580300304|FG001|Overall Study|Treatment Delay|0|||
160705140|NCT00121134|580300305|FG002|Overall Study|Treatment Delay|0|||
160705141|NCT00121134|580300306|FG003|Overall Study|Treatment Delay|0|||
160705142|NCT00121134|580300303|FG000|Overall Study|Intercurrent Illness|0|||
160705143|NCT00121134|580300304|FG001|Overall Study|Intercurrent Illness|0|||
160705144|NCT00121134|580300305|FG002|Overall Study|Intercurrent Illness|0|||
160705145|NCT00121134|580300306|FG003|Overall Study|Intercurrent Illness|1|||
160705146|NCT00121134|580300303|FG000|Overall Study|Patient Personal Reasons|0|||
160705147|NCT00121134|580300304|FG001|Overall Study|Patient Personal Reasons|1|||
160705148|NCT00121134|580300305|FG002|Overall Study|Patient Personal Reasons|0|||
160705149|NCT00121134|580300306|FG003|Overall Study|Patient Personal Reasons|0|||
160705150|NCT02478320|580300312|FG000|Overall Study|Adverse Event|2|||
160705151|NCT02478320|580300313|FG001|Overall Study|Adverse Event|0|||
160705152|NCT02478320|580300312|FG000|Overall Study|Death|1|||
160705153|NCT02478320|580300313|FG001|Overall Study|Death|0|||
160705154|NCT02478320|580300312|FG000|Overall Study|Lack of Efficacy|4|||
160705155|NCT02478320|580300313|FG001|Overall Study|Lack of Efficacy|0|||
160705156|NCT02478320|580300312|FG000|Overall Study|Withdrawal by Subject|2|||
160705157|NCT02478320|580300313|FG001|Overall Study|Withdrawal by Subject|0|||
160705158|NCT02478320|580300312|FG000|Overall Study|Screen Failure|3|||
160705159|NCT02478320|580300313|FG001|Overall Study|Screen Failure|0|||
160705160|NCT00197496|580300317|FG000|Baseline to Discharge|not interested|1|||
160705161|NCT00197496|580300318|FG001|Baseline to Discharge|not interested|0|||
160705162|NCT00197496|580300317|FG000|Baseline to Discharge|MRSA|1|||
160705163|NCT00197496|580300318|FG001|Baseline to Discharge|MRSA|0|||
160705164|NCT00197496|580300317|FG000|Baseline to Discharge|Physician Decision|0|||
160705165|NCT00197496|580300318|FG001|Baseline to Discharge|Physician Decision|1|||
160705166|NCT00197496|580300317|FG000|Baseline to Discharge|Protocol Violation|0|||
160705167|NCT00197496|580300318|FG001|Baseline to Discharge|Protocol Violation|1|||
160705168|NCT00197496|580300317|FG000|Follow-up|Lost to Follow-up|2|||
160705169|NCT00197496|580300318|FG001|Follow-up|Lost to Follow-up|1|||
160705170|NCT00857584|580300321|FG000|Overall Study|Lack of Efficacy|1|||
160705171|NCT00857584|580300322|FG001|Overall Study|Lack of Efficacy|2|||
160705172|NCT00857584|580300321|FG000|Overall Study|Adverse Event|2|||
160705173|NCT00857584|580300322|FG001|Overall Study|Adverse Event|2|||
160705174|NCT00857584|580300321|FG000|Overall Study|Physician Decision|1|||
160705175|NCT00857584|580300322|FG001|Overall Study|Physician Decision|1|||
160705176|NCT02533375|580300323|FG000|Overall Study|Lack of Efficacy|3|||
160705177|NCT02533375|580300323|FG000|Overall Study|Adverse Event|2|||
160705178|NCT00673387|580300324|FG000|Overall Study|Withdrawal by Subject|15|||
160705179|NCT00673387|580300325|FG001|Overall Study|Withdrawal by Subject|16|||
160705180|NCT00673387|580300326|FG002|Overall Study|Withdrawal by Subject|20|||
160705181|NCT00673387|580300327|FG003|Overall Study|Withdrawal by Subject|16|||
160705182|NCT00673387|580300328|FG004|Overall Study|Withdrawal by Subject|18|||
160705183|NCT00673387|580300329|FG005|Overall Study|Withdrawal by Subject|21|||
160705184|NCT00673387|580300330|FG006|Overall Study|Withdrawal by Subject|15|||
160705185|NCT00673387|580300331|FG007|Overall Study|Withdrawal by Subject|21|||
160705186|NCT00673387|580300324|FG000|Overall Study|Adverse Event|3|||
160705187|NCT00673387|580300325|FG001|Overall Study|Adverse Event|1|||
160705188|NCT00673387|580300326|FG002|Overall Study|Adverse Event|5|||
160705189|NCT00673387|580300327|FG003|Overall Study|Adverse Event|2|||
160705190|NCT00673387|580300328|FG004|Overall Study|Adverse Event|6|||
160705191|NCT00673387|580300329|FG005|Overall Study|Adverse Event|2|||
160705192|NCT00673387|580300330|FG006|Overall Study|Adverse Event|5|||
160705193|NCT00673387|580300331|FG007|Overall Study|Adverse Event|5|||
160705194|NCT00673387|580300324|FG000|Overall Study|Physician Decision|0|||
160705195|NCT00673387|580300325|FG001|Overall Study|Physician Decision|0|||
160705196|NCT00673387|580300326|FG002|Overall Study|Physician Decision|0|||
160705197|NCT00673387|580300327|FG003|Overall Study|Physician Decision|0|||
160705198|NCT00673387|580300328|FG004|Overall Study|Physician Decision|0|||
160705199|NCT00673387|580300329|FG005|Overall Study|Physician Decision|5|||
160705200|NCT00673387|580300330|FG006|Overall Study|Physician Decision|1|||
160705201|NCT00673387|580300331|FG007|Overall Study|Physician Decision|1|||
160705202|NCT00673387|580300324|FG000|Overall Study|Protocol Violation|3|||
160705203|NCT00673387|580300325|FG001|Overall Study|Protocol Violation|0|||
160705204|NCT00673387|580300326|FG002|Overall Study|Protocol Violation|1|||
160705205|NCT00673387|580300327|FG003|Overall Study|Protocol Violation|2|||
160705206|NCT00673387|580300328|FG004|Overall Study|Protocol Violation|0|||
160705207|NCT00673387|580300329|FG005|Overall Study|Protocol Violation|1|||
160705208|NCT00673387|580300330|FG006|Overall Study|Protocol Violation|1|||
160705209|NCT00673387|580300331|FG007|Overall Study|Protocol Violation|3|||
160705210|NCT00673387|580300324|FG000|Overall Study|Lost to Follow-up|8|||
160705211|NCT00673387|580300325|FG001|Overall Study|Lost to Follow-up|6|||
160705212|NCT00673387|580300326|FG002|Overall Study|Lost to Follow-up|5|||
160705213|NCT00673387|580300327|FG003|Overall Study|Lost to Follow-up|6|||
160705214|NCT00673387|580300328|FG004|Overall Study|Lost to Follow-up|6|||
160705215|NCT00673387|580300329|FG005|Overall Study|Lost to Follow-up|5|||
160705216|NCT00673387|580300330|FG006|Overall Study|Lost to Follow-up|8|||
160705217|NCT00673387|580300331|FG007|Overall Study|Lost to Follow-up|5|||
160705218|NCT00960115|580300332|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
160705219|NCT00960115|580300333|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
160705220|NCT01102374|580300334|FG000|Overall Study|Death|9|||
160705221|NCT01102374|580300335|FG001|Overall Study|Death|13|||
160705222|NCT01102374|580300334|FG000|Overall Study|Lost to Follow-up|7|||
160705223|NCT01102374|580300335|FG001|Overall Study|Lost to Follow-up|6|||
160705224|NCT02071849|580300336|FG000|6-month Primary Endpoint|Did not receive device|4|||
160705225|NCT02071849|580300336|FG000|6-month Primary Endpoint|Adverse Event|1|||
160705226|NCT02071849|580300336|FG000|2-year Extended Follow-up|Adverse Event|1|||
160705227|NCT02952898|580300341|FG000|Overall Study|Withdrawal by Subject|10|||
160705228|NCT02952898|580300342|FG001|Overall Study|Withdrawal by Subject|8|||
160705229|NCT02952898|580300343|FG002|Overall Study|Withdrawal by Subject|8|||
160705230|NCT02952898|580300341|FG000|Overall Study|Adverse Event|8|||
160705231|NCT02952898|580300342|FG001|Overall Study|Adverse Event|8|||
160705232|NCT02952898|580300343|FG002|Overall Study|Adverse Event|3|||
160705233|NCT02952898|580300341|FG000|Overall Study|Lost to Follow-up|3|||
160705234|NCT02952898|580300342|FG001|Overall Study|Lost to Follow-up|2|||
160705235|NCT02952898|580300343|FG002|Overall Study|Lost to Follow-up|2|||
160705236|NCT02952898|580300341|FG000|Overall Study|Non-compliance with study drug|1|||
160705237|NCT02952898|580300342|FG001|Overall Study|Non-compliance with study drug|1|||
160705238|NCT02952898|580300343|FG002|Overall Study|Non-compliance with study drug|2|||
160705239|NCT00477633|580300344|FG000|Overall Study|Did not receive treatment|23|||
160705240|NCT00477633|580300344|FG000|Overall Study|Adverse Event|143|||
160705241|NCT00477633|580300344|FG000|Overall Study|Pregnancy|23|||
160705242|NCT00477633|580300344|FG000|Overall Study|Lost to Follow-up|271|||
160705243|NCT00477633|580300344|FG000|Overall Study|Withdrawal by Subject|149|||
160705244|NCT00477633|580300344|FG000|Overall Study|Protocol Violation|25|||
160705245|NCT00477633|580300344|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
160705246|NCT02968849|580300345|FG000|Overall Study|Death|8|||
160705247|NCT02968849|580300346|FG001|Overall Study|Death|10|||
160705248|NCT02968849|580300345|FG000|Overall Study|Lost to Follow-up|31|||
160705249|NCT02968849|580300346|FG001|Overall Study|Lost to Follow-up|29|||
160705250|NCT02968849|580300345|FG000|Overall Study|Withdrawal by Subject|73|||
160705251|NCT02968849|580300346|FG001|Overall Study|Withdrawal by Subject|64|||
160705252|NCT02968849|580300345|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
160705253|NCT02968849|580300346|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
160705254|NCT02968849|580300345|FG000|Overall Study|Physician Decision|6|||
160705255|NCT02968849|580300346|FG001|Overall Study|Physician Decision|9|||
160705256|NCT02968849|580300345|FG000|Overall Study|Other|16|||
160705257|NCT02968849|580300346|FG001|Overall Study|Other|10|||
160705258|NCT02203331|580300349|FG000|Overall Study|Pregnancy|1|||
160705259|NCT02203331|580300350|FG001|Overall Study|Pregnancy|0|||
160705260|NCT02203331|580300351|FG002|Overall Study|Pregnancy|0|||
160705261|NCT02203331|580300352|FG003|Overall Study|Pregnancy|0|||
160705262|NCT02203331|580300353|FG004|Overall Study|Pregnancy|2|||
160705263|NCT02203331|580300354|FG005|Overall Study|Pregnancy|0|||
160705264|NCT02203331|580300349|FG000|Overall Study|Withdrawal by Subject|1|||
160705265|NCT02203331|580300350|FG001|Overall Study|Withdrawal by Subject|0|||
160705266|NCT02203331|580300351|FG002|Overall Study|Withdrawal by Subject|1|||
160705267|NCT02203331|580300352|FG003|Overall Study|Withdrawal by Subject|0|||
160705268|NCT02203331|580300353|FG004|Overall Study|Withdrawal by Subject|0|||
160705269|NCT02203331|580300354|FG005|Overall Study|Withdrawal by Subject|3|||
160705270|NCT02203331|580300349|FG000|Overall Study|Adverse Event|4|||
160705271|NCT02203331|580300350|FG001|Overall Study|Adverse Event|8|||
160705272|NCT02203331|580300351|FG002|Overall Study|Adverse Event|3|||
160705273|NCT02203331|580300352|FG003|Overall Study|Adverse Event|4|||
160705274|NCT02203331|580300353|FG004|Overall Study|Adverse Event|3|||
160705275|NCT02203331|580300354|FG005|Overall Study|Adverse Event|3|||
160705276|NCT02203331|580300349|FG000|Overall Study|Other Reasons|1|||
160705277|NCT02203331|580300350|FG001|Overall Study|Other Reasons|2|||
160705278|NCT02203331|580300351|FG002|Overall Study|Other Reasons|0|||
160705279|NCT02203331|580300352|FG003|Overall Study|Other Reasons|2|||
160705280|NCT02203331|580300353|FG004|Overall Study|Other Reasons|0|||
160705281|NCT02203331|580300354|FG005|Overall Study|Other Reasons|0|||
160705282|NCT02203331|580300349|FG000|Overall Study|Lack of Efficacy|0|||
160705283|NCT02203331|580300350|FG001|Overall Study|Lack of Efficacy|2|||
160705284|NCT02203331|580300351|FG002|Overall Study|Lack of Efficacy|1|||
160705285|NCT02203331|580300352|FG003|Overall Study|Lack of Efficacy|0|||
160705286|NCT02203331|580300353|FG004|Overall Study|Lack of Efficacy|0|||
160705287|NCT02203331|580300354|FG005|Overall Study|Lack of Efficacy|1|||
160705288|NCT02203331|580300349|FG000|Overall Study|Protocol Violation|0|||
160705289|NCT02203331|580300350|FG001|Overall Study|Protocol Violation|2|||
160705290|NCT02203331|580300351|FG002|Overall Study|Protocol Violation|0|||
160705291|NCT02203331|580300352|FG003|Overall Study|Protocol Violation|1|||
160705292|NCT02203331|580300353|FG004|Overall Study|Protocol Violation|1|||
160705293|NCT02203331|580300354|FG005|Overall Study|Protocol Violation|0|||
160705294|NCT02203331|580300349|FG000|Overall Study|Lost to Follow-up|0|||
160705295|NCT02203331|580300350|FG001|Overall Study|Lost to Follow-up|0|||
160705296|NCT02203331|580300351|FG002|Overall Study|Lost to Follow-up|0|||
160705297|NCT02203331|580300352|FG003|Overall Study|Lost to Follow-up|0|||
160705298|NCT02203331|580300353|FG004|Overall Study|Lost to Follow-up|1|||
160705299|NCT02203331|580300354|FG005|Overall Study|Lost to Follow-up|0|||
160705300|NCT02542605|580300355|FG000|Part B: Challenge Phase|Sponsor decision|1|||
160705301|NCT02542605|580300356|FG001|Part B: Challenge Phase|Sponsor decision|0|||
160705302|NCT02542605|580300357|FG002|Part B: Challenge Phase|Sponsor decision|0|||
160705303|NCT02542605|580300355|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
160705304|NCT02542605|580300356|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
160705305|NCT02542605|580300357|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
160705306|NCT03316547|580300360|FG000|Overall Study|Death|3|||
160705307|NCT03316547|580300361|FG001|Overall Study|Death|1|||
160705308|NCT03316547|580300360|FG000|Overall Study|Lost to Follow-up|6|||
160705309|NCT03316547|580300361|FG001|Overall Study|Lost to Follow-up|6|||
160705310|NCT03316547|580300360|FG000|Overall Study|Withdrawal by Subject|3|||
160705311|NCT03316547|580300361|FG001|Overall Study|Withdrawal by Subject|2|||
160705312|NCT03316547|580300360|FG000|Overall Study|Transfer to another hospital|6|||
160705313|NCT03316547|580300361|FG001|Overall Study|Transfer to another hospital|4|||
160705314|NCT00278889|580300362|FG000|Overall Study|Withdrawal by Subject|0|||
160705315|NCT00278889|580300363|FG001|Overall Study|Withdrawal by Subject|5|||
160705316|NCT00278889|580300364|FG002|Overall Study|Withdrawal by Subject|3|||
160705317|NCT00278889|580300362|FG000|Overall Study|Lost to Follow-up|1|||
160705318|NCT00278889|580300363|FG001|Overall Study|Lost to Follow-up|1|||
160705319|NCT00278889|580300364|FG002|Overall Study|Lost to Follow-up|0|||
160705320|NCT00278889|580300362|FG000|Overall Study|Death|24|||
160705321|NCT00278889|580300363|FG001|Overall Study|Death|21|||
160705322|NCT00278889|580300364|FG002|Overall Study|Death|17|||
160705323|NCT00704730|580300365|FG000|Overall Study|Adverse Event|35|||
160705324|NCT00704730|580300366|FG001|Overall Study|Adverse Event|9|||
160705325|NCT00704730|580300365|FG000|Overall Study|Death|11|||
160705326|NCT00704730|580300366|FG001|Overall Study|Death|5|||
160705327|NCT00704730|580300365|FG000|Overall Study|Physician Decision|2|||
160705328|NCT00704730|580300366|FG001|Overall Study|Physician Decision|0|||
160705329|NCT00704730|580300365|FG000|Overall Study|Did not receive drug|5|||
160705330|NCT00704730|580300366|FG001|Overall Study|Did not receive drug|2|||
160705331|NCT00704730|580300365|FG000|Overall Study|Disease progression per PI|58|||
160705332|NCT00704730|580300366|FG001|Overall Study|Disease progression per PI|67|||
160705333|NCT00704730|580300365|FG000|Overall Study|data unavailable|1|||
160705334|NCT00704730|580300366|FG001|Overall Study|data unavailable|0|||
160705335|NCT00704730|580300365|FG000|Overall Study|Withdrawal by Subject|9|||
160705336|NCT00704730|580300366|FG001|Overall Study|Withdrawal by Subject|13|||
160705337|NCT05292183|580302181|FG000|Overall Study|Adverse Event|1|||
160705338|NCT02017015|580302186|FG000|Overall Study|Adverse Event|9|||
160705339|NCT02017015|580302186|FG000|Overall Study|Withdrawal by Subject|21|||
160705340|NCT02017015|580302186|FG000|Overall Study|Death|4|||
160705341|NCT02017015|580302186|FG000|Overall Study|Progressive Disease|31|||
160705342|NCT02017015|580302186|FG000|Overall Study|Non-compliance with study drug|2|||
160705343|NCT02017015|580302186|FG000|Overall Study|Physician Decision|2|||
160705344|NCT01277601|580302189|FG000|Overall Study|Adverse Event|5|||
160705345|NCT01277601|580302190|FG001|Overall Study|Adverse Event|3|||
160705346|NCT01277601|580302191|FG002|Overall Study|Adverse Event|0|||
160705347|NCT01277601|580302192|FG003|Overall Study|Adverse Event|7|||
160705348|NCT01277601|580302189|FG000|Overall Study|Withdrawal by Subject|18|||
160705349|NCT01277601|580302190|FG001|Overall Study|Withdrawal by Subject|21|||
160705350|NCT01277601|580302191|FG002|Overall Study|Withdrawal by Subject|8|||
160705351|NCT01277601|580302192|FG003|Overall Study|Withdrawal by Subject|17|||
160705352|NCT01277601|580302189|FG000|Overall Study|Lost to Follow-up|7|||
160705353|NCT01277601|580302190|FG001|Overall Study|Lost to Follow-up|9|||
160705354|NCT01277601|580302191|FG002|Overall Study|Lost to Follow-up|4|||
160705355|NCT01277601|580302192|FG003|Overall Study|Lost to Follow-up|2|||
160705356|NCT01277601|580302189|FG000|Overall Study|Physician Decision|3|||
160705357|NCT01277601|580302190|FG001|Overall Study|Physician Decision|5|||
160705358|NCT01277601|580302191|FG002|Overall Study|Physician Decision|1|||
160705359|NCT01277601|580302192|FG003|Overall Study|Physician Decision|6|||
160705360|NCT01277601|580302189|FG000|Overall Study|Pregnancy|2|||
160705361|NCT01277601|580302190|FG001|Overall Study|Pregnancy|2|||
160705362|NCT01277601|580302191|FG002|Overall Study|Pregnancy|4|||
160705363|NCT01277601|580302192|FG003|Overall Study|Pregnancy|1|||
160705364|NCT01277601|580302189|FG000|Overall Study|Noncompliance with Study Drug|1|||
160705365|NCT01277601|580302190|FG001|Overall Study|Noncompliance with Study Drug|3|||
160705366|NCT01277601|580302191|FG002|Overall Study|Noncompliance with Study Drug|2|||
160705367|NCT01277601|580302192|FG003|Overall Study|Noncompliance with Study Drug|0|||
160705368|NCT01277601|580302189|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
160705369|NCT01277601|580302190|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
160705370|NCT01277601|580302191|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
160705371|NCT01277601|580302192|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
160705372|NCT01277601|580302189|FG000|Overall Study|Protocol Violation|0|||
160705373|NCT01277601|580302190|FG001|Overall Study|Protocol Violation|2|||
160705374|NCT01277601|580302191|FG002|Overall Study|Protocol Violation|5|||
160705375|NCT01277601|580302192|FG003|Overall Study|Protocol Violation|0|||
160705376|NCT01277601|580302189|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
160705377|NCT01277601|580302190|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
160705378|NCT01277601|580302191|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
160705379|NCT01277601|580302192|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
160705380|NCT02260570|580302194|FG000|Overall Study|Withdrawal by Subject|2|||
160705381|NCT02260570|580302195|FG001|Overall Study|Withdrawal by Subject|1|||
160705382|NCT02260570|580302194|FG000|Overall Study|Physician Decision|1|||
160705383|NCT02260570|580302195|FG001|Overall Study|Physician Decision|1|||
160705384|NCT04034927|580302196|FG000|Overall Study|Adverse Event|4|||
160705385|NCT04034927|580302197|FG001|Overall Study|Adverse Event|9|||
160705386|NCT04034927|580302196|FG000|Overall Study|Death|0|||
160705387|NCT04034927|580302197|FG001|Overall Study|Death|1|||
160705388|NCT04034927|580302196|FG000|Overall Study|Withdrawal by Subject|0|||
160705389|NCT04034927|580302197|FG001|Overall Study|Withdrawal by Subject|3|||
160705390|NCT04034927|580302196|FG000|Overall Study|Still on Treatment|2|||
160705391|NCT04034927|580302197|FG001|Overall Study|Still on Treatment|1|||
160705392|NCT04034927|580302196|FG000|Overall Study|Other|1|||
160705393|NCT04034927|580302197|FG001|Overall Study|Other|1|||
160705394|NCT00369486|580302201|FG000|4-Week Visit|Missed visit|2|||
160705395|NCT00369486|580302202|FG001|4-Week Visit|Missed visit|2|||
160705396|NCT00369486|580302203|FG002|4-Week Visit|Missed visit|0|||
160705397|NCT00369486|580302204|FG003|4-Week Visit|Missed visit|2|||
160705398|NCT00369486|580302205|FG004|4-Week Visit|Missed visit|1|||
160705399|NCT00369486|580302201|FG000|4-Week Visit|Dropped|0|||
160705400|NCT00369486|580302202|FG001|4-Week Visit|Dropped|0|||
160705401|NCT00369486|580302203|FG002|4-Week Visit|Dropped|1|||
160705402|NCT00369486|580302204|FG003|4-Week Visit|Dropped|0|||
160705403|NCT00369486|580302205|FG004|4-Week Visit|Dropped|0|||
160705404|NCT00369486|580302201|FG000|8-Week Visit|Missed visit|0|||
160705405|NCT00369486|580302202|FG001|8-Week Visit|Missed visit|1|||
160705406|NCT00369486|580302203|FG002|8-Week Visit|Missed visit|0|||
160705407|NCT00369486|580302204|FG003|8-Week Visit|Missed visit|0|||
160705408|NCT00369486|580302205|FG004|8-Week Visit|Missed visit|1|||
160705409|NCT00369486|580302201|FG000|8-Week Visit|Dropped|0|||
160705410|NCT00369486|580302202|FG001|8-Week Visit|Dropped|0|||
160705411|NCT00369486|580302203|FG002|8-Week Visit|Dropped|0|||
160705412|NCT00369486|580302204|FG003|8-Week Visit|Dropped|1|||
160705413|NCT00369486|580302205|FG004|8-Week Visit|Dropped|0|||
160705414|NCT00369486|580302201|FG000|17-Week Visit|Missed visit|0|||
160705415|NCT00369486|580302202|FG001|17-Week Visit|Missed visit|0|||
160705416|NCT00369486|580302203|FG002|17-Week Visit|Missed visit|1|||
160705417|NCT00369486|580302204|FG003|17-Week Visit|Missed visit|1|||
160705418|NCT00369486|580302205|FG004|17-Week Visit|Missed visit|1|||
160705419|NCT00369486|580302201|FG000|34-Week Visit|Dropped|0|||
160705420|NCT00369486|580302202|FG001|34-Week Visit|Dropped|1|||
160705421|NCT00369486|580302203|FG002|34-Week Visit|Dropped|1|||
160705422|NCT00369486|580302204|FG003|34-Week Visit|Dropped|3|||
160705423|NCT00369486|580302205|FG004|34-Week Visit|Dropped|3|||
160705424|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #1|24|||
160705425|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #1|0|||
160705426|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
160705427|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
160705428|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
160705429|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
160705430|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
160705431|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
160705432|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
160705433|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
160705434|NCT03888066|580302206|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
160705435|NCT03888066|580302207|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
160705436|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
160705437|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
160705438|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
160705439|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
160705440|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
160705441|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
160705442|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
160705443|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
160705444|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #2|5|||
160705445|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #2|0|||
160705446|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
160705447|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
160705448|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
160705449|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
160705450|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
160705451|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
160705452|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #3|11|||
160705453|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #3|0|||
160705454|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
160705455|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
160705456|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
160705457|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
160705458|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
160705459|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
160705460|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #4|3|||
160705461|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #4|0|||
160705462|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
160705463|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
160705464|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
160705465|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
160705466|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
160705467|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
160705468|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
160705469|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
160705470|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
160705471|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
160705472|NCT03888066|580302206|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
160705473|NCT03888066|580302207|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
160705474|NCT03888066|580302206|FG000|Run-in Phase|AE (Adverse Event)|17|||
160705475|NCT03888066|580302207|FG001|Run-in Phase|AE (Adverse Event)|0|||
160705476|NCT03888066|580302206|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
160705477|NCT03888066|580302207|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
160705478|NCT03888066|580302206|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
160705479|NCT03888066|580302207|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
160705480|NCT03888066|580302206|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
160705481|NCT03888066|580302207|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
160705482|NCT03888066|580302206|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
160705483|NCT03888066|580302207|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
160705484|NCT03888066|580302206|FG000|Run-in Phase|Withdrawal by Subject|43|||
160705485|NCT03888066|580302207|FG001|Run-in Phase|Withdrawal by Subject|0|||
160705486|NCT03888066|580302206|FG000|Run-in Phase|AE; Physician Decision|1|||
160705487|NCT03888066|580302207|FG001|Run-in Phase|AE; Physician Decision|0|||
160705488|NCT03888066|580302206|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
160705489|NCT03888066|580302207|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
160705490|NCT03888066|580302206|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
160705491|NCT03888066|580302207|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
160705492|NCT03888066|580302206|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
160705493|NCT03888066|580302207|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
160705494|NCT03888066|580302206|FG000|Run-in Phase|Death|1|||
160705495|NCT03888066|580302207|FG001|Run-in Phase|Death|0|||
160705496|NCT03888066|580302206|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
160705497|NCT03888066|580302207|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
160705498|NCT03888066|580302206|FG000|Run-in Phase|Physician Decision|1|||
160705499|NCT03888066|580302207|FG001|Run-in Phase|Physician Decision|0|||
160705500|NCT03888066|580302206|FG000|Run-in Phase|Protocol Violation|13|||
160705501|NCT03888066|580302207|FG001|Run-in Phase|Protocol Violation|0|||
160705502|NCT03888066|580302206|FG000|Run-in Phase|Sponsor Request|34|||
160705503|NCT03888066|580302207|FG001|Run-in Phase|Sponsor Request|0|||
160705504|NCT03888066|580302206|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
160705505|NCT03888066|580302207|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
160705506|NCT03888066|580302206|FG000|Run-in Phase|Withdrawal Of Consent|1|||
160705507|NCT03888066|580302207|FG001|Run-in Phase|Withdrawal Of Consent|0|||
160705508|NCT03888066|580302206|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
160705509|NCT03888066|580302207|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
160705510|NCT03888066|580302206|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
160705511|NCT03888066|580302207|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
160705512|NCT03888066|580302206|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
160705513|NCT03888066|580302207|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
160705514|NCT03888066|580302206|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
160705515|NCT03888066|580302207|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
160705516|NCT03888066|580302206|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
160705517|NCT03888066|580302207|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
160705518|NCT03888066|580302206|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
160705519|NCT03888066|580302207|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
160705520|NCT03888066|580302206|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
160705521|NCT03888066|580302207|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
160705522|NCT03888066|580302206|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
160705523|NCT03888066|580302207|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
160705524|NCT03888066|580302206|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
160705525|NCT03888066|580302207|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
160705526|NCT03888066|580302206|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
160705527|NCT03888066|580302207|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
160705528|NCT03888066|580302206|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
160705529|NCT03888066|580302207|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
160705530|NCT03888066|580302206|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
160705531|NCT03888066|580302207|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
160705532|NCT02077140|580302208|FG000|Overall Study|Lost to Follow-up|4|||
160705533|NCT02077140|580302209|FG001|Overall Study|Lost to Follow-up|1|||
160705534|NCT02077140|580302210|FG002|Overall Study|Lost to Follow-up|2|||
160705535|NCT02077140|580302211|FG003|Overall Study|Lost to Follow-up|2|||
160705536|NCT02077140|580302212|FG004|Overall Study|Lost to Follow-up|3|||
160705537|NCT02077140|580302208|FG000|Overall Study|Withdrawal by Subject|0|||
160705538|NCT02077140|580302209|FG001|Overall Study|Withdrawal by Subject|1|||
160705539|NCT02077140|580302210|FG002|Overall Study|Withdrawal by Subject|0|||
160705540|NCT02077140|580302211|FG003|Overall Study|Withdrawal by Subject|2|||
160705541|NCT02077140|580302212|FG004|Overall Study|Withdrawal by Subject|2|||
160705542|NCT01762800|580302214|FG000|Overall Study|Adverse Event|8|||
160705543|NCT01762800|580302215|FG001|Overall Study|Adverse Event|13|||
160705544|NCT01762800|580302214|FG000|Overall Study|Lack of Efficacy|3|||
160705545|NCT01762800|580302215|FG001|Overall Study|Lack of Efficacy|2|||
160705546|NCT01762800|580302214|FG000|Overall Study|Study Closed/Terminated|0|||
160705547|NCT01762800|580302215|FG001|Overall Study|Study Closed/Terminated|1|||
160705548|NCT01762800|580302214|FG000|Overall Study|Physician Decision|1|||
160705549|NCT01762800|580302215|FG001|Overall Study|Physician Decision|1|||
160705550|NCT01762800|580302214|FG000|Overall Study|Withdrawal by Subject|7|||
160705551|NCT01762800|580302215|FG001|Overall Study|Withdrawal by Subject|4|||
160705552|NCT02640482|580302216|FG000|Overall Study|Lost to Follow-up|3|||
160705553|NCT02640482|580302217|FG001|Overall Study|Lost to Follow-up|0|||
160705554|NCT00113763|580302218|FG000|Overall Study|Adverse Event|5|||
160705555|NCT00113763|580302219|FG001|Overall Study|Adverse Event|2|||
160705556|NCT00113763|580302218|FG000|Overall Study|Disease Progression|28|||
160705557|NCT00113763|580302219|FG001|Overall Study|Disease Progression|14|||
160705558|NCT00113763|580302218|FG000|Overall Study|Lost to Follow-up|10|||
160705559|NCT00113763|580302219|FG001|Overall Study|Lost to Follow-up|0|||
160705560|NCT00113763|580302218|FG000|Overall Study|Withdrawal by Subject|1|||
160705561|NCT00113763|580302219|FG001|Overall Study|Withdrawal by Subject|4|||
160705562|NCT00113763|580302218|FG000|Overall Study|Other|27|||
160705563|NCT00113763|580302219|FG001|Overall Study|Other|6|||
160705564|NCT00113763|580302218|FG000|Overall Study|Non-compliance|1|||
160705565|NCT00113763|580302219|FG001|Overall Study|Non-compliance|0|||
160705566|NCT00113763|580302218|FG000|Overall Study|Ongoing|1|||
160705567|NCT00113763|580302219|FG001|Overall Study|Ongoing|0|||
160705568|NCT00517881|580302220|FG000|Overall Study|Protocol Violation|2|||
160705569|NCT00517881|580302220|FG000|Overall Study|Adverse Event|1|||
160705570|NCT00517881|580302220|FG000|Overall Study|Renal transplantation|2|||
160705571|NCT03743415|580302221|FG000|Overall Study|Death|5|||
160705572|NCT03743415|580302222|FG001|Overall Study|Death|3|||
160705573|NCT03743415|580302223|FG002|Overall Study|Death|1|||
160705574|NCT03743415|580302224|FG003|Overall Study|Death|4|||
160705575|NCT03743415|580302225|FG004|Overall Study|Death|0|||
160705576|NCT03743415|580302226|FG005|Overall Study|Death|0|||
160705577|NCT03743415|580302227|FG006|Overall Study|Death|0|||
160705578|NCT03743415|580302228|FG007|Overall Study|Death|0|||
160705579|NCT03743415|580302229|FG008|Overall Study|Death|1|||
160705580|NCT03743415|580302230|FG009|Overall Study|Death|0|||
160705581|NCT03743415|580302221|FG000|Overall Study|Withdrawal by Subject|1|||
160705582|NCT03743415|580302222|FG001|Overall Study|Withdrawal by Subject|0|||
160705583|NCT03743415|580302223|FG002|Overall Study|Withdrawal by Subject|4|||
160705584|NCT03743415|580302224|FG003|Overall Study|Withdrawal by Subject|5|||
160705585|NCT03743415|580302225|FG004|Overall Study|Withdrawal by Subject|5|||
160705586|NCT03743415|580302226|FG005|Overall Study|Withdrawal by Subject|2|||
160705587|NCT03743415|580302227|FG006|Overall Study|Withdrawal by Subject|2|||
160705588|NCT03743415|580302228|FG007|Overall Study|Withdrawal by Subject|5|||
160705589|NCT03743415|580302229|FG008|Overall Study|Withdrawal by Subject|9|||
160705590|NCT03743415|580302230|FG009|Overall Study|Withdrawal by Subject|10|||
160705591|NCT03743415|580302221|FG000|Overall Study|Lost to Follow-up|2|||
160705592|NCT03743415|580302222|FG001|Overall Study|Lost to Follow-up|0|||
160705593|NCT03743415|580302223|FG002|Overall Study|Lost to Follow-up|2|||
160705594|NCT03743415|580302224|FG003|Overall Study|Lost to Follow-up|1|||
160705595|NCT03743415|580302225|FG004|Overall Study|Lost to Follow-up|1|||
160705596|NCT03743415|580302226|FG005|Overall Study|Lost to Follow-up|0|||
160705597|NCT03743415|580302227|FG006|Overall Study|Lost to Follow-up|1|||
160705598|NCT03743415|580302228|FG007|Overall Study|Lost to Follow-up|4|||
160705599|NCT03743415|580302229|FG008|Overall Study|Lost to Follow-up|13|||
160705600|NCT03743415|580302230|FG009|Overall Study|Lost to Follow-up|13|||
160705601|NCT00264550|580302231|FG000|Overall Study|Death|0|||
160705602|NCT00264550|580302232|FG001|Overall Study|Death|3|||
160705603|NCT00264550|580302233|FG002|Overall Study|Death|0|||
160705604|NCT00264550|580302234|FG003|Overall Study|Death|0|||
160705605|NCT00264550|580302231|FG000|Overall Study|Lost to Follow-up|3|||
160705606|NCT00264550|580302232|FG001|Overall Study|Lost to Follow-up|1|||
160705607|NCT00264550|580302233|FG002|Overall Study|Lost to Follow-up|1|||
160705608|NCT00264550|580302234|FG003|Overall Study|Lost to Follow-up|1|||
160705609|NCT00264550|580302231|FG000|Overall Study|Adverse Event|23|||
160705610|NCT00264550|580302232|FG001|Overall Study|Adverse Event|18|||
160705611|NCT00264550|580302233|FG002|Overall Study|Adverse Event|9|||
160705612|NCT00264550|580302234|FG003|Overall Study|Adverse Event|14|||
160705613|NCT00264550|580302231|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160705614|NCT00264550|580302232|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
160705615|NCT00264550|580302233|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
160705616|NCT00264550|580302234|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
160705617|NCT00264550|580302231|FG000|Overall Study|Discontinued oral study agent|0|||
160705618|NCT00264550|580302232|FG001|Overall Study|Discontinued oral study agent|1|||
160705619|NCT00264550|580302233|FG002|Overall Study|Discontinued oral study agent|0|||
160705620|NCT00264550|580302234|FG003|Overall Study|Discontinued oral study agent|0|||
160705621|NCT00264550|580302231|FG000|Overall Study|Other|13|||
160705622|NCT00264550|580302232|FG001|Overall Study|Other|7|||
160705623|NCT00264550|580302233|FG002|Overall Study|Other|3|||
160705624|NCT00264550|580302234|FG003|Overall Study|Other|9|||
160705625|NCT02129608|580302235|FG000|Overall Study|Lost to Follow-up|0|||
160705626|NCT02129608|580302236|FG001|Overall Study|Lost to Follow-up|1|||
160705627|NCT02129608|580302237|FG002|Overall Study|Lost to Follow-up|1|||
160705628|NCT02129608|580302235|FG000|Overall Study|Withdrawal by Subject|0|||
160705629|NCT02129608|580302236|FG001|Overall Study|Withdrawal by Subject|0|||
160705630|NCT02129608|580302237|FG002|Overall Study|Withdrawal by Subject|2|||
160705631|NCT00425373|580302246|FG000|Overall Study|Adverse Event|2|||
160705632|NCT00425373|580302247|FG001|Overall Study|Adverse Event|2|||
160705633|NCT00425373|580302248|FG002|Overall Study|Adverse Event|0|||
160705634|NCT00425373|580302249|FG003|Overall Study|Adverse Event|1|||
160705635|NCT00425373|580302250|FG004|Overall Study|Adverse Event|4|||
160705636|NCT00425373|580302251|FG005|Overall Study|Adverse Event|6|||
160705637|NCT00425373|580302252|FG006|Overall Study|Adverse Event|2|||
160705638|NCT00425373|580302253|FG007|Overall Study|Adverse Event|3|||
160705639|NCT00425373|580302254|FG008|Overall Study|Adverse Event|8|||
160705640|NCT00425373|580302246|FG000|Overall Study|Lost to Follow-up|0|||
160705641|NCT00425373|580302247|FG001|Overall Study|Lost to Follow-up|1|||
160705642|NCT00425373|580302248|FG002|Overall Study|Lost to Follow-up|0|||
160705643|NCT00425373|580302249|FG003|Overall Study|Lost to Follow-up|0|||
160705644|NCT00425373|580302250|FG004|Overall Study|Lost to Follow-up|1|||
160705645|NCT00425373|580302251|FG005|Overall Study|Lost to Follow-up|0|||
160705646|NCT00425373|580302252|FG006|Overall Study|Lost to Follow-up|0|||
160705647|NCT00425373|580302253|FG007|Overall Study|Lost to Follow-up|0|||
160705648|NCT00425373|580302254|FG008|Overall Study|Lost to Follow-up|0|||
160705649|NCT00425373|580302246|FG000|Overall Study|Protocol Violation|1|||
160705650|NCT00425373|580302247|FG001|Overall Study|Protocol Violation|0|||
160705651|NCT00425373|580302248|FG002|Overall Study|Protocol Violation|1|||
160705652|NCT00425373|580302249|FG003|Overall Study|Protocol Violation|0|||
160705653|NCT00425373|580302250|FG004|Overall Study|Protocol Violation|0|||
160705654|NCT00425373|580302251|FG005|Overall Study|Protocol Violation|0|||
160705655|NCT00425373|580302252|FG006|Overall Study|Protocol Violation|0|||
160705656|NCT00425373|580302253|FG007|Overall Study|Protocol Violation|5|||
160705657|NCT00425373|580302254|FG008|Overall Study|Protocol Violation|3|||
160705658|NCT00425373|580302246|FG000|Overall Study|Withdrawal by Subject|2|||
160705659|NCT00425373|580302247|FG001|Overall Study|Withdrawal by Subject|0|||
160705660|NCT00425373|580302248|FG002|Overall Study|Withdrawal by Subject|2|||
160705661|NCT00425373|580302249|FG003|Overall Study|Withdrawal by Subject|1|||
160705662|NCT00425373|580302250|FG004|Overall Study|Withdrawal by Subject|4|||
160705663|NCT00425373|580302251|FG005|Overall Study|Withdrawal by Subject|0|||
160705664|NCT00425373|580302252|FG006|Overall Study|Withdrawal by Subject|2|||
160705665|NCT00425373|580302253|FG007|Overall Study|Withdrawal by Subject|2|||
160705666|NCT00425373|580302254|FG008|Overall Study|Withdrawal by Subject|2|||
160705667|NCT00425373|580302246|FG000|Overall Study|Lack of Efficacy|0|||
160705668|NCT00425373|580302247|FG001|Overall Study|Lack of Efficacy|0|||
160705669|NCT00425373|580302248|FG002|Overall Study|Lack of Efficacy|0|||
160705670|NCT00425373|580302249|FG003|Overall Study|Lack of Efficacy|0|||
160705671|NCT00425373|580302250|FG004|Overall Study|Lack of Efficacy|1|||
160705672|NCT00425373|580302251|FG005|Overall Study|Lack of Efficacy|3|||
160705673|NCT00425373|580302252|FG006|Overall Study|Lack of Efficacy|3|||
160705674|NCT00425373|580302253|FG007|Overall Study|Lack of Efficacy|0|||
160705675|NCT00425373|580302254|FG008|Overall Study|Lack of Efficacy|5|||
160705676|NCT01721317|580302257|FG000|Overall Study|Study Closed / Terminated|2|||
160705677|NCT01721317|580302258|FG001|Overall Study|Study Closed / Terminated|2|||
160705678|NCT01721317|580302257|FG000|Overall Study|Physician Decision|0|||
160705679|NCT01721317|580302258|FG001|Overall Study|Physician Decision|1|||
160705680|NCT01721317|580302257|FG000|Overall Study|Withdrawal by Subject|0|||
160705681|NCT01721317|580302258|FG001|Overall Study|Withdrawal by Subject|1|||
160705682|NCT03485365|580302260|FG000|Overall Study|Protocol Violation|0|||
160705683|NCT03485365|580302261|FG001|Overall Study|Protocol Violation|0|||
160705684|NCT03485365|580302262|FG002|Overall Study|Protocol Violation|0|||
160705685|NCT03485365|580302263|FG003|Overall Study|Protocol Violation|1|||
160705686|NCT03485365|580302264|FG004|Overall Study|Protocol Violation|0|||
160705687|NCT03485365|580302265|FG005|Overall Study|Protocol Violation|0|||
160705688|NCT03485365|580302266|FG006|Overall Study|Protocol Violation|1|||
160705689|NCT03485365|580302267|FG007|Overall Study|Protocol Violation|0|||
160705690|NCT03485365|580302268|FG008|Overall Study|Protocol Violation|0|||
160705691|NCT01275430|580302274|FG000|Overall Study|Adverse Event|1|||
160705692|NCT01275430|580302274|FG000|Overall Study|No Contrast Injection|6|||
160705693|NCT01275430|580302274|FG000|Overall Study|Device Malfunction|1|||
160705694|NCT01275430|580302274|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
160705695|NCT04988087|580302275|FG000|Overall Study|Adverse Event|4|||
160705696|NCT04988087|580302276|FG001|Overall Study|Adverse Event|0|||
160705697|NCT04988087|580302277|FG002|Overall Study|Adverse Event|0|||
160705698|NCT04988087|580302278|FG003|Overall Study|Adverse Event|0|||
160705699|NCT04988087|580302275|FG000|Overall Study|Withdrawal by Subject|1|||
160705700|NCT04988087|580302276|FG001|Overall Study|Withdrawal by Subject|1|||
160705701|NCT04988087|580302277|FG002|Overall Study|Withdrawal by Subject|0|||
160705702|NCT04988087|580302278|FG003|Overall Study|Withdrawal by Subject|0|||
160705703|NCT04988087|580302275|FG000|Overall Study|Technical problems|7|||
160705704|NCT04988087|580302276|FG001|Overall Study|Technical problems|9|||
160705705|NCT04988087|580302277|FG002|Overall Study|Technical problems|1|||
160705706|NCT04988087|580302278|FG003|Overall Study|Technical problems|2|||
160705707|NCT02613182|580302279|FG000|Overall Study|Death|6|||
160705708|NCT02613182|580302279|FG000|Overall Study|Physician Decision|1|||
160705709|NCT02613182|580302279|FG000|Overall Study|Study Terminated by Sponsor|21|||
160705710|NCT02613182|580302279|FG000|Overall Study|Withdrawal by Subject|6|||
160705711|NCT03968978|580302280|FG000|Overall Study|Adverse Event|1|||
160705712|NCT03968978|580302281|FG001|Overall Study|Adverse Event|0|||
160705713|NCT00863772|580302282|FG000|Overall Study|Adverse Event|1|||
160705714|NCT00863772|580302283|FG001|Overall Study|Adverse Event|4|||
160705715|NCT00863772|580302284|FG002|Overall Study|Adverse Event|0|||
160705716|NCT00863772|580302282|FG000|Overall Study|Lack of Efficacy|4|||
160705717|NCT00863772|580302283|FG001|Overall Study|Lack of Efficacy|2|||
160705718|NCT00863772|580302284|FG002|Overall Study|Lack of Efficacy|4|||
160705719|NCT00863772|580302282|FG000|Overall Study|Lost to Follow-up|5|||
160705720|NCT00863772|580302283|FG001|Overall Study|Lost to Follow-up|1|||
160705721|NCT00863772|580302284|FG002|Overall Study|Lost to Follow-up|1|||
160705722|NCT00863772|580302282|FG000|Overall Study|Protocol Violation|2|||
160705723|NCT00863772|580302283|FG001|Overall Study|Protocol Violation|0|||
160705724|NCT00863772|580302284|FG002|Overall Study|Protocol Violation|2|||
160705725|NCT00863772|580302282|FG000|Overall Study|Withdrawal by Subject|4|||
160705726|NCT00863772|580302283|FG001|Overall Study|Withdrawal by Subject|7|||
160705727|NCT00863772|580302284|FG002|Overall Study|Withdrawal by Subject|5|||
160705728|NCT00863772|580302282|FG000|Overall Study|Study terminated by sponsor|44|||
160705729|NCT00863772|580302283|FG001|Overall Study|Study terminated by sponsor|45|||
160705730|NCT00863772|580302284|FG002|Overall Study|Study terminated by sponsor|36|||
160705731|NCT00863772|580302282|FG000|Overall Study|Entered extension study|6|||
160705732|NCT00863772|580302283|FG001|Overall Study|Entered extension study|4|||
160705733|NCT00863772|580302284|FG002|Overall Study|Entered extension study|9|||
160705734|NCT00863772|580302282|FG000|Overall Study|Other|1|||
160705735|NCT00863772|580302283|FG001|Overall Study|Other|2|||
160705736|NCT00863772|580302284|FG002|Overall Study|Other|4|||
160705737|NCT00863772|580302282|FG000|Overall Study|Randomized but not Treated|1|||
160705738|NCT00863772|580302283|FG001|Overall Study|Randomized but not Treated|0|||
160705739|NCT00863772|580302284|FG002|Overall Study|Randomized but not Treated|0|||
160705740|NCT02785952|580302285|FG000|Overall Study|Adverse Event|31|||
160705741|NCT02785952|580302286|FG001|Overall Study|Adverse Event|19|||
160705742|NCT02785952|580302285|FG000|Overall Study|Refusal unrelated to adverse events|10|||
160705743|NCT02785952|580302286|FG001|Overall Study|Refusal unrelated to adverse events|5|||
160705744|NCT02785952|580302285|FG000|Overall Study|Disease progression/relapse|61|||
160705745|NCT02785952|580302286|FG001|Overall Study|Disease progression/relapse|89|||
160705746|NCT02785952|580302285|FG000|Overall Study|Death|11|||
160705747|NCT02785952|580302286|FG001|Overall Study|Death|7|||
160705748|NCT02785952|580302285|FG000|Overall Study|Other- not protocol specified|6|||
160705749|NCT02785952|580302286|FG001|Overall Study|Other- not protocol specified|4|||
160705750|NCT02785952|580302285|FG000|Overall Study|On protocol treatment|6|||
160705751|NCT02785952|580302286|FG001|Overall Study|On protocol treatment|3|||
160705752|NCT00090363|580302287|FG000|Overall Study|Lost to Follow-up|1|||
160705753|NCT00090363|580302288|FG001|Overall Study|Lost to Follow-up|2|||
160705754|NCT00090363|580302289|FG002|Overall Study|Lost to Follow-up|1|||
160705755|NCT00090363|580302287|FG000|Overall Study|Withdrawal by Subject|7|||
160705756|NCT00090363|580302288|FG001|Overall Study|Withdrawal by Subject|7|||
160705757|NCT00090363|580302289|FG002|Overall Study|Withdrawal by Subject|6|||
160705758|NCT00090363|580302287|FG000|Overall Study|Study-specific discontinuation criteria|75|||
160705759|NCT00090363|580302288|FG001|Overall Study|Study-specific discontinuation criteria|74|||
160705760|NCT00090363|580302289|FG002|Overall Study|Study-specific discontinuation criteria|62|||
160705761|NCT00090363|580302287|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160705762|NCT00090363|580302288|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160705763|NCT00090363|580302289|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
160705764|NCT00090363|580302287|FG000|Overall Study|Consent expired|7|||
160705765|NCT00090363|580302288|FG001|Overall Study|Consent expired|10|||
160705766|NCT00090363|580302289|FG002|Overall Study|Consent expired|9|||
160705767|NCT00090363|580302287|FG000|Overall Study|Reasons not specified|2|||
160705768|NCT00090363|580302288|FG001|Overall Study|Reasons not specified|1|||
160705769|NCT00090363|580302289|FG002|Overall Study|Reasons not specified|1|||
160705770|NCT00090363|580302287|FG000|Overall Study|Continuing on study off treatment|14|||
160705771|NCT00090363|580302288|FG001|Overall Study|Continuing on study off treatment|13|||
160705772|NCT00090363|580302289|FG002|Overall Study|Continuing on study off treatment|16|||
160705773|NCT03185013|580302290|FG000|Overall Study|Withdrawal by Subject|5|||
160705774|NCT03185013|580302291|FG001|Overall Study|Withdrawal by Subject|3|||
160705775|NCT03185013|580302290|FG000|Overall Study|Adverse Event|1|||
160705776|NCT03185013|580302291|FG001|Overall Study|Adverse Event|0|||
160705777|NCT03185013|580302290|FG000|Overall Study|Progressive Disease|1|||
160705778|NCT03185013|580302291|FG001|Overall Study|Progressive Disease|0|||
160705779|NCT03185013|580302290|FG000|Overall Study|Lost to Follow-up|8|||
160705780|NCT03185013|580302291|FG001|Overall Study|Lost to Follow-up|2|||
160705781|NCT03185013|580302290|FG000|Overall Study|Physician Decision|1|||
160705782|NCT03185013|580302291|FG001|Overall Study|Physician Decision|0|||
160705783|NCT03185013|580302290|FG000|Overall Study|Protocol Deviation|2|||
160705784|NCT03185013|580302291|FG001|Overall Study|Protocol Deviation|0|||
160705785|NCT03185013|580302290|FG000|Overall Study|Reason not Specified|3|||
160705786|NCT03185013|580302291|FG001|Overall Study|Reason not Specified|2|||
160705787|NCT03185013|580302290|FG000|Overall Study|Death|1|||
160705788|NCT03185013|580302291|FG001|Overall Study|Death|0|||
160705789|NCT01104792|580302295|FG000|Overall Study|Adverse Event|77|||
160705790|NCT01104792|580302295|FG000|Overall Study|Insufficient Therapeutic Response|22|||
160705791|NCT01104792|580302295|FG000|Overall Study|Protocol Violation|45|||
160705792|NCT01104792|580302295|FG000|Overall Study|Withdrawal of Consent|179|||
160705793|NCT01104792|580302295|FG000|Overall Study|Lost to Follow-up|43|||
160705794|NCT01104792|580302295|FG000|Overall Study|Reasons Not Specified|27|||
160705795|NCT01104792|580302295|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
160705796|NCT03255655|580302297|FG000|Overall Study|Lost to Follow-up|7|||
160705797|NCT03255655|580302298|FG001|Overall Study|Lost to Follow-up|4|||
160705798|NCT02056392|580302302|FG000|Overall Study|Lost to Follow-up|0|||
160705799|NCT02056392|580302303|FG001|Overall Study|Lost to Follow-up|1|||
160705800|NCT02056392|580302304|FG002|Overall Study|Lost to Follow-up|2|||
160705801|NCT02056392|580302305|FG003|Overall Study|Lost to Follow-up|0|||
160705802|NCT02056392|580302306|FG004|Overall Study|Lost to Follow-up|0|||
160705803|NCT02056392|580302307|FG005|Overall Study|Lost to Follow-up|0|||
160705804|NCT02056392|580302302|FG000|Overall Study|Protocol Violation|1|||
160705805|NCT02056392|580302303|FG001|Overall Study|Protocol Violation|0|||
160705806|NCT02056392|580302304|FG002|Overall Study|Protocol Violation|1|||
160705807|NCT02056392|580302305|FG003|Overall Study|Protocol Violation|0|||
160705808|NCT02056392|580302306|FG004|Overall Study|Protocol Violation|0|||
160705809|NCT02056392|580302307|FG005|Overall Study|Protocol Violation|0|||
160705810|NCT02056392|580302302|FG000|Overall Study|Withdrawal by Subject|1|||
160705811|NCT02056392|580302303|FG001|Overall Study|Withdrawal by Subject|0|||
160705812|NCT02056392|580302304|FG002|Overall Study|Withdrawal by Subject|0|||
160705813|NCT02056392|580302305|FG003|Overall Study|Withdrawal by Subject|0|||
160705814|NCT02056392|580302306|FG004|Overall Study|Withdrawal by Subject|1|||
160705815|NCT02056392|580302307|FG005|Overall Study|Withdrawal by Subject|0|||
160705816|NCT00103610|580302308|FG000|Overall Study|Entered Rescue Procedure|10|||
160705817|NCT00103610|580302309|FG001|Overall Study|Entered Rescue Procedure|52|||
160705818|NCT00103610|580302308|FG000|Overall Study|Death|16|||
160705819|NCT00103610|580302309|FG001|Overall Study|Death|12|||
160705820|NCT00103610|580302308|FG000|Overall Study|Elective Withdrawal|4|||
160705821|NCT00103610|580302309|FG001|Overall Study|Elective Withdrawal|0|||
160705822|NCT00103610|580302308|FG000|Overall Study|Lost to Follow-up|3|||
160705823|NCT00103610|580302309|FG001|Overall Study|Lost to Follow-up|1|||
160705824|NCT00103610|580302308|FG000|Overall Study|Adverse Event|2|||
160705825|NCT00103610|580302309|FG001|Overall Study|Adverse Event|2|||
160705826|NCT00103610|580302308|FG000|Overall Study|Other|2|||
160705827|NCT00103610|580302309|FG001|Overall Study|Other|7|||
160705828|NCT00103610|580302308|FG000|Overall Study|Failed mobilization|1|||
160705829|NCT00103610|580302309|FG001|Overall Study|Failed mobilization|5|||
160705830|NCT00103610|580302308|FG000|Overall Study|Noncompliance|0|||
160705831|NCT00103610|580302309|FG001|Overall Study|Noncompliance|1|||
160705832|NCT00658021|580302310|FG000|28-Week Treatment Period|Adverse Event|3|||
160705833|NCT00658021|580302311|FG001|28-Week Treatment Period|Adverse Event|1|||
160705834|NCT00658021|580302312|FG002|28-Week Treatment Period|Adverse Event|0|||
160705835|NCT00658021|580302310|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
160705836|NCT00658021|580302311|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
160705837|NCT00658021|580302312|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
160705838|NCT00658021|580302310|FG000|28-Week Treatment Period|Protocol Violation|0|||
160705839|NCT00658021|580302311|FG001|28-Week Treatment Period|Protocol Violation|2|||
160705840|NCT00658021|580302312|FG002|28-Week Treatment Period|Protocol Violation|1|||
160705841|NCT00658021|580302310|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
160705842|NCT00658021|580302311|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
160705843|NCT00658021|580302312|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
160705844|NCT00658021|580302310|FG000|28-Week Treatment Period|Physician Decision|1|||
160705845|NCT00658021|580302311|FG001|28-Week Treatment Period|Physician Decision|2|||
160705846|NCT00658021|580302312|FG002|28-Week Treatment Period|Physician Decision|1|||
160705847|NCT00658021|580302310|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
160705848|NCT00658021|580302311|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
160705849|NCT00658021|580302312|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
160705850|NCT00658021|580302310|FG000|28-Week Treatment Period|Loss of glucose control|1|||
160705851|NCT00658021|580302311|FG001|28-Week Treatment Period|Loss of glucose control|1|||
160705852|NCT00658021|580302312|FG002|28-Week Treatment Period|Loss of glucose control|10|||
160705853|NCT00658021|580302310|FG000|28-Week Treatment Period|Other|2|||
160705854|NCT00658021|580302311|FG001|28-Week Treatment Period|Other|3|||
160705855|NCT00658021|580302312|FG002|28-Week Treatment Period|Other|1|||
160705856|NCT00658021|580302310|FG000|28-Week Treatment Period|Did not receive treatment|2|||
160705857|NCT00658021|580302311|FG001|28-Week Treatment Period|Did not receive treatment|0|||
160705858|NCT00658021|580302312|FG002|28-Week Treatment Period|Did not receive treatment|0|||
160705859|NCT00658021|580302310|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
160705860|NCT00658021|580302311|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
160705861|NCT00658021|580302312|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
160705862|NCT00658021|580302310|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
160705863|NCT00658021|580302311|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
160705864|NCT00658021|580302312|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
160705865|NCT01806506|580302313|FG000|Overall Study|Lost to Follow-up|2|||
160705866|NCT01806506|580302314|FG001|Overall Study|Lost to Follow-up|1|||
160705867|NCT03014180|580302319|FG000|Overall Study|Protocol Violation|2|||
160705868|NCT05819203|580302320|FG000|Overall Study|Protocol Violation|1|||
160705869|NCT05819203|580302321|FG001|Overall Study|Protocol Violation|2|||
160705870|NCT05819203|580302320|FG000|Overall Study|Withdrawal by Subject|1|||
160705871|NCT05819203|580302321|FG001|Overall Study|Withdrawal by Subject|0|||
160705872|NCT04844762|580302322|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705873|NCT04844762|580302323|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705874|NCT04844762|580302324|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
160705875|NCT04844762|580302325|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705876|NCT04844762|580302326|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705877|NCT04844762|580302327|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705878|NCT04844762|580302322|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
160705879|NCT04844762|580302323|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
160705880|NCT04844762|580302324|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
160705881|NCT04844762|580302325|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
160705882|NCT04844762|580302326|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
160705883|NCT04844762|580302327|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
160705884|NCT04844762|580302322|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705885|NCT04844762|580302323|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705886|NCT04844762|580302324|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
160705887|NCT04844762|580302325|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
160705888|NCT04844762|580302326|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705889|NCT04844762|580302327|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
160705890|NCT04844762|580302322|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705891|NCT04844762|580302323|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705892|NCT04844762|580302324|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
160705893|NCT04844762|580302325|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
160705894|NCT04844762|580302326|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
160705895|NCT04844762|580302327|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705896|NCT04844762|580302322|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
160705897|NCT04844762|580302323|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
160705898|NCT04844762|580302324|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
160705899|NCT04844762|580302325|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
160705900|NCT04844762|580302326|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
160705901|NCT04844762|580302327|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
160705902|NCT04844762|580302322|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
160705903|NCT04844762|580302323|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705904|NCT04844762|580302324|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705905|NCT04844762|580302325|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705906|NCT04844762|580302326|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705907|NCT04844762|580302327|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705908|NCT04844762|580302322|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705909|NCT04844762|580302323|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705910|NCT04844762|580302324|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705911|NCT04844762|580302325|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705912|NCT04844762|580302326|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
160705913|NCT04844762|580302327|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
160705914|NCT04844762|580302322|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
160705915|NCT04844762|580302323|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
160705916|NCT04844762|580302324|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
160705917|NCT04844762|580302325|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
160705918|NCT04844762|580302326|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
160705919|NCT04844762|580302327|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
160705920|NCT04844762|580302322|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
160705921|NCT04844762|580302323|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705922|NCT04844762|580302324|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705923|NCT04844762|580302325|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705924|NCT04844762|580302326|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
160705925|NCT04844762|580302327|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
160705926|NCT04844762|580302322|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
160705927|NCT04844762|580302323|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
160705928|NCT04844762|580302324|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
160705929|NCT04844762|580302325|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
160705930|NCT04844762|580302326|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
160705931|NCT04844762|580302327|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
160705932|NCT04844762|580302322|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
160705933|NCT04844762|580302323|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
160705934|NCT04844762|580302324|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
160705935|NCT04844762|580302325|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
160705936|NCT04844762|580302326|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
160705937|NCT04844762|580302327|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
160705938|NCT02099682|580302330|FG000|Overall Study|Data Not Available|51|||
160705939|NCT02099682|580302330|FG000|Overall Study|Lost to Follow-up|31|||
160705940|NCT02099682|580302330|FG000|Overall Study|Other|29|||
160705941|NCT02802631|580302331|FG000|Overall Study|Withdrawal by Subject|1|||
160705942|NCT02802631|580302332|FG001|Overall Study|Withdrawal by Subject|0|||
160705943|NCT02802631|580302333|FG002|Overall Study|Withdrawal by Subject|0|||
160705944|NCT02802631|580302334|FG003|Overall Study|Withdrawal by Subject|0|||
160705945|NCT02802631|580302335|FG004|Overall Study|Withdrawal by Subject|0|||
160705946|NCT02802631|580302336|FG005|Overall Study|Withdrawal by Subject|0|||
160705947|NCT02802631|580302337|FG006|Overall Study|Withdrawal by Subject|0|||
160705948|NCT02802631|580302338|FG007|Overall Study|Withdrawal by Subject|0|||
160705949|NCT02802631|580302331|FG000|Overall Study|Physician Decision|1|||
160705950|NCT02802631|580302332|FG001|Overall Study|Physician Decision|0|||
160705951|NCT02802631|580302333|FG002|Overall Study|Physician Decision|0|||
160705952|NCT02802631|580302334|FG003|Overall Study|Physician Decision|0|||
160705953|NCT02802631|580302335|FG004|Overall Study|Physician Decision|0|||
160705954|NCT02802631|580302336|FG005|Overall Study|Physician Decision|0|||
160705955|NCT02802631|580302337|FG006|Overall Study|Physician Decision|1|||
160705956|NCT02802631|580302338|FG007|Overall Study|Physician Decision|0|||
160705957|NCT02802631|580302331|FG000|Overall Study|Adverse Event|0|||
160705958|NCT02802631|580302332|FG001|Overall Study|Adverse Event|2|||
160705959|NCT02802631|580302333|FG002|Overall Study|Adverse Event|0|||
160705960|NCT02802631|580302334|FG003|Overall Study|Adverse Event|1|||
160705961|NCT02802631|580302335|FG004|Overall Study|Adverse Event|6|||
160705962|NCT02802631|580302336|FG005|Overall Study|Adverse Event|1|||
160705963|NCT02802631|580302337|FG006|Overall Study|Adverse Event|4|||
160705964|NCT02802631|580302338|FG007|Overall Study|Adverse Event|0|||
160705965|NCT02802631|580302331|FG000|Overall Study|Sponsor Decision|0|||
160705966|NCT02802631|580302332|FG001|Overall Study|Sponsor Decision|0|||
160705967|NCT02802631|580302333|FG002|Overall Study|Sponsor Decision|6|||
160705968|NCT02802631|580302334|FG003|Overall Study|Sponsor Decision|0|||
160705969|NCT02802631|580302335|FG004|Overall Study|Sponsor Decision|2|||
160705970|NCT02802631|580302336|FG005|Overall Study|Sponsor Decision|0|||
160705971|NCT02802631|580302337|FG006|Overall Study|Sponsor Decision|0|||
160705972|NCT02802631|580302338|FG007|Overall Study|Sponsor Decision|4|||
160705973|NCT04784533|580302339|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
160705974|NCT04784533|580302340|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
160705975|NCT04784533|580302341|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
160705976|NCT04784533|580302342|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
160705977|NCT04784533|580302343|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
160705978|NCT04784533|580302344|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
160705979|NCT04784533|580302345|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
160705980|NCT04784533|580302346|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
160705981|NCT04784533|580302347|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
160705982|NCT04784533|580302348|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
160705983|NCT04784533|580302339|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
160705984|NCT04784533|580302340|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
160705985|NCT04784533|580302341|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
160705986|NCT04784533|580302342|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
160705987|NCT04784533|580302343|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
160705988|NCT04784533|580302344|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
160705989|NCT04784533|580302345|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
160705990|NCT04784533|580302346|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
160705991|NCT04784533|580302347|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
160705992|NCT04784533|580302348|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
160705993|NCT04784533|580302339|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
160705994|NCT04784533|580302340|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
160705995|NCT04784533|580302341|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
160705996|NCT04784533|580302342|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
160705997|NCT04784533|580302343|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
160705998|NCT04784533|580302344|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
160705999|NCT04784533|580302345|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
160706000|NCT04784533|580302346|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
160706001|NCT04784533|580302347|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
160706002|NCT04784533|580302348|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
160706003|NCT04784533|580302339|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
160706004|NCT04784533|580302340|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
160706005|NCT04784533|580302341|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
160706006|NCT04784533|580302342|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
160706007|NCT04784533|580302343|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
160706008|NCT04784533|580302344|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
160706009|NCT04784533|580302345|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
160706010|NCT04784533|580302346|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
160706011|NCT04784533|580302347|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
160706012|NCT04784533|580302348|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
160706013|NCT04784533|580302339|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
160706014|NCT04784533|580302340|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
160706015|NCT04784533|580302341|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
160706016|NCT04784533|580302342|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
160706017|NCT04784533|580302343|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
160706018|NCT04784533|580302344|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
160706019|NCT04784533|580302345|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
160706020|NCT04784533|580302346|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
160706021|NCT04784533|580302347|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
160706022|NCT04784533|580302348|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
160706023|NCT04784533|580302339|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
160706024|NCT04784533|580302340|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
160706025|NCT04784533|580302341|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
160706026|NCT04784533|580302342|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
160706027|NCT04784533|580302343|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
160706028|NCT04784533|580302344|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
160706029|NCT04784533|580302345|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
160706030|NCT04784533|580302346|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
160706031|NCT04784533|580302347|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
160706032|NCT04784533|580302348|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
160706033|NCT04784533|580302339|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
160706034|NCT04784533|580302340|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
160706035|NCT04784533|580302341|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
160706036|NCT04784533|580302342|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
160706037|NCT04784533|580302343|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
160706038|NCT04784533|580302344|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
160706039|NCT04784533|580302345|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
160706040|NCT04784533|580302346|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
160706041|NCT04784533|580302347|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
160706042|NCT04784533|580302348|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
160706043|NCT04784533|580302339|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
160706044|NCT04784533|580302340|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
160706045|NCT04784533|580302341|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
160706046|NCT04784533|580302342|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
160706047|NCT04784533|580302343|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
160706048|NCT04784533|580302344|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
160706049|NCT04784533|580302345|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
160706050|NCT04784533|580302346|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
160706051|NCT04784533|580302347|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
160706052|NCT04784533|580302348|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
160706053|NCT04784533|580302339|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
160706054|NCT04784533|580302340|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
160706055|NCT04784533|580302341|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
160706056|NCT04784533|580302342|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
160706057|NCT04784533|580302343|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
160706058|NCT04784533|580302344|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
160706059|NCT04784533|580302345|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
160706060|NCT04784533|580302346|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
160706061|NCT04784533|580302347|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
160706062|NCT04784533|580302348|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
160706063|NCT02105974|580302349|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
160706064|NCT02105974|580302350|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
160706065|NCT02105974|580302351|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
160706066|NCT02105974|580302349|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
160706067|NCT02105974|580302350|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
160706068|NCT02105974|580302351|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
160706069|NCT02105974|580302349|FG000|2 Week Run-in Period|Adverse Event|6|||
160706070|NCT02105974|580302350|FG001|2 Week Run-in Period|Adverse Event|0|||
160706071|NCT02105974|580302351|FG002|2 Week Run-in Period|Adverse Event|0|||
160706072|NCT02105974|580302349|FG000|2 Week Run-in Period|Study closed/terminated|1|||
160706073|NCT02105974|580302350|FG001|2 Week Run-in Period|Study closed/terminated|0|||
160706074|NCT02105974|580302351|FG002|2 Week Run-in Period|Study closed/terminated|0|||
160706075|NCT02105974|580302349|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
160706076|NCT02105974|580302350|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
160706077|NCT02105974|580302351|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
160706078|NCT02105974|580302349|FG000|2 Week Run-in Period|Withdrew consent|23|||
160706079|NCT02105974|580302350|FG001|2 Week Run-in Period|Withdrew consent|0|||
160706080|NCT02105974|580302351|FG002|2 Week Run-in Period|Withdrew consent|0|||
160706081|NCT02105974|580302349|FG000|2 Week Run-in Period|Investigator discretion|8|||
160706082|NCT02105974|580302350|FG001|2 Week Run-in Period|Investigator discretion|0|||
160706083|NCT02105974|580302351|FG002|2 Week Run-in Period|Investigator discretion|0|||
160706084|NCT02105974|580302349|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
160706085|NCT02105974|580302350|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
160706086|NCT02105974|580302351|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
160706087|NCT02105974|580302349|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
160706088|NCT02105974|580302350|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
160706089|NCT02105974|580302351|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
160706090|NCT02105974|580302349|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
160706091|NCT02105974|580302350|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
160706092|NCT02105974|580302351|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
160706093|NCT02105974|580302349|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
160706094|NCT02105974|580302350|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
160706095|NCT02105974|580302351|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
160706096|NCT02105974|580302349|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
160706097|NCT02105974|580302350|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
160706098|NCT02105974|580302351|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
160706099|NCT02105974|580302349|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
160706100|NCT02105974|580302350|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
160706101|NCT02105974|580302351|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
160706102|NCT02105974|580302349|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
160706103|NCT02105974|580302350|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
160706104|NCT02105974|580302351|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
160706105|NCT03597464|580302355|FG000|Overall Study|Withdrawal by Subject|4|||
160706106|NCT03597464|580302356|FG001|Overall Study|Withdrawal by Subject|5|||
160706107|NCT03597464|580302355|FG000|Overall Study|Lost to Follow-up|3|||
160706108|NCT03597464|580302356|FG001|Overall Study|Lost to Follow-up|1|||
160706109|NCT03597464|580302355|FG000|Overall Study|Pregnancy|3|||
160706110|NCT03597464|580302356|FG001|Overall Study|Pregnancy|1|||
160706111|NCT03597464|580302355|FG000|Overall Study|Lack of Efficacy|2|||
160706112|NCT03597464|580302356|FG001|Overall Study|Lack of Efficacy|0|||
160706113|NCT03597464|580302355|FG000|Overall Study|Physician Decision|2|||
160706114|NCT03597464|580302356|FG001|Overall Study|Physician Decision|2|||
160706115|NCT03597464|580302355|FG000|Overall Study|Protocol Violation|1|||
160706116|NCT03597464|580302356|FG001|Overall Study|Protocol Violation|1|||
160706117|NCT03597464|580302355|FG000|Overall Study|Adverse Event|0|||
160706118|NCT03597464|580302356|FG001|Overall Study|Adverse Event|2|||
160706119|NCT03597464|580302355|FG000|Overall Study|Death|0|||
160706120|NCT03597464|580302356|FG001|Overall Study|Death|3|||
160706121|NCT00287586|580303651|FG000|Overall Study|Withdrew Consent|19|||
160706122|NCT00287586|580303652|FG001|Overall Study|Withdrew Consent|30|||
160706123|NCT00287586|580303651|FG000|Overall Study|Lost to Follow-up|5|||
160706124|NCT00287586|580303652|FG001|Overall Study|Lost to Follow-up|4|||
160706125|NCT00287586|580303651|FG000|Overall Study|Death|2|||
160706126|NCT00287586|580303652|FG001|Overall Study|Death|3|||
160706127|NCT00287586|580303651|FG000|Overall Study|Elevated Hematocrit|3|||
160706128|NCT00287586|580303652|FG001|Overall Study|Elevated Hematocrit|0|||
160706129|NCT00287586|580303651|FG000|Overall Study|Rash|3|||
160706130|NCT00287586|580303652|FG001|Overall Study|Rash|0|||
160706131|NCT00287586|580303651|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
160706132|NCT00287586|580303652|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
160706133|NCT00287586|580303651|FG000|Overall Study|Stroke|2|||
160706134|NCT00287586|580303652|FG001|Overall Study|Stroke|0|||
160706135|NCT00287586|580303651|FG000|Overall Study|Myocardial Infarction|1|||
160706136|NCT00287586|580303652|FG001|Overall Study|Myocardial Infarction|0|||
160706137|NCT00287586|580303651|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
160706138|NCT00287586|580303652|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
160706139|NCT00287586|580303651|FG000|Overall Study|Cognitive Impairment|1|||
160706140|NCT00287586|580303652|FG001|Overall Study|Cognitive Impairment|0|||
160706141|NCT00287586|580303651|FG000|Overall Study|Pancreatic Cancer|1|||
160706142|NCT00287586|580303652|FG001|Overall Study|Pancreatic Cancer|3|||
160706143|NCT00287586|580303651|FG000|Overall Study|Sleep Apnea|1|||
160706144|NCT00287586|580303652|FG001|Overall Study|Sleep Apnea|0|||
160706145|NCT00287586|580303651|FG000|Overall Study|Shoulder Pain|1|||
160706146|NCT00287586|580303652|FG001|Overall Study|Shoulder Pain|0|||
160706147|NCT00287586|580303651|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
160706148|NCT00287586|580303652|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
160706149|NCT00287586|580303651|FG000|Overall Study|Nonadherence|1|||
160706150|NCT00287586|580303652|FG001|Overall Study|Nonadherence|1|||
160706151|NCT00287586|580303651|FG000|Overall Study|Enrolled in Another Study|1|||
160706152|NCT00287586|580303652|FG001|Overall Study|Enrolled in Another Study|0|||
160706153|NCT00287586|580303651|FG000|Overall Study|Major Depression|0|||
160706154|NCT00287586|580303652|FG001|Overall Study|Major Depression|2|||
160706155|NCT00287586|580303651|FG000|Overall Study|Lung Cancer|0|||
160706156|NCT00287586|580303652|FG001|Overall Study|Lung Cancer|2|||
160706157|NCT00287586|580303651|FG000|Overall Study|Elevated IPSS Score|0|||
160706158|NCT00287586|580303652|FG001|Overall Study|Elevated IPSS Score|1|||
160706159|NCT00287586|580303651|FG000|Overall Study|Retroperitoneal Cancer|0|||
160706160|NCT00287586|580303652|FG001|Overall Study|Retroperitoneal Cancer|1|||
160706161|NCT00287586|580303651|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
160706162|NCT00287586|580303652|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
160706163|NCT00287586|580303651|FG000|Overall Study|Mood Swings and Irritability|0|||
160706164|NCT00287586|580303652|FG001|Overall Study|Mood Swings and Irritability|1|||
160706165|NCT00287586|580303651|FG000|Overall Study|Bradycardia|0|||
160706166|NCT00287586|580303652|FG001|Overall Study|Bradycardia|1|||
160706167|NCT00287586|580303651|FG000|Overall Study|Itchy Swollen Eyes|0|||
160706168|NCT00287586|580303652|FG001|Overall Study|Itchy Swollen Eyes|1|||
160706169|NCT00287586|580303651|FG000|Overall Study|Recurrent Melanoma|0|||
160706170|NCT00287586|580303652|FG001|Overall Study|Recurrent Melanoma|1|||
160706171|NCT02847260|580303655|FG000|Overall Study|Adverse Event|3|||
160706172|NCT02847260|580303655|FG000|Overall Study|Withdrawal by Subject|2|||
160706173|NCT02847260|580303655|FG000|Overall Study|Clinical Deterioration|1|||
160706174|NCT02847260|580303655|FG000|Overall Study|Physician Decision|1|||
160706175|NCT00129389|580303658|FG000|Overall Study|Adverse Event|19|||
160706176|NCT00129389|580303659|FG001|Overall Study|Adverse Event|87|||
160706177|NCT00129389|580303658|FG000|Overall Study|Death|0|||
160706178|NCT00129389|580303659|FG001|Overall Study|Death|1|||
160706179|NCT00129389|580303658|FG000|Overall Study|Lost to Follow-up|2|||
160706180|NCT00129389|580303659|FG001|Overall Study|Lost to Follow-up|1|||
160706181|NCT00129389|580303658|FG000|Overall Study|Physician Decision|0|||
160706182|NCT00129389|580303659|FG001|Overall Study|Physician Decision|4|||
160706183|NCT00129389|580303658|FG000|Overall Study|Protocol Violation|0|||
160706184|NCT00129389|580303659|FG001|Overall Study|Protocol Violation|6|||
160706185|NCT00129389|580303658|FG000|Overall Study|Withdrawal by Subject|9|||
160706186|NCT00129389|580303659|FG001|Overall Study|Withdrawal by Subject|23|||
160706187|NCT00129389|580303658|FG000|Overall Study|Relapse|1|||
160706188|NCT00129389|580303659|FG001|Overall Study|Relapse|0|||
160706189|NCT00129389|580303658|FG000|Overall Study|Not eligible|1|||
160706190|NCT00129389|580303659|FG001|Overall Study|Not eligible|2|||
160706191|NCT00129389|580303658|FG000|Overall Study|Crossed to the other arm|1|||
160706192|NCT00129389|580303659|FG001|Overall Study|Crossed to the other arm|16|||
160706193|NCT02794246|580303662|FG000|Overall Study|Withdrawal by Subject|2|||
160706194|NCT02794246|580303662|FG000|Overall Study|Physician Decision|4|||
160706195|NCT01753297|580303669|FG000|Overall Study|Lost to Follow-up|7|||
160706196|NCT01753297|580303670|FG001|Overall Study|Lost to Follow-up|2|||
160706197|NCT01753297|580303669|FG000|Overall Study|Withdrawal by Subject|26|||
160706198|NCT01753297|580303670|FG001|Overall Study|Withdrawal by Subject|23|||
160706199|NCT01753297|580303669|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
160706200|NCT01753297|580303670|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
160706201|NCT01753297|580303669|FG000|Overall Study|Death|0|||
160706202|NCT01753297|580303670|FG001|Overall Study|Death|2|||
160706203|NCT01753297|580303669|FG000|Overall Study|Did not attend end of study visit|7|||
160706204|NCT01753297|580303670|FG001|Overall Study|Did not attend end of study visit|8|||
160706205|NCT02533180|580303671|FG000|Overall Study|Death|0|||
160706206|NCT02533180|580303672|FG001|Overall Study|Death|2|||
160706207|NCT02533180|580303671|FG000|Overall Study|Lost to Follow-up|0|||
160706208|NCT02533180|580303672|FG001|Overall Study|Lost to Follow-up|1|||
160706209|NCT02533180|580303671|FG000|Overall Study|Physician Decision|0|||
160706210|NCT02533180|580303672|FG001|Overall Study|Physician Decision|1|||
160706211|NCT02533180|580303671|FG000|Overall Study|Withdrawal by Subject|2|||
160706212|NCT02533180|580303672|FG001|Overall Study|Withdrawal by Subject|5|||
160706213|NCT02533180|580303671|FG000|Overall Study|Screen Failure|37|||
160706214|NCT02533180|580303672|FG001|Overall Study|Screen Failure|0|||
160706215|NCT02533180|580303671|FG000|Overall Study|Protocol Deviation|0|||
160706216|NCT02533180|580303672|FG001|Overall Study|Protocol Deviation|1|||
160706217|NCT02533180|580303671|FG000|Overall Study|Non-compliance|0|||
160706218|NCT02533180|580303672|FG001|Overall Study|Non-compliance|1|||
160706219|NCT01174043|580303674|FG000|Overall Study|Disease progression|5|||
160706220|NCT01174043|580303674|FG000|Overall Study|Adverse Event|3|||
160706221|NCT01174043|580303674|FG000|Overall Study|Death|1|||
160706222|NCT01174043|580303674|FG000|Overall Study|Withdrawal by Subject|2|||
160706223|NCT01371539|580303685|FG000|Period One: One Week|Lost to Follow-up|0|||
160706224|NCT01371539|580303686|FG001|Period One: One Week|Lost to Follow-up|1|||
160706225|NCT01371539|580303685|FG000|Period Two: One Week|Lost to Follow-up|0|||
160706226|NCT01371539|580303686|FG001|Period Two: One Week|Lost to Follow-up|1|||
160706227|NCT01371539|580303685|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
160706228|NCT01371539|580303686|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
160706229|NCT01371539|580303685|FG000|Period Two: One Week|Time/job conflict|0|||
160706230|NCT01371539|580303686|FG001|Period Two: One Week|Time/job conflict|1|||
160706231|NCT02620579|580303689|FG000|Overall Study|Physician Decision|0|||
160706232|NCT02620579|580303690|FG001|Overall Study|Physician Decision|0|||
160706233|NCT02620579|580303691|FG002|Overall Study|Physician Decision|0|||
160706234|NCT02620579|580303692|FG003|Overall Study|Physician Decision|1|||
160706235|NCT02620579|580303689|FG000|Overall Study|Withdrawal by Subject|0|||
160706236|NCT02620579|580303690|FG001|Overall Study|Withdrawal by Subject|1|||
160706237|NCT02620579|580303691|FG002|Overall Study|Withdrawal by Subject|1|||
160706238|NCT02620579|580303692|FG003|Overall Study|Withdrawal by Subject|0|||
160706239|NCT02661217|580303697|FG000|Overall Study|Physician Decision|12|||
160706240|NCT02661217|580303698|FG001|Overall Study|Physician Decision|15|||
160706241|NCT02661217|580303697|FG000|Overall Study|Lost to Follow-up|1|||
160706242|NCT02661217|580303698|FG001|Overall Study|Lost to Follow-up|4|||
160706243|NCT02661217|580303697|FG000|Overall Study|Protocol Deviation|0|||
160706244|NCT02661217|580303698|FG001|Overall Study|Protocol Deviation|4|||
160706245|NCT02661217|580303697|FG000|Overall Study|Non-compliance with study treatment|5|||
160706246|NCT02661217|580303698|FG001|Overall Study|Non-compliance with study treatment|5|||
160706247|NCT02661217|580303697|FG000|Overall Study|Death|21|||
160706248|NCT02661217|580303698|FG001|Overall Study|Death|15|||
160706249|NCT02661217|580303697|FG000|Overall Study|Adverse Event|10|||
160706250|NCT02661217|580303698|FG001|Overall Study|Adverse Event|8|||
160706251|NCT02661217|580303697|FG000|Overall Study|Withdrawal by Subject|15|||
160706252|NCT02661217|580303698|FG001|Overall Study|Withdrawal by Subject|19|||
160706253|NCT02661217|580303697|FG000|Overall Study|Did not enter follow-up epoch|7|||
160706254|NCT02661217|580303698|FG001|Overall Study|Did not enter follow-up epoch|10|||
160706255|NCT02661217|580303697|FG000|Overall Study|Death - no study drug received|1|||
160706256|NCT02661217|580303698|FG001|Overall Study|Death - no study drug received|2|||
160706257|NCT02661217|580303697|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
160706258|NCT02661217|580303698|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
160706259|NCT00958893|580303699|FG000|Overall Study|Study prematurely terminated|4|||
160706260|NCT02892149|580303702|FG000|Overall Study|Death|262|||
160706261|NCT02892149|580303703|FG001|Overall Study|Death|278|||
160706262|NCT02892149|580303702|FG000|Overall Study|Withdrawal by Subject|53|||
160706263|NCT02892149|580303703|FG001|Overall Study|Withdrawal by Subject|47|||
160706264|NCT02892149|580303702|FG000|Overall Study|Lost to Follow-up|37|||
160706265|NCT02892149|580303703|FG001|Overall Study|Lost to Follow-up|31|||
160706266|NCT03066258|580303708|FG000|Overall Study|Death|1|||
160706267|NCT03066258|580303709|FG001|Overall Study|Death|0|||
160706268|NCT03066258|580303710|FG002|Overall Study|Death|0|||
160706269|NCT03066258|580303711|FG003|Overall Study|Death|0|||
160706270|NCT03066258|580303712|FG004|Overall Study|Death|1|||
160706271|NCT02165735|580303713|FG000|Overall Study|Lost to Follow-up|12|||
160706272|NCT02165735|580303714|FG001|Overall Study|Lost to Follow-up|10|||
160706273|NCT02165735|580303713|FG000|Overall Study|Withdrawal by Subject|3|||
160706274|NCT02165735|580303714|FG001|Overall Study|Withdrawal by Subject|0|||
160706275|NCT02165735|580303713|FG000|Overall Study|Participant indicated lack of time|1|||
160706276|NCT02165735|580303714|FG001|Overall Study|Participant indicated lack of time|3|||
160706277|NCT02165735|580303713|FG000|Overall Study|Protocol Violation|0|||
160706278|NCT02165735|580303714|FG001|Overall Study|Protocol Violation|1|||
160706279|NCT02784795|580303715|FG000|Overall Study|Progressive Disease|2|||
160706280|NCT02784795|580303716|FG001|Overall Study|Progressive Disease|1|||
160706281|NCT02784795|580303717|FG002|Overall Study|Progressive Disease|1|||
160706282|NCT02784795|580303718|FG003|Overall Study|Progressive Disease|0|||
160706283|NCT02784795|580303719|FG004|Overall Study|Progressive Disease|2|||
160706284|NCT02784795|580303720|FG005|Overall Study|Progressive Disease|0|||
160706285|NCT02784795|580303721|FG006|Overall Study|Progressive Disease|2|||
160706286|NCT02784795|580303722|FG007|Overall Study|Progressive Disease|0|||
160706287|NCT02784795|580303723|FG008|Overall Study|Progressive Disease|0|||
160706288|NCT02784795|580303724|FG009|Overall Study|Progressive Disease|0|||
160706289|NCT02784795|580303725|FG010|Overall Study|Progressive Disease|1|||
160706290|NCT02784795|580303726|FG011|Overall Study|Progressive Disease|0|||
160706291|NCT02784795|580303715|FG000|Overall Study|Adverse Event|1|||
160706292|NCT02784795|580303716|FG001|Overall Study|Adverse Event|0|||
160706293|NCT02784795|580303717|FG002|Overall Study|Adverse Event|0|||
160706294|NCT02784795|580303718|FG003|Overall Study|Adverse Event|1|||
160706295|NCT02784795|580303719|FG004|Overall Study|Adverse Event|0|||
160706296|NCT02784795|580303720|FG005|Overall Study|Adverse Event|0|||
160706297|NCT02784795|580303721|FG006|Overall Study|Adverse Event|1|||
160706298|NCT02784795|580303722|FG007|Overall Study|Adverse Event|0|||
160706299|NCT02784795|580303723|FG008|Overall Study|Adverse Event|0|||
160706300|NCT02784795|580303724|FG009|Overall Study|Adverse Event|0|||
160706301|NCT02784795|580303725|FG010|Overall Study|Adverse Event|0|||
160706302|NCT02784795|580303726|FG011|Overall Study|Adverse Event|2|||
160706303|NCT02784795|580303715|FG000|Overall Study|Withdrawal by Subject|1|||
160706304|NCT02784795|580303716|FG001|Overall Study|Withdrawal by Subject|0|||
160706305|NCT02784795|580303717|FG002|Overall Study|Withdrawal by Subject|2|||
160706306|NCT02784795|580303718|FG003|Overall Study|Withdrawal by Subject|1|||
160706307|NCT02784795|580303719|FG004|Overall Study|Withdrawal by Subject|3|||
160706308|NCT02784795|580303720|FG005|Overall Study|Withdrawal by Subject|0|||
160706309|NCT02784795|580303721|FG006|Overall Study|Withdrawal by Subject|0|||
160706310|NCT02784795|580303722|FG007|Overall Study|Withdrawal by Subject|1|||
160706311|NCT02784795|580303723|FG008|Overall Study|Withdrawal by Subject|0|||
160706312|NCT02784795|580303724|FG009|Overall Study|Withdrawal by Subject|0|||
160706313|NCT02784795|580303725|FG010|Overall Study|Withdrawal by Subject|0|||
160706314|NCT02784795|580303726|FG011|Overall Study|Withdrawal by Subject|2|||
160706315|NCT02784795|580303715|FG000|Overall Study|Death|0|||
160706316|NCT02784795|580303716|FG001|Overall Study|Death|0|||
160706317|NCT02784795|580303717|FG002|Overall Study|Death|0|||
160706318|NCT02784795|580303718|FG003|Overall Study|Death|0|||
160706319|NCT02784795|580303719|FG004|Overall Study|Death|1|||
160706320|NCT02784795|580303720|FG005|Overall Study|Death|0|||
160706321|NCT02784795|580303721|FG006|Overall Study|Death|0|||
160706322|NCT02784795|580303722|FG007|Overall Study|Death|0|||
160706323|NCT02784795|580303723|FG008|Overall Study|Death|0|||
160706324|NCT02784795|580303724|FG009|Overall Study|Death|0|||
160706325|NCT02784795|580303725|FG010|Overall Study|Death|0|||
160706326|NCT02784795|580303726|FG011|Overall Study|Death|0|||
160706327|NCT02784795|580303715|FG000|Overall Study|Physician Decision|0|||
160706328|NCT02784795|580303716|FG001|Overall Study|Physician Decision|0|||
160706329|NCT02784795|580303717|FG002|Overall Study|Physician Decision|0|||
160706330|NCT02784795|580303718|FG003|Overall Study|Physician Decision|0|||
160706331|NCT02784795|580303719|FG004|Overall Study|Physician Decision|0|||
160706332|NCT02784795|580303720|FG005|Overall Study|Physician Decision|0|||
160706333|NCT02784795|580303721|FG006|Overall Study|Physician Decision|1|||
160706334|NCT02784795|580303722|FG007|Overall Study|Physician Decision|0|||
160706335|NCT02784795|580303723|FG008|Overall Study|Physician Decision|0|||
160706336|NCT02784795|580303724|FG009|Overall Study|Physician Decision|0|||
160706337|NCT02784795|580303725|FG010|Overall Study|Physician Decision|0|||
160706338|NCT02784795|580303726|FG011|Overall Study|Physician Decision|0|||
160706339|NCT00101283|580303727|FG000|Overall Study|Withdrawal by Subject|0|||
160706340|NCT00101283|580303728|FG001|Overall Study|Withdrawal by Subject|1|||
160706341|NCT00101283|580303727|FG000|Overall Study|Insurance Refusal|0|||
160706342|NCT00101283|580303728|FG001|Overall Study|Insurance Refusal|1|||
160706343|NCT00101283|580303727|FG000|Overall Study|Prostate Cancer Recurrence|0|||
160706344|NCT00101283|580303728|FG001|Overall Study|Prostate Cancer Recurrence|1|||
160706345|NCT00595309|580303729|FG000|Overall Study|Lost to Follow-up|1|||
160706346|NCT00595309|580303729|FG000|Overall Study|planned vaccination against yellow fever|1|||
160706347|NCT00595309|580303729|FG000|Overall Study|acute infection after V0|1|||
160706348|NCT00595309|580303729|FG000|Overall Study|personal reason|1|||
160706349|NCT00704132|580303732|FG000|Overall Study|Clinical Adverse Experience|1|||
160706350|NCT00704132|580303733|FG001|Overall Study|Clinical Adverse Experience|0|||
160706351|NCT00704132|580303732|FG000|Overall Study|Lack of Efficacy|0|||
160706352|NCT00704132|580303733|FG001|Overall Study|Lack of Efficacy|1|||
160706353|NCT00704132|580303732|FG000|Overall Study|Withdrawal by Subject|0|||
160706354|NCT00704132|580303733|FG001|Overall Study|Withdrawal by Subject|1|||
160706355|NCT00442962|580303734|FG000|Overall Study|Pregnancy|1|||
160706356|NCT00442962|580303734|FG000|Overall Study|Lost to Follow-up|7|||
160706357|NCT04238650|580303735|FG000|Overall Study|Withdrawal by Subject|0|||
160706358|NCT04238650|580303736|FG001|Overall Study|Withdrawal by Subject|1|||
160706359|NCT03348163|580303737|FG000|Overall Study|Withdrawal by Subject|2|||
160706360|NCT03348163|580303738|FG001|Overall Study|Withdrawal by Subject|0|||
160706361|NCT02756208|580303739|FG000|Overall Study|Withdrawal by Subject|1|||
160706362|NCT02756208|580303740|FG001|Overall Study|Withdrawal by Subject|0|||
160706363|NCT02756208|580303741|FG002|Overall Study|Withdrawal by Subject|1|||
160706364|NCT02756208|580303742|FG003|Overall Study|Withdrawal by Subject|3|||
160706365|NCT02756208|580303739|FG000|Overall Study|Lost to Follow-up|3|||
160706366|NCT02756208|580303740|FG001|Overall Study|Lost to Follow-up|1|||
160706367|NCT02756208|580303741|FG002|Overall Study|Lost to Follow-up|1|||
160706368|NCT02756208|580303742|FG003|Overall Study|Lost to Follow-up|1|||
160706369|NCT02756208|580303739|FG000|Overall Study|Physician Decision|1|||
160706370|NCT02756208|580303740|FG001|Overall Study|Physician Decision|0|||
160706371|NCT02756208|580303741|FG002|Overall Study|Physician Decision|0|||
160706372|NCT02756208|580303742|FG003|Overall Study|Physician Decision|0|||
160706373|NCT02756208|580303739|FG000|Overall Study|Protocol Violation|0|||
160706374|NCT02756208|580303740|FG001|Overall Study|Protocol Violation|1|||
160706375|NCT02756208|580303741|FG002|Overall Study|Protocol Violation|0|||
160706376|NCT02756208|580303742|FG003|Overall Study|Protocol Violation|0|||
160706377|NCT02585778|580303743|FG000|Overall Study|Adverse Event|17|||
160706378|NCT02585778|580303744|FG001|Overall Study|Adverse Event|4|||
160706379|NCT02585778|580303743|FG000|Overall Study|Participant did not wish to continue|9|||
160706380|NCT02585778|580303744|FG001|Overall Study|Participant did not wish to continue|4|||
160706381|NCT02585778|580303743|FG000|Overall Study|Poor compliance to study protocol|0|||
160706382|NCT02585778|580303744|FG001|Overall Study|Poor compliance to study protocol|2|||
160706383|NCT02585778|580303743|FG000|Overall Study|Death|0|||
160706384|NCT02585778|580303744|FG001|Overall Study|Death|1|||
160706385|NCT02585778|580303743|FG000|Overall Study|Randomized but not treated|1|||
160706386|NCT02585778|580303744|FG001|Overall Study|Randomized but not treated|2|||
160706387|NCT02585778|580303743|FG000|Overall Study|Other than specified above|6|||
160706388|NCT02585778|580303744|FG001|Overall Study|Other than specified above|2|||
160706389|NCT05211726|580303745|FG000|Overall Study|Withdrawal by Subject|2|||
160706390|NCT05211726|580303746|FG001|Overall Study|Withdrawal by Subject|3|||
160706391|NCT05211726|580303745|FG000|Overall Study|Protocol Violation|0|||
160706392|NCT05211726|580303746|FG001|Overall Study|Protocol Violation|1|||
160706393|NCT02714426|580303752|FG000|Overall Study|Withdrawal by Subject|2|||
160706394|NCT02714426|580303753|FG001|Overall Study|Withdrawal by Subject|2|||
160706395|NCT04400682|580303760|FG000|Period 1|Withdrawal by Subject|1|||
160706396|NCT04400682|580303761|FG001|Period 1|Withdrawal by Subject|4|||
160706397|NCT02212379|580303762|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
160706398|NCT02212379|580303762|FG000|From Baseline to Week 48|Adverse Event|7|||
160706399|NCT02212379|580303762|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
160706400|NCT02212379|580303762|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
160706401|NCT02212379|580303762|FG000|From Week 48 to Week 96|Adverse Event|1|||
160706402|NCT02212379|580303762|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
160706403|NCT03104400|580305193|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
160706404|NCT03104400|580305194|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
160706405|NCT03104400|580305195|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
160706406|NCT03104400|580305196|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
160706407|NCT03104400|580305197|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
160706408|NCT03104400|580305198|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
160706409|NCT03104400|580305199|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
160706410|NCT03104400|580305200|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
160706411|NCT03104400|580305201|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
160706412|NCT03104400|580305202|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
160706413|NCT03104400|580305193|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
160706414|NCT03104400|580305194|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
160706415|NCT03104400|580305195|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
160706416|NCT03104400|580305196|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
160706417|NCT03104400|580305197|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
160706418|NCT03104400|580305198|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
160706419|NCT03104400|580305199|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
160706420|NCT03104400|580305200|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
160706421|NCT03104400|580305201|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
160706422|NCT03104400|580305202|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
160706423|NCT03104400|580305193|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
160706424|NCT03104400|580305194|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
160706425|NCT03104400|580305195|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
160706426|NCT03104400|580305196|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
160706427|NCT03104400|580305197|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
160706428|NCT03104400|580305198|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
160706429|NCT03104400|580305199|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
160706430|NCT03104400|580305200|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
160706431|NCT03104400|580305201|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
160706432|NCT03104400|580305202|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
160706433|NCT03104400|580305193|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
160706434|NCT03104400|580305194|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
160706435|NCT03104400|580305195|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
160706436|NCT03104400|580305196|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
160706437|NCT03104400|580305197|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
160706438|NCT03104400|580305198|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
160706439|NCT03104400|580305199|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
160706440|NCT03104400|580305200|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
160706441|NCT03104400|580305201|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
160706442|NCT03104400|580305202|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
160706443|NCT03104400|580305193|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
160706444|NCT03104400|580305194|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
160706445|NCT03104400|580305195|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
160706446|NCT03104400|580305196|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
160706447|NCT03104400|580305197|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
160706448|NCT03104400|580305198|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
160706449|NCT03104400|580305199|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
160706450|NCT03104400|580305200|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
160706451|NCT03104400|580305201|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
160706452|NCT03104400|580305202|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
160706453|NCT03104400|580305193|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
160706454|NCT03104400|580305194|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
160706455|NCT03104400|580305195|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
160706456|NCT03104400|580305196|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
160706457|NCT03104400|580305197|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
160706458|NCT03104400|580305198|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
160706459|NCT03104400|580305199|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
160706460|NCT03104400|580305200|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
160706461|NCT03104400|580305201|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
160706462|NCT03104400|580305202|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
160706463|NCT03104400|580305193|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
160706464|NCT03104400|580305194|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
160706465|NCT03104400|580305195|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
160706466|NCT03104400|580305196|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
160706467|NCT03104400|580305197|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
160706468|NCT03104400|580305198|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
160706469|NCT03104400|580305199|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
160706470|NCT03104400|580305200|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
160706471|NCT03104400|580305201|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
160706472|NCT03104400|580305202|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
160706473|NCT03104400|580305193|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
160706474|NCT03104400|580305194|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
160706475|NCT03104400|580305195|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
160706476|NCT03104400|580305196|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
160706477|NCT03104400|580305197|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
160706478|NCT03104400|580305198|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
160706479|NCT03104400|580305199|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
160706480|NCT03104400|580305200|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
160706481|NCT03104400|580305201|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
160706482|NCT03104400|580305202|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
160706483|NCT03104400|580305193|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
160706484|NCT03104400|580305194|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
160706485|NCT03104400|580305195|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
160706486|NCT03104400|580305196|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
160706487|NCT03104400|580305197|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
160706488|NCT03104400|580305198|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
160706489|NCT03104400|580305199|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
160706490|NCT03104400|580305200|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
160706491|NCT03104400|580305201|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
160706492|NCT03104400|580305202|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
160706493|NCT03104400|580305193|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
160706494|NCT03104400|580305194|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
160706495|NCT03104400|580305195|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
160706496|NCT03104400|580305196|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
160706497|NCT03104400|580305197|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
160706498|NCT03104400|580305198|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
160706499|NCT03104400|580305199|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
160706500|NCT03104400|580305200|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
160706501|NCT03104400|580305201|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
160706502|NCT03104400|580305202|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
160706503|NCT03104400|580305193|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
160706504|NCT03104400|580305194|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
160706505|NCT03104400|580305195|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
160706506|NCT03104400|580305196|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
160706507|NCT03104400|580305197|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
160706508|NCT03104400|580305198|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
160706509|NCT03104400|580305199|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
160706510|NCT03104400|580305200|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
160706511|NCT03104400|580305201|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
160706512|NCT03104400|580305202|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
160706513|NCT03104400|580305193|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
160706514|NCT03104400|580305194|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
160706515|NCT03104400|580305195|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
160706516|NCT03104400|580305196|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
160706517|NCT03104400|580305197|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
160706518|NCT03104400|580305198|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
160706519|NCT03104400|580305199|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
160706520|NCT03104400|580305200|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
160706521|NCT03104400|580305201|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
160706522|NCT03104400|580305202|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
160706523|NCT03104400|580305193|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
160706524|NCT03104400|580305194|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
160706525|NCT03104400|580305195|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
160706526|NCT03104400|580305196|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
160706527|NCT03104400|580305197|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
160706528|NCT03104400|580305198|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
160706529|NCT03104400|580305199|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
160706530|NCT03104400|580305200|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
160706531|NCT03104400|580305201|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
160706532|NCT03104400|580305202|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
160706533|NCT03104400|580305193|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
160706534|NCT03104400|580305194|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
160706535|NCT03104400|580305195|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
160706536|NCT03104400|580305196|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
160706537|NCT03104400|580305197|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
160706538|NCT03104400|580305198|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
160706539|NCT03104400|580305199|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
160706540|NCT03104400|580305200|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
160706541|NCT03104400|580305201|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
160706542|NCT03104400|580305202|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
160706543|NCT03104400|580305193|FG000|Period 2 Week 56 - 260)|Other|0|||
160706544|NCT03104400|580305194|FG001|Period 2 Week 56 - 260)|Other|0|||
160706545|NCT03104400|580305195|FG002|Period 2 Week 56 - 260)|Other|0|||
160706546|NCT03104400|580305196|FG003|Period 2 Week 56 - 260)|Other|0|||
160706547|NCT03104400|580305197|FG004|Period 2 Week 56 - 260)|Other|0|||
160706548|NCT03104400|580305198|FG005|Period 2 Week 56 - 260)|Other|0|||
160706549|NCT03104400|580305199|FG006|Period 2 Week 56 - 260)|Other|0|||
160706550|NCT03104400|580305200|FG007|Period 2 Week 56 - 260)|Other|0|||
160706551|NCT03104400|580305201|FG008|Period 2 Week 56 - 260)|Other|1|||
160706552|NCT03104400|580305202|FG009|Period 2 Week 56 - 260)|Other|1|||
160706553|NCT00094861|580305203|FG000|Overall Study|Adverse Event|5|||
160706554|NCT00094861|580305204|FG001|Overall Study|Adverse Event|2|||
160706555|NCT00094861|580305203|FG000|Overall Study|Withdrawal by Subject|5|||
160706556|NCT00094861|580305204|FG001|Overall Study|Withdrawal by Subject|3|||
160706557|NCT00094861|580305203|FG000|Overall Study|Physician Decision|1|||
160706558|NCT00094861|580305204|FG001|Overall Study|Physician Decision|1|||
160706559|NCT00094861|580305203|FG000|Overall Study|Lost to Follow-up|0|||
160706560|NCT00094861|580305204|FG001|Overall Study|Lost to Follow-up|1|||
160706561|NCT00094861|580305203|FG000|Overall Study|Death|4|||
160706562|NCT00094861|580305204|FG001|Overall Study|Death|2|||
160706563|NCT00094861|580305203|FG000|Overall Study|Other|3|||
160706564|NCT00094861|580305204|FG001|Overall Study|Other|0|||
160706565|NCT00451204|580305205|FG000|Overall Study|Adverse Event|4|||
160706566|NCT00451204|580305206|FG001|Overall Study|Adverse Event|6|||
160706567|NCT00451204|580305205|FG000|Overall Study|Lack of Efficacy|4|||
160706568|NCT00451204|580305206|FG001|Overall Study|Lack of Efficacy|4|||
160706569|NCT00451204|580305205|FG000|Overall Study|Lost to Follow-up|4|||
160706570|NCT00451204|580305206|FG001|Overall Study|Lost to Follow-up|4|||
160706571|NCT00451204|580305205|FG000|Overall Study|Protocol Violation|1|||
160706572|NCT00451204|580305206|FG001|Overall Study|Protocol Violation|0|||
160706573|NCT00451204|580305205|FG000|Overall Study|Patient refusal|8|||
160706574|NCT00451204|580305206|FG001|Overall Study|Patient refusal|4|||
160706575|NCT00451204|580305205|FG000|Overall Study|Other|1|||
160706576|NCT00451204|580305206|FG001|Overall Study|Other|2|||
160706577|NCT01191944|580305210|FG000|Overall Study|Adverse Event|11|||
160706578|NCT01191944|580305211|FG001|Overall Study|Adverse Event|12|||
160706579|NCT01191944|580305210|FG000|Overall Study|Protocol Violation|1|||
160706580|NCT01191944|580305211|FG001|Overall Study|Protocol Violation|2|||
160706581|NCT01191944|580305210|FG000|Overall Study|Withdrawal by Subject|4|||
160706582|NCT01191944|580305211|FG001|Overall Study|Withdrawal by Subject|2|||
160706583|NCT01191944|580305210|FG000|Overall Study|Other|1|||
160706584|NCT01191944|580305211|FG001|Overall Study|Other|3|||
160706585|NCT04602546|580305216|FG000|Overall Study|Training|2|||
160706586|NCT04602546|580305217|FG001|Overall Study|Training|2|||
160706587|NCT04602546|580305218|FG002|Overall Study|Training|1|||
160706588|NCT04602546|580305219|FG003|Overall Study|Training|2|||
160706589|NCT04602546|580305220|FG004|Overall Study|Training|0|||
160706590|NCT04602546|580305216|FG000|Overall Study|Randomized with disqualified data|2|||
160706591|NCT04602546|580305217|FG001|Overall Study|Randomized with disqualified data|0|||
160706592|NCT04602546|580305218|FG002|Overall Study|Randomized with disqualified data|2|||
160706593|NCT04602546|580305219|FG003|Overall Study|Randomized with disqualified data|5|||
160706594|NCT04602546|580305220|FG004|Overall Study|Randomized with disqualified data|3|||
160706595|NCT01831258|580305223|FG000|Overall Study|Withdrawal by Subject|2|||
160706596|NCT01831258|580305224|FG001|Overall Study|Withdrawal by Subject|1|||
160706597|NCT01831258|580305223|FG000|Overall Study|Lost to Follow-up|3|||
160706598|NCT01831258|580305224|FG001|Overall Study|Lost to Follow-up|2|||
160706599|NCT00794339|580305227|FG000|Overall Study|Withdrawal by Subject|3|||
160706600|NCT00794339|580305227|FG000|Overall Study|Ineligible|4|||
160706601|NCT00794339|580305227|FG000|Overall Study|Tx prior to ATSM|3|||
160706602|NCT00794339|580305227|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
160706603|NCT00794339|580305227|FG000|Overall Study|Tx not per protocol|1|||
160706604|NCT02952586|580305230|FG000|Lead-In Phase (7 Days)|Death|0|||
160706605|NCT02952586|580305231|FG001|Lead-In Phase (7 Days)|Death|1|||
160706606|NCT02952586|580305230|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
160706607|NCT02952586|580305231|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
160706608|NCT02952586|580305230|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
160706609|NCT02952586|580305231|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
160706610|NCT02952586|580305230|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
160706611|NCT02952586|580305231|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
160706612|NCT02952586|580305230|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
160706613|NCT02952586|580305231|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
160706614|NCT02952586|580305230|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
160706615|NCT02952586|580305231|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
160706616|NCT02952586|580305230|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
160706617|NCT02952586|580305231|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
160706618|NCT02952586|580305230|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
160706619|NCT02952586|580305231|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
160706620|NCT02952586|580305230|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
160706621|NCT02952586|580305231|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
160706622|NCT02952586|580305230|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
160706623|NCT02952586|580305231|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
160706624|NCT02952586|580305230|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
160706625|NCT02952586|580305231|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
160706626|NCT02952586|580305230|FG000|CRT for Cisplatin (63 Days)|Death|3|||
160706627|NCT02952586|580305231|FG001|CRT for Cisplatin (63 Days)|Death|8|||
160706628|NCT02952586|580305230|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
160706629|NCT02952586|580305231|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
160706630|NCT02952586|580305230|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
160706631|NCT02952586|580305231|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
160706632|NCT02952586|580305230|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
160706633|NCT02952586|580305231|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
160706634|NCT02952586|580305230|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
160706635|NCT02952586|580305231|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
160706636|NCT02952586|580305230|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
160706637|NCT02952586|580305231|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
160706638|NCT02952586|580305230|FG000|CRT for Cisplatin (63 Days)|Other|1|||
160706639|NCT02952586|580305231|FG001|CRT for Cisplatin (63 Days)|Other|1|||
160706640|NCT02952586|580305230|FG000|CRT for IMRT (63 Days)|Death|5|||
160706641|NCT02952586|580305231|FG001|CRT for IMRT (63 Days)|Death|8|||
160706642|NCT02952586|580305230|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
160706643|NCT02952586|580305231|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
160706644|NCT02952586|580305230|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
160706645|NCT02952586|580305231|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
160706646|NCT02952586|580305230|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
160706647|NCT02952586|580305231|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
160706648|NCT02952586|580305230|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
160706649|NCT02952586|580305231|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
160706650|NCT02952586|580305230|FG000|CRT for IMRT (63 Days)|Other|1|||
160706651|NCT02952586|580305231|FG001|CRT for IMRT (63 Days)|Other|0|||
160706652|NCT02952586|580305230|FG000|Maintenance Phase (12 Months)|Death|17|||
160706653|NCT02952586|580305231|FG001|Maintenance Phase (12 Months)|Death|11|||
160706654|NCT02952586|580305230|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
160706655|NCT02952586|580305231|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
160706656|NCT02952586|580305230|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
160706657|NCT02952586|580305231|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
160706658|NCT02952586|580305230|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
160706659|NCT02952586|580305231|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
160706660|NCT02952586|580305230|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
160706661|NCT02952586|580305231|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
160706662|NCT02952586|580305230|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
160706663|NCT02952586|580305231|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
160706664|NCT02952586|580305230|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
160706665|NCT02952586|580305231|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
160706666|NCT02952586|580305230|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
160706667|NCT02952586|580305231|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
160706668|NCT02952586|580305230|FG000|Maintenance Phase (12 Months)|Other|2|||
160706669|NCT02952586|580305231|FG001|Maintenance Phase (12 Months)|Other|1|||
160706670|NCT02952586|580305230|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
160706671|NCT02952586|580305231|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
160706672|NCT02952586|580305230|FG000|Follow-Up Phase (90 Days)|Death|12|||
160706673|NCT02952586|580305231|FG001|Follow-Up Phase (90 Days)|Death|10|||
160706674|NCT02952586|580305230|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
160706675|NCT02952586|580305231|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
160706676|NCT02952586|580305230|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
160706677|NCT02952586|580305231|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
160706678|NCT02952586|580305230|FG000|Follow-Up Phase (90 Days)|Other|7|||
160706679|NCT02952586|580305231|FG001|Follow-Up Phase (90 Days)|Other|5|||
160706680|NCT02952586|580305230|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
160706681|NCT02952586|580305231|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
160706682|NCT02952586|580305230|FG000|LT Follow-up (up to 45 Months)|Death|51|||
160706683|NCT02952586|580305231|FG001|LT Follow-up (up to 45 Months)|Death|31|||
160706684|NCT02952586|580305230|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
160706685|NCT02952586|580305231|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
160706686|NCT02952586|580305230|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
160706687|NCT02952586|580305231|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
160706688|NCT02952586|580305230|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
160706689|NCT02952586|580305231|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
160706690|NCT00789035|580305232|FG000|Overall Study|Adverse Event|0|||
160706691|NCT00789035|580305233|FG001|Overall Study|Adverse Event|2|||
160706692|NCT00789035|580305234|FG002|Overall Study|Adverse Event|0|||
160706693|NCT00789035|580305235|FG003|Overall Study|Adverse Event|1|||
160706694|NCT00789035|580305236|FG004|Overall Study|Adverse Event|3|||
160706695|NCT00789035|580305232|FG000|Overall Study|Lack of Efficacy|3|||
160706696|NCT00789035|580305233|FG001|Overall Study|Lack of Efficacy|0|||
160706697|NCT00789035|580305234|FG002|Overall Study|Lack of Efficacy|0|||
160706698|NCT00789035|580305235|FG003|Overall Study|Lack of Efficacy|0|||
160706699|NCT00789035|580305236|FG004|Overall Study|Lack of Efficacy|2|||
160706700|NCT00789035|580305232|FG000|Overall Study|Protocol Violation|1|||
160706701|NCT00789035|580305233|FG001|Overall Study|Protocol Violation|0|||
160706702|NCT00789035|580305234|FG002|Overall Study|Protocol Violation|0|||
160706703|NCT00789035|580305235|FG003|Overall Study|Protocol Violation|0|||
160706704|NCT00789035|580305236|FG004|Overall Study|Protocol Violation|0|||
160706705|NCT00789035|580305232|FG000|Overall Study|Withdrawal by Subject|0|||
160706706|NCT00789035|580305233|FG001|Overall Study|Withdrawal by Subject|2|||
160706707|NCT00789035|580305234|FG002|Overall Study|Withdrawal by Subject|0|||
160706708|NCT00789035|580305235|FG003|Overall Study|Withdrawal by Subject|0|||
160706709|NCT00789035|580305236|FG004|Overall Study|Withdrawal by Subject|0|||
160706710|NCT00789035|580305232|FG000|Overall Study|Other reason not defined above|2|||
160706711|NCT00789035|580305233|FG001|Overall Study|Other reason not defined above|3|||
160706712|NCT00789035|580305234|FG002|Overall Study|Other reason not defined above|1|||
160706713|NCT00789035|580305235|FG003|Overall Study|Other reason not defined above|0|||
160706714|NCT00789035|580305236|FG004|Overall Study|Other reason not defined above|1|||
160706715|NCT00658879|580305237|FG000|Overall Study|Protocol Violation|1|||
160706716|NCT02640690|580305238|FG000|Overall Study|Lost to Follow-up|7|||
160706717|NCT02640690|580305239|FG001|Overall Study|Lost to Follow-up|7|||
160706718|NCT02640690|580305238|FG000|Overall Study|Withdrawal by Subject|16|||
160706719|NCT02640690|580305239|FG001|Overall Study|Withdrawal by Subject|20|||
160706720|NCT02640690|580305238|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
160706721|NCT02640690|580305239|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
160706722|NCT01118975|580305240|FG000|Overall Study|Adverse Event|0|||
160706723|NCT01118975|580305241|FG001|Overall Study|Adverse Event|1|||
160706724|NCT02289456|580305242|FG000|Induction Period|Death|2|||
160706725|NCT02289456|580305242|FG000|Induction Period|Adverse Event|11|||
160706726|NCT02289456|580305242|FG000|Induction Period|Progressive Disease (PD)|4|||
160706727|NCT02289456|580305242|FG000|Induction Period|Symptomatic Deterioration|4|||
160706728|NCT02289456|580305242|FG000|Induction Period|Withdrawal by Subject|2|||
160706729|NCT02289456|580305242|FG000|Induction Period|Miscellaneous|1|||
160706730|NCT02289456|580305242|FG000|Monotherapy Period|Death|1|||
160706731|NCT02289456|580305242|FG000|Monotherapy Period|Adverse Event|1|||
160706732|NCT02289456|580305242|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
160706733|NCT02289456|580305242|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
160706734|NCT02289456|580305242|FG000|Monotherapy Period|Withdrawal by Subject|2|||
160706735|NCT02289456|580305242|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
160706736|NCT02289456|580305242|FG000|Monotherapy Period|Miscellaneous|1|||
160706737|NCT01399658|580305243|FG000|Overall Study|Ineligible|1|||
160706738|NCT01399658|580305243|FG000|Overall Study|Machine Technical Issue|3|||
160706739|NCT01399658|580305243|FG000|Overall Study|Alternative therapy|1|||
160706740|NCT01399658|580305243|FG000|Overall Study|No reason given|1|||
160706741|NCT04315506|580305245|FG000|Overall Study|Lost to Follow-up|74|||
160706742|NCT04315506|580305246|FG001|Overall Study|Lost to Follow-up|82|||
160706743|NCT04315506|580305245|FG000|Overall Study|Withdrawal by Subject|8|||
160706744|NCT04315506|580305246|FG001|Overall Study|Withdrawal by Subject|8|||
160706745|NCT04315506|580305245|FG000|Overall Study|Physician Decision|0|||
160706746|NCT04315506|580305246|FG001|Overall Study|Physician Decision|1|||
160706747|NCT00626561|580305249|FG000|Overall Study|Withdrawal by Subject|2|||
160706748|NCT00626561|580305249|FG000|Overall Study|Disease Progression|2|||
160706749|NCT01372748|580305250|FG000|Overall Study|Lost to Follow-up|16|||
160706750|NCT01372748|580305251|FG001|Overall Study|Lost to Follow-up|34|||
160706751|NCT01372748|580305250|FG000|Overall Study|Withdrawal by Subject|7|||
160706752|NCT01372748|580305251|FG001|Overall Study|Withdrawal by Subject|5|||
160706753|NCT00711880|580305252|FG000|Overall Study|Adverse Event|11|||
160706754|NCT00711880|580305253|FG001|Overall Study|Adverse Event|2|||
160706755|NCT00711880|580305252|FG000|Overall Study|Patient non-compliance|1|||
160706756|NCT00711880|580305253|FG001|Overall Study|Patient non-compliance|0|||
160706757|NCT00711880|580305252|FG000|Overall Study|Lack of Efficacy|1|||
160706758|NCT00711880|580305253|FG001|Overall Study|Lack of Efficacy|5|||
160706759|NCT03908437|580305254|FG000|Overall Study|Death|0|||
160706760|NCT03908437|580305255|FG001|Overall Study|Death|1|||
160706761|NCT03908437|580305254|FG000|Overall Study|Lost to Follow-up|31|||
160706762|NCT03908437|580305255|FG001|Overall Study|Lost to Follow-up|24|||
160706763|NCT03633825|580305256|FG000|Enrollment|Did not post on network|5066|||
160706764|NCT03633825|580305257|FG001|Enrollment|Did not post on network|5080|||
160706765|NCT03633825|580305256|FG000|Enrollment|Post not classified as crisis|13967|||
160706766|NCT03633825|580305257|FG001|Enrollment|Post not classified as crisis|13757|||
160706767|NCT03633825|580305256|FG000|Follow up|Lost to Follow-up|478|||
160706768|NCT03633825|580305257|FG001|Follow up|Lost to Follow-up|450|||
160706769|NCT04841577|580305258|FG000|Overall Study|Adverse Event|5|||
160706770|NCT04841577|580305259|FG001|Overall Study|Adverse Event|10|||
160706771|NCT04841577|580305258|FG000|Overall Study|Lost to Follow-up|8|||
160706772|NCT04841577|580305259|FG001|Overall Study|Lost to Follow-up|7|||
160706773|NCT04841577|580305258|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
160706774|NCT04841577|580305259|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
160706775|NCT04841577|580305258|FG000|Overall Study|Other|0|||
160706776|NCT04841577|580305259|FG001|Overall Study|Other|1|||
160706777|NCT00356525|580305260|FG000|Overall Study|Progressive Disease|8|||
160706778|NCT00356525|580305261|FG001|Overall Study|Progressive Disease|5|||
160706779|NCT00356525|580305262|FG002|Overall Study|Progressive Disease|4|||
160706780|NCT00356525|580305263|FG003|Overall Study|Progressive Disease|2|||
160706781|NCT00356525|580305260|FG000|Overall Study|Adverse Event|1|||
160706782|NCT00356525|580305261|FG001|Overall Study|Adverse Event|3|||
160706783|NCT00356525|580305262|FG002|Overall Study|Adverse Event|1|||
160706784|NCT00356525|580305263|FG003|Overall Study|Adverse Event|1|||
160706785|NCT00356525|580305260|FG000|Overall Study|Lost to Follow-up|1|||
160706786|NCT00356525|580305261|FG001|Overall Study|Lost to Follow-up|0|||
160706787|NCT00356525|580305262|FG002|Overall Study|Lost to Follow-up|0|||
160706788|NCT00356525|580305263|FG003|Overall Study|Lost to Follow-up|0|||
160706789|NCT00356525|580305260|FG000|Overall Study|Physician Decision|2|||
160706790|NCT00356525|580305261|FG001|Overall Study|Physician Decision|2|||
160706791|NCT00356525|580305262|FG002|Overall Study|Physician Decision|2|||
160706792|NCT00356525|580305263|FG003|Overall Study|Physician Decision|1|||
160706793|NCT00356525|580305260|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
160706794|NCT00356525|580305261|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
160706795|NCT00356525|580305262|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
160706796|NCT00356525|580305263|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
160706797|NCT00356525|580305260|FG000|Overall Study|Withdrawal by Subject|1|||
160706798|NCT00356525|580305261|FG001|Overall Study|Withdrawal by Subject|1|||
160706799|NCT00356525|580305262|FG002|Overall Study|Withdrawal by Subject|0|||
160706800|NCT00356525|580305263|FG003|Overall Study|Withdrawal by Subject|3|||
160706801|NCT00356525|580305260|FG000|Overall Study|Death|0|||
160706802|NCT00356525|580305261|FG001|Overall Study|Death|0|||
160706803|NCT00356525|580305262|FG002|Overall Study|Death|0|||
160706804|NCT00356525|580305263|FG003|Overall Study|Death|1|||
160706805|NCT00356525|580305260|FG000|Overall Study|Sponsor Decision|0|||
160706806|NCT00356525|580305261|FG001|Overall Study|Sponsor Decision|0|||
160706807|NCT00356525|580305262|FG002|Overall Study|Sponsor Decision|0|||
160706808|NCT00356525|580305263|FG003|Overall Study|Sponsor Decision|1|||
160706809|NCT03682107|580305264|FG000|Overall Study|Withdrawal by Subject|0|||
160706810|NCT03682107|580305265|FG001|Overall Study|Withdrawal by Subject|1|||
160706811|NCT03682107|580305266|FG002|Overall Study|Withdrawal by Subject|0|||
160706812|NCT03682107|580305267|FG003|Overall Study|Withdrawal by Subject|0|||
160706813|NCT03682107|580305268|FG004|Overall Study|Withdrawal by Subject|0|||
160706814|NCT00428116|580305269|FG000|Overall Study|Death|1|||
160706815|NCT00428116|580305270|FG001|Overall Study|Death|0|||
160706816|NCT00428116|580305269|FG000|Overall Study|Withdrawal by Subject|1|||
160706817|NCT00428116|580305270|FG001|Overall Study|Withdrawal by Subject|0|||
160706818|NCT00428116|580305269|FG000|Overall Study|Lost to Follow-up|1|||
160706819|NCT00428116|580305270|FG001|Overall Study|Lost to Follow-up|0|||
160706820|NCT01038297|580305271|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
160706821|NCT01038297|580305272|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
160706822|NCT01038297|580305273|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
160706823|NCT02257385|580305279|FG000|Overall Study|Adverse Event|12|||
160706824|NCT02257385|580305280|FG001|Overall Study|Adverse Event|8|||
160706825|NCT02257385|580305279|FG000|Overall Study|Lack of Efficacy|1|||
160706826|NCT02257385|580305280|FG001|Overall Study|Lack of Efficacy|2|||
160706827|NCT02257385|580305279|FG000|Overall Study|Protocol Violation|5|||
160706828|NCT02257385|580305280|FG001|Overall Study|Protocol Violation|7|||
160706829|NCT02257385|580305279|FG000|Overall Study|Lost to Follow-up|0|||
160706830|NCT02257385|580305280|FG001|Overall Study|Lost to Follow-up|1|||
160706831|NCT02257385|580305279|FG000|Overall Study|Withdrawal by Subject|4|||
160706832|NCT02257385|580305280|FG001|Overall Study|Withdrawal by Subject|4|||
160706833|NCT00086281|580305287|FG000|Phase 1|Adverse Event|0|||
160706834|NCT00086281|580305288|FG001|Phase 1|Adverse Event|0|||
160706835|NCT00086281|580305289|FG002|Phase 1|Adverse Event|0|||
160706836|NCT00086281|580305290|FG003|Phase 1|Adverse Event|0|||
160706837|NCT00086281|580305291|FG004|Phase 1|Adverse Event|0|||
160706838|NCT00086281|580305292|FG005|Phase 1|Adverse Event|0|||
160706839|NCT00086281|580305293|FG006|Phase 1|Adverse Event|0|||
160706840|NCT00086281|580305294|FG007|Phase 1|Adverse Event|0|||
160706841|NCT00086281|580305295|FG008|Phase 1|Adverse Event|0|||
160706842|NCT00086281|580305296|FG009|Phase 1|Adverse Event|1|||
160706843|NCT00086281|580305297|FG010|Phase 1|Adverse Event|2|||
160706844|NCT00086281|580305298|FG011|Phase 1|Adverse Event|1|||
160706845|NCT00086281|580305299|FG012|Phase 1|Adverse Event|1|||
160706846|NCT00086281|580305300|FG013|Phase 1|Adverse Event|1|||
160706847|NCT00086281|580305301|FG014|Phase 1|Adverse Event|2|||
160706848|NCT00086281|580305287|FG000|Phase 1|Protocol Violation|0|||
160706849|NCT00086281|580305288|FG001|Phase 1|Protocol Violation|0|||
160706850|NCT00086281|580305289|FG002|Phase 1|Protocol Violation|0|||
160706851|NCT00086281|580305290|FG003|Phase 1|Protocol Violation|0|||
160706852|NCT00086281|580305291|FG004|Phase 1|Protocol Violation|0|||
160706853|NCT00086281|580305292|FG005|Phase 1|Protocol Violation|0|||
160706854|NCT00086281|580305293|FG006|Phase 1|Protocol Violation|0|||
160706855|NCT00086281|580305294|FG007|Phase 1|Protocol Violation|0|||
160706856|NCT00086281|580305295|FG008|Phase 1|Protocol Violation|0|||
160706857|NCT00086281|580305296|FG009|Phase 1|Protocol Violation|0|||
160706858|NCT00086281|580305297|FG010|Phase 1|Protocol Violation|1|||
160706859|NCT00086281|580305298|FG011|Phase 1|Protocol Violation|0|||
160706860|NCT00086281|580305299|FG012|Phase 1|Protocol Violation|0|||
160706861|NCT00086281|580305300|FG013|Phase 1|Protocol Violation|0|||
160706862|NCT00086281|580305301|FG014|Phase 1|Protocol Violation|0|||
160706863|NCT00086281|580305287|FG000|Phase 1|Serious Adverse Event|0|||
160706864|NCT00086281|580305288|FG001|Phase 1|Serious Adverse Event|0|||
160706865|NCT00086281|580305289|FG002|Phase 1|Serious Adverse Event|0|||
160706866|NCT00086281|580305290|FG003|Phase 1|Serious Adverse Event|0|||
160706867|NCT00086281|580305291|FG004|Phase 1|Serious Adverse Event|0|||
160706868|NCT00086281|580305292|FG005|Phase 1|Serious Adverse Event|0|||
160706869|NCT00086281|580305293|FG006|Phase 1|Serious Adverse Event|0|||
160706870|NCT00086281|580305294|FG007|Phase 1|Serious Adverse Event|0|||
160706871|NCT00086281|580305295|FG008|Phase 1|Serious Adverse Event|0|||
160706872|NCT00086281|580305296|FG009|Phase 1|Serious Adverse Event|0|||
160706873|NCT00086281|580305297|FG010|Phase 1|Serious Adverse Event|0|||
160706874|NCT00086281|580305298|FG011|Phase 1|Serious Adverse Event|0|||
160706875|NCT00086281|580305299|FG012|Phase 1|Serious Adverse Event|0|||
160706876|NCT00086281|580305300|FG013|Phase 1|Serious Adverse Event|0|||
160706877|NCT00086281|580305301|FG014|Phase 1|Serious Adverse Event|1|||
160706878|NCT00086281|580305287|FG000|Phase 2|Adverse Event|0|||
160706879|NCT00086281|580305288|FG001|Phase 2|Adverse Event|0|||
160706880|NCT00086281|580305289|FG002|Phase 2|Adverse Event|0|||
160706881|NCT00086281|580305290|FG003|Phase 2|Adverse Event|0|||
160706882|NCT00086281|580305291|FG004|Phase 2|Adverse Event|0|||
160706883|NCT00086281|580305292|FG005|Phase 2|Adverse Event|0|||
160706884|NCT00086281|580305293|FG006|Phase 2|Adverse Event|0|||
160706885|NCT00086281|580305294|FG007|Phase 2|Adverse Event|0|||
160706886|NCT00086281|580305295|FG008|Phase 2|Adverse Event|0|||
160706887|NCT00086281|580305296|FG009|Phase 2|Adverse Event|0|||
160706888|NCT00086281|580305297|FG010|Phase 2|Adverse Event|0|||
160706889|NCT00086281|580305298|FG011|Phase 2|Adverse Event|0|||
160706890|NCT00086281|580305299|FG012|Phase 2|Adverse Event|1|||
160706891|NCT00086281|580305300|FG013|Phase 2|Adverse Event|1|||
160706892|NCT00086281|580305301|FG014|Phase 2|Adverse Event|0|||
160706893|NCT00908310|580305304|FG000|Overall Study|Death|37|||
160706894|NCT00908310|580305304|FG000|Overall Study|Withdrawal by Subject|7|||
160706895|NCT00908310|580305304|FG000|Overall Study|Lost to Follow-up|7|||
160706896|NCT00908310|580305304|FG000|Overall Study|Screening failure|5|||
160706897|NCT00908310|580305304|FG000|Overall Study|Other reasons|4|||
160706898|NCT03456453|580305307|FG000|Overall Study|Withdrawal by Subject|2|||
160706899|NCT03456453|580305308|FG001|Overall Study|Withdrawal by Subject|0|||
160706900|NCT03456453|580305307|FG000|Overall Study|Not released to community|1|||
160706901|NCT03456453|580305308|FG001|Overall Study|Not released to community|5|||
160706902|NCT03456453|580305307|FG000|Overall Study|Lost to Follow-up|0|||
160706903|NCT03456453|580305308|FG001|Overall Study|Lost to Follow-up|2|||
160706904|NCT00896480|580305309|FG000|Overall Study|Disease progression/recurrence|21|||
160706905|NCT00351533|580305310|FG000|Overall Study|Extubated before first BAL|1|||
160706906|NCT00351533|580305311|FG001|Overall Study|Extubated before first BAL|0|||
160706907|NCT00351533|580305310|FG000|Overall Study|Lost to Follow-up|1|||
160706908|NCT00351533|580305311|FG001|Overall Study|Lost to Follow-up|3|||
160706909|NCT00351533|580305310|FG000|Overall Study|Physician Decision|0|||
160706910|NCT00351533|580305311|FG001|Overall Study|Physician Decision|1|||
160706911|NCT00351533|580305310|FG000|Overall Study|Withdrawal by Subject|0|||
160706912|NCT00351533|580305311|FG001|Overall Study|Withdrawal by Subject|1|||
160706913|NCT00315731|580305312|FG000|Overall Study|Lost to Follow-up|1|||
160706914|NCT00315731|580305312|FG000|Overall Study|Death|5|||
160706915|NCT01680497|580305316|FG000|Overall Study|Lost to Follow-up|2|||
160706916|NCT00725205|580305317|FG000|Overall Study|Adverse Event|22|||
160706917|NCT00725205|580305317|FG000|Overall Study|Investigator Discontinued|1|||
160706918|NCT00725205|580305317|FG000|Overall Study|Non-compliance With Protocol|14|||
160706919|NCT00725205|580305317|FG000|Overall Study|Other|8|||
160706920|NCT00725205|580305317|FG000|Overall Study|Protocol Defined Clinical Event|1|||
160706921|NCT00725205|580305317|FG000|Overall Study|Treatment Failure|41|||
160706922|NCT04123561|580305320|FG000|Overall Study|Lost to Follow-up|20|||
160706923|NCT04123561|580305321|FG001|Overall Study|Lost to Follow-up|12|||
160706924|NCT04123561|580305322|FG002|Overall Study|Lost to Follow-up|5|||
160706925|NCT04123561|580305320|FG000|Overall Study|Withdrawal by Subject|9|||
160706926|NCT04123561|580305321|FG001|Overall Study|Withdrawal by Subject|7|||
160706927|NCT04123561|580305322|FG002|Overall Study|Withdrawal by Subject|9|||
160706928|NCT04123561|580305320|FG000|Overall Study|Lack of Efficacy|7|||
160706929|NCT04123561|580305321|FG001|Overall Study|Lack of Efficacy|8|||
160706930|NCT04123561|580305322|FG002|Overall Study|Lack of Efficacy|6|||
160706931|NCT04123561|580305320|FG000|Overall Study|Adverse Event|5|||
160706932|NCT04123561|580305321|FG001|Overall Study|Adverse Event|2|||
160706933|NCT04123561|580305322|FG002|Overall Study|Adverse Event|3|||
160706934|NCT04123561|580305320|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
160706935|NCT04123561|580305321|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
160706936|NCT04123561|580305322|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
160706937|NCT04123561|580305320|FG000|Overall Study|Death|0|||
160706938|NCT04123561|580305321|FG001|Overall Study|Death|0|||
160706939|NCT04123561|580305322|FG002|Overall Study|Death|1|||
160706940|NCT04123561|580305320|FG000|Overall Study|Protocol Violation|0|||
160706941|NCT04123561|580305321|FG001|Overall Study|Protocol Violation|1|||
160706942|NCT04123561|580305322|FG002|Overall Study|Protocol Violation|0|||
160706943|NCT02682927|580305332|FG000|Overall Study|Adverse Event|0|||
160706944|NCT02682927|580305333|FG001|Overall Study|Adverse Event|0|||
160706945|NCT02682927|580305334|FG002|Overall Study|Adverse Event|5|||
160706946|NCT02682927|580305335|FG003|Overall Study|Adverse Event|1|||
160706947|NCT02682927|580305336|FG004|Overall Study|Adverse Event|0|||
160706948|NCT02682927|580305337|FG005|Overall Study|Adverse Event|2|||
160706949|NCT02682927|580305332|FG000|Overall Study|Death|0|||
160706950|NCT02682927|580305333|FG001|Overall Study|Death|0|||
160706951|NCT02682927|580305334|FG002|Overall Study|Death|0|||
160706952|NCT02682927|580305335|FG003|Overall Study|Death|1|||
160706953|NCT02682927|580305336|FG004|Overall Study|Death|0|||
160706954|NCT02682927|580305337|FG005|Overall Study|Death|0|||
160706955|NCT02682927|580305332|FG000|Overall Study|Lack of Efficacy|1|||
160706956|NCT02682927|580305333|FG001|Overall Study|Lack of Efficacy|0|||
160706957|NCT02682927|580305334|FG002|Overall Study|Lack of Efficacy|0|||
160706958|NCT02682927|580305335|FG003|Overall Study|Lack of Efficacy|1|||
160706959|NCT02682927|580305336|FG004|Overall Study|Lack of Efficacy|0|||
160706960|NCT02682927|580305337|FG005|Overall Study|Lack of Efficacy|0|||
160706961|NCT02682927|580305332|FG000|Overall Study|Other|0|||
160706962|NCT02682927|580305333|FG001|Overall Study|Other|0|||
160706963|NCT02682927|580305334|FG002|Overall Study|Other|0|||
160706964|NCT02682927|580305335|FG003|Overall Study|Other|2|||
160706965|NCT02682927|580305336|FG004|Overall Study|Other|0|||
160706966|NCT02682927|580305337|FG005|Overall Study|Other|0|||
160706967|NCT02682927|580305332|FG000|Overall Study|Withdrawal by Subject|2|||
160706968|NCT02682927|580305333|FG001|Overall Study|Withdrawal by Subject|0|||
160706969|NCT02682927|580305334|FG002|Overall Study|Withdrawal by Subject|1|||
160706970|NCT02682927|580305335|FG003|Overall Study|Withdrawal by Subject|0|||
160706971|NCT02682927|580305336|FG004|Overall Study|Withdrawal by Subject|1|||
160706972|NCT02682927|580305337|FG005|Overall Study|Withdrawal by Subject|1|||
160706973|NCT03462459|580305338|FG000|Overall Study|Death|1|||
160706974|NCT03462459|580305339|FG001|Overall Study|Death|0|||
160706975|NCT03462459|580305338|FG000|Overall Study|Lack of Efficacy|2|||
160706976|NCT03462459|580305339|FG001|Overall Study|Lack of Efficacy|4|||
160706977|NCT03462459|580305338|FG000|Overall Study|Lost to Follow-up|1|||
160706978|NCT03462459|580305339|FG001|Overall Study|Lost to Follow-up|3|||
160706979|NCT03462459|580305338|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
160706980|NCT03462459|580305339|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
160706981|NCT03462459|580305338|FG000|Overall Study|Withdrawal by Subject|3|||
160706982|NCT03462459|580305339|FG001|Overall Study|Withdrawal by Subject|2|||
160706983|NCT03462459|580305338|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
160706984|NCT03462459|580305339|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
160706985|NCT01177059|580305340|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
160706986|NCT01177059|580305340|FG000|Overall Study|Withdrew consent|2|||
160706987|NCT01177059|580305340|FG000|Overall Study|Lost to Follow-up|18|||
160706988|NCT01243775|580305341|FG000|Overall Study|Withdrawal by Subject|2|||
160706989|NCT04051619|580305342|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
160706990|NCT04051619|580305343|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
160706991|NCT04051619|580305342|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
160706992|NCT04051619|580305343|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
160706993|NCT05938621|580307310|FG000|Overall Study|Lost to Follow-up|1|||
160706994|NCT05938621|580307311|FG001|Overall Study|Lost to Follow-up|5|||
160706995|NCT05938621|580307312|FG002|Overall Study|Lost to Follow-up|2|||
160706996|NCT05938621|580307313|FG003|Overall Study|Lost to Follow-up|2|||
160706997|NCT03922529|580307318|FG000|Overall Study|Withdrawal by Subject|13|||
160706998|NCT03922529|580307319|FG001|Overall Study|Withdrawal by Subject|12|||
160706999|NCT03922529|580307318|FG000|Overall Study|Death|7|||
160707000|NCT03922529|580307319|FG001|Overall Study|Death|12|||
160707001|NCT03922529|580307318|FG000|Overall Study|Lost to Follow-up|12|||
160707002|NCT03922529|580307319|FG001|Overall Study|Lost to Follow-up|19|||
160707003|NCT03922529|580307318|FG000|Overall Study|Adverse Event|1|||
160707004|NCT03922529|580307319|FG001|Overall Study|Adverse Event|0|||
160707005|NCT03922529|580307318|FG000|Overall Study|Death after withdrawal|1|||
160707006|NCT03922529|580307319|FG001|Overall Study|Death after withdrawal|0|||
160707007|NCT03922529|580307318|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
160707008|NCT03922529|580307319|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
160707009|NCT03922529|580307318|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
160707010|NCT03922529|580307319|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
160707011|NCT02731638|580307320|FG000|Overall Study|Lost to Follow-up|6|||
160707012|NCT02731638|580307321|FG001|Overall Study|Lost to Follow-up|9|||
160707013|NCT04158245|580307322|FG000|Overall Study|Lost to Follow-up|1|||
160707014|NCT03760185|580307325|FG000|Overall Study|Lost to Follow-up|1|||
160707015|NCT03760185|580307326|FG001|Overall Study|Lost to Follow-up|1|||
160707016|NCT02473523|580307327|FG000|Overall Study|Death|1|||
160707017|NCT02473523|580307327|FG000|Overall Study|Lost to Follow-up|1|||
160707018|NCT02111603|580307330|FG000|Overall Study|Withdrawal by Subject|1|||
160707019|NCT00976911|580307331|FG000|Overall Study|Withdrawal by Subject|4|||
160707020|NCT00976911|580307332|FG001|Overall Study|Withdrawal by Subject|6|||
160707021|NCT00976911|580307331|FG000|Overall Study|Death|138|||
160707022|NCT00976911|580307332|FG001|Overall Study|Death|126|||
160707023|NCT00976911|580307331|FG000|Overall Study|Adverse Event|0|||
160707024|NCT00976911|580307332|FG001|Overall Study|Adverse Event|1|||
160707025|NCT00976911|580307331|FG000|Overall Study|Protocol Violation|2|||
160707026|NCT00976911|580307332|FG001|Overall Study|Protocol Violation|0|||
160707027|NCT00976911|580307331|FG000|Overall Study|Other|8|||
160707028|NCT00976911|580307332|FG001|Overall Study|Other|9|||
160707029|NCT00976911|580307331|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
160707030|NCT00976911|580307332|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
160707031|NCT02954991|580307333|FG000|Overall Study|Death|92|||
160707032|NCT02954991|580307334|FG001|Overall Study|Death|11|||
160707033|NCT02954991|580307335|FG002|Overall Study|Death|2|||
160707034|NCT02954991|580307333|FG000|Overall Study|Lost to Follow-up|3|||
160707035|NCT02954991|580307334|FG001|Overall Study|Lost to Follow-up|2|||
160707036|NCT02954991|580307335|FG002|Overall Study|Lost to Follow-up|0|||
160707037|NCT02954991|580307333|FG000|Overall Study|Withdrawal by Subject|9|||
160707038|NCT02954991|580307334|FG001|Overall Study|Withdrawal by Subject|8|||
160707039|NCT02954991|580307335|FG002|Overall Study|Withdrawal by Subject|1|||
160707040|NCT02954991|580307333|FG000|Overall Study|Study Terminated by Sponsor|18|||
160707041|NCT02954991|580307334|FG001|Overall Study|Study Terminated by Sponsor|10|||
160707042|NCT02954991|580307335|FG002|Overall Study|Study Terminated by Sponsor|1|||
160707043|NCT02954991|580307333|FG000|Overall Study|Miscellaneous|2|||
160707044|NCT02954991|580307334|FG001|Overall Study|Miscellaneous|1|||
160707045|NCT02954991|580307335|FG002|Overall Study|Miscellaneous|1|||
160707046|NCT00576316|580307336|FG000|Overall Study|Adverse Event|9|||
160707047|NCT00576316|580307336|FG000|Overall Study|Withdrawal by Subject|2|||
160707048|NCT00576316|580307336|FG000|Overall Study|Protocol Violation|9|||
160707049|NCT02552303|580307339|FG000|Allocation|Withdrawal by Subject|2|||
160707050|NCT02552303|580307340|FG001|Allocation|Withdrawal by Subject|1|||
160707051|NCT02552303|580307341|FG002|Allocation|Withdrawal by Subject|1|||
160707052|NCT02552303|580307342|FG003|Allocation|Withdrawal by Subject|1|||
160707053|NCT02552303|580307339|FG000|Allocation|ineligible|1|||
160707054|NCT02552303|580307340|FG001|Allocation|ineligible|1|||
160707055|NCT02552303|580307341|FG002|Allocation|ineligible|0|||
160707056|NCT02552303|580307342|FG003|Allocation|ineligible|0|||
160707057|NCT02552303|580307339|FG000|Follow-Up|Lost to Follow-up|0|||
160707058|NCT02552303|580307340|FG001|Follow-Up|Lost to Follow-up|0|||
160707059|NCT02552303|580307341|FG002|Follow-Up|Lost to Follow-up|1|||
160707060|NCT02552303|580307342|FG003|Follow-Up|Lost to Follow-up|0|||
160707061|NCT02552303|580307339|FG000|Follow-Up|ineligible|0|||
160707062|NCT02552303|580307340|FG001|Follow-Up|ineligible|2|||
160707063|NCT02552303|580307341|FG002|Follow-Up|ineligible|0|||
160707064|NCT02552303|580307342|FG003|Follow-Up|ineligible|0|||
160707065|NCT01582152|580307343|FG000|Overall Study|Disease Progression|4|||
160707066|NCT01582152|580307344|FG001|Overall Study|Disease Progression|5|||
160707067|NCT01582152|580307343|FG000|Overall Study|Adverse Event|2|||
160707068|NCT01582152|580307344|FG001|Overall Study|Adverse Event|1|||
160707069|NCT00230178|580307347|FG000|Overall Study|Adverse Event|1|||
160707070|NCT00230178|580307348|FG001|Overall Study|Adverse Event|5|||
160707071|NCT00230178|580307349|FG002|Overall Study|Adverse Event|2|||
160707072|NCT00230178|580307347|FG000|Overall Study|Withdrawal by Subject|0|||
160707073|NCT00230178|580307348|FG001|Overall Study|Withdrawal by Subject|0|||
160707074|NCT00230178|580307349|FG002|Overall Study|Withdrawal by Subject|1|||
160707075|NCT00230178|580307347|FG000|Overall Study|Various other reasons|3|||
160707076|NCT00230178|580307348|FG001|Overall Study|Various other reasons|2|||
160707077|NCT00230178|580307349|FG002|Overall Study|Various other reasons|4|||
160707078|NCT01275729|580307352|FG000|Overall Study|Death|3|||
160707079|NCT01275729|580307352|FG000|Overall Study|Withdrawal by Subject|1|||
160707080|NCT00447876|580307355|FG000|Overall Study|Withdrawal by Subject|1|||
160707081|NCT00447876|580307356|FG001|Overall Study|Withdrawal by Subject|4|||
160707082|NCT00447876|580307355|FG000|Overall Study|Lost to Follow-up|1|||
160707083|NCT00447876|580307356|FG001|Overall Study|Lost to Follow-up|0|||
160707084|NCT00447876|580307355|FG000|Overall Study|Deterioration of symptomology|1|||
160707085|NCT00447876|580307356|FG001|Overall Study|Deterioration of symptomology|0|||
160707086|NCT00005957|580307357|FG000|Overall Study|No treated|3|||
160707087|NCT00005957|580307358|FG001|Overall Study|No treated|9|||
160707088|NCT00005957|580307357|FG000|Overall Study|Crossover to the other arm|5|||
160707089|NCT00005957|580307358|FG001|Overall Study|Crossover to the other arm|19|||
160707090|NCT01609023|580307359|FG000|Overall Study|Lack of Efficacy|3|||
160707091|NCT01609023|580307359|FG000|Overall Study|Withdrawal by Subject|4|||
160707092|NCT01609023|580307359|FG000|Overall Study|Lost to Follow-up|8|||
160707093|NCT01609023|580307359|FG000|Overall Study|Toxicity|3|||
160707094|NCT01609023|580307359|FG000|Overall Study|Disease progression|10|||
160707095|NCT01609023|580307359|FG000|Overall Study|Physician Decision|2|||
160707096|NCT01609023|580307359|FG000|Overall Study|Death|2|||
160707097|NCT01609023|580307359|FG000|Overall Study|Personal reasons|1|||
160707098|NCT04172597|580307360|FG000|Overall Study|Disease Progression|0|||
160707099|NCT04172597|580307361|FG001|Overall Study|Disease Progression|0|||
160707100|NCT04172597|580307362|FG002|Overall Study|Disease Progression|0|||
160707101|NCT04172597|580307363|FG003|Overall Study|Disease Progression|0|||
160707102|NCT04172597|580307364|FG004|Overall Study|Disease Progression|1|||
160707103|NCT00492778|580307370|FG000|Overall Study|Ineligible by Pathology Review|8|||
160707104|NCT00492778|580307371|FG001|Overall Study|Ineligible by Pathology Review|1|||
160707105|NCT03717012|580307386|FG000|Overall Study|Due to trial termination|1|||
160707106|NCT03717012|580307387|FG001|Overall Study|Due to trial termination|2|||
160707107|NCT03717012|580307386|FG000|Overall Study|Protocol Violation|0|||
160707108|NCT03717012|580307387|FG001|Overall Study|Protocol Violation|2|||
160707109|NCT03717012|580307386|FG000|Overall Study|Adverse Event|0|||
160707110|NCT03717012|580307387|FG001|Overall Study|Adverse Event|1|||
160707111|NCT03717012|580307386|FG000|Overall Study|Lung transplant|0|||
160707112|NCT03717012|580307387|FG001|Overall Study|Lung transplant|1|||
160707113|NCT04414618|580307388|FG000|Overall Study|Death|3|||
160707114|NCT04414618|580307389|FG001|Overall Study|Death|3|||
160707115|NCT04414618|580307388|FG000|Overall Study|Withdrawal by Subject|2|||
160707116|NCT04414618|580307389|FG001|Overall Study|Withdrawal by Subject|1|||
160707117|NCT04414618|580307388|FG000|Overall Study|Lost to Follow-up|2|||
160707118|NCT04414618|580307389|FG001|Overall Study|Lost to Follow-up|3|||
160707119|NCT04414618|580307388|FG000|Overall Study|Physician Decision|1|||
160707120|NCT04414618|580307389|FG001|Overall Study|Physician Decision|0|||
160707121|NCT00362336|580307390|FG000|Overall Study|Serious Adverse Event|1|||
160707122|NCT00362336|580307391|FG001|Overall Study|Serious Adverse Event|0|||
160707123|NCT00362336|580307392|FG002|Overall Study|Serious Adverse Event|1|||
160707124|NCT00362336|580307390|FG000|Overall Study|Protocol Violation|0|||
160707125|NCT00362336|580307391|FG001|Overall Study|Protocol Violation|0|||
160707126|NCT00362336|580307392|FG002|Overall Study|Protocol Violation|1|||
160707127|NCT00362336|580307390|FG000|Overall Study|Lost to Follow-up|6|||
160707128|NCT00362336|580307391|FG001|Overall Study|Lost to Follow-up|4|||
160707129|NCT00362336|580307392|FG002|Overall Study|Lost to Follow-up|0|||
160707130|NCT00362336|580307390|FG000|Overall Study|Withdrawal by Subject|3|||
160707131|NCT00362336|580307391|FG001|Overall Study|Withdrawal by Subject|3|||
160707132|NCT00362336|580307392|FG002|Overall Study|Withdrawal by Subject|1|||
160707133|NCT01520870|580307393|FG000|Overall Study|Withdrawal by Subject|2|||
160707134|NCT01645787|580307394|FG000|Washout (2 Weeks)|Adverse Event|1|||
160707135|NCT01645787|580307395|FG001|Washout (2 Weeks)|Adverse Event|0|||
160707136|NCT00796107|580307401|FG000|Overall Study|Lack of Efficacy|1|||
160707137|NCT00796107|580307401|FG000|Overall Study|Progressive Disease|5|||
160707138|NCT02681510|580307409|FG000|Overall Study|Withdrawal by Subject|1|||
160707139|NCT02681510|580307409|FG000|Overall Study|Lost to Follow-up|9|||
160707140|NCT02075515|580307410|FG000|Overall Study|Serious Adverse Event|1|||
160707141|NCT02075515|580307411|FG001|Overall Study|Serious Adverse Event|1|||
160707142|NCT02075515|580307412|FG002|Overall Study|Serious Adverse Event|1|||
160707143|NCT02075515|580307410|FG000|Overall Study|Non-Serious Adverse Event|0|||
160707144|NCT02075515|580307411|FG001|Overall Study|Non-Serious Adverse Event|1|||
160707145|NCT02075515|580307412|FG002|Overall Study|Non-Serious Adverse Event|0|||
160707146|NCT02075515|580307410|FG000|Overall Study|Withdrawal by Subject|2|||
160707147|NCT02075515|580307411|FG001|Overall Study|Withdrawal by Subject|0|||
160707148|NCT02075515|580307412|FG002|Overall Study|Withdrawal by Subject|1|||
160707149|NCT02075515|580307410|FG000|Overall Study|Lost to Follow-up|1|||
160707150|NCT02075515|580307411|FG001|Overall Study|Lost to Follow-up|3|||
160707151|NCT02075515|580307412|FG002|Overall Study|Lost to Follow-up|6|||
160707152|NCT03593395|580307423|FG000|Overall Study|Lost to Follow-up|48|||
160707153|NCT03593395|580307424|FG001|Overall Study|Lost to Follow-up|3|||
160707154|NCT03593395|580307423|FG000|Overall Study|Withdrawal by Subject|5|||
160707155|NCT03593395|580307424|FG001|Overall Study|Withdrawal by Subject|24|||
160707156|NCT03593395|580307423|FG000|Overall Study|Death|2|||
160707157|NCT03593395|580307424|FG001|Overall Study|Death|3|||
160707158|NCT03593395|580307423|FG000|Overall Study|Physician Decision|0|||
160707159|NCT03593395|580307424|FG001|Overall Study|Physician Decision|6|||
160707160|NCT03593395|580307423|FG000|Overall Study|Participant Relocated|19|||
160707161|NCT03593395|580307424|FG001|Overall Study|Participant Relocated|3|||
160707162|NCT03593395|580307423|FG000|Overall Study|No Information|1|||
160707163|NCT03593395|580307424|FG001|Overall Study|No Information|7|||
160707164|NCT02806024|580307425|FG000|Overall Study|Night Delivery|1|||
160707165|NCT02806024|580307426|FG001|Overall Study|Night Delivery|1|||
160707166|NCT02806024|580307425|FG000|Overall Study|DVT during antepartum admission|0|||
160707167|NCT02806024|580307426|FG001|Overall Study|DVT during antepartum admission|1|||
160707168|NCT01098474|580307427|FG000|Active Phase|Other|0|||
160707169|NCT01098474|580307428|FG001|Active Phase|Other|0|||
160707170|NCT01098474|580307429|FG002|Active Phase|Other|3|||
160707171|NCT01098474|580307430|FG003|Active Phase|Other|0|||
160707172|NCT01098474|580307431|FG004|Active Phase|Other|0|||
160707173|NCT01098474|580307432|FG005|Active Phase|Other|0|||
160707174|NCT01098474|580307427|FG000|Active Phase|Withdrawal by Subject|1|||
160707175|NCT01098474|580307428|FG001|Active Phase|Withdrawal by Subject|1|||
160707176|NCT01098474|580307429|FG002|Active Phase|Withdrawal by Subject|2|||
160707177|NCT01098474|580307430|FG003|Active Phase|Withdrawal by Subject|0|||
160707178|NCT01098474|580307431|FG004|Active Phase|Withdrawal by Subject|0|||
160707179|NCT01098474|580307432|FG005|Active Phase|Withdrawal by Subject|0|||
160707180|NCT01098474|580307427|FG000|Active Phase|Lost to Follow-up|1|||
160707181|NCT01098474|580307428|FG001|Active Phase|Lost to Follow-up|0|||
160707182|NCT01098474|580307429|FG002|Active Phase|Lost to Follow-up|0|||
160707183|NCT01098474|580307430|FG003|Active Phase|Lost to Follow-up|0|||
160707184|NCT01098474|580307431|FG004|Active Phase|Lost to Follow-up|0|||
160707185|NCT01098474|580307432|FG005|Active Phase|Lost to Follow-up|0|||
160707186|NCT01098474|580307427|FG000|Follow Up Phase|Travelled out of study area|0|||
160707187|NCT01098474|580307428|FG001|Follow Up Phase|Travelled out of study area|0|||
160707188|NCT01098474|580307429|FG002|Follow Up Phase|Travelled out of study area|0|||
160707189|NCT01098474|580307430|FG003|Follow Up Phase|Travelled out of study area|0|||
160707190|NCT01098474|580307431|FG004|Follow Up Phase|Travelled out of study area|1|||
160707191|NCT01098474|580307432|FG005|Follow Up Phase|Travelled out of study area|0|||
160707192|NCT01098474|580307427|FG000|Follow Up Phase|Other|0|||
160707193|NCT01098474|580307428|FG001|Follow Up Phase|Other|0|||
160707194|NCT01098474|580307429|FG002|Follow Up Phase|Other|0|||
160707195|NCT01098474|580307430|FG003|Follow Up Phase|Other|0|||
160707196|NCT01098474|580307431|FG004|Follow Up Phase|Other|0|||
160707197|NCT01098474|580307432|FG005|Follow Up Phase|Other|4|||
160707198|NCT01098474|580307427|FG000|Follow Up Phase|Withdrawal by Subject|0|||
160707199|NCT01098474|580307428|FG001|Follow Up Phase|Withdrawal by Subject|0|||
160707200|NCT01098474|580307429|FG002|Follow Up Phase|Withdrawal by Subject|0|||
160707201|NCT01098474|580307430|FG003|Follow Up Phase|Withdrawal by Subject|2|||
160707202|NCT01098474|580307431|FG004|Follow Up Phase|Withdrawal by Subject|0|||
160707203|NCT01098474|580307432|FG005|Follow Up Phase|Withdrawal by Subject|1|||
160707204|NCT01098474|580307427|FG000|Follow Up Phase|Lost to Follow-up|0|||
160707205|NCT01098474|580307428|FG001|Follow Up Phase|Lost to Follow-up|0|||
160707206|NCT01098474|580307429|FG002|Follow Up Phase|Lost to Follow-up|0|||
160707207|NCT01098474|580307430|FG003|Follow Up Phase|Lost to Follow-up|0|||
160707208|NCT01098474|580307431|FG004|Follow Up Phase|Lost to Follow-up|1|||
160707209|NCT01098474|580307432|FG005|Follow Up Phase|Lost to Follow-up|0|||
160707210|NCT02797171|580307435|FG000|Overall Study|Lost to Follow-up|2|||
160707211|NCT02797171|580307436|FG001|Overall Study|Lost to Follow-up|0|||
160707212|NCT02797171|580307437|FG002|Overall Study|Lost to Follow-up|2|||
160707213|NCT02797171|580307438|FG003|Overall Study|Lost to Follow-up|1|||
160707214|NCT02797171|580307439|FG004|Overall Study|Lost to Follow-up|2|||
160707215|NCT02797171|580307440|FG005|Overall Study|Lost to Follow-up|0|||
160707216|NCT02797171|580307435|FG000|Overall Study|Withdrawal by Subject|1|||
160707217|NCT02797171|580307436|FG001|Overall Study|Withdrawal by Subject|1|||
160707218|NCT02797171|580307437|FG002|Overall Study|Withdrawal by Subject|0|||
160707219|NCT02797171|580307438|FG003|Overall Study|Withdrawal by Subject|0|||
160707220|NCT02797171|580307439|FG004|Overall Study|Withdrawal by Subject|0|||
160707221|NCT02797171|580307440|FG005|Overall Study|Withdrawal by Subject|0|||
160707222|NCT02797171|580307435|FG000|Overall Study|Protocol Violation|1|||
160707223|NCT02797171|580307436|FG001|Overall Study|Protocol Violation|0|||
160707224|NCT02797171|580307437|FG002|Overall Study|Protocol Violation|0|||
160707225|NCT02797171|580307438|FG003|Overall Study|Protocol Violation|0|||
160707226|NCT02797171|580307439|FG004|Overall Study|Protocol Violation|0|||
160707227|NCT02797171|580307440|FG005|Overall Study|Protocol Violation|0|||
160707228|NCT02797171|580307435|FG000|Overall Study|Participant unable to adhere|0|||
160707229|NCT02797171|580307436|FG001|Overall Study|Participant unable to adhere|1|||
160707230|NCT02797171|580307437|FG002|Overall Study|Participant unable to adhere|0|||
160707231|NCT02797171|580307438|FG003|Overall Study|Participant unable to adhere|0|||
160707232|NCT02797171|580307439|FG004|Overall Study|Participant unable to adhere|0|||
160707233|NCT02797171|580307440|FG005|Overall Study|Participant unable to adhere|0|||
160707234|NCT02797171|580307435|FG000|Overall Study|Not Randomized|0|||
160707235|NCT02797171|580307436|FG001|Overall Study|Not Randomized|0|||
160707236|NCT02797171|580307437|FG002|Overall Study|Not Randomized|0|||
160707237|NCT02797171|580307438|FG003|Overall Study|Not Randomized|0|||
160707238|NCT02797171|580307439|FG004|Overall Study|Not Randomized|0|||
160707239|NCT02797171|580307440|FG005|Overall Study|Not Randomized|1|||
160707240|NCT00134901|580307443|FG000|Overall Study|Lost to Follow-up|5|||
160707241|NCT00134901|580307444|FG001|Overall Study|Lost to Follow-up|5|||
160707242|NCT00134901|580307443|FG000|Overall Study|discontinued intervention|12|||
160707243|NCT00134901|580307444|FG001|Overall Study|discontinued intervention|10|||
160707244|NCT00606632|580307445|FG000|Overall Study|Withdrawal by Subject|13|||
160707245|NCT00606632|580307445|FG000|Overall Study|Miscellaneous reasons|9|||
160707246|NCT05246670|580307448|FG000|Overall Study|Withdrawal by Subject|2|||
160707247|NCT05246670|580307449|FG001|Overall Study|Withdrawal by Subject|3|||
160707248|NCT05246670|580307450|FG002|Overall Study|Withdrawal by Subject|0|||
160707249|NCT05246670|580307451|FG003|Overall Study|Withdrawal by Subject|1|||
160707250|NCT05246670|580307448|FG000|Overall Study|Adverse Event|0|||
160707251|NCT05246670|580307449|FG001|Overall Study|Adverse Event|0|||
160707252|NCT05246670|580307450|FG002|Overall Study|Adverse Event|1|||
160707253|NCT05246670|580307451|FG003|Overall Study|Adverse Event|0|||
160707254|NCT05246670|580307448|FG000|Overall Study|Physician Decision|1|||
160707255|NCT05246670|580307449|FG001|Overall Study|Physician Decision|0|||
160707256|NCT05246670|580307450|FG002|Overall Study|Physician Decision|0|||
160707257|NCT05246670|580307451|FG003|Overall Study|Physician Decision|0|||
160707258|NCT05246670|580307448|FG000|Overall Study|Protocol Violation|1|||
160707259|NCT05246670|580307449|FG001|Overall Study|Protocol Violation|0|||
160707260|NCT05246670|580307450|FG002|Overall Study|Protocol Violation|0|||
160707261|NCT05246670|580307451|FG003|Overall Study|Protocol Violation|0|||
160707262|NCT00652340|580307457|FG000|Overall Study|Had not progressed.|4|||
160707263|NCT00652340|580307458|FG001|Overall Study|Had not progressed.|3|||
160707264|NCT00214383|580307461|FG000|Overall Study|Lost to Follow-up|16|||
160707265|NCT00214383|580307462|FG001|Overall Study|Lost to Follow-up|26|||
160707266|NCT04152291|580307463|FG000|Overall Study|Covid-19 restrictions|27|||
160707267|NCT04152291|580307463|FG000|Overall Study|Withdrawal by Subject|3|||
160707268|NCT03597295|580307464|FG000|Overall Study|Death|70|||
160707269|NCT03597295|580307464|FG000|Overall Study|Lost to Follow-up|7|||
160707270|NCT00879411|580307465|FG000|Overall Study|lost to follow-up (non-AE)|162|||
160707271|NCT05124691|580307466|FG000|Phase II|Eligibility criteria|0|||
160707272|NCT05124691|580307467|FG001|Phase II|Eligibility criteria|1|||
160707273|NCT05124691|580307468|FG002|Phase II|Eligibility criteria|0|||
160707274|NCT05124691|580307466|FG000|Phase II|Withdrawal by Subject|6|||
160707275|NCT05124691|580307467|FG001|Phase II|Withdrawal by Subject|2|||
160707276|NCT05124691|580307468|FG002|Phase II|Withdrawal by Subject|3|||
160707277|NCT05124691|580307466|FG000|Phase III|Withdrawal by Subject|6|||
160707278|NCT05124691|580307467|FG001|Phase III|Withdrawal by Subject|4|||
160707279|NCT05124691|580307468|FG002|Phase III|Withdrawal by Subject|4|||
160707280|NCT05124691|580307466|FG000|Phase III|Lost to Follow-up|1|||
160707281|NCT05124691|580307467|FG001|Phase III|Lost to Follow-up|0|||
160707282|NCT05124691|580307468|FG002|Phase III|Lost to Follow-up|0|||
160707283|NCT01890434|580307469|FG000|Overall Study|Adverse Event|8|||
160707284|NCT01890434|580307469|FG000|Overall Study|PCI at external hospital|1|||
160707285|NCT01890434|580307469|FG000|Overall Study|Assessment discrepancy|1|||
160707286|NCT01890434|580307469|FG000|Overall Study|CRC didn't contact participant for FU|1|||
160707287|NCT01890434|580307469|FG000|Overall Study|Could not get whole set of images|1|||
160707288|NCT01890434|580307469|FG000|Overall Study|Decline to return for GSPECT|1|||
160707289|NCT01890434|580307469|FG000|Overall Study|GSPECT at rest was not done|1|||
160707290|NCT01890434|580307469|FG000|Overall Study|Participant didn't complete MRI|1|||
160707291|NCT01890434|580307469|FG000|Overall Study|Uncontactable by phone|1|||
160707292|NCT01890434|580307469|FG000|Overall Study|Moved out of position|1|||
160707293|NCT01890434|580307469|FG000|Overall Study|Unable to contact|1|||
160707294|NCT01890434|580307469|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
160707295|NCT03837743|580307475|FG000|Overall Study|Adverse Event|1|||
160707296|NCT03837743|580307475|FG000|Overall Study|Withdrawal by Subject|2|||
160707297|NCT01449370|580307478|FG000|Overall Study|Disease Progression|5|||
160707298|NCT01449370|580307479|FG001|Overall Study|Disease Progression|4|||
160707299|NCT01449370|580307480|FG002|Overall Study|Disease Progression|8|||
160707300|NCT01449370|580307481|FG003|Overall Study|Disease Progression|3|||
160707301|NCT01449370|580307482|FG004|Overall Study|Disease Progression|3|||
160707302|NCT01449370|580307483|FG005|Overall Study|Disease Progression|3|||
160707303|NCT01449370|580307484|FG006|Overall Study|Disease Progression|3|||
160707304|NCT01449370|580307485|FG007|Overall Study|Disease Progression|2|||
160707305|NCT01449370|580307486|FG008|Overall Study|Disease Progression|9|||
160707306|NCT01449370|580307487|FG009|Overall Study|Disease Progression|1|||
160707307|NCT01449370|580307488|FG010|Overall Study|Disease Progression|3|||
160707308|NCT01449370|580307489|FG011|Overall Study|Disease Progression|3|||
160707309|NCT01449370|580307490|FG012|Overall Study|Disease Progression|2|||
160707310|NCT01449370|580307491|FG013|Overall Study|Disease Progression|8|||
160707311|NCT01449370|580307492|FG014|Overall Study|Disease Progression|3|||
160707312|NCT01449370|580307493|FG015|Overall Study|Disease Progression|1|||
160707313|NCT01449370|580307494|FG016|Overall Study|Disease Progression|4|||
160707314|NCT01449370|580307495|FG017|Overall Study|Disease Progression|3|||
160707315|NCT01449370|580307496|FG018|Overall Study|Disease Progression|1|||
160707316|NCT01449370|580307497|FG019|Overall Study|Disease Progression|2|||
160707317|NCT01449370|580307498|FG020|Overall Study|Disease Progression|5|||
160707318|NCT01449370|580307499|FG021|Overall Study|Disease Progression|2|||
160707319|NCT01449370|580307500|FG022|Overall Study|Disease Progression|3|||
160707320|NCT01449370|580307501|FG023|Overall Study|Disease Progression|7|||
160707321|NCT01449370|580307502|FG024|Overall Study|Disease Progression|3|||
160707322|NCT01449370|580307478|FG000|Overall Study|Adverse Event|1|||
160707323|NCT01449370|580307479|FG001|Overall Study|Adverse Event|2|||
160707324|NCT01449370|580307480|FG002|Overall Study|Adverse Event|0|||
160707325|NCT01449370|580307481|FG003|Overall Study|Adverse Event|1|||
160707326|NCT01449370|580307482|FG004|Overall Study|Adverse Event|0|||
160707327|NCT01449370|580307483|FG005|Overall Study|Adverse Event|0|||
160707328|NCT01449370|580307484|FG006|Overall Study|Adverse Event|0|||
160707329|NCT01449370|580307485|FG007|Overall Study|Adverse Event|0|||
160707330|NCT01449370|580307486|FG008|Overall Study|Adverse Event|1|||
160707331|NCT01449370|580307487|FG009|Overall Study|Adverse Event|1|||
160707332|NCT01449370|580307488|FG010|Overall Study|Adverse Event|0|||
160707333|NCT01449370|580307489|FG011|Overall Study|Adverse Event|0|||
160707334|NCT01449370|580307490|FG012|Overall Study|Adverse Event|0|||
160707335|NCT01449370|580307491|FG013|Overall Study|Adverse Event|2|||
160707336|NCT01449370|580307492|FG014|Overall Study|Adverse Event|0|||
160707337|NCT01449370|580307493|FG015|Overall Study|Adverse Event|1|||
160707338|NCT01449370|580307494|FG016|Overall Study|Adverse Event|0|||
160707339|NCT01449370|580307495|FG017|Overall Study|Adverse Event|0|||
160707340|NCT01449370|580307496|FG018|Overall Study|Adverse Event|1|||
160707341|NCT01449370|580307497|FG019|Overall Study|Adverse Event|1|||
160707342|NCT01449370|580307498|FG020|Overall Study|Adverse Event|0|||
160707343|NCT01449370|580307499|FG021|Overall Study|Adverse Event|1|||
160707344|NCT01449370|580307500|FG022|Overall Study|Adverse Event|0|||
160707345|NCT01449370|580307501|FG023|Overall Study|Adverse Event|1|||
160707346|NCT01449370|580307502|FG024|Overall Study|Adverse Event|3|||
160707347|NCT01449370|580307478|FG000|Overall Study|Participant Decision|0|||
160707348|NCT01449370|580307479|FG001|Overall Study|Participant Decision|0|||
160707349|NCT01449370|580307480|FG002|Overall Study|Participant Decision|0|||
160707350|NCT01449370|580307481|FG003|Overall Study|Participant Decision|0|||
160707351|NCT01449370|580307482|FG004|Overall Study|Participant Decision|0|||
160707352|NCT01449370|580307483|FG005|Overall Study|Participant Decision|0|||
160707353|NCT01449370|580307484|FG006|Overall Study|Participant Decision|0|||
160707354|NCT01449370|580307485|FG007|Overall Study|Participant Decision|1|||
160707355|NCT01449370|580307486|FG008|Overall Study|Participant Decision|1|||
160707356|NCT01449370|580307487|FG009|Overall Study|Participant Decision|0|||
160707357|NCT01449370|580307488|FG010|Overall Study|Participant Decision|0|||
160707358|NCT01449370|580307489|FG011|Overall Study|Participant Decision|0|||
160707359|NCT01449370|580307490|FG012|Overall Study|Participant Decision|1|||
160707360|NCT01449370|580307491|FG013|Overall Study|Participant Decision|1|||
160707361|NCT01449370|580307492|FG014|Overall Study|Participant Decision|0|||
160707362|NCT01449370|580307493|FG015|Overall Study|Participant Decision|1|||
160707363|NCT01449370|580307494|FG016|Overall Study|Participant Decision|3|||
160707364|NCT01449370|580307495|FG017|Overall Study|Participant Decision|0|||
160707365|NCT01449370|580307496|FG018|Overall Study|Participant Decision|1|||
160707366|NCT01449370|580307497|FG019|Overall Study|Participant Decision|0|||
160707367|NCT01449370|580307498|FG020|Overall Study|Participant Decision|0|||
160707368|NCT01449370|580307499|FG021|Overall Study|Participant Decision|1|||
160707369|NCT01449370|580307500|FG022|Overall Study|Participant Decision|0|||
160707370|NCT01449370|580307501|FG023|Overall Study|Participant Decision|0|||
160707371|NCT01449370|580307502|FG024|Overall Study|Participant Decision|1|||
160707372|NCT01449370|580307478|FG000|Overall Study|Lost to Follow-up|0|||
160707373|NCT01449370|580307479|FG001|Overall Study|Lost to Follow-up|0|||
160707374|NCT01449370|580307480|FG002|Overall Study|Lost to Follow-up|0|||
160707375|NCT01449370|580307481|FG003|Overall Study|Lost to Follow-up|0|||
160707376|NCT01449370|580307482|FG004|Overall Study|Lost to Follow-up|0|||
160707377|NCT01449370|580307483|FG005|Overall Study|Lost to Follow-up|0|||
160707378|NCT01449370|580307484|FG006|Overall Study|Lost to Follow-up|0|||
160707379|NCT01449370|580307485|FG007|Overall Study|Lost to Follow-up|0|||
160707380|NCT01449370|580307486|FG008|Overall Study|Lost to Follow-up|0|||
160707381|NCT01449370|580307487|FG009|Overall Study|Lost to Follow-up|0|||
160707382|NCT01449370|580307488|FG010|Overall Study|Lost to Follow-up|0|||
160707383|NCT01449370|580307489|FG011|Overall Study|Lost to Follow-up|0|||
160707384|NCT01449370|580307490|FG012|Overall Study|Lost to Follow-up|0|||
160707385|NCT01449370|580307491|FG013|Overall Study|Lost to Follow-up|0|||
160707386|NCT01449370|580307492|FG014|Overall Study|Lost to Follow-up|0|||
160707387|NCT01449370|580307493|FG015|Overall Study|Lost to Follow-up|0|||
160707388|NCT01449370|580307494|FG016|Overall Study|Lost to Follow-up|0|||
160707389|NCT01449370|580307495|FG017|Overall Study|Lost to Follow-up|0|||
160707390|NCT01449370|580307496|FG018|Overall Study|Lost to Follow-up|0|||
160707391|NCT01449370|580307497|FG019|Overall Study|Lost to Follow-up|0|||
160707392|NCT01449370|580307498|FG020|Overall Study|Lost to Follow-up|1|||
160707393|NCT01449370|580307499|FG021|Overall Study|Lost to Follow-up|0|||
160707394|NCT01449370|580307500|FG022|Overall Study|Lost to Follow-up|0|||
160707395|NCT01449370|580307501|FG023|Overall Study|Lost to Follow-up|0|||
160707396|NCT01449370|580307502|FG024|Overall Study|Lost to Follow-up|0|||
160707397|NCT01449370|580307478|FG000|Overall Study|Other|0|||
160707398|NCT01449370|580307479|FG001|Overall Study|Other|0|||
160707399|NCT01449370|580307480|FG002|Overall Study|Other|0|||
160707400|NCT01449370|580307481|FG003|Overall Study|Other|0|||
160707401|NCT01449370|580307482|FG004|Overall Study|Other|0|||
160707402|NCT01449370|580307483|FG005|Overall Study|Other|0|||
160707403|NCT01449370|580307484|FG006|Overall Study|Other|0|||
160707404|NCT01449370|580307485|FG007|Overall Study|Other|0|||
160707405|NCT01449370|580307486|FG008|Overall Study|Other|1|||
160707406|NCT01449370|580307487|FG009|Overall Study|Other|1|||
160707407|NCT01449370|580307488|FG010|Overall Study|Other|0|||
160707408|NCT01449370|580307489|FG011|Overall Study|Other|0|||
160707409|NCT01449370|580307490|FG012|Overall Study|Other|0|||
160707410|NCT01449370|580307491|FG013|Overall Study|Other|0|||
160707411|NCT01449370|580307492|FG014|Overall Study|Other|0|||
160707412|NCT01449370|580307493|FG015|Overall Study|Other|0|||
160707413|NCT01449370|580307494|FG016|Overall Study|Other|0|||
160707414|NCT01449370|580307495|FG017|Overall Study|Other|0|||
160707415|NCT01449370|580307496|FG018|Overall Study|Other|0|||
160707416|NCT01449370|580307497|FG019|Overall Study|Other|0|||
160707417|NCT01449370|580307498|FG020|Overall Study|Other|0|||
160707418|NCT01449370|580307499|FG021|Overall Study|Other|0|||
160707419|NCT01449370|580307500|FG022|Overall Study|Other|1|||
160707420|NCT01449370|580307501|FG023|Overall Study|Other|1|||
160707421|NCT01449370|580307502|FG024|Overall Study|Other|0|||
160707422|NCT01449370|580307478|FG000|Overall Study|Medication Prohibited by Protocol|0|||
160707423|NCT01449370|580307479|FG001|Overall Study|Medication Prohibited by Protocol|0|||
160707424|NCT01449370|580307480|FG002|Overall Study|Medication Prohibited by Protocol|0|||
160707425|NCT01449370|580307481|FG003|Overall Study|Medication Prohibited by Protocol|0|||
160707426|NCT01449370|580307482|FG004|Overall Study|Medication Prohibited by Protocol|0|||
160707427|NCT01449370|580307483|FG005|Overall Study|Medication Prohibited by Protocol|0|||
160707428|NCT01449370|580307484|FG006|Overall Study|Medication Prohibited by Protocol|0|||
160707429|NCT01449370|580307485|FG007|Overall Study|Medication Prohibited by Protocol|0|||
160707430|NCT01449370|580307486|FG008|Overall Study|Medication Prohibited by Protocol|0|||
160707431|NCT01449370|580307487|FG009|Overall Study|Medication Prohibited by Protocol|0|||
160707432|NCT01449370|580307488|FG010|Overall Study|Medication Prohibited by Protocol|0|||
160707433|NCT01449370|580307489|FG011|Overall Study|Medication Prohibited by Protocol|0|||
160707434|NCT01449370|580307490|FG012|Overall Study|Medication Prohibited by Protocol|0|||
160707435|NCT01449370|580307491|FG013|Overall Study|Medication Prohibited by Protocol|0|||
160707436|NCT01449370|580307492|FG014|Overall Study|Medication Prohibited by Protocol|0|||
160707437|NCT01449370|580307493|FG015|Overall Study|Medication Prohibited by Protocol|0|||
160707438|NCT01449370|580307494|FG016|Overall Study|Medication Prohibited by Protocol|0|||
160707439|NCT01449370|580307495|FG017|Overall Study|Medication Prohibited by Protocol|0|||
160707440|NCT01449370|580307496|FG018|Overall Study|Medication Prohibited by Protocol|0|||
160707441|NCT01449370|580307497|FG019|Overall Study|Medication Prohibited by Protocol|0|||
160707442|NCT01449370|580307498|FG020|Overall Study|Medication Prohibited by Protocol|0|||
160707443|NCT01449370|580307499|FG021|Overall Study|Medication Prohibited by Protocol|0|||
160707444|NCT01449370|580307500|FG022|Overall Study|Medication Prohibited by Protocol|0|||
160707445|NCT01449370|580307501|FG023|Overall Study|Medication Prohibited by Protocol|1|||
160707446|NCT01449370|580307502|FG024|Overall Study|Medication Prohibited by Protocol|0|||
160707447|NCT01449370|580307478|FG000|Overall Study|Death|0|||
160707448|NCT01449370|580307479|FG001|Overall Study|Death|0|||
160707449|NCT01449370|580307480|FG002|Overall Study|Death|0|||
160707450|NCT01449370|580307481|FG003|Overall Study|Death|0|||
160707451|NCT01449370|580307482|FG004|Overall Study|Death|0|||
160707452|NCT01449370|580307483|FG005|Overall Study|Death|0|||
160707453|NCT01449370|580307484|FG006|Overall Study|Death|0|||
160707454|NCT01449370|580307485|FG007|Overall Study|Death|0|||
160707455|NCT01449370|580307486|FG008|Overall Study|Death|0|||
160707456|NCT01449370|580307487|FG009|Overall Study|Death|0|||
160707457|NCT01449370|580307488|FG010|Overall Study|Death|0|||
160707458|NCT01449370|580307489|FG011|Overall Study|Death|0|||
160707459|NCT01449370|580307490|FG012|Overall Study|Death|0|||
160707460|NCT01449370|580307491|FG013|Overall Study|Death|0|||
160707461|NCT01449370|580307492|FG014|Overall Study|Death|0|||
160707462|NCT01449370|580307493|FG015|Overall Study|Death|0|||
160707463|NCT01449370|580307494|FG016|Overall Study|Death|0|||
160707464|NCT01449370|580307495|FG017|Overall Study|Death|0|||
160707465|NCT01449370|580307496|FG018|Overall Study|Death|0|||
160707466|NCT01449370|580307497|FG019|Overall Study|Death|0|||
160707467|NCT01449370|580307498|FG020|Overall Study|Death|0|||
160707468|NCT01449370|580307499|FG021|Overall Study|Death|0|||
160707469|NCT01449370|580307500|FG022|Overall Study|Death|0|||
160707470|NCT01449370|580307501|FG023|Overall Study|Death|0|||
160707471|NCT01449370|580307502|FG024|Overall Study|Death|1|||
160707472|NCT01685840|580307503|FG000|Overall Study|Death|77|||
160707473|NCT01685840|580307504|FG001|Overall Study|Death|66|||
160707474|NCT01685840|580307503|FG000|Overall Study|Lost to Follow-up|27|||
160707475|NCT01685840|580307504|FG001|Overall Study|Lost to Follow-up|25|||
160707476|NCT01685840|580307503|FG000|Overall Study|Physician Decision|3|||
160707477|NCT01685840|580307504|FG001|Overall Study|Physician Decision|7|||
160707478|NCT01685840|580307503|FG000|Overall Study|Withdrawal by Subject|14|||
160707479|NCT01685840|580307504|FG001|Overall Study|Withdrawal by Subject|17|||
160707480|NCT01685840|580307503|FG000|Overall Study|Futility|197|||
160707481|NCT01685840|580307504|FG001|Overall Study|Futility|200|||
160707482|NCT01685840|580307503|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
160707483|NCT01685840|580307504|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
160707484|NCT00710866|580307505|FG000|Overall Study|Protocol Violation|5|||
160707485|NCT00710866|580307506|FG001|Overall Study|Protocol Violation|4|||
160707486|NCT00710866|580307505|FG000|Overall Study|Withdrawal by Subject|2|||
160707487|NCT00710866|580307506|FG001|Overall Study|Withdrawal by Subject|1|||
160707488|NCT00710866|580307505|FG000|Overall Study|Lost to Follow-up|1|||
160707489|NCT00710866|580307506|FG001|Overall Study|Lost to Follow-up|0|||
160707490|NCT00710866|580307505|FG000|Overall Study|Failed to meet eligibility|1|||
160707491|NCT00710866|580307506|FG001|Overall Study|Failed to meet eligibility|1|||
160707492|NCT01004003|580307510|FG000|Overall Study|Progressive disease|2|||
160707493|NCT01004003|580307511|FG001|Overall Study|Progressive disease|1|||
160707494|NCT01004003|580307512|FG002|Overall Study|Progressive disease|1|||
160707495|NCT01004003|580307513|FG003|Overall Study|Progressive disease|0|||
160707496|NCT01004003|580307514|FG004|Overall Study|Progressive disease|2|||
160707497|NCT01004003|580307515|FG005|Overall Study|Progressive disease|1|||
160707498|NCT01004003|580307516|FG006|Overall Study|Progressive disease|1|||
160707499|NCT01004003|580307517|FG007|Overall Study|Progressive disease|39|||
160707500|NCT01004003|580307518|FG008|Overall Study|Progressive disease|22|||
160707501|NCT01004003|580307510|FG000|Overall Study|Adverse Event|4|||
160707502|NCT01004003|580307511|FG001|Overall Study|Adverse Event|2|||
160707503|NCT01004003|580307512|FG002|Overall Study|Adverse Event|3|||
160707504|NCT01004003|580307513|FG003|Overall Study|Adverse Event|3|||
160707505|NCT01004003|580307514|FG004|Overall Study|Adverse Event|2|||
160707506|NCT01004003|580307515|FG005|Overall Study|Adverse Event|2|||
160707507|NCT01004003|580307516|FG006|Overall Study|Adverse Event|7|||
160707508|NCT01004003|580307517|FG007|Overall Study|Adverse Event|21|||
160707509|NCT01004003|580307518|FG008|Overall Study|Adverse Event|6|||
160707510|NCT01004003|580307510|FG000|Overall Study|Refused to continue taking trial med.|0|||
160707511|NCT01004003|580307511|FG001|Overall Study|Refused to continue taking trial med.|0|||
160707512|NCT01004003|580307512|FG002|Overall Study|Refused to continue taking trial med.|0|||
160707513|NCT01004003|580307513|FG003|Overall Study|Refused to continue taking trial med.|0|||
160707514|NCT01004003|580307514|FG004|Overall Study|Refused to continue taking trial med.|0|||
160707515|NCT01004003|580307515|FG005|Overall Study|Refused to continue taking trial med.|0|||
160707516|NCT01004003|580307516|FG006|Overall Study|Refused to continue taking trial med.|0|||
160707517|NCT01004003|580307517|FG007|Overall Study|Refused to continue taking trial med.|0|||
160707518|NCT01004003|580307518|FG008|Overall Study|Refused to continue taking trial med.|2|||
160707519|NCT01004003|580307510|FG000|Overall Study|Other|0|||
160707520|NCT01004003|580307511|FG001|Overall Study|Other|0|||
160707521|NCT01004003|580307512|FG002|Overall Study|Other|0|||
160707522|NCT01004003|580307513|FG003|Overall Study|Other|0|||
160707523|NCT01004003|580307514|FG004|Overall Study|Other|0|||
160707524|NCT01004003|580307515|FG005|Overall Study|Other|1|||
160707525|NCT01004003|580307516|FG006|Overall Study|Other|0|||
160707526|NCT01004003|580307517|FG007|Overall Study|Other|0|||
160707527|NCT01004003|580307518|FG008|Overall Study|Other|0|||
160707528|NCT01290302|580309101|FG000|Overall Study|Adverse Event|2|||
160707529|NCT01290302|580309102|FG001|Overall Study|Adverse Event|0|||
160707530|NCT01290302|580309101|FG000|Overall Study|Withdrawal by Subject|1|||
160707531|NCT01290302|580309102|FG001|Overall Study|Withdrawal by Subject|0|||
160707532|NCT01290302|580309101|FG000|Overall Study|Physician Decision|0|||
160707533|NCT01290302|580309102|FG001|Overall Study|Physician Decision|2|||
160707534|NCT01290302|580309101|FG000|Overall Study|Expiration of time for screening window|1|||
160707535|NCT01290302|580309102|FG001|Overall Study|Expiration of time for screening window|0|||
160707536|NCT03816878|580309105|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
160707537|NCT03816878|580309106|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
160707538|NCT03816878|580309105|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
160707539|NCT03816878|580309106|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
160707540|NCT03355469|580309107|FG000|Overall Study|COVID-19|3|||
160707541|NCT03355469|580309108|FG001|Overall Study|COVID-19|2|||
160707542|NCT03355469|580309109|FG002|Overall Study|COVID-19|3|||
160707543|NCT03355469|580309110|FG003|Overall Study|COVID-19|3|||
160707544|NCT03355469|580309107|FG000|Overall Study|Lost to Follow-up|1|||
160707545|NCT03355469|580309108|FG001|Overall Study|Lost to Follow-up|0|||
160707546|NCT03355469|580309109|FG002|Overall Study|Lost to Follow-up|1|||
160707547|NCT03355469|580309110|FG003|Overall Study|Lost to Follow-up|0|||
160707548|NCT03355469|580309107|FG000|Overall Study|Withdrawal by Subject|2|||
160707549|NCT03355469|580309108|FG001|Overall Study|Withdrawal by Subject|1|||
160707550|NCT03355469|580309109|FG002|Overall Study|Withdrawal by Subject|0|||
160707551|NCT03355469|580309110|FG003|Overall Study|Withdrawal by Subject|3|||
160707552|NCT02291510|580309111|FG000|Overall Study|Adverse Event|0|||
160707553|NCT02291510|580309112|FG001|Overall Study|Adverse Event|0|||
160707554|NCT02291510|580309113|FG002|Overall Study|Adverse Event|0|||
160707555|NCT02291510|580309114|FG003|Overall Study|Adverse Event|1|||
160707556|NCT02454608|580309115|FG000|Double-Blind Period|Lack of Efficacy|0|||
160707557|NCT02454608|580309116|FG001|Double-Blind Period|Lack of Efficacy|2|||
160707558|NCT02454608|580309117|FG002|Double-Blind Period|Lack of Efficacy|0|||
160707559|NCT02454608|580309115|FG000|Open Label Period|Lost to Follow-up|0|||
160707560|NCT02454608|580309116|FG001|Open Label Period|Lost to Follow-up|0|||
160707561|NCT02454608|580309117|FG002|Open Label Period|Lost to Follow-up|11|||
160707562|NCT02454608|580309115|FG000|Open Label Period|Withdrawal by Subject|0|||
160707563|NCT02454608|580309116|FG001|Open Label Period|Withdrawal by Subject|0|||
160707564|NCT02454608|580309117|FG002|Open Label Period|Withdrawal by Subject|8|||
160707565|NCT04856930|580309119|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
160707566|NCT04856930|580309120|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
160707567|NCT04856930|580309121|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
160707568|NCT04856930|580309119|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
160707569|NCT04856930|580309120|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
160707570|NCT04856930|580309121|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
160707571|NCT04856930|580309119|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
160707572|NCT04856930|580309120|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
160707573|NCT04856930|580309121|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
160707574|NCT04856930|580309119|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
160707575|NCT04856930|580309120|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
160707576|NCT04856930|580309121|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
160707577|NCT04856930|580309119|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
160707578|NCT04856930|580309120|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
160707579|NCT04856930|580309121|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
160707580|NCT04856930|580309119|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
160707581|NCT04856930|580309120|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
160707582|NCT04856930|580309121|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
160707583|NCT04856930|580309119|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
160707584|NCT04856930|580309120|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
160707585|NCT04856930|580309121|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
160707586|NCT04856930|580309119|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
160707587|NCT04856930|580309120|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
160707588|NCT04856930|580309121|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
160707589|NCT04856930|580309119|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
160707590|NCT04856930|580309120|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
160707591|NCT04856930|580309121|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
160707592|NCT04856930|580309119|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
160707593|NCT04856930|580309120|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
160707594|NCT04856930|580309121|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
160707595|NCT04856930|580309119|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
160707596|NCT04856930|580309120|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
160707597|NCT04856930|580309121|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
160707598|NCT04856930|580309119|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
160707599|NCT04856930|580309120|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
160707600|NCT04856930|580309121|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
160707601|NCT04856930|580309119|FG000|Extension Period (16 Weeks)|Other than specified|0|||
160707602|NCT04856930|580309120|FG001|Extension Period (16 Weeks)|Other than specified|0|||
160707603|NCT04856930|580309121|FG002|Extension Period (16 Weeks)|Other than specified|1|||
160707604|NCT04856930|580309119|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
160707605|NCT04856930|580309120|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
160707606|NCT04856930|580309121|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
160707607|NCT04856930|580309119|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
160707608|NCT04856930|580309120|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
160707609|NCT04856930|580309121|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
160707610|NCT04856930|580309119|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
160707611|NCT04856930|580309120|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
160707612|NCT04856930|580309121|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
160707613|NCT04856930|580309119|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
160707614|NCT04856930|580309120|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
160707615|NCT04856930|580309121|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
160707616|NCT01173120|580309124|FG000|Overall Study|Lack of Efficacy|2|||
160707617|NCT01173120|580309124|FG000|Overall Study|Lost to Follow-up|1|||
160707618|NCT01173120|580309124|FG000|Overall Study|Participant Decision|2|||
160707619|NCT01173120|580309124|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
160707620|NCT01173120|580309124|FG000|Overall Study|Switch-Participant Decision|12|||
160707621|NCT01173120|580309124|FG000|Overall Study|Switch-Difficulty With Device|12|||
160707622|NCT01383707|580309126|FG000|Overall Study|Consent withdrawal|6|||
160707623|NCT01383707|580309126|FG000|Overall Study|Death|19|||
160707624|NCT01383707|580309126|FG000|Overall Study|Other|8|||
160707625|NCT01383707|580309126|FG000|Overall Study|Sponsor's decision|2|||
160707626|NCT01383707|580309126|FG000|Overall Study|Adverse Event|14|||
160707627|NCT01383707|580309126|FG000|Overall Study|Progressive disease|23|||
160707628|NCT02906358|580309127|FG000|Overall Study|Withdrawal by Subject|10|||
160707629|NCT02906358|580309128|FG001|Overall Study|Withdrawal by Subject|7|||
160707630|NCT02906358|580309127|FG000|Overall Study|Lost to Follow-up|12|||
160707631|NCT02906358|580309128|FG001|Overall Study|Lost to Follow-up|15|||
160707632|NCT02699684|580309129|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
160707633|NCT02699684|580309130|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
160707634|NCT02540850|580309131|FG000|Overall Study|Lost to Follow-up|69|||
160707635|NCT02540850|580309132|FG001|Overall Study|Lost to Follow-up|66|||
160707636|NCT02540850|580309133|FG002|Overall Study|Lost to Follow-up|34|||
160707637|NCT02252406|580309148|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
160707638|NCT02252406|580309149|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
160707639|NCT02252406|580309148|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
160707640|NCT02252406|580309149|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
160707641|NCT02252406|580309148|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
160707642|NCT02252406|580309149|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
160707643|NCT02252406|580309148|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
160707644|NCT02252406|580309149|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
160707645|NCT02252406|580309148|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
160707646|NCT02252406|580309149|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
160707647|NCT00799825|580309150|FG000|Overall Study|Adverse Event|1|||
160707648|NCT00799825|580309150|FG000|Overall Study|Withdrawal by Subject|6|||
160707649|NCT00799825|580309150|FG000|Overall Study|Lost to Follow-up|38|||
160707650|NCT00799825|580309150|FG000|Overall Study|Pregnancy|3|||
160707651|NCT04974749|580309151|FG000|Overall Study|Withdrawal by Subject|2|||
160707652|NCT04974749|580309151|FG000|Overall Study|Gestation|1|||
160707653|NCT00741338|580309152|FG000|Overall Study|Adverse Event|0|||
160707654|NCT00741338|580309153|FG001|Overall Study|Adverse Event|1|||
160707655|NCT02370238|580309160|FG000|Overall Study|Death|42|||
160707656|NCT02370238|580309161|FG001|Overall Study|Death|35|||
160707657|NCT02370238|580309160|FG000|Overall Study|Lost to Follow-up|1|||
160707658|NCT02370238|580309161|FG001|Overall Study|Lost to Follow-up|3|||
160707659|NCT02370238|580309160|FG000|Overall Study|Withdrawal by Subject|2|||
160707660|NCT02370238|580309161|FG001|Overall Study|Withdrawal by Subject|6|||
160707661|NCT02370238|580309160|FG000|Overall Study|Other|2|||
160707662|NCT02370238|580309161|FG001|Overall Study|Other|1|||
160707663|NCT01295320|580309162|FG000|Overall Study|Adverse Event|2|||
160707664|NCT01295320|580309162|FG000|Overall Study|Lost to Follow-up|4|||
160707665|NCT01295320|580309162|FG000|Overall Study|Withdrawal by Subject|2|||
160707666|NCT01295320|580309162|FG000|Overall Study|Subject was bedridden|1|||
160707667|NCT01295320|580309162|FG000|Overall Study|Unable to travel|1|||
160707668|NCT00462904|580309163|FG000|Overall Study|Lost to Follow-up|1|||
160707669|NCT01973595|580309164|FG000|Washout|Withdrawal by Subject|1|||
160707670|NCT01973595|580309165|FG001|Washout|Withdrawal by Subject|0|||
160707671|NCT01973595|580309166|FG002|Washout|Withdrawal by Subject|1|||
160707672|NCT01973595|580309167|FG003|Washout|Withdrawal by Subject|0|||
160707673|NCT02125877|580309168|FG000|Overall Study|Physician Decision|1|||
160707674|NCT02125877|580309169|FG001|Overall Study|Physician Decision|0|||
160707675|NCT02125877|580309168|FG000|Overall Study|Death|0|||
160707676|NCT02125877|580309169|FG001|Overall Study|Death|1|||
160707677|NCT02125877|580309168|FG000|Overall Study|Administrative problems|0|||
160707678|NCT02125877|580309169|FG001|Overall Study|Administrative problems|1|||
160707679|NCT02125877|580309168|FG000|Overall Study|Participant/guardian decision|0|||
160707680|NCT02125877|580309169|FG001|Overall Study|Participant/guardian decision|2|||
160707681|NCT02125877|580309168|FG000|Overall Study|Withdrawal by Subject|2|||
160707682|NCT02125877|580309169|FG001|Overall Study|Withdrawal by Subject|1|||
160707683|NCT02125877|580309168|FG000|Overall Study|Protocol deviation|4|||
160707684|NCT02125877|580309169|FG001|Overall Study|Protocol deviation|1|||
160707685|NCT02125877|580309168|FG000|Overall Study|Adverse Event|6|||
160707686|NCT02125877|580309169|FG001|Overall Study|Adverse Event|4|||
160707687|NCT01141205|580309170|FG000|Overall Study|Physician Decision|1|||
160707688|NCT01141205|580309171|FG001|Overall Study|Physician Decision|1|||
160707689|NCT01141205|580309170|FG000|Overall Study|Lost to Follow-up|1|||
160707690|NCT01141205|580309171|FG001|Overall Study|Lost to Follow-up|0|||
160707691|NCT01141205|580309170|FG000|Overall Study|Withdrawal by Subject|1|||
160707692|NCT01141205|580309171|FG001|Overall Study|Withdrawal by Subject|1|||
160707693|NCT01822366|580309172|FG000|Overall Study|Lost to Follow-up|5|||
160707694|NCT01822366|580309173|FG001|Overall Study|Lost to Follow-up|1|||
160707695|NCT01822366|580309174|FG002|Overall Study|Lost to Follow-up|5|||
160707696|NCT01822366|580309175|FG003|Overall Study|Lost to Follow-up|1|||
160707697|NCT01822366|580309172|FG000|Overall Study|Withdrawal by Subject|0|||
160707698|NCT01822366|580309173|FG001|Overall Study|Withdrawal by Subject|6|||
160707699|NCT01822366|580309174|FG002|Overall Study|Withdrawal by Subject|0|||
160707700|NCT01822366|580309175|FG003|Overall Study|Withdrawal by Subject|6|||
160707701|NCT01822366|580309172|FG000|Overall Study|Partial Intervention Completion|0|||
160707702|NCT01822366|580309173|FG001|Overall Study|Partial Intervention Completion|15|||
160707703|NCT01822366|580309174|FG002|Overall Study|Partial Intervention Completion|0|||
160707704|NCT01822366|580309175|FG003|Overall Study|Partial Intervention Completion|15|||
160707705|NCT03489109|580309176|FG000|Overall Study|Lost to Follow-up|1|||
160707706|NCT03489109|580309177|FG001|Overall Study|Lost to Follow-up|2|||
160707707|NCT04868968|580309178|FG000|Overall Study|Lost to Follow-up|1|||
160707708|NCT00384930|580309179|FG000|Overall Study|Adverse Event|5|||
160707709|NCT00384930|580309180|FG001|Overall Study|Adverse Event|4|||
160707710|NCT00384930|580309181|FG002|Overall Study|Adverse Event|12|||
160707711|NCT00384930|580309182|FG003|Overall Study|Adverse Event|11|||
160707712|NCT00384930|580309183|FG004|Overall Study|Adverse Event|14|||
160707713|NCT00384930|580309179|FG000|Overall Study|Entry Criteria Not Met|2|||
160707714|NCT00384930|580309180|FG001|Overall Study|Entry Criteria Not Met|6|||
160707715|NCT00384930|580309181|FG002|Overall Study|Entry Criteria Not Met|7|||
160707716|NCT00384930|580309182|FG003|Overall Study|Entry Criteria Not Met|8|||
160707717|NCT00384930|580309183|FG004|Overall Study|Entry Criteria Not Met|4|||
160707718|NCT00384930|580309179|FG000|Overall Study|Lack of Efficacy|1|||
160707719|NCT00384930|580309180|FG001|Overall Study|Lack of Efficacy|1|||
160707720|NCT00384930|580309181|FG002|Overall Study|Lack of Efficacy|2|||
160707721|NCT00384930|580309182|FG003|Overall Study|Lack of Efficacy|1|||
160707722|NCT00384930|580309183|FG004|Overall Study|Lack of Efficacy|2|||
160707723|NCT00384930|580309179|FG000|Overall Study|Lost to Follow-up|5|||
160707724|NCT00384930|580309180|FG001|Overall Study|Lost to Follow-up|3|||
160707725|NCT00384930|580309181|FG002|Overall Study|Lost to Follow-up|0|||
160707726|NCT00384930|580309182|FG003|Overall Study|Lost to Follow-up|4|||
160707727|NCT00384930|580309183|FG004|Overall Study|Lost to Follow-up|6|||
160707728|NCT00384930|580309179|FG000|Overall Study|Physician Decision|0|||
160707729|NCT00384930|580309180|FG001|Overall Study|Physician Decision|1|||
160707730|NCT00384930|580309181|FG002|Overall Study|Physician Decision|1|||
160707731|NCT00384930|580309182|FG003|Overall Study|Physician Decision|0|||
160707732|NCT00384930|580309183|FG004|Overall Study|Physician Decision|1|||
160707733|NCT00384930|580309179|FG000|Overall Study|Protocol Violation|1|||
160707734|NCT00384930|580309180|FG001|Overall Study|Protocol Violation|0|||
160707735|NCT00384930|580309181|FG002|Overall Study|Protocol Violation|1|||
160707736|NCT00384930|580309182|FG003|Overall Study|Protocol Violation|6|||
160707737|NCT00384930|580309183|FG004|Overall Study|Protocol Violation|4|||
160707738|NCT00384930|580309179|FG000|Overall Study|Sponsor Decision|3|||
160707739|NCT00384930|580309180|FG001|Overall Study|Sponsor Decision|4|||
160707740|NCT00384930|580309181|FG002|Overall Study|Sponsor Decision|0|||
160707741|NCT00384930|580309182|FG003|Overall Study|Sponsor Decision|5|||
160707742|NCT00384930|580309183|FG004|Overall Study|Sponsor Decision|0|||
160707743|NCT00384930|580309179|FG000|Overall Study|Withdrawal by Subject|9|||
160707744|NCT00384930|580309180|FG001|Overall Study|Withdrawal by Subject|7|||
160707745|NCT00384930|580309181|FG002|Overall Study|Withdrawal by Subject|7|||
160707746|NCT00384930|580309182|FG003|Overall Study|Withdrawal by Subject|6|||
160707747|NCT00384930|580309183|FG004|Overall Study|Withdrawal by Subject|16|||
160707748|NCT00384930|580309179|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
160707749|NCT00384930|580309180|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
160707750|NCT00384930|580309181|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
160707751|NCT00384930|580309182|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
160707752|NCT00384930|580309183|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
160707753|NCT02552732|580309184|FG000|Overall Study|Lost to Follow-up|2|||
160707754|NCT02552732|580309184|FG000|Overall Study|Physician Decision|1|||
160707755|NCT02552732|580309184|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
160707756|NCT02552732|580309184|FG000|Overall Study|Withdrawal by Subject|6|||
160707757|NCT01547130|580309187|FG000|Overall Study|Lost to Follow-up|9|||
160707758|NCT01547130|580309188|FG001|Overall Study|Lost to Follow-up|5|||
160707759|NCT00025259|580309190|FG000|Overall Study|Death|1|||
160707760|NCT00025259|580309191|FG001|Overall Study|Death|3|||
160707761|NCT00025259|580309192|FG002|Overall Study|Death|0|||
160707762|NCT00025259|580309193|FG003|Overall Study|Death|3|||
160707763|NCT00025259|580309194|FG004|Overall Study|Death|0|||
160707764|NCT00025259|580309195|FG005|Overall Study|Death|1|||
160707765|NCT00025259|580309196|FG006|Overall Study|Death|2|||
160707766|NCT00025259|580309190|FG000|Overall Study|Lack of Efficacy|2|||
160707767|NCT00025259|580309191|FG001|Overall Study|Lack of Efficacy|46|||
160707768|NCT00025259|580309192|FG002|Overall Study|Lack of Efficacy|60|||
160707769|NCT00025259|580309193|FG003|Overall Study|Lack of Efficacy|78|||
160707770|NCT00025259|580309194|FG004|Overall Study|Lack of Efficacy|11|||
160707771|NCT00025259|580309195|FG005|Overall Study|Lack of Efficacy|30|||
160707772|NCT00025259|580309196|FG006|Overall Study|Lack of Efficacy|38|||
160707773|NCT00025259|580309190|FG000|Overall Study|Lost to Follow-up|2|||
160707774|NCT00025259|580309191|FG001|Overall Study|Lost to Follow-up|9|||
160707775|NCT00025259|580309192|FG002|Overall Study|Lost to Follow-up|13|||
160707776|NCT00025259|580309193|FG003|Overall Study|Lost to Follow-up|13|||
160707777|NCT00025259|580309194|FG004|Overall Study|Lost to Follow-up|1|||
160707778|NCT00025259|580309195|FG005|Overall Study|Lost to Follow-up|3|||
160707779|NCT00025259|580309196|FG006|Overall Study|Lost to Follow-up|1|||
160707780|NCT00025259|580309190|FG000|Overall Study|Physician Decision|12|||
160707781|NCT00025259|580309191|FG001|Overall Study|Physician Decision|1|||
160707782|NCT00025259|580309192|FG002|Overall Study|Physician Decision|0|||
160707783|NCT00025259|580309193|FG003|Overall Study|Physician Decision|5|||
160707784|NCT00025259|580309194|FG004|Overall Study|Physician Decision|4|||
160707785|NCT00025259|580309195|FG005|Overall Study|Physician Decision|2|||
160707786|NCT00025259|580309196|FG006|Overall Study|Physician Decision|1|||
160707787|NCT00025259|580309190|FG000|Overall Study|Protocol Violation|3|||
160707788|NCT00025259|580309191|FG001|Overall Study|Protocol Violation|2|||
160707789|NCT00025259|580309192|FG002|Overall Study|Protocol Violation|2|||
160707790|NCT00025259|580309193|FG003|Overall Study|Protocol Violation|1|||
160707791|NCT00025259|580309194|FG004|Overall Study|Protocol Violation|2|||
160707792|NCT00025259|580309195|FG005|Overall Study|Protocol Violation|1|||
160707793|NCT00025259|580309196|FG006|Overall Study|Protocol Violation|3|||
160707794|NCT00025259|580309190|FG000|Overall Study|Withdrawal by Subject|9|||
160707795|NCT00025259|580309191|FG001|Overall Study|Withdrawal by Subject|27|||
160707796|NCT00025259|580309192|FG002|Overall Study|Withdrawal by Subject|6|||
160707797|NCT00025259|580309193|FG003|Overall Study|Withdrawal by Subject|14|||
160707798|NCT00025259|580309194|FG004|Overall Study|Withdrawal by Subject|11|||
160707799|NCT00025259|580309195|FG005|Overall Study|Withdrawal by Subject|8|||
160707800|NCT00025259|580309196|FG006|Overall Study|Withdrawal by Subject|3|||
160707801|NCT00025259|580309190|FG000|Overall Study|Ineligible|14|||
160707802|NCT00025259|580309191|FG001|Overall Study|Ineligible|1|||
160707803|NCT00025259|580309192|FG002|Overall Study|Ineligible|0|||
160707804|NCT00025259|580309193|FG003|Overall Study|Ineligible|0|||
160707805|NCT00025259|580309194|FG004|Overall Study|Ineligible|6|||
160707806|NCT00025259|580309195|FG005|Overall Study|Ineligible|0|||
160707807|NCT00025259|580309196|FG006|Overall Study|Ineligible|1|||
160707808|NCT00025259|580309190|FG000|Overall Study|Randomization error|1|||
160707809|NCT00025259|580309191|FG001|Overall Study|Randomization error|0|||
160707810|NCT00025259|580309192|FG002|Overall Study|Randomization error|0|||
160707811|NCT00025259|580309193|FG003|Overall Study|Randomization error|0|||
160707812|NCT00025259|580309194|FG004|Overall Study|Randomization error|1|||
160707813|NCT00025259|580309195|FG005|Overall Study|Randomization error|7|||
160707814|NCT00025259|580309196|FG006|Overall Study|Randomization error|2|||
160707815|NCT00025259|580309190|FG000|Overall Study|Adverse Event|1|||
160707816|NCT00025259|580309191|FG001|Overall Study|Adverse Event|0|||
160707817|NCT00025259|580309192|FG002|Overall Study|Adverse Event|0|||
160707818|NCT00025259|580309193|FG003|Overall Study|Adverse Event|0|||
160707819|NCT00025259|580309194|FG004|Overall Study|Adverse Event|0|||
160707820|NCT00025259|580309195|FG005|Overall Study|Adverse Event|0|||
160707821|NCT00025259|580309196|FG006|Overall Study|Adverse Event|0|||
160707822|NCT00246324|580309200|FG000|Overall Study|Withdrawal by Subject|1|||
160707823|NCT00345631|580309202|FG000|Overall Study|Withdrawal by Subject|1|||
160707824|NCT00345631|580309203|FG001|Overall Study|Withdrawal by Subject|0|||
160707825|NCT00345631|580309204|FG002|Overall Study|Withdrawal by Subject|1|||
160707826|NCT00345631|580309202|FG000|Overall Study|Adverse Event|0|||
160707827|NCT00345631|580309203|FG001|Overall Study|Adverse Event|1|||
160707828|NCT00345631|580309204|FG002|Overall Study|Adverse Event|0|||
160707829|NCT00345631|580309202|FG000|Overall Study|Lost to Follow-up|3|||
160707830|NCT00345631|580309203|FG001|Overall Study|Lost to Follow-up|7|||
160707831|NCT00345631|580309204|FG002|Overall Study|Lost to Follow-up|4|||
160707832|NCT00345631|580309202|FG000|Overall Study|Other reasons|0|||
160707833|NCT00345631|580309203|FG001|Overall Study|Other reasons|0|||
160707834|NCT00345631|580309204|FG002|Overall Study|Other reasons|1|||
160707835|NCT03371459|580309212|FG000|Washout|Lost to Follow-up|0|||
160707836|NCT03371459|580309213|FG001|Washout|Lost to Follow-up|1|||
160707837|NCT01589497|580309216|FG000|Overall Study|Withdrawal by Subject|0|||
160707838|NCT01589497|580309217|FG001|Overall Study|Withdrawal by Subject|1|||
160707839|NCT01589497|580309218|FG002|Overall Study|Withdrawal by Subject|0|||
160707840|NCT01589497|580309219|FG003|Overall Study|Withdrawal by Subject|1|||
160707841|NCT01589497|580309216|FG000|Overall Study|Death|1|||
160707842|NCT01589497|580309217|FG001|Overall Study|Death|0|||
160707843|NCT01589497|580309218|FG002|Overall Study|Death|0|||
160707844|NCT01589497|580309219|FG003|Overall Study|Death|0|||
160707845|NCT01589497|580309216|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
160707846|NCT01589497|580309217|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
160707847|NCT01589497|580309218|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
160707848|NCT01589497|580309219|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
160707849|NCT01885195|580309220|FG000|Overall Study|Adverse Event|29|||
160707850|NCT01885195|580309220|FG000|Overall Study|Death|1|||
160707851|NCT01885195|580309220|FG000|Overall Study|Disease Progression|67|||
160707852|NCT01885195|580309220|FG000|Overall Study|Protocol Deviation|2|||
160707853|NCT01885195|580309220|FG000|Overall Study|Physician Decision|3|||
160707854|NCT01885195|580309220|FG000|Overall Study|Patient/guardian decision|8|||
160707855|NCT03390426|580309221|FG000|Overall Study|Protocol Violation|0|||
160707856|NCT03390426|580309222|FG001|Overall Study|Protocol Violation|1|||
160707857|NCT00259272|580309223|FG000|Overall Study|Adverse Event|2|||
160707858|NCT00259272|580309224|FG001|Overall Study|Adverse Event|1|||
160707859|NCT00259272|580309225|FG002|Overall Study|Adverse Event|0|||
160707860|NCT00259272|580309226|FG003|Overall Study|Adverse Event|3|||
160707861|NCT00259272|580309223|FG000|Overall Study|Lack of Efficacy|5|||
160707862|NCT00259272|580309224|FG001|Overall Study|Lack of Efficacy|1|||
160707863|NCT00259272|580309225|FG002|Overall Study|Lack of Efficacy|2|||
160707864|NCT00259272|580309226|FG003|Overall Study|Lack of Efficacy|6|||
160707865|NCT00259272|580309223|FG000|Overall Study|Physician Decision|1|||
160707866|NCT00259272|580309224|FG001|Overall Study|Physician Decision|2|||
160707867|NCT00259272|580309225|FG002|Overall Study|Physician Decision|1|||
160707868|NCT00259272|580309226|FG003|Overall Study|Physician Decision|3|||
160707869|NCT00259272|580309223|FG000|Overall Study|Protocol Violation|2|||
160707870|NCT00259272|580309224|FG001|Overall Study|Protocol Violation|0|||
160707871|NCT00259272|580309225|FG002|Overall Study|Protocol Violation|0|||
160707872|NCT00259272|580309226|FG003|Overall Study|Protocol Violation|1|||
160707873|NCT00259272|580309223|FG000|Overall Study|Sponsor Decision|0|||
160707874|NCT00259272|580309224|FG001|Overall Study|Sponsor Decision|1|||
160707875|NCT00259272|580309225|FG002|Overall Study|Sponsor Decision|0|||
160707876|NCT00259272|580309226|FG003|Overall Study|Sponsor Decision|0|||
160707877|NCT00259272|580309223|FG000|Overall Study|Withdrawal by Subject|4|||
160707878|NCT00259272|580309224|FG001|Overall Study|Withdrawal by Subject|2|||
160707879|NCT00259272|580309225|FG002|Overall Study|Withdrawal by Subject|2|||
160707880|NCT00259272|580309226|FG003|Overall Study|Withdrawal by Subject|7|||
160707881|NCT00259272|580309223|FG000|Overall Study|Lost to Follow-up|1|||
160707882|NCT00259272|580309224|FG001|Overall Study|Lost to Follow-up|0|||
160707883|NCT00259272|580309225|FG002|Overall Study|Lost to Follow-up|0|||
160707884|NCT00259272|580309226|FG003|Overall Study|Lost to Follow-up|1|||
160707885|NCT01374269|580309228|FG000|Overall Study|Withdrawal by Subject|4|||
160707886|NCT01374269|580309229|FG001|Overall Study|Withdrawal by Subject|0|||
160707887|NCT01374269|580309228|FG000|Overall Study|Lost to Follow-up|1|||
160707888|NCT01374269|580309229|FG001|Overall Study|Lost to Follow-up|3|||
160707889|NCT01374269|580309228|FG000|Overall Study|closed research|1|||
160707890|NCT01374269|580309229|FG001|Overall Study|closed research|2|||
160707891|NCT00708227|580309234|FG000|Overall Study|Physician Decision|0|||
160707892|NCT00708227|580309235|FG001|Overall Study|Physician Decision|3|||
160707893|NCT00708227|580309236|FG002|Overall Study|Physician Decision|1|||
160707894|NCT00708227|580309237|FG003|Overall Study|Physician Decision|2|||
160707895|NCT00708227|580309234|FG000|Overall Study|Withdrawal by Subject|1|||
160707896|NCT00708227|580309235|FG001|Overall Study|Withdrawal by Subject|2|||
160707897|NCT00708227|580309236|FG002|Overall Study|Withdrawal by Subject|0|||
160707898|NCT00708227|580309237|FG003|Overall Study|Withdrawal by Subject|1|||
160707899|NCT04007991|580309238|FG000|Overall Study|Withdrawal by Subject|1|||
160707900|NCT04007991|580309239|FG001|Overall Study|Withdrawal by Subject|1|||
160707901|NCT04007991|580309238|FG000|Overall Study|Physician Decision|1|||
160707902|NCT04007991|580309239|FG001|Overall Study|Physician Decision|1|||
160707903|NCT04007991|580309238|FG000|Overall Study|Non-compliance with Study Drug|0|||
160707904|NCT04007991|580309239|FG001|Overall Study|Non-compliance with Study Drug|1|||
160707905|NCT04007991|580309238|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
160707906|NCT04007991|580309239|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
160707907|NCT04007991|580309238|FG000|Overall Study|Adverse event, non-fatal|5|||
160707908|NCT04007991|580309239|FG001|Overall Study|Adverse event, non-fatal|0|||
160707909|NCT04007991|580309238|FG000|Overall Study|Lost to Follow-up|2|||
160707910|NCT04007991|580309239|FG001|Overall Study|Lost to Follow-up|1|||
160707911|NCT03654599|580309242|FG000|Overall Study|Lost to Follow-up|14|||
160707912|NCT03654599|580309243|FG001|Overall Study|Lost to Follow-up|12|||
160707913|NCT03654599|580309242|FG000|Overall Study|Death|8|||
160707914|NCT03654599|580309243|FG001|Overall Study|Death|6|||
160707915|NCT03654599|580309242|FG000|Overall Study|Withdrawal by Subject|6|||
160707916|NCT03654599|580309243|FG001|Overall Study|Withdrawal by Subject|4|||
160707917|NCT02551666|580309245|FG000|Overall Study|Withdrawal by Subject|1|||
160707918|NCT02551666|580309246|FG001|Overall Study|Withdrawal by Subject|3|||
160707919|NCT02465398|580310995|FG000|Overall Study|Death|7|||
160707920|NCT02465398|580310995|FG000|Overall Study|Revision|7|||
160707921|NCT02465398|580310995|FG000|Overall Study|did not receive study device|1|||
160707922|NCT02465398|580310995|FG000|Overall Study|Withdrawal by Subject|1|||
160707923|NCT02465398|580310995|FG000|Overall Study|Lost to Follow-up|14|||
160707924|NCT00678210|580310996|FG000|Overall Study|Adverse Event|1|||
160707925|NCT00678210|580310997|FG001|Overall Study|Adverse Event|2|||
160707926|NCT00678210|580310998|FG002|Overall Study|Adverse Event|3|||
160707927|NCT00678210|580310999|FG003|Overall Study|Adverse Event|3|||
160707928|NCT00678210|580310996|FG000|Overall Study|Lack of Efficacy|2|||
160707929|NCT00678210|580310997|FG001|Overall Study|Lack of Efficacy|3|||
160707930|NCT00678210|580310998|FG002|Overall Study|Lack of Efficacy|1|||
160707931|NCT00678210|580310999|FG003|Overall Study|Lack of Efficacy|9|||
160707932|NCT00678210|580310996|FG000|Overall Study|Lost to Follow-up|4|||
160707933|NCT00678210|580310997|FG001|Overall Study|Lost to Follow-up|2|||
160707934|NCT00678210|580310998|FG002|Overall Study|Lost to Follow-up|0|||
160707935|NCT00678210|580310999|FG003|Overall Study|Lost to Follow-up|1|||
160707936|NCT00678210|580310996|FG000|Overall Study|Withdrawal by Subject|3|||
160707937|NCT00678210|580310997|FG001|Overall Study|Withdrawal by Subject|4|||
160707938|NCT00678210|580310998|FG002|Overall Study|Withdrawal by Subject|1|||
160707939|NCT00678210|580310999|FG003|Overall Study|Withdrawal by Subject|7|||
160707940|NCT00678210|580310996|FG000|Overall Study|Other|1|||
160707941|NCT00678210|580310997|FG001|Overall Study|Other|0|||
160707942|NCT00678210|580310998|FG002|Overall Study|Other|1|||
160707943|NCT00678210|580310999|FG003|Overall Study|Other|0|||
160707944|NCT00615199|580311000|FG000|Overall Study|Adverse Event|3|||
160707945|NCT00615199|580311001|FG001|Overall Study|Adverse Event|1|||
160707946|NCT00615199|580311002|FG002|Overall Study|Adverse Event|1|||
160707947|NCT00615199|580311003|FG003|Overall Study|Adverse Event|0|||
160707948|NCT00615199|580311000|FG000|Overall Study|Lack of Efficacy|2|||
160707949|NCT00615199|580311001|FG001|Overall Study|Lack of Efficacy|0|||
160707950|NCT00615199|580311002|FG002|Overall Study|Lack of Efficacy|0|||
160707951|NCT00615199|580311003|FG003|Overall Study|Lack of Efficacy|1|||
160707952|NCT00615199|580311000|FG000|Overall Study|Lost to Follow-up|1|||
160707953|NCT00615199|580311001|FG001|Overall Study|Lost to Follow-up|0|||
160707954|NCT00615199|580311002|FG002|Overall Study|Lost to Follow-up|0|||
160707955|NCT00615199|580311003|FG003|Overall Study|Lost to Follow-up|0|||
160707956|NCT00615199|580311000|FG000|Overall Study|Other|0|||
160707957|NCT00615199|580311001|FG001|Overall Study|Other|0|||
160707958|NCT00615199|580311002|FG002|Overall Study|Other|0|||
160707959|NCT00615199|580311003|FG003|Overall Study|Other|1|||
160707960|NCT00615199|580311000|FG000|Overall Study|Withdrawal by Subject|2|||
160707961|NCT00615199|580311001|FG001|Overall Study|Withdrawal by Subject|1|||
160707962|NCT00615199|580311002|FG002|Overall Study|Withdrawal by Subject|0|||
160707963|NCT00615199|580311003|FG003|Overall Study|Withdrawal by Subject|0|||
160707964|NCT04825912|580311004|FG000|Overall Study|Death|3|||
160707965|NCT04825912|580311004|FG000|Overall Study|Withdrawal by Subject|1|||
160707966|NCT00459355|580311007|FG000|Overall Study|Subject no longer met inc criteria|20|||
160707967|NCT00459355|580311008|FG001|Overall Study|Subject no longer met inc criteria|18|||
160707968|NCT01009814|580311009|FG000|Overall Study|No longer met study criteria|1|||
160707969|NCT01009814|580311010|FG001|Overall Study|No longer met study criteria|1|||
160707970|NCT01009814|580311011|FG002|Overall Study|No longer met study criteria|0|||
160707971|NCT01009814|580311012|FG003|Overall Study|No longer met study criteria|0|||
160707972|NCT01009814|580311013|FG004|Overall Study|No longer met study criteria|0|||
160707973|NCT00618371|580311014|FG000|Overall Study|Withdrawal by Subject|2|||
160707974|NCT02653625|580311015|FG000|Overall Study|Adverse Event|1|||
160707975|NCT02653625|580311015|FG000|Overall Study|Non-compliance with Study Drug|1|||
160707976|NCT02653625|580311015|FG000|Overall Study|Protocol Violation|1|||
160707977|NCT02653625|580311015|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
160707978|NCT03965689|580311016|FG000|Overall Study|Too sick to get study intervention|2|||
160707979|NCT00764881|580311018|FG000|Overall Study|Adverse Event|5|||
160707980|NCT00764881|580311019|FG001|Overall Study|Adverse Event|1|||
160707981|NCT00764881|580311018|FG000|Overall Study|Withdrawal by Subject|1|||
160707982|NCT00764881|580311019|FG001|Overall Study|Withdrawal by Subject|3|||
160707983|NCT00764881|580311018|FG000|Overall Study|Protocol Violation|2|||
160707984|NCT00764881|580311019|FG001|Overall Study|Protocol Violation|2|||
160707985|NCT00764881|580311018|FG000|Overall Study|Lost to Follow-up|2|||
160707986|NCT00764881|580311019|FG001|Overall Study|Lost to Follow-up|0|||
160707987|NCT00764881|580311018|FG000|Overall Study|Noncompliant|1|||
160707988|NCT00764881|580311019|FG001|Overall Study|Noncompliant|0|||
160707989|NCT00764881|580311018|FG000|Overall Study|Accidentally discontinued study drug|1|||
160707990|NCT00764881|580311019|FG001|Overall Study|Accidentally discontinued study drug|0|||
160707991|NCT00764881|580311018|FG000|Overall Study|Wished to become pregnant|1|||
160707992|NCT00764881|580311019|FG001|Overall Study|Wished to become pregnant|0|||
160707993|NCT00764881|580311018|FG000|Overall Study|Carcinoma detected|1|||
160707994|NCT00764881|580311019|FG001|Overall Study|Carcinoma detected|0|||
160707995|NCT00764881|580311018|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
160707996|NCT00764881|580311019|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
160707997|NCT00764881|580311018|FG000|Overall Study|no treatment or no observation|2|||
160707998|NCT00764881|580311019|FG001|Overall Study|no treatment or no observation|2|||
160707999|NCT01214655|580311020|FG000|Part A|Progressive Disease|7|||
160708000|NCT01214655|580311021|FG001|Part A|Progressive Disease|0|||
160708001|NCT01214655|580311022|FG002|Part A|Progressive Disease|0|||
160708002|NCT01214655|580311020|FG000|Part A|Physician Decision|1|||
160708003|NCT01214655|580311021|FG001|Part A|Physician Decision|0|||
160708004|NCT01214655|580311022|FG002|Part A|Physician Decision|0|||
160708005|NCT01214655|580311020|FG000|Part B|Progressive disease|0|||
160708006|NCT01214655|580311021|FG001|Part B|Progressive disease|10|||
160708007|NCT01214655|580311022|FG002|Part B|Progressive disease|0|||
160708008|NCT01214655|580311020|FG000|Part B|Death|0|||
160708009|NCT01214655|580311021|FG001|Part B|Death|1|||
160708010|NCT01214655|580311022|FG002|Part B|Death|0|||
160708011|NCT01214655|580311020|FG000|Part B|Withdrawal by Subject|0|||
160708012|NCT01214655|580311021|FG001|Part B|Withdrawal by Subject|2|||
160708013|NCT01214655|580311022|FG002|Part B|Withdrawal by Subject|0|||
160708014|NCT01214655|580311020|FG000|Part C|Progressive Disease|0|||
160708015|NCT01214655|580311021|FG001|Part C|Progressive Disease|0|||
160708016|NCT01214655|580311022|FG002|Part C|Progressive Disease|5|||
160708017|NCT01214655|580311020|FG000|Part C|Death|0|||
160708018|NCT01214655|580311021|FG001|Part C|Death|0|||
160708019|NCT01214655|580311022|FG002|Part C|Death|1|||
160708020|NCT01214655|580311020|FG000|Part C|Physician Decision|0|||
160708021|NCT01214655|580311021|FG001|Part C|Physician Decision|0|||
160708022|NCT01214655|580311022|FG002|Part C|Physician Decision|1|||
160708023|NCT01977417|580311028|FG000|Overall Study|Adverse Event|1|||
160708024|NCT01977417|580311029|FG001|Overall Study|Adverse Event|0|||
160708025|NCT01977417|580311028|FG000|Overall Study|Withdrawal by Subject|2|||
160708026|NCT01977417|580311029|FG001|Overall Study|Withdrawal by Subject|4|||
160708027|NCT01977417|580311028|FG000|Overall Study|Female enrollment goal met|0|||
160708028|NCT01977417|580311029|FG001|Overall Study|Female enrollment goal met|2|||
160708029|NCT03055624|580311033|FG000|Overall Study|Study closed|9|||
160708030|NCT02437903|580311034|FG000|Overall Study|Adverse Event|1|||
160708031|NCT02437903|580311034|FG000|Overall Study|Withdrawal by Subject|1|||
160708032|NCT02437903|580311034|FG000|Overall Study|Lost to Follow-up|3|||
160708033|NCT01625988|580311036|FG000|Overall Study|Lost to Follow-up|5|||
160708034|NCT01625988|580311037|FG001|Overall Study|Lost to Follow-up|6|||
160708035|NCT01625988|580311036|FG000|Overall Study|Withdrawal by Subject|8|||
160708036|NCT01625988|580311037|FG001|Overall Study|Withdrawal by Subject|3|||
160708037|NCT01625988|580311036|FG000|Overall Study|Adverse Event|0|||
160708038|NCT01625988|580311037|FG001|Overall Study|Adverse Event|1|||
160708039|NCT01625988|580311036|FG000|Overall Study|Lack of Efficacy|0|||
160708040|NCT01625988|580311037|FG001|Overall Study|Lack of Efficacy|1|||
160708041|NCT01625988|580311036|FG000|Overall Study|Randomized Inappropriately|1|||
160708042|NCT01625988|580311037|FG001|Overall Study|Randomized Inappropriately|0|||
160708043|NCT01625988|580311036|FG000|Overall Study|Protocol Violation|0|||
160708044|NCT01625988|580311037|FG001|Overall Study|Protocol Violation|2|||
160708045|NCT03713632|580311040|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
160708046|NCT03713632|580311041|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
160708047|NCT03713632|580311042|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
160708048|NCT03713632|580311043|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
160708049|NCT03713632|580311044|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
160708050|NCT03713632|580311040|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
160708051|NCT03713632|580311041|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
160708052|NCT03713632|580311042|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
160708053|NCT03713632|580311043|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
160708054|NCT03713632|580311044|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
160708055|NCT03713632|580311040|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
160708056|NCT03713632|580311041|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
160708057|NCT03713632|580311042|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
160708058|NCT03713632|580311043|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
160708059|NCT03713632|580311044|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
160708060|NCT03713632|580311040|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
160708061|NCT03713632|580311041|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
160708062|NCT03713632|580311042|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
160708063|NCT03713632|580311043|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
160708064|NCT03713632|580311044|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
160708065|NCT03713632|580311040|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
160708066|NCT03713632|580311041|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
160708067|NCT03713632|580311042|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
160708068|NCT03713632|580311043|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
160708069|NCT03713632|580311044|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
160708070|NCT03713632|580311040|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
160708071|NCT03713632|580311041|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
160708072|NCT03713632|580311042|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
160708073|NCT03713632|580311043|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
160708074|NCT03713632|580311044|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
160708075|NCT03713632|580311040|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
160708076|NCT03713632|580311041|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
160708077|NCT03713632|580311042|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
160708078|NCT03713632|580311043|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
160708079|NCT03713632|580311044|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
160708080|NCT03713632|580311040|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
160708081|NCT03713632|580311041|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
160708082|NCT03713632|580311042|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
160708083|NCT03713632|580311043|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
160708084|NCT03713632|580311044|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
160708085|NCT03713632|580311040|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
160708086|NCT03713632|580311041|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
160708087|NCT03713632|580311042|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
160708088|NCT03713632|580311043|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
160708089|NCT03713632|580311044|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
160708090|NCT03713632|580311040|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
160708091|NCT03713632|580311041|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
160708092|NCT03713632|580311042|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
160708093|NCT03713632|580311043|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
160708094|NCT03713632|580311044|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
160708095|NCT03713632|580311040|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
160708096|NCT03713632|580311041|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
160708097|NCT03713632|580311042|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
160708098|NCT03713632|580311043|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
160708099|NCT03713632|580311044|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
160708100|NCT03713632|580311040|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
160708101|NCT03713632|580311041|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
160708102|NCT03713632|580311042|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
160708103|NCT03713632|580311043|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
160708104|NCT03713632|580311044|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
160708105|NCT03713632|580311040|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
160708106|NCT03713632|580311041|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
160708107|NCT03713632|580311042|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
160708108|NCT03713632|580311043|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
160708109|NCT03713632|580311044|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
160708110|NCT03713632|580311040|FG000|Treatment Period 2 (After Week 16)|Death|0|||
160708111|NCT03713632|580311041|FG001|Treatment Period 2 (After Week 16)|Death|1|||
160708112|NCT03713632|580311042|FG002|Treatment Period 2 (After Week 16)|Death|0|||
160708113|NCT03713632|580311043|FG003|Treatment Period 2 (After Week 16)|Death|0|||
160708114|NCT03713632|580311044|FG004|Treatment Period 2 (After Week 16)|Death|0|||
160708115|NCT03713632|580311040|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
160708116|NCT03713632|580311041|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
160708117|NCT03713632|580311042|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
160708118|NCT03713632|580311043|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
160708119|NCT03713632|580311044|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
160708120|NCT01524978|580311045|FG000|Overall Study|Other|16|||
160708121|NCT01524978|580311046|FG001|Overall Study|Other|2|||
160708122|NCT01524978|580311047|FG002|Overall Study|Other|1|||
160708123|NCT01524978|580311048|FG003|Overall Study|Other|2|||
160708124|NCT01524978|580311049|FG004|Overall Study|Other|1|||
160708125|NCT01524978|580311050|FG005|Overall Study|Other|3|||
160708126|NCT01524978|580311051|FG006|Overall Study|Other|17|||
160708127|NCT01524978|580311052|FG007|Overall Study|Other|1|||
160708128|NCT01524978|580311053|FG008|Overall Study|Other|2|||
160708129|NCT01524978|580311054|FG009|Overall Study|Other|2|||
160708130|NCT01524978|580311055|FG010|Overall Study|Other|5|||
160708131|NCT01524978|580311045|FG000|Overall Study|Withdrawal by Subject|12|||
160708132|NCT01524978|580311046|FG001|Overall Study|Withdrawal by Subject|0|||
160708133|NCT01524978|580311047|FG002|Overall Study|Withdrawal by Subject|1|||
160708134|NCT01524978|580311048|FG003|Overall Study|Withdrawal by Subject|1|||
160708135|NCT01524978|580311049|FG004|Overall Study|Withdrawal by Subject|3|||
160708136|NCT01524978|580311050|FG005|Overall Study|Withdrawal by Subject|1|||
160708137|NCT01524978|580311051|FG006|Overall Study|Withdrawal by Subject|6|||
160708138|NCT01524978|580311052|FG007|Overall Study|Withdrawal by Subject|2|||
160708139|NCT01524978|580311053|FG008|Overall Study|Withdrawal by Subject|4|||
160708140|NCT01524978|580311054|FG009|Overall Study|Withdrawal by Subject|0|||
160708141|NCT01524978|580311055|FG010|Overall Study|Withdrawal by Subject|5|||
160708142|NCT01524978|580311045|FG000|Overall Study|Lost to Follow-up|0|||
160708143|NCT01524978|580311046|FG001|Overall Study|Lost to Follow-up|0|||
160708144|NCT01524978|580311047|FG002|Overall Study|Lost to Follow-up|3|||
160708145|NCT01524978|580311048|FG003|Overall Study|Lost to Follow-up|0|||
160708146|NCT01524978|580311049|FG004|Overall Study|Lost to Follow-up|1|||
160708147|NCT01524978|580311050|FG005|Overall Study|Lost to Follow-up|1|||
160708148|NCT01524978|580311051|FG006|Overall Study|Lost to Follow-up|2|||
160708149|NCT01524978|580311052|FG007|Overall Study|Lost to Follow-up|0|||
160708150|NCT01524978|580311053|FG008|Overall Study|Lost to Follow-up|1|||
160708151|NCT01524978|580311054|FG009|Overall Study|Lost to Follow-up|1|||
160708152|NCT01524978|580311055|FG010|Overall Study|Lost to Follow-up|1|||
160708153|NCT01524978|580311045|FG000|Overall Study|Death|34|||
160708154|NCT01524978|580311046|FG001|Overall Study|Death|2|||
160708155|NCT01524978|580311047|FG002|Overall Study|Death|5|||
160708156|NCT01524978|580311048|FG003|Overall Study|Death|24|||
160708157|NCT01524978|580311049|FG004|Overall Study|Death|4|||
160708158|NCT01524978|580311050|FG005|Overall Study|Death|4|||
160708159|NCT01524978|580311051|FG006|Overall Study|Death|1|||
160708160|NCT01524978|580311052|FG007|Overall Study|Death|9|||
160708161|NCT01524978|580311053|FG008|Overall Study|Death|5|||
160708162|NCT01524978|580311054|FG009|Overall Study|Death|6|||
160708163|NCT01524978|580311055|FG010|Overall Study|Death|17|||
160708164|NCT05445492|580311061|FG000|Overall Study|Physician Decision|1|||
160708165|NCT04289363|580311063|FG000|Overall Study|Lost to Follow-up|14|||
160708166|NCT04289363|580311064|FG001|Overall Study|Lost to Follow-up|0|||
160708167|NCT03790657|580311065|FG000|Overall Study|Adverse Event|1|||
160708168|NCT03790657|580311066|FG001|Overall Study|Adverse Event|1|||
160708169|NCT03790657|580311065|FG000|Overall Study|Withdrawal by Subject|1|||
160708170|NCT03790657|580311066|FG001|Overall Study|Withdrawal by Subject|1|||
160708171|NCT03126435|580311067|FG000|Overall Study|Death|90|||
160708172|NCT03126435|580311068|FG001|Overall Study|Death|84|||
160708173|NCT03126435|580311067|FG000|Overall Study|Lost to Follow-up|4|||
160708174|NCT03126435|580311068|FG001|Overall Study|Lost to Follow-up|3|||
160708175|NCT03126435|580311067|FG000|Overall Study|Physician Decision|0|||
160708176|NCT03126435|580311068|FG001|Overall Study|Physician Decision|1|||
160708177|NCT03126435|580311067|FG000|Overall Study|Withdrawal by Subject|6|||
160708178|NCT03126435|580311068|FG001|Overall Study|Withdrawal by Subject|12|||
160708179|NCT03126435|580311067|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
160708180|NCT03126435|580311068|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
160708181|NCT03971474|580311069|FG000|Overall Study|Adverse Event|11|||
160708182|NCT03971474|580311070|FG001|Overall Study|Adverse Event|7|||
160708183|NCT03971474|580311069|FG000|Overall Study|Refusal unrelated to adverse event|5|||
160708184|NCT03971474|580311070|FG001|Overall Study|Refusal unrelated to adverse event|1|||
160708185|NCT03971474|580311069|FG000|Overall Study|Progression/relapse|40|||
160708186|NCT03971474|580311070|FG001|Overall Study|Progression/relapse|47|||
160708187|NCT03971474|580311069|FG000|Overall Study|Death|6|||
160708188|NCT03971474|580311070|FG001|Overall Study|Death|3|||
160708189|NCT03971474|580311069|FG000|Overall Study|Other - not protocol specified|5|||
160708190|NCT03971474|580311070|FG001|Overall Study|Other - not protocol specified|4|||
160708191|NCT03971474|580311069|FG000|Overall Study|On treatment|0|||
160708192|NCT03971474|580311070|FG001|Overall Study|On treatment|7|||
160708193|NCT01023035|580311072|FG000|Treatment Period|Adverse Event|27|||
160708194|NCT01023035|580311073|FG001|Treatment Period|Adverse Event|32|||
160708195|NCT01023035|580311074|FG002|Treatment Period|Adverse Event|50|||
160708196|NCT01023035|580311072|FG000|Treatment Period|Non-Medical Reasons|19|||
160708197|NCT01023035|580311073|FG001|Treatment Period|Non-Medical Reasons|22|||
160708198|NCT01023035|580311074|FG002|Treatment Period|Non-Medical Reasons|44|||
160708199|NCT01023035|580311072|FG000|Treatment Period|Treatment Failure|26|||
160708200|NCT01023035|580311073|FG001|Treatment Period|Treatment Failure|31|||
160708201|NCT01023035|580311074|FG002|Treatment Period|Treatment Failure|24|||
160708202|NCT01023035|580311072|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
160708203|NCT01023035|580311073|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
160708204|NCT01023035|580311074|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
160708205|NCT01023035|580311072|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
160708206|NCT01023035|580311073|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
160708207|NCT01023035|580311074|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
160708208|NCT01937871|580311076|FG000|Overall Study|Adverse Event|6|||
160708209|NCT01937871|580311077|FG001|Overall Study|Adverse Event|6|||
160708210|NCT01937871|580311078|FG002|Overall Study|Adverse Event|2|||
160708211|NCT01937871|580311076|FG000|Overall Study|Lost to Follow-up|8|||
160708212|NCT01937871|580311077|FG001|Overall Study|Lost to Follow-up|2|||
160708213|NCT01937871|580311078|FG002|Overall Study|Lost to Follow-up|4|||
160708214|NCT01937871|580311076|FG000|Overall Study|Withdrawal by Subject|9|||
160708215|NCT01937871|580311077|FG001|Overall Study|Withdrawal by Subject|6|||
160708216|NCT01937871|580311078|FG002|Overall Study|Withdrawal by Subject|4|||
160708217|NCT01937871|580311076|FG000|Overall Study|Physician Decision|0|||
160708218|NCT01937871|580311077|FG001|Overall Study|Physician Decision|1|||
160708219|NCT01937871|580311078|FG002|Overall Study|Physician Decision|0|||
160708220|NCT01937871|580311076|FG000|Overall Study|Entry Criteria Not Met|1|||
160708221|NCT01937871|580311077|FG001|Overall Study|Entry Criteria Not Met|2|||
160708222|NCT01937871|580311078|FG002|Overall Study|Entry Criteria Not Met|1|||
160708223|NCT01482312|580311079|FG000|Period 1, 90 Minutes of Wear|Other|1|||
160708224|NCT01482312|580311080|FG001|Period 1, 90 Minutes of Wear|Other|0|||
160708225|NCT01482312|580311081|FG002|Period 1, 90 Minutes of Wear|Other|0|||
160708226|NCT01482312|580311079|FG000|Period 2, 90 Minutes of Wear|Other|1|||
160708227|NCT01482312|580311080|FG001|Period 2, 90 Minutes of Wear|Other|0|||
160708228|NCT01482312|580311081|FG002|Period 2, 90 Minutes of Wear|Other|0|||
160708229|NCT02652949|580311082|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
160708230|NCT02652949|580311082|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
160708231|NCT02652949|580311082|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
160708232|NCT02652949|580311082|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
160708233|NCT02652949|580311082|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
160708234|NCT02652949|580311082|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
160708235|NCT02652949|580311082|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
160708236|NCT02652949|580311082|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
160708237|NCT02652949|580311082|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
160708238|NCT02652949|580311082|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
160708239|NCT02652949|580311082|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
160708240|NCT02652949|580311082|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
160708241|NCT02652949|580311082|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
160708242|NCT02652949|580311082|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
160708243|NCT02652949|580311082|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
160708244|NCT02652949|580311082|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
160708245|NCT02652949|580311082|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
160708246|NCT05199090|580311083|FG000|Overall Study|Adverse Event|1|||
160708247|NCT05199090|580311084|FG001|Overall Study|Adverse Event|4|||
160708248|NCT05199090|580311085|FG002|Overall Study|Adverse Event|0|||
160708249|NCT05199090|580311086|FG003|Overall Study|Adverse Event|0|||
160708250|NCT05199090|580311087|FG004|Overall Study|Adverse Event|0|||
160708251|NCT05199090|580311088|FG005|Overall Study|Adverse Event|0|||
160708252|NCT05199090|580311083|FG000|Overall Study|Lost to Follow-up|1|||
160708253|NCT05199090|580311084|FG001|Overall Study|Lost to Follow-up|0|||
160708254|NCT05199090|580311085|FG002|Overall Study|Lost to Follow-up|1|||
160708255|NCT05199090|580311086|FG003|Overall Study|Lost to Follow-up|4|||
160708256|NCT05199090|580311087|FG004|Overall Study|Lost to Follow-up|0|||
160708257|NCT05199090|580311088|FG005|Overall Study|Lost to Follow-up|5|||
160708258|NCT05199090|580311083|FG000|Overall Study|Physician Decision|0|||
160708259|NCT05199090|580311084|FG001|Overall Study|Physician Decision|0|||
160708260|NCT05199090|580311085|FG002|Overall Study|Physician Decision|0|||
160708261|NCT05199090|580311086|FG003|Overall Study|Physician Decision|0|||
160708262|NCT05199090|580311087|FG004|Overall Study|Physician Decision|0|||
160708263|NCT05199090|580311088|FG005|Overall Study|Physician Decision|1|||
160708264|NCT05199090|580311083|FG000|Overall Study|Study terminated by sponsor|0|||
160708265|NCT05199090|580311084|FG001|Overall Study|Study terminated by sponsor|6|||
160708266|NCT05199090|580311085|FG002|Overall Study|Study terminated by sponsor|0|||
160708267|NCT05199090|580311086|FG003|Overall Study|Study terminated by sponsor|0|||
160708268|NCT05199090|580311087|FG004|Overall Study|Study terminated by sponsor|0|||
160708269|NCT05199090|580311088|FG005|Overall Study|Study terminated by sponsor|5|||
160708270|NCT05199090|580311083|FG000|Overall Study|Subject decision|0|||
160708271|NCT05199090|580311084|FG001|Overall Study|Subject decision|4|||
160708272|NCT05199090|580311085|FG002|Overall Study|Subject decision|0|||
160708273|NCT05199090|580311086|FG003|Overall Study|Subject decision|2|||
160708274|NCT05199090|580311087|FG004|Overall Study|Subject decision|5|||
160708275|NCT05199090|580311088|FG005|Overall Study|Subject decision|2|||
160708276|NCT04324021|580311093|FG000|Overall Study|Adverse Event|1|||
160708277|NCT04324021|580311094|FG001|Overall Study|Adverse Event|0|||
160708278|NCT04324021|580311095|FG002|Overall Study|Adverse Event|0|||
160708279|NCT04324021|580311093|FG000|Overall Study|Lack of Efficacy|0|||
160708280|NCT04324021|580311094|FG001|Overall Study|Lack of Efficacy|0|||
160708281|NCT04324021|580311095|FG002|Overall Study|Lack of Efficacy|1|||
160708282|NCT04324021|580311093|FG000|Overall Study|Death|1|||
160708283|NCT04324021|580311094|FG001|Overall Study|Death|1|||
160708284|NCT04324021|580311095|FG002|Overall Study|Death|0|||
160708285|NCT01277211|580311096|FG000|Overall Study|Adverse Event|60|||
160708286|NCT01277211|580311097|FG001|Overall Study|Adverse Event|22|||
160708287|NCT01277211|580311096|FG000|Overall Study|Pregnancy|9|||
160708288|NCT01277211|580311097|FG001|Overall Study|Pregnancy|4|||
160708289|NCT01277211|580311096|FG000|Overall Study|Lost to Follow-up|14|||
160708290|NCT01277211|580311097|FG001|Overall Study|Lost to Follow-up|9|||
160708291|NCT01277211|580311096|FG000|Overall Study|Did not wish to continue|17|||
160708292|NCT01277211|580311097|FG001|Overall Study|Did not wish to continue|0|||
160708293|NCT01277211|580311096|FG000|Overall Study|Withdrew Consent|9|||
160708294|NCT01277211|580311097|FG001|Overall Study|Withdrew Consent|9|||
160708295|NCT01277211|580311096|FG000|Overall Study|Non-compliance with protocol|13|||
160708296|NCT01277211|580311097|FG001|Overall Study|Non-compliance with protocol|4|||
160708297|NCT01277211|580311096|FG000|Overall Study|Did not meet protocol eligibility|1|||
160708298|NCT01277211|580311097|FG001|Overall Study|Did not meet protocol eligibility|0|||
160708299|NCT01277211|580311096|FG000|Overall Study|Administrative|3|||
160708300|NCT01277211|580311097|FG001|Overall Study|Administrative|0|||
160708301|NCT01277211|580311096|FG000|Overall Study|Pregnancy wish|0|||
160708302|NCT01277211|580311097|FG001|Overall Study|Pregnancy wish|2|||
160708303|NCT01277211|580311096|FG000|Overall Study|Discontinued prior to treatment|24|||
160708304|NCT01277211|580311097|FG001|Overall Study|Discontinued prior to treatment|13|||
160708305|NCT04697069|580311098|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
160708306|NCT04697069|580311099|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
160708307|NCT04697069|580311098|FG000|Overall Study|Study termination|2|||
160708308|NCT04697069|580311099|FG001|Overall Study|Study termination|1|||
160708309|NCT05180227|580311100|FG000|Overall Study|Hypertension at screening|1|||
160708310|NCT05180227|580311100|FG000|Overall Study|Lost to Follow-up|1|||
160708311|NCT01098487|580311101|FG000|Overall Study|Adverse Event|22|||
160708312|NCT01098487|580311101|FG000|Overall Study|Lack of Efficacy|11|||
160708313|NCT01098487|580311101|FG000|Overall Study|Withdrawal by Subject|7|||
160708314|NCT01098487|580311101|FG000|Overall Study|Lost to Follow-up|3|||
160708315|NCT01098487|580311101|FG000|Overall Study|Physician Decision|1|||
160708316|NCT03301623|580311110|FG000|Overall Study|Death|3|||
160708317|NCT03301623|580311111|FG001|Overall Study|Death|1|||
160708318|NCT03301623|580311110|FG000|Overall Study|Withdrawal by Subject|11|||
160708319|NCT03301623|580311111|FG001|Overall Study|Withdrawal by Subject|13|||
160708320|NCT03301623|580311110|FG000|Overall Study|Lost to Follow-up|3|||
160708321|NCT03301623|580311111|FG001|Overall Study|Lost to Follow-up|1|||
160708322|NCT02516553|580311112|FG000|Overall Study|Progressive disease|2|||
160708323|NCT02516553|580311113|FG001|Overall Study|Progressive disease|2|||
160708324|NCT02516553|580311114|FG002|Overall Study|Progressive disease|3|||
160708325|NCT02516553|580311115|FG003|Overall Study|Progressive disease|5|||
160708326|NCT02516553|580311116|FG004|Overall Study|Progressive disease|3|||
160708327|NCT02516553|580311117|FG005|Overall Study|Progressive disease|0|||
160708328|NCT02516553|580311118|FG006|Overall Study|Progressive disease|5|||
160708329|NCT02516553|580311119|FG007|Overall Study|Progressive disease|5|||
160708330|NCT02516553|580311120|FG008|Overall Study|Progressive disease|11|||
160708331|NCT02516553|580311121|FG009|Overall Study|Progressive disease|3|||
160708332|NCT02516553|580311122|FG010|Overall Study|Progressive disease|10|||
160708333|NCT02516553|580311123|FG011|Overall Study|Progressive disease|8|||
160708334|NCT02516553|580311124|FG012|Overall Study|Progressive disease|8|||
160708335|NCT02516553|580311125|FG013|Overall Study|Progressive disease|2|||
160708336|NCT02516553|580311126|FG014|Overall Study|Progressive disease|2|||
160708337|NCT02516553|580311127|FG015|Overall Study|Progressive disease|2|||
160708338|NCT02516553|580311128|FG016|Overall Study|Progressive disease|1|||
160708339|NCT02516553|580311129|FG017|Overall Study|Progressive disease|9|||
160708340|NCT02516553|580311130|FG018|Overall Study|Progressive disease|12|||
160708341|NCT02516553|580311131|FG019|Overall Study|Progressive disease|7|||
160708342|NCT02516553|580311132|FG020|Overall Study|Progressive disease|16|||
160708343|NCT02516553|580311133|FG021|Overall Study|Progressive disease|18|||
160708344|NCT02516553|580311112|FG000|Overall Study|Dose limiting toxicity|0|||
160708345|NCT02516553|580311113|FG001|Overall Study|Dose limiting toxicity|0|||
160708346|NCT02516553|580311114|FG002|Overall Study|Dose limiting toxicity|0|||
160708347|NCT02516553|580311115|FG003|Overall Study|Dose limiting toxicity|0|||
160708348|NCT02516553|580311116|FG004|Overall Study|Dose limiting toxicity|3|||
160708349|NCT02516553|580311117|FG005|Overall Study|Dose limiting toxicity|1|||
160708350|NCT02516553|580311118|FG006|Overall Study|Dose limiting toxicity|1|||
160708351|NCT02516553|580311119|FG007|Overall Study|Dose limiting toxicity|0|||
160708352|NCT02516553|580311120|FG008|Overall Study|Dose limiting toxicity|1|||
160708353|NCT02516553|580311121|FG009|Overall Study|Dose limiting toxicity|0|||
160708354|NCT02516553|580311122|FG010|Overall Study|Dose limiting toxicity|0|||
160708355|NCT02516553|580311123|FG011|Overall Study|Dose limiting toxicity|1|||
160708356|NCT02516553|580311124|FG012|Overall Study|Dose limiting toxicity|0|||
160708357|NCT02516553|580311125|FG013|Overall Study|Dose limiting toxicity|1|||
160708358|NCT02516553|580311126|FG014|Overall Study|Dose limiting toxicity|0|||
160708359|NCT02516553|580311127|FG015|Overall Study|Dose limiting toxicity|0|||
160708360|NCT02516553|580311128|FG016|Overall Study|Dose limiting toxicity|1|||
160708361|NCT02516553|580311129|FG017|Overall Study|Dose limiting toxicity|1|||
160708362|NCT02516553|580311130|FG018|Overall Study|Dose limiting toxicity|0|||
160708363|NCT02516553|580311131|FG019|Overall Study|Dose limiting toxicity|2|||
160708364|NCT02516553|580311132|FG020|Overall Study|Dose limiting toxicity|0|||
160708365|NCT02516553|580311133|FG021|Overall Study|Dose limiting toxicity|0|||
160708366|NCT02516553|580311112|FG000|Overall Study|Other Adverse Events|0|||
160708367|NCT02516553|580311113|FG001|Overall Study|Other Adverse Events|0|||
160708368|NCT02516553|580311114|FG002|Overall Study|Other Adverse Events|0|||
160708369|NCT02516553|580311115|FG003|Overall Study|Other Adverse Events|1|||
160708370|NCT02516553|580311116|FG004|Overall Study|Other Adverse Events|0|||
160708371|NCT02516553|580311117|FG005|Overall Study|Other Adverse Events|1|||
160708372|NCT02516553|580311118|FG006|Overall Study|Other Adverse Events|0|||
160708373|NCT02516553|580311119|FG007|Overall Study|Other Adverse Events|0|||
160708374|NCT02516553|580311120|FG008|Overall Study|Other Adverse Events|0|||
160708375|NCT02516553|580311121|FG009|Overall Study|Other Adverse Events|1|||
160708376|NCT02516553|580311122|FG010|Overall Study|Other Adverse Events|3|||
160708377|NCT02516553|580311123|FG011|Overall Study|Other Adverse Events|2|||
160708378|NCT02516553|580311124|FG012|Overall Study|Other Adverse Events|0|||
160708379|NCT02516553|580311125|FG013|Overall Study|Other Adverse Events|1|||
160708380|NCT02516553|580311126|FG014|Overall Study|Other Adverse Events|0|||
160708381|NCT02516553|580311127|FG015|Overall Study|Other Adverse Events|0|||
160708382|NCT02516553|580311128|FG016|Overall Study|Other Adverse Events|0|||
160708383|NCT02516553|580311129|FG017|Overall Study|Other Adverse Events|2|||
160708384|NCT02516553|580311130|FG018|Overall Study|Other Adverse Events|1|||
160708385|NCT02516553|580311131|FG019|Overall Study|Other Adverse Events|2|||
160708386|NCT02516553|580311132|FG020|Overall Study|Other Adverse Events|2|||
160708387|NCT02516553|580311133|FG021|Overall Study|Other Adverse Events|1|||
160708388|NCT02516553|580311112|FG000|Overall Study|Refused to continue trial medication|0|||
160708389|NCT02516553|580311113|FG001|Overall Study|Refused to continue trial medication|0|||
160708390|NCT02516553|580311114|FG002|Overall Study|Refused to continue trial medication|0|||
160708391|NCT02516553|580311115|FG003|Overall Study|Refused to continue trial medication|0|||
160708392|NCT02516553|580311116|FG004|Overall Study|Refused to continue trial medication|0|||
160708393|NCT02516553|580311117|FG005|Overall Study|Refused to continue trial medication|0|||
160708394|NCT02516553|580311118|FG006|Overall Study|Refused to continue trial medication|0|||
160708395|NCT02516553|580311119|FG007|Overall Study|Refused to continue trial medication|0|||
160708396|NCT02516553|580311120|FG008|Overall Study|Refused to continue trial medication|0|||
160708397|NCT02516553|580311121|FG009|Overall Study|Refused to continue trial medication|0|||
160708398|NCT02516553|580311122|FG010|Overall Study|Refused to continue trial medication|1|||
160708399|NCT02516553|580311123|FG011|Overall Study|Refused to continue trial medication|0|||
160708400|NCT02516553|580311124|FG012|Overall Study|Refused to continue trial medication|0|||
160708401|NCT02516553|580311125|FG013|Overall Study|Refused to continue trial medication|0|||
160708402|NCT02516553|580311126|FG014|Overall Study|Refused to continue trial medication|0|||
160708403|NCT02516553|580311127|FG015|Overall Study|Refused to continue trial medication|0|||
160708404|NCT02516553|580311128|FG016|Overall Study|Refused to continue trial medication|0|||
160708405|NCT02516553|580311129|FG017|Overall Study|Refused to continue trial medication|0|||
160708406|NCT02516553|580311130|FG018|Overall Study|Refused to continue trial medication|1|||
160708407|NCT02516553|580311131|FG019|Overall Study|Refused to continue trial medication|0|||
160708408|NCT02516553|580311132|FG020|Overall Study|Refused to continue trial medication|0|||
160708409|NCT02516553|580311133|FG021|Overall Study|Refused to continue trial medication|1|||
160708410|NCT02516553|580311112|FG000|Overall Study|other reasons than listed|0|||
160708411|NCT02516553|580311113|FG001|Overall Study|other reasons than listed|0|||
160708412|NCT02516553|580311114|FG002|Overall Study|other reasons than listed|0|||
160708413|NCT02516553|580311115|FG003|Overall Study|other reasons than listed|0|||
160708414|NCT02516553|580311116|FG004|Overall Study|other reasons than listed|0|||
160708415|NCT02516553|580311117|FG005|Overall Study|other reasons than listed|0|||
160708416|NCT02516553|580311118|FG006|Overall Study|other reasons than listed|0|||
160708417|NCT02516553|580311119|FG007|Overall Study|other reasons than listed|1|||
160708418|NCT02516553|580311120|FG008|Overall Study|other reasons than listed|1|||
160708419|NCT02516553|580311121|FG009|Overall Study|other reasons than listed|0|||
160708420|NCT02516553|580311122|FG010|Overall Study|other reasons than listed|1|||
160708421|NCT02516553|580311123|FG011|Overall Study|other reasons than listed|1|||
160708422|NCT02516553|580311124|FG012|Overall Study|other reasons than listed|0|||
160708423|NCT02516553|580311125|FG013|Overall Study|other reasons than listed|0|||
160708424|NCT02516553|580311126|FG014|Overall Study|other reasons than listed|0|||
160708425|NCT02516553|580311127|FG015|Overall Study|other reasons than listed|0|||
160708426|NCT02516553|580311128|FG016|Overall Study|other reasons than listed|0|||
160708427|NCT02516553|580311129|FG017|Overall Study|other reasons than listed|0|||
160708428|NCT02516553|580311130|FG018|Overall Study|other reasons than listed|0|||
160708429|NCT02516553|580311131|FG019|Overall Study|other reasons than listed|0|||
160708430|NCT02516553|580311132|FG020|Overall Study|other reasons than listed|2|||
160708431|NCT02516553|580311133|FG021|Overall Study|other reasons than listed|2|||
160708432|NCT04614246|580311135|FG000|Overall Study|Adverse Event|0|||
160708433|NCT04614246|580311136|FG001|Overall Study|Adverse Event|1|||
160708434|NCT04614246|580311137|FG002|Overall Study|Adverse Event|1|||
160708435|NCT04614246|580311138|FG003|Overall Study|Adverse Event|2|||
160708436|NCT04614246|580311139|FG004|Overall Study|Adverse Event|1|||
160708437|NCT04614246|580311135|FG000|Overall Study|Lost to Follow-up|0|||
160708438|NCT04614246|580311136|FG001|Overall Study|Lost to Follow-up|1|||
160708439|NCT04614246|580311137|FG002|Overall Study|Lost to Follow-up|0|||
160708440|NCT04614246|580311138|FG003|Overall Study|Lost to Follow-up|1|||
160708441|NCT04614246|580311139|FG004|Overall Study|Lost to Follow-up|3|||
160708442|NCT04614246|580311135|FG000|Overall Study|Other reason|0|||
160708443|NCT04614246|580311136|FG001|Overall Study|Other reason|1|||
160708444|NCT04614246|580311137|FG002|Overall Study|Other reason|2|||
160708445|NCT04614246|580311138|FG003|Overall Study|Other reason|0|||
160708446|NCT04614246|580311139|FG004|Overall Study|Other reason|0|||
160708447|NCT04614246|580311135|FG000|Overall Study|Withdrawal by Subject|4|||
160708448|NCT04614246|580311136|FG001|Overall Study|Withdrawal by Subject|2|||
160708449|NCT04614246|580311137|FG002|Overall Study|Withdrawal by Subject|4|||
160708450|NCT04614246|580311138|FG003|Overall Study|Withdrawal by Subject|3|||
160708451|NCT04614246|580311139|FG004|Overall Study|Withdrawal by Subject|4|||
160708452|NCT04614246|580311135|FG000|Overall Study|Physician Decision|0|||
160708453|NCT04614246|580311136|FG001|Overall Study|Physician Decision|2|||
160708454|NCT04614246|580311137|FG002|Overall Study|Physician Decision|1|||
160708455|NCT04614246|580311138|FG003|Overall Study|Physician Decision|0|||
160708456|NCT04614246|580311139|FG004|Overall Study|Physician Decision|0|||
160708457|NCT04614246|580311135|FG000|Overall Study|Study terminated by sponsor|10|||
160708458|NCT04614246|580311136|FG001|Overall Study|Study terminated by sponsor|15|||
160708459|NCT04614246|580311137|FG002|Overall Study|Study terminated by sponsor|12|||
160708460|NCT04614246|580311138|FG003|Overall Study|Study terminated by sponsor|13|||
160708461|NCT04614246|580311139|FG004|Overall Study|Study terminated by sponsor|9|||
160708462|NCT04614246|580311135|FG000|Overall Study|Pregnancy|2|||
160708463|NCT04614246|580311136|FG001|Overall Study|Pregnancy|0|||
160708464|NCT04614246|580311137|FG002|Overall Study|Pregnancy|1|||
160708465|NCT04614246|580311138|FG003|Overall Study|Pregnancy|0|||
160708466|NCT04614246|580311139|FG004|Overall Study|Pregnancy|0|||
160708467|NCT02185053|580311140|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
160708468|NCT02185053|580311141|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
160708469|NCT02185053|580311142|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
160708470|NCT02185053|580311140|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
160708471|NCT02185053|580311141|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
160708472|NCT02185053|580311142|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
160708473|NCT02185053|580311140|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
160708474|NCT02185053|580311141|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
160708475|NCT02185053|580311142|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
160708476|NCT02185053|580311140|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
160708477|NCT02185053|580311141|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
160708478|NCT02185053|580311142|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
160708479|NCT02185053|580311140|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
160708480|NCT02185053|580311141|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
160708481|NCT02185053|580311142|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
160708482|NCT02185053|580311140|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
160708483|NCT02185053|580311141|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
160708484|NCT02185053|580311142|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
160708485|NCT02185053|580311140|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
160708486|NCT02185053|580311141|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
160708487|NCT02185053|580311142|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
160708488|NCT02185053|580311140|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
160708489|NCT02185053|580311141|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
160708490|NCT02185053|580311142|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
160708491|NCT02521376|580311150|FG000|Overall Study|Enrolled, But Not Treated|1|||
160708492|NCT02521376|580311151|FG001|Overall Study|Enrolled, But Not Treated|0|||
160708493|NCT02521376|580311152|FG002|Overall Study|Enrolled, But Not Treated|0|||
160708494|NCT02521376|580311153|FG003|Overall Study|Enrolled, But Not Treated|0|||
160708495|NCT00340678|580311154|FG000|Overall Study|Lost to Follow-up|1|||
160708496|NCT00340678|580311155|FG001|Overall Study|Lost to Follow-up|0|||
160708497|NCT00340678|580311156|FG002|Overall Study|Lost to Follow-up|0|||
160708498|NCT00340678|580311157|FG003|Overall Study|Lost to Follow-up|0|||
160708499|NCT01653912|580311158|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
160708500|NCT01653912|580311159|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
160708501|NCT01653912|580311160|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
160708502|NCT01653912|580311161|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
160708503|NCT01653912|580311162|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
160708504|NCT01653912|580311163|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
160708505|NCT01653912|580311158|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
160708506|NCT01653912|580311159|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
160708507|NCT01653912|580311160|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
160708508|NCT01653912|580311161|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
160708509|NCT01653912|580311162|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
160708510|NCT01653912|580311163|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
160708511|NCT01653912|580311158|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
160708512|NCT01653912|580311159|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
160708513|NCT01653912|580311160|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
160708514|NCT01653912|580311161|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
160708515|NCT01653912|580311162|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
160708516|NCT01653912|580311163|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
160708517|NCT01653912|580311158|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
160708518|NCT01653912|580311159|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
160708519|NCT01653912|580311160|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
160708520|NCT01653912|580311161|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
160708521|NCT01653912|580311162|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
160708522|NCT01653912|580311163|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
160708523|NCT01653912|580311158|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
160708524|NCT01653912|580311159|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
160708525|NCT01653912|580311160|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
160708526|NCT01653912|580311161|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
160708527|NCT01653912|580311162|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
160708528|NCT01653912|580311163|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
160708529|NCT01653912|580311158|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
160708530|NCT01653912|580311159|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
160708531|NCT01653912|580311160|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
160708532|NCT01653912|580311161|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
160708533|NCT01653912|580311162|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
160708534|NCT01653912|580311163|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
160708535|NCT01653912|580311158|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
160708536|NCT01653912|580311159|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
160708537|NCT01653912|580311160|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
160708538|NCT01653912|580311161|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
160708539|NCT01653912|580311162|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
160708540|NCT01653912|580311163|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
160708541|NCT01987479|580311164|FG000|Overall Study|Protocol Violation|1|||
160708542|NCT01987479|580311164|FG000|Overall Study|Physician Decision|2|||
160708543|NCT01987479|580311164|FG000|Overall Study|Participant/legal guardian decision|1|||
160708544|NCT01987479|580311164|FG000|Overall Study|Other|5|||
160708545|NCT01987479|580311164|FG000|Overall Study|Lost to Follow-up|1|||
160708546|NCT01987479|580311164|FG000|Overall Study|Adverse Event|7|||
160708547|NCT01954745|580311165|FG000|Overall Study|Radiological Progression|11|||
160708548|NCT01954745|580311165|FG000|Overall Study|Clinical Progression|5|||
160708549|NCT01954745|580311165|FG000|Overall Study|Adverse Event|2|||
160708550|NCT01954745|580311165|FG000|Overall Study|Death|1|||
160708551|NCT05314816|580311166|FG000|Overall Study|Lost to Follow-up|5|||
160708552|NCT05314816|580311167|FG001|Overall Study|Lost to Follow-up|0|||
160708553|NCT05314816|580311168|FG002|Overall Study|Lost to Follow-up|1|||
160708554|NCT05314816|580311166|FG000|Overall Study|Protocol Violation|13|||
160708555|NCT05314816|580311167|FG001|Overall Study|Protocol Violation|8|||
160708556|NCT05314816|580311168|FG002|Overall Study|Protocol Violation|0|||
160708557|NCT01059786|580313211|FG000|Overall Study|Did not receive 6 cycles.|0|||
160708558|NCT01059786|580313212|FG001|Overall Study|Did not receive 6 cycles.|0|||
160708559|NCT01059786|580313213|FG002|Overall Study|Did not receive 6 cycles.|4|||
160708560|NCT01059786|580313214|FG003|Overall Study|Did not receive 6 cycles.|1|||
160708561|NCT01059786|580313215|FG004|Overall Study|Did not receive 6 cycles.|0|||
160708562|NCT04205812|580313216|FG000|Randomized Treatment Period|Ongoing|28|||
160708563|NCT04205812|580313217|FG001|Randomized Treatment Period|Ongoing|138|||
160708564|NCT04205812|580313216|FG000|Randomized Treatment Period|Death|94|||
160708565|NCT04205812|580313217|FG001|Randomized Treatment Period|Death|226|||
160708566|NCT04205812|580313216|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
160708567|NCT04205812|580313217|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
160708568|NCT04205812|580313216|FG000|Randomized Treatment Period|Physician Decision|1|||
160708569|NCT04205812|580313217|FG001|Randomized Treatment Period|Physician Decision|4|||
160708570|NCT04205812|580313216|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
160708571|NCT04205812|580313217|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
160708572|NCT04205812|580313216|FG000|Randomized Treatment Period|Progressive Disease|0|||
160708573|NCT04205812|580313217|FG001|Randomized Treatment Period|Progressive Disease|1|||
160708574|NCT04205812|580313216|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
160708575|NCT04205812|580313217|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
160708576|NCT04205812|580313216|FG000|Monotherapy Treatment Period|Ongoing|17|||
160708577|NCT04205812|580313217|FG001|Monotherapy Treatment Period|Ongoing|0|||
160708578|NCT04205812|580313216|FG000|Monotherapy Treatment Period|Death|39|||
160708579|NCT04205812|580313217|FG001|Monotherapy Treatment Period|Death|0|||
160708580|NCT04205812|580313216|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
160708581|NCT04205812|580313217|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
160708582|NCT04205812|580313216|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
160708583|NCT04205812|580313217|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
160708584|NCT04559347|580313218|FG000|Overall Study|Death|1|||
160708585|NCT04559347|580313219|FG001|Overall Study|Death|0|||
160708586|NCT04559347|580313218|FG000|Overall Study|Thoracotomy conversion|1|||
160708587|NCT04559347|580313219|FG001|Overall Study|Thoracotomy conversion|1|||
160708588|NCT04559347|580313218|FG000|Overall Study|Provider unavailable|2|||
160708589|NCT04559347|580313219|FG001|Overall Study|Provider unavailable|1|||
160708590|NCT04559347|580313218|FG000|Overall Study|Other|2|||
160708591|NCT04559347|580313219|FG001|Overall Study|Other|1|||
160708592|NCT00371033|580313220|FG000|Overall Study|Lost to Follow-up|3|||
160708593|NCT00371033|580313221|FG001|Overall Study|Lost to Follow-up|2|||
160708594|NCT00371033|580313220|FG000|Overall Study|No longer interested|2|||
160708595|NCT00371033|580313221|FG001|Overall Study|No longer interested|0|||
160708596|NCT00371033|580313220|FG000|Overall Study|Uknown|3|||
160708597|NCT00371033|580313221|FG001|Overall Study|Uknown|1|||
160708598|NCT05929651|580313228|FG000|Overall Study|Protocol Deviation|1|||
160708599|NCT05929651|580313228|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
160708600|NCT05026177|580313229|FG000|Overall Study|Adverse Event|33|||
160708601|NCT05026177|580313230|FG001|Overall Study|Adverse Event|33|||
160708602|NCT05026177|580313231|FG002|Overall Study|Adverse Event|17|||
160708603|NCT05026177|580313229|FG000|Overall Study|Lost to Follow-up|7|||
160708604|NCT05026177|580313230|FG001|Overall Study|Lost to Follow-up|6|||
160708605|NCT05026177|580313231|FG002|Overall Study|Lost to Follow-up|8|||
160708606|NCT05026177|580313229|FG000|Overall Study|Noncompliance with study drug|6|||
160708607|NCT05026177|580313230|FG001|Overall Study|Noncompliance with study drug|2|||
160708608|NCT05026177|580313231|FG002|Overall Study|Noncompliance with study drug|1|||
160708609|NCT05026177|580313229|FG000|Overall Study|Physician Decision|4|||
160708610|NCT05026177|580313230|FG001|Overall Study|Physician Decision|1|||
160708611|NCT05026177|580313231|FG002|Overall Study|Physician Decision|0|||
160708612|NCT05026177|580313229|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
160708613|NCT05026177|580313230|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
160708614|NCT05026177|580313231|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
160708615|NCT05026177|580313229|FG000|Overall Study|Withdrawal by Subject|53|||
160708616|NCT05026177|580313230|FG001|Overall Study|Withdrawal by Subject|51|||
160708617|NCT05026177|580313231|FG002|Overall Study|Withdrawal by Subject|55|||
160708618|NCT05026177|580313229|FG000|Overall Study|Protocol Violation|0|||
160708619|NCT05026177|580313230|FG001|Overall Study|Protocol Violation|1|||
160708620|NCT05026177|580313231|FG002|Overall Study|Protocol Violation|0|||
160708621|NCT05026177|580313229|FG000|Overall Study|Study terminated by sponsor|70|||
160708622|NCT05026177|580313230|FG001|Overall Study|Study terminated by sponsor|74|||
160708623|NCT05026177|580313231|FG002|Overall Study|Study terminated by sponsor|67|||
160708624|NCT05026177|580313229|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
160708625|NCT05026177|580313230|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
160708626|NCT05026177|580313231|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
160708627|NCT05026177|580313229|FG000|Overall Study|Starting alternative treatment|0|||
160708628|NCT05026177|580313230|FG001|Overall Study|Starting alternative treatment|1|||
160708629|NCT05026177|580313231|FG002|Overall Study|Starting alternative treatment|1|||
160708630|NCT05026177|580313229|FG000|Overall Study|Noncompliance with study procedures|0|||
160708631|NCT05026177|580313230|FG001|Overall Study|Noncompliance with study procedures|1|||
160708632|NCT05026177|580313231|FG002|Overall Study|Noncompliance with study procedures|1|||
160708633|NCT05026177|580313229|FG000|Overall Study|Met stopping criteria|0|||
160708634|NCT05026177|580313230|FG001|Overall Study|Met stopping criteria|0|||
160708635|NCT05026177|580313231|FG002|Overall Study|Met stopping criteria|1|||
160708636|NCT05026177|580313229|FG000|Overall Study|Health issues preventing continuation|0|||
160708637|NCT05026177|580313230|FG001|Overall Study|Health issues preventing continuation|0|||
160708638|NCT05026177|580313231|FG002|Overall Study|Health issues preventing continuation|1|||
160708639|NCT05026177|580313229|FG000|Overall Study|Randomized in error, not treated|0|||
160708640|NCT05026177|580313230|FG001|Overall Study|Randomized in error, not treated|0|||
160708641|NCT05026177|580313231|FG002|Overall Study|Randomized in error, not treated|2|||
160708642|NCT02717455|580313234|FG000|Overall Study|Adverse Event|1|||
160708643|NCT02717455|580313235|FG001|Overall Study|Adverse Event|0|||
160708644|NCT02717455|580313236|FG002|Overall Study|Adverse Event|0|||
160708645|NCT02717455|580313237|FG003|Overall Study|Adverse Event|2|||
160708646|NCT02717455|580313238|FG004|Overall Study|Adverse Event|2|||
160708647|NCT02717455|580313239|FG005|Overall Study|Adverse Event|2|||
160708648|NCT02717455|580313234|FG000|Overall Study|Withdrawal by Subject|1|||
160708649|NCT02717455|580313235|FG001|Overall Study|Withdrawal by Subject|1|||
160708650|NCT02717455|580313236|FG002|Overall Study|Withdrawal by Subject|0|||
160708651|NCT02717455|580313237|FG003|Overall Study|Withdrawal by Subject|2|||
160708652|NCT02717455|580313238|FG004|Overall Study|Withdrawal by Subject|2|||
160708653|NCT02717455|580313239|FG005|Overall Study|Withdrawal by Subject|1|||
160708654|NCT02717455|580313234|FG000|Overall Study|Death|1|||
160708655|NCT02717455|580313235|FG001|Overall Study|Death|0|||
160708656|NCT02717455|580313236|FG002|Overall Study|Death|0|||
160708657|NCT02717455|580313237|FG003|Overall Study|Death|0|||
160708658|NCT02717455|580313238|FG004|Overall Study|Death|1|||
160708659|NCT02717455|580313239|FG005|Overall Study|Death|0|||
160708660|NCT02717455|580313234|FG000|Overall Study|Did not receive study drug|0|||
160708661|NCT02717455|580313235|FG001|Overall Study|Did not receive study drug|0|||
160708662|NCT02717455|580313236|FG002|Overall Study|Did not receive study drug|0|||
160708663|NCT02717455|580313237|FG003|Overall Study|Did not receive study drug|1|||
160708664|NCT02717455|580313238|FG004|Overall Study|Did not receive study drug|0|||
160708665|NCT02717455|580313239|FG005|Overall Study|Did not receive study drug|1|||
160708666|NCT02717455|580313234|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
160708667|NCT02717455|580313235|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
160708668|NCT02717455|580313236|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
160708669|NCT02717455|580313237|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
160708670|NCT02717455|580313238|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
160708671|NCT02717455|580313239|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
160708672|NCT02717455|580313234|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
160708673|NCT02717455|580313235|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
160708674|NCT02717455|580313236|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
160708675|NCT02717455|580313237|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
160708676|NCT02717455|580313238|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
160708677|NCT02717455|580313239|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
160708678|NCT01433055|580313240|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
160708679|NCT01433055|580313241|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
160708680|NCT01433055|580313240|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
160708681|NCT01433055|580313241|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
160708682|NCT00733005|580313247|FG000|Overall Study|Adverse Event|0|||
160708683|NCT00733005|580313248|FG001|Overall Study|Adverse Event|1|||
160708684|NCT00733005|580313247|FG000|Overall Study|Treatment Failure|0|||
160708685|NCT00733005|580313248|FG001|Overall Study|Treatment Failure|1|||
160708686|NCT00733005|580313247|FG000|Overall Study|Withdrawal by Subject|0|||
160708687|NCT00733005|580313248|FG001|Overall Study|Withdrawal by Subject|1|||
160708688|NCT00733005|580313247|FG000|Overall Study|Protocol Violation|2|||
160708689|NCT00733005|580313248|FG001|Overall Study|Protocol Violation|0|||
160708690|NCT05244122|580313255|FG000|Overall Study|Withdrawal by Subject|318|||
160708691|NCT05377749|580313260|FG000|3 Weeks|Lost to Follow-up|2|||
160708692|NCT05377749|580313261|FG001|3 Weeks|Lost to Follow-up|4|||
160708693|NCT05377749|580313260|FG000|3 Weeks|Withdrawal by Subject|1|||
160708694|NCT05377749|580313261|FG001|3 Weeks|Withdrawal by Subject|1|||
160708695|NCT05256134|580313264|FG000|Overall Study|Study Terminated by Sponsor|11|||
160708696|NCT05256134|580313265|FG001|Overall Study|Study Terminated by Sponsor|10|||
160708697|NCT05256134|580313264|FG000|Overall Study|Withdrawal by Subject|1|||
160708698|NCT05256134|580313265|FG001|Overall Study|Withdrawal by Subject|3|||
160708699|NCT00886015|580313272|FG000|Overall Study|Death|0|||
160708700|NCT00886015|580313273|FG001|Overall Study|Death|2|||
160708701|NCT02013817|580313274|FG000|Overall Study|Adverse Event|12|||
160708702|NCT02013817|580313274|FG000|Overall Study|Withdrawal by Subject|4|||
160708703|NCT02013817|580313274|FG000|Overall Study|Death|2|||
160708704|NCT02013817|580313274|FG000|Overall Study|Other|9|||
160708705|NCT01692626|580313275|FG000|Overall Study|Death|0|||
160708706|NCT01692626|580313276|FG001|Overall Study|Death|1|||
160708707|NCT01692626|580313275|FG000|Overall Study|Adverse Event|2|||
160708708|NCT01692626|580313276|FG001|Overall Study|Adverse Event|3|||
160708709|NCT01692626|580313275|FG000|Overall Study|Protocol Violation|1|||
160708710|NCT01692626|580313276|FG001|Overall Study|Protocol Violation|2|||
160708711|NCT01692626|580313275|FG000|Overall Study|Withdrawal by Subject|1|||
160708712|NCT01692626|580313276|FG001|Overall Study|Withdrawal by Subject|0|||
160708713|NCT00855894|580313277|FG000|Overall Study|Death|31|||
160708714|NCT00855894|580313277|FG000|Overall Study|Patient's decision|1|||
160708715|NCT00855894|580313277|FG000|Overall Study|Disease progression|1|||
160708716|NCT01145508|580313278|FG000|Overall Study|Adverse Event|1|||
160708717|NCT01145508|580313279|FG001|Overall Study|Adverse Event|0|||
160708718|NCT01145508|580313278|FG000|Overall Study|Death|1|||
160708719|NCT01145508|580313279|FG001|Overall Study|Death|0|||
160708720|NCT01145508|580313278|FG000|Overall Study|Physician Decision|2|||
160708721|NCT01145508|580313279|FG001|Overall Study|Physician Decision|1|||
160708722|NCT01145508|580313278|FG000|Overall Study|Never started treatment|1|||
160708723|NCT01145508|580313279|FG001|Overall Study|Never started treatment|1|||
160708724|NCT01611857|580313290|FG000|Overall Study|Withdrawal by Subject|0|||
160708725|NCT01611857|580313291|FG001|Overall Study|Withdrawal by Subject|2|||
160708726|NCT02439970|580313292|FG000|Overall Study|Study Terminated|2|||
160708727|NCT02439970|580313293|FG001|Overall Study|Study Terminated|3|||
160708728|NCT01121562|580313294|FG000|Overall Study|Objective progression or relapse|8|||
160708729|NCT01121562|580313294|FG000|Overall Study|Withdrawal by Subject|1|||
160708730|NCT01121562|580313294|FG000|Overall Study|Adverse Event|1|||
160708731|NCT01121562|580313294|FG000|Overall Study|Sponsor Decision|1|||
160708732|NCT01121562|580313294|FG000|Overall Study|Met study discontinuation criteria|1|||
160708733|NCT01495702|580313295|FG000|Randomized Phase|Randomized But Not Treated|1|||
160708734|NCT01495702|580313296|FG001|Randomized Phase|Randomized But Not Treated|4|||
160708735|NCT01495702|580313295|FG000|Randomized Phase|Adverse Event|2|||
160708736|NCT01495702|580313296|FG001|Randomized Phase|Adverse Event|2|||
160708737|NCT01495702|580313295|FG000|Randomized Phase|Death|1|||
160708738|NCT01495702|580313296|FG001|Randomized Phase|Death|0|||
160708739|NCT01495702|580313295|FG000|Randomized Phase|Lack of Efficacy|2|||
160708740|NCT01495702|580313296|FG001|Randomized Phase|Lack of Efficacy|0|||
160708741|NCT01495702|580313295|FG000|Randomized Phase|Investigators Discretion|2|||
160708742|NCT01495702|580313296|FG001|Randomized Phase|Investigators Discretion|0|||
160708743|NCT01495702|580313295|FG000|Randomized Phase|Withdrew Consent|10|||
160708744|NCT01495702|580313296|FG001|Randomized Phase|Withdrew Consent|18|||
160708745|NCT01495702|580313295|FG000|Randomized Phase|Lost to Follow-up|4|||
160708746|NCT01495702|580313296|FG001|Randomized Phase|Lost to Follow-up|3|||
160708747|NCT01495702|580313295|FG000|Randomized Phase|Participant Noncompliance|1|||
160708748|NCT01495702|580313296|FG001|Randomized Phase|Participant Noncompliance|0|||
160708749|NCT01495702|580313295|FG000|Randomized Phase|Protocol Violation|3|||
160708750|NCT01495702|580313296|FG001|Randomized Phase|Protocol Violation|1|||
160708751|NCT00616421|580313297|FG000|Overall Study|Withdrawal by Subject|9|||
160708752|NCT00616421|580313298|FG001|Overall Study|Withdrawal by Subject|11|||
160708753|NCT00616421|580313299|FG002|Overall Study|Withdrawal by Subject|8|||
160708754|NCT00616421|580313297|FG000|Overall Study|Lost to Follow-up|12|||
160708755|NCT00616421|580313298|FG001|Overall Study|Lost to Follow-up|26|||
160708756|NCT00616421|580313299|FG002|Overall Study|Lost to Follow-up|30|||
160708757|NCT00616421|580313297|FG000|Overall Study|Inappropriate enrollment|3|||
160708758|NCT00616421|580313298|FG001|Overall Study|Inappropriate enrollment|0|||
160708759|NCT00616421|580313299|FG002|Overall Study|Inappropriate enrollment|1|||
160708760|NCT00616421|580313297|FG000|Overall Study|Administrative reason|1|||
160708761|NCT00616421|580313298|FG001|Overall Study|Administrative reason|0|||
160708762|NCT00616421|580313299|FG002|Overall Study|Administrative reason|0|||
160708763|NCT00616421|580313297|FG000|Overall Study|Protocol Violation|0|||
160708764|NCT00616421|580313298|FG001|Overall Study|Protocol Violation|1|||
160708765|NCT00616421|580313299|FG002|Overall Study|Protocol Violation|2|||
160708766|NCT00616421|580313297|FG000|Overall Study|Unable to classify|1|||
160708767|NCT00616421|580313298|FG001|Overall Study|Unable to classify|0|||
160708768|NCT00616421|580313299|FG002|Overall Study|Unable to classify|0|||
160708769|NCT04152863|580313300|FG000|Overall Study|Death|13|||
160708770|NCT04152863|580313301|FG001|Overall Study|Death|12|||
160708771|NCT04152863|580313302|FG002|Overall Study|Death|7|||
160708772|NCT04152863|580313300|FG000|Overall Study|Physician Decision|1|||
160708773|NCT04152863|580313301|FG001|Overall Study|Physician Decision|1|||
160708774|NCT04152863|580313302|FG002|Overall Study|Physician Decision|1|||
160708775|NCT04152863|580313300|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
160708776|NCT04152863|580313301|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
160708777|NCT04152863|580313302|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
160708778|NCT04152863|580313300|FG000|Overall Study|Withdrawal by Subject|2|||
160708779|NCT04152863|580313301|FG001|Overall Study|Withdrawal by Subject|1|||
160708780|NCT04152863|580313302|FG002|Overall Study|Withdrawal by Subject|3|||
160708781|NCT01644617|580313306|FG000|Overall Study|Withdrawal by Subject|3|||
160708782|NCT01644617|580313307|FG001|Overall Study|Withdrawal by Subject|4|||
160708783|NCT01644617|580313308|FG002|Overall Study|Withdrawal by Subject|1|||
160708784|NCT01644617|580313306|FG000|Overall Study|Lost to Follow-up|0|||
160708785|NCT01644617|580313307|FG001|Overall Study|Lost to Follow-up|1|||
160708786|NCT01644617|580313308|FG002|Overall Study|Lost to Follow-up|0|||
160708787|NCT01644617|580313306|FG000|Overall Study|Adverse Event|3|||
160708788|NCT01644617|580313307|FG001|Overall Study|Adverse Event|0|||
160708789|NCT01644617|580313308|FG002|Overall Study|Adverse Event|6|||
160708790|NCT01807065|580313312|FG000|Overall Study|Receive no sip-T due to IV access|1|||
160708791|NCT01807065|580313313|FG001|Overall Study|Receive no sip-T due to IV access|1|||
160708792|NCT01699815|580313314|FG000|Overall Study|Protocol Violation|4|||
160708793|NCT01699815|580313315|FG001|Overall Study|Protocol Violation|7|||
160708794|NCT01699815|580313314|FG000|Overall Study|record could not be located|1|||
160708795|NCT01699815|580313315|FG001|Overall Study|record could not be located|0|||
160708796|NCT01699815|580313314|FG000|Overall Study|Adverse Event|0|||
160708797|NCT01699815|580313315|FG001|Overall Study|Adverse Event|1|||
160708798|NCT00699816|580313318|FG000|Overall Study|Protocol Violation|1|||
160708799|NCT00699816|580313319|FG001|Overall Study|Protocol Violation|3|||
160708800|NCT00560391|580313320|FG000|Overall Study|Still on treatment|0|||
160708801|NCT00560391|580313321|FG001|Overall Study|Still on treatment|0|||
160708802|NCT00560391|580313322|FG002|Overall Study|Still on treatment|0|||
160708803|NCT00560391|580313323|FG003|Overall Study|Still on treatment|1|||
160708804|NCT00560391|580313324|FG004|Overall Study|Still on treatment|2|||
160708805|NCT01895777|580313325|FG000|Overall Study|Adverse Event|1|||
160708806|NCT01895777|580313326|FG001|Overall Study|Adverse Event|2|||
160708807|NCT01895777|580313325|FG000|Overall Study|Lost to Follow-up|2|||
160708808|NCT01895777|580313326|FG001|Overall Study|Lost to Follow-up|0|||
160708809|NCT01895777|580313325|FG000|Overall Study|Not treated|1|||
160708810|NCT01895777|580313326|FG001|Overall Study|Not treated|0|||
160708811|NCT01895777|580313325|FG000|Overall Study|Other reasons|3|||
160708812|NCT01895777|580313326|FG001|Overall Study|Other reasons|2|||
160708813|NCT01895777|580313325|FG000|Overall Study|Non-compliance with the CTP|2|||
160708814|NCT01895777|580313326|FG001|Overall Study|Non-compliance with the CTP|1|||
160708815|NCT04223752|580313327|FG000|Overall Study|Participant enrolled in error|0|||
160708816|NCT04223752|580313328|FG001|Overall Study|Participant enrolled in error|0|||
160708817|NCT04223752|580313329|FG002|Overall Study|Participant enrolled in error|0|||
160708818|NCT04223752|580313330|FG003|Overall Study|Participant enrolled in error|0|||
160708819|NCT04223752|580313331|FG004|Overall Study|Participant enrolled in error|1|||
160708820|NCT04223752|580313327|FG000|Overall Study|Death|0|||
160708821|NCT04223752|580313328|FG001|Overall Study|Death|0|||
160708822|NCT04223752|580313329|FG002|Overall Study|Death|0|||
160708823|NCT04223752|580313330|FG003|Overall Study|Death|2|||
160708824|NCT04223752|580313331|FG004|Overall Study|Death|1|||
160708825|NCT05061420|580313332|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
160708826|NCT05061420|580313333|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
160708827|NCT05061420|580313334|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
160708828|NCT05061420|580313332|FG000|Overall Study|Progressive disease|11|||
160708829|NCT05061420|580313333|FG001|Overall Study|Progressive disease|15|||
160708830|NCT05061420|580313334|FG002|Overall Study|Progressive disease|14|||
160708831|NCT05061420|580313332|FG000|Overall Study|Withdrawal by Subject|2|||
160708832|NCT05061420|580313333|FG001|Overall Study|Withdrawal by Subject|0|||
160708833|NCT05061420|580313334|FG002|Overall Study|Withdrawal by Subject|1|||
160708834|NCT05061420|580313332|FG000|Overall Study|Not related to COVID-19|2|||
160708835|NCT05061420|580313333|FG001|Overall Study|Not related to COVID-19|0|||
160708836|NCT05061420|580313334|FG002|Overall Study|Not related to COVID-19|0|||
160708837|NCT01814553|580313335|FG000|Overall Study|PD per clinical progression|6|||
160708838|NCT01814553|580313336|FG001|Overall Study|PD per clinical progression|8|||
160708839|NCT01814553|580313335|FG000|Overall Study|Other Adverse Event|4|||
160708840|NCT01814553|580313336|FG001|Overall Study|Other Adverse Event|5|||
160708841|NCT01814553|580313335|FG000|Overall Study|Withdrawal by Subject|1|||
160708842|NCT01814553|580313336|FG001|Overall Study|Withdrawal by Subject|1|||
160708843|NCT01814553|580313335|FG000|Overall Study|Other than stated|7|||
160708844|NCT01814553|580313336|FG001|Overall Study|Other than stated|8|||
160708845|NCT03138655|580313340|FG000|Overall Study|Adverse Event|2|||
160708846|NCT03138655|580313341|FG001|Overall Study|Adverse Event|1|||
160708847|NCT03138655|580313342|FG002|Overall Study|Adverse Event|2|||
160708848|NCT03138655|580313343|FG003|Overall Study|Adverse Event|1|||
160708849|NCT03138655|580313344|FG004|Overall Study|Adverse Event|1|||
160708850|NCT03138655|580313345|FG005|Overall Study|Adverse Event|4|||
160708851|NCT03138655|580313346|FG006|Overall Study|Adverse Event|2|||
160708852|NCT03138655|580313347|FG007|Overall Study|Adverse Event|2|||
160708853|NCT03138655|580313340|FG000|Overall Study|Withdrawal by Subject|0|||
160708854|NCT03138655|580313341|FG001|Overall Study|Withdrawal by Subject|1|||
160708855|NCT03138655|580313342|FG002|Overall Study|Withdrawal by Subject|0|||
160708856|NCT03138655|580313343|FG003|Overall Study|Withdrawal by Subject|0|||
160708857|NCT03138655|580313344|FG004|Overall Study|Withdrawal by Subject|0|||
160708858|NCT03138655|580313345|FG005|Overall Study|Withdrawal by Subject|0|||
160708859|NCT03138655|580313346|FG006|Overall Study|Withdrawal by Subject|1|||
160708860|NCT03138655|580313347|FG007|Overall Study|Withdrawal by Subject|0|||
160708861|NCT03138655|580313340|FG000|Overall Study|Reason not Specified|1|||
160708862|NCT03138655|580313341|FG001|Overall Study|Reason not Specified|0|||
160708863|NCT03138655|580313342|FG002|Overall Study|Reason not Specified|0|||
160708864|NCT03138655|580313343|FG003|Overall Study|Reason not Specified|2|||
160708865|NCT03138655|580313344|FG004|Overall Study|Reason not Specified|1|||
160708866|NCT03138655|580313345|FG005|Overall Study|Reason not Specified|1|||
160708867|NCT03138655|580313346|FG006|Overall Study|Reason not Specified|0|||
160708868|NCT03138655|580313347|FG007|Overall Study|Reason not Specified|0|||
160708869|NCT04036110|580313353|FG000|Overall Study|Lost to Follow-up|3|||
160708870|NCT04036110|580313354|FG001|Overall Study|Lost to Follow-up|2|||
160708871|NCT04036110|580313355|FG002|Overall Study|Lost to Follow-up|1|||
160708872|NCT04036110|580313353|FG000|Overall Study|Study Suspended|4|||
160708873|NCT04036110|580313354|FG001|Overall Study|Study Suspended|5|||
160708874|NCT04036110|580313355|FG002|Overall Study|Study Suspended|1|||
160708875|NCT00534404|580313356|FG000|Overall Study|Death|0|||
160708876|NCT00534404|580313357|FG001|Overall Study|Death|0|||
160708877|NCT00534404|580313358|FG002|Overall Study|Death|2|||
160708878|NCT00534404|580313356|FG000|Overall Study|Withdrawal by Subject|8|||
160708879|NCT00534404|580313357|FG001|Overall Study|Withdrawal by Subject|2|||
160708880|NCT00534404|580313358|FG002|Overall Study|Withdrawal by Subject|38|||
160708881|NCT00534404|580313356|FG000|Overall Study|Removed by study staff|2|||
160708882|NCT00534404|580313357|FG001|Overall Study|Removed by study staff|3|||
160708883|NCT00534404|580313358|FG002|Overall Study|Removed by study staff|1|||
160708884|NCT00534404|580313356|FG000|Overall Study|Lost to Follow-up|170|||
160708885|NCT00534404|580313357|FG001|Overall Study|Lost to Follow-up|138|||
160708886|NCT00534404|580313358|FG002|Overall Study|Lost to Follow-up|201|||
160708887|NCT04759768|580313361|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
160708888|NCT04759768|580313362|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
160708889|NCT04759768|580313361|FG000|Washout (7 Days)|Physician Decision|0|||
160708890|NCT04759768|580313362|FG001|Washout (7 Days)|Physician Decision|1|||
160708891|NCT02996487|580313363|FG000|Overall Study|Lost to Follow-up|1|||
160708892|NCT02996487|580313364|FG001|Overall Study|Lost to Follow-up|1|||
160708893|NCT02996487|580313365|FG002|Overall Study|Lost to Follow-up|0|||
160708894|NCT02996487|580313363|FG000|Overall Study|Death|0|||
160708895|NCT02996487|580313364|FG001|Overall Study|Death|1|||
160708896|NCT02996487|580313365|FG002|Overall Study|Death|0|||
160708897|NCT02996487|580313363|FG000|Overall Study|Withdrawal by Subject|2|||
160708898|NCT02996487|580313364|FG001|Overall Study|Withdrawal by Subject|3|||
160708899|NCT02996487|580313365|FG002|Overall Study|Withdrawal by Subject|0|||
160708900|NCT02800642|580313366|FG000|Overall Study|Death|3|||
160708901|NCT02800642|580313366|FG000|Overall Study|Other|10|||
160708902|NCT02800642|580313366|FG000|Overall Study|Physician Decision|2|||
160708903|NCT02800642|580313366|FG000|Overall Study|Adverse Event|6|||
160708904|NCT02800642|580313366|FG000|Overall Study|Withdrawal by Subject|3|||
160708905|NCT02800642|580313366|FG000|Overall Study|Lost to Follow-up|1|||
160708906|NCT02027428|580313367|FG000|Induction|Never treated|7|||
160708907|NCT02027428|580313368|FG001|Induction|Never treated|0|||
160708908|NCT02027428|580313369|FG002|Induction|Never treated|0|||
160708909|NCT02027428|580313367|FG000|Induction|Progressive disease|77|||
160708910|NCT02027428|580313368|FG001|Induction|Progressive disease|0|||
160708911|NCT02027428|580313369|FG002|Induction|Progressive disease|0|||
160708912|NCT02027428|580313367|FG000|Induction|Adverse Event|51|||
160708913|NCT02027428|580313368|FG001|Induction|Adverse Event|0|||
160708914|NCT02027428|580313369|FG002|Induction|Adverse Event|0|||
160708915|NCT02027428|580313367|FG000|Induction|Withdrawal by Subject|22|||
160708916|NCT02027428|580313368|FG001|Induction|Withdrawal by Subject|0|||
160708917|NCT02027428|580313369|FG002|Induction|Withdrawal by Subject|0|||
160708918|NCT02027428|580313367|FG000|Induction|Death|21|||
160708919|NCT02027428|580313368|FG001|Induction|Death|0|||
160708920|NCT02027428|580313369|FG002|Induction|Death|0|||
160708921|NCT02027428|580313367|FG000|Induction|Symptomatic deterioration|16|||
160708922|NCT02027428|580313368|FG001|Induction|Symptomatic deterioration|0|||
160708923|NCT02027428|580313369|FG002|Induction|Symptomatic deterioration|0|||
160708924|NCT02027428|580313367|FG000|Induction|Study terminated by sponsor|12|||
160708925|NCT02027428|580313368|FG001|Induction|Study terminated by sponsor|0|||
160708926|NCT02027428|580313369|FG002|Induction|Study terminated by sponsor|0|||
160708927|NCT02027428|580313367|FG000|Induction|Protocol Violation|1|||
160708928|NCT02027428|580313368|FG001|Induction|Protocol Violation|0|||
160708929|NCT02027428|580313369|FG002|Induction|Protocol Violation|0|||
160708930|NCT02027428|580313367|FG000|Induction|Miscellaneous|14|||
160708931|NCT02027428|580313368|FG001|Induction|Miscellaneous|0|||
160708932|NCT02027428|580313369|FG002|Induction|Miscellaneous|0|||
160708933|NCT02027428|580313367|FG000|Induction|Induction Treatment Ongoing|4|||
160708934|NCT02027428|580313368|FG001|Induction|Induction Treatment Ongoing|0|||
160708935|NCT02027428|580313369|FG002|Induction|Induction Treatment Ongoing|0|||
160708936|NCT02027428|580313367|FG000|Maintenance|Death|0|||
160708937|NCT02027428|580313368|FG001|Maintenance|Death|3|||
160708938|NCT02027428|580313369|FG002|Maintenance|Death|2|||
160708939|NCT02027428|580313367|FG000|Maintenance|Adverse Event|0|||
160708940|NCT02027428|580313368|FG001|Maintenance|Adverse Event|21|||
160708941|NCT02027428|580313369|FG002|Maintenance|Adverse Event|1|||
160708942|NCT02027428|580313367|FG000|Maintenance|Progressive disease|0|||
160708943|NCT02027428|580313368|FG001|Maintenance|Progressive disease|84|||
160708944|NCT02027428|580313369|FG002|Maintenance|Progressive disease|47|||
160708945|NCT02027428|580313367|FG000|Maintenance|Symptomatic deterioration|0|||
160708946|NCT02027428|580313368|FG001|Maintenance|Symptomatic deterioration|4|||
160708947|NCT02027428|580313369|FG002|Maintenance|Symptomatic deterioration|1|||
160708948|NCT02027428|580313367|FG000|Maintenance|Withdrawal by Subject|0|||
160708949|NCT02027428|580313368|FG001|Maintenance|Withdrawal by Subject|6|||
160708950|NCT02027428|580313369|FG002|Maintenance|Withdrawal by Subject|5|||
160708951|NCT02027428|580313367|FG000|Maintenance|Protocol Violation|0|||
160708952|NCT02027428|580313368|FG001|Maintenance|Protocol Violation|0|||
160708953|NCT02027428|580313369|FG002|Maintenance|Protocol Violation|1|||
160708954|NCT02027428|580313367|FG000|Maintenance|Other|0|||
160708955|NCT02027428|580313368|FG001|Maintenance|Other|6|||
160708956|NCT02027428|580313369|FG002|Maintenance|Other|3|||
160708957|NCT02027428|580313367|FG000|Survival Follow-up|Death|0|||
160708958|NCT02027428|580313368|FG001|Survival Follow-up|Death|78|||
160708959|NCT02027428|580313369|FG002|Survival Follow-up|Death|45|||
160708960|NCT02027428|580313367|FG000|Survival Follow-up|Lost to Follow-up|0|||
160708961|NCT02027428|580313368|FG001|Survival Follow-up|Lost to Follow-up|1|||
160708962|NCT02027428|580313369|FG002|Survival Follow-up|Lost to Follow-up|1|||
160708963|NCT02859142|580313370|FG000|Overall Study|Adverse Event|1|||
160708964|NCT02859142|580313371|FG001|Overall Study|Adverse Event|2|||
160708965|NCT02859142|580313370|FG000|Overall Study|Lost to Follow-up|1|||
160708966|NCT02859142|580313371|FG001|Overall Study|Lost to Follow-up|4|||
160708967|NCT02859142|580313370|FG000|Overall Study|Withdrawal by Subject|2|||
160708968|NCT02859142|580313371|FG001|Overall Study|Withdrawal by Subject|0|||
160708969|NCT02859142|580313370|FG000|Overall Study|Scheduling difficulties|0|||
160708970|NCT02859142|580313371|FG001|Overall Study|Scheduling difficulties|3|||
160708971|NCT02676765|580313372|FG000|Overall Study|Lost to Follow-up|0|||
160708972|NCT02676765|580313373|FG001|Overall Study|Lost to Follow-up|1|||
160708973|NCT03340974|580313377|FG000|Completion of Study -Long Term Follow up|Death|8|||
160708974|NCT03340974|580313378|FG001|Completion of Study -Long Term Follow up|Death|5|||
160708975|NCT03340974|580313379|FG002|Completion of Study -Long Term Follow up|Death|5|||
160708976|NCT03340974|580313380|FG003|Completion of Study -Long Term Follow up|Death|7|||
160708977|NCT03340974|580313377|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
160708978|NCT03340974|580313378|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
160708979|NCT03340974|580313379|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
160708980|NCT03340974|580313380|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
160708981|NCT03340974|580313377|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
160708982|NCT03340974|580313378|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
160708983|NCT03340974|580313379|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
160708984|NCT03340974|580313380|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
160708985|NCT03340974|580313377|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
160708986|NCT03340974|580313378|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
160708987|NCT03340974|580313379|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
160708988|NCT03340974|580313380|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
160708989|NCT01128543|580313381|FG000|Overall Study|Withdrawal by Subject|3|||
160708990|NCT01128543|580313381|FG000|Overall Study|Protocol Violation|1|||
160708991|NCT02374346|580313385|FG000|Overall Study|operated or discharged during weekend|48|||
160708992|NCT00396565|580313391|FG000|Overall Study|Physician Decision|3|||
160708993|NCT00396565|580313392|FG001|Overall Study|Physician Decision|1|||
160708994|NCT00396565|580313393|FG002|Overall Study|Physician Decision|2|||
160708995|NCT00396565|580313391|FG000|Overall Study|Adverse Event|5|||
160708996|NCT00396565|580313392|FG001|Overall Study|Adverse Event|13|||
160708997|NCT00396565|580313393|FG002|Overall Study|Adverse Event|3|||
160708998|NCT00396565|580313391|FG000|Overall Study|Withdrawal by Subject|8|||
160708999|NCT00396565|580313392|FG001|Overall Study|Withdrawal by Subject|13|||
160709000|NCT00396565|580313393|FG002|Overall Study|Withdrawal by Subject|1|||
160709001|NCT00396565|580313391|FG000|Overall Study|Lack of Efficacy|32|||
160709002|NCT00396565|580313392|FG001|Overall Study|Lack of Efficacy|64|||
160709003|NCT00396565|580313393|FG002|Overall Study|Lack of Efficacy|11|||
160709004|NCT04487067|580313398|FG000|Overall Study|Adverse Event|3|||
160709005|NCT04487067|580313398|FG000|Overall Study|Death Other Than Progressive Disease|60|||
160709006|NCT04487067|580313398|FG000|Overall Study|Death Due To Progressive Disease|40|||
160709007|NCT04487067|580313398|FG000|Overall Study|Lost to Follow-up|3|||
160709008|NCT04487067|580313398|FG000|Overall Study|Progressive Disease|1|||
160709009|NCT04487067|580313398|FG000|Overall Study|Protocol Violation|3|||
160709010|NCT04487067|580313398|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
160709011|NCT04487067|580313398|FG000|Overall Study|Withdrawal by Subject|15|||
160709012|NCT05299528|580313399|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
160709013|NCT05299528|580313400|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
160709014|NCT05299528|580313401|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
160709015|NCT05299528|580313402|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
160709016|NCT05299528|580313403|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
160709017|NCT05299528|580313404|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
160709018|NCT05299528|580313405|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
160709019|NCT05299528|580313399|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
160709020|NCT05299528|580313400|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
160709021|NCT05299528|580313401|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
160709022|NCT05299528|580313402|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
160709023|NCT05299528|580313403|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
160709024|NCT05299528|580313404|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
160709025|NCT05299528|580313405|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
160709026|NCT05299528|580313399|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
160709027|NCT05299528|580313400|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
160709028|NCT05299528|580313401|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
160709029|NCT05299528|580313402|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
160709030|NCT05299528|580313403|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
160709031|NCT05299528|580313404|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
160709032|NCT05299528|580313405|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
160709033|NCT04877457|580313406|FG000|Overall Study|Early termination of study due to low enrollment|2|||
160709034|NCT04877457|580313407|FG001|Overall Study|Early termination of study due to low enrollment|1|||
160709035|NCT00299130|580313408|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
160709036|NCT00299130|580313409|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
160709037|NCT00299130|580313410|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
160709038|NCT00299130|580313408|FG000|Treatment Period (up to 5 Years)|Death|1|||
160709039|NCT00299130|580313409|FG001|Treatment Period (up to 5 Years)|Death|3|||
160709040|NCT00299130|580313410|FG002|Treatment Period (up to 5 Years)|Death|1|||
160709041|NCT00299130|580313408|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
160709042|NCT00299130|580313409|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
160709043|NCT00299130|580313410|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
160709044|NCT00299130|580313408|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
160709045|NCT00299130|580313409|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
160709046|NCT00299130|580313410|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
160709047|NCT00299130|580313408|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
160709048|NCT00299130|580313409|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
160709049|NCT00299130|580313410|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
160709050|NCT00299130|580313408|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
160709051|NCT00299130|580313409|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
160709052|NCT00299130|580313410|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
160709053|NCT00299130|580313408|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
160709054|NCT00299130|580313409|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
160709055|NCT00299130|580313410|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
160709056|NCT00299130|580313408|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
160709057|NCT00299130|580313409|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
160709058|NCT00299130|580313410|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
160709059|NCT00299130|580313408|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
160709060|NCT00299130|580313409|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
160709061|NCT00299130|580313410|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
160709062|NCT00299130|580313408|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
160709063|NCT00299130|580313409|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
160709064|NCT00299130|580313410|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
160709065|NCT00299130|580313408|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
160709066|NCT00299130|580313409|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
160709067|NCT00299130|580313410|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
160709068|NCT00299130|580313408|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
160709069|NCT00299130|580313409|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
160709070|NCT00299130|580313410|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
160709071|NCT00299130|580313408|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
160709072|NCT00299130|580313409|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
160709073|NCT00299130|580313410|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
160709074|NCT00299130|580313408|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
160709075|NCT00299130|580313409|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
160709076|NCT00299130|580313410|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
160709077|NCT00299130|580313408|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
160709078|NCT00299130|580313409|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
160709079|NCT00299130|580313410|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
160709080|NCT00299130|580313408|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
160709081|NCT00299130|580313409|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
160709082|NCT00299130|580313410|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
160709083|NCT00299130|580313408|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
160709084|NCT00299130|580313409|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
160709085|NCT00299130|580313410|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
160709086|NCT02211417|580313411|FG000|Overall Study|Withdrawal by Subject|11|||
160709087|NCT02211417|580313412|FG001|Overall Study|Withdrawal by Subject|8|||
160709088|NCT02211417|580313411|FG000|Overall Study|Protocol Violation|1|||
160709089|NCT02211417|580313412|FG001|Overall Study|Protocol Violation|0|||
160709090|NCT02211417|580313411|FG000|Overall Study|Pregnancy|0|||
160709091|NCT02211417|580313412|FG001|Overall Study|Pregnancy|1|||
160709092|NCT02211417|580313411|FG000|Overall Study|Lost to Follow-up|2|||
160709093|NCT02211417|580313412|FG001|Overall Study|Lost to Follow-up|3|||
160709094|NCT02211417|580313411|FG000|Overall Study|Adverse Event|1|||
160709095|NCT02211417|580313412|FG001|Overall Study|Adverse Event|4|||
160709096|NCT01198132|580313413|FG000|Overall Study|Withdrawal by Subject|4|||
160709097|NCT01198132|580313414|FG001|Overall Study|Withdrawal by Subject|5|||
160709098|NCT01198132|580313413|FG000|Overall Study|Physician Decision|5|||
160709099|NCT01198132|580313414|FG001|Overall Study|Physician Decision|4|||
160709100|NCT01198132|580313413|FG000|Overall Study|Other Unspecified|3|||
160709101|NCT01198132|580313414|FG001|Overall Study|Other Unspecified|6|||
160709102|NCT01198132|580313413|FG000|Overall Study|Lack of Efficacy|2|||
160709103|NCT01198132|580313414|FG001|Overall Study|Lack of Efficacy|3|||
160709104|NCT01198132|580313413|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
160709105|NCT01198132|580313414|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
160709106|NCT01198132|580313413|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
160709107|NCT01198132|580313414|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
160709108|NCT01198132|580313413|FG000|Overall Study|Adverse Event|0|||
160709109|NCT01198132|580313414|FG001|Overall Study|Adverse Event|1|||
160709110|NCT01198132|580313413|FG000|Overall Study|Protocol Violation|1|||
160709111|NCT01198132|580313414|FG001|Overall Study|Protocol Violation|0|||
160709112|NCT00490841|580313415|FG000|Overall Study|Death|5|||
160709113|NCT00490841|580313415|FG000|Overall Study|Withdrawal by Subject|4|||
160709114|NCT00490841|580313415|FG000|Overall Study|Lost to Follow-up|1|||
160709115|NCT00490841|580313415|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
160709116|NCT03452943|580313416|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
160709117|NCT03452943|580313417|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
160709118|NCT03452943|580313416|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
160709119|NCT03452943|580313417|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
160709120|NCT03452943|580313416|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
160709121|NCT03452943|580313417|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
160709122|NCT03452943|580313416|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
160709123|NCT03452943|580313417|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
160709124|NCT03452943|580313416|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
160709125|NCT03452943|580313417|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
160709126|NCT03452943|580313416|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
160709127|NCT03452943|580313417|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
160709128|NCT01301729|580313423|FG000|Overall Study|Withdrawal by Subject|2|||
160709129|NCT01301729|580313423|FG000|Overall Study|Participant did not Return for Treatment|1|||
160709130|NCT01301729|580313423|FG000|Overall Study|Violated Selection Criteria|1|||
160709131|NCT03071276|580313424|FG000|Overall Study|Adverse Event|1|||
160709132|NCT03071276|580313424|FG000|Overall Study|Lack of Efficacy|14|||
160709133|NCT02924727|580313425|FG000|Overall Study|Withdrawal by Subject|2|||
160709134|NCT02924727|580313426|FG001|Overall Study|Withdrawal by Subject|4|||
160709135|NCT02924727|580313425|FG000|Overall Study|Lost to Follow-up|2|||
160709136|NCT02924727|580313426|FG001|Overall Study|Lost to Follow-up|5|||
160709137|NCT02924727|580313425|FG000|Overall Study|Death|221|||
160709138|NCT02924727|580313426|FG001|Overall Study|Death|247|||
160709139|NCT02924727|580313425|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
160709140|NCT02924727|580313426|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
160709141|NCT05422625|580313427|FG000|Overall Study|Withdrawal by Subject|1|||
160709142|NCT05422625|580313428|FG001|Overall Study|Withdrawal by Subject|0|||
160709143|NCT03130777|580315531|FG000|Overall Study|Death|0|||
160709144|NCT03130777|580315532|FG001|Overall Study|Death|1|||
160709145|NCT03130777|580315531|FG000|Overall Study|Did not meet eligibility criteria|1|||
160709146|NCT03130777|580315532|FG001|Overall Study|Did not meet eligibility criteria|0|||
160709147|NCT05109611|580315533|FG000|Overall Study|Adverse Event|13|||
160709148|NCT05109611|580315534|FG001|Overall Study|Adverse Event|10|||
160709149|NCT05109611|580315533|FG000|Overall Study|Withdrawal by Subject|1|||
160709150|NCT05109611|580315534|FG001|Overall Study|Withdrawal by Subject|0|||
160709151|NCT05109611|580315533|FG000|Overall Study|Lost to Follow-up|1|||
160709152|NCT05109611|580315534|FG001|Overall Study|Lost to Follow-up|2|||
160709153|NCT05109611|580315533|FG000|Overall Study|Protocol Violation|0|||
160709154|NCT05109611|580315534|FG001|Overall Study|Protocol Violation|4|||
160709155|NCT05109611|580315533|FG000|Overall Study|Information unavailable|1|||
160709156|NCT05109611|580315534|FG001|Overall Study|Information unavailable|1|||
160709157|NCT03203850|580315538|FG000|Overall Study|Subject/guardian decision|4|||
160709158|NCT03203850|580315539|FG001|Overall Study|Subject/guardian decision|3|||
160709159|NCT03203850|580315538|FG000|Overall Study|Adverse Event|3|||
160709160|NCT03203850|580315539|FG001|Overall Study|Adverse Event|0|||
160709161|NCT03203850|580315538|FG000|Overall Study|Death|1|||
160709162|NCT03203850|580315539|FG001|Overall Study|Death|0|||
160709163|NCT01769456|580315540|FG000|Overall Study|Lost to Follow-up|19|||
160709164|NCT01769456|580315540|FG000|Overall Study|Withdrawal by Subject|3|||
160709165|NCT01769456|580315540|FG000|Overall Study|Did not receive PCC intervention|6|||
160709166|NCT01769456|580315540|FG000|Overall Study|Moved out of the area|3|||
160709167|NCT01769456|580315540|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
160709168|NCT01769456|580315540|FG000|Overall Study|Parental request to youth to withdraw|1|||
160709169|NCT02969382|580315543|FG000|Overall Study|Adverse Event|8|||
160709170|NCT02969382|580315544|FG001|Overall Study|Adverse Event|10|||
160709171|NCT02969382|580315543|FG000|Overall Study|Lack of Efficacy|4|||
160709172|NCT02969382|580315544|FG001|Overall Study|Lack of Efficacy|5|||
160709173|NCT02969382|580315543|FG000|Overall Study|Death|0|||
160709174|NCT02969382|580315544|FG001|Overall Study|Death|1|||
160709175|NCT02969382|580315543|FG000|Overall Study|PROTOCOL DEVIATION|0|||
160709176|NCT02969382|580315544|FG001|Overall Study|PROTOCOL DEVIATION|1|||
160709177|NCT02969382|580315543|FG000|Overall Study|Withdrawal by Subject|14|||
160709178|NCT02969382|580315544|FG001|Overall Study|Withdrawal by Subject|9|||
160709179|NCT02090725|580315545|FG000|Overall Study|Withdrawal by Subject|1|||
160709180|NCT02090725|580315545|FG000|Overall Study|participants moved from area|3|||
160709181|NCT01434810|580315552|FG000|Overall Study|Did not receive treatment|11|||
160709182|NCT01434810|580315553|FG001|Overall Study|Did not receive treatment|3|||
160709183|NCT01434810|580315552|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
160709184|NCT01434810|580315553|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
160709185|NCT02794870|580315555|FG000|Overall Study|Withdrawal by Subject|2|||
160709186|NCT02794870|580315556|FG001|Overall Study|Withdrawal by Subject|0|||
160709187|NCT02540083|580315560|FG000|Overall Study|Withdrawal by Subject|16|||
160709188|NCT02301390|580315561|FG000|Overall Study|Withdrawal by Subject|3|||
160709189|NCT02301390|580315562|FG001|Overall Study|Withdrawal by Subject|5|||
160709190|NCT02301390|580315561|FG000|Overall Study|Protocol Violation|1|||
160709191|NCT02301390|580315562|FG001|Overall Study|Protocol Violation|0|||
160709192|NCT02301390|580315561|FG000|Overall Study|Physician Decision|1|||
160709193|NCT02301390|580315562|FG001|Overall Study|Physician Decision|0|||
160709194|NCT02301390|580315561|FG000|Overall Study|Lost to Follow-up|0|||
160709195|NCT02301390|580315562|FG001|Overall Study|Lost to Follow-up|1|||
160709196|NCT02301390|580315561|FG000|Overall Study|Death|2|||
160709197|NCT02301390|580315562|FG001|Overall Study|Death|2|||
160709198|NCT02301390|580315561|FG000|Overall Study|Procedure not completed|0|||
160709199|NCT02301390|580315562|FG001|Overall Study|Procedure not completed|4|||
160709200|NCT02301390|580315561|FG000|Overall Study|Missed multiple visits|1|||
160709201|NCT02301390|580315562|FG001|Overall Study|Missed multiple visits|1|||
160709202|NCT02301390|580315561|FG000|Overall Study|study terminated|2|||
160709203|NCT02301390|580315562|FG001|Overall Study|study terminated|0|||
160709204|NCT00185588|580315563|FG000|Overall Study|Adverse Event|3|||
160709205|NCT00185588|580315564|FG001|Overall Study|Adverse Event|1|||
160709206|NCT00185588|580315565|FG002|Overall Study|Adverse Event|4|||
160709207|NCT00185588|580315566|FG003|Overall Study|Adverse Event|2|||
160709208|NCT00185588|580315563|FG000|Overall Study|Lost to Follow-up|0|||
160709209|NCT00185588|580315564|FG001|Overall Study|Lost to Follow-up|0|||
160709210|NCT00185588|580315565|FG002|Overall Study|Lost to Follow-up|1|||
160709211|NCT00185588|580315566|FG003|Overall Study|Lost to Follow-up|2|||
160709212|NCT00185588|580315563|FG000|Overall Study|Withdrawal by Subject|0|||
160709213|NCT00185588|580315564|FG001|Overall Study|Withdrawal by Subject|1|||
160709214|NCT00185588|580315565|FG002|Overall Study|Withdrawal by Subject|0|||
160709215|NCT00185588|580315566|FG003|Overall Study|Withdrawal by Subject|0|||
160709216|NCT00185588|580315563|FG000|Overall Study|Physician Decision|0|||
160709217|NCT00185588|580315564|FG001|Overall Study|Physician Decision|0|||
160709218|NCT00185588|580315565|FG002|Overall Study|Physician Decision|1|||
160709219|NCT00185588|580315566|FG003|Overall Study|Physician Decision|0|||
160709220|NCT00398866|580315567|FG000|Overall Study|Adverse Event|1|||
160709221|NCT00398866|580315568|FG001|Overall Study|Adverse Event|0|||
160709222|NCT00398866|580315569|FG002|Overall Study|Adverse Event|0|||
160709223|NCT00398866|580315567|FG000|Overall Study|Lack of Efficacy|0|||
160709224|NCT00398866|580315568|FG001|Overall Study|Lack of Efficacy|0|||
160709225|NCT00398866|580315569|FG002|Overall Study|Lack of Efficacy|1|||
160709226|NCT00398866|580315567|FG000|Overall Study|Lost to Follow-up|7|||
160709227|NCT00398866|580315568|FG001|Overall Study|Lost to Follow-up|6|||
160709228|NCT00398866|580315569|FG002|Overall Study|Lost to Follow-up|4|||
160709229|NCT00398866|580315567|FG000|Overall Study|Withdrawal by Subject|5|||
160709230|NCT00398866|580315568|FG001|Overall Study|Withdrawal by Subject|1|||
160709231|NCT00398866|580315569|FG002|Overall Study|Withdrawal by Subject|2|||
160709232|NCT00398866|580315567|FG000|Overall Study|Unable to complete requirements of study|1|||
160709233|NCT00398866|580315568|FG001|Overall Study|Unable to complete requirements of study|1|||
160709234|NCT00398866|580315569|FG002|Overall Study|Unable to complete requirements of study|1|||
160709235|NCT01153425|580315577|FG000|Overall Study|Withdrawal by Subject|3|||
160709236|NCT01153425|580315578|FG001|Overall Study|Withdrawal by Subject|3|||
160709237|NCT03154125|580315579|FG000|Overall Study|Lost to Follow-up|11|||
160709238|NCT03154125|580315580|FG001|Overall Study|Lost to Follow-up|11|||
160709239|NCT03154125|580315581|FG002|Overall Study|Lost to Follow-up|0|||
160709240|NCT03154125|580315579|FG000|Overall Study|Withdrawal by Subject|49|||
160709241|NCT03154125|580315580|FG001|Overall Study|Withdrawal by Subject|55|||
160709242|NCT03154125|580315581|FG002|Overall Study|Withdrawal by Subject|8|||
160709243|NCT03154125|580315579|FG000|Overall Study|Physician Decision|13|||
160709244|NCT03154125|580315580|FG001|Overall Study|Physician Decision|6|||
160709245|NCT03154125|580315581|FG002|Overall Study|Physician Decision|0|||
160709246|NCT03154125|580315579|FG000|Overall Study|Protocol Violation|3|||
160709247|NCT03154125|580315580|FG001|Overall Study|Protocol Violation|5|||
160709248|NCT03154125|580315581|FG002|Overall Study|Protocol Violation|0|||
160709249|NCT00810511|580315582|FG000|Overall Study|Protocol Violation|0|||
160709250|NCT00810511|580315583|FG001|Overall Study|Protocol Violation|1|||
160709251|NCT00810511|580315582|FG000|Overall Study|Lack of Efficacy|9|||
160709252|NCT00810511|580315583|FG001|Overall Study|Lack of Efficacy|1|||
160709253|NCT00810511|580315582|FG000|Overall Study|death in the family|0|||
160709254|NCT00810511|580315583|FG001|Overall Study|death in the family|1|||
160709255|NCT00810511|580315582|FG000|Overall Study|Lost to Follow-up|1|||
160709256|NCT00810511|580315583|FG001|Overall Study|Lost to Follow-up|0|||
160709257|NCT00810511|580315582|FG000|Overall Study|deposits on contact lens|0|||
160709258|NCT00810511|580315583|FG001|Overall Study|deposits on contact lens|1|||
160709259|NCT04342819|580315585|FG000|Overall Study|Declined|4|||
160709260|NCT04342819|580315585|FG000|Overall Study|Not meeeting selection criteria|1|||
160709261|NCT00911300|580315586|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
160709262|NCT00911300|580315587|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
160709263|NCT00911300|580315586|FG000|Overall Study|Death|1|||
160709264|NCT00911300|580315587|FG001|Overall Study|Death|0|||
160709265|NCT00911300|580315586|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
160709266|NCT00911300|580315587|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
160709267|NCT00911300|580315586|FG000|Overall Study|Adverse Event|14|||
160709268|NCT00911300|580315587|FG001|Overall Study|Adverse Event|6|||
160709269|NCT00911300|580315586|FG000|Overall Study|Protocol Violation|3|||
160709270|NCT00911300|580315587|FG001|Overall Study|Protocol Violation|2|||
160709271|NCT00911300|580315586|FG000|Overall Study|Consent Withdrawn|4|||
160709272|NCT00911300|580315587|FG001|Overall Study|Consent Withdrawn|12|||
160709273|NCT00911300|580315586|FG000|Overall Study|Coronary Angiography Performed|1|||
160709274|NCT00911300|580315587|FG001|Overall Study|Coronary Angiography Performed|0|||
160709275|NCT00911300|580315586|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
160709276|NCT00911300|580315587|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
160709277|NCT00911300|580315586|FG000|Overall Study|Received Commercial Treatment|1|||
160709278|NCT00911300|580315587|FG001|Overall Study|Received Commercial Treatment|0|||
160709279|NCT00911300|580315586|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
160709280|NCT00911300|580315587|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
160709281|NCT00911300|580315586|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
160709282|NCT00911300|580315587|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
160709283|NCT00911300|580315586|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
160709284|NCT00911300|580315587|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
160709285|NCT00911300|580315586|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
160709286|NCT00911300|580315587|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
160709287|NCT00911300|580315586|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
160709288|NCT00911300|580315587|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
160709289|NCT00911300|580315586|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
160709290|NCT00911300|580315587|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
160709291|NCT00911300|580315586|FG000|Overall Study|International Normalized Ratio Too High|0|||
160709292|NCT00911300|580315587|FG001|Overall Study|International Normalized Ratio Too High|1|||
160709293|NCT00911300|580315586|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
160709294|NCT00911300|580315587|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
160709295|NCT00911300|580315586|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
160709296|NCT00911300|580315587|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
160709297|NCT00911300|580315586|FG000|Overall Study|Physician Decision|0|||
160709298|NCT00911300|580315587|FG001|Overall Study|Physician Decision|1|||
160709299|NCT00911300|580315586|FG000|Overall Study|Treatment Stopped by Mistake|0|||
160709300|NCT00911300|580315587|FG001|Overall Study|Treatment Stopped by Mistake|1|||
160709301|NCT00911300|580315586|FG000|Overall Study|Randomized; No Study Medication Received|0|||
160709302|NCT00911300|580315587|FG001|Overall Study|Randomized; No Study Medication Received|2|||
160709303|NCT03668808|580315591|FG000|First Intervention|Withdrawal by Subject|2|||
160709304|NCT03668808|580315592|FG001|First Intervention|Withdrawal by Subject|2|||
160709305|NCT01569295|580315595|FG000|Overall Study|Progressive Disease|75|||
160709306|NCT01569295|580315596|FG001|Overall Study|Progressive Disease|139|||
160709307|NCT01569295|580315595|FG000|Overall Study|Adverse Event|39|||
160709308|NCT01569295|580315596|FG001|Overall Study|Adverse Event|14|||
160709309|NCT01569295|580315595|FG000|Overall Study|Withdrawal by Subject|25|||
160709310|NCT01569295|580315596|FG001|Overall Study|Withdrawal by Subject|12|||
160709311|NCT01569295|580315595|FG000|Overall Study|Death|19|||
160709312|NCT01569295|580315596|FG001|Overall Study|Death|15|||
160709313|NCT01569295|580315595|FG000|Overall Study|Physician Decision|13|||
160709314|NCT01569295|580315596|FG001|Overall Study|Physician Decision|18|||
160709315|NCT01569295|580315595|FG000|Overall Study|Study Terminated by Sponsor|24|||
160709316|NCT01569295|580315596|FG001|Overall Study|Study Terminated by Sponsor|2|||
160709317|NCT01569295|580315595|FG000|Overall Study|Other Reason not Specified|3|||
160709318|NCT01569295|580315596|FG001|Overall Study|Other Reason not Specified|5|||
160709319|NCT01569295|580315595|FG000|Overall Study|Non-Compliance with Study Drug|6|||
160709320|NCT01569295|580315596|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160709321|NCT01569295|580315595|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
160709322|NCT01569295|580315596|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
160709323|NCT01569295|580315595|FG000|Overall Study|Lost to Follow-up|1|||
160709324|NCT01569295|580315596|FG001|Overall Study|Lost to Follow-up|1|||
160709325|NCT00280735|580315597|FG000|Overall Study|Adverse Event|5|||
160709326|NCT00280735|580315597|FG000|Overall Study|Lack of Efficacy|3|||
160709327|NCT00280735|580315597|FG000|Overall Study|Withdrawal by Subject|8|||
160709328|NCT00280735|580315597|FG000|Overall Study|Intercurrent Illness|2|||
160709329|NCT02064296|580315601|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
160709330|NCT02064296|580315602|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
160709331|NCT02064296|580315603|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
160709332|NCT02064296|580315601|FG000|Intervention|Withdrawal by Subject|0|||
160709333|NCT02064296|580315602|FG001|Intervention|Withdrawal by Subject|1|||
160709334|NCT02064296|580315603|FG002|Intervention|Withdrawal by Subject|2|||
160709335|NCT00666328|580315615|FG000|Overall Study|Death|2|||
160709336|NCT00666328|580315615|FG000|Overall Study|Lost to Follow-up|2|||
160709337|NCT00666328|580315615|FG000|Overall Study|No longer met eligibility criteria|1|||
160709338|NCT02288325|580315616|FG000|Run-in Period|Adverse Event|48|||
160709339|NCT02288325|580315617|FG001|Run-in Period|Adverse Event|0|||
160709340|NCT02288325|580315618|FG002|Run-in Period|Adverse Event|0|||
160709341|NCT02288325|580315616|FG000|Run-in Period|Lack of Efficacy|16|||
160709342|NCT02288325|580315617|FG001|Run-in Period|Lack of Efficacy|0|||
160709343|NCT02288325|580315618|FG002|Run-in Period|Lack of Efficacy|0|||
160709344|NCT02288325|580315616|FG000|Run-in Period|Withdrawal of Consent|28|||
160709345|NCT02288325|580315617|FG001|Run-in Period|Withdrawal of Consent|0|||
160709346|NCT02288325|580315618|FG002|Run-in Period|Withdrawal of Consent|0|||
160709347|NCT02288325|580315616|FG000|Run-in Period|Lost to Follow-up|25|||
160709348|NCT02288325|580315617|FG001|Run-in Period|Lost to Follow-up|0|||
160709349|NCT02288325|580315618|FG002|Run-in Period|Lost to Follow-up|0|||
160709350|NCT02288325|580315616|FG000|Run-in Period|Protocol Violation|17|||
160709351|NCT02288325|580315617|FG001|Run-in Period|Protocol Violation|0|||
160709352|NCT02288325|580315618|FG002|Run-in Period|Protocol Violation|0|||
160709353|NCT02288325|580315616|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
160709354|NCT02288325|580315617|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
160709355|NCT02288325|580315618|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
160709356|NCT02288325|580315616|FG000|Run-in Period|Reason not Specified|8|||
160709357|NCT02288325|580315617|FG001|Run-in Period|Reason not Specified|0|||
160709358|NCT02288325|580315618|FG002|Run-in Period|Reason not Specified|0|||
160709359|NCT02288325|580315616|FG000|Stabilization Period|Adverse Event|13|||
160709360|NCT02288325|580315617|FG001|Stabilization Period|Adverse Event|0|||
160709361|NCT02288325|580315618|FG002|Stabilization Period|Adverse Event|0|||
160709362|NCT02288325|580315616|FG000|Stabilization Period|Lack of Efficacy|22|||
160709363|NCT02288325|580315617|FG001|Stabilization Period|Lack of Efficacy|0|||
160709364|NCT02288325|580315618|FG002|Stabilization Period|Lack of Efficacy|0|||
160709365|NCT02288325|580315616|FG000|Stabilization Period|Withdrawal of Consent|23|||
160709366|NCT02288325|580315617|FG001|Stabilization Period|Withdrawal of Consent|0|||
160709367|NCT02288325|580315618|FG002|Stabilization Period|Withdrawal of Consent|0|||
160709368|NCT02288325|580315616|FG000|Stabilization Period|Lost to Follow-up|12|||
160709369|NCT02288325|580315617|FG001|Stabilization Period|Lost to Follow-up|0|||
160709370|NCT02288325|580315618|FG002|Stabilization Period|Lost to Follow-up|0|||
160709371|NCT02288325|580315616|FG000|Stabilization Period|Protocol Violation|8|||
160709372|NCT02288325|580315617|FG001|Stabilization Period|Protocol Violation|0|||
160709373|NCT02288325|580315618|FG002|Stabilization Period|Protocol Violation|0|||
160709374|NCT02288325|580315616|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
160709375|NCT02288325|580315617|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
160709376|NCT02288325|580315618|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
160709377|NCT02288325|580315616|FG000|Stabilization Period|Reason not Specified|15|||
160709378|NCT02288325|580315617|FG001|Stabilization Period|Reason not Specified|0|||
160709379|NCT02288325|580315618|FG002|Stabilization Period|Reason not Specified|0|||
160709380|NCT02288325|580315616|FG000|Double-blind Treatment Period|Adverse Event|0|||
160709381|NCT02288325|580315617|FG001|Double-blind Treatment Period|Adverse Event|2|||
160709382|NCT02288325|580315618|FG002|Double-blind Treatment Period|Adverse Event|5|||
160709383|NCT02288325|580315616|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
160709384|NCT02288325|580315617|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
160709385|NCT02288325|580315618|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
160709386|NCT02288325|580315616|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
160709387|NCT02288325|580315617|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
160709388|NCT02288325|580315618|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
160709389|NCT02288325|580315616|FG000|Double-blind Treatment Period|Protocol Violation|0|||
160709390|NCT02288325|580315617|FG001|Double-blind Treatment Period|Protocol Violation|1|||
160709391|NCT02288325|580315618|FG002|Double-blind Treatment Period|Protocol Violation|2|||
160709392|NCT02288325|580315616|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
160709393|NCT02288325|580315617|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
160709394|NCT02288325|580315618|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
160709395|NCT02288325|580315616|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
160709396|NCT02288325|580315617|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
160709397|NCT02288325|580315618|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
160709398|NCT03607487|580315622|FG000|Overall Study|Withdrawal by Subject|2|||
160709399|NCT03607487|580315623|FG001|Overall Study|Withdrawal by Subject|0|||
160709400|NCT03607487|580315624|FG002|Overall Study|Withdrawal by Subject|0|||
160709401|NCT03607487|580315625|FG003|Overall Study|Withdrawal by Subject|1|||
160709402|NCT01130597|580315631|FG000|Overall Study|Protocol-specified (High K+)|1|||
160709403|NCT01130597|580315631|FG000|Overall Study|Adverse Event|4|||
160709404|NCT01130597|580315631|FG000|Overall Study|Death|1|||
160709405|NCT01130597|580315631|FG000|Overall Study|Protocol Violation|1|||
160709406|NCT05794503|580315632|FG000|Overall Study|Operation Cancelled|2|||
160709407|NCT05794503|580315633|FG001|Overall Study|Operation Cancelled|0|||
160709408|NCT05794503|580315632|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
160709409|NCT05794503|580315633|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
160709410|NCT05794503|580315632|FG000|Overall Study|Protocol Violation|1|||
160709411|NCT05794503|580315633|FG001|Overall Study|Protocol Violation|0|||
160709412|NCT00447993|580315634|FG000|Overall Study|Lost to Follow-up|0|||
160709413|NCT00447993|580315635|FG001|Overall Study|Lost to Follow-up|0|||
160709414|NCT00447993|580315636|FG002|Overall Study|Lost to Follow-up|2|||
160709415|NCT00447993|580315637|FG003|Overall Study|Lost to Follow-up|2|||
160709416|NCT00447993|580315634|FG000|Overall Study|Withdrawal by Subject|0|||
160709417|NCT00447993|580315635|FG001|Overall Study|Withdrawal by Subject|0|||
160709418|NCT00447993|580315636|FG002|Overall Study|Withdrawal by Subject|2|||
160709419|NCT00447993|580315637|FG003|Overall Study|Withdrawal by Subject|2|||
160709420|NCT03052127|580315638|FG000|Overall Study|Withdrawal by Subject|0|||
160709421|NCT03052127|580315639|FG001|Overall Study|Withdrawal by Subject|0|||
160709422|NCT03052127|580315640|FG002|Overall Study|Withdrawal by Subject|0|||
160709423|NCT03052127|580315641|FG003|Overall Study|Withdrawal by Subject|0|||
160709424|NCT03052127|580315642|FG004|Overall Study|Withdrawal by Subject|0|||
160709425|NCT03052127|580315643|FG005|Overall Study|Withdrawal by Subject|0|||
160709426|NCT03052127|580315644|FG006|Overall Study|Withdrawal by Subject|0|||
160709427|NCT03052127|580315645|FG007|Overall Study|Withdrawal by Subject|1|||
160709428|NCT03052127|580315646|FG008|Overall Study|Withdrawal by Subject|1|||
160709429|NCT03052127|580315647|FG009|Overall Study|Withdrawal by Subject|1|||
160709430|NCT03052127|580315648|FG010|Overall Study|Withdrawal by Subject|0|||
160709431|NCT03052127|580315649|FG011|Overall Study|Withdrawal by Subject|0|||
160709432|NCT03052127|580315638|FG000|Overall Study|Discontinuation by Sponsor|0|||
160709433|NCT03052127|580315639|FG001|Overall Study|Discontinuation by Sponsor|0|||
160709434|NCT03052127|580315640|FG002|Overall Study|Discontinuation by Sponsor|0|||
160709435|NCT03052127|580315641|FG003|Overall Study|Discontinuation by Sponsor|0|||
160709436|NCT03052127|580315642|FG004|Overall Study|Discontinuation by Sponsor|0|||
160709437|NCT03052127|580315643|FG005|Overall Study|Discontinuation by Sponsor|0|||
160709438|NCT03052127|580315644|FG006|Overall Study|Discontinuation by Sponsor|0|||
160709439|NCT03052127|580315645|FG007|Overall Study|Discontinuation by Sponsor|0|||
160709440|NCT03052127|580315646|FG008|Overall Study|Discontinuation by Sponsor|4|||
160709441|NCT03052127|580315647|FG009|Overall Study|Discontinuation by Sponsor|2|||
160709442|NCT03052127|580315648|FG010|Overall Study|Discontinuation by Sponsor|5|||
160709443|NCT03052127|580315649|FG011|Overall Study|Discontinuation by Sponsor|13|||
160709444|NCT03052127|580315638|FG000|Overall Study|Inability to comply with trial requirements|0|||
160709445|NCT03052127|580315639|FG001|Overall Study|Inability to comply with trial requirements|0|||
160709446|NCT03052127|580315640|FG002|Overall Study|Inability to comply with trial requirements|1|||
160709447|NCT03052127|580315641|FG003|Overall Study|Inability to comply with trial requirements|0|||
160709448|NCT03052127|580315642|FG004|Overall Study|Inability to comply with trial requirements|0|||
160709449|NCT03052127|580315643|FG005|Overall Study|Inability to comply with trial requirements|0|||
160709450|NCT03052127|580315644|FG006|Overall Study|Inability to comply with trial requirements|0|||
160709451|NCT03052127|580315645|FG007|Overall Study|Inability to comply with trial requirements|0|||
160709452|NCT03052127|580315646|FG008|Overall Study|Inability to comply with trial requirements|0|||
160709453|NCT03052127|580315647|FG009|Overall Study|Inability to comply with trial requirements|0|||
160709454|NCT03052127|580315648|FG010|Overall Study|Inability to comply with trial requirements|0|||
160709455|NCT03052127|580315649|FG011|Overall Study|Inability to comply with trial requirements|0|||
160709456|NCT03052127|580315638|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
160709457|NCT03052127|580315639|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
160709458|NCT03052127|580315640|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
160709459|NCT03052127|580315641|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
160709460|NCT03052127|580315642|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
160709461|NCT03052127|580315643|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
160709462|NCT03052127|580315644|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
160709463|NCT03052127|580315645|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
160709464|NCT03052127|580315646|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
160709465|NCT03052127|580315647|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
160709466|NCT03052127|580315648|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
160709467|NCT03052127|580315649|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
160709468|NCT03694327|580315650|FG000|Overall Study|Lost to Follow-up|13|||
160709469|NCT03694327|580315651|FG001|Overall Study|Lost to Follow-up|23|||
160709470|NCT01464931|580315652|FG000|Overall Study|Withdrawal by Subject|1|||
160709471|NCT01464931|580315653|FG001|Overall Study|Withdrawal by Subject|0|||
160709472|NCT01982812|580315656|FG000|Overall Study|Death|1|||
160709473|NCT01982812|580315657|FG001|Overall Study|Death|5|||
160709474|NCT01982812|580315656|FG000|Overall Study|Adverse Event|0|||
160709475|NCT01982812|580315657|FG001|Overall Study|Adverse Event|5|||
160709476|NCT00307437|580315659|FG000|Controlled Period|Adverse Event|7|||
160709477|NCT00307437|580315660|FG001|Controlled Period|Adverse Event|2|||
160709478|NCT00307437|580315661|FG002|Controlled Period|Adverse Event|5|||
160709479|NCT00307437|580315662|FG003|Controlled Period|Adverse Event|0|||
160709480|NCT00307437|580315663|FG004|Controlled Period|Adverse Event|0|||
160709481|NCT00307437|580315664|FG005|Controlled Period|Adverse Event|0|||
160709482|NCT00307437|580315665|FG006|Controlled Period|Adverse Event|0|||
160709483|NCT00307437|580315659|FG000|Controlled Period|Death|0|||
160709484|NCT00307437|580315660|FG001|Controlled Period|Death|0|||
160709485|NCT00307437|580315661|FG002|Controlled Period|Death|1|||
160709486|NCT00307437|580315662|FG003|Controlled Period|Death|0|||
160709487|NCT00307437|580315663|FG004|Controlled Period|Death|0|||
160709488|NCT00307437|580315664|FG005|Controlled Period|Death|0|||
160709489|NCT00307437|580315665|FG006|Controlled Period|Death|0|||
160709490|NCT00307437|580315659|FG000|Controlled Period|Lack of Efficacy|2|||
160709491|NCT00307437|580315660|FG001|Controlled Period|Lack of Efficacy|0|||
160709492|NCT00307437|580315661|FG002|Controlled Period|Lack of Efficacy|0|||
160709493|NCT00307437|580315662|FG003|Controlled Period|Lack of Efficacy|0|||
160709494|NCT00307437|580315663|FG004|Controlled Period|Lack of Efficacy|0|||
160709495|NCT00307437|580315664|FG005|Controlled Period|Lack of Efficacy|0|||
160709496|NCT00307437|580315665|FG006|Controlled Period|Lack of Efficacy|0|||
160709497|NCT00307437|580315659|FG000|Controlled Period|Lost to Follow-up|2|||
160709498|NCT00307437|580315660|FG001|Controlled Period|Lost to Follow-up|3|||
160709499|NCT00307437|580315661|FG002|Controlled Period|Lost to Follow-up|0|||
160709500|NCT00307437|580315662|FG003|Controlled Period|Lost to Follow-up|0|||
160709501|NCT00307437|580315663|FG004|Controlled Period|Lost to Follow-up|0|||
160709502|NCT00307437|580315664|FG005|Controlled Period|Lost to Follow-up|0|||
160709503|NCT00307437|580315665|FG006|Controlled Period|Lost to Follow-up|0|||
160709504|NCT00307437|580315659|FG000|Controlled Period|Other|5|||
160709505|NCT00307437|580315660|FG001|Controlled Period|Other|1|||
160709506|NCT00307437|580315661|FG002|Controlled Period|Other|3|||
160709507|NCT00307437|580315662|FG003|Controlled Period|Other|0|||
160709508|NCT00307437|580315663|FG004|Controlled Period|Other|0|||
160709509|NCT00307437|580315664|FG005|Controlled Period|Other|0|||
160709510|NCT00307437|580315665|FG006|Controlled Period|Other|0|||
160709511|NCT00307437|580315659|FG000|After Controlled Period|Adverse Event|0|||
160709512|NCT00307437|580315660|FG001|After Controlled Period|Adverse Event|0|||
160709513|NCT00307437|580315661|FG002|After Controlled Period|Adverse Event|0|||
160709514|NCT00307437|580315662|FG003|After Controlled Period|Adverse Event|18|||
160709515|NCT00307437|580315663|FG004|After Controlled Period|Adverse Event|16|||
160709516|NCT00307437|580315664|FG005|After Controlled Period|Adverse Event|31|||
160709517|NCT00307437|580315665|FG006|After Controlled Period|Adverse Event|40|||
160709518|NCT00307437|580315659|FG000|After Controlled Period|Death|0|||
160709519|NCT00307437|580315660|FG001|After Controlled Period|Death|0|||
160709520|NCT00307437|580315661|FG002|After Controlled Period|Death|0|||
160709521|NCT00307437|580315662|FG003|After Controlled Period|Death|3|||
160709522|NCT00307437|580315663|FG004|After Controlled Period|Death|1|||
160709523|NCT00307437|580315664|FG005|After Controlled Period|Death|1|||
160709524|NCT00307437|580315665|FG006|After Controlled Period|Death|3|||
160709525|NCT00307437|580315659|FG000|After Controlled Period|Lack of Efficacy|0|||
160709526|NCT00307437|580315660|FG001|After Controlled Period|Lack of Efficacy|0|||
160709527|NCT00307437|580315661|FG002|After Controlled Period|Lack of Efficacy|0|||
160709528|NCT00307437|580315662|FG003|After Controlled Period|Lack of Efficacy|15|||
160709529|NCT00307437|580315663|FG004|After Controlled Period|Lack of Efficacy|17|||
160709530|NCT00307437|580315664|FG005|After Controlled Period|Lack of Efficacy|37|||
160709531|NCT00307437|580315665|FG006|After Controlled Period|Lack of Efficacy|24|||
160709532|NCT00307437|580315659|FG000|After Controlled Period|Lost to Follow-up|0|||
160709533|NCT00307437|580315660|FG001|After Controlled Period|Lost to Follow-up|0|||
160709534|NCT00307437|580315661|FG002|After Controlled Period|Lost to Follow-up|0|||
160709535|NCT00307437|580315662|FG003|After Controlled Period|Lost to Follow-up|7|||
160709536|NCT00307437|580315663|FG004|After Controlled Period|Lost to Follow-up|12|||
160709537|NCT00307437|580315664|FG005|After Controlled Period|Lost to Follow-up|13|||
160709538|NCT00307437|580315665|FG006|After Controlled Period|Lost to Follow-up|18|||
160709539|NCT00307437|580315659|FG000|After Controlled Period|Other|0|||
160709540|NCT00307437|580315660|FG001|After Controlled Period|Other|0|||
160709541|NCT00307437|580315661|FG002|After Controlled Period|Other|0|||
160709542|NCT00307437|580315662|FG003|After Controlled Period|Other|15|||
160709543|NCT00307437|580315663|FG004|After Controlled Period|Other|9|||
160709544|NCT00307437|580315664|FG005|After Controlled Period|Other|40|||
160709545|NCT00307437|580315665|FG006|After Controlled Period|Other|28|||
160709546|NCT00338728|580315666|FG000|Overall Study|Screen Failure|14|||
160709547|NCT04380961|580315671|FG000|Overall Study|Lost to Follow-up|17|||
160709548|NCT04380961|580315672|FG001|Overall Study|Lost to Follow-up|11|||
160709549|NCT04380961|580315671|FG000|Overall Study|Withdrawal by Subject|3|||
160709550|NCT04380961|580315672|FG001|Overall Study|Withdrawal by Subject|0|||
160709551|NCT04380961|580315671|FG000|Overall Study|Death|22|||
160709552|NCT04380961|580315672|FG001|Overall Study|Death|16|||
160709553|NCT04380961|580315671|FG000|Overall Study|Other|1|||
160709554|NCT04380961|580315672|FG001|Overall Study|Other|0|||
160709555|NCT04380961|580315671|FG000|Overall Study|Randomized but Not Treated|1|||
160709556|NCT04380961|580315672|FG001|Overall Study|Randomized but Not Treated|2|||
160709557|NCT04803305|580315673|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
160709558|NCT04803305|580315674|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
160709559|NCT04803305|580315673|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
160709560|NCT04803305|580315674|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
160709561|NCT04803305|580315673|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
160709562|NCT04803305|580315674|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
160709563|NCT04803305|580315673|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
160709564|NCT04803305|580315674|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
160709565|NCT04803305|580315673|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
160709566|NCT04803305|580315674|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
160709567|NCT04803305|580315673|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
160709568|NCT04803305|580315674|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
160709569|NCT04803305|580315673|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
160709570|NCT04803305|580315674|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
160709571|NCT04803305|580315673|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
160709572|NCT04803305|580315674|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
160709573|NCT01862484|580315676|FG000|Overall Study|Lack of Efficacy|1|||
160709574|NCT01862484|580315677|FG001|Overall Study|Lack of Efficacy|1|||
160709575|NCT01862484|580315676|FG000|Overall Study|Lost to Follow-up|1|||
160709576|NCT01862484|580315677|FG001|Overall Study|Lost to Follow-up|2|||
160709577|NCT01862484|580315676|FG000|Overall Study|Protocol Violation|0|||
160709578|NCT01862484|580315677|FG001|Overall Study|Protocol Violation|2|||
160709579|NCT01862484|580315676|FG000|Overall Study|Withdrawal by Subject|0|||
160709580|NCT01862484|580315677|FG001|Overall Study|Withdrawal by Subject|3|||
160709581|NCT00996892|580315678|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
160709582|NCT00996892|580315679|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
160709583|NCT00996892|580315680|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
160709584|NCT00996892|580315681|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
160709585|NCT00996892|580315682|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
160709586|NCT00996892|580315683|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
160709587|NCT00996892|580315684|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
160709588|NCT00996892|580315685|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
160709589|NCT00996892|580315686|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
160709590|NCT00996892|580315687|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
160709591|NCT00996892|580315688|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
160709592|NCT00996892|580315689|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
160709593|NCT00996892|580315690|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
160709594|NCT00996892|580315691|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
160709595|NCT00996892|580315692|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
160709596|NCT00996892|580315693|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
160709597|NCT00996892|580315694|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
160709598|NCT00996892|580315695|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
160709599|NCT00996892|580315696|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
160709600|NCT00996892|580315697|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
160709601|NCT00996892|580315678|FG000|Dose-Escalation Stage 1|Death|1|||
160709602|NCT00996892|580315679|FG001|Dose-Escalation Stage 1|Death|0|||
160709603|NCT00996892|580315680|FG002|Dose-Escalation Stage 1|Death|0|||
160709604|NCT00996892|580315681|FG003|Dose-Escalation Stage 1|Death|0|||
160709605|NCT00996892|580315682|FG004|Dose-Escalation Stage 1|Death|0|||
160709606|NCT00996892|580315683|FG005|Dose-Escalation Stage 1|Death|1|||
160709607|NCT00996892|580315684|FG006|Dose-Escalation Stage 1|Death|0|||
160709608|NCT00996892|580315685|FG007|Dose-Escalation Stage 1|Death|0|||
160709609|NCT00996892|580315686|FG008|Dose-Escalation Stage 1|Death|0|||
160709610|NCT00996892|580315687|FG009|Dose-Escalation Stage 1|Death|0|||
160709611|NCT00996892|580315688|FG010|Dose-Escalation Stage 1|Death|0|||
160709612|NCT00996892|580315689|FG011|Dose-Escalation Stage 1|Death|0|||
160709613|NCT00996892|580315690|FG012|Dose-Escalation Stage 1|Death|0|||
160709614|NCT00996892|580315691|FG013|Dose-Escalation Stage 1|Death|0|||
160709615|NCT00996892|580315692|FG014|Dose-Escalation Stage 1|Death|0|||
160709616|NCT00996892|580315693|FG015|Dose-Escalation Stage 1|Death|0|||
160709617|NCT00996892|580315694|FG016|Dose-Escalation Stage 1|Death|0|||
160709618|NCT00996892|580315695|FG017|Dose-Escalation Stage 1|Death|0|||
160709619|NCT00996892|580315696|FG018|Dose-Escalation Stage 1|Death|0|||
160709620|NCT00996892|580315697|FG019|Dose-Escalation Stage 1|Death|0|||
160709621|NCT00996892|580315678|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
160709622|NCT00996892|580315679|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
160709623|NCT00996892|580315680|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
160709624|NCT00996892|580315681|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
160709625|NCT00996892|580315682|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
160709626|NCT00996892|580315683|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
160709627|NCT00996892|580315684|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
160709628|NCT00996892|580315685|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
160709629|NCT00996892|580315686|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
160709630|NCT00996892|580315687|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
160709631|NCT00996892|580315688|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
160709632|NCT00996892|580315689|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
160709633|NCT00996892|580315690|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
160709634|NCT00996892|580315691|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
160709635|NCT00996892|580315692|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
160709636|NCT00996892|580315693|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
160709637|NCT00996892|580315694|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
160709638|NCT00996892|580315695|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
160709639|NCT00996892|580315696|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
160709640|NCT00996892|580315697|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
160709641|NCT00996892|580315678|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709642|NCT00996892|580315679|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
160709643|NCT00996892|580315680|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709644|NCT00996892|580315681|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
160709645|NCT00996892|580315682|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
160709646|NCT00996892|580315683|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
160709647|NCT00996892|580315684|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
160709648|NCT00996892|580315685|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709649|NCT00996892|580315686|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709650|NCT00996892|580315687|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709651|NCT00996892|580315688|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709652|NCT00996892|580315689|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709653|NCT00996892|580315690|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709654|NCT00996892|580315691|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709655|NCT00996892|580315692|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709656|NCT00996892|580315693|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709657|NCT00996892|580315694|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709658|NCT00996892|580315695|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709659|NCT00996892|580315696|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709660|NCT00996892|580315697|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
160709661|NCT00996892|580315678|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
160709662|NCT00996892|580315679|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
160709663|NCT00996892|580315680|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
160709664|NCT00996892|580315681|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
160709665|NCT00996892|580315682|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
160709666|NCT00996892|580315683|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
160709667|NCT00996892|580315684|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
160709668|NCT00996892|580315685|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
160709669|NCT00996892|580315686|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
160709670|NCT00996892|580315687|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
160709671|NCT00996892|580315688|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
160709672|NCT00996892|580315689|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
160709673|NCT00996892|580315690|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
160709674|NCT00996892|580315691|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
160709675|NCT00996892|580315692|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
160709676|NCT00996892|580315693|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
160709677|NCT00996892|580315694|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
160709678|NCT00996892|580315695|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
160709679|NCT00996892|580315696|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
160709680|NCT00996892|580315697|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
160709681|NCT00996892|580315678|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
160709682|NCT00996892|580315679|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
160709683|NCT00996892|580315680|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
160709684|NCT00996892|580315681|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
160709685|NCT00996892|580315682|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
160709686|NCT00996892|580315683|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
160709687|NCT00996892|580315684|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
160709688|NCT00996892|580315685|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
160709689|NCT00996892|580315686|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
160709690|NCT00996892|580315687|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
160709691|NCT00996892|580315688|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
160709692|NCT00996892|580315689|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
160709693|NCT00996892|580315690|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
160709694|NCT00996892|580315691|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
160709695|NCT00996892|580315692|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
160709696|NCT00996892|580315693|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
160709697|NCT00996892|580315694|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
160709698|NCT00996892|580315695|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
160709699|NCT00996892|580315696|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
160709700|NCT00996892|580315697|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
160709701|NCT00996892|580315678|FG000|Dose-Escalation Stage 1A|Death|0|||
160709702|NCT00996892|580315679|FG001|Dose-Escalation Stage 1A|Death|0|||
160709703|NCT00996892|580315680|FG002|Dose-Escalation Stage 1A|Death|0|||
160709704|NCT00996892|580315681|FG003|Dose-Escalation Stage 1A|Death|0|||
160709705|NCT00996892|580315682|FG004|Dose-Escalation Stage 1A|Death|0|||
160709706|NCT00996892|580315683|FG005|Dose-Escalation Stage 1A|Death|0|||
160709707|NCT00996892|580315684|FG006|Dose-Escalation Stage 1A|Death|0|||
160709708|NCT00996892|580315685|FG007|Dose-Escalation Stage 1A|Death|0|||
160709709|NCT00996892|580315686|FG008|Dose-Escalation Stage 1A|Death|0|||
160709710|NCT00996892|580315687|FG009|Dose-Escalation Stage 1A|Death|2|||
160709711|NCT00996892|580315688|FG010|Dose-Escalation Stage 1A|Death|0|||
160709712|NCT00996892|580315689|FG011|Dose-Escalation Stage 1A|Death|1|||
160709713|NCT00996892|580315690|FG012|Dose-Escalation Stage 1A|Death|1|||
160709714|NCT00996892|580315691|FG013|Dose-Escalation Stage 1A|Death|0|||
160709715|NCT00996892|580315692|FG014|Dose-Escalation Stage 1A|Death|0|||
160709716|NCT00996892|580315693|FG015|Dose-Escalation Stage 1A|Death|0|||
160709717|NCT00996892|580315694|FG016|Dose-Escalation Stage 1A|Death|0|||
160709718|NCT00996892|580315695|FG017|Dose-Escalation Stage 1A|Death|0|||
160709719|NCT00996892|580315696|FG018|Dose-Escalation Stage 1A|Death|0|||
160709720|NCT00996892|580315697|FG019|Dose-Escalation Stage 1A|Death|0|||
160709721|NCT00996892|580315678|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
160709722|NCT00996892|580315679|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
160709723|NCT00996892|580315680|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
160709724|NCT00996892|580315681|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
160709725|NCT00996892|580315682|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
160709726|NCT00996892|580315683|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
160709727|NCT00996892|580315684|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
160709728|NCT00996892|580315685|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
160709729|NCT00996892|580315686|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
160709730|NCT00996892|580315687|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
160709731|NCT00996892|580315688|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
160709732|NCT00996892|580315689|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
160709733|NCT00996892|580315690|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
160709734|NCT00996892|580315691|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
160709735|NCT00996892|580315692|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
160709736|NCT00996892|580315693|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
160709737|NCT00996892|580315694|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
160709738|NCT00996892|580315695|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
160709739|NCT00996892|580315696|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
160709740|NCT00996892|580315697|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
160709741|NCT00996892|580315678|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709742|NCT00996892|580315679|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709743|NCT00996892|580315680|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709744|NCT00996892|580315681|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709745|NCT00996892|580315682|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709746|NCT00996892|580315683|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709747|NCT00996892|580315684|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709748|NCT00996892|580315685|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709749|NCT00996892|580315686|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709750|NCT00996892|580315687|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
160709751|NCT00996892|580315688|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
160709752|NCT00996892|580315689|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
160709753|NCT00996892|580315690|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
160709754|NCT00996892|580315691|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709755|NCT00996892|580315692|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709756|NCT00996892|580315693|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709757|NCT00996892|580315694|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709758|NCT00996892|580315695|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709759|NCT00996892|580315696|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709760|NCT00996892|580315697|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
160709761|NCT00996892|580315678|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
160709762|NCT00996892|580315679|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
160709763|NCT00996892|580315680|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
160709764|NCT00996892|580315681|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
160709765|NCT00996892|580315682|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
160709766|NCT00996892|580315683|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
160709767|NCT00996892|580315684|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
160709768|NCT00996892|580315685|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
160709769|NCT00996892|580315686|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
160709770|NCT00996892|580315687|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
160709771|NCT00996892|580315688|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
160709772|NCT00996892|580315689|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
160709773|NCT00996892|580315690|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
160709774|NCT00996892|580315691|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
160709775|NCT00996892|580315692|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
160709776|NCT00996892|580315693|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
160709777|NCT00996892|580315694|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
160709778|NCT00996892|580315695|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
160709779|NCT00996892|580315696|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
160709780|NCT00996892|580315697|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
160709781|NCT00996892|580315678|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
160709782|NCT00996892|580315679|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
160709783|NCT00996892|580315680|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
160709784|NCT00996892|580315681|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
160709785|NCT00996892|580315682|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
160709786|NCT00996892|580315683|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
160709787|NCT00996892|580315684|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
160709788|NCT00996892|580315685|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
160709789|NCT00996892|580315686|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
160709790|NCT00996892|580315687|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
160709791|NCT00996892|580315688|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
160709792|NCT00996892|580315689|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
160709793|NCT00996892|580315690|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
160709794|NCT00996892|580315691|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
160709795|NCT00996892|580315692|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
160709796|NCT00996892|580315693|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
160709797|NCT00996892|580315694|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
160709798|NCT00996892|580315695|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
160709799|NCT00996892|580315696|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
160709800|NCT00996892|580315697|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
160709801|NCT00996892|580315678|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
160709802|NCT00996892|580315679|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
160709803|NCT00996892|580315680|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
160709804|NCT00996892|580315681|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
160709805|NCT00996892|580315682|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
160709806|NCT00996892|580315683|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
160709807|NCT00996892|580315684|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
160709808|NCT00996892|580315685|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
160709809|NCT00996892|580315686|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
160709810|NCT00996892|580315687|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
160709811|NCT00996892|580315688|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
160709812|NCT00996892|580315689|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
160709813|NCT00996892|580315690|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
160709814|NCT00996892|580315691|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
160709815|NCT00996892|580315692|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
160709816|NCT00996892|580315693|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
160709817|NCT00996892|580315694|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
160709818|NCT00996892|580315695|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
160709819|NCT00996892|580315696|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
160709820|NCT00996892|580315697|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
160709821|NCT00996892|580315678|FG000|Expansion Stage 2|Adverse Event|0|||
160709822|NCT00996892|580315679|FG001|Expansion Stage 2|Adverse Event|0|||
160709823|NCT00996892|580315680|FG002|Expansion Stage 2|Adverse Event|0|||
160709824|NCT00996892|580315681|FG003|Expansion Stage 2|Adverse Event|0|||
160709825|NCT00996892|580315682|FG004|Expansion Stage 2|Adverse Event|0|||
160709826|NCT00996892|580315683|FG005|Expansion Stage 2|Adverse Event|0|||
160709827|NCT00996892|580315684|FG006|Expansion Stage 2|Adverse Event|0|||
160709828|NCT00996892|580315685|FG007|Expansion Stage 2|Adverse Event|0|||
160709829|NCT00996892|580315686|FG008|Expansion Stage 2|Adverse Event|0|||
160709830|NCT00996892|580315687|FG009|Expansion Stage 2|Adverse Event|0|||
160709831|NCT00996892|580315688|FG010|Expansion Stage 2|Adverse Event|0|||
160709832|NCT00996892|580315689|FG011|Expansion Stage 2|Adverse Event|0|||
160709833|NCT00996892|580315690|FG012|Expansion Stage 2|Adverse Event|0|||
160709834|NCT00996892|580315691|FG013|Expansion Stage 2|Adverse Event|0|||
160709835|NCT00996892|580315692|FG014|Expansion Stage 2|Adverse Event|0|||
160709836|NCT00996892|580315693|FG015|Expansion Stage 2|Adverse Event|0|||
160709837|NCT00996892|580315694|FG016|Expansion Stage 2|Adverse Event|0|||
160709838|NCT00996892|580315695|FG017|Expansion Stage 2|Adverse Event|0|||
160709839|NCT00996892|580315696|FG018|Expansion Stage 2|Adverse Event|3|||
160709840|NCT00996892|580315697|FG019|Expansion Stage 2|Adverse Event|0|||
160709841|NCT00996892|580315678|FG000|Expansion Stage 2|Death|0|||
160709842|NCT00996892|580315679|FG001|Expansion Stage 2|Death|0|||
160709843|NCT00996892|580315680|FG002|Expansion Stage 2|Death|0|||
160709844|NCT00996892|580315681|FG003|Expansion Stage 2|Death|0|||
160709845|NCT00996892|580315682|FG004|Expansion Stage 2|Death|0|||
160709846|NCT00996892|580315683|FG005|Expansion Stage 2|Death|0|||
160709847|NCT00996892|580315684|FG006|Expansion Stage 2|Death|0|||
160709848|NCT00996892|580315685|FG007|Expansion Stage 2|Death|0|||
160709849|NCT00996892|580315686|FG008|Expansion Stage 2|Death|0|||
160709850|NCT00996892|580315687|FG009|Expansion Stage 2|Death|0|||
160709851|NCT00996892|580315688|FG010|Expansion Stage 2|Death|0|||
160709852|NCT00996892|580315689|FG011|Expansion Stage 2|Death|0|||
160709853|NCT00996892|580315690|FG012|Expansion Stage 2|Death|0|||
160709854|NCT00996892|580315691|FG013|Expansion Stage 2|Death|0|||
160709855|NCT00996892|580315692|FG014|Expansion Stage 2|Death|0|||
160709856|NCT00996892|580315693|FG015|Expansion Stage 2|Death|0|||
160709857|NCT00996892|580315694|FG016|Expansion Stage 2|Death|0|||
160709858|NCT00996892|580315695|FG017|Expansion Stage 2|Death|0|||
160709859|NCT00996892|580315696|FG018|Expansion Stage 2|Death|2|||
160709860|NCT00996892|580315697|FG019|Expansion Stage 2|Death|0|||
160709861|NCT00996892|580315678|FG000|Expansion Stage 2|Physician Decision|0|||
160709862|NCT00996892|580315679|FG001|Expansion Stage 2|Physician Decision|0|||
160709863|NCT00996892|580315680|FG002|Expansion Stage 2|Physician Decision|0|||
160709864|NCT00996892|580315681|FG003|Expansion Stage 2|Physician Decision|0|||
160709865|NCT00996892|580315682|FG004|Expansion Stage 2|Physician Decision|0|||
160709866|NCT00996892|580315683|FG005|Expansion Stage 2|Physician Decision|0|||
160709867|NCT00996892|580315684|FG006|Expansion Stage 2|Physician Decision|0|||
160709868|NCT00996892|580315685|FG007|Expansion Stage 2|Physician Decision|0|||
160709869|NCT00996892|580315686|FG008|Expansion Stage 2|Physician Decision|0|||
160709870|NCT00996892|580315687|FG009|Expansion Stage 2|Physician Decision|0|||
160709871|NCT00996892|580315688|FG010|Expansion Stage 2|Physician Decision|0|||
160709872|NCT00996892|580315689|FG011|Expansion Stage 2|Physician Decision|0|||
160709873|NCT00996892|580315690|FG012|Expansion Stage 2|Physician Decision|0|||
160709874|NCT00996892|580315691|FG013|Expansion Stage 2|Physician Decision|0|||
160709875|NCT00996892|580315692|FG014|Expansion Stage 2|Physician Decision|0|||
160709876|NCT00996892|580315693|FG015|Expansion Stage 2|Physician Decision|0|||
160709877|NCT00996892|580315694|FG016|Expansion Stage 2|Physician Decision|0|||
160709878|NCT00996892|580315695|FG017|Expansion Stage 2|Physician Decision|0|||
160709879|NCT00996892|580315696|FG018|Expansion Stage 2|Physician Decision|1|||
160709880|NCT00996892|580315697|FG019|Expansion Stage 2|Physician Decision|0|||
160709881|NCT00996892|580315678|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
160709882|NCT00996892|580315679|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
160709883|NCT00996892|580315680|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
160709884|NCT00996892|580315681|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
160709885|NCT00996892|580315682|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
160709886|NCT00996892|580315683|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
160709887|NCT00996892|580315684|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
160709888|NCT00996892|580315685|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
160709889|NCT00996892|580315686|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
160709890|NCT00996892|580315687|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
160709891|NCT00996892|580315688|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
160709892|NCT00996892|580315689|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
160709893|NCT00996892|580315690|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
160709894|NCT00996892|580315691|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
160709895|NCT00996892|580315692|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
160709896|NCT00996892|580315693|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
160709897|NCT00996892|580315694|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
160709898|NCT00996892|580315695|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
160709899|NCT00996892|580315696|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
160709900|NCT00996892|580315697|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
160709901|NCT00996892|580315678|FG000|Expansion Stage 2|Disease Progression|0|||
160709902|NCT00996892|580315679|FG001|Expansion Stage 2|Disease Progression|0|||
160709903|NCT00996892|580315680|FG002|Expansion Stage 2|Disease Progression|0|||
160709904|NCT00996892|580315681|FG003|Expansion Stage 2|Disease Progression|0|||
160709905|NCT00996892|580315682|FG004|Expansion Stage 2|Disease Progression|0|||
160709906|NCT00996892|580315683|FG005|Expansion Stage 2|Disease Progression|0|||
160709907|NCT00996892|580315684|FG006|Expansion Stage 2|Disease Progression|0|||
160709908|NCT00996892|580315685|FG007|Expansion Stage 2|Disease Progression|0|||
160709909|NCT00996892|580315686|FG008|Expansion Stage 2|Disease Progression|0|||
160709910|NCT00996892|580315687|FG009|Expansion Stage 2|Disease Progression|0|||
160709911|NCT00996892|580315688|FG010|Expansion Stage 2|Disease Progression|0|||
160709912|NCT00996892|580315689|FG011|Expansion Stage 2|Disease Progression|0|||
160709913|NCT00996892|580315690|FG012|Expansion Stage 2|Disease Progression|0|||
160709914|NCT00996892|580315691|FG013|Expansion Stage 2|Disease Progression|0|||
160709915|NCT00996892|580315692|FG014|Expansion Stage 2|Disease Progression|0|||
160709916|NCT00996892|580315693|FG015|Expansion Stage 2|Disease Progression|0|||
160709917|NCT00996892|580315694|FG016|Expansion Stage 2|Disease Progression|0|||
160709918|NCT00996892|580315695|FG017|Expansion Stage 2|Disease Progression|0|||
160709919|NCT00996892|580315696|FG018|Expansion Stage 2|Disease Progression|28|||
160709920|NCT00996892|580315697|FG019|Expansion Stage 2|Disease Progression|0|||
160709921|NCT00996892|580315678|FG000|Expansion Stage 2A|Adverse Event|0|||
160709922|NCT00996892|580315679|FG001|Expansion Stage 2A|Adverse Event|0|||
160709923|NCT00996892|580315680|FG002|Expansion Stage 2A|Adverse Event|0|||
160709924|NCT00996892|580315681|FG003|Expansion Stage 2A|Adverse Event|0|||
160709925|NCT00996892|580315682|FG004|Expansion Stage 2A|Adverse Event|0|||
160709926|NCT00996892|580315683|FG005|Expansion Stage 2A|Adverse Event|0|||
160709927|NCT00996892|580315684|FG006|Expansion Stage 2A|Adverse Event|0|||
160709928|NCT00996892|580315685|FG007|Expansion Stage 2A|Adverse Event|0|||
160709929|NCT00996892|580315686|FG008|Expansion Stage 2A|Adverse Event|0|||
160709930|NCT00996892|580315687|FG009|Expansion Stage 2A|Adverse Event|0|||
160709931|NCT00996892|580315688|FG010|Expansion Stage 2A|Adverse Event|0|||
160709932|NCT00996892|580315689|FG011|Expansion Stage 2A|Adverse Event|0|||
160709933|NCT00996892|580315690|FG012|Expansion Stage 2A|Adverse Event|0|||
160709934|NCT00996892|580315691|FG013|Expansion Stage 2A|Adverse Event|0|||
160709935|NCT00996892|580315692|FG014|Expansion Stage 2A|Adverse Event|0|||
160709936|NCT00996892|580315693|FG015|Expansion Stage 2A|Adverse Event|0|||
160709937|NCT00996892|580315694|FG016|Expansion Stage 2A|Adverse Event|0|||
160709938|NCT00996892|580315695|FG017|Expansion Stage 2A|Adverse Event|0|||
160709939|NCT00996892|580315696|FG018|Expansion Stage 2A|Adverse Event|0|||
160709940|NCT00996892|580315697|FG019|Expansion Stage 2A|Adverse Event|8|||
160709941|NCT00996892|580315678|FG000|Expansion Stage 2A|Physician Decision|0|||
160709942|NCT00996892|580315679|FG001|Expansion Stage 2A|Physician Decision|0|||
160709943|NCT00996892|580315680|FG002|Expansion Stage 2A|Physician Decision|0|||
160709944|NCT00996892|580315681|FG003|Expansion Stage 2A|Physician Decision|0|||
160709945|NCT00996892|580315682|FG004|Expansion Stage 2A|Physician Decision|0|||
160709946|NCT00996892|580315683|FG005|Expansion Stage 2A|Physician Decision|0|||
160709947|NCT00996892|580315684|FG006|Expansion Stage 2A|Physician Decision|0|||
160709948|NCT00996892|580315685|FG007|Expansion Stage 2A|Physician Decision|0|||
160709949|NCT00996892|580315686|FG008|Expansion Stage 2A|Physician Decision|0|||
160709950|NCT00996892|580315687|FG009|Expansion Stage 2A|Physician Decision|0|||
160709951|NCT00996892|580315688|FG010|Expansion Stage 2A|Physician Decision|0|||
160709952|NCT00996892|580315689|FG011|Expansion Stage 2A|Physician Decision|0|||
160709953|NCT00996892|580315690|FG012|Expansion Stage 2A|Physician Decision|0|||
160709954|NCT00996892|580315691|FG013|Expansion Stage 2A|Physician Decision|0|||
160709955|NCT00996892|580315692|FG014|Expansion Stage 2A|Physician Decision|0|||
160709956|NCT00996892|580315693|FG015|Expansion Stage 2A|Physician Decision|0|||
160709957|NCT00996892|580315694|FG016|Expansion Stage 2A|Physician Decision|0|||
160709958|NCT00996892|580315695|FG017|Expansion Stage 2A|Physician Decision|0|||
160709959|NCT00996892|580315696|FG018|Expansion Stage 2A|Physician Decision|0|||
160709960|NCT00996892|580315697|FG019|Expansion Stage 2A|Physician Decision|2|||
160709961|NCT00996892|580315678|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
160709962|NCT00996892|580315679|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
160709963|NCT00996892|580315680|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
160709964|NCT00996892|580315681|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
160709965|NCT00996892|580315682|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
160709966|NCT00996892|580315683|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
160709967|NCT00996892|580315684|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
160709968|NCT00996892|580315685|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
160709969|NCT00996892|580315686|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
160709970|NCT00996892|580315687|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
160709971|NCT00996892|580315688|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
160709972|NCT00996892|580315689|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
160709973|NCT00996892|580315690|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
160709974|NCT00996892|580315691|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
160709975|NCT00996892|580315692|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
160709976|NCT00996892|580315693|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
160709977|NCT00996892|580315694|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
160709978|NCT00996892|580315695|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
160709979|NCT00996892|580315696|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
160709980|NCT00996892|580315697|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
160709981|NCT00996892|580315678|FG000|Expansion Stage 2A|Disease Progression|0|||
160709982|NCT00996892|580315679|FG001|Expansion Stage 2A|Disease Progression|0|||
160709983|NCT00996892|580315680|FG002|Expansion Stage 2A|Disease Progression|0|||
160709984|NCT00996892|580315681|FG003|Expansion Stage 2A|Disease Progression|0|||
160709985|NCT00996892|580315682|FG004|Expansion Stage 2A|Disease Progression|0|||
160709986|NCT00996892|580315683|FG005|Expansion Stage 2A|Disease Progression|0|||
160709987|NCT00996892|580315684|FG006|Expansion Stage 2A|Disease Progression|0|||
160709988|NCT00996892|580315685|FG007|Expansion Stage 2A|Disease Progression|0|||
160709989|NCT00996892|580315686|FG008|Expansion Stage 2A|Disease Progression|0|||
160709990|NCT00996892|580315687|FG009|Expansion Stage 2A|Disease Progression|0|||
160709991|NCT00996892|580315688|FG010|Expansion Stage 2A|Disease Progression|0|||
160709992|NCT00996892|580315689|FG011|Expansion Stage 2A|Disease Progression|0|||
160709993|NCT00996892|580315690|FG012|Expansion Stage 2A|Disease Progression|0|||
160709994|NCT00996892|580315691|FG013|Expansion Stage 2A|Disease Progression|0|||
160709995|NCT00996892|580315692|FG014|Expansion Stage 2A|Disease Progression|0|||
160709996|NCT00996892|580315693|FG015|Expansion Stage 2A|Disease Progression|0|||
160709997|NCT00996892|580315694|FG016|Expansion Stage 2A|Disease Progression|0|||
160709998|NCT00996892|580315695|FG017|Expansion Stage 2A|Disease Progression|0|||
160709999|NCT00996892|580315696|FG018|Expansion Stage 2A|Disease Progression|0|||
160710000|NCT00996892|580315697|FG019|Expansion Stage 2A|Disease Progression|31|||
160710001|NCT00993421|580315698|FG000|Overall Study|Adverse Event|2|||
160710002|NCT00993421|580315699|FG001|Overall Study|Adverse Event|7|||
160710003|NCT00993421|580315700|FG002|Overall Study|Adverse Event|6|||
160710004|NCT00993421|580315701|FG003|Overall Study|Adverse Event|9|||
160710005|NCT00993421|580315702|FG004|Overall Study|Adverse Event|5|||
160710006|NCT00993421|580315703|FG005|Overall Study|Adverse Event|7|||
160710007|NCT00993421|580315704|FG006|Overall Study|Adverse Event|1|||
160710008|NCT00993421|580315698|FG000|Overall Study|Sponsor Decision|36|||
160710009|NCT00993421|580315699|FG001|Overall Study|Sponsor Decision|31|||
160710010|NCT00993421|580315700|FG002|Overall Study|Sponsor Decision|28|||
160710011|NCT00993421|580315701|FG003|Overall Study|Sponsor Decision|30|||
160710012|NCT00993421|580315702|FG004|Overall Study|Sponsor Decision|38|||
160710013|NCT00993421|580315703|FG005|Overall Study|Sponsor Decision|30|||
160710014|NCT00993421|580315704|FG006|Overall Study|Sponsor Decision|29|||
160710015|NCT00993421|580315698|FG000|Overall Study|Lost to Follow-up|3|||
160710016|NCT00993421|580315699|FG001|Overall Study|Lost to Follow-up|5|||
160710017|NCT00993421|580315700|FG002|Overall Study|Lost to Follow-up|5|||
160710018|NCT00993421|580315701|FG003|Overall Study|Lost to Follow-up|0|||
160710019|NCT00993421|580315702|FG004|Overall Study|Lost to Follow-up|0|||
160710020|NCT00993421|580315703|FG005|Overall Study|Lost to Follow-up|0|||
160710021|NCT00993421|580315704|FG006|Overall Study|Lost to Follow-up|6|||
160710022|NCT00993421|580315698|FG000|Overall Study|Withdrawal by Subject|3|||
160710023|NCT00993421|580315699|FG001|Overall Study|Withdrawal by Subject|2|||
160710024|NCT00993421|580315700|FG002|Overall Study|Withdrawal by Subject|3|||
160710025|NCT00993421|580315701|FG003|Overall Study|Withdrawal by Subject|3|||
160710026|NCT00993421|580315702|FG004|Overall Study|Withdrawal by Subject|3|||
160710027|NCT00993421|580315703|FG005|Overall Study|Withdrawal by Subject|5|||
160710028|NCT00993421|580315704|FG006|Overall Study|Withdrawal by Subject|3|||
160710029|NCT00993421|580315698|FG000|Overall Study|Death|0|||
160710030|NCT00993421|580315699|FG001|Overall Study|Death|0|||
160710031|NCT00993421|580315700|FG002|Overall Study|Death|0|||
160710032|NCT00993421|580315701|FG003|Overall Study|Death|0|||
160710033|NCT00993421|580315702|FG004|Overall Study|Death|0|||
160710034|NCT00993421|580315703|FG005|Overall Study|Death|0|||
160710035|NCT00993421|580315704|FG006|Overall Study|Death|1|||
160710036|NCT00993421|580315698|FG000|Overall Study|Entry Criteria Exclusion|0|||
160710037|NCT00993421|580315699|FG001|Overall Study|Entry Criteria Exclusion|0|||
160710038|NCT00993421|580315700|FG002|Overall Study|Entry Criteria Exclusion|1|||
160710039|NCT00993421|580315701|FG003|Overall Study|Entry Criteria Exclusion|3|||
160710040|NCT00993421|580315702|FG004|Overall Study|Entry Criteria Exclusion|0|||
160710041|NCT00993421|580315703|FG005|Overall Study|Entry Criteria Exclusion|1|||
160710042|NCT00993421|580315704|FG006|Overall Study|Entry Criteria Exclusion|0|||
160710043|NCT00993421|580315698|FG000|Overall Study|Physician Decision|0|||
160710044|NCT00993421|580315699|FG001|Overall Study|Physician Decision|0|||
160710045|NCT00993421|580315700|FG002|Overall Study|Physician Decision|0|||
160710046|NCT00993421|580315701|FG003|Overall Study|Physician Decision|0|||
160710047|NCT00993421|580315702|FG004|Overall Study|Physician Decision|0|||
160710048|NCT00993421|580315703|FG005|Overall Study|Physician Decision|1|||
160710049|NCT00993421|580315704|FG006|Overall Study|Physician Decision|1|||
160710050|NCT00993421|580315698|FG000|Overall Study|Protocol Violation|0|||
160710051|NCT00993421|580315699|FG001|Overall Study|Protocol Violation|0|||
160710052|NCT00993421|580315700|FG002|Overall Study|Protocol Violation|0|||
160710053|NCT00993421|580315701|FG003|Overall Study|Protocol Violation|0|||
160710054|NCT00993421|580315702|FG004|Overall Study|Protocol Violation|0|||
160710055|NCT00993421|580315703|FG005|Overall Study|Protocol Violation|2|||
160710056|NCT00993421|580315704|FG006|Overall Study|Protocol Violation|1|||
160710057|NCT02759692|580315705|FG000|Period 1|Test article no longer available|1|||
160710058|NCT02759692|580315706|FG001|Period 1|Test article no longer available|1|||
160710059|NCT02759692|580315705|FG000|Period 1|No longer meets eligibility criteria.|1|||
160710060|NCT02759692|580315706|FG001|Period 1|No longer meets eligibility criteria.|0|||
160710061|NCT02759692|580315705|FG000|Period 1|Miss-Randomized|1|||
160710062|NCT02759692|580315706|FG001|Period 1|Miss-Randomized|1|||
160710063|NCT02759692|580315705|FG000|Period 2|Lost to Follow-up|1|||
160710064|NCT02759692|580315706|FG001|Period 2|Lost to Follow-up|0|||
160710065|NCT02759692|580315705|FG000|Period 2|Test article no longer available|0|||
160710066|NCT02759692|580315706|FG001|Period 2|Test article no longer available|1|||
160710067|NCT04042376|580315712|FG000|Overall Study|Withdrawal by Subject|1|||
160710068|NCT04042376|580315712|FG000|Overall Study|Death|3|||
160710069|NCT02514447|580317710|FG000|Overall Study|Withdrawal by Subject|3|||
160710070|NCT02514447|580317711|FG001|Overall Study|Withdrawal by Subject|1|||
160710071|NCT02514447|580317712|FG002|Overall Study|Withdrawal by Subject|1|||
160710072|NCT02514447|580317713|FG003|Overall Study|Withdrawal by Subject|0|||
160710073|NCT02514447|580317714|FG004|Overall Study|Withdrawal by Subject|0|||
160710074|NCT02514447|580317715|FG005|Overall Study|Withdrawal by Subject|0|||
160710075|NCT02514447|580317716|FG006|Overall Study|Withdrawal by Subject|0|||
160710076|NCT02514447|580317717|FG007|Overall Study|Withdrawal by Subject|1|||
160710077|NCT02514447|580317718|FG008|Overall Study|Withdrawal by Subject|1|||
160710078|NCT02514447|580317710|FG000|Overall Study|Death|24|||
160710079|NCT02514447|580317711|FG001|Overall Study|Death|28|||
160710080|NCT02514447|580317712|FG002|Overall Study|Death|29|||
160710081|NCT02514447|580317713|FG003|Overall Study|Death|0|||
160710082|NCT02514447|580317714|FG004|Overall Study|Death|3|||
160710083|NCT02514447|580317715|FG005|Overall Study|Death|4|||
160710084|NCT02514447|580317716|FG006|Overall Study|Death|8|||
160710085|NCT02514447|580317717|FG007|Overall Study|Death|6|||
160710086|NCT02514447|580317718|FG008|Overall Study|Death|5|||
160710087|NCT02514447|580317710|FG000|Overall Study|Lost to Follow-up|1|||
160710088|NCT02514447|580317711|FG001|Overall Study|Lost to Follow-up|0|||
160710089|NCT02514447|580317712|FG002|Overall Study|Lost to Follow-up|0|||
160710090|NCT02514447|580317713|FG003|Overall Study|Lost to Follow-up|0|||
160710091|NCT02514447|580317714|FG004|Overall Study|Lost to Follow-up|0|||
160710092|NCT02514447|580317715|FG005|Overall Study|Lost to Follow-up|0|||
160710093|NCT02514447|580317716|FG006|Overall Study|Lost to Follow-up|0|||
160710094|NCT02514447|580317717|FG007|Overall Study|Lost to Follow-up|0|||
160710095|NCT02514447|580317718|FG008|Overall Study|Lost to Follow-up|1|||
160710096|NCT02514447|580317710|FG000|Overall Study|Sponsor Termination of Study|0|||
160710097|NCT02514447|580317711|FG001|Overall Study|Sponsor Termination of Study|1|||
160710098|NCT02514447|580317712|FG002|Overall Study|Sponsor Termination of Study|1|||
160710099|NCT02514447|580317713|FG003|Overall Study|Sponsor Termination of Study|0|||
160710100|NCT02514447|580317714|FG004|Overall Study|Sponsor Termination of Study|0|||
160710101|NCT02514447|580317715|FG005|Overall Study|Sponsor Termination of Study|0|||
160710102|NCT02514447|580317716|FG006|Overall Study|Sponsor Termination of Study|0|||
160710103|NCT02514447|580317717|FG007|Overall Study|Sponsor Termination of Study|0|||
160710104|NCT02514447|580317718|FG008|Overall Study|Sponsor Termination of Study|0|||
160710105|NCT02514447|580317710|FG000|Overall Study|Study completion per Investigator|1|||
160710106|NCT02514447|580317711|FG001|Overall Study|Study completion per Investigator|0|||
160710107|NCT02514447|580317712|FG002|Overall Study|Study completion per Investigator|1|||
160710108|NCT02514447|580317713|FG003|Overall Study|Study completion per Investigator|2|||
160710109|NCT02514447|580317714|FG004|Overall Study|Study completion per Investigator|0|||
160710110|NCT02514447|580317715|FG005|Overall Study|Study completion per Investigator|0|||
160710111|NCT02514447|580317716|FG006|Overall Study|Study completion per Investigator|0|||
160710112|NCT02514447|580317717|FG007|Overall Study|Study completion per Investigator|0|||
160710113|NCT02514447|580317718|FG008|Overall Study|Study completion per Investigator|1|||
160710114|NCT02481869|580317725|FG000|Overall Study|Lost to Follow-up|3|||
160710115|NCT02481869|580317726|FG001|Overall Study|Lost to Follow-up|4|||
160710116|NCT02481869|580317725|FG000|Overall Study|Withdrawal by Subject|2|||
160710117|NCT02481869|580317726|FG001|Overall Study|Withdrawal by Subject|0|||
160710118|NCT01090414|580317727|FG000|Study 101-99|Progressive Disease|28|||
160710119|NCT01090414|580317728|FG001|Study 101-99|Progressive Disease|48|||
160710120|NCT01090414|580317729|FG002|Study 101-99|Progressive Disease|10|||
160710121|NCT01090414|580317730|FG003|Study 101-99|Progressive Disease|4|||
160710122|NCT01090414|580317727|FG000|Study 101-99|Adverse Event|10|||
160710123|NCT01090414|580317728|FG001|Study 101-99|Adverse Event|28|||
160710124|NCT01090414|580317729|FG002|Study 101-99|Adverse Event|18|||
160710125|NCT01090414|580317730|FG003|Study 101-99|Adverse Event|0|||
160710126|NCT01090414|580317727|FG000|Study 101-99|Investigator Request|1|||
160710127|NCT01090414|580317728|FG001|Study 101-99|Investigator Request|11|||
160710128|NCT01090414|580317729|FG002|Study 101-99|Investigator Request|4|||
160710129|NCT01090414|580317730|FG003|Study 101-99|Investigator Request|0|||
160710130|NCT01090414|580317727|FG000|Study 101-99|Death|3|||
160710131|NCT01090414|580317728|FG001|Study 101-99|Death|8|||
160710132|NCT01090414|580317729|FG002|Study 101-99|Death|1|||
160710133|NCT01090414|580317730|FG003|Study 101-99|Death|0|||
160710134|NCT01090414|580317727|FG000|Study 101-99|Sponsor Discontinued Study|0|||
160710135|NCT01090414|580317728|FG001|Study 101-99|Sponsor Discontinued Study|7|||
160710136|NCT01090414|580317729|FG002|Study 101-99|Sponsor Discontinued Study|5|||
160710137|NCT01090414|580317730|FG003|Study 101-99|Sponsor Discontinued Study|0|||
160710138|NCT01090414|580317727|FG000|Study 101-99|Other (Unknown Reasons)|3|||
160710139|NCT01090414|580317728|FG001|Study 101-99|Other (Unknown Reasons)|3|||
160710140|NCT01090414|580317729|FG002|Study 101-99|Other (Unknown Reasons)|0|||
160710141|NCT01090414|580317730|FG003|Study 101-99|Other (Unknown Reasons)|0|||
160710142|NCT01090414|580317727|FG000|Study 101-99|Withdrew Consent|0|||
160710143|NCT01090414|580317728|FG001|Study 101-99|Withdrew Consent|2|||
160710144|NCT01090414|580317729|FG002|Study 101-99|Withdrew Consent|3|||
160710145|NCT01090414|580317730|FG003|Study 101-99|Withdrew Consent|1|||
160710146|NCT01090414|580317727|FG000|Study 101-99|Participant Request|3|||
160710147|NCT01090414|580317728|FG001|Study 101-99|Participant Request|1|||
160710148|NCT01090414|580317729|FG002|Study 101-99|Participant Request|0|||
160710149|NCT01090414|580317730|FG003|Study 101-99|Participant Request|0|||
160710150|NCT00668317|580317731|FG000|Overall Study|Adverse Event|2|||
160710151|NCT04753216|580317732|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
160710152|NCT04753216|580317732|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
160710153|NCT04753216|580317732|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
160710154|NCT02001987|580317734|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
160710155|NCT02001987|580317734|FG000|Core Study Period (24 Weeks)|Death|1|||
160710156|NCT02001987|580317734|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
160710157|NCT02001987|580317734|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
160710158|NCT02001987|580317734|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
160710159|NCT02001987|580317734|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
160710160|NCT02001987|580317734|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
160710161|NCT02001987|580317734|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
160710162|NCT02001987|580317734|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
160710163|NCT02001987|580317734|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
160710164|NCT02001987|580317734|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
160710165|NCT02001987|580317734|FG000|LTE Period (52 Weeks)|Other|3|||
160710166|NCT01965860|580317735|FG000|Overall Study|Pregnancy|1|||
160710167|NCT01965860|580317736|FG001|Overall Study|Pregnancy|0|||
160710168|NCT01965860|580317737|FG002|Overall Study|Pregnancy|1|||
160710169|NCT01965860|580317735|FG000|Overall Study|Logistics|1|||
160710170|NCT01965860|580317736|FG001|Overall Study|Logistics|0|||
160710171|NCT01965860|580317737|FG002|Overall Study|Logistics|0|||
160710172|NCT01884337|580317742|FG000|Treatment|Adverse Event|2|||
160710173|NCT01884337|580317743|FG001|Treatment|Adverse Event|2|||
160710174|NCT01884337|580317742|FG000|Treatment|Subj. request to discont. treatment|2|||
160710175|NCT01884337|580317743|FG001|Treatment|Subj. request to discont. treatment|0|||
160710176|NCT01884337|580317742|FG000|Follow-up Period|Lost to Follow-up|1|||
160710177|NCT01884337|580317743|FG001|Follow-up Period|Lost to Follow-up|1|||
160710178|NCT02455518|580317744|FG000|Overall Study|Protocol Violation|0|||
160710179|NCT02455518|580317745|FG001|Overall Study|Protocol Violation|1|||
160710180|NCT02455518|580317746|FG002|Overall Study|Protocol Violation|1|||
160710181|NCT02455518|580317747|FG003|Overall Study|Protocol Violation|3|||
160710182|NCT02508935|580317748|FG000|Overall Study|Withdrawal by Subject|1|||
160710183|NCT02508935|580317748|FG000|Overall Study|Withdrawal by Caregiver|8|||
160710184|NCT02508935|580317748|FG000|Overall Study|Pain Score <4|1|||
160710185|NCT02508935|580317748|FG000|Overall Study|Emesis|3|||
160710186|NCT02508935|580317748|FG000|Overall Study|Adverse Event|3|||
160710187|NCT02508935|580317748|FG000|Overall Study|Protocol Violation|1|||
160710188|NCT02508935|580317748|FG000|Overall Study|Physician Decision|1|||
160710189|NCT02508935|580317748|FG000|Overall Study|Trial terminated by sponsor|5|||
160710190|NCT04759703|580317761|FG000|Overall Study|Withdrawal by Subject|4|||
160710191|NCT04759703|580317762|FG001|Overall Study|Withdrawal by Subject|9|||
160710192|NCT04759703|580317761|FG000|Overall Study|Adverse Event|1|||
160710193|NCT04759703|580317762|FG001|Overall Study|Adverse Event|0|||
160710194|NCT04759703|580317761|FG000|Overall Study|Lost to Follow-up|2|||
160710195|NCT04759703|580317762|FG001|Overall Study|Lost to Follow-up|0|||
160710196|NCT04186845|580317766|FG000|Overall Study|Death|2|||
160710197|NCT04186845|580317766|FG000|Overall Study|Lost to Follow-up|1|||
160710198|NCT04186845|580317766|FG000|Overall Study|Physician Decision|1|||
160710199|NCT04186845|580317766|FG000|Overall Study|Protocol Violation|1|||
160710200|NCT04186845|580317766|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
160710201|NCT04186845|580317766|FG000|Overall Study|Biopsy ordered but not done|1|||
160710202|NCT04186845|580317766|FG000|Overall Study|It was previously confirmed|1|||
160710203|NCT04186845|580317766|FG000|Overall Study|Patient cancelled scheduled scans|2|||
160710204|NCT04186845|580317766|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
160710205|NCT04186845|580317766|FG000|Overall Study|Subject refused confirmatory imaging|1|||
160710206|NCT04186845|580317766|FG000|Overall Study|Too small to biopsy|1|||
160710207|NCT04138823|580317767|FG000|Overall Study|Clinical disease progression|0|||
160710208|NCT04138823|580317768|FG001|Overall Study|Clinical disease progression|0|||
160710209|NCT04138823|580317769|FG002|Overall Study|Clinical disease progression|1|||
160710210|NCT04138823|580317767|FG000|Overall Study|Objective disease progression|3|||
160710211|NCT04138823|580317768|FG001|Overall Study|Objective disease progression|2|||
160710212|NCT04138823|580317769|FG002|Overall Study|Objective disease progression|5|||
160710213|NCT03151304|580317770|FG000|Overall Study|Termination of study by Sponsor|23|||
160710214|NCT03151304|580317770|FG000|Overall Study|missing|3|||
160710215|NCT03151304|580317770|FG000|Overall Study|Withdrawal by Subject|8|||
160710216|NCT03151304|580317770|FG000|Overall Study|multiple reasons|30|||
160710217|NCT04868500|580317771|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
160710218|NCT04868500|580317772|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
160710219|NCT04868500|580317771|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
160710220|NCT04868500|580317772|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
160710221|NCT02466685|580317773|FG000|Overall Study|Adverse Event|5|||
160710222|NCT02466685|580317774|FG001|Overall Study|Adverse Event|2|||
160710223|NCT02466685|580317773|FG000|Overall Study|Lost to Follow-up|1|||
160710224|NCT02466685|580317774|FG001|Overall Study|Lost to Follow-up|1|||
160710225|NCT02466685|580317773|FG000|Overall Study|Withdrawal by Subject|1|||
160710226|NCT02466685|580317774|FG001|Overall Study|Withdrawal by Subject|0|||
160710227|NCT02466685|580317773|FG000|Overall Study|Physician Decision|1|||
160710228|NCT02466685|580317774|FG001|Overall Study|Physician Decision|1|||
160710229|NCT02565511|580317775|FG000|Overall Study|Study terminated by Sponsor|35|||
160710230|NCT02565511|580317776|FG001|Overall Study|Study terminated by Sponsor|22|||
160710231|NCT02565511|580317777|FG002|Overall Study|Study terminated by Sponsor|235|||
160710232|NCT02565511|580317778|FG003|Overall Study|Study terminated by Sponsor|156|||
160710233|NCT02565511|580317775|FG000|Overall Study|Withdrawal by Subject|3|||
160710234|NCT02565511|580317776|FG001|Overall Study|Withdrawal by Subject|0|||
160710235|NCT02565511|580317777|FG002|Overall Study|Withdrawal by Subject|12|||
160710236|NCT02565511|580317778|FG003|Overall Study|Withdrawal by Subject|5|||
160710237|NCT02565511|580317775|FG000|Overall Study|Adverse Event|0|||
160710238|NCT02565511|580317776|FG001|Overall Study|Adverse Event|0|||
160710239|NCT02565511|580317777|FG002|Overall Study|Adverse Event|1|||
160710240|NCT02565511|580317778|FG003|Overall Study|Adverse Event|1|||
160710241|NCT02565511|580317775|FG000|Overall Study|Lost to Follow-up|4|||
160710242|NCT02565511|580317776|FG001|Overall Study|Lost to Follow-up|1|||
160710243|NCT02565511|580317777|FG002|Overall Study|Lost to Follow-up|0|||
160710244|NCT02565511|580317778|FG003|Overall Study|Lost to Follow-up|1|||
160710245|NCT02565511|580317775|FG000|Overall Study|Physician Decision|0|||
160710246|NCT02565511|580317776|FG001|Overall Study|Physician Decision|0|||
160710247|NCT02565511|580317777|FG002|Overall Study|Physician Decision|0|||
160710248|NCT02565511|580317778|FG003|Overall Study|Physician Decision|1|||
160710249|NCT02565511|580317775|FG000|Overall Study|Protocol deviation|0|||
160710250|NCT02565511|580317776|FG001|Overall Study|Protocol deviation|0|||
160710251|NCT02565511|580317777|FG002|Overall Study|Protocol deviation|3|||
160710252|NCT02565511|580317778|FG003|Overall Study|Protocol deviation|0|||
160710253|NCT01941498|580317779|FG000|Overall Study|Relocated out of state|1|||
160710254|NCT01332292|580317781|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
160710255|NCT01332292|580317782|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
160710256|NCT01332292|580317781|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
160710257|NCT01332292|580317782|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
160710258|NCT01332292|580317781|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
160710259|NCT01332292|580317782|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
160710260|NCT00104572|580317783|FG000|Overall Study|Withdrawal by Subject|3|||
160710261|NCT00104572|580317784|FG001|Overall Study|Withdrawal by Subject|3|||
160710262|NCT00104572|580317785|FG002|Overall Study|Withdrawal by Subject|0|||
160710263|NCT00098774|580317786|FG000|Overall Study|Adverse Event|2|||
160710264|NCT00098774|580317786|FG000|Overall Study|Disease Progression|9|||
160710265|NCT00098774|580317786|FG000|Overall Study|Withdrawal by Subject|1|||
160710266|NCT00098774|580317786|FG000|Overall Study|Failed (to respond) during induction|4|||
160710267|NCT00098774|580317786|FG000|Overall Study|Physician Decision|2|||
160710268|NCT03097991|580317787|FG000|Overall Study|Didn't meet study criteria|8|||
160710269|NCT03097991|580317788|FG001|Overall Study|Didn't meet study criteria|0|||
160710270|NCT03097991|580317787|FG000|Overall Study|Withdrawal by Subject|12|||
160710271|NCT03097991|580317788|FG001|Overall Study|Withdrawal by Subject|6|||
160710272|NCT03097991|580317787|FG000|Overall Study|Death of Baby|3|||
160710273|NCT03097991|580317788|FG001|Overall Study|Death of Baby|1|||
160710274|NCT03097991|580317787|FG000|Overall Study|Lost to Follow-up|24|||
160710275|NCT03097991|580317788|FG001|Overall Study|Lost to Follow-up|38|||
160710276|NCT03097991|580317787|FG000|Overall Study|Adverse Event|3|||
160710277|NCT03097991|580317788|FG001|Overall Study|Adverse Event|5|||
160710278|NCT02006732|580317789|FG000|Overall Study|Adverse Event|10|||
160710279|NCT02006732|580317790|FG001|Overall Study|Adverse Event|7|||
160710280|NCT02006732|580317791|FG002|Overall Study|Adverse Event|4|||
160710281|NCT02006732|580317792|FG003|Overall Study|Adverse Event|2|||
160710282|NCT02006732|580317789|FG000|Overall Study|Lack of Efficacy|6|||
160710283|NCT02006732|580317790|FG001|Overall Study|Lack of Efficacy|3|||
160710284|NCT02006732|580317791|FG002|Overall Study|Lack of Efficacy|1|||
160710285|NCT02006732|580317792|FG003|Overall Study|Lack of Efficacy|1|||
160710286|NCT02006732|580317789|FG000|Overall Study|Protocol Violation|1|||
160710287|NCT02006732|580317790|FG001|Overall Study|Protocol Violation|1|||
160710288|NCT02006732|580317791|FG002|Overall Study|Protocol Violation|0|||
160710289|NCT02006732|580317792|FG003|Overall Study|Protocol Violation|0|||
160710290|NCT02006732|580317789|FG000|Overall Study|Lost to Follow-up|0|||
160710291|NCT02006732|580317790|FG001|Overall Study|Lost to Follow-up|1|||
160710292|NCT02006732|580317791|FG002|Overall Study|Lost to Follow-up|0|||
160710293|NCT02006732|580317792|FG003|Overall Study|Lost to Follow-up|0|||
160710294|NCT02006732|580317789|FG000|Overall Study|Withdrawal by Subject|3|||
160710295|NCT02006732|580317790|FG001|Overall Study|Withdrawal by Subject|0|||
160710296|NCT02006732|580317791|FG002|Overall Study|Withdrawal by Subject|4|||
160710297|NCT02006732|580317792|FG003|Overall Study|Withdrawal by Subject|1|||
160710298|NCT01755091|580317793|FG000|Overall Study|Withdrawal by Subject|6|||
160710299|NCT01755091|580317794|FG001|Overall Study|Withdrawal by Subject|1|||
160710300|NCT01755091|580317795|FG002|Overall Study|Withdrawal by Subject|3|||
160710301|NCT01755091|580317793|FG000|Overall Study|Adverse Event|1|||
160710302|NCT01755091|580317794|FG001|Overall Study|Adverse Event|1|||
160710303|NCT01755091|580317795|FG002|Overall Study|Adverse Event|1|||
160710304|NCT01755091|580317793|FG000|Overall Study|Lost to Follow-up|1|||
160710305|NCT01755091|580317794|FG001|Overall Study|Lost to Follow-up|0|||
160710306|NCT01755091|580317795|FG002|Overall Study|Lost to Follow-up|1|||
160710307|NCT01755091|580317793|FG000|Overall Study|Physician Decision|1|||
160710308|NCT01755091|580317794|FG001|Overall Study|Physician Decision|1|||
160710309|NCT01755091|580317795|FG002|Overall Study|Physician Decision|2|||
160710310|NCT02969044|580317796|FG000|Overall Study|Withdrawal by Subject|2|||
160710311|NCT02969044|580317797|FG001|Overall Study|Withdrawal by Subject|6|||
160710312|NCT02969044|580317796|FG000|Overall Study|Adverse Event|3|||
160710313|NCT02969044|580317797|FG001|Overall Study|Adverse Event|0|||
160710314|NCT01330303|580317799|FG000|Period 1|Adverse Event|1|||
160710315|NCT01330303|580317800|FG001|Period 1|Adverse Event|0|||
160710316|NCT01330303|580317799|FG000|Period 1|Protocol Violation|0|||
160710317|NCT01330303|580317800|FG001|Period 1|Protocol Violation|1|||
160710318|NCT01330303|580317799|FG000|Period 1|Withdrawal by Subject|0|||
160710319|NCT01330303|580317800|FG001|Period 1|Withdrawal by Subject|1|||
160710320|NCT00796757|580317801|FG000|Overall Study|Withdrawal by Subject|14|||
160710321|NCT00796757|580317801|FG000|Overall Study|Death|61|||
160710322|NCT00796757|580317801|FG000|Overall Study|Protocol Violation|1|||
160710323|NCT00796757|580317801|FG000|Overall Study|Participant noncompliance|1|||
160710324|NCT00796757|580317801|FG000|Overall Study|Investigator's decision|2|||
160710325|NCT00796757|580317801|FG000|Overall Study|Other|7|||
160710326|NCT01107197|580317802|FG000|Overall Study|Death|12|||
160710327|NCT01107197|580317803|FG001|Overall Study|Death|10|||
160710328|NCT01107197|580317802|FG000|Overall Study|Lost to Follow-up|5|||
160710329|NCT01107197|580317803|FG001|Overall Study|Lost to Follow-up|8|||
160710330|NCT01107197|580317802|FG000|Overall Study|Withdrawal by Subject|3|||
160710331|NCT01107197|580317803|FG001|Overall Study|Withdrawal by Subject|5|||
160710332|NCT03516513|580317805|FG000|Overall Study|Withdrawal by Subject|2|||
160710333|NCT03516513|580317806|FG001|Overall Study|Withdrawal by Subject|2|||
160710334|NCT03516513|580317807|FG002|Overall Study|Withdrawal by Subject|0|||
160710335|NCT03516513|580317808|FG003|Overall Study|Withdrawal by Subject|0|||
160710336|NCT02593110|580317809|FG000|Overall Study|Withdrawal by Subject|0|||
160710337|NCT02593110|580317810|FG001|Overall Study|Withdrawal by Subject|3|||
160710338|NCT02593110|580317811|FG002|Overall Study|Withdrawal by Subject|3|||
160710339|NCT02593110|580317812|FG003|Overall Study|Withdrawal by Subject|2|||
160710340|NCT02593110|580317809|FG000|Overall Study|Death|0|||
160710341|NCT02593110|580317810|FG001|Overall Study|Death|0|||
160710342|NCT02593110|580317811|FG002|Overall Study|Death|1|||
160710343|NCT02593110|580317812|FG003|Overall Study|Death|0|||
160710344|NCT03548337|580317813|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
160710345|NCT03548337|580317814|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
160710346|NCT03548337|580317813|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
160710347|NCT03548337|580317814|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
160710348|NCT03548337|580317813|FG000|Infant Series|Lost to Follow-up|2|||
160710349|NCT03548337|580317814|FG001|Infant Series|Lost to Follow-up|1|||
160710350|NCT03548337|580317813|FG000|Infant Series|Adverse Event|0|||
160710351|NCT03548337|580317814|FG001|Infant Series|Adverse Event|2|||
160710352|NCT03548337|580317813|FG000|Infant Series|Randomized but Not Vaccinated|1|||
160710353|NCT03548337|580317814|FG001|Infant Series|Randomized but Not Vaccinated|0|||
160710354|NCT03548337|580317813|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
160710355|NCT03548337|580317814|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
160710356|NCT03017612|580317818|FG000|Overall Study|Adverse Event|2|||
160710357|NCT01893346|580317820|FG000|Overall Study|Lost to Follow-up|0|||
160710358|NCT01893346|580317821|FG001|Overall Study|Lost to Follow-up|1|||
160710359|NCT01893346|580317822|FG002|Overall Study|Lost to Follow-up|0|||
160710360|NCT01893346|580317823|FG003|Overall Study|Lost to Follow-up|0|||
160710361|NCT01893346|580317820|FG000|Overall Study|Protocol Violation|1|||
160710362|NCT01893346|580317821|FG001|Overall Study|Protocol Violation|0|||
160710363|NCT01893346|580317822|FG002|Overall Study|Protocol Violation|0|||
160710364|NCT01893346|580317823|FG003|Overall Study|Protocol Violation|0|||
160710365|NCT01893346|580317820|FG000|Overall Study|Withdrawal by Subject|2|||
160710366|NCT01893346|580317821|FG001|Overall Study|Withdrawal by Subject|0|||
160710367|NCT01893346|580317822|FG002|Overall Study|Withdrawal by Subject|0|||
160710368|NCT01893346|580317823|FG003|Overall Study|Withdrawal by Subject|0|||
160710369|NCT00143247|580317826|FG000|Overall Study|Death|8|||
160710370|NCT00143247|580317826|FG000|Overall Study|Adverse Event|19|||
160710371|NCT00143247|580317826|FG000|Overall Study|Lack of Efficacy|3|||
160710372|NCT00143247|580317826|FG000|Overall Study|Withdrawal by Subject|55|||
160710373|NCT00143247|580317826|FG000|Overall Study|Study terminated by sponsor|31|||
160710374|NCT00143247|580317826|FG000|Overall Study|Protocol Violation|15|||
160710375|NCT00143247|580317826|FG000|Overall Study|Lost to Follow-up|12|||
160710376|NCT00143247|580317826|FG000|Overall Study|following inaccurate lab adverse event|1|||
160710377|NCT00143247|580317826|FG000|Overall Study|Other|12|||
160710378|NCT00489827|580317827|FG000|Overall Study|Intraoperative exclusion criteria|1|||
160710379|NCT00489827|580317828|FG001|Overall Study|Intraoperative exclusion criteria|1|||
160710380|NCT00489827|580317827|FG000|Overall Study|Intraoperative exclusion criteria|1|||
160710381|NCT00489827|580317828|FG001|Overall Study|Intraoperative exclusion criteria|1|||
160710382|NCT02766283|580317829|FG000|Overall Study|Lost to Follow-up|27|||
160710383|NCT00721227|580317830|FG000|Overall Study|Lost to Follow-up|3|||
160710384|NCT00721227|580317831|FG001|Overall Study|Lost to Follow-up|0|||
160710385|NCT00721227|580317830|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
160710386|NCT00721227|580317831|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
160710387|NCT01632280|580317845|FG000|Overall Study|Withdrawal by Subject|1|||
160710388|NCT01632280|580317846|FG001|Overall Study|Withdrawal by Subject|0|||
160710389|NCT03086551|580317849|FG000|First Intervention|Failure to meet inclusion criterion|1|||
160710390|NCT03086551|580317850|FG001|First Intervention|Failure to meet inclusion criterion|0|||
160710391|NCT03086551|580317849|FG000|First Intervention|Lost to Follow-up|0|||
160710392|NCT03086551|580317850|FG001|First Intervention|Lost to Follow-up|1|||
160710393|NCT03086551|580317849|FG000|Washout|Lost to Follow-up|1|||
160710394|NCT03086551|580317850|FG001|Washout|Lost to Follow-up|2|||
160710395|NCT03086551|580317849|FG000|Washout|Withdrawal by Subject|2|||
160710396|NCT03086551|580317850|FG001|Washout|Withdrawal by Subject|1|||
160710397|NCT02447744|580317851|FG000|Overall Study|Withdrawal by Subject|3|||
160710398|NCT02447744|580317852|FG001|Overall Study|Withdrawal by Subject|1|||
160710399|NCT02447744|580317851|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
160710400|NCT02447744|580317852|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
160710401|NCT00912912|580317853|FG000|Overall Study|Withdrawal by Subject|1|||
160710402|NCT00912912|580317853|FG000|Overall Study|Disease Progression|3|||
160710403|NCT00306995|580317854|FG000|Study Part I|Withdrawal by Subject|0|||
160710404|NCT00306995|580317855|FG001|Study Part I|Withdrawal by Subject|0|||
160710405|NCT00306995|580317856|FG002|Study Part I|Withdrawal by Subject|0|||
160710406|NCT00306995|580317857|FG003|Study Part I|Withdrawal by Subject|0|||
160710407|NCT00306995|580317858|FG004|Study Part I|Withdrawal by Subject|0|||
160710408|NCT00306995|580317859|FG005|Study Part I|Withdrawal by Subject|0|||
160710409|NCT00306995|580317860|FG006|Study Part I|Withdrawal by Subject|1|||
160710410|NCT00306995|580317854|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
160710411|NCT00306995|580317855|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
160710412|NCT00306995|580317856|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
160710413|NCT00306995|580317857|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
160710414|NCT00306995|580317858|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
160710415|NCT00306995|580317859|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
160710416|NCT00306995|580317860|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
160710417|NCT06419907|580319517|FG000|Overall Study|Protocol Violation|0|||
160710418|NCT06419907|580319518|FG001|Overall Study|Protocol Violation|3|||
160710419|NCT06419907|580319519|FG002|Overall Study|Protocol Violation|0|||
160710420|NCT06419907|580319520|FG003|Overall Study|Protocol Violation|1|||
160710421|NCT06419907|580319517|FG000|Overall Study|Lost to Follow-up|0|||
160710422|NCT06419907|580319518|FG001|Overall Study|Lost to Follow-up|0|||
160710423|NCT06419907|580319519|FG002|Overall Study|Lost to Follow-up|2|||
160710424|NCT06419907|580319520|FG003|Overall Study|Lost to Follow-up|1|||
160710425|NCT02586688|580319521|FG000|Overall Study|Lost to Follow-up|2|||
160710426|NCT02586688|580319522|FG001|Overall Study|Lost to Follow-up|1|||
160710427|NCT02586688|580319521|FG000|Overall Study|Withdrawal by Subject|1|||
160710428|NCT02586688|580319522|FG001|Overall Study|Withdrawal by Subject|1|||
160710429|NCT02586688|580319521|FG000|Overall Study|Adverse Event|3|||
160710430|NCT02586688|580319522|FG001|Overall Study|Adverse Event|1|||
160710431|NCT04856917|580319523|FG000|Overall Study|Withdrawal by Subject|4|||
160710432|NCT04856917|580319524|FG001|Overall Study|Withdrawal by Subject|3|||
160710433|NCT04856917|580319525|FG002|Overall Study|Withdrawal by Subject|1|||
160710434|NCT04856917|580319523|FG000|Overall Study|Lost to Follow-up|3|||
160710435|NCT04856917|580319524|FG001|Overall Study|Lost to Follow-up|1|||
160710436|NCT04856917|580319525|FG002|Overall Study|Lost to Follow-up|1|||
160710437|NCT04856917|580319523|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
160710438|NCT04856917|580319524|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
160710439|NCT04856917|580319525|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
160710440|NCT04856917|580319523|FG000|Overall Study|Other|1|||
160710441|NCT04856917|580319524|FG001|Overall Study|Other|1|||
160710442|NCT04856917|580319525|FG002|Overall Study|Other|0|||
160710443|NCT03573830|580319528|FG000|Overall Study|Dropped without completing treatment|0|||
160710444|NCT03573830|580319529|FG001|Overall Study|Dropped without completing treatment|7|||
160710445|NCT03573830|580319528|FG000|Overall Study|Lost to Follow-up|4|||
160710446|NCT03573830|580319529|FG001|Overall Study|Lost to Follow-up|0|||
160710447|NCT00266630|580319530|FG000|Overall Study|Adverse Event|8|||
160710448|NCT00266630|580319531|FG001|Overall Study|Adverse Event|6|||
160710449|NCT00266630|580319530|FG000|Overall Study|Lack of Efficacy|1|||
160710450|NCT00266630|580319531|FG001|Overall Study|Lack of Efficacy|4|||
160710451|NCT00266630|580319530|FG000|Overall Study|Entry Criteria not met|1|||
160710452|NCT00266630|580319531|FG001|Overall Study|Entry Criteria not met|0|||
160710453|NCT00266630|580319530|FG000|Overall Study|Protocol Violation|1|||
160710454|NCT00266630|580319531|FG001|Overall Study|Protocol Violation|3|||
160710455|NCT00266630|580319530|FG000|Overall Study|Physician Decision|1|||
160710456|NCT00266630|580319531|FG001|Overall Study|Physician Decision|2|||
160710457|NCT00266630|580319530|FG000|Overall Study|Withdrawal by Subject|10|||
160710458|NCT00266630|580319531|FG001|Overall Study|Withdrawal by Subject|2|||
160710459|NCT00266630|580319530|FG000|Overall Study|Lost to Follow-up|1|||
160710460|NCT00266630|580319531|FG001|Overall Study|Lost to Follow-up|0|||
160710461|NCT00266630|580319530|FG000|Overall Study|Other|19|||
160710462|NCT00266630|580319531|FG001|Overall Study|Other|11|||
160710463|NCT01427608|580319538|FG000|Overall Study|Death|1|||
160710464|NCT01427608|580319539|FG001|Overall Study|Death|0|||
160710465|NCT01427608|580319538|FG000|Overall Study|Withdrawal by Subject|7|||
160710466|NCT01427608|580319539|FG001|Overall Study|Withdrawal by Subject|3|||
160710467|NCT01427608|580319538|FG000|Overall Study|Relapsed-all cause|13|||
160710468|NCT01427608|580319539|FG001|Overall Study|Relapsed-all cause|34|||
160710469|NCT01427608|580319538|FG000|Overall Study|Events not attributed to study meds|0|||
160710470|NCT01427608|580319539|FG001|Overall Study|Events not attributed to study meds|1|||
160710471|NCT01473407|580319540|FG000|Overall Study|Physician Decision|1|||
160710472|NCT01473407|580319541|FG001|Overall Study|Physician Decision|4|||
160710473|NCT01473407|580319540|FG000|Overall Study|Lost to Follow-up|10|||
160710474|NCT01473407|580319541|FG001|Overall Study|Lost to Follow-up|4|||
160710475|NCT01473407|580319540|FG000|Overall Study|Adverse Event|8|||
160710476|NCT01473407|580319541|FG001|Overall Study|Adverse Event|8|||
160710477|NCT01473407|580319540|FG000|Overall Study|Randomization Error|3|||
160710478|NCT01473407|580319541|FG001|Overall Study|Randomization Error|1|||
160710479|NCT01473407|580319540|FG000|Overall Study|Withdrawal by Subject|4|||
160710480|NCT01473407|580319541|FG001|Overall Study|Withdrawal by Subject|7|||
160710481|NCT01473407|580319540|FG000|Overall Study|Kidney Transplant|7|||
160710482|NCT01473407|580319541|FG001|Overall Study|Kidney Transplant|6|||
160710483|NCT01473407|580319540|FG000|Overall Study|Vacation/Travel|1|||
160710484|NCT01473407|580319541|FG001|Overall Study|Vacation/Travel|1|||
160710485|NCT01473407|580319540|FG000|Overall Study|Elevated Hemoglobin|1|||
160710486|NCT01473407|580319541|FG001|Overall Study|Elevated Hemoglobin|0|||
160710487|NCT01473407|580319540|FG000|Overall Study|Patient Received Aranesp|1|||
160710488|NCT01473407|580319541|FG001|Overall Study|Patient Received Aranesp|0|||
160710489|NCT01473407|580319540|FG000|Overall Study|Patient Lost Green Card Status|1|||
160710490|NCT01473407|580319541|FG001|Overall Study|Patient Lost Green Card Status|0|||
160710491|NCT01473407|580319540|FG000|Overall Study|Temperature Excursion|2|||
160710492|NCT01473407|580319541|FG001|Overall Study|Temperature Excursion|3|||
160710493|NCT01473407|580319540|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
160710494|NCT01473407|580319541|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
160710495|NCT01473407|580319540|FG000|Overall Study|Sponsor's Decision|10|||
160710496|NCT01473407|580319541|FG001|Overall Study|Sponsor's Decision|10|||
160710497|NCT01473407|580319540|FG000|Overall Study|Site Closure|1|||
160710498|NCT01473407|580319541|FG001|Overall Study|Site Closure|0|||
160710499|NCT04071405|580319542|FG000|Overall Study|Protocol Violation|3|||
160710500|NCT02422797|580319543|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
160710501|NCT02422797|580319544|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
160710502|NCT02422797|580319543|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
160710503|NCT02422797|580319544|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
160710504|NCT02422797|580319543|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
160710505|NCT02422797|580319544|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
160710506|NCT02422797|580319543|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
160710507|NCT02422797|580319544|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
160710508|NCT02422797|580319543|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
160710509|NCT02422797|580319544|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
160710510|NCT02422797|580319543|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
160710511|NCT02422797|580319544|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
160710512|NCT02422797|580319543|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
160710513|NCT02422797|580319544|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
160710514|NCT02422797|580319543|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
160710515|NCT02422797|580319544|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
160710516|NCT02422797|580319543|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
160710517|NCT02422797|580319544|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
160710518|NCT02422797|580319543|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
160710519|NCT02422797|580319544|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
160710520|NCT02422797|580319543|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
160710521|NCT02422797|580319544|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
160710522|NCT02422797|580319543|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
160710523|NCT02422797|580319544|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
160710524|NCT02422797|580319543|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
160710525|NCT02422797|580319544|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
160710526|NCT02422797|580319543|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
160710527|NCT02422797|580319544|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
160710528|NCT02422797|580319543|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
160710529|NCT02422797|580319544|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
160710530|NCT02422797|580319543|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
160710531|NCT02422797|580319544|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
160710532|NCT02422797|580319543|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
160710533|NCT02422797|580319544|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
160710534|NCT02422797|580319543|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
160710535|NCT02422797|580319544|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
160710536|NCT02422797|580319543|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
160710537|NCT02422797|580319544|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
160710538|NCT02422797|580319543|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
160710539|NCT02422797|580319544|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
160710540|NCT02422797|580319543|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
160710541|NCT02422797|580319544|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
160710542|NCT01027702|580319549|FG000|Overall Study|Received subsequent therapy|1|||
160710543|NCT01027702|580319550|FG001|Overall Study|Received subsequent therapy|2|||
160710544|NCT01027702|580319551|FG002|Overall Study|Received subsequent therapy|0|||
160710545|NCT01027702|580319552|FG003|Overall Study|Received subsequent therapy|4|||
160710546|NCT01027702|580319553|FG004|Overall Study|Received subsequent therapy|1|||
160710547|NCT01027702|580319554|FG005|Overall Study|Received subsequent therapy|0|||
160710548|NCT01027702|580319555|FG006|Overall Study|Received subsequent therapy|1|||
160710549|NCT01027702|580319549|FG000|Overall Study|Death|0|||
160710550|NCT01027702|580319550|FG001|Overall Study|Death|0|||
160710551|NCT01027702|580319551|FG002|Overall Study|Death|1|||
160710552|NCT01027702|580319552|FG003|Overall Study|Death|0|||
160710553|NCT01027702|580319553|FG004|Overall Study|Death|0|||
160710554|NCT01027702|580319554|FG005|Overall Study|Death|0|||
160710555|NCT01027702|580319555|FG006|Overall Study|Death|0|||
160710556|NCT00403585|580319556|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
160710557|NCT00403585|580319556|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
160710558|NCT00403585|580319556|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
160710559|NCT02604407|580319557|FG000|Overall Study|Adverse Event|0|||
160710560|NCT02604407|580319558|FG001|Overall Study|Adverse Event|7|||
160710561|NCT02604407|580319559|FG002|Overall Study|Adverse Event|5|||
160710562|NCT02604407|580319557|FG000|Overall Study|Protocol Violation|2|||
160710563|NCT02604407|580319558|FG001|Overall Study|Protocol Violation|0|||
160710564|NCT02604407|580319559|FG002|Overall Study|Protocol Violation|0|||
160710565|NCT02604407|580319557|FG000|Overall Study|Withdrawal by Subject|3|||
160710566|NCT02604407|580319558|FG001|Overall Study|Withdrawal by Subject|3|||
160710567|NCT02604407|580319559|FG002|Overall Study|Withdrawal by Subject|5|||
160710568|NCT02604407|580319557|FG000|Overall Study|Lost to Follow-up|2|||
160710569|NCT02604407|580319558|FG001|Overall Study|Lost to Follow-up|1|||
160710570|NCT02604407|580319559|FG002|Overall Study|Lost to Follow-up|2|||
160710571|NCT02604407|580319557|FG000|Overall Study|Lack of Efficacy|1|||
160710572|NCT02604407|580319558|FG001|Overall Study|Lack of Efficacy|0|||
160710573|NCT02604407|580319559|FG002|Overall Study|Lack of Efficacy|0|||
160710574|NCT02604407|580319557|FG000|Overall Study|Other|3|||
160710575|NCT02604407|580319558|FG001|Overall Study|Other|1|||
160710576|NCT02604407|580319559|FG002|Overall Study|Other|4|||
160710577|NCT02862730|580319564|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
160710578|NCT02862730|580319565|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
160710579|NCT02862730|580319566|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
160710580|NCT02862730|580319567|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
160710581|NCT02862730|580319568|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
160710582|NCT02862730|580319569|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
160710583|NCT02862730|580319570|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
160710584|NCT02862730|580319564|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
160710585|NCT02862730|580319565|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
160710586|NCT02862730|580319566|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
160710587|NCT02862730|580319567|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
160710588|NCT02862730|580319568|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
160710589|NCT02862730|580319569|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
160710590|NCT02862730|580319570|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
160710591|NCT02862730|580319564|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
160710592|NCT02862730|580319565|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
160710593|NCT02862730|580319566|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
160710594|NCT02862730|580319567|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
160710595|NCT02862730|580319568|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
160710596|NCT02862730|580319569|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
160710597|NCT02862730|580319570|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
160710598|NCT02862730|580319564|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
160710599|NCT02862730|580319565|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
160710600|NCT02862730|580319566|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
160710601|NCT02862730|580319567|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
160710602|NCT02862730|580319568|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
160710603|NCT02862730|580319569|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
160710604|NCT02862730|580319570|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
160710605|NCT00191191|580319571|FG000|Overall Study|Entry Criteria Exclusion|2|||
160710606|NCT00191191|580319572|FG001|Overall Study|Entry Criteria Exclusion|0|||
160710607|NCT00191191|580319571|FG000|Overall Study|Treated with Another Systemic Agent|1|||
160710608|NCT00191191|580319572|FG001|Overall Study|Treated with Another Systemic Agent|1|||
160710609|NCT00191191|580319571|FG000|Overall Study|Adverse Event|11|||
160710610|NCT00191191|580319572|FG001|Overall Study|Adverse Event|21|||
160710611|NCT00191191|580319571|FG000|Overall Study|Progressive Disease|84|||
160710612|NCT00191191|580319572|FG001|Overall Study|Progressive Disease|72|||
160710613|NCT00191191|580319571|FG000|Overall Study|Toxicity After Dose Reduction|7|||
160710614|NCT00191191|580319572|FG001|Overall Study|Toxicity After Dose Reduction|8|||
160710615|NCT00191191|580319571|FG000|Overall Study|Family/Caregiver Decision|5|||
160710616|NCT00191191|580319572|FG001|Overall Study|Family/Caregiver Decision|7|||
160710617|NCT00191191|580319571|FG000|Overall Study|Lost to Follow-up|1|||
160710618|NCT00191191|580319572|FG001|Overall Study|Lost to Follow-up|0|||
160710619|NCT00191191|580319571|FG000|Overall Study|Physician Decision|3|||
160710620|NCT00191191|580319572|FG001|Overall Study|Physician Decision|2|||
160710621|NCT00191191|580319571|FG000|Overall Study|Good Clinical Practice Violation|0|||
160710622|NCT00191191|580319572|FG001|Overall Study|Good Clinical Practice Violation|1|||
160710623|NCT03685344|580319573|FG000|Overall Study|Withdrawal by Subject|1|||
160710624|NCT03685344|580319574|FG001|Overall Study|Withdrawal by Subject|1|||
160710625|NCT03685344|580319575|FG002|Overall Study|Withdrawal by Subject|2|||
160710626|NCT03685344|580319576|FG003|Overall Study|Withdrawal by Subject|0|||
160710627|NCT03685344|580319573|FG000|Overall Study|Physician Decision|1|||
160710628|NCT03685344|580319574|FG001|Overall Study|Physician Decision|1|||
160710629|NCT03685344|580319575|FG002|Overall Study|Physician Decision|5|||
160710630|NCT03685344|580319576|FG003|Overall Study|Physician Decision|0|||
160710631|NCT03685344|580319573|FG000|Overall Study|Death|1|||
160710632|NCT03685344|580319574|FG001|Overall Study|Death|1|||
160710633|NCT03685344|580319575|FG002|Overall Study|Death|0|||
160710634|NCT03685344|580319576|FG003|Overall Study|Death|0|||
160710635|NCT02121652|580319579|FG000|Overall Study|Lost to Follow-up|2|||
160710636|NCT02121652|580319580|FG001|Overall Study|Lost to Follow-up|1|||
160710637|NCT02121652|580319579|FG000|Overall Study|Death|1|||
160710638|NCT02121652|580319580|FG001|Overall Study|Death|0|||
160710639|NCT02121652|580319579|FG000|Overall Study|Withdrawal by Subject|3|||
160710640|NCT02121652|580319580|FG001|Overall Study|Withdrawal by Subject|3|||
160710641|NCT00799058|580319590|FG000|Overall Study|Withdrawal by Subject|2|||
160710642|NCT00799058|580319591|FG001|Overall Study|Withdrawal by Subject|2|||
160710643|NCT00799058|580319592|FG002|Overall Study|Withdrawal by Subject|2|||
160710644|NCT00799058|580319590|FG000|Overall Study|Lost to Follow-up|1|||
160710645|NCT00799058|580319591|FG001|Overall Study|Lost to Follow-up|2|||
160710646|NCT00799058|580319592|FG002|Overall Study|Lost to Follow-up|1|||
160710647|NCT00799058|580319590|FG000|Overall Study|Adverse Event|0|||
160710648|NCT00799058|580319591|FG001|Overall Study|Adverse Event|2|||
160710649|NCT00799058|580319592|FG002|Overall Study|Adverse Event|0|||
160710650|NCT00799058|580319590|FG000|Overall Study|Pregnancy|1|||
160710651|NCT00799058|580319591|FG001|Overall Study|Pregnancy|0|||
160710652|NCT00799058|580319592|FG002|Overall Study|Pregnancy|0|||
160710653|NCT00799058|580319590|FG000|Overall Study|Not adherent|3|||
160710654|NCT00799058|580319591|FG001|Overall Study|Not adherent|2|||
160710655|NCT00799058|580319592|FG002|Overall Study|Not adherent|1|||
160710656|NCT00799058|580319590|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
160710657|NCT00799058|580319591|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
160710658|NCT00799058|580319592|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
160710659|NCT00799058|580319590|FG000|Overall Study|IP dispensing error|1|||
160710660|NCT00799058|580319591|FG001|Overall Study|IP dispensing error|0|||
160710661|NCT00799058|580319592|FG002|Overall Study|IP dispensing error|0|||
160710662|NCT00799058|580319590|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
160710663|NCT00799058|580319591|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
160710664|NCT00799058|580319592|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
160710665|NCT00799058|580319590|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
160710666|NCT00799058|580319591|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
160710667|NCT00799058|580319592|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
160710668|NCT00799058|580319590|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
160710669|NCT00799058|580319591|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
160710670|NCT00799058|580319592|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
160710671|NCT00799058|580319590|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
160710672|NCT00799058|580319591|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
160710673|NCT00799058|580319592|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
160710674|NCT02088697|580319597|FG000|Period I|Physician Decision|1|||
160710675|NCT02088697|580319598|FG001|Period I|Physician Decision|4|||
160710676|NCT02088697|580319597|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
160710677|NCT02088697|580319598|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
160710678|NCT00247676|580319599|FG000|Overall Study|Death|5|||
160710679|NCT00247676|580319599|FG000|Overall Study|Adverse Event|11|||
160710680|NCT00247676|580319599|FG000|Overall Study|Lack of Efficacy|15|||
160710681|NCT00247676|580319599|FG000|Overall Study|Other|3|||
160710682|NCT00247676|580319599|FG000|Overall Study|Withdrawal by Subject|2|||
160710683|NCT03594071|580319600|FG000|Overall Study|Re-operation|3|||
160710684|NCT03594071|580319600|FG000|Overall Study|Missed visit|2|||
160710685|NCT02287922|580319601|FG000|Overall Study|Adverse Event|1|||
160710686|NCT02287922|580319602|FG001|Overall Study|Adverse Event|1|||
160710687|NCT02287922|580319603|FG002|Overall Study|Adverse Event|3|||
160710688|NCT02287922|580319604|FG003|Overall Study|Adverse Event|4|||
160710689|NCT02287922|580319601|FG000|Overall Study|Withdrawal by Subject|1|||
160710690|NCT02287922|580319602|FG001|Overall Study|Withdrawal by Subject|1|||
160710691|NCT02287922|580319603|FG002|Overall Study|Withdrawal by Subject|1|||
160710692|NCT02287922|580319604|FG003|Overall Study|Withdrawal by Subject|2|||
160710693|NCT02287922|580319601|FG000|Overall Study|Lost to Follow-up|0|||
160710694|NCT02287922|580319602|FG001|Overall Study|Lost to Follow-up|0|||
160710695|NCT02287922|580319603|FG002|Overall Study|Lost to Follow-up|1|||
160710696|NCT02287922|580319604|FG003|Overall Study|Lost to Follow-up|0|||
160710697|NCT02287922|580319601|FG000|Overall Study|Sponsor's decision|0|||
160710698|NCT02287922|580319602|FG001|Overall Study|Sponsor's decision|0|||
160710699|NCT02287922|580319603|FG002|Overall Study|Sponsor's decision|0|||
160710700|NCT02287922|580319604|FG003|Overall Study|Sponsor's decision|1|||
160710701|NCT02287922|580319601|FG000|Overall Study|Other|1|||
160710702|NCT02287922|580319602|FG001|Overall Study|Other|0|||
160710703|NCT02287922|580319603|FG002|Overall Study|Other|2|||
160710704|NCT02287922|580319604|FG003|Overall Study|Other|0|||
160710705|NCT03022370|580319605|FG000|Overall Study|Death|6|||
160710706|NCT03022370|580319606|FG001|Overall Study|Death|12|||
160710707|NCT03022370|580319605|FG000|Overall Study|Lost to Follow-up|174|||
160710708|NCT03022370|580319606|FG001|Overall Study|Lost to Follow-up|109|||
160710709|NCT01526655|580319607|FG000|Overall Study|Withdrawal by Subject|0|||
160710710|NCT01526655|580319608|FG001|Overall Study|Withdrawal by Subject|1|||
160710711|NCT04502212|580319609|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
160710712|NCT04502212|580319609|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
160710713|NCT01320150|580319616|FG000|Overall Study|Protocol Violation|15|||
160710714|NCT01320150|580319616|FG000|Overall Study|Withdrawal by Subject|5|||
160710715|NCT01320150|580319616|FG000|Overall Study|Death|2|||
160710716|NCT01320150|580319616|FG000|Overall Study|Lost to Follow-up|44|||
160710717|NCT00919854|580319617|FG000|Overall Study|Adverse Event|1|||
160710718|NCT00985491|580319621|FG000|Overall Study|Adverse Event|8|||
160710719|NCT00985491|580319621|FG000|Overall Study|device migration|7|||
160710720|NCT00985491|580319621|FG000|Overall Study|Withdrawal by Subject|1|||
160710721|NCT00985491|580319621|FG000|Overall Study|implant failure|3|||
160710722|NCT02933255|580319625|FG000|Overall Study|Discontinued due to study closure.|1|||
160710723|NCT02933255|580319626|FG001|Overall Study|Discontinued due to study closure.|0|||
160710724|NCT03736031|580319630|FG000|Overall Study|Death|2|||
160710725|NCT03736031|580319631|FG001|Overall Study|Death|4|||
160710726|NCT03736031|580319630|FG000|Overall Study|Lost to Follow-up|21|||
160710727|NCT03736031|580319631|FG001|Overall Study|Lost to Follow-up|2|||
160710728|NCT03736031|580319630|FG000|Overall Study|Withdrawal by Subject|9|||
160710729|NCT03736031|580319631|FG001|Overall Study|Withdrawal by Subject|0|||
160710730|NCT00451178|580319634|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
160710731|NCT00451178|580319635|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
160710732|NCT00451178|580319634|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
160710733|NCT00451178|580319635|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
160710734|NCT00451178|580319634|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
160710735|NCT00451178|580319635|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
160710736|NCT00451178|580319634|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
160710737|NCT00451178|580319635|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
160710738|NCT00451178|580319634|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
160710739|NCT00451178|580319635|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
160710740|NCT00451178|580319634|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
160710741|NCT00451178|580319635|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
160710742|NCT00451178|580319634|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
160710743|NCT00451178|580319635|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
160710744|NCT00451178|580319634|FG000|Prior to Maintenance Therapy|PD|2|||
160710745|NCT00451178|580319635|FG001|Prior to Maintenance Therapy|PD|0|||
160710746|NCT00451178|580319634|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
160710747|NCT00451178|580319635|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
160710748|NCT00451178|580319634|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
160710749|NCT00451178|580319635|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
160710750|NCT00451178|580319634|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
160710751|NCT00451178|580319635|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
160710752|NCT00451178|580319634|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
160710753|NCT00451178|580319635|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
160710754|NCT00451178|580319634|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
160710755|NCT00451178|580319635|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
160710756|NCT00451178|580319634|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
160710757|NCT00451178|580319635|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
160710758|NCT00451178|580319634|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
160710759|NCT00451178|580319635|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
160710760|NCT02215967|580319636|FG000|Overall Study|Patient became ineligible for treatment|0|||
160710761|NCT02215967|580319637|FG001|Overall Study|Patient became ineligible for treatment|0|||
160710762|NCT02215967|580319638|FG002|Overall Study|Patient became ineligible for treatment|0|||
160710763|NCT02215967|580319639|FG003|Overall Study|Patient became ineligible for treatment|3|||
160710764|NCT02215967|580319636|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
160710765|NCT02215967|580319637|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
160710766|NCT02215967|580319638|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
160710767|NCT02215967|580319639|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
160710768|NCT00352417|580319642|FG000|Overall Study|Adverse Event|1|||
160710769|NCT00352417|580319643|FG001|Overall Study|Adverse Event|0|||
160710770|NCT00352417|580319642|FG000|Overall Study|Protocol Violation|0|||
160710771|NCT00352417|580319643|FG001|Overall Study|Protocol Violation|2|||
160710772|NCT00352417|580319642|FG000|Overall Study|Withdrawal by Subject|1|||
160710773|NCT00352417|580319643|FG001|Overall Study|Withdrawal by Subject|2|||
160710774|NCT00352417|580319642|FG000|Overall Study|Lost to Follow-up|1|||
160710775|NCT00352417|580319643|FG001|Overall Study|Lost to Follow-up|0|||
160710776|NCT00352417|580319642|FG000|Overall Study|Schedule Change|2|||
160710777|NCT00352417|580319643|FG001|Overall Study|Schedule Change|1|||
160710778|NCT03207867|580319644|FG000|Overall Study|Adverse Event|1|||
160710779|NCT03207867|580319645|FG001|Overall Study|Adverse Event|0|||
160710780|NCT03207867|580319646|FG002|Overall Study|Adverse Event|1|||
160710781|NCT03207867|580319647|FG003|Overall Study|Adverse Event|0|||
160710782|NCT03207867|580319648|FG004|Overall Study|Adverse Event|0|||
160710783|NCT03207867|580319649|FG005|Overall Study|Adverse Event|2|||
160710784|NCT03207867|580319650|FG006|Overall Study|Adverse Event|1|||
160710785|NCT03207867|580319651|FG007|Overall Study|Adverse Event|1|||
160710786|NCT03207867|580319652|FG008|Overall Study|Adverse Event|2|||
160710787|NCT03207867|580319653|FG009|Overall Study|Adverse Event|2|||
160710788|NCT03207867|580319654|FG010|Overall Study|Adverse Event|0|||
160710789|NCT03207867|580319655|FG011|Overall Study|Adverse Event|0|||
160710790|NCT03207867|580319656|FG012|Overall Study|Adverse Event|0|||
160710791|NCT03207867|580319657|FG013|Overall Study|Adverse Event|0|||
160710792|NCT03207867|580319658|FG014|Overall Study|Adverse Event|0|||
160710793|NCT03207867|580319659|FG015|Overall Study|Adverse Event|0|||
160710794|NCT03207867|580319660|FG016|Overall Study|Adverse Event|3|||
160710795|NCT03207867|580319661|FG017|Overall Study|Adverse Event|1|||
160710796|NCT03207867|580319662|FG018|Overall Study|Adverse Event|2|||
160710797|NCT03207867|580319663|FG019|Overall Study|Adverse Event|1|||
160710798|NCT03207867|580319664|FG020|Overall Study|Adverse Event|0|||
160710799|NCT03207867|580319665|FG021|Overall Study|Adverse Event|0|||
160710800|NCT03207867|580319666|FG022|Overall Study|Adverse Event|0|||
160710801|NCT03207867|580319667|FG023|Overall Study|Adverse Event|0|||
160710802|NCT03207867|580319644|FG000|Overall Study|Death|0|||
160710803|NCT03207867|580319645|FG001|Overall Study|Death|0|||
160710804|NCT03207867|580319646|FG002|Overall Study|Death|0|||
160710805|NCT03207867|580319647|FG003|Overall Study|Death|0|||
160710806|NCT03207867|580319648|FG004|Overall Study|Death|0|||
160710807|NCT03207867|580319649|FG005|Overall Study|Death|1|||
160710808|NCT03207867|580319650|FG006|Overall Study|Death|0|||
160710809|NCT03207867|580319651|FG007|Overall Study|Death|3|||
160710810|NCT03207867|580319652|FG008|Overall Study|Death|1|||
160710811|NCT03207867|580319653|FG009|Overall Study|Death|2|||
160710812|NCT03207867|580319654|FG010|Overall Study|Death|0|||
160710813|NCT03207867|580319655|FG011|Overall Study|Death|1|||
160710814|NCT03207867|580319656|FG012|Overall Study|Death|0|||
160710815|NCT03207867|580319657|FG013|Overall Study|Death|1|||
160710816|NCT03207867|580319658|FG014|Overall Study|Death|0|||
160710817|NCT03207867|580319659|FG015|Overall Study|Death|0|||
160710818|NCT03207867|580319660|FG016|Overall Study|Death|0|||
160710819|NCT03207867|580319661|FG017|Overall Study|Death|2|||
160710820|NCT03207867|580319662|FG018|Overall Study|Death|0|||
160710821|NCT03207867|580319663|FG019|Overall Study|Death|1|||
160710822|NCT03207867|580319664|FG020|Overall Study|Death|0|||
160710823|NCT03207867|580319665|FG021|Overall Study|Death|0|||
160710824|NCT03207867|580319666|FG022|Overall Study|Death|0|||
160710825|NCT03207867|580319667|FG023|Overall Study|Death|0|||
160710826|NCT03207867|580319644|FG000|Overall Study|Physician Decision|3|||
160710827|NCT03207867|580319645|FG001|Overall Study|Physician Decision|5|||
160710828|NCT03207867|580319646|FG002|Overall Study|Physician Decision|0|||
160710829|NCT03207867|580319647|FG003|Overall Study|Physician Decision|3|||
160710830|NCT03207867|580319648|FG004|Overall Study|Physician Decision|2|||
160710831|NCT03207867|580319649|FG005|Overall Study|Physician Decision|0|||
160710832|NCT03207867|580319650|FG006|Overall Study|Physician Decision|0|||
160710833|NCT03207867|580319651|FG007|Overall Study|Physician Decision|0|||
160710834|NCT03207867|580319652|FG008|Overall Study|Physician Decision|4|||
160710835|NCT03207867|580319653|FG009|Overall Study|Physician Decision|2|||
160710836|NCT03207867|580319654|FG010|Overall Study|Physician Decision|0|||
160710837|NCT03207867|580319655|FG011|Overall Study|Physician Decision|4|||
160710838|NCT03207867|580319656|FG012|Overall Study|Physician Decision|0|||
160710839|NCT03207867|580319657|FG013|Overall Study|Physician Decision|0|||
160710840|NCT03207867|580319658|FG014|Overall Study|Physician Decision|2|||
160710841|NCT03207867|580319659|FG015|Overall Study|Physician Decision|1|||
160710842|NCT03207867|580319660|FG016|Overall Study|Physician Decision|1|||
160710843|NCT03207867|580319661|FG017|Overall Study|Physician Decision|2|||
160710844|NCT03207867|580319662|FG018|Overall Study|Physician Decision|1|||
160710845|NCT03207867|580319663|FG019|Overall Study|Physician Decision|3|||
160710846|NCT03207867|580319664|FG020|Overall Study|Physician Decision|0|||
160710847|NCT03207867|580319665|FG021|Overall Study|Physician Decision|0|||
160710848|NCT03207867|580319666|FG022|Overall Study|Physician Decision|0|||
160710849|NCT03207867|580319667|FG023|Overall Study|Physician Decision|0|||
160710850|NCT03207867|580319644|FG000|Overall Study|Progressive Disease|7|||
160710851|NCT03207867|580319645|FG001|Overall Study|Progressive Disease|7|||
160710852|NCT03207867|580319646|FG002|Overall Study|Progressive Disease|9|||
160710853|NCT03207867|580319647|FG003|Overall Study|Progressive Disease|10|||
160710854|NCT03207867|580319648|FG004|Overall Study|Progressive Disease|11|||
160710855|NCT03207867|580319649|FG005|Overall Study|Progressive Disease|10|||
160710856|NCT03207867|580319650|FG006|Overall Study|Progressive Disease|9|||
160710857|NCT03207867|580319651|FG007|Overall Study|Progressive Disease|8|||
160710858|NCT03207867|580319652|FG008|Overall Study|Progressive Disease|19|||
160710859|NCT03207867|580319653|FG009|Overall Study|Progressive Disease|23|||
160710860|NCT03207867|580319654|FG010|Overall Study|Progressive Disease|2|||
160710861|NCT03207867|580319655|FG011|Overall Study|Progressive Disease|24|||
160710862|NCT03207867|580319656|FG012|Overall Study|Progressive Disease|3|||
160710863|NCT03207867|580319657|FG013|Overall Study|Progressive Disease|11|||
160710864|NCT03207867|580319658|FG014|Overall Study|Progressive Disease|9|||
160710865|NCT03207867|580319659|FG015|Overall Study|Progressive Disease|5|||
160710866|NCT03207867|580319660|FG016|Overall Study|Progressive Disease|10|||
160710867|NCT03207867|580319661|FG017|Overall Study|Progressive Disease|14|||
160710868|NCT03207867|580319662|FG018|Overall Study|Progressive Disease|13|||
160710869|NCT03207867|580319663|FG019|Overall Study|Progressive Disease|14|||
160710870|NCT03207867|580319664|FG020|Overall Study|Progressive Disease|6|||
160710871|NCT03207867|580319665|FG021|Overall Study|Progressive Disease|3|||
160710872|NCT03207867|580319666|FG022|Overall Study|Progressive Disease|3|||
160710873|NCT03207867|580319667|FG023|Overall Study|Progressive Disease|3|||
160710874|NCT03207867|580319644|FG000|Overall Study|Patient/guardian Decision|0|||
160710875|NCT03207867|580319645|FG001|Overall Study|Patient/guardian Decision|0|||
160710876|NCT03207867|580319646|FG002|Overall Study|Patient/guardian Decision|1|||
160710877|NCT03207867|580319647|FG003|Overall Study|Patient/guardian Decision|1|||
160710878|NCT03207867|580319648|FG004|Overall Study|Patient/guardian Decision|1|||
160710879|NCT03207867|580319649|FG005|Overall Study|Patient/guardian Decision|2|||
160710880|NCT03207867|580319650|FG006|Overall Study|Patient/guardian Decision|1|||
160710881|NCT03207867|580319651|FG007|Overall Study|Patient/guardian Decision|0|||
160710882|NCT03207867|580319652|FG008|Overall Study|Patient/guardian Decision|1|||
160710883|NCT03207867|580319653|FG009|Overall Study|Patient/guardian Decision|0|||
160710884|NCT03207867|580319654|FG010|Overall Study|Patient/guardian Decision|0|||
160710885|NCT03207867|580319655|FG011|Overall Study|Patient/guardian Decision|1|||
160710886|NCT03207867|580319656|FG012|Overall Study|Patient/guardian Decision|0|||
160710887|NCT03207867|580319657|FG013|Overall Study|Patient/guardian Decision|1|||
160710888|NCT03207867|580319658|FG014|Overall Study|Patient/guardian Decision|2|||
160710889|NCT03207867|580319659|FG015|Overall Study|Patient/guardian Decision|0|||
160710890|NCT03207867|580319660|FG016|Overall Study|Patient/guardian Decision|1|||
160710891|NCT03207867|580319661|FG017|Overall Study|Patient/guardian Decision|3|||
160710892|NCT03207867|580319662|FG018|Overall Study|Patient/guardian Decision|4|||
160710893|NCT03207867|580319663|FG019|Overall Study|Patient/guardian Decision|1|||
160710894|NCT03207867|580319664|FG020|Overall Study|Patient/guardian Decision|0|||
160710895|NCT03207867|580319665|FG021|Overall Study|Patient/guardian Decision|0|||
160710896|NCT03207867|580319666|FG022|Overall Study|Patient/guardian Decision|0|||
160710897|NCT03207867|580319667|FG023|Overall Study|Patient/guardian Decision|0|||
160710898|NCT06473519|580322075|FG000|Overall Study|Lost to Follow-up|2|||
160710899|NCT06473519|580322076|FG001|Overall Study|Lost to Follow-up|5|||
160710900|NCT06473519|580322075|FG000|Overall Study|Withdrawal by Subject|1|||
160710901|NCT06473519|580322076|FG001|Overall Study|Withdrawal by Subject|4|||
160710902|NCT06473519|580322075|FG000|Overall Study|Randomized but not vaccinated|1|||
160710903|NCT06473519|580322076|FG001|Overall Study|Randomized but not vaccinated|2|||
160710904|NCT03560037|580322077|FG000|Overall Study|Protocol Violation|1|||
160710905|NCT03560037|580322078|FG001|Overall Study|Protocol Violation|0|||
160710906|NCT03560037|580322077|FG000|Overall Study|Physician Decision|0|||
160710907|NCT03560037|580322078|FG001|Overall Study|Physician Decision|1|||
160710908|NCT05168202|580322079|FG000|Overall Study|Progressive Disease|4|||
160710909|NCT05168202|580322080|FG001|Overall Study|Progressive Disease|4|||
160710910|NCT05168202|580322081|FG002|Overall Study|Progressive Disease|2|||
160710911|NCT05168202|580322082|FG003|Overall Study|Progressive Disease|3|||
160710912|NCT05168202|580322083|FG004|Overall Study|Progressive Disease|2|||
160710913|NCT05168202|580322084|FG005|Overall Study|Progressive Disease|3|||
160710914|NCT05168202|580322085|FG006|Overall Study|Progressive Disease|2|||
160710915|NCT05168202|580322079|FG000|Overall Study|Adverse Event|2|||
160710916|NCT05168202|580322080|FG001|Overall Study|Adverse Event|1|||
160710917|NCT05168202|580322081|FG002|Overall Study|Adverse Event|4|||
160710918|NCT05168202|580322082|FG003|Overall Study|Adverse Event|4|||
160710919|NCT05168202|580322083|FG004|Overall Study|Adverse Event|3|||
160710920|NCT05168202|580322084|FG005|Overall Study|Adverse Event|2|||
160710921|NCT05168202|580322085|FG006|Overall Study|Adverse Event|0|||
160710922|NCT05168202|580322079|FG000|Overall Study|Lack of Efficacy|0|||
160710923|NCT05168202|580322080|FG001|Overall Study|Lack of Efficacy|1|||
160710924|NCT05168202|580322081|FG002|Overall Study|Lack of Efficacy|1|||
160710925|NCT05168202|580322082|FG003|Overall Study|Lack of Efficacy|0|||
160710926|NCT05168202|580322083|FG004|Overall Study|Lack of Efficacy|1|||
160710927|NCT05168202|580322084|FG005|Overall Study|Lack of Efficacy|2|||
160710928|NCT05168202|580322085|FG006|Overall Study|Lack of Efficacy|2|||
160710929|NCT05168202|580322079|FG000|Overall Study|Withdrawal by Subject|0|||
160710930|NCT05168202|580322080|FG001|Overall Study|Withdrawal by Subject|0|||
160710931|NCT05168202|580322081|FG002|Overall Study|Withdrawal by Subject|1|||
160710932|NCT05168202|580322082|FG003|Overall Study|Withdrawal by Subject|1|||
160710933|NCT05168202|580322083|FG004|Overall Study|Withdrawal by Subject|1|||
160710934|NCT05168202|580322084|FG005|Overall Study|Withdrawal by Subject|1|||
160710935|NCT05168202|580322085|FG006|Overall Study|Withdrawal by Subject|0|||
160710936|NCT05168202|580322079|FG000|Overall Study|Disease Relapse|0|||
160710937|NCT05168202|580322080|FG001|Overall Study|Disease Relapse|1|||
160710938|NCT05168202|580322081|FG002|Overall Study|Disease Relapse|0|||
160710939|NCT05168202|580322082|FG003|Overall Study|Disease Relapse|1|||
160710940|NCT05168202|580322083|FG004|Overall Study|Disease Relapse|1|||
160710941|NCT05168202|580322084|FG005|Overall Study|Disease Relapse|0|||
160710942|NCT05168202|580322085|FG006|Overall Study|Disease Relapse|0|||
160710943|NCT05168202|580322079|FG000|Overall Study|Other Reasons|0|||
160710944|NCT05168202|580322080|FG001|Overall Study|Other Reasons|0|||
160710945|NCT05168202|580322081|FG002|Overall Study|Other Reasons|0|||
160710946|NCT05168202|580322082|FG003|Overall Study|Other Reasons|0|||
160710947|NCT05168202|580322083|FG004|Overall Study|Other Reasons|0|||
160710948|NCT05168202|580322084|FG005|Overall Study|Other Reasons|2|||
160710949|NCT05168202|580322085|FG006|Overall Study|Other Reasons|1|||
160710950|NCT05168202|580322079|FG000|Overall Study|Physician Decision|0|||
160710951|NCT05168202|580322080|FG001|Overall Study|Physician Decision|1|||
160710952|NCT05168202|580322081|FG002|Overall Study|Physician Decision|1|||
160710953|NCT05168202|580322082|FG003|Overall Study|Physician Decision|0|||
160710954|NCT05168202|580322083|FG004|Overall Study|Physician Decision|0|||
160710955|NCT05168202|580322084|FG005|Overall Study|Physician Decision|0|||
160710956|NCT05168202|580322085|FG006|Overall Study|Physician Decision|0|||
160710957|NCT05168202|580322079|FG000|Overall Study|Study Terminated by Sponsor|0|||
160710958|NCT05168202|580322080|FG001|Overall Study|Study Terminated by Sponsor|0|||
160710959|NCT05168202|580322081|FG002|Overall Study|Study Terminated by Sponsor|0|||
160710960|NCT05168202|580322082|FG003|Overall Study|Study Terminated by Sponsor|1|||
160710961|NCT05168202|580322083|FG004|Overall Study|Study Terminated by Sponsor|0|||
160710962|NCT05168202|580322084|FG005|Overall Study|Study Terminated by Sponsor|0|||
160710963|NCT05168202|580322085|FG006|Overall Study|Study Terminated by Sponsor|0|||
160710964|NCT04011722|580322086|FG000|30 Days|Death|5|||
160710965|NCT04011722|580322087|FG001|30 Days|Death|1|||
160710966|NCT04011722|580322086|FG000|1 Year|Death|13|||
160710967|NCT04011722|580322087|FG001|1 Year|Death|5|||
160710968|NCT04011722|580322086|FG000|1 Year|Withdrawal by Subject|8|||
160710969|NCT04011722|580322087|FG001|1 Year|Withdrawal by Subject|2|||
160710970|NCT04011722|580322086|FG000|1 Year|Missed Visit|6|||
160710971|NCT04011722|580322087|FG001|1 Year|Missed Visit|1|||
160710972|NCT04011722|580322086|FG000|1 Year|Pending Visit|0|||
160710973|NCT04011722|580322087|FG001|1 Year|Pending Visit|11|||
160710974|NCT04011722|580322086|FG000|1 Year|Not Yet Due|0|||
160710975|NCT04011722|580322087|FG001|1 Year|Not Yet Due|9|||
160710976|NCT04011722|580322086|FG000|2 Year|Death|16|||
160710977|NCT04011722|580322087|FG001|2 Year|Death|1|||
160710978|NCT04011722|580322086|FG000|2 Year|Withdrawal by Subject|10|||
160710979|NCT04011722|580322087|FG001|2 Year|Withdrawal by Subject|1|||
160710980|NCT04011722|580322086|FG000|2 Year|Missed Visit|9|||
160710981|NCT04011722|580322087|FG001|2 Year|Missed Visit|0|||
160710982|NCT04011722|580322086|FG000|2 Year|Visit Pending|1|||
160710983|NCT04011722|580322087|FG001|2 Year|Visit Pending|3|||
160710984|NCT04011722|580322086|FG000|2 Year|Not Yet Due|43|||
160710985|NCT04011722|580322087|FG001|2 Year|Not Yet Due|54|||
160710986|NCT04011722|580322086|FG000|3 Year|Death|10|||
160710987|NCT04011722|580322087|FG001|3 Year|Death|0|||
160710988|NCT04011722|580322086|FG000|3 Year|Withdrawal by Subject|2|||
160710989|NCT04011722|580322087|FG001|3 Year|Withdrawal by Subject|0|||
160710990|NCT04011722|580322086|FG000|3 Year|Missed Visit|2|||
160710991|NCT04011722|580322087|FG001|3 Year|Missed Visit|0|||
160710992|NCT04011722|580322086|FG000|3 Year|Pending Visit|34|||
160710993|NCT04011722|580322087|FG001|3 Year|Pending Visit|0|||
160710994|NCT04011722|580322086|FG000|3 Year|Not Yet Due|99|||
160710995|NCT04011722|580322087|FG001|3 Year|Not Yet Due|0|||
160710996|NCT05626231|580322088|FG000|Provider Enrollment|Worked part-time|4|||
160710997|NCT05626231|580322088|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
160710998|NCT05626231|580322088|FG000|Provider Enrollment|Non-clinical employee|1|||
160710999|NCT05626231|580322088|FG000|Provider Enrollment|Provider does not see clients|3|||
160711000|NCT05626231|580322088|FG000|Provider Enrollment|Other|5|||
160711001|NCT06195930|580322089|FG000|Overall Study|Adverse Event|4|||
160711002|NCT00233948|580322096|FG000|Overall Study|Adverse Event|1|||
160711003|NCT00233948|580322097|FG001|Overall Study|Adverse Event|0|||
160711004|NCT00233948|580322098|FG002|Overall Study|Adverse Event|0|||
160711005|NCT00233948|580322099|FG003|Overall Study|Adverse Event|0|||
160711006|NCT00233948|580322100|FG004|Overall Study|Adverse Event|0|||
160711007|NCT00233948|580322101|FG005|Overall Study|Adverse Event|0|||
160711008|NCT03284723|580322102|FG000|Overall Study|Death|0|||
160711009|NCT03284723|580322103|FG001|Overall Study|Death|0|||
160711010|NCT03284723|580322104|FG002|Overall Study|Death|0|||
160711011|NCT03284723|580322105|FG003|Overall Study|Death|1|||
160711012|NCT03284723|580322106|FG004|Overall Study|Death|0|||
160711013|NCT03284723|580322107|FG005|Overall Study|Death|0|||
160711014|NCT03284723|580322108|FG006|Overall Study|Death|1|||
160711015|NCT03284723|580322109|FG007|Overall Study|Death|0|||
160711016|NCT03284723|580322110|FG008|Overall Study|Death|0|||
160711017|NCT03284723|580322111|FG009|Overall Study|Death|2|||
160711018|NCT03284723|580322112|FG010|Overall Study|Death|1|||
160711019|NCT03284723|580322113|FG011|Overall Study|Death|0|||
160711020|NCT03284723|580322102|FG000|Overall Study|Lost to Follow-up|0|||
160711021|NCT03284723|580322103|FG001|Overall Study|Lost to Follow-up|0|||
160711022|NCT03284723|580322104|FG002|Overall Study|Lost to Follow-up|0|||
160711023|NCT03284723|580322105|FG003|Overall Study|Lost to Follow-up|0|||
160711024|NCT03284723|580322106|FG004|Overall Study|Lost to Follow-up|0|||
160711025|NCT03284723|580322107|FG005|Overall Study|Lost to Follow-up|2|||
160711026|NCT03284723|580322108|FG006|Overall Study|Lost to Follow-up|1|||
160711027|NCT03284723|580322109|FG007|Overall Study|Lost to Follow-up|0|||
160711028|NCT03284723|580322110|FG008|Overall Study|Lost to Follow-up|0|||
160711029|NCT03284723|580322111|FG009|Overall Study|Lost to Follow-up|2|||
160711030|NCT03284723|580322112|FG010|Overall Study|Lost to Follow-up|0|||
160711031|NCT03284723|580322113|FG011|Overall Study|Lost to Follow-up|0|||
160711032|NCT03284723|580322102|FG000|Overall Study|Study Terminated By Sponsor|0|||
160711033|NCT03284723|580322103|FG001|Overall Study|Study Terminated By Sponsor|0|||
160711034|NCT03284723|580322104|FG002|Overall Study|Study Terminated By Sponsor|0|||
160711035|NCT03284723|580322105|FG003|Overall Study|Study Terminated By Sponsor|0|||
160711036|NCT03284723|580322106|FG004|Overall Study|Study Terminated By Sponsor|1|||
160711037|NCT03284723|580322107|FG005|Overall Study|Study Terminated By Sponsor|0|||
160711038|NCT03284723|580322108|FG006|Overall Study|Study Terminated By Sponsor|0|||
160711039|NCT03284723|580322109|FG007|Overall Study|Study Terminated By Sponsor|0|||
160711040|NCT03284723|580322110|FG008|Overall Study|Study Terminated By Sponsor|1|||
160711041|NCT03284723|580322111|FG009|Overall Study|Study Terminated By Sponsor|1|||
160711042|NCT03284723|580322112|FG010|Overall Study|Study Terminated By Sponsor|1|||
160711043|NCT03284723|580322113|FG011|Overall Study|Study Terminated By Sponsor|1|||
160711044|NCT03284723|580322102|FG000|Overall Study|Withdrawal by Subject|0|||
160711045|NCT03284723|580322103|FG001|Overall Study|Withdrawal by Subject|0|||
160711046|NCT03284723|580322104|FG002|Overall Study|Withdrawal by Subject|0|||
160711047|NCT03284723|580322105|FG003|Overall Study|Withdrawal by Subject|0|||
160711048|NCT03284723|580322106|FG004|Overall Study|Withdrawal by Subject|5|||
160711049|NCT03284723|580322107|FG005|Overall Study|Withdrawal by Subject|3|||
160711050|NCT03284723|580322108|FG006|Overall Study|Withdrawal by Subject|1|||
160711051|NCT03284723|580322109|FG007|Overall Study|Withdrawal by Subject|0|||
160711052|NCT03284723|580322110|FG008|Overall Study|Withdrawal by Subject|6|||
160711053|NCT03284723|580322111|FG009|Overall Study|Withdrawal by Subject|0|||
160711054|NCT03284723|580322112|FG010|Overall Study|Withdrawal by Subject|3|||
160711055|NCT03284723|580322113|FG011|Overall Study|Withdrawal by Subject|1|||
160711056|NCT03284723|580322102|FG000|Overall Study|Other|1|||
160711057|NCT03284723|580322103|FG001|Overall Study|Other|0|||
160711058|NCT03284723|580322104|FG002|Overall Study|Other|1|||
160711059|NCT03284723|580322105|FG003|Overall Study|Other|0|||
160711060|NCT03284723|580322106|FG004|Overall Study|Other|1|||
160711061|NCT03284723|580322107|FG005|Overall Study|Other|0|||
160711062|NCT03284723|580322108|FG006|Overall Study|Other|0|||
160711063|NCT03284723|580322109|FG007|Overall Study|Other|0|||
160711064|NCT03284723|580322110|FG008|Overall Study|Other|0|||
160711065|NCT03284723|580322111|FG009|Overall Study|Other|0|||
160711066|NCT03284723|580322112|FG010|Overall Study|Other|1|||
160711067|NCT03284723|580322113|FG011|Overall Study|Other|0|||
160711068|NCT03284723|580322102|FG000|Overall Study|Adverse Event|0|||
160711069|NCT03284723|580322103|FG001|Overall Study|Adverse Event|0|||
160711070|NCT03284723|580322104|FG002|Overall Study|Adverse Event|0|||
160711071|NCT03284723|580322105|FG003|Overall Study|Adverse Event|0|||
160711072|NCT03284723|580322106|FG004|Overall Study|Adverse Event|0|||
160711073|NCT03284723|580322107|FG005|Overall Study|Adverse Event|0|||
160711074|NCT03284723|580322108|FG006|Overall Study|Adverse Event|0|||
160711075|NCT03284723|580322109|FG007|Overall Study|Adverse Event|0|||
160711076|NCT03284723|580322110|FG008|Overall Study|Adverse Event|1|||
160711077|NCT03284723|580322111|FG009|Overall Study|Adverse Event|0|||
160711078|NCT03284723|580322112|FG010|Overall Study|Adverse Event|0|||
160711079|NCT03284723|580322113|FG011|Overall Study|Adverse Event|0|||
160711080|NCT00064987|580322116|FG000|Overall Study|Physician Decision|3|||
160711081|NCT00064987|580322117|FG001|Overall Study|Physician Decision|0|||
160711082|NCT01499095|580322118|FG000|Overall Study|Randomized But Not Treated|1|||
160711083|NCT01499095|580322119|FG001|Overall Study|Randomized But Not Treated|1|||
160711084|NCT01499095|580322118|FG000|Overall Study|Adverse Event|12|||
160711085|NCT01499095|580322119|FG001|Overall Study|Adverse Event|7|||
160711086|NCT01499095|580322118|FG000|Overall Study|Lack of Efficacy|2|||
160711087|NCT01499095|580322119|FG001|Overall Study|Lack of Efficacy|1|||
160711088|NCT01499095|580322118|FG000|Overall Study|Protocol Violation|6|||
160711089|NCT01499095|580322119|FG001|Overall Study|Protocol Violation|7|||
160711090|NCT01499095|580322118|FG000|Overall Study|Received Rescue Therapy|32|||
160711091|NCT01499095|580322119|FG001|Overall Study|Received Rescue Therapy|40|||
160711092|NCT01499095|580322118|FG000|Overall Study|Diverse Reasons|22|||
160711093|NCT01499095|580322119|FG001|Overall Study|Diverse Reasons|25|||
160711094|NCT01499095|580322118|FG000|Overall Study|Lost to Follow-up|6|||
160711095|NCT01499095|580322119|FG001|Overall Study|Lost to Follow-up|4|||
160711096|NCT01499095|580322118|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
160711097|NCT01499095|580322119|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
160711098|NCT01499095|580322118|FG000|Overall Study|Hypoglycemia|3|||
160711099|NCT01499095|580322119|FG001|Overall Study|Hypoglycemia|1|||
160711100|NCT01499095|580322118|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
160711101|NCT01499095|580322119|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
160711102|NCT01499095|580322118|FG000|Overall Study|Change in Injection Schedule|2|||
160711103|NCT01499095|580322119|FG001|Overall Study|Change in Injection Schedule|0|||
160711104|NCT01499095|580322118|FG000|Overall Study|Perceived Lack of Efficacy|1|||
160711105|NCT01499095|580322119|FG001|Overall Study|Perceived Lack of Efficacy|1|||
160711106|NCT01368497|580322120|FG000|Overall Study|Lost to Follow-up|2|||
160711107|NCT01567462|580322121|FG000|Overall Study|Withdrawal by Subject|4|||
160711108|NCT01567462|580322122|FG001|Overall Study|Withdrawal by Subject|7|||
160711109|NCT00443729|580322126|FG000|Overall Study|Never Treated|0|||
160711110|NCT00443729|580322127|FG001|Overall Study|Never Treated|1|||
160711111|NCT00443729|580322126|FG000|Overall Study|Lack of Efficacy|4|||
160711112|NCT00443729|580322127|FG001|Overall Study|Lack of Efficacy|2|||
160711113|NCT00443729|580322126|FG000|Overall Study|Lost to Follow-up|0|||
160711114|NCT00443729|580322127|FG001|Overall Study|Lost to Follow-up|1|||
160711115|NCT00443729|580322126|FG000|Overall Study|Physician Decision|2|||
160711116|NCT00443729|580322127|FG001|Overall Study|Physician Decision|1|||
160711117|NCT00443729|580322126|FG000|Overall Study|Protocol Violation|1|||
160711118|NCT00443729|580322127|FG001|Overall Study|Protocol Violation|1|||
160711119|NCT00443729|580322126|FG000|Overall Study|Withdrawal by Subject|3|||
160711120|NCT00443729|580322127|FG001|Overall Study|Withdrawal by Subject|1|||
160711121|NCT00782626|580322131|FG000|Overall Study|Adverse Event|1|||
160711122|NCT00782626|580322131|FG000|Overall Study|Progressive Disease|5|||
160711123|NCT00782626|580322131|FG000|Overall Study|Other Complicating Disease|1|||
160711124|NCT00077207|580322134|FG000|Overall Study|Adverse Event|5|||
160711125|NCT00077207|580322134|FG000|Overall Study|Lack of Efficacy|12|||
160711126|NCT00077207|580322134|FG000|Overall Study|Physician Decision|6|||
160711127|NCT00077207|580322134|FG000|Overall Study|Withdrawal by Subject|6|||
160711128|NCT00077207|580322134|FG000|Overall Study|Ineligible|1|||
160711129|NCT03052751|580322137|FG000|Dosing Period 1|Adverse Event|0|||
160711130|NCT03052751|580322138|FG001|Dosing Period 1|Adverse Event|1|||
160711131|NCT03052751|580322139|FG002|Dosing Period 1|Adverse Event|0|||
160711132|NCT03052751|580322140|FG003|Dosing Period 1|Adverse Event|0|||
160711133|NCT03052751|580322141|FG004|Dosing Period 1|Adverse Event|0|||
160711134|NCT03052751|580322142|FG005|Dosing Period 1|Adverse Event|0|||
160711135|NCT03052751|580322137|FG000|Dosing Period 2|Adverse Event|0|||
160711136|NCT03052751|580322138|FG001|Dosing Period 2|Adverse Event|0|||
160711137|NCT03052751|580322139|FG002|Dosing Period 2|Adverse Event|3|||
160711138|NCT03052751|580322140|FG003|Dosing Period 2|Adverse Event|0|||
160711139|NCT03052751|580322141|FG004|Dosing Period 2|Adverse Event|0|||
160711140|NCT03052751|580322142|FG005|Dosing Period 2|Adverse Event|0|||
160711141|NCT03052751|580322137|FG000|Observation Period|Adverse Event|0|||
160711142|NCT03052751|580322138|FG001|Observation Period|Adverse Event|0|||
160711143|NCT03052751|580322139|FG002|Observation Period|Adverse Event|0|||
160711144|NCT03052751|580322140|FG003|Observation Period|Adverse Event|0|||
160711145|NCT03052751|580322141|FG004|Observation Period|Adverse Event|1|||
160711146|NCT03052751|580322142|FG005|Observation Period|Adverse Event|0|||
160711147|NCT02276807|580322153|FG000|Overall Study|Withdrawal by Subject|8|||
160711148|NCT02276807|580322154|FG001|Overall Study|Withdrawal by Subject|7|||
160711149|NCT02276807|580322153|FG000|Overall Study|Lost to Follow-up|10|||
160711150|NCT02276807|580322154|FG001|Overall Study|Lost to Follow-up|10|||
160711151|NCT00261950|580322155|FG000|Overall Study|Lost to Follow-up|2|||
160711152|NCT00261950|580322155|FG000|Overall Study|Death|6|||
160711153|NCT00261950|580322155|FG000|Overall Study|Withdrawal by Subject|5|||
160711154|NCT00261950|580322155|FG000|Overall Study|Other|1|||
160711155|NCT00261950|580322155|FG000|Overall Study|Physician Decision|1|||
160711156|NCT00261950|580322155|FG000|Overall Study|Protocol specified Criteria|11|||
160711157|NCT02789137|580322156|FG000|Overall Study|Dropped out/Died|58|||
160711158|NCT00445432|580322157|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
160711159|NCT00445432|580322158|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
160711160|NCT00445432|580322159|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
160711161|NCT00445432|580322160|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
160711162|NCT00445432|580322157|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
160711163|NCT00445432|580322158|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
160711164|NCT00445432|580322159|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
160711165|NCT00445432|580322160|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
160711166|NCT00445432|580322157|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
160711167|NCT00445432|580322158|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
160711168|NCT00445432|580322159|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
160711169|NCT00445432|580322160|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
160711170|NCT00445432|580322157|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
160711171|NCT00445432|580322158|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
160711172|NCT00445432|580322159|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
160711173|NCT00445432|580322160|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
160711174|NCT00445432|580322157|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
160711175|NCT00445432|580322158|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
160711176|NCT00445432|580322159|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
160711177|NCT00445432|580322160|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
160711178|NCT00445432|580322157|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
160711179|NCT00445432|580322158|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
160711180|NCT00445432|580322159|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
160711181|NCT00445432|580322160|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
160711182|NCT00445432|580322157|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
160711183|NCT00445432|580322158|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
160711184|NCT00445432|580322159|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
160711185|NCT00445432|580322160|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
160711186|NCT01995513|580322165|FG000|Period 1: First Open Label Treatment|Other|34|||
160711187|NCT01995513|580322166|FG001|Period 1: First Open Label Treatment|Other|0|||
160711188|NCT01995513|580322167|FG002|Period 1: First Open Label Treatment|Other|0|||
160711189|NCT01995513|580322168|FG003|Period 1: First Open Label Treatment|Other|0|||
160711190|NCT01995513|580322165|FG000|Period 1: First Open Label Treatment|Death|14|||
160711191|NCT01995513|580322166|FG001|Period 1: First Open Label Treatment|Death|0|||
160711192|NCT01995513|580322167|FG002|Period 1: First Open Label Treatment|Death|0|||
160711193|NCT01995513|580322168|FG003|Period 1: First Open Label Treatment|Death|0|||
160711194|NCT01995513|580322165|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
160711195|NCT01995513|580322166|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
160711196|NCT01995513|580322167|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
160711197|NCT01995513|580322168|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
160711198|NCT01995513|580322165|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
160711199|NCT01995513|580322166|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
160711200|NCT01995513|580322167|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
160711201|NCT01995513|580322168|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
160711202|NCT01995513|580322165|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
160711203|NCT01995513|580322166|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
160711204|NCT01995513|580322167|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
160711205|NCT01995513|580322168|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
160711206|NCT01995513|580322165|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
160711207|NCT01995513|580322166|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
160711208|NCT01995513|580322167|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
160711209|NCT01995513|580322168|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
160711210|NCT01995513|580322165|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
160711211|NCT01995513|580322166|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
160711212|NCT01995513|580322167|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
160711213|NCT01995513|580322168|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
160711214|NCT01995513|580322165|FG000|Period 1: Second Open Label Treatment|Other|0|||
160711215|NCT01995513|580322166|FG001|Period 1: Second Open Label Treatment|Other|2|||
160711216|NCT01995513|580322167|FG002|Period 1: Second Open Label Treatment|Other|0|||
160711217|NCT01995513|580322168|FG003|Period 1: Second Open Label Treatment|Other|0|||
160711218|NCT01995513|580322165|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
160711219|NCT01995513|580322166|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
160711220|NCT01995513|580322167|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
160711221|NCT01995513|580322168|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
160711222|NCT01995513|580322165|FG000|Period 2: Double Blind Treatment|Death|0|||
160711223|NCT01995513|580322166|FG001|Period 2: Double Blind Treatment|Death|0|||
160711224|NCT01995513|580322167|FG002|Period 2: Double Blind Treatment|Death|0|||
160711225|NCT01995513|580322168|FG003|Period 2: Double Blind Treatment|Death|1|||
160711226|NCT01995513|580322165|FG000|Period 2: Double Blind Treatment|Other|0|||
160711227|NCT01995513|580322166|FG001|Period 2: Double Blind Treatment|Other|0|||
160711228|NCT01995513|580322167|FG002|Period 2: Double Blind Treatment|Other|3|||
160711229|NCT01995513|580322168|FG003|Period 2: Double Blind Treatment|Other|3|||
160711230|NCT01995513|580322165|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
160711231|NCT01995513|580322166|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
160711232|NCT01995513|580322167|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
160711233|NCT01995513|580322168|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
160711234|NCT01995513|580322165|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
160711235|NCT01995513|580322166|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
160711236|NCT01995513|580322167|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
160711237|NCT01995513|580322168|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
160711238|NCT01995513|580322165|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
160711239|NCT01995513|580322166|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
160711240|NCT01995513|580322167|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
160711241|NCT01995513|580322168|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
160711242|NCT01995513|580322165|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
160711243|NCT01995513|580322166|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
160711244|NCT01995513|580322167|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
160711245|NCT01995513|580322168|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
160711246|NCT01232452|580322169|FG000|Overall Study|Adverse Event|17|||
160711247|NCT01232452|580322170|FG001|Overall Study|Adverse Event|15|||
160711248|NCT01232452|580322169|FG000|Overall Study|Withdrawal by Subject|11|||
160711249|NCT01232452|580322170|FG001|Overall Study|Withdrawal by Subject|8|||
160711250|NCT01232452|580322169|FG000|Overall Study|Physician Decision|8|||
160711251|NCT01232452|580322170|FG001|Overall Study|Physician Decision|12|||
160711252|NCT01232452|580322169|FG000|Overall Study|Protocol entry criterion not met|0|||
160711253|NCT01232452|580322170|FG001|Overall Study|Protocol entry criterion not met|2|||
160711254|NCT01232452|580322169|FG000|Overall Study|Sponsor Decision|3|||
160711255|NCT01232452|580322170|FG001|Overall Study|Sponsor Decision|1|||
160711256|NCT01232452|580322169|FG000|Overall Study|Protocol Violation|0|||
160711257|NCT01232452|580322170|FG001|Overall Study|Protocol Violation|1|||
160711258|NCT05219448|580322175|FG000|Overall Study|Lost to Follow-up|9|||
160711259|NCT05219448|580322176|FG001|Overall Study|Lost to Follow-up|0|||
160711260|NCT01750190|580322177|FG000|Overall Study|Adverse Event|47|||
160711261|NCT01750190|580322178|FG001|Overall Study|Adverse Event|19|||
160711262|NCT01750190|580322177|FG000|Overall Study|Death|38|||
160711263|NCT01750190|580322178|FG001|Overall Study|Death|11|||
160711264|NCT01750190|580322177|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
160711265|NCT01750190|580322178|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
160711266|NCT01750190|580322177|FG000|Overall Study|Lost to Follow-up|28|||
160711267|NCT01750190|580322178|FG001|Overall Study|Lost to Follow-up|7|||
160711268|NCT01750190|580322177|FG000|Overall Study|Physician Decision|16|||
160711269|NCT01750190|580322178|FG001|Overall Study|Physician Decision|17|||
160711270|NCT01750190|580322177|FG000|Overall Study|Protocol Violation|6|||
160711271|NCT01750190|580322178|FG001|Overall Study|Protocol Violation|5|||
160711272|NCT01750190|580322177|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
160711273|NCT01750190|580322178|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
160711274|NCT01750190|580322177|FG000|Overall Study|Withdrawal by Subject|83|||
160711275|NCT01750190|580322178|FG001|Overall Study|Withdrawal by Subject|89|||
160711276|NCT01750190|580322177|FG000|Overall Study|Kidney Transplant|8|||
160711277|NCT01750190|580322178|FG001|Overall Study|Kidney Transplant|4|||
160711278|NCT01750190|580322177|FG000|Overall Study|Dialysis|22|||
160711279|NCT01750190|580322178|FG001|Overall Study|Dialysis|8|||
160711280|NCT01750190|580322177|FG000|Overall Study|Other than Specified|13|||
160711281|NCT01750190|580322178|FG001|Overall Study|Other than Specified|4|||
160711282|NCT03571828|580322185|FG000|Overall Study|Withdrawal by Subject|1|||
160711283|NCT03571828|580322186|FG001|Overall Study|Withdrawal by Subject|0|||
160711284|NCT03571828|580322185|FG000|Overall Study|Decision by sponsor|5|||
160711285|NCT03571828|580322186|FG001|Overall Study|Decision by sponsor|1|||
160711286|NCT03571828|580322185|FG000|Overall Study|Death|2|||
160711287|NCT03571828|580322186|FG001|Overall Study|Death|0|||
160711288|NCT02232984|580322187|FG000|Overall Study|Withdrawal by Subject|5|||
160711289|NCT02232984|580322187|FG000|Overall Study|Death|1|||
160711290|NCT02232984|580322187|FG000|Overall Study|Investigator withdrawal|10|||
160711291|NCT02232984|580322187|FG000|Overall Study|Device implant unsuccessful|53|||
160711292|NCT02232984|580322187|FG000|Overall Study|not disclosed by site|7|||
160711293|NCT02232984|580322187|FG000|Overall Study|Protocol Violation|1|||
160711294|NCT00769379|580322192|FG000|Overall Study|No follow up data mapped to Other.|3|||
160711295|NCT00769379|580322193|FG001|Overall Study|No follow up data mapped to Other.|13|||
160711296|NCT03762239|580322198|FG000|Overall Study|Appointment to the doctor|1|||
160711297|NCT03762239|580322199|FG001|Overall Study|Appointment to the doctor|1|||
160711298|NCT04650204|580322213|FG000|Overall Study|Study was Terminated|2|||
160711299|NCT04650204|580322214|FG001|Overall Study|Study was Terminated|1|||
160711300|NCT03164616|580322215|FG000|Overall Study|Death|250|||
160711301|NCT03164616|580322216|FG001|Overall Study|Death|264|||
160711302|NCT03164616|580322217|FG002|Overall Study|Death|279|||
160711303|NCT03164616|580322215|FG000|Overall Study|Lost to Follow-up|2|||
160711304|NCT03164616|580322216|FG001|Overall Study|Lost to Follow-up|2|||
160711305|NCT03164616|580322217|FG002|Overall Study|Lost to Follow-up|2|||
160711306|NCT03164616|580322215|FG000|Overall Study|Withdrawal by Subject|6|||
160711307|NCT03164616|580322216|FG001|Overall Study|Withdrawal by Subject|7|||
160711308|NCT03164616|580322217|FG002|Overall Study|Withdrawal by Subject|16|||
160711309|NCT01911273|580322220|FG000|Overall Study|Progression of Disease|1|||
160711310|NCT01911273|580322221|FG001|Overall Study|Progression of Disease|0|||
160711311|NCT01911273|580322220|FG000|Overall Study|Withdrawal by Subject|0|||
160711312|NCT01911273|580322221|FG001|Overall Study|Withdrawal by Subject|2|||
160711313|NCT02503787|580322226|FG000|Enrollment|Withdrawal by Subject|6|||
160711314|NCT02503787|580322226|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
160711315|NCT02503787|580322226|FG000|Enrollment|Physician Decision|2|||
160711316|NCT02503787|580322226|FG000|Enrollment|Insurance issue|2|||
160711317|NCT02503787|580322226|FG000|Enrollment|Lost to Follow-up|1|||
160711318|NCT02503787|580322226|FG000|Enrollment|Study closure|1|||
160711319|NCT02503787|580322226|FG000|Enrollment|Adverse Event|1|||
160711320|NCT02503787|580322226|FG000|Enrollment|Protocol Violation|1|||
160711321|NCT02503787|580322226|FG000|Enrollment|Inability to implant system|1|||
160711322|NCT02503787|580322226|FG000|Enrollment|Unable to be programmed|1|||
160711323|NCT02503787|580322226|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
160711324|NCT02503787|580322226|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
160711325|NCT02503787|580322226|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
160711326|NCT02503787|580322226|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
160711327|NCT02503787|580322226|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
160711328|NCT02503787|580322226|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
160711329|NCT04787627|580322227|FG000|Overall Study|Withdrawal by Subject|3|||
160711330|NCT04787627|580322228|FG001|Overall Study|Withdrawal by Subject|0|||
160711331|NCT04787627|580322227|FG000|Overall Study|Physician Decision|2|||
160711332|NCT04787627|580322228|FG001|Overall Study|Physician Decision|0|||
160711333|NCT04787627|580322227|FG000|Overall Study|Excluded|0|||
160711334|NCT04787627|580322228|FG001|Overall Study|Excluded|1|||
160711335|NCT00548093|580322229|FG000|Overall Study|Death|33|||
160711336|NCT00548093|580322230|FG001|Overall Study|Death|13|||
160711337|NCT00548093|580322229|FG000|Overall Study|Lost to Follow-up|3|||
160711338|NCT00548093|580322230|FG001|Overall Study|Lost to Follow-up|1|||
160711339|NCT00548093|580322229|FG000|Overall Study|Objective progression or relapse|1|||
160711340|NCT00548093|580322230|FG001|Overall Study|Objective progression or relapse|1|||
160711341|NCT00548093|580322229|FG000|Overall Study|Other|11|||
160711342|NCT00548093|580322230|FG001|Overall Study|Other|1|||
160711343|NCT00548093|580322229|FG000|Overall Study|Withdrawal by Subject|1|||
160711344|NCT00548093|580322230|FG001|Overall Study|Withdrawal by Subject|0|||
160711345|NCT00548093|580322229|FG000|Overall Study|Completed post-treatment follow-up|1|||
160711346|NCT00548093|580322230|FG001|Overall Study|Completed post-treatment follow-up|0|||
160711347|NCT00174954|580322233|FG000|Overall Study|Adverse Event|2|||
160711348|NCT00174954|580322233|FG000|Overall Study|No tophi found in MRI|1|||
160711349|NCT00174954|580322233|FG000|Overall Study|Physician Decision|1|||
160711350|NCT00839254|580322234|FG000|Overall Study|Protocol Violation|0|||
160711351|NCT00839254|580322235|FG001|Overall Study|Protocol Violation|1|||
160711352|NCT00839254|580322236|FG002|Overall Study|Protocol Violation|1|||
160711353|NCT00839254|580322237|FG003|Overall Study|Protocol Violation|1|||
160711354|NCT00839254|580322238|FG004|Overall Study|Protocol Violation|0|||
160711355|NCT00839254|580322239|FG005|Overall Study|Protocol Violation|0|||
160711356|NCT00839254|580322240|FG006|Overall Study|Protocol Violation|1|||
160711357|NCT00839254|580322241|FG007|Overall Study|Protocol Violation|2|||
160711358|NCT00839254|580322234|FG000|Overall Study|Physician Decision|0|||
160711359|NCT00839254|580322235|FG001|Overall Study|Physician Decision|1|||
160711360|NCT00839254|580322236|FG002|Overall Study|Physician Decision|0|||
160711361|NCT00839254|580322237|FG003|Overall Study|Physician Decision|0|||
160711362|NCT00839254|580322238|FG004|Overall Study|Physician Decision|0|||
160711363|NCT00839254|580322239|FG005|Overall Study|Physician Decision|0|||
160711364|NCT00839254|580322240|FG006|Overall Study|Physician Decision|0|||
160711365|NCT00839254|580322241|FG007|Overall Study|Physician Decision|1|||
160711366|NCT00839254|580322234|FG000|Overall Study|Wrong treatment number allocation|0|||
160711367|NCT00839254|580322235|FG001|Overall Study|Wrong treatment number allocation|1|||
160711368|NCT00839254|580322236|FG002|Overall Study|Wrong treatment number allocation|0|||
160711369|NCT00839254|580322237|FG003|Overall Study|Wrong treatment number allocation|0|||
160711370|NCT00839254|580322238|FG004|Overall Study|Wrong treatment number allocation|0|||
160711371|NCT00839254|580322239|FG005|Overall Study|Wrong treatment number allocation|1|||
160711372|NCT00839254|580322240|FG006|Overall Study|Wrong treatment number allocation|0|||
160711373|NCT00839254|580322241|FG007|Overall Study|Wrong treatment number allocation|0|||
160711374|NCT00839254|580322234|FG000|Overall Study|Adverse Event|12|||
160711375|NCT00839254|580322235|FG001|Overall Study|Adverse Event|6|||
160711376|NCT00839254|580322236|FG002|Overall Study|Adverse Event|3|||
160711377|NCT00839254|580322237|FG003|Overall Study|Adverse Event|5|||
160711378|NCT00839254|580322238|FG004|Overall Study|Adverse Event|2|||
160711379|NCT00839254|580322239|FG005|Overall Study|Adverse Event|1|||
160711380|NCT00839254|580322240|FG006|Overall Study|Adverse Event|0|||
160711381|NCT00839254|580322241|FG007|Overall Study|Adverse Event|1|||
160711382|NCT00839254|580322234|FG000|Overall Study|Withdrawal by Subject|87|||
160711383|NCT00839254|580322235|FG001|Overall Study|Withdrawal by Subject|53|||
160711384|NCT00839254|580322236|FG002|Overall Study|Withdrawal by Subject|54|||
160711385|NCT00839254|580322237|FG003|Overall Study|Withdrawal by Subject|32|||
160711386|NCT00839254|580322238|FG004|Overall Study|Withdrawal by Subject|27|||
160711387|NCT00839254|580322239|FG005|Overall Study|Withdrawal by Subject|15|||
160711388|NCT00839254|580322240|FG006|Overall Study|Withdrawal by Subject|22|||
160711389|NCT00839254|580322241|FG007|Overall Study|Withdrawal by Subject|9|||
160711390|NCT00839254|580322234|FG000|Overall Study|Wrong group allocation|0|||
160711391|NCT00839254|580322235|FG001|Overall Study|Wrong group allocation|0|||
160711392|NCT00839254|580322236|FG002|Overall Study|Wrong group allocation|0|||
160711393|NCT00839254|580322237|FG003|Overall Study|Wrong group allocation|0|||
160711394|NCT00839254|580322238|FG004|Overall Study|Wrong group allocation|0|||
160711395|NCT00839254|580322239|FG005|Overall Study|Wrong group allocation|0|||
160711396|NCT00839254|580322240|FG006|Overall Study|Wrong group allocation|1|||
160711397|NCT00839254|580322241|FG007|Overall Study|Wrong group allocation|0|||
160711398|NCT00839254|580322234|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
160711399|NCT00839254|580322235|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
160711400|NCT00839254|580322236|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
160711401|NCT00839254|580322237|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
160711402|NCT00839254|580322238|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
160711403|NCT00839254|580322239|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
160711404|NCT00839254|580322240|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
160711405|NCT00839254|580322241|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
160711406|NCT00839254|580322234|FG000|Overall Study|Withdrawn due to non-compliance|2|||
160711407|NCT00839254|580322235|FG001|Overall Study|Withdrawn due to non-compliance|0|||
160711408|NCT00839254|580322236|FG002|Overall Study|Withdrawn due to non-compliance|0|||
160711409|NCT00839254|580322237|FG003|Overall Study|Withdrawn due to non-compliance|0|||
160711410|NCT00839254|580322238|FG004|Overall Study|Withdrawn due to non-compliance|0|||
160711411|NCT00839254|580322239|FG005|Overall Study|Withdrawn due to non-compliance|0|||
160711412|NCT00839254|580322240|FG006|Overall Study|Withdrawn due to non-compliance|0|||
160711413|NCT00839254|580322241|FG007|Overall Study|Withdrawn due to non-compliance|0|||
160711414|NCT00839254|580322234|FG000|Overall Study|Lost to Follow-up|51|||
160711415|NCT00839254|580322235|FG001|Overall Study|Lost to Follow-up|30|||
160711416|NCT00839254|580322236|FG002|Overall Study|Lost to Follow-up|32|||
160711417|NCT00839254|580322237|FG003|Overall Study|Lost to Follow-up|24|||
160711418|NCT00839254|580322238|FG004|Overall Study|Lost to Follow-up|8|||
160711419|NCT00839254|580322239|FG005|Overall Study|Lost to Follow-up|8|||
160711420|NCT00839254|580322240|FG006|Overall Study|Lost to Follow-up|4|||
160711421|NCT00839254|580322241|FG007|Overall Study|Lost to Follow-up|2|||
160711422|NCT02359994|580322243|FG000|Overall Population Study|Adverse Event|1|||
160711423|NCT02359994|580322244|FG001|Overall Population Study|Adverse Event|1|||
160711424|NCT02359994|580322243|FG000|Overall Population Study|Death|1|||
160711425|NCT02359994|580322244|FG001|Overall Population Study|Death|5|||
160711426|NCT02359994|580322243|FG000|Overall Population Study|Lost to Follow-up|1|||
160711427|NCT02359994|580322244|FG001|Overall Population Study|Lost to Follow-up|1|||
160711428|NCT02359994|580322243|FG000|Overall Population Study|Withdrawal by Subject|1|||
160711429|NCT02359994|580322244|FG001|Overall Population Study|Withdrawal by Subject|0|||
160711430|NCT02359994|580322243|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
160711431|NCT02359994|580322244|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
160711432|NCT02359994|580322243|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
160711433|NCT02359994|580322244|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
160711434|NCT02359994|580322243|FG000|Extended Oncology 24-Month Survival|Death|19|||
160711435|NCT02359994|580322244|FG001|Extended Oncology 24-Month Survival|Death|21|||
160711436|NCT02359994|580322243|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
160711437|NCT02359994|580322244|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
160711438|NCT04597632|580322245|FG000|Overall Study|Withdrawal by Subject|10|||
160711439|NCT04597632|580322245|FG000|Overall Study|Lost to Follow-up|1|||
160711440|NCT04597632|580322245|FG000|Overall Study|Death|1|||
160711441|NCT04597632|580322245|FG000|Overall Study|Adverse Event|5|||
160711442|NCT01823835|580322246|FG000|Overall Study|Adverse Event|0|||
160711443|NCT01823835|580322247|FG001|Overall Study|Adverse Event|0|||
160711444|NCT01823835|580322248|FG002|Overall Study|Adverse Event|0|||
160711445|NCT01823835|580322249|FG003|Overall Study|Adverse Event|0|||
160711446|NCT01823835|580322250|FG004|Overall Study|Adverse Event|1|||
160711447|NCT01823835|580322251|FG005|Overall Study|Adverse Event|0|||
160711448|NCT01823835|580322252|FG006|Overall Study|Adverse Event|1|||
160711449|NCT01823835|580322253|FG007|Overall Study|Adverse Event|0|||
160711450|NCT01823835|580322254|FG008|Overall Study|Adverse Event|0|||
160711451|NCT01823835|580322255|FG009|Overall Study|Adverse Event|0|||
160711452|NCT01823835|580322256|FG010|Overall Study|Adverse Event|1|||
160711453|NCT01823835|580322257|FG011|Overall Study|Adverse Event|2|||
160711454|NCT01823835|580322258|FG012|Overall Study|Adverse Event|0|||
160711455|NCT01823835|580322259|FG013|Overall Study|Adverse Event|0|||
160711456|NCT01823835|580322260|FG014|Overall Study|Adverse Event|0|||
160711457|NCT01823835|580322246|FG000|Overall Study|Physician Decision|0|||
160711458|NCT01823835|580322247|FG001|Overall Study|Physician Decision|0|||
160711459|NCT01823835|580322248|FG002|Overall Study|Physician Decision|0|||
160711460|NCT01823835|580322249|FG003|Overall Study|Physician Decision|0|||
160711461|NCT01823835|580322250|FG004|Overall Study|Physician Decision|0|||
160711462|NCT01823835|580322251|FG005|Overall Study|Physician Decision|0|||
160711463|NCT01823835|580322252|FG006|Overall Study|Physician Decision|0|||
160711464|NCT01823835|580322253|FG007|Overall Study|Physician Decision|0|||
160711465|NCT01823835|580322254|FG008|Overall Study|Physician Decision|0|||
160711466|NCT01823835|580322255|FG009|Overall Study|Physician Decision|0|||
160711467|NCT01823835|580322256|FG010|Overall Study|Physician Decision|0|||
160711468|NCT01823835|580322257|FG011|Overall Study|Physician Decision|2|||
160711469|NCT01823835|580322258|FG012|Overall Study|Physician Decision|0|||
160711470|NCT01823835|580322259|FG013|Overall Study|Physician Decision|0|||
160711471|NCT01823835|580322260|FG014|Overall Study|Physician Decision|0|||
160711472|NCT01823835|580322246|FG000|Overall Study|Progressive Disease|3|||
160711473|NCT01823835|580322247|FG001|Overall Study|Progressive Disease|4|||
160711474|NCT01823835|580322248|FG002|Overall Study|Progressive Disease|3|||
160711475|NCT01823835|580322249|FG003|Overall Study|Progressive Disease|6|||
160711476|NCT01823835|580322250|FG004|Overall Study|Progressive Disease|4|||
160711477|NCT01823835|580322251|FG005|Overall Study|Progressive Disease|6|||
160711478|NCT01823835|580322252|FG006|Overall Study|Progressive Disease|5|||
160711479|NCT01823835|580322253|FG007|Overall Study|Progressive Disease|3|||
160711480|NCT01823835|580322254|FG008|Overall Study|Progressive Disease|3|||
160711481|NCT01823835|580322255|FG009|Overall Study|Progressive Disease|18|||
160711482|NCT01823835|580322256|FG010|Overall Study|Progressive Disease|8|||
160711483|NCT01823835|580322257|FG011|Overall Study|Progressive Disease|46|||
160711484|NCT01823835|580322258|FG012|Overall Study|Progressive Disease|18|||
160711485|NCT01823835|580322259|FG013|Overall Study|Progressive Disease|4|||
160711486|NCT01823835|580322260|FG014|Overall Study|Progressive Disease|6|||
160711487|NCT01823835|580322246|FG000|Overall Study|Study Termination|0|||
160711488|NCT01823835|580322247|FG001|Overall Study|Study Termination|0|||
160711489|NCT01823835|580322248|FG002|Overall Study|Study Termination|0|||
160711490|NCT01823835|580322249|FG003|Overall Study|Study Termination|0|||
160711491|NCT01823835|580322250|FG004|Overall Study|Study Termination|1|||
160711492|NCT01823835|580322251|FG005|Overall Study|Study Termination|0|||
160711493|NCT01823835|580322252|FG006|Overall Study|Study Termination|0|||
160711494|NCT01823835|580322253|FG007|Overall Study|Study Termination|0|||
160711495|NCT01823835|580322254|FG008|Overall Study|Study Termination|0|||
160711496|NCT01823835|580322255|FG009|Overall Study|Study Termination|0|||
160711497|NCT01823835|580322256|FG010|Overall Study|Study Termination|0|||
160711498|NCT01823835|580322257|FG011|Overall Study|Study Termination|1|||
160711499|NCT01823835|580322258|FG012|Overall Study|Study Termination|0|||
160711500|NCT01823835|580322259|FG013|Overall Study|Study Termination|0|||
160711501|NCT01823835|580322260|FG014|Overall Study|Study Termination|0|||
160711502|NCT01823835|580322246|FG000|Overall Study|Withdrawal by Subject|0|||
160711503|NCT01823835|580322247|FG001|Overall Study|Withdrawal by Subject|0|||
160711504|NCT01823835|580322248|FG002|Overall Study|Withdrawal by Subject|1|||
160711505|NCT01823835|580322249|FG003|Overall Study|Withdrawal by Subject|0|||
160711506|NCT01823835|580322250|FG004|Overall Study|Withdrawal by Subject|0|||
160711507|NCT01823835|580322251|FG005|Overall Study|Withdrawal by Subject|0|||
160711508|NCT01823835|580322252|FG006|Overall Study|Withdrawal by Subject|0|||
160711509|NCT01823835|580322253|FG007|Overall Study|Withdrawal by Subject|0|||
160711510|NCT01823835|580322254|FG008|Overall Study|Withdrawal by Subject|0|||
160711511|NCT01823835|580322255|FG009|Overall Study|Withdrawal by Subject|1|||
160711512|NCT01823835|580322256|FG010|Overall Study|Withdrawal by Subject|1|||
160711513|NCT01823835|580322257|FG011|Overall Study|Withdrawal by Subject|2|||
160711514|NCT01823835|580322258|FG012|Overall Study|Withdrawal by Subject|1|||
160711515|NCT01823835|580322259|FG013|Overall Study|Withdrawal by Subject|0|||
160711516|NCT01823835|580322260|FG014|Overall Study|Withdrawal by Subject|0|||
160711517|NCT00509795|580322261|FG000|Overall Study|Adverse Event|4|||
160711518|NCT00509795|580322262|FG001|Overall Study|Adverse Event|3|||
160711519|NCT00509795|580322263|FG002|Overall Study|Adverse Event|5|||
160711520|NCT00509795|580322264|FG003|Overall Study|Adverse Event|4|||
160711521|NCT00509795|580322261|FG000|Overall Study|Death|3|||
160711522|NCT00509795|580322262|FG001|Overall Study|Death|1|||
160711523|NCT00509795|580322263|FG002|Overall Study|Death|2|||
160711524|NCT00509795|580322264|FG003|Overall Study|Death|7|||
160711525|NCT00509795|580322261|FG000|Overall Study|Lack of Efficacy|0|||
160711526|NCT00509795|580322262|FG001|Overall Study|Lack of Efficacy|0|||
160711527|NCT00509795|580322263|FG002|Overall Study|Lack of Efficacy|2|||
160711528|NCT00509795|580322264|FG003|Overall Study|Lack of Efficacy|2|||
160711529|NCT00509795|580322261|FG000|Overall Study|Lost to Follow-up|1|||
160711530|NCT00509795|580322262|FG001|Overall Study|Lost to Follow-up|2|||
160711531|NCT00509795|580322263|FG002|Overall Study|Lost to Follow-up|4|||
160711532|NCT00509795|580322264|FG003|Overall Study|Lost to Follow-up|4|||
160711533|NCT00509795|580322261|FG000|Overall Study|OTHER|1|||
160711534|NCT00509795|580322262|FG001|Overall Study|OTHER|0|||
160711535|NCT00509795|580322263|FG002|Overall Study|OTHER|4|||
160711536|NCT00509795|580322264|FG003|Overall Study|OTHER|1|||
160711537|NCT00509795|580322261|FG000|Overall Study|Protocol Violation|3|||
160711538|NCT00509795|580322262|FG001|Overall Study|Protocol Violation|0|||
160711539|NCT00509795|580322263|FG002|Overall Study|Protocol Violation|3|||
160711540|NCT00509795|580322264|FG003|Overall Study|Protocol Violation|1|||
160711541|NCT00509795|580322261|FG000|Overall Study|Withdrawal by Subject|10|||
160711542|NCT00509795|580322262|FG001|Overall Study|Withdrawal by Subject|5|||
160711543|NCT00509795|580322263|FG002|Overall Study|Withdrawal by Subject|7|||
160711544|NCT00509795|580322264|FG003|Overall Study|Withdrawal by Subject|8|||
160711545|NCT04895982|580322265|FG000|Overall Study|Withdrawal by Subject|0|||
160711546|NCT04895982|580322266|FG001|Overall Study|Withdrawal by Subject|0|||
160711547|NCT04895982|580322267|FG002|Overall Study|Withdrawal by Subject|0|||
160711548|NCT04895982|580322268|FG003|Overall Study|Withdrawal by Subject|0|||
160711549|NCT04895982|580322269|FG004|Overall Study|Withdrawal by Subject|0|||
160711550|NCT04895982|580322270|FG005|Overall Study|Withdrawal by Subject|1|||
160711551|NCT04895982|580322271|FG006|Overall Study|Withdrawal by Subject|1|||
160711552|NCT04895982|580322272|FG007|Overall Study|Withdrawal by Subject|0|||
160711553|NCT04895982|580322273|FG008|Overall Study|Withdrawal by Subject|0|||
160711554|NCT04895982|580322274|FG009|Overall Study|Withdrawal by Subject|1|||
160711555|NCT04895982|580322275|FG010|Overall Study|Withdrawal by Subject|0|||
160711556|NCT04895982|580322276|FG011|Overall Study|Withdrawal by Subject|1|||
160711557|NCT04895982|580322265|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160711558|NCT04895982|580322266|FG001|Overall Study|Withdrawal by parent/guardian|3|||
160711559|NCT04895982|580322267|FG002|Overall Study|Withdrawal by parent/guardian|3|||
160711560|NCT04895982|580322268|FG003|Overall Study|Withdrawal by parent/guardian|1|||
160711561|NCT04895982|580322269|FG004|Overall Study|Withdrawal by parent/guardian|3|||
160711562|NCT04895982|580322270|FG005|Overall Study|Withdrawal by parent/guardian|2|||
160711563|NCT04895982|580322271|FG006|Overall Study|Withdrawal by parent/guardian|1|||
160711564|NCT04895982|580322272|FG007|Overall Study|Withdrawal by parent/guardian|0|||
160711565|NCT04895982|580322273|FG008|Overall Study|Withdrawal by parent/guardian|3|||
160711566|NCT04895982|580322274|FG009|Overall Study|Withdrawal by parent/guardian|0|||
160711567|NCT04895982|580322275|FG010|Overall Study|Withdrawal by parent/guardian|0|||
160711568|NCT04895982|580322276|FG011|Overall Study|Withdrawal by parent/guardian|0|||
160711569|NCT04895982|580322265|FG000|Overall Study|Other|0|||
160711570|NCT04895982|580322266|FG001|Overall Study|Other|0|||
160711571|NCT04895982|580322267|FG002|Overall Study|Other|1|||
160711572|NCT04895982|580322268|FG003|Overall Study|Other|1|||
160711573|NCT04895982|580322269|FG004|Overall Study|Other|0|||
160711574|NCT04895982|580322270|FG005|Overall Study|Other|0|||
160711575|NCT04895982|580322271|FG006|Overall Study|Other|0|||
160711576|NCT04895982|580322272|FG007|Overall Study|Other|0|||
160711577|NCT04895982|580322273|FG008|Overall Study|Other|0|||
160711578|NCT04895982|580322274|FG009|Overall Study|Other|1|||
160711579|NCT04895982|580322275|FG010|Overall Study|Other|0|||
160711580|NCT04895982|580322276|FG011|Overall Study|Other|0|||
160711581|NCT04895982|580322265|FG000|Overall Study|Protocol Violation|0|||
160711582|NCT04895982|580322266|FG001|Overall Study|Protocol Violation|0|||
160711583|NCT04895982|580322267|FG002|Overall Study|Protocol Violation|1|||
160711584|NCT04895982|580322268|FG003|Overall Study|Protocol Violation|1|||
160711585|NCT04895982|580322269|FG004|Overall Study|Protocol Violation|1|||
160711586|NCT04895982|580322270|FG005|Overall Study|Protocol Violation|0|||
160711587|NCT04895982|580322271|FG006|Overall Study|Protocol Violation|0|||
160711588|NCT04895982|580322272|FG007|Overall Study|Protocol Violation|1|||
160711589|NCT04895982|580322273|FG008|Overall Study|Protocol Violation|0|||
160711590|NCT04895982|580322274|FG009|Overall Study|Protocol Violation|0|||
160711591|NCT04895982|580322275|FG010|Overall Study|Protocol Violation|0|||
160711592|NCT04895982|580322276|FG011|Overall Study|Protocol Violation|0|||
160711593|NCT04895982|580322265|FG000|Overall Study|Lost to Follow-up|0|||
160711594|NCT04895982|580322266|FG001|Overall Study|Lost to Follow-up|0|||
160711595|NCT04895982|580322267|FG002|Overall Study|Lost to Follow-up|1|||
160711596|NCT04895982|580322268|FG003|Overall Study|Lost to Follow-up|0|||
160711597|NCT04895982|580322269|FG004|Overall Study|Lost to Follow-up|0|||
160711598|NCT04895982|580322270|FG005|Overall Study|Lost to Follow-up|1|||
160711599|NCT04895982|580322271|FG006|Overall Study|Lost to Follow-up|0|||
160711600|NCT04895982|580322272|FG007|Overall Study|Lost to Follow-up|0|||
160711601|NCT04895982|580322273|FG008|Overall Study|Lost to Follow-up|1|||
160711602|NCT04895982|580322274|FG009|Overall Study|Lost to Follow-up|0|||
160711603|NCT04895982|580322275|FG010|Overall Study|Lost to Follow-up|0|||
160711604|NCT04895982|580322276|FG011|Overall Study|Lost to Follow-up|0|||
160711605|NCT04895982|580322265|FG000|Overall Study|Refused further study procedures|0|||
160711606|NCT04895982|580322266|FG001|Overall Study|Refused further study procedures|0|||
160711607|NCT04895982|580322267|FG002|Overall Study|Refused further study procedures|1|||
160711608|NCT04895982|580322268|FG003|Overall Study|Refused further study procedures|0|||
160711609|NCT04895982|580322269|FG004|Overall Study|Refused further study procedures|0|||
160711610|NCT04895982|580322270|FG005|Overall Study|Refused further study procedures|0|||
160711611|NCT04895982|580322271|FG006|Overall Study|Refused further study procedures|0|||
160711612|NCT04895982|580322272|FG007|Overall Study|Refused further study procedures|0|||
160711613|NCT04895982|580322273|FG008|Overall Study|Refused further study procedures|0|||
160711614|NCT04895982|580322274|FG009|Overall Study|Refused further study procedures|0|||
160711615|NCT04895982|580322275|FG010|Overall Study|Refused further study procedures|0|||
160711616|NCT04895982|580322276|FG011|Overall Study|Refused further study procedures|0|||
160711617|NCT02517463|580322282|FG000|Overall Study|Lost to Follow-up|5|||
160711618|NCT02517463|580322283|FG001|Overall Study|Lost to Follow-up|2|||
160711619|NCT02296931|580322290|FG000|Overall Study|Protocol Violation|0|||
160711620|NCT02296931|580322291|FG001|Overall Study|Protocol Violation|2|||
160711621|NCT05221320|580324204|FG000|Overall Study|Lack of Efficacy|3|||
160711622|NCT05221320|580324205|FG001|Overall Study|Lack of Efficacy|7|||
160711623|NCT05221320|580324206|FG002|Overall Study|Lack of Efficacy|10|||
160711624|NCT05221320|580324207|FG003|Overall Study|Lack of Efficacy|1|||
160711625|NCT05221320|580324208|FG004|Overall Study|Lack of Efficacy|0|||
160711626|NCT05221320|580324209|FG005|Overall Study|Lack of Efficacy|0|||
160711627|NCT05221320|580324204|FG000|Overall Study|Physician Decision|1|||
160711628|NCT05221320|580324205|FG001|Overall Study|Physician Decision|0|||
160711629|NCT05221320|580324206|FG002|Overall Study|Physician Decision|3|||
160711630|NCT05221320|580324207|FG003|Overall Study|Physician Decision|1|||
160711631|NCT05221320|580324208|FG004|Overall Study|Physician Decision|0|||
160711632|NCT05221320|580324209|FG005|Overall Study|Physician Decision|0|||
160711633|NCT05221320|580324204|FG000|Overall Study|Withdrawal by Subject|0|||
160711634|NCT05221320|580324205|FG001|Overall Study|Withdrawal by Subject|3|||
160711635|NCT05221320|580324206|FG002|Overall Study|Withdrawal by Subject|1|||
160711636|NCT05221320|580324207|FG003|Overall Study|Withdrawal by Subject|0|||
160711637|NCT05221320|580324208|FG004|Overall Study|Withdrawal by Subject|0|||
160711638|NCT05221320|580324209|FG005|Overall Study|Withdrawal by Subject|0|||
160711639|NCT05221320|580324204|FG000|Overall Study|Death|0|||
160711640|NCT05221320|580324205|FG001|Overall Study|Death|5|||
160711641|NCT05221320|580324206|FG002|Overall Study|Death|6|||
160711642|NCT05221320|580324207|FG003|Overall Study|Death|0|||
160711643|NCT05221320|580324208|FG004|Overall Study|Death|1|||
160711644|NCT05221320|580324209|FG005|Overall Study|Death|0|||
160711645|NCT03300817|580324213|FG000|Overall Study|Withdrawal by Subject|1|||
160711646|NCT03300817|580324213|FG000|Overall Study|Adverse Event|1|||
160711647|NCT03300817|580324213|FG000|Overall Study|Subject Found to be Ineligible|2|||
160711648|NCT03729596|580324215|FG000|Overall Study|Death|3|||
160711649|NCT03729596|580324216|FG001|Overall Study|Death|5|||
160711650|NCT03729596|580324217|FG002|Overall Study|Death|4|||
160711651|NCT03729596|580324218|FG003|Overall Study|Death|1|||
160711652|NCT03729596|580324219|FG004|Overall Study|Death|0|||
160711653|NCT03729596|580324220|FG005|Overall Study|Death|34|||
160711654|NCT03729596|580324221|FG006|Overall Study|Death|18|||
160711655|NCT03729596|580324222|FG007|Overall Study|Death|14|||
160711656|NCT03729596|580324223|FG008|Overall Study|Death|19|||
160711657|NCT03729596|580324224|FG009|Overall Study|Death|9|||
160711658|NCT03729596|580324215|FG000|Overall Study|Lost to Follow-up|0|||
160711659|NCT03729596|580324216|FG001|Overall Study|Lost to Follow-up|0|||
160711660|NCT03729596|580324217|FG002|Overall Study|Lost to Follow-up|0|||
160711661|NCT03729596|580324218|FG003|Overall Study|Lost to Follow-up|0|||
160711662|NCT03729596|580324219|FG004|Overall Study|Lost to Follow-up|0|||
160711663|NCT03729596|580324220|FG005|Overall Study|Lost to Follow-up|0|||
160711664|NCT03729596|580324221|FG006|Overall Study|Lost to Follow-up|1|||
160711665|NCT03729596|580324222|FG007|Overall Study|Lost to Follow-up|0|||
160711666|NCT03729596|580324223|FG008|Overall Study|Lost to Follow-up|0|||
160711667|NCT03729596|580324224|FG009|Overall Study|Lost to Follow-up|1|||
160711668|NCT03729596|580324215|FG000|Overall Study|protocol amendment|0|||
160711669|NCT03729596|580324216|FG001|Overall Study|protocol amendment|1|||
160711670|NCT03729596|580324217|FG002|Overall Study|protocol amendment|3|||
160711671|NCT03729596|580324218|FG003|Overall Study|protocol amendment|6|||
160711672|NCT03729596|580324219|FG004|Overall Study|protocol amendment|5|||
160711673|NCT03729596|580324220|FG005|Overall Study|protocol amendment|0|||
160711674|NCT03729596|580324221|FG006|Overall Study|protocol amendment|0|||
160711675|NCT03729596|580324222|FG007|Overall Study|protocol amendment|0|||
160711676|NCT03729596|580324223|FG008|Overall Study|protocol amendment|0|||
160711677|NCT03729596|580324224|FG009|Overall Study|protocol amendment|0|||
160711678|NCT03729596|580324215|FG000|Overall Study|Withdrawal by Subject|0|||
160711679|NCT03729596|580324216|FG001|Overall Study|Withdrawal by Subject|0|||
160711680|NCT03729596|580324217|FG002|Overall Study|Withdrawal by Subject|0|||
160711681|NCT03729596|580324218|FG003|Overall Study|Withdrawal by Subject|0|||
160711682|NCT03729596|580324219|FG004|Overall Study|Withdrawal by Subject|0|||
160711683|NCT03729596|580324220|FG005|Overall Study|Withdrawal by Subject|4|||
160711684|NCT03729596|580324221|FG006|Overall Study|Withdrawal by Subject|2|||
160711685|NCT03729596|580324222|FG007|Overall Study|Withdrawal by Subject|3|||
160711686|NCT03729596|580324223|FG008|Overall Study|Withdrawal by Subject|2|||
160711687|NCT03729596|580324224|FG009|Overall Study|Withdrawal by Subject|3|||
160711688|NCT03729596|580324215|FG000|Overall Study|study terminated by sponsor|0|||
160711689|NCT03729596|580324216|FG001|Overall Study|study terminated by sponsor|0|||
160711690|NCT03729596|580324217|FG002|Overall Study|study terminated by sponsor|0|||
160711691|NCT03729596|580324218|FG003|Overall Study|study terminated by sponsor|0|||
160711692|NCT03729596|580324219|FG004|Overall Study|study terminated by sponsor|1|||
160711693|NCT03729596|580324220|FG005|Overall Study|study terminated by sponsor|3|||
160711694|NCT03729596|580324221|FG006|Overall Study|study terminated by sponsor|0|||
160711695|NCT03729596|580324222|FG007|Overall Study|study terminated by sponsor|1|||
160711696|NCT03729596|580324223|FG008|Overall Study|study terminated by sponsor|0|||
160711697|NCT03729596|580324224|FG009|Overall Study|study terminated by sponsor|0|||
160711698|NCT03620708|580324226|FG000|Overall Study|Lost to Follow-up|1|||
160711699|NCT03620708|580324227|FG001|Overall Study|Lost to Follow-up|1|||
160711700|NCT03620708|580324228|FG002|Overall Study|Lost to Follow-up|2|||
160711701|NCT03620708|580324226|FG000|Overall Study|Withdrawal by Subject|0|||
160711702|NCT03620708|580324227|FG001|Overall Study|Withdrawal by Subject|0|||
160711703|NCT03620708|580324228|FG002|Overall Study|Withdrawal by Subject|1|||
160711704|NCT02498613|580324229|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
160711705|NCT02498613|580324230|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
160711706|NCT02498613|580324231|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
160711707|NCT02498613|580324232|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
160711708|NCT02498613|580324229|FG000|Overall Study|Withdrawal by Subject|3|||
160711709|NCT02498613|580324230|FG001|Overall Study|Withdrawal by Subject|1|||
160711710|NCT02498613|580324231|FG002|Overall Study|Withdrawal by Subject|0|||
160711711|NCT02498613|580324232|FG003|Overall Study|Withdrawal by Subject|0|||
160711712|NCT03631199|580324242|FG000|Overall Study|Progressive disease|9|||
160711713|NCT03631199|580324243|FG001|Overall Study|Progressive disease|5|||
160711714|NCT03631199|580324244|FG002|Overall Study|Progressive disease|5|||
160711715|NCT03631199|580324245|FG003|Overall Study|Progressive disease|149|||
160711716|NCT03631199|580324246|FG004|Overall Study|Progressive disease|148|||
160711717|NCT03631199|580324242|FG000|Overall Study|Physician Decision|0|||
160711718|NCT03631199|580324243|FG001|Overall Study|Physician Decision|2|||
160711719|NCT03631199|580324244|FG002|Overall Study|Physician Decision|3|||
160711720|NCT03631199|580324245|FG003|Overall Study|Physician Decision|19|||
160711721|NCT03631199|580324246|FG004|Overall Study|Physician Decision|13|||
160711722|NCT03631199|580324242|FG000|Overall Study|Adverse Event|1|||
160711723|NCT03631199|580324243|FG001|Overall Study|Adverse Event|1|||
160711724|NCT03631199|580324244|FG002|Overall Study|Adverse Event|0|||
160711725|NCT03631199|580324245|FG003|Overall Study|Adverse Event|28|||
160711726|NCT03631199|580324246|FG004|Overall Study|Adverse Event|29|||
160711727|NCT03631199|580324242|FG000|Overall Study|Death|0|||
160711728|NCT03631199|580324243|FG001|Overall Study|Death|1|||
160711729|NCT03631199|580324244|FG002|Overall Study|Death|0|||
160711730|NCT03631199|580324245|FG003|Overall Study|Death|35|||
160711731|NCT03631199|580324246|FG004|Overall Study|Death|48|||
160711732|NCT03631199|580324242|FG000|Overall Study|Subject decision|0|||
160711733|NCT03631199|580324243|FG001|Overall Study|Subject decision|1|||
160711734|NCT03631199|580324244|FG002|Overall Study|Subject decision|0|||
160711735|NCT03631199|580324245|FG003|Overall Study|Subject decision|12|||
160711736|NCT03631199|580324246|FG004|Overall Study|Subject decision|12|||
160711737|NCT03631199|580324242|FG000|Overall Study|No treated|0|||
160711738|NCT03631199|580324243|FG001|Overall Study|No treated|0|||
160711739|NCT03631199|580324244|FG002|Overall Study|No treated|0|||
160711740|NCT03631199|580324245|FG003|Overall Study|No treated|0|||
160711741|NCT03631199|580324246|FG004|Overall Study|No treated|1|||
160711742|NCT03631199|580324242|FG000|Overall Study|Treatment ongoing|0|||
160711743|NCT03631199|580324243|FG001|Overall Study|Treatment ongoing|1|||
160711744|NCT03631199|580324244|FG002|Overall Study|Treatment ongoing|1|||
160711745|NCT03631199|580324245|FG003|Overall Study|Treatment ongoing|76|||
160711746|NCT03631199|580324246|FG004|Overall Study|Treatment ongoing|71|||
160711747|NCT03631199|580324242|FG000|Overall Study|Guardian decision|0|||
160711748|NCT03631199|580324243|FG001|Overall Study|Guardian decision|0|||
160711749|NCT03631199|580324244|FG002|Overall Study|Guardian decision|0|||
160711750|NCT03631199|580324245|FG003|Overall Study|Guardian decision|1|||
160711751|NCT03631199|580324246|FG004|Overall Study|Guardian decision|1|||
160711752|NCT03999996|580324247|FG000|Prior to Booster|Adverse Event|2|||
160711753|NCT03999996|580324248|FG001|Prior to Booster|Adverse Event|0|||
160711754|NCT03999996|580324249|FG002|Prior to Booster|Adverse Event|0|||
160711755|NCT03999996|580324250|FG003|Prior to Booster|Adverse Event|0|||
160711756|NCT03999996|580324247|FG000|Prior to Booster|Lost to Follow-up|17|||
160711757|NCT03999996|580324248|FG001|Prior to Booster|Lost to Follow-up|22|||
160711758|NCT03999996|580324249|FG002|Prior to Booster|Lost to Follow-up|0|||
160711759|NCT03999996|580324250|FG003|Prior to Booster|Lost to Follow-up|0|||
160711760|NCT03999996|580324247|FG000|Prior to Booster|Withdrawal of Consent|51|||
160711761|NCT03999996|580324248|FG001|Prior to Booster|Withdrawal of Consent|8|||
160711762|NCT03999996|580324249|FG002|Prior to Booster|Withdrawal of Consent|0|||
160711763|NCT03999996|580324250|FG003|Prior to Booster|Withdrawal of Consent|0|||
160711764|NCT03999996|580324247|FG000|Prior to Booster|Death|0|||
160711765|NCT03999996|580324248|FG001|Prior to Booster|Death|1|||
160711766|NCT03999996|580324249|FG002|Prior to Booster|Death|0|||
160711767|NCT03999996|580324250|FG003|Prior to Booster|Death|0|||
160711768|NCT03999996|580324247|FG000|Prior to Booster|Reason Not Specified|27|||
160711769|NCT03999996|580324248|FG001|Prior to Booster|Reason Not Specified|4|||
160711770|NCT03999996|580324249|FG002|Prior to Booster|Reason Not Specified|0|||
160711771|NCT03999996|580324250|FG003|Prior to Booster|Reason Not Specified|0|||
160711772|NCT03999996|580324247|FG000|Booster Phase|Lost to Follow-up|0|||
160711773|NCT03999996|580324248|FG001|Booster Phase|Lost to Follow-up|0|||
160711774|NCT03999996|580324249|FG002|Booster Phase|Lost to Follow-up|3|||
160711775|NCT03999996|580324250|FG003|Booster Phase|Lost to Follow-up|3|||
160711776|NCT03999996|580324247|FG000|Booster Phase|Withdrawal of Consent|0|||
160711777|NCT03999996|580324248|FG001|Booster Phase|Withdrawal of Consent|0|||
160711778|NCT03999996|580324249|FG002|Booster Phase|Withdrawal of Consent|0|||
160711779|NCT03999996|580324250|FG003|Booster Phase|Withdrawal of Consent|1|||
160711780|NCT03999996|580324247|FG000|Booster Phase|Reason Not Specified|0|||
160711781|NCT03999996|580324248|FG001|Booster Phase|Reason Not Specified|0|||
160711782|NCT03999996|580324249|FG002|Booster Phase|Reason Not Specified|0|||
160711783|NCT03999996|580324250|FG003|Booster Phase|Reason Not Specified|1|||
160711784|NCT01720225|580324253|FG000|Overall Study|Withdrawal by Subject|0|||
160711785|NCT01720225|580324254|FG001|Overall Study|Withdrawal by Subject|1|||
160711786|NCT01720225|580324253|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
160711787|NCT01720225|580324254|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
160711788|NCT02964312|580324255|FG000|Overall Study|Lost to Follow-up|28|||
160711789|NCT02964312|580324255|FG000|Overall Study|Withdrawal by Subject|11|||
160711790|NCT02964312|580324255|FG000|Overall Study|Lack of Efficacy|10|||
160711791|NCT02964312|580324255|FG000|Overall Study|Did not consent to long-term FU|14|||
160711792|NCT02964312|580324255|FG000|Overall Study|Death|1|||
160711793|NCT03288714|580324262|FG000|Overall Study|Lost to Follow-up|2|||
160711794|NCT03288714|580324263|FG001|Overall Study|Lost to Follow-up|1|||
160711795|NCT03288714|580324262|FG000|Overall Study|Non-compliance with study schedule|2|||
160711796|NCT03288714|580324263|FG001|Overall Study|Non-compliance with study schedule|0|||
160711797|NCT03288714|580324262|FG000|Overall Study|Withdrawal by Subject|3|||
160711798|NCT03288714|580324263|FG001|Overall Study|Withdrawal by Subject|1|||
160711799|NCT03288714|580324262|FG000|Overall Study|Clinical Worsening|2|||
160711800|NCT03288714|580324263|FG001|Overall Study|Clinical Worsening|1|||
160711801|NCT03288714|580324262|FG000|Overall Study|Adverse Event|1|||
160711802|NCT03288714|580324263|FG001|Overall Study|Adverse Event|0|||
160711803|NCT03280264|580324264|FG000|Overall Study|Adverse Event|1|||
160711804|NCT03280264|580324264|FG000|Overall Study|Physician Decision|1|||
160711805|NCT03280264|580324264|FG000|Overall Study|Withdrawal by Subject|1|||
160711806|NCT00524420|580324272|FG000|Overall Study|Lack of Efficacy|1|||
160711807|NCT00524420|580324273|FG001|Overall Study|Lack of Efficacy|0|||
160711808|NCT00577863|580324274|FG000|Overall Study|Adverse Event|4|||
160711809|NCT00577863|580324275|FG001|Overall Study|Adverse Event|2|||
160711810|NCT00577863|580324274|FG000|Overall Study|Death|1|||
160711811|NCT00577863|580324275|FG001|Overall Study|Death|0|||
160711812|NCT00577863|580324274|FG000|Overall Study|Lost to Follow-up|2|||
160711813|NCT00577863|580324275|FG001|Overall Study|Lost to Follow-up|2|||
160711814|NCT00577863|580324274|FG000|Overall Study|Entry Criteria Exclusion|1|||
160711815|NCT00577863|580324275|FG001|Overall Study|Entry Criteria Exclusion|0|||
160711816|NCT00577863|580324274|FG000|Overall Study|Withdrawal by Subject|0|||
160711817|NCT00577863|580324275|FG001|Overall Study|Withdrawal by Subject|2|||
160711818|NCT00577863|580324274|FG000|Overall Study|Sponsor Decision|2|||
160711819|NCT00577863|580324275|FG001|Overall Study|Sponsor Decision|7|||
160711820|NCT00577863|580324274|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
160711821|NCT00577863|580324275|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
160711822|NCT02738138|580324279|FG000|Overall Study|Adverse Event|0|||
160711823|NCT02738138|580324280|FG001|Overall Study|Adverse Event|1|||
160711824|NCT02738138|580324279|FG000|Overall Study|Lost to Follow-up|2|||
160711825|NCT02738138|580324280|FG001|Overall Study|Lost to Follow-up|0|||
160711826|NCT02738138|580324279|FG000|Overall Study|Other - not further specified|1|||
160711827|NCT02738138|580324280|FG001|Overall Study|Other - not further specified|0|||
160711828|NCT03639779|580324289|FG000|Overall Study|Lost to Follow-up|1|||
160711829|NCT02932462|580324292|FG000|Overall Study|Adverse Event|1|||
160711830|NCT02932462|580324293|FG001|Overall Study|Adverse Event|2|||
160711831|NCT02932462|580324292|FG000|Overall Study|Lost to Follow-up|4|||
160711832|NCT02932462|580324293|FG001|Overall Study|Lost to Follow-up|1|||
160711833|NCT02932462|580324292|FG000|Overall Study|Protocol Violation|0|||
160711834|NCT02932462|580324293|FG001|Overall Study|Protocol Violation|5|||
160711835|NCT02932462|580324292|FG000|Overall Study|Withdrawal by Subject|1|||
160711836|NCT02932462|580324293|FG001|Overall Study|Withdrawal by Subject|4|||
160711837|NCT02932462|580324292|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160711838|NCT02932462|580324293|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160711839|NCT02932462|580324292|FG000|Overall Study|Progressive Disease|1|||
160711840|NCT02932462|580324293|FG001|Overall Study|Progressive Disease|0|||
160711841|NCT02413229|580324294|FG000|Overall Study|Adverse Event|0|||
160711842|NCT02413229|580324295|FG001|Overall Study|Adverse Event|0|||
160711843|NCT02413229|580324296|FG002|Overall Study|Adverse Event|0|||
160711844|NCT02413229|580324297|FG003|Overall Study|Adverse Event|1|||
160711845|NCT02413229|580324298|FG004|Overall Study|Adverse Event|0|||
160711846|NCT02413229|580324299|FG005|Overall Study|Adverse Event|0|||
160711847|NCT02413229|580324300|FG006|Overall Study|Adverse Event|0|||
160711848|NCT02413229|580324301|FG007|Overall Study|Adverse Event|1|||
160711849|NCT02413229|580324294|FG000|Overall Study|Lost to Follow-up|0|||
160711850|NCT02413229|580324295|FG001|Overall Study|Lost to Follow-up|0|||
160711851|NCT02413229|580324296|FG002|Overall Study|Lost to Follow-up|1|||
160711852|NCT02413229|580324297|FG003|Overall Study|Lost to Follow-up|0|||
160711853|NCT02413229|580324298|FG004|Overall Study|Lost to Follow-up|2|||
160711854|NCT02413229|580324299|FG005|Overall Study|Lost to Follow-up|0|||
160711855|NCT02413229|580324300|FG006|Overall Study|Lost to Follow-up|0|||
160711856|NCT02413229|580324301|FG007|Overall Study|Lost to Follow-up|0|||
160711857|NCT02413229|580324294|FG000|Overall Study|Withdrawal by Subject|1|||
160711858|NCT02413229|580324295|FG001|Overall Study|Withdrawal by Subject|1|||
160711859|NCT02413229|580324296|FG002|Overall Study|Withdrawal by Subject|0|||
160711860|NCT02413229|580324297|FG003|Overall Study|Withdrawal by Subject|0|||
160711861|NCT02413229|580324298|FG004|Overall Study|Withdrawal by Subject|1|||
160711862|NCT02413229|580324299|FG005|Overall Study|Withdrawal by Subject|0|||
160711863|NCT02413229|580324300|FG006|Overall Study|Withdrawal by Subject|0|||
160711864|NCT02413229|580324301|FG007|Overall Study|Withdrawal by Subject|2|||
160711865|NCT02413229|580324294|FG000|Overall Study|Progressive Disease|0|||
160711866|NCT02413229|580324295|FG001|Overall Study|Progressive Disease|0|||
160711867|NCT02413229|580324296|FG002|Overall Study|Progressive Disease|0|||
160711868|NCT02413229|580324297|FG003|Overall Study|Progressive Disease|0|||
160711869|NCT02413229|580324298|FG004|Overall Study|Progressive Disease|0|||
160711870|NCT02413229|580324299|FG005|Overall Study|Progressive Disease|0|||
160711871|NCT02413229|580324300|FG006|Overall Study|Progressive Disease|0|||
160711872|NCT02413229|580324301|FG007|Overall Study|Progressive Disease|1|||
160711873|NCT05024747|580324305|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
160711874|NCT05024747|580324306|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
160711875|NCT05024747|580324305|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
160711876|NCT05024747|580324306|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
160711877|NCT05024747|580324305|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
160711878|NCT05024747|580324306|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
160711879|NCT00662649|580324307|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
160711880|NCT00662649|580324308|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
160711881|NCT00662649|580324309|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
160711882|NCT00662649|580324310|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
160711883|NCT00662649|580324311|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
160711884|NCT00662649|580324307|FG000|Core Study (24 Months)|Adverse Event|22|||
160711885|NCT00662649|580324308|FG001|Core Study (24 Months)|Adverse Event|13|||
160711886|NCT00662649|580324309|FG002|Core Study (24 Months)|Adverse Event|18|||
160711887|NCT00662649|580324310|FG003|Core Study (24 Months)|Adverse Event|0|||
160711888|NCT00662649|580324311|FG004|Core Study (24 Months)|Adverse Event|0|||
160711889|NCT00662649|580324307|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
160711890|NCT00662649|580324308|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
160711891|NCT00662649|580324309|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
160711892|NCT00662649|580324310|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
160711893|NCT00662649|580324311|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
160711894|NCT00662649|580324307|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
160711895|NCT00662649|580324308|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
160711896|NCT00662649|580324309|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
160711897|NCT00662649|580324310|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
160711898|NCT00662649|580324311|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
160711899|NCT00662649|580324307|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
160711900|NCT00662649|580324308|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
160711901|NCT00662649|580324309|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
160711902|NCT00662649|580324310|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
160711903|NCT00662649|580324311|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
160711904|NCT00662649|580324307|FG000|Core Study (24 Months)|Protocol Violation|5|||
160711905|NCT00662649|580324308|FG001|Core Study (24 Months)|Protocol Violation|5|||
160711906|NCT00662649|580324309|FG002|Core Study (24 Months)|Protocol Violation|4|||
160711907|NCT00662649|580324310|FG003|Core Study (24 Months)|Protocol Violation|0|||
160711908|NCT00662649|580324311|FG004|Core Study (24 Months)|Protocol Violation|0|||
160711909|NCT00662649|580324307|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
160711910|NCT00662649|580324308|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
160711911|NCT00662649|580324309|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
160711912|NCT00662649|580324310|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
160711913|NCT00662649|580324311|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
160711914|NCT00662649|580324307|FG000|Core Study (24 Months)|Death|1|||
160711915|NCT00662649|580324308|FG001|Core Study (24 Months)|Death|0|||
160711916|NCT00662649|580324309|FG002|Core Study (24 Months)|Death|2|||
160711917|NCT00662649|580324310|FG003|Core Study (24 Months)|Death|0|||
160711918|NCT00662649|580324311|FG004|Core Study (24 Months)|Death|0|||
160711919|NCT00662649|580324307|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
160711920|NCT00662649|580324308|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
160711921|NCT00662649|580324309|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
160711922|NCT00662649|580324310|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
160711923|NCT00662649|580324311|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
160711924|NCT00662649|580324307|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
160711925|NCT00662649|580324308|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
160711926|NCT00662649|580324309|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
160711927|NCT00662649|580324310|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
160711928|NCT00662649|580324311|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
160711929|NCT00662649|580324307|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
160711930|NCT00662649|580324308|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
160711931|NCT00662649|580324309|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
160711932|NCT00662649|580324310|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
160711933|NCT00662649|580324311|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
160711934|NCT00662649|580324307|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
160711935|NCT00662649|580324308|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
160711936|NCT00662649|580324309|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
160711937|NCT00662649|580324310|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
160711938|NCT00662649|580324311|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
160711939|NCT00662649|580324307|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
160711940|NCT00662649|580324308|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
160711941|NCT00662649|580324309|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
160711942|NCT00662649|580324310|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
160711943|NCT00662649|580324311|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
160711944|NCT00662649|580324307|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
160711945|NCT00662649|580324308|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
160711946|NCT00662649|580324309|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
160711947|NCT00662649|580324310|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
160711948|NCT00662649|580324311|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
160711949|NCT00662649|580324307|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
160711950|NCT00662649|580324308|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
160711951|NCT00662649|580324309|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
160711952|NCT00662649|580324310|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
160711953|NCT00662649|580324311|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
160711954|NCT00662649|580324307|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
160711955|NCT00662649|580324308|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
160711956|NCT00662649|580324309|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
160711957|NCT00662649|580324310|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
160711958|NCT00662649|580324311|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
160711959|NCT00662649|580324307|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
160711960|NCT00662649|580324308|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
160711961|NCT00662649|580324309|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
160711962|NCT00662649|580324310|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
160711963|NCT00662649|580324311|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
160711964|NCT02009722|580324319|FG000|Overall Study|Protocol Violation|1|||
160711965|NCT02009722|580324320|FG001|Overall Study|Protocol Violation|2|||
160711966|NCT02009722|580324319|FG000|Overall Study|Did not receive intervention|0|||
160711967|NCT02009722|580324320|FG001|Overall Study|Did not receive intervention|1|||
160711968|NCT02955212|580324321|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
160711969|NCT02955212|580324322|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
160711970|NCT02955212|580324321|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
160711971|NCT02955212|580324322|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
160711972|NCT02955212|580324321|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
160711973|NCT02955212|580324322|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
160711974|NCT02955212|580324321|FG000|Period 1: Double-blind Treatment Period|Other|3|||
160711975|NCT02955212|580324322|FG001|Period 1: Double-blind Treatment Period|Other|2|||
160711976|NCT02955212|580324321|FG000|Period 2: Open-label Extension|Adverse Event|11|||
160711977|NCT02955212|580324322|FG001|Period 2: Open-label Extension|Adverse Event|7|||
160711978|NCT02955212|580324321|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
160711979|NCT02955212|580324322|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
160711980|NCT02955212|580324321|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
160711981|NCT02955212|580324322|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
160711982|NCT02955212|580324321|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
160711983|NCT02955212|580324322|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
160711984|NCT02955212|580324321|FG000|Period 2: Open-label Extension|Other|2|||
160711985|NCT02955212|580324322|FG001|Period 2: Open-label Extension|Other|4|||
160711986|NCT02454933|580324323|FG000|Overall Study|Progressive disease|10|||
160711987|NCT02454933|580324324|FG001|Overall Study|Progressive disease|7|||
160711988|NCT02454933|580324323|FG000|Overall Study|Adverse Event|1|||
160711989|NCT02454933|580324324|FG001|Overall Study|Adverse Event|1|||
160711990|NCT02454933|580324323|FG000|Overall Study|Withdrawal by Subject|0|||
160711991|NCT02454933|580324324|FG001|Overall Study|Withdrawal by Subject|3|||
160711992|NCT02454933|580324323|FG000|Overall Study|Lost to Follow-up|1|||
160711993|NCT02454933|580324324|FG001|Overall Study|Lost to Follow-up|0|||
160711994|NCT02071225|580324332|FG000|Overall Study|Withdrawal of Consent|2|||
160711995|NCT02071225|580324332|FG000|Overall Study|Protocol Deviation|1|||
160711996|NCT02071225|580324332|FG000|Overall Study|Lost to Follow-up|2|||
160711997|NCT02071225|580324332|FG000|Overall Study|Death|25|||
160711998|NCT04720053|580324336|FG000|Overall Study|Lost to Follow-up|12|||
160711999|NCT01960257|580324337|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
160712000|NCT01960257|580324338|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
160712001|NCT01960257|580324339|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
160712002|NCT01960257|580324337|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
160712003|NCT01960257|580324338|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
160712004|NCT01960257|580324339|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
160712005|NCT01960257|580324337|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
160712006|NCT01960257|580324338|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
160712007|NCT01960257|580324339|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
160712008|NCT02038010|580324340|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
160712009|NCT02038010|580324341|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
160712010|NCT02038010|580324342|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
160712011|NCT02038010|580324343|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
160712012|NCT02038010|580324340|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
160712013|NCT02038010|580324341|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
160712014|NCT02038010|580324342|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
160712015|NCT02038010|580324343|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
160712016|NCT02038010|580324340|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
160712017|NCT02038010|580324341|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
160712018|NCT02038010|580324342|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
160712019|NCT02038010|580324343|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
160712020|NCT02038010|580324340|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
160712021|NCT02038010|580324341|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
160712022|NCT02038010|580324342|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
160712023|NCT02038010|580324343|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
160712024|NCT02038010|580324340|FG000|Follow Up|Death|4|||
160712025|NCT02038010|580324341|FG001|Follow Up|Death|3|||
160712026|NCT02038010|580324342|FG002|Follow Up|Death|0|||
160712027|NCT02038010|580324343|FG003|Follow Up|Death|0|||
160712028|NCT02038010|580324340|FG000|Follow Up|Other|3|||
160712029|NCT02038010|580324341|FG001|Follow Up|Other|0|||
160712030|NCT02038010|580324342|FG002|Follow Up|Other|0|||
160712031|NCT02038010|580324343|FG003|Follow Up|Other|0|||
160712032|NCT00958828|580324349|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
160712033|NCT00958828|580324350|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
160712034|NCT00958828|580324349|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
160712035|NCT00958828|580324350|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
160712036|NCT02673775|580324359|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
160712037|NCT02673775|580324360|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
160712038|NCT02673775|580324359|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
160712039|NCT02673775|580324360|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
160712040|NCT02673775|580324359|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
160712041|NCT02673775|580324360|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
160712042|NCT02673775|580324359|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
160712043|NCT02673775|580324360|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
160712044|NCT00535405|580324361|FG000|Overall Study|Adverse Event|6|||
160712045|NCT00535405|580324362|FG001|Overall Study|Adverse Event|8|||
160712046|NCT00535405|580324363|FG002|Overall Study|Adverse Event|3|||
160712047|NCT00535405|580324364|FG003|Overall Study|Adverse Event|8|||
160712048|NCT00535405|580324365|FG004|Overall Study|Adverse Event|6|||
160712049|NCT00535405|580324361|FG000|Overall Study|Lost to Follow-up|1|||
160712050|NCT00535405|580324362|FG001|Overall Study|Lost to Follow-up|3|||
160712051|NCT00535405|580324363|FG002|Overall Study|Lost to Follow-up|3|||
160712052|NCT00535405|580324364|FG003|Overall Study|Lost to Follow-up|2|||
160712053|NCT00535405|580324365|FG004|Overall Study|Lost to Follow-up|1|||
160712054|NCT00535405|580324361|FG000|Overall Study|Physician Decision|3|||
160712055|NCT00535405|580324362|FG001|Overall Study|Physician Decision|2|||
160712056|NCT00535405|580324363|FG002|Overall Study|Physician Decision|0|||
160712057|NCT00535405|580324364|FG003|Overall Study|Physician Decision|1|||
160712058|NCT00535405|580324365|FG004|Overall Study|Physician Decision|1|||
160712059|NCT00535405|580324361|FG000|Overall Study|Protocol Violation|2|||
160712060|NCT00535405|580324362|FG001|Overall Study|Protocol Violation|2|||
160712061|NCT00535405|580324363|FG002|Overall Study|Protocol Violation|2|||
160712062|NCT00535405|580324364|FG003|Overall Study|Protocol Violation|1|||
160712063|NCT00535405|580324365|FG004|Overall Study|Protocol Violation|0|||
160712064|NCT00535405|580324361|FG000|Overall Study|Withdrawal by Subject|5|||
160712065|NCT00535405|580324362|FG001|Overall Study|Withdrawal by Subject|11|||
160712066|NCT00535405|580324363|FG002|Overall Study|Withdrawal by Subject|10|||
160712067|NCT00535405|580324364|FG003|Overall Study|Withdrawal by Subject|10|||
160712068|NCT00535405|580324365|FG004|Overall Study|Withdrawal by Subject|8|||
160712069|NCT03910673|580324368|FG000|Overall Study|Adverse Event|0|||
160712070|NCT03910673|580324369|FG001|Overall Study|Adverse Event|0|||
160712071|NCT03910673|580324370|FG002|Overall Study|Adverse Event|0|||
160712072|NCT03910673|580324371|FG003|Overall Study|Adverse Event|2|||
160712073|NCT03910673|580324372|FG004|Overall Study|Adverse Event|0|||
160712074|NCT02016183|580324373|FG000|Overall Study|Case Report Forms Uncollected|13|||
160712075|NCT02016183|580324373|FG000|Overall Study|Protocol Violation|52|||
160712076|NCT00770328|580324380|FG000|Overall Study|Adverse Event|11|||
160712077|NCT00770328|580324381|FG001|Overall Study|Adverse Event|2|||
160712078|NCT00770328|580324380|FG000|Overall Study|Lost to Follow-up|2|||
160712079|NCT00770328|580324381|FG001|Overall Study|Lost to Follow-up|2|||
160712080|NCT04388553|580324382|FG000|Overall Study|Protocol Violation|1|||
160712081|NCT04388553|580324383|FG001|Overall Study|Protocol Violation|0|||
160712082|NCT04604795|580324384|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
160712083|NCT04604795|580324385|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
160712084|NCT04604795|580324386|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
160712085|NCT04604795|580324387|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
160712086|NCT04604795|580324388|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
160712087|NCT04604795|580324389|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
160712088|NCT04604795|580324390|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
160712089|NCT04604795|580324391|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
160712090|NCT04604795|580324392|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
160712091|NCT04604795|580324393|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
160712092|NCT04604795|580324384|FG000|Part B: Up to Day 14|Adverse Event|0|||
160712093|NCT04604795|580324385|FG001|Part B: Up to Day 14|Adverse Event|0|||
160712094|NCT04604795|580324386|FG002|Part B: Up to Day 14|Adverse Event|0|||
160712095|NCT04604795|580324387|FG003|Part B: Up to Day 14|Adverse Event|0|||
160712096|NCT04604795|580324388|FG004|Part B: Up to Day 14|Adverse Event|2|||
160712097|NCT04604795|580324389|FG005|Part B: Up to Day 14|Adverse Event|1|||
160712098|NCT04604795|580324390|FG006|Part B: Up to Day 14|Adverse Event|0|||
160712099|NCT04604795|580324391|FG007|Part B: Up to Day 14|Adverse Event|0|||
160712100|NCT04604795|580324392|FG008|Part B: Up to Day 14|Adverse Event|0|||
160712101|NCT04604795|580324393|FG009|Part B: Up to Day 14|Adverse Event|0|||
160712102|NCT04604795|580324384|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
160712103|NCT04604795|580324385|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
160712104|NCT04604795|580324386|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
160712105|NCT04604795|580324387|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
160712106|NCT04604795|580324388|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
160712107|NCT04604795|580324389|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
160712108|NCT04604795|580324390|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
160712109|NCT04604795|580324391|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
160712110|NCT04604795|580324392|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
160712111|NCT04604795|580324393|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
160712112|NCT04604795|580324384|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
160712113|NCT04604795|580324385|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
160712114|NCT04604795|580324386|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
160712115|NCT04604795|580324387|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
160712116|NCT04604795|580324388|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
160712117|NCT04604795|580324389|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
160712118|NCT04604795|580324390|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
160712119|NCT04604795|580324391|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
160712120|NCT04604795|580324392|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
160712121|NCT04604795|580324393|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
160712122|NCT04604795|580324384|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
160712123|NCT04604795|580324385|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
160712124|NCT04604795|580324386|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
160712125|NCT04604795|580324387|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
160712126|NCT04604795|580324388|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
160712127|NCT04604795|580324389|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
160712128|NCT04604795|580324390|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
160712129|NCT04604795|580324391|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
160712130|NCT04604795|580324392|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
160712131|NCT04604795|580324393|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
160712132|NCT04604795|580324384|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
160712133|NCT04604795|580324385|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
160712134|NCT04604795|580324386|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
160712135|NCT04604795|580324387|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
160712136|NCT04604795|580324388|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
160712137|NCT04604795|580324389|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
160712138|NCT04604795|580324390|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
160712139|NCT04604795|580324391|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
160712140|NCT04604795|580324392|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
160712141|NCT04604795|580324393|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
160712142|NCT01590277|580324396|FG000|Overall Study|Withdrawal by Subject|3|||
160712143|NCT01590277|580324396|FG000|Overall Study|Withdrawal by Subject|2|||
160712144|NCT01590277|580324396|FG000|Overall Study|Withdrawal by Subject|1|||
160712145|NCT01590277|580324396|FG000|Overall Study|Withdrawal by Subject|1|||
160712146|NCT04386616|580324397|FG000|Overall Study|Death|22|||
160712147|NCT04386616|580324398|FG001|Overall Study|Death|22|||
160712148|NCT04386616|580324399|FG002|Overall Study|Death|21|||
160712149|NCT04386616|580324397|FG000|Overall Study|Lost to Follow-up|5|||
160712150|NCT04386616|580324398|FG001|Overall Study|Lost to Follow-up|8|||
160712151|NCT04386616|580324399|FG002|Overall Study|Lost to Follow-up|6|||
160712152|NCT04386616|580324397|FG000|Overall Study|Withdrawal by Subject|2|||
160712153|NCT04386616|580324398|FG001|Overall Study|Withdrawal by Subject|4|||
160712154|NCT04386616|580324399|FG002|Overall Study|Withdrawal by Subject|1|||
160712155|NCT04386616|580324397|FG000|Overall Study|Adverse Event|1|||
160712156|NCT04386616|580324398|FG001|Overall Study|Adverse Event|1|||
160712157|NCT04386616|580324399|FG002|Overall Study|Adverse Event|0|||
160712158|NCT01377012|580324400|FG000|Core Study|Study terminated by Sponsor|47|||
160712159|NCT01377012|580324401|FG001|Core Study|Study terminated by Sponsor|54|||
160712160|NCT01377012|580324402|FG002|Core Study|Study terminated by Sponsor|46|||
160712161|NCT01377012|580324400|FG000|Core Study|Technical problems|1|||
160712162|NCT01377012|580324401|FG001|Core Study|Technical problems|0|||
160712163|NCT01377012|580324402|FG002|Core Study|Technical problems|0|||
160712164|NCT01377012|580324400|FG000|Core Study|Withdrawal by Subject|15|||
160712165|NCT01377012|580324401|FG001|Core Study|Withdrawal by Subject|23|||
160712166|NCT01377012|580324402|FG002|Core Study|Withdrawal by Subject|18|||
160712167|NCT01377012|580324400|FG000|Core Study|Protocol Violation|7|||
160712168|NCT01377012|580324401|FG001|Core Study|Protocol Violation|3|||
160712169|NCT01377012|580324402|FG002|Core Study|Protocol Violation|2|||
160712170|NCT01377012|580324400|FG000|Core Study|Pregnancy|0|||
160712171|NCT01377012|580324401|FG001|Core Study|Pregnancy|0|||
160712172|NCT01377012|580324402|FG002|Core Study|Pregnancy|1|||
160712173|NCT01377012|580324400|FG000|Core Study|Physician Decision|5|||
160712174|NCT01377012|580324401|FG001|Core Study|Physician Decision|4|||
160712175|NCT01377012|580324402|FG002|Core Study|Physician Decision|10|||
160712176|NCT01377012|580324400|FG000|Core Study|Non-Compliant with study treatment|0|||
160712177|NCT01377012|580324401|FG001|Core Study|Non-Compliant with study treatment|0|||
160712178|NCT01377012|580324402|FG002|Core Study|Non-Compliant with study treatment|1|||
160712179|NCT01377012|580324400|FG000|Core Study|No Longer require treatment|0|||
160712180|NCT01377012|580324401|FG001|Core Study|No Longer require treatment|0|||
160712181|NCT01377012|580324402|FG002|Core Study|No Longer require treatment|1|||
160712182|NCT01377012|580324400|FG000|Core Study|Lost to Follow-up|7|||
160712183|NCT01377012|580324401|FG001|Core Study|Lost to Follow-up|5|||
160712184|NCT01377012|580324402|FG002|Core Study|Lost to Follow-up|4|||
160712185|NCT01377012|580324400|FG000|Core Study|Lack of Efficacy|41|||
160712186|NCT01377012|580324401|FG001|Core Study|Lack of Efficacy|28|||
160712187|NCT01377012|580324402|FG002|Core Study|Lack of Efficacy|37|||
160712188|NCT01377012|580324400|FG000|Core Study|Death|1|||
160712189|NCT01377012|580324401|FG001|Core Study|Death|1|||
160712190|NCT01377012|580324402|FG002|Core Study|Death|1|||
160712191|NCT01377012|580324400|FG000|Core Study|Adverse Event|10|||
160712192|NCT01377012|580324401|FG001|Core Study|Adverse Event|14|||
160712193|NCT01377012|580324402|FG002|Core Study|Adverse Event|13|||
160712194|NCT01377012|580324400|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
160712195|NCT01377012|580324401|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
160712196|NCT01377012|580324402|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
160712197|NCT01377012|580324400|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
160712198|NCT01377012|580324401|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
160712199|NCT01377012|580324402|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
160712200|NCT01377012|580324400|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
160712201|NCT01377012|580324401|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
160712202|NCT01377012|580324402|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
160712203|NCT01377012|580324400|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
160712204|NCT01377012|580324401|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
160712205|NCT01377012|580324402|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
160712206|NCT01377012|580324400|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
160712207|NCT01377012|580324401|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
160712208|NCT01377012|580324402|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
160712209|NCT01377012|580324400|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
160712210|NCT01377012|580324401|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
160712211|NCT01377012|580324402|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
160712212|NCT00805961|580324403|FG000|Modality Therapy|Withdrawal by Subject|1|||
160712213|NCT00805961|580324403|FG000|Modality Therapy|Adverse Event|1|||
160712214|NCT00805961|580324403|FG000|Modality Therapy|Disease Progression|2|||
160712215|NCT00805961|580324403|FG000|Treatment-Free Interval|Adverse Event|3|||
160712216|NCT00805961|580324403|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
160712217|NCT00805961|580324403|FG000|Treatment-Free Interval|Physician Decision|1|||
160712218|NCT00805961|580324403|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
160712219|NCT00805961|580324403|FG000|Maintenance Treatment|Lack of Efficacy|13|||
160712220|NCT00805961|580324403|FG000|Maintenance Treatment|Intercurrent Illness|7|||
160712221|NCT00805961|580324403|FG000|Maintenance Treatment|Adverse Event|6|||
160712222|NCT00805961|580324403|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
160712223|NCT00805961|580324403|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
160712224|NCT00805961|580324403|FG000|Maintenance Treatment|Withdrawn Consent|1|||
160712225|NCT02603146|580326454|FG000|Overall Study|Lost to Follow-up|5|||
160712226|NCT02603146|580326455|FG001|Overall Study|Lost to Follow-up|6|||
160712227|NCT02603146|580326454|FG000|Overall Study|Withdrawal by Subject|8|||
160712228|NCT02603146|580326455|FG001|Overall Study|Withdrawal by Subject|10|||
160712229|NCT02603146|580326454|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
160712230|NCT02603146|580326455|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
160712231|NCT02603146|580326454|FG000|Overall Study|Participant moved|2|||
160712232|NCT02603146|580326455|FG001|Overall Study|Participant moved|0|||
160712233|NCT02603146|580326454|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
160712234|NCT02603146|580326455|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
160712235|NCT05016960|580326458|FG000|Overall Study|Withdrawal by Subject|1|||
160712236|NCT05016960|580326459|FG001|Overall Study|Withdrawal by Subject|9|||
160712237|NCT03690388|580326463|FG000|Overall Study|Adverse Event|8|||
160712238|NCT03690388|580326464|FG001|Overall Study|Adverse Event|1|||
160712239|NCT03690388|580326463|FG000|Overall Study|Radiographic Progression|14|||
160712240|NCT03690388|580326464|FG001|Overall Study|Radiographic Progression|29|||
160712241|NCT03690388|580326463|FG000|Overall Study|Clinical deterioration|10|||
160712242|NCT03690388|580326464|FG001|Overall Study|Clinical deterioration|6|||
160712243|NCT03690388|580326463|FG000|Overall Study|Withdrawal by Subject|2|||
160712244|NCT03690388|580326464|FG001|Overall Study|Withdrawal by Subject|0|||
160712245|NCT03690388|580326463|FG000|Overall Study|Lack of Efficacy|1|||
160712246|NCT03690388|580326464|FG001|Overall Study|Lack of Efficacy|0|||
160712247|NCT03690388|580326463|FG000|Overall Study|Lost to Follow-up|1|||
160712248|NCT03690388|580326464|FG001|Overall Study|Lost to Follow-up|0|||
160712249|NCT03765788|580326465|FG000|Overall Study|Subject decision|2|||
160712250|NCT03765788|580326466|FG001|Overall Study|Subject decision|3|||
160712251|NCT03765788|580326465|FG000|Overall Study|Physician Decision|2|||
160712252|NCT03765788|580326466|FG001|Overall Study|Physician Decision|4|||
160712253|NCT03765788|580326465|FG000|Overall Study|Death|0|||
160712254|NCT03765788|580326466|FG001|Overall Study|Death|1|||
160712255|NCT03765788|580326465|FG000|Overall Study|Lost to Follow-up|1|||
160712256|NCT03765788|580326466|FG001|Overall Study|Lost to Follow-up|0|||
160712257|NCT00001521|580326467|FG000|Overall Study|Withdrawal by Subject|3|||
160712258|NCT00001521|580326468|FG001|Overall Study|Withdrawal by Subject|3|||
160712259|NCT00001521|580326467|FG000|Overall Study|Physician Decision|1|||
160712260|NCT00001521|580326468|FG001|Overall Study|Physician Decision|1|||
160712261|NCT00001521|580326467|FG000|Overall Study|Noncompliant|6|||
160712262|NCT00001521|580326468|FG001|Overall Study|Noncompliant|3|||
160712263|NCT01130532|580326472|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
160712264|NCT01130532|580326473|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
160712265|NCT01130532|580326474|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
160712266|NCT01130532|580326475|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
160712267|NCT01130532|580326472|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
160712268|NCT01130532|580326473|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
160712269|NCT01130532|580326474|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
160712270|NCT01130532|580326475|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
160712271|NCT01130532|580326472|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
160712272|NCT01130532|580326473|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
160712273|NCT01130532|580326474|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
160712274|NCT01130532|580326475|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
160712275|NCT01130532|580326472|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
160712276|NCT01130532|580326473|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
160712277|NCT01130532|580326474|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
160712278|NCT01130532|580326475|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
160712279|NCT01130532|580326472|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
160712280|NCT01130532|580326473|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
160712281|NCT01130532|580326474|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
160712282|NCT01130532|580326475|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
160712283|NCT01130532|580326472|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
160712284|NCT01130532|580326473|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
160712285|NCT01130532|580326474|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
160712286|NCT01130532|580326475|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
160712287|NCT01130532|580326472|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
160712288|NCT01130532|580326473|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
160712289|NCT01130532|580326474|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
160712290|NCT01130532|580326475|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
160712291|NCT01130532|580326472|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
160712292|NCT01130532|580326473|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
160712293|NCT01130532|580326474|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
160712294|NCT01130532|580326475|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
160712295|NCT01130532|580326472|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
160712296|NCT01130532|580326473|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
160712297|NCT01130532|580326474|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
160712298|NCT01130532|580326475|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
160712299|NCT01130532|580326472|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
160712300|NCT01130532|580326473|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
160712301|NCT01130532|580326474|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
160712302|NCT01130532|580326475|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
160712303|NCT01130532|580326472|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
160712304|NCT01130532|580326473|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
160712305|NCT01130532|580326474|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
160712306|NCT01130532|580326475|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
160712307|NCT02656303|580326476|FG000|Overall Study|Adverse Event|3|||
160712308|NCT02656303|580326477|FG001|Overall Study|Adverse Event|2|||
160712309|NCT02656303|580326478|FG002|Overall Study|Adverse Event|0|||
160712310|NCT02656303|580326476|FG000|Overall Study|Death|12|||
160712311|NCT02656303|580326477|FG001|Overall Study|Death|4|||
160712312|NCT02656303|580326478|FG002|Overall Study|Death|1|||
160712313|NCT02656303|580326476|FG000|Overall Study|Lack of Efficacy|1|||
160712314|NCT02656303|580326477|FG001|Overall Study|Lack of Efficacy|0|||
160712315|NCT02656303|580326478|FG002|Overall Study|Lack of Efficacy|0|||
160712316|NCT02656303|580326476|FG000|Overall Study|Non-Compliance with Study|1|||
160712317|NCT02656303|580326477|FG001|Overall Study|Non-Compliance with Study|1|||
160712318|NCT02656303|580326478|FG002|Overall Study|Non-Compliance with Study|0|||
160712319|NCT02656303|580326476|FG000|Overall Study|Investigator Decision|2|||
160712320|NCT02656303|580326477|FG001|Overall Study|Investigator Decision|1|||
160712321|NCT02656303|580326478|FG002|Overall Study|Investigator Decision|0|||
160712322|NCT02656303|580326476|FG000|Overall Study|Progressive Disease|25|||
160712323|NCT02656303|580326477|FG001|Overall Study|Progressive Disease|14|||
160712324|NCT02656303|580326478|FG002|Overall Study|Progressive Disease|10|||
160712325|NCT02656303|580326476|FG000|Overall Study|Study Terminated by Sponsor|20|||
160712326|NCT02656303|580326477|FG001|Overall Study|Study Terminated by Sponsor|7|||
160712327|NCT02656303|580326478|FG002|Overall Study|Study Terminated by Sponsor|5|||
160712328|NCT02656303|580326476|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
160712329|NCT02656303|580326477|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
160712330|NCT02656303|580326478|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
160712331|NCT02656303|580326476|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
160712332|NCT02656303|580326477|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
160712333|NCT02656303|580326478|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
160712334|NCT02656303|580326476|FG000|Overall Study|Reason not Specified|1|||
160712335|NCT02656303|580326477|FG001|Overall Study|Reason not Specified|1|||
160712336|NCT02656303|580326478|FG002|Overall Study|Reason not Specified|2|||
160712337|NCT03041311|580326481|FG000|Overall Study|Death|39|||
160712338|NCT03041311|580326482|FG001|Overall Study|Death|42|||
160712339|NCT03041311|580326481|FG000|Overall Study|Lost to Follow-up|0|||
160712340|NCT03041311|580326482|FG001|Overall Study|Lost to Follow-up|1|||
160712341|NCT03041311|580326481|FG000|Overall Study|Withdrawal by Subject|8|||
160712342|NCT03041311|580326482|FG001|Overall Study|Withdrawal by Subject|5|||
160712343|NCT03041311|580326481|FG000|Overall Study|Sponsor Terminated Study|2|||
160712344|NCT03041311|580326482|FG001|Overall Study|Sponsor Terminated Study|4|||
160712345|NCT03041311|580326481|FG000|Overall Study|Disease Progression|3|||
160712346|NCT03041311|580326482|FG001|Overall Study|Disease Progression|1|||
160712347|NCT03041311|580326481|FG000|Overall Study|Randomized in error, did not receive drug|2|||
160712348|NCT03041311|580326482|FG001|Overall Study|Randomized in error, did not receive drug|0|||
160712349|NCT01842438|580326483|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
160712350|NCT01842438|580326484|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
160712351|NCT01842438|580326483|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
160712352|NCT01842438|580326484|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
160712353|NCT01842438|580326483|FG000|T2: 6month Follow-up|Death|0|||
160712354|NCT01842438|580326484|FG001|T2: 6month Follow-up|Death|1|||
160712355|NCT04909853|580326485|FG000|Part 1|Assigned but not treated|0|||
160712356|NCT04909853|580326486|FG001|Part 1|Assigned but not treated|0|||
160712357|NCT04909853|580326487|FG002|Part 1|Assigned but not treated|1|||
160712358|NCT04909853|580326488|FG003|Part 1|Assigned but not treated|0|||
160712359|NCT04909853|580326485|FG000|Part 2|Adverse Event|0|||
160712360|NCT04909853|580326486|FG001|Part 2|Adverse Event|0|||
160712361|NCT04909853|580326487|FG002|Part 2|Adverse Event|0|||
160712362|NCT04909853|580326488|FG003|Part 2|Adverse Event|1|||
160712363|NCT02548156|580326491|FG000|Washout Period 1|Lost to Follow-up|0|||
160712364|NCT02548156|580326492|FG001|Washout Period 1|Lost to Follow-up|0|||
160712365|NCT02548156|580326493|FG002|Washout Period 1|Lost to Follow-up|0|||
160712366|NCT02548156|580326494|FG003|Washout Period 1|Lost to Follow-up|0|||
160712367|NCT02548156|580326495|FG004|Washout Period 1|Lost to Follow-up|1|||
160712368|NCT02548156|580326496|FG005|Washout Period 1|Lost to Follow-up|0|||
160712369|NCT00444587|580326497|FG000|Overall Study|Death|2|||
160712370|NCT00444587|580326498|FG001|Overall Study|Death|1|||
160712371|NCT00444587|580326497|FG000|Overall Study|Progression of the disease|73|||
160712372|NCT00444587|580326498|FG001|Overall Study|Progression of the disease|8|||
160712373|NCT00444587|580326497|FG000|Overall Study|Refused treatment/did not cooperate|4|||
160712374|NCT00444587|580326498|FG001|Overall Study|Refused treatment/did not cooperate|1|||
160712375|NCT00444587|580326497|FG000|Overall Study|Investigator decision|3|||
160712376|NCT00444587|580326498|FG001|Overall Study|Investigator decision|0|||
160712377|NCT00444587|580326497|FG000|Overall Study|Protocol Violation|1|||
160712378|NCT00444587|580326498|FG001|Overall Study|Protocol Violation|0|||
160712379|NCT00444587|580326497|FG000|Overall Study|Missing|0|||
160712380|NCT00444587|580326498|FG001|Overall Study|Missing|5|||
160712381|NCT00196326|580326499|FG000|Overall Study|Did not meet protocol requirements|64|||
160712382|NCT00196326|580326499|FG000|Overall Study|Non-compliance with the protocol|81|||
160712383|NCT00196326|580326499|FG000|Overall Study|Physician Decision|3|||
160712384|NCT00196326|580326499|FG000|Overall Study|Withdrawal by Subject|225|||
160712385|NCT00196326|580326499|FG000|Overall Study|Adverse Event|253|||
160712386|NCT00196326|580326499|FG000|Overall Study|Pregnancy|34|||
160712387|NCT00196326|580326499|FG000|Overall Study|Lost to Follow-up|304|||
160712388|NCT00196326|580326499|FG000|Overall Study|Other|22|||
160712389|NCT05223920|580326506|FG000|Overall Study|Adverse Event|6|||
160712390|NCT05223920|580326507|FG001|Overall Study|Adverse Event|3|||
160712391|NCT05223920|580326506|FG000|Overall Study|Death|2|||
160712392|NCT05223920|580326507|FG001|Overall Study|Death|0|||
160712393|NCT05223920|580326506|FG000|Overall Study|Disease Progression|1|||
160712394|NCT05223920|580326507|FG001|Overall Study|Disease Progression|2|||
160712395|NCT05223920|580326506|FG000|Overall Study|Physician Decision|1|||
160712396|NCT05223920|580326507|FG001|Overall Study|Physician Decision|2|||
160712397|NCT05223920|580326506|FG000|Overall Study|Sponsor decision|11|||
160712398|NCT05223920|580326507|FG001|Overall Study|Sponsor decision|9|||
160712399|NCT05223920|580326506|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
160712400|NCT05223920|580326507|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
160712401|NCT05223920|580326506|FG000|Overall Study|Subject decision|1|||
160712402|NCT05223920|580326507|FG001|Overall Study|Subject decision|0|||
160712403|NCT05223920|580326506|FG000|Overall Study|Withdrawal by Subject|1|||
160712404|NCT05223920|580326507|FG001|Overall Study|Withdrawal by Subject|6|||
160712405|NCT00369941|580326508|FG000|Overall Study|Never Treated|1|||
160712406|NCT00369941|580326509|FG001|Overall Study|Never Treated|2|||
160712407|NCT00369941|580326508|FG000|Overall Study|Adverse Event|14|||
160712408|NCT00369941|580326509|FG001|Overall Study|Adverse Event|28|||
160712409|NCT00369941|580326508|FG000|Overall Study|Lack of Efficacy|6|||
160712410|NCT00369941|580326509|FG001|Overall Study|Lack of Efficacy|10|||
160712411|NCT00369941|580326508|FG000|Overall Study|Lost to Follow-up|12|||
160712412|NCT00369941|580326509|FG001|Overall Study|Lost to Follow-up|22|||
160712413|NCT00369941|580326508|FG000|Overall Study|Protocol Violation|5|||
160712414|NCT00369941|580326509|FG001|Overall Study|Protocol Violation|3|||
160712415|NCT00369941|580326508|FG000|Overall Study|Withdrawal by Subject|5|||
160712416|NCT00369941|580326509|FG001|Overall Study|Withdrawal by Subject|18|||
160712417|NCT00369941|580326508|FG000|Overall Study|Pregnancy|4|||
160712418|NCT00369941|580326509|FG001|Overall Study|Pregnancy|2|||
160712419|NCT00369941|580326508|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
160712420|NCT00369941|580326509|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
160712421|NCT00369941|580326508|FG000|Overall Study|Moved|11|||
160712422|NCT00369941|580326509|FG001|Overall Study|Moved|5|||
160712423|NCT00369941|580326508|FG000|Overall Study|Treatment with Prohibited Medication|3|||
160712424|NCT00369941|580326509|FG001|Overall Study|Treatment with Prohibited Medication|1|||
160712425|NCT00369941|580326508|FG000|Overall Study|Employment Interfered with Study Visits|1|||
160712426|NCT00369941|580326509|FG001|Overall Study|Employment Interfered with Study Visits|0|||
160712427|NCT00369941|580326508|FG000|Overall Study|Study Site Terminated|2|||
160712428|NCT00369941|580326509|FG001|Overall Study|Study Site Terminated|0|||
160712429|NCT00369941|580326508|FG000|Overall Study|Miscellaneous|3|||
160712430|NCT00369941|580326509|FG001|Overall Study|Miscellaneous|3|||
160712431|NCT00661193|580326510|FG000|Overall Study|Adverse Event|2|||
160712432|NCT00661193|580326511|FG001|Overall Study|Adverse Event|1|||
160712433|NCT00661193|580326510|FG000|Overall Study|Withdrawal by Subject|3|||
160712434|NCT00661193|580326511|FG001|Overall Study|Withdrawal by Subject|1|||
160712435|NCT00661193|580326510|FG000|Overall Study|Progression|27|||
160712436|NCT00661193|580326511|FG001|Overall Study|Progression|24|||
160712437|NCT00661193|580326510|FG000|Overall Study|Not protocol specified|1|||
160712438|NCT00661193|580326511|FG001|Overall Study|Not protocol specified|0|||
160712439|NCT04882241|580326516|FG000|Overall Study|Ongoing in study|46|||
160712440|NCT04882241|580326517|FG001|Overall Study|Ongoing in study|48|||
160712441|NCT04882241|580326518|FG002|Overall Study|Ongoing in study|0|||
160712442|NCT04882241|580326519|FG003|Overall Study|Ongoing in study|0|||
160712443|NCT04882241|580326516|FG000|Overall Study|Death|13|||
160712444|NCT04882241|580326517|FG001|Overall Study|Death|13|||
160712445|NCT04882241|580326518|FG002|Overall Study|Death|0|||
160712446|NCT04882241|580326519|FG003|Overall Study|Death|0|||
160712447|NCT01342081|580326526|FG000|Overall Study|Did not receive allocated intervention|0|||
160712448|NCT01342081|580326527|FG001|Overall Study|Did not receive allocated intervention|0|||
160712449|NCT01342081|580326528|FG002|Overall Study|Did not receive allocated intervention|1|||
160712450|NCT01342081|580326526|FG000|Overall Study|Adverse Event|1|||
160712451|NCT01342081|580326527|FG001|Overall Study|Adverse Event|0|||
160712452|NCT01342081|580326528|FG002|Overall Study|Adverse Event|0|||
160712453|NCT01342081|580326526|FG000|Overall Study|Physician Decision|0|||
160712454|NCT01342081|580326527|FG001|Overall Study|Physician Decision|1|||
160712455|NCT01342081|580326528|FG002|Overall Study|Physician Decision|0|||
160712456|NCT01342081|580326526|FG000|Overall Study|Withdrawal by Subject|1|||
160712457|NCT01342081|580326527|FG001|Overall Study|Withdrawal by Subject|1|||
160712458|NCT01342081|580326528|FG002|Overall Study|Withdrawal by Subject|0|||
160712459|NCT01942993|580326530|FG000|Overall Study|Lost to Follow-up|1|||
160712460|NCT01942993|580326530|FG000|Overall Study|Physician Decision|1|||
160712461|NCT01350271|580326531|FG000|Overall Study|Lost to Follow-up|21|||
160712462|NCT01350271|580326532|FG001|Overall Study|Lost to Follow-up|17|||
160712463|NCT01350271|580326533|FG002|Overall Study|Lost to Follow-up|26|||
160712464|NCT02906670|580326537|FG000|Cohort 1, QW|Radiological Progression|1|||
160712465|NCT02906670|580326538|FG001|Cohort 1, QW|Radiological Progression|0|||
160712466|NCT02906670|580326539|FG002|Cohort 1, QW|Radiological Progression|0|||
160712467|NCT02906670|580326540|FG003|Cohort 1, QW|Radiological Progression|0|||
160712468|NCT02906670|580326541|FG004|Cohort 1, QW|Radiological Progression|0|||
160712469|NCT02906670|580326542|FG005|Cohort 1, QW|Radiological Progression|0|||
160712470|NCT02906670|580326543|FG006|Cohort 1, QW|Radiological Progression|0|||
160712471|NCT02906670|580326544|FG007|Cohort 1, QW|Radiological Progression|0|||
160712472|NCT02906670|580326545|FG008|Cohort 1, QW|Radiological Progression|0|||
160712473|NCT02906670|580326546|FG009|Cohort 1, QW|Radiological Progression|0|||
160712474|NCT02906670|580326537|FG000|Cohort 2, QW|Radiological Progression|0|||
160712475|NCT02906670|580326538|FG001|Cohort 2, QW|Radiological Progression|1|||
160712476|NCT02906670|580326539|FG002|Cohort 2, QW|Radiological Progression|0|||
160712477|NCT02906670|580326540|FG003|Cohort 2, QW|Radiological Progression|0|||
160712478|NCT02906670|580326541|FG004|Cohort 2, QW|Radiological Progression|0|||
160712479|NCT02906670|580326542|FG005|Cohort 2, QW|Radiological Progression|0|||
160712480|NCT02906670|580326543|FG006|Cohort 2, QW|Radiological Progression|0|||
160712481|NCT02906670|580326544|FG007|Cohort 2, QW|Radiological Progression|0|||
160712482|NCT02906670|580326545|FG008|Cohort 2, QW|Radiological Progression|0|||
160712483|NCT02906670|580326546|FG009|Cohort 2, QW|Radiological Progression|0|||
160712484|NCT02906670|580326537|FG000|Cohort 3, QW|Radiological Progression|0|||
160712485|NCT02906670|580326538|FG001|Cohort 3, QW|Radiological Progression|0|||
160712486|NCT02906670|580326539|FG002|Cohort 3, QW|Radiological Progression|2|||
160712487|NCT02906670|580326540|FG003|Cohort 3, QW|Radiological Progression|0|||
160712488|NCT02906670|580326541|FG004|Cohort 3, QW|Radiological Progression|0|||
160712489|NCT02906670|580326542|FG005|Cohort 3, QW|Radiological Progression|0|||
160712490|NCT02906670|580326543|FG006|Cohort 3, QW|Radiological Progression|0|||
160712491|NCT02906670|580326544|FG007|Cohort 3, QW|Radiological Progression|0|||
160712492|NCT02906670|580326545|FG008|Cohort 3, QW|Radiological Progression|0|||
160712493|NCT02906670|580326546|FG009|Cohort 3, QW|Radiological Progression|0|||
160712494|NCT02906670|580326537|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
160712495|NCT02906670|580326538|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
160712496|NCT02906670|580326539|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
160712497|NCT02906670|580326540|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
160712498|NCT02906670|580326541|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
160712499|NCT02906670|580326542|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
160712500|NCT02906670|580326543|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
160712501|NCT02906670|580326544|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
160712502|NCT02906670|580326545|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
160712503|NCT02906670|580326546|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
160712504|NCT02906670|580326537|FG000|Cohort 4, Q2W|Radiological Progression|0|||
160712505|NCT02906670|580326538|FG001|Cohort 4, Q2W|Radiological Progression|0|||
160712506|NCT02906670|580326539|FG002|Cohort 4, Q2W|Radiological Progression|0|||
160712507|NCT02906670|580326540|FG003|Cohort 4, Q2W|Radiological Progression|0|||
160712508|NCT02906670|580326541|FG004|Cohort 4, Q2W|Radiological Progression|0|||
160712509|NCT02906670|580326542|FG005|Cohort 4, Q2W|Radiological Progression|1|||
160712510|NCT02906670|580326543|FG006|Cohort 4, Q2W|Radiological Progression|0|||
160712511|NCT02906670|580326544|FG007|Cohort 4, Q2W|Radiological Progression|0|||
160712512|NCT02906670|580326545|FG008|Cohort 4, Q2W|Radiological Progression|0|||
160712513|NCT02906670|580326546|FG009|Cohort 4, Q2W|Radiological Progression|0|||
160712514|NCT02906670|580326537|FG000|Cohort 4, Q2W|Clinical Progression|0|||
160712515|NCT02906670|580326538|FG001|Cohort 4, Q2W|Clinical Progression|0|||
160712516|NCT02906670|580326539|FG002|Cohort 4, Q2W|Clinical Progression|0|||
160712517|NCT02906670|580326540|FG003|Cohort 4, Q2W|Clinical Progression|0|||
160712518|NCT02906670|580326541|FG004|Cohort 4, Q2W|Clinical Progression|0|||
160712519|NCT02906670|580326542|FG005|Cohort 4, Q2W|Clinical Progression|2|||
160712520|NCT02906670|580326543|FG006|Cohort 4, Q2W|Clinical Progression|0|||
160712521|NCT02906670|580326544|FG007|Cohort 4, Q2W|Clinical Progression|0|||
160712522|NCT02906670|580326545|FG008|Cohort 4, Q2W|Clinical Progression|0|||
160712523|NCT02906670|580326546|FG009|Cohort 4, Q2W|Clinical Progression|0|||
160712524|NCT02906670|580326537|FG000|Cohort 5, Q2W|Radiological Progression|0|||
160712525|NCT02906670|580326538|FG001|Cohort 5, Q2W|Radiological Progression|0|||
160712526|NCT02906670|580326539|FG002|Cohort 5, Q2W|Radiological Progression|0|||
160712527|NCT02906670|580326540|FG003|Cohort 5, Q2W|Radiological Progression|0|||
160712528|NCT02906670|580326541|FG004|Cohort 5, Q2W|Radiological Progression|0|||
160712529|NCT02906670|580326542|FG005|Cohort 5, Q2W|Radiological Progression|0|||
160712530|NCT02906670|580326543|FG006|Cohort 5, Q2W|Radiological Progression|4|||
160712531|NCT02906670|580326544|FG007|Cohort 5, Q2W|Radiological Progression|0|||
160712532|NCT02906670|580326545|FG008|Cohort 5, Q2W|Radiological Progression|0|||
160712533|NCT02906670|580326546|FG009|Cohort 5, Q2W|Radiological Progression|0|||
160712534|NCT02906670|580326537|FG000|Cohort 5, Q2W|Clinical Progression|0|||
160712535|NCT02906670|580326538|FG001|Cohort 5, Q2W|Clinical Progression|0|||
160712536|NCT02906670|580326539|FG002|Cohort 5, Q2W|Clinical Progression|0|||
160712537|NCT02906670|580326540|FG003|Cohort 5, Q2W|Clinical Progression|0|||
160712538|NCT02906670|580326541|FG004|Cohort 5, Q2W|Clinical Progression|0|||
160712539|NCT02906670|580326542|FG005|Cohort 5, Q2W|Clinical Progression|0|||
160712540|NCT02906670|580326543|FG006|Cohort 5, Q2W|Clinical Progression|1|||
160712541|NCT02906670|580326544|FG007|Cohort 5, Q2W|Clinical Progression|0|||
160712542|NCT02906670|580326545|FG008|Cohort 5, Q2W|Clinical Progression|0|||
160712543|NCT02906670|580326546|FG009|Cohort 5, Q2W|Clinical Progression|0|||
160712544|NCT02906670|580326537|FG000|Cohort 5, Q2W|Adverse Event|0|||
160712545|NCT02906670|580326538|FG001|Cohort 5, Q2W|Adverse Event|0|||
160712546|NCT02906670|580326539|FG002|Cohort 5, Q2W|Adverse Event|0|||
160712547|NCT02906670|580326540|FG003|Cohort 5, Q2W|Adverse Event|0|||
160712548|NCT02906670|580326541|FG004|Cohort 5, Q2W|Adverse Event|0|||
160712549|NCT02906670|580326542|FG005|Cohort 5, Q2W|Adverse Event|0|||
160712550|NCT02906670|580326543|FG006|Cohort 5, Q2W|Adverse Event|1|||
160712551|NCT02906670|580326544|FG007|Cohort 5, Q2W|Adverse Event|0|||
160712552|NCT02906670|580326545|FG008|Cohort 5, Q2W|Adverse Event|0|||
160712553|NCT02906670|580326546|FG009|Cohort 5, Q2W|Adverse Event|0|||
160712554|NCT02906670|580326537|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
160712555|NCT02906670|580326538|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
160712556|NCT02906670|580326539|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
160712557|NCT02906670|580326540|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
160712558|NCT02906670|580326541|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
160712559|NCT02906670|580326542|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
160712560|NCT02906670|580326543|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
160712561|NCT02906670|580326544|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
160712562|NCT02906670|580326545|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
160712563|NCT02906670|580326546|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
160712564|NCT02906670|580326537|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
160712565|NCT02906670|580326538|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
160712566|NCT02906670|580326539|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
160712567|NCT02906670|580326540|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
160712568|NCT02906670|580326541|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
160712569|NCT02906670|580326542|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
160712570|NCT02906670|580326543|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
160712571|NCT02906670|580326544|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
160712572|NCT02906670|580326545|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
160712573|NCT02906670|580326546|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
160712574|NCT02906670|580326537|FG000|Cohort 5P, Q2W|Adverse Event|0|||
160712575|NCT02906670|580326538|FG001|Cohort 5P, Q2W|Adverse Event|0|||
160712576|NCT02906670|580326539|FG002|Cohort 5P, Q2W|Adverse Event|0|||
160712577|NCT02906670|580326540|FG003|Cohort 5P, Q2W|Adverse Event|0|||
160712578|NCT02906670|580326541|FG004|Cohort 5P, Q2W|Adverse Event|0|||
160712579|NCT02906670|580326542|FG005|Cohort 5P, Q2W|Adverse Event|0|||
160712580|NCT02906670|580326543|FG006|Cohort 5P, Q2W|Adverse Event|0|||
160712581|NCT02906670|580326544|FG007|Cohort 5P, Q2W|Adverse Event|1|||
160712582|NCT02906670|580326545|FG008|Cohort 5P, Q2W|Adverse Event|0|||
160712583|NCT02906670|580326546|FG009|Cohort 5P, Q2W|Adverse Event|0|||
160712584|NCT02906670|580326537|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
160712585|NCT02906670|580326538|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
160712586|NCT02906670|580326539|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
160712587|NCT02906670|580326540|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
160712588|NCT02906670|580326541|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
160712589|NCT02906670|580326542|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
160712590|NCT02906670|580326543|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
160712591|NCT02906670|580326544|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
160712592|NCT02906670|580326545|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
160712593|NCT02906670|580326546|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
160712594|NCT02906670|580326537|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
160712595|NCT02906670|580326538|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
160712596|NCT02906670|580326539|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
160712597|NCT02906670|580326540|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
160712598|NCT02906670|580326541|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
160712599|NCT02906670|580326542|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
160712600|NCT02906670|580326543|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
160712601|NCT02906670|580326544|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
160712602|NCT02906670|580326545|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
160712603|NCT02906670|580326546|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
160712604|NCT02906670|580326537|FG000|Cohort 4P, QW|Radiological Progression|0|||
160712605|NCT02906670|580326538|FG001|Cohort 4P, QW|Radiological Progression|0|||
160712606|NCT02906670|580326539|FG002|Cohort 4P, QW|Radiological Progression|0|||
160712607|NCT02906670|580326540|FG003|Cohort 4P, QW|Radiological Progression|3|||
160712608|NCT02906670|580326541|FG004|Cohort 4P, QW|Radiological Progression|0|||
160712609|NCT02906670|580326542|FG005|Cohort 4P, QW|Radiological Progression|0|||
160712610|NCT02906670|580326543|FG006|Cohort 4P, QW|Radiological Progression|0|||
160712611|NCT02906670|580326544|FG007|Cohort 4P, QW|Radiological Progression|0|||
160712612|NCT02906670|580326545|FG008|Cohort 4P, QW|Radiological Progression|0|||
160712613|NCT02906670|580326546|FG009|Cohort 4P, QW|Radiological Progression|0|||
160712614|NCT02906670|580326537|FG000|Cohort 7P, Q2W|Adverse Event|0|||
160712615|NCT02906670|580326538|FG001|Cohort 7P, Q2W|Adverse Event|0|||
160712616|NCT02906670|580326539|FG002|Cohort 7P, Q2W|Adverse Event|0|||
160712617|NCT02906670|580326540|FG003|Cohort 7P, Q2W|Adverse Event|0|||
160712618|NCT02906670|580326541|FG004|Cohort 7P, Q2W|Adverse Event|0|||
160712619|NCT02906670|580326542|FG005|Cohort 7P, Q2W|Adverse Event|0|||
160712620|NCT02906670|580326543|FG006|Cohort 7P, Q2W|Adverse Event|0|||
160712621|NCT02906670|580326544|FG007|Cohort 7P, Q2W|Adverse Event|0|||
160712622|NCT02906670|580326545|FG008|Cohort 7P, Q2W|Adverse Event|0|||
160712623|NCT02906670|580326546|FG009|Cohort 7P, Q2W|Adverse Event|1|||
160712624|NCT02906670|580326537|FG000|Cohort 7P, Q2W|Physician Decision|0|||
160712625|NCT02906670|580326538|FG001|Cohort 7P, Q2W|Physician Decision|0|||
160712626|NCT02906670|580326539|FG002|Cohort 7P, Q2W|Physician Decision|0|||
160712627|NCT02906670|580326540|FG003|Cohort 7P, Q2W|Physician Decision|0|||
160712628|NCT02906670|580326541|FG004|Cohort 7P, Q2W|Physician Decision|0|||
160712629|NCT02906670|580326542|FG005|Cohort 7P, Q2W|Physician Decision|0|||
160712630|NCT02906670|580326543|FG006|Cohort 7P, Q2W|Physician Decision|0|||
160712631|NCT02906670|580326544|FG007|Cohort 7P, Q2W|Physician Decision|0|||
160712632|NCT02906670|580326545|FG008|Cohort 7P, Q2W|Physician Decision|0|||
160712633|NCT02906670|580326546|FG009|Cohort 7P, Q2W|Physician Decision|1|||
160712634|NCT02906670|580326537|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
160712635|NCT02906670|580326538|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
160712636|NCT02906670|580326539|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
160712637|NCT02906670|580326540|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
160712638|NCT02906670|580326541|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
160712639|NCT02906670|580326542|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
160712640|NCT02906670|580326543|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
160712641|NCT02906670|580326544|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
160712642|NCT02906670|580326545|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
160712643|NCT02906670|580326546|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
160712644|NCT02906670|580326537|FG000|Cohort 5P, QW|Radiological Progression|0|||
160712645|NCT02906670|580326538|FG001|Cohort 5P, QW|Radiological Progression|0|||
160712646|NCT02906670|580326539|FG002|Cohort 5P, QW|Radiological Progression|0|||
160712647|NCT02906670|580326540|FG003|Cohort 5P, QW|Radiological Progression|0|||
160712648|NCT02906670|580326541|FG004|Cohort 5P, QW|Radiological Progression|3|||
160712649|NCT02906670|580326542|FG005|Cohort 5P, QW|Radiological Progression|0|||
160712650|NCT02906670|580326543|FG006|Cohort 5P, QW|Radiological Progression|0|||
160712651|NCT02906670|580326544|FG007|Cohort 5P, QW|Radiological Progression|0|||
160712652|NCT02906670|580326545|FG008|Cohort 5P, QW|Radiological Progression|0|||
160712653|NCT02906670|580326546|FG009|Cohort 5P, QW|Radiological Progression|0|||
160712654|NCT01349192|580326547|FG000|Overall Study|Protocol Violation|0|||
160712655|NCT01349192|580326548|FG001|Overall Study|Protocol Violation|1|||
160712656|NCT01349192|580326547|FG000|Overall Study|Withdrawal by Subject|0|||
160712657|NCT01349192|580326548|FG001|Overall Study|Withdrawal by Subject|2|||
160712658|NCT01349192|580326547|FG000|Overall Study|Lost to Follow-up|1|||
160712659|NCT01349192|580326548|FG001|Overall Study|Lost to Follow-up|3|||
160712660|NCT01349192|580326547|FG000|Overall Study|Failure to adhere to Protocol|2|||
160712661|NCT01349192|580326548|FG001|Overall Study|Failure to adhere to Protocol|0|||
160712662|NCT03749330|580326549|FG000|Overall Study|Clinicians left work in the CICU|0|||
160712663|NCT03749330|580326550|FG001|Overall Study|Clinicians left work in the CICU|2|||
160712664|NCT03749330|580326551|FG002|Overall Study|Clinicians left work in the CICU|0|||
160712665|NCT03749330|580326552|FG003|Overall Study|Clinicians left work in the CICU|0|||
160712666|NCT03749330|580326553|FG004|Overall Study|Clinicians left work in the CICU|0|||
160712667|NCT03749330|580326554|FG005|Overall Study|Clinicians left work in the CICU|0|||
160712668|NCT01973439|580326555|FG000|Overall Study|Lost samples from one PK Day|2|||
160712669|NCT01973439|580326555|FG000|Overall Study|Vomiting after commencing once daily|1|||
160712670|NCT01973439|580326555|FG000|Overall Study|PK curve incomplete|2|||
160712671|NCT02105467|580326558|FG000|Period 1|Lost to Follow-up|1|||
160712672|NCT02105467|580326559|FG001|Period 1|Lost to Follow-up|0|||
160712673|NCT02105467|580326558|FG000|Period 1|Death|1|||
160712674|NCT02105467|580326559|FG001|Period 1|Death|0|||
160712675|NCT02105467|580326558|FG000|Period 2|Lost to Follow-up|1|||
160712676|NCT02105467|580326559|FG001|Period 2|Lost to Follow-up|0|||
160712677|NCT02105467|580326558|FG000|Period 2|Death|1|||
160712678|NCT02105467|580326559|FG001|Period 2|Death|0|||
160712679|NCT02105467|580326558|FG000|Period 2|Withdrawal by Subject|0|||
160712680|NCT02105467|580326559|FG001|Period 2|Withdrawal by Subject|2|||
160712681|NCT02105467|580326558|FG000|Period 3|Lost to Follow-up|0|||
160712682|NCT02105467|580326559|FG001|Period 3|Lost to Follow-up|1|||
160712683|NCT03908125|580326560|FG000|Overall Study|Withdrawal by Subject|92|||
160712684|NCT03908125|580326560|FG000|Overall Study|Lost to Follow-up|8|||
160712685|NCT02262325|580326561|FG000|Overall Study|Death|16|||
160712686|NCT02262325|580326561|FG000|Overall Study|Lost to Follow-up|1|||
160712687|NCT02815995|580326562|FG000|Overall Study|Disease Progression|3|||
160712688|NCT02815995|580326563|FG001|Overall Study|Disease Progression|7|||
160712689|NCT02815995|580326564|FG002|Overall Study|Disease Progression|2|||
160712690|NCT02815995|580326565|FG003|Overall Study|Disease Progression|4|||
160712691|NCT02815995|580326566|FG004|Overall Study|Disease Progression|3|||
160712692|NCT02815995|580326567|FG005|Overall Study|Disease Progression|9|||
160712693|NCT02815995|580326568|FG006|Overall Study|Disease Progression|3|||
160712694|NCT02815995|580326569|FG007|Overall Study|Disease Progression|1|||
160712695|NCT02815995|580326562|FG000|Overall Study|Adverse Event|1|||
160712696|NCT02815995|580326563|FG001|Overall Study|Adverse Event|2|||
160712697|NCT02815995|580326564|FG002|Overall Study|Adverse Event|2|||
160712698|NCT02815995|580326565|FG003|Overall Study|Adverse Event|0|||
160712699|NCT02815995|580326566|FG004|Overall Study|Adverse Event|0|||
160712700|NCT02815995|580326567|FG005|Overall Study|Adverse Event|1|||
160712701|NCT02815995|580326568|FG006|Overall Study|Adverse Event|0|||
160712702|NCT02815995|580326569|FG007|Overall Study|Adverse Event|0|||
160712703|NCT02815995|580326562|FG000|Overall Study|Pregnancy|0|||
160712704|NCT02815995|580326563|FG001|Overall Study|Pregnancy|0|||
160712705|NCT02815995|580326564|FG002|Overall Study|Pregnancy|0|||
160712706|NCT02815995|580326565|FG003|Overall Study|Pregnancy|0|||
160712707|NCT02815995|580326566|FG004|Overall Study|Pregnancy|0|||
160712708|NCT02815995|580326567|FG005|Overall Study|Pregnancy|0|||
160712709|NCT02815995|580326568|FG006|Overall Study|Pregnancy|1|||
160712710|NCT02815995|580326569|FG007|Overall Study|Pregnancy|0|||
160712711|NCT01071915|580326573|FG000|Overall Study|Adverse Event|3|||
160712712|NCT01071915|580326573|FG000|Overall Study|Physician Decision|2|||
160712713|NCT01071915|580326573|FG000|Overall Study|Withdrawal by Subject|2|||
160712714|NCT01071915|580326573|FG000|Overall Study|Miscellaneous Reasons|2|||
160712715|NCT00344448|580326574|FG000|Screening|Withdrawal by Subject|0|||
160712716|NCT00344448|580326575|FG001|Screening|Withdrawal by Subject|1|||
160712717|NCT00344448|580326574|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
160712718|NCT00344448|580326575|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
160712719|NCT00344448|580326574|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
160712720|NCT00344448|580326575|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
160712721|NCT00344448|580326574|FG000|Open Label|Withdrawal by Subject|1|||
160712722|NCT00344448|580326575|FG001|Open Label|Withdrawal by Subject|1|||
160712723|NCT00344448|580326574|FG000|Open Label|Study terminated|1|||
160712724|NCT00344448|580326575|FG001|Open Label|Study terminated|0|||
160712735|NCT03519087|580326579|FG000|Clinic Evaluation|Physician Decision|15|||
160712736|NCT03519087|580326580|FG001|Clinic Evaluation|Physician Decision|18|||
160712737|NCT03519087|580326581|FG002|Clinic Evaluation|Physician Decision|0|||
160712738|NCT03519087|580326582|FG003|Clinic Evaluation|Physician Decision|0|||
160712739|NCT03519087|580326583|FG004|Clinic Evaluation|Physician Decision|0|||
160712740|NCT03519087|580326579|FG000|Clinic Evaluation|Protocol Violation|1|||
160712741|NCT03519087|580326580|FG001|Clinic Evaluation|Protocol Violation|0|||
160712742|NCT03519087|580326581|FG002|Clinic Evaluation|Protocol Violation|0|||
160712743|NCT03519087|580326582|FG003|Clinic Evaluation|Protocol Violation|0|||
160712744|NCT03519087|580326583|FG004|Clinic Evaluation|Protocol Violation|0|||
160712745|NCT03519087|580326579|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
160712746|NCT03519087|580326580|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
160712747|NCT03519087|580326581|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
160712748|NCT03519087|580326582|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
160712749|NCT03519087|580326583|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
160712750|NCT03519087|580326579|FG000|Re-randomization for Treatment|Not appropriate|2|||
160712751|NCT03519087|580326580|FG001|Re-randomization for Treatment|Not appropriate|3|||
160712752|NCT03519087|580326581|FG002|Re-randomization for Treatment|Not appropriate|0|||
160712753|NCT03519087|580326582|FG003|Re-randomization for Treatment|Not appropriate|0|||
160712754|NCT03519087|580326583|FG004|Re-randomization for Treatment|Not appropriate|0|||
160712755|NCT03519087|580326579|FG000|Laboratory Testing|Lost to Follow-up|0|||
160712756|NCT03519087|580326580|FG001|Laboratory Testing|Lost to Follow-up|0|||
160712757|NCT03519087|580326581|FG002|Laboratory Testing|Lost to Follow-up|2|||
160712758|NCT03519087|580326582|FG003|Laboratory Testing|Lost to Follow-up|3|||
160712759|NCT03519087|580326583|FG004|Laboratory Testing|Lost to Follow-up|6|||
160712760|NCT03519087|580326579|FG000|Laboratory Testing|Protocol Violation|0|||
160712761|NCT03519087|580326580|FG001|Laboratory Testing|Protocol Violation|0|||
160712762|NCT03519087|580326581|FG002|Laboratory Testing|Protocol Violation|0|||
160712763|NCT03519087|580326582|FG003|Laboratory Testing|Protocol Violation|1|||
160712764|NCT03519087|580326583|FG004|Laboratory Testing|Protocol Violation|0|||
160712765|NCT01137071|580326584|FG000|Overall Study|Disease Progression|11|||
160712766|NCT01137071|580326584|FG000|Overall Study|Withdrawal by Subject|2|||
160712767|NCT01137071|580326584|FG000|Overall Study|Wrongly Included|1|||
160712768|NCT04807400|580326585|FG000|Overall Study|Adverse Event|2|||
160712769|NCT04807400|580326586|FG001|Overall Study|Adverse Event|3|||
160712770|NCT04807400|580326587|FG002|Overall Study|Adverse Event|3|||
160712771|NCT04807400|580326585|FG000|Overall Study|Death|2|||
160712772|NCT04807400|580326586|FG001|Overall Study|Death|0|||
160712773|NCT04807400|580326587|FG002|Overall Study|Death|0|||
160712774|NCT04807400|580326585|FG000|Overall Study|Lost to Follow-up|8|||
160712775|NCT04807400|580326586|FG001|Overall Study|Lost to Follow-up|6|||
160712776|NCT04807400|580326587|FG002|Overall Study|Lost to Follow-up|6|||
160712777|NCT04807400|580326585|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160712778|NCT04807400|580326586|FG001|Overall Study|Non-Compliance With Study Drug|4|||
160712779|NCT04807400|580326587|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160712780|NCT04807400|580326585|FG000|Overall Study|Participant Decision|20|||
160712781|NCT04807400|580326586|FG001|Overall Study|Participant Decision|19|||
160712782|NCT04807400|580326587|FG002|Overall Study|Participant Decision|26|||
160712783|NCT04807400|580326585|FG000|Overall Study|Physician Decision|0|||
160712784|NCT04807400|580326586|FG001|Overall Study|Physician Decision|1|||
160712785|NCT04807400|580326587|FG002|Overall Study|Physician Decision|0|||
160712786|NCT04807400|580326585|FG000|Overall Study|Protocol Violation|4|||
160712787|NCT04807400|580326586|FG001|Overall Study|Protocol Violation|3|||
160712788|NCT04807400|580326587|FG002|Overall Study|Protocol Violation|7|||
160712789|NCT04807400|580326585|FG000|Overall Study|Withdrawal by Subject|13|||
160712790|NCT04807400|580326586|FG001|Overall Study|Withdrawal by Subject|9|||
160712791|NCT04807400|580326587|FG002|Overall Study|Withdrawal by Subject|20|||
160712792|NCT04807400|580326585|FG000|Overall Study|Mis-randomized|1|||
160712793|NCT04807400|580326586|FG001|Overall Study|Mis-randomized|0|||
160712794|NCT04807400|580326587|FG002|Overall Study|Mis-randomized|0|||
160712795|NCT04194645|580326588|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712796|NCT04194645|580326589|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712797|NCT04194645|580326590|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712798|NCT04194645|580326591|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712799|NCT04194645|580326592|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712800|NCT04194645|580326593|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712801|NCT04194645|580326594|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712802|NCT04194645|580326595|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712803|NCT04194645|580326596|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712804|NCT04194645|580326597|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
160712805|NCT04194645|580326598|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712806|NCT04194645|580326599|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712807|NCT04194645|580326600|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712808|NCT04194645|580326601|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712809|NCT04194645|580326602|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
160712810|NCT03656744|580326603|FG000|Overall Study|Adverse Event|1|||
160712811|NCT03656744|580326604|FG001|Overall Study|Adverse Event|4|||
160712812|NCT03656744|580326605|FG002|Overall Study|Adverse Event|1|||
160712813|NCT03656744|580326603|FG000|Overall Study|Protocol Violation|1|||
160712814|NCT03656744|580326604|FG001|Overall Study|Protocol Violation|0|||
160712815|NCT03656744|580326605|FG002|Overall Study|Protocol Violation|0|||
160712816|NCT03656744|580326603|FG000|Overall Study|Lost to Follow-up|2|||
160712817|NCT03656744|580326604|FG001|Overall Study|Lost to Follow-up|2|||
160712818|NCT03656744|580326605|FG002|Overall Study|Lost to Follow-up|0|||
160712819|NCT03656744|580326603|FG000|Overall Study|Withdrawal by Subject|0|||
160712820|NCT03656744|580326604|FG001|Overall Study|Withdrawal by Subject|1|||
160712821|NCT03656744|580326605|FG002|Overall Study|Withdrawal by Subject|0|||
160712822|NCT03656744|580326603|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
160712823|NCT03656744|580326604|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
160712824|NCT03656744|580326605|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
160712825|NCT03076775|580326606|FG000|Overall Study|Lost to Follow-up|1|||
160712826|NCT03076775|580326607|FG001|Overall Study|Lost to Follow-up|0|||
160712827|NCT02290405|580326608|FG000|Overall Study|Withdrawal by Subject|1|||
160712828|NCT02290405|580326609|FG001|Overall Study|Withdrawal by Subject|0|||
160712829|NCT03142191|580326610|FG000|Placebo Controlled Period|Death|0|||
160712830|NCT03142191|580326611|FG001|Placebo Controlled Period|Death|1|||
160712831|NCT03142191|580326612|FG002|Placebo Controlled Period|Death|1|||
160712832|NCT03142191|580326613|FG003|Placebo Controlled Period|Death|0|||
160712833|NCT03142191|580326614|FG004|Placebo Controlled Period|Death|0|||
160712834|NCT03142191|580326610|FG000|Placebo Controlled Period|Adverse Event|4|||
160712835|NCT03142191|580326611|FG001|Placebo Controlled Period|Adverse Event|5|||
160712836|NCT03142191|580326612|FG002|Placebo Controlled Period|Adverse Event|1|||
160712837|NCT03142191|580326613|FG003|Placebo Controlled Period|Adverse Event|0|||
160712838|NCT03142191|580326614|FG004|Placebo Controlled Period|Adverse Event|0|||
160712839|NCT03142191|580326610|FG000|Placebo Controlled Period|Progressive Disease|1|||
160712840|NCT03142191|580326611|FG001|Placebo Controlled Period|Progressive Disease|0|||
160712841|NCT03142191|580326612|FG002|Placebo Controlled Period|Progressive Disease|1|||
160712842|NCT03142191|580326613|FG003|Placebo Controlled Period|Progressive Disease|0|||
160712843|NCT03142191|580326614|FG004|Placebo Controlled Period|Progressive Disease|0|||
160712844|NCT03142191|580326610|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
160712845|NCT03142191|580326611|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
160712846|NCT03142191|580326612|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
160712847|NCT03142191|580326613|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
160712848|NCT03142191|580326614|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
160712849|NCT03142191|580326610|FG000|Placebo Controlled Period|Other Reasons|1|||
160712850|NCT03142191|580326611|FG001|Placebo Controlled Period|Other Reasons|0|||
160712851|NCT03142191|580326612|FG002|Placebo Controlled Period|Other Reasons|0|||
160712852|NCT03142191|580326613|FG003|Placebo Controlled Period|Other Reasons|0|||
160712853|NCT03142191|580326614|FG004|Placebo Controlled Period|Other Reasons|0|||
160712854|NCT03142191|580326610|FG000|Active Treatment Extension Period|Death|2|||
160712855|NCT03142191|580326611|FG001|Active Treatment Extension Period|Death|1|||
160712856|NCT03142191|580326612|FG002|Active Treatment Extension Period|Death|1|||
160712857|NCT03142191|580326613|FG003|Active Treatment Extension Period|Death|1|||
160712858|NCT03142191|580326614|FG004|Active Treatment Extension Period|Death|0|||
160712859|NCT03142191|580326610|FG000|Active Treatment Extension Period|Adverse Event|6|||
160712860|NCT03142191|580326611|FG001|Active Treatment Extension Period|Adverse Event|5|||
160712861|NCT03142191|580326612|FG002|Active Treatment Extension Period|Adverse Event|4|||
160712862|NCT03142191|580326613|FG003|Active Treatment Extension Period|Adverse Event|1|||
160712863|NCT03142191|580326614|FG004|Active Treatment Extension Period|Adverse Event|0|||
160712864|NCT03142191|580326610|FG000|Active Treatment Extension Period|Progressive Disease|10|||
160712865|NCT03142191|580326611|FG001|Active Treatment Extension Period|Progressive Disease|5|||
160712866|NCT03142191|580326612|FG002|Active Treatment Extension Period|Progressive Disease|4|||
160712867|NCT03142191|580326613|FG003|Active Treatment Extension Period|Progressive Disease|1|||
160712868|NCT03142191|580326614|FG004|Active Treatment Extension Period|Progressive Disease|2|||
160712869|NCT03142191|580326610|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
160712870|NCT03142191|580326611|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
160712871|NCT03142191|580326612|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
160712872|NCT03142191|580326613|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
160712873|NCT03142191|580326614|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
160712874|NCT03142191|580326610|FG000|Active Treatment Extension Period|Physician Decision|2|||
160712875|NCT03142191|580326611|FG001|Active Treatment Extension Period|Physician Decision|0|||
160712876|NCT03142191|580326612|FG002|Active Treatment Extension Period|Physician Decision|0|||
160712877|NCT03142191|580326613|FG003|Active Treatment Extension Period|Physician Decision|0|||
160712878|NCT03142191|580326614|FG004|Active Treatment Extension Period|Physician Decision|0|||
160712879|NCT03142191|580326610|FG000|Active Treatment Extension Period|Other Reasons|3|||
160712880|NCT03142191|580326611|FG001|Active Treatment Extension Period|Other Reasons|3|||
160712881|NCT03142191|580326612|FG002|Active Treatment Extension Period|Other Reasons|3|||
160712882|NCT03142191|580326613|FG003|Active Treatment Extension Period|Other Reasons|8|||
160712883|NCT03142191|580326614|FG004|Active Treatment Extension Period|Other Reasons|3|||
160712884|NCT03142191|580326610|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
160712885|NCT03142191|580326611|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
160712886|NCT03142191|580326612|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
160712887|NCT03142191|580326613|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
160712888|NCT03142191|580326614|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
160712889|NCT03541317|580326615|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
160712890|NCT03541317|580326616|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
160712891|NCT03541317|580326617|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
160712892|NCT03541317|580326618|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
160712893|NCT03541317|580326619|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
160712894|NCT03541317|580326620|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
160712895|NCT00879086|580326623|FG000|Overall Study|Adverse Event|3|||
160712896|NCT00879086|580326624|FG001|Overall Study|Adverse Event|15|||
160712897|NCT00879086|580326623|FG000|Overall Study|Participant choice|2|||
160712898|NCT00879086|580326624|FG001|Overall Study|Participant choice|2|||
160712899|NCT00879086|580326623|FG000|Overall Study|Progression of disease|40|||
160712900|NCT00879086|580326624|FG001|Overall Study|Progression of disease|26|||
160712901|NCT00879086|580326623|FG000|Overall Study|Withdrawal of consent|2|||
160712902|NCT00879086|580326624|FG001|Overall Study|Withdrawal of consent|1|||
160712903|NCT00879086|580326623|FG000|Overall Study|Other|4|||
160712904|NCT00879086|580326624|FG001|Overall Study|Other|6|||
160712905|NCT00879086|580326623|FG000|Overall Study|Death|1|||
160712906|NCT00879086|580326624|FG001|Overall Study|Death|2|||
160712907|NCT04728802|580326625|FG000|Overall Study|Withdrawal by Subject|4|||
160712908|NCT04728802|580326626|FG001|Overall Study|Withdrawal by Subject|20|||
160712909|NCT04728802|580326625|FG000|Overall Study|Physician Decision|7|||
160712910|NCT04728802|580326626|FG001|Overall Study|Physician Decision|7|||
160712911|NCT04728802|580326625|FG000|Overall Study|Protocol Violation|10|||
160712912|NCT04728802|580326626|FG001|Overall Study|Protocol Violation|4|||
160712913|NCT04728802|580326625|FG000|Overall Study|Transfer|1|||
160712914|NCT04728802|580326626|FG001|Overall Study|Transfer|0|||
160712915|NCT04728802|580326625|FG000|Overall Study|Death|4|||
160712916|NCT04728802|580326626|FG001|Overall Study|Death|5|||
160712917|NCT04728802|580326625|FG000|Overall Study|Other|3|||
160712918|NCT04728802|580326626|FG001|Overall Study|Other|0|||
160712919|NCT02286843|580326629|FG000|Overall Study|Not Treated|4|||
160712920|NCT02286843|580326629|FG000|Overall Study|Protocol Violation|1|||
160712921|NCT02286843|580326629|FG000|Overall Study|Withdrawal by Subject|1|||
160712922|NCT02536846|580326630|FG000|Overall Study|Withdrawal by Subject|1|||
160712923|NCT01070953|580326633|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
160712924|NCT01070953|580326633|FG000|Participants for Safety Evaluation|Off-label use|283|||
160712925|NCT01070953|580326633|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
160712926|NCT01070953|580326633|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
160712927|NCT01070953|580326633|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
160712928|NCT01070953|580326633|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
160712929|NCT01070953|580326633|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
160712930|NCT01070953|580326633|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
160712931|NCT01070953|580326633|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
160712932|NCT01070953|580326633|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
160712933|NCT04700137|580326634|FG000|Overall Study|Lost to Follow-up|1|||
160712934|NCT04700137|580326635|FG001|Overall Study|Lost to Follow-up|6|||
160712935|NCT04700137|580326636|FG002|Overall Study|Lost to Follow-up|1|||
160712936|NCT04700137|580326637|FG003|Overall Study|Lost to Follow-up|1|||
160712937|NCT04700137|580326634|FG000|Overall Study|Withdrawal by Subject|0|||
160712938|NCT04700137|580326635|FG001|Overall Study|Withdrawal by Subject|0|||
160712939|NCT04700137|580326636|FG002|Overall Study|Withdrawal by Subject|1|||
160712940|NCT04700137|580326637|FG003|Overall Study|Withdrawal by Subject|0|||
160712941|NCT04700137|580326634|FG000|Overall Study|Death|0|||
160712942|NCT04700137|580326635|FG001|Overall Study|Death|0|||
160712943|NCT04700137|580326636|FG002|Overall Study|Death|1|||
160712944|NCT04700137|580326637|FG003|Overall Study|Death|0|||
160712945|NCT03449446|580326640|FG000|Overall Study|Randomized but Never Treated|0|||
160712946|NCT03449446|580326641|FG001|Overall Study|Randomized but Never Treated|0|||
160712947|NCT03449446|580326642|FG002|Overall Study|Randomized but Never Treated|1|||
160712948|NCT03449446|580326643|FG003|Overall Study|Randomized but Never Treated|1|||
160712949|NCT03449446|580326644|FG004|Overall Study|Randomized but Never Treated|1|||
160712950|NCT03449446|580326645|FG005|Overall Study|Randomized but Never Treated|0|||
160712951|NCT03449446|580326646|FG006|Overall Study|Randomized but Never Treated|0|||
160712952|NCT03449446|580326640|FG000|Overall Study|Unknown Reason|33|||
160712953|NCT03449446|580326641|FG001|Overall Study|Unknown Reason|1|||
160712954|NCT03449446|580326642|FG002|Overall Study|Unknown Reason|1|||
160712955|NCT03449446|580326643|FG003|Overall Study|Unknown Reason|1|||
160712956|NCT03449446|580326644|FG004|Overall Study|Unknown Reason|2|||
160712957|NCT03449446|580326645|FG005|Overall Study|Unknown Reason|2|||
160712958|NCT03449446|580326646|FG006|Overall Study|Unknown Reason|0|||
160712959|NCT03449446|580326640|FG000|Overall Study|Withdrew Consent|1|||
160712960|NCT03449446|580326641|FG001|Overall Study|Withdrew Consent|3|||
160712961|NCT03449446|580326642|FG002|Overall Study|Withdrew Consent|1|||
160712962|NCT03449446|580326643|FG003|Overall Study|Withdrew Consent|4|||
160712963|NCT03449446|580326644|FG004|Overall Study|Withdrew Consent|4|||
160712964|NCT03449446|580326645|FG005|Overall Study|Withdrew Consent|4|||
160712965|NCT03449446|580326646|FG006|Overall Study|Withdrew Consent|1|||
160712966|NCT03449446|580326640|FG000|Overall Study|Adverse Event|1|||
160712967|NCT03449446|580326641|FG001|Overall Study|Adverse Event|2|||
160712968|NCT03449446|580326642|FG002|Overall Study|Adverse Event|1|||
160712969|NCT03449446|580326643|FG003|Overall Study|Adverse Event|0|||
160712970|NCT03449446|580326644|FG004|Overall Study|Adverse Event|0|||
160712971|NCT03449446|580326645|FG005|Overall Study|Adverse Event|2|||
160712972|NCT03449446|580326646|FG006|Overall Study|Adverse Event|0|||
160712973|NCT03449446|580326640|FG000|Overall Study|Lost to Follow-up|0|||
160712974|NCT03449446|580326641|FG001|Overall Study|Lost to Follow-up|0|||
160712975|NCT03449446|580326642|FG002|Overall Study|Lost to Follow-up|2|||
160712976|NCT03449446|580326643|FG003|Overall Study|Lost to Follow-up|1|||
160712977|NCT03449446|580326644|FG004|Overall Study|Lost to Follow-up|3|||
160712978|NCT03449446|580326645|FG005|Overall Study|Lost to Follow-up|0|||
160712979|NCT03449446|580326646|FG006|Overall Study|Lost to Follow-up|0|||
160712980|NCT03449446|580326640|FG000|Overall Study|Investigator's Discretion|0|||
160712981|NCT03449446|580326641|FG001|Overall Study|Investigator's Discretion|1|||
160712982|NCT03449446|580326642|FG002|Overall Study|Investigator's Discretion|1|||
160712983|NCT03449446|580326643|FG003|Overall Study|Investigator's Discretion|2|||
160712984|NCT03449446|580326644|FG004|Overall Study|Investigator's Discretion|0|||
160712985|NCT03449446|580326645|FG005|Overall Study|Investigator's Discretion|0|||
160712986|NCT03449446|580326646|FG006|Overall Study|Investigator's Discretion|0|||
160712987|NCT03449446|580326640|FG000|Overall Study|Non Compliance with Study Drug|1|||
160712988|NCT03449446|580326641|FG001|Overall Study|Non Compliance with Study Drug|0|||
160712989|NCT03449446|580326642|FG002|Overall Study|Non Compliance with Study Drug|0|||
160712990|NCT03449446|580326643|FG003|Overall Study|Non Compliance with Study Drug|0|||
160712991|NCT03449446|580326644|FG004|Overall Study|Non Compliance with Study Drug|0|||
160712992|NCT03449446|580326645|FG005|Overall Study|Non Compliance with Study Drug|0|||
160712993|NCT03449446|580326646|FG006|Overall Study|Non Compliance with Study Drug|0|||
160712994|NCT03449446|580326640|FG000|Overall Study|Protocol Violation|0|||
160712995|NCT03449446|580326641|FG001|Overall Study|Protocol Violation|0|||
160712996|NCT03449446|580326642|FG002|Overall Study|Protocol Violation|0|||
160712997|NCT03449446|580326643|FG003|Overall Study|Protocol Violation|0|||
160712998|NCT03449446|580326644|FG004|Overall Study|Protocol Violation|1|||
160712999|NCT03449446|580326645|FG005|Overall Study|Protocol Violation|1|||
160713000|NCT03449446|580326646|FG006|Overall Study|Protocol Violation|0|||
160713001|NCT03449446|580326640|FG000|Overall Study|Death|0|||
160713002|NCT03449446|580326641|FG001|Overall Study|Death|0|||
160713003|NCT03449446|580326642|FG002|Overall Study|Death|0|||
160713004|NCT03449446|580326643|FG003|Overall Study|Death|0|||
160713005|NCT03449446|580326644|FG004|Overall Study|Death|1|||
160713006|NCT03449446|580326645|FG005|Overall Study|Death|0|||
160713007|NCT03449446|580326646|FG006|Overall Study|Death|0|||
160713008|NCT03180645|580326659|FG000|Overall Study|Adverse Event|0|||
160713009|NCT03180645|580326660|FG001|Overall Study|Adverse Event|1|||
160713010|NCT03180645|580326661|FG002|Overall Study|Adverse Event|2|||
160713011|NCT04208750|580326662|FG000|Overall Study|Lost to Follow-up|16|||
160713012|NCT04208750|580326663|FG001|Overall Study|Lost to Follow-up|15|||
160713013|NCT02201277|580326664|FG000|Overall Study|Death|3|||
160713014|NCT02201277|580326665|FG001|Overall Study|Death|4|||
160713015|NCT02201277|580326664|FG000|Overall Study|Lost to Follow-up|2|||
160713016|NCT02201277|580326665|FG001|Overall Study|Lost to Follow-up|1|||
160713017|NCT02201277|580326664|FG000|Overall Study|Failed retrieval|1|||
160713018|NCT02201277|580326665|FG001|Overall Study|Failed retrieval|0|||
160713019|NCT02201277|580326664|FG000|Overall Study|Physician Decision|1|||
160713020|NCT02201277|580326665|FG001|Overall Study|Physician Decision|0|||
160713021|NCT05022212|580326668|FG000|Overall Study|Lost to Follow-up|0|||
160713022|NCT05022212|580326669|FG001|Overall Study|Lost to Follow-up|2|||
160713023|NCT02905032|580326670|FG000|Overall Study|Withdrawal by Subject|2|||
160713024|NCT02905032|580326671|FG001|Overall Study|Withdrawal by Subject|0|||
160713025|NCT02905032|580326672|FG002|Overall Study|Withdrawal by Subject|0|||
160713026|NCT02905032|580326670|FG000|Overall Study|Protocol Violation|6|||
160713027|NCT02905032|580326671|FG001|Overall Study|Protocol Violation|12|||
160713028|NCT02905032|580326672|FG002|Overall Study|Protocol Violation|0|||
160713029|NCT03713593|580328018|FG000|Overall Study|Sponsor Decision|73|||
160713030|NCT03713593|580328019|FG001|Overall Study|Sponsor Decision|41|||
160713031|NCT03713593|580328018|FG000|Overall Study|Lost to Follow-up|2|||
160713032|NCT03713593|580328019|FG001|Overall Study|Lost to Follow-up|1|||
160713033|NCT03713593|580328018|FG000|Overall Study|Death|314|||
160713034|NCT03713593|580328019|FG001|Overall Study|Death|349|||
160713035|NCT03713593|580328018|FG000|Overall Study|Withdrawal by Subject|6|||
160713036|NCT03713593|580328019|FG001|Overall Study|Withdrawal by Subject|8|||
160713037|NCT05126693|580328020|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
160713038|NCT05126693|580328021|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
160713039|NCT05126693|580328020|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
160713040|NCT05126693|580328021|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
160713041|NCT05126693|580328020|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
160713042|NCT05126693|580328021|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
160713043|NCT05061134|580328022|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
160713044|NCT05061134|580328023|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
160713045|NCT05061134|580328024|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
160713046|NCT05061134|580328022|FG000|Overall Study|Subject not treated|0|||
160713047|NCT05061134|580328023|FG001|Overall Study|Subject not treated|0|||
160713048|NCT05061134|580328024|FG002|Overall Study|Subject not treated|2|||
160713049|NCT05061134|580328022|FG000|Overall Study|Other|0|||
160713050|NCT05061134|580328023|FG001|Overall Study|Other|0|||
160713051|NCT05061134|580328024|FG002|Overall Study|Other|9|||
160713052|NCT05061134|580328022|FG000|Overall Study|Withdrawal by Subject|9|||
160713053|NCT05061134|580328023|FG001|Overall Study|Withdrawal by Subject|8|||
160713054|NCT05061134|580328024|FG002|Overall Study|Withdrawal by Subject|5|||
160713055|NCT05061134|580328022|FG000|Overall Study|Study Terminated by Sponsor|22|||
160713056|NCT05061134|580328023|FG001|Overall Study|Study Terminated by Sponsor|14|||
160713057|NCT05061134|580328024|FG002|Overall Study|Study Terminated by Sponsor|7|||
160713058|NCT05061134|580328022|FG000|Overall Study|Progressive Disease|1|||
160713059|NCT05061134|580328023|FG001|Overall Study|Progressive Disease|2|||
160713060|NCT05061134|580328024|FG002|Overall Study|Progressive Disease|0|||
160713061|NCT05061134|580328022|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
160713062|NCT05061134|580328023|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
160713063|NCT05061134|580328024|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
160713064|NCT05061134|580328022|FG000|Overall Study|Lost to Follow-up|1|||
160713065|NCT05061134|580328023|FG001|Overall Study|Lost to Follow-up|0|||
160713066|NCT05061134|580328024|FG002|Overall Study|Lost to Follow-up|0|||
160713067|NCT05061134|580328022|FG000|Overall Study|Physician Decision|1|||
160713068|NCT05061134|580328023|FG001|Overall Study|Physician Decision|1|||
160713069|NCT05061134|580328024|FG002|Overall Study|Physician Decision|0|||
160713070|NCT05061134|580328022|FG000|Overall Study|Disease progression|1|||
160713071|NCT05061134|580328023|FG001|Overall Study|Disease progression|0|||
160713072|NCT05061134|580328024|FG002|Overall Study|Disease progression|0|||
160713073|NCT05061134|580328022|FG000|Overall Study|Death|43|||
160713074|NCT05061134|580328023|FG001|Overall Study|Death|23|||
160713075|NCT05061134|580328024|FG002|Overall Study|Death|14|||
160713076|NCT05061134|580328022|FG000|Overall Study|Database lock|2|||
160713077|NCT05061134|580328023|FG001|Overall Study|Database lock|0|||
160713078|NCT05061134|580328024|FG002|Overall Study|Database lock|0|||
160713079|NCT03176134|580328025|FG000|Overall Study|Lost to Follow-up|0|||
160713080|NCT03176134|580328026|FG001|Overall Study|Lost to Follow-up|2|||
160713081|NCT03176134|580328027|FG002|Overall Study|Lost to Follow-up|0|||
160713082|NCT03176134|580328028|FG003|Overall Study|Lost to Follow-up|0|||
160713083|NCT03176134|580328029|FG004|Overall Study|Lost to Follow-up|0|||
160713084|NCT03176134|580328030|FG005|Overall Study|Lost to Follow-up|0|||
160713085|NCT03176134|580328031|FG006|Overall Study|Lost to Follow-up|0|||
160713086|NCT03176134|580328032|FG007|Overall Study|Lost to Follow-up|0|||
160713087|NCT03176134|580328025|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160713088|NCT03176134|580328026|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160713089|NCT03176134|580328027|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
160713090|NCT03176134|580328028|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160713091|NCT03176134|580328029|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
160713092|NCT03176134|580328030|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
160713093|NCT03176134|580328031|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
160713094|NCT03176134|580328032|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
160713095|NCT03410056|580328037|FG000|Overall Study|Decision by Sponsor|0|||
160713096|NCT03410056|580328038|FG001|Overall Study|Decision by Sponsor|0|||
160713097|NCT03410056|580328039|FG002|Overall Study|Decision by Sponsor|3|||
160713098|NCT03410056|580328040|FG003|Overall Study|Decision by Sponsor|0|||
160713099|NCT03410056|580328041|FG004|Overall Study|Decision by Sponsor|0|||
160713100|NCT03410056|580328042|FG005|Overall Study|Decision by Sponsor|0|||
160713101|NCT03410056|580328043|FG006|Overall Study|Decision by Sponsor|0|||
160713102|NCT03410056|580328037|FG000|Overall Study|Withdrawal by Subject|0|||
160713103|NCT03410056|580328038|FG001|Overall Study|Withdrawal by Subject|2|||
160713104|NCT03410056|580328039|FG002|Overall Study|Withdrawal by Subject|5|||
160713105|NCT03410056|580328040|FG003|Overall Study|Withdrawal by Subject|5|||
160713106|NCT03410056|580328041|FG004|Overall Study|Withdrawal by Subject|0|||
160713107|NCT03410056|580328042|FG005|Overall Study|Withdrawal by Subject|0|||
160713108|NCT03410056|580328043|FG006|Overall Study|Withdrawal by Subject|0|||
160713109|NCT02762929|580328044|FG000|Overall Study|Adverse Event|0|||
160713110|NCT02762929|580328045|FG001|Overall Study|Adverse Event|0|||
160713111|NCT02762929|580328046|FG002|Overall Study|Adverse Event|0|||
160713112|NCT02762929|580328047|FG003|Overall Study|Adverse Event|1|||
160713113|NCT02762929|580328048|FG004|Overall Study|Adverse Event|0|||
160713114|NCT02762929|580328049|FG005|Overall Study|Adverse Event|0|||
160713115|NCT02762929|580328044|FG000|Overall Study|Lost to Follow-up|1|||
160713116|NCT02762929|580328045|FG001|Overall Study|Lost to Follow-up|2|||
160713117|NCT02762929|580328046|FG002|Overall Study|Lost to Follow-up|0|||
160713118|NCT02762929|580328047|FG003|Overall Study|Lost to Follow-up|1|||
160713119|NCT02762929|580328048|FG004|Overall Study|Lost to Follow-up|0|||
160713120|NCT02762929|580328049|FG005|Overall Study|Lost to Follow-up|0|||
160713121|NCT02762929|580328044|FG000|Overall Study|Withdrawal by Subject|0|||
160713122|NCT02762929|580328045|FG001|Overall Study|Withdrawal by Subject|1|||
160713123|NCT02762929|580328046|FG002|Overall Study|Withdrawal by Subject|0|||
160713124|NCT02762929|580328047|FG003|Overall Study|Withdrawal by Subject|0|||
160713125|NCT02762929|580328048|FG004|Overall Study|Withdrawal by Subject|0|||
160713126|NCT02762929|580328049|FG005|Overall Study|Withdrawal by Subject|0|||
160713127|NCT02762929|580328044|FG000|Overall Study|exclusionary medication disclosed late|0|||
160713128|NCT02762929|580328045|FG001|Overall Study|exclusionary medication disclosed late|0|||
160713129|NCT02762929|580328046|FG002|Overall Study|exclusionary medication disclosed late|0|||
160713130|NCT02762929|580328047|FG003|Overall Study|exclusionary medication disclosed late|1|||
160713131|NCT02762929|580328048|FG004|Overall Study|exclusionary medication disclosed late|0|||
160713132|NCT02762929|580328049|FG005|Overall Study|exclusionary medication disclosed late|0|||
160713133|NCT02366689|580328057|FG000|Overall Study|Withdrawal by Subject|1|||
160713134|NCT02366689|580328058|FG001|Overall Study|Withdrawal by Subject|0|||
160713135|NCT02366689|580328059|FG002|Overall Study|Withdrawal by Subject|1|||
160713136|NCT02366689|580328057|FG000|Overall Study|Lost to Follow-up|3|||
160713137|NCT02366689|580328058|FG001|Overall Study|Lost to Follow-up|2|||
160713138|NCT02366689|580328059|FG002|Overall Study|Lost to Follow-up|0|||
160713139|NCT02366689|580328057|FG000|Overall Study|Pregnancy|0|||
160713140|NCT02366689|580328058|FG001|Overall Study|Pregnancy|1|||
160713141|NCT02366689|580328059|FG002|Overall Study|Pregnancy|1|||
160713142|NCT03718832|580328060|FG000|Analysis Sample|Withdrawal by Subject|18|||
160713143|NCT03718832|580328061|FG001|Analysis Sample|Withdrawal by Subject|15|||
160713144|NCT03718832|580328060|FG000|Analysis Sample|Legal hold on data|1|||
160713145|NCT03718832|580328061|FG001|Analysis Sample|Legal hold on data|0|||
160713146|NCT03718832|580328060|FG000|Analysis Sample|Participant from treated household|0|||
160713147|NCT03718832|580328061|FG001|Analysis Sample|Participant from treated household|1|||
160713148|NCT03718832|580328060|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
160713149|NCT03718832|580328061|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
160713150|NCT01996241|580328063|FG000|Overall Study|Lost to Follow-up|252|||
160713151|NCT01996241|580328064|FG001|Overall Study|Lost to Follow-up|235|||
160713152|NCT01068262|580328070|FG000|Overall Study|Adverse Event|2|||
160713153|NCT01068262|580328071|FG001|Overall Study|Adverse Event|0|||
160713154|NCT01068262|580328072|FG002|Overall Study|Adverse Event|1|||
160713155|NCT01068262|580328073|FG003|Overall Study|Adverse Event|0|||
160713156|NCT01068262|580328070|FG000|Overall Study|Protocol Violation|1|||
160713157|NCT01068262|580328071|FG001|Overall Study|Protocol Violation|0|||
160713158|NCT01068262|580328072|FG002|Overall Study|Protocol Violation|0|||
160713159|NCT01068262|580328073|FG003|Overall Study|Protocol Violation|0|||
160713160|NCT01068262|580328070|FG000|Overall Study|Withdrawal by Subject|0|||
160713161|NCT01068262|580328071|FG001|Overall Study|Withdrawal by Subject|1|||
160713162|NCT01068262|580328072|FG002|Overall Study|Withdrawal by Subject|0|||
160713163|NCT01068262|580328073|FG003|Overall Study|Withdrawal by Subject|0|||
160713164|NCT04182490|580328074|FG000|Overall Study|Withdrawal by Subject|3|||
160713165|NCT04182490|580328075|FG001|Overall Study|Withdrawal by Subject|3|||
160713166|NCT04182490|580328074|FG000|Overall Study|Lost to Follow-up|0|||
160713167|NCT04182490|580328075|FG001|Overall Study|Lost to Follow-up|1|||
160713168|NCT04182490|580328074|FG000|Overall Study|Physician Decision|0|||
160713169|NCT04182490|580328075|FG001|Overall Study|Physician Decision|1|||
160713170|NCT01811472|580328081|FG000|Overall Study|Adverse Event|1|||
160713171|NCT01811472|580328082|FG001|Overall Study|Adverse Event|0|||
160713172|NCT01811472|580328083|FG002|Overall Study|Adverse Event|4|||
160713173|NCT01811472|580328081|FG000|Overall Study|Lost to Follow-up|0|||
160713174|NCT01811472|580328082|FG001|Overall Study|Lost to Follow-up|0|||
160713175|NCT01811472|580328083|FG002|Overall Study|Lost to Follow-up|1|||
160713176|NCT01811472|580328081|FG000|Overall Study|Subject/guardian decision|1|||
160713177|NCT01811472|580328082|FG001|Overall Study|Subject/guardian decision|0|||
160713178|NCT01811472|580328083|FG002|Overall Study|Subject/guardian decision|0|||
160713179|NCT02676882|580328096|FG000|Overall Study|Adverse Event|1|||
160713180|NCT02676882|580328097|FG001|Overall Study|Adverse Event|0|||
160713181|NCT02676882|580328096|FG000|Overall Study|Lost to Follow-up|1|||
160713182|NCT02676882|580328097|FG001|Overall Study|Lost to Follow-up|0|||
160713183|NCT02676882|580328096|FG000|Overall Study|Withdrawal by Subject|1|||
160713184|NCT02676882|580328097|FG001|Overall Study|Withdrawal by Subject|2|||
160713185|NCT01783886|580328100|FG000|Overall Study|Lost to Follow-up|0|||
160713186|NCT01783886|580328101|FG001|Overall Study|Lost to Follow-up|3|||
160713187|NCT01783886|580328102|FG002|Overall Study|Lost to Follow-up|0|||
160713188|NCT01783886|580328100|FG000|Overall Study|Protocol deviation|0|||
160713189|NCT01783886|580328101|FG001|Overall Study|Protocol deviation|0|||
160713190|NCT01783886|580328102|FG002|Overall Study|Protocol deviation|2|||
160713191|NCT01783886|580328100|FG000|Overall Study|Withdrawal of consent by participant|1|||
160713192|NCT01783886|580328101|FG001|Overall Study|Withdrawal of consent by participant|3|||
160713193|NCT01783886|580328102|FG002|Overall Study|Withdrawal of consent by participant|4|||
160713194|NCT01783886|580328100|FG000|Overall Study|Adverse Event|4|||
160713195|NCT01783886|580328101|FG001|Overall Study|Adverse Event|5|||
160713196|NCT01783886|580328102|FG002|Overall Study|Adverse Event|4|||
160713197|NCT00940316|580328103|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
160713198|NCT00940316|580328104|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
160713199|NCT00940316|580328105|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
160713200|NCT00940316|580328103|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
160713201|NCT00940316|580328104|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
160713202|NCT00940316|580328105|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
160713203|NCT00940316|580328103|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
160713204|NCT00940316|580328104|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
160713205|NCT00940316|580328105|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
160713206|NCT00940316|580328103|FG000|Treated After Cycle 5|Adverse Event|0|||
160713207|NCT00940316|580328104|FG001|Treated After Cycle 5|Adverse Event|0|||
160713208|NCT00940316|580328105|FG002|Treated After Cycle 5|Adverse Event|1|||
160713209|NCT00940316|580328103|FG000|Treated After Cycle 5|Progressive disease|0|||
160713210|NCT00940316|580328104|FG001|Treated After Cycle 5|Progressive disease|1|||
160713211|NCT00940316|580328105|FG002|Treated After Cycle 5|Progressive disease|0|||
160713212|NCT02324582|580328106|FG000|Overall Study|Screen Failures|0|||
160713213|NCT02324582|580328107|FG001|Overall Study|Screen Failures|5|||
160713214|NCT00996489|580328109|FG000|Overall Study|Device failure|45|||
160713215|NCT00996489|580328109|FG000|Overall Study|Discontinued|116|||
160713216|NCT00129545|580328112|FG000|Overall Study|Death|5|||
160713217|NCT00129545|580328113|FG001|Overall Study|Death|60|||
160713218|NCT00129545|580328114|FG002|Overall Study|Death|44|||
160713219|NCT00129545|580328112|FG000|Overall Study|Withdrawal by Subject|3|||
160713220|NCT00129545|580328113|FG001|Overall Study|Withdrawal by Subject|18|||
160713221|NCT00129545|580328114|FG002|Overall Study|Withdrawal by Subject|44|||
160713222|NCT00129545|580328112|FG000|Overall Study|Lost to Follow-up|2|||
160713223|NCT00129545|580328113|FG001|Overall Study|Lost to Follow-up|22|||
160713224|NCT00129545|580328114|FG002|Overall Study|Lost to Follow-up|13|||
160713225|NCT00129545|580328112|FG000|Overall Study|Physician Decision|0|||
160713226|NCT00129545|580328113|FG001|Overall Study|Physician Decision|3|||
160713227|NCT00129545|580328114|FG002|Overall Study|Physician Decision|10|||
160713228|NCT00129545|580328112|FG000|Overall Study|Device not implanted|16|||
160713229|NCT00129545|580328113|FG001|Overall Study|Device not implanted|61|||
160713230|NCT00129545|580328114|FG002|Overall Study|Device not implanted|0|||
160713231|NCT04660331|580328115|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
160713232|NCT04660331|580328116|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
160713233|NCT04660331|580328117|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
160713234|NCT01130493|580328122|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
160713235|NCT01130493|580328123|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
160713236|NCT01130493|580328124|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
160713237|NCT01130493|580328122|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
160713238|NCT01130493|580328123|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
160713239|NCT01130493|580328124|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
160713240|NCT01130493|580328122|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
160713241|NCT01130493|580328123|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
160713242|NCT01130493|580328124|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
160713243|NCT01130493|580328122|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
160713244|NCT01130493|580328123|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
160713245|NCT01130493|580328124|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
160713246|NCT01130493|580328122|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
160713247|NCT01130493|580328123|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
160713248|NCT01130493|580328124|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
160713249|NCT01130493|580328122|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
160713250|NCT01130493|580328123|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
160713251|NCT01130493|580328124|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
160713252|NCT01130493|580328122|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
160713253|NCT01130493|580328123|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
160713254|NCT01130493|580328124|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
160713255|NCT01130493|580328122|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
160713256|NCT01130493|580328123|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
160713257|NCT01130493|580328124|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
160713258|NCT01130493|580328122|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
160713259|NCT01130493|580328123|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
160713260|NCT01130493|580328124|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
160713261|NCT01130493|580328122|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
160713262|NCT01130493|580328123|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
160713263|NCT01130493|580328124|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
160713264|NCT01130493|580328122|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
160713265|NCT01130493|580328123|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
160713266|NCT01130493|580328124|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
160713267|NCT01130493|580328122|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
160713268|NCT01130493|580328123|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
160713269|NCT01130493|580328124|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
160713270|NCT01130493|580328122|FG000|Part 2: OLE|Adverse Event|0|||
160713271|NCT01130493|580328123|FG001|Part 2: OLE|Adverse Event|2|||
160713272|NCT01130493|580328124|FG002|Part 2: OLE|Adverse Event|1|||
160713273|NCT01130493|580328122|FG000|Part 2: OLE|Withdrawal by Subject|0|||
160713274|NCT01130493|580328123|FG001|Part 2: OLE|Withdrawal by Subject|1|||
160713275|NCT01130493|580328124|FG002|Part 2: OLE|Withdrawal by Subject|4|||
160713276|NCT00739063|580328130|FG000|Overall Study|Screen failures|8|||
160713277|NCT00866359|580328132|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
160713278|NCT00866359|580328133|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
160713279|NCT00866359|580328134|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
160713280|NCT00866359|580328135|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
160713281|NCT00866359|580328132|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
160713282|NCT00866359|580328133|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
160713283|NCT00866359|580328134|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
160713284|NCT00866359|580328135|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
160713285|NCT00866359|580328132|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
160713286|NCT00866359|580328133|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
160713287|NCT00866359|580328134|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
160713288|NCT00866359|580328135|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
160713289|NCT00866359|580328132|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
160713290|NCT00866359|580328133|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
160713291|NCT00866359|580328134|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
160713292|NCT00866359|580328135|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
160713293|NCT00866359|580328132|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
160713294|NCT00866359|580328133|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
160713295|NCT00866359|580328134|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
160713296|NCT00866359|580328135|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
160713297|NCT00866359|580328132|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
160713298|NCT00866359|580328133|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
160713299|NCT00866359|580328134|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
160713300|NCT00866359|580328135|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
160713301|NCT02163057|580328136|FG000|Overall Study|Participant Refusal to Continue|2|||
160713302|NCT02163057|580328137|FG001|Overall Study|Participant Refusal to Continue|2|||
160713303|NCT02163057|580328136|FG000|Overall Study|Participant Significant Noncompliance|0|||
160713304|NCT02163057|580328137|FG001|Overall Study|Participant Significant Noncompliance|1|||
160713305|NCT02163057|580328136|FG000|Overall Study|Progression of Disease|1|||
160713306|NCT02163057|580328137|FG001|Overall Study|Progression of Disease|2|||
160713307|NCT01625091|580328138|FG000|Intervention|Death|1|||
160713308|NCT01625091|580328139|FG001|Intervention|Death|1|||
160713309|NCT01625091|580328138|FG000|Intervention|Withdrawal by Subject|4|||
160713310|NCT01625091|580328139|FG001|Intervention|Withdrawal by Subject|1|||
160713311|NCT01625091|580328138|FG000|Intervention|Adverse Event|0|||
160713312|NCT01625091|580328139|FG001|Intervention|Adverse Event|2|||
160713313|NCT01625091|580328138|FG000|Intervention|Lost to Follow-up|4|||
160713314|NCT01625091|580328139|FG001|Intervention|Lost to Follow-up|4|||
160713315|NCT01625091|580328138|FG000|Intervention|Study termination|2|||
160713316|NCT01625091|580328139|FG001|Intervention|Study termination|3|||
160713317|NCT01625091|580328138|FG000|Post-intervention|Death|0|||
160713318|NCT01625091|580328139|FG001|Post-intervention|Death|1|||
160713319|NCT01625091|580328138|FG000|Post-intervention|Lost to Follow-up|2|||
160713320|NCT01625091|580328139|FG001|Post-intervention|Lost to Follow-up|0|||
160713321|NCT01625091|580328138|FG000|Post-intervention|Study termination|2|||
160713322|NCT01625091|580328139|FG001|Post-intervention|Study termination|1|||
160713323|NCT01547390|580328146|FG000|Overall Study|Withdrawal by Subject|10|||
160713324|NCT01547390|580328147|FG001|Overall Study|Withdrawal by Subject|7|||
160713325|NCT01547390|580328146|FG000|Overall Study|termination of pregnancy|0|||
160713326|NCT01547390|580328147|FG001|Overall Study|termination of pregnancy|1|||
160713327|NCT01547390|580328146|FG000|Overall Study|Lost to Follow-up|0|||
160713328|NCT01547390|580328147|FG001|Overall Study|Lost to Follow-up|2|||
160713329|NCT01547390|580328146|FG000|Overall Study|Adverse Event|3|||
160713330|NCT01547390|580328147|FG001|Overall Study|Adverse Event|0|||
160713331|NCT04917861|580328152|FG000|Main Study (196 Days)|Adverse Event|0|||
160713332|NCT04917861|580328153|FG001|Main Study (196 Days)|Adverse Event|1|||
160713333|NCT04917861|580328154|FG002|Main Study (196 Days)|Adverse Event|0|||
160713334|NCT04917861|580328155|FG003|Main Study (196 Days)|Adverse Event|0|||
160713335|NCT04917861|580328152|FG000|Main Study (196 Days)|Death|0|||
160713336|NCT04917861|580328153|FG001|Main Study (196 Days)|Death|0|||
160713337|NCT04917861|580328154|FG002|Main Study (196 Days)|Death|0|||
160713338|NCT04917861|580328155|FG003|Main Study (196 Days)|Death|1|||
160713339|NCT04917861|580328152|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
160713340|NCT04917861|580328153|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
160713341|NCT04917861|580328154|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
160713342|NCT04917861|580328155|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
160713343|NCT04917861|580328152|FG000|Main Study (196 Days)|Physician Decision|0|||
160713344|NCT04917861|580328153|FG001|Main Study (196 Days)|Physician Decision|0|||
160713345|NCT04917861|580328154|FG002|Main Study (196 Days)|Physician Decision|0|||
160713346|NCT04917861|580328155|FG003|Main Study (196 Days)|Physician Decision|1|||
160713347|NCT04917861|580328152|FG000|Main Study (196 Days)|Pregnancy|1|||
160713348|NCT04917861|580328153|FG001|Main Study (196 Days)|Pregnancy|1|||
160713349|NCT04917861|580328154|FG002|Main Study (196 Days)|Pregnancy|0|||
160713350|NCT04917861|580328155|FG003|Main Study (196 Days)|Pregnancy|0|||
160713351|NCT04917861|580328152|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
160713352|NCT04917861|580328153|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
160713353|NCT04917861|580328154|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
160713354|NCT04917861|580328155|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
160713355|NCT04917861|580328152|FG000|Main Study (196 Days)|Other Than Specified|1|||
160713356|NCT04917861|580328153|FG001|Main Study (196 Days)|Other Than Specified|0|||
160713357|NCT04917861|580328154|FG002|Main Study (196 Days)|Other Than Specified|1|||
160713358|NCT04917861|580328155|FG003|Main Study (196 Days)|Other Than Specified|2|||
160713359|NCT04917861|580328152|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
160713360|NCT04917861|580328153|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
160713361|NCT04917861|580328154|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
160713362|NCT04917861|580328155|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
160713363|NCT04917861|580328152|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
160713364|NCT04917861|580328153|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
160713365|NCT04917861|580328154|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
160713366|NCT04917861|580328155|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
160713367|NCT04917861|580328152|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
160713368|NCT04917861|580328153|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
160713369|NCT04917861|580328154|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
160713370|NCT04917861|580328155|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
160713371|NCT04917861|580328152|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
160713372|NCT04917861|580328153|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
160713373|NCT04917861|580328154|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
160713374|NCT04917861|580328155|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
160713375|NCT04917861|580328152|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
160713376|NCT04917861|580328153|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
160713377|NCT04917861|580328154|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
160713378|NCT04917861|580328155|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
160713379|NCT04917861|580328152|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
160713380|NCT04917861|580328153|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
160713381|NCT04917861|580328154|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
160713382|NCT04917861|580328155|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
160713383|NCT01260701|580328156|FG000|Overall Study|Adverse Event|9|||
160713384|NCT01260701|580328156|FG000|Overall Study|Withdrawal by Subject|2|||
160713385|NCT01260701|580328156|FG000|Overall Study|Progression|53|||
160713386|NCT01260701|580328156|FG000|Overall Study|Death|2|||
160713387|NCT01260701|580328156|FG000|Overall Study|Not protocol specified|3|||
160713388|NCT01260701|580328156|FG000|Overall Study|Under review|1|||
160713389|NCT01260701|580328156|FG000|Overall Study|Ineligible|4|||
160713390|NCT01260701|580328156|FG000|Overall Study|Did not begin protocol therapy|1|||
160713391|NCT00720382|580328157|FG000|Overall Study|Adverse Event|54|||
160713392|NCT00720382|580328158|FG001|Overall Study|Adverse Event|17|||
160713393|NCT00720382|580328157|FG000|Overall Study|Lack of Efficacy|18|||
160713394|NCT00720382|580328158|FG001|Overall Study|Lack of Efficacy|7|||
160713395|NCT00720382|580328157|FG000|Overall Study|Non-Compliance|15|||
160713396|NCT00720382|580328158|FG001|Overall Study|Non-Compliance|5|||
160713397|NCT00720382|580328157|FG000|Overall Study|Withdrawal by Subject|47|||
160713398|NCT00720382|580328158|FG001|Overall Study|Withdrawal by Subject|11|||
160713399|NCT00720382|580328157|FG000|Overall Study|Lost to Follow-up|28|||
160713400|NCT00720382|580328158|FG001|Overall Study|Lost to Follow-up|14|||
160713401|NCT00720382|580328157|FG000|Overall Study|administrative|14|||
160713402|NCT00720382|580328158|FG001|Overall Study|administrative|5|||
160713403|NCT05192889|580328160|FG000|Block 1: All Eligible Patients|Death|2|||
160713404|NCT05192889|580328161|FG001|Block 1: All Eligible Patients|Death|0|||
160713405|NCT05192889|580328162|FG002|Block 1: All Eligible Patients|Death|0|||
160713406|NCT05192889|580328160|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
160713407|NCT05192889|580328161|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
160713408|NCT05192889|580328162|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
160713409|NCT05192889|580328160|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
160713410|NCT05192889|580328161|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
160713411|NCT05192889|580328162|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
160713412|NCT03989102|580330440|FG000|Year 1|Withdrawal by Subject|6|||
160713413|NCT03989102|580330441|FG001|Year 1|Withdrawal by Subject|2|||
160713414|NCT03989102|580330442|FG002|Year 1|Withdrawal by Subject|7|||
160713415|NCT03989102|580330440|FG000|Year 1|Lost to Follow-up|5|||
160713416|NCT03989102|580330441|FG001|Year 1|Lost to Follow-up|2|||
160713417|NCT03989102|580330442|FG002|Year 1|Lost to Follow-up|5|||
160713418|NCT03989102|580330440|FG000|Year 1|Subject met withdrawal criteria|1|||
160713419|NCT03989102|580330441|FG001|Year 1|Subject met withdrawal criteria|0|||
160713420|NCT03989102|580330442|FG002|Year 1|Subject met withdrawal criteria|1|||
160713421|NCT03989102|580330440|FG000|Year 2|Lost to Follow-up|7|||
160713422|NCT03989102|580330441|FG001|Year 2|Lost to Follow-up|3|||
160713423|NCT03989102|580330442|FG002|Year 2|Lost to Follow-up|4|||
160713424|NCT03989102|580330440|FG000|Year 2|Withdrawal by Subject|3|||
160713425|NCT03989102|580330441|FG001|Year 2|Withdrawal by Subject|1|||
160713426|NCT03989102|580330442|FG002|Year 2|Withdrawal by Subject|2|||
160713427|NCT03989102|580330440|FG000|Year 2|Subject non-compliant|3|||
160713428|NCT03989102|580330441|FG001|Year 2|Subject non-compliant|2|||
160713429|NCT03989102|580330442|FG002|Year 2|Subject non-compliant|0|||
160713430|NCT03989102|580330440|FG000|Year 2|Travel|1|||
160713431|NCT03989102|580330441|FG001|Year 2|Travel|0|||
160713432|NCT03989102|580330442|FG002|Year 2|Travel|1|||
160713433|NCT03989102|580330440|FG000|Year 2|P16 missing|4|||
160713434|NCT03989102|580330441|FG001|Year 2|P16 missing|2|||
160713435|NCT03989102|580330442|FG002|Year 2|P16 missing|1|||
160713436|NCT03989102|580330440|FG000|Year 2|P11 missing|1|||
160713437|NCT03989102|580330441|FG001|Year 2|P11 missing|3|||
160713438|NCT03989102|580330442|FG002|Year 2|P11 missing|7|||
160713439|NCT03989102|580330440|FG000|Year 2|Definitive displacement outside the study site|0|||
160713440|NCT03989102|580330441|FG001|Year 2|Definitive displacement outside the study site|1|||
160713441|NCT03989102|580330442|FG002|Year 2|Definitive displacement outside the study site|0|||
160713442|NCT03989102|580330440|FG000|Year 2|Subject missed last study visit|0|||
160713443|NCT03989102|580330441|FG001|Year 2|Subject missed last study visit|1|||
160713444|NCT03989102|580330442|FG002|Year 2|Subject missed last study visit|0|||
160713445|NCT03989102|580330440|FG000|Year 2|Death|0|||
160713446|NCT03989102|580330441|FG001|Year 2|Death|1|||
160713447|NCT03989102|580330442|FG002|Year 2|Death|0|||
160713448|NCT03989102|580330440|FG000|Year 2|Subject not reachable|0|||
160713449|NCT03989102|580330441|FG001|Year 2|Subject not reachable|0|||
160713450|NCT03989102|580330442|FG002|Year 2|Subject not reachable|1|||
160713451|NCT03989102|580330440|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
160713452|NCT03989102|580330441|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
160713453|NCT03989102|580330442|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
160713454|NCT03989102|580330440|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
160713455|NCT03989102|580330441|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
160713456|NCT03989102|580330442|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
160713457|NCT03989102|580330440|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
160713458|NCT03989102|580330441|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
160713459|NCT03989102|580330442|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
160713460|NCT03989102|580330440|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
160713461|NCT03989102|580330441|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
160713462|NCT03989102|580330442|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
160713463|NCT03989102|580330440|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
160713464|NCT03989102|580330441|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
160713465|NCT03989102|580330442|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
160713466|NCT03989102|580330440|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
160713467|NCT03989102|580330441|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
160713468|NCT03989102|580330442|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
160713469|NCT02719184|580330443|FG000|Overall Study|Other than listed|1|||
160713470|NCT02719184|580330444|FG001|Overall Study|Other than listed|12|||
160713471|NCT02719184|580330445|FG002|Overall Study|Other than listed|13|||
160713472|NCT02719184|580330446|FG003|Overall Study|Other than listed|22|||
160713473|NCT02719184|580330447|FG004|Overall Study|Other than listed|9|||
160713474|NCT02719184|580330443|FG000|Overall Study|Withdrawal by Subject|5|||
160713475|NCT02719184|580330444|FG001|Overall Study|Withdrawal by Subject|3|||
160713476|NCT02719184|580330445|FG002|Overall Study|Withdrawal by Subject|6|||
160713477|NCT02719184|580330446|FG003|Overall Study|Withdrawal by Subject|6|||
160713478|NCT02719184|580330447|FG004|Overall Study|Withdrawal by Subject|0|||
160713479|NCT02719184|580330443|FG000|Overall Study|Lost to Follow-up|0|||
160713480|NCT02719184|580330444|FG001|Overall Study|Lost to Follow-up|4|||
160713481|NCT02719184|580330445|FG002|Overall Study|Lost to Follow-up|1|||
160713482|NCT02719184|580330446|FG003|Overall Study|Lost to Follow-up|3|||
160713483|NCT02719184|580330447|FG004|Overall Study|Lost to Follow-up|0|||
160713484|NCT02719184|580330443|FG000|Overall Study|Protocol Violation|0|||
160713485|NCT02719184|580330444|FG001|Overall Study|Protocol Violation|3|||
160713486|NCT02719184|580330445|FG002|Overall Study|Protocol Violation|0|||
160713487|NCT02719184|580330446|FG003|Overall Study|Protocol Violation|2|||
160713488|NCT02719184|580330447|FG004|Overall Study|Protocol Violation|0|||
160713489|NCT02719184|580330443|FG000|Overall Study|Adverse Event|0|||
160713490|NCT02719184|580330444|FG001|Overall Study|Adverse Event|0|||
160713491|NCT02719184|580330445|FG002|Overall Study|Adverse Event|0|||
160713492|NCT02719184|580330446|FG003|Overall Study|Adverse Event|3|||
160713493|NCT02719184|580330447|FG004|Overall Study|Adverse Event|0|||
160713494|NCT04108299|580330448|FG000|Overall Study|Not interested in participating|2|||
160713495|NCT04108299|580330449|FG001|Overall Study|Not interested in participating|1|||
160713496|NCT04108299|580330450|FG002|Overall Study|Not interested in participating|2|||
160713497|NCT04108299|580330451|FG003|Overall Study|Not interested in participating|1|||
160713498|NCT04428034|580330454|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
160713499|NCT02556801|580330457|FG000|Overall Study|Lost to Follow-up|1|||
160713500|NCT02556801|580330458|FG001|Overall Study|Lost to Follow-up|0|||
160713501|NCT02556801|580330459|FG002|Overall Study|Lost to Follow-up|2|||
160713502|NCT02556801|580330460|FG003|Overall Study|Lost to Follow-up|0|||
160713503|NCT02556801|580330457|FG000|Overall Study|Withdrawal by Subject|1|||
160713504|NCT02556801|580330458|FG001|Overall Study|Withdrawal by Subject|1|||
160713505|NCT02556801|580330459|FG002|Overall Study|Withdrawal by Subject|1|||
160713506|NCT02556801|580330460|FG003|Overall Study|Withdrawal by Subject|0|||
160713507|NCT02556801|580330457|FG000|Overall Study|Protocol Violation|0|||
160713508|NCT02556801|580330458|FG001|Overall Study|Protocol Violation|3|||
160713509|NCT02556801|580330459|FG002|Overall Study|Protocol Violation|1|||
160713510|NCT02556801|580330460|FG003|Overall Study|Protocol Violation|1|||
160713511|NCT02556801|580330457|FG000|Overall Study|Adverse Event|0|||
160713512|NCT02556801|580330458|FG001|Overall Study|Adverse Event|2|||
160713513|NCT02556801|580330459|FG002|Overall Study|Adverse Event|0|||
160713514|NCT02556801|580330460|FG003|Overall Study|Adverse Event|3|||
160713515|NCT02556801|580330457|FG000|Overall Study|Pregnancy|0|||
160713516|NCT02556801|580330458|FG001|Overall Study|Pregnancy|1|||
160713517|NCT02556801|580330459|FG002|Overall Study|Pregnancy|0|||
160713518|NCT02556801|580330460|FG003|Overall Study|Pregnancy|0|||
160713519|NCT02556801|580330457|FG000|Overall Study|Personal reasons patient|0|||
160713520|NCT02556801|580330458|FG001|Overall Study|Personal reasons patient|0|||
160713521|NCT02556801|580330459|FG002|Overall Study|Personal reasons patient|0|||
160713522|NCT02556801|580330460|FG003|Overall Study|Personal reasons patient|1|||
160713523|NCT02515331|580330465|FG000|Overall Study|Withdrawal by Subject|0|||
160713524|NCT02515331|580330466|FG001|Overall Study|Withdrawal by Subject|0|||
160713525|NCT02515331|580330467|FG002|Overall Study|Withdrawal by Subject|1|||
160713526|NCT02515331|580330465|FG000|Overall Study|Protocol deviation|0|||
160713527|NCT02515331|580330466|FG001|Overall Study|Protocol deviation|0|||
160713528|NCT02515331|580330467|FG002|Overall Study|Protocol deviation|3|||
160713529|NCT02515331|580330465|FG000|Overall Study|Adverse Event|2|||
160713530|NCT02515331|580330466|FG001|Overall Study|Adverse Event|0|||
160713531|NCT02515331|580330467|FG002|Overall Study|Adverse Event|0|||
160713532|NCT00124748|580330468|FG000|Overall Study|Adverse Event|8|||
160713533|NCT00124748|580330469|FG001|Overall Study|Adverse Event|39|||
160713534|NCT00124748|580330468|FG000|Overall Study|Abnormal laboratory Value|2|||
160713535|NCT00124748|580330469|FG001|Overall Study|Abnormal laboratory Value|2|||
160713536|NCT00124748|580330468|FG000|Overall Study|Abnormal Procedure|0|||
160713537|NCT00124748|580330469|FG001|Overall Study|Abnormal Procedure|1|||
160713538|NCT00124748|580330468|FG000|Overall Study|Lack of Efficacy|20|||
160713539|NCT00124748|580330469|FG001|Overall Study|Lack of Efficacy|41|||
160713540|NCT00124748|580330468|FG000|Overall Study|No longer requires study drug|1|||
160713541|NCT00124748|580330469|FG001|Overall Study|No longer requires study drug|1|||
160713542|NCT00124748|580330468|FG000|Overall Study|Protocol Violation|3|||
160713543|NCT00124748|580330469|FG001|Overall Study|Protocol Violation|1|||
160713544|NCT00124748|580330468|FG000|Overall Study|Withdrawal by Subject|5|||
160713545|NCT00124748|580330469|FG001|Overall Study|Withdrawal by Subject|15|||
160713546|NCT00124748|580330468|FG000|Overall Study|Lost to Follow-up|2|||
160713547|NCT00124748|580330469|FG001|Overall Study|Lost to Follow-up|7|||
160713548|NCT00124748|580330468|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
160713549|NCT00124748|580330469|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
160713550|NCT00124748|580330468|FG000|Overall Study|Death|1|||
160713551|NCT00124748|580330469|FG001|Overall Study|Death|3|||
160713552|NCT00322712|580330470|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
160713553|NCT04176250|580330473|FG000|Overall Study|Adverse Event|0|||
160713554|NCT04176250|580330474|FG001|Overall Study|Adverse Event|1|||
160713555|NCT04176250|580330475|FG002|Overall Study|Adverse Event|0|||
160713556|NCT04176250|580330476|FG003|Overall Study|Adverse Event|1|||
160713557|NCT04176250|580330477|FG004|Overall Study|Adverse Event|0|||
160713558|NCT04176250|580330478|FG005|Overall Study|Adverse Event|1|||
160713559|NCT04176250|580330473|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
160713560|NCT04176250|580330474|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
160713561|NCT04176250|580330475|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
160713562|NCT04176250|580330476|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
160713563|NCT04176250|580330477|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
160713564|NCT04176250|580330478|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
160713565|NCT04176250|580330473|FG000|Overall Study|Withdrawal by Subject|0|||
160713566|NCT04176250|580330474|FG001|Overall Study|Withdrawal by Subject|0|||
160713567|NCT04176250|580330475|FG002|Overall Study|Withdrawal by Subject|0|||
160713568|NCT04176250|580330476|FG003|Overall Study|Withdrawal by Subject|0|||
160713569|NCT04176250|580330477|FG004|Overall Study|Withdrawal by Subject|0|||
160713570|NCT04176250|580330478|FG005|Overall Study|Withdrawal by Subject|1|||
160713571|NCT04176250|580330473|FG000|Overall Study|Randomized in error|0|||
160713572|NCT04176250|580330474|FG001|Overall Study|Randomized in error|0|||
160713573|NCT04176250|580330475|FG002|Overall Study|Randomized in error|0|||
160713574|NCT04176250|580330476|FG003|Overall Study|Randomized in error|0|||
160713575|NCT04176250|580330477|FG004|Overall Study|Randomized in error|1|||
160713576|NCT04176250|580330478|FG005|Overall Study|Randomized in error|0|||
160713577|NCT00758524|580330479|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
160713578|NCT00758524|580330480|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
160713579|NCT00758524|580330481|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
160713580|NCT00758524|580330482|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713581|NCT00758524|580330483|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
160713582|NCT00758524|580330484|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
160713583|NCT00758524|580330485|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713584|NCT00758524|580330486|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713585|NCT00758524|580330487|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713586|NCT00758524|580330488|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713587|NCT00758524|580330489|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713588|NCT00758524|580330490|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713589|NCT00758524|580330491|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713590|NCT00758524|580330492|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713591|NCT00758524|580330493|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713592|NCT00758524|580330494|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713593|NCT00758524|580330495|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
160713594|NCT00758524|580330479|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
160713595|NCT00758524|580330480|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713596|NCT00758524|580330481|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
160713597|NCT00758524|580330482|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
160713598|NCT00758524|580330483|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
160713599|NCT00758524|580330484|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
160713600|NCT00758524|580330485|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713601|NCT00758524|580330486|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713602|NCT00758524|580330487|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713603|NCT00758524|580330488|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713604|NCT00758524|580330489|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713605|NCT00758524|580330490|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713606|NCT00758524|580330491|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713607|NCT00758524|580330492|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713608|NCT00758524|580330493|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713609|NCT00758524|580330494|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713610|NCT00758524|580330495|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
160713611|NCT00758524|580330479|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
160713612|NCT00758524|580330480|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
160713613|NCT00758524|580330481|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
160713614|NCT00758524|580330482|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
160713615|NCT00758524|580330483|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
160713616|NCT00758524|580330484|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
160713617|NCT00758524|580330485|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713618|NCT00758524|580330486|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713619|NCT00758524|580330487|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713620|NCT00758524|580330488|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713621|NCT00758524|580330489|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713622|NCT00758524|580330490|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713623|NCT00758524|580330491|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713624|NCT00758524|580330492|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713625|NCT00758524|580330493|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713626|NCT00758524|580330494|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713627|NCT00758524|580330495|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
160713628|NCT00758524|580330479|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713629|NCT00758524|580330480|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
160713630|NCT00758524|580330481|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
160713631|NCT00758524|580330482|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713632|NCT00758524|580330483|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
160713633|NCT00758524|580330484|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
160713634|NCT00758524|580330485|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713635|NCT00758524|580330486|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713636|NCT00758524|580330487|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713637|NCT00758524|580330488|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713638|NCT00758524|580330489|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713639|NCT00758524|580330490|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713640|NCT00758524|580330491|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713641|NCT00758524|580330492|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713642|NCT00758524|580330493|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713643|NCT00758524|580330494|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713644|NCT00758524|580330495|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
160713645|NCT00758524|580330479|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713646|NCT00758524|580330480|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713647|NCT00758524|580330481|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
160713648|NCT00758524|580330482|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
160713649|NCT00758524|580330483|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713650|NCT00758524|580330484|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713651|NCT00758524|580330485|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713652|NCT00758524|580330486|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713653|NCT00758524|580330487|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713654|NCT00758524|580330488|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713655|NCT00758524|580330489|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713656|NCT00758524|580330490|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713657|NCT00758524|580330491|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713658|NCT00758524|580330492|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713659|NCT00758524|580330493|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713660|NCT00758524|580330494|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713661|NCT00758524|580330495|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
160713662|NCT00758524|580330479|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713663|NCT00758524|580330480|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713664|NCT00758524|580330481|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713665|NCT00758524|580330482|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713666|NCT00758524|580330483|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
160713667|NCT00758524|580330484|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713668|NCT00758524|580330485|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713669|NCT00758524|580330486|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713670|NCT00758524|580330487|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713671|NCT00758524|580330488|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713672|NCT00758524|580330489|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713673|NCT00758524|580330490|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713674|NCT00758524|580330491|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713675|NCT00758524|580330492|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713676|NCT00758524|580330493|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713677|NCT00758524|580330494|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713678|NCT00758524|580330495|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
160713679|NCT00758524|580330479|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713680|NCT00758524|580330480|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
160713681|NCT00758524|580330481|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713682|NCT00758524|580330482|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713683|NCT00758524|580330483|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713684|NCT00758524|580330484|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713685|NCT00758524|580330485|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713686|NCT00758524|580330486|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713687|NCT00758524|580330487|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713688|NCT00758524|580330488|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713689|NCT00758524|580330489|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713690|NCT00758524|580330490|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713691|NCT00758524|580330491|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713692|NCT00758524|580330492|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713693|NCT00758524|580330493|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713694|NCT00758524|580330494|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713695|NCT00758524|580330495|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
160713696|NCT00758524|580330479|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713697|NCT00758524|580330480|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
160713698|NCT00758524|580330481|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713699|NCT00758524|580330482|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713700|NCT00758524|580330483|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713701|NCT00758524|580330484|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713702|NCT00758524|580330485|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713703|NCT00758524|580330486|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713704|NCT00758524|580330487|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713705|NCT00758524|580330488|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713706|NCT00758524|580330489|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713707|NCT00758524|580330490|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713708|NCT00758524|580330491|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713709|NCT00758524|580330492|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713710|NCT00758524|580330493|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713711|NCT00758524|580330494|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713712|NCT00758524|580330495|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
160713713|NCT00758524|580330479|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713714|NCT00758524|580330480|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713715|NCT00758524|580330481|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713716|NCT00758524|580330482|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713717|NCT00758524|580330483|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713718|NCT00758524|580330484|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713719|NCT00758524|580330485|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713720|NCT00758524|580330486|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713721|NCT00758524|580330487|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
160713722|NCT00758524|580330488|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713723|NCT00758524|580330489|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713724|NCT00758524|580330490|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713725|NCT00758524|580330491|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713726|NCT00758524|580330492|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713727|NCT00758524|580330493|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713728|NCT00758524|580330494|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713729|NCT00758524|580330495|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
160713730|NCT00758524|580330479|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713731|NCT00758524|580330480|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713732|NCT00758524|580330481|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713733|NCT00758524|580330482|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713734|NCT00758524|580330483|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713735|NCT00758524|580330484|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713736|NCT00758524|580330485|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
160713737|NCT00758524|580330486|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713738|NCT00758524|580330487|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713739|NCT00758524|580330488|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713740|NCT00758524|580330489|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713741|NCT00758524|580330490|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713742|NCT00758524|580330491|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713743|NCT00758524|580330492|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713744|NCT00758524|580330493|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713745|NCT00758524|580330494|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713746|NCT00758524|580330495|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
160713747|NCT04747470|580330498|FG000|Overall Study|Death|0|||
160713748|NCT04747470|580330499|FG001|Overall Study|Death|3|||
160713749|NCT04747470|580330500|FG002|Overall Study|Death|2|||
160713750|NCT04747470|580330501|FG003|Overall Study|Death|2|||
160713751|NCT04747470|580330502|FG004|Overall Study|Death|2|||
160713752|NCT04747470|580330503|FG005|Overall Study|Death|0|||
160713753|NCT04747470|580330504|FG006|Overall Study|Death|0|||
160713754|NCT04747470|580330505|FG007|Overall Study|Death|0|||
160713755|NCT04747470|580330506|FG008|Overall Study|Death|0|||
160713756|NCT04747470|580330507|FG009|Overall Study|Death|0|||
160713757|NCT04747470|580330508|FG010|Overall Study|Death|0|||
160713758|NCT04747470|580330498|FG000|Overall Study|Withdrew Consent|0|||
160713759|NCT04747470|580330499|FG001|Overall Study|Withdrew Consent|0|||
160713760|NCT04747470|580330500|FG002|Overall Study|Withdrew Consent|0|||
160713761|NCT04747470|580330501|FG003|Overall Study|Withdrew Consent|1|||
160713762|NCT04747470|580330502|FG004|Overall Study|Withdrew Consent|0|||
160713763|NCT04747470|580330503|FG005|Overall Study|Withdrew Consent|0|||
160713764|NCT04747470|580330504|FG006|Overall Study|Withdrew Consent|0|||
160713765|NCT04747470|580330505|FG007|Overall Study|Withdrew Consent|0|||
160713766|NCT04747470|580330506|FG008|Overall Study|Withdrew Consent|0|||
160713767|NCT04747470|580330507|FG009|Overall Study|Withdrew Consent|0|||
160713768|NCT04747470|580330508|FG010|Overall Study|Withdrew Consent|0|||
160713769|NCT04747470|580330498|FG000|Overall Study|Study Terminated by Sponsor|0|||
160713770|NCT04747470|580330499|FG001|Overall Study|Study Terminated by Sponsor|0|||
160713771|NCT04747470|580330500|FG002|Overall Study|Study Terminated by Sponsor|1|||
160713772|NCT04747470|580330501|FG003|Overall Study|Study Terminated by Sponsor|0|||
160713773|NCT04747470|580330502|FG004|Overall Study|Study Terminated by Sponsor|2|||
160713774|NCT04747470|580330503|FG005|Overall Study|Study Terminated by Sponsor|0|||
160713775|NCT04747470|580330504|FG006|Overall Study|Study Terminated by Sponsor|0|||
160713776|NCT04747470|580330505|FG007|Overall Study|Study Terminated by Sponsor|0|||
160713777|NCT04747470|580330506|FG008|Overall Study|Study Terminated by Sponsor|0|||
160713778|NCT04747470|580330507|FG009|Overall Study|Study Terminated by Sponsor|0|||
160713779|NCT04747470|580330508|FG010|Overall Study|Study Terminated by Sponsor|0|||
160713780|NCT04688671|580330509|FG000|Overall Study|Adverse Event|3|||
160713781|NCT04688671|580330510|FG001|Overall Study|Adverse Event|1|||
160713782|NCT04688671|580330509|FG000|Overall Study|Withdrawal by Subject|3|||
160713783|NCT04688671|580330510|FG001|Overall Study|Withdrawal by Subject|1|||
160713784|NCT04688671|580330509|FG000|Overall Study|Lack of Efficacy|1|||
160713785|NCT04688671|580330510|FG001|Overall Study|Lack of Efficacy|1|||
160713786|NCT04688671|580330509|FG000|Overall Study|Protocol Violation|1|||
160713787|NCT04688671|580330510|FG001|Overall Study|Protocol Violation|0|||
160713788|NCT04688671|580330509|FG000|Overall Study|Lost to Follow-up|0|||
160713789|NCT04688671|580330510|FG001|Overall Study|Lost to Follow-up|1|||
160713790|NCT01125189|580330515|FG000|Treatment Period|Lack of Efficacy|15|||
160713791|NCT01125189|580330516|FG001|Treatment Period|Lack of Efficacy|18|||
160713792|NCT01125189|580330517|FG002|Treatment Period|Lack of Efficacy|25|||
160713793|NCT01125189|580330515|FG000|Treatment Period|Adverse Event|7|||
160713794|NCT01125189|580330516|FG001|Treatment Period|Adverse Event|8|||
160713795|NCT01125189|580330517|FG002|Treatment Period|Adverse Event|8|||
160713796|NCT01125189|580330515|FG000|Treatment Period|Withdrawal by Subject|3|||
160713797|NCT01125189|580330516|FG001|Treatment Period|Withdrawal by Subject|1|||
160713798|NCT01125189|580330517|FG002|Treatment Period|Withdrawal by Subject|1|||
160713799|NCT01125189|580330515|FG000|Treatment Period|Death|1|||
160713800|NCT01125189|580330516|FG001|Treatment Period|Death|0|||
160713801|NCT01125189|580330517|FG002|Treatment Period|Death|0|||
160713802|NCT01125189|580330515|FG000|Treatment Period|Lost to Follow-up|1|||
160713803|NCT01125189|580330516|FG001|Treatment Period|Lost to Follow-up|2|||
160713804|NCT01125189|580330517|FG002|Treatment Period|Lost to Follow-up|1|||
160713805|NCT01125189|580330515|FG000|Treatment Period|Poor compliance/noncompliance|0|||
160713806|NCT01125189|580330516|FG001|Treatment Period|Poor compliance/noncompliance|1|||
160713807|NCT01125189|580330517|FG002|Treatment Period|Poor compliance/noncompliance|0|||
160713808|NCT01125189|580330515|FG000|Treatment Period|Participants requested to discontinue|1|||
160713809|NCT01125189|580330516|FG001|Treatment Period|Participants requested to discontinue|3|||
160713810|NCT01125189|580330517|FG002|Treatment Period|Participants requested to discontinue|4|||
160713811|NCT01125189|580330515|FG000|Treatment Period|Other reasons|1|||
160713812|NCT01125189|580330516|FG001|Treatment Period|Other reasons|1|||
160713813|NCT01125189|580330517|FG002|Treatment Period|Other reasons|0|||
160713814|NCT01125189|580330515|FG000|Treatment Period|Completed 24 week treatment period only|2|||
160713815|NCT01125189|580330516|FG001|Treatment Period|Completed 24 week treatment period only|1|||
160713816|NCT01125189|580330517|FG002|Treatment Period|Completed 24 week treatment period only|2|||
160713817|NCT01125189|580330515|FG000|Follow up Period|Withdrawal by Subject|3|||
160713818|NCT01125189|580330516|FG001|Follow up Period|Withdrawal by Subject|2|||
160713819|NCT01125189|580330517|FG002|Follow up Period|Withdrawal by Subject|5|||
160713820|NCT01125189|580330515|FG000|Follow up Period|Death|1|||
160713821|NCT01125189|580330516|FG001|Follow up Period|Death|0|||
160713822|NCT01125189|580330517|FG002|Follow up Period|Death|0|||
160713823|NCT01125189|580330515|FG000|Follow up Period|Lost to Follow-up|12|||
160713824|NCT01125189|580330516|FG001|Follow up Period|Lost to Follow-up|9|||
160713825|NCT01125189|580330517|FG002|Follow up Period|Lost to Follow-up|6|||
160713826|NCT01125189|580330515|FG000|Follow up Period|Other reasons|4|||
160713827|NCT01125189|580330516|FG001|Follow up Period|Other reasons|4|||
160713828|NCT01125189|580330517|FG002|Follow up Period|Other reasons|5|||
160713829|NCT00114140|580330518|FG000|Overall Study|Protocol Violation|7|||
160713830|NCT02414958|580330519|FG000|Overall Study|Adverse Event|6|||
160713831|NCT02414958|580330520|FG001|Overall Study|Adverse Event|6|||
160713832|NCT02414958|580330521|FG002|Overall Study|Adverse Event|3|||
160713833|NCT02414958|580330519|FG000|Overall Study|Protocol Violation|10|||
160713834|NCT02414958|580330520|FG001|Overall Study|Protocol Violation|3|||
160713835|NCT02414958|580330521|FG002|Overall Study|Protocol Violation|1|||
160713836|NCT02414958|580330519|FG000|Overall Study|Lost to Follow-up|7|||
160713837|NCT02414958|580330520|FG001|Overall Study|Lost to Follow-up|4|||
160713838|NCT02414958|580330521|FG002|Overall Study|Lost to Follow-up|0|||
160713839|NCT02414958|580330519|FG000|Overall Study|Withdrawal by Subject|5|||
160713840|NCT02414958|580330520|FG001|Overall Study|Withdrawal by Subject|3|||
160713841|NCT02414958|580330521|FG002|Overall Study|Withdrawal by Subject|5|||
160713842|NCT02414958|580330519|FG000|Overall Study|Other than specified|4|||
160713843|NCT02414958|580330520|FG001|Overall Study|Other than specified|4|||
160713844|NCT02414958|580330521|FG002|Overall Study|Other than specified|5|||
160713845|NCT00811733|580330526|FG000|Overall Study|Investigator Discretion|10|||
160713846|NCT00811733|580330527|FG001|Overall Study|Investigator Discretion|8|||
160713847|NCT00811733|580330526|FG000|Overall Study|Withdrawal by Subject|1|||
160713848|NCT00811733|580330527|FG001|Overall Study|Withdrawal by Subject|2|||
160713849|NCT00793871|580330528|FG000|Overall Study|Death|50|||
160713850|NCT00793871|580330528|FG000|Overall Study|Lost to Follow-up|3|||
160713851|NCT00793871|580330528|FG000|Overall Study|Study terminated by the Sponsor|7|||
160713852|NCT02500589|580330529|FG000|Overall Study|Withdrawal by Subject|11|||
160713853|NCT02500589|580330530|FG001|Overall Study|Withdrawal by Subject|14|||
160713854|NCT02500589|580330529|FG000|Overall Study|Lost to Follow-up|10|||
160713855|NCT02500589|580330530|FG001|Overall Study|Lost to Follow-up|12|||
160713856|NCT02500589|580330529|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
160713857|NCT02500589|580330530|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
160713858|NCT02500589|580330529|FG000|Overall Study|Death|7|||
160713859|NCT02500589|580330530|FG001|Overall Study|Death|5|||
160713860|NCT00245466|580330531|FG000|Overall Study|Adverse Event|2|||
160713861|NCT00245466|580330532|FG001|Overall Study|Adverse Event|8|||
160713862|NCT00245466|580330533|FG002|Overall Study|Adverse Event|4|||
160713863|NCT00245466|580330531|FG000|Overall Study|Low prostate specific antigen suppr|16|||
160713864|NCT00245466|580330532|FG001|Overall Study|Low prostate specific antigen suppr|14|||
160713865|NCT00245466|580330533|FG002|Overall Study|Low prostate specific antigen suppr|5|||
160713866|NCT00245466|580330531|FG000|Overall Study|Insufficient testosterone suppr|12|||
160713867|NCT00245466|580330532|FG001|Overall Study|Insufficient testosterone suppr|12|||
160713868|NCT00245466|580330533|FG002|Overall Study|Insufficient testosterone suppr|21|||
160713869|NCT00245466|580330531|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
160713870|NCT00245466|580330532|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
160713871|NCT00245466|580330533|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
160713872|NCT00245466|580330531|FG000|Overall Study|Withdrawal by Subject|2|||
160713873|NCT00245466|580330532|FG001|Overall Study|Withdrawal by Subject|2|||
160713874|NCT00245466|580330533|FG002|Overall Study|Withdrawal by Subject|1|||
160713875|NCT00245466|580330531|FG000|Overall Study|Lost to Follow-up|3|||
160713876|NCT00245466|580330532|FG001|Overall Study|Lost to Follow-up|0|||
160713877|NCT00245466|580330533|FG002|Overall Study|Lost to Follow-up|0|||
160713878|NCT00245466|580330531|FG000|Overall Study|Disease progression|0|||
160713879|NCT00245466|580330532|FG001|Overall Study|Disease progression|3|||
160713880|NCT00245466|580330533|FG002|Overall Study|Disease progression|1|||
160713881|NCT00245466|580330531|FG000|Overall Study|Protocol Violation|1|||
160713882|NCT00245466|580330532|FG001|Overall Study|Protocol Violation|2|||
160713883|NCT00245466|580330533|FG002|Overall Study|Protocol Violation|2|||
160713884|NCT00245466|580330531|FG000|Overall Study|Death|0|||
160713885|NCT00245466|580330532|FG001|Overall Study|Death|2|||
160713886|NCT00245466|580330533|FG002|Overall Study|Death|0|||
160713887|NCT00245466|580330531|FG000|Overall Study|Administrative reasons|0|||
160713888|NCT00245466|580330532|FG001|Overall Study|Administrative reasons|1|||
160713889|NCT00245466|580330533|FG002|Overall Study|Administrative reasons|0|||
160713890|NCT00856193|580330534|FG000|Period 2|Abnormal test procedure results|0|||
160713891|NCT00856193|580330535|FG001|Period 2|Abnormal test procedure results|1|||
160713892|NCT00856193|580330534|FG000|Period 2|Lost to Follow-up|0|||
160713893|NCT00856193|580330535|FG001|Period 2|Lost to Follow-up|1|||
160713894|NCT03885661|580330536|FG000|Overall Study|Withdrawal by Subject|0|||
160713895|NCT03885661|580330537|FG001|Overall Study|Withdrawal by Subject|1|||
160713896|NCT03885661|580330536|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
160713897|NCT03885661|580330537|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
160713898|NCT05064397|580330538|FG000|Overall Study|Adverse Event|4|||
160713899|NCT05064397|580330538|FG000|Overall Study|Lack of Efficacy|12|||
160713900|NCT05064397|580330538|FG000|Overall Study|Withdrawal by Subject|3|||
160713901|NCT05064397|580330538|FG000|Overall Study|Lost to Follow-up|1|||
160713902|NCT05064397|580330538|FG000|Overall Study|Other reasons|3|||
160713903|NCT04542057|580330541|FG000|Overall Study|Death|3|||
160713904|NCT04542057|580330542|FG001|Overall Study|Death|1|||
160713905|NCT04542057|580330541|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
160713906|NCT04542057|580330542|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
160713907|NCT04542057|580330541|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
160713908|NCT04542057|580330542|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
160713909|NCT04542057|580330541|FG000|Overall Study|Adverse Event|15|||
160713910|NCT04542057|580330542|FG001|Overall Study|Adverse Event|6|||
160713911|NCT04542057|580330541|FG000|Overall Study|COVID-19 adverse event|6|||
160713912|NCT04542057|580330542|FG001|Overall Study|COVID-19 adverse event|4|||
160713913|NCT04542057|580330541|FG000|Overall Study|Lack of Efficacy|2|||
160713914|NCT04542057|580330542|FG001|Overall Study|Lack of Efficacy|5|||
160713915|NCT04542057|580330541|FG000|Overall Study|Study terminated by sponsor|1|||
160713916|NCT04542057|580330542|FG001|Overall Study|Study terminated by sponsor|0|||
160713917|NCT04542057|580330541|FG000|Overall Study|Investigator discretion|2|||
160713918|NCT04542057|580330542|FG001|Overall Study|Investigator discretion|1|||
160713919|NCT04542057|580330541|FG000|Overall Study|Withdrawal by Subject|52|||
160713920|NCT04542057|580330542|FG001|Overall Study|Withdrawal by Subject|30|||
160713921|NCT04542057|580330541|FG000|Overall Study|Lost to Follow-up|8|||
160713922|NCT04542057|580330542|FG001|Overall Study|Lost to Follow-up|11|||
160713923|NCT04542057|580330541|FG000|Overall Study|Other|2|||
160713924|NCT04542057|580330542|FG001|Overall Study|Other|2|||
160713925|NCT00838526|580330546|FG000|Overall Study|Adverse Event|3|||
160713926|NCT00838526|580330547|FG001|Overall Study|Adverse Event|12|||
160713927|NCT00838526|580330546|FG000|Overall Study|Lost to Follow-up|4|||
160713928|NCT00838526|580330547|FG001|Overall Study|Lost to Follow-up|12|||
160713929|NCT00838526|580330546|FG000|Overall Study|Withdrawal by Subject|4|||
160713930|NCT00838526|580330547|FG001|Overall Study|Withdrawal by Subject|5|||
160713931|NCT00838526|580330546|FG000|Overall Study|Lack of Efficacy|2|||
160713932|NCT00838526|580330547|FG001|Overall Study|Lack of Efficacy|3|||
160713933|NCT00838526|580330546|FG000|Overall Study|Other|11|||
160713934|NCT00838526|580330547|FG001|Overall Study|Other|7|||
160713935|NCT00111241|580330550|FG000|Overall Study|Lost to Follow-up|1|||
160713936|NCT00111241|580330551|FG001|Overall Study|Lost to Follow-up|0|||
160713937|NCT00111241|580330550|FG000|Overall Study|Withdrawal by Subject|4|||
160713938|NCT00111241|580330551|FG001|Overall Study|Withdrawal by Subject|0|||
160713939|NCT00111241|580330550|FG000|Overall Study|Protocol Violation|9|||
160713940|NCT00111241|580330551|FG001|Overall Study|Protocol Violation|8|||
160713941|NCT00111241|580330550|FG000|Overall Study|Adverse Event|1|||
160713942|NCT00111241|580330551|FG001|Overall Study|Adverse Event|0|||
160713943|NCT04338022|580330552|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
160713944|NCT04338022|580330553|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
160713945|NCT04338022|580330552|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
160713946|NCT04338022|580330553|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
160713947|NCT04338022|580330552|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
160713948|NCT04338022|580330553|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
160713949|NCT04338022|580330552|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
160713950|NCT04338022|580330553|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
160713951|NCT04338022|580330552|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
160713952|NCT04338022|580330553|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
160713953|NCT04338022|580330552|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
160713954|NCT04338022|580330553|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
160713955|NCT04338022|580330552|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
160713956|NCT04338022|580330553|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
160713957|NCT04338022|580330552|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
160713958|NCT04338022|580330553|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
160713959|NCT04338022|580330552|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
160713960|NCT04338022|580330553|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
160713961|NCT04338022|580330552|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
160713962|NCT04338022|580330553|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
160713963|NCT04338022|580330552|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
160713964|NCT04338022|580330553|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
160713965|NCT04338022|580330552|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
160713966|NCT04338022|580330553|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
160713967|NCT04338022|580330552|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
160713968|NCT04338022|580330553|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
160713969|NCT04338022|580330552|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
160713970|NCT04338022|580330553|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
160713971|NCT02096744|580330564|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
160713972|NCT02096744|580330565|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
160713973|NCT02096744|580330564|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
160713974|NCT02096744|580330565|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
160713975|NCT02096744|580330564|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
160713976|NCT02096744|580330565|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
160713977|NCT05724589|580330571|FG000|Overall Study|Lost to Follow-up|1|||
160713978|NCT00786409|580330572|FG000|Overall Study|Withdrawal by Subject|2|||
160713979|NCT00786409|580330572|FG000|Overall Study|Adverse Event|2|||
160713980|NCT00786409|580330572|FG000|Overall Study|Pregnancy|2|||
160713981|NCT00786409|580330572|FG000|Overall Study|Lost to Follow-up|1|||
160713982|NCT00610129|580330573|FG000|Overall Study|Not treated since patients ineligible|3|||
160713983|NCT02273388|580330577|FG000|Overall Study|Adverse Event|0|||
160713984|NCT02273388|580330578|FG001|Overall Study|Adverse Event|0|||
160713985|NCT02273388|580330579|FG002|Overall Study|Adverse Event|0|||
160713986|NCT02273388|580330580|FG003|Overall Study|Adverse Event|0|||
160713987|NCT02273388|580330581|FG004|Overall Study|Adverse Event|0|||
160713988|NCT02273388|580330582|FG005|Overall Study|Adverse Event|0|||
160713989|NCT02273388|580330583|FG006|Overall Study|Adverse Event|1|||
160713990|NCT02273388|580330584|FG007|Overall Study|Adverse Event|2|||
160713991|NCT02273388|580330585|FG008|Overall Study|Adverse Event|0|||
160713992|NCT02273388|580330586|FG009|Overall Study|Adverse Event|0|||
160713993|NCT02273388|580330587|FG010|Overall Study|Adverse Event|0|||
160713994|NCT02273388|580330588|FG011|Overall Study|Adverse Event|0|||
160713995|NCT02273388|580330577|FG000|Overall Study|Adverse Event study disease worse|4|||
160713996|NCT02273388|580330578|FG001|Overall Study|Adverse Event study disease worse|3|||
160713997|NCT02273388|580330579|FG002|Overall Study|Adverse Event study disease worse|3|||
160713998|NCT02273388|580330580|FG003|Overall Study|Adverse Event study disease worse|2|||
160713999|NCT02273388|580330581|FG004|Overall Study|Adverse Event study disease worse|4|||
160714000|NCT02273388|580330582|FG005|Overall Study|Adverse Event study disease worse|3|||
160714001|NCT02273388|580330583|FG006|Overall Study|Adverse Event study disease worse|14|||
160714002|NCT02273388|580330584|FG007|Overall Study|Adverse Event study disease worse|6|||
160714003|NCT02273388|580330585|FG008|Overall Study|Adverse Event study disease worse|6|||
160714004|NCT02273388|580330586|FG009|Overall Study|Adverse Event study disease worse|5|||
160714005|NCT02273388|580330587|FG010|Overall Study|Adverse Event study disease worse|10|||
160714006|NCT02273388|580330588|FG011|Overall Study|Adverse Event study disease worse|1|||
160714007|NCT02273388|580330577|FG000|Overall Study|Sponsor decision|0|||
160714008|NCT02273388|580330578|FG001|Overall Study|Sponsor decision|0|||
160714009|NCT02273388|580330579|FG002|Overall Study|Sponsor decision|0|||
160714010|NCT02273388|580330580|FG003|Overall Study|Sponsor decision|0|||
160714011|NCT02273388|580330581|FG004|Overall Study|Sponsor decision|0|||
160714012|NCT02273388|580330582|FG005|Overall Study|Sponsor decision|0|||
160714013|NCT02273388|580330583|FG006|Overall Study|Sponsor decision|0|||
160714014|NCT02273388|580330584|FG007|Overall Study|Sponsor decision|0|||
160714015|NCT02273388|580330585|FG008|Overall Study|Sponsor decision|0|||
160714016|NCT02273388|580330586|FG009|Overall Study|Sponsor decision|0|||
160714017|NCT02273388|580330587|FG010|Overall Study|Sponsor decision|0|||
160714018|NCT02273388|580330588|FG011|Overall Study|Sponsor decision|1|||
160714019|NCT02445963|580330589|FG000|Overall Study|Lost to Follow-up|1|||
160714020|NCT02445963|580330590|FG001|Overall Study|Lost to Follow-up|0|||
160714021|NCT02445963|580330591|FG002|Overall Study|Lost to Follow-up|0|||
160714022|NCT02445963|580330592|FG003|Overall Study|Lost to Follow-up|0|||
160714023|NCT02445963|580330589|FG000|Overall Study|Change in employment|1|||
160714024|NCT02445963|580330590|FG001|Overall Study|Change in employment|0|||
160714025|NCT02445963|580330591|FG002|Overall Study|Change in employment|0|||
160714026|NCT02445963|580330592|FG003|Overall Study|Change in employment|0|||
160714027|NCT02445963|580330589|FG000|Overall Study|Symptoms post-vaccination|0|||
160714028|NCT02445963|580330590|FG001|Overall Study|Symptoms post-vaccination|0|||
160714029|NCT02445963|580330591|FG002|Overall Study|Symptoms post-vaccination|1|||
160714030|NCT02445963|580330592|FG003|Overall Study|Symptoms post-vaccination|0|||
160714031|NCT01957176|580330596|FG000|Overall Study|Adverse Event|2|||
160714032|NCT01957176|580330597|FG001|Overall Study|Adverse Event|0|||
160714033|NCT01957176|580330596|FG000|Overall Study|Physician Decision|2|||
160714034|NCT01957176|580330597|FG001|Overall Study|Physician Decision|1|||
160714035|NCT01957176|580330596|FG000|Overall Study|Withdrawal by Subject|1|||
160714036|NCT01957176|580330597|FG001|Overall Study|Withdrawal by Subject|0|||
160714037|NCT01449812|580330598|FG000|Overall Study|Migrated/moved from study area|1|||
160714038|NCT01449812|580330599|FG001|Overall Study|Migrated/moved from study area|0|||
160714039|NCT01449812|580330600|FG002|Overall Study|Migrated/moved from study area|0|||
160714040|NCT01449812|580330598|FG000|Overall Study|Withdrawal by Subject|0|||
160714041|NCT01449812|580330599|FG001|Overall Study|Withdrawal by Subject|0|||
160714042|NCT01449812|580330600|FG002|Overall Study|Withdrawal by Subject|1|||
160714043|NCT01449812|580330598|FG000|Overall Study|Lost to Follow-up|1|||
160714044|NCT01449812|580330599|FG001|Overall Study|Lost to Follow-up|0|||
160714045|NCT01449812|580330600|FG002|Overall Study|Lost to Follow-up|0|||
160714046|NCT00625872|580330601|FG000|Overall Study|Withdrawal by Subject|1|||
160714047|NCT00625872|580330602|FG001|Overall Study|Withdrawal by Subject|0|||
160714048|NCT00625872|580330601|FG000|Overall Study|Does not meet inclusion criteria|1|||
160714049|NCT00625872|580330602|FG001|Overall Study|Does not meet inclusion criteria|0|||
160714050|NCT00625872|580330601|FG000|Overall Study|Terminated by sponsor|2|||
160714051|NCT00625872|580330602|FG001|Overall Study|Terminated by sponsor|5|||
160714052|NCT00625872|580330601|FG000|Overall Study|Randomized but not treated|0|||
160714053|NCT00625872|580330602|FG001|Overall Study|Randomized but not treated|1|||
160714054|NCT01512160|580330606|FG000|Overall Study|Lost to Follow-up|1|||
160714055|NCT01512160|580330607|FG001|Overall Study|Lost to Follow-up|0|||
160714056|NCT01512160|580330608|FG002|Overall Study|Lost to Follow-up|0|||
160714057|NCT01512160|580330609|FG003|Overall Study|Lost to Follow-up|0|||
160714058|NCT01512160|580330606|FG000|Overall Study|Withdrawal by Subject|1|||
160714059|NCT01512160|580330607|FG001|Overall Study|Withdrawal by Subject|0|||
160714060|NCT01512160|580330608|FG002|Overall Study|Withdrawal by Subject|0|||
160714061|NCT01512160|580330609|FG003|Overall Study|Withdrawal by Subject|1|||
160714062|NCT02729909|580330610|FG000|Overall Study|Lost to Follow-up|0|||
160714063|NCT02729909|580330611|FG001|Overall Study|Lost to Follow-up|1|||
160714064|NCT02729909|580330610|FG000|Overall Study|Lack of Efficacy|0|||
160714065|NCT02729909|580330611|FG001|Overall Study|Lack of Efficacy|2|||
160714066|NCT02729909|580330610|FG000|Overall Study|Significant Protocol Deviation|0|||
160714067|NCT02729909|580330611|FG001|Overall Study|Significant Protocol Deviation|2|||
160714068|NCT02729909|580330610|FG000|Overall Study|Voluntary Withdrawal|1|||
160714069|NCT02729909|580330611|FG001|Overall Study|Voluntary Withdrawal|0|||
160714070|NCT01128179|580330612|FG000|Overall Study|Death|1|||
160714071|NCT01128179|580330613|FG001|Overall Study|Death|0|||
160714072|NCT01128179|580330612|FG000|Overall Study|Protocol Violation|1|||
160714073|NCT01128179|580330613|FG001|Overall Study|Protocol Violation|0|||
160714074|NCT04075487|580331990|FG000|Overall Study|Withdrawal by Subject|1|||
160714075|NCT00265759|580331993|FG000|Overall Study|Withdrawal by Subject|0|||
160714076|NCT00265759|580331994|FG001|Overall Study|Withdrawal by Subject|1|||
160714077|NCT00265759|580331995|FG002|Overall Study|Withdrawal by Subject|2|||
160714078|NCT00265759|580331996|FG003|Overall Study|Withdrawal by Subject|2|||
160714079|NCT00265759|580331993|FG000|Overall Study|Cancel|0|||
160714080|NCT00265759|580331994|FG001|Overall Study|Cancel|0|||
160714081|NCT00265759|580331995|FG002|Overall Study|Cancel|0|||
160714082|NCT00265759|580331996|FG003|Overall Study|Cancel|3|||
160714083|NCT00265759|580331993|FG000|Overall Study|Ineligible|0|||
160714084|NCT00265759|580331994|FG001|Overall Study|Ineligible|0|||
160714085|NCT00265759|580331995|FG002|Overall Study|Ineligible|0|||
160714086|NCT00265759|580331996|FG003|Overall Study|Ineligible|1|||
160714087|NCT00265759|580331993|FG000|Overall Study|Bilateral disease|0|||
160714088|NCT00265759|580331994|FG001|Overall Study|Bilateral disease|0|||
160714089|NCT00265759|580331995|FG002|Overall Study|Bilateral disease|0|||
160714090|NCT00265759|580331996|FG003|Overall Study|Bilateral disease|2|||
160714091|NCT00265759|580331993|FG000|Overall Study|Discontinued due to intolerability|0|||
160714092|NCT00265759|580331994|FG001|Overall Study|Discontinued due to intolerability|0|||
160714093|NCT00265759|580331995|FG002|Overall Study|Discontinued due to intolerability|0|||
160714094|NCT00265759|580331996|FG003|Overall Study|Discontinued due to intolerability|1|||
160714095|NCT04467840|580331997|FG000|Overall Study|Death|35|||
160714096|NCT04467840|580331998|FG001|Overall Study|Death|39|||
160714097|NCT04467840|580331997|FG000|Overall Study|Withdrawal by Subject|8|||
160714098|NCT04467840|580331998|FG001|Overall Study|Withdrawal by Subject|4|||
160714099|NCT04467840|580331997|FG000|Overall Study|Adverse Event|2|||
160714100|NCT04467840|580331998|FG001|Overall Study|Adverse Event|0|||
160714101|NCT04467840|580331997|FG000|Overall Study|Lost to Follow-up|1|||
160714102|NCT04467840|580331998|FG001|Overall Study|Lost to Follow-up|3|||
160714103|NCT04467840|580331997|FG000|Overall Study|Physician Decision|1|||
160714104|NCT04467840|580331998|FG001|Overall Study|Physician Decision|0|||
160714105|NCT04467840|580331997|FG000|Overall Study|Other|1|||
160714106|NCT04467840|580331998|FG001|Overall Study|Other|5|||
160714107|NCT04467840|580331997|FG000|Overall Study|Missing study completion status|3|||
160714108|NCT04467840|580331998|FG001|Overall Study|Missing study completion status|1|||
160714109|NCT06082843|580332005|FG000|Overall Study|Withdrawal by Subject|0|||
160714110|NCT06082843|580332006|FG001|Overall Study|Withdrawal by Subject|2|||
160714111|NCT06082843|580332005|FG000|Overall Study|Study terminated by sponsor|12|||
160714112|NCT06082843|580332006|FG001|Overall Study|Study terminated by sponsor|8|||
160714113|NCT04358081|580332009|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
160714114|NCT04358081|580332010|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
160714115|NCT04358081|580332011|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
160714116|NCT04358081|580332009|FG000|Treatment Phase of Study|Adverse Event|1|||
160714117|NCT04358081|580332010|FG001|Treatment Phase of Study|Adverse Event|0|||
160714118|NCT04358081|580332011|FG002|Treatment Phase of Study|Adverse Event|1|||
160714119|NCT04358081|580332009|FG000|Treatment Phase of Study|Physician Decision|2|||
160714120|NCT04358081|580332010|FG001|Treatment Phase of Study|Physician Decision|0|||
160714121|NCT04358081|580332011|FG002|Treatment Phase of Study|Physician Decision|1|||
160714122|NCT04358081|580332009|FG000|Treatment Phase of Study|Protocol Violation|1|||
160714123|NCT04358081|580332010|FG001|Treatment Phase of Study|Protocol Violation|0|||
160714124|NCT04358081|580332011|FG002|Treatment Phase of Study|Protocol Violation|0|||
160714125|NCT04358081|580332009|FG000|Study Completion Phase|Death|0|||
160714126|NCT04358081|580332010|FG001|Study Completion Phase|Death|0|||
160714127|NCT04358081|580332011|FG002|Study Completion Phase|Death|1|||
160714128|NCT04358081|580332009|FG000|Study Completion Phase|Lost to Follow-up|1|||
160714129|NCT04358081|580332010|FG001|Study Completion Phase|Lost to Follow-up|0|||
160714130|NCT04358081|580332011|FG002|Study Completion Phase|Lost to Follow-up|1|||
160714131|NCT00696423|580332012|FG000|Overall Study|Lost to Follow-up|0|||
160714132|NCT00696423|580332013|FG001|Overall Study|Lost to Follow-up|5|||
160714133|NCT04054765|580332014|FG000|Baseline|Withdrawal by Subject|5|||
160714134|NCT04054765|580332015|FG001|Baseline|Withdrawal by Subject|3|||
160714135|NCT04054765|580332014|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
160714136|NCT04054765|580332015|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
160714137|NCT04054765|580332014|FG000|3-month Follow up|Withdrawal by Subject|0|||
160714138|NCT04054765|580332015|FG001|3-month Follow up|Withdrawal by Subject|3|||
160714139|NCT04054765|580332014|FG000|6-month Follow up|Lost to Follow-up|32|||
160714140|NCT04054765|580332015|FG001|6-month Follow up|Lost to Follow-up|32|||
160714141|NCT01290068|580332016|FG000|Overall Study|Adverse Event|1|||
160714142|NCT01290068|580332017|FG001|Overall Study|Adverse Event|3|||
160714143|NCT01290068|580332016|FG000|Overall Study|Lost to Follow-up|3|||
160714144|NCT01290068|580332017|FG001|Overall Study|Lost to Follow-up|0|||
160714145|NCT01290068|580332016|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
160714146|NCT01290068|580332017|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
160714147|NCT01290068|580332016|FG000|Overall Study|Other|3|||
160714148|NCT01290068|580332017|FG001|Overall Study|Other|1|||
160714149|NCT03283566|580332020|FG000|Overall Study|Lost to Follow-up|1|||
160714150|NCT03283566|580332021|FG001|Overall Study|Lost to Follow-up|2|||
160714151|NCT04515147|580332022|FG000|Overall Study|Withdrawal by Subject|1|||
160714152|NCT04515147|580332023|FG001|Overall Study|Withdrawal by Subject|0|||
160714153|NCT04515147|580332024|FG002|Overall Study|Withdrawal by Subject|10|||
160714154|NCT04515147|580332025|FG003|Overall Study|Withdrawal by Subject|18|||
160714155|NCT04515147|580332026|FG004|Overall Study|Withdrawal by Subject|1|||
160714156|NCT04515147|580332027|FG005|Overall Study|Withdrawal by Subject|8|||
160714157|NCT04515147|580332022|FG000|Overall Study|Lost to Follow-up|0|||
160714158|NCT04515147|580332023|FG001|Overall Study|Lost to Follow-up|1|||
160714159|NCT04515147|580332024|FG002|Overall Study|Lost to Follow-up|5|||
160714160|NCT04515147|580332025|FG003|Overall Study|Lost to Follow-up|6|||
160714161|NCT04515147|580332026|FG004|Overall Study|Lost to Follow-up|2|||
160714162|NCT04515147|580332027|FG005|Overall Study|Lost to Follow-up|1|||
160714163|NCT04515147|580332022|FG000|Overall Study|Adverse Event|0|||
160714164|NCT04515147|580332023|FG001|Overall Study|Adverse Event|0|||
160714165|NCT04515147|580332024|FG002|Overall Study|Adverse Event|0|||
160714166|NCT04515147|580332025|FG003|Overall Study|Adverse Event|2|||
160714167|NCT04515147|580332026|FG004|Overall Study|Adverse Event|0|||
160714168|NCT04515147|580332027|FG005|Overall Study|Adverse Event|0|||
160714169|NCT04515147|580332022|FG000|Overall Study|Miscellaneous|0|||
160714170|NCT04515147|580332023|FG001|Overall Study|Miscellaneous|0|||
160714171|NCT04515147|580332024|FG002|Overall Study|Miscellaneous|0|||
160714172|NCT04515147|580332025|FG003|Overall Study|Miscellaneous|1|||
160714173|NCT04515147|580332026|FG004|Overall Study|Miscellaneous|0|||
160714174|NCT04515147|580332027|FG005|Overall Study|Miscellaneous|1|||
160714175|NCT04123405|580332028|FG000|Overall Study|Adverse Event|1|||
160714176|NCT04123405|580332029|FG001|Overall Study|Adverse Event|2|||
160714177|NCT04123405|580332030|FG002|Overall Study|Adverse Event|3|||
160714178|NCT04123405|580332031|FG003|Overall Study|Adverse Event|3|||
160714179|NCT04123405|580332028|FG000|Overall Study|Exclusion criteria met|1|||
160714180|NCT04123405|580332029|FG001|Overall Study|Exclusion criteria met|2|||
160714181|NCT04123405|580332030|FG002|Overall Study|Exclusion criteria met|0|||
160714182|NCT04123405|580332031|FG003|Overall Study|Exclusion criteria met|2|||
160714183|NCT04123405|580332028|FG000|Overall Study|Withdrawal by Subject|1|||
160714184|NCT04123405|580332029|FG001|Overall Study|Withdrawal by Subject|3|||
160714185|NCT04123405|580332030|FG002|Overall Study|Withdrawal by Subject|0|||
160714186|NCT04123405|580332031|FG003|Overall Study|Withdrawal by Subject|2|||
160714187|NCT04123405|580332028|FG000|Overall Study|Contact to subject lost|0|||
160714188|NCT04123405|580332029|FG001|Overall Study|Contact to subject lost|0|||
160714189|NCT04123405|580332030|FG002|Overall Study|Contact to subject lost|0|||
160714190|NCT04123405|580332031|FG003|Overall Study|Contact to subject lost|1|||
160714191|NCT04123405|580332028|FG000|Overall Study|screening failure|1|||
160714192|NCT04123405|580332029|FG001|Overall Study|screening failure|0|||
160714193|NCT04123405|580332030|FG002|Overall Study|screening failure|0|||
160714194|NCT04123405|580332031|FG003|Overall Study|screening failure|0|||
160714195|NCT01050530|580332032|FG000|Overall Study|Adverse Event|6|||
160714196|NCT01050530|580332033|FG001|Overall Study|Adverse Event|3|||
160714197|NCT01050530|580332032|FG000|Overall Study|Lack of Efficacy|1|||
160714198|NCT01050530|580332033|FG001|Overall Study|Lack of Efficacy|4|||
160714199|NCT01050530|580332032|FG000|Overall Study|Withdrawal by Subject|0|||
160714200|NCT01050530|580332033|FG001|Overall Study|Withdrawal by Subject|3|||
160714201|NCT01050530|580332032|FG000|Overall Study|Protocol Violation|1|||
160714202|NCT01050530|580332033|FG001|Overall Study|Protocol Violation|0|||
160714203|NCT00545714|580332034|FG000|Induction Phase (6 Months)|Physician Decision|3|||
160714204|NCT00545714|580332034|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
160714205|NCT00545714|580332034|FG000|Induction Phase (6 Months)|Disease Progression|1|||
160714206|NCT00545714|580332034|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
160714207|NCT00545714|580332034|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
160714208|NCT00545714|580332034|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
160714209|NCT00545714|580332034|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
160714210|NCT00545714|580332034|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
160714211|NCT00545714|580332034|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
160714212|NCT00545714|580332034|FG000|Maintenance Phase (36 Months)|Death|2|||
160714213|NCT01431079|580332042|FG000|Overall Study|Lost to Follow-up|35|||
160714214|NCT01431079|580332043|FG001|Overall Study|Lost to Follow-up|39|||
160714215|NCT02790437|580332044|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
160714216|NCT02790437|580332045|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
160714217|NCT02790437|580332044|FG000|Overall Study|Adverse Event|1|||
160714218|NCT02790437|580332045|FG001|Overall Study|Adverse Event|0|||
160714219|NCT02790437|580332044|FG000|Overall Study|Withdrawal by Subject|1|||
160714220|NCT02790437|580332045|FG001|Overall Study|Withdrawal by Subject|0|||
160714221|NCT01202175|580332046|FG000|Overall Study|Lost to Follow-up|2|||
160714222|NCT01202175|580332046|FG000|Overall Study|Withdrawal by Subject|1|||
160714223|NCT01202175|580332046|FG000|Overall Study|Adverse Event|2|||
160714224|NCT01626690|580332049|FG000|Overall Study|Protocol Violation|1|||
160714225|NCT01626690|580332050|FG001|Overall Study|Protocol Violation|0|||
160714226|NCT01626690|580332049|FG000|Overall Study|Adverse Event|1|||
160714227|NCT01626690|580332050|FG001|Overall Study|Adverse Event|0|||
160714228|NCT00110396|580332055|FG000|Overall Study|Adverse Event|15|||
160714229|NCT00110396|580332055|FG000|Overall Study|Lost to Follow-up|1|||
160714230|NCT00110396|580332055|FG000|Overall Study|Administration of plasmapheresis|1|||
160714231|NCT00110396|580332055|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
160714232|NCT00110396|580332055|FG000|Overall Study|Lack of Efficacy|1|||
160714233|NCT00110396|580332055|FG000|Overall Study|Decided not to continue treatment|1|||
160714234|NCT00110396|580332055|FG000|Overall Study|Patient non-compliance|1|||
160714235|NCT00110396|580332055|FG000|Overall Study|Patient refused to continue|1|||
160714236|NCT00110396|580332055|FG000|Overall Study|Patient refused to participate|1|||
160714237|NCT00110396|580332055|FG000|Overall Study|Patient will|1|||
160714238|NCT00110396|580332055|FG000|Overall Study|Patient's decision|1|||
160714239|NCT00110396|580332055|FG000|Overall Study|Participation in MS vaccine study|1|||
160714240|NCT00110396|580332055|FG000|Overall Study|Pregnancy|1|||
160714241|NCT00110396|580332055|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
160714242|NCT00110396|580332055|FG000|Overall Study|Protocol Violation|2|||
160714243|NCT00110396|580332055|FG000|Overall Study|Patient refused to come back|1|||
160714244|NCT00110396|580332055|FG000|Overall Study|The patient has refused|2|||
160714245|NCT00110396|580332055|FG000|Overall Study|The patient has refused to visit site|1|||
160714246|NCT00110396|580332055|FG000|Overall Study|Patient is to be administered copaxone|1|||
160714247|NCT01269918|580332056|FG000|Overall Study|Did not receive study drug|0|||
160714248|NCT01269918|580332057|FG001|Overall Study|Did not receive study drug|3|||
160714249|NCT03934541|580332060|FG000|Overall Study|Study Terminated by Sponsor|0|||
160714250|NCT03934541|580332061|FG001|Overall Study|Study Terminated by Sponsor|1|||
160714251|NCT03934541|580332062|FG002|Overall Study|Study Terminated by Sponsor|0|||
160714252|NCT03934541|580332063|FG003|Overall Study|Study Terminated by Sponsor|0|||
160714253|NCT01928472|580332066|FG000|Overall Study|Death|0|||
160714254|NCT01928472|580332067|FG001|Overall Study|Death|0|||
160714255|NCT01928472|580332068|FG002|Overall Study|Death|1|||
160714256|NCT01928472|580332069|FG003|Overall Study|Death|0|||
160714257|NCT01928472|580332066|FG000|Overall Study|Withdrawal by Subject|4|||
160714258|NCT01928472|580332067|FG001|Overall Study|Withdrawal by Subject|4|||
160714259|NCT01928472|580332068|FG002|Overall Study|Withdrawal by Subject|1|||
160714260|NCT01928472|580332069|FG003|Overall Study|Withdrawal by Subject|2|||
160714261|NCT01928472|580332066|FG000|Overall Study|Lost to Follow-up|2|||
160714262|NCT01928472|580332067|FG001|Overall Study|Lost to Follow-up|3|||
160714263|NCT01928472|580332068|FG002|Overall Study|Lost to Follow-up|4|||
160714264|NCT01928472|580332069|FG003|Overall Study|Lost to Follow-up|0|||
160714265|NCT01928472|580332066|FG000|Overall Study|Administrative Reason|2|||
160714266|NCT01928472|580332067|FG001|Overall Study|Administrative Reason|1|||
160714267|NCT01928472|580332068|FG002|Overall Study|Administrative Reason|0|||
160714268|NCT01928472|580332069|FG003|Overall Study|Administrative Reason|0|||
160714269|NCT01928472|580332066|FG000|Overall Study|Unclassified|0|||
160714270|NCT01928472|580332067|FG001|Overall Study|Unclassified|0|||
160714271|NCT01928472|580332068|FG002|Overall Study|Unclassified|1|||
160714272|NCT01928472|580332069|FG003|Overall Study|Unclassified|0|||
160714273|NCT03624192|580332071|FG000|Overall Study|Lost to Follow-up|1|||
160714274|NCT03624192|580332072|FG001|Overall Study|Lost to Follow-up|1|||
160714275|NCT00065156|580332073|FG000|Overall Study|Adverse Event|37|||
160714276|NCT00065156|580332073|FG000|Overall Study|Lack of Efficacy|52|||
160714277|NCT00065156|580332073|FG000|Overall Study|Withdrawal by Subject|8|||
160714278|NCT00065156|580332073|FG000|Overall Study|Lost to Follow-up|1|||
160714279|NCT00065156|580332073|FG000|Overall Study|Death|11|||
160714280|NCT00065156|580332073|FG000|Overall Study|Study Closed by Sponsor|2|||
160714281|NCT00065156|580332073|FG000|Overall Study|Disease Progression|7|||
160714282|NCT00065156|580332073|FG000|Overall Study|Investigator Decision|2|||
160714283|NCT00065156|580332073|FG000|Overall Study|Non-Compliance|2|||
160714284|NCT00065156|580332073|FG000|Overall Study|Loss of Response|1|||
160714285|NCT00065156|580332073|FG000|Overall Study|Secondary Malign Disease|1|||
160714286|NCT04583735|580332074|FG000|Double-masked Treatment Period|Adverse Event|0|||
160714287|NCT04583735|580332075|FG001|Double-masked Treatment Period|Adverse Event|1|||
160714288|NCT04583735|580332074|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
160714289|NCT04583735|580332075|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
160714290|NCT04583735|580332074|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
160714291|NCT04583735|580332075|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
160714292|NCT04583735|580332074|FG000|Open-label Treatment Period|Adverse Event|1|||
160714293|NCT04583735|580332075|FG001|Open-label Treatment Period|Adverse Event|1|||
160714294|NCT04583735|580332074|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
160714295|NCT04583735|580332075|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
160714296|NCT04583735|580332074|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
160714297|NCT04583735|580332075|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
160714298|NCT01176513|580332076|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
160714299|NCT01197911|580332077|FG000|Overall Study|Adverse Event|0|||
160714300|NCT01197911|580332078|FG001|Overall Study|Adverse Event|0|||
160714301|NCT01197911|580332079|FG002|Overall Study|Adverse Event|1|||
160714302|NCT02123446|580332080|FG000|Washout Period (1 Day)|Physician Decision|1|||
160714303|NCT02123446|580332081|FG001|Washout Period (1 Day)|Physician Decision|0|||
160714304|NCT02553772|580332083|FG000|Overall Study|Adverse Event|2|||
160714305|NCT02553772|580332084|FG001|Overall Study|Adverse Event|3|||
160714306|NCT02553772|580332083|FG000|Overall Study|Lost to Follow-up|2|||
160714307|NCT02553772|580332084|FG001|Overall Study|Lost to Follow-up|1|||
160714308|NCT02553772|580332083|FG000|Overall Study|Withdrawal of Consent|1|||
160714309|NCT02553772|580332084|FG001|Overall Study|Withdrawal of Consent|1|||
160714310|NCT02553772|580332083|FG000|Overall Study|Lack of Efficacy|1|||
160714311|NCT02553772|580332084|FG001|Overall Study|Lack of Efficacy|0|||
160714312|NCT02553772|580332083|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160714313|NCT02553772|580332084|FG001|Overall Study|Other Miscellaneous Reasons|1|||
160714314|NCT02466321|580332085|FG000|Overall Study|Death|26|||
160714315|NCT02466321|580332085|FG000|Overall Study|Revision|6|||
160714316|NCT02466321|580332085|FG000|Overall Study|Lost to Follow-up|60|||
160714317|NCT02466321|580332085|FG000|Overall Study|Did not receive study device|1|||
160714318|NCT04331808|580332088|FG000|Overall Study|Withdrew consent|1|||
160714319|NCT04331808|580332089|FG001|Overall Study|Withdrew consent|0|||
160714320|NCT04331808|580332090|FG002|Overall Study|Withdrew consent|2|||
160714321|NCT04331808|580332091|FG003|Overall Study|Withdrew consent|3|||
160714322|NCT00952731|580332092|FG000|Overall Study|Drug supply expired|1|||
160714323|NCT00952731|580332093|FG001|Overall Study|Drug supply expired|0|||
160714324|NCT01682811|580332094|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
160714325|NCT01682811|580332095|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
160714326|NCT01682811|580332096|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
160714327|NCT01682811|580332097|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
160714328|NCT01682811|580332098|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
160714329|NCT01682811|580332099|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
160714330|NCT01682811|580332100|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
160714331|NCT01682811|580332094|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
160714332|NCT01682811|580332095|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
160714333|NCT01682811|580332096|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
160714334|NCT01682811|580332097|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
160714335|NCT01682811|580332098|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
160714336|NCT01682811|580332099|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
160714337|NCT01682811|580332100|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
160714338|NCT01682811|580332094|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
160714339|NCT01682811|580332095|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
160714340|NCT01682811|580332096|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
160714341|NCT01682811|580332097|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
160714342|NCT01682811|580332098|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
160714343|NCT01682811|580332099|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
160714344|NCT01682811|580332100|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
160714345|NCT01682811|580332094|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
160714346|NCT01682811|580332095|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
160714347|NCT01682811|580332096|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
160714348|NCT01682811|580332097|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
160714349|NCT01682811|580332098|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
160714350|NCT01682811|580332099|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
160714351|NCT01682811|580332100|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
160714352|NCT02694328|580332101|FG000|Overall Study|Adverse Event|27|||
160714353|NCT02694328|580332102|FG001|Overall Study|Adverse Event|33|||
160714354|NCT02694328|580332101|FG000|Overall Study|Withdrawal by Subject|27|||
160714355|NCT02694328|580332102|FG001|Overall Study|Withdrawal by Subject|23|||
160714356|NCT02694328|580332101|FG000|Overall Study|Lost to Follow-up|26|||
160714357|NCT02694328|580332102|FG001|Overall Study|Lost to Follow-up|22|||
160714358|NCT02694328|580332101|FG000|Overall Study|Noncompliant with study drug|11|||
160714359|NCT02694328|580332102|FG001|Overall Study|Noncompliant with study drug|8|||
160714360|NCT02694328|580332101|FG000|Overall Study|Incarceration|1|||
160714361|NCT02694328|580332102|FG001|Overall Study|Incarceration|1|||
160714362|NCT02694328|580332101|FG000|Overall Study|Lack of Efficacy|1|||
160714363|NCT02694328|580332102|FG001|Overall Study|Lack of Efficacy|2|||
160714364|NCT02694328|580332101|FG000|Overall Study|Pregnancy|1|||
160714365|NCT02694328|580332102|FG001|Overall Study|Pregnancy|1|||
160714366|NCT02694328|580332101|FG000|Overall Study|Protocol Violation|6|||
160714367|NCT02694328|580332102|FG001|Overall Study|Protocol Violation|5|||
160714368|NCT02694328|580332101|FG000|Overall Study|Abnormal Laboratory Value|0|||
160714369|NCT02694328|580332102|FG001|Overall Study|Abnormal Laboratory Value|3|||
160714370|NCT05525520|580334304|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
160714371|NCT05525520|580334305|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
160714372|NCT05525520|580334304|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
160714373|NCT05525520|580334305|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
160714374|NCT00116779|580334312|FG000|Overall Study|Adverse Event|4|||
160714375|NCT00116779|580334313|FG001|Overall Study|Adverse Event|2|||
160714376|NCT00116779|580334312|FG000|Overall Study|Protocol Violation|1|||
160714377|NCT00116779|580334313|FG001|Overall Study|Protocol Violation|4|||
160714378|NCT00116779|580334312|FG000|Overall Study|Withdrawal by Subject|4|||
160714379|NCT00116779|580334313|FG001|Overall Study|Withdrawal by Subject|1|||
160714380|NCT00116779|580334312|FG000|Overall Study|Inadequate testosterone suppression|7|||
160714381|NCT00116779|580334313|FG001|Overall Study|Inadequate testosterone suppression|9|||
160714382|NCT00116779|580334312|FG000|Overall Study|Physician Decision|3|||
160714383|NCT00116779|580334313|FG001|Overall Study|Physician Decision|1|||
160714384|NCT00116779|580334312|FG000|Overall Study|Elevated PSA levels|2|||
160714385|NCT00116779|580334313|FG001|Overall Study|Elevated PSA levels|2|||
160714386|NCT01958437|580334323|FG000|Overall Study|Incidental MRI findings|0|||
160714387|NCT01958437|580334324|FG001|Overall Study|Incidental MRI findings|0|||
160714388|NCT01958437|580334325|FG002|Overall Study|Incidental MRI findings|1|||
160714389|NCT01958437|580334326|FG003|Overall Study|Incidental MRI findings|1|||
160714390|NCT02569801|580334329|FG000|Overall Study|Withdrawal by Subject|9|||
160714391|NCT02569801|580334330|FG001|Overall Study|Withdrawal by Subject|9|||
160714392|NCT02569801|580334329|FG000|Overall Study|Sponsor Decision|13|||
160714393|NCT02569801|580334330|FG001|Overall Study|Sponsor Decision|14|||
160714394|NCT02569801|580334329|FG000|Overall Study|Progressive Disease|2|||
160714395|NCT02569801|580334330|FG001|Overall Study|Progressive Disease|7|||
160714396|NCT02569801|580334329|FG000|Overall Study|Lost to Follow-up|0|||
160714397|NCT02569801|580334330|FG001|Overall Study|Lost to Follow-up|1|||
160714398|NCT02569801|580334329|FG000|Overall Study|Death|12|||
160714399|NCT02569801|580334330|FG001|Overall Study|Death|4|||
160714400|NCT03442751|580334334|FG000|Overall Study|Withdrawal by Subject|3|||
160714401|NCT03442751|580334335|FG001|Overall Study|Withdrawal by Subject|1|||
160714402|NCT03442751|580334334|FG000|Overall Study|Lost to Follow-up|3|||
160714403|NCT03442751|580334335|FG001|Overall Study|Lost to Follow-up|0|||
160714404|NCT01308424|580334339|FG000|Baseline Eligibility|Screen Failures|71|||
160714405|NCT01308424|580334340|FG001|Baseline Eligibility|Screen Failures|0|||
160714406|NCT01308424|580334341|FG002|Baseline Eligibility|Screen Failures|0|||
160714407|NCT01308424|580334339|FG000|Randomization|Adverse Event|0|||
160714408|NCT01308424|580334340|FG001|Randomization|Adverse Event|1|||
160714409|NCT01308424|580334341|FG002|Randomization|Adverse Event|1|||
160714410|NCT01308424|580334339|FG000|Randomization|Lost to Follow-up|0|||
160714411|NCT01308424|580334340|FG001|Randomization|Lost to Follow-up|1|||
160714412|NCT01308424|580334341|FG002|Randomization|Lost to Follow-up|0|||
160714413|NCT01308424|580334339|FG000|Randomization|Physician Decision|0|||
160714414|NCT01308424|580334340|FG001|Randomization|Physician Decision|1|||
160714415|NCT01308424|580334341|FG002|Randomization|Physician Decision|1|||
160714416|NCT00948155|580334342|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
160714417|NCT00948155|580334343|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
160714418|NCT00948155|580334342|FG000|Washout 14 Days|Lost to Follow-up|1|||
160714419|NCT00948155|580334343|FG001|Washout 14 Days|Lost to Follow-up|2|||
160714420|NCT04620746|580334344|FG000|Overall Study|Adverse Event|2|||
160714421|NCT04620746|580334345|FG001|Overall Study|Adverse Event|0|||
160714422|NCT04620746|580334344|FG000|Overall Study|Uniterpretable skin test|1|||
160714423|NCT04620746|580334345|FG001|Overall Study|Uniterpretable skin test|0|||
160714424|NCT04620746|580334344|FG000|Overall Study|Withdrawal by Subject|0|||
160714425|NCT04620746|580334345|FG001|Overall Study|Withdrawal by Subject|1|||
160714426|NCT05767905|580334350|FG000|Overall Study|Adverse Event|0|||
160714427|NCT05767905|580334351|FG001|Overall Study|Adverse Event|0|||
160714428|NCT05767905|580334352|FG002|Overall Study|Adverse Event|1|||
160714429|NCT03404674|580334358|FG000|Overall Study|Inability to Attend Future Visits|0|||
160714430|NCT03404674|580334359|FG001|Overall Study|Inability to Attend Future Visits|1|||
160714431|NCT03404674|580334360|FG002|Overall Study|Inability to Attend Future Visits|1|||
160714432|NCT03404674|580334361|FG003|Overall Study|Inability to Attend Future Visits|0|||
160714433|NCT03404674|580334362|FG004|Overall Study|Inability to Attend Future Visits|0|||
160714434|NCT03404674|580334363|FG005|Overall Study|Inability to Attend Future Visits|0|||
160714435|NCT03404674|580334358|FG000|Overall Study|Behavioral Problems|0|||
160714436|NCT03404674|580334359|FG001|Overall Study|Behavioral Problems|0|||
160714437|NCT03404674|580334360|FG002|Overall Study|Behavioral Problems|1|||
160714438|NCT03404674|580334361|FG003|Overall Study|Behavioral Problems|0|||
160714439|NCT03404674|580334362|FG004|Overall Study|Behavioral Problems|0|||
160714440|NCT03404674|580334363|FG005|Overall Study|Behavioral Problems|0|||
160714441|NCT03404674|580334358|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
160714442|NCT03404674|580334359|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
160714443|NCT03404674|580334360|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
160714444|NCT03404674|580334361|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
160714445|NCT03404674|580334362|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
160714446|NCT03404674|580334363|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
160714447|NCT01640249|580334368|FG000|Period 1|Withdrawal by Subject|1|||
160714448|NCT01640249|580334369|FG001|Period 1|Withdrawal by Subject|0|||
160714449|NCT01640249|580334370|FG002|Period 1|Withdrawal by Subject|0|||
160714450|NCT01640249|580334371|FG003|Period 1|Withdrawal by Subject|0|||
160714451|NCT01640249|580334372|FG004|Period 1|Withdrawal by Subject|0|||
160714452|NCT01640249|580334373|FG005|Period 1|Withdrawal by Subject|1|||
160714453|NCT01640249|580334374|FG006|Period 1|Withdrawal by Subject|0|||
160714454|NCT00312338|580334375|FG000|Overall Study|Adverse Event|7|||
160714455|NCT00312338|580334376|FG001|Overall Study|Adverse Event|2|||
160714456|NCT00312338|580334375|FG000|Overall Study|Lost to Follow-up|9|||
160714457|NCT00312338|580334376|FG001|Overall Study|Lost to Follow-up|1|||
160714458|NCT00312338|580334375|FG000|Overall Study|Withdrawal by Subject|4|||
160714459|NCT00312338|580334376|FG001|Overall Study|Withdrawal by Subject|0|||
160714460|NCT00312338|580334375|FG000|Overall Study|Subsequent infection|2|||
160714461|NCT00312338|580334376|FG001|Overall Study|Subsequent infection|0|||
160714462|NCT00100828|580334377|FG000|Overall Study|Physician Decision|6|||
160714463|NCT01215136|580334378|FG000|Overall Study|Adverse Event|2|||
160714464|NCT01215136|580334379|FG001|Overall Study|Adverse Event|9|||
160714465|NCT01215136|580334378|FG000|Overall Study|Disease Progression|3|||
160714466|NCT01215136|580334379|FG001|Overall Study|Disease Progression|14|||
160714467|NCT01215136|580334378|FG000|Overall Study|Symptomatic Deterioration|1|||
160714468|NCT01215136|580334379|FG001|Overall Study|Symptomatic Deterioration|1|||
160714469|NCT01215136|580334378|FG000|Overall Study|Death|0|||
160714470|NCT01215136|580334379|FG001|Overall Study|Death|2|||
160714471|NCT01215136|580334378|FG000|Overall Study|Withdrawal by Subject|0|||
160714472|NCT01215136|580334379|FG001|Overall Study|Withdrawal by Subject|1|||
160714473|NCT01125917|580334384|FG000|Overall Study|Adverse Event|43|||
160714474|NCT01125917|580334384|FG000|Overall Study|Lost to Follow-up|23|||
160714475|NCT01125917|580334384|FG000|Overall Study|Withdrawal by Subject|31|||
160714476|NCT01125917|580334384|FG000|Overall Study|Administrative|223|||
160714477|NCT01125917|580334384|FG000|Overall Study|Lack of Efficacy|19|||
160714478|NCT04421131|580334385|FG000|Overall Study|Lost to Follow-up|1|||
160714479|NCT04421131|580334385|FG000|Overall Study|Protocol Violation|2|||
160714480|NCT04421131|580334385|FG000|Overall Study|App crashed|5|||
160714481|NCT02501928|580334390|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
160714482|NCT02501928|580334391|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
160714483|NCT02501928|580334392|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
160714484|NCT02501928|580334393|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
160714485|NCT02501928|580334394|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
160714486|NCT02501928|580334395|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
160714487|NCT01526057|580334399|FG000|Overall Study|Withdrawal by Subject|3|||
160714488|NCT01526057|580334400|FG001|Overall Study|Withdrawal by Subject|2|||
160714489|NCT01526057|580334401|FG002|Overall Study|Withdrawal by Subject|2|||
160714490|NCT01526057|580334399|FG000|Overall Study|Adverse Event|3|||
160714491|NCT01526057|580334400|FG001|Overall Study|Adverse Event|1|||
160714492|NCT01526057|580334401|FG002|Overall Study|Adverse Event|1|||
160714493|NCT01526057|580334399|FG000|Overall Study|Death|1|||
160714494|NCT01526057|580334400|FG001|Overall Study|Death|0|||
160714495|NCT01526057|580334401|FG002|Overall Study|Death|0|||
160714496|NCT01526057|580334399|FG000|Overall Study|Lost to Follow-up|1|||
160714497|NCT01526057|580334400|FG001|Overall Study|Lost to Follow-up|0|||
160714498|NCT01526057|580334401|FG002|Overall Study|Lost to Follow-up|1|||
160714499|NCT01526057|580334399|FG000|Overall Study|Other|1|||
160714500|NCT01526057|580334400|FG001|Overall Study|Other|0|||
160714501|NCT01526057|580334401|FG002|Overall Study|Other|1|||
160714502|NCT01526057|580334399|FG000|Overall Study|Protocol Violation|0|||
160714503|NCT01526057|580334400|FG001|Overall Study|Protocol Violation|0|||
160714504|NCT01526057|580334401|FG002|Overall Study|Protocol Violation|1|||
160714505|NCT01329900|580334402|FG000|Overall Study|Elevated creatinine/renal function|1|||
160714506|NCT01855828|580334403|FG000|Overall Study|Adverse Event|1|||
160714507|NCT01855828|580334403|FG000|Overall Study|Withdrawal by Subject|1|||
160714508|NCT01866098|580334404|FG000|Overall Study|Lost to Follow-up|11|||
160714509|NCT01866098|580334405|FG001|Overall Study|Lost to Follow-up|18|||
160714510|NCT01866098|580334406|FG002|Overall Study|Lost to Follow-up|13|||
160714511|NCT01866098|580334404|FG000|Overall Study|Physician Decision|0|||
160714512|NCT01866098|580334405|FG001|Overall Study|Physician Decision|1|||
160714513|NCT01866098|580334406|FG002|Overall Study|Physician Decision|2|||
160714514|NCT01866098|580334404|FG000|Overall Study|Adverse Event|1|||
160714515|NCT01866098|580334405|FG001|Overall Study|Adverse Event|5|||
160714516|NCT01866098|580334406|FG002|Overall Study|Adverse Event|4|||
160714517|NCT01866098|580334404|FG000|Overall Study|Protocol Violation|1|||
160714518|NCT01866098|580334405|FG001|Overall Study|Protocol Violation|0|||
160714519|NCT01866098|580334406|FG002|Overall Study|Protocol Violation|0|||
160714520|NCT01866098|580334404|FG000|Overall Study|Withdrawal by Subject|1|||
160714521|NCT01866098|580334405|FG001|Overall Study|Withdrawal by Subject|2|||
160714522|NCT01866098|580334406|FG002|Overall Study|Withdrawal by Subject|0|||
160714523|NCT01866098|580334404|FG000|Overall Study|Unrelated Hospitalization|2|||
160714524|NCT01866098|580334405|FG001|Overall Study|Unrelated Hospitalization|0|||
160714525|NCT01866098|580334406|FG002|Overall Study|Unrelated Hospitalization|1|||
160714526|NCT01866098|580334404|FG000|Overall Study|Non-compliance|1|||
160714527|NCT01866098|580334405|FG001|Overall Study|Non-compliance|0|||
160714528|NCT01866098|580334406|FG002|Overall Study|Non-compliance|1|||
160714529|NCT01866098|580334404|FG000|Overall Study|Pregnancy|2|||
160714530|NCT01866098|580334405|FG001|Overall Study|Pregnancy|0|||
160714531|NCT01866098|580334406|FG002|Overall Study|Pregnancy|0|||
160714532|NCT01866098|580334404|FG000|Overall Study|Death|0|||
160714533|NCT01866098|580334405|FG001|Overall Study|Death|1|||
160714534|NCT01866098|580334406|FG002|Overall Study|Death|0|||
160714535|NCT04239027|580334411|FG000|Overall Study|Adverse Event|4|||
160714536|NCT04239027|580334411|FG000|Overall Study|Withdrawal by Subject|9|||
160714537|NCT04239027|580334411|FG000|Overall Study|Death|1|||
160714538|NCT04239027|580334411|FG000|Overall Study|Physician Decision|9|||
160714539|NCT04239027|580334411|FG000|Overall Study|Lost to Follow-up|2|||
160714540|NCT04239027|580334411|FG000|Overall Study|Lack of Efficacy|1|||
160714541|NCT01184079|580334421|FG000|Overall Study|Lost to Follow-up|14|||
160714542|NCT01184079|580334422|FG001|Overall Study|Lost to Follow-up|2|||
160714543|NCT03172494|580334423|FG000|Overall Study|Adverse Event|5|||
160714544|NCT03172494|580334424|FG001|Overall Study|Adverse Event|1|||
160714545|NCT03172494|580334425|FG002|Overall Study|Adverse Event|15|||
160714546|NCT03172494|580334423|FG000|Overall Study|Protocol Violation|3|||
160714547|NCT03172494|580334424|FG001|Overall Study|Protocol Violation|2|||
160714548|NCT03172494|580334425|FG002|Overall Study|Protocol Violation|1|||
160714549|NCT03172494|580334423|FG000|Overall Study|Lack of Efficacy|0|||
160714550|NCT03172494|580334424|FG001|Overall Study|Lack of Efficacy|0|||
160714551|NCT03172494|580334425|FG002|Overall Study|Lack of Efficacy|4|||
160714552|NCT03172494|580334423|FG000|Overall Study|Pregnancy|0|||
160714553|NCT03172494|580334424|FG001|Overall Study|Pregnancy|1|||
160714554|NCT03172494|580334425|FG002|Overall Study|Pregnancy|0|||
160714555|NCT03172494|580334423|FG000|Overall Study|Withdrawal by Subject|10|||
160714556|NCT03172494|580334424|FG001|Overall Study|Withdrawal by Subject|8|||
160714557|NCT03172494|580334425|FG002|Overall Study|Withdrawal by Subject|8|||
160714558|NCT03172494|580334423|FG000|Overall Study|Severe hypoglycaemic episode|0|||
160714559|NCT03172494|580334424|FG001|Overall Study|Severe hypoglycaemic episode|0|||
160714560|NCT03172494|580334425|FG002|Overall Study|Severe hypoglycaemic episode|1|||
160714561|NCT03172494|580334423|FG000|Overall Study|Non-compliance towards treatment|2|||
160714562|NCT03172494|580334424|FG001|Overall Study|Non-compliance towards treatment|0|||
160714563|NCT03172494|580334425|FG002|Overall Study|Non-compliance towards treatment|0|||
160714564|NCT04233073|580334426|FG000|Overall Study|Death|5|||
160714565|NCT00143390|580334427|FG000|Overall Study|Death|2|||
160714566|NCT00143390|580334428|FG001|Overall Study|Death|0|||
160714567|NCT00143390|580334427|FG000|Overall Study|Not meeting entry criteria|2|||
160714568|NCT00143390|580334428|FG001|Overall Study|Not meeting entry criteria|5|||
160714569|NCT00143390|580334427|FG000|Overall Study|Withdrawal by Subject|4|||
160714570|NCT00143390|580334428|FG001|Overall Study|Withdrawal by Subject|4|||
160714571|NCT00143390|580334427|FG000|Overall Study|Progressive disease|119|||
160714572|NCT00143390|580334428|FG001|Overall Study|Progressive disease|115|||
160714573|NCT00143390|580334427|FG000|Overall Study|Protocol Violation|2|||
160714574|NCT00143390|580334428|FG001|Overall Study|Protocol Violation|0|||
160714575|NCT00143390|580334427|FG000|Overall Study|Study termination|10|||
160714576|NCT00143390|580334428|FG001|Overall Study|Study termination|15|||
160714577|NCT00143390|580334427|FG000|Overall Study|Adverse Event|9|||
160714578|NCT00143390|580334428|FG001|Overall Study|Adverse Event|8|||
160714579|NCT00143390|580334427|FG000|Overall Study|Other|1|||
160714580|NCT00143390|580334428|FG001|Overall Study|Other|2|||
160714581|NCT00243412|580334429|FG000|Overall Study|Death|0|||
160714582|NCT00243412|580334430|FG001|Overall Study|Death|1|||
160714583|NCT00243412|580334429|FG000|Overall Study|Adverse Event|4|||
160714584|NCT00243412|580334430|FG001|Overall Study|Adverse Event|2|||
160714585|NCT00243412|580334429|FG000|Overall Study|Lost to Follow-up|0|||
160714586|NCT00243412|580334430|FG001|Overall Study|Lost to Follow-up|1|||
160714587|NCT00243412|580334429|FG000|Overall Study|Physician Decision|1|||
160714588|NCT00243412|580334430|FG001|Overall Study|Physician Decision|1|||
160714589|NCT00243412|580334429|FG000|Overall Study|Withdrawal by Subject|4|||
160714590|NCT00243412|580334430|FG001|Overall Study|Withdrawal by Subject|5|||
160714591|NCT00243412|580334429|FG000|Overall Study|Other|1|||
160714592|NCT00243412|580334430|FG001|Overall Study|Other|1|||
160714593|NCT00041132|580334432|FG000|Overall Study|Adverse Event|19|||
160714594|NCT00041132|580334432|FG000|Overall Study|Death|1|||
160714595|NCT00041132|580334432|FG000|Overall Study|Not Eligible|7|||
160714596|NCT00041132|580334432|FG000|Overall Study|Withdrawal by Subject|1|||
160714597|NCT00041132|580334432|FG000|Overall Study|Physician Decision|2|||
160714598|NCT02764151|580334433|FG000|Overall Study|Subject refused further follow-up|0|||
160714599|NCT02764151|580334434|FG001|Overall Study|Subject refused further follow-up|0|||
160714600|NCT02764151|580334435|FG002|Overall Study|Subject refused further follow-up|0|||
160714601|NCT02764151|580334436|FG003|Overall Study|Subject refused further follow-up|1|||
160714602|NCT02764151|580334433|FG000|Overall Study|Other|0|||
160714603|NCT02764151|580334434|FG001|Overall Study|Other|0|||
160714604|NCT02764151|580334435|FG002|Overall Study|Other|0|||
160714605|NCT02764151|580334436|FG003|Overall Study|Other|2|||
160714606|NCT01450683|580334440|FG000|Overall Study|Adverse Event|2|||
160714607|NCT01523002|580334450|FG000|Period 1|Withdrawal by Subject|1|||
160714608|NCT01523002|580334451|FG001|Period 1|Withdrawal by Subject|3|||
160714609|NCT01523002|580334450|FG000|Period 1|Lost to Follow-up|1|||
160714610|NCT01523002|580334451|FG001|Period 1|Lost to Follow-up|0|||
160714611|NCT01523002|580334450|FG000|Period 1|Adverse Event|0|||
160714612|NCT01523002|580334451|FG001|Period 1|Adverse Event|8|||
160714613|NCT01523002|580334450|FG000|Period 2|Withdrawal by Subject|4|||
160714614|NCT01523002|580334451|FG001|Period 2|Withdrawal by Subject|1|||
160714615|NCT01523002|580334450|FG000|Period 2|Adverse Event|2|||
160714616|NCT01523002|580334451|FG001|Period 2|Adverse Event|5|||
160714617|NCT01523002|580334450|FG000|Period 3|Withdrawal by Subject|1|||
160714618|NCT01523002|580334451|FG001|Period 3|Withdrawal by Subject|0|||
160714619|NCT01523002|580334450|FG000|Period 3|Adverse Event|3|||
160714620|NCT01523002|580334451|FG001|Period 3|Adverse Event|0|||
160714621|NCT01256502|580334452|FG000|Overall Study|Had scaffold removed|4|||
160714622|NCT01256502|580334452|FG000|Overall Study|Personal reasons|5|||
160714623|NCT01256502|580334452|FG000|Overall Study|Protocol deviation|1|||
160714624|NCT00489255|580334453|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
160714625|NCT00489255|580334454|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
160714626|NCT00489255|580334453|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
160714627|NCT00489255|580334454|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
160714628|NCT00489255|580334453|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
160714629|NCT00489255|580334454|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
160714630|NCT00489255|580334453|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
160714631|NCT00489255|580334454|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
160714632|NCT00489255|580334453|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
160714633|NCT00489255|580334454|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
160714634|NCT00489255|580334453|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
160714635|NCT00489255|580334454|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
160714636|NCT00489255|580334453|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
160714637|NCT00489255|580334454|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
160714638|NCT00489255|580334453|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
160714639|NCT00489255|580334454|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
160714640|NCT00489255|580334453|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
160714641|NCT00489255|580334454|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
160714642|NCT00489255|580334453|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
160714643|NCT00489255|580334454|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
160714644|NCT03953612|580334455|FG000|Overall Study|Randomized but did not start|1|||
160714645|NCT03953612|580334456|FG001|Overall Study|Randomized but did not start|1|||
160714646|NCT03953612|580334457|FG002|Overall Study|Randomized but did not start|1|||
160714647|NCT03953612|580334455|FG000|Overall Study|Withdrawal by Subject|2|||
160714648|NCT03953612|580334456|FG001|Overall Study|Withdrawal by Subject|1|||
160714649|NCT03953612|580334457|FG002|Overall Study|Withdrawal by Subject|0|||
160714650|NCT03485352|580334458|FG000|Overall Study|Lost to Follow-up|9|||
160714651|NCT04779879|580334463|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
160714652|NCT04779879|580334464|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
160714653|NCT04779879|580334465|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
160714654|NCT04779879|580334466|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
160714655|NCT04779879|580334467|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
160714656|NCT04779879|580334468|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
160714657|NCT04779879|580334463|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
160714658|NCT04779879|580334464|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
160714659|NCT04779879|580334465|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
160714660|NCT04779879|580334466|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
160714661|NCT04779879|580334467|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
160714662|NCT04779879|580334468|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
160714663|NCT04779879|580334463|FG000|Part C: Up to Week 36|Death|0|||
160714664|NCT04779879|580334464|FG001|Part C: Up to Week 36|Death|0|||
160714665|NCT04779879|580334465|FG002|Part C: Up to Week 36|Death|0|||
160714666|NCT04779879|580334466|FG003|Part C: Up to Week 36|Death|0|||
160714667|NCT04779879|580334467|FG004|Part C: Up to Week 36|Death|0|||
160714668|NCT04779879|580334468|FG005|Part C: Up to Week 36|Death|1|||
160714669|NCT04779879|580334463|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
160714670|NCT04779879|580334464|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
160714671|NCT04779879|580334465|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
160714672|NCT04779879|580334466|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
160714673|NCT04779879|580334467|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
160714674|NCT04779879|580334468|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
160714675|NCT05101343|580334469|FG000|Overall Study|Withdrawal by Subject|2|||
160714676|NCT05101343|580334470|FG001|Overall Study|Withdrawal by Subject|1|||
160714677|NCT02854527|580334471|FG000|Overall Study|Adverse Event|0|||
160714678|NCT02854527|580334472|FG001|Overall Study|Adverse Event|0|||
160714679|NCT02854527|580334473|FG002|Overall Study|Adverse Event|0|||
160714680|NCT02854527|580334474|FG003|Overall Study|Adverse Event|0|||
160714681|NCT02854527|580334475|FG004|Overall Study|Adverse Event|1|||
160714682|NCT02854527|580334476|FG005|Overall Study|Adverse Event|0|||
160714683|NCT02854527|580334477|FG006|Overall Study|Adverse Event|0|||
160714684|NCT02854527|580334478|FG007|Overall Study|Adverse Event|0|||
160714685|NCT02854527|580334479|FG008|Overall Study|Adverse Event|0|||
160714686|NCT02854527|580334480|FG009|Overall Study|Adverse Event|0|||
160714687|NCT02854527|580334471|FG000|Overall Study|Lost to Follow-up|0|||
160714688|NCT02854527|580334472|FG001|Overall Study|Lost to Follow-up|0|||
160714689|NCT02854527|580334473|FG002|Overall Study|Lost to Follow-up|0|||
160714690|NCT02854527|580334474|FG003|Overall Study|Lost to Follow-up|1|||
160714691|NCT02854527|580334475|FG004|Overall Study|Lost to Follow-up|0|||
160714692|NCT02854527|580334476|FG005|Overall Study|Lost to Follow-up|0|||
160714693|NCT02854527|580334477|FG006|Overall Study|Lost to Follow-up|0|||
160714694|NCT02854527|580334478|FG007|Overall Study|Lost to Follow-up|0|||
160714695|NCT02854527|580334479|FG008|Overall Study|Lost to Follow-up|0|||
160714696|NCT02854527|580334480|FG009|Overall Study|Lost to Follow-up|0|||
160714697|NCT01959295|580334481|FG000|Overall Study|Adverse Event|2|||
160714698|NCT01959295|580334482|FG001|Overall Study|Adverse Event|0|||
160714699|NCT01959295|580334481|FG000|Overall Study|Lost to Follow-up|0|||
160714700|NCT01959295|580334482|FG001|Overall Study|Lost to Follow-up|2|||
160714701|NCT01959295|580334481|FG000|Overall Study|Physician Decision|2|||
160714702|NCT01959295|580334482|FG001|Overall Study|Physician Decision|3|||
160714703|NCT01959295|580334481|FG000|Overall Study|Protocol Violation|16|||
160714704|NCT01959295|580334482|FG001|Overall Study|Protocol Violation|5|||
160714705|NCT01959295|580334481|FG000|Overall Study|Withdrawal by Subject|3|||
160714706|NCT01959295|580334482|FG001|Overall Study|Withdrawal by Subject|1|||
160714707|NCT01959295|580334481|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
160714708|NCT01959295|580334482|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
160714709|NCT05655546|580336820|FG000|Overall Study|Withdrawal by Subject|2|||
160714710|NCT05655546|580336821|FG001|Overall Study|Withdrawal by Subject|4|||
160714711|NCT03493685|580336822|FG000|Overall Study|Death|4|||
160714712|NCT03493685|580336823|FG001|Overall Study|Death|3|||
160714713|NCT03493685|580336822|FG000|Overall Study|Lost to Follow-up|3|||
160714714|NCT03493685|580336823|FG001|Overall Study|Lost to Follow-up|2|||
160714715|NCT03493685|580336822|FG000|Overall Study|Physician Decision|2|||
160714716|NCT03493685|580336823|FG001|Overall Study|Physician Decision|0|||
160714717|NCT03493685|580336822|FG000|Overall Study|Withdrawal by Subject|7|||
160714718|NCT03493685|580336823|FG001|Overall Study|Withdrawal by Subject|11|||
160714719|NCT04452669|580336824|FG000|Overall Study|Death|1|||
160714720|NCT04452669|580336825|FG001|Overall Study|Death|4|||
160714721|NCT04576507|580336829|FG000|Overall Study|Adverse Event|4|||
160714722|NCT04576507|580336829|FG000|Overall Study|Withdrawal by Subject|1|||
160714723|NCT04653454|580336830|FG000|Overall Study|Withdrawal by Subject|1|||
160714724|NCT04653454|580336830|FG000|Overall Study|Physician Decision|40|||
160714725|NCT05878093|580336831|FG000|Overall Study|Withdrawal by Subject|3|||
160714726|NCT05878093|580336832|FG001|Overall Study|Withdrawal by Subject|1|||
160714727|NCT02721732|580336833|FG000|Overall Study|Adverse Event|2|||
160714728|NCT02721732|580336834|FG001|Overall Study|Adverse Event|0|||
160714729|NCT02721732|580336835|FG002|Overall Study|Adverse Event|2|||
160714730|NCT02721732|580336836|FG003|Overall Study|Adverse Event|0|||
160714731|NCT02721732|580336837|FG004|Overall Study|Adverse Event|1|||
160714732|NCT02721732|580336838|FG005|Overall Study|Adverse Event|0|||
160714733|NCT02721732|580336839|FG006|Overall Study|Adverse Event|1|||
160714734|NCT02721732|580336840|FG007|Overall Study|Adverse Event|0|||
160714735|NCT02721732|580336841|FG008|Overall Study|Adverse Event|1|||
160714736|NCT02721732|580336842|FG009|Overall Study|Adverse Event|1|||
160714737|NCT02721732|580336833|FG000|Overall Study|Death|0|||
160714738|NCT02721732|580336834|FG001|Overall Study|Death|0|||
160714739|NCT02721732|580336835|FG002|Overall Study|Death|0|||
160714740|NCT02721732|580336836|FG003|Overall Study|Death|0|||
160714741|NCT02721732|580336837|FG004|Overall Study|Death|1|||
160714742|NCT02721732|580336838|FG005|Overall Study|Death|0|||
160714743|NCT02721732|580336839|FG006|Overall Study|Death|1|||
160714744|NCT02721732|580336840|FG007|Overall Study|Death|0|||
160714745|NCT02721732|580336841|FG008|Overall Study|Death|0|||
160714746|NCT02721732|580336842|FG009|Overall Study|Death|1|||
160714747|NCT02721732|580336833|FG000|Overall Study|Lack of Efficacy|12|||
160714748|NCT02721732|580336834|FG001|Overall Study|Lack of Efficacy|11|||
160714749|NCT02721732|580336835|FG002|Overall Study|Lack of Efficacy|18|||
160714750|NCT02721732|580336836|FG003|Overall Study|Lack of Efficacy|5|||
160714751|NCT02721732|580336837|FG004|Overall Study|Lack of Efficacy|21|||
160714752|NCT02721732|580336838|FG005|Overall Study|Lack of Efficacy|2|||
160714753|NCT02721732|580336839|FG006|Overall Study|Lack of Efficacy|8|||
160714754|NCT02721732|580336840|FG007|Overall Study|Lack of Efficacy|11|||
160714755|NCT02721732|580336841|FG008|Overall Study|Lack of Efficacy|10|||
160714756|NCT02721732|580336842|FG009|Overall Study|Lack of Efficacy|20|||
160714757|NCT02721732|580336833|FG000|Overall Study|Physician Decision|0|||
160714758|NCT02721732|580336834|FG001|Overall Study|Physician Decision|0|||
160714759|NCT02721732|580336835|FG002|Overall Study|Physician Decision|1|||
160714760|NCT02721732|580336836|FG003|Overall Study|Physician Decision|0|||
160714761|NCT02721732|580336837|FG004|Overall Study|Physician Decision|0|||
160714762|NCT02721732|580336838|FG005|Overall Study|Physician Decision|0|||
160714763|NCT02721732|580336839|FG006|Overall Study|Physician Decision|0|||
160714764|NCT02721732|580336840|FG007|Overall Study|Physician Decision|0|||
160714765|NCT02721732|580336841|FG008|Overall Study|Physician Decision|0|||
160714766|NCT02721732|580336842|FG009|Overall Study|Physician Decision|0|||
160714767|NCT02721732|580336833|FG000|Overall Study|Withdrawal by Subject|1|||
160714768|NCT02721732|580336834|FG001|Overall Study|Withdrawal by Subject|0|||
160714769|NCT02721732|580336835|FG002|Overall Study|Withdrawal by Subject|0|||
160714770|NCT02721732|580336836|FG003|Overall Study|Withdrawal by Subject|0|||
160714771|NCT02721732|580336837|FG004|Overall Study|Withdrawal by Subject|3|||
160714772|NCT02721732|580336838|FG005|Overall Study|Withdrawal by Subject|0|||
160714773|NCT02721732|580336839|FG006|Overall Study|Withdrawal by Subject|1|||
160714774|NCT02721732|580336840|FG007|Overall Study|Withdrawal by Subject|1|||
160714775|NCT02721732|580336841|FG008|Overall Study|Withdrawal by Subject|0|||
160714776|NCT02721732|580336842|FG009|Overall Study|Withdrawal by Subject|1|||
160714777|NCT02721732|580336833|FG000|Overall Study|Participant Choice|1|||
160714778|NCT02721732|580336834|FG001|Overall Study|Participant Choice|0|||
160714779|NCT02721732|580336835|FG002|Overall Study|Participant Choice|0|||
160714780|NCT02721732|580336836|FG003|Overall Study|Participant Choice|0|||
160714781|NCT02721732|580336837|FG004|Overall Study|Participant Choice|0|||
160714782|NCT02721732|580336838|FG005|Overall Study|Participant Choice|0|||
160714783|NCT02721732|580336839|FG006|Overall Study|Participant Choice|0|||
160714784|NCT02721732|580336840|FG007|Overall Study|Participant Choice|0|||
160714785|NCT02721732|580336841|FG008|Overall Study|Participant Choice|0|||
160714786|NCT02721732|580336842|FG009|Overall Study|Participant Choice|1|||
160714787|NCT02721732|580336833|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
160714788|NCT02721732|580336834|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
160714789|NCT02721732|580336835|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
160714790|NCT02721732|580336836|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
160714791|NCT02721732|580336837|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
160714792|NCT02721732|580336838|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
160714793|NCT02721732|580336839|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
160714794|NCT02721732|580336840|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
160714795|NCT02721732|580336841|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
160714796|NCT02721732|580336842|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
160714797|NCT02721732|580336833|FG000|Overall Study|Progression and withdrew consent|1|||
160714798|NCT02721732|580336834|FG001|Overall Study|Progression and withdrew consent|1|||
160714799|NCT02721732|580336835|FG002|Overall Study|Progression and withdrew consent|0|||
160714800|NCT02721732|580336836|FG003|Overall Study|Progression and withdrew consent|0|||
160714801|NCT02721732|580336837|FG004|Overall Study|Progression and withdrew consent|0|||
160714802|NCT02721732|580336838|FG005|Overall Study|Progression and withdrew consent|0|||
160714803|NCT02721732|580336839|FG006|Overall Study|Progression and withdrew consent|0|||
160714804|NCT02721732|580336840|FG007|Overall Study|Progression and withdrew consent|0|||
160714805|NCT02721732|580336841|FG008|Overall Study|Progression and withdrew consent|0|||
160714806|NCT02721732|580336842|FG009|Overall Study|Progression and withdrew consent|1|||
160714807|NCT02721732|580336833|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
160714808|NCT02721732|580336834|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
160714809|NCT02721732|580336835|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
160714810|NCT02721732|580336836|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
160714811|NCT02721732|580336837|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
160714812|NCT02721732|580336838|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
160714813|NCT02721732|580336839|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
160714814|NCT02721732|580336840|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
160714815|NCT02721732|580336841|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
160714816|NCT02721732|580336842|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
160714817|NCT04100018|580336843|FG000|Pre-Treatment Period|Not Reported|0|||
160714818|NCT04100018|580336844|FG001|Pre-Treatment Period|Not Reported|4|||
160714819|NCT04100018|580336843|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
160714820|NCT04100018|580336844|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
160714821|NCT04100018|580336843|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
160714822|NCT04100018|580336844|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
160714823|NCT04100018|580336843|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
160714824|NCT04100018|580336844|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
160714825|NCT04100018|580336843|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
160714826|NCT04100018|580336844|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
160714827|NCT04100018|580336843|FG000|Treatment Period|Ongoing Treatment|1|||
160714828|NCT04100018|580336844|FG001|Treatment Period|Ongoing Treatment|0|||
160714829|NCT04100018|580336843|FG000|Treatment Period|Other Reason|26|||
160714830|NCT04100018|580336844|FG001|Treatment Period|Other Reason|37|||
160714831|NCT04100018|580336843|FG000|Treatment Period|Completed treatment as per protocol|1|||
160714832|NCT04100018|580336844|FG001|Treatment Period|Completed treatment as per protocol|2|||
160714833|NCT04100018|580336843|FG000|Treatment Period|Maximum clinical benefit|3|||
160714834|NCT04100018|580336844|FG001|Treatment Period|Maximum clinical benefit|0|||
160714835|NCT04100018|580336843|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
160714836|NCT04100018|580336844|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
160714837|NCT04100018|580336843|FG000|Treatment Period|Study drug toxicity|67|||
160714838|NCT04100018|580336844|FG001|Treatment Period|Study drug toxicity|28|||
160714839|NCT04100018|580336843|FG000|Treatment Period|Disease Progression|284|||
160714840|NCT04100018|580336844|FG001|Treatment Period|Disease Progression|327|||
160714841|NCT04100018|580336843|FG000|Treatment Period|Administrative reasons by sponsor|16|||
160714842|NCT04100018|580336844|FG001|Treatment Period|Administrative reasons by sponsor|30|||
160714843|NCT04100018|580336843|FG000|Treatment Period|Poor/Non-Compliance|1|||
160714844|NCT04100018|580336844|FG001|Treatment Period|Poor/Non-Compliance|0|||
160714845|NCT04100018|580336843|FG000|Treatment Period|Lost to Follow-up|2|||
160714846|NCT04100018|580336844|FG001|Treatment Period|Lost to Follow-up|2|||
160714847|NCT04100018|580336843|FG000|Treatment Period|Death|16|||
160714848|NCT04100018|580336844|FG001|Treatment Period|Death|11|||
160714849|NCT04100018|580336843|FG000|Treatment Period|Participant withdrew consent|10|||
160714850|NCT04100018|580336844|FG001|Treatment Period|Participant withdrew consent|10|||
160714851|NCT04100018|580336843|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
160714852|NCT04100018|580336844|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
160714853|NCT04100018|580336843|FG000|Treatment Period|Adverse Event|14|||
160714854|NCT04100018|580336844|FG001|Treatment Period|Adverse Event|6|||
160714855|NCT04100018|580336843|FG000|Treatment Period|Lack of Efficacy|4|||
160714856|NCT04100018|580336844|FG001|Treatment Period|Lack of Efficacy|2|||
160714857|NCT02848001|580336845|FG000|Overall Study|other reasons|0|||
160714858|NCT02848001|580336846|FG001|Overall Study|other reasons|0|||
160714859|NCT02848001|580336847|FG002|Overall Study|other reasons|1|||
160714860|NCT02848001|580336848|FG003|Overall Study|other reasons|0|||
160714861|NCT02848001|580336849|FG004|Overall Study|other reasons|4|||
160714862|NCT02848001|580336850|FG005|Overall Study|other reasons|1|||
160714863|NCT02848001|580336851|FG006|Overall Study|other reasons|0|||
160714864|NCT02848001|580336852|FG007|Overall Study|other reasons|2|||
160714865|NCT02848001|580336853|FG008|Overall Study|other reasons|2|||
160714866|NCT02848001|580336854|FG009|Overall Study|other reasons|3|||
160714867|NCT02848001|580336855|FG010|Overall Study|other reasons|0|||
160714868|NCT02848001|580336856|FG011|Overall Study|other reasons|1|||
160714869|NCT02848001|580336857|FG012|Overall Study|other reasons|1|||
160714870|NCT02848001|580336858|FG013|Overall Study|other reasons|0|||
160714871|NCT02848001|580336859|FG014|Overall Study|other reasons|0|||
160714872|NCT02848001|580336860|FG015|Overall Study|other reasons|2|||
160714873|NCT02848001|580336861|FG016|Overall Study|other reasons|1|||
160714874|NCT02848001|580336845|FG000|Overall Study|Lack of Efficacy|0|||
160714875|NCT02848001|580336846|FG001|Overall Study|Lack of Efficacy|1|||
160714876|NCT02848001|580336847|FG002|Overall Study|Lack of Efficacy|1|||
160714877|NCT02848001|580336848|FG003|Overall Study|Lack of Efficacy|2|||
160714878|NCT02848001|580336849|FG004|Overall Study|Lack of Efficacy|3|||
160714879|NCT02848001|580336850|FG005|Overall Study|Lack of Efficacy|0|||
160714880|NCT02848001|580336851|FG006|Overall Study|Lack of Efficacy|1|||
160714881|NCT02848001|580336852|FG007|Overall Study|Lack of Efficacy|0|||
160714882|NCT02848001|580336853|FG008|Overall Study|Lack of Efficacy|0|||
160714883|NCT02848001|580336854|FG009|Overall Study|Lack of Efficacy|1|||
160714884|NCT02848001|580336855|FG010|Overall Study|Lack of Efficacy|0|||
160714885|NCT02848001|580336856|FG011|Overall Study|Lack of Efficacy|2|||
160714886|NCT02848001|580336857|FG012|Overall Study|Lack of Efficacy|0|||
160714887|NCT02848001|580336858|FG013|Overall Study|Lack of Efficacy|2|||
160714888|NCT02848001|580336859|FG014|Overall Study|Lack of Efficacy|2|||
160714889|NCT02848001|580336860|FG015|Overall Study|Lack of Efficacy|0|||
160714890|NCT02848001|580336861|FG016|Overall Study|Lack of Efficacy|0|||
160714891|NCT02848001|580336845|FG000|Overall Study|Progressive Disease|2|||
160714892|NCT02848001|580336846|FG001|Overall Study|Progressive Disease|1|||
160714893|NCT02848001|580336847|FG002|Overall Study|Progressive Disease|0|||
160714894|NCT02848001|580336848|FG003|Overall Study|Progressive Disease|4|||
160714895|NCT02848001|580336849|FG004|Overall Study|Progressive Disease|3|||
160714896|NCT02848001|580336850|FG005|Overall Study|Progressive Disease|0|||
160714897|NCT02848001|580336851|FG006|Overall Study|Progressive Disease|4|||
160714898|NCT02848001|580336852|FG007|Overall Study|Progressive Disease|1|||
160714899|NCT02848001|580336853|FG008|Overall Study|Progressive Disease|0|||
160714900|NCT02848001|580336854|FG009|Overall Study|Progressive Disease|2|||
160714901|NCT02848001|580336855|FG010|Overall Study|Progressive Disease|3|||
160714902|NCT02848001|580336856|FG011|Overall Study|Progressive Disease|2|||
160714903|NCT02848001|580336857|FG012|Overall Study|Progressive Disease|1|||
160714904|NCT02848001|580336858|FG013|Overall Study|Progressive Disease|0|||
160714905|NCT02848001|580336859|FG014|Overall Study|Progressive Disease|2|||
160714906|NCT02848001|580336860|FG015|Overall Study|Progressive Disease|4|||
160714907|NCT02848001|580336861|FG016|Overall Study|Progressive Disease|0|||
160714908|NCT02848001|580336845|FG000|Overall Study|Adverse Event|0|||
160714909|NCT02848001|580336846|FG001|Overall Study|Adverse Event|0|||
160714910|NCT02848001|580336847|FG002|Overall Study|Adverse Event|0|||
160714911|NCT02848001|580336848|FG003|Overall Study|Adverse Event|0|||
160714912|NCT02848001|580336849|FG004|Overall Study|Adverse Event|2|||
160714913|NCT02848001|580336850|FG005|Overall Study|Adverse Event|0|||
160714914|NCT02848001|580336851|FG006|Overall Study|Adverse Event|0|||
160714915|NCT02848001|580336852|FG007|Overall Study|Adverse Event|0|||
160714916|NCT02848001|580336853|FG008|Overall Study|Adverse Event|0|||
160714917|NCT02848001|580336854|FG009|Overall Study|Adverse Event|1|||
160714918|NCT02848001|580336855|FG010|Overall Study|Adverse Event|0|||
160714919|NCT02848001|580336856|FG011|Overall Study|Adverse Event|1|||
160714920|NCT02848001|580336857|FG012|Overall Study|Adverse Event|1|||
160714921|NCT02848001|580336858|FG013|Overall Study|Adverse Event|0|||
160714922|NCT02848001|580336859|FG014|Overall Study|Adverse Event|2|||
160714923|NCT02848001|580336860|FG015|Overall Study|Adverse Event|0|||
160714924|NCT02848001|580336861|FG016|Overall Study|Adverse Event|0|||
160714925|NCT02848001|580336845|FG000|Overall Study|Death|0|||
160714926|NCT02848001|580336846|FG001|Overall Study|Death|0|||
160714927|NCT02848001|580336847|FG002|Overall Study|Death|0|||
160714928|NCT02848001|580336848|FG003|Overall Study|Death|1|||
160714929|NCT02848001|580336849|FG004|Overall Study|Death|3|||
160714930|NCT02848001|580336850|FG005|Overall Study|Death|1|||
160714931|NCT02848001|580336851|FG006|Overall Study|Death|2|||
160714932|NCT02848001|580336852|FG007|Overall Study|Death|3|||
160714933|NCT02848001|580336853|FG008|Overall Study|Death|4|||
160714934|NCT02848001|580336854|FG009|Overall Study|Death|1|||
160714935|NCT02848001|580336855|FG010|Overall Study|Death|0|||
160714936|NCT02848001|580336856|FG011|Overall Study|Death|1|||
160714937|NCT02848001|580336857|FG012|Overall Study|Death|3|||
160714938|NCT02848001|580336858|FG013|Overall Study|Death|0|||
160714939|NCT02848001|580336859|FG014|Overall Study|Death|2|||
160714940|NCT02848001|580336860|FG015|Overall Study|Death|3|||
160714941|NCT02848001|580336861|FG016|Overall Study|Death|0|||
160714942|NCT02848001|580336845|FG000|Overall Study|Physician Decision|0|||
160714943|NCT02848001|580336846|FG001|Overall Study|Physician Decision|0|||
160714944|NCT02848001|580336847|FG002|Overall Study|Physician Decision|0|||
160714945|NCT02848001|580336848|FG003|Overall Study|Physician Decision|0|||
160714946|NCT02848001|580336849|FG004|Overall Study|Physician Decision|0|||
160714947|NCT02848001|580336850|FG005|Overall Study|Physician Decision|0|||
160714948|NCT02848001|580336851|FG006|Overall Study|Physician Decision|0|||
160714949|NCT02848001|580336852|FG007|Overall Study|Physician Decision|0|||
160714950|NCT02848001|580336853|FG008|Overall Study|Physician Decision|1|||
160714951|NCT02848001|580336854|FG009|Overall Study|Physician Decision|1|||
160714952|NCT02848001|580336855|FG010|Overall Study|Physician Decision|0|||
160714953|NCT02848001|580336856|FG011|Overall Study|Physician Decision|0|||
160714954|NCT02848001|580336857|FG012|Overall Study|Physician Decision|2|||
160714955|NCT02848001|580336858|FG013|Overall Study|Physician Decision|0|||
160714956|NCT02848001|580336859|FG014|Overall Study|Physician Decision|0|||
160714957|NCT02848001|580336860|FG015|Overall Study|Physician Decision|0|||
160714958|NCT02848001|580336861|FG016|Overall Study|Physician Decision|0|||
160714959|NCT02848001|580336845|FG000|Overall Study|Withdrawal by Subject|0|||
160714960|NCT02848001|580336846|FG001|Overall Study|Withdrawal by Subject|0|||
160714961|NCT02848001|580336847|FG002|Overall Study|Withdrawal by Subject|0|||
160714962|NCT02848001|580336848|FG003|Overall Study|Withdrawal by Subject|0|||
160714963|NCT02848001|580336849|FG004|Overall Study|Withdrawal by Subject|0|||
160714964|NCT02848001|580336850|FG005|Overall Study|Withdrawal by Subject|1|||
160714965|NCT02848001|580336851|FG006|Overall Study|Withdrawal by Subject|1|||
160714966|NCT02848001|580336852|FG007|Overall Study|Withdrawal by Subject|1|||
160714967|NCT02848001|580336853|FG008|Overall Study|Withdrawal by Subject|0|||
160714968|NCT02848001|580336854|FG009|Overall Study|Withdrawal by Subject|0|||
160714969|NCT02848001|580336855|FG010|Overall Study|Withdrawal by Subject|0|||
160714970|NCT02848001|580336856|FG011|Overall Study|Withdrawal by Subject|0|||
160714971|NCT02848001|580336857|FG012|Overall Study|Withdrawal by Subject|0|||
160714972|NCT02848001|580336858|FG013|Overall Study|Withdrawal by Subject|0|||
160714973|NCT02848001|580336859|FG014|Overall Study|Withdrawal by Subject|0|||
160714974|NCT02848001|580336860|FG015|Overall Study|Withdrawal by Subject|0|||
160714975|NCT02848001|580336861|FG016|Overall Study|Withdrawal by Subject|0|||
160714976|NCT00725283|580336865|FG000|Overall Study|Missing Code|3|||
160714977|NCT00725283|580336865|FG000|Overall Study|Death|5|||
160714978|NCT00725283|580336865|FG000|Overall Study|Other|6|||
160714979|NCT00725283|580336865|FG000|Overall Study|Withdrawal by Subject|10|||
160714980|NCT03103087|580336866|FG000|Overall Study|Did not receive any study drug|1|||
160714981|NCT03103087|580336867|FG001|Overall Study|Did not receive any study drug|0|||
160714982|NCT03103087|580336868|FG002|Overall Study|Did not receive any study drug|0|||
160714983|NCT03103087|580336866|FG000|Overall Study|Protocol Violation|1|||
160714984|NCT03103087|580336867|FG001|Overall Study|Protocol Violation|2|||
160714985|NCT03103087|580336868|FG002|Overall Study|Protocol Violation|1|||
160714986|NCT03103087|580336866|FG000|Overall Study|Lack of Efficacy|2|||
160714987|NCT03103087|580336867|FG001|Overall Study|Lack of Efficacy|1|||
160714988|NCT03103087|580336868|FG002|Overall Study|Lack of Efficacy|1|||
160714989|NCT03103087|580336866|FG000|Overall Study|Pregnancy|0|||
160714990|NCT03103087|580336867|FG001|Overall Study|Pregnancy|0|||
160714991|NCT03103087|580336868|FG002|Overall Study|Pregnancy|1|||
160714992|NCT03103087|580336866|FG000|Overall Study|Adverse Event|2|||
160714993|NCT03103087|580336867|FG001|Overall Study|Adverse Event|15|||
160714994|NCT03103087|580336868|FG002|Overall Study|Adverse Event|6|||
160714995|NCT03103087|580336866|FG000|Overall Study|Withdrawal by Subject|13|||
160714996|NCT03103087|580336867|FG001|Overall Study|Withdrawal by Subject|6|||
160714997|NCT03103087|580336868|FG002|Overall Study|Withdrawal by Subject|6|||
160714998|NCT03103087|580336866|FG000|Overall Study|Lost to Follow-up|4|||
160714999|NCT03103087|580336867|FG001|Overall Study|Lost to Follow-up|2|||
160715000|NCT03103087|580336868|FG002|Overall Study|Lost to Follow-up|7|||
160715001|NCT03103087|580336866|FG000|Overall Study|Other reason not reported|1|||
160715002|NCT03103087|580336867|FG001|Overall Study|Other reason not reported|3|||
160715003|NCT03103087|580336868|FG002|Overall Study|Other reason not reported|5|||
160715004|NCT00118157|580336869|FG000|Overall Study|Adverse Event|2|||
160715005|NCT00118157|580336869|FG000|Overall Study|Death|8|||
160715006|NCT00118157|580336869|FG000|Overall Study|Withdrawal by Subject|2|||
160715007|NCT00413699|580336870|FG000|Initial Period|Death|25|||
160715008|NCT00413699|580336871|FG001|Initial Period|Death|30|||
160715009|NCT00413699|580336872|FG002|Initial Period|Death|0|||
160715010|NCT00413699|580336870|FG000|Initial Period|Lack of Efficacy|59|||
160715011|NCT00413699|580336871|FG001|Initial Period|Lack of Efficacy|115|||
160715012|NCT00413699|580336872|FG002|Initial Period|Lack of Efficacy|0|||
160715013|NCT00413699|580336870|FG000|Initial Period|Lost to Follow-up|31|||
160715014|NCT00413699|580336871|FG001|Initial Period|Lost to Follow-up|101|||
160715015|NCT00413699|580336872|FG002|Initial Period|Lost to Follow-up|0|||
160715016|NCT00413699|580336870|FG000|Initial Period|Protocol Violation|38|||
160715017|NCT00413699|580336871|FG001|Initial Period|Protocol Violation|89|||
160715018|NCT00413699|580336872|FG002|Initial Period|Protocol Violation|0|||
160715019|NCT00413699|580336870|FG000|Initial Period|Pregnancy|10|||
160715020|NCT00413699|580336871|FG001|Initial Period|Pregnancy|8|||
160715021|NCT00413699|580336872|FG002|Initial Period|Pregnancy|0|||
160715022|NCT00413699|580336870|FG000|Initial Period|Did not meet entrance criteria|2|||
160715023|NCT00413699|580336871|FG001|Initial Period|Did not meet entrance criteria|2|||
160715024|NCT00413699|580336872|FG002|Initial Period|Did not meet entrance criteria|0|||
160715025|NCT00413699|580336870|FG000|Initial Period|Medication error without adverse event|0|||
160715026|NCT00413699|580336871|FG001|Initial Period|Medication error without adverse event|1|||
160715027|NCT00413699|580336872|FG002|Initial Period|Medication error without adverse event|0|||
160715028|NCT00413699|580336870|FG000|Initial Period|Study terminated by Sponsor|0|||
160715029|NCT00413699|580336871|FG001|Initial Period|Study terminated by Sponsor|1|||
160715030|NCT00413699|580336872|FG002|Initial Period|Study terminated by Sponsor|0|||
160715031|NCT00413699|580336870|FG000|Initial Period|Other|67|||
160715032|NCT00413699|580336871|FG001|Initial Period|Other|211|||
160715033|NCT00413699|580336872|FG002|Initial Period|Other|0|||
160715034|NCT00413699|580336870|FG000|Initial Period|Adverse event related to study drug|178|||
160715035|NCT00413699|580336871|FG001|Initial Period|Adverse event related to study drug|527|||
160715036|NCT00413699|580336872|FG002|Initial Period|Adverse event related to study drug|0|||
160715037|NCT00413699|580336870|FG000|Initial Period|Adverse event not related to study drug|113|||
160715038|NCT00413699|580336871|FG001|Initial Period|Adverse event not related to study drug|248|||
160715039|NCT00413699|580336872|FG002|Initial Period|Adverse event not related to study drug|0|||
160715040|NCT00413699|580336870|FG000|Initial Period|Missing end of study page|0|||
160715041|NCT00413699|580336871|FG001|Initial Period|Missing end of study page|4|||
160715042|NCT00413699|580336872|FG002|Initial Period|Missing end of study page|0|||
160715043|NCT00413699|580336870|FG000|Initial Period|No longer willing to participate|116|||
160715044|NCT00413699|580336871|FG001|Initial Period|No longer willing to participate|368|||
160715045|NCT00413699|580336872|FG002|Initial Period|No longer willing to participate|0|||
160715046|NCT00413699|580336870|FG000|Extension Period|No Longer Willing to Participate|0|||
160715047|NCT00413699|580336871|FG001|Extension Period|No Longer Willing to Participate|0|||
160715048|NCT00413699|580336872|FG002|Extension Period|No Longer Willing to Participate|2|||
160715049|NCT00413699|580336870|FG000|Extension Period|Protocol Violation|0|||
160715050|NCT00413699|580336871|FG001|Extension Period|Protocol Violation|0|||
160715051|NCT00413699|580336872|FG002|Extension Period|Protocol Violation|1|||
160715052|NCT00413699|580336870|FG000|Extension Period|Adverse Event|0|||
160715053|NCT00413699|580336871|FG001|Extension Period|Adverse Event|0|||
160715054|NCT00413699|580336872|FG002|Extension Period|Adverse Event|2|||
160715055|NCT02115269|580336873|FG000|Overall Study|Lost to Follow-up|43|||
160715056|NCT02115269|580336873|FG000|Overall Study|Did not complete patient diary|3|||
160715057|NCT02115269|580336873|FG000|Overall Study|Moved to another city|7|||
160715058|NCT02115269|580336873|FG000|Overall Study|Withdrawal by Subject|2|||
160715059|NCT02115269|580336873|FG000|Overall Study|Didn't take study drug|2|||
160715060|NCT04179838|580336875|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
160715061|NCT04179838|580336876|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
160715062|NCT04179838|580336875|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
160715063|NCT04179838|580336876|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
160715064|NCT01103180|580336879|FG000|Overall Study|Withdrawal by Subject|8|||
160715065|NCT01103180|580336880|FG001|Overall Study|Withdrawal by Subject|13|||
160715066|NCT01103180|580336879|FG000|Overall Study|Lost to Follow-up|13|||
160715067|NCT01103180|580336880|FG001|Overall Study|Lost to Follow-up|7|||
160715068|NCT01103180|580336879|FG000|Overall Study|Physician Decision|1|||
160715069|NCT01103180|580336880|FG001|Overall Study|Physician Decision|0|||
160715070|NCT01103180|580336879|FG000|Overall Study|Protocol Violation|0|||
160715071|NCT01103180|580336880|FG001|Overall Study|Protocol Violation|1|||
160715072|NCT02760004|580336881|FG000|Overall Study|Lost to Follow-up|13|||
160715073|NCT02760004|580336882|FG001|Overall Study|Lost to Follow-up|22|||
160715074|NCT00725491|580336891|FG000|Overall Study|Adverse Event|3|||
160715075|NCT00725491|580336892|FG001|Overall Study|Adverse Event|2|||
160715076|NCT00725491|580336891|FG000|Overall Study|Pregnancy|0|||
160715077|NCT00725491|580336892|FG001|Overall Study|Pregnancy|3|||
160715078|NCT00725491|580336891|FG000|Overall Study|Risk for hyperstimulation|2|||
160715079|NCT00725491|580336892|FG001|Overall Study|Risk for hyperstimulation|9|||
160715080|NCT00725491|580336891|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
160715081|NCT00725491|580336892|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
160715082|NCT00725491|580336891|FG000|Overall Study|Fertilization failure|0|||
160715083|NCT00725491|580336892|FG001|Overall Study|Fertilization failure|1|||
160715084|NCT00725491|580336891|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
160715085|NCT00725491|580336892|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
160715086|NCT01495000|580336895|FG000|Overall Study|Lost to Follow-up|2|||
160715087|NCT01495000|580336896|FG001|Overall Study|Lost to Follow-up|2|||
160715088|NCT01495000|580336895|FG000|Overall Study|Protocol Violation|1|||
160715089|NCT01495000|580336896|FG001|Overall Study|Protocol Violation|0|||
160715090|NCT01495000|580336895|FG000|Overall Study|Withdrawal by Subject|10|||
160715091|NCT01495000|580336896|FG001|Overall Study|Withdrawal by Subject|10|||
160715092|NCT02070965|580336897|FG000|Overall Study|Lost to Follow-up|0|||
160715093|NCT02070965|580336898|FG001|Overall Study|Lost to Follow-up|1|||
160715094|NCT02070965|580336899|FG002|Overall Study|Lost to Follow-up|0|||
160715095|NCT02070965|580336897|FG000|Overall Study|Withdrawal by Subject|1|||
160715096|NCT02070965|580336898|FG001|Overall Study|Withdrawal by Subject|1|||
160715097|NCT02070965|580336899|FG002|Overall Study|Withdrawal by Subject|1|||
160715098|NCT02070965|580336897|FG000|Overall Study|Subject moved|1|||
160715099|NCT02070965|580336898|FG001|Overall Study|Subject moved|0|||
160715100|NCT02070965|580336899|FG002|Overall Study|Subject moved|0|||
160715101|NCT03889886|580336901|FG000|Overall Study|Other|0|||
160715102|NCT03889886|580336902|FG001|Overall Study|Other|1|||
160715103|NCT03889886|580336903|FG002|Overall Study|Other|0|||
160715104|NCT03889886|580336904|FG003|Overall Study|Other|1|||
160715105|NCT03889886|580336901|FG000|Overall Study|Withdrawal by Subject|0|||
160715106|NCT03889886|580336902|FG001|Overall Study|Withdrawal by Subject|0|||
160715107|NCT03889886|580336903|FG002|Overall Study|Withdrawal by Subject|1|||
160715108|NCT03889886|580336904|FG003|Overall Study|Withdrawal by Subject|0|||
160715109|NCT03889886|580336901|FG000|Overall Study|Adverse Event|0|||
160715110|NCT03889886|580336902|FG001|Overall Study|Adverse Event|0|||
160715111|NCT03889886|580336903|FG002|Overall Study|Adverse Event|0|||
160715112|NCT03889886|580336904|FG003|Overall Study|Adverse Event|6|||
160715113|NCT00276484|580336905|FG000|Overall Study|Adverse Event|4|||
160715114|NCT00276484|580336906|FG001|Overall Study|Adverse Event|7|||
160715115|NCT00276484|580336905|FG000|Overall Study|Lost to Follow-up|1|||
160715116|NCT00276484|580336906|FG001|Overall Study|Lost to Follow-up|1|||
160715117|NCT00276484|580336905|FG000|Overall Study|Protocol Violation|0|||
160715118|NCT00276484|580336906|FG001|Overall Study|Protocol Violation|1|||
160715119|NCT00276484|580336905|FG000|Overall Study|Withdrawal by Subject|4|||
160715120|NCT00276484|580336906|FG001|Overall Study|Withdrawal by Subject|3|||
160715121|NCT00276484|580336905|FG000|Overall Study|Could not take time off work|0|||
160715122|NCT00276484|580336906|FG001|Overall Study|Could not take time off work|1|||
160715123|NCT00942357|580336920|FG000|Overall Study|Ineligible|37|||
160715124|NCT00942357|580336921|FG001|Overall Study|Ineligible|40|||
160715125|NCT03347110|580336922|FG000|Overall Study|Other (Participant is incarcerated)|1|||
160715126|NCT03347110|580336922|FG000|Overall Study|Withdrawal by Subject|9|||
160715127|NCT03347110|580336922|FG000|Overall Study|Lost to Follow-up|1|||
160715128|NCT03347110|580336922|FG000|Overall Study|Lack of Efficacy|2|||
160715129|NCT03347110|580336922|FG000|Overall Study|Adverse Event, non-fatal|9|||
160715130|NCT01321879|580336923|FG000|Overall Study|Lack of Efficacy|5|||
160715131|NCT01321879|580336923|FG000|Overall Study|Adverse Event|5|||
160715132|NCT01321879|580336923|FG000|Overall Study|Death|3|||
160715133|NCT01321879|580336923|FG000|Overall Study|Withdrawal by Subject|1|||
160715134|NCT02687451|580336924|FG000|Overall Study|Withdrawal by Subject|1|||
160715135|NCT02687451|580336925|FG001|Overall Study|Withdrawal by Subject|0|||
160715136|NCT02687451|580336926|FG002|Overall Study|Withdrawal by Subject|0|||
160715137|NCT02687451|580336927|FG003|Overall Study|Withdrawal by Subject|0|||
160715138|NCT02687451|580336928|FG004|Overall Study|Withdrawal by Subject|0|||
160715139|NCT02687451|580336929|FG005|Overall Study|Withdrawal by Subject|1|||
160715140|NCT00707239|580336930|FG000|Overall Study|Adverse Event|5|||
160715141|NCT00707239|580336931|FG001|Overall Study|Adverse Event|3|||
160715142|NCT00707239|580336932|FG002|Overall Study|Adverse Event|2|||
160715143|NCT00707239|580336930|FG000|Overall Study|Death|3|||
160715144|NCT00707239|580336931|FG001|Overall Study|Death|1|||
160715145|NCT00707239|580336932|FG002|Overall Study|Death|3|||
160715146|NCT00707239|580336930|FG000|Overall Study|Physician Decision|1|||
160715147|NCT00707239|580336931|FG001|Overall Study|Physician Decision|1|||
160715148|NCT00707239|580336932|FG002|Overall Study|Physician Decision|2|||
160715149|NCT00707239|580336930|FG000|Overall Study|Protocol Violation|0|||
160715150|NCT00707239|580336931|FG001|Overall Study|Protocol Violation|0|||
160715151|NCT00707239|580336932|FG002|Overall Study|Protocol Violation|1|||
160715152|NCT00707239|580336930|FG000|Overall Study|Lack of Efficacy|1|||
160715153|NCT00707239|580336931|FG001|Overall Study|Lack of Efficacy|2|||
160715154|NCT00707239|580336932|FG002|Overall Study|Lack of Efficacy|0|||
160715155|NCT00707239|580336930|FG000|Overall Study|Randomized, but not treated|1|||
160715156|NCT00707239|580336931|FG001|Overall Study|Randomized, but not treated|1|||
160715157|NCT00707239|580336932|FG002|Overall Study|Randomized, but not treated|1|||
160715158|NCT00707239|580336930|FG000|Overall Study|Other|8|||
160715159|NCT00707239|580336931|FG001|Overall Study|Other|3|||
160715160|NCT00707239|580336932|FG002|Overall Study|Other|5|||
160715161|NCT01518322|580336933|FG000|Overall Study|FeNO measurement was missing|13|||
160715162|NCT01778530|580336934|FG000|Overall Study|Progression on study|1|||
160715163|NCT01778530|580336934|FG000|Overall Study|Adverse event/side effect|1|||
160715164|NCT03472014|580336935|FG000|Overall Study|Lost to Follow-up|4|||
160715165|NCT00711087|580336936|FG000|Overall Study|Lost to Follow-up|1|||
160715166|NCT00711087|580336937|FG001|Overall Study|Lost to Follow-up|0|||
160715167|NCT03652051|580336938|FG000|Stage 1|Adverse Event|0|||
160715168|NCT03652051|580336939|FG001|Stage 1|Adverse Event|5|||
160715169|NCT03652051|580336940|FG002|Stage 1|Adverse Event|7|||
160715170|NCT03652051|580336941|FG003|Stage 1|Adverse Event|1|||
160715171|NCT03652051|580336938|FG000|Stage 1|Withdrawal by Subject|0|||
160715172|NCT03652051|580336939|FG001|Stage 1|Withdrawal by Subject|0|||
160715173|NCT03652051|580336940|FG002|Stage 1|Withdrawal by Subject|1|||
160715174|NCT03652051|580336941|FG003|Stage 1|Withdrawal by Subject|0|||
160715175|NCT03652051|580336938|FG000|Stage 2|Adverse Event|0|||
160715176|NCT03652051|580336939|FG001|Stage 2|Adverse Event|2|||
160715177|NCT03652051|580336940|FG002|Stage 2|Adverse Event|1|||
160715178|NCT03652051|580336941|FG003|Stage 2|Adverse Event|0|||
160715179|NCT03652051|580336938|FG000|Stage 2|Protocol Violation|0|||
160715180|NCT03652051|580336939|FG001|Stage 2|Protocol Violation|1|||
160715181|NCT03652051|580336940|FG002|Stage 2|Protocol Violation|6|||
160715182|NCT03652051|580336941|FG003|Stage 2|Protocol Violation|0|||
160715183|NCT03652051|580336938|FG000|Stage 2|Lost to Follow-up|0|||
160715184|NCT03652051|580336939|FG001|Stage 2|Lost to Follow-up|2|||
160715185|NCT03652051|580336940|FG002|Stage 2|Lost to Follow-up|0|||
160715186|NCT03652051|580336941|FG003|Stage 2|Lost to Follow-up|3|||
160715187|NCT03652051|580336938|FG000|Stage 2|Withdrawal by Subject|0|||
160715188|NCT03652051|580336939|FG001|Stage 2|Withdrawal by Subject|11|||
160715189|NCT03652051|580336940|FG002|Stage 2|Withdrawal by Subject|9|||
160715190|NCT03652051|580336941|FG003|Stage 2|Withdrawal by Subject|3|||
160715191|NCT01930162|580336942|FG000|Overall Study|Abnormal test procedure result(s)|4|||
160715192|NCT01930162|580336942|FG000|Overall Study|Death|1|||
160715193|NCT02394600|580336943|FG000|Overall Study|Adverse Event|3|||
160715194|NCT02394600|580336944|FG001|Overall Study|Adverse Event|0|||
160715195|NCT02394600|580336943|FG000|Overall Study|Lost to Follow-up|0|||
160715196|NCT02394600|580336944|FG001|Overall Study|Lost to Follow-up|1|||
160715197|NCT02394600|580336943|FG000|Overall Study|Withdrawal by Subject|0|||
160715198|NCT02394600|580336944|FG001|Overall Study|Withdrawal by Subject|1|||
160715199|NCT02394600|580336943|FG000|Overall Study|Protocol Violation|1|||
160715200|NCT02394600|580336944|FG001|Overall Study|Protocol Violation|0|||
160715201|NCT01841593|580336945|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
160715202|NCT01841593|580336946|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
160715203|NCT01841593|580336945|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
160715204|NCT01841593|580336946|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
160715205|NCT02635984|580336947|FG000|Overall Study|Lost to Follow-up|2|||
160715206|NCT02635984|580336948|FG001|Overall Study|Lost to Follow-up|4|||
160715207|NCT02635984|580336947|FG000|Overall Study|Study Arm Closed|1|||
160715208|NCT02635984|580336948|FG001|Overall Study|Study Arm Closed|0|||
160715209|NCT00307086|580336951|FG000|Overall Study|ineligible|5|||
160715210|NCT01487525|580336952|FG000|Overall Study|Withdrawal by Subject|0|||
160715211|NCT01487525|580336953|FG001|Overall Study|Withdrawal by Subject|1|||
160715212|NCT01870778|580336955|FG000|Overall Study|Withdrawal by Subject|8|||
160715213|NCT01870778|580336956|FG001|Overall Study|Withdrawal by Subject|7|||
160715214|NCT01870778|580336955|FG000|Overall Study|Lost to Follow-up|0|||
160715215|NCT01870778|580336956|FG001|Overall Study|Lost to Follow-up|2|||
160715216|NCT03518008|580336957|FG000|Period 2, Second Week of Wear|Family emergency|0|||
160715217|NCT03518008|580336958|FG001|Period 2, Second Week of Wear|Family emergency|1|||
160715218|NCT02308124|580336960|FG000|Overall Study|Lost to Follow-up|6|||
160715219|NCT02308124|580336961|FG001|Overall Study|Lost to Follow-up|6|||
160715220|NCT02308124|580336962|FG002|Overall Study|Lost to Follow-up|6|||
160715221|NCT02308124|580336960|FG000|Overall Study|Adverse Event|0|||
160715222|NCT02308124|580336961|FG001|Overall Study|Adverse Event|2|||
160715223|NCT02308124|580336962|FG002|Overall Study|Adverse Event|2|||
160715224|NCT02860546|580336963|FG000|Overall Study|Clinical Progression|6|||
160715225|NCT02860546|580336963|FG000|Overall Study|Radiological Progression|12|||
160715226|NCT01876446|580336969|FG000|Overall Study|Death|0|||
160715227|NCT01876446|580336970|FG001|Overall Study|Death|1|||
160715228|NCT01876446|580336969|FG000|Overall Study|Withdrawal by Subject|1|||
160715229|NCT01876446|580336970|FG001|Overall Study|Withdrawal by Subject|2|||
160715230|NCT01876446|580336969|FG000|Overall Study|Physician Decision|1|||
160715231|NCT01876446|580336970|FG001|Overall Study|Physician Decision|3|||
160715232|NCT02108912|580336971|FG000|Overall Study|Lost to Follow-up|1|||
160715233|NCT02108912|580336972|FG001|Overall Study|Lost to Follow-up|1|||
160715234|NCT02108912|580336971|FG000|Overall Study|lack of transportation|1|||
160715235|NCT02108912|580336972|FG001|Overall Study|lack of transportation|0|||
160715236|NCT02108912|580336971|FG000|Overall Study|high blood pressure|1|||
160715237|NCT02108912|580336972|FG001|Overall Study|high blood pressure|0|||
160715238|NCT01808573|580336973|FG000|Overall Study|Death|212|||
160715239|NCT01808573|580336974|FG001|Overall Study|Death|240|||
160715240|NCT01808573|580336973|FG000|Overall Study|Withdrawal by Subject|12|||
160715241|NCT01808573|580336974|FG001|Overall Study|Withdrawal by Subject|10|||
160715242|NCT01808573|580336973|FG000|Overall Study|Lost to Follow-up|3|||
160715243|NCT01808573|580336974|FG001|Overall Study|Lost to Follow-up|0|||
160715244|NCT01808573|580336973|FG000|Overall Study|Discontinuation of study by sponsor|79|||
160715245|NCT01808573|580336974|FG001|Overall Study|Discontinuation of study by sponsor|64|||
160715246|NCT01808573|580336973|FG000|Overall Study|Randomized in Error|1|||
160715247|NCT01808573|580336974|FG001|Overall Study|Randomized in Error|0|||
160715248|NCT00852202|580336985|FG000|Overall Study|Adverse Event|2|||
160715249|NCT00852202|580336986|FG001|Overall Study|Adverse Event|3|||
160715250|NCT00852202|580336987|FG002|Overall Study|Adverse Event|7|||
160715251|NCT00852202|580336985|FG000|Overall Study|Lack of Efficacy|4|||
160715252|NCT00852202|580336986|FG001|Overall Study|Lack of Efficacy|1|||
160715253|NCT00852202|580336987|FG002|Overall Study|Lack of Efficacy|2|||
160715254|NCT00852202|580336985|FG000|Overall Study|Protocol Violation|2|||
160715255|NCT00852202|580336986|FG001|Overall Study|Protocol Violation|2|||
160715256|NCT00852202|580336987|FG002|Overall Study|Protocol Violation|7|||
160715257|NCT00852202|580336985|FG000|Overall Study|Withdrawal by Subject|3|||
160715258|NCT00852202|580336986|FG001|Overall Study|Withdrawal by Subject|1|||
160715259|NCT00852202|580336987|FG002|Overall Study|Withdrawal by Subject|2|||
160715260|NCT00852202|580336985|FG000|Overall Study|Lost to Follow-up|5|||
160715261|NCT00852202|580336986|FG001|Overall Study|Lost to Follow-up|5|||
160715262|NCT00852202|580336987|FG002|Overall Study|Lost to Follow-up|6|||
160715263|NCT00852202|580336985|FG000|Overall Study|pregnancy,moving away and surgery|1|||
160715264|NCT00852202|580336986|FG001|Overall Study|pregnancy,moving away and surgery|0|||
160715265|NCT00852202|580336987|FG002|Overall Study|pregnancy,moving away and surgery|2|||
160715266|NCT03629184|580336993|FG000|Overall Study|Withdrawal by Subject|2|||
160715267|NCT03629184|580336994|FG001|Overall Study|Withdrawal by Subject|1|||
160715268|NCT03629184|580336993|FG000|Overall Study|Physician Decision|1|||
160715269|NCT03629184|580336994|FG001|Overall Study|Physician Decision|0|||
160715270|NCT01461538|580336995|FG000|Overall Study|Death|15|||
160715271|NCT01461538|580336996|FG001|Overall Study|Death|6|||
160715272|NCT01461538|580336997|FG002|Overall Study|Death|2|||
160715273|NCT01461538|580336995|FG000|Overall Study|Study Stopped by Sponsor|2|||
160715274|NCT01461538|580336996|FG001|Overall Study|Study Stopped by Sponsor|1|||
160715275|NCT01461538|580336997|FG002|Overall Study|Study Stopped by Sponsor|0|||
160715276|NCT01461538|580336995|FG000|Overall Study|Withdrawal by Subject|1|||
160715277|NCT01461538|580336996|FG001|Overall Study|Withdrawal by Subject|1|||
160715278|NCT01461538|580336997|FG002|Overall Study|Withdrawal by Subject|0|||
160715279|NCT00141778|580336998|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
160715280|NCT00141778|580336999|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
160715281|NCT00141778|580337000|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
160715282|NCT00141778|580336998|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
160715283|NCT00141778|580336999|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
160715284|NCT00141778|580337000|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
160715285|NCT00141778|580336998|FG000|Started Study Medication|Withdrawal by Subject|0|||
160715286|NCT00141778|580336999|FG001|Started Study Medication|Withdrawal by Subject|2|||
160715287|NCT00141778|580337000|FG002|Started Study Medication|Withdrawal by Subject|0|||
160715288|NCT00141778|580336998|FG000|Started Study Medication|Difficulty Swallowing|0|||
160715289|NCT00141778|580336999|FG001|Started Study Medication|Difficulty Swallowing|1|||
160715290|NCT00141778|580337000|FG002|Started Study Medication|Difficulty Swallowing|0|||
160715291|NCT00141778|580336998|FG000|Started Study Medication|Chest Discomfort|0|||
160715292|NCT00141778|580336999|FG001|Started Study Medication|Chest Discomfort|0|||
160715293|NCT00141778|580337000|FG002|Started Study Medication|Chest Discomfort|1|||
160715294|NCT01982955|580337001|FG000|Overall Study|Randomized but not treated|0|||
160715295|NCT01982955|580337002|FG001|Overall Study|Randomized but not treated|0|||
160715296|NCT01982955|580337003|FG002|Overall Study|Randomized but not treated|0|||
160715297|NCT01982955|580337004|FG003|Overall Study|Randomized but not treated|1|||
160715298|NCT01982955|580337005|FG004|Overall Study|Randomized but not treated|0|||
160715299|NCT05989672|580338427|FG000|Overall Study|Adverse Event|3|||
160715300|NCT05989672|580338428|FG001|Overall Study|Adverse Event|0|||
160715301|NCT05989672|580338429|FG002|Overall Study|Adverse Event|0|||
160715302|NCT03511105|580338430|FG000|Overall Study|Adverse Event|1|||
160715303|NCT03511105|580338431|FG001|Overall Study|Adverse Event|0|||
160715304|NCT03511105|580338430|FG000|Overall Study|Withdrew consent|1|||
160715305|NCT03511105|580338431|FG001|Overall Study|Withdrew consent|0|||
160715306|NCT02810457|580338432|FG000|Overall Study|Randomised but no treatment received|2|||
160715307|NCT02810457|580338433|FG001|Overall Study|Randomised but no treatment received|1|||
160715308|NCT02810457|580338432|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
160715309|NCT02810457|580338433|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
160715310|NCT02810457|580338432|FG000|Overall Study|Adverse Event|37|||
160715311|NCT02810457|580338433|FG001|Overall Study|Adverse Event|43|||
160715312|NCT02810457|580338432|FG000|Overall Study|Patient decision|31|||
160715313|NCT02810457|580338433|FG001|Overall Study|Patient decision|35|||
160715314|NCT02810457|580338432|FG000|Overall Study|Patient lost to follow-up|2|||
160715315|NCT02810457|580338433|FG001|Overall Study|Patient lost to follow-up|2|||
160715316|NCT02810457|580338432|FG000|Overall Study|Death|39|||
160715317|NCT02810457|580338433|FG001|Overall Study|Death|28|||
160715318|NCT02810457|580338432|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
160715319|NCT02810457|580338433|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
160715320|NCT02810457|580338432|FG000|Overall Study|Clinical progression|15|||
160715321|NCT02810457|580338433|FG001|Overall Study|Clinical progression|16|||
160715322|NCT02810457|580338432|FG000|Overall Study|Investigator decision|3|||
160715323|NCT02810457|580338433|FG001|Overall Study|Investigator decision|2|||
160715324|NCT02810457|580338432|FG000|Overall Study|Patient ineligibility|3|||
160715325|NCT02810457|580338433|FG001|Overall Study|Patient ineligibility|0|||
160715326|NCT02810457|580338432|FG000|Overall Study|Miscalculated PD|1|||
160715327|NCT02810457|580338433|FG001|Overall Study|Miscalculated PD|0|||
160715328|NCT02810457|580338432|FG000|Overall Study|Physician Decision|0|||
160715329|NCT02810457|580338433|FG001|Overall Study|Physician Decision|1|||
160715330|NCT01557504|580338436|FG000|Overall Study|Physician Decision|1|||
160715331|NCT01557504|580338437|FG001|Overall Study|Physician Decision|0|||
160715332|NCT01962103|580338441|FG000|Phase 1|Adverse Event|4|||
160715333|NCT01962103|580338442|FG001|Phase 1|Adverse Event|0|||
160715334|NCT01962103|580338443|FG002|Phase 1|Adverse Event|2|||
160715335|NCT01962103|580338444|FG003|Phase 1|Adverse Event|1|||
160715336|NCT01962103|580338445|FG004|Phase 1|Adverse Event|2|||
160715337|NCT01962103|580338446|FG005|Phase 1|Adverse Event|2|||
160715338|NCT01962103|580338447|FG006|Phase 1|Adverse Event|0|||
160715339|NCT01962103|580338448|FG007|Phase 1|Adverse Event|0|||
160715340|NCT01962103|580338449|FG008|Phase 1|Adverse Event|0|||
160715341|NCT01962103|580338441|FG000|Phase 1|Progressive Disease|8|||
160715342|NCT01962103|580338442|FG001|Phase 1|Progressive Disease|6|||
160715343|NCT01962103|580338443|FG002|Phase 1|Progressive Disease|8|||
160715344|NCT01962103|580338444|FG003|Phase 1|Progressive Disease|4|||
160715345|NCT01962103|580338445|FG004|Phase 1|Progressive Disease|5|||
160715346|NCT01962103|580338446|FG005|Phase 1|Progressive Disease|4|||
160715347|NCT01962103|580338447|FG006|Phase 1|Progressive Disease|0|||
160715348|NCT01962103|580338448|FG007|Phase 1|Progressive Disease|0|||
160715349|NCT01962103|580338449|FG008|Phase 1|Progressive Disease|0|||
160715350|NCT01962103|580338441|FG000|Phase 1|Withdrawal by Subject|0|||
160715351|NCT01962103|580338442|FG001|Phase 1|Withdrawal by Subject|0|||
160715352|NCT01962103|580338443|FG002|Phase 1|Withdrawal by Subject|0|||
160715353|NCT01962103|580338444|FG003|Phase 1|Withdrawal by Subject|2|||
160715354|NCT01962103|580338445|FG004|Phase 1|Withdrawal by Subject|0|||
160715355|NCT01962103|580338446|FG005|Phase 1|Withdrawal by Subject|0|||
160715356|NCT01962103|580338447|FG006|Phase 1|Withdrawal by Subject|0|||
160715357|NCT01962103|580338448|FG007|Phase 1|Withdrawal by Subject|0|||
160715358|NCT01962103|580338449|FG008|Phase 1|Withdrawal by Subject|0|||
160715359|NCT01962103|580338441|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
160715360|NCT01962103|580338442|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
160715361|NCT01962103|580338443|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
160715362|NCT01962103|580338444|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
160715363|NCT01962103|580338445|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
160715364|NCT01962103|580338446|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
160715365|NCT01962103|580338447|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
160715366|NCT01962103|580338448|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
160715367|NCT01962103|580338449|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
160715368|NCT01962103|580338441|FG000|Phase 1|Physician Decision|0|||
160715369|NCT01962103|580338442|FG001|Phase 1|Physician Decision|0|||
160715370|NCT01962103|580338443|FG002|Phase 1|Physician Decision|0|||
160715371|NCT01962103|580338444|FG003|Phase 1|Physician Decision|1|||
160715372|NCT01962103|580338445|FG004|Phase 1|Physician Decision|0|||
160715373|NCT01962103|580338446|FG005|Phase 1|Physician Decision|0|||
160715374|NCT01962103|580338447|FG006|Phase 1|Physician Decision|0|||
160715375|NCT01962103|580338448|FG007|Phase 1|Physician Decision|0|||
160715376|NCT01962103|580338449|FG008|Phase 1|Physician Decision|0|||
160715377|NCT01962103|580338441|FG000|Phase 1|Symptomatic Deterioration|3|||
160715378|NCT01962103|580338442|FG001|Phase 1|Symptomatic Deterioration|2|||
160715379|NCT01962103|580338443|FG002|Phase 1|Symptomatic Deterioration|2|||
160715380|NCT01962103|580338444|FG003|Phase 1|Symptomatic Deterioration|2|||
160715381|NCT01962103|580338445|FG004|Phase 1|Symptomatic Deterioration|1|||
160715382|NCT01962103|580338446|FG005|Phase 1|Symptomatic Deterioration|1|||
160715383|NCT01962103|580338447|FG006|Phase 1|Symptomatic Deterioration|0|||
160715384|NCT01962103|580338448|FG007|Phase 1|Symptomatic Deterioration|0|||
160715385|NCT01962103|580338449|FG008|Phase 1|Symptomatic Deterioration|0|||
160715386|NCT01962103|580338441|FG000|Phase 1|Miscellaneous|1|||
160715387|NCT01962103|580338442|FG001|Phase 1|Miscellaneous|0|||
160715388|NCT01962103|580338443|FG002|Phase 1|Miscellaneous|0|||
160715389|NCT01962103|580338444|FG003|Phase 1|Miscellaneous|0|||
160715390|NCT01962103|580338445|FG004|Phase 1|Miscellaneous|0|||
160715391|NCT01962103|580338446|FG005|Phase 1|Miscellaneous|0|||
160715392|NCT01962103|580338447|FG006|Phase 1|Miscellaneous|0|||
160715393|NCT01962103|580338448|FG007|Phase 1|Miscellaneous|0|||
160715394|NCT01962103|580338449|FG008|Phase 1|Miscellaneous|0|||
160715395|NCT01962103|580338441|FG000|Phase 2|Adverse Event|0|||
160715396|NCT01962103|580338442|FG001|Phase 2|Adverse Event|0|||
160715397|NCT01962103|580338443|FG002|Phase 2|Adverse Event|0|||
160715398|NCT01962103|580338444|FG003|Phase 2|Adverse Event|0|||
160715399|NCT01962103|580338445|FG004|Phase 2|Adverse Event|0|||
160715400|NCT01962103|580338446|FG005|Phase 2|Adverse Event|0|||
160715401|NCT01962103|580338447|FG006|Phase 2|Adverse Event|1|||
160715402|NCT01962103|580338448|FG007|Phase 2|Adverse Event|0|||
160715403|NCT01962103|580338449|FG008|Phase 2|Adverse Event|3|||
160715404|NCT01962103|580338441|FG000|Phase 2|Progressive Disease|0|||
160715405|NCT01962103|580338442|FG001|Phase 2|Progressive Disease|0|||
160715406|NCT01962103|580338443|FG002|Phase 2|Progressive Disease|0|||
160715407|NCT01962103|580338444|FG003|Phase 2|Progressive Disease|0|||
160715408|NCT01962103|580338445|FG004|Phase 2|Progressive Disease|0|||
160715409|NCT01962103|580338446|FG005|Phase 2|Progressive Disease|0|||
160715410|NCT01962103|580338447|FG006|Phase 2|Progressive Disease|11|||
160715411|NCT01962103|580338448|FG007|Phase 2|Progressive Disease|12|||
160715412|NCT01962103|580338449|FG008|Phase 2|Progressive Disease|11|||
160715413|NCT01962103|580338441|FG000|Phase 2|Symptomatic Deterioration|0|||
160715414|NCT01962103|580338442|FG001|Phase 2|Symptomatic Deterioration|0|||
160715415|NCT01962103|580338443|FG002|Phase 2|Symptomatic Deterioration|0|||
160715416|NCT01962103|580338444|FG003|Phase 2|Symptomatic Deterioration|0|||
160715417|NCT01962103|580338445|FG004|Phase 2|Symptomatic Deterioration|0|||
160715418|NCT01962103|580338446|FG005|Phase 2|Symptomatic Deterioration|0|||
160715419|NCT01962103|580338447|FG006|Phase 2|Symptomatic Deterioration|2|||
160715420|NCT01962103|580338448|FG007|Phase 2|Symptomatic Deterioration|2|||
160715421|NCT01962103|580338449|FG008|Phase 2|Symptomatic Deterioration|0|||
160715422|NCT01321749|580338452|FG000|Overall Study|Lost to Follow-up|4|||
160715423|NCT01321749|580338453|FG001|Overall Study|Lost to Follow-up|11|||
160715424|NCT01321749|580338452|FG000|Overall Study|Protocol Violation|4|||
160715425|NCT01321749|580338453|FG001|Overall Study|Protocol Violation|7|||
160715426|NCT01321749|580338452|FG000|Overall Study|Withdrawal by Subject|5|||
160715427|NCT01321749|580338453|FG001|Overall Study|Withdrawal by Subject|4|||
160715428|NCT02750618|580338457|FG000|Overall Study|Withdrawal by Subject|1|||
160715429|NCT02763046|580338464|FG000|Overall Study|Adverse Event|5|||
160715430|NCT02763046|580338465|FG001|Overall Study|Adverse Event|4|||
160715431|NCT02763046|580338466|FG002|Overall Study|Adverse Event|0|||
160715432|NCT02763046|580338464|FG000|Overall Study|Lack of Efficacy|1|||
160715433|NCT02763046|580338465|FG001|Overall Study|Lack of Efficacy|1|||
160715434|NCT02763046|580338466|FG002|Overall Study|Lack of Efficacy|3|||
160715435|NCT02763046|580338464|FG000|Overall Study|Physician Decision|1|||
160715436|NCT02763046|580338465|FG001|Overall Study|Physician Decision|0|||
160715437|NCT02763046|580338466|FG002|Overall Study|Physician Decision|1|||
160715438|NCT02763046|580338464|FG000|Overall Study|Subject/guardian decision|2|||
160715439|NCT02763046|580338465|FG001|Overall Study|Subject/guardian decision|0|||
160715440|NCT02763046|580338466|FG002|Overall Study|Subject/guardian decision|4|||
160715441|NCT00818766|580338471|FG000|Overall Study|Could not be Contacted on Day 28|11|||
160715442|NCT00818766|580338472|FG001|Overall Study|Could not be Contacted on Day 28|10|||
160715443|NCT00818766|580338471|FG000|Overall Study|Death|1|||
160715444|NCT00818766|580338472|FG001|Overall Study|Death|0|||
160715445|NCT00818766|580338471|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
160715446|NCT00818766|580338472|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
160715447|NCT00086684|580338473|FG000|Overall Study|Adverse Event|12|||
160715448|NCT00086684|580338474|FG001|Overall Study|Adverse Event|17|||
160715449|NCT00086684|580338475|FG002|Overall Study|Adverse Event|14|||
160715450|NCT00086684|580338473|FG000|Overall Study|Lack of Efficacy|6|||
160715451|NCT00086684|580338474|FG001|Overall Study|Lack of Efficacy|6|||
160715452|NCT00086684|580338475|FG002|Overall Study|Lack of Efficacy|5|||
160715453|NCT00086684|580338473|FG000|Overall Study|Lost to Follow-up|15|||
160715454|NCT00086684|580338474|FG001|Overall Study|Lost to Follow-up|8|||
160715455|NCT00086684|580338475|FG002|Overall Study|Lost to Follow-up|10|||
160715456|NCT00086684|580338473|FG000|Overall Study|Protocol Violation|8|||
160715457|NCT00086684|580338474|FG001|Overall Study|Protocol Violation|3|||
160715458|NCT00086684|580338475|FG002|Overall Study|Protocol Violation|0|||
160715459|NCT00086684|580338473|FG000|Overall Study|Withdrawal by Subject|0|||
160715460|NCT00086684|580338474|FG001|Overall Study|Withdrawal by Subject|4|||
160715461|NCT00086684|580338475|FG002|Overall Study|Withdrawal by Subject|10|||
160715462|NCT00086684|580338473|FG000|Overall Study|NONCOMPLIANCE|5|||
160715463|NCT00086684|580338474|FG001|Overall Study|NONCOMPLIANCE|7|||
160715464|NCT00086684|580338475|FG002|Overall Study|NONCOMPLIANCE|6|||
160715465|NCT00086684|580338473|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
160715466|NCT00086684|580338474|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
160715467|NCT00086684|580338475|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
160715468|NCT00086684|580338473|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
160715469|NCT00086684|580338474|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
160715470|NCT00086684|580338475|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
160715471|NCT00086684|580338473|FG000|Overall Study|Other|4|||
160715472|NCT00086684|580338474|FG001|Overall Study|Other|2|||
160715473|NCT00086684|580338475|FG002|Overall Study|Other|3|||
160715474|NCT01067105|580338476|FG000|Overall Study|Adverse Event|14|||
160715475|NCT01067105|580338476|FG000|Overall Study|Protocol Violation|48|||
160715476|NCT01067105|580338476|FG000|Overall Study|Withdrawal by Subject|36|||
160715477|NCT01067105|580338476|FG000|Overall Study|Lost to Follow-up|6|||
160715478|NCT01067105|580338476|FG000|Overall Study|Physician Decision|6|||
160715479|NCT01067105|580338476|FG000|Overall Study|Other|31|||
160715480|NCT00853099|580338477|FG000|Double-blind Period|Adverse Event|7|||
160715481|NCT00853099|580338478|FG001|Double-blind Period|Adverse Event|9|||
160715482|NCT00853099|580338479|FG002|Double-blind Period|Adverse Event|13|||
160715483|NCT00853099|580338480|FG003|Double-blind Period|Adverse Event|0|||
160715484|NCT00853099|580338477|FG000|Double-blind Period|Withdrawal by Subject|2|||
160715485|NCT00853099|580338478|FG001|Double-blind Period|Withdrawal by Subject|3|||
160715486|NCT00853099|580338479|FG002|Double-blind Period|Withdrawal by Subject|0|||
160715487|NCT00853099|580338480|FG003|Double-blind Period|Withdrawal by Subject|0|||
160715488|NCT00853099|580338477|FG000|Double-blind Period|Lack of Efficacy|14|||
160715489|NCT00853099|580338478|FG001|Double-blind Period|Lack of Efficacy|17|||
160715490|NCT00853099|580338479|FG002|Double-blind Period|Lack of Efficacy|16|||
160715491|NCT00853099|580338480|FG003|Double-blind Period|Lack of Efficacy|0|||
160715492|NCT00853099|580338477|FG000|Double-blind Period|Other|0|||
160715493|NCT00853099|580338478|FG001|Double-blind Period|Other|0|||
160715494|NCT00853099|580338479|FG002|Double-blind Period|Other|1|||
160715495|NCT00853099|580338480|FG003|Double-blind Period|Other|0|||
160715496|NCT00853099|580338477|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
160715497|NCT00853099|580338478|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
160715498|NCT00853099|580338479|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
160715499|NCT00853099|580338480|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
160715500|NCT00853099|580338477|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
160715501|NCT00853099|580338478|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
160715502|NCT00853099|580338479|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
160715503|NCT00853099|580338480|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
160715504|NCT00853099|580338477|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
160715505|NCT00853099|580338478|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
160715506|NCT00853099|580338479|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
160715507|NCT00853099|580338480|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
160715508|NCT00853099|580338477|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
160715509|NCT00853099|580338478|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
160715510|NCT00853099|580338479|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
160715511|NCT00853099|580338480|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
160715512|NCT00853099|580338477|FG000|Double-blind + Open-label Periods|Other|0|||
160715513|NCT00853099|580338478|FG001|Double-blind + Open-label Periods|Other|0|||
160715514|NCT00853099|580338479|FG002|Double-blind + Open-label Periods|Other|0|||
160715515|NCT00853099|580338480|FG003|Double-blind + Open-label Periods|Other|6|||
160715516|NCT00970593|580338482|FG000|Overall Study|Adverse Event|1|||
160715517|NCT00970593|580338483|FG001|Overall Study|Adverse Event|1|||
160715518|NCT00970593|580338484|FG002|Overall Study|Adverse Event|0|||
160715519|NCT00970593|580338485|FG003|Overall Study|Adverse Event|0|||
160715520|NCT00970593|580338486|FG004|Overall Study|Adverse Event|0|||
160715521|NCT00970593|580338487|FG005|Overall Study|Adverse Event|0|||
160715522|NCT00970593|580338488|FG006|Overall Study|Adverse Event|0|||
160715523|NCT00970593|580338482|FG000|Overall Study|Discontinuation of study by sponsor|0|||
160715524|NCT00970593|580338483|FG001|Overall Study|Discontinuation of study by sponsor|0|||
160715525|NCT00970593|580338484|FG002|Overall Study|Discontinuation of study by sponsor|5|||
160715526|NCT00970593|580338485|FG003|Overall Study|Discontinuation of study by sponsor|0|||
160715527|NCT00970593|580338486|FG004|Overall Study|Discontinuation of study by sponsor|0|||
160715528|NCT00970593|580338487|FG005|Overall Study|Discontinuation of study by sponsor|0|||
160715529|NCT00970593|580338488|FG006|Overall Study|Discontinuation of study by sponsor|2|||
160715530|NCT00970593|580338482|FG000|Overall Study|Withdrawal by Subject|0|||
160715531|NCT00970593|580338483|FG001|Overall Study|Withdrawal by Subject|0|||
160715532|NCT00970593|580338484|FG002|Overall Study|Withdrawal by Subject|1|||
160715533|NCT00970593|580338485|FG003|Overall Study|Withdrawal by Subject|0|||
160715534|NCT00970593|580338486|FG004|Overall Study|Withdrawal by Subject|0|||
160715535|NCT00970593|580338487|FG005|Overall Study|Withdrawal by Subject|0|||
160715536|NCT00970593|580338488|FG006|Overall Study|Withdrawal by Subject|0|||
160715537|NCT02203357|580338489|FG000|Overall Study|Lost to Follow-up|58|||
160715538|NCT02203357|580338490|FG001|Overall Study|Lost to Follow-up|66|||
160715539|NCT02203357|580338491|FG002|Overall Study|Lost to Follow-up|70|||
160715540|NCT02094300|580338495|FG000|Overall Study|Death|7|||
160715541|NCT02094300|580338495|FG000|Overall Study|Lost to Follow-up|10|||
160715542|NCT02094300|580338495|FG000|Overall Study|Still be eligible for follow-up|3|||
160715543|NCT01641640|580338496|FG000|Overall Study|Enrolled but not treated|1|||
160715544|NCT01641640|580338496|FG000|Overall Study|Efficacy failure|29|||
160715545|NCT01641640|580338496|FG000|Overall Study|Lost to Follow-up|3|||
160715546|NCT01641640|580338496|FG000|Overall Study|Withdrawal by Subject|2|||
160715547|NCT01641640|580338496|FG000|Overall Study|Adverse Event|1|||
160715548|NCT01199939|580338500|FG000|Overall Study|Adverse Event|4|||
160715549|NCT01199939|580338500|FG000|Overall Study|Protocol Violation|3|||
160715550|NCT01199939|580338500|FG000|Overall Study|Lost to Follow-up|2|||
160715551|NCT01199939|580338500|FG000|Overall Study|Reached a virologic endpoint|4|||
160715552|NCT02792517|580338508|FG000|Overall Study|Withdrawal by Subject|10|||
160715553|NCT02792517|580338508|FG000|Overall Study|Decision by Sponsor|7|||
160715554|NCT02792517|580338508|FG000|Overall Study|Lost to Follow-up|3|||
160715555|NCT00882518|580338509|FG000|Overall Study|Adverse Event|9|||
160715556|NCT00882518|580338510|FG001|Overall Study|Adverse Event|18|||
160715557|NCT00882518|580338509|FG000|Overall Study|Withdrawal by Subject|9|||
160715558|NCT00882518|580338510|FG001|Overall Study|Withdrawal by Subject|13|||
160715559|NCT00882518|580338509|FG000|Overall Study|Lack of Efficacy|12|||
160715560|NCT00882518|580338510|FG001|Overall Study|Lack of Efficacy|9|||
160715561|NCT00882518|580338509|FG000|Overall Study|Severe non-compliance to protocol|3|||
160715562|NCT00882518|580338510|FG001|Overall Study|Severe non-compliance to protocol|1|||
160715563|NCT00882518|580338509|FG000|Overall Study|Incorrect enrolment|4|||
160715564|NCT00882518|580338510|FG001|Overall Study|Incorrect enrolment|2|||
160715565|NCT00882518|580338509|FG000|Overall Study|Central lab closure for National day|1|||
160715566|NCT00882518|580338510|FG001|Overall Study|Central lab closure for National day|0|||
160715567|NCT00882518|580338509|FG000|Overall Study|Allocating random number by mistake|0|||
160715568|NCT00882518|580338510|FG001|Overall Study|Allocating random number by mistake|1|||
160715569|NCT03238651|580338511|FG000|Overall Study|Other|0|||
160715570|NCT03238651|580338512|FG001|Overall Study|Other|0|||
160715571|NCT03238651|580338513|FG002|Overall Study|Other|0|||
160715572|NCT03238651|580338514|FG003|Overall Study|Other|0|||
160715573|NCT03238651|580338515|FG004|Overall Study|Other|1|||
160715574|NCT03238651|580338511|FG000|Overall Study|Progressive Disease|2|||
160715575|NCT03238651|580338512|FG001|Overall Study|Progressive Disease|2|||
160715576|NCT03238651|580338513|FG002|Overall Study|Progressive Disease|2|||
160715577|NCT03238651|580338514|FG003|Overall Study|Progressive Disease|2|||
160715578|NCT03238651|580338515|FG004|Overall Study|Progressive Disease|0|||
160715579|NCT03238651|580338511|FG000|Overall Study|Withdrawal by Subject|0|||
160715580|NCT03238651|580338512|FG001|Overall Study|Withdrawal by Subject|1|||
160715581|NCT03238651|580338513|FG002|Overall Study|Withdrawal by Subject|0|||
160715582|NCT03238651|580338514|FG003|Overall Study|Withdrawal by Subject|1|||
160715583|NCT03238651|580338515|FG004|Overall Study|Withdrawal by Subject|0|||
160715584|NCT03238651|580338511|FG000|Overall Study|Adverse Event|1|||
160715585|NCT03238651|580338512|FG001|Overall Study|Adverse Event|3|||
160715586|NCT03238651|580338513|FG002|Overall Study|Adverse Event|2|||
160715587|NCT03238651|580338514|FG003|Overall Study|Adverse Event|0|||
160715588|NCT03238651|580338515|FG004|Overall Study|Adverse Event|0|||
160715589|NCT03875508|580338516|FG000|Overall Study|Adverse Event|1|||
160715590|NCT03875508|580338516|FG000|Overall Study|Lost to Follow-up|8|||
160715591|NCT03875508|580338516|FG000|Overall Study|Lack of Efficacy|1|||
160715592|NCT03875508|580338516|FG000|Overall Study|Other, not specified|2|||
160715593|NCT03743051|580338517|FG000|Overall Study|Adverse Event|5|||
160715594|NCT03743051|580338518|FG001|Overall Study|Adverse Event|9|||
160715595|NCT03743051|580338517|FG000|Overall Study|Death|27|||
160715596|NCT03743051|580338518|FG001|Overall Study|Death|26|||
160715597|NCT03743051|580338517|FG000|Overall Study|Lost to Follow-up|4|||
160715598|NCT03743051|580338518|FG001|Overall Study|Lost to Follow-up|8|||
160715599|NCT03743051|580338517|FG000|Overall Study|Withdrawal by Subject|32|||
160715600|NCT03743051|580338518|FG001|Overall Study|Withdrawal by Subject|19|||
160715601|NCT03743051|580338517|FG000|Overall Study|Physician Decision|10|||
160715602|NCT03743051|580338518|FG001|Overall Study|Physician Decision|15|||
160715603|NCT03743051|580338517|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
160715604|NCT03743051|580338518|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
160715605|NCT02137252|580338519|FG000|Overall Study|trial terminated early|2|||
160715606|NCT02137252|580338520|FG001|Overall Study|trial terminated early|1|||
160715607|NCT02550561|580338524|FG000|Overall Study|Lost to Follow-up|5|||
160715608|NCT02550561|580338524|FG000|Overall Study|Withdrawal by Subject|1|||
160715609|NCT00428246|580338525|FG000|Overall Study|Withdrawal by Subject|0|||
160715610|NCT00428246|580338526|FG001|Overall Study|Withdrawal by Subject|0|||
160715611|NCT00428246|580338527|FG002|Overall Study|Withdrawal by Subject|1|||
160715612|NCT00428246|580338525|FG000|Overall Study|Adverse Event|1|||
160715613|NCT00428246|580338526|FG001|Overall Study|Adverse Event|0|||
160715614|NCT00428246|580338527|FG002|Overall Study|Adverse Event|0|||
160715615|NCT02603887|580338529|FG000|Stage 1|Adverse Event|4|||
160715616|NCT02603887|580338529|FG000|Stage 1|Disease progression|1|||
160715617|NCT02603887|580338529|FG000|Stage 2|FDA guidance|1|||
160715618|NCT03535740|580338530|FG000|Overall Study|Death|44|||
160715619|NCT03535740|580338530|FG000|Overall Study|Lost to Follow-up|1|||
160715620|NCT03535740|580338530|FG000|Overall Study|Withdrawal by Subject|13|||
160715621|NCT03535740|580338530|FG000|Overall Study|Site terminated by Sponsor|45|||
160715622|NCT05198518|580338533|FG000|Screening Visit|Deemed unable to participate|58|||
160715623|NCT05198518|580338534|FG001|Screening Visit|Deemed unable to participate|0|||
160715624|NCT05198518|580338535|FG002|Screening Visit|Deemed unable to participate|0|||
160715625|NCT05317312|580338541|FG000|Overall Study|Withdrawal by Subject|0|||
160715626|NCT05317312|580338542|FG001|Overall Study|Withdrawal by Subject|1|||
160715627|NCT05317312|580338543|FG002|Overall Study|Withdrawal by Subject|0|||
160715628|NCT05317312|580338544|FG003|Overall Study|Withdrawal by Subject|0|||
160715629|NCT05317312|580338541|FG000|Overall Study|Lost to Follow-up|0|||
160715630|NCT05317312|580338542|FG001|Overall Study|Lost to Follow-up|0|||
160715631|NCT05317312|580338543|FG002|Overall Study|Lost to Follow-up|0|||
160715632|NCT05317312|580338544|FG003|Overall Study|Lost to Follow-up|1|||
160715633|NCT05317312|580338541|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
160715634|NCT05317312|580338542|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
160715635|NCT05317312|580338543|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
160715636|NCT05317312|580338544|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
160715637|NCT00124917|580338545|FG000|Overall Study|Physician Decision|3|||
160715638|NCT01169350|580338548|FG000|Overall Study|Physician Decision|3|||
160715639|NCT01169350|580338548|FG000|Overall Study|Lost to Follow-up|2|||
160715640|NCT04870710|580338550|FG000|Overall Study|Lost to Follow-up|3|||
160715641|NCT01998841|580338557|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
160715642|NCT01998841|580338558|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
160715643|NCT01998841|580338559|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
160715644|NCT01998841|580338560|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
160715645|NCT01998841|580338561|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
160715646|NCT01998841|580338557|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
160715647|NCT01998841|580338558|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
160715648|NCT01998841|580338559|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
160715649|NCT01998841|580338560|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
160715650|NCT01998841|580338561|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
160715651|NCT03447743|580338562|FG000|Overall Study|Withdrawal by Subject|2|||
160715652|NCT03447743|580338562|FG000|Overall Study|Lost to Follow-up|3|||
160715653|NCT03447743|580338562|FG000|Overall Study|Adverse Event|1|||
160715654|NCT03447743|580338562|FG000|Overall Study|Did not meet criteria to continue|1|||
160715655|NCT01112059|580338563|FG000|Overall Study|Withdrawal by Subject|1|||
160715656|NCT01112059|580338564|FG001|Overall Study|Withdrawal by Subject|0|||
160715657|NCT00768248|580338567|FG000|Overall Study|Research coordinator didn't collect data|1|||
160715658|NCT00768248|580338568|FG001|Overall Study|Research coordinator didn't collect data|1|||
160715659|NCT02548143|580338572|FG000|Overall Study|Adverse Event|1|||
160715660|NCT02548143|580338573|FG001|Overall Study|Adverse Event|0|||
160715661|NCT02548143|580338572|FG000|Overall Study|Withdrawal by Subject|0|||
160715662|NCT02548143|580338573|FG001|Overall Study|Withdrawal by Subject|1|||
160715663|NCT04796961|580340533|FG000|Overall Study|Lost to Follow-up|10|||
160715664|NCT04796961|580340533|FG000|Overall Study|Withdrawal by Subject|3|||
160715665|NCT04796961|580340533|FG000|Overall Study|Left Organization|10|||
160715666|NCT01173523|580340536|FG000|Overall Study|Clinical Progression|1|||
160715667|NCT01173523|580340537|FG001|Overall Study|Clinical Progression|1|||
160715668|NCT01173523|580340536|FG000|Overall Study|Progressive Disease|10|||
160715669|NCT01173523|580340537|FG001|Overall Study|Progressive Disease|8|||
160715670|NCT01173523|580340536|FG000|Overall Study|Other|2|||
160715671|NCT01173523|580340537|FG001|Overall Study|Other|3|||
160715672|NCT02439216|580340544|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
160715673|NCT02439216|580340545|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
160715674|NCT02439216|580340546|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
160715675|NCT02439216|580340547|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
160715676|NCT02439216|580340548|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
160715677|NCT02439216|580340549|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
160715678|NCT02439216|580340550|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
160715679|NCT02439216|580340551|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
160715680|NCT02439216|580340552|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
160715681|NCT02439216|580340544|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
160715682|NCT02439216|580340545|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
160715683|NCT02439216|580340546|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
160715684|NCT02439216|580340547|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
160715685|NCT02439216|580340548|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
160715686|NCT02439216|580340549|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
160715687|NCT02439216|580340550|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
160715688|NCT02439216|580340551|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
160715689|NCT02439216|580340552|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
160715690|NCT02439216|580340544|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
160715691|NCT02439216|580340545|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
160715692|NCT02439216|580340546|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
160715693|NCT02439216|580340547|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
160715694|NCT02439216|580340548|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
160715695|NCT02439216|580340549|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
160715696|NCT02439216|580340550|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
160715697|NCT02439216|580340551|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
160715698|NCT02439216|580340552|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
160715699|NCT02439216|580340544|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
160715700|NCT02439216|580340545|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
160715701|NCT02439216|580340546|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
160715702|NCT02439216|580340547|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
160715703|NCT02439216|580340548|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
160715704|NCT02439216|580340549|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
160715705|NCT02439216|580340550|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
160715706|NCT02439216|580340551|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
160715707|NCT02439216|580340552|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
160715708|NCT02439216|580340544|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
160715709|NCT02439216|580340545|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
160715710|NCT02439216|580340546|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
160715711|NCT02439216|580340547|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
160715712|NCT02439216|580340548|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
160715713|NCT02439216|580340549|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
160715714|NCT02439216|580340550|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
160715715|NCT02439216|580340551|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
160715716|NCT02439216|580340552|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
160715717|NCT00470535|580340553|FG000|Overall Study|Disease Progression|13|||
160715718|NCT00470535|580340553|FG000|Overall Study|Withdrawal by Subject|1|||
160715719|NCT00470535|580340553|FG000|Overall Study|Adverse Event|1|||
160715720|NCT00470535|580340553|FG000|Overall Study|Death|1|||
160715721|NCT00470535|580340553|FG000|Overall Study|Other|2|||
160715722|NCT01866826|580340554|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
160715723|NCT01866826|580340555|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
160715724|NCT01866826|580340554|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
160715725|NCT01866826|580340555|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
160715726|NCT01866826|580340554|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
160715727|NCT01866826|580340555|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
160715728|NCT02288312|580340556|FG000|Overall Study|Pregnancy|1|||
160715729|NCT02288312|580340557|FG001|Overall Study|Pregnancy|0|||
160715730|NCT02288312|580340558|FG002|Overall Study|Pregnancy|0|||
160715731|NCT01276041|580340559|FG000|Overall Study|Adverse Event|2|||
160715732|NCT01276041|580340559|FG000|Overall Study|Protocol Violation|1|||
160715733|NCT02968576|580340560|FG000|Overall Study|Pregnancy|0|||
160715734|NCT02968576|580340561|FG001|Overall Study|Pregnancy|1|||
160715735|NCT02058069|580340564|FG000|Overall Study|Exclusion due to implant size|5|||
160715736|NCT02058069|580340564|FG000|Overall Study|Withdrawal by Subject|6|||
160715737|NCT02222922|580340565|FG000|Overall Study|Death|0|||
160715738|NCT02222922|580340566|FG001|Overall Study|Death|0|||
160715739|NCT02222922|580340567|FG002|Overall Study|Death|0|||
160715740|NCT02222922|580340568|FG003|Overall Study|Death|0|||
160715741|NCT02222922|580340569|FG004|Overall Study|Death|13|||
160715742|NCT02222922|580340570|FG005|Overall Study|Death|0|||
160715743|NCT02222922|580340571|FG006|Overall Study|Death|0|||
160715744|NCT02222922|580340572|FG007|Overall Study|Death|0|||
160715745|NCT02222922|580340573|FG008|Overall Study|Death|2|||
160715746|NCT02222922|580340565|FG000|Overall Study|Lost to Follow-up|0|||
160715747|NCT02222922|580340566|FG001|Overall Study|Lost to Follow-up|0|||
160715748|NCT02222922|580340567|FG002|Overall Study|Lost to Follow-up|1|||
160715749|NCT02222922|580340568|FG003|Overall Study|Lost to Follow-up|0|||
160715750|NCT02222922|580340569|FG004|Overall Study|Lost to Follow-up|9|||
160715751|NCT02222922|580340570|FG005|Overall Study|Lost to Follow-up|1|||
160715752|NCT02222922|580340571|FG006|Overall Study|Lost to Follow-up|0|||
160715753|NCT02222922|580340572|FG007|Overall Study|Lost to Follow-up|0|||
160715754|NCT02222922|580340573|FG008|Overall Study|Lost to Follow-up|0|||
160715755|NCT02222922|580340565|FG000|Overall Study|Other|0|||
160715756|NCT02222922|580340566|FG001|Overall Study|Other|0|||
160715757|NCT02222922|580340567|FG002|Overall Study|Other|0|||
160715758|NCT02222922|580340568|FG003|Overall Study|Other|2|||
160715759|NCT02222922|580340569|FG004|Overall Study|Other|10|||
160715760|NCT02222922|580340570|FG005|Overall Study|Other|2|||
160715761|NCT02222922|580340571|FG006|Overall Study|Other|2|||
160715762|NCT02222922|580340572|FG007|Overall Study|Other|4|||
160715763|NCT02222922|580340573|FG008|Overall Study|Other|1|||
160715764|NCT02222922|580340565|FG000|Overall Study|Participant refused further follow-up|1|||
160715765|NCT02222922|580340566|FG001|Overall Study|Participant refused further follow-up|0|||
160715766|NCT02222922|580340567|FG002|Overall Study|Participant refused further follow-up|0|||
160715767|NCT02222922|580340568|FG003|Overall Study|Participant refused further follow-up|1|||
160715768|NCT02222922|580340569|FG004|Overall Study|Participant refused further follow-up|6|||
160715769|NCT02222922|580340570|FG005|Overall Study|Participant refused further follow-up|0|||
160715770|NCT02222922|580340571|FG006|Overall Study|Participant refused further follow-up|0|||
160715771|NCT02222922|580340572|FG007|Overall Study|Participant refused further follow-up|0|||
160715772|NCT02222922|580340573|FG008|Overall Study|Participant refused further follow-up|3|||
160715773|NCT02002221|580340574|FG000|Overall Study|Adverse Event|2|||
160715774|NCT02002221|580340575|FG001|Overall Study|Adverse Event|1|||
160715775|NCT02002221|580340574|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160715776|NCT02002221|580340575|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160715777|NCT02002221|580340574|FG000|Overall Study|Patient withdrew consent|0|||
160715778|NCT02002221|580340575|FG001|Overall Study|Patient withdrew consent|1|||
160715779|NCT01998919|580340576|FG000|Overall Study|Death|2|||
160715780|NCT01998919|580340577|FG001|Overall Study|Death|2|||
160715781|NCT01998919|580340576|FG000|Overall Study|Adverse Event|0|||
160715782|NCT01998919|580340577|FG001|Overall Study|Adverse Event|5|||
160715783|NCT01998919|580340576|FG000|Overall Study|Disease progression|31|||
160715784|NCT01998919|580340577|FG001|Overall Study|Disease progression|22|||
160715785|NCT01998919|580340576|FG000|Overall Study|Withdrawal by Subject|2|||
160715786|NCT01998919|580340577|FG001|Overall Study|Withdrawal by Subject|4|||
160715787|NCT01998919|580340576|FG000|Overall Study|Lost to Follow-up|2|||
160715788|NCT01998919|580340577|FG001|Overall Study|Lost to Follow-up|0|||
160715789|NCT01998919|580340576|FG000|Overall Study|Other|5|||
160715790|NCT01998919|580340577|FG001|Overall Study|Other|2|||
160715791|NCT01068860|580340578|FG000|Overall Study|Withdrawal by Subject|0|||
160715792|NCT01068860|580340579|FG001|Overall Study|Withdrawal by Subject|0|||
160715793|NCT01068860|580340580|FG002|Overall Study|Withdrawal by Subject|0|||
160715794|NCT01068860|580340581|FG003|Overall Study|Withdrawal by Subject|0|||
160715795|NCT01068860|580340582|FG004|Overall Study|Withdrawal by Subject|0|||
160715796|NCT01068860|580340583|FG005|Overall Study|Withdrawal by Subject|2|||
160715797|NCT01068860|580340584|FG006|Overall Study|Withdrawal by Subject|0|||
160715798|NCT01068860|580340585|FG007|Overall Study|Withdrawal by Subject|0|||
160715799|NCT01068860|580340586|FG008|Overall Study|Withdrawal by Subject|0|||
160715800|NCT01068860|580340587|FG009|Overall Study|Withdrawal by Subject|3|||
160715801|NCT01068860|580340578|FG000|Overall Study|Administrative problems; misrandomized|0|||
160715802|NCT01068860|580340579|FG001|Overall Study|Administrative problems; misrandomized|0|||
160715803|NCT01068860|580340580|FG002|Overall Study|Administrative problems; misrandomized|0|||
160715804|NCT01068860|580340581|FG003|Overall Study|Administrative problems; misrandomized|1|||
160715805|NCT01068860|580340582|FG004|Overall Study|Administrative problems; misrandomized|0|||
160715806|NCT01068860|580340583|FG005|Overall Study|Administrative problems; misrandomized|0|||
160715807|NCT01068860|580340584|FG006|Overall Study|Administrative problems; misrandomized|0|||
160715808|NCT01068860|580340585|FG007|Overall Study|Administrative problems; misrandomized|0|||
160715809|NCT01068860|580340586|FG008|Overall Study|Administrative problems; misrandomized|0|||
160715810|NCT01068860|580340587|FG009|Overall Study|Administrative problems; misrandomized|1|||
160715811|NCT01068860|580340578|FG000|Overall Study|Lost to Follow-up|0|||
160715812|NCT01068860|580340579|FG001|Overall Study|Lost to Follow-up|1|||
160715813|NCT01068860|580340580|FG002|Overall Study|Lost to Follow-up|0|||
160715814|NCT01068860|580340581|FG003|Overall Study|Lost to Follow-up|0|||
160715815|NCT01068860|580340582|FG004|Overall Study|Lost to Follow-up|0|||
160715816|NCT01068860|580340583|FG005|Overall Study|Lost to Follow-up|0|||
160715817|NCT01068860|580340584|FG006|Overall Study|Lost to Follow-up|0|||
160715818|NCT01068860|580340585|FG007|Overall Study|Lost to Follow-up|0|||
160715819|NCT01068860|580340586|FG008|Overall Study|Lost to Follow-up|0|||
160715820|NCT01068860|580340587|FG009|Overall Study|Lost to Follow-up|0|||
160715821|NCT02568072|580340588|FG000|Overall Study|Unavailable for appointment|23|||
160715822|NCT02568072|580340588|FG000|Overall Study|Unable to contact|3|||
160715823|NCT02568072|580340588|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
160715824|NCT02568072|580340588|FG000|Overall Study|Withdrawal by Subject|1|||
160715825|NCT02568072|580340588|FG000|Overall Study|Sustained injury, marathon not run|24|||
160715826|NCT00897715|580340592|FG000|Overall Study|Lost to Follow-up|0|||
160715827|NCT00897715|580340593|FG001|Overall Study|Lost to Follow-up|1|||
160715828|NCT00897715|580340592|FG000|Overall Study|Physician Decision|1|||
160715829|NCT00897715|580340593|FG001|Overall Study|Physician Decision|0|||
160715830|NCT00897715|580340592|FG000|Overall Study|increased risk of infection|1|||
160715831|NCT00897715|580340593|FG001|Overall Study|increased risk of infection|0|||
160715832|NCT00927589|580340595|FG000|Overall Study|Death|1|||
160715833|NCT00927589|580340595|FG000|Overall Study|Physician Decision|1|||
160715834|NCT00927589|580340595|FG000|Overall Study|Withdrawal by Subject|3|||
160715835|NCT00927589|580340595|FG000|Overall Study|Adverse Event|2|||
160715836|NCT00927589|580340595|FG000|Overall Study|Disease Progression|8|||
160715837|NCT00927589|580340595|FG000|Overall Study|Non-compliance|1|||
160715838|NCT05263908|580340596|FG000|Overall Study|No informed consent for publication of study results|397|||
160715839|NCT05263908|580340596|FG000|Overall Study|CRF not collected|1|||
160715840|NCT02714218|580340597|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160715841|NCT02714218|580340598|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
160715842|NCT02714218|580340599|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160715843|NCT02714218|580340597|FG000|Pre-Treatment Period|Other reasons|0|||
160715844|NCT02714218|580340598|FG001|Pre-Treatment Period|Other reasons|1|||
160715845|NCT02714218|580340599|FG002|Pre-Treatment Period|Other reasons|0|||
160715846|NCT02714218|580340597|FG000|Treatment Period|Disease Progression|55|||
160715847|NCT02714218|580340598|FG001|Treatment Period|Disease Progression|52|||
160715848|NCT02714218|580340599|FG002|Treatment Period|Disease Progression|14|||
160715849|NCT02714218|580340597|FG000|Treatment Period|Study drug toxicity|46|||
160715850|NCT02714218|580340598|FG001|Treatment Period|Study drug toxicity|70|||
160715851|NCT02714218|580340599|FG002|Treatment Period|Study drug toxicity|6|||
160715852|NCT02714218|580340597|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
160715853|NCT02714218|580340598|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
160715854|NCT02714218|580340599|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
160715855|NCT02714218|580340597|FG000|Treatment Period|Request to discontinue treatment|1|||
160715856|NCT02714218|580340598|FG001|Treatment Period|Request to discontinue treatment|4|||
160715857|NCT02714218|580340599|FG002|Treatment Period|Request to discontinue treatment|1|||
160715858|NCT02714218|580340597|FG000|Treatment Period|Participant withdrew consent|2|||
160715859|NCT02714218|580340598|FG001|Treatment Period|Participant withdrew consent|2|||
160715860|NCT02714218|580340599|FG002|Treatment Period|Participant withdrew consent|0|||
160715861|NCT02714218|580340597|FG000|Treatment Period|Maximum clinical benefit|4|||
160715862|NCT02714218|580340598|FG001|Treatment Period|Maximum clinical benefit|2|||
160715863|NCT02714218|580340599|FG002|Treatment Period|Maximum clinical benefit|0|||
160715864|NCT02714218|580340597|FG000|Treatment Period|Administrative reason by sponsor|2|||
160715865|NCT02714218|580340598|FG001|Treatment Period|Administrative reason by sponsor|1|||
160715866|NCT02714218|580340599|FG002|Treatment Period|Administrative reason by sponsor|0|||
160715867|NCT02714218|580340597|FG000|Treatment Period|Other reasons|6|||
160715868|NCT02714218|580340598|FG001|Treatment Period|Other reasons|6|||
160715869|NCT02714218|580340599|FG002|Treatment Period|Other reasons|0|||
160715870|NCT02714218|580340597|FG000|Treatment Period|Completed treatment as per protocol|36|||
160715871|NCT02714218|580340598|FG001|Treatment Period|Completed treatment as per protocol|27|||
160715872|NCT02714218|580340599|FG002|Treatment Period|Completed treatment as per protocol|3|||
160715873|NCT02714218|580340597|FG000|Treatment Period|Not reported|9|||
160715874|NCT02714218|580340598|FG001|Treatment Period|Not reported|6|||
160715875|NCT02714218|580340599|FG002|Treatment Period|Not reported|0|||
160715876|NCT00789854|580340600|FG000|Overall Study|Adverse Event|28|||
160715877|NCT00789854|580340601|FG001|Overall Study|Adverse Event|23|||
160715878|NCT00789854|580340602|FG002|Overall Study|Adverse Event|18|||
160715879|NCT00789854|580340600|FG000|Overall Study|Lost to Follow-up|1|||
160715880|NCT00789854|580340601|FG001|Overall Study|Lost to Follow-up|1|||
160715881|NCT00789854|580340602|FG002|Overall Study|Lost to Follow-up|4|||
160715882|NCT00789854|580340600|FG000|Overall Study|Withdrawal by Subject|9|||
160715883|NCT00789854|580340601|FG001|Overall Study|Withdrawal by Subject|6|||
160715884|NCT00789854|580340602|FG002|Overall Study|Withdrawal by Subject|17|||
160715885|NCT00789854|580340600|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
160715886|NCT00789854|580340601|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
160715887|NCT00789854|580340602|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
160715888|NCT00789854|580340600|FG000|Overall Study|Severe non-compliance to the protocol|3|||
160715889|NCT00789854|580340601|FG001|Overall Study|Severe non-compliance to the protocol|0|||
160715890|NCT00789854|580340602|FG002|Overall Study|Severe non-compliance to the protocol|0|||
160715891|NCT00789854|580340600|FG000|Overall Study|Safety reasons|0|||
160715892|NCT00789854|580340601|FG001|Overall Study|Safety reasons|0|||
160715893|NCT00789854|580340602|FG002|Overall Study|Safety reasons|2|||
160715894|NCT00789854|580340600|FG000|Overall Study|Other|6|||
160715895|NCT00789854|580340601|FG001|Overall Study|Other|0|||
160715896|NCT00789854|580340602|FG002|Overall Study|Other|5|||
160715897|NCT03411863|580340603|FG000|Overall Study|Withdrawal by Subject|3|||
160715898|NCT03411863|580340604|FG001|Overall Study|Withdrawal by Subject|1|||
160715899|NCT03411863|580340603|FG000|Overall Study|Physician Decision|0|||
160715900|NCT03411863|580340604|FG001|Overall Study|Physician Decision|1|||
160715901|NCT02756611|580340607|FG000|Overall Study|Death|70|||
160715902|NCT02756611|580340607|FG000|Overall Study|Withdrawal by Subject|2|||
160715903|NCT02756611|580340607|FG000|Overall Study|Lost to Follow-up|3|||
160715904|NCT02756611|580340607|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
160715905|NCT02756611|580340607|FG000|Overall Study|Other|10|||
160715906|NCT03125798|580340609|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
160715907|NCT03125798|580340610|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
160715908|NCT03125798|580340609|FG000|Overall Study|Conversion to thoracotomy|7|||
160715909|NCT03125798|580340610|FG001|Overall Study|Conversion to thoracotomy|7|||
160715910|NCT00262028|580340614|FG000|Overall Study|Withdrawal by Subject|6|||
160715911|NCT00262028|580340615|FG001|Overall Study|Withdrawal by Subject|3|||
160715912|NCT00262028|580340616|FG002|Overall Study|Withdrawal by Subject|6|||
160715913|NCT00262028|580340617|FG003|Overall Study|Withdrawal by Subject|5|||
160715914|NCT00262028|580340618|FG004|Overall Study|Withdrawal by Subject|2|||
160715915|NCT00262028|580340619|FG005|Overall Study|Withdrawal by Subject|3|||
160715916|NCT00262028|580340620|FG006|Overall Study|Withdrawal by Subject|5|||
160715917|NCT00262028|580340621|FG007|Overall Study|Withdrawal by Subject|7|||
160715918|NCT00262028|580340622|FG008|Overall Study|Withdrawal by Subject|2|||
160715919|NCT00262028|580340614|FG000|Overall Study|Lost to Follow-up|7|||
160715920|NCT00262028|580340615|FG001|Overall Study|Lost to Follow-up|7|||
160715921|NCT00262028|580340616|FG002|Overall Study|Lost to Follow-up|5|||
160715922|NCT00262028|580340617|FG003|Overall Study|Lost to Follow-up|5|||
160715923|NCT00262028|580340618|FG004|Overall Study|Lost to Follow-up|4|||
160715924|NCT00262028|580340619|FG005|Overall Study|Lost to Follow-up|3|||
160715925|NCT00262028|580340620|FG006|Overall Study|Lost to Follow-up|3|||
160715926|NCT00262028|580340621|FG007|Overall Study|Lost to Follow-up|5|||
160715927|NCT00262028|580340622|FG008|Overall Study|Lost to Follow-up|6|||
160715928|NCT00262028|580340614|FG000|Overall Study|Administrative Reason|11|||
160715929|NCT00262028|580340615|FG001|Overall Study|Administrative Reason|14|||
160715930|NCT00262028|580340616|FG002|Overall Study|Administrative Reason|9|||
160715931|NCT00262028|580340617|FG003|Overall Study|Administrative Reason|12|||
160715932|NCT00262028|580340618|FG004|Overall Study|Administrative Reason|6|||
160715933|NCT00262028|580340619|FG005|Overall Study|Administrative Reason|7|||
160715934|NCT00262028|580340620|FG006|Overall Study|Administrative Reason|4|||
160715935|NCT00262028|580340621|FG007|Overall Study|Administrative Reason|6|||
160715936|NCT00262028|580340622|FG008|Overall Study|Administrative Reason|10|||
160715937|NCT00262028|580340614|FG000|Overall Study|Protocol Violation|0|||
160715938|NCT00262028|580340615|FG001|Overall Study|Protocol Violation|0|||
160715939|NCT00262028|580340616|FG002|Overall Study|Protocol Violation|0|||
160715940|NCT00262028|580340617|FG003|Overall Study|Protocol Violation|1|||
160715941|NCT00262028|580340618|FG004|Overall Study|Protocol Violation|0|||
160715942|NCT00262028|580340619|FG005|Overall Study|Protocol Violation|0|||
160715943|NCT00262028|580340620|FG006|Overall Study|Protocol Violation|0|||
160715944|NCT00262028|580340621|FG007|Overall Study|Protocol Violation|0|||
160715945|NCT00262028|580340622|FG008|Overall Study|Protocol Violation|0|||
160715946|NCT00262028|580340614|FG000|Overall Study|Unable to classify|0|||
160715947|NCT00262028|580340615|FG001|Overall Study|Unable to classify|3|||
160715948|NCT00262028|580340616|FG002|Overall Study|Unable to classify|0|||
160715949|NCT00262028|580340617|FG003|Overall Study|Unable to classify|0|||
160715950|NCT00262028|580340618|FG004|Overall Study|Unable to classify|0|||
160715951|NCT00262028|580340619|FG005|Overall Study|Unable to classify|0|||
160715952|NCT00262028|580340620|FG006|Overall Study|Unable to classify|0|||
160715953|NCT00262028|580340621|FG007|Overall Study|Unable to classify|0|||
160715954|NCT00262028|580340622|FG008|Overall Study|Unable to classify|1|||
160715955|NCT03164551|580340623|FG000|Overall Study|Imaging discontinued prior completion|8|||
160715956|NCT03164551|580340624|FG001|Overall Study|Imaging discontinued prior completion|0|||
160715957|NCT03164551|580340623|FG000|Overall Study|Participant was non-compliant|1|||
160715958|NCT03164551|580340624|FG001|Overall Study|Participant was non-compliant|0|||
160715959|NCT03164551|580340623|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
160715960|NCT03164551|580340624|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
160715961|NCT03164551|580340623|FG000|Overall Study|Other|8|||
160715962|NCT03164551|580340624|FG001|Overall Study|Other|2|||
160715963|NCT01515423|580340625|FG000|Open Label Phase|Adverse Event|57|||
160715964|NCT01515423|580340626|FG001|Open Label Phase|Adverse Event|0|||
160715965|NCT01515423|580340627|FG002|Open Label Phase|Adverse Event|0|||
160715966|NCT01515423|580340625|FG000|Open Label Phase|Death|2|||
160715967|NCT01515423|580340626|FG001|Open Label Phase|Death|0|||
160715968|NCT01515423|580340627|FG002|Open Label Phase|Death|0|||
160715969|NCT01515423|580340625|FG000|Open Label Phase|Lack of Efficacy|117|||
160715970|NCT01515423|580340626|FG001|Open Label Phase|Lack of Efficacy|0|||
160715971|NCT01515423|580340627|FG002|Open Label Phase|Lack of Efficacy|0|||
160715972|NCT01515423|580340625|FG000|Open Label Phase|Lost to Follow-up|21|||
160715973|NCT01515423|580340626|FG001|Open Label Phase|Lost to Follow-up|0|||
160715974|NCT01515423|580340627|FG002|Open Label Phase|Lost to Follow-up|0|||
160715975|NCT01515423|580340625|FG000|Open Label Phase|Withdrawal by Subject|118|||
160715976|NCT01515423|580340626|FG001|Open Label Phase|Withdrawal by Subject|0|||
160715977|NCT01515423|580340627|FG002|Open Label Phase|Withdrawal by Subject|0|||
160715978|NCT01515423|580340625|FG000|Open Label Phase|excluded from DB Phase|70|||
160715979|NCT01515423|580340626|FG001|Open Label Phase|excluded from DB Phase|0|||
160715980|NCT01515423|580340627|FG002|Open Label Phase|excluded from DB Phase|0|||
160715981|NCT01515423|580340625|FG000|Open Label Phase|Other|28|||
160715982|NCT01515423|580340626|FG001|Open Label Phase|Other|0|||
160715983|NCT01515423|580340627|FG002|Open Label Phase|Other|0|||
160715984|NCT01515423|580340625|FG000|DOUBLE BLIND|Adverse Event|0|||
160715985|NCT01515423|580340626|FG001|DOUBLE BLIND|Adverse Event|15|||
160715986|NCT01515423|580340627|FG002|DOUBLE BLIND|Adverse Event|13|||
160715987|NCT01515423|580340625|FG000|DOUBLE BLIND|Death|0|||
160715988|NCT01515423|580340626|FG001|DOUBLE BLIND|Death|1|||
160715989|NCT01515423|580340627|FG002|DOUBLE BLIND|Death|2|||
160715990|NCT01515423|580340625|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
160715991|NCT01515423|580340626|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
160715992|NCT01515423|580340627|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
160715993|NCT01515423|580340625|FG000|DOUBLE BLIND|Pregnancy|0|||
160715994|NCT01515423|580340626|FG001|DOUBLE BLIND|Pregnancy|2|||
160715995|NCT01515423|580340627|FG002|DOUBLE BLIND|Pregnancy|0|||
160715996|NCT01515423|580340625|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
160715997|NCT01515423|580340626|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
160715998|NCT01515423|580340627|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
160715999|NCT01515423|580340625|FG000|DOUBLE BLIND|Other|0|||
160716000|NCT01515423|580340626|FG001|DOUBLE BLIND|Other|6|||
160716001|NCT01515423|580340627|FG002|DOUBLE BLIND|Other|12|||
160716002|NCT01515423|580340625|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
160716003|NCT01515423|580340626|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
160716004|NCT01515423|580340627|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
160716005|NCT01422213|580340632|FG000|Overall Study|Adverse Event|8|||
160716006|NCT01422213|580340633|FG001|Overall Study|Adverse Event|7|||
160716007|NCT01422213|580340634|FG002|Overall Study|Adverse Event|11|||
160716008|NCT01422213|580340632|FG000|Overall Study|Lack of Efficacy|10|||
160716009|NCT01422213|580340633|FG001|Overall Study|Lack of Efficacy|2|||
160716010|NCT01422213|580340634|FG002|Overall Study|Lack of Efficacy|2|||
160716011|NCT01422213|580340632|FG000|Overall Study|Non-compliance with study drug|0|||
160716012|NCT01422213|580340633|FG001|Overall Study|Non-compliance with study drug|1|||
160716013|NCT01422213|580340634|FG002|Overall Study|Non-compliance with study drug|0|||
160716014|NCT01422213|580340632|FG000|Overall Study|Protocol Violation|0|||
160716015|NCT01422213|580340633|FG001|Overall Study|Protocol Violation|2|||
160716016|NCT01422213|580340634|FG002|Overall Study|Protocol Violation|4|||
160716017|NCT01422213|580340632|FG000|Overall Study|Withdrawal of Consent|7|||
160716018|NCT01422213|580340633|FG001|Overall Study|Withdrawal of Consent|3|||
160716019|NCT01422213|580340634|FG002|Overall Study|Withdrawal of Consent|5|||
160716020|NCT01422213|580340632|FG000|Overall Study|Lost to Follow-up|3|||
160716021|NCT01422213|580340633|FG001|Overall Study|Lost to Follow-up|3|||
160716022|NCT01422213|580340634|FG002|Overall Study|Lost to Follow-up|5|||
160716023|NCT01422213|580340632|FG000|Overall Study|Administrative or Other Reason(s)|5|||
160716024|NCT01422213|580340633|FG001|Overall Study|Administrative or Other Reason(s)|4|||
160716025|NCT01422213|580340634|FG002|Overall Study|Administrative or Other Reason(s)|2|||
160716026|NCT00613171|580340639|FG000|Overall Study|Adverse Event|7|||
160716027|NCT00613171|580340639|FG000|Overall Study|Withdrawal by Subject|3|||
160716028|NCT00613171|580340639|FG000|Overall Study|Reason not Specified|4|||
160716029|NCT00951496|580340644|FG000|Overall Study|Did not initiate study treatment|10|||
160716030|NCT00951496|580340645|FG001|Overall Study|Did not initiate study treatment|8|||
160716031|NCT00951496|580340646|FG002|Overall Study|Did not initiate study treatment|13|||
160716032|NCT00476190|580340658|FG000|Overall Study|Ineligible|1|||
160716033|NCT00476190|580340659|FG001|Overall Study|Ineligible|1|||
160716034|NCT00476190|580340658|FG000|Overall Study|Induction Death|2|||
160716035|NCT00476190|580340659|FG001|Overall Study|Induction Death|0|||
160716036|NCT00476190|580340658|FG000|Overall Study|Induction Failure|2|||
160716037|NCT00476190|580340659|FG001|Overall Study|Induction Failure|4|||
160716038|NCT00476190|580340658|FG000|Overall Study|Lost to Follow-up|1|||
160716039|NCT00476190|580340659|FG001|Overall Study|Lost to Follow-up|0|||
160716040|NCT00476190|580340658|FG000|Overall Study|Relapse/Progression|5|||
160716041|NCT00476190|580340659|FG001|Overall Study|Relapse/Progression|2|||
160716042|NCT00476190|580340658|FG000|Overall Study|Remission Death|0|||
160716043|NCT00476190|580340659|FG001|Overall Study|Remission Death|1|||
160716044|NCT00476190|580340658|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
160716045|NCT00476190|580340659|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
160716046|NCT00476190|580340658|FG000|Overall Study|Withdrawal by Subject|6|||
160716047|NCT00476190|580340659|FG001|Overall Study|Withdrawal by Subject|2|||
160716048|NCT00476190|580340658|FG000|Overall Study|Other|9|||
160716049|NCT00476190|580340659|FG001|Overall Study|Other|10|||
160716050|NCT04782076|580340660|FG000|Overall Study|Family Emergency|1|||
160716051|NCT01042093|580340664|FG000|Overall Study|Protocol Violation|2|||
160716052|NCT01042093|580340665|FG001|Overall Study|Protocol Violation|2|||
160716053|NCT01042093|580340666|FG002|Overall Study|Protocol Violation|2|||
160716054|NCT01042093|580340667|FG003|Overall Study|Protocol Violation|3|||
160716055|NCT01042093|580340664|FG000|Overall Study|Withdrawal by Subject|0|||
160716056|NCT01042093|580340665|FG001|Overall Study|Withdrawal by Subject|0|||
160716057|NCT01042093|580340666|FG002|Overall Study|Withdrawal by Subject|0|||
160716058|NCT01042093|580340667|FG003|Overall Study|Withdrawal by Subject|1|||
160716059|NCT02189837|580340668|FG000|Overall Study|Withdrawal by Subject|2|||
160716060|NCT02189837|580340669|FG001|Overall Study|Withdrawal by Subject|1|||
160716061|NCT02189837|580340670|FG002|Overall Study|Withdrawal by Subject|3|||
160716062|NCT02189837|580340671|FG003|Overall Study|Withdrawal by Subject|1|||
160716063|NCT02189837|580340668|FG000|Overall Study|Sponsor Decision|0|||
160716064|NCT02189837|580340669|FG001|Overall Study|Sponsor Decision|0|||
160716065|NCT02189837|580340670|FG002|Overall Study|Sponsor Decision|0|||
160716066|NCT02189837|580340671|FG003|Overall Study|Sponsor Decision|1|||
160716067|NCT00995774|580340672|FG000|Training Period 2|Withdrawal by Subject|2|||
160716068|NCT00995774|580340673|FG001|Training Period 2|Withdrawal by Subject|0|||
160716069|NCT02552121|580340676|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
160716070|NCT02552121|580340677|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
160716071|NCT02552121|580340678|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
160716072|NCT02552121|580340679|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
160716073|NCT02552121|580340680|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
160716074|NCT02552121|580340681|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
160716075|NCT02552121|580340682|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
160716076|NCT02552121|580340683|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
160716077|NCT02552121|580340676|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
160716078|NCT02552121|580340677|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
160716079|NCT02552121|580340678|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
160716080|NCT02552121|580340679|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
160716081|NCT02552121|580340680|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
160716082|NCT02552121|580340681|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
160716083|NCT02552121|580340682|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
160716084|NCT02552121|580340683|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
160716085|NCT02552121|580340676|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
160716086|NCT02552121|580340677|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
160716087|NCT02552121|580340678|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
160716088|NCT02552121|580340679|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
160716089|NCT02552121|580340680|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
160716090|NCT02552121|580340681|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
160716091|NCT02552121|580340682|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
160716092|NCT02552121|580340683|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
160716093|NCT02552121|580340676|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
160716094|NCT02552121|580340677|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
160716095|NCT02552121|580340678|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
160716096|NCT02552121|580340679|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
160716097|NCT02552121|580340680|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
160716098|NCT02552121|580340681|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
160716099|NCT02552121|580340682|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
160716100|NCT02552121|580340683|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
160716101|NCT02552121|580340676|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
160716102|NCT02552121|580340677|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
160716103|NCT02552121|580340678|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
160716104|NCT02552121|580340679|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
160716105|NCT02552121|580340680|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
160716106|NCT02552121|580340681|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
160716107|NCT02552121|580340682|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
160716108|NCT02552121|580340683|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
160716109|NCT02552121|580340676|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
160716110|NCT02552121|580340677|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
160716111|NCT02552121|580340678|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
160716112|NCT02552121|580340679|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
160716113|NCT02552121|580340680|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
160716114|NCT02552121|580340681|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
160716115|NCT02552121|580340682|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
160716116|NCT02552121|580340683|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
160716117|NCT02552121|580340676|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
160716118|NCT02552121|580340677|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
160716119|NCT02552121|580340678|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
160716120|NCT02552121|580340679|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
160716121|NCT02552121|580340680|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
160716122|NCT02552121|580340681|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
160716123|NCT02552121|580340682|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
160716124|NCT02552121|580340683|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
160716125|NCT02552121|580340676|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
160716126|NCT02552121|580340677|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
160716127|NCT02552121|580340678|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
160716128|NCT02552121|580340679|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
160716129|NCT02552121|580340680|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
160716130|NCT02552121|580340681|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
160716131|NCT02552121|580340682|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
160716132|NCT02552121|580340683|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
160716133|NCT02552121|580340676|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
160716134|NCT02552121|580340677|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
160716135|NCT02552121|580340678|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
160716136|NCT02552121|580340679|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
160716137|NCT02552121|580340680|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
160716138|NCT02552121|580340681|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
160716139|NCT02552121|580340682|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
160716140|NCT02552121|580340683|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
160716141|NCT02552121|580340676|FG000|Part 2: Cohort Expansion|Death|0|||
160716142|NCT02552121|580340677|FG001|Part 2: Cohort Expansion|Death|0|||
160716143|NCT02552121|580340678|FG002|Part 2: Cohort Expansion|Death|1|||
160716144|NCT02552121|580340679|FG003|Part 2: Cohort Expansion|Death|0|||
160716145|NCT02552121|580340680|FG004|Part 2: Cohort Expansion|Death|0|||
160716146|NCT02552121|580340681|FG005|Part 2: Cohort Expansion|Death|0|||
160716147|NCT02552121|580340682|FG006|Part 2: Cohort Expansion|Death|0|||
160716148|NCT02552121|580340683|FG007|Part 2: Cohort Expansion|Death|0|||
160716149|NCT00972595|580340684|FG000|Period 1|Adverse Event|1|||
160716150|NCT00972595|580340685|FG001|Period 1|Adverse Event|0|||
160716151|NCT01406574|580340688|FG000|Overall Study|Adverse Event|0|||
160716152|NCT01406574|580340689|FG001|Overall Study|Adverse Event|0|||
160716153|NCT01406574|580340690|FG002|Overall Study|Adverse Event|1|||
160716154|NCT01406574|580340691|FG003|Overall Study|Adverse Event|3|||
160716155|NCT01406574|580340688|FG000|Overall Study|Physician Decision|0|||
160716156|NCT01406574|580340689|FG001|Overall Study|Physician Decision|0|||
160716157|NCT01406574|580340690|FG002|Overall Study|Physician Decision|0|||
160716158|NCT01406574|580340691|FG003|Overall Study|Physician Decision|1|||
160716159|NCT01406574|580340688|FG000|Overall Study|Withdrawal by Subject|0|||
160716160|NCT01406574|580340689|FG001|Overall Study|Withdrawal by Subject|1|||
160716161|NCT01406574|580340690|FG002|Overall Study|Withdrawal by Subject|0|||
160716162|NCT01406574|580340691|FG003|Overall Study|Withdrawal by Subject|0|||
160716163|NCT01406574|580340688|FG000|Overall Study|Definite progression of primary disease|1|||
160716164|NCT01406574|580340689|FG001|Overall Study|Definite progression of primary disease|0|||
160716165|NCT01406574|580340690|FG002|Overall Study|Definite progression of primary disease|0|||
160716166|NCT01406574|580340691|FG003|Overall Study|Definite progression of primary disease|0|||
160716167|NCT04052620|580340692|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
160716168|NCT04052620|580340693|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
160716169|NCT04052620|580340692|FG000|Overall Study|Withdrawal by Subject|1|||
160716170|NCT04052620|580340693|FG001|Overall Study|Withdrawal by Subject|0|||
160716171|NCT04052620|580340692|FG000|Overall Study|Lost to Follow-up|1|||
160716172|NCT04052620|580340693|FG001|Overall Study|Lost to Follow-up|1|||
160716173|NCT04052620|580340692|FG000|Overall Study|Adverse Event|1|||
160716174|NCT04052620|580340693|FG001|Overall Study|Adverse Event|0|||
160716175|NCT04052620|580340692|FG000|Overall Study|Subject did not meet study Criteria|0|||
160716176|NCT04052620|580340693|FG001|Overall Study|Subject did not meet study Criteria|1|||
160716177|NCT04052620|580340692|FG000|Overall Study|Screened failure, randomized by mistake|0|||
160716178|NCT04052620|580340693|FG001|Overall Study|Screened failure, randomized by mistake|1|||
160716179|NCT04052620|580340692|FG000|Overall Study|Personal reasons|2|||
160716180|NCT04052620|580340693|FG001|Overall Study|Personal reasons|4|||
160716181|NCT04052620|580340692|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
160716182|NCT04052620|580340693|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
160716183|NCT03552380|580340695|FG000|Study Treatment|Disease Progression|3|||
160716184|NCT03552380|580340696|FG001|Study Treatment|Disease Progression|4|||
160716185|NCT03552380|580340695|FG000|Study Treatment|Adverse Event|2|||
160716186|NCT03552380|580340696|FG001|Study Treatment|Adverse Event|2|||
160716187|NCT03552380|580340695|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
160716188|NCT03552380|580340696|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
160716189|NCT03552380|580340695|FG000|Follow up|Death|3|||
160716190|NCT03552380|580340696|FG001|Follow up|Death|4|||
160716191|NCT03552380|580340695|FG000|Follow up|Site IRB terminated|0|||
160716192|NCT03552380|580340696|FG001|Follow up|Site IRB terminated|1|||
160716193|NCT03567980|580340697|FG000|Overall Study|Adverse Event|1|||
160716194|NCT02575833|580340698|FG000|Overall Study|Withdrawal by Subject|0|||
160716195|NCT02575833|580340699|FG001|Overall Study|Withdrawal by Subject|1|||
160716196|NCT02575833|580340698|FG000|Overall Study|Lost to Follow-up|1|||
160716197|NCT02575833|580340699|FG001|Overall Study|Lost to Follow-up|0|||
160716198|NCT04211831|580340702|FG000|Overall Study|Withdrawal by Subject|4|||
160716199|NCT04211831|580340703|FG001|Overall Study|Withdrawal by Subject|1|||
160716200|NCT04211831|580340704|FG002|Overall Study|Withdrawal by Subject|1|||
160716201|NCT04211831|580340702|FG000|Overall Study|Protocol Violation|0|||
160716202|NCT04211831|580340703|FG001|Overall Study|Protocol Violation|0|||
160716203|NCT04211831|580340704|FG002|Overall Study|Protocol Violation|1|||
160716204|NCT04211831|580340702|FG000|Overall Study|Adverse Event|0|||
160716205|NCT04211831|580340703|FG001|Overall Study|Adverse Event|1|||
160716206|NCT04211831|580340704|FG002|Overall Study|Adverse Event|0|||
160716207|NCT04211831|580340702|FG000|Overall Study|Lack of Efficacy|0|||
160716208|NCT04211831|580340703|FG001|Overall Study|Lack of Efficacy|0|||
160716209|NCT04211831|580340704|FG002|Overall Study|Lack of Efficacy|1|||
160716210|NCT04211831|580340702|FG000|Overall Study|Lost to Follow-up|0|||
160716211|NCT04211831|580340703|FG001|Overall Study|Lost to Follow-up|0|||
160716212|NCT04211831|580340704|FG002|Overall Study|Lost to Follow-up|2|||
160716213|NCT04211831|580340702|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
160716214|NCT04211831|580340703|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
160716215|NCT04211831|580340704|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
160716216|NCT04211831|580340702|FG000|Overall Study|Other|0|||
160716217|NCT04211831|580340703|FG001|Overall Study|Other|1|||
160716218|NCT04211831|580340704|FG002|Overall Study|Other|0|||
160716219|NCT00967330|580340705|FG000|Overall Study|Protocol Violation|3|||
160716220|NCT00967330|580340706|FG001|Overall Study|Protocol Violation|4|||
160716221|NCT00967330|580340705|FG000|Overall Study|Regular|10|||
160716222|NCT00967330|580340706|FG001|Overall Study|Regular|3|||
160716223|NCT00967330|580340705|FG000|Overall Study|Withdrawal by Subject|6|||
160716224|NCT00967330|580340706|FG001|Overall Study|Withdrawal by Subject|0|||
160716225|NCT00967330|580340705|FG000|Overall Study|Lost to Follow-up|1|||
160716226|NCT00967330|580340706|FG001|Overall Study|Lost to Follow-up|1|||
160716227|NCT00967330|580340705|FG000|Overall Study|Death|102|||
160716228|NCT00967330|580340706|FG001|Overall Study|Death|51|||
160716229|NCT00967330|580340705|FG000|Overall Study|Severe protocol deviation|0|||
160716230|NCT00967330|580340706|FG001|Overall Study|Severe protocol deviation|1|||
160716231|NCT02698163|580340707|FG000|Overall Study|Lost to Follow-up|0|||
160716232|NCT02698163|580340708|FG001|Overall Study|Lost to Follow-up|1|||
160716233|NCT01133067|580340709|FG000|Overall Study|Death|136|||
160716234|NCT01133067|580340709|FG000|Overall Study|Lost to Follow-up|3|||
160716235|NCT00752128|580340710|FG000|Overall Study|Withdrawal by Subject|4|||
160716236|NCT00349973|580340711|FG000|Overall Study|Adverse Event|3|||
160716237|NCT00349973|580340712|FG001|Overall Study|Adverse Event|3|||
160716238|NCT00349973|580340711|FG000|Overall Study|Withdrawal by Subject|1|||
160716239|NCT00349973|580340712|FG001|Overall Study|Withdrawal by Subject|0|||
160716240|NCT04135937|580340713|FG000|Overall Study|Lost to Follow-up|2|||
160716241|NCT04135937|580340713|FG000|Overall Study|Withdrawal by Subject|1|||
160716242|NCT04563754|580342879|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
160716243|NCT04563754|580342880|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
160716244|NCT04563754|580342881|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
160716245|NCT04563754|580342879|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
160716246|NCT04563754|580342880|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
160716247|NCT04563754|580342881|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
160716248|NCT04563754|580342879|FG000|Follow up|Lost to Follow-up|61|||
160716249|NCT04563754|580342880|FG001|Follow up|Lost to Follow-up|23|||
160716250|NCT04563754|580342881|FG002|Follow up|Lost to Follow-up|5|||
160716251|NCT04563754|580342879|FG000|Follow up|Death|0|||
160716252|NCT04563754|580342880|FG001|Follow up|Death|2|||
160716253|NCT04563754|580342881|FG002|Follow up|Death|0|||
160716254|NCT04563754|580342879|FG000|Follow up|Ongoing|0|||
160716255|NCT04563754|580342880|FG001|Follow up|Ongoing|28|||
160716256|NCT04563754|580342881|FG002|Follow up|Ongoing|0|||
160716257|NCT00070564|580342882|FG000|Overall Study|Progression|2|||
160716258|NCT00070564|580342883|FG001|Overall Study|Progression|4|||
160716259|NCT00070564|580342884|FG002|Overall Study|Progression|7|||
160716260|NCT00070564|580342885|FG003|Overall Study|Progression|7|||
160716261|NCT00070564|580342886|FG004|Overall Study|Progression|1|||
160716262|NCT00070564|580342887|FG005|Overall Study|Progression|0|||
160716263|NCT00070564|580342882|FG000|Overall Study|Delinquent|1|||
160716264|NCT00070564|580342883|FG001|Overall Study|Delinquent|4|||
160716265|NCT00070564|580342884|FG002|Overall Study|Delinquent|2|||
160716266|NCT00070564|580342885|FG003|Overall Study|Delinquent|0|||
160716267|NCT00070564|580342886|FG004|Overall Study|Delinquent|0|||
160716268|NCT00070564|580342887|FG005|Overall Study|Delinquent|0|||
160716269|NCT00070564|580342882|FG000|Overall Study|Adverse Event|150|||
160716270|NCT00070564|580342883|FG001|Overall Study|Adverse Event|142|||
160716271|NCT00070564|580342884|FG002|Overall Study|Adverse Event|120|||
160716272|NCT00070564|580342885|FG003|Overall Study|Adverse Event|108|||
160716273|NCT00070564|580342886|FG004|Overall Study|Adverse Event|63|||
160716274|NCT00070564|580342887|FG005|Overall Study|Adverse Event|36|||
160716275|NCT00070564|580342882|FG000|Overall Study|Death|4|||
160716276|NCT00070564|580342883|FG001|Overall Study|Death|1|||
160716277|NCT00070564|580342884|FG002|Overall Study|Death|5|||
160716278|NCT00070564|580342885|FG003|Overall Study|Death|3|||
160716279|NCT00070564|580342886|FG004|Overall Study|Death|0|||
160716280|NCT00070564|580342887|FG005|Overall Study|Death|1|||
160716281|NCT00070564|580342882|FG000|Overall Study|Other, not protocol specified|17|||
160716282|NCT00070564|580342883|FG001|Overall Study|Other, not protocol specified|15|||
160716283|NCT00070564|580342884|FG002|Overall Study|Other, not protocol specified|14|||
160716284|NCT00070564|580342885|FG003|Overall Study|Other, not protocol specified|19|||
160716285|NCT00070564|580342886|FG004|Overall Study|Other, not protocol specified|6|||
160716286|NCT00070564|580342887|FG005|Overall Study|Other, not protocol specified|7|||
160716287|NCT00070564|580342882|FG000|Overall Study|Withdrawal by Subject|26|||
160716288|NCT00070564|580342883|FG001|Overall Study|Withdrawal by Subject|37|||
160716289|NCT00070564|580342884|FG002|Overall Study|Withdrawal by Subject|23|||
160716290|NCT00070564|580342885|FG003|Overall Study|Withdrawal by Subject|30|||
160716291|NCT00070564|580342886|FG004|Overall Study|Withdrawal by Subject|8|||
160716292|NCT00070564|580342887|FG005|Overall Study|Withdrawal by Subject|8|||
160716293|NCT00070564|580342882|FG000|Overall Study|Not reported|0|||
160716294|NCT00070564|580342883|FG001|Overall Study|Not reported|0|||
160716295|NCT00070564|580342884|FG002|Overall Study|Not reported|0|||
160716296|NCT00070564|580342885|FG003|Overall Study|Not reported|0|||
160716297|NCT00070564|580342886|FG004|Overall Study|Not reported|1|||
160716298|NCT00070564|580342887|FG005|Overall Study|Not reported|0|||
160716299|NCT04510090|580342892|FG000|FE-HS|Withdrawal by Subject|0|||
160716300|NCT04510090|580342893|FG001|FE-HS|Withdrawal by Subject|0|||
160716301|NCT04510090|580342894|FG002|FE-HS|Withdrawal by Subject|0|||
160716302|NCT04510090|580342895|FG003|FE-HS|Withdrawal by Subject|0|||
160716303|NCT04510090|580342896|FG004|FE-HS|Withdrawal by Subject|1|||
160716304|NCT04510090|580342897|FG005|FE-HS|Withdrawal by Subject|0|||
160716305|NCT04510090|580342898|FG006|FE-HS|Withdrawal by Subject|0|||
160716306|NCT04510090|580342899|FG007|FE-HS|Withdrawal by Subject|0|||
160716307|NCT01127256|580342900|FG000|Overall Study|Adverse Event|13|||
160716308|NCT01127256|580342901|FG001|Overall Study|Adverse Event|13|||
160716309|NCT01127256|580342900|FG000|Overall Study|Lack of Efficacy|4|||
160716310|NCT01127256|580342901|FG001|Overall Study|Lack of Efficacy|0|||
160716311|NCT01127256|580342900|FG000|Overall Study|Lost to Follow-up|16|||
160716312|NCT01127256|580342901|FG001|Overall Study|Lost to Follow-up|17|||
160716313|NCT01127256|580342900|FG000|Overall Study|Withdrawal by Subject|5|||
160716314|NCT01127256|580342901|FG001|Overall Study|Withdrawal by Subject|9|||
160716315|NCT01127256|580342900|FG000|Overall Study|Protocol Violation|1|||
160716316|NCT01127256|580342901|FG001|Overall Study|Protocol Violation|0|||
160716317|NCT01922037|580342902|FG000|Overall Study|Withdrawal by Subject|2|||
160716318|NCT01922037|580342903|FG001|Overall Study|Withdrawal by Subject|44|||
160716319|NCT01922037|580342902|FG000|Overall Study|Adverse Event|1|||
160716320|NCT01922037|580342903|FG001|Overall Study|Adverse Event|7|||
160716321|NCT01922037|580342902|FG000|Overall Study|Death|0|||
160716322|NCT01922037|580342903|FG001|Overall Study|Death|5|||
160716323|NCT01922037|580342902|FG000|Overall Study|Pregnancy|0|||
160716324|NCT01922037|580342903|FG001|Overall Study|Pregnancy|2|||
160716325|NCT01922037|580342902|FG000|Overall Study|Participant non-compliance|4|||
160716326|NCT01922037|580342903|FG001|Overall Study|Participant non-compliance|46|||
160716327|NCT01922037|580342902|FG000|Overall Study|Investigator/Sponsor decision|1|||
160716328|NCT01922037|580342903|FG001|Overall Study|Investigator/Sponsor decision|4|||
160716329|NCT01922037|580342902|FG000|Overall Study|Other unspecified|2|||
160716330|NCT01922037|580342903|FG001|Overall Study|Other unspecified|66|||
160716331|NCT00679211|580342904|FG000|Overall Study|Progressive disease|82|||
160716332|NCT00679211|580342904|FG000|Overall Study|Adverse Event|7|||
160716333|NCT00679211|580342904|FG000|Overall Study|Withdrawal by Subject|2|||
160716334|NCT00679211|580342904|FG000|Overall Study|Physician Decision|5|||
160716335|NCT00679211|580342904|FG000|Overall Study|Refused to undergo protocol procedures|1|||
160716336|NCT00679211|580342904|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
160716337|NCT00679211|580342904|FG000|Overall Study|Other|1|||
160716338|NCT00931528|580342905|FG000|Overall Study|Protocol Violation|9|||
160716339|NCT00931528|580342906|FG001|Overall Study|Protocol Violation|12|||
160716340|NCT00931528|580342905|FG000|Overall Study|Withdrawal by Subject|4|||
160716341|NCT00931528|580342906|FG001|Overall Study|Withdrawal by Subject|12|||
160716342|NCT00931528|580342905|FG000|Overall Study|Lost to Follow-up|6|||
160716343|NCT00931528|580342906|FG001|Overall Study|Lost to Follow-up|13|||
160716344|NCT00931528|580342905|FG000|Overall Study|Assessment outside of Time Frame|22|||
160716345|NCT00931528|580342906|FG001|Overall Study|Assessment outside of Time Frame|23|||
160716346|NCT01470248|580342907|FG000|Overall Study|Withdrawal by Subject|1|||
160716347|NCT02243605|580342910|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
160716348|NCT02243605|580342911|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
160716349|NCT02243605|580342910|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
160716350|NCT02243605|580342911|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
160716351|NCT02243605|580342910|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
160716352|NCT02243605|580342911|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
160716353|NCT02243605|580342910|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
160716354|NCT02243605|580342911|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
160716355|NCT02243605|580342910|FG000|Stage 2 - Final Analysis Population|Progression|0|||
160716356|NCT02243605|580342911|FG001|Stage 2 - Final Analysis Population|Progression|1|||
160716357|NCT05842967|580342912|FG000|Period 1: SSA|Adverse Event|1|||
160716358|NCT05842967|580342913|FG001|Period 1: SSA|Adverse Event|1|||
160716359|NCT05842967|580342914|FG002|Period 1: SSA|Adverse Event|0|||
160716360|NCT05842967|580342915|FG003|Period 1: SSA|Adverse Event|0|||
160716361|NCT05842967|580342912|FG000|Period 1: SSA|Death|1|||
160716362|NCT05842967|580342913|FG001|Period 1: SSA|Death|0|||
160716363|NCT05842967|580342914|FG002|Period 1: SSA|Death|0|||
160716364|NCT05842967|580342915|FG003|Period 1: SSA|Death|0|||
160716365|NCT05842967|580342912|FG000|Period 1: SSA|Lost to Follow-up|16|||
160716366|NCT05842967|580342913|FG001|Period 1: SSA|Lost to Follow-up|4|||
160716367|NCT05842967|580342914|FG002|Period 1: SSA|Lost to Follow-up|0|||
160716368|NCT05842967|580342915|FG003|Period 1: SSA|Lost to Follow-up|0|||
160716369|NCT05842967|580342912|FG000|Period 1: SSA|Physician Decision|1|||
160716370|NCT05842967|580342913|FG001|Period 1: SSA|Physician Decision|0|||
160716371|NCT05842967|580342914|FG002|Period 1: SSA|Physician Decision|0|||
160716372|NCT05842967|580342915|FG003|Period 1: SSA|Physician Decision|0|||
160716373|NCT05842967|580342912|FG000|Period 1: SSA|Withdrawal by Subject|2|||
160716374|NCT05842967|580342913|FG001|Period 1: SSA|Withdrawal by Subject|2|||
160716375|NCT05842967|580342914|FG002|Period 1: SSA|Withdrawal by Subject|0|||
160716376|NCT05842967|580342915|FG003|Period 1: SSA|Withdrawal by Subject|0|||
160716377|NCT05842967|580342912|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
160716378|NCT05842967|580342913|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
160716379|NCT05842967|580342914|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
160716380|NCT05842967|580342915|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
160716381|NCT05842967|580342912|FG000|Period 2: SSB|Adverse Event|0|||
160716382|NCT05842967|580342913|FG001|Period 2: SSB|Adverse Event|0|||
160716383|NCT05842967|580342914|FG002|Period 2: SSB|Adverse Event|2|||
160716384|NCT05842967|580342915|FG003|Period 2: SSB|Adverse Event|0|||
160716385|NCT05842967|580342912|FG000|Period 2: SSB|Lost to Follow-up|0|||
160716386|NCT05842967|580342913|FG001|Period 2: SSB|Lost to Follow-up|0|||
160716387|NCT05842967|580342914|FG002|Period 2: SSB|Lost to Follow-up|4|||
160716388|NCT05842967|580342915|FG003|Period 2: SSB|Lost to Follow-up|3|||
160716389|NCT05842967|580342912|FG000|Period 2: SSB|Withdrawal by Subject|0|||
160716390|NCT05842967|580342913|FG001|Period 2: SSB|Withdrawal by Subject|0|||
160716391|NCT05842967|580342914|FG002|Period 2: SSB|Withdrawal by Subject|1|||
160716392|NCT05842967|580342915|FG003|Period 2: SSB|Withdrawal by Subject|0|||
160716393|NCT05842967|580342912|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
160716394|NCT05842967|580342913|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
160716395|NCT05842967|580342914|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
160716396|NCT05842967|580342915|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
160716397|NCT05842967|580342912|FG000|Period 2: SSB|Protocol Violation|0|||
160716398|NCT05842967|580342913|FG001|Period 2: SSB|Protocol Violation|0|||
160716399|NCT05842967|580342914|FG002|Period 2: SSB|Protocol Violation|0|||
160716400|NCT05842967|580342915|FG003|Period 2: SSB|Protocol Violation|1|||
160716401|NCT03657797|580342921|FG000|Overall Study|Lost to Follow-up|0|||
160716402|NCT03657797|580342922|FG001|Overall Study|Lost to Follow-up|1|||
160716403|NCT03657797|580342923|FG002|Overall Study|Lost to Follow-up|1|||
160716404|NCT03657797|580342924|FG003|Overall Study|Lost to Follow-up|0|||
160716405|NCT03657797|580342921|FG000|Overall Study|Physician Decision|0|||
160716406|NCT03657797|580342922|FG001|Overall Study|Physician Decision|1|||
160716407|NCT03657797|580342923|FG002|Overall Study|Physician Decision|0|||
160716408|NCT03657797|580342924|FG003|Overall Study|Physician Decision|0|||
160716409|NCT03657797|580342921|FG000|Overall Study|Withdrawal by Subject|0|||
160716410|NCT03657797|580342922|FG001|Overall Study|Withdrawal by Subject|1|||
160716411|NCT03657797|580342923|FG002|Overall Study|Withdrawal by Subject|2|||
160716412|NCT03657797|580342924|FG003|Overall Study|Withdrawal by Subject|0|||
160716413|NCT03657797|580342921|FG000|Overall Study|Adverse Event|0|||
160716414|NCT03657797|580342922|FG001|Overall Study|Adverse Event|0|||
160716415|NCT03657797|580342923|FG002|Overall Study|Adverse Event|2|||
160716416|NCT03657797|580342924|FG003|Overall Study|Adverse Event|0|||
160716417|NCT00711243|580342927|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
160716418|NCT00711243|580342928|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
160716419|NCT00711243|580342929|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
160716420|NCT00711243|580342930|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
160716421|NCT00711243|580342931|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
160716422|NCT00711243|580342932|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
160716423|NCT00711243|580342927|FG000|Reached First Response/4 Cycles|Death|0|||
160716424|NCT00711243|580342928|FG001|Reached First Response/4 Cycles|Death|0|||
160716425|NCT00711243|580342929|FG002|Reached First Response/4 Cycles|Death|0|||
160716426|NCT00711243|580342930|FG003|Reached First Response/4 Cycles|Death|0|||
160716427|NCT00711243|580342931|FG004|Reached First Response/4 Cycles|Death|0|||
160716428|NCT00711243|580342932|FG005|Reached First Response/4 Cycles|Death|2|||
160716429|NCT00711243|580342927|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
160716430|NCT00711243|580342928|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
160716431|NCT00711243|580342929|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
160716432|NCT00711243|580342930|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
160716433|NCT00711243|580342931|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
160716434|NCT00711243|580342932|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
160716435|NCT00711243|580342927|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
160716436|NCT00711243|580342928|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
160716437|NCT00711243|580342929|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
160716438|NCT00711243|580342930|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
160716439|NCT00711243|580342931|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
160716440|NCT00711243|580342932|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
160716441|NCT00711243|580342927|FG000|Treated Cycle 5 After First Response|Death|0|||
160716442|NCT00711243|580342928|FG001|Treated Cycle 5 After First Response|Death|0|||
160716443|NCT00711243|580342929|FG002|Treated Cycle 5 After First Response|Death|0|||
160716444|NCT00711243|580342930|FG003|Treated Cycle 5 After First Response|Death|0|||
160716445|NCT00711243|580342931|FG004|Treated Cycle 5 After First Response|Death|0|||
160716446|NCT00711243|580342932|FG005|Treated Cycle 5 After First Response|Death|2|||
160716447|NCT00711243|580342927|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
160716448|NCT00711243|580342928|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
160716449|NCT00711243|580342929|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
160716450|NCT00711243|580342930|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
160716451|NCT00711243|580342931|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
160716452|NCT00711243|580342932|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
160716453|NCT00711243|580342927|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
160716454|NCT00711243|580342928|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
160716455|NCT00711243|580342929|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
160716456|NCT00711243|580342930|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
160716457|NCT00711243|580342931|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
160716458|NCT00711243|580342932|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
160716459|NCT01402570|580342935|FG000|Overall Study|Adverse Event|1|||
160716460|NCT03642262|580342936|FG000|Period 1|Withdrawal by Subject|1|||
160716461|NCT03642262|580342937|FG001|Period 1|Withdrawal by Subject|1|||
160716462|NCT03642262|580342936|FG000|Period 1|Adverse Event|0|||
160716463|NCT03642262|580342937|FG001|Period 1|Adverse Event|1|||
160716464|NCT02019472|580342938|FG000|Overall Study|Adverse Event|14|||
160716465|NCT02019472|580342939|FG001|Overall Study|Adverse Event|23|||
160716466|NCT02019472|580342940|FG002|Overall Study|Adverse Event|17|||
160716467|NCT02019472|580342938|FG000|Overall Study|Death|0|||
160716468|NCT02019472|580342939|FG001|Overall Study|Death|1|||
160716469|NCT02019472|580342940|FG002|Overall Study|Death|1|||
160716470|NCT02019472|580342938|FG000|Overall Study|Lack of Efficacy|7|||
160716471|NCT02019472|580342939|FG001|Overall Study|Lack of Efficacy|4|||
160716472|NCT02019472|580342940|FG002|Overall Study|Lack of Efficacy|4|||
160716473|NCT02019472|580342938|FG000|Overall Study|Lost to Follow-up|0|||
160716474|NCT02019472|580342939|FG001|Overall Study|Lost to Follow-up|2|||
160716475|NCT02019472|580342940|FG002|Overall Study|Lost to Follow-up|1|||
160716476|NCT02019472|580342938|FG000|Overall Study|Physician Decision|1|||
160716477|NCT02019472|580342939|FG001|Overall Study|Physician Decision|2|||
160716478|NCT02019472|580342940|FG002|Overall Study|Physician Decision|0|||
160716479|NCT02019472|580342938|FG000|Overall Study|Pregnancy|1|||
160716480|NCT02019472|580342939|FG001|Overall Study|Pregnancy|2|||
160716481|NCT02019472|580342940|FG002|Overall Study|Pregnancy|2|||
160716482|NCT02019472|580342938|FG000|Overall Study|Withdrawal by Subject|11|||
160716483|NCT02019472|580342939|FG001|Overall Study|Withdrawal by Subject|10|||
160716484|NCT02019472|580342940|FG002|Overall Study|Withdrawal by Subject|11|||
160716485|NCT02019472|580342938|FG000|Overall Study|Other|3|||
160716486|NCT02019472|580342939|FG001|Overall Study|Other|8|||
160716487|NCT02019472|580342940|FG002|Overall Study|Other|6|||
160716488|NCT00513695|580342941|FG000|Overall Study|Discontinued therapy|2|||
160716489|NCT00513695|580342941|FG000|Overall Study|Progression prior to surgery|3|||
160716490|NCT02157935|580342942|FG000|Overall Study|Withdrawal by Subject|25|||
160716491|NCT02157935|580342943|FG001|Overall Study|Withdrawal by Subject|39|||
160716492|NCT02157935|580342942|FG000|Overall Study|Screen failure|1|||
160716493|NCT02157935|580342943|FG001|Overall Study|Screen failure|2|||
160716494|NCT02157935|580342942|FG000|Overall Study|Protocol Violation|1|||
160716495|NCT02157935|580342943|FG001|Overall Study|Protocol Violation|0|||
160716496|NCT02157935|580342942|FG000|Overall Study|Progressive disease|0|||
160716497|NCT02157935|580342943|FG001|Overall Study|Progressive disease|2|||
160716498|NCT02157935|580342942|FG000|Overall Study|Other|5|||
160716499|NCT02157935|580342943|FG001|Overall Study|Other|12|||
160716500|NCT02157935|580342942|FG000|Overall Study|Lack of Efficacy|0|||
160716501|NCT02157935|580342943|FG001|Overall Study|Lack of Efficacy|1|||
160716502|NCT02157935|580342942|FG000|Overall Study|Death|4|||
160716503|NCT02157935|580342943|FG001|Overall Study|Death|4|||
160716504|NCT02157935|580342942|FG000|Overall Study|Adverse Event|3|||
160716505|NCT02157935|580342943|FG001|Overall Study|Adverse Event|5|||
160716506|NCT04429503|580342948|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
160716507|NCT04429503|580342949|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
160716508|NCT04429503|580342950|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
160716509|NCT04429503|580342951|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
160716510|NCT04429503|580342952|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
160716511|NCT04429503|580342953|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
160716512|NCT04429503|580342948|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
160716513|NCT04429503|580342949|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
160716514|NCT04429503|580342950|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
160716515|NCT04429503|580342951|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
160716516|NCT04429503|580342952|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
160716517|NCT04429503|580342953|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
160716518|NCT04429503|580342948|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
160716519|NCT04429503|580342949|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
160716520|NCT04429503|580342950|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
160716521|NCT04429503|580342951|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
160716522|NCT04429503|580342952|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
160716523|NCT04429503|580342953|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
160716524|NCT04429503|580342948|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
160716525|NCT04429503|580342949|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
160716526|NCT04429503|580342950|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
160716527|NCT04429503|580342951|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
160716528|NCT04429503|580342952|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
160716529|NCT04429503|580342953|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
160716530|NCT04429503|580342948|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
160716531|NCT04429503|580342949|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
160716532|NCT04429503|580342950|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
160716533|NCT04429503|580342951|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
160716534|NCT04429503|580342952|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
160716535|NCT04429503|580342953|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
160716536|NCT04429503|580342948|FG000|Main Study (Up to Wk 96)|Death|9|||
160716537|NCT04429503|580342949|FG001|Main Study (Up to Wk 96)|Death|18|||
160716538|NCT04429503|580342950|FG002|Main Study (Up to Wk 96)|Death|5|||
160716539|NCT04429503|580342951|FG003|Main Study (Up to Wk 96)|Death|0|||
160716540|NCT04429503|580342952|FG004|Main Study (Up to Wk 96)|Death|0|||
160716541|NCT04429503|580342953|FG005|Main Study (Up to Wk 96)|Death|0|||
160716542|NCT04429503|580342948|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
160716543|NCT04429503|580342949|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
160716544|NCT04429503|580342950|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
160716545|NCT04429503|580342951|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
160716546|NCT04429503|580342952|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
160716547|NCT04429503|580342953|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
160716548|NCT04429503|580342948|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
160716549|NCT04429503|580342949|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
160716550|NCT04429503|580342950|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
160716551|NCT04429503|580342951|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
160716552|NCT04429503|580342952|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
160716553|NCT04429503|580342953|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
160716554|NCT04429503|580342948|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
160716555|NCT04429503|580342949|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
160716556|NCT04429503|580342950|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
160716557|NCT04429503|580342951|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
160716558|NCT04429503|580342952|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
160716559|NCT04429503|580342953|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
160716560|NCT04429503|580342948|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
160716561|NCT04429503|580342949|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
160716562|NCT04429503|580342950|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
160716563|NCT04429503|580342951|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
160716564|NCT04429503|580342952|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
160716565|NCT04429503|580342953|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
160716566|NCT04429503|580342948|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
160716567|NCT04429503|580342949|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
160716568|NCT04429503|580342950|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
160716569|NCT04429503|580342951|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
160716570|NCT04429503|580342952|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
160716571|NCT04429503|580342953|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
160716572|NCT04429503|580342948|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
160716573|NCT04429503|580342949|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
160716574|NCT04429503|580342950|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
160716575|NCT04429503|580342951|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
160716576|NCT04429503|580342952|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
160716577|NCT04429503|580342953|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
160716578|NCT05516108|580342954|FG000|Overall Study|Time Commitment|3|||
160716579|NCT05516108|580342955|FG001|Overall Study|Time Commitment|1|||
160716580|NCT05516108|580342954|FG000|Overall Study|Reason Unknown|2|||
160716581|NCT05516108|580342955|FG001|Overall Study|Reason Unknown|4|||
160716582|NCT00709995|580342956|FG000|Overall Study|Adverse Event|4|||
160716583|NCT00709995|580342957|FG001|Overall Study|Adverse Event|2|||
160716584|NCT00709995|580342956|FG000|Overall Study|Withdrawal by Subject|1|||
160716585|NCT00709995|580342957|FG001|Overall Study|Withdrawal by Subject|3|||
160716586|NCT00840749|580342958|FG000|Overall Study|Death|1|||
160716587|NCT00840749|580342959|FG001|Overall Study|Death|2|||
160716588|NCT00840749|580342958|FG000|Overall Study|not treated on study arm|11|||
160716589|NCT00840749|580342959|FG001|Overall Study|not treated on study arm|11|||
160716590|NCT00840749|580342958|FG000|Overall Study|study closed|19|||
160716591|NCT00840749|580342959|FG001|Overall Study|study closed|14|||
160716592|NCT01113892|580342964|FG000|Overall Study|Lost to Follow-up|2|||
160716593|NCT01113892|580342965|FG001|Overall Study|Lost to Follow-up|2|||
160716594|NCT01113892|580342964|FG000|Overall Study|Withdrawal by Subject|1|||
160716595|NCT01113892|580342965|FG001|Overall Study|Withdrawal by Subject|1|||
160716596|NCT01113892|580342964|FG000|Overall Study|Death|2|||
160716597|NCT01113892|580342965|FG001|Overall Study|Death|4|||
160716598|NCT01113892|580342964|FG000|Overall Study|Graft no longer evaluable|9|||
160716599|NCT01113892|580342965|FG001|Overall Study|Graft no longer evaluable|9|||
160716600|NCT03473925|580342970|FG000|Overall Study|Death|48|||
160716601|NCT03473925|580342971|FG001|Overall Study|Death|44|||
160716602|NCT03473925|580342970|FG000|Overall Study|Sponsor Decision|2|||
160716603|NCT03473925|580342971|FG001|Overall Study|Sponsor Decision|7|||
160716604|NCT03473925|580342970|FG000|Overall Study|Withdrawal by Subject|1|||
160716605|NCT03473925|580342971|FG001|Overall Study|Withdrawal by Subject|3|||
160716606|NCT03473925|580342970|FG000|Overall Study|Not Treated|1|||
160716607|NCT03473925|580342971|FG001|Overall Study|Not Treated|1|||
160716608|NCT02766335|580342972|FG000|Initial Registration|Adverse Event|6|||
160716609|NCT02766335|580342973|FG001|Initial Registration|Adverse Event|3|||
160716610|NCT02766335|580342974|FG002|Initial Registration|Adverse Event|0|||
160716611|NCT02766335|580342972|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
160716612|NCT02766335|580342973|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
160716613|NCT02766335|580342974|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
160716614|NCT02766335|580342972|FG000|Initial Registration|Progression/relapse|49|||
160716615|NCT02766335|580342973|FG001|Initial Registration|Progression/relapse|15|||
160716616|NCT02766335|580342974|FG002|Initial Registration|Progression/relapse|0|||
160716617|NCT02766335|580342972|FG000|Initial Registration|Death|1|||
160716618|NCT02766335|580342973|FG001|Initial Registration|Death|3|||
160716619|NCT02766335|580342974|FG002|Initial Registration|Death|0|||
160716620|NCT02766335|580342972|FG000|Initial Registration|not protocol specified|1|||
160716621|NCT02766335|580342973|FG001|Initial Registration|not protocol specified|9|||
160716622|NCT02766335|580342974|FG002|Initial Registration|not protocol specified|0|||
160716623|NCT02766335|580342972|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
160716624|NCT02766335|580342973|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
160716625|NCT02766335|580342974|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
160716626|NCT02766335|580342972|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
160716627|NCT02766335|580342973|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
160716628|NCT02766335|580342974|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
160716629|NCT00729937|580342978|FG000|Overall Study|Lost to Follow-up|49|||
160716630|NCT00729937|580342979|FG001|Overall Study|Lost to Follow-up|58|||
160716631|NCT00729937|580342980|FG002|Overall Study|Lost to Follow-up|18|||
160716632|NCT00729937|580342981|FG003|Overall Study|Lost to Follow-up|33|||
160716633|NCT00729937|580342982|FG004|Overall Study|Lost to Follow-up|18|||
160716634|NCT00729937|580342983|FG005|Overall Study|Lost to Follow-up|23|||
160716635|NCT00729937|580342978|FG000|Overall Study|Physician Decision|7|||
160716636|NCT00729937|580342979|FG001|Overall Study|Physician Decision|16|||
160716637|NCT00729937|580342980|FG002|Overall Study|Physician Decision|2|||
160716638|NCT00729937|580342981|FG003|Overall Study|Physician Decision|0|||
160716639|NCT00729937|580342982|FG004|Overall Study|Physician Decision|5|||
160716640|NCT00729937|580342983|FG005|Overall Study|Physician Decision|8|||
160716641|NCT00729937|580342978|FG000|Overall Study|Death|1|||
160716642|NCT00729937|580342979|FG001|Overall Study|Death|0|||
160716643|NCT00729937|580342980|FG002|Overall Study|Death|1|||
160716644|NCT00729937|580342981|FG003|Overall Study|Death|0|||
160716645|NCT00729937|580342982|FG004|Overall Study|Death|0|||
160716646|NCT00729937|580342983|FG005|Overall Study|Death|1|||
160716647|NCT00729937|580342978|FG000|Overall Study|Withdrawal by Subject|3|||
160716648|NCT00729937|580342979|FG001|Overall Study|Withdrawal by Subject|5|||
160716649|NCT00729937|580342980|FG002|Overall Study|Withdrawal by Subject|6|||
160716650|NCT00729937|580342981|FG003|Overall Study|Withdrawal by Subject|0|||
160716651|NCT00729937|580342982|FG004|Overall Study|Withdrawal by Subject|4|||
160716652|NCT00729937|580342983|FG005|Overall Study|Withdrawal by Subject|2|||
160716653|NCT00729937|580342978|FG000|Overall Study|Randomized but not treated|12|||
160716654|NCT00729937|580342979|FG001|Overall Study|Randomized but not treated|6|||
160716655|NCT00729937|580342980|FG002|Overall Study|Randomized but not treated|1|||
160716656|NCT00729937|580342981|FG003|Overall Study|Randomized but not treated|0|||
160716657|NCT00729937|580342982|FG004|Overall Study|Randomized but not treated|1|||
160716658|NCT00729937|580342983|FG005|Overall Study|Randomized but not treated|3|||
160716659|NCT00729937|580342978|FG000|Overall Study|Did not meet eligibility criteria|2|||
160716660|NCT00729937|580342979|FG001|Overall Study|Did not meet eligibility criteria|1|||
160716661|NCT00729937|580342980|FG002|Overall Study|Did not meet eligibility criteria|0|||
160716662|NCT00729937|580342981|FG003|Overall Study|Did not meet eligibility criteria|0|||
160716663|NCT00729937|580342982|FG004|Overall Study|Did not meet eligibility criteria|0|||
160716664|NCT00729937|580342983|FG005|Overall Study|Did not meet eligibility criteria|0|||
160716665|NCT00729937|580342978|FG000|Overall Study|Incarcerated|0|||
160716666|NCT00729937|580342979|FG001|Overall Study|Incarcerated|2|||
160716667|NCT00729937|580342980|FG002|Overall Study|Incarcerated|1|||
160716668|NCT00729937|580342981|FG003|Overall Study|Incarcerated|1|||
160716669|NCT00729937|580342982|FG004|Overall Study|Incarcerated|0|||
160716670|NCT00729937|580342983|FG005|Overall Study|Incarcerated|0|||
160716671|NCT02198963|580342987|FG000|Overall Study|Adverse Event|1|||
160716672|NCT02198963|580342987|FG000|Overall Study|Withdrawal by Subject|6|||
160716673|NCT00683657|580342988|FG000|Overall Study|Adverse Event|0|||
160716674|NCT00683657|580342989|FG001|Overall Study|Adverse Event|1|||
160716675|NCT00683657|580342988|FG000|Overall Study|Subject Withdrew Consent|1|||
160716676|NCT00683657|580342989|FG001|Overall Study|Subject Withdrew Consent|0|||
160716677|NCT02586155|580342993|FG000|Overall Study|Adverse Event|2|||
160716678|NCT02586155|580342994|FG001|Overall Study|Adverse Event|3|||
160716679|NCT02586155|580342993|FG000|Overall Study|Withdrawal by Subject|31|||
160716680|NCT02586155|580342994|FG001|Overall Study|Withdrawal by Subject|24|||
160716681|NCT02586155|580342993|FG000|Overall Study|Lost to Follow-up|7|||
160716682|NCT02586155|580342994|FG001|Overall Study|Lost to Follow-up|13|||
160716683|NCT02586155|580342993|FG000|Overall Study|Death|61|||
160716684|NCT02586155|580342994|FG001|Overall Study|Death|72|||
160716685|NCT02586155|580342993|FG000|Overall Study|Other reasons|26|||
160716686|NCT02586155|580342994|FG001|Overall Study|Other reasons|15|||
160716687|NCT02461160|580342995|FG000|Overall Study|Lost to Follow-up|0|||
160716688|NCT02461160|580342996|FG001|Overall Study|Lost to Follow-up|0|||
160716689|NCT02461160|580342997|FG002|Overall Study|Lost to Follow-up|0|||
160716690|NCT02461160|580342998|FG003|Overall Study|Lost to Follow-up|0|||
160716691|NCT02461160|580342999|FG004|Overall Study|Lost to Follow-up|0|||
160716692|NCT02461160|580343000|FG005|Overall Study|Lost to Follow-up|0|||
160716693|NCT02461160|580343001|FG006|Overall Study|Lost to Follow-up|0|||
160716694|NCT02461160|580343002|FG007|Overall Study|Lost to Follow-up|1|||
160716695|NCT02461160|580343003|FG008|Overall Study|Lost to Follow-up|0|||
160716696|NCT02461160|580343004|FG009|Overall Study|Lost to Follow-up|0|||
160716697|NCT02461160|580343005|FG010|Overall Study|Lost to Follow-up|0|||
160716698|NCT02461160|580343006|FG011|Overall Study|Lost to Follow-up|0|||
160716699|NCT02461160|580343007|FG012|Overall Study|Lost to Follow-up|0|||
160716700|NCT00193050|580343008|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
160716701|NCT00193050|580343008|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
160716702|NCT00193050|580343008|FG000|Neoadjuvant Treatment|Physician Decision|2|||
160716703|NCT00193050|580343008|FG000|Neoadjuvant Treatment|Adverse Event|2|||
160716704|NCT00193050|580343008|FG000|Adjuvant|Physician Decision|5|||
160716705|NCT00193050|580343008|FG000|Adjuvant|Intercurrent Hospitalization|3|||
160716706|NCT00193050|580343008|FG000|Adjuvant|Lack of Efficacy|2|||
160716707|NCT00916383|580343009|FG000|Overall Study|Adverse Event|1|||
160716708|NCT00916383|580343009|FG000|Overall Study|Death|1|||
160716709|NCT00916383|580343009|FG000|Overall Study|Protocol Violation|1|||
160716710|NCT02899962|580343010|FG000|Open-label Phase|Adverse Event|2|||
160716711|NCT02899962|580343011|FG001|Open-label Phase|Adverse Event|0|||
160716712|NCT02899962|580343012|FG002|Open-label Phase|Adverse Event|0|||
160716713|NCT02899962|580343010|FG000|Open-label Phase|Lost to Follow-up|9|||
160716714|NCT02899962|580343011|FG001|Open-label Phase|Lost to Follow-up|0|||
160716715|NCT02899962|580343012|FG002|Open-label Phase|Lost to Follow-up|0|||
160716716|NCT02899962|580343010|FG000|Open-label Phase|Other reasons|9|||
160716717|NCT02899962|580343011|FG001|Open-label Phase|Other reasons|0|||
160716718|NCT02899962|580343012|FG002|Open-label Phase|Other reasons|0|||
160716719|NCT02899962|580343010|FG000|Open-label Phase|Withdrawal by Subject|7|||
160716720|NCT02899962|580343011|FG001|Open-label Phase|Withdrawal by Subject|0|||
160716721|NCT02899962|580343012|FG002|Open-label Phase|Withdrawal by Subject|0|||
160716722|NCT02899962|580343010|FG000|Maintenance Phase|Adverse Event|0|||
160716723|NCT02899962|580343011|FG001|Maintenance Phase|Adverse Event|2|||
160716724|NCT02899962|580343012|FG002|Maintenance Phase|Adverse Event|1|||
160716725|NCT02899962|580343010|FG000|Maintenance Phase|Death|0|||
160716726|NCT02899962|580343011|FG001|Maintenance Phase|Death|0|||
160716727|NCT02899962|580343012|FG002|Maintenance Phase|Death|1|||
160716728|NCT02899962|580343010|FG000|Maintenance Phase|Lack of Efficacy|0|||
160716729|NCT02899962|580343011|FG001|Maintenance Phase|Lack of Efficacy|20|||
160716730|NCT02899962|580343012|FG002|Maintenance Phase|Lack of Efficacy|16|||
160716731|NCT02899962|580343010|FG000|Maintenance Phase|Lost to Follow-up|0|||
160716732|NCT02899962|580343011|FG001|Maintenance Phase|Lost to Follow-up|12|||
160716733|NCT02899962|580343012|FG002|Maintenance Phase|Lost to Follow-up|14|||
160716734|NCT02899962|580343010|FG000|Maintenance Phase|Other reasons|0|||
160716735|NCT02899962|580343011|FG001|Maintenance Phase|Other reasons|9|||
160716736|NCT02899962|580343012|FG002|Maintenance Phase|Other reasons|13|||
160716737|NCT02899962|580343010|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
160716738|NCT02899962|580343011|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
160716739|NCT02899962|580343012|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
160716740|NCT02899962|580343010|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
160716741|NCT02899962|580343011|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
160716742|NCT02899962|580343012|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
160716743|NCT02899962|580343010|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160716744|NCT02899962|580343011|FG001|Maintenance Phase|Withdrawal by Subject|30|||
160716745|NCT02899962|580343012|FG002|Maintenance Phase|Withdrawal by Subject|36|||
160716746|NCT00258960|580343013|FG000|Overall Study|Death|2|||
160716747|NCT00258960|580343013|FG000|Overall Study|Disease Progression|7|||
160716748|NCT00258960|580343013|FG000|Overall Study|Adverse Event|4|||
160716749|NCT00258960|580343013|FG000|Overall Study|Physician Decision|1|||
160716750|NCT00258960|580343013|FG000|Overall Study|Withdrawal by Subject|1|||
160716751|NCT00258960|580343013|FG000|Overall Study|Mistake|2|||
160716752|NCT00473590|580343014|FG000|Overall Study|Adverse Event|3|||
160716753|NCT00473590|580343015|FG001|Overall Study|Adverse Event|3|||
160716754|NCT00473590|580343014|FG000|Overall Study|Death|4|||
160716755|NCT00473590|580343015|FG001|Overall Study|Death|2|||
160716756|NCT00473590|580343014|FG000|Overall Study|Progression not resulting in death|24|||
160716757|NCT00473590|580343015|FG001|Overall Study|Progression not resulting in death|20|||
160716758|NCT00473590|580343014|FG000|Overall Study|Non-protocol-specified therapy|7|||
160716759|NCT00473590|580343015|FG001|Overall Study|Non-protocol-specified therapy|5|||
160716760|NCT00473590|580343014|FG000|Overall Study|Physician Decision|2|||
160716761|NCT00473590|580343015|FG001|Overall Study|Physician Decision|4|||
160716762|NCT00473590|580343014|FG000|Overall Study|Withdrawal by Subject|5|||
160716763|NCT00473590|580343015|FG001|Overall Study|Withdrawal by Subject|3|||
160716764|NCT00473590|580343014|FG000|Overall Study|Other|0|||
160716765|NCT00473590|580343015|FG001|Overall Study|Other|1|||
160716766|NCT01245283|580343018|FG000|Overall Study|Lost to Follow-up|14|||
160716767|NCT01245283|580343019|FG001|Overall Study|Lost to Follow-up|11|||
160716768|NCT01245283|580343020|FG002|Overall Study|Lost to Follow-up|11|||
160716769|NCT01610492|580343029|FG000|Overall Study|Adverse Event|1|||
160716770|NCT01610492|580343029|FG000|Overall Study|Lack of Efficacy|3|||
160716771|NCT01610492|580343029|FG000|Overall Study|Other: Reached stopping criteria|1|||
160716772|NCT01610492|580343029|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
160716773|NCT03093259|580343031|FG000|Overall Study|Adverse Event|1|||
160716774|NCT03093259|580343032|FG001|Overall Study|Adverse Event|0|||
160716775|NCT03093259|580343031|FG000|Overall Study|Withdrawal by Subject|1|||
160716776|NCT03093259|580343032|FG001|Overall Study|Withdrawal by Subject|0|||
160716777|NCT01757275|580343033|FG000|Overall Study|Lost to Follow-up|1|||
160716778|NCT01757275|580343034|FG001|Overall Study|Lost to Follow-up|2|||
160716779|NCT01757275|580343033|FG000|Overall Study|Adverse Event|3|||
160716780|NCT01757275|580343034|FG001|Overall Study|Adverse Event|3|||
160716781|NCT01757275|580343033|FG000|Overall Study|Withdrawal by Subject|2|||
160716782|NCT01757275|580343034|FG001|Overall Study|Withdrawal by Subject|4|||
160716783|NCT01757275|580343033|FG000|Overall Study|Not treated|3|||
160716784|NCT01757275|580343034|FG001|Overall Study|Not treated|4|||
160716785|NCT01821807|580343037|FG000|Overall Study|Lost to Follow-up|3|||
160716786|NCT01821807|580343038|FG001|Overall Study|Lost to Follow-up|1|||
160716787|NCT03367819|580343040|FG000|Overall Study|Adverse Event|4|||
160716788|NCT03367819|580343041|FG001|Overall Study|Adverse Event|4|||
160716789|NCT03367819|580343040|FG000|Overall Study|Progressive Disease|15|||
160716790|NCT03367819|580343041|FG001|Overall Study|Progressive Disease|13|||
160716791|NCT03367819|580343040|FG000|Overall Study|Withdrawal by Subject|1|||
160716792|NCT03367819|580343041|FG001|Overall Study|Withdrawal by Subject|0|||
160716793|NCT03367819|580343040|FG000|Overall Study|Other|4|||
160716794|NCT03367819|580343041|FG001|Overall Study|Other|2|||
160716795|NCT00550459|580343042|FG000|Overall Study|Adverse Event|0|||
160716796|NCT00550459|580343043|FG001|Overall Study|Adverse Event|2|||
160716797|NCT00550459|580343042|FG000|Overall Study|Withdrawal by Subject|1|||
160716798|NCT00550459|580343043|FG001|Overall Study|Withdrawal by Subject|1|||
160716799|NCT02633787|580343044|FG000|Overall Study|Withdrawal by Subject|1|||
160716800|NCT01401452|580343045|FG000|Overall Study|Adverse reaction|9|||
160716801|NCT01401452|580343045|FG000|Overall Study|Lost to Follow-up|12|||
160716802|NCT01401452|580343045|FG000|Overall Study|Lack of Efficacy|30|||
160716803|NCT01401452|580343045|FG000|Overall Study|Participant developed breast cancer|1|||
160716804|NCT01401452|580343045|FG000|Overall Study|Tx stopped due to financial reasons|1|||
160716805|NCT01401452|580343045|FG000|Overall Study|Tx stopped by psychiatrist|1|||
160716806|NCT01401452|580343045|FG000|Overall Study|No more visits within the 36 wk followup|4|||
160716807|NCT01401452|580343045|FG000|Overall Study|Subject did not come to follow up visits|2|||
160716808|NCT01401452|580343045|FG000|Overall Study|Subject didn't return for routine visits|1|||
160716809|NCT01401452|580343045|FG000|Overall Study|Subject moved to another city|1|||
160716810|NCT01401452|580343045|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
160716811|NCT01401452|580343045|FG000|Overall Study|Psoriatic arthritis|1|||
160716812|NCT01401452|580343045|FG000|Overall Study|Participant stopped Tx|2|||
160716813|NCT01401452|580343045|FG000|Overall Study|Discontinuation for personal reasons|1|||
160716814|NCT01401452|580343045|FG000|Overall Study|Treatment failure|1|||
160716815|NCT01401452|580343045|FG000|Overall Study|Unsatisfactory output|1|||
160716816|NCT01401452|580343045|FG000|Overall Study|Subject withdrew because of Tx success|1|||
160716817|NCT01401452|580343045|FG000|Overall Study|Subject chose to discontinue treatment|1|||
160716818|NCT01401452|580343045|FG000|Overall Study|Participant withdrew consent|1|||
160716819|NCT00584454|580343046|FG000|Overall Study|Adverse Event|1|||
160716820|NCT00584454|580343046|FG000|Overall Study|Relocation|1|||
160716821|NCT00584454|580343046|FG000|Overall Study|Clinical Hold|2|||
160716822|NCT01742897|580343047|FG000|Overall Study|Adverse Event|3|||
160716823|NCT01742897|580343047|FG000|Overall Study|Withdrawal by Subject|1|||
160716824|NCT01742897|580343047|FG000|Overall Study|Other|1|||
160716825|NCT02404805|580343048|FG000|Overall Study|Withdrawal by Subject|1|||
160716826|NCT02404805|580343049|FG001|Overall Study|Withdrawal by Subject|0|||
160716827|NCT02404805|580343050|FG002|Overall Study|Withdrawal by Subject|0|||
160716828|NCT02404805|580343051|FG003|Overall Study|Withdrawal by Subject|0|||
160716829|NCT02404805|580343052|FG004|Overall Study|Withdrawal by Subject|0|||
160716830|NCT02404805|580343053|FG005|Overall Study|Withdrawal by Subject|0|||
160716831|NCT01459783|580343057|FG000|Baseline to 6 Months|Death|1|||
160716832|NCT01459783|580343058|FG001|Baseline to 6 Months|Death|0|||
160716833|NCT01459783|580343057|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
160716834|NCT01459783|580343058|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
160716835|NCT01459783|580343057|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
160716836|NCT01459783|580343058|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
160716837|NCT01459783|580343057|FG000|6 Months to 12 Months|Death|0|||
160716838|NCT01459783|580343058|FG001|6 Months to 12 Months|Death|1|||
160716839|NCT01459783|580343057|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
160716840|NCT01459783|580343058|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
160716841|NCT01459783|580343057|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
160716842|NCT01459783|580343058|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
160716843|NCT01459783|580343057|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
160716844|NCT01459783|580343058|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
160716845|NCT02601014|580343059|FG000|Overall Study|Adverse Event|3|||
160716846|NCT02601014|580343060|FG001|Overall Study|Adverse Event|3|||
160716847|NCT02601014|580343059|FG000|Overall Study|Death|3|||
160716848|NCT02601014|580343060|FG001|Overall Study|Death|1|||
160716849|NCT02601014|580343059|FG000|Overall Study|Disease progression|4|||
160716850|NCT02601014|580343060|FG001|Overall Study|Disease progression|8|||
160716851|NCT00445146|580343064|FG000|Overall Study|Withdrew Consent|29|||
160716852|NCT00445146|580343064|FG000|Overall Study|Lack of Efficacy|28|||
160716853|NCT00445146|580343064|FG000|Overall Study|Investigator's Discretion|22|||
160716854|NCT00445146|580343064|FG000|Overall Study|Adverse Event|13|||
160716855|NCT00445146|580343064|FG000|Overall Study|Lost to Follow-up|13|||
160716856|NCT00445146|580343064|FG000|Overall Study|Death|9|||
160716857|NCT00445146|580343064|FG000|Overall Study|Protocol Violation|4|||
160716858|NCT00445146|580343064|FG000|Overall Study|Pregnancy|1|||
160716859|NCT03918629|580343065|FG000|Overall Study|Adverse Event|19|||
160716860|NCT03918629|580343066|FG001|Overall Study|Adverse Event|20|||
160716861|NCT03918629|580343065|FG000|Overall Study|Death|14|||
160716862|NCT03918629|580343066|FG001|Overall Study|Death|7|||
160716863|NCT03918629|580343065|FG000|Overall Study|Lost to Follow-up|36|||
160716864|NCT03918629|580343066|FG001|Overall Study|Lost to Follow-up|28|||
160716865|NCT03918629|580343065|FG000|Overall Study|Physician Decision|1|||
160716866|NCT03918629|580343066|FG001|Overall Study|Physician Decision|0|||
160716867|NCT03918629|580343065|FG000|Overall Study|Protocol Violation|7|||
160716868|NCT03918629|580343066|FG001|Overall Study|Protocol Violation|4|||
160716869|NCT03918629|580343065|FG000|Overall Study|Withdrawal by Subject|47|||
160716870|NCT03918629|580343066|FG001|Overall Study|Withdrawal by Subject|47|||
160716871|NCT03918629|580343065|FG000|Overall Study|Other|7|||
160716872|NCT03918629|580343066|FG001|Overall Study|Other|11|||
160716873|NCT03918629|580343065|FG000|Overall Study|Randomized but not vaccinated|2|||
160716874|NCT03918629|580343066|FG001|Overall Study|Randomized but not vaccinated|1|||
160716875|NCT02456740|580343067|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
160716876|NCT02456740|580343068|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
160716877|NCT02456740|580343069|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
160716878|NCT02456740|580343070|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
160716879|NCT02456740|580343071|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
160716880|NCT02456740|580343072|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
160716881|NCT02456740|580343073|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
160716882|NCT02456740|580343074|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
160716883|NCT02456740|580343075|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
160716884|NCT02456740|580343067|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
160716885|NCT02456740|580343068|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
160716886|NCT02456740|580343069|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
160716887|NCT02456740|580343070|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
160716888|NCT02456740|580343071|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
160716889|NCT02456740|580343072|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
160716890|NCT02456740|580343073|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
160716891|NCT02456740|580343074|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
160716892|NCT02456740|580343075|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
160716893|NCT02456740|580343067|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
160716894|NCT02456740|580343068|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
160716895|NCT02456740|580343069|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
160716896|NCT02456740|580343070|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
160716897|NCT02456740|580343071|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
160716898|NCT02456740|580343072|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
160716899|NCT02456740|580343073|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
160716900|NCT02456740|580343074|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
160716901|NCT02456740|580343075|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
160716902|NCT02456740|580343067|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
160716903|NCT02456740|580343068|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
160716904|NCT02456740|580343069|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
160716905|NCT02456740|580343070|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
160716906|NCT02456740|580343071|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
160716907|NCT02456740|580343072|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
160716908|NCT02456740|580343073|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
160716909|NCT02456740|580343074|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
160716910|NCT02456740|580343075|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
160716911|NCT02456740|580343067|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
160716912|NCT02456740|580343068|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
160716913|NCT02456740|580343069|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
160716914|NCT02456740|580343070|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
160716915|NCT02456740|580343071|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
160716916|NCT02456740|580343072|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
160716917|NCT02456740|580343073|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
160716918|NCT02456740|580343074|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
160716919|NCT02456740|580343075|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
160716920|NCT02456740|580343067|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
160716921|NCT02456740|580343068|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
160716922|NCT02456740|580343069|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
160716923|NCT02456740|580343070|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
160716924|NCT02456740|580343071|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
160716925|NCT02456740|580343072|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
160716926|NCT02456740|580343073|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
160716927|NCT02456740|580343074|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
160716928|NCT02456740|580343075|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
160716929|NCT02456740|580343067|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160716930|NCT02456740|580343068|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160716931|NCT02456740|580343069|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160716932|NCT02456740|580343070|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
160716933|NCT02456740|580343071|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
160716934|NCT02456740|580343072|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
160716935|NCT02456740|580343073|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
160716936|NCT02456740|580343074|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
160716937|NCT02456740|580343075|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
160716938|NCT02623725|580343077|FG000|Overall Study|Non compliance with protocol|9|||
160716939|NCT02623725|580343078|FG001|Overall Study|Non compliance with protocol|3|||
160716940|NCT02623725|580343077|FG000|Overall Study|Serious adverse event|0|||
160716941|NCT02623725|580343078|FG001|Overall Study|Serious adverse event|2|||
160716942|NCT02623725|580343077|FG000|Overall Study|Withdrawal by Subject|7|||
160716943|NCT02623725|580343078|FG001|Overall Study|Withdrawal by Subject|1|||
160716944|NCT01891864|580343082|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
160716945|NCT01891864|580343083|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
160716946|NCT01891864|580343084|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
160716947|NCT01891864|580343085|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
160716948|NCT01891864|580343086|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
160716949|NCT01891864|580343087|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
160716950|NCT01891864|580343082|FG000|Treatment Period 1|Physician Decision|0|||
160716951|NCT01891864|580343083|FG001|Treatment Period 1|Physician Decision|1|||
160716952|NCT01891864|580343084|FG002|Treatment Period 1|Physician Decision|0|||
160716953|NCT01891864|580343085|FG003|Treatment Period 1|Physician Decision|0|||
160716954|NCT01891864|580343086|FG004|Treatment Period 1|Physician Decision|0|||
160716955|NCT01891864|580343087|FG005|Treatment Period 1|Physician Decision|0|||
160716956|NCT01891864|580343082|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
160716957|NCT01891864|580343083|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
160716958|NCT01891864|580343084|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
160716959|NCT01891864|580343085|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
160716960|NCT01891864|580343086|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
160716961|NCT01891864|580343087|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
160716962|NCT01891864|580343082|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
160716963|NCT01891864|580343083|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
160716964|NCT01891864|580343084|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
160716965|NCT01891864|580343085|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
160716966|NCT01891864|580343086|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
160716967|NCT01891864|580343087|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
160716968|NCT01891864|580343082|FG000|Treatment Period 1|Withdrawal by Subject|2|||
160716969|NCT01891864|580343083|FG001|Treatment Period 1|Withdrawal by Subject|5|||
160716970|NCT01891864|580343084|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160716971|NCT01891864|580343085|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160716972|NCT01891864|580343086|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160716973|NCT01891864|580343087|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160716974|NCT01891864|580343082|FG000|Treatment Period 1|Lost to Follow-up|1|||
160716975|NCT01891864|580343083|FG001|Treatment Period 1|Lost to Follow-up|0|||
160716976|NCT01891864|580343084|FG002|Treatment Period 1|Lost to Follow-up|0|||
160716977|NCT01891864|580343085|FG003|Treatment Period 1|Lost to Follow-up|0|||
160716978|NCT01891864|580343086|FG004|Treatment Period 1|Lost to Follow-up|0|||
160716979|NCT01891864|580343087|FG005|Treatment Period 1|Lost to Follow-up|0|||
160716980|NCT01891864|580343082|FG000|Treatment Period 2|Protocol Violation|0|||
160716981|NCT01891864|580343083|FG001|Treatment Period 2|Protocol Violation|0|||
160716982|NCT01891864|580343084|FG002|Treatment Period 2|Protocol Violation|0|||
160716983|NCT01891864|580343085|FG003|Treatment Period 2|Protocol Violation|1|||
160716984|NCT01891864|580343086|FG004|Treatment Period 2|Protocol Violation|0|||
160716985|NCT01891864|580343087|FG005|Treatment Period 2|Protocol Violation|0|||
160716986|NCT01891864|580343082|FG000|Treatment Period 2|Physician Decision|0|||
160716987|NCT01891864|580343083|FG001|Treatment Period 2|Physician Decision|0|||
160716988|NCT01891864|580343084|FG002|Treatment Period 2|Physician Decision|1|||
160716989|NCT01891864|580343085|FG003|Treatment Period 2|Physician Decision|0|||
160716990|NCT01891864|580343086|FG004|Treatment Period 2|Physician Decision|0|||
160716991|NCT01891864|580343087|FG005|Treatment Period 2|Physician Decision|0|||
160716992|NCT01891864|580343082|FG000|Treatment Period 2|Site Termination|0|||
160716993|NCT01891864|580343083|FG001|Treatment Period 2|Site Termination|0|||
160716994|NCT01891864|580343084|FG002|Treatment Period 2|Site Termination|1|||
160716995|NCT01891864|580343085|FG003|Treatment Period 2|Site Termination|2|||
160716996|NCT01891864|580343086|FG004|Treatment Period 2|Site Termination|0|||
160716997|NCT01891864|580343087|FG005|Treatment Period 2|Site Termination|0|||
160716998|NCT01891864|580343082|FG000|Treatment Period 2|Lack of Efficacy|0|||
160716999|NCT01891864|580343083|FG001|Treatment Period 2|Lack of Efficacy|0|||
160717000|NCT01891864|580343084|FG002|Treatment Period 2|Lack of Efficacy|1|||
160717001|NCT01891864|580343085|FG003|Treatment Period 2|Lack of Efficacy|0|||
160717002|NCT01891864|580343086|FG004|Treatment Period 2|Lack of Efficacy|1|||
160717003|NCT01891864|580343087|FG005|Treatment Period 2|Lack of Efficacy|0|||
160717004|NCT01891864|580343082|FG000|Treatment Period 2|Adverse Event|0|||
160717005|NCT01891864|580343083|FG001|Treatment Period 2|Adverse Event|0|||
160717006|NCT01891864|580343084|FG002|Treatment Period 2|Adverse Event|1|||
160717007|NCT01891864|580343085|FG003|Treatment Period 2|Adverse Event|2|||
160717008|NCT01891864|580343086|FG004|Treatment Period 2|Adverse Event|0|||
160717009|NCT01891864|580343087|FG005|Treatment Period 2|Adverse Event|4|||
160717010|NCT01891864|580343082|FG000|Treatment Period 2|Termination of Site|0|||
160717011|NCT01891864|580343083|FG001|Treatment Period 2|Termination of Site|0|||
160717012|NCT01891864|580343084|FG002|Treatment Period 2|Termination of Site|0|||
160717013|NCT01891864|580343085|FG003|Treatment Period 2|Termination of Site|0|||
160717014|NCT01891864|580343086|FG004|Treatment Period 2|Termination of Site|2|||
160717015|NCT01891864|580343087|FG005|Treatment Period 2|Termination of Site|0|||
160717016|NCT01891864|580343082|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160717017|NCT01891864|580343083|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160717018|NCT01891864|580343084|FG002|Treatment Period 2|Withdrawal by Subject|3|||
160717019|NCT01891864|580343085|FG003|Treatment Period 2|Withdrawal by Subject|4|||
160717020|NCT01891864|580343086|FG004|Treatment Period 2|Withdrawal by Subject|1|||
160717021|NCT01891864|580343087|FG005|Treatment Period 2|Withdrawal by Subject|1|||
160717022|NCT01891864|580343082|FG000|Extension Period|Lack of Efficacy|0|||
160717023|NCT01891864|580343083|FG001|Extension Period|Lack of Efficacy|0|||
160717024|NCT01891864|580343084|FG002|Extension Period|Lack of Efficacy|0|||
160717025|NCT01891864|580343085|FG003|Extension Period|Lack of Efficacy|1|||
160717026|NCT01891864|580343086|FG004|Extension Period|Lack of Efficacy|1|||
160717027|NCT01891864|580343087|FG005|Extension Period|Lack of Efficacy|0|||
160717028|NCT01891864|580343082|FG000|Extension Period|Pregnancy|0|||
160717029|NCT01891864|580343083|FG001|Extension Period|Pregnancy|0|||
160717030|NCT01891864|580343084|FG002|Extension Period|Pregnancy|1|||
160717031|NCT01891864|580343085|FG003|Extension Period|Pregnancy|0|||
160717032|NCT01891864|580343086|FG004|Extension Period|Pregnancy|0|||
160717033|NCT01891864|580343087|FG005|Extension Period|Pregnancy|0|||
160717034|NCT01891864|580343082|FG000|Extension Period|Adverse Event|0|||
160717035|NCT01891864|580343083|FG001|Extension Period|Adverse Event|0|||
160717036|NCT01891864|580343084|FG002|Extension Period|Adverse Event|4|||
160717037|NCT01891864|580343085|FG003|Extension Period|Adverse Event|2|||
160717038|NCT01891864|580343086|FG004|Extension Period|Adverse Event|2|||
160717039|NCT01891864|580343087|FG005|Extension Period|Adverse Event|0|||
160717040|NCT01891864|580343082|FG000|Extension Period|Withdrawal by Subject|0|||
160717041|NCT01891864|580343083|FG001|Extension Period|Withdrawal by Subject|0|||
160717042|NCT01891864|580343084|FG002|Extension Period|Withdrawal by Subject|1|||
160717043|NCT01891864|580343085|FG003|Extension Period|Withdrawal by Subject|2|||
160717044|NCT01891864|580343086|FG004|Extension Period|Withdrawal by Subject|4|||
160717045|NCT01891864|580343087|FG005|Extension Period|Withdrawal by Subject|0|||
160717046|NCT01891864|580343082|FG000|Extension Period|Lost to Follow-up|0|||
160717047|NCT01891864|580343083|FG001|Extension Period|Lost to Follow-up|0|||
160717048|NCT01891864|580343084|FG002|Extension Period|Lost to Follow-up|2|||
160717049|NCT01891864|580343085|FG003|Extension Period|Lost to Follow-up|0|||
160717050|NCT01891864|580343086|FG004|Extension Period|Lost to Follow-up|0|||
160717051|NCT01891864|580343087|FG005|Extension Period|Lost to Follow-up|0|||
160717052|NCT05620082|580343088|FG000|Overall Study|Discharged before study end|1|||
160717053|NCT05620082|580343089|FG001|Overall Study|Discharged before study end|4|||
160717054|NCT05620082|580343090|FG002|Overall Study|Discharged before study end|0|||
160717055|NCT05620082|580343088|FG000|Overall Study|Moved to a different ward|1|||
160717056|NCT05620082|580343089|FG001|Overall Study|Moved to a different ward|0|||
160717057|NCT05620082|580343090|FG002|Overall Study|Moved to a different ward|0|||
160717058|NCT05620082|580343088|FG000|Overall Study|Feeling too unwell|1|||
160717059|NCT05620082|580343089|FG001|Overall Study|Feeling too unwell|0|||
160717060|NCT05620082|580343090|FG002|Overall Study|Feeling too unwell|0|||
160717061|NCT04199104|580345023|FG000|Overall Study|Death|148|||
160717062|NCT04199104|580345024|FG001|Overall Study|Death|134|||
160717063|NCT04199104|580345023|FG000|Overall Study|Lost to Follow-up|1|||
160717064|NCT04199104|580345024|FG001|Overall Study|Lost to Follow-up|1|||
160717065|NCT04199104|580345023|FG000|Overall Study|Withdrawal by Subject|4|||
160717066|NCT04199104|580345024|FG001|Overall Study|Withdrawal by Subject|4|||
160717067|NCT04199104|580345023|FG000|Overall Study|Participants Ongoing|103|||
160717068|NCT04199104|580345024|FG001|Overall Study|Participants Ongoing|116|||
160717069|NCT02325973|580345031|FG000|Overall Study|Death|5|||
160717070|NCT02325973|580345031|FG000|Overall Study|Withdrawal by subject or investigator|16|||
160717071|NCT05201794|580345032|FG000|Overall Study|Withdrawal by Subject|13|||
160717072|NCT05201794|580345033|FG001|Overall Study|Withdrawal by Subject|12|||
160717073|NCT05201794|580345034|FG002|Overall Study|Withdrawal by Subject|14|||
160717074|NCT05201794|580345035|FG003|Overall Study|Withdrawal by Subject|0|||
160717075|NCT05201794|580345032|FG000|Overall Study|Adverse Event|5|||
160717076|NCT05201794|580345033|FG001|Overall Study|Adverse Event|5|||
160717077|NCT05201794|580345034|FG002|Overall Study|Adverse Event|4|||
160717078|NCT05201794|580345035|FG003|Overall Study|Adverse Event|0|||
160717079|NCT05201794|580345032|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
160717080|NCT05201794|580345033|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
160717081|NCT05201794|580345034|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
160717082|NCT05201794|580345035|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160717083|NCT05201794|580345032|FG000|Overall Study|Non-Compliance With Study Drug|2|||
160717084|NCT05201794|580345033|FG001|Overall Study|Non-Compliance With Study Drug|3|||
160717085|NCT05201794|580345034|FG002|Overall Study|Non-Compliance With Study Drug|3|||
160717086|NCT05201794|580345035|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160717087|NCT05201794|580345032|FG000|Overall Study|Physician Decision|1|||
160717088|NCT05201794|580345033|FG001|Overall Study|Physician Decision|3|||
160717089|NCT05201794|580345034|FG002|Overall Study|Physician Decision|2|||
160717090|NCT05201794|580345035|FG003|Overall Study|Physician Decision|0|||
160717091|NCT05201794|580345032|FG000|Overall Study|Lost to Follow-up|2|||
160717092|NCT05201794|580345033|FG001|Overall Study|Lost to Follow-up|2|||
160717093|NCT05201794|580345034|FG002|Overall Study|Lost to Follow-up|0|||
160717094|NCT05201794|580345035|FG003|Overall Study|Lost to Follow-up|0|||
160717095|NCT05201794|580345032|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
160717096|NCT05201794|580345033|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
160717097|NCT05201794|580345034|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
160717098|NCT05201794|580345035|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
160717099|NCT05201794|580345032|FG000|Overall Study|Protocol Violation|2|||
160717100|NCT05201794|580345033|FG001|Overall Study|Protocol Violation|0|||
160717101|NCT05201794|580345034|FG002|Overall Study|Protocol Violation|1|||
160717102|NCT05201794|580345035|FG003|Overall Study|Protocol Violation|0|||
160717103|NCT05201794|580345032|FG000|Overall Study|Death|1|||
160717104|NCT05201794|580345033|FG001|Overall Study|Death|0|||
160717105|NCT05201794|580345034|FG002|Overall Study|Death|0|||
160717106|NCT05201794|580345035|FG003|Overall Study|Death|0|||
160717107|NCT05201794|580345032|FG000|Overall Study|Site Terminated By Sponsor|0|||
160717108|NCT05201794|580345033|FG001|Overall Study|Site Terminated By Sponsor|1|||
160717109|NCT05201794|580345034|FG002|Overall Study|Site Terminated By Sponsor|0|||
160717110|NCT05201794|580345035|FG003|Overall Study|Site Terminated By Sponsor|0|||
160717111|NCT05201794|580345032|FG000|Overall Study|Other|3|||
160717112|NCT05201794|580345033|FG001|Overall Study|Other|3|||
160717113|NCT05201794|580345034|FG002|Overall Study|Other|3|||
160717114|NCT05201794|580345035|FG003|Overall Study|Other|0|||
160717115|NCT05201794|580345032|FG000|Overall Study|Randomized But Not Treated|1|||
160717116|NCT05201794|580345033|FG001|Overall Study|Randomized But Not Treated|2|||
160717117|NCT05201794|580345034|FG002|Overall Study|Randomized But Not Treated|1|||
160717118|NCT05201794|580345035|FG003|Overall Study|Randomized But Not Treated|0|||
160717119|NCT03874117|580345036|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
160717120|NCT03874117|580345037|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
160717121|NCT03874117|580345036|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
160717122|NCT03874117|580345037|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
160717123|NCT03874117|580345036|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
160717124|NCT03874117|580345037|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160717125|NCT03874117|580345036|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
160717126|NCT03874117|580345037|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
160717127|NCT03874117|580345036|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160717128|NCT03874117|580345037|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
160717129|NCT01490086|580345040|FG000|Overall Study|Consent withdrawn|4|||
160717130|NCT01490086|580345041|FG001|Overall Study|Consent withdrawn|4|||
160717131|NCT01490086|580345042|FG002|Overall Study|Consent withdrawn|3|||
160717132|NCT01490086|580345043|FG003|Overall Study|Consent withdrawn|0|||
160717133|NCT01490086|580345044|FG004|Overall Study|Consent withdrawn|1|||
160717134|NCT01490086|580345040|FG000|Overall Study|Non-compliance|0|||
160717135|NCT01490086|580345041|FG001|Overall Study|Non-compliance|1|||
160717136|NCT01490086|580345042|FG002|Overall Study|Non-compliance|0|||
160717137|NCT01490086|580345043|FG003|Overall Study|Non-compliance|0|||
160717138|NCT01490086|580345044|FG004|Overall Study|Non-compliance|0|||
160717139|NCT01490086|580345040|FG000|Overall Study|Abnormal laboratory findings|1|||
160717140|NCT01490086|580345041|FG001|Overall Study|Abnormal laboratory findings|0|||
160717141|NCT01490086|580345042|FG002|Overall Study|Abnormal laboratory findings|0|||
160717142|NCT01490086|580345043|FG003|Overall Study|Abnormal laboratory findings|0|||
160717143|NCT01490086|580345044|FG004|Overall Study|Abnormal laboratory findings|0|||
160717144|NCT01490086|580345040|FG000|Overall Study|Lost to Follow-up|0|||
160717145|NCT01490086|580345041|FG001|Overall Study|Lost to Follow-up|0|||
160717146|NCT01490086|580345042|FG002|Overall Study|Lost to Follow-up|0|||
160717147|NCT01490086|580345043|FG003|Overall Study|Lost to Follow-up|0|||
160717148|NCT01490086|580345044|FG004|Overall Study|Lost to Follow-up|1|||
160717149|NCT01490086|580345040|FG000|Overall Study|Physician Decision|3|||
160717150|NCT01490086|580345041|FG001|Overall Study|Physician Decision|4|||
160717151|NCT01490086|580345042|FG002|Overall Study|Physician Decision|2|||
160717152|NCT01490086|580345043|FG003|Overall Study|Physician Decision|3|||
160717153|NCT01490086|580345044|FG004|Overall Study|Physician Decision|1|||
160717154|NCT01490086|580345040|FG000|Overall Study|Adverse Event|0|||
160717155|NCT01490086|580345041|FG001|Overall Study|Adverse Event|0|||
160717156|NCT01490086|580345042|FG002|Overall Study|Adverse Event|1|||
160717157|NCT01490086|580345043|FG003|Overall Study|Adverse Event|2|||
160717158|NCT01490086|580345044|FG004|Overall Study|Adverse Event|0|||
160717159|NCT01490086|580345040|FG000|Overall Study|Lack of Efficacy|0|||
160717160|NCT01490086|580345041|FG001|Overall Study|Lack of Efficacy|3|||
160717161|NCT01490086|580345042|FG002|Overall Study|Lack of Efficacy|1|||
160717162|NCT01490086|580345043|FG003|Overall Study|Lack of Efficacy|0|||
160717163|NCT01490086|580345044|FG004|Overall Study|Lack of Efficacy|8|||
160717164|NCT01490086|580345040|FG000|Overall Study|Worsening of symptoms|0|||
160717165|NCT01490086|580345041|FG001|Overall Study|Worsening of symptoms|1|||
160717166|NCT01490086|580345042|FG002|Overall Study|Worsening of symptoms|0|||
160717167|NCT01490086|580345043|FG003|Overall Study|Worsening of symptoms|1|||
160717168|NCT01490086|580345044|FG004|Overall Study|Worsening of symptoms|0|||
160717169|NCT01490086|580345040|FG000|Overall Study|Subject uncontrollable and abusive|0|||
160717170|NCT01490086|580345041|FG001|Overall Study|Subject uncontrollable and abusive|1|||
160717171|NCT01490086|580345042|FG002|Overall Study|Subject uncontrollable and abusive|0|||
160717172|NCT01490086|580345043|FG003|Overall Study|Subject uncontrollable and abusive|0|||
160717173|NCT01490086|580345044|FG004|Overall Study|Subject uncontrollable and abusive|0|||
160717174|NCT01490086|580345040|FG000|Overall Study|Subject left hospital|0|||
160717175|NCT01490086|580345041|FG001|Overall Study|Subject left hospital|1|||
160717176|NCT01490086|580345042|FG002|Overall Study|Subject left hospital|0|||
160717177|NCT01490086|580345043|FG003|Overall Study|Subject left hospital|1|||
160717178|NCT01490086|580345044|FG004|Overall Study|Subject left hospital|0|||
160717179|NCT05825404|580345045|FG000|First Intervention (Weeks 2-5)|Death|0|||
160717180|NCT05825404|580345046|FG001|First Intervention (Weeks 2-5)|Death|1|||
160717181|NCT05825404|580345045|FG000|Second Intervention (Weeks 8-11)|Death|0|||
160717182|NCT05825404|580345046|FG001|Second Intervention (Weeks 8-11)|Death|1|||
160717183|NCT01749826|580345047|FG000|Overall Study|Study Terminated|20|||
160717184|NCT01749826|580345048|FG001|Overall Study|Study Terminated|0|||
160717185|NCT05085834|580345049|FG000|Overall Study|Lost to Follow-up|9|||
160717186|NCT05085834|580345050|FG001|Overall Study|Lost to Follow-up|2|||
160717187|NCT05085834|580345049|FG000|Overall Study|Adverse Event|6|||
160717188|NCT05085834|580345050|FG001|Overall Study|Adverse Event|0|||
160717189|NCT05085834|580345049|FG000|Overall Study|Death|1|||
160717190|NCT05085834|580345050|FG001|Overall Study|Death|0|||
160717191|NCT05085834|580345049|FG000|Overall Study|Inability to swallow the pill|0|||
160717192|NCT05085834|580345050|FG001|Overall Study|Inability to swallow the pill|1|||
160717193|NCT02572570|580345055|FG000|Overall Study|Study Terminated|27|||
160717194|NCT01417156|580345058|FG000|Overall Study|Adverse Event|12|||
160717195|NCT01417156|580345058|FG000|Overall Study|Protocol Violation|2|||
160717196|NCT03192488|580345059|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
160717197|NCT03192488|580345060|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
160717198|NCT03192488|580345061|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
160717199|NCT03192488|580345062|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
160717200|NCT03192488|580345063|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
160717201|NCT03192488|580345064|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
160717202|NCT03192488|580345059|FG000|Third Intervention (d1)|Adverse Event|0|||
160717203|NCT03192488|580345060|FG001|Third Intervention (d1)|Adverse Event|0|||
160717204|NCT03192488|580345061|FG002|Third Intervention (d1)|Adverse Event|0|||
160717205|NCT03192488|580345062|FG003|Third Intervention (d1)|Adverse Event|0|||
160717206|NCT03192488|580345063|FG004|Third Intervention (d1)|Adverse Event|1|||
160717207|NCT03192488|580345064|FG005|Third Intervention (d1)|Adverse Event|0|||
160717208|NCT00611923|580345066|FG000|Overall Study|Withdrawal by Subject|2|||
160717209|NCT00611923|580345067|FG001|Overall Study|Withdrawal by Subject|2|||
160717210|NCT02302833|580345080|FG000|Overall Study|Lost to Follow-up|3|||
160717211|NCT03664232|580345081|FG000|Overall Study|Withdrawal by Subject|0|||
160717212|NCT03664232|580345082|FG001|Overall Study|Withdrawal by Subject|1|||
160717213|NCT03664232|580345083|FG002|Overall Study|Withdrawal by Subject|0|||
160717214|NCT03664232|580345084|FG003|Overall Study|Withdrawal by Subject|1|||
160717215|NCT03664232|580345081|FG000|Overall Study|Adverse Event|0|||
160717216|NCT03664232|580345082|FG001|Overall Study|Adverse Event|0|||
160717217|NCT03664232|580345083|FG002|Overall Study|Adverse Event|1|||
160717218|NCT03664232|580345084|FG003|Overall Study|Adverse Event|0|||
160717219|NCT03664232|580345081|FG000|Overall Study|Other-Non-compliance with study drug|0|||
160717220|NCT03664232|580345082|FG001|Overall Study|Other-Non-compliance with study drug|1|||
160717221|NCT03664232|580345083|FG002|Overall Study|Other-Non-compliance with study drug|0|||
160717222|NCT03664232|580345084|FG003|Overall Study|Other-Non-compliance with study drug|2|||
160717223|NCT03664232|580345081|FG000|Overall Study|Other-Unspecified|0|||
160717224|NCT03664232|580345082|FG001|Overall Study|Other-Unspecified|3|||
160717225|NCT03664232|580345083|FG002|Overall Study|Other-Unspecified|0|||
160717226|NCT03664232|580345084|FG003|Overall Study|Other-Unspecified|1|||
160717227|NCT03664232|580345081|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
160717228|NCT03664232|580345082|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
160717229|NCT03664232|580345083|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
160717230|NCT03664232|580345084|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
160717231|NCT02717507|580345085|FG000|Overall Study|Lost to Follow-up|5|||
160717232|NCT02717507|580345086|FG001|Overall Study|Lost to Follow-up|8|||
160717233|NCT02717507|580345085|FG000|Overall Study|Pregnancy|1|||
160717234|NCT02717507|580345086|FG001|Overall Study|Pregnancy|1|||
160717235|NCT02717507|580345085|FG000|Overall Study|Protocol Violation|2|||
160717236|NCT02717507|580345086|FG001|Overall Study|Protocol Violation|2|||
160717237|NCT02717507|580345085|FG000|Overall Study|Withdrawal by Subject|20|||
160717238|NCT02717507|580345086|FG001|Overall Study|Withdrawal by Subject|20|||
160717239|NCT02717507|580345085|FG000|Overall Study|Relapse|1|||
160717240|NCT02717507|580345086|FG001|Overall Study|Relapse|1|||
160717241|NCT02717507|580345085|FG000|Overall Study|Cardiac Event|2|||
160717242|NCT02717507|580345086|FG001|Overall Study|Cardiac Event|6|||
160717243|NCT05017246|580345087|FG000|Overall Study|Withdrawal by Subject|5|||
160717244|NCT05017246|580345088|FG001|Overall Study|Withdrawal by Subject|3|||
160717245|NCT05017246|580345087|FG000|Overall Study|Determined to be ineligible|0|||
160717246|NCT05017246|580345088|FG001|Overall Study|Determined to be ineligible|1|||
160717247|NCT05017246|580345087|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
160717248|NCT05017246|580345088|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
160717249|NCT05017246|580345087|FG000|Overall Study|Technical failure|1|||
160717250|NCT05017246|580345088|FG001|Overall Study|Technical failure|3|||
160717251|NCT02493660|580345091|FG000|Overall Study|Physician Decision|0|||
160717252|NCT02493660|580345092|FG001|Overall Study|Physician Decision|1|||
160717253|NCT02493660|580345091|FG000|Overall Study|Adverse Event|4|||
160717254|NCT02493660|580345092|FG001|Overall Study|Adverse Event|2|||
160717255|NCT02493660|580345091|FG000|Overall Study|Withdrawal by Subject|2|||
160717256|NCT02493660|580345092|FG001|Overall Study|Withdrawal by Subject|3|||
160717257|NCT02493660|580345091|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
160717258|NCT02493660|580345092|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
160717259|NCT02493660|580345091|FG000|Overall Study|Protocol Violation|0|||
160717260|NCT02493660|580345092|FG001|Overall Study|Protocol Violation|1|||
160717261|NCT02493660|580345091|FG000|Overall Study|Death|0|||
160717262|NCT02493660|580345092|FG001|Overall Study|Death|1|||
160717263|NCT02493660|580345091|FG000|Overall Study|Lost to Follow-up|2|||
160717264|NCT02493660|580345092|FG001|Overall Study|Lost to Follow-up|4|||
160717265|NCT00638508|580345098|FG000|Overall Study|Physician Decision|5|||
160717266|NCT00638508|580345099|FG001|Overall Study|Physician Decision|2|||
160717267|NCT03500198|580345102|FG000|Overall Study|Lost to Follow-up|0|||
160717268|NCT03500198|580345103|FG001|Overall Study|Lost to Follow-up|1|||
160717269|NCT01514461|580345104|FG000|Overall Study|Adverse Event|2|||
160717270|NCT01514461|580345105|FG001|Overall Study|Adverse Event|1|||
160717271|NCT01514461|580345106|FG002|Overall Study|Adverse Event|3|||
160717272|NCT01514461|580345104|FG000|Overall Study|Physician Decision|1|||
160717273|NCT01514461|580345105|FG001|Overall Study|Physician Decision|1|||
160717274|NCT01514461|580345106|FG002|Overall Study|Physician Decision|0|||
160717275|NCT01514461|580345104|FG000|Overall Study|Patient/guardian decision|1|||
160717276|NCT01514461|580345105|FG001|Overall Study|Patient/guardian decision|1|||
160717277|NCT01514461|580345106|FG002|Overall Study|Patient/guardian decision|1|||
160717278|NCT01514461|580345104|FG000|Overall Study|Death|1|||
160717279|NCT01514461|580345105|FG001|Overall Study|Death|0|||
160717280|NCT01514461|580345106|FG002|Overall Study|Death|0|||
160717281|NCT00654095|580345107|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
160717282|NCT00654095|580345107|FG000|Overall Study|Elevated triglyceride level (2)|1|||
160717283|NCT00654095|580345107|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
160717284|NCT00654095|580345107|FG000|Overall Study|Adverse Event|11|||
160717285|NCT00654095|580345107|FG000|Overall Study|Withdrawal by Subject|5|||
160717286|NCT00654095|580345107|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
160717287|NCT00654095|580345107|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
160717288|NCT00654095|580345107|FG000|Overall Study|Did not meet inclusion criteria|1|||
160717289|NCT00595621|580345113|FG000|Open Label Run in|Adverse Event|1|||
160717290|NCT00595621|580345114|FG001|Open Label Run in|Adverse Event|0|||
160717291|NCT00595621|580345113|FG000|Open Label Run in|Physician Decision|1|||
160717292|NCT00595621|580345114|FG001|Open Label Run in|Physician Decision|0|||
160717293|NCT00595621|580345113|FG000|Open Label Run in|Withdrawal by Subject|1|||
160717294|NCT00595621|580345114|FG001|Open Label Run in|Withdrawal by Subject|0|||
160717295|NCT00595621|580345113|FG000|Randomization and Study|Adverse Event|2|||
160717296|NCT00595621|580345114|FG001|Randomization and Study|Adverse Event|0|||
160717297|NCT00595621|580345113|FG000|Randomization and Study|Withdrawal by Subject|0|||
160717298|NCT00595621|580345114|FG001|Randomization and Study|Withdrawal by Subject|1|||
160717299|NCT02440464|580345115|FG000|Overall Study|Withdrawal by Subject|3|||
160717300|NCT02440464|580345116|FG001|Overall Study|Withdrawal by Subject|2|||
160717301|NCT00324987|580345117|FG000|Overall Study|Adverse Event|2|||
160717302|NCT00324987|580345118|FG001|Overall Study|Adverse Event|1|||
160717303|NCT00324987|580345117|FG000|Overall Study|Withdrawal by Subject|1|||
160717304|NCT00324987|580345118|FG001|Overall Study|Withdrawal by Subject|1|||
160717305|NCT00324987|580345117|FG000|Overall Study|Progression|1|||
160717306|NCT00324987|580345118|FG001|Overall Study|Progression|1|||
160717307|NCT00324987|580345117|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
160717308|NCT00324987|580345118|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
160717309|NCT03565900|580345120|FG000|Overall Study|Disposition Unknown|4|||
160717310|NCT03565900|580345121|FG001|Overall Study|Disposition Unknown|1|||
160717311|NCT03565900|580345120|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
160717312|NCT03565900|580345121|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
160717313|NCT03565900|580345120|FG000|Overall Study|Withdrawal by Subject|4|||
160717314|NCT03565900|580345121|FG001|Overall Study|Withdrawal by Subject|5|||
160717315|NCT03565900|580345120|FG000|Overall Study|Randomized By Mistake|0|||
160717316|NCT03565900|580345121|FG001|Overall Study|Randomized By Mistake|2|||
160717317|NCT03565900|580345120|FG000|Overall Study|Physician Decision|7|||
160717318|NCT03565900|580345121|FG001|Overall Study|Physician Decision|11|||
160717319|NCT03565900|580345120|FG000|Overall Study|Death|9|||
160717320|NCT03565900|580345121|FG001|Overall Study|Death|7|||
160717321|NCT01254643|580345122|FG000|Overall Study|Withdrawal by Subject|1|||
160717322|NCT03359850|580345125|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
160717323|NCT03359850|580345126|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
160717324|NCT03359850|580345125|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
160717325|NCT03359850|580345126|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
160717326|NCT03359850|580345125|FG000|Extension Phase (Up to 28 Months)|Death|2|||
160717327|NCT03359850|580345126|FG001|Extension Phase (Up to 28 Months)|Death|4|||
160717328|NCT03359850|580345125|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
160717329|NCT03359850|580345126|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
160717330|NCT03359850|580345125|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
160717331|NCT03359850|580345126|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
160717332|NCT03817125|580345144|FG000|Overall Study|Adverse Event|1|||
160717333|NCT03817125|580345145|FG001|Overall Study|Adverse Event|0|||
160717334|NCT03817125|580345144|FG000|Overall Study|Physician Decision|0|||
160717335|NCT03817125|580345145|FG001|Overall Study|Physician Decision|1|||
160717336|NCT03817125|580345144|FG000|Overall Study|Lack of Efficacy|1|||
160717337|NCT03817125|580345145|FG001|Overall Study|Lack of Efficacy|5|||
160717338|NCT00942084|580345146|FG000|Overall Study|Death|2|||
160717339|NCT01037218|580345147|FG000|Overall Study|Adverse Event|4|||
160717340|NCT01037218|580345148|FG001|Overall Study|Adverse Event|2|||
160717341|NCT01037218|580345149|FG002|Overall Study|Adverse Event|2|||
160717342|NCT01037218|580345150|FG003|Overall Study|Adverse Event|1|||
160717343|NCT01037218|580345147|FG000|Overall Study|Lack of Efficacy|0|||
160717344|NCT01037218|580345148|FG001|Overall Study|Lack of Efficacy|2|||
160717345|NCT01037218|580345149|FG002|Overall Study|Lack of Efficacy|1|||
160717346|NCT01037218|580345150|FG003|Overall Study|Lack of Efficacy|5|||
160717347|NCT01037218|580345147|FG000|Overall Study|Lost to Follow-up|3|||
160717348|NCT01037218|580345148|FG001|Overall Study|Lost to Follow-up|5|||
160717349|NCT01037218|580345149|FG002|Overall Study|Lost to Follow-up|4|||
160717350|NCT01037218|580345150|FG003|Overall Study|Lost to Follow-up|2|||
160717351|NCT01037218|580345147|FG000|Overall Study|Withdrawal by Subject|6|||
160717352|NCT01037218|580345148|FG001|Overall Study|Withdrawal by Subject|7|||
160717353|NCT01037218|580345149|FG002|Overall Study|Withdrawal by Subject|7|||
160717354|NCT01037218|580345150|FG003|Overall Study|Withdrawal by Subject|4|||
160717355|NCT01037218|580345147|FG000|Overall Study|Partner Withdrew Consent|0|||
160717356|NCT01037218|580345148|FG001|Overall Study|Partner Withdrew Consent|3|||
160717357|NCT01037218|580345149|FG002|Overall Study|Partner Withdrew Consent|2|||
160717358|NCT01037218|580345150|FG003|Overall Study|Partner Withdrew Consent|1|||
160717359|NCT01037218|580345147|FG000|Overall Study|Protocol Violation|0|||
160717360|NCT01037218|580345148|FG001|Overall Study|Protocol Violation|0|||
160717361|NCT01037218|580345149|FG002|Overall Study|Protocol Violation|2|||
160717362|NCT01037218|580345150|FG003|Overall Study|Protocol Violation|2|||
160717363|NCT01037218|580345147|FG000|Overall Study|Various|3|||
160717364|NCT01037218|580345148|FG001|Overall Study|Various|2|||
160717365|NCT01037218|580345149|FG002|Overall Study|Various|3|||
160717366|NCT01037218|580345150|FG003|Overall Study|Various|1|||
160717367|NCT00513240|580345151|FG000|Overall Study|Did not have intended surgery|3|||
160717368|NCT00513240|580345152|FG001|Overall Study|Did not have intended surgery|0|||
160717369|NCT00513240|580345151|FG000|Overall Study|Death|3|||
160717370|NCT00513240|580345152|FG001|Overall Study|Death|3|||
160717371|NCT00513240|580345151|FG000|Overall Study|Withdrawal by Subject|7|||
160717372|NCT00513240|580345152|FG001|Overall Study|Withdrawal by Subject|4|||
160717373|NCT02857816|580345154|FG000|Overall Study|Screen Failure|33|||
160717374|NCT02857816|580345154|FG000|Overall Study|Withdrawal by Subject|4|||
160717375|NCT02857816|580345154|FG000|Overall Study|Lost to Follow-up|1|||
160717376|NCT02291237|580345155|FG000|Overall Study|Study Terminated by Sponsor|72|||
160717377|NCT02291237|580345156|FG001|Overall Study|Study Terminated by Sponsor|67|||
160717378|NCT02291237|580345155|FG000|Overall Study|Adverse Event|1|||
160717379|NCT02291237|580345156|FG001|Overall Study|Adverse Event|3|||
160717380|NCT02291237|580345155|FG000|Overall Study|Investigator's Discretion|0|||
160717381|NCT02291237|580345156|FG001|Overall Study|Investigator's Discretion|3|||
160717382|NCT02291237|580345155|FG000|Overall Study|Withdrew Consent|11|||
160717383|NCT02291237|580345156|FG001|Overall Study|Withdrew Consent|11|||
160717384|NCT02291237|580345155|FG000|Overall Study|Lost to Follow-up|0|||
160717385|NCT02291237|580345156|FG001|Overall Study|Lost to Follow-up|2|||
160717386|NCT02291237|580345155|FG000|Overall Study|Subject Required Prohibited Medication|2|||
160717387|NCT02291237|580345156|FG001|Overall Study|Subject Required Prohibited Medication|0|||
160717388|NCT03281876|580345158|FG000|Overall Study|Adverse Event|4|||
160717389|NCT03281876|580345159|FG001|Overall Study|Adverse Event|15|||
160717390|NCT03281876|580345158|FG000|Overall Study|Lost to Follow-up|1|||
160717391|NCT03281876|580345159|FG001|Overall Study|Lost to Follow-up|4|||
160717392|NCT03281876|580345158|FG000|Overall Study|Withdrawal by Subject|11|||
160717393|NCT03281876|580345159|FG001|Overall Study|Withdrawal by Subject|15|||
160717394|NCT03281876|580345158|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
160717395|NCT03281876|580345159|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160717396|NCT03281876|580345158|FG000|Overall Study|OTHER|5|||
160717397|NCT03281876|580345159|FG001|Overall Study|OTHER|5|||
160717398|NCT02208089|580345160|FG000|Overall Study|Withdrawal by Subject|1|||
160717399|NCT02208089|580345161|FG001|Overall Study|Withdrawal by Subject|0|||
160717400|NCT02208089|580345160|FG000|Overall Study|Lost to Follow-up|6|||
160717401|NCT02208089|580345161|FG001|Overall Study|Lost to Follow-up|0|||
160717402|NCT00456300|580345162|FG000|Overall Study|Adverse Event|1|||
160717403|NCT00456300|580345163|FG001|Overall Study|Adverse Event|0|||
160717404|NCT01478373|580345165|FG000|Treatment Phase|Protocol Violation|1|||
160717405|NCT01478373|580345165|FG000|Survival Phase|Adverse Event|8|||
160717406|NCT01478373|580345165|FG000|Survival Phase|Protocol Violation|1|||
160717407|NCT01478373|580345165|FG000|Survival Phase|crossover to another study|2|||
160717408|NCT01478373|580345165|FG000|Survival Phase|Progressive Disease|27|||
160717409|NCT01074944|580345174|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
160717410|NCT01074944|580345175|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
160717411|NCT01074944|580345176|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
160717412|NCT01074944|580345177|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
160717413|NCT01074944|580345178|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
160717414|NCT01074944|580345174|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
160717415|NCT01074944|580345175|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
160717416|NCT01074944|580345176|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
160717417|NCT01074944|580345177|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
160717418|NCT01074944|580345178|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
160717419|NCT01074944|580345174|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
160717420|NCT01074944|580345175|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
160717421|NCT01074944|580345176|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
160717422|NCT01074944|580345177|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
160717423|NCT01074944|580345178|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
160717424|NCT01074944|580345174|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
160717425|NCT01074944|580345175|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
160717426|NCT01074944|580345176|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
160717427|NCT01074944|580345177|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
160717428|NCT01074944|580345178|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
160717429|NCT01074944|580345174|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
160717430|NCT01074944|580345175|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
160717431|NCT01074944|580345176|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
160717432|NCT01074944|580345177|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
160717433|NCT01074944|580345178|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
160717434|NCT01074944|580345174|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
160717435|NCT01074944|580345175|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
160717436|NCT01074944|580345176|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
160717437|NCT01074944|580345177|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
160717438|NCT01074944|580345178|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
160717439|NCT01074944|580345174|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
160717440|NCT01074944|580345175|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
160717441|NCT01074944|580345176|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
160717442|NCT01074944|580345177|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
160717443|NCT01074944|580345178|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
160717444|NCT01074944|580345174|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
160717445|NCT01074944|580345175|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
160717446|NCT01074944|580345176|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
160717447|NCT01074944|580345177|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
160717448|NCT01074944|580345178|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
160717449|NCT01074944|580345174|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
160717450|NCT01074944|580345175|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
160717451|NCT01074944|580345176|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
160717452|NCT01074944|580345177|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
160717453|NCT01074944|580345178|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
160717454|NCT01074944|580345174|FG000|Long Term Treatment|Adverse Event|0|||
160717455|NCT01074944|580345175|FG001|Long Term Treatment|Adverse Event|0|||
160717456|NCT01074944|580345176|FG002|Long Term Treatment|Adverse Event|0|||
160717457|NCT01074944|580345177|FG003|Long Term Treatment|Adverse Event|3|||
160717458|NCT01074944|580345178|FG004|Long Term Treatment|Adverse Event|0|||
160717459|NCT01074944|580345174|FG000|Long Term Treatment|Lost to Follow-up|0|||
160717460|NCT01074944|580345175|FG001|Long Term Treatment|Lost to Follow-up|0|||
160717461|NCT01074944|580345176|FG002|Long Term Treatment|Lost to Follow-up|0|||
160717462|NCT01074944|580345177|FG003|Long Term Treatment|Lost to Follow-up|2|||
160717463|NCT01074944|580345178|FG004|Long Term Treatment|Lost to Follow-up|0|||
160717464|NCT01074944|580345174|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
160717465|NCT01074944|580345175|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
160717466|NCT01074944|580345176|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
160717467|NCT01074944|580345177|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
160717468|NCT01074944|580345178|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
160717469|NCT01074944|580345174|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
160717470|NCT01074944|580345175|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
160717471|NCT01074944|580345176|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
160717472|NCT01074944|580345177|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
160717473|NCT01074944|580345178|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
160717474|NCT01074944|580345174|FG000|Long Term Treatment|Withdrawal by Subject|0|||
160717475|NCT01074944|580345175|FG001|Long Term Treatment|Withdrawal by Subject|0|||
160717476|NCT01074944|580345176|FG002|Long Term Treatment|Withdrawal by Subject|0|||
160717477|NCT01074944|580345177|FG003|Long Term Treatment|Withdrawal by Subject|2|||
160717478|NCT01074944|580345178|FG004|Long Term Treatment|Withdrawal by Subject|0|||
160717479|NCT01074944|580345174|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
160717480|NCT01074944|580345175|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
160717481|NCT01074944|580345176|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
160717482|NCT01074944|580345177|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
160717483|NCT01074944|580345178|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
160717484|NCT01074944|580345174|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
160717485|NCT01074944|580345175|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
160717486|NCT01074944|580345176|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
160717487|NCT01074944|580345177|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
160717488|NCT01074944|580345178|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
160717489|NCT03200717|580345184|FG000|Overall Study|Progressive disease|24|||
160717490|NCT03200717|580345185|FG001|Overall Study|Progressive disease|5|||
160717491|NCT03200717|580345184|FG000|Overall Study|Adverse Event|11|||
160717492|NCT03200717|580345185|FG001|Overall Study|Adverse Event|8|||
160717493|NCT03200717|580345184|FG000|Overall Study|Physician Decision|3|||
160717494|NCT03200717|580345185|FG001|Overall Study|Physician Decision|2|||
160717495|NCT03200717|580345184|FG000|Overall Study|Death|2|||
160717496|NCT03200717|580345185|FG001|Overall Study|Death|0|||
160717497|NCT03200717|580345184|FG000|Overall Study|Subject/Guardian Decision|1|||
160717498|NCT03200717|580345185|FG001|Overall Study|Subject/Guardian Decision|0|||
160717499|NCT01522456|580345186|FG000|Overall Study|Adverse Event|2|||
160717500|NCT01522456|580345186|FG000|Overall Study|Lost to Follow-up|2|||
160717501|NCT01522456|580345186|FG000|Overall Study|Withdrawal by Subject|2|||
160717502|NCT01522456|580345186|FG000|Overall Study|Pregnancy|1|||
160717503|NCT01522456|580345186|FG000|Overall Study|Tolerability Assessment|1|||
160717504|NCT02201784|580345187|FG000|Overall Study|Failure to achieve adequate block|2|||
160717505|NCT02201784|580345188|FG001|Overall Study|Failure to achieve adequate block|0|||
160717506|NCT02046603|580345189|FG000|Overall Study|Other|11|||
160717507|NCT02046603|580345190|FG001|Overall Study|Other|66|||
160717508|NCT02046603|580345189|FG000|Overall Study|Protocol Violation|0|||
160717509|NCT02046603|580345190|FG001|Overall Study|Protocol Violation|1|||
160717510|NCT02046603|580345189|FG000|Overall Study|Participant/legal guardian decision|1|||
160717511|NCT02046603|580345190|FG001|Overall Study|Participant/legal guardian decision|3|||
160717512|NCT02046603|580345189|FG000|Overall Study|Physician Decision|2|||
160717513|NCT02046603|580345190|FG001|Overall Study|Physician Decision|1|||
160717514|NCT02046603|580345189|FG000|Overall Study|Lost to Follow-up|1|||
160717515|NCT02046603|580345190|FG001|Overall Study|Lost to Follow-up|2|||
160717516|NCT02046603|580345189|FG000|Overall Study|Death|0|||
160717517|NCT02046603|580345190|FG001|Overall Study|Death|1|||
160717518|NCT02046603|580345189|FG000|Overall Study|Adverse Event|0|||
160717519|NCT02046603|580345190|FG001|Overall Study|Adverse Event|1|||
160717520|NCT02072980|580345191|FG000|Period 2, Second Wear|Adverse Event|0|||
160717521|NCT02072980|580345192|FG001|Period 2, Second Wear|Adverse Event|1|||
160717522|NCT02431364|580345193|FG000|Overall Study|Adverse Event|0|||
160717523|NCT02431364|580345194|FG001|Overall Study|Adverse Event|1|||
160717524|NCT02431364|580345195|FG002|Overall Study|Adverse Event|0|||
160717525|NCT02431364|580345196|FG003|Overall Study|Adverse Event|0|||
160717526|NCT02431364|580345197|FG004|Overall Study|Adverse Event|0|||
160717527|NCT02431364|580345193|FG000|Overall Study|Randomized but never treated|0|||
160717528|NCT02431364|580345194|FG001|Overall Study|Randomized but never treated|0|||
160717529|NCT02431364|580345195|FG002|Overall Study|Randomized but never treated|0|||
160717530|NCT02431364|580345196|FG003|Overall Study|Randomized but never treated|1|||
160717531|NCT02431364|580345197|FG004|Overall Study|Randomized but never treated|0|||
160717532|NCT00061932|580345198|FG000|Overall Study|Withdrawal by Subject|13|||
160717533|NCT00061932|580345199|FG001|Overall Study|Withdrawal by Subject|4|||
160717534|NCT04720105|580345200|FG000|Overall Study|Lack of Efficacy|1|||
160717535|NCT04720105|580345200|FG000|Overall Study|Lost to Follow-up|1|||
160717536|NCT04720105|580345200|FG000|Overall Study|Withdrawal by Subject|3|||
160717537|NCT00625820|580345203|FG000|Overall Study|Withdrawal by Subject|1|||
160717538|NCT04023396|580346975|FG000|Overall Study|Adverse Event|16|||
160717539|NCT04023396|580346975|FG000|Overall Study|Death|1|||
160717540|NCT04023396|580346975|FG000|Overall Study|Lost to Follow-up|1|||
160717541|NCT04023396|580346975|FG000|Overall Study|Withdrawal by Subject|14|||
160717542|NCT04023396|580346975|FG000|Overall Study|Pregnancy|4|||
160717543|NCT04023396|580346975|FG000|Overall Study|Lack of Efficacy|3|||
160717544|NCT04023396|580346975|FG000|Overall Study|Physician Decision|4|||
160717545|NCT04023396|580346975|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
160717546|NCT04075825|580346976|FG000|Overall Study|Withdrawal by Subject|6|||
160717547|NCT04075825|580346977|FG001|Overall Study|Withdrawal by Subject|8|||
160717548|NCT04075825|580346976|FG000|Overall Study|Physician Decision|3|||
160717549|NCT04075825|580346977|FG001|Overall Study|Physician Decision|1|||
160717550|NCT04075825|580346976|FG000|Overall Study|Lost to Follow-up|5|||
160717551|NCT04075825|580346977|FG001|Overall Study|Lost to Follow-up|1|||
160717552|NCT04075825|580346976|FG000|Overall Study|Participation in New Clinical Trial|1|||
160717553|NCT04075825|580346977|FG001|Overall Study|Participation in New Clinical Trial|1|||
160717554|NCT04075825|580346976|FG000|Overall Study|Reason Not Specified|2|||
160717555|NCT04075825|580346977|FG001|Overall Study|Reason Not Specified|2|||
160717556|NCT02513160|580346978|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
160717557|NCT02513160|580346979|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
160717558|NCT02513160|580346980|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
160717559|NCT02513160|580346981|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
160717560|NCT02513160|580346978|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
160717561|NCT02513160|580346979|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
160717562|NCT02513160|580346980|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
160717563|NCT02513160|580346981|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
160717564|NCT02513160|580346978|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
160717565|NCT02513160|580346979|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
160717566|NCT02513160|580346980|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
160717567|NCT02513160|580346981|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
160717568|NCT02513160|580346978|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
160717569|NCT02513160|580346979|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
160717570|NCT02513160|580346980|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
160717571|NCT02513160|580346981|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
160717572|NCT02513160|580346978|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
160717573|NCT02513160|580346979|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
160717574|NCT02513160|580346980|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
160717575|NCT02513160|580346981|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
160717576|NCT02513160|580346978|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
160717577|NCT02513160|580346979|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
160717578|NCT02513160|580346980|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
160717579|NCT02513160|580346981|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
160717580|NCT02513160|580346978|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
160717581|NCT02513160|580346979|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
160717582|NCT02513160|580346980|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
160717583|NCT02513160|580346981|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
160717584|NCT02513160|580346978|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
160717585|NCT02513160|580346979|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
160717586|NCT02513160|580346980|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
160717587|NCT02513160|580346981|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
160717588|NCT02513160|580346978|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
160717589|NCT02513160|580346979|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
160717590|NCT02513160|580346980|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
160717591|NCT02513160|580346981|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
160717592|NCT02513160|580346978|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
160717593|NCT02513160|580346979|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
160717594|NCT02513160|580346980|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
160717595|NCT02513160|580346981|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
160717596|NCT02513160|580346978|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
160717597|NCT02513160|580346979|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
160717598|NCT02513160|580346980|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
160717599|NCT02513160|580346981|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
160717600|NCT02513160|580346978|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
160717601|NCT02513160|580346979|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
160717602|NCT02513160|580346980|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
160717603|NCT02513160|580346981|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
160717604|NCT01168232|580346982|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
160717605|NCT01168232|580346982|FG000|Overall Study|Ineligible- Wrong cell type|6|||
160717606|NCT01168232|580346982|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
160717607|NCT03879135|580346993|FG000|Overall Study|Physician Decision|0|||
160717608|NCT03879135|580346994|FG001|Overall Study|Physician Decision|0|||
160717609|NCT03879135|580346995|FG002|Overall Study|Physician Decision|0|||
160717610|NCT03879135|580346996|FG003|Overall Study|Physician Decision|1|||
160717611|NCT03879135|580346997|FG004|Overall Study|Physician Decision|0|||
160717612|NCT03879135|580346998|FG005|Overall Study|Physician Decision|0|||
160717613|NCT03879135|580346993|FG000|Overall Study|Withdrawal by Subject|0|||
160717614|NCT03879135|580346994|FG001|Overall Study|Withdrawal by Subject|0|||
160717615|NCT03879135|580346995|FG002|Overall Study|Withdrawal by Subject|0|||
160717616|NCT03879135|580346996|FG003|Overall Study|Withdrawal by Subject|0|||
160717617|NCT03879135|580346997|FG004|Overall Study|Withdrawal by Subject|0|||
160717618|NCT03879135|580346998|FG005|Overall Study|Withdrawal by Subject|1|||
160717619|NCT03879135|580346993|FG000|Overall Study|Site Closed by Sponsor|0|||
160717620|NCT03879135|580346994|FG001|Overall Study|Site Closed by Sponsor|0|||
160717621|NCT03879135|580346995|FG002|Overall Study|Site Closed by Sponsor|0|||
160717622|NCT03879135|580346996|FG003|Overall Study|Site Closed by Sponsor|1|||
160717623|NCT03879135|580346997|FG004|Overall Study|Site Closed by Sponsor|1|||
160717624|NCT03879135|580346998|FG005|Overall Study|Site Closed by Sponsor|0|||
160717625|NCT03428958|580346999|FG000|Overall Study|Adverse Event|0|||
160717626|NCT03428958|580347000|FG001|Overall Study|Adverse Event|0|||
160717627|NCT03428958|580347001|FG002|Overall Study|Adverse Event|0|||
160717628|NCT03428958|580347002|FG003|Overall Study|Adverse Event|1|||
160717629|NCT03428958|580347003|FG004|Overall Study|Adverse Event|0|||
160717630|NCT03428958|580347004|FG005|Overall Study|Adverse Event|2|||
160717631|NCT03428958|580347005|FG006|Overall Study|Adverse Event|1|||
160717632|NCT03428958|580347006|FG007|Overall Study|Adverse Event|0|||
160717633|NCT03428958|580347007|FG008|Overall Study|Adverse Event|0|||
160717634|NCT03428958|580347008|FG009|Overall Study|Adverse Event|0|||
160717635|NCT03428958|580347009|FG010|Overall Study|Adverse Event|0|||
160717636|NCT03428958|580347010|FG011|Overall Study|Adverse Event|0|||
160717637|NCT03428958|580347011|FG012|Overall Study|Adverse Event|0|||
160717638|NCT03428958|580347012|FG013|Overall Study|Adverse Event|0|||
160717639|NCT03428958|580347013|FG014|Overall Study|Adverse Event|0|||
160717640|NCT03428958|580347014|FG015|Overall Study|Adverse Event|0|||
160717641|NCT03428958|580347015|FG016|Overall Study|Adverse Event|0|||
160717642|NCT03428958|580346999|FG000|Overall Study|Clinical Progression|2|||
160717643|NCT03428958|580347000|FG001|Overall Study|Clinical Progression|3|||
160717644|NCT03428958|580347001|FG002|Overall Study|Clinical Progression|2|||
160717645|NCT03428958|580347002|FG003|Overall Study|Clinical Progression|1|||
160717646|NCT03428958|580347003|FG004|Overall Study|Clinical Progression|0|||
160717647|NCT03428958|580347004|FG005|Overall Study|Clinical Progression|2|||
160717648|NCT03428958|580347005|FG006|Overall Study|Clinical Progression|0|||
160717649|NCT03428958|580347006|FG007|Overall Study|Clinical Progression|0|||
160717650|NCT03428958|580347007|FG008|Overall Study|Clinical Progression|0|||
160717651|NCT03428958|580347008|FG009|Overall Study|Clinical Progression|0|||
160717652|NCT03428958|580347009|FG010|Overall Study|Clinical Progression|0|||
160717653|NCT03428958|580347010|FG011|Overall Study|Clinical Progression|0|||
160717654|NCT03428958|580347011|FG012|Overall Study|Clinical Progression|0|||
160717655|NCT03428958|580347012|FG013|Overall Study|Clinical Progression|0|||
160717656|NCT03428958|580347013|FG014|Overall Study|Clinical Progression|0|||
160717657|NCT03428958|580347014|FG015|Overall Study|Clinical Progression|0|||
160717658|NCT03428958|580347015|FG016|Overall Study|Clinical Progression|0|||
160717659|NCT03428958|580346999|FG000|Overall Study|Progression per RECIST|6|||
160717660|NCT03428958|580347000|FG001|Overall Study|Progression per RECIST|6|||
160717661|NCT03428958|580347001|FG002|Overall Study|Progression per RECIST|7|||
160717662|NCT03428958|580347002|FG003|Overall Study|Progression per RECIST|4|||
160717663|NCT03428958|580347003|FG004|Overall Study|Progression per RECIST|0|||
160717664|NCT03428958|580347004|FG005|Overall Study|Progression per RECIST|7|||
160717665|NCT03428958|580347005|FG006|Overall Study|Progression per RECIST|8|||
160717666|NCT03428958|580347006|FG007|Overall Study|Progression per RECIST|0|||
160717667|NCT03428958|580347007|FG008|Overall Study|Progression per RECIST|0|||
160717668|NCT03428958|580347008|FG009|Overall Study|Progression per RECIST|0|||
160717669|NCT03428958|580347009|FG010|Overall Study|Progression per RECIST|0|||
160717670|NCT03428958|580347010|FG011|Overall Study|Progression per RECIST|0|||
160717671|NCT03428958|580347011|FG012|Overall Study|Progression per RECIST|1|||
160717672|NCT03428958|580347012|FG013|Overall Study|Progression per RECIST|0|||
160717673|NCT03428958|580347013|FG014|Overall Study|Progression per RECIST|0|||
160717674|NCT03428958|580347014|FG015|Overall Study|Progression per RECIST|0|||
160717675|NCT03428958|580347015|FG016|Overall Study|Progression per RECIST|0|||
160717676|NCT03428958|580346999|FG000|Overall Study|Death|2|||
160717677|NCT03428958|580347000|FG001|Overall Study|Death|2|||
160717678|NCT03428958|580347001|FG002|Overall Study|Death|0|||
160717679|NCT03428958|580347002|FG003|Overall Study|Death|0|||
160717680|NCT03428958|580347003|FG004|Overall Study|Death|0|||
160717681|NCT03428958|580347004|FG005|Overall Study|Death|7|||
160717682|NCT03428958|580347005|FG006|Overall Study|Death|9|||
160717683|NCT03428958|580347006|FG007|Overall Study|Death|6|||
160717684|NCT03428958|580347007|FG008|Overall Study|Death|0|||
160717685|NCT03428958|580347008|FG009|Overall Study|Death|0|||
160717686|NCT03428958|580347009|FG010|Overall Study|Death|3|||
160717687|NCT03428958|580347010|FG011|Overall Study|Death|0|||
160717688|NCT03428958|580347011|FG012|Overall Study|Death|4|||
160717689|NCT03428958|580347012|FG013|Overall Study|Death|0|||
160717690|NCT03428958|580347013|FG014|Overall Study|Death|0|||
160717691|NCT03428958|580347014|FG015|Overall Study|Death|0|||
160717692|NCT03428958|580347015|FG016|Overall Study|Death|0|||
160717693|NCT03428958|580346999|FG000|Overall Study|Lost to Follow-up|0|||
160717694|NCT03428958|580347000|FG001|Overall Study|Lost to Follow-up|0|||
160717695|NCT03428958|580347001|FG002|Overall Study|Lost to Follow-up|0|||
160717696|NCT03428958|580347002|FG003|Overall Study|Lost to Follow-up|0|||
160717697|NCT03428958|580347003|FG004|Overall Study|Lost to Follow-up|0|||
160717698|NCT03428958|580347004|FG005|Overall Study|Lost to Follow-up|1|||
160717699|NCT03428958|580347005|FG006|Overall Study|Lost to Follow-up|1|||
160717700|NCT03428958|580347006|FG007|Overall Study|Lost to Follow-up|0|||
160717701|NCT03428958|580347007|FG008|Overall Study|Lost to Follow-up|0|||
160717702|NCT03428958|580347008|FG009|Overall Study|Lost to Follow-up|0|||
160717703|NCT03428958|580347009|FG010|Overall Study|Lost to Follow-up|0|||
160717704|NCT03428958|580347010|FG011|Overall Study|Lost to Follow-up|0|||
160717705|NCT03428958|580347011|FG012|Overall Study|Lost to Follow-up|0|||
160717706|NCT03428958|580347012|FG013|Overall Study|Lost to Follow-up|0|||
160717707|NCT03428958|580347013|FG014|Overall Study|Lost to Follow-up|0|||
160717708|NCT03428958|580347014|FG015|Overall Study|Lost to Follow-up|0|||
160717709|NCT03428958|580347015|FG016|Overall Study|Lost to Follow-up|0|||
160717710|NCT03428958|580346999|FG000|Overall Study|Physician/Sponsor Decision|1|||
160717711|NCT03428958|580347000|FG001|Overall Study|Physician/Sponsor Decision|0|||
160717712|NCT03428958|580347001|FG002|Overall Study|Physician/Sponsor Decision|1|||
160717713|NCT03428958|580347002|FG003|Overall Study|Physician/Sponsor Decision|0|||
160717714|NCT03428958|580347003|FG004|Overall Study|Physician/Sponsor Decision|0|||
160717715|NCT03428958|580347004|FG005|Overall Study|Physician/Sponsor Decision|2|||
160717716|NCT03428958|580347005|FG006|Overall Study|Physician/Sponsor Decision|2|||
160717717|NCT03428958|580347006|FG007|Overall Study|Physician/Sponsor Decision|2|||
160717718|NCT03428958|580347007|FG008|Overall Study|Physician/Sponsor Decision|0|||
160717719|NCT03428958|580347008|FG009|Overall Study|Physician/Sponsor Decision|0|||
160717720|NCT03428958|580347009|FG010|Overall Study|Physician/Sponsor Decision|2|||
160717721|NCT03428958|580347010|FG011|Overall Study|Physician/Sponsor Decision|0|||
160717722|NCT03428958|580347011|FG012|Overall Study|Physician/Sponsor Decision|4|||
160717723|NCT03428958|580347012|FG013|Overall Study|Physician/Sponsor Decision|0|||
160717724|NCT03428958|580347013|FG014|Overall Study|Physician/Sponsor Decision|0|||
160717725|NCT03428958|580347014|FG015|Overall Study|Physician/Sponsor Decision|0|||
160717726|NCT03428958|580347015|FG016|Overall Study|Physician/Sponsor Decision|0|||
160717727|NCT03428958|580346999|FG000|Overall Study|Withdrawal by Subject|0|||
160717728|NCT03428958|580347000|FG001|Overall Study|Withdrawal by Subject|0|||
160717729|NCT03428958|580347001|FG002|Overall Study|Withdrawal by Subject|2|||
160717730|NCT03428958|580347002|FG003|Overall Study|Withdrawal by Subject|0|||
160717731|NCT03428958|580347003|FG004|Overall Study|Withdrawal by Subject|0|||
160717732|NCT03428958|580347004|FG005|Overall Study|Withdrawal by Subject|2|||
160717733|NCT03428958|580347005|FG006|Overall Study|Withdrawal by Subject|4|||
160717734|NCT03428958|580347006|FG007|Overall Study|Withdrawal by Subject|1|||
160717735|NCT03428958|580347007|FG008|Overall Study|Withdrawal by Subject|0|||
160717736|NCT03428958|580347008|FG009|Overall Study|Withdrawal by Subject|0|||
160717737|NCT03428958|580347009|FG010|Overall Study|Withdrawal by Subject|0|||
160717738|NCT03428958|580347010|FG011|Overall Study|Withdrawal by Subject|0|||
160717739|NCT03428958|580347011|FG012|Overall Study|Withdrawal by Subject|0|||
160717740|NCT03428958|580347012|FG013|Overall Study|Withdrawal by Subject|0|||
160717741|NCT03428958|580347013|FG014|Overall Study|Withdrawal by Subject|0|||
160717742|NCT03428958|580347014|FG015|Overall Study|Withdrawal by Subject|0|||
160717743|NCT03428958|580347015|FG016|Overall Study|Withdrawal by Subject|0|||
160717744|NCT05012098|580347016|FG000|Overall Study|Disease progression|5|||
160717745|NCT05012098|580347017|FG001|Overall Study|Disease progression|2|||
160717746|NCT05012098|580347016|FG000|Overall Study|Adverse Event|1|||
160717747|NCT05012098|580347017|FG001|Overall Study|Adverse Event|0|||
160717748|NCT05012098|580347016|FG000|Overall Study|Withdrawal by Subject|1|||
160717749|NCT05012098|580347017|FG001|Overall Study|Withdrawal by Subject|0|||
160717750|NCT05012098|580347016|FG000|Overall Study|Discontinuation per protocol|1|||
160717751|NCT05012098|580347017|FG001|Overall Study|Discontinuation per protocol|0|||
160717752|NCT04565145|580347019|FG000|Overall Study|Withdrawal by Subject|1|||
160717753|NCT04565145|580347020|FG001|Overall Study|Withdrawal by Subject|1|||
160717754|NCT00742209|580347025|FG000|Overall Study|Adverse Event|11|||
160717755|NCT00742209|580347026|FG001|Overall Study|Adverse Event|4|||
160717756|NCT00742209|580347027|FG002|Overall Study|Adverse Event|17|||
160717757|NCT00742209|580347028|FG003|Overall Study|Adverse Event|16|||
160717758|NCT00742209|580347029|FG004|Overall Study|Adverse Event|13|||
160717759|NCT00742209|580347025|FG000|Overall Study|Participant Withdrew Consent|8|||
160717760|NCT00742209|580347026|FG001|Overall Study|Participant Withdrew Consent|4|||
160717761|NCT00742209|580347027|FG002|Overall Study|Participant Withdrew Consent|14|||
160717762|NCT00742209|580347028|FG003|Overall Study|Participant Withdrew Consent|7|||
160717763|NCT00742209|580347029|FG004|Overall Study|Participant Withdrew Consent|4|||
160717764|NCT00742209|580347025|FG000|Overall Study|Protocol Violation|6|||
160717765|NCT00742209|580347026|FG001|Overall Study|Protocol Violation|5|||
160717766|NCT00742209|580347027|FG002|Overall Study|Protocol Violation|4|||
160717767|NCT00742209|580347028|FG003|Overall Study|Protocol Violation|5|||
160717768|NCT00742209|580347029|FG004|Overall Study|Protocol Violation|3|||
160717769|NCT00742209|580347025|FG000|Overall Study|Lost to Follow-up|3|||
160717770|NCT00742209|580347026|FG001|Overall Study|Lost to Follow-up|4|||
160717771|NCT00742209|580347027|FG002|Overall Study|Lost to Follow-up|5|||
160717772|NCT00742209|580347028|FG003|Overall Study|Lost to Follow-up|5|||
160717773|NCT00742209|580347029|FG004|Overall Study|Lost to Follow-up|3|||
160717774|NCT00742209|580347025|FG000|Overall Study|Lack of Efficacy|6|||
160717775|NCT00742209|580347026|FG001|Overall Study|Lack of Efficacy|1|||
160717776|NCT00742209|580347027|FG002|Overall Study|Lack of Efficacy|1|||
160717777|NCT00742209|580347028|FG003|Overall Study|Lack of Efficacy|3|||
160717778|NCT00742209|580347029|FG004|Overall Study|Lack of Efficacy|1|||
160717779|NCT00742209|580347025|FG000|Overall Study|Investigator Discretion|0|||
160717780|NCT00742209|580347026|FG001|Overall Study|Investigator Discretion|0|||
160717781|NCT00742209|580347027|FG002|Overall Study|Investigator Discretion|5|||
160717782|NCT00742209|580347028|FG003|Overall Study|Investigator Discretion|1|||
160717783|NCT00742209|580347029|FG004|Overall Study|Investigator Discretion|1|||
160717784|NCT02003209|580347030|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
160717785|NCT02003209|580347031|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
160717786|NCT00485264|580347032|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
160717787|NCT00485264|580347033|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
160717788|NCT00485264|580347034|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
160717789|NCT00485264|580347035|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
160717790|NCT00485264|580347036|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
160717791|NCT00485264|580347037|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
160717792|NCT00485264|580347032|FG000|Overall Study|Death|1|||
160717793|NCT00485264|580347033|FG001|Overall Study|Death|0|||
160717794|NCT00485264|580347034|FG002|Overall Study|Death|0|||
160717795|NCT00485264|580347035|FG003|Overall Study|Death|0|||
160717796|NCT00485264|580347036|FG004|Overall Study|Death|1|||
160717797|NCT00485264|580347037|FG005|Overall Study|Death|0|||
160717798|NCT00485264|580347032|FG000|Overall Study|Adverse Event|1|||
160717799|NCT00485264|580347033|FG001|Overall Study|Adverse Event|0|||
160717800|NCT00485264|580347034|FG002|Overall Study|Adverse Event|2|||
160717801|NCT00485264|580347035|FG003|Overall Study|Adverse Event|3|||
160717802|NCT00485264|580347036|FG004|Overall Study|Adverse Event|1|||
160717803|NCT00485264|580347037|FG005|Overall Study|Adverse Event|3|||
160717804|NCT00485264|580347032|FG000|Overall Study|Pregnancy|4|||
160717805|NCT00485264|580347033|FG001|Overall Study|Pregnancy|0|||
160717806|NCT00485264|580347034|FG002|Overall Study|Pregnancy|0|||
160717807|NCT00485264|580347035|FG003|Overall Study|Pregnancy|0|||
160717808|NCT00485264|580347036|FG004|Overall Study|Pregnancy|0|||
160717809|NCT00485264|580347037|FG005|Overall Study|Pregnancy|0|||
160717810|NCT00485264|580347032|FG000|Overall Study|Disallowed Medication|0|||
160717811|NCT00485264|580347033|FG001|Overall Study|Disallowed Medication|0|||
160717812|NCT00485264|580347034|FG002|Overall Study|Disallowed Medication|0|||
160717813|NCT00485264|580347035|FG003|Overall Study|Disallowed Medication|0|||
160717814|NCT00485264|580347036|FG004|Overall Study|Disallowed Medication|0|||
160717815|NCT00485264|580347037|FG005|Overall Study|Disallowed Medication|1|||
160717816|NCT00485264|580347032|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
160717817|NCT00485264|580347033|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
160717818|NCT00485264|580347034|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
160717819|NCT00485264|580347035|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
160717820|NCT00485264|580347036|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
160717821|NCT00485264|580347037|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
160717822|NCT00485264|580347032|FG000|Overall Study|Lack of Efficacy|0|||
160717823|NCT00485264|580347033|FG001|Overall Study|Lack of Efficacy|1|||
160717824|NCT00485264|580347034|FG002|Overall Study|Lack of Efficacy|0|||
160717825|NCT00485264|580347035|FG003|Overall Study|Lack of Efficacy|0|||
160717826|NCT00485264|580347036|FG004|Overall Study|Lack of Efficacy|0|||
160717827|NCT00485264|580347037|FG005|Overall Study|Lack of Efficacy|0|||
160717828|NCT00485264|580347032|FG000|Overall Study|Guardian Consent Withdrawn|1|||
160717829|NCT00485264|580347033|FG001|Overall Study|Guardian Consent Withdrawn|0|||
160717830|NCT00485264|580347034|FG002|Overall Study|Guardian Consent Withdrawn|0|||
160717831|NCT00485264|580347035|FG003|Overall Study|Guardian Consent Withdrawn|0|||
160717832|NCT00485264|580347036|FG004|Overall Study|Guardian Consent Withdrawn|1|||
160717833|NCT00485264|580347037|FG005|Overall Study|Guardian Consent Withdrawn|0|||
160717834|NCT00485264|580347032|FG000|Overall Study|Physician Decision|0|||
160717835|NCT00485264|580347033|FG001|Overall Study|Physician Decision|2|||
160717836|NCT00485264|580347034|FG002|Overall Study|Physician Decision|0|||
160717837|NCT00485264|580347035|FG003|Overall Study|Physician Decision|0|||
160717838|NCT00485264|580347036|FG004|Overall Study|Physician Decision|0|||
160717839|NCT00485264|580347037|FG005|Overall Study|Physician Decision|0|||
160717840|NCT00485264|580347032|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
160717841|NCT00485264|580347033|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
160717842|NCT00485264|580347034|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
160717843|NCT00485264|580347035|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
160717844|NCT00485264|580347036|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
160717845|NCT00485264|580347037|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
160717846|NCT00485264|580347032|FG000|Overall Study|Not Able to Attend Clinic|5|||
160717847|NCT00485264|580347033|FG001|Overall Study|Not Able to Attend Clinic|0|||
160717848|NCT00485264|580347034|FG002|Overall Study|Not Able to Attend Clinic|0|||
160717849|NCT00485264|580347035|FG003|Overall Study|Not Able to Attend Clinic|1|||
160717850|NCT00485264|580347036|FG004|Overall Study|Not Able to Attend Clinic|1|||
160717851|NCT00485264|580347037|FG005|Overall Study|Not Able to Attend Clinic|2|||
160717852|NCT00485264|580347032|FG000|Overall Study|Non-Compliant|17|||
160717853|NCT00485264|580347033|FG001|Overall Study|Non-Compliant|2|||
160717854|NCT00485264|580347034|FG002|Overall Study|Non-Compliant|1|||
160717855|NCT00485264|580347035|FG003|Overall Study|Non-Compliant|0|||
160717856|NCT00485264|580347036|FG004|Overall Study|Non-Compliant|1|||
160717857|NCT00485264|580347037|FG005|Overall Study|Non-Compliant|0|||
160717858|NCT00485264|580347032|FG000|Overall Study|Lost to Follow-up|2|||
160717859|NCT00485264|580347033|FG001|Overall Study|Lost to Follow-up|1|||
160717860|NCT00485264|580347034|FG002|Overall Study|Lost to Follow-up|1|||
160717861|NCT00485264|580347035|FG003|Overall Study|Lost to Follow-up|0|||
160717862|NCT00485264|580347036|FG004|Overall Study|Lost to Follow-up|0|||
160717863|NCT00485264|580347037|FG005|Overall Study|Lost to Follow-up|1|||
160717864|NCT00485264|580347032|FG000|Overall Study|Other Reason|3|||
160717865|NCT00485264|580347033|FG001|Overall Study|Other Reason|0|||
160717866|NCT00485264|580347034|FG002|Overall Study|Other Reason|0|||
160717867|NCT00485264|580347035|FG003|Overall Study|Other Reason|0|||
160717868|NCT00485264|580347036|FG004|Overall Study|Other Reason|0|||
160717869|NCT00485264|580347037|FG005|Overall Study|Other Reason|0|||
160717870|NCT02548832|580347038|FG000|Overall Study|Lost to Follow-up|2|||
160717871|NCT02548832|580347039|FG001|Overall Study|Lost to Follow-up|2|||
160717872|NCT02548832|580347040|FG002|Overall Study|Lost to Follow-up|2|||
160717873|NCT01062425|580347044|FG000|Overall Study|Protocol Violation|3|||
160717874|NCT01062425|580347045|FG001|Overall Study|Protocol Violation|6|||
160717875|NCT02088177|580347048|FG000|Overall Study|Lost to Follow-up|3|||
160717876|NCT01234350|580347049|FG000|Overall Study|Adverse Event|277|||
160717877|NCT01234350|580347050|FG001|Overall Study|Adverse Event|92|||
160717878|NCT01234350|580347049|FG000|Overall Study|Withdrawal by Subject|61|||
160717879|NCT01234350|580347050|FG001|Overall Study|Withdrawal by Subject|36|||
160717880|NCT01234350|580347049|FG000|Overall Study|Lost to Follow-up|115|||
160717881|NCT01234350|580347050|FG001|Overall Study|Lost to Follow-up|47|||
160717882|NCT01234350|580347049|FG000|Overall Study|Covers a diverse set of reasons|234|||
160717883|NCT01234350|580347050|FG001|Overall Study|Covers a diverse set of reasons|92|||
160717884|NCT00289848|580347051|FG000|Overall Study|Adverse Event|6|||
160717885|NCT00289848|580347052|FG001|Overall Study|Adverse Event|4|||
160717886|NCT00289848|580347051|FG000|Overall Study|Death|1|||
160717887|NCT00289848|580347052|FG001|Overall Study|Death|0|||
160717888|NCT00289848|580347051|FG000|Overall Study|Lack of Efficacy|20|||
160717889|NCT00289848|580347052|FG001|Overall Study|Lack of Efficacy|24|||
160717890|NCT00289848|580347051|FG000|Overall Study|Lost to Follow-up|3|||
160717891|NCT00289848|580347052|FG001|Overall Study|Lost to Follow-up|1|||
160717892|NCT00289848|580347051|FG000|Overall Study|Protocol Violation|5|||
160717893|NCT00289848|580347052|FG001|Overall Study|Protocol Violation|2|||
160717894|NCT00289848|580347051|FG000|Overall Study|Withdrawal by Subject|5|||
160717895|NCT00289848|580347052|FG001|Overall Study|Withdrawal by Subject|11|||
160717896|NCT00289848|580347051|FG000|Overall Study|Patient Moved|6|||
160717897|NCT00289848|580347052|FG001|Overall Study|Patient Moved|2|||
160717898|NCT00289848|580347051|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
160717899|NCT00289848|580347052|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
160717900|NCT01433471|580347055|FG000|Overall Study|Withdrawal by Subject|0|||
160717901|NCT01433471|580347056|FG001|Overall Study|Withdrawal by Subject|1|||
160717902|NCT03428152|580347061|FG000|Overall Study|Physician Decision|4|||
160717903|NCT03428152|580347062|FG001|Overall Study|Physician Decision|2|||
160717904|NCT03428152|580347061|FG000|Overall Study|Protocol Violation|3|||
160717905|NCT03428152|580347062|FG001|Overall Study|Protocol Violation|5|||
160717906|NCT03428152|580347061|FG000|Overall Study|Lack of Efficacy|0|||
160717907|NCT03428152|580347062|FG001|Overall Study|Lack of Efficacy|4|||
160717908|NCT00395629|580347063|FG000|Core Study|Adverse Event|0|||
160717909|NCT00395629|580347064|FG001|Core Study|Adverse Event|3|||
160717910|NCT00395629|580347065|FG002|Core Study|Adverse Event|4|||
160717911|NCT00395629|580347063|FG000|Core Study|Abnormal laboratory value(s)|0|||
160717912|NCT00395629|580347064|FG001|Core Study|Abnormal laboratory value(s)|0|||
160717913|NCT00395629|580347065|FG002|Core Study|Abnormal laboratory value(s)|1|||
160717914|NCT00395629|580347063|FG000|Core Study|Protocol Violation|1|||
160717915|NCT00395629|580347064|FG001|Core Study|Protocol Violation|0|||
160717916|NCT00395629|580347065|FG002|Core Study|Protocol Violation|0|||
160717917|NCT00395629|580347063|FG000|Core Study|Withdrawal by Subject|0|||
160717918|NCT00395629|580347064|FG001|Core Study|Withdrawal by Subject|1|||
160717919|NCT00395629|580347065|FG002|Core Study|Withdrawal by Subject|1|||
160717920|NCT00395629|580347063|FG000|Core Study|Lost to Follow-up|0|||
160717921|NCT00395629|580347064|FG001|Core Study|Lost to Follow-up|0|||
160717922|NCT00395629|580347065|FG002|Core Study|Lost to Follow-up|1|||
160717923|NCT00395629|580347063|FG000|Extension Study|Adverse Event|0|||
160717924|NCT00395629|580347064|FG001|Extension Study|Adverse Event|0|||
160717925|NCT00395629|580347065|FG002|Extension Study|Adverse Event|2|||
160717926|NCT00395629|580347063|FG000|Extension Study|Administrative problems|0|||
160717927|NCT00395629|580347064|FG001|Extension Study|Administrative problems|0|||
160717928|NCT00395629|580347065|FG002|Extension Study|Administrative problems|1|||
160717929|NCT01686373|580347066|FG000|Overall Study|Lost to Follow-up|3|||
160717930|NCT01686373|580347067|FG001|Overall Study|Lost to Follow-up|0|||
160717931|NCT01686373|580347066|FG000|Overall Study|Withdrawal by Subject|0|||
160717932|NCT01686373|580347067|FG001|Overall Study|Withdrawal by Subject|1|||
160717933|NCT01686373|580347066|FG000|Overall Study|Adverse Event|0|||
160717934|NCT01686373|580347067|FG001|Overall Study|Adverse Event|1|||
160717935|NCT01836471|580347074|FG000|Overall Study|Pregnancy|1|||
160717936|NCT01836471|580347075|FG001|Overall Study|Pregnancy|0|||
160717937|NCT01836471|580347076|FG002|Overall Study|Pregnancy|0|||
160717938|NCT01836471|580347077|FG003|Overall Study|Pregnancy|0|||
160717939|NCT01836471|580347078|FG004|Overall Study|Pregnancy|0|||
160717940|NCT01836471|580347074|FG000|Overall Study|Withdrawal by Subject|3|||
160717941|NCT01836471|580347075|FG001|Overall Study|Withdrawal by Subject|4|||
160717942|NCT01836471|580347076|FG002|Overall Study|Withdrawal by Subject|1|||
160717943|NCT01836471|580347077|FG003|Overall Study|Withdrawal by Subject|0|||
160717944|NCT01836471|580347078|FG004|Overall Study|Withdrawal by Subject|2|||
160717945|NCT01836471|580347074|FG000|Overall Study|Physician Decision|0|||
160717946|NCT01836471|580347075|FG001|Overall Study|Physician Decision|1|||
160717947|NCT01836471|580347076|FG002|Overall Study|Physician Decision|0|||
160717948|NCT01836471|580347077|FG003|Overall Study|Physician Decision|0|||
160717949|NCT01836471|580347078|FG004|Overall Study|Physician Decision|0|||
160717950|NCT01836471|580347074|FG000|Overall Study|Lost to Follow-up|0|||
160717951|NCT01836471|580347075|FG001|Overall Study|Lost to Follow-up|0|||
160717952|NCT01836471|580347076|FG002|Overall Study|Lost to Follow-up|0|||
160717953|NCT01836471|580347077|FG003|Overall Study|Lost to Follow-up|1|||
160717954|NCT01836471|580347078|FG004|Overall Study|Lost to Follow-up|1|||
160717955|NCT01836471|580347074|FG000|Overall Study|Adverse Event|6|||
160717956|NCT01836471|580347075|FG001|Overall Study|Adverse Event|3|||
160717957|NCT01836471|580347076|FG002|Overall Study|Adverse Event|1|||
160717958|NCT01836471|580347077|FG003|Overall Study|Adverse Event|1|||
160717959|NCT01836471|580347078|FG004|Overall Study|Adverse Event|2|||
160717960|NCT01836471|580347074|FG000|Overall Study|Non compliance with tx|1|||
160717961|NCT01836471|580347075|FG001|Overall Study|Non compliance with tx|1|||
160717962|NCT01836471|580347076|FG002|Overall Study|Non compliance with tx|0|||
160717963|NCT01836471|580347077|FG003|Overall Study|Non compliance with tx|0|||
160717964|NCT01836471|580347078|FG004|Overall Study|Non compliance with tx|0|||
160717965|NCT01960413|580347082|FG000|Overall Study|Withdrawal by Subject|1|||
160717966|NCT01960413|580347083|FG001|Overall Study|Withdrawal by Subject|1|||
160717967|NCT01960413|580347082|FG000|Overall Study|Physician Decision|1|||
160717968|NCT01960413|580347083|FG001|Overall Study|Physician Decision|0|||
160717969|NCT01960413|580347082|FG000|Overall Study|Lost to Follow-up|2|||
160717970|NCT01960413|580347083|FG001|Overall Study|Lost to Follow-up|0|||
160717971|NCT02285361|580347084|FG000|Overall Study|Protocol Violation|43|||
160717972|NCT02285361|580347084|FG000|Overall Study|Lost to Follow-up|5|||
160717973|NCT02285361|580347084|FG000|Overall Study|Not taken GIOTRIF|2|||
160717974|NCT02285361|580347084|FG000|Overall Study|Consented prior to the contract date|1|||
160717975|NCT02059135|580347085|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
160717976|NCT02059135|580347086|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
160717977|NCT02059135|580347085|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
160717978|NCT02059135|580347086|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
160717979|NCT02059135|580347085|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
160717980|NCT02059135|580347086|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
160717981|NCT02059135|580347085|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
160717982|NCT02059135|580347086|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
160717983|NCT02059135|580347085|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
160717984|NCT02059135|580347086|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
160717985|NCT02059135|580347085|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
160717986|NCT02059135|580347086|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
160717987|NCT02059135|580347085|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
160717988|NCT02059135|580347086|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
160717989|NCT02059135|580347085|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
160717990|NCT02059135|580347086|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
160717991|NCT00191477|580347087|FG000|Overall Study|Tumor Recurrence|49|||
160717992|NCT00191477|580347088|FG001|Overall Study|Tumor Recurrence|48|||
160717993|NCT00191477|580347087|FG000|Overall Study|Death, Study Disease|1|||
160717994|NCT00191477|580347088|FG001|Overall Study|Death, Study Disease|1|||
160717995|NCT00191477|580347087|FG000|Overall Study|Death, Other Cause|3|||
160717996|NCT00191477|580347088|FG001|Overall Study|Death, Other Cause|6|||
160717997|NCT00191477|580347087|FG000|Overall Study|Lost to Follow-up|23|||
160717998|NCT00191477|580347088|FG001|Overall Study|Lost to Follow-up|21|||
160717999|NCT00191477|580347087|FG000|Overall Study|Protocol Violation|1|||
160718000|NCT00191477|580347088|FG001|Overall Study|Protocol Violation|1|||
160718001|NCT00191477|580347087|FG000|Overall Study|Treatment Change|2|||
160718002|NCT00191477|580347088|FG001|Overall Study|Treatment Change|0|||
160718003|NCT00191477|580347087|FG000|Overall Study|Withdrawal by Subject|2|||
160718004|NCT00191477|580347088|FG001|Overall Study|Withdrawal by Subject|0|||
160718005|NCT00191477|580347087|FG000|Overall Study|Other|2|||
160718006|NCT00191477|580347088|FG001|Overall Study|Other|0|||
160718007|NCT00191477|580347087|FG000|Overall Study|Not Eligible|41|||
160718008|NCT00191477|580347088|FG001|Overall Study|Not Eligible|38|||
160718009|NCT00191477|580347087|FG000|Overall Study|Pathological Specimen Lost|1|||
160718010|NCT00191477|580347088|FG001|Overall Study|Pathological Specimen Lost|0|||
160718011|NCT00191477|580347087|FG000|Overall Study|Discontinued Prior to Instillation|13|||
160718012|NCT00191477|580347088|FG001|Overall Study|Discontinued Prior to Instillation|14|||
160718013|NCT02411656|580347089|FG000|Overall Study|Adverse Event|4|||
160718014|NCT02411656|580347089|FG000|Overall Study|Clinical Progression|33|||
160718015|NCT06481709|580347090|FG000|Overall Study|Withdrawal by Subject|0|||
160718016|NCT06481709|580347091|FG001|Overall Study|Withdrawal by Subject|0|||
160718017|NCT06481709|580347092|FG002|Overall Study|Withdrawal by Subject|2|||
160718018|NCT06481709|580347093|FG003|Overall Study|Withdrawal by Subject|0|||
160718019|NCT05366010|580347095|FG000|Overall Study|Withdrawal by Subject|1|||
160718020|NCT05366010|580347095|FG000|Overall Study|Protocol Violation|1|||
160718021|NCT05366010|580347095|FG000|Overall Study|Lost to Follow-up|2|||
160718022|NCT05366010|580347095|FG000|Overall Study|Screen Failure|2|||
160718023|NCT02224157|580347096|FG000|Overall Study|Severe non-compliance to protocol|2|||
160718024|NCT02224157|580347097|FG001|Overall Study|Severe non-compliance to protocol|2|||
160718025|NCT02224157|580347096|FG000|Overall Study|Other|13|||
160718026|NCT02224157|580347097|FG001|Overall Study|Other|10|||
160718027|NCT02224157|580347096|FG000|Overall Study|Subject decision|58|||
160718028|NCT02224157|580347097|FG001|Overall Study|Subject decision|50|||
160718029|NCT02224157|580347096|FG000|Overall Study|Prematurely closed site|4|||
160718030|NCT02224157|580347097|FG001|Overall Study|Prematurely closed site|2|||
160718031|NCT02224157|580347096|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
160718032|NCT02224157|580347097|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
160718033|NCT02224157|580347096|FG000|Overall Study|Lost to Follow-up|27|||
160718034|NCT02224157|580347097|FG001|Overall Study|Lost to Follow-up|35|||
160718035|NCT02224157|580347096|FG000|Overall Study|Death|1|||
160718036|NCT02224157|580347097|FG001|Overall Study|Death|1|||
160718037|NCT02224157|580347096|FG000|Overall Study|Adverse Event|1|||
160718038|NCT02224157|580347097|FG001|Overall Study|Adverse Event|3|||
160718039|NCT05906628|580347098|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
160718040|NCT05906628|580347099|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
160718041|NCT05906628|580347098|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
160718042|NCT05906628|580347099|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
160718043|NCT05906628|580347098|FG000|16-Week DBVC Period|Protocol Violation|4|||
160718044|NCT05906628|580347099|FG001|16-Week DBVC Period|Protocol Violation|2|||
160718045|NCT05906628|580347098|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
160718046|NCT05906628|580347099|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
160718047|NCT05906628|580347098|FG000|16-Week OLE Period|Death|1|||
160718048|NCT05906628|580347099|FG001|16-Week OLE Period|Death|0|||
160718049|NCT05906628|580347098|FG000|16-Week OLE Period|Lost to Follow-up|1|||
160718050|NCT05906628|580347099|FG001|16-Week OLE Period|Lost to Follow-up|1|||
160718051|NCT05906628|580347098|FG000|16-Week OLE Period|Protocol Violation|0|||
160718052|NCT05906628|580347099|FG001|16-Week OLE Period|Protocol Violation|1|||
160718053|NCT05906628|580347098|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
160718054|NCT05906628|580347099|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
160718055|NCT01108718|580347100|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
160718056|NCT01108718|580347101|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
160718057|NCT01949662|580347104|FG000|Overall Study|Death|9|||
160718058|NCT01949662|580347105|FG001|Overall Study|Death|7|||
160718059|NCT01949662|580347104|FG000|Overall Study|Discharged before an agitation event|8|||
160718060|NCT01949662|580347105|FG001|Overall Study|Discharged before an agitation event|3|||
160718061|NCT01949662|580347104|FG000|Overall Study|Dropped out|1|||
160718062|NCT01949662|580347105|FG001|Overall Study|Dropped out|3|||
160718063|NCT01949662|580347104|FG000|Overall Study|Ineligible|0|||
160718064|NCT01949662|580347105|FG001|Overall Study|Ineligible|1|||
160718065|NCT00281957|580347106|FG000|Overall Study|Adverse Event|7|||
160718066|NCT00281957|580347107|FG001|Overall Study|Adverse Event|2|||
160718067|NCT00281957|580347106|FG000|Overall Study|Death|1|||
160718068|NCT00281957|580347107|FG001|Overall Study|Death|0|||
160718069|NCT00281957|580347106|FG000|Overall Study|Progression/relapse|47|||
160718070|NCT00281957|580347107|FG001|Overall Study|Progression/relapse|35|||
160718071|NCT00281957|580347106|FG000|Overall Study|Not protocol specified|8|||
160718072|NCT00281957|580347107|FG001|Overall Study|Not protocol specified|1|||
160718073|NCT00281957|580347106|FG000|Overall Study|Not eligible|1|||
160718074|NCT00281957|580347107|FG001|Overall Study|Not eligible|2|||
160718075|NCT00281957|580347106|FG000|Overall Study|Did not start treatment|3|||
160718076|NCT00281957|580347107|FG001|Overall Study|Did not start treatment|1|||
160718077|NCT00281957|580347106|FG000|Overall Study|Refusal unrelated to adverse events|0|||
160718078|NCT00281957|580347107|FG001|Overall Study|Refusal unrelated to adverse events|1|||
160718079|NCT02443740|580347115|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
160718080|NCT02443740|580347116|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
160718081|NCT02443740|580347117|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
160718082|NCT02443740|580347118|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
160718083|NCT02443740|580347119|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
160718084|NCT02443740|580347120|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
160718085|NCT02443740|580347121|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
160718086|NCT02443740|580347122|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
160718087|NCT02443740|580347123|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
160718088|NCT02443740|580347124|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
160718089|NCT02443740|580347125|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
160718090|NCT02443740|580347115|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
160718091|NCT02443740|580347116|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
160718092|NCT02443740|580347117|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
160718093|NCT02443740|580347118|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
160718094|NCT02443740|580347119|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
160718095|NCT02443740|580347120|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
160718096|NCT02443740|580347121|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
160718097|NCT02443740|580347122|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
160718098|NCT02443740|580347123|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
160718099|NCT02443740|580347124|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
160718100|NCT02443740|580347125|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
160718101|NCT02443740|580347115|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
160718102|NCT02443740|580347116|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
160718103|NCT02443740|580347117|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
160718104|NCT02443740|580347118|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
160718105|NCT02443740|580347119|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
160718106|NCT02443740|580347120|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
160718107|NCT02443740|580347121|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
160718108|NCT02443740|580347122|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
160718109|NCT02443740|580347123|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
160718110|NCT02443740|580347124|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
160718111|NCT02443740|580347125|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
160718112|NCT05373108|580347126|FG000|Overall Study|Withdrawal by Subject|2|||
160718113|NCT02892331|580347127|FG000|Overall Study|Withdrawal by Subject|0|||
160718114|NCT02892331|580347128|FG001|Overall Study|Withdrawal by Subject|1|||
160718115|NCT02892331|580347129|FG002|Overall Study|Withdrawal by Subject|1|||
160718116|NCT02892331|580347127|FG000|Overall Study|Sick family member|0|||
160718117|NCT02892331|580347128|FG001|Overall Study|Sick family member|0|||
160718118|NCT02892331|580347129|FG002|Overall Study|Sick family member|1|||
160718119|NCT02892331|580347127|FG000|Overall Study|Corona virus pandemic|1|||
160718120|NCT02892331|580347128|FG001|Overall Study|Corona virus pandemic|0|||
160718121|NCT02892331|580347129|FG002|Overall Study|Corona virus pandemic|1|||
160718122|NCT02892331|580347127|FG000|Overall Study|Lost to Follow-up|1|||
160718123|NCT02892331|580347128|FG001|Overall Study|Lost to Follow-up|0|||
160718124|NCT02892331|580347129|FG002|Overall Study|Lost to Follow-up|1|||
160718125|NCT02892331|580347127|FG000|Overall Study|Blood pressure was too elevated|0|||
160718126|NCT02892331|580347128|FG001|Overall Study|Blood pressure was too elevated|1|||
160718127|NCT02892331|580347129|FG002|Overall Study|Blood pressure was too elevated|0|||
160718128|NCT02892331|580347127|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
160718129|NCT02892331|580347128|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
160718130|NCT02892331|580347129|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
160718131|NCT04871776|580347131|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
160718132|NCT04871776|580347132|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
160718133|NCT04871776|580347133|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
160718134|NCT04871776|580347131|FG000|Overall Study|Did not meet eligibility criteria|1|||
160718135|NCT04871776|580347132|FG001|Overall Study|Did not meet eligibility criteria|1|||
160718136|NCT04871776|580347133|FG002|Overall Study|Did not meet eligibility criteria|1|||
160718137|NCT02141438|580349346|FG000|Overall Study|Death|1308|||
160718138|NCT02141438|580349346|FG000|Overall Study|Lost to Follow-up|84|||
160718139|NCT02141438|580349346|FG000|Overall Study|Withdrawal by Subject|52|||
160718140|NCT02141438|580349346|FG000|Overall Study|Physician Decision|1|||
160718141|NCT02141438|580349346|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
160718142|NCT02546986|580349349|FG000|Treatment Period|Progressive Disease|20|||
160718143|NCT02546986|580349350|FG001|Treatment Period|Progressive Disease|22|||
160718144|NCT02546986|580349349|FG000|Treatment Period|Adverse Event|14|||
160718145|NCT02546986|580349350|FG001|Treatment Period|Adverse Event|6|||
160718146|NCT02546986|580349349|FG000|Treatment Period|Symptomatic Deterioration|4|||
160718147|NCT02546986|580349350|FG001|Treatment Period|Symptomatic Deterioration|3|||
160718148|NCT02546986|580349349|FG000|Treatment Period|Death|3|||
160718149|NCT02546986|580349350|FG001|Treatment Period|Death|4|||
160718150|NCT02546986|580349349|FG000|Treatment Period|Physician Decision|1|||
160718151|NCT02546986|580349350|FG001|Treatment Period|Physician Decision|2|||
160718152|NCT02546986|580349349|FG000|Treatment Period|Protocol Violation|1|||
160718153|NCT02546986|580349350|FG001|Treatment Period|Protocol Violation|0|||
160718154|NCT02546986|580349349|FG000|Treatment Period|Withdrawal by Subject|1|||
160718155|NCT02546986|580349350|FG001|Treatment Period|Withdrawal by Subject|1|||
160718156|NCT02546986|580349349|FG000|Treatment Period|Non-compliance with Study Drug|0|||
160718157|NCT02546986|580349350|FG001|Treatment Period|Non-compliance with Study Drug|1|||
160718158|NCT02546986|580349349|FG000|Treatment Period|Study Terminated by Sponsor|0|||
160718159|NCT02546986|580349350|FG001|Treatment Period|Study Terminated by Sponsor|1|||
160718160|NCT02546986|580349349|FG000|Treatment Period|Miscellaneous|7|||
160718161|NCT02546986|580349350|FG001|Treatment Period|Miscellaneous|9|||
160718162|NCT02546986|580349349|FG000|Survival Follow-Up Phase|Missing Status|3|||
160718163|NCT02546986|580349350|FG001|Survival Follow-Up Phase|Missing Status|5|||
160718164|NCT02546986|580349349|FG000|Survival Follow-Up Phase|Death|18|||
160718165|NCT02546986|580349350|FG001|Survival Follow-Up Phase|Death|12|||
160718166|NCT02546986|580349349|FG000|Survival Follow-Up Phase|Alive|13|||
160718167|NCT02546986|580349350|FG001|Survival Follow-Up Phase|Alive|16|||
160718168|NCT02546986|580349349|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
160718169|NCT02546986|580349350|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
160718170|NCT02861586|580349351|FG000|Overall Study|Withdrawal by Subject|1|||
160718171|NCT02861586|580349352|FG001|Overall Study|Withdrawal by Subject|2|||
160718172|NCT02861586|580349353|FG002|Overall Study|Withdrawal by Subject|0|||
160718173|NCT02861586|580349354|FG003|Overall Study|Withdrawal by Subject|0|||
160718174|NCT02861586|580349355|FG004|Overall Study|Withdrawal by Subject|0|||
160718175|NCT02861586|580349356|FG005|Overall Study|Withdrawal by Subject|1|||
160718176|NCT02861586|580349357|FG006|Overall Study|Withdrawal by Subject|1|||
160718177|NCT02861586|580349358|FG007|Overall Study|Withdrawal by Subject|0|||
160718178|NCT02861586|580349351|FG000|Overall Study|Lost to Follow-up|3|||
160718179|NCT02861586|580349352|FG001|Overall Study|Lost to Follow-up|1|||
160718180|NCT02861586|580349353|FG002|Overall Study|Lost to Follow-up|1|||
160718181|NCT02861586|580349354|FG003|Overall Study|Lost to Follow-up|0|||
160718182|NCT02861586|580349355|FG004|Overall Study|Lost to Follow-up|0|||
160718183|NCT02861586|580349356|FG005|Overall Study|Lost to Follow-up|3|||
160718184|NCT02861586|580349357|FG006|Overall Study|Lost to Follow-up|0|||
160718185|NCT02861586|580349358|FG007|Overall Study|Lost to Follow-up|0|||
160718186|NCT02861586|580349351|FG000|Overall Study|Adverse Event|0|||
160718187|NCT02861586|580349352|FG001|Overall Study|Adverse Event|0|||
160718188|NCT02861586|580349353|FG002|Overall Study|Adverse Event|0|||
160718189|NCT02861586|580349354|FG003|Overall Study|Adverse Event|0|||
160718190|NCT02861586|580349355|FG004|Overall Study|Adverse Event|0|||
160718191|NCT02861586|580349356|FG005|Overall Study|Adverse Event|1|||
160718192|NCT02861586|580349357|FG006|Overall Study|Adverse Event|0|||
160718193|NCT02861586|580349358|FG007|Overall Study|Adverse Event|0|||
160718194|NCT00803790|580349359|FG000|Period 1|Adverse Event|0|||
160718195|NCT00803790|580349360|FG001|Period 1|Adverse Event|1|||
160718196|NCT00803790|580349361|FG002|Period 1|Adverse Event|0|||
160718197|NCT00803790|580349362|FG003|Period 1|Adverse Event|0|||
160718198|NCT00803790|580349359|FG000|Period 1|Lost to Follow-up|1|||
160718199|NCT00803790|580349360|FG001|Period 1|Lost to Follow-up|2|||
160718200|NCT00803790|580349361|FG002|Period 1|Lost to Follow-up|0|||
160718201|NCT00803790|580349362|FG003|Period 1|Lost to Follow-up|0|||
160718202|NCT00803790|580349359|FG000|Period 1|Withdrawal by Subject|8|||
160718203|NCT00803790|580349360|FG001|Period 1|Withdrawal by Subject|6|||
160718204|NCT00803790|580349361|FG002|Period 1|Withdrawal by Subject|0|||
160718205|NCT00803790|580349362|FG003|Period 1|Withdrawal by Subject|0|||
160718206|NCT00803790|580349359|FG000|Period 1|positive drug screen or personal reasons|0|||
160718207|NCT00803790|580349360|FG001|Period 1|positive drug screen or personal reasons|3|||
160718208|NCT00803790|580349361|FG002|Period 1|positive drug screen or personal reasons|0|||
160718209|NCT00803790|580349362|FG003|Period 1|positive drug screen or personal reasons|4|||
160718210|NCT00803790|580349359|FG000|Period 1|Protocol Violation|0|||
160718211|NCT00803790|580349360|FG001|Period 1|Protocol Violation|0|||
160718212|NCT00803790|580349361|FG002|Period 1|Protocol Violation|1|||
160718213|NCT00803790|580349362|FG003|Period 1|Protocol Violation|0|||
160718214|NCT00803790|580349359|FG000|Period 2|Adverse Event|0|||
160718215|NCT00803790|580349360|FG001|Period 2|Adverse Event|0|||
160718216|NCT00803790|580349361|FG002|Period 2|Adverse Event|1|||
160718217|NCT00803790|580349362|FG003|Period 2|Adverse Event|1|||
160718218|NCT00803790|580349359|FG000|Period 2|Withdrawal by Subject|1|||
160718219|NCT00803790|580349360|FG001|Period 2|Withdrawal by Subject|0|||
160718220|NCT00803790|580349361|FG002|Period 2|Withdrawal by Subject|0|||
160718221|NCT00803790|580349362|FG003|Period 2|Withdrawal by Subject|0|||
160718222|NCT00803790|580349359|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
160718223|NCT00803790|580349360|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
160718224|NCT00803790|580349361|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
160718225|NCT00803790|580349362|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
160718226|NCT04710576|580349363|FG000|Overall Study|Participants still in the study|73|||
160718227|NCT04710576|580349364|FG001|Overall Study|Participants still in the study|70|||
160718228|NCT04710576|580349365|FG002|Overall Study|Participants still in the study|60|||
160718229|NCT04710576|580349363|FG000|Overall Study|Death|2|||
160718230|NCT04710576|580349364|FG001|Overall Study|Death|7|||
160718231|NCT04710576|580349365|FG002|Overall Study|Death|12|||
160718232|NCT04710576|580349363|FG000|Overall Study|Withdrawal by Subject|4|||
160718233|NCT04710576|580349364|FG001|Overall Study|Withdrawal by Subject|3|||
160718234|NCT04710576|580349365|FG002|Overall Study|Withdrawal by Subject|7|||
160718235|NCT04710576|580349363|FG000|Overall Study|Sponsor decision|1|||
160718236|NCT04710576|580349364|FG001|Overall Study|Sponsor decision|0|||
160718237|NCT04710576|580349365|FG002|Overall Study|Sponsor decision|0|||
160718238|NCT04581824|580349366|FG000|Overall Study|Lost to Follow-up|1|||
160718239|NCT04581824|580349367|FG001|Overall Study|Lost to Follow-up|0|||
160718240|NCT04581824|580349366|FG000|Overall Study|Withdrawal by Subject|2|||
160718241|NCT04581824|580349367|FG001|Overall Study|Withdrawal by Subject|7|||
160718242|NCT04581824|580349366|FG000|Overall Study|Study terminated by sponsor|37|||
160718243|NCT04581824|580349367|FG001|Overall Study|Study terminated by sponsor|23|||
160718244|NCT04796909|580349368|FG000|Overall Study|Withdrawal by Subject|1|||
160718245|NCT04796909|580349369|FG001|Overall Study|Withdrawal by Subject|1|||
160718246|NCT00437021|580349370|FG000|Overall Study|Adverse Event|0|||
160718247|NCT00437021|580349371|FG001|Overall Study|Adverse Event|0|||
160718248|NCT00437021|580349372|FG002|Overall Study|Adverse Event|0|||
160718249|NCT00437021|580349373|FG003|Overall Study|Adverse Event|0|||
160718250|NCT00437021|580349374|FG004|Overall Study|Adverse Event|0|||
160718251|NCT00437021|580349375|FG005|Overall Study|Adverse Event|0|||
160718252|NCT00437021|580349376|FG006|Overall Study|Adverse Event|1|||
160718253|NCT00437021|580349377|FG007|Overall Study|Adverse Event|0|||
160718254|NCT00437021|580349378|FG008|Overall Study|Adverse Event|0|||
160718255|NCT00437021|580349379|FG009|Overall Study|Adverse Event|0|||
160718256|NCT00437021|580349380|FG010|Overall Study|Adverse Event|0|||
160718257|NCT00437021|580349381|FG011|Overall Study|Adverse Event|0|||
160718258|NCT00437021|580349370|FG000|Overall Study|Lost to Follow-up|0|||
160718259|NCT00437021|580349371|FG001|Overall Study|Lost to Follow-up|3|||
160718260|NCT00437021|580349372|FG002|Overall Study|Lost to Follow-up|0|||
160718261|NCT00437021|580349373|FG003|Overall Study|Lost to Follow-up|0|||
160718262|NCT00437021|580349374|FG004|Overall Study|Lost to Follow-up|0|||
160718263|NCT00437021|580349375|FG005|Overall Study|Lost to Follow-up|2|||
160718264|NCT00437021|580349376|FG006|Overall Study|Lost to Follow-up|0|||
160718265|NCT00437021|580349377|FG007|Overall Study|Lost to Follow-up|1|||
160718266|NCT00437021|580349378|FG008|Overall Study|Lost to Follow-up|0|||
160718267|NCT00437021|580349379|FG009|Overall Study|Lost to Follow-up|0|||
160718268|NCT00437021|580349380|FG010|Overall Study|Lost to Follow-up|0|||
160718269|NCT00437021|580349381|FG011|Overall Study|Lost to Follow-up|0|||
160718270|NCT00437021|580349370|FG000|Overall Study|Withdrawal by Subject|2|||
160718271|NCT00437021|580349371|FG001|Overall Study|Withdrawal by Subject|1|||
160718272|NCT00437021|580349372|FG002|Overall Study|Withdrawal by Subject|0|||
160718273|NCT00437021|580349373|FG003|Overall Study|Withdrawal by Subject|0|||
160718274|NCT00437021|580349374|FG004|Overall Study|Withdrawal by Subject|0|||
160718275|NCT00437021|580349375|FG005|Overall Study|Withdrawal by Subject|0|||
160718276|NCT00437021|580349376|FG006|Overall Study|Withdrawal by Subject|0|||
160718277|NCT00437021|580349377|FG007|Overall Study|Withdrawal by Subject|0|||
160718278|NCT00437021|580349378|FG008|Overall Study|Withdrawal by Subject|0|||
160718279|NCT00437021|580349379|FG009|Overall Study|Withdrawal by Subject|0|||
160718280|NCT00437021|580349380|FG010|Overall Study|Withdrawal by Subject|0|||
160718281|NCT00437021|580349381|FG011|Overall Study|Withdrawal by Subject|0|||
160718282|NCT04162847|580349382|FG000|Overall Study|Withdrawal by Subject|7|||
160718283|NCT04162847|580349383|FG001|Overall Study|Withdrawal by Subject|1|||
160718284|NCT03985800|580349384|FG000|Overall Study|Death|1|||
160718285|NCT03985800|580349385|FG001|Overall Study|Death|2|||
160718286|NCT03985800|580349384|FG000|Overall Study|Withdrawal by Subject|3|||
160718287|NCT03985800|580349385|FG001|Overall Study|Withdrawal by Subject|6|||
160718288|NCT03985800|580349384|FG000|Overall Study|Protocol Violation|2|||
160718289|NCT03985800|580349385|FG001|Overall Study|Protocol Violation|0|||
160718290|NCT05258773|580349386|FG000|Overall Study|Screen Failure|1|||
160718291|NCT05258773|580349387|FG001|Overall Study|Screen Failure|1|||
160718292|NCT05258773|580349386|FG000|Overall Study|Adverse Event|1|||
160718293|NCT05258773|580349387|FG001|Overall Study|Adverse Event|0|||
160718294|NCT05258773|580349386|FG000|Overall Study|Withdrawal by Subject|0|||
160718295|NCT05258773|580349387|FG001|Overall Study|Withdrawal by Subject|1|||
160718296|NCT03018288|580349390|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
160718297|NCT03018288|580349391|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
160718298|NCT03018288|580349392|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
160718299|NCT03018288|580349393|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
160718300|NCT03018288|580349390|FG000|Overall Study|Participant withdrew consent.|0|||
160718301|NCT03018288|580349391|FG001|Overall Study|Participant withdrew consent.|0|||
160718302|NCT03018288|580349392|FG002|Overall Study|Participant withdrew consent.|1|||
160718303|NCT03018288|580349393|FG003|Overall Study|Participant withdrew consent.|0|||
160718304|NCT03018288|580349390|FG000|Overall Study|Switched to alternative treatment.|0|||
160718305|NCT03018288|580349391|FG001|Overall Study|Switched to alternative treatment.|0|||
160718306|NCT03018288|580349392|FG002|Overall Study|Switched to alternative treatment.|1|||
160718307|NCT03018288|580349393|FG003|Overall Study|Switched to alternative treatment.|0|||
160718308|NCT03018288|580349390|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
160718309|NCT03018288|580349391|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
160718310|NCT03018288|580349392|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
160718311|NCT03018288|580349393|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
160718312|NCT03018288|580349390|FG000|Overall Study|Screen failures|0|||
160718313|NCT03018288|580349391|FG001|Overall Study|Screen failures|0|||
160718314|NCT03018288|580349392|FG002|Overall Study|Screen failures|0|||
160718315|NCT03018288|580349393|FG003|Overall Study|Screen failures|51|||
160718316|NCT03018288|580349390|FG000|Overall Study|Chose treatment outside of UNC|0|||
160718317|NCT03018288|580349391|FG001|Overall Study|Chose treatment outside of UNC|0|||
160718318|NCT03018288|580349392|FG002|Overall Study|Chose treatment outside of UNC|0|||
160718319|NCT03018288|580349393|FG003|Overall Study|Chose treatment outside of UNC|1|||
160718320|NCT03018288|580349390|FG000|Overall Study|Unable to comply with protocol requirements|1|||
160718321|NCT03018288|580349391|FG001|Overall Study|Unable to comply with protocol requirements|1|||
160718322|NCT03018288|580349392|FG002|Overall Study|Unable to comply with protocol requirements|0|||
160718323|NCT03018288|580349393|FG003|Overall Study|Unable to comply with protocol requirements|1|||
160718324|NCT03018288|580349390|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
160718325|NCT03018288|580349391|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
160718326|NCT03018288|580349392|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
160718327|NCT03018288|580349393|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
160718328|NCT03018288|580349390|FG000|Overall Study|Physician Decision|0|||
160718329|NCT03018288|580349391|FG001|Overall Study|Physician Decision|0|||
160718330|NCT03018288|580349392|FG002|Overall Study|Physician Decision|0|||
160718331|NCT03018288|580349393|FG003|Overall Study|Physician Decision|1|||
160718332|NCT05573464|580349394|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
160718333|NCT05573464|580349395|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
160718334|NCT05573464|580349394|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
160718335|NCT05573464|580349395|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
160718336|NCT05573464|580349394|FG000|12-week Treatment Period|Protocol Violation|3|||
160718337|NCT05573464|580349395|FG001|12-week Treatment Period|Protocol Violation|1|||
160718338|NCT05573464|580349394|FG000|12-week Treatment Period|Physician Decision|1|||
160718339|NCT05573464|580349395|FG001|12-week Treatment Period|Physician Decision|2|||
160718340|NCT05573464|580349394|FG000|12-week Treatment Period|Lost to Follow-up|2|||
160718341|NCT05573464|580349395|FG001|12-week Treatment Period|Lost to Follow-up|0|||
160718342|NCT05573464|580349394|FG000|12-week Treatment Period|Adverse Event|20|||
160718343|NCT05573464|580349395|FG001|12-week Treatment Period|Adverse Event|9|||
160718344|NCT05573464|580349394|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
160718345|NCT05573464|580349395|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
160718346|NCT05573464|580349394|FG000|12-week Treatment Period|Randomised, not treated|0|||
160718347|NCT05573464|580349395|FG001|12-week Treatment Period|Randomised, not treated|1|||
160718348|NCT05573464|580349394|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
160718349|NCT05573464|580349395|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
160718350|NCT05573464|580349394|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
160718351|NCT05573464|580349395|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
160718352|NCT05573464|580349394|FG000|52-week Treatment Period|Protocol Violation|1|||
160718353|NCT05573464|580349395|FG001|52-week Treatment Period|Protocol Violation|1|||
160718354|NCT05573464|580349394|FG000|52-week Treatment Period|Physician Decision|2|||
160718355|NCT05573464|580349395|FG001|52-week Treatment Period|Physician Decision|2|||
160718356|NCT05573464|580349394|FG000|52-week Treatment Period|Lost to Follow-up|1|||
160718357|NCT05573464|580349395|FG001|52-week Treatment Period|Lost to Follow-up|1|||
160718358|NCT05573464|580349394|FG000|52-week Treatment Period|Adverse Event|11|||
160718359|NCT05573464|580349395|FG001|52-week Treatment Period|Adverse Event|8|||
160718360|NCT05573464|580349394|FG000|52-week Treatment Period|Death|1|||
160718361|NCT05573464|580349395|FG001|52-week Treatment Period|Death|1|||
160718362|NCT05734157|580349396|FG000|Overall Study|Death|3|||
160718363|NCT05734157|580349396|FG000|Overall Study|Withdrawal by Subject|2|||
160718364|NCT05734157|580349396|FG000|Overall Study|Lost to Follow-up|1|||
160718365|NCT05734157|580349396|FG000|Overall Study|Telephone call|3|||
160718366|NCT04815083|580349397|FG000|Overall Study|Physician Decision|1|||
160718367|NCT04815083|580349397|FG000|Overall Study|Study pause|2|||
160718368|NCT04815083|580349397|FG000|Overall Study|Screening failure|4|||
160718369|NCT06025721|580349398|FG000|Overall Study|Physician Decision|1|||
160718370|NCT06025721|580349398|FG000|Overall Study|Protocol Violation|1|||
160718371|NCT06025721|580349398|FG000|Overall Study|Incarceration|1|||
160718372|NCT01730053|580349401|FG000|Overall Study|Participant moved|0|||
160718373|NCT01730053|580349402|FG001|Overall Study|Participant moved|0|||
160718374|NCT01730053|580349403|FG002|Overall Study|Participant moved|1|||
160718375|NCT01730053|580349404|FG003|Overall Study|Participant moved|0|||
160718376|NCT01730053|580349405|FG004|Overall Study|Participant moved|0|||
160718377|NCT01730053|580349406|FG005|Overall Study|Participant moved|0|||
160718378|NCT01730053|580349401|FG000|Overall Study|Physician Decision|0|||
160718379|NCT01730053|580349402|FG001|Overall Study|Physician Decision|0|||
160718380|NCT01730053|580349403|FG002|Overall Study|Physician Decision|0|||
160718381|NCT01730053|580349404|FG003|Overall Study|Physician Decision|1|||
160718382|NCT01730053|580349405|FG004|Overall Study|Physician Decision|0|||
160718383|NCT01730053|580349406|FG005|Overall Study|Physician Decision|0|||
160718384|NCT01730053|580349401|FG000|Overall Study|Adverse Event|2|||
160718385|NCT01730053|580349402|FG001|Overall Study|Adverse Event|6|||
160718386|NCT01730053|580349403|FG002|Overall Study|Adverse Event|3|||
160718387|NCT01730053|580349404|FG003|Overall Study|Adverse Event|3|||
160718388|NCT01730053|580349405|FG004|Overall Study|Adverse Event|2|||
160718389|NCT01730053|580349406|FG005|Overall Study|Adverse Event|2|||
160718390|NCT01730053|580349401|FG000|Overall Study|Poor compliance to protocol|1|||
160718391|NCT01730053|580349402|FG001|Overall Study|Poor compliance to protocol|2|||
160718392|NCT01730053|580349403|FG002|Overall Study|Poor compliance to protocol|2|||
160718393|NCT01730053|580349404|FG003|Overall Study|Poor compliance to protocol|0|||
160718394|NCT01730053|580349405|FG004|Overall Study|Poor compliance to protocol|0|||
160718395|NCT01730053|580349406|FG005|Overall Study|Poor compliance to protocol|2|||
160718396|NCT01730053|580349401|FG000|Overall Study|Other than specified|2|||
160718397|NCT01730053|580349402|FG001|Overall Study|Other than specified|6|||
160718398|NCT01730053|580349403|FG002|Overall Study|Other than specified|5|||
160718399|NCT01730053|580349404|FG003|Overall Study|Other than specified|4|||
160718400|NCT01730053|580349405|FG004|Overall Study|Other than specified|7|||
160718401|NCT01730053|580349406|FG005|Overall Study|Other than specified|9|||
160718402|NCT02068508|580349407|FG000|Overall Study|Case report forms uncollected|27|||
160718403|NCT02068508|580349407|FG000|Overall Study|Patient did not visit the study site|1|||
160718404|NCT02068508|580349407|FG000|Overall Study|Protocol Violation|4|||
160718405|NCT00813150|580349408|FG000|Treatment Period|Adverse Event|16|||
160718406|NCT00813150|580349409|FG001|Treatment Period|Adverse Event|15|||
160718407|NCT00813150|580349408|FG000|Treatment Period|Death|2|||
160718408|NCT00813150|580349409|FG001|Treatment Period|Death|0|||
160718409|NCT00813150|580349408|FG000|Treatment Period|Progressive disease|1|||
160718410|NCT00813150|580349409|FG001|Treatment Period|Progressive disease|0|||
160718411|NCT00813150|580349408|FG000|Treatment Period|Complete response|0|||
160718412|NCT00813150|580349409|FG001|Treatment Period|Complete response|1|||
160718413|NCT00813150|580349408|FG000|Treatment Period|Stable disease|1|||
160718414|NCT00813150|580349409|FG001|Treatment Period|Stable disease|2|||
160718415|NCT00813150|580349408|FG000|Treatment Period|Protocol Violation|3|||
160718416|NCT00813150|580349409|FG001|Treatment Period|Protocol Violation|4|||
160718417|NCT00813150|580349408|FG000|Treatment Period|Withdrawal by Subject|5|||
160718418|NCT00813150|580349409|FG001|Treatment Period|Withdrawal by Subject|3|||
160718419|NCT00813150|580349408|FG000|Treatment Period|Non compliance|0|||
160718420|NCT00813150|580349409|FG001|Treatment Period|Non compliance|1|||
160718421|NCT00813150|580349408|FG000|Treatment Period|Reason not specified|3|||
160718422|NCT00813150|580349409|FG001|Treatment Period|Reason not specified|4|||
160718423|NCT00813150|580349408|FG000|Treatment Period|Data not available|1|||
160718424|NCT00813150|580349409|FG001|Treatment Period|Data not available|2|||
160718425|NCT00813150|580349408|FG000|Long Term Follow-up|Death|0|||
160718426|NCT00813150|580349409|FG001|Long Term Follow-up|Death|4|||
160718427|NCT00813150|580349408|FG000|Long Term Follow-up|Other|0|||
160718428|NCT00813150|580349409|FG001|Long Term Follow-up|Other|3|||
160718429|NCT00813150|580349408|FG000|Long Term Follow-up|Lost to Follow-up|2|||
160718430|NCT00813150|580349409|FG001|Long Term Follow-up|Lost to Follow-up|0|||
160718431|NCT00813150|580349408|FG000|Long Term Follow-up|Progression/Relapse|22|||
160718432|NCT00813150|580349409|FG001|Long Term Follow-up|Progression/Relapse|24|||
160718433|NCT00075816|580349417|FG000|Overall Study|Did not undergo transplantation|14|||
160718434|NCT00075816|580349418|FG001|Overall Study|Did not undergo transplantation|11|||
160718435|NCT01823328|580349419|FG000|Overall Study|Withdrawal by Subject|8|||
160718436|NCT01823328|580349420|FG001|Overall Study|Withdrawal by Subject|6|||
160718437|NCT04173507|580349421|FG000|Overall Study|On Treatment|3|||
160718438|NCT04173507|580349421|FG000|Overall Study|Adverse Event|3|||
160718439|NCT04173507|580349421|FG000|Overall Study|Progression/Relapse|34|||
160718440|NCT04173507|580349421|FG000|Overall Study|Death|2|||
160718441|NCT02832687|580349422|FG000|Overall Study|Adverse Event|0|||
160718442|NCT02832687|580349423|FG001|Overall Study|Adverse Event|2|||
160718443|NCT04231825|580349424|FG000|Overall Study|Protocol Violation|3|||
160718444|NCT04231825|580349425|FG001|Overall Study|Protocol Violation|3|||
160718445|NCT04231825|580349424|FG000|Overall Study|Lost to Follow-up|0|||
160718446|NCT04231825|580349425|FG001|Overall Study|Lost to Follow-up|1|||
160718447|NCT01662635|580349426|FG000|Overall Study|scarce samples for evaluation|30|||
160718448|NCT01217112|580349427|FG000|Overall Study|Adverse Event|0|||
160718449|NCT01217112|580349428|FG001|Overall Study|Adverse Event|2|||
160718450|NCT01217112|580349429|FG002|Overall Study|Adverse Event|0|||
160718451|NCT01217112|580349430|FG003|Overall Study|Adverse Event|2|||
160718452|NCT01217112|580349431|FG004|Overall Study|Adverse Event|0|||
160718453|NCT01217112|580349427|FG000|Overall Study|Withdrawal by Subject|0|||
160718454|NCT01217112|580349428|FG001|Overall Study|Withdrawal by Subject|0|||
160718455|NCT01217112|580349429|FG002|Overall Study|Withdrawal by Subject|1|||
160718456|NCT01217112|580349430|FG003|Overall Study|Withdrawal by Subject|0|||
160718457|NCT01217112|580349431|FG004|Overall Study|Withdrawal by Subject|0|||
160718458|NCT01217112|580349427|FG000|Overall Study|Physician Decision|0|||
160718459|NCT01217112|580349428|FG001|Overall Study|Physician Decision|0|||
160718460|NCT01217112|580349429|FG002|Overall Study|Physician Decision|0|||
160718461|NCT01217112|580349430|FG003|Overall Study|Physician Decision|0|||
160718462|NCT01217112|580349431|FG004|Overall Study|Physician Decision|1|||
160718463|NCT01401361|580349432|FG000|Overall Study|Withdrawal by Subject|16|||
160718464|NCT01401361|580349432|FG000|Overall Study|Lack of Efficacy|6|||
160718465|NCT01401361|580349432|FG000|Overall Study|Physician Decision|1|||
160718466|NCT01401361|580349432|FG000|Overall Study|Lost to Follow-up|3|||
160718467|NCT01401361|580349432|FG000|Overall Study|Subject/family decision post procedure|2|||
160718468|NCT00595920|580349435|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
160718469|NCT00351468|580349436|FG000|Overall Study|Adverse Event|42|||
160718470|NCT00351468|580349436|FG000|Overall Study|Withdrawal by Subject|39|||
160718471|NCT00351468|580349436|FG000|Overall Study|Various -follow up w clinical team|39|||
160718472|NCT00351468|580349436|FG000|Overall Study|Lack of Efficacy|32|||
160718473|NCT00351468|580349436|FG000|Overall Study|Non-compliance|8|||
160718474|NCT00351468|580349436|FG000|Overall Study|Lost to Follow-up|4|||
160718475|NCT00351468|580349436|FG000|Overall Study|Protocol Violation|3|||
160718476|NCT03588910|580349437|FG000|Overall Study|Withdrawal by Subject|1|||
160718477|NCT03588910|580349438|FG001|Overall Study|Withdrawal by Subject|0|||
160718478|NCT03588910|580349437|FG000|Overall Study|Allergy|2|||
160718479|NCT03588910|580349438|FG001|Overall Study|Allergy|0|||
160718480|NCT03588910|580349437|FG000|Overall Study|Protocol Violation|0|||
160718481|NCT03588910|580349438|FG001|Overall Study|Protocol Violation|3|||
160718482|NCT03588910|580349437|FG000|Overall Study|Did not complete Day 1 Survey|5|||
160718483|NCT03588910|580349438|FG001|Overall Study|Did not complete Day 1 Survey|10|||
160718484|NCT03588910|580349437|FG000|Overall Study|Did not complete Day 7 Survey|5|||
160718485|NCT03588910|580349438|FG001|Overall Study|Did not complete Day 7 Survey|2|||
160718486|NCT03096314|580349439|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
160718487|NCT03096314|580349440|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
160718488|NCT00471822|580349441|FG000|Overall Study|Protocol Violation|2|||
160718489|NCT02547428|580349442|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
160718490|NCT02547428|580349443|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
160718491|NCT02547428|580349442|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
160718492|NCT02547428|580349443|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
160718493|NCT02547428|580349442|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
160718494|NCT02547428|580349443|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
160718495|NCT02547428|580349442|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
160718496|NCT02547428|580349443|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
160718497|NCT02547428|580349442|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
160718498|NCT02547428|580349443|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
160718499|NCT02547428|580349442|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
160718500|NCT02547428|580349443|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
160718501|NCT02547428|580349442|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
160718502|NCT02547428|580349443|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
160718503|NCT02547428|580349442|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
160718504|NCT02547428|580349443|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
160718505|NCT03318861|580349444|FG000|Overall Study|Death|2|||
160718506|NCT03318861|580349445|FG001|Overall Study|Death|3|||
160718507|NCT03318861|580349446|FG002|Overall Study|Death|3|||
160718508|NCT03318861|580349447|FG003|Overall Study|Death|2|||
160718509|NCT03318861|580349448|FG004|Overall Study|Death|2|||
160718510|NCT03318861|580349444|FG000|Overall Study|Enrolled But Never Treated|0|||
160718511|NCT03318861|580349445|FG001|Overall Study|Enrolled But Never Treated|1|||
160718512|NCT03318861|580349446|FG002|Overall Study|Enrolled But Never Treated|0|||
160718513|NCT03318861|580349447|FG003|Overall Study|Enrolled But Never Treated|1|||
160718514|NCT03318861|580349448|FG004|Overall Study|Enrolled But Never Treated|1|||
160718515|NCT03318861|580349444|FG000|Overall Study|Informed Consent Withdraw|0|||
160718516|NCT03318861|580349445|FG001|Overall Study|Informed Consent Withdraw|0|||
160718517|NCT03318861|580349446|FG002|Overall Study|Informed Consent Withdraw|0|||
160718518|NCT03318861|580349447|FG003|Overall Study|Informed Consent Withdraw|1|||
160718519|NCT03318861|580349448|FG004|Overall Study|Informed Consent Withdraw|0|||
160718520|NCT03318861|580349444|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
160718521|NCT03318861|580349445|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
160718522|NCT03318861|580349446|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
160718523|NCT03318861|580349447|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
160718524|NCT03318861|580349448|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
160718525|NCT01439802|580349449|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
160718526|NCT01439802|580349449|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
160718527|NCT03499067|580349453|FG000|First Intervention|Physician Decision|2|||
160718528|NCT03499067|580349454|FG001|First Intervention|Physician Decision|1|||
160718529|NCT03499067|580349453|FG000|First Intervention|Withdrawal by Subject|3|||
160718530|NCT03499067|580349454|FG001|First Intervention|Withdrawal by Subject|6|||
160718531|NCT02502149|580349455|FG000|Intermediate|Discontinued prematurely|1|||
160718532|NCT02502149|580349456|FG001|Intermediate|Discontinued prematurely|0|||
160718533|NCT02502149|580349457|FG002|Intermediate|Discontinued prematurely|0|||
160718534|NCT02502149|580349458|FG003|Intermediate|Discontinued prematurely|0|||
160718535|NCT02502149|580349459|FG004|Intermediate|Discontinued prematurely|0|||
160718536|NCT03711188|580349460|FG000|Overall Study|Disease progression|11|||
160718537|NCT03711188|580349460|FG000|Overall Study|Adverse Event|1|||
160718538|NCT00063934|580349461|FG000|Overall Study|Ineligible|1|||
160718539|NCT03534687|580349462|FG000|Overall Study|Lost to Follow-up|7|||
160718540|NCT03534687|580349463|FG001|Overall Study|Lost to Follow-up|2|||
160718541|NCT02570308|580349466|FG000|Overall Study|Death|1|||
160718542|NCT02570308|580349467|FG001|Overall Study|Death|5|||
160718543|NCT02570308|580349468|FG002|Overall Study|Death|4|||
160718544|NCT02570308|580349469|FG003|Overall Study|Death|4|||
160718545|NCT02570308|580349470|FG004|Overall Study|Death|69|||
160718546|NCT02570308|580349466|FG000|Overall Study|Lost to Follow-up|0|||
160718547|NCT02570308|580349467|FG001|Overall Study|Lost to Follow-up|0|||
160718548|NCT02570308|580349468|FG002|Overall Study|Lost to Follow-up|0|||
160718549|NCT02570308|580349469|FG003|Overall Study|Lost to Follow-up|0|||
160718550|NCT02570308|580349470|FG004|Overall Study|Lost to Follow-up|2|||
160718551|NCT02570308|580349466|FG000|Overall Study|Withdrawal by Subject|0|||
160718552|NCT02570308|580349467|FG001|Overall Study|Withdrawal by Subject|0|||
160718553|NCT02570308|580349468|FG002|Overall Study|Withdrawal by Subject|0|||
160718554|NCT02570308|580349469|FG003|Overall Study|Withdrawal by Subject|0|||
160718555|NCT02570308|580349470|FG004|Overall Study|Withdrawal by Subject|1|||
160718556|NCT02570308|580349466|FG000|Overall Study|Other|0|||
160718557|NCT02570308|580349467|FG001|Overall Study|Other|0|||
160718558|NCT02570308|580349468|FG002|Overall Study|Other|0|||
160718559|NCT02570308|580349469|FG003|Overall Study|Other|0|||
160718560|NCT02570308|580349470|FG004|Overall Study|Other|2|||
160718561|NCT00314340|580349472|FG000|Overall Study|lost interest|1|||
160718562|NCT02069015|580349473|FG000|Overall Study|Lost to Follow-up|39|||
160718563|NCT02069015|580349474|FG001|Overall Study|Lost to Follow-up|32|||
160718564|NCT02069015|580349473|FG000|Overall Study|Withdrawal by Subject|1|||
160718565|NCT02069015|580349474|FG001|Overall Study|Withdrawal by Subject|1|||
160718566|NCT01283464|580349475|FG000|Overall Study|Lost to Follow-up|0|||
160718567|NCT01283464|580349476|FG001|Overall Study|Lost to Follow-up|1|||
160718568|NCT01283464|580349475|FG000|Overall Study|Withdrawal by Subject|1|||
160718569|NCT01283464|580349476|FG001|Overall Study|Withdrawal by Subject|0|||
160718570|NCT01283464|580349475|FG000|Overall Study|Physician Decision|1|||
160718571|NCT01283464|580349476|FG001|Overall Study|Physician Decision|0|||
160718572|NCT03051100|580349477|FG000|Overall Study|Withdrawal by Subject|1|||
160718573|NCT03051100|580349478|FG001|Overall Study|Withdrawal by Subject|0|||
160718574|NCT04886596|580349481|FG000|Overall Study|Adverse Event|442|||
160718575|NCT04886596|580349482|FG001|Overall Study|Adverse Event|441|||
160718576|NCT04886596|580349481|FG000|Overall Study|Lost to Follow-up|448|||
160718577|NCT04886596|580349482|FG001|Overall Study|Lost to Follow-up|465|||
160718578|NCT04886596|580349481|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
160718579|NCT04886596|580349482|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
160718580|NCT04886596|580349481|FG000|Overall Study|Migrated/moved from the study area|201|||
160718581|NCT04886596|580349482|FG001|Overall Study|Migrated/moved from the study area|184|||
160718582|NCT04886596|580349481|FG000|Overall Study|Other|298|||
160718583|NCT04886596|580349482|FG001|Overall Study|Other|326|||
160718584|NCT01060072|580349483|FG000|Overall Study|Adverse Event|1|||
160718585|NCT01060072|580349484|FG001|Overall Study|Adverse Event|1|||
160718586|NCT01060072|580349483|FG000|Overall Study|Physician Decision|0|||
160718587|NCT01060072|580349484|FG001|Overall Study|Physician Decision|2|||
160718588|NCT01060072|580349483|FG000|Overall Study|Protocol Violation|0|||
160718589|NCT01060072|580349484|FG001|Overall Study|Protocol Violation|1|||
160718590|NCT01060072|580349483|FG000|Overall Study|Acute cholecystitis|1|||
160718591|NCT01060072|580349484|FG001|Overall Study|Acute cholecystitis|0|||
160718592|NCT01060072|580349483|FG000|Overall Study|Excluded Medications|0|||
160718593|NCT01060072|580349484|FG001|Overall Study|Excluded Medications|1|||
160718594|NCT02301169|580349485|FG000|Overall Study|Adverse Event|1|||
160718595|NCT02301169|580349486|FG001|Overall Study|Adverse Event|0|||
160718596|NCT03762265|580349487|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
160718597|NCT03762265|580349488|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
160718598|NCT03762265|580349487|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
160718599|NCT03762265|580349488|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
160718600|NCT03762265|580349487|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
160718601|NCT03762265|580349488|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
160718602|NCT03762265|580349487|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
160718603|NCT03762265|580349488|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
160718604|NCT03762265|580349487|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
160718605|NCT03762265|580349488|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
160718606|NCT03762265|580349487|FG000|BT Period: Weeks 1 to 37|Other|0|||
160718607|NCT03762265|580349488|FG001|BT Period: Weeks 1 to 37|Other|1|||
160718608|NCT03762265|580349487|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
160718609|NCT03762265|580349488|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
160718610|NCT03762265|580349487|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
160718611|NCT03762265|580349488|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
160718612|NCT03762265|580349487|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
160718613|NCT03762265|580349488|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
160718614|NCT03762265|580349487|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
160718615|NCT03762265|580349488|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
160718616|NCT03762265|580349487|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
160718617|NCT03762265|580349488|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
160718618|NCT03762265|580349487|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
160718619|NCT03762265|580349488|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
160718620|NCT03762265|580349487|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
160718621|NCT03762265|580349488|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
160718622|NCT03762265|580349487|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
160718623|NCT03762265|580349488|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
160718624|NCT03762265|580349487|FG000|LTE Period: Weeks 61 to 109|Other|1|||
160718625|NCT03762265|580349488|FG001|LTE Period: Weeks 61 to 109|Other|0|||
160718626|NCT02289729|580349490|FG000|Overall Study|Lack of Efficacy|3|||
160718627|NCT02289729|580349490|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
160718628|NCT02289729|580349490|FG000|Overall Study|Withdrawal by Subject|1|||
160718629|NCT02289729|580349490|FG000|Overall Study|Death|1|||
160718630|NCT00470470|580349491|FG000|Overall Study|Adverse Event|2|||
160718631|NCT00470470|580349491|FG000|Overall Study|Death|2|||
160718632|NCT00470470|580349491|FG000|Overall Study|Not treated|1|||
160718633|NCT00822692|580349503|FG000|Overall Study|Lost to Follow-up|17|||
160718634|NCT00822692|580349504|FG001|Overall Study|Lost to Follow-up|25|||
160718635|NCT02452476|580349505|FG000|Overall Study|Death|4|||
160718636|NCT02452476|580349506|FG001|Overall Study|Death|7|||
160718637|NCT02452476|580349505|FG000|Overall Study|Lost to Follow-up|1|||
160718638|NCT02452476|580349506|FG001|Overall Study|Lost to Follow-up|1|||
160718639|NCT02452476|580349505|FG000|Overall Study|Physician Decision|1|||
160718640|NCT02452476|580349506|FG001|Overall Study|Physician Decision|1|||
160718641|NCT02452476|580349505|FG000|Overall Study|Not treated|5|||
160718642|NCT02452476|580349506|FG001|Overall Study|Not treated|1|||
160718643|NCT01964976|580349507|FG000|Overall Study|Protocol Violation|31|||
160718644|NCT02348112|580349508|FG000|Overall Study|Withdrawal by Subject|32|||
160718645|NCT02348112|580349509|FG001|Overall Study|Withdrawal by Subject|29|||
160718646|NCT02348112|580349508|FG000|Overall Study|Lost to Follow-up|24|||
160718647|NCT02348112|580349509|FG001|Overall Study|Lost to Follow-up|20|||
160718648|NCT02348112|580349508|FG000|Overall Study|Physician Decision|17|||
160718649|NCT02348112|580349509|FG001|Overall Study|Physician Decision|15|||
160718650|NCT02348112|580349508|FG000|Overall Study|Site closed due to PI leaving|0|||
160718651|NCT02348112|580349509|FG001|Overall Study|Site closed due to PI leaving|30|||
160718652|NCT02348112|580349508|FG000|Overall Study|Sponsor withdrawal|0|||
160718653|NCT02348112|580349509|FG001|Overall Study|Sponsor withdrawal|7|||
160718654|NCT02348112|580349508|FG000|Overall Study|Death|0|||
160718655|NCT02348112|580349509|FG001|Overall Study|Death|1|||
160718656|NCT00946920|580349511|FG000|Overall Study|Withdrawal by Subject|28|||
160718657|NCT00946920|580349512|FG001|Overall Study|Withdrawal by Subject|15|||
160718658|NCT00946920|580349511|FG000|Overall Study|Lost to Follow-up|2|||
160718659|NCT00946920|580349512|FG001|Overall Study|Lost to Follow-up|2|||
160718660|NCT00946920|580349511|FG000|Overall Study|Physician Decision|5|||
160718661|NCT00946920|580349512|FG001|Overall Study|Physician Decision|2|||
160718662|NCT00946920|580349511|FG000|Overall Study|Adverse Event|41|||
160718663|NCT00946920|580349512|FG001|Overall Study|Adverse Event|14|||
160718664|NCT00946920|580349511|FG000|Overall Study|Protocol Violation|16|||
160718665|NCT00946920|580349512|FG001|Overall Study|Protocol Violation|8|||
160718666|NCT00946920|580349511|FG000|Overall Study|Miscellaneous reasons|18|||
160718667|NCT00946920|580349512|FG001|Overall Study|Miscellaneous reasons|3|||
160718668|NCT00397514|580349513|FG000|Overall Study|Withdrawal by Subject|1|||
160718669|NCT00397514|580349513|FG000|Overall Study|Pacing wire malfunction|1|||
160718670|NCT00397514|580349513|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
160718671|NCT00397514|580349513|FG000|Overall Study|early extubation|2|||
160718672|NCT00397514|580349513|FG000|Overall Study|poor echocardiographic windows|1|||
160718673|NCT02654054|580349517|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
160718674|NCT02654054|580349518|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
160718675|NCT02654054|580349519|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
160718676|NCT02654054|580349517|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
160718677|NCT02654054|580349518|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160718678|NCT02654054|580349519|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
160718679|NCT02654054|580349517|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
160718680|NCT02654054|580349518|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
160718681|NCT02654054|580349519|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
160718682|NCT02654054|580349517|FG000|Post-Treatment Follow-Up Period|Other|1|||
160718683|NCT02654054|580349518|FG001|Post-Treatment Follow-Up Period|Other|0|||
160718684|NCT02654054|580349519|FG002|Post-Treatment Follow-Up Period|Other|4|||
160718685|NCT02654054|580349517|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
160718686|NCT02654054|580349518|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
160718687|NCT02654054|580349519|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
160718688|NCT06389487|580349522|FG000|Overall Study|Lost to Follow-up|9|||
160718689|NCT06389487|580349523|FG001|Overall Study|Lost to Follow-up|5|||
160718690|NCT06389487|580349524|FG002|Overall Study|Lost to Follow-up|13|||
160718691|NCT06389487|580349522|FG000|Overall Study|Protocol Violation|0|||
160718692|NCT06389487|580349523|FG001|Overall Study|Protocol Violation|0|||
160718693|NCT06389487|580349524|FG002|Overall Study|Protocol Violation|2|||
160718694|NCT06389487|580349522|FG000|Overall Study|Withdrawal by Subject|2|||
160718695|NCT06389487|580349523|FG001|Overall Study|Withdrawal by Subject|2|||
160718696|NCT06389487|580349524|FG002|Overall Study|Withdrawal by Subject|1|||
160718697|NCT06389487|580349522|FG000|Overall Study|Other|1|||
160718698|NCT06389487|580349523|FG001|Overall Study|Other|0|||
160718699|NCT06389487|580349524|FG002|Overall Study|Other|1|||
160718700|NCT04021914|580351371|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
160718701|NCT02844543|580351372|FG000|Overall Study|Withdrawal by Subject|4|||
160718702|NCT02844543|580351372|FG000|Overall Study|Did not meet eligibility criteria|1|||
160718703|NCT03349060|580351373|FG000|Overall Study|Adverse Event|9|||
160718704|NCT03349060|580351374|FG001|Overall Study|Adverse Event|9|||
160718705|NCT03349060|580351375|FG002|Overall Study|Adverse Event|7|||
160718706|NCT03349060|580351373|FG000|Overall Study|Lack of Efficacy|1|||
160718707|NCT03349060|580351374|FG001|Overall Study|Lack of Efficacy|0|||
160718708|NCT03349060|580351375|FG002|Overall Study|Lack of Efficacy|2|||
160718709|NCT03349060|580351373|FG000|Overall Study|Lost to Follow-up|2|||
160718710|NCT03349060|580351374|FG001|Overall Study|Lost to Follow-up|1|||
160718711|NCT03349060|580351375|FG002|Overall Study|Lost to Follow-up|1|||
160718712|NCT03349060|580351373|FG000|Overall Study|Protocol Violation|2|||
160718713|NCT03349060|580351374|FG001|Overall Study|Protocol Violation|2|||
160718714|NCT03349060|580351375|FG002|Overall Study|Protocol Violation|1|||
160718715|NCT03349060|580351373|FG000|Overall Study|Withdrawal by Subject|5|||
160718716|NCT03349060|580351374|FG001|Overall Study|Withdrawal by Subject|3|||
160718717|NCT03349060|580351375|FG002|Overall Study|Withdrawal by Subject|4|||
160718718|NCT03349060|580351373|FG000|Overall Study|Medication error,no linked adverse event|0|||
160718719|NCT03349060|580351374|FG001|Overall Study|Medication error,no linked adverse event|0|||
160718720|NCT03349060|580351375|FG002|Overall Study|Medication error,no linked adverse event|1|||
160718721|NCT03349060|580351373|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
160718722|NCT03349060|580351374|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
160718723|NCT03349060|580351375|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
160718724|NCT03349060|580351373|FG000|Overall Study|Other|2|||
160718725|NCT03349060|580351374|FG001|Overall Study|Other|1|||
160718726|NCT03349060|580351375|FG002|Overall Study|Other|0|||
160718727|NCT00955409|580351376|FG000|Overall Study|Lack of Efficacy|1|||
160718728|NCT00955409|580351377|FG001|Overall Study|Lack of Efficacy|0|||
160718729|NCT00955409|580351378|FG002|Overall Study|Lack of Efficacy|0|||
160718730|NCT00955409|580351379|FG003|Overall Study|Lack of Efficacy|0|||
160718731|NCT00955409|580351380|FG004|Overall Study|Lack of Efficacy|0|||
160718732|NCT00955409|580351381|FG005|Overall Study|Lack of Efficacy|0|||
160718733|NCT00955409|580351382|FG006|Overall Study|Lack of Efficacy|0|||
160718734|NCT00955409|580351383|FG007|Overall Study|Lack of Efficacy|0|||
160718735|NCT00955409|580351384|FG008|Overall Study|Lack of Efficacy|0|||
160718736|NCT00955409|580351385|FG009|Overall Study|Lack of Efficacy|0|||
160718737|NCT00955409|580351376|FG000|Overall Study|Withdrawal by Subject|1|||
160718738|NCT00955409|580351377|FG001|Overall Study|Withdrawal by Subject|0|||
160718739|NCT00955409|580351378|FG002|Overall Study|Withdrawal by Subject|5|||
160718740|NCT00955409|580351379|FG003|Overall Study|Withdrawal by Subject|2|||
160718741|NCT00955409|580351380|FG004|Overall Study|Withdrawal by Subject|0|||
160718742|NCT00955409|580351381|FG005|Overall Study|Withdrawal by Subject|0|||
160718743|NCT00955409|580351382|FG006|Overall Study|Withdrawal by Subject|2|||
160718744|NCT00955409|580351383|FG007|Overall Study|Withdrawal by Subject|0|||
160718745|NCT00955409|580351384|FG008|Overall Study|Withdrawal by Subject|1|||
160718746|NCT00955409|580351385|FG009|Overall Study|Withdrawal by Subject|0|||
160718747|NCT00955409|580351376|FG000|Overall Study|Caregiver Request|2|||
160718748|NCT00955409|580351377|FG001|Overall Study|Caregiver Request|0|||
160718749|NCT00955409|580351378|FG002|Overall Study|Caregiver Request|6|||
160718750|NCT00955409|580351379|FG003|Overall Study|Caregiver Request|5|||
160718751|NCT00955409|580351380|FG004|Overall Study|Caregiver Request|0|||
160718752|NCT00955409|580351381|FG005|Overall Study|Caregiver Request|2|||
160718753|NCT00955409|580351382|FG006|Overall Study|Caregiver Request|3|||
160718754|NCT00955409|580351383|FG007|Overall Study|Caregiver Request|1|||
160718755|NCT00955409|580351384|FG008|Overall Study|Caregiver Request|3|||
160718756|NCT00955409|580351385|FG009|Overall Study|Caregiver Request|0|||
160718757|NCT00955409|580351376|FG000|Overall Study|Investigator Request|0|||
160718758|NCT00955409|580351377|FG001|Overall Study|Investigator Request|0|||
160718759|NCT00955409|580351378|FG002|Overall Study|Investigator Request|1|||
160718760|NCT00955409|580351379|FG003|Overall Study|Investigator Request|0|||
160718761|NCT00955409|580351380|FG004|Overall Study|Investigator Request|0|||
160718762|NCT00955409|580351381|FG005|Overall Study|Investigator Request|0|||
160718763|NCT00955409|580351382|FG006|Overall Study|Investigator Request|0|||
160718764|NCT00955409|580351383|FG007|Overall Study|Investigator Request|0|||
160718765|NCT00955409|580351384|FG008|Overall Study|Investigator Request|0|||
160718766|NCT00955409|580351385|FG009|Overall Study|Investigator Request|0|||
160718767|NCT00955409|580351376|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
160718768|NCT00955409|580351377|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
160718769|NCT00955409|580351378|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
160718770|NCT00955409|580351379|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
160718771|NCT00955409|580351380|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
160718772|NCT00955409|580351381|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
160718773|NCT00955409|580351382|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
160718774|NCT00955409|580351383|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
160718775|NCT00955409|580351384|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
160718776|NCT00955409|580351385|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
160718777|NCT00955409|580351376|FG000|Overall Study|Lost to Follow-up|0|||
160718778|NCT00955409|580351377|FG001|Overall Study|Lost to Follow-up|0|||
160718779|NCT00955409|580351378|FG002|Overall Study|Lost to Follow-up|1|||
160718780|NCT00955409|580351379|FG003|Overall Study|Lost to Follow-up|0|||
160718781|NCT00955409|580351380|FG004|Overall Study|Lost to Follow-up|0|||
160718782|NCT00955409|580351381|FG005|Overall Study|Lost to Follow-up|0|||
160718783|NCT00955409|580351382|FG006|Overall Study|Lost to Follow-up|1|||
160718784|NCT00955409|580351383|FG007|Overall Study|Lost to Follow-up|0|||
160718785|NCT00955409|580351384|FG008|Overall Study|Lost to Follow-up|0|||
160718786|NCT00955409|580351385|FG009|Overall Study|Lost to Follow-up|0|||
160718787|NCT00955409|580351376|FG000|Overall Study|Failed to Return|2|||
160718788|NCT00955409|580351377|FG001|Overall Study|Failed to Return|0|||
160718789|NCT00955409|580351378|FG002|Overall Study|Failed to Return|0|||
160718790|NCT00955409|580351379|FG003|Overall Study|Failed to Return|0|||
160718791|NCT00955409|580351380|FG004|Overall Study|Failed to Return|0|||
160718792|NCT00955409|580351381|FG005|Overall Study|Failed to Return|0|||
160718793|NCT00955409|580351382|FG006|Overall Study|Failed to Return|0|||
160718794|NCT00955409|580351383|FG007|Overall Study|Failed to Return|2|||
160718795|NCT00955409|580351384|FG008|Overall Study|Failed to Return|0|||
160718796|NCT00955409|580351385|FG009|Overall Study|Failed to Return|0|||
160718797|NCT00955409|580351376|FG000|Overall Study|Adverse Event (AE)|2|||
160718798|NCT00955409|580351377|FG001|Overall Study|Adverse Event (AE)|0|||
160718799|NCT00955409|580351378|FG002|Overall Study|Adverse Event (AE)|0|||
160718800|NCT00955409|580351379|FG003|Overall Study|Adverse Event (AE)|0|||
160718801|NCT00955409|580351380|FG004|Overall Study|Adverse Event (AE)|0|||
160718802|NCT00955409|580351381|FG005|Overall Study|Adverse Event (AE)|1|||
160718803|NCT00955409|580351382|FG006|Overall Study|Adverse Event (AE)|2|||
160718804|NCT00955409|580351383|FG007|Overall Study|Adverse Event (AE)|0|||
160718805|NCT00955409|580351384|FG008|Overall Study|Adverse Event (AE)|2|||
160718806|NCT00955409|580351385|FG009|Overall Study|Adverse Event (AE)|0|||
160718807|NCT00955409|580351376|FG000|Overall Study|Reason not Specified|2|||
160718808|NCT00955409|580351377|FG001|Overall Study|Reason not Specified|1|||
160718809|NCT00955409|580351378|FG002|Overall Study|Reason not Specified|13|||
160718810|NCT00955409|580351379|FG003|Overall Study|Reason not Specified|1|||
160718811|NCT00955409|580351380|FG004|Overall Study|Reason not Specified|2|||
160718812|NCT00955409|580351381|FG005|Overall Study|Reason not Specified|0|||
160718813|NCT00955409|580351382|FG006|Overall Study|Reason not Specified|16|||
160718814|NCT00955409|580351383|FG007|Overall Study|Reason not Specified|0|||
160718815|NCT00955409|580351384|FG008|Overall Study|Reason not Specified|8|||
160718816|NCT00955409|580351385|FG009|Overall Study|Reason not Specified|1|||
160718817|NCT02764762|580351386|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
160718818|NCT02764762|580351386|FG000|Overall Study|Lost to Follow-up|4|||
160718819|NCT02764762|580351386|FG000|Overall Study|Voluntary Withdrawal|8|||
160718820|NCT02764762|580351386|FG000|Overall Study|Site Termination|1|||
160718821|NCT02764762|580351386|FG000|Overall Study|Lack of Efficacy|16|||
160718822|NCT02764762|580351386|FG000|Overall Study|Reason not Specified|1|||
160718823|NCT00917852|580351387|FG000|Overall Study|Death|6|||
160718824|NCT00471081|580351388|FG000|Active Phase|Protocol Violation|1|||
160718825|NCT00471081|580351389|FG001|Active Phase|Protocol Violation|1|||
160718826|NCT00471081|580351388|FG000|Active Phase|Withdrawal by Subject|0|||
160718827|NCT00471081|580351389|FG001|Active Phase|Withdrawal by Subject|3|||
160718828|NCT00471081|580351388|FG000|Active Phase|Lost to Follow-up|0|||
160718829|NCT00471081|580351389|FG001|Active Phase|Lost to Follow-up|1|||
160718830|NCT00471081|580351388|FG000|Active Phase|Lost health plan/insurance|1|||
160718831|NCT00471081|580351389|FG001|Active Phase|Lost health plan/insurance|8|||
160718832|NCT00471081|580351388|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
160718833|NCT00471081|580351389|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
160718834|NCT00471081|580351388|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
160718835|NCT00471081|580351389|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
160718836|NCT00471081|580351388|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
160718837|NCT00471081|580351389|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
160718838|NCT02844933|580351390|FG000|Overall Study|Discontinued due to premature termination of study|3|||
160718839|NCT02844933|580351391|FG001|Overall Study|Discontinued due to premature termination of study|2|||
160718840|NCT01479465|580351392|FG000|Overall Study|Disease Progression|9|||
160718841|NCT01479465|580351393|FG001|Overall Study|Disease Progression|61|||
160718842|NCT01479465|580351394|FG002|Overall Study|Disease Progression|65|||
160718843|NCT01479465|580351395|FG003|Overall Study|Disease Progression|70|||
160718844|NCT01479465|580351392|FG000|Overall Study|Study Discontinued by Sponsor|0|||
160718845|NCT01479465|580351393|FG001|Overall Study|Study Discontinued by Sponsor|7|||
160718846|NCT01479465|580351394|FG002|Overall Study|Study Discontinued by Sponsor|5|||
160718847|NCT01479465|580351395|FG003|Overall Study|Study Discontinued by Sponsor|3|||
160718848|NCT01479465|580351392|FG000|Overall Study|Adverse Event|0|||
160718849|NCT01479465|580351393|FG001|Overall Study|Adverse Event|3|||
160718850|NCT01479465|580351394|FG002|Overall Study|Adverse Event|6|||
160718851|NCT01479465|580351395|FG003|Overall Study|Adverse Event|4|||
160718852|NCT01479465|580351392|FG000|Overall Study|Investigator Discretion|1|||
160718853|NCT01479465|580351393|FG001|Overall Study|Investigator Discretion|4|||
160718854|NCT01479465|580351394|FG002|Overall Study|Investigator Discretion|2|||
160718855|NCT01479465|580351395|FG003|Overall Study|Investigator Discretion|4|||
160718856|NCT01479465|580351392|FG000|Overall Study|Subject Request|1|||
160718857|NCT01479465|580351393|FG001|Overall Study|Subject Request|3|||
160718858|NCT01479465|580351394|FG002|Overall Study|Subject Request|4|||
160718859|NCT01479465|580351395|FG003|Overall Study|Subject Request|2|||
160718860|NCT01479465|580351392|FG000|Overall Study|Subject Withdrew Consent|0|||
160718861|NCT01479465|580351393|FG001|Overall Study|Subject Withdrew Consent|5|||
160718862|NCT01479465|580351394|FG002|Overall Study|Subject Withdrew Consent|2|||
160718863|NCT01479465|580351395|FG003|Overall Study|Subject Withdrew Consent|1|||
160718864|NCT01479465|580351392|FG000|Overall Study|Protocol Violation|0|||
160718865|NCT01479465|580351393|FG001|Overall Study|Protocol Violation|1|||
160718866|NCT01479465|580351394|FG002|Overall Study|Protocol Violation|1|||
160718867|NCT01479465|580351395|FG003|Overall Study|Protocol Violation|0|||
160718868|NCT01479465|580351392|FG000|Overall Study|Death|0|||
160718869|NCT01479465|580351393|FG001|Overall Study|Death|0|||
160718870|NCT01479465|580351394|FG002|Overall Study|Death|0|||
160718871|NCT01479465|580351395|FG003|Overall Study|Death|1|||
160718872|NCT01479465|580351392|FG000|Overall Study|Lost to Follow-up|0|||
160718873|NCT01479465|580351393|FG001|Overall Study|Lost to Follow-up|0|||
160718874|NCT01479465|580351394|FG002|Overall Study|Lost to Follow-up|1|||
160718875|NCT01479465|580351395|FG003|Overall Study|Lost to Follow-up|0|||
160718876|NCT01892501|580351396|FG000|Overall Study|Protocol Violation|2|||
160718877|NCT01892501|580351396|FG000|Overall Study|Puncture not carried out|9|||
160718878|NCT01892501|580351396|FG000|Overall Study|Radiological monitoring not carried out|5|||
160718879|NCT01892501|580351396|FG000|Overall Study|Non-contributory histological result|12|||
160718880|NCT04335123|580351402|FG000|Overall Study|Withdrawal by Subject|2|||
160718881|NCT04335123|580351403|FG001|Overall Study|Withdrawal by Subject|0|||
160718882|NCT04335123|580351402|FG000|Overall Study|Physician Decision|2|||
160718883|NCT04335123|580351403|FG001|Overall Study|Physician Decision|0|||
160718884|NCT05486091|580351404|FG000|Overall Study|Withdrawal by Subject|1|||
160718885|NCT05486091|580351404|FG000|Overall Study|Lost to Follow-up|2|||
160718886|NCT02392481|580351405|FG000|Overall Study|Adverse Event|0|||
160718887|NCT02392481|580351406|FG001|Overall Study|Adverse Event|0|||
160718888|NCT02392481|580351407|FG002|Overall Study|Adverse Event|1|||
160718889|NCT02392481|580351408|FG003|Overall Study|Adverse Event|2|||
160718890|NCT02392481|580351405|FG000|Overall Study|Withdrawal by Subject|0|||
160718891|NCT02392481|580351406|FG001|Overall Study|Withdrawal by Subject|0|||
160718892|NCT02392481|580351407|FG002|Overall Study|Withdrawal by Subject|1|||
160718893|NCT02392481|580351408|FG003|Overall Study|Withdrawal by Subject|0|||
160718894|NCT02383017|580351423|FG000|Overall Study|Injury Sustained Outside Study|1|||
160718895|NCT02383017|580351424|FG001|Overall Study|Injury Sustained Outside Study|0|||
160718896|NCT02383017|580351423|FG000|Overall Study|Compliance|3|||
160718897|NCT02383017|580351424|FG001|Overall Study|Compliance|2|||
160718898|NCT02383017|580351423|FG000|Overall Study|Found to be Hypogonadal|1|||
160718899|NCT02383017|580351424|FG001|Overall Study|Found to be Hypogonadal|0|||
160718900|NCT03871543|580351432|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
160718901|NCT03871543|580351432|FG000|Period 1|Investigator Error|1|||
160718902|NCT03871543|580351432|FG000|Period 1|Protocol Violation|2|||
160718903|NCT03871543|580351432|FG000|Period 1|COVID-19 Related|1|||
160718904|NCT03871543|580351432|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
160718905|NCT03871543|580351432|FG000|Period 1|Withdrawal by Subject|10|||
160718906|NCT03871543|580351432|FG000|Period 2|Adverse Event|1|||
160718907|NCT03871543|580351432|FG000|Period 2|Withdrawal by Subject|1|||
160718908|NCT01894919|580351433|FG000|Overall Study|Withdrawal by Subject|1|||
160718909|NCT01894919|580351434|FG001|Overall Study|Withdrawal by Subject|0|||
160718910|NCT01894919|580351435|FG002|Overall Study|Withdrawal by Subject|0|||
160718911|NCT01894919|580351436|FG003|Overall Study|Withdrawal by Subject|0|||
160718912|NCT01894919|580351437|FG004|Overall Study|Withdrawal by Subject|1|||
160718913|NCT01894919|580351438|FG005|Overall Study|Withdrawal by Subject|0|||
160718914|NCT01894919|580351439|FG006|Overall Study|Withdrawal by Subject|0|||
160718915|NCT01894919|580351440|FG007|Overall Study|Withdrawal by Subject|0|||
160718916|NCT01894919|580351441|FG008|Overall Study|Withdrawal by Subject|0|||
160718917|NCT01894919|580351442|FG009|Overall Study|Withdrawal by Subject|1|||
160718918|NCT01894919|580351443|FG010|Overall Study|Withdrawal by Subject|1|||
160718919|NCT01894919|580351444|FG011|Overall Study|Withdrawal by Subject|0|||
160718920|NCT01894919|580351445|FG012|Overall Study|Withdrawal by Subject|0|||
160718921|NCT01894919|580351433|FG000|Overall Study|Adverse Event|0|||
160718922|NCT01894919|580351434|FG001|Overall Study|Adverse Event|0|||
160718923|NCT01894919|580351435|FG002|Overall Study|Adverse Event|0|||
160718924|NCT01894919|580351436|FG003|Overall Study|Adverse Event|0|||
160718925|NCT01894919|580351437|FG004|Overall Study|Adverse Event|0|||
160718926|NCT01894919|580351438|FG005|Overall Study|Adverse Event|0|||
160718927|NCT01894919|580351439|FG006|Overall Study|Adverse Event|0|||
160718928|NCT01894919|580351440|FG007|Overall Study|Adverse Event|0|||
160718929|NCT01894919|580351441|FG008|Overall Study|Adverse Event|0|||
160718930|NCT01894919|580351442|FG009|Overall Study|Adverse Event|0|||
160718931|NCT01894919|580351443|FG010|Overall Study|Adverse Event|1|||
160718932|NCT01894919|580351444|FG011|Overall Study|Adverse Event|0|||
160718933|NCT01894919|580351445|FG012|Overall Study|Adverse Event|0|||
160718934|NCT01894919|580351433|FG000|Overall Study|Other-Unspecified|1|||
160718935|NCT01894919|580351434|FG001|Overall Study|Other-Unspecified|0|||
160718936|NCT01894919|580351435|FG002|Overall Study|Other-Unspecified|0|||
160718937|NCT01894919|580351436|FG003|Overall Study|Other-Unspecified|0|||
160718938|NCT01894919|580351437|FG004|Overall Study|Other-Unspecified|0|||
160718939|NCT01894919|580351438|FG005|Overall Study|Other-Unspecified|0|||
160718940|NCT01894919|580351439|FG006|Overall Study|Other-Unspecified|0|||
160718941|NCT01894919|580351440|FG007|Overall Study|Other-Unspecified|0|||
160718942|NCT01894919|580351441|FG008|Overall Study|Other-Unspecified|0|||
160718943|NCT01894919|580351442|FG009|Overall Study|Other-Unspecified|0|||
160718944|NCT01894919|580351443|FG010|Overall Study|Other-Unspecified|0|||
160718945|NCT01894919|580351444|FG011|Overall Study|Other-Unspecified|0|||
160718946|NCT01894919|580351445|FG012|Overall Study|Other-Unspecified|0|||
160718947|NCT01894919|580351433|FG000|Overall Study|Lost to Follow-up|0|||
160718948|NCT01894919|580351434|FG001|Overall Study|Lost to Follow-up|0|||
160718949|NCT01894919|580351435|FG002|Overall Study|Lost to Follow-up|0|||
160718950|NCT01894919|580351436|FG003|Overall Study|Lost to Follow-up|0|||
160718951|NCT01894919|580351437|FG004|Overall Study|Lost to Follow-up|2|||
160718952|NCT01894919|580351438|FG005|Overall Study|Lost to Follow-up|0|||
160718953|NCT01894919|580351439|FG006|Overall Study|Lost to Follow-up|0|||
160718954|NCT01894919|580351440|FG007|Overall Study|Lost to Follow-up|0|||
160718955|NCT01894919|580351441|FG008|Overall Study|Lost to Follow-up|0|||
160718956|NCT01894919|580351442|FG009|Overall Study|Lost to Follow-up|0|||
160718957|NCT01894919|580351443|FG010|Overall Study|Lost to Follow-up|0|||
160718958|NCT01894919|580351444|FG011|Overall Study|Lost to Follow-up|0|||
160718959|NCT01894919|580351445|FG012|Overall Study|Lost to Follow-up|0|||
160718960|NCT04341363|580351448|FG000|Overall Study|Adverse Event|1|||
160718961|NCT04341363|580351448|FG000|Overall Study|Withdrawal by Subject|1|||
160718962|NCT01286467|580351453|FG000|Overall Study|Death|1|||
160718963|NCT01286467|580351454|FG001|Overall Study|Death|1|||
160718964|NCT01286467|580351455|FG002|Overall Study|Death|1|||
160718965|NCT01286467|580351456|FG003|Overall Study|Death|0|||
160718966|NCT01286467|580351453|FG000|Overall Study|Lost to Follow-up|0|||
160718967|NCT01286467|580351454|FG001|Overall Study|Lost to Follow-up|0|||
160718968|NCT01286467|580351455|FG002|Overall Study|Lost to Follow-up|0|||
160718969|NCT01286467|580351456|FG003|Overall Study|Lost to Follow-up|1|||
160718970|NCT01286467|580351453|FG000|Overall Study|Withdrawal by Subject|0|||
160718971|NCT01286467|580351454|FG001|Overall Study|Withdrawal by Subject|0|||
160718972|NCT01286467|580351455|FG002|Overall Study|Withdrawal by Subject|1|||
160718973|NCT01286467|580351456|FG003|Overall Study|Withdrawal by Subject|0|||
160718974|NCT01286467|580351453|FG000|Overall Study|Physician Decision|0|||
160718975|NCT01286467|580351454|FG001|Overall Study|Physician Decision|0|||
160718976|NCT01286467|580351455|FG002|Overall Study|Physician Decision|0|||
160718977|NCT01286467|580351456|FG003|Overall Study|Physician Decision|1|||
160718978|NCT01286467|580351453|FG000|Overall Study|Disease progression|3|||
160718979|NCT01286467|580351454|FG001|Overall Study|Disease progression|2|||
160718980|NCT01286467|580351455|FG002|Overall Study|Disease progression|2|||
160718981|NCT01286467|580351456|FG003|Overall Study|Disease progression|3|||
160718982|NCT01286467|580351453|FG000|Overall Study|Adverse Event|0|||
160718983|NCT01286467|580351454|FG001|Overall Study|Adverse Event|1|||
160718984|NCT01286467|580351455|FG002|Overall Study|Adverse Event|2|||
160718985|NCT01286467|580351456|FG003|Overall Study|Adverse Event|3|||
160718986|NCT01286467|580351453|FG000|Overall Study|Study drug stop longer than 14 days|0|||
160718987|NCT01286467|580351454|FG001|Overall Study|Study drug stop longer than 14 days|0|||
160718988|NCT01286467|580351455|FG002|Overall Study|Study drug stop longer than 14 days|1|||
160718989|NCT01286467|580351456|FG003|Overall Study|Study drug stop longer than 14 days|0|||
160718990|NCT03335475|580351457|FG000|Overall Study|Did not wear accelerometer|4|||
160718991|NCT03335475|580351458|FG001|Overall Study|Did not wear accelerometer|0|||
160718992|NCT03335475|580351457|FG000|Overall Study|Withdrawal by Subject|0|||
160718993|NCT03335475|580351458|FG001|Overall Study|Withdrawal by Subject|1|||
160718994|NCT03751098|580351461|FG000|Overall Study|Withdrawal by Subject|0|||
160718995|NCT03751098|580351462|FG001|Overall Study|Withdrawal by Subject|1|||
160718996|NCT05921903|580351463|FG000|Overall Study|Unsolicited non-SAE|0|||
160718997|NCT05921903|580351464|FG001|Overall Study|Unsolicited non-SAE|1|||
160718998|NCT05921903|580351465|FG002|Overall Study|Unsolicited non-SAE|0|||
160718999|NCT05921903|580351463|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
160719000|NCT05921903|580351464|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
160719001|NCT05921903|580351465|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
160719002|NCT05921903|580351463|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
160719003|NCT05921903|580351464|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
160719004|NCT05921903|580351465|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
160719005|NCT03305848|580351466|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
160719006|NCT03305848|580351466|FG000|Overall Study|Physician Decision|2|||
160719007|NCT00923013|580351467|FG000|Overall Study|Refused further treatment|0|||
160719008|NCT00923013|580351468|FG001|Overall Study|Refused further treatment|1|||
160719009|NCT00923013|580351469|FG002|Overall Study|Refused further treatment|2|||
160719010|NCT00923013|580351470|FG003|Overall Study|Refused further treatment|0|||
160719011|NCT00923013|580351471|FG004|Overall Study|Refused further treatment|0|||
160719012|NCT00923013|580351472|FG005|Overall Study|Refused further treatment|0|||
160719013|NCT00923013|580351467|FG000|Overall Study|Switched to alternative treatment|0|||
160719014|NCT00923013|580351468|FG001|Overall Study|Switched to alternative treatment|1|||
160719015|NCT00923013|580351469|FG002|Overall Study|Switched to alternative treatment|0|||
160719016|NCT00923013|580351470|FG003|Overall Study|Switched to alternative treatment|0|||
160719017|NCT00923013|580351471|FG004|Overall Study|Switched to alternative treatment|0|||
160719018|NCT00923013|580351472|FG005|Overall Study|Switched to alternative treatment|0|||
160719019|NCT00923013|580351467|FG000|Overall Study|Death on study|2|||
160719020|NCT00923013|580351468|FG001|Overall Study|Death on study|2|||
160719021|NCT00923013|580351469|FG002|Overall Study|Death on study|0|||
160719022|NCT00923013|580351470|FG003|Overall Study|Death on study|1|||
160719023|NCT00923013|580351471|FG004|Overall Study|Death on study|0|||
160719024|NCT00923013|580351472|FG005|Overall Study|Death on study|0|||
160719025|NCT00765102|580351476|FG000|Overall Study|Progressive disease|18|||
160719026|NCT00765102|580351476|FG000|Overall Study|Adverse Event|6|||
160719027|NCT00765102|580351476|FG000|Overall Study|Physician Decision|4|||
160719028|NCT00765102|580351476|FG000|Overall Study|Withdrawal by Subject|2|||
160719029|NCT00765102|580351476|FG000|Overall Study|Protocol Violation|1|||
160719030|NCT01149863|580351482|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
160719031|NCT03326193|580351483|FG000|Overall Study|Sponsor decision|35|||
160719032|NCT01408043|580351484|FG000|Overall Study|unable to collect cells|1|||
160719033|NCT01168427|580351485|FG000|Overall Study|Patient exited prior to implant|1|||
160719034|NCT00640315|580351486|FG000|Overall Study|Withdrawal by Subject|0|||
160719035|NCT00640315|580351487|FG001|Overall Study|Withdrawal by Subject|1|||
160719036|NCT01256879|580351488|FG000|Overall Study|Withdrawal by Subject|1|||
160719037|NCT02964247|580351489|FG000|Overall Study|Lost to Follow-up|2|||
160719038|NCT02964247|580351490|FG001|Overall Study|Lost to Follow-up|0|||
160719039|NCT02964247|580351489|FG000|Overall Study|Withdrawal by Subject|1|||
160719040|NCT02964247|580351490|FG001|Overall Study|Withdrawal by Subject|2|||
160719041|NCT00725920|580351491|FG000|Overall Study|Lack of Efficacy|3|||
160719042|NCT00725920|580351492|FG001|Overall Study|Lack of Efficacy|6|||
160719043|NCT01530464|580351493|FG000|Washout (24h)|Withdrawal by Subject|1|||
160719044|NCT01530464|580351494|FG001|Washout (24h)|Withdrawal by Subject|0|||
160719045|NCT01530464|580351493|FG000|Washout (24h)|Withdrawal by Subject|0|||
160719046|NCT01530464|580351494|FG001|Washout (24h)|Withdrawal by Subject|1|||
160719047|NCT01709500|580351495|FG000|Overall Study|Randomized but not treated|0|||
160719048|NCT01709500|580351496|FG001|Overall Study|Randomized but not treated|1|||
160719049|NCT01709500|580351495|FG000|Overall Study|Adverse Event|5|||
160719050|NCT01709500|580351496|FG001|Overall Study|Adverse Event|1|||
160719051|NCT01709500|580351495|FG000|Overall Study|Poor compliance to protocol|2|||
160719052|NCT01709500|580351496|FG001|Overall Study|Poor compliance to protocol|1|||
160719053|NCT01709500|580351495|FG000|Overall Study|Other|3|||
160719054|NCT01709500|580351496|FG001|Overall Study|Other|1|||
160719055|NCT01709500|580351495|FG000|Overall Study|Related to IMP administration|1|||
160719056|NCT01709500|580351496|FG001|Overall Study|Related to IMP administration|0|||
160719057|NCT01709500|580351495|FG000|Overall Study|Treatment ongoing|156|||
160719058|NCT01709500|580351496|FG001|Overall Study|Treatment ongoing|78|||
160719059|NCT02107131|580351498|FG000|Overall Study|Lost to Follow-up|4|||
160719060|NCT02107131|580351499|FG001|Overall Study|Lost to Follow-up|4|||
160719061|NCT02107131|580351498|FG000|Overall Study|Physician Decision|1|||
160719062|NCT02107131|580351499|FG001|Overall Study|Physician Decision|0|||
160719063|NCT02107131|580351498|FG000|Overall Study|Withdrawal by Subject|2|||
160719064|NCT02107131|580351499|FG001|Overall Study|Withdrawal by Subject|0|||
160719065|NCT02107131|580351498|FG000|Overall Study|mental instability|1|||
160719066|NCT02107131|580351499|FG001|Overall Study|mental instability|0|||
160719067|NCT02107131|580351498|FG000|Overall Study|Death|0|||
160719068|NCT02107131|580351499|FG001|Overall Study|Death|1|||
160719069|NCT02107131|580351498|FG000|Overall Study|Protocol Violation|0|||
160719070|NCT02107131|580351499|FG001|Overall Study|Protocol Violation|4|||
160719071|NCT02286713|580351500|FG000|One Week Follow-Up|Death|1|||
160719072|NCT02286713|580351501|FG001|One Week Follow-Up|Death|0|||
160719073|NCT02286713|580351500|FG000|One Week Follow-Up|Lost to Follow-up|17|||
160719074|NCT02286713|580351501|FG001|One Week Follow-Up|Lost to Follow-up|21|||
160719075|NCT02286713|580351500|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
160719076|NCT02286713|580351501|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
160719077|NCT02286713|580351500|FG000|Three Month Follow-Up|Death|1|||
160719078|NCT02286713|580351501|FG001|Three Month Follow-Up|Death|1|||
160719079|NCT02286713|580351500|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
160719080|NCT02286713|580351501|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
160719081|NCT02286713|580351500|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
160719082|NCT02286713|580351501|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
160719083|NCT02286713|580351500|FG000|Six Month Follow-Up|Death|2|||
160719084|NCT02286713|580351501|FG001|Six Month Follow-Up|Death|0|||
160719085|NCT02286713|580351500|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
160719086|NCT02286713|580351501|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
160719087|NCT04314037|580351502|FG000|Treatment Period 2|Adverse Event|1|||
160719088|NCT04314037|580351503|FG001|Treatment Period 2|Adverse Event|0|||
160719089|NCT04314037|580351502|FG000|Treatment Period 3|Protocol Violation|1|||
160719090|NCT04314037|580351503|FG001|Treatment Period 3|Protocol Violation|0|||
160719091|NCT04314037|580351502|FG000|Treatment Period 3|Adverse Event|0|||
160719092|NCT04314037|580351503|FG001|Treatment Period 3|Adverse Event|1|||
160719093|NCT00856492|580351506|FG000|Overall Study|Ineligible or withdrew consent|1|||
160719094|NCT00856492|580351507|FG001|Overall Study|Ineligible or withdrew consent|1|||
160719095|NCT00856492|580351508|FG002|Overall Study|Ineligible or withdrew consent|2|||
160719096|NCT06018129|580351509|FG000|Overall Study|Death|1|||
160719097|NCT06018129|580351510|FG001|Overall Study|Death|1|||
160719098|NCT06018129|580351511|FG002|Overall Study|Death|2|||
160719099|NCT06018129|580351509|FG000|Overall Study|Sponsor Decision|2|||
160719100|NCT06018129|580351510|FG001|Overall Study|Sponsor Decision|2|||
160719101|NCT06018129|580351511|FG002|Overall Study|Sponsor Decision|1|||
160719102|NCT03832686|580351512|FG000|Overall Study|Lost to Follow-up|6|||
160719103|NCT03832686|580351513|FG001|Overall Study|Lost to Follow-up|9|||
160719104|NCT03832686|580351512|FG000|Overall Study|Discontinued Intervention|5|||
160719105|NCT03832686|580351513|FG001|Overall Study|Discontinued Intervention|4|||
160719106|NCT02235454|580351514|FG000|Overall Study|Withdrawal by Subject|2|||
160719107|NCT03323398|580351515|FG000|Overall Study|Other than Specified|0|||
160719108|NCT03323398|580351516|FG001|Overall Study|Other than Specified|1|||
160719109|NCT03323398|580351517|FG002|Overall Study|Other than Specified|2|||
160719110|NCT03323398|580351518|FG003|Overall Study|Other than Specified|0|||
160719111|NCT03323398|580351519|FG004|Overall Study|Other than Specified|0|||
160719112|NCT03323398|580351520|FG005|Overall Study|Other than Specified|0|||
160719113|NCT03323398|580351521|FG006|Overall Study|Other than Specified|1|||
160719114|NCT03323398|580351522|FG007|Overall Study|Other than Specified|0|||
160719115|NCT03323398|580351523|FG008|Overall Study|Other than Specified|2|||
160719116|NCT03323398|580351515|FG000|Overall Study|Lost to Follow-up|1|||
160719117|NCT03323398|580351516|FG001|Overall Study|Lost to Follow-up|2|||
160719118|NCT03323398|580351517|FG002|Overall Study|Lost to Follow-up|1|||
160719119|NCT03323398|580351518|FG003|Overall Study|Lost to Follow-up|0|||
160719120|NCT03323398|580351519|FG004|Overall Study|Lost to Follow-up|0|||
160719121|NCT03323398|580351520|FG005|Overall Study|Lost to Follow-up|0|||
160719122|NCT03323398|580351521|FG006|Overall Study|Lost to Follow-up|0|||
160719123|NCT03323398|580351522|FG007|Overall Study|Lost to Follow-up|0|||
160719124|NCT03323398|580351523|FG008|Overall Study|Lost to Follow-up|0|||
160719125|NCT03323398|580351515|FG000|Overall Study|Death|4|||
160719126|NCT03323398|580351516|FG001|Overall Study|Death|6|||
160719127|NCT03323398|580351517|FG002|Overall Study|Death|2|||
160719128|NCT03323398|580351518|FG003|Overall Study|Death|2|||
160719129|NCT03323398|580351519|FG004|Overall Study|Death|1|||
160719130|NCT03323398|580351520|FG005|Overall Study|Death|2|||
160719131|NCT03323398|580351521|FG006|Overall Study|Death|0|||
160719132|NCT03323398|580351522|FG007|Overall Study|Death|0|||
160719133|NCT03323398|580351523|FG008|Overall Study|Death|6|||
160719134|NCT03323398|580351515|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
160719135|NCT03323398|580351516|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
160719136|NCT03323398|580351517|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
160719137|NCT03323398|580351518|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
160719138|NCT03323398|580351519|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
160719139|NCT03323398|580351520|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
160719140|NCT03323398|580351521|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
160719141|NCT03323398|580351522|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
160719142|NCT03323398|580351523|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
160719143|NCT03323398|580351515|FG000|Overall Study|Withdrawal by Subject|2|||
160719144|NCT03323398|580351516|FG001|Overall Study|Withdrawal by Subject|1|||
160719145|NCT03323398|580351517|FG002|Overall Study|Withdrawal by Subject|3|||
160719146|NCT03323398|580351518|FG003|Overall Study|Withdrawal by Subject|0|||
160719147|NCT03323398|580351519|FG004|Overall Study|Withdrawal by Subject|0|||
160719148|NCT03323398|580351520|FG005|Overall Study|Withdrawal by Subject|1|||
160719149|NCT03323398|580351521|FG006|Overall Study|Withdrawal by Subject|0|||
160719150|NCT03323398|580351522|FG007|Overall Study|Withdrawal by Subject|0|||
160719151|NCT03323398|580351523|FG008|Overall Study|Withdrawal by Subject|0|||
160719152|NCT03323398|580351515|FG000|Overall Study|Participant was Put on Hospice|0|||
160719153|NCT03323398|580351516|FG001|Overall Study|Participant was Put on Hospice|0|||
160719154|NCT03323398|580351517|FG002|Overall Study|Participant was Put on Hospice|0|||
160719155|NCT03323398|580351518|FG003|Overall Study|Participant was Put on Hospice|0|||
160719156|NCT03323398|580351519|FG004|Overall Study|Participant was Put on Hospice|0|||
160719157|NCT03323398|580351520|FG005|Overall Study|Participant was Put on Hospice|0|||
160719158|NCT03323398|580351521|FG006|Overall Study|Participant was Put on Hospice|1|||
160719159|NCT03323398|580351522|FG007|Overall Study|Participant was Put on Hospice|0|||
160719160|NCT03323398|580351523|FG008|Overall Study|Participant was Put on Hospice|0|||
160719161|NCT03323398|580351515|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
160719162|NCT03323398|580351516|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
160719163|NCT03323398|580351517|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
160719164|NCT03323398|580351518|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
160719165|NCT03323398|580351519|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
160719166|NCT03323398|580351520|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
160719167|NCT03323398|580351521|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
160719168|NCT03323398|580351522|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
160719169|NCT03323398|580351523|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
160719170|NCT03641469|580351524|FG000|Overall Study|Ineligible|2|||
160719171|NCT03641469|580351524|FG000|Overall Study|Withdrawal by Subject|5|||
160719172|NCT03641469|580351524|FG000|Overall Study|Physician Decision|1|||
160719173|NCT03641469|580351524|FG000|Overall Study|Protocol Violation|1|||
160719174|NCT03641469|580351524|FG000|Overall Study|Lost to Follow-up|2|||
160719175|NCT00485732|580352881|FG000|Overall Study|Protocol Violation|1|||
160719176|NCT00485732|580352882|FG001|Overall Study|Protocol Violation|3|||
160719177|NCT00485732|580352881|FG000|Overall Study|Withdrawal by Subject|5|||
160719178|NCT00485732|580352882|FG001|Overall Study|Withdrawal by Subject|4|||
160719179|NCT00485732|580352881|FG000|Overall Study|Lost to Follow-up|2|||
160719180|NCT00485732|580352882|FG001|Overall Study|Lost to Follow-up|2|||
160719181|NCT05423093|580352884|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
160719182|NCT05423093|580352884|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
160719183|NCT05423093|580352884|FG000|Attended Intervention Session|Lost to Follow-up|3|||
160719184|NCT05423093|580352884|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
160719185|NCT05423093|580352884|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
160719186|NCT03593525|580352885|FG000|Overall Study|Withdrawal by Subject|1|||
160719187|NCT03593525|580352886|FG001|Overall Study|Withdrawal by Subject|0|||
160719188|NCT03593525|580352885|FG000|Overall Study|Lost to Follow-up|7|||
160719189|NCT03593525|580352886|FG001|Overall Study|Lost to Follow-up|5|||
160719190|NCT00210210|580352894|FG000|Overall Study|Withdrawal by Subject|3|||
160719191|NCT00210210|580352895|FG001|Overall Study|Withdrawal by Subject|2|||
160719192|NCT00210210|580352894|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
160719193|NCT00210210|580352895|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
160719194|NCT02445248|580352896|FG000|Overall Study|Death|45|||
160719195|NCT02445248|580352897|FG001|Overall Study|Death|12|||
160719196|NCT02445248|580352896|FG000|Overall Study|Progressive disease|13|||
160719197|NCT02445248|580352897|FG001|Overall Study|Progressive disease|1|||
160719198|NCT02445248|580352896|FG000|Overall Study|Subject decision|8|||
160719199|NCT02445248|580352897|FG001|Overall Study|Subject decision|0|||
160719200|NCT02445248|580352896|FG000|Overall Study|Physician Decision|5|||
160719201|NCT02445248|580352897|FG001|Overall Study|Physician Decision|0|||
160719202|NCT02445248|580352896|FG000|Overall Study|Adverse Event|1|||
160719203|NCT02445248|580352897|FG001|Overall Study|Adverse Event|0|||
160719204|NCT02445248|580352896|FG000|Overall Study|Lost to Follow-up|1|||
160719205|NCT02445248|580352897|FG001|Overall Study|Lost to Follow-up|0|||
160719206|NCT02596971|580352898|FG000|Overall Study|Death|5|||
160719207|NCT02596971|580352899|FG001|Overall Study|Death|1|||
160719208|NCT02596971|580352900|FG002|Overall Study|Death|5|||
160719209|NCT02596971|580352898|FG000|Overall Study|Withdrawal by Subject|5|||
160719210|NCT02596971|580352899|FG001|Overall Study|Withdrawal by Subject|1|||
160719211|NCT02596971|580352900|FG002|Overall Study|Withdrawal by Subject|4|||
160719212|NCT02954601|580352903|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
160719213|NCT02954601|580352904|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
160719214|NCT02954601|580352905|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
160719215|NCT02954601|580352906|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
160719216|NCT02393950|580352912|FG000|Overall Study|Adverse Event|1|||
160719217|NCT02393950|580352913|FG001|Overall Study|Adverse Event|0|||
160719218|NCT02393950|580352912|FG000|Overall Study|Withdrawal by Subject|0|||
160719219|NCT02393950|580352913|FG001|Overall Study|Withdrawal by Subject|1|||
160719220|NCT00370552|580352914|FG000|Overall Study|Adverse Event|2|||
160719221|NCT00370552|580352915|FG001|Overall Study|Adverse Event|2|||
160719222|NCT00370552|580352916|FG002|Overall Study|Adverse Event|2|||
160719223|NCT00370552|580352914|FG000|Overall Study|Disease progression|23|||
160719224|NCT00370552|580352915|FG001|Overall Study|Disease progression|23|||
160719225|NCT00370552|580352916|FG002|Overall Study|Disease progression|15|||
160719226|NCT00370552|580352914|FG000|Overall Study|Maximum clinical benefit|3|||
160719227|NCT00370552|580352915|FG001|Overall Study|Maximum clinical benefit|5|||
160719228|NCT00370552|580352916|FG002|Overall Study|Maximum clinical benefit|5|||
160719229|NCT00370552|580352914|FG000|Overall Study|Poor or noncompliance|0|||
160719230|NCT00370552|580352915|FG001|Overall Study|Poor or noncompliance|0|||
160719231|NCT00370552|580352916|FG002|Overall Study|Poor or noncompliance|1|||
160719232|NCT00370552|580352914|FG000|Overall Study|Study drug toxicity|11|||
160719233|NCT00370552|580352915|FG001|Overall Study|Study drug toxicity|8|||
160719234|NCT00370552|580352916|FG002|Overall Study|Study drug toxicity|6|||
160719235|NCT00370552|580352914|FG000|Overall Study|Withdrawal by Subject|2|||
160719236|NCT00370552|580352915|FG001|Overall Study|Withdrawal by Subject|0|||
160719237|NCT00370552|580352916|FG002|Overall Study|Withdrawal by Subject|1|||
160719238|NCT00370552|580352914|FG000|Overall Study|Still on treatment|1|||
160719239|NCT00370552|580352915|FG001|Overall Study|Still on treatment|3|||
160719240|NCT00370552|580352916|FG002|Overall Study|Still on treatment|2|||
160719241|NCT00370552|580352914|FG000|Overall Study|Never treated|1|||
160719242|NCT00370552|580352915|FG001|Overall Study|Never treated|0|||
160719243|NCT00370552|580352916|FG002|Overall Study|Never treated|0|||
160719244|NCT00370552|580352914|FG000|Overall Study|Physician Decision|1|||
160719245|NCT00370552|580352915|FG001|Overall Study|Physician Decision|1|||
160719246|NCT00370552|580352916|FG002|Overall Study|Physician Decision|0|||
160719247|NCT00370552|580352914|FG000|Overall Study|Investigator decision|2|||
160719248|NCT00370552|580352915|FG001|Overall Study|Investigator decision|1|||
160719249|NCT00370552|580352916|FG002|Overall Study|Investigator decision|0|||
160719250|NCT00370552|580352914|FG000|Overall Study|High risk of allergic reaction|0|||
160719251|NCT00370552|580352915|FG001|Overall Study|High risk of allergic reaction|1|||
160719252|NCT00370552|580352916|FG002|Overall Study|High risk of allergic reaction|0|||
160719253|NCT00370552|580352914|FG000|Overall Study|Planned radiation for palliation|0|||
160719254|NCT00370552|580352915|FG001|Overall Study|Planned radiation for palliation|1|||
160719255|NCT00370552|580352916|FG002|Overall Study|Planned radiation for palliation|0|||
160719256|NCT04067050|580352917|FG000|One Month|Lost to Follow-up|4|||
160719257|NCT04067050|580352918|FG001|One Month|Lost to Follow-up|0|||
160719258|NCT04067050|580352917|FG000|Two Month|Lost to Follow-up|1|||
160719259|NCT04067050|580352918|FG001|Two Month|Lost to Follow-up|0|||
160719260|NCT04067050|580352917|FG000|Two Month|Adverse Event|1|||
160719261|NCT04067050|580352918|FG001|Two Month|Adverse Event|0|||
160719262|NCT03776357|580352921|FG000|Overall Study|Lost to Follow-up|3|||
160719263|NCT00837148|580352922|FG000|Overall Study|Adverse Event|1|||
160719264|NCT00837148|580352922|FG000|Overall Study|Death|1|||
160719265|NCT00931411|580352925|FG000|First Intervention - 42 Days|Adverse Event|2|||
160719266|NCT00931411|580352926|FG001|First Intervention - 42 Days|Adverse Event|3|||
160719267|NCT00931411|580352925|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
160719268|NCT00931411|580352926|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
160719269|NCT00931411|580352925|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
160719270|NCT00931411|580352926|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
160719271|NCT01827111|580352927|FG000|Overall Study|Disease Progression|1|||
160719272|NCT03181633|580352930|FG000|Overall Study|Withdrawal by Subject|1|||
160719273|NCT03181633|580352930|FG000|Overall Study|Missing follow-up visit|1|||
160719274|NCT04383327|580352937|FG000|Overall Study|Lost to Follow-up|112|||
160719275|NCT04383327|580352938|FG001|Overall Study|Lost to Follow-up|14|||
160719276|NCT04383327|580352939|FG002|Overall Study|Lost to Follow-up|78|||
160719277|NCT04383327|580352940|FG003|Overall Study|Lost to Follow-up|13|||
160719278|NCT04383327|580352941|FG004|Overall Study|Lost to Follow-up|110|||
160719279|NCT04383327|580352942|FG005|Overall Study|Lost to Follow-up|13|||
160719280|NCT04383327|580352943|FG006|Overall Study|Lost to Follow-up|74|||
160719281|NCT04383327|580352944|FG007|Overall Study|Lost to Follow-up|13|||
160719282|NCT04383327|580352945|FG008|Overall Study|Lost to Follow-up|78|||
160719283|NCT04383327|580352946|FG009|Overall Study|Lost to Follow-up|10|||
160719284|NCT04383327|580352947|FG010|Overall Study|Lost to Follow-up|160|||
160719285|NCT04383327|580352948|FG011|Overall Study|Lost to Follow-up|13|||
160719286|NCT04837196|580352949|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
160719287|NCT04837196|580352950|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
160719288|NCT04837196|580352951|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
160719289|NCT04837196|580352952|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
160719290|NCT04837196|580352953|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
160719291|NCT04837196|580352949|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
160719292|NCT04837196|580352950|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
160719293|NCT04837196|580352951|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
160719294|NCT04837196|580352952|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
160719295|NCT04837196|580352953|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
160719296|NCT04837196|580352949|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
160719297|NCT04837196|580352950|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
160719298|NCT04837196|580352951|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
160719299|NCT04837196|580352952|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
160719300|NCT04837196|580352953|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
160719301|NCT04837196|580352949|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
160719302|NCT04837196|580352950|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
160719303|NCT04837196|580352951|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
160719304|NCT04837196|580352952|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
160719305|NCT04837196|580352953|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
160719306|NCT04837196|580352949|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
160719307|NCT04837196|580352950|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
160719308|NCT04837196|580352951|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
160719309|NCT04837196|580352952|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
160719310|NCT04837196|580352953|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
160719311|NCT01306305|580352954|FG000|Overall Study|Lost to Follow-up|1|||
160719312|NCT01306305|580352955|FG001|Overall Study|Lost to Follow-up|0|||
160719313|NCT01306305|580352954|FG000|Overall Study|Withdrew consent|1|||
160719314|NCT01306305|580352955|FG001|Overall Study|Withdrew consent|0|||
160719315|NCT04030299|580352956|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
160719316|NCT04030299|580352956|FG000|Overall Study|Withdrawal by Subject|3|||
160719317|NCT00699998|580352957|FG000|Overall Study|Withdrawal by Subject|194|||
160719318|NCT00699998|580352958|FG001|Overall Study|Withdrawal by Subject|83|||
160719319|NCT00699998|580352959|FG002|Overall Study|Withdrawal by Subject|202|||
160719320|NCT00699998|580352960|FG003|Overall Study|Withdrawal by Subject|80|||
160719321|NCT00699998|580352957|FG000|Overall Study|Physician Decision|3|||
160719322|NCT00699998|580352958|FG001|Overall Study|Physician Decision|2|||
160719323|NCT00699998|580352959|FG002|Overall Study|Physician Decision|1|||
160719324|NCT00699998|580352960|FG003|Overall Study|Physician Decision|1|||
160719325|NCT00699998|580352957|FG000|Overall Study|Lost to Follow-up|2|||
160719326|NCT00699998|580352958|FG001|Overall Study|Lost to Follow-up|1|||
160719327|NCT00699998|580352959|FG002|Overall Study|Lost to Follow-up|3|||
160719328|NCT00699998|580352960|FG003|Overall Study|Lost to Follow-up|1|||
160719329|NCT00359424|580352968|FG000|Overall Study|Death|99|||
160719330|NCT00359424|580352969|FG001|Overall Study|Death|58|||
160719331|NCT00359424|580352968|FG000|Overall Study|Lost to Follow-up|19|||
160719332|NCT00359424|580352969|FG001|Overall Study|Lost to Follow-up|7|||
160719333|NCT00359424|580352968|FG000|Overall Study|Withdrawal by Subject|10|||
160719334|NCT00359424|580352969|FG001|Overall Study|Withdrawal by Subject|2|||
160719335|NCT00359424|580352968|FG000|Overall Study|follow up not conducted|2|||
160719336|NCT00359424|580352969|FG001|Overall Study|follow up not conducted|0|||
160719337|NCT02208362|580352970|FG000|Overall Study|Participant did not complete treatment|0|||
160719338|NCT02208362|580352971|FG001|Overall Study|Participant did not complete treatment|1|||
160719339|NCT02208362|580352972|FG002|Overall Study|Participant did not complete treatment|0|||
160719340|NCT02208362|580352973|FG003|Overall Study|Participant did not complete treatment|0|||
160719341|NCT02208362|580352974|FG004|Overall Study|Participant did not complete treatment|0|||
160719342|NCT02208362|580352975|FG005|Overall Study|Participant did not complete treatment|0|||
160719343|NCT02208362|580352976|FG006|Overall Study|Participant did not complete treatment|1|||
160719344|NCT02208362|580352977|FG007|Overall Study|Participant did not complete treatment|1|||
160719345|NCT02208362|580352978|FG008|Overall Study|Participant did not complete treatment|2|||
160719346|NCT02208362|580352979|FG009|Overall Study|Participant did not complete treatment|0|||
160719347|NCT02208362|580352980|FG010|Overall Study|Participant did not complete treatment|1|||
160719348|NCT02208362|580352981|FG011|Overall Study|Participant did not complete treatment|0|||
160719349|NCT02208362|580352970|FG000|Overall Study|Participant received disallowed treatment|0|||
160719350|NCT02208362|580352971|FG001|Overall Study|Participant received disallowed treatment|0|||
160719351|NCT02208362|580352972|FG002|Overall Study|Participant received disallowed treatment|0|||
160719352|NCT02208362|580352973|FG003|Overall Study|Participant received disallowed treatment|0|||
160719353|NCT02208362|580352974|FG004|Overall Study|Participant received disallowed treatment|0|||
160719354|NCT02208362|580352975|FG005|Overall Study|Participant received disallowed treatment|0|||
160719355|NCT02208362|580352976|FG006|Overall Study|Participant received disallowed treatment|0|||
160719356|NCT02208362|580352977|FG007|Overall Study|Participant received disallowed treatment|0|||
160719357|NCT02208362|580352978|FG008|Overall Study|Participant received disallowed treatment|1|||
160719358|NCT02208362|580352979|FG009|Overall Study|Participant received disallowed treatment|0|||
160719359|NCT02208362|580352980|FG010|Overall Study|Participant received disallowed treatment|0|||
160719360|NCT02208362|580352981|FG011|Overall Study|Participant received disallowed treatment|0|||
160719361|NCT05479435|580352984|FG000|Overall Study|Withdrawal by Subject|1|||
160719362|NCT05479435|580352985|FG001|Overall Study|Withdrawal by Subject|0|||
160719363|NCT05479435|580352986|FG002|Overall Study|Withdrawal by Subject|0|||
160719364|NCT05479435|580352984|FG000|Overall Study|Covid 19|0|||
160719365|NCT05479435|580352985|FG001|Overall Study|Covid 19|0|||
160719366|NCT05479435|580352986|FG002|Overall Study|Covid 19|2|||
160719367|NCT00955617|580352990|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
160719368|NCT00955617|580352991|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
160719369|NCT00955617|580352990|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
160719370|NCT00955617|580352991|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
160719371|NCT00955617|580352990|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
160719372|NCT00955617|580352991|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
160719373|NCT00955617|580352990|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
160719374|NCT00955617|580352991|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
160719375|NCT00982657|580352992|FG000|Overall Study|Death|1|||
160719376|NCT00982657|580352993|FG001|Overall Study|Death|0|||
160719377|NCT00982657|580352994|FG002|Overall Study|Death|1|||
160719378|NCT00982657|580352995|FG003|Overall Study|Death|1|||
160719379|NCT00982657|580352992|FG000|Overall Study|Withdrawal by Subject|0|||
160719380|NCT00982657|580352993|FG001|Overall Study|Withdrawal by Subject|0|||
160719381|NCT00982657|580352994|FG002|Overall Study|Withdrawal by Subject|1|||
160719382|NCT00982657|580352995|FG003|Overall Study|Withdrawal by Subject|3|||
160719383|NCT00982657|580352992|FG000|Overall Study|Other|0|||
160719384|NCT00982657|580352993|FG001|Overall Study|Other|0|||
160719385|NCT00982657|580352994|FG002|Overall Study|Other|0|||
160719386|NCT00982657|580352995|FG003|Overall Study|Other|4|||
160719387|NCT00982657|580352992|FG000|Overall Study|On going at date of cut-off|0|||
160719388|NCT00982657|580352993|FG001|Overall Study|On going at date of cut-off|0|||
160719389|NCT00982657|580352994|FG002|Overall Study|On going at date of cut-off|0|||
160719390|NCT00982657|580352995|FG003|Overall Study|On going at date of cut-off|1|||
160719391|NCT05207865|580354475|FG000|Open-Label Treatment Phase|Adverse Event|7|||
160719392|NCT05207865|580354475|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
160719393|NCT05207865|580354475|FG000|Open-Label Treatment Phase|Non-compliance|3|||
160719394|NCT05207865|580354475|FG000|Open-Label Treatment Phase|Other|17|||
160719395|NCT05207865|580354475|FG000|Open-Label Treatment Phase|Physician Decision|2|||
160719396|NCT05207865|580354475|FG000|Open-Label Treatment Phase|Pregnancy|1|||
160719397|NCT05207865|580354475|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
160719398|NCT05207865|580354475|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
160719399|NCT05207865|580354475|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
160719400|NCT05207865|580354475|FG000|Follow-up Phase|Lost to Follow-up|1|||
160719401|NCT05207865|580354475|FG000|Follow-up Phase|Non-compliance|1|||
160719402|NCT05207865|580354475|FG000|Follow-up Phase|Not reported|2|||
160719403|NCT05207865|580354475|FG000|Follow-up Phase|Not collected|11|||
160719404|NCT00739882|580354480|FG000|Double-blind Period|Adverse Event|1|||
160719405|NCT00739882|580354481|FG001|Double-blind Period|Adverse Event|2|||
160719406|NCT00739882|580354480|FG000|Double-blind Period|Protocol Violation|1|||
160719407|NCT00739882|580354481|FG001|Double-blind Period|Protocol Violation|0|||
160719408|NCT00739882|580354480|FG000|Double-blind Period|Lack of Efficacy|1|||
160719409|NCT00739882|580354481|FG001|Double-blind Period|Lack of Efficacy|1|||
160719410|NCT00739882|580354480|FG000|Double-blind Period|Other|16|||
160719411|NCT00739882|580354481|FG001|Double-blind Period|Other|8|||
160719412|NCT00739882|580354480|FG000|Open-label Period|Adverse Event|1|||
160719413|NCT00739882|580354481|FG001|Open-label Period|Adverse Event|0|||
160719414|NCT00739882|580354480|FG000|Open-label Period|Other|9|||
160719415|NCT00739882|580354481|FG001|Open-label Period|Other|5|||
160719416|NCT01415518|580354482|FG000|Overall Study|Withdrawal by Subject|2|||
160719417|NCT01415518|580354483|FG001|Overall Study|Withdrawal by Subject|12|||
160719418|NCT01415518|580354482|FG000|Overall Study|Protocol Violation|6|||
160719419|NCT01415518|580354483|FG001|Overall Study|Protocol Violation|8|||
160719420|NCT01415518|580354482|FG000|Overall Study|Lost to Follow-up|3|||
160719421|NCT01415518|580354483|FG001|Overall Study|Lost to Follow-up|5|||
160719422|NCT01415518|580354482|FG000|Overall Study|Adverse Event|3|||
160719423|NCT01415518|580354483|FG001|Overall Study|Adverse Event|4|||
160719424|NCT01415518|580354482|FG000|Overall Study|Death|1|||
160719425|NCT01415518|580354483|FG001|Overall Study|Death|1|||
160719426|NCT01415518|580354482|FG000|Overall Study|Condition under Investigation Worsened|1|||
160719427|NCT01415518|580354483|FG001|Overall Study|Condition under Investigation Worsened|1|||
160719428|NCT05364931|580354487|FG000|Overall Study|Adverse Event|0|||
160719429|NCT05364931|580354488|FG001|Overall Study|Adverse Event|2|||
160719430|NCT05364931|580354489|FG002|Overall Study|Adverse Event|1|||
160719431|NCT05364931|580354490|FG003|Overall Study|Adverse Event|0|||
160719432|NCT05364931|580354487|FG000|Overall Study|Lost to Follow-up|1|||
160719433|NCT05364931|580354488|FG001|Overall Study|Lost to Follow-up|0|||
160719434|NCT05364931|580354489|FG002|Overall Study|Lost to Follow-up|0|||
160719435|NCT05364931|580354490|FG003|Overall Study|Lost to Follow-up|0|||
160719436|NCT05364931|580354487|FG000|Overall Study|Withdrawal by Subject|1|||
160719437|NCT05364931|580354488|FG001|Overall Study|Withdrawal by Subject|1|||
160719438|NCT05364931|580354489|FG002|Overall Study|Withdrawal by Subject|3|||
160719439|NCT05364931|580354490|FG003|Overall Study|Withdrawal by Subject|2|||
160719440|NCT05364931|580354487|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
160719441|NCT05364931|580354488|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
160719442|NCT05364931|580354489|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
160719443|NCT05364931|580354490|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
160719444|NCT05364931|580354487|FG000|Overall Study|Discontinued|1|||
160719445|NCT05364931|580354488|FG001|Overall Study|Discontinued|0|||
160719446|NCT05364931|580354489|FG002|Overall Study|Discontinued|0|||
160719447|NCT05364931|580354490|FG003|Overall Study|Discontinued|0|||
160719448|NCT03976362|580354491|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
160719449|NCT03976362|580354492|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
160719450|NCT03976362|580354493|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
160719451|NCT03976362|580354491|FG000|Induction Phase|Death|62|||
160719452|NCT03976362|580354492|FG001|Induction Phase|Death|0|||
160719453|NCT03976362|580354493|FG002|Induction Phase|Death|0|||
160719454|NCT03976362|580354491|FG000|Maintenance Phase|Participants Ongoing|0|||
160719455|NCT03976362|580354492|FG001|Maintenance Phase|Participants Ongoing|106|||
160719456|NCT03976362|580354493|FG002|Maintenance Phase|Participants Ongoing|103|||
160719457|NCT03976362|580354491|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160719458|NCT03976362|580354492|FG001|Maintenance Phase|Withdrawal by Subject|4|||
160719459|NCT03976362|580354493|FG002|Maintenance Phase|Withdrawal by Subject|4|||
160719460|NCT03976362|580354491|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
160719461|NCT03976362|580354492|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
160719462|NCT03976362|580354493|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
160719463|NCT03976362|580354491|FG000|Maintenance Phase|Death|0|||
160719464|NCT03976362|580354492|FG001|Maintenance Phase|Death|186|||
160719465|NCT03976362|580354493|FG002|Maintenance Phase|Death|187|||
160719466|NCT04846569|580354494|FG000|Overall Study|Withdrawal by Subject|3|||
160719467|NCT04846569|580354495|FG001|Overall Study|Withdrawal by Subject|1|||
160719468|NCT01120184|580354500|FG000|Overall Study|Adverse Event|0|||
160719469|NCT01120184|580354501|FG001|Overall Study|Adverse Event|1|||
160719470|NCT01120184|580354502|FG002|Overall Study|Adverse Event|0|||
160719471|NCT01120184|580354500|FG000|Overall Study|Lost to Follow-up|13|||
160719472|NCT01120184|580354501|FG001|Overall Study|Lost to Follow-up|13|||
160719473|NCT01120184|580354502|FG002|Overall Study|Lost to Follow-up|11|||
160719474|NCT01120184|580354500|FG000|Overall Study|Physician Decision|9|||
160719475|NCT01120184|580354501|FG001|Overall Study|Physician Decision|1|||
160719476|NCT01120184|580354502|FG002|Overall Study|Physician Decision|3|||
160719477|NCT01120184|580354500|FG000|Overall Study|Reason not Specified|8|||
160719478|NCT01120184|580354501|FG001|Overall Study|Reason not Specified|3|||
160719479|NCT01120184|580354502|FG002|Overall Study|Reason not Specified|12|||
160719480|NCT01120184|580354500|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
160719481|NCT01120184|580354501|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
160719482|NCT01120184|580354502|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
160719483|NCT01120184|580354500|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
160719484|NCT01120184|580354501|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
160719485|NCT01120184|580354502|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
160719486|NCT01120184|580354500|FG000|Overall Study|Death|170|||
160719487|NCT01120184|580354501|FG001|Overall Study|Death|176|||
160719488|NCT01120184|580354502|FG002|Overall Study|Death|169|||
160719489|NCT02525783|580354504|FG000|Overall Study|Lost to Follow-up|10|||
160719490|NCT00824772|580354505|FG000|Overall Study|Withdrawal by Subject|8|||
160719491|NCT00683618|580354508|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
160719492|NCT00683618|580354509|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
160719493|NCT00683618|580354510|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
160719494|NCT00683618|580354508|FG000|Randomised Treatment Period|Protocol Violation|0|||
160719495|NCT00683618|580354509|FG001|Randomised Treatment Period|Protocol Violation|1|||
160719496|NCT00683618|580354510|FG002|Randomised Treatment Period|Protocol Violation|0|||
160719497|NCT00683618|580354508|FG000|Randomised Treatment Period|Adverse Event|2|||
160719498|NCT00683618|580354509|FG001|Randomised Treatment Period|Adverse Event|0|||
160719499|NCT00683618|580354510|FG002|Randomised Treatment Period|Adverse Event|2|||
160719500|NCT00683618|580354508|FG000|Randomised Treatment Period|Reason not provided|0|||
160719501|NCT00683618|580354509|FG001|Randomised Treatment Period|Reason not provided|0|||
160719502|NCT00683618|580354510|FG002|Randomised Treatment Period|Reason not provided|2|||
160719503|NCT00683618|580354508|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
160719504|NCT00683618|580354509|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
160719505|NCT00683618|580354510|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
160719506|NCT00683618|580354508|FG000|Extension Treatment Period|Adverse Event|1|||
160719507|NCT00683618|580354509|FG001|Extension Treatment Period|Adverse Event|0|||
160719508|NCT00683618|580354510|FG002|Extension Treatment Period|Adverse Event|0|||
160719509|NCT00683618|580354508|FG000|Extension Treatment Period|Protocol Violation|1|||
160719510|NCT00683618|580354509|FG001|Extension Treatment Period|Protocol Violation|0|||
160719511|NCT00683618|580354510|FG002|Extension Treatment Period|Protocol Violation|0|||
160719512|NCT04570670|580354511|FG000|Overall Study|Withdrawal by Subject|1|||
160719513|NCT04570670|580354512|FG001|Overall Study|Withdrawal by Subject|0|||
160719514|NCT01002989|580354516|FG000|Overall Study|exclusion criteria, no consent|5|||
160719515|NCT00318474|580354517|FG000|Overall Study|Adverse Event|1|||
160719516|NCT00318474|580354518|FG001|Overall Study|Adverse Event|1|||
160719517|NCT00318474|580354517|FG000|Overall Study|Lost to Follow-up|0|||
160719518|NCT00318474|580354518|FG001|Overall Study|Lost to Follow-up|1|||
160719519|NCT00318474|580354517|FG000|Overall Study|Pregnancy|0|||
160719520|NCT00318474|580354518|FG001|Overall Study|Pregnancy|2|||
160719521|NCT00318474|580354517|FG000|Overall Study|Protocol Violation|1|||
160719522|NCT00318474|580354518|FG001|Overall Study|Protocol Violation|0|||
160719523|NCT00318474|580354517|FG000|Overall Study|Withdrawal by Subject|3|||
160719524|NCT00318474|580354518|FG001|Overall Study|Withdrawal by Subject|2|||
160719525|NCT00318474|580354517|FG000|Overall Study|Fall in GFR|3|||
160719526|NCT00318474|580354518|FG001|Overall Study|Fall in GFR|3|||
160719527|NCT00318474|580354517|FG000|Overall Study|Post-therapy hyperflycemia|0|||
160719528|NCT00318474|580354518|FG001|Overall Study|Post-therapy hyperflycemia|1|||
160719529|NCT00318474|580354517|FG000|Overall Study|Trial terminated|10|||
160719530|NCT00318474|580354518|FG001|Overall Study|Trial terminated|7|||
160719531|NCT02342678|580354519|FG000|Overall Study|Lost to Follow-up|0|||
160719532|NCT02342678|580354520|FG001|Overall Study|Lost to Follow-up|1|||
160719533|NCT02342678|580354519|FG000|Overall Study|Too busy to complete study|0|||
160719534|NCT02342678|580354520|FG001|Overall Study|Too busy to complete study|2|||
160719535|NCT02342678|580354519|FG000|Overall Study|Family illness/emergency|0|||
160719536|NCT02342678|580354520|FG001|Overall Study|Family illness/emergency|1|||
160719537|NCT02342678|580354519|FG000|Overall Study|Illness/medical reason|1|||
160719538|NCT02342678|580354520|FG001|Overall Study|Illness/medical reason|1|||
160719539|NCT00460603|580354521|FG000|Phase 1|Death|1|||
160719540|NCT00460603|580354522|FG001|Phase 1|Death|0|||
160719541|NCT00460603|580354523|FG002|Phase 1|Death|0|||
160719542|NCT00460603|580354524|FG003|Phase 1|Death|2|||
160719543|NCT00460603|580354525|FG004|Phase 1|Death|0|||
160719544|NCT00460603|580354526|FG005|Phase 1|Death|0|||
160719545|NCT00460603|580354527|FG006|Phase 1|Death|0|||
160719546|NCT00460603|580354528|FG007|Phase 1|Death|0|||
160719547|NCT00460603|580354529|FG008|Phase 1|Death|1|||
160719548|NCT00460603|580354530|FG009|Phase 1|Death|0|||
160719549|NCT00460603|580354531|FG010|Phase 1|Death|0|||
160719550|NCT00460603|580354532|FG011|Phase 1|Death|0|||
160719551|NCT00460603|580354521|FG000|Phase 1|Adverse Event|3|||
160719552|NCT00460603|580354522|FG001|Phase 1|Adverse Event|1|||
160719553|NCT00460603|580354523|FG002|Phase 1|Adverse Event|1|||
160719554|NCT00460603|580354524|FG003|Phase 1|Adverse Event|2|||
160719555|NCT00460603|580354525|FG004|Phase 1|Adverse Event|0|||
160719556|NCT00460603|580354526|FG005|Phase 1|Adverse Event|0|||
160719557|NCT00460603|580354527|FG006|Phase 1|Adverse Event|3|||
160719558|NCT00460603|580354528|FG007|Phase 1|Adverse Event|0|||
160719559|NCT00460603|580354529|FG008|Phase 1|Adverse Event|4|||
160719560|NCT00460603|580354530|FG009|Phase 1|Adverse Event|0|||
160719561|NCT00460603|580354531|FG010|Phase 1|Adverse Event|0|||
160719562|NCT00460603|580354532|FG011|Phase 1|Adverse Event|0|||
160719563|NCT00460603|580354521|FG000|Phase 1|Lack of Efficacy|1|||
160719564|NCT00460603|580354522|FG001|Phase 1|Lack of Efficacy|0|||
160719565|NCT00460603|580354523|FG002|Phase 1|Lack of Efficacy|1|||
160719566|NCT00460603|580354524|FG003|Phase 1|Lack of Efficacy|2|||
160719567|NCT00460603|580354525|FG004|Phase 1|Lack of Efficacy|2|||
160719568|NCT00460603|580354526|FG005|Phase 1|Lack of Efficacy|2|||
160719569|NCT00460603|580354527|FG006|Phase 1|Lack of Efficacy|2|||
160719570|NCT00460603|580354528|FG007|Phase 1|Lack of Efficacy|2|||
160719571|NCT00460603|580354529|FG008|Phase 1|Lack of Efficacy|11|||
160719572|NCT00460603|580354530|FG009|Phase 1|Lack of Efficacy|0|||
160719573|NCT00460603|580354531|FG010|Phase 1|Lack of Efficacy|0|||
160719574|NCT00460603|580354532|FG011|Phase 1|Lack of Efficacy|0|||
160719575|NCT00460603|580354521|FG000|Phase 1|Withdrawal by Subject|1|||
160719576|NCT00460603|580354522|FG001|Phase 1|Withdrawal by Subject|2|||
160719577|NCT00460603|580354523|FG002|Phase 1|Withdrawal by Subject|1|||
160719578|NCT00460603|580354524|FG003|Phase 1|Withdrawal by Subject|1|||
160719579|NCT00460603|580354525|FG004|Phase 1|Withdrawal by Subject|3|||
160719580|NCT00460603|580354526|FG005|Phase 1|Withdrawal by Subject|0|||
160719581|NCT00460603|580354527|FG006|Phase 1|Withdrawal by Subject|1|||
160719582|NCT00460603|580354528|FG007|Phase 1|Withdrawal by Subject|0|||
160719583|NCT00460603|580354529|FG008|Phase 1|Withdrawal by Subject|2|||
160719584|NCT00460603|580354530|FG009|Phase 1|Withdrawal by Subject|0|||
160719585|NCT00460603|580354531|FG010|Phase 1|Withdrawal by Subject|0|||
160719586|NCT00460603|580354532|FG011|Phase 1|Withdrawal by Subject|0|||
160719587|NCT00460603|580354521|FG000|Phase 1|Other|0|||
160719588|NCT00460603|580354522|FG001|Phase 1|Other|3|||
160719589|NCT00460603|580354523|FG002|Phase 1|Other|1|||
160719590|NCT00460603|580354524|FG003|Phase 1|Other|1|||
160719591|NCT00460603|580354525|FG004|Phase 1|Other|1|||
160719592|NCT00460603|580354526|FG005|Phase 1|Other|2|||
160719593|NCT00460603|580354527|FG006|Phase 1|Other|0|||
160719594|NCT00460603|580354528|FG007|Phase 1|Other|1|||
160719595|NCT00460603|580354529|FG008|Phase 1|Other|0|||
160719596|NCT00460603|580354530|FG009|Phase 1|Other|0|||
160719597|NCT00460603|580354531|FG010|Phase 1|Other|0|||
160719598|NCT00460603|580354532|FG011|Phase 1|Other|0|||
160719599|NCT00460603|580354521|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719600|NCT00460603|580354522|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719601|NCT00460603|580354523|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719602|NCT00460603|580354524|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719603|NCT00460603|580354525|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719604|NCT00460603|580354526|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719605|NCT00460603|580354527|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719606|NCT00460603|580354528|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719607|NCT00460603|580354529|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719608|NCT00460603|580354530|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
160719609|NCT00460603|580354531|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719610|NCT00460603|580354532|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
160719611|NCT00460603|580354521|FG000|Phase 2|Adverse Event|0|||
160719612|NCT00460603|580354522|FG001|Phase 2|Adverse Event|0|||
160719613|NCT00460603|580354523|FG002|Phase 2|Adverse Event|0|||
160719614|NCT00460603|580354524|FG003|Phase 2|Adverse Event|0|||
160719615|NCT00460603|580354525|FG004|Phase 2|Adverse Event|0|||
160719616|NCT00460603|580354526|FG005|Phase 2|Adverse Event|0|||
160719617|NCT00460603|580354527|FG006|Phase 2|Adverse Event|0|||
160719618|NCT00460603|580354528|FG007|Phase 2|Adverse Event|0|||
160719619|NCT00460603|580354529|FG008|Phase 2|Adverse Event|0|||
160719620|NCT00460603|580354530|FG009|Phase 2|Adverse Event|12|||
160719621|NCT00460603|580354531|FG010|Phase 2|Adverse Event|9|||
160719622|NCT00460603|580354532|FG011|Phase 2|Adverse Event|10|||
160719623|NCT00460603|580354521|FG000|Phase 2|Death|0|||
160719624|NCT00460603|580354522|FG001|Phase 2|Death|0|||
160719625|NCT00460603|580354523|FG002|Phase 2|Death|0|||
160719626|NCT00460603|580354524|FG003|Phase 2|Death|0|||
160719627|NCT00460603|580354525|FG004|Phase 2|Death|0|||
160719628|NCT00460603|580354526|FG005|Phase 2|Death|0|||
160719629|NCT00460603|580354527|FG006|Phase 2|Death|0|||
160719630|NCT00460603|580354528|FG007|Phase 2|Death|0|||
160719631|NCT00460603|580354529|FG008|Phase 2|Death|0|||
160719632|NCT00460603|580354530|FG009|Phase 2|Death|4|||
160719633|NCT00460603|580354531|FG010|Phase 2|Death|2|||
160719634|NCT00460603|580354532|FG011|Phase 2|Death|2|||
160719635|NCT00460603|580354521|FG000|Phase 2|Protocol Violation|0|||
160719636|NCT00460603|580354522|FG001|Phase 2|Protocol Violation|0|||
160719637|NCT00460603|580354523|FG002|Phase 2|Protocol Violation|0|||
160719638|NCT00460603|580354524|FG003|Phase 2|Protocol Violation|0|||
160719639|NCT00460603|580354525|FG004|Phase 2|Protocol Violation|0|||
160719640|NCT00460603|580354526|FG005|Phase 2|Protocol Violation|0|||
160719641|NCT00460603|580354527|FG006|Phase 2|Protocol Violation|0|||
160719642|NCT00460603|580354528|FG007|Phase 2|Protocol Violation|0|||
160719643|NCT00460603|580354529|FG008|Phase 2|Protocol Violation|0|||
160719644|NCT00460603|580354530|FG009|Phase 2|Protocol Violation|1|||
160719645|NCT00460603|580354531|FG010|Phase 2|Protocol Violation|1|||
160719646|NCT00460603|580354532|FG011|Phase 2|Protocol Violation|0|||
160719647|NCT00460603|580354521|FG000|Phase 2|Lost to Follow-up|0|||
160719648|NCT00460603|580354522|FG001|Phase 2|Lost to Follow-up|0|||
160719649|NCT00460603|580354523|FG002|Phase 2|Lost to Follow-up|0|||
160719650|NCT00460603|580354524|FG003|Phase 2|Lost to Follow-up|0|||
160719651|NCT00460603|580354525|FG004|Phase 2|Lost to Follow-up|0|||
160719652|NCT00460603|580354526|FG005|Phase 2|Lost to Follow-up|0|||
160719653|NCT00460603|580354527|FG006|Phase 2|Lost to Follow-up|0|||
160719654|NCT00460603|580354528|FG007|Phase 2|Lost to Follow-up|0|||
160719655|NCT00460603|580354529|FG008|Phase 2|Lost to Follow-up|0|||
160719656|NCT00460603|580354530|FG009|Phase 2|Lost to Follow-up|1|||
160719657|NCT00460603|580354531|FG010|Phase 2|Lost to Follow-up|0|||
160719658|NCT00460603|580354532|FG011|Phase 2|Lost to Follow-up|0|||
160719659|NCT00460603|580354521|FG000|Phase 2|Other|0|||
160719660|NCT00460603|580354522|FG001|Phase 2|Other|0|||
160719661|NCT00460603|580354523|FG002|Phase 2|Other|0|||
160719662|NCT00460603|580354524|FG003|Phase 2|Other|0|||
160719663|NCT00460603|580354525|FG004|Phase 2|Other|0|||
160719664|NCT00460603|580354526|FG005|Phase 2|Other|0|||
160719665|NCT00460603|580354527|FG006|Phase 2|Other|0|||
160719666|NCT00460603|580354528|FG007|Phase 2|Other|0|||
160719667|NCT00460603|580354529|FG008|Phase 2|Other|0|||
160719668|NCT00460603|580354530|FG009|Phase 2|Other|6|||
160719669|NCT00460603|580354531|FG010|Phase 2|Other|16|||
160719670|NCT00460603|580354532|FG011|Phase 2|Other|7|||
160719671|NCT00460603|580354521|FG000|Phase 2|Objective Progression or Relapse|0|||
160719672|NCT00460603|580354522|FG001|Phase 2|Objective Progression or Relapse|0|||
160719673|NCT00460603|580354523|FG002|Phase 2|Objective Progression or Relapse|0|||
160719674|NCT00460603|580354524|FG003|Phase 2|Objective Progression or Relapse|0|||
160719675|NCT00460603|580354525|FG004|Phase 2|Objective Progression or Relapse|0|||
160719676|NCT00460603|580354526|FG005|Phase 2|Objective Progression or Relapse|0|||
160719677|NCT00460603|580354527|FG006|Phase 2|Objective Progression or Relapse|0|||
160719678|NCT00460603|580354528|FG007|Phase 2|Objective Progression or Relapse|0|||
160719679|NCT00460603|580354529|FG008|Phase 2|Objective Progression or Relapse|0|||
160719680|NCT00460603|580354530|FG009|Phase 2|Objective Progression or Relapse|9|||
160719681|NCT00460603|580354531|FG010|Phase 2|Objective Progression or Relapse|10|||
160719682|NCT00460603|580354532|FG011|Phase 2|Objective Progression or Relapse|17|||
160719683|NCT00460603|580354521|FG000|Phase 2|Global Deterioration of Health Status|0|||
160719684|NCT00460603|580354522|FG001|Phase 2|Global Deterioration of Health Status|0|||
160719685|NCT00460603|580354523|FG002|Phase 2|Global Deterioration of Health Status|0|||
160719686|NCT00460603|580354524|FG003|Phase 2|Global Deterioration of Health Status|0|||
160719687|NCT00460603|580354525|FG004|Phase 2|Global Deterioration of Health Status|0|||
160719688|NCT00460603|580354526|FG005|Phase 2|Global Deterioration of Health Status|0|||
160719689|NCT00460603|580354527|FG006|Phase 2|Global Deterioration of Health Status|0|||
160719690|NCT00460603|580354528|FG007|Phase 2|Global Deterioration of Health Status|0|||
160719691|NCT00460603|580354529|FG008|Phase 2|Global Deterioration of Health Status|0|||
160719692|NCT00460603|580354530|FG009|Phase 2|Global Deterioration of Health Status|0|||
160719693|NCT00460603|580354531|FG010|Phase 2|Global Deterioration of Health Status|1|||
160719694|NCT00460603|580354532|FG011|Phase 2|Global Deterioration of Health Status|0|||
160719695|NCT00460603|580354521|FG000|Phase 2|Withdrawal by Subject|0|||
160719696|NCT00460603|580354522|FG001|Phase 2|Withdrawal by Subject|0|||
160719697|NCT00460603|580354523|FG002|Phase 2|Withdrawal by Subject|0|||
160719698|NCT00460603|580354524|FG003|Phase 2|Withdrawal by Subject|0|||
160719699|NCT00460603|580354525|FG004|Phase 2|Withdrawal by Subject|0|||
160719700|NCT00460603|580354526|FG005|Phase 2|Withdrawal by Subject|0|||
160719701|NCT00460603|580354527|FG006|Phase 2|Withdrawal by Subject|0|||
160719702|NCT00460603|580354528|FG007|Phase 2|Withdrawal by Subject|0|||
160719703|NCT00460603|580354529|FG008|Phase 2|Withdrawal by Subject|0|||
160719704|NCT00460603|580354530|FG009|Phase 2|Withdrawal by Subject|5|||
160719705|NCT00460603|580354531|FG010|Phase 2|Withdrawal by Subject|4|||
160719706|NCT00460603|580354532|FG011|Phase 2|Withdrawal by Subject|5|||
160719707|NCT00460603|580354521|FG000|Phase 2|Randomized, but not treated|0|||
160719708|NCT00460603|580354522|FG001|Phase 2|Randomized, but not treated|0|||
160719709|NCT00460603|580354523|FG002|Phase 2|Randomized, but not treated|0|||
160719710|NCT00460603|580354524|FG003|Phase 2|Randomized, but not treated|0|||
160719711|NCT00460603|580354525|FG004|Phase 2|Randomized, but not treated|0|||
160719712|NCT00460603|580354526|FG005|Phase 2|Randomized, but not treated|0|||
160719713|NCT00460603|580354527|FG006|Phase 2|Randomized, but not treated|0|||
160719714|NCT00460603|580354528|FG007|Phase 2|Randomized, but not treated|0|||
160719715|NCT00460603|580354529|FG008|Phase 2|Randomized, but not treated|0|||
160719716|NCT00460603|580354530|FG009|Phase 2|Randomized, but not treated|3|||
160719717|NCT00460603|580354531|FG010|Phase 2|Randomized, but not treated|0|||
160719718|NCT00460603|580354532|FG011|Phase 2|Randomized, but not treated|0|||
160719719|NCT01651117|580354536|FG000|Overall Study|Death|2|||
160719720|NCT01651117|580354537|FG001|Overall Study|Death|3|||
160719721|NCT01651117|580354538|FG002|Overall Study|Death|2|||
160719722|NCT01651117|580354539|FG003|Overall Study|Death|2|||
160719723|NCT01293695|580354544|FG000|Overall Study|Withdrawal by Subject|7|||
160719724|NCT01293695|580354545|FG001|Overall Study|Withdrawal by Subject|1|||
160719725|NCT01293695|580354544|FG000|Overall Study|Lost to Follow-up|8|||
160719726|NCT01293695|580354545|FG001|Overall Study|Lost to Follow-up|6|||
160719727|NCT01082328|580354548|FG000|Overall Study|Adverse Event|1|||
160719728|NCT00791778|580354549|FG000|Double-blind Treatment|Adverse Event|49|||
160719729|NCT00791778|580354550|FG001|Double-blind Treatment|Adverse Event|9|||
160719730|NCT00791778|580354549|FG000|Double-blind Treatment|Physician Decision|6|||
160719731|NCT00791778|580354550|FG001|Double-blind Treatment|Physician Decision|26|||
160719732|NCT00791778|580354549|FG000|Double-blind Treatment|Protocol Violation|0|||
160719733|NCT00791778|580354550|FG001|Double-blind Treatment|Protocol Violation|4|||
160719734|NCT00791778|580354549|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
160719735|NCT00791778|580354550|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
160719736|NCT00791778|580354549|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
160719737|NCT00791778|580354550|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
160719738|NCT00791778|580354549|FG000|Follow-up|Withdrawal by Subject|3|||
160719739|NCT00791778|580354550|FG001|Follow-up|Withdrawal by Subject|0|||
160719740|NCT00791778|580354549|FG000|Follow-up|Lost to Follow-up|2|||
160719741|NCT00791778|580354550|FG001|Follow-up|Lost to Follow-up|1|||
160719742|NCT00957801|580354551|FG000|Overall Study|Withdrawal by Subject|0|||
160719743|NCT00957801|580354552|FG001|Overall Study|Withdrawal by Subject|0|||
160719744|NCT00957801|580354553|FG002|Overall Study|Withdrawal by Subject|0|||
160719745|NCT00957801|580354554|FG003|Overall Study|Withdrawal by Subject|1|||
160719746|NCT02626026|580354556|FG000|Overall Study|Randomized but Never Treated|0|||
160719747|NCT02626026|580354557|FG001|Overall Study|Randomized but Never Treated|0|||
160719748|NCT02626026|580354558|FG002|Overall Study|Randomized but Never Treated|0|||
160719749|NCT02626026|580354559|FG003|Overall Study|Randomized but Never Treated|0|||
160719750|NCT02626026|580354560|FG004|Overall Study|Randomized but Never Treated|1|||
160719751|NCT02626026|580354561|FG005|Overall Study|Randomized but Never Treated|0|||
160719752|NCT01778855|580354562|FG000|Overall Study|Death|0|||
160719753|NCT01778855|580354563|FG001|Overall Study|Death|1|||
160719754|NCT00991887|580354566|FG000|Overall Study|Lost to Follow-up|2|||
160719755|NCT00991887|580354567|FG001|Overall Study|Lost to Follow-up|1|||
160719756|NCT04616612|580354568|FG000|Overall Study|Lost to Follow-up|6|||
160719757|NCT04616612|580354569|FG001|Overall Study|Lost to Follow-up|3|||
160719758|NCT04740918|580354571|FG000|Overall Study|Study Terminated by Sponsor|41|||
160719759|NCT04740918|580354572|FG001|Overall Study|Study Terminated by Sponsor|32|||
160719760|NCT04740918|580354571|FG000|Overall Study|Death|3|||
160719761|NCT04740918|580354572|FG001|Overall Study|Death|6|||
160719762|NCT04740918|580354571|FG000|Overall Study|Withdrawal by Subject|5|||
160719763|NCT04740918|580354572|FG001|Overall Study|Withdrawal by Subject|4|||
160719764|NCT04740918|580354571|FG000|Overall Study|Lost to Follow-up|1|||
160719765|NCT04740918|580354572|FG001|Overall Study|Lost to Follow-up|3|||
160719766|NCT04740918|580354571|FG000|Overall Study|Progressive disease|0|||
160719767|NCT04740918|580354572|FG001|Overall Study|Progressive disease|1|||
160719768|NCT03759392|580354575|FG000|Overall Study|Adverse Event|12|||
160719769|NCT03759392|580354576|FG001|Overall Study|Adverse Event|4|||
160719770|NCT03759392|580354575|FG000|Overall Study|Death|2|||
160719771|NCT03759392|580354576|FG001|Overall Study|Death|1|||
160719772|NCT03759392|580354575|FG000|Overall Study|Withdrawal by Subject|2|||
160719773|NCT03759392|580354576|FG001|Overall Study|Withdrawal by Subject|0|||
160719774|NCT03759392|580354575|FG000|Overall Study|Protocol Violation|2|||
160719775|NCT03759392|580354576|FG001|Overall Study|Protocol Violation|0|||
160719776|NCT03759392|580354575|FG000|Overall Study|Physician Decision|0|||
160719777|NCT03759392|580354576|FG001|Overall Study|Physician Decision|1|||
160719778|NCT03759392|580354575|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
160719779|NCT03759392|580354576|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
160719780|NCT03759392|580354575|FG000|Overall Study|No longer able to take medicines|1|||
160719781|NCT03759392|580354576|FG001|Overall Study|No longer able to take medicines|0|||
160719782|NCT03759392|580354575|FG000|Overall Study|Stopped taking study drug|1|||
160719783|NCT03759392|580354576|FG001|Overall Study|Stopped taking study drug|0|||
160719784|NCT01288079|580354577|FG000|Overall Study|Withdrawal by Subject|2|||
160719785|NCT01288079|580354578|FG001|Overall Study|Withdrawal by Subject|4|||
160719786|NCT01288079|580354579|FG002|Overall Study|Withdrawal by Subject|1|||
160719787|NCT01288079|580354580|FG003|Overall Study|Withdrawal by Subject|0|||
160719788|NCT01288079|580354577|FG000|Overall Study|Adverse Event|2|||
160719789|NCT01288079|580354578|FG001|Overall Study|Adverse Event|1|||
160719790|NCT01288079|580354579|FG002|Overall Study|Adverse Event|2|||
160719791|NCT01288079|580354580|FG003|Overall Study|Adverse Event|3|||
160719792|NCT01288079|580354577|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
160719793|NCT01288079|580354578|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
160719794|NCT01288079|580354579|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
160719795|NCT01288079|580354580|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
160719796|NCT01288079|580354577|FG000|Overall Study|Condition under Investigation Worsened|0|||
160719797|NCT01288079|580354578|FG001|Overall Study|Condition under Investigation Worsened|0|||
160719798|NCT01288079|580354579|FG002|Overall Study|Condition under Investigation Worsened|0|||
160719799|NCT01288079|580354580|FG003|Overall Study|Condition under Investigation Worsened|1|||
160719800|NCT01288079|580354577|FG000|Overall Study|Lack of Efficacy|2|||
160719801|NCT01288079|580354578|FG001|Overall Study|Lack of Efficacy|2|||
160719802|NCT01288079|580354579|FG002|Overall Study|Lack of Efficacy|0|||
160719803|NCT01288079|580354580|FG003|Overall Study|Lack of Efficacy|2|||
160719804|NCT01288079|580354577|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
160719805|NCT01288079|580354578|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
160719806|NCT01288079|580354579|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
160719807|NCT01288079|580354580|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
160719808|NCT01288079|580354577|FG000|Overall Study|Lost to Follow-up|1|||
160719809|NCT01288079|580354578|FG001|Overall Study|Lost to Follow-up|1|||
160719810|NCT01288079|580354579|FG002|Overall Study|Lost to Follow-up|1|||
160719811|NCT01288079|580354580|FG003|Overall Study|Lost to Follow-up|0|||
160719812|NCT01288079|580354577|FG000|Overall Study|Other or Study Termination|11|||
160719813|NCT01288079|580354578|FG001|Overall Study|Other or Study Termination|15|||
160719814|NCT01288079|580354579|FG002|Overall Study|Other or Study Termination|14|||
160719815|NCT01288079|580354580|FG003|Overall Study|Other or Study Termination|8|||
160719816|NCT02387840|580354581|FG000|Overall Study|Death|0|||
160719817|NCT02387840|580354582|FG001|Overall Study|Death|0|||
160719818|NCT02387840|580354583|FG002|Overall Study|Death|0|||
160719819|NCT02387840|580354584|FG003|Overall Study|Death|0|||
160719820|NCT02387840|580354585|FG004|Overall Study|Death|0|||
160719821|NCT02387840|580354586|FG005|Overall Study|Death|1|||
160719822|NCT01213966|580354587|FG000|Overall Study|Protocol Violation|1|||
160719823|NCT01213966|580354588|FG001|Overall Study|Protocol Violation|0|||
160719824|NCT01213966|580354589|FG002|Overall Study|Protocol Violation|3|||
160719825|NCT01213966|580354590|FG003|Overall Study|Protocol Violation|1|||
160719826|NCT01609790|580354604|FG000|Overall Study|Protocol Violation|1|||
160719827|NCT01609790|580354605|FG001|Overall Study|Protocol Violation|7|||
160719828|NCT01609790|580354606|FG002|Overall Study|Protocol Violation|8|||
160719829|NCT00858273|580354607|FG000|Overall Study|Protocol Violation|3|||
160719830|NCT00858273|580354608|FG001|Overall Study|Protocol Violation|5|||
160719831|NCT03760744|580356593|FG000|Overall Study|Lost to Follow-up|3|||
160719832|NCT03760744|580356594|FG001|Overall Study|Lost to Follow-up|0|||
160719833|NCT03055338|580356597|FG000|Overall Study|Lost to Follow-up|9|||
160719834|NCT03055338|580356598|FG001|Overall Study|Lost to Follow-up|2|||
160719835|NCT03055338|580356599|FG002|Overall Study|Lost to Follow-up|3|||
160719836|NCT03055338|580356597|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
160719837|NCT03055338|580356598|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
160719838|NCT03055338|580356599|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
160719839|NCT03055338|580356597|FG000|Overall Study|Physician Decision|0|||
160719840|NCT03055338|580356598|FG001|Overall Study|Physician Decision|0|||
160719841|NCT03055338|580356599|FG002|Overall Study|Physician Decision|2|||
160719842|NCT03055338|580356597|FG000|Overall Study|Withdrawal by Subject|9|||
160719843|NCT03055338|580356598|FG001|Overall Study|Withdrawal by Subject|8|||
160719844|NCT03055338|580356599|FG002|Overall Study|Withdrawal by Subject|7|||
160719845|NCT00975611|580356600|FG000|Overall Study|Screen Fail|16|||
160719846|NCT00975611|580356600|FG000|Overall Study|Physician Decision|1|||
160719847|NCT03058705|580356601|FG000|Overall Study|Withdrawal by Subject|2|||
160719848|NCT03058705|580356601|FG000|Overall Study|Physician Decision|2|||
160719849|NCT01880554|580356602|FG000|Overall Study|Protocol Violation|14|||
160719850|NCT01880554|580356602|FG000|Overall Study|Simon's design requirements|2|||
160719851|NCT05161481|580356603|FG000|Overall Study|Withdrawal of consent|0|||
160719852|NCT05161481|580356604|FG001|Overall Study|Withdrawal of consent|1|||
160719853|NCT05161481|580356605|FG002|Overall Study|Withdrawal of consent|1|||
160719854|NCT05161481|580356603|FG000|Overall Study|Study terminated by sponsor|3|||
160719855|NCT05161481|580356604|FG001|Overall Study|Study terminated by sponsor|3|||
160719856|NCT05161481|580356605|FG002|Overall Study|Study terminated by sponsor|2|||
160719857|NCT05161481|580356603|FG000|Overall Study|Adverse Event|3|||
160719858|NCT05161481|580356604|FG001|Overall Study|Adverse Event|0|||
160719859|NCT05161481|580356605|FG002|Overall Study|Adverse Event|6|||
160719860|NCT05161481|580356603|FG000|Overall Study|Randomised in error and was not treated|1|||
160719861|NCT05161481|580356604|FG001|Overall Study|Randomised in error and was not treated|0|||
160719862|NCT05161481|580356605|FG002|Overall Study|Randomised in error and was not treated|0|||
160719863|NCT05161481|580356603|FG000|Overall Study|Subject decision|0|||
160719864|NCT05161481|580356604|FG001|Overall Study|Subject decision|0|||
160719865|NCT05161481|580356605|FG002|Overall Study|Subject decision|1|||
160719866|NCT01102257|580356606|FG000|Overall Study|Adverse Event|1|||
160719867|NCT01102257|580356607|FG001|Overall Study|Adverse Event|0|||
160719868|NCT01102257|580356606|FG000|Overall Study|Adverse Event|1|||
160719869|NCT01102257|580356607|FG001|Overall Study|Adverse Event|0|||
160719870|NCT01100086|580356608|FG000|Period 1|Withdrawal by Subject|1|||
160719871|NCT01100086|580356609|FG001|Period 1|Withdrawal by Subject|0|||
160719872|NCT01735916|580356618|FG000|Overall Study|Subject not eligible to be randomized|11|||
160719873|NCT01735916|580356619|FG001|Overall Study|Subject not eligible to be randomized|0|||
160719874|NCT01735916|580356620|FG002|Overall Study|Subject not eligible to be randomized|0|||
160719875|NCT01735916|580356618|FG000|Overall Study|Early termination of study by sponsor|4|||
160719876|NCT01735916|580356619|FG001|Overall Study|Early termination of study by sponsor|19|||
160719877|NCT01735916|580356620|FG002|Overall Study|Early termination of study by sponsor|7|||
160719878|NCT01735916|580356618|FG000|Overall Study|Withdrawal by Subject|3|||
160719879|NCT01735916|580356619|FG001|Overall Study|Withdrawal by Subject|0|||
160719880|NCT01735916|580356620|FG002|Overall Study|Withdrawal by Subject|0|||
160719881|NCT05177484|580356626|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
160719882|NCT05177484|580356627|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
160719883|NCT05177484|580356626|FG000|Overall Study|Inadvertently withdrawn|3|||
160719884|NCT05177484|580356627|FG001|Overall Study|Inadvertently withdrawn|1|||
160719885|NCT05177484|580356626|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
160719886|NCT05177484|580356627|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
160719887|NCT01379768|580356628|FG000|Overall Study|Adverse Event|1|||
160719888|NCT01379768|580356629|FG001|Overall Study|Adverse Event|1|||
160719889|NCT01379768|580356630|FG002|Overall Study|Adverse Event|0|||
160719890|NCT01379768|580356628|FG000|Overall Study|Lost to Follow-up|2|||
160719891|NCT01379768|580356629|FG001|Overall Study|Lost to Follow-up|0|||
160719892|NCT01379768|580356630|FG002|Overall Study|Lost to Follow-up|0|||
160719893|NCT03334435|580356635|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
160719894|NCT03334435|580356636|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
160719895|NCT03334435|580356637|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
160719896|NCT03334435|580356638|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
160719897|NCT03334435|580356639|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
160719898|NCT03334435|580356640|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
160719899|NCT03334435|580356641|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
160719900|NCT03334435|580356642|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
160719901|NCT03334435|580356643|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
160719902|NCT03334435|580356644|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
160719903|NCT03334435|580356645|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
160719904|NCT03334435|580356646|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
160719905|NCT03334435|580356647|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
160719906|NCT03334435|580356648|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
160719907|NCT03334435|580356649|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
160719908|NCT03334435|580356635|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
160719909|NCT03334435|580356636|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
160719910|NCT03334435|580356637|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
160719911|NCT03334435|580356638|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
160719912|NCT03334435|580356639|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
160719913|NCT03334435|580356640|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
160719914|NCT03334435|580356641|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
160719915|NCT03334435|580356642|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
160719916|NCT03334435|580356643|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
160719917|NCT03334435|580356644|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
160719918|NCT03334435|580356645|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
160719919|NCT03334435|580356646|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
160719920|NCT03334435|580356647|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
160719921|NCT03334435|580356648|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
160719922|NCT03334435|580356649|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
160719923|NCT03334435|580356635|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
160719924|NCT03334435|580356636|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
160719925|NCT03334435|580356637|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
160719926|NCT03334435|580356638|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
160719927|NCT03334435|580356639|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
160719928|NCT03334435|580356640|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
160719929|NCT03334435|580356641|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
160719930|NCT03334435|580356642|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
160719931|NCT03334435|580356643|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
160719932|NCT03334435|580356644|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
160719933|NCT03334435|580356645|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
160719934|NCT03334435|580356646|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
160719935|NCT03334435|580356647|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
160719936|NCT03334435|580356648|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
160719937|NCT03334435|580356649|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
160719938|NCT03334435|580356635|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
160719939|NCT03334435|580356636|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
160719940|NCT03334435|580356637|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
160719941|NCT03334435|580356638|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
160719942|NCT03334435|580356639|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
160719943|NCT03334435|580356640|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
160719944|NCT03334435|580356641|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
160719945|NCT03334435|580356642|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
160719946|NCT03334435|580356643|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
160719947|NCT03334435|580356644|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
160719948|NCT03334435|580356645|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
160719949|NCT03334435|580356646|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
160719950|NCT03334435|580356647|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
160719951|NCT03334435|580356648|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
160719952|NCT03334435|580356649|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
160719953|NCT03334435|580356635|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
160719954|NCT03334435|580356636|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719955|NCT03334435|580356637|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
160719956|NCT03334435|580356638|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
160719957|NCT03334435|580356639|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
160719958|NCT03334435|580356640|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719959|NCT03334435|580356641|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719960|NCT03334435|580356642|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719961|NCT03334435|580356643|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719962|NCT03334435|580356644|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719963|NCT03334435|580356645|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719964|NCT03334435|580356646|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719965|NCT03334435|580356647|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719966|NCT03334435|580356648|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719967|NCT03334435|580356649|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
160719968|NCT03334435|580356635|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719969|NCT03334435|580356636|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719970|NCT03334435|580356637|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719971|NCT03334435|580356638|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
160719972|NCT03334435|580356639|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719973|NCT03334435|580356640|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719974|NCT03334435|580356641|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719975|NCT03334435|580356642|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719976|NCT03334435|580356643|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719977|NCT03334435|580356644|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719978|NCT03334435|580356645|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719979|NCT03334435|580356646|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719980|NCT03334435|580356647|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719981|NCT03334435|580356648|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719982|NCT03334435|580356649|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
160719983|NCT03334435|580356635|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719984|NCT03334435|580356636|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
160719985|NCT03334435|580356637|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
160719986|NCT03334435|580356638|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
160719987|NCT03334435|580356639|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
160719988|NCT03334435|580356640|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719989|NCT03334435|580356641|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719990|NCT03334435|580356642|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719991|NCT03334435|580356643|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719992|NCT03334435|580356644|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719993|NCT03334435|580356645|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719994|NCT03334435|580356646|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719995|NCT03334435|580356647|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719996|NCT03334435|580356648|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719997|NCT03334435|580356649|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
160719998|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
160719999|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
160720000|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
160720001|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
160720002|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
160720003|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
160720004|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
160720005|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
160720006|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
160720007|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
160720008|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
160720009|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
160720010|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
160720011|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
160720012|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
160720013|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
160720014|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
160720015|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
160720016|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
160720017|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
160720018|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
160720019|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
160720020|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
160720021|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
160720022|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
160720023|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
160720024|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
160720025|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
160720026|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
160720027|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
160720028|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
160720029|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
160720030|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
160720031|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
160720032|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
160720033|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
160720034|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
160720035|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
160720036|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
160720037|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
160720038|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
160720039|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
160720040|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
160720041|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
160720042|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
160720043|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
160720044|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
160720045|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
160720046|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
160720047|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
160720048|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
160720049|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
160720050|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
160720051|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
160720052|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
160720053|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
160720054|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
160720055|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
160720056|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
160720057|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
160720058|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
160720059|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
160720060|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
160720061|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
160720062|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
160720063|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
160720064|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
160720065|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
160720066|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
160720067|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
160720068|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
160720069|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
160720070|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
160720071|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
160720072|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
160720073|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720074|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720075|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720076|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720077|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720078|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720079|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720080|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720081|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720082|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720083|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720084|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
160720085|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720086|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
160720087|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
160720088|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720089|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720090|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720091|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720092|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720093|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
160720094|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720095|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720096|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720097|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720098|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720099|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720100|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720101|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
160720102|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
160720103|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
160720104|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
160720105|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
160720106|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
160720107|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
160720108|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
160720109|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
160720110|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
160720111|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
160720112|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
160720113|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
160720114|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
160720115|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
160720116|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
160720117|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
160720118|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
160720119|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
160720120|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
160720121|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
160720122|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
160720123|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
160720124|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
160720125|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
160720126|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
160720127|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
160720128|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
160720129|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
160720130|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
160720131|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
160720132|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
160720133|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720134|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720135|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720136|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720137|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720138|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
160720139|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720140|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720141|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720142|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720143|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
160720144|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720145|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720146|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
160720147|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
160720148|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
160720149|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
160720150|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
160720151|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
160720152|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
160720153|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
160720154|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
160720155|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
160720156|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
160720157|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
160720158|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
160720159|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
160720160|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
160720161|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
160720162|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
160720163|NCT03334435|580356635|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720164|NCT03334435|580356636|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720165|NCT03334435|580356637|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720166|NCT03334435|580356638|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720167|NCT03334435|580356639|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720168|NCT03334435|580356640|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720169|NCT03334435|580356641|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720170|NCT03334435|580356642|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720171|NCT03334435|580356643|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720172|NCT03334435|580356644|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720173|NCT03334435|580356645|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720174|NCT03334435|580356646|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
160720175|NCT03334435|580356647|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
160720176|NCT03334435|580356648|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
160720177|NCT03334435|580356649|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
160720178|NCT03922321|580356650|FG000|Overall Study|Participant Moved|1|||
160720179|NCT03922321|580356650|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
160720180|NCT02075203|580356655|FG000|Overall Study|Withdrawal by Subject|1|||
160720181|NCT02075203|580356656|FG001|Overall Study|Withdrawal by Subject|0|||
160720182|NCT02075203|580356657|FG002|Overall Study|Withdrawal by Subject|1|||
160720183|NCT02075203|580356655|FG000|Overall Study|Adverse Event|1|||
160720184|NCT02075203|580356656|FG001|Overall Study|Adverse Event|0|||
160720185|NCT02075203|580356657|FG002|Overall Study|Adverse Event|0|||
160720186|NCT02075203|580356655|FG000|Overall Study|participant refused to use contraception|1|||
160720187|NCT02075203|580356656|FG001|Overall Study|participant refused to use contraception|0|||
160720188|NCT02075203|580356657|FG002|Overall Study|participant refused to use contraception|0|||
160720189|NCT00350207|580356658|FG000|Overall Study|Adverse Event|5|||
160720190|NCT00350207|580356659|FG001|Overall Study|Adverse Event|2|||
160720191|NCT00350207|580356660|FG002|Overall Study|Adverse Event|2|||
160720192|NCT00350207|580356658|FG000|Overall Study|Lack of Efficacy|1|||
160720193|NCT00350207|580356659|FG001|Overall Study|Lack of Efficacy|0|||
160720194|NCT00350207|580356660|FG002|Overall Study|Lack of Efficacy|2|||
160720195|NCT00350207|580356658|FG000|Overall Study|Lost to Follow-up|1|||
160720196|NCT00350207|580356659|FG001|Overall Study|Lost to Follow-up|0|||
160720197|NCT00350207|580356660|FG002|Overall Study|Lost to Follow-up|1|||
160720198|NCT00350207|580356658|FG000|Overall Study|Withdrawal by Subject|0|||
160720199|NCT00350207|580356659|FG001|Overall Study|Withdrawal by Subject|1|||
160720200|NCT00350207|580356660|FG002|Overall Study|Withdrawal by Subject|1|||
160720201|NCT00350207|580356658|FG000|Overall Study|Other|1|||
160720202|NCT00350207|580356659|FG001|Overall Study|Other|3|||
160720203|NCT00350207|580356660|FG002|Overall Study|Other|1|||
160720204|NCT00495391|580356661|FG000|Overall Study|Lack of Efficacy|34|||
160720205|NCT00495391|580356662|FG001|Overall Study|Lack of Efficacy|18|||
160720206|NCT00495391|580356661|FG000|Overall Study|Withdrawal by Subject|2|||
160720207|NCT00495391|580356662|FG001|Overall Study|Withdrawal by Subject|3|||
160720208|NCT03214224|580356663|FG000|Overall Study|Protocol Violation|1|||
160720209|NCT03214224|580356663|FG000|Overall Study|Withdrawal by Subject|2|||
160720210|NCT03214224|580356663|FG000|Overall Study|Practice controls or therapists|6|||
160720211|NCT02712320|580356672|FG000|Overall Study|Lost to Follow-up|1|||
160720212|NCT02712320|580356672|FG000|Overall Study|Withdrawal by Subject|1|||
160720213|NCT02712320|580356672|FG000|Overall Study|Transferred to another facility|1|||
160720214|NCT02712320|580356672|FG000|Overall Study|Treating with the prohibited medications|2|||
160720215|NCT03802825|580356673|FG000|Overall Study|Lost to follow-up for intervention|12|||
160720216|NCT03802825|580356674|FG001|Overall Study|Lost to follow-up for intervention|3|||
160720217|NCT03802825|580356673|FG000|Overall Study|Received only 1 component of intervention|0|||
160720218|NCT03802825|580356674|FG001|Overall Study|Received only 1 component of intervention|13|||
160720219|NCT00568451|580356675|FG000|Overall Study|Disease Progression|0|||
160720220|NCT00568451|580356676|FG001|Overall Study|Disease Progression|0|||
160720221|NCT00568451|580356677|FG002|Overall Study|Disease Progression|2|||
160720222|NCT00568451|580356678|FG003|Overall Study|Disease Progression|7|||
160720223|NCT05266053|580356679|FG000|Overall Study|Withdrawal by Subject|8|||
160720224|NCT05266053|580356680|FG001|Overall Study|Withdrawal by Subject|4|||
160720225|NCT05344560|580356681|FG000|Period 1|Subject out of visit window|1|||
160720226|NCT05344560|580356682|FG001|Period 1|Subject out of visit window|1|||
160720227|NCT05344560|580356681|FG000|Period 2|Covid-19 Related|1|||
160720228|NCT05344560|580356682|FG001|Period 2|Covid-19 Related|0|||
160720229|NCT05344560|580356681|FG000|Period 2|Adverse Event|1|||
160720230|NCT05344560|580356682|FG001|Period 2|Adverse Event|0|||
160720231|NCT05344560|580356681|FG000|Period 2|Subject out of visit window|1|||
160720232|NCT05344560|580356682|FG001|Period 2|Subject out of visit window|1|||
160720233|NCT05344560|580356681|FG000|Period 3|Subject out of visit window|1|||
160720234|NCT05344560|580356682|FG001|Period 3|Subject out of visit window|0|||
160720235|NCT01051960|580356686|FG000|Overall Study|Adverse Event|1|||
160720236|NCT02996968|580356687|FG000|Overall Study|Withdrawal by Subject|1|||
160720237|NCT02996968|580356688|FG001|Overall Study|Withdrawal by Subject|0|||
160720238|NCT00031590|580356693|FG000|Overall Study|Adverse Event|1|||
160720239|NCT00031590|580356693|FG000|Overall Study|Withdrawal by parents|2|||
160720240|NCT05506046|580356696|FG000|Overall Study|Lost to Follow-up|89|||
160720241|NCT05506046|580356697|FG001|Overall Study|Lost to Follow-up|101|||
160720242|NCT05506046|580356698|FG002|Overall Study|Lost to Follow-up|102|||
160720243|NCT05506046|580356699|FG003|Overall Study|Lost to Follow-up|99|||
160720244|NCT03313180|580356703|FG000|Overall Study|Adverse Event|120|||
160720245|NCT03313180|580356703|FG000|Overall Study|Lost to Follow-up|3|||
160720246|NCT03313180|580356703|FG000|Overall Study|Withdrawal by Subject|39|||
160720247|NCT03313180|580356703|FG000|Overall Study|Other than listed above|15|||
160720248|NCT03313180|580356703|FG000|Overall Study|Covid-19 related|2|||
160720249|NCT01058642|580356705|FG000|Treatment Period 1|Adverse Event|0|||
160720250|NCT01058642|580356706|FG001|Treatment Period 1|Adverse Event|1|||
160720251|NCT01058642|580356707|FG002|Treatment Period 1|Adverse Event|1|||
160720252|NCT01058642|580356708|FG003|Treatment Period 1|Adverse Event|0|||
160720253|NCT01058642|580356705|FG000|Treatment Period 1|Physician Decision|0|||
160720254|NCT01058642|580356706|FG001|Treatment Period 1|Physician Decision|0|||
160720255|NCT01058642|580356707|FG002|Treatment Period 1|Physician Decision|1|||
160720256|NCT01058642|580356708|FG003|Treatment Period 1|Physician Decision|0|||
160720257|NCT01058642|580356705|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160720258|NCT01058642|580356706|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160720259|NCT01058642|580356707|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160720260|NCT01058642|580356708|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160720261|NCT01058642|580356705|FG000|Treatment Period 1|Lack of Efficacy|0|||
160720262|NCT01058642|580356706|FG001|Treatment Period 1|Lack of Efficacy|0|||
160720263|NCT01058642|580356707|FG002|Treatment Period 1|Lack of Efficacy|0|||
160720264|NCT01058642|580356708|FG003|Treatment Period 1|Lack of Efficacy|1|||
160720265|NCT01058642|580356705|FG000|Treatment Period 1|Protocol Violation|0|||
160720266|NCT01058642|580356706|FG001|Treatment Period 1|Protocol Violation|0|||
160720267|NCT01058642|580356707|FG002|Treatment Period 1|Protocol Violation|0|||
160720268|NCT01058642|580356708|FG003|Treatment Period 1|Protocol Violation|1|||
160720269|NCT01058642|580356705|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
160720270|NCT01058642|580356706|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
160720271|NCT01058642|580356707|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
160720272|NCT01058642|580356708|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
160720273|NCT04177095|580356720|FG000|Overall Study|Withdrawal by Subject|3|||
160720274|NCT04177095|580356720|FG000|Overall Study|Screen Failure|3|||
160720275|NCT04177095|580356720|FG000|Overall Study|Problems with the Trugraf assay|1|||
160720276|NCT02275819|580356721|FG000|Overall Study|Adverse Event|0|||
160720277|NCT02275819|580356722|FG001|Overall Study|Adverse Event|1|||
160720278|NCT02556775|580356723|FG000|Overall Study|Withdrawal by Subject|1|||
160720279|NCT02556775|580356724|FG001|Overall Study|Withdrawal by Subject|0|||
160720280|NCT02556775|580356725|FG002|Overall Study|Withdrawal by Subject|1|||
160720281|NCT02556775|580356726|FG003|Overall Study|Withdrawal by Subject|0|||
160720282|NCT02556775|580356723|FG000|Overall Study|Lost to Follow-up|1|||
160720283|NCT02556775|580356724|FG001|Overall Study|Lost to Follow-up|0|||
160720284|NCT02556775|580356725|FG002|Overall Study|Lost to Follow-up|0|||
160720285|NCT02556775|580356726|FG003|Overall Study|Lost to Follow-up|0|||
160720286|NCT01346059|580356727|FG000|Overall Study|Withdrawal by Subject|1|||
160720287|NCT01346059|580356728|FG001|Overall Study|Withdrawal by Subject|0|||
160720288|NCT00777296|580356729|FG000|Overall Study|Adverse Event|0|||
160720289|NCT00777296|580356730|FG001|Overall Study|Adverse Event|1|||
160720290|NCT00777296|580356731|FG002|Overall Study|Adverse Event|0|||
160720291|NCT00777296|580356732|FG003|Overall Study|Adverse Event|1|||
160720292|NCT00777296|580356729|FG000|Overall Study|Withdrawal by Subject|1|||
160720293|NCT00777296|580356730|FG001|Overall Study|Withdrawal by Subject|0|||
160720294|NCT00777296|580356731|FG002|Overall Study|Withdrawal by Subject|0|||
160720295|NCT00777296|580356732|FG003|Overall Study|Withdrawal by Subject|0|||
160720296|NCT00777296|580356729|FG000|Overall Study|CRF form not completed|0|||
160720297|NCT00777296|580356730|FG001|Overall Study|CRF form not completed|0|||
160720298|NCT00777296|580356731|FG002|Overall Study|CRF form not completed|2|||
160720299|NCT00777296|580356732|FG003|Overall Study|CRF form not completed|0|||
160720300|NCT02211209|580356733|FG000|Overall Study|Investigator judgment|0|||
160720301|NCT02211209|580356734|FG001|Overall Study|Investigator judgment|1|||
160720302|NCT02211209|580356733|FG000|Overall Study|Voluntary withdrawal|1|||
160720303|NCT02211209|580356734|FG001|Overall Study|Voluntary withdrawal|4|||
160720304|NCT02211209|580356733|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
160720305|NCT02211209|580356734|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
160720306|NCT02211209|580356733|FG000|Overall Study|Reason Not Specified|1|||
160720307|NCT02211209|580356734|FG001|Overall Study|Reason Not Specified|0|||
160720308|NCT00658723|580356738|FG000|Overall Study|Lost to Follow-up|0|||
160720309|NCT00658723|580356739|FG001|Overall Study|Lost to Follow-up|2|||
160720310|NCT00658723|580356740|FG002|Overall Study|Lost to Follow-up|2|||
160720311|NCT00658723|580356738|FG000|Overall Study|Death|2|||
160720312|NCT00658723|580356739|FG001|Overall Study|Death|1|||
160720313|NCT00658723|580356740|FG002|Overall Study|Death|4|||
160720314|NCT00658723|580356738|FG000|Overall Study|Scheduling Issue|1|||
160720315|NCT00658723|580356739|FG001|Overall Study|Scheduling Issue|1|||
160720316|NCT00658723|580356740|FG002|Overall Study|Scheduling Issue|0|||
160720317|NCT00658723|580356738|FG000|Overall Study|Withdrawal by Subject|1|||
160720318|NCT00658723|580356739|FG001|Overall Study|Withdrawal by Subject|0|||
160720319|NCT00658723|580356740|FG002|Overall Study|Withdrawal by Subject|1|||
160720320|NCT03876743|580356741|FG000|Overall Study|Lost to Follow-up|6|||
160720321|NCT03876743|580356742|FG001|Overall Study|Lost to Follow-up|4|||
160720322|NCT03876743|580356743|FG002|Overall Study|Lost to Follow-up|4|||
160720323|NCT03876743|580356744|FG003|Overall Study|Lost to Follow-up|7|||
160720324|NCT03889418|580356745|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
160720325|NCT03889418|580356746|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
160720326|NCT03889418|580356747|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
160720327|NCT03889418|580356748|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
160720328|NCT03889418|580356749|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
160720329|NCT03889418|580356750|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
160720330|NCT03889418|580356751|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
160720331|NCT03889418|580356752|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
160720332|NCT03889418|580356753|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
160720333|NCT03889418|580356754|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
160720334|NCT03889418|580356745|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
160720335|NCT03889418|580356746|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
160720336|NCT03889418|580356747|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
160720337|NCT03889418|580356748|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
160720338|NCT03889418|580356749|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
160720339|NCT03889418|580356750|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
160720340|NCT03889418|580356751|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
160720341|NCT03889418|580356752|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
160720342|NCT03889418|580356753|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
160720343|NCT03889418|580356754|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
160720344|NCT03889418|580356745|FG000|October-December 2019 (Month 7-9)|Death|0|||
160720345|NCT03889418|580356746|FG001|October-December 2019 (Month 7-9)|Death|0|||
160720346|NCT03889418|580356747|FG002|October-December 2019 (Month 7-9)|Death|0|||
160720347|NCT03889418|580356748|FG003|October-December 2019 (Month 7-9)|Death|0|||
160720348|NCT03889418|580356749|FG004|October-December 2019 (Month 7-9)|Death|0|||
160720349|NCT03889418|580356750|FG005|October-December 2019 (Month 7-9)|Death|0|||
160720350|NCT03889418|580356751|FG006|October-December 2019 (Month 7-9)|Death|0|||
160720351|NCT03889418|580356752|FG007|October-December 2019 (Month 7-9)|Death|0|||
160720352|NCT03889418|580356753|FG008|October-December 2019 (Month 7-9)|Death|1|||
160720353|NCT03889418|580356754|FG009|October-December 2019 (Month 7-9)|Death|0|||
160720354|NCT03889418|580356745|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
160720355|NCT03889418|580356746|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
160720356|NCT03889418|580356747|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
160720357|NCT03889418|580356748|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
160720358|NCT03889418|580356749|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
160720359|NCT03889418|580356750|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
160720360|NCT03889418|580356751|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
160720361|NCT03889418|580356752|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
160720362|NCT03889418|580356753|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
160720363|NCT03889418|580356754|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
160720364|NCT03889418|580356745|FG000|April - June 2020 (Month 13-15)|Death|0|||
160720365|NCT03889418|580356746|FG001|April - June 2020 (Month 13-15)|Death|1|||
160720366|NCT03889418|580356747|FG002|April - June 2020 (Month 13-15)|Death|0|||
160720367|NCT03889418|580356748|FG003|April - June 2020 (Month 13-15)|Death|0|||
160720368|NCT03889418|580356749|FG004|April - June 2020 (Month 13-15)|Death|0|||
160720369|NCT03889418|580356750|FG005|April - June 2020 (Month 13-15)|Death|0|||
160720370|NCT03889418|580356751|FG006|April - June 2020 (Month 13-15)|Death|0|||
160720371|NCT03889418|580356752|FG007|April - June 2020 (Month 13-15)|Death|0|||
160720372|NCT03889418|580356753|FG008|April - June 2020 (Month 13-15)|Death|0|||
160720373|NCT03889418|580356754|FG009|April - June 2020 (Month 13-15)|Death|0|||
160720374|NCT03889418|580356745|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
160720375|NCT03889418|580356746|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
160720376|NCT03889418|580356747|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
160720377|NCT03889418|580356748|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
160720378|NCT03889418|580356749|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
160720379|NCT03889418|580356750|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
160720380|NCT03889418|580356751|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
160720381|NCT03889418|580356752|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
160720382|NCT03889418|580356753|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
160720383|NCT03889418|580356754|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
160720384|NCT03889418|580356745|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
160720385|NCT03889418|580356746|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
160720386|NCT03889418|580356747|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
160720387|NCT03889418|580356748|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
160720388|NCT03889418|580356749|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
160720389|NCT03889418|580356750|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
160720390|NCT03889418|580356751|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
160720391|NCT03889418|580356752|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
160720392|NCT03889418|580356753|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
160720393|NCT03889418|580356754|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
160720394|NCT03889418|580356745|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
160720395|NCT03889418|580356746|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
160720396|NCT03889418|580356747|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
160720397|NCT03889418|580356748|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
160720398|NCT03889418|580356749|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
160720399|NCT03889418|580356750|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
160720400|NCT03889418|580356751|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
160720401|NCT03889418|580356752|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
160720402|NCT03889418|580356753|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
160720403|NCT03889418|580356754|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
160720404|NCT00092118|580356756|FG000|Overall Study|Adverse Event|35|||
160720405|NCT00092118|580356757|FG001|Overall Study|Adverse Event|32|||
160720406|NCT00092118|580356756|FG000|Overall Study|Lack of Efficacy|12|||
160720407|NCT00092118|580356757|FG001|Overall Study|Lack of Efficacy|14|||
160720408|NCT00092118|580356756|FG000|Overall Study|Lost to Follow-up|4|||
160720409|NCT00092118|580356757|FG001|Overall Study|Lost to Follow-up|3|||
160720410|NCT00092118|580356756|FG000|Overall Study|Protocol Violation|23|||
160720411|NCT00092118|580356757|FG001|Overall Study|Protocol Violation|25|||
160720412|NCT00092118|580356756|FG000|Overall Study|Withdrawal by Subject|4|||
160720413|NCT00092118|580356757|FG001|Overall Study|Withdrawal by Subject|10|||
160720414|NCT00092118|580356756|FG000|Overall Study|Other|6|||
160720415|NCT00092118|580356757|FG001|Overall Study|Other|5|||
160720416|NCT01139125|580356761|FG000|Overall Study|Withdrawal by Subject|1|||
160720417|NCT01592786|580356762|FG000|Overall Study|Adverse Event|60|||
160720418|NCT01592786|580356762|FG000|Overall Study|Lack of Efficacy|19|||
160720419|NCT01592786|580356762|FG000|Overall Study|Protocol Violation|14|||
160720420|NCT01592786|580356762|FG000|Overall Study|Withdrawal by Subject|23|||
160720421|NCT01592786|580356762|FG000|Overall Study|Lost to Follow-up|19|||
160720422|NCT01592786|580356762|FG000|Overall Study|Other|3|||
160720423|NCT02025725|580356763|FG000|Overall Study|Adverse Event|5|||
160720424|NCT02025725|580356764|FG001|Overall Study|Adverse Event|0|||
160720425|NCT02025725|580356763|FG000|Overall Study|Lost to Follow-up|2|||
160720426|NCT02025725|580356764|FG001|Overall Study|Lost to Follow-up|0|||
160720427|NCT02025725|580356763|FG000|Overall Study|Protocol Violation|1|||
160720428|NCT02025725|580356764|FG001|Overall Study|Protocol Violation|1|||
160720429|NCT02025725|580356763|FG000|Overall Study|Withdrawal by Subject|3|||
160720430|NCT02025725|580356764|FG001|Overall Study|Withdrawal by Subject|2|||
160720431|NCT02025725|580356763|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
160720432|NCT02025725|580356764|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
160720433|NCT04578535|580356765|FG000|Overall Study|Lost to Follow-up|1|||
160720434|NCT04578535|580356766|FG001|Overall Study|Lost to Follow-up|0|||
160720435|NCT04578535|580356767|FG002|Overall Study|Lost to Follow-up|0|||
160720436|NCT04578535|580356768|FG003|Overall Study|Lost to Follow-up|1|||
160720437|NCT04578535|580356769|FG004|Overall Study|Lost to Follow-up|0|||
160720438|NCT04578535|580356770|FG005|Overall Study|Lost to Follow-up|2|||
160720439|NCT04578535|580356765|FG000|Overall Study|Pregnancy|1|||
160720440|NCT04578535|580356766|FG001|Overall Study|Pregnancy|0|||
160720441|NCT04578535|580356767|FG002|Overall Study|Pregnancy|0|||
160720442|NCT04578535|580356768|FG003|Overall Study|Pregnancy|0|||
160720443|NCT04578535|580356769|FG004|Overall Study|Pregnancy|0|||
160720444|NCT04578535|580356770|FG005|Overall Study|Pregnancy|0|||
160720445|NCT04578535|580356765|FG000|Overall Study|Withdrawal by Subject|0|||
160720446|NCT04578535|580356766|FG001|Overall Study|Withdrawal by Subject|0|||
160720447|NCT04578535|580356767|FG002|Overall Study|Withdrawal by Subject|0|||
160720448|NCT04578535|580356768|FG003|Overall Study|Withdrawal by Subject|1|||
160720449|NCT04578535|580356769|FG004|Overall Study|Withdrawal by Subject|1|||
160720450|NCT04578535|580356770|FG005|Overall Study|Withdrawal by Subject|5|||
160720451|NCT04578535|580356765|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
160720452|NCT04578535|580356766|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
160720453|NCT04578535|580356767|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
160720454|NCT04578535|580356768|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
160720455|NCT04578535|580356769|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
160720456|NCT04578535|580356770|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
160720457|NCT00806403|580356775|FG000|Overall Study|Death|4|||
160720458|NCT00806403|580356776|FG001|Overall Study|Death|3|||
160720459|NCT03267212|580356777|FG000|First Intervention|Lost to Follow-up|0|||
160720460|NCT03267212|580356778|FG001|First Intervention|Lost to Follow-up|2|||
160720461|NCT03267212|580356777|FG000|First Intervention|Withdrawal by Subject|1|||
160720462|NCT03267212|580356778|FG001|First Intervention|Withdrawal by Subject|1|||
160720463|NCT03267212|580356777|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
160720464|NCT03267212|580356778|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
160720465|NCT05691712|580356779|FG000|Overall Study|Adverse Event|0|||
160720466|NCT05691712|580356780|FG001|Overall Study|Adverse Event|1|||
160720467|NCT05691712|580356781|FG002|Overall Study|Adverse Event|2|||
160720468|NCT05691712|580356782|FG003|Overall Study|Adverse Event|1|||
160720469|NCT05691712|580356779|FG000|Overall Study|Withdrawal by Subject|2|||
160720470|NCT05691712|580356780|FG001|Overall Study|Withdrawal by Subject|3|||
160720471|NCT05691712|580356781|FG002|Overall Study|Withdrawal by Subject|3|||
160720472|NCT05691712|580356782|FG003|Overall Study|Withdrawal by Subject|1|||
160720473|NCT05691712|580356779|FG000|Overall Study|Death|1|||
160720474|NCT05691712|580356780|FG001|Overall Study|Death|0|||
160720475|NCT05691712|580356781|FG002|Overall Study|Death|0|||
160720476|NCT05691712|580356782|FG003|Overall Study|Death|0|||
160720477|NCT05691712|580356779|FG000|Overall Study|Pregnancy|0|||
160720478|NCT05691712|580356780|FG001|Overall Study|Pregnancy|1|||
160720479|NCT05691712|580356781|FG002|Overall Study|Pregnancy|0|||
160720480|NCT05691712|580356782|FG003|Overall Study|Pregnancy|0|||
160720481|NCT05691712|580356779|FG000|Overall Study|Assigned Treatment by Mistake|1|||
160720482|NCT05691712|580356780|FG001|Overall Study|Assigned Treatment by Mistake|0|||
160720483|NCT05691712|580356781|FG002|Overall Study|Assigned Treatment by Mistake|0|||
160720484|NCT05691712|580356782|FG003|Overall Study|Assigned Treatment by Mistake|1|||
160720485|NCT05303194|580356783|FG000|Overall Study|Lost to Follow-up|1|||
160720486|NCT05303194|580356784|FG001|Overall Study|Lost to Follow-up|1|||
160720487|NCT05303194|580356783|FG000|Overall Study|Withdrawal by Subject|0|||
160720488|NCT05303194|580356784|FG001|Overall Study|Withdrawal by Subject|1|||
160720489|NCT02524847|580356788|FG000|Overall Study|Adverse Event|4|||
160720490|NCT02524847|580356788|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
160720491|NCT02524847|580356788|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
160720492|NCT02524847|580356788|FG000|Overall Study|Death|1|||
160720493|NCT02524847|580356788|FG000|Overall Study|Reason not Specified|1|||
160720494|NCT03170544|580356791|FG000|Part 1|Lost to Follow-up|1|||
160720495|NCT03170544|580356792|FG001|Part 1|Lost to Follow-up|0|||
160720496|NCT03170544|580356793|FG002|Part 1|Lost to Follow-up|0|||
160720497|NCT03170544|580356794|FG003|Part 1|Lost to Follow-up|0|||
160720498|NCT03170544|580356795|FG004|Part 1|Lost to Follow-up|0|||
160720499|NCT03170544|580356796|FG005|Part 1|Lost to Follow-up|0|||
160720500|NCT03170544|580356797|FG006|Part 1|Lost to Follow-up|0|||
160720501|NCT03170544|580356798|FG007|Part 1|Lost to Follow-up|0|||
160720502|NCT03170544|580356799|FG008|Part 1|Lost to Follow-up|0|||
160720503|NCT03170544|580356800|FG009|Part 1|Lost to Follow-up|0|||
160720504|NCT03170544|580356801|FG010|Part 1|Lost to Follow-up|0|||
160720505|NCT03170544|580356802|FG011|Part 1|Lost to Follow-up|0|||
160720506|NCT03170544|580356791|FG000|Part 1|Not treated|0|||
160720507|NCT03170544|580356792|FG001|Part 1|Not treated|0|||
160720508|NCT03170544|580356793|FG002|Part 1|Not treated|0|||
160720509|NCT03170544|580356794|FG003|Part 1|Not treated|1|||
160720510|NCT03170544|580356795|FG004|Part 1|Not treated|0|||
160720511|NCT03170544|580356796|FG005|Part 1|Not treated|0|||
160720512|NCT03170544|580356797|FG006|Part 1|Not treated|0|||
160720513|NCT03170544|580356798|FG007|Part 1|Not treated|0|||
160720514|NCT03170544|580356799|FG008|Part 1|Not treated|0|||
160720515|NCT03170544|580356800|FG009|Part 1|Not treated|0|||
160720516|NCT03170544|580356801|FG010|Part 1|Not treated|0|||
160720517|NCT03170544|580356802|FG011|Part 1|Not treated|0|||
160720518|NCT03539302|580356803|FG000|Overall Study|Spontaneous cardio version|0|||
160720519|NCT03539302|580356804|FG001|Overall Study|Spontaneous cardio version|0|||
160720520|NCT03539302|580356805|FG002|Overall Study|Spontaneous cardio version|0|||
160720521|NCT03539302|580356806|FG003|Overall Study|Spontaneous cardio version|0|||
160720522|NCT03539302|580356807|FG004|Overall Study|Spontaneous cardio version|0|||
160720523|NCT03539302|580356808|FG005|Overall Study|Spontaneous cardio version|1|||
160720524|NCT03539302|580356809|FG006|Overall Study|Spontaneous cardio version|1|||
160720525|NCT03752970|580358720|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
160720526|NCT03752970|580358721|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
160720527|NCT03752970|580358722|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
160720528|NCT03752970|580358720|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
160720529|NCT03752970|580358721|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
160720530|NCT03752970|580358722|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
160720531|NCT03752970|580358720|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
160720532|NCT03752970|580358721|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
160720533|NCT03752970|580358722|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
160720534|NCT03752970|580358720|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
160720535|NCT03752970|580358721|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
160720536|NCT03752970|580358722|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
160720537|NCT03752970|580358720|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
160720538|NCT03752970|580358721|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
160720539|NCT03752970|580358722|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
160720540|NCT04767282|580358723|FG000|Overall Study|Refused or did not begin surveys|6|||
160720541|NCT04767282|580358724|FG001|Overall Study|Refused or did not begin surveys|2|||
160720542|NCT04767282|580358725|FG002|Overall Study|Refused or did not begin surveys|2|||
160720543|NCT04767282|580358723|FG000|Overall Study|Duplicate household previously enrolled|2|||
160720544|NCT04767282|580358724|FG001|Overall Study|Duplicate household previously enrolled|0|||
160720545|NCT04767282|580358725|FG002|Overall Study|Duplicate household previously enrolled|8|||
160720546|NCT04767282|580358723|FG000|Overall Study|Unable to confirm legal guardian|0|||
160720547|NCT04767282|580358724|FG001|Overall Study|Unable to confirm legal guardian|2|||
160720548|NCT04767282|580358725|FG002|Overall Study|Unable to confirm legal guardian|8|||
160720549|NCT04767282|580358723|FG000|Overall Study|Withdrawal by Subject|0|||
160720550|NCT04767282|580358724|FG001|Overall Study|Withdrawal by Subject|0|||
160720551|NCT04767282|580358725|FG002|Overall Study|Withdrawal by Subject|6|||
160720552|NCT04767282|580358723|FG000|Overall Study|Survey comprehension challenges|4|||
160720553|NCT04767282|580358724|FG001|Overall Study|Survey comprehension challenges|0|||
160720554|NCT04767282|580358725|FG002|Overall Study|Survey comprehension challenges|0|||
160720555|NCT01467713|580358727|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
160720556|NCT01467713|580358728|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
160720557|NCT01467713|580358729|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
160720558|NCT01467713|580358730|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
160720559|NCT01467713|580358727|FG000|Overall Study|Major Protocol Deviation|2|||
160720560|NCT01467713|580358728|FG001|Overall Study|Major Protocol Deviation|4|||
160720561|NCT01467713|580358729|FG002|Overall Study|Major Protocol Deviation|4|||
160720562|NCT01467713|580358730|FG003|Overall Study|Major Protocol Deviation|1|||
160720563|NCT01467713|580358727|FG000|Overall Study|Lost to Follow-up|9|||
160720564|NCT01467713|580358728|FG001|Overall Study|Lost to Follow-up|12|||
160720565|NCT01467713|580358729|FG002|Overall Study|Lost to Follow-up|6|||
160720566|NCT01467713|580358730|FG003|Overall Study|Lost to Follow-up|9|||
160720567|NCT01467713|580358727|FG000|Overall Study|Voluntary Withdrawal|18|||
160720568|NCT01467713|580358728|FG001|Overall Study|Voluntary Withdrawal|14|||
160720569|NCT01467713|580358729|FG002|Overall Study|Voluntary Withdrawal|21|||
160720570|NCT01467713|580358730|FG003|Overall Study|Voluntary Withdrawal|20|||
160720571|NCT01467713|580358727|FG000|Overall Study|Study Termination|23|||
160720572|NCT01467713|580358728|FG001|Overall Study|Study Termination|33|||
160720573|NCT01467713|580358729|FG002|Overall Study|Study Termination|28|||
160720574|NCT01467713|580358730|FG003|Overall Study|Study Termination|29|||
160720575|NCT01467713|580358727|FG000|Overall Study|Pregnancy|0|||
160720576|NCT01467713|580358728|FG001|Overall Study|Pregnancy|1|||
160720577|NCT01467713|580358729|FG002|Overall Study|Pregnancy|1|||
160720578|NCT01467713|580358730|FG003|Overall Study|Pregnancy|3|||
160720579|NCT01467713|580358727|FG000|Overall Study|Relapse|35|||
160720580|NCT01467713|580358728|FG001|Overall Study|Relapse|25|||
160720581|NCT01467713|580358729|FG002|Overall Study|Relapse|28|||
160720582|NCT01467713|580358730|FG003|Overall Study|Relapse|35|||
160720583|NCT01467713|580358727|FG000|Overall Study|Reason not Specified|6|||
160720584|NCT01467713|580358728|FG001|Overall Study|Reason not Specified|11|||
160720585|NCT01467713|580358729|FG002|Overall Study|Reason not Specified|8|||
160720586|NCT01467713|580358730|FG003|Overall Study|Reason not Specified|7|||
160720587|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
160720588|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
160720589|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
160720590|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
160720591|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
160720592|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
160720593|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
160720594|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
160720595|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
160720596|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
160720597|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
160720598|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
160720599|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
160720600|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
160720601|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
160720602|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
160720603|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
160720604|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
160720605|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
160720606|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
160720607|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
160720608|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
160720609|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
160720610|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
160720611|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
160720612|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
160720613|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
160720614|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
160720615|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
160720616|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
160720617|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
160720618|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
160720619|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
160720620|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
160720621|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
160720622|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
160720623|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
160720624|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
160720625|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
160720626|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
160720627|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
160720628|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
160720629|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
160720630|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
160720631|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
160720632|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
160720633|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
160720634|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
160720635|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
160720636|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
160720637|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
160720638|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
160720639|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Site closed|0|||
160720640|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Site closed|0|||
160720641|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Site closed|1|||
160720642|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Site closed|0|||
160720643|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
160720644|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
160720645|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
160720646|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
160720647|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
160720648|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
160720649|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
160720650|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
160720651|NCT00838903|580358733|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
160720652|NCT00838903|580358734|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
160720653|NCT00838903|580358735|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
160720654|NCT00838903|580358736|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
160720655|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
160720656|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
160720657|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
160720658|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
160720659|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
160720660|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
160720661|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
160720662|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
160720663|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
160720664|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
160720665|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
160720666|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
160720667|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
160720668|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
160720669|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
160720670|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
160720671|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
160720672|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
160720673|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
160720674|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
160720675|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
160720676|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
160720677|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
160720678|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
160720679|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
160720680|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
160720681|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
160720682|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
160720683|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
160720684|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
160720685|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
160720686|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
160720687|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
160720688|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
160720689|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
160720690|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
160720691|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
160720692|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
160720693|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
160720694|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
160720695|NCT00838903|580358733|FG000|Follow-up Period (8 Weeks)|Missing|1|||
160720696|NCT00838903|580358734|FG001|Follow-up Period (8 Weeks)|Missing|2|||
160720697|NCT00838903|580358735|FG002|Follow-up Period (8 Weeks)|Missing|1|||
160720698|NCT00838903|580358736|FG003|Follow-up Period (8 Weeks)|Missing|1|||
160720699|NCT01894841|580358737|FG000|Overall Study|Withdrawal by Subject|9|||
160720700|NCT01894841|580358738|FG001|Overall Study|Withdrawal by Subject|4|||
160720701|NCT01894841|580358737|FG000|Overall Study|Withdrawn by investigator|2|||
160720702|NCT01894841|580358738|FG001|Overall Study|Withdrawn by investigator|2|||
160720703|NCT01894841|580358737|FG000|Overall Study|Lost to Follow-up|7|||
160720704|NCT01894841|580358738|FG001|Overall Study|Lost to Follow-up|3|||
160720705|NCT02512302|580358739|FG000|Period 1|Adverse Event|0|||
160720706|NCT02512302|580358740|FG001|Period 1|Adverse Event|1|||
160720707|NCT02512302|580358741|FG002|Period 1|Adverse Event|0|||
160720708|NCT02512302|580358742|FG003|Period 1|Adverse Event|0|||
160720709|NCT02512302|580358743|FG004|Period 1|Adverse Event|0|||
160720710|NCT02512302|580358744|FG005|Period 1|Adverse Event|0|||
160720711|NCT02512302|580358745|FG006|Period 1|Adverse Event|0|||
160720712|NCT02512302|580358746|FG007|Period 1|Adverse Event|0|||
160720713|NCT02512302|580358747|FG008|Period 1|Adverse Event|0|||
160720714|NCT02512302|580358748|FG009|Period 1|Adverse Event|0|||
160720715|NCT02512302|580358739|FG000|Period 2|Adverse Event|0|||
160720716|NCT02512302|580358740|FG001|Period 2|Adverse Event|0|||
160720717|NCT02512302|580358741|FG002|Period 2|Adverse Event|0|||
160720718|NCT02512302|580358742|FG003|Period 2|Adverse Event|0|||
160720719|NCT02512302|580358743|FG004|Period 2|Adverse Event|0|||
160720720|NCT02512302|580358744|FG005|Period 2|Adverse Event|0|||
160720721|NCT02512302|580358745|FG006|Period 2|Adverse Event|0|||
160720722|NCT02512302|580358746|FG007|Period 2|Adverse Event|0|||
160720723|NCT02512302|580358747|FG008|Period 2|Adverse Event|0|||
160720724|NCT02512302|580358748|FG009|Period 2|Adverse Event|1|||
160720725|NCT02512302|580358739|FG000|Period 3|Lost to Follow-up|0|||
160720726|NCT02512302|580358740|FG001|Period 3|Lost to Follow-up|0|||
160720727|NCT02512302|580358741|FG002|Period 3|Lost to Follow-up|1|||
160720728|NCT02512302|580358742|FG003|Period 3|Lost to Follow-up|0|||
160720729|NCT02512302|580358743|FG004|Period 3|Lost to Follow-up|0|||
160720730|NCT02512302|580358744|FG005|Period 3|Lost to Follow-up|0|||
160720731|NCT02512302|580358745|FG006|Period 3|Lost to Follow-up|0|||
160720732|NCT02512302|580358746|FG007|Period 3|Lost to Follow-up|0|||
160720733|NCT02512302|580358747|FG008|Period 3|Lost to Follow-up|0|||
160720734|NCT02512302|580358748|FG009|Period 3|Lost to Follow-up|0|||
160720735|NCT02512302|580358739|FG000|Period 4|Adverse Event|0|||
160720736|NCT02512302|580358740|FG001|Period 4|Adverse Event|0|||
160720737|NCT02512302|580358741|FG002|Period 4|Adverse Event|0|||
160720738|NCT02512302|580358742|FG003|Period 4|Adverse Event|0|||
160720739|NCT02512302|580358743|FG004|Period 4|Adverse Event|0|||
160720740|NCT02512302|580358744|FG005|Period 4|Adverse Event|0|||
160720741|NCT02512302|580358745|FG006|Period 4|Adverse Event|1|||
160720742|NCT02512302|580358746|FG007|Period 4|Adverse Event|0|||
160720743|NCT02512302|580358747|FG008|Period 4|Adverse Event|0|||
160720744|NCT02512302|580358748|FG009|Period 4|Adverse Event|0|||
160720745|NCT01611935|580358751|FG000|Overall Study|Family Declined Participation|1|||
160720746|NCT01611935|580358752|FG001|Overall Study|Family Declined Participation|0|||
160720747|NCT04227197|580358753|FG000|Randomization|Protocol Violation|1|||
160720748|NCT04227197|580358754|FG001|Randomization|Protocol Violation|0|||
160720749|NCT04227197|580358753|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
160720750|NCT04227197|580358754|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
160720751|NCT04227197|580358753|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
160720752|NCT04227197|580358754|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
160720753|NCT04227197|580358753|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
160720754|NCT04227197|580358754|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
160720755|NCT04227197|580358753|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
160720756|NCT04227197|580358754|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
160720757|NCT04227197|580358753|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
160720758|NCT04227197|580358754|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
160720759|NCT04227197|580358753|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
160720760|NCT04227197|580358754|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
160720761|NCT02549859|580358759|FG000|Long-term 60 Hz DBS|Study Closed|1|||
160720762|NCT01209949|580358767|FG000|Overall Study|Lost to Follow-up|3|||
160720763|NCT00729612|580358768|FG000|Overall Study|Non evaluable for response|10|||
160720764|NCT00708552|580358769|FG000|Overall Study|Adverse Event|10|||
160720765|NCT00708552|580358770|FG001|Overall Study|Adverse Event|3|||
160720766|NCT00708552|580358771|FG002|Overall Study|Adverse Event|4|||
160720767|NCT00708552|580358772|FG003|Overall Study|Adverse Event|6|||
160720768|NCT00708552|580358769|FG000|Overall Study|Lack of Efficacy|0|||
160720769|NCT00708552|580358770|FG001|Overall Study|Lack of Efficacy|4|||
160720770|NCT00708552|580358771|FG002|Overall Study|Lack of Efficacy|1|||
160720771|NCT00708552|580358772|FG003|Overall Study|Lack of Efficacy|0|||
160720772|NCT00708552|580358769|FG000|Overall Study|Protocol Violation|0|||
160720773|NCT00708552|580358770|FG001|Overall Study|Protocol Violation|0|||
160720774|NCT00708552|580358771|FG002|Overall Study|Protocol Violation|2|||
160720775|NCT00708552|580358772|FG003|Overall Study|Protocol Violation|4|||
160720776|NCT00708552|580358769|FG000|Overall Study|Lost to Follow-up|4|||
160720777|NCT00708552|580358770|FG001|Overall Study|Lost to Follow-up|2|||
160720778|NCT00708552|580358771|FG002|Overall Study|Lost to Follow-up|0|||
160720779|NCT00708552|580358772|FG003|Overall Study|Lost to Follow-up|1|||
160720780|NCT00708552|580358769|FG000|Overall Study|Physician Decision|1|||
160720781|NCT00708552|580358770|FG001|Overall Study|Physician Decision|2|||
160720782|NCT00708552|580358771|FG002|Overall Study|Physician Decision|0|||
160720783|NCT00708552|580358772|FG003|Overall Study|Physician Decision|0|||
160720784|NCT00708552|580358769|FG000|Overall Study|Withdrawal by Subject|12|||
160720785|NCT00708552|580358770|FG001|Overall Study|Withdrawal by Subject|7|||
160720786|NCT00708552|580358771|FG002|Overall Study|Withdrawal by Subject|8|||
160720787|NCT00708552|580358772|FG003|Overall Study|Withdrawal by Subject|10|||
160720788|NCT04878432|580358773|FG000|Overall Study|Adverse Event|1|||
160720789|NCT04878432|580358773|FG000|Overall Study|Death|2|||
160720790|NCT04878432|580358773|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160720791|NCT04878432|580358773|FG000|Overall Study|Withdrawal by Subject|6|||
160720792|NCT04878432|580358773|FG000|Overall Study|Progressive Disease|7|||
160720793|NCT04878432|580358773|FG000|Overall Study|New Therapy for Study Indication|7|||
160720794|NCT04878432|580358773|FG000|Overall Study|Physician Decision|11|||
160720795|NCT03971071|580358774|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
160720796|NCT03971071|580358775|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
160720797|NCT03971071|580358776|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
160720798|NCT03971071|580358777|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
160720799|NCT03971071|580358778|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
160720800|NCT03971071|580358774|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
160720801|NCT03971071|580358775|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
160720802|NCT03971071|580358776|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
160720803|NCT03971071|580358777|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
160720804|NCT03971071|580358778|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
160720805|NCT03971071|580358774|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
160720806|NCT03971071|580358775|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
160720807|NCT03971071|580358776|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
160720808|NCT03971071|580358777|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
160720809|NCT03971071|580358778|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
160720810|NCT03971071|580358774|FG000|Open-label Treatment Period|Sponsor decision|0|||
160720811|NCT03971071|580358775|FG001|Open-label Treatment Period|Sponsor decision|0|||
160720812|NCT03971071|580358776|FG002|Open-label Treatment Period|Sponsor decision|0|||
160720813|NCT03971071|580358777|FG003|Open-label Treatment Period|Sponsor decision|0|||
160720814|NCT03971071|580358778|FG004|Open-label Treatment Period|Sponsor decision|1|||
160720815|NCT03971071|580358774|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
160720816|NCT03971071|580358775|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
160720817|NCT03971071|580358776|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
160720818|NCT03971071|580358777|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
160720819|NCT03971071|580358778|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
160720820|NCT03971071|580358774|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
160720821|NCT03971071|580358775|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
160720822|NCT03971071|580358776|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
160720823|NCT03971071|580358777|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
160720824|NCT03971071|580358778|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
160720825|NCT02172664|580358786|FG000|Overall Study|Lost to Follow-up|4|||
160720826|NCT02172664|580358787|FG001|Overall Study|Lost to Follow-up|4|||
160720827|NCT02172664|580358786|FG000|Overall Study|Death|1|||
160720828|NCT02172664|580358787|FG001|Overall Study|Death|1|||
160720829|NCT02172664|580358786|FG000|Overall Study|Moved out of area|1|||
160720830|NCT02172664|580358787|FG001|Overall Study|Moved out of area|1|||
160720831|NCT01909934|580358788|FG000|Overall Study|Withdrawal by Subject|3|||
160720832|NCT01909934|580358788|FG000|Overall Study|Lost to Follow-up|1|||
160720833|NCT01909934|580358788|FG000|Overall Study|Death|25|||
160720834|NCT01909934|580358788|FG000|Overall Study|Withdrawal of Informed Consent|1|||
160720835|NCT01909934|580358788|FG000|Overall Study|Reason Not Specified|1|||
160720836|NCT03810092|580358789|FG000|Overall Study|no ground support|17|||
160720837|NCT03810092|580358789|FG000|Overall Study|ADL not done at J0|16|||
160720838|NCT03810092|580358789|FG000|Overall Study|No hemoglobin measure at J5|27|||
160720839|NCT00235755|580358791|FG000|4-Week Titration Phase|Adverse Event|6|||
160720840|NCT00235755|580358792|FG001|4-Week Titration Phase|Adverse Event|14|||
160720841|NCT00235755|580358793|FG002|4-Week Titration Phase|Adverse Event|20|||
160720842|NCT00235755|580358791|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
160720843|NCT00235755|580358792|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
160720844|NCT00235755|580358793|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
160720845|NCT00235755|580358791|FG000|4-Week Titration Phase|Protocol Violation|2|||
160720846|NCT00235755|580358792|FG001|4-Week Titration Phase|Protocol Violation|2|||
160720847|NCT00235755|580358793|FG002|4-Week Titration Phase|Protocol Violation|1|||
160720848|NCT00235755|580358791|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
160720849|NCT00235755|580358792|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
160720850|NCT00235755|580358793|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
160720851|NCT00235755|580358791|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
160720852|NCT00235755|580358792|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
160720853|NCT00235755|580358793|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
160720854|NCT00235755|580358791|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
160720855|NCT00235755|580358792|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
160720856|NCT00235755|580358793|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
160720857|NCT00235755|580358791|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
160720858|NCT00235755|580358792|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
160720859|NCT00235755|580358793|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
160720860|NCT00235755|580358791|FG000|12-Week Maintenance Phase|Adverse Event|8|||
160720861|NCT00235755|580358792|FG001|12-Week Maintenance Phase|Adverse Event|12|||
160720862|NCT00235755|580358793|FG002|12-Week Maintenance Phase|Adverse Event|26|||
160720863|NCT00235755|580358791|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
160720864|NCT00235755|580358792|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
160720865|NCT00235755|580358793|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
160720866|NCT00235755|580358791|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
160720867|NCT00235755|580358792|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
160720868|NCT00235755|580358793|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
160720869|NCT00235755|580358791|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
160720870|NCT00235755|580358792|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
160720871|NCT00235755|580358793|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
160720872|NCT00235755|580358791|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
160720873|NCT00235755|580358792|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
160720874|NCT00235755|580358793|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
160720875|NCT00235755|580358791|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
160720876|NCT00235755|580358792|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
160720877|NCT00235755|580358793|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
160720878|NCT03839628|580358794|FG000|Overall Study|Withdrawal by Subject|1|||
160720879|NCT03380429|580358795|FG000|Overall Study|Physician Decision|0|||
160720880|NCT03380429|580358796|FG001|Overall Study|Physician Decision|1|||
160720881|NCT03380429|580358797|FG002|Overall Study|Physician Decision|0|||
160720882|NCT03380429|580358798|FG003|Overall Study|Physician Decision|1|||
160720883|NCT03380429|580358799|FG004|Overall Study|Physician Decision|1|||
160720884|NCT03380429|580358795|FG000|Overall Study|Withdrawal by Subject|3|||
160720885|NCT03380429|580358796|FG001|Overall Study|Withdrawal by Subject|3|||
160720886|NCT03380429|580358797|FG002|Overall Study|Withdrawal by Subject|5|||
160720887|NCT03380429|580358798|FG003|Overall Study|Withdrawal by Subject|2|||
160720888|NCT03380429|580358799|FG004|Overall Study|Withdrawal by Subject|1|||
160720889|NCT03380429|580358795|FG000|Overall Study|Lost to Follow-up|0|||
160720890|NCT03380429|580358796|FG001|Overall Study|Lost to Follow-up|2|||
160720891|NCT03380429|580358797|FG002|Overall Study|Lost to Follow-up|4|||
160720892|NCT03380429|580358798|FG003|Overall Study|Lost to Follow-up|3|||
160720893|NCT03380429|580358799|FG004|Overall Study|Lost to Follow-up|1|||
160720894|NCT03380429|580358795|FG000|Overall Study|Protocol Violation|1|||
160720895|NCT03380429|580358796|FG001|Overall Study|Protocol Violation|0|||
160720896|NCT03380429|580358797|FG002|Overall Study|Protocol Violation|1|||
160720897|NCT03380429|580358798|FG003|Overall Study|Protocol Violation|0|||
160720898|NCT03380429|580358799|FG004|Overall Study|Protocol Violation|1|||
160720899|NCT03380429|580358795|FG000|Overall Study|Lack of Efficacy|0|||
160720900|NCT03380429|580358796|FG001|Overall Study|Lack of Efficacy|0|||
160720901|NCT03380429|580358797|FG002|Overall Study|Lack of Efficacy|0|||
160720902|NCT03380429|580358798|FG003|Overall Study|Lack of Efficacy|2|||
160720903|NCT03380429|580358799|FG004|Overall Study|Lack of Efficacy|1|||
160720904|NCT03380429|580358795|FG000|Overall Study|Adverse Event|1|||
160720905|NCT03380429|580358796|FG001|Overall Study|Adverse Event|1|||
160720906|NCT03380429|580358797|FG002|Overall Study|Adverse Event|1|||
160720907|NCT03380429|580358798|FG003|Overall Study|Adverse Event|2|||
160720908|NCT03380429|580358799|FG004|Overall Study|Adverse Event|0|||
160720909|NCT01707290|580358804|FG000|Overall Study|Adverse event (AE)|1|||
160720910|NCT01707290|580358805|FG001|Overall Study|Adverse event (AE)|0|||
160720911|NCT01707290|580358804|FG000|Overall Study|Physician Decision|1|||
160720912|NCT01707290|580358805|FG001|Overall Study|Physician Decision|0|||
160720913|NCT01707290|580358804|FG000|Overall Study|Lost to Follow-up|3|||
160720914|NCT01707290|580358805|FG001|Overall Study|Lost to Follow-up|0|||
160720915|NCT01707290|580358804|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
160720916|NCT01707290|580358805|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
160720917|NCT01707290|580358804|FG000|Overall Study|Commercial drug available|60|||
160720918|NCT01707290|580358805|FG001|Overall Study|Commercial drug available|1|||
160720919|NCT01707290|580358804|FG000|Overall Study|Other unspecified|17|||
160720920|NCT01707290|580358805|FG001|Overall Study|Other unspecified|0|||
160720921|NCT01882985|580358808|FG000|Overall Study|Lost to Follow-up|1|||
160720922|NCT01882985|580358808|FG000|Overall Study|Withdrawal by Subject|1|||
160720923|NCT03193853|580358815|FG000|Overall Study|Death|6|||
160720924|NCT04129125|580358816|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
160720925|NCT04129125|580358816|FG000|Overall Study|Study device was not used|3|||
160720926|NCT01320293|580358824|FG000|Overall Study|Lack of Efficacy|1|||
160720927|NCT01320293|580358824|FG000|Overall Study|Adverse Event|1|||
160720928|NCT01787292|580358827|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
160720929|NCT01787292|580358828|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
160720930|NCT01787292|580358827|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
160720931|NCT01787292|580358828|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
160720932|NCT01532934|580358829|FG000|Overall Study|Lost to Follow-up|11|||
160720933|NCT01532934|580358830|FG001|Overall Study|Lost to Follow-up|11|||
160720934|NCT01532934|580358829|FG000|Overall Study|In controlled environment|3|||
160720935|NCT01532934|580358830|FG001|Overall Study|In controlled environment|2|||
160720936|NCT01147068|580358831|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
160720937|NCT01147068|580358832|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
160720938|NCT01147068|580358833|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
160720939|NCT01147068|580358834|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
160720940|NCT01147068|580358835|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
160720941|NCT01147068|580358836|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
160720942|NCT01147068|580358837|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
160720943|NCT01147068|580358831|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
160720944|NCT01147068|580358832|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
160720945|NCT01147068|580358833|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
160720946|NCT01147068|580358834|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
160720947|NCT01147068|580358835|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
160720948|NCT01147068|580358836|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
160720949|NCT01147068|580358837|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
160720950|NCT01147068|580358831|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
160720951|NCT01147068|580358832|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
160720952|NCT01147068|580358833|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
160720953|NCT01147068|580358834|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
160720954|NCT01147068|580358835|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
160720955|NCT01147068|580358836|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
160720956|NCT01147068|580358837|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
160720957|NCT01147068|580358831|FG000|Subjects That Received 2nd Dose|Other|0|||
160720958|NCT01147068|580358832|FG001|Subjects That Received 2nd Dose|Other|3|||
160720959|NCT01147068|580358833|FG002|Subjects That Received 2nd Dose|Other|3|||
160720960|NCT01147068|580358834|FG003|Subjects That Received 2nd Dose|Other|0|||
160720961|NCT01147068|580358835|FG004|Subjects That Received 2nd Dose|Other|1|||
160720962|NCT01147068|580358836|FG005|Subjects That Received 2nd Dose|Other|0|||
160720963|NCT01147068|580358837|FG006|Subjects That Received 2nd Dose|Other|0|||
160720964|NCT01147068|580358831|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
160720965|NCT01147068|580358832|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
160720966|NCT01147068|580358833|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
160720967|NCT01147068|580358834|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
160720968|NCT01147068|580358835|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
160720969|NCT01147068|580358836|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
160720970|NCT01147068|580358837|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
160720971|NCT01147068|580358831|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
160720972|NCT01147068|580358832|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
160720973|NCT01147068|580358833|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
160720974|NCT01147068|580358834|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
160720975|NCT01147068|580358835|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
160720976|NCT01147068|580358836|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
160720977|NCT01147068|580358837|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
160720978|NCT01147068|580358831|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
160720979|NCT01147068|580358832|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
160720980|NCT01147068|580358833|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
160720981|NCT01147068|580358834|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
160720982|NCT01147068|580358835|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
160720983|NCT01147068|580358836|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
160720984|NCT01147068|580358837|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
160720985|NCT02962648|580358839|FG000|Overall Study|Withdrawal by Subject|3|||
160720986|NCT02962648|580358839|FG000|Overall Study|Lost to Follow-up|3|||
160720987|NCT02962648|580358839|FG000|Overall Study|Physician Decision|1|||
160720988|NCT02962648|580358839|FG000|Overall Study|Subject had problems with transportation|2|||
160720989|NCT01597778|580358840|FG000|Overall Study|Death|7|||
160720990|NCT01597778|580358841|FG001|Overall Study|Death|10|||
160720991|NCT01597778|580358840|FG000|Overall Study|Withdrawal by Subject|3|||
160720992|NCT01597778|580358841|FG001|Overall Study|Withdrawal by Subject|4|||
160720993|NCT01597778|580358840|FG000|Overall Study|Adverse Event|1|||
160720994|NCT01597778|580358841|FG001|Overall Study|Adverse Event|1|||
160720995|NCT01597778|580358840|FG000|Overall Study|Protocol Violation|1|||
160720996|NCT01597778|580358841|FG001|Overall Study|Protocol Violation|11|||
160720997|NCT01597778|580358840|FG000|Overall Study|Transplanted off protocol|2|||
160720998|NCT01597778|580358841|FG001|Overall Study|Transplanted off protocol|3|||
160720999|NCT01289678|580358852|FG000|Overall Study|Physician Decision|6|||
160721000|NCT00226499|580358853|FG000|Overall Study|Adverse Event|10|||
160721001|NCT00226499|580358854|FG001|Overall Study|Adverse Event|6|||
160721002|NCT00226499|580358855|FG002|Overall Study|Adverse Event|3|||
160721003|NCT00226499|580358853|FG000|Overall Study|Others|1064|||
160721004|NCT00226499|580358854|FG001|Overall Study|Others|1066|||
160721005|NCT00226499|580358855|FG002|Overall Study|Others|356|||
160721006|NCT00468819|580358856|FG000|Overall Study|Withdrawal by Subject|4|||
160721007|NCT00468819|580358857|FG001|Overall Study|Withdrawal by Subject|0|||
160721008|NCT00468819|580358858|FG002|Overall Study|Withdrawal by Subject|1|||
160721009|NCT00468819|580358856|FG000|Overall Study|Lost to Follow-up|0|||
160721010|NCT00468819|580358857|FG001|Overall Study|Lost to Follow-up|0|||
160721011|NCT00468819|580358858|FG002|Overall Study|Lost to Follow-up|1|||
160721012|NCT00468819|580358856|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
160721013|NCT00468819|580358857|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
160721014|NCT00468819|580358858|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
160721015|NCT02723344|580358859|FG000|Overall Study|Lost to Follow-up|0|||
160721016|NCT02723344|580358860|FG001|Overall Study|Lost to Follow-up|4|||
160721017|NCT04352101|580358861|FG000|Overall Study|Physician Decision|2|||
160721018|NCT04352101|580358862|FG001|Overall Study|Physician Decision|1|||
160721019|NCT04564092|580358869|FG000|Overall Study|Withdrawal by Subject|1|||
160721020|NCT00420420|580358872|FG000|Overall Study|Adverse Event|5|||
160721021|NCT00420420|580358873|FG001|Overall Study|Adverse Event|3|||
160721022|NCT00420420|580358872|FG000|Overall Study|Protocol Violation|1|||
160721023|NCT00420420|580358873|FG001|Overall Study|Protocol Violation|1|||
160721024|NCT00420420|580358872|FG000|Overall Study|Withdrawal by Subject|1|||
160721025|NCT00420420|580358873|FG001|Overall Study|Withdrawal by Subject|0|||
160721026|NCT00420420|580358872|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
160721027|NCT00420420|580358873|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
160721028|NCT00273182|580358874|FG000|Overall Study|Death|450|||
160721029|NCT00273182|580358874|FG000|Overall Study|Lost to Follow-up|88|||
160721030|NCT00273182|580358874|FG000|Overall Study|Withdrawal by Subject|257|||
160721031|NCT00273182|580358874|FG000|Overall Study|Device/System Explant|154|||
160721032|NCT00273182|580358874|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
160721033|NCT04762160|580358875|FG000|Overall Study|Study terminated early due to business reasons|5|||
160721034|NCT02362360|580358882|FG000|Period 1|Lack of Efficacy|1|||
160721035|NCT02362360|580358883|FG001|Period 1|Lack of Efficacy|0|||
160721036|NCT02362360|580358882|FG000|Period 1|Withdrawal by Subject|2|||
160721037|NCT02362360|580358883|FG001|Period 1|Withdrawal by Subject|1|||
160721038|NCT04146012|580358884|FG000|Overall Study|Study Terminated|30|||
160721039|NCT04146012|580358885|FG001|Overall Study|Study Terminated|15|||
160721040|NCT03817190|580358886|FG000|Overall Study|Early Termination|13|||
160721041|NCT03817190|580358887|FG001|Overall Study|Early Termination|20|||
160721042|NCT03817190|580358886|FG000|Overall Study|Adverse Event|10|||
160721043|NCT03817190|580358887|FG001|Overall Study|Adverse Event|17|||
160721044|NCT03817190|580358886|FG000|Overall Study|Withdrawal by Subject|12|||
160721045|NCT03817190|580358887|FG001|Overall Study|Withdrawal by Subject|8|||
160721046|NCT03817190|580358886|FG000|Overall Study|Lost to Follow-up|11|||
160721047|NCT03817190|580358887|FG001|Overall Study|Lost to Follow-up|7|||
160721048|NCT03817190|580358886|FG000|Overall Study|Lack of Efficacy|7|||
160721049|NCT03817190|580358887|FG001|Overall Study|Lack of Efficacy|5|||
160721050|NCT03817190|580358886|FG000|Overall Study|Investigator Decision|5|||
160721051|NCT03817190|580358887|FG001|Overall Study|Investigator Decision|1|||
160721052|NCT03817190|580358886|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
160721053|NCT03817190|580358887|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
160721054|NCT03817190|580358886|FG000|Overall Study|Lack of Contact|1|||
160721055|NCT03817190|580358887|FG001|Overall Study|Lack of Contact|0|||
160721056|NCT03817190|580358886|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
160721057|NCT03817190|580358887|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
160721058|NCT01546025|580358888|FG000|Overall Study|Lost to Follow-up|0|||
160721059|NCT01546025|580358889|FG001|Overall Study|Lost to Follow-up|1|||
160721060|NCT00868530|580358892|FG000|Overall Study|Adverse Event|3|||
160721061|NCT00868530|580358892|FG000|Overall Study|Lost to Follow-up|1|||
160748714|NCT00303472|580465928|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
160748715|NCT00303472|580465929|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
160748716|NCT00303472|580465930|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
160748717|NCT00303472|580465931|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
160748718|NCT00303472|580465932|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
160748719|NCT00303472|580465926|FG000|Treatment Extension (Optional)|Physician Decision|0|||
160748720|NCT00303472|580465927|FG001|Treatment Extension (Optional)|Physician Decision|4|||
160721062|NCT04955691|580360647|FG000|Period 2|Discontinued intervention|1|||
160721063|NCT04955691|580360648|FG001|Period 2|Discontinued intervention|2|||
160721064|NCT05795153|580360649|FG000|Overall Study|Adverse Event|2|||
160721065|NCT05795153|580360649|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160721066|NCT05795153|580360649|FG000|Overall Study|Lost to Follow-up|1|||
160721067|NCT05795153|580360649|FG000|Overall Study|Subject decision|2|||
160721068|NCT03668119|580360650|FG000|Pre-treatment|Disease Progression|1|||
160721069|NCT03668119|580360651|FG001|Pre-treatment|Disease Progression|0|||
160721070|NCT03668119|580360650|FG000|Treatment|Disease Progression|76|||
160721071|NCT03668119|580360651|FG001|Treatment|Disease Progression|57|||
160721072|NCT03668119|580360650|FG000|Treatment|Study drug toxicity|19|||
160721073|NCT03668119|580360651|FG001|Treatment|Study drug toxicity|1|||
160721074|NCT03668119|580360650|FG000|Treatment|Death|3|||
160721075|NCT03668119|580360651|FG001|Treatment|Death|0|||
160721076|NCT03668119|580360650|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
160721077|NCT03668119|580360651|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
160721078|NCT03668119|580360650|FG000|Treatment|Withdrawal by Subject|1|||
160721079|NCT03668119|580360651|FG001|Treatment|Withdrawal by Subject|1|||
160721080|NCT03668119|580360650|FG000|Treatment|Participant request to discontinue study treatment|3|||
160721081|NCT03668119|580360651|FG001|Treatment|Participant request to discontinue study treatment|1|||
160721082|NCT03668119|580360650|FG000|Treatment|Maximum Clinical Benefit|0|||
160721083|NCT03668119|580360651|FG001|Treatment|Maximum Clinical Benefit|1|||
160721084|NCT03668119|580360650|FG000|Treatment|Participants completed treatment|27|||
160721085|NCT03668119|580360651|FG001|Treatment|Participants completed treatment|11|||
160721086|NCT03668119|580360650|FG000|Treatment|Other reasons|2|||
160721087|NCT03668119|580360651|FG001|Treatment|Other reasons|1|||
160721088|NCT03769168|580360652|FG000|Overall Study|Adverse Event|0|||
160721089|NCT03769168|580360653|FG001|Overall Study|Adverse Event|1|||
160721090|NCT03769168|580360652|FG000|Overall Study|Lack of Efficacy|2|||
160721091|NCT03769168|580360653|FG001|Overall Study|Lack of Efficacy|4|||
160721092|NCT03769168|580360652|FG000|Overall Study|Post study access to treatment|3|||
160721093|NCT03769168|580360653|FG001|Overall Study|Post study access to treatment|11|||
160721094|NCT03769168|580360652|FG000|Overall Study|Physician Decision|1|||
160721095|NCT03769168|580360653|FG001|Overall Study|Physician Decision|4|||
160721096|NCT03769168|580360652|FG000|Overall Study|Subject Decision|2|||
160721097|NCT03769168|580360653|FG001|Overall Study|Subject Decision|4|||
160721098|NCT03769168|580360652|FG000|Overall Study|Guardian decision|1|||
160721099|NCT03769168|580360653|FG001|Overall Study|Guardian decision|0|||
160721100|NCT05142722|580360654|FG000|Overall Study|Lost to Follow-up|16|||
160721101|NCT05142722|580360655|FG001|Overall Study|Lost to Follow-up|38|||
160721102|NCT05142722|580360654|FG000|Overall Study|Withdrawal by Subject|20|||
160721103|NCT05142722|580360655|FG001|Overall Study|Withdrawal by Subject|27|||
160721104|NCT05142722|580360654|FG000|Overall Study|Death|11|||
160721105|NCT05142722|580360655|FG001|Overall Study|Death|17|||
160721106|NCT05142722|580360654|FG000|Overall Study|Physician Decision|0|||
160721107|NCT05142722|580360655|FG001|Overall Study|Physician Decision|1|||
160721108|NCT05142722|580360654|FG000|Overall Study|Participant Moved Away|0|||
160721109|NCT05142722|580360655|FG001|Overall Study|Participant Moved Away|2|||
160721110|NCT05142722|580360654|FG000|Overall Study|Adverse Event|2|||
160721111|NCT05142722|580360655|FG001|Overall Study|Adverse Event|1|||
160721112|NCT05086744|580360656|FG000|Part A|Adverse Event|0|||
160721113|NCT05086744|580360657|FG001|Part A|Adverse Event|1|||
160721114|NCT05086744|580360656|FG000|Part A|Lack of Efficacy|3|||
160721115|NCT05086744|580360657|FG001|Part A|Lack of Efficacy|0|||
160721116|NCT05086744|580360656|FG000|Part A|Protocol deviation|1|||
160721117|NCT05086744|580360657|FG001|Part A|Protocol deviation|0|||
160721118|NCT05086744|580360656|FG000|Part A|Subject decision|1|||
160721119|NCT05086744|580360657|FG001|Part A|Subject decision|0|||
160721120|NCT05086744|580360656|FG000|Part B|Adverse Event|0|||
160721121|NCT05086744|580360657|FG001|Part B|Adverse Event|1|||
160721122|NCT05086744|580360656|FG000|Part B|Lack of Efficacy|0|||
160721123|NCT05086744|580360657|FG001|Part B|Lack of Efficacy|1|||
160721124|NCT05086744|580360656|FG000|Part B|Study terminated by sponsor|1|||
160721125|NCT05086744|580360657|FG001|Part B|Study terminated by sponsor|6|||
160721126|NCT04053868|580360660|FG000|Overall Study|Withdrawal by Subject|1|||
160721127|NCT04053868|580360661|FG001|Overall Study|Withdrawal by Subject|0|||
160721128|NCT05731700|580360662|FG000|Overall Study|Death|1|||
160721129|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
160721130|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
160721131|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
160721132|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
160721133|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
160721134|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
160721135|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
160721136|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
160721137|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
160721138|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
160721139|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
160721140|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
160721141|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
160721142|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
160721143|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
160721144|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
160721145|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
160721146|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
160721147|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
160721148|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
160721149|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
160721150|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
160721151|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
160721152|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
160721153|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
160721154|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
160721155|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
160721156|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
160721157|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
160721158|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
160721159|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
160721160|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
160721161|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721162|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721163|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
160721164|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721165|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721166|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721167|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
160721168|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721169|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
160721170|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
160721171|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
160721172|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
160721173|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
160721174|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
160721175|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
160721176|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
160721177|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
160721178|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
160721179|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
160721180|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
160721181|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
160721182|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
160721183|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
160721184|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
160721185|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
160721186|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
160721187|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
160721188|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
160721189|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
160721190|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
160721191|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
160721192|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
160721193|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
160721194|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
160721195|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
160721196|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
160721197|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
160721198|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
160721199|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
160721200|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
160721201|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721202|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721203|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721204|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721205|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721206|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
160721207|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721208|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
160721209|NCT03896503|580360665|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
160721210|NCT03896503|580360666|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
160721211|NCT03896503|580360667|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
160721212|NCT03896503|580360668|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
160721213|NCT03896503|580360669|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
160721214|NCT03896503|580360670|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
160721215|NCT03896503|580360671|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
160721216|NCT03896503|580360672|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
160721217|NCT05400655|580360673|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
160721218|NCT05400655|580360674|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
160721219|NCT05400655|580360675|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
160721220|NCT05400655|580360676|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
160721221|NCT05400655|580360677|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
160721222|NCT05400655|580360678|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
160721223|NCT05400655|580360679|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
160721224|NCT05400655|580360680|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
160721225|NCT05400655|580360681|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
160721226|NCT05400655|580360682|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
160721227|NCT05400655|580360683|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
160721228|NCT05400655|580360684|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
160721229|NCT05400655|580360685|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
160721230|NCT05400655|580360686|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
160721231|NCT05400655|580360687|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
160721232|NCT05400655|580360688|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
160721233|NCT05400655|580360689|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
160721234|NCT05400655|580360690|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
160721235|NCT05400655|580360691|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
160721236|NCT05400655|580360692|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
160721237|NCT05400655|580360693|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
160721238|NCT05400655|580360694|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
160721239|NCT05400655|580360673|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721240|NCT05400655|580360674|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721241|NCT05400655|580360675|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721242|NCT05400655|580360676|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721243|NCT05400655|580360677|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721244|NCT05400655|580360678|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721245|NCT05400655|580360679|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721246|NCT05400655|580360680|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721247|NCT05400655|580360681|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721248|NCT05400655|580360682|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721249|NCT05400655|580360683|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721250|NCT05400655|580360684|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721251|NCT05400655|580360685|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
160721252|NCT05400655|580360686|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721253|NCT05400655|580360687|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721254|NCT05400655|580360688|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721255|NCT05400655|580360689|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
160721256|NCT05400655|580360690|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721257|NCT05400655|580360691|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
160721258|NCT05400655|580360692|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
160721259|NCT05400655|580360693|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721260|NCT05400655|580360694|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
160721261|NCT05400655|580360673|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721262|NCT05400655|580360674|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721263|NCT05400655|580360675|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721264|NCT05400655|580360676|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721265|NCT05400655|580360677|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721266|NCT05400655|580360678|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721267|NCT05400655|580360679|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721268|NCT05400655|580360680|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721269|NCT05400655|580360681|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721270|NCT05400655|580360682|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721271|NCT05400655|580360683|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721272|NCT05400655|580360684|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721273|NCT05400655|580360685|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721274|NCT05400655|580360686|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
160721275|NCT05400655|580360687|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721276|NCT05400655|580360688|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721277|NCT05400655|580360689|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
160721278|NCT05400655|580360690|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721279|NCT05400655|580360691|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
160721280|NCT05400655|580360692|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721281|NCT05400655|580360693|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721282|NCT05400655|580360694|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
160721283|NCT05400655|580360673|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721284|NCT05400655|580360674|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721285|NCT05400655|580360675|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721286|NCT05400655|580360676|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721287|NCT05400655|580360677|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721288|NCT05400655|580360678|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721289|NCT05400655|580360679|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721290|NCT05400655|580360680|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721291|NCT05400655|580360681|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721292|NCT05400655|580360682|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721293|NCT05400655|580360683|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721294|NCT05400655|580360684|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721295|NCT05400655|580360685|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721296|NCT05400655|580360686|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721297|NCT05400655|580360687|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721298|NCT05400655|580360688|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721299|NCT05400655|580360689|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
160721300|NCT05400655|580360690|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
160721301|NCT05400655|580360691|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
160721302|NCT05400655|580360692|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
160721303|NCT05400655|580360693|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
160721304|NCT05400655|580360694|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
160721305|NCT05400655|580360673|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721306|NCT05400655|580360674|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721307|NCT05400655|580360675|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721308|NCT05400655|580360676|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721309|NCT05400655|580360677|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721310|NCT05400655|580360678|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721311|NCT05400655|580360679|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721312|NCT05400655|580360680|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721313|NCT05400655|580360681|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721314|NCT05400655|580360682|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721315|NCT05400655|580360683|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721316|NCT05400655|580360684|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721317|NCT05400655|580360685|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721318|NCT05400655|580360686|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721319|NCT05400655|580360687|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721320|NCT05400655|580360688|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721321|NCT05400655|580360689|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721322|NCT05400655|580360690|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
160721323|NCT05400655|580360691|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
160721324|NCT05400655|580360692|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721325|NCT05400655|580360693|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721326|NCT05400655|580360694|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
160721327|NCT05400655|580360673|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721328|NCT05400655|580360674|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721329|NCT05400655|580360675|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721330|NCT05400655|580360676|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721331|NCT05400655|580360677|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721332|NCT05400655|580360678|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721333|NCT05400655|580360679|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721334|NCT05400655|580360680|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721335|NCT05400655|580360681|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721336|NCT05400655|580360682|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721337|NCT05400655|580360683|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721338|NCT05400655|580360684|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721339|NCT05400655|580360685|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721340|NCT05400655|580360686|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721341|NCT05400655|580360687|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721342|NCT05400655|580360688|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721343|NCT05400655|580360689|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
160721344|NCT05400655|580360690|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
160721345|NCT05400655|580360691|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
160721346|NCT05400655|580360692|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
160721347|NCT05400655|580360693|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
160721348|NCT05400655|580360694|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
160721349|NCT01068678|580360703|FG000|Overall Study|Lack of Efficacy|3|||
160721350|NCT01068678|580360704|FG001|Overall Study|Lack of Efficacy|2|||
160721351|NCT01068678|580360703|FG000|Overall Study|Protocol Violation|5|||
160721352|NCT01068678|580360704|FG001|Overall Study|Protocol Violation|1|||
160721353|NCT01068678|580360703|FG000|Overall Study|Withdrawal criteria|12|||
160721354|NCT01068678|580360704|FG001|Overall Study|Withdrawal criteria|6|||
160721355|NCT01068678|580360703|FG000|Overall Study|Unclassified|18|||
160721356|NCT01068678|580360704|FG001|Overall Study|Unclassified|15|||
160721357|NCT00360282|580360705|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
160721358|NCT00360282|580360706|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
160721359|NCT00360282|580360707|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
160721360|NCT00360282|580360708|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
160721361|NCT00360282|580360705|FG000|Second Intervention|Adverse Event|0|||
160721362|NCT00360282|580360706|FG001|Second Intervention|Adverse Event|1|||
160721363|NCT00360282|580360707|FG002|Second Intervention|Adverse Event|0|||
160721364|NCT00360282|580360708|FG003|Second Intervention|Adverse Event|0|||
160721365|NCT00925704|580360709|FG000|First Intervention|Withdrew consent|0|||
160721366|NCT00925704|580360710|FG001|First Intervention|Withdrew consent|0|||
160721367|NCT00925704|580360711|FG002|First Intervention|Withdrew consent|0|||
160721368|NCT00925704|580360712|FG003|First Intervention|Withdrew consent|1|||
160721369|NCT00925704|580360713|FG004|First Intervention|Withdrew consent|1|||
160721370|NCT00925704|580360714|FG005|First Intervention|Withdrew consent|0|||
160721371|NCT00925704|580360709|FG000|Second Intervention|Withdrawal by Subject|1|||
160721372|NCT00925704|580360710|FG001|Second Intervention|Withdrawal by Subject|0|||
160721373|NCT00925704|580360711|FG002|Second Intervention|Withdrawal by Subject|0|||
160721374|NCT00925704|580360712|FG003|Second Intervention|Withdrawal by Subject|0|||
160721375|NCT00925704|580360713|FG004|Second Intervention|Withdrawal by Subject|1|||
160721376|NCT00925704|580360714|FG005|Second Intervention|Withdrawal by Subject|0|||
160721377|NCT00925704|580360709|FG000|Third Intervention|Withdrew consent|0|||
160721378|NCT00925704|580360710|FG001|Third Intervention|Withdrew consent|0|||
160721379|NCT00925704|580360711|FG002|Third Intervention|Withdrew consent|0|||
160721380|NCT00925704|580360712|FG003|Third Intervention|Withdrew consent|0|||
160721381|NCT00925704|580360713|FG004|Third Intervention|Withdrew consent|0|||
160721382|NCT00925704|580360714|FG005|Third Intervention|Withdrew consent|1|||
160721383|NCT03207815|580360717|FG000|Overall Study|Protocol Violation|3|||
160721384|NCT03207815|580360718|FG001|Overall Study|Protocol Violation|1|||
160721385|NCT03207815|580360717|FG000|Overall Study|Adverse Event|1|||
160721386|NCT03207815|580360718|FG001|Overall Study|Adverse Event|2|||
160721387|NCT03207815|580360717|FG000|Overall Study|Lost to Follow-up|1|||
160721388|NCT03207815|580360718|FG001|Overall Study|Lost to Follow-up|2|||
160721389|NCT03207815|580360717|FG000|Overall Study|Investigator's Discretion|1|||
160721390|NCT03207815|580360718|FG001|Overall Study|Investigator's Discretion|1|||
160721391|NCT03207815|580360717|FG000|Overall Study|Lack of Efficacy|0|||
160721392|NCT03207815|580360718|FG001|Overall Study|Lack of Efficacy|1|||
160721393|NCT03207815|580360717|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
160721394|NCT03207815|580360718|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
160721395|NCT03207815|580360717|FG000|Overall Study|Withdrew Consent|1|||
160721396|NCT03207815|580360718|FG001|Overall Study|Withdrew Consent|0|||
160721397|NCT04537078|580360719|FG000|Overall Study|Protocol Violation|3|||
160721398|NCT04537078|580360720|FG001|Overall Study|Protocol Violation|2|||
160721399|NCT04537078|580360719|FG000|Overall Study|Lost to Follow-up|1|||
160721400|NCT04537078|580360720|FG001|Overall Study|Lost to Follow-up|0|||
160721401|NCT04537078|580360719|FG000|Overall Study|Withdrawal by Subject|0|||
160721402|NCT04537078|580360720|FG001|Overall Study|Withdrawal by Subject|1|||
160721403|NCT03817853|580360721|FG000|Induction Phase|Adverse Event|5|||
160721404|NCT03817853|580360722|FG001|Induction Phase|Adverse Event|0|||
160721405|NCT03817853|580360723|FG002|Induction Phase|Adverse Event|0|||
160721406|NCT03817853|580360721|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
160721407|NCT03817853|580360722|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
160721408|NCT03817853|580360723|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
160721409|NCT03817853|580360721|FG000|Induction Phase|Physician Decision|2|||
160721410|NCT03817853|580360722|FG001|Induction Phase|Physician Decision|0|||
160721411|NCT03817853|580360723|FG002|Induction Phase|Physician Decision|0|||
160721412|NCT03817853|580360721|FG000|Induction Phase|Progressive Disease|6|||
160721413|NCT03817853|580360722|FG001|Induction Phase|Progressive Disease|0|||
160721414|NCT03817853|580360723|FG002|Induction Phase|Progressive Disease|0|||
160721415|NCT03817853|580360721|FG000|Induction Phase|Withdrawal by Subject|4|||
160721416|NCT03817853|580360722|FG001|Induction Phase|Withdrawal by Subject|0|||
160721417|NCT03817853|580360723|FG002|Induction Phase|Withdrawal by Subject|0|||
160721418|NCT03817853|580360721|FG000|Maintenance Phase|Adverse Event|0|||
160721419|NCT03817853|580360722|FG001|Maintenance Phase|Adverse Event|8|||
160721420|NCT03817853|580360723|FG002|Maintenance Phase|Adverse Event|0|||
160721421|NCT03817853|580360721|FG000|Maintenance Phase|Death|0|||
160721422|NCT03817853|580360722|FG001|Maintenance Phase|Death|5|||
160721423|NCT03817853|580360723|FG002|Maintenance Phase|Death|0|||
160721424|NCT03817853|580360721|FG000|Maintenance Phase|Progressive Disease|0|||
160721425|NCT03817853|580360722|FG001|Maintenance Phase|Progressive Disease|7|||
160721426|NCT03817853|580360723|FG002|Maintenance Phase|Progressive Disease|0|||
160721427|NCT03817853|580360721|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160721428|NCT03817853|580360722|FG001|Maintenance Phase|Withdrawal by Subject|2|||
160721429|NCT03817853|580360723|FG002|Maintenance Phase|Withdrawal by Subject|0|||
160721430|NCT03817853|580360721|FG000|Maintenance Phase|Physician Decision|0|||
160721431|NCT03817853|580360722|FG001|Maintenance Phase|Physician Decision|1|||
160721432|NCT03817853|580360723|FG002|Maintenance Phase|Physician Decision|0|||
160721433|NCT03817853|580360721|FG000|Maintenance Phase|Various reasons|0|||
160721434|NCT03817853|580360722|FG001|Maintenance Phase|Various reasons|4|||
160721435|NCT03817853|580360723|FG002|Maintenance Phase|Various reasons|0|||
160721436|NCT03817853|580360721|FG000|Maintenance Phase|Protocol Deviation|0|||
160721437|NCT03817853|580360722|FG001|Maintenance Phase|Protocol Deviation|1|||
160721438|NCT03817853|580360723|FG002|Maintenance Phase|Protocol Deviation|0|||
160721439|NCT03817853|580360721|FG000|Follow-up Phase|Adverse Event|0|||
160721440|NCT03817853|580360722|FG001|Follow-up Phase|Adverse Event|0|||
160721441|NCT03817853|580360723|FG002|Follow-up Phase|Adverse Event|2|||
160721442|NCT03817853|580360721|FG000|Follow-up Phase|Death|0|||
160721443|NCT03817853|580360722|FG001|Follow-up Phase|Death|0|||
160721444|NCT03817853|580360723|FG002|Follow-up Phase|Death|1|||
160721445|NCT03817853|580360721|FG000|Follow-up Phase|Progressive Disease|0|||
160721446|NCT03817853|580360722|FG001|Follow-up Phase|Progressive Disease|0|||
160721447|NCT03817853|580360723|FG002|Follow-up Phase|Progressive Disease|3|||
160721448|NCT03817853|580360721|FG000|Follow-up Phase|Withdrawal by Subject|0|||
160721449|NCT03817853|580360722|FG001|Follow-up Phase|Withdrawal by Subject|0|||
160721450|NCT03817853|580360723|FG002|Follow-up Phase|Withdrawal by Subject|1|||
160721451|NCT00391768|580360724|FG000|Overall Study|Withdrawal by Subject|0|||
160721452|NCT00391768|580360725|FG001|Overall Study|Withdrawal by Subject|0|||
160721453|NCT00391768|580360726|FG002|Overall Study|Withdrawal by Subject|1|||
160721454|NCT00391768|580360727|FG003|Overall Study|Withdrawal by Subject|0|||
160721455|NCT00391768|580360728|FG004|Overall Study|Withdrawal by Subject|0|||
160721456|NCT00391768|580360729|FG005|Overall Study|Withdrawal by Subject|1|||
160721457|NCT00391768|580360730|FG006|Overall Study|Withdrawal by Subject|1|||
160721458|NCT00391768|580360724|FG000|Overall Study|Lost to Follow-up|0|||
160721459|NCT00391768|580360725|FG001|Overall Study|Lost to Follow-up|0|||
160721460|NCT00391768|580360726|FG002|Overall Study|Lost to Follow-up|0|||
160721461|NCT00391768|580360727|FG003|Overall Study|Lost to Follow-up|1|||
160721462|NCT00391768|580360728|FG004|Overall Study|Lost to Follow-up|2|||
160721463|NCT00391768|580360729|FG005|Overall Study|Lost to Follow-up|2|||
160721464|NCT00391768|580360730|FG006|Overall Study|Lost to Follow-up|3|||
160721465|NCT01620138|580360731|FG000|Overall Study|Withdrawal by Subject|3|||
160721466|NCT01620138|580360732|FG001|Overall Study|Withdrawal by Subject|0|||
160721467|NCT01620138|580360731|FG000|Overall Study|Lack of Efficacy|1|||
160721468|NCT01620138|580360732|FG001|Overall Study|Lack of Efficacy|0|||
160721469|NCT01620138|580360731|FG000|Overall Study|Adverse Event|2|||
160721470|NCT01620138|580360732|FG001|Overall Study|Adverse Event|0|||
160721471|NCT00444535|580360735|FG000|Overall Study|Withdrawal by Subject|5|||
160721472|NCT00444535|580360735|FG000|Overall Study|Physician Decision|5|||
160721473|NCT00444535|580360735|FG000|Overall Study|progressive disease|1|||
160721474|NCT00444535|580360735|FG000|Overall Study|Adverse Event|2|||
160721475|NCT01568892|580360736|FG000|Open-label Phase|Adverse Event|2|||
160721476|NCT01568892|580360737|FG001|Open-label Phase|Adverse Event|0|||
160721477|NCT01568892|580360736|FG000|Open-label Phase|Lack of Efficacy|4|||
160721478|NCT01568892|580360737|FG001|Open-label Phase|Lack of Efficacy|2|||
160721479|NCT01568892|580360736|FG000|Open-label Phase|Lost to Follow-up|0|||
160721480|NCT01568892|580360737|FG001|Open-label Phase|Lost to Follow-up|1|||
160721481|NCT03922308|580360742|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
160721482|NCT03922308|580360743|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
160721483|NCT03922308|580360744|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
160721484|NCT03922308|580360742|FG000|Overall Study|Lost to Follow-up|1|||
160721485|NCT03922308|580360743|FG001|Overall Study|Lost to Follow-up|0|||
160721486|NCT03922308|580360744|FG002|Overall Study|Lost to Follow-up|0|||
160721487|NCT03922308|580360742|FG000|Overall Study|Reason not Specified|0|||
160721488|NCT03922308|580360743|FG001|Overall Study|Reason not Specified|2|||
160721489|NCT03922308|580360744|FG002|Overall Study|Reason not Specified|1|||
160721490|NCT05005507|580360745|FG000|Overall Study|Premature termination of study|1|||
160721491|NCT01697748|580360749|FG000|Overall Study|ineligible skin incision|1|||
160721492|NCT01697748|580360750|FG001|Overall Study|ineligible skin incision|2|||
160721493|NCT01697748|580360749|FG000|Overall Study|ineligible uterine incision|4|||
160721494|NCT01697748|580360750|FG001|Overall Study|ineligible uterine incision|1|||
160721495|NCT01697748|580360749|FG000|Overall Study|Lost to Follow-up|53|||
160721496|NCT01697748|580360750|FG001|Overall Study|Lost to Follow-up|65|||
160721497|NCT01256450|580360753|FG000|Open-label Titration|Adverse Event|39|||
160721498|NCT01256450|580360754|FG001|Open-label Titration|Adverse Event|0|||
160721499|NCT01256450|580360755|FG002|Open-label Titration|Adverse Event|0|||
160721500|NCT01256450|580360753|FG000|Open-label Titration|Lost to Follow-up|7|||
160721501|NCT01256450|580360754|FG001|Open-label Titration|Lost to Follow-up|0|||
160721502|NCT01256450|580360755|FG002|Open-label Titration|Lost to Follow-up|0|||
160721503|NCT01256450|580360753|FG000|Open-label Titration|Lack of analgesic effect|30|||
160721504|NCT01256450|580360754|FG001|Open-label Titration|Lack of analgesic effect|0|||
160721505|NCT01256450|580360755|FG002|Open-label Titration|Lack of analgesic effect|0|||
160721506|NCT01256450|580360753|FG000|Open-label Titration|Non-compliance|9|||
160721507|NCT01256450|580360754|FG001|Open-label Titration|Non-compliance|0|||
160721508|NCT01256450|580360755|FG002|Open-label Titration|Non-compliance|0|||
160721509|NCT01256450|580360753|FG000|Open-label Titration|Screen failure|1|||
160721510|NCT01256450|580360754|FG001|Open-label Titration|Screen failure|0|||
160721511|NCT01256450|580360755|FG002|Open-label Titration|Screen failure|0|||
160721512|NCT01256450|580360753|FG000|Open-label Titration|Other|13|||
160721513|NCT01256450|580360754|FG001|Open-label Titration|Other|0|||
160721514|NCT01256450|580360755|FG002|Open-label Titration|Other|0|||
160721515|NCT01256450|580360753|FG000|Double-blind Treatment|Adverse Event|0|||
160721516|NCT01256450|580360754|FG001|Double-blind Treatment|Adverse Event|8|||
160721517|NCT01256450|580360755|FG002|Double-blind Treatment|Adverse Event|6|||
160721518|NCT01256450|580360753|FG000|Double-blind Treatment|Lost to Follow-up|0|||
160721519|NCT01256450|580360754|FG001|Double-blind Treatment|Lost to Follow-up|1|||
160721520|NCT01256450|580360755|FG002|Double-blind Treatment|Lost to Follow-up|7|||
160721521|NCT01256450|580360753|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
160721522|NCT01256450|580360754|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
160721523|NCT01256450|580360755|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
160721524|NCT01256450|580360753|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
160721525|NCT01256450|580360754|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
160721526|NCT01256450|580360755|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
160721527|NCT01256450|580360753|FG000|Double-blind Treatment|Non-compliance|0|||
160721528|NCT01256450|580360754|FG001|Double-blind Treatment|Non-compliance|5|||
160721529|NCT01256450|580360755|FG002|Double-blind Treatment|Non-compliance|4|||
160721530|NCT01256450|580360753|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
160721531|NCT01256450|580360754|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
160721532|NCT01256450|580360755|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
160721533|NCT01256450|580360753|FG000|Double-blind Treatment|Other|0|||
160721534|NCT01256450|580360754|FG001|Double-blind Treatment|Other|9|||
160721535|NCT01256450|580360755|FG002|Double-blind Treatment|Other|12|||
160721536|NCT01704495|580360756|FG000|Subjects Randomized|Other Reason|3|||
160721537|NCT01704495|580360757|FG001|Subjects Randomized|Other Reason|2|||
160721538|NCT01704495|580360758|FG002|Subjects Randomized|Other Reason|3|||
160721539|NCT01704495|580360759|FG003|Subjects Randomized|Other Reason|2|||
160721540|NCT01704495|580360756|FG000|Subjects Randomized|Discontinuation criteria met|4|||
160721541|NCT01704495|580360757|FG001|Subjects Randomized|Discontinuation criteria met|2|||
160721542|NCT01704495|580360758|FG002|Subjects Randomized|Discontinuation criteria met|2|||
160721543|NCT01704495|580360759|FG003|Subjects Randomized|Discontinuation criteria met|0|||
160721544|NCT01704495|580360756|FG000|Subjects Randomized|Adverse Event|8|||
160721545|NCT01704495|580360757|FG001|Subjects Randomized|Adverse Event|2|||
160721546|NCT01704495|580360758|FG002|Subjects Randomized|Adverse Event|0|||
160721547|NCT01704495|580360759|FG003|Subjects Randomized|Adverse Event|7|||
160721548|NCT01704495|580360756|FG000|Subjects Randomized|Withdrawal by Subject|5|||
160721549|NCT01704495|580360757|FG001|Subjects Randomized|Withdrawal by Subject|5|||
160721550|NCT01704495|580360758|FG002|Subjects Randomized|Withdrawal by Subject|5|||
160721551|NCT01704495|580360759|FG003|Subjects Randomized|Withdrawal by Subject|5|||
160721552|NCT01704495|580360756|FG000|Subjects Randomized|Protocol Violation|1|||
160721553|NCT01704495|580360757|FG001|Subjects Randomized|Protocol Violation|1|||
160721554|NCT01704495|580360758|FG002|Subjects Randomized|Protocol Violation|2|||
160721555|NCT01704495|580360759|FG003|Subjects Randomized|Protocol Violation|0|||
160721556|NCT01704495|580360756|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
160721557|NCT01704495|580360757|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
160721558|NCT01704495|580360758|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
160721559|NCT01704495|580360759|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
160721560|NCT01704495|580360756|FG000|Optional Safety Extension|Adverse Event|0|||
160721561|NCT01704495|580360757|FG001|Optional Safety Extension|Adverse Event|4|||
160721562|NCT01704495|580360758|FG002|Optional Safety Extension|Adverse Event|0|||
160721563|NCT01704495|580360759|FG003|Optional Safety Extension|Adverse Event|1|||
160721564|NCT01704495|580360756|FG000|Optional Safety Extension|Other reason|27|||
160721565|NCT01704495|580360757|FG001|Optional Safety Extension|Other reason|29|||
160721566|NCT01704495|580360758|FG002|Optional Safety Extension|Other reason|30|||
160721567|NCT01704495|580360759|FG003|Optional Safety Extension|Other reason|28|||
160721568|NCT01704495|580360756|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
160721569|NCT01704495|580360757|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
160721570|NCT01704495|580360758|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
160721571|NCT01704495|580360759|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
160721572|NCT02375971|580360761|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
160721573|NCT02375971|580360762|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
160721574|NCT02375971|580360763|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
160721575|NCT02375971|580360761|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
160721576|NCT02375971|580360762|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
160721577|NCT02375971|580360763|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
160721578|NCT02375971|580360761|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
160721579|NCT02375971|580360762|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
160721580|NCT02375971|580360763|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
160721581|NCT02375971|580360761|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
160721582|NCT02375971|580360762|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
160721583|NCT02375971|580360763|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
160721584|NCT02375971|580360761|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
160721585|NCT02375971|580360762|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
160721586|NCT02375971|580360763|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
160721587|NCT02375971|580360761|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
160721588|NCT02375971|580360762|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
160721589|NCT02375971|580360763|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
160721590|NCT02375971|580360761|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
160721591|NCT02375971|580360762|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
160721592|NCT02375971|580360763|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
160721593|NCT02375971|580360761|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
160721594|NCT02375971|580360762|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
160721595|NCT02375971|580360763|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
160721596|NCT00891020|580360764|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
160721597|NCT00891020|580360765|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
160721598|NCT00891020|580360766|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
160721599|NCT00891020|580360764|FG000|24 Week Treatment Period|Death|0|||
160721600|NCT00891020|580360765|FG001|24 Week Treatment Period|Death|2|||
160721601|NCT00891020|580360766|FG002|24 Week Treatment Period|Death|0|||
160721602|NCT00891020|580360764|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
160721603|NCT00891020|580360765|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
160721604|NCT00891020|580360766|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
160721605|NCT00891020|580360764|FG000|24 Week Treatment Period|Failure to return|4|||
160721606|NCT00891020|580360765|FG001|24 Week Treatment Period|Failure to return|5|||
160721607|NCT00891020|580360766|FG002|24 Week Treatment Period|Failure to return|5|||
160721608|NCT00891020|580360764|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
160721609|NCT00891020|580360765|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
160721610|NCT00891020|580360766|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
160721611|NCT00891020|580360764|FG000|24 Week Treatment Period|Other protocol violation|1|||
160721612|NCT00891020|580360765|FG001|24 Week Treatment Period|Other protocol violation|1|||
160721613|NCT00891020|580360766|FG002|24 Week Treatment Period|Other protocol violation|2|||
160721614|NCT00891020|580360764|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
160721615|NCT00891020|580360765|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
160721616|NCT00891020|580360766|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
160721617|NCT00891020|580360764|FG000|24 Week Treatment Period|Withdrew consent|6|||
160721618|NCT00891020|580360765|FG001|24 Week Treatment Period|Withdrew consent|3|||
160721619|NCT00891020|580360766|FG002|24 Week Treatment Period|Withdrew consent|15|||
160721620|NCT00891020|580360764|FG000|24 Week Treatment Period|Administrative/Other|5|||
160721621|NCT00891020|580360765|FG001|24 Week Treatment Period|Administrative/Other|6|||
160721622|NCT00891020|580360766|FG002|24 Week Treatment Period|Administrative/Other|1|||
160721623|NCT00891020|580360764|FG000|Long-term Extension Period|Adverse Event|1|||
160721624|NCT00891020|580360765|FG001|Long-term Extension Period|Adverse Event|11|||
160721625|NCT00891020|580360766|FG002|Long-term Extension Period|Adverse Event|10|||
160721626|NCT00891020|580360764|FG000|Long-term Extension Period|Death|0|||
160721627|NCT00891020|580360765|FG001|Long-term Extension Period|Death|0|||
160721628|NCT00891020|580360766|FG002|Long-term Extension Period|Death|1|||
160721629|NCT00891020|580360764|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
160721630|NCT00891020|580360765|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
160721631|NCT00891020|580360766|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
160721632|NCT00891020|580360764|FG000|Long-term Extension Period|Protocol Violation|0|||
160721633|NCT00891020|580360765|FG001|Long-term Extension Period|Protocol Violation|1|||
160721634|NCT00891020|580360766|FG002|Long-term Extension Period|Protocol Violation|1|||
160721635|NCT00891020|580360764|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
160721636|NCT00891020|580360765|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
160721637|NCT00891020|580360766|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
160721638|NCT00891020|580360764|FG000|Long-term Extension Period|Failure to return|0|||
160721639|NCT00891020|580360765|FG001|Long-term Extension Period|Failure to return|2|||
160721640|NCT00891020|580360766|FG002|Long-term Extension Period|Failure to return|3|||
160721641|NCT00891020|580360764|FG000|Long-term Extension Period|Administrative|1|||
160721642|NCT00891020|580360765|FG001|Long-term Extension Period|Administrative|2|||
160721643|NCT00891020|580360766|FG002|Long-term Extension Period|Administrative|2|||
160721644|NCT03866512|580360768|FG000|Overall Study|Lost to Follow-up|1|||
160721645|NCT03866512|580360769|FG001|Overall Study|Lost to Follow-up|2|||
160721646|NCT03866512|580360770|FG002|Overall Study|Lost to Follow-up|1|||
160721647|NCT03866512|580360768|FG000|Overall Study|Cannulation issues|0|||
160721648|NCT03866512|580360769|FG001|Overall Study|Cannulation issues|1|||
160721649|NCT03866512|580360770|FG002|Overall Study|Cannulation issues|2|||
160721650|NCT00320710|580360771|FG000|Overall Study|Disease progression|24|||
160721651|NCT00320710|580360772|FG001|Overall Study|Disease progression|19|||
160721652|NCT00320710|580360773|FG002|Overall Study|Disease progression|2|||
160721653|NCT00320710|580360771|FG000|Overall Study|Death|10|||
160721654|NCT00320710|580360772|FG001|Overall Study|Death|7|||
160721655|NCT00320710|580360773|FG002|Overall Study|Death|1|||
160721656|NCT00320710|580360771|FG000|Overall Study|Administrative problems|1|||
160721657|NCT00320710|580360772|FG001|Overall Study|Administrative problems|2|||
160721658|NCT00320710|580360773|FG002|Overall Study|Administrative problems|0|||
160721659|NCT00320710|580360771|FG000|Overall Study|Withdrawal by Subject|20|||
160721660|NCT00320710|580360772|FG001|Overall Study|Withdrawal by Subject|26|||
160721661|NCT00320710|580360773|FG002|Overall Study|Withdrawal by Subject|1|||
160721662|NCT00320710|580360771|FG000|Overall Study|Protocol Violation|6|||
160721663|NCT00320710|580360772|FG001|Overall Study|Protocol Violation|5|||
160721664|NCT00320710|580360773|FG002|Overall Study|Protocol Violation|0|||
160721665|NCT00320710|580360771|FG000|Overall Study|Abnormal test procedure result(s)|2|||
160721666|NCT00320710|580360772|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160721667|NCT00320710|580360773|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160721668|NCT00320710|580360771|FG000|Overall Study|Abnormal laboratory value(s)|12|||
160721669|NCT00320710|580360772|FG001|Overall Study|Abnormal laboratory value(s)|3|||
160721670|NCT00320710|580360773|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160721671|NCT00320710|580360771|FG000|Overall Study|Adverse Event|18|||
160721672|NCT00320710|580360772|FG001|Overall Study|Adverse Event|14|||
160721673|NCT00320710|580360773|FG002|Overall Study|Adverse Event|1|||
160721674|NCT00320710|580360771|FG000|Overall Study|Lost to Follow-up|1|||
160721675|NCT00320710|580360772|FG001|Overall Study|Lost to Follow-up|0|||
160721676|NCT00320710|580360773|FG002|Overall Study|Lost to Follow-up|0|||
160721677|NCT00506415|580360779|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
160721678|NCT00506415|580360780|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
160721679|NCT00506415|580360781|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
160721680|NCT00506415|580360782|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
160721681|NCT00506415|580360779|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
160721682|NCT00506415|580360780|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
160721683|NCT00506415|580360781|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
160721684|NCT00506415|580360782|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
160721685|NCT00506415|580360779|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
160721686|NCT00506415|580360780|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
160721687|NCT00506415|580360781|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
160721688|NCT00506415|580360782|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
160721689|NCT00506415|580360779|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
160721690|NCT00506415|580360780|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
160721691|NCT00506415|580360781|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
160721692|NCT00506415|580360782|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
160721693|NCT00506415|580360779|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
160721694|NCT00506415|580360780|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
160721695|NCT00506415|580360781|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
160721696|NCT00506415|580360782|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
160721697|NCT00506415|580360779|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
160721698|NCT00506415|580360780|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
160721699|NCT00506415|580360781|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
160721700|NCT00506415|580360782|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
160721701|NCT00506415|580360779|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
160721702|NCT00506415|580360780|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
160721703|NCT00506415|580360781|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
160721704|NCT00506415|580360782|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
160721705|NCT00506415|580360779|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
160721706|NCT00506415|580360780|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
160721707|NCT00506415|580360781|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
160721708|NCT00506415|580360782|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
160721709|NCT00506415|580360779|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
160721710|NCT00506415|580360780|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
160721711|NCT00506415|580360781|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
160721712|NCT00506415|580360782|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
160721713|NCT00506415|580360779|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
160721714|NCT00506415|580360780|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
160721715|NCT00506415|580360781|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
160721716|NCT00506415|580360782|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
160721717|NCT00506415|580360779|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
160721718|NCT00506415|580360780|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
160721719|NCT00506415|580360781|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
160721720|NCT00506415|580360782|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
160721721|NCT00506415|580360779|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
160721722|NCT00506415|580360780|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
160721723|NCT00506415|580360781|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
160721724|NCT00506415|580360782|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
160721725|NCT00506415|580360779|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
160721726|NCT00506415|580360780|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
160721727|NCT00506415|580360781|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
160721728|NCT00506415|580360782|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
160721729|NCT00506415|580360779|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
160721730|NCT00506415|580360780|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
160721731|NCT00506415|580360781|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
160721732|NCT00506415|580360782|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
160721733|NCT00506415|580360779|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
160721734|NCT00506415|580360780|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
160721735|NCT00506415|580360781|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
160721736|NCT00506415|580360782|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
160721737|NCT00506415|580360779|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
160721738|NCT00506415|580360780|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
160721739|NCT00506415|580360781|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
160721740|NCT00506415|580360782|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
160721741|NCT00506415|580360779|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
160721742|NCT00506415|580360780|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
160721743|NCT00506415|580360781|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
160721744|NCT00506415|580360782|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
160721745|NCT00506415|580360779|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
160721746|NCT00506415|580360780|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
160721747|NCT00506415|580360781|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
160721748|NCT00506415|580360782|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
160721749|NCT00506415|580360779|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
160721750|NCT00506415|580360780|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
160721751|NCT00506415|580360781|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
160721752|NCT00506415|580360782|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
160721753|NCT00506415|580360779|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
160721754|NCT00506415|580360780|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
160721755|NCT00506415|580360781|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
160721756|NCT00506415|580360782|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
160721757|NCT00506415|580360779|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
160721758|NCT00506415|580360780|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
160721759|NCT00506415|580360781|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
160721760|NCT00506415|580360782|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
160721761|NCT00506415|580360779|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
160721762|NCT00506415|580360780|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
160721763|NCT00506415|580360781|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
160721764|NCT00506415|580360782|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
160721765|NCT00506415|580360779|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
160721766|NCT00506415|580360780|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
160721767|NCT00506415|580360781|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
160721768|NCT00506415|580360782|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
160721769|NCT00506415|580360779|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
160721770|NCT00506415|580360780|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
160721771|NCT00506415|580360781|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
160721772|NCT00506415|580360782|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
160721773|NCT04578457|580360783|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
160721774|NCT04578457|580360783|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
160721775|NCT04578457|580360783|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
160721776|NCT04578457|580360783|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
160721777|NCT00997373|580360784|FG000|Overall Study|Withdrawal by Subject|5|||
160721778|NCT00997373|580360785|FG001|Overall Study|Withdrawal by Subject|0|||
160721779|NCT00997373|580360784|FG000|Overall Study|wrong tumor type|4|||
160721780|NCT00997373|580360785|FG001|Overall Study|wrong tumor type|0|||
160721781|NCT00997373|580360784|FG000|Overall Study|could not have hysterectomy|6|||
160721782|NCT00997373|580360785|FG001|Overall Study|could not have hysterectomy|0|||
160721783|NCT00832455|580360786|FG000|Overall Study|Adverse Event|13|||
160721784|NCT00832455|580360786|FG000|Overall Study|Lost to Follow-up|26|||
160721785|NCT00832455|580360786|FG000|Overall Study|Protocol Violation|4|||
160721786|NCT00832455|580360786|FG000|Overall Study|Withdrawal by Subject|17|||
160721787|NCT00832455|580360786|FG000|Overall Study|Screening Failure|2|||
160721788|NCT00832455|580360786|FG000|Overall Study|Stopped Medication|4|||
160721789|NCT00832455|580360786|FG000|Overall Study|Parent misunderstood study|1|||
160721790|NCT00832455|580360786|FG000|Overall Study|Parent dissatisfied|1|||
160721791|NCT00832455|580360786|FG000|Overall Study|No improvement|3|||
160721792|NCT00832455|580360786|FG000|Overall Study|Patient moved|1|||
160721793|NCT00739661|580360788|FG000|Overall Study|Adverse Event|2|||
160721794|NCT00739661|580360789|FG001|Overall Study|Adverse Event|0|||
160721795|NCT00739661|580360788|FG000|Overall Study|Physician decision to withdraw patient|1|||
160721796|NCT00739661|580360789|FG001|Overall Study|Physician decision to withdraw patient|0|||
160721797|NCT00739661|580360788|FG000|Overall Study|Patient decision to withdraw|9|||
160721798|NCT00739661|580360789|FG001|Overall Study|Patient decision to withdraw|4|||
160721799|NCT00739661|580360788|FG000|Overall Study|Disease progression, radiographic|33|||
160721800|NCT00739661|580360789|FG001|Overall Study|Disease progression, radiographic|37|||
160721801|NCT00739661|580360788|FG000|Overall Study|Reason for discontinuation not available|1|||
160721802|NCT00739661|580360789|FG001|Overall Study|Reason for discontinuation not available|1|||
160721803|NCT02883062|580360792|FG000|Overall Study|Withdrawal by Subject|6|||
160721804|NCT02883062|580360793|FG001|Overall Study|Withdrawal by Subject|0|||
160721805|NCT00380874|580360794|FG000|Overall Study|Adverse Event|7|||
160721806|NCT00380874|580360795|FG001|Overall Study|Adverse Event|7|||
160721807|NCT00380874|580360794|FG000|Overall Study|Death|1|||
160721808|NCT00380874|580360795|FG001|Overall Study|Death|0|||
160721809|NCT00380874|580360794|FG000|Overall Study|Withdrawal by Subject|2|||
160721810|NCT00380874|580360795|FG001|Overall Study|Withdrawal by Subject|1|||
160721811|NCT00380874|580360794|FG000|Overall Study|Not related to study drug|3|||
160721812|NCT00380874|580360795|FG001|Overall Study|Not related to study drug|2|||
160721813|NCT01198470|580360796|FG000|Overall Study|Adverse Event|2|||
160721814|NCT02314026|580360797|FG000|Overall Study|Protocol Violation|28|||
160721815|NCT01139775|580360798|FG000|Overall Study|Adverse Event|0|||
160721816|NCT01139775|580360799|FG001|Overall Study|Adverse Event|6|||
160721817|NCT01139775|580360800|FG002|Overall Study|Adverse Event|2|||
160721818|NCT01139775|580360798|FG000|Overall Study|Protocol Violation|0|||
160721819|NCT01139775|580360799|FG001|Overall Study|Protocol Violation|5|||
160721820|NCT01139775|580360800|FG002|Overall Study|Protocol Violation|0|||
160721821|NCT01139775|580360798|FG000|Overall Study|Withdrawal by Subject|1|||
160721822|NCT01139775|580360799|FG001|Overall Study|Withdrawal by Subject|0|||
160721823|NCT01139775|580360800|FG002|Overall Study|Withdrawal by Subject|2|||
160721824|NCT01139775|580360798|FG000|Overall Study|Physician Decision|0|||
160721825|NCT01139775|580360799|FG001|Overall Study|Physician Decision|2|||
160721826|NCT01139775|580360800|FG002|Overall Study|Physician Decision|2|||
160721827|NCT01924689|580360801|FG000|Overall Study|Death|0|||
160721828|NCT01924689|580360802|FG001|Overall Study|Death|1|||
160721829|NCT01924689|580360803|FG002|Overall Study|Death|0|||
160721830|NCT01924689|580360804|FG003|Overall Study|Death|1|||
160721831|NCT01924689|580360805|FG004|Overall Study|Death|0|||
160721832|NCT01924689|580360806|FG005|Overall Study|Death|0|||
160721833|NCT01924689|580360801|FG000|Overall Study|Disease progression|0|||
160721834|NCT01924689|580360802|FG001|Overall Study|Disease progression|0|||
160721835|NCT01924689|580360803|FG002|Overall Study|Disease progression|2|||
160721836|NCT01924689|580360804|FG003|Overall Study|Disease progression|0|||
160721837|NCT01924689|580360805|FG004|Overall Study|Disease progression|3|||
160721838|NCT01924689|580360806|FG005|Overall Study|Disease progression|2|||
160721839|NCT01924689|580360801|FG000|Overall Study|New therapy or study|3|||
160721840|NCT01924689|580360802|FG001|Overall Study|New therapy or study|2|||
160721841|NCT01924689|580360803|FG002|Overall Study|New therapy or study|1|||
160721842|NCT01924689|580360804|FG003|Overall Study|New therapy or study|4|||
160721843|NCT01924689|580360805|FG004|Overall Study|New therapy or study|2|||
160721844|NCT01924689|580360806|FG005|Overall Study|New therapy or study|0|||
160721845|NCT01924689|580360801|FG000|Overall Study|Withdrawal of consent|0|||
160721846|NCT01924689|580360802|FG001|Overall Study|Withdrawal of consent|0|||
160721847|NCT01924689|580360803|FG002|Overall Study|Withdrawal of consent|1|||
160721848|NCT01924689|580360804|FG003|Overall Study|Withdrawal of consent|1|||
160721849|NCT01924689|580360805|FG004|Overall Study|Withdrawal of consent|0|||
160721850|NCT01924689|580360806|FG005|Overall Study|Withdrawal of consent|0|||
160721851|NCT01924689|580360801|FG000|Overall Study|Other|0|||
160721852|NCT01924689|580360802|FG001|Overall Study|Other|0|||
160721853|NCT01924689|580360803|FG002|Overall Study|Other|0|||
160721854|NCT01924689|580360804|FG003|Overall Study|Other|0|||
160721855|NCT01924689|580360805|FG004|Overall Study|Other|1|||
160721856|NCT01924689|580360806|FG005|Overall Study|Other|0|||
160721857|NCT02492867|580360808|FG000|Overall Study|Alternate therapy|1|||
160721858|NCT02492867|580360808|FG000|Overall Study|Withdrawal by Subject|2|||
160721859|NCT02492867|580360808|FG000|Overall Study|Disease progression after treatment started|1|||
160721860|NCT02492867|580360808|FG000|Overall Study|Death|1|||
160721861|NCT03296527|580360809|FG000|Overall Study|Adverse Event|15|||
160721862|NCT03296527|580360810|FG001|Overall Study|Adverse Event|33|||
160721863|NCT03296527|580360809|FG000|Overall Study|Protocol Deviation|4|||
160721864|NCT03296527|580360810|FG001|Overall Study|Protocol Deviation|0|||
160721865|NCT03296527|580360809|FG000|Overall Study|Participant withdrew consent|3|||
160721866|NCT03296527|580360810|FG001|Overall Study|Participant withdrew consent|1|||
160721867|NCT03296527|580360809|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
160721868|NCT03296527|580360810|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
160721869|NCT03296527|580360809|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
160721870|NCT03296527|580360810|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
160721871|NCT03296527|580360809|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
160721872|NCT03296527|580360810|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
160721873|NCT03296527|580360809|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
160721874|NCT03296527|580360810|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
160721875|NCT03296527|580360809|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
160721876|NCT03296527|580360810|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
160721877|NCT01597973|580360811|FG000|Overall Study|Found ineligible before study medication started|4|||
160721878|NCT01597973|580360812|FG001|Overall Study|Found ineligible before study medication started|2|||
160721879|NCT01597973|580360811|FG000|Overall Study|Eligible pathogen not confirmed|14|||
160721880|NCT01597973|580360812|FG001|Overall Study|Eligible pathogen not confirmed|15|||
160721881|NCT01597973|580360811|FG000|Overall Study|LAR not authorized to consent|0|||
160721882|NCT01597973|580360812|FG001|Overall Study|LAR not authorized to consent|1|||
160721883|NCT01597973|580360811|FG000|Overall Study|Ineligible due to early seizures|1|||
160721884|NCT01597973|580360812|FG001|Overall Study|Ineligible due to early seizures|0|||
160721885|NCT01597973|580360811|FG000|Overall Study|Ineligible due to non-target infection|1|||
160721886|NCT01597973|580360812|FG001|Overall Study|Ineligible due to non-target infection|1|||
160721887|NCT01326845|580360813|FG000|Overall Study|Administrative Problems|5|||
160721888|NCT01326845|580360814|FG001|Overall Study|Administrative Problems|2|||
160721889|NCT01326845|580360813|FG000|Overall Study|Adverse Event|1|||
160721890|NCT01326845|580360814|FG001|Overall Study|Adverse Event|0|||
160721891|NCT01326845|580360813|FG000|Overall Study|Misisng|1|||
160721892|NCT01326845|580360814|FG001|Overall Study|Misisng|3|||
160721893|NCT05468164|580362644|FG000|Treatment Period 4|Adverse Event|0|||
160721894|NCT05468164|580362645|FG001|Treatment Period 4|Adverse Event|0|||
160721895|NCT05468164|580362646|FG002|Treatment Period 4|Adverse Event|0|||
160721896|NCT05468164|580362647|FG003|Treatment Period 4|Adverse Event|1|||
160721897|NCT04632927|580362648|FG000|Overall Study|Adverse Event|0|||
160721898|NCT04632927|580362649|FG001|Overall Study|Adverse Event|1|||
160721899|NCT04632927|580362648|FG000|Overall Study|Lack of Efficacy|0|||
160721900|NCT04632927|580362649|FG001|Overall Study|Lack of Efficacy|4|||
160721901|NCT04632927|580362648|FG000|Overall Study|Loss of efficacy|0|||
160721902|NCT04632927|580362649|FG001|Overall Study|Loss of efficacy|1|||
160721903|NCT04632927|580362648|FG000|Overall Study|Non-compliance with study drug|0|||
160721904|NCT04632927|580362649|FG001|Overall Study|Non-compliance with study drug|1|||
160721905|NCT04632927|580362648|FG000|Overall Study|Physician Decision|0|||
160721906|NCT04632927|580362649|FG001|Overall Study|Physician Decision|1|||
160721907|NCT04632927|580362648|FG000|Overall Study|Subject decision|0|||
160721908|NCT04632927|580362649|FG001|Overall Study|Subject decision|1|||
160721909|NCT04632927|580362648|FG000|Overall Study|Withdrawal by Subject|0|||
160721910|NCT04632927|580362649|FG001|Overall Study|Withdrawal by Subject|1|||
160721911|NCT03827291|580362650|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
160721912|NCT03827291|580362651|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
160721913|NCT04795466|580362652|FG000|Overall Study|Adverse Event|3|||
160721914|NCT04795466|580362653|FG001|Overall Study|Adverse Event|1|||
160721915|NCT04795466|580362652|FG000|Overall Study|Physician Decision|1|||
160721916|NCT04795466|580362653|FG001|Overall Study|Physician Decision|0|||
160721917|NCT04795466|580362652|FG000|Overall Study|Withdrawal by Subject|2|||
160721918|NCT04795466|580362653|FG001|Overall Study|Withdrawal by Subject|1|||
160721925|NCT00536939|580362667|FG000|Overall Study|Withdrawal by Subject|1|||
160721926|NCT00536939|580362668|FG001|Overall Study|Withdrawal by Subject|0|||
160721927|NCT00536939|580362667|FG000|Overall Study|Other Complicating Disease|1|||
160721928|NCT00536939|580362668|FG001|Overall Study|Other Complicating Disease|0|||
160721929|NCT04225715|580362669|FG000|Overall Study|Reason not Specified|1|||
160721930|NCT04225715|580362670|FG001|Overall Study|Reason not Specified|0|||
160721931|NCT04225715|580362671|FG002|Overall Study|Reason not Specified|0|||
160721932|NCT04225715|580362672|FG003|Overall Study|Reason not Specified|0|||
160721933|NCT04225715|580362673|FG004|Overall Study|Reason not Specified|0|||
160721934|NCT04225715|580362674|FG005|Overall Study|Reason not Specified|0|||
160721935|NCT04225715|580362675|FG006|Overall Study|Reason not Specified|0|||
160721936|NCT04225715|580362676|FG007|Overall Study|Reason not Specified|0|||
160721937|NCT04225715|580362677|FG008|Overall Study|Reason not Specified|0|||
160721938|NCT04225715|580362669|FG000|Overall Study|Protocol Violation|1|||
160721939|NCT04225715|580362670|FG001|Overall Study|Protocol Violation|0|||
160721940|NCT04225715|580362671|FG002|Overall Study|Protocol Violation|0|||
160721941|NCT04225715|580362672|FG003|Overall Study|Protocol Violation|0|||
160721942|NCT04225715|580362673|FG004|Overall Study|Protocol Violation|0|||
160721943|NCT04225715|580362674|FG005|Overall Study|Protocol Violation|9|||
160721944|NCT04225715|580362675|FG006|Overall Study|Protocol Violation|0|||
160721945|NCT04225715|580362676|FG007|Overall Study|Protocol Violation|0|||
160721946|NCT04225715|580362677|FG008|Overall Study|Protocol Violation|0|||
160721947|NCT04225715|580362669|FG000|Overall Study|Withdrawal by Subject|4|||
160721948|NCT04225715|580362670|FG001|Overall Study|Withdrawal by Subject|1|||
160721949|NCT04225715|580362671|FG002|Overall Study|Withdrawal by Subject|1|||
160721950|NCT04225715|580362672|FG003|Overall Study|Withdrawal by Subject|0|||
160721951|NCT04225715|580362673|FG004|Overall Study|Withdrawal by Subject|3|||
160721952|NCT04225715|580362674|FG005|Overall Study|Withdrawal by Subject|1|||
160721953|NCT04225715|580362675|FG006|Overall Study|Withdrawal by Subject|1|||
160721954|NCT04225715|580362676|FG007|Overall Study|Withdrawal by Subject|1|||
160721955|NCT04225715|580362677|FG008|Overall Study|Withdrawal by Subject|0|||
160721956|NCT04225715|580362669|FG000|Overall Study|Adverse Event|0|||
160721957|NCT04225715|580362670|FG001|Overall Study|Adverse Event|0|||
160721958|NCT04225715|580362671|FG002|Overall Study|Adverse Event|0|||
160721959|NCT04225715|580362672|FG003|Overall Study|Adverse Event|0|||
160721960|NCT04225715|580362673|FG004|Overall Study|Adverse Event|0|||
160721961|NCT04225715|580362674|FG005|Overall Study|Adverse Event|0|||
160721962|NCT04225715|580362675|FG006|Overall Study|Adverse Event|0|||
160721963|NCT04225715|580362676|FG007|Overall Study|Adverse Event|0|||
160721964|NCT04225715|580362677|FG008|Overall Study|Adverse Event|1|||
160721965|NCT04225715|580362669|FG000|Overall Study|Arm Terminated By Sponsor|0|||
160721966|NCT04225715|580362670|FG001|Overall Study|Arm Terminated By Sponsor|0|||
160721967|NCT04225715|580362671|FG002|Overall Study|Arm Terminated By Sponsor|0|||
160721968|NCT04225715|580362672|FG003|Overall Study|Arm Terminated By Sponsor|0|||
160721969|NCT04225715|580362673|FG004|Overall Study|Arm Terminated By Sponsor|0|||
160721970|NCT04225715|580362674|FG005|Overall Study|Arm Terminated By Sponsor|0|||
160721971|NCT04225715|580362675|FG006|Overall Study|Arm Terminated By Sponsor|0|||
160721972|NCT04225715|580362676|FG007|Overall Study|Arm Terminated By Sponsor|17|||
160721973|NCT04225715|580362677|FG008|Overall Study|Arm Terminated By Sponsor|18|||
160721974|NCT02275546|580362680|FG000|Treatment Period 2|Withdrawal by Subject|2|||
160721975|NCT02275546|580362681|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160721976|NCT02275546|580362680|FG000|Treatment Period 2|Protocol Violation|0|||
160721977|NCT02275546|580362681|FG001|Treatment Period 2|Protocol Violation|1|||
160721978|NCT00570141|580362691|FG000|Overall Study|Adverse Event|1|||
160721979|NCT00570141|580362691|FG000|Overall Study|Missed visits|1|||
160721980|NCT00570141|580362691|FG000|Overall Study|Lost to Follow-up|1|||
160721981|NCT02309411|580362692|FG000|Overall Study|Physician Decision|1|||
160721982|NCT02309411|580362693|FG001|Overall Study|Physician Decision|0|||
160721983|NCT02309411|580362694|FG002|Overall Study|Physician Decision|0|||
160721984|NCT02309411|580362692|FG000|Overall Study|Withdrawal by Subject|1|||
160721985|NCT02309411|580362693|FG001|Overall Study|Withdrawal by Subject|1|||
160721986|NCT02309411|580362694|FG002|Overall Study|Withdrawal by Subject|0|||
160721987|NCT02841995|580362696|FG000|Overall Study|Disease progression|5|||
160721988|NCT02841995|580362697|FG001|Overall Study|Disease progression|11|||
160721989|NCT02841995|580362698|FG002|Overall Study|Disease progression|8|||
160721990|NCT02841995|580362696|FG000|Overall Study|Withdrawal by Subject|2|||
160721991|NCT02841995|580362697|FG001|Overall Study|Withdrawal by Subject|4|||
160721992|NCT02841995|580362698|FG002|Overall Study|Withdrawal by Subject|4|||
160721993|NCT02841995|580362696|FG000|Overall Study|Adverse Event|2|||
160721994|NCT02841995|580362697|FG001|Overall Study|Adverse Event|0|||
160721995|NCT02841995|580362698|FG002|Overall Study|Adverse Event|1|||
160721996|NCT02841995|580362696|FG000|Overall Study|Investigator decision|2|||
160721997|NCT02841995|580362697|FG001|Overall Study|Investigator decision|0|||
160721998|NCT02841995|580362698|FG002|Overall Study|Investigator decision|1|||
160721999|NCT02841995|580362696|FG000|Overall Study|Death|0|||
160722000|NCT02841995|580362697|FG001|Overall Study|Death|0|||
160722001|NCT02841995|580362698|FG002|Overall Study|Death|2|||
160722002|NCT02841995|580362696|FG000|Overall Study|Noncompliance to protocol|1|||
160722003|NCT02841995|580362697|FG001|Overall Study|Noncompliance to protocol|0|||
160722004|NCT02841995|580362698|FG002|Overall Study|Noncompliance to protocol|0|||
160722005|NCT02841995|580362696|FG000|Overall Study|Sponsor decision|1|||
160722006|NCT02841995|580362697|FG001|Overall Study|Sponsor decision|0|||
160722007|NCT02841995|580362698|FG002|Overall Study|Sponsor decision|0|||
160722008|NCT02841995|580362696|FG000|Overall Study|Other|4|||
160722009|NCT02841995|580362697|FG001|Overall Study|Other|1|||
160722010|NCT02841995|580362698|FG002|Overall Study|Other|5|||
160722011|NCT02755103|580362706|FG000|Overall Study|Lost to Follow-up|17|||
160722012|NCT02755103|580362707|FG001|Overall Study|Lost to Follow-up|15|||
160722013|NCT02755103|580362706|FG000|Overall Study|Death|0|||
160722014|NCT02755103|580362707|FG001|Overall Study|Death|1|||
160722015|NCT02755103|580362706|FG000|Overall Study|Physician Decision|0|||
160722016|NCT02755103|580362707|FG001|Overall Study|Physician Decision|1|||
160722017|NCT02755103|580362706|FG000|Overall Study|Pregnancy|0|||
160722018|NCT02755103|580362707|FG001|Overall Study|Pregnancy|1|||
160722019|NCT02755103|580362706|FG000|Overall Study|Withdrawal by Subject|3|||
160722020|NCT02755103|580362707|FG001|Overall Study|Withdrawal by Subject|0|||
160722021|NCT02198664|580362713|FG000|Overall Study|Adverse Event|2|||
160722022|NCT02198664|580362714|FG001|Overall Study|Adverse Event|0|||
160722023|NCT02198664|580362713|FG000|Overall Study|Withdrawal by Subject|11|||
160722024|NCT02198664|580362714|FG001|Overall Study|Withdrawal by Subject|8|||
160722025|NCT02198664|580362713|FG000|Overall Study|Failure to tolerate|2|||
160722026|NCT02198664|580362714|FG001|Overall Study|Failure to tolerate|0|||
160722027|NCT02198664|580362713|FG000|Overall Study|Not stated|1|||
160722028|NCT02198664|580362714|FG001|Overall Study|Not stated|0|||
160722029|NCT02632409|580362715|FG000|Randomized|AE unrelated to study Drug|0|||
160722030|NCT02632409|580362716|FG001|Randomized|AE unrelated to study Drug|1|||
160722031|NCT02632409|580362715|FG000|Randomized|Participant withdrew consent|2|||
160722032|NCT02632409|580362716|FG001|Randomized|Participant withdrew consent|1|||
160722033|NCT02632409|580362715|FG000|Randomized|No Longer meets study criteria|5|||
160722034|NCT02632409|580362716|FG001|Randomized|No Longer meets study criteria|0|||
160722035|NCT02632409|580362715|FG000|Randomized|other reasons|1|||
160722036|NCT02632409|580362716|FG001|Randomized|other reasons|0|||
160722037|NCT02632409|580362715|FG000|Treatment Period|Ongoing Treatment|20|||
160722038|NCT02632409|580362716|FG001|Treatment Period|Ongoing Treatment|21|||
160722039|NCT02632409|580362715|FG000|Treatment Period|Disease Recurrence|147|||
160722040|NCT02632409|580362716|FG001|Treatment Period|Disease Recurrence|90|||
160722041|NCT02632409|580362715|FG000|Treatment Period|Study Drug Toxicity|8|||
160722042|NCT02632409|580362716|FG001|Treatment Period|Study Drug Toxicity|49|||
160722043|NCT02632409|580362715|FG000|Treatment Period|Death|1|||
160722044|NCT02632409|580362716|FG001|Treatment Period|Death|0|||
160722045|NCT02632409|580362715|FG000|Treatment Period|AE unrelated to study drug|15|||
160722046|NCT02632409|580362716|FG001|Treatment Period|AE unrelated to study drug|16|||
160722047|NCT02632409|580362715|FG000|Treatment Period|Request to discontinue treatment|4|||
160722048|NCT02632409|580362716|FG001|Treatment Period|Request to discontinue treatment|19|||
160722049|NCT02632409|580362715|FG000|Treatment Period|Participant withdrew consent|7|||
160722050|NCT02632409|580362716|FG001|Treatment Period|Participant withdrew consent|5|||
160722051|NCT02632409|580362715|FG000|Treatment Period|Lost to Follow-up|0|||
160722052|NCT02632409|580362716|FG001|Treatment Period|Lost to Follow-up|1|||
160722053|NCT02632409|580362715|FG000|Treatment Period|Maximum clinical benefit|1|||
160722054|NCT02632409|580362716|FG001|Treatment Period|Maximum clinical benefit|0|||
160722055|NCT02632409|580362715|FG000|Treatment Period|No longer meets study criteria|3|||
160722056|NCT02632409|580362716|FG001|Treatment Period|No longer meets study criteria|0|||
160722057|NCT02632409|580362715|FG000|Treatment Period|Administrative Reason by sponsor|0|||
160722058|NCT02632409|580362716|FG001|Treatment Period|Administrative Reason by sponsor|1|||
160722059|NCT02632409|580362715|FG000|Treatment Period|Other Reasons|10|||
160722060|NCT02632409|580362716|FG001|Treatment Period|Other Reasons|6|||
160722061|NCT04426006|580362717|FG000|Inclusion|Protocol Violation|1|||
160722062|NCT04426006|580362717|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
160722063|NCT04426006|580362717|FG000|Inclusion|Blood sample at inclusion not done|1|||
160722064|NCT04426006|580362717|FG000|3 Months|Lost to Follow-up|17|||
160722065|NCT04426006|580362717|FG000|12 Months|Lost to Follow-up|38|||
160722066|NCT01262872|580362720|FG000|Step 2|Death|0|||
160722067|NCT01262872|580362721|FG001|Step 2|Death|0|||
160722068|NCT01262872|580362722|FG002|Step 2|Death|0|||
160722069|NCT01262872|580362723|FG003|Step 2|Death|1|||
160722070|NCT01262872|580362724|FG004|Step 2|Death|0|||
160722071|NCT01262872|580362725|FG005|Step 2|Death|2|||
160722072|NCT01262872|580362726|FG006|Step 2|Death|2|||
160722073|NCT01262872|580362727|FG007|Step 2|Death|1|||
160722074|NCT01262872|580362720|FG000|Step 2|Protocol Violation|0|||
160722075|NCT01262872|580362721|FG001|Step 2|Protocol Violation|0|||
160722076|NCT01262872|580362722|FG002|Step 2|Protocol Violation|1|||
160722077|NCT01262872|580362723|FG003|Step 2|Protocol Violation|0|||
160722078|NCT01262872|580362724|FG004|Step 2|Protocol Violation|0|||
160722079|NCT01262872|580362725|FG005|Step 2|Protocol Violation|0|||
160722080|NCT01262872|580362726|FG006|Step 2|Protocol Violation|3|||
160722081|NCT01262872|580362727|FG007|Step 2|Protocol Violation|1|||
160722082|NCT01262872|580362720|FG000|Step 2|Withdrawal by Subject|0|||
160722083|NCT01262872|580362721|FG001|Step 2|Withdrawal by Subject|0|||
160722084|NCT01262872|580362722|FG002|Step 2|Withdrawal by Subject|4|||
160722085|NCT01262872|580362723|FG003|Step 2|Withdrawal by Subject|6|||
160722086|NCT01262872|580362724|FG004|Step 2|Withdrawal by Subject|3|||
160722087|NCT01262872|580362725|FG005|Step 2|Withdrawal by Subject|1|||
160722088|NCT01262872|580362726|FG006|Step 2|Withdrawal by Subject|2|||
160722089|NCT01262872|580362727|FG007|Step 2|Withdrawal by Subject|1|||
160722090|NCT01262872|580362720|FG000|Step 2|Migrated/moved from study area|0|||
160722091|NCT01262872|580362721|FG001|Step 2|Migrated/moved from study area|0|||
160722092|NCT01262872|580362722|FG002|Step 2|Migrated/moved from study area|4|||
160722093|NCT01262872|580362723|FG003|Step 2|Migrated/moved from study area|3|||
160722094|NCT01262872|580362724|FG004|Step 2|Migrated/moved from study area|2|||
160722095|NCT01262872|580362725|FG005|Step 2|Migrated/moved from study area|6|||
160722096|NCT01262872|580362726|FG006|Step 2|Migrated/moved from study area|2|||
160722097|NCT01262872|580362727|FG007|Step 2|Migrated/moved from study area|3|||
160722098|NCT01000155|580362730|FG000|Overall Study|Withdrawal by Subject|1|||
160722099|NCT01000155|580362730|FG000|Overall Study|Adverse Event|1|||
160722100|NCT00720213|580362733|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
160722101|NCT00720213|580362734|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
160722102|NCT00720213|580362735|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
160722103|NCT02949973|580362739|FG000|Overall Study|Physician Decision|1|||
160722104|NCT00586703|580362740|FG000|Overall Study|Death|12|||
160722105|NCT02946463|580362741|FG000|Primary Evaluation Period|Physician Decision|0|||
160722106|NCT02946463|580362742|FG001|Primary Evaluation Period|Physician Decision|1|||
160722107|NCT02946463|580362743|FG002|Primary Evaluation Period|Physician Decision|0|||
160722108|NCT02946463|580362744|FG003|Primary Evaluation Period|Physician Decision|0|||
160722109|NCT02946463|580362741|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
160722110|NCT02946463|580362742|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
160722111|NCT02946463|580362743|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
160722112|NCT02946463|580362744|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
160722113|NCT02946463|580362741|FG000|Extension Period|Death|4|||
160722114|NCT02946463|580362742|FG001|Extension Period|Death|4|||
160722115|NCT02946463|580362743|FG002|Extension Period|Death|0|||
160722116|NCT02946463|580362744|FG003|Extension Period|Death|0|||
160722117|NCT02946463|580362741|FG000|Extension Period|Withdrawal by Subject|4|||
160722118|NCT02946463|580362742|FG001|Extension Period|Withdrawal by Subject|3|||
160722119|NCT02946463|580362743|FG002|Extension Period|Withdrawal by Subject|0|||
160722120|NCT02946463|580362744|FG003|Extension Period|Withdrawal by Subject|0|||
160722121|NCT02946463|580362741|FG000|Extension Period|Other than specified|2|||
160722122|NCT02946463|580362742|FG001|Extension Period|Other than specified|3|||
160722123|NCT02946463|580362743|FG002|Extension Period|Other than specified|2|||
160722124|NCT02946463|580362744|FG003|Extension Period|Other than specified|0|||
160722125|NCT02946463|580362741|FG000|Extension Period|Physician Decision|1|||
160722126|NCT02946463|580362742|FG001|Extension Period|Physician Decision|4|||
160722127|NCT02946463|580362743|FG002|Extension Period|Physician Decision|0|||
160722128|NCT02946463|580362744|FG003|Extension Period|Physician Decision|0|||
160722129|NCT02946463|580362741|FG000|Extension Period|Pregnancy|3|||
160722130|NCT02946463|580362742|FG001|Extension Period|Pregnancy|1|||
160722131|NCT02946463|580362743|FG002|Extension Period|Pregnancy|0|||
160722132|NCT02946463|580362744|FG003|Extension Period|Pregnancy|0|||
160722133|NCT02946463|580362741|FG000|Extension Period|Adverse Event|1|||
160722134|NCT02946463|580362742|FG001|Extension Period|Adverse Event|2|||
160722135|NCT02946463|580362743|FG002|Extension Period|Adverse Event|0|||
160722136|NCT02946463|580362744|FG003|Extension Period|Adverse Event|0|||
160722137|NCT02946463|580362741|FG000|Extension Period|Lost to Follow-up|1|||
160722138|NCT02946463|580362742|FG001|Extension Period|Lost to Follow-up|0|||
160722139|NCT02946463|580362743|FG002|Extension Period|Lost to Follow-up|0|||
160722140|NCT02946463|580362744|FG003|Extension Period|Lost to Follow-up|0|||
160722141|NCT02022202|580362745|FG000|Overall Study|Withdrawal by Subject|2|||
160722142|NCT02022202|580362745|FG000|Overall Study|Disease Progression|3|||
160722143|NCT02022202|580362745|FG000|Overall Study|Desire go to immediately to surgery|3|||
160722144|NCT05271175|580362747|FG000|One Week Follow up|Lost to Follow-up|10|||
160722145|NCT05271175|580362748|FG001|One Week Follow up|Lost to Follow-up|7|||
160722146|NCT05271175|580362749|FG002|One Week Follow up|Lost to Follow-up|5|||
160722147|NCT05271175|580362747|FG000|One Month Follow up|Lost to Follow-up|12|||
160722148|NCT05271175|580362748|FG001|One Month Follow up|Lost to Follow-up|7|||
160722149|NCT05271175|580362749|FG002|One Month Follow up|Lost to Follow-up|9|||
160722150|NCT05271175|580362747|FG000|Six Months Follow up|Lost to Follow-up|8|||
160722151|NCT05271175|580362748|FG001|Six Months Follow up|Lost to Follow-up|2|||
160722152|NCT05271175|580362749|FG002|Six Months Follow up|Lost to Follow-up|2|||
160722153|NCT00740636|580362754|FG000|Overall Study|Adverse Event|0|||
160722154|NCT00740636|580362755|FG001|Overall Study|Adverse Event|2|||
160722155|NCT00740636|580362754|FG000|Overall Study|Patient Ineligible|0|||
160722156|NCT00740636|580362755|FG001|Overall Study|Patient Ineligible|1|||
160722157|NCT00740636|580362754|FG000|Overall Study|Patient Not Treated|0|||
160722158|NCT00740636|580362755|FG001|Overall Study|Patient Not Treated|1|||
160722159|NCT00740636|580362754|FG000|Overall Study|Progressive Disease|1|||
160722160|NCT00740636|580362755|FG001|Overall Study|Progressive Disease|0|||
160722161|NCT00740636|580362754|FG000|Overall Study|Death|1|||
160722162|NCT00740636|580362755|FG001|Overall Study|Death|0|||
160722163|NCT02174627|580362758|FG000|Overall Study|Missing|0|||
160722164|NCT02174627|580362759|FG001|Overall Study|Missing|1|||
160722165|NCT02174627|580362758|FG000|Overall Study|Incorrect enrolment before randomization|0|||
160722166|NCT02174627|580362759|FG001|Overall Study|Incorrect enrolment before randomization|1|||
160722167|NCT02174627|580362758|FG000|Overall Study|Participant decision|84|||
160722168|NCT02174627|580362759|FG001|Overall Study|Participant decision|128|||
160722169|NCT02166333|580362760|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
160722170|NCT02166333|580362761|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
160722171|NCT02166333|580362762|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
160722172|NCT02166333|580362763|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
160722173|NCT02166333|580362764|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
160722174|NCT02166333|580362765|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
160722175|NCT02166333|580362760|FG000|Stage 1|Death|4|||
160722176|NCT02166333|580362761|FG001|Stage 1|Death|0|||
160722177|NCT02166333|580362762|FG002|Stage 1|Death|2|||
160722178|NCT02166333|580362763|FG003|Stage 1|Death|0|||
160722179|NCT02166333|580362764|FG004|Stage 1|Death|3|||
160722180|NCT02166333|580362765|FG005|Stage 1|Death|2|||
160722181|NCT02166333|580362760|FG000|Stage 1|Lost to Follow-up|12|||
160722182|NCT02166333|580362761|FG001|Stage 1|Lost to Follow-up|0|||
160722183|NCT02166333|580362762|FG002|Stage 1|Lost to Follow-up|6|||
160722184|NCT02166333|580362763|FG003|Stage 1|Lost to Follow-up|0|||
160722185|NCT02166333|580362764|FG004|Stage 1|Lost to Follow-up|3|||
160722186|NCT02166333|580362765|FG005|Stage 1|Lost to Follow-up|3|||
160722187|NCT02166333|580362760|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
160722188|NCT02166333|580362761|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
160722189|NCT02166333|580362762|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
160722190|NCT02166333|580362763|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
160722191|NCT02166333|580362764|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
160722192|NCT02166333|580362765|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
160722193|NCT02166333|580362760|FG000|Stage 2|Death|4|||
160722194|NCT02166333|580362761|FG001|Stage 2|Death|2|||
160722195|NCT02166333|580362762|FG002|Stage 2|Death|1|||
160722196|NCT02166333|580362763|FG003|Stage 2|Death|0|||
160722197|NCT02166333|580362764|FG004|Stage 2|Death|0|||
160722198|NCT02166333|580362765|FG005|Stage 2|Death|1|||
160722199|NCT02166333|580362760|FG000|Stage 2|Lost to Follow-up|23|||
160722200|NCT02166333|580362761|FG001|Stage 2|Lost to Follow-up|4|||
160722201|NCT02166333|580362762|FG002|Stage 2|Lost to Follow-up|11|||
160722202|NCT02166333|580362763|FG003|Stage 2|Lost to Follow-up|9|||
160722203|NCT02166333|580362764|FG004|Stage 2|Lost to Follow-up|3|||
160722204|NCT02166333|580362765|FG005|Stage 2|Lost to Follow-up|6|||
160722205|NCT02269098|580362766|FG000|Overall Study|Lost to Follow-up|14|||
160722206|NCT02269098|580362767|FG001|Overall Study|Lost to Follow-up|9|||
160722207|NCT00503698|580362768|FG000|Overall Study|Protocol Violation|5|||
160722208|NCT00503698|580362769|FG001|Overall Study|Protocol Violation|6|||
160722209|NCT00503698|580362768|FG000|Overall Study|Adverse Event|52|||
160722210|NCT00503698|580362769|FG001|Overall Study|Adverse Event|41|||
160722211|NCT00503698|580362768|FG000|Overall Study|Death|1|||
160722212|NCT00503698|580362769|FG001|Overall Study|Death|0|||
160722213|NCT00503698|580362768|FG000|Overall Study|Lack of Efficacy|3|||
160722214|NCT00503698|580362769|FG001|Overall Study|Lack of Efficacy|4|||
160722215|NCT00503698|580362768|FG000|Overall Study|Trial terminated|216|||
160722216|NCT00503698|580362769|FG001|Overall Study|Trial terminated|253|||
160722217|NCT00503698|580362768|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
160722218|NCT00503698|580362769|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
160722219|NCT00503698|580362768|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
160722220|NCT00503698|580362769|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
160722221|NCT00503698|580362768|FG000|Overall Study|Any condition in exclusion criteria|4|||
160722222|NCT00503698|580362769|FG001|Overall Study|Any condition in exclusion criteria|6|||
160722223|NCT00503698|580362768|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
160722224|NCT00503698|580362769|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
160722225|NCT00503698|580362768|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
160722226|NCT00503698|580362769|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
160722227|NCT00503698|580362768|FG000|Overall Study|Critically ill|2|||
160722228|NCT00503698|580362769|FG001|Overall Study|Critically ill|0|||
160722229|NCT00503698|580362768|FG000|Overall Study|Unclassified|48|||
160722230|NCT00503698|580362769|FG001|Overall Study|Unclassified|32|||
160722231|NCT00503698|580362768|FG000|Overall Study|Not exposed to trial drug|11|||
160722232|NCT00503698|580362769|FG001|Overall Study|Not exposed to trial drug|6|||
160722233|NCT00682786|580362775|FG000|Overall Study|Withdrawal by Subject|2|||
160722234|NCT00682786|580362776|FG001|Overall Study|Withdrawal by Subject|2|||
160722235|NCT00682786|580362775|FG000|Overall Study|Did not receive irinotecan|0|||
160722236|NCT00682786|580362776|FG001|Overall Study|Did not receive irinotecan|1|||
160722237|NCT03644342|580362777|FG000|Overall Study|Adverse Event|2|||
160722238|NCT03644342|580362778|FG001|Overall Study|Adverse Event|0|||
160722239|NCT03644342|580362777|FG000|Overall Study|Protocol Violation|0|||
160722240|NCT03644342|580362778|FG001|Overall Study|Protocol Violation|1|||
160722241|NCT02259010|580362781|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
160722242|NCT01662492|580362782|FG000|Overall Study|Other miscellaneous reasons.|1|||
160722243|NCT01662492|580362783|FG001|Overall Study|Other miscellaneous reasons.|0|||
160722244|NCT01662492|580362784|FG002|Overall Study|Other miscellaneous reasons.|1|||
160722245|NCT01662492|580362782|FG000|Overall Study|Withdrawal by Subject|0|||
160722246|NCT01662492|580362783|FG001|Overall Study|Withdrawal by Subject|0|||
160722247|NCT01662492|580362784|FG002|Overall Study|Withdrawal by Subject|1|||
160722248|NCT01662492|580362782|FG000|Overall Study|Protocol Violation|1|||
160722249|NCT01662492|580362783|FG001|Overall Study|Protocol Violation|0|||
160722250|NCT01662492|580362784|FG002|Overall Study|Protocol Violation|0|||
160722251|NCT01662492|580362782|FG000|Overall Study|Lost to Follow-up|0|||
160722252|NCT01662492|580362783|FG001|Overall Study|Lost to Follow-up|0|||
160722253|NCT01662492|580362784|FG002|Overall Study|Lost to Follow-up|2|||
160722254|NCT01662492|580362782|FG000|Overall Study|Lack of Efficacy|1|||
160722255|NCT01662492|580362783|FG001|Overall Study|Lack of Efficacy|1|||
160722256|NCT01662492|580362784|FG002|Overall Study|Lack of Efficacy|2|||
160722257|NCT01591096|580362785|FG000|Overall Study|Adverse Event|1|||
160722258|NCT01831635|580362786|FG000|Overall Study|Withdrawal by Subject|0|||
160722259|NCT01831635|580362787|FG001|Overall Study|Withdrawal by Subject|2|||
160722260|NCT01831635|580362788|FG002|Overall Study|Withdrawal by Subject|0|||
160722261|NCT03655405|580362791|FG000|Overall Study|Death after initial data collection|4|||
160722262|NCT03655405|580362792|FG001|Overall Study|Death after initial data collection|2|||
160722263|NCT03655405|580362791|FG000|Overall Study|Died before initial data collection|1|||
160722264|NCT03655405|580362792|FG001|Overall Study|Died before initial data collection|2|||
160722265|NCT03655405|580362791|FG000|Overall Study|Protocol Violation|0|||
160722266|NCT03655405|580362792|FG001|Overall Study|Protocol Violation|1|||
160722267|NCT01991743|580362794|FG000|Overall Study|external cephalic version not performed|0|||
160722268|NCT01991743|580362795|FG001|Overall Study|external cephalic version not performed|0|||
160722269|NCT01991743|580362796|FG002|Overall Study|external cephalic version not performed|1|||
160722270|NCT01991743|580362797|FG003|Overall Study|external cephalic version not performed|0|||
160722271|NCT02859337|580362798|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
160722272|NCT02859337|580362799|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
160722273|NCT02859337|580362800|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
160722274|NCT02859337|580362798|FG000|Overall Study|Withdrawal by Subject|3|||
160722275|NCT02859337|580362799|FG001|Overall Study|Withdrawal by Subject|1|||
160722276|NCT02859337|580362800|FG002|Overall Study|Withdrawal by Subject|0|||
160722277|NCT02859337|580362798|FG000|Overall Study|Lost to Follow-up|1|||
160722278|NCT02859337|580362799|FG001|Overall Study|Lost to Follow-up|0|||
160722279|NCT02859337|580362800|FG002|Overall Study|Lost to Follow-up|0|||
160722280|NCT05336227|580364543|FG000|Overall Study|Adverse Event|1|||
160722281|NCT05336227|580364544|FG001|Overall Study|Adverse Event|0|||
160722282|NCT05336227|580364543|FG000|Overall Study|Lost to Follow-up|2|||
160722283|NCT05336227|580364544|FG001|Overall Study|Lost to Follow-up|0|||
160722284|NCT05336227|580364543|FG000|Overall Study|Withdrawal by Subject|1|||
160722285|NCT05336227|580364544|FG001|Overall Study|Withdrawal by Subject|0|||
160722286|NCT04050462|580364545|FG000|Overall Study|Withdrawal by Subject|1|||
160722287|NCT04050462|580364546|FG001|Overall Study|Withdrawal by Subject|0|||
160722288|NCT04050462|580364547|FG002|Overall Study|Withdrawal by Subject|0|||
160722289|NCT05151744|580364548|FG000|Overall Study|Adverse Event|6|||
160722290|NCT05151744|580364549|FG001|Overall Study|Adverse Event|2|||
160722291|NCT05151744|580364548|FG000|Overall Study|Death|1|||
160722292|NCT05151744|580364549|FG001|Overall Study|Death|2|||
160722293|NCT05151744|580364548|FG000|Overall Study|Lack of Efficacy|1|||
160722294|NCT05151744|580364549|FG001|Overall Study|Lack of Efficacy|1|||
160722295|NCT05151744|580364548|FG000|Overall Study|Lost to Follow-up|2|||
160722296|NCT05151744|580364549|FG001|Overall Study|Lost to Follow-up|2|||
160722297|NCT05151744|580364548|FG000|Overall Study|Need for Rescue Treatment|0|||
160722298|NCT05151744|580364549|FG001|Overall Study|Need for Rescue Treatment|1|||
160722299|NCT05151744|580364548|FG000|Overall Study|Non-compliance with Study Drug|0|||
160722300|NCT05151744|580364549|FG001|Overall Study|Non-compliance with Study Drug|1|||
160722301|NCT05151744|580364548|FG000|Overall Study|Reason not Specified|10|||
160722302|NCT05151744|580364549|FG001|Overall Study|Reason not Specified|0|||
160722303|NCT05151744|580364548|FG000|Overall Study|Physician Decision|2|||
160722304|NCT05151744|580364549|FG001|Overall Study|Physician Decision|1|||
160722305|NCT05151744|580364548|FG000|Overall Study|Protocol Violation|1|||
160722306|NCT05151744|580364549|FG001|Overall Study|Protocol Violation|0|||
160722307|NCT05151744|580364548|FG000|Overall Study|Withdrawal by Subject|6|||
160722308|NCT05151744|580364549|FG001|Overall Study|Withdrawal by Subject|3|||
160722309|NCT01682226|580364552|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
160722310|NCT01682226|580364552|FG000|Overall Study|Participants did not receive treatment|2|||
160722311|NCT01682226|580364552|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
160722312|NCT03771898|580364561|FG000|Overall Study|Adverse Event|1|||
160722313|NCT03771898|580364562|FG001|Overall Study|Adverse Event|0|||
160722314|NCT03771898|580364563|FG002|Overall Study|Adverse Event|0|||
160722315|NCT03771898|580364564|FG003|Overall Study|Adverse Event|0|||
160722316|NCT03771898|580364565|FG004|Overall Study|Adverse Event|0|||
160722317|NCT03771898|580364561|FG000|Overall Study|Lost to Follow-up|1|||
160722318|NCT03771898|580364562|FG001|Overall Study|Lost to Follow-up|1|||
160722319|NCT03771898|580364563|FG002|Overall Study|Lost to Follow-up|1|||
160722320|NCT03771898|580364564|FG003|Overall Study|Lost to Follow-up|0|||
160722321|NCT03771898|580364565|FG004|Overall Study|Lost to Follow-up|0|||
160722322|NCT03771898|580364561|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160722323|NCT03771898|580364562|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160722324|NCT03771898|580364563|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160722325|NCT03771898|580364564|FG003|Overall Study|Withdrawal by parent/guardian|0|||
160722326|NCT03771898|580364565|FG004|Overall Study|Withdrawal by parent/guardian|0|||
160722327|NCT03771898|580364561|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
160722328|NCT03771898|580364562|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
160722329|NCT03771898|580364563|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
160722330|NCT03771898|580364564|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
160722331|NCT03771898|580364565|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
160722332|NCT03123120|580364566|FG000|Overall Study|Lost to Follow-up|0|||
160722333|NCT03123120|580364567|FG001|Overall Study|Lost to Follow-up|1|||
160722334|NCT03123120|580364566|FG000|Overall Study|Withdrawal by Subject|0|||
160722335|NCT03123120|580364567|FG001|Overall Study|Withdrawal by Subject|1|||
160722336|NCT03135548|580364568|FG000|Overall Study|Lost to Follow-up|3|||
160722337|NCT03135548|580364569|FG001|Overall Study|Lost to Follow-up|0|||
160722338|NCT03135548|580364570|FG002|Overall Study|Lost to Follow-up|0|||
160722339|NCT03135548|580364568|FG000|Overall Study|Withdrawal by Subject|2|||
160722340|NCT03135548|580364569|FG001|Overall Study|Withdrawal by Subject|2|||
160722341|NCT03135548|580364570|FG002|Overall Study|Withdrawal by Subject|1|||
160722342|NCT03135548|580364568|FG000|Overall Study|Other than listed|0|||
160722343|NCT03135548|580364569|FG001|Overall Study|Other than listed|2|||
160722344|NCT03135548|580364570|FG002|Overall Study|Other than listed|2|||
160722345|NCT02632175|580364571|FG000|Overall Study|Withdrawal by Subject|6|||
160722346|NCT02632175|580364571|FG000|Overall Study|Lost to Follow-up|1|||
160722347|NCT02632175|580364571|FG000|Overall Study|Lack of Efficacy|18|||
160722348|NCT02632175|580364571|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
160722349|NCT02632175|580364571|FG000|Overall Study|Subject noncompliance|3|||
160722350|NCT02632175|580364571|FG000|Overall Study|other|2|||
160722351|NCT02088554|580364572|FG000|Overall Study|Exited before procedure|130|||
160722352|NCT02088554|580364572|FG000|Overall Study|Attempted but not implanted|31|||
160722353|NCT02088554|580364572|FG000|Overall Study|Implant not attempted|19|||
160722354|NCT02088554|580364572|FG000|Overall Study|Pending next visit|532|||
160722355|NCT02088554|580364572|FG000|Overall Study|Death|170|||
160722356|NCT02088554|580364572|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
160722357|NCT02088554|580364572|FG000|Overall Study|Lost to Follow-up|23|||
160722358|NCT02088554|580364572|FG000|Overall Study|Explanted|32|||
160722359|NCT02088554|580364572|FG000|Overall Study|Any other reason not covered by previous categories|11|||
160722360|NCT04623216|580364573|FG000|Overall Study|Death|5|||
160722361|NCT04623216|580364574|FG001|Overall Study|Death|2|||
160722362|NCT04623216|580364575|FG002|Overall Study|Death|0|||
160722363|NCT04623216|580364576|FG003|Overall Study|Death|0|||
160722364|NCT04623216|580364573|FG000|Overall Study|Terminated by Sponsor|3|||
160722365|NCT04623216|580364574|FG001|Overall Study|Terminated by Sponsor|2|||
160722366|NCT04623216|580364575|FG002|Overall Study|Terminated by Sponsor|2|||
160722367|NCT04623216|580364576|FG003|Overall Study|Terminated by Sponsor|0|||
160722368|NCT04623216|580364573|FG000|Overall Study|Physician Decision|1|||
160722369|NCT04623216|580364574|FG001|Overall Study|Physician Decision|0|||
160722370|NCT04623216|580364575|FG002|Overall Study|Physician Decision|0|||
160722371|NCT04623216|580364576|FG003|Overall Study|Physician Decision|0|||
160722372|NCT03521154|580364577|FG000|Overall Study|Ongoing study at data cut-off|111|||
160722373|NCT03521154|580364578|FG001|Overall Study|Ongoing study at data cut-off|52|||
160722375|NCT04066244|580364581|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
160722376|NCT04066244|580364582|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
160722377|NCT04066244|580364583|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
160722378|NCT04066244|580364584|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
160722379|NCT04066244|580364585|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
160722380|NCT04066244|580364586|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
160722381|NCT04066244|580364581|FG000|Part 2 (Cohort 5)|Death|0|||
160722382|NCT04066244|580364582|FG001|Part 2 (Cohort 5)|Death|0|||
160722383|NCT04066244|580364583|FG002|Part 2 (Cohort 5)|Death|0|||
160722384|NCT04066244|580364584|FG003|Part 2 (Cohort 5)|Death|0|||
160722385|NCT04066244|580364585|FG004|Part 2 (Cohort 5)|Death|0|||
160722386|NCT04066244|580364586|FG005|Part 2 (Cohort 5)|Death|2|||
160722387|NCT04066244|580364581|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
160722388|NCT04066244|580364582|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
160722389|NCT04066244|580364583|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
160722390|NCT04066244|580364584|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
160722391|NCT04066244|580364585|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
160722392|NCT04066244|580364586|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
160722393|NCT04066244|580364581|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
160722394|NCT04066244|580364582|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
160722395|NCT04066244|580364583|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
160722396|NCT04066244|580364584|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
160722397|NCT04066244|580364585|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
160722398|NCT04066244|580364586|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
160722399|NCT00866281|580364587|FG000|Overall Study|Adverse Event|1|||
160722400|NCT00866281|580364588|FG001|Overall Study|Adverse Event|0|||
160722401|NCT00866281|580364587|FG000|Overall Study|Withdrawal by participants|3|||
160722402|NCT00866281|580364588|FG001|Overall Study|Withdrawal by participants|0|||
160722403|NCT00866281|580364587|FG000|Overall Study|Disease progression|3|||
160722404|NCT00866281|580364588|FG001|Overall Study|Disease progression|11|||
160722405|NCT00866281|580364587|FG000|Overall Study|New cancer therapy|0|||
160722406|NCT00866281|580364588|FG001|Overall Study|New cancer therapy|4|||
160722407|NCT00529087|580364591|FG000|Overall Study|Adverse Event|10|||
160722408|NCT00529087|580364592|FG001|Overall Study|Adverse Event|13|||
160722409|NCT00529087|580364593|FG002|Overall Study|Adverse Event|4|||
160722410|NCT00529087|580364591|FG000|Overall Study|Lost to Follow-up|6|||
160722411|NCT00529087|580364592|FG001|Overall Study|Lost to Follow-up|4|||
160722412|NCT00529087|580364593|FG002|Overall Study|Lost to Follow-up|1|||
160722413|NCT00529087|580364591|FG000|Overall Study|Protocol Violation|8|||
160722414|NCT00529087|580364592|FG001|Overall Study|Protocol Violation|7|||
160722415|NCT00529087|580364593|FG002|Overall Study|Protocol Violation|6|||
160722416|NCT00529087|580364591|FG000|Overall Study|Withdrawal by Subject|3|||
160722417|NCT00529087|580364592|FG001|Overall Study|Withdrawal by Subject|3|||
160722418|NCT00529087|580364593|FG002|Overall Study|Withdrawal by Subject|3|||
160722419|NCT00529087|580364591|FG000|Overall Study|Protocol deviation|1|||
160722420|NCT00529087|580364592|FG001|Overall Study|Protocol deviation|1|||
160722421|NCT00529087|580364593|FG002|Overall Study|Protocol deviation|2|||
160722422|NCT04168112|580364594|FG000|Overall Study|Lost to Follow-up|1|||
160722423|NCT04168112|580364595|FG001|Overall Study|Lost to Follow-up|0|||
160722424|NCT04168112|580364594|FG000|Overall Study|Withdrawal by Subject|1|||
160722425|NCT04168112|580364595|FG001|Overall Study|Withdrawal by Subject|0|||
160722426|NCT02955355|580364601|FG000|Overall Study|Adverse Event|4|||
160722427|NCT02955355|580364601|FG000|Overall Study|Death|1|||
160722428|NCT02955355|580364601|FG000|Overall Study|Physician Decision|21|||
160722429|NCT02955355|580364601|FG000|Overall Study|Site Terminated by Sponsor|35|||
160722430|NCT02955355|580364601|FG000|Overall Study|Withdrawal by Subject|19|||
160722431|NCT02955355|580364601|FG000|Overall Study|Reason Not Specified|5|||
160722432|NCT02612623|580364602|FG000|Overall Study|Withdrawal by Subject|0|||
160722433|NCT02612623|580364603|FG001|Overall Study|Withdrawal by Subject|1|||
160722434|NCT02612623|580364604|FG002|Overall Study|Withdrawal by Subject|0|||
160722435|NCT02612623|580364605|FG003|Overall Study|Withdrawal by Subject|0|||
160722436|NCT02612623|580364602|FG000|Overall Study|Adverse Event|1|||
160722437|NCT02612623|580364603|FG001|Overall Study|Adverse Event|0|||
160722438|NCT02612623|580364604|FG002|Overall Study|Adverse Event|1|||
160722439|NCT02612623|580364605|FG003|Overall Study|Adverse Event|0|||
160722440|NCT03809663|580364608|FG000|Overall Study|Decision by sponsor|24|||
160722441|NCT03809663|580364609|FG001|Overall Study|Decision by sponsor|18|||
160722442|NCT03809663|580364610|FG002|Overall Study|Decision by sponsor|20|||
160722443|NCT03809663|580364611|FG003|Overall Study|Decision by sponsor|20|||
160722444|NCT03809663|580364612|FG004|Overall Study|Decision by sponsor|0|||
160722445|NCT03809663|580364613|FG005|Overall Study|Decision by sponsor|0|||
160722446|NCT03809663|580364608|FG000|Overall Study|Withdrawal by Subject|26|||
160722447|NCT03809663|580364609|FG001|Overall Study|Withdrawal by Subject|22|||
160722448|NCT03809663|580364610|FG002|Overall Study|Withdrawal by Subject|27|||
160722449|NCT03809663|580364611|FG003|Overall Study|Withdrawal by Subject|26|||
160722450|NCT03809663|580364612|FG004|Overall Study|Withdrawal by Subject|0|||
160722451|NCT03809663|580364613|FG005|Overall Study|Withdrawal by Subject|0|||
160722452|NCT03809663|580364608|FG000|Overall Study|Lost to Follow-up|1|||
160722453|NCT03809663|580364609|FG001|Overall Study|Lost to Follow-up|4|||
160722454|NCT03809663|580364610|FG002|Overall Study|Lost to Follow-up|1|||
160722455|NCT03809663|580364611|FG003|Overall Study|Lost to Follow-up|1|||
160722456|NCT03809663|580364612|FG004|Overall Study|Lost to Follow-up|0|||
160722457|NCT03809663|580364613|FG005|Overall Study|Lost to Follow-up|0|||
160722458|NCT03376789|580364614|FG000|Overall Study|Withdrawal by Subject|3|||
160722459|NCT03376789|580364615|FG001|Overall Study|Withdrawal by Subject|5|||
160722460|NCT03376789|580364614|FG000|Overall Study|Protocol Violation|0|||
160722461|NCT03376789|580364615|FG001|Overall Study|Protocol Violation|1|||
160722462|NCT03376789|580364614|FG000|Overall Study|Adverse Event|0|||
160722463|NCT03376789|580364615|FG001|Overall Study|Adverse Event|1|||
160722464|NCT03376789|580364614|FG000|Overall Study|Lost to Follow-up|1|||
160722465|NCT03376789|580364615|FG001|Overall Study|Lost to Follow-up|1|||
160722466|NCT03376789|580364614|FG000|Overall Study|Per sponsor due to noncompliance|1|||
160722467|NCT03376789|580364615|FG001|Overall Study|Per sponsor due to noncompliance|0|||
160722468|NCT03376789|580364614|FG000|Overall Study|Subject off study medication|0|||
160722469|NCT03376789|580364615|FG001|Overall Study|Subject off study medication|1|||
160722470|NCT01703260|580364616|FG000|Overall Study|Adverse Event|1|||
160722471|NCT01703260|580364617|FG001|Overall Study|Adverse Event|2|||
160722472|NCT01703260|580364618|FG002|Overall Study|Adverse Event|2|||
160722473|NCT01703260|580364616|FG000|Overall Study|Lost to Follow-up|1|||
160722474|NCT01703260|580364617|FG001|Overall Study|Lost to Follow-up|0|||
160722475|NCT01703260|580364618|FG002|Overall Study|Lost to Follow-up|0|||
160722476|NCT01703260|580364616|FG000|Overall Study|Withdrawal by Subject|0|||
160722477|NCT01703260|580364617|FG001|Overall Study|Withdrawal by Subject|0|||
160722478|NCT01703260|580364618|FG002|Overall Study|Withdrawal by Subject|1|||
160722479|NCT01703260|580364616|FG000|Overall Study|Study Termination|1|||
160722480|NCT01703260|580364617|FG001|Overall Study|Study Termination|2|||
160722481|NCT01703260|580364618|FG002|Overall Study|Study Termination|0|||
160722482|NCT02230904|580364622|FG000|Overall Study|Safety follow up could not take place|0|||
160722483|NCT02230904|580364623|FG001|Overall Study|Safety follow up could not take place|1|||
160722484|NCT01464424|580364626|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
160722485|NCT01464424|580364627|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
160722486|NCT05047211|580364629|FG000|Overall Study|Lost to Follow-up|8|||
160722487|NCT05047211|580364630|FG001|Overall Study|Lost to Follow-up|5|||
160722488|NCT00561392|580364631|FG000|Overall Study|Adverse Event|38|||
160722489|NCT00561392|580364631|FG000|Overall Study|Lack of Efficacy|2|||
160722490|NCT00561392|580364631|FG000|Overall Study|Protocol Violation|1|||
160722491|NCT00561392|580364631|FG000|Overall Study|Withdrawal by Subject|8|||
160722492|NCT00561392|580364631|FG000|Overall Study|Administrative problems|4|||
160722493|NCT03822468|580364632|FG000|Treatment Period|Progressive disease|98|||
160722494|NCT03822468|580364633|FG001|Treatment Period|Progressive disease|94|||
160722495|NCT03822468|580364632|FG000|Treatment Period|Adverse Event|21|||
160722496|NCT03822468|580364633|FG001|Treatment Period|Adverse Event|24|||
160722497|NCT03822468|580364632|FG000|Treatment Period|Withdrawal by Subject|9|||
160722498|NCT03822468|580364633|FG001|Treatment Period|Withdrawal by Subject|5|||
160722499|NCT03822468|580364632|FG000|Treatment Period|Physician Decision|9|||
160722500|NCT03822468|580364633|FG001|Treatment Period|Physician Decision|7|||
160722501|NCT03822468|580364632|FG000|Treatment Period|Protocol Violation|2|||
160722502|NCT03822468|580364633|FG001|Treatment Period|Protocol Violation|1|||
160722503|NCT03822468|580364632|FG000|Treatment Period|Death|2|||
160722504|NCT03822468|580364633|FG001|Treatment Period|Death|3|||
160722505|NCT03822468|580364632|FG000|Treatment Period|Lost to Follow-up|1|||
160722506|NCT03822468|580364633|FG001|Treatment Period|Lost to Follow-up|1|||
160722507|NCT03822468|580364632|FG000|Treatment Period|Sponsor decision|46|||
160722508|NCT03822468|580364633|FG001|Treatment Period|Sponsor decision|53|||
160722509|NCT03822468|580364632|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
160722510|NCT03822468|580364633|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
160722511|NCT03822468|580364632|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
160722512|NCT03822468|580364633|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
160722513|NCT03822468|580364632|FG000|Post-treatment Efficacy Follow-up|Death|1|||
160722514|NCT03822468|580364633|FG001|Post-treatment Efficacy Follow-up|Death|0|||
160722515|NCT03822468|580364632|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160722516|NCT03822468|580364633|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
160722517|NCT03822468|580364632|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
160722518|NCT03822468|580364633|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160722519|NCT03822468|580364632|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
160722520|NCT03822468|580364633|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160722521|NCT03822468|580364632|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
160722522|NCT03822468|580364633|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
160722523|NCT03331796|580364634|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
160722524|NCT03331796|580364635|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
160722525|NCT03331796|580364636|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
160722526|NCT03331796|580364634|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
160722527|NCT03331796|580364635|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
160722528|NCT03331796|580364636|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
160722529|NCT03331796|580364634|FG000|Extended Follow-up|Adverse Event|1|||
160722530|NCT03331796|580364635|FG001|Extended Follow-up|Adverse Event|0|||
160722531|NCT03331796|580364636|FG002|Extended Follow-up|Adverse Event|1|||
160722532|NCT03331796|580364634|FG000|Extended Follow-up|Lost to Follow-up|0|||
160722533|NCT03331796|580364635|FG001|Extended Follow-up|Lost to Follow-up|0|||
160722534|NCT03331796|580364636|FG002|Extended Follow-up|Lost to Follow-up|1|||
160722535|NCT03331796|580364634|FG000|Extended Follow-up|Withdrawal by Subject|1|||
160722536|NCT03331796|580364635|FG001|Extended Follow-up|Withdrawal by Subject|0|||
160722537|NCT03331796|580364636|FG002|Extended Follow-up|Withdrawal by Subject|0|||
160722538|NCT03331796|580364634|FG000|Extended Follow-up|Termination of Funding|0|||
160722539|NCT03331796|580364635|FG001|Extended Follow-up|Termination of Funding|1|||
160722540|NCT03331796|580364636|FG002|Extended Follow-up|Termination of Funding|0|||
160722541|NCT01808066|580364638|FG000|Overall Study|Withdrawal by Subject|15|||
160722542|NCT01252095|580364643|FG000|Overall Study|Disease progression|1|||
160722543|NCT01252095|580364644|FG001|Overall Study|Disease progression|0|||
160722544|NCT01420068|580364645|FG000|Overall Study|Administrative problems|1|||
160722545|NCT01420068|580364646|FG001|Overall Study|Administrative problems|3|||
160722546|NCT01420068|580364645|FG000|Overall Study|Withdrawal by Subject|1|||
160722547|NCT01420068|580364646|FG001|Overall Study|Withdrawal by Subject|2|||
160722548|NCT00365794|580364647|FG000|Overall Study|Withdrawal by Subject|2|||
160722549|NCT04760626|580364648|FG000|Overall Study|Withdrawal by Subject|24|||
160722550|NCT04760626|580364649|FG001|Overall Study|Withdrawal by Subject|20|||
160722551|NCT04760626|580364648|FG000|Overall Study|Lost to Follow-up|14|||
160722552|NCT04760626|580364649|FG001|Overall Study|Lost to Follow-up|19|||
160722553|NCT04760626|580364648|FG000|Overall Study|Physician Decision|3|||
160722554|NCT04760626|580364649|FG001|Overall Study|Physician Decision|5|||
160722555|NCT04760626|580364648|FG000|Overall Study|Death|3|||
160722556|NCT04760626|580364649|FG001|Overall Study|Death|6|||
160722557|NCT04760626|580364648|FG000|Overall Study|Site closure|1|||
160722558|NCT04760626|580364649|FG001|Overall Study|Site closure|0|||
160722559|NCT02554682|580364652|FG000|Overall Study|Lost to Follow-up|11|||
160722560|NCT02554682|580364653|FG001|Overall Study|Lost to Follow-up|9|||
160722561|NCT02554682|580364654|FG002|Overall Study|Lost to Follow-up|4|||
160722562|NCT02554682|580364655|FG003|Overall Study|Lost to Follow-up|3|||
160722563|NCT02554682|580364656|FG004|Overall Study|Lost to Follow-up|2|||
160722564|NCT02554682|580364657|FG005|Overall Study|Lost to Follow-up|1|||
160722565|NCT02554682|580364658|FG006|Overall Study|Lost to Follow-up|6|||
160722566|NCT02554682|580364659|FG007|Overall Study|Lost to Follow-up|6|||
160722567|NCT02554682|580364660|FG008|Overall Study|Lost to Follow-up|2|||
160722568|NCT02554682|580364661|FG009|Overall Study|Lost to Follow-up|2|||
160722569|NCT02554682|580364652|FG000|Overall Study|Withdrawal by Subject|2|||
160722570|NCT02554682|580364653|FG001|Overall Study|Withdrawal by Subject|1|||
160722571|NCT02554682|580364654|FG002|Overall Study|Withdrawal by Subject|0|||
160722572|NCT02554682|580364655|FG003|Overall Study|Withdrawal by Subject|0|||
160722573|NCT02554682|580364656|FG004|Overall Study|Withdrawal by Subject|0|||
160722574|NCT02554682|580364657|FG005|Overall Study|Withdrawal by Subject|0|||
160722575|NCT02554682|580364658|FG006|Overall Study|Withdrawal by Subject|0|||
160722576|NCT02554682|580364659|FG007|Overall Study|Withdrawal by Subject|0|||
160722577|NCT02554682|580364660|FG008|Overall Study|Withdrawal by Subject|0|||
160722578|NCT02554682|580364661|FG009|Overall Study|Withdrawal by Subject|0|||
160722579|NCT02554682|580364652|FG000|Overall Study|Physician Decision|2|||
160722580|NCT02554682|580364653|FG001|Overall Study|Physician Decision|2|||
160722581|NCT02554682|580364654|FG002|Overall Study|Physician Decision|0|||
160722582|NCT02554682|580364655|FG003|Overall Study|Physician Decision|0|||
160722583|NCT02554682|580364656|FG004|Overall Study|Physician Decision|0|||
160722584|NCT02554682|580364657|FG005|Overall Study|Physician Decision|0|||
160722585|NCT02554682|580364658|FG006|Overall Study|Physician Decision|0|||
160722586|NCT02554682|580364659|FG007|Overall Study|Physician Decision|0|||
160722587|NCT02554682|580364660|FG008|Overall Study|Physician Decision|0|||
160722588|NCT02554682|580364661|FG009|Overall Study|Physician Decision|0|||
160722589|NCT00884117|580364664|FG000|Overall Study|Adverse Event|2|||
160722590|NCT00884117|580364664|FG000|Overall Study|Withdrawal by Subject|89|||
160722591|NCT00884117|580364664|FG000|Overall Study|Death|3|||
160722592|NCT00884117|580364664|FG000|Overall Study|Lost to Follow-up|143|||
160722593|NCT00884117|580364664|FG000|Overall Study|Other|12|||
160722594|NCT01565889|580364665|FG000|Part A|Withdrawal by Subject|1|||
160722595|NCT01565889|580364666|FG001|Part A|Withdrawal by Subject|0|||
160722596|NCT01565889|580364667|FG002|Part A|Withdrawal by Subject|0|||
160722597|NCT01565889|580364668|FG003|Part A|Withdrawal by Subject|0|||
160722598|NCT01565889|580364669|FG004|Part A|Withdrawal by Subject|0|||
160722599|NCT01565889|580364670|FG005|Part A|Withdrawal by Subject|0|||
160722600|NCT01565889|580364665|FG000|Part B|Withdrawal by Subject|0|||
160722601|NCT01565889|580364666|FG001|Part B|Withdrawal by Subject|0|||
160722602|NCT01565889|580364667|FG002|Part B|Withdrawal by Subject|0|||
160722603|NCT01565889|580364668|FG003|Part B|Withdrawal by Subject|0|||
160722604|NCT01565889|580364669|FG004|Part B|Withdrawal by Subject|0|||
160722605|NCT01565889|580364670|FG005|Part B|Withdrawal by Subject|1|||
160722606|NCT01565889|580364665|FG000|Part B|Lack of Efficacy|0|||
160722607|NCT01565889|580364666|FG001|Part B|Lack of Efficacy|0|||
160722608|NCT01565889|580364667|FG002|Part B|Lack of Efficacy|0|||
160722609|NCT01565889|580364668|FG003|Part B|Lack of Efficacy|0|||
160722610|NCT01565889|580364669|FG004|Part B|Lack of Efficacy|0|||
160722611|NCT01565889|580364670|FG005|Part B|Lack of Efficacy|2|||
160722612|NCT01565889|580364665|FG000|Part B|Lost to Follow-up|0|||
160722613|NCT01565889|580364666|FG001|Part B|Lost to Follow-up|0|||
160722614|NCT01565889|580364667|FG002|Part B|Lost to Follow-up|0|||
160722615|NCT01565889|580364668|FG003|Part B|Lost to Follow-up|0|||
160722616|NCT01565889|580364669|FG004|Part B|Lost to Follow-up|0|||
160722617|NCT01565889|580364670|FG005|Part B|Lost to Follow-up|1|||
160722618|NCT00122382|580364671|FG000|Double-Blind Study|Adverse Event|9|||
160722619|NCT00122382|580364672|FG001|Double-Blind Study|Adverse Event|11|||
160722620|NCT00122382|580364673|FG002|Double-Blind Study|Adverse Event|0|||
160722621|NCT00122382|580364671|FG000|Double-Blind Study|Death|2|||
160722622|NCT00122382|580364672|FG001|Double-Blind Study|Death|2|||
160722623|NCT00122382|580364673|FG002|Double-Blind Study|Death|0|||
160722624|NCT00122382|580364671|FG000|Double-Blind Study|Lack of Efficacy|0|||
160722625|NCT00122382|580364672|FG001|Double-Blind Study|Lack of Efficacy|8|||
160722626|NCT00122382|580364673|FG002|Double-Blind Study|Lack of Efficacy|0|||
160722627|NCT00122382|580364671|FG000|Double-Blind Study|Lost to Follow-up|2|||
160722628|NCT00122382|580364672|FG001|Double-Blind Study|Lost to Follow-up|1|||
160722629|NCT00122382|580364673|FG002|Double-Blind Study|Lost to Follow-up|0|||
160722630|NCT00122382|580364671|FG000|Double-Blind Study|Pregnancy|2|||
160722631|NCT00122382|580364672|FG001|Double-Blind Study|Pregnancy|0|||
160722632|NCT00122382|580364673|FG002|Double-Blind Study|Pregnancy|0|||
160722633|NCT00122382|580364671|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
160722634|NCT00122382|580364672|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
160722635|NCT00122382|580364673|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
160722636|NCT00122382|580364671|FG000|Double-Blind Study|Withdrawal of Consent|7|||
160722637|NCT00122382|580364672|FG001|Double-Blind Study|Withdrawal of Consent|3|||
160722638|NCT00122382|580364673|FG002|Double-Blind Study|Withdrawal of Consent|0|||
160722639|NCT00122382|580364671|FG000|Double-Blind Study|Protocol Violation|1|||
160722640|NCT00122382|580364672|FG001|Double-Blind Study|Protocol Violation|0|||
160722641|NCT00122382|580364673|FG002|Double-Blind Study|Protocol Violation|0|||
160722642|NCT00122382|580364671|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
160722643|NCT00122382|580364672|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
160722644|NCT00122382|580364673|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
160722645|NCT00122382|580364671|FG000|Double-Blind Study|Randomized but not treated|0|||
160722646|NCT00122382|580364672|FG001|Double-Blind Study|Randomized but not treated|2|||
160722647|NCT00122382|580364673|FG002|Double-Blind Study|Randomized but not treated|0|||
160722648|NCT00122382|580364671|FG000|Open-Label Study|Adverse Event|0|||
160722649|NCT00122382|580364672|FG001|Open-Label Study|Adverse Event|0|||
160722650|NCT00122382|580364673|FG002|Open-Label Study|Adverse Event|11|||
160722651|NCT00122382|580364671|FG000|Open-Label Study|Death|0|||
160722652|NCT00122382|580364672|FG001|Open-Label Study|Death|0|||
160722653|NCT00122382|580364673|FG002|Open-Label Study|Death|2|||
160722654|NCT00122382|580364671|FG000|Open-Label Study|Lack of Efficacy|0|||
160722655|NCT00122382|580364672|FG001|Open-Label Study|Lack of Efficacy|0|||
160722656|NCT00122382|580364673|FG002|Open-Label Study|Lack of Efficacy|3|||
160722657|NCT00122382|580364671|FG000|Open-Label Study|Lost to Follow-up|0|||
160722658|NCT00122382|580364672|FG001|Open-Label Study|Lost to Follow-up|0|||
160722659|NCT00122382|580364673|FG002|Open-Label Study|Lost to Follow-up|3|||
160722660|NCT00122382|580364671|FG000|Open-Label Study|Pregnancy|0|||
160722661|NCT00122382|580364672|FG001|Open-Label Study|Pregnancy|0|||
160722662|NCT00122382|580364673|FG002|Open-Label Study|Pregnancy|2|||
160722663|NCT00122382|580364671|FG000|Open-Label Study|Poor/Non-Compliance|0|||
160722664|NCT00122382|580364672|FG001|Open-Label Study|Poor/Non-Compliance|0|||
160722665|NCT00122382|580364673|FG002|Open-Label Study|Poor/Non-Compliance|1|||
160722666|NCT00122382|580364671|FG000|Open-Label Study|Withdrawal of Consent|0|||
160722667|NCT00122382|580364672|FG001|Open-Label Study|Withdrawal of Consent|0|||
160722668|NCT00122382|580364673|FG002|Open-Label Study|Withdrawal of Consent|4|||
160722669|NCT02040805|580364675|FG000|Overall Study|Lost to Follow-up|14|||
160722670|NCT02040805|580364676|FG001|Overall Study|Lost to Follow-up|9|||
160722671|NCT02040805|580364675|FG000|Overall Study|Withdrawal by Subject|28|||
160722672|NCT02040805|580364676|FG001|Overall Study|Withdrawal by Subject|41|||
160722673|NCT00908544|580364677|FG000|Overall Study|Withdrawal by Subject|2|||
160722674|NCT00908544|580364678|FG001|Overall Study|Withdrawal by Subject|4|||
160722675|NCT00908544|580364677|FG000|Overall Study|Lack of Efficacy|0|||
160722676|NCT00908544|580364678|FG001|Overall Study|Lack of Efficacy|1|||
160722677|NCT00908544|580364677|FG000|Overall Study|Pregnancy|1|||
160722678|NCT00908544|580364678|FG001|Overall Study|Pregnancy|0|||
160722679|NCT00908544|580364677|FG000|Overall Study|Relocation abroad|1|||
160722680|NCT00908544|580364678|FG001|Overall Study|Relocation abroad|1|||
160722681|NCT00908544|580364677|FG000|Overall Study|Unable to visit sutdy center|1|||
160722682|NCT00908544|580364678|FG001|Overall Study|Unable to visit sutdy center|0|||
160722683|NCT02462603|580364679|FG000|Overall Study|Investigator Decision|1|||
160722684|NCT02462603|580364679|FG000|Overall Study|Non-Compliance|1|||
160722685|NCT02462603|580364679|FG000|Overall Study|Withdrawal by Subject|2|||
160722686|NCT00848718|580364680|FG000|Overall Study|Adverse Event|2|||
160722687|NCT00848718|580364681|FG001|Overall Study|Adverse Event|2|||
160722688|NCT00848718|580364682|FG002|Overall Study|Adverse Event|1|||
160722689|NCT00848718|580364683|FG003|Overall Study|Adverse Event|1|||
160722690|NCT00848718|580364684|FG004|Overall Study|Adverse Event|1|||
160722691|NCT00848718|580364685|FG005|Overall Study|Adverse Event|0|||
160722692|NCT00848718|580364686|FG006|Overall Study|Adverse Event|0|||
160722693|NCT00848718|580364687|FG007|Overall Study|Adverse Event|1|||
160722694|NCT00848718|580364688|FG008|Overall Study|Adverse Event|1|||
160722695|NCT00848718|580364689|FG009|Overall Study|Adverse Event|0|||
160722696|NCT00848718|580364690|FG010|Overall Study|Adverse Event|0|||
160722697|NCT00848718|580364691|FG011|Overall Study|Adverse Event|0|||
160722698|NCT00848718|580364692|FG012|Overall Study|Adverse Event|2|||
160722699|NCT00848718|580364680|FG000|Overall Study|Lack of Efficacy|0|||
160722700|NCT00848718|580364681|FG001|Overall Study|Lack of Efficacy|0|||
160722701|NCT00848718|580364682|FG002|Overall Study|Lack of Efficacy|1|||
160722702|NCT00848718|580364683|FG003|Overall Study|Lack of Efficacy|0|||
160722703|NCT00848718|580364684|FG004|Overall Study|Lack of Efficacy|0|||
160722704|NCT00848718|580364685|FG005|Overall Study|Lack of Efficacy|0|||
160722705|NCT00848718|580364686|FG006|Overall Study|Lack of Efficacy|1|||
160722706|NCT00848718|580364687|FG007|Overall Study|Lack of Efficacy|0|||
160722707|NCT00848718|580364688|FG008|Overall Study|Lack of Efficacy|0|||
160722708|NCT00848718|580364689|FG009|Overall Study|Lack of Efficacy|0|||
160722709|NCT00848718|580364690|FG010|Overall Study|Lack of Efficacy|0|||
160722710|NCT00848718|580364691|FG011|Overall Study|Lack of Efficacy|0|||
160722711|NCT00848718|580364692|FG012|Overall Study|Lack of Efficacy|0|||
160722712|NCT00848718|580364680|FG000|Overall Study|Physician Decision|0|||
160722713|NCT00848718|580364681|FG001|Overall Study|Physician Decision|1|||
160722714|NCT00848718|580364682|FG002|Overall Study|Physician Decision|0|||
160722715|NCT00848718|580364683|FG003|Overall Study|Physician Decision|0|||
160722716|NCT00848718|580364684|FG004|Overall Study|Physician Decision|1|||
160722717|NCT00848718|580364685|FG005|Overall Study|Physician Decision|1|||
160722718|NCT00848718|580364686|FG006|Overall Study|Physician Decision|0|||
160722719|NCT00848718|580364687|FG007|Overall Study|Physician Decision|0|||
160722720|NCT00848718|580364688|FG008|Overall Study|Physician Decision|1|||
160722721|NCT00848718|580364689|FG009|Overall Study|Physician Decision|2|||
160722722|NCT00848718|580364690|FG010|Overall Study|Physician Decision|0|||
160722723|NCT00848718|580364691|FG011|Overall Study|Physician Decision|0|||
160722724|NCT00848718|580364692|FG012|Overall Study|Physician Decision|1|||
160722725|NCT00848718|580364680|FG000|Overall Study|Progressive disease before treatment|1|||
160722726|NCT00848718|580364681|FG001|Overall Study|Progressive disease before treatment|5|||
160722727|NCT00848718|580364682|FG002|Overall Study|Progressive disease before treatment|1|||
160722728|NCT00848718|580364683|FG003|Overall Study|Progressive disease before treatment|3|||
160722729|NCT00848718|580364684|FG004|Overall Study|Progressive disease before treatment|4|||
160722730|NCT00848718|580364685|FG005|Overall Study|Progressive disease before treatment|4|||
160722731|NCT00848718|580364686|FG006|Overall Study|Progressive disease before treatment|2|||
160722732|NCT00848718|580364687|FG007|Overall Study|Progressive disease before treatment|1|||
160722733|NCT00848718|580364688|FG008|Overall Study|Progressive disease before treatment|2|||
160722734|NCT00848718|580364689|FG009|Overall Study|Progressive disease before treatment|7|||
160722735|NCT00848718|580364690|FG010|Overall Study|Progressive disease before treatment|3|||
160722736|NCT00848718|580364691|FG011|Overall Study|Progressive disease before treatment|6|||
160722737|NCT00848718|580364692|FG012|Overall Study|Progressive disease before treatment|2|||
160722738|NCT00848718|580364680|FG000|Overall Study|Protocol Violation|0|||
160722739|NCT00848718|580364681|FG001|Overall Study|Protocol Violation|1|||
160722740|NCT00848718|580364682|FG002|Overall Study|Protocol Violation|0|||
160722741|NCT00848718|580364683|FG003|Overall Study|Protocol Violation|0|||
160722742|NCT00848718|580364684|FG004|Overall Study|Protocol Violation|0|||
160722743|NCT00848718|580364685|FG005|Overall Study|Protocol Violation|0|||
160722744|NCT00848718|580364686|FG006|Overall Study|Protocol Violation|0|||
160722745|NCT00848718|580364687|FG007|Overall Study|Protocol Violation|1|||
160722746|NCT00848718|580364688|FG008|Overall Study|Protocol Violation|0|||
160722747|NCT00848718|580364689|FG009|Overall Study|Protocol Violation|0|||
160722748|NCT00848718|580364690|FG010|Overall Study|Protocol Violation|0|||
160722749|NCT00848718|580364691|FG011|Overall Study|Protocol Violation|0|||
160722750|NCT00848718|580364692|FG012|Overall Study|Protocol Violation|1|||
160722751|NCT00848718|580364680|FG000|Overall Study|Withdrawal by Subject|1|||
160722752|NCT00848718|580364681|FG001|Overall Study|Withdrawal by Subject|0|||
160722753|NCT00848718|580364682|FG002|Overall Study|Withdrawal by Subject|0|||
160722754|NCT00848718|580364683|FG003|Overall Study|Withdrawal by Subject|1|||
160722755|NCT00848718|580364684|FG004|Overall Study|Withdrawal by Subject|0|||
160722756|NCT00848718|580364685|FG005|Overall Study|Withdrawal by Subject|0|||
160722757|NCT00848718|580364686|FG006|Overall Study|Withdrawal by Subject|0|||
160722758|NCT00848718|580364687|FG007|Overall Study|Withdrawal by Subject|0|||
160722759|NCT00848718|580364688|FG008|Overall Study|Withdrawal by Subject|0|||
160722760|NCT00848718|580364689|FG009|Overall Study|Withdrawal by Subject|0|||
160722761|NCT00848718|580364690|FG010|Overall Study|Withdrawal by Subject|1|||
160722762|NCT00848718|580364691|FG011|Overall Study|Withdrawal by Subject|0|||
160722763|NCT00848718|580364692|FG012|Overall Study|Withdrawal by Subject|0|||
160722764|NCT00848718|580364680|FG000|Overall Study|Progressive disease during treatment|3|||
160722765|NCT00848718|580364681|FG001|Overall Study|Progressive disease during treatment|0|||
160722766|NCT00848718|580364682|FG002|Overall Study|Progressive disease during treatment|3|||
160722767|NCT00848718|580364683|FG003|Overall Study|Progressive disease during treatment|0|||
160722768|NCT00848718|580364684|FG004|Overall Study|Progressive disease during treatment|0|||
160722769|NCT00848718|580364685|FG005|Overall Study|Progressive disease during treatment|0|||
160722770|NCT00848718|580364686|FG006|Overall Study|Progressive disease during treatment|0|||
160722771|NCT00848718|580364687|FG007|Overall Study|Progressive disease during treatment|2|||
160722772|NCT00848718|580364688|FG008|Overall Study|Progressive disease during treatment|0|||
160722773|NCT00848718|580364689|FG009|Overall Study|Progressive disease during treatment|0|||
160722774|NCT00848718|580364690|FG010|Overall Study|Progressive disease during treatment|0|||
160722775|NCT00848718|580364691|FG011|Overall Study|Progressive disease during treatment|0|||
160722776|NCT00848718|580364692|FG012|Overall Study|Progressive disease during treatment|2|||
160722777|NCT02389829|580364698|FG000|Overall Study|Lost to Follow-up|0|||
160722778|NCT02389829|580364699|FG001|Overall Study|Lost to Follow-up|1|||
160722779|NCT05514873|580364702|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
160722780|NCT05514873|580364702|FG000|Main Treatment Period|Adverse Event|2|||
160722781|NCT05514873|580364702|FG000|Extension Treatment Period|Lost to Follow-up|3|||
160722782|NCT03525678|580364703|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
160722783|NCT03525678|580364704|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
160722784|NCT03525678|580364705|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
160722785|NCT03525678|580364706|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
160722786|NCT03525678|580364707|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
160722787|NCT03525678|580364703|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
160722788|NCT03525678|580364704|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
160722789|NCT03525678|580364705|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
160722790|NCT03525678|580364706|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
160722791|NCT03525678|580364707|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
160722792|NCT03525678|580364703|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
160722793|NCT03525678|580364704|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
160722794|NCT03525678|580364705|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
160722795|NCT03525678|580364706|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
160722796|NCT03525678|580364707|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
160722797|NCT03525678|580364703|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
160722798|NCT03525678|580364704|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
160722799|NCT03525678|580364705|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
160722800|NCT03525678|580364706|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
160722801|NCT03525678|580364707|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
160722802|NCT03525678|580364703|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
160722803|NCT03525678|580364704|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
160722804|NCT03525678|580364705|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
160722805|NCT03525678|580364706|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
160722806|NCT03525678|580364707|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
160722807|NCT03525678|580364703|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
160722808|NCT03525678|580364704|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
160722809|NCT03525678|580364705|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
160722810|NCT03525678|580364706|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
160722811|NCT03525678|580364707|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
160722812|NCT01436370|580366228|FG000|Overall Study|Lost to Follow-up|0|||
160722813|NCT01436370|580366229|FG001|Overall Study|Lost to Follow-up|0|||
160722814|NCT01436370|580366230|FG002|Overall Study|Lost to Follow-up|0|||
160722815|NCT01436370|580366231|FG003|Overall Study|Lost to Follow-up|0|||
160722816|NCT01436370|580366232|FG004|Overall Study|Lost to Follow-up|1|||
160722817|NCT01436370|580366233|FG005|Overall Study|Lost to Follow-up|0|||
160722818|NCT01436370|580366234|FG006|Overall Study|Lost to Follow-up|0|||
160722819|NCT01436370|580366235|FG007|Overall Study|Lost to Follow-up|0|||
160722820|NCT03168711|580366238|FG000|Overall Study|Adverse Event|2|||
160722821|NCT03168711|580366239|FG001|Overall Study|Adverse Event|0|||
160722822|NCT03168711|580366238|FG000|Overall Study|Withdrawal by Subject|0|||
160722823|NCT03168711|580366239|FG001|Overall Study|Withdrawal by Subject|1|||
160722824|NCT03168711|580366238|FG000|Overall Study|Death|0|||
160722825|NCT03168711|580366239|FG001|Overall Study|Death|1|||
160722826|NCT02770170|580366245|FG000|Overall Study|Withdrawal by Subject|0|||
160722827|NCT02770170|580366246|FG001|Overall Study|Withdrawal by Subject|0|||
160722828|NCT02770170|580366247|FG002|Overall Study|Withdrawal by Subject|0|||
160722829|NCT02770170|580366248|FG003|Overall Study|Withdrawal by Subject|2|||
160722830|NCT02770170|580366245|FG000|Overall Study|due to pregnancy|1|||
160722831|NCT02770170|580366246|FG001|Overall Study|due to pregnancy|0|||
160722832|NCT02770170|580366247|FG002|Overall Study|due to pregnancy|0|||
160722833|NCT02770170|580366248|FG003|Overall Study|due to pregnancy|0|||
160722834|NCT02770170|580366245|FG000|Overall Study|Lack of Efficacy|2|||
160722835|NCT02770170|580366246|FG001|Overall Study|Lack of Efficacy|0|||
160722836|NCT02770170|580366247|FG002|Overall Study|Lack of Efficacy|0|||
160722837|NCT02770170|580366248|FG003|Overall Study|Lack of Efficacy|1|||
160722838|NCT02770170|580366245|FG000|Overall Study|Adverse Event|4|||
160722839|NCT02770170|580366246|FG001|Overall Study|Adverse Event|3|||
160722840|NCT02770170|580366247|FG002|Overall Study|Adverse Event|5|||
160722841|NCT02770170|580366248|FG003|Overall Study|Adverse Event|3|||
160722842|NCT02770170|580366245|FG000|Overall Study|due to disease worsening|0|||
160722843|NCT02770170|580366246|FG001|Overall Study|due to disease worsening|0|||
160722844|NCT02770170|580366247|FG002|Overall Study|due to disease worsening|0|||
160722845|NCT02770170|580366248|FG003|Overall Study|due to disease worsening|1|||
160722846|NCT03270657|580366249|FG000|Overall Study|Withdrawal by Subject|1|||
160722847|NCT00162981|580366250|FG000|Overall Study|Adverse Event|2|||
160722848|NCT00162981|580366251|FG001|Overall Study|Adverse Event|5|||
160722849|NCT00162981|580366250|FG000|Overall Study|Withdrawal by Subject|1|||
160722850|NCT00162981|580366251|FG001|Overall Study|Withdrawal by Subject|1|||
160722851|NCT00162981|580366250|FG000|Overall Study|Physician Decision|1|||
160722852|NCT00162981|580366251|FG001|Overall Study|Physician Decision|0|||
160722853|NCT01671007|580366259|FG000|Overall Study|Other reasons than listed|166|||
160722854|NCT01671007|580366260|FG001|Overall Study|Other reasons than listed|373|||
160722855|NCT01671007|580366261|FG002|Overall Study|Other reasons than listed|197|||
160722856|NCT01671007|580366262|FG003|Overall Study|Other reasons than listed|228|||
160722857|NCT01671007|580366263|FG004|Overall Study|Other reasons than listed|14|||
160722858|NCT01671007|580366264|FG005|Overall Study|Other reasons than listed|71|||
160722859|NCT01671007|580366265|FG006|Overall Study|Other reasons than listed|17|||
160722860|NCT01671007|580366266|FG007|Overall Study|Other reasons than listed|66|||
160722861|NCT01671007|580366267|FG008|Overall Study|Other reasons than listed|0|||
160722862|NCT01671007|580366259|FG000|Overall Study|Withdrawal by Subject|36|||
160722863|NCT01671007|580366260|FG001|Overall Study|Withdrawal by Subject|59|||
160722864|NCT01671007|580366261|FG002|Overall Study|Withdrawal by Subject|53|||
160722865|NCT01671007|580366262|FG003|Overall Study|Withdrawal by Subject|58|||
160722866|NCT01671007|580366263|FG004|Overall Study|Withdrawal by Subject|4|||
160722867|NCT01671007|580366264|FG005|Overall Study|Withdrawal by Subject|15|||
160722868|NCT01671007|580366265|FG006|Overall Study|Withdrawal by Subject|1|||
160722869|NCT01671007|580366266|FG007|Overall Study|Withdrawal by Subject|19|||
160722870|NCT01671007|580366267|FG008|Overall Study|Withdrawal by Subject|0|||
160722871|NCT01671007|580366259|FG000|Overall Study|Lost to Follow-up|93|||
160722872|NCT01671007|580366260|FG001|Overall Study|Lost to Follow-up|142|||
160722873|NCT01671007|580366261|FG002|Overall Study|Lost to Follow-up|91|||
160722874|NCT01671007|580366262|FG003|Overall Study|Lost to Follow-up|63|||
160722875|NCT01671007|580366263|FG004|Overall Study|Lost to Follow-up|7|||
160722876|NCT01671007|580366264|FG005|Overall Study|Lost to Follow-up|20|||
160722877|NCT01671007|580366265|FG006|Overall Study|Lost to Follow-up|2|||
160722878|NCT01671007|580366266|FG007|Overall Study|Lost to Follow-up|28|||
160722879|NCT01671007|580366267|FG008|Overall Study|Lost to Follow-up|0|||
160722880|NCT01671007|580366259|FG000|Overall Study|No end of study case report form|3|||
160722881|NCT01671007|580366260|FG001|Overall Study|No end of study case report form|1|||
160722882|NCT01671007|580366261|FG002|Overall Study|No end of study case report form|0|||
160722883|NCT01671007|580366262|FG003|Overall Study|No end of study case report form|2|||
160722884|NCT01671007|580366263|FG004|Overall Study|No end of study case report form|0|||
160722885|NCT01671007|580366264|FG005|Overall Study|No end of study case report form|0|||
160722886|NCT01671007|580366265|FG006|Overall Study|No end of study case report form|0|||
160722887|NCT01671007|580366266|FG007|Overall Study|No end of study case report form|0|||
160722888|NCT01671007|580366267|FG008|Overall Study|No end of study case report form|0|||
160722889|NCT01671007|580366259|FG000|Overall Study|Not eligible|23|||
160722890|NCT01671007|580366260|FG001|Overall Study|Not eligible|76|||
160722891|NCT01671007|580366261|FG002|Overall Study|Not eligible|25|||
160722892|NCT01671007|580366262|FG003|Overall Study|Not eligible|17|||
160722893|NCT01671007|580366263|FG004|Overall Study|Not eligible|0|||
160722894|NCT01671007|580366264|FG005|Overall Study|Not eligible|6|||
160722895|NCT01671007|580366265|FG006|Overall Study|Not eligible|1|||
160722896|NCT01671007|580366266|FG007|Overall Study|Not eligible|19|||
160722897|NCT01671007|580366267|FG008|Overall Study|Not eligible|0|||
160722898|NCT03877068|580366268|FG000|Overall Study|Physician Decision|9|||
160722899|NCT03877068|580366269|FG001|Overall Study|Physician Decision|3|||
160722900|NCT00449865|580366270|FG000|Overall Study|Withdrawal by Subject|110|||
160722901|NCT00449865|580366271|FG001|Overall Study|Withdrawal by Subject|110|||
160722902|NCT00449865|580366270|FG000|Overall Study|Lost to Follow-up|36|||
160722903|NCT00449865|580366271|FG001|Overall Study|Lost to Follow-up|37|||
160722904|NCT00449865|580366270|FG000|Overall Study|Physician Decision|13|||
160722905|NCT00449865|580366271|FG001|Overall Study|Physician Decision|12|||
160722906|NCT00449865|580366270|FG000|Overall Study|Death|31|||
160722907|NCT00449865|580366271|FG001|Overall Study|Death|40|||
160722908|NCT00449865|580366270|FG000|Overall Study|Protocol Violation|8|||
160722909|NCT00449865|580366271|FG001|Overall Study|Protocol Violation|7|||
160722910|NCT00449865|580366270|FG000|Overall Study|Study was stopped|324|||
160722911|NCT00449865|580366271|FG001|Overall Study|Study was stopped|328|||
160722912|NCT00406367|580366272|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
160722913|NCT00406367|580366273|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
160722914|NCT00406367|580366272|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
160722915|NCT00406367|580366273|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
160722916|NCT00406367|580366272|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
160722917|NCT00406367|580366273|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
160722918|NCT00406367|580366272|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
160722919|NCT00406367|580366273|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
160722920|NCT00406367|580366272|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
160722921|NCT00406367|580366273|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
160722922|NCT00406367|580366272|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
160722923|NCT00406367|580366273|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
160722924|NCT00406367|580366272|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
160722925|NCT00406367|580366273|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
160722926|NCT00406367|580366272|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
160722927|NCT00406367|580366273|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
160722928|NCT00406367|580366272|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
160722929|NCT00406367|580366273|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
160722930|NCT00406367|580366272|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
160722931|NCT00406367|580366273|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
160722932|NCT00406367|580366272|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
160722933|NCT00406367|580366273|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
160722934|NCT00406367|580366272|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
160722935|NCT00406367|580366273|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
160722936|NCT00171210|580366274|FG000|Overall Study|Adverse Event|16|||
160722937|NCT00171210|580366275|FG001|Overall Study|Adverse Event|27|||
160722938|NCT00171210|580366274|FG000|Overall Study|Abnormal laboratory value(s)|6|||
160722939|NCT00171210|580366275|FG001|Overall Study|Abnormal laboratory value(s)|3|||
160722940|NCT00171210|580366274|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160722941|NCT00171210|580366275|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160722942|NCT00171210|580366274|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
160722943|NCT00171210|580366275|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
160722944|NCT00171210|580366274|FG000|Overall Study|Protocol Violation|0|||
160722945|NCT00171210|580366275|FG001|Overall Study|Protocol Violation|2|||
160722946|NCT00171210|580366274|FG000|Overall Study|Withdrawal by Subject|32|||
160722947|NCT00171210|580366275|FG001|Overall Study|Withdrawal by Subject|30|||
160722948|NCT00171210|580366274|FG000|Overall Study|Lost to Follow-up|1|||
160722949|NCT00171210|580366275|FG001|Overall Study|Lost to Follow-up|0|||
160722950|NCT00171210|580366274|FG000|Overall Study|Administrative problems|1|||
160722951|NCT00171210|580366275|FG001|Overall Study|Administrative problems|1|||
160722952|NCT00171210|580366274|FG000|Overall Study|Death|2|||
160722953|NCT00171210|580366275|FG001|Overall Study|Death|3|||
160722954|NCT00171210|580366274|FG000|Overall Study|Stopped at end of core|0|||
160722955|NCT00171210|580366275|FG001|Overall Study|Stopped at end of core|32|||
160722956|NCT00171210|580366274|FG000|Overall Study|Stopped at end of extension 1|0|||
160722957|NCT00171210|580366275|FG001|Overall Study|Stopped at end of extension 1|1|||
160722958|NCT03187301|580366278|FG000|Titration Period|Adverse Event|0|||
160722959|NCT03187301|580366279|FG001|Titration Period|Adverse Event|0|||
160722960|NCT03187301|580366280|FG002|Titration Period|Adverse Event|0|||
160722961|NCT03187301|580366281|FG003|Titration Period|Adverse Event|0|||
160722962|NCT03187301|580366282|FG004|Titration Period|Adverse Event|0|||
160722963|NCT03187301|580366283|FG005|Titration Period|Adverse Event|0|||
160722964|NCT03187301|580366284|FG006|Titration Period|Adverse Event|5|||
160722965|NCT03187301|580366278|FG000|Titration Period|Withdrawal by Subject|0|||
160722966|NCT03187301|580366279|FG001|Titration Period|Withdrawal by Subject|0|||
160722967|NCT03187301|580366280|FG002|Titration Period|Withdrawal by Subject|0|||
160722968|NCT03187301|580366281|FG003|Titration Period|Withdrawal by Subject|0|||
160722969|NCT03187301|580366282|FG004|Titration Period|Withdrawal by Subject|0|||
160722970|NCT03187301|580366283|FG005|Titration Period|Withdrawal by Subject|0|||
160722971|NCT03187301|580366284|FG006|Titration Period|Withdrawal by Subject|1|||
160722972|NCT03187301|580366278|FG000|Titration Period|Exclusion Criteria Met|0|||
160722973|NCT03187301|580366279|FG001|Titration Period|Exclusion Criteria Met|0|||
160722974|NCT03187301|580366280|FG002|Titration Period|Exclusion Criteria Met|0|||
160722975|NCT03187301|580366281|FG003|Titration Period|Exclusion Criteria Met|0|||
160722976|NCT03187301|580366282|FG004|Titration Period|Exclusion Criteria Met|0|||
160722977|NCT03187301|580366283|FG005|Titration Period|Exclusion Criteria Met|0|||
160722978|NCT03187301|580366284|FG006|Titration Period|Exclusion Criteria Met|1|||
160722979|NCT03187301|580366278|FG000|Pre-Intervention|Withdrawal by Subject|1|||
160722980|NCT03187301|580366279|FG001|Pre-Intervention|Withdrawal by Subject|0|||
160722981|NCT03187301|580366280|FG002|Pre-Intervention|Withdrawal by Subject|0|||
160722982|NCT03187301|580366281|FG003|Pre-Intervention|Withdrawal by Subject|0|||
160722983|NCT03187301|580366282|FG004|Pre-Intervention|Withdrawal by Subject|0|||
160722984|NCT03187301|580366283|FG005|Pre-Intervention|Withdrawal by Subject|0|||
160722985|NCT03187301|580366284|FG006|Pre-Intervention|Withdrawal by Subject|0|||
160722986|NCT03252535|580366286|FG000|Overall Study|Withdrawal by Subject|1|||
160722987|NCT03252535|580366287|FG001|Overall Study|Withdrawal by Subject|0|||
160722988|NCT03252535|580366288|FG002|Overall Study|Withdrawal by Subject|0|||
160722989|NCT03252535|580366286|FG000|Overall Study|Physician Decision|0|||
160722990|NCT03252535|580366287|FG001|Overall Study|Physician Decision|1|||
160722991|NCT03252535|580366288|FG002|Overall Study|Physician Decision|0|||
160722992|NCT03252535|580366286|FG000|Overall Study|Met discontinuation criteria|0|||
160722993|NCT03252535|580366287|FG001|Overall Study|Met discontinuation criteria|1|||
160722994|NCT03252535|580366288|FG002|Overall Study|Met discontinuation criteria|0|||
160722995|NCT01966120|580366293|FG000|Overall Study|Withdrawal by Subject|0|||
160722996|NCT01966120|580366294|FG001|Overall Study|Withdrawal by Subject|5|||
160722997|NCT01966120|580366293|FG000|Overall Study|Lost to Follow-up|1|||
160722998|NCT01966120|580366294|FG001|Overall Study|Lost to Follow-up|1|||
160722999|NCT00461630|580366295|FG000|Overall Study|Death|798|||
160723000|NCT00461630|580366296|FG001|Overall Study|Death|732|||
160723001|NCT00461630|580366295|FG000|Overall Study|Lost to Follow-up|108|||
160723002|NCT00461630|580366296|FG001|Overall Study|Lost to Follow-up|95|||
160723003|NCT02588612|580366300|FG000|Overall Study|Physician Decision|1|||
160723004|NCT02588612|580366300|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
160723005|NCT02588612|580366300|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
160723006|NCT02588612|580366300|FG000|Overall Study|Death prior to T-cell infusion|1|||
160723007|NCT02042014|580366301|FG000|Overall Study|Adverse Event|1|||
160723008|NCT02042014|580366301|FG000|Overall Study|Physician Decision|7|||
160723009|NCT02792062|580366302|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
160723010|NCT02792062|580366303|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
160723011|NCT02792062|580366304|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
160723012|NCT02792062|580366305|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
160723013|NCT02792062|580366306|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
160723014|NCT02792062|580366307|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
160723015|NCT03123393|580366310|FG000|Overall Study|Study Terminated by Sponsor|6|||
160723016|NCT03123393|580366311|FG001|Overall Study|Study Terminated by Sponsor|9|||
160723017|NCT03123393|580366310|FG000|Overall Study|Withdrawal by Subject|2|||
160723018|NCT03123393|580366311|FG001|Overall Study|Withdrawal by Subject|1|||
160723019|NCT03123393|580366310|FG000|Overall Study|Reason not Specified|13|||
160723020|NCT03123393|580366311|FG001|Overall Study|Reason not Specified|13|||
160723021|NCT00427648|580366313|FG000|Overall Study|Protocol Violation|1|||
160723022|NCT00427648|580366314|FG001|Overall Study|Protocol Violation|2|||
160723023|NCT00427648|580366313|FG000|Overall Study|Adverse Event|0|||
160723024|NCT00427648|580366314|FG001|Overall Study|Adverse Event|1|||
160723025|NCT01681212|580366315|FG000|Overall Study|No longer met study criteria|5|||
160723026|NCT01681212|580366315|FG000|Overall Study|Administrative reason by sponsor|1|||
160723027|NCT01464333|580366316|FG000|Overall Study|Adverse Event|34|||
160723028|NCT01464333|580366316|FG000|Overall Study|Lack of Efficacy|72|||
160723029|NCT01464333|580366316|FG000|Overall Study|Withdrawal by Subject|11|||
160723030|NCT01464333|580366316|FG000|Overall Study|Other|4|||
160723031|NCT01464333|580366316|FG000|Overall Study|No Hospital Visit|42|||
160723032|NCT03321968|580366319|FG000|Overall Study|Withdrawal by Subject|1|||
160723033|NCT03321968|580366320|FG001|Overall Study|Withdrawal by Subject|2|||
160723034|NCT03321968|580366321|FG002|Overall Study|Withdrawal by Subject|1|||
160723035|NCT03321968|580366319|FG000|Overall Study|Lost to Follow-up|2|||
160723036|NCT03321968|580366320|FG001|Overall Study|Lost to Follow-up|0|||
160723037|NCT03321968|580366321|FG002|Overall Study|Lost to Follow-up|1|||
160723038|NCT03321968|580366319|FG000|Overall Study|Other than specified|0|||
160723039|NCT03321968|580366320|FG001|Overall Study|Other than specified|0|||
160723040|NCT03321968|580366321|FG002|Overall Study|Other than specified|1|||
160723041|NCT00529308|580366322|FG000|Overall Study|Withdrawal by Subject|1|||
160723042|NCT00529308|580366323|FG001|Overall Study|Withdrawal by Subject|1|||
160723043|NCT00745901|580366324|FG000|Overall Study|Adverse Event|3|||
160723044|NCT00745901|580366325|FG001|Overall Study|Adverse Event|4|||
160723045|NCT00745901|580366324|FG000|Overall Study|Protocol Violation|0|||
160723046|NCT00745901|580366325|FG001|Overall Study|Protocol Violation|1|||
160723047|NCT00745901|580366324|FG000|Overall Study|Withdrawal by Subject|1|||
160723048|NCT00745901|580366325|FG001|Overall Study|Withdrawal by Subject|0|||
160723049|NCT00745901|580366324|FG000|Overall Study|Lost to Follow-up|7|||
160723050|NCT00745901|580366325|FG001|Overall Study|Lost to Follow-up|4|||
160723051|NCT00745901|580366324|FG000|Overall Study|Pregnancy|2|||
160723052|NCT00745901|580366325|FG001|Overall Study|Pregnancy|4|||
160723053|NCT00745901|580366324|FG000|Overall Study|Lack of compliance|2|||
160723054|NCT00745901|580366325|FG001|Overall Study|Lack of compliance|2|||
160723055|NCT00745901|580366324|FG000|Overall Study|Patient's next menses did not start with|1|||
160723056|NCT00745901|580366325|FG001|Overall Study|Patient's next menses did not start with|0|||
160723057|NCT00745901|580366324|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
160723058|NCT00745901|580366325|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
160723059|NCT00745901|580366324|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
160723060|NCT00745901|580366325|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
160723061|NCT00745901|580366324|FG000|Overall Study|Patient didn't take any study medication|7|||
160723062|NCT00745901|580366325|FG001|Overall Study|Patient didn't take any study medication|3|||
160723063|NCT05581641|580366326|FG000|Overall Study|Withdrawal by Subject|0|||
160723064|NCT05581641|580366327|FG001|Overall Study|Withdrawal by Subject|1|||
160723065|NCT05581641|580366328|FG002|Overall Study|Withdrawal by Subject|3|||
160723066|NCT05581641|580366329|FG003|Overall Study|Withdrawal by Subject|1|||
160723067|NCT05581641|580366326|FG000|Overall Study|Lost to Follow-up|0|||
160723068|NCT05581641|580366327|FG001|Overall Study|Lost to Follow-up|1|||
160723069|NCT05581641|580366328|FG002|Overall Study|Lost to Follow-up|0|||
160723070|NCT05581641|580366329|FG003|Overall Study|Lost to Follow-up|1|||
160723071|NCT05581641|580366326|FG000|Overall Study|Protocol Violation|1|||
160723072|NCT05581641|580366327|FG001|Overall Study|Protocol Violation|0|||
160723073|NCT05581641|580366328|FG002|Overall Study|Protocol Violation|0|||
160723074|NCT05581641|580366329|FG003|Overall Study|Protocol Violation|0|||
160723075|NCT05581641|580366326|FG000|Overall Study|Other|1|||
160723076|NCT05581641|580366327|FG001|Overall Study|Other|0|||
160723077|NCT05581641|580366328|FG002|Overall Study|Other|2|||
160723078|NCT05581641|580366329|FG003|Overall Study|Other|1|||
160723079|NCT04390763|580366330|FG000|Safety run-in Part|Adverse Event|4|||
160723080|NCT04390763|580366331|FG001|Safety run-in Part|Adverse Event|0|||
160723081|NCT04390763|580366332|FG002|Safety run-in Part|Adverse Event|0|||
160723082|NCT04390763|580366333|FG003|Safety run-in Part|Adverse Event|0|||
160723083|NCT04390763|580366330|FG000|Safety run-in Part|Physician Decision|1|||
160723084|NCT04390763|580366331|FG001|Safety run-in Part|Physician Decision|0|||
160723085|NCT04390763|580366332|FG002|Safety run-in Part|Physician Decision|0|||
160723086|NCT04390763|580366333|FG003|Safety run-in Part|Physician Decision|0|||
160723087|NCT04390763|580366330|FG000|Safety run-in Part|Progressive Disease|6|||
160723088|NCT04390763|580366331|FG001|Safety run-in Part|Progressive Disease|0|||
160723089|NCT04390763|580366332|FG002|Safety run-in Part|Progressive Disease|0|||
160723090|NCT04390763|580366333|FG003|Safety run-in Part|Progressive Disease|0|||
160723091|NCT04390763|580366330|FG000|Randomized Part|Adverse Event|0|||
160723092|NCT04390763|580366331|FG001|Randomized Part|Adverse Event|11|||
160723093|NCT04390763|580366332|FG002|Randomized Part|Adverse Event|5|||
160723094|NCT04390763|580366333|FG003|Randomized Part|Adverse Event|5|||
160723095|NCT04390763|580366330|FG000|Randomized Part|Death|0|||
160723096|NCT04390763|580366331|FG001|Randomized Part|Death|3|||
160723097|NCT04390763|580366332|FG002|Randomized Part|Death|4|||
160723098|NCT04390763|580366333|FG003|Randomized Part|Death|2|||
160723099|NCT04390763|580366330|FG000|Randomized Part|Physician Decision|0|||
160723100|NCT04390763|580366331|FG001|Randomized Part|Physician Decision|2|||
160723101|NCT04390763|580366332|FG002|Randomized Part|Physician Decision|2|||
160723102|NCT04390763|580366333|FG003|Randomized Part|Physician Decision|9|||
160723103|NCT04390763|580366330|FG000|Randomized Part|Progressive Disease|0|||
160723104|NCT04390763|580366331|FG001|Randomized Part|Progressive Disease|24|||
160723105|NCT04390763|580366332|FG002|Randomized Part|Progressive Disease|31|||
160723106|NCT04390763|580366333|FG003|Randomized Part|Progressive Disease|23|||
160723107|NCT04390763|580366330|FG000|Randomized Part|Study terminated by sponsor|0|||
160723108|NCT04390763|580366331|FG001|Randomized Part|Study terminated by sponsor|1|||
160723109|NCT04390763|580366332|FG002|Randomized Part|Study terminated by sponsor|0|||
160723110|NCT04390763|580366333|FG003|Randomized Part|Study terminated by sponsor|0|||
160723111|NCT04390763|580366330|FG000|Randomized Part|Participant Decision|0|||
160723112|NCT04390763|580366331|FG001|Randomized Part|Participant Decision|5|||
160723113|NCT04390763|580366332|FG002|Randomized Part|Participant Decision|7|||
160723114|NCT04390763|580366333|FG003|Randomized Part|Participant Decision|6|||
160723115|NCT04390763|580366330|FG000|Randomized Part|Not treated|0|||
160723116|NCT04390763|580366331|FG001|Randomized Part|Not treated|4|||
160723117|NCT04390763|580366332|FG002|Randomized Part|Not treated|2|||
160723118|NCT04390763|580366333|FG003|Randomized Part|Not treated|7|||
160723119|NCT01956773|580366340|FG000|Overall Study|Lost to Follow-up|628|||
160723120|NCT01956773|580366341|FG001|Overall Study|Lost to Follow-up|1|||
160723121|NCT01383174|580366342|FG000|3 Month Assessment|Death|0|||
160723122|NCT01383174|580366343|FG001|3 Month Assessment|Death|1|||
160723123|NCT01383174|580366342|FG000|3 Month Assessment|Lost to Follow-up|2|||
160723124|NCT01383174|580366343|FG001|3 Month Assessment|Lost to Follow-up|0|||
160723125|NCT01383174|580366342|FG000|3 Month Assessment|Refused to complete|4|||
160723126|NCT01383174|580366343|FG001|3 Month Assessment|Refused to complete|0|||
160723127|NCT01383174|580366342|FG000|6 Month Assessment|Lost to Follow-up|1|||
160723128|NCT01383174|580366343|FG001|6 Month Assessment|Lost to Follow-up|1|||
160723129|NCT01383174|580366342|FG000|6 Month Assessment|Refused to complete|4|||
160723130|NCT01383174|580366343|FG001|6 Month Assessment|Refused to complete|0|||
160723131|NCT01153815|580366344|FG000|Overall Study|Adverse Event|3|||
160723132|NCT01153815|580366345|FG001|Overall Study|Adverse Event|1|||
160723133|NCT01153815|580366344|FG000|Overall Study|Withdrawal by Subject|6|||
160723134|NCT01153815|580366345|FG001|Overall Study|Withdrawal by Subject|4|||
160723135|NCT01786993|580366348|FG000|Overall Study|Death|6|||
160723136|NCT01786993|580366349|FG001|Overall Study|Death|7|||
160723137|NCT01786993|580366348|FG000|Overall Study|Withdrawal by Subject|3|||
160723138|NCT01786993|580366349|FG001|Overall Study|Withdrawal by Subject|2|||
160723139|NCT01786993|580366348|FG000|Overall Study|Lost to Follow-up|0|||
160723140|NCT01786993|580366349|FG001|Overall Study|Lost to Follow-up|1|||
160723141|NCT01786993|580366348|FG000|Overall Study|Subject Non-Compliance|1|||
160723142|NCT01786993|580366349|FG001|Overall Study|Subject Non-Compliance|0|||
160723143|NCT01786993|580366348|FG000|Overall Study|System Explant|1|||
160723144|NCT01786993|580366349|FG001|Overall Study|System Explant|0|||
160723145|NCT01786993|580366348|FG000|Overall Study|Hospice Admission|1|||
160723146|NCT01786993|580366349|FG001|Overall Study|Hospice Admission|0|||
160723147|NCT00450437|580366350|FG000|Overall Study|Withdrawal by Subject|10|||
160723148|NCT00450437|580366351|FG001|Overall Study|Withdrawal by Subject|2|||
160723149|NCT00450437|580366352|FG002|Overall Study|Withdrawal by Subject|0|||
160723150|NCT00450437|580366353|FG003|Overall Study|Withdrawal by Subject|1|||
160723151|NCT00450437|580366350|FG000|Overall Study|Lost to Follow-up|31|||
160723152|NCT00450437|580366351|FG001|Overall Study|Lost to Follow-up|12|||
160723153|NCT00450437|580366352|FG002|Overall Study|Lost to Follow-up|19|||
160723154|NCT00450437|580366353|FG003|Overall Study|Lost to Follow-up|9|||
160723155|NCT00450437|580366350|FG000|Overall Study|Protocol Violation|0|||
160723156|NCT00450437|580366351|FG001|Overall Study|Protocol Violation|1|||
160723157|NCT00450437|580366352|FG002|Overall Study|Protocol Violation|0|||
160723158|NCT00450437|580366353|FG003|Overall Study|Protocol Violation|1|||
160723159|NCT00450437|580366350|FG000|Overall Study|Inappropriate enrollment|4|||
160723160|NCT00450437|580366351|FG001|Overall Study|Inappropriate enrollment|1|||
160723161|NCT00450437|580366352|FG002|Overall Study|Inappropriate enrollment|3|||
160723162|NCT00450437|580366353|FG003|Overall Study|Inappropriate enrollment|0|||
160723163|NCT00450437|580366350|FG000|Overall Study|Administrative reason|0|||
160723164|NCT00450437|580366351|FG001|Overall Study|Administrative reason|0|||
160723165|NCT00450437|580366352|FG002|Overall Study|Administrative reason|1|||
160723166|NCT00450437|580366353|FG003|Overall Study|Administrative reason|0|||
160723167|NCT00450437|580366350|FG000|Overall Study|Unable to Classify|1|||
160723168|NCT00450437|580366351|FG001|Overall Study|Unable to Classify|0|||
160723169|NCT00450437|580366352|FG002|Overall Study|Unable to Classify|1|||
160723170|NCT00450437|580366353|FG003|Overall Study|Unable to Classify|0|||
160723171|NCT01890122|580366354|FG000|Overall Study|Adverse Event|1|||
160723172|NCT01890122|580366355|FG001|Overall Study|Adverse Event|1|||
160723173|NCT01890122|580366356|FG002|Overall Study|Adverse Event|1|||
160723174|NCT01890122|580366357|FG003|Overall Study|Adverse Event|2|||
160723175|NCT01890122|580366354|FG000|Overall Study|Major Protocol Deviation|3|||
160723176|NCT01890122|580366355|FG001|Overall Study|Major Protocol Deviation|1|||
160723177|NCT01890122|580366356|FG002|Overall Study|Major Protocol Deviation|0|||
160723178|NCT01890122|580366357|FG003|Overall Study|Major Protocol Deviation|1|||
160723179|NCT01890122|580366354|FG000|Overall Study|Lost to Follow-up|0|||
160723180|NCT01890122|580366355|FG001|Overall Study|Lost to Follow-up|1|||
160723181|NCT01890122|580366356|FG002|Overall Study|Lost to Follow-up|2|||
160723182|NCT01890122|580366357|FG003|Overall Study|Lost to Follow-up|2|||
160723183|NCT01890122|580366354|FG000|Overall Study|Voluntary Withdrawal|8|||
160723184|NCT01890122|580366355|FG001|Overall Study|Voluntary Withdrawal|8|||
160723185|NCT01890122|580366356|FG002|Overall Study|Voluntary Withdrawal|2|||
160723186|NCT01890122|580366357|FG003|Overall Study|Voluntary Withdrawal|11|||
160723187|NCT01890122|580366354|FG000|Overall Study|Lack of Efficacy|14|||
160723188|NCT01890122|580366355|FG001|Overall Study|Lack of Efficacy|24|||
160723189|NCT01890122|580366356|FG002|Overall Study|Lack of Efficacy|7|||
160723190|NCT01890122|580366357|FG003|Overall Study|Lack of Efficacy|41|||
160723191|NCT01890122|580366354|FG000|Overall Study|Reason not Specified|0|||
160723192|NCT01890122|580366355|FG001|Overall Study|Reason not Specified|1|||
160723193|NCT01890122|580366356|FG002|Overall Study|Reason not Specified|1|||
160723194|NCT01890122|580366357|FG003|Overall Study|Reason not Specified|2|||
160723195|NCT01890122|580366354|FG000|Overall Study|Randomized but not Treated|1|||
160723196|NCT01890122|580366355|FG001|Overall Study|Randomized but not Treated|1|||
160723197|NCT01890122|580366356|FG002|Overall Study|Randomized but not Treated|0|||
160723198|NCT01890122|580366357|FG003|Overall Study|Randomized but not Treated|0|||
160723199|NCT04025879|580366358|FG000|Randomization|Participant withdrew consent|0|||
160723200|NCT04025879|580366359|FG001|Randomization|Participant withdrew consent|1|||
160723201|NCT04025879|580366358|FG000|Randomization|Participant no longer met study criteria|1|||
160723202|NCT04025879|580366359|FG001|Randomization|Participant no longer met study criteria|1|||
160723203|NCT04025879|580366358|FG000|Treatment|Ongoing treatment|10|||
160723204|NCT04025879|580366359|FG001|Treatment|Ongoing treatment|8|||
160723205|NCT04025879|580366358|FG000|Treatment|Disease progression/recurrence|36|||
160723206|NCT04025879|580366359|FG001|Treatment|Disease progression/recurrence|72|||
160723207|NCT04025879|580366358|FG000|Treatment|Study drug toxicity|36|||
160723208|NCT04025879|580366359|FG001|Treatment|Study drug toxicity|13|||
160723209|NCT04025879|580366358|FG000|Treatment|Death|2|||
160723210|NCT04025879|580366359|FG001|Treatment|Death|0|||
160723211|NCT04025879|580366358|FG000|Treatment|Adverse event unrelated to study drug|21|||
160723212|NCT04025879|580366359|FG001|Treatment|Adverse event unrelated to study drug|14|||
160723213|NCT04025879|580366358|FG000|Treatment|Participant request to discontinue study treatment|16|||
160723214|NCT04025879|580366359|FG001|Treatment|Participant request to discontinue study treatment|8|||
160723215|NCT04025879|580366358|FG000|Treatment|Participant withdrew consent|1|||
160723216|NCT04025879|580366359|FG001|Treatment|Participant withdrew consent|3|||
160723217|NCT04025879|580366358|FG000|Treatment|Participant no longer meets study criteria|3|||
160723218|NCT04025879|580366359|FG001|Treatment|Participant no longer meets study criteria|2|||
160723219|NCT04025879|580366358|FG000|Treatment|Lost to Follow-up|1|||
160723220|NCT04025879|580366359|FG001|Treatment|Lost to Follow-up|0|||
160723221|NCT04025879|580366358|FG000|Treatment|Other reasons|15|||
160723222|NCT04025879|580366359|FG001|Treatment|Other reasons|17|||
160723223|NCT04025879|580366358|FG000|Treatment|Administrative reason by sponsor|0|||
160723224|NCT04025879|580366359|FG001|Treatment|Administrative reason by sponsor|1|||
160723225|NCT04025879|580366358|FG000|Treatment|Not reported|2|||
160723226|NCT04025879|580366359|FG001|Treatment|Not reported|0|||
160723227|NCT00071110|580366364|FG000|Overall Study|Protocol Violation|0|||
160723228|NCT00071110|580366365|FG001|Overall Study|Protocol Violation|4|||
160723229|NCT02640664|580366374|FG000|Epoch 1|Withdrawal of informed consent|1|||
160723230|NCT02640664|580366375|FG001|Epoch 1|Withdrawal of informed consent|0|||
160723231|NCT02640664|580366376|FG002|Epoch 1|Withdrawal of informed consent|0|||
160723232|NCT02640664|580366374|FG000|Epoch 1|Death|0|||
160723233|NCT02640664|580366375|FG001|Epoch 1|Death|0|||
160723234|NCT02640664|580366376|FG002|Epoch 1|Death|1|||
160723235|NCT02640664|580366374|FG000|Epoch 2|Withdrawal of informed consent|3|||
160723236|NCT02640664|580366375|FG001|Epoch 2|Withdrawal of informed consent|4|||
160723237|NCT02640664|580366376|FG002|Epoch 2|Withdrawal of informed consent|2|||
160723238|NCT02640664|580366374|FG000|Epoch 2|Subject/guardian decision|0|||
160723239|NCT02640664|580366375|FG001|Epoch 2|Subject/guardian decision|2|||
160723240|NCT02640664|580366376|FG002|Epoch 2|Subject/guardian decision|2|||
160723241|NCT02640664|580366374|FG000|Epoch 2|Lost to Follow-up|3|||
160723242|NCT02640664|580366375|FG001|Epoch 2|Lost to Follow-up|4|||
160723243|NCT02640664|580366376|FG002|Epoch 2|Lost to Follow-up|1|||
160723244|NCT02640664|580366374|FG000|Epoch 2|Death|0|||
160723245|NCT02640664|580366375|FG001|Epoch 2|Death|0|||
160723246|NCT02640664|580366376|FG002|Epoch 2|Death|1|||
160723247|NCT00722137|580366377|FG000|Overall Study|Overt Disease Progression|5|||
160723248|NCT00722137|580366378|FG001|Overall Study|Overt Disease Progression|4|||
160723249|NCT00722137|580366377|FG000|Overall Study|Adverse Event|17|||
160723250|NCT00722137|580366378|FG001|Overall Study|Adverse Event|21|||
160723251|NCT00722137|580366377|FG000|Overall Study|Death|12|||
160723252|NCT00722137|580366378|FG001|Overall Study|Death|7|||
160723253|NCT00722137|580366377|FG000|Overall Study|Withdrawal by Subject|6|||
160723254|NCT00722137|580366378|FG001|Overall Study|Withdrawal by Subject|9|||
160723255|NCT00722137|580366377|FG000|Overall Study|Other Reason Unknown|3|||
160723256|NCT00722137|580366378|FG001|Overall Study|Other Reason Unknown|4|||
160723257|NCT00722137|580366377|FG000|Overall Study|Randomized But Not Treated|2|||
160723258|NCT00722137|580366378|FG001|Overall Study|Randomized But Not Treated|3|||
160723259|NCT02729025|580366379|FG000|Overall Study|Sponsor Decision|0|||
160723260|NCT02729025|580366380|FG001|Overall Study|Sponsor Decision|1|||
160723261|NCT05343000|580368187|FG000|Overall Study|Physician Decision|2|||
160723262|NCT04432831|580368188|FG000|Overall Study|Withdrawal by Subject|24|||
160723263|NCT04432831|580368189|FG001|Overall Study|Withdrawal by Subject|28|||
160723264|NCT04432831|580368190|FG002|Overall Study|Withdrawal by Subject|21|||
160723265|NCT04432831|580368188|FG000|Overall Study|Death|23|||
160723266|NCT04432831|580368189|FG001|Overall Study|Death|23|||
160723267|NCT04432831|580368190|FG002|Overall Study|Death|17|||
160723268|NCT04432831|580368188|FG000|Overall Study|Lost to Follow-up|15|||
160723269|NCT04432831|580368189|FG001|Overall Study|Lost to Follow-up|15|||
160723270|NCT04432831|580368190|FG002|Overall Study|Lost to Follow-up|12|||
160723271|NCT04432831|580368188|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
160723272|NCT04432831|580368189|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
160723273|NCT04432831|580368190|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
160723274|NCT04432831|580368188|FG000|Overall Study|Reason Not Specified|7|||
160723275|NCT04432831|580368189|FG001|Overall Study|Reason Not Specified|11|||
160723276|NCT04432831|580368190|FG002|Overall Study|Reason Not Specified|9|||
160723277|NCT04432831|580368188|FG000|Overall Study|Adverse Event|7|||
160723278|NCT04432831|580368189|FG001|Overall Study|Adverse Event|7|||
160723279|NCT04432831|580368190|FG002|Overall Study|Adverse Event|7|||
160723280|NCT04432831|580368188|FG000|Overall Study|Physician Decision|1|||
160723281|NCT04432831|580368189|FG001|Overall Study|Physician Decision|3|||
160723282|NCT04432831|580368190|FG002|Overall Study|Physician Decision|6|||
160723283|NCT04432831|580368188|FG000|Overall Study|Protocol Violation|1|||
160723284|NCT04432831|580368189|FG001|Overall Study|Protocol Violation|0|||
160723285|NCT04432831|580368190|FG002|Overall Study|Protocol Violation|2|||
160723286|NCT04432831|580368188|FG000|Overall Study|Pregnancy|0|||
160723287|NCT04432831|580368189|FG001|Overall Study|Pregnancy|1|||
160723288|NCT04432831|580368190|FG002|Overall Study|Pregnancy|0|||
160723289|NCT04432831|580368188|FG000|Overall Study|Lack of Efficacy|0|||
160723290|NCT04432831|580368189|FG001|Overall Study|Lack of Efficacy|0|||
160723291|NCT04432831|580368190|FG002|Overall Study|Lack of Efficacy|2|||
160723292|NCT03782792|580368191|FG000|Overall Study|Patient left the country|0|||
160723293|NCT03782792|580368192|FG001|Overall Study|Patient left the country|1|||
160723294|NCT03782792|580368191|FG000|Overall Study|Withdrawal by Subject|1|||
160723295|NCT03782792|580368192|FG001|Overall Study|Withdrawal by Subject|2|||
160723296|NCT05271370|580368195|FG000|Overall Study|Study early termination|8|||
160723297|NCT05271370|580368196|FG001|Overall Study|Study early termination|16|||
160723298|NCT05271370|580368197|FG002|Overall Study|Study early termination|29|||
160723299|NCT00617890|580368198|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
160723300|NCT00617890|580368199|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
160723301|NCT00617890|580368200|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
160723302|NCT00617890|580368201|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
160723303|NCT00617890|580368198|FG000|Overall Study|Lack of Efficacy|23|||
160723304|NCT00617890|580368199|FG001|Overall Study|Lack of Efficacy|26|||
160723305|NCT00617890|580368200|FG002|Overall Study|Lack of Efficacy|30|||
160723306|NCT00617890|580368201|FG003|Overall Study|Lack of Efficacy|97|||
160723307|NCT00617890|580368198|FG000|Overall Study|Lost to Follow-up|0|||
160723308|NCT00617890|580368199|FG001|Overall Study|Lost to Follow-up|0|||
160723309|NCT00617890|580368200|FG002|Overall Study|Lost to Follow-up|1|||
160723310|NCT00617890|580368201|FG003|Overall Study|Lost to Follow-up|2|||
160723311|NCT00617890|580368198|FG000|Overall Study|Withdrawal by Subject|4|||
160723312|NCT00617890|580368199|FG001|Overall Study|Withdrawal by Subject|1|||
160723313|NCT00617890|580368200|FG002|Overall Study|Withdrawal by Subject|0|||
160723314|NCT00617890|580368201|FG003|Overall Study|Withdrawal by Subject|2|||
160723315|NCT00617890|580368198|FG000|Overall Study|Protocol Violation|2|||
160723316|NCT00617890|580368199|FG001|Overall Study|Protocol Violation|1|||
160723317|NCT00617890|580368200|FG002|Overall Study|Protocol Violation|0|||
160723318|NCT00617890|580368201|FG003|Overall Study|Protocol Violation|0|||
160723319|NCT00617890|580368198|FG000|Overall Study|Adverse Event|1|||
160723320|NCT00617890|580368199|FG001|Overall Study|Adverse Event|0|||
160723321|NCT00617890|580368200|FG002|Overall Study|Adverse Event|3|||
160723322|NCT00617890|580368201|FG003|Overall Study|Adverse Event|8|||
160723323|NCT00617890|580368198|FG000|Overall Study|Not treated|1|||
160723324|NCT00617890|580368199|FG001|Overall Study|Not treated|0|||
160723325|NCT00617890|580368200|FG002|Overall Study|Not treated|1|||
160723326|NCT00617890|580368201|FG003|Overall Study|Not treated|1|||
160723327|NCT02283268|580368211|FG000|Overall Study|Withdrawal by Subject|1|||
160723328|NCT00333983|580368212|FG000|Overall Study|Lost to Follow-up|2|||
160723329|NCT00333983|580368213|FG001|Overall Study|Lost to Follow-up|1|||
160723330|NCT00333983|580368214|FG002|Overall Study|Lost to Follow-up|0|||
160723331|NCT00333983|580368212|FG000|Overall Study|Adverse Event|1|||
160723332|NCT00333983|580368213|FG001|Overall Study|Adverse Event|1|||
160723333|NCT00333983|580368214|FG002|Overall Study|Adverse Event|1|||
160723334|NCT00333983|580368212|FG000|Overall Study|Withdrawal by Subject|0|||
160723335|NCT00333983|580368213|FG001|Overall Study|Withdrawal by Subject|3|||
160723336|NCT00333983|580368214|FG002|Overall Study|Withdrawal by Subject|1|||
160723337|NCT00833105|580368215|FG000|Overall Study|Withdrawal by Subject|1|||
160723338|NCT00833105|580368215|FG000|Overall Study|Adverse Event|2|||
160723339|NCT02898597|580368216|FG000|Overall Study|Protocol Violation|4|||
160723340|NCT02898597|580368217|FG001|Overall Study|Protocol Violation|2|||
160723341|NCT02898597|580368216|FG000|Overall Study|Lost to Follow-up|0|||
160723342|NCT02898597|580368217|FG001|Overall Study|Lost to Follow-up|9|||
160723343|NCT02898597|580368216|FG000|Overall Study|Death|0|||
160723344|NCT02898597|580368217|FG001|Overall Study|Death|1|||
160723345|NCT03656068|580368218|FG000|Overall Study|Withdrawal by Subject|4|||
160723346|NCT03656068|580368218|FG000|Overall Study|Adverse Event|1|||
160723347|NCT01295671|580368228|FG000|Overall Study|Lost to Follow-up|4|||
160723348|NCT01295671|580368229|FG001|Overall Study|Lost to Follow-up|6|||
160723349|NCT01295671|580368230|FG002|Overall Study|Lost to Follow-up|3|||
160723350|NCT01295671|580368228|FG000|Overall Study|Withdrawal by Subject|3|||
160723351|NCT01295671|580368229|FG001|Overall Study|Withdrawal by Subject|1|||
160723352|NCT01295671|580368230|FG002|Overall Study|Withdrawal by Subject|0|||
160723353|NCT01780038|580368231|FG000|Overall Study|Lost to Follow-up|4|||
160723354|NCT01780038|580368232|FG001|Overall Study|Lost to Follow-up|1|||
160723355|NCT00455403|580368233|FG000|Overall Study|Lost to Follow-up|2|||
160723356|NCT00455403|580368234|FG001|Overall Study|Lost to Follow-up|1|||
160723357|NCT00455403|580368233|FG000|Overall Study|Withdrawal by Subject|1|||
160723358|NCT00455403|580368234|FG001|Overall Study|Withdrawal by Subject|3|||
160723359|NCT00455403|580368233|FG000|Overall Study|Protocol Violation|0|||
160723360|NCT00455403|580368234|FG001|Overall Study|Protocol Violation|2|||
160723361|NCT00442897|580368236|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
160723362|NCT00442897|580368237|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
160723363|NCT00442897|580368236|FG000|Base Study (12 Week Follow-up)|Death|0|||
160723364|NCT00442897|580368237|FG001|Base Study (12 Week Follow-up)|Death|1|||
160723365|NCT00442897|580368236|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
160723366|NCT00442897|580368237|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
160723367|NCT00442897|580368236|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
160723368|NCT00442897|580368237|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
160723369|NCT00442897|580368236|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
160723370|NCT00442897|580368237|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
160723371|NCT00442897|580368236|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
160723372|NCT00442897|580368237|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
160723373|NCT00442897|580368236|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
160723374|NCT00442897|580368237|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
160723375|NCT00442897|580368236|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
160723376|NCT00442897|580368237|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
160723377|NCT04498182|580368238|FG000|Overall Study|Adverse Event|2|||
160723378|NCT04498182|580368239|FG001|Overall Study|Adverse Event|3|||
160723379|NCT04498182|580368240|FG002|Overall Study|Adverse Event|2|||
160723380|NCT04498182|580368238|FG000|Overall Study|Withdrawal of Consent|3|||
160723381|NCT04498182|580368239|FG001|Overall Study|Withdrawal of Consent|4|||
160723382|NCT04498182|580368240|FG002|Overall Study|Withdrawal of Consent|3|||
160723383|NCT04498182|580368238|FG000|Overall Study|Non-Compliant|1|||
160723384|NCT04498182|580368239|FG001|Overall Study|Non-Compliant|0|||
160723385|NCT04498182|580368240|FG002|Overall Study|Non-Compliant|1|||
160723386|NCT04498182|580368238|FG000|Overall Study|Lost to Follow-up|0|||
160723387|NCT04498182|580368239|FG001|Overall Study|Lost to Follow-up|0|||
160723388|NCT04498182|580368240|FG002|Overall Study|Lost to Follow-up|1|||
160723389|NCT04498182|580368238|FG000|Overall Study|Investigator Decision|0|||
160723390|NCT04498182|580368239|FG001|Overall Study|Investigator Decision|0|||
160723391|NCT04498182|580368240|FG002|Overall Study|Investigator Decision|1|||
160723392|NCT04498182|580368238|FG000|Overall Study|Protocol Violation|1|||
160723393|NCT04498182|580368239|FG001|Overall Study|Protocol Violation|0|||
160723394|NCT04498182|580368240|FG002|Overall Study|Protocol Violation|2|||
160723395|NCT04548193|580368243|FG000|Overall Study|Lost to Follow-up|0|||
160723396|NCT04548193|580368244|FG001|Overall Study|Lost to Follow-up|1|||
160723397|NCT04548193|580368243|FG000|Overall Study|Death|0|||
160723398|NCT04548193|580368244|FG001|Overall Study|Death|1|||
160723399|NCT04548193|580368243|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
160723400|NCT04548193|580368244|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
160723401|NCT04548193|580368243|FG000|Overall Study|Withdrawal by Subject|2|||
160723402|NCT04548193|580368244|FG001|Overall Study|Withdrawal by Subject|2|||
160723403|NCT00630825|580368245|FG000|Overall Study|Adverse Event|4|||
160723404|NCT00630825|580368246|FG001|Overall Study|Adverse Event|4|||
160723405|NCT00630825|580368247|FG002|Overall Study|Adverse Event|3|||
160723406|NCT00630825|580368248|FG003|Overall Study|Adverse Event|1|||
160723407|NCT00630825|580368245|FG000|Overall Study|Entry Criteria Not Met|1|||
160723408|NCT00630825|580368246|FG001|Overall Study|Entry Criteria Not Met|0|||
160723409|NCT00630825|580368247|FG002|Overall Study|Entry Criteria Not Met|2|||
160723410|NCT00630825|580368248|FG003|Overall Study|Entry Criteria Not Met|1|||
160723411|NCT00630825|580368245|FG000|Overall Study|Lost to Follow-up|1|||
160723412|NCT00630825|580368246|FG001|Overall Study|Lost to Follow-up|1|||
160723413|NCT00630825|580368247|FG002|Overall Study|Lost to Follow-up|1|||
160723414|NCT00630825|580368248|FG003|Overall Study|Lost to Follow-up|1|||
160723415|NCT00630825|580368245|FG000|Overall Study|Physician Decision|1|||
160723416|NCT00630825|580368246|FG001|Overall Study|Physician Decision|0|||
160723417|NCT00630825|580368247|FG002|Overall Study|Physician Decision|0|||
160723418|NCT00630825|580368248|FG003|Overall Study|Physician Decision|0|||
160723419|NCT00630825|580368245|FG000|Overall Study|Withdrawal by Subject|2|||
160723420|NCT00630825|580368246|FG001|Overall Study|Withdrawal by Subject|2|||
160723421|NCT00630825|580368247|FG002|Overall Study|Withdrawal by Subject|2|||
160723422|NCT00630825|580368248|FG003|Overall Study|Withdrawal by Subject|3|||
160723423|NCT01081769|580368251|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
160723424|NCT01081769|580368252|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
160723425|NCT01081769|580368251|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
160723426|NCT01081769|580368252|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
160723427|NCT01081769|580368251|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
160723428|NCT01081769|580368252|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
160723429|NCT01081769|580368251|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
160723430|NCT01081769|580368252|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
160723431|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Adverse Event|14|||
160723432|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Adverse Event|11|||
160723433|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Death|1|||
160723434|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Death|1|||
160723435|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
160723436|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
160723437|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
160723438|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
160723439|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Pregnancy|1|||
160723440|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Pregnancy|0|||
160723441|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
160723442|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
160723443|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
160723444|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
160723445|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Other|0|||
160723446|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Other|1|||
160723447|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Ineligibility|3|||
160723448|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Ineligibility|4|||
160723449|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
160723450|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
160723451|NCT01081769|580368251|FG000|CORE Intent-To-Treat|Patient Moved|2|||
160723452|NCT01081769|580368252|FG001|CORE Intent-To-Treat|Patient Moved|2|||
160723453|NCT03309943|580368253|FG000|Overall Study|Withdrawal by Subject|0|||
160723454|NCT03309943|580368254|FG001|Overall Study|Withdrawal by Subject|1|||
160723455|NCT03309943|580368253|FG000|Overall Study|Inappropriate behavior towards staff|0|||
160723456|NCT03309943|580368254|FG001|Overall Study|Inappropriate behavior towards staff|1|||
160723457|NCT00558701|580368258|FG000|Overall Study|Protocol Deviations|1|||
160723458|NCT00558701|580368259|FG001|Overall Study|Protocol Deviations|4|||
160723459|NCT01609296|580368260|FG000|Overall Study|Death|253|||
160723460|NCT01609296|580368260|FG000|Overall Study|Withdrawal by Subject|151|||
160723461|NCT01609296|580368260|FG000|Overall Study|Lost to Follow-up|21|||
160723462|NCT01609296|580368260|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
160723463|NCT01609296|580368260|FG000|Overall Study|missed visit but known to be alive|28|||
160723464|NCT02187198|580368264|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
160723465|NCT02187198|580368265|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
160723466|NCT02187198|580368264|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
160723467|NCT02187198|580368265|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
160723468|NCT00546377|580368266|FG000|Overall Study|Deemed ineligible|1|||
160723469|NCT00546377|580368266|FG000|Overall Study|Adverse Event|6|||
160723470|NCT01532518|580368267|FG000|Overall Study|Withdrawal by Subject|0|||
160723471|NCT01532518|580368268|FG001|Overall Study|Withdrawal by Subject|0|||
160723472|NCT01532518|580368269|FG002|Overall Study|Withdrawal by Subject|1|||
160723473|NCT01575834|580368270|FG000|Overall Study|Withdrawal by Subject|352|||
160723474|NCT01575834|580368271|FG001|Overall Study|Withdrawal by Subject|390|||
160723475|NCT01575834|580368270|FG000|Overall Study|Death|81|||
160723476|NCT01575834|580368271|FG001|Overall Study|Death|74|||
160723477|NCT01575834|580368270|FG000|Overall Study|Other|70|||
160723478|NCT01575834|580368271|FG001|Overall Study|Other|70|||
160723479|NCT01575834|580368270|FG000|Overall Study|Adverse Event|63|||
160723480|NCT01575834|580368271|FG001|Overall Study|Adverse Event|61|||
160723481|NCT01575834|580368270|FG000|Overall Study|Lost to Follow-up|55|||
160723482|NCT01575834|580368271|FG001|Overall Study|Lost to Follow-up|68|||
160723483|NCT01575834|580368270|FG000|Overall Study|Noncompliance|52|||
160723484|NCT01575834|580368271|FG001|Overall Study|Noncompliance|27|||
160723485|NCT01575834|580368270|FG000|Overall Study|Administrative decision|15|||
160723486|NCT01575834|580368271|FG001|Overall Study|Administrative decision|33|||
160723487|NCT01575834|580368270|FG000|Overall Study|Ineligibility Determined|5|||
160723488|NCT01575834|580368271|FG001|Overall Study|Ineligibility Determined|8|||
160723489|NCT01575834|580368270|FG000|Overall Study|Protocol Deviation|4|||
160723490|NCT01575834|580368271|FG001|Overall Study|Protocol Deviation|3|||
160723491|NCT01575834|580368270|FG000|Overall Study|Requirement for Alternative Therapy|2|||
160723492|NCT01575834|580368271|FG001|Overall Study|Requirement for Alternative Therapy|4|||
160723493|NCT02282813|580368274|FG000|Overall Study|Withdrawal by Subject|4|||
160723494|NCT02282813|580368275|FG001|Overall Study|Withdrawal by Subject|5|||
160723495|NCT02282813|580368276|FG002|Overall Study|Withdrawal by Subject|0|||
160723496|NCT02282813|580368274|FG000|Overall Study|Adverse Event|3|||
160723497|NCT02282813|580368275|FG001|Overall Study|Adverse Event|10|||
160723498|NCT02282813|580368276|FG002|Overall Study|Adverse Event|1|||
160723499|NCT02282813|580368274|FG000|Overall Study|Subject non-compliance|1|||
160723500|NCT02282813|580368275|FG001|Overall Study|Subject non-compliance|4|||
160723501|NCT02282813|580368276|FG002|Overall Study|Subject non-compliance|0|||
160723502|NCT02282813|580368274|FG000|Overall Study|Physician Decision|0|||
160723503|NCT02282813|580368275|FG001|Overall Study|Physician Decision|3|||
160723504|NCT02282813|580368276|FG002|Overall Study|Physician Decision|1|||
160723505|NCT02282813|580368274|FG000|Overall Study|Lost to Follow-up|2|||
160723506|NCT02282813|580368275|FG001|Overall Study|Lost to Follow-up|0|||
160723507|NCT02282813|580368276|FG002|Overall Study|Lost to Follow-up|1|||
160723508|NCT02282813|580368274|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
160723509|NCT02282813|580368275|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
160723510|NCT02282813|580368276|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
160723511|NCT02282813|580368274|FG000|Overall Study|Lack of Efficacy|1|||
160723512|NCT02282813|580368275|FG001|Overall Study|Lack of Efficacy|0|||
160723513|NCT02282813|580368276|FG002|Overall Study|Lack of Efficacy|0|||
160723514|NCT02282813|580368274|FG000|Overall Study|Administrative reasons|0|||
160723515|NCT02282813|580368275|FG001|Overall Study|Administrative reasons|1|||
160723516|NCT02282813|580368276|FG002|Overall Study|Administrative reasons|0|||
160723517|NCT06509438|580368277|FG000|Overall Study|Adverse Event|1|||
160723518|NCT06509438|580368277|FG000|Overall Study|Lost to Follow-up|3|||
160723519|NCT01753310|580368280|FG000|Overall Study|Entered into open label extension study|25|||
160723520|NCT01753310|580368281|FG001|Overall Study|Entered into open label extension study|22|||
160723521|NCT01753310|580368280|FG000|Overall Study|Adverse Event|1|||
160723522|NCT01753310|580368281|FG001|Overall Study|Adverse Event|0|||
160723523|NCT01753310|580368280|FG000|Overall Study|Lost to Follow-up|2|||
160723524|NCT01753310|580368281|FG001|Overall Study|Lost to Follow-up|0|||
160723525|NCT01753310|580368280|FG000|Overall Study|Subject decision|2|||
160723526|NCT01753310|580368281|FG001|Overall Study|Subject decision|2|||
160723527|NCT01753310|580368280|FG000|Overall Study|Sponsor decision|1|||
160723528|NCT01753310|580368281|FG001|Overall Study|Sponsor decision|0|||
160723529|NCT01753310|580368280|FG000|Overall Study|Withdrawal by Subject|1|||
160723530|NCT01753310|580368281|FG001|Overall Study|Withdrawal by Subject|0|||
160723531|NCT00488644|580368282|FG000|Overall Study|Not Eligible|1|||
160723532|NCT00488644|580368282|FG000|Overall Study|Not Evaluable|1|||
160723533|NCT02169271|580368283|FG000|Overall Study|Protocol Violation|1|||
160723534|NCT02169271|580368284|FG001|Overall Study|Protocol Violation|2|||
160723535|NCT03591874|580368285|FG000|Overall Study|Adverse Event|4|||
160723536|NCT03591874|580368286|FG001|Overall Study|Adverse Event|0|||
160723537|NCT03591874|580368285|FG000|Overall Study|Withdrawal by Subject|2|||
160723538|NCT03591874|580368286|FG001|Overall Study|Withdrawal by Subject|1|||
160723539|NCT03591874|580368285|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
160723540|NCT03591874|580368286|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
160723541|NCT03591874|580368285|FG000|Overall Study|On Study at Time of Study Termination|12|||
160723542|NCT03591874|580368286|FG001|Overall Study|On Study at Time of Study Termination|6|||
160723543|NCT03194542|580368289|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
160723544|NCT03194542|580368290|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
160723545|NCT03194542|580368291|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
160723546|NCT03194542|580368292|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
160723547|NCT03194542|580368289|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
160723548|NCT03194542|580368290|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
160723549|NCT03194542|580368291|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
160723550|NCT03194542|580368292|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
160723551|NCT03194542|580368289|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
160723552|NCT03194542|580368290|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
160723553|NCT03194542|580368291|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
160723554|NCT03194542|580368292|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
160723555|NCT03194542|580368289|FG000|Overall Study|Loss of Response|4|||
160723556|NCT03194542|580368290|FG001|Overall Study|Loss of Response|2|||
160723557|NCT03194542|580368291|FG002|Overall Study|Loss of Response|3|||
160723558|NCT03194542|580368292|FG003|Overall Study|Loss of Response|4|||
160723559|NCT03194542|580368289|FG000|Overall Study|Physician Decision|0|||
160723560|NCT03194542|580368290|FG001|Overall Study|Physician Decision|1|||
160723561|NCT03194542|580368291|FG002|Overall Study|Physician Decision|0|||
160723562|NCT03194542|580368292|FG003|Overall Study|Physician Decision|0|||
160723563|NCT03194542|580368289|FG000|Overall Study|Lack of Efficacy|2|||
160723564|NCT03194542|580368290|FG001|Overall Study|Lack of Efficacy|2|||
160723565|NCT03194542|580368291|FG002|Overall Study|Lack of Efficacy|2|||
160723566|NCT03194542|580368292|FG003|Overall Study|Lack of Efficacy|6|||
160723567|NCT03194542|580368289|FG000|Overall Study|Withdrawal by Subject|2|||
160723568|NCT03194542|580368290|FG001|Overall Study|Withdrawal by Subject|1|||
160723569|NCT03194542|580368291|FG002|Overall Study|Withdrawal by Subject|5|||
160723570|NCT03194542|580368292|FG003|Overall Study|Withdrawal by Subject|4|||
160723571|NCT03194542|580368289|FG000|Overall Study|Progressive Disease|1|||
160723572|NCT03194542|580368290|FG001|Overall Study|Progressive Disease|0|||
160723573|NCT03194542|580368291|FG002|Overall Study|Progressive Disease|1|||
160723574|NCT03194542|580368292|FG003|Overall Study|Progressive Disease|1|||
160723575|NCT03194542|580368289|FG000|Overall Study|Adverse Event|1|||
160723576|NCT03194542|580368290|FG001|Overall Study|Adverse Event|2|||
160723577|NCT03194542|580368291|FG002|Overall Study|Adverse Event|0|||
160723578|NCT03194542|580368292|FG003|Overall Study|Adverse Event|5|||
160723579|NCT03194542|580368289|FG000|Overall Study|Death|1|||
160723580|NCT03194542|580368290|FG001|Overall Study|Death|2|||
160723581|NCT03194542|580368291|FG002|Overall Study|Death|0|||
160723582|NCT03194542|580368292|FG003|Overall Study|Death|5|||
160723583|NCT03194542|580368289|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
160723584|NCT03194542|580368290|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
160723585|NCT03194542|580368291|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
160723586|NCT03194542|580368292|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
160723587|NCT03859427|580368296|FG000|Overall Study|Withdrawal by Subject|4|||
160723588|NCT03859427|580368297|FG001|Overall Study|Withdrawal by Subject|7|||
160723589|NCT03859427|580368296|FG000|Overall Study|Decision by sponsor|0|||
160723590|NCT03859427|580368297|FG001|Overall Study|Decision by sponsor|3|||
160723591|NCT03859427|580368296|FG000|Overall Study|Lost to Follow-up|3|||
160723592|NCT03859427|580368297|FG001|Overall Study|Lost to Follow-up|2|||
160723593|NCT03859427|580368296|FG000|Overall Study|Death|22|||
160723594|NCT03859427|580368297|FG001|Overall Study|Death|25|||
160723595|NCT02503540|580368298|FG000|Overall Study|Death|2|||
160723596|NCT02503540|580368298|FG000|Overall Study|Withdrawal by Subject|1|||
160723597|NCT00564850|580368299|FG000|Overall Study|Protocol Violation|2|||
160723598|NCT03830333|580368300|FG000|Overall Study|Death|0|||
160723599|NCT03830333|580368301|FG001|Overall Study|Death|1|||
160723600|NCT03830333|580368300|FG000|Overall Study|Withdrawal by Subject|5|||
160723601|NCT03830333|580368301|FG001|Overall Study|Withdrawal by Subject|1|||
160723602|NCT03830333|580368300|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
160723603|NCT03830333|580368301|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
160723604|NCT04390113|580368302|FG000|Overall Study|Not Treated|0|||
160723605|NCT04390113|580368303|FG001|Overall Study|Not Treated|1|||
160723606|NCT04390113|580368302|FG000|Overall Study|Adverse Event|1|||
160723607|NCT04390113|580368303|FG001|Overall Study|Adverse Event|0|||
160723608|NCT04390113|580368302|FG000|Overall Study|Death|2|||
160723609|NCT04390113|580368303|FG001|Overall Study|Death|1|||
160723610|NCT04390113|580368302|FG000|Overall Study|Physician Decision|1|||
160723611|NCT04390113|580368303|FG001|Overall Study|Physician Decision|3|||
160723612|NCT04390113|580368302|FG000|Overall Study|Study Terminated by Sponsor|5|||
160723613|NCT04390113|580368303|FG001|Overall Study|Study Terminated by Sponsor|3|||
160723614|NCT04390113|580368302|FG000|Overall Study|Withdrawal by Subject|10|||
160723615|NCT04390113|580368303|FG001|Overall Study|Withdrawal by Subject|5|||
160723616|NCT04390113|580368302|FG000|Overall Study|Other|1|||
160723617|NCT04390113|580368303|FG001|Overall Study|Other|0|||
160723618|NCT04390113|580368302|FG000|Overall Study|Missing|0|||
160723619|NCT04390113|580368303|FG001|Overall Study|Missing|1|||
160723620|NCT04031846|580368307|FG000|Overall Study|Lost to Follow-up|4|||
160723621|NCT04031846|580368308|FG001|Overall Study|Lost to Follow-up|4|||
160723622|NCT04031846|580368307|FG000|Overall Study|Physician Decision|0|||
160723623|NCT04031846|580368308|FG001|Overall Study|Physician Decision|1|||
160723624|NCT04031846|580368307|FG000|Overall Study|Protocol Violation|1|||
160723625|NCT04031846|580368308|FG001|Overall Study|Protocol Violation|1|||
160723626|NCT04031846|580368307|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
160723627|NCT04031846|580368308|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
160723628|NCT02431676|580368309|FG000|Overall Study|no lab obtained|0|||
160723629|NCT02431676|580368310|FG001|Overall Study|no lab obtained|1|||
160723630|NCT02431676|580368311|FG002|Overall Study|no lab obtained|2|||
160723631|NCT00571727|580368312|FG000|Overall Study|Did not enter in this study|1|||
160723632|NCT00571727|580368312|FG000|Overall Study|Non-compliance|4|||
160723633|NCT00571727|580368312|FG000|Overall Study|Lost to Follow-up|30|||
160723634|NCT00571727|580368312|FG000|Overall Study|Poor growth|1|||
160723635|NCT00571727|580368312|FG000|Overall Study|Parent/patient decision|2|||
160723636|NCT00571727|580368312|FG000|Overall Study|Participant transferred to commercial drug|14|||
160723637|NCT00571727|580368312|FG000|Overall Study|Unable to provide study drug|6|||
160723638|NCT00571727|580368312|FG000|Overall Study|On-treatment at end of study|8|||
160723639|NCT01622673|580368313|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160723640|NCT01622673|580368314|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160723641|NCT01622673|580368315|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160723642|NCT01622673|580368316|FG003|Treatment Period 1|Withdrawal by Subject|1|||
160723643|NCT01622673|580368317|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160723644|NCT01622673|580368318|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160723645|NCT01622673|580368313|FG000|Treatment Period 1|Protocol Violation|0|||
160723646|NCT01622673|580368314|FG001|Treatment Period 1|Protocol Violation|1|||
160723647|NCT01622673|580368315|FG002|Treatment Period 1|Protocol Violation|0|||
160723648|NCT01622673|580368316|FG003|Treatment Period 1|Protocol Violation|0|||
160723649|NCT01622673|580368317|FG004|Treatment Period 1|Protocol Violation|0|||
160723650|NCT01622673|580368318|FG005|Treatment Period 1|Protocol Violation|0|||
160723651|NCT01622673|580368313|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160723652|NCT01622673|580368314|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160723653|NCT01622673|580368315|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160723654|NCT01622673|580368316|FG003|Treatment Period 2|Withdrawal by Subject|1|||
160723655|NCT01622673|580368317|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160723656|NCT01622673|580368318|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160723657|NCT01622673|580368313|FG000|Treatment Period 3|Protocol Violation|0|||
160723658|NCT01622673|580368314|FG001|Treatment Period 3|Protocol Violation|1|||
160723659|NCT01622673|580368315|FG002|Treatment Period 3|Protocol Violation|0|||
160723660|NCT01622673|580368316|FG003|Treatment Period 3|Protocol Violation|0|||
160723661|NCT01622673|580368317|FG004|Treatment Period 3|Protocol Violation|0|||
160723662|NCT01622673|580368318|FG005|Treatment Period 3|Protocol Violation|0|||
160723663|NCT00154284|580370046|FG000|Overall Study|Adverse Event|6|||
160723664|NCT00154284|580370047|FG001|Overall Study|Adverse Event|9|||
160723665|NCT00154284|580370046|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160723666|NCT00154284|580370047|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160723667|NCT00154284|580370046|FG000|Overall Study|Lack of Efficacy|1|||
160723668|NCT00154284|580370047|FG001|Overall Study|Lack of Efficacy|2|||
160723669|NCT00154284|580370046|FG000|Overall Study|Protocol Violation|0|||
160723670|NCT00154284|580370047|FG001|Overall Study|Protocol Violation|1|||
160723671|NCT02395848|580370050|FG000|Overall Study|Lost to Follow-up|2|||
160723672|NCT02276560|580370051|FG000|Overall Study|Adverse Event|1|||
160723673|NCT02276560|580370052|FG001|Overall Study|Adverse Event|0|||
160723674|NCT02276560|580370053|FG002|Overall Study|Adverse Event|0|||
160723675|NCT02058537|580370054|FG000|Overall Study|Withdrawal by Subject|1|||
160723676|NCT02126579|580370055|FG000|Overall Study|disease progression|0|||
160723677|NCT02126579|580370056|FG001|Overall Study|disease progression|0|||
160723678|NCT02126579|580370057|FG002|Overall Study|disease progression|0|||
160723679|NCT02126579|580370058|FG003|Overall Study|disease progression|1|||
160723680|NCT02126579|580370059|FG004|Overall Study|disease progression|0|||
160723681|NCT02126579|580370060|FG005|Overall Study|disease progression|0|||
160723682|NCT02126579|580370061|FG006|Overall Study|disease progression|1|||
160723683|NCT01609010|580370066|FG000|Overall Study|Stable disease (SD)|22|||
160723684|NCT01609010|580370067|FG001|Overall Study|Stable disease (SD)|16|||
160723685|NCT01609010|580370066|FG000|Overall Study|Progressive disease (PD)|8|||
160723686|NCT01609010|580370067|FG001|Overall Study|Progressive disease (PD)|10|||
160723687|NCT01609010|580370066|FG000|Overall Study|Adverse Event|3|||
160723688|NCT01609010|580370067|FG001|Overall Study|Adverse Event|6|||
160723689|NCT01609010|580370066|FG000|Overall Study|Withdrawal by Subject|2|||
160723690|NCT01609010|580370067|FG001|Overall Study|Withdrawal by Subject|2|||
160723691|NCT01609010|580370066|FG000|Overall Study|Other|2|||
160723692|NCT01609010|580370067|FG001|Overall Study|Other|0|||
160723693|NCT01609010|580370066|FG000|Overall Study|Other malignancy|1|||
160723694|NCT01609010|580370067|FG001|Overall Study|Other malignancy|0|||
160723695|NCT01609010|580370066|FG000|Overall Study|Pathology review|2|||
160723696|NCT01609010|580370067|FG001|Overall Study|Pathology review|1|||
160723697|NCT01609010|580370066|FG000|Overall Study|Protocol Violation|1|||
160723698|NCT01609010|580370067|FG001|Overall Study|Protocol Violation|1|||
160723699|NCT01609010|580370066|FG000|Overall Study|New cancer|1|||
160723700|NCT01609010|580370067|FG001|Overall Study|New cancer|0|||
160723701|NCT01609010|580370066|FG000|Overall Study|Lost to Follow-up|1|||
160723702|NCT01609010|580370067|FG001|Overall Study|Lost to Follow-up|1|||
160723703|NCT01134107|580370068|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
160723704|NCT01134107|580370069|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
160723705|NCT01134107|580370068|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
160723706|NCT01134107|580370069|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
160723707|NCT01134107|580370068|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
160723708|NCT01134107|580370069|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
160723709|NCT01134107|580370068|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
160723710|NCT01134107|580370069|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
160723711|NCT01134107|580370068|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
160723712|NCT01134107|580370069|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
160723713|NCT01134107|580370068|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
160723714|NCT01134107|580370069|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
160723715|NCT01134107|580370068|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
160723716|NCT01134107|580370069|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
160723717|NCT03581123|580370075|FG000|2-month Follow-up|Withdrawal by Subject|5|||
160723718|NCT03581123|580370076|FG001|2-month Follow-up|Withdrawal by Subject|4|||
160723719|NCT03581123|580370077|FG002|2-month Follow-up|Withdrawal by Subject|6|||
160723720|NCT03581123|580370078|FG003|2-month Follow-up|Withdrawal by Subject|4|||
160723721|NCT03581123|580370075|FG000|2-month Follow-up|Lost to Follow-up|8|||
160723722|NCT03581123|580370076|FG001|2-month Follow-up|Lost to Follow-up|1|||
160723723|NCT03581123|580370077|FG002|2-month Follow-up|Lost to Follow-up|2|||
160723724|NCT03581123|580370078|FG003|2-month Follow-up|Lost to Follow-up|2|||
160723725|NCT03581123|580370075|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
160723726|NCT03581123|580370076|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
160723727|NCT03581123|580370077|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
160723728|NCT03581123|580370078|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
160723729|NCT03581123|580370075|FG000|6-Month Follow-up|Lost to Follow-up|3|||
160723730|NCT03581123|580370076|FG001|6-Month Follow-up|Lost to Follow-up|3|||
160723731|NCT03581123|580370077|FG002|6-Month Follow-up|Lost to Follow-up|1|||
160723732|NCT03581123|580370078|FG003|6-Month Follow-up|Lost to Follow-up|1|||
160723733|NCT03581123|580370075|FG000|12-Month Follow-up|Lost to Follow-up|4|||
160723734|NCT03581123|580370076|FG001|12-Month Follow-up|Lost to Follow-up|3|||
160723735|NCT03581123|580370077|FG002|12-Month Follow-up|Lost to Follow-up|4|||
160723736|NCT03581123|580370078|FG003|12-Month Follow-up|Lost to Follow-up|5|||
160723737|NCT04195685|580370079|FG000|Overall Study|Withdrawal by Subject|6|||
160723738|NCT04195685|580370080|FG001|Overall Study|Withdrawal by Subject|2|||
160723739|NCT04195685|580370079|FG000|Overall Study|Lost to Follow-up|1|||
160723740|NCT04195685|580370080|FG001|Overall Study|Lost to Follow-up|4|||
160723741|NCT04509076|580370082|FG000|Overall Study|Withdrawal by Subject|1|||
160723742|NCT04509076|580370083|FG001|Overall Study|Withdrawal by Subject|2|||
160723743|NCT04509076|580370082|FG000|Overall Study|Lost to Follow-up|1|||
160723744|NCT04509076|580370083|FG001|Overall Study|Lost to Follow-up|2|||
160723745|NCT03351608|580370084|FG000|Overall Study|Lost to Follow-up|0|||
160723746|NCT03351608|580370085|FG001|Overall Study|Lost to Follow-up|1|||
160723747|NCT03351608|580370086|FG002|Overall Study|Lost to Follow-up|1|||
160723748|NCT03351608|580370087|FG003|Overall Study|Lost to Follow-up|1|||
160723749|NCT03351608|580370088|FG004|Overall Study|Lost to Follow-up|1|||
160723750|NCT03351608|580370084|FG000|Overall Study|Physician Decision|1|||
160723751|NCT03351608|580370085|FG001|Overall Study|Physician Decision|0|||
160723752|NCT03351608|580370086|FG002|Overall Study|Physician Decision|0|||
160723753|NCT03351608|580370087|FG003|Overall Study|Physician Decision|2|||
160723754|NCT03351608|580370088|FG004|Overall Study|Physician Decision|1|||
160723755|NCT03351608|580370084|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
160723756|NCT03351608|580370085|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
160723757|NCT03351608|580370086|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
160723758|NCT03351608|580370087|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
160723759|NCT03351608|580370088|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
160723760|NCT03351608|580370084|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160723761|NCT03351608|580370085|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160723762|NCT03351608|580370086|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160723763|NCT03351608|580370087|FG003|Overall Study|Withdrawal by parent/guardian|1|||
160723764|NCT03351608|580370088|FG004|Overall Study|Withdrawal by parent/guardian|0|||
160723765|NCT03351608|580370084|FG000|Overall Study|Other|0|||
160723766|NCT03351608|580370085|FG001|Overall Study|Other|1|||
160723767|NCT03351608|580370086|FG002|Overall Study|Other|1|||
160723768|NCT03351608|580370087|FG003|Overall Study|Other|3|||
160723769|NCT03351608|580370088|FG004|Overall Study|Other|0|||
160723770|NCT02877004|580370089|FG000|Overall Study|Pregnancy|0|||
160723771|NCT02877004|580370090|FG001|Overall Study|Pregnancy|0|||
160723772|NCT02877004|580370091|FG002|Overall Study|Pregnancy|1|||
160723773|NCT02727478|580370092|FG000|Overall Study|Withdrawal by Subject|8|||
160723774|NCT02727478|580370093|FG001|Overall Study|Withdrawal by Subject|10|||
160723775|NCT02633293|580370094|FG000|Overall Study|Death|56|||
160723776|NCT02633293|580370094|FG000|Overall Study|Progressive Disease|12|||
160723777|NCT02633293|580370094|FG000|Overall Study|Adverse Event|29|||
160723778|NCT02633293|580370094|FG000|Overall Study|Withdrawal by Subject|41|||
160723779|NCT02633293|580370094|FG000|Overall Study|Protocol Violation|1|||
160723780|NCT02633293|580370094|FG000|Overall Study|Lost to Follow-up|1|||
160723781|NCT02633293|580370094|FG000|Overall Study|Study Terminated by Sponsor|24|||
160723782|NCT02633293|580370094|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
160723783|NCT02633293|580370094|FG000|Overall Study|Lung Transplant|5|||
160723784|NCT02633293|580370094|FG000|Overall Study|Lack of Efficacy|2|||
160723785|NCT02633293|580370094|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
160723786|NCT01343043|580370095|FG000|Overall Study|Disease progression before treatment|1|||
160723787|NCT01343043|580370096|FG001|Overall Study|Disease progression before treatment|0|||
160723788|NCT01343043|580370097|FG002|Overall Study|Disease progression before treatment|0|||
160723789|NCT01343043|580370098|FG003|Overall Study|Disease progression before treatment|0|||
160723790|NCT01343043|580370095|FG000|Overall Study|Withdrawal by Subject|1|||
160723791|NCT01343043|580370096|FG001|Overall Study|Withdrawal by Subject|0|||
160723792|NCT01343043|580370097|FG002|Overall Study|Withdrawal by Subject|0|||
160723793|NCT01343043|580370098|FG003|Overall Study|Withdrawal by Subject|0|||
160723794|NCT01343043|580370095|FG000|Overall Study|Death|1|||
160723795|NCT01343043|580370096|FG001|Overall Study|Death|1|||
160723796|NCT01343043|580370097|FG002|Overall Study|Death|0|||
160723797|NCT01343043|580370098|FG003|Overall Study|Death|1|||
160723798|NCT00502242|580370101|FG000|Overall Study|Lack of Efficacy|1|||
160723799|NCT00502242|580370102|FG001|Overall Study|Lack of Efficacy|11|||
160723800|NCT00502242|580370101|FG000|Overall Study|Adverse Event|31|||
160723801|NCT00502242|580370102|FG001|Overall Study|Adverse Event|20|||
160723802|NCT00502242|580370101|FG000|Overall Study|Physician Decision|2|||
160723803|NCT00502242|580370102|FG001|Overall Study|Physician Decision|3|||
160723804|NCT00502242|580370101|FG000|Overall Study|Other - Unspecified|8|||
160723805|NCT00502242|580370102|FG001|Overall Study|Other - Unspecified|14|||
160723806|NCT00502242|580370101|FG000|Overall Study|Protocol Violation|3|||
160723807|NCT00502242|580370102|FG001|Overall Study|Protocol Violation|1|||
160723808|NCT00502242|580370101|FG000|Overall Study|Withdrawal by Subject|6|||
160723809|NCT00502242|580370102|FG001|Overall Study|Withdrawal by Subject|7|||
160723810|NCT02356588|580370103|FG000|Overall Study|Lack of Efficacy|4|||
160723811|NCT02356588|580370104|FG001|Overall Study|Lack of Efficacy|10|||
160723812|NCT02356588|580370103|FG000|Overall Study|Adverse Event|0|||
160723813|NCT02356588|580370104|FG001|Overall Study|Adverse Event|2|||
160723814|NCT02356588|580370103|FG000|Overall Study|Withdrawal by Subject|1|||
160723815|NCT02356588|580370104|FG001|Overall Study|Withdrawal by Subject|0|||
160723816|NCT02356588|580370103|FG000|Overall Study|Protocol Violation|0|||
160723817|NCT02356588|580370104|FG001|Overall Study|Protocol Violation|1|||
160723818|NCT01418378|580370105|FG000|Overall Study|Death|1|||
160723819|NCT01418378|580370106|FG001|Overall Study|Death|2|||
160723820|NCT01418378|580370105|FG000|Overall Study|Physician Decision|0|||
160723821|NCT01418378|580370106|FG001|Overall Study|Physician Decision|1|||
160723822|NCT01418378|580370105|FG000|Overall Study|ligament imbalance|0|||
160723823|NCT01418378|580370106|FG001|Overall Study|ligament imbalance|1|||
160723824|NCT01418378|580370105|FG000|Overall Study|developed chronic myopathy|0|||
160723825|NCT01418378|580370106|FG001|Overall Study|developed chronic myopathy|1|||
160723826|NCT01812109|580370109|FG000|Overall Study|research personnel delay|16|||
160723827|NCT01812109|580370109|FG000|Overall Study|NIRS Unattainable|17|||
160723828|NCT04630002|580370110|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
160723829|NCT04630002|580370111|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
160723830|NCT04630002|580370112|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
160723831|NCT04630002|580370110|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
160723832|NCT04630002|580370111|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
160723833|NCT04630002|580370112|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
160723834|NCT04630002|580370110|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
160723835|NCT04630002|580370111|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
160723836|NCT04630002|580370112|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
160723837|NCT04630002|580370110|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
160723838|NCT04630002|580370111|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
160723839|NCT04630002|580370112|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
160723840|NCT04630002|580370110|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
160723841|NCT04630002|580370111|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
160723842|NCT04630002|580370112|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
160723843|NCT04630002|580370110|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
160723844|NCT04630002|580370111|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
160723845|NCT04630002|580370112|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
160723846|NCT04630002|580370110|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
160723847|NCT04630002|580370111|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
160723848|NCT04630002|580370112|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
160723849|NCT04630002|580370110|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
160723850|NCT04630002|580370111|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
160723851|NCT04630002|580370112|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
160723852|NCT02182843|580370113|FG000|Overall Study|Withdrawal by Subject|7|||
160723853|NCT02182843|580370113|FG000|Overall Study|Lost to Follow-up|2|||
160723854|NCT02182843|580370113|FG000|Overall Study|Adverse Event|1|||
160723855|NCT01372618|580370127|FG000|Overall Study|PI Died. Study Terminated|9|||
160723856|NCT03448419|580370128|FG000|Overall Study|Adverse Event|10|||
160723857|NCT03448419|580370129|FG001|Overall Study|Adverse Event|9|||
160723858|NCT03448419|580370128|FG000|Overall Study|Lost to Follow-up|0|||
160723859|NCT03448419|580370129|FG001|Overall Study|Lost to Follow-up|2|||
160723860|NCT03448419|580370128|FG000|Overall Study|Withdrawal by Subject|3|||
160723861|NCT03448419|580370129|FG001|Overall Study|Withdrawal by Subject|1|||
160723862|NCT03448419|580370128|FG000|Overall Study|Not treated|0|||
160723863|NCT03448419|580370129|FG001|Overall Study|Not treated|1|||
160723864|NCT03448419|580370128|FG000|Overall Study|Patient did not attend all visits|0|||
160723865|NCT03448419|580370129|FG001|Overall Study|Patient did not attend all visits|2|||
160723866|NCT03448419|580370128|FG000|Overall Study|Withdrawn by Sponsor|0|||
160723867|NCT03448419|580370129|FG001|Overall Study|Withdrawn by Sponsor|1|||
160723868|NCT00979654|580370148|FG000|Overall Study|Lost to Follow-up|1|||
160723869|NCT00979654|580370148|FG000|Overall Study|Withdrawal by Subject|22|||
160723870|NCT00979654|580370148|FG000|Overall Study|Death|1|||
160723871|NCT00979654|580370148|FG000|Overall Study|Lack of Efficacy|6|||
160723872|NCT00979654|580370148|FG000|Overall Study|Adverse Event|1|||
160723873|NCT00979654|580370148|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
160723874|NCT00979654|580370148|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
160723875|NCT00979654|580370148|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
160723876|NCT00979654|580370148|FG000|Overall Study|Serious Adverse Event|1|||
160723877|NCT00979654|580370148|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
160723878|NCT01804946|580370151|FG000|Overall Study|Protocol Violation|1|||
160723879|NCT01804946|580370152|FG001|Overall Study|Protocol Violation|0|||
160723880|NCT01804946|580370151|FG000|Overall Study|Adverse Event|0|||
160723881|NCT01804946|580370152|FG001|Overall Study|Adverse Event|1|||
160723882|NCT01804946|580370151|FG000|Overall Study|Insufficient data available|0|||
160723883|NCT01804946|580370152|FG001|Overall Study|Insufficient data available|1|||
160723884|NCT01804946|580370151|FG000|Overall Study|Do not meet inclusion criteria|1|||
160723885|NCT01804946|580370152|FG001|Overall Study|Do not meet inclusion criteria|2|||
160723886|NCT01129557|580370155|FG000|Overall Study|Adverse Event|1|||
160723887|NCT01129557|580370156|FG001|Overall Study|Adverse Event|2|||
160723888|NCT01129557|580370157|FG002|Overall Study|Adverse Event|2|||
160723889|NCT01129557|580370155|FG000|Overall Study|Novartis terminated study early|3|||
160723890|NCT01129557|580370156|FG001|Overall Study|Novartis terminated study early|3|||
160723891|NCT01129557|580370157|FG002|Overall Study|Novartis terminated study early|2|||
160723892|NCT01486446|580370158|FG000|Overall Study|Adverse Event|1|||
160723893|NCT01486446|580370159|FG001|Overall Study|Adverse Event|0|||
160723894|NCT01445730|580370160|FG000|Overall Study|Adverse Event|1|||
160723895|NCT01445730|580370160|FG000|Overall Study|For the advice of a dentist|1|||
160723896|NCT01445730|580370160|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
160723897|NCT01367886|580370165|FG000|Overall Study|Lost to Follow-up|4|||
160723898|NCT01367886|580370165|FG000|Overall Study|Lack of Efficacy|2|||
160723899|NCT01367886|580370165|FG000|Overall Study|Death|1|||
160723900|NCT00985504|580370170|FG000|Acute Treatment Period|Adverse Event|3|||
160723901|NCT00985504|580370171|FG001|Acute Treatment Period|Adverse Event|4|||
160723902|NCT00985504|580370170|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
160723903|NCT00985504|580370171|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
160723904|NCT00985504|580370170|FG000|Acute Treatment Period|Protocol Violation|2|||
160723905|NCT00985504|580370171|FG001|Acute Treatment Period|Protocol Violation|0|||
160723906|NCT00985504|580370170|FG000|Acute Treatment Period|Sponsor Decision|0|||
160723907|NCT00985504|580370171|FG001|Acute Treatment Period|Sponsor Decision|1|||
160723908|NCT00985504|580370170|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
160723909|NCT00985504|580370171|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
160723910|NCT00985504|580370170|FG000|Optimization Period|Adverse Event|7|||
160723911|NCT00985504|580370171|FG001|Optimization Period|Adverse Event|9|||
160723912|NCT00985504|580370170|FG000|Optimization Period|Death|0|||
160723913|NCT00985504|580370171|FG001|Optimization Period|Death|1|||
160723914|NCT00985504|580370170|FG000|Optimization Period|Lack of Efficacy|5|||
160723915|NCT00985504|580370171|FG001|Optimization Period|Lack of Efficacy|3|||
160723916|NCT00985504|580370170|FG000|Optimization Period|Lost to Follow-up|0|||
160723917|NCT00985504|580370171|FG001|Optimization Period|Lost to Follow-up|1|||
160723918|NCT00985504|580370170|FG000|Optimization Period|Physician Decision|1|||
160723919|NCT00985504|580370171|FG001|Optimization Period|Physician Decision|0|||
160723920|NCT00985504|580370170|FG000|Optimization Period|Protocol Violation|3|||
160723921|NCT00985504|580370171|FG001|Optimization Period|Protocol Violation|1|||
160723922|NCT00985504|580370170|FG000|Optimization Period|Withdrawal by Subject|10|||
160723923|NCT00985504|580370171|FG001|Optimization Period|Withdrawal by Subject|8|||
160723924|NCT01167140|580370172|FG000|Overall Study|Withdrawal by Subject|1|||
160723925|NCT03805412|580370175|FG000|Overall Study|Lost to Follow-up|0|||
160723926|NCT03805412|580370176|FG001|Overall Study|Lost to Follow-up|1|||
160723927|NCT01611883|580370178|FG000|Overall Study|Adverse Event|1|||
160723928|NCT01611883|580370179|FG001|Overall Study|Adverse Event|1|||
160723929|NCT03379727|580370180|FG000|Overall Study|Lack of Efficacy|73|||
160723930|NCT03379727|580370180|FG000|Overall Study|Adverse Event|32|||
160723931|NCT03379727|580370180|FG000|Overall Study|Death|18|||
160723932|NCT03379727|580370180|FG000|Overall Study|Patient/guardian decision|17|||
160723933|NCT03379727|580370180|FG000|Overall Study|Physician Decision|104|||
160723934|NCT03379727|580370180|FG000|Overall Study|Protocol Violation|4|||
160723935|NCT03379727|580370180|FG000|Overall Study|Lost to Follow-up|1|||
160723936|NCT00030901|580370181|FG000|Initial Registration|Ineligible|167|||
160723937|NCT00030901|580370182|FG001|Initial Registration|Ineligible|0|||
160723938|NCT00030901|580370183|FG002|Initial Registration|Ineligible|0|||
160723939|NCT00030901|580370181|FG000|Randomization|Adverse Event|0|||
160723940|NCT00030901|580370182|FG001|Randomization|Adverse Event|11|||
160723941|NCT00030901|580370183|FG002|Randomization|Adverse Event|7|||
160723942|NCT00030901|580370181|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
160723943|NCT00030901|580370182|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
160723944|NCT00030901|580370183|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
160723945|NCT00030901|580370181|FG000|Randomization|Progression/Relapse|0|||
160723946|NCT00030901|580370182|FG001|Randomization|Progression/Relapse|22|||
160723947|NCT00030901|580370183|FG002|Randomization|Progression/Relapse|21|||
160723948|NCT00030901|580370181|FG000|Randomization|Death|0|||
160723949|NCT00030901|580370182|FG001|Randomization|Death|1|||
160723950|NCT00030901|580370183|FG002|Randomization|Death|3|||
160723951|NCT00030901|580370181|FG000|Randomization|Other|0|||
160723952|NCT00030901|580370182|FG001|Randomization|Other|36|||
160723953|NCT00030901|580370183|FG002|Randomization|Other|33|||
160723954|NCT00030901|580370181|FG000|Randomization|Ineligible|0|||
160723955|NCT00030901|580370182|FG001|Randomization|Ineligible|15|||
160723956|NCT00030901|580370183|FG002|Randomization|Ineligible|14|||
160723957|NCT01806051|580370186|FG000|Overall Study|Withdrawal by Subject|6|||
160723958|NCT02576847|580370187|FG000|Overall Study|Adverse Event|27|||
160723959|NCT02576847|580370187|FG000|Overall Study|Lost to Follow-up|22|||
160723960|NCT02576847|580370187|FG000|Overall Study|Physician Decision|1|||
160723961|NCT02576847|580370187|FG000|Overall Study|Pregnancy|1|||
160723962|NCT02576847|580370187|FG000|Overall Study|Protocol Violation|3|||
160723963|NCT02576847|580370187|FG000|Overall Study|Withdrawal by Subject|78|||
160723964|NCT02576847|580370187|FG000|Overall Study|Other|5|||
160723965|NCT01205776|580370190|FG000|Overall Study|Lost to Follow-up|53|||
160723966|NCT01205776|580370191|FG001|Overall Study|Lost to Follow-up|61|||
160723967|NCT01205776|580370190|FG000|Overall Study|Withdrawal by Subject|11|||
160723968|NCT01205776|580370191|FG001|Overall Study|Withdrawal by Subject|34|||
160723969|NCT02418182|580370192|FG000|Overall Study|Unable to re-consent|18|||
160723970|NCT02418182|580370193|FG001|Overall Study|Unable to re-consent|15|||
160723971|NCT02418182|580370192|FG000|Overall Study|Lost to Follow-up|0|||
160723972|NCT02418182|580370193|FG001|Overall Study|Lost to Follow-up|2|||
160723973|NCT00734994|580370194|FG000|Overall Study|Withdrawal by Subject|1|||
160723988|NCT06360588|580372167|FG000|Overall Study|Adverse Event|3|||
160723989|NCT06360588|580372167|FG000|Overall Study|Death|2|||
160723990|NCT06360588|580372167|FG000|Overall Study|Disease Progression|14|||
160723991|NCT06360588|580372167|FG000|Overall Study|Withdrawal by Subject|1|||
160723992|NCT06360588|580372167|FG000|Overall Study|Lack of Efficacy|1|||
160723993|NCT06360588|580372167|FG000|Overall Study|Ineligible|1|||
160723994|NCT00326716|580372169|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
160723995|NCT00326716|580372170|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
160723996|NCT00326716|580372171|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
160723997|NCT00326716|580372172|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
160723998|NCT00684411|580372173|FG000|Overall Study|New Primary Cancer|1|||
160723999|NCT00684411|580372173|FG000|Overall Study|Disease Progression|10|||
160724000|NCT00684411|580372173|FG000|Overall Study|Adverse Event|1|||
160724001|NCT00734162|580372174|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
160724002|NCT00734162|580372175|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
160724003|NCT00734162|580372176|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
160724004|NCT00734162|580372177|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
160724005|NCT00734162|580372174|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
160724006|NCT00734162|580372175|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
160724007|NCT00734162|580372176|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
160724008|NCT00734162|580372177|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
160724009|NCT00734162|580372174|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
160724010|NCT00734162|580372175|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
160724011|NCT00734162|580372176|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
160724012|NCT00734162|580372177|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
160724013|NCT00734162|580372174|FG000|Open-Label Phase|Withdrew Consent|1|||
160724014|NCT00734162|580372175|FG001|Open-Label Phase|Withdrew Consent|0|||
160724015|NCT00734162|580372176|FG002|Open-Label Phase|Withdrew Consent|1|||
160724016|NCT00734162|580372177|FG003|Open-Label Phase|Withdrew Consent|1|||
160724017|NCT00734162|580372174|FG000|Open-Label Phase|Lost to Follow-up|1|||
160724018|NCT00734162|580372175|FG001|Open-Label Phase|Lost to Follow-up|2|||
160724019|NCT00734162|580372176|FG002|Open-Label Phase|Lost to Follow-up|0|||
160724020|NCT00734162|580372177|FG003|Open-Label Phase|Lost to Follow-up|1|||
160724021|NCT00734162|580372174|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
160724022|NCT00734162|580372175|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
160724023|NCT00734162|580372176|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
160724024|NCT00734162|580372177|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
160724025|NCT05253573|580372178|FG000|Overall Study|Death|1|||
160724026|NCT05253573|580372179|FG001|Overall Study|Death|0|||
160724027|NCT01344824|580372180|FG000|Overall Study|Adverse Event|15|||
160724028|NCT01344824|580372180|FG000|Overall Study|Withdrawal by Subject|6|||
160724029|NCT01344824|580372180|FG000|Overall Study|Other complicating disease|1|||
160724030|NCT01344824|580372180|FG000|Overall Study|Progression|15|||
160724031|NCT00566020|580372181|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
160724032|NCT00566020|580372182|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
160724033|NCT00566020|580372181|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
160724034|NCT00566020|580372182|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
160724035|NCT00566020|580372181|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
160724036|NCT00566020|580372182|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
160724037|NCT00566020|580372181|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
160724038|NCT00566020|580372182|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
160724039|NCT00566020|580372181|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
160724040|NCT00566020|580372182|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
160724041|NCT00566020|580372181|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
160724042|NCT00566020|580372182|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
160724043|NCT01754129|580372183|FG000|Overall Study|Death|13|||
160724044|NCT01754129|580372183|FG000|Overall Study|Duodopa discontinuation|9|||
160724045|NCT01754129|580372183|FG000|Overall Study|Lost to Follow-up|7|||
160724046|NCT01754129|580372183|FG000|Overall Study|Withdrew consent|1|||
160724047|NCT01754129|580372183|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
160724048|NCT01085630|580372184|FG000|Overall Study|Insufficient data|1|||
160724049|NCT01085630|580372185|FG001|Overall Study|Insufficient data|0|||
160724050|NCT01085630|580372184|FG000|Overall Study|Ineligible|3|||
160724051|NCT01085630|580372185|FG001|Overall Study|Ineligible|0|||
160724052|NCT02366637|580372191|FG000|First Intervention Period|Adverse Event|0|||
160724053|NCT02366637|580372192|FG001|First Intervention Period|Adverse Event|1|||
160724054|NCT02366637|580372191|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
160724055|NCT02366637|580372192|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
160724056|NCT02366637|580372191|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
160724057|NCT02366637|580372192|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
160724058|NCT02609607|580372198|FG000|Overall Study|Lost to Follow-up|0|||
160724059|NCT02609607|580372199|FG001|Overall Study|Lost to Follow-up|1|||
160724060|NCT03691207|580372200|FG000|Overall Study|Death|41|||
160724061|NCT03691207|580372201|FG001|Overall Study|Death|26|||
160724062|NCT03691207|580372200|FG000|Overall Study|Lost to Follow-up|1|||
160724063|NCT03691207|580372201|FG001|Overall Study|Lost to Follow-up|1|||
160724064|NCT03691207|580372200|FG000|Overall Study|Withdrawal by Subject|2|||
160724065|NCT03691207|580372201|FG001|Overall Study|Withdrawal by Subject|8|||
160724066|NCT03691207|580372200|FG000|Overall Study|Sponsor decision|1|||
160724067|NCT03691207|580372201|FG001|Overall Study|Sponsor decision|7|||
160724068|NCT00651261|580372202|FG000|Overall Study|Adverse Event|32|||
160724069|NCT00651261|580372203|FG001|Overall Study|Adverse Event|22|||
160724070|NCT00651261|580372202|FG000|Overall Study|Death|18|||
160724071|NCT00651261|580372203|FG001|Overall Study|Death|18|||
160724072|NCT00651261|580372202|FG000|Overall Study|Withdrawal by Subject|22|||
160724073|NCT00651261|580372203|FG001|Overall Study|Withdrawal by Subject|40|||
160724074|NCT00651261|580372202|FG000|Overall Study|Induction failure|24|||
160724075|NCT00651261|580372203|FG001|Overall Study|Induction failure|35|||
160724076|NCT00651261|580372202|FG000|Overall Study|Disease progression|58|||
160724077|NCT00651261|580372203|FG001|Overall Study|Disease progression|58|||
160724078|NCT00651261|580372202|FG000|Overall Study|Alternative therapy|109|||
160724079|NCT00651261|580372203|FG001|Overall Study|Alternative therapy|107|||
160724080|NCT00651261|580372202|FG000|Overall Study|Other disease or participant decisions|23|||
160724081|NCT00651261|580372203|FG001|Overall Study|Other disease or participant decisions|23|||
160724082|NCT00651261|580372202|FG000|Overall Study|Never treated|5|||
160724083|NCT00651261|580372203|FG001|Overall Study|Never treated|3|||
160724084|NCT02027545|580372204|FG000|Overall Study|Failed to sign HIPAA|0|||
160724085|NCT02027545|580372205|FG001|Overall Study|Failed to sign HIPAA|2|||
160724086|NCT02027545|580372204|FG000|Overall Study|Failed to attend study visit|2|||
160724087|NCT02027545|580372205|FG001|Overall Study|Failed to attend study visit|0|||
160724088|NCT02027545|580372204|FG000|Overall Study|Protocol Violation|1|||
160724089|NCT02027545|580372205|FG001|Overall Study|Protocol Violation|0|||
160724090|NCT04541589|580372206|FG000|Treatment Period|Adverse Event|8|||
160724091|NCT04541589|580372207|FG001|Treatment Period|Adverse Event|2|||
160724092|NCT04541589|580372206|FG000|Treatment Period|Physician Decision|3|||
160724093|NCT04541589|580372207|FG001|Treatment Period|Physician Decision|1|||
160724094|NCT04541589|580372206|FG000|Treatment Period|Subject decision|7|||
160724095|NCT04541589|580372207|FG001|Treatment Period|Subject decision|4|||
160724096|NCT04541589|580372206|FG000|Treatment Period|Withdrawal by Subject|1|||
160724097|NCT04541589|580372207|FG001|Treatment Period|Withdrawal by Subject|0|||
160724098|NCT04541589|580372206|FG000|Safety Follow-up Period|Adverse Event|2|||
160724099|NCT04541589|580372207|FG001|Safety Follow-up Period|Adverse Event|1|||
160724100|NCT04541589|580372206|FG000|Safety Follow-up Period|Physician Decision|1|||
160724101|NCT04541589|580372207|FG001|Safety Follow-up Period|Physician Decision|0|||
160724102|NCT04541589|580372206|FG000|Safety Follow-up Period|Subject decision|5|||
160724103|NCT04541589|580372207|FG001|Safety Follow-up Period|Subject decision|3|||
160724104|NCT04541589|580372206|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
160724105|NCT04541589|580372207|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
160724106|NCT01790984|580372215|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
160724107|NCT01790984|580372216|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
160724108|NCT01790984|580372217|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
160724109|NCT01790984|580372218|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
160724110|NCT01346696|580372221|FG000|Overall Study|Death|1|||
160724111|NCT01051791|580372225|FG000|Overall Study|Failed screening|3|||
160724112|NCT01051791|580372225|FG000|Overall Study|Withdrawal by Subject|1|||
160724113|NCT00288626|580372226|FG000|Overall Study|Death|3|||
160724114|NCT00288626|580372226|FG000|Overall Study|Withdrawal by Subject|4|||
160724115|NCT04610346|580372227|FG000|Overall Study|Withdrawal by Subject|1|||
160724116|NCT04610346|580372228|FG001|Overall Study|Withdrawal by Subject|1|||
160724117|NCT04610346|580372227|FG000|Overall Study|did not complete shelter onboarding|2|||
160724118|NCT04610346|580372228|FG001|Overall Study|did not complete shelter onboarding|1|||
160724119|NCT00558467|580372229|FG000|Overall Study|Adverse Event|1|||
160724120|NCT00558467|580372230|FG001|Overall Study|Adverse Event|2|||
160724121|NCT00558467|580372229|FG000|Overall Study|Lack of Efficacy|0|||
160724122|NCT00558467|580372230|FG001|Overall Study|Lack of Efficacy|1|||
160724123|NCT00558467|580372229|FG000|Overall Study|Patient moving out of state|0|||
160724124|NCT00558467|580372230|FG001|Overall Study|Patient moving out of state|1|||
160724125|NCT00931255|580372231|FG000|Overall Study|Follow up biopsy not done|2|||
160724126|NCT00931255|580372232|FG001|Overall Study|Follow up biopsy not done|3|||
160724127|NCT02019264|580372233|FG000|Overall Study|Not treated|6|||
160724128|NCT02019264|580372234|FG001|Overall Study|Not treated|4|||
160724129|NCT02019264|580372233|FG000|Overall Study|Lost to Follow-up|50|||
160724130|NCT02019264|580372234|FG001|Overall Study|Lost to Follow-up|47|||
160724131|NCT02019264|580372233|FG000|Overall Study|Withdrawal by Subject|142|||
160724132|NCT02019264|580372234|FG001|Overall Study|Withdrawal by Subject|117|||
160724133|NCT02019264|580372233|FG000|Overall Study|Administrative reason|36|||
160724134|NCT02019264|580372234|FG001|Overall Study|Administrative reason|28|||
160724135|NCT02019264|580372233|FG000|Overall Study|Missing|14|||
160724136|NCT02019264|580372234|FG001|Overall Study|Missing|11|||
160724137|NCT01163851|580372241|FG000|Overall Study|Site Closure|0|||
160724138|NCT01163851|580372242|FG001|Overall Study|Site Closure|1|||
160724139|NCT01163851|580372241|FG000|Overall Study|Enrolled but not treated|1|||
160724140|NCT01163851|580372242|FG001|Overall Study|Enrolled but not treated|0|||
160724141|NCT00789373|580372246|FG000|Induction|Adverse Event|64|||
160724142|NCT00789373|580372247|FG001|Induction|Adverse Event|0|||
160724143|NCT00789373|580372248|FG002|Induction|Adverse Event|0|||
160724144|NCT00789373|580372246|FG000|Induction|Death Due to study disease|24|||
160724145|NCT00789373|580372247|FG001|Induction|Death Due to study disease|0|||
160724146|NCT00789373|580372248|FG002|Induction|Death Due to study disease|0|||
160724147|NCT00789373|580372246|FG000|Induction|Death due to adverse event|19|||
160724148|NCT00789373|580372247|FG001|Induction|Death due to adverse event|0|||
160724149|NCT00789373|580372248|FG002|Induction|Death due to adverse event|0|||
160724150|NCT00789373|580372246|FG000|Induction|Death due to toxicity|11|||
160724151|NCT00789373|580372247|FG001|Induction|Death due to toxicity|0|||
160724152|NCT00789373|580372248|FG002|Induction|Death due to toxicity|0|||
160724153|NCT00789373|580372246|FG000|Induction|Death due to procedure|1|||
160724154|NCT00789373|580372247|FG001|Induction|Death due to procedure|0|||
160724155|NCT00789373|580372248|FG002|Induction|Death due to procedure|0|||
160724156|NCT00789373|580372246|FG000|Induction|Investigator decision|7|||
160724157|NCT00789373|580372247|FG001|Induction|Investigator decision|0|||
160724158|NCT00789373|580372248|FG002|Induction|Investigator decision|0|||
160724159|NCT00789373|580372246|FG000|Induction|Protocol entry criteria not met|9|||
160724160|NCT00789373|580372247|FG001|Induction|Protocol entry criteria not met|0|||
160724161|NCT00789373|580372248|FG002|Induction|Protocol entry criteria not met|0|||
160724162|NCT00789373|580372246|FG000|Induction|Lost to Follow-up|6|||
160724163|NCT00789373|580372247|FG001|Induction|Lost to Follow-up|0|||
160724164|NCT00789373|580372248|FG002|Induction|Lost to Follow-up|0|||
160724165|NCT00789373|580372246|FG000|Induction|Protocol Violation|1|||
160724166|NCT00789373|580372247|FG001|Induction|Protocol Violation|0|||
160724167|NCT00789373|580372248|FG002|Induction|Protocol Violation|0|||
160724168|NCT00789373|580372246|FG000|Induction|Progressive Disease|220|||
160724169|NCT00789373|580372247|FG001|Induction|Progressive Disease|0|||
160724170|NCT00789373|580372248|FG002|Induction|Progressive Disease|0|||
160724171|NCT00789373|580372246|FG000|Induction|Withdrawal by Subject|37|||
160724172|NCT00789373|580372247|FG001|Induction|Withdrawal by Subject|0|||
160724173|NCT00789373|580372248|FG002|Induction|Withdrawal by Subject|0|||
160724174|NCT00789373|580372246|FG000|Maintenance|Adverse Event|0|||
160724175|NCT00789373|580372247|FG001|Maintenance|Adverse Event|65|||
160724176|NCT00789373|580372248|FG002|Maintenance|Adverse Event|12|||
160724177|NCT00789373|580372246|FG000|Maintenance|Death due to study disease|0|||
160724178|NCT00789373|580372247|FG001|Maintenance|Death due to study disease|3|||
160724179|NCT00789373|580372248|FG002|Maintenance|Death due to study disease|1|||
160724180|NCT00789373|580372246|FG000|Maintenance|Death due to adverse event|0|||
160724181|NCT00789373|580372247|FG001|Maintenance|Death due to adverse event|4|||
160724182|NCT00789373|580372248|FG002|Maintenance|Death due to adverse event|1|||
160724183|NCT00789373|580372246|FG000|Maintenance|Death due to toxicity|0|||
160724184|NCT00789373|580372247|FG001|Maintenance|Death due to toxicity|1|||
160724185|NCT00789373|580372248|FG002|Maintenance|Death due to toxicity|2|||
160724186|NCT00789373|580372246|FG000|Maintenance|Investigator Decision|0|||
160724187|NCT00789373|580372247|FG001|Maintenance|Investigator Decision|4|||
160724188|NCT00789373|580372248|FG002|Maintenance|Investigator Decision|2|||
160724189|NCT00789373|580372246|FG000|Maintenance|Protocol entry criteria not met|0|||
160724190|NCT00789373|580372247|FG001|Maintenance|Protocol entry criteria not met|2|||
160724191|NCT00789373|580372248|FG002|Maintenance|Protocol entry criteria not met|0|||
160724192|NCT00789373|580372246|FG000|Maintenance|Lost to Follow-up|0|||
160724193|NCT00789373|580372247|FG001|Maintenance|Lost to Follow-up|2|||
160724194|NCT00789373|580372248|FG002|Maintenance|Lost to Follow-up|0|||
160724195|NCT00789373|580372246|FG000|Maintenance|Progressive Disease|0|||
160724196|NCT00789373|580372247|FG001|Maintenance|Progressive Disease|253|||
160724197|NCT00789373|580372248|FG002|Maintenance|Progressive Disease|152|||
160724198|NCT00789373|580372246|FG000|Maintenance|Withdrawal by Subject|0|||
160724199|NCT00789373|580372247|FG001|Maintenance|Withdrawal by Subject|21|||
160724200|NCT00789373|580372248|FG002|Maintenance|Withdrawal by Subject|8|||
160724201|NCT00789373|580372246|FG000|Maintenance|Sponsor Decision|0|||
160724202|NCT00789373|580372247|FG001|Maintenance|Sponsor Decision|0|||
160724203|NCT00789373|580372248|FG002|Maintenance|Sponsor Decision|2|||
160724204|NCT00789373|580372246|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
160724205|NCT00789373|580372247|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
160724206|NCT00789373|580372248|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
160724207|NCT01684423|580372253|FG000|Overall Study|Withdrawal by Subject|0|||
160724208|NCT01684423|580372254|FG001|Overall Study|Withdrawal by Subject|0|||
160724209|NCT01684423|580372255|FG002|Overall Study|Withdrawal by Subject|1|||
160724210|NCT01684423|580372256|FG003|Overall Study|Withdrawal by Subject|0|||
160724211|NCT01684423|580372257|FG004|Overall Study|Withdrawal by Subject|0|||
160724212|NCT02155283|580372259|FG000|Overall Study|Lost to Follow-up|3|||
160724213|NCT02155283|580372259|FG000|Overall Study|Withdrawal by Subject|1|||
160724214|NCT02155283|580372259|FG000|Overall Study|Protocol Violation|3|||
160724215|NCT01741688|580372262|FG000|Overall Study|Lack of insurance coverage|2|||
160724216|NCT01741688|580372262|FG000|Overall Study|Withdrawal by Subject|1|||
160724217|NCT03850496|580372267|FG000|Overall Study|Withdrawal by Subject|1|||
160724218|NCT03850496|580372268|FG001|Overall Study|Withdrawal by Subject|0|||
160724219|NCT03850496|580372269|FG002|Overall Study|Withdrawal by Subject|0|||
160724220|NCT03850496|580372267|FG000|Overall Study|Lost to Follow-up|0|||
160724221|NCT03850496|580372268|FG001|Overall Study|Lost to Follow-up|1|||
160724222|NCT03850496|580372269|FG002|Overall Study|Lost to Follow-up|4|||
160724223|NCT00869999|580372277|FG000|Overall Study|Withdrawal by Subject|1|||
160724224|NCT00869999|580372277|FG000|Overall Study|removed prior to starting therapy|1|||
160724225|NCT03674112|580372281|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
160724226|NCT03674112|580372282|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
160724227|NCT03674112|580372281|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
160724228|NCT03674112|580372282|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
160724229|NCT03674112|580372281|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
160724230|NCT03674112|580372282|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
160724231|NCT03674112|580372281|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
160724232|NCT03674112|580372282|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
160724233|NCT03674112|580372281|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
160724234|NCT03674112|580372282|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
160724235|NCT03674112|580372281|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
160724236|NCT03674112|580372282|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
160724237|NCT03674112|580372281|FG000|Follow-Up Period (≥3 Years)|Death|2|||
160724238|NCT03674112|580372282|FG001|Follow-Up Period (≥3 Years)|Death|0|||
160724239|NCT03674112|580372281|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
160724240|NCT03674112|580372282|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
160724241|NCT04157348|580372283|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
160724242|NCT04157348|580372284|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
160724243|NCT04157348|580372283|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
160724244|NCT04157348|580372284|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
160724245|NCT04157348|580372283|FG000|Double-blind Treatment Period|Adverse Event|0|||
160724246|NCT04157348|580372284|FG001|Double-blind Treatment Period|Adverse Event|1|||
160724247|NCT04157348|580372283|FG000|Open-label Extension Period|Adverse Event|1|||
160724248|NCT04157348|580372284|FG001|Open-label Extension Period|Adverse Event|1|||
160724249|NCT04157348|580372283|FG000|Open-label Extension Period|Death|0|||
160724250|NCT04157348|580372284|FG001|Open-label Extension Period|Death|1|||
160724251|NCT04157348|580372283|FG000|Open-label Extension Period|Lack of Efficacy|2|||
160724252|NCT04157348|580372284|FG001|Open-label Extension Period|Lack of Efficacy|2|||
160724253|NCT04157348|580372283|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
160724254|NCT04157348|580372284|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
160724255|NCT04157348|580372283|FG000|Open-label Extension Period|Ongoing|60|||
160724256|NCT04157348|580372284|FG001|Open-label Extension Period|Ongoing|57|||
160724257|NCT04157348|580372283|FG000|Open-label Extension Period|other reasons|1|||
160724258|NCT04157348|580372284|FG001|Open-label Extension Period|other reasons|1|||
160724259|NCT02220764|580372287|FG000|Overall Study|Lost to Follow-up|3|||
160724260|NCT02220764|580372288|FG001|Overall Study|Lost to Follow-up|1|||
160724261|NCT02220764|580372287|FG000|Overall Study|Death|1|||
160724262|NCT02220764|580372288|FG001|Overall Study|Death|0|||
160724263|NCT04526288|580372289|FG000|Overall Study|Disease Progression|1|||
160724264|NCT04526288|580372290|FG001|Overall Study|Disease Progression|0|||
160724265|NCT00952068|580372291|FG000|Overall Study|Adverse Event|3|||
160724266|NCT00952068|580372291|FG000|Overall Study|Withdrawal by Subject|4|||
160724267|NCT04926831|580372292|FG000|Overall Study|Withdrawal by Subject|2|||
160724268|NCT04926831|580372292|FG000|Overall Study|Adverse Event|2|||
160724269|NCT02712554|580372293|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
160724270|NCT02712554|580372294|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
160724271|NCT02712554|580372293|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
160724272|NCT02712554|580372294|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
160724273|NCT02712554|580372293|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
160724274|NCT02712554|580372294|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
160724275|NCT02712554|580372293|FG000|Part B: Qualification Phase|Adverse Event|0|||
160724276|NCT02712554|580372294|FG001|Part B: Qualification Phase|Adverse Event|1|||
160724277|NCT02712554|580372293|FG000|Part B: Treatment Phase|Adverse Event|0|||
160724278|NCT02712554|580372294|FG001|Part B: Treatment Phase|Adverse Event|1|||
160724279|NCT02712554|580372293|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
160724280|NCT02712554|580372294|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
160724281|NCT02712554|580372293|FG000|Part B: Treatment Phase|Other|0|||
160724282|NCT02712554|580372294|FG001|Part B: Treatment Phase|Other|1|||
160724283|NCT03711786|580372299|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
160724284|NCT03711786|580372300|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
160724285|NCT03711786|580372299|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
160724286|NCT03711786|580372300|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
160724287|NCT03711786|580372299|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
160724288|NCT03711786|580372300|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
160724289|NCT03711786|580372299|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
160724290|NCT03711786|580372300|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
160724291|NCT03711786|580372299|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
160724292|NCT03711786|580372300|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
160724293|NCT03711786|580372299|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
160724294|NCT03711786|580372300|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
160724295|NCT00669669|580372301|FG000|Overall Study|To late to start treatment|1|||
160724296|NCT02747108|580372303|FG000|Overall Study|Death|2|||
160724297|NCT02747108|580372304|FG001|Overall Study|Death|2|||
160724298|NCT02747108|580372303|FG000|Overall Study|Withdrawal by Subject|1|||
160724299|NCT02747108|580372304|FG001|Overall Study|Withdrawal by Subject|0|||
160724300|NCT02747108|580372303|FG000|Overall Study|Protocol Violation|2|||
160724301|NCT02747108|580372304|FG001|Overall Study|Protocol Violation|0|||
160724302|NCT03103152|580372305|FG000|Overall Study|Physician Decision|5|||
160724303|NCT03103152|580372306|FG001|Overall Study|Physician Decision|2|||
160724304|NCT03103152|580372307|FG002|Overall Study|Physician Decision|6|||
160724305|NCT03103152|580372308|FG003|Overall Study|Physician Decision|3|||
160724306|NCT03103152|580372309|FG004|Overall Study|Physician Decision|3|||
160724307|NCT03103152|580372310|FG005|Overall Study|Physician Decision|1|||
160724308|NCT03103152|580372305|FG000|Overall Study|Protocol Violation|2|||
160724309|NCT03103152|580372306|FG001|Overall Study|Protocol Violation|2|||
160724310|NCT03103152|580372307|FG002|Overall Study|Protocol Violation|1|||
160724311|NCT03103152|580372308|FG003|Overall Study|Protocol Violation|2|||
160724312|NCT03103152|580372309|FG004|Overall Study|Protocol Violation|1|||
160724313|NCT03103152|580372310|FG005|Overall Study|Protocol Violation|1|||
160724314|NCT03103152|580372305|FG000|Overall Study|Inter-current illness|0|||
160724315|NCT03103152|580372306|FG001|Overall Study|Inter-current illness|0|||
160724316|NCT03103152|580372307|FG002|Overall Study|Inter-current illness|1|||
160724317|NCT03103152|580372308|FG003|Overall Study|Inter-current illness|0|||
160724318|NCT03103152|580372309|FG004|Overall Study|Inter-current illness|0|||
160724319|NCT03103152|580372310|FG005|Overall Study|Inter-current illness|0|||
160724320|NCT03103152|580372305|FG000|Overall Study|Death|0|||
160724321|NCT03103152|580372306|FG001|Overall Study|Death|1|||
160724322|NCT03103152|580372307|FG002|Overall Study|Death|0|||
160724323|NCT03103152|580372308|FG003|Overall Study|Death|0|||
160724324|NCT03103152|580372309|FG004|Overall Study|Death|0|||
160724325|NCT03103152|580372310|FG005|Overall Study|Death|0|||
160724326|NCT03103152|580372305|FG000|Overall Study|Adverse Event|0|||
160724327|NCT03103152|580372306|FG001|Overall Study|Adverse Event|0|||
160724328|NCT03103152|580372307|FG002|Overall Study|Adverse Event|1|||
160724329|NCT03103152|580372308|FG003|Overall Study|Adverse Event|0|||
160724330|NCT03103152|580372309|FG004|Overall Study|Adverse Event|0|||
160724331|NCT03103152|580372310|FG005|Overall Study|Adverse Event|1|||
160724332|NCT03103152|580372305|FG000|Overall Study|Withdrawal by Subject|1|||
160724333|NCT03103152|580372306|FG001|Overall Study|Withdrawal by Subject|0|||
160724334|NCT03103152|580372307|FG002|Overall Study|Withdrawal by Subject|1|||
160724335|NCT03103152|580372308|FG003|Overall Study|Withdrawal by Subject|1|||
160724336|NCT03103152|580372309|FG004|Overall Study|Withdrawal by Subject|1|||
160724337|NCT03103152|580372310|FG005|Overall Study|Withdrawal by Subject|1|||
160724338|NCT03103152|580372305|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
160724339|NCT03103152|580372306|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
160724340|NCT03103152|580372307|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
160724341|NCT03103152|580372308|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
160724342|NCT03103152|580372309|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
160724343|NCT03103152|580372310|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
160724344|NCT03103152|580372305|FG000|Overall Study|Unacceptable side effects|0|||
160724345|NCT03103152|580372306|FG001|Overall Study|Unacceptable side effects|0|||
160724346|NCT03103152|580372307|FG002|Overall Study|Unacceptable side effects|0|||
160724347|NCT03103152|580372308|FG003|Overall Study|Unacceptable side effects|0|||
160724348|NCT03103152|580372309|FG004|Overall Study|Unacceptable side effects|0|||
160724349|NCT03103152|580372310|FG005|Overall Study|Unacceptable side effects|1|||
160724350|NCT03103152|580372305|FG000|Overall Study|Lost to Follow-up|0|||
160724351|NCT03103152|580372306|FG001|Overall Study|Lost to Follow-up|1|||
160724352|NCT03103152|580372307|FG002|Overall Study|Lost to Follow-up|0|||
160724353|NCT03103152|580372308|FG003|Overall Study|Lost to Follow-up|1|||
160724354|NCT03103152|580372309|FG004|Overall Study|Lost to Follow-up|0|||
160724355|NCT03103152|580372310|FG005|Overall Study|Lost to Follow-up|1|||
160724356|NCT03103152|580372305|FG000|Overall Study|Testicular pain|0|||
160724357|NCT03103152|580372306|FG001|Overall Study|Testicular pain|0|||
160724358|NCT03103152|580372307|FG002|Overall Study|Testicular pain|0|||
160724359|NCT03103152|580372308|FG003|Overall Study|Testicular pain|1|||
160724360|NCT03103152|580372309|FG004|Overall Study|Testicular pain|0|||
160724361|NCT03103152|580372310|FG005|Overall Study|Testicular pain|0|||
160724362|NCT05966584|580372311|FG000|Overall Study|Lost to Follow-up|1|||
160724363|NCT03100903|580374308|FG000|Overall Study|Withdrawal by Subject|0|||
160724364|NCT03100903|580374309|FG001|Overall Study|Withdrawal by Subject|0|||
160724365|NCT03100903|580374310|FG002|Overall Study|Withdrawal by Subject|1|||
160724366|NCT04659993|580374311|FG000|Overall Study|Withdrawal by Subject|2|||
160724367|NCT04659993|580374311|FG000|Overall Study|Lost to Follow-up|2|||
160724368|NCT04010240|580374312|FG000|Overall Study|IHC not performed|2299|||
160724369|NCT01481766|580374313|FG000|4 months|Lost to Follow-up|3|||
160724370|NCT01481766|580374314|FG001|4 months|Lost to Follow-up|2|||
160724371|NCT01481766|580374315|FG002|4 months|Lost to Follow-up|1|||
160724372|NCT01481766|580374316|FG003|4 months|Lost to Follow-up|5|||
160724373|NCT01481766|580374313|FG000|12 months|Lost to Follow-up|7|||
160724374|NCT01481766|580374314|FG001|12 months|Lost to Follow-up|8|||
160724375|NCT01481766|580374315|FG002|12 months|Lost to Follow-up|5|||
160724376|NCT01481766|580374316|FG003|12 months|Lost to Follow-up|3|||
160724377|NCT00347958|580374317|FG000|Overall Study|Adverse Event|1|||
160724378|NCT00347958|580374317|FG000|Overall Study|Protocol Violation|2|||
160724379|NCT00347958|580374317|FG000|Overall Study|Withdrawal by Subject|1|||
160724380|NCT00754234|580374318|FG000|Overall Study|Withdrawal by Subject|3|||
160724381|NCT00570687|580374319|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724382|NCT00570687|580374320|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724383|NCT00570687|580374321|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724384|NCT00570687|580374322|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724385|NCT00570687|580374323|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
160724386|NCT00570687|580374324|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
160724387|NCT00570687|580374325|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
160724388|NCT00570687|580374326|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
160724389|NCT00570687|580374327|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
160724390|NCT00570687|580374328|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
160724391|NCT00570687|580374319|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724392|NCT00570687|580374320|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724393|NCT00570687|580374321|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724394|NCT00570687|580374322|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724395|NCT00570687|580374323|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724396|NCT00570687|580374324|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724397|NCT00570687|580374325|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724398|NCT00570687|580374326|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724399|NCT00570687|580374327|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
160724400|NCT00570687|580374328|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724401|NCT00570687|580374319|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724402|NCT00570687|580374320|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724403|NCT00570687|580374321|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724404|NCT00570687|580374322|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724405|NCT00570687|580374323|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724406|NCT00570687|580374324|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724407|NCT00570687|580374325|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
160724408|NCT00570687|580374326|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724409|NCT00570687|580374327|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724410|NCT00570687|580374328|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
160724411|NCT03263936|580374329|FG000|Overall Study|Adverse Event|0|||
160724412|NCT03263936|580374330|FG001|Overall Study|Adverse Event|1|||
160724413|NCT03263936|580374331|FG002|Overall Study|Adverse Event|0|||
160724414|NCT03263936|580374329|FG000|Overall Study|Death|0|||
160724415|NCT03263936|580374330|FG001|Overall Study|Death|1|||
160724416|NCT03263936|580374331|FG002|Overall Study|Death|0|||
160724417|NCT01540487|580374332|FG000|Overall Study|Protocol Violation|1|||
160724418|NCT01540487|580374333|FG001|Overall Study|Protocol Violation|0|||
160724419|NCT03503370|580374334|FG000|Overall Study|Death|3|||
160724420|NCT03503370|580374335|FG001|Overall Study|Death|1|||
160724421|NCT03483961|580374336|FG000|Overall Study|Lost to Follow-up|7|||
160724422|NCT03483961|580374337|FG001|Overall Study|Lost to Follow-up|6|||
160724423|NCT03483961|580374338|FG002|Overall Study|Lost to Follow-up|6|||
160724424|NCT03483961|580374339|FG003|Overall Study|Lost to Follow-up|6|||
160724425|NCT03483961|580374340|FG004|Overall Study|Lost to Follow-up|6|||
160724426|NCT03483961|580374341|FG005|Overall Study|Lost to Follow-up|4|||
160724427|NCT03483961|580374342|FG006|Overall Study|Lost to Follow-up|4|||
160724428|NCT03483961|580374343|FG007|Overall Study|Lost to Follow-up|11|||
160724429|NCT03483961|580374344|FG008|Overall Study|Lost to Follow-up|1|||
160724430|NCT03483961|580374345|FG009|Overall Study|Lost to Follow-up|0|||
160724431|NCT03483961|580374336|FG000|Overall Study|Withdrawal by Subject|3|||
160724432|NCT03483961|580374337|FG001|Overall Study|Withdrawal by Subject|4|||
160724433|NCT03483961|580374338|FG002|Overall Study|Withdrawal by Subject|5|||
160724434|NCT03483961|580374339|FG003|Overall Study|Withdrawal by Subject|3|||
160724435|NCT03483961|580374340|FG004|Overall Study|Withdrawal by Subject|4|||
160724436|NCT03483961|580374341|FG005|Overall Study|Withdrawal by Subject|2|||
160724437|NCT03483961|580374342|FG006|Overall Study|Withdrawal by Subject|1|||
160724438|NCT03483961|580374343|FG007|Overall Study|Withdrawal by Subject|2|||
160724439|NCT03483961|580374344|FG008|Overall Study|Withdrawal by Subject|1|||
160724440|NCT03483961|580374345|FG009|Overall Study|Withdrawal by Subject|0|||
160724441|NCT03483961|580374336|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
160724442|NCT03483961|580374337|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
160724443|NCT03483961|580374338|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
160724444|NCT03483961|580374339|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
160724445|NCT03483961|580374340|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
160724446|NCT03483961|580374341|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
160724447|NCT03483961|580374342|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
160724448|NCT03483961|580374343|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
160724449|NCT03483961|580374344|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
160724450|NCT03483961|580374345|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
160724451|NCT03483961|580374336|FG000|Overall Study|Adverse Event|0|||
160724452|NCT03483961|580374337|FG001|Overall Study|Adverse Event|0|||
160724453|NCT03483961|580374338|FG002|Overall Study|Adverse Event|1|||
160724454|NCT03483961|580374339|FG003|Overall Study|Adverse Event|0|||
160724455|NCT03483961|580374340|FG004|Overall Study|Adverse Event|0|||
160724456|NCT03483961|580374341|FG005|Overall Study|Adverse Event|0|||
160724457|NCT03483961|580374342|FG006|Overall Study|Adverse Event|0|||
160724458|NCT03483961|580374343|FG007|Overall Study|Adverse Event|0|||
160724459|NCT03483961|580374344|FG008|Overall Study|Adverse Event|0|||
160724460|NCT03483961|580374345|FG009|Overall Study|Adverse Event|0|||
160724461|NCT04545489|580374346|FG000|Overall Study|Withdrawal by Subject|12|||
160724462|NCT04545489|580374347|FG001|Overall Study|Withdrawal by Subject|4|||
160724463|NCT04545489|580374346|FG000|Overall Study|Lost to Follow-up|17|||
160724464|NCT04545489|580374347|FG001|Overall Study|Lost to Follow-up|18|||
160724465|NCT04545489|580374346|FG000|Overall Study|12month BP not collected|4|||
160724466|NCT04545489|580374347|FG001|Overall Study|12month BP not collected|4|||
160724467|NCT00298272|580374351|FG000|Double-blind Phase|Adverse Event|2|||
160724468|NCT00298272|580374352|FG001|Double-blind Phase|Adverse Event|0|||
160724469|NCT00298272|580374351|FG000|Double-blind Phase|Failure to Return|2|||
160724470|NCT00298272|580374352|FG001|Double-blind Phase|Failure to Return|0|||
160724471|NCT00298272|580374351|FG000|Double-blind Phase|Protocol Violation|2|||
160724472|NCT00298272|580374352|FG001|Double-blind Phase|Protocol Violation|0|||
160724473|NCT00298272|580374351|FG000|Double-blind Phase|Withdrawal by Subject|2|||
160724474|NCT00298272|580374352|FG001|Double-blind Phase|Withdrawal by Subject|0|||
160724475|NCT00298272|580374351|FG000|Open Label Retreatment Phase|Adverse Event|1|||
160724476|NCT00298272|580374352|FG001|Open Label Retreatment Phase|Adverse Event|2|||
160724477|NCT00298272|580374351|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
160724478|NCT00298272|580374352|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
160724479|NCT00298272|580374351|FG000|Open Label Retreatment Phase|Failure to Return|1|||
160724480|NCT00298272|580374352|FG001|Open Label Retreatment Phase|Failure to Return|0|||
160724481|NCT00298272|580374351|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
160724482|NCT00298272|580374352|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
160724483|NCT00298272|580374351|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
160724484|NCT00298272|580374352|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
160724485|NCT00298272|580374351|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
160724486|NCT00298272|580374352|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
160724487|NCT00298272|580374351|FG000|Safety Follow-up Phase|Failure to Return|1|||
160724488|NCT00298272|580374352|FG001|Safety Follow-up Phase|Failure to Return|1|||
160724489|NCT00298272|580374351|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
160724490|NCT00298272|580374352|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
160724491|NCT00298272|580374351|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
160724492|NCT00298272|580374352|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
160724493|NCT02582242|580374353|FG000|Overall Study|Adverse Event|4|||
160724494|NCT02582242|580374354|FG001|Overall Study|Adverse Event|3|||
160724495|NCT02582242|580374353|FG000|Overall Study|Protocol Violation|3|||
160724496|NCT02582242|580374354|FG001|Overall Study|Protocol Violation|1|||
160724497|NCT02582242|580374353|FG000|Overall Study|Lost to Follow-up|0|||
160724498|NCT02582242|580374354|FG001|Overall Study|Lost to Follow-up|1|||
160724499|NCT02582242|580374353|FG000|Overall Study|Withdrawal by Subject|11|||
160724500|NCT02582242|580374354|FG001|Overall Study|Withdrawal by Subject|11|||
160724501|NCT02582242|580374353|FG000|Overall Study|Unclassified|2|||
160724502|NCT02582242|580374354|FG001|Overall Study|Unclassified|1|||
160724503|NCT02101736|580374355|FG000|Overall Study|Protocol Violation|3|||
160724504|NCT02101736|580374356|FG001|Overall Study|Protocol Violation|0|||
160724505|NCT02101736|580374355|FG000|Overall Study|Withdrawal by Subject|1|||
160724506|NCT02101736|580374356|FG001|Overall Study|Withdrawal by Subject|1|||
160724507|NCT01017874|580374361|FG000|Overall Study|Withdrawal by Subject|23|||
160724508|NCT01017874|580374362|FG001|Overall Study|Withdrawal by Subject|20|||
160724509|NCT01017874|580374361|FG000|Overall Study|Sponsor decision|3|||
160724510|NCT01017874|580374362|FG001|Overall Study|Sponsor decision|1|||
160724511|NCT01017874|580374361|FG000|Overall Study|Lost to Follow-up|3|||
160724512|NCT01017874|580374362|FG001|Overall Study|Lost to Follow-up|2|||
160724513|NCT01017874|580374361|FG000|Overall Study|Physician Decision|1|||
160724514|NCT01017874|580374362|FG001|Overall Study|Physician Decision|3|||
160724515|NCT00778817|580374367|FG000|Overall Study|Adverse Event|2|||
160724516|NCT00778817|580374367|FG000|Overall Study|Withdrawal by Subject|2|||
160724517|NCT02509507|580374368|FG000|Overall Study|Death|21|||
160724518|NCT02509507|580374369|FG001|Overall Study|Death|3|||
160724519|NCT02509507|580374370|FG002|Overall Study|Death|22|||
160724520|NCT02509507|580374371|FG003|Overall Study|Death|14|||
160724521|NCT02509507|580374372|FG004|Overall Study|Death|8|||
160724522|NCT02509507|580374373|FG005|Overall Study|Death|12|||
160724523|NCT02509507|580374374|FG006|Overall Study|Death|5|||
160724524|NCT02509507|580374375|FG007|Overall Study|Death|4|||
160724525|NCT02509507|580374376|FG008|Overall Study|Death|8|||
160724526|NCT02509507|580374368|FG000|Overall Study|Lost to Follow-up|0|||
160724527|NCT02509507|580374369|FG001|Overall Study|Lost to Follow-up|1|||
160724528|NCT02509507|580374370|FG002|Overall Study|Lost to Follow-up|0|||
160724529|NCT02509507|580374371|FG003|Overall Study|Lost to Follow-up|0|||
160724530|NCT02509507|580374372|FG004|Overall Study|Lost to Follow-up|0|||
160724531|NCT02509507|580374373|FG005|Overall Study|Lost to Follow-up|2|||
160724532|NCT02509507|580374374|FG006|Overall Study|Lost to Follow-up|0|||
160724533|NCT02509507|580374375|FG007|Overall Study|Lost to Follow-up|0|||
160724534|NCT02509507|580374376|FG008|Overall Study|Lost to Follow-up|0|||
160724535|NCT02509507|580374368|FG000|Overall Study|Withdrawal by Subject|2|||
160724536|NCT02509507|580374369|FG001|Overall Study|Withdrawal by Subject|0|||
160724537|NCT02509507|580374370|FG002|Overall Study|Withdrawal by Subject|1|||
160724538|NCT02509507|580374371|FG003|Overall Study|Withdrawal by Subject|4|||
160724539|NCT02509507|580374372|FG004|Overall Study|Withdrawal by Subject|1|||
160724540|NCT02509507|580374373|FG005|Overall Study|Withdrawal by Subject|3|||
160724541|NCT02509507|580374374|FG006|Overall Study|Withdrawal by Subject|4|||
160724542|NCT02509507|580374375|FG007|Overall Study|Withdrawal by Subject|0|||
160724543|NCT02509507|580374376|FG008|Overall Study|Withdrawal by Subject|1|||
160724544|NCT03150719|580374377|FG000|Overall Study|Adverse Event|0|||
160724545|NCT03150719|580374378|FG001|Overall Study|Adverse Event|1|||
160724546|NCT03150719|580374377|FG000|Overall Study|Death|0|||
160724547|NCT03150719|580374378|FG001|Overall Study|Death|1|||
160724548|NCT03150719|580374377|FG000|Overall Study|Other|1|||
160724549|NCT03150719|580374378|FG001|Overall Study|Other|0|||
160724550|NCT05000164|580374389|FG000|Overall Study|Adverse Event|1|||
160724551|NCT05000164|580374389|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
160724552|NCT05000164|580374389|FG000|Overall Study|Lens Discomfort|3|||
160724553|NCT05000164|580374389|FG000|Overall Study|Withdrew Consent during Study|2|||
160724554|NCT05000164|580374389|FG000|Overall Study|Subject Withdrawn by PI|2|||
160724555|NCT05000164|580374389|FG000|Overall Study|Other Fractured Test Article|1|||
160724556|NCT03020992|580374390|FG000|Overall Study|Adverse Event|5|||
160724557|NCT03020992|580374390|FG000|Overall Study|Withdrawal by Subject|1|||
160724558|NCT01006122|580374391|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
160724559|NCT01006122|580374392|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
160724560|NCT01006122|580374391|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
160724561|NCT01006122|580374392|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
160724562|NCT01006122|580374391|FG000|First Double-blind Intervention Period|Pregnancy|0|||
160724563|NCT01006122|580374392|FG001|First Double-blind Intervention Period|Pregnancy|1|||
160724564|NCT01006122|580374391|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
160724565|NCT01006122|580374392|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
160724566|NCT01006122|580374391|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
160724567|NCT01006122|580374392|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
160724568|NCT01006122|580374391|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
160724569|NCT01006122|580374392|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
160724570|NCT01006122|580374391|FG000|First Double-blind Intervention Period|Other|3|||
160724571|NCT01006122|580374392|FG001|First Double-blind Intervention Period|Other|0|||
160724572|NCT01006122|580374391|FG000|First Double-blind Intervention Period|Adverse Event|0|||
160724573|NCT01006122|580374392|FG001|First Double-blind Intervention Period|Adverse Event|4|||
160724574|NCT01006122|580374391|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
160724575|NCT01006122|580374392|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
160724576|NCT01006122|580374391|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
160724577|NCT01006122|580374392|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
160724578|NCT01006122|580374391|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
160724579|NCT01006122|580374392|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
160724580|NCT01006122|580374391|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
160724581|NCT01006122|580374392|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
160724582|NCT01006122|580374391|FG000|Second Double-blind Intervention Period|Death|0|||
160724583|NCT01006122|580374392|FG001|Second Double-blind Intervention Period|Death|1|||
160724584|NCT03493854|580374393|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
160724585|NCT03493854|580374394|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
160724586|NCT03493854|580374393|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
160724587|NCT03493854|580374394|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
160724588|NCT03493854|580374393|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
160724589|NCT03493854|580374394|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
160724590|NCT03493854|580374393|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
160724591|NCT03493854|580374394|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
160724592|NCT03493854|580374393|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
160724593|NCT03493854|580374394|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
160724594|NCT03493854|580374393|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
160724595|NCT03493854|580374394|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
160724596|NCT03493854|580374393|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
160724597|NCT03493854|580374394|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
160724598|NCT03493854|580374393|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
160724599|NCT03493854|580374394|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
160724600|NCT03493854|580374393|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
160724601|NCT03493854|580374394|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
160724602|NCT03493854|580374393|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
160724603|NCT03493854|580374394|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
160724604|NCT03493854|580374393|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
160724605|NCT03493854|580374394|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
160724606|NCT03493854|580374393|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
160724607|NCT03493854|580374394|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
160724608|NCT03493854|580374393|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
160724609|NCT03493854|580374394|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
160724610|NCT03493854|580374393|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
160724611|NCT03493854|580374394|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
160724612|NCT03493854|580374393|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
160724613|NCT03493854|580374394|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
160724614|NCT03493854|580374393|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
160724615|NCT03493854|580374394|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
160724616|NCT03493854|580374393|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
160724617|NCT03493854|580374394|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
160724618|NCT03493854|580374393|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
160724619|NCT03493854|580374394|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
160724620|NCT00410813|580374397|FG000|Overall Study|Adverse Event|6|||
160724621|NCT00410813|580374398|FG001|Overall Study|Adverse Event|11|||
160724622|NCT00410813|580374397|FG000|Overall Study|Progression|32|||
160724623|NCT00410813|580374398|FG001|Overall Study|Progression|21|||
160724624|NCT00410813|580374397|FG000|Overall Study|Not protocol specified|3|||
160724625|NCT00410813|580374398|FG001|Overall Study|Not protocol specified|4|||
160724626|NCT00410813|580374397|FG000|Overall Study|Ineligible|2|||
160724627|NCT00410813|580374398|FG001|Overall Study|Ineligible|4|||
160724628|NCT00410813|580374397|FG000|Overall Study|Death|0|||
160724629|NCT00410813|580374398|FG001|Overall Study|Death|2|||
160724630|NCT04278417|580374417|FG000|Overall Study|Withdrawal by Subject|20|||
160724631|NCT04278417|580374418|FG001|Overall Study|Withdrawal by Subject|20|||
160724632|NCT04278417|580374417|FG000|Overall Study|Progressive disease|0|||
160724633|NCT04278417|580374418|FG001|Overall Study|Progressive disease|2|||
160724634|NCT04278417|580374417|FG000|Overall Study|Physician Decision|4|||
160724635|NCT04278417|580374418|FG001|Overall Study|Physician Decision|6|||
160724636|NCT04278417|580374417|FG000|Overall Study|Lost to Follow-up|11|||
160724637|NCT04278417|580374418|FG001|Overall Study|Lost to Follow-up|13|||
160724638|NCT04278417|580374417|FG000|Overall Study|Death|8|||
160724639|NCT04278417|580374418|FG001|Overall Study|Death|9|||
160724640|NCT04278417|580374417|FG000|Overall Study|Adverse Event|3|||
160724641|NCT04278417|580374418|FG001|Overall Study|Adverse Event|5|||
160724642|NCT02268916|580374421|FG000|Overall Study|Lost to Follow-up|1|||
160724643|NCT02268916|580374422|FG001|Overall Study|Lost to Follow-up|1|||
160724644|NCT02268916|580374421|FG000|Overall Study|Withdrawal by Subject|6|||
160724645|NCT02268916|580374422|FG001|Overall Study|Withdrawal by Subject|5|||
160724646|NCT02268916|580374421|FG000|Overall Study|Participant did not have diabetes|1|||
160724647|NCT02268916|580374422|FG001|Overall Study|Participant did not have diabetes|0|||
160724648|NCT02268916|580374421|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
160724649|NCT02268916|580374422|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
160724650|NCT00594165|580374426|FG000|Overall Study|Major protocol violation|1|||
160724651|NCT00594165|580374426|FG000|Overall Study|Lack of Efficacy|12|||
160724652|NCT00594165|580374426|FG000|Overall Study|Adverse Event|52|||
160724653|NCT00594165|580374426|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
160724654|NCT00594165|580374426|FG000|Overall Study|Subject withdrew consent|27|||
160724655|NCT00594165|580374426|FG000|Overall Study|Study ended per sponsor|102|||
160724656|NCT00594165|580374426|FG000|Overall Study|Lost to Follow-up|4|||
160724657|NCT00594165|580374426|FG000|Overall Study|Other: PI discretion|5|||
160724658|NCT00594165|580374426|FG000|Overall Study|Other: Subject moving|3|||
160724659|NCT00594165|580374426|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
160724660|NCT00594165|580374426|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
160724661|NCT00594165|580374426|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
160724662|NCT00594165|580374426|FG000|Overall Study|Other: Site terminated participation|2|||
160724663|NCT04830969|580374427|FG000|Overall Study|Withdrawal by Subject|6|||
160724664|NCT04830969|580374428|FG001|Overall Study|Withdrawal by Subject|2|||
160724665|NCT04830969|580374427|FG000|Overall Study|Protocol Violation|3|||
160724666|NCT04830969|580374428|FG001|Overall Study|Protocol Violation|9|||
160724667|NCT04830969|580374427|FG000|Overall Study|Lost to Follow-up|4|||
160724668|NCT04830969|580374428|FG001|Overall Study|Lost to Follow-up|4|||
160724669|NCT00996125|580374429|FG000|Overall Study|Adverse Event|0|||
160724670|NCT00996125|580374430|FG001|Overall Study|Adverse Event|2|||
160724671|NCT00996125|580374429|FG000|Overall Study|Lost to Follow-up|1|||
160724672|NCT00996125|580374430|FG001|Overall Study|Lost to Follow-up|6|||
160724673|NCT00996125|580374429|FG000|Overall Study|Withdrawal by Subject|4|||
160724674|NCT00996125|580374430|FG001|Overall Study|Withdrawal by Subject|3|||
160724675|NCT05236764|580374431|FG000|Overall Study|In follow up (ongoing)|1|||
160724676|NCT05236764|580374431|FG000|Overall Study|Taken off study - secondary graft failure|1|||
160724677|NCT05236764|580374431|FG000|Overall Study|Death|1|||
160724678|NCT02062450|580374437|FG000|Overall Study|No follow-up visit|124|||
160724679|NCT00347009|580374441|FG000|Overall Study|Death|1|||
160724680|NCT00347009|580374441|FG000|Overall Study|Adverse Event|6|||
160724681|NCT00347009|580374441|FG000|Overall Study|Withdrawal by Subject|3|||
160724682|NCT00347009|580374441|FG000|Overall Study|Physician Decision|5|||
160724683|NCT00347009|580374441|FG000|Overall Study|Lost to Follow-up|4|||
160724684|NCT00347009|580374441|FG000|Overall Study|Protocol Violation|2|||
160724685|NCT00347009|580374441|FG000|Overall Study|Adverse Laboratory Experience|1|||
160724686|NCT00347009|580374441|FG000|Overall Study|Insufficient Viral Suppression|3|||
160724687|NCT00347009|580374441|FG000|Overall Study|Increased ALT/HBV DNA|1|||
160724688|NCT00347009|580374441|FG000|Overall Study|Serious Adverse Event|1|||
160724689|NCT02907177|580374442|FG000|Overall Study|Death|0|||
160724690|NCT02907177|580374443|FG001|Overall Study|Death|1|||
160724691|NCT02907177|580374442|FG000|Overall Study|Physician Decision|3|||
160724692|NCT02907177|580374443|FG001|Overall Study|Physician Decision|3|||
160724693|NCT02907177|580374442|FG000|Overall Study|Withdrawal by Subject|15|||
160724694|NCT02907177|580374443|FG001|Overall Study|Withdrawal by Subject|7|||
160724695|NCT02907177|580374442|FG000|Overall Study|Sponsor's Decision|50|||
160724696|NCT02907177|580374443|FG001|Overall Study|Sponsor's Decision|57|||
160724697|NCT01796392|580374444|FG000|Overall Study|Withdrawal by Subject|2|||
160724698|NCT01796392|580374445|FG001|Overall Study|Withdrawal by Subject|0|||
160724699|NCT01796392|580374444|FG000|Overall Study|Death|5|||
160724700|NCT01796392|580374445|FG001|Overall Study|Death|1|||
160724701|NCT01796392|580374444|FG000|Overall Study|Excluded for medical reasons|1|||
160724702|NCT01796392|580374445|FG001|Overall Study|Excluded for medical reasons|2|||
160724703|NCT01796392|580374444|FG000|Overall Study|Lost to Follow-up|1|||
160724704|NCT01796392|580374445|FG001|Overall Study|Lost to Follow-up|0|||
160724705|NCT03482635|580374446|FG000|Overall Study|Lack of Efficacy|0|||
160724706|NCT03482635|580374447|FG001|Overall Study|Lack of Efficacy|0|||
160724707|NCT03482635|580374448|FG002|Overall Study|Lack of Efficacy|1|||
160724708|NCT03482635|580374449|FG003|Overall Study|Lack of Efficacy|3|||
160724709|NCT03482635|580374446|FG000|Overall Study|Adverse Event|2|||
160724710|NCT03482635|580374447|FG001|Overall Study|Adverse Event|2|||
160724711|NCT03482635|580374448|FG002|Overall Study|Adverse Event|0|||
160724712|NCT03482635|580374449|FG003|Overall Study|Adverse Event|3|||
160724713|NCT03482635|580374446|FG000|Overall Study|Withdrawal by Subject|2|||
160724714|NCT03482635|580374447|FG001|Overall Study|Withdrawal by Subject|1|||
160724715|NCT03482635|580374448|FG002|Overall Study|Withdrawal by Subject|0|||
160724716|NCT03482635|580374449|FG003|Overall Study|Withdrawal by Subject|1|||
160724717|NCT03482635|580374446|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
160724718|NCT03482635|580374447|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
160724719|NCT03482635|580374448|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
160724720|NCT03482635|580374449|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
160724721|NCT03482635|580374446|FG000|Overall Study|Not treated|0|||
160724722|NCT03482635|580374447|FG001|Overall Study|Not treated|0|||
160724723|NCT03482635|580374448|FG002|Overall Study|Not treated|0|||
160724724|NCT03482635|580374449|FG003|Overall Study|Not treated|1|||
160724725|NCT04639219|580374450|FG000|Overall Study|Withdrawal by Subject|8|||
160724726|NCT04639219|580374450|FG000|Overall Study|Lost to Follow-up|6|||
160724727|NCT04639219|580374450|FG000|Overall Study|Death|55|||
160724728|NCT04681066|580374451|FG000|Overall Study|Lost to Follow-up|3|||
160724729|NCT04681066|580374452|FG001|Overall Study|Lost to Follow-up|1|||
160724730|NCT04681066|580374453|FG002|Overall Study|Lost to Follow-up|2|||
160724731|NCT04681066|580374454|FG003|Overall Study|Lost to Follow-up|1|||
160724732|NCT04681066|580374451|FG000|Overall Study|Withdrawal by Subject|2|||
160724733|NCT04681066|580374452|FG001|Overall Study|Withdrawal by Subject|1|||
160724734|NCT04681066|580374453|FG002|Overall Study|Withdrawal by Subject|0|||
160724735|NCT04681066|580374454|FG003|Overall Study|Withdrawal by Subject|3|||
160724736|NCT04681066|580374451|FG000|Overall Study|Death|0|||
160724737|NCT04681066|580374452|FG001|Overall Study|Death|1|||
160724738|NCT04681066|580374453|FG002|Overall Study|Death|0|||
160724739|NCT04681066|580374454|FG003|Overall Study|Death|0|||
160724740|NCT04495829|580374455|FG000|Overall Study|Lost to Follow-up|2|||
160724741|NCT04495829|580374455|FG000|Overall Study|Inclusion criterion not met|3|||
160724742|NCT01205269|580374464|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
160724743|NCT01205269|580374465|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
160724744|NCT01205269|580374466|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
160724745|NCT01205269|580374467|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
160724746|NCT01205269|580374468|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
160724747|NCT01205269|580374469|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
160724748|NCT03474965|580374470|FG000|Overall Study|Pregnancy|1|||
160724749|NCT03474965|580374471|FG001|Overall Study|Pregnancy|0|||
160724750|NCT03474965|580374472|FG002|Overall Study|Pregnancy|0|||
160724751|NCT03474965|580374473|FG003|Overall Study|Pregnancy|0|||
160724752|NCT03474965|580374470|FG000|Overall Study|Lost to Follow-up|0|||
160724753|NCT03474965|580374471|FG001|Overall Study|Lost to Follow-up|0|||
160724754|NCT03474965|580374472|FG002|Overall Study|Lost to Follow-up|1|||
160724755|NCT03474965|580374473|FG003|Overall Study|Lost to Follow-up|0|||
160724756|NCT03474965|580374470|FG000|Overall Study|Death|1|||
160724757|NCT03474965|580374471|FG001|Overall Study|Death|0|||
160724758|NCT03474965|580374472|FG002|Overall Study|Death|0|||
160724759|NCT03474965|580374473|FG003|Overall Study|Death|0|||
160724760|NCT03474965|580374470|FG000|Overall Study|Adverse Event|1|||
160724761|NCT03474965|580374471|FG001|Overall Study|Adverse Event|0|||
160724762|NCT03474965|580374472|FG002|Overall Study|Adverse Event|0|||
160724763|NCT03474965|580374473|FG003|Overall Study|Adverse Event|1|||
160724764|NCT03474965|580374470|FG000|Overall Study|Physician Decision|3|||
160724765|NCT03474965|580374471|FG001|Overall Study|Physician Decision|1|||
160724766|NCT03474965|580374472|FG002|Overall Study|Physician Decision|2|||
160724767|NCT03474965|580374473|FG003|Overall Study|Physician Decision|0|||
160724768|NCT03474965|580374470|FG000|Overall Study|Participant Decision|7|||
160724769|NCT03474965|580374471|FG001|Overall Study|Participant Decision|0|||
160724770|NCT03474965|580374472|FG002|Overall Study|Participant Decision|1|||
160724771|NCT03474965|580374473|FG003|Overall Study|Participant Decision|0|||
160724772|NCT03474965|580374470|FG000|Overall Study|Guardian Decision|4|||
160724773|NCT03474965|580374471|FG001|Overall Study|Guardian Decision|2|||
160724774|NCT03474965|580374472|FG002|Overall Study|Guardian Decision|7|||
160724775|NCT03474965|580374473|FG003|Overall Study|Guardian Decision|2|||
160724776|NCT03868930|580375908|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
160724777|NCT03868930|580375909|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
160724778|NCT03868930|580375908|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
160724779|NCT03868930|580375909|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
160724780|NCT03868930|580375908|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
160724781|NCT03868930|580375909|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
160724782|NCT03868930|580375908|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
160724783|NCT03868930|580375909|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
160724784|NCT03868930|580375908|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
160724785|NCT03868930|580375909|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
160724786|NCT02151851|580375912|FG000|Overall Study|Lack of Efficacy|67|||
160724787|NCT02151851|580375913|FG001|Overall Study|Lack of Efficacy|94|||
160724788|NCT02151851|580375912|FG000|Overall Study|Protocol Violation|0|||
160724789|NCT02151851|580375913|FG001|Overall Study|Protocol Violation|1|||
160724790|NCT02151851|580375912|FG000|Overall Study|Withdrawal by Subject|2|||
160724791|NCT02151851|580375913|FG001|Overall Study|Withdrawal by Subject|5|||
160724792|NCT02151851|580375912|FG000|Overall Study|Medical impairment|1|||
160724793|NCT02151851|580375913|FG001|Overall Study|Medical impairment|0|||
160724794|NCT02151851|580375912|FG000|Overall Study|Low compliance to study visits|0|||
160724795|NCT02151851|580375913|FG001|Overall Study|Low compliance to study visits|1|||
160724796|NCT02151851|580375912|FG000|Overall Study|Subject entered into study in error|0|||
160724797|NCT02151851|580375913|FG001|Overall Study|Subject entered into study in error|1|||
160724798|NCT02151851|580375912|FG000|Overall Study|Adverse Event|6|||
160724799|NCT02151851|580375913|FG001|Overall Study|Adverse Event|28|||
160724800|NCT02159053|580375914|FG000|Overall Study|Death|2|||
160724801|NCT02159053|580375915|FG001|Overall Study|Death|0|||
160724802|NCT02159053|580375916|FG002|Overall Study|Death|1|||
160724803|NCT02159053|580375914|FG000|Overall Study|Physician Decision|0|||
160724804|NCT02159053|580375915|FG001|Overall Study|Physician Decision|1|||
160724805|NCT02159053|580375916|FG002|Overall Study|Physician Decision|1|||
160724806|NCT02159053|580375914|FG000|Overall Study|Lack of Efficacy|3|||
160724807|NCT02159053|580375915|FG001|Overall Study|Lack of Efficacy|4|||
160724808|NCT02159053|580375916|FG002|Overall Study|Lack of Efficacy|7|||
160724809|NCT02159053|580375914|FG000|Overall Study|Adverse Event|7|||
160724810|NCT02159053|580375915|FG001|Overall Study|Adverse Event|6|||
160724811|NCT02159053|580375916|FG002|Overall Study|Adverse Event|5|||
160724812|NCT02159053|580375914|FG000|Overall Study|Participants/guardian decision|8|||
160724813|NCT02159053|580375915|FG001|Overall Study|Participants/guardian decision|10|||
160724814|NCT02159053|580375916|FG002|Overall Study|Participants/guardian decision|6|||
160724815|NCT02640950|580375917|FG000|Overall Study|Adverse Event|1|||
160724816|NCT02640950|580375917|FG000|Overall Study|Withdrawal by Subject|1|||
160724817|NCT00652626|580375918|FG000|Initial Treatment Phase|Adverse Event|0|||
160724818|NCT00652626|580375919|FG001|Initial Treatment Phase|Adverse Event|0|||
160724819|NCT00652626|580375920|FG002|Initial Treatment Phase|Adverse Event|0|||
160724820|NCT00652626|580375921|FG003|Initial Treatment Phase|Adverse Event|0|||
160724821|NCT00652626|580375922|FG004|Initial Treatment Phase|Adverse Event|1|||
160724822|NCT00652626|580375923|FG005|Initial Treatment Phase|Adverse Event|0|||
160724823|NCT00652626|580375924|FG006|Initial Treatment Phase|Adverse Event|0|||
160724824|NCT00652626|580375918|FG000|Initial Treatment Phase|Protocol Violation|0|||
160724825|NCT00652626|580375919|FG001|Initial Treatment Phase|Protocol Violation|0|||
160724826|NCT00652626|580375920|FG002|Initial Treatment Phase|Protocol Violation|0|||
160724827|NCT00652626|580375921|FG003|Initial Treatment Phase|Protocol Violation|1|||
160724828|NCT00652626|580375922|FG004|Initial Treatment Phase|Protocol Violation|0|||
160724829|NCT00652626|580375923|FG005|Initial Treatment Phase|Protocol Violation|0|||
160724830|NCT00652626|580375924|FG006|Initial Treatment Phase|Protocol Violation|0|||
160724831|NCT00652626|580375918|FG000|Initial Treatment Phase|Physician Decision|0|||
160724832|NCT00652626|580375919|FG001|Initial Treatment Phase|Physician Decision|0|||
160724833|NCT00652626|580375920|FG002|Initial Treatment Phase|Physician Decision|0|||
160724834|NCT00652626|580375921|FG003|Initial Treatment Phase|Physician Decision|0|||
160724835|NCT00652626|580375922|FG004|Initial Treatment Phase|Physician Decision|1|||
160724836|NCT00652626|580375923|FG005|Initial Treatment Phase|Physician Decision|0|||
160724837|NCT00652626|580375924|FG006|Initial Treatment Phase|Physician Decision|0|||
160724838|NCT00652626|580375918|FG000|Initial Treatment Phase|Sponsor Request|0|||
160724839|NCT00652626|580375919|FG001|Initial Treatment Phase|Sponsor Request|0|||
160724840|NCT00652626|580375920|FG002|Initial Treatment Phase|Sponsor Request|1|||
160724841|NCT00652626|580375921|FG003|Initial Treatment Phase|Sponsor Request|0|||
160724842|NCT00652626|580375922|FG004|Initial Treatment Phase|Sponsor Request|0|||
160724843|NCT00652626|580375923|FG005|Initial Treatment Phase|Sponsor Request|0|||
160724844|NCT00652626|580375924|FG006|Initial Treatment Phase|Sponsor Request|0|||
160724845|NCT00652626|580375918|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
160724846|NCT00652626|580375919|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
160724847|NCT00652626|580375920|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
160724848|NCT00652626|580375921|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
160724849|NCT00652626|580375922|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
160724850|NCT00652626|580375923|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
160724851|NCT00652626|580375924|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
160724852|NCT00652626|580375918|FG000|Extension Phase|Withdrawal by Subject|0|||
160724853|NCT00652626|580375919|FG001|Extension Phase|Withdrawal by Subject|0|||
160724854|NCT00652626|580375920|FG002|Extension Phase|Withdrawal by Subject|0|||
160724855|NCT00652626|580375921|FG003|Extension Phase|Withdrawal by Subject|0|||
160724856|NCT00652626|580375922|FG004|Extension Phase|Withdrawal by Subject|0|||
160724857|NCT00652626|580375923|FG005|Extension Phase|Withdrawal by Subject|2|||
160724858|NCT00652626|580375924|FG006|Extension Phase|Withdrawal by Subject|0|||
160724859|NCT00652626|580375918|FG000|Extension Phase|Adverse Event|0|||
160724860|NCT00652626|580375919|FG001|Extension Phase|Adverse Event|0|||
160724861|NCT00652626|580375920|FG002|Extension Phase|Adverse Event|0|||
160724862|NCT00652626|580375921|FG003|Extension Phase|Adverse Event|0|||
160724863|NCT00652626|580375922|FG004|Extension Phase|Adverse Event|0|||
160724864|NCT00652626|580375923|FG005|Extension Phase|Adverse Event|2|||
160724865|NCT00652626|580375924|FG006|Extension Phase|Adverse Event|1|||
160724866|NCT00652626|580375918|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
160724867|NCT00652626|580375919|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
160724868|NCT00652626|580375920|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
160724869|NCT00652626|580375921|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
160724870|NCT00652626|580375922|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
160724871|NCT00652626|580375923|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
160724872|NCT00652626|580375924|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
160724873|NCT00652626|580375918|FG000|Extension Phase|Physician Decision|0|||
160724874|NCT00652626|580375919|FG001|Extension Phase|Physician Decision|0|||
160724875|NCT00652626|580375920|FG002|Extension Phase|Physician Decision|0|||
160724876|NCT00652626|580375921|FG003|Extension Phase|Physician Decision|0|||
160724877|NCT00652626|580375922|FG004|Extension Phase|Physician Decision|0|||
160724878|NCT00652626|580375923|FG005|Extension Phase|Physician Decision|1|||
160724879|NCT00652626|580375924|FG006|Extension Phase|Physician Decision|1|||
160724880|NCT00652626|580375918|FG000|Extension Phase|Death|0|||
160724881|NCT00652626|580375919|FG001|Extension Phase|Death|0|||
160724882|NCT00652626|580375920|FG002|Extension Phase|Death|0|||
160724883|NCT00652626|580375921|FG003|Extension Phase|Death|0|||
160724884|NCT00652626|580375922|FG004|Extension Phase|Death|0|||
160724885|NCT00652626|580375923|FG005|Extension Phase|Death|1|||
160724886|NCT00652626|580375924|FG006|Extension Phase|Death|1|||
160724887|NCT04003636|580375925|FG000|Overall Study|Death|409|||
160724888|NCT04003636|580375926|FG001|Overall Study|Death|443|||
160724889|NCT04003636|580375925|FG000|Overall Study|Lost to Follow-up|0|||
160724890|NCT04003636|580375926|FG001|Overall Study|Lost to Follow-up|1|||
160724891|NCT04003636|580375925|FG000|Overall Study|Withdrawal by Subject|5|||
160724892|NCT04003636|580375926|FG001|Overall Study|Withdrawal by Subject|2|||
160724893|NCT04003636|580375925|FG000|Overall Study|Participant On-going|119|||
160724894|NCT04003636|580375926|FG001|Overall Study|Participant On-going|90|||
160724895|NCT03048747|580375927|FG000|Overall Study|Adverse Event|2|||
160724896|NCT03048747|580375927|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
160724897|NCT03048747|580375927|FG000|Overall Study|Physician Decision|1|||
160724898|NCT00915018|580375930|FG000|Overall Study|Death|75|||
160724899|NCT00915018|580375931|FG001|Overall Study|Death|70|||
160724900|NCT00915018|580375930|FG000|Overall Study|Lost to Follow-up|10|||
160724901|NCT00915018|580375931|FG001|Overall Study|Lost to Follow-up|5|||
160724902|NCT00915018|580375930|FG000|Overall Study|Withdrawal by Subject|38|||
160724903|NCT00915018|580375931|FG001|Overall Study|Withdrawal by Subject|27|||
160724904|NCT00915018|580375930|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
160724905|NCT00915018|580375931|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
160724906|NCT00457002|580375932|FG000|Overall Study|Death|40|||
160724907|NCT00457002|580375933|FG001|Overall Study|Death|47|||
160724908|NCT00457002|580375932|FG000|Overall Study|Adverse Event|284|||
160724909|NCT00457002|580375933|FG001|Overall Study|Adverse Event|260|||
160724910|NCT00457002|580375932|FG000|Overall Study|Withdrawal by Subject|299|||
160724911|NCT00457002|580375933|FG001|Overall Study|Withdrawal by Subject|271|||
160724912|NCT00457002|580375932|FG000|Overall Study|Lost to Follow-up|72|||
160724913|NCT00457002|580375933|FG001|Overall Study|Lost to Follow-up|71|||
160724914|NCT00457002|580375932|FG000|Overall Study|Poor/Non-compliance|46|||
160724915|NCT00457002|580375933|FG001|Overall Study|Poor/Non-compliance|33|||
160724916|NCT00457002|580375932|FG000|Overall Study|No longer met criteria|41|||
160724917|NCT00457002|580375933|FG001|Overall Study|No longer met criteria|37|||
160724918|NCT00457002|580375932|FG000|Overall Study|Administrative reason by Sponsor|1|||
160724919|NCT00457002|580375933|FG001|Overall Study|Administrative reason by Sponsor|0|||
160724920|NCT00457002|580375932|FG000|Overall Study|non-specified|29|||
160724921|NCT00457002|580375933|FG001|Overall Study|non-specified|38|||
160724922|NCT00457002|580375932|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
160724923|NCT00457002|580375933|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
160724924|NCT01623310|580375934|FG000|Overall Study|Adverse Event|21|||
160724925|NCT01623310|580375934|FG000|Overall Study|Lost to Follow-up|18|||
160724926|NCT01623310|580375934|FG000|Overall Study|Lack of Efficacy|6|||
160724927|NCT01623310|580375934|FG000|Overall Study|Protocol Violation|6|||
160724928|NCT01623310|580375934|FG000|Overall Study|Withdrawal by Subject|25|||
160724929|NCT01623310|580375934|FG000|Overall Study|Became potentially child-bearing|1|||
160724930|NCT01623310|580375934|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
160724931|NCT01623310|580375934|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
160724932|NCT00454246|580375935|FG000|Overall Study|Adverse Event|2|||
160724933|NCT00454246|580375936|FG001|Overall Study|Adverse Event|2|||
160724934|NCT00454246|580375937|FG002|Overall Study|Adverse Event|0|||
160724935|NCT00454246|580375935|FG000|Overall Study|Violation of selection criteria at entry|6|||
160724936|NCT00454246|580375936|FG001|Overall Study|Violation of selection criteria at entry|0|||
160724937|NCT00454246|580375937|FG002|Overall Study|Violation of selection criteria at entry|0|||
160724938|NCT00454246|580375935|FG000|Overall Study|Protocol Violation|1|||
160724939|NCT00454246|580375936|FG001|Overall Study|Protocol Violation|0|||
160724940|NCT00454246|580375937|FG002|Overall Study|Protocol Violation|0|||
160724941|NCT00454246|580375935|FG000|Overall Study|Refused Treatment|1|||
160724942|NCT00454246|580375936|FG001|Overall Study|Refused Treatment|1|||
160724943|NCT00454246|580375937|FG002|Overall Study|Refused Treatment|0|||
160724944|NCT00454246|580375935|FG000|Overall Study|Failure to return|1|||
160724945|NCT00454246|580375936|FG001|Overall Study|Failure to return|0|||
160724946|NCT00454246|580375937|FG002|Overall Study|Failure to return|0|||
160724947|NCT00454246|580375935|FG000|Overall Study|Early termination of study|62|||
160724948|NCT00454246|580375936|FG001|Overall Study|Early termination of study|26|||
160724949|NCT00454246|580375937|FG002|Overall Study|Early termination of study|9|||
160724950|NCT00356603|580375938|FG000|Overall Study|Other|6|||
160724951|NCT00356603|580375939|FG001|Overall Study|Other|3|||
160724952|NCT05326529|580375940|FG000|Overall Study|Lack of Efficacy|0|||
160724953|NCT05326529|580375941|FG001|Overall Study|Lack of Efficacy|1|||
160724954|NCT05326529|580375942|FG002|Overall Study|Lack of Efficacy|0|||
160724955|NCT05326529|580375940|FG000|Overall Study|Physician Decision|0|||
160724956|NCT05326529|580375941|FG001|Overall Study|Physician Decision|0|||
160724957|NCT05326529|580375942|FG002|Overall Study|Physician Decision|2|||
160724958|NCT01262287|580375944|FG000|Overall Study|Lost to Follow-up|2|||
160724959|NCT01262287|580375945|FG001|Overall Study|Lost to Follow-up|1|||
160724960|NCT00932373|580375946|FG000|Overall Study|Progressive disease|3|||
160724961|NCT00932373|580375947|FG001|Overall Study|Progressive disease|1|||
160724962|NCT00932373|580375948|FG002|Overall Study|Progressive disease|0|||
160724963|NCT00932373|580375949|FG003|Overall Study|Progressive disease|0|||
160724964|NCT00932373|580375950|FG004|Overall Study|Progressive disease|10|||
160724965|NCT00932373|580375951|FG005|Overall Study|Progressive disease|1|||
160724966|NCT00932373|580375952|FG006|Overall Study|Progressive disease|0|||
160724967|NCT00932373|580375953|FG007|Overall Study|Progressive disease|2|||
160724968|NCT00932373|580375954|FG008|Overall Study|Progressive disease|1|||
160724969|NCT00932373|580375955|FG009|Overall Study|Progressive disease|9|||
160724970|NCT00932373|580375956|FG010|Overall Study|Progressive disease|2|||
160724971|NCT00932373|580375946|FG000|Overall Study|Adverse Event|0|||
160724972|NCT00932373|580375947|FG001|Overall Study|Adverse Event|0|||
160724973|NCT00932373|580375948|FG002|Overall Study|Adverse Event|0|||
160724974|NCT00932373|580375949|FG003|Overall Study|Adverse Event|0|||
160724975|NCT00932373|580375950|FG004|Overall Study|Adverse Event|2|||
160724976|NCT00932373|580375951|FG005|Overall Study|Adverse Event|1|||
160724977|NCT00932373|580375952|FG006|Overall Study|Adverse Event|0|||
160724978|NCT00932373|580375953|FG007|Overall Study|Adverse Event|1|||
160724979|NCT00932373|580375954|FG008|Overall Study|Adverse Event|0|||
160724980|NCT00932373|580375955|FG009|Overall Study|Adverse Event|2|||
160724981|NCT00932373|580375956|FG010|Overall Study|Adverse Event|1|||
160724982|NCT00932373|580375946|FG000|Overall Study|Physician Decision|0|||
160724983|NCT00932373|580375947|FG001|Overall Study|Physician Decision|0|||
160724984|NCT00932373|580375948|FG002|Overall Study|Physician Decision|1|||
160724985|NCT00932373|580375949|FG003|Overall Study|Physician Decision|0|||
160724986|NCT00932373|580375950|FG004|Overall Study|Physician Decision|2|||
160724987|NCT00932373|580375951|FG005|Overall Study|Physician Decision|0|||
160724988|NCT00932373|580375952|FG006|Overall Study|Physician Decision|0|||
160724989|NCT00932373|580375953|FG007|Overall Study|Physician Decision|0|||
160724990|NCT00932373|580375954|FG008|Overall Study|Physician Decision|0|||
160724991|NCT00932373|580375955|FG009|Overall Study|Physician Decision|1|||
160724992|NCT00932373|580375956|FG010|Overall Study|Physician Decision|0|||
160724993|NCT00932373|580375946|FG000|Overall Study|Dose limiting toxicity|0|||
160724994|NCT00932373|580375947|FG001|Overall Study|Dose limiting toxicity|0|||
160724995|NCT00932373|580375948|FG002|Overall Study|Dose limiting toxicity|0|||
160724996|NCT00932373|580375949|FG003|Overall Study|Dose limiting toxicity|0|||
160724997|NCT00932373|580375950|FG004|Overall Study|Dose limiting toxicity|0|||
160724998|NCT00932373|580375951|FG005|Overall Study|Dose limiting toxicity|1|||
160724999|NCT00932373|580375952|FG006|Overall Study|Dose limiting toxicity|0|||
160725000|NCT00932373|580375953|FG007|Overall Study|Dose limiting toxicity|0|||
160725001|NCT00932373|580375954|FG008|Overall Study|Dose limiting toxicity|0|||
160725002|NCT00932373|580375955|FG009|Overall Study|Dose limiting toxicity|0|||
160725003|NCT00932373|580375956|FG010|Overall Study|Dose limiting toxicity|0|||
160725004|NCT00932373|580375946|FG000|Overall Study|Withdrawal by Subject|0|||
160725005|NCT00932373|580375947|FG001|Overall Study|Withdrawal by Subject|0|||
160725006|NCT00932373|580375948|FG002|Overall Study|Withdrawal by Subject|0|||
160725007|NCT00932373|580375949|FG003|Overall Study|Withdrawal by Subject|0|||
160725008|NCT00932373|580375950|FG004|Overall Study|Withdrawal by Subject|0|||
160725009|NCT00932373|580375951|FG005|Overall Study|Withdrawal by Subject|0|||
160725010|NCT00932373|580375952|FG006|Overall Study|Withdrawal by Subject|0|||
160725011|NCT00932373|580375953|FG007|Overall Study|Withdrawal by Subject|0|||
160725012|NCT00932373|580375954|FG008|Overall Study|Withdrawal by Subject|1|||
160725013|NCT00932373|580375955|FG009|Overall Study|Withdrawal by Subject|0|||
160725014|NCT00932373|580375956|FG010|Overall Study|Withdrawal by Subject|0|||
160725015|NCT00932373|580375946|FG000|Overall Study|Clinical progression|0|||
160725016|NCT00932373|580375947|FG001|Overall Study|Clinical progression|0|||
160725017|NCT00932373|580375948|FG002|Overall Study|Clinical progression|0|||
160725018|NCT00932373|580375949|FG003|Overall Study|Clinical progression|0|||
160725019|NCT00932373|580375950|FG004|Overall Study|Clinical progression|0|||
160725020|NCT00932373|580375951|FG005|Overall Study|Clinical progression|0|||
160725021|NCT00932373|580375952|FG006|Overall Study|Clinical progression|1|||
160725022|NCT00932373|580375953|FG007|Overall Study|Clinical progression|0|||
160725023|NCT00932373|580375954|FG008|Overall Study|Clinical progression|0|||
160725024|NCT00932373|580375955|FG009|Overall Study|Clinical progression|0|||
160725025|NCT00932373|580375956|FG010|Overall Study|Clinical progression|0|||
160725026|NCT00932373|580375946|FG000|Overall Study|Lack of Efficacy|0|||
160725027|NCT00932373|580375947|FG001|Overall Study|Lack of Efficacy|0|||
160725028|NCT00932373|580375948|FG002|Overall Study|Lack of Efficacy|0|||
160725029|NCT00932373|580375949|FG003|Overall Study|Lack of Efficacy|0|||
160725030|NCT00932373|580375950|FG004|Overall Study|Lack of Efficacy|0|||
160725031|NCT00932373|580375951|FG005|Overall Study|Lack of Efficacy|0|||
160725032|NCT00932373|580375952|FG006|Overall Study|Lack of Efficacy|0|||
160725033|NCT00932373|580375953|FG007|Overall Study|Lack of Efficacy|0|||
160725034|NCT00932373|580375954|FG008|Overall Study|Lack of Efficacy|0|||
160725035|NCT00932373|580375955|FG009|Overall Study|Lack of Efficacy|1|||
160725036|NCT00932373|580375956|FG010|Overall Study|Lack of Efficacy|0|||
160725037|NCT04134767|580375959|FG000|Overall Study|Death|0|||
160725038|NCT04134767|580375960|FG001|Overall Study|Death|1|||
160725039|NCT04134767|580375959|FG000|Overall Study|Removed for harassing staff|0|||
160725040|NCT04134767|580375960|FG001|Overall Study|Removed for harassing staff|1|||
160725041|NCT04134767|580375959|FG000|Overall Study|Lost to Follow-up|44|||
160725042|NCT04134767|580375960|FG001|Overall Study|Lost to Follow-up|40|||
160725043|NCT00638404|580375961|FG000|Overall Study|Physician Decision|8|||
160725044|NCT00638404|580375962|FG001|Overall Study|Physician Decision|0|||
160725045|NCT02492984|580375966|FG000|Overall Study|Adverse Event|1|||
160725046|NCT02492984|580375967|FG001|Overall Study|Adverse Event|0|||
160725047|NCT02492984|580375966|FG000|Overall Study|Protocol Violation|1|||
160725048|NCT02492984|580375967|FG001|Overall Study|Protocol Violation|0|||
160725049|NCT02492984|580375966|FG000|Overall Study|Withdrawal by Subject|1|||
160725050|NCT02492984|580375967|FG001|Overall Study|Withdrawal by Subject|0|||
160725051|NCT02282631|580375968|FG000|Overall Study|Lost to Follow-up|2|||
160725052|NCT02282631|580375969|FG001|Overall Study|Lost to Follow-up|0|||
160725053|NCT00459290|580375970|FG000|Overall Study|Adverse Event|3|||
160725054|NCT00459290|580375970|FG000|Overall Study|Ineligible|2|||
160725055|NCT00687271|580375971|FG000|Overall Study|Adverse Event|1|||
160725056|NCT00687271|580375972|FG001|Overall Study|Adverse Event|3|||
160725057|NCT00687271|580375973|FG002|Overall Study|Adverse Event|1|||
160725058|NCT00687271|580375974|FG003|Overall Study|Adverse Event|0|||
160725059|NCT00687271|580375971|FG000|Overall Study|Lost to Follow-up|0|||
160725060|NCT00687271|580375972|FG001|Overall Study|Lost to Follow-up|1|||
160725061|NCT00687271|580375973|FG002|Overall Study|Lost to Follow-up|0|||
160725062|NCT00687271|580375974|FG003|Overall Study|Lost to Follow-up|0|||
160725063|NCT00687271|580375971|FG000|Overall Study|Protocol Violation|2|||
160725064|NCT00687271|580375972|FG001|Overall Study|Protocol Violation|1|||
160725065|NCT00687271|580375973|FG002|Overall Study|Protocol Violation|1|||
160725066|NCT00687271|580375974|FG003|Overall Study|Protocol Violation|0|||
160725067|NCT00687271|580375971|FG000|Overall Study|Withdrawal by Subject|0|||
160725068|NCT00687271|580375972|FG001|Overall Study|Withdrawal by Subject|1|||
160725069|NCT00687271|580375973|FG002|Overall Study|Withdrawal by Subject|3|||
160725070|NCT00687271|580375974|FG003|Overall Study|Withdrawal by Subject|0|||
160725071|NCT02453334|580375975|FG000|Overall Study|Death|15|||
160725072|NCT02453334|580375976|FG001|Overall Study|Death|13|||
160725073|NCT02453334|580375975|FG000|Overall Study|Adverse Event|2|||
160725074|NCT02453334|580375976|FG001|Overall Study|Adverse Event|1|||
160725075|NCT02453334|580375975|FG000|Overall Study|Lost to Follow-up|5|||
160725076|NCT02453334|580375976|FG001|Overall Study|Lost to Follow-up|9|||
160725077|NCT02453334|580375975|FG000|Overall Study|Physician Decision|1|||
160725078|NCT02453334|580375976|FG001|Overall Study|Physician Decision|0|||
160725079|NCT02453334|580375975|FG000|Overall Study|Withdrawal by Subject|17|||
160725080|NCT02453334|580375976|FG001|Overall Study|Withdrawal by Subject|13|||
160725081|NCT02453334|580375975|FG000|Overall Study|Other reason|1|||
160725082|NCT02453334|580375976|FG001|Overall Study|Other reason|4|||
160725083|NCT01841762|580375977|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
160725084|NCT01841762|580375977|FG000|Treatment Period|Adverse Event|16|||
160725085|NCT01841762|580375977|FG000|Treatment Period|Death|1|||
160725086|NCT01841762|580375977|FG000|Treatment Period|Withdrawal by Subject|7|||
160725087|NCT01841762|580375977|FG000|Treatment Period|Lost to Follow-up|1|||
160725088|NCT01841762|580375977|FG000|Treatment Period|Physician Decision|2|||
160725089|NCT01841762|580375977|FG000|Treatment Period|Other, including non-compliance|5|||
160725090|NCT01841762|580375977|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
160725091|NCT01841762|580375977|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
160725092|NCT01841762|580375977|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
160725093|NCT01841762|580375977|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
160725094|NCT06152224|580375981|FG000|Overall Study|Withdrawal by Subject|1|||
160725095|NCT06152224|580375982|FG001|Overall Study|Withdrawal by Subject|0|||
160725096|NCT06152224|580375981|FG000|Overall Study|Lost to Follow-up|0|||
160725097|NCT06152224|580375982|FG001|Overall Study|Lost to Follow-up|1|||
160725098|NCT06152224|580375981|FG000|Overall Study|On Follow Up|18|||
160725099|NCT06152224|580375982|FG001|Overall Study|On Follow Up|18|||
160725100|NCT05780983|580375983|FG000|Overall Study|Withdrawal by Subject|1|||
160725101|NCT06028438|580375984|FG000|Overall Study|Adverse Event|3|||
160725102|NCT06028438|580375985|FG001|Overall Study|Adverse Event|9|||
160725103|NCT06028438|580375984|FG000|Overall Study|Lack of Efficacy|1|||
160725104|NCT06028438|580375985|FG001|Overall Study|Lack of Efficacy|1|||
160725105|NCT06028438|580375984|FG000|Overall Study|Lost to Follow-up|1|||
160725106|NCT06028438|580375985|FG001|Overall Study|Lost to Follow-up|0|||
160725107|NCT06028438|580375984|FG000|Overall Study|Withdrawal by Subject|1|||
160725108|NCT06028438|580375985|FG001|Overall Study|Withdrawal by Subject|0|||
160725109|NCT06028438|580375984|FG000|Overall Study|Other|3|||
160725110|NCT06028438|580375985|FG001|Overall Study|Other|3|||
160725111|NCT00808210|580375986|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
160725112|NCT00808210|580375987|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
160725113|NCT00808210|580375986|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
160725114|NCT00808210|580375987|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
160725115|NCT00808210|580375986|FG000|Double-Blind TX Period|Adverse Event|0|||
160725116|NCT00808210|580375987|FG001|Double-Blind TX Period|Adverse Event|1|||
160725117|NCT00808210|580375986|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
160725118|NCT00808210|580375987|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
160725119|NCT00808210|580375986|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
160725120|NCT00808210|580375987|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
160725121|NCT00808210|580375986|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
160725122|NCT00808210|580375987|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
160725123|NCT02044302|580375988|FG000|Overall Study|study terminated|2|||
160725124|NCT02044302|580375989|FG001|Overall Study|study terminated|0|||
160725125|NCT03337113|580375996|FG000|Overall Study|Adverse Event|1|||
160725126|NCT03337113|580375997|FG001|Overall Study|Adverse Event|1|||
160725127|NCT03337113|580375998|FG002|Overall Study|Adverse Event|0|||
160725128|NCT03337113|580375999|FG003|Overall Study|Adverse Event|1|||
160725129|NCT03337113|580375996|FG000|Overall Study|Physician Decision|0|||
160725130|NCT03337113|580375997|FG001|Overall Study|Physician Decision|2|||
160725131|NCT03337113|580375998|FG002|Overall Study|Physician Decision|0|||
160725132|NCT03337113|580375999|FG003|Overall Study|Physician Decision|1|||
160725133|NCT03337113|580375996|FG000|Overall Study|Withdrawal by Subject|0|||
160725134|NCT03337113|580375997|FG001|Overall Study|Withdrawal by Subject|0|||
160725135|NCT03337113|580375998|FG002|Overall Study|Withdrawal by Subject|1|||
160725136|NCT03337113|580375999|FG003|Overall Study|Withdrawal by Subject|0|||
160725137|NCT01372995|580376008|FG000|Overall Study|Spouse withdrew participant from study|0|||
160725138|NCT01372995|580376009|FG001|Overall Study|Spouse withdrew participant from study|1|||
160725139|NCT01372995|580376010|FG002|Overall Study|Spouse withdrew participant from study|0|||
160725140|NCT01372995|580376008|FG000|Overall Study|Physician Decision|0|||
160725141|NCT01372995|580376009|FG001|Overall Study|Physician Decision|0|||
160725142|NCT01372995|580376010|FG002|Overall Study|Physician Decision|1|||
160725143|NCT01297517|580376013|FG000|Overall Study|Adverse Event|21|||
160725144|NCT01297517|580376014|FG001|Overall Study|Adverse Event|7|||
160725145|NCT01297517|580376015|FG002|Overall Study|Adverse Event|16|||
160725146|NCT01297517|580376013|FG000|Overall Study|Lost to Follow-up|1|||
160725147|NCT01297517|580376014|FG001|Overall Study|Lost to Follow-up|0|||
160725148|NCT01297517|580376015|FG002|Overall Study|Lost to Follow-up|1|||
160725149|NCT01297517|580376013|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
160725150|NCT01297517|580376014|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
160725151|NCT01297517|580376015|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
160725152|NCT01297517|580376013|FG000|Overall Study|Noncompliance|1|||
160725153|NCT01297517|580376014|FG001|Overall Study|Noncompliance|0|||
160725154|NCT01297517|580376015|FG002|Overall Study|Noncompliance|0|||
160725155|NCT01297517|580376013|FG000|Overall Study|Protocol Violation|1|||
160725156|NCT01297517|580376014|FG001|Overall Study|Protocol Violation|1|||
160725157|NCT01297517|580376015|FG002|Overall Study|Protocol Violation|1|||
160725158|NCT01297517|580376013|FG000|Overall Study|Inadequate Control of IOP|1|||
160725159|NCT01297517|580376014|FG001|Overall Study|Inadequate Control of IOP|1|||
160725160|NCT01297517|580376015|FG002|Overall Study|Inadequate Control of IOP|2|||
160725161|NCT04938180|580376016|FG000|Overall Study|Adverse Event|1|||
160725162|NCT01964222|580376017|FG000|Overall Study|Lost to Follow-up|7|||
160725163|NCT01964222|580376018|FG001|Overall Study|Lost to Follow-up|5|||
160725164|NCT01964222|580376017|FG000|Overall Study|Withdrawal by Subject|6|||
160725165|NCT01964222|580376018|FG001|Overall Study|Withdrawal by Subject|6|||
160725166|NCT01964222|580376017|FG000|Overall Study|Screening Failure|2|||
160725167|NCT01964222|580376018|FG001|Overall Study|Screening Failure|0|||
160725168|NCT01019694|580376021|FG000|Overall Study|Adverse Event|12|||
160725169|NCT01019694|580376022|FG001|Overall Study|Adverse Event|16|||
160725170|NCT01019694|580376023|FG002|Overall Study|Adverse Event|19|||
160725171|NCT01019694|580376021|FG000|Overall Study|Protocol Violation|2|||
160725172|NCT01019694|580376022|FG001|Overall Study|Protocol Violation|6|||
160725173|NCT01019694|580376023|FG002|Overall Study|Protocol Violation|4|||
160725174|NCT01019694|580376021|FG000|Overall Study|Lost to Follow-up|5|||
160725175|NCT01019694|580376022|FG001|Overall Study|Lost to Follow-up|3|||
160725176|NCT01019694|580376023|FG002|Overall Study|Lost to Follow-up|3|||
160725177|NCT01019694|580376021|FG000|Overall Study|Withdrawal by Subject|4|||
160725178|NCT01019694|580376022|FG001|Overall Study|Withdrawal by Subject|6|||
160725179|NCT01019694|580376023|FG002|Overall Study|Withdrawal by Subject|12|||
160725180|NCT01019694|580376021|FG000|Overall Study|Not treated|0|||
160725181|NCT01019694|580376022|FG001|Overall Study|Not treated|2|||
160725182|NCT01019694|580376023|FG002|Overall Study|Not treated|3|||
160725183|NCT01019694|580376021|FG000|Overall Study|Other reason (not specified)|1|||
160725184|NCT01019694|580376022|FG001|Overall Study|Other reason (not specified)|5|||
160725185|NCT01019694|580376023|FG002|Overall Study|Other reason (not specified)|6|||
160725186|NCT00463047|580376025|FG000|Titration Period 1|Adverse Event|10|||
160725187|NCT00463047|580376026|FG001|Titration Period 1|Adverse Event|8|||
160725188|NCT00463047|580376025|FG000|Titration Period 1|Lack of Efficacy|10|||
160725189|NCT00463047|580376026|FG001|Titration Period 1|Lack of Efficacy|4|||
160725190|NCT00463047|580376025|FG000|Titration Period 1|Lost to Follow-up|2|||
160725191|NCT00463047|580376026|FG001|Titration Period 1|Lost to Follow-up|0|||
160725192|NCT00463047|580376025|FG000|Titration Period 1|Non-compliance with study medication|3|||
160725193|NCT00463047|580376026|FG001|Titration Period 1|Non-compliance with study medication|5|||
160725194|NCT00463047|580376025|FG000|Titration Period 1|Protocol Violation|5|||
160725195|NCT00463047|580376026|FG001|Titration Period 1|Protocol Violation|5|||
160725196|NCT00463047|580376025|FG000|Titration Period 1|Withdrawal by Subject|3|||
160725197|NCT00463047|580376026|FG001|Titration Period 1|Withdrawal by Subject|5|||
160725198|NCT00463047|580376025|FG000|Titration Period 1|Non-compliance procedures|4|||
160725199|NCT00463047|580376026|FG001|Titration Period 1|Non-compliance procedures|10|||
160725200|NCT00463047|580376025|FG000|Titration Period 1|Other|0|||
160725201|NCT00463047|580376026|FG001|Titration Period 1|Other|2|||
160725202|NCT00463047|580376025|FG000|Titration Period 2|Adverse Event|9|||
160725203|NCT00463047|580376026|FG001|Titration Period 2|Adverse Event|9|||
160725204|NCT00463047|580376025|FG000|Titration Period 2|Lack of Efficacy|6|||
160725205|NCT00463047|580376026|FG001|Titration Period 2|Lack of Efficacy|4|||
160725206|NCT00463047|580376025|FG000|Titration Period 2|Withdrawal by Subject|1|||
160725207|NCT00463047|580376026|FG001|Titration Period 2|Withdrawal by Subject|0|||
160725208|NCT00463047|580376025|FG000|Titration Period 2|Protocol Violation|2|||
160725209|NCT00463047|580376026|FG001|Titration Period 2|Protocol Violation|3|||
160725210|NCT00463047|580376025|FG000|Titration Period 2|Lost to Follow-up|1|||
160725211|NCT00463047|580376026|FG001|Titration Period 2|Lost to Follow-up|2|||
160725212|NCT00463047|580376025|FG000|Titration Period 2|Non-compliance study medication|4|||
160725213|NCT00463047|580376026|FG001|Titration Period 2|Non-compliance study medication|2|||
160725214|NCT00463047|580376025|FG000|Titration Period 2|Non-compliance procedures|4|||
160725215|NCT00463047|580376026|FG001|Titration Period 2|Non-compliance procedures|1|||
160725216|NCT00463047|580376025|FG000|Titration Period 2|Other|3|||
160725217|NCT00463047|580376026|FG001|Titration Period 2|Other|2|||
160725218|NCT00463047|580376025|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
160725219|NCT00463047|580376026|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
160725220|NCT00463047|580376025|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
160725221|NCT00463047|580376026|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
160725222|NCT00463047|580376025|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
160725223|NCT00463047|580376026|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
160725224|NCT00463047|580376025|FG000|Double-Blind Treatment Period 1|Other|1|||
160725225|NCT00463047|580376026|FG001|Double-Blind Treatment Period 1|Other|0|||
160725226|NCT00463047|580376025|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
160725227|NCT00463047|580376026|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
160725228|NCT00463047|580376025|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
160725229|NCT00463047|580376026|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
160725230|NCT00463047|580376025|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
160725231|NCT00463047|580376026|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
160725232|NCT00987337|580376034|FG000|Overall Study|Adverse Event|10|||
160725233|NCT00987337|580376035|FG001|Overall Study|Adverse Event|9|||
160725234|NCT00987337|580376036|FG002|Overall Study|Adverse Event|8|||
160725235|NCT00987337|580376034|FG000|Overall Study|Insufficient Virologic Response|10|||
160725236|NCT00987337|580376035|FG001|Overall Study|Insufficient Virologic Response|7|||
160725237|NCT00987337|580376036|FG002|Overall Study|Insufficient Virologic Response|12|||
160725238|NCT00987337|580376034|FG000|Overall Study|Virologic Breakthrough|2|||
160725239|NCT00987337|580376035|FG001|Overall Study|Virologic Breakthrough|2|||
160725240|NCT00987337|580376036|FG002|Overall Study|Virologic Breakthrough|8|||
160725241|NCT00987337|580376034|FG000|Overall Study|Lost to Follow-up|10|||
160725242|NCT00987337|580376035|FG001|Overall Study|Lost to Follow-up|6|||
160725243|NCT00987337|580376036|FG002|Overall Study|Lost to Follow-up|2|||
160725244|NCT00987337|580376034|FG000|Overall Study|Withdrawal by Subject|6|||
160725245|NCT00987337|580376035|FG001|Overall Study|Withdrawal by Subject|9|||
160725246|NCT00987337|580376036|FG002|Overall Study|Withdrawal by Subject|9|||
160725247|NCT00987337|580376034|FG000|Overall Study|Other|0|||
160725248|NCT00987337|580376035|FG001|Overall Study|Other|2|||
160725249|NCT00987337|580376036|FG002|Overall Study|Other|5|||
160725250|NCT00987337|580376034|FG000|Overall Study|Protocol Violation|1|||
160725251|NCT00987337|580376035|FG001|Overall Study|Protocol Violation|0|||
160725252|NCT00987337|580376036|FG002|Overall Study|Protocol Violation|2|||
160725253|NCT00987337|580376034|FG000|Overall Study|Participant Relapsed|18|||
160725254|NCT00987337|580376035|FG001|Overall Study|Participant Relapsed|20|||
160725255|NCT00987337|580376036|FG002|Overall Study|Participant Relapsed|5|||
160725256|NCT00300885|580377382|FG000|Treatment|Adverse Event|134|||
160725257|NCT00300885|580377383|FG001|Treatment|Adverse Event|82|||
160725258|NCT00300885|580377382|FG000|Treatment|Death|20|||
160725259|NCT00300885|580377383|FG001|Treatment|Death|7|||
160725260|NCT00300885|580377382|FG000|Treatment|Lack of Efficacy|1|||
160725261|NCT00300885|580377383|FG001|Treatment|Lack of Efficacy|1|||
160725262|NCT00300885|580377382|FG000|Treatment|Lost to Follow-up|3|||
160725263|NCT00300885|580377383|FG001|Treatment|Lost to Follow-up|2|||
160725264|NCT00300885|580377382|FG000|Treatment|Physician Decision|4|||
160725265|NCT00300885|580377383|FG001|Treatment|Physician Decision|5|||
160725266|NCT00300885|580377382|FG000|Treatment|Protocol Violation|11|||
160725267|NCT00300885|580377383|FG001|Treatment|Protocol Violation|11|||
160725268|NCT00300885|580377382|FG000|Treatment|Withdrawal by Subject|26|||
160725269|NCT00300885|580377383|FG001|Treatment|Withdrawal by Subject|23|||
160725270|NCT00300885|580377382|FG000|Treatment|Disease progression|171|||
160725271|NCT00300885|580377383|FG001|Treatment|Disease progression|238|||
160725272|NCT00300885|580377382|FG000|Treatment|Random code broken (subject died)|0|||
160725273|NCT00300885|580377383|FG001|Treatment|Random code broken (subject died)|1|||
160725274|NCT00300885|580377382|FG000|Treatment|Non-compliant with study medication|3|||
160725275|NCT00300885|580377383|FG001|Treatment|Non-compliant with study medication|4|||
160725276|NCT00300885|580377382|FG000|Follow-up|Death|141|||
160725277|NCT00300885|580377383|FG001|Follow-up|Death|163|||
160725278|NCT00300885|580377382|FG000|Follow-up|Lost to Follow-up|11|||
160725279|NCT00300885|580377383|FG001|Follow-up|Lost to Follow-up|7|||
160725280|NCT00300885|580377382|FG000|Follow-up|Withdrawal by Subject|26|||
160725281|NCT00300885|580377383|FG001|Follow-up|Withdrawal by Subject|25|||
160725282|NCT01637922|580377384|FG000|Overall Study|Adverse Event|0|||
160725283|NCT01637922|580377385|FG001|Overall Study|Adverse Event|1|||
160725284|NCT01637922|580377384|FG000|Overall Study|Protocol Violation|0|||
160725285|NCT01637922|580377385|FG001|Overall Study|Protocol Violation|1|||
160725286|NCT01637922|580377384|FG000|Overall Study|Withdrawal by Subject|0|||
160725287|NCT01637922|580377385|FG001|Overall Study|Withdrawal by Subject|3|||
160725288|NCT01637922|580377384|FG000|Overall Study|Lost to Follow-up|2|||
160725289|NCT01637922|580377385|FG001|Overall Study|Lost to Follow-up|0|||
160725290|NCT02914613|580377388|FG000|Overall Study|Withdrawal by Subject|1|||
160725291|NCT02914613|580377389|FG001|Overall Study|Withdrawal by Subject|2|||
160725292|NCT02914613|580377388|FG000|Overall Study|Adverse Event|1|||
160725293|NCT02914613|580377389|FG001|Overall Study|Adverse Event|0|||
160725294|NCT00441129|580377394|FG000|Overall Study|Withdrawal by Subject|6|||
160725295|NCT00441129|580377395|FG001|Overall Study|Withdrawal by Subject|14|||
160725296|NCT01737710|580377397|FG000|Overall Study|Lost to Follow-up|0|||
160725297|NCT01737710|580377398|FG001|Overall Study|Lost to Follow-up|2|||
160725298|NCT01737710|580377399|FG002|Overall Study|Lost to Follow-up|2|||
160725299|NCT01737710|580377400|FG003|Overall Study|Lost to Follow-up|0|||
160725300|NCT01737710|580377401|FG004|Overall Study|Lost to Follow-up|0|||
160725301|NCT01737710|580377397|FG000|Overall Study|Withdrawal by Subject|1|||
160725302|NCT01737710|580377398|FG001|Overall Study|Withdrawal by Subject|1|||
160725303|NCT01737710|580377399|FG002|Overall Study|Withdrawal by Subject|1|||
160725304|NCT01737710|580377400|FG003|Overall Study|Withdrawal by Subject|0|||
160725305|NCT01737710|580377401|FG004|Overall Study|Withdrawal by Subject|0|||
160725306|NCT01737710|580377397|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
160725307|NCT01737710|580377398|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
160725308|NCT01737710|580377399|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
160725309|NCT01737710|580377400|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
160725310|NCT01737710|580377401|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
160725311|NCT00758485|580377405|FG000|Overall Study|Lost to Follow-up|0|||
160725312|NCT00758485|580377406|FG001|Overall Study|Lost to Follow-up|1|||
160725313|NCT00758485|580377405|FG000|Overall Study|Not Treated|1|||
160725314|NCT00758485|580377406|FG001|Overall Study|Not Treated|2|||
160725315|NCT00656292|580377407|FG000|Overall Study|Withdrawal by Subject|2|||
160725316|NCT00656292|580377408|FG001|Overall Study|Withdrawal by Subject|3|||
160725317|NCT00656292|580377407|FG000|Overall Study|Screen failure|1|||
160725318|NCT00656292|580377408|FG001|Overall Study|Screen failure|2|||
160725319|NCT00921557|580377409|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
160725320|NCT00921557|580377410|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
160725321|NCT00921557|580377411|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
160725322|NCT00921557|580377409|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
160725323|NCT00921557|580377410|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
160725324|NCT00921557|580377411|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
160725325|NCT00921557|580377409|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
160725326|NCT00921557|580377410|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
160725327|NCT00921557|580377411|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
160725328|NCT00921557|580377409|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
160725329|NCT00921557|580377410|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
160725330|NCT00921557|580377411|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
160725331|NCT00921557|580377409|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
160725332|NCT00921557|580377410|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
160725333|NCT00921557|580377411|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
160725334|NCT03259425|580377412|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
160725335|NCT03363776|580377413|FG000|Overall Study|Progressive disease|2|||
160725336|NCT03363776|580377414|FG001|Overall Study|Progressive disease|3|||
160725337|NCT03363776|580377415|FG002|Overall Study|Progressive disease|1|||
160725338|NCT03363776|580377413|FG000|Overall Study|Study drug toxicity|0|||
160725339|NCT03363776|580377414|FG001|Overall Study|Study drug toxicity|0|||
160725340|NCT03363776|580377415|FG002|Overall Study|Study drug toxicity|1|||
160725341|NCT03363776|580377413|FG000|Overall Study|Death|1|||
160725342|NCT03363776|580377414|FG001|Overall Study|Death|0|||
160725343|NCT03363776|580377415|FG002|Overall Study|Death|0|||
160725344|NCT02993250|580377423|FG000|Overall Study|Lost to Follow-up|0|||
160725345|NCT02993250|580377424|FG001|Overall Study|Lost to Follow-up|1|||
160725346|NCT02527434|580377426|FG000|Overall Study|Lost to Follow-up|2|||
160725347|NCT02527434|580377427|FG001|Overall Study|Lost to Follow-up|2|||
160725348|NCT02527434|580377428|FG002|Overall Study|Lost to Follow-up|0|||
160725349|NCT02527434|580377426|FG000|Overall Study|Death|19|||
160725350|NCT02527434|580377427|FG001|Overall Study|Death|6|||
160725351|NCT02527434|580377428|FG002|Overall Study|Death|17|||
160725352|NCT02527434|580377426|FG000|Overall Study|Withdrawal by Subject|5|||
160725353|NCT02527434|580377427|FG001|Overall Study|Withdrawal by Subject|3|||
160725354|NCT02527434|580377428|FG002|Overall Study|Withdrawal by Subject|3|||
160725355|NCT02527434|580377426|FG000|Overall Study|Reason Not Specified|1|||
160725356|NCT02527434|580377427|FG001|Overall Study|Reason Not Specified|0|||
160725357|NCT02527434|580377428|FG002|Overall Study|Reason Not Specified|0|||
160725358|NCT02527434|580377426|FG000|Overall Study|Site closure|1|||
160725359|NCT02527434|580377427|FG001|Overall Study|Site closure|0|||
160725360|NCT02527434|580377428|FG002|Overall Study|Site closure|0|||
160725361|NCT02861807|580377429|FG000|Overall Study|Lost to Follow-up|7|||
160725362|NCT02861807|580377430|FG001|Overall Study|Lost to Follow-up|6|||
160725363|NCT02861807|580377429|FG000|Overall Study|Withdrawal by Subject|5|||
160725364|NCT02861807|580377430|FG001|Overall Study|Withdrawal by Subject|8|||
160725365|NCT00568061|580377435|FG000|Overall Study|Inclusion / exclusion criteria|5|||
160725366|NCT00568061|580377436|FG001|Overall Study|Inclusion / exclusion criteria|1|||
160725367|NCT00568061|580377435|FG000|Overall Study|Adverse Event|0|||
160725368|NCT00568061|580377436|FG001|Overall Study|Adverse Event|1|||
160725369|NCT05027451|580377437|FG000|Overall Study|Lost to Follow-up|1|||
160725370|NCT05027451|580377438|FG001|Overall Study|Lost to Follow-up|1|||
160725371|NCT00356148|580377439|FG000|Overall Study|Reoperation within 30 days|2|||
160725372|NCT00356148|580377440|FG001|Overall Study|Reoperation within 30 days|1|||
160725373|NCT02693002|580377442|FG000|Overall Study|Withdrawal by Subject|1|||
160725374|NCT02693002|580377443|FG001|Overall Study|Withdrawal by Subject|0|||
160725375|NCT00812981|580377444|FG000|Overall Study|Other|0|||
160725376|NCT00812981|580377445|FG001|Overall Study|Other|1|||
160725377|NCT04666259|580377447|FG000|Treatment Phase|Physician Decision|9|||
160725378|NCT04666259|580377448|FG001|Treatment Phase|Physician Decision|3|||
160725379|NCT04666259|580377449|FG002|Treatment Phase|Physician Decision|3|||
160725380|NCT04666259|580377447|FG000|Treatment Phase|Adverse Event|3|||
160725381|NCT04666259|580377448|FG001|Treatment Phase|Adverse Event|1|||
160725382|NCT04666259|580377449|FG002|Treatment Phase|Adverse Event|0|||
160725383|NCT04666259|580377447|FG000|Treatment Phase|Subject decision|1|||
160725384|NCT04666259|580377448|FG001|Treatment Phase|Subject decision|2|||
160725385|NCT04666259|580377449|FG002|Treatment Phase|Subject decision|0|||
160725386|NCT04666259|580377447|FG000|Treatment Phase|Progressive disease|0|||
160725387|NCT04666259|580377448|FG001|Treatment Phase|Progressive disease|1|||
160725388|NCT04666259|580377449|FG002|Treatment Phase|Progressive disease|0|||
160725389|NCT04666259|580377447|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
160725390|NCT04666259|580377448|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
160725391|NCT04666259|580377449|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
160725392|NCT04666259|580377447|FG000|Safety Follow-up Phase|Physician Decision|2|||
160725393|NCT04666259|580377448|FG001|Safety Follow-up Phase|Physician Decision|0|||
160725394|NCT04666259|580377449|FG002|Safety Follow-up Phase|Physician Decision|0|||
160725395|NCT04666259|580377447|FG000|Safety Follow-up Phase|Subject decision|1|||
160725396|NCT04666259|580377448|FG001|Safety Follow-up Phase|Subject decision|0|||
160725397|NCT04666259|580377449|FG002|Safety Follow-up Phase|Subject decision|0|||
160725398|NCT04666259|580377447|FG000|Safety Follow-up Phase|Death|0|||
160725399|NCT04666259|580377448|FG001|Safety Follow-up Phase|Death|1|||
160725400|NCT04666259|580377449|FG002|Safety Follow-up Phase|Death|0|||
160725401|NCT04178122|580377450|FG000|Overall Study|Withdrawal by Subject|1|||
160725402|NCT04178122|580377451|FG001|Overall Study|Withdrawal by Subject|1|||
160725403|NCT04178122|580377450|FG000|Overall Study|Death|2|||
160725404|NCT04178122|580377451|FG001|Overall Study|Death|0|||
160725405|NCT04178122|580377450|FG000|Overall Study|Did not complete testing|3|||
160725406|NCT04178122|580377451|FG001|Overall Study|Did not complete testing|13|||
160725407|NCT03124407|580377456|FG000|Overall Study|Lost to Follow-up|1|||
160725408|NCT03124407|580377457|FG001|Overall Study|Lost to Follow-up|0|||
160725409|NCT03124407|580377458|FG002|Overall Study|Lost to Follow-up|0|||
160725410|NCT03124407|580377459|FG003|Overall Study|Lost to Follow-up|0|||
160725411|NCT03124407|580377456|FG000|Overall Study|Adverse Event|0|||
160725412|NCT03124407|580377457|FG001|Overall Study|Adverse Event|0|||
160725413|NCT03124407|580377458|FG002|Overall Study|Adverse Event|1|||
160725414|NCT03124407|580377459|FG003|Overall Study|Adverse Event|0|||
160725415|NCT05343364|580377460|FG000|Overall Study|Miscellaneous|0|||
160725416|NCT05343364|580377461|FG001|Overall Study|Miscellaneous|1|||
160725417|NCT01791894|580377462|FG000|Overall Study|Adverse Event|1|||
160725418|NCT00984542|580377465|FG000|Overall Study|disease progression|19|||
160725419|NCT00984542|580377465|FG000|Overall Study|toxicity|7|||
160725420|NCT00984542|580377465|FG000|Overall Study|Death|7|||
160725421|NCT00984542|580377465|FG000|Overall Study|complicating disease|3|||
160725422|NCT00984542|580377465|FG000|Overall Study|Withdrawal by Subject|3|||
160725423|NCT00984542|580377465|FG000|Overall Study|clinical deterioration|2|||
160725424|NCT01422889|580377466|FG000|Overall Study|No Data Entered for Study Stent|9|||
160725425|NCT02097745|580377475|FG000|Overall Study|Adverse Event|25|||
160725426|NCT02097745|580377475|FG000|Overall Study|Death|16|||
160725427|NCT02097745|580377475|FG000|Overall Study|Failure to Return|14|||
160725428|NCT02097745|580377475|FG000|Overall Study|Administrative/Other|27|||
160725429|NCT02097745|580377475|FG000|Overall Study|Reason Not Specified|96|||
160725430|NCT02748356|580377476|FG000|Overall Study|Withdrawal by Subject|1|||
160725431|NCT00425750|580377477|FG000|Overall Study|Death|1|||
160725432|NCT00425750|580377477|FG000|Overall Study|Withdrawal by Subject|3|||
160725433|NCT00425750|580377477|FG000|Overall Study|Adverse Event|3|||
160725434|NCT00425750|580377477|FG000|Overall Study|Progression of disease|18|||
160725435|NCT01732458|580377478|FG000|Overall Study|Lost to Follow-up|0|||
160725436|NCT01732458|580377479|FG001|Overall Study|Lost to Follow-up|2|||
160725437|NCT01732458|580377480|FG002|Overall Study|Lost to Follow-up|0|||
160725438|NCT01732458|580377481|FG003|Overall Study|Lost to Follow-up|0|||
160725439|NCT01732458|580377478|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160725440|NCT01732458|580377479|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160725441|NCT01732458|580377480|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160725442|NCT01732458|580377481|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160725443|NCT01732458|580377478|FG000|Overall Study|Physician Decision|1|||
160725444|NCT01732458|580377479|FG001|Overall Study|Physician Decision|2|||
160725445|NCT01732458|580377480|FG002|Overall Study|Physician Decision|2|||
160725446|NCT01732458|580377481|FG003|Overall Study|Physician Decision|0|||
160725447|NCT01732458|580377478|FG000|Overall Study|Protocol Violation|2|||
160725448|NCT01732458|580377479|FG001|Overall Study|Protocol Violation|0|||
160725449|NCT01732458|580377480|FG002|Overall Study|Protocol Violation|0|||
160725450|NCT01732458|580377481|FG003|Overall Study|Protocol Violation|2|||
160725451|NCT01732458|580377478|FG000|Overall Study|Screen Failure|0|||
160725452|NCT01732458|580377479|FG001|Overall Study|Screen Failure|1|||
160725453|NCT01732458|580377480|FG002|Overall Study|Screen Failure|0|||
160725454|NCT01732458|580377481|FG003|Overall Study|Screen Failure|0|||
160725455|NCT04331067|580377482|FG000|Overall Study|Adverse Event|1|||
160725456|NCT04331067|580377483|FG001|Overall Study|Adverse Event|3|||
160725457|NCT04331067|580377484|FG002|Overall Study|Adverse Event|1|||
160725458|NCT04331067|580377482|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
160725459|NCT04331067|580377483|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
160725460|NCT04331067|580377484|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
160725461|NCT05870371|580377485|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
160725462|NCT05870371|580377486|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
160725463|NCT02589639|580377487|FG000|Overall Study|Lost to Follow-up|1|||
160725464|NCT02589639|580377488|FG001|Overall Study|Lost to Follow-up|0|||
160725465|NCT02589639|580377489|FG002|Overall Study|Lost to Follow-up|0|||
160725466|NCT02589639|580377487|FG000|Overall Study|Protocol Violation|1|||
160725467|NCT02589639|580377488|FG001|Overall Study|Protocol Violation|0|||
160725468|NCT02589639|580377489|FG002|Overall Study|Protocol Violation|0|||
160725469|NCT02589639|580377487|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
160725470|NCT02589639|580377488|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
160725471|NCT02589639|580377489|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
160725472|NCT02589639|580377487|FG000|Overall Study|Adverse Event|4|||
160725473|NCT02589639|580377488|FG001|Overall Study|Adverse Event|5|||
160725474|NCT02589639|580377489|FG002|Overall Study|Adverse Event|3|||
160725475|NCT02589639|580377487|FG000|Overall Study|Other reason than specified above|1|||
160725476|NCT02589639|580377488|FG001|Overall Study|Other reason than specified above|2|||
160725477|NCT02589639|580377489|FG002|Overall Study|Other reason than specified above|1|||
160725478|NCT02589639|580377487|FG000|Overall Study|Not Treated|0|||
160725479|NCT02589639|580377488|FG001|Overall Study|Not Treated|3|||
160725480|NCT02589639|580377489|FG002|Overall Study|Not Treated|0|||
160725481|NCT02203721|580377492|FG000|Overall Study|Lost to Follow-up|1|||
160725482|NCT02203721|580377493|FG001|Overall Study|Lost to Follow-up|0|||
160725483|NCT02203721|580377492|FG000|Overall Study|Death|0|||
160725484|NCT02203721|580377493|FG001|Overall Study|Death|2|||
160725485|NCT02203721|580377492|FG000|Overall Study|Illness|0|||
160725486|NCT02203721|580377493|FG001|Overall Study|Illness|1|||
160725487|NCT00703157|580377494|FG000|Overall Study|Lost to Follow-up|0|||
160725488|NCT00703157|580377495|FG001|Overall Study|Lost to Follow-up|1|||
160725489|NCT00703157|580377494|FG000|Overall Study|source data permanently lost/ other|4|||
160725490|NCT00703157|580377495|FG001|Overall Study|source data permanently lost/ other|1|||
160725491|NCT02522884|580377496|FG000|Overall Study|Withdrawal by Subject|6|||
160725492|NCT02522884|580377496|FG000|Overall Study|Death|3|||
160725493|NCT02522884|580377496|FG000|Overall Study|Missed 12-month Follow-up|9|||
160725494|NCT04495751|580377499|FG000|Overall Study|Withdrawal by Subject|1|||
160725495|NCT04495751|580377500|FG001|Overall Study|Withdrawal by Subject|0|||
160725496|NCT04495751|580377499|FG000|Overall Study|Lost to Follow-up|1|||
160725497|NCT04495751|580377500|FG001|Overall Study|Lost to Follow-up|0|||
160725498|NCT03289754|580377501|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
160725499|NCT04873934|580377502|FG000|Overall Study|Adverse Event|0|||
160725500|NCT04873934|580377503|FG001|Overall Study|Adverse Event|1|||
160725501|NCT04873934|580377502|FG000|Overall Study|Death|0|||
160725502|NCT04873934|580377503|FG001|Overall Study|Death|2|||
160725503|NCT04873934|580377502|FG000|Overall Study|Lost to Follow-up|13|||
160725504|NCT04873934|580377503|FG001|Overall Study|Lost to Follow-up|9|||
160725505|NCT04873934|580377502|FG000|Overall Study|Physician Decision|1|||
160725506|NCT04873934|580377503|FG001|Overall Study|Physician Decision|1|||
160725507|NCT04873934|580377502|FG000|Overall Study|Protocol deviation|2|||
160725508|NCT04873934|580377503|FG001|Overall Study|Protocol deviation|1|||
160725509|NCT04873934|580377502|FG000|Overall Study|Subject decision|1|||
160725510|NCT04873934|580377503|FG001|Overall Study|Subject decision|8|||
160725511|NCT04873934|580377502|FG000|Overall Study|Withdrew consent|0|||
160725512|NCT04873934|580377503|FG001|Overall Study|Withdrew consent|4|||
160725513|NCT04873934|580377502|FG000|Overall Study|Missing|1|||
160725514|NCT04873934|580377503|FG001|Overall Study|Missing|0|||
160725515|NCT00708461|580377505|FG000|Overall Study|Lost to Follow-up|18|||
160725516|NCT00708461|580377506|FG001|Overall Study|Lost to Follow-up|11|||
160725517|NCT00708461|580377505|FG000|Overall Study|Withdrawal by Subject|8|||
160725518|NCT00708461|580377506|FG001|Overall Study|Withdrawal by Subject|9|||
160725519|NCT00708461|580377505|FG000|Overall Study|left workforce|115|||
160725520|NCT00708461|580377506|FG001|Overall Study|left workforce|180|||
160725521|NCT03584854|580377507|FG000|Overall Study|Primary outcome not measured|1|||
160725522|NCT03584854|580377508|FG001|Overall Study|Primary outcome not measured|2|||
160725523|NCT02968173|580377509|FG000|Overall Study|Withdrawal by Subject|1|||
160725524|NCT00314327|580377513|FG000|Overall Study|Withdrawal by Subject|1|||
160725525|NCT01207687|580377514|FG000|Overall Study|Adverse Event|1|||
160725526|NCT01207687|580377514|FG000|Overall Study|Withdrawal by Subject|1|||
160725527|NCT01801865|580377515|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
160725528|NCT01801865|580377515|FG000|Overall Study|Physician Decision|7|||
160725529|NCT01500382|580377516|FG000|Washout Period|Study site went out of business|0|||
160725530|NCT01500382|580377517|FG001|Washout Period|Study site went out of business|0|||
160725531|NCT01500382|580377518|FG002|Washout Period|Study site went out of business|1|||
160725532|NCT01500382|580377519|FG003|Washout Period|Study site went out of business|0|||
160725533|NCT02134015|580377520|FG000|Overall Study|Protocol Violation|0|||
160725534|NCT02134015|580377521|FG001|Overall Study|Protocol Violation|1|||
160725535|NCT02134015|580377520|FG000|Overall Study|Death|2|||
160725536|NCT02134015|580377521|FG001|Overall Study|Death|1|||
160725537|NCT02134015|580377520|FG000|Overall Study|Reason not provided|1|||
160725538|NCT02134015|580377521|FG001|Overall Study|Reason not provided|2|||
160725539|NCT02134015|580377520|FG000|Overall Study|Clinical progression|14|||
160725540|NCT02134015|580377521|FG001|Overall Study|Clinical progression|7|||
160725541|NCT02134015|580377520|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
160725542|NCT02134015|580377521|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
160725543|NCT02134015|580377520|FG000|Overall Study|Study terminated by sponsor|2|||
160725544|NCT02134015|580377521|FG001|Overall Study|Study terminated by sponsor|3|||
160725545|NCT02134015|580377520|FG000|Overall Study|Adverse Event|9|||
160725546|NCT02134015|580377521|FG001|Overall Study|Adverse Event|10|||
160725547|NCT02134015|580377520|FG000|Overall Study|Withdrawal by Subject|3|||
160725548|NCT02134015|580377521|FG001|Overall Study|Withdrawal by Subject|7|||
160725549|NCT01515865|580379172|FG000|Part A (Open-label)|Other|3|||
160725550|NCT01515865|580379173|FG001|Part A (Open-label)|Other|0|||
160725551|NCT01515865|580379174|FG002|Part A (Open-label)|Other|0|||
160725552|NCT01515865|580379172|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
160725553|NCT01515865|580379173|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
160725554|NCT01515865|580379174|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
160725555|NCT01515865|580379172|FG000|Part B (Open-label)|Other|1|||
160725556|NCT01515865|580379173|FG001|Part B (Open-label)|Other|0|||
160725557|NCT01515865|580379174|FG002|Part B (Open-label)|Other|0|||
160725558|NCT05483686|580379175|FG000|Overall Study|Lost to Follow-up|5|||
160725559|NCT05483686|580379176|FG001|Overall Study|Lost to Follow-up|7|||
160725560|NCT02693106|580379177|FG000|Overall Study|No time|3|||
160725561|NCT03981900|580379179|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
160725562|NCT03981900|580379179|FG000|Overall Study|Adverse Event|5|||
160725563|NCT03981900|580379179|FG000|Overall Study|Protocol Violation|1|||
160725564|NCT03981900|580379179|FG000|Overall Study|Withdrawal by Subject|7|||
160725565|NCT03981900|580379179|FG000|Overall Study|Lost to Follow-up|46|||
160725566|NCT03981900|580379179|FG000|Overall Study|Decision of the researcher|3|||
160725567|NCT03981900|580379179|FG000|Overall Study|Death|3|||
160725568|NCT03981900|580379179|FG000|Overall Study|Other|5|||
160725569|NCT05625802|580379189|FG000|Overall Study|Lost to Follow-up|1|||
160725570|NCT05625802|580379190|FG001|Overall Study|Lost to Follow-up|0|||
160725571|NCT01954056|580379193|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
160725572|NCT01954056|580379194|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
160725573|NCT04090060|580379195|FG000|Overall Study|Lost to Follow-up|76|||
160725574|NCT04090060|580379196|FG001|Overall Study|Lost to Follow-up|77|||
160725575|NCT01164579|580379203|FG000|Overall Study|Lack of Efficacy|0|||
160725576|NCT01164579|580379204|FG001|Overall Study|Lack of Efficacy|0|||
160725577|NCT01164579|580379205|FG002|Overall Study|Lack of Efficacy|6|||
160725578|NCT01164579|580379203|FG000|Overall Study|Lost to Follow-up|1|||
160725579|NCT01164579|580379204|FG001|Overall Study|Lost to Follow-up|1|||
160725580|NCT01164579|580379205|FG002|Overall Study|Lost to Follow-up|0|||
160725581|NCT01164579|580379203|FG000|Overall Study|Withdrawal by Subject|2|||
160725582|NCT01164579|580379204|FG001|Overall Study|Withdrawal by Subject|5|||
160725583|NCT01164579|580379205|FG002|Overall Study|Withdrawal by Subject|3|||
160725584|NCT01164579|580379203|FG000|Overall Study|Protocol Violation|0|||
160725585|NCT01164579|580379204|FG001|Overall Study|Protocol Violation|1|||
160725586|NCT01164579|580379205|FG002|Overall Study|Protocol Violation|2|||
160725587|NCT01164579|580379203|FG000|Overall Study|Adverse Event|4|||
160725588|NCT01164579|580379204|FG001|Overall Study|Adverse Event|2|||
160725589|NCT01164579|580379205|FG002|Overall Study|Adverse Event|5|||
160725590|NCT01164579|580379203|FG000|Overall Study|Reason not specified|1|||
160725591|NCT01164579|580379204|FG001|Overall Study|Reason not specified|0|||
160725592|NCT01164579|580379205|FG002|Overall Study|Reason not specified|0|||
160725593|NCT00507455|580379206|FG000|Overall Study|Adverse Event|3|||
160725594|NCT00507455|580379207|FG001|Overall Study|Adverse Event|3|||
160725595|NCT00507455|580379208|FG002|Overall Study|Adverse Event|6|||
160725596|NCT00507455|580379206|FG000|Overall Study|Withdrawal by Subject|2|||
160725597|NCT00507455|580379207|FG001|Overall Study|Withdrawal by Subject|1|||
160725598|NCT00507455|580379208|FG002|Overall Study|Withdrawal by Subject|2|||
160725599|NCT00507455|580379206|FG000|Overall Study|Protocol Violation|4|||
160725600|NCT00507455|580379207|FG001|Overall Study|Protocol Violation|1|||
160725601|NCT00507455|580379208|FG002|Overall Study|Protocol Violation|1|||
160725602|NCT00507455|580379206|FG000|Overall Study|Lost to Follow-up|2|||
160725603|NCT00507455|580379207|FG001|Overall Study|Lost to Follow-up|0|||
160725604|NCT00507455|580379208|FG002|Overall Study|Lost to Follow-up|2|||
160725605|NCT00507455|580379206|FG000|Overall Study|Lack of Efficacy|0|||
160725606|NCT00507455|580379207|FG001|Overall Study|Lack of Efficacy|1|||
160725607|NCT00507455|580379208|FG002|Overall Study|Lack of Efficacy|0|||
160725608|NCT00507455|580379206|FG000|Overall Study|Other - miscellaneous reason|1|||
160725609|NCT00507455|580379207|FG001|Overall Study|Other - miscellaneous reason|0|||
160725610|NCT00507455|580379208|FG002|Overall Study|Other - miscellaneous reason|1|||
160725611|NCT06110494|580379214|FG000|Overall Study|Protocol Violation|2|||
160725612|NCT06110494|580379215|FG001|Overall Study|Protocol Violation|0|||
160725613|NCT06110494|580379216|FG002|Overall Study|Protocol Violation|1|||
160725614|NCT06110494|580379214|FG000|Overall Study|Dixon's test for outlier analysis|1|||
160725615|NCT06110494|580379215|FG001|Overall Study|Dixon's test for outlier analysis|1|||
160725616|NCT06110494|580379216|FG002|Overall Study|Dixon's test for outlier analysis|0|||
160725617|NCT00105079|580379217|FG000|Overall Study|Adverse Event|5|||
160725618|NCT00105079|580379218|FG001|Overall Study|Adverse Event|12|||
160725619|NCT00105079|580379217|FG000|Overall Study|Death|3|||
160725620|NCT00105079|580379218|FG001|Overall Study|Death|1|||
160725621|NCT00105079|580379217|FG000|Overall Study|Lost to Follow-up|12|||
160725622|NCT00105079|580379218|FG001|Overall Study|Lost to Follow-up|12|||
160725623|NCT00105079|580379217|FG000|Overall Study|Lack of Efficacy|9|||
160725624|NCT00105079|580379218|FG001|Overall Study|Lack of Efficacy|3|||
160725625|NCT00105079|580379217|FG000|Overall Study|Refused treatment|6|||
160725626|NCT00105079|580379218|FG001|Overall Study|Refused treatment|4|||
160725627|NCT00105079|580379217|FG000|Overall Study|Violation of selection criteria at entry|0|||
160725628|NCT00105079|580379218|FG001|Overall Study|Violation of selection criteria at entry|2|||
160725629|NCT00105079|580379217|FG000|Overall Study|Protocol Violation|1|||
160725630|NCT00105079|580379218|FG001|Overall Study|Protocol Violation|0|||
160725631|NCT00105079|580379217|FG000|Overall Study|Other|3|||
160725632|NCT00105079|580379218|FG001|Overall Study|Other|1|||
160725633|NCT01464593|580379219|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
160725634|NCT02490371|580379222|FG000|Overall Study|Lost to Follow-up|1|||
160725635|NCT02490371|580379223|FG001|Overall Study|Lost to Follow-up|1|||
160725636|NCT00740792|580379228|FG000|Overall Study|Adverse Event|3|||
160725637|NCT00740792|580379229|FG001|Overall Study|Adverse Event|1|||
160725638|NCT00740792|580379230|FG002|Overall Study|Adverse Event|1|||
160725639|NCT00740792|580379231|FG003|Overall Study|Adverse Event|3|||
160725640|NCT00740792|580379228|FG000|Overall Study|Lack of Efficacy|1|||
160725641|NCT00740792|580379229|FG001|Overall Study|Lack of Efficacy|1|||
160725642|NCT00740792|580379230|FG002|Overall Study|Lack of Efficacy|0|||
160725643|NCT00740792|580379231|FG003|Overall Study|Lack of Efficacy|3|||
160725644|NCT00740792|580379228|FG000|Overall Study|Lost to Follow-up|2|||
160725645|NCT00740792|580379229|FG001|Overall Study|Lost to Follow-up|1|||
160725646|NCT00740792|580379230|FG002|Overall Study|Lost to Follow-up|0|||
160725647|NCT00740792|580379231|FG003|Overall Study|Lost to Follow-up|0|||
160725648|NCT00740792|580379228|FG000|Overall Study|Protocol Violation|0|||
160725649|NCT00740792|580379229|FG001|Overall Study|Protocol Violation|1|||
160725650|NCT00740792|580379230|FG002|Overall Study|Protocol Violation|0|||
160725651|NCT00740792|580379231|FG003|Overall Study|Protocol Violation|2|||
160725652|NCT00740792|580379228|FG000|Overall Study|Withdrawal by Subject|1|||
160725653|NCT00740792|580379229|FG001|Overall Study|Withdrawal by Subject|1|||
160725654|NCT00740792|580379230|FG002|Overall Study|Withdrawal by Subject|0|||
160725655|NCT00740792|580379231|FG003|Overall Study|Withdrawal by Subject|0|||
160725656|NCT00740792|580379228|FG000|Overall Study|administrative|3|||
160725657|NCT00740792|580379229|FG001|Overall Study|administrative|3|||
160725658|NCT00740792|580379230|FG002|Overall Study|administrative|8|||
160725659|NCT00740792|580379231|FG003|Overall Study|administrative|2|||
160725660|NCT00026494|580379234|FG000|Overall Study|Withdrawal by Subject|1|||
160725661|NCT00026494|580379235|FG001|Overall Study|Withdrawal by Subject|0|||
160725662|NCT00026494|580379236|FG002|Overall Study|Withdrawal by Subject|1|||
160725663|NCT00026494|580379237|FG003|Overall Study|Withdrawal by Subject|0|||
160725664|NCT00026494|580379234|FG000|Overall Study|Patient non-compliance|1|||
160725665|NCT00026494|580379235|FG001|Overall Study|Patient non-compliance|0|||
160725666|NCT00026494|580379236|FG002|Overall Study|Patient non-compliance|0|||
160725667|NCT00026494|580379237|FG003|Overall Study|Patient non-compliance|0|||
160725668|NCT00026494|580379234|FG000|Overall Study|Patient not treated|0|||
160725669|NCT00026494|580379235|FG001|Overall Study|Patient not treated|0|||
160725670|NCT00026494|580379236|FG002|Overall Study|Patient not treated|2|||
160725671|NCT00026494|580379237|FG003|Overall Study|Patient not treated|0|||
160725672|NCT00026494|580379234|FG000|Overall Study|Clinical progression|0|||
160725673|NCT00026494|580379235|FG001|Overall Study|Clinical progression|0|||
160725674|NCT00026494|580379236|FG002|Overall Study|Clinical progression|3|||
160725675|NCT00026494|580379237|FG003|Overall Study|Clinical progression|0|||
160725676|NCT01455597|580379238|FG000|Overall Study|Adverse Event|7|||
160725677|NCT01455597|580379239|FG001|Overall Study|Adverse Event|0|||
160725678|NCT01455597|580379240|FG002|Overall Study|Adverse Event|5|||
160725679|NCT01455597|580379241|FG003|Overall Study|Adverse Event|1|||
160725680|NCT01455597|580379238|FG000|Overall Study|Lack of Efficacy|0|||
160725681|NCT01455597|580379239|FG001|Overall Study|Lack of Efficacy|1|||
160725682|NCT01455597|580379240|FG002|Overall Study|Lack of Efficacy|2|||
160725683|NCT01455597|580379241|FG003|Overall Study|Lack of Efficacy|0|||
160725684|NCT01455597|580379238|FG000|Overall Study|Lost to Follow-up|3|||
160725685|NCT01455597|580379239|FG001|Overall Study|Lost to Follow-up|0|||
160725686|NCT01455597|580379240|FG002|Overall Study|Lost to Follow-up|2|||
160725687|NCT01455597|580379241|FG003|Overall Study|Lost to Follow-up|1|||
160725688|NCT01455597|580379238|FG000|Overall Study|Withdrew Consent|6|||
160725689|NCT01455597|580379239|FG001|Overall Study|Withdrew Consent|5|||
160725690|NCT01455597|580379240|FG002|Overall Study|Withdrew Consent|8|||
160725691|NCT01455597|580379241|FG003|Overall Study|Withdrew Consent|5|||
160725692|NCT01455597|580379238|FG000|Overall Study|Reason not Specified|1|||
160725693|NCT01455597|580379239|FG001|Overall Study|Reason not Specified|2|||
160725694|NCT01455597|580379240|FG002|Overall Study|Reason not Specified|3|||
160725695|NCT01455597|580379241|FG003|Overall Study|Reason not Specified|3|||
160725696|NCT03412734|580379245|FG000|Overall Study|Incorrect labeling of samples|2|||
160725697|NCT03412734|580379246|FG001|Overall Study|Incorrect labeling of samples|0|||
160725698|NCT03412734|580379245|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
160725699|NCT03412734|580379246|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
160725700|NCT00423332|580379247|FG000|Overall Study|Adverse Event|6|||
160725701|NCT00423332|580379248|FG001|Overall Study|Adverse Event|2|||
160725702|NCT00423332|580379247|FG000|Overall Study|Withdrawal by Subject|1|||
160725703|NCT00423332|580379248|FG001|Overall Study|Withdrawal by Subject|0|||
160725704|NCT00423332|580379247|FG000|Overall Study|Condition under investigation worsened|1|||
160725705|NCT00423332|580379248|FG001|Overall Study|Condition under investigation worsened|1|||
160725706|NCT00423332|580379247|FG000|Overall Study|Progressive at Week 6|0|||
160725707|NCT00423332|580379248|FG001|Overall Study|Progressive at Week 6|1|||
160725708|NCT00423332|580379247|FG000|Overall Study|Unblinded before 12 weeks|1|||
160725709|NCT00423332|580379248|FG001|Overall Study|Unblinded before 12 weeks|3|||
160725710|NCT02035202|580379249|FG000|Overall Study|Lost to Follow-up|8|||
160725711|NCT02035202|580379250|FG001|Overall Study|Lost to Follow-up|16|||
160725712|NCT02035202|580379251|FG002|Overall Study|Lost to Follow-up|2|||
160725713|NCT03777436|580379252|FG000|Placebo-controlled Phase|Adverse Event|8|||
160725714|NCT03777436|580379253|FG001|Placebo-controlled Phase|Adverse Event|10|||
160725715|NCT03777436|580379254|FG002|Placebo-controlled Phase|Adverse Event|0|||
160725716|NCT03777436|580379252|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
160725717|NCT03777436|580379253|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
160725718|NCT03777436|580379254|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
160725719|NCT03777436|580379252|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
160725720|NCT03777436|580379253|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
160725721|NCT03777436|580379254|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
160725722|NCT03777436|580379252|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
160725723|NCT03777436|580379253|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
160725724|NCT03777436|580379254|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
160725725|NCT03777436|580379252|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
160725726|NCT03777436|580379253|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
160725727|NCT03777436|580379254|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
160725728|NCT03777436|580379252|FG000|Placebo-controlled Phase|Physician Decision|0|||
160725729|NCT03777436|580379253|FG001|Placebo-controlled Phase|Physician Decision|1|||
160725730|NCT03777436|580379254|FG002|Placebo-controlled Phase|Physician Decision|0|||
160725731|NCT03777436|580379252|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
160725732|NCT03777436|580379253|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
160725733|NCT03777436|580379254|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
160725734|NCT03777436|580379252|FG000|Apremilast Extension Phase|Adverse Event|0|||
160725735|NCT03777436|580379253|FG001|Apremilast Extension Phase|Adverse Event|0|||
160725736|NCT03777436|580379254|FG002|Apremilast Extension Phase|Adverse Event|6|||
160725737|NCT03777436|580379252|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
160725738|NCT03777436|580379253|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
160725739|NCT03777436|580379254|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
160725740|NCT03777436|580379252|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
160725741|NCT03777436|580379253|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
160725742|NCT03777436|580379254|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
160725743|NCT03777436|580379252|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
160725744|NCT03777436|580379253|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
160725745|NCT03777436|580379254|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
160725746|NCT03777436|580379252|FG000|Apremilast Extension Phase|Miscellaneous|0|||
160725747|NCT03777436|580379253|FG001|Apremilast Extension Phase|Miscellaneous|0|||
160725748|NCT03777436|580379254|FG002|Apremilast Extension Phase|Miscellaneous|1|||
160725749|NCT04468347|580379258|FG000|Overall Study|Withdrawal by Subject|0|||
160725750|NCT04468347|580379259|FG001|Overall Study|Withdrawal by Subject|1|||
160725751|NCT04468347|580379260|FG002|Overall Study|Withdrawal by Subject|3|||
160725752|NCT04468347|580379261|FG003|Overall Study|Withdrawal by Subject|3|||
160725753|NCT04468347|580379258|FG000|Overall Study|Lost to Follow-up|0|||
160725754|NCT04468347|580379259|FG001|Overall Study|Lost to Follow-up|0|||
160725755|NCT04468347|580379260|FG002|Overall Study|Lost to Follow-up|1|||
160725756|NCT04468347|580379261|FG003|Overall Study|Lost to Follow-up|1|||
160725757|NCT04468347|580379258|FG000|Overall Study|Physician Decision|1|||
160725758|NCT04468347|580379259|FG001|Overall Study|Physician Decision|0|||
160725759|NCT04468347|580379260|FG002|Overall Study|Physician Decision|2|||
160725760|NCT04468347|580379261|FG003|Overall Study|Physician Decision|0|||
160725761|NCT04468347|580379258|FG000|Overall Study|Protocol Violation|1|||
160725762|NCT04468347|580379259|FG001|Overall Study|Protocol Violation|0|||
160725763|NCT04468347|580379260|FG002|Overall Study|Protocol Violation|0|||
160725764|NCT04468347|580379261|FG003|Overall Study|Protocol Violation|0|||
160725765|NCT00994461|580379263|FG000|Overall Study|Adverse Event|2|||
160725766|NCT00994461|580379264|FG001|Overall Study|Adverse Event|1|||
160725767|NCT00994461|580379265|FG002|Overall Study|Adverse Event|0|||
160725768|NCT04339062|580379266|FG000|Overall Study|Death|0|||
160725769|NCT04339062|580379267|FG001|Overall Study|Death|1|||
160725770|NCT01276756|580379270|FG000|Overall Study|Lost to Follow-up|2|||
160725771|NCT01276756|580379271|FG001|Overall Study|Lost to Follow-up|0|||
160725772|NCT01276756|580379270|FG000|Overall Study|Adverse Event|3|||
160725773|NCT01276756|580379271|FG001|Overall Study|Adverse Event|2|||
160725774|NCT05868577|580379272|FG000|Overall Study|Lost to Follow-up|5|||
160725775|NCT05868577|580379273|FG001|Overall Study|Lost to Follow-up|5|||
160725776|NCT02630251|580379274|FG000|Overall Study|Physician Decision|0|||
160725777|NCT02630251|580379275|FG001|Overall Study|Physician Decision|0|||
160725778|NCT02630251|580379276|FG002|Overall Study|Physician Decision|1|||
160725779|NCT02630251|580379277|FG003|Overall Study|Physician Decision|0|||
160725780|NCT02505217|580379278|FG000|Overall Study|Withdrawal by Subject|1|||
160725781|NCT02505217|580379279|FG001|Overall Study|Withdrawal by Subject|2|||
160725782|NCT00153179|580379285|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
160725783|NCT00153179|580379286|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
160725784|NCT00153179|580379287|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
160725785|NCT00153179|580379288|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
160725786|NCT03517540|580379289|FG000|Overall Study|Protocol Violation|2|||
160725787|NCT03517540|580379290|FG001|Overall Study|Protocol Violation|0|||
160725788|NCT03517540|580379291|FG002|Overall Study|Protocol Violation|0|||
160725789|NCT03517540|580379292|FG003|Overall Study|Protocol Violation|1|||
160725790|NCT03517540|580379289|FG000|Overall Study|Adverse Event|9|||
160725791|NCT03517540|580379290|FG001|Overall Study|Adverse Event|3|||
160725792|NCT03517540|580379291|FG002|Overall Study|Adverse Event|8|||
160725793|NCT03517540|580379292|FG003|Overall Study|Adverse Event|1|||
160725794|NCT03517540|580379289|FG000|Overall Study|Withdrawal by Subject|3|||
160725795|NCT03517540|580379290|FG001|Overall Study|Withdrawal by Subject|4|||
160725796|NCT03517540|580379291|FG002|Overall Study|Withdrawal by Subject|1|||
160725797|NCT03517540|580379292|FG003|Overall Study|Withdrawal by Subject|3|||
160725798|NCT00615550|580379297|FG000|Overall Study|Lost to Follow-up|6|||
160725799|NCT00615550|580379298|FG001|Overall Study|Lost to Follow-up|1|||
160725800|NCT01408303|580379299|FG000|Overall Study|Adverse Event|3|||
160725801|NCT01408303|580379300|FG001|Overall Study|Adverse Event|7|||
160725802|NCT01408303|580379301|FG002|Overall Study|Adverse Event|2|||
160725803|NCT01408303|580379299|FG000|Overall Study|Lost to Follow-up|0|||
160725804|NCT01408303|580379300|FG001|Overall Study|Lost to Follow-up|1|||
160725805|NCT01408303|580379301|FG002|Overall Study|Lost to Follow-up|2|||
160725806|NCT01408303|580379299|FG000|Overall Study|Withdrawal by Subject|2|||
160725807|NCT01408303|580379300|FG001|Overall Study|Withdrawal by Subject|3|||
160725808|NCT01408303|580379301|FG002|Overall Study|Withdrawal by Subject|1|||
160725809|NCT01408303|580379299|FG000|Overall Study|Protocol Violation|0|||
160725810|NCT01408303|580379300|FG001|Overall Study|Protocol Violation|1|||
160725811|NCT01408303|580379301|FG002|Overall Study|Protocol Violation|0|||
160725812|NCT01408303|580379299|FG000|Overall Study|Noncompliance|1|||
160725813|NCT01408303|580379300|FG001|Overall Study|Noncompliance|0|||
160725814|NCT01408303|580379301|FG002|Overall Study|Noncompliance|1|||
160725815|NCT02644668|580379302|FG000|Overall Study|Adverse Event|2|||
160725816|NCT02644668|580379303|FG001|Overall Study|Adverse Event|0|||
160725817|NCT02644668|580379304|FG002|Overall Study|Adverse Event|1|||
160725818|NCT02644668|580379302|FG000|Overall Study|Protocol Violation|0|||
160725819|NCT02644668|580379303|FG001|Overall Study|Protocol Violation|0|||
160725820|NCT02644668|580379304|FG002|Overall Study|Protocol Violation|1|||
160725821|NCT02644668|580379302|FG000|Overall Study|Withdrawal by Subject|0|||
160725822|NCT02644668|580379303|FG001|Overall Study|Withdrawal by Subject|0|||
160725823|NCT02644668|580379304|FG002|Overall Study|Withdrawal by Subject|1|||
160725824|NCT05763875|580379313|FG000|Overall Study|Subject decision|5|||
160725825|NCT05763875|580379314|FG001|Overall Study|Subject decision|2|||
160725826|NCT05763875|580379315|FG002|Overall Study|Subject decision|1|||
160725827|NCT05763875|580379313|FG000|Overall Study|Lost to Follow-up|4|||
160725828|NCT05763875|580379314|FG001|Overall Study|Lost to Follow-up|1|||
160725829|NCT05763875|580379315|FG002|Overall Study|Lost to Follow-up|2|||
160725830|NCT05763875|580379313|FG000|Overall Study|Adverse Event|1|||
160725831|NCT05763875|580379314|FG001|Overall Study|Adverse Event|0|||
160725832|NCT05763875|580379315|FG002|Overall Study|Adverse Event|0|||
160725833|NCT01777282|580379316|FG000|Overall Study|Persistent Hyperglycemia|0|||
160725834|NCT01777282|580379317|FG001|Overall Study|Persistent Hyperglycemia|0|||
160725835|NCT01777282|580379318|FG002|Overall Study|Persistent Hyperglycemia|1|||
160725836|NCT01777282|580379319|FG003|Overall Study|Persistent Hyperglycemia|0|||
160725837|NCT01777282|580379320|FG004|Overall Study|Persistent Hyperglycemia|0|||
160725838|NCT01777282|580379316|FG000|Overall Study|New Antidiabetic Medication|0|||
160725839|NCT01777282|580379317|FG001|Overall Study|New Antidiabetic Medication|0|||
160725840|NCT01777282|580379318|FG002|Overall Study|New Antidiabetic Medication|1|||
160725841|NCT01777282|580379319|FG003|Overall Study|New Antidiabetic Medication|0|||
160725842|NCT01777282|580379320|FG004|Overall Study|New Antidiabetic Medication|0|||
160725843|NCT01777282|580379316|FG000|Overall Study|Adverse Event|4|||
160725844|NCT01777282|580379317|FG001|Overall Study|Adverse Event|4|||
160725845|NCT01777282|580379318|FG002|Overall Study|Adverse Event|2|||
160725846|NCT01777282|580379319|FG003|Overall Study|Adverse Event|1|||
160725847|NCT01777282|580379320|FG004|Overall Study|Adverse Event|3|||
160725848|NCT01777282|580379316|FG000|Overall Study|Withdrawal by Subject|4|||
160725849|NCT01777282|580379317|FG001|Overall Study|Withdrawal by Subject|0|||
160725850|NCT01777282|580379318|FG002|Overall Study|Withdrawal by Subject|0|||
160725851|NCT01777282|580379319|FG003|Overall Study|Withdrawal by Subject|1|||
160725852|NCT01777282|580379320|FG004|Overall Study|Withdrawal by Subject|2|||
160725853|NCT01777282|580379316|FG000|Overall Study|Protocol Violation|2|||
160725854|NCT01777282|580379317|FG001|Overall Study|Protocol Violation|0|||
160725855|NCT01777282|580379318|FG002|Overall Study|Protocol Violation|1|||
160725856|NCT01777282|580379319|FG003|Overall Study|Protocol Violation|0|||
160725857|NCT01777282|580379320|FG004|Overall Study|Protocol Violation|2|||
160725858|NCT01777282|580379316|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
160725859|NCT01777282|580379317|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
160725860|NCT01777282|580379318|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
160725861|NCT01777282|580379319|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
160725862|NCT01777282|580379320|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
160725863|NCT04015518|580379321|FG000|Overall Study|Adverse Event|6|||
160725864|NCT04015518|580379322|FG001|Overall Study|Adverse Event|1|||
160725865|NCT04015518|580379323|FG002|Overall Study|Adverse Event|1|||
160725866|NCT04015518|580379324|FG003|Overall Study|Adverse Event|3|||
160725867|NCT04015518|580379325|FG004|Overall Study|Adverse Event|3|||
160725868|NCT04015518|580379321|FG000|Overall Study|Lack of Efficacy|1|||
160725869|NCT04015518|580379322|FG001|Overall Study|Lack of Efficacy|0|||
160725870|NCT04015518|580379323|FG002|Overall Study|Lack of Efficacy|1|||
160725871|NCT04015518|580379324|FG003|Overall Study|Lack of Efficacy|0|||
160725872|NCT04015518|580379325|FG004|Overall Study|Lack of Efficacy|4|||
160725873|NCT04015518|580379321|FG000|Overall Study|Lost to Follow-up|0|||
160725874|NCT04015518|580379322|FG001|Overall Study|Lost to Follow-up|0|||
160725875|NCT04015518|580379323|FG002|Overall Study|Lost to Follow-up|0|||
160725876|NCT04015518|580379324|FG003|Overall Study|Lost to Follow-up|0|||
160725877|NCT04015518|580379325|FG004|Overall Study|Lost to Follow-up|1|||
160725878|NCT04015518|580379321|FG000|Overall Study|Withdrawal by Subject|0|||
160725879|NCT04015518|580379322|FG001|Overall Study|Withdrawal by Subject|1|||
160725880|NCT04015518|580379323|FG002|Overall Study|Withdrawal by Subject|0|||
160725881|NCT04015518|580379324|FG003|Overall Study|Withdrawal by Subject|1|||
160725882|NCT04015518|580379325|FG004|Overall Study|Withdrawal by Subject|1|||
160725883|NCT04015518|580379321|FG000|Overall Study|Patient did not come for consecutive visits|0|||
160725884|NCT04015518|580379322|FG001|Overall Study|Patient did not come for consecutive visits|1|||
160725885|NCT04015518|580379323|FG002|Overall Study|Patient did not come for consecutive visits|0|||
160725886|NCT04015518|580379324|FG003|Overall Study|Patient did not come for consecutive visits|0|||
160725887|NCT04015518|580379325|FG004|Overall Study|Patient did not come for consecutive visits|0|||
160725888|NCT04015518|580379321|FG000|Overall Study|not willing to travel due to Covid-19|0|||
160725889|NCT04015518|580379322|FG001|Overall Study|not willing to travel due to Covid-19|0|||
160725890|NCT04015518|580379323|FG002|Overall Study|not willing to travel due to Covid-19|1|||
160725891|NCT04015518|580379324|FG003|Overall Study|not willing to travel due to Covid-19|0|||
160725892|NCT04015518|580379325|FG004|Overall Study|not willing to travel due to Covid-19|0|||
160725893|NCT04015518|580379321|FG000|Overall Study|Patient wants to discontinue treatment|0|||
160725894|NCT04015518|580379322|FG001|Overall Study|Patient wants to discontinue treatment|0|||
160725895|NCT04015518|580379323|FG002|Overall Study|Patient wants to discontinue treatment|0|||
160725896|NCT04015518|580379324|FG003|Overall Study|Patient wants to discontinue treatment|1|||
160725897|NCT04015518|580379325|FG004|Overall Study|Patient wants to discontinue treatment|0|||
160725898|NCT04015518|580379321|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
160725899|NCT04015518|580379322|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
160725900|NCT04015518|580379323|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
160725901|NCT04015518|580379324|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
160725902|NCT04015518|580379325|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
160725903|NCT04015518|580379321|FG000|Overall Study|Pregnancy|0|||
160725904|NCT04015518|580379322|FG001|Overall Study|Pregnancy|0|||
160725905|NCT04015518|580379323|FG002|Overall Study|Pregnancy|0|||
160725906|NCT04015518|580379324|FG003|Overall Study|Pregnancy|0|||
160725907|NCT04015518|580379325|FG004|Overall Study|Pregnancy|1|||
160725908|NCT04015518|580379321|FG000|Overall Study|Personal reasons|1|||
160725909|NCT04015518|580379322|FG001|Overall Study|Personal reasons|0|||
160725910|NCT04015518|580379323|FG002|Overall Study|Personal reasons|0|||
160725911|NCT04015518|580379324|FG003|Overall Study|Personal reasons|0|||
160725912|NCT04015518|580379325|FG004|Overall Study|Personal reasons|1|||
160725913|NCT04015518|580379321|FG000|Overall Study|Withdrew consent|1|||
160725914|NCT04015518|580379322|FG001|Overall Study|Withdrew consent|0|||
160725915|NCT04015518|580379323|FG002|Overall Study|Withdrew consent|0|||
160725916|NCT04015518|580379324|FG003|Overall Study|Withdrew consent|0|||
160725917|NCT04015518|580379325|FG004|Overall Study|Withdrew consent|0|||
160725918|NCT04015518|580379321|FG000|Overall Study|Prostate carcinoma|1|||
160725919|NCT04015518|580379322|FG001|Overall Study|Prostate carcinoma|0|||
160725920|NCT04015518|580379323|FG002|Overall Study|Prostate carcinoma|0|||
160725921|NCT04015518|580379324|FG003|Overall Study|Prostate carcinoma|0|||
160725922|NCT04015518|580379325|FG004|Overall Study|Prostate carcinoma|0|||
160725923|NCT04015518|580379321|FG000|Overall Study|Could not keep appointments due to work|1|||
160725924|NCT04015518|580379322|FG001|Overall Study|Could not keep appointments due to work|0|||
160725925|NCT04015518|580379323|FG002|Overall Study|Could not keep appointments due to work|0|||
160725926|NCT04015518|580379324|FG003|Overall Study|Could not keep appointments due to work|0|||
160725927|NCT04015518|580379325|FG004|Overall Study|Could not keep appointments due to work|0|||
160725928|NCT00550745|580379326|FG000|Overall Study|Death|20|||
160725929|NCT00550745|580379327|FG001|Overall Study|Death|16|||
160725930|NCT00550745|580379326|FG000|Overall Study|Lost to Follow-up|45|||
160725931|NCT00550745|580379327|FG001|Overall Study|Lost to Follow-up|30|||
160725932|NCT00550745|580379326|FG000|Overall Study|Physician Decision|0|||
160725933|NCT00550745|580379327|FG001|Overall Study|Physician Decision|2|||
160725934|NCT00550745|580379326|FG000|Overall Study|Protocol Violation|4|||
160725935|NCT00550745|580379327|FG001|Overall Study|Protocol Violation|2|||
160725936|NCT00550745|580379326|FG000|Overall Study|Withdrawal by Subject|17|||
160725937|NCT00550745|580379327|FG001|Overall Study|Withdrawal by Subject|10|||
160725938|NCT00550745|580379326|FG000|Overall Study|Screen failure|1|||
160725939|NCT00550745|580379327|FG001|Overall Study|Screen failure|0|||
160725940|NCT00764660|580379328|FG000|Overall Study|Adverse Event|6|||
160725941|NCT00764660|580379329|FG001|Overall Study|Adverse Event|3|||
160725942|NCT00764660|580379328|FG000|Overall Study|Lost to Follow-up|3|||
160725943|NCT00764660|580379329|FG001|Overall Study|Lost to Follow-up|4|||
160725944|NCT00764660|580379328|FG000|Overall Study|Withdrawal by Subject|7|||
160725945|NCT00764660|580379329|FG001|Overall Study|Withdrawal by Subject|3|||
160725946|NCT00764660|580379328|FG000|Overall Study|Noncompliance With Protocol|5|||
160725947|NCT00764660|580379329|FG001|Overall Study|Noncompliance With Protocol|1|||
160725948|NCT00764660|580379328|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
160725949|NCT00764660|580379329|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
160725950|NCT01131455|580379330|FG000|Overall Study|Death of PI|6|||
160725951|NCT01131455|580379331|FG001|Overall Study|Death of PI|4|||
160725952|NCT01131455|580379332|FG002|Overall Study|Death of PI|0|||
160725953|NCT02510664|580380985|FG000|Overall Study|Transferred Care|9|||
160725954|NCT02510664|580380986|FG001|Overall Study|Transferred Care|9|||
160725955|NCT02510664|580380987|FG002|Overall Study|Transferred Care|0|||
160725956|NCT02510664|580380985|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
160725957|NCT02510664|580380986|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
160725958|NCT02510664|580380987|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
160725959|NCT02510664|580380985|FG000|Overall Study|Time Constraints|1|||
160725960|NCT02510664|580380986|FG001|Overall Study|Time Constraints|1|||
160725961|NCT02510664|580380987|FG002|Overall Study|Time Constraints|0|||
160725962|NCT02176655|580380991|FG000|Overall Study|Subjects did not treat|6|||
160725963|NCT00386360|580380994|FG000|Overall Study|Adverse Event|4|||
160725964|NCT00386360|580380995|FG001|Overall Study|Adverse Event|2|||
160725965|NCT00386360|580380994|FG000|Overall Study|Physician Decision|2|||
160725966|NCT00386360|580380995|FG001|Overall Study|Physician Decision|2|||
160725967|NCT00386360|580380994|FG000|Overall Study|Lost to Follow-up|0|||
160725968|NCT00386360|580380995|FG001|Overall Study|Lost to Follow-up|2|||
160725969|NCT00386360|580380994|FG000|Overall Study|Protocol Violation|0|||
160725970|NCT00386360|580380995|FG001|Overall Study|Protocol Violation|3|||
160725971|NCT00386360|580380994|FG000|Overall Study|Withdrawal by Subject|3|||
160725972|NCT00386360|580380995|FG001|Overall Study|Withdrawal by Subject|6|||
160725973|NCT00386360|580380994|FG000|Overall Study|Did not take any study medication|0|||
160725974|NCT00386360|580380995|FG001|Overall Study|Did not take any study medication|2|||
160725975|NCT01073605|580380996|FG000|Overall Study|Ongoing at Cutoff Date|1|||
160725976|NCT01073605|580380997|FG001|Overall Study|Ongoing at Cutoff Date|1|||
160725977|NCT01073605|580380998|FG002|Overall Study|Ongoing at Cutoff Date|0|||
160725978|NCT01073605|580380996|FG000|Overall Study|Adverse Event|2|||
160725979|NCT01073605|580380997|FG001|Overall Study|Adverse Event|1|||
160725980|NCT01073605|580380998|FG002|Overall Study|Adverse Event|0|||
160725981|NCT01073605|580380996|FG000|Overall Study|Lost to Follow-up|3|||
160725982|NCT01073605|580380997|FG001|Overall Study|Lost to Follow-up|4|||
160725983|NCT01073605|580380998|FG002|Overall Study|Lost to Follow-up|9|||
160725984|NCT01073605|580380996|FG000|Overall Study|Other|25|||
160725985|NCT01073605|580380997|FG001|Overall Study|Other|21|||
160725986|NCT01073605|580380998|FG002|Overall Study|Other|29|||
160725987|NCT01073605|580380996|FG000|Overall Study|Withdrawal by Subject|31|||
160725988|NCT01073605|580380997|FG001|Overall Study|Withdrawal by Subject|39|||
160725989|NCT01073605|580380998|FG002|Overall Study|Withdrawal by Subject|22|||
160725990|NCT01073605|580380996|FG000|Overall Study|Randomized But Not Treated|0|||
160725991|NCT01073605|580380997|FG001|Overall Study|Randomized But Not Treated|1|||
160725992|NCT01073605|580380998|FG002|Overall Study|Randomized But Not Treated|1|||
160725993|NCT03491462|580380999|FG000|Overall Study|Lost to Follow-up|2|||
160725994|NCT03491462|580381000|FG001|Overall Study|Lost to Follow-up|0|||
160725995|NCT03491462|580380999|FG000|Overall Study|Adverse Event|11|||
160725996|NCT03491462|580381000|FG001|Overall Study|Adverse Event|1|||
160725997|NCT03491462|580380999|FG000|Overall Study|Physician Decision|3|||
160725998|NCT03491462|580381000|FG001|Overall Study|Physician Decision|0|||
160725999|NCT03491462|580380999|FG000|Overall Study|Withdrawal by Subject|22|||
160726000|NCT03491462|580381000|FG001|Overall Study|Withdrawal by Subject|15|||
160726001|NCT03018080|580381001|FG000|Overall Study|Death|12|||
160726002|NCT03018080|580381002|FG001|Overall Study|Death|19|||
160726003|NCT00179660|580381011|FG000|Overall Study|Adverse Event|7|||
160726004|NCT00179660|580381011|FG000|Overall Study|Lack of therapeutic effect|28|||
160726005|NCT00179660|580381011|FG000|Overall Study|Withdrawal by Subject|2|||
160726006|NCT00179660|580381011|FG000|Overall Study|Lost to Follow-up|1|||
160726007|NCT00179660|580381011|FG000|Overall Study|Death|3|||
160726008|NCT00179660|580381011|FG000|Overall Study|Other - Unspecified|9|||
160726009|NCT00685399|580381012|FG000|Treatment Period 1|Withdrawal by Subject|2|||
160726010|NCT00685399|580381013|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160726011|NCT00685399|580381014|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160726012|NCT00685399|580381015|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160726013|NCT00685399|580381016|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160726014|NCT00685399|580381017|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160726015|NCT00685399|580381018|FG006|Treatment Period 1|Withdrawal by Subject|0|||
160726016|NCT00685399|580381019|FG007|Treatment Period 1|Withdrawal by Subject|0|||
160726017|NCT00685399|580381012|FG000|Treatment Period 1|Protocol Violation|1|||
160726018|NCT00685399|580381013|FG001|Treatment Period 1|Protocol Violation|0|||
160726019|NCT00685399|580381014|FG002|Treatment Period 1|Protocol Violation|0|||
160726020|NCT00685399|580381015|FG003|Treatment Period 1|Protocol Violation|0|||
160726021|NCT00685399|580381016|FG004|Treatment Period 1|Protocol Violation|0|||
160726022|NCT00685399|580381017|FG005|Treatment Period 1|Protocol Violation|0|||
160726023|NCT00685399|580381018|FG006|Treatment Period 1|Protocol Violation|0|||
160726024|NCT00685399|580381019|FG007|Treatment Period 1|Protocol Violation|0|||
160726025|NCT00685399|580381012|FG000|Treatment Period 1|Administrative|2|||
160726026|NCT00685399|580381013|FG001|Treatment Period 1|Administrative|0|||
160726027|NCT00685399|580381014|FG002|Treatment Period 1|Administrative|0|||
160726028|NCT00685399|580381015|FG003|Treatment Period 1|Administrative|0|||
160726029|NCT00685399|580381016|FG004|Treatment Period 1|Administrative|0|||
160726030|NCT00685399|580381017|FG005|Treatment Period 1|Administrative|0|||
160726031|NCT00685399|580381018|FG006|Treatment Period 1|Administrative|0|||
160726032|NCT00685399|580381019|FG007|Treatment Period 1|Administrative|0|||
160726033|NCT00685399|580381012|FG000|Treatment Period 1|Lack of Efficacy|1|||
160726034|NCT00685399|580381013|FG001|Treatment Period 1|Lack of Efficacy|0|||
160726035|NCT00685399|580381014|FG002|Treatment Period 1|Lack of Efficacy|0|||
160726036|NCT00685399|580381015|FG003|Treatment Period 1|Lack of Efficacy|0|||
160726037|NCT00685399|580381016|FG004|Treatment Period 1|Lack of Efficacy|0|||
160726038|NCT00685399|580381017|FG005|Treatment Period 1|Lack of Efficacy|0|||
160726039|NCT00685399|580381018|FG006|Treatment Period 1|Lack of Efficacy|0|||
160726040|NCT00685399|580381019|FG007|Treatment Period 1|Lack of Efficacy|0|||
160726041|NCT00685399|580381012|FG000|Treatment Period 2|Administrative Problems|0|||
160726042|NCT00685399|580381013|FG001|Treatment Period 2|Administrative Problems|2|||
160726043|NCT00685399|580381014|FG002|Treatment Period 2|Administrative Problems|1|||
160726044|NCT00685399|580381015|FG003|Treatment Period 2|Administrative Problems|0|||
160726045|NCT00685399|580381016|FG004|Treatment Period 2|Administrative Problems|0|||
160726046|NCT00685399|580381017|FG005|Treatment Period 2|Administrative Problems|0|||
160726047|NCT00685399|580381018|FG006|Treatment Period 2|Administrative Problems|0|||
160726048|NCT00685399|580381019|FG007|Treatment Period 2|Administrative Problems|0|||
160726049|NCT00685399|580381012|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160726050|NCT00685399|580381013|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160726051|NCT00685399|580381014|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160726052|NCT00685399|580381015|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160726053|NCT00685399|580381016|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160726054|NCT00685399|580381017|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160726055|NCT00685399|580381018|FG006|Treatment Period 2|Withdrawal by Subject|0|||
160726056|NCT00685399|580381019|FG007|Treatment Period 2|Withdrawal by Subject|2|||
160726057|NCT00685399|580381012|FG000|Treatment Period 2|Adverse Event|0|||
160726058|NCT00685399|580381013|FG001|Treatment Period 2|Adverse Event|0|||
160726059|NCT00685399|580381014|FG002|Treatment Period 2|Adverse Event|0|||
160726060|NCT00685399|580381015|FG003|Treatment Period 2|Adverse Event|0|||
160726061|NCT00685399|580381016|FG004|Treatment Period 2|Adverse Event|0|||
160726062|NCT00685399|580381017|FG005|Treatment Period 2|Adverse Event|1|||
160726063|NCT00685399|580381018|FG006|Treatment Period 2|Adverse Event|0|||
160726064|NCT00685399|580381019|FG007|Treatment Period 2|Adverse Event|0|||
160726065|NCT00685399|580381012|FG000|Treatment Period 2|Lack of Efficacy|0|||
160726066|NCT00685399|580381013|FG001|Treatment Period 2|Lack of Efficacy|10|||
160726067|NCT00685399|580381014|FG002|Treatment Period 2|Lack of Efficacy|2|||
160726068|NCT00685399|580381015|FG003|Treatment Period 2|Lack of Efficacy|0|||
160726069|NCT00685399|580381016|FG004|Treatment Period 2|Lack of Efficacy|0|||
160726070|NCT00685399|580381017|FG005|Treatment Period 2|Lack of Efficacy|1|||
160726071|NCT00685399|580381018|FG006|Treatment Period 2|Lack of Efficacy|0|||
160726072|NCT00685399|580381019|FG007|Treatment Period 2|Lack of Efficacy|0|||
160726073|NCT00685399|580381012|FG000|Extension|Administrative Issues|0|||
160726074|NCT00685399|580381013|FG001|Extension|Administrative Issues|0|||
160726075|NCT00685399|580381014|FG002|Extension|Administrative Issues|0|||
160726076|NCT00685399|580381015|FG003|Extension|Administrative Issues|1|||
160726077|NCT00685399|580381016|FG004|Extension|Administrative Issues|0|||
160726078|NCT00685399|580381017|FG005|Extension|Administrative Issues|0|||
160726079|NCT00685399|580381018|FG006|Extension|Administrative Issues|0|||
160726080|NCT00685399|580381019|FG007|Extension|Administrative Issues|0|||
160726081|NCT00685399|580381012|FG000|Extension|Withdrawal by Subject|0|||
160726082|NCT00685399|580381013|FG001|Extension|Withdrawal by Subject|0|||
160726083|NCT00685399|580381014|FG002|Extension|Withdrawal by Subject|0|||
160726084|NCT00685399|580381015|FG003|Extension|Withdrawal by Subject|1|||
160726085|NCT00685399|580381016|FG004|Extension|Withdrawal by Subject|0|||
160726086|NCT00685399|580381017|FG005|Extension|Withdrawal by Subject|0|||
160726087|NCT00685399|580381018|FG006|Extension|Withdrawal by Subject|0|||
160726088|NCT00685399|580381019|FG007|Extension|Withdrawal by Subject|0|||
160726089|NCT00685399|580381012|FG000|Extension|Protocol Violation|0|||
160726090|NCT00685399|580381013|FG001|Extension|Protocol Violation|0|||
160726091|NCT00685399|580381014|FG002|Extension|Protocol Violation|0|||
160726092|NCT00685399|580381015|FG003|Extension|Protocol Violation|1|||
160726093|NCT00685399|580381016|FG004|Extension|Protocol Violation|0|||
160726094|NCT00685399|580381017|FG005|Extension|Protocol Violation|0|||
160726095|NCT00685399|580381018|FG006|Extension|Protocol Violation|0|||
160726096|NCT00685399|580381019|FG007|Extension|Protocol Violation|0|||
160726097|NCT00685399|580381012|FG000|Extension|Lack of Efficacy|0|||
160726098|NCT00685399|580381013|FG001|Extension|Lack of Efficacy|0|||
160726099|NCT00685399|580381014|FG002|Extension|Lack of Efficacy|0|||
160726100|NCT00685399|580381015|FG003|Extension|Lack of Efficacy|2|||
160726101|NCT00685399|580381016|FG004|Extension|Lack of Efficacy|0|||
160726102|NCT00685399|580381017|FG005|Extension|Lack of Efficacy|0|||
160726103|NCT00685399|580381018|FG006|Extension|Lack of Efficacy|0|||
160726104|NCT00685399|580381019|FG007|Extension|Lack of Efficacy|0|||
160726105|NCT00685399|580381012|FG000|Extension|Adverse Event|0|||
160726106|NCT00685399|580381013|FG001|Extension|Adverse Event|0|||
160726107|NCT00685399|580381014|FG002|Extension|Adverse Event|0|||
160726108|NCT00685399|580381015|FG003|Extension|Adverse Event|2|||
160726109|NCT00685399|580381016|FG004|Extension|Adverse Event|0|||
160726110|NCT00685399|580381017|FG005|Extension|Adverse Event|0|||
160726111|NCT00685399|580381018|FG006|Extension|Adverse Event|0|||
160726112|NCT00685399|580381019|FG007|Extension|Adverse Event|0|||
160726113|NCT04478695|580381020|FG000|Overall Study|Death|1|||
160726114|NCT04478695|580381021|FG001|Overall Study|Death|0|||
160726115|NCT00644917|580381022|FG000|Overall Study|Withdrawal by Subject|2|||
160726116|NCT01136356|580381023|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
160726117|NCT01136356|580381024|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
160726118|NCT01136356|580381023|FG000|First 18-day Withdrawal|Physician Decision|1|||
160726119|NCT01136356|580381024|FG001|First 18-day Withdrawal|Physician Decision|0|||
160726120|NCT01136356|580381023|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
160726121|NCT01136356|580381024|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
160726122|NCT00402688|580381025|FG000|Overall Study|Adverse Event|12|||
160726123|NCT00402688|580381026|FG001|Overall Study|Adverse Event|9|||
160726124|NCT00402688|580381027|FG002|Overall Study|Adverse Event|3|||
160726125|NCT00402688|580381025|FG000|Overall Study|Withdrawal by Subject|3|||
160726126|NCT00402688|580381026|FG001|Overall Study|Withdrawal by Subject|1|||
160726127|NCT00402688|580381027|FG002|Overall Study|Withdrawal by Subject|1|||
160726128|NCT00402688|580381025|FG000|Overall Study|Physician Decision|0|||
160726129|NCT00402688|580381026|FG001|Overall Study|Physician Decision|0|||
160726130|NCT00402688|580381027|FG002|Overall Study|Physician Decision|1|||
160726131|NCT00402688|580381025|FG000|Overall Study|Lack of Efficacy|4|||
160726132|NCT00402688|580381026|FG001|Overall Study|Lack of Efficacy|4|||
160726133|NCT00402688|580381027|FG002|Overall Study|Lack of Efficacy|5|||
160726134|NCT00402688|580381025|FG000|Overall Study|Protocol Violation|1|||
160726135|NCT00402688|580381026|FG001|Overall Study|Protocol Violation|1|||
160726136|NCT00402688|580381027|FG002|Overall Study|Protocol Violation|1|||
160726137|NCT00402688|580381025|FG000|Overall Study|Lost to Follow-up|1|||
160726138|NCT00402688|580381026|FG001|Overall Study|Lost to Follow-up|0|||
160726139|NCT00402688|580381027|FG002|Overall Study|Lost to Follow-up|2|||
160726140|NCT00402688|580381025|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
160726141|NCT00402688|580381026|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
160726142|NCT00402688|580381027|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
160726143|NCT00402688|580381025|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
160726144|NCT00402688|580381026|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
160726145|NCT00402688|580381027|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
160726146|NCT00402688|580381025|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
160726147|NCT00402688|580381026|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
160726148|NCT00402688|580381027|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
160726149|NCT00178685|580381028|FG000|Overall Study|Death|3|||
160726150|NCT00178685|580381029|FG001|Overall Study|Death|3|||
160726151|NCT00178685|580381030|FG002|Overall Study|Death|6|||
160726152|NCT00178685|580381028|FG000|Overall Study|Lost to Follow-up|100|||
160726153|NCT00178685|580381029|FG001|Overall Study|Lost to Follow-up|187|||
160726154|NCT00178685|580381030|FG002|Overall Study|Lost to Follow-up|183|||
160726155|NCT00178685|580381028|FG000|Overall Study|Withdrawal by Subject|8|||
160726156|NCT00178685|580381029|FG001|Overall Study|Withdrawal by Subject|14|||
160726157|NCT00178685|580381030|FG002|Overall Study|Withdrawal by Subject|7|||
160726158|NCT00927862|580381031|FG000|Overall Study|Missing data needed for endpt analyses|27|||
160726159|NCT00927862|580381032|FG001|Overall Study|Missing data needed for endpt analyses|45|||
160726160|NCT00820248|580381033|FG000|Overall Study|No treated|4|||
160726161|NCT00820248|580381034|FG001|Overall Study|No treated|1|||
160726162|NCT04157296|580381044|FG000|Overall Study|Withdrawal by Subject|0|||
160726163|NCT04157296|580381045|FG001|Overall Study|Withdrawal by Subject|1|||
160726164|NCT04157296|580381044|FG000|Overall Study|Did not obtain second fMRI.|0|||
160726165|NCT04157296|580381045|FG001|Overall Study|Did not obtain second fMRI.|1|||
160726166|NCT04157296|580381044|FG000|Overall Study|MRI failed/no second fMRI|0|||
160726167|NCT04157296|580381045|FG001|Overall Study|MRI failed/no second fMRI|1|||
160726168|NCT02088905|580381052|FG000|Overall Study|Withdrawal by Subject|5|||
160726169|NCT02088905|580381053|FG001|Overall Study|Withdrawal by Subject|1|||
160726170|NCT01562782|580381059|FG000|Overall Study|Withdrawal by Subject|3|||
160726171|NCT01562782|580381060|FG001|Overall Study|Withdrawal by Subject|3|||
160726172|NCT01562782|580381059|FG000|Overall Study|screen failure|1|||
160726173|NCT01562782|580381060|FG001|Overall Study|screen failure|2|||
160726174|NCT02308540|580381061|FG000|Overall Study|Lost to Follow-up|0|||
160726175|NCT02308540|580381062|FG001|Overall Study|Lost to Follow-up|0|||
160726176|NCT02308540|580381063|FG002|Overall Study|Lost to Follow-up|0|||
160726177|NCT02308540|580381064|FG003|Overall Study|Lost to Follow-up|0|||
160726178|NCT02308540|580381065|FG004|Overall Study|Lost to Follow-up|0|||
160726179|NCT02308540|580381066|FG005|Overall Study|Lost to Follow-up|1|||
160726180|NCT04109391|580381067|FG000|Overall Study|Adverse Event|2|||
160726181|NCT04109391|580381068|FG001|Overall Study|Adverse Event|2|||
160726182|NCT04109391|580381069|FG002|Overall Study|Adverse Event|0|||
160726183|NCT04109391|580381067|FG000|Overall Study|Withdrawal by Subject|2|||
160726184|NCT04109391|580381068|FG001|Overall Study|Withdrawal by Subject|0|||
160726185|NCT04109391|580381069|FG002|Overall Study|Withdrawal by Subject|0|||
160726186|NCT04109391|580381067|FG000|Overall Study|Pregnancy|1|||
160726187|NCT04109391|580381068|FG001|Overall Study|Pregnancy|0|||
160726188|NCT04109391|580381069|FG002|Overall Study|Pregnancy|0|||
160726189|NCT04109391|580381067|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
160726190|NCT04109391|580381068|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
160726191|NCT04109391|580381069|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
160726192|NCT04109391|580381067|FG000|Overall Study|Lost to Follow-up|0|||
160726193|NCT04109391|580381068|FG001|Overall Study|Lost to Follow-up|0|||
160726194|NCT04109391|580381069|FG002|Overall Study|Lost to Follow-up|1|||
160726195|NCT04109391|580381067|FG000|Overall Study|Lack of Efficacy|2|||
160726196|NCT04109391|580381068|FG001|Overall Study|Lack of Efficacy|2|||
160726197|NCT04109391|580381069|FG002|Overall Study|Lack of Efficacy|3|||
160726198|NCT02649439|580381070|FG000|Overall Study|Switched to alternative treatment|6|||
160726199|NCT02649439|580381071|FG001|Overall Study|Switched to alternative treatment|4|||
160726200|NCT02649439|580381070|FG000|Overall Study|Patient decision|1|||
160726201|NCT02649439|580381071|FG001|Overall Study|Patient decision|0|||
160726202|NCT02649439|580381070|FG000|Overall Study|Patient going out of country|1|||
160726203|NCT02649439|580381071|FG001|Overall Study|Patient going out of country|0|||
160726204|NCT02649439|580381070|FG000|Overall Study|To start finasteride|1|||
160726205|NCT02649439|580381071|FG001|Overall Study|To start finasteride|0|||
160726206|NCT02649439|580381070|FG000|Overall Study|Physician Decision|1|||
160726207|NCT02649439|580381071|FG001|Overall Study|Physician Decision|0|||
160726208|NCT02649439|580381070|FG000|Overall Study|Disease progression on study|12|||
160726209|NCT02649439|580381071|FG001|Overall Study|Disease progression on study|13|||
160726210|NCT02649439|580381070|FG000|Overall Study|Refused further treatment|1|||
160726211|NCT02649439|580381071|FG001|Overall Study|Refused further treatment|0|||
160726212|NCT02649439|580381070|FG000|Overall Study|Refused further follow up|2|||
160726213|NCT02649439|580381071|FG001|Overall Study|Refused further follow up|7|||
160726214|NCT02649439|580381070|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
160726215|NCT02649439|580381071|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
160726216|NCT02649439|580381070|FG000|Overall Study|No treatment, per protocol|1|||
160726217|NCT02649439|580381071|FG001|Overall Study|No treatment, per protocol|0|||
160726218|NCT02649439|580381070|FG000|Overall Study|PSA DT makes ineligible|0|||
160726219|NCT02649439|580381071|FG001|Overall Study|PSA DT makes ineligible|1|||
160726220|NCT02649439|580381070|FG000|Overall Study|Rising PSA No Mets|0|||
160726221|NCT02649439|580381071|FG001|Overall Study|Rising PSA No Mets|1|||
160726222|NCT02649439|580381070|FG000|Overall Study|Rising PSA|0|||
160726223|NCT02649439|580381071|FG001|Overall Study|Rising PSA|1|||
160726224|NCT02649439|580381070|FG000|Overall Study|Signed follow up protocol|0|||
160726225|NCT02649439|580381071|FG001|Overall Study|Signed follow up protocol|1|||
160726226|NCT02097238|580381075|FG000|Overall Study|Death|1|||
160726227|NCT02097238|580381075|FG000|Overall Study|Physician Decision|1|||
160726228|NCT02097238|580381075|FG000|Overall Study|Progressive Disease|17|||
160726229|NCT01106911|580381076|FG000|Overall Study|Physician Decision|2|||
160726230|NCT01106911|580381076|FG000|Overall Study|deemed ineligible after screening|3|||
160726231|NCT01282372|580381085|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
160726232|NCT01282372|580381085|FG000|Overall Study|Lost to Follow-up|23|||
160726233|NCT01282372|580381085|FG000|Overall Study|Withdrawal by Subject|11|||
160726234|NCT01282372|580381085|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
160726235|NCT01282372|580381085|FG000|Overall Study|Death|1|||
160726236|NCT01282372|580381085|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
160726237|NCT01282372|580381085|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
160726238|NCT01282372|580381085|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
160726239|NCT01282372|580381085|FG000|Overall Study|Adverse Event|12|||
160726240|NCT01814696|580381086|FG000|Overall Study|Withdrawal by Subject|1|||
160726241|NCT01814696|580381087|FG001|Overall Study|Withdrawal by Subject|0|||
160726242|NCT01814696|580381086|FG000|Overall Study|Randomized to wrong group|1|||
160726243|NCT01814696|580381087|FG001|Overall Study|Randomized to wrong group|0|||
160726244|NCT02737930|580381092|FG000|Overall Study|Withdrawal by Subject|0|||
160726245|NCT02737930|580381093|FG001|Overall Study|Withdrawal by Subject|1|||
160726246|NCT05708976|580381102|FG000|Overall Study|Withdrawal by Subject|0|||
160726247|NCT05708976|580381103|FG001|Overall Study|Withdrawal by Subject|1|||
160726248|NCT02105987|580381104|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
160726249|NCT02105987|580381105|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
160726250|NCT02105987|580381106|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
160726251|NCT02105987|580381107|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
160726252|NCT02105987|580381108|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
160726253|NCT02105987|580381109|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
160726254|NCT02105987|580381104|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
160726255|NCT02105987|580381105|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
160726256|NCT02105987|580381106|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
160726257|NCT02105987|580381107|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
160726258|NCT02105987|580381108|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
160726259|NCT02105987|580381109|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
160726260|NCT02105987|580381104|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
160726261|NCT02105987|580381105|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
160726262|NCT02105987|580381106|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
160726263|NCT02105987|580381107|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
160726264|NCT02105987|580381108|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
160726265|NCT02105987|580381109|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
160726266|NCT02105987|580381104|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
160726267|NCT02105987|580381105|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
160726268|NCT02105987|580381106|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
160726269|NCT02105987|580381107|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
160726270|NCT02105987|580381108|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
160726271|NCT02105987|580381109|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
160726272|NCT02105987|580381104|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
160726273|NCT02105987|580381105|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
160726274|NCT02105987|580381106|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
160726275|NCT02105987|580381107|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
160726276|NCT02105987|580381108|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
160726277|NCT02105987|580381109|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
160726278|NCT02105987|580381104|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
160726279|NCT02105987|580381105|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
160726280|NCT02105987|580381106|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
160726281|NCT02105987|580381107|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
160726282|NCT02105987|580381108|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
160726283|NCT02105987|580381109|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
160726284|NCT02105987|580381104|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
160726285|NCT02105987|580381105|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
160726286|NCT02105987|580381106|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
160726287|NCT02105987|580381107|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
160726288|NCT02105987|580381108|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
160726289|NCT02105987|580381109|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
160726290|NCT02105987|580381104|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
160726291|NCT02105987|580381105|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
160726292|NCT02105987|580381106|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
160726293|NCT02105987|580381107|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
160726294|NCT02105987|580381108|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
160726295|NCT02105987|580381109|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
160726296|NCT02105987|580381104|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
160726297|NCT02105987|580381105|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
160726298|NCT02105987|580381106|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
160726299|NCT02105987|580381107|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
160726300|NCT02105987|580381108|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
160726301|NCT02105987|580381109|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
160726302|NCT02105987|580381104|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
160726303|NCT02105987|580381105|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
160726304|NCT02105987|580381106|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
160726305|NCT02105987|580381107|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
160726306|NCT02105987|580381108|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
160726307|NCT02105987|580381109|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
160726308|NCT02105987|580381104|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
160726309|NCT02105987|580381105|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
160726310|NCT02105987|580381106|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
160726311|NCT02105987|580381107|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
160726312|NCT02105987|580381108|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
160726313|NCT02105987|580381109|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
160726314|NCT02105987|580381104|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
160726315|NCT02105987|580381105|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
160726316|NCT02105987|580381106|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
160726317|NCT02105987|580381107|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
160726318|NCT02105987|580381108|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
160726319|NCT02105987|580381109|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
160726320|NCT02105987|580381104|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
160726321|NCT02105987|580381105|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
160726322|NCT02105987|580381106|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
160726323|NCT02105987|580381107|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
160726324|NCT02105987|580381108|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
160726325|NCT02105987|580381109|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
160726326|NCT02105987|580381104|FG000|Continuation Phase|Protocol Violation|0|||
160726327|NCT02105987|580381105|FG001|Continuation Phase|Protocol Violation|0|||
160726328|NCT02105987|580381106|FG002|Continuation Phase|Protocol Violation|0|||
160726329|NCT02105987|580381107|FG003|Continuation Phase|Protocol Violation|0|||
160726330|NCT02105987|580381108|FG004|Continuation Phase|Protocol Violation|1|||
160726331|NCT02105987|580381109|FG005|Continuation Phase|Protocol Violation|0|||
160726332|NCT00396656|580381121|FG000|First Treatment Period|Withdrawal by Subject|0|||
160726333|NCT00396656|580381122|FG001|First Treatment Period|Withdrawal by Subject|2|||
160726334|NCT00396656|580381121|FG000|Second Treatment Period|Adverse Event|0|||
160726335|NCT00396656|580381122|FG001|Second Treatment Period|Adverse Event|1|||
160726336|NCT02343939|580381123|FG000|Overall Study|Death|0|||
160726337|NCT02343939|580381124|FG001|Overall Study|Death|15|||
160726338|NCT02343939|580381125|FG002|Overall Study|Death|4|||
160726339|NCT02343939|580381126|FG003|Overall Study|Death|2|||
160726340|NCT02343939|580381127|FG004|Overall Study|Death|5|||
160726341|NCT02343939|580381128|FG005|Overall Study|Death|11|||
160726342|NCT02343939|580381129|FG006|Overall Study|Death|8|||
160726343|NCT02343939|580381130|FG007|Overall Study|Death|22|||
160726344|NCT02343939|580381131|FG008|Overall Study|Death|1|||
160726345|NCT02343939|580381123|FG000|Overall Study|Study terminated by sponsor|0|||
160726346|NCT02343939|580381124|FG001|Overall Study|Study terminated by sponsor|27|||
160726347|NCT02343939|580381125|FG002|Overall Study|Study terminated by sponsor|0|||
160726348|NCT02343939|580381126|FG003|Overall Study|Study terminated by sponsor|1|||
160726349|NCT02343939|580381127|FG004|Overall Study|Study terminated by sponsor|1|||
160726350|NCT02343939|580381128|FG005|Overall Study|Study terminated by sponsor|5|||
160726351|NCT02343939|580381129|FG006|Overall Study|Study terminated by sponsor|3|||
160726352|NCT02343939|580381130|FG007|Overall Study|Study terminated by sponsor|4|||
160726353|NCT02343939|580381131|FG008|Overall Study|Study terminated by sponsor|0|||
160726354|NCT02343939|580381123|FG000|Overall Study|Withdrew consent|3|||
160726355|NCT02343939|580381124|FG001|Overall Study|Withdrew consent|6|||
160726356|NCT02343939|580381125|FG002|Overall Study|Withdrew consent|1|||
160726357|NCT02343939|580381126|FG003|Overall Study|Withdrew consent|2|||
160726358|NCT02343939|580381127|FG004|Overall Study|Withdrew consent|2|||
160726359|NCT02343939|580381128|FG005|Overall Study|Withdrew consent|0|||
160726360|NCT02343939|580381129|FG006|Overall Study|Withdrew consent|0|||
160726361|NCT02343939|580381130|FG007|Overall Study|Withdrew consent|8|||
160726362|NCT02343939|580381131|FG008|Overall Study|Withdrew consent|6|||
160726363|NCT02343939|580381123|FG000|Overall Study|Treatment failure|0|||
160726364|NCT02343939|580381124|FG001|Overall Study|Treatment failure|0|||
160726365|NCT02343939|580381125|FG002|Overall Study|Treatment failure|0|||
160726366|NCT02343939|580381126|FG003|Overall Study|Treatment failure|0|||
160726367|NCT02343939|580381127|FG004|Overall Study|Treatment failure|0|||
160726368|NCT02343939|580381128|FG005|Overall Study|Treatment failure|0|||
160726369|NCT02343939|580381129|FG006|Overall Study|Treatment failure|2|||
160726370|NCT02343939|580381130|FG007|Overall Study|Treatment failure|1|||
160726371|NCT02343939|580381131|FG008|Overall Study|Treatment failure|0|||
160726372|NCT02343939|580381123|FG000|Overall Study|Investigator's discretion|0|||
160726373|NCT02343939|580381124|FG001|Overall Study|Investigator's discretion|0|||
160726374|NCT02343939|580381125|FG002|Overall Study|Investigator's discretion|0|||
160726375|NCT02343939|580381126|FG003|Overall Study|Investigator's discretion|1|||
160726376|NCT02343939|580381127|FG004|Overall Study|Investigator's discretion|0|||
160726377|NCT02343939|580381128|FG005|Overall Study|Investigator's discretion|0|||
160726378|NCT02343939|580381129|FG006|Overall Study|Investigator's discretion|1|||
160726379|NCT02343939|580381130|FG007|Overall Study|Investigator's discretion|0|||
160726380|NCT02343939|580381131|FG008|Overall Study|Investigator's discretion|0|||
160726381|NCT02343939|580381123|FG000|Overall Study|Adverse Event|0|||
160726382|NCT02343939|580381124|FG001|Overall Study|Adverse Event|0|||
160726383|NCT02343939|580381125|FG002|Overall Study|Adverse Event|0|||
160726384|NCT02343939|580381126|FG003|Overall Study|Adverse Event|0|||
160726385|NCT02343939|580381127|FG004|Overall Study|Adverse Event|0|||
160726386|NCT02343939|580381128|FG005|Overall Study|Adverse Event|1|||
160726387|NCT02343939|580381129|FG006|Overall Study|Adverse Event|0|||
160726388|NCT02343939|580381130|FG007|Overall Study|Adverse Event|0|||
160726389|NCT02343939|580381131|FG008|Overall Study|Adverse Event|0|||
160726390|NCT02343939|580381123|FG000|Overall Study|Never Treated With ENTO|0|||
160726391|NCT02343939|580381124|FG001|Overall Study|Never Treated With ENTO|0|||
160726392|NCT02343939|580381125|FG002|Overall Study|Never Treated With ENTO|0|||
160726393|NCT02343939|580381126|FG003|Overall Study|Never Treated With ENTO|0|||
160726394|NCT02343939|580381127|FG004|Overall Study|Never Treated With ENTO|0|||
160726395|NCT02343939|580381128|FG005|Overall Study|Never Treated With ENTO|0|||
160726396|NCT02343939|580381129|FG006|Overall Study|Never Treated With ENTO|1|||
160726397|NCT02343939|580381130|FG007|Overall Study|Never Treated With ENTO|2|||
160726398|NCT02343939|580381131|FG008|Overall Study|Never Treated With ENTO|0|||
160726399|NCT01303172|580381132|FG000|Overall Study|Physician Decision|9|||
160726400|NCT01303172|580381133|FG001|Overall Study|Physician Decision|6|||
160726401|NCT01303172|580381132|FG000|Overall Study|Adverse Event|5|||
160726402|NCT01303172|580381133|FG001|Overall Study|Adverse Event|2|||
160726403|NCT01303172|580381132|FG000|Overall Study|Withdrawal by Subject|4|||
160726404|NCT01303172|580381133|FG001|Overall Study|Withdrawal by Subject|2|||
160726405|NCT01303172|580381132|FG000|Overall Study|Death|20|||
160726406|NCT01303172|580381133|FG001|Overall Study|Death|7|||
160726407|NCT01303172|580381132|FG000|Overall Study|Lack of Efficacy|25|||
160726408|NCT01303172|580381133|FG001|Overall Study|Lack of Efficacy|17|||
160726409|NCT02684097|580381134|FG000|Overall Study|Lack of Efficacy|13|||
160726410|NCT02684097|580381135|FG001|Overall Study|Lack of Efficacy|6|||
160726411|NCT00462709|580381136|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
160726412|NCT00462709|580381136|FG000|Overall Study|Lost to Follow-up|10|||
160726413|NCT00462709|580381136|FG000|Overall Study|Withdrawal by Subject|8|||
160726414|NCT00462709|580381136|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
160726415|NCT00462709|580381136|FG000|Overall Study|Death|2|||
160726416|NCT00462709|580381136|FG000|Overall Study|Logistical reasons|2|||
160726417|NCT00462709|580381136|FG000|Overall Study|Physician Decision|1|||
160726418|NCT00462709|580381136|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
160726419|NCT02099110|580381141|FG000|Overall Study|Protocol Violation|2|||
160726420|NCT02099110|580381142|FG001|Overall Study|Protocol Violation|1|||
160726421|NCT02099110|580381143|FG002|Overall Study|Protocol Violation|0|||
160726422|NCT02099110|580381144|FG003|Overall Study|Protocol Violation|3|||
160726423|NCT02099110|580381145|FG004|Overall Study|Protocol Violation|1|||
160726424|NCT02099110|580381141|FG000|Overall Study|Participant moved|1|||
160726425|NCT02099110|580381142|FG001|Overall Study|Participant moved|1|||
160726426|NCT02099110|580381143|FG002|Overall Study|Participant moved|1|||
160726427|NCT02099110|580381144|FG003|Overall Study|Participant moved|0|||
160726428|NCT02099110|580381145|FG004|Overall Study|Participant moved|2|||
160726429|NCT02099110|580381141|FG000|Overall Study|Withdrawal by Subject|7|||
160726430|NCT02099110|580381142|FG001|Overall Study|Withdrawal by Subject|11|||
160726431|NCT02099110|580381143|FG002|Overall Study|Withdrawal by Subject|13|||
160726432|NCT02099110|580381144|FG003|Overall Study|Withdrawal by Subject|9|||
160726433|NCT02099110|580381145|FG004|Overall Study|Withdrawal by Subject|13|||
160726434|NCT02099110|580381141|FG000|Overall Study|Adverse Event|3|||
160726435|NCT02099110|580381142|FG001|Overall Study|Adverse Event|5|||
160726436|NCT02099110|580381143|FG002|Overall Study|Adverse Event|2|||
160726437|NCT02099110|580381144|FG003|Overall Study|Adverse Event|3|||
160726438|NCT02099110|580381145|FG004|Overall Study|Adverse Event|2|||
160726439|NCT02099110|580381141|FG000|Overall Study|Lost to Follow-up|6|||
160726440|NCT02099110|580381142|FG001|Overall Study|Lost to Follow-up|12|||
160726441|NCT02099110|580381143|FG002|Overall Study|Lost to Follow-up|11|||
160726442|NCT02099110|580381144|FG003|Overall Study|Lost to Follow-up|5|||
160726443|NCT02099110|580381145|FG004|Overall Study|Lost to Follow-up|6|||
160726444|NCT02099110|580381141|FG000|Overall Study|Death|0|||
160726445|NCT02099110|580381142|FG001|Overall Study|Death|1|||
160726446|NCT02099110|580381143|FG002|Overall Study|Death|0|||
160726447|NCT02099110|580381144|FG003|Overall Study|Death|0|||
160726448|NCT02099110|580381145|FG004|Overall Study|Death|0|||
160726449|NCT02099110|580381141|FG000|Overall Study|Screen failure|0|||
160726450|NCT02099110|580381142|FG001|Overall Study|Screen failure|0|||
160726451|NCT02099110|580381143|FG002|Overall Study|Screen failure|0|||
160726452|NCT02099110|580381144|FG003|Overall Study|Screen failure|0|||
160726453|NCT02099110|580381145|FG004|Overall Study|Screen failure|1|||
160726454|NCT02099110|580381141|FG000|Overall Study|Non-compliance with study drug|2|||
160726455|NCT02099110|580381142|FG001|Overall Study|Non-compliance with study drug|0|||
160726456|NCT02099110|580381143|FG002|Overall Study|Non-compliance with study drug|0|||
160726457|NCT02099110|580381144|FG003|Overall Study|Non-compliance with study drug|0|||
160726458|NCT02099110|580381145|FG004|Overall Study|Non-compliance with study drug|1|||
160726459|NCT02099110|580381141|FG000|Overall Study|Physician Decision|3|||
160726460|NCT02099110|580381142|FG001|Overall Study|Physician Decision|0|||
160726461|NCT02099110|580381143|FG002|Overall Study|Physician Decision|1|||
160726462|NCT02099110|580381144|FG003|Overall Study|Physician Decision|2|||
160726463|NCT02099110|580381145|FG004|Overall Study|Physician Decision|1|||
160726464|NCT02064816|580381146|FG000|Overall Study|Adverse Event|3|||
160726465|NCT02064816|580381147|FG001|Overall Study|Adverse Event|2|||
160726466|NCT02064816|580381146|FG000|Overall Study|Withdrawal by Subject|2|||
160726467|NCT02064816|580381147|FG001|Overall Study|Withdrawal by Subject|1|||
160726468|NCT02064816|580381146|FG000|Overall Study|Lost to Follow-up|2|||
160726469|NCT02064816|580381147|FG001|Overall Study|Lost to Follow-up|1|||
160726470|NCT02064816|580381146|FG000|Overall Study|Therapeutic failure|0|||
160726471|NCT02064816|580381147|FG001|Overall Study|Therapeutic failure|1|||
160726472|NCT02064816|580381146|FG000|Overall Study|Other|1|||
160726473|NCT02064816|580381147|FG001|Overall Study|Other|3|||
160726474|NCT01757184|580381154|FG000|Double-blind Period|Adverse Event|1|||
160726475|NCT01757184|580381155|FG001|Double-blind Period|Adverse Event|0|||
160726476|NCT01757184|580381156|FG002|Double-blind Period|Adverse Event|0|||
160726477|NCT01757184|580381157|FG003|Double-blind Period|Adverse Event|0|||
160726478|NCT01757184|580381154|FG000|Open-label Period|Lost to Follow-up|0|||
160726479|NCT01757184|580381155|FG001|Open-label Period|Lost to Follow-up|0|||
160726480|NCT01757184|580381156|FG002|Open-label Period|Lost to Follow-up|2|||
160726481|NCT01757184|580381157|FG003|Open-label Period|Lost to Follow-up|0|||
160726482|NCT01757184|580381154|FG000|Open-label Period|Withdrawal by Subject|0|||
160726483|NCT01757184|580381155|FG001|Open-label Period|Withdrawal by Subject|0|||
160726484|NCT01757184|580381156|FG002|Open-label Period|Withdrawal by Subject|1|||
160726485|NCT01757184|580381157|FG003|Open-label Period|Withdrawal by Subject|1|||
160726486|NCT01757184|580381154|FG000|Open-label Period|Discontinued by Sponsor|0|||
160726487|NCT01757184|580381155|FG001|Open-label Period|Discontinued by Sponsor|0|||
160726488|NCT01757184|580381156|FG002|Open-label Period|Discontinued by Sponsor|1|||
160726489|NCT01757184|580381157|FG003|Open-label Period|Discontinued by Sponsor|2|||
160726490|NCT05107492|580381158|FG000|Overall Study|Lost to Follow-up|1|||
160726491|NCT05107492|580381159|FG001|Overall Study|Lost to Follow-up|0|||
160726492|NCT04586244|580381166|FG000|Overall Study|Lost to Follow-up|1|||
160726493|NCT04586244|580381167|FG001|Overall Study|Lost to Follow-up|0|||
160726494|NCT04586244|580381168|FG002|Overall Study|Lost to Follow-up|0|||
160726495|NCT04586244|580381169|FG003|Overall Study|Lost to Follow-up|1|||
160726496|NCT04586244|580381170|FG004|Overall Study|Lost to Follow-up|0|||
160726497|NCT04586244|580381166|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
160726498|NCT04586244|580381167|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
160726499|NCT04586244|580381168|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
160726500|NCT04586244|580381169|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
160726501|NCT04586244|580381170|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
160726502|NCT03896022|580381171|FG000|Overall Study|Withdrawal by Subject|1|||
160726503|NCT03896022|580381172|FG001|Overall Study|Withdrawal by Subject|0|||
160726504|NCT03896022|580381173|FG002|Overall Study|Withdrawal by Subject|0|||
160726505|NCT03896022|580381171|FG000|Overall Study|Did not have procedure|3|||
160726506|NCT03896022|580381172|FG001|Overall Study|Did not have procedure|0|||
160726507|NCT03896022|580381173|FG002|Overall Study|Did not have procedure|0|||
160726508|NCT02186873|580382622|FG000|Overall Study|Adverse Event|1|||
160726509|NCT02186873|580382623|FG001|Overall Study|Adverse Event|3|||
160726510|NCT02186873|580382622|FG000|Overall Study|Lack of Efficacy|0|||
160726511|NCT02186873|580382623|FG001|Overall Study|Lack of Efficacy|1|||
160726512|NCT02186873|580382622|FG000|Overall Study|Lost to Follow-up|1|||
160726513|NCT02186873|580382623|FG001|Overall Study|Lost to Follow-up|2|||
160726514|NCT02186873|580382622|FG000|Overall Study|Withdrawal by Subject|7|||
160726515|NCT02186873|580382623|FG001|Overall Study|Withdrawal by Subject|2|||
160726516|NCT03694002|580382624|FG000|Overall Study|Progression|4|||
160726517|NCT03694002|580382625|FG001|Overall Study|Progression|2|||
160726518|NCT03694002|580382624|FG000|Overall Study|Adverse Event|2|||
160726519|NCT03694002|580382625|FG001|Overall Study|Adverse Event|0|||
160726520|NCT03694002|580382624|FG000|Overall Study|Other not protocol specified|1|||
160726521|NCT03694002|580382625|FG001|Overall Study|Other not protocol specified|0|||
160726522|NCT03694002|580382624|FG000|Overall Study|Ineligible|0|||
160726523|NCT03694002|580382625|FG001|Overall Study|Ineligible|1|||
160726524|NCT03694002|580382624|FG000|Overall Study|Withdrew consent before starting treatment|0|||
160726525|NCT03694002|580382625|FG001|Overall Study|Withdrew consent before starting treatment|3|||
160726526|NCT01760655|580382626|FG000|Overall Study|Death|18|||
160726527|NCT01760655|580382626|FG000|Overall Study|Physician Decision|1|||
160726528|NCT00068393|580382631|FG000|Overall Study|Adverse Event|2|||
160726529|NCT00068393|580382631|FG000|Overall Study|Death|3|||
160726530|NCT00068393|580382631|FG000|Overall Study|Withdrawal by Subject|3|||
160726531|NCT00068393|580382631|FG000|Overall Study|Alternative treatment|1|||
160726532|NCT00068393|580382631|FG000|Overall Study|Quality of life worsening|1|||
160726533|NCT01399047|580382632|FG000|Overall Study|Withdrawal by Subject|0|||
160726534|NCT01399047|580382633|FG001|Overall Study|Withdrawal by Subject|1|||
160726535|NCT03300505|580382653|FG000|Overall Study|Death|0|||
160726536|NCT03300505|580382654|FG001|Overall Study|Death|1|||
160726537|NCT03300505|580382655|FG002|Overall Study|Death|0|||
160726538|NCT03300505|580382653|FG000|Overall Study|Withdrawal by Subject|0|||
160726539|NCT03300505|580382654|FG001|Overall Study|Withdrawal by Subject|1|||
160726540|NCT03300505|580382655|FG002|Overall Study|Withdrawal by Subject|1|||
160726541|NCT03300505|580382653|FG000|Overall Study|Sponsor Termination|0|||
160726542|NCT03300505|580382654|FG001|Overall Study|Sponsor Termination|1|||
160726543|NCT03300505|580382655|FG002|Overall Study|Sponsor Termination|0|||
160726544|NCT03300505|580382653|FG000|Overall Study|Adverse Event|0|||
160726545|NCT03300505|580382654|FG001|Overall Study|Adverse Event|0|||
160726546|NCT03300505|580382655|FG002|Overall Study|Adverse Event|2|||
160726547|NCT05119595|580382656|FG000|Overall Study|Death|1|||
160726548|NCT05119595|580382656|FG000|Overall Study|Lost to Follow-up|7|||
160726549|NCT01806961|580382657|FG000|Overall Study|sponsor decision|16|||
160726550|NCT01108341|580382662|FG000|Overall Study|Death|2|||
160726551|NCT01108341|580382662|FG000|Overall Study|Withdrawal by Subject|1|||
160726552|NCT01108341|580382662|FG000|Overall Study|Lost to Follow-up|1|||
160726553|NCT01108341|580382662|FG000|Overall Study|Other|1|||
160726554|NCT03056638|580382668|FG000|Overall Study|Death|1|||
160726555|NCT03056638|580382669|FG001|Overall Study|Death|0|||
160726556|NCT02530125|580382670|FG000|Completed Treatment|Early termination of study|1|||
160726557|NCT02530125|580382670|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
160726558|NCT00468481|580382671|FG000|Overall Study|Adverse Event|13|||
160726559|NCT00468481|580382672|FG001|Overall Study|Adverse Event|3|||
160726560|NCT00468481|580382671|FG000|Overall Study|Lost to Follow-up|25|||
160726561|NCT00468481|580382672|FG001|Overall Study|Lost to Follow-up|8|||
160726562|NCT00468481|580382671|FG000|Overall Study|Pregnancy|2|||
160726563|NCT00468481|580382672|FG001|Overall Study|Pregnancy|0|||
160726564|NCT00468481|580382671|FG000|Overall Study|Protocol Violation|18|||
160726565|NCT00468481|580382672|FG001|Overall Study|Protocol Violation|8|||
160726566|NCT00468481|580382671|FG000|Overall Study|Withdrawal by Subject|12|||
160726567|NCT00468481|580382672|FG001|Overall Study|Withdrawal by Subject|3|||
160726568|NCT00468481|580382671|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
160726569|NCT00468481|580382672|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
160726570|NCT00468481|580382671|FG000|Overall Study|Prohibited Medication|1|||
160726571|NCT00468481|580382672|FG001|Overall Study|Prohibited Medication|1|||
160726572|NCT00468481|580382671|FG000|Overall Study|Egg Donor|1|||
160726573|NCT00468481|580382672|FG001|Overall Study|Egg Donor|0|||
160726574|NCT00468481|580382671|FG000|Overall Study|Moved out of area|4|||
160726575|NCT00468481|580382672|FG001|Overall Study|Moved out of area|1|||
160726576|NCT00468481|580382671|FG000|Overall Study|Non-Compliance|5|||
160726577|NCT00468481|580382672|FG001|Overall Study|Non-Compliance|0|||
160726578|NCT00468481|580382671|FG000|Overall Study|Other|6|||
160726579|NCT00468481|580382672|FG001|Overall Study|Other|0|||
160726580|NCT01568034|580382673|FG000|Overall Study|Withdrawal by Subject|1|||
160726581|NCT01568034|580382674|FG001|Overall Study|Withdrawal by Subject|0|||
160726582|NCT01568034|580382675|FG002|Overall Study|Withdrawal by Subject|0|||
160726583|NCT01568034|580382676|FG003|Overall Study|Withdrawal by Subject|0|||
160726584|NCT00728468|580382677|FG000|Overall Study|Enrolled but not treated|1|||
160726585|NCT00728468|580382677|FG000|Overall Study|Death|1|||
160726586|NCT00728468|580382677|FG000|Overall Study|Protocol Violation|4|||
160726587|NCT00728468|580382677|FG000|Overall Study|Objective progression or relapse|9|||
160726588|NCT00728468|580382677|FG000|Overall Study|Study terminated by sponsor|1|||
160726589|NCT00596687|580382678|FG000|Overall Study|< 24 hours of insulin treatment|8|||
160726590|NCT00596687|580382679|FG001|Overall Study|< 24 hours of insulin treatment|6|||
160726591|NCT00596687|580382678|FG000|Overall Study|continuous insulin infusion during TPN|2|||
160726592|NCT00596687|580382679|FG001|Overall Study|continuous insulin infusion during TPN|1|||
160726593|NCT00596687|580382678|FG000|Overall Study|Withdrawal by Subject|3|||
160726594|NCT00596687|580382679|FG001|Overall Study|Withdrawal by Subject|1|||
160726595|NCT00596687|580382678|FG000|Overall Study|cancelled surgery|1|||
160726596|NCT00596687|580382679|FG001|Overall Study|cancelled surgery|1|||
160726597|NCT06098339|580382680|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
160726598|NCT06098339|580382681|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
160726599|NCT06098339|580382680|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
160726600|NCT06098339|580382681|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
160726601|NCT03831113|580382682|FG000|Overall Study|Withdrawal by Subject|0|||
160726602|NCT03831113|580382683|FG001|Overall Study|Withdrawal by Subject|2|||
160726603|NCT03831113|580382682|FG000|Overall Study|Protocol Violation|0|||
160726604|NCT03831113|580382683|FG001|Overall Study|Protocol Violation|9|||
160726605|NCT03656692|580382687|FG000|Overall Study|Worsening of disease activity|2|||
160726606|NCT03656692|580382687|FG000|Overall Study|Physician Decision|1|||
160726607|NCT02498444|580382688|FG000|Overall Study|Withdrawal by Subject|3|||
160726608|NCT02498444|580382689|FG001|Overall Study|Withdrawal by Subject|0|||
160726609|NCT02498444|580382688|FG000|Overall Study|Physician Decision|1|||
160726610|NCT02498444|580382689|FG001|Overall Study|Physician Decision|0|||
160726611|NCT01718535|580382706|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
160726612|NCT01718535|580382707|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
160726613|NCT01718535|580382708|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
160726614|NCT01718535|580382709|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
160726615|NCT01718535|580382710|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
160726616|NCT01718535|580382711|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
160726617|NCT01718535|580382712|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
160726618|NCT01718535|580382713|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
160726619|NCT01718535|580382714|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
160726620|NCT01718535|580382715|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
160726621|NCT02476578|580382716|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
160726622|NCT02476578|580382717|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
160726623|NCT02476578|580382716|FG000|Overall Study|Lost to Follow-up|6|||
160726624|NCT02476578|580382717|FG001|Overall Study|Lost to Follow-up|13|||
160726625|NCT00912743|580382724|FG000|Overall Study|Adverse Event|3|||
160726626|NCT00912743|580382725|FG001|Overall Study|Adverse Event|1|||
160726627|NCT00912743|580382724|FG000|Overall Study|Lack of Efficacy|9|||
160726628|NCT00912743|580382725|FG001|Overall Study|Lack of Efficacy|18|||
160726629|NCT00912743|580382724|FG000|Overall Study|Toxicity|0|||
160726630|NCT00912743|580382725|FG001|Overall Study|Toxicity|1|||
160726631|NCT00912743|580382724|FG000|Overall Study|End of treatment form was not collected|1|||
160726632|NCT00912743|580382725|FG001|Overall Study|End of treatment form was not collected|0|||
160726633|NCT04747886|580382726|FG000|Overall Study|Withdrawal by Subject|1|||
160726634|NCT04747886|580382727|FG001|Overall Study|Withdrawal by Subject|4|||
160726635|NCT02237196|580382728|FG000|Overall Study|Adverse Event|0|||
160726636|NCT02237196|580382729|FG001|Overall Study|Adverse Event|1|||
160726637|NCT02237196|580382730|FG002|Overall Study|Adverse Event|1|||
160726638|NCT02237196|580382731|FG003|Overall Study|Adverse Event|0|||
160726639|NCT02237196|580382728|FG000|Overall Study|Lost to Follow-up|4|||
160726640|NCT02237196|580382729|FG001|Overall Study|Lost to Follow-up|2|||
160726641|NCT02237196|580382730|FG002|Overall Study|Lost to Follow-up|4|||
160726642|NCT02237196|580382731|FG003|Overall Study|Lost to Follow-up|6|||
160726643|NCT02237196|580382728|FG000|Overall Study|Physician Decision|2|||
160726644|NCT02237196|580382729|FG001|Overall Study|Physician Decision|0|||
160726645|NCT02237196|580382730|FG002|Overall Study|Physician Decision|0|||
160726646|NCT02237196|580382731|FG003|Overall Study|Physician Decision|1|||
160726647|NCT02237196|580382728|FG000|Overall Study|Pregnancy|0|||
160726648|NCT02237196|580382729|FG001|Overall Study|Pregnancy|0|||
160726649|NCT02237196|580382730|FG002|Overall Study|Pregnancy|1|||
160726650|NCT02237196|580382731|FG003|Overall Study|Pregnancy|1|||
160726651|NCT02237196|580382728|FG000|Overall Study|Withdrawal by Subject|1|||
160726652|NCT02237196|580382729|FG001|Overall Study|Withdrawal by Subject|1|||
160726653|NCT02237196|580382730|FG002|Overall Study|Withdrawal by Subject|4|||
160726654|NCT02237196|580382731|FG003|Overall Study|Withdrawal by Subject|1|||
160726655|NCT02237196|580382728|FG000|Overall Study|Site Error|1|||
160726656|NCT02237196|580382729|FG001|Overall Study|Site Error|2|||
160726657|NCT02237196|580382730|FG002|Overall Study|Site Error|0|||
160726658|NCT02237196|580382731|FG003|Overall Study|Site Error|2|||
160726659|NCT01057810|580382732|FG000|Overall Study|Disease progression|156|||
160726660|NCT01057810|580382733|FG001|Overall Study|Disease progression|197|||
160726661|NCT01057810|580382732|FG000|Overall Study|Study drug toxicity|5|||
160726662|NCT01057810|580382733|FG001|Overall Study|Study drug toxicity|114|||
160726663|NCT01057810|580382732|FG000|Overall Study|Adverse event unrelated to study drug|13|||
160726664|NCT01057810|580382733|FG001|Overall Study|Adverse event unrelated to study drug|29|||
160726665|NCT01057810|580382732|FG000|Overall Study|Withdrawal by Subject|10|||
160726666|NCT01057810|580382733|FG001|Overall Study|Withdrawal by Subject|25|||
160726667|NCT01057810|580382732|FG000|Overall Study|Death|2|||
160726668|NCT01057810|580382733|FG001|Overall Study|Death|12|||
160726669|NCT01057810|580382732|FG000|Overall Study|Maximum clinical benefit|5|||
160726670|NCT01057810|580382733|FG001|Overall Study|Maximum clinical benefit|5|||
160726671|NCT01057810|580382732|FG000|Overall Study|Poor/non-compliance|0|||
160726672|NCT01057810|580382733|FG001|Overall Study|Poor/non-compliance|1|||
160726673|NCT01057810|580382732|FG000|Overall Study|No longer met study criteria|0|||
160726674|NCT01057810|580382733|FG001|Overall Study|No longer met study criteria|1|||
160726675|NCT01057810|580382732|FG000|Overall Study|Other|7|||
160726676|NCT01057810|580382733|FG001|Overall Study|Other|14|||
160726677|NCT00862823|580382734|FG000|First Intervention|Withdrawal by Subject|1|||
160726678|NCT00862823|580382735|FG001|First Intervention|Withdrawal by Subject|1|||
160726679|NCT00887315|580382736|FG000|Overall Study|Study termination|7|||
160726680|NCT00887315|580382737|FG001|Overall Study|Study termination|4|||
160726681|NCT00619892|580382741|FG000|Overall Study|Adverse Event|3|||
160726682|NCT00619892|580382742|FG001|Overall Study|Adverse Event|0|||
160726683|NCT00619892|580382741|FG000|Overall Study|Lost to Follow-up|0|||
160726684|NCT00619892|580382742|FG001|Overall Study|Lost to Follow-up|1|||
160726685|NCT00619892|580382741|FG000|Overall Study|Intercurrent illness|0|||
160726686|NCT00619892|580382742|FG001|Overall Study|Intercurrent illness|1|||
160726687|NCT00857896|580382749|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
160726688|NCT05310071|580382762|FG000|Overall Study|Death|0|||
160726689|NCT05310071|580382763|FG001|Overall Study|Death|3|||
160726690|NCT05310071|580382762|FG000|Overall Study|Adverse Event|4|||
160726691|NCT05310071|580382763|FG001|Overall Study|Adverse Event|31|||
160726692|NCT05310071|580382762|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
160726693|NCT05310071|580382763|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
160726694|NCT05310071|580382762|FG000|Overall Study|Protocol Deviation|2|||
160726695|NCT05310071|580382763|FG001|Overall Study|Protocol Deviation|0|||
160726696|NCT05310071|580382762|FG000|Overall Study|Randomized by Mistake|0|||
160726697|NCT05310071|580382763|FG001|Overall Study|Randomized by Mistake|1|||
160726698|NCT05310071|580382762|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
160726699|NCT05310071|580382763|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
160726700|NCT05310071|580382762|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
160726701|NCT05310071|580382763|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
160726702|NCT05310071|580382762|FG000|Overall Study|Site Terminated by Sponsor|0|||
160726703|NCT05310071|580382763|FG001|Overall Study|Site Terminated by Sponsor|2|||
160726704|NCT05310071|580382762|FG000|Overall Study|Study Terminated by Sponsor|282|||
160726705|NCT05310071|580382763|FG001|Overall Study|Study Terminated by Sponsor|559|||
160726706|NCT05310071|580382762|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
160726707|NCT05310071|580382763|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
160726708|NCT05310071|580382762|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
160726709|NCT05310071|580382763|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
160726710|NCT05310071|580382762|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
160726711|NCT05310071|580382763|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
160726712|NCT05310071|580382762|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
160726713|NCT05310071|580382763|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
160726714|NCT05310071|580382762|FG000|Overall Study|Withdrawal by Participant - Other|25|||
160726715|NCT05310071|580382763|FG001|Overall Study|Withdrawal by Participant - Other|30|||
160726716|NCT05310071|580382762|FG000|Overall Study|Lost to Follow-up|2|||
160726717|NCT05310071|580382763|FG001|Overall Study|Lost to Follow-up|4|||
160726718|NCT05310071|580382762|FG000|Overall Study|Reason Not Specified|1|||
160726719|NCT05310071|580382763|FG001|Overall Study|Reason Not Specified|3|||
160726720|NCT02418949|580382764|FG000|Overall Study|Withdrawal by Subject|1|||
160726721|NCT02418949|580382765|FG001|Overall Study|Withdrawal by Subject|0|||
160726722|NCT02418949|580382766|FG002|Overall Study|Withdrawal by Subject|1|||
160726723|NCT02418949|580382767|FG003|Overall Study|Withdrawal by Subject|1|||
160726724|NCT02418949|580382764|FG000|Overall Study|Lost to Follow-up|1|||
160726725|NCT02418949|580382765|FG001|Overall Study|Lost to Follow-up|0|||
160726726|NCT02418949|580382766|FG002|Overall Study|Lost to Follow-up|1|||
160726727|NCT02418949|580382767|FG003|Overall Study|Lost to Follow-up|0|||
160726728|NCT02418949|580382764|FG000|Overall Study|Physician Decision|1|||
160726729|NCT02418949|580382765|FG001|Overall Study|Physician Decision|1|||
160726730|NCT02418949|580382766|FG002|Overall Study|Physician Decision|1|||
160726731|NCT02418949|580382767|FG003|Overall Study|Physician Decision|0|||
160726732|NCT03515811|580382769|FG000|Overall Study|Lost to Follow-up|2|||
160726733|NCT03515811|580382770|FG001|Overall Study|Lost to Follow-up|1|||
160726734|NCT03515811|580382769|FG000|Overall Study|Protocol Violation|1|||
160726735|NCT03515811|580382770|FG001|Overall Study|Protocol Violation|1|||
160726736|NCT03515811|580382769|FG000|Overall Study|Death|1|||
160726737|NCT03515811|580382770|FG001|Overall Study|Death|1|||
160726738|NCT03515811|580382769|FG000|Overall Study|Withdrawal by Subject|0|||
160726739|NCT03515811|580382770|FG001|Overall Study|Withdrawal by Subject|2|||
160726740|NCT03515811|580382769|FG000|Overall Study|Technical Problems|1|||
160726741|NCT03515811|580382770|FG001|Overall Study|Technical Problems|0|||
160726742|NCT03515811|580382769|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
160726743|NCT03515811|580382770|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
160726744|NCT03515811|580382769|FG000|Overall Study|COVID-19|0|||
160726745|NCT03515811|580382770|FG001|Overall Study|COVID-19|1|||
160726746|NCT00237458|580382771|FG000|Overall Study|Lack of Efficacy|1|||
160726747|NCT00237458|580382771|FG000|Overall Study|Adverse Event|1|||
160726748|NCT00237458|580382771|FG000|Overall Study|Withdrawal by Subject|1|||
160726749|NCT03218826|580382772|FG000|Overall Study|Non-compliance with protocol|1|||
160726750|NCT03218826|580382773|FG001|Overall Study|Non-compliance with protocol|0|||
160726751|NCT03218826|580382774|FG002|Overall Study|Non-compliance with protocol|2|||
160726752|NCT03218826|580382775|FG003|Overall Study|Non-compliance with protocol|1|||
160726753|NCT03218826|580382776|FG004|Overall Study|Non-compliance with protocol|1|||
160726754|NCT01197534|580382777|FG000|Overall Study|Not reported|16|||
160726755|NCT01197534|580382778|FG001|Overall Study|Not reported|10|||
160726756|NCT01197534|580382779|FG002|Overall Study|Not reported|16|||
160726757|NCT01197534|580382777|FG000|Overall Study|Enrolment in long term extension|57|||
160726758|NCT01197534|580382778|FG001|Overall Study|Enrolment in long term extension|66|||
160726759|NCT01197534|580382779|FG002|Overall Study|Enrolment in long term extension|119|||
160726760|NCT01197534|580382777|FG000|Overall Study|Severe non-compliance to protocol|3|||
160726761|NCT01197534|580382778|FG001|Overall Study|Severe non-compliance to protocol|4|||
160726762|NCT01197534|580382779|FG002|Overall Study|Severe non-compliance to protocol|1|||
160726763|NCT01197534|580382777|FG000|Overall Study|Lack of therapeutic response|9|||
160726764|NCT01197534|580382778|FG001|Overall Study|Lack of therapeutic response|4|||
160726765|NCT01197534|580382779|FG002|Overall Study|Lack of therapeutic response|9|||
160726766|NCT01197534|580382777|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
160726767|NCT01197534|580382778|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
160726768|NCT01197534|580382779|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
160726769|NCT01197534|580382777|FG000|Overall Study|Lost to Follow-up|1|||
160726770|NCT01197534|580382778|FG001|Overall Study|Lost to Follow-up|4|||
160726771|NCT01197534|580382779|FG002|Overall Study|Lost to Follow-up|2|||
160726772|NCT01197534|580382777|FG000|Overall Study|Adverse Event|35|||
160726773|NCT01197534|580382778|FG001|Overall Study|Adverse Event|36|||
160726774|NCT01197534|580382779|FG002|Overall Study|Adverse Event|24|||
160726775|NCT03564119|580382782|FG000|Overall Study|Adverse Event|4|||
160726776|NCT03564119|580382783|FG001|Overall Study|Adverse Event|0|||
160726777|NCT03564119|580382782|FG000|Overall Study|Lost to Follow-up|1|||
160726778|NCT03564119|580382783|FG001|Overall Study|Lost to Follow-up|4|||
160726779|NCT03564119|580382782|FG000|Overall Study|Protocol Violation|1|||
160726780|NCT03564119|580382783|FG001|Overall Study|Protocol Violation|0|||
160726781|NCT03564119|580382782|FG000|Overall Study|Withdrawal by Subject|9|||
160726782|NCT03564119|580382783|FG001|Overall Study|Withdrawal by Subject|4|||
160726783|NCT03564119|580382782|FG000|Overall Study|Other Than Specified|0|||
160726784|NCT03564119|580382783|FG001|Overall Study|Other Than Specified|1|||
160726785|NCT00634036|580382784|FG000|Overall Study|Lost to Follow-up|1|||
160726786|NCT00634036|580382785|FG001|Overall Study|Lost to Follow-up|1|||
160726787|NCT00634036|580382784|FG000|Overall Study|Withdrawal by Subject|1|||
160726788|NCT00634036|580382785|FG001|Overall Study|Withdrawal by Subject|1|||
160726789|NCT02741076|580382786|FG000|Overall Study|Adverse Event|0|||
160726790|NCT02741076|580382787|FG001|Overall Study|Adverse Event|1|||
160726791|NCT02741076|580382788|FG002|Overall Study|Adverse Event|1|||
160726792|NCT02741076|580382789|FG003|Overall Study|Adverse Event|0|||
160726793|NCT02741076|580382786|FG000|Overall Study|Lack of Efficacy|1|||
160726794|NCT02741076|580382787|FG001|Overall Study|Lack of Efficacy|0|||
160726795|NCT02741076|580382788|FG002|Overall Study|Lack of Efficacy|0|||
160726796|NCT02741076|580382789|FG003|Overall Study|Lack of Efficacy|0|||
160726797|NCT02741076|580382786|FG000|Overall Study|Withdrawal by Subject|0|||
160726798|NCT02741076|580382787|FG001|Overall Study|Withdrawal by Subject|1|||
160726799|NCT02741076|580382788|FG002|Overall Study|Withdrawal by Subject|0|||
160726800|NCT02741076|580382789|FG003|Overall Study|Withdrawal by Subject|0|||
160726801|NCT02741076|580382786|FG000|Overall Study|Sponsor Request|2|||
160726802|NCT02741076|580382787|FG001|Overall Study|Sponsor Request|3|||
160726803|NCT02741076|580382788|FG002|Overall Study|Sponsor Request|0|||
160726804|NCT02741076|580382789|FG003|Overall Study|Sponsor Request|1|||
160726805|NCT02741076|580382786|FG000|Overall Study|No additional information available|0|||
160726806|NCT02741076|580382787|FG001|Overall Study|No additional information available|0|||
160726807|NCT02741076|580382788|FG002|Overall Study|No additional information available|1|||
160726808|NCT02741076|580382789|FG003|Overall Study|No additional information available|1|||
160726809|NCT01779440|580382790|FG000|Overall Study|Withdrawal by Subject|3|||
160726810|NCT01779440|580382791|FG001|Overall Study|Withdrawal by Subject|5|||
160726811|NCT01283334|580384248|FG000|Overall Study|Withdrawal by Subject|1|||
160726812|NCT01283334|580384248|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
160726813|NCT01283334|580384248|FG000|Overall Study|Adverse Event|4|||
160726814|NCT01283334|580384248|FG000|Overall Study|Physician Decision|1|||
160726815|NCT03467217|580384249|FG000|Overall Study|Trial stopped early|5|||
160726816|NCT03467217|580384250|FG001|Overall Study|Trial stopped early|2|||
160726817|NCT03467217|580384249|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
160726818|NCT03467217|580384250|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
160726819|NCT03467217|580384249|FG000|Overall Study|Lost to Follow-up|0|||
160726820|NCT03467217|580384250|FG001|Overall Study|Lost to Follow-up|2|||
160726821|NCT00769067|580384251|FG000|Overall Study|Death|89|||
160726822|NCT00769067|580384252|FG001|Overall Study|Death|86|||
160726823|NCT00769067|580384251|FG000|Overall Study|Lost to Follow-up|3|||
160726824|NCT00769067|580384252|FG001|Overall Study|Lost to Follow-up|1|||
160726825|NCT00769067|580384251|FG000|Overall Study|Study terminated by sponsor|1|||
160726826|NCT00769067|580384252|FG001|Overall Study|Study terminated by sponsor|3|||
160726827|NCT00769067|580384251|FG000|Overall Study|Other|1|||
160726828|NCT00769067|580384252|FG001|Overall Study|Other|3|||
160726829|NCT00769067|580384251|FG000|Overall Study|Withdrawal by Subject|0|||
160726830|NCT00769067|580384252|FG001|Overall Study|Withdrawal by Subject|1|||
160726831|NCT04981470|580384255|FG000|Overall Study|Device failure in all 4 patients|4|||
160726832|NCT04402138|580384256|FG000|Overall Study|Progressive Disease|2|||
160726833|NCT04402138|580384256|FG000|Overall Study|Adverse Event|1|||
160726834|NCT00784238|580384257|FG000|Overall Study|Adverse Event|14|||
160726835|NCT00784238|580384257|FG000|Overall Study|Death|2|||
160726836|NCT00784238|580384257|FG000|Overall Study|Lack of Efficacy|33|||
160726837|NCT00784238|580384257|FG000|Overall Study|Lost to Follow-up|29|||
160726838|NCT00784238|580384257|FG000|Overall Study|Pregnancy|1|||
160726839|NCT00784238|580384257|FG000|Overall Study|Withdrawal by Subject|26|||
160726840|NCT00784238|580384257|FG000|Overall Study|Other|14|||
160726841|NCT04390503|580384259|FG000|Overall Study|Physician Decision|2|||
160726842|NCT04390503|580384260|FG001|Overall Study|Physician Decision|1|||
160726843|NCT04390503|580384259|FG000|Overall Study|Adverse Event|1|||
160726844|NCT04390503|580384260|FG001|Overall Study|Adverse Event|0|||
160726845|NCT00078767|580384261|FG000|Overall Study|Withdrawal by Subject|1|||
160726846|NCT00078767|580384262|FG001|Overall Study|Withdrawal by Subject|1|||
160726847|NCT03508726|580384263|FG000|Overall Study|Withdrawal by Subject|0|||
160726848|NCT03508726|580384264|FG001|Overall Study|Withdrawal by Subject|1|||
160726849|NCT01068730|580384265|FG000|Period 3|Personal reason|1|||
160726850|NCT01068730|580384266|FG001|Period 3|Personal reason|0|||
160726851|NCT01068730|580384267|FG002|Period 3|Personal reason|0|||
160726852|NCT01068730|580384268|FG003|Period 3|Personal reason|0|||
160726853|NCT01068730|580384265|FG000|Period 4|Family emergency|0|||
160726854|NCT01068730|580384266|FG001|Period 4|Family emergency|1|||
160726855|NCT01068730|580384267|FG002|Period 4|Family emergency|0|||
160726856|NCT01068730|580384268|FG003|Period 4|Family emergency|0|||
160726857|NCT03233529|580384271|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
160726858|NCT03233529|580384271|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
160726859|NCT01177293|580384272|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
160726860|NCT01177293|580384273|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
160726861|NCT00594100|580384274|FG000|Procedure|Technical Failure|9|||
160726862|NCT00594100|580384274|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
160726863|NCT00594100|580384274|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
160726864|NCT00594100|580384274|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
160726865|NCT02448537|580384275|FG000|Overall Study|Withdrawal by Subject|1|||
160726866|NCT02448537|580384276|FG001|Overall Study|Withdrawal by Subject|1|||
160726867|NCT02448537|580384277|FG002|Overall Study|Withdrawal by Subject|1|||
160726868|NCT03528369|580384280|FG000|Overall Study|Withdrawal by Subject|2|||
160726869|NCT03528369|580384281|FG001|Overall Study|Withdrawal by Subject|0|||
160726870|NCT03528369|580384282|FG002|Overall Study|Withdrawal by Subject|0|||
160726871|NCT03528369|580384280|FG000|Overall Study|Lost to Follow-up|1|||
160726872|NCT03528369|580384281|FG001|Overall Study|Lost to Follow-up|0|||
160726873|NCT03528369|580384282|FG002|Overall Study|Lost to Follow-up|0|||
160726874|NCT03528369|580384280|FG000|Overall Study|Adverse Event|0|||
160726875|NCT03528369|580384281|FG001|Overall Study|Adverse Event|1|||
160726876|NCT03528369|580384282|FG002|Overall Study|Adverse Event|0|||
160726877|NCT04725812|580384283|FG000|Overall Study|Withdrawal by Subject|1|||
160726878|NCT05656534|580384285|FG000|Overall Study|Withdrawal by Subject|1|||
160726879|NCT05656534|580384286|FG001|Overall Study|Withdrawal by Subject|1|||
160726880|NCT05656534|580384287|FG002|Overall Study|Withdrawal by Subject|0|||
160726881|NCT05656534|580384288|FG003|Overall Study|Withdrawal by Subject|0|||
160726882|NCT05656534|580384285|FG000|Overall Study|Physician Decision|1|||
160726883|NCT05656534|580384286|FG001|Overall Study|Physician Decision|1|||
160726884|NCT05656534|580384287|FG002|Overall Study|Physician Decision|0|||
160726885|NCT05656534|580384288|FG003|Overall Study|Physician Decision|0|||
160726886|NCT00839800|580384289|FG000|Overall Study|Adverse Event|8|||
160726887|NCT00839800|580384290|FG001|Overall Study|Adverse Event|12|||
160726888|NCT00839800|580384289|FG000|Overall Study|Lost to Follow-up|31|||
160726889|NCT00839800|580384290|FG001|Overall Study|Lost to Follow-up|26|||
160726890|NCT00839800|580384289|FG000|Overall Study|Withdrawal by Subject|28|||
160726891|NCT00839800|580384290|FG001|Overall Study|Withdrawal by Subject|34|||
160726892|NCT00839800|580384289|FG000|Overall Study|Incorrect Enrolment|3|||
160726893|NCT00839800|580384290|FG001|Overall Study|Incorrect Enrolment|3|||
160726894|NCT00839800|580384289|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
160726895|NCT00839800|580384290|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
160726896|NCT00839800|580384289|FG000|Overall Study|Safety Reasons|2|||
160726897|NCT00839800|580384290|FG001|Overall Study|Safety Reasons|1|||
160726898|NCT00839800|580384289|FG000|Overall Study|Other|8|||
160726899|NCT00839800|580384290|FG001|Overall Study|Other|14|||
160726900|NCT00839800|580384289|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
160726901|NCT00839800|580384290|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
160726902|NCT02801617|580384291|FG000|Overall Study|Protocol Violation|2|||
160726903|NCT02801617|580384292|FG001|Overall Study|Protocol Violation|6|||
160726904|NCT00302328|580384293|FG000|Overall Study|Physician Decision|0|||
160726905|NCT00302328|580384294|FG001|Overall Study|Physician Decision|1|||
160726906|NCT00302328|580384295|FG002|Overall Study|Physician Decision|0|||
160726907|NCT00267969|580384296|FG000|Controlled Period|Adverse Event|6|||
160726908|NCT00267969|580384297|FG001|Controlled Period|Adverse Event|0|||
160726909|NCT00267969|580384298|FG002|Controlled Period|Adverse Event|2|||
160726910|NCT00267969|580384299|FG003|Controlled Period|Adverse Event|0|||
160726911|NCT00267969|580384300|FG004|Controlled Period|Adverse Event|0|||
160726912|NCT00267969|580384301|FG005|Controlled Period|Adverse Event|0|||
160726913|NCT00267969|580384302|FG006|Controlled Period|Adverse Event|0|||
160726914|NCT00267969|580384296|FG000|Controlled Period|Lack of Efficacy|3|||
160726915|NCT00267969|580384297|FG001|Controlled Period|Lack of Efficacy|0|||
160726916|NCT00267969|580384298|FG002|Controlled Period|Lack of Efficacy|1|||
160726917|NCT00267969|580384299|FG003|Controlled Period|Lack of Efficacy|0|||
160726918|NCT00267969|580384300|FG004|Controlled Period|Lack of Efficacy|0|||
160726919|NCT00267969|580384301|FG005|Controlled Period|Lack of Efficacy|0|||
160726920|NCT00267969|580384302|FG006|Controlled Period|Lack of Efficacy|0|||
160726921|NCT00267969|580384296|FG000|Controlled Period|Lost to Follow-up|1|||
160726922|NCT00267969|580384297|FG001|Controlled Period|Lost to Follow-up|0|||
160726923|NCT00267969|580384298|FG002|Controlled Period|Lost to Follow-up|1|||
160726924|NCT00267969|580384299|FG003|Controlled Period|Lost to Follow-up|0|||
160726925|NCT00267969|580384300|FG004|Controlled Period|Lost to Follow-up|0|||
160726926|NCT00267969|580384301|FG005|Controlled Period|Lost to Follow-up|0|||
160726927|NCT00267969|580384302|FG006|Controlled Period|Lost to Follow-up|0|||
160726928|NCT00267969|580384296|FG000|Controlled Period|Randomized but not treated|0|||
160726929|NCT00267969|580384297|FG001|Controlled Period|Randomized but not treated|0|||
160726930|NCT00267969|580384298|FG002|Controlled Period|Randomized but not treated|1|||
160726931|NCT00267969|580384299|FG003|Controlled Period|Randomized but not treated|0|||
160726932|NCT00267969|580384300|FG004|Controlled Period|Randomized but not treated|0|||
160726933|NCT00267969|580384301|FG005|Controlled Period|Randomized but not treated|0|||
160726934|NCT00267969|580384302|FG006|Controlled Period|Randomized but not treated|0|||
160726935|NCT00267969|580384296|FG000|Controlled Period|Other|2|||
160726936|NCT00267969|580384297|FG001|Controlled Period|Other|1|||
160726937|NCT00267969|580384298|FG002|Controlled Period|Other|6|||
160726938|NCT00267969|580384299|FG003|Controlled Period|Other|0|||
160726939|NCT00267969|580384300|FG004|Controlled Period|Other|0|||
160726940|NCT00267969|580384301|FG005|Controlled Period|Other|0|||
160726941|NCT00267969|580384302|FG006|Controlled Period|Other|0|||
160726942|NCT00267969|580384296|FG000|After Controlled Period|Adverse Event|0|||
160726943|NCT00267969|580384297|FG001|After Controlled Period|Adverse Event|0|||
160726944|NCT00267969|580384298|FG002|After Controlled Period|Adverse Event|0|||
160726945|NCT00267969|580384299|FG003|After Controlled Period|Adverse Event|7|||
160726946|NCT00267969|580384300|FG004|After Controlled Period|Adverse Event|8|||
160726947|NCT00267969|580384301|FG005|After Controlled Period|Adverse Event|23|||
160726948|NCT00267969|580384302|FG006|After Controlled Period|Adverse Event|21|||
160726949|NCT00267969|580384296|FG000|After Controlled Period|Death|0|||
160726950|NCT00267969|580384297|FG001|After Controlled Period|Death|0|||
160726951|NCT00267969|580384298|FG002|After Controlled Period|Death|0|||
160726952|NCT00267969|580384299|FG003|After Controlled Period|Death|1|||
160726953|NCT00267969|580384300|FG004|After Controlled Period|Death|2|||
160726954|NCT00267969|580384301|FG005|After Controlled Period|Death|0|||
160726955|NCT00267969|580384302|FG006|After Controlled Period|Death|1|||
160726956|NCT00267969|580384296|FG000|After Controlled Period|Lack of Efficacy|0|||
160726957|NCT00267969|580384297|FG001|After Controlled Period|Lack of Efficacy|0|||
160726958|NCT00267969|580384298|FG002|After Controlled Period|Lack of Efficacy|0|||
160726959|NCT00267969|580384299|FG003|After Controlled Period|Lack of Efficacy|10|||
160726960|NCT00267969|580384300|FG004|After Controlled Period|Lack of Efficacy|6|||
160726961|NCT00267969|580384301|FG005|After Controlled Period|Lack of Efficacy|28|||
160726962|NCT00267969|580384302|FG006|After Controlled Period|Lack of Efficacy|15|||
160726963|NCT00267969|580384296|FG000|After Controlled Period|Lost to Follow-up|0|||
160726964|NCT00267969|580384297|FG001|After Controlled Period|Lost to Follow-up|0|||
160726965|NCT00267969|580384298|FG002|After Controlled Period|Lost to Follow-up|0|||
160726966|NCT00267969|580384299|FG003|After Controlled Period|Lost to Follow-up|5|||
160726967|NCT00267969|580384300|FG004|After Controlled Period|Lost to Follow-up|8|||
160726968|NCT00267969|580384301|FG005|After Controlled Period|Lost to Follow-up|9|||
160726969|NCT00267969|580384302|FG006|After Controlled Period|Lost to Follow-up|10|||
160726970|NCT00267969|580384296|FG000|After Controlled Period|Other|0|||
160726971|NCT00267969|580384297|FG001|After Controlled Period|Other|0|||
160726972|NCT00267969|580384298|FG002|After Controlled Period|Other|0|||
160726973|NCT00267969|580384299|FG003|After Controlled Period|Other|13|||
160726974|NCT00267969|580384300|FG004|After Controlled Period|Other|11|||
160726975|NCT00267969|580384301|FG005|After Controlled Period|Other|22|||
160726976|NCT00267969|580384302|FG006|After Controlled Period|Other|25|||
160726977|NCT01091662|580384303|FG000|Overall Study|Adverse Event|1|||
160726978|NCT01091662|580384304|FG001|Overall Study|Adverse Event|9|||
160726979|NCT01091662|580384303|FG000|Overall Study|Physician Decision|1|||
160726980|NCT01091662|580384304|FG001|Overall Study|Physician Decision|1|||
160726981|NCT01091662|580384303|FG000|Overall Study|Withdrawal by Subject|7|||
160726982|NCT01091662|580384304|FG001|Overall Study|Withdrawal by Subject|6|||
160726983|NCT01091662|580384303|FG000|Overall Study|met exit criteria|7|||
160726984|NCT01091662|580384304|FG001|Overall Study|met exit criteria|13|||
160726985|NCT01091662|580384303|FG000|Overall Study|met exclusion criteria|1|||
160726986|NCT01091662|580384304|FG001|Overall Study|met exclusion criteria|0|||
160726987|NCT01091662|580384303|FG000|Overall Study|Lost to Follow-up|0|||
160726988|NCT01091662|580384304|FG001|Overall Study|Lost to Follow-up|1|||
160726989|NCT01091662|580384303|FG000|Overall Study|Pregnancy|0|||
160726990|NCT01091662|580384304|FG001|Overall Study|Pregnancy|1|||
160726991|NCT01091662|580384303|FG000|Overall Study|Protocol Violation|0|||
160726992|NCT01091662|580384304|FG001|Overall Study|Protocol Violation|2|||
160726993|NCT01091662|580384303|FG000|Overall Study|unable to swallow capsule|0|||
160726994|NCT01091662|580384304|FG001|Overall Study|unable to swallow capsule|1|||
160726995|NCT00443079|580384307|FG000|Overall Study|Lost to Follow-up|0|||
160726996|NCT00443079|580384308|FG001|Overall Study|Lost to Follow-up|1|||
160726997|NCT01421225|580384309|FG000|Overall Study|Withdrawal by Subject|0|||
160726998|NCT01421225|580384310|FG001|Overall Study|Withdrawal by Subject|1|||
160726999|NCT02049814|580384311|FG000|Overall Study|Reason not Specified|4|||
160727000|NCT02049814|580384312|FG001|Overall Study|Reason not Specified|3|||
160727001|NCT02049814|580384311|FG000|Overall Study|Pregnancy|1|||
160727002|NCT02049814|580384312|FG001|Overall Study|Pregnancy|0|||
160727003|NCT02049814|580384311|FG000|Overall Study|Lost to Follow-up|2|||
160727004|NCT02049814|580384312|FG001|Overall Study|Lost to Follow-up|3|||
160727005|NCT02049814|580384311|FG000|Overall Study|Serious Protocol Violation|5|||
160727006|NCT02049814|580384312|FG001|Overall Study|Serious Protocol Violation|7|||
160727007|NCT02049814|580384311|FG000|Overall Study|Study Termination|0|||
160727008|NCT02049814|580384312|FG001|Overall Study|Study Termination|1|||
160727009|NCT02049814|580384311|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
160727010|NCT02049814|580384312|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
160727011|NCT02049814|580384311|FG000|Overall Study|Voluntary withdrawal|9|||
160727012|NCT02049814|580384312|FG001|Overall Study|Voluntary withdrawal|8|||
160727013|NCT02714595|580384313|FG000|Overall Study|Lost to Follow-up|1|||
160727014|NCT02714595|580384314|FG001|Overall Study|Lost to Follow-up|0|||
160727015|NCT02714595|580384313|FG000|Overall Study|Withdrawal by Subject|1|||
160727016|NCT02714595|580384314|FG001|Overall Study|Withdrawal by Subject|2|||
160727017|NCT02714595|580384313|FG000|Overall Study|Lack of Efficacy|0|||
160727018|NCT02714595|580384314|FG001|Overall Study|Lack of Efficacy|1|||
160727019|NCT02714595|580384313|FG000|Overall Study|Death|30|||
160727020|NCT02714595|580384314|FG001|Overall Study|Death|9|||
160727021|NCT02714595|580384313|FG000|Overall Study|Other-Miscellaneous|0|||
160727022|NCT02714595|580384314|FG001|Overall Study|Other-Miscellaneous|1|||
160727023|NCT00713258|580384315|FG000|Overall Study|Adverse Event|2|||
160727024|NCT00713258|580384316|FG001|Overall Study|Adverse Event|4|||
160727025|NCT00713258|580384315|FG000|Overall Study|Non-Compliance|2|||
160727026|NCT00713258|580384316|FG001|Overall Study|Non-Compliance|1|||
160727027|NCT00713258|580384315|FG000|Overall Study|Other|1|||
160727028|NCT00713258|580384316|FG001|Overall Study|Other|1|||
160727029|NCT01431716|580384317|FG000|Overall Study|Withdrawal of consent|1|||
160727030|NCT02484456|580384320|FG000|Washout Period|Withdrawal by Subject|0|||
160727031|NCT02484456|580384321|FG001|Washout Period|Withdrawal by Subject|1|||
160727032|NCT02484456|580384320|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
160727033|NCT02484456|580384321|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
160727034|NCT02484456|580384320|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
160727035|NCT02484456|580384321|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
160727036|NCT02484456|580384320|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
160727037|NCT02484456|580384321|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
160727038|NCT00708214|580384322|FG000|Overall Study|Other Adverse Event|3|||
160727039|NCT00708214|580384323|FG001|Overall Study|Other Adverse Event|6|||
160727040|NCT00708214|580384324|FG002|Overall Study|Other Adverse Event|2|||
160727041|NCT00708214|580384322|FG000|Overall Study|Other|0|||
160727042|NCT00708214|580384323|FG001|Overall Study|Other|1|||
160727043|NCT00708214|580384324|FG002|Overall Study|Other|1|||
160727044|NCT00708214|580384322|FG000|Overall Study|Progressive Disease|4|||
160727045|NCT00708214|580384323|FG001|Overall Study|Progressive Disease|6|||
160727046|NCT00708214|580384324|FG002|Overall Study|Progressive Disease|5|||
160727047|NCT02199795|580384325|FG000|Overall Study|no longer met inclusion criteria|1|||
160727048|NCT02199795|580384326|FG001|Overall Study|no longer met inclusion criteria|0|||
160727049|NCT02199795|580384325|FG000|Overall Study|withdrew due to shoulder pain|1|||
160727050|NCT02199795|580384326|FG001|Overall Study|withdrew due to shoulder pain|0|||
160727051|NCT01430403|580384329|FG000|Overall Study|Lost to Follow-up|5|||
160727052|NCT01430403|580384330|FG001|Overall Study|Lost to Follow-up|5|||
160727053|NCT01430403|580384331|FG002|Overall Study|Lost to Follow-up|3|||
160727054|NCT01430403|580384329|FG000|Overall Study|Physician Decision|1|||
160727055|NCT01430403|580384330|FG001|Overall Study|Physician Decision|0|||
160727056|NCT01430403|580384331|FG002|Overall Study|Physician Decision|0|||
160727057|NCT01430403|580384329|FG000|Overall Study|Protocol Violation|2|||
160727058|NCT01430403|580384330|FG001|Overall Study|Protocol Violation|3|||
160727059|NCT01430403|580384331|FG002|Overall Study|Protocol Violation|2|||
160727060|NCT01430403|580384329|FG000|Overall Study|Withdrawal by Subject|9|||
160727061|NCT01430403|580384330|FG001|Overall Study|Withdrawal by Subject|1|||
160727062|NCT01430403|580384331|FG002|Overall Study|Withdrawal by Subject|3|||
160727063|NCT02677922|580384332|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
160727064|NCT02677922|580384333|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
160727065|NCT02677922|580384334|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
160727066|NCT02677922|580384335|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
160727067|NCT02677922|580384336|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
160727068|NCT02677922|580384337|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
160727069|NCT02677922|580384332|FG000|Treatment Period|Adverse Event|0|||
160727070|NCT02677922|580384333|FG001|Treatment Period|Adverse Event|0|||
160727071|NCT02677922|580384334|FG002|Treatment Period|Adverse Event|1|||
160727072|NCT02677922|580384335|FG003|Treatment Period|Adverse Event|3|||
160727073|NCT02677922|580384336|FG004|Treatment Period|Adverse Event|5|||
160727074|NCT02677922|580384337|FG005|Treatment Period|Adverse Event|2|||
160727075|NCT02677922|580384332|FG000|Treatment Period|Progressive Disease|1|||
160727076|NCT02677922|580384333|FG001|Treatment Period|Progressive Disease|1|||
160727077|NCT02677922|580384334|FG002|Treatment Period|Progressive Disease|0|||
160727078|NCT02677922|580384335|FG003|Treatment Period|Progressive Disease|0|||
160727079|NCT02677922|580384336|FG004|Treatment Period|Progressive Disease|8|||
160727080|NCT02677922|580384337|FG005|Treatment Period|Progressive Disease|7|||
160727081|NCT02677922|580384332|FG000|Treatment Period|Lack of Efficacy|0|||
160727082|NCT02677922|580384333|FG001|Treatment Period|Lack of Efficacy|0|||
160727083|NCT02677922|580384334|FG002|Treatment Period|Lack of Efficacy|0|||
160727084|NCT02677922|580384335|FG003|Treatment Period|Lack of Efficacy|1|||
160727085|NCT02677922|580384336|FG004|Treatment Period|Lack of Efficacy|1|||
160727086|NCT02677922|580384337|FG005|Treatment Period|Lack of Efficacy|6|||
160727087|NCT02677922|580384332|FG000|Treatment Period|Withdrawal by Subject|0|||
160727088|NCT02677922|580384333|FG001|Treatment Period|Withdrawal by Subject|0|||
160727089|NCT02677922|580384334|FG002|Treatment Period|Withdrawal by Subject|1|||
160727090|NCT02677922|580384335|FG003|Treatment Period|Withdrawal by Subject|3|||
160727091|NCT02677922|580384336|FG004|Treatment Period|Withdrawal by Subject|5|||
160727092|NCT02677922|580384337|FG005|Treatment Period|Withdrawal by Subject|5|||
160727093|NCT02677922|580384332|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
160727094|NCT02677922|580384333|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
160727095|NCT02677922|580384334|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
160727096|NCT02677922|580384335|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
160727097|NCT02677922|580384336|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
160727098|NCT02677922|580384337|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
160727099|NCT02677922|580384332|FG000|Treatment Period|Disease Relapse|0|||
160727100|NCT02677922|580384333|FG001|Treatment Period|Disease Relapse|0|||
160727101|NCT02677922|580384334|FG002|Treatment Period|Disease Relapse|0|||
160727102|NCT02677922|580384335|FG003|Treatment Period|Disease Relapse|3|||
160727103|NCT02677922|580384336|FG004|Treatment Period|Disease Relapse|6|||
160727104|NCT02677922|580384337|FG005|Treatment Period|Disease Relapse|1|||
160727105|NCT02677922|580384332|FG000|Treatment Period|Allogeneic HSCT|1|||
160727106|NCT02677922|580384333|FG001|Treatment Period|Allogeneic HSCT|0|||
160727107|NCT02677922|580384334|FG002|Treatment Period|Allogeneic HSCT|0|||
160727108|NCT02677922|580384335|FG003|Treatment Period|Allogeneic HSCT|1|||
160727109|NCT02677922|580384336|FG004|Treatment Period|Allogeneic HSCT|4|||
160727110|NCT02677922|580384337|FG005|Treatment Period|Allogeneic HSCT|1|||
160727111|NCT02677922|580384332|FG000|Treatment Period|Other Reasons|0|||
160727112|NCT02677922|580384333|FG001|Treatment Period|Other Reasons|0|||
160727113|NCT02677922|580384334|FG002|Treatment Period|Other Reasons|0|||
160727114|NCT02677922|580384335|FG003|Treatment Period|Other Reasons|1|||
160727115|NCT02677922|580384336|FG004|Treatment Period|Other Reasons|3|||
160727116|NCT02677922|580384337|FG005|Treatment Period|Other Reasons|5|||
160727117|NCT02677922|580384332|FG000|Treatment Period|Death|0|||
160727118|NCT02677922|580384333|FG001|Treatment Period|Death|0|||
160727119|NCT02677922|580384334|FG002|Treatment Period|Death|0|||
160727120|NCT02677922|580384335|FG003|Treatment Period|Death|0|||
160727121|NCT02677922|580384336|FG004|Treatment Period|Death|12|||
160727122|NCT02677922|580384337|FG005|Treatment Period|Death|1|||
160727123|NCT02677922|580384332|FG000|Treatment Period|Non-compliance with Study Drug|0|||
160727124|NCT02677922|580384333|FG001|Treatment Period|Non-compliance with Study Drug|0|||
160727125|NCT02677922|580384334|FG002|Treatment Period|Non-compliance with Study Drug|0|||
160727126|NCT02677922|580384335|FG003|Treatment Period|Non-compliance with Study Drug|0|||
160727127|NCT02677922|580384336|FG004|Treatment Period|Non-compliance with Study Drug|1|||
160727128|NCT02677922|580384337|FG005|Treatment Period|Non-compliance with Study Drug|0|||
160727129|NCT02677922|580384332|FG000|Treatment Period|Physician Decision|0|||
160727130|NCT02677922|580384333|FG001|Treatment Period|Physician Decision|0|||
160727131|NCT02677922|580384334|FG002|Treatment Period|Physician Decision|0|||
160727132|NCT02677922|580384335|FG003|Treatment Period|Physician Decision|0|||
160727133|NCT02677922|580384336|FG004|Treatment Period|Physician Decision|0|||
160727134|NCT02677922|580384337|FG005|Treatment Period|Physician Decision|1|||
160727135|NCT02677922|580384332|FG000|Treatment Period|Symptomatic Deterioration|0|||
160727136|NCT02677922|580384333|FG001|Treatment Period|Symptomatic Deterioration|0|||
160727137|NCT02677922|580384334|FG002|Treatment Period|Symptomatic Deterioration|0|||
160727138|NCT02677922|580384335|FG003|Treatment Period|Symptomatic Deterioration|0|||
160727139|NCT02677922|580384336|FG004|Treatment Period|Symptomatic Deterioration|1|||
160727140|NCT02677922|580384337|FG005|Treatment Period|Symptomatic Deterioration|0|||
160727141|NCT00637000|580384338|FG000|Overall Study|Withdrawal by Subject|4|||
160727142|NCT00637000|580384339|FG001|Overall Study|Withdrawal by Subject|3|||
160727143|NCT00014495|580384344|FG000|Overall Study|Death|0|||
160727144|NCT00014495|580384345|FG001|Overall Study|Death|0|||
160727145|NCT00014495|580384346|FG002|Overall Study|Death|1|||
160727146|NCT00014495|580384347|FG003|Overall Study|Death|0|||
160727147|NCT00014495|580384344|FG000|Overall Study|Clinical deterioration|0|||
160727148|NCT00014495|580384345|FG001|Overall Study|Clinical deterioration|0|||
160727149|NCT00014495|580384346|FG002|Overall Study|Clinical deterioration|0|||
160727150|NCT00014495|580384347|FG003|Overall Study|Clinical deterioration|1|||
160727151|NCT02593097|580384354|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
160727152|NCT02593097|580384355|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
160727153|NCT02593097|580384354|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
160727154|NCT02593097|580384355|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
160727155|NCT02593097|580384354|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
160727156|NCT02593097|580384355|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
160727157|NCT02593097|580384354|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
160727158|NCT02593097|580384355|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
160727159|NCT02593097|580384354|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
160727160|NCT02593097|580384355|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
160727161|NCT02858583|580384356|FG000|Overall Study|Declined consent|1|||
160727162|NCT02858583|580384357|FG001|Overall Study|Declined consent|1|||
160727163|NCT03759587|580384358|FG000|Overall Study|Adverse Event|5|||
160727164|NCT03759587|580384358|FG000|Overall Study|Progressive Disease|10|||
160727165|NCT03759587|580384358|FG000|Overall Study|Site Terminated by Sponsor|3|||
160727166|NCT03759587|580384358|FG000|Overall Study|Withdrawal by Subject|1|||
160727167|NCT01863667|580384361|FG000|Overall Study|Adverse Event|1|||
160727168|NCT01863667|580384362|FG001|Overall Study|Adverse Event|0|||
160727169|NCT01863667|580384361|FG000|Overall Study|Study terminated by Sponsor|30|||
160727170|NCT01863667|580384362|FG001|Overall Study|Study terminated by Sponsor|30|||
160727171|NCT01863667|580384361|FG000|Overall Study|Withdrawal by Subject|2|||
160727172|NCT01863667|580384362|FG001|Overall Study|Withdrawal by Subject|2|||
160727173|NCT03627546|580384363|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
160727174|NCT03627546|580384364|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
160727175|NCT03627546|580384365|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
160727176|NCT03627546|580384363|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
160727177|NCT03627546|580384364|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
160727178|NCT03627546|580384365|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
160727179|NCT00086619|580384370|FG000|Overall Study|Withdrawal by Subject|6|||
160727180|NCT00086619|580384371|FG001|Overall Study|Withdrawal by Subject|6|||
160727181|NCT00086619|580384370|FG000|Overall Study|Adverse Event|8|||
160727182|NCT00086619|580384371|FG001|Overall Study|Adverse Event|10|||
160727183|NCT00086619|580384370|FG000|Overall Study|Protocol Violation|1|||
160727184|NCT00086619|580384371|FG001|Overall Study|Protocol Violation|1|||
160727185|NCT01209520|580384372|FG000|Overall Study|Withdrawal by Subject|3|||
160727186|NCT00961350|580384373|FG000|Overall Study|Adverse Event|18|||
160727187|NCT00961350|580384374|FG001|Overall Study|Adverse Event|33|||
160727188|NCT00961350|580384373|FG000|Overall Study|Withdrawal by Subject|10|||
160727189|NCT00961350|580384374|FG001|Overall Study|Withdrawal by Subject|10|||
160727190|NCT00961350|580384373|FG000|Overall Study|Lost to Follow-up|3|||
160727191|NCT00961350|580384374|FG001|Overall Study|Lost to Follow-up|3|||
160727192|NCT00961350|580384373|FG000|Overall Study|Misc|16|||
160727193|NCT00961350|580384374|FG001|Overall Study|Misc|21|||
160727194|NCT03291431|580384376|FG000|Overall Study|Protocol Violation|2|||
160727195|NCT03291431|580384377|FG001|Overall Study|Protocol Violation|1|||
160727196|NCT03291431|580384376|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
160727197|NCT03291431|580384377|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
160727198|NCT03291431|580384376|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
160727199|NCT03291431|580384377|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
160727200|NCT06868654|580384378|FG000|Overall Study|Death|4|||
160727201|NCT06868654|580384379|FG001|Overall Study|Death|14|||
160727202|NCT06868654|580384378|FG000|Overall Study|Lost to Follow-up|0|||
160727203|NCT06868654|580384379|FG001|Overall Study|Lost to Follow-up|1|||
160727204|NCT06868654|580384378|FG000|Overall Study|Withdrawal by Subject|5|||
160727205|NCT06868654|580384379|FG001|Overall Study|Withdrawal by Subject|3|||
160727206|NCT06868654|580384378|FG000|Overall Study|Physician Decision|0|||
160727207|NCT06868654|580384379|FG001|Overall Study|Physician Decision|1|||
160727208|NCT06868654|580384378|FG000|Overall Study|Ongoing|23|||
160727209|NCT06868654|580384379|FG001|Overall Study|Ongoing|21|||
160727210|NCT03867201|580384380|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
160727211|NCT03867201|580384381|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
160727212|NCT03867201|580384380|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
160727213|NCT03867201|580384381|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
160727214|NCT03867201|580384380|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
160727215|NCT03867201|580384381|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
160727216|NCT03867201|580384380|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
160727217|NCT03867201|580384381|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
160727218|NCT03867201|580384380|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
160727219|NCT03867201|580384381|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
160727220|NCT03867201|580384380|FG000|Open-Label Period From Week 12|Adverse Event|5|||
160727221|NCT03867201|580384381|FG001|Open-Label Period From Week 12|Adverse Event|11|||
160727222|NCT03867201|580384380|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
160727223|NCT03867201|580384381|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
160727224|NCT03867201|580384380|FG000|Open-Label Period From Week 12|Physician Decision|6|||
160727225|NCT03867201|580384381|FG001|Open-Label Period From Week 12|Physician Decision|3|||
160727226|NCT03867201|580384380|FG000|Open-Label Period From Week 12|Pregnancy|2|||
160727227|NCT03867201|580384381|FG001|Open-Label Period From Week 12|Pregnancy|2|||
160727228|NCT03867201|580384380|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
160727229|NCT03867201|580384381|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
160727230|NCT03867201|580384380|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
160727231|NCT03867201|580384381|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
160727232|NCT03867201|580384380|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
160727233|NCT03867201|580384381|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
160727234|NCT03867201|580384380|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
160727235|NCT03867201|580384381|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
160727236|NCT01190410|580386030|FG000|Overall Study|Adverse Event|0|||
160727237|NCT01190410|580386031|FG001|Overall Study|Adverse Event|3|||
160727238|NCT01190410|580386030|FG000|Overall Study|Lack of Efficacy|0|||
160727239|NCT01190410|580386031|FG001|Overall Study|Lack of Efficacy|2|||
160727240|NCT01190410|580386030|FG000|Overall Study|Withdrawal by Subject|0|||
160727241|NCT01190410|580386031|FG001|Overall Study|Withdrawal by Subject|2|||
160727242|NCT01190410|580386030|FG000|Overall Study|Administrative decision|1|||
160727243|NCT01190410|580386031|FG001|Overall Study|Administrative decision|0|||
160727244|NCT01190410|580386030|FG000|Overall Study|PI discretion|0|||
160727245|NCT01190410|580386031|FG001|Overall Study|PI discretion|2|||
160727246|NCT03260244|580386038|FG000|Overall Study|Death|19|||
160727247|NCT03260244|580386038|FG000|Overall Study|Lost to Follow-up|60|||
160727248|NCT03260244|580386038|FG000|Overall Study|Withdrawal by Subject|48|||
160727249|NCT03260244|580386038|FG000|Overall Study|Procedure Not Performed|21|||
160727250|NCT03260244|580386038|FG000|Overall Study|Enrollment Criteria Not Met|31|||
160727251|NCT03260244|580386038|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
160727252|NCT03260244|580386038|FG000|Overall Study|Subject Noncompliance|6|||
160727253|NCT03260244|580386038|FG000|Overall Study|No inducible Arrhythmia|2|||
160727254|NCT03260244|580386038|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
160727255|NCT03260244|580386038|FG000|Overall Study|Screen Failure|2|||
160727256|NCT03260244|580386038|FG000|Overall Study|Treated Off Label|69|||
160727257|NCT03260244|580386038|FG000|Overall Study|No Radiofrequency Ablation|14|||
160727258|NCT02285166|580386046|FG000|Overall Study|Case Report Forms Uncollected|564|||
160727259|NCT02285166|580386046|FG000|Overall Study|Protocol Deviation|402|||
160727260|NCT00384839|580386053|FG000|Overall Study|Adverse Event|4|||
160727261|NCT00384839|580386053|FG000|Overall Study|Investigator Request|1|||
160727262|NCT00384839|580386053|FG000|Overall Study|Patient Request|1|||
160727263|NCT00384839|580386053|FG000|Overall Study|Ineligible|2|||
160727264|NCT01908829|580386059|FG000|Overall Study|Adverse Event|13|||
160727265|NCT01908829|580386060|FG001|Overall Study|Adverse Event|11|||
160727266|NCT01908829|580386061|FG002|Overall Study|Adverse Event|13|||
160727267|NCT01908829|580386059|FG000|Overall Study|Lost to Follow-up|4|||
160727268|NCT01908829|580386060|FG001|Overall Study|Lost to Follow-up|2|||
160727269|NCT01908829|580386061|FG002|Overall Study|Lost to Follow-up|1|||
160727270|NCT01908829|580386059|FG000|Overall Study|Randomized no double-blind drug received|1|||
160727271|NCT01908829|580386060|FG001|Overall Study|Randomized no double-blind drug received|0|||
160727272|NCT01908829|580386061|FG002|Overall Study|Randomized no double-blind drug received|1|||
160727273|NCT01908829|580386059|FG000|Overall Study|Discontinued (no EoT page)|2|||
160727274|NCT01908829|580386060|FG001|Overall Study|Discontinued (no EoT page)|0|||
160727275|NCT01908829|580386061|FG002|Overall Study|Discontinued (no EoT page)|0|||
160727276|NCT01908829|580386059|FG000|Overall Study|Miscellaneous|0|||
160727277|NCT01908829|580386060|FG001|Overall Study|Miscellaneous|2|||
160727278|NCT01908829|580386061|FG002|Overall Study|Miscellaneous|0|||
160727279|NCT01908829|580386059|FG000|Overall Study|Protocol Violation|2|||
160727280|NCT01908829|580386060|FG001|Overall Study|Protocol Violation|2|||
160727281|NCT01908829|580386061|FG002|Overall Study|Protocol Violation|0|||
160727282|NCT01908829|580386059|FG000|Overall Study|Lack of Efficacy|1|||
160727283|NCT01908829|580386060|FG001|Overall Study|Lack of Efficacy|3|||
160727284|NCT01908829|580386061|FG002|Overall Study|Lack of Efficacy|2|||
160727285|NCT01908829|580386059|FG000|Overall Study|Withdrawal by Subject|26|||
160727286|NCT01908829|580386060|FG001|Overall Study|Withdrawal by Subject|29|||
160727287|NCT01908829|580386061|FG002|Overall Study|Withdrawal by Subject|22|||
160727288|NCT02792192|580386062|FG000|Overall Study|Death|1|||
160727289|NCT02792192|580386063|FG001|Overall Study|Death|0|||
160727290|NCT02792192|580386064|FG002|Overall Study|Death|0|||
160727291|NCT02792192|580386065|FG003|Overall Study|Death|0|||
160727292|NCT02792192|580386062|FG000|Overall Study|Informed Consent Withdrawn|4|||
160727293|NCT02792192|580386063|FG001|Overall Study|Informed Consent Withdrawn|0|||
160727294|NCT02792192|580386064|FG002|Overall Study|Informed Consent Withdrawn|0|||
160727295|NCT02792192|580386065|FG003|Overall Study|Informed Consent Withdrawn|0|||
160727296|NCT02792192|580386062|FG000|Overall Study|Physician Decision|1|||
160727297|NCT02792192|580386063|FG001|Overall Study|Physician Decision|0|||
160727298|NCT02792192|580386064|FG002|Overall Study|Physician Decision|0|||
160727299|NCT02792192|580386065|FG003|Overall Study|Physician Decision|0|||
160727300|NCT02792192|580386062|FG000|Overall Study|Progressive Disease|0|||
160727301|NCT02792192|580386063|FG001|Overall Study|Progressive Disease|1|||
160727302|NCT02792192|580386064|FG002|Overall Study|Progressive Disease|0|||
160727303|NCT02792192|580386065|FG003|Overall Study|Progressive Disease|0|||
160727304|NCT02792192|580386062|FG000|Overall Study|Study Terminated By Sponsor|6|||
160727305|NCT02792192|580386063|FG001|Overall Study|Study Terminated By Sponsor|10|||
160727306|NCT02792192|580386064|FG002|Overall Study|Study Terminated By Sponsor|0|||
160727307|NCT02792192|580386065|FG003|Overall Study|Study Terminated By Sponsor|0|||
160727308|NCT01339923|580386066|FG000|Overall Study|Adverse Event|1|||
160727309|NCT01339923|580386067|FG001|Overall Study|Adverse Event|1|||
160727310|NCT01339923|580386068|FG002|Overall Study|Adverse Event|1|||
160727311|NCT01339923|580386069|FG003|Overall Study|Adverse Event|0|||
160727312|NCT01339923|580386070|FG004|Overall Study|Adverse Event|0|||
160727313|NCT01339923|580386071|FG005|Overall Study|Adverse Event|0|||
160727314|NCT01339923|580386072|FG006|Overall Study|Adverse Event|1|||
160727315|NCT01339923|580386066|FG000|Overall Study|Inappropriate Enrollment|1|||
160727316|NCT01339923|580386067|FG001|Overall Study|Inappropriate Enrollment|0|||
160727317|NCT01339923|580386068|FG002|Overall Study|Inappropriate Enrollment|0|||
160727318|NCT01339923|580386069|FG003|Overall Study|Inappropriate Enrollment|0|||
160727319|NCT01339923|580386070|FG004|Overall Study|Inappropriate Enrollment|0|||
160727320|NCT01339923|580386071|FG005|Overall Study|Inappropriate Enrollment|1|||
160727321|NCT01339923|580386072|FG006|Overall Study|Inappropriate Enrollment|0|||
160727322|NCT01339923|580386066|FG000|Overall Study|Lost to Follow-up|4|||
160727323|NCT01339923|580386067|FG001|Overall Study|Lost to Follow-up|4|||
160727324|NCT01339923|580386068|FG002|Overall Study|Lost to Follow-up|0|||
160727325|NCT01339923|580386069|FG003|Overall Study|Lost to Follow-up|3|||
160727326|NCT01339923|580386070|FG004|Overall Study|Lost to Follow-up|1|||
160727327|NCT01339923|580386071|FG005|Overall Study|Lost to Follow-up|1|||
160727328|NCT01339923|580386072|FG006|Overall Study|Lost to Follow-up|5|||
160727329|NCT01339923|580386066|FG000|Overall Study|Protocol Violation|0|||
160727330|NCT01339923|580386067|FG001|Overall Study|Protocol Violation|0|||
160727331|NCT01339923|580386068|FG002|Overall Study|Protocol Violation|0|||
160727332|NCT01339923|580386069|FG003|Overall Study|Protocol Violation|0|||
160727333|NCT01339923|580386070|FG004|Overall Study|Protocol Violation|0|||
160727334|NCT01339923|580386071|FG005|Overall Study|Protocol Violation|3|||
160727335|NCT01339923|580386072|FG006|Overall Study|Protocol Violation|1|||
160727336|NCT01339923|580386066|FG000|Overall Study|Unable to Classify|1|||
160727337|NCT01339923|580386067|FG001|Overall Study|Unable to Classify|0|||
160727338|NCT01339923|580386068|FG002|Overall Study|Unable to Classify|1|||
160727339|NCT01339923|580386069|FG003|Overall Study|Unable to Classify|0|||
160727340|NCT01339923|580386070|FG004|Overall Study|Unable to Classify|0|||
160727341|NCT01339923|580386071|FG005|Overall Study|Unable to Classify|1|||
160727342|NCT01339923|580386072|FG006|Overall Study|Unable to Classify|5|||
160727343|NCT01339923|580386066|FG000|Overall Study|Withdrawal by Subject|7|||
160727344|NCT01339923|580386067|FG001|Overall Study|Withdrawal by Subject|11|||
160727345|NCT01339923|580386068|FG002|Overall Study|Withdrawal by Subject|6|||
160727346|NCT01339923|580386069|FG003|Overall Study|Withdrawal by Subject|1|||
160727347|NCT01339923|580386070|FG004|Overall Study|Withdrawal by Subject|4|||
160727348|NCT01339923|580386071|FG005|Overall Study|Withdrawal by Subject|3|||
160727349|NCT01339923|580386072|FG006|Overall Study|Withdrawal by Subject|2|||
160727350|NCT00183885|580386091|FG000|Overall Study|Adverse Event|11|||
160727351|NCT00183885|580386091|FG000|Overall Study|Death|1|||
160727352|NCT00183885|580386091|FG000|Overall Study|Lost to Follow-up|3|||
160727353|NCT00183885|580386091|FG000|Overall Study|Physician Decision|6|||
160727354|NCT00183885|580386091|FG000|Overall Study|Withdrawal by Subject|5|||
160727355|NCT00183885|580386091|FG000|Overall Study|Switched to alternative treatment|8|||
160727356|NCT00183885|580386091|FG000|Overall Study|Treatment delayed too long|4|||
160727357|NCT00183885|580386091|FG000|Overall Study|Developed second malignancy|1|||
160727358|NCT00828568|580386094|FG000|Randomized|Withdrawal by Subject|1|||
160727359|NCT00828568|580386095|FG001|Randomized|Withdrawal by Subject|0|||
160727360|NCT00828568|580386096|FG002|Randomized|Withdrawal by Subject|2|||
160727361|NCT00828568|580386094|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
160727362|NCT00828568|580386095|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
160727363|NCT00828568|580386096|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
160727364|NCT00828568|580386094|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
160727365|NCT00828568|580386095|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
160727366|NCT00828568|580386096|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
160727367|NCT00828568|580386094|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
160727368|NCT00828568|580386095|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
160727369|NCT00828568|580386096|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
160727370|NCT00828568|580386094|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
160727371|NCT00828568|580386095|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
160727372|NCT00828568|580386096|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
160727373|NCT00403481|580386131|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
160727374|NCT00403481|580386131|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
160727375|NCT00403481|580386131|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
160727376|NCT00403481|580386131|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
160727377|NCT00403481|580386131|FG000|Olm 40 mg|Adverse Event|2|||
160727378|NCT00403481|580386131|FG000|Olm 40 mg|Protocol Violation|1|||
160727379|NCT00403481|580386131|FG000|Olm 40 mg|Withdrawal by Subject|1|||
160727380|NCT00403481|580386131|FG000|Olm 40 mg|Other|1|||
160727381|NCT00403481|580386131|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
160727382|NCT00403481|580386131|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
160727383|NCT00403481|580386131|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
160727384|NCT00403481|580386131|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
160727385|NCT00403481|580386131|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
160727386|NCT00403481|580386131|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
160727387|NCT02091089|580386133|FG000|Overall Study|Lost to Follow-up|2|||
160727388|NCT02929589|580386134|FG000|Overall Study|Withdrawal by Subject|1|||
160727389|NCT02929589|580386135|FG001|Overall Study|Withdrawal by Subject|0|||
160727390|NCT02929589|580386136|FG002|Overall Study|Withdrawal by Subject|0|||
160727391|NCT02929589|580386137|FG003|Overall Study|Withdrawal by Subject|0|||
160727392|NCT02929589|580386134|FG000|Overall Study|Physician Decision|2|||
160727393|NCT02929589|580386135|FG001|Overall Study|Physician Decision|0|||
160727394|NCT02929589|580386136|FG002|Overall Study|Physician Decision|0|||
160727395|NCT02929589|580386137|FG003|Overall Study|Physician Decision|0|||
160727396|NCT00460811|580386142|FG000|Overall Study|Adverse Event|4|||
160727397|NCT00460811|580386143|FG001|Overall Study|Adverse Event|6|||
160727398|NCT00460811|580386144|FG002|Overall Study|Adverse Event|3|||
160727399|NCT00460811|580386145|FG003|Overall Study|Adverse Event|10|||
160727400|NCT00460811|580386146|FG004|Overall Study|Adverse Event|2|||
160727401|NCT00460811|580386142|FG000|Overall Study|Noncompliance|1|||
160727402|NCT00460811|580386143|FG001|Overall Study|Noncompliance|0|||
160727403|NCT00460811|580386144|FG002|Overall Study|Noncompliance|0|||
160727404|NCT00460811|580386145|FG003|Overall Study|Noncompliance|2|||
160727405|NCT00460811|580386146|FG004|Overall Study|Noncompliance|1|||
160727406|NCT00460811|580386142|FG000|Overall Study|Withdrawal by Subject|7|||
160727407|NCT00460811|580386143|FG001|Overall Study|Withdrawal by Subject|7|||
160727408|NCT00460811|580386144|FG002|Overall Study|Withdrawal by Subject|6|||
160727409|NCT00460811|580386145|FG003|Overall Study|Withdrawal by Subject|3|||
160727410|NCT00460811|580386146|FG004|Overall Study|Withdrawal by Subject|11|||
160727411|NCT00460811|580386142|FG000|Overall Study|Physician Decision|1|||
160727412|NCT00460811|580386143|FG001|Overall Study|Physician Decision|0|||
160727413|NCT00460811|580386144|FG002|Overall Study|Physician Decision|0|||
160727414|NCT00460811|580386145|FG003|Overall Study|Physician Decision|0|||
160727415|NCT00460811|580386146|FG004|Overall Study|Physician Decision|0|||
160727416|NCT00460811|580386142|FG000|Overall Study|Lost to Follow-up|3|||
160727417|NCT00460811|580386143|FG001|Overall Study|Lost to Follow-up|2|||
160727418|NCT00460811|580386144|FG002|Overall Study|Lost to Follow-up|5|||
160727419|NCT00460811|580386145|FG003|Overall Study|Lost to Follow-up|3|||
160727420|NCT00460811|580386146|FG004|Overall Study|Lost to Follow-up|6|||
160727421|NCT02821754|580386147|FG000|Overall Study|Procedure not required prior to amendment change|13|||
160727422|NCT02821754|580386148|FG001|Overall Study|Procedure not required prior to amendment change|11|||
160727423|NCT02821754|580386149|FG002|Overall Study|Procedure not required prior to amendment change|0|||
160727424|NCT02821754|580386147|FG000|Overall Study|Participant's Clinical status|2|||
160727425|NCT02821754|580386148|FG001|Overall Study|Participant's Clinical status|0|||
160727426|NCT02821754|580386149|FG002|Overall Study|Participant's Clinical status|0|||
160727427|NCT02821754|580386147|FG000|Overall Study|Participant removed for noncompliance|1|||
160727428|NCT02821754|580386148|FG001|Overall Study|Participant removed for noncompliance|0|||
160727429|NCT02821754|580386149|FG002|Overall Study|Participant removed for noncompliance|0|||
160727430|NCT02821754|580386147|FG000|Overall Study|Drug not available.|0|||
160727431|NCT02821754|580386148|FG001|Overall Study|Drug not available.|0|||
160727432|NCT02821754|580386149|FG002|Overall Study|Drug not available.|1|||
160727433|NCT02821754|580386147|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
160727434|NCT02821754|580386148|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
160727435|NCT02821754|580386149|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
160727436|NCT01355575|580386155|FG000|Overall Study|Withdrawal by Subject|2|||
160727437|NCT02477332|580386156|FG000|Overall Study|Adverse Event|0|||
160727438|NCT02477332|580386157|FG001|Overall Study|Adverse Event|1|||
160727439|NCT02477332|580386158|FG002|Overall Study|Adverse Event|1|||
160727440|NCT02477332|580386159|FG003|Overall Study|Adverse Event|2|||
160727441|NCT02477332|580386160|FG004|Overall Study|Adverse Event|1|||
160727442|NCT02477332|580386161|FG005|Overall Study|Adverse Event|2|||
160727443|NCT02477332|580386156|FG000|Overall Study|Lack of Efficacy|1|||
160727444|NCT02477332|580386157|FG001|Overall Study|Lack of Efficacy|2|||
160727445|NCT02477332|580386158|FG002|Overall Study|Lack of Efficacy|1|||
160727446|NCT02477332|580386159|FG003|Overall Study|Lack of Efficacy|2|||
160727447|NCT02477332|580386160|FG004|Overall Study|Lack of Efficacy|1|||
160727448|NCT02477332|580386161|FG005|Overall Study|Lack of Efficacy|1|||
160727449|NCT02477332|580386156|FG000|Overall Study|Non-compliance with study treatment|0|||
160727450|NCT02477332|580386157|FG001|Overall Study|Non-compliance with study treatment|1|||
160727451|NCT02477332|580386158|FG002|Overall Study|Non-compliance with study treatment|2|||
160727452|NCT02477332|580386159|FG003|Overall Study|Non-compliance with study treatment|0|||
160727453|NCT02477332|580386160|FG004|Overall Study|Non-compliance with study treatment|0|||
160727454|NCT02477332|580386161|FG005|Overall Study|Non-compliance with study treatment|0|||
160727455|NCT02477332|580386156|FG000|Overall Study|Pregnancy|0|||
160727456|NCT02477332|580386157|FG001|Overall Study|Pregnancy|0|||
160727457|NCT02477332|580386158|FG002|Overall Study|Pregnancy|0|||
160727458|NCT02477332|580386159|FG003|Overall Study|Pregnancy|1|||
160727459|NCT02477332|580386160|FG004|Overall Study|Pregnancy|0|||
160727460|NCT02477332|580386161|FG005|Overall Study|Pregnancy|0|||
160727461|NCT02477332|580386156|FG000|Overall Study|Protocol Violation|2|||
160727462|NCT02477332|580386157|FG001|Overall Study|Protocol Violation|0|||
160727463|NCT02477332|580386158|FG002|Overall Study|Protocol Violation|3|||
160727464|NCT02477332|580386159|FG003|Overall Study|Protocol Violation|3|||
160727465|NCT02477332|580386160|FG004|Overall Study|Protocol Violation|1|||
160727466|NCT02477332|580386161|FG005|Overall Study|Protocol Violation|1|||
160727467|NCT02477332|580386156|FG000|Overall Study|Technical problems|0|||
160727468|NCT02477332|580386157|FG001|Overall Study|Technical problems|0|||
160727469|NCT02477332|580386158|FG002|Overall Study|Technical problems|1|||
160727470|NCT02477332|580386159|FG003|Overall Study|Technical problems|0|||
160727471|NCT02477332|580386160|FG004|Overall Study|Technical problems|0|||
160727472|NCT02477332|580386161|FG005|Overall Study|Technical problems|0|||
160727473|NCT02477332|580386156|FG000|Overall Study|Lost to Follow-up|0|||
160727474|NCT02477332|580386157|FG001|Overall Study|Lost to Follow-up|0|||
160727475|NCT02477332|580386158|FG002|Overall Study|Lost to Follow-up|2|||
160727476|NCT02477332|580386159|FG003|Overall Study|Lost to Follow-up|0|||
160727477|NCT02477332|580386160|FG004|Overall Study|Lost to Follow-up|0|||
160727478|NCT02477332|580386161|FG005|Overall Study|Lost to Follow-up|0|||
160727479|NCT02477332|580386156|FG000|Overall Study|Physician Decision|0|||
160727480|NCT02477332|580386157|FG001|Overall Study|Physician Decision|0|||
160727481|NCT02477332|580386158|FG002|Overall Study|Physician Decision|1|||
160727482|NCT02477332|580386159|FG003|Overall Study|Physician Decision|3|||
160727483|NCT02477332|580386160|FG004|Overall Study|Physician Decision|0|||
160727484|NCT02477332|580386161|FG005|Overall Study|Physician Decision|1|||
160727485|NCT02477332|580386156|FG000|Overall Study|Withdrawal by Subject|0|||
160727486|NCT02477332|580386157|FG001|Overall Study|Withdrawal by Subject|3|||
160727487|NCT02477332|580386158|FG002|Overall Study|Withdrawal by Subject|1|||
160727488|NCT02477332|580386159|FG003|Overall Study|Withdrawal by Subject|2|||
160727489|NCT02477332|580386160|FG004|Overall Study|Withdrawal by Subject|1|||
160727490|NCT02477332|580386161|FG005|Overall Study|Withdrawal by Subject|0|||
160727491|NCT04657198|580386162|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
160727492|NCT04657198|580386163|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
160727493|NCT04657198|580386164|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
160727494|NCT02977572|580386167|FG000|Overall Study|Exclusion criterion|2|||
160727495|NCT02977572|580386168|FG001|Overall Study|Exclusion criterion|2|||
160727496|NCT01166438|580386171|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
160727497|NCT01166438|580386172|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
160727498|NCT01166438|580386171|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
160727499|NCT01166438|580386172|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
160727500|NCT01166438|580386171|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
160727501|NCT01166438|580386172|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
160727502|NCT01166438|580386171|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
160727503|NCT01166438|580386172|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
160727504|NCT01166438|580386171|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
160727505|NCT01166438|580386172|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
160727506|NCT01166438|580386171|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
160727507|NCT01166438|580386172|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
160727508|NCT01075256|580386173|FG000|Overall Study|Withdrawal by Subject|1|||
160727509|NCT01075256|580386174|FG001|Overall Study|Withdrawal by Subject|0|||
160727510|NCT01075256|580386175|FG002|Overall Study|Withdrawal by Subject|0|||
160727511|NCT03502070|580386176|FG000|Overall Study|Withdrawal by Subject|1|||
160727512|NCT03502070|580386176|FG000|Overall Study|Screen Failure|1|||
160727513|NCT00552396|580386188|FG000|Overall Study|protocol withdrawal criteria|3|||
160727514|NCT00552396|580386189|FG001|Overall Study|protocol withdrawal criteria|3|||
160727515|NCT00552396|580386190|FG002|Overall Study|protocol withdrawal criteria|3|||
160727516|NCT00552396|580386191|FG003|Overall Study|protocol withdrawal criteria|6|||
160727517|NCT00552396|580386192|FG004|Overall Study|protocol withdrawal criteria|3|||
160727518|NCT00552396|580386193|FG005|Overall Study|protocol withdrawal criteria|3|||
160727519|NCT00552396|580386194|FG006|Overall Study|protocol withdrawal criteria|9|||
160727520|NCT00591565|580386195|FG000|Overall Study|lost follow up, withdrawn|5|||
160727521|NCT00454363|580386196|FG000|Overall Study|Adverse Event|1|||
160727522|NCT00454363|580386197|FG001|Overall Study|Adverse Event|2|||
160727523|NCT00454363|580386196|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
160727524|NCT00454363|580386197|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
160727525|NCT01554527|580386199|FG000|Overall Study|Withdrawal by Subject|1|||
160727526|NCT01554527|580386200|FG001|Overall Study|Withdrawal by Subject|0|||
160727527|NCT01554527|580386201|FG002|Overall Study|Withdrawal by Subject|3|||
160727528|NCT01554527|580386199|FG000|Overall Study|Lost to Follow-up|0|||
160727529|NCT01554527|580386200|FG001|Overall Study|Lost to Follow-up|0|||
160727530|NCT01554527|580386201|FG002|Overall Study|Lost to Follow-up|4|||
160727531|NCT01554527|580386199|FG000|Overall Study|Physician Decision|0|||
160727532|NCT01554527|580386200|FG001|Overall Study|Physician Decision|0|||
160727533|NCT01554527|580386201|FG002|Overall Study|Physician Decision|1|||
160727534|NCT01537042|580386209|FG000|Overall Study|Adverse Event|0|||
160727535|NCT01537042|580386210|FG001|Overall Study|Adverse Event|2|||
160727536|NCT01537042|580386209|FG000|Overall Study|Lack of Efficacy|0|||
160727537|NCT01537042|580386210|FG001|Overall Study|Lack of Efficacy|1|||
160727538|NCT01537042|580386209|FG000|Overall Study|Protocol Violation|0|||
160727539|NCT01537042|580386210|FG001|Overall Study|Protocol Violation|1|||
160727540|NCT01537042|580386209|FG000|Overall Study|Other|0|||
160727541|NCT01537042|580386210|FG001|Overall Study|Other|1|||
160727542|NCT02837731|580386211|FG000|Allocation|Admitted to General Floor|3|||
160727543|NCT02837731|580386212|FG001|Allocation|Admitted to General Floor|4|||
160727544|NCT02837731|580386211|FG000|Allocation|Immediate surgery/withdrew|2|||
160727545|NCT02837731|580386212|FG001|Allocation|Immediate surgery/withdrew|0|||
160727546|NCT02837731|580386211|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
160727547|NCT02837731|580386212|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
160727548|NCT02837731|580386211|FG000|Allocation|Withdrawal by Subject|2|||
160727549|NCT02837731|580386212|FG001|Allocation|Withdrawal by Subject|0|||
160727550|NCT02837731|580386211|FG000|Allocation|Device not available|1|||
160727551|NCT02837731|580386212|FG001|Allocation|Device not available|0|||
160727552|NCT02837731|580386211|FG000|Allocation|Protocol not implemented|7|||
160727553|NCT02837731|580386212|FG001|Allocation|Protocol not implemented|0|||
160727554|NCT02837731|580386211|FG000|Allocation|Moribund/Do not resuscitate|2|||
160727555|NCT02837731|580386212|FG001|Allocation|Moribund/Do not resuscitate|0|||
160727556|NCT02837731|580386211|FG000|Allocation|Did not meet sepsis criteria|1|||
160727557|NCT02837731|580386212|FG001|Allocation|Did not meet sepsis criteria|2|||
160727558|NCT02837731|580386211|FG000|Allocation|Known aortic abnormalities|0|||
160727559|NCT02837731|580386212|FG001|Allocation|Known aortic abnormalities|1|||
160727560|NCT02965573|580386214|FG000|Overall Study|Lack of Efficacy|1|||
160727561|NCT02965573|580386215|FG001|Overall Study|Lack of Efficacy|0|||
160727562|NCT00315458|580386216|FG000|Overall Study|Administrative|0|||
160727563|NCT00315458|580386217|FG001|Overall Study|Administrative|3|||
160727564|NCT00315458|580386218|FG002|Overall Study|Administrative|8|||
160727565|NCT00315458|580386219|FG003|Overall Study|Administrative|21|||
160727566|NCT00315458|580386216|FG000|Overall Study|Adverse Event|2|||
160727567|NCT00315458|580386217|FG001|Overall Study|Adverse Event|4|||
160727568|NCT00315458|580386218|FG002|Overall Study|Adverse Event|23|||
160727569|NCT00315458|580386219|FG003|Overall Study|Adverse Event|3|||
160727570|NCT00315458|580386216|FG000|Overall Study|Lost to Follow-up|1|||
160727571|NCT00315458|580386217|FG001|Overall Study|Lost to Follow-up|2|||
160727572|NCT00315458|580386218|FG002|Overall Study|Lost to Follow-up|0|||
160727573|NCT00315458|580386219|FG003|Overall Study|Lost to Follow-up|2|||
160727574|NCT00315458|580386216|FG000|Overall Study|Withdrawal by Subject|0|||
160727575|NCT00315458|580386217|FG001|Overall Study|Withdrawal by Subject|3|||
160727576|NCT00315458|580386218|FG002|Overall Study|Withdrawal by Subject|0|||
160727577|NCT00315458|580386219|FG003|Overall Study|Withdrawal by Subject|2|||
160727578|NCT00315458|580386216|FG000|Overall Study|Lack of Efficacy|0|||
160727579|NCT00315458|580386217|FG001|Overall Study|Lack of Efficacy|0|||
160727580|NCT00315458|580386218|FG002|Overall Study|Lack of Efficacy|20|||
160727581|NCT00315458|580386219|FG003|Overall Study|Lack of Efficacy|1|||
160727582|NCT00315458|580386216|FG000|Overall Study|Did not qualify|0|||
160727583|NCT00315458|580386217|FG001|Overall Study|Did not qualify|0|||
160727584|NCT00315458|580386218|FG002|Overall Study|Did not qualify|1|||
160727585|NCT00315458|580386219|FG003|Overall Study|Did not qualify|0|||
160727586|NCT00523848|580386221|FG000|Overall Study|Adverse Event|11|||
160727587|NCT00523848|580386221|FG000|Overall Study|Withdrawal by Subject|2|||
160727588|NCT00523848|580386221|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
160727589|NCT00523848|580386221|FG000|Overall Study|Disease Progression|5|||
160727590|NCT00523848|580386221|FG000|Overall Study|Other, unspecified|4|||
160727591|NCT00489918|580386223|FG000|Overall Study|Withdrawal by Subject|2|||
160727592|NCT00489918|580386224|FG001|Overall Study|Withdrawal by Subject|1|||
160727593|NCT00489918|580386225|FG002|Overall Study|Withdrawal by Subject|1|||
160727594|NCT00489918|580386226|FG003|Overall Study|Withdrawal by Subject|0|||
160727595|NCT00489918|580386227|FG004|Overall Study|Withdrawal by Subject|1|||
160727596|NCT00489918|580386223|FG000|Overall Study|Adverse Event|0|||
160727597|NCT00489918|580386224|FG001|Overall Study|Adverse Event|1|||
160727598|NCT00489918|580386225|FG002|Overall Study|Adverse Event|1|||
160727599|NCT00489918|580386226|FG003|Overall Study|Adverse Event|0|||
160727600|NCT00489918|580386227|FG004|Overall Study|Adverse Event|0|||
160727601|NCT00489918|580386223|FG000|Overall Study|Lost to Follow-up|0|||
160727602|NCT00489918|580386224|FG001|Overall Study|Lost to Follow-up|0|||
160727603|NCT00489918|580386225|FG002|Overall Study|Lost to Follow-up|1|||
160727604|NCT00489918|580386226|FG003|Overall Study|Lost to Follow-up|1|||
160727605|NCT00489918|580386227|FG004|Overall Study|Lost to Follow-up|0|||
160727606|NCT00489918|580386223|FG000|Overall Study|Physician Decision|0|||
160727607|NCT00489918|580386224|FG001|Overall Study|Physician Decision|0|||
160727608|NCT00489918|580386225|FG002|Overall Study|Physician Decision|1|||
160727609|NCT00489918|580386226|FG003|Overall Study|Physician Decision|0|||
160727610|NCT00489918|580386227|FG004|Overall Study|Physician Decision|0|||
160727611|NCT02748213|580386228|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
160727612|NCT02748213|580386229|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
160727613|NCT02748213|580386228|FG000|Overall Study|Abnormal Laboratory Test|1|||
160727614|NCT02748213|580386229|FG001|Overall Study|Abnormal Laboratory Test|0|||
160727615|NCT02748213|580386228|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
160727616|NCT02748213|580386229|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
160727617|NCT02748213|580386228|FG000|Overall Study|Death|5|||
160727618|NCT02748213|580386229|FG001|Overall Study|Death|3|||
160727619|NCT02748213|580386228|FG000|Overall Study|Insufficient Therapeutic Response|56|||
160727620|NCT02748213|580386229|FG001|Overall Study|Insufficient Therapeutic Response|57|||
160727621|NCT02748213|580386228|FG000|Overall Study|Violation of Selection Criteria|2|||
160727622|NCT02748213|580386229|FG001|Overall Study|Violation of Selection Criteria|0|||
160727623|NCT02748213|580386228|FG000|Overall Study|Protocol Violation|6|||
160727624|NCT02748213|580386229|FG001|Overall Study|Protocol Violation|4|||
160727625|NCT02748213|580386228|FG000|Overall Study|Refused Treatment*|6|||
160727626|NCT02748213|580386229|FG001|Overall Study|Refused Treatment*|6|||
160727627|NCT02748213|580386228|FG000|Overall Study|Failure to Return|1|||
160727628|NCT02748213|580386229|FG001|Overall Study|Failure to Return|0|||
160727629|NCT02748213|580386228|FG000|Overall Study|Other|30|||
160727630|NCT02748213|580386229|FG001|Overall Study|Other|29|||
160727631|NCT03850483|580386235|FG000|Treatment for Stage 1|Adverse Event|1|||
160727632|NCT03850483|580386236|FG001|Treatment for Stage 1|Adverse Event|1|||
160727633|NCT03850483|580386237|FG002|Treatment for Stage 1|Adverse Event|3|||
160727634|NCT03850483|580386238|FG003|Treatment for Stage 1|Adverse Event|0|||
160727635|NCT03850483|580386239|FG004|Treatment for Stage 1|Adverse Event|2|||
160727636|NCT03850483|580386240|FG005|Treatment for Stage 1|Adverse Event|0|||
160727637|NCT03850483|580386241|FG006|Treatment for Stage 1|Adverse Event|2|||
160727638|NCT03850483|580386242|FG007|Treatment for Stage 1|Adverse Event|2|||
160727639|NCT03850483|580386243|FG008|Treatment for Stage 1|Adverse Event|0|||
160727640|NCT03850483|580386244|FG009|Treatment for Stage 1|Adverse Event|0|||
160727641|NCT03850483|580386235|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
160727642|NCT03850483|580386236|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
160727643|NCT03850483|580386237|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
160727644|NCT03850483|580386238|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
160727645|NCT03850483|580386239|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
160727646|NCT03850483|580386240|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
160727647|NCT03850483|580386241|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
160727648|NCT03850483|580386242|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
160727649|NCT03850483|580386243|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
160727650|NCT03850483|580386244|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
160727651|NCT03850483|580386235|FG000|Treatment for Stage 1|Protocol Violation|1|||
160727652|NCT03850483|580386236|FG001|Treatment for Stage 1|Protocol Violation|0|||
160727653|NCT03850483|580386237|FG002|Treatment for Stage 1|Protocol Violation|0|||
160727654|NCT03850483|580386238|FG003|Treatment for Stage 1|Protocol Violation|0|||
160727655|NCT03850483|580386239|FG004|Treatment for Stage 1|Protocol Violation|0|||
160727656|NCT03850483|580386240|FG005|Treatment for Stage 1|Protocol Violation|0|||
160727657|NCT03850483|580386241|FG006|Treatment for Stage 1|Protocol Violation|1|||
160727658|NCT03850483|580386242|FG007|Treatment for Stage 1|Protocol Violation|0|||
160727659|NCT03850483|580386243|FG008|Treatment for Stage 1|Protocol Violation|0|||
160727660|NCT03850483|580386244|FG009|Treatment for Stage 1|Protocol Violation|0|||
160727661|NCT03850483|580386235|FG000|Treatment for Stage 1|Physician Decision|0|||
160727662|NCT03850483|580386236|FG001|Treatment for Stage 1|Physician Decision|0|||
160727663|NCT03850483|580386237|FG002|Treatment for Stage 1|Physician Decision|0|||
160727664|NCT03850483|580386238|FG003|Treatment for Stage 1|Physician Decision|0|||
160727665|NCT03850483|580386239|FG004|Treatment for Stage 1|Physician Decision|0|||
160727666|NCT03850483|580386240|FG005|Treatment for Stage 1|Physician Decision|1|||
160727667|NCT03850483|580386241|FG006|Treatment for Stage 1|Physician Decision|0|||
160727668|NCT03850483|580386242|FG007|Treatment for Stage 1|Physician Decision|0|||
160727669|NCT03850483|580386243|FG008|Treatment for Stage 1|Physician Decision|0|||
160727670|NCT03850483|580386244|FG009|Treatment for Stage 1|Physician Decision|0|||
160727671|NCT03850483|580386235|FG000|Treatment for Stage 1|Other|0|||
160727672|NCT03850483|580386236|FG001|Treatment for Stage 1|Other|0|||
160727673|NCT03850483|580386237|FG002|Treatment for Stage 1|Other|0|||
160727674|NCT03850483|580386238|FG003|Treatment for Stage 1|Other|0|||
160727675|NCT03850483|580386239|FG004|Treatment for Stage 1|Other|2|||
160727676|NCT03850483|580386240|FG005|Treatment for Stage 1|Other|1|||
160727677|NCT03850483|580386241|FG006|Treatment for Stage 1|Other|0|||
160727678|NCT03850483|580386242|FG007|Treatment for Stage 1|Other|0|||
160727679|NCT03850483|580386243|FG008|Treatment for Stage 1|Other|0|||
160727680|NCT03850483|580386244|FG009|Treatment for Stage 1|Other|0|||
160727681|NCT03850483|580386235|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
160727682|NCT03850483|580386236|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
160727683|NCT03850483|580386237|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
160727684|NCT03850483|580386238|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
160727685|NCT03850483|580386239|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
160727686|NCT03850483|580386240|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
160727687|NCT03850483|580386241|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
160727688|NCT03850483|580386242|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
160727689|NCT03850483|580386243|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
160727690|NCT03850483|580386244|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
160727691|NCT03850483|580386235|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
160727692|NCT03850483|580386236|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
160727693|NCT03850483|580386237|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
160727694|NCT03850483|580386238|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
160727695|NCT03850483|580386239|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
160727696|NCT03850483|580386240|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
160727697|NCT03850483|580386241|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
160727698|NCT03850483|580386242|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
160727699|NCT03850483|580386243|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
160727700|NCT03850483|580386244|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
160727701|NCT03850483|580386235|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
160727702|NCT03850483|580386236|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
160727703|NCT03850483|580386237|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
160727704|NCT03850483|580386238|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
160727705|NCT03850483|580386239|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
160727706|NCT03850483|580386240|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
160727707|NCT03850483|580386241|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
160727708|NCT03850483|580386242|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
160727709|NCT03850483|580386243|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
160727710|NCT03850483|580386244|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
160727711|NCT03850483|580386235|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
160727712|NCT03850483|580386236|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
160727713|NCT03850483|580386237|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
160727714|NCT03850483|580386238|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
160727715|NCT03850483|580386239|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
160727716|NCT03850483|580386240|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
160727717|NCT03850483|580386241|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
160727718|NCT03850483|580386242|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
160727719|NCT03850483|580386243|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
160727720|NCT03850483|580386244|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
160727721|NCT03850483|580386235|FG000|Treatment for Stage 1|Death|0|||
160727722|NCT03850483|580386236|FG001|Treatment for Stage 1|Death|0|||
160727723|NCT03850483|580386237|FG002|Treatment for Stage 1|Death|0|||
160727724|NCT03850483|580386238|FG003|Treatment for Stage 1|Death|0|||
160727725|NCT03850483|580386239|FG004|Treatment for Stage 1|Death|0|||
160727726|NCT03850483|580386240|FG005|Treatment for Stage 1|Death|1|||
160727727|NCT03850483|580386241|FG006|Treatment for Stage 1|Death|0|||
160727728|NCT03850483|580386242|FG007|Treatment for Stage 1|Death|0|||
160727729|NCT03850483|580386243|FG008|Treatment for Stage 1|Death|0|||
160727730|NCT03850483|580386244|FG009|Treatment for Stage 1|Death|0|||
160727731|NCT03850483|580386235|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
160727732|NCT03850483|580386236|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
160727733|NCT03850483|580386237|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
160727734|NCT03850483|580386238|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
160727735|NCT03850483|580386239|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
160727736|NCT03850483|580386240|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
160727737|NCT03850483|580386241|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
160727738|NCT03850483|580386242|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
160727739|NCT03850483|580386243|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
160727740|NCT03850483|580386244|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
160727741|NCT03850483|580386235|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
160727742|NCT03850483|580386236|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
160727743|NCT03850483|580386237|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
160727744|NCT03850483|580386238|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
160727745|NCT03850483|580386239|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
160727746|NCT03850483|580386240|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
160727747|NCT03850483|580386241|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
160727748|NCT03850483|580386242|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
160727749|NCT03850483|580386243|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
160727750|NCT03850483|580386244|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
160727751|NCT03850483|580386235|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
160727752|NCT03850483|580386236|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
160727753|NCT03850483|580386237|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
160727754|NCT03850483|580386238|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
160727755|NCT03850483|580386239|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
160727756|NCT03850483|580386240|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
160727757|NCT03850483|580386241|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
160727758|NCT03850483|580386242|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
160727759|NCT03850483|580386243|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
160727760|NCT03850483|580386244|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
160727761|NCT03850483|580386235|FG000|Follow-up for Stage 1|Physician Decision|0|||
160727762|NCT03850483|580386236|FG001|Follow-up for Stage 1|Physician Decision|0|||
160727763|NCT03850483|580386237|FG002|Follow-up for Stage 1|Physician Decision|0|||
160727764|NCT03850483|580386238|FG003|Follow-up for Stage 1|Physician Decision|0|||
160727765|NCT03850483|580386239|FG004|Follow-up for Stage 1|Physician Decision|1|||
160727766|NCT03850483|580386240|FG005|Follow-up for Stage 1|Physician Decision|0|||
160727767|NCT03850483|580386241|FG006|Follow-up for Stage 1|Physician Decision|1|||
160727768|NCT03850483|580386242|FG007|Follow-up for Stage 1|Physician Decision|0|||
160727769|NCT03850483|580386243|FG008|Follow-up for Stage 1|Physician Decision|0|||
160727770|NCT03850483|580386244|FG009|Follow-up for Stage 1|Physician Decision|0|||
160727771|NCT03850483|580386235|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
160727772|NCT03850483|580386236|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
160727773|NCT03850483|580386237|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
160727774|NCT03850483|580386238|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
160727775|NCT03850483|580386239|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
160727776|NCT03850483|580386240|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
160727777|NCT03850483|580386241|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
160727778|NCT03850483|580386242|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
160727779|NCT03850483|580386243|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
160727780|NCT03850483|580386244|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
160727781|NCT03850483|580386235|FG000|Follow-up for Stage 1|Adverse Event|0|||
160727782|NCT03850483|580386236|FG001|Follow-up for Stage 1|Adverse Event|0|||
160727783|NCT03850483|580386237|FG002|Follow-up for Stage 1|Adverse Event|1|||
160727784|NCT03850483|580386238|FG003|Follow-up for Stage 1|Adverse Event|0|||
160727785|NCT03850483|580386239|FG004|Follow-up for Stage 1|Adverse Event|0|||
160727786|NCT03850483|580386240|FG005|Follow-up for Stage 1|Adverse Event|1|||
160727787|NCT03850483|580386241|FG006|Follow-up for Stage 1|Adverse Event|0|||
160727788|NCT03850483|580386242|FG007|Follow-up for Stage 1|Adverse Event|0|||
160727789|NCT03850483|580386243|FG008|Follow-up for Stage 1|Adverse Event|0|||
160727790|NCT03850483|580386244|FG009|Follow-up for Stage 1|Adverse Event|0|||
160727791|NCT03850483|580386235|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
160727792|NCT03850483|580386236|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
160727793|NCT03850483|580386237|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
160727794|NCT03850483|580386238|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
160727795|NCT03850483|580386239|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
160727796|NCT03850483|580386240|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
160727797|NCT03850483|580386241|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
160727798|NCT03850483|580386242|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
160727799|NCT03850483|580386243|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
160727800|NCT03850483|580386244|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
160727801|NCT03850483|580386235|FG000|Follow-up for Stage 1|Other|0|||
160727802|NCT03850483|580386236|FG001|Follow-up for Stage 1|Other|2|||
160727803|NCT03850483|580386237|FG002|Follow-up for Stage 1|Other|0|||
160727804|NCT03850483|580386238|FG003|Follow-up for Stage 1|Other|2|||
160727805|NCT03850483|580386239|FG004|Follow-up for Stage 1|Other|0|||
160727806|NCT03850483|580386240|FG005|Follow-up for Stage 1|Other|1|||
160727807|NCT03850483|580386241|FG006|Follow-up for Stage 1|Other|0|||
160727808|NCT03850483|580386242|FG007|Follow-up for Stage 1|Other|0|||
160727809|NCT03850483|580386243|FG008|Follow-up for Stage 1|Other|0|||
160727810|NCT03850483|580386244|FG009|Follow-up for Stage 1|Other|0|||
160727811|NCT03850483|580386235|FG000|Treatment for Stage 2|Adverse Event|0|||
160727812|NCT03850483|580386236|FG001|Treatment for Stage 2|Adverse Event|0|||
160727813|NCT03850483|580386237|FG002|Treatment for Stage 2|Adverse Event|0|||
160727814|NCT03850483|580386238|FG003|Treatment for Stage 2|Adverse Event|0|||
160727815|NCT03850483|580386239|FG004|Treatment for Stage 2|Adverse Event|0|||
160727816|NCT03850483|580386240|FG005|Treatment for Stage 2|Adverse Event|0|||
160727817|NCT03850483|580386241|FG006|Treatment for Stage 2|Adverse Event|0|||
160727818|NCT03850483|580386242|FG007|Treatment for Stage 2|Adverse Event|0|||
160727819|NCT03850483|580386243|FG008|Treatment for Stage 2|Adverse Event|0|||
160727820|NCT03850483|580386244|FG009|Treatment for Stage 2|Adverse Event|1|||
160727821|NCT03850483|580386235|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
160727822|NCT03850483|580386236|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
160727823|NCT03850483|580386237|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
160727824|NCT03850483|580386238|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
160727825|NCT03850483|580386239|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
160727826|NCT03850483|580386240|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
160727827|NCT03850483|580386241|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
160727828|NCT03850483|580386242|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
160727829|NCT03850483|580386243|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
160727830|NCT03850483|580386244|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
160727831|NCT03850483|580386235|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
160727832|NCT03850483|580386236|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
160727833|NCT03850483|580386237|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
160727834|NCT03850483|580386238|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
160727835|NCT03850483|580386239|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
160727836|NCT03850483|580386240|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
160727837|NCT03850483|580386241|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
160727838|NCT03850483|580386242|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
160727839|NCT03850483|580386243|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
160727840|NCT03850483|580386244|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
160727841|NCT03850483|580386235|FG000|Treatment for Stage 2|Physician Decision|0|||
160727842|NCT03850483|580386236|FG001|Treatment for Stage 2|Physician Decision|0|||
160727843|NCT03850483|580386237|FG002|Treatment for Stage 2|Physician Decision|0|||
160727844|NCT03850483|580386238|FG003|Treatment for Stage 2|Physician Decision|0|||
160727845|NCT03850483|580386239|FG004|Treatment for Stage 2|Physician Decision|0|||
160727846|NCT03850483|580386240|FG005|Treatment for Stage 2|Physician Decision|0|||
160727847|NCT03850483|580386241|FG006|Treatment for Stage 2|Physician Decision|0|||
160727848|NCT03850483|580386242|FG007|Treatment for Stage 2|Physician Decision|0|||
160727849|NCT03850483|580386243|FG008|Treatment for Stage 2|Physician Decision|0|||
160727850|NCT03850483|580386244|FG009|Treatment for Stage 2|Physician Decision|1|||
160727851|NCT03850483|580386235|FG000|Treatment for Stage 2|Protocol Violation|0|||
160727852|NCT03850483|580386236|FG001|Treatment for Stage 2|Protocol Violation|0|||
160727853|NCT03850483|580386237|FG002|Treatment for Stage 2|Protocol Violation|0|||
160727854|NCT03850483|580386238|FG003|Treatment for Stage 2|Protocol Violation|0|||
160727855|NCT03850483|580386239|FG004|Treatment for Stage 2|Protocol Violation|0|||
160727856|NCT03850483|580386240|FG005|Treatment for Stage 2|Protocol Violation|0|||
160727857|NCT03850483|580386241|FG006|Treatment for Stage 2|Protocol Violation|0|||
160727858|NCT03850483|580386242|FG007|Treatment for Stage 2|Protocol Violation|0|||
160727859|NCT03850483|580386243|FG008|Treatment for Stage 2|Protocol Violation|1|||
160727860|NCT03850483|580386244|FG009|Treatment for Stage 2|Protocol Violation|0|||
160727861|NCT03850483|580386235|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
160727862|NCT03850483|580386236|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
160727863|NCT03850483|580386237|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
160727864|NCT03850483|580386238|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
160727865|NCT03850483|580386239|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
160727866|NCT03850483|580386240|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
160727867|NCT03850483|580386241|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
160727868|NCT03850483|580386242|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
160727869|NCT03850483|580386243|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
160727870|NCT03850483|580386244|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
160727871|NCT03850483|580386235|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
160727872|NCT03850483|580386236|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
160727873|NCT03850483|580386237|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
160727874|NCT03850483|580386238|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
160727875|NCT03850483|580386239|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
160727876|NCT03850483|580386240|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
160727877|NCT03850483|580386241|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
160727878|NCT03850483|580386242|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
160727879|NCT03850483|580386243|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
160727880|NCT03850483|580386244|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
160727881|NCT03850483|580386235|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
160727882|NCT03850483|580386236|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
160727883|NCT03850483|580386237|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
160727884|NCT03850483|580386238|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
160727885|NCT03850483|580386239|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
160727886|NCT03850483|580386240|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
160727887|NCT03850483|580386241|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
160727888|NCT03850483|580386242|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
160727889|NCT03850483|580386243|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
160727890|NCT03850483|580386244|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
160727891|NCT03850483|580386235|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
160727892|NCT03850483|580386236|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
160727893|NCT03850483|580386237|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
160727894|NCT03850483|580386238|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
160727895|NCT03850483|580386239|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
160727896|NCT03850483|580386240|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
160727897|NCT03850483|580386241|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
160727898|NCT03850483|580386242|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
160727899|NCT03850483|580386243|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
160727900|NCT03850483|580386244|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
160727901|NCT03850483|580386235|FG000|Follow-up For Stage 2|Other|0|||
160727902|NCT03850483|580386236|FG001|Follow-up For Stage 2|Other|0|||
160727903|NCT03850483|580386237|FG002|Follow-up For Stage 2|Other|0|||
160727904|NCT03850483|580386238|FG003|Follow-up For Stage 2|Other|0|||
160727905|NCT03850483|580386239|FG004|Follow-up For Stage 2|Other|0|||
160727906|NCT03850483|580386240|FG005|Follow-up For Stage 2|Other|0|||
160727907|NCT03850483|580386241|FG006|Follow-up For Stage 2|Other|0|||
160727908|NCT03850483|580386242|FG007|Follow-up For Stage 2|Other|0|||
160727909|NCT03850483|580386243|FG008|Follow-up For Stage 2|Other|0|||
160727910|NCT03850483|580386244|FG009|Follow-up For Stage 2|Other|1|||
160727911|NCT03232931|580387594|FG000|Overall Study|Physician Decision|1|||
160727912|NCT03232931|580387595|FG001|Overall Study|Physician Decision|1|||
160727913|NCT03232931|580387594|FG000|Overall Study|Withdrawal by Subject|6|||
160727914|NCT03232931|580387595|FG001|Overall Study|Withdrawal by Subject|0|||
160727915|NCT03232931|580387594|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
160727916|NCT03232931|580387595|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
160727917|NCT03232931|580387594|FG000|Overall Study|Parent did not record voice|1|||
160727918|NCT03232931|580387595|FG001|Overall Study|Parent did not record voice|2|||
160727919|NCT03232931|580387594|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
160727920|NCT03232931|580387595|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
160727921|NCT04925557|580387596|FG000|Overall Study|Study closed|5|||
160727922|NCT04925557|580387597|FG001|Overall Study|Study closed|3|||
160727923|NCT05488470|580387598|FG000|Overall Study|Physician Decision|2|||
160727924|NCT05488470|580387598|FG000|Overall Study|Withdrawal by Subject|1|||
160727925|NCT05488470|580387598|FG000|Overall Study|Death|1|||
160727926|NCT01270464|580387602|FG000|Overall Study|Protocol Violation|4|||
160727927|NCT01270464|580387603|FG001|Overall Study|Protocol Violation|3|||
160727928|NCT01270464|580387604|FG002|Overall Study|Protocol Violation|2|||
160727929|NCT01270464|580387602|FG000|Overall Study|Lack of Efficacy|2|||
160727930|NCT01270464|580387603|FG001|Overall Study|Lack of Efficacy|3|||
160727931|NCT01270464|580387604|FG002|Overall Study|Lack of Efficacy|1|||
160727932|NCT01270464|580387602|FG000|Overall Study|Adverse Event|9|||
160727933|NCT01270464|580387603|FG001|Overall Study|Adverse Event|1|||
160727934|NCT01270464|580387604|FG002|Overall Study|Adverse Event|7|||
160727935|NCT01270464|580387602|FG000|Overall Study|Withdrawal by Subject|2|||
160727936|NCT01270464|580387603|FG001|Overall Study|Withdrawal by Subject|1|||
160727937|NCT01270464|580387604|FG002|Overall Study|Withdrawal by Subject|4|||
160727938|NCT01270464|580387602|FG000|Overall Study|Lost to Follow-up|2|||
160727939|NCT01270464|580387603|FG001|Overall Study|Lost to Follow-up|3|||
160727940|NCT01270464|580387604|FG002|Overall Study|Lost to Follow-up|1|||
160727941|NCT01270464|580387602|FG000|Overall Study|Other|1|||
160727942|NCT01270464|580387603|FG001|Overall Study|Other|1|||
160727943|NCT01270464|580387604|FG002|Overall Study|Other|3|||
160727944|NCT01288937|580387605|FG000|Overall Study|Adverse Event|1|||
160727945|NCT01288937|580387606|FG001|Overall Study|Adverse Event|0|||
160727946|NCT02875613|580387607|FG000|Overall Study|Withdrawal by Subject|1|||
160727947|NCT02875613|580387607|FG000|Overall Study|Screen Failure|1|||
160727948|NCT02347774|580387608|FG000|Study Participation|Lost to Follow-up|3|||
160727949|NCT02347774|580387609|FG001|Study Participation|Lost to Follow-up|6|||
160727950|NCT02347774|580387610|FG002|Study Participation|Lost to Follow-up|2|||
160727951|NCT02347774|580387608|FG000|Study Participation|Withdrawal by Subject|8|||
160727952|NCT02347774|580387609|FG001|Study Participation|Withdrawal by Subject|9|||
160727953|NCT02347774|580387610|FG002|Study Participation|Withdrawal by Subject|15|||
160727954|NCT02347774|580387608|FG000|Study Participation|Adverse Event|1|||
160727955|NCT02347774|580387609|FG001|Study Participation|Adverse Event|4|||
160727956|NCT02347774|580387610|FG002|Study Participation|Adverse Event|6|||
160727957|NCT02347774|580387608|FG000|Study Participation|withdrew consent|1|||
160727958|NCT02347774|580387609|FG001|Study Participation|withdrew consent|1|||
160727959|NCT02347774|580387610|FG002|Study Participation|withdrew consent|1|||
160727960|NCT02347774|580387608|FG000|Study Participation|Met Prolonged QT criteria|1|||
160727961|NCT02347774|580387609|FG001|Study Participation|Met Prolonged QT criteria|0|||
160727962|NCT02347774|580387610|FG002|Study Participation|Met Prolonged QT criteria|0|||
160727963|NCT02347774|580387608|FG000|Study Participation|non-compliance with study drug|0|||
160727964|NCT02347774|580387609|FG001|Study Participation|non-compliance with study drug|1|||
160727965|NCT02347774|580387610|FG002|Study Participation|non-compliance with study drug|0|||
160727966|NCT02347774|580387608|FG000|Study Participation|incarceration|1|||
160727967|NCT02347774|580387609|FG001|Study Participation|incarceration|0|||
160727968|NCT02347774|580387610|FG002|Study Participation|incarceration|0|||
160727969|NCT02347774|580387608|FG000|Study Participation|randomized in error|0|||
160727970|NCT02347774|580387609|FG001|Study Participation|randomized in error|0|||
160727971|NCT02347774|580387610|FG002|Study Participation|randomized in error|1|||
160727972|NCT02347774|580387608|FG000|On Study Treatment|Adverse Event|9|||
160727973|NCT02347774|580387609|FG001|On Study Treatment|Adverse Event|15|||
160727974|NCT02347774|580387610|FG002|On Study Treatment|Adverse Event|19|||
160727975|NCT02347774|580387608|FG000|On Study Treatment|Lack of Efficacy|3|||
160727976|NCT02347774|580387609|FG001|On Study Treatment|Lack of Efficacy|0|||
160727977|NCT02347774|580387610|FG002|On Study Treatment|Lack of Efficacy|2|||
160727978|NCT02347774|580387608|FG000|On Study Treatment|non-complicance with study medication|0|||
160727979|NCT02347774|580387609|FG001|On Study Treatment|non-complicance with study medication|2|||
160727980|NCT02347774|580387610|FG002|On Study Treatment|non-complicance with study medication|0|||
160727981|NCT02347774|580387608|FG000|On Study Treatment|Protocol Violation|0|||
160727982|NCT02347774|580387609|FG001|On Study Treatment|Protocol Violation|0|||
160727983|NCT02347774|580387610|FG002|On Study Treatment|Protocol Violation|1|||
160727984|NCT02347774|580387608|FG000|On Study Treatment|withdrew consent|9|||
160727985|NCT02347774|580387609|FG001|On Study Treatment|withdrew consent|8|||
160727986|NCT02347774|580387610|FG002|On Study Treatment|withdrew consent|12|||
160727987|NCT02347774|580387608|FG000|On Study Treatment|Lost to Follow-up|2|||
160727988|NCT02347774|580387609|FG001|On Study Treatment|Lost to Follow-up|6|||
160727989|NCT02347774|580387610|FG002|On Study Treatment|Lost to Follow-up|1|||
160727990|NCT02347774|580387608|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
160727991|NCT02347774|580387609|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
160727992|NCT02347774|580387610|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
160727993|NCT02347774|580387608|FG000|On Study Treatment|ranomized in error|0|||
160727994|NCT02347774|580387609|FG001|On Study Treatment|ranomized in error|0|||
160727995|NCT02347774|580387610|FG002|On Study Treatment|ranomized in error|1|||
160727996|NCT01750697|580387611|FG000|Overall Study|Transferred Back to Local Hospital|1|||
160727997|NCT01750697|580387611|FG000|Overall Study|Physician and Family Decision|1|||
160727998|NCT01750697|580387611|FG000|Overall Study|Transferred to Adult Services|5|||
160727999|NCT01750697|580387611|FG000|Overall Study|Physician Decision|1|||
160728000|NCT01750697|580387611|FG000|Overall Study|Withdrawal by Subject|1|||
160728001|NCT00892151|580387612|FG000|Overall Study|Protocol Violation|1|||
160728002|NCT01222520|580387615|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
160728003|NCT01222520|580387616|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
160728004|NCT01222520|580387615|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
160728005|NCT01222520|580387616|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
160728006|NCT01222520|580387615|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
160728007|NCT01222520|580387616|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
160728008|NCT01222520|580387615|FG000|Double-blind Period|Adverse Event|0|||
160728009|NCT01222520|580387616|FG001|Double-blind Period|Adverse Event|1|||
160728010|NCT01222520|580387615|FG000|Double-blind Period|Lack of Efficacy|0|||
160728011|NCT01222520|580387616|FG001|Double-blind Period|Lack of Efficacy|1|||
160728012|NCT01222520|580387615|FG000|Double-blind Period|Study medication stolen|1|||
160728013|NCT01222520|580387616|FG001|Double-blind Period|Study medication stolen|0|||
160728014|NCT01322490|580387619|FG000|Treatment Period|Adverse Event|12|||
160728015|NCT01322490|580387620|FG001|Treatment Period|Adverse Event|18|||
160728016|NCT01322490|580387621|FG002|Treatment Period|Adverse Event|15|||
160728017|NCT01322490|580387619|FG000|Treatment Period|Death|5|||
160728018|NCT01322490|580387620|FG001|Treatment Period|Death|7|||
160728019|NCT01322490|580387621|FG002|Treatment Period|Death|3|||
160728020|NCT01322490|580387619|FG000|Treatment Period|Lack of Efficacy|89|||
160728021|NCT01322490|580387620|FG001|Treatment Period|Lack of Efficacy|100|||
160728022|NCT01322490|580387621|FG002|Treatment Period|Lack of Efficacy|112|||
160728023|NCT01322490|580387619|FG000|Treatment Period|Physician Decision|0|||
160728024|NCT01322490|580387620|FG001|Treatment Period|Physician Decision|2|||
160728025|NCT01322490|580387621|FG002|Treatment Period|Physician Decision|1|||
160728026|NCT01322490|580387619|FG000|Treatment Period|Protocol Violation|7|||
160728027|NCT01322490|580387620|FG001|Treatment Period|Protocol Violation|5|||
160728028|NCT01322490|580387621|FG002|Treatment Period|Protocol Violation|4|||
160728029|NCT01322490|580387619|FG000|Treatment Period|Withdrawal by Subject|14|||
160728030|NCT01322490|580387620|FG001|Treatment Period|Withdrawal by Subject|16|||
160728031|NCT01322490|580387621|FG002|Treatment Period|Withdrawal by Subject|11|||
160728032|NCT01322490|580387619|FG000|Treatment Period|Non-compliance with study drug|0|||
160728033|NCT01322490|580387620|FG001|Treatment Period|Non-compliance with study drug|0|||
160728034|NCT01322490|580387621|FG002|Treatment Period|Non-compliance with study drug|1|||
160728035|NCT01322490|580387619|FG000|Treatment Period|Other per report|2|||
160728036|NCT01322490|580387620|FG001|Treatment Period|Other per report|2|||
160728037|NCT01322490|580387621|FG002|Treatment Period|Other per report|1|||
160728038|NCT01322490|580387619|FG000|Treatment Period|Randomized but Not Treated|3|||
160728039|NCT01322490|580387620|FG001|Treatment Period|Randomized but Not Treated|3|||
160728040|NCT01322490|580387621|FG002|Treatment Period|Randomized but Not Treated|5|||
160728041|NCT01322490|580387619|FG000|Long Term Follow-up Period|Death|235|||
160728042|NCT01322490|580387620|FG001|Long Term Follow-up Period|Death|239|||
160728043|NCT01322490|580387621|FG002|Long Term Follow-up Period|Death|236|||
160728044|NCT01322490|580387619|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
160728045|NCT01322490|580387620|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
160728046|NCT01322490|580387621|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
160728047|NCT01322490|580387619|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
160728048|NCT01322490|580387620|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
160728049|NCT01322490|580387621|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
160728050|NCT01322490|580387619|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
160728051|NCT01322490|580387620|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
160728052|NCT01322490|580387621|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
160728053|NCT01322490|580387619|FG000|Long Term Follow-up Period|Other per report|3|||
160728054|NCT01322490|580387620|FG001|Long Term Follow-up Period|Other per report|2|||
160728055|NCT01322490|580387621|FG002|Long Term Follow-up Period|Other per report|2|||
160728056|NCT01322490|580387619|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
160728057|NCT01322490|580387620|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
160728058|NCT01322490|580387621|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
160728059|NCT02257489|580387622|FG000|Overall Study|Withdrawal by Subject|0|||
160728060|NCT02257489|580387623|FG001|Overall Study|Withdrawal by Subject|0|||
160728061|NCT02257489|580387624|FG002|Overall Study|Withdrawal by Subject|0|||
160728062|NCT02257489|580387625|FG003|Overall Study|Withdrawal by Subject|1|||
160728063|NCT02257489|580387626|FG004|Overall Study|Withdrawal by Subject|0|||
160728064|NCT02257489|580387627|FG005|Overall Study|Withdrawal by Subject|0|||
160728065|NCT02257489|580387628|FG006|Overall Study|Withdrawal by Subject|0|||
160728066|NCT02257489|580387629|FG007|Overall Study|Withdrawal by Subject|0|||
160728067|NCT02257489|580387630|FG008|Overall Study|Withdrawal by Subject|0|||
160728068|NCT04606394|580387633|FG000|Overall Study|Withdrawal by Subject|3|||
160728069|NCT04606394|580387633|FG000|Overall Study|Exclusion criteria screen failure|12|||
160728070|NCT01896128|580387634|FG000|Overall Study|Withdrawal by Subject|3|||
160728071|NCT01896128|580387635|FG001|Overall Study|Withdrawal by Subject|3|||
160728072|NCT00954941|580387636|FG000|Overall Study|Received treatment at home|1|||
160728073|NCT00954941|580387637|FG001|Overall Study|Received treatment at home|0|||
160728074|NCT00954941|580387636|FG000|Overall Study|Withdrawal by Subject|1|||
160728075|NCT00954941|580387637|FG001|Overall Study|Withdrawal by Subject|0|||
160728076|NCT00954941|580387636|FG000|Overall Study|Insurance Denial|2|||
160728077|NCT00954941|580387637|FG001|Overall Study|Insurance Denial|2|||
160728078|NCT00954941|580387636|FG000|Overall Study|Physician Decision|2|||
160728079|NCT00954941|580387637|FG001|Overall Study|Physician Decision|2|||
160728080|NCT00954941|580387636|FG000|Overall Study|Ineligible|2|||
160728081|NCT00954941|580387637|FG001|Overall Study|Ineligible|2|||
160728082|NCT00954941|580387636|FG000|Overall Study|Adverse Event|0|||
160728083|NCT00954941|580387637|FG001|Overall Study|Adverse Event|1|||
160728084|NCT00955955|580387638|FG000|Overall Study|Lost to Follow-up|2|||
160728085|NCT00955955|580387639|FG001|Overall Study|Lost to Follow-up|0|||
160728086|NCT00955955|580387640|FG002|Overall Study|Lost to Follow-up|0|||
160728087|NCT02920008|580387642|FG000|Overall Study|Death|117|||
160728088|NCT02920008|580387643|FG001|Overall Study|Death|127|||
160728089|NCT02920008|580387642|FG000|Overall Study|Withdrawal by Subject|3|||
160728090|NCT02920008|580387643|FG001|Overall Study|Withdrawal by Subject|6|||
160728091|NCT02920008|580387642|FG000|Overall Study|Lost to Follow-up|0|||
160728092|NCT02920008|580387643|FG001|Overall Study|Lost to Follow-up|1|||
160728093|NCT03852264|580387646|FG000|Third Research Visit|Lost to Follow-up|1|||
160728094|NCT03852264|580387647|FG001|Third Research Visit|Lost to Follow-up|0|||
160728095|NCT01862250|580387648|FG000|Overall Study|Adverse Event|4|||
160728096|NCT02411396|580387652|FG000|Overall Study|Lost to Follow-up|31|||
160728097|NCT02411396|580387652|FG000|Overall Study|Death|10|||
160728098|NCT03575793|580387659|FG000|Overall Study|Withdrawal by Subject|0|||
160728099|NCT03575793|580387660|FG001|Overall Study|Withdrawal by Subject|1|||
160728100|NCT03575793|580387659|FG000|Overall Study|Never Treated|0|||
160728101|NCT03575793|580387660|FG001|Overall Study|Never Treated|2|||
160728102|NCT02016105|580387661|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
160728103|NCT02016105|580387662|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
160728104|NCT02016105|580387663|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
160728105|NCT02016105|580387664|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
160728106|NCT02016105|580387665|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
160728107|NCT02016105|580387666|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
160728108|NCT02016105|580387661|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
160728109|NCT02016105|580387662|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
160728110|NCT02016105|580387663|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
160728111|NCT02016105|580387664|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
160728112|NCT02016105|580387665|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
160728113|NCT02016105|580387666|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
160728114|NCT02016105|580387661|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
160728115|NCT02016105|580387662|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
160728116|NCT02016105|580387663|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
160728117|NCT02016105|580387664|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
160728118|NCT02016105|580387665|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
160728119|NCT02016105|580387666|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
160728120|NCT02016105|580387661|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
160728121|NCT02016105|580387662|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
160728122|NCT02016105|580387663|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
160728123|NCT02016105|580387664|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
160728124|NCT02016105|580387665|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
160728125|NCT02016105|580387666|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
160728126|NCT02016105|580387661|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
160728127|NCT02016105|580387662|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
160728128|NCT02016105|580387663|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
160728129|NCT02016105|580387664|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
160728130|NCT02016105|580387665|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
160728131|NCT02016105|580387666|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
160728132|NCT02016105|580387661|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
160728133|NCT02016105|580387662|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
160728134|NCT02016105|580387663|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
160728135|NCT02016105|580387664|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
160728136|NCT02016105|580387665|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
160728137|NCT02016105|580387666|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
160728138|NCT02016105|580387661|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
160728139|NCT02016105|580387662|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
160728140|NCT02016105|580387663|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
160728141|NCT02016105|580387664|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
160728142|NCT02016105|580387665|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
160728143|NCT02016105|580387666|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
160728144|NCT02016105|580387661|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
160728145|NCT02016105|580387662|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
160728146|NCT02016105|580387663|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
160728147|NCT02016105|580387664|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
160728148|NCT02016105|580387665|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
160728149|NCT02016105|580387666|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
160728150|NCT02016105|580387661|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
160728151|NCT02016105|580387662|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
160728152|NCT02016105|580387663|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
160728153|NCT02016105|580387664|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
160728154|NCT02016105|580387665|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
160728155|NCT02016105|580387666|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
160728156|NCT02016105|580387661|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
160728157|NCT02016105|580387662|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
160728158|NCT02016105|580387663|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
160728159|NCT02016105|580387664|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
160728160|NCT02016105|580387665|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
160728161|NCT02016105|580387666|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
160728162|NCT02016105|580387661|FG000|TREATMENT PERIOD 2|Death|0|||
160728163|NCT02016105|580387662|FG001|TREATMENT PERIOD 2|Death|0|||
160728164|NCT02016105|580387663|FG002|TREATMENT PERIOD 2|Death|0|||
160728165|NCT02016105|580387664|FG003|TREATMENT PERIOD 2|Death|0|||
160728166|NCT02016105|580387665|FG004|TREATMENT PERIOD 2|Death|0|||
160728167|NCT02016105|580387666|FG005|TREATMENT PERIOD 2|Death|1|||
160728168|NCT02016105|580387661|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
160728169|NCT02016105|580387662|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
160728170|NCT02016105|580387663|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
160728171|NCT02016105|580387664|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
160728172|NCT02016105|580387665|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
160728173|NCT02016105|580387666|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
160728174|NCT02016105|580387661|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
160728175|NCT02016105|580387662|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
160728176|NCT02016105|580387663|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
160728177|NCT02016105|580387664|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
160728178|NCT02016105|580387665|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
160728179|NCT02016105|580387666|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
160728180|NCT02016105|580387661|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
160728181|NCT02016105|580387662|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
160728182|NCT02016105|580387663|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
160728183|NCT02016105|580387664|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
160728184|NCT02016105|580387665|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
160728185|NCT02016105|580387666|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
160728186|NCT02016105|580387661|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
160728187|NCT02016105|580387662|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
160728188|NCT02016105|580387663|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
160728189|NCT02016105|580387664|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
160728190|NCT02016105|580387665|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
160728191|NCT02016105|580387666|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
160728192|NCT02016105|580387661|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
160728193|NCT02016105|580387662|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
160728194|NCT02016105|580387663|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
160728195|NCT02016105|580387664|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
160728196|NCT02016105|580387665|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
160728197|NCT02016105|580387666|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
160728198|NCT02016105|580387661|FG000|EXTENSION PERIOD|Adverse Event|0|||
160728199|NCT02016105|580387662|FG001|EXTENSION PERIOD|Adverse Event|0|||
160728200|NCT02016105|580387663|FG002|EXTENSION PERIOD|Adverse Event|2|||
160728201|NCT02016105|580387664|FG003|EXTENSION PERIOD|Adverse Event|0|||
160728202|NCT02016105|580387665|FG004|EXTENSION PERIOD|Adverse Event|1|||
160728203|NCT02016105|580387666|FG005|EXTENSION PERIOD|Adverse Event|0|||
160728204|NCT02016105|580387661|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
160728205|NCT02016105|580387662|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
160728206|NCT02016105|580387663|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
160728207|NCT02016105|580387664|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
160728208|NCT02016105|580387665|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
160728209|NCT02016105|580387666|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
160728210|NCT02016105|580387661|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
160728211|NCT02016105|580387662|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
160728212|NCT02016105|580387663|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
160728213|NCT02016105|580387664|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
160728214|NCT02016105|580387665|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
160728215|NCT02016105|580387666|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
160728216|NCT02016105|580387661|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
160728217|NCT02016105|580387662|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
160728218|NCT02016105|580387663|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
160728219|NCT02016105|580387664|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
160728220|NCT02016105|580387665|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
160728221|NCT02016105|580387666|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
160728222|NCT00090493|580387667|FG000|Overall Study|Physician Decision|2|||
160728223|NCT02865499|580387670|FG000|Baseline|Adverse Event|1|||
160728224|NCT02865499|580387670|FG000|Baseline|Withdrawal by Subject|1|||
160728225|NCT02320058|580387671|FG000|Overall Study|Death|25|||
160728226|NCT02320058|580387672|FG001|Overall Study|Death|10|||
160728227|NCT02320058|580387671|FG000|Overall Study|Lost to Follow-up|4|||
160728228|NCT02320058|580387672|FG001|Overall Study|Lost to Follow-up|0|||
160728229|NCT02320058|580387671|FG000|Overall Study|Other reasons|4|||
160728230|NCT02320058|580387672|FG001|Overall Study|Other reasons|1|||
160728231|NCT02320058|580387671|FG000|Overall Study|Withdrawal by Subject|8|||
160728232|NCT02320058|580387672|FG001|Overall Study|Withdrawal by Subject|2|||
160728233|NCT02320058|580387671|FG000|Overall Study|Not reported|1|||
160728234|NCT02320058|580387672|FG001|Overall Study|Not reported|0|||
160728235|NCT00661609|580387673|FG000|Overall Study|Adverse Event|4|||
160728236|NCT00661609|580387673|FG000|Overall Study|Death|20|||
160728237|NCT00661609|580387673|FG000|Overall Study|Withdrawal by Subject|2|||
160728238|NCT00661609|580387673|FG000|Overall Study|PI Decision|1|||
160728239|NCT00661609|580387673|FG000|Overall Study|Survival follow up stage discontinued|11|||
160728240|NCT00661609|580387673|FG000|Overall Study|Disease progression|3|||
160728241|NCT01769508|580387674|FG000|Overall Study|Death|3|||
160728242|NCT01769508|580387674|FG000|Overall Study|Withdrawal by Subject|1|||
160728243|NCT01769508|580387674|FG000|Overall Study|Adverse Event|1|||
160728244|NCT01769508|580387674|FG000|Overall Study|Lost to Follow-up|1|||
160728245|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
160728246|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
160728247|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
160728248|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
160728249|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
160728250|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
160728251|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
160728252|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
160728253|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
160728254|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
160728255|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
160728256|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
160728257|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
160728258|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
160728259|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
160728260|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
160728261|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
160728262|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
160728263|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
160728264|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
160728265|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
160728266|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
160728267|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
160728268|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
160728269|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
160728270|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
160728271|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
160728272|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
160728273|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
160728274|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
160728275|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
160728276|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
160728277|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
160728278|NCT00839527|580387675|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
160728279|NCT00839527|580387676|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
160728280|NCT00839527|580387677|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
160728281|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
160728282|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
160728283|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
160728284|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
160728285|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
160728286|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
160728287|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
160728288|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
160728289|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
160728290|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
160728291|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
160728292|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
160728293|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
160728294|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
160728295|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
160728296|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
160728297|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
160728298|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
160728299|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
160728300|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
160728301|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
160728302|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
160728303|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
160728304|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
160728305|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
160728306|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
160728307|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
160728308|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
160728309|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
160728310|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
160728311|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
160728312|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
160728313|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
160728314|NCT00839527|580387675|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
160728315|NCT00839527|580387676|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
160728316|NCT00839527|580387677|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
160728317|NCT02751450|580387678|FG000|Overall Study|Adverse Event|1|||
160728318|NCT02751450|580387679|FG001|Overall Study|Adverse Event|0|||
160728319|NCT02587598|580387680|FG000|Overall Study|Death|4|||
160728320|NCT02587598|580387681|FG001|Overall Study|Death|8|||
160728321|NCT02587598|580387682|FG002|Overall Study|Death|4|||
160728322|NCT02587598|580387683|FG003|Overall Study|Death|16|||
160728323|NCT02587598|580387684|FG004|Overall Study|Death|9|||
160728324|NCT02587598|580387685|FG005|Overall Study|Death|4|||
160728325|NCT02587598|580387686|FG006|Overall Study|Death|6|||
160728326|NCT02587598|580387687|FG007|Overall Study|Death|7|||
160728327|NCT02587598|580387688|FG008|Overall Study|Death|9|||
160728328|NCT02587598|580387689|FG009|Overall Study|Death|1|||
160728329|NCT02587598|580387690|FG010|Overall Study|Death|3|||
160728330|NCT02587598|580387680|FG000|Overall Study|Study Terminated by the Sponsor|0|||
160728331|NCT02587598|580387681|FG001|Overall Study|Study Terminated by the Sponsor|1|||
160728332|NCT02587598|580387682|FG002|Overall Study|Study Terminated by the Sponsor|0|||
160728333|NCT02587598|580387683|FG003|Overall Study|Study Terminated by the Sponsor|3|||
160728334|NCT02587598|580387684|FG004|Overall Study|Study Terminated by the Sponsor|0|||
160728335|NCT02587598|580387685|FG005|Overall Study|Study Terminated by the Sponsor|1|||
160728336|NCT02587598|580387686|FG006|Overall Study|Study Terminated by the Sponsor|0|||
160728337|NCT02587598|580387687|FG007|Overall Study|Study Terminated by the Sponsor|0|||
160728338|NCT02587598|580387688|FG008|Overall Study|Study Terminated by the Sponsor|0|||
160728339|NCT02587598|580387689|FG009|Overall Study|Study Terminated by the Sponsor|1|||
160728340|NCT02587598|580387690|FG010|Overall Study|Study Terminated by the Sponsor|6|||
160728341|NCT02587598|580387680|FG000|Overall Study|Reason for study withdrawal not specified|0|||
160728342|NCT02587598|580387681|FG001|Overall Study|Reason for study withdrawal not specified|1|||
160728343|NCT02587598|580387682|FG002|Overall Study|Reason for study withdrawal not specified|0|||
160728344|NCT02587598|580387683|FG003|Overall Study|Reason for study withdrawal not specified|0|||
160728345|NCT02587598|580387684|FG004|Overall Study|Reason for study withdrawal not specified|0|||
160728346|NCT02587598|580387685|FG005|Overall Study|Reason for study withdrawal not specified|0|||
160728347|NCT02587598|580387686|FG006|Overall Study|Reason for study withdrawal not specified|0|||
160728348|NCT02587598|580387687|FG007|Overall Study|Reason for study withdrawal not specified|0|||
160728349|NCT02587598|580387688|FG008|Overall Study|Reason for study withdrawal not specified|0|||
160728350|NCT02587598|580387689|FG009|Overall Study|Reason for study withdrawal not specified|0|||
160728351|NCT02587598|580387690|FG010|Overall Study|Reason for study withdrawal not specified|0|||
160728352|NCT02587598|580387680|FG000|Overall Study|Withdrawal by Subject|0|||
160728353|NCT02587598|580387681|FG001|Overall Study|Withdrawal by Subject|1|||
160728354|NCT02587598|580387682|FG002|Overall Study|Withdrawal by Subject|0|||
160728355|NCT02587598|580387683|FG003|Overall Study|Withdrawal by Subject|2|||
160728356|NCT02587598|580387684|FG004|Overall Study|Withdrawal by Subject|3|||
160728357|NCT02587598|580387685|FG005|Overall Study|Withdrawal by Subject|1|||
160728358|NCT02587598|580387686|FG006|Overall Study|Withdrawal by Subject|0|||
160728359|NCT02587598|580387687|FG007|Overall Study|Withdrawal by Subject|0|||
160728360|NCT02587598|580387688|FG008|Overall Study|Withdrawal by Subject|0|||
160728361|NCT02587598|580387689|FG009|Overall Study|Withdrawal by Subject|1|||
160728362|NCT02587598|580387690|FG010|Overall Study|Withdrawal by Subject|2|||
160728363|NCT02587598|580387680|FG000|Overall Study|Physician Decision|0|||
160728364|NCT02587598|580387681|FG001|Overall Study|Physician Decision|0|||
160728365|NCT02587598|580387682|FG002|Overall Study|Physician Decision|0|||
160728366|NCT02587598|580387683|FG003|Overall Study|Physician Decision|0|||
160728367|NCT02587598|580387684|FG004|Overall Study|Physician Decision|0|||
160728368|NCT02587598|580387685|FG005|Overall Study|Physician Decision|0|||
160728369|NCT02587598|580387686|FG006|Overall Study|Physician Decision|0|||
160728370|NCT02587598|580387687|FG007|Overall Study|Physician Decision|0|||
160728371|NCT02587598|580387688|FG008|Overall Study|Physician Decision|0|||
160728372|NCT02587598|580387689|FG009|Overall Study|Physician Decision|0|||
160728373|NCT02587598|580387690|FG010|Overall Study|Physician Decision|3|||
160728374|NCT00679289|580387691|FG000|Overall Study|Progressive disease|4|||
160728375|NCT00679289|580387692|FG001|Overall Study|Progressive disease|5|||
160728376|NCT00679289|580387693|FG002|Overall Study|Progressive disease|18|||
160728377|NCT00679289|580387691|FG000|Overall Study|Withdrawal by Subject|0|||
160728378|NCT00679289|580387692|FG001|Overall Study|Withdrawal by Subject|1|||
160728379|NCT00679289|580387693|FG002|Overall Study|Withdrawal by Subject|1|||
160728380|NCT00679289|580387691|FG000|Overall Study|Adverse Event|0|||
160728381|NCT00679289|580387692|FG001|Overall Study|Adverse Event|0|||
160728382|NCT00679289|580387693|FG002|Overall Study|Adverse Event|3|||
160728383|NCT00679289|580387691|FG000|Overall Study|Physician Decision|1|||
160728384|NCT00679289|580387692|FG001|Overall Study|Physician Decision|0|||
160728385|NCT00679289|580387693|FG002|Overall Study|Physician Decision|1|||
160728386|NCT00937040|580387694|FG000|Overall Study|Adverse Event|5|||
160728387|NCT00937040|580387695|FG001|Overall Study|Adverse Event|8|||
160728388|NCT00937040|580387694|FG000|Overall Study|Lost to Follow-up|12|||
160728389|NCT00937040|580387695|FG001|Overall Study|Lost to Follow-up|12|||
160728390|NCT00937040|580387694|FG000|Overall Study|Protocol Violation|3|||
160728391|NCT00937040|580387695|FG001|Overall Study|Protocol Violation|0|||
160728392|NCT00937040|580387694|FG000|Overall Study|Withdrawal by Subject|13|||
160728393|NCT00937040|580387695|FG001|Overall Study|Withdrawal by Subject|7|||
160728394|NCT00937040|580387694|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
160728395|NCT00937040|580387695|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
160728396|NCT00937040|580387694|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
160728397|NCT00937040|580387695|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
160728398|NCT02477826|580387696|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
160728399|NCT02477826|580387697|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
160728400|NCT02477826|580387698|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
160728401|NCT02477826|580387699|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
160728402|NCT02477826|580387700|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
160728403|NCT02477826|580387701|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
160728404|NCT02477826|580387702|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
160728405|NCT02477826|580387703|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
160728406|NCT02477826|580387704|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
160728407|NCT02477826|580387705|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
160728408|NCT02477826|580387696|FG000|Pre-Treatment|Other reasons|4|||
160728409|NCT02477826|580387697|FG001|Pre-Treatment|Other reasons|1|||
160728410|NCT02477826|580387698|FG002|Pre-Treatment|Other reasons|4|||
160728411|NCT02477826|580387699|FG003|Pre-Treatment|Other reasons|1|||
160728412|NCT02477826|580387700|FG004|Pre-Treatment|Other reasons|4|||
160728413|NCT02477826|580387701|FG005|Pre-Treatment|Other reasons|2|||
160728414|NCT02477826|580387702|FG006|Pre-Treatment|Other reasons|0|||
160728415|NCT02477826|580387703|FG007|Pre-Treatment|Other reasons|0|||
160728416|NCT02477826|580387704|FG008|Pre-Treatment|Other reasons|0|||
160728417|NCT02477826|580387705|FG009|Pre-Treatment|Other reasons|0|||
160728418|NCT02477826|580387696|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
160728419|NCT02477826|580387697|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
160728420|NCT02477826|580387698|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
160728421|NCT02477826|580387699|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
160728422|NCT02477826|580387700|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
160728423|NCT02477826|580387701|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
160728424|NCT02477826|580387702|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
160728425|NCT02477826|580387703|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
160728426|NCT02477826|580387704|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
160728427|NCT02477826|580387705|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
160728428|NCT02477826|580387696|FG000|Pre-Treatment|Subject withdrew consent|0|||
160728429|NCT02477826|580387697|FG001|Pre-Treatment|Subject withdrew consent|0|||
160728430|NCT02477826|580387698|FG002|Pre-Treatment|Subject withdrew consent|3|||
160728431|NCT02477826|580387699|FG003|Pre-Treatment|Subject withdrew consent|0|||
160728432|NCT02477826|580387700|FG004|Pre-Treatment|Subject withdrew consent|0|||
160728433|NCT02477826|580387701|FG005|Pre-Treatment|Subject withdrew consent|1|||
160728434|NCT02477826|580387702|FG006|Pre-Treatment|Subject withdrew consent|0|||
160728435|NCT02477826|580387703|FG007|Pre-Treatment|Subject withdrew consent|1|||
160728436|NCT02477826|580387704|FG008|Pre-Treatment|Subject withdrew consent|0|||
160728437|NCT02477826|580387705|FG009|Pre-Treatment|Subject withdrew consent|3|||
160728438|NCT02477826|580387696|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
160728439|NCT02477826|580387697|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
160728440|NCT02477826|580387698|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
160728441|NCT02477826|580387699|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
160728442|NCT02477826|580387700|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
160728443|NCT02477826|580387701|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
160728444|NCT02477826|580387702|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
160728445|NCT02477826|580387703|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
160728446|NCT02477826|580387704|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
160728447|NCT02477826|580387705|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
160728448|NCT02477826|580387696|FG000|Pre-Treatment|Death|0|||
160728449|NCT02477826|580387697|FG001|Pre-Treatment|Death|0|||
160728450|NCT02477826|580387698|FG002|Pre-Treatment|Death|0|||
160728451|NCT02477826|580387699|FG003|Pre-Treatment|Death|0|||
160728452|NCT02477826|580387700|FG004|Pre-Treatment|Death|0|||
160728453|NCT02477826|580387701|FG005|Pre-Treatment|Death|0|||
160728454|NCT02477826|580387702|FG006|Pre-Treatment|Death|1|||
160728455|NCT02477826|580387703|FG007|Pre-Treatment|Death|0|||
160728456|NCT02477826|580387704|FG008|Pre-Treatment|Death|0|||
160728457|NCT02477826|580387705|FG009|Pre-Treatment|Death|0|||
160728458|NCT02477826|580387696|FG000|Treatment Period|Not reported|8|||
160728459|NCT02477826|580387697|FG001|Treatment Period|Not reported|6|||
160728460|NCT02477826|580387698|FG002|Treatment Period|Not reported|4|||
160728461|NCT02477826|580387699|FG003|Treatment Period|Not reported|4|||
160728462|NCT02477826|580387700|FG004|Treatment Period|Not reported|2|||
160728463|NCT02477826|580387701|FG005|Treatment Period|Not reported|1|||
160728464|NCT02477826|580387702|FG006|Treatment Period|Not reported|14|||
160728465|NCT02477826|580387703|FG007|Treatment Period|Not reported|8|||
160728466|NCT02477826|580387704|FG008|Treatment Period|Not reported|5|||
160728467|NCT02477826|580387705|FG009|Treatment Period|Not reported|2|||
160728468|NCT02477826|580387696|FG000|Treatment Period|Other reasons|5|||
160728469|NCT02477826|580387697|FG001|Treatment Period|Other reasons|6|||
160728470|NCT02477826|580387698|FG002|Treatment Period|Other reasons|12|||
160728471|NCT02477826|580387699|FG003|Treatment Period|Other reasons|7|||
160728472|NCT02477826|580387700|FG004|Treatment Period|Other reasons|5|||
160728473|NCT02477826|580387701|FG005|Treatment Period|Other reasons|1|||
160728474|NCT02477826|580387702|FG006|Treatment Period|Other reasons|8|||
160728475|NCT02477826|580387703|FG007|Treatment Period|Other reasons|8|||
160728476|NCT02477826|580387704|FG008|Treatment Period|Other reasons|21|||
160728477|NCT02477826|580387705|FG009|Treatment Period|Other reasons|1|||
160728478|NCT02477826|580387696|FG000|Treatment Period|Administrative reason by sponsor|0|||
160728479|NCT02477826|580387697|FG001|Treatment Period|Administrative reason by sponsor|3|||
160728480|NCT02477826|580387698|FG002|Treatment Period|Administrative reason by sponsor|0|||
160728481|NCT02477826|580387699|FG003|Treatment Period|Administrative reason by sponsor|0|||
160728482|NCT02477826|580387700|FG004|Treatment Period|Administrative reason by sponsor|0|||
160728483|NCT02477826|580387701|FG005|Treatment Period|Administrative reason by sponsor|0|||
160728484|NCT02477826|580387702|FG006|Treatment Period|Administrative reason by sponsor|0|||
160728485|NCT02477826|580387703|FG007|Treatment Period|Administrative reason by sponsor|0|||
160728486|NCT02477826|580387704|FG008|Treatment Period|Administrative reason by sponsor|0|||
160728487|NCT02477826|580387705|FG009|Treatment Period|Administrative reason by sponsor|0|||
160728488|NCT02477826|580387696|FG000|Treatment Period|Participant meet no longer study criteria|1|||
160728489|NCT02477826|580387697|FG001|Treatment Period|Participant meet no longer study criteria|1|||
160728490|NCT02477826|580387698|FG002|Treatment Period|Participant meet no longer study criteria|0|||
160728491|NCT02477826|580387699|FG003|Treatment Period|Participant meet no longer study criteria|0|||
160728492|NCT02477826|580387700|FG004|Treatment Period|Participant meet no longer study criteria|1|||
160728493|NCT02477826|580387701|FG005|Treatment Period|Participant meet no longer study criteria|1|||
160728494|NCT02477826|580387702|FG006|Treatment Period|Participant meet no longer study criteria|0|||
160728495|NCT02477826|580387703|FG007|Treatment Period|Participant meet no longer study criteria|1|||
160728496|NCT02477826|580387704|FG008|Treatment Period|Participant meet no longer study criteria|0|||
160728497|NCT02477826|580387705|FG009|Treatment Period|Participant meet no longer study criteria|0|||
160728498|NCT02477826|580387696|FG000|Treatment Period|Poor/Non Compliance|1|||
160728499|NCT02477826|580387697|FG001|Treatment Period|Poor/Non Compliance|0|||
160728500|NCT02477826|580387698|FG002|Treatment Period|Poor/Non Compliance|2|||
160728501|NCT02477826|580387699|FG003|Treatment Period|Poor/Non Compliance|0|||
160728502|NCT02477826|580387700|FG004|Treatment Period|Poor/Non Compliance|0|||
160728503|NCT02477826|580387701|FG005|Treatment Period|Poor/Non Compliance|1|||
160728504|NCT02477826|580387702|FG006|Treatment Period|Poor/Non Compliance|1|||
160728505|NCT02477826|580387703|FG007|Treatment Period|Poor/Non Compliance|0|||
160728506|NCT02477826|580387704|FG008|Treatment Period|Poor/Non Compliance|0|||
160728507|NCT02477826|580387705|FG009|Treatment Period|Poor/Non Compliance|1|||
160728508|NCT02477826|580387696|FG000|Treatment Period|Maximum Clinical Benefit|3|||
160728509|NCT02477826|580387697|FG001|Treatment Period|Maximum Clinical Benefit|3|||
160728510|NCT02477826|580387698|FG002|Treatment Period|Maximum Clinical Benefit|1|||
160728511|NCT02477826|580387699|FG003|Treatment Period|Maximum Clinical Benefit|1|||
160728512|NCT02477826|580387700|FG004|Treatment Period|Maximum Clinical Benefit|3|||
160728513|NCT02477826|580387701|FG005|Treatment Period|Maximum Clinical Benefit|0|||
160728514|NCT02477826|580387702|FG006|Treatment Period|Maximum Clinical Benefit|3|||
160728515|NCT02477826|580387703|FG007|Treatment Period|Maximum Clinical Benefit|2|||
160728516|NCT02477826|580387704|FG008|Treatment Period|Maximum Clinical Benefit|2|||
160728517|NCT02477826|580387705|FG009|Treatment Period|Maximum Clinical Benefit|2|||
160728518|NCT02477826|580387696|FG000|Treatment Period|Lost to Follow-up|0|||
160728519|NCT02477826|580387697|FG001|Treatment Period|Lost to Follow-up|0|||
160728520|NCT02477826|580387698|FG002|Treatment Period|Lost to Follow-up|1|||
160728521|NCT02477826|580387699|FG003|Treatment Period|Lost to Follow-up|1|||
160728522|NCT02477826|580387700|FG004|Treatment Period|Lost to Follow-up|0|||
160728523|NCT02477826|580387701|FG005|Treatment Period|Lost to Follow-up|0|||
160728524|NCT02477826|580387702|FG006|Treatment Period|Lost to Follow-up|2|||
160728525|NCT02477826|580387703|FG007|Treatment Period|Lost to Follow-up|2|||
160728526|NCT02477826|580387704|FG008|Treatment Period|Lost to Follow-up|0|||
160728527|NCT02477826|580387705|FG009|Treatment Period|Lost to Follow-up|0|||
160728528|NCT02477826|580387696|FG000|Treatment Period|Participant withdrew Consent|5|||
160728529|NCT02477826|580387697|FG001|Treatment Period|Participant withdrew Consent|5|||
160728530|NCT02477826|580387698|FG002|Treatment Period|Participant withdrew Consent|3|||
160728531|NCT02477826|580387699|FG003|Treatment Period|Participant withdrew Consent|3|||
160728532|NCT02477826|580387700|FG004|Treatment Period|Participant withdrew Consent|1|||
160728533|NCT02477826|580387701|FG005|Treatment Period|Participant withdrew Consent|3|||
160728534|NCT02477826|580387702|FG006|Treatment Period|Participant withdrew Consent|3|||
160728535|NCT02477826|580387703|FG007|Treatment Period|Participant withdrew Consent|3|||
160728536|NCT02477826|580387704|FG008|Treatment Period|Participant withdrew Consent|2|||
160728537|NCT02477826|580387705|FG009|Treatment Period|Participant withdrew Consent|3|||
160728538|NCT02477826|580387696|FG000|Treatment Period|Participant request to discontinue treatment|5|||
160728539|NCT02477826|580387697|FG001|Treatment Period|Participant request to discontinue treatment|3|||
160728540|NCT02477826|580387698|FG002|Treatment Period|Participant request to discontinue treatment|15|||
160728541|NCT02477826|580387699|FG003|Treatment Period|Participant request to discontinue treatment|5|||
160728542|NCT02477826|580387700|FG004|Treatment Period|Participant request to discontinue treatment|3|||
160728543|NCT02477826|580387701|FG005|Treatment Period|Participant request to discontinue treatment|6|||
160728544|NCT02477826|580387702|FG006|Treatment Period|Participant request to discontinue treatment|13|||
160728545|NCT02477826|580387703|FG007|Treatment Period|Participant request to discontinue treatment|15|||
160728546|NCT02477826|580387704|FG008|Treatment Period|Participant request to discontinue treatment|4|||
160728547|NCT02477826|580387705|FG009|Treatment Period|Participant request to discontinue treatment|18|||
160728548|NCT02477826|580387696|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
160728549|NCT02477826|580387697|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
160728550|NCT02477826|580387698|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
160728551|NCT02477826|580387699|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
160728552|NCT02477826|580387700|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
160728553|NCT02477826|580387701|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
160728554|NCT02477826|580387702|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
160728555|NCT02477826|580387703|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
160728556|NCT02477826|580387704|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
160728557|NCT02477826|580387705|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
160728558|NCT02477826|580387696|FG000|Treatment Period|Death|4|||
160728559|NCT02477826|580387697|FG001|Treatment Period|Death|7|||
160728560|NCT02477826|580387698|FG002|Treatment Period|Death|0|||
160728561|NCT02477826|580387699|FG003|Treatment Period|Death|0|||
160728562|NCT02477826|580387700|FG004|Treatment Period|Death|1|||
160728563|NCT02477826|580387701|FG005|Treatment Period|Death|2|||
160728564|NCT02477826|580387702|FG006|Treatment Period|Death|6|||
160728565|NCT02477826|580387703|FG007|Treatment Period|Death|5|||
160728566|NCT02477826|580387704|FG008|Treatment Period|Death|9|||
160728567|NCT02477826|580387705|FG009|Treatment Period|Death|0|||
160728568|NCT02477826|580387696|FG000|Treatment Period|Study Drug Toxicity|79|||
160728569|NCT02477826|580387697|FG001|Treatment Period|Study Drug Toxicity|51|||
160728570|NCT02477826|580387698|FG002|Treatment Period|Study Drug Toxicity|31|||
160728571|NCT02477826|580387699|FG003|Treatment Period|Study Drug Toxicity|39|||
160728572|NCT02477826|580387700|FG004|Treatment Period|Study Drug Toxicity|12|||
160728573|NCT02477826|580387701|FG005|Treatment Period|Study Drug Toxicity|25|||
160728574|NCT02477826|580387702|FG006|Treatment Period|Study Drug Toxicity|52|||
160728575|NCT02477826|580387703|FG007|Treatment Period|Study Drug Toxicity|30|||
160728576|NCT02477826|580387704|FG008|Treatment Period|Study Drug Toxicity|20|||
160728577|NCT02477826|580387705|FG009|Treatment Period|Study Drug Toxicity|9|||
160728578|NCT02477826|580387696|FG000|Treatment Period|Disease progression|212|||
160728579|NCT02477826|580387697|FG001|Treatment Period|Disease progression|240|||
160728580|NCT02477826|580387698|FG002|Treatment Period|Disease progression|202|||
160728581|NCT02477826|580387699|FG003|Treatment Period|Disease progression|93|||
160728582|NCT02477826|580387700|FG004|Treatment Period|Disease progression|113|||
160728583|NCT02477826|580387701|FG005|Treatment Period|Disease progression|96|||
160728584|NCT02477826|580387702|FG006|Treatment Period|Disease progression|208|||
160728585|NCT02477826|580387703|FG007|Treatment Period|Disease progression|195|||
160728586|NCT02477826|580387704|FG008|Treatment Period|Disease progression|59|||
160728587|NCT02477826|580387705|FG009|Treatment Period|Disease progression|46|||
160728588|NCT02477826|580387696|FG000|Treatment Period|Pregnancy|0|||
160728589|NCT02477826|580387697|FG001|Treatment Period|Pregnancy|0|||
160728590|NCT02477826|580387698|FG002|Treatment Period|Pregnancy|0|||
160728591|NCT02477826|580387699|FG003|Treatment Period|Pregnancy|0|||
160728592|NCT02477826|580387700|FG004|Treatment Period|Pregnancy|0|||
160728593|NCT02477826|580387701|FG005|Treatment Period|Pregnancy|0|||
160728594|NCT02477826|580387702|FG006|Treatment Period|Pregnancy|0|||
160728595|NCT02477826|580387703|FG007|Treatment Period|Pregnancy|0|||
160728596|NCT02477826|580387704|FG008|Treatment Period|Pregnancy|0|||
160728597|NCT02477826|580387705|FG009|Treatment Period|Pregnancy|1|||
160728598|NCT02477826|580387696|FG000|Treatment Period|Other|0|||
160728599|NCT02477826|580387697|FG001|Treatment Period|Other|0|||
160728600|NCT02477826|580387698|FG002|Treatment Period|Other|0|||
160728601|NCT02477826|580387699|FG003|Treatment Period|Other|0|||
160728602|NCT02477826|580387700|FG004|Treatment Period|Other|0|||
160728603|NCT02477826|580387701|FG005|Treatment Period|Other|0|||
160728604|NCT02477826|580387702|FG006|Treatment Period|Other|0|||
160728605|NCT02477826|580387703|FG007|Treatment Period|Other|0|||
160728606|NCT02477826|580387704|FG008|Treatment Period|Other|0|||
160728607|NCT02477826|580387705|FG009|Treatment Period|Other|1|||
160728608|NCT00766636|580387707|FG000|Overall Study|Withdrawal by Subject|1|||
160728609|NCT00766636|580387708|FG001|Overall Study|Withdrawal by Subject|1|||
160728610|NCT00766636|580387707|FG000|Overall Study|Incomplete Treatment|0|||
160728611|NCT00766636|580387708|FG001|Overall Study|Incomplete Treatment|1|||
160728612|NCT00766636|580387707|FG000|Overall Study|Adverse Event|1|||
160728613|NCT00766636|580387708|FG001|Overall Study|Adverse Event|0|||
160728614|NCT00766636|580387707|FG000|Overall Study|Disease Progression|1|||
160728615|NCT00766636|580387708|FG001|Overall Study|Disease Progression|0|||
160728616|NCT01218087|580387715|FG000|Overall Study|Death|2|||
160728617|NCT01218087|580387716|FG001|Overall Study|Death|1|||
160728618|NCT01218087|580387715|FG000|Overall Study|Withdrawal by Subject|5|||
160728619|NCT01218087|580387716|FG001|Overall Study|Withdrawal by Subject|0|||
160728620|NCT01218087|580387715|FG000|Overall Study|Transferred|8|||
160728621|NCT01218087|580387716|FG001|Overall Study|Transferred|5|||
160728622|NCT03170362|580387717|FG000|Overall Study|Death|2|||
160728623|NCT03170362|580387718|FG001|Overall Study|Death|2|||
160728624|NCT03170362|580387717|FG000|Overall Study|Withdrawal by Subject|23|||
160728625|NCT03170362|580387718|FG001|Overall Study|Withdrawal by Subject|22|||
160728626|NCT03170362|580387717|FG000|Overall Study|Lost to Follow-up|187|||
160728627|NCT03170362|580387718|FG001|Overall Study|Lost to Follow-up|167|||
160728628|NCT03340454|580387719|FG000|Overall Study|Lost to Follow-up|0|||
160728629|NCT03340454|580387720|FG001|Overall Study|Lost to Follow-up|4|||
160728630|NCT03307252|580387726|FG000|Part 2, Period 1|Treatment not received|0|||
160728631|NCT03307252|580387727|FG001|Part 2, Period 1|Treatment not received|0|||
160728632|NCT03307252|580387728|FG002|Part 2, Period 1|Treatment not received|0|||
160728633|NCT03307252|580387729|FG003|Part 2, Period 1|Treatment not received|0|||
160728634|NCT03307252|580387730|FG004|Part 2, Period 1|Treatment not received|0|||
160728635|NCT03307252|580387731|FG005|Part 2, Period 1|Treatment not received|1|||
160728636|NCT03307252|580387732|FG006|Part 2, Period 1|Treatment not received|0|||
160728637|NCT03307252|580387733|FG007|Part 2, Period 1|Treatment not received|0|||
160728638|NCT03307252|580387734|FG008|Part 2, Period 1|Treatment not received|0|||
160728639|NCT03307252|580387735|FG009|Part 2, Period 1|Treatment not received|0|||
160728640|NCT03307252|580387736|FG010|Part 2, Period 1|Treatment not received|0|||
160728641|NCT03307252|580387726|FG000|Part 2, Period 3|Other than listed|0|||
160728642|NCT03307252|580387727|FG001|Part 2, Period 3|Other than listed|0|||
160728643|NCT03307252|580387728|FG002|Part 2, Period 3|Other than listed|0|||
160728644|NCT03307252|580387729|FG003|Part 2, Period 3|Other than listed|0|||
160728645|NCT03307252|580387730|FG004|Part 2, Period 3|Other than listed|1|||
160728646|NCT03307252|580387731|FG005|Part 2, Period 3|Other than listed|0|||
160728647|NCT03307252|580387732|FG006|Part 2, Period 3|Other than listed|0|||
160728648|NCT03307252|580387733|FG007|Part 2, Period 3|Other than listed|0|||
160728649|NCT03307252|580387734|FG008|Part 2, Period 3|Other than listed|0|||
160728650|NCT03307252|580387735|FG009|Part 2, Period 3|Other than listed|0|||
160728651|NCT03307252|580387736|FG010|Part 2, Period 3|Other than listed|0|||
160728652|NCT03307252|580387726|FG000|Part 2, Period 4|Other than listed|0|||
160728653|NCT03307252|580387727|FG001|Part 2, Period 4|Other than listed|0|||
160728654|NCT03307252|580387728|FG002|Part 2, Period 4|Other than listed|0|||
160728655|NCT03307252|580387729|FG003|Part 2, Period 4|Other than listed|0|||
160728656|NCT03307252|580387730|FG004|Part 2, Period 4|Other than listed|0|||
160728657|NCT03307252|580387731|FG005|Part 2, Period 4|Other than listed|0|||
160728658|NCT03307252|580387732|FG006|Part 2, Period 4|Other than listed|1|||
160728659|NCT03307252|580387733|FG007|Part 2, Period 4|Other than listed|0|||
160728660|NCT03307252|580387734|FG008|Part 2, Period 4|Other than listed|0|||
160728661|NCT03307252|580387735|FG009|Part 2, Period 4|Other than listed|0|||
160728662|NCT03307252|580387736|FG010|Part 2, Period 4|Other than listed|0|||
160728663|NCT03307252|580387726|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
160728664|NCT03307252|580387727|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
160728665|NCT03307252|580387728|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
160728666|NCT03307252|580387729|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
160728667|NCT03307252|580387730|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
160728668|NCT03307252|580387731|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
160728669|NCT03307252|580387732|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
160728670|NCT03307252|580387733|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
160728671|NCT03307252|580387734|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
160728672|NCT03307252|580387735|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
160728673|NCT03307252|580387736|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
160728674|NCT01052480|580387737|FG000|Overall Study|Lost to Follow-up|3|||
160728675|NCT01052480|580387738|FG001|Overall Study|Lost to Follow-up|3|||
160728676|NCT01052480|580387737|FG000|Overall Study|Protocol Violation|1|||
160728677|NCT01052480|580387738|FG001|Overall Study|Protocol Violation|0|||
160728678|NCT01052480|580387737|FG000|Overall Study|Withdrawal by Subject|3|||
160728679|NCT01052480|580387738|FG001|Overall Study|Withdrawal by Subject|7|||
160728680|NCT01052480|580387737|FG000|Overall Study|Physician Decision|0|||
160728681|NCT01052480|580387738|FG001|Overall Study|Physician Decision|2|||
160728682|NCT01052480|580387737|FG000|Overall Study|Death|1|||
160728683|NCT01052480|580387738|FG001|Overall Study|Death|5|||
160728684|NCT04185220|580387743|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
160728685|NCT04185220|580387744|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
160728686|NCT04185220|580387743|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
160728687|NCT04185220|580387744|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
160728688|NCT03225105|580387752|FG000|Overall Study|Withdrawal by Subject|1|||
160728689|NCT03225105|580387753|FG001|Overall Study|Withdrawal by Subject|0|||
160728690|NCT03225105|580387754|FG002|Overall Study|Withdrawal by Subject|0|||
160728691|NCT03225105|580387755|FG003|Overall Study|Withdrawal by Subject|0|||
160728692|NCT03225105|580387752|FG000|Overall Study|Death|0|||
160728693|NCT03225105|580387753|FG001|Overall Study|Death|4|||
160728694|NCT03225105|580387754|FG002|Overall Study|Death|2|||
160728695|NCT03225105|580387755|FG003|Overall Study|Death|0|||
160728696|NCT03225105|580387752|FG000|Overall Study|Study termination per Sponsor Decision|2|||
160728697|NCT03225105|580387753|FG001|Overall Study|Study termination per Sponsor Decision|0|||
160728698|NCT03225105|580387754|FG002|Overall Study|Study termination per Sponsor Decision|3|||
160728699|NCT03225105|580387755|FG003|Overall Study|Study termination per Sponsor Decision|3|||
160728700|NCT01736397|580389722|FG000|Overall Study|Lack of Efficacy|1|||
160728701|NCT01736397|580389723|FG001|Overall Study|Lack of Efficacy|11|||
160728702|NCT01736397|580389722|FG000|Overall Study|Withdrawal by Subject|6|||
160728703|NCT01736397|580389723|FG001|Overall Study|Withdrawal by Subject|5|||
160728704|NCT01736397|580389722|FG000|Overall Study|Lost to Follow-up|0|||
160728705|NCT01736397|580389723|FG001|Overall Study|Lost to Follow-up|1|||
160728706|NCT01736397|580389722|FG000|Overall Study|Adverse Event|6|||
160728707|NCT01736397|580389723|FG001|Overall Study|Adverse Event|3|||
160728708|NCT01736397|580389722|FG000|Overall Study|Not stated|1|||
160728709|NCT01736397|580389723|FG001|Overall Study|Not stated|4|||
160728710|NCT01868438|580389724|FG000|First Intervention|Withdrawal by Subject|5|||
160728711|NCT01868438|580389725|FG001|First Intervention|Withdrawal by Subject|1|||
160728712|NCT01868438|580389724|FG000|First Intervention|Lost to Follow-up|2|||
160728713|NCT01868438|580389725|FG001|First Intervention|Lost to Follow-up|3|||
160728714|NCT01868438|580389724|FG000|First Intervention|Meeting the non-redosing criteria|0|||
160728715|NCT01868438|580389725|FG001|First Intervention|Meeting the non-redosing criteria|1|||
160728716|NCT01868438|580389724|FG000|Second Intervention|Adverse Event|3|||
160728717|NCT01868438|580389725|FG001|Second Intervention|Adverse Event|3|||
160728718|NCT00076752|580389726|FG000|Overall Study|Death|2|||
160728719|NCT00076752|580389726|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
160728720|NCT02028767|580389727|FG000|Treatment Period 2|Non compliant with protocol|1|||
160728721|NCT02028767|580389728|FG001|Treatment Period 2|Non compliant with protocol|0|||
160728722|NCT02028767|580389727|FG000|Treatment Period 2|Reason other than those specified above|1|||
160728723|NCT02028767|580389728|FG001|Treatment Period 2|Reason other than those specified above|0|||
160728724|NCT01284348|580389729|FG000|Overall Study|Death|1|||
160728725|NCT01284348|580389730|FG001|Overall Study|Death|1|||
160728726|NCT01284348|580389729|FG000|Overall Study|Withdrew consent|0|||
160728727|NCT01284348|580389730|FG001|Overall Study|Withdrew consent|1|||
160728728|NCT01284348|580389729|FG000|Overall Study|Status not recorded|9|||
160728729|NCT01284348|580389730|FG001|Overall Study|Status not recorded|10|||
160728730|NCT04112043|580389734|FG000|Overall Study|Withdrawal by Subject|1|||
160728731|NCT04112043|580389735|FG001|Overall Study|Withdrawal by Subject|1|||
160728732|NCT04112043|580389736|FG002|Overall Study|Withdrawal by Subject|1|||
160728733|NCT04112043|580389734|FG000|Overall Study|Taking NR supplement|1|||
160728734|NCT04112043|580389735|FG001|Overall Study|Taking NR supplement|0|||
160728735|NCT04112043|580389736|FG002|Overall Study|Taking NR supplement|0|||
160728736|NCT04112043|580389734|FG000|Overall Study|Adverse Event|0|||
160728737|NCT04112043|580389735|FG001|Overall Study|Adverse Event|1|||
160728738|NCT04112043|580389736|FG002|Overall Study|Adverse Event|0|||
160728739|NCT01996254|580389739|FG000|Overall Study|Change in Eligibility|0|||
160728740|NCT01996254|580389740|FG001|Overall Study|Change in Eligibility|2|||
160728741|NCT01996254|580389741|FG002|Overall Study|Change in Eligibility|0|||
160728742|NCT01996254|580389739|FG000|Overall Study|Withdrawal by Subject|0|||
160728743|NCT01996254|580389740|FG001|Overall Study|Withdrawal by Subject|3|||
160728744|NCT01996254|580389741|FG002|Overall Study|Withdrawal by Subject|4|||
160728745|NCT01996254|580389739|FG000|Overall Study|Lost to Follow-up|1|||
160728746|NCT01996254|580389740|FG001|Overall Study|Lost to Follow-up|0|||
160728747|NCT01996254|580389741|FG002|Overall Study|Lost to Follow-up|4|||
160728748|NCT03423173|580389744|FG000|Overall Study|Randomized but not vaccinated|1|||
160728749|NCT03423173|580389745|FG001|Overall Study|Randomized but not vaccinated|0|||
160728750|NCT03423173|580389746|FG002|Overall Study|Randomized but not vaccinated|2|||
160728751|NCT03423173|580389747|FG003|Overall Study|Randomized but not vaccinated|1|||
160728752|NCT03423173|580389744|FG000|Overall Study|Adverse Event|1|||
160728753|NCT03423173|580389745|FG001|Overall Study|Adverse Event|1|||
160728754|NCT03423173|580389746|FG002|Overall Study|Adverse Event|1|||
160728755|NCT03423173|580389747|FG003|Overall Study|Adverse Event|1|||
160728756|NCT03423173|580389744|FG000|Overall Study|Lost to Follow-up|10|||
160728757|NCT03423173|580389745|FG001|Overall Study|Lost to Follow-up|19|||
160728758|NCT03423173|580389746|FG002|Overall Study|Lost to Follow-up|17|||
160728759|NCT03423173|580389747|FG003|Overall Study|Lost to Follow-up|22|||
160728760|NCT03423173|580389744|FG000|Overall Study|Withdrawal of consent|4|||
160728761|NCT03423173|580389745|FG001|Overall Study|Withdrawal of consent|10|||
160728762|NCT03423173|580389746|FG002|Overall Study|Withdrawal of consent|4|||
160728763|NCT03423173|580389747|FG003|Overall Study|Withdrawal of consent|5|||
160728764|NCT03423173|580389744|FG000|Overall Study|Death|1|||
160728765|NCT03423173|580389745|FG001|Overall Study|Death|0|||
160728766|NCT03423173|580389746|FG002|Overall Study|Death|0|||
160728767|NCT03423173|580389747|FG003|Overall Study|Death|0|||
160728768|NCT03423173|580389744|FG000|Overall Study|Reason not Specified|2|||
160728769|NCT03423173|580389745|FG001|Overall Study|Reason not Specified|5|||
160728770|NCT03423173|580389746|FG002|Overall Study|Reason not Specified|3|||
160728771|NCT03423173|580389747|FG003|Overall Study|Reason not Specified|1|||
160728772|NCT01053663|580389748|FG000|Overall Study|Death|2|||
160728773|NCT01053663|580389748|FG000|Overall Study|Lost to Follow-up|1|||
160728774|NCT01053663|580389748|FG000|Overall Study|Poor IV Access|1|||
160728775|NCT01053663|580389748|FG000|Overall Study|Transferred to Another Hospital|1|||
160728776|NCT01053663|580389748|FG000|Overall Study|Negative Influenza Diagnosis|1|||
160728777|NCT03533114|580389749|FG000|Overall|Adverse Event|16|||
160728778|NCT03533114|580389750|FG001|Overall|Adverse Event|11|||
160728779|NCT03533114|580389749|FG000|Overall|Consent Withdrawal by Participant|7|||
160728780|NCT03533114|580389750|FG001|Overall|Consent Withdrawal by Participant|6|||
160728781|NCT03533114|580389749|FG000|Overall|Lack of Efficacy|5|||
160728782|NCT03533114|580389750|FG001|Overall|Lack of Efficacy|3|||
160728783|NCT03533114|580389749|FG000|Overall|Lost to Follow-up|1|||
160728784|NCT03533114|580389750|FG001|Overall|Lost to Follow-up|1|||
160728785|NCT03533114|580389749|FG000|Overall|Physician Decision|0|||
160728786|NCT03533114|580389750|FG001|Overall|Physician Decision|2|||
160728787|NCT03533114|580389749|FG000|Overall|Protocol deviation|1|||
160728788|NCT03533114|580389750|FG001|Overall|Protocol deviation|1|||
160728789|NCT03533114|580389749|FG000|Overall|Failure to meet randomization criteria|1|||
160728790|NCT03533114|580389750|FG001|Overall|Failure to meet randomization criteria|2|||
160728791|NCT03533114|580389749|FG000|Overall|Non-Compliance with study drug|0|||
160728792|NCT03533114|580389750|FG001|Overall|Non-Compliance with study drug|1|||
160728793|NCT03533114|580389749|FG000|Overall|Other|0|||
160728794|NCT03533114|580389750|FG001|Overall|Other|1|||
160728795|NCT03533114|580389749|FG000|Open Label Titration and Optimization|Adverse Event|11|||
160728796|NCT03533114|580389750|FG001|Open Label Titration and Optimization|Adverse Event|8|||
160728797|NCT03533114|580389749|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
160728798|NCT03533114|580389750|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
160728799|NCT03533114|580389749|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
160728800|NCT03533114|580389750|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
160728801|NCT03533114|580389749|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
160728802|NCT03533114|580389750|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
160728803|NCT03533114|580389749|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
160728804|NCT03533114|580389750|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
160728805|NCT03533114|580389749|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
160728806|NCT03533114|580389750|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
160728807|NCT03533114|580389749|FG000|Stable Dose|Adverse Event|0|||
160728808|NCT03533114|580389750|FG001|Stable Dose|Adverse Event|2|||
160728809|NCT03533114|580389749|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
160728810|NCT03533114|580389750|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
160728811|NCT03533114|580389749|FG000|Stable Dose|Lack of Efficacy|1|||
160728812|NCT03533114|580389750|FG001|Stable Dose|Lack of Efficacy|0|||
160728813|NCT03533114|580389749|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
160728814|NCT03533114|580389750|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
160728815|NCT03533114|580389749|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
160728816|NCT03533114|580389750|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
160728817|NCT03533114|580389749|FG000|Open-Label Safety Extension|Adverse Event|3|||
160728818|NCT03533114|580389750|FG001|Open-Label Safety Extension|Adverse Event|0|||
160728819|NCT03533114|580389749|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
160728820|NCT03533114|580389750|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
160728821|NCT03533114|580389749|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
160728822|NCT03533114|580389750|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
160728823|NCT03533114|580389749|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
160728824|NCT03533114|580389750|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
160728825|NCT03533114|580389749|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
160728826|NCT03533114|580389750|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
160728827|NCT02071706|580389753|FG000|Overall Study|Adverse Event|1|||
160728828|NCT02071706|580389753|FG000|Overall Study|Withdrawal by Subject|2|||
160728829|NCT02247440|580389754|FG000|Overall Study|Withdrawal by Subject|1|||
160728830|NCT02247440|580389754|FG000|Overall Study|Lack of Efficacy|3|||
160728831|NCT00729157|580389755|FG000|Overall Study|Withdrawal by Subject|1|||
160728832|NCT03521115|580389756|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
160728833|NCT03521115|580389757|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
160728834|NCT03521115|580389756|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
160728835|NCT03521115|580389757|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
160728836|NCT02295020|580389767|FG000|Overall Study|Adverse Event|0|||
160728837|NCT02295020|580389768|FG001|Overall Study|Adverse Event|1|||
160728838|NCT02295020|580389767|FG000|Overall Study|Withdrawal by Subject|3|||
160728839|NCT02295020|580389768|FG001|Overall Study|Withdrawal by Subject|2|||
160728840|NCT00562302|580389769|FG000|Overall Study|Lost to Follow-up|3|||
160728841|NCT00562302|580389770|FG001|Overall Study|Lost to Follow-up|3|||
160728842|NCT00562302|580389769|FG000|Overall Study|Adverse Event|0|||
160728843|NCT00562302|580389770|FG001|Overall Study|Adverse Event|6|||
160728844|NCT00562302|580389769|FG000|Overall Study|Non-compliance|1|||
160728845|NCT00562302|580389770|FG001|Overall Study|Non-compliance|2|||
160728846|NCT00562302|580389769|FG000|Overall Study|Withdrawal by Subject|7|||
160728847|NCT00562302|580389770|FG001|Overall Study|Withdrawal by Subject|8|||
160728848|NCT00562302|580389769|FG000|Overall Study|Death|1|||
160728849|NCT00562302|580389770|FG001|Overall Study|Death|2|||
160728850|NCT00562302|580389769|FG000|Overall Study|Lung resection prior to study completion|7|||
160728851|NCT00562302|580389770|FG001|Overall Study|Lung resection prior to study completion|7|||
160728852|NCT00562302|580389769|FG000|Overall Study|Not stated|1|||
160728853|NCT00562302|580389770|FG001|Overall Study|Not stated|4|||
160728854|NCT01855243|580389771|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
160728855|NCT01855243|580389772|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
160728856|NCT01855243|580389773|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
160728857|NCT03615144|580389774|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
160728858|NCT03615144|580389775|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
160728859|NCT01860040|580389776|FG000|Overall Study|Withdrawal by Subject|1|||
160728860|NCT01860040|580389777|FG001|Overall Study|Withdrawal by Subject|0|||
160728861|NCT01931995|580389778|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
160728862|NCT01931995|580389779|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
160728863|NCT01931995|580389778|FG000|First Intervention (1 Day)|Physician Decision|1|||
160728864|NCT01931995|580389779|FG001|First Intervention (1 Day)|Physician Decision|1|||
160728865|NCT01931995|580389778|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
160728866|NCT01931995|580389779|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
160728867|NCT00791661|580389780|FG000|7 Day Wash-out|Adverse Event|0|||
160728868|NCT00791661|580389781|FG001|7 Day Wash-out|Adverse Event|0|||
160728869|NCT00791661|580389782|FG002|7 Day Wash-out|Adverse Event|1|||
160728870|NCT00791661|580389780|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
160728871|NCT00791661|580389781|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
160728872|NCT00791661|580389782|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
160728873|NCT00364923|580389785|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
160728874|NCT00364923|580389785|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
160728875|NCT00554515|580389792|FG000|Overall Study|Withdrawal by Subject|3|||
160728876|NCT00554515|580389792|FG000|Overall Study|Disease progression|52|||
160728877|NCT00554515|580389792|FG000|Overall Study|Physician Decision|18|||
160728878|NCT00554515|580389792|FG000|Overall Study|Withdrawal by Subject|11|||
160728879|NCT00554515|580389792|FG000|Overall Study|Adverse Event|9|||
160728880|NCT00554515|580389792|FG000|Overall Study|Death|2|||
160728881|NCT00554515|580389792|FG000|Overall Study|Achieved Stable Disease|7|||
160728882|NCT00554515|580389792|FG000|Overall Study|Other|1|||
160728883|NCT00554515|580389792|FG000|Overall Study|Misc|15|||
160728884|NCT02549287|580389797|FG000|Overall Study|Lost to Follow-up|65|||
160728885|NCT02549287|580389798|FG001|Overall Study|Lost to Follow-up|26|||
160728886|NCT02549287|580389797|FG000|Overall Study|Withdrawal by Subject|15|||
160728887|NCT02549287|580389798|FG001|Overall Study|Withdrawal by Subject|6|||
160728888|NCT03793842|580389799|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
160728889|NCT03793842|580389800|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
160728890|NCT03793842|580389799|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
160728891|NCT03793842|580389800|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
160728892|NCT04087720|580389801|FG000|Overall Study|Withdrawal by Subject|2|||
160728893|NCT04087720|580389801|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
160728894|NCT00427921|580389807|FG000|Overall Study|Adverse Event|26|||
160728895|NCT00427921|580389807|FG000|Overall Study|Withdrawal by Subject|4|||
160728896|NCT00427921|580389807|FG000|Overall Study|Lost to Follow-up|2|||
160728897|NCT00427921|580389807|FG000|Overall Study|Other reason not specified|10|||
160728898|NCT00427921|580389807|FG000|Overall Study|Adverse Event + Hospitalization|1|||
160728899|NCT00427921|580389807|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
160728900|NCT00427921|580389807|FG000|Overall Study|Adverse Event + No Response|1|||
160728901|NCT00427921|580389807|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
160728902|NCT00427921|580389807|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
160728903|NCT00427921|580389807|FG000|Overall Study|Adverse Event + Lost Response|1|||
160728904|NCT00427921|580389807|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
160728905|NCT00427921|580389807|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
160728906|NCT00520533|580389810|FG000|Overall Study|Death|1|||
160728907|NCT00520533|580389810|FG000|Overall Study|Suspension of the study for safety reasons|1|||
160728908|NCT00520533|580389810|FG000|Overall Study|Withdrawal by Subject|1|||
160728909|NCT00520533|580389810|FG000|Overall Study|Physician Decision|1|||
160728910|NCT04615403|580389816|FG000|Overall Study|Death|1|||
160728911|NCT00665431|580389817|FG000|Overall Study|Adverse Event|16|||
160728912|NCT00665431|580389818|FG001|Overall Study|Adverse Event|22|||
160728913|NCT00665431|580389819|FG002|Overall Study|Adverse Event|6|||
160728914|NCT00665431|580389817|FG000|Overall Study|Withdrawal by Subject|17|||
160728915|NCT00665431|580389818|FG001|Overall Study|Withdrawal by Subject|25|||
160728916|NCT00665431|580389819|FG002|Overall Study|Withdrawal by Subject|15|||
160728917|NCT00665431|580389817|FG000|Overall Study|Lost to Follow-up|3|||
160728918|NCT00665431|580389818|FG001|Overall Study|Lost to Follow-up|3|||
160728919|NCT00665431|580389819|FG002|Overall Study|Lost to Follow-up|1|||
160728920|NCT00665431|580389817|FG000|Overall Study|Other|4|||
160728921|NCT00665431|580389818|FG001|Overall Study|Other|7|||
160728922|NCT00665431|580389819|FG002|Overall Study|Other|2|||
160728923|NCT01972438|580389820|FG000|Baseline-Month 3 Crossover Period|Death|1|||
160728924|NCT01972438|580389821|FG001|Baseline-Month 3 Crossover Period|Death|0|||
160728925|NCT01972438|580389820|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
160728926|NCT01972438|580389821|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
160728927|NCT01972438|580389820|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
160728928|NCT01972438|580389821|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
160728929|NCT01972438|580389820|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
160728930|NCT01972438|580389821|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
160728931|NCT01972438|580389820|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
160728932|NCT01972438|580389821|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
160728933|NCT01972438|580389820|FG000|Months 6-12 Study Period|Death|1|||
160728934|NCT01972438|580389821|FG001|Months 6-12 Study Period|Death|0|||
160728935|NCT01972438|580389820|FG000|Months 6-12 Study Period|Early Study Closure|2|||
160728936|NCT01972438|580389821|FG001|Months 6-12 Study Period|Early Study Closure|2|||
160728937|NCT01972438|580389820|FG000|Post Month 12 Study Period|Early Study Closure|3|||
160728938|NCT01972438|580389821|FG001|Post Month 12 Study Period|Early Study Closure|4|||
160728939|NCT00697463|580389822|FG000|Overall Study|Withdrawal by Subject|1|||
160728940|NCT02568189|580389823|FG000|Overall Study|Protocol Violation|0|||
160728941|NCT02568189|580389824|FG001|Overall Study|Protocol Violation|0|||
160728942|NCT02568189|580389825|FG002|Overall Study|Protocol Violation|19|||
160728943|NCT02568189|580389826|FG003|Overall Study|Protocol Violation|18|||
160728944|NCT00529373|580389827|FG000|Base Study|Adverse Event|525|||
160728945|NCT00529373|580389828|FG001|Base Study|Adverse Event|470|||
160728946|NCT00529373|580389827|FG000|Base Study|Lack of Efficacy|16|||
160728947|NCT00529373|580389828|FG001|Base Study|Lack of Efficacy|75|||
160728948|NCT00529373|580389827|FG000|Base Study|Lost to Follow-up|221|||
160728949|NCT00529373|580389828|FG001|Base Study|Lost to Follow-up|208|||
160728950|NCT00529373|580389827|FG000|Base Study|Other Protocol Specified Criteria|19|||
160728951|NCT00529373|580389828|FG001|Base Study|Other Protocol Specified Criteria|20|||
160728952|NCT00529373|580389827|FG000|Base Study|Physician Decision|60|||
160728953|NCT00529373|580389828|FG001|Base Study|Physician Decision|52|||
160728954|NCT00529373|580389827|FG000|Base Study|Protocol Violation|48|||
160728955|NCT00529373|580389828|FG001|Base Study|Protocol Violation|38|||
160728956|NCT00529373|580389827|FG000|Base Study|Withdrawal by Subject|1062|||
160728957|NCT00529373|580389828|FG001|Base Study|Withdrawal by Subject|967|||
160728958|NCT00529373|580389827|FG000|Base Study|Did not continue into Extension|1795|||
160728959|NCT00529373|580389828|FG001|Base Study|Did not continue into Extension|2238|||
160728960|NCT00529373|580389827|FG000|First Extension Study|Adverse Event|162|||
160728961|NCT00529373|580389828|FG001|First Extension Study|Adverse Event|142|||
160728962|NCT00529373|580389827|FG000|First Extension Study|Lack of Efficacy|65|||
160728963|NCT00529373|580389828|FG001|First Extension Study|Lack of Efficacy|427|||
160728964|NCT00529373|580389827|FG000|First Extension Study|Lost to Follow-up|41|||
160728965|NCT00529373|580389828|FG001|First Extension Study|Lost to Follow-up|37|||
160728966|NCT00529373|580389827|FG000|First Extension Study|Other|27|||
160728967|NCT00529373|580389828|FG001|First Extension Study|Other|47|||
160728968|NCT00529373|580389827|FG000|First Extension Study|Physician Decision|50|||
160728969|NCT00529373|580389828|FG001|First Extension Study|Physician Decision|45|||
160728970|NCT00529373|580389827|FG000|First Extension Study|Protocol Violation|16|||
160728971|NCT00529373|580389828|FG001|First Extension Study|Protocol Violation|13|||
160728972|NCT00529373|580389827|FG000|First Extension Study|Withdrawal by Subject|296|||
160728973|NCT00529373|580389828|FG001|First Extension Study|Withdrawal by Subject|287|||
160728974|NCT00529373|580389827|FG000|First Extension Study|Disposition record non-existing|0|||
160728975|NCT00529373|580389828|FG001|First Extension Study|Disposition record non-existing|1|||
160728976|NCT00529373|580389827|FG000|First Extension Study|Discontinued after 5 years completion|208|||
160728977|NCT00529373|580389828|FG001|First Extension Study|Discontinued after 5 years completion|346|||
160728978|NCT00529373|580389827|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
160728979|NCT00529373|580389828|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
160728980|NCT00529373|580389827|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
160728981|NCT00529373|580389828|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
160728982|NCT00529373|580389827|FG000|Second Extension Study|Adverse Event|101|||
160728983|NCT00529373|580389828|FG001|Second Extension Study|Adverse Event|51|||
160728984|NCT00529373|580389827|FG000|Second Extension Study|Lack of Efficacy|7|||
160728985|NCT00529373|580389828|FG001|Second Extension Study|Lack of Efficacy|15|||
160728986|NCT00529373|580389827|FG000|Second Extension Study|Lost to Follow-up|18|||
160728987|NCT00529373|580389828|FG001|Second Extension Study|Lost to Follow-up|12|||
160728988|NCT00529373|580389827|FG000|Second Extension Study|Other|7|||
160728989|NCT00529373|580389828|FG001|Second Extension Study|Other|12|||
160728990|NCT00529373|580389827|FG000|Second Extension Study|Physician Decision|63|||
160728991|NCT00529373|580389828|FG001|Second Extension Study|Physician Decision|26|||
160728992|NCT00529373|580389827|FG000|Second Extension Study|Protocol Violation|2|||
160728993|NCT00529373|580389828|FG001|Second Extension Study|Protocol Violation|1|||
160728994|NCT00529373|580389827|FG000|Second Extension Study|Withdrawal by Subject|97|||
160728995|NCT00529373|580389828|FG001|Second Extension Study|Withdrawal by Subject|75|||
160728996|NCT00529373|580389827|FG000|Second Extension Study|Status Missing|5|||
160728997|NCT00529373|580389828|FG001|Second Extension Study|Status Missing|5|||
160728998|NCT01074268|580389829|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
160728999|NCT01074268|580389830|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
160729000|NCT01074268|580389829|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
160729001|NCT01074268|580389830|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
160729002|NCT01074268|580389829|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
160729003|NCT01074268|580389830|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
160729004|NCT01074268|580389829|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
160729005|NCT01074268|580389830|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
160729006|NCT01074268|580389829|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
160729007|NCT01074268|580389830|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
160729008|NCT01074268|580389829|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
160729009|NCT01074268|580389830|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
160729010|NCT01074268|580389829|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
160729011|NCT01074268|580389830|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
160729012|NCT01074268|580389829|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
160729013|NCT01074268|580389830|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
160729014|NCT01074268|580389829|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
160729015|NCT01074268|580389830|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
160729016|NCT02347813|580389835|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
160729017|NCT02347813|580389836|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
160729018|NCT02347813|580389835|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
160729019|NCT02347813|580389836|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
160729020|NCT01119859|580389837|FG000|Overall Study|Adverse Event|9|||
160729021|NCT01119859|580389838|FG001|Overall Study|Adverse Event|10|||
160729022|NCT01119859|580389837|FG000|Overall Study|Death|2|||
160729023|NCT01119859|580389838|FG001|Overall Study|Death|0|||
160729024|NCT01119859|580389837|FG000|Overall Study|Insufficient therapeutic response|7|||
160729025|NCT01119859|580389838|FG001|Overall Study|Insufficient therapeutic response|14|||
160729026|NCT01119859|580389837|FG000|Overall Study|Refused treatment|3|||
160729027|NCT01119859|580389838|FG001|Overall Study|Refused treatment|6|||
160729028|NCT01119859|580389837|FG000|Overall Study|Failure to return|3|||
160729029|NCT01119859|580389838|FG001|Overall Study|Failure to return|0|||
160729030|NCT00603473|580389839|FG000|Overall Study|Adverse Event|4|||
160729031|NCT00603473|580389839|FG000|Overall Study|Lack of Efficacy|4|||
160729032|NCT00603473|580389839|FG000|Overall Study|Protocol Violation|1|||
160729033|NCT01134939|580389843|FG000|Overall Study|Adverse Event|9|||
160729034|NCT01134939|580389844|FG001|Overall Study|Adverse Event|3|||
160729035|NCT01134939|580389845|FG002|Overall Study|Adverse Event|4|||
160729036|NCT01134939|580389846|FG003|Overall Study|Adverse Event|5|||
160729037|NCT01134939|580389847|FG004|Overall Study|Adverse Event|5|||
160729038|NCT01134939|580389848|FG005|Overall Study|Adverse Event|5|||
160729039|NCT01134939|580389849|FG006|Overall Study|Adverse Event|1|||
160729040|NCT01134939|580389850|FG007|Overall Study|Adverse Event|0|||
160729041|NCT01134939|580389843|FG000|Overall Study|Lack of Efficacy|2|||
160729042|NCT01134939|580389844|FG001|Overall Study|Lack of Efficacy|5|||
160729043|NCT01134939|580389845|FG002|Overall Study|Lack of Efficacy|1|||
160729044|NCT01134939|580389846|FG003|Overall Study|Lack of Efficacy|0|||
160729045|NCT01134939|580389847|FG004|Overall Study|Lack of Efficacy|3|||
160729046|NCT01134939|580389848|FG005|Overall Study|Lack of Efficacy|0|||
160729047|NCT01134939|580389849|FG006|Overall Study|Lack of Efficacy|1|||
160729048|NCT01134939|580389850|FG007|Overall Study|Lack of Efficacy|0|||
160729049|NCT01134939|580389843|FG000|Overall Study|Lost to Follow-up|2|||
160729050|NCT01134939|580389844|FG001|Overall Study|Lost to Follow-up|3|||
160729051|NCT01134939|580389845|FG002|Overall Study|Lost to Follow-up|0|||
160729052|NCT01134939|580389846|FG003|Overall Study|Lost to Follow-up|1|||
160729053|NCT01134939|580389847|FG004|Overall Study|Lost to Follow-up|2|||
160729054|NCT01134939|580389848|FG005|Overall Study|Lost to Follow-up|1|||
160729055|NCT01134939|580389849|FG006|Overall Study|Lost to Follow-up|0|||
160729056|NCT01134939|580389850|FG007|Overall Study|Lost to Follow-up|0|||
160729057|NCT01134939|580389843|FG000|Overall Study|Death|0|||
160729058|NCT01134939|580389844|FG001|Overall Study|Death|1|||
160729059|NCT01134939|580389845|FG002|Overall Study|Death|0|||
160729060|NCT01134939|580389846|FG003|Overall Study|Death|0|||
160729061|NCT01134939|580389847|FG004|Overall Study|Death|0|||
160729062|NCT01134939|580389848|FG005|Overall Study|Death|0|||
160729063|NCT01134939|580389849|FG006|Overall Study|Death|0|||
160729064|NCT01134939|580389850|FG007|Overall Study|Death|0|||
160729065|NCT01134939|580389843|FG000|Overall Study|Termination page not available|4|||
160729066|NCT01134939|580389844|FG001|Overall Study|Termination page not available|6|||
160729067|NCT01134939|580389845|FG002|Overall Study|Termination page not available|5|||
160729068|NCT01134939|580389846|FG003|Overall Study|Termination page not available|8|||
160729069|NCT01134939|580389847|FG004|Overall Study|Termination page not available|0|||
160729070|NCT01134939|580389848|FG005|Overall Study|Termination page not available|3|||
160729071|NCT01134939|580389849|FG006|Overall Study|Termination page not available|7|||
160729072|NCT01134939|580389850|FG007|Overall Study|Termination page not available|0|||
160729073|NCT00733421|580389851|FG000|Overall Study|Withdrawal by Subject|1|||
160729074|NCT00733421|580389852|FG001|Overall Study|Withdrawal by Subject|1|||
160729075|NCT02547220|580389853|FG000|Overall Study|Withdrawal by Subject|1|||
160729076|NCT02547220|580389854|FG001|Overall Study|Withdrawal by Subject|0|||
160729077|NCT02547220|580389853|FG000|Overall Study|Study terminated by sponsor|18|||
160729078|NCT02547220|580389854|FG001|Overall Study|Study terminated by sponsor|20|||
160729079|NCT01029782|580389858|FG000|Overall Study|Lost to Follow-up|2|||
160729080|NCT01029782|580389859|FG001|Overall Study|Lost to Follow-up|2|||
160729081|NCT01029782|580389858|FG000|Overall Study|Diagnosis changed|1|||
160729082|NCT01029782|580389859|FG001|Overall Study|Diagnosis changed|1|||
160729083|NCT01029782|580389858|FG000|Overall Study|Adverse Event|0|||
160729084|NCT01029782|580389859|FG001|Overall Study|Adverse Event|1|||
160729085|NCT01029782|580389858|FG000|Overall Study|Physician Decision|0|||
160729086|NCT01029782|580389859|FG001|Overall Study|Physician Decision|1|||
160729087|NCT01029782|580389858|FG000|Overall Study|Protocol Violation|0|||
160729088|NCT01029782|580389859|FG001|Overall Study|Protocol Violation|2|||
160729089|NCT01029782|580389858|FG000|Overall Study|Withdrawal by Subject|0|||
160729090|NCT01029782|580389859|FG001|Overall Study|Withdrawal by Subject|1|||
160729091|NCT00757042|580389864|FG000|Overall Study|Lost to Follow-up|0|||
160729092|NCT00757042|580389865|FG001|Overall Study|Lost to Follow-up|0|||
160729093|NCT00757042|580389866|FG002|Overall Study|Lost to Follow-up|0|||
160729094|NCT00757042|580389867|FG003|Overall Study|Lost to Follow-up|0|||
160729095|NCT00757042|580389868|FG004|Overall Study|Lost to Follow-up|0|||
160729096|NCT00757042|580389869|FG005|Overall Study|Lost to Follow-up|0|||
160729097|NCT00757042|580389870|FG006|Overall Study|Lost to Follow-up|0|||
160729098|NCT00757042|580389871|FG007|Overall Study|Lost to Follow-up|0|||
160729099|NCT00757042|580389872|FG008|Overall Study|Lost to Follow-up|1|||
160729100|NCT00757042|580389873|FG009|Overall Study|Lost to Follow-up|0|||
160729101|NCT00757042|580389874|FG010|Overall Study|Lost to Follow-up|0|||
160729102|NCT00757042|580389864|FG000|Overall Study|Ineligibility Determined|0|||
160729103|NCT00757042|580389865|FG001|Overall Study|Ineligibility Determined|0|||
160729104|NCT00757042|580389866|FG002|Overall Study|Ineligibility Determined|0|||
160729105|NCT00757042|580389867|FG003|Overall Study|Ineligibility Determined|0|||
160729106|NCT00757042|580389868|FG004|Overall Study|Ineligibility Determined|0|||
160729107|NCT00757042|580389869|FG005|Overall Study|Ineligibility Determined|0|||
160729108|NCT00757042|580389870|FG006|Overall Study|Ineligibility Determined|0|||
160729109|NCT00757042|580389871|FG007|Overall Study|Ineligibility Determined|0|||
160729110|NCT00757042|580389872|FG008|Overall Study|Ineligibility Determined|0|||
160729111|NCT00757042|580389873|FG009|Overall Study|Ineligibility Determined|0|||
160729112|NCT00757042|580389874|FG010|Overall Study|Ineligibility Determined|1|||
160729113|NCT00757042|580389864|FG000|Overall Study|Withdrawal by Subject|0|||
160729114|NCT00757042|580389865|FG001|Overall Study|Withdrawal by Subject|0|||
160729115|NCT00757042|580389866|FG002|Overall Study|Withdrawal by Subject|0|||
160729116|NCT00757042|580389867|FG003|Overall Study|Withdrawal by Subject|0|||
160729117|NCT00757042|580389868|FG004|Overall Study|Withdrawal by Subject|0|||
160729118|NCT00757042|580389869|FG005|Overall Study|Withdrawal by Subject|0|||
160729119|NCT00757042|580389870|FG006|Overall Study|Withdrawal by Subject|0|||
160729120|NCT00757042|580389871|FG007|Overall Study|Withdrawal by Subject|0|||
160729121|NCT00757042|580389872|FG008|Overall Study|Withdrawal by Subject|0|||
160729122|NCT00757042|580389873|FG009|Overall Study|Withdrawal by Subject|1|||
160729123|NCT00757042|580389874|FG010|Overall Study|Withdrawal by Subject|0|||
160729124|NCT02729051|580389875|FG000|Overall Study|Adverse Event|21|||
160729125|NCT02729051|580389876|FG001|Overall Study|Adverse Event|11|||
160729126|NCT02729051|580389875|FG000|Overall Study|Lack of Efficacy|1|||
160729127|NCT02729051|580389876|FG001|Overall Study|Lack of Efficacy|1|||
160729128|NCT02729051|580389875|FG000|Overall Study|Lost to Follow-up|1|||
160729129|NCT02729051|580389876|FG001|Overall Study|Lost to Follow-up|2|||
160729130|NCT02729051|580389875|FG000|Overall Study|Physician Decision|1|||
160729131|NCT02729051|580389876|FG001|Overall Study|Physician Decision|1|||
160729132|NCT02729051|580389875|FG000|Overall Study|Withdrawal by Subject|6|||
160729133|NCT02729051|580389876|FG001|Overall Study|Withdrawal by Subject|17|||
160729134|NCT03652636|580391378|FG000|Overall Study|Withdrawal by Subject|7|||
160729135|NCT03806933|580391382|FG000|Main Period|Physician Decision|0|||
160729136|NCT03806933|580391383|FG001|Main Period|Physician Decision|0|||
160729137|NCT03806933|580391384|FG002|Main Period|Physician Decision|0|||
160729138|NCT03806933|580391385|FG003|Main Period|Physician Decision|1|||
160729139|NCT03806933|580391382|FG000|Main Period|Pregnancy|0|||
160729140|NCT03806933|580391383|FG001|Main Period|Pregnancy|0|||
160729141|NCT03806933|580391384|FG002|Main Period|Pregnancy|1|||
160729142|NCT03806933|580391385|FG003|Main Period|Pregnancy|0|||
160729143|NCT03806933|580391382|FG000|Main Period|Withdrawal by Subject|2|||
160729144|NCT03806933|580391383|FG001|Main Period|Withdrawal by Subject|1|||
160729145|NCT03806933|580391384|FG002|Main Period|Withdrawal by Subject|1|||
160729146|NCT03806933|580391385|FG003|Main Period|Withdrawal by Subject|2|||
160729147|NCT03806933|580391382|FG000|Main Period|Lost to Follow-up|2|||
160729148|NCT03806933|580391383|FG001|Main Period|Lost to Follow-up|2|||
160729149|NCT03806933|580391384|FG002|Main Period|Lost to Follow-up|0|||
160729150|NCT03806933|580391385|FG003|Main Period|Lost to Follow-up|0|||
160729151|NCT03806933|580391382|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
160729152|NCT03806933|580391383|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
160729153|NCT03806933|580391384|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
160729154|NCT03806933|580391385|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
160729155|NCT05088603|580391386|FG000|Overall Study|Protocol Violation|6|||
160729156|NCT05088603|580391387|FG001|Overall Study|Protocol Violation|1|||
160729157|NCT03555565|580391390|FG000|Overall Study|Case Report Forms Uncollected|2|||
160729158|NCT03555565|580391390|FG000|Overall Study|Protocol Deviation|13|||
160729159|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
160729160|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
160729161|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
160729162|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
160729163|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
160729164|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
160729165|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
160729166|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
160729167|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Death|0|||
160729168|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Death|1|||
160729169|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
160729170|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
160729171|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
160729172|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
160729173|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
160729174|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
160729175|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
160729176|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
160729177|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
160729178|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
160729179|NCT00394836|580391395|FG000|Teatment or Follow-up Phase|Non compliance|0|||
160729180|NCT00394836|580391396|FG001|Teatment or Follow-up Phase|Non compliance|1|||
160729181|NCT00394836|580391395|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
160729182|NCT00394836|580391396|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
160729183|NCT00394836|580391395|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
160729184|NCT00394836|580391396|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
160729185|NCT00394836|580391395|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
160729186|NCT00394836|580391396|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
160729187|NCT00394836|580391395|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
160729188|NCT00394836|580391396|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
160729189|NCT03692325|580391397|FG000|Overall Study|Adverse Event|2|||
160729190|NCT03692325|580391397|FG000|Overall Study|Progression/Recurrence|2|||
160729191|NCT02817516|580391398|FG000|Overall Study|Other|0|||
160729192|NCT02817516|580391399|FG001|Overall Study|Other|0|||
160729193|NCT02817516|580391400|FG002|Overall Study|Other|1|||
160729194|NCT02817516|580391401|FG003|Overall Study|Other|0|||
160729195|NCT01560234|580391403|FG000|Overall Study|Lost to Follow-up|3|||
160729196|NCT01560234|580391404|FG001|Overall Study|Lost to Follow-up|0|||
160729197|NCT01560234|580391405|FG002|Overall Study|Lost to Follow-up|1|||
160729198|NCT01560234|580391406|FG003|Overall Study|Lost to Follow-up|0|||
160729199|NCT01560234|580391407|FG004|Overall Study|Lost to Follow-up|0|||
160729200|NCT01560234|580391408|FG005|Overall Study|Lost to Follow-up|2|||
160729201|NCT01560234|580391409|FG006|Overall Study|Lost to Follow-up|0|||
160729202|NCT01560234|580391410|FG007|Overall Study|Lost to Follow-up|2|||
160729203|NCT00083759|580391414|FG000|Overall Study|Adverse Event|5|||
160729204|NCT00083759|580391415|FG001|Overall Study|Adverse Event|3|||
160729205|NCT00083759|580391414|FG000|Overall Study|Lost to Follow-up|1|||
160729206|NCT00083759|580391415|FG001|Overall Study|Lost to Follow-up|0|||
160729207|NCT00083759|580391414|FG000|Overall Study|Death|1|||
160729208|NCT00083759|580391415|FG001|Overall Study|Death|1|||
160729209|NCT00083759|580391414|FG000|Overall Study|Inadequate Therapeutic Response|32|||
160729210|NCT00083759|580391415|FG001|Overall Study|Inadequate Therapeutic Response|35|||
160729211|NCT00083759|580391414|FG000|Overall Study|Subject Withdrew Consent|2|||
160729212|NCT00083759|580391415|FG001|Overall Study|Subject Withdrew Consent|2|||
160729213|NCT00083759|580391414|FG000|Overall Study|Non-Compliance|1|||
160729214|NCT00083759|580391415|FG001|Overall Study|Non-Compliance|0|||
160729215|NCT00083759|580391414|FG000|Overall Study|Sponsor's Discretion|28|||
160729216|NCT00083759|580391415|FG001|Overall Study|Sponsor's Discretion|29|||
160729217|NCT00083759|580391414|FG000|Overall Study|Other|14|||
160729218|NCT00083759|580391415|FG001|Overall Study|Other|13|||
160729219|NCT04075682|580391418|FG000|Overall Study|Lost to Follow-up|5|||
160729220|NCT04075682|580391419|FG001|Overall Study|Lost to Follow-up|5|||
160729221|NCT04075682|580391420|FG002|Overall Study|Lost to Follow-up|2|||
160729222|NCT04075682|580391421|FG003|Overall Study|Lost to Follow-up|2|||
160729223|NCT04075682|580391418|FG000|Overall Study|Withdrawal by Subject|1|||
160729224|NCT04075682|580391419|FG001|Overall Study|Withdrawal by Subject|0|||
160729225|NCT04075682|580391420|FG002|Overall Study|Withdrawal by Subject|1|||
160729226|NCT04075682|580391421|FG003|Overall Study|Withdrawal by Subject|0|||
160729227|NCT04075682|580391418|FG000|Overall Study|Protocol Violation|0|||
160729228|NCT04075682|580391419|FG001|Overall Study|Protocol Violation|1|||
160729229|NCT04075682|580391420|FG002|Overall Study|Protocol Violation|1|||
160729230|NCT04075682|580391421|FG003|Overall Study|Protocol Violation|0|||
160729231|NCT04075682|580391418|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
160729232|NCT04075682|580391419|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
160729233|NCT04075682|580391420|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
160729234|NCT04075682|580391421|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
160729235|NCT04075682|580391418|FG000|Overall Study|Lost study phone the first day of study participation|0|||
160729236|NCT04075682|580391419|FG001|Overall Study|Lost study phone the first day of study participation|1|||
160729237|NCT04075682|580391420|FG002|Overall Study|Lost study phone the first day of study participation|0|||
160729238|NCT04075682|580391421|FG003|Overall Study|Lost study phone the first day of study participation|0|||
160729239|NCT04292912|580391422|FG000|Overall Study|Physician Decision|1|||
160729240|NCT04292912|580391422|FG000|Overall Study|Protocol Violation|6|||
160729241|NCT03348930|580391423|FG000|Washout (1 Week)|Lost to Follow-up|1|||
160729242|NCT03348930|580391424|FG001|Washout (1 Week)|Lost to Follow-up|1|||
160729243|NCT05338502|580391425|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
160729244|NCT05338502|580391426|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
160729245|NCT05338502|580391427|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
160729246|NCT05338502|580391425|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
160729247|NCT05338502|580391426|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
160729248|NCT05338502|580391427|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
160729249|NCT01062113|580391435|FG000|Overall Study|Adverse Event|1|||
160729250|NCT01062113|580391436|FG001|Overall Study|Adverse Event|0|||
160729251|NCT01062113|580391437|FG002|Overall Study|Adverse Event|0|||
160729252|NCT01062113|580391435|FG000|Overall Study|Lack of Efficacy|38|||
160729253|NCT01062113|580391436|FG001|Overall Study|Lack of Efficacy|22|||
160729254|NCT01062113|580391437|FG002|Overall Study|Lack of Efficacy|31|||
160729255|NCT01062113|580391435|FG000|Overall Study|Withdrawal by Subject|1|||
160729256|NCT01062113|580391436|FG001|Overall Study|Withdrawal by Subject|0|||
160729257|NCT01062113|580391437|FG002|Overall Study|Withdrawal by Subject|0|||
160729258|NCT03655470|580391438|FG000|Overall Study|Lost to Follow-up|6|||
160729259|NCT03655470|580391439|FG001|Overall Study|Lost to Follow-up|7|||
160729260|NCT03063086|580391440|FG000|Overall Study|technical problems|1|||
160729261|NCT03063086|580391441|FG001|Overall Study|technical problems|0|||
160729262|NCT03063086|580391442|FG002|Overall Study|technical problems|0|||
160729263|NCT03063086|580391443|FG003|Overall Study|technical problems|0|||
160729264|NCT03063086|580391444|FG004|Overall Study|technical problems|0|||
160729265|NCT03063086|580391445|FG005|Overall Study|technical problems|0|||
160729266|NCT03063086|580391440|FG000|Overall Study|Adverse Event|1|||
160729267|NCT03063086|580391441|FG001|Overall Study|Adverse Event|1|||
160729268|NCT03063086|580391442|FG002|Overall Study|Adverse Event|1|||
160729269|NCT03063086|580391443|FG003|Overall Study|Adverse Event|1|||
160729270|NCT03063086|580391444|FG004|Overall Study|Adverse Event|0|||
160729271|NCT03063086|580391445|FG005|Overall Study|Adverse Event|0|||
160729272|NCT03063086|580391440|FG000|Overall Study|subject/guardian decision|1|||
160729273|NCT03063086|580391441|FG001|Overall Study|subject/guardian decision|0|||
160729274|NCT03063086|580391442|FG002|Overall Study|subject/guardian decision|0|||
160729275|NCT03063086|580391443|FG003|Overall Study|subject/guardian decision|0|||
160729276|NCT03063086|580391444|FG004|Overall Study|subject/guardian decision|0|||
160729277|NCT03063086|580391445|FG005|Overall Study|subject/guardian decision|0|||
160729278|NCT03063086|580391440|FG000|Overall Study|Non-compliance with study treatment|0|||
160729279|NCT03063086|580391441|FG001|Overall Study|Non-compliance with study treatment|0|||
160729280|NCT03063086|580391442|FG002|Overall Study|Non-compliance with study treatment|0|||
160729281|NCT03063086|580391443|FG003|Overall Study|Non-compliance with study treatment|1|||
160729282|NCT03063086|580391444|FG004|Overall Study|Non-compliance with study treatment|0|||
160729283|NCT03063086|580391445|FG005|Overall Study|Non-compliance with study treatment|1|||
160729284|NCT03063086|580391440|FG000|Overall Study|Physician Decision|0|||
160729285|NCT03063086|580391441|FG001|Overall Study|Physician Decision|0|||
160729286|NCT03063086|580391442|FG002|Overall Study|Physician Decision|0|||
160729287|NCT03063086|580391443|FG003|Overall Study|Physician Decision|1|||
160729288|NCT03063086|580391444|FG004|Overall Study|Physician Decision|0|||
160729289|NCT03063086|580391445|FG005|Overall Study|Physician Decision|0|||
160729290|NCT02244463|580391448|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
160729291|NCT02244463|580391449|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
160729292|NCT02244463|580391450|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
160729293|NCT02244463|580391451|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
160729294|NCT02244463|580391452|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
160729295|NCT02244463|580391453|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
160729296|NCT02244463|580391448|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
160729297|NCT02244463|580391449|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
160729298|NCT02244463|580391450|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
160729299|NCT02244463|580391451|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
160729300|NCT02244463|580391452|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
160729301|NCT02244463|580391453|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
160729302|NCT02244463|580391448|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
160729303|NCT02244463|580391449|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
160729304|NCT02244463|580391450|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
160729305|NCT02244463|580391451|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
160729306|NCT02244463|580391452|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
160729307|NCT02244463|580391453|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
160729308|NCT02244463|580391448|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
160729309|NCT02244463|580391449|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
160729310|NCT02244463|580391450|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
160729311|NCT02244463|580391451|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
160729312|NCT02244463|580391452|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
160729313|NCT02244463|580391453|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
160729314|NCT02244463|580391448|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
160729315|NCT02244463|580391449|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
160729316|NCT02244463|580391450|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
160729317|NCT02244463|580391451|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
160729318|NCT02244463|580391452|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
160729319|NCT02244463|580391453|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
160729320|NCT02244463|580391448|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
160729321|NCT02244463|580391449|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
160729322|NCT02244463|580391450|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
160729323|NCT02244463|580391451|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
160729324|NCT02244463|580391452|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
160729325|NCT02244463|580391453|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
160729326|NCT02244463|580391448|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
160729327|NCT02244463|580391449|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
160729328|NCT02244463|580391450|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
160729329|NCT02244463|580391451|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
160729330|NCT02244463|580391452|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
160729331|NCT02244463|580391453|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
160729332|NCT02244463|580391448|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
160729333|NCT02244463|580391449|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
160729334|NCT02244463|580391450|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
160729335|NCT02244463|580391451|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
160729336|NCT02244463|580391452|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
160729337|NCT02244463|580391453|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
160729338|NCT02244463|580391448|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
160729339|NCT02244463|580391449|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
160729340|NCT02244463|580391450|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
160729341|NCT02244463|580391451|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
160729342|NCT02244463|580391452|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
160729343|NCT02244463|580391453|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
160729344|NCT02244463|580391448|FG000|Period 5: Phase II|Disease Progression|0|||
160729345|NCT02244463|580391449|FG001|Period 5: Phase II|Disease Progression|0|||
160729346|NCT02244463|580391450|FG002|Period 5: Phase II|Disease Progression|0|||
160729347|NCT02244463|580391451|FG003|Period 5: Phase II|Disease Progression|0|||
160729348|NCT02244463|580391452|FG004|Period 5: Phase II|Disease Progression|10|||
160729349|NCT02244463|580391453|FG005|Period 5: Phase II|Disease Progression|11|||
160729350|NCT02244463|580391448|FG000|Period 5: Phase II|Physician Decision|0|||
160729351|NCT02244463|580391449|FG001|Period 5: Phase II|Physician Decision|0|||
160729352|NCT02244463|580391450|FG002|Period 5: Phase II|Physician Decision|0|||
160729353|NCT02244463|580391451|FG003|Period 5: Phase II|Physician Decision|0|||
160729354|NCT02244463|580391452|FG004|Period 5: Phase II|Physician Decision|3|||
160729355|NCT02244463|580391453|FG005|Period 5: Phase II|Physician Decision|2|||
160729356|NCT02244463|580391448|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
160729357|NCT02244463|580391449|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
160729358|NCT02244463|580391450|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
160729359|NCT02244463|580391451|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
160729360|NCT02244463|580391452|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
160729361|NCT02244463|580391453|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
160729362|NCT02244463|580391448|FG000|Period 5: Phase II|Intercurrent Illness|0|||
160729363|NCT02244463|580391449|FG001|Period 5: Phase II|Intercurrent Illness|0|||
160729364|NCT02244463|580391450|FG002|Period 5: Phase II|Intercurrent Illness|0|||
160729365|NCT02244463|580391451|FG003|Period 5: Phase II|Intercurrent Illness|0|||
160729366|NCT02244463|580391452|FG004|Period 5: Phase II|Intercurrent Illness|2|||
160729367|NCT02244463|580391453|FG005|Period 5: Phase II|Intercurrent Illness|0|||
160729368|NCT02244463|580391448|FG000|Period 5: Phase II|Adverse Event|0|||
160729369|NCT02244463|580391449|FG001|Period 5: Phase II|Adverse Event|0|||
160729370|NCT02244463|580391450|FG002|Period 5: Phase II|Adverse Event|0|||
160729371|NCT02244463|580391451|FG003|Period 5: Phase II|Adverse Event|0|||
160729372|NCT02244463|580391452|FG004|Period 5: Phase II|Adverse Event|0|||
160729373|NCT02244463|580391453|FG005|Period 5: Phase II|Adverse Event|2|||
160729374|NCT02244463|580391448|FG000|Period 5: Phase II|Still On treatment|0|||
160729375|NCT02244463|580391449|FG001|Period 5: Phase II|Still On treatment|0|||
160729376|NCT02244463|580391450|FG002|Period 5: Phase II|Still On treatment|0|||
160729377|NCT02244463|580391451|FG003|Period 5: Phase II|Still On treatment|0|||
160729378|NCT02244463|580391452|FG004|Period 5: Phase II|Still On treatment|0|||
160729379|NCT02244463|580391453|FG005|Period 5: Phase II|Still On treatment|3|||
160729380|NCT05481125|580391454|FG000|Overall Study|Adverse Event|1|||
160729381|NCT05481125|580391455|FG001|Overall Study|Adverse Event|0|||
160729382|NCT05481125|580391454|FG000|Overall Study|Lost to Follow-up|0|||
160729383|NCT05481125|580391455|FG001|Overall Study|Lost to Follow-up|1|||
160729384|NCT05481125|580391454|FG000|Overall Study|Withdrawal by Subject|0|||
160729385|NCT05481125|580391455|FG001|Overall Study|Withdrawal by Subject|1|||
160729386|NCT03702010|580391460|FG000|Follow-up (30days)|Lack of Efficacy|2|||
160729387|NCT03702010|580391461|FG001|Follow-up (30days)|Lack of Efficacy|2|||
160729388|NCT01598090|580391462|FG000|Treatment Period|Poor/non-compliance|0|||
160729389|NCT01598090|580391463|FG001|Treatment Period|Poor/non-compliance|2|||
160729390|NCT01598090|580391464|FG002|Treatment Period|Poor/non-compliance|0|||
160729391|NCT01598090|580391462|FG000|Treatment Period|No longer meet study criteria|0|||
160729392|NCT01598090|580391463|FG001|Treatment Period|No longer meet study criteria|1|||
160729393|NCT01598090|580391464|FG002|Treatment Period|No longer meet study criteria|0|||
160729394|NCT01598090|580391462|FG000|Treatment Period|Lack of Efficacy|5|||
160729395|NCT01598090|580391463|FG001|Treatment Period|Lack of Efficacy|14|||
160729396|NCT01598090|580391464|FG002|Treatment Period|Lack of Efficacy|6|||
160729397|NCT01598090|580391462|FG000|Treatment Period|Adverse Event|2|||
160729398|NCT01598090|580391463|FG001|Treatment Period|Adverse Event|33|||
160729399|NCT01598090|580391464|FG002|Treatment Period|Adverse Event|17|||
160729400|NCT01598090|580391462|FG000|Treatment Period|Other reasons|0|||
160729401|NCT01598090|580391463|FG001|Treatment Period|Other reasons|4|||
160729402|NCT01598090|580391464|FG002|Treatment Period|Other reasons|1|||
160729403|NCT01598090|580391462|FG000|Treatment Period|Withdrawal by Subject|3|||
160729404|NCT01598090|580391463|FG001|Treatment Period|Withdrawal by Subject|13|||
160729405|NCT01598090|580391464|FG002|Treatment Period|Withdrawal by Subject|10|||
160729406|NCT01598090|580391462|FG000|Treatment Period|Lost to Follow-up|1|||
160729407|NCT01598090|580391463|FG001|Treatment Period|Lost to Follow-up|5|||
160729408|NCT01598090|580391464|FG002|Treatment Period|Lost to Follow-up|1|||
160729409|NCT01598090|580391462|FG000|Follow-up Period|Death|0|||
160729410|NCT01598090|580391463|FG001|Follow-up Period|Death|1|||
160729411|NCT01598090|580391464|FG002|Follow-up Period|Death|0|||
160729412|NCT01598090|580391462|FG000|Follow-up Period|No longer required per protocol|1|||
160729413|NCT01598090|580391463|FG001|Follow-up Period|No longer required per protocol|3|||
160729414|NCT01598090|580391464|FG002|Follow-up Period|No longer required per protocol|2|||
160729415|NCT01598090|580391462|FG000|Follow-up Period|Not reported|0|||
160729416|NCT01598090|580391463|FG001|Follow-up Period|Not reported|10|||
160729417|NCT01598090|580391464|FG002|Follow-up Period|Not reported|4|||
160729418|NCT01598090|580391462|FG000|Follow-up Period|Withdrawal by Subject|0|||
160729419|NCT01598090|580391463|FG001|Follow-up Period|Withdrawal by Subject|3|||
160729420|NCT01598090|580391464|FG002|Follow-up Period|Withdrawal by Subject|2|||
160729421|NCT01598090|580391462|FG000|Follow-up Period|Other reasons|2|||
160729422|NCT01598090|580391463|FG001|Follow-up Period|Other reasons|8|||
160729423|NCT01598090|580391464|FG002|Follow-up Period|Other reasons|8|||
160729424|NCT01598090|580391462|FG000|Follow-up Period|Lost to Follow-up|2|||
160729425|NCT01598090|580391463|FG001|Follow-up Period|Lost to Follow-up|10|||
160729426|NCT01598090|580391464|FG002|Follow-up Period|Lost to Follow-up|12|||
160729427|NCT04791319|580391467|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
160729428|NCT04791319|580391468|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
160729429|NCT04791319|580391469|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
160729430|NCT04791319|580391470|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
160729431|NCT04791319|580391471|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
160729432|NCT04791319|580391472|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
160729433|NCT04791319|580391473|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
160729434|NCT04791319|580391474|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
160729435|NCT04791319|580391475|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
160729436|NCT04791319|580391476|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
160729437|NCT04791319|580391477|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
160729438|NCT04791319|580391467|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
160729439|NCT04791319|580391468|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
160729440|NCT04791319|580391469|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
160729441|NCT04791319|580391470|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
160729442|NCT04791319|580391471|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
160729443|NCT04791319|580391472|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
160729444|NCT04791319|580391473|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
160729445|NCT04791319|580391474|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
160729446|NCT04791319|580391475|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
160729447|NCT04791319|580391476|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
160729448|NCT04791319|580391477|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
160729449|NCT04791319|580391467|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
160729450|NCT04791319|580391468|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
160729451|NCT04791319|580391469|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
160729452|NCT04791319|580391470|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
160729453|NCT04791319|580391471|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
160729454|NCT04791319|580391472|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
160729455|NCT04791319|580391473|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
160729456|NCT04791319|580391474|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
160729457|NCT04791319|580391475|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
160729458|NCT04791319|580391476|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
160729459|NCT04791319|580391477|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
160729460|NCT04791319|580391467|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
160729461|NCT04791319|580391468|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
160729462|NCT04791319|580391469|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
160729463|NCT04791319|580391470|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
160729464|NCT04791319|580391471|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
160729465|NCT04791319|580391472|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
160729466|NCT04791319|580391473|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
160729467|NCT04791319|580391474|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
160729468|NCT04791319|580391475|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
160729469|NCT04791319|580391476|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
160729470|NCT04791319|580391477|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
160729471|NCT04791319|580391467|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
160729472|NCT04791319|580391468|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
160729473|NCT04791319|580391469|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
160729474|NCT04791319|580391470|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
160729475|NCT04791319|580391471|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
160729476|NCT04791319|580391472|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
160729477|NCT04791319|580391473|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
160729478|NCT04791319|580391474|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
160729479|NCT04791319|580391475|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
160729480|NCT04791319|580391476|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
160729481|NCT04791319|580391477|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
160729482|NCT04791319|580391467|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
160729483|NCT04791319|580391468|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
160729484|NCT04791319|580391469|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
160729485|NCT04791319|580391470|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
160729486|NCT04791319|580391471|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
160729487|NCT04791319|580391472|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
160729488|NCT04791319|580391473|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
160729489|NCT04791319|580391474|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
160729490|NCT04791319|580391475|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
160729491|NCT04791319|580391476|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
160729492|NCT04791319|580391477|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
160729493|NCT04791319|580391467|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
160729494|NCT04791319|580391468|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
160729495|NCT04791319|580391469|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
160729496|NCT04791319|580391470|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
160729497|NCT04791319|580391471|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
160729498|NCT04791319|580391472|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
160729499|NCT04791319|580391473|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
160729500|NCT04791319|580391474|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
160729501|NCT04791319|580391475|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
160729502|NCT04791319|580391476|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
160729503|NCT04791319|580391477|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
160729504|NCT04791319|580391467|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
160729505|NCT04791319|580391468|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
160729506|NCT04791319|580391469|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
160729507|NCT04791319|580391470|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
160729508|NCT04791319|580391471|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
160729509|NCT04791319|580391472|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
160729510|NCT04791319|580391473|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
160729511|NCT04791319|580391474|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
160729512|NCT04791319|580391475|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
160729513|NCT04791319|580391476|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
160729514|NCT04791319|580391477|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
160729515|NCT04791319|580391467|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
160729516|NCT04791319|580391468|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
160729517|NCT04791319|580391469|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
160729518|NCT04791319|580391470|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
160729519|NCT04791319|580391471|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
160729520|NCT04791319|580391472|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
160729521|NCT04791319|580391473|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
160729522|NCT04791319|580391474|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
160729523|NCT04791319|580391475|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
160729524|NCT04791319|580391476|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
160729525|NCT04791319|580391477|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
160729526|NCT01704651|580391482|FG000|Overall Study|Pre-op withdrawal by subject|1|||
160729527|NCT01704651|580391483|FG001|Overall Study|Pre-op withdrawal by subject|1|||
160729528|NCT01704651|580391482|FG000|Overall Study|Pre-op change in treatment plan|1|||
160729529|NCT01704651|580391483|FG001|Overall Study|Pre-op change in treatment plan|4|||
160729530|NCT01704651|580391482|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
160729531|NCT01704651|580391483|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
160729532|NCT01704651|580391482|FG000|Overall Study|Post-op did not have laparotomy|2|||
160729533|NCT01704651|580391483|FG001|Overall Study|Post-op did not have laparotomy|1|||
160729534|NCT03474731|580391485|FG000|Overall Study|Withdrawal by Subject|36|||
160729535|NCT03474731|580391486|FG001|Overall Study|Withdrawal by Subject|29|||
160729536|NCT03474731|580391487|FG002|Overall Study|Withdrawal by Subject|11|||
160729537|NCT03474731|580391488|FG003|Overall Study|Withdrawal by Subject|27|||
160729538|NCT03474731|580391485|FG000|Overall Study|COVID|0|||
160729539|NCT03474731|580391486|FG001|Overall Study|COVID|23|||
160729540|NCT03474731|580391487|FG002|Overall Study|COVID|0|||
160729541|NCT03474731|580391488|FG003|Overall Study|COVID|0|||
160729542|NCT03474731|580391485|FG000|Overall Study|Participant moved from area|1|||
160729543|NCT03474731|580391486|FG001|Overall Study|Participant moved from area|0|||
160729544|NCT03474731|580391487|FG002|Overall Study|Participant moved from area|0|||
160729545|NCT03474731|580391488|FG003|Overall Study|Participant moved from area|0|||
160729546|NCT03474731|580391485|FG000|Overall Study|Lost to Follow-up|11|||
160729547|NCT03474731|580391486|FG001|Overall Study|Lost to Follow-up|3|||
160729548|NCT03474731|580391487|FG002|Overall Study|Lost to Follow-up|18|||
160729549|NCT03474731|580391488|FG003|Overall Study|Lost to Follow-up|17|||
160729550|NCT03474731|580391485|FG000|Overall Study|Death|0|||
160729551|NCT03474731|580391486|FG001|Overall Study|Death|1|||
160729552|NCT03474731|580391487|FG002|Overall Study|Death|0|||
160729553|NCT03474731|580391488|FG003|Overall Study|Death|0|||
160729554|NCT03474731|580391485|FG000|Overall Study|Participant Removed|0|||
160729555|NCT03474731|580391486|FG001|Overall Study|Participant Removed|0|||
160729556|NCT03474731|580391487|FG002|Overall Study|Participant Removed|0|||
160729557|NCT03474731|580391488|FG003|Overall Study|Participant Removed|1|||
160729558|NCT00900159|580391492|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
160729559|NCT00900159|580391493|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
160729560|NCT00765336|580391494|FG000|Overall Study|Protocol Violation|4|||
160729561|NCT00765336|580391495|FG001|Overall Study|Protocol Violation|2|||
160729562|NCT00765336|580391494|FG000|Overall Study|Withdrawal by Subject|6|||
160729563|NCT00765336|580391495|FG001|Overall Study|Withdrawal by Subject|4|||
160729564|NCT00765336|580391494|FG000|Overall Study|Lost to Follow-up|7|||
160729565|NCT00765336|580391495|FG001|Overall Study|Lost to Follow-up|9|||
160729566|NCT00765336|580391494|FG000|Overall Study|Adverse Event|2|||
160729567|NCT00765336|580391495|FG001|Overall Study|Adverse Event|1|||
160729568|NCT01377922|580391496|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
160729569|NCT01377922|580391497|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
160729570|NCT01464164|580391501|FG000|Overall Study|Screen failure|0|||
160729571|NCT01464164|580391502|FG001|Overall Study|Screen failure|1|||
160729572|NCT01464164|580391503|FG002|Overall Study|Screen failure|2|||
160729573|NCT01464164|580391504|FG003|Overall Study|Screen failure|0|||
160729574|NCT01464164|580391505|FG004|Overall Study|Screen failure|0|||
160729575|NCT01464164|580391506|FG005|Overall Study|Screen failure|0|||
160729576|NCT01464164|580391507|FG006|Overall Study|Screen failure|0|||
160729577|NCT01464164|580391501|FG000|Overall Study|Physician Decision|0|||
160729578|NCT01464164|580391502|FG001|Overall Study|Physician Decision|1|||
160729579|NCT01464164|580391503|FG002|Overall Study|Physician Decision|0|||
160729580|NCT01464164|580391504|FG003|Overall Study|Physician Decision|0|||
160729581|NCT01464164|580391505|FG004|Overall Study|Physician Decision|0|||
160729582|NCT01464164|580391506|FG005|Overall Study|Physician Decision|0|||
160729583|NCT01464164|580391507|FG006|Overall Study|Physician Decision|2|||
160729584|NCT01578239|580391508|FG000|Treatment Period|Progressive Disease|19|||
160729585|NCT01578239|580391509|FG001|Treatment Period|Progressive Disease|64|||
160729586|NCT01578239|580391508|FG000|Treatment Period|Physician Decision|17|||
160729587|NCT01578239|580391509|FG001|Treatment Period|Physician Decision|17|||
160729588|NCT01578239|580391508|FG000|Treatment Period|Adverse Event|13|||
160729589|NCT01578239|580391509|FG001|Treatment Period|Adverse Event|10|||
160729590|NCT01578239|580391508|FG000|Treatment Period|Non-compliance|2|||
160729591|NCT01578239|580391509|FG001|Treatment Period|Non-compliance|0|||
160729592|NCT01578239|580391508|FG000|Treatment Period|Withdrawal by Subject|10|||
160729593|NCT01578239|580391509|FG001|Treatment Period|Withdrawal by Subject|9|||
160729594|NCT01578239|580391508|FG000|Treatment Period|Other|6|||
160729595|NCT01578239|580391509|FG001|Treatment Period|Other|1|||
160729596|NCT01578239|580391508|FG000|Long-term Follow-Up Period|Death|69|||
160729597|NCT01578239|580391509|FG001|Long-term Follow-Up Period|Death|64|||
160729598|NCT01578239|580391508|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
160729599|NCT01578239|580391509|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
160729600|NCT01578239|580391508|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
160729601|NCT01578239|580391509|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
160729602|NCT01578239|580391508|FG000|Long-term Follow-Up Period|Other|2|||
160729603|NCT01578239|580391509|FG001|Long-term Follow-Up Period|Other|2|||
160729604|NCT03817229|580391510|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
160729605|NCT03817229|580391511|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
160729606|NCT03817229|580391512|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
160729607|NCT03817229|580391513|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
160729608|NCT03817229|580391510|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
160729609|NCT03817229|580391511|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
160729610|NCT03817229|580391512|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
160729611|NCT03817229|580391513|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
160729612|NCT03817229|580391510|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
160729613|NCT03817229|580391511|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
160729614|NCT03817229|580391512|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
160729615|NCT03817229|580391513|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
160729616|NCT03817229|580391510|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
160729617|NCT03817229|580391511|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
160729618|NCT03817229|580391512|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
160729619|NCT03817229|580391513|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
160729620|NCT03817229|580391510|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
160729621|NCT03817229|580391511|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
160729622|NCT03817229|580391512|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
160729623|NCT03817229|580391513|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
160729624|NCT03817229|580391510|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
160729625|NCT03817229|580391511|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
160729626|NCT03817229|580391512|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
160729627|NCT03817229|580391513|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
160729628|NCT03817229|580391510|FG000|Post-Intervention|Withdrawal by Subject|6|||
160729629|NCT03817229|580391511|FG001|Post-Intervention|Withdrawal by Subject|0|||
160729630|NCT03817229|580391512|FG002|Post-Intervention|Withdrawal by Subject|2|||
160729631|NCT03817229|580391513|FG003|Post-Intervention|Withdrawal by Subject|2|||
160729632|NCT03817229|580391510|FG000|Post-Intervention|Withdrawal by Study Team|3|||
160729633|NCT03817229|580391511|FG001|Post-Intervention|Withdrawal by Study Team|1|||
160729634|NCT03817229|580391512|FG002|Post-Intervention|Withdrawal by Study Team|1|||
160729635|NCT03817229|580391513|FG003|Post-Intervention|Withdrawal by Study Team|4|||
160729636|NCT03817229|580391510|FG000|Post-Intervention|Weaned from medication|3|||
160729637|NCT03817229|580391511|FG001|Post-Intervention|Weaned from medication|0|||
160729638|NCT03817229|580391512|FG002|Post-Intervention|Weaned from medication|2|||
160729639|NCT03817229|580391513|FG003|Post-Intervention|Weaned from medication|1|||
160729640|NCT03817229|580391510|FG000|Post-Intervention|Transferred care to another institution|1|||
160729641|NCT03817229|580391511|FG001|Post-Intervention|Transferred care to another institution|0|||
160729642|NCT03817229|580391512|FG002|Post-Intervention|Transferred care to another institution|0|||
160729643|NCT03817229|580391513|FG003|Post-Intervention|Transferred care to another institution|0|||
160729644|NCT03817229|580391510|FG000|Post-Intervention|Change in parental guardianship|0|||
160729645|NCT03817229|580391511|FG001|Post-Intervention|Change in parental guardianship|0|||
160729646|NCT03817229|580391512|FG002|Post-Intervention|Change in parental guardianship|1|||
160729647|NCT03817229|580391513|FG003|Post-Intervention|Change in parental guardianship|0|||
160729648|NCT03817229|580391510|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
160729649|NCT03817229|580391511|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
160729650|NCT03817229|580391512|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
160729651|NCT03817229|580391513|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
160729652|NCT03817229|580391510|FG000|Follow-up 1|Withdrawal by Subject|1|||
160729653|NCT03817229|580391511|FG001|Follow-up 1|Withdrawal by Subject|2|||
160729654|NCT03817229|580391512|FG002|Follow-up 1|Withdrawal by Subject|0|||
160729655|NCT03817229|580391513|FG003|Follow-up 1|Withdrawal by Subject|0|||
160729656|NCT03817229|580391510|FG000|Follow-up 1|Withdrawal by Study Team|3|||
160729657|NCT03817229|580391511|FG001|Follow-up 1|Withdrawal by Study Team|1|||
160729658|NCT03817229|580391512|FG002|Follow-up 1|Withdrawal by Study Team|0|||
160729659|NCT03817229|580391513|FG003|Follow-up 1|Withdrawal by Study Team|0|||
160729660|NCT03817229|580391510|FG000|Follow-up 1|Wean from medication|3|||
160729661|NCT03817229|580391511|FG001|Follow-up 1|Wean from medication|4|||
160729662|NCT03817229|580391512|FG002|Follow-up 1|Wean from medication|0|||
160729663|NCT03817229|580391513|FG003|Follow-up 1|Wean from medication|1|||
160729664|NCT03817229|580391510|FG000|Follow-up 1|Transferred care to another hospital|1|||
160729665|NCT03817229|580391511|FG001|Follow-up 1|Transferred care to another hospital|0|||
160729666|NCT03817229|580391512|FG002|Follow-up 1|Transferred care to another hospital|0|||
160729667|NCT03817229|580391513|FG003|Follow-up 1|Transferred care to another hospital|0|||
160729668|NCT03817229|580391510|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
160729669|NCT03817229|580391511|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
160729670|NCT03817229|580391512|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
160729671|NCT03817229|580391513|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
160729672|NCT03817229|580391510|FG000|Follow-up 2|Withdrawal by Subject|2|||
160729673|NCT03817229|580391511|FG001|Follow-up 2|Withdrawal by Subject|0|||
160729674|NCT03817229|580391512|FG002|Follow-up 2|Withdrawal by Subject|1|||
160729675|NCT03817229|580391513|FG003|Follow-up 2|Withdrawal by Subject|1|||
160729676|NCT03817229|580391510|FG000|Follow-up 2|Withdrawal by Study Team|2|||
160729677|NCT03817229|580391511|FG001|Follow-up 2|Withdrawal by Study Team|0|||
160729678|NCT03817229|580391512|FG002|Follow-up 2|Withdrawal by Study Team|1|||
160729679|NCT03817229|580391513|FG003|Follow-up 2|Withdrawal by Study Team|0|||
160729680|NCT03817229|580391510|FG000|Follow-up 2|Wean from medication|1|||
160729681|NCT03817229|580391511|FG001|Follow-up 2|Wean from medication|0|||
160729682|NCT03817229|580391512|FG002|Follow-up 2|Wean from medication|0|||
160729683|NCT03817229|580391513|FG003|Follow-up 2|Wean from medication|0|||
160729684|NCT03817229|580391510|FG000|Follow-up 2|Transferred care|0|||
160729685|NCT03817229|580391511|FG001|Follow-up 2|Transferred care|0|||
160729686|NCT03817229|580391512|FG002|Follow-up 2|Transferred care|1|||
160729687|NCT03817229|580391513|FG003|Follow-up 2|Transferred care|0|||
160729688|NCT02887183|580391515|FG000|Overall Study|Adverse Event|44|||
160729689|NCT02887183|580391515|FG000|Overall Study|Death|30|||
160729690|NCT02887183|580391515|FG000|Overall Study|Pregnancy|1|||
160729691|NCT02887183|580391515|FG000|Overall Study|Protocol Violation|6|||
160729692|NCT02887183|580391515|FG000|Overall Study|Technical Problems|2|||
160729693|NCT02887183|580391515|FG000|Overall Study|Lost to Follow-up|13|||
160729694|NCT02887183|580391515|FG000|Overall Study|Physician Decision|10|||
160729695|NCT02887183|580391515|FG000|Overall Study|Withdrawal by Subject|35|||
160729696|NCT02195869|580391516|FG000|Overall Study|cGVHD Progression|5|||
160729697|NCT02195869|580391516|FG000|Overall Study|Malignancy Progression/relapse|2|||
160729698|NCT02195869|580391516|FG000|Overall Study|Adverse Event|15|||
160729699|NCT02195869|580391516|FG000|Overall Study|Withdrawal by Subject|7|||
160729700|NCT02195869|580391516|FG000|Overall Study|Physician Decision|4|||
160729701|NCT02195869|580391516|FG000|Overall Study|Study Terminated by Sponsor|7|||
160729702|NCT02195869|580391516|FG000|Overall Study|Noncompliance with study drug|2|||
160729703|NCT02654977|580391517|FG000|Overall Study|Death|1|||
160729704|NCT02654977|580391517|FG000|Overall Study|Lost to Follow-up|1|||
160729705|NCT02654977|580391517|FG000|Overall Study|Adverse Event|1|||
160729706|NCT02654977|580391517|FG000|Overall Study|Withdrawal by Subject|1|||
160729707|NCT02654977|580391517|FG000|Overall Study|Lack of Efficacy|3|||
160729708|NCT01266291|580391518|FG000|Overall Study|Adverse Event|1|||
160729709|NCT02702388|580391522|FG000|Overall Study|Disease Progression|18|||
160729710|NCT02702388|580391523|FG001|Overall Study|Disease Progression|25|||
160729711|NCT02702388|580391522|FG000|Overall Study|Withdrawal by Subject|9|||
160729712|NCT02702388|580391523|FG001|Overall Study|Withdrawal by Subject|7|||
160729713|NCT02702388|580391522|FG000|Overall Study|Adverse Event|11|||
160729714|NCT02702388|580391523|FG001|Overall Study|Adverse Event|15|||
160729715|NCT02702388|580391522|FG000|Overall Study|Other|2|||
160729716|NCT02702388|580391523|FG001|Overall Study|Other|4|||
160729717|NCT02981082|580391524|FG000|Overall Study|Withdrawal by Subject|2|||
160729718|NCT02981082|580391525|FG001|Overall Study|Withdrawal by Subject|0|||
160729719|NCT02981082|580391524|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
160729720|NCT02981082|580391525|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
160729721|NCT02981082|580391524|FG000|Overall Study|Adverse Event|0|||
160729722|NCT02981082|580391525|FG001|Overall Study|Adverse Event|1|||
160729723|NCT00679029|580392785|FG000|Overall Study|Adverse Event|3|||
160729724|NCT00679029|580392785|FG000|Overall Study|Withdrawal by Subject|1|||
160729725|NCT00679029|580392785|FG000|Overall Study|Lost to Follow-up|1|||
160729726|NCT00972816|580392786|FG000|Overall Study|Adverse Event|0|||
160729727|NCT00972816|580392787|FG001|Overall Study|Adverse Event|0|||
160729728|NCT00972816|580392788|FG002|Overall Study|Adverse Event|1|||
160729729|NCT00972816|580392789|FG003|Overall Study|Adverse Event|0|||
160729730|NCT00972816|580392790|FG004|Overall Study|Adverse Event|0|||
160729731|NCT00972816|580392791|FG005|Overall Study|Adverse Event|0|||
160729732|NCT00972816|580392792|FG006|Overall Study|Adverse Event|0|||
160729733|NCT00972816|580392793|FG007|Overall Study|Adverse Event|0|||
160729734|NCT00972816|580392786|FG000|Overall Study|Withdrawal by Subject|4|||
160729735|NCT00972816|580392787|FG001|Overall Study|Withdrawal by Subject|2|||
160729736|NCT00972816|580392788|FG002|Overall Study|Withdrawal by Subject|1|||
160729737|NCT00972816|580392789|FG003|Overall Study|Withdrawal by Subject|3|||
160729738|NCT00972816|580392790|FG004|Overall Study|Withdrawal by Subject|0|||
160729739|NCT00972816|580392791|FG005|Overall Study|Withdrawal by Subject|1|||
160729740|NCT00972816|580392792|FG006|Overall Study|Withdrawal by Subject|1|||
160729741|NCT00972816|580392793|FG007|Overall Study|Withdrawal by Subject|2|||
160729742|NCT00972816|580392786|FG000|Overall Study|Lost to Follow-up|11|||
160729743|NCT00972816|580392787|FG001|Overall Study|Lost to Follow-up|9|||
160729744|NCT00972816|580392788|FG002|Overall Study|Lost to Follow-up|7|||
160729745|NCT00972816|580392789|FG003|Overall Study|Lost to Follow-up|5|||
160729746|NCT00972816|580392790|FG004|Overall Study|Lost to Follow-up|11|||
160729747|NCT00972816|580392791|FG005|Overall Study|Lost to Follow-up|10|||
160729748|NCT00972816|580392792|FG006|Overall Study|Lost to Follow-up|7|||
160729749|NCT00972816|580392793|FG007|Overall Study|Lost to Follow-up|7|||
160729750|NCT00972816|580392786|FG000|Overall Study|Inappropriate enrolment|0|||
160729751|NCT00972816|580392787|FG001|Overall Study|Inappropriate enrolment|0|||
160729752|NCT00972816|580392788|FG002|Overall Study|Inappropriate enrolment|0|||
160729753|NCT00972816|580392789|FG003|Overall Study|Inappropriate enrolment|0|||
160729754|NCT00972816|580392790|FG004|Overall Study|Inappropriate enrolment|0|||
160729755|NCT00972816|580392791|FG005|Overall Study|Inappropriate enrolment|0|||
160729756|NCT00972816|580392792|FG006|Overall Study|Inappropriate enrolment|2|||
160729757|NCT00972816|580392793|FG007|Overall Study|Inappropriate enrolment|0|||
160729758|NCT00972816|580392786|FG000|Overall Study|Unable to classify|2|||
160729759|NCT00972816|580392787|FG001|Overall Study|Unable to classify|0|||
160729760|NCT00972816|580392788|FG002|Overall Study|Unable to classify|0|||
160729761|NCT00972816|580392789|FG003|Overall Study|Unable to classify|0|||
160729762|NCT00972816|580392790|FG004|Overall Study|Unable to classify|1|||
160729763|NCT00972816|580392791|FG005|Overall Study|Unable to classify|0|||
160729764|NCT00972816|580392792|FG006|Overall Study|Unable to classify|0|||
160729765|NCT00972816|580392793|FG007|Overall Study|Unable to classify|0|||
160729766|NCT00956592|580392796|FG000|Overall Study|Protocol Violation|1|||
160729767|NCT00956592|580392797|FG001|Overall Study|Protocol Violation|3|||
160729768|NCT00160706|580392798|FG000|Overall Study|Adverse Event|53|||
160729769|NCT00160706|580392798|FG000|Overall Study|Adverse Event and Other Reason|105|||
160729770|NCT00160706|580392798|FG000|Overall Study|Protocol Violation|3|||
160729771|NCT00160706|580392798|FG000|Overall Study|Withdrawal by Subject|41|||
160729772|NCT00160706|580392798|FG000|Overall Study|Withdrawal by Subject and Other|12|||
160729773|NCT00160706|580392798|FG000|Overall Study|Physician Decision|10|||
160729774|NCT00160706|580392798|FG000|Overall Study|Physician Decision and Other|3|||
160729775|NCT00160706|580392798|FG000|Overall Study|Lost to Follow-up|4|||
160729776|NCT00160706|580392798|FG000|Overall Study|Lost to Follow-up and Other|1|||
160729777|NCT00160706|580392798|FG000|Overall Study|Lack of Efficacy|42|||
160729778|NCT00160706|580392798|FG000|Overall Study|Lack of Efficacy and Other|1|||
160729779|NCT00160706|580392798|FG000|Overall Study|Other Reason|11|||
160729780|NCT02162719|580392799|FG000|Overall Study|Death|41|||
160729781|NCT02162719|580392800|FG001|Overall Study|Death|46|||
160729782|NCT02162719|580392799|FG000|Overall Study|Lost to Follow-up|1|||
160729783|NCT02162719|580392800|FG001|Overall Study|Lost to Follow-up|3|||
160729784|NCT02162719|580392799|FG000|Overall Study|Disease Progression|2|||
160729785|NCT02162719|580392800|FG001|Overall Study|Disease Progression|1|||
160729786|NCT02162719|580392799|FG000|Overall Study|Withdrawal by Subject|8|||
160729787|NCT02162719|580392800|FG001|Overall Study|Withdrawal by Subject|2|||
160729788|NCT02162719|580392799|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
160729789|NCT02162719|580392800|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
160729790|NCT03214380|580392801|FG000|Lead-in|Adverse Event|3|||
160729791|NCT03214380|580392802|FG001|Lead-in|Adverse Event|0|||
160729792|NCT03214380|580392803|FG002|Lead-in|Adverse Event|0|||
160729793|NCT03214380|580392804|FG003|Lead-in|Adverse Event|1|||
160729794|NCT03214380|580392805|FG004|Lead-in|Adverse Event|0|||
160729795|NCT03214380|580392806|FG005|Lead-in|Adverse Event|0|||
160729796|NCT03214380|580392801|FG000|Lead-in|Lost to Follow-up|4|||
160729797|NCT03214380|580392802|FG001|Lead-in|Lost to Follow-up|0|||
160729798|NCT03214380|580392803|FG002|Lead-in|Lost to Follow-up|0|||
160729799|NCT03214380|580392804|FG003|Lead-in|Lost to Follow-up|1|||
160729800|NCT03214380|580392805|FG004|Lead-in|Lost to Follow-up|0|||
160729801|NCT03214380|580392806|FG005|Lead-in|Lost to Follow-up|0|||
160729802|NCT03214380|580392801|FG000|Lead-in|Eligibility Criteria|3|||
160729803|NCT03214380|580392802|FG001|Lead-in|Eligibility Criteria|0|||
160729804|NCT03214380|580392803|FG002|Lead-in|Eligibility Criteria|0|||
160729805|NCT03214380|580392804|FG003|Lead-in|Eligibility Criteria|0|||
160729806|NCT03214380|580392805|FG004|Lead-in|Eligibility Criteria|0|||
160729807|NCT03214380|580392806|FG005|Lead-in|Eligibility Criteria|0|||
160729808|NCT03214380|580392801|FG000|Lead-in|Physician Decision|6|||
160729809|NCT03214380|580392802|FG001|Lead-in|Physician Decision|0|||
160729810|NCT03214380|580392803|FG002|Lead-in|Physician Decision|0|||
160729811|NCT03214380|580392804|FG003|Lead-in|Physician Decision|0|||
160729812|NCT03214380|580392805|FG004|Lead-in|Physician Decision|0|||
160729813|NCT03214380|580392806|FG005|Lead-in|Physician Decision|0|||
160729814|NCT03214380|580392801|FG000|Lead-in|Protocol Deviation|7|||
160729815|NCT03214380|580392802|FG001|Lead-in|Protocol Deviation|0|||
160729816|NCT03214380|580392803|FG002|Lead-in|Protocol Deviation|0|||
160729817|NCT03214380|580392804|FG003|Lead-in|Protocol Deviation|3|||
160729818|NCT03214380|580392805|FG004|Lead-in|Protocol Deviation|0|||
160729819|NCT03214380|580392806|FG005|Lead-in|Protocol Deviation|0|||
160729820|NCT03214380|580392801|FG000|Lead-in|Withdrawal by Subject|41|||
160729821|NCT03214380|580392802|FG001|Lead-in|Withdrawal by Subject|0|||
160729822|NCT03214380|580392803|FG002|Lead-in|Withdrawal by Subject|0|||
160729823|NCT03214380|580392804|FG003|Lead-in|Withdrawal by Subject|14|||
160729824|NCT03214380|580392805|FG004|Lead-in|Withdrawal by Subject|0|||
160729825|NCT03214380|580392806|FG005|Lead-in|Withdrawal by Subject|0|||
160729826|NCT03214380|580392801|FG000|Lead-in|Family Emergency|1|||
160729827|NCT03214380|580392802|FG001|Lead-in|Family Emergency|0|||
160729828|NCT03214380|580392803|FG002|Lead-in|Family Emergency|0|||
160729829|NCT03214380|580392804|FG003|Lead-in|Family Emergency|0|||
160729830|NCT03214380|580392805|FG004|Lead-in|Family Emergency|0|||
160729831|NCT03214380|580392806|FG005|Lead-in|Family Emergency|0|||
160729832|NCT03214380|580392801|FG000|Lead-in|Natural Disaster|9|||
160729833|NCT03214380|580392802|FG001|Lead-in|Natural Disaster|0|||
160729834|NCT03214380|580392803|FG002|Lead-in|Natural Disaster|0|||
160729835|NCT03214380|580392804|FG003|Lead-in|Natural Disaster|0|||
160729836|NCT03214380|580392805|FG004|Lead-in|Natural Disaster|0|||
160729837|NCT03214380|580392806|FG005|Lead-in|Natural Disaster|0|||
160729838|NCT03214380|580392801|FG000|Lead-in|Non Compliance|1|||
160729839|NCT03214380|580392802|FG001|Lead-in|Non Compliance|0|||
160729840|NCT03214380|580392803|FG002|Lead-in|Non Compliance|0|||
160729841|NCT03214380|580392804|FG003|Lead-in|Non Compliance|0|||
160729842|NCT03214380|580392805|FG004|Lead-in|Non Compliance|0|||
160729843|NCT03214380|580392806|FG005|Lead-in|Non Compliance|0|||
160729844|NCT03214380|580392801|FG000|Lead-in|Participant Schedule|2|||
160729845|NCT03214380|580392802|FG001|Lead-in|Participant Schedule|0|||
160729846|NCT03214380|580392803|FG002|Lead-in|Participant Schedule|0|||
160729847|NCT03214380|580392804|FG003|Lead-in|Participant Schedule|0|||
160729848|NCT03214380|580392805|FG004|Lead-in|Participant Schedule|0|||
160729849|NCT03214380|580392806|FG005|Lead-in|Participant Schedule|0|||
160729850|NCT03214380|580392801|FG000|Treatment Period|Adverse Event|0|||
160729851|NCT03214380|580392802|FG001|Treatment Period|Adverse Event|1|||
160729852|NCT03214380|580392803|FG002|Treatment Period|Adverse Event|1|||
160729853|NCT03214380|580392804|FG003|Treatment Period|Adverse Event|0|||
160729854|NCT03214380|580392805|FG004|Treatment Period|Adverse Event|1|||
160729855|NCT03214380|580392806|FG005|Treatment Period|Adverse Event|0|||
160729856|NCT03214380|580392801|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
160729857|NCT03214380|580392802|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
160729858|NCT03214380|580392803|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
160729859|NCT03214380|580392804|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
160729860|NCT03214380|580392805|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
160729861|NCT03214380|580392806|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
160729862|NCT03214380|580392801|FG000|Treatment Period|Withdrawal by Subject|0|||
160729863|NCT03214380|580392802|FG001|Treatment Period|Withdrawal by Subject|10|||
160729864|NCT03214380|580392803|FG002|Treatment Period|Withdrawal by Subject|8|||
160729865|NCT03214380|580392804|FG003|Treatment Period|Withdrawal by Subject|0|||
160729866|NCT03214380|580392805|FG004|Treatment Period|Withdrawal by Subject|7|||
160729867|NCT03214380|580392806|FG005|Treatment Period|Withdrawal by Subject|11|||
160729868|NCT03214380|580392801|FG000|Treatment Period|Death|0|||
160729869|NCT03214380|580392802|FG001|Treatment Period|Death|1|||
160729870|NCT03214380|580392803|FG002|Treatment Period|Death|2|||
160729871|NCT03214380|580392804|FG003|Treatment Period|Death|0|||
160729872|NCT03214380|580392805|FG004|Treatment Period|Death|0|||
160729873|NCT03214380|580392806|FG005|Treatment Period|Death|0|||
160729874|NCT03214380|580392801|FG000|Treatment Period|Lost to Follow-up|0|||
160729875|NCT03214380|580392802|FG001|Treatment Period|Lost to Follow-up|6|||
160729876|NCT03214380|580392803|FG002|Treatment Period|Lost to Follow-up|3|||
160729877|NCT03214380|580392804|FG003|Treatment Period|Lost to Follow-up|0|||
160729878|NCT03214380|580392805|FG004|Treatment Period|Lost to Follow-up|0|||
160729879|NCT03214380|580392806|FG005|Treatment Period|Lost to Follow-up|0|||
160729880|NCT03214380|580392801|FG000|Treatment Period|Participant schedule|0|||
160729881|NCT03214380|580392802|FG001|Treatment Period|Participant schedule|0|||
160729882|NCT03214380|580392803|FG002|Treatment Period|Participant schedule|1|||
160729883|NCT03214380|580392804|FG003|Treatment Period|Participant schedule|0|||
160729884|NCT03214380|580392805|FG004|Treatment Period|Participant schedule|0|||
160729885|NCT03214380|580392806|FG005|Treatment Period|Participant schedule|0|||
160729886|NCT03214380|580392801|FG000|Treatment Period|Treatment Interruption|0|||
160729887|NCT03214380|580392802|FG001|Treatment Period|Treatment Interruption|0|||
160729888|NCT03214380|580392803|FG002|Treatment Period|Treatment Interruption|1|||
160729889|NCT03214380|580392804|FG003|Treatment Period|Treatment Interruption|0|||
160729890|NCT03214380|580392805|FG004|Treatment Period|Treatment Interruption|0|||
160729891|NCT03214380|580392806|FG005|Treatment Period|Treatment Interruption|0|||
160729892|NCT00614523|580392808|FG000|Overall Study|Adverse Event|4|||
160729893|NCT00614523|580392809|FG001|Overall Study|Adverse Event|20|||
160729894|NCT00614523|580392808|FG000|Overall Study|Death|5|||
160729895|NCT00614523|580392809|FG001|Overall Study|Death|8|||
160729896|NCT00614523|580392808|FG000|Overall Study|Lack of Efficacy|9|||
160729897|NCT00614523|580392809|FG001|Overall Study|Lack of Efficacy|11|||
160729898|NCT00614523|580392808|FG000|Overall Study|Lost to Follow-up|0|||
160729899|NCT00614523|580392809|FG001|Overall Study|Lost to Follow-up|1|||
160729900|NCT00614523|580392808|FG000|Overall Study|Protocol Violation|3|||
160729901|NCT00614523|580392809|FG001|Overall Study|Protocol Violation|2|||
160729902|NCT00614523|580392808|FG000|Overall Study|Withdrawal by Subject|12|||
160729903|NCT00614523|580392809|FG001|Overall Study|Withdrawal by Subject|22|||
160729904|NCT00614523|580392808|FG000|Overall Study|Other|6|||
160729905|NCT00614523|580392809|FG001|Overall Study|Other|11|||
160729906|NCT00614523|580392808|FG000|Overall Study|Ineligibility Determined|1|||
160729907|NCT00614523|580392809|FG001|Overall Study|Ineligibility Determined|2|||
160729908|NCT00614523|580392808|FG000|Overall Study|Disease Progression|0|||
160729909|NCT00614523|580392809|FG001|Overall Study|Disease Progression|8|||
160729910|NCT00614523|580392808|FG000|Overall Study|Administrative Decision|23|||
160729911|NCT00614523|580392809|FG001|Overall Study|Administrative Decision|46|||
160729912|NCT02656290|580392813|FG000|Overall Study|Lost to Follow-up|1|||
160729913|NCT02656290|580392813|FG000|Overall Study|Reintervention|3|||
160729914|NCT04696055|580392816|FG000|Overall Study|Adverse Event|10|||
160729915|NCT04696055|580392817|FG001|Overall Study|Adverse Event|2|||
160729916|NCT04696055|580392816|FG000|Overall Study|Death|4|||
160729917|NCT04696055|580392817|FG001|Overall Study|Death|0|||
160729918|NCT04696055|580392816|FG000|Overall Study|Other|7|||
160729919|NCT04696055|580392817|FG001|Overall Study|Other|2|||
160729920|NCT04696055|580392816|FG000|Overall Study|Physician Decision|3|||
160729921|NCT04696055|580392817|FG001|Overall Study|Physician Decision|0|||
160729922|NCT04696055|580392816|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
160729923|NCT04696055|580392817|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
160729924|NCT04696055|580392816|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
160729925|NCT04696055|580392817|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
160729926|NCT04696055|580392816|FG000|Overall Study|Subject Decision|1|||
160729927|NCT04696055|580392817|FG001|Overall Study|Subject Decision|2|||
160729928|NCT01920958|580392820|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
160729929|NCT00610155|580392821|FG000|Period 1|Withdrawal by Subject|0|||
160729930|NCT00610155|580392822|FG001|Period 1|Withdrawal by Subject|0|||
160729931|NCT00610155|580392823|FG002|Period 1|Withdrawal by Subject|1|||
160729932|NCT00610155|580392824|FG003|Period 1|Withdrawal by Subject|0|||
160729933|NCT00610155|580392825|FG004|Period 1|Withdrawal by Subject|0|||
160729934|NCT00610155|580392826|FG005|Period 1|Withdrawal by Subject|0|||
160729935|NCT00610155|580392821|FG000|Period 3|Adverse Event|1|||
160729936|NCT00610155|580392822|FG001|Period 3|Adverse Event|0|||
160729937|NCT00610155|580392823|FG002|Period 3|Adverse Event|0|||
160729938|NCT00610155|580392824|FG003|Period 3|Adverse Event|0|||
160729939|NCT00610155|580392825|FG004|Period 3|Adverse Event|0|||
160729940|NCT00610155|580392826|FG005|Period 3|Adverse Event|0|||
160729941|NCT00379080|580392833|FG000|Overall Study|Withdrawal by Subject|0|||
160729942|NCT00379080|580392834|FG001|Overall Study|Withdrawal by Subject|4|||
160729943|NCT00379080|580392835|FG002|Overall Study|Withdrawal by Subject|0|||
160729944|NCT01089608|580392836|FG000|Overall Study|Adverse Event|0|||
160729945|NCT01089608|580392837|FG001|Overall Study|Adverse Event|4|||
160729946|NCT01089608|580392836|FG000|Overall Study|Lost to Follow-up|0|||
160729947|NCT01089608|580392837|FG001|Overall Study|Lost to Follow-up|2|||
160729948|NCT02429778|580392839|FG000|Overall Study|Lost to Follow-up|2|||
160729949|NCT02429778|580392840|FG001|Overall Study|Lost to Follow-up|0|||
160729950|NCT02429778|580392839|FG000|Overall Study|Withdrawal by Subject|5|||
160729951|NCT02429778|580392840|FG001|Overall Study|Withdrawal by Subject|0|||
160729952|NCT03499899|580392841|FG000|Overall Study|Adverse Event|2|||
160729953|NCT03499899|580392842|FG001|Overall Study|Adverse Event|3|||
160729954|NCT03499899|580392843|FG002|Overall Study|Adverse Event|3|||
160729955|NCT03499899|580392841|FG000|Overall Study|Death|0|||
160729956|NCT03499899|580392842|FG001|Overall Study|Death|0|||
160729957|NCT03499899|580392843|FG002|Overall Study|Death|1|||
160729958|NCT03499899|580392841|FG000|Overall Study|Physician Decision|3|||
160729959|NCT03499899|580392842|FG001|Overall Study|Physician Decision|6|||
160729960|NCT03499899|580392843|FG002|Overall Study|Physician Decision|6|||
160729961|NCT03499899|580392841|FG000|Overall Study|Progressive disease|15|||
160729962|NCT03499899|580392842|FG001|Overall Study|Progressive disease|23|||
160729963|NCT03499899|580392843|FG002|Overall Study|Progressive disease|23|||
160729964|NCT03499899|580392841|FG000|Overall Study|Patient decision|0|||
160729965|NCT03499899|580392842|FG001|Overall Study|Patient decision|1|||
160729966|NCT03499899|580392843|FG002|Overall Study|Patient decision|1|||
160729967|NCT03499899|580392841|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
160729968|NCT03499899|580392842|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
160729969|NCT03499899|580392843|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
160729970|NCT01893281|580392844|FG000|Overall Study|Adverse Event|1|||
160729971|NCT01893281|580392844|FG000|Overall Study|Protocol Violation|1|||
160729972|NCT01893281|580392844|FG000|Overall Study|Withdrawal by Subject|1|||
160729973|NCT01290679|580392850|FG000|Overall Study|Adverse Event|2|||
160729974|NCT01290679|580392851|FG001|Overall Study|Adverse Event|0|||
160729975|NCT01290679|580392850|FG000|Overall Study|Lost to Follow-up|8|||
160729976|NCT01290679|580392851|FG001|Overall Study|Lost to Follow-up|10|||
160729977|NCT01290679|580392850|FG000|Overall Study|Protocol Violation|0|||
160729978|NCT01290679|580392851|FG001|Overall Study|Protocol Violation|1|||
160729979|NCT01290679|580392850|FG000|Overall Study|Withdrawal by Subject|6|||
160729980|NCT01290679|580392851|FG001|Overall Study|Withdrawal by Subject|5|||
160729981|NCT01290679|580392850|FG000|Overall Study|Subject Entered Another Trial|0|||
160729982|NCT01290679|580392851|FG001|Overall Study|Subject Entered Another Trial|5|||
160729983|NCT00355147|580392856|FG000|Overall Study|Lost to Follow-up|10|||
160729984|NCT00355147|580392857|FG001|Overall Study|Lost to Follow-up|8|||
160729985|NCT00355147|580392856|FG000|Overall Study|Withdrawal by Subject|8|||
160729986|NCT00355147|580392857|FG001|Overall Study|Withdrawal by Subject|12|||
160729987|NCT03557931|580392864|FG000|Overall Study|Adverse Event|4|||
160729988|NCT03557931|580392865|FG001|Overall Study|Adverse Event|6|||
160729989|NCT03557931|580392866|FG002|Overall Study|Adverse Event|1|||
160729990|NCT03557931|580392864|FG000|Overall Study|Lost to Follow-up|4|||
160729991|NCT03557931|580392865|FG001|Overall Study|Lost to Follow-up|4|||
160729992|NCT03557931|580392866|FG002|Overall Study|Lost to Follow-up|1|||
160729993|NCT03557931|580392864|FG000|Overall Study|Protocol Violation|1|||
160729994|NCT03557931|580392865|FG001|Overall Study|Protocol Violation|4|||
160729995|NCT03557931|580392866|FG002|Overall Study|Protocol Violation|1|||
160729996|NCT03557931|580392864|FG000|Overall Study|Withdrawal by Subject|14|||
160729997|NCT03557931|580392865|FG001|Overall Study|Withdrawal by Subject|0|||
160729998|NCT03557931|580392866|FG002|Overall Study|Withdrawal by Subject|7|||
160729999|NCT03557931|580392864|FG000|Overall Study|Miscellaneous|8|||
160730000|NCT03557931|580392865|FG001|Overall Study|Miscellaneous|5|||
160730001|NCT03557931|580392866|FG002|Overall Study|Miscellaneous|3|||
160730002|NCT02394340|580392867|FG000|Overall Study|Failed drug screen test|1|||
160730003|NCT02394340|580392867|FG000|Overall Study|Adverse Event|1|||
160730004|NCT03605862|580392870|FG000|Overall Study|Withdrawal by Subject|12|||
160730005|NCT03605862|580392871|FG001|Overall Study|Withdrawal by Subject|9|||
160730006|NCT03605862|580392870|FG000|Overall Study|Adverse Event|2|||
160730007|NCT03605862|580392871|FG001|Overall Study|Adverse Event|1|||
160730008|NCT03605862|580392870|FG000|Overall Study|Physician Decision|3|||
160730009|NCT03605862|580392871|FG001|Overall Study|Physician Decision|1|||
160730010|NCT03605862|580392870|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
160730011|NCT03605862|580392871|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
160730012|NCT00675428|580392874|FG000|Overall Study|Disease Progression|2|||
160730013|NCT00675428|580392875|FG001|Overall Study|Disease Progression|2|||
160730014|NCT00675428|580392874|FG000|Overall Study|No Disease Response After Cycle 6|0|||
160730015|NCT00675428|580392875|FG001|Overall Study|No Disease Response After Cycle 6|1|||
160730016|NCT00675428|580392874|FG000|Overall Study|Physician Decision|1|||
160730017|NCT00675428|580392875|FG001|Overall Study|Physician Decision|0|||
160730018|NCT00886743|580392877|FG000|Overall Study|Adverse Event|3|||
160730019|NCT00886743|580392877|FG000|Overall Study|Other|1|||
160730020|NCT00478777|580392878|FG000|Overall Study|Adverse Event|29|||
160730021|NCT00478777|580392878|FG000|Overall Study|Lack of Efficacy|23|||
160730022|NCT00478777|580392878|FG000|Overall Study|Withdrawal by Subject|4|||
160730023|NCT00478777|580392878|FG000|Overall Study|Death|3|||
160730024|NCT00478777|580392878|FG000|Overall Study|Protocol Violation|3|||
160730025|NCT00478777|580392878|FG000|Overall Study|Lost to Follow-up|3|||
160730026|NCT00478777|580392878|FG000|Overall Study|Physician Decision|1|||
160730027|NCT00478777|580392878|FG000|Overall Study|Intolerance of therapy|1|||
160730028|NCT00478777|580392878|FG000|Overall Study|Lack of compliance|1|||
160730029|NCT00478777|580392878|FG000|Overall Study|Lymphocytes infusion|1|||
160730030|NCT00478777|580392878|FG000|Overall Study|End of therapy|2|||
160730031|NCT00478777|580392878|FG000|Overall Study|Not treated with lenalidomide|6|||
160730032|NCT01582178|580392881|FG000|Overall Study|Physician Decision|6|||
160730033|NCT01582178|580392882|FG001|Overall Study|Physician Decision|5|||
160730034|NCT01323387|580392883|FG000|Overall Study|Withdrawal by Subject|41|||
160730035|NCT01323387|580392883|FG000|Overall Study|Radiographic Data Unavailable|1|||
160730036|NCT01323387|580392883|FG000|Overall Study|Revision|14|||
160730037|NCT01323387|580392883|FG000|Overall Study|Protocol Violation|12|||
160730038|NCT01323387|580392883|FG000|Overall Study|Randomized but Never Treated|16|||
160730039|NCT01726270|580392884|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
160730040|NCT01726270|580392884|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
160730041|NCT01726270|580392884|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
160730042|NCT01726270|580392884|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
160730043|NCT01726270|580392884|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
160730044|NCT01726270|580392884|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
160730045|NCT02157376|580392887|FG000|Overall Study|Death|10|||
160730046|NCT02157376|580392888|FG001|Overall Study|Death|4|||
160730047|NCT02157376|580392887|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160730048|NCT02157376|580392888|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160730049|NCT02157376|580392887|FG000|Overall Study|Withdrawal by Subject|3|||
160730050|NCT02157376|580392888|FG001|Overall Study|Withdrawal by Subject|8|||
160730051|NCT02157376|580392887|FG000|Overall Study|Not treated|8|||
160730052|NCT02157376|580392888|FG001|Overall Study|Not treated|3|||
160730053|NCT02157376|580392887|FG000|Overall Study|Investigator's misjudgement|1|||
160730054|NCT02157376|580392888|FG001|Overall Study|Investigator's misjudgement|2|||
160730055|NCT04200651|580392889|FG000|Overall Study|Moved to another country during follow-up|2|||
160730056|NCT04200651|580392890|FG001|Overall Study|Moved to another country during follow-up|2|||
160730057|NCT04200651|580392889|FG000|Overall Study|Lost to Follow-up|1|||
160730058|NCT04200651|580392890|FG001|Overall Study|Lost to Follow-up|3|||
160730059|NCT01031680|580392892|FG000|Overall Study|Adverse Event|8|||
160730060|NCT01031680|580392893|FG001|Overall Study|Adverse Event|3|||
160730061|NCT01031680|580392892|FG000|Overall Study|Lost to Follow-up|2|||
160730062|NCT01031680|580392893|FG001|Overall Study|Lost to Follow-up|10|||
160730063|NCT01031680|580392892|FG000|Overall Study|Withdrawal by Subject|12|||
160730064|NCT01031680|580392893|FG001|Overall Study|Withdrawal by Subject|16|||
160730065|NCT01031680|580392892|FG000|Overall Study|Death|2|||
160730066|NCT01031680|580392893|FG001|Overall Study|Death|1|||
160730067|NCT01031680|580392892|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
160730068|NCT01031680|580392893|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
160730069|NCT01031680|580392892|FG000|Overall Study|Poor/Non-compliance|5|||
160730070|NCT01031680|580392893|FG001|Overall Study|Poor/Non-compliance|6|||
160730071|NCT01031680|580392892|FG000|Overall Study|Safety|1|||
160730072|NCT01031680|580392893|FG001|Overall Study|Safety|0|||
160730073|NCT01031680|580392892|FG000|Overall Study|Incorrect Enrolment|1|||
160730074|NCT01031680|580392893|FG001|Overall Study|Incorrect Enrolment|2|||
160730075|NCT01031680|580392892|FG000|Overall Study|Administrative Reason by Sponsor|0|||
160730076|NCT01031680|580392893|FG001|Overall Study|Administrative Reason by Sponsor|1|||
160730077|NCT01031680|580392892|FG000|Overall Study|Various|0|||
160730078|NCT01031680|580392893|FG001|Overall Study|Various|2|||
160730079|NCT01186692|580392899|FG000|Overall Study|Not Catheterized|11|||
160730080|NCT01186692|580392899|FG000|Overall Study|Futher testing contraindicated implant|19|||
160730081|NCT01186692|580392899|FG000|Overall Study|Adverse Event|2|||
160730082|NCT03319732|580392900|FG000|Overall Study|Adverse Event|40|||
160730083|NCT03319732|580392900|FG000|Overall Study|Withdrawal by Subject|50|||
160730084|NCT03319732|580392900|FG000|Overall Study|MS relapse|10|||
160730085|NCT03319732|580392900|FG000|Overall Study|reason not specified|5|||
160730086|NCT01921101|580392902|FG000|Overall Study|Death|16|||
160730087|NCT01921101|580392903|FG001|Overall Study|Death|6|||
160730088|NCT00596817|580392905|FG000|Open-label Period|Adverse Event|0|||
160730089|NCT00596817|580392906|FG001|Open-label Period|Adverse Event|49|||
160730090|NCT00596817|580392905|FG000|Open-label Period|Lack of Efficacy|0|||
160730091|NCT00596817|580392906|FG001|Open-label Period|Lack of Efficacy|33|||
160730092|NCT00596817|580392905|FG000|Open-label Period|Other Reasons|0|||
160730093|NCT00596817|580392906|FG001|Open-label Period|Other Reasons|65|||
160730094|NCT00596817|580392905|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
160730095|NCT00596817|580392906|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
160730096|NCT00596817|580392905|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
160730097|NCT00596817|580392906|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
160730098|NCT00596817|580392905|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
160730099|NCT00596817|580392906|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
160730100|NCT00596817|580392905|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
160730101|NCT00596817|580392906|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
160730102|NCT00596817|580392905|FG000|Double-blind Period|Adverse Event|5|||
160730103|NCT00596817|580392906|FG001|Double-blind Period|Adverse Event|16|||
160730104|NCT00596817|580392905|FG000|Double-blind Period|Lack of Efficacy|52|||
160730105|NCT00596817|580392906|FG001|Double-blind Period|Lack of Efficacy|28|||
160730106|NCT00596817|580392905|FG000|Double-blind Period|Non-compliance With Study Product|3|||
160730107|NCT00596817|580392906|FG001|Double-blind Period|Non-compliance With Study Product|4|||
160730108|NCT00596817|580392905|FG000|Double-blind Period|Protocol Violation|11|||
160730109|NCT00596817|580392906|FG001|Double-blind Period|Protocol Violation|8|||
160730110|NCT00596817|580392905|FG000|Double-blind Period|Withdrawal of Consent|7|||
160730111|NCT00596817|580392906|FG001|Double-blind Period|Withdrawal of Consent|3|||
160730112|NCT00596817|580392905|FG000|Double-blind Period|Lost to Follow-up|0|||
160730113|NCT00596817|580392906|FG001|Double-blind Period|Lost to Follow-up|2|||
160730114|NCT00596817|580392905|FG000|Double-blind Period|Other Reasons|10|||
160730115|NCT00596817|580392906|FG001|Double-blind Period|Other Reasons|18|||
160730116|NCT01314872|580392912|FG000|Treatment Period 1|Protocol Violation|2|||
160730117|NCT01314872|580392913|FG001|Treatment Period 1|Protocol Violation|1|||
160730118|NCT01314872|580392914|FG002|Treatment Period 1|Protocol Violation|1|||
160730119|NCT01314872|580392915|FG003|Treatment Period 1|Protocol Violation|0|||
160730120|NCT01314872|580392916|FG004|Treatment Period 1|Protocol Violation|1|||
160730121|NCT01314872|580392917|FG005|Treatment Period 1|Protocol Violation|0|||
160730122|NCT01314872|580392918|FG006|Treatment Period 1|Protocol Violation|0|||
160730123|NCT01314872|580392919|FG007|Treatment Period 1|Protocol Violation|0|||
160730124|NCT01314872|580392920|FG008|Treatment Period 1|Protocol Violation|0|||
160730125|NCT01314872|580392921|FG009|Treatment Period 1|Protocol Violation|1|||
160730126|NCT01314872|580392922|FG010|Treatment Period 1|Protocol Violation|1|||
160730127|NCT01314872|580392923|FG011|Treatment Period 1|Protocol Violation|0|||
160730128|NCT01314872|580392924|FG012|Treatment Period 1|Protocol Violation|0|||
160730129|NCT01314872|580392925|FG013|Treatment Period 1|Protocol Violation|0|||
160730130|NCT01314872|580392926|FG014|Treatment Period 1|Protocol Violation|0|||
160730131|NCT01314872|580392912|FG000|Treatment Period 1|Physician Decision|0|||
160730132|NCT01314872|580392913|FG001|Treatment Period 1|Physician Decision|1|||
160730133|NCT01314872|580392914|FG002|Treatment Period 1|Physician Decision|0|||
160730134|NCT01314872|580392915|FG003|Treatment Period 1|Physician Decision|1|||
160730135|NCT01314872|580392916|FG004|Treatment Period 1|Physician Decision|0|||
160730136|NCT01314872|580392917|FG005|Treatment Period 1|Physician Decision|0|||
160730137|NCT01314872|580392918|FG006|Treatment Period 1|Physician Decision|0|||
160730138|NCT01314872|580392919|FG007|Treatment Period 1|Physician Decision|0|||
160730139|NCT01314872|580392920|FG008|Treatment Period 1|Physician Decision|0|||
160730140|NCT01314872|580392921|FG009|Treatment Period 1|Physician Decision|1|||
160730141|NCT01314872|580392922|FG010|Treatment Period 1|Physician Decision|0|||
160730142|NCT01314872|580392923|FG011|Treatment Period 1|Physician Decision|0|||
160730143|NCT01314872|580392924|FG012|Treatment Period 1|Physician Decision|0|||
160730144|NCT01314872|580392925|FG013|Treatment Period 1|Physician Decision|0|||
160730145|NCT01314872|580392926|FG014|Treatment Period 1|Physician Decision|0|||
160730146|NCT01314872|580392912|FG000|Treatment Period 1|Lack of Efficacy|1|||
160730147|NCT01314872|580392913|FG001|Treatment Period 1|Lack of Efficacy|0|||
160730148|NCT01314872|580392914|FG002|Treatment Period 1|Lack of Efficacy|0|||
160730149|NCT01314872|580392915|FG003|Treatment Period 1|Lack of Efficacy|0|||
160730150|NCT01314872|580392916|FG004|Treatment Period 1|Lack of Efficacy|0|||
160730151|NCT01314872|580392917|FG005|Treatment Period 1|Lack of Efficacy|1|||
160730152|NCT01314872|580392918|FG006|Treatment Period 1|Lack of Efficacy|0|||
160730153|NCT01314872|580392919|FG007|Treatment Period 1|Lack of Efficacy|2|||
160730154|NCT01314872|580392920|FG008|Treatment Period 1|Lack of Efficacy|0|||
160730155|NCT01314872|580392921|FG009|Treatment Period 1|Lack of Efficacy|0|||
160730156|NCT01314872|580392922|FG010|Treatment Period 1|Lack of Efficacy|0|||
160730157|NCT01314872|580392923|FG011|Treatment Period 1|Lack of Efficacy|0|||
160730158|NCT01314872|580392924|FG012|Treatment Period 1|Lack of Efficacy|0|||
160730159|NCT01314872|580392925|FG013|Treatment Period 1|Lack of Efficacy|0|||
160730160|NCT01314872|580392926|FG014|Treatment Period 1|Lack of Efficacy|0|||
160730161|NCT01314872|580392912|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
160730162|NCT01314872|580392913|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
160730163|NCT01314872|580392914|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
160730164|NCT01314872|580392915|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
160730165|NCT01314872|580392916|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
160730166|NCT01314872|580392917|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
160730167|NCT01314872|580392918|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
160730168|NCT01314872|580392919|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
160730169|NCT01314872|580392920|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
160730170|NCT01314872|580392921|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
160730171|NCT01314872|580392922|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
160730172|NCT01314872|580392923|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
160730173|NCT01314872|580392924|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
160730174|NCT01314872|580392925|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
160730175|NCT01314872|580392926|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
160730176|NCT01314872|580392912|FG000|Treatment Period 1|Withdrawal by Subject|3|||
160730177|NCT01314872|580392913|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160730178|NCT01314872|580392914|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160730179|NCT01314872|580392915|FG003|Treatment Period 1|Withdrawal by Subject|2|||
160730180|NCT01314872|580392916|FG004|Treatment Period 1|Withdrawal by Subject|3|||
160730181|NCT01314872|580392917|FG005|Treatment Period 1|Withdrawal by Subject|1|||
160730182|NCT01314872|580392918|FG006|Treatment Period 1|Withdrawal by Subject|3|||
160730183|NCT01314872|580392919|FG007|Treatment Period 1|Withdrawal by Subject|2|||
160730184|NCT01314872|580392920|FG008|Treatment Period 1|Withdrawal by Subject|2|||
160730185|NCT01314872|580392921|FG009|Treatment Period 1|Withdrawal by Subject|2|||
160730186|NCT01314872|580392922|FG010|Treatment Period 1|Withdrawal by Subject|1|||
160730187|NCT01314872|580392923|FG011|Treatment Period 1|Withdrawal by Subject|0|||
160730188|NCT01314872|580392924|FG012|Treatment Period 1|Withdrawal by Subject|0|||
160730189|NCT01314872|580392925|FG013|Treatment Period 1|Withdrawal by Subject|0|||
160730190|NCT01314872|580392926|FG014|Treatment Period 1|Withdrawal by Subject|0|||
160730191|NCT01314872|580392912|FG000|Treatment Period 1|Lost to Follow-up|0|||
160730192|NCT01314872|580392913|FG001|Treatment Period 1|Lost to Follow-up|1|||
160730193|NCT01314872|580392914|FG002|Treatment Period 1|Lost to Follow-up|2|||
160730194|NCT01314872|580392915|FG003|Treatment Period 1|Lost to Follow-up|2|||
160730195|NCT01314872|580392916|FG004|Treatment Period 1|Lost to Follow-up|1|||
160730196|NCT01314872|580392917|FG005|Treatment Period 1|Lost to Follow-up|1|||
160730197|NCT01314872|580392918|FG006|Treatment Period 1|Lost to Follow-up|1|||
160730198|NCT01314872|580392919|FG007|Treatment Period 1|Lost to Follow-up|1|||
160730199|NCT01314872|580392920|FG008|Treatment Period 1|Lost to Follow-up|1|||
160730200|NCT01314872|580392921|FG009|Treatment Period 1|Lost to Follow-up|0|||
160730201|NCT01314872|580392922|FG010|Treatment Period 1|Lost to Follow-up|0|||
160730202|NCT01314872|580392923|FG011|Treatment Period 1|Lost to Follow-up|0|||
160730203|NCT01314872|580392924|FG012|Treatment Period 1|Lost to Follow-up|0|||
160730204|NCT01314872|580392925|FG013|Treatment Period 1|Lost to Follow-up|0|||
160730205|NCT01314872|580392926|FG014|Treatment Period 1|Lost to Follow-up|0|||
160730206|NCT01314872|580392912|FG000|Period 2|Protocol Violation|0|||
160730207|NCT01314872|580392913|FG001|Period 2|Protocol Violation|0|||
160730208|NCT01314872|580392914|FG002|Period 2|Protocol Violation|0|||
160730209|NCT01314872|580392915|FG003|Period 2|Protocol Violation|0|||
160730210|NCT01314872|580392916|FG004|Period 2|Protocol Violation|0|||
160730211|NCT01314872|580392917|FG005|Period 2|Protocol Violation|0|||
160730212|NCT01314872|580392918|FG006|Period 2|Protocol Violation|0|||
160730213|NCT01314872|580392919|FG007|Period 2|Protocol Violation|0|||
160730214|NCT01314872|580392920|FG008|Period 2|Protocol Violation|0|||
160730215|NCT01314872|580392921|FG009|Period 2|Protocol Violation|0|||
160730216|NCT01314872|580392922|FG010|Period 2|Protocol Violation|0|||
160730217|NCT01314872|580392923|FG011|Period 2|Protocol Violation|3|||
160730218|NCT01314872|580392924|FG012|Period 2|Protocol Violation|3|||
160730219|NCT01314872|580392925|FG013|Period 2|Protocol Violation|2|||
160730220|NCT01314872|580392926|FG014|Period 2|Protocol Violation|0|||
160730221|NCT01314872|580392912|FG000|Period 2|Non-compliance with study drug|0|||
160730222|NCT01314872|580392913|FG001|Period 2|Non-compliance with study drug|0|||
160730223|NCT01314872|580392914|FG002|Period 2|Non-compliance with study drug|0|||
160730224|NCT01314872|580392915|FG003|Period 2|Non-compliance with study drug|0|||
160730225|NCT01314872|580392916|FG004|Period 2|Non-compliance with study drug|0|||
160730226|NCT01314872|580392917|FG005|Period 2|Non-compliance with study drug|0|||
160730227|NCT01314872|580392918|FG006|Period 2|Non-compliance with study drug|0|||
160730228|NCT01314872|580392919|FG007|Period 2|Non-compliance with study drug|0|||
160730229|NCT01314872|580392920|FG008|Period 2|Non-compliance with study drug|0|||
160730230|NCT01314872|580392921|FG009|Period 2|Non-compliance with study drug|0|||
160730231|NCT01314872|580392922|FG010|Period 2|Non-compliance with study drug|0|||
160730232|NCT01314872|580392923|FG011|Period 2|Non-compliance with study drug|3|||
160730233|NCT01314872|580392924|FG012|Period 2|Non-compliance with study drug|3|||
160730234|NCT01314872|580392925|FG013|Period 2|Non-compliance with study drug|1|||
160730235|NCT01314872|580392926|FG014|Period 2|Non-compliance with study drug|2|||
160730236|NCT01314872|580392912|FG000|Period 2|Lack of Efficacy|0|||
160730237|NCT01314872|580392913|FG001|Period 2|Lack of Efficacy|0|||
160730238|NCT01314872|580392914|FG002|Period 2|Lack of Efficacy|0|||
160730239|NCT01314872|580392915|FG003|Period 2|Lack of Efficacy|0|||
160730240|NCT01314872|580392916|FG004|Period 2|Lack of Efficacy|0|||
160730241|NCT01314872|580392917|FG005|Period 2|Lack of Efficacy|0|||
160730242|NCT01314872|580392918|FG006|Period 2|Lack of Efficacy|0|||
160730243|NCT01314872|580392919|FG007|Period 2|Lack of Efficacy|0|||
160730244|NCT01314872|580392920|FG008|Period 2|Lack of Efficacy|0|||
160730245|NCT01314872|580392921|FG009|Period 2|Lack of Efficacy|0|||
160730246|NCT01314872|580392922|FG010|Period 2|Lack of Efficacy|0|||
160730247|NCT01314872|580392923|FG011|Period 2|Lack of Efficacy|7|||
160730248|NCT01314872|580392924|FG012|Period 2|Lack of Efficacy|12|||
160730249|NCT01314872|580392925|FG013|Period 2|Lack of Efficacy|9|||
160730250|NCT01314872|580392926|FG014|Period 2|Lack of Efficacy|2|||
160730251|NCT01314872|580392912|FG000|Period 2|Pregnancy|0|||
160730252|NCT01314872|580392913|FG001|Period 2|Pregnancy|0|||
160730253|NCT01314872|580392914|FG002|Period 2|Pregnancy|0|||
160730254|NCT01314872|580392915|FG003|Period 2|Pregnancy|0|||
160730255|NCT01314872|580392916|FG004|Period 2|Pregnancy|0|||
160730256|NCT01314872|580392917|FG005|Period 2|Pregnancy|0|||
160730257|NCT01314872|580392918|FG006|Period 2|Pregnancy|0|||
160730258|NCT01314872|580392919|FG007|Period 2|Pregnancy|0|||
160730259|NCT01314872|580392920|FG008|Period 2|Pregnancy|0|||
160730260|NCT01314872|580392921|FG009|Period 2|Pregnancy|0|||
160730261|NCT01314872|580392922|FG010|Period 2|Pregnancy|0|||
160730262|NCT01314872|580392923|FG011|Period 2|Pregnancy|0|||
160730263|NCT01314872|580392924|FG012|Period 2|Pregnancy|0|||
160730264|NCT01314872|580392925|FG013|Period 2|Pregnancy|0|||
160730265|NCT01314872|580392926|FG014|Period 2|Pregnancy|1|||
160730266|NCT01314872|580392912|FG000|Period 2|Study terminated by Sponsor|0|||
160730267|NCT01314872|580392913|FG001|Period 2|Study terminated by Sponsor|0|||
160730268|NCT01314872|580392914|FG002|Period 2|Study terminated by Sponsor|0|||
160730269|NCT01314872|580392915|FG003|Period 2|Study terminated by Sponsor|0|||
160730270|NCT01314872|580392916|FG004|Period 2|Study terminated by Sponsor|0|||
160730271|NCT01314872|580392917|FG005|Period 2|Study terminated by Sponsor|0|||
160730272|NCT01314872|580392918|FG006|Period 2|Study terminated by Sponsor|0|||
160730273|NCT01314872|580392919|FG007|Period 2|Study terminated by Sponsor|0|||
160730274|NCT01314872|580392920|FG008|Period 2|Study terminated by Sponsor|0|||
160730275|NCT01314872|580392921|FG009|Period 2|Study terminated by Sponsor|0|||
160730276|NCT01314872|580392922|FG010|Period 2|Study terminated by Sponsor|0|||
160730277|NCT01314872|580392923|FG011|Period 2|Study terminated by Sponsor|2|||
160730278|NCT01314872|580392924|FG012|Period 2|Study terminated by Sponsor|2|||
160730279|NCT01314872|580392925|FG013|Period 2|Study terminated by Sponsor|3|||
160730280|NCT01314872|580392926|FG014|Period 2|Study terminated by Sponsor|0|||
160730281|NCT01314872|580392912|FG000|Period 2|Adverse event, non-fatal|0|||
160730282|NCT01314872|580392913|FG001|Period 2|Adverse event, non-fatal|0|||
160730283|NCT01314872|580392914|FG002|Period 2|Adverse event, non-fatal|0|||
160730284|NCT01314872|580392915|FG003|Period 2|Adverse event, non-fatal|0|||
160730285|NCT01314872|580392916|FG004|Period 2|Adverse event, non-fatal|0|||
160730286|NCT01314872|580392917|FG005|Period 2|Adverse event, non-fatal|0|||
160730287|NCT01314872|580392918|FG006|Period 2|Adverse event, non-fatal|0|||
160730288|NCT01314872|580392919|FG007|Period 2|Adverse event, non-fatal|0|||
160730289|NCT01314872|580392920|FG008|Period 2|Adverse event, non-fatal|0|||
160730290|NCT01314872|580392921|FG009|Period 2|Adverse event, non-fatal|0|||
160730291|NCT01314872|580392922|FG010|Period 2|Adverse event, non-fatal|0|||
160730292|NCT01314872|580392923|FG011|Period 2|Adverse event, non-fatal|13|||
160730293|NCT01314872|580392924|FG012|Period 2|Adverse event, non-fatal|16|||
160730294|NCT01314872|580392925|FG013|Period 2|Adverse event, non-fatal|24|||
160730295|NCT01314872|580392926|FG014|Period 2|Adverse event, non-fatal|9|||
160730296|NCT01314872|580392912|FG000|Period 2|Withdrawal by Subject|0|||
160730297|NCT01314872|580392913|FG001|Period 2|Withdrawal by Subject|0|||
160730298|NCT01314872|580392914|FG002|Period 2|Withdrawal by Subject|0|||
160730299|NCT01314872|580392915|FG003|Period 2|Withdrawal by Subject|0|||
160730300|NCT01314872|580392916|FG004|Period 2|Withdrawal by Subject|0|||
160730301|NCT01314872|580392917|FG005|Period 2|Withdrawal by Subject|0|||
160730302|NCT01314872|580392918|FG006|Period 2|Withdrawal by Subject|0|||
160730303|NCT01314872|580392919|FG007|Period 2|Withdrawal by Subject|0|||
160730304|NCT01314872|580392920|FG008|Period 2|Withdrawal by Subject|0|||
160730305|NCT01314872|580392921|FG009|Period 2|Withdrawal by Subject|0|||
160730306|NCT01314872|580392922|FG010|Period 2|Withdrawal by Subject|0|||
160730307|NCT01314872|580392923|FG011|Period 2|Withdrawal by Subject|14|||
160730308|NCT01314872|580392924|FG012|Period 2|Withdrawal by Subject|17|||
160730309|NCT01314872|580392925|FG013|Period 2|Withdrawal by Subject|12|||
160730310|NCT01314872|580392926|FG014|Period 2|Withdrawal by Subject|4|||
160730311|NCT01314872|580392912|FG000|Period 2|Lost to Follow-up|0|||
160730312|NCT01314872|580392913|FG001|Period 2|Lost to Follow-up|0|||
160730313|NCT01314872|580392914|FG002|Period 2|Lost to Follow-up|0|||
160730314|NCT01314872|580392915|FG003|Period 2|Lost to Follow-up|0|||
160730315|NCT01314872|580392916|FG004|Period 2|Lost to Follow-up|0|||
160730316|NCT01314872|580392917|FG005|Period 2|Lost to Follow-up|0|||
160730317|NCT01314872|580392918|FG006|Period 2|Lost to Follow-up|0|||
160730318|NCT01314872|580392919|FG007|Period 2|Lost to Follow-up|0|||
160730319|NCT01314872|580392920|FG008|Period 2|Lost to Follow-up|0|||
160730320|NCT01314872|580392921|FG009|Period 2|Lost to Follow-up|0|||
160730321|NCT01314872|580392922|FG010|Period 2|Lost to Follow-up|0|||
160730322|NCT01314872|580392923|FG011|Period 2|Lost to Follow-up|6|||
160730323|NCT01314872|580392924|FG012|Period 2|Lost to Follow-up|7|||
160730324|NCT01314872|580392925|FG013|Period 2|Lost to Follow-up|2|||
160730325|NCT01314872|580392926|FG014|Period 2|Lost to Follow-up|6|||
160730326|NCT00504725|580394617|FG000|Overall Study|Protocol Violation|1|||
160730327|NCT00504725|580394618|FG001|Overall Study|Protocol Violation|0|||
160730328|NCT01435018|580394619|FG000|Overall Study|Death|37|||
160730329|NCT01435018|580394620|FG001|Overall Study|Death|18|||
160730330|NCT01435018|580394621|FG002|Overall Study|Death|25|||
160730331|NCT01435018|580394619|FG000|Overall Study|Site is closing|4|||
160730332|NCT01435018|580394620|FG001|Overall Study|Site is closing|9|||
160730333|NCT01435018|580394621|FG002|Overall Study|Site is closing|7|||
160730334|NCT01435018|580394619|FG000|Overall Study|Withdrew consent|0|||
160730335|NCT01435018|580394620|FG001|Overall Study|Withdrew consent|3|||
160730336|NCT01435018|580394621|FG002|Overall Study|Withdrew consent|1|||
160730337|NCT01435018|580394619|FG000|Overall Study|Not willing to adhere to requirements|0|||
160730338|NCT01435018|580394620|FG001|Overall Study|Not willing to adhere to requirements|2|||
160730339|NCT01435018|580394621|FG002|Overall Study|Not willing to adhere to requirements|3|||
160730340|NCT01435018|580394619|FG000|Overall Study|Not able to get to clinic|2|||
160730341|NCT01435018|580394620|FG001|Overall Study|Not able to get to clinic|0|||
160730342|NCT01435018|580394621|FG002|Overall Study|Not able to get to clinic|2|||
160730343|NCT01435018|580394619|FG000|Overall Study|Severe debilitation, unable to continue|0|||
160730344|NCT01435018|580394620|FG001|Overall Study|Severe debilitation, unable to continue|0|||
160730345|NCT01435018|580394621|FG002|Overall Study|Severe debilitation, unable to continue|1|||
160730346|NCT01435018|580394619|FG000|Overall Study|Unable to contact participant/parent|1|||
160730347|NCT01435018|580394620|FG001|Overall Study|Unable to contact participant/parent|1|||
160730348|NCT01435018|580394621|FG002|Overall Study|Unable to contact participant/parent|1|||
160730349|NCT01435018|580394619|FG000|Overall Study|Enrollment Violation|0|||
160730350|NCT01435018|580394620|FG001|Overall Study|Enrollment Violation|1|||
160730351|NCT01435018|580394621|FG002|Overall Study|Enrollment Violation|0|||
160730352|NCT01435018|580394619|FG000|Overall Study|Never started chemotherapy|3|||
160730353|NCT01435018|580394620|FG001|Overall Study|Never started chemotherapy|0|||
160730354|NCT01435018|580394621|FG002|Overall Study|Never started chemotherapy|1|||
160730355|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
160730356|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
160730357|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
160730358|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
160730359|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Death|0|||
160730360|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Death|0|||
160730361|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Death|1|||
160730362|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Death|0|||
160730363|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
160730364|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
160730365|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
160730366|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
160730367|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
160730368|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
160730369|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
160730370|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
160730371|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
160730372|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
160730373|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
160730374|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
160730375|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
160730376|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
160730377|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
160730378|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
160730379|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
160730380|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
160730381|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
160730382|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
160730383|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
160730384|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
160730385|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
160730386|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
160730387|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
160730388|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
160730389|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
160730390|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
160730391|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
160730392|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
160730393|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
160730394|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
160730395|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
160730396|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
160730397|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
160730398|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
160730399|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Other|8|||
160730400|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Other|14|||
160730401|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Other|8|||
160730402|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Other|23|||
160730403|NCT01106677|580394622|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
160730404|NCT01106677|580394623|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
160730405|NCT01106677|580394624|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
160730406|NCT01106677|580394625|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
160730407|NCT01106677|580394622|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
160730408|NCT01106677|580394623|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
160730409|NCT01106677|580394624|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
160730410|NCT01106677|580394625|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
160730411|NCT01106677|580394622|FG000|Extension Period: Week 26 to Week 52|Death|0|||
160730412|NCT01106677|580394623|FG001|Extension Period: Week 26 to Week 52|Death|0|||
160730413|NCT01106677|580394624|FG002|Extension Period: Week 26 to Week 52|Death|0|||
160730414|NCT01106677|580394625|FG003|Extension Period: Week 26 to Week 52|Death|1|||
160730415|NCT01106677|580394622|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
160730416|NCT01106677|580394623|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
160730417|NCT01106677|580394624|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
160730418|NCT01106677|580394625|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
160730419|NCT01106677|580394622|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
160730420|NCT01106677|580394623|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
160730421|NCT01106677|580394624|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
160730422|NCT01106677|580394625|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
160730423|NCT01106677|580394622|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
160730424|NCT01106677|580394623|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
160730425|NCT01106677|580394624|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
160730426|NCT01106677|580394625|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
160730427|NCT01106677|580394622|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
160730428|NCT01106677|580394623|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
160730429|NCT01106677|580394624|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
160730430|NCT01106677|580394625|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
160730431|NCT01106677|580394622|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
160730432|NCT01106677|580394623|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
160730433|NCT01106677|580394624|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
160730434|NCT01106677|580394625|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
160730435|NCT01106677|580394622|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
160730436|NCT01106677|580394623|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
160730437|NCT01106677|580394624|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
160730438|NCT01106677|580394625|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
160730439|NCT01106677|580394622|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
160730440|NCT01106677|580394623|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
160730441|NCT01106677|580394624|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
160730442|NCT01106677|580394625|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
160730443|NCT01106677|580394622|FG000|Extension Period: Week 26 to Week 52|Other|6|||
160730444|NCT01106677|580394623|FG001|Extension Period: Week 26 to Week 52|Other|5|||
160730445|NCT01106677|580394624|FG002|Extension Period: Week 26 to Week 52|Other|8|||
160730446|NCT01106677|580394625|FG003|Extension Period: Week 26 to Week 52|Other|5|||
160730447|NCT03937908|580394626|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
160730448|NCT03937908|580394627|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
160730449|NCT03875092|580394628|FG000|Overall Study|Adverse Event|2|||
160730450|NCT03875092|580394629|FG001|Overall Study|Adverse Event|5|||
160730451|NCT03875092|580394628|FG000|Overall Study|Death|44|||
160730452|NCT03875092|580394629|FG001|Overall Study|Death|51|||
160730453|NCT03875092|580394628|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
160730454|NCT03875092|580394629|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
160730455|NCT03205761|580394630|FG000|Overall Study|Withdrawal by Subject|1|||
160730456|NCT03205761|580394630|FG000|Overall Study|Progressive Disease|10|||
160730457|NCT00636194|580394631|FG000|Overall Study|Study related symptoms and complaints|1|||
160730458|NCT00636194|580394632|FG001|Overall Study|Study related symptoms and complaints|0|||
160730459|NCT00636194|580394631|FG000|Overall Study|Protocol Violation|2|||
160730460|NCT00636194|580394632|FG001|Overall Study|Protocol Violation|0|||
160730461|NCT04114357|580394634|FG000|Baseline-Randomization|Adverse Event|2|||
160730462|NCT04114357|580394635|FG001|Baseline-Randomization|Adverse Event|1|||
160730463|NCT04114357|580394634|FG000|Baseline-Randomization|Lost to Follow-up|1|||
160730464|NCT04114357|580394635|FG001|Baseline-Randomization|Lost to Follow-up|1|||
160730465|NCT04114357|580394634|FG000|Cross-over|Adverse Event|0|||
160730466|NCT04114357|580394635|FG001|Cross-over|Adverse Event|1|||
160730467|NCT02163226|580394636|FG000|Overall Study|Death|2|||
160730468|NCT02163226|580394637|FG001|Overall Study|Death|1|||
160730469|NCT02163226|580394636|FG000|Overall Study|Withdrawal by Subject|5|||
160730470|NCT02163226|580394637|FG001|Overall Study|Withdrawal by Subject|2|||
160730471|NCT02163226|580394636|FG000|Overall Study|Returned home, local radiotherapy|3|||
160730472|NCT02163226|580394637|FG001|Overall Study|Returned home, local radiotherapy|0|||
160730473|NCT02163226|580394636|FG000|Overall Study|Repeat imaging showed no disease|2|||
160730474|NCT02163226|580394637|FG001|Overall Study|Repeat imaging showed no disease|0|||
160730475|NCT02163226|580394636|FG000|Overall Study|Incomplete radiotherapy|3|||
160730476|NCT02163226|580394637|FG001|Overall Study|Incomplete radiotherapy|0|||
160730477|NCT02163226|580394636|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
160730478|NCT02163226|580394637|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
160730479|NCT02163226|580394636|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
160730480|NCT02163226|580394637|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
160730481|NCT02163226|580394636|FG000|Overall Study|ineligible|0|||
160730482|NCT02163226|580394637|FG001|Overall Study|ineligible|3|||
160730483|NCT03625466|580394641|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
160730484|NCT03625466|580394642|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
160730485|NCT03625466|580394643|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
160730486|NCT03625466|580394641|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
160730487|NCT03625466|580394642|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
160730488|NCT03625466|580394643|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
160730489|NCT03625466|580394641|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
160730490|NCT03625466|580394642|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
160730491|NCT03625466|580394643|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
160730492|NCT00723255|580394647|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
160730493|NCT00723255|580394647|FG000|Overall Study|Ineligible: Second primary|1|||
160730494|NCT00723255|580394647|FG000|Overall Study|Ineligible: Wrong Primary|2|||
160730495|NCT03854370|580394653|FG000|Overall Study|samples not collected|1|||
160730496|NCT03854370|580394654|FG001|Overall Study|samples not collected|1|||
160730497|NCT03854370|580394655|FG002|Overall Study|samples not collected|1|||
160730498|NCT03854370|580394656|FG003|Overall Study|samples not collected|1|||
160730499|NCT00452673|580394657|FG000|Dose Escalation Period|Disease Progression|6|||
160730500|NCT00452673|580394658|FG001|Dose Escalation Period|Disease Progression|6|||
160730501|NCT00452673|580394659|FG002|Dose Escalation Period|Disease Progression|2|||
160730502|NCT00452673|580394660|FG003|Dose Escalation Period|Disease Progression|6|||
160730503|NCT00452673|580394661|FG004|Dose Escalation Period|Disease Progression|0|||
160730504|NCT00452673|580394657|FG000|Dose Escalation Period|study drug toxicity|1|||
160730505|NCT00452673|580394658|FG001|Dose Escalation Period|study drug toxicity|3|||
160730506|NCT00452673|580394659|FG002|Dose Escalation Period|study drug toxicity|3|||
160730507|NCT00452673|580394660|FG003|Dose Escalation Period|study drug toxicity|1|||
160730508|NCT00452673|580394661|FG004|Dose Escalation Period|study drug toxicity|0|||
160730509|NCT00452673|580394657|FG000|Dose Escalation Period|Other|0|||
160730510|NCT00452673|580394658|FG001|Dose Escalation Period|Other|0|||
160730511|NCT00452673|580394659|FG002|Dose Escalation Period|Other|1|||
160730512|NCT00452673|580394660|FG003|Dose Escalation Period|Other|0|||
160730513|NCT00452673|580394661|FG004|Dose Escalation Period|Other|0|||
160730514|NCT00452673|580394657|FG000|Dose Escalation Period|Adverse Event|0|||
160730515|NCT00452673|580394658|FG001|Dose Escalation Period|Adverse Event|0|||
160730516|NCT00452673|580394659|FG002|Dose Escalation Period|Adverse Event|0|||
160730517|NCT00452673|580394660|FG003|Dose Escalation Period|Adverse Event|1|||
160730518|NCT00452673|580394661|FG004|Dose Escalation Period|Adverse Event|0|||
160730519|NCT00452673|580394657|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
160730520|NCT00452673|580394658|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
160730521|NCT00452673|580394659|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
160730522|NCT00452673|580394660|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
160730523|NCT00452673|580394661|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
160730524|NCT00452673|580394657|FG000|Dose Expansion Period|Disease Progression|0|||
160730525|NCT00452673|580394658|FG001|Dose Expansion Period|Disease Progression|0|||
160730526|NCT00452673|580394659|FG002|Dose Expansion Period|Disease Progression|0|||
160730527|NCT00452673|580394660|FG003|Dose Expansion Period|Disease Progression|0|||
160730528|NCT00452673|580394661|FG004|Dose Expansion Period|Disease Progression|19|||
160730529|NCT00452673|580394657|FG000|Dose Expansion Period|Other|0|||
160730530|NCT00452673|580394658|FG001|Dose Expansion Period|Other|0|||
160730531|NCT00452673|580394659|FG002|Dose Expansion Period|Other|0|||
160730532|NCT00452673|580394660|FG003|Dose Expansion Period|Other|0|||
160730533|NCT00452673|580394661|FG004|Dose Expansion Period|Other|2|||
160730534|NCT00748189|580394664|FG000|Overall Study|Death|99|||
160730535|NCT00748189|580394665|FG001|Overall Study|Death|84|||
160730536|NCT00748189|580394664|FG000|Overall Study|Withdrawal by Subject|23|||
160730537|NCT00748189|580394665|FG001|Overall Study|Withdrawal by Subject|29|||
160730538|NCT00748189|580394664|FG000|Overall Study|Physician Decision|16|||
160730539|NCT00748189|580394665|FG001|Overall Study|Physician Decision|5|||
160730540|NCT00748189|580394664|FG000|Overall Study|Lost to Follow-up|8|||
160730541|NCT00748189|580394665|FG001|Overall Study|Lost to Follow-up|15|||
160730542|NCT00748189|580394664|FG000|Overall Study|Study terminated by Sponsor|70|||
160730543|NCT00748189|580394665|FG001|Overall Study|Study terminated by Sponsor|79|||
160730544|NCT04481191|580394672|FG000|Overall Study|Withdrawn by parent/guardian|15|||
160730545|NCT04481191|580394673|FG001|Overall Study|Withdrawn by parent/guardian|10|||
160730546|NCT00546117|580394678|FG000|Overall Study|Withdrawal by Subject|3|||
160730547|NCT00546117|580394679|FG001|Overall Study|Withdrawal by Subject|0|||
160730548|NCT00546117|580394678|FG000|Overall Study|Inability to schedule follow-up visit|1|||
160730549|NCT00546117|580394679|FG001|Overall Study|Inability to schedule follow-up visit|0|||
160730550|NCT04984278|580394682|FG000|Period 1|Withdrawal by Subject|1|||
160730551|NCT04984278|580394683|FG001|Period 1|Withdrawal by Subject|0|||
160730552|NCT04984278|580394682|FG000|Period 1|Other|0|||
160730553|NCT04984278|580394683|FG001|Period 1|Other|1|||
160730554|NCT04984278|580394682|FG000|Period 2|Adverse Event|1|||
160730555|NCT04984278|580394683|FG001|Period 2|Adverse Event|0|||
160730556|NCT04984278|580394682|FG000|Period 2|Other|0|||
160730557|NCT04984278|580394683|FG001|Period 2|Other|1|||
160730558|NCT03969901|580394684|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160730559|NCT03969901|580394685|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160730560|NCT03969901|580394686|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160730561|NCT03969901|580394687|FG003|Overall Study|Withdrawal by parent/guardian|0|||
160730562|NCT03969901|580394688|FG004|Overall Study|Withdrawal by parent/guardian|1|||
160730563|NCT03969901|580394689|FG005|Overall Study|Withdrawal by parent/guardian|0|||
160730564|NCT03969901|580394690|FG006|Overall Study|Withdrawal by parent/guardian|0|||
160730565|NCT03969901|580394691|FG007|Overall Study|Withdrawal by parent/guardian|1|||
160730566|NCT03969901|580394692|FG008|Overall Study|Withdrawal by parent/guardian|1|||
160730567|NCT03969901|580394693|FG009|Overall Study|Withdrawal by parent/guardian|0|||
160730568|NCT00348595|580394694|FG000|Overall Study|Adverse Event|5|||
160730569|NCT00348595|580394695|FG001|Overall Study|Adverse Event|8|||
160730570|NCT03192306|580394696|FG000|Overall Study|Did not treat cold sore during study|149|||
160730571|NCT03192306|580394697|FG001|Overall Study|Did not treat cold sore during study|143|||
160730572|NCT03192306|580394696|FG000|Overall Study|Withdrawal by Subject|1|||
160730573|NCT03192306|580394697|FG001|Overall Study|Withdrawal by Subject|1|||
160730574|NCT03192306|580394696|FG000|Overall Study|Lost to Follow-up|1|||
160730575|NCT03192306|580394697|FG001|Overall Study|Lost to Follow-up|0|||
160730576|NCT03192306|580394696|FG000|Overall Study|Protocol Violation|1|||
160730577|NCT03192306|580394697|FG001|Overall Study|Protocol Violation|1|||
160730578|NCT02589626|580394702|FG000|Overall Study|Other than the reason specified|1|||
160730579|NCT02589626|580394703|FG001|Overall Study|Other than the reason specified|0|||
160730580|NCT02589626|580394702|FG000|Overall Study|Withdrawal by Subject|1|||
160730581|NCT02589626|580394703|FG001|Overall Study|Withdrawal by Subject|1|||
160730582|NCT02589626|580394702|FG000|Overall Study|Adverse Event|1|||
160730583|NCT02589626|580394703|FG001|Overall Study|Adverse Event|1|||
160730584|NCT03645395|580394704|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
160730585|NCT03645395|580394705|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
160730586|NCT03645395|580394706|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
160730587|NCT03645395|580394707|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
160730588|NCT03645395|580394704|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
160730589|NCT03645395|580394705|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
160730590|NCT03645395|580394706|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
160730591|NCT03645395|580394707|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
160730592|NCT03645395|580394704|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
160730593|NCT03645395|580394705|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
160730594|NCT03645395|580394706|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
160730595|NCT03645395|580394707|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
160730596|NCT03645395|580394704|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
160730597|NCT03645395|580394705|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
160730598|NCT03645395|580394706|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
160730599|NCT03645395|580394707|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
160730600|NCT01289639|580394709|FG000|Overall Study|Lost to Follow-up|1|||
160730601|NCT01289639|580394710|FG001|Overall Study|Lost to Follow-up|0|||
160730602|NCT01289639|580394711|FG002|Overall Study|Lost to Follow-up|0|||
160730603|NCT02780713|580394712|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
160730604|NCT02780713|580394713|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
160730605|NCT02780713|580394714|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
160730606|NCT02780713|580394715|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
160730607|NCT02780713|580394716|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
160730608|NCT01931475|580394717|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
160730609|NCT01931475|580394718|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
160730610|NCT01931475|580394717|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
160730611|NCT01931475|580394718|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
160730612|NCT01931475|580394717|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
160730613|NCT01931475|580394718|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
160730614|NCT01931475|580394717|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
160730615|NCT01931475|580394718|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
160730616|NCT01931475|580394717|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
160730617|NCT01931475|580394718|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
160730618|NCT01931475|580394717|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
160730619|NCT01931475|580394718|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
160730620|NCT01931475|580394717|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
160730621|NCT01931475|580394718|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
160730622|NCT01931475|580394717|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
160730623|NCT01931475|580394718|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
160730624|NCT01931475|580394717|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
160730625|NCT01931475|580394718|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
160730626|NCT01931475|580394717|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
160730627|NCT01931475|580394718|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
160730628|NCT01931475|580394717|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
160730629|NCT01931475|580394718|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
160730630|NCT01028014|580394730|FG000|Overall Study|Lost to Follow-up|1|||
160730631|NCT01028014|580394731|FG001|Overall Study|Lost to Follow-up|2|||
160730632|NCT01028014|580394732|FG002|Overall Study|Lost to Follow-up|0|||
160730633|NCT01028014|580394733|FG003|Overall Study|Lost to Follow-up|1|||
160730634|NCT01028014|580394734|FG004|Overall Study|Lost to Follow-up|1|||
160730635|NCT01028014|580394735|FG005|Overall Study|Lost to Follow-up|2|||
160730636|NCT01127451|580394736|FG000|Overall Study|Other|2|||
160730637|NCT01127451|580394737|FG001|Overall Study|Other|1|||
160730638|NCT01127451|580394736|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
160730639|NCT01127451|580394737|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
160730640|NCT01127451|580394736|FG000|Overall Study|Death|22|||
160730641|NCT01127451|580394737|FG001|Overall Study|Death|17|||
160730642|NCT01127451|580394736|FG000|Overall Study|Lost to Follow-up|3|||
160730643|NCT01127451|580394737|FG001|Overall Study|Lost to Follow-up|0|||
160730644|NCT01127451|580394736|FG000|Overall Study|Administrative Reason by Sponsor|2|||
160730645|NCT01127451|580394737|FG001|Overall Study|Administrative Reason by Sponsor|2|||
160730646|NCT04590586|580394742|FG000|Overall Study|Death|7|||
160730647|NCT04590586|580394743|FG001|Overall Study|Death|1|||
160730648|NCT04590586|580394744|FG002|Overall Study|Death|37|||
160730649|NCT04590586|580394745|FG003|Overall Study|Death|34|||
160730650|NCT04590586|580394746|FG004|Overall Study|Death|19|||
160730651|NCT04590586|580394747|FG005|Overall Study|Death|3|||
160730652|NCT04590586|580394742|FG000|Overall Study|Lost to Follow-up|3|||
160730653|NCT04590586|580394743|FG001|Overall Study|Lost to Follow-up|0|||
160730654|NCT04590586|580394744|FG002|Overall Study|Lost to Follow-up|11|||
160730655|NCT04590586|580394745|FG003|Overall Study|Lost to Follow-up|11|||
160730656|NCT04590586|580394746|FG004|Overall Study|Lost to Follow-up|6|||
160730657|NCT04590586|580394747|FG005|Overall Study|Lost to Follow-up|0|||
160730658|NCT04590586|580394742|FG000|Overall Study|Withdrawal by Subject|0|||
160730659|NCT04590586|580394743|FG001|Overall Study|Withdrawal by Subject|0|||
160730660|NCT04590586|580394744|FG002|Overall Study|Withdrawal by Subject|6|||
160730661|NCT04590586|580394745|FG003|Overall Study|Withdrawal by Subject|0|||
160730662|NCT04590586|580394746|FG004|Overall Study|Withdrawal by Subject|3|||
160730663|NCT04590586|580394747|FG005|Overall Study|Withdrawal by Subject|0|||
160730664|NCT04590586|580394742|FG000|Overall Study|Other|3|||
160730665|NCT04590586|580394743|FG001|Overall Study|Other|0|||
160730666|NCT04590586|580394744|FG002|Overall Study|Other|1|||
160730667|NCT04590586|580394745|FG003|Overall Study|Other|1|||
160730668|NCT04590586|580394746|FG004|Overall Study|Other|2|||
160730669|NCT04590586|580394747|FG005|Overall Study|Other|1|||
160730670|NCT00634803|580394748|FG000|Overall Study|Lost to Follow-up|6|||
160730671|NCT00634803|580394749|FG001|Overall Study|Lost to Follow-up|7|||
160730672|NCT00634803|580394750|FG002|Overall Study|Lost to Follow-up|7|||
160730673|NCT04105218|580394752|FG000|Overall Study|Withdrawal by Subject|3|||
160730674|NCT04105218|580394753|FG001|Overall Study|Withdrawal by Subject|2|||
160730675|NCT04105218|580394752|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
160730676|NCT04105218|580394753|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
160730677|NCT04105218|580394752|FG000|Overall Study|Failed screening tests|2|||
160730678|NCT04105218|580394753|FG001|Overall Study|Failed screening tests|1|||
160730679|NCT02553499|580394760|FG000|Overall Study|Adverse Event|0|||
160730680|NCT02553499|580394761|FG001|Overall Study|Adverse Event|0|||
160730681|NCT02553499|580394762|FG002|Overall Study|Adverse Event|0|||
160730682|NCT02553499|580394763|FG003|Overall Study|Adverse Event|0|||
160730683|NCT02553499|580394764|FG004|Overall Study|Adverse Event|0|||
160730684|NCT02553499|580394765|FG005|Overall Study|Adverse Event|0|||
160730685|NCT02553499|580394766|FG006|Overall Study|Adverse Event|1|||
160730686|NCT02553499|580394767|FG007|Overall Study|Adverse Event|1|||
160730687|NCT02553499|580394768|FG008|Overall Study|Adverse Event|0|||
160730688|NCT02553499|580394769|FG009|Overall Study|Adverse Event|0|||
160730689|NCT02553499|580394770|FG010|Overall Study|Adverse Event|0|||
160730690|NCT02553499|580394771|FG011|Overall Study|Adverse Event|0|||
160730691|NCT02553499|580394772|FG012|Overall Study|Adverse Event|0|||
160730692|NCT02553499|580394773|FG013|Overall Study|Adverse Event|1|||
160730693|NCT02553499|580394760|FG000|Overall Study|Death|0|||
160730694|NCT02553499|580394761|FG001|Overall Study|Death|1|||
160730695|NCT02553499|580394762|FG002|Overall Study|Death|1|||
160730696|NCT02553499|580394763|FG003|Overall Study|Death|0|||
160730697|NCT02553499|580394764|FG004|Overall Study|Death|1|||
160730698|NCT02553499|580394765|FG005|Overall Study|Death|2|||
160730699|NCT02553499|580394766|FG006|Overall Study|Death|0|||
160730700|NCT02553499|580394767|FG007|Overall Study|Death|0|||
160730701|NCT02553499|580394768|FG008|Overall Study|Death|0|||
160730702|NCT02553499|580394769|FG009|Overall Study|Death|0|||
160730703|NCT02553499|580394770|FG010|Overall Study|Death|1|||
160730704|NCT02553499|580394771|FG011|Overall Study|Death|0|||
160730705|NCT02553499|580394772|FG012|Overall Study|Death|0|||
160730706|NCT02553499|580394773|FG013|Overall Study|Death|0|||
160730707|NCT02553499|580394760|FG000|Overall Study|Lost to Follow-up|0|||
160730708|NCT02553499|580394761|FG001|Overall Study|Lost to Follow-up|0|||
160730709|NCT02553499|580394762|FG002|Overall Study|Lost to Follow-up|0|||
160730710|NCT02553499|580394763|FG003|Overall Study|Lost to Follow-up|0|||
160730711|NCT02553499|580394764|FG004|Overall Study|Lost to Follow-up|0|||
160730712|NCT02553499|580394765|FG005|Overall Study|Lost to Follow-up|0|||
160730713|NCT02553499|580394766|FG006|Overall Study|Lost to Follow-up|1|||
160730714|NCT02553499|580394767|FG007|Overall Study|Lost to Follow-up|0|||
160730715|NCT02553499|580394768|FG008|Overall Study|Lost to Follow-up|0|||
160730716|NCT02553499|580394769|FG009|Overall Study|Lost to Follow-up|0|||
160730717|NCT02553499|580394770|FG010|Overall Study|Lost to Follow-up|0|||
160730718|NCT02553499|580394771|FG011|Overall Study|Lost to Follow-up|0|||
160730719|NCT02553499|580394772|FG012|Overall Study|Lost to Follow-up|0|||
160730720|NCT02553499|580394773|FG013|Overall Study|Lost to Follow-up|0|||
160730721|NCT02553499|580394760|FG000|Overall Study|Physician Decision|0|||
160730722|NCT02553499|580394761|FG001|Overall Study|Physician Decision|1|||
160730723|NCT02553499|580394762|FG002|Overall Study|Physician Decision|1|||
160730724|NCT02553499|580394763|FG003|Overall Study|Physician Decision|0|||
160730725|NCT02553499|580394764|FG004|Overall Study|Physician Decision|1|||
160730726|NCT02553499|580394765|FG005|Overall Study|Physician Decision|0|||
160730727|NCT02553499|580394766|FG006|Overall Study|Physician Decision|0|||
160730728|NCT02553499|580394767|FG007|Overall Study|Physician Decision|1|||
160730729|NCT02553499|580394768|FG008|Overall Study|Physician Decision|1|||
160730730|NCT02553499|580394769|FG009|Overall Study|Physician Decision|2|||
160730731|NCT02553499|580394770|FG010|Overall Study|Physician Decision|1|||
160730732|NCT02553499|580394771|FG011|Overall Study|Physician Decision|3|||
160730733|NCT02553499|580394772|FG012|Overall Study|Physician Decision|1|||
160730734|NCT02553499|580394773|FG013|Overall Study|Physician Decision|0|||
160730735|NCT02553499|580394760|FG000|Overall Study|Progressive Disease|0|||
160730736|NCT02553499|580394761|FG001|Overall Study|Progressive Disease|0|||
160730737|NCT02553499|580394762|FG002|Overall Study|Progressive Disease|0|||
160730738|NCT02553499|580394763|FG003|Overall Study|Progressive Disease|2|||
160730739|NCT02553499|580394764|FG004|Overall Study|Progressive Disease|1|||
160730740|NCT02553499|580394765|FG005|Overall Study|Progressive Disease|1|||
160730741|NCT02553499|580394766|FG006|Overall Study|Progressive Disease|1|||
160730742|NCT02553499|580394767|FG007|Overall Study|Progressive Disease|0|||
160730743|NCT02553499|580394768|FG008|Overall Study|Progressive Disease|0|||
160730744|NCT02553499|580394769|FG009|Overall Study|Progressive Disease|1|||
160730745|NCT02553499|580394770|FG010|Overall Study|Progressive Disease|0|||
160730746|NCT02553499|580394771|FG011|Overall Study|Progressive Disease|0|||
160730747|NCT02553499|580394772|FG012|Overall Study|Progressive Disease|2|||
160730748|NCT02553499|580394773|FG013|Overall Study|Progressive Disease|1|||
160730749|NCT02553499|580394760|FG000|Overall Study|Study Terminated by Sponsor|0|||
160730750|NCT02553499|580394761|FG001|Overall Study|Study Terminated by Sponsor|0|||
160730751|NCT02553499|580394762|FG002|Overall Study|Study Terminated by Sponsor|0|||
160730752|NCT02553499|580394763|FG003|Overall Study|Study Terminated by Sponsor|0|||
160730753|NCT02553499|580394764|FG004|Overall Study|Study Terminated by Sponsor|0|||
160730754|NCT02553499|580394765|FG005|Overall Study|Study Terminated by Sponsor|0|||
160730755|NCT02553499|580394766|FG006|Overall Study|Study Terminated by Sponsor|0|||
160730756|NCT02553499|580394767|FG007|Overall Study|Study Terminated by Sponsor|0|||
160730757|NCT02553499|580394768|FG008|Overall Study|Study Terminated by Sponsor|1|||
160730758|NCT02553499|580394769|FG009|Overall Study|Study Terminated by Sponsor|0|||
160730759|NCT02553499|580394770|FG010|Overall Study|Study Terminated by Sponsor|0|||
160730760|NCT02553499|580394771|FG011|Overall Study|Study Terminated by Sponsor|0|||
160730761|NCT02553499|580394772|FG012|Overall Study|Study Terminated by Sponsor|0|||
160730762|NCT02553499|580394773|FG013|Overall Study|Study Terminated by Sponsor|0|||
160730763|NCT02553499|580394760|FG000|Overall Study|Withdrawal by Subject|2|||
160730764|NCT02553499|580394761|FG001|Overall Study|Withdrawal by Subject|0|||
160730765|NCT02553499|580394762|FG002|Overall Study|Withdrawal by Subject|0|||
160730766|NCT02553499|580394763|FG003|Overall Study|Withdrawal by Subject|0|||
160730767|NCT02553499|580394764|FG004|Overall Study|Withdrawal by Subject|0|||
160730768|NCT02553499|580394765|FG005|Overall Study|Withdrawal by Subject|0|||
160730769|NCT02553499|580394766|FG006|Overall Study|Withdrawal by Subject|0|||
160730770|NCT02553499|580394767|FG007|Overall Study|Withdrawal by Subject|1|||
160730771|NCT02553499|580394768|FG008|Overall Study|Withdrawal by Subject|1|||
160730772|NCT02553499|580394769|FG009|Overall Study|Withdrawal by Subject|0|||
160730773|NCT02553499|580394770|FG010|Overall Study|Withdrawal by Subject|1|||
160730774|NCT02553499|580394771|FG011|Overall Study|Withdrawal by Subject|0|||
160730775|NCT02553499|580394772|FG012|Overall Study|Withdrawal by Subject|0|||
160730776|NCT02553499|580394773|FG013|Overall Study|Withdrawal by Subject|0|||
160730777|NCT00570063|580394774|FG000|Overall Study|Adverse Event|4|||
160730778|NCT00570063|580394775|FG001|Overall Study|Adverse Event|1|||
160730779|NCT00570063|580394774|FG000|Overall Study|Lack of Efficacy|0|||
160730780|NCT00570063|580394775|FG001|Overall Study|Lack of Efficacy|1|||
160730781|NCT00570063|580394774|FG000|Overall Study|Withdrawal by Subject|4|||
160730782|NCT00570063|580394775|FG001|Overall Study|Withdrawal by Subject|3|||
160730783|NCT00570063|580394774|FG000|Overall Study|Sponsor's Decision|7|||
160730784|NCT00570063|580394775|FG001|Overall Study|Sponsor's Decision|3|||
160730785|NCT00550043|580394779|FG000|Overall Study|Adverse Event|0|||
160730786|NCT00550043|580394780|FG001|Overall Study|Adverse Event|0|||
160730787|NCT00550043|580394781|FG002|Overall Study|Adverse Event|0|||
160730788|NCT00550043|580394782|FG003|Overall Study|Adverse Event|1|||
160730789|NCT00550043|580394783|FG004|Overall Study|Adverse Event|1|||
160730790|NCT00550043|580394779|FG000|Overall Study|Subject Withdrew Consent|0|||
160730791|NCT00550043|580394780|FG001|Overall Study|Subject Withdrew Consent|2|||
160730792|NCT00550043|580394781|FG002|Overall Study|Subject Withdrew Consent|1|||
160730793|NCT00550043|580394782|FG003|Overall Study|Subject Withdrew Consent|0|||
160730794|NCT00550043|580394783|FG004|Overall Study|Subject Withdrew Consent|0|||
160730795|NCT00550043|580394779|FG000|Overall Study|Other Reasons- Unspecified|0|||
160730796|NCT00550043|580394780|FG001|Overall Study|Other Reasons- Unspecified|1|||
160730797|NCT00550043|580394781|FG002|Overall Study|Other Reasons- Unspecified|0|||
160730798|NCT00550043|580394782|FG003|Overall Study|Other Reasons- Unspecified|1|||
160730799|NCT00550043|580394783|FG004|Overall Study|Other Reasons- Unspecified|0|||
160730800|NCT00789698|580394787|FG000|Overall Study|Lack of Efficacy|10|||
160730801|NCT00789698|580394788|FG001|Overall Study|Lack of Efficacy|4|||
160730802|NCT00789698|580394789|FG002|Overall Study|Lack of Efficacy|5|||
160730803|NCT00789698|580394790|FG003|Overall Study|Lack of Efficacy|18|||
160730804|NCT00789698|580394787|FG000|Overall Study|Adverse Event|5|||
160730805|NCT00789698|580394788|FG001|Overall Study|Adverse Event|5|||
160730806|NCT00789698|580394789|FG002|Overall Study|Adverse Event|3|||
160730807|NCT00789698|580394790|FG003|Overall Study|Adverse Event|4|||
160730808|NCT00789698|580394787|FG000|Overall Study|Lost to Follow-up|5|||
160730809|NCT00789698|580394788|FG001|Overall Study|Lost to Follow-up|5|||
160730810|NCT00789698|580394789|FG002|Overall Study|Lost to Follow-up|2|||
160730811|NCT00789698|580394790|FG003|Overall Study|Lost to Follow-up|9|||
160730812|NCT00789698|580394787|FG000|Overall Study|Protocol Violation|6|||
160730813|NCT00789698|580394788|FG001|Overall Study|Protocol Violation|1|||
160730814|NCT00789698|580394789|FG002|Overall Study|Protocol Violation|2|||
160730815|NCT00789698|580394790|FG003|Overall Study|Protocol Violation|1|||
160730816|NCT00789698|580394787|FG000|Overall Study|Withdrawal by Subject|14|||
160730817|NCT00789698|580394788|FG001|Overall Study|Withdrawal by Subject|15|||
160730818|NCT00789698|580394789|FG002|Overall Study|Withdrawal by Subject|12|||
160730819|NCT00789698|580394790|FG003|Overall Study|Withdrawal by Subject|19|||
160730820|NCT00789698|580394787|FG000|Overall Study|Administrative|0|||
160730821|NCT00789698|580394788|FG001|Overall Study|Administrative|3|||
160730822|NCT00789698|580394789|FG002|Overall Study|Administrative|3|||
160730823|NCT00789698|580394790|FG003|Overall Study|Administrative|1|||
160730824|NCT03634033|580396973|FG000|Overall Study|Did not have a post-assessment|384|||
160730825|NCT03634033|580396974|FG001|Overall Study|Did not have a post-assessment|291|||
160730826|NCT03634033|580396975|FG002|Overall Study|Did not have a post-assessment|114|||
160730827|NCT03634033|580396976|FG003|Overall Study|Did not have a post-assessment|161|||
160730828|NCT03634033|580396977|FG004|Overall Study|Did not have a post-assessment|5|||
160730829|NCT03634033|580396978|FG005|Overall Study|Did not have a post-assessment|0|||
160730830|NCT03634033|580396979|FG006|Overall Study|Did not have a post-assessment|0|||
160730831|NCT03634033|580396973|FG000|Overall Study|Death|0|||
160730832|NCT03634033|580396974|FG001|Overall Study|Death|0|||
160730833|NCT03634033|580396975|FG002|Overall Study|Death|0|||
160730834|NCT03634033|580396976|FG003|Overall Study|Death|0|||
160730835|NCT03634033|580396977|FG004|Overall Study|Death|0|||
160730836|NCT03634033|580396978|FG005|Overall Study|Death|7|||
160730837|NCT03634033|580396979|FG006|Overall Study|Death|7|||
160730838|NCT03634033|580396973|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
160730839|NCT03634033|580396974|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
160730840|NCT03634033|580396975|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
160730841|NCT03634033|580396976|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
160730842|NCT03634033|580396977|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
160730843|NCT03634033|580396978|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
160730844|NCT03634033|580396979|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
160730845|NCT03634033|580396973|FG000|Overall Study|Lost to Follow-up|0|||
160730846|NCT03634033|580396974|FG001|Overall Study|Lost to Follow-up|0|||
160730847|NCT03634033|580396975|FG002|Overall Study|Lost to Follow-up|0|||
160730848|NCT03634033|580396976|FG003|Overall Study|Lost to Follow-up|0|||
160730849|NCT03634033|580396977|FG004|Overall Study|Lost to Follow-up|0|||
160730850|NCT03634033|580396978|FG005|Overall Study|Lost to Follow-up|1|||
160730851|NCT03634033|580396979|FG006|Overall Study|Lost to Follow-up|2|||
160730852|NCT03634033|580396973|FG000|Overall Study|Withdrawal by Subject|0|||
160730853|NCT03634033|580396974|FG001|Overall Study|Withdrawal by Subject|0|||
160730854|NCT03634033|580396975|FG002|Overall Study|Withdrawal by Subject|0|||
160730855|NCT03634033|580396976|FG003|Overall Study|Withdrawal by Subject|0|||
160730856|NCT03634033|580396977|FG004|Overall Study|Withdrawal by Subject|0|||
160730857|NCT03634033|580396978|FG005|Overall Study|Withdrawal by Subject|0|||
160730858|NCT03634033|580396979|FG006|Overall Study|Withdrawal by Subject|1|||
160730859|NCT06366087|580396980|FG000|Overall Study|Withdrawal by Subject|0|||
160730860|NCT06366087|580396981|FG001|Overall Study|Withdrawal by Subject|1|||
160730861|NCT00199797|580396983|FG000|Overall Study|Progressive Disease|1|||
160730862|NCT00199797|580396983|FG000|Overall Study|Adverse Event|1|||
160730863|NCT00199797|580396983|FG000|Overall Study|Physician Decision|1|||
160730864|NCT01397786|580396984|FG000|Phase A|Lost to Follow-up|0|||
160730865|NCT01397786|580396985|FG001|Phase A|Lost to Follow-up|0|||
160730866|NCT01397786|580396986|FG002|Phase A|Lost to Follow-up|6|||
160730867|NCT01397786|580396984|FG000|Phase A|Adverse Event|0|||
160730868|NCT01397786|580396985|FG001|Phase A|Adverse Event|0|||
160730869|NCT01397786|580396986|FG002|Phase A|Adverse Event|8|||
160730870|NCT01397786|580396984|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
160730871|NCT01397786|580396985|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
160730872|NCT01397786|580396986|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
160730873|NCT01397786|580396984|FG000|Phase A|Physician Decision|0|||
160730874|NCT01397786|580396985|FG001|Phase A|Physician Decision|0|||
160730875|NCT01397786|580396986|FG002|Phase A|Physician Decision|1|||
160730876|NCT01397786|580396984|FG000|Phase A|Withdrawal by Subject|0|||
160730877|NCT01397786|580396985|FG001|Phase A|Withdrawal by Subject|0|||
160730878|NCT01397786|580396986|FG002|Phase A|Withdrawal by Subject|5|||
160730879|NCT01397786|580396984|FG000|Phase A|Lack of Efficacy|0|||
160730880|NCT01397786|580396985|FG001|Phase A|Lack of Efficacy|0|||
160730881|NCT01397786|580396986|FG002|Phase A|Lack of Efficacy|1|||
160730882|NCT01397786|580396984|FG000|Phase B|Lost to Follow-up|22|||
160730883|NCT01397786|580396985|FG001|Phase B|Lost to Follow-up|12|||
160730884|NCT01397786|580396986|FG002|Phase B|Lost to Follow-up|22|||
160730885|NCT01397786|580396984|FG000|Phase B|Adverse Event|109|||
160730886|NCT01397786|580396985|FG001|Phase B|Adverse Event|23|||
160730887|NCT01397786|580396986|FG002|Phase B|Adverse Event|27|||
160730888|NCT01397786|580396984|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
160730889|NCT01397786|580396985|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
160730890|NCT01397786|580396986|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
160730891|NCT01397786|580396984|FG000|Phase B|Physician Decision|9|||
160730892|NCT01397786|580396985|FG001|Phase B|Physician Decision|1|||
160730893|NCT01397786|580396986|FG002|Phase B|Physician Decision|3|||
160730894|NCT01397786|580396984|FG000|Phase B|Withdrawal by Subject|102|||
160730895|NCT01397786|580396985|FG001|Phase B|Withdrawal by Subject|45|||
160730896|NCT01397786|580396986|FG002|Phase B|Withdrawal by Subject|30|||
160730897|NCT01397786|580396984|FG000|Phase B|Protocol Deviation|1|||
160730898|NCT01397786|580396985|FG001|Phase B|Protocol Deviation|2|||
160730899|NCT01397786|580396986|FG002|Phase B|Protocol Deviation|4|||
160730900|NCT01397786|580396984|FG000|Phase B|Lack of Efficacy|22|||
160730901|NCT01397786|580396985|FG001|Phase B|Lack of Efficacy|7|||
160730902|NCT01397786|580396986|FG002|Phase B|Lack of Efficacy|14|||
160730903|NCT04250350|580396990|FG000|Overall Study|Withdrawal by Subject|13|||
160730904|NCT04250350|580396990|FG000|Overall Study|Lost to Follow-up|8|||
160730905|NCT04250350|580396990|FG000|Overall Study|Adverse Event|5|||
160730906|NCT04250350|580396990|FG000|Overall Study|Lack of Efficacy|4|||
160730907|NCT04250350|580396990|FG000|Overall Study|Physician Decision|1|||
160730908|NCT04250350|580396990|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
160730909|NCT00860249|580396991|FG000|Overall Study|trial was terminated prior to completion|21|||
160730910|NCT00860249|580396992|FG001|Overall Study|trial was terminated prior to completion|18|||
160730911|NCT00860249|580396993|FG002|Overall Study|trial was terminated prior to completion|21|||
160730912|NCT00743288|580396994|FG000|Overall Study|Adverse Event|1|||
160730913|NCT00743288|580396995|FG001|Overall Study|Adverse Event|1|||
160730914|NCT00743288|580396996|FG002|Overall Study|Adverse Event|2|||
160730915|NCT00743288|580396997|FG003|Overall Study|Adverse Event|2|||
160730916|NCT00743288|580396998|FG004|Overall Study|Adverse Event|1|||
160730917|NCT00743288|580396999|FG005|Overall Study|Adverse Event|1|||
160730918|NCT00743288|580397000|FG006|Overall Study|Adverse Event|2|||
160730919|NCT00743288|580396994|FG000|Overall Study|Withdrawal by Subject|0|||
160730920|NCT00743288|580396995|FG001|Overall Study|Withdrawal by Subject|0|||
160730921|NCT00743288|580396996|FG002|Overall Study|Withdrawal by Subject|1|||
160730922|NCT00743288|580396997|FG003|Overall Study|Withdrawal by Subject|0|||
160730923|NCT00743288|580396998|FG004|Overall Study|Withdrawal by Subject|0|||
160730924|NCT00743288|580396999|FG005|Overall Study|Withdrawal by Subject|1|||
160730925|NCT00743288|580397000|FG006|Overall Study|Withdrawal by Subject|1|||
160730926|NCT00743288|580396994|FG000|Overall Study|Progressive disease (PD)|2|||
160730927|NCT00743288|580396995|FG001|Overall Study|Progressive disease (PD)|0|||
160730928|NCT00743288|580396996|FG002|Overall Study|Progressive disease (PD)|1|||
160730929|NCT00743288|580396997|FG003|Overall Study|Progressive disease (PD)|4|||
160730930|NCT00743288|580396998|FG004|Overall Study|Progressive disease (PD)|5|||
160730931|NCT00743288|580396999|FG005|Overall Study|Progressive disease (PD)|3|||
160730932|NCT00743288|580397000|FG006|Overall Study|Progressive disease (PD)|6|||
160730933|NCT00743288|580396994|FG000|Overall Study|Worsening of condition (Not PD)|0|||
160730934|NCT00743288|580396995|FG001|Overall Study|Worsening of condition (Not PD)|2|||
160730935|NCT00743288|580396996|FG002|Overall Study|Worsening of condition (Not PD)|1|||
160730936|NCT00743288|580396997|FG003|Overall Study|Worsening of condition (Not PD)|1|||
160730937|NCT00743288|580396998|FG004|Overall Study|Worsening of condition (Not PD)|0|||
160730938|NCT00743288|580396999|FG005|Overall Study|Worsening of condition (Not PD)|0|||
160730939|NCT00743288|580397000|FG006|Overall Study|Worsening of condition (Not PD)|0|||
160730940|NCT02836236|580397005|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
160730941|NCT02836236|580397006|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
160730942|NCT02836236|580397007|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
160730943|NCT02836236|580397008|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
160730944|NCT02836236|580397005|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
160730945|NCT02836236|580397006|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
160730946|NCT02836236|580397007|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
160730947|NCT02836236|580397008|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
160730948|NCT02836236|580397005|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
160730949|NCT02836236|580397006|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
160730950|NCT02836236|580397007|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
160730951|NCT02836236|580397008|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
160730952|NCT02836236|580397005|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
160730953|NCT02836236|580397006|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
160730954|NCT02836236|580397007|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
160730955|NCT02836236|580397008|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
160730956|NCT02836236|580397005|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
160730957|NCT02836236|580397006|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
160730958|NCT02836236|580397007|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
160730959|NCT02836236|580397008|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
160730960|NCT02836236|580397005|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
160730961|NCT02836236|580397006|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
160730962|NCT02836236|580397007|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
160730963|NCT02836236|580397008|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
160730964|NCT02836236|580397005|FG000|Open-Label TAF Treatment Phase|Death|0|||
160730965|NCT02836236|580397006|FG001|Open-Label TAF Treatment Phase|Death|0|||
160730966|NCT02836236|580397007|FG002|Open-Label TAF Treatment Phase|Death|1|||
160730967|NCT02836236|580397008|FG003|Open-Label TAF Treatment Phase|Death|1|||
160730968|NCT02836236|580397005|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
160730969|NCT02836236|580397006|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
160730970|NCT02836236|580397007|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
160730971|NCT02836236|580397008|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
160730972|NCT00378508|580397009|FG000|Overall Study|Withdrawal by Subject|1|||
160730973|NCT00378508|580397010|FG001|Overall Study|Withdrawal by Subject|3|||
160730974|NCT00378508|580397009|FG000|Overall Study|Lost to Follow-up|1|||
160730975|NCT00378508|580397010|FG001|Overall Study|Lost to Follow-up|0|||
160730976|NCT00593684|580397011|FG000|Overall Study|Death|2|||
160730977|NCT00593684|580397012|FG001|Overall Study|Death|1|||
160730978|NCT00809471|580397014|FG000|Overall Study|Protocol non-compliance|15|||
160730979|NCT00809471|580397015|FG001|Overall Study|Protocol non-compliance|15|||
160730980|NCT00809471|580397016|FG002|Overall Study|Protocol non-compliance|6|||
160730981|NCT00809471|580397014|FG000|Overall Study|Lost to Follow-up|4|||
160730982|NCT00809471|580397015|FG001|Overall Study|Lost to Follow-up|2|||
160730983|NCT00809471|580397016|FG002|Overall Study|Lost to Follow-up|9|||
160730984|NCT00809471|580397014|FG000|Overall Study|Adverse Event|0|||
160730985|NCT00809471|580397015|FG001|Overall Study|Adverse Event|2|||
160730986|NCT00809471|580397016|FG002|Overall Study|Adverse Event|2|||
160730987|NCT00809471|580397014|FG000|Overall Study|Requirement for restricted medication|1|||
160730988|NCT00809471|580397015|FG001|Overall Study|Requirement for restricted medication|1|||
160730989|NCT00809471|580397016|FG002|Overall Study|Requirement for restricted medication|0|||
160730990|NCT00831311|580397018|FG000|Overall Study|Definitive Contraindication|3|||
160730991|NCT00831311|580397019|FG001|Overall Study|Definitive Contraindication|3|||
160730992|NCT00831311|580397018|FG000|Overall Study|Lost to Follow-up|3|||
160730993|NCT00831311|580397019|FG001|Overall Study|Lost to Follow-up|0|||
160730994|NCT00831311|580397018|FG000|Overall Study|Physician Decision|0|||
160730995|NCT00831311|580397019|FG001|Overall Study|Physician Decision|1|||
160730996|NCT00831311|580397018|FG000|Overall Study|Withdrawal by Subject|6|||
160730997|NCT00831311|580397019|FG001|Overall Study|Withdrawal by Subject|4|||
160730998|NCT05318092|580397023|FG000|Overall Study|Lost to Follow-up|3|||
160730999|NCT05318092|580397023|FG000|Overall Study|Withdrawal by Subject|1|||
160731000|NCT01669174|580397031|FG000|Overall Study|Subject withdrew consent|2|||
160731001|NCT01669174|580397032|FG001|Overall Study|Subject withdrew consent|2|||
160731002|NCT01669174|580397031|FG000|Overall Study|Lost to Follow-up|1|||
160731003|NCT01669174|580397032|FG001|Overall Study|Lost to Follow-up|0|||
160731004|NCT01669174|580397031|FG000|Overall Study|Adverse Event|2|||
160731005|NCT01669174|580397032|FG001|Overall Study|Adverse Event|2|||
160731006|NCT01669174|580397031|FG000|Overall Study|Administrative problems|1|||
160731007|NCT01669174|580397032|FG001|Overall Study|Administrative problems|2|||
160731008|NCT01953601|580397036|FG000|Part 1 (Base Study)|Adverse Event|24|||
160731009|NCT01953601|580397037|FG001|Part 1 (Base Study)|Adverse Event|37|||
160731010|NCT01953601|580397038|FG002|Part 1 (Base Study)|Adverse Event|15|||
160731011|NCT01953601|580397036|FG000|Part 1 (Base Study)|Death|2|||
160731012|NCT01953601|580397037|FG001|Part 1 (Base Study)|Death|0|||
160731013|NCT01953601|580397038|FG002|Part 1 (Base Study)|Death|3|||
160731014|NCT01953601|580397036|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
160731015|NCT01953601|580397037|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
160731016|NCT01953601|580397038|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
160731017|NCT01953601|580397036|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
160731018|NCT01953601|580397037|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
160731019|NCT01953601|580397038|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
160731020|NCT01953601|580397036|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
160731021|NCT01953601|580397037|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
160731022|NCT01953601|580397038|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
160731023|NCT01953601|580397036|FG000|Part 1 (Base Study)|Physician Decision|3|||
160731024|NCT01953601|580397037|FG001|Part 1 (Base Study)|Physician Decision|7|||
160731025|NCT01953601|580397038|FG002|Part 1 (Base Study)|Physician Decision|4|||
160731026|NCT01953601|580397036|FG000|Part 1 (Base Study)|Screen failure|1|||
160731027|NCT01953601|580397037|FG001|Part 1 (Base Study)|Screen failure|0|||
160731028|NCT01953601|580397038|FG002|Part 1 (Base Study)|Screen failure|1|||
160731029|NCT01953601|580397036|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
160731030|NCT01953601|580397037|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
160731031|NCT01953601|580397038|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
160731032|NCT01953601|580397036|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
160731033|NCT01953601|580397037|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
160731034|NCT01953601|580397038|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
160731035|NCT01953601|580397036|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
160731036|NCT01953601|580397037|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
160731037|NCT01953601|580397038|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
160731038|NCT01953601|580397036|FG000|Part 1 (Base Study)|Subject moved|2|||
160731039|NCT01953601|580397037|FG001|Part 1 (Base Study)|Subject moved|2|||
160731040|NCT01953601|580397038|FG002|Part 1 (Base Study)|Subject moved|1|||
160731041|NCT01953601|580397036|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
160731042|NCT01953601|580397037|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
160731043|NCT01953601|580397038|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
160731044|NCT01953601|580397036|FG000|Part 2 (Extension Study)|Adverse Event|1|||
160731045|NCT01953601|580397037|FG001|Part 2 (Extension Study)|Adverse Event|1|||
160731046|NCT01953601|580397038|FG002|Part 2 (Extension Study)|Adverse Event|10|||
160731047|NCT01953601|580397036|FG000|Part 2 (Extension Study)|Death|0|||
160731048|NCT01953601|580397037|FG001|Part 2 (Extension Study)|Death|3|||
160731049|NCT01953601|580397038|FG002|Part 2 (Extension Study)|Death|0|||
160731050|NCT01953601|580397036|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
160731051|NCT01953601|580397037|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
160731052|NCT01953601|580397038|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
160731053|NCT01953601|580397036|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
160731054|NCT01953601|580397037|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
160731055|NCT01953601|580397038|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
160731056|NCT01953601|580397036|FG000|Part 2 (Extension Study)|Physician Decision|2|||
160731057|NCT01953601|580397037|FG001|Part 2 (Extension Study)|Physician Decision|0|||
160731058|NCT01953601|580397038|FG002|Part 2 (Extension Study)|Physician Decision|2|||
160731059|NCT01953601|580397036|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
160731060|NCT01953601|580397037|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
160731061|NCT01953601|580397038|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
160731062|NCT01953601|580397036|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
160731063|NCT01953601|580397037|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
160731064|NCT01953601|580397038|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
160731065|NCT01953601|580397036|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
160731066|NCT01953601|580397037|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
160731067|NCT01953601|580397038|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
160731068|NCT01953601|580397036|FG000|Part 2 (Extension Study)|Subject moved|0|||
160731069|NCT01953601|580397037|FG001|Part 2 (Extension Study)|Subject moved|0|||
160731070|NCT01953601|580397038|FG002|Part 2 (Extension Study)|Subject moved|1|||
160731071|NCT01953601|580397036|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
160731072|NCT01953601|580397037|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
160731073|NCT01953601|580397038|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
160731074|NCT01905553|580397045|FG000|Period 2|Adverse Event|1|||
160731075|NCT01905553|580397046|FG001|Period 2|Adverse Event|0|||
160731076|NCT04310397|580397047|FG000|Overall Study|Lack of Efficacy|3|||
160731077|NCT04310397|580397047|FG000|Overall Study|Withdrawal by Subject|1|||
160731078|NCT03962790|580397050|FG000|Period 1|Adverse Event|0|||
160731079|NCT03962790|580397051|FG001|Period 1|Adverse Event|1|||
160731080|NCT03962790|580397050|FG000|Period 1|Failed to meet all eligibility criteria|1|||
160731081|NCT03962790|580397051|FG001|Period 1|Failed to meet all eligibility criteria|1|||
160731082|NCT03962790|580397050|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
160731083|NCT03962790|580397051|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
160731084|NCT03962790|580397050|FG000|Period 1|Withdrawal by Subject|1|||
160731085|NCT03962790|580397051|FG001|Period 1|Withdrawal by Subject|0|||
160731086|NCT01608087|580397059|FG000|Overall Study|Lost to Follow-up|0|||
160731087|NCT01608087|580397060|FG001|Overall Study|Lost to Follow-up|1|||
160731088|NCT01608087|580397061|FG002|Overall Study|Lost to Follow-up|0|||
160731089|NCT01608087|580397059|FG000|Overall Study|Other Reason|0|||
160731090|NCT01608087|580397060|FG001|Overall Study|Other Reason|1|||
160731091|NCT01608087|580397061|FG002|Overall Study|Other Reason|0|||
160731092|NCT00664859|580397070|FG000|Overall Study|Adverse Event|2|||
160731093|NCT00664859|580397071|FG001|Overall Study|Adverse Event|1|||
160731094|NCT00664859|580397072|FG002|Overall Study|Adverse Event|3|||
160731095|NCT00664859|580397070|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
160731096|NCT00664859|580397071|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
160731097|NCT00664859|580397072|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
160731098|NCT00664859|580397070|FG000|Overall Study|Noncompliance with protocol|1|||
160731099|NCT00664859|580397071|FG001|Overall Study|Noncompliance with protocol|0|||
160731100|NCT00664859|580397072|FG002|Overall Study|Noncompliance with protocol|4|||
160731101|NCT00664859|580397070|FG000|Overall Study|Laboratory abnormality|2|||
160731102|NCT00664859|580397071|FG001|Overall Study|Laboratory abnormality|1|||
160731103|NCT00664859|580397072|FG002|Overall Study|Laboratory abnormality|4|||
160731104|NCT00664859|580397070|FG000|Overall Study|Withdrawal by Subject|4|||
160731105|NCT00664859|580397071|FG001|Overall Study|Withdrawal by Subject|1|||
160731106|NCT00664859|580397072|FG002|Overall Study|Withdrawal by Subject|3|||
160731107|NCT00664859|580397070|FG000|Overall Study|Lost to Follow-up|2|||
160731108|NCT00664859|580397071|FG001|Overall Study|Lost to Follow-up|2|||
160731109|NCT00664859|580397072|FG002|Overall Study|Lost to Follow-up|1|||
160731110|NCT00664859|580397070|FG000|Overall Study|Other|0|||
160731111|NCT00664859|580397071|FG001|Overall Study|Other|1|||
160731112|NCT00664859|580397072|FG002|Overall Study|Other|2|||
160731113|NCT01943851|580397075|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731114|NCT01943851|580397076|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731115|NCT01943851|580397077|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731116|NCT01943851|580397078|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
160731117|NCT01943851|580397079|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731118|NCT01943851|580397080|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731119|NCT01943851|580397081|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
160731120|NCT01943851|580397082|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
160731121|NCT01943851|580397083|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
160731122|NCT01943851|580397084|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731123|NCT01943851|580397085|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731124|NCT01943851|580397086|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731125|NCT01943851|580397087|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731126|NCT01943851|580397088|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731127|NCT01943851|580397089|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731128|NCT01943851|580397090|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731129|NCT01943851|580397091|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731130|NCT01943851|580397092|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
160731131|NCT01943851|580397075|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731132|NCT01943851|580397076|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731133|NCT01943851|580397077|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731134|NCT01943851|580397078|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731135|NCT01943851|580397079|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
160731136|NCT01943851|580397080|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731137|NCT01943851|580397081|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731138|NCT01943851|580397082|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
160731139|NCT01943851|580397083|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731140|NCT01943851|580397084|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731141|NCT01943851|580397085|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731142|NCT01943851|580397086|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731143|NCT01943851|580397087|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731144|NCT01943851|580397088|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731145|NCT01943851|580397089|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731146|NCT01943851|580397090|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731147|NCT01943851|580397091|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731148|NCT01943851|580397092|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
160731149|NCT01943851|580397075|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731150|NCT01943851|580397076|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731151|NCT01943851|580397077|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731152|NCT01943851|580397078|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731153|NCT01943851|580397079|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731154|NCT01943851|580397080|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731155|NCT01943851|580397081|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731156|NCT01943851|580397082|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731157|NCT01943851|580397083|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731158|NCT01943851|580397084|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731159|NCT01943851|580397085|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731160|NCT01943851|580397086|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731161|NCT01943851|580397087|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731162|NCT01943851|580397088|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
160731163|NCT01943851|580397089|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731164|NCT01943851|580397090|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731165|NCT01943851|580397091|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731166|NCT01943851|580397092|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
160731167|NCT01943851|580397075|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731168|NCT01943851|580397076|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731169|NCT01943851|580397077|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731170|NCT01943851|580397078|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731171|NCT01943851|580397079|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731172|NCT01943851|580397080|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731173|NCT01943851|580397081|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731174|NCT01943851|580397082|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731175|NCT01943851|580397083|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731176|NCT01943851|580397084|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731177|NCT01943851|580397085|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731178|NCT01943851|580397086|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731179|NCT01943851|580397087|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731180|NCT01943851|580397088|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731181|NCT01943851|580397089|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731182|NCT01943851|580397090|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
160731183|NCT01943851|580397091|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731184|NCT01943851|580397092|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
160731185|NCT01943851|580397075|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731186|NCT01943851|580397076|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731187|NCT01943851|580397077|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731188|NCT01943851|580397078|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731189|NCT01943851|580397079|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731190|NCT01943851|580397080|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731191|NCT01943851|580397081|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731192|NCT01943851|580397082|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731193|NCT01943851|580397083|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731194|NCT01943851|580397084|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731195|NCT01943851|580397085|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731196|NCT01943851|580397086|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731197|NCT01943851|580397087|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731198|NCT01943851|580397088|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731199|NCT01943851|580397089|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
160731200|NCT01943851|580397090|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
160731201|NCT01943851|580397091|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
160731202|NCT01943851|580397092|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
160731203|NCT00280397|580397093|FG000|Overall Study|Adverse Event|1|||
160731204|NCT01250873|580397094|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
160731205|NCT01250873|580397094|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
160731206|NCT00930774|580397095|FG000|Overall Study|Withdrawal by Subject|1|||
160731207|NCT00930774|580397096|FG001|Overall Study|Withdrawal by Subject|9|||
160731208|NCT00930774|580397097|FG002|Overall Study|Withdrawal by Subject|2|||
160731209|NCT00930774|580397098|FG003|Overall Study|Withdrawal by Subject|0|||
160731210|NCT03200704|580397099|FG000|Overall Study|Withdrawal by Subject|1|||
160731211|NCT00425061|580397100|FG000|Overall Study|Adverse Event|1|||
160731212|NCT00425061|580397101|FG001|Overall Study|Adverse Event|0|||
160731213|NCT00425061|580397102|FG002|Overall Study|Adverse Event|0|||
160731214|NCT00425061|580397103|FG003|Overall Study|Adverse Event|2|||
160731215|NCT00425061|580397104|FG004|Overall Study|Adverse Event|2|||
160731216|NCT00425061|580397105|FG005|Overall Study|Adverse Event|0|||
160731217|NCT00425061|580397106|FG006|Overall Study|Adverse Event|0|||
160731218|NCT00425061|580397100|FG000|Overall Study|Lost to Follow-up|0|||
160731219|NCT00425061|580397101|FG001|Overall Study|Lost to Follow-up|1|||
160731220|NCT00425061|580397102|FG002|Overall Study|Lost to Follow-up|0|||
160731221|NCT00425061|580397103|FG003|Overall Study|Lost to Follow-up|0|||
160731222|NCT00425061|580397104|FG004|Overall Study|Lost to Follow-up|0|||
160731223|NCT00425061|580397105|FG005|Overall Study|Lost to Follow-up|0|||
160731224|NCT00425061|580397106|FG006|Overall Study|Lost to Follow-up|0|||
160731225|NCT00425061|580397100|FG000|Overall Study|Protocol Violation|1|||
160731226|NCT00425061|580397101|FG001|Overall Study|Protocol Violation|0|||
160731227|NCT00425061|580397102|FG002|Overall Study|Protocol Violation|0|||
160731228|NCT00425061|580397103|FG003|Overall Study|Protocol Violation|0|||
160731229|NCT00425061|580397104|FG004|Overall Study|Protocol Violation|0|||
160731230|NCT00425061|580397105|FG005|Overall Study|Protocol Violation|0|||
160731231|NCT00425061|580397106|FG006|Overall Study|Protocol Violation|0|||
160731232|NCT00425061|580397100|FG000|Overall Study|Withdrawal by Subject|0|||
160731233|NCT00425061|580397101|FG001|Overall Study|Withdrawal by Subject|1|||
160731234|NCT00425061|580397102|FG002|Overall Study|Withdrawal by Subject|0|||
160731235|NCT00425061|580397103|FG003|Overall Study|Withdrawal by Subject|0|||
160731236|NCT00425061|580397104|FG004|Overall Study|Withdrawal by Subject|1|||
160731237|NCT00425061|580397105|FG005|Overall Study|Withdrawal by Subject|0|||
160731238|NCT00425061|580397106|FG006|Overall Study|Withdrawal by Subject|3|||
160731239|NCT00425061|580397100|FG000|Overall Study|Sponsor's request|0|||
160731240|NCT00425061|580397101|FG001|Overall Study|Sponsor's request|0|||
160731241|NCT00425061|580397102|FG002|Overall Study|Sponsor's request|0|||
160731242|NCT00425061|580397103|FG003|Overall Study|Sponsor's request|0|||
160731243|NCT00425061|580397104|FG004|Overall Study|Sponsor's request|19|||
160731244|NCT00425061|580397105|FG005|Overall Study|Sponsor's request|4|||
160731245|NCT00425061|580397106|FG006|Overall Study|Sponsor's request|15|||
160731246|NCT00425061|580397100|FG000|Overall Study|Physician Decision|0|||
160731247|NCT00425061|580397101|FG001|Overall Study|Physician Decision|0|||
160731248|NCT00425061|580397102|FG002|Overall Study|Physician Decision|0|||
160731249|NCT00425061|580397103|FG003|Overall Study|Physician Decision|0|||
160731250|NCT00425061|580397104|FG004|Overall Study|Physician Decision|1|||
160731251|NCT00425061|580397105|FG005|Overall Study|Physician Decision|0|||
160731252|NCT00425061|580397106|FG006|Overall Study|Physician Decision|0|||
160731253|NCT00425061|580397100|FG000|Overall Study|Other|0|||
160731254|NCT00425061|580397101|FG001|Overall Study|Other|0|||
160731255|NCT00425061|580397102|FG002|Overall Study|Other|0|||
160731256|NCT00425061|580397103|FG003|Overall Study|Other|0|||
160731257|NCT00425061|580397104|FG004|Overall Study|Other|3|||
160731258|NCT00425061|580397105|FG005|Overall Study|Other|0|||
160731259|NCT00425061|580397106|FG006|Overall Study|Other|1|||
160731260|NCT02111577|580397107|FG000|Overall Study|Protocol Violation|2|||
160731261|NCT02111577|580397108|FG001|Overall Study|Protocol Violation|0|||
160731262|NCT02111577|580397107|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
160731263|NCT02111577|580397108|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
160731264|NCT02111577|580397107|FG000|Overall Study|Failure to produce study treatment|6|||
160731265|NCT02111577|580397108|FG001|Overall Study|Failure to produce study treatment|0|||
160731266|NCT02111577|580397107|FG000|Overall Study|Death|518|||
160731267|NCT02111577|580397108|FG001|Overall Study|Death|254|||
160731268|NCT02111577|580397107|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
160731269|NCT02111577|580397108|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
160731270|NCT02111577|580397107|FG000|Overall Study|Adverse Event|1|||
160731271|NCT02111577|580397108|FG001|Overall Study|Adverse Event|1|||
160731272|NCT02111577|580397107|FG000|Overall Study|Withdrawal by Subject|51|||
160731273|NCT02111577|580397108|FG001|Overall Study|Withdrawal by Subject|23|||
160731274|NCT02111577|580397107|FG000|Overall Study|Disease progression|0|||
160731275|NCT02111577|580397108|FG001|Overall Study|Disease progression|1|||
160731276|NCT02111577|580397107|FG000|Overall Study|Lost to Follow-up|19|||
160731277|NCT02111577|580397108|FG001|Overall Study|Lost to Follow-up|10|||
160731278|NCT04967885|580397109|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
160731279|NCT04967885|580397110|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
160731280|NCT04967885|580397109|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
160731281|NCT04967885|580397110|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
160731282|NCT04967885|580397109|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
160731283|NCT04967885|580397110|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
160731284|NCT04967885|580397109|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
160731285|NCT04967885|580397110|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
160731286|NCT04967885|580397109|FG000|EMI-II Intervention|Lost to Follow-up|14|||
160731287|NCT04967885|580397110|FG001|EMI-II Intervention|Lost to Follow-up|10|||
160731288|NCT01940887|580397111|FG000|Year 1|Protocol Violation|0|||
160731289|NCT01940887|580397112|FG001|Year 1|Protocol Violation|1|||
160731290|NCT01940887|580397111|FG000|Year 1|Physician Decision|7|||
160731291|NCT01940887|580397112|FG001|Year 1|Physician Decision|3|||
160731292|NCT01940887|580397111|FG000|Year 1|Death|5|||
160731293|NCT01940887|580397112|FG001|Year 1|Death|3|||
160731294|NCT01940887|580397111|FG000|Year 1|Adverse Event|7|||
160731295|NCT01940887|580397112|FG001|Year 1|Adverse Event|6|||
160731296|NCT01940887|580397111|FG000|Year 1|Withdrawal by Subject|18|||
160731297|NCT01940887|580397112|FG001|Year 1|Withdrawal by Subject|9|||
160731298|NCT01940887|580397111|FG000|Year 1|Lost to Follow-up|2|||
160731299|NCT01940887|580397112|FG001|Year 1|Lost to Follow-up|1|||
160731300|NCT01940887|580397111|FG000|Year 2|Physician Decision|8|||
160731301|NCT01940887|580397112|FG001|Year 2|Physician Decision|1|||
160731302|NCT01940887|580397111|FG000|Year 2|Death|0|||
160731303|NCT01940887|580397112|FG001|Year 2|Death|2|||
160731304|NCT01940887|580397111|FG000|Year 2|Sponsor Decision, early termination|192|||
160731305|NCT01940887|580397112|FG001|Year 2|Sponsor Decision, early termination|203|||
160731306|NCT01940887|580397111|FG000|Year 2|Adverse Event|8|||
160731307|NCT01940887|580397112|FG001|Year 2|Adverse Event|2|||
160731308|NCT01940887|580397111|FG000|Year 2|Withdrawal by Subject|8|||
160731309|NCT01940887|580397112|FG001|Year 2|Withdrawal by Subject|8|||
160731310|NCT01940887|580397111|FG000|Year 2|Lost to Follow-up|1|||
160731311|NCT01940887|580397112|FG001|Year 2|Lost to Follow-up|6|||
160731312|NCT02475265|580397113|FG000|Overall Study|Physician Decision|1|||
160731313|NCT02475265|580397113|FG000|Overall Study|Withdrawal by Subject|2|||
160731314|NCT01254318|580397116|FG000|Overall Study|Lost to Follow-up|5|||
160731315|NCT01254318|580397116|FG000|Overall Study|Death|47|||
160731316|NCT01137110|580397123|FG000|Overall Study|Protocol Violation|1|||
160731317|NCT01137110|580397124|FG001|Overall Study|Protocol Violation|0|||
160731318|NCT02828124|580397127|FG000|Overall Study|Disease Progression|1|||
160731319|NCT02828124|580397128|FG001|Overall Study|Disease Progression|2|||
160731320|NCT02828124|580397129|FG002|Overall Study|Disease Progression|1|||
160731321|NCT02828124|580397130|FG003|Overall Study|Disease Progression|4|||
160731322|NCT02828124|580397127|FG000|Overall Study|AE Unrelated to Study Drug|0|||
160731323|NCT02828124|580397128|FG001|Overall Study|AE Unrelated to Study Drug|0|||
160731324|NCT02828124|580397129|FG002|Overall Study|AE Unrelated to Study Drug|0|||
160731325|NCT02828124|580397130|FG003|Overall Study|AE Unrelated to Study Drug|1|||
160731326|NCT02828124|580397127|FG000|Overall Study|Subject Withdrew Consent|0|||
160731327|NCT02828124|580397128|FG001|Overall Study|Subject Withdrew Consent|0|||
160731328|NCT02828124|580397129|FG002|Overall Study|Subject Withdrew Consent|0|||
160731329|NCT02828124|580397130|FG003|Overall Study|Subject Withdrew Consent|1|||
160731330|NCT06586788|580397131|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
160731331|NCT03990571|580397133|FG000|Overall Study|Withdrawal by Subject|1|||
160731332|NCT03990571|580397133|FG000|Overall Study|Insurance Issues|3|||
160731333|NCT03990571|580397133|FG000|Overall Study|Covid Restrictions|2|||
160731334|NCT03514485|580397134|FG000|Overall Study|Lost to Follow-up|5|||
160731335|NCT03514485|580397135|FG001|Overall Study|Lost to Follow-up|3|||
160731336|NCT03514485|580397136|FG002|Overall Study|Lost to Follow-up|2|||
160731337|NCT03514485|580397137|FG003|Overall Study|Lost to Follow-up|0|||
160731338|NCT03514485|580397138|FG004|Overall Study|Lost to Follow-up|1|||
160731339|NCT03514485|580397139|FG005|Overall Study|Lost to Follow-up|4|||
160731340|NCT03514485|580397134|FG000|Overall Study|Withdrawal by Subject|0|||
160731341|NCT03514485|580397135|FG001|Overall Study|Withdrawal by Subject|1|||
160731342|NCT03514485|580397136|FG002|Overall Study|Withdrawal by Subject|3|||
160731343|NCT03514485|580397137|FG003|Overall Study|Withdrawal by Subject|1|||
160731344|NCT03514485|580397138|FG004|Overall Study|Withdrawal by Subject|2|||
160731345|NCT03514485|580397139|FG005|Overall Study|Withdrawal by Subject|1|||
160731346|NCT01870973|580397140|FG000|Overall Study|Lost to Follow-up|10|||
160731347|NCT01870973|580397141|FG001|Overall Study|Lost to Follow-up|3|||
160731348|NCT03693612|580399878|FG000|Overall Study|Lost to Follow-up|0|||
160731349|NCT03693612|580399879|FG001|Overall Study|Lost to Follow-up|0|||
160731350|NCT03693612|580399880|FG002|Overall Study|Lost to Follow-up|0|||
160731351|NCT03693612|580399881|FG003|Overall Study|Lost to Follow-up|0|||
160731352|NCT03693612|580399882|FG004|Overall Study|Lost to Follow-up|1|||
160731353|NCT03693612|580399883|FG005|Overall Study|Lost to Follow-up|0|||
160731354|NCT03693612|580399884|FG006|Overall Study|Lost to Follow-up|0|||
160731355|NCT03693612|580399878|FG000|Overall Study|Withdrawal by Subject|0|||
160731356|NCT03693612|580399879|FG001|Overall Study|Withdrawal by Subject|0|||
160731357|NCT03693612|580399880|FG002|Overall Study|Withdrawal by Subject|1|||
160731358|NCT03693612|580399881|FG003|Overall Study|Withdrawal by Subject|0|||
160731359|NCT03693612|580399882|FG004|Overall Study|Withdrawal by Subject|2|||
160731360|NCT03693612|580399883|FG005|Overall Study|Withdrawal by Subject|0|||
160731361|NCT03693612|580399884|FG006|Overall Study|Withdrawal by Subject|0|||
160731362|NCT03693612|580399878|FG000|Overall Study|Study Terminated by Sponsor|0|||
160731363|NCT03693612|580399879|FG001|Overall Study|Study Terminated by Sponsor|1|||
160731364|NCT03693612|580399880|FG002|Overall Study|Study Terminated by Sponsor|0|||
160731365|NCT03693612|580399881|FG003|Overall Study|Study Terminated by Sponsor|0|||
160731366|NCT03693612|580399882|FG004|Overall Study|Study Terminated by Sponsor|3|||
160731367|NCT03693612|580399883|FG005|Overall Study|Study Terminated by Sponsor|0|||
160731368|NCT03693612|580399884|FG006|Overall Study|Study Terminated by Sponsor|0|||
160731369|NCT00401544|580399888|FG000|Overall Study|Adverse Event|5|||
160731370|NCT00401544|580399889|FG001|Overall Study|Adverse Event|1|||
160731371|NCT00401544|580399890|FG002|Overall Study|Adverse Event|1|||
160731372|NCT00401544|580399891|FG003|Overall Study|Adverse Event|1|||
160731373|NCT00401544|580399888|FG000|Overall Study|Death|3|||
160731374|NCT00401544|580399889|FG001|Overall Study|Death|6|||
160731375|NCT00401544|580399890|FG002|Overall Study|Death|2|||
160731376|NCT00401544|580399891|FG003|Overall Study|Death|5|||
160731377|NCT00401544|580399888|FG000|Overall Study|Lost to Follow-up|2|||
160731378|NCT00401544|580399889|FG001|Overall Study|Lost to Follow-up|0|||
160731379|NCT00401544|580399890|FG002|Overall Study|Lost to Follow-up|1|||
160731380|NCT00401544|580399891|FG003|Overall Study|Lost to Follow-up|1|||
160731381|NCT00401544|580399888|FG000|Overall Study|Withdrawal by Subject|7|||
160731382|NCT00401544|580399889|FG001|Overall Study|Withdrawal by Subject|6|||
160731383|NCT00401544|580399890|FG002|Overall Study|Withdrawal by Subject|6|||
160731384|NCT00401544|580399891|FG003|Overall Study|Withdrawal by Subject|5|||
160731385|NCT00401544|580399888|FG000|Overall Study|Physician Decision|1|||
160731386|NCT00401544|580399889|FG001|Overall Study|Physician Decision|3|||
160731387|NCT00401544|580399890|FG002|Overall Study|Physician Decision|0|||
160731388|NCT00401544|580399891|FG003|Overall Study|Physician Decision|0|||
160731389|NCT00401544|580399888|FG000|Overall Study|Ineligibility determined|0|||
160731390|NCT00401544|580399889|FG001|Overall Study|Ineligibility determined|1|||
160731391|NCT00401544|580399890|FG002|Overall Study|Ineligibility determined|0|||
160731392|NCT00401544|580399891|FG003|Overall Study|Ineligibility determined|2|||
160731393|NCT00401544|580399888|FG000|Overall Study|Disease progression|0|||
160731394|NCT00401544|580399889|FG001|Overall Study|Disease progression|1|||
160731395|NCT00401544|580399890|FG002|Overall Study|Disease progression|0|||
160731396|NCT00401544|580399891|FG003|Overall Study|Disease progression|0|||
160731397|NCT00401544|580399888|FG000|Overall Study|Other|0|||
160731398|NCT00401544|580399889|FG001|Overall Study|Other|0|||
160731399|NCT00401544|580399890|FG002|Overall Study|Other|2|||
160731400|NCT00401544|580399891|FG003|Overall Study|Other|2|||
160731401|NCT02564900|580399893|FG000|Dose Escalation|Progressive disease per RECIST|2|||
160731402|NCT02564900|580399894|FG001|Dose Escalation|Progressive disease per RECIST|3|||
160731403|NCT02564900|580399895|FG002|Dose Escalation|Progressive disease per RECIST|3|||
160731404|NCT02564900|580399896|FG003|Dose Escalation|Progressive disease per RECIST|3|||
160731405|NCT02564900|580399897|FG004|Dose Escalation|Progressive disease per RECIST|3|||
160731406|NCT02564900|580399898|FG005|Dose Escalation|Progressive disease per RECIST|1|||
160731407|NCT02564900|580399899|FG006|Dose Escalation|Progressive disease per RECIST|0|||
160731408|NCT02564900|580399900|FG007|Dose Escalation|Progressive disease per RECIST|0|||
160731409|NCT02564900|580399901|FG008|Dose Escalation|Progressive disease per RECIST|0|||
160731410|NCT02564900|580399902|FG009|Dose Escalation|Progressive disease per RECIST|0|||
160731411|NCT02564900|580399903|FG010|Dose Escalation|Progressive disease per RECIST|0|||
160731412|NCT02564900|580399904|FG011|Dose Escalation|Progressive disease per RECIST|0|||
160731413|NCT02564900|580399905|FG012|Dose Escalation|Progressive disease per RECIST|0|||
160731414|NCT02564900|580399906|FG013|Dose Escalation|Progressive disease per RECIST|0|||
160731415|NCT02564900|580399907|FG014|Dose Escalation|Progressive disease per RECIST|0|||
160731416|NCT02564900|580399893|FG000|Dose Escalation|Ongoing|1|||
160731417|NCT02564900|580399894|FG001|Dose Escalation|Ongoing|0|||
160731418|NCT02564900|580399895|FG002|Dose Escalation|Ongoing|0|||
160731419|NCT02564900|580399896|FG003|Dose Escalation|Ongoing|2|||
160731420|NCT02564900|580399897|FG004|Dose Escalation|Ongoing|2|||
160731421|NCT02564900|580399898|FG005|Dose Escalation|Ongoing|2|||
160731422|NCT02564900|580399899|FG006|Dose Escalation|Ongoing|0|||
160731423|NCT02564900|580399900|FG007|Dose Escalation|Ongoing|0|||
160731424|NCT02564900|580399901|FG008|Dose Escalation|Ongoing|0|||
160731425|NCT02564900|580399902|FG009|Dose Escalation|Ongoing|0|||
160731426|NCT02564900|580399903|FG010|Dose Escalation|Ongoing|0|||
160731427|NCT02564900|580399904|FG011|Dose Escalation|Ongoing|0|||
160731428|NCT02564900|580399905|FG012|Dose Escalation|Ongoing|0|||
160731429|NCT02564900|580399906|FG013|Dose Escalation|Ongoing|0|||
160731430|NCT02564900|580399907|FG014|Dose Escalation|Ongoing|0|||
160731431|NCT02564900|580399893|FG000|Dose Escalation|Adverse Event|0|||
160731432|NCT02564900|580399894|FG001|Dose Escalation|Adverse Event|0|||
160731433|NCT02564900|580399895|FG002|Dose Escalation|Adverse Event|0|||
160731434|NCT02564900|580399896|FG003|Dose Escalation|Adverse Event|1|||
160731435|NCT02564900|580399897|FG004|Dose Escalation|Adverse Event|1|||
160731436|NCT02564900|580399898|FG005|Dose Escalation|Adverse Event|3|||
160731437|NCT02564900|580399899|FG006|Dose Escalation|Adverse Event|0|||
160731438|NCT02564900|580399900|FG007|Dose Escalation|Adverse Event|0|||
160731439|NCT02564900|580399901|FG008|Dose Escalation|Adverse Event|0|||
160731440|NCT02564900|580399902|FG009|Dose Escalation|Adverse Event|0|||
160731441|NCT02564900|580399903|FG010|Dose Escalation|Adverse Event|0|||
160731442|NCT02564900|580399904|FG011|Dose Escalation|Adverse Event|0|||
160731443|NCT02564900|580399905|FG012|Dose Escalation|Adverse Event|0|||
160731444|NCT02564900|580399906|FG013|Dose Escalation|Adverse Event|0|||
160731445|NCT02564900|580399907|FG014|Dose Escalation|Adverse Event|0|||
160731446|NCT02564900|580399893|FG000|Dose Expansion|Progressive disease per RECIST|0|||
160731447|NCT02564900|580399894|FG001|Dose Expansion|Progressive disease per RECIST|0|||
160731448|NCT02564900|580399895|FG002|Dose Expansion|Progressive disease per RECIST|0|||
160731449|NCT02564900|580399896|FG003|Dose Expansion|Progressive disease per RECIST|0|||
160731450|NCT02564900|580399897|FG004|Dose Expansion|Progressive disease per RECIST|0|||
160731451|NCT02564900|580399898|FG005|Dose Expansion|Progressive disease per RECIST|0|||
160731452|NCT02564900|580399899|FG006|Dose Expansion|Progressive disease per RECIST|19|||
160731453|NCT02564900|580399900|FG007|Dose Expansion|Progressive disease per RECIST|17|||
160731454|NCT02564900|580399901|FG008|Dose Expansion|Progressive disease per RECIST|8|||
160731455|NCT02564900|580399902|FG009|Dose Expansion|Progressive disease per RECIST|16|||
160731456|NCT02564900|580399903|FG010|Dose Expansion|Progressive disease per RECIST|13|||
160731457|NCT02564900|580399904|FG011|Dose Expansion|Progressive disease per RECIST|19|||
160731458|NCT02564900|580399905|FG012|Dose Expansion|Progressive disease per RECIST|10|||
160731459|NCT02564900|580399906|FG013|Dose Expansion|Progressive disease per RECIST|13|||
160731460|NCT02564900|580399907|FG014|Dose Expansion|Progressive disease per RECIST|11|||
160731461|NCT02564900|580399893|FG000|Dose Expansion|Clinical progression|0|||
160731462|NCT02564900|580399894|FG001|Dose Expansion|Clinical progression|0|||
160731463|NCT02564900|580399895|FG002|Dose Expansion|Clinical progression|0|||
160731464|NCT02564900|580399896|FG003|Dose Expansion|Clinical progression|0|||
160731465|NCT02564900|580399897|FG004|Dose Expansion|Clinical progression|0|||
160731466|NCT02564900|580399898|FG005|Dose Expansion|Clinical progression|0|||
160731467|NCT02564900|580399899|FG006|Dose Expansion|Clinical progression|5|||
160731468|NCT02564900|580399900|FG007|Dose Expansion|Clinical progression|12|||
160731469|NCT02564900|580399901|FG008|Dose Expansion|Clinical progression|0|||
160731470|NCT02564900|580399902|FG009|Dose Expansion|Clinical progression|3|||
160731471|NCT02564900|580399903|FG010|Dose Expansion|Clinical progression|2|||
160731472|NCT02564900|580399904|FG011|Dose Expansion|Clinical progression|0|||
160731473|NCT02564900|580399905|FG012|Dose Expansion|Clinical progression|1|||
160731474|NCT02564900|580399906|FG013|Dose Expansion|Clinical progression|3|||
160731475|NCT02564900|580399907|FG014|Dose Expansion|Clinical progression|1|||
160731476|NCT02564900|580399893|FG000|Dose Expansion|Adverse Event|0|||
160731477|NCT02564900|580399894|FG001|Dose Expansion|Adverse Event|0|||
160731478|NCT02564900|580399895|FG002|Dose Expansion|Adverse Event|0|||
160731479|NCT02564900|580399896|FG003|Dose Expansion|Adverse Event|0|||
160731480|NCT02564900|580399897|FG004|Dose Expansion|Adverse Event|0|||
160731481|NCT02564900|580399898|FG005|Dose Expansion|Adverse Event|0|||
160731482|NCT02564900|580399899|FG006|Dose Expansion|Adverse Event|9|||
160731483|NCT02564900|580399900|FG007|Dose Expansion|Adverse Event|22|||
160731484|NCT02564900|580399901|FG008|Dose Expansion|Adverse Event|0|||
160731485|NCT02564900|580399902|FG009|Dose Expansion|Adverse Event|11|||
160731486|NCT02564900|580399903|FG010|Dose Expansion|Adverse Event|0|||
160731487|NCT02564900|580399904|FG011|Dose Expansion|Adverse Event|5|||
160731488|NCT02564900|580399905|FG012|Dose Expansion|Adverse Event|2|||
160731489|NCT02564900|580399906|FG013|Dose Expansion|Adverse Event|2|||
160731490|NCT02564900|580399907|FG014|Dose Expansion|Adverse Event|1|||
160731491|NCT02564900|580399893|FG000|Dose Expansion|Ongoing|0|||
160731492|NCT02564900|580399894|FG001|Dose Expansion|Ongoing|0|||
160731493|NCT02564900|580399895|FG002|Dose Expansion|Ongoing|0|||
160731494|NCT02564900|580399896|FG003|Dose Expansion|Ongoing|0|||
160731495|NCT02564900|580399897|FG004|Dose Expansion|Ongoing|0|||
160731496|NCT02564900|580399898|FG005|Dose Expansion|Ongoing|0|||
160731497|NCT02564900|580399899|FG006|Dose Expansion|Ongoing|9|||
160731498|NCT02564900|580399900|FG007|Dose Expansion|Ongoing|10|||
160731499|NCT02564900|580399901|FG008|Dose Expansion|Ongoing|11|||
160731500|NCT02564900|580399902|FG009|Dose Expansion|Ongoing|3|||
160731501|NCT02564900|580399903|FG010|Dose Expansion|Ongoing|0|||
160731502|NCT02564900|580399904|FG011|Dose Expansion|Ongoing|0|||
160731503|NCT02564900|580399905|FG012|Dose Expansion|Ongoing|4|||
160731504|NCT02564900|580399906|FG013|Dose Expansion|Ongoing|0|||
160731505|NCT02564900|580399907|FG014|Dose Expansion|Ongoing|6|||
160731506|NCT02564900|580399893|FG000|Dose Expansion|Death|0|||
160731507|NCT02564900|580399894|FG001|Dose Expansion|Death|0|||
160731508|NCT02564900|580399895|FG002|Dose Expansion|Death|0|||
160731509|NCT02564900|580399896|FG003|Dose Expansion|Death|0|||
160731510|NCT02564900|580399897|FG004|Dose Expansion|Death|0|||
160731511|NCT02564900|580399898|FG005|Dose Expansion|Death|0|||
160731512|NCT02564900|580399899|FG006|Dose Expansion|Death|1|||
160731513|NCT02564900|580399900|FG007|Dose Expansion|Death|0|||
160731514|NCT02564900|580399901|FG008|Dose Expansion|Death|0|||
160731515|NCT02564900|580399902|FG009|Dose Expansion|Death|0|||
160731516|NCT02564900|580399903|FG010|Dose Expansion|Death|1|||
160731517|NCT02564900|580399904|FG011|Dose Expansion|Death|0|||
160731518|NCT02564900|580399905|FG012|Dose Expansion|Death|1|||
160731519|NCT02564900|580399906|FG013|Dose Expansion|Death|1|||
160731520|NCT02564900|580399907|FG014|Dose Expansion|Death|0|||
160731521|NCT02564900|580399893|FG000|Dose Expansion|Withdrawal by Subject|0|||
160731522|NCT02564900|580399894|FG001|Dose Expansion|Withdrawal by Subject|0|||
160731523|NCT02564900|580399895|FG002|Dose Expansion|Withdrawal by Subject|0|||
160731524|NCT02564900|580399896|FG003|Dose Expansion|Withdrawal by Subject|0|||
160731525|NCT02564900|580399897|FG004|Dose Expansion|Withdrawal by Subject|0|||
160731526|NCT02564900|580399898|FG005|Dose Expansion|Withdrawal by Subject|0|||
160731527|NCT02564900|580399899|FG006|Dose Expansion|Withdrawal by Subject|4|||
160731528|NCT02564900|580399900|FG007|Dose Expansion|Withdrawal by Subject|0|||
160731529|NCT02564900|580399901|FG008|Dose Expansion|Withdrawal by Subject|0|||
160731530|NCT02564900|580399902|FG009|Dose Expansion|Withdrawal by Subject|0|||
160731531|NCT02564900|580399903|FG010|Dose Expansion|Withdrawal by Subject|1|||
160731532|NCT02564900|580399904|FG011|Dose Expansion|Withdrawal by Subject|0|||
160731533|NCT02564900|580399905|FG012|Dose Expansion|Withdrawal by Subject|0|||
160731534|NCT02564900|580399906|FG013|Dose Expansion|Withdrawal by Subject|1|||
160731535|NCT02564900|580399907|FG014|Dose Expansion|Withdrawal by Subject|1|||
160731536|NCT02564900|580399893|FG000|Dose Expansion|Other|0|||
160731537|NCT02564900|580399894|FG001|Dose Expansion|Other|0|||
160731538|NCT02564900|580399895|FG002|Dose Expansion|Other|0|||
160731539|NCT02564900|580399896|FG003|Dose Expansion|Other|0|||
160731540|NCT02564900|580399897|FG004|Dose Expansion|Other|0|||
160731541|NCT02564900|580399898|FG005|Dose Expansion|Other|0|||
160731542|NCT02564900|580399899|FG006|Dose Expansion|Other|1|||
160731543|NCT02564900|580399900|FG007|Dose Expansion|Other|0|||
160731544|NCT02564900|580399901|FG008|Dose Expansion|Other|1|||
160731545|NCT02564900|580399902|FG009|Dose Expansion|Other|0|||
160731546|NCT02564900|580399903|FG010|Dose Expansion|Other|0|||
160731547|NCT02564900|580399904|FG011|Dose Expansion|Other|0|||
160731548|NCT02564900|580399905|FG012|Dose Expansion|Other|0|||
160731549|NCT02564900|580399906|FG013|Dose Expansion|Other|0|||
160731550|NCT02564900|580399907|FG014|Dose Expansion|Other|1|||
160731551|NCT02564900|580399893|FG000|Dose Expansion|Did not receive treatment|0|||
160731552|NCT02564900|580399894|FG001|Dose Expansion|Did not receive treatment|0|||
160731553|NCT02564900|580399895|FG002|Dose Expansion|Did not receive treatment|0|||
160731554|NCT02564900|580399896|FG003|Dose Expansion|Did not receive treatment|0|||
160731555|NCT02564900|580399897|FG004|Dose Expansion|Did not receive treatment|0|||
160731556|NCT02564900|580399898|FG005|Dose Expansion|Did not receive treatment|0|||
160731557|NCT02564900|580399899|FG006|Dose Expansion|Did not receive treatment|1|||
160731558|NCT02564900|580399900|FG007|Dose Expansion|Did not receive treatment|1|||
160731559|NCT02564900|580399901|FG008|Dose Expansion|Did not receive treatment|0|||
160731560|NCT02564900|580399902|FG009|Dose Expansion|Did not receive treatment|0|||
160731561|NCT02564900|580399903|FG010|Dose Expansion|Did not receive treatment|0|||
160731562|NCT02564900|580399904|FG011|Dose Expansion|Did not receive treatment|0|||
160731563|NCT02564900|580399905|FG012|Dose Expansion|Did not receive treatment|0|||
160731564|NCT02564900|580399906|FG013|Dose Expansion|Did not receive treatment|0|||
160731565|NCT02564900|580399907|FG014|Dose Expansion|Did not receive treatment|1|||
160731566|NCT03991299|580399908|FG000|Overall Study|Study closed, sponsor decision|3|||
160731567|NCT03991299|580399908|FG000|Overall Study|Withdrawal by Subject|1|||
160731568|NCT02423343|580399914|FG000|Overall Study|Withdrawal by Subject|0|||
160731569|NCT02423343|580399915|FG001|Overall Study|Withdrawal by Subject|1|||
160731570|NCT02423343|580399916|FG002|Overall Study|Withdrawal by Subject|0|||
160731571|NCT02423343|580399917|FG003|Overall Study|Withdrawal by Subject|0|||
160731572|NCT02423343|580399918|FG004|Overall Study|Withdrawal by Subject|0|||
160731573|NCT02423343|580399919|FG005|Overall Study|Withdrawal by Subject|0|||
160731574|NCT02423343|580399914|FG000|Overall Study|Progressive Disease|0|||
160731575|NCT02423343|580399915|FG001|Overall Study|Progressive Disease|0|||
160731576|NCT02423343|580399916|FG002|Overall Study|Progressive Disease|0|||
160731577|NCT02423343|580399917|FG003|Overall Study|Progressive Disease|0|||
160731578|NCT02423343|580399918|FG004|Overall Study|Progressive Disease|2|||
160731579|NCT02423343|580399919|FG005|Overall Study|Progressive Disease|0|||
160731580|NCT02423343|580399914|FG000|Overall Study|Adverse Event|0|||
160731581|NCT02423343|580399915|FG001|Overall Study|Adverse Event|0|||
160731582|NCT02423343|580399916|FG002|Overall Study|Adverse Event|0|||
160731583|NCT02423343|580399917|FG003|Overall Study|Adverse Event|0|||
160731584|NCT02423343|580399918|FG004|Overall Study|Adverse Event|2|||
160731585|NCT02423343|580399919|FG005|Overall Study|Adverse Event|0|||
160731586|NCT02423343|580399914|FG000|Overall Study|Death|0|||
160731587|NCT02423343|580399915|FG001|Overall Study|Death|0|||
160731588|NCT02423343|580399916|FG002|Overall Study|Death|0|||
160731589|NCT02423343|580399917|FG003|Overall Study|Death|0|||
160731590|NCT02423343|580399918|FG004|Overall Study|Death|1|||
160731591|NCT02423343|580399919|FG005|Overall Study|Death|0|||
160731592|NCT04429555|580399924|FG000|Overall Study|Death|0|||
160731593|NCT04429555|580399925|FG001|Overall Study|Death|2|||
160731594|NCT04429555|580399924|FG000|Overall Study|Other|2|||
160731595|NCT04429555|580399925|FG001|Overall Study|Other|0|||
160731596|NCT00654875|580399926|FG000|Overall Study|Adverse Event|5|||
160731597|NCT00654875|580399927|FG001|Overall Study|Adverse Event|5|||
160731598|NCT00654875|580399926|FG000|Overall Study|Withdrawal by Subject|4|||
160731599|NCT00654875|580399927|FG001|Overall Study|Withdrawal by Subject|4|||
160731600|NCT00654875|580399926|FG000|Overall Study|Protocol Violation|3|||
160731601|NCT00654875|580399927|FG001|Overall Study|Protocol Violation|3|||
160731602|NCT00654875|580399926|FG000|Overall Study|Lack of Efficacy|2|||
160731603|NCT00654875|580399927|FG001|Overall Study|Lack of Efficacy|2|||
160731604|NCT00654875|580399926|FG000|Overall Study|Lost to Follow-up|1|||
160731605|NCT00654875|580399927|FG001|Overall Study|Lost to Follow-up|3|||
160731606|NCT00654875|580399926|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
160731607|NCT00654875|580399927|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
160731608|NCT00654875|580399926|FG000|Overall Study|Administrative Problems|1|||
160731609|NCT00654875|580399927|FG001|Overall Study|Administrative Problems|0|||
160731610|NCT01011465|580399928|FG000|Overall Study|Withdrawal by Subject|2|||
160731611|NCT01011465|580399929|FG001|Overall Study|Withdrawal by Subject|1|||
160731612|NCT01011465|580399930|FG002|Overall Study|Withdrawal by Subject|0|||
160731613|NCT01011465|580399931|FG003|Overall Study|Withdrawal by Subject|0|||
160731614|NCT01011465|580399932|FG004|Overall Study|Withdrawal by Subject|1|||
160731615|NCT01011465|580399933|FG005|Overall Study|Withdrawal by Subject|0|||
160731616|NCT01011465|580399934|FG006|Overall Study|Withdrawal by Subject|1|||
160731617|NCT01011465|580399935|FG007|Overall Study|Withdrawal by Subject|0|||
160731618|NCT02042950|580399938|FG000|Overall Study|Progressive Disease|4|||
160731619|NCT00723008|580399939|FG000|Enrollment|Lost to Follow-up|1|||
160731620|NCT00723008|580399940|FG001|Enrollment|Lost to Follow-up|0|||
160731621|NCT00723008|580399939|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
160731622|NCT00723008|580399940|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
160731623|NCT00723008|580399939|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
160731624|NCT00723008|580399940|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
160731625|NCT00723008|580399939|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
160731626|NCT00723008|580399940|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
160731627|NCT00723008|580399939|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
160731628|NCT00723008|580399940|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
160731629|NCT00723008|580399939|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
160731630|NCT00723008|580399940|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
160731631|NCT01014988|580399943|FG000|Overall Study|Adverse Event|20|||
160731632|NCT01014988|580399944|FG001|Overall Study|Adverse Event|0|||
160731633|NCT01014988|580399945|FG002|Overall Study|Adverse Event|1|||
160731634|NCT01014988|580399946|FG003|Overall Study|Adverse Event|0|||
160731635|NCT01014988|580399947|FG004|Overall Study|Adverse Event|1|||
160731636|NCT01014988|580399948|FG005|Overall Study|Adverse Event|3|||
160731637|NCT01014988|580399943|FG000|Overall Study|Lost to Follow-up|1|||
160731638|NCT01014988|580399944|FG001|Overall Study|Lost to Follow-up|0|||
160731639|NCT01014988|580399945|FG002|Overall Study|Lost to Follow-up|1|||
160731640|NCT01014988|580399946|FG003|Overall Study|Lost to Follow-up|0|||
160731641|NCT01014988|580399947|FG004|Overall Study|Lost to Follow-up|0|||
160731642|NCT01014988|580399948|FG005|Overall Study|Lost to Follow-up|0|||
160731643|NCT01014988|580399943|FG000|Overall Study|Physician Decision|1|||
160731644|NCT01014988|580399944|FG001|Overall Study|Physician Decision|0|||
160731645|NCT01014988|580399945|FG002|Overall Study|Physician Decision|0|||
160731646|NCT01014988|580399946|FG003|Overall Study|Physician Decision|0|||
160731647|NCT01014988|580399947|FG004|Overall Study|Physician Decision|0|||
160731648|NCT01014988|580399948|FG005|Overall Study|Physician Decision|0|||
160731649|NCT01014988|580399943|FG000|Overall Study|Withdrawal by Subject|1|||
160731650|NCT01014988|580399944|FG001|Overall Study|Withdrawal by Subject|0|||
160731651|NCT01014988|580399945|FG002|Overall Study|Withdrawal by Subject|0|||
160731652|NCT01014988|580399946|FG003|Overall Study|Withdrawal by Subject|0|||
160731653|NCT01014988|580399947|FG004|Overall Study|Withdrawal by Subject|0|||
160731654|NCT01014988|580399948|FG005|Overall Study|Withdrawal by Subject|0|||
160731655|NCT01683266|580399951|FG000|Overall Study|Adverse Event|5|||
160731656|NCT01683266|580399952|FG001|Overall Study|Adverse Event|4|||
160731657|NCT01683266|580399951|FG000|Overall Study|Lack of Efficacy|5|||
160731658|NCT01683266|580399952|FG001|Overall Study|Lack of Efficacy|2|||
160731659|NCT01683266|580399951|FG000|Overall Study|Protocol Violation|13|||
160731660|NCT01683266|580399952|FG001|Overall Study|Protocol Violation|6|||
160731661|NCT01683266|580399951|FG000|Overall Study|Personal Reason|17|||
160731662|NCT01683266|580399952|FG001|Overall Study|Personal Reason|25|||
160731663|NCT01683266|580399951|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
160731664|NCT01683266|580399952|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
160731665|NCT01683266|580399951|FG000|Overall Study|Lost to Follow-up|5|||
160731666|NCT01683266|580399952|FG001|Overall Study|Lost to Follow-up|0|||
160731667|NCT01683266|580399951|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
160731668|NCT01683266|580399952|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
160731669|NCT01683266|580399951|FG000|Overall Study|Nonserious Hypoglycemia|0|||
160731670|NCT01683266|580399952|FG001|Overall Study|Nonserious Hypoglycemia|3|||
160731671|NCT01683266|580399951|FG000|Overall Study|Perceived Lack of Efficacy|1|||
160731672|NCT01683266|580399952|FG001|Overall Study|Perceived Lack of Efficacy|1|||
160731673|NCT01683266|580399951|FG000|Overall Study|Possibly Hypoglycemia|1|||
160731674|NCT01683266|580399952|FG001|Overall Study|Possibly Hypoglycemia|0|||
160731675|NCT01683266|580399951|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
160731676|NCT01683266|580399952|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
160731677|NCT00626821|580399955|FG000|Overall Study|Adverse Event|44|||
160731678|NCT00626821|580399955|FG000|Overall Study|Protocol Violation|33|||
160731679|NCT00626821|580399955|FG000|Overall Study|Withdrawal by Subject|10|||
160731680|NCT00626821|580399955|FG000|Overall Study|Physician Decision|9|||
160731681|NCT00626821|580399955|FG000|Overall Study|Product dysfunction|21|||
160731682|NCT00626821|580399955|FG000|Overall Study|other/unknown reason|104|||
160731683|NCT00941863|580399956|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
160731684|NCT00941863|580399957|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
160731685|NCT00941863|580399958|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
160731686|NCT00941863|580399959|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
160731687|NCT00941863|580399960|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
160731688|NCT00941863|580399956|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
160731689|NCT00941863|580399957|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
160731690|NCT00941863|580399958|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
160731691|NCT00941863|580399959|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
160731692|NCT00941863|580399960|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
160731693|NCT00941863|580399956|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
160731694|NCT00941863|580399957|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
160731695|NCT00941863|580399958|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
160731696|NCT00941863|580399959|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
160731697|NCT00941863|580399960|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
160731698|NCT00941863|580399956|FG000|Until Primary Completion Date (PCD)|Death|0|||
160731699|NCT00941863|580399957|FG001|Until Primary Completion Date (PCD)|Death|0|||
160731700|NCT00941863|580399958|FG002|Until Primary Completion Date (PCD)|Death|1|||
160731701|NCT00941863|580399959|FG003|Until Primary Completion Date (PCD)|Death|2|||
160731702|NCT00941863|580399960|FG004|Until Primary Completion Date (PCD)|Death|7|||
160731703|NCT00941863|580399956|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
160731704|NCT00941863|580399957|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
160731705|NCT00941863|580399958|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
160731706|NCT00941863|580399959|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
160731707|NCT00941863|580399960|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
160731708|NCT00941863|580399956|FG000|Continued After PCD|Withdrawal by Subject|0|||
160731709|NCT00941863|580399957|FG001|Continued After PCD|Withdrawal by Subject|0|||
160731710|NCT00941863|580399958|FG002|Continued After PCD|Withdrawal by Subject|0|||
160731711|NCT00941863|580399959|FG003|Continued After PCD|Withdrawal by Subject|0|||
160731712|NCT00941863|580399960|FG004|Continued After PCD|Withdrawal by Subject|1|||
160731713|NCT00941863|580399956|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
160731714|NCT00941863|580399957|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
160731715|NCT00941863|580399958|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
160731716|NCT00941863|580399959|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
160731717|NCT00941863|580399960|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
160731718|NCT01609543|580399966|FG000|Overall Study|Disease Progression|28|||
160731719|NCT01609543|580399966|FG000|Overall Study|Adverse Event|5|||
160731720|NCT01609543|580399966|FG000|Overall Study|Withdrawal by Subject|1|||
160731721|NCT01609543|580399966|FG000|Overall Study|Protocol Violation|1|||
160731722|NCT01609543|580399966|FG000|Overall Study|Death|7|||
160731723|NCT03315286|580399968|FG000|Overall Study|Lost to Follow-up|0|||
160731724|NCT03315286|580399969|FG001|Overall Study|Lost to Follow-up|3|||
160731725|NCT03315286|580399968|FG000|Overall Study|Withdrawal by Subject|1|||
160731726|NCT03315286|580399969|FG001|Overall Study|Withdrawal by Subject|0|||
160731727|NCT03315286|580399968|FG000|Overall Study|Protocol Violation|0|||
160731728|NCT03315286|580399969|FG001|Overall Study|Protocol Violation|1|||
160731729|NCT02829723|580399971|FG000|Overall Study|Adverse Event|0|||
160731730|NCT02829723|580399972|FG001|Overall Study|Adverse Event|0|||
160731731|NCT02829723|580399973|FG002|Overall Study|Adverse Event|1|||
160731732|NCT02829723|580399974|FG003|Overall Study|Adverse Event|1|||
160731733|NCT02829723|580399975|FG004|Overall Study|Adverse Event|0|||
160731734|NCT02829723|580399976|FG005|Overall Study|Adverse Event|0|||
160731735|NCT02829723|580399977|FG006|Overall Study|Adverse Event|0|||
160731736|NCT02829723|580399978|FG007|Overall Study|Adverse Event|1|||
160731737|NCT02829723|580399979|FG008|Overall Study|Adverse Event|0|||
160731738|NCT02829723|580399980|FG009|Overall Study|Adverse Event|0|||
160731739|NCT02829723|580399981|FG010|Overall Study|Adverse Event|0|||
160731740|NCT02829723|580399982|FG011|Overall Study|Adverse Event|0|||
160731741|NCT02829723|580399983|FG012|Overall Study|Adverse Event|0|||
160731742|NCT02829723|580399984|FG013|Overall Study|Adverse Event|0|||
160731743|NCT02829723|580399985|FG014|Overall Study|Adverse Event|1|||
160731744|NCT02829723|580399986|FG015|Overall Study|Adverse Event|1|||
160731745|NCT02829723|580399987|FG016|Overall Study|Adverse Event|1|||
160731746|NCT02829723|580399988|FG017|Overall Study|Adverse Event|2|||
160731747|NCT02829723|580399989|FG018|Overall Study|Adverse Event|1|||
160731748|NCT02829723|580399990|FG019|Overall Study|Adverse Event|1|||
160731749|NCT02829723|580399991|FG020|Overall Study|Adverse Event|3|||
160731750|NCT02829723|580399992|FG021|Overall Study|Adverse Event|0|||
160731751|NCT02829723|580399993|FG022|Overall Study|Adverse Event|0|||
160731752|NCT02829723|580399994|FG023|Overall Study|Adverse Event|1|||
160731753|NCT02829723|580399995|FG024|Overall Study|Adverse Event|1|||
160731754|NCT02829723|580399996|FG025|Overall Study|Adverse Event|3|||
160731755|NCT02829723|580399997|FG026|Overall Study|Adverse Event|5|||
160731756|NCT02829723|580399971|FG000|Overall Study|Death|1|||
160731757|NCT02829723|580399972|FG001|Overall Study|Death|0|||
160731758|NCT02829723|580399973|FG002|Overall Study|Death|1|||
160731759|NCT02829723|580399974|FG003|Overall Study|Death|1|||
160731760|NCT02829723|580399975|FG004|Overall Study|Death|0|||
160731761|NCT02829723|580399976|FG005|Overall Study|Death|0|||
160731762|NCT02829723|580399977|FG006|Overall Study|Death|2|||
160731763|NCT02829723|580399978|FG007|Overall Study|Death|0|||
160731764|NCT02829723|580399979|FG008|Overall Study|Death|1|||
160731765|NCT02829723|580399980|FG009|Overall Study|Death|0|||
160731766|NCT02829723|580399981|FG010|Overall Study|Death|0|||
160731767|NCT02829723|580399982|FG011|Overall Study|Death|0|||
160731768|NCT02829723|580399983|FG012|Overall Study|Death|2|||
160731769|NCT02829723|580399984|FG013|Overall Study|Death|1|||
160731770|NCT02829723|580399985|FG014|Overall Study|Death|0|||
160731771|NCT02829723|580399986|FG015|Overall Study|Death|0|||
160731772|NCT02829723|580399987|FG016|Overall Study|Death|0|||
160731773|NCT02829723|580399988|FG017|Overall Study|Death|0|||
160731774|NCT02829723|580399989|FG018|Overall Study|Death|0|||
160731775|NCT02829723|580399990|FG019|Overall Study|Death|0|||
160731776|NCT02829723|580399991|FG020|Overall Study|Death|0|||
160731777|NCT02829723|580399992|FG021|Overall Study|Death|2|||
160731778|NCT02829723|580399993|FG022|Overall Study|Death|0|||
160731779|NCT02829723|580399994|FG023|Overall Study|Death|0|||
160731780|NCT02829723|580399995|FG024|Overall Study|Death|0|||
160731781|NCT02829723|580399996|FG025|Overall Study|Death|1|||
160731782|NCT02829723|580399997|FG026|Overall Study|Death|2|||
160731783|NCT02829723|580399971|FG000|Overall Study|Physician Decision|0|||
160731784|NCT02829723|580399972|FG001|Overall Study|Physician Decision|0|||
160731785|NCT02829723|580399973|FG002|Overall Study|Physician Decision|0|||
160731786|NCT02829723|580399974|FG003|Overall Study|Physician Decision|0|||
160731787|NCT02829723|580399975|FG004|Overall Study|Physician Decision|0|||
160731788|NCT02829723|580399976|FG005|Overall Study|Physician Decision|0|||
160731789|NCT02829723|580399977|FG006|Overall Study|Physician Decision|0|||
160731790|NCT02829723|580399978|FG007|Overall Study|Physician Decision|0|||
160731791|NCT02829723|580399979|FG008|Overall Study|Physician Decision|0|||
160731792|NCT02829723|580399980|FG009|Overall Study|Physician Decision|1|||
160731793|NCT02829723|580399981|FG010|Overall Study|Physician Decision|1|||
160731794|NCT02829723|580399982|FG011|Overall Study|Physician Decision|0|||
160731795|NCT02829723|580399983|FG012|Overall Study|Physician Decision|0|||
160731796|NCT02829723|580399984|FG013|Overall Study|Physician Decision|1|||
160731797|NCT02829723|580399985|FG014|Overall Study|Physician Decision|0|||
160731798|NCT02829723|580399986|FG015|Overall Study|Physician Decision|0|||
160731799|NCT02829723|580399987|FG016|Overall Study|Physician Decision|2|||
160731800|NCT02829723|580399988|FG017|Overall Study|Physician Decision|0|||
160731801|NCT02829723|580399989|FG018|Overall Study|Physician Decision|0|||
160731802|NCT02829723|580399990|FG019|Overall Study|Physician Decision|0|||
160731803|NCT02829723|580399991|FG020|Overall Study|Physician Decision|0|||
160731804|NCT02829723|580399992|FG021|Overall Study|Physician Decision|0|||
160731805|NCT02829723|580399993|FG022|Overall Study|Physician Decision|1|||
160731806|NCT02829723|580399994|FG023|Overall Study|Physician Decision|1|||
160731807|NCT02829723|580399995|FG024|Overall Study|Physician Decision|1|||
160731808|NCT02829723|580399996|FG025|Overall Study|Physician Decision|1|||
160731809|NCT02829723|580399997|FG026|Overall Study|Physician Decision|3|||
160731810|NCT02829723|580399971|FG000|Overall Study|Progressive disease|4|||
160731811|NCT02829723|580399972|FG001|Overall Study|Progressive disease|6|||
160731812|NCT02829723|580399973|FG002|Overall Study|Progressive disease|3|||
160731813|NCT02829723|580399974|FG003|Overall Study|Progressive disease|3|||
160731814|NCT02829723|580399975|FG004|Overall Study|Progressive disease|3|||
160731815|NCT02829723|580399976|FG005|Overall Study|Progressive disease|5|||
160731816|NCT02829723|580399977|FG006|Overall Study|Progressive disease|4|||
160731817|NCT02829723|580399978|FG007|Overall Study|Progressive disease|6|||
160731818|NCT02829723|580399979|FG008|Overall Study|Progressive disease|8|||
160731819|NCT02829723|580399980|FG009|Overall Study|Progressive disease|4|||
160731820|NCT02829723|580399981|FG010|Overall Study|Progressive disease|9|||
160731821|NCT02829723|580399982|FG011|Overall Study|Progressive disease|0|||
160731822|NCT02829723|580399983|FG012|Overall Study|Progressive disease|3|||
160731823|NCT02829723|580399984|FG013|Overall Study|Progressive disease|4|||
160731824|NCT02829723|580399985|FG014|Overall Study|Progressive disease|2|||
160731825|NCT02829723|580399986|FG015|Overall Study|Progressive disease|4|||
160731826|NCT02829723|580399987|FG016|Overall Study|Progressive disease|5|||
160731827|NCT02829723|580399988|FG017|Overall Study|Progressive disease|3|||
160731828|NCT02829723|580399989|FG018|Overall Study|Progressive disease|4|||
160731829|NCT02829723|580399990|FG019|Overall Study|Progressive disease|4|||
160731830|NCT02829723|580399991|FG020|Overall Study|Progressive disease|7|||
160731831|NCT02829723|580399992|FG021|Overall Study|Progressive disease|6|||
160731832|NCT02829723|580399993|FG022|Overall Study|Progressive disease|3|||
160731833|NCT02829723|580399994|FG023|Overall Study|Progressive disease|3|||
160731834|NCT02829723|580399995|FG024|Overall Study|Progressive disease|3|||
160731835|NCT02829723|580399996|FG025|Overall Study|Progressive disease|16|||
160731836|NCT02829723|580399997|FG026|Overall Study|Progressive disease|10|||
160731837|NCT02829723|580399971|FG000|Overall Study|Subject/guardian decision|0|||
160731838|NCT02829723|580399972|FG001|Overall Study|Subject/guardian decision|1|||
160731839|NCT02829723|580399973|FG002|Overall Study|Subject/guardian decision|0|||
160731840|NCT02829723|580399974|FG003|Overall Study|Subject/guardian decision|1|||
160731841|NCT02829723|580399975|FG004|Overall Study|Subject/guardian decision|0|||
160731842|NCT02829723|580399976|FG005|Overall Study|Subject/guardian decision|0|||
160731843|NCT02829723|580399977|FG006|Overall Study|Subject/guardian decision|0|||
160731844|NCT02829723|580399978|FG007|Overall Study|Subject/guardian decision|1|||
160731845|NCT02829723|580399979|FG008|Overall Study|Subject/guardian decision|0|||
160731846|NCT02829723|580399980|FG009|Overall Study|Subject/guardian decision|0|||
160731847|NCT02829723|580399981|FG010|Overall Study|Subject/guardian decision|0|||
160731848|NCT02829723|580399982|FG011|Overall Study|Subject/guardian decision|0|||
160731849|NCT02829723|580399983|FG012|Overall Study|Subject/guardian decision|0|||
160731850|NCT02829723|580399984|FG013|Overall Study|Subject/guardian decision|0|||
160731851|NCT02829723|580399985|FG014|Overall Study|Subject/guardian decision|1|||
160731852|NCT02829723|580399986|FG015|Overall Study|Subject/guardian decision|0|||
160731853|NCT02829723|580399987|FG016|Overall Study|Subject/guardian decision|1|||
160731854|NCT02829723|580399988|FG017|Overall Study|Subject/guardian decision|0|||
160731855|NCT02829723|580399989|FG018|Overall Study|Subject/guardian decision|1|||
160731856|NCT02829723|580399990|FG019|Overall Study|Subject/guardian decision|0|||
160731857|NCT02829723|580399991|FG020|Overall Study|Subject/guardian decision|1|||
160731858|NCT02829723|580399992|FG021|Overall Study|Subject/guardian decision|0|||
160731859|NCT02829723|580399993|FG022|Overall Study|Subject/guardian decision|0|||
160731860|NCT02829723|580399994|FG023|Overall Study|Subject/guardian decision|1|||
160731861|NCT02829723|580399995|FG024|Overall Study|Subject/guardian decision|0|||
160731862|NCT02829723|580399996|FG025|Overall Study|Subject/guardian decision|1|||
160731863|NCT02829723|580399997|FG026|Overall Study|Subject/guardian decision|1|||
160731864|NCT02829723|580399971|FG000|Overall Study|Study terminated by sponsor|0|||
160731865|NCT02829723|580399972|FG001|Overall Study|Study terminated by sponsor|0|||
160731866|NCT02829723|580399973|FG002|Overall Study|Study terminated by sponsor|0|||
160731867|NCT02829723|580399974|FG003|Overall Study|Study terminated by sponsor|0|||
160731868|NCT02829723|580399975|FG004|Overall Study|Study terminated by sponsor|0|||
160731869|NCT02829723|580399976|FG005|Overall Study|Study terminated by sponsor|0|||
160731870|NCT02829723|580399977|FG006|Overall Study|Study terminated by sponsor|0|||
160731871|NCT02829723|580399978|FG007|Overall Study|Study terminated by sponsor|0|||
160731872|NCT02829723|580399979|FG008|Overall Study|Study terminated by sponsor|0|||
160731873|NCT02829723|580399980|FG009|Overall Study|Study terminated by sponsor|0|||
160731874|NCT02829723|580399981|FG010|Overall Study|Study terminated by sponsor|0|||
160731875|NCT02829723|580399982|FG011|Overall Study|Study terminated by sponsor|0|||
160731876|NCT02829723|580399983|FG012|Overall Study|Study terminated by sponsor|0|||
160731877|NCT02829723|580399984|FG013|Overall Study|Study terminated by sponsor|0|||
160731878|NCT02829723|580399985|FG014|Overall Study|Study terminated by sponsor|0|||
160731879|NCT02829723|580399986|FG015|Overall Study|Study terminated by sponsor|0|||
160731880|NCT02829723|580399987|FG016|Overall Study|Study terminated by sponsor|0|||
160731881|NCT02829723|580399988|FG017|Overall Study|Study terminated by sponsor|0|||
160731882|NCT02829723|580399989|FG018|Overall Study|Study terminated by sponsor|0|||
160731883|NCT02829723|580399990|FG019|Overall Study|Study terminated by sponsor|0|||
160731884|NCT02829723|580399991|FG020|Overall Study|Study terminated by sponsor|0|||
160731885|NCT02829723|580399992|FG021|Overall Study|Study terminated by sponsor|1|||
160731886|NCT02829723|580399993|FG022|Overall Study|Study terminated by sponsor|0|||
160731887|NCT02829723|580399994|FG023|Overall Study|Study terminated by sponsor|0|||
160731888|NCT02829723|580399995|FG024|Overall Study|Study terminated by sponsor|0|||
160731889|NCT02829723|580399996|FG025|Overall Study|Study terminated by sponsor|0|||
160731890|NCT02829723|580399997|FG026|Overall Study|Study terminated by sponsor|0|||
160731891|NCT03075891|580399998|FG000|Overall Study|Withdrawal by Subject|3|||
160731892|NCT03075891|580399999|FG001|Overall Study|Withdrawal by Subject|6|||
160731893|NCT03075891|580399998|FG000|Overall Study|Lost to Follow-up|1|||
160731894|NCT03075891|580399999|FG001|Overall Study|Lost to Follow-up|0|||
160731895|NCT03075891|580399998|FG000|Overall Study|Pregnancy|3|||
160731896|NCT03075891|580399999|FG001|Overall Study|Pregnancy|1|||
160731897|NCT03075891|580399998|FG000|Overall Study|visits not performed (no time)|1|||
160731898|NCT03075891|580399999|FG001|Overall Study|visits not performed (no time)|0|||
160731899|NCT03075891|580399998|FG000|Overall Study|Drug abuse relapse issue|0|||
160731900|NCT03075891|580399999|FG001|Overall Study|Drug abuse relapse issue|1|||
160731901|NCT03075891|580399998|FG000|Overall Study|Participant requiring study withdrawal|0|||
160731902|NCT03075891|580399999|FG001|Overall Study|Participant requiring study withdrawal|1|||
160731903|NCT03075891|580399998|FG000|Overall Study|Adverse event, non-fatal|1|||
160731904|NCT03075891|580399999|FG001|Overall Study|Adverse event, non-fatal|4|||
160731905|NCT00179673|580400001|FG000|Overall Study|Adverse Event|7|||
160731906|NCT00179673|580400001|FG000|Overall Study|Lack of Efficacy|15|||
160731907|NCT00179673|580400001|FG000|Overall Study|Withdrawal by Subject|3|||
160731908|NCT00179673|580400001|FG000|Overall Study|Death|4|||
160731909|NCT00179673|580400001|FG000|Overall Study|Other Observations and options|14|||
160731910|NCT00282113|580400002|FG000|Overall Study|Removed at parents request|1|||
160731911|NCT00282113|580400003|FG001|Overall Study|Removed at parents request|0|||
160731912|NCT00282113|580400004|FG002|Overall Study|Removed at parents request|0|||
160731913|NCT02294396|580400005|FG000|Overall Study|Adverse Event|26|||
160731914|NCT02294396|580400006|FG001|Overall Study|Adverse Event|25|||
160731915|NCT02294396|580400007|FG002|Overall Study|Adverse Event|21|||
160731916|NCT02294396|580400008|FG003|Overall Study|Adverse Event|24|||
160731917|NCT02294396|580400005|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
160731918|NCT02294396|580400006|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
160731919|NCT02294396|580400007|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
160731920|NCT02294396|580400008|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
160731921|NCT02294396|580400005|FG000|Overall Study|Withdrawal by Subject|8|||
160731922|NCT02294396|580400006|FG001|Overall Study|Withdrawal by Subject|6|||
160731923|NCT02294396|580400007|FG002|Overall Study|Withdrawal by Subject|6|||
160731924|NCT02294396|580400008|FG003|Overall Study|Withdrawal by Subject|8|||
160731925|NCT02294396|580400005|FG000|Overall Study|Lost to Follow-up|0|||
160731926|NCT02294396|580400006|FG001|Overall Study|Lost to Follow-up|0|||
160731927|NCT02294396|580400007|FG002|Overall Study|Lost to Follow-up|1|||
160731928|NCT02294396|580400008|FG003|Overall Study|Lost to Follow-up|1|||
160731929|NCT02294396|580400005|FG000|Overall Study|Protocol Deviation|3|||
160731930|NCT02294396|580400006|FG001|Overall Study|Protocol Deviation|2|||
160731931|NCT02294396|580400007|FG002|Overall Study|Protocol Deviation|2|||
160731932|NCT02294396|580400008|FG003|Overall Study|Protocol Deviation|1|||
160731933|NCT02294396|580400005|FG000|Overall Study|Miscellaneous|2|||
160731934|NCT02294396|580400006|FG001|Overall Study|Miscellaneous|0|||
160731935|NCT02294396|580400007|FG002|Overall Study|Miscellaneous|5|||
160731936|NCT02294396|580400008|FG003|Overall Study|Miscellaneous|2|||
160731937|NCT02120833|580400009|FG000|Overall Study|Adverse Event|1|||
160731938|NCT02120833|580400010|FG001|Overall Study|Adverse Event|0|||
160731939|NCT02120833|580400009|FG000|Overall Study|Withdrawal by Subject|2|||
160731940|NCT02120833|580400010|FG001|Overall Study|Withdrawal by Subject|0|||
160731941|NCT02120833|580400009|FG000|Overall Study|Lost to Follow-up|1|||
160731942|NCT02120833|580400010|FG001|Overall Study|Lost to Follow-up|1|||
160731943|NCT02438826|580400011|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
160731944|NCT02438826|580400012|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
160731945|NCT02438826|580400013|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
160731946|NCT02438826|580400014|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
160731947|NCT02438826|580400011|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
160731948|NCT02438826|580400012|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
160731949|NCT02438826|580400013|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
160731950|NCT02438826|580400014|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
160731951|NCT02438826|580400011|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
160731952|NCT02438826|580400012|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
160731953|NCT02438826|580400013|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
160731954|NCT02438826|580400014|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
160731955|NCT02438826|580400011|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
160731956|NCT02438826|580400012|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
160731957|NCT02438826|580400013|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
160731958|NCT02438826|580400014|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
160731959|NCT02438826|580400011|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
160731960|NCT02438826|580400012|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
160731961|NCT02438826|580400013|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
160731962|NCT02438826|580400014|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
160731963|NCT02438826|580400011|FG000|Open-Label Treatment Phase|Adverse Event|11|||
160731964|NCT02438826|580400012|FG001|Open-Label Treatment Phase|Adverse Event|6|||
160731965|NCT02438826|580400013|FG002|Open-Label Treatment Phase|Adverse Event|0|||
160731966|NCT02438826|580400014|FG003|Open-Label Treatment Phase|Adverse Event|0|||
160731967|NCT02438826|580400011|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
160731968|NCT02438826|580400012|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
160731969|NCT02438826|580400013|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
160731970|NCT02438826|580400014|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
160731971|NCT02438826|580400011|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
160731972|NCT02438826|580400012|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
160731973|NCT02438826|580400013|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
160731974|NCT02438826|580400014|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
160731975|NCT02438826|580400011|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
160731976|NCT02438826|580400012|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
160731977|NCT02438826|580400013|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
160731978|NCT02438826|580400014|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
160731979|NCT02438826|580400011|FG000|Post-Treatment Phase|Adverse Event|3|||
160731980|NCT02438826|580400012|FG001|Post-Treatment Phase|Adverse Event|0|||
160731981|NCT02438826|580400013|FG002|Post-Treatment Phase|Adverse Event|0|||
160731982|NCT02438826|580400014|FG003|Post-Treatment Phase|Adverse Event|0|||
160731983|NCT02438826|580400011|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
160731984|NCT02438826|580400012|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
160731985|NCT02438826|580400013|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
160731986|NCT02438826|580400014|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
160731987|NCT02438826|580400011|FG000|Post-Treatment Phase|Physician Decision|1|||
160731988|NCT02438826|580400012|FG001|Post-Treatment Phase|Physician Decision|0|||
160731989|NCT02438826|580400013|FG002|Post-Treatment Phase|Physician Decision|0|||
160731990|NCT02438826|580400014|FG003|Post-Treatment Phase|Physician Decision|0|||
160731991|NCT02438826|580400011|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
160731992|NCT02438826|580400012|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
160731993|NCT02438826|580400013|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
160731994|NCT02438826|580400014|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
160731995|NCT03429244|580400015|FG000|Overall Study|Withdrawal by Subject|2|||
160731996|NCT03429244|580400016|FG001|Overall Study|Withdrawal by Subject|1|||
160731997|NCT03429244|580400017|FG002|Overall Study|Withdrawal by Subject|1|||
160731998|NCT01500187|580400018|FG000|Overall Study|Lost to Follow-up|6|||
160731999|NCT01500187|580400019|FG001|Overall Study|Lost to Follow-up|0|||
160732000|NCT00582608|580400035|FG000|Overall Study|Not Treated|7|||
160732001|NCT00582608|580400035|FG000|Overall Study|Patient Ineligible|1|||
160732002|NCT00582608|580400035|FG000|Overall Study|Lack of accrual|4|||
160732003|NCT03482453|580400036|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732004|NCT03482453|580400037|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732005|NCT03482453|580400038|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732006|NCT03482453|580400039|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732007|NCT03482453|580400040|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732008|NCT03482453|580400041|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732009|NCT03482453|580400042|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732010|NCT03482453|580400043|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732011|NCT03482453|580400044|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732012|NCT03482453|580400045|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732013|NCT03482453|580400046|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
160732014|NCT03482453|580400047|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
160732015|NCT03478644|580400048|FG000|Phase 2|Withdrawal by Subject|2|||
160732016|NCT03478644|580400049|FG001|Phase 2|Withdrawal by Subject|1|||
160732017|NCT03478644|580400048|FG000|Phase 2|Lost to Follow-up|1|||
160732018|NCT03478644|580400049|FG001|Phase 2|Lost to Follow-up|0|||
160732019|NCT02073929|580400050|FG000|Overall Study|Lost to Follow-up|2|||
160732020|NCT02073929|580400051|FG001|Overall Study|Lost to Follow-up|1|||
160732021|NCT02073929|580400050|FG000|Overall Study|Adverse Event|2|||
160732022|NCT02073929|580400051|FG001|Overall Study|Adverse Event|1|||
160732023|NCT02073929|580400050|FG000|Overall Study|Withdrawal by Subject|0|||
160732024|NCT02073929|580400051|FG001|Overall Study|Withdrawal by Subject|1|||
160732025|NCT02504827|580400054|FG000|Overall Study|Could not produce sputum|1|||
160732026|NCT00686829|580400055|FG000|Overall Study|Adverse Event|5|||
160732027|NCT00686829|580400055|FG000|Overall Study|Lack of Efficacy|6|||
160732028|NCT00686829|580400055|FG000|Overall Study|Lost to Follow-up|4|||
160732029|NCT00686829|580400055|FG000|Overall Study|Withdrawal by Subject|14|||
160732030|NCT00686829|580400055|FG000|Overall Study|Protocol Violation|3|||
160732031|NCT00686829|580400055|FG000|Overall Study|Sponsor discontinued VCV|47|||
160732032|NCT00712543|580400056|FG000|Day 8-14|Lost to Follow-up|0|||
160732033|NCT00712543|580400057|FG001|Day 8-14|Lost to Follow-up|2|||
160732034|NCT04740827|580400058|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
160732035|NCT04740827|580400059|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
160732036|NCT04740827|580400058|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
160732037|NCT04740827|580400059|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
160732038|NCT04740827|580400058|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
160732039|NCT04740827|580400059|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
160732040|NCT04740827|580400058|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
160732041|NCT04740827|580400059|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
160732042|NCT04740827|580400058|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
160732043|NCT04740827|580400059|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
160732044|NCT04740827|580400058|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
160732045|NCT04740827|580400059|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
160732046|NCT00940823|580400060|FG000|Overall Study|Death|8|||
160732047|NCT00940823|580400061|FG001|Overall Study|Death|12|||
160732048|NCT00940823|580400060|FG000|Overall Study|Lost to Follow-up|27|||
160732049|NCT00940823|580400061|FG001|Overall Study|Lost to Follow-up|20|||
160732050|NCT00519428|580401556|FG000|Overall Study|Adverse Event|5|||
160732051|NCT00519428|580401557|FG001|Overall Study|Adverse Event|2|||
160732052|NCT00519428|580401558|FG002|Overall Study|Adverse Event|10|||
160732053|NCT00519428|580401556|FG000|Overall Study|Lost to Follow-up|7|||
160732054|NCT00519428|580401557|FG001|Overall Study|Lost to Follow-up|7|||
160732055|NCT00519428|580401558|FG002|Overall Study|Lost to Follow-up|6|||
160732056|NCT00519428|580401556|FG000|Overall Study|Withdrawal by Subject|8|||
160732057|NCT00519428|580401557|FG001|Overall Study|Withdrawal by Subject|3|||
160732058|NCT00519428|580401558|FG002|Overall Study|Withdrawal by Subject|7|||
160732059|NCT00519428|580401556|FG000|Overall Study|unstated|1|||
160732060|NCT00519428|580401557|FG001|Overall Study|unstated|3|||
160732061|NCT00519428|580401558|FG002|Overall Study|unstated|2|||
160732062|NCT00688701|580401559|FG000|Overall Study|Adverse Event|1|||
160732063|NCT00688701|580401560|FG001|Overall Study|Adverse Event|0|||
160732064|NCT00688701|580401561|FG002|Overall Study|Adverse Event|5|||
160732065|NCT00688701|580401562|FG003|Overall Study|Adverse Event|3|||
160732066|NCT00688701|580401559|FG000|Overall Study|Lack of Efficacy|0|||
160732067|NCT00688701|580401560|FG001|Overall Study|Lack of Efficacy|1|||
160732068|NCT00688701|580401561|FG002|Overall Study|Lack of Efficacy|0|||
160732069|NCT00688701|580401562|FG003|Overall Study|Lack of Efficacy|0|||
160732070|NCT00688701|580401559|FG000|Overall Study|Withdrawal by Subject|3|||
160732071|NCT00688701|580401560|FG001|Overall Study|Withdrawal by Subject|3|||
160732072|NCT00688701|580401561|FG002|Overall Study|Withdrawal by Subject|4|||
160732073|NCT00688701|580401562|FG003|Overall Study|Withdrawal by Subject|8|||
160732074|NCT00688701|580401559|FG000|Overall Study|Poor compliance to protocol|0|||
160732075|NCT00688701|580401560|FG001|Overall Study|Poor compliance to protocol|1|||
160732076|NCT00688701|580401561|FG002|Overall Study|Poor compliance to protocol|1|||
160732077|NCT00688701|580401562|FG003|Overall Study|Poor compliance to protocol|0|||
160732078|NCT01275755|580401564|FG000|Double-blind Treatment Period|Adverse Event|0|||
160732079|NCT01275755|580401565|FG001|Double-blind Treatment Period|Adverse Event|2|||
160732080|NCT01275755|580401564|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
160732081|NCT01275755|580401565|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
160732082|NCT01275755|580401564|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
160732083|NCT01275755|580401565|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
160732084|NCT01275755|580401564|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
160732085|NCT01275755|580401565|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
160732086|NCT04420585|580401570|FG000|Overall Study|Adverse Event|1|||
160732087|NCT04420585|580401570|FG000|Overall Study|Never initiated medication|2|||
160732088|NCT00477750|580401571|FG000|Overall Study|Currently Receiving Treatment|11|||
160732089|NCT01300338|580401573|FG000|Overall Study|Lost to Follow-up|5|||
160732090|NCT01300338|580401574|FG001|Overall Study|Lost to Follow-up|0|||
160732091|NCT02461524|580401576|FG000|Overall Study|Death|16|||
160732092|NCT02461524|580401576|FG000|Overall Study|Withdrawal by Subject|4|||
160732093|NCT02461524|580401576|FG000|Overall Study|Device Explanted|5|||
160732094|NCT02461524|580401576|FG000|Overall Study|Missed Visit|6|||
160732095|NCT00381238|580401580|FG000|Overall Study|Adverse Event|3|||
160732096|NCT00381238|580401580|FG000|Overall Study|Protocol Violation|1|||
160732097|NCT00381238|580401580|FG000|Overall Study|Withdrawal by Subject|4|||
160732098|NCT00381238|580401580|FG000|Overall Study|Lack of Efficacy|2|||
160732099|NCT00381238|580401580|FG000|Overall Study|Withdrew by physician|1|||
160732100|NCT00381238|580401580|FG000|Overall Study|Disease progression|1|||
160732101|NCT00843037|580401583|FG000|Overall Study|Lost to Follow-up|1|||
160732102|NCT02278939|580401584|FG000|Overall Study|lack of time|1|||
160732103|NCT02278939|580401585|FG001|Overall Study|lack of time|0|||
160732104|NCT02278939|580401584|FG000|Overall Study|Lost to Follow-up|1|||
160732105|NCT02278939|580401585|FG001|Overall Study|Lost to Follow-up|1|||
160732106|NCT02278939|580401584|FG000|Overall Study|death in family|1|||
160732107|NCT02278939|580401585|FG001|Overall Study|death in family|0|||
160732108|NCT02278939|580401584|FG000|Overall Study|family emergency unable to commit|2|||
160732109|NCT02278939|580401585|FG001|Overall Study|family emergency unable to commit|0|||
160732110|NCT00712881|580401586|FG000|Overall Study|Adverse Event|3|||
160732111|NCT00712881|580401587|FG001|Overall Study|Adverse Event|3|||
160732112|NCT00712881|580401586|FG000|Overall Study|Withdrawal by Subject|1|||
160732113|NCT00712881|580401587|FG001|Overall Study|Withdrawal by Subject|1|||
160732114|NCT00712881|580401586|FG000|Overall Study|Disease Progression|2|||
160732115|NCT00712881|580401587|FG001|Overall Study|Disease Progression|1|||
160732116|NCT00712881|580401586|FG000|Overall Study|Lost to Follow-up|1|||
160732117|NCT00712881|580401587|FG001|Overall Study|Lost to Follow-up|1|||
160732118|NCT00712881|580401586|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
160732119|NCT00712881|580401587|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
160732120|NCT00712881|580401586|FG000|Overall Study|Protocol Violation|1|||
160732121|NCT00712881|580401587|FG001|Overall Study|Protocol Violation|1|||
160732122|NCT00712881|580401586|FG000|Overall Study|Randomized but not treated|1|||
160732123|NCT00712881|580401587|FG001|Overall Study|Randomized but not treated|0|||
160732124|NCT05835011|580401588|FG000|Overall Study|Study Terminated by the Sponsor|1|||
160732125|NCT05835011|580401588|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
160732126|NCT02217410|580401591|FG000|Overall Study|Graft Loss|0|||
160732127|NCT02217410|580401592|FG001|Overall Study|Graft Loss|0|||
160732128|NCT02217410|580401593|FG002|Overall Study|Graft Loss|2|||
160732129|NCT02217410|580401591|FG000|Overall Study|Withdrawal by Subject|0|||
160732130|NCT02217410|580401592|FG001|Overall Study|Withdrawal by Subject|0|||
160732131|NCT02217410|580401593|FG002|Overall Study|Withdrawal by Subject|2|||
160732132|NCT02217410|580401591|FG000|Overall Study|Lost to Follow-up|0|||
160732133|NCT02217410|580401592|FG001|Overall Study|Lost to Follow-up|0|||
160732134|NCT02217410|580401593|FG002|Overall Study|Lost to Follow-up|1|||
160732135|NCT02217410|580401591|FG000|Overall Study|Lack of Efficacy|0|||
160732136|NCT02217410|580401592|FG001|Overall Study|Lack of Efficacy|1|||
160732137|NCT02217410|580401593|FG002|Overall Study|Lack of Efficacy|0|||
160732138|NCT02217410|580401591|FG000|Overall Study|Physician Decision|1|||
160732139|NCT02217410|580401592|FG001|Overall Study|Physician Decision|3|||
160732140|NCT02217410|580401593|FG002|Overall Study|Physician Decision|0|||
160732141|NCT00090220|580401594|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
160732142|NCT00090220|580401595|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
160732143|NCT00090220|580401596|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
160732144|NCT00090220|580401597|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
160732145|NCT00090220|580401598|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
160732146|NCT00090220|580401599|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
160732147|NCT00090220|580401594|FG000|Base Study Vaccination Period|Adverse Event|6|||
160732148|NCT00090220|580401595|FG001|Base Study Vaccination Period|Adverse Event|1|||
160732149|NCT00090220|580401596|FG002|Base Study Vaccination Period|Adverse Event|0|||
160732150|NCT00090220|580401597|FG003|Base Study Vaccination Period|Adverse Event|0|||
160732151|NCT00090220|580401598|FG004|Base Study Vaccination Period|Adverse Event|0|||
160732152|NCT00090220|580401599|FG005|Base Study Vaccination Period|Adverse Event|0|||
160732153|NCT00090220|580401594|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
160732154|NCT00090220|580401595|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
160732155|NCT00090220|580401596|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
160732156|NCT00090220|580401597|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
160732157|NCT00090220|580401598|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
160732158|NCT00090220|580401599|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
160732159|NCT00090220|580401594|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
160732160|NCT00090220|580401595|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
160732161|NCT00090220|580401596|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
160732162|NCT00090220|580401597|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
160732163|NCT00090220|580401598|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
160732164|NCT00090220|580401599|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
160732165|NCT00090220|580401594|FG000|Base Study Vaccination Period|Patient Moved|6|||
160732166|NCT00090220|580401595|FG001|Base Study Vaccination Period|Patient Moved|2|||
160732167|NCT00090220|580401596|FG002|Base Study Vaccination Period|Patient Moved|0|||
160732168|NCT00090220|580401597|FG003|Base Study Vaccination Period|Patient Moved|0|||
160732169|NCT00090220|580401598|FG004|Base Study Vaccination Period|Patient Moved|0|||
160732170|NCT00090220|580401599|FG005|Base Study Vaccination Period|Patient Moved|0|||
160732171|NCT00090220|580401594|FG000|Base Study Vaccination Period|Other|4|||
160732172|NCT00090220|580401595|FG001|Base Study Vaccination Period|Other|4|||
160732173|NCT00090220|580401596|FG002|Base Study Vaccination Period|Other|0|||
160732174|NCT00090220|580401597|FG003|Base Study Vaccination Period|Other|0|||
160732175|NCT00090220|580401598|FG004|Base Study Vaccination Period|Other|0|||
160732176|NCT00090220|580401599|FG005|Base Study Vaccination Period|Other|0|||
160732177|NCT00090220|580401594|FG000|Base Study Follow-up Period|Adverse Event|6|||
160732178|NCT00090220|580401595|FG001|Base Study Follow-up Period|Adverse Event|1|||
160732179|NCT00090220|580401596|FG002|Base Study Follow-up Period|Adverse Event|0|||
160732180|NCT00090220|580401597|FG003|Base Study Follow-up Period|Adverse Event|0|||
160732181|NCT00090220|580401598|FG004|Base Study Follow-up Period|Adverse Event|0|||
160732182|NCT00090220|580401599|FG005|Base Study Follow-up Period|Adverse Event|0|||
160732183|NCT00090220|580401594|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
160732184|NCT00090220|580401595|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
160732185|NCT00090220|580401596|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
160732186|NCT00090220|580401597|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
160732187|NCT00090220|580401598|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
160732188|NCT00090220|580401599|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
160732189|NCT00090220|580401594|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
160732190|NCT00090220|580401595|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
160732191|NCT00090220|580401596|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
160732192|NCT00090220|580401597|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
160732193|NCT00090220|580401598|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
160732194|NCT00090220|580401599|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
160732195|NCT00090220|580401594|FG000|Base Study Follow-up Period|Patient Moved|20|||
160732196|NCT00090220|580401595|FG001|Base Study Follow-up Period|Patient Moved|28|||
160732197|NCT00090220|580401596|FG002|Base Study Follow-up Period|Patient Moved|0|||
160732198|NCT00090220|580401597|FG003|Base Study Follow-up Period|Patient Moved|0|||
160732199|NCT00090220|580401598|FG004|Base Study Follow-up Period|Patient Moved|0|||
160732200|NCT00090220|580401599|FG005|Base Study Follow-up Period|Patient Moved|0|||
160732201|NCT00090220|580401594|FG000|Base Study Follow-up Period|Other|19|||
160732202|NCT00090220|580401595|FG001|Base Study Follow-up Period|Other|21|||
160732203|NCT00090220|580401596|FG002|Base Study Follow-up Period|Other|0|||
160732204|NCT00090220|580401597|FG003|Base Study Follow-up Period|Other|0|||
160732205|NCT00090220|580401598|FG004|Base Study Follow-up Period|Other|0|||
160732206|NCT00090220|580401599|FG005|Base Study Follow-up Period|Other|0|||
160732207|NCT00090220|580401594|FG000|Extension 1 (EXT1)|Adverse Event|0|||
160732208|NCT00090220|580401595|FG001|Extension 1 (EXT1)|Adverse Event|0|||
160732209|NCT00090220|580401596|FG002|Extension 1 (EXT1)|Adverse Event|4|||
160732210|NCT00090220|580401597|FG003|Extension 1 (EXT1)|Adverse Event|0|||
160732211|NCT00090220|580401598|FG004|Extension 1 (EXT1)|Adverse Event|0|||
160732212|NCT00090220|580401599|FG005|Extension 1 (EXT1)|Adverse Event|0|||
160732213|NCT00090220|580401594|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
160732214|NCT00090220|580401595|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
160732215|NCT00090220|580401596|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
160732216|NCT00090220|580401597|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
160732217|NCT00090220|580401598|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
160732218|NCT00090220|580401599|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
160732219|NCT00090220|580401594|FG000|Extension 1 (EXT1)|Moved|0|||
160732220|NCT00090220|580401595|FG001|Extension 1 (EXT1)|Moved|0|||
160732221|NCT00090220|580401596|FG002|Extension 1 (EXT1)|Moved|2|||
160732222|NCT00090220|580401597|FG003|Extension 1 (EXT1)|Moved|1|||
160732223|NCT00090220|580401598|FG004|Extension 1 (EXT1)|Moved|0|||
160732224|NCT00090220|580401599|FG005|Extension 1 (EXT1)|Moved|0|||
160732225|NCT00090220|580401594|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
160732226|NCT00090220|580401595|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
160732227|NCT00090220|580401596|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
160732228|NCT00090220|580401597|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
160732229|NCT00090220|580401598|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
160732230|NCT00090220|580401599|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
160732231|NCT00090220|580401594|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
160732232|NCT00090220|580401595|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
160732233|NCT00090220|580401596|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
160732234|NCT00090220|580401597|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
160732235|NCT00090220|580401598|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
160732236|NCT00090220|580401599|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
160732237|NCT00090220|580401594|FG000|Extension 1 (EXT1)|Other reason|0|||
160732238|NCT00090220|580401595|FG001|Extension 1 (EXT1)|Other reason|0|||
160732239|NCT00090220|580401596|FG002|Extension 1 (EXT1)|Other reason|2|||
160732240|NCT00090220|580401597|FG003|Extension 1 (EXT1)|Other reason|0|||
160732241|NCT00090220|580401598|FG004|Extension 1 (EXT1)|Other reason|0|||
160732242|NCT00090220|580401599|FG005|Extension 1 (EXT1)|Other reason|0|||
160732243|NCT00090220|580401594|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
160732244|NCT00090220|580401595|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
160732245|NCT00090220|580401596|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
160732246|NCT00090220|580401597|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
160732247|NCT00090220|580401598|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
160732248|NCT00090220|580401599|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
160732249|NCT00090220|580401594|FG000|Long-term Follow-up (EXT2)|Death|0|||
160732250|NCT00090220|580401595|FG001|Long-term Follow-up (EXT2)|Death|0|||
160732251|NCT00090220|580401596|FG002|Long-term Follow-up (EXT2)|Death|0|||
160732252|NCT00090220|580401597|FG003|Long-term Follow-up (EXT2)|Death|0|||
160732253|NCT00090220|580401598|FG004|Long-term Follow-up (EXT2)|Death|1|||
160732254|NCT00090220|580401599|FG005|Long-term Follow-up (EXT2)|Death|1|||
160732255|NCT00090220|580401594|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
160732256|NCT00090220|580401595|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
160732257|NCT00090220|580401596|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
160732258|NCT00090220|580401597|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
160732259|NCT00090220|580401598|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
160732260|NCT00090220|580401599|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
160732261|NCT00090220|580401594|FG000|Long-term Follow-up (EXT2)|Other|0|||
160732262|NCT00090220|580401595|FG001|Long-term Follow-up (EXT2)|Other|0|||
160732263|NCT00090220|580401596|FG002|Long-term Follow-up (EXT2)|Other|0|||
160732264|NCT00090220|580401597|FG003|Long-term Follow-up (EXT2)|Other|0|||
160732265|NCT00090220|580401598|FG004|Long-term Follow-up (EXT2)|Other|1|||
160732266|NCT00090220|580401599|FG005|Long-term Follow-up (EXT2)|Other|0|||
160732267|NCT01471340|580401600|FG000|Overall Study|Death|5|||
160732268|NCT01471340|580401601|FG001|Overall Study|Death|4|||
160732269|NCT01471340|580401600|FG000|Overall Study|Lost to Follow-up|0|||
160732270|NCT01471340|580401601|FG001|Overall Study|Lost to Follow-up|1|||
160732271|NCT01471340|580401600|FG000|Overall Study|Investigational site closure|0|||
160732272|NCT01471340|580401601|FG001|Overall Study|Investigational site closure|1|||
160732273|NCT01471340|580401600|FG000|Overall Study|Invalid informed consent|1|||
160732274|NCT01471340|580401601|FG001|Overall Study|Invalid informed consent|0|||
160732275|NCT03452488|580401602|FG000|Overall Study|Adverse Event|4|||
160732276|NCT03452488|580401603|FG001|Overall Study|Adverse Event|6|||
160732277|NCT03452488|580401604|FG002|Overall Study|Adverse Event|1|||
160732278|NCT03452488|580401602|FG000|Overall Study|Death|0|||
160732279|NCT03452488|580401603|FG001|Overall Study|Death|0|||
160732280|NCT03452488|580401604|FG002|Overall Study|Death|1|||
160732281|NCT03452488|580401602|FG000|Overall Study|Lost to Follow-up|1|||
160732282|NCT03452488|580401603|FG001|Overall Study|Lost to Follow-up|2|||
160732283|NCT03452488|580401604|FG002|Overall Study|Lost to Follow-up|0|||
160732284|NCT03452488|580401602|FG000|Overall Study|PI Decision|1|||
160732285|NCT03452488|580401603|FG001|Overall Study|PI Decision|0|||
160732286|NCT03452488|580401604|FG002|Overall Study|PI Decision|0|||
160732287|NCT03452488|580401602|FG000|Overall Study|Withdrew consent|4|||
160732288|NCT03452488|580401603|FG001|Overall Study|Withdrew consent|2|||
160732289|NCT03452488|580401604|FG002|Overall Study|Withdrew consent|2|||
160732290|NCT03452488|580401602|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
160732291|NCT03452488|580401603|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
160732292|NCT03452488|580401604|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
160732293|NCT03452488|580401602|FG000|Overall Study|Other|0|||
160732294|NCT03452488|580401603|FG001|Overall Study|Other|2|||
160732295|NCT03452488|580401604|FG002|Overall Study|Other|2|||
160732296|NCT00747474|580401605|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732297|NCT00747474|580401606|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732298|NCT00747474|580401607|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732299|NCT00747474|580401608|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732300|NCT00747474|580401609|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732301|NCT00747474|580401610|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732302|NCT00747474|580401611|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732303|NCT00747474|580401612|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
160732304|NCT00747474|580401613|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732305|NCT00747474|580401614|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732306|NCT00747474|580401615|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732307|NCT00747474|580401616|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
160732308|NCT02989649|580401617|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
160732309|NCT02989649|580401617|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
160732310|NCT02989649|580401617|FG000|Overall Study|Lost For Observation During Study|3|||
160732311|NCT02989649|580401617|FG000|Overall Study|Reason Not Specified|13|||
160732312|NCT00330343|580401618|FG000|Overall Study|Lost to Follow-up|5|||
160732313|NCT00256854|580401619|FG000|Overall Study|Withdrawal by Subject|2|||
160732314|NCT00256854|580401620|FG001|Overall Study|Withdrawal by Subject|3|||
160732315|NCT00256854|580401621|FG002|Overall Study|Withdrawal by Subject|0|||
160732316|NCT00256854|580401622|FG003|Overall Study|Withdrawal by Subject|0|||
160732317|NCT00256854|580401623|FG004|Overall Study|Withdrawal by Subject|0|||
160732318|NCT00256854|580401624|FG005|Overall Study|Withdrawal by Subject|0|||
160732319|NCT00256854|580401619|FG000|Overall Study|Lack of Efficacy|1|||
160732320|NCT00256854|580401620|FG001|Overall Study|Lack of Efficacy|0|||
160732321|NCT00256854|580401621|FG002|Overall Study|Lack of Efficacy|0|||
160732322|NCT00256854|580401622|FG003|Overall Study|Lack of Efficacy|0|||
160732323|NCT00256854|580401623|FG004|Overall Study|Lack of Efficacy|0|||
160732324|NCT00256854|580401624|FG005|Overall Study|Lack of Efficacy|0|||
160732325|NCT00256854|580401619|FG000|Overall Study|Protocol Violation|0|||
160732326|NCT00256854|580401620|FG001|Overall Study|Protocol Violation|1|||
160732327|NCT00256854|580401621|FG002|Overall Study|Protocol Violation|1|||
160732328|NCT00256854|580401622|FG003|Overall Study|Protocol Violation|1|||
160732329|NCT00256854|580401623|FG004|Overall Study|Protocol Violation|0|||
160732330|NCT00256854|580401624|FG005|Overall Study|Protocol Violation|0|||
160732331|NCT00256854|580401619|FG000|Overall Study|Adverse Event|0|||
160732332|NCT00256854|580401620|FG001|Overall Study|Adverse Event|0|||
160732333|NCT00256854|580401621|FG002|Overall Study|Adverse Event|2|||
160732334|NCT00256854|580401622|FG003|Overall Study|Adverse Event|2|||
160732335|NCT00256854|580401623|FG004|Overall Study|Adverse Event|0|||
160732336|NCT00256854|580401624|FG005|Overall Study|Adverse Event|1|||
160732337|NCT00256854|580401619|FG000|Overall Study|Not compliant with the study drug|0|||
160732338|NCT00256854|580401620|FG001|Overall Study|Not compliant with the study drug|0|||
160732339|NCT00256854|580401621|FG002|Overall Study|Not compliant with the study drug|0|||
160732340|NCT00256854|580401622|FG003|Overall Study|Not compliant with the study drug|0|||
160732341|NCT00256854|580401623|FG004|Overall Study|Not compliant with the study drug|1|||
160732342|NCT00256854|580401624|FG005|Overall Study|Not compliant with the study drug|0|||
160732343|NCT00281632|580401625|FG000|Overall Study|Adverse Event|7|||
160732344|NCT00281632|580401625|FG000|Overall Study|Withdrawal by Subject|2|||
160732345|NCT00281632|580401625|FG000|Overall Study|Disease Progression|22|||
160732346|NCT00281632|580401625|FG000|Overall Study|Death|1|||
160732347|NCT00281632|580401625|FG000|Overall Study|Physician Decision|1|||
160732348|NCT00281632|580401625|FG000|Overall Study|Ongoing|3|||
160732349|NCT03047720|580401631|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
160732350|NCT03047720|580401632|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
160732351|NCT04603482|580401633|FG000|Overall Study|Lost to Follow-up|15|||
160732352|NCT04603482|580401634|FG001|Overall Study|Lost to Follow-up|15|||
160732353|NCT04603482|580401635|FG002|Overall Study|Lost to Follow-up|15|||
160732354|NCT00732758|580401636|FG000|Overall Study|Lost to Follow-up|8|||
160732355|NCT00732758|580401637|FG001|Overall Study|Lost to Follow-up|16|||
160732356|NCT00373958|580401638|FG000|Infant Series|Withdrawal by Subject|13|||
160732357|NCT00373958|580401639|FG001|Infant Series|Withdrawal by Subject|15|||
160732358|NCT00373958|580401638|FG000|Infant Series|Failed to return|8|||
160732359|NCT00373958|580401639|FG001|Infant Series|Failed to return|13|||
160732360|NCT00373958|580401638|FG000|Infant Series|Lost to Follow-up|6|||
160732361|NCT00373958|580401639|FG001|Infant Series|Lost to Follow-up|5|||
160732362|NCT00373958|580401638|FG000|Infant Series|Protocol Violation|3|||
160732363|NCT00373958|580401639|FG001|Infant Series|Protocol Violation|7|||
160732364|NCT00373958|580401638|FG000|Infant Series|Lost Kaiser coverage|4|||
160732365|NCT00373958|580401639|FG001|Infant Series|Lost Kaiser coverage|0|||
160732366|NCT00373958|580401638|FG000|Infant Series|Child relocated|1|||
160732367|NCT00373958|580401639|FG001|Infant Series|Child relocated|0|||
160732368|NCT00373958|580401638|FG000|Infant Series|Consent was not received|1|||
160732369|NCT00373958|580401639|FG001|Infant Series|Consent was not received|0|||
160732370|NCT00373958|580401638|FG000|Infant Series|Adverse Event|3|||
160732371|NCT00373958|580401639|FG001|Infant Series|Adverse Event|1|||
160732372|NCT00373958|580401638|FG000|Infant Series|Physician Decision|1|||
160732373|NCT00373958|580401639|FG001|Infant Series|Physician Decision|1|||
160732374|NCT00373958|580401638|FG000|Toddler Dose|Lost to Follow-up|5|||
160732375|NCT00373958|580401639|FG001|Toddler Dose|Lost to Follow-up|8|||
160732376|NCT00373958|580401638|FG000|Toddler Dose|Withdrawal by Subject|2|||
160732377|NCT00373958|580401639|FG001|Toddler Dose|Withdrawal by Subject|2|||
160732378|NCT00373958|580401638|FG000|Toddler Dose|Failed to return|1|||
160732379|NCT00373958|580401639|FG001|Toddler Dose|Failed to return|2|||
160732380|NCT00373958|580401638|FG000|Toddler Dose|Protocol Violation|0|||
160732381|NCT00373958|580401639|FG001|Toddler Dose|Protocol Violation|1|||
160732382|NCT00373958|580401638|FG000|Toddler Dose|Withdrawn after infant series|22|||
160732383|NCT00373958|580401639|FG001|Toddler Dose|Withdrawn after infant series|25|||
160732384|NCT00492648|580401642|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
160732385|NCT00492648|580401643|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
160732386|NCT03382834|580401644|FG000|Step 1|Lost to Follow-up|0|||
160732387|NCT03382834|580401645|FG001|Step 1|Lost to Follow-up|1|||
160732388|NCT03382834|580401644|FG000|Step 2|Death|1|||
160732389|NCT03382834|580401645|FG001|Step 2|Death|0|||
160732390|NCT03382834|580401644|FG000|Step 2|Lost to Follow-up|2|||
160732391|NCT03382834|580401645|FG001|Step 2|Lost to Follow-up|2|||
160732392|NCT03382834|580401644|FG000|Step 2|Site Terminated by Sponsor|1|||
160732393|NCT03382834|580401645|FG001|Step 2|Site Terminated by Sponsor|0|||
160732394|NCT02387957|580401646|FG000|Overall Study|The study was discontinued|21|||
160732395|NCT02387957|580401647|FG001|Overall Study|The study was discontinued|21|||
160732396|NCT02387957|580401648|FG002|Overall Study|The study was discontinued|20|||
160732397|NCT02887248|580401649|FG000|Overall Study|Withdrawal by Subject|1|||
160732398|NCT02887248|580401649|FG000|Overall Study|Adverse Event|1|||
160732399|NCT02887248|580401649|FG000|Overall Study|Progressive Disease|1|||
160732400|NCT04152837|580401665|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
160732401|NCT04152837|580401665|FG000|Maintenance Period|Adverse Event|1|||
160732402|NCT04152837|580401665|FG000|Maintenance Period|Withdrawal by Subject|1|||
160732403|NCT04152837|580401665|FG000|Maintenance Period|Sponsor Termination of Study|2|||
160732404|NCT00586820|580401666|FG000|Overall Study|Unsuccessful PCI|1|||
160732405|NCT00586820|580401667|FG001|Overall Study|Unsuccessful PCI|0|||
160732406|NCT00430573|580401668|FG000|Overall Study|Withdrawal by Subject|5|||
160732407|NCT01483027|580401673|FG000|Overall Study|Administrative Reasons|2|||
160732408|NCT01483027|580401674|FG001|Overall Study|Administrative Reasons|1|||
160732409|NCT01483027|580401673|FG000|Overall Study|Withdrawal by Subject|21|||
160732410|NCT01483027|580401674|FG001|Overall Study|Withdrawal by Subject|32|||
160732411|NCT01483027|580401673|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
160732412|NCT01483027|580401674|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
160732413|NCT01483027|580401673|FG000|Overall Study|Lost to Follow-up|1|||
160732414|NCT01483027|580401674|FG001|Overall Study|Lost to Follow-up|1|||
160732415|NCT01483027|580401673|FG000|Overall Study|Adverse Event|0|||
160732416|NCT01483027|580401674|FG001|Overall Study|Adverse Event|1|||
160732417|NCT01483027|580401673|FG000|Overall Study|Withdrawal by Subject|0|||
160732418|NCT01483027|580401674|FG001|Overall Study|Withdrawal by Subject|1|||
160732419|NCT04463251|580401677|FG000|Overall Study|Death|1|||
160732420|NCT04463251|580401678|FG001|Overall Study|Death|0|||
160732421|NCT04463251|580401679|FG002|Overall Study|Death|1|||
160732422|NCT04463251|580401677|FG000|Overall Study|Adverse Event|0|||
160732423|NCT04463251|580401678|FG001|Overall Study|Adverse Event|1|||
160732424|NCT04463251|580401679|FG002|Overall Study|Adverse Event|0|||
160732425|NCT04463251|580401677|FG000|Overall Study|Lost to Follow-up|0|||
160732426|NCT04463251|580401678|FG001|Overall Study|Lost to Follow-up|1|||
160732427|NCT04463251|580401679|FG002|Overall Study|Lost to Follow-up|0|||
160732428|NCT04463251|580401677|FG000|Overall Study|Withdrawal by Subject|0|||
160732429|NCT04463251|580401678|FG001|Overall Study|Withdrawal by Subject|2|||
160732430|NCT04463251|580401679|FG002|Overall Study|Withdrawal by Subject|2|||
160732431|NCT05020665|580401680|FG000|Overall Study|Study terminated by Sponsor|5|||
160732432|NCT05020665|580401681|FG001|Overall Study|Study terminated by Sponsor|4|||
160732433|NCT05020665|580401680|FG000|Overall Study|Death|2|||
160732434|NCT05020665|580401681|FG001|Overall Study|Death|1|||
160732435|NCT05020665|580401680|FG000|Overall Study|Physician Decision|0|||
160732436|NCT05020665|580401681|FG001|Overall Study|Physician Decision|1|||
160732437|NCT05020665|580401680|FG000|Overall Study|Withdrawal by Subject|0|||
160732438|NCT05020665|580401681|FG001|Overall Study|Withdrawal by Subject|1|||
160732439|NCT05020665|580401680|FG000|Overall Study|Reason not specified|1|||
160732440|NCT05020665|580401681|FG001|Overall Study|Reason not specified|0|||
160732441|NCT01743560|580401686|FG000|Overall Study|Disease progression|26|||
160732442|NCT01743560|580401686|FG000|Overall Study|Adverse Event|8|||
160732443|NCT01743560|580401686|FG000|Overall Study|Death|3|||
160732444|NCT01743560|580401686|FG000|Overall Study|Withdrawal by Subject|2|||
160732445|NCT01743560|580401686|FG000|Overall Study|Protocol Violation|1|||
160732446|NCT01743560|580401686|FG000|Overall Study|>1 dose of study drug|3|||
160732447|NCT01732640|580401692|FG000|Overall Study|Adverse Event|0|||
160732448|NCT01732640|580401693|FG001|Overall Study|Adverse Event|1|||
160732449|NCT01732640|580401692|FG000|Overall Study|Death|0|||
160732450|NCT01732640|580401693|FG001|Overall Study|Death|1|||
160732451|NCT00877487|580401696|FG000|Open-label Treatment Phase|Adverse Event|1|||
160732452|NCT00877487|580401697|FG001|Open-label Treatment Phase|Adverse Event|0|||
160732453|NCT00877487|580401696|FG000|Open-label Treatment Phase|Protocol Violation|3|||
160732454|NCT00877487|580401697|FG001|Open-label Treatment Phase|Protocol Violation|0|||
160732455|NCT00877487|580401696|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
160732456|NCT00877487|580401697|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
160732457|NCT00877487|580401696|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
160732458|NCT00877487|580401697|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
160732459|NCT00877487|580401696|FG000|Open-label Treatment Phase|Out of country for business|1|||
160732460|NCT00877487|580401697|FG001|Open-label Treatment Phase|Out of country for business|0|||
160732461|NCT00877487|580401696|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
160732462|NCT00877487|580401697|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
160732463|NCT00877487|580401696|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
160732464|NCT00877487|580401697|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
160732465|NCT00877487|580401696|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
160732466|NCT00877487|580401697|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
160732467|NCT00877487|580401696|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
160732468|NCT00877487|580401697|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
160732469|NCT03070002|580401698|FG000|Follow up for 2 Years|Death|1|||
160732470|NCT03425396|580401710|FG000|Overall Study|Lost to Follow-up|2|||
160732471|NCT03425396|580401711|FG001|Overall Study|Lost to Follow-up|5|||
160732472|NCT03425396|580401712|FG002|Overall Study|Lost to Follow-up|2|||
160732473|NCT03425396|580401713|FG003|Overall Study|Lost to Follow-up|0|||
160732474|NCT03425396|580401714|FG004|Overall Study|Lost to Follow-up|0|||
160732475|NCT03425396|580401710|FG000|Overall Study|Withdrawal by Subject|0|||
160732476|NCT03425396|580401711|FG001|Overall Study|Withdrawal by Subject|1|||
160732477|NCT03425396|580401712|FG002|Overall Study|Withdrawal by Subject|0|||
160732478|NCT03425396|580401713|FG003|Overall Study|Withdrawal by Subject|1|||
160732479|NCT03425396|580401714|FG004|Overall Study|Withdrawal by Subject|0|||
160732480|NCT03425396|580401710|FG000|Overall Study|Other|0|||
160732481|NCT03425396|580401711|FG001|Overall Study|Other|1|||
160732482|NCT03425396|580401712|FG002|Overall Study|Other|1|||
160732483|NCT03425396|580401713|FG003|Overall Study|Other|0|||
160732484|NCT03425396|580401714|FG004|Overall Study|Other|1|||
160732485|NCT03558152|580403488|FG000|Overall Study|Adverse Event|0|||
160732486|NCT03558152|580403489|FG001|Overall Study|Adverse Event|0|||
160732487|NCT03558152|580403490|FG002|Overall Study|Adverse Event|1|||
160732488|NCT03558152|580403491|FG003|Overall Study|Adverse Event|1|||
160732489|NCT03558152|580403492|FG004|Overall Study|Adverse Event|2|||
160732490|NCT03558152|580403493|FG005|Overall Study|Adverse Event|1|||
160732491|NCT03558152|580403494|FG006|Overall Study|Adverse Event|1|||
160732492|NCT03558152|580403495|FG007|Overall Study|Adverse Event|0|||
160732493|NCT03558152|580403488|FG000|Overall Study|Death|0|||
160732494|NCT03558152|580403489|FG001|Overall Study|Death|0|||
160732495|NCT03558152|580403490|FG002|Overall Study|Death|0|||
160732496|NCT03558152|580403491|FG003|Overall Study|Death|0|||
160732497|NCT03558152|580403492|FG004|Overall Study|Death|1|||
160732498|NCT03558152|580403493|FG005|Overall Study|Death|0|||
160732499|NCT03558152|580403494|FG006|Overall Study|Death|0|||
160732500|NCT03558152|580403495|FG007|Overall Study|Death|0|||
160732501|NCT03558152|580403488|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
160732502|NCT03558152|580403489|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
160732503|NCT03558152|580403490|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
160732504|NCT03558152|580403491|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
160732505|NCT03558152|580403492|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
160732506|NCT03558152|580403493|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
160732507|NCT03558152|580403494|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
160732508|NCT03558152|580403495|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
160732509|NCT03558152|580403488|FG000|Overall Study|Miscalculation in mmcs|0|||
160732510|NCT03558152|580403489|FG001|Overall Study|Miscalculation in mmcs|0|||
160732511|NCT03558152|580403490|FG002|Overall Study|Miscalculation in mmcs|0|||
160732512|NCT03558152|580403491|FG003|Overall Study|Miscalculation in mmcs|0|||
160732513|NCT03558152|580403492|FG004|Overall Study|Miscalculation in mmcs|0|||
160732514|NCT03558152|580403493|FG005|Overall Study|Miscalculation in mmcs|0|||
160732515|NCT03558152|580403494|FG006|Overall Study|Miscalculation in mmcs|1|||
160732516|NCT03558152|580403495|FG007|Overall Study|Miscalculation in mmcs|0|||
160732517|NCT03558152|580403488|FG000|Overall Study|Mistake in calculation|0|||
160732518|NCT03558152|580403489|FG001|Overall Study|Mistake in calculation|0|||
160732519|NCT03558152|580403490|FG002|Overall Study|Mistake in calculation|0|||
160732520|NCT03558152|580403491|FG003|Overall Study|Mistake in calculation|1|||
160732521|NCT03558152|580403492|FG004|Overall Study|Mistake in calculation|0|||
160732522|NCT03558152|580403493|FG005|Overall Study|Mistake in calculation|0|||
160732523|NCT03558152|580403494|FG006|Overall Study|Mistake in calculation|0|||
160732524|NCT03558152|580403495|FG007|Overall Study|Mistake in calculation|0|||
160732525|NCT03558152|580403488|FG000|Overall Study|Mistake in evaluation of disease status|0|||
160732526|NCT03558152|580403489|FG001|Overall Study|Mistake in evaluation of disease status|0|||
160732527|NCT03558152|580403490|FG002|Overall Study|Mistake in evaluation of disease status|0|||
160732528|NCT03558152|580403491|FG003|Overall Study|Mistake in evaluation of disease status|0|||
160732529|NCT03558152|580403492|FG004|Overall Study|Mistake in evaluation of disease status|0|||
160732530|NCT03558152|580403493|FG005|Overall Study|Mistake in evaluation of disease status|0|||
160732531|NCT03558152|580403494|FG006|Overall Study|Mistake in evaluation of disease status|0|||
160732532|NCT03558152|580403495|FG007|Overall Study|Mistake in evaluation of disease status|1|||
160732533|NCT03558152|580403488|FG000|Overall Study|Physician Decision|0|||
160732534|NCT03558152|580403489|FG001|Overall Study|Physician Decision|0|||
160732535|NCT03558152|580403490|FG002|Overall Study|Physician Decision|0|||
160732536|NCT03558152|580403491|FG003|Overall Study|Physician Decision|0|||
160732537|NCT03558152|580403492|FG004|Overall Study|Physician Decision|0|||
160732538|NCT03558152|580403493|FG005|Overall Study|Physician Decision|0|||
160732539|NCT03558152|580403494|FG006|Overall Study|Physician Decision|1|||
160732540|NCT03558152|580403495|FG007|Overall Study|Physician Decision|0|||
160732541|NCT03558152|580403488|FG000|Overall Study|Withdrawal by Subject|2|||
160732542|NCT03558152|580403489|FG001|Overall Study|Withdrawal by Subject|3|||
160732543|NCT03558152|580403490|FG002|Overall Study|Withdrawal by Subject|2|||
160732544|NCT03558152|580403491|FG003|Overall Study|Withdrawal by Subject|1|||
160732545|NCT03558152|580403492|FG004|Overall Study|Withdrawal by Subject|1|||
160732546|NCT03558152|580403493|FG005|Overall Study|Withdrawal by Subject|1|||
160732547|NCT03558152|580403494|FG006|Overall Study|Withdrawal by Subject|3|||
160732548|NCT03558152|580403495|FG007|Overall Study|Withdrawal by Subject|2|||
160732549|NCT03558152|580403488|FG000|Overall Study|Lack of Efficacy|11|||
160732550|NCT03558152|580403489|FG001|Overall Study|Lack of Efficacy|11|||
160732551|NCT03558152|580403490|FG002|Overall Study|Lack of Efficacy|10|||
160732552|NCT03558152|580403491|FG003|Overall Study|Lack of Efficacy|11|||
160732553|NCT03558152|580403492|FG004|Overall Study|Lack of Efficacy|14|||
160732554|NCT03558152|580403493|FG005|Overall Study|Lack of Efficacy|12|||
160732555|NCT03558152|580403494|FG006|Overall Study|Lack of Efficacy|14|||
160732556|NCT03558152|580403495|FG007|Overall Study|Lack of Efficacy|13|||
160732557|NCT03558152|580403488|FG000|Overall Study|Protocol Violation|1|||
160732558|NCT03558152|580403489|FG001|Overall Study|Protocol Violation|1|||
160732559|NCT03558152|580403490|FG002|Overall Study|Protocol Violation|0|||
160732560|NCT03558152|580403491|FG003|Overall Study|Protocol Violation|1|||
160732561|NCT03558152|580403492|FG004|Overall Study|Protocol Violation|1|||
160732562|NCT03558152|580403493|FG005|Overall Study|Protocol Violation|0|||
160732563|NCT03558152|580403494|FG006|Overall Study|Protocol Violation|2|||
160732564|NCT03558152|580403495|FG007|Overall Study|Protocol Violation|0|||
160732565|NCT03960021|580403496|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
160732566|NCT01936181|580403500|FG000|Randomised, Double-blind|Adverse Event|27|||
160732567|NCT01936181|580403501|FG001|Randomised, Double-blind|Adverse Event|21|||
160732568|NCT01936181|580403502|FG002|Randomised, Double-blind|Adverse Event|0|||
160732569|NCT01936181|580403503|FG003|Randomised, Double-blind|Adverse Event|0|||
160732570|NCT01936181|580403500|FG000|Randomised, Double-blind|Protocol Violation|1|||
160732571|NCT01936181|580403501|FG001|Randomised, Double-blind|Protocol Violation|5|||
160732572|NCT01936181|580403502|FG002|Randomised, Double-blind|Protocol Violation|0|||
160732573|NCT01936181|580403503|FG003|Randomised, Double-blind|Protocol Violation|0|||
160732574|NCT01936181|580403500|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
160732575|NCT01936181|580403501|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
160732576|NCT01936181|580403502|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
160732577|NCT01936181|580403503|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
160732578|NCT01936181|580403500|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
160732579|NCT01936181|580403501|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
160732580|NCT01936181|580403502|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
160732581|NCT01936181|580403503|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
160732582|NCT01936181|580403500|FG000|Randomised, Double-blind|Pregnancy|0|||
160732583|NCT01936181|580403501|FG001|Randomised, Double-blind|Pregnancy|1|||
160732584|NCT01936181|580403502|FG002|Randomised, Double-blind|Pregnancy|0|||
160732585|NCT01936181|580403503|FG003|Randomised, Double-blind|Pregnancy|0|||
160732586|NCT01936181|580403500|FG000|Randomised, Double-blind|Physician Decision|4|||
160732587|NCT01936181|580403501|FG001|Randomised, Double-blind|Physician Decision|4|||
160732588|NCT01936181|580403502|FG002|Randomised, Double-blind|Physician Decision|0|||
160732589|NCT01936181|580403503|FG003|Randomised, Double-blind|Physician Decision|0|||
160732590|NCT01936181|580403500|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
160732591|NCT01936181|580403501|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
160732592|NCT01936181|580403502|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
160732593|NCT01936181|580403503|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
160732594|NCT01936181|580403500|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
160732595|NCT01936181|580403501|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
160732596|NCT01936181|580403502|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
160732597|NCT01936181|580403503|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
160732598|NCT01936181|580403500|FG000|Transition-extension|Adverse Event|3|||
160732599|NCT01936181|580403501|FG001|Transition-extension|Adverse Event|0|||
160732600|NCT01936181|580403502|FG002|Transition-extension|Adverse Event|3|||
160732601|NCT01936181|580403503|FG003|Transition-extension|Adverse Event|1|||
160732602|NCT01936181|580403500|FG000|Transition-extension|Lost to Follow-up|3|||
160732603|NCT01936181|580403501|FG001|Transition-extension|Lost to Follow-up|0|||
160732604|NCT01936181|580403502|FG002|Transition-extension|Lost to Follow-up|1|||
160732605|NCT01936181|580403503|FG003|Transition-extension|Lost to Follow-up|2|||
160732606|NCT01936181|580403500|FG000|Transition-extension|Physician Decision|2|||
160732607|NCT01936181|580403501|FG001|Transition-extension|Physician Decision|0|||
160732608|NCT01936181|580403502|FG002|Transition-extension|Physician Decision|0|||
160732609|NCT01936181|580403503|FG003|Transition-extension|Physician Decision|1|||
160732610|NCT01936181|580403500|FG000|Transition-extension|Withdrawal by Subject|7|||
160732611|NCT01936181|580403501|FG001|Transition-extension|Withdrawal by Subject|0|||
160732612|NCT01936181|580403502|FG002|Transition-extension|Withdrawal by Subject|2|||
160732613|NCT01936181|580403503|FG003|Transition-extension|Withdrawal by Subject|1|||
160732614|NCT01346189|580403504|FG000|Overall Study|Withdrawal by Subject|7|||
160732615|NCT01346189|580403505|FG001|Overall Study|Withdrawal by Subject|5|||
160732616|NCT01346189|580403506|FG002|Overall Study|Withdrawal by Subject|3|||
160732617|NCT01346189|580403507|FG003|Overall Study|Withdrawal by Subject|5|||
160732618|NCT01346189|580403504|FG000|Overall Study|Physician Decision|4|||
160732619|NCT01346189|580403505|FG001|Overall Study|Physician Decision|0|||
160732620|NCT01346189|580403506|FG002|Overall Study|Physician Decision|0|||
160732621|NCT01346189|580403507|FG003|Overall Study|Physician Decision|0|||
160732622|NCT01346189|580403504|FG000|Overall Study|Moved|3|||
160732623|NCT01346189|580403505|FG001|Overall Study|Moved|0|||
160732624|NCT01346189|580403506|FG002|Overall Study|Moved|4|||
160732625|NCT01346189|580403507|FG003|Overall Study|Moved|0|||
160732626|NCT01346189|580403504|FG000|Overall Study|Other|2|||
160732627|NCT01346189|580403505|FG001|Overall Study|Other|4|||
160732628|NCT01346189|580403506|FG002|Overall Study|Other|7|||
160732629|NCT01346189|580403507|FG003|Overall Study|Other|3|||
160732630|NCT01346189|580403504|FG000|Overall Study|Death|0|||
160732631|NCT01346189|580403505|FG001|Overall Study|Death|3|||
160732632|NCT01346189|580403506|FG002|Overall Study|Death|0|||
160732633|NCT01346189|580403507|FG003|Overall Study|Death|0|||
160732634|NCT01346189|580403504|FG000|Overall Study|Non-health system primary care physician|0|||
160732635|NCT01346189|580403505|FG001|Overall Study|Non-health system primary care physician|5|||
160732636|NCT01346189|580403506|FG002|Overall Study|Non-health system primary care physician|0|||
160732637|NCT01346189|580403507|FG003|Overall Study|Non-health system primary care physician|0|||
160732638|NCT01346189|580403504|FG000|Overall Study|Travel|0|||
160732639|NCT01346189|580403505|FG001|Overall Study|Travel|0|||
160732640|NCT01346189|580403506|FG002|Overall Study|Travel|0|||
160732641|NCT01346189|580403507|FG003|Overall Study|Travel|3|||
160732642|NCT00900757|580403508|FG000|Overall Study|screen failure|19|||
160732643|NCT03535194|580403511|FG000|Induction Period|Adverse Event|2|||
160732644|NCT03535194|580403512|FG001|Induction Period|Adverse Event|2|||
160732645|NCT03535194|580403513|FG002|Induction Period|Adverse Event|1|||
160732646|NCT03535194|580403514|FG003|Induction Period|Adverse Event|3|||
160732647|NCT03535194|580403515|FG004|Induction Period|Adverse Event|0|||
160732648|NCT03535194|580403511|FG000|Induction Period|Death|0|||
160732649|NCT03535194|580403512|FG001|Induction Period|Death|1|||
160732650|NCT03535194|580403513|FG002|Induction Period|Death|0|||
160732651|NCT03535194|580403514|FG003|Induction Period|Death|0|||
160732652|NCT03535194|580403515|FG004|Induction Period|Death|0|||
160732653|NCT03535194|580403511|FG000|Induction Period|Lack of Efficacy|1|||
160732654|NCT03535194|580403512|FG001|Induction Period|Lack of Efficacy|3|||
160732655|NCT03535194|580403513|FG002|Induction Period|Lack of Efficacy|2|||
160732656|NCT03535194|580403514|FG003|Induction Period|Lack of Efficacy|2|||
160732657|NCT03535194|580403515|FG004|Induction Period|Lack of Efficacy|0|||
160732658|NCT03535194|580403511|FG000|Induction Period|Lost to Follow-up|3|||
160732659|NCT03535194|580403512|FG001|Induction Period|Lost to Follow-up|5|||
160732660|NCT03535194|580403513|FG002|Induction Period|Lost to Follow-up|2|||
160732661|NCT03535194|580403514|FG003|Induction Period|Lost to Follow-up|3|||
160732662|NCT03535194|580403515|FG004|Induction Period|Lost to Follow-up|0|||
160732663|NCT03535194|580403511|FG000|Induction Period|Physician Decision|1|||
160732664|NCT03535194|580403512|FG001|Induction Period|Physician Decision|1|||
160732665|NCT03535194|580403513|FG002|Induction Period|Physician Decision|0|||
160732666|NCT03535194|580403514|FG003|Induction Period|Physician Decision|0|||
160732667|NCT03535194|580403515|FG004|Induction Period|Physician Decision|0|||
160732668|NCT03535194|580403511|FG000|Induction Period|Protocol Violation|1|||
160732669|NCT03535194|580403512|FG001|Induction Period|Protocol Violation|0|||
160732670|NCT03535194|580403513|FG002|Induction Period|Protocol Violation|0|||
160732671|NCT03535194|580403514|FG003|Induction Period|Protocol Violation|1|||
160732672|NCT03535194|580403515|FG004|Induction Period|Protocol Violation|0|||
160732673|NCT03535194|580403511|FG000|Induction Period|Screen Failure|0|||
160732674|NCT03535194|580403512|FG001|Induction Period|Screen Failure|1|||
160732675|NCT03535194|580403513|FG002|Induction Period|Screen Failure|0|||
160732676|NCT03535194|580403514|FG003|Induction Period|Screen Failure|0|||
160732677|NCT03535194|580403515|FG004|Induction Period|Screen Failure|0|||
160732678|NCT03535194|580403511|FG000|Induction Period|Withdrawal by Subject|3|||
160732679|NCT03535194|580403512|FG001|Induction Period|Withdrawal by Subject|4|||
160732680|NCT03535194|580403513|FG002|Induction Period|Withdrawal by Subject|3|||
160732681|NCT03535194|580403514|FG003|Induction Period|Withdrawal by Subject|2|||
160732682|NCT03535194|580403515|FG004|Induction Period|Withdrawal by Subject|0|||
160732683|NCT03535194|580403511|FG000|Maintenance Period|Adverse Event|6|||
160732684|NCT03535194|580403512|FG001|Maintenance Period|Adverse Event|5|||
160732685|NCT03535194|580403513|FG002|Maintenance Period|Adverse Event|1|||
160732686|NCT03535194|580403514|FG003|Maintenance Period|Adverse Event|11|||
160732687|NCT03535194|580403515|FG004|Maintenance Period|Adverse Event|4|||
160732688|NCT03535194|580403511|FG000|Maintenance Period|Lack of Efficacy|3|||
160732689|NCT03535194|580403512|FG001|Maintenance Period|Lack of Efficacy|2|||
160732690|NCT03535194|580403513|FG002|Maintenance Period|Lack of Efficacy|5|||
160732691|NCT03535194|580403514|FG003|Maintenance Period|Lack of Efficacy|9|||
160732692|NCT03535194|580403515|FG004|Maintenance Period|Lack of Efficacy|0|||
160732693|NCT03535194|580403511|FG000|Maintenance Period|Lost to Follow-up|4|||
160732694|NCT03535194|580403512|FG001|Maintenance Period|Lost to Follow-up|2|||
160732695|NCT03535194|580403513|FG002|Maintenance Period|Lost to Follow-up|1|||
160732696|NCT03535194|580403514|FG003|Maintenance Period|Lost to Follow-up|5|||
160732697|NCT03535194|580403515|FG004|Maintenance Period|Lost to Follow-up|2|||
160732698|NCT03535194|580403511|FG000|Maintenance Period|Other|1|||
160732699|NCT03535194|580403512|FG001|Maintenance Period|Other|2|||
160732700|NCT03535194|580403513|FG002|Maintenance Period|Other|0|||
160732701|NCT03535194|580403514|FG003|Maintenance Period|Other|0|||
160732702|NCT03535194|580403515|FG004|Maintenance Period|Other|0|||
160732703|NCT03535194|580403511|FG000|Maintenance Period|Physician Decision|1|||
160732704|NCT03535194|580403512|FG001|Maintenance Period|Physician Decision|2|||
160732705|NCT03535194|580403513|FG002|Maintenance Period|Physician Decision|0|||
160732706|NCT03535194|580403514|FG003|Maintenance Period|Physician Decision|2|||
160732707|NCT03535194|580403515|FG004|Maintenance Period|Physician Decision|0|||
160732708|NCT03535194|580403511|FG000|Maintenance Period|Pregnancy|0|||
160732709|NCT03535194|580403512|FG001|Maintenance Period|Pregnancy|0|||
160732710|NCT03535194|580403513|FG002|Maintenance Period|Pregnancy|0|||
160732711|NCT03535194|580403514|FG003|Maintenance Period|Pregnancy|2|||
160732712|NCT03535194|580403515|FG004|Maintenance Period|Pregnancy|0|||
160732713|NCT03535194|580403511|FG000|Maintenance Period|Protocol Violation|0|||
160732714|NCT03535194|580403512|FG001|Maintenance Period|Protocol Violation|1|||
160732715|NCT03535194|580403513|FG002|Maintenance Period|Protocol Violation|0|||
160732716|NCT03535194|580403514|FG003|Maintenance Period|Protocol Violation|0|||
160732717|NCT03535194|580403515|FG004|Maintenance Period|Protocol Violation|0|||
160732718|NCT03535194|580403511|FG000|Maintenance Period|Withdrawal by Subject|7|||
160732719|NCT03535194|580403512|FG001|Maintenance Period|Withdrawal by Subject|2|||
160732720|NCT03535194|580403513|FG002|Maintenance Period|Withdrawal by Subject|1|||
160732721|NCT03535194|580403514|FG003|Maintenance Period|Withdrawal by Subject|8|||
160732722|NCT03535194|580403515|FG004|Maintenance Period|Withdrawal by Subject|0|||
160732723|NCT03535194|580403511|FG000|Post-Treatment Followup Period|Adverse Event|4|||
160732724|NCT03535194|580403512|FG001|Post-Treatment Followup Period|Adverse Event|5|||
160732725|NCT03535194|580403513|FG002|Post-Treatment Followup Period|Adverse Event|1|||
160732726|NCT03535194|580403514|FG003|Post-Treatment Followup Period|Adverse Event|8|||
160732727|NCT03535194|580403515|FG004|Post-Treatment Followup Period|Adverse Event|0|||
160732728|NCT03535194|580403511|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
160732729|NCT03535194|580403512|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
160732730|NCT03535194|580403513|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
160732731|NCT03535194|580403514|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
160732732|NCT03535194|580403515|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
160732733|NCT03535194|580403511|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
160732734|NCT03535194|580403512|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
160732735|NCT03535194|580403513|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
160732736|NCT03535194|580403514|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
160732737|NCT03535194|580403515|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
160732738|NCT03535194|580403511|FG000|Post-Treatment Followup Period|Other|1|||
160732739|NCT03535194|580403512|FG001|Post-Treatment Followup Period|Other|0|||
160732740|NCT03535194|580403513|FG002|Post-Treatment Followup Period|Other|0|||
160732741|NCT03535194|580403514|FG003|Post-Treatment Followup Period|Other|5|||
160732742|NCT03535194|580403515|FG004|Post-Treatment Followup Period|Other|0|||
160732743|NCT03535194|580403511|FG000|Post-Treatment Followup Period|Physician Decision|0|||
160732744|NCT03535194|580403512|FG001|Post-Treatment Followup Period|Physician Decision|2|||
160732745|NCT03535194|580403513|FG002|Post-Treatment Followup Period|Physician Decision|1|||
160732746|NCT03535194|580403514|FG003|Post-Treatment Followup Period|Physician Decision|1|||
160732747|NCT03535194|580403515|FG004|Post-Treatment Followup Period|Physician Decision|0|||
160732748|NCT03535194|580403511|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
160732749|NCT03535194|580403512|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
160732750|NCT03535194|580403513|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
160732751|NCT03535194|580403514|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
160732752|NCT03535194|580403515|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160732753|NCT04411810|580403516|FG000|Overall Study|Screen failure|1|||
160732754|NCT04411810|580403516|FG000|Overall Study|Withdrawal by Subject|1|||
160732755|NCT04304235|580403520|FG000|Overall Study|incomplete triage data|0|||
160732756|NCT04304235|580403521|FG001|Overall Study|incomplete triage data|69|||
160732757|NCT04304235|580403522|FG002|Overall Study|incomplete triage data|0|||
160732758|NCT04304235|580403523|FG003|Overall Study|incomplete triage data|0|||
160732759|NCT04304235|580403524|FG004|Overall Study|incomplete triage data|289|||
160732760|NCT04304235|580403525|FG005|Overall Study|incomplete triage data|123|||
160732761|NCT04304235|580403526|FG006|Overall Study|incomplete triage data|65|||
160732762|NCT02703272|580403531|FG000|Overall Study|Death|4|||
160732763|NCT02703272|580403532|FG001|Overall Study|Death|9|||
160732764|NCT02703272|580403533|FG002|Overall Study|Death|19|||
160732765|NCT02703272|580403534|FG003|Overall Study|Death|10|||
160732766|NCT02703272|580403531|FG000|Overall Study|Withdrawal by Subject|0|||
160732767|NCT02703272|580403532|FG001|Overall Study|Withdrawal by Subject|0|||
160732768|NCT02703272|580403533|FG002|Overall Study|Withdrawal by Subject|4|||
160732769|NCT02703272|580403534|FG003|Overall Study|Withdrawal by Subject|2|||
160732770|NCT02703272|580403531|FG000|Overall Study|Study Terminated by Sponsor|6|||
160732771|NCT02703272|580403532|FG001|Overall Study|Study Terminated by Sponsor|1|||
160732772|NCT02703272|580403533|FG002|Overall Study|Study Terminated by Sponsor|12|||
160732773|NCT02703272|580403534|FG003|Overall Study|Study Terminated by Sponsor|4|||
160732774|NCT02703272|580403531|FG000|Overall Study|Other|1|||
160732775|NCT02703272|580403532|FG001|Overall Study|Other|0|||
160732776|NCT02703272|580403533|FG002|Overall Study|Other|0|||
160732777|NCT02703272|580403534|FG003|Overall Study|Other|0|||
160732778|NCT04470544|580403535|FG000|Overall Study|Withdrawal by Subject|4|||
160732779|NCT04470544|580403536|FG001|Overall Study|Withdrawal by Subject|6|||
160732780|NCT01680861|580403539|FG000|Early Post-transplant Period|Protocol Violation|1|||
160732781|NCT01680861|580403540|FG001|Early Post-transplant Period|Protocol Violation|1|||
160732782|NCT02222545|580403541|FG000|Overall Study|Adverse Event|1|||
160732783|NCT02222545|580403542|FG001|Overall Study|Adverse Event|0|||
160732784|NCT02222545|580403543|FG002|Overall Study|Adverse Event|2|||
160732785|NCT02222545|580403541|FG000|Overall Study|Death|0|||
160732786|NCT02222545|580403542|FG001|Overall Study|Death|0|||
160732787|NCT02222545|580403543|FG002|Overall Study|Death|9|||
160732788|NCT02222545|580403541|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
160732789|NCT02222545|580403542|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
160732790|NCT02222545|580403543|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
160732791|NCT02222545|580403541|FG000|Overall Study|Withdrawal by Subject|0|||
160732792|NCT02222545|580403542|FG001|Overall Study|Withdrawal by Subject|0|||
160732793|NCT02222545|580403543|FG002|Overall Study|Withdrawal by Subject|3|||
160732794|NCT02222545|580403541|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
160732795|NCT02222545|580403542|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
160732796|NCT02222545|580403543|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
160732797|NCT05113979|580403547|FG000|Overall Study|Death|2|||
160732798|NCT05113979|580403547|FG000|Overall Study|Lost to Follow-up|1|||
160732799|NCT00526669|580403548|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
160732800|NCT00526669|580403549|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
160732801|NCT00526669|580403548|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
160732802|NCT00526669|580403549|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
160732803|NCT00526669|580403548|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
160732804|NCT00526669|580403549|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
160732805|NCT00526669|580403548|FG000|Combined Treatment Phase|Death|0|||
160732806|NCT00526669|580403549|FG001|Combined Treatment Phase|Death|2|||
160732807|NCT01981954|580403552|FG000|Titration Period|Protocol Deviation|1|||
160732808|NCT01981954|580403552|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
160732809|NCT02218736|580403555|FG000|Overall Study|Withdrawal by Subject|10|||
160732810|NCT02218736|580403556|FG001|Overall Study|Withdrawal by Subject|9|||
160732811|NCT02218736|580403555|FG000|Overall Study|Protocol Violation|2|||
160732812|NCT02218736|580403556|FG001|Overall Study|Protocol Violation|0|||
160732813|NCT04016779|580403559|FG000|Overall Study|Adverse Event|9|||
160732814|NCT04016779|580403560|FG001|Overall Study|Adverse Event|17|||
160732815|NCT04016779|580403559|FG000|Overall Study|Lack of Efficacy|4|||
160732816|NCT04016779|580403560|FG001|Overall Study|Lack of Efficacy|1|||
160732817|NCT04016779|580403559|FG000|Overall Study|Lost to Follow-up|5|||
160732818|NCT04016779|580403560|FG001|Overall Study|Lost to Follow-up|14|||
160732819|NCT04016779|580403559|FG000|Overall Study|Physician Decision|1|||
160732820|NCT04016779|580403560|FG001|Overall Study|Physician Decision|3|||
160732821|NCT04016779|580403559|FG000|Overall Study|Withdrawal by Subject|6|||
160732822|NCT04016779|580403560|FG001|Overall Study|Withdrawal by Subject|8|||
160732823|NCT04016779|580403559|FG000|Overall Study|Non-compliance with Study Drug|2|||
160732824|NCT04016779|580403560|FG001|Overall Study|Non-compliance with Study Drug|3|||
160732825|NCT04016779|580403559|FG000|Overall Study|Other, Multiple categories|17|||
160732826|NCT04016779|580403560|FG001|Overall Study|Other, Multiple categories|17|||
160732827|NCT00623935|580403561|FG000|Overall Study|Death|1|||
160732828|NCT00623935|580403561|FG000|Overall Study|Patient Declined Transplant|1|||
160732829|NCT01878084|580403562|FG000|Overall Study|Physician Decision|2|||
160732830|NCT01876784|580403563|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
160732831|NCT01876784|580403564|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
160732832|NCT01876784|580403563|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
160732833|NCT01876784|580403564|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
160732834|NCT01876784|580403563|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
160732835|NCT01876784|580403564|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
160732836|NCT01876784|580403563|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
160732837|NCT01876784|580403564|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
160732838|NCT01876784|580403563|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
160732839|NCT01876784|580403564|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
160732840|NCT01876784|580403563|FG000|Randomized Treatment Period (40 Months)|Death|1|||
160732841|NCT01876784|580403564|FG001|Randomized Treatment Period (40 Months)|Death|0|||
160732842|NCT01876784|580403563|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
160732843|NCT01876784|580403564|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
160732844|NCT01876784|580403563|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
160732845|NCT01876784|580403564|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
160732846|NCT01876784|580403563|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
160732847|NCT01876784|580403564|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
160732848|NCT01876784|580403563|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
160732849|NCT01876784|580403564|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
160732850|NCT01876784|580403563|FG000|Open-label Period (31 Months)|Adverse Event|2|||
160732851|NCT01876784|580403564|FG001|Open-label Period (31 Months)|Adverse Event|6|||
160732852|NCT01876784|580403563|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
160732853|NCT01876784|580403564|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
160732854|NCT01876784|580403563|FG000|Open-label Period (31 Months)|Progressive disease|4|||
160732855|NCT01876784|580403564|FG001|Open-label Period (31 Months)|Progressive disease|35|||
160732856|NCT01876784|580403563|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
160732857|NCT01876784|580403564|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
160732858|NCT01876784|580403563|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
160732859|NCT01876784|580403564|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
160732860|NCT01876784|580403563|FG000|Open-label Period (31 Months)|Death|0|||
160732861|NCT01876784|580403564|FG001|Open-label Period (31 Months)|Death|1|||
160732862|NCT01876784|580403563|FG000|Open-label Period (31 Months)|Other than specified above|9|||
160732863|NCT01876784|580403564|FG001|Open-label Period (31 Months)|Other than specified above|18|||
160732864|NCT00638443|580403565|FG000|First Intervention|Adverse Event|2|||
160732865|NCT00638443|580403566|FG001|First Intervention|Adverse Event|1|||
160732866|NCT01044290|580403567|FG000|Follow-up 1|Death|3|||
160732867|NCT01044290|580403568|FG001|Follow-up 1|Death|3|||
160732868|NCT01044290|580403569|FG002|Follow-up 1|Death|1|||
160732869|NCT01044290|580403567|FG000|Follow-up 1|Withdrawal by Subject|2|||
160732870|NCT01044290|580403568|FG001|Follow-up 1|Withdrawal by Subject|2|||
160732871|NCT01044290|580403569|FG002|Follow-up 1|Withdrawal by Subject|0|||
160732872|NCT01044290|580403567|FG000|Follow-Up 2|Death|0|||
160732873|NCT01044290|580403568|FG001|Follow-Up 2|Death|1|||
160732874|NCT01044290|580403569|FG002|Follow-Up 2|Death|1|||
160732875|NCT01044290|580403567|FG000|Follow-Up 2|Withdrawal by Subject|0|||
160732876|NCT01044290|580403568|FG001|Follow-Up 2|Withdrawal by Subject|1|||
160732877|NCT01044290|580403569|FG002|Follow-Up 2|Withdrawal by Subject|1|||
160732878|NCT01967706|580403572|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
160732879|NCT01967706|580403573|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
160732880|NCT01967706|580403574|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
160732881|NCT01967706|580403575|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
160732882|NCT01475851|580403586|FG000|Overall Study|Protocol defined stopping criteria|1|||
160732883|NCT01475851|580403587|FG001|Overall Study|Protocol defined stopping criteria|0|||
160732884|NCT01552915|580403588|FG000|Overall Study|Adverse Event|3|||
160732885|NCT01552915|580403589|FG001|Overall Study|Adverse Event|14|||
160732886|NCT01552915|580403590|FG002|Overall Study|Adverse Event|3|||
160732887|NCT01552915|580403588|FG000|Overall Study|Lost to Follow-up|4|||
160732888|NCT01552915|580403589|FG001|Overall Study|Lost to Follow-up|6|||
160732889|NCT01552915|580403590|FG002|Overall Study|Lost to Follow-up|5|||
160732890|NCT01552915|580403588|FG000|Overall Study|Withdrawal by Subject|6|||
160732891|NCT01552915|580403589|FG001|Overall Study|Withdrawal by Subject|4|||
160732892|NCT01552915|580403590|FG002|Overall Study|Withdrawal by Subject|5|||
160732893|NCT01552915|580403588|FG000|Overall Study|Protocol Violation|0|||
160732894|NCT01552915|580403589|FG001|Overall Study|Protocol Violation|4|||
160732895|NCT01552915|580403590|FG002|Overall Study|Protocol Violation|4|||
160732896|NCT01552915|580403588|FG000|Overall Study|Lack of Efficacy|8|||
160732897|NCT01552915|580403589|FG001|Overall Study|Lack of Efficacy|1|||
160732898|NCT01552915|580403590|FG002|Overall Study|Lack of Efficacy|4|||
160732899|NCT01552915|580403588|FG000|Overall Study|Other|2|||
160732900|NCT01552915|580403589|FG001|Overall Study|Other|0|||
160732901|NCT01552915|580403590|FG002|Overall Study|Other|6|||
160732902|NCT02949843|580403591|FG000|Overall Study|Withdrawal by Subject|0|||
160732903|NCT02949843|580403592|FG001|Overall Study|Withdrawal by Subject|1|||
160732904|NCT02949843|580403593|FG002|Overall Study|Withdrawal by Subject|1|||
160732905|NCT03613649|580403594|FG000|Second Treatment|Lost to Follow-up|0|||
160732906|NCT03613649|580403595|FG001|Second Treatment|Lost to Follow-up|0|||
160732907|NCT03613649|580403596|FG002|Second Treatment|Lost to Follow-up|1|||
160732908|NCT03613649|580403597|FG003|Second Treatment|Lost to Follow-up|0|||
160732909|NCT03613649|580403598|FG004|Second Treatment|Lost to Follow-up|0|||
160732910|NCT03613649|580403599|FG005|Second Treatment|Lost to Follow-up|0|||
160732911|NCT03613649|580403600|FG006|Second Treatment|Lost to Follow-up|0|||
160732912|NCT03613649|580403601|FG007|Second Treatment|Lost to Follow-up|0|||
160732913|NCT03613649|580403602|FG008|Second Treatment|Lost to Follow-up|0|||
160732914|NCT03613649|580403603|FG009|Second Treatment|Lost to Follow-up|0|||
160732915|NCT03613649|580403604|FG010|Second Treatment|Lost to Follow-up|0|||
160732916|NCT03613649|580403605|FG011|Second Treatment|Lost to Follow-up|0|||
160732917|NCT03613649|580403594|FG000|Second Treatment|Withdrawal by Subject|0|||
160732918|NCT03613649|580403595|FG001|Second Treatment|Withdrawal by Subject|0|||
160732919|NCT03613649|580403596|FG002|Second Treatment|Withdrawal by Subject|0|||
160732920|NCT03613649|580403597|FG003|Second Treatment|Withdrawal by Subject|0|||
160732921|NCT03613649|580403598|FG004|Second Treatment|Withdrawal by Subject|1|||
160732922|NCT03613649|580403599|FG005|Second Treatment|Withdrawal by Subject|0|||
160732923|NCT03613649|580403600|FG006|Second Treatment|Withdrawal by Subject|0|||
160732924|NCT03613649|580403601|FG007|Second Treatment|Withdrawal by Subject|0|||
160732925|NCT03613649|580403602|FG008|Second Treatment|Withdrawal by Subject|0|||
160732926|NCT03613649|580403603|FG009|Second Treatment|Withdrawal by Subject|0|||
160732927|NCT03613649|580403604|FG010|Second Treatment|Withdrawal by Subject|0|||
160732928|NCT03613649|580403605|FG011|Second Treatment|Withdrawal by Subject|0|||
160732929|NCT03613649|580403594|FG000|Third Treatment|Lost to Follow-up|0|||
160732930|NCT03613649|580403595|FG001|Third Treatment|Lost to Follow-up|0|||
160732931|NCT03613649|580403596|FG002|Third Treatment|Lost to Follow-up|0|||
160732932|NCT03613649|580403597|FG003|Third Treatment|Lost to Follow-up|0|||
160732933|NCT03613649|580403598|FG004|Third Treatment|Lost to Follow-up|1|||
160732934|NCT03613649|580403599|FG005|Third Treatment|Lost to Follow-up|0|||
160732935|NCT03613649|580403600|FG006|Third Treatment|Lost to Follow-up|0|||
160732936|NCT03613649|580403601|FG007|Third Treatment|Lost to Follow-up|0|||
160732937|NCT03613649|580403602|FG008|Third Treatment|Lost to Follow-up|0|||
160732938|NCT03613649|580403603|FG009|Third Treatment|Lost to Follow-up|0|||
160732939|NCT03613649|580403604|FG010|Third Treatment|Lost to Follow-up|0|||
160732940|NCT03613649|580403605|FG011|Third Treatment|Lost to Follow-up|1|||
160732941|NCT03613649|580403594|FG000|Third Treatment|Protocol Violation|0|||
160732942|NCT03613649|580403595|FG001|Third Treatment|Protocol Violation|0|||
160732943|NCT03613649|580403596|FG002|Third Treatment|Protocol Violation|0|||
160732944|NCT03613649|580403597|FG003|Third Treatment|Protocol Violation|0|||
160732945|NCT03613649|580403598|FG004|Third Treatment|Protocol Violation|0|||
160732946|NCT03613649|580403599|FG005|Third Treatment|Protocol Violation|0|||
160732947|NCT03613649|580403600|FG006|Third Treatment|Protocol Violation|1|||
160732948|NCT03613649|580403601|FG007|Third Treatment|Protocol Violation|0|||
160732949|NCT03613649|580403602|FG008|Third Treatment|Protocol Violation|0|||
160732950|NCT03613649|580403603|FG009|Third Treatment|Protocol Violation|0|||
160732951|NCT03613649|580403604|FG010|Third Treatment|Protocol Violation|0|||
160732952|NCT03613649|580403605|FG011|Third Treatment|Protocol Violation|1|||
160732953|NCT03613649|580403594|FG000|Fourth Treatment|Protocol Violation|1|||
160732954|NCT03613649|580403595|FG001|Fourth Treatment|Protocol Violation|0|||
160732955|NCT03613649|580403596|FG002|Fourth Treatment|Protocol Violation|0|||
160732956|NCT03613649|580403597|FG003|Fourth Treatment|Protocol Violation|0|||
160732957|NCT03613649|580403598|FG004|Fourth Treatment|Protocol Violation|1|||
160732958|NCT03613649|580403599|FG005|Fourth Treatment|Protocol Violation|0|||
160732959|NCT03613649|580403600|FG006|Fourth Treatment|Protocol Violation|0|||
160732960|NCT03613649|580403601|FG007|Fourth Treatment|Protocol Violation|0|||
160732961|NCT03613649|580403602|FG008|Fourth Treatment|Protocol Violation|0|||
160732962|NCT03613649|580403603|FG009|Fourth Treatment|Protocol Violation|0|||
160732963|NCT03613649|580403604|FG010|Fourth Treatment|Protocol Violation|0|||
160732964|NCT03613649|580403605|FG011|Fourth Treatment|Protocol Violation|0|||
160732965|NCT03613649|580403594|FG000|Fourth Treatment|Physician Decision|0|||
160732966|NCT03613649|580403595|FG001|Fourth Treatment|Physician Decision|0|||
160732967|NCT03613649|580403596|FG002|Fourth Treatment|Physician Decision|0|||
160732968|NCT03613649|580403597|FG003|Fourth Treatment|Physician Decision|0|||
160732969|NCT03613649|580403598|FG004|Fourth Treatment|Physician Decision|0|||
160732970|NCT03613649|580403599|FG005|Fourth Treatment|Physician Decision|0|||
160732971|NCT03613649|580403600|FG006|Fourth Treatment|Physician Decision|1|||
160732972|NCT03613649|580403601|FG007|Fourth Treatment|Physician Decision|0|||
160732973|NCT03613649|580403602|FG008|Fourth Treatment|Physician Decision|0|||
160732974|NCT03613649|580403603|FG009|Fourth Treatment|Physician Decision|0|||
160732975|NCT03613649|580403604|FG010|Fourth Treatment|Physician Decision|0|||
160732976|NCT03613649|580403605|FG011|Fourth Treatment|Physician Decision|0|||
160732977|NCT02693171|580403607|FG000|Overall Study|Adverse Event|1|||
160732978|NCT02693171|580403607|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
160732979|NCT00319592|580403608|FG000|Overall Study|Protocol Violation|1|||
160732980|NCT00319592|580403609|FG001|Overall Study|Protocol Violation|0|||
160732981|NCT00319592|580403608|FG000|Overall Study|Physician Decision|0|||
160732982|NCT00319592|580403609|FG001|Overall Study|Physician Decision|1|||
160732983|NCT00658775|580403617|FG000|Overall Study|Adverse Event|4|||
160732984|NCT00658775|580403618|FG001|Overall Study|Adverse Event|6|||
160732985|NCT00658775|580403617|FG000|Overall Study|Lost to Follow-up|17|||
160732986|NCT00658775|580403618|FG001|Overall Study|Lost to Follow-up|18|||
160732987|NCT00658775|580403617|FG000|Overall Study|Withdrawal by Subject|6|||
160732988|NCT00658775|580403618|FG001|Overall Study|Withdrawal by Subject|4|||
160732989|NCT00658775|580403617|FG000|Overall Study|Withdrawal of consent|8|||
160732990|NCT00658775|580403618|FG001|Overall Study|Withdrawal of consent|7|||
160732991|NCT00658775|580403617|FG000|Overall Study|Other|7|||
160732992|NCT00658775|580403618|FG001|Overall Study|Other|8|||
160732993|NCT03887442|580403623|FG000|Overall Study|Adverse Event|1|||
160732994|NCT03887442|580403624|FG001|Overall Study|Adverse Event|0|||
160732995|NCT00767455|580403627|FG000|Overall Study|Investigator error|19|||
160732996|NCT00746564|580403628|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
160732997|NCT01628198|580403629|FG000|Overall Study|Lost to Follow-up|7|||
160732998|NCT01628198|580403629|FG000|Overall Study|Withdrawal by Subject|10|||
160732999|NCT01628198|580403629|FG000|Overall Study|Screen failure|1|||
160733000|NCT03386994|580403630|FG000|Overall Study|Lung transplant|1|||
160733001|NCT03386994|580403630|FG000|Overall Study|Adverse Event|14|||
160733002|NCT03386994|580403630|FG000|Overall Study|Lost to Follow-up|4|||
160733003|NCT03386994|580403630|FG000|Overall Study|Withdrawal by Subject|3|||
160733004|NCT03386994|580403630|FG000|Overall Study|Death|16|||
160733005|NCT01827267|580403631|FG000|Overall Study|Did not receive study drug|1|||
160733006|NCT01827267|580403632|FG001|Overall Study|Did not receive study drug|1|||
160733007|NCT01827267|580403631|FG000|Overall Study|Physician Decision|1|||
160733008|NCT01827267|580403632|FG001|Overall Study|Physician Decision|0|||
160733009|NCT01827267|580403631|FG000|Overall Study|Disease Progression|1|||
160733010|NCT01827267|580403632|FG001|Overall Study|Disease Progression|1|||
160733011|NCT01827267|580403631|FG000|Overall Study|Sponsor Discontinued Study|2|||
160733012|NCT01827267|580403632|FG001|Overall Study|Sponsor Discontinued Study|8|||
160733013|NCT01827267|580403631|FG000|Overall Study|Still on study|0|||
160733014|NCT01827267|580403632|FG001|Overall Study|Still on study|2|||
160733015|NCT02147158|580403636|FG000|Treatment Course 1|Adverse Event|1|||
160733016|NCT02147158|580403637|FG001|Treatment Course 1|Adverse Event|4|||
160733017|NCT02147158|580403638|FG002|Treatment Course 1|Adverse Event|3|||
160733018|NCT02147158|580403639|FG003|Treatment Course 1|Adverse Event|4|||
160733019|NCT02147158|580403640|FG004|Treatment Course 1|Adverse Event|1|||
160733020|NCT02147158|580403641|FG005|Treatment Course 1|Adverse Event|2|||
160733021|NCT02147158|580403636|FG000|Treatment Course 1|Lost to Follow-up|2|||
160733022|NCT02147158|580403637|FG001|Treatment Course 1|Lost to Follow-up|4|||
160733023|NCT02147158|580403638|FG002|Treatment Course 1|Lost to Follow-up|3|||
160733024|NCT02147158|580403639|FG003|Treatment Course 1|Lost to Follow-up|3|||
160733025|NCT02147158|580403640|FG004|Treatment Course 1|Lost to Follow-up|2|||
160733026|NCT02147158|580403641|FG005|Treatment Course 1|Lost to Follow-up|4|||
160733027|NCT02147158|580403636|FG000|Treatment Course 1|Protocol Violation|0|||
160733028|NCT02147158|580403637|FG001|Treatment Course 1|Protocol Violation|0|||
160733029|NCT02147158|580403638|FG002|Treatment Course 1|Protocol Violation|1|||
160733030|NCT02147158|580403639|FG003|Treatment Course 1|Protocol Violation|1|||
160733031|NCT02147158|580403640|FG004|Treatment Course 1|Protocol Violation|0|||
160733032|NCT02147158|580403641|FG005|Treatment Course 1|Protocol Violation|0|||
160733033|NCT02147158|580403636|FG000|Treatment Course 1|Withdrawal of Consent|1|||
160733034|NCT02147158|580403637|FG001|Treatment Course 1|Withdrawal of Consent|1|||
160733035|NCT02147158|580403638|FG002|Treatment Course 1|Withdrawal of Consent|1|||
160733036|NCT02147158|580403639|FG003|Treatment Course 1|Withdrawal of Consent|5|||
160733037|NCT02147158|580403640|FG004|Treatment Course 1|Withdrawal of Consent|3|||
160733038|NCT02147158|580403641|FG005|Treatment Course 1|Withdrawal of Consent|2|||
160733039|NCT02147158|580403636|FG000|Off-Treatment Interval 1|Adverse Event|1|||
160733040|NCT02147158|580403637|FG001|Off-Treatment Interval 1|Adverse Event|0|||
160733041|NCT02147158|580403638|FG002|Off-Treatment Interval 1|Adverse Event|0|||
160733042|NCT02147158|580403639|FG003|Off-Treatment Interval 1|Adverse Event|1|||
160733043|NCT02147158|580403640|FG004|Off-Treatment Interval 1|Adverse Event|0|||
160733044|NCT02147158|580403641|FG005|Off-Treatment Interval 1|Adverse Event|0|||
160733045|NCT02147158|580403636|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
160733046|NCT02147158|580403637|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
160733047|NCT02147158|580403638|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
160733048|NCT02147158|580403639|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
160733049|NCT02147158|580403640|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
160733050|NCT02147158|580403641|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
160733051|NCT02147158|580403636|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
160733052|NCT02147158|580403637|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
160733053|NCT02147158|580403638|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
160733054|NCT02147158|580403639|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
160733055|NCT02147158|580403640|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
160733056|NCT02147158|580403641|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
160733057|NCT02147158|580403636|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
160733058|NCT02147158|580403637|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
160733059|NCT02147158|580403638|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
160733060|NCT02147158|580403639|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
160733061|NCT02147158|580403640|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
160733062|NCT02147158|580403641|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
160733063|NCT02147158|580403636|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
160733064|NCT02147158|580403637|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
160733065|NCT02147158|580403638|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
160733066|NCT02147158|580403639|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
160733067|NCT02147158|580403640|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
160733068|NCT02147158|580403641|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
160733069|NCT02147158|580403636|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
160733070|NCT02147158|580403637|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
160733071|NCT02147158|580403638|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
160733072|NCT02147158|580403639|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
160733073|NCT02147158|580403640|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
160733074|NCT02147158|580403641|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
160733075|NCT02147158|580403636|FG000|Treatment Course 2|Adverse Event|0|||
160733076|NCT02147158|580403637|FG001|Treatment Course 2|Adverse Event|4|||
160733077|NCT02147158|580403638|FG002|Treatment Course 2|Adverse Event|2|||
160733078|NCT02147158|580403639|FG003|Treatment Course 2|Adverse Event|1|||
160733079|NCT02147158|580403640|FG004|Treatment Course 2|Adverse Event|0|||
160733080|NCT02147158|580403641|FG005|Treatment Course 2|Adverse Event|1|||
160733081|NCT02147158|580403636|FG000|Treatment Course 2|Withdrawal of Consent|0|||
160733082|NCT02147158|580403637|FG001|Treatment Course 2|Withdrawal of Consent|1|||
160733083|NCT02147158|580403638|FG002|Treatment Course 2|Withdrawal of Consent|2|||
160733084|NCT02147158|580403639|FG003|Treatment Course 2|Withdrawal of Consent|3|||
160733085|NCT02147158|580403640|FG004|Treatment Course 2|Withdrawal of Consent|0|||
160733086|NCT02147158|580403641|FG005|Treatment Course 2|Withdrawal of Consent|0|||
160733087|NCT02147158|580403636|FG000|Treatment Course 2|Lost to Follow-up|1|||
160733088|NCT02147158|580403637|FG001|Treatment Course 2|Lost to Follow-up|0|||
160733089|NCT02147158|580403638|FG002|Treatment Course 2|Lost to Follow-up|1|||
160733090|NCT02147158|580403639|FG003|Treatment Course 2|Lost to Follow-up|1|||
160733091|NCT02147158|580403640|FG004|Treatment Course 2|Lost to Follow-up|0|||
160733092|NCT02147158|580403641|FG005|Treatment Course 2|Lost to Follow-up|1|||
160733093|NCT02147158|580403636|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
160733094|NCT02147158|580403637|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
160733095|NCT02147158|580403638|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
160733096|NCT02147158|580403639|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
160733097|NCT02147158|580403640|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
160733098|NCT02147158|580403641|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
160733099|NCT02147158|580403636|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
160733100|NCT02147158|580403637|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
160733101|NCT02147158|580403638|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
160733102|NCT02147158|580403639|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
160733103|NCT02147158|580403640|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
160733104|NCT02147158|580403641|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
160733105|NCT02147158|580403636|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
160733106|NCT02147158|580403637|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
160733107|NCT02147158|580403638|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
160733108|NCT02147158|580403639|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
160733109|NCT02147158|580403640|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
160733110|NCT02147158|580403641|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
160733111|NCT02147158|580403636|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
160733112|NCT02147158|580403637|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
160733113|NCT02147158|580403638|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
160733114|NCT02147158|580403639|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
160733115|NCT02147158|580403640|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
160733116|NCT02147158|580403641|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
160733117|NCT02147158|580403636|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
160733118|NCT02147158|580403637|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
160733119|NCT02147158|580403638|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
160733120|NCT02147158|580403639|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
160733121|NCT02147158|580403640|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
160733122|NCT02147158|580403641|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
160733123|NCT04520997|580403642|FG000|Overall Study|Lost to Follow-up|1|||
160733124|NCT04520997|580403643|FG001|Overall Study|Lost to Follow-up|1|||
160733125|NCT04520997|580403642|FG000|Overall Study|Withdrawal by Subject|1|||
160733126|NCT04520997|580403643|FG001|Overall Study|Withdrawal by Subject|0|||
160733127|NCT04520997|580403642|FG000|Overall Study|Not Treated|0|||
160733128|NCT04520997|580403643|FG001|Overall Study|Not Treated|1|||
160733129|NCT03689374|580403644|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
160733130|NCT03689374|580403645|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
160733131|NCT03689374|580403646|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
160733132|NCT03689374|580403644|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
160733133|NCT03689374|580403645|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
160733134|NCT03689374|580403646|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
160733135|NCT03689374|580403644|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
160733136|NCT03689374|580403645|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
160733137|NCT03689374|580403646|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
160733138|NCT03689374|580403644|FG000|Treatment Period (Week 0 to 52)|Death|0|||
160733139|NCT03689374|580403645|FG001|Treatment Period (Week 0 to 52)|Death|11|||
160733140|NCT03689374|580403646|FG002|Treatment Period (Week 0 to 52)|Death|1|||
160733141|NCT05367973|580403647|FG000|Overall Study|Adverse Event|0|||
160733142|NCT05367973|580403648|FG001|Overall Study|Adverse Event|2|||
160733143|NCT00986921|580403649|FG000|Overall Study|Physician Decision|1|||
160733144|NCT00986921|580403650|FG001|Overall Study|Physician Decision|0|||
160733145|NCT01758731|580403651|FG000|Overall Study|Physician Decision|1|||
160733146|NCT04445714|580403652|FG000|Overall Study|Discontinuation of the study|14|||
160733147|NCT04445714|580403652|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
160733148|NCT04445714|580403652|FG000|Overall Study|Withdrawal of Informed Consent|8|||
160733149|NCT02396420|580403653|FG000|Overall Study|Death|1|||
160733150|NCT01273623|580403658|FG000|Overall Study|did not meet IVUS criteria|29|||
160733151|NCT02122887|580403666|FG000|Overall Study|Withdrawal by Subject|20|||
160733152|NCT02122887|580403667|FG001|Overall Study|Withdrawal by Subject|2|||
160733153|NCT01082211|580403668|FG000|Overall Study|Protocol Violation|4|||
160733154|NCT01082211|580403668|FG000|Overall Study|No protocol treatment received|3|||
160733155|NCT04999163|580403669|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
160733156|NCT04999163|580403670|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
160733157|NCT04999163|580403669|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
160733158|NCT04999163|580403670|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
160733159|NCT04999163|580403669|FG000|Overall Study|Withdrawal by Subject|1|||
160733160|NCT04999163|580403670|FG001|Overall Study|Withdrawal by Subject|0|||
160733161|NCT00784550|580405610|FG000|Overall Study|Adverse Event|12|||
160733162|NCT00784550|580405611|FG001|Overall Study|Adverse Event|10|||
160733163|NCT00784550|580405610|FG000|Overall Study|Lack of Efficacy|0|||
160733164|NCT00784550|580405611|FG001|Overall Study|Lack of Efficacy|1|||
160733165|NCT00784550|580405610|FG000|Overall Study|Protocol Violation|10|||
160733166|NCT00784550|580405611|FG001|Overall Study|Protocol Violation|10|||
160733167|NCT00784550|580405610|FG000|Overall Study|Lost to Follow-up|8|||
160733168|NCT00784550|580405611|FG001|Overall Study|Lost to Follow-up|5|||
160733169|NCT00784550|580405610|FG000|Overall Study|Physician Decision|2|||
160733170|NCT00784550|580405611|FG001|Overall Study|Physician Decision|3|||
160733171|NCT00784550|580405610|FG000|Overall Study|Withdrawal by Subject|4|||
160733172|NCT00784550|580405611|FG001|Overall Study|Withdrawal by Subject|13|||
160733173|NCT04166591|580405612|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
160733174|NCT04166591|580405613|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
160733175|NCT04166591|580405614|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
160733176|NCT04166591|580405615|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
160733177|NCT04166591|580405612|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
160733178|NCT04166591|580405613|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
160733179|NCT04166591|580405614|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
160733180|NCT04166591|580405615|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
160733181|NCT00601172|580405616|FG000|Overall Study|Adverse Event|43|||
160733182|NCT00601172|580405617|FG001|Overall Study|Adverse Event|32|||
160733183|NCT00601172|580405616|FG000|Overall Study|Lack of Efficacy|11|||
160733184|NCT00601172|580405617|FG001|Overall Study|Lack of Efficacy|12|||
160733185|NCT00601172|580405616|FG000|Overall Study|Protocol Violation|2|||
160733186|NCT00601172|580405617|FG001|Overall Study|Protocol Violation|5|||
160733187|NCT00601172|580405616|FG000|Overall Study|Lost to Follow-up|4|||
160733188|NCT00601172|580405617|FG001|Overall Study|Lost to Follow-up|3|||
160733189|NCT00601172|580405616|FG000|Overall Study|Physician Decision|27|||
160733190|NCT00601172|580405617|FG001|Overall Study|Physician Decision|28|||
160733191|NCT00601172|580405616|FG000|Overall Study|Withdrawal by Subject|35|||
160733192|NCT00601172|580405617|FG001|Overall Study|Withdrawal by Subject|27|||
160733193|NCT00601172|580405616|FG000|Overall Study|Did not meet continuation criteria|19|||
160733194|NCT00601172|580405617|FG001|Overall Study|Did not meet continuation criteria|20|||
160733195|NCT04434469|580405621|FG000|Overall Study|Death|2|||
160733196|NCT04434469|580405622|FG001|Overall Study|Death|3|||
160733197|NCT04434469|580405623|FG002|Overall Study|Death|2|||
160733198|NCT04434469|580405624|FG003|Overall Study|Death|2|||
160733199|NCT04434469|580405625|FG004|Overall Study|Death|2|||
160733200|NCT04434469|580405626|FG005|Overall Study|Death|0|||
160733201|NCT04434469|580405621|FG000|Overall Study|Lost to Follow-up|0|||
160733202|NCT04434469|580405622|FG001|Overall Study|Lost to Follow-up|0|||
160733203|NCT04434469|580405623|FG002|Overall Study|Lost to Follow-up|0|||
160733204|NCT04434469|580405624|FG003|Overall Study|Lost to Follow-up|1|||
160733205|NCT04434469|580405625|FG004|Overall Study|Lost to Follow-up|1|||
160733206|NCT04434469|580405626|FG005|Overall Study|Lost to Follow-up|0|||
160733207|NCT04434469|580405621|FG000|Overall Study|Study terminated by sponsor|1|||
160733208|NCT04434469|580405622|FG001|Overall Study|Study terminated by sponsor|1|||
160733209|NCT04434469|580405623|FG002|Overall Study|Study terminated by sponsor|1|||
160733210|NCT04434469|580405624|FG003|Overall Study|Study terminated by sponsor|2|||
160733211|NCT04434469|580405625|FG004|Overall Study|Study terminated by sponsor|3|||
160733212|NCT04434469|580405626|FG005|Overall Study|Study terminated by sponsor|3|||
160733213|NCT04434469|580405621|FG000|Overall Study|Withdrawal by Subject|0|||
160733214|NCT04434469|580405622|FG001|Overall Study|Withdrawal by Subject|0|||
160733215|NCT04434469|580405623|FG002|Overall Study|Withdrawal by Subject|1|||
160733216|NCT04434469|580405624|FG003|Overall Study|Withdrawal by Subject|0|||
160733217|NCT04434469|580405625|FG004|Overall Study|Withdrawal by Subject|0|||
160733218|NCT04434469|580405626|FG005|Overall Study|Withdrawal by Subject|0|||
160733219|NCT02005692|580405627|FG000|Overall Study|Protocol Violation|1|||
160733220|NCT02005692|580405627|FG000|Overall Study|Withdrawal by Subject|1|||
160733221|NCT02005692|580405627|FG000|Overall Study|Discharged earlier than anticipated|5|||
160733222|NCT05896527|580405628|FG000|Overall Study|Withdrawal by Subject|11|||
160733223|NCT05896527|580405629|FG001|Overall Study|Withdrawal by Subject|10|||
160733224|NCT05896527|580405630|FG002|Overall Study|Withdrawal by Subject|4|||
160733225|NCT05896527|580405631|FG003|Overall Study|Withdrawal by Subject|3|||
160733226|NCT05896527|580405632|FG004|Overall Study|Withdrawal by Subject|2|||
160733227|NCT05896527|580405628|FG000|Overall Study|Lost to Follow-up|0|||
160733228|NCT05896527|580405629|FG001|Overall Study|Lost to Follow-up|2|||
160733229|NCT05896527|580405630|FG002|Overall Study|Lost to Follow-up|2|||
160733230|NCT05896527|580405631|FG003|Overall Study|Lost to Follow-up|2|||
160733231|NCT05896527|580405632|FG004|Overall Study|Lost to Follow-up|1|||
160733232|NCT05896527|580405628|FG000|Overall Study|Significant protocol noncompliance|0|||
160733233|NCT05896527|580405629|FG001|Overall Study|Significant protocol noncompliance|1|||
160733234|NCT05896527|580405630|FG002|Overall Study|Significant protocol noncompliance|0|||
160733235|NCT05896527|580405631|FG003|Overall Study|Significant protocol noncompliance|0|||
160733236|NCT05896527|580405632|FG004|Overall Study|Significant protocol noncompliance|0|||
160733237|NCT05896527|580405628|FG000|Overall Study|Eligibility criteria not met|1|||
160733238|NCT05896527|580405629|FG001|Overall Study|Eligibility criteria not met|0|||
160733239|NCT05896527|580405630|FG002|Overall Study|Eligibility criteria not met|0|||
160733240|NCT05896527|580405631|FG003|Overall Study|Eligibility criteria not met|0|||
160733241|NCT05896527|580405632|FG004|Overall Study|Eligibility criteria not met|0|||
160733242|NCT05896527|580405628|FG000|Overall Study|Sponsor's decision|0|||
160733243|NCT05896527|580405629|FG001|Overall Study|Sponsor's decision|0|||
160733244|NCT05896527|580405630|FG002|Overall Study|Sponsor's decision|0|||
160733245|NCT05896527|580405631|FG003|Overall Study|Sponsor's decision|1|||
160733246|NCT05896527|580405632|FG004|Overall Study|Sponsor's decision|0|||
160733247|NCT05896527|580405628|FG000|Overall Study|Investigator's decision|0|||
160733248|NCT05896527|580405629|FG001|Overall Study|Investigator's decision|1|||
160733249|NCT05896527|580405630|FG002|Overall Study|Investigator's decision|0|||
160733250|NCT05896527|580405631|FG003|Overall Study|Investigator's decision|0|||
160733251|NCT05896527|580405632|FG004|Overall Study|Investigator's decision|0|||
160733252|NCT05896527|580405628|FG000|Overall Study|Pregnancy of his partner|0|||
160733253|NCT05896527|580405629|FG001|Overall Study|Pregnancy of his partner|0|||
160733254|NCT05896527|580405630|FG002|Overall Study|Pregnancy of his partner|0|||
160733255|NCT05896527|580405631|FG003|Overall Study|Pregnancy of his partner|1|||
160733256|NCT05896527|580405632|FG004|Overall Study|Pregnancy of his partner|0|||
160733257|NCT02651155|580405633|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
160733258|NCT02651155|580405634|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
160733259|NCT02651155|580405633|FG000|Overall Study|Voluntary Withdrawal|5|||
160733260|NCT02651155|580405634|FG001|Overall Study|Voluntary Withdrawal|0|||
160733261|NCT01867710|580405637|FG000|Overall Study|Death|25|||
160733262|NCT01867710|580405638|FG001|Overall Study|Death|15|||
160733263|NCT01867710|580405639|FG002|Overall Study|Death|27|||
160733264|NCT01867710|580405640|FG003|Overall Study|Death|20|||
160733265|NCT01867710|580405637|FG000|Overall Study|Lost to Follow-up|3|||
160733266|NCT01867710|580405638|FG001|Overall Study|Lost to Follow-up|4|||
160733267|NCT01867710|580405639|FG002|Overall Study|Lost to Follow-up|3|||
160733268|NCT01867710|580405640|FG003|Overall Study|Lost to Follow-up|2|||
160733269|NCT01867710|580405637|FG000|Overall Study|Withdrawal of consent|2|||
160733270|NCT01867710|580405638|FG001|Overall Study|Withdrawal of consent|5|||
160733271|NCT01867710|580405639|FG002|Overall Study|Withdrawal of consent|1|||
160733272|NCT01867710|580405640|FG003|Overall Study|Withdrawal of consent|2|||
160733273|NCT01867710|580405637|FG000|Overall Study|Study Terminated by Sponsor|9|||
160733274|NCT01867710|580405638|FG001|Overall Study|Study Terminated by Sponsor|13|||
160733275|NCT01867710|580405639|FG002|Overall Study|Study Terminated by Sponsor|8|||
160733276|NCT01867710|580405640|FG003|Overall Study|Study Terminated by Sponsor|16|||
160733277|NCT01867710|580405637|FG000|Overall Study|Biochemical progression|0|||
160733278|NCT01867710|580405638|FG001|Overall Study|Biochemical progression|1|||
160733279|NCT01867710|580405639|FG002|Overall Study|Biochemical progression|0|||
160733280|NCT01867710|580405640|FG003|Overall Study|Biochemical progression|0|||
160733281|NCT01867710|580405637|FG000|Overall Study|Clinical progression|0|||
160733282|NCT01867710|580405638|FG001|Overall Study|Clinical progression|0|||
160733283|NCT01867710|580405639|FG002|Overall Study|Clinical progression|1|||
160733284|NCT01867710|580405640|FG003|Overall Study|Clinical progression|0|||
160733285|NCT01867710|580405637|FG000|Overall Study|Disease progression|1|||
160733286|NCT01867710|580405638|FG001|Overall Study|Disease progression|0|||
160733287|NCT01867710|580405639|FG002|Overall Study|Disease progression|0|||
160733288|NCT01867710|580405640|FG003|Overall Study|Disease progression|0|||
160733289|NCT01867710|580405637|FG000|Overall Study|Patient decision|0|||
160733290|NCT01867710|580405638|FG001|Overall Study|Patient decision|0|||
160733291|NCT01867710|580405639|FG002|Overall Study|Patient decision|0|||
160733292|NCT01867710|580405640|FG003|Overall Study|Patient decision|1|||
160733293|NCT01867710|580405637|FG000|Overall Study|Patient to follow subsequent treatment|0|||
160733294|NCT01867710|580405638|FG001|Overall Study|Patient to follow subsequent treatment|1|||
160733295|NCT01867710|580405639|FG002|Overall Study|Patient to follow subsequent treatment|0|||
160733296|NCT01867710|580405640|FG003|Overall Study|Patient to follow subsequent treatment|0|||
160733297|NCT01867710|580405637|FG000|Overall Study|Progressive disease|1|||
160733298|NCT01867710|580405638|FG001|Overall Study|Progressive disease|0|||
160733299|NCT01867710|580405639|FG002|Overall Study|Progressive disease|0|||
160733300|NCT01867710|580405640|FG003|Overall Study|Progressive disease|0|||
160733301|NCT01867710|580405637|FG000|Overall Study|Protocol Violation|0|||
160733302|NCT01867710|580405638|FG001|Overall Study|Protocol Violation|0|||
160733303|NCT01867710|580405639|FG002|Overall Study|Protocol Violation|0|||
160733304|NCT01867710|580405640|FG003|Overall Study|Protocol Violation|1|||
160733305|NCT01867710|580405637|FG000|Overall Study|PSA-progression|0|||
160733306|NCT01867710|580405638|FG001|Overall Study|PSA-progression|1|||
160733307|NCT01867710|580405639|FG002|Overall Study|PSA-progression|0|||
160733308|NCT01867710|580405640|FG003|Overall Study|PSA-progression|0|||
160733309|NCT01867710|580405637|FG000|Overall Study|Study medication no longer effective|0|||
160733310|NCT01867710|580405638|FG001|Overall Study|Study medication no longer effective|1|||
160733311|NCT01867710|580405639|FG002|Overall Study|Study medication no longer effective|0|||
160733312|NCT01867710|580405640|FG003|Overall Study|Study medication no longer effective|0|||
160733313|NCT02048826|580405641|FG000|Overall Study|Withdrawal by Subject|1|||
160733314|NCT02048826|580405642|FG001|Overall Study|Withdrawal by Subject|0|||
160733315|NCT00976820|580405643|FG000|Overall Study|Lost to Follow-up|5|||
160733316|NCT00976820|580405644|FG001|Overall Study|Lost to Follow-up|16|||
160733317|NCT00976820|580405645|FG002|Overall Study|Lost to Follow-up|2|||
160733318|NCT00976820|580405646|FG003|Overall Study|Lost to Follow-up|3|||
160733319|NCT00976820|580405643|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
160733320|NCT00976820|580405644|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
160733321|NCT00976820|580405645|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
160733322|NCT00976820|580405646|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
160733323|NCT00976820|580405643|FG000|Overall Study|Withdrawal by Subject|2|||
160733324|NCT00976820|580405644|FG001|Overall Study|Withdrawal by Subject|4|||
160733325|NCT00976820|580405645|FG002|Overall Study|Withdrawal by Subject|1|||
160733326|NCT00976820|580405646|FG003|Overall Study|Withdrawal by Subject|4|||
160733327|NCT00968981|580405647|FG000|Overall Study|Adverse Event|2|||
160733328|NCT00968981|580405648|FG001|Overall Study|Adverse Event|0|||
160733329|NCT00968981|580405649|FG002|Overall Study|Adverse Event|0|||
160733330|NCT00968981|580405647|FG000|Overall Study|Disease Progression|14|||
160733331|NCT00968981|580405648|FG001|Overall Study|Disease Progression|16|||
160733332|NCT00968981|580405649|FG002|Overall Study|Disease Progression|13|||
160733333|NCT00968981|580405647|FG000|Overall Study|Lost to Follow-up|0|||
160733334|NCT00968981|580405648|FG001|Overall Study|Lost to Follow-up|0|||
160733335|NCT00968981|580405649|FG002|Overall Study|Lost to Follow-up|1|||
160733336|NCT00968981|580405647|FG000|Overall Study|Physician Decision|5|||
160733337|NCT00968981|580405648|FG001|Overall Study|Physician Decision|3|||
160733338|NCT00968981|580405649|FG002|Overall Study|Physician Decision|5|||
160733339|NCT00968981|580405647|FG000|Overall Study|Withdrawal by Subject|1|||
160733340|NCT00968981|580405648|FG001|Overall Study|Withdrawal by Subject|3|||
160733341|NCT00968981|580405649|FG002|Overall Study|Withdrawal by Subject|3|||
160733342|NCT01489254|580405660|FG000|Double-blind Part|Adverse Event|7|||
160733343|NCT01489254|580405661|FG001|Double-blind Part|Adverse Event|2|||
160733344|NCT01489254|580405662|FG002|Double-blind Part|Adverse Event|2|||
160733345|NCT01489254|580405663|FG003|Double-blind Part|Adverse Event|0|||
160733346|NCT01489254|580405660|FG000|Double-blind Part|Pregnancy|1|||
160733347|NCT01489254|580405661|FG001|Double-blind Part|Pregnancy|3|||
160733348|NCT01489254|580405662|FG002|Double-blind Part|Pregnancy|0|||
160733349|NCT01489254|580405663|FG003|Double-blind Part|Pregnancy|0|||
160733350|NCT01489254|580405660|FG000|Double-blind Part|Withdrawal by Subject|12|||
160733351|NCT01489254|580405661|FG001|Double-blind Part|Withdrawal by Subject|20|||
160733352|NCT01489254|580405662|FG002|Double-blind Part|Withdrawal by Subject|1|||
160733353|NCT01489254|580405663|FG003|Double-blind Part|Withdrawal by Subject|0|||
160733354|NCT01489254|580405660|FG000|Double-blind Part|Lost to Follow-up|1|||
160733355|NCT01489254|580405661|FG001|Double-blind Part|Lost to Follow-up|2|||
160733356|NCT01489254|580405662|FG002|Double-blind Part|Lost to Follow-up|0|||
160733357|NCT01489254|580405663|FG003|Double-blind Part|Lost to Follow-up|0|||
160733358|NCT01489254|580405660|FG000|Double-blind Part|Other reasons for not completing study|4|||
160733359|NCT01489254|580405661|FG001|Double-blind Part|Other reasons for not completing study|6|||
160733360|NCT01489254|580405662|FG002|Double-blind Part|Other reasons for not completing study|0|||
160733361|NCT01489254|580405663|FG003|Double-blind Part|Other reasons for not completing study|0|||
160733362|NCT01489254|580405660|FG000|Open-label Extension Part|Adverse Event|0|||
160733363|NCT01489254|580405661|FG001|Open-label Extension Part|Adverse Event|0|||
160733364|NCT01489254|580405662|FG002|Open-label Extension Part|Adverse Event|0|||
160733365|NCT01489254|580405663|FG003|Open-label Extension Part|Adverse Event|10|||
160733366|NCT01489254|580405660|FG000|Open-label Extension Part|Pregnancy|0|||
160733367|NCT01489254|580405661|FG001|Open-label Extension Part|Pregnancy|0|||
160733368|NCT01489254|580405662|FG002|Open-label Extension Part|Pregnancy|0|||
160733369|NCT01489254|580405663|FG003|Open-label Extension Part|Pregnancy|3|||
160733370|NCT01489254|580405660|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
160733371|NCT01489254|580405661|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
160733372|NCT01489254|580405662|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
160733373|NCT01489254|580405663|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
160733374|NCT01489254|580405660|FG000|Open-label Extension Part|Protocol Violation|0|||
160733375|NCT01489254|580405661|FG001|Open-label Extension Part|Protocol Violation|0|||
160733376|NCT01489254|580405662|FG002|Open-label Extension Part|Protocol Violation|0|||
160733377|NCT01489254|580405663|FG003|Open-label Extension Part|Protocol Violation|1|||
160733378|NCT01489254|580405660|FG000|Open-label Extension Part|Lost to Follow-up|0|||
160733379|NCT01489254|580405661|FG001|Open-label Extension Part|Lost to Follow-up|0|||
160733380|NCT01489254|580405662|FG002|Open-label Extension Part|Lost to Follow-up|0|||
160733381|NCT01489254|580405663|FG003|Open-label Extension Part|Lost to Follow-up|9|||
160733382|NCT01489254|580405660|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
160733383|NCT01489254|580405661|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
160733384|NCT01489254|580405662|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
160733385|NCT01489254|580405663|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
160733386|NCT00890084|580405676|FG000|Overall Study|Adverse Event|16|||
160733387|NCT00890084|580405676|FG000|Overall Study|Lost to Follow-up|126|||
160733388|NCT02738879|580405677|FG000|Overall Study|Adverse Event|1|||
160733389|NCT02738879|580405678|FG001|Overall Study|Adverse Event|1|||
160733390|NCT02738879|580405677|FG000|Overall Study|Death|0|||
160733391|NCT02738879|580405678|FG001|Overall Study|Death|2|||
160733392|NCT02738879|580405677|FG000|Overall Study|Lost to Follow-up|1|||
160733393|NCT02738879|580405678|FG001|Overall Study|Lost to Follow-up|5|||
160733394|NCT02738879|580405677|FG000|Overall Study|Protocol Violation|1|||
160733395|NCT02738879|580405678|FG001|Overall Study|Protocol Violation|3|||
160733396|NCT02738879|580405677|FG000|Overall Study|Physician Decision|3|||
160733397|NCT02738879|580405678|FG001|Overall Study|Physician Decision|4|||
160733398|NCT02738879|580405677|FG000|Overall Study|Pregnancy|0|||
160733399|NCT02738879|580405678|FG001|Overall Study|Pregnancy|1|||
160733400|NCT02738879|580405677|FG000|Overall Study|Screen Failure|1|||
160733401|NCT02738879|580405678|FG001|Overall Study|Screen Failure|2|||
160733402|NCT02738879|580405677|FG000|Overall Study|Site Discontinued Study Participation|1|||
160733403|NCT02738879|580405678|FG001|Overall Study|Site Discontinued Study Participation|0|||
160733404|NCT02738879|580405677|FG000|Overall Study|Withdrawal by Subject|5|||
160733405|NCT02738879|580405678|FG001|Overall Study|Withdrawal by Subject|7|||
160733406|NCT01647516|580405683|FG000|Induction Period (IP)|Physician Decision|2|||
160733407|NCT01647516|580405684|FG001|Induction Period (IP)|Physician Decision|0|||
160733408|NCT01647516|580405685|FG002|Induction Period (IP)|Physician Decision|0|||
160733409|NCT01647516|580405686|FG003|Induction Period (IP)|Physician Decision|0|||
160733410|NCT01647516|580405687|FG004|Induction Period (IP)|Physician Decision|0|||
160733411|NCT01647516|580405688|FG005|Induction Period (IP)|Physician Decision|0|||
160733412|NCT01647516|580405683|FG000|Induction Period (IP)|Adverse Event|1|||
160733413|NCT01647516|580405684|FG001|Induction Period (IP)|Adverse Event|2|||
160733414|NCT01647516|580405685|FG002|Induction Period (IP)|Adverse Event|0|||
160733415|NCT01647516|580405686|FG003|Induction Period (IP)|Adverse Event|0|||
160733416|NCT01647516|580405687|FG004|Induction Period (IP)|Adverse Event|0|||
160733417|NCT01647516|580405688|FG005|Induction Period (IP)|Adverse Event|0|||
160733418|NCT01647516|580405683|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
160733419|NCT01647516|580405684|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
160733420|NCT01647516|580405685|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
160733421|NCT01647516|580405686|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
160733422|NCT01647516|580405687|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
160733423|NCT01647516|580405688|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
160733424|NCT01647516|580405683|FG000|Induction Period (IP)|Participant Choice|0|||
160733425|NCT01647516|580405684|FG001|Induction Period (IP)|Participant Choice|0|||
160733426|NCT01647516|580405685|FG002|Induction Period (IP)|Participant Choice|1|||
160733427|NCT01647516|580405686|FG003|Induction Period (IP)|Participant Choice|0|||
160733428|NCT01647516|580405687|FG004|Induction Period (IP)|Participant Choice|0|||
160733429|NCT01647516|580405688|FG005|Induction Period (IP)|Participant Choice|0|||
160733430|NCT01647516|580405683|FG000|Induction Period (IP)|Lack of Efficacy|1|||
160733431|NCT01647516|580405684|FG001|Induction Period (IP)|Lack of Efficacy|0|||
160733432|NCT01647516|580405685|FG002|Induction Period (IP)|Lack of Efficacy|0|||
160733433|NCT01647516|580405686|FG003|Induction Period (IP)|Lack of Efficacy|0|||
160733434|NCT01647516|580405687|FG004|Induction Period (IP)|Lack of Efficacy|0|||
160733435|NCT01647516|580405688|FG005|Induction Period (IP)|Lack of Efficacy|0|||
160733436|NCT01647516|580405683|FG000|Induction Period (IP)|No study drug received|1|||
160733437|NCT01647516|580405684|FG001|Induction Period (IP)|No study drug received|1|||
160733438|NCT01647516|580405685|FG002|Induction Period (IP)|No study drug received|0|||
160733439|NCT01647516|580405686|FG003|Induction Period (IP)|No study drug received|0|||
160733440|NCT01647516|580405687|FG004|Induction Period (IP)|No study drug received|0|||
160733441|NCT01647516|580405688|FG005|Induction Period (IP)|No study drug received|0|||
160733442|NCT01647516|580405683|FG000|Maintenance Period (MP)|Adverse Event|2|||
160733443|NCT01647516|580405684|FG001|Maintenance Period (MP)|Adverse Event|1|||
160733444|NCT01647516|580405685|FG002|Maintenance Period (MP)|Adverse Event|0|||
160733445|NCT01647516|580405686|FG003|Maintenance Period (MP)|Adverse Event|0|||
160733446|NCT01647516|580405687|FG004|Maintenance Period (MP)|Adverse Event|0|||
160733447|NCT01647516|580405688|FG005|Maintenance Period (MP)|Adverse Event|0|||
160733448|NCT01647516|580405683|FG000|Maintenance Period (MP)|Non-compliance|1|||
160733449|NCT01647516|580405684|FG001|Maintenance Period (MP)|Non-compliance|0|||
160733450|NCT01647516|580405685|FG002|Maintenance Period (MP)|Non-compliance|0|||
160733451|NCT01647516|580405686|FG003|Maintenance Period (MP)|Non-compliance|0|||
160733452|NCT01647516|580405687|FG004|Maintenance Period (MP)|Non-compliance|0|||
160733453|NCT01647516|580405688|FG005|Maintenance Period (MP)|Non-compliance|0|||
160733454|NCT01647516|580405683|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
160733455|NCT01647516|580405684|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
160733456|NCT01647516|580405685|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
160733457|NCT01647516|580405686|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
160733458|NCT01647516|580405687|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
160733459|NCT01647516|580405688|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
160733460|NCT01647516|580405683|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
160733461|NCT01647516|580405684|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
160733462|NCT01647516|580405685|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
160733463|NCT01647516|580405686|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
160733464|NCT01647516|580405687|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
160733465|NCT01647516|580405688|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
160733466|NCT01647516|580405683|FG000|Open-Label Period|Adverse Event|0|||
160733467|NCT01647516|580405684|FG001|Open-Label Period|Adverse Event|0|||
160733468|NCT01647516|580405685|FG002|Open-Label Period|Adverse Event|0|||
160733469|NCT01647516|580405686|FG003|Open-Label Period|Adverse Event|5|||
160733470|NCT01647516|580405687|FG004|Open-Label Period|Adverse Event|6|||
160733471|NCT01647516|580405688|FG005|Open-Label Period|Adverse Event|3|||
160733472|NCT01647516|580405683|FG000|Open-Label Period|Pregnancy|0|||
160733473|NCT01647516|580405684|FG001|Open-Label Period|Pregnancy|0|||
160733474|NCT01647516|580405685|FG002|Open-Label Period|Pregnancy|0|||
160733475|NCT01647516|580405686|FG003|Open-Label Period|Pregnancy|0|||
160733476|NCT01647516|580405687|FG004|Open-Label Period|Pregnancy|0|||
160733477|NCT01647516|580405688|FG005|Open-Label Period|Pregnancy|1|||
160733478|NCT01647516|580405683|FG000|Open-Label Period|Non-compliance|0|||
160733479|NCT01647516|580405684|FG001|Open-Label Period|Non-compliance|0|||
160733480|NCT01647516|580405685|FG002|Open-Label Period|Non-compliance|0|||
160733481|NCT01647516|580405686|FG003|Open-Label Period|Non-compliance|1|||
160733482|NCT01647516|580405687|FG004|Open-Label Period|Non-compliance|0|||
160733483|NCT01647516|580405688|FG005|Open-Label Period|Non-compliance|1|||
160733484|NCT01647516|580405683|FG000|Open-Label Period|Physician Decision|0|||
160733485|NCT01647516|580405684|FG001|Open-Label Period|Physician Decision|0|||
160733486|NCT01647516|580405685|FG002|Open-Label Period|Physician Decision|0|||
160733487|NCT01647516|580405686|FG003|Open-Label Period|Physician Decision|1|||
160733488|NCT01647516|580405687|FG004|Open-Label Period|Physician Decision|1|||
160733489|NCT01647516|580405688|FG005|Open-Label Period|Physician Decision|0|||
160733490|NCT01647516|580405683|FG000|Open-Label Period|Withdrawal by Subject|0|||
160733491|NCT01647516|580405684|FG001|Open-Label Period|Withdrawal by Subject|0|||
160733492|NCT01647516|580405685|FG002|Open-Label Period|Withdrawal by Subject|0|||
160733493|NCT01647516|580405686|FG003|Open-Label Period|Withdrawal by Subject|9|||
160733494|NCT01647516|580405687|FG004|Open-Label Period|Withdrawal by Subject|11|||
160733495|NCT01647516|580405688|FG005|Open-Label Period|Withdrawal by Subject|6|||
160733496|NCT01647516|580405683|FG000|Open-Label Period|Lost to Follow-up|0|||
160733497|NCT01647516|580405684|FG001|Open-Label Period|Lost to Follow-up|0|||
160733498|NCT01647516|580405685|FG002|Open-Label Period|Lost to Follow-up|0|||
160733499|NCT01647516|580405686|FG003|Open-Label Period|Lost to Follow-up|1|||
160733500|NCT01647516|580405687|FG004|Open-Label Period|Lost to Follow-up|0|||
160733501|NCT01647516|580405688|FG005|Open-Label Period|Lost to Follow-up|1|||
160733502|NCT01647516|580405683|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
160733503|NCT01647516|580405684|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
160733504|NCT01647516|580405685|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
160733505|NCT01647516|580405686|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
160733506|NCT01647516|580405687|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
160733507|NCT01647516|580405688|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
160733508|NCT01647516|580405683|FG000|Open-Label Period|Lack of Efficacy|0|||
160733509|NCT01647516|580405684|FG001|Open-Label Period|Lack of Efficacy|0|||
160733510|NCT01647516|580405685|FG002|Open-Label Period|Lack of Efficacy|0|||
160733511|NCT01647516|580405686|FG003|Open-Label Period|Lack of Efficacy|7|||
160733512|NCT01647516|580405687|FG004|Open-Label Period|Lack of Efficacy|9|||
160733513|NCT01647516|580405688|FG005|Open-Label Period|Lack of Efficacy|10|||
160733514|NCT01647516|580405683|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
160733515|NCT01647516|580405684|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
160733516|NCT01647516|580405685|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
160733517|NCT01647516|580405686|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
160733518|NCT01647516|580405687|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
160733519|NCT01647516|580405688|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
160733520|NCT01647516|580405683|FG000|Open-Label Period|No completion / discontinuation visit|0|||
160733521|NCT01647516|580405684|FG001|Open-Label Period|No completion / discontinuation visit|0|||
160733522|NCT01647516|580405685|FG002|Open-Label Period|No completion / discontinuation visit|0|||
160733523|NCT01647516|580405686|FG003|Open-Label Period|No completion / discontinuation visit|0|||
160733524|NCT01647516|580405687|FG004|Open-Label Period|No completion / discontinuation visit|2|||
160733525|NCT01647516|580405688|FG005|Open-Label Period|No completion / discontinuation visit|1|||
160733526|NCT02980341|580405689|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
160733527|NCT02980341|580405690|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
160733528|NCT02980341|580405691|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
160733529|NCT02980341|580405692|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
160733530|NCT02980341|580405693|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
160733531|NCT02980341|580405694|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
160733532|NCT02980341|580405695|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
160733533|NCT02980341|580405696|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
160733534|NCT02980341|580405697|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
160733535|NCT02980341|580405698|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
160733536|NCT02980341|580405699|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
160733537|NCT02980341|580405689|FG000|Dose Escalation|Clinical progression|0|||
160733538|NCT02980341|580405690|FG001|Dose Escalation|Clinical progression|0|||
160733539|NCT02980341|580405691|FG002|Dose Escalation|Clinical progression|2|||
160733540|NCT02980341|580405692|FG003|Dose Escalation|Clinical progression|1|||
160733541|NCT02980341|580405693|FG004|Dose Escalation|Clinical progression|0|||
160733542|NCT02980341|580405694|FG005|Dose Escalation|Clinical progression|0|||
160733543|NCT02980341|580405695|FG006|Dose Escalation|Clinical progression|0|||
160733544|NCT02980341|580405696|FG007|Dose Escalation|Clinical progression|0|||
160733545|NCT02980341|580405697|FG008|Dose Escalation|Clinical progression|0|||
160733546|NCT02980341|580405698|FG009|Dose Escalation|Clinical progression|0|||
160733547|NCT02980341|580405699|FG010|Dose Escalation|Clinical progression|0|||
160733548|NCT02980341|580405689|FG000|Dose Escalation|Adverse Event|0|||
160733549|NCT02980341|580405690|FG001|Dose Escalation|Adverse Event|0|||
160733550|NCT02980341|580405691|FG002|Dose Escalation|Adverse Event|1|||
160733551|NCT02980341|580405692|FG003|Dose Escalation|Adverse Event|2|||
160733552|NCT02980341|580405693|FG004|Dose Escalation|Adverse Event|2|||
160733553|NCT02980341|580405694|FG005|Dose Escalation|Adverse Event|0|||
160733554|NCT02980341|580405695|FG006|Dose Escalation|Adverse Event|0|||
160733555|NCT02980341|580405696|FG007|Dose Escalation|Adverse Event|0|||
160733556|NCT02980341|580405697|FG008|Dose Escalation|Adverse Event|0|||
160733557|NCT02980341|580405698|FG009|Dose Escalation|Adverse Event|0|||
160733558|NCT02980341|580405699|FG010|Dose Escalation|Adverse Event|0|||
160733559|NCT02980341|580405689|FG000|Dose Escalation|Withdrawal by Subject|0|||
160733560|NCT02980341|580405690|FG001|Dose Escalation|Withdrawal by Subject|0|||
160733561|NCT02980341|580405691|FG002|Dose Escalation|Withdrawal by Subject|1|||
160733562|NCT02980341|580405692|FG003|Dose Escalation|Withdrawal by Subject|0|||
160733563|NCT02980341|580405693|FG004|Dose Escalation|Withdrawal by Subject|0|||
160733564|NCT02980341|580405694|FG005|Dose Escalation|Withdrawal by Subject|0|||
160733565|NCT02980341|580405695|FG006|Dose Escalation|Withdrawal by Subject|0|||
160733566|NCT02980341|580405696|FG007|Dose Escalation|Withdrawal by Subject|0|||
160733567|NCT02980341|580405697|FG008|Dose Escalation|Withdrawal by Subject|0|||
160733568|NCT02980341|580405698|FG009|Dose Escalation|Withdrawal by Subject|0|||
160733569|NCT02980341|580405699|FG010|Dose Escalation|Withdrawal by Subject|0|||
160733570|NCT02980341|580405689|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
160733571|NCT02980341|580405690|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
160733572|NCT02980341|580405691|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
160733573|NCT02980341|580405692|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
160733574|NCT02980341|580405693|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
160733575|NCT02980341|580405694|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
160733576|NCT02980341|580405695|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
160733577|NCT02980341|580405696|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
160733578|NCT02980341|580405697|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
160733579|NCT02980341|580405698|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
160733580|NCT02980341|580405699|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
160733581|NCT02980341|580405689|FG000|Dose Escalation|Due to investigator's decision|0|||
160733582|NCT02980341|580405690|FG001|Dose Escalation|Due to investigator's decision|0|||
160733583|NCT02980341|580405691|FG002|Dose Escalation|Due to investigator's decision|0|||
160733584|NCT02980341|580405692|FG003|Dose Escalation|Due to investigator's decision|0|||
160733585|NCT02980341|580405693|FG004|Dose Escalation|Due to investigator's decision|1|||
160733586|NCT02980341|580405694|FG005|Dose Escalation|Due to investigator's decision|0|||
160733587|NCT02980341|580405695|FG006|Dose Escalation|Due to investigator's decision|0|||
160733588|NCT02980341|580405696|FG007|Dose Escalation|Due to investigator's decision|0|||
160733589|NCT02980341|580405697|FG008|Dose Escalation|Due to investigator's decision|0|||
160733590|NCT02980341|580405698|FG009|Dose Escalation|Due to investigator's decision|0|||
160733591|NCT02980341|580405699|FG010|Dose Escalation|Due to investigator's decision|0|||
160733592|NCT02980341|580405689|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
160733593|NCT02980341|580405690|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
160733594|NCT02980341|580405691|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
160733595|NCT02980341|580405692|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
160733596|NCT02980341|580405693|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
160733597|NCT02980341|580405694|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
160733598|NCT02980341|580405695|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
160733599|NCT02980341|580405696|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
160733600|NCT02980341|580405697|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
160733601|NCT02980341|580405698|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
160733602|NCT02980341|580405699|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
160733603|NCT02980341|580405689|FG000|Dose Finding|Adverse Event|0|||
160733604|NCT02980341|580405690|FG001|Dose Finding|Adverse Event|0|||
160733605|NCT02980341|580405691|FG002|Dose Finding|Adverse Event|0|||
160733606|NCT02980341|580405692|FG003|Dose Finding|Adverse Event|0|||
160733607|NCT02980341|580405693|FG004|Dose Finding|Adverse Event|0|||
160733608|NCT02980341|580405694|FG005|Dose Finding|Adverse Event|3|||
160733609|NCT02980341|580405695|FG006|Dose Finding|Adverse Event|0|||
160733610|NCT02980341|580405696|FG007|Dose Finding|Adverse Event|0|||
160733611|NCT02980341|580405697|FG008|Dose Finding|Adverse Event|0|||
160733612|NCT02980341|580405698|FG009|Dose Finding|Adverse Event|0|||
160733613|NCT02980341|580405699|FG010|Dose Finding|Adverse Event|0|||
160733614|NCT02980341|580405689|FG000|Dose Finding|Withdrawal by Subject|0|||
160733615|NCT02980341|580405690|FG001|Dose Finding|Withdrawal by Subject|0|||
160733616|NCT02980341|580405691|FG002|Dose Finding|Withdrawal by Subject|0|||
160733617|NCT02980341|580405692|FG003|Dose Finding|Withdrawal by Subject|0|||
160733618|NCT02980341|580405693|FG004|Dose Finding|Withdrawal by Subject|0|||
160733619|NCT02980341|580405694|FG005|Dose Finding|Withdrawal by Subject|1|||
160733620|NCT02980341|580405695|FG006|Dose Finding|Withdrawal by Subject|1|||
160733621|NCT02980341|580405696|FG007|Dose Finding|Withdrawal by Subject|0|||
160733622|NCT02980341|580405697|FG008|Dose Finding|Withdrawal by Subject|0|||
160733623|NCT02980341|580405698|FG009|Dose Finding|Withdrawal by Subject|0|||
160733624|NCT02980341|580405699|FG010|Dose Finding|Withdrawal by Subject|0|||
160733625|NCT02980341|580405689|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
160733626|NCT02980341|580405690|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
160733627|NCT02980341|580405691|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
160733628|NCT02980341|580405692|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
160733629|NCT02980341|580405693|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
160733630|NCT02980341|580405694|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
160733631|NCT02980341|580405695|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
160733632|NCT02980341|580405696|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
160733633|NCT02980341|580405697|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
160733634|NCT02980341|580405698|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
160733635|NCT02980341|580405699|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
160733636|NCT02980341|580405689|FG000|Dose Expansion|Clinical progression|0|||
160733637|NCT02980341|580405690|FG001|Dose Expansion|Clinical progression|0|||
160733638|NCT02980341|580405691|FG002|Dose Expansion|Clinical progression|0|||
160733639|NCT02980341|580405692|FG003|Dose Expansion|Clinical progression|0|||
160733640|NCT02980341|580405693|FG004|Dose Expansion|Clinical progression|0|||
160733641|NCT02980341|580405694|FG005|Dose Expansion|Clinical progression|0|||
160733642|NCT02980341|580405695|FG006|Dose Expansion|Clinical progression|0|||
160733643|NCT02980341|580405696|FG007|Dose Expansion|Clinical progression|4|||
160733644|NCT02980341|580405697|FG008|Dose Expansion|Clinical progression|3|||
160733645|NCT02980341|580405698|FG009|Dose Expansion|Clinical progression|1|||
160733646|NCT02980341|580405699|FG010|Dose Expansion|Clinical progression|4|||
160733647|NCT02980341|580405689|FG000|Dose Expansion|Adverse Event|0|||
160733648|NCT02980341|580405690|FG001|Dose Expansion|Adverse Event|0|||
160733649|NCT02980341|580405691|FG002|Dose Expansion|Adverse Event|0|||
160733650|NCT02980341|580405692|FG003|Dose Expansion|Adverse Event|0|||
160733651|NCT02980341|580405693|FG004|Dose Expansion|Adverse Event|0|||
160733652|NCT02980341|580405694|FG005|Dose Expansion|Adverse Event|0|||
160733653|NCT02980341|580405695|FG006|Dose Expansion|Adverse Event|0|||
160733654|NCT02980341|580405696|FG007|Dose Expansion|Adverse Event|3|||
160733655|NCT02980341|580405697|FG008|Dose Expansion|Adverse Event|0|||
160733656|NCT02980341|580405698|FG009|Dose Expansion|Adverse Event|1|||
160733657|NCT02980341|580405699|FG010|Dose Expansion|Adverse Event|3|||
160733658|NCT02980341|580405689|FG000|Dose Expansion|Death|0|||
160733659|NCT02980341|580405690|FG001|Dose Expansion|Death|0|||
160733660|NCT02980341|580405691|FG002|Dose Expansion|Death|0|||
160733661|NCT02980341|580405692|FG003|Dose Expansion|Death|0|||
160733662|NCT02980341|580405693|FG004|Dose Expansion|Death|0|||
160733663|NCT02980341|580405694|FG005|Dose Expansion|Death|0|||
160733664|NCT02980341|580405695|FG006|Dose Expansion|Death|0|||
160733665|NCT02980341|580405696|FG007|Dose Expansion|Death|0|||
160733666|NCT02980341|580405697|FG008|Dose Expansion|Death|2|||
160733667|NCT02980341|580405698|FG009|Dose Expansion|Death|1|||
160733668|NCT02980341|580405699|FG010|Dose Expansion|Death|0|||
160733669|NCT02980341|580405689|FG000|Dose Expansion|Withdrawal by Subject|0|||
160733670|NCT02980341|580405690|FG001|Dose Expansion|Withdrawal by Subject|0|||
160733671|NCT02980341|580405691|FG002|Dose Expansion|Withdrawal by Subject|0|||
160733672|NCT02980341|580405692|FG003|Dose Expansion|Withdrawal by Subject|0|||
160733673|NCT02980341|580405693|FG004|Dose Expansion|Withdrawal by Subject|0|||
160733674|NCT02980341|580405694|FG005|Dose Expansion|Withdrawal by Subject|0|||
160733675|NCT02980341|580405695|FG006|Dose Expansion|Withdrawal by Subject|0|||
160733676|NCT02980341|580405696|FG007|Dose Expansion|Withdrawal by Subject|2|||
160733677|NCT02980341|580405697|FG008|Dose Expansion|Withdrawal by Subject|0|||
160733678|NCT02980341|580405698|FG009|Dose Expansion|Withdrawal by Subject|1|||
160733679|NCT02980341|580405699|FG010|Dose Expansion|Withdrawal by Subject|0|||
160733680|NCT02980341|580405689|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
160733681|NCT02980341|580405690|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
160733682|NCT02980341|580405691|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
160733683|NCT02980341|580405692|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
160733684|NCT02980341|580405693|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
160733685|NCT02980341|580405694|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
160733686|NCT02980341|580405695|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
160733687|NCT02980341|580405696|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
160733688|NCT02980341|580405697|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
160733689|NCT02980341|580405698|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
160733690|NCT02980341|580405699|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
160733691|NCT02980341|580405689|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
160733692|NCT02980341|580405690|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
160733693|NCT02980341|580405691|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
160733694|NCT02980341|580405692|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
160733695|NCT02980341|580405693|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
160733696|NCT02980341|580405694|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
160733697|NCT02980341|580405695|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
160733698|NCT02980341|580405696|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
160733699|NCT02980341|580405697|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
160733700|NCT02980341|580405698|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
160733701|NCT02980341|580405699|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
160733702|NCT02980341|580405689|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
160733703|NCT02980341|580405690|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
160733704|NCT02980341|580405691|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
160733705|NCT02980341|580405692|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
160733706|NCT02980341|580405693|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
160733707|NCT02980341|580405694|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
160733708|NCT02980341|580405695|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
160733709|NCT02980341|580405696|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
160733710|NCT02980341|580405697|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
160733711|NCT02980341|580405698|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
160733712|NCT02980341|580405699|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
160733713|NCT02980341|580405689|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
160733714|NCT02980341|580405690|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
160733715|NCT02980341|580405691|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
160733716|NCT02980341|580405692|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
160733717|NCT02980341|580405693|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
160733718|NCT02980341|580405694|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
160733719|NCT02980341|580405695|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
160733720|NCT02980341|580405696|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
160733721|NCT02980341|580405697|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
160733722|NCT02980341|580405698|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
160733723|NCT02980341|580405699|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
160733724|NCT04964544|580405704|FG000|Overall Study|Screen failure or other uncategorised|10|||
160733725|NCT04964544|580405704|FG000|Overall Study|Physician Decision|4|||
160733726|NCT04964544|580405704|FG000|Overall Study|Lost to Follow-up|9|||
160733727|NCT04964544|580405704|FG000|Overall Study|Withdrawal by Subject|18|||
160733728|NCT04964544|580405704|FG000|Overall Study|Death|1|||
160733729|NCT01895608|580405708|FG000|Overall Study|change in health status|0|||
160733730|NCT01895608|580405709|FG001|Overall Study|change in health status|1|||
160733731|NCT01895608|580405710|FG002|Overall Study|change in health status|1|||
160733732|NCT01895608|580405711|FG003|Overall Study|change in health status|0|||
160733733|NCT01895608|580405708|FG000|Overall Study|Withdrawal by Subject|0|||
160733734|NCT01895608|580405709|FG001|Overall Study|Withdrawal by Subject|0|||
160733735|NCT01895608|580405710|FG002|Overall Study|Withdrawal by Subject|2|||
160733736|NCT01895608|580405711|FG003|Overall Study|Withdrawal by Subject|0|||
160733737|NCT02691936|580405717|FG000|Overall Study|Withdrawal by Subject|2|||
160733738|NCT02691936|580405718|FG001|Overall Study|Withdrawal by Subject|5|||
160733739|NCT00749684|580405719|FG000|Overall Study|Death|1|||
160733740|NCT00749684|580405719|FG000|Overall Study|Adverse Event|27|||
160733741|NCT00749684|580405719|FG000|Overall Study|Participant's Wish|10|||
160733742|NCT00749684|580405719|FG000|Overall Study|Not Documented|1|||
160733743|NCT00749684|580405719|FG000|Overall Study|Progressive Desease|31|||
160733744|NCT00749684|580405719|FG000|Overall Study|Therapy according to protocol + AE|2|||
160733745|NCT00749684|580405719|FG000|Overall Study|AE+discontinuation on participants wish|1|||
160733746|NCT00749684|580405719|FG000|Overall Study|Missing|9|||
160733747|NCT03696108|580405720|FG000|Overall Study|Physician Decision|1|||
160733748|NCT03696108|580405721|FG001|Overall Study|Physician Decision|0|||
160733749|NCT03696108|580405720|FG000|Overall Study|Withdrawal by Subject|3|||
160733750|NCT03696108|580405721|FG001|Overall Study|Withdrawal by Subject|6|||
160733751|NCT03891862|580405723|FG000|Open-label Period|Adverse Event|2|||
160733752|NCT03891862|580405724|FG001|Open-label Period|Adverse Event|0|||
160733753|NCT03891862|580405725|FG002|Open-label Period|Adverse Event|0|||
160733754|NCT03891862|580405723|FG000|Open-label Period|Protocol Violation|5|||
160733755|NCT03891862|580405724|FG001|Open-label Period|Protocol Violation|0|||
160733756|NCT03891862|580405725|FG002|Open-label Period|Protocol Violation|0|||
160733757|NCT03891862|580405723|FG000|Open-label Period|Withdrawal by Subject|6|||
160733758|NCT03891862|580405724|FG001|Open-label Period|Withdrawal by Subject|0|||
160733759|NCT03891862|580405725|FG002|Open-label Period|Withdrawal by Subject|0|||
160733760|NCT03891862|580405723|FG000|Open-label Period|Death|1|||
160733761|NCT03891862|580405724|FG001|Open-label Period|Death|0|||
160733762|NCT03891862|580405725|FG002|Open-label Period|Death|0|||
160733763|NCT03891862|580405723|FG000|Open-label Period|Lost to Follow-up|2|||
160733764|NCT03891862|580405724|FG001|Open-label Period|Lost to Follow-up|0|||
160733765|NCT03891862|580405725|FG002|Open-label Period|Lost to Follow-up|0|||
160733766|NCT03891862|580405723|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
160733767|NCT03891862|580405724|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
160733768|NCT03891862|580405725|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
160733769|NCT03891862|580405723|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
160733770|NCT03891862|580405724|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
160733771|NCT03891862|580405725|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
160733772|NCT03891862|580405723|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
160733773|NCT03891862|580405724|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
160733774|NCT03891862|580405725|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
160733775|NCT03891862|580405723|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
160733776|NCT03891862|580405724|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
160733777|NCT03891862|580405725|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
160733778|NCT01194531|580405726|FG000|Overall Study|Withdrawal by Subject|1|||
160733779|NCT01194531|580405727|FG001|Overall Study|Withdrawal by Subject|0|||
160733780|NCT01194531|580405726|FG000|Overall Study|Protocol Violation|4|||
160733781|NCT01194531|580405727|FG001|Overall Study|Protocol Violation|1|||
160733782|NCT01194531|580405726|FG000|Overall Study|Physician Decision|0|||
160733783|NCT01194531|580405727|FG001|Overall Study|Physician Decision|2|||
160733784|NCT01053962|580405728|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
160733785|NCT01053962|580405729|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
160733786|NCT01053962|580405730|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
160733787|NCT01053962|580405731|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
160733788|NCT01053962|580405732|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
160733789|NCT01053962|580405728|FG000|Pretreatment Period|Venipuncture Failure|0|||
160733790|NCT01053962|580405729|FG001|Pretreatment Period|Venipuncture Failure|0|||
160733791|NCT01053962|580405730|FG002|Pretreatment Period|Venipuncture Failure|1|||
160733792|NCT01053962|580405731|FG003|Pretreatment Period|Venipuncture Failure|0|||
160733793|NCT01053962|580405732|FG004|Pretreatment Period|Venipuncture Failure|0|||
160733794|NCT01053962|580405728|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
160733795|NCT01053962|580405729|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
160733796|NCT01053962|580405730|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
160733797|NCT01053962|580405731|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
160733798|NCT01053962|580405732|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
160733799|NCT01053962|580405728|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
160733800|NCT01053962|580405729|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
160733801|NCT01053962|580405730|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
160733802|NCT01053962|580405731|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
160733803|NCT01053962|580405732|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
160733804|NCT01053962|580405728|FG000|Treatment Period|Lack of Efficacy|0|||
160733805|NCT01053962|580405729|FG001|Treatment Period|Lack of Efficacy|0|||
160733806|NCT01053962|580405730|FG002|Treatment Period|Lack of Efficacy|0|||
160733807|NCT01053962|580405731|FG003|Treatment Period|Lack of Efficacy|0|||
160733808|NCT01053962|580405732|FG004|Treatment Period|Lack of Efficacy|1|||
160733809|NCT01053962|580405728|FG000|Treatment Period|Adverse Event|0|||
160733810|NCT01053962|580405729|FG001|Treatment Period|Adverse Event|0|||
160733811|NCT01053962|580405730|FG002|Treatment Period|Adverse Event|0|||
160733812|NCT01053962|580405731|FG003|Treatment Period|Adverse Event|0|||
160733813|NCT01053962|580405732|FG004|Treatment Period|Adverse Event|1|||
160733814|NCT01053962|580405728|FG000|Treatment Period|Withdrawal by Subject|0|||
160733815|NCT01053962|580405729|FG001|Treatment Period|Withdrawal by Subject|0|||
160733816|NCT01053962|580405730|FG002|Treatment Period|Withdrawal by Subject|0|||
160733817|NCT01053962|580405731|FG003|Treatment Period|Withdrawal by Subject|0|||
160733818|NCT01053962|580405732|FG004|Treatment Period|Withdrawal by Subject|1|||
160733819|NCT01053962|580405728|FG000|Treatment Period|Noncompliance with protocol|1|||
160733820|NCT01053962|580405729|FG001|Treatment Period|Noncompliance with protocol|0|||
160733821|NCT01053962|580405730|FG002|Treatment Period|Noncompliance with protocol|0|||
160733822|NCT01053962|580405731|FG003|Treatment Period|Noncompliance with protocol|0|||
160733823|NCT01053962|580405732|FG004|Treatment Period|Noncompliance with protocol|0|||
160733824|NCT04143594|580405733|FG000|Overall Study|Withdrew consent|3|||
160733825|NCT04143594|580405734|FG001|Overall Study|Withdrew consent|10|||
160733826|NCT04143594|580405735|FG002|Overall Study|Withdrew consent|3|||
160733827|NCT04143594|580405736|FG003|Overall Study|Withdrew consent|1|||
160733828|NCT04143594|580405733|FG000|Overall Study|Lost to Follow-up|3|||
160733829|NCT04143594|580405734|FG001|Overall Study|Lost to Follow-up|5|||
160733830|NCT04143594|580405735|FG002|Overall Study|Lost to Follow-up|11|||
160733831|NCT04143594|580405736|FG003|Overall Study|Lost to Follow-up|0|||
160733832|NCT04143594|580405733|FG000|Overall Study|Investigator's discretion|2|||
160733833|NCT04143594|580405734|FG001|Overall Study|Investigator's discretion|2|||
160733834|NCT04143594|580405735|FG002|Overall Study|Investigator's discretion|0|||
160733835|NCT04143594|580405736|FG003|Overall Study|Investigator's discretion|0|||
160733836|NCT04143594|580405733|FG000|Overall Study|Randomized but never treated|0|||
160733837|NCT04143594|580405734|FG001|Overall Study|Randomized but never treated|0|||
160733838|NCT04143594|580405735|FG002|Overall Study|Randomized but never treated|0|||
160733839|NCT04143594|580405736|FG003|Overall Study|Randomized but never treated|1|||
160733840|NCT04143594|580405733|FG000|Overall Study|Death|1|||
160733841|NCT04143594|580405734|FG001|Overall Study|Death|0|||
160733842|NCT04143594|580405735|FG002|Overall Study|Death|1|||
160733843|NCT04143594|580405736|FG003|Overall Study|Death|0|||
160733844|NCT04143594|580405733|FG000|Overall Study|Adverse Event|1|||
160733845|NCT04143594|580405734|FG001|Overall Study|Adverse Event|0|||
160733846|NCT04143594|580405735|FG002|Overall Study|Adverse Event|0|||
160733847|NCT04143594|580405736|FG003|Overall Study|Adverse Event|0|||
160733848|NCT04143594|580405733|FG000|Overall Study|Pregnancy|0|||
160733849|NCT04143594|580405734|FG001|Overall Study|Pregnancy|0|||
160733850|NCT04143594|580405735|FG002|Overall Study|Pregnancy|1|||
160733851|NCT04143594|580405736|FG003|Overall Study|Pregnancy|0|||
160733852|NCT04143594|580405733|FG000|Overall Study|Lack of Efficacy|1|||
160733853|NCT04143594|580405734|FG001|Overall Study|Lack of Efficacy|1|||
160733854|NCT04143594|580405735|FG002|Overall Study|Lack of Efficacy|0|||
160733855|NCT04143594|580405736|FG003|Overall Study|Lack of Efficacy|0|||
160733856|NCT03089697|580405737|FG000|Overall Study|Adverse Event|1|||
160733857|NCT03089697|580405738|FG001|Overall Study|Adverse Event|2|||
160733858|NCT03089697|580405737|FG000|Overall Study|Withdrawal by Subject|1|||
160733859|NCT03089697|580405738|FG001|Overall Study|Withdrawal by Subject|0|||
160733860|NCT01154088|580405739|FG000|Overall Study|Lost to Follow-up|4|||
160733861|NCT01154088|580405740|FG001|Overall Study|Lost to Follow-up|6|||
160733862|NCT01154088|580405741|FG002|Overall Study|Lost to Follow-up|7|||
160733863|NCT05129137|580405743|FG000|Second Period|Adverse Event|1|||
160733864|NCT05129137|580405744|FG001|Second Period|Adverse Event|0|||
160733865|NCT05129137|580405745|FG002|Second Period|Adverse Event|0|||
160733866|NCT05129137|580405746|FG003|Second Period|Adverse Event|0|||
160733867|NCT05129137|580405743|FG000|Second Period|Protocol Violation|0|||
160733868|NCT05129137|580405744|FG001|Second Period|Protocol Violation|0|||
160733869|NCT05129137|580405745|FG002|Second Period|Protocol Violation|0|||
160733870|NCT05129137|580405746|FG003|Second Period|Protocol Violation|1|||
160733871|NCT05129137|580405743|FG000|Third Period|Protocol Violation|0|||
160733872|NCT05129137|580405744|FG001|Third Period|Protocol Violation|0|||
160733873|NCT05129137|580405745|FG002|Third Period|Protocol Violation|0|||
160733874|NCT05129137|580405746|FG003|Third Period|Protocol Violation|1|||
160733875|NCT05129137|580405743|FG000|Forth Period|Protocol Violation|0|||
160733876|NCT05129137|580405744|FG001|Forth Period|Protocol Violation|1|||
160733877|NCT05129137|580405745|FG002|Forth Period|Protocol Violation|0|||
160733878|NCT05129137|580405746|FG003|Forth Period|Protocol Violation|0|||
160733879|NCT05129137|580405743|FG000|Forth Period|Withdrawal by Subject|0|||
160733880|NCT05129137|580405744|FG001|Forth Period|Withdrawal by Subject|0|||
160733881|NCT05129137|580405745|FG002|Forth Period|Withdrawal by Subject|1|||
160733882|NCT05129137|580405746|FG003|Forth Period|Withdrawal by Subject|0|||
160733883|NCT00750139|580405750|FG000|Overall Study|Adverse Event|1|||
160733884|NCT00750139|580405751|FG001|Overall Study|Adverse Event|2|||
160733885|NCT00750139|580405752|FG002|Overall Study|Adverse Event|0|||
160733886|NCT00750139|580405753|FG003|Overall Study|Adverse Event|1|||
160733887|NCT00750139|580405750|FG000|Overall Study|Lost to Follow-up|17|||
160733888|NCT00750139|580405751|FG001|Overall Study|Lost to Follow-up|12|||
160733889|NCT00750139|580405752|FG002|Overall Study|Lost to Follow-up|15|||
160733890|NCT00750139|580405753|FG003|Overall Study|Lost to Follow-up|6|||
160733891|NCT00750139|580405750|FG000|Overall Study|Withdrawal by Subject|3|||
160733892|NCT00750139|580405751|FG001|Overall Study|Withdrawal by Subject|2|||
160733893|NCT00750139|580405752|FG002|Overall Study|Withdrawal by Subject|6|||
160733894|NCT00750139|580405753|FG003|Overall Study|Withdrawal by Subject|2|||
160733895|NCT00750139|580405750|FG000|Overall Study|Physician Decision|1|||
160733896|NCT00750139|580405751|FG001|Overall Study|Physician Decision|1|||
160733897|NCT00750139|580405752|FG002|Overall Study|Physician Decision|0|||
160733898|NCT00750139|580405753|FG003|Overall Study|Physician Decision|0|||
160733899|NCT00750139|580405750|FG000|Overall Study|Non-compliance|1|||
160733900|NCT00750139|580405751|FG001|Overall Study|Non-compliance|0|||
160733901|NCT00750139|580405752|FG002|Overall Study|Non-compliance|1|||
160733902|NCT00750139|580405753|FG003|Overall Study|Non-compliance|3|||
160733903|NCT00750139|580405750|FG000|Overall Study|Termination by sponsor|4|||
160733904|NCT00750139|580405751|FG001|Overall Study|Termination by sponsor|0|||
160733905|NCT00750139|580405752|FG002|Overall Study|Termination by sponsor|0|||
160733906|NCT00750139|580405753|FG003|Overall Study|Termination by sponsor|1|||
160733907|NCT00750139|580405750|FG000|Overall Study|Non-specific|62|||
160733908|NCT00750139|580405751|FG001|Overall Study|Non-specific|42|||
160733909|NCT00750139|580405752|FG002|Overall Study|Non-specific|79|||
160733910|NCT00750139|580405753|FG003|Overall Study|Non-specific|33|||
160733911|NCT01992653|580405754|FG000|Overall Study|Death|0|||
160733912|NCT01992653|580405755|FG001|Overall Study|Death|0|||
160733913|NCT01992653|580405756|FG002|Overall Study|Death|1|||
160733914|NCT01992653|580405757|FG003|Overall Study|Death|0|||
160733915|NCT01992653|580405758|FG004|Overall Study|Death|1|||
160733916|NCT01992653|580405759|FG005|Overall Study|Death|0|||
160733917|NCT01992653|580405760|FG006|Overall Study|Death|4|||
160733918|NCT01992653|580405761|FG007|Overall Study|Death|2|||
160733919|NCT01992653|580405754|FG000|Overall Study|Lost to Follow-up|0|||
160733920|NCT01992653|580405755|FG001|Overall Study|Lost to Follow-up|0|||
160733921|NCT01992653|580405756|FG002|Overall Study|Lost to Follow-up|0|||
160733922|NCT01992653|580405757|FG003|Overall Study|Lost to Follow-up|0|||
160733923|NCT01992653|580405758|FG004|Overall Study|Lost to Follow-up|0|||
160733924|NCT01992653|580405759|FG005|Overall Study|Lost to Follow-up|0|||
160733925|NCT01992653|580405760|FG006|Overall Study|Lost to Follow-up|0|||
160733926|NCT01992653|580405761|FG007|Overall Study|Lost to Follow-up|1|||
160733927|NCT01992653|580405754|FG000|Overall Study|Study Completed|0|||
160733928|NCT01992653|580405755|FG001|Overall Study|Study Completed|0|||
160733929|NCT01992653|580405756|FG002|Overall Study|Study Completed|0|||
160733930|NCT01992653|580405757|FG003|Overall Study|Study Completed|0|||
160733931|NCT01992653|580405758|FG004|Overall Study|Study Completed|0|||
160733932|NCT01992653|580405759|FG005|Overall Study|Study Completed|0|||
160733933|NCT01992653|580405760|FG006|Overall Study|Study Completed|0|||
160733934|NCT01992653|580405761|FG007|Overall Study|Study Completed|1|||
160733935|NCT01992653|580405754|FG000|Overall Study|Disease Progression|0|||
160733936|NCT01992653|580405755|FG001|Overall Study|Disease Progression|0|||
160733937|NCT01992653|580405756|FG002|Overall Study|Disease Progression|0|||
160733938|NCT01992653|580405757|FG003|Overall Study|Disease Progression|0|||
160733939|NCT01992653|580405758|FG004|Overall Study|Disease Progression|0|||
160733940|NCT01992653|580405759|FG005|Overall Study|Disease Progression|0|||
160733941|NCT01992653|580405760|FG006|Overall Study|Disease Progression|4|||
160733942|NCT01992653|580405761|FG007|Overall Study|Disease Progression|0|||
160733943|NCT01435460|580405762|FG000|Overall Study|Adverse Event|2|||
160733944|NCT01435460|580405763|FG001|Overall Study|Adverse Event|1|||
160733945|NCT01435460|580405762|FG000|Overall Study|Lost to Follow-up|6|||
160733946|NCT01435460|580405763|FG001|Overall Study|Lost to Follow-up|1|||
160733947|NCT01435460|580405762|FG000|Overall Study|Withdrawal by Subject|1|||
160733948|NCT01435460|580405763|FG001|Overall Study|Withdrawal by Subject|3|||
160733949|NCT01435460|580405762|FG000|Overall Study|Protocol Violation|0|||
160733950|NCT01435460|580405763|FG001|Overall Study|Protocol Violation|1|||
160733951|NCT01435460|580405762|FG000|Overall Study|Did not meet eligibility criteria|2|||
160733952|NCT01435460|580405763|FG001|Overall Study|Did not meet eligibility criteria|0|||
160733953|NCT01706939|580405764|FG000|Pre Randomization|Screen Failure|1|||
160733954|NCT01706939|580405765|FG001|Pre Randomization|Screen Failure|0|||
160733955|NCT01706939|580405766|FG002|Pre Randomization|Screen Failure|0|||
160733956|NCT01706939|580405764|FG000|Pre Randomization|Ineligible for Randomization|1|||
160733957|NCT01706939|580405765|FG001|Pre Randomization|Ineligible for Randomization|0|||
160733958|NCT01706939|580405766|FG002|Pre Randomization|Ineligible for Randomization|0|||
160733959|NCT01706939|580405764|FG000|Pre Randomization|Withdrawal by Subject|1|||
160733960|NCT01706939|580405765|FG001|Pre Randomization|Withdrawal by Subject|0|||
160733961|NCT01706939|580405766|FG002|Pre Randomization|Withdrawal by Subject|0|||
160733962|NCT01706939|580405764|FG000|Randomization|Insufficient QoL survey compliance|0|||
160733963|NCT01706939|580405765|FG001|Randomization|Insufficient QoL survey compliance|1|||
160733964|NCT01706939|580405766|FG002|Randomization|Insufficient QoL survey compliance|1|||
160733965|NCT01706939|580405764|FG000|Randomization|Progression of disease|0|||
160733966|NCT01706939|580405765|FG001|Randomization|Progression of disease|2|||
160733967|NCT01706939|580405766|FG002|Randomization|Progression of disease|1|||
160733968|NCT01046903|580405767|FG000|Overall Study|Lost to Follow-up|16|||
160733969|NCT01046903|580405767|FG000|Overall Study|Adverse Event|4|||
160733970|NCT01046903|580405767|FG000|Overall Study|Withdrawal by Subject|3|||
160733971|NCT01046903|580405767|FG000|Overall Study|Other|5|||
160733972|NCT00977314|580405768|FG000|Overall Study|Withdrawal by Subject|1|||
160733973|NCT00977314|580405769|FG001|Overall Study|Withdrawal by Subject|0|||
160733974|NCT00977314|580405768|FG000|Overall Study|Physician Decision|1|||
160733975|NCT00977314|580405769|FG001|Overall Study|Physician Decision|0|||
160733976|NCT01343277|580405770|FG000|Overall Study|Other|3|||
160733977|NCT01343277|580405771|FG001|Overall Study|Other|3|||
160733978|NCT01343277|580405770|FG000|Overall Study|Withdrawal by Subject|18|||
160733979|NCT01343277|580405771|FG001|Overall Study|Withdrawal by Subject|13|||
160733980|NCT01343277|580405770|FG000|Overall Study|Physician Decision|1|||
160733981|NCT01343277|580405771|FG001|Overall Study|Physician Decision|2|||
160733982|NCT01343277|580405770|FG000|Overall Study|Death|10|||
160733983|NCT01343277|580405771|FG001|Overall Study|Death|1|||
160733984|NCT01343277|580405770|FG000|Overall Study|Adverse Event|67|||
160733985|NCT01343277|580405771|FG001|Overall Study|Adverse Event|13|||
160733986|NCT01343277|580405770|FG000|Overall Study|Disease progression|270|||
160733987|NCT01343277|580405771|FG001|Overall Study|Disease progression|138|||
160733988|NCT01343277|580405770|FG000|Overall Study|Randomized not treated|6|||
160733989|NCT01343277|580405771|FG001|Overall Study|Randomized not treated|21|||
160733990|NCT01343277|580405770|FG000|Overall Study|Treatment ongoing|8|||
160733991|NCT01343277|580405771|FG001|Overall Study|Treatment ongoing|2|||
160733992|NCT01343277|580405770|FG000|Overall Study|Subsequent anticancer therapy|1|||
160733993|NCT01343277|580405771|FG001|Overall Study|Subsequent anticancer therapy|0|||
160733994|NCT00135512|580405774|FG000|Overall Study|Adverse Event|56|||
160733995|NCT00135512|580405774|FG000|Overall Study|Lack of Efficacy|25|||
160733996|NCT00135512|580405774|FG000|Overall Study|Other|42|||
160733997|NCT02964208|580405775|FG000|Overall Study|Death|103|||
160733998|NCT02964208|580405775|FG000|Overall Study|Withdrawal by Subject|6|||
160733999|NCT02964208|580405775|FG000|Overall Study|Lost to Follow-up|6|||
160734000|NCT02964208|580405775|FG000|Overall Study|Unsuccessful Procedure|5|||
160734001|NCT02964208|580405775|FG000|Overall Study|Device Explant|1|||
160734002|NCT02964208|580405775|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
160734003|NCT00556933|580405776|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
160734004|NCT00556933|580405777|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
160734005|NCT00556933|580405778|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
160734006|NCT00556933|580405779|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
160734007|NCT00556933|580405776|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
160734008|NCT00556933|580405777|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
160734009|NCT00556933|580405778|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
160734010|NCT00556933|580405779|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
160734011|NCT00556933|580405776|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
160734012|NCT00556933|580405777|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
160734013|NCT00556933|580405778|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
160734014|NCT00556933|580405779|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
160734015|NCT00556933|580405776|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
160734016|NCT00556933|580405777|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
160734017|NCT00556933|580405778|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
160734018|NCT00556933|580405779|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
160734019|NCT00556933|580405776|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
160734020|NCT00556933|580405777|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
160734021|NCT00556933|580405778|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
160734022|NCT00556933|580405779|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
160734023|NCT00556933|580405776|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
160734024|NCT00556933|580405777|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
160734025|NCT00556933|580405778|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
160734026|NCT00556933|580405779|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
160734027|NCT00556933|580405776|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
160734028|NCT00556933|580405777|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
160734029|NCT00556933|580405778|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
160734030|NCT00556933|580405779|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
160734031|NCT00556933|580405776|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
160734032|NCT00556933|580405777|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
160734033|NCT00556933|580405778|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
160734034|NCT00556933|580405779|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
160734035|NCT00556933|580405776|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
160734036|NCT00556933|580405777|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
160734037|NCT00556933|580405778|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
160734038|NCT00556933|580405779|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
160734039|NCT00556933|580405776|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
160734040|NCT00556933|580405777|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
160734041|NCT00556933|580405778|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
160734042|NCT00556933|580405779|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
160734043|NCT00556933|580405776|FG000|CNI Withdrawal vs. Minimization|Death|0|||
160734044|NCT00556933|580405777|FG001|CNI Withdrawal vs. Minimization|Death|0|||
160734045|NCT00556933|580405778|FG002|CNI Withdrawal vs. Minimization|Death|0|||
160734046|NCT00556933|580405779|FG003|CNI Withdrawal vs. Minimization|Death|1|||
160734047|NCT00174967|580407722|FG000|Overall Study|Adverse Event|1|||
160734048|NCT00174967|580407723|FG001|Overall Study|Adverse Event|2|||
160734049|NCT00174967|580407724|FG002|Overall Study|Adverse Event|2|||
160734050|NCT00174967|580407725|FG003|Overall Study|Adverse Event|1|||
160734051|NCT00174967|580407722|FG000|Overall Study|Gout Flare|0|||
160734052|NCT00174967|580407723|FG001|Overall Study|Gout Flare|0|||
160734053|NCT00174967|580407724|FG002|Overall Study|Gout Flare|0|||
160734054|NCT00174967|580407725|FG003|Overall Study|Gout Flare|1|||
160734055|NCT00174967|580407722|FG000|Overall Study|Other|0|||
160734056|NCT00174967|580407723|FG001|Overall Study|Other|1|||
160734057|NCT00174967|580407724|FG002|Overall Study|Other|0|||
160734058|NCT00174967|580407725|FG003|Overall Study|Other|0|||
160734059|NCT03030989|580407726|FG000|Overall Study|Fever|2|||
160734060|NCT03030989|580407727|FG001|Overall Study|Fever|2|||
160734061|NCT03030989|580407726|FG000|Overall Study|Rash|2|||
160734062|NCT03030989|580407727|FG001|Overall Study|Rash|1|||
160734063|NCT03030989|580407726|FG000|Overall Study|Fatigue/Overwhelmed|1|||
160734064|NCT03030989|580407727|FG001|Overall Study|Fatigue/Overwhelmed|5|||
160734065|NCT03030989|580407726|FG000|Overall Study|Positive Blood Cultures|2|||
160734066|NCT03030989|580407727|FG001|Overall Study|Positive Blood Cultures|1|||
160734067|NCT03030989|580407726|FG000|Overall Study|Line Removed|0|||
160734068|NCT03030989|580407727|FG001|Overall Study|Line Removed|2|||
160734069|NCT03030989|580407726|FG000|Overall Study|No longer interested|5|||
160734070|NCT03030989|580407727|FG001|Overall Study|No longer interested|3|||
160734071|NCT02730377|580407728|FG000|Overall Study|Other|5|||
160734072|NCT02730377|580407729|FG001|Overall Study|Other|4|||
160734073|NCT02730377|580407728|FG000|Overall Study|Death|1|||
160734074|NCT02730377|580407729|FG001|Overall Study|Death|8|||
160734075|NCT02730377|580407728|FG000|Overall Study|Inadequate glycaemic control|368|||
160734076|NCT02730377|580407729|FG001|Overall Study|Inadequate glycaemic control|473|||
160734077|NCT02730377|580407728|FG000|Overall Study|Adverse Event|79|||
160734078|NCT02730377|580407729|FG001|Overall Study|Adverse Event|41|||
160734079|NCT02730377|580407728|FG000|Overall Study|Protocol Violation|23|||
160734080|NCT02730377|580407729|FG001|Overall Study|Protocol Violation|30|||
160734081|NCT02730377|580407728|FG000|Overall Study|Lack of Efficacy|4|||
160734082|NCT02730377|580407729|FG001|Overall Study|Lack of Efficacy|13|||
160734083|NCT02730377|580407728|FG000|Overall Study|Pregnancy|0|||
160734084|NCT02730377|580407729|FG001|Overall Study|Pregnancy|1|||
160734085|NCT02730377|580407728|FG000|Overall Study|Withdrawal by Subject|45|||
160734086|NCT02730377|580407729|FG001|Overall Study|Withdrawal by Subject|42|||
160734087|NCT02730377|580407728|FG000|Overall Study|Lost to Follow-up|25|||
160734088|NCT02730377|580407729|FG001|Overall Study|Lost to Follow-up|21|||
160734089|NCT02706886|580407730|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
160734090|NCT02706886|580407731|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
160734091|NCT02706886|580407732|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
160734092|NCT02706886|580407733|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
160734093|NCT02706886|580407734|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
160734094|NCT02706886|580407735|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
160734095|NCT02706886|580407736|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
160734096|NCT02706886|580407737|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
160734097|NCT02706886|580407738|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
160734098|NCT03917472|580407739|FG000|Overall Study|Physician Decision|4|||
160734099|NCT03917472|580407740|FG001|Overall Study|Physician Decision|0|||
160734100|NCT03917472|580407739|FG000|Overall Study|Adverse Event|3|||
160734101|NCT03917472|580407740|FG001|Overall Study|Adverse Event|1|||
160734102|NCT03917472|580407739|FG000|Overall Study|Death|7|||
160734103|NCT03917472|580407740|FG001|Overall Study|Death|5|||
160734104|NCT03917472|580407739|FG000|Overall Study|Withdrawal by Subject|11|||
160734105|NCT03917472|580407740|FG001|Overall Study|Withdrawal by Subject|4|||
160734106|NCT03917472|580407739|FG000|Overall Study|Lost to Follow-up|10|||
160734107|NCT03917472|580407740|FG001|Overall Study|Lost to Follow-up|5|||
160734108|NCT01154296|580407741|FG000|Randomization and Intervention|Decided to decline|1|||
160734109|NCT01154296|580407742|FG001|Randomization and Intervention|Decided to decline|1|||
160734110|NCT01154296|580407741|FG000|Randomization and Intervention|Declined by staff|1|||
160734111|NCT01154296|580407742|FG001|Randomization and Intervention|Declined by staff|0|||
160734112|NCT01154296|580407741|FG000|Randomization and Intervention|Did not return|1|||
160734113|NCT01154296|580407742|FG001|Randomization and Intervention|Did not return|0|||
160734114|NCT01154296|580407741|FG000|Randomization and Intervention|Left before test|0|||
160734115|NCT01154296|580407742|FG001|Randomization and Intervention|Left before test|1|||
160734116|NCT01154296|580407741|FG000|Randomization and Intervention|Left clinic early|2|||
160734117|NCT01154296|580407742|FG001|Randomization and Intervention|Left clinic early|0|||
160734118|NCT01154296|580407741|FG000|6-month Follow-up|Lost contact|269|||
160734119|NCT01154296|580407742|FG001|6-month Follow-up|Lost contact|275|||
160734120|NCT01154296|580407741|FG000|6-month Follow-up|Incarcerated|37|||
160734121|NCT01154296|580407742|FG001|6-month Follow-up|Incarcerated|32|||
160734122|NCT01154296|580407741|FG000|6-month Follow-up|Withdrew consent|14|||
160734123|NCT01154296|580407742|FG001|6-month Follow-up|Withdrew consent|15|||
160734124|NCT01154296|580407741|FG000|6-month Follow-up|Death|3|||
160734125|NCT01154296|580407742|FG001|6-month Follow-up|Death|2|||
160734126|NCT01154296|580407741|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
160734127|NCT01154296|580407742|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
160734128|NCT02203851|580407743|FG000|Overall Study|Lost to Follow-up|4|||
160734129|NCT02203851|580407743|FG000|Overall Study|Withdrawal by Subject|6|||
160734130|NCT02203851|580407743|FG000|Overall Study|Other|1|||
160734131|NCT03320850|580407744|FG000|Overall Study|Lost to Follow-up|0|||
160734132|NCT03320850|580407745|FG001|Overall Study|Lost to Follow-up|0|||
160734133|NCT03320850|580407746|FG002|Overall Study|Lost to Follow-up|0|||
160734134|NCT03320850|580407747|FG003|Overall Study|Lost to Follow-up|0|||
160734135|NCT03320850|580407748|FG004|Overall Study|Lost to Follow-up|1|||
160734136|NCT03320850|580407749|FG005|Overall Study|Lost to Follow-up|2|||
160734137|NCT03320850|580407750|FG006|Overall Study|Lost to Follow-up|2|||
160734138|NCT03320850|580407751|FG007|Overall Study|Lost to Follow-up|0|||
160734139|NCT03320850|580407752|FG008|Overall Study|Lost to Follow-up|6|||
160734140|NCT03320850|580407753|FG009|Overall Study|Lost to Follow-up|4|||
160734141|NCT03320850|580407744|FG000|Overall Study|Withdrawal by Subject|0|||
160734142|NCT03320850|580407745|FG001|Overall Study|Withdrawal by Subject|0|||
160734143|NCT03320850|580407746|FG002|Overall Study|Withdrawal by Subject|0|||
160734144|NCT03320850|580407747|FG003|Overall Study|Withdrawal by Subject|0|||
160734145|NCT03320850|580407748|FG004|Overall Study|Withdrawal by Subject|1|||
160734146|NCT03320850|580407749|FG005|Overall Study|Withdrawal by Subject|2|||
160734147|NCT03320850|580407750|FG006|Overall Study|Withdrawal by Subject|4|||
160734148|NCT03320850|580407751|FG007|Overall Study|Withdrawal by Subject|5|||
160734149|NCT03320850|580407752|FG008|Overall Study|Withdrawal by Subject|2|||
160734150|NCT03320850|580407753|FG009|Overall Study|Withdrawal by Subject|1|||
160734151|NCT03320850|580407744|FG000|Overall Study|Lack of Efficacy|0|||
160734152|NCT03320850|580407745|FG001|Overall Study|Lack of Efficacy|0|||
160734153|NCT03320850|580407746|FG002|Overall Study|Lack of Efficacy|0|||
160734154|NCT03320850|580407747|FG003|Overall Study|Lack of Efficacy|1|||
160734155|NCT03320850|580407748|FG004|Overall Study|Lack of Efficacy|0|||
160734156|NCT03320850|580407749|FG005|Overall Study|Lack of Efficacy|1|||
160734157|NCT03320850|580407750|FG006|Overall Study|Lack of Efficacy|0|||
160734158|NCT03320850|580407751|FG007|Overall Study|Lack of Efficacy|2|||
160734159|NCT03320850|580407752|FG008|Overall Study|Lack of Efficacy|0|||
160734160|NCT03320850|580407753|FG009|Overall Study|Lack of Efficacy|3|||
160734161|NCT03320850|580407744|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
160734162|NCT03320850|580407745|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
160734163|NCT03320850|580407746|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
160734164|NCT03320850|580407747|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
160734165|NCT03320850|580407748|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
160734166|NCT03320850|580407749|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
160734167|NCT03320850|580407750|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
160734168|NCT03320850|580407751|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
160734169|NCT03320850|580407752|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
160734170|NCT03320850|580407753|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
160734171|NCT03320850|580407744|FG000|Overall Study|Adverse Event|0|||
160734172|NCT03320850|580407745|FG001|Overall Study|Adverse Event|0|||
160734173|NCT03320850|580407746|FG002|Overall Study|Adverse Event|0|||
160734174|NCT03320850|580407747|FG003|Overall Study|Adverse Event|0|||
160734175|NCT03320850|580407748|FG004|Overall Study|Adverse Event|0|||
160734176|NCT03320850|580407749|FG005|Overall Study|Adverse Event|2|||
160734177|NCT03320850|580407750|FG006|Overall Study|Adverse Event|1|||
160734178|NCT03320850|580407751|FG007|Overall Study|Adverse Event|0|||
160734179|NCT03320850|580407752|FG008|Overall Study|Adverse Event|2|||
160734180|NCT03320850|580407753|FG009|Overall Study|Adverse Event|0|||
160734181|NCT03320850|580407744|FG000|Overall Study|Reason Not Specified|0|||
160734182|NCT03320850|580407745|FG001|Overall Study|Reason Not Specified|0|||
160734183|NCT03320850|580407746|FG002|Overall Study|Reason Not Specified|0|||
160734184|NCT03320850|580407747|FG003|Overall Study|Reason Not Specified|0|||
160734185|NCT03320850|580407748|FG004|Overall Study|Reason Not Specified|0|||
160734186|NCT03320850|580407749|FG005|Overall Study|Reason Not Specified|1|||
160734187|NCT03320850|580407750|FG006|Overall Study|Reason Not Specified|0|||
160734188|NCT03320850|580407751|FG007|Overall Study|Reason Not Specified|0|||
160734189|NCT03320850|580407752|FG008|Overall Study|Reason Not Specified|0|||
160734190|NCT03320850|580407753|FG009|Overall Study|Reason Not Specified|1|||
160734191|NCT02086448|580407755|FG000|Overall Study|Withdrawal by Subject|1|||
160734192|NCT02086448|580407756|FG001|Overall Study|Withdrawal by Subject|0|||
160734193|NCT02086448|580407757|FG002|Overall Study|Withdrawal by Subject|0|||
160734194|NCT02086448|580407758|FG003|Overall Study|Withdrawal by Subject|2|||
160734195|NCT01871402|580407767|FG000|Overall Study|Lost to Follow-up|1|||
160734196|NCT01871402|580407768|FG001|Overall Study|Lost to Follow-up|0|||
160734197|NCT01871402|580407767|FG000|Overall Study|Withdrawal by Subject|0|||
160734198|NCT01871402|580407768|FG001|Overall Study|Withdrawal by Subject|2|||
160734199|NCT01871402|580407767|FG000|Overall Study|Non-compliance|0|||
160734200|NCT01871402|580407768|FG001|Overall Study|Non-compliance|1|||
160734201|NCT04594941|580407769|FG000|Overall Study|Other|0|||
160734202|NCT04594941|580407770|FG001|Overall Study|Other|3|||
160734203|NCT04594941|580407771|FG002|Overall Study|Other|1|||
160734204|NCT04594941|580407772|FG003|Overall Study|Other|0|||
160734205|NCT00231114|580407773|FG000|Randomized|Withdrawal by Subject|6|||
160734206|NCT00231114|580407774|FG001|Randomized|Withdrawal by Subject|3|||
160734207|NCT00231114|580407773|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
160734208|NCT00231114|580407774|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
160734209|NCT00231114|580407773|FG000|Post-Treatment Period|Lost to Follow-up|6|||
160734210|NCT00231114|580407774|FG001|Post-Treatment Period|Lost to Follow-up|1|||
160734211|NCT00231114|580407773|FG000|Post-Treatment Period|Physician Decision|1|||
160734212|NCT00231114|580407774|FG001|Post-Treatment Period|Physician Decision|0|||
160734213|NCT00231114|580407773|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
160734214|NCT00231114|580407774|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
160734215|NCT02031640|580407778|FG000|Screening Period|Adverse Event|1|||
160734216|NCT02031640|580407779|FG001|Screening Period|Adverse Event|0|||
160734217|NCT02031640|580407780|FG002|Screening Period|Adverse Event|0|||
160734218|NCT02031640|580407781|FG003|Screening Period|Adverse Event|0|||
160734219|NCT02031640|580407782|FG004|Screening Period|Adverse Event|0|||
160734220|NCT02031640|580407783|FG005|Screening Period|Adverse Event|0|||
160734221|NCT02031640|580407778|FG000|Screening Period|Withdrawal by Subject|29|||
160734222|NCT02031640|580407779|FG001|Screening Period|Withdrawal by Subject|0|||
160734223|NCT02031640|580407780|FG002|Screening Period|Withdrawal by Subject|0|||
160734224|NCT02031640|580407781|FG003|Screening Period|Withdrawal by Subject|0|||
160734225|NCT02031640|580407782|FG004|Screening Period|Withdrawal by Subject|0|||
160734226|NCT02031640|580407783|FG005|Screening Period|Withdrawal by Subject|0|||
160734227|NCT02031640|580407778|FG000|Screening Period|Inclusion criteria not met|312|||
160734228|NCT02031640|580407779|FG001|Screening Period|Inclusion criteria not met|0|||
160734229|NCT02031640|580407780|FG002|Screening Period|Inclusion criteria not met|0|||
160734230|NCT02031640|580407781|FG003|Screening Period|Inclusion criteria not met|0|||
160734231|NCT02031640|580407782|FG004|Screening Period|Inclusion criteria not met|0|||
160734232|NCT02031640|580407783|FG005|Screening Period|Inclusion criteria not met|0|||
160734233|NCT02031640|580407778|FG000|Screening Period|Exclusion criteria met|30|||
160734234|NCT02031640|580407779|FG001|Screening Period|Exclusion criteria met|0|||
160734235|NCT02031640|580407780|FG002|Screening Period|Exclusion criteria met|0|||
160734236|NCT02031640|580407781|FG003|Screening Period|Exclusion criteria met|0|||
160734237|NCT02031640|580407782|FG004|Screening Period|Exclusion criteria met|0|||
160734238|NCT02031640|580407783|FG005|Screening Period|Exclusion criteria met|0|||
160734239|NCT02031640|580407778|FG000|Screening Period|Lost to Follow-up|14|||
160734240|NCT02031640|580407779|FG001|Screening Period|Lost to Follow-up|0|||
160734241|NCT02031640|580407780|FG002|Screening Period|Lost to Follow-up|0|||
160734242|NCT02031640|580407781|FG003|Screening Period|Lost to Follow-up|0|||
160734243|NCT02031640|580407782|FG004|Screening Period|Lost to Follow-up|0|||
160734244|NCT02031640|580407783|FG005|Screening Period|Lost to Follow-up|0|||
160734245|NCT02031640|580407778|FG000|Screening Period|Enrollment closed|26|||
160734246|NCT02031640|580407779|FG001|Screening Period|Enrollment closed|0|||
160734247|NCT02031640|580407780|FG002|Screening Period|Enrollment closed|0|||
160734248|NCT02031640|580407781|FG003|Screening Period|Enrollment closed|0|||
160734249|NCT02031640|580407782|FG004|Screening Period|Enrollment closed|0|||
160734250|NCT02031640|580407783|FG005|Screening Period|Enrollment closed|0|||
160734251|NCT02031640|580407778|FG000|Run-In Period|Adverse Event|4|||
160734252|NCT02031640|580407779|FG001|Run-In Period|Adverse Event|0|||
160734253|NCT02031640|580407780|FG002|Run-In Period|Adverse Event|0|||
160734254|NCT02031640|580407781|FG003|Run-In Period|Adverse Event|0|||
160734255|NCT02031640|580407782|FG004|Run-In Period|Adverse Event|0|||
160734256|NCT02031640|580407783|FG005|Run-In Period|Adverse Event|0|||
160734257|NCT02031640|580407778|FG000|Run-In Period|Withdrawal by Subject|17|||
160734258|NCT02031640|580407779|FG001|Run-In Period|Withdrawal by Subject|0|||
160734259|NCT02031640|580407780|FG002|Run-In Period|Withdrawal by Subject|0|||
160734260|NCT02031640|580407781|FG003|Run-In Period|Withdrawal by Subject|0|||
160734261|NCT02031640|580407782|FG004|Run-In Period|Withdrawal by Subject|0|||
160734262|NCT02031640|580407783|FG005|Run-In Period|Withdrawal by Subject|0|||
160734263|NCT02031640|580407778|FG000|Run-In Period|Inclusion criteria not met|38|||
160734264|NCT02031640|580407779|FG001|Run-In Period|Inclusion criteria not met|0|||
160734265|NCT02031640|580407780|FG002|Run-In Period|Inclusion criteria not met|0|||
160734266|NCT02031640|580407781|FG003|Run-In Period|Inclusion criteria not met|0|||
160734267|NCT02031640|580407782|FG004|Run-In Period|Inclusion criteria not met|0|||
160734268|NCT02031640|580407783|FG005|Run-In Period|Inclusion criteria not met|0|||
160734269|NCT02031640|580407778|FG000|Run-In Period|Exclusion criteria met|8|||
160734270|NCT02031640|580407779|FG001|Run-In Period|Exclusion criteria met|0|||
160734271|NCT02031640|580407780|FG002|Run-In Period|Exclusion criteria met|0|||
160734272|NCT02031640|580407781|FG003|Run-In Period|Exclusion criteria met|0|||
160734273|NCT02031640|580407782|FG004|Run-In Period|Exclusion criteria met|0|||
160734274|NCT02031640|580407783|FG005|Run-In Period|Exclusion criteria met|0|||
160734275|NCT02031640|580407778|FG000|Run-In Period|Randomization criteria not met|85|||
160734276|NCT02031640|580407779|FG001|Run-In Period|Randomization criteria not met|0|||
160734277|NCT02031640|580407780|FG002|Run-In Period|Randomization criteria not met|0|||
160734278|NCT02031640|580407781|FG003|Run-In Period|Randomization criteria not met|0|||
160734279|NCT02031640|580407782|FG004|Run-In Period|Randomization criteria not met|0|||
160734280|NCT02031640|580407783|FG005|Run-In Period|Randomization criteria not met|0|||
160734281|NCT02031640|580407778|FG000|Run-In Period|Various administrative reasons|17|||
160734282|NCT02031640|580407779|FG001|Run-In Period|Various administrative reasons|0|||
160734283|NCT02031640|580407780|FG002|Run-In Period|Various administrative reasons|0|||
160734284|NCT02031640|580407781|FG003|Run-In Period|Various administrative reasons|0|||
160734285|NCT02031640|580407782|FG004|Run-In Period|Various administrative reasons|0|||
160734286|NCT02031640|580407783|FG005|Run-In Period|Various administrative reasons|0|||
160734287|NCT02031640|580407778|FG000|Double-blind Treatment Period|Protocol deviation|0|||
160734288|NCT02031640|580407779|FG001|Double-blind Treatment Period|Protocol deviation|2|||
160734289|NCT02031640|580407780|FG002|Double-blind Treatment Period|Protocol deviation|0|||
160734290|NCT02031640|580407781|FG003|Double-blind Treatment Period|Protocol deviation|1|||
160734291|NCT02031640|580407782|FG004|Double-blind Treatment Period|Protocol deviation|3|||
160734292|NCT02031640|580407783|FG005|Double-blind Treatment Period|Protocol deviation|1|||
160734293|NCT02031640|580407778|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
160734294|NCT02031640|580407779|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
160734295|NCT02031640|580407780|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
160734296|NCT02031640|580407781|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
160734297|NCT02031640|580407782|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
160734298|NCT02031640|580407783|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
160734299|NCT02031640|580407778|FG000|Double-blind Treatment Period|Non-compliance|0|||
160734300|NCT02031640|580407779|FG001|Double-blind Treatment Period|Non-compliance|1|||
160734301|NCT02031640|580407780|FG002|Double-blind Treatment Period|Non-compliance|0|||
160734302|NCT02031640|580407781|FG003|Double-blind Treatment Period|Non-compliance|1|||
160734303|NCT02031640|580407782|FG004|Double-blind Treatment Period|Non-compliance|1|||
160734304|NCT02031640|580407783|FG005|Double-blind Treatment Period|Non-compliance|0|||
160734305|NCT02031640|580407778|FG000|Double-blind Treatment Period|Adverse Event|0|||
160734306|NCT02031640|580407779|FG001|Double-blind Treatment Period|Adverse Event|0|||
160734307|NCT02031640|580407780|FG002|Double-blind Treatment Period|Adverse Event|0|||
160734308|NCT02031640|580407781|FG003|Double-blind Treatment Period|Adverse Event|2|||
160734309|NCT02031640|580407782|FG004|Double-blind Treatment Period|Adverse Event|0|||
160734310|NCT02031640|580407783|FG005|Double-blind Treatment Period|Adverse Event|0|||
160734311|NCT02031640|580407778|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
160734312|NCT02031640|580407779|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
160734313|NCT02031640|580407780|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
160734314|NCT02031640|580407781|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
160734315|NCT02031640|580407782|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
160734316|NCT02031640|580407783|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
160734317|NCT02031640|580407778|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
160734318|NCT02031640|580407779|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
160734319|NCT02031640|580407780|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
160734320|NCT02031640|580407781|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
160734321|NCT02031640|580407782|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
160734322|NCT02031640|580407783|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
160734323|NCT01895270|580407786|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
160734324|NCT01895270|580407787|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
160734325|NCT01895270|580407786|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
160734326|NCT01895270|580407787|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
160734327|NCT01895270|580407786|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
160734328|NCT01895270|580407787|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
160734329|NCT01895270|580407786|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
160734330|NCT01895270|580407787|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
160734331|NCT01895270|580407786|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
160734332|NCT01895270|580407787|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
160734333|NCT01895270|580407786|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
160734334|NCT01895270|580407787|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
160734335|NCT01895270|580407786|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
160734336|NCT01895270|580407787|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
160734337|NCT01194999|580407788|FG000|Overall Study|Lost to Follow-up|17|||
160734338|NCT02091375|580407791|FG000|Overall Study|Adverse Event|8|||
160734339|NCT02091375|580407792|FG001|Overall Study|Adverse Event|1|||
160734340|NCT02091375|580407791|FG000|Overall Study|Lost to Follow-up|0|||
160734341|NCT02091375|580407792|FG001|Overall Study|Lost to Follow-up|1|||
160734342|NCT02091375|580407791|FG000|Overall Study|Withdrawal by Subject|0|||
160734343|NCT02091375|580407792|FG001|Overall Study|Withdrawal by Subject|1|||
160734344|NCT02091375|580407791|FG000|Overall Study|Withdrawn by the investigator|1|||
160734345|NCT02091375|580407792|FG001|Overall Study|Withdrawn by the investigator|0|||
160734346|NCT01279070|580407795|FG000|Overall Study|Withdrawal by Subject|2|||
160734347|NCT01279070|580407796|FG001|Overall Study|Withdrawal by Subject|3|||
160734348|NCT01279070|580407795|FG000|Overall Study|Acute exacerbation|3|||
160734349|NCT01279070|580407796|FG001|Overall Study|Acute exacerbation|1|||
160734350|NCT03781583|580407799|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
160734351|NCT03781583|580407800|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
160734352|NCT03781583|580407801|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
160734353|NCT03781583|580407802|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
160734354|NCT03781583|580407799|FG000|Overall Study|Technology did not work for that person in that environment|1|||
160734355|NCT03781583|580407800|FG001|Overall Study|Technology did not work for that person in that environment|0|||
160734356|NCT03781583|580407801|FG002|Overall Study|Technology did not work for that person in that environment|0|||
160734357|NCT03781583|580407802|FG003|Overall Study|Technology did not work for that person in that environment|0|||
160734358|NCT03781583|580407799|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
160734359|NCT03781583|580407800|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
160734360|NCT03781583|580407801|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
160734361|NCT03781583|580407802|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
160734362|NCT03781583|580407799|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
160734363|NCT03781583|580407800|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
160734364|NCT03781583|580407801|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
160734365|NCT03781583|580407802|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
160734366|NCT04720911|580407803|FG000|Overall Study|Withdrawal by Subject|0|||
160734367|NCT04720911|580407804|FG001|Overall Study|Withdrawal by Subject|1|||
160734368|NCT04720911|580407805|FG002|Overall Study|Withdrawal by Subject|0|||
160734369|NCT01938430|580407807|FG000|Overall Study|Randomized but Not Treated|0|||
160734370|NCT01938430|580407808|FG001|Overall Study|Randomized but Not Treated|0|||
160734371|NCT01938430|580407809|FG002|Overall Study|Randomized but Not Treated|0|||
160734372|NCT01938430|580407810|FG003|Overall Study|Randomized but Not Treated|0|||
160734373|NCT01938430|580407811|FG004|Overall Study|Randomized but Not Treated|0|||
160734374|NCT01938430|580407812|FG005|Overall Study|Randomized but Not Treated|0|||
160734375|NCT01938430|580407813|FG006|Overall Study|Randomized but Not Treated|0|||
160734376|NCT01938430|580407814|FG007|Overall Study|Randomized but Not Treated|0|||
160734377|NCT01938430|580407815|FG008|Overall Study|Randomized but Not Treated|0|||
160734378|NCT01938430|580407816|FG009|Overall Study|Randomized but Not Treated|0|||
160734379|NCT01938430|580407817|FG010|Overall Study|Randomized but Not Treated|1|||
160734380|NCT01938430|580407818|FG011|Overall Study|Randomized but Not Treated|0|||
160734381|NCT01938430|580407819|FG012|Overall Study|Randomized but Not Treated|0|||
160734382|NCT01938430|580407820|FG013|Overall Study|Randomized but Not Treated|1|||
160734383|NCT01938430|580407807|FG000|Overall Study|Adverse Event|0|||
160734384|NCT01938430|580407808|FG001|Overall Study|Adverse Event|0|||
160734385|NCT01938430|580407809|FG002|Overall Study|Adverse Event|0|||
160734386|NCT01938430|580407810|FG003|Overall Study|Adverse Event|0|||
160734387|NCT01938430|580407811|FG004|Overall Study|Adverse Event|0|||
160734388|NCT01938430|580407812|FG005|Overall Study|Adverse Event|0|||
160734389|NCT01938430|580407813|FG006|Overall Study|Adverse Event|1|||
160734390|NCT01938430|580407814|FG007|Overall Study|Adverse Event|0|||
160734391|NCT01938430|580407815|FG008|Overall Study|Adverse Event|0|||
160734392|NCT01938430|580407816|FG009|Overall Study|Adverse Event|0|||
160734393|NCT01938430|580407817|FG010|Overall Study|Adverse Event|0|||
160734394|NCT01938430|580407818|FG011|Overall Study|Adverse Event|0|||
160734395|NCT01938430|580407819|FG012|Overall Study|Adverse Event|0|||
160734396|NCT01938430|580407820|FG013|Overall Study|Adverse Event|0|||
160734397|NCT01938430|580407807|FG000|Overall Study|Death|1|||
160734398|NCT01938430|580407808|FG001|Overall Study|Death|2|||
160734399|NCT01938430|580407809|FG002|Overall Study|Death|2|||
160734400|NCT01938430|580407810|FG003|Overall Study|Death|1|||
160734401|NCT01938430|580407811|FG004|Overall Study|Death|0|||
160734402|NCT01938430|580407812|FG005|Overall Study|Death|0|||
160734403|NCT01938430|580407813|FG006|Overall Study|Death|1|||
160734404|NCT01938430|580407814|FG007|Overall Study|Death|1|||
160734405|NCT01938430|580407815|FG008|Overall Study|Death|2|||
160734406|NCT01938430|580407816|FG009|Overall Study|Death|3|||
160734407|NCT01938430|580407817|FG010|Overall Study|Death|0|||
160734408|NCT01938430|580407818|FG011|Overall Study|Death|0|||
160734409|NCT01938430|580407819|FG012|Overall Study|Death|0|||
160734410|NCT01938430|580407820|FG013|Overall Study|Death|0|||
160734411|NCT01938430|580407807|FG000|Overall Study|Investigator's Discretion|0|||
160734412|NCT01938430|580407808|FG001|Overall Study|Investigator's Discretion|0|||
160734413|NCT01938430|580407809|FG002|Overall Study|Investigator's Discretion|1|||
160734414|NCT01938430|580407810|FG003|Overall Study|Investigator's Discretion|0|||
160734415|NCT01938430|580407811|FG004|Overall Study|Investigator's Discretion|0|||
160734416|NCT01938430|580407812|FG005|Overall Study|Investigator's Discretion|0|||
160734417|NCT01938430|580407813|FG006|Overall Study|Investigator's Discretion|0|||
160734418|NCT01938430|580407814|FG007|Overall Study|Investigator's Discretion|0|||
160734419|NCT01938430|580407815|FG008|Overall Study|Investigator's Discretion|0|||
160734420|NCT01938430|580407816|FG009|Overall Study|Investigator's Discretion|0|||
160734421|NCT01938430|580407817|FG010|Overall Study|Investigator's Discretion|0|||
160734422|NCT01938430|580407818|FG011|Overall Study|Investigator's Discretion|0|||
160734423|NCT01938430|580407819|FG012|Overall Study|Investigator's Discretion|0|||
160734424|NCT01938430|580407820|FG013|Overall Study|Investigator's Discretion|0|||
160734425|NCT01938430|580407807|FG000|Overall Study|Lack of Efficacy|3|||
160734426|NCT01938430|580407808|FG001|Overall Study|Lack of Efficacy|1|||
160734427|NCT01938430|580407809|FG002|Overall Study|Lack of Efficacy|1|||
160734428|NCT01938430|580407810|FG003|Overall Study|Lack of Efficacy|1|||
160734429|NCT01938430|580407811|FG004|Overall Study|Lack of Efficacy|0|||
160734430|NCT01938430|580407812|FG005|Overall Study|Lack of Efficacy|0|||
160734431|NCT01938430|580407813|FG006|Overall Study|Lack of Efficacy|0|||
160734432|NCT01938430|580407814|FG007|Overall Study|Lack of Efficacy|0|||
160734433|NCT01938430|580407815|FG008|Overall Study|Lack of Efficacy|1|||
160734434|NCT01938430|580407816|FG009|Overall Study|Lack of Efficacy|0|||
160734435|NCT01938430|580407817|FG010|Overall Study|Lack of Efficacy|2|||
160734436|NCT01938430|580407818|FG011|Overall Study|Lack of Efficacy|1|||
160734437|NCT01938430|580407819|FG012|Overall Study|Lack of Efficacy|0|||
160734438|NCT01938430|580407820|FG013|Overall Study|Lack of Efficacy|0|||
160734439|NCT01938430|580407807|FG000|Overall Study|Lost to Follow-up|0|||
160734440|NCT01938430|580407808|FG001|Overall Study|Lost to Follow-up|0|||
160734441|NCT01938430|580407809|FG002|Overall Study|Lost to Follow-up|1|||
160734442|NCT01938430|580407810|FG003|Overall Study|Lost to Follow-up|0|||
160734443|NCT01938430|580407811|FG004|Overall Study|Lost to Follow-up|0|||
160734444|NCT01938430|580407812|FG005|Overall Study|Lost to Follow-up|1|||
160734445|NCT01938430|580407813|FG006|Overall Study|Lost to Follow-up|0|||
160734446|NCT01938430|580407814|FG007|Overall Study|Lost to Follow-up|0|||
160734447|NCT01938430|580407815|FG008|Overall Study|Lost to Follow-up|0|||
160734448|NCT01938430|580407816|FG009|Overall Study|Lost to Follow-up|0|||
160734449|NCT01938430|580407817|FG010|Overall Study|Lost to Follow-up|0|||
160734450|NCT01938430|580407818|FG011|Overall Study|Lost to Follow-up|0|||
160734451|NCT01938430|580407819|FG012|Overall Study|Lost to Follow-up|0|||
160734452|NCT01938430|580407820|FG013|Overall Study|Lost to Follow-up|0|||
160734453|NCT01938430|580407807|FG000|Overall Study|Withdrew Consent|0|||
160734454|NCT01938430|580407808|FG001|Overall Study|Withdrew Consent|0|||
160734455|NCT01938430|580407809|FG002|Overall Study|Withdrew Consent|0|||
160734456|NCT01938430|580407810|FG003|Overall Study|Withdrew Consent|0|||
160734457|NCT01938430|580407811|FG004|Overall Study|Withdrew Consent|0|||
160734458|NCT01938430|580407812|FG005|Overall Study|Withdrew Consent|0|||
160734459|NCT01938430|580407813|FG006|Overall Study|Withdrew Consent|0|||
160734460|NCT01938430|580407814|FG007|Overall Study|Withdrew Consent|0|||
160734461|NCT01938430|580407815|FG008|Overall Study|Withdrew Consent|1|||
160734462|NCT01938430|580407816|FG009|Overall Study|Withdrew Consent|0|||
160734463|NCT01938430|580407817|FG010|Overall Study|Withdrew Consent|0|||
160734464|NCT01938430|580407818|FG011|Overall Study|Withdrew Consent|0|||
160734465|NCT01938430|580407819|FG012|Overall Study|Withdrew Consent|0|||
160734466|NCT01938430|580407820|FG013|Overall Study|Withdrew Consent|0|||
160734467|NCT00537316|580407821|FG000|Part 1|Adverse Event|7|||
160734468|NCT00537316|580407822|FG001|Part 1|Adverse Event|11|||
160734469|NCT00537316|580407823|FG002|Part 1|Adverse Event|8|||
160734470|NCT00537316|580407824|FG003|Part 1|Adverse Event|0|||
160734471|NCT00537316|580407825|FG004|Part 1|Adverse Event|0|||
160734472|NCT00537316|580407826|FG005|Part 1|Adverse Event|0|||
160734473|NCT00537316|580407827|FG006|Part 1|Adverse Event|0|||
160734474|NCT00537316|580407821|FG000|Part 1|Protocol defined clinical event|1|||
160734475|NCT00537316|580407822|FG001|Part 1|Protocol defined clinical event|0|||
160734476|NCT00537316|580407823|FG002|Part 1|Protocol defined clinical event|0|||
160734477|NCT00537316|580407824|FG003|Part 1|Protocol defined clinical event|0|||
160734478|NCT00537316|580407825|FG004|Part 1|Protocol defined clinical event|0|||
160734479|NCT00537316|580407826|FG005|Part 1|Protocol defined clinical event|0|||
160734480|NCT00537316|580407827|FG006|Part 1|Protocol defined clinical event|0|||
160734481|NCT00537316|580407821|FG000|Part 1|Lost to Follow-up|1|||
160734482|NCT00537316|580407822|FG001|Part 1|Lost to Follow-up|0|||
160734483|NCT00537316|580407823|FG002|Part 1|Lost to Follow-up|0|||
160734484|NCT00537316|580407824|FG003|Part 1|Lost to Follow-up|0|||
160734485|NCT00537316|580407825|FG004|Part 1|Lost to Follow-up|0|||
160734486|NCT00537316|580407826|FG005|Part 1|Lost to Follow-up|0|||
160734487|NCT00537316|580407827|FG006|Part 1|Lost to Follow-up|0|||
160734488|NCT00537316|580407821|FG000|Part 1|Withdrawal by Subject|3|||
160734489|NCT00537316|580407822|FG001|Part 1|Withdrawal by Subject|8|||
160734490|NCT00537316|580407823|FG002|Part 1|Withdrawal by Subject|4|||
160734491|NCT00537316|580407824|FG003|Part 1|Withdrawal by Subject|0|||
160734492|NCT00537316|580407825|FG004|Part 1|Withdrawal by Subject|0|||
160734493|NCT00537316|580407826|FG005|Part 1|Withdrawal by Subject|0|||
160734494|NCT00537316|580407827|FG006|Part 1|Withdrawal by Subject|0|||
160734495|NCT00537316|580407821|FG000|Part 1|Protocol Violation|1|||
160734496|NCT00537316|580407822|FG001|Part 1|Protocol Violation|5|||
160734497|NCT00537316|580407823|FG002|Part 1|Protocol Violation|1|||
160734498|NCT00537316|580407824|FG003|Part 1|Protocol Violation|0|||
160734499|NCT00537316|580407825|FG004|Part 1|Protocol Violation|0|||
160734500|NCT00537316|580407826|FG005|Part 1|Protocol Violation|0|||
160734501|NCT00537316|580407827|FG006|Part 1|Protocol Violation|0|||
160734502|NCT00537316|580407821|FG000|Part 1|Did not meet protocol eligibility|1|||
160734503|NCT00537316|580407822|FG001|Part 1|Did not meet protocol eligibility|3|||
160734504|NCT00537316|580407823|FG002|Part 1|Did not meet protocol eligibility|2|||
160734505|NCT00537316|580407824|FG003|Part 1|Did not meet protocol eligibility|0|||
160734506|NCT00537316|580407825|FG004|Part 1|Did not meet protocol eligibility|0|||
160734507|NCT00537316|580407826|FG005|Part 1|Did not meet protocol eligibility|0|||
160734508|NCT00537316|580407827|FG006|Part 1|Did not meet protocol eligibility|0|||
160734509|NCT00537316|580407821|FG000|Part 1|Administrative|0|||
160734510|NCT00537316|580407822|FG001|Part 1|Administrative|0|||
160734511|NCT00537316|580407823|FG002|Part 1|Administrative|2|||
160734512|NCT00537316|580407824|FG003|Part 1|Administrative|0|||
160734513|NCT00537316|580407825|FG004|Part 1|Administrative|0|||
160734514|NCT00537316|580407826|FG005|Part 1|Administrative|0|||
160734515|NCT00537316|580407827|FG006|Part 1|Administrative|0|||
160734516|NCT00537316|580407821|FG000|Part 2|Never entered follow-up|0|||
160734517|NCT00537316|580407822|FG001|Part 2|Never entered follow-up|0|||
160734518|NCT00537316|580407823|FG002|Part 2|Never entered follow-up|0|||
160734519|NCT00537316|580407824|FG003|Part 2|Never entered follow-up|0|||
160734520|NCT00537316|580407825|FG004|Part 2|Never entered follow-up|0|||
160734521|NCT00537316|580407826|FG005|Part 2|Never entered follow-up|0|||
160734522|NCT00537316|580407827|FG006|Part 2|Never entered follow-up|1|||
160734523|NCT00537316|580407821|FG000|Part 2|Adverse Event|4|||
160734524|NCT00537316|580407822|FG001|Part 2|Adverse Event|0|||
160734525|NCT00537316|580407823|FG002|Part 2|Adverse Event|2|||
160734526|NCT00537316|580407824|FG003|Part 2|Adverse Event|0|||
160734527|NCT00537316|580407825|FG004|Part 2|Adverse Event|0|||
160734528|NCT00537316|580407826|FG005|Part 2|Adverse Event|0|||
160734529|NCT00537316|580407827|FG006|Part 2|Adverse Event|0|||
160734530|NCT00537316|580407821|FG000|Part 2|Lost to Follow-up|1|||
160734531|NCT00537316|580407822|FG001|Part 2|Lost to Follow-up|0|||
160734532|NCT00537316|580407823|FG002|Part 2|Lost to Follow-up|2|||
160734533|NCT00537316|580407824|FG003|Part 2|Lost to Follow-up|0|||
160734534|NCT00537316|580407825|FG004|Part 2|Lost to Follow-up|0|||
160734535|NCT00537316|580407826|FG005|Part 2|Lost to Follow-up|0|||
160734536|NCT00537316|580407827|FG006|Part 2|Lost to Follow-up|0|||
160734537|NCT00537316|580407821|FG000|Part 2|Withdrawal by Subject|5|||
160734538|NCT00537316|580407822|FG001|Part 2|Withdrawal by Subject|1|||
160734539|NCT00537316|580407823|FG002|Part 2|Withdrawal by Subject|4|||
160734540|NCT00537316|580407824|FG003|Part 2|Withdrawal by Subject|0|||
160734541|NCT00537316|580407825|FG004|Part 2|Withdrawal by Subject|0|||
160734542|NCT00537316|580407826|FG005|Part 2|Withdrawal by Subject|0|||
160734543|NCT00537316|580407827|FG006|Part 2|Withdrawal by Subject|0|||
160734544|NCT00537316|580407821|FG000|Part 2|Administrative|16|||
160734545|NCT00537316|580407822|FG001|Part 2|Administrative|8|||
160734546|NCT00537316|580407823|FG002|Part 2|Administrative|24|||
160734547|NCT00537316|580407824|FG003|Part 2|Administrative|3|||
160734548|NCT00537316|580407825|FG004|Part 2|Administrative|1|||
160734549|NCT00537316|580407826|FG005|Part 2|Administrative|4|||
160734550|NCT00537316|580407827|FG006|Part 2|Administrative|1|||
160734551|NCT04533412|580407829|FG000|Overall Study|Withdrawal by Subject|1|||
160734552|NCT04533412|580407830|FG001|Overall Study|Withdrawal by Subject|1|||
160734553|NCT04533412|580407829|FG000|Overall Study|Lost to Follow-up|1|||
160734554|NCT04533412|580407830|FG001|Overall Study|Lost to Follow-up|4|||
160734555|NCT03261674|580407831|FG000|Overall Study|Lost to Follow-up|6|||
160734556|NCT03261674|580407832|FG001|Overall Study|Lost to Follow-up|7|||
160734557|NCT03261674|580407831|FG000|Overall Study|Protocol Violation|1|||
160734558|NCT03261674|580407832|FG001|Overall Study|Protocol Violation|4|||
160734559|NCT03261674|580407831|FG000|Overall Study|Withdrawal by Subject|1|||
160734560|NCT03261674|580407832|FG001|Overall Study|Withdrawal by Subject|4|||
160734561|NCT03261674|580407831|FG000|Overall Study|Physician Decision|1|||
160734562|NCT03261674|580407832|FG001|Overall Study|Physician Decision|0|||
160734563|NCT01438294|580407835|FG000|Overall Study|Lost to Follow-up|3|||
160734564|NCT01438294|580407836|FG001|Overall Study|Lost to Follow-up|7|||
160734565|NCT01730534|580407841|FG000|Overall Study|Withdrawal by Subject|97|||
160734566|NCT01730534|580407842|FG001|Overall Study|Withdrawal by Subject|127|||
160734567|NCT01730534|580407841|FG000|Overall Study|Lost to Follow-up|12|||
160734568|NCT01730534|580407842|FG001|Overall Study|Lost to Follow-up|18|||
160734569|NCT01676896|580407843|FG000|Overall Study|Withdrawal by Subject|12|||
160734570|NCT01676896|580407844|FG001|Overall Study|Withdrawal by Subject|7|||
160734571|NCT01676896|580407845|FG002|Overall Study|Withdrawal by Subject|19|||
160734572|NCT03614078|580407846|FG000|Overall Study|Withdrawal by Subject|2|||
160734573|NCT03614078|580407847|FG001|Overall Study|Withdrawal by Subject|2|||
160734574|NCT03614078|580407848|FG002|Overall Study|Withdrawal by Subject|3|||
160734575|NCT03614078|580407846|FG000|Overall Study|Participant Did Not Return for Visit|0|||
160734576|NCT03614078|580407847|FG001|Overall Study|Participant Did Not Return for Visit|1|||
160734577|NCT03614078|580407848|FG002|Overall Study|Participant Did Not Return for Visit|0|||
160734578|NCT03614078|580407846|FG000|Overall Study|High Neutrophils|0|||
160734579|NCT03614078|580407847|FG001|Overall Study|High Neutrophils|0|||
160734580|NCT03614078|580407848|FG002|Overall Study|High Neutrophils|2|||
160734581|NCT03614078|580407846|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
160734582|NCT03614078|580407847|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
160734583|NCT03614078|580407848|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
160734584|NCT03614078|580407846|FG000|Overall Study|Exacerbation of Psoriasis|0|||
160734585|NCT03614078|580407847|FG001|Overall Study|Exacerbation of Psoriasis|1|||
160734586|NCT03614078|580407848|FG002|Overall Study|Exacerbation of Psoriasis|0|||
160734587|NCT03614078|580407846|FG000|Overall Study|Adverse Event|0|||
160734588|NCT03614078|580407847|FG001|Overall Study|Adverse Event|2|||
160734589|NCT03614078|580407848|FG002|Overall Study|Adverse Event|0|||
160734590|NCT03614078|580407846|FG000|Overall Study|Dizziness and Rash|0|||
160734591|NCT03614078|580407847|FG001|Overall Study|Dizziness and Rash|1|||
160734592|NCT03614078|580407848|FG002|Overall Study|Dizziness and Rash|0|||
160734593|NCT01613222|580407849|FG000|Overall Study|Physician Decision|1|||
160734594|NCT01613222|580407849|FG000|Overall Study|Unable to place arterial line|1|||
160734595|NCT01613222|580407849|FG000|Overall Study|Reused disposable sensors|10|||
160734596|NCT03505593|580407850|FG000|Overall Study|Withdrawal by Subject|1|||
160734597|NCT03505593|580407850|FG000|Overall Study|Died before procedure|1|||
160734598|NCT03505593|580407850|FG000|Overall Study|Anatomical abnormality|1|||
160734599|NCT03505593|580407850|FG000|Overall Study|Unable to pass through esophagus|1|||
160734600|NCT03505593|580407850|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
160734601|NCT01023256|580407855|FG000|Overall Study|Protocol Violation|2|||
160734602|NCT01023256|580407856|FG001|Overall Study|Protocol Violation|3|||
160734603|NCT01023256|580407857|FG002|Overall Study|Protocol Violation|0|||
160734604|NCT01023256|580407858|FG003|Overall Study|Protocol Violation|0|||
160734605|NCT01023256|580407855|FG000|Overall Study|Randomized but not treated|1|||
160734606|NCT01023256|580407856|FG001|Overall Study|Randomized but not treated|0|||
160734607|NCT01023256|580407857|FG002|Overall Study|Randomized but not treated|1|||
160734608|NCT01023256|580407858|FG003|Overall Study|Randomized but not treated|0|||
160734609|NCT01023256|580407855|FG000|Overall Study|Other|1|||
160734610|NCT01023256|580407856|FG001|Overall Study|Other|0|||
160734611|NCT01023256|580407857|FG002|Overall Study|Other|0|||
160734612|NCT01023256|580407858|FG003|Overall Study|Other|2|||
160734613|NCT01023256|580407855|FG000|Overall Study|Adverse Event|0|||
160734614|NCT01023256|580407856|FG001|Overall Study|Adverse Event|0|||
160734615|NCT01023256|580407857|FG002|Overall Study|Adverse Event|0|||
160734616|NCT01023256|580407858|FG003|Overall Study|Adverse Event|1|||
160734617|NCT01023256|580407855|FG000|Overall Study|Withdrawal by Subject|0|||
160734618|NCT01023256|580407856|FG001|Overall Study|Withdrawal by Subject|0|||
160734619|NCT01023256|580407857|FG002|Overall Study|Withdrawal by Subject|0|||
160734620|NCT01023256|580407858|FG003|Overall Study|Withdrawal by Subject|2|||
160734621|NCT00308087|580407859|FG000|Overall Study|Progressive Disease|19|||
160734622|NCT00308087|580407860|FG001|Overall Study|Progressive Disease|21|||
160734623|NCT00308087|580407859|FG000|Overall Study|Study Closure|11|||
160734624|NCT00308087|580407860|FG001|Overall Study|Study Closure|12|||
160734625|NCT00308087|580407859|FG000|Overall Study|Withdrawal by Subject|2|||
160734626|NCT00308087|580407860|FG001|Overall Study|Withdrawal by Subject|1|||
160734627|NCT00308087|580407859|FG000|Overall Study|Other|4|||
160734628|NCT00308087|580407860|FG001|Overall Study|Other|3|||
160734629|NCT04712019|580407862|FG000|Overall Study|Withdrawal by Subject|2|||
160734630|NCT04712019|580407863|FG001|Overall Study|Withdrawal by Subject|2|||
160734631|NCT04712019|580407862|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
160734632|NCT04712019|580407863|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
160734633|NCT01646021|580407864|FG000|Overall Study|Death|77|||
160734634|NCT01646021|580407865|FG001|Overall Study|Death|83|||
160734635|NCT01646021|580407864|FG000|Overall Study|Study Terminated by Sponsor|50|||
160734636|NCT01646021|580407865|FG001|Overall Study|Study Terminated by Sponsor|41|||
160734637|NCT01646021|580407864|FG000|Overall Study|Lost to Follow-up|2|||
160734638|NCT01646021|580407865|FG001|Overall Study|Lost to Follow-up|2|||
160734639|NCT01646021|580407864|FG000|Overall Study|Withdrawal by Subject|10|||
160734640|NCT01646021|580407865|FG001|Overall Study|Withdrawal by Subject|15|||
160734641|NCT00725608|580407868|FG000|Overall Study|Lost to Follow-up|60|||
160734642|NCT00725608|580407868|FG000|Overall Study|Adverse Event|14|||
160734643|NCT00725608|580407868|FG000|Overall Study|Individual reasons|86|||
160734644|NCT00725608|580407868|FG000|Overall Study|Other|7|||
160734645|NCT00614120|580407872|FG000|Overall Study|Adverse Event|9|||
160734646|NCT00614120|580407873|FG001|Overall Study|Adverse Event|22|||
160734647|NCT00614120|580407874|FG002|Overall Study|Adverse Event|30|||
160734648|NCT00614120|580407875|FG003|Overall Study|Adverse Event|3|||
160734649|NCT00614120|580407872|FG000|Overall Study|Lack of Efficacy|3|||
160734650|NCT00614120|580407873|FG001|Overall Study|Lack of Efficacy|3|||
160734651|NCT00614120|580407874|FG002|Overall Study|Lack of Efficacy|2|||
160734652|NCT00614120|580407875|FG003|Overall Study|Lack of Efficacy|2|||
160734653|NCT00614120|580407872|FG000|Overall Study|Protocol Violation|2|||
160734654|NCT00614120|580407873|FG001|Overall Study|Protocol Violation|5|||
160734655|NCT00614120|580407874|FG002|Overall Study|Protocol Violation|3|||
160734656|NCT00614120|580407875|FG003|Overall Study|Protocol Violation|1|||
160734657|NCT00614120|580407872|FG000|Overall Study|Withdrawal criteria|1|||
160734658|NCT00614120|580407873|FG001|Overall Study|Withdrawal criteria|0|||
160734659|NCT00614120|580407874|FG002|Overall Study|Withdrawal criteria|0|||
160734660|NCT00614120|580407875|FG003|Overall Study|Withdrawal criteria|0|||
160734661|NCT00614120|580407872|FG000|Overall Study|Withdrawal by Subject|9|||
160734662|NCT00614120|580407873|FG001|Overall Study|Withdrawal by Subject|10|||
160734663|NCT00614120|580407874|FG002|Overall Study|Withdrawal by Subject|16|||
160734664|NCT00614120|580407875|FG003|Overall Study|Withdrawal by Subject|3|||
160734665|NCT00614120|580407872|FG000|Overall Study|Did not meet trial criteria|0|||
160734666|NCT00614120|580407873|FG001|Overall Study|Did not meet trial criteria|1|||
160734667|NCT00614120|580407874|FG002|Overall Study|Did not meet trial criteria|1|||
160734668|NCT00614120|580407875|FG003|Overall Study|Did not meet trial criteria|1|||
160734669|NCT00614120|580407872|FG000|Overall Study|hCG positive (not pregnant)|0|||
160734670|NCT00614120|580407873|FG001|Overall Study|hCG positive (not pregnant)|0|||
160734671|NCT00614120|580407874|FG002|Overall Study|hCG positive (not pregnant)|1|||
160734672|NCT00614120|580407875|FG003|Overall Study|hCG positive (not pregnant)|0|||
160734673|NCT00614120|580407872|FG000|Overall Study|Hypoglycaemia|0|||
160734674|NCT00614120|580407873|FG001|Overall Study|Hypoglycaemia|0|||
160734675|NCT00614120|580407874|FG002|Overall Study|Hypoglycaemia|0|||
160734676|NCT00614120|580407875|FG003|Overall Study|Hypoglycaemia|1|||
160734677|NCT00614120|580407872|FG000|Overall Study|Lack of trial product|3|||
160734678|NCT00614120|580407873|FG001|Overall Study|Lack of trial product|3|||
160734679|NCT00614120|580407874|FG002|Overall Study|Lack of trial product|2|||
160734680|NCT00614120|580407875|FG003|Overall Study|Lack of trial product|0|||
160734681|NCT00614120|580407872|FG000|Overall Study|Late syphilis, latent|1|||
160734682|NCT00614120|580407873|FG001|Overall Study|Late syphilis, latent|0|||
160734683|NCT00614120|580407874|FG002|Overall Study|Late syphilis, latent|0|||
160734684|NCT00614120|580407875|FG003|Overall Study|Late syphilis, latent|0|||
160734685|NCT00614120|580407872|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
160734686|NCT00614120|580407873|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
160734687|NCT00614120|580407874|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
160734688|NCT00614120|580407875|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
160734689|NCT00614120|580407872|FG000|Overall Study|Lost to Follow-up|1|||
160734690|NCT00614120|580407873|FG001|Overall Study|Lost to Follow-up|2|||
160734691|NCT00614120|580407874|FG002|Overall Study|Lost to Follow-up|3|||
160734692|NCT00614120|580407875|FG003|Overall Study|Lost to Follow-up|4|||
160734693|NCT01084668|580407876|FG000|Overall Study|Lack of Efficacy|5|||
160734694|NCT01084668|580407876|FG000|Overall Study|Withdrawal by Subject|2|||
160734695|NCT01084668|580407876|FG000|Overall Study|Pregnancy|1|||
160734696|NCT01084668|580407876|FG000|Overall Study|Non-compliance|1|||
160734697|NCT02783729|580407881|FG000|Overall Study|Lack of Efficacy|1|||
160734698|NCT02783729|580407882|FG001|Overall Study|Lack of Efficacy|0|||
160734699|NCT02783729|580407883|FG002|Overall Study|Lack of Efficacy|0|||
160734700|NCT02783729|580407884|FG003|Overall Study|Lack of Efficacy|0|||
160734701|NCT02783729|580407881|FG000|Overall Study|Adverse Event|2|||
160734702|NCT02783729|580407882|FG001|Overall Study|Adverse Event|6|||
160734703|NCT02783729|580407883|FG002|Overall Study|Adverse Event|2|||
160734704|NCT02783729|580407884|FG003|Overall Study|Adverse Event|3|||
160734705|NCT02783729|580407881|FG000|Overall Study|Other|1|||
160734706|NCT02783729|580407882|FG001|Overall Study|Other|6|||
160734707|NCT02783729|580407883|FG002|Overall Study|Other|2|||
160734708|NCT02783729|580407884|FG003|Overall Study|Other|3|||
160734709|NCT02783729|580407881|FG000|Overall Study|Withdrawal by Subject|2|||
160734710|NCT02783729|580407882|FG001|Overall Study|Withdrawal by Subject|3|||
160734711|NCT02783729|580407883|FG002|Overall Study|Withdrawal by Subject|1|||
160734712|NCT02783729|580407884|FG003|Overall Study|Withdrawal by Subject|2|||
160734713|NCT02783729|580407881|FG000|Overall Study|Participant's choice|2|||
160734714|NCT02783729|580407882|FG001|Overall Study|Participant's choice|1|||
160734715|NCT02783729|580407883|FG002|Overall Study|Participant's choice|2|||
160734716|NCT02783729|580407884|FG003|Overall Study|Participant's choice|1|||
160734717|NCT02783729|580407881|FG000|Overall Study|Lost to Follow-up|2|||
160734718|NCT02783729|580407882|FG001|Overall Study|Lost to Follow-up|1|||
160734719|NCT02783729|580407883|FG002|Overall Study|Lost to Follow-up|1|||
160734720|NCT02783729|580407884|FG003|Overall Study|Lost to Follow-up|0|||
160734721|NCT03085238|580407886|FG000|Overall Study|Adverse Event|2|||
160734722|NCT03085238|580407886|FG000|Overall Study|Death|2|||
160734723|NCT01894100|580407889|FG000|Overall Study|Lost to Follow-up|0|||
160734724|NCT01894100|580407890|FG001|Overall Study|Lost to Follow-up|1|||
160734725|NCT01894100|580407889|FG000|Overall Study|Withdrawal by Subject|3|||
160734726|NCT01894100|580407890|FG001|Overall Study|Withdrawal by Subject|0|||
160734727|NCT01094301|580407891|FG000|Trial Stage|Withdrawal by Subject|1|||
160734728|NCT01094301|580407891|FG000|Implant Stage|Adverse Event|1|||
160734729|NCT01094301|580407891|FG000|Implant Stage|Protocol Violation|1|||
160734730|NCT01094301|580407891|FG000|Implant Stage|Withdrawal by Subject|2|||
160734731|NCT01094301|580407891|FG000|Implant Stage|No return of pain|4|||
160734732|NCT04439214|580407895|FG000|Overall Study|Adverse Event|13|||
160734733|NCT04439214|580407895|FG000|Overall Study|Disease progression|16|||
160734734|NCT04439214|580407895|FG000|Overall Study|Death|1|||
160734735|NCT04439214|580407895|FG000|Overall Study|Withdrawal by Subject|2|||
160734736|NCT04439214|580407895|FG000|Overall Study|Declining health|1|||
160734737|NCT04439214|580407895|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
160734738|NCT04439214|580407895|FG000|Overall Study|Ineligible|5|||
160734739|NCT04013672|580407897|FG000|Overall Study|Withdrawal by Subject|3|||
160734740|NCT04013672|580407898|FG001|Overall Study|Withdrawal by Subject|0|||
160734741|NCT04013672|580407897|FG000|Overall Study|Death|1|||
160734742|NCT04013672|580407898|FG001|Overall Study|Death|0|||
160734743|NCT04013672|580407897|FG000|Overall Study|Physician Decision|5|||
160734744|NCT04013672|580407898|FG001|Overall Study|Physician Decision|0|||
160734745|NCT00022698|580407899|FG000|Overall Study|Adverse Event|5|||
160734746|NCT00022698|580407900|FG001|Overall Study|Adverse Event|9|||
160734747|NCT00022698|580407899|FG000|Overall Study|Death|0|||
160734748|NCT00022698|580407900|FG001|Overall Study|Death|2|||
160734749|NCT00022698|580407899|FG000|Overall Study|Failure to return|0|||
160734750|NCT00022698|580407900|FG001|Overall Study|Failure to return|1|||
160734751|NCT00022698|580407899|FG000|Overall Study|Refused treatment|0|||
160734752|NCT00022698|580407900|FG001|Overall Study|Refused treatment|2|||
160734753|NCT00022698|580407899|FG000|Overall Study|Insufficient therapeutic response|2|||
160734754|NCT00022698|580407900|FG001|Overall Study|Insufficient therapeutic response|14|||
160734755|NCT00022698|580407899|FG000|Overall Study|Administrative /other|1|||
160734756|NCT00022698|580407900|FG001|Overall Study|Administrative /other|7|||
160734757|NCT01493284|580407908|FG000|Overall Study|Death|29|||
160734758|NCT01493284|580407908|FG000|Overall Study|Withdrawal by Subject|32|||
160734759|NCT05903924|580409938|FG000|Overall Study|Lost to Follow-up|1|||
160734760|NCT05903924|580409939|FG001|Overall Study|Lost to Follow-up|0|||
160734761|NCT05903924|580409940|FG002|Overall Study|Lost to Follow-up|0|||
160734762|NCT04338269|580409941|FG000|Overall Study|Death|86|||
160734763|NCT04338269|580409942|FG001|Overall Study|Death|89|||
160734764|NCT04338269|580409941|FG000|Overall Study|Lost to Follow-up|1|||
160734765|NCT04338269|580409942|FG001|Overall Study|Lost to Follow-up|2|||
160734766|NCT04338269|580409941|FG000|Overall Study|Physician Decision|1|||
160734767|NCT04338269|580409942|FG001|Overall Study|Physician Decision|0|||
160734768|NCT04338269|580409941|FG000|Overall Study|Withdrawal by Subject|14|||
160734769|NCT04338269|580409942|FG001|Overall Study|Withdrawal by Subject|11|||
160734770|NCT04934189|580409943|FG000|Overall Study|Lost to Follow-up|4|||
160734771|NCT04934189|580409943|FG000|Overall Study|Withdrawal by Subject|17|||
160734772|NCT02002533|580409946|FG000|Overall Study|Withdrawal by Subject|6|||
160734773|NCT02002533|580409947|FG001|Overall Study|Withdrawal by Subject|13|||
160734774|NCT02002533|580409946|FG000|Overall Study|Protocol Violation|0|||
160734775|NCT02002533|580409947|FG001|Overall Study|Protocol Violation|1|||
160734776|NCT02002533|580409946|FG000|Overall Study|Adverse Event|0|||
160734777|NCT02002533|580409947|FG001|Overall Study|Adverse Event|3|||
160734778|NCT02002533|580409946|FG000|Overall Study|Lost to Follow-up|0|||
160734779|NCT02002533|580409947|FG001|Overall Study|Lost to Follow-up|1|||
160734780|NCT03408444|580409956|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
160734781|NCT03408444|580409957|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
160734782|NCT03408444|580409958|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
160734783|NCT03408444|580409959|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
160734784|NCT03408444|580409956|FG000|Overall Study|Lens Discomfort|0|||
160734785|NCT03408444|580409957|FG001|Overall Study|Lens Discomfort|1|||
160734786|NCT03408444|580409958|FG002|Overall Study|Lens Discomfort|0|||
160734787|NCT03408444|580409959|FG003|Overall Study|Lens Discomfort|0|||
160734788|NCT03408444|580409956|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
160734789|NCT03408444|580409957|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
160734790|NCT03408444|580409958|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
160734791|NCT03408444|580409959|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
160734792|NCT03408444|580409956|FG000|Overall Study|Withdrawal by Subject|0|||
160734793|NCT03408444|580409957|FG001|Overall Study|Withdrawal by Subject|2|||
160734794|NCT03408444|580409958|FG002|Overall Study|Withdrawal by Subject|3|||
160734795|NCT03408444|580409959|FG003|Overall Study|Withdrawal by Subject|0|||
160734796|NCT03408444|580409956|FG000|Overall Study|Lost to Follow-up|0|||
160734797|NCT03408444|580409957|FG001|Overall Study|Lost to Follow-up|0|||
160734798|NCT03408444|580409958|FG002|Overall Study|Lost to Follow-up|1|||
160734799|NCT03408444|580409959|FG003|Overall Study|Lost to Follow-up|0|||
160734800|NCT03408444|580409956|FG000|Overall Study|Adverse Event|0|||
160734801|NCT03408444|580409957|FG001|Overall Study|Adverse Event|0|||
160734802|NCT03408444|580409958|FG002|Overall Study|Adverse Event|0|||
160734803|NCT03408444|580409959|FG003|Overall Study|Adverse Event|1|||
160734804|NCT03408444|580409956|FG000|Overall Study|Lens Handling Difficulties|0|||
160734805|NCT03408444|580409957|FG001|Overall Study|Lens Handling Difficulties|0|||
160734806|NCT03408444|580409958|FG002|Overall Study|Lens Handling Difficulties|1|||
160734807|NCT03408444|580409959|FG003|Overall Study|Lens Handling Difficulties|0|||
160734808|NCT03408444|580409956|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
160734809|NCT03408444|580409957|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
160734810|NCT03408444|580409958|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
160734811|NCT03408444|580409959|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
160734812|NCT02682823|580409960|FG000|Overall Study|Withdrawal by Subject|0|||
160734813|NCT02682823|580409961|FG001|Overall Study|Withdrawal by Subject|0|||
160734814|NCT02682823|580409962|FG002|Overall Study|Withdrawal by Subject|1|||
160734815|NCT02682823|580409963|FG003|Overall Study|Withdrawal by Subject|0|||
160734816|NCT02682823|580409964|FG004|Overall Study|Withdrawal by Subject|1|||
160734817|NCT02682823|580409960|FG000|Overall Study|Protocol Deviation|0|||
160734818|NCT02682823|580409961|FG001|Overall Study|Protocol Deviation|1|||
160734819|NCT02682823|580409962|FG002|Overall Study|Protocol Deviation|0|||
160734820|NCT02682823|580409963|FG003|Overall Study|Protocol Deviation|0|||
160734821|NCT02682823|580409964|FG004|Overall Study|Protocol Deviation|0|||
160734822|NCT02682823|580409960|FG000|Overall Study|Adverse Event|0|||
160734823|NCT02682823|580409961|FG001|Overall Study|Adverse Event|0|||
160734824|NCT02682823|580409962|FG002|Overall Study|Adverse Event|0|||
160734825|NCT02682823|580409963|FG003|Overall Study|Adverse Event|1|||
160734826|NCT02682823|580409964|FG004|Overall Study|Adverse Event|0|||
160734827|NCT02353442|580409967|FG000|Overall Study|Withdrawal by Subject|3|||
160734828|NCT02353442|580409968|FG001|Overall Study|Withdrawal by Subject|4|||
160734829|NCT00782184|580409969|FG000|Overall Study|Adverse Event|1|||
160734830|NCT00782184|580409970|FG001|Overall Study|Adverse Event|2|||
160734831|NCT00782184|580409969|FG000|Overall Study|Protocol Violation|0|||
160734832|NCT00782184|580409970|FG001|Overall Study|Protocol Violation|1|||
160734833|NCT00782184|580409969|FG000|Overall Study|Withdrawal by Subject|3|||
160734834|NCT00782184|580409970|FG001|Overall Study|Withdrawal by Subject|2|||
160734835|NCT01075646|580409971|FG000|Overall Study|Lost to Follow-up|4|||
160734836|NCT01075646|580409972|FG001|Overall Study|Lost to Follow-up|3|||
160734837|NCT01075646|580409973|FG002|Overall Study|Lost to Follow-up|1|||
160734838|NCT01075646|580409974|FG003|Overall Study|Lost to Follow-up|2|||
160734839|NCT02004886|580409978|FG000|Overall Study|Adverse Event|0|||
160734840|NCT02004886|580409979|FG001|Overall Study|Adverse Event|1|||
160734841|NCT02004886|580409980|FG002|Overall Study|Adverse Event|0|||
160734842|NCT02004886|580409981|FG003|Overall Study|Adverse Event|0|||
160734843|NCT02004886|580409978|FG000|Overall Study|Unable to attend future visits|1|||
160734844|NCT02004886|580409979|FG001|Overall Study|Unable to attend future visits|0|||
160734845|NCT02004886|580409980|FG002|Overall Study|Unable to attend future visits|0|||
160734846|NCT02004886|580409981|FG003|Overall Study|Unable to attend future visits|0|||
160734847|NCT02892422|580409982|FG000|Overall Study|Enrolled not treated|4|||
160734848|NCT02892422|580409982|FG000|Overall Study|Adverse Event|38|||
160734849|NCT02892422|580409982|FG000|Overall Study|Lack of Efficacy|32|||
160734850|NCT02892422|580409982|FG000|Overall Study|Non-compliance with study drug|11|||
160734851|NCT02892422|580409982|FG000|Overall Study|Protocol Violation|4|||
160734852|NCT02892422|580409982|FG000|Overall Study|Withdrawal by Subject|56|||
160734853|NCT02892422|580409982|FG000|Overall Study|Lost to Follow-up|5|||
160734854|NCT02892422|580409982|FG000|Overall Study|sponsor information 16159A results|21|||
160734855|NCT02892422|580409982|FG000|Overall Study|withdrawal of consent|13|||
160734856|NCT02892422|580409982|FG000|Overall Study|exclusion criteria met|3|||
160734857|NCT02892422|580409982|FG000|Overall Study|moving elsewhere|4|||
160734858|NCT02892422|580409982|FG000|Overall Study|non-compliance|10|||
160734859|NCT02892422|580409982|FG000|Overall Study|patient legally incapable|1|||
160734860|NCT02892422|580409982|FG000|Overall Study|patient decision|7|||
160734861|NCT02892422|580409982|FG000|Overall Study|Investigator decision|1|||
160734862|NCT02855359|580409983|FG000|Overall Study|Death|2|||
160734863|NCT02855359|580409984|FG001|Overall Study|Death|2|||
160734864|NCT02855359|580409985|FG002|Overall Study|Death|0|||
160734865|NCT02855359|580409986|FG003|Overall Study|Death|0|||
160734866|NCT02855359|580409983|FG000|Overall Study|Study Termination by Sponsor|9|||
160734867|NCT02855359|580409984|FG001|Overall Study|Study Termination by Sponsor|11|||
160734868|NCT02855359|580409985|FG002|Overall Study|Study Termination by Sponsor|0|||
160734869|NCT02855359|580409986|FG003|Overall Study|Study Termination by Sponsor|0|||
160734870|NCT03155178|580409987|FG000|Overall Study|Did not meet treatment day baseline|7|||
160734871|NCT03155178|580409988|FG001|Overall Study|Did not meet treatment day baseline|7|||
160734872|NCT03155178|580409989|FG002|Overall Study|Did not meet treatment day baseline|7|||
160734873|NCT03155178|580409990|FG003|Overall Study|Did not meet treatment day baseline|7|||
160734874|NCT02833844|580409991|FG000|Double-Blind Period|Withdrawal by Subject|2|||
160734875|NCT02833844|580409992|FG001|Double-Blind Period|Withdrawal by Subject|3|||
160734876|NCT02833844|580409991|FG000|Double-Blind Period|Protocol Violation|0|||
160734877|NCT02833844|580409992|FG001|Double-Blind Period|Protocol Violation|4|||
160734878|NCT02833844|580409991|FG000|Open-Label Period|Death|0|||
160734879|NCT02833844|580409992|FG001|Open-Label Period|Death|2|||
160734880|NCT02833844|580409991|FG000|Open-Label Period|Lost to Follow-up|1|||
160734881|NCT02833844|580409992|FG001|Open-Label Period|Lost to Follow-up|0|||
160734882|NCT02833844|580409991|FG000|Open-Label Period|Withdrawal by Subject|1|||
160734883|NCT02833844|580409992|FG001|Open-Label Period|Withdrawal by Subject|0|||
160734884|NCT04323306|580409993|FG000|Overall Study|Physician Decision|1|||
160734885|NCT04323306|580409994|FG001|Overall Study|Physician Decision|0|||
160734886|NCT04323306|580409995|FG002|Overall Study|Physician Decision|0|||
160734887|NCT04323306|580409996|FG003|Overall Study|Physician Decision|0|||
160734888|NCT04323306|580409997|FG004|Overall Study|Physician Decision|0|||
160734889|NCT04323306|580409998|FG005|Overall Study|Physician Decision|0|||
160734890|NCT04323306|580409999|FG006|Overall Study|Physician Decision|0|||
160734891|NCT04323306|580410000|FG007|Overall Study|Physician Decision|0|||
160734892|NCT04323306|580410001|FG008|Overall Study|Physician Decision|0|||
160734893|NCT04323306|580409993|FG000|Overall Study|Withdrawal by Subject|0|||
160734894|NCT04323306|580409994|FG001|Overall Study|Withdrawal by Subject|0|||
160734895|NCT04323306|580409995|FG002|Overall Study|Withdrawal by Subject|0|||
160734896|NCT04323306|580409996|FG003|Overall Study|Withdrawal by Subject|0|||
160734897|NCT04323306|580409997|FG004|Overall Study|Withdrawal by Subject|0|||
160734898|NCT04323306|580409998|FG005|Overall Study|Withdrawal by Subject|1|||
160734899|NCT04323306|580409999|FG006|Overall Study|Withdrawal by Subject|3|||
160734900|NCT04323306|580410000|FG007|Overall Study|Withdrawal by Subject|0|||
160734901|NCT04323306|580410001|FG008|Overall Study|Withdrawal by Subject|1|||
160734902|NCT00089778|580410002|FG000|Overall Study|Protocol Violation|0|||
160734903|NCT00089778|580410003|FG001|Overall Study|Protocol Violation|0|||
160734904|NCT00089778|580410004|FG002|Overall Study|Protocol Violation|1|||
160734905|NCT02347891|580410013|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
160734906|NCT02347891|580410014|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
160734907|NCT02347891|580410013|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
160734908|NCT02347891|580410014|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
160734909|NCT02447497|580410015|FG000|Overall Study|Did not meet treatment day baseline.|6|||
160734910|NCT02447497|580410016|FG001|Overall Study|Did not meet treatment day baseline.|5|||
160734911|NCT02447497|580410017|FG002|Overall Study|Did not meet treatment day baseline.|2|||
160734912|NCT02447497|580410018|FG003|Overall Study|Did not meet treatment day baseline.|2|||
160734913|NCT02447497|580410015|FG000|Overall Study|Dressing was compromised|0|||
160734914|NCT02447497|580410016|FG001|Overall Study|Dressing was compromised|1|||
160734915|NCT02447497|580410017|FG002|Overall Study|Dressing was compromised|0|||
160734916|NCT02447497|580410018|FG003|Overall Study|Dressing was compromised|0|||
160734917|NCT02017912|580410019|FG000|Overall Study|Withdrawal by Subject|2|||
160734918|NCT02017912|580410020|FG001|Overall Study|Withdrawal by Subject|1|||
160734919|NCT02017912|580410019|FG000|Overall Study|miscellaneous|1|||
160734920|NCT02017912|580410020|FG001|Overall Study|miscellaneous|1|||
160734921|NCT04569968|580410021|FG000|Overall Study|Lost to Follow-up|2|||
160734922|NCT04569968|580410022|FG001|Overall Study|Lost to Follow-up|5|||
160734923|NCT04569968|580410021|FG000|Overall Study|Story of head and/or neck surgery|2|||
160734924|NCT04569968|580410022|FG001|Overall Study|Story of head and/or neck surgery|2|||
160734925|NCT04569968|580410021|FG000|Overall Study|Time of stroke onset|8|||
160734926|NCT04569968|580410022|FG001|Overall Study|Time of stroke onset|7|||
160734927|NCT04569968|580410021|FG000|Overall Study|Type of strokr|12|||
160734928|NCT04569968|580410022|FG001|Overall Study|Type of strokr|8|||
160734929|NCT04569968|580410021|FG000|Overall Study|Cooperation|8|||
160734930|NCT04569968|580410022|FG001|Overall Study|Cooperation|8|||
160734931|NCT04569968|580410021|FG000|Overall Study|Age interval|17|||
160734932|NCT04569968|580410022|FG001|Overall Study|Age interval|6|||
160734933|NCT04569968|580410021|FG000|Overall Study|Denial of participation to the study|0|||
160734934|NCT04569968|580410022|FG001|Overall Study|Denial of participation to the study|3|||
160734935|NCT04569968|580410021|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
160734936|NCT04569968|580410022|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
160734937|NCT04569968|580410021|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
160734938|NCT04569968|580410022|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
160734939|NCT04569968|580410021|FG000|Overall Study|Quarantine|1|||
160734940|NCT04569968|580410022|FG001|Overall Study|Quarantine|0|||
160734941|NCT04569968|580410021|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
160734942|NCT04569968|580410022|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
160734943|NCT04569968|580410021|FG000|Overall Study|Repetitive stroke|8|||
160734944|NCT04569968|580410022|FG001|Overall Study|Repetitive stroke|0|||
160734945|NCT04569968|580410021|FG000|Overall Study|Insufficient mastication|1|||
160734946|NCT04569968|580410022|FG001|Overall Study|Insufficient mastication|0|||
160734947|NCT04569968|580410021|FG000|Overall Study|Infection|1|||
160734948|NCT04569968|580410022|FG001|Overall Study|Infection|0|||
160734949|NCT00727844|580410023|FG000|Initial Randomization|Physician Decision|2|||
160734950|NCT00727844|580410024|FG001|Initial Randomization|Physician Decision|0|||
160734951|NCT00727844|580410025|FG002|Initial Randomization|Physician Decision|0|||
160734952|NCT00727844|580410026|FG003|Initial Randomization|Physician Decision|0|||
160734953|NCT00985959|580410030|FG000|Overall Study|Adverse Event|0|||
160734954|NCT00985959|580410031|FG001|Overall Study|Adverse Event|0|||
160734955|NCT00985959|580410032|FG002|Overall Study|Adverse Event|19|||
160734956|NCT00985959|580410030|FG000|Overall Study|Withdrawal by Subject|0|||
160734957|NCT00985959|580410031|FG001|Overall Study|Withdrawal by Subject|0|||
160734958|NCT00985959|580410032|FG002|Overall Study|Withdrawal by Subject|8|||
160734959|NCT00985959|580410030|FG000|Overall Study|Progressive disease|1|||
160734960|NCT00985959|580410031|FG001|Overall Study|Progressive disease|2|||
160734961|NCT00985959|580410032|FG002|Overall Study|Progressive disease|8|||
160734962|NCT00985959|580410030|FG000|Overall Study|Unrecovered toxicity|0|||
160734963|NCT00985959|580410031|FG001|Overall Study|Unrecovered toxicity|0|||
160734964|NCT00985959|580410032|FG002|Overall Study|Unrecovered toxicity|7|||
160734965|NCT00985959|580410030|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
160734966|NCT00985959|580410031|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
160734967|NCT00985959|580410032|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
160734968|NCT00985959|580410030|FG000|Overall Study|Complete response observed over 2 cycles|0|||
160734969|NCT00985959|580410031|FG001|Overall Study|Complete response observed over 2 cycles|1|||
160734970|NCT00985959|580410032|FG002|Overall Study|Complete response observed over 2 cycles|4|||
160734971|NCT00985959|580410030|FG000|Overall Study|Other|0|||
160734972|NCT00985959|580410031|FG001|Overall Study|Other|0|||
160734973|NCT00985959|580410032|FG002|Overall Study|Other|11|||
160734974|NCT00979420|580410033|FG000|Overall Study|Adverse Event|1|||
160734975|NCT00979420|580410034|FG001|Overall Study|Adverse Event|0|||
160734976|NCT00979420|580410035|FG002|Overall Study|Adverse Event|0|||
160734977|NCT00979420|580410036|FG003|Overall Study|Adverse Event|0|||
160734978|NCT00979420|580410033|FG000|Overall Study|Lack of Efficacy|3|||
160734979|NCT00979420|580410034|FG001|Overall Study|Lack of Efficacy|0|||
160734980|NCT00979420|580410035|FG002|Overall Study|Lack of Efficacy|1|||
160734981|NCT00979420|580410036|FG003|Overall Study|Lack of Efficacy|1|||
160734982|NCT00979420|580410033|FG000|Overall Study|Other reasons not related to Viramune|3|||
160734983|NCT00979420|580410034|FG001|Overall Study|Other reasons not related to Viramune|0|||
160734984|NCT00979420|580410035|FG002|Overall Study|Other reasons not related to Viramune|0|||
160734985|NCT00979420|580410036|FG003|Overall Study|Other reasons not related to Viramune|1|||
160734986|NCT01054196|580410037|FG000|Overall Study|Physician Decision|0|||
160734987|NCT01054196|580410038|FG001|Overall Study|Physician Decision|0|||
160734988|NCT01054196|580410039|FG002|Overall Study|Physician Decision|0|||
160734989|NCT01054196|580410040|FG003|Overall Study|Physician Decision|1|||
160734990|NCT01054196|580410041|FG004|Overall Study|Physician Decision|0|||
160734991|NCT01054196|580410042|FG005|Overall Study|Physician Decision|0|||
160734992|NCT01054196|580410043|FG006|Overall Study|Physician Decision|1|||
160734993|NCT03843632|580410048|FG000|Overall Study|Withdrawal by Subject|1|||
160734994|NCT03843632|580410049|FG001|Overall Study|Withdrawal by Subject|0|||
160734995|NCT03843632|580410050|FG002|Overall Study|Withdrawal by Subject|0|||
160734996|NCT03843632|580410051|FG003|Overall Study|Withdrawal by Subject|0|||
160734997|NCT01820572|580410052|FG000|Randomization|Not Treated|2|||
160734998|NCT01820572|580410053|FG001|Randomization|Not Treated|1|||
160734999|NCT01820572|580410052|FG000|Treatment Period|Adverse Event|12|||
160735000|NCT01820572|580410053|FG001|Treatment Period|Adverse Event|7|||
160735001|NCT01820572|580410052|FG000|Treatment Period|Death|3|||
160735002|NCT01820572|580410053|FG001|Treatment Period|Death|3|||
160735003|NCT01820572|580410052|FG000|Treatment Period|Lack of Efficacy|1|||
160735004|NCT01820572|580410053|FG001|Treatment Period|Lack of Efficacy|0|||
160735005|NCT01820572|580410052|FG000|Treatment Period|poor/non compliance|0|||
160735006|NCT01820572|580410053|FG001|Treatment Period|poor/non compliance|3|||
160735007|NCT01820572|580410052|FG000|Treatment Period|request to discontinue|6|||
160735008|NCT01820572|580410053|FG001|Treatment Period|request to discontinue|11|||
160735009|NCT01820572|580410052|FG000|Treatment Period|No longer meets study criteria|3|||
160735010|NCT01820572|580410053|FG001|Treatment Period|No longer meets study criteria|10|||
160735011|NCT01820572|580410052|FG000|Treatment Period|withdrew consent|1|||
160735012|NCT01820572|580410053|FG001|Treatment Period|withdrew consent|2|||
160735013|NCT00595517|580410054|FG000|Overall Study|Adverse Event|6|||
160735014|NCT00595517|580410054|FG000|Overall Study|Withdrawal by Subject|4|||
160735015|NCT00595517|580410054|FG000|Overall Study|Protocol Violation|2|||
160735016|NCT00595517|580410054|FG000|Overall Study|Recurrence of ulcer|5|||
160735017|NCT00595517|580410054|FG000|Overall Study|usage of prohibited treatment|1|||
160735018|NCT00595517|580410054|FG000|Overall Study|No intention to attend regularly|1|||
160735019|NCT00387010|580410057|FG000|Dose Titration Period|Adverse Event|12|||
160735020|NCT00387010|580410057|FG000|Dose Titration Period|Lack of Efficacy|5|||
160735021|NCT00387010|580410057|FG000|Dose Titration Period|Withdrawal by Subject|3|||
160735022|NCT00387010|580410057|FG000|Dose Titration Period|Protocol Violation|1|||
160735023|NCT00387010|580410057|FG000|Dose Titration Period|Lost to Follow-up|2|||
160735024|NCT00387010|580410057|FG000|Dose Titration Period|Noncompliance with study medication|8|||
160735025|NCT00387010|580410057|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
160735026|NCT00387010|580410057|FG000|Treatment Period|Adverse Event|4|||
160735027|NCT00387010|580410057|FG000|Treatment Period|Withdrawal by Subject|1|||
160735028|NCT00387010|580410057|FG000|Treatment Period|Noncompliance with study medication|2|||
160735029|NCT00387010|580410057|FG000|Treatment Period|Noncompliance with study procedures|3|||
160735030|NCT00387010|580410057|FG000|Treatment Period|Participant reported study drug stolen|1|||
160735031|NCT01167881|580410060|FG000|Overall Study|Adverse Event|47|||
160735032|NCT01167881|580410061|FG001|Overall Study|Adverse Event|51|||
160735033|NCT01167881|580410060|FG000|Overall Study|Lack of Efficacy|4|||
160735034|NCT01167881|580410061|FG001|Overall Study|Lack of Efficacy|7|||
160735035|NCT01167881|580410060|FG000|Overall Study|Non compliant with protocol|9|||
160735036|NCT01167881|580410061|FG001|Overall Study|Non compliant with protocol|18|||
160735037|NCT01167881|580410060|FG000|Overall Study|Lost to Follow-up|19|||
160735038|NCT01167881|580410061|FG001|Overall Study|Lost to Follow-up|20|||
160735039|NCT01167881|580410060|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
160735040|NCT01167881|580410061|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
160735041|NCT01167881|580410060|FG000|Overall Study|Not treated|4|||
160735042|NCT01167881|580410061|FG001|Overall Study|Not treated|0|||
160735043|NCT01167881|580410060|FG000|Overall Study|Other not defined above|31|||
160735044|NCT01167881|580410061|FG001|Overall Study|Other not defined above|55|||
160735045|NCT02107859|580410062|FG000|Overall Study|Withdrawal by Subject|14|||
160735046|NCT02107859|580410062|FG000|Overall Study|Adverse Event|3|||
160735047|NCT02107859|580410062|FG000|Overall Study|Study closure|41|||
160735048|NCT02107859|580410062|FG000|Overall Study|Other than specified|3|||
160735049|NCT02235077|580410063|FG000|Overall Study|Death|5|||
160735050|NCT02235077|580410064|FG001|Overall Study|Death|7|||
160735051|NCT02235077|580410063|FG000|Overall Study|Lost to Follow-up|5|||
160735052|NCT02235077|580410064|FG001|Overall Study|Lost to Follow-up|6|||
160735053|NCT02235077|580410063|FG000|Overall Study|Withdrawal by Subject|8|||
160735054|NCT02235077|580410064|FG001|Overall Study|Withdrawal by Subject|5|||
160735055|NCT02235077|580410063|FG000|Overall Study|Physician Decision|0|||
160735056|NCT02235077|580410064|FG001|Overall Study|Physician Decision|1|||
160735057|NCT03852628|580410065|FG000|Overall Study|Lost to Follow-up|7|||
160735058|NCT03852628|580410066|FG001|Overall Study|Lost to Follow-up|6|||
160735059|NCT03852628|580410065|FG000|Overall Study|Lack of Efficacy|6|||
160735060|NCT03852628|580410066|FG001|Overall Study|Lack of Efficacy|6|||
160735061|NCT02847494|580410074|FG000|Overall Study|Lost to Follow-up|8|||
160735062|NCT02847494|580410075|FG001|Overall Study|Lost to Follow-up|5|||
160735063|NCT01668173|580410085|FG000|Overall Study|Adverse Event|3|||
160735064|NCT01668173|580410085|FG000|Overall Study|Trial suspension|4|||
160735065|NCT01295827|580410086|FG000|Overall Study|Adverse Event|1|||
160735066|NCT01295827|580410087|FG001|Overall Study|Adverse Event|2|||
160735067|NCT01295827|580410088|FG002|Overall Study|Adverse Event|2|||
160735068|NCT01295827|580410089|FG003|Overall Study|Adverse Event|1|||
160735069|NCT01295827|580410090|FG004|Overall Study|Adverse Event|1|||
160735070|NCT01295827|580410091|FG005|Overall Study|Adverse Event|4|||
160735071|NCT01295827|580410092|FG006|Overall Study|Adverse Event|15|||
160735072|NCT01295827|580410093|FG007|Overall Study|Adverse Event|49|||
160735073|NCT01295827|580410094|FG008|Overall Study|Adverse Event|22|||
160735074|NCT01295827|580410095|FG009|Overall Study|Adverse Event|7|||
160735075|NCT01295827|580410096|FG010|Overall Study|Adverse Event|50|||
160735076|NCT01295827|580410097|FG011|Overall Study|Adverse Event|21|||
160735077|NCT01295827|580410098|FG012|Overall Study|Adverse Event|0|||
160735078|NCT01295827|580410099|FG013|Overall Study|Adverse Event|0|||
160735079|NCT01295827|580410100|FG014|Overall Study|Adverse Event|0|||
160735080|NCT01295827|580410086|FG000|Overall Study|Lost to Follow-up|0|||
160735081|NCT01295827|580410087|FG001|Overall Study|Lost to Follow-up|0|||
160735082|NCT01295827|580410088|FG002|Overall Study|Lost to Follow-up|3|||
160735083|NCT01295827|580410089|FG003|Overall Study|Lost to Follow-up|0|||
160735084|NCT01295827|580410090|FG004|Overall Study|Lost to Follow-up|1|||
160735085|NCT01295827|580410091|FG005|Overall Study|Lost to Follow-up|0|||
160735086|NCT01295827|580410092|FG006|Overall Study|Lost to Follow-up|4|||
160735087|NCT01295827|580410093|FG007|Overall Study|Lost to Follow-up|8|||
160735088|NCT01295827|580410094|FG008|Overall Study|Lost to Follow-up|7|||
160735089|NCT01295827|580410095|FG009|Overall Study|Lost to Follow-up|4|||
160735090|NCT01295827|580410096|FG010|Overall Study|Lost to Follow-up|7|||
160735091|NCT01295827|580410097|FG011|Overall Study|Lost to Follow-up|3|||
160735092|NCT01295827|580410098|FG012|Overall Study|Lost to Follow-up|0|||
160735093|NCT01295827|580410099|FG013|Overall Study|Lost to Follow-up|0|||
160735094|NCT01295827|580410100|FG014|Overall Study|Lost to Follow-up|0|||
160735095|NCT01295827|580410086|FG000|Overall Study|Not Reported|0|||
160735096|NCT01295827|580410087|FG001|Overall Study|Not Reported|0|||
160735097|NCT01295827|580410088|FG002|Overall Study|Not Reported|0|||
160735098|NCT01295827|580410089|FG003|Overall Study|Not Reported|1|||
160735099|NCT01295827|580410090|FG004|Overall Study|Not Reported|0|||
160735100|NCT01295827|580410091|FG005|Overall Study|Not Reported|0|||
160735101|NCT01295827|580410092|FG006|Overall Study|Not Reported|24|||
160735102|NCT01295827|580410093|FG007|Overall Study|Not Reported|58|||
160735103|NCT01295827|580410094|FG008|Overall Study|Not Reported|41|||
160735104|NCT01295827|580410095|FG009|Overall Study|Not Reported|2|||
160735105|NCT01295827|580410096|FG010|Overall Study|Not Reported|23|||
160735106|NCT01295827|580410097|FG011|Overall Study|Not Reported|13|||
160735107|NCT01295827|580410098|FG012|Overall Study|Not Reported|0|||
160735108|NCT01295827|580410099|FG013|Overall Study|Not Reported|0|||
160735109|NCT01295827|580410100|FG014|Overall Study|Not Reported|0|||
160735110|NCT01295827|580410086|FG000|Overall Study|Progressive Disease|2|||
160735111|NCT01295827|580410087|FG001|Overall Study|Progressive Disease|1|||
160735112|NCT01295827|580410088|FG002|Overall Study|Progressive Disease|5|||
160735113|NCT01295827|580410089|FG003|Overall Study|Progressive Disease|2|||
160735114|NCT01295827|580410090|FG004|Overall Study|Progressive Disease|0|||
160735115|NCT01295827|580410091|FG005|Overall Study|Progressive Disease|1|||
160735116|NCT01295827|580410092|FG006|Overall Study|Progressive Disease|87|||
160735117|NCT01295827|580410093|FG007|Overall Study|Progressive Disease|144|||
160735118|NCT01295827|580410094|FG008|Overall Study|Progressive Disease|85|||
160735119|NCT01295827|580410095|FG009|Overall Study|Progressive Disease|40|||
160735120|NCT01295827|580410096|FG010|Overall Study|Progressive Disease|175|||
160735121|NCT01295827|580410097|FG011|Overall Study|Progressive Disease|136|||
160735122|NCT01295827|580410098|FG012|Overall Study|Progressive Disease|0|||
160735123|NCT01295827|580410099|FG013|Overall Study|Progressive Disease|0|||
160735124|NCT01295827|580410100|FG014|Overall Study|Progressive Disease|0|||
160735125|NCT01295827|580410086|FG000|Overall Study|Screen Failure|0|||
160735126|NCT01295827|580410087|FG001|Overall Study|Screen Failure|0|||
160735127|NCT01295827|580410088|FG002|Overall Study|Screen Failure|0|||
160735128|NCT01295827|580410089|FG003|Overall Study|Screen Failure|0|||
160735129|NCT01295827|580410090|FG004|Overall Study|Screen Failure|0|||
160735130|NCT01295827|580410091|FG005|Overall Study|Screen Failure|0|||
160735131|NCT01295827|580410092|FG006|Overall Study|Screen Failure|2|||
160735132|NCT01295827|580410093|FG007|Overall Study|Screen Failure|2|||
160735133|NCT01295827|580410094|FG008|Overall Study|Screen Failure|2|||
160735134|NCT01295827|580410095|FG009|Overall Study|Screen Failure|0|||
160735135|NCT01295827|580410096|FG010|Overall Study|Screen Failure|1|||
160735136|NCT01295827|580410097|FG011|Overall Study|Screen Failure|0|||
160735137|NCT01295827|580410098|FG012|Overall Study|Screen Failure|0|||
160735138|NCT01295827|580410099|FG013|Overall Study|Screen Failure|0|||
160735139|NCT01295827|580410100|FG014|Overall Study|Screen Failure|0|||
160735140|NCT01295827|580410086|FG000|Overall Study|Withdrawal by Subject|1|||
160735141|NCT01295827|580410087|FG001|Overall Study|Withdrawal by Subject|0|||
160735142|NCT01295827|580410088|FG002|Overall Study|Withdrawal by Subject|2|||
160735143|NCT01295827|580410089|FG003|Overall Study|Withdrawal by Subject|0|||
160735144|NCT01295827|580410090|FG004|Overall Study|Withdrawal by Subject|0|||
160735145|NCT01295827|580410091|FG005|Overall Study|Withdrawal by Subject|1|||
160735146|NCT01295827|580410092|FG006|Overall Study|Withdrawal by Subject|13|||
160735147|NCT01295827|580410093|FG007|Overall Study|Withdrawal by Subject|35|||
160735148|NCT01295827|580410094|FG008|Overall Study|Withdrawal by Subject|11|||
160735149|NCT01295827|580410095|FG009|Overall Study|Withdrawal by Subject|2|||
160735150|NCT01295827|580410096|FG010|Overall Study|Withdrawal by Subject|18|||
160735151|NCT01295827|580410097|FG011|Overall Study|Withdrawal by Subject|13|||
160735152|NCT01295827|580410098|FG012|Overall Study|Withdrawal by Subject|0|||
160735153|NCT01295827|580410099|FG013|Overall Study|Withdrawal by Subject|0|||
160735154|NCT01295827|580410100|FG014|Overall Study|Withdrawal by Subject|0|||
160735155|NCT01295827|580410086|FG000|Overall Study|Other|0|||
160735156|NCT01295827|580410087|FG001|Overall Study|Other|0|||
160735157|NCT01295827|580410088|FG002|Overall Study|Other|0|||
160735158|NCT01295827|580410089|FG003|Overall Study|Other|0|||
160735159|NCT01295827|580410090|FG004|Overall Study|Other|0|||
160735160|NCT01295827|580410091|FG005|Overall Study|Other|0|||
160735161|NCT01295827|580410092|FG006|Overall Study|Other|1|||
160735162|NCT01295827|580410093|FG007|Overall Study|Other|1|||
160735163|NCT01295827|580410094|FG008|Overall Study|Other|1|||
160735164|NCT01295827|580410095|FG009|Overall Study|Other|0|||
160735165|NCT01295827|580410096|FG010|Overall Study|Other|2|||
160735166|NCT01295827|580410097|FG011|Overall Study|Other|0|||
160735167|NCT01295827|580410098|FG012|Overall Study|Other|0|||
160735168|NCT01295827|580410099|FG013|Overall Study|Other|0|||
160735169|NCT01295827|580410100|FG014|Overall Study|Other|0|||
160735170|NCT00101166|580410101|FG000|Overall Study|progressive disease|10|||
160735171|NCT01868022|580410102|FG000|Overall Study|Withdrawal by Subject|0|||
160735172|NCT01868022|580410103|FG001|Overall Study|Withdrawal by Subject|0|||
160735173|NCT01868022|580410104|FG002|Overall Study|Withdrawal by Subject|1|||
160735174|NCT01868022|580410105|FG003|Overall Study|Withdrawal by Subject|1|||
160735175|NCT01868022|580410106|FG004|Overall Study|Withdrawal by Subject|0|||
160735176|NCT01868022|580410107|FG005|Overall Study|Withdrawal by Subject|0|||
160735177|NCT01868022|580410108|FG006|Overall Study|Withdrawal by Subject|0|||
160735178|NCT01868022|580410109|FG007|Overall Study|Withdrawal by Subject|1|||
160735179|NCT01868022|580410110|FG008|Overall Study|Withdrawal by Subject|0|||
160735180|NCT01868022|580410102|FG000|Overall Study|Adverse Event|0|||
160735181|NCT01868022|580410103|FG001|Overall Study|Adverse Event|0|||
160735182|NCT01868022|580410104|FG002|Overall Study|Adverse Event|0|||
160735183|NCT01868022|580410105|FG003|Overall Study|Adverse Event|0|||
160735184|NCT01868022|580410106|FG004|Overall Study|Adverse Event|2|||
160735185|NCT01868022|580410107|FG005|Overall Study|Adverse Event|0|||
160735186|NCT01868022|580410108|FG006|Overall Study|Adverse Event|0|||
160735187|NCT01868022|580410109|FG007|Overall Study|Adverse Event|2|||
160735188|NCT01868022|580410110|FG008|Overall Study|Adverse Event|2|||
160735189|NCT01868022|580410102|FG000|Overall Study|Physician Decision|0|||
160735190|NCT01868022|580410103|FG001|Overall Study|Physician Decision|0|||
160735191|NCT01868022|580410104|FG002|Overall Study|Physician Decision|0|||
160735192|NCT01868022|580410105|FG003|Overall Study|Physician Decision|0|||
160735193|NCT01868022|580410106|FG004|Overall Study|Physician Decision|0|||
160735194|NCT01868022|580410107|FG005|Overall Study|Physician Decision|1|||
160735195|NCT01868022|580410108|FG006|Overall Study|Physician Decision|0|||
160735196|NCT01868022|580410109|FG007|Overall Study|Physician Decision|2|||
160735197|NCT01868022|580410110|FG008|Overall Study|Physician Decision|0|||
160735198|NCT01868022|580410102|FG000|Overall Study|Study closed/terminated|0|||
160735199|NCT01868022|580410103|FG001|Overall Study|Study closed/terminated|0|||
160735200|NCT01868022|580410104|FG002|Overall Study|Study closed/terminated|0|||
160735201|NCT01868022|580410105|FG003|Overall Study|Study closed/terminated|0|||
160735202|NCT01868022|580410106|FG004|Overall Study|Study closed/terminated|0|||
160735203|NCT01868022|580410107|FG005|Overall Study|Study closed/terminated|0|||
160735204|NCT01868022|580410108|FG006|Overall Study|Study closed/terminated|0|||
160735205|NCT01868022|580410109|FG007|Overall Study|Study closed/terminated|1|||
160735206|NCT01868022|580410110|FG008|Overall Study|Study closed/terminated|0|||
160735207|NCT01868022|580410102|FG000|Overall Study|Ongoing|0|||
160735208|NCT01868022|580410103|FG001|Overall Study|Ongoing|0|||
160735209|NCT01868022|580410104|FG002|Overall Study|Ongoing|0|||
160735210|NCT01868022|580410105|FG003|Overall Study|Ongoing|0|||
160735211|NCT01868022|580410106|FG004|Overall Study|Ongoing|0|||
160735212|NCT01868022|580410107|FG005|Overall Study|Ongoing|0|||
160735213|NCT01868022|580410108|FG006|Overall Study|Ongoing|0|||
160735214|NCT01868022|580410109|FG007|Overall Study|Ongoing|3|||
160735215|NCT01868022|580410110|FG008|Overall Study|Ongoing|0|||
160735216|NCT03226769|580410113|FG000|Overall Study|Withdrawal by Subject|0|||
160735217|NCT03226769|580410114|FG001|Overall Study|Withdrawal by Subject|1|||
160735218|NCT02640677|580410115|FG000|Overall Study|Lost to Follow-up|1|||
160735219|NCT02640677|580410115|FG000|Overall Study|Withdrawal by Subject|1|||
160735220|NCT01684943|580410121|FG000|Overall Study|Inadequate Venous Access|3|||
160735221|NCT01684943|580410122|FG001|Overall Study|Inadequate Venous Access|0|||
160735222|NCT01684943|580410123|FG002|Overall Study|Inadequate Venous Access|0|||
160735223|NCT01684943|580410121|FG000|Overall Study|Principal Investigator Determination|1|||
160735224|NCT01684943|580410122|FG001|Overall Study|Principal Investigator Determination|0|||
160735225|NCT01684943|580410123|FG002|Overall Study|Principal Investigator Determination|0|||
160735226|NCT01684943|580410121|FG000|Overall Study|Excluded from Analysis|1|||
160735227|NCT01684943|580410122|FG001|Overall Study|Excluded from Analysis|1|||
160735228|NCT01684943|580410123|FG002|Overall Study|Excluded from Analysis|1|||
160735229|NCT01684943|580410121|FG000|Overall Study|Lost to Follow-up|3|||
160735230|NCT01684943|580410122|FG001|Overall Study|Lost to Follow-up|0|||
160735231|NCT01684943|580410123|FG002|Overall Study|Lost to Follow-up|0|||
160735232|NCT01684943|580410121|FG000|Overall Study|Planning Pregnancy|1|||
160735233|NCT01684943|580410122|FG001|Overall Study|Planning Pregnancy|0|||
160735234|NCT01684943|580410123|FG002|Overall Study|Planning Pregnancy|0|||
160735235|NCT03489707|580410124|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
160735236|NCT03489707|580410125|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
160735237|NCT03489707|580410124|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
160735238|NCT03489707|580410125|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
160735239|NCT00325156|580410126|FG000|Overall Study|Protocol Violation|8|||
160735240|NCT00325156|580410126|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
160735241|NCT00325156|580410126|FG000|Overall Study|Migrated/moved from study area|12|||
160735242|NCT00325156|580410126|FG000|Overall Study|Adverse event, non-fatal|3|||
160735243|NCT00325156|580410126|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
160735244|NCT00325156|580410126|FG000|Overall Study|Other|1|||
160735245|NCT00325156|580410126|FG000|Overall Study|Withdrawal by Subject|31|||
160735246|NCT04064411|580410127|FG000|Overall Study|Adverse Event|29|||
160735247|NCT04064411|580410128|FG001|Overall Study|Adverse Event|19|||
160735248|NCT04064411|580410127|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
160735249|NCT04064411|580410128|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
160735250|NCT04064411|580410127|FG000|Overall Study|Protocol Deviation|0|||
160735251|NCT04064411|580410128|FG001|Overall Study|Protocol Deviation|2|||
160735252|NCT04064411|580410127|FG000|Overall Study|Withdrawal by Subject|25|||
160735253|NCT04064411|580410128|FG001|Overall Study|Withdrawal by Subject|29|||
160735254|NCT04064411|580410127|FG000|Overall Study|Lost to Follow-up|5|||
160735255|NCT04064411|580410128|FG001|Overall Study|Lost to Follow-up|2|||
160735256|NCT04064411|580410127|FG000|Overall Study|Other than Specified|4|||
160735257|NCT04064411|580410128|FG001|Overall Study|Other than Specified|1|||
160735258|NCT04064411|580410127|FG000|Overall Study|Death|1|||
160735259|NCT04064411|580410128|FG001|Overall Study|Death|0|||
160735260|NCT03512210|580410129|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
160735261|NCT03512210|580410129|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
160735262|NCT03512210|580410129|FG000|Step 2:Post-MINMON|Death|2|||
160735263|NCT03512210|580410129|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
160735264|NCT03512210|580410129|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
160735265|NCT03725761|580410130|FG000|Overall Study|still on study|1|||
160735266|NCT03197467|580411806|FG000|Overall Study|Withdrawal by Subject|1|||
160735267|NCT03666533|580411807|FG000|Overall Study|Lost to Follow-up|2|||
160735268|NCT03666533|580411808|FG001|Overall Study|Lost to Follow-up|2|||
160735269|NCT02017717|580411809|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
160735270|NCT02017717|580411810|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
160735271|NCT02017717|580411811|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
160735272|NCT02017717|580411812|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
160735273|NCT02017717|580411813|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
160735274|NCT02017717|580411814|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
160735275|NCT02017717|580411815|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
160735276|NCT02017717|580411816|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
160735277|NCT02017717|580411817|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
160735278|NCT02017717|580411809|FG000|Before Treatment Period|Participant request to stop therapy|0|||
160735279|NCT02017717|580411810|FG001|Before Treatment Period|Participant request to stop therapy|0|||
160735280|NCT02017717|580411811|FG002|Before Treatment Period|Participant request to stop therapy|0|||
160735281|NCT02017717|580411812|FG003|Before Treatment Period|Participant request to stop therapy|0|||
160735282|NCT02017717|580411813|FG004|Before Treatment Period|Participant request to stop therapy|0|||
160735283|NCT02017717|580411814|FG005|Before Treatment Period|Participant request to stop therapy|0|||
160735284|NCT02017717|580411815|FG006|Before Treatment Period|Participant request to stop therapy|0|||
160735285|NCT02017717|580411816|FG007|Before Treatment Period|Participant request to stop therapy|0|||
160735286|NCT02017717|580411817|FG008|Before Treatment Period|Participant request to stop therapy|5|||
160735287|NCT02017717|580411809|FG000|Before Treatment Period|Participant withdrew consent|0|||
160735288|NCT02017717|580411810|FG001|Before Treatment Period|Participant withdrew consent|0|||
160735289|NCT02017717|580411811|FG002|Before Treatment Period|Participant withdrew consent|0|||
160735290|NCT02017717|580411812|FG003|Before Treatment Period|Participant withdrew consent|0|||
160735291|NCT02017717|580411813|FG004|Before Treatment Period|Participant withdrew consent|0|||
160735292|NCT02017717|580411814|FG005|Before Treatment Period|Participant withdrew consent|0|||
160735293|NCT02017717|580411815|FG006|Before Treatment Period|Participant withdrew consent|2|||
160735294|NCT02017717|580411816|FG007|Before Treatment Period|Participant withdrew consent|0|||
160735295|NCT02017717|580411817|FG008|Before Treatment Period|Participant withdrew consent|11|||
160735296|NCT02017717|580411809|FG000|Before Treatment Period|Lost to Follow-up|0|||
160735297|NCT02017717|580411810|FG001|Before Treatment Period|Lost to Follow-up|0|||
160735298|NCT02017717|580411811|FG002|Before Treatment Period|Lost to Follow-up|0|||
160735299|NCT02017717|580411812|FG003|Before Treatment Period|Lost to Follow-up|0|||
160735300|NCT02017717|580411813|FG004|Before Treatment Period|Lost to Follow-up|0|||
160735301|NCT02017717|580411814|FG005|Before Treatment Period|Lost to Follow-up|0|||
160735302|NCT02017717|580411815|FG006|Before Treatment Period|Lost to Follow-up|0|||
160735303|NCT02017717|580411816|FG007|Before Treatment Period|Lost to Follow-up|0|||
160735304|NCT02017717|580411817|FG008|Before Treatment Period|Lost to Follow-up|1|||
160735305|NCT02017717|580411809|FG000|Before Treatment Period|Participant no longer met criteria|0|||
160735306|NCT02017717|580411810|FG001|Before Treatment Period|Participant no longer met criteria|0|||
160735307|NCT02017717|580411811|FG002|Before Treatment Period|Participant no longer met criteria|0|||
160735308|NCT02017717|580411812|FG003|Before Treatment Period|Participant no longer met criteria|0|||
160735309|NCT02017717|580411813|FG004|Before Treatment Period|Participant no longer met criteria|0|||
160735310|NCT02017717|580411814|FG005|Before Treatment Period|Participant no longer met criteria|1|||
160735311|NCT02017717|580411815|FG006|Before Treatment Period|Participant no longer met criteria|0|||
160735312|NCT02017717|580411816|FG007|Before Treatment Period|Participant no longer met criteria|1|||
160735313|NCT02017717|580411817|FG008|Before Treatment Period|Participant no longer met criteria|2|||
160735314|NCT02017717|580411809|FG000|Before Treatment Period|other reason|0|||
160735315|NCT02017717|580411810|FG001|Before Treatment Period|other reason|0|||
160735316|NCT02017717|580411811|FG002|Before Treatment Period|other reason|0|||
160735317|NCT02017717|580411812|FG003|Before Treatment Period|other reason|0|||
160735318|NCT02017717|580411813|FG004|Before Treatment Period|other reason|0|||
160735319|NCT02017717|580411814|FG005|Before Treatment Period|other reason|0|||
160735320|NCT02017717|580411815|FG006|Before Treatment Period|other reason|0|||
160735321|NCT02017717|580411816|FG007|Before Treatment Period|other reason|0|||
160735322|NCT02017717|580411817|FG008|Before Treatment Period|other reason|1|||
160735323|NCT02017717|580411809|FG000|Treatment Period|Disease progression|7|||
160735324|NCT02017717|580411810|FG001|Treatment Period|Disease progression|9|||
160735325|NCT02017717|580411811|FG002|Treatment Period|Disease progression|12|||
160735326|NCT02017717|580411812|FG003|Treatment Period|Disease progression|20|||
160735327|NCT02017717|580411813|FG004|Treatment Period|Disease progression|26|||
160735328|NCT02017717|580411814|FG005|Treatment Period|Disease progression|16|||
160735329|NCT02017717|580411815|FG006|Treatment Period|Disease progression|22|||
160735330|NCT02017717|580411816|FG007|Treatment Period|Disease progression|165|||
160735331|NCT02017717|580411817|FG008|Treatment Period|Disease progression|135|||
160735332|NCT02017717|580411809|FG000|Treatment Period|Study drug toxicity|3|||
160735333|NCT02017717|580411810|FG001|Treatment Period|Study drug toxicity|0|||
160735334|NCT02017717|580411811|FG002|Treatment Period|Study drug toxicity|1|||
160735335|NCT02017717|580411812|FG003|Treatment Period|Study drug toxicity|4|||
160735336|NCT02017717|580411813|FG004|Treatment Period|Study drug toxicity|4|||
160735337|NCT02017717|580411814|FG005|Treatment Period|Study drug toxicity|5|||
160735338|NCT02017717|580411815|FG006|Treatment Period|Study drug toxicity|3|||
160735339|NCT02017717|580411816|FG007|Treatment Period|Study drug toxicity|7|||
160735340|NCT02017717|580411817|FG008|Treatment Period|Study drug toxicity|11|||
160735341|NCT02017717|580411809|FG000|Treatment Period|Death|0|||
160735342|NCT02017717|580411810|FG001|Treatment Period|Death|0|||
160735343|NCT02017717|580411811|FG002|Treatment Period|Death|1|||
160735344|NCT02017717|580411812|FG003|Treatment Period|Death|0|||
160735345|NCT02017717|580411813|FG004|Treatment Period|Death|0|||
160735346|NCT02017717|580411814|FG005|Treatment Period|Death|2|||
160735347|NCT02017717|580411815|FG006|Treatment Period|Death|0|||
160735348|NCT02017717|580411816|FG007|Treatment Period|Death|0|||
160735349|NCT02017717|580411817|FG008|Treatment Period|Death|0|||
160735350|NCT02017717|580411809|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
160735351|NCT02017717|580411810|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
160735352|NCT02017717|580411811|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
160735353|NCT02017717|580411812|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
160735354|NCT02017717|580411813|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
160735355|NCT02017717|580411814|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
160735356|NCT02017717|580411815|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
160735357|NCT02017717|580411816|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
160735358|NCT02017717|580411817|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
160735359|NCT02017717|580411809|FG000|Treatment Period|Participant request to stop therapy|0|||
160735360|NCT02017717|580411810|FG001|Treatment Period|Participant request to stop therapy|0|||
160735361|NCT02017717|580411811|FG002|Treatment Period|Participant request to stop therapy|3|||
160735362|NCT02017717|580411812|FG003|Treatment Period|Participant request to stop therapy|6|||
160735363|NCT02017717|580411813|FG004|Treatment Period|Participant request to stop therapy|0|||
160735364|NCT02017717|580411814|FG005|Treatment Period|Participant request to stop therapy|2|||
160735365|NCT02017717|580411815|FG006|Treatment Period|Participant request to stop therapy|1|||
160735366|NCT02017717|580411816|FG007|Treatment Period|Participant request to stop therapy|4|||
160735367|NCT02017717|580411817|FG008|Treatment Period|Participant request to stop therapy|7|||
160735368|NCT02017717|580411809|FG000|Treatment Period|Participant withdrew consent|0|||
160735369|NCT02017717|580411810|FG001|Treatment Period|Participant withdrew consent|0|||
160735370|NCT02017717|580411811|FG002|Treatment Period|Participant withdrew consent|1|||
160735371|NCT02017717|580411812|FG003|Treatment Period|Participant withdrew consent|0|||
160735372|NCT02017717|580411813|FG004|Treatment Period|Participant withdrew consent|0|||
160735373|NCT02017717|580411814|FG005|Treatment Period|Participant withdrew consent|2|||
160735374|NCT02017717|580411815|FG006|Treatment Period|Participant withdrew consent|0|||
160735375|NCT02017717|580411816|FG007|Treatment Period|Participant withdrew consent|1|||
160735376|NCT02017717|580411817|FG008|Treatment Period|Participant withdrew consent|4|||
160735377|NCT02017717|580411809|FG000|Treatment Period|Participant no longer met criteria|0|||
160735378|NCT02017717|580411810|FG001|Treatment Period|Participant no longer met criteria|0|||
160735379|NCT02017717|580411811|FG002|Treatment Period|Participant no longer met criteria|0|||
160735380|NCT02017717|580411812|FG003|Treatment Period|Participant no longer met criteria|0|||
160735381|NCT02017717|580411813|FG004|Treatment Period|Participant no longer met criteria|0|||
160735382|NCT02017717|580411814|FG005|Treatment Period|Participant no longer met criteria|0|||
160735383|NCT02017717|580411815|FG006|Treatment Period|Participant no longer met criteria|0|||
160735384|NCT02017717|580411816|FG007|Treatment Period|Participant no longer met criteria|0|||
160735385|NCT02017717|580411817|FG008|Treatment Period|Participant no longer met criteria|1|||
160735386|NCT02017717|580411809|FG000|Treatment Period|Other reasons|0|||
160735387|NCT02017717|580411810|FG001|Treatment Period|Other reasons|0|||
160735388|NCT02017717|580411811|FG002|Treatment Period|Other reasons|0|||
160735389|NCT02017717|580411812|FG003|Treatment Period|Other reasons|1|||
160735390|NCT02017717|580411813|FG004|Treatment Period|Other reasons|0|||
160735391|NCT02017717|580411814|FG005|Treatment Period|Other reasons|1|||
160735392|NCT02017717|580411815|FG006|Treatment Period|Other reasons|1|||
160735393|NCT02017717|580411816|FG007|Treatment Period|Other reasons|1|||
160735394|NCT02017717|580411817|FG008|Treatment Period|Other reasons|1|||
160735395|NCT02017717|580411809|FG000|Treatment Period|Maximum clinical benefit|0|||
160735396|NCT02017717|580411810|FG001|Treatment Period|Maximum clinical benefit|0|||
160735397|NCT02017717|580411811|FG002|Treatment Period|Maximum clinical benefit|0|||
160735398|NCT02017717|580411812|FG003|Treatment Period|Maximum clinical benefit|0|||
160735399|NCT02017717|580411813|FG004|Treatment Period|Maximum clinical benefit|0|||
160735400|NCT02017717|580411814|FG005|Treatment Period|Maximum clinical benefit|0|||
160735401|NCT02017717|580411815|FG006|Treatment Period|Maximum clinical benefit|0|||
160735402|NCT02017717|580411816|FG007|Treatment Period|Maximum clinical benefit|0|||
160735403|NCT02017717|580411817|FG008|Treatment Period|Maximum clinical benefit|1|||
160735404|NCT02017717|580411809|FG000|Treatment Period|Not reported|0|||
160735405|NCT02017717|580411810|FG001|Treatment Period|Not reported|1|||
160735406|NCT02017717|580411811|FG002|Treatment Period|Not reported|0|||
160735407|NCT02017717|580411812|FG003|Treatment Period|Not reported|0|||
160735408|NCT02017717|580411813|FG004|Treatment Period|Not reported|0|||
160735409|NCT02017717|580411814|FG005|Treatment Period|Not reported|0|||
160735410|NCT02017717|580411815|FG006|Treatment Period|Not reported|0|||
160735411|NCT02017717|580411816|FG007|Treatment Period|Not reported|0|||
160735412|NCT02017717|580411817|FG008|Treatment Period|Not reported|0|||
160735413|NCT04488419|580411819|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
160735414|NCT04488419|580411820|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
160735415|NCT04488419|580411821|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
160735416|NCT04488419|580411819|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
160735417|NCT04488419|580411820|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
160735418|NCT04488419|580411821|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
160735419|NCT04488419|580411819|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
160735420|NCT04488419|580411820|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
160735421|NCT04488419|580411821|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
160735422|NCT04488419|580411819|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
160735423|NCT04488419|580411820|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
160735424|NCT04488419|580411821|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
160735425|NCT04488419|580411819|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
160735426|NCT04488419|580411820|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
160735427|NCT04488419|580411821|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
160735428|NCT04488419|580411819|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
160735429|NCT04488419|580411820|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
160735430|NCT04488419|580411821|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
160735431|NCT04488419|580411819|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
160735432|NCT04488419|580411820|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
160735433|NCT04488419|580411821|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
160735434|NCT04488419|580411819|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
160735435|NCT04488419|580411820|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
160735436|NCT04488419|580411821|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
160735437|NCT04488419|580411819|FG000|Primary Analysis Population|Adverse Event|6|||
160735438|NCT04488419|580411820|FG001|Primary Analysis Population|Adverse Event|9|||
160735439|NCT04488419|580411821|FG002|Primary Analysis Population|Adverse Event|0|||
160735440|NCT04488419|580411819|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
160735441|NCT04488419|580411820|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
160735442|NCT04488419|580411821|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
160735443|NCT04488419|580411819|FG000|Primary Analysis Population|Protocol Violation|1|||
160735444|NCT04488419|580411820|FG001|Primary Analysis Population|Protocol Violation|1|||
160735445|NCT04488419|580411821|FG002|Primary Analysis Population|Protocol Violation|0|||
160735446|NCT04488419|580411819|FG000|Primary Analysis Population|Undetermined|7|||
160735447|NCT04488419|580411820|FG001|Primary Analysis Population|Undetermined|3|||
160735448|NCT04488419|580411821|FG002|Primary Analysis Population|Undetermined|0|||
160735449|NCT04488419|580411819|FG000|Primary Analysis Population|>1 Reason|2|||
160735450|NCT04488419|580411820|FG001|Primary Analysis Population|>1 Reason|4|||
160735451|NCT04488419|580411821|FG002|Primary Analysis Population|>1 Reason|0|||
160735452|NCT04743804|580411824|FG000|Overall Study|Other|1|||
160735453|NCT04743804|580411825|FG001|Overall Study|Other|0|||
160735454|NCT04743804|580411824|FG000|Overall Study|Withdrawal by Subject|0|||
160735455|NCT04743804|580411825|FG001|Overall Study|Withdrawal by Subject|1|||
160735456|NCT04743804|580411824|FG000|Overall Study|Study Terminated by Sponsor|1|||
160735457|NCT04743804|580411825|FG001|Overall Study|Study Terminated by Sponsor|4|||
160735458|NCT04743804|580411824|FG000|Overall Study|Physician Decision|0|||
160735459|NCT04743804|580411825|FG001|Overall Study|Physician Decision|1|||
160735460|NCT04743804|580411824|FG000|Overall Study|Death|3|||
160735461|NCT04743804|580411825|FG001|Overall Study|Death|0|||
160735462|NCT00970632|580411831|FG000|Overall Study|Adverse Event|2|||
160735463|NCT00970632|580411832|FG001|Overall Study|Adverse Event|2|||
160735464|NCT00970632|580411833|FG002|Overall Study|Adverse Event|1|||
160735465|NCT00970632|580411831|FG000|Overall Study|Lack of Efficacy|3|||
160735466|NCT00970632|580411832|FG001|Overall Study|Lack of Efficacy|0|||
160735467|NCT00970632|580411833|FG002|Overall Study|Lack of Efficacy|0|||
160735468|NCT00970632|580411831|FG000|Overall Study|Lost to Follow-up|3|||
160735469|NCT00970632|580411832|FG001|Overall Study|Lost to Follow-up|0|||
160735470|NCT00970632|580411833|FG002|Overall Study|Lost to Follow-up|2|||
160735471|NCT00970632|580411831|FG000|Overall Study|Protocol Violation|8|||
160735472|NCT00970632|580411832|FG001|Overall Study|Protocol Violation|5|||
160735473|NCT00970632|580411833|FG002|Overall Study|Protocol Violation|8|||
160735474|NCT00970632|580411831|FG000|Overall Study|Withdrawal by Subject|7|||
160735475|NCT00970632|580411832|FG001|Overall Study|Withdrawal by Subject|6|||
160735476|NCT00970632|580411833|FG002|Overall Study|Withdrawal by Subject|4|||
160735477|NCT00970632|580411831|FG000|Overall Study|Entry criteria not met|0|||
160735478|NCT00970632|580411832|FG001|Overall Study|Entry criteria not met|2|||
160735479|NCT00970632|580411833|FG002|Overall Study|Entry criteria not met|2|||
160735480|NCT00970632|580411831|FG000|Overall Study|Sponsor decision|1|||
160735481|NCT00970632|580411832|FG001|Overall Study|Sponsor decision|0|||
160735482|NCT00970632|580411833|FG002|Overall Study|Sponsor decision|1|||
160735483|NCT01286168|580411840|FG000|Overall Study|Withdrawal by Subject|1|||
160735484|NCT01286168|580411840|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
160735485|NCT02487771|580411841|FG000|Overall Study|Lost to Follow-up|2|||
160735486|NCT02487771|580411842|FG001|Overall Study|Lost to Follow-up|3|||
160735487|NCT02487771|580411841|FG000|Overall Study|Moved out of area|5|||
160735488|NCT02487771|580411842|FG001|Overall Study|Moved out of area|6|||
160735489|NCT02487771|580411841|FG000|Overall Study|Withdrawal by Subject|3|||
160735490|NCT02487771|580411842|FG001|Overall Study|Withdrawal by Subject|5|||
160735491|NCT01482065|580411845|FG000|Overall Study|Withdrawal by Subject|0|||
160735492|NCT01482065|580411846|FG001|Overall Study|Withdrawal by Subject|1|||
160735493|NCT01942486|580411847|FG000|Overall Study|Lost to Follow-up|27|||
160735494|NCT03728426|580411848|FG000|Overall Study|Death|3|||
160735495|NCT02424630|580411851|FG000|Overall Study|No rotator cuff tear|1|||
160735496|NCT02424630|580411852|FG001|Overall Study|No rotator cuff tear|2|||
160735497|NCT02424630|580411851|FG000|Overall Study|Open procedure|0|||
160735498|NCT02424630|580411852|FG001|Overall Study|Open procedure|1|||
160735499|NCT01741792|580411853|FG000|Overall Study|Death|6|||
160735500|NCT01741792|580411854|FG001|Overall Study|Death|1|||
160735501|NCT01741792|580411855|FG002|Overall Study|Death|12|||
160735502|NCT01995175|580411856|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
160735503|NCT01995175|580411856|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
160735504|NCT01995175|580411856|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
160735505|NCT01995175|580411856|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
160735506|NCT01995175|580411856|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
160735507|NCT01995175|580411856|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
160735508|NCT01995175|580411856|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
160735509|NCT01995175|580411856|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
160735510|NCT01995175|580411856|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
160735511|NCT02045862|580411857|FG000|Overall Study|Death|0|||
160735512|NCT02045862|580411858|FG001|Overall Study|Death|0|||
160735513|NCT02045862|580411859|FG002|Overall Study|Death|1|||
160735514|NCT02045862|580411857|FG000|Overall Study|Miscellaneous|5|||
160735515|NCT02045862|580411858|FG001|Overall Study|Miscellaneous|0|||
160735516|NCT02045862|580411859|FG002|Overall Study|Miscellaneous|8|||
160735517|NCT02045862|580411857|FG000|Overall Study|Withdrawal by Patient|18|||
160735518|NCT02045862|580411858|FG001|Overall Study|Withdrawal by Patient|27|||
160735519|NCT02045862|580411859|FG002|Overall Study|Withdrawal by Patient|57|||
160735520|NCT02045862|580411857|FG000|Overall Study|Protocol Violation|0|||
160735521|NCT02045862|580411858|FG001|Overall Study|Protocol Violation|0|||
160735522|NCT02045862|580411859|FG002|Overall Study|Protocol Violation|6|||
160735523|NCT02045862|580411857|FG000|Overall Study|Lack of Efficacy|8|||
160735524|NCT02045862|580411858|FG001|Overall Study|Lack of Efficacy|4|||
160735525|NCT02045862|580411859|FG002|Overall Study|Lack of Efficacy|13|||
160735526|NCT02045862|580411857|FG000|Overall Study|Randomized but not Received Study Drug|0|||
160735527|NCT02045862|580411858|FG001|Overall Study|Randomized but not Received Study Drug|2|||
160735528|NCT02045862|580411859|FG002|Overall Study|Randomized but not Received Study Drug|8|||
160735529|NCT02045862|580411857|FG000|Overall Study|Adverse Event|7|||
160735530|NCT02045862|580411858|FG001|Overall Study|Adverse Event|5|||
160735531|NCT02045862|580411859|FG002|Overall Study|Adverse Event|27|||
160735532|NCT02045862|580411857|FG000|Overall Study|Lost to Follow-up|1|||
160735533|NCT02045862|580411858|FG001|Overall Study|Lost to Follow-up|2|||
160735534|NCT02045862|580411859|FG002|Overall Study|Lost to Follow-up|6|||
160735535|NCT02691013|580411862|FG000|Overall Study|Withdrawal by Subject|3|||
160735536|NCT02691013|580411863|FG001|Overall Study|Withdrawal by Subject|0|||
160735537|NCT02111785|580411864|FG000|Overall Study|Death|0|||
160735538|NCT02111785|580411865|FG001|Overall Study|Death|1|||
160735539|NCT02111785|580411866|FG002|Overall Study|Death|0|||
160735540|NCT02111785|580411867|FG003|Overall Study|Death|0|||
160735541|NCT04507256|580411868|FG000|Overall Study|Withdrawal by Subject|1|||
160735542|NCT04507256|580411869|FG001|Overall Study|Withdrawal by Subject|0|||
160735543|NCT04507256|580411870|FG002|Overall Study|Withdrawal by Subject|0|||
160735544|NCT04507256|580411871|FG003|Overall Study|Withdrawal by Subject|1|||
160735545|NCT04507256|580411872|FG004|Overall Study|Withdrawal by Subject|0|||
160735546|NCT04507256|580411873|FG005|Overall Study|Withdrawal by Subject|0|||
160735547|NCT05239494|580411877|FG000|Overall Study|Lost to Follow-up|1|||
160735548|NCT02822573|580411878|FG000|Overall Study|Lost to Follow-up|5|||
160735549|NCT02822573|580411879|FG001|Overall Study|Lost to Follow-up|3|||
160735550|NCT02822573|580411878|FG000|Overall Study|Physician Decision|1|||
160735551|NCT02822573|580411879|FG001|Overall Study|Physician Decision|1|||
160735552|NCT02822573|580411878|FG000|Overall Study|Withdrawal by Subject|9|||
160735553|NCT02822573|580411879|FG001|Overall Study|Withdrawal by Subject|5|||
160735554|NCT02822573|580411878|FG000|Overall Study|Protocol Violation|6|||
160735555|NCT02822573|580411879|FG001|Overall Study|Protocol Violation|4|||
160735556|NCT02822573|580411878|FG000|Overall Study|Too sick or ill|2|||
160735557|NCT02822573|580411879|FG001|Overall Study|Too sick or ill|1|||
160735558|NCT02822573|580411878|FG000|Overall Study|Disease Progression|1|||
160735559|NCT02822573|580411879|FG001|Overall Study|Disease Progression|1|||
160735560|NCT02822573|580411878|FG000|Overall Study|No reason given|6|||
160735561|NCT02822573|580411879|FG001|Overall Study|No reason given|4|||
160735562|NCT00759785|580411884|FG000|Overall Study|Participant sample not evaluable|11|||
160735563|NCT00759785|580411885|FG001|Overall Study|Participant sample not evaluable|2|||
160735564|NCT00759785|580411884|FG000|Overall Study|Participant sample lost|0|||
160735565|NCT00759785|580411885|FG001|Overall Study|Participant sample lost|1|||
160735566|NCT00759785|580411884|FG000|Overall Study|Protocol Violation|1|||
160735567|NCT00759785|580411885|FG001|Overall Study|Protocol Violation|0|||
160735568|NCT00759785|580411884|FG000|Overall Study|Physician Decision|0|||
160735569|NCT00759785|580411885|FG001|Overall Study|Physician Decision|1|||
160735570|NCT00759785|580411884|FG000|Overall Study|Withdrawal by Subject|0|||
160735571|NCT00759785|580411885|FG001|Overall Study|Withdrawal by Subject|1|||
160735572|NCT02677038|580411886|FG000|Overall Study|Physician Decision|1|||
160735573|NCT02677038|580411886|FG000|Overall Study|Withdrawal by Subject|1|||
160735574|NCT02777970|580411891|FG000|Overall Study|Lost to Follow-up|0|||
160735575|NCT02777970|580411892|FG001|Overall Study|Lost to Follow-up|1|||
160735576|NCT02777970|580411893|FG002|Overall Study|Lost to Follow-up|0|||
160735577|NCT02777970|580411891|FG000|Overall Study|Protocol Violation|1|||
160735578|NCT02777970|580411892|FG001|Overall Study|Protocol Violation|0|||
160735579|NCT02777970|580411893|FG002|Overall Study|Protocol Violation|0|||
160735580|NCT03729570|580411899|FG000|Overall Study|Lost to Follow-up|16|||
160735581|NCT03729570|580411900|FG001|Overall Study|Lost to Follow-up|20|||
160735582|NCT03729570|580411899|FG000|Overall Study|Seroconversion|5|||
160735583|NCT03729570|580411900|FG001|Overall Study|Seroconversion|0|||
160735584|NCT03729570|580411899|FG000|Overall Study|Moved out of the city|1|||
160735585|NCT03729570|580411900|FG001|Overall Study|Moved out of the city|0|||
160735586|NCT03729570|580411899|FG000|Overall Study|Time Conflict|1|||
160735587|NCT03729570|580411900|FG001|Overall Study|Time Conflict|0|||
160735588|NCT03729570|580411899|FG000|Overall Study|Time Commitment|2|||
160735589|NCT03729570|580411900|FG001|Overall Study|Time Commitment|0|||
160735590|NCT03729570|580411899|FG000|Overall Study|Bad Experience|0|||
160735591|NCT03729570|580411900|FG001|Overall Study|Bad Experience|1|||
160735592|NCT03729570|580411899|FG000|Overall Study|No reason provided|2|||
160735593|NCT03729570|580411900|FG001|Overall Study|No reason provided|1|||
160735594|NCT03729570|580411899|FG000|Overall Study|Family Conflict|0|||
160735595|NCT03729570|580411900|FG001|Overall Study|Family Conflict|1|||
160735596|NCT03729570|580411899|FG000|Overall Study|Did not want to continue taking medications|0|||
160735597|NCT03729570|580411900|FG001|Overall Study|Did not want to continue taking medications|1|||
160735598|NCT03729570|580411899|FG000|Overall Study|Found another PrEP provider|1|||
160735599|NCT03729570|580411900|FG001|Overall Study|Found another PrEP provider|0|||
160735600|NCT03729570|580411899|FG000|Overall Study|Did not enjoy being in the control group|0|||
160735601|NCT03729570|580411900|FG001|Overall Study|Did not enjoy being in the control group|1|||
160735602|NCT00631410|580411905|FG000|Overall Study|Adverse Event|1|||
160735603|NCT00631410|580411906|FG001|Overall Study|Adverse Event|3|||
160735604|NCT00631410|580411905|FG000|Overall Study|Objective Progression or Relapse|4|||
160735605|NCT00631410|580411906|FG001|Overall Study|Objective Progression or Relapse|3|||
160735606|NCT00631410|580411905|FG000|Overall Study|Surgery|1|||
160735607|NCT00631410|580411906|FG001|Overall Study|Surgery|0|||
160735608|NCT02858180|580411908|FG000|Overall Study|Lost to Follow-up|0|||
160735609|NCT02858180|580411909|FG001|Overall Study|Lost to Follow-up|2|||
160735610|NCT01516008|580411916|FG000|Overall Study|Adverse Event|0|||
160735611|NCT01516008|580411917|FG001|Overall Study|Adverse Event|2|||
160735612|NCT01516008|580411918|FG002|Overall Study|Adverse Event|7|||
160735613|NCT01516008|580411916|FG000|Overall Study|Lack of Efficacy|44|||
160735614|NCT01516008|580411917|FG001|Overall Study|Lack of Efficacy|14|||
160735615|NCT01516008|580411918|FG002|Overall Study|Lack of Efficacy|10|||
160735616|NCT01516008|580411916|FG000|Overall Study|Protocol Violation|1|||
160735617|NCT01516008|580411917|FG001|Overall Study|Protocol Violation|0|||
160735618|NCT01516008|580411918|FG002|Overall Study|Protocol Violation|0|||
160735619|NCT01516008|580411916|FG000|Overall Study|Reason not specified|0|||
160735620|NCT01516008|580411917|FG001|Overall Study|Reason not specified|0|||
160735621|NCT01516008|580411918|FG002|Overall Study|Reason not specified|1|||
160735622|NCT04553471|580411919|FG000|Overall Study|Did not start treatment on protocol|3|||
160735623|NCT04553471|580411919|FG000|Overall Study|Death|1|||
160735624|NCT01217476|580411920|FG000|Overall Study|Adverse Event|6|||
160735625|NCT01217476|580411921|FG001|Overall Study|Adverse Event|1|||
160735626|NCT01217476|580411920|FG000|Overall Study|Physician Decision|0|||
160735627|NCT01217476|580411921|FG001|Overall Study|Physician Decision|1|||
160735628|NCT01217476|580411920|FG000|Overall Study|Withdrawal by Subject|3|||
160735629|NCT01217476|580411921|FG001|Overall Study|Withdrawal by Subject|3|||
160735630|NCT01217476|580411920|FG000|Overall Study|Surgery on the Target Limb|0|||
160735631|NCT01217476|580411921|FG001|Overall Study|Surgery on the Target Limb|2|||
160735632|NCT01217476|580411920|FG000|Overall Study|Protocol Deviation|1|||
160735633|NCT01217476|580411921|FG001|Overall Study|Protocol Deviation|0|||
160735634|NCT01217476|580411920|FG000|Overall Study|Other|2|||
160735635|NCT01217476|580411921|FG001|Overall Study|Other|0|||
160735636|NCT03033602|580411922|FG000|Overall Study|Withdrawal by Subject|11|||
160735637|NCT03033602|580411923|FG001|Overall Study|Withdrawal by Subject|21|||
160735638|NCT03033602|580411922|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
160735639|NCT03033602|580411923|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
160735640|NCT01441765|580411924|FG000|Overall Study|Death|1|||
160735641|NCT01441765|580411925|FG001|Overall Study|Death|0|||
160735642|NCT00813813|580411926|FG000|Overall Study|Withdrawal by Subject|1|||
160735643|NCT00813813|580411927|FG001|Overall Study|Withdrawal by Subject|1|||
160735644|NCT00813813|580411926|FG000|Overall Study|Lost to Follow-up|2|||
160735645|NCT00813813|580411927|FG001|Overall Study|Lost to Follow-up|7|||
160735646|NCT00813813|580411926|FG000|Overall Study|Other|0|||
160735647|NCT00813813|580411927|FG001|Overall Study|Other|1|||
160735648|NCT02805660|580411928|FG000|Overall Study|Death|5|||
160735649|NCT02805660|580411929|FG001|Overall Study|Death|2|||
160735650|NCT02805660|580411930|FG002|Overall Study|Death|9|||
160735651|NCT02805660|580411931|FG003|Overall Study|Death|5|||
160735652|NCT02805660|580411932|FG004|Overall Study|Death|0|||
160735653|NCT02805660|580411933|FG005|Overall Study|Death|14|||
160735654|NCT02805660|580411934|FG006|Overall Study|Death|12|||
160735655|NCT02805660|580411928|FG000|Overall Study|Lost to Follow-up|0|||
160735656|NCT02805660|580411929|FG001|Overall Study|Lost to Follow-up|1|||
160735657|NCT02805660|580411930|FG002|Overall Study|Lost to Follow-up|1|||
160735658|NCT02805660|580411931|FG003|Overall Study|Lost to Follow-up|2|||
160735659|NCT02805660|580411932|FG004|Overall Study|Lost to Follow-up|0|||
160735660|NCT02805660|580411933|FG005|Overall Study|Lost to Follow-up|0|||
160735661|NCT02805660|580411934|FG006|Overall Study|Lost to Follow-up|0|||
160735662|NCT02805660|580411928|FG000|Overall Study|Withdrawal by Subject|0|||
160735663|NCT02805660|580411929|FG001|Overall Study|Withdrawal by Subject|0|||
160735664|NCT02805660|580411930|FG002|Overall Study|Withdrawal by Subject|0|||
160735665|NCT02805660|580411931|FG003|Overall Study|Withdrawal by Subject|3|||
160735666|NCT02805660|580411932|FG004|Overall Study|Withdrawal by Subject|1|||
160735667|NCT02805660|580411933|FG005|Overall Study|Withdrawal by Subject|0|||
160735668|NCT02805660|580411934|FG006|Overall Study|Withdrawal by Subject|2|||
160735669|NCT02805660|580411928|FG000|Overall Study|Study terminated by Sponsor|0|||
160735670|NCT02805660|580411929|FG001|Overall Study|Study terminated by Sponsor|0|||
160735671|NCT02805660|580411930|FG002|Overall Study|Study terminated by Sponsor|1|||
160735672|NCT02805660|580411931|FG003|Overall Study|Study terminated by Sponsor|4|||
160735673|NCT02805660|580411932|FG004|Overall Study|Study terminated by Sponsor|2|||
160735674|NCT02805660|580411933|FG005|Overall Study|Study terminated by Sponsor|3|||
160735675|NCT02805660|580411934|FG006|Overall Study|Study terminated by Sponsor|1|||
160735676|NCT02805660|580411928|FG000|Overall Study|Miscellaneous|0|||
160735677|NCT02805660|580411929|FG001|Overall Study|Miscellaneous|1|||
160735678|NCT02805660|580411930|FG002|Overall Study|Miscellaneous|0|||
160735679|NCT02805660|580411931|FG003|Overall Study|Miscellaneous|4|||
160735680|NCT02805660|580411932|FG004|Overall Study|Miscellaneous|0|||
160735681|NCT02805660|580411933|FG005|Overall Study|Miscellaneous|6|||
160735682|NCT02805660|580411934|FG006|Overall Study|Miscellaneous|4|||
160735683|NCT02572076|580411936|FG000|Overall Study|Protocol Violation|1|||
160735684|NCT02778074|580411937|FG000|Overall Study|Lost to Follow-up|7|||
160735685|NCT02778074|580411938|FG001|Overall Study|Lost to Follow-up|10|||
160735686|NCT03395184|580411939|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
160735687|NCT03395184|580411940|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
160735688|NCT03395184|580411941|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
160735689|NCT03395184|580411942|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
160735690|NCT03395184|580411943|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
160735691|NCT03395184|580411944|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
160735692|NCT03395184|580411945|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
160735693|NCT03395184|580411939|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
160735694|NCT03395184|580411940|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
160735695|NCT03395184|580411941|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
160735696|NCT03395184|580411942|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
160735697|NCT03395184|580411943|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
160735698|NCT03395184|580411944|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
160735699|NCT03395184|580411945|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
160735700|NCT03395184|580411939|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
160735701|NCT03395184|580411940|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
160735702|NCT03395184|580411941|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
160735703|NCT03395184|580411942|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
160735704|NCT03395184|580411943|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
160735705|NCT03395184|580411944|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
160735706|NCT03395184|580411945|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
160735707|NCT03395184|580411939|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
160735708|NCT03395184|580411940|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
160735709|NCT03395184|580411941|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
160735710|NCT03395184|580411942|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
160735711|NCT03395184|580411943|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
160735712|NCT03395184|580411944|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
160735713|NCT03395184|580411945|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
160735714|NCT03395184|580411939|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
160735715|NCT03395184|580411940|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
160735716|NCT03395184|580411941|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
160735717|NCT03395184|580411942|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
160735718|NCT03395184|580411943|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
160735719|NCT03395184|580411944|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
160735720|NCT03395184|580411945|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
160735721|NCT03395184|580411939|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
160735722|NCT03395184|580411940|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
160735723|NCT03395184|580411941|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
160735724|NCT03395184|580411942|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
160735725|NCT03395184|580411943|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
160735726|NCT03395184|580411944|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
160735727|NCT03395184|580411945|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
160735728|NCT03395184|580411939|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
160735729|NCT03395184|580411940|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
160735730|NCT03395184|580411941|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
160735731|NCT03395184|580411942|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
160735732|NCT03395184|580411943|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
160735733|NCT03395184|580411944|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
160735734|NCT03395184|580411945|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
160735735|NCT03395184|580411939|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
160735736|NCT03395184|580411940|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
160735737|NCT03395184|580411941|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
160735738|NCT03395184|580411942|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
160735739|NCT03395184|580411943|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
160735740|NCT03395184|580411944|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
160735741|NCT03395184|580411945|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
160735742|NCT03395184|580411939|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
160735743|NCT03395184|580411940|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
160735744|NCT03395184|580411941|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
160735745|NCT03395184|580411942|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
160735746|NCT03395184|580411943|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
160735747|NCT03395184|580411944|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
160735748|NCT03395184|580411945|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
160735749|NCT03395184|580411939|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
160735750|NCT03395184|580411940|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
160735751|NCT03395184|580411941|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
160735752|NCT03395184|580411942|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
160735753|NCT03395184|580411943|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
160735754|NCT03395184|580411944|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
160735755|NCT03395184|580411945|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
160735756|NCT03395184|580411939|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
160735757|NCT03395184|580411940|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
160735758|NCT03395184|580411941|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
160735759|NCT03395184|580411942|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
160735760|NCT03395184|580411943|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
160735761|NCT03395184|580411944|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
160735762|NCT03395184|580411945|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
160735763|NCT03395184|580411939|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
160735764|NCT03395184|580411940|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
160735765|NCT03395184|580411941|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
160735766|NCT03395184|580411942|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
160735767|NCT03395184|580411943|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
160735768|NCT03395184|580411944|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
160735769|NCT03395184|580411945|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
160735770|NCT03617770|580411949|FG000|Overall Study|Lost to Follow-up|1|||
160735771|NCT03617770|580411950|FG001|Overall Study|Lost to Follow-up|0|||
160735772|NCT03963232|580411951|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
160735773|NCT03963232|580411952|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
160735774|NCT03963232|580411951|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
160735775|NCT03963232|580411952|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
160735776|NCT03963232|580411951|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
160735777|NCT03963232|580411952|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
160735778|NCT03963232|580411951|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
160735779|NCT03963232|580411952|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
160735780|NCT03963232|580411951|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
160735781|NCT03963232|580411952|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
160735782|NCT03963232|580411951|FG000|Open-Label Treatment Phase|Adverse Event|1|||
160735783|NCT03963232|580411952|FG001|Open-Label Treatment Phase|Adverse Event|2|||
160735784|NCT03963232|580411951|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
160735785|NCT03963232|580411952|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
160735786|NCT03963232|580411951|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
160735787|NCT03963232|580411952|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
160735788|NCT03963232|580411951|FG000|Open-Label Treatment Phase|Pregnancy|1|||
160735789|NCT03963232|580411952|FG001|Open-Label Treatment Phase|Pregnancy|0|||
160735790|NCT03963232|580411951|FG000|Follow-up Phase|Withdrawal by Subject|7|||
160735791|NCT03963232|580411952|FG001|Follow-up Phase|Withdrawal by Subject|5|||
160735792|NCT03963232|580411951|FG000|Follow-up Phase|Protocol Violation|0|||
160735793|NCT03963232|580411952|FG001|Follow-up Phase|Protocol Violation|2|||
160735794|NCT03963232|580411951|FG000|Follow-up Phase|Adverse Event|0|||
160735795|NCT03963232|580411952|FG001|Follow-up Phase|Adverse Event|1|||
160735796|NCT03963232|580411951|FG000|Follow-up Phase|Lost to Follow-up|0|||
160735797|NCT03963232|580411952|FG001|Follow-up Phase|Lost to Follow-up|1|||
160735798|NCT00356135|580411953|FG000|Overall Study|Protocol Violation|1|||
160735799|NCT00356135|580411954|FG001|Overall Study|Protocol Violation|0|||
160735800|NCT00356135|580411955|FG002|Overall Study|Protocol Violation|0|||
160735801|NCT00356135|580411953|FG000|Overall Study|Adverse Event|1|||
160735802|NCT00356135|580411954|FG001|Overall Study|Adverse Event|0|||
160735803|NCT00356135|580411955|FG002|Overall Study|Adverse Event|0|||
160735804|NCT00356135|580411953|FG000|Overall Study|Lost to Follow-up|0|||
160735805|NCT00356135|580411954|FG001|Overall Study|Lost to Follow-up|0|||
160735806|NCT00356135|580411955|FG002|Overall Study|Lost to Follow-up|1|||
160735807|NCT00356135|580411953|FG000|Overall Study|Physician Decision|1|||
160735808|NCT00356135|580411954|FG001|Overall Study|Physician Decision|1|||
160735809|NCT00356135|580411955|FG002|Overall Study|Physician Decision|1|||
160735810|NCT00356135|580411953|FG000|Overall Study|Subject non-compliance|1|||
160735811|NCT00356135|580411954|FG001|Overall Study|Subject non-compliance|1|||
160735812|NCT00356135|580411955|FG002|Overall Study|Subject non-compliance|3|||
160735813|NCT01672710|580411956|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
160735814|NCT01672710|580411957|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
160735815|NCT01672710|580411956|FG000|3 Month Follow up|Lost to Follow-up|2|||
160735816|NCT01672710|580411957|FG001|3 Month Follow up|Lost to Follow-up|3|||
160735817|NCT01672710|580411956|FG000|3 Month Follow up|follow up due after termination date|4|||
160735818|NCT01672710|580411957|FG001|3 Month Follow up|follow up due after termination date|1|||
160735819|NCT05033262|580411963|FG000|Overall Study|Lost to Follow-up|1|||
160735820|NCT05033262|580411964|FG001|Overall Study|Lost to Follow-up|0|||
160735821|NCT05033262|580411965|FG002|Overall Study|Lost to Follow-up|0|||
160735822|NCT05033262|580411966|FG003|Overall Study|Lost to Follow-up|1|||
160735823|NCT05270395|580411967|FG000|Overall Study|Lost to Follow-up|2|||
160735824|NCT05270395|580411968|FG001|Overall Study|Lost to Follow-up|2|||
160735825|NCT05270395|580411967|FG000|Overall Study|Death|1|||
160735826|NCT05270395|580411968|FG001|Overall Study|Death|2|||
160735827|NCT05270395|580411967|FG000|Overall Study|Study Team Withdrew|1|||
160735828|NCT05270395|580411968|FG001|Overall Study|Study Team Withdrew|0|||
160735829|NCT03055494|580414167|FG000|Overall Study|Lost to Follow-up|6|||
160735830|NCT03055494|580414168|FG001|Overall Study|Lost to Follow-up|0|||
160735831|NCT03055494|580414167|FG000|Overall Study|Physician Decision|2|||
160735832|NCT03055494|580414168|FG001|Overall Study|Physician Decision|0|||
160735833|NCT03055494|580414167|FG000|Overall Study|Withdrawal by Subject|1|||
160735834|NCT03055494|580414168|FG001|Overall Study|Withdrawal by Subject|0|||
160735835|NCT03055494|580414167|FG000|Overall Study|Adverse Event|0|||
160735836|NCT03055494|580414168|FG001|Overall Study|Adverse Event|1|||
160735837|NCT03055494|580414167|FG000|Overall Study|Non-compliance with study treatment|1|||
160735838|NCT03055494|580414168|FG001|Overall Study|Non-compliance with study treatment|0|||
160735839|NCT00984061|580414169|FG000|Clarithromycin Alone|Protocol Violation|1|||
160735840|NCT05139303|580414170|FG000|Overall Study|Lost to Follow-up|3|||
160735841|NCT05139303|580414171|FG001|Overall Study|Lost to Follow-up|0|||
160735842|NCT05139303|580414170|FG000|Overall Study|Adverse Event|1|||
160735843|NCT05139303|580414171|FG001|Overall Study|Adverse Event|0|||
160735844|NCT00761280|580414172|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
160735845|NCT00761280|580414173|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
160735846|NCT00761280|580414172|FG000|Randomization to First Dose|Sponsor decision|1|||
160735847|NCT00761280|580414173|FG001|Randomization to First Dose|Sponsor decision|0|||
160735848|NCT00761280|580414172|FG000|Randomization to First Dose|Other|1|||
160735849|NCT00761280|580414173|FG001|Randomization to First Dose|Other|0|||
160735850|NCT00761280|580414172|FG000|First Dose to End of Study|End of trial|5|||
160735851|NCT00761280|580414173|FG001|First Dose to End of Study|End of trial|5|||
160735852|NCT00761280|580414172|FG000|First Dose to End of Study|Progressive disease|5|||
160735853|NCT00761280|580414173|FG001|First Dose to End of Study|Progressive disease|3|||
160735854|NCT00761280|580414172|FG000|First Dose to End of Study|Sponsor decision|1|||
160735855|NCT00761280|580414173|FG001|First Dose to End of Study|Sponsor decision|2|||
160735856|NCT00761280|580414172|FG000|First Dose to End of Study|Death|1|||
160735857|NCT00761280|580414173|FG001|First Dose to End of Study|Death|0|||
160735858|NCT00761280|580414172|FG000|First Dose to End of Study|Lost to Follow-up|0|||
160735859|NCT00761280|580414173|FG001|First Dose to End of Study|Lost to Follow-up|1|||
160735860|NCT03875482|580414177|FG000|Overall Study|Adverse Event|0|||
160735861|NCT03875482|580414178|FG001|Overall Study|Adverse Event|1|||
160735862|NCT03875482|580414177|FG000|Overall Study|Withdrew consent|5|||
160735863|NCT03875482|580414178|FG001|Overall Study|Withdrew consent|6|||
160735864|NCT03875482|580414177|FG000|Overall Study|Lost to Follow-up|8|||
160735865|NCT03875482|580414178|FG001|Overall Study|Lost to Follow-up|2|||
160735866|NCT03875482|580414177|FG000|Overall Study|Lack of Efficacy|0|||
160735867|NCT03875482|580414178|FG001|Overall Study|Lack of Efficacy|11|||
160735868|NCT02256982|580414181|FG000|Overall Study|Disease Progression|0|||
160735869|NCT02256982|580414182|FG001|Overall Study|Disease Progression|1|||
160735870|NCT02275780|580414183|FG000|Base Study: 96 Weeks|Adverse Event|6|||
160735871|NCT02275780|580414184|FG001|Base Study: 96 Weeks|Adverse Event|14|||
160735872|NCT02275780|580414183|FG000|Base Study: 96 Weeks|Death|3|||
160735873|NCT02275780|580414184|FG001|Base Study: 96 Weeks|Death|1|||
160735874|NCT02275780|580414183|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
160735875|NCT02275780|580414184|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
160735876|NCT02275780|580414183|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
160735877|NCT02275780|580414184|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
160735878|NCT02275780|580414183|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
160735879|NCT02275780|580414184|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
160735880|NCT02275780|580414183|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
160735881|NCT02275780|580414184|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
160735882|NCT02275780|580414183|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
160735883|NCT02275780|580414184|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
160735884|NCT02275780|580414183|FG000|Base Study: 96 Weeks|Physician Decision|2|||
160735885|NCT02275780|580414184|FG001|Base Study: 96 Weeks|Physician Decision|4|||
160735886|NCT02275780|580414183|FG000|Base Study: 96 Weeks|Pregnancy|2|||
160735887|NCT02275780|580414184|FG001|Base Study: 96 Weeks|Pregnancy|1|||
160735888|NCT02275780|580414183|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
160735889|NCT02275780|580414184|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
160735890|NCT02275780|580414183|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
160735891|NCT02275780|580414184|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
160735892|NCT02275780|580414183|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
160735893|NCT02275780|580414184|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
160735894|NCT02275780|580414183|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
160735895|NCT02275780|580414184|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
160735896|NCT02275780|580414183|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
160735897|NCT02275780|580414184|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
160735898|NCT02275780|580414183|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
160735899|NCT02275780|580414184|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
160735900|NCT02275780|580414183|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
160735901|NCT02275780|580414184|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
160735902|NCT02275780|580414183|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
160735903|NCT02275780|580414184|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
160735904|NCT02275780|580414183|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
160735905|NCT02275780|580414184|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
160735906|NCT02275780|580414183|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
160735907|NCT02275780|580414184|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
160735908|NCT02275780|580414183|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
160735909|NCT02275780|580414184|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
160735910|NCT02275780|580414183|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
160735911|NCT02275780|580414184|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
160735912|NCT02275780|580414183|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
160735913|NCT02275780|580414184|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
160735914|NCT02275780|580414183|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
160735915|NCT02275780|580414184|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
160735916|NCT02275780|580414183|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
160735917|NCT02275780|580414184|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
160735918|NCT02275780|580414183|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
160735919|NCT02275780|580414184|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
160735920|NCT02275780|580414183|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
160735921|NCT02275780|580414184|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
160735922|NCT02275780|580414183|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
160735923|NCT02275780|580414184|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
160735924|NCT02275780|580414183|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
160735925|NCT02275780|580414184|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
160735926|NCT02275780|580414183|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
160735927|NCT02275780|580414184|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
160735928|NCT02275780|580414183|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
160735929|NCT02275780|580414184|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
160735930|NCT02275780|580414183|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
160735931|NCT02275780|580414184|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
160735932|NCT01054300|580414189|FG000|Period 1|Adverse Event|1|||
160735933|NCT01054300|580414190|FG001|Period 1|Adverse Event|0|||
160735934|NCT01054300|580414191|FG002|Period 1|Adverse Event|0|||
160735935|NCT01054300|580414192|FG003|Period 1|Adverse Event|0|||
160735936|NCT01054300|580414189|FG000|Period 2|Withdrawal by Subject|0|||
160735937|NCT01054300|580414190|FG001|Period 2|Withdrawal by Subject|0|||
160735938|NCT01054300|580414191|FG002|Period 2|Withdrawal by Subject|1|||
160735939|NCT01054300|580414192|FG003|Period 2|Withdrawal by Subject|0|||
160735940|NCT01899742|580414195|FG000|Overall Study|Adverse Event|5|||
160735941|NCT01899742|580414196|FG001|Overall Study|Adverse Event|4|||
160735942|NCT01899742|580414195|FG000|Overall Study|Lack of Efficacy|1|||
160735943|NCT01899742|580414196|FG001|Overall Study|Lack of Efficacy|5|||
160735944|NCT01899742|580414195|FG000|Overall Study|Protocol Violation|2|||
160735945|NCT01899742|580414196|FG001|Overall Study|Protocol Violation|2|||
160735946|NCT01899742|580414195|FG000|Overall Study|Withdrawal by Subject|9|||
160735947|NCT01899742|580414196|FG001|Overall Study|Withdrawal by Subject|5|||
160735948|NCT02662764|580414200|FG000|Overall Study|Adverse Event|6|||
160735949|NCT02662764|580414200|FG000|Overall Study|Lack of Efficacy|8|||
160735950|NCT02662764|580414200|FG000|Overall Study|Protocol Violation|1|||
160735951|NCT02662764|580414200|FG000|Overall Study|Withdrawal by Subject|5|||
160735952|NCT02662764|580414200|FG000|Overall Study|Device failure|4|||
160735953|NCT02662764|580414200|FG000|Overall Study|Patient changed treatment|1|||
160735954|NCT02662764|580414200|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
160735955|NCT01282164|580414201|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
160735956|NCT01282164|580414202|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
160735957|NCT02083185|580414203|FG000|Overall Study|Lost to Follow-up|0|||
160735958|NCT02083185|580414204|FG001|Overall Study|Lost to Follow-up|3|||
160735959|NCT02083185|580414205|FG002|Overall Study|Lost to Follow-up|0|||
160735960|NCT02083185|580414203|FG000|Overall Study|Withdrawal by Subject|9|||
160735961|NCT02083185|580414204|FG001|Overall Study|Withdrawal by Subject|15|||
160735962|NCT02083185|580414205|FG002|Overall Study|Withdrawal by Subject|1|||
160735963|NCT02083185|580414203|FG000|Overall Study|Death|2|||
160735964|NCT02083185|580414204|FG001|Overall Study|Death|2|||
160735965|NCT02083185|580414205|FG002|Overall Study|Death|1|||
160735966|NCT02083185|580414203|FG000|Overall Study|Reason not Specified|9|||
160735967|NCT02083185|580414204|FG001|Overall Study|Reason not Specified|6|||
160735968|NCT02083185|580414205|FG002|Overall Study|Reason not Specified|5|||
160735969|NCT02083185|580414203|FG000|Overall Study|Study Terminated by Sponsor|0|||
160735970|NCT02083185|580414204|FG001|Overall Study|Study Terminated by Sponsor|1|||
160735971|NCT02083185|580414205|FG002|Overall Study|Study Terminated by Sponsor|0|||
160735972|NCT02083185|580414203|FG000|Overall Study|Did not Receive Study Drug|0|||
160735973|NCT02083185|580414204|FG001|Overall Study|Did not Receive Study Drug|2|||
160735974|NCT02083185|580414205|FG002|Overall Study|Did not Receive Study Drug|0|||
160735975|NCT03419598|580414206|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
160735976|NCT02474589|580414207|FG000|Overall Study|Adverse Event|6|||
160735977|NCT02474589|580414208|FG001|Overall Study|Adverse Event|2|||
160735978|NCT02474589|580414207|FG000|Overall Study|Lost to Follow-up|6|||
160735979|NCT02474589|580414208|FG001|Overall Study|Lost to Follow-up|1|||
160735980|NCT02474589|580414207|FG000|Overall Study|Protocol Violation|4|||
160735981|NCT02474589|580414208|FG001|Overall Study|Protocol Violation|1|||
160735982|NCT02474589|580414207|FG000|Overall Study|Withdrawal by Subject|4|||
160735983|NCT02474589|580414208|FG001|Overall Study|Withdrawal by Subject|0|||
160735984|NCT02474589|580414207|FG000|Overall Study|Inability to complete study procedures|5|||
160735985|NCT02474589|580414208|FG001|Overall Study|Inability to complete study procedures|1|||
160735986|NCT00380081|580414211|FG000|Overall Study|Withdrawal by Subject|0|||
160735987|NCT00380081|580414212|FG001|Overall Study|Withdrawal by Subject|0|||
160735988|NCT00380081|580414213|FG002|Overall Study|Withdrawal by Subject|0|||
160735989|NCT00380081|580414214|FG003|Overall Study|Withdrawal by Subject|0|||
160735990|NCT00380081|580414215|FG004|Overall Study|Withdrawal by Subject|1|||
160735991|NCT00380081|580414216|FG005|Overall Study|Withdrawal by Subject|0|||
160735992|NCT00380081|580414211|FG000|Overall Study|Family Emergency|0|||
160735993|NCT00380081|580414212|FG001|Overall Study|Family Emergency|0|||
160735994|NCT00380081|580414213|FG002|Overall Study|Family Emergency|0|||
160735995|NCT00380081|580414214|FG003|Overall Study|Family Emergency|0|||
160735996|NCT00380081|580414215|FG004|Overall Study|Family Emergency|0|||
160735997|NCT00380081|580414216|FG005|Overall Study|Family Emergency|1|||
160735998|NCT02231879|580414217|FG000|Overall Study|Adverse Event|2|||
160735999|NCT02231879|580414218|FG001|Overall Study|Adverse Event|1|||
160736000|NCT02231879|580414217|FG000|Overall Study|Lack of Efficacy|0|||
160736001|NCT02231879|580414218|FG001|Overall Study|Lack of Efficacy|1|||
160736002|NCT00189306|580414219|FG000|Treatment Period|Withdrawal by Subject|2|||
160736003|NCT00189306|580414219|FG000|Treatment Period|Adverse Event|2|||
160736004|NCT00189306|580414219|FG000|Treatment Period|Protocol Violation|1|||
160736005|NCT00189306|580414219|FG000|Posttreatment Period|Death|1|||
160736006|NCT00189306|580414219|FG000|Posttreatment Period|Withdrawal by Subject|2|||
160736007|NCT00189306|580414219|FG000|Posttreatment Period|Noncompliance|1|||
160736008|NCT00189306|580414219|FG000|Posttreatment Period|Target lesion excised|1|||
160736009|NCT00189306|580414219|FG000|Posttreatment Period|Protocol Violation|1|||
160736010|NCT00189306|580414219|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
160736011|NCT00189306|580414219|FG000|Posttreatment Period|Local skin reaction/sign|1|||
160736012|NCT00189306|580414219|FG000|Long-Term Follow-up|Adverse Event|2|||
160736013|NCT00189306|580414219|FG000|Long-Term Follow-up|Death|4|||
160736014|NCT00189306|580414219|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
160736015|NCT00189306|580414219|FG000|Long-Term Follow-up|Intercurrent disease|2|||
160736016|NCT00189306|580414219|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
160736017|NCT00189306|580414219|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
160736018|NCT00459706|580414220|FG000|Overall Study|Adverse Event|19|||
160736019|NCT00459706|580414221|FG001|Overall Study|Adverse Event|13|||
160736020|NCT00459706|580414220|FG000|Overall Study|Withdrawal by Subject|1|||
160736021|NCT00459706|580414221|FG001|Overall Study|Withdrawal by Subject|6|||
160736022|NCT00459706|580414220|FG000|Overall Study|Physician Decision|2|||
160736023|NCT00459706|580414221|FG001|Overall Study|Physician Decision|0|||
160736024|NCT00459706|580414220|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
160736025|NCT00459706|580414221|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
160736026|NCT00459706|580414220|FG000|Overall Study|Protocol Violation|2|||
160736027|NCT00459706|580414221|FG001|Overall Study|Protocol Violation|1|||
160736028|NCT00459706|580414220|FG000|Overall Study|Failed to Return|1|||
160736029|NCT00459706|580414221|FG001|Overall Study|Failed to Return|0|||
160736030|NCT00459706|580414220|FG000|Overall Study|Other|0|||
160736031|NCT00459706|580414221|FG001|Overall Study|Other|1|||
160736032|NCT03640481|580414222|FG000|Overall Study|Death|14|||
160736033|NCT03640481|580414223|FG001|Overall Study|Death|14|||
160736034|NCT03640481|580414224|FG002|Overall Study|Death|0|||
160736035|NCT03640481|580414225|FG003|Overall Study|Death|0|||
160736036|NCT03640481|580414222|FG000|Overall Study|Lost to Follow-up|2|||
160736037|NCT03640481|580414223|FG001|Overall Study|Lost to Follow-up|0|||
160736038|NCT03640481|580414224|FG002|Overall Study|Lost to Follow-up|0|||
160736039|NCT03640481|580414225|FG003|Overall Study|Lost to Follow-up|0|||
160736040|NCT03640481|580414222|FG000|Overall Study|Site terminated by sponsor|1|||
160736041|NCT03640481|580414223|FG001|Overall Study|Site terminated by sponsor|3|||
160736042|NCT03640481|580414224|FG002|Overall Study|Site terminated by sponsor|0|||
160736043|NCT03640481|580414225|FG003|Overall Study|Site terminated by sponsor|0|||
160736044|NCT03640481|580414222|FG000|Overall Study|Study terminated by sponsor|29|||
160736045|NCT03640481|580414223|FG001|Overall Study|Study terminated by sponsor|42|||
160736046|NCT03640481|580414224|FG002|Overall Study|Study terminated by sponsor|1|||
160736047|NCT03640481|580414225|FG003|Overall Study|Study terminated by sponsor|0|||
160736048|NCT03640481|580414222|FG000|Overall Study|Withdrawal by Subject|5|||
160736049|NCT03640481|580414223|FG001|Overall Study|Withdrawal by Subject|4|||
160736050|NCT03640481|580414224|FG002|Overall Study|Withdrawal by Subject|0|||
160736051|NCT03640481|580414225|FG003|Overall Study|Withdrawal by Subject|1|||
160736052|NCT03640481|580414222|FG000|Overall Study|Other|26|||
160736053|NCT03640481|580414223|FG001|Overall Study|Other|12|||
160736054|NCT03640481|580414224|FG002|Overall Study|Other|1|||
160736055|NCT03640481|580414225|FG003|Overall Study|Other|0|||
160736056|NCT03640481|580414222|FG000|Overall Study|Randomized, but not treated|1|||
160736057|NCT03640481|580414223|FG001|Overall Study|Randomized, but not treated|3|||
160736058|NCT03640481|580414224|FG002|Overall Study|Randomized, but not treated|0|||
160736059|NCT03640481|580414225|FG003|Overall Study|Randomized, but not treated|0|||
160736060|NCT01322035|580414226|FG000|Overall Study|Lost to Follow-up|8|||
160736061|NCT01322035|580414227|FG001|Overall Study|Lost to Follow-up|3|||
160736062|NCT00535847|580414228|FG000|Overall Study|Adverse Event|5|||
160736063|NCT00535847|580414229|FG001|Overall Study|Adverse Event|3|||
160736064|NCT00535847|580414230|FG002|Overall Study|Adverse Event|2|||
160736065|NCT00535847|580414228|FG000|Overall Study|Non compliance|1|||
160736066|NCT00535847|580414229|FG001|Overall Study|Non compliance|1|||
160736067|NCT00535847|580414230|FG002|Overall Study|Non compliance|0|||
160736068|NCT00535847|580414228|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
160736069|NCT00535847|580414229|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
160736070|NCT00535847|580414230|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
160736071|NCT01546168|580414233|FG000|Overall Study|Lost to Follow-up|1|||
160736072|NCT01546168|580414234|FG001|Overall Study|Lost to Follow-up|0|||
160736073|NCT01546168|580414233|FG000|Overall Study|Withdrawal by Subject|1|||
160736074|NCT01546168|580414234|FG001|Overall Study|Withdrawal by Subject|0|||
160736075|NCT01546168|580414233|FG000|Overall Study|ineligible after signing consent|2|||
160736076|NCT01546168|580414234|FG001|Overall Study|ineligible after signing consent|0|||
160736077|NCT02850016|580414237|FG000|Overall Study|Withdrawal by Subject|1|||
160736078|NCT02850016|580414238|FG001|Overall Study|Withdrawal by Subject|2|||
160736079|NCT00070018|580414241|FG000|Overall Study|Adverse Event|2|||
160736080|NCT00070018|580414241|FG000|Overall Study|Lack of Efficacy|1|||
160736081|NCT00070018|580414241|FG000|Overall Study|Withdrawal by Subject|1|||
160736082|NCT02939716|580414242|FG000|Overall Study|scanner failure|0|||
160736083|NCT02939716|580414243|FG001|Overall Study|scanner failure|0|||
160736084|NCT02939716|580414244|FG002|Overall Study|scanner failure|0|||
160736085|NCT02939716|580414245|FG003|Overall Study|scanner failure|1|||
160736086|NCT02939716|580414246|FG004|Overall Study|scanner failure|1|||
160736087|NCT02939716|580414247|FG005|Overall Study|scanner failure|1|||
160736088|NCT04240457|580414253|FG000|Overall Study|Lost to Follow-up|5|||
160736089|NCT04240457|580414254|FG001|Overall Study|Lost to Follow-up|1|||
160736090|NCT00844480|580414259|FG000|Overall Study|Withdrawal by Subject|2|||
160736091|NCT00844480|580414260|FG001|Overall Study|Withdrawal by Subject|3|||
160736092|NCT03197870|580414265|FG000|Overall Study|Adverse Event|9|||
160736093|NCT03197870|580414266|FG001|Overall Study|Adverse Event|4|||
160736094|NCT03197870|580414267|FG002|Overall Study|Adverse Event|6|||
160736095|NCT03197870|580414265|FG000|Overall Study|Withdrawal by Subject|2|||
160736096|NCT03197870|580414266|FG001|Overall Study|Withdrawal by Subject|3|||
160736097|NCT03197870|580414267|FG002|Overall Study|Withdrawal by Subject|0|||
160736098|NCT03197870|580414265|FG000|Overall Study|Lost to Follow-up|2|||
160736099|NCT03197870|580414266|FG001|Overall Study|Lost to Follow-up|2|||
160736100|NCT03197870|580414267|FG002|Overall Study|Lost to Follow-up|0|||
160736101|NCT03197870|580414265|FG000|Overall Study|data not available|1|||
160736102|NCT03197870|580414266|FG001|Overall Study|data not available|1|||
160736103|NCT03197870|580414267|FG002|Overall Study|data not available|0|||
160736104|NCT01618019|580414269|FG000|Overall Study|Withdrawal by Subject|14|||
160736105|NCT01618019|580414270|FG001|Overall Study|Withdrawal by Subject|14|||
160736106|NCT01508130|580414274|FG000|Overall Study|Adverse Event|81|||
160736107|NCT01508130|580414275|FG001|Overall Study|Adverse Event|28|||
160736108|NCT01508130|580414274|FG000|Overall Study|Death|3|||
160736109|NCT01508130|580414275|FG001|Overall Study|Death|1|||
160736110|NCT01508130|580414274|FG000|Overall Study|Protocol Violation|2|||
160736111|NCT01508130|580414275|FG001|Overall Study|Protocol Violation|0|||
160736112|NCT01508130|580414274|FG000|Overall Study|Lost to Follow-up|25|||
160736113|NCT01508130|580414275|FG001|Overall Study|Lost to Follow-up|2|||
160736114|NCT01508130|580414274|FG000|Overall Study|Withdrawal by Subject|3|||
160736115|NCT01508130|580414275|FG001|Overall Study|Withdrawal by Subject|3|||
160736116|NCT01508130|580414274|FG000|Overall Study|Subject's substantial non-compliance|25|||
160736117|NCT01508130|580414275|FG001|Overall Study|Subject's substantial non-compliance|9|||
160736118|NCT01508130|580414274|FG000|Overall Study|Insufficient therapeutic response|74|||
160736119|NCT01508130|580414275|FG001|Overall Study|Insufficient therapeutic response|23|||
160736120|NCT01508130|580414274|FG000|Overall Study|Administrative|14|||
160736121|NCT01508130|580414275|FG001|Overall Study|Administrative|3|||
160736122|NCT02288091|580414278|FG000|Overall Study|Lost to Follow-up|1|||
160736123|NCT02288091|580414278|FG000|Overall Study|Screen fail|7|||
160736124|NCT03403751|580414285|FG000|Overall Study|Death|5|||
160736125|NCT03403751|580414286|FG001|Overall Study|Death|6|||
160736126|NCT03403751|580414285|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
160736127|NCT03403751|580414286|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
160736128|NCT00520481|580414294|FG000|Overall Study|Adverse Event|4|||
160736129|NCT00520481|580414295|FG001|Overall Study|Adverse Event|1|||
160736130|NCT00520481|580414294|FG000|Overall Study|Withdrawal by Subject|3|||
160736131|NCT00520481|580414295|FG001|Overall Study|Withdrawal by Subject|0|||
160736132|NCT04442269|580414298|FG000|Overall Study|Adverse Event|1|||
160736133|NCT04442269|580414299|FG001|Overall Study|Adverse Event|0|||
160736134|NCT04442269|580414298|FG000|Overall Study|Death|0|||
160736135|NCT04442269|580414299|FG001|Overall Study|Death|1|||
160736136|NCT04442269|580414298|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
160736137|NCT04442269|580414299|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
160736138|NCT04442269|580414298|FG000|Overall Study|Lost to Follow-up|1|||
160736139|NCT04442269|580414299|FG001|Overall Study|Lost to Follow-up|0|||
160736140|NCT04442269|580414298|FG000|Overall Study|Withdrawal by Subject|3|||
160736141|NCT04442269|580414299|FG001|Overall Study|Withdrawal by Subject|2|||
160736142|NCT04442269|580414298|FG000|Overall Study|Protocol Deviation|0|||
160736143|NCT04442269|580414299|FG001|Overall Study|Protocol Deviation|1|||
160736144|NCT04442269|580414298|FG000|Overall Study|Travel Limitations|1|||
160736145|NCT04442269|580414299|FG001|Overall Study|Travel Limitations|1|||
160736146|NCT03802565|580414303|FG000|Overall Study|Adverse Event|0|||
160736147|NCT03802565|580414304|FG001|Overall Study|Adverse Event|1|||
160736148|NCT03802565|580414305|FG002|Overall Study|Adverse Event|2|||
160736149|NCT03802565|580414306|FG003|Overall Study|Adverse Event|1|||
160736150|NCT03802565|580414307|FG004|Overall Study|Adverse Event|1|||
160736151|NCT03802565|580414303|FG000|Overall Study|Withdrawal by Subject|2|||
160736152|NCT03802565|580414304|FG001|Overall Study|Withdrawal by Subject|2|||
160736153|NCT03802565|580414305|FG002|Overall Study|Withdrawal by Subject|2|||
160736154|NCT03802565|580414306|FG003|Overall Study|Withdrawal by Subject|0|||
160736155|NCT03802565|580414307|FG004|Overall Study|Withdrawal by Subject|1|||
160736156|NCT03802565|580414303|FG000|Overall Study|Protocol Violation|2|||
160736157|NCT03802565|580414304|FG001|Overall Study|Protocol Violation|1|||
160736158|NCT03802565|580414305|FG002|Overall Study|Protocol Violation|4|||
160736159|NCT03802565|580414306|FG003|Overall Study|Protocol Violation|5|||
160736160|NCT03802565|580414307|FG004|Overall Study|Protocol Violation|1|||
160736161|NCT03802565|580414303|FG000|Overall Study|Lost to Follow-up|0|||
160736162|NCT03802565|580414304|FG001|Overall Study|Lost to Follow-up|0|||
160736163|NCT03802565|580414305|FG002|Overall Study|Lost to Follow-up|1|||
160736164|NCT03802565|580414306|FG003|Overall Study|Lost to Follow-up|0|||
160736165|NCT03802565|580414307|FG004|Overall Study|Lost to Follow-up|0|||
160736166|NCT03802565|580414303|FG000|Overall Study|Subjects Related to Each Other|1|||
160736167|NCT03802565|580414304|FG001|Overall Study|Subjects Related to Each Other|0|||
160736168|NCT03802565|580414305|FG002|Overall Study|Subjects Related to Each Other|0|||
160736169|NCT03802565|580414306|FG003|Overall Study|Subjects Related to Each Other|2|||
160736170|NCT03802565|580414307|FG004|Overall Study|Subjects Related to Each Other|1|||
160736171|NCT03802565|580414303|FG000|Overall Study|Elevated Enzymes|0|||
160736172|NCT03802565|580414304|FG001|Overall Study|Elevated Enzymes|0|||
160736173|NCT03802565|580414305|FG002|Overall Study|Elevated Enzymes|0|||
160736174|NCT03802565|580414306|FG003|Overall Study|Elevated Enzymes|0|||
160736175|NCT03802565|580414307|FG004|Overall Study|Elevated Enzymes|2|||
160736176|NCT00430352|580414308|FG000|Overall Study|Disease progression|58|||
160736177|NCT00430352|580414308|FG000|Overall Study|Withdrawal by Subject|11|||
160736178|NCT00430352|580414308|FG000|Overall Study|Adverse Event|16|||
160736179|NCT00430352|580414308|FG000|Overall Study|Death|5|||
160736180|NCT00430352|580414308|FG000|Overall Study|Other|48|||
160736181|NCT03099694|580414309|FG000|Overall Study|Withdrawal by Subject|11|||
160736182|NCT03099694|580414310|FG001|Overall Study|Withdrawal by Subject|13|||
160736183|NCT03099694|580414309|FG000|Overall Study|Lost to Follow-up|9|||
160736184|NCT03099694|580414310|FG001|Overall Study|Lost to Follow-up|5|||
160736185|NCT04326439|580414311|FG000|Overall Study|Withdrawal by Subject|1|||
160736186|NCT04326439|580414312|FG001|Overall Study|Withdrawal by Subject|0|||
160736187|NCT04326439|580414311|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
160736188|NCT04326439|580414312|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
160736189|NCT04326439|580414311|FG000|Overall Study|Relapse after Induction 2|0|||
160736190|NCT04326439|580414312|FG001|Overall Study|Relapse after Induction 2|1|||
160736191|NCT04326439|580414311|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
160736192|NCT04326439|580414312|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
160736193|NCT00471718|580414316|FG000|Overall Study|Adverse Event|3|||
160736194|NCT00471718|580414316|FG000|Overall Study|other complicating disease|1|||
160736195|NCT00471718|580414316|FG000|Overall Study|disease progression|22|||
160736196|NCT00471718|580414316|FG000|Overall Study|Withdrawal by Subject|1|||
160736197|NCT01446237|580414317|FG000|Overall Study|Adverse Event|1|||
160736198|NCT01446237|580414317|FG000|Overall Study|Lost to Follow-up|2|||
160736199|NCT01446237|580414317|FG000|Overall Study|Withdrawal by Subject|7|||
160736200|NCT01931956|580414329|FG000|Overall Study|Death|42|||
160736201|NCT01931956|580414330|FG001|Overall Study|Death|7|||
160736202|NCT01931956|580414331|FG002|Overall Study|Death|379|||
160736203|NCT01931956|580414332|FG003|Overall Study|Death|96|||
160736204|NCT01931956|580414329|FG000|Overall Study|Withdrawal by Subject|5|||
160736205|NCT01931956|580414330|FG001|Overall Study|Withdrawal by Subject|0|||
160736206|NCT01931956|580414331|FG002|Overall Study|Withdrawal by Subject|70|||
160736207|NCT01931956|580414332|FG003|Overall Study|Withdrawal by Subject|30|||
160736208|NCT01931956|580414329|FG000|Overall Study|Lost to Follow-up|2|||
160736209|NCT01931956|580414330|FG001|Overall Study|Lost to Follow-up|0|||
160736210|NCT01931956|580414331|FG002|Overall Study|Lost to Follow-up|11|||
160736211|NCT01931956|580414332|FG003|Overall Study|Lost to Follow-up|7|||
160736212|NCT01931956|580414329|FG000|Overall Study|Expected|2|||
160736213|NCT01931956|580414330|FG001|Overall Study|Expected|0|||
160736214|NCT01931956|580414331|FG002|Overall Study|Expected|6|||
160736215|NCT01931956|580414332|FG003|Overall Study|Expected|0|||
160736216|NCT01931956|580414329|FG000|Overall Study|Not due|0|||
160736217|NCT01931956|580414330|FG001|Overall Study|Not due|0|||
160736218|NCT01931956|580414331|FG002|Overall Study|Not due|21|||
160736219|NCT01931956|580414332|FG003|Overall Study|Not due|0|||
160736220|NCT02294175|580414333|FG000|Overall Study|Withdrawal by Subject|1|||
160736221|NCT02294175|580414334|FG001|Overall Study|Withdrawal by Subject|2|||
160736222|NCT02294175|580414333|FG000|Overall Study|pt taking excluded medication|3|||
160736223|NCT02294175|580414334|FG001|Overall Study|pt taking excluded medication|1|||
160736224|NCT02294175|580414333|FG000|Overall Study|Protocol Violation|1|||
160736225|NCT02294175|580414334|FG001|Overall Study|Protocol Violation|0|||
160736226|NCT02294175|580414333|FG000|Overall Study|Lost to Follow-up|0|||
160736227|NCT02294175|580414334|FG001|Overall Study|Lost to Follow-up|1|||
160736228|NCT02294175|580414333|FG000|Overall Study|wound healed|0|||
160736229|NCT02294175|580414334|FG001|Overall Study|wound healed|2|||
160736230|NCT01901653|580414335|FG000|Overall Study|Death|2|||
160736231|NCT01901653|580414336|FG001|Overall Study|Death|1|||
160736232|NCT01901653|580414337|FG002|Overall Study|Death|8|||
160736233|NCT01901653|580414338|FG003|Overall Study|Death|3|||
160736234|NCT01901653|580414339|FG004|Overall Study|Death|2|||
160736235|NCT01901653|580414340|FG005|Overall Study|Death|2|||
160736236|NCT01901653|580414341|FG006|Overall Study|Death|6|||
160736237|NCT01901653|580414342|FG007|Overall Study|Death|9|||
160736238|NCT01901653|580414343|FG008|Overall Study|Death|1|||
160736239|NCT01901653|580414344|FG009|Overall Study|Death|16|||
160736240|NCT01901653|580414345|FG010|Overall Study|Death|2|||
160736241|NCT01901653|580414346|FG011|Overall Study|Death|15|||
160736242|NCT01901653|580414347|FG012|Overall Study|Death|4|||
160736243|NCT01901653|580414335|FG000|Overall Study|Lost to Follow-up|1|||
160736244|NCT01901653|580414336|FG001|Overall Study|Lost to Follow-up|0|||
160736245|NCT01901653|580414337|FG002|Overall Study|Lost to Follow-up|2|||
160736246|NCT01901653|580414338|FG003|Overall Study|Lost to Follow-up|0|||
160736247|NCT01901653|580414339|FG004|Overall Study|Lost to Follow-up|0|||
160736248|NCT01901653|580414340|FG005|Overall Study|Lost to Follow-up|1|||
160736249|NCT01901653|580414341|FG006|Overall Study|Lost to Follow-up|0|||
160736250|NCT01901653|580414342|FG007|Overall Study|Lost to Follow-up|1|||
160736251|NCT01901653|580414343|FG008|Overall Study|Lost to Follow-up|0|||
160736252|NCT01901653|580414344|FG009|Overall Study|Lost to Follow-up|0|||
160736253|NCT01901653|580414345|FG010|Overall Study|Lost to Follow-up|0|||
160736254|NCT01901653|580414346|FG011|Overall Study|Lost to Follow-up|0|||
160736255|NCT01901653|580414347|FG012|Overall Study|Lost to Follow-up|0|||
160736256|NCT01901653|580414335|FG000|Overall Study|Withdrawal by Subject|0|||
160736257|NCT01901653|580414336|FG001|Overall Study|Withdrawal by Subject|0|||
160736258|NCT01901653|580414337|FG002|Overall Study|Withdrawal by Subject|0|||
160736259|NCT01901653|580414338|FG003|Overall Study|Withdrawal by Subject|0|||
160736260|NCT01901653|580414339|FG004|Overall Study|Withdrawal by Subject|0|||
160736261|NCT01901653|580414340|FG005|Overall Study|Withdrawal by Subject|0|||
160736262|NCT01901653|580414341|FG006|Overall Study|Withdrawal by Subject|1|||
160736263|NCT01901653|580414342|FG007|Overall Study|Withdrawal by Subject|0|||
160736264|NCT01901653|580414343|FG008|Overall Study|Withdrawal by Subject|0|||
160736265|NCT01901653|580414344|FG009|Overall Study|Withdrawal by Subject|0|||
160736266|NCT01901653|580414345|FG010|Overall Study|Withdrawal by Subject|0|||
160736267|NCT01901653|580414346|FG011|Overall Study|Withdrawal by Subject|0|||
160736268|NCT01901653|580414347|FG012|Overall Study|Withdrawal by Subject|0|||
160736269|NCT01901653|580414335|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
160736270|NCT01901653|580414336|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
160736271|NCT01901653|580414337|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
160736272|NCT01901653|580414338|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
160736273|NCT01901653|580414339|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
160736274|NCT01901653|580414340|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
160736275|NCT01901653|580414341|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
160736276|NCT01901653|580414342|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
160736277|NCT01901653|580414343|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
160736278|NCT01901653|580414344|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
160736279|NCT01901653|580414345|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
160736280|NCT01901653|580414346|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
160736281|NCT01901653|580414347|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
160736282|NCT02548351|580414348|FG000|Overall Study|Withdrawal by Subject|149|||
160736283|NCT02548351|580414349|FG001|Overall Study|Withdrawal by Subject|154|||
160736284|NCT02548351|580414350|FG002|Overall Study|Withdrawal by Subject|152|||
160736285|NCT02548351|580414348|FG000|Overall Study|Death|11|||
160736286|NCT02548351|580414349|FG001|Overall Study|Death|15|||
160736287|NCT02548351|580414350|FG002|Overall Study|Death|12|||
160736288|NCT02548351|580414348|FG000|Overall Study|Adverse Event|22|||
160736289|NCT02548351|580414349|FG001|Overall Study|Adverse Event|56|||
160736290|NCT02548351|580414350|FG002|Overall Study|Adverse Event|36|||
160736291|NCT02548351|580414348|FG000|Overall Study|Study Terminated by Sponsor|549|||
160736292|NCT02548351|580414349|FG001|Overall Study|Study Terminated by Sponsor|509|||
160736293|NCT02548351|580414350|FG002|Overall Study|Study Terminated by Sponsor|528|||
160736294|NCT02548351|580414348|FG000|Overall Study|Site Closure|14|||
160736295|NCT02548351|580414349|FG001|Overall Study|Site Closure|5|||
160736296|NCT02548351|580414350|FG002|Overall Study|Site Closure|7|||
160736297|NCT02548351|580414348|FG000|Overall Study|Non-compliance with Study Drug|4|||
160736298|NCT02548351|580414349|FG001|Overall Study|Non-compliance with Study Drug|2|||
160736299|NCT02548351|580414350|FG002|Overall Study|Non-compliance with Study Drug|0|||
160736300|NCT02548351|580414348|FG000|Overall Study|Protocol Violation|2|||
160736301|NCT02548351|580414349|FG001|Overall Study|Protocol Violation|1|||
160736302|NCT02548351|580414350|FG002|Overall Study|Protocol Violation|2|||
160736303|NCT02548351|580414348|FG000|Overall Study|Physician Decision|11|||
160736304|NCT02548351|580414349|FG001|Overall Study|Physician Decision|18|||
160736305|NCT02548351|580414350|FG002|Overall Study|Physician Decision|11|||
160736306|NCT02548351|580414348|FG000|Overall Study|Lost to Follow-up|43|||
160736307|NCT02548351|580414349|FG001|Overall Study|Lost to Follow-up|50|||
160736308|NCT02548351|580414350|FG002|Overall Study|Lost to Follow-up|57|||
160736309|NCT02548351|580414348|FG000|Overall Study|Other|19|||
160736310|NCT02548351|580414349|FG001|Overall Study|Other|16|||
160736311|NCT02548351|580414350|FG002|Overall Study|Other|20|||
160736312|NCT02548351|580414348|FG000|Overall Study|Missing|1|||
160736313|NCT02548351|580414349|FG001|Overall Study|Missing|1|||
160736314|NCT02548351|580414350|FG002|Overall Study|Missing|0|||
160736315|NCT01817582|580414356|FG000|Overall Study|Withdrawal by Subject|0|||
160736316|NCT01817582|580414357|FG001|Overall Study|Withdrawal by Subject|1|||
160736317|NCT01817582|580414358|FG002|Overall Study|Withdrawal by Subject|0|||
160736318|NCT01817582|580414356|FG000|Overall Study|Participant revealed masked treatment|1|||
160736319|NCT01817582|580414357|FG001|Overall Study|Participant revealed masked treatment|0|||
160736320|NCT01817582|580414358|FG002|Overall Study|Participant revealed masked treatment|0|||
160736321|NCT01817582|580414356|FG000|Overall Study|Randomized but exclusion criteria met|1|||
160736322|NCT01817582|580414357|FG001|Overall Study|Randomized but exclusion criteria met|0|||
160736323|NCT01817582|580414358|FG002|Overall Study|Randomized but exclusion criteria met|0|||
160736324|NCT03053063|580414364|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
160736325|NCT03053063|580414365|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
160736326|NCT03053063|580414366|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
160736327|NCT03053063|580414367|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
160736328|NCT03053063|580414364|FG000|Randomized Phase|Withdrew consent|8|||
160736329|NCT03053063|580414365|FG001|Randomized Phase|Withdrew consent|11|||
160736330|NCT03053063|580414366|FG002|Randomized Phase|Withdrew consent|5|||
160736331|NCT03053063|580414367|FG003|Randomized Phase|Withdrew consent|0|||
160736332|NCT03053063|580414364|FG000|Randomized Phase|Investigator's Discretion|8|||
160736333|NCT03053063|580414365|FG001|Randomized Phase|Investigator's Discretion|6|||
160736334|NCT03053063|580414366|FG002|Randomized Phase|Investigator's Discretion|2|||
160736335|NCT03053063|580414367|FG003|Randomized Phase|Investigator's Discretion|0|||
160736336|NCT03053063|580414364|FG000|Randomized Phase|Lost to Follow-up|3|||
160736337|NCT03053063|580414365|FG001|Randomized Phase|Lost to Follow-up|5|||
160736338|NCT03053063|580414366|FG002|Randomized Phase|Lost to Follow-up|1|||
160736339|NCT03053063|580414367|FG003|Randomized Phase|Lost to Follow-up|0|||
160736340|NCT03053063|580414364|FG000|Randomized Phase|Adverse Event|0|||
160736341|NCT03053063|580414365|FG001|Randomized Phase|Adverse Event|1|||
160736342|NCT03053063|580414366|FG002|Randomized Phase|Adverse Event|0|||
160736343|NCT03053063|580414367|FG003|Randomized Phase|Adverse Event|0|||
160736344|NCT03053063|580414364|FG000|Randomized Phase|Randomized but Never Treated|1|||
160736345|NCT03053063|580414365|FG001|Randomized Phase|Randomized but Never Treated|3|||
160736346|NCT03053063|580414366|FG002|Randomized Phase|Randomized but Never Treated|2|||
160736347|NCT03053063|580414367|FG003|Randomized Phase|Randomized but Never Treated|0|||
160736348|NCT03053063|580414364|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
160736349|NCT03053063|580414365|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
160736350|NCT03053063|580414366|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
160736351|NCT03053063|580414367|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
160736352|NCT03053063|580414364|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
160736353|NCT03053063|580414365|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
160736354|NCT03053063|580414366|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
160736355|NCT03053063|580414367|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
160736356|NCT03053063|580414364|FG000|Open-Label Phase|Death|0|||
160736357|NCT03053063|580414365|FG001|Open-Label Phase|Death|0|||
160736358|NCT03053063|580414366|FG002|Open-Label Phase|Death|0|||
160736359|NCT03053063|580414367|FG003|Open-Label Phase|Death|2|||
160736360|NCT03053063|580414364|FG000|Open-Label Phase|Investigator's discretion|0|||
160736361|NCT03053063|580414365|FG001|Open-Label Phase|Investigator's discretion|0|||
160736362|NCT03053063|580414366|FG002|Open-Label Phase|Investigator's discretion|0|||
160736363|NCT03053063|580414367|FG003|Open-Label Phase|Investigator's discretion|2|||
160736364|NCT02600845|580414368|FG000|Overall Study|Reason Not Specified|3|||
160736365|NCT02600845|580414368|FG000|Overall Study|Non-compliance with Study Procedures|10|||
160736366|NCT02600845|580414368|FG000|Overall Study|Consent Withdrawal|5|||
160736367|NCT00197002|580416473|FG000|Overall Study|Adverse Event|0|||
160736368|NCT00197002|580416474|FG001|Overall Study|Adverse Event|1|||
160736369|NCT00197002|580416475|FG002|Overall Study|Adverse Event|0|||
160736370|NCT00197002|580416473|FG000|Overall Study|Protocol Violation|1|||
160736371|NCT00197002|580416474|FG001|Overall Study|Protocol Violation|0|||
160736372|NCT00197002|580416475|FG002|Overall Study|Protocol Violation|2|||
160736373|NCT00197002|580416473|FG000|Overall Study|Withdrawal by Subject|9|||
160736374|NCT00197002|580416474|FG001|Overall Study|Withdrawal by Subject|5|||
160736375|NCT00197002|580416475|FG002|Overall Study|Withdrawal by Subject|7|||
160736376|NCT00197002|580416473|FG000|Overall Study|Migrated/moved from study area|3|||
160736377|NCT00197002|580416474|FG001|Overall Study|Migrated/moved from study area|5|||
160736378|NCT00197002|580416475|FG002|Overall Study|Migrated/moved from study area|1|||
160736379|NCT00197002|580416473|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
160736380|NCT00197002|580416474|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
160736381|NCT00197002|580416475|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
160736382|NCT00197002|580416473|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
160736383|NCT00197002|580416474|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
160736384|NCT00197002|580416475|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
160736385|NCT00197002|580416473|FG000|Overall Study|Others|3|||
160736386|NCT00197002|580416474|FG001|Overall Study|Others|1|||
160736387|NCT00197002|580416475|FG002|Overall Study|Others|1|||
160736388|NCT02515994|580416476|FG000|Overall Study|Protocol Violation|3|||
160736389|NCT02515994|580416477|FG001|Overall Study|Protocol Violation|5|||
160736390|NCT02515994|580416476|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
160736391|NCT02515994|580416477|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
160736392|NCT02515994|580416476|FG000|Overall Study|Adverse Event|3|||
160736393|NCT02515994|580416477|FG001|Overall Study|Adverse Event|1|||
160736394|NCT02515994|580416476|FG000|Overall Study|Withdrawal by Subject|2|||
160736395|NCT02515994|580416477|FG001|Overall Study|Withdrawal by Subject|0|||
160736396|NCT01424514|580416478|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
160736397|NCT01424514|580416479|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
160736398|NCT01424514|580416478|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
160736399|NCT01424514|580416479|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
160736400|NCT04598451|580416480|FG000|Overall Study|Adverse Event|3|||
160736401|NCT04598451|580416481|FG001|Overall Study|Adverse Event|2|||
160736402|NCT04598451|580416480|FG000|Overall Study|Withdrawal by Subject|3|||
160736403|NCT04598451|580416481|FG001|Overall Study|Withdrawal by Subject|7|||
160736404|NCT04598451|580416480|FG000|Overall Study|Lost to Follow-up|2|||
160736405|NCT04598451|580416481|FG001|Overall Study|Lost to Follow-up|0|||
160736406|NCT04598451|580416480|FG000|Overall Study|Physician Decision|4|||
160736407|NCT04598451|580416481|FG001|Overall Study|Physician Decision|1|||
160736408|NCT04598451|580416480|FG000|Overall Study|Requires Prohibited Medication|1|||
160736409|NCT04598451|580416481|FG001|Overall Study|Requires Prohibited Medication|0|||
160736410|NCT04598451|580416480|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
160736411|NCT04598451|580416481|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
160736412|NCT02653170|580416482|FG000|Overall Study|Withdrawal by Subject|3|||
160736413|NCT02653170|580416483|FG001|Overall Study|Withdrawal by Subject|8|||
160736414|NCT02653170|580416484|FG002|Overall Study|Withdrawal by Subject|3|||
160736415|NCT02653170|580416482|FG000|Overall Study|withdrawn by study team|2|||
160736416|NCT02653170|580416483|FG001|Overall Study|withdrawn by study team|4|||
160736417|NCT02653170|580416484|FG002|Overall Study|withdrawn by study team|5|||
160736418|NCT02653170|580416482|FG000|Overall Study|Lost to Follow-up|12|||
160736419|NCT02653170|580416483|FG001|Overall Study|Lost to Follow-up|4|||
160736420|NCT02653170|580416484|FG002|Overall Study|Lost to Follow-up|10|||
160736421|NCT01632150|580416485|FG000|Overall Study|Disease progression|27|||
160736422|NCT01632150|580416485|FG000|Overall Study|Study drug toxicity|1|||
160736423|NCT01632150|580416485|FG000|Overall Study|Unrelated adverse event|7|||
160736424|NCT01632150|580416485|FG000|Overall Study|Withdrawal by Subject|2|||
160736425|NCT01632150|580416485|FG000|Overall Study|Patient underwent autologous transplant|1|||
160736426|NCT01632150|580416485|FG000|Overall Study|Moved to compassionate program|2|||
160736427|NCT02879994|580416488|FG000|Overall Study|off treatment early|7|||
160736428|NCT02879994|580416488|FG000|Overall Study|Adverse Event|2|||
160736429|NCT02879994|580416488|FG000|Overall Study|Death|2|||
160736430|NCT02143791|580416489|FG000|Enrolled|Withdrawal by Subject|4|||
160736431|NCT02143791|580416489|FG000|Trial Stimulation|Lack of Efficacy|21|||
160736432|NCT02143791|580416489|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
160736433|NCT02143791|580416489|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
160736434|NCT02143791|580416489|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
160736435|NCT02143791|580416489|FG000|Any Programming (3-6 Months)|Missing Data|1|||
160736436|NCT02143791|580416489|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
160736437|NCT04984681|580416494|FG000|Overall Study|Lost to Follow-up|3|||
160736438|NCT04984681|580416495|FG001|Overall Study|Lost to Follow-up|1|||
160736439|NCT04327661|580416496|FG000|Overall Study|Withdrawal by Subject|1|||
160736440|NCT04327661|580416497|FG001|Overall Study|Withdrawal by Subject|0|||
160736441|NCT04327661|580416498|FG002|Overall Study|Withdrawal by Subject|0|||
160736442|NCT03391232|580416499|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
160736443|NCT03391232|580416500|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
160736444|NCT03391232|580416499|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
160736445|NCT03391232|580416500|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
160736446|NCT02091960|580416501|FG000|Overall Study|Death|7|||
160736447|NCT02091960|580416501|FG000|Overall Study|Withdrawal by Subject|1|||
160736448|NCT02091960|580416501|FG000|Overall Study|Miscellaneous Reasons|37|||
160736449|NCT02637895|580416512|FG000|Overall Study|Lost to Follow-up|4|||
160736450|NCT02637895|580416513|FG001|Overall Study|Lost to Follow-up|0|||
160736451|NCT02637895|580416512|FG000|Overall Study|Protocol Violation|0|||
160736452|NCT02637895|580416513|FG001|Overall Study|Protocol Violation|1|||
160736453|NCT02637895|580416512|FG000|Overall Study|Lack of Efficacy|1|||
160736454|NCT02637895|580416513|FG001|Overall Study|Lack of Efficacy|0|||
160736455|NCT02637895|580416512|FG000|Overall Study|Withdrawal by Subject|1|||
160736456|NCT02637895|580416513|FG001|Overall Study|Withdrawal by Subject|1|||
160736457|NCT02637895|580416512|FG000|Overall Study|Abnormal baseline lab|0|||
160736458|NCT02637895|580416513|FG001|Overall Study|Abnormal baseline lab|1|||
160736459|NCT04777201|580416516|FG000|Main Study|Withdrawal by Subject|19|||
160736460|NCT04777201|580416517|FG001|Main Study|Withdrawal by Subject|27|||
160736461|NCT04777201|580416518|FG002|Main Study|Withdrawal by Subject|0|||
160736462|NCT04777201|580416516|FG000|Main Study|Death|13|||
160736463|NCT04777201|580416517|FG001|Main Study|Death|27|||
160736464|NCT04777201|580416518|FG002|Main Study|Death|0|||
160736465|NCT04777201|580416516|FG000|Main Study|Subject missed the safety follow-up visit|9|||
160736466|NCT04777201|580416517|FG001|Main Study|Subject missed the safety follow-up visit|10|||
160736467|NCT04777201|580416518|FG002|Main Study|Subject missed the safety follow-up visit|0|||
160736468|NCT04777201|580416516|FG000|Main Study|Physician Decision|8|||
160736469|NCT04777201|580416517|FG001|Main Study|Physician Decision|10|||
160736470|NCT04777201|580416518|FG002|Main Study|Physician Decision|0|||
160736471|NCT04777201|580416516|FG000|Main Study|Adverse Event|8|||
160736472|NCT04777201|580416517|FG001|Main Study|Adverse Event|8|||
160736473|NCT04777201|580416518|FG002|Main Study|Adverse Event|0|||
160736474|NCT04777201|580416516|FG000|Main Study|Lost to Follow-up|9|||
160736475|NCT04777201|580416517|FG001|Main Study|Lost to Follow-up|4|||
160736476|NCT04777201|580416518|FG002|Main Study|Lost to Follow-up|0|||
160736477|NCT04777201|580416516|FG000|Main Study|Reason not specified|3|||
160736478|NCT04777201|580416517|FG001|Main Study|Reason not specified|3|||
160736479|NCT04777201|580416518|FG002|Main Study|Reason not specified|0|||
160736480|NCT04777201|580416516|FG000|Main Study|Lack of Efficacy|1|||
160736481|NCT04777201|580416517|FG001|Main Study|Lack of Efficacy|1|||
160736482|NCT04777201|580416518|FG002|Main Study|Lack of Efficacy|0|||
160736483|NCT04777201|580416516|FG000|Main Study|Protocol Violation|1|||
160736484|NCT04777201|580416517|FG001|Main Study|Protocol Violation|0|||
160736485|NCT04777201|580416518|FG002|Main Study|Protocol Violation|0|||
160736486|NCT04777201|580416516|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
160736487|NCT04777201|580416517|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
160736488|NCT04777201|580416518|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
160736489|NCT04777201|580416516|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
160736490|NCT04777201|580416517|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
160736491|NCT04777201|580416518|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
160736492|NCT04777201|580416516|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
160736493|NCT04777201|580416517|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
160736494|NCT04777201|580416518|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
160736495|NCT04777201|580416516|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
160736496|NCT04777201|580416517|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
160736497|NCT04777201|580416518|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
160736498|NCT04777201|580416516|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
160736499|NCT04777201|580416517|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
160736500|NCT04777201|580416518|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
160736501|NCT04777201|580416516|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
160736502|NCT04777201|580416517|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
160736503|NCT04777201|580416518|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
160736504|NCT00507819|580416521|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
160736505|NCT00507819|580416522|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
160736506|NCT00738881|580416525|FG000|Overall Study|Withdrawal by Subject|0|||
160736507|NCT00738881|580416526|FG001|Overall Study|Withdrawal by Subject|2|||
160736508|NCT00177307|580416528|FG000|Overall Study|Withdrawal by Subject|1|||
160736509|NCT03671564|580416531|FG000|Overall Study|Progressive Disease|3|||
160736510|NCT03671564|580416532|FG001|Overall Study|Progressive Disease|5|||
160736511|NCT03671564|580416533|FG002|Overall Study|Progressive Disease|3|||
160736512|NCT03671564|580416531|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
160736513|NCT03671564|580416532|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
160736514|NCT03671564|580416533|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
160736515|NCT03671564|580416531|FG000|Overall Study|Withdrawal by Subject|1|||
160736516|NCT03671564|580416532|FG001|Overall Study|Withdrawal by Subject|1|||
160736517|NCT03671564|580416533|FG002|Overall Study|Withdrawal by Subject|0|||
160736518|NCT04521621|580416534|FG000|Overall Study|Death|17|||
160736519|NCT04521621|580416535|FG001|Overall Study|Death|8|||
160736520|NCT04521621|580416536|FG002|Overall Study|Death|8|||
160736521|NCT04521621|580416537|FG003|Overall Study|Death|5|||
160736522|NCT04521621|580416538|FG004|Overall Study|Death|2|||
160736523|NCT04521621|580416539|FG005|Overall Study|Death|7|||
160736524|NCT04521621|580416540|FG006|Overall Study|Death|0|||
160736525|NCT04521621|580416541|FG007|Overall Study|Death|0|||
160736526|NCT04521621|580416534|FG000|Overall Study|Study Terminated by Sponsor|4|||
160736527|NCT04521621|580416535|FG001|Overall Study|Study Terminated by Sponsor|6|||
160736528|NCT04521621|580416536|FG002|Overall Study|Study Terminated by Sponsor|8|||
160736529|NCT04521621|580416537|FG003|Overall Study|Study Terminated by Sponsor|0|||
160736530|NCT04521621|580416538|FG004|Overall Study|Study Terminated by Sponsor|1|||
160736531|NCT04521621|580416539|FG005|Overall Study|Study Terminated by Sponsor|7|||
160736532|NCT04521621|580416540|FG006|Overall Study|Study Terminated by Sponsor|0|||
160736533|NCT04521621|580416541|FG007|Overall Study|Study Terminated by Sponsor|0|||
160736534|NCT04521621|580416534|FG000|Overall Study|Withdrawal by Subject|0|||
160736535|NCT04521621|580416535|FG001|Overall Study|Withdrawal by Subject|0|||
160736536|NCT04521621|580416536|FG002|Overall Study|Withdrawal by Subject|1|||
160736537|NCT04521621|580416537|FG003|Overall Study|Withdrawal by Subject|1|||
160736538|NCT04521621|580416538|FG004|Overall Study|Withdrawal by Subject|0|||
160736539|NCT04521621|580416539|FG005|Overall Study|Withdrawal by Subject|0|||
160736540|NCT04521621|580416540|FG006|Overall Study|Withdrawal by Subject|0|||
160736541|NCT04521621|580416541|FG007|Overall Study|Withdrawal by Subject|0|||
160736542|NCT04521621|580416534|FG000|Overall Study|Allocated in error without study intervention|1|||
160736543|NCT04521621|580416535|FG001|Overall Study|Allocated in error without study intervention|0|||
160736544|NCT04521621|580416536|FG002|Overall Study|Allocated in error without study intervention|0|||
160736545|NCT04521621|580416537|FG003|Overall Study|Allocated in error without study intervention|0|||
160736546|NCT04521621|580416538|FG004|Overall Study|Allocated in error without study intervention|0|||
160736547|NCT04521621|580416539|FG005|Overall Study|Allocated in error without study intervention|0|||
160736548|NCT04521621|580416540|FG006|Overall Study|Allocated in error without study intervention|0|||
160736549|NCT04521621|580416541|FG007|Overall Study|Allocated in error without study intervention|0|||
160736550|NCT02541669|580416550|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
160736551|NCT02541669|580416551|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
160736552|NCT02541669|580416552|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
160736553|NCT02541669|580416553|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
160736554|NCT02541669|580416554|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
160736555|NCT00834639|580416555|FG000|Second Intervention|Physician Decision|0|||
160736556|NCT00834639|580416556|FG001|Second Intervention|Physician Decision|2|||
160736557|NCT04739722|580416560|FG000|Overall Study|Lost to Follow-up|5301|||
160736558|NCT04739722|580416560|FG000|Overall Study|Withdrawal by Subject|42|||
160736559|NCT04739722|580416560|FG000|Overall Study|Non Average-risk|1157|||
160736560|NCT01968707|580416561|FG000|Overall Study|Did not meet treatment day baseline|49|||
160736561|NCT01968707|580416562|FG001|Overall Study|Did not meet treatment day baseline|12|||
160736562|NCT01968707|580416563|FG002|Overall Study|Did not meet treatment day baseline|41|||
160736563|NCT01968707|580416564|FG003|Overall Study|Did not meet treatment day baseline|44|||
160736564|NCT01968707|580416565|FG004|Overall Study|Did not meet treatment day baseline|36|||
160736565|NCT01968707|580416566|FG005|Overall Study|Did not meet treatment day baseline|11|||
160736566|NCT01968707|580416567|FG006|Overall Study|Did not meet treatment day baseline|34|||
160736567|NCT01968707|580416568|FG007|Overall Study|Did not meet treatment day baseline|35|||
160736568|NCT01104246|580416573|FG000|Overall Study|Withdrawal by Subject|1|||
160736569|NCT01104246|580416573|FG000|Overall Study|did not meet inclusion criteria|4|||
160736570|NCT05178641|580416574|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
160736571|NCT05178641|580416575|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
160736572|NCT05178641|580416574|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
160736573|NCT05178641|580416575|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
160736574|NCT01869699|580416578|FG000|Overall Study|Withdrawal by Subject|1|||
160736575|NCT01869699|580416579|FG001|Overall Study|Withdrawal by Subject|0|||
160736576|NCT01083186|580416584|FG000|Overall Study|Lost to Follow-up|48|||
160736577|NCT01083186|580416584|FG000|Overall Study|Consent Withdrawal|7|||
160736578|NCT01083186|580416584|FG000|Overall Study|Death|3|||
160736579|NCT01083186|580416584|FG000|Overall Study|Adverse Event|3|||
160736580|NCT01083186|580416584|FG000|Overall Study|Lack of Efficacy|2|||
160736581|NCT01083186|580416584|FG000|Overall Study|Hemodialysis Initiation|28|||
160736582|NCT01083186|580416584|FG000|Overall Study|Administrative Reasons|2|||
160736583|NCT01083186|580416584|FG000|Overall Study|Non-compliance to Study Treatment|1|||
160736584|NCT01867294|580416591|FG000|Overall Study|Withdrawal by Subject|1|||
160736585|NCT01867294|580416592|FG001|Overall Study|Withdrawal by Subject|1|||
160736586|NCT01867294|580416593|FG002|Overall Study|Withdrawal by Subject|0|||
160736587|NCT01867294|580416594|FG003|Overall Study|Withdrawal by Subject|0|||
160736588|NCT02062944|580416595|FG000|Overall Study|Lost to Follow-up|1|||
160736589|NCT02062944|580416595|FG000|Overall Study|New hemotological disorder identified|1|||
160736590|NCT02062944|580416595|FG000|Overall Study|Uncontrolled Hypertension|1|||
160736591|NCT02062944|580416595|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
160736592|NCT00278148|580416596|FG000|Phase II - Expansion Phase|Disease progression|0|||
160736593|NCT00278148|580416597|FG001|Phase II - Expansion Phase|Disease progression|0|||
160736594|NCT00278148|580416598|FG002|Phase II - Expansion Phase|Disease progression|4|||
160736595|NCT00278148|580416596|FG000|Phase II - Expansion Phase|Adverse Event|0|||
160736596|NCT00278148|580416597|FG001|Phase II - Expansion Phase|Adverse Event|0|||
160736597|NCT00278148|580416598|FG002|Phase II - Expansion Phase|Adverse Event|2|||
160736598|NCT00976209|580416601|FG000|Treatment Period 1|Protocol Violation|1|||
160736599|NCT00976209|580416602|FG001|Treatment Period 1|Protocol Violation|0|||
160736600|NCT00976209|580416601|FG000|Treatment Period 1|Lost to Follow-up|2|||
160736601|NCT00976209|580416602|FG001|Treatment Period 1|Lost to Follow-up|0|||
160736602|NCT00976209|580416601|FG000|Treatment Period 1|Other|0|||
160736603|NCT00976209|580416602|FG001|Treatment Period 1|Other|1|||
160736604|NCT00976209|580416601|FG000|Wash-out Period|Adverse Event|1|||
160736605|NCT00976209|580416602|FG001|Wash-out Period|Adverse Event|2|||
160736606|NCT00976209|580416601|FG000|Wash-out Period|Lost to Follow-up|1|||
160736607|NCT00976209|580416602|FG001|Wash-out Period|Lost to Follow-up|0|||
160736608|NCT00976209|580416601|FG000|Wash-out Period|Protocol Violation|1|||
160736609|NCT00976209|580416602|FG001|Wash-out Period|Protocol Violation|0|||
160736610|NCT00976209|580416601|FG000|Wash-out Period|Other|1|||
160736611|NCT00976209|580416602|FG001|Wash-out Period|Other|0|||
160736612|NCT00976209|580416601|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160736613|NCT00976209|580416602|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160736614|NCT00976209|580416601|FG000|Treatment Period 2|Lost to Follow-up|0|||
160736615|NCT00976209|580416602|FG001|Treatment Period 2|Lost to Follow-up|1|||
160736616|NCT00574249|580416603|FG000|Overall Study|Adverse Event|6|||
160736617|NCT00574249|580416604|FG001|Overall Study|Adverse Event|18|||
160736618|NCT00574249|580416603|FG000|Overall Study|Lack of Efficacy|5|||
160736619|NCT00574249|580416604|FG001|Overall Study|Lack of Efficacy|3|||
160736620|NCT00574249|580416603|FG000|Overall Study|Lost to Follow-up|4|||
160736621|NCT00574249|580416604|FG001|Overall Study|Lost to Follow-up|3|||
160736622|NCT00574249|580416603|FG000|Overall Study|Protocol Violation|5|||
160736623|NCT00574249|580416604|FG001|Overall Study|Protocol Violation|2|||
160736624|NCT00574249|580416603|FG000|Overall Study|History of carcinoma|1|||
160736625|NCT00574249|580416604|FG001|Overall Study|History of carcinoma|0|||
160736626|NCT00574249|580416603|FG000|Overall Study|Withdrawal by Subject|3|||
160736627|NCT00574249|580416604|FG001|Overall Study|Withdrawal by Subject|0|||
160736628|NCT00574249|580416603|FG000|Overall Study|Physician Decision|1|||
160736629|NCT00574249|580416604|FG001|Overall Study|Physician Decision|0|||
160736630|NCT00574249|580416603|FG000|Overall Study|Pregnancy|1|||
160736631|NCT00574249|580416604|FG001|Overall Study|Pregnancy|0|||
160736632|NCT00574249|580416603|FG000|Overall Study|Excluded by company|0|||
160736633|NCT00574249|580416604|FG001|Overall Study|Excluded by company|1|||
160736634|NCT00574249|580416603|FG000|Overall Study|PPD test taken twice|0|||
160736635|NCT00574249|580416604|FG001|Overall Study|PPD test taken twice|1|||
160736636|NCT01542034|580416605|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
160736637|NCT01542034|580416606|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
160736638|NCT01542034|580416605|FG000|Overall Study|Administrative decision|0|||
160736639|NCT01542034|580416606|FG001|Overall Study|Administrative decision|3|||
160736640|NCT01542034|580416605|FG000|Overall Study|Subject Noncompliance|1|||
160736641|NCT01542034|580416606|FG001|Overall Study|Subject Noncompliance|0|||
160736642|NCT01542034|580416605|FG000|Overall Study|Adverse Event|2|||
160736643|NCT01542034|580416606|FG001|Overall Study|Adverse Event|2|||
160736644|NCT01542034|580416605|FG000|Overall Study|Lost to Follow-up|7|||
160736645|NCT01542034|580416606|FG001|Overall Study|Lost to Follow-up|6|||
160736646|NCT02612610|580416607|FG000|Overall Study|Withdrawal by Subject|1|||
160736647|NCT02612610|580416608|FG001|Overall Study|Withdrawal by Subject|1|||
160736648|NCT02612610|580416609|FG002|Overall Study|Withdrawal by Subject|0|||
160736649|NCT02612610|580416610|FG003|Overall Study|Withdrawal by Subject|2|||
160736650|NCT02612610|580416607|FG000|Overall Study|Adverse Event|2|||
160736651|NCT02612610|580416608|FG001|Overall Study|Adverse Event|2|||
160736652|NCT02612610|580416609|FG002|Overall Study|Adverse Event|3|||
160736653|NCT02612610|580416610|FG003|Overall Study|Adverse Event|10|||
160736654|NCT02612610|580416607|FG000|Overall Study|Lost to Follow-up|0|||
160736655|NCT02612610|580416608|FG001|Overall Study|Lost to Follow-up|1|||
160736656|NCT02612610|580416609|FG002|Overall Study|Lost to Follow-up|0|||
160736657|NCT02612610|580416610|FG003|Overall Study|Lost to Follow-up|0|||
160736658|NCT02612610|580416607|FG000|Overall Study|Protocol Violation|0|||
160736659|NCT02612610|580416608|FG001|Overall Study|Protocol Violation|1|||
160736660|NCT02612610|580416609|FG002|Overall Study|Protocol Violation|1|||
160736661|NCT02612610|580416610|FG003|Overall Study|Protocol Violation|0|||
160736662|NCT02612610|580416607|FG000|Overall Study|Lack of Efficacy|1|||
160736663|NCT02612610|580416608|FG001|Overall Study|Lack of Efficacy|2|||
160736664|NCT02612610|580416609|FG002|Overall Study|Lack of Efficacy|0|||
160736665|NCT02612610|580416610|FG003|Overall Study|Lack of Efficacy|1|||
160736666|NCT02612610|580416607|FG000|Overall Study|Physician Decision|0|||
160736667|NCT02612610|580416608|FG001|Overall Study|Physician Decision|1|||
160736668|NCT02612610|580416609|FG002|Overall Study|Physician Decision|0|||
160736669|NCT02612610|580416610|FG003|Overall Study|Physician Decision|0|||
160736670|NCT02612610|580416607|FG000|Overall Study|Noncompliance|1|||
160736671|NCT02612610|580416608|FG001|Overall Study|Noncompliance|0|||
160736672|NCT02612610|580416609|FG002|Overall Study|Noncompliance|0|||
160736673|NCT02612610|580416610|FG003|Overall Study|Noncompliance|0|||
160736674|NCT02612610|580416607|FG000|Overall Study|Cough Improvement|0|||
160736675|NCT02612610|580416608|FG001|Overall Study|Cough Improvement|0|||
160736676|NCT02612610|580416609|FG002|Overall Study|Cough Improvement|1|||
160736677|NCT02612610|580416610|FG003|Overall Study|Cough Improvement|0|||
160736678|NCT01546571|580416613|FG000|Overall Study|Adverse Event|1|||
160736679|NCT01546571|580416614|FG001|Overall Study|Adverse Event|0|||
160736680|NCT01546571|580416615|FG002|Overall Study|Adverse Event|0|||
160736681|NCT01546571|580416616|FG003|Overall Study|Adverse Event|1|||
160736682|NCT01546571|580416617|FG004|Overall Study|Adverse Event|0|||
160736683|NCT01546571|580416613|FG000|Overall Study|assigned placebo in Part A|0|||
160736684|NCT01546571|580416614|FG001|Overall Study|assigned placebo in Part A|0|||
160736685|NCT01546571|580416615|FG002|Overall Study|assigned placebo in Part A|22|||
160736686|NCT01546571|580416616|FG003|Overall Study|assigned placebo in Part A|0|||
160736687|NCT01546571|580416617|FG004|Overall Study|assigned placebo in Part A|0|||
160736688|NCT01546571|580416613|FG000|Overall Study|Death|0|||
160736689|NCT01546571|580416614|FG001|Overall Study|Death|1|||
160736690|NCT01546571|580416615|FG002|Overall Study|Death|0|||
160736691|NCT01546571|580416616|FG003|Overall Study|Death|0|||
160736692|NCT01546571|580416617|FG004|Overall Study|Death|0|||
160736693|NCT01546571|580416613|FG000|Overall Study|Lost to Follow-up|0|||
160736694|NCT01546571|580416614|FG001|Overall Study|Lost to Follow-up|0|||
160736695|NCT01546571|580416615|FG002|Overall Study|Lost to Follow-up|2|||
160736696|NCT01546571|580416616|FG003|Overall Study|Lost to Follow-up|2|||
160736697|NCT01546571|580416617|FG004|Overall Study|Lost to Follow-up|3|||
160736698|NCT01546571|580416613|FG000|Overall Study|Pregnancy|0|||
160736699|NCT01546571|580416614|FG001|Overall Study|Pregnancy|0|||
160736700|NCT01546571|580416615|FG002|Overall Study|Pregnancy|0|||
160736701|NCT01546571|580416616|FG003|Overall Study|Pregnancy|1|||
160736702|NCT01546571|580416617|FG004|Overall Study|Pregnancy|0|||
160736703|NCT01546571|580416613|FG000|Overall Study|Disease Progression|20|||
160736704|NCT01546571|580416614|FG001|Overall Study|Disease Progression|18|||
160736705|NCT01546571|580416615|FG002|Overall Study|Disease Progression|15|||
160736706|NCT01546571|580416616|FG003|Overall Study|Disease Progression|73|||
160736707|NCT01546571|580416617|FG004|Overall Study|Disease Progression|37|||
160736708|NCT01546571|580416613|FG000|Overall Study|Withdrawal by Subject|1|||
160736709|NCT01546571|580416614|FG001|Overall Study|Withdrawal by Subject|2|||
160736710|NCT01546571|580416615|FG002|Overall Study|Withdrawal by Subject|4|||
160736711|NCT01546571|580416616|FG003|Overall Study|Withdrawal by Subject|9|||
160736712|NCT01546571|580416617|FG004|Overall Study|Withdrawal by Subject|2|||
160736713|NCT01546571|580416613|FG000|Overall Study|Intercurrent Illness|1|||
160736714|NCT01546571|580416614|FG001|Overall Study|Intercurrent Illness|2|||
160736715|NCT01546571|580416615|FG002|Overall Study|Intercurrent Illness|0|||
160736716|NCT01546571|580416616|FG003|Overall Study|Intercurrent Illness|0|||
160736717|NCT01546571|580416617|FG004|Overall Study|Intercurrent Illness|0|||
160736718|NCT01546571|580416613|FG000|Overall Study|Other Cancers|0|||
160736719|NCT01546571|580416614|FG001|Overall Study|Other Cancers|0|||
160736720|NCT01546571|580416615|FG002|Overall Study|Other Cancers|0|||
160736721|NCT01546571|580416616|FG003|Overall Study|Other Cancers|3|||
160736722|NCT01546571|580416617|FG004|Overall Study|Other Cancers|1|||
160736723|NCT01546571|580416613|FG000|Overall Study|Other|0|||
160736724|NCT01546571|580416614|FG001|Overall Study|Other|0|||
160736725|NCT01546571|580416615|FG002|Overall Study|Other|3|||
160736726|NCT01546571|580416616|FG003|Overall Study|Other|0|||
160736727|NCT01546571|580416617|FG004|Overall Study|Other|0|||
160736728|NCT00478699|580416620|FG000|Overall Study|Inclusion Error|1|||
160736729|NCT00478699|580416621|FG001|Overall Study|Inclusion Error|7|||
160736730|NCT00478699|580416620|FG000|Overall Study|Not receive study treatment|6|||
160736731|NCT00478699|580416621|FG001|Overall Study|Not receive study treatment|30|||
160736732|NCT01252563|580416623|FG000|Overall Study|Contract Deviation|41|||
160736733|NCT01252563|580416623|FG000|Overall Study|Centralized Registration Deviation|30|||
160736734|NCT01252563|580416623|FG000|Overall Study|Lost to Follow-up|161|||
160736735|NCT01252563|580416623|FG000|Overall Study|No visit after first day of treatment|194|||
160736736|NCT01252563|580416623|FG000|Overall Study|No drug administration|6|||
160736737|NCT01866657|580416624|FG000|Overall Study|Surgery canceled|2|||
160736738|NCT01866657|580416625|FG001|Overall Study|Surgery canceled|0|||
160736739|NCT01880086|580416631|FG000|Overall Study|Lost to Follow-up|1|||
160736740|NCT01880086|580416632|FG001|Overall Study|Lost to Follow-up|1|||
160736741|NCT00978250|580416636|FG000|Overall Study|Late determination of ineligibility|0|||
160736742|NCT00978250|580416637|FG001|Overall Study|Late determination of ineligibility|1|||
160736743|NCT00978250|580416638|FG002|Overall Study|Late determination of ineligibility|0|||
160736744|NCT00978250|580416639|FG003|Overall Study|Late determination of ineligibility|1|||
160736745|NCT02951533|580416642|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
160736746|NCT02951533|580416643|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
160736747|NCT02951533|580416644|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
160736748|NCT02951533|580416642|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
160736749|NCT02951533|580416643|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
160736750|NCT02951533|580416644|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
160736751|NCT02951533|580416642|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
160736752|NCT02951533|580416643|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
160736753|NCT02951533|580416644|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
160736754|NCT02951533|580416642|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
160736755|NCT02951533|580416643|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
160736756|NCT02951533|580416644|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
160736757|NCT02951533|580416642|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
160736758|NCT02951533|580416643|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
160736759|NCT02951533|580416644|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
160736760|NCT02951533|580416642|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
160736761|NCT02951533|580416643|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
160736762|NCT02951533|580416644|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
160736763|NCT02951533|580416642|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
160736764|NCT02951533|580416643|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
160736765|NCT02951533|580416644|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
160736766|NCT02951533|580416642|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
160736767|NCT02951533|580416643|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
160736768|NCT02951533|580416644|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
160736769|NCT02951533|580416642|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
160736770|NCT02951533|580416643|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
160736771|NCT02951533|580416644|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
160736772|NCT02951533|580416642|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
160736773|NCT02951533|580416643|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
160736774|NCT02951533|580416644|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
160736775|NCT02951533|580416642|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
160736776|NCT02951533|580416643|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
160736777|NCT02951533|580416644|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
160736778|NCT05174949|580416645|FG000|Overall Study|Physician Decision|1|||
160736779|NCT05174949|580416646|FG001|Overall Study|Physician Decision|2|||
160736780|NCT05174949|580416647|FG002|Overall Study|Physician Decision|0|||
160736781|NCT05174949|580416648|FG003|Overall Study|Physician Decision|1|||
160736782|NCT05174949|580416649|FG004|Overall Study|Physician Decision|0|||
160736783|NCT05174949|580416650|FG005|Overall Study|Physician Decision|0|||
160736784|NCT05174949|580416645|FG000|Overall Study|Withdrawal by Subject|0|||
160736785|NCT05174949|580416646|FG001|Overall Study|Withdrawal by Subject|1|||
160736786|NCT05174949|580416647|FG002|Overall Study|Withdrawal by Subject|0|||
160736787|NCT05174949|580416648|FG003|Overall Study|Withdrawal by Subject|0|||
160736788|NCT05174949|580416649|FG004|Overall Study|Withdrawal by Subject|0|||
160736789|NCT05174949|580416650|FG005|Overall Study|Withdrawal by Subject|0|||
160736790|NCT05174949|580416645|FG000|Overall Study|Lost to Follow-up|0|||
160736791|NCT05174949|580416646|FG001|Overall Study|Lost to Follow-up|0|||
160736792|NCT05174949|580416647|FG002|Overall Study|Lost to Follow-up|0|||
160736793|NCT05174949|580416648|FG003|Overall Study|Lost to Follow-up|1|||
160736794|NCT05174949|580416649|FG004|Overall Study|Lost to Follow-up|0|||
160736795|NCT05174949|580416650|FG005|Overall Study|Lost to Follow-up|0|||
160736796|NCT02029989|580416651|FG000|Overall Study|Withdrawal by Subject|1|||
160736797|NCT02029989|580416652|FG001|Overall Study|Withdrawal by Subject|0|||
160736798|NCT02029989|580416651|FG000|Overall Study|Withdrawal: Fear of needles|1|||
160736799|NCT02029989|580416652|FG001|Overall Study|Withdrawal: Fear of needles|0|||
160736800|NCT02029989|580416651|FG000|Overall Study|Change of location|2|||
160736801|NCT02029989|580416652|FG001|Overall Study|Change of location|3|||
160736802|NCT02029989|580416651|FG000|Overall Study|Physician Decision|2|||
160736803|NCT02029989|580416652|FG001|Overall Study|Physician Decision|0|||
160736804|NCT02029989|580416651|FG000|Overall Study|Lost to Follow-up|9|||
160736805|NCT02029989|580416652|FG001|Overall Study|Lost to Follow-up|7|||
160736806|NCT02029989|580416651|FG000|Overall Study|Death|0|||
160736807|NCT02029989|580416652|FG001|Overall Study|Death|1|||
160736808|NCT02029989|580416651|FG000|Overall Study|Protocol Violation|1|||
160736809|NCT02029989|580416652|FG001|Overall Study|Protocol Violation|0|||
160736810|NCT04351373|580416653|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
160736811|NCT01123941|580416659|FG000|Overall Study|Lost to Follow-up|2|||
160736812|NCT01123941|580416660|FG001|Overall Study|Lost to Follow-up|1|||
160736813|NCT05036668|580416661|FG000|Overall Study|lost to follow Up|0|||
160736814|NCT05036668|580416662|FG001|Overall Study|lost to follow Up|0|||
160736815|NCT05036668|580416663|FG002|Overall Study|lost to follow Up|1|||
160736816|NCT01537068|580416664|FG000|Overall Study|Lost to Follow-up|2|||
160736817|NCT01537068|580416665|FG001|Overall Study|Lost to Follow-up|1|||
160736818|NCT01537068|580416664|FG000|Overall Study|Adverse Event|0|||
160736819|NCT01537068|580416665|FG001|Overall Study|Adverse Event|1|||
160736820|NCT01537068|580416664|FG000|Overall Study|Withdrawal by Subject|1|||
160736821|NCT01537068|580416665|FG001|Overall Study|Withdrawal by Subject|1|||
160736822|NCT01537068|580416664|FG000|Overall Study|Lack of Efficacy|1|||
160736823|NCT01537068|580416665|FG001|Overall Study|Lack of Efficacy|0|||
160736824|NCT00072280|580416667|FG000|Treatment|Found ineligible|1|||
160736825|NCT00072280|580416668|FG001|Treatment|Found ineligible|2|||
160736826|NCT00072280|580416667|FG000|Follow-up|Early termination of study|2|||
160736827|NCT00072280|580416668|FG001|Follow-up|Early termination of study|2|||
160736828|NCT00833482|580416670|FG000|Days 11-20|Adverse Event|0|||
160736829|NCT00833482|580416671|FG001|Days 11-20|Adverse Event|2|||
160736830|NCT00833482|580416672|FG002|Days 11-20|Adverse Event|0|||
160736831|NCT00833482|580416673|FG003|Days 11-20|Adverse Event|0|||
160736832|NCT00833482|580416674|FG004|Days 11-20|Adverse Event|0|||
160736833|NCT00833482|580416675|FG005|Days 11-20|Adverse Event|0|||
160736834|NCT00833482|580416670|FG000|Days 11-20|Withdrawal by Subject|0|||
160736835|NCT00833482|580416671|FG001|Days 11-20|Withdrawal by Subject|1|||
160736836|NCT00833482|580416672|FG002|Days 11-20|Withdrawal by Subject|0|||
160736837|NCT00833482|580416673|FG003|Days 11-20|Withdrawal by Subject|0|||
160736838|NCT00833482|580416674|FG004|Days 11-20|Withdrawal by Subject|0|||
160736839|NCT00833482|580416675|FG005|Days 11-20|Withdrawal by Subject|0|||
160736840|NCT00833482|580416670|FG000|Days 21-30|Adverse Event|0|||
160736841|NCT00833482|580416671|FG001|Days 21-30|Adverse Event|0|||
160736842|NCT00833482|580416672|FG002|Days 21-30|Adverse Event|1|||
160736843|NCT00833482|580416673|FG003|Days 21-30|Adverse Event|0|||
160736844|NCT00833482|580416674|FG004|Days 21-30|Adverse Event|0|||
160736845|NCT00833482|580416675|FG005|Days 21-30|Adverse Event|0|||
160736846|NCT00833482|580416670|FG000|Days 21-30|Withdrawal by Subject|0|||
160736847|NCT00833482|580416671|FG001|Days 21-30|Withdrawal by Subject|0|||
160736848|NCT00833482|580416672|FG002|Days 21-30|Withdrawal by Subject|0|||
160736849|NCT00833482|580416673|FG003|Days 21-30|Withdrawal by Subject|0|||
160736850|NCT00833482|580416674|FG004|Days 21-30|Withdrawal by Subject|1|||
160736851|NCT00833482|580416675|FG005|Days 21-30|Withdrawal by Subject|0|||
160736852|NCT02234596|580416676|FG000|Overall Study|Participant not treated|2|||
160736853|NCT05072106|580419043|FG000|Overall Study|Progressive disease|3|||
160736854|NCT05072106|580419044|FG001|Overall Study|Progressive disease|3|||
160736855|NCT05072106|580419043|FG000|Overall Study|Compassionate use|3|||
160736856|NCT05072106|580419044|FG001|Overall Study|Compassionate use|1|||
160736857|NCT05072106|580419043|FG000|Overall Study|Withdrawal by Subject|1|||
160736858|NCT05072106|580419044|FG001|Overall Study|Withdrawal by Subject|0|||
160736859|NCT03839459|580419045|FG000|Overall Study|Withdrawal by Subject|2|||
160736860|NCT03839459|580419045|FG000|Overall Study|progression of disease|3|||
160736861|NCT04240886|580419046|FG000|Treatment Phase|Death|4|||
160736862|NCT04240886|580419046|FG000|Treatment Phase|Discontinuation by Subject|1|||
160736863|NCT04240886|580419046|FG000|Treatment Phase|Adverse Event|5|||
160736864|NCT04240886|580419046|FG000|Follow-up Phase|Withdrawal by Subject|1|||
160736865|NCT04240886|580419046|FG000|Follow-up Phase|Discontinuation by Subject|1|||
160736866|NCT04240886|580419046|FG000|Follow-up Phase|Death|2|||
160736867|NCT03339726|580419051|FG000|Overall Study|Withdrawal by Subject|1|||
160736868|NCT03339726|580419052|FG001|Overall Study|Withdrawal by Subject|0|||
160736869|NCT03339726|580419053|FG002|Overall Study|Withdrawal by Subject|0|||
160736870|NCT03339726|580419051|FG000|Overall Study|Lost to Follow-up|0|||
160736871|NCT03339726|580419052|FG001|Overall Study|Lost to Follow-up|1|||
160736872|NCT03339726|580419053|FG002|Overall Study|Lost to Follow-up|0|||
160736873|NCT04542499|580419059|FG000|Overall Study|Adverse Event|23|||
160736874|NCT04542499|580419060|FG001|Overall Study|Adverse Event|43|||
160736875|NCT04542499|580419059|FG000|Overall Study|Lack of Efficacy|5|||
160736876|NCT04542499|580419060|FG001|Overall Study|Lack of Efficacy|2|||
160736877|NCT04542499|580419059|FG000|Overall Study|Lost to Follow-up|3|||
160736878|NCT04542499|580419060|FG001|Overall Study|Lost to Follow-up|4|||
160736879|NCT04542499|580419059|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
160736880|NCT04542499|580419060|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
160736881|NCT04542499|580419059|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
160736882|NCT04542499|580419060|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
160736883|NCT04542499|580419059|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160736884|NCT04542499|580419060|FG001|Overall Study|Non-Compliance with Study Drug|2|||
160736885|NCT04542499|580419059|FG000|Overall Study|Physician Decision|0|||
160736886|NCT04542499|580419060|FG001|Overall Study|Physician Decision|1|||
160736887|NCT04542499|580419059|FG000|Overall Study|Site Terminated by Sponsor|3|||
160736888|NCT04542499|580419060|FG001|Overall Study|Site Terminated by Sponsor|5|||
160736889|NCT04542499|580419059|FG000|Overall Study|Withdrawal by Subject|12|||
160736890|NCT04542499|580419060|FG001|Overall Study|Withdrawal by Subject|33|||
160736891|NCT04542499|580419059|FG000|Overall Study|Other|2|||
160736892|NCT04542499|580419060|FG001|Overall Study|Other|2|||
160736893|NCT04035434|580419066|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736894|NCT04035434|580419067|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
160736895|NCT04035434|580419068|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736896|NCT04035434|580419069|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
160736897|NCT04035434|580419070|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
160736898|NCT04035434|580419071|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736899|NCT04035434|580419072|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736900|NCT04035434|580419073|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736901|NCT04035434|580419074|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736902|NCT04035434|580419075|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736903|NCT04035434|580419076|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
160736904|NCT04035434|580419077|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
160736905|NCT04035434|580419078|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736906|NCT04035434|580419066|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
160736907|NCT04035434|580419067|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
160736908|NCT04035434|580419068|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
160736909|NCT04035434|580419069|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
160736910|NCT04035434|580419070|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
160736911|NCT04035434|580419071|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
160736912|NCT04035434|580419072|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
160736913|NCT04035434|580419073|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
160736914|NCT04035434|580419074|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
160736915|NCT04035434|580419075|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
160736916|NCT04035434|580419076|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
160736917|NCT04035434|580419077|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
160736918|NCT04035434|580419078|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
160736919|NCT04035434|580419066|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736920|NCT04035434|580419067|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
160736921|NCT04035434|580419068|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
160736922|NCT04035434|580419069|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736923|NCT04035434|580419070|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
160736924|NCT04035434|580419071|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
160736925|NCT04035434|580419072|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736926|NCT04035434|580419073|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736927|NCT04035434|580419074|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
160736928|NCT04035434|580419075|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
160736929|NCT04035434|580419076|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736930|NCT04035434|580419077|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
160736931|NCT04035434|580419078|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
160736932|NCT04035434|580419066|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736933|NCT04035434|580419067|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736934|NCT04035434|580419068|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736935|NCT04035434|580419069|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
160736936|NCT04035434|580419070|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736937|NCT04035434|580419071|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736938|NCT04035434|580419072|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736939|NCT04035434|580419073|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736940|NCT04035434|580419074|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736941|NCT04035434|580419075|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736942|NCT04035434|580419076|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736943|NCT04035434|580419077|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736944|NCT04035434|580419078|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
160736945|NCT04035434|580419066|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736946|NCT04035434|580419067|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736947|NCT04035434|580419068|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736948|NCT04035434|580419069|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736949|NCT04035434|580419070|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736950|NCT04035434|580419071|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
160736951|NCT04035434|580419072|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
160736952|NCT04035434|580419073|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736953|NCT04035434|580419074|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736954|NCT04035434|580419075|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736955|NCT04035434|580419076|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736956|NCT04035434|580419077|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736957|NCT04035434|580419078|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
160736958|NCT04035434|580419066|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736959|NCT04035434|580419067|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736960|NCT04035434|580419068|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736961|NCT04035434|580419069|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736962|NCT04035434|580419070|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736963|NCT04035434|580419071|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
160736964|NCT04035434|580419072|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
160736965|NCT04035434|580419073|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736966|NCT04035434|580419074|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736967|NCT04035434|580419075|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736968|NCT04035434|580419076|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736969|NCT04035434|580419077|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736970|NCT04035434|580419078|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
160736971|NCT04035434|580419066|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736972|NCT04035434|580419067|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736973|NCT04035434|580419068|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736974|NCT04035434|580419069|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736975|NCT04035434|580419070|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736976|NCT04035434|580419071|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
160736977|NCT04035434|580419072|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
160736978|NCT04035434|580419073|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736979|NCT04035434|580419074|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736980|NCT04035434|580419075|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736981|NCT04035434|580419076|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736982|NCT04035434|580419077|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736983|NCT04035434|580419078|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
160736984|NCT04322539|580419079|FG000|Overall Study|Adverse Event|2|||
160736985|NCT04322539|580419080|FG001|Overall Study|Adverse Event|0|||
160736986|NCT04322539|580419079|FG000|Overall Study|Death|411|||
160736987|NCT04322539|580419080|FG001|Overall Study|Death|203|||
160736988|NCT04322539|580419079|FG000|Overall Study|Lost to Follow-up|3|||
160736989|NCT04322539|580419080|FG001|Overall Study|Lost to Follow-up|1|||
160736990|NCT04322539|580419079|FG000|Overall Study|Withdrawal of consent|14|||
160736991|NCT04322539|580419080|FG001|Overall Study|Withdrawal of consent|8|||
160736992|NCT04322539|580419079|FG000|Overall Study|Radiological Disease Progression|6|||
160736993|NCT04322539|580419080|FG001|Overall Study|Radiological Disease Progression|0|||
160736994|NCT04322539|580419079|FG000|Overall Study|Sponsor Decision|19|||
160736995|NCT04322539|580419080|FG001|Overall Study|Sponsor Decision|14|||
160736996|NCT04322539|580419079|FG000|Overall Study|Other|6|||
160736997|NCT04322539|580419080|FG001|Overall Study|Other|4|||
160736998|NCT02759055|580419083|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
160736999|NCT02759055|580419084|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
160737000|NCT04161079|580419085|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
160737001|NCT04045132|580419089|FG000|Overall Study|Lost to Follow-up|3|||
160737002|NCT04045132|580419090|FG001|Overall Study|Lost to Follow-up|6|||
160737003|NCT04063657|580419091|FG000|Overall Study|Lost to Follow-up|1|||
160737004|NCT04063657|580419092|FG001|Overall Study|Lost to Follow-up|0|||
160737005|NCT01473394|580419093|FG000|Overall Study|Adverse Event|13|||
160737006|NCT01473394|580419094|FG001|Overall Study|Adverse Event|16|||
160737007|NCT01473394|580419093|FG000|Overall Study|Insufficient Therapeutic Response|4|||
160737008|NCT01473394|580419094|FG001|Overall Study|Insufficient Therapeutic Response|1|||
160737009|NCT01473394|580419093|FG000|Overall Study|Protocol Violation|7|||
160737010|NCT01473394|580419094|FG001|Overall Study|Protocol Violation|5|||
160737011|NCT01473394|580419093|FG000|Overall Study|Withdrew Consent|12|||
160737012|NCT01473394|580419094|FG001|Overall Study|Withdrew Consent|10|||
160737013|NCT01473394|580419093|FG000|Overall Study|Lost to Follow-up|9|||
160737014|NCT01473394|580419094|FG001|Overall Study|Lost to Follow-up|11|||
160737015|NCT00552032|580419095|FG000|Overall Study|Withdrawal by Subject|2|||
160737016|NCT00552032|580419096|FG001|Overall Study|Withdrawal by Subject|2|||
160737017|NCT00552032|580419095|FG000|Overall Study|Protocol Violation|7|||
160737018|NCT00552032|580419096|FG001|Overall Study|Protocol Violation|12|||
160737019|NCT00552032|580419095|FG000|Overall Study|Lost to Follow-up|8|||
160737020|NCT00552032|580419096|FG001|Overall Study|Lost to Follow-up|5|||
160737021|NCT05845567|580419102|FG000|Overall Study|Withdrawal by Subject|1|||
160737022|NCT02035748|580419107|FG000|Overall Study|Adverse Event|5|||
160737023|NCT02035748|580419107|FG000|Overall Study|Death|3|||
160737024|NCT02035748|580419107|FG000|Overall Study|Lost to Follow-up|2|||
160737025|NCT02035748|580419107|FG000|Overall Study|Physician Decision|3|||
160737026|NCT02035748|580419107|FG000|Overall Study|Withdrawal by Subject|6|||
160737027|NCT02035748|580419107|FG000|Overall Study|Progressive Disease|1|||
160737028|NCT01740128|580419108|FG000|Overall Study|Pregnancy|0|||
160737029|NCT01740128|580419109|FG001|Overall Study|Pregnancy|1|||
160737030|NCT01740128|580419108|FG000|Overall Study|Protocol Violation|1|||
160737031|NCT01740128|580419109|FG001|Overall Study|Protocol Violation|2|||
160737032|NCT01740128|580419108|FG000|Overall Study|Lost to Follow-up|2|||
160737033|NCT01740128|580419109|FG001|Overall Study|Lost to Follow-up|2|||
160737034|NCT01740128|580419108|FG000|Overall Study|Withdrawal by Subject|1|||
160737035|NCT01740128|580419109|FG001|Overall Study|Withdrawal by Subject|0|||
160737036|NCT01740128|580419108|FG000|Overall Study|Insufficient protocol compliance|2|||
160737037|NCT01740128|580419109|FG001|Overall Study|Insufficient protocol compliance|2|||
160737038|NCT01041976|580419110|FG000|Overall Study|Withdrawal by Subject|3|||
160737039|NCT01041976|580419111|FG001|Overall Study|Withdrawal by Subject|0|||
160737040|NCT01041976|580419110|FG000|Overall Study|Incarceration|2|||
160737041|NCT01041976|580419111|FG001|Overall Study|Incarceration|0|||
160737042|NCT01041976|580419110|FG000|Overall Study|Death|0|||
160737043|NCT01041976|580419111|FG001|Overall Study|Death|4|||
160737044|NCT02658734|580419112|FG000|Overall Study|Adverse Event|2|||
160737045|NCT02658734|580419112|FG000|Overall Study|Death|4|||
160737046|NCT02658734|580419112|FG000|Overall Study|Lost to Follow-up|7|||
160737047|NCT02658734|580419112|FG000|Overall Study|Withdrawal of Consent|16|||
160737048|NCT02658734|580419112|FG000|Overall Study|Disease Progression|28|||
160737049|NCT05007041|580419122|FG000|Overall Study|Missing Diary Entries|0|||
160737050|NCT05007041|580419123|FG001|Overall Study|Missing Diary Entries|1|||
160737051|NCT00705718|580419124|FG000|Overall Study|Death|6|||
160737052|NCT00705718|580419125|FG001|Overall Study|Death|6|||
160737053|NCT00705718|580419124|FG000|Overall Study|Not due for Visit|0|||
160737054|NCT00705718|580419125|FG001|Overall Study|Not due for Visit|12|||
160737055|NCT00705718|580419124|FG000|Overall Study|Follow up not done|1|||
160737056|NCT00705718|580419125|FG001|Overall Study|Follow up not done|4|||
160737057|NCT01459718|580419129|FG000|Overall Study|Physician Decision|1|||
160737058|NCT01459718|580419129|FG000|Overall Study|Lost to Follow-up|1|||
160737059|NCT01459718|580419129|FG000|Overall Study|Adverse Event|1|||
160737060|NCT01258075|580419130|FG000|Overall Study|Adverse Event|8|||
160737061|NCT01258075|580419131|FG001|Overall Study|Adverse Event|3|||
160737062|NCT01258075|580419130|FG000|Overall Study|Lost to Follow-up|11|||
160737063|NCT01258075|580419131|FG001|Overall Study|Lost to Follow-up|6|||
160737064|NCT01258075|580419130|FG000|Overall Study|Withdrawal by Subject|10|||
160737065|NCT01258075|580419131|FG001|Overall Study|Withdrawal by Subject|7|||
160737066|NCT01258075|580419130|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
160737067|NCT01258075|580419131|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
160737068|NCT01258075|580419130|FG000|Overall Study|Other|12|||
160737069|NCT01258075|580419131|FG001|Overall Study|Other|5|||
160737070|NCT04021121|580419136|FG000|Overall Study|Death|3|||
160737071|NCT04021121|580419137|FG001|Overall Study|Death|3|||
160737072|NCT04021121|580419138|FG002|Overall Study|Death|5|||
160737073|NCT04021121|580419139|FG003|Overall Study|Death|4|||
160737074|NCT06011161|580419140|FG000|Overall Study|Withdrawal by Subject|2|||
160737075|NCT06011161|580419140|FG000|Overall Study|Lost to Follow-up|5|||
160737076|NCT02291601|580419143|FG000|Abdomen|Did not qualify|333|||
160737077|NCT02291601|580419144|FG001|Abdomen|Did not qualify|54|||
160737078|NCT02291601|580419145|FG002|Abdomen|Did not qualify|339|||
160737079|NCT02291601|580419143|FG000|Groin|Did not qualify|183|||
160737080|NCT02291601|580419144|FG001|Groin|Did not qualify|30|||
160737081|NCT02291601|580419145|FG002|Groin|Did not qualify|177|||
160737082|NCT01597375|580419153|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
160737083|NCT01597375|580419154|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
160737084|NCT01597375|580419153|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
160737085|NCT01597375|580419154|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
160737086|NCT01597375|580419153|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
160737087|NCT01597375|580419154|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
160737088|NCT01597375|580419153|FG000|Washout (2 Weeks)|Adverse Event|1|||
160737089|NCT01597375|580419154|FG001|Washout (2 Weeks)|Adverse Event|0|||
160737090|NCT01597375|580419153|FG000|Second Intervention|Failed to react at both Aspirin|1|||
160737091|NCT01597375|580419154|FG001|Second Intervention|Failed to react at both Aspirin|1|||
160737092|NCT04017832|580419157|FG000|Overall Study|Withdrawal by Subject|13|||
160737093|NCT04017832|580419158|FG001|Overall Study|Withdrawal by Subject|12|||
160737094|NCT04017832|580419159|FG002|Overall Study|Withdrawal by Subject|21|||
160737095|NCT04017832|580419160|FG003|Overall Study|Withdrawal by Subject|7|||
160737096|NCT04017832|580419157|FG000|Overall Study|Lost to Follow-up|0|||
160737097|NCT04017832|580419158|FG001|Overall Study|Lost to Follow-up|3|||
160737098|NCT04017832|580419159|FG002|Overall Study|Lost to Follow-up|3|||
160737099|NCT04017832|580419160|FG003|Overall Study|Lost to Follow-up|1|||
160737100|NCT04017832|580419157|FG000|Overall Study|Physician Decision|1|||
160737101|NCT04017832|580419158|FG001|Overall Study|Physician Decision|1|||
160737102|NCT04017832|580419159|FG002|Overall Study|Physician Decision|1|||
160737103|NCT04017832|580419160|FG003|Overall Study|Physician Decision|1|||
160737104|NCT04017832|580419157|FG000|Overall Study|Death|2|||
160737105|NCT04017832|580419158|FG001|Overall Study|Death|2|||
160737106|NCT04017832|580419159|FG002|Overall Study|Death|1|||
160737107|NCT04017832|580419160|FG003|Overall Study|Death|0|||
160737108|NCT02375555|580419161|FG000|Induction Period|Adverse Event|7|||
160737109|NCT02375555|580419161|FG000|Induction Period|Withdrawal by Subject|2|||
160737110|NCT02375555|580419161|FG000|Induction Period|Other|1|||
160737111|NCT02375555|580419161|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
160737112|NCT02375555|580419161|FG000|Maintenance Period|Adverse Event|2|||
160737113|NCT02375555|580419161|FG000|Maintenance Period|Withdrawal by Subject|4|||
160737114|NCT02375555|580419161|FG000|Maintenance Period|Death|1|||
160737115|NCT02375555|580419161|FG000|Maintenance Period|Disease Progression|5|||
160737116|NCT02375555|580419161|FG000|Maintenance Period|Patient Non-compliance|1|||
160737117|NCT02375555|580419161|FG000|Maintenance Period|Still on maintenance|16|||
160737118|NCT01744184|580419167|FG000|Overall Study|Adverse Event|1|||
160737119|NCT01744184|580419168|FG001|Overall Study|Adverse Event|0|||
160737120|NCT01744184|580419167|FG000|Overall Study|Withdrawal by Subject|0|||
160737121|NCT01744184|580419168|FG001|Overall Study|Withdrawal by Subject|1|||
160737122|NCT02091986|580419169|FG000|Overall Study|7 rand in error 1 patient decision|2|||
160737123|NCT02091986|580419170|FG001|Overall Study|7 rand in error 1 patient decision|3|||
160737124|NCT02091986|580419171|FG002|Overall Study|7 rand in error 1 patient decision|3|||
160737125|NCT02091986|580419169|FG000|Overall Study|Lost to Follow-up|1|||
160737126|NCT02091986|580419170|FG001|Overall Study|Lost to Follow-up|0|||
160737127|NCT02091986|580419171|FG002|Overall Study|Lost to Follow-up|0|||
160737128|NCT02091986|580419169|FG000|Overall Study|Withdrawal by Subject|4|||
160737129|NCT02091986|580419170|FG001|Overall Study|Withdrawal by Subject|8|||
160737130|NCT02091986|580419171|FG002|Overall Study|Withdrawal by Subject|3|||
160737131|NCT02091986|580419169|FG000|Overall Study|Adverse Event|0|||
160737132|NCT02091986|580419170|FG001|Overall Study|Adverse Event|0|||
160737133|NCT02091986|580419171|FG002|Overall Study|Adverse Event|2|||
160737134|NCT02841280|580419172|FG000|Overall Study|Adverse Event|2|||
160737135|NCT02841280|580419173|FG001|Overall Study|Adverse Event|1|||
160737136|NCT02841280|580419172|FG000|Overall Study|Death|1|||
160737137|NCT02841280|580419173|FG001|Overall Study|Death|0|||
160737138|NCT02841280|580419172|FG000|Overall Study|Lost to Follow-up|2|||
160737139|NCT02841280|580419173|FG001|Overall Study|Lost to Follow-up|2|||
160737140|NCT02841280|580419172|FG000|Overall Study|Withdrawal by Subject|7|||
160737141|NCT02841280|580419173|FG001|Overall Study|Withdrawal by Subject|3|||
160737142|NCT02841280|580419172|FG000|Overall Study|Stop Point: BP above threshold|2|||
160737143|NCT02841280|580419173|FG001|Overall Study|Stop Point: BP above threshold|0|||
160737144|NCT00125242|580419174|FG000|Overall Study|did not qualify|7|||
160737145|NCT00125242|580419175|FG001|Overall Study|did not qualify|2|||
160737146|NCT01664949|580419176|FG000|Overall Study|Adverse Event|11|||
160737147|NCT01664949|580419177|FG001|Overall Study|Adverse Event|12|||
160737148|NCT01664949|580419176|FG000|Overall Study|Lack of Efficacy|1|||
160737149|NCT01664949|580419177|FG001|Overall Study|Lack of Efficacy|1|||
160737150|NCT01664949|580419176|FG000|Overall Study|Lost to Follow-up|1|||
160737151|NCT01664949|580419177|FG001|Overall Study|Lost to Follow-up|2|||
160737152|NCT01664949|580419176|FG000|Overall Study|Personal Reasons|3|||
160737153|NCT01664949|580419177|FG001|Overall Study|Personal Reasons|4|||
160737154|NCT01664949|580419176|FG000|Overall Study|Protocol Violation|5|||
160737155|NCT01664949|580419177|FG001|Overall Study|Protocol Violation|5|||
160737156|NCT01664949|580419176|FG000|Overall Study|Other Miscellaneous Reasons|3|||
160737157|NCT01664949|580419177|FG001|Overall Study|Other Miscellaneous Reasons|1|||
160737158|NCT02727777|580419184|FG000|Overall Study|Screen Failure|2|||
160737159|NCT02727777|580419185|FG001|Overall Study|Screen Failure|0|||
160737160|NCT02727777|580419186|FG002|Overall Study|Screen Failure|0|||
160737161|NCT02727777|580419184|FG000|Overall Study|Progressive disease|2|||
160737162|NCT02727777|580419185|FG001|Overall Study|Progressive disease|0|||
160737163|NCT02727777|580419186|FG002|Overall Study|Progressive disease|0|||
160737164|NCT03003494|580419187|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
160737165|NCT00957268|580419188|FG000|Overall Study|Voluntary Withdrawal|0|||
160737166|NCT00957268|580419189|FG001|Overall Study|Voluntary Withdrawal|0|||
160737167|NCT00957268|580419190|FG002|Overall Study|Voluntary Withdrawal|1|||
160737168|NCT00957268|580419191|FG003|Overall Study|Voluntary Withdrawal|0|||
160737169|NCT00957268|580419192|FG004|Overall Study|Voluntary Withdrawal|0|||
160737170|NCT01738503|580419193|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
160737171|NCT01738503|580419194|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
160737172|NCT01738503|580419195|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
160737173|NCT01738503|580419196|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
160737174|NCT01738503|580419197|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
160737175|NCT01738503|580419198|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
160737176|NCT01738503|580419199|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
160737177|NCT01738503|580419193|FG000|Treatment Period|Adverse Event|0|||
160737178|NCT01738503|580419194|FG001|Treatment Period|Adverse Event|1|||
160737179|NCT01738503|580419195|FG002|Treatment Period|Adverse Event|0|||
160737180|NCT01738503|580419196|FG003|Treatment Period|Adverse Event|1|||
160737181|NCT01738503|580419197|FG004|Treatment Period|Adverse Event|2|||
160737182|NCT01738503|580419198|FG005|Treatment Period|Adverse Event|2|||
160737183|NCT01738503|580419199|FG006|Treatment Period|Adverse Event|2|||
160737184|NCT01738503|580419193|FG000|Treatment Period|Lost to Follow-up|0|||
160737185|NCT01738503|580419194|FG001|Treatment Period|Lost to Follow-up|0|||
160737186|NCT01738503|580419195|FG002|Treatment Period|Lost to Follow-up|3|||
160737187|NCT01738503|580419196|FG003|Treatment Period|Lost to Follow-up|4|||
160737188|NCT01738503|580419197|FG004|Treatment Period|Lost to Follow-up|1|||
160737189|NCT01738503|580419198|FG005|Treatment Period|Lost to Follow-up|1|||
160737190|NCT01738503|580419199|FG006|Treatment Period|Lost to Follow-up|5|||
160737191|NCT01738503|580419193|FG000|Treatment Period|Withdrawal by Subject|0|||
160737192|NCT01738503|580419194|FG001|Treatment Period|Withdrawal by Subject|1|||
160737193|NCT01738503|580419195|FG002|Treatment Period|Withdrawal by Subject|0|||
160737194|NCT01738503|580419196|FG003|Treatment Period|Withdrawal by Subject|1|||
160737195|NCT01738503|580419197|FG004|Treatment Period|Withdrawal by Subject|1|||
160737196|NCT01738503|580419198|FG005|Treatment Period|Withdrawal by Subject|1|||
160737197|NCT01738503|580419199|FG006|Treatment Period|Withdrawal by Subject|1|||
160737198|NCT01738503|580419193|FG000|Treatment Period|Protocol Violation|0|||
160737199|NCT01738503|580419194|FG001|Treatment Period|Protocol Violation|3|||
160737200|NCT01738503|580419195|FG002|Treatment Period|Protocol Violation|1|||
160737201|NCT01738503|580419196|FG003|Treatment Period|Protocol Violation|0|||
160737202|NCT01738503|580419197|FG004|Treatment Period|Protocol Violation|4|||
160737203|NCT01738503|580419198|FG005|Treatment Period|Protocol Violation|2|||
160737204|NCT01738503|580419199|FG006|Treatment Period|Protocol Violation|0|||
160737205|NCT01738503|580419193|FG000|Treatment Period|Other|0|||
160737206|NCT01738503|580419194|FG001|Treatment Period|Other|0|||
160737207|NCT01738503|580419195|FG002|Treatment Period|Other|1|||
160737208|NCT01738503|580419196|FG003|Treatment Period|Other|0|||
160737209|NCT01738503|580419197|FG004|Treatment Period|Other|0|||
160737210|NCT01738503|580419198|FG005|Treatment Period|Other|0|||
160737211|NCT01738503|580419199|FG006|Treatment Period|Other|0|||
160737212|NCT01738503|580419193|FG000|PET Imaging Sub-study|Adverse Event|0|||
160737213|NCT01738503|580419194|FG001|PET Imaging Sub-study|Adverse Event|0|||
160737214|NCT01738503|580419195|FG002|PET Imaging Sub-study|Adverse Event|0|||
160737215|NCT01738503|580419196|FG003|PET Imaging Sub-study|Adverse Event|0|||
160737216|NCT01738503|580419197|FG004|PET Imaging Sub-study|Adverse Event|0|||
160737217|NCT01738503|580419198|FG005|PET Imaging Sub-study|Adverse Event|1|||
160737218|NCT01738503|580419199|FG006|PET Imaging Sub-study|Adverse Event|0|||
160737219|NCT01738503|580419193|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
160737220|NCT01738503|580419194|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
160737221|NCT01738503|580419195|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
160737222|NCT01738503|580419196|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
160737223|NCT01738503|580419197|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
160737224|NCT01738503|580419198|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
160737225|NCT01738503|580419199|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
160737226|NCT01340027|580419200|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
160737227|NCT01340027|580419201|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
160737228|NCT01340027|580419202|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
160737229|NCT01340027|580419203|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
160737230|NCT01340027|580419204|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
160737231|NCT01340027|580419205|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
160737232|NCT01340027|580419206|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
160737233|NCT01340027|580419207|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
160737234|NCT01340027|580419208|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
160737235|NCT01340027|580419209|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
160737236|NCT01340027|580419210|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
160737237|NCT01340027|580419211|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
160737238|NCT01340027|580419200|FG000|Overall Study|Adverse Event|0|||
160737239|NCT01340027|580419201|FG001|Overall Study|Adverse Event|1|||
160737240|NCT01340027|580419202|FG002|Overall Study|Adverse Event|2|||
160737241|NCT01340027|580419203|FG003|Overall Study|Adverse Event|0|||
160737242|NCT01340027|580419204|FG004|Overall Study|Adverse Event|1|||
160737243|NCT01340027|580419205|FG005|Overall Study|Adverse Event|2|||
160737244|NCT01340027|580419206|FG006|Overall Study|Adverse Event|2|||
160737245|NCT01340027|580419207|FG007|Overall Study|Adverse Event|1|||
160737246|NCT01340027|580419208|FG008|Overall Study|Adverse Event|4|||
160737247|NCT01340027|580419209|FG009|Overall Study|Adverse Event|1|||
160737248|NCT01340027|580419210|FG010|Overall Study|Adverse Event|1|||
160737249|NCT01340027|580419211|FG011|Overall Study|Adverse Event|3|||
160737250|NCT01340027|580419200|FG000|Overall Study|Lack of Efficacy|0|||
160737251|NCT01340027|580419201|FG001|Overall Study|Lack of Efficacy|0|||
160737252|NCT01340027|580419202|FG002|Overall Study|Lack of Efficacy|0|||
160737253|NCT01340027|580419203|FG003|Overall Study|Lack of Efficacy|0|||
160737254|NCT01340027|580419204|FG004|Overall Study|Lack of Efficacy|0|||
160737255|NCT01340027|580419205|FG005|Overall Study|Lack of Efficacy|0|||
160737256|NCT01340027|580419206|FG006|Overall Study|Lack of Efficacy|1|||
160737257|NCT01340027|580419207|FG007|Overall Study|Lack of Efficacy|1|||
160737258|NCT01340027|580419208|FG008|Overall Study|Lack of Efficacy|1|||
160737259|NCT01340027|580419209|FG009|Overall Study|Lack of Efficacy|0|||
160737260|NCT01340027|580419210|FG010|Overall Study|Lack of Efficacy|0|||
160737261|NCT01340027|580419211|FG011|Overall Study|Lack of Efficacy|0|||
160737262|NCT01340027|580419200|FG000|Overall Study|Lost to Follow-up|0|||
160737263|NCT01340027|580419201|FG001|Overall Study|Lost to Follow-up|1|||
160737264|NCT01340027|580419202|FG002|Overall Study|Lost to Follow-up|0|||
160737265|NCT01340027|580419203|FG003|Overall Study|Lost to Follow-up|0|||
160737266|NCT01340027|580419204|FG004|Overall Study|Lost to Follow-up|0|||
160737267|NCT01340027|580419205|FG005|Overall Study|Lost to Follow-up|0|||
160737268|NCT01340027|580419206|FG006|Overall Study|Lost to Follow-up|1|||
160737269|NCT01340027|580419207|FG007|Overall Study|Lost to Follow-up|0|||
160737270|NCT01340027|580419208|FG008|Overall Study|Lost to Follow-up|0|||
160737271|NCT01340027|580419209|FG009|Overall Study|Lost to Follow-up|1|||
160737272|NCT01340027|580419210|FG010|Overall Study|Lost to Follow-up|0|||
160737273|NCT01340027|580419211|FG011|Overall Study|Lost to Follow-up|0|||
160737274|NCT01340027|580419200|FG000|Overall Study|Protocol Violation|1|||
160737275|NCT01340027|580419201|FG001|Overall Study|Protocol Violation|2|||
160737276|NCT01340027|580419202|FG002|Overall Study|Protocol Violation|0|||
160737277|NCT01340027|580419203|FG003|Overall Study|Protocol Violation|0|||
160737278|NCT01340027|580419204|FG004|Overall Study|Protocol Violation|6|||
160737279|NCT01340027|580419205|FG005|Overall Study|Protocol Violation|0|||
160737280|NCT01340027|580419206|FG006|Overall Study|Protocol Violation|0|||
160737281|NCT01340027|580419207|FG007|Overall Study|Protocol Violation|1|||
160737282|NCT01340027|580419208|FG008|Overall Study|Protocol Violation|2|||
160737283|NCT01340027|580419209|FG009|Overall Study|Protocol Violation|2|||
160737284|NCT01340027|580419210|FG010|Overall Study|Protocol Violation|0|||
160737285|NCT01340027|580419211|FG011|Overall Study|Protocol Violation|0|||
160737286|NCT01340027|580419200|FG000|Overall Study|Withdrawal by Subject|4|||
160737287|NCT01340027|580419201|FG001|Overall Study|Withdrawal by Subject|3|||
160737288|NCT01340027|580419202|FG002|Overall Study|Withdrawal by Subject|1|||
160737289|NCT01340027|580419203|FG003|Overall Study|Withdrawal by Subject|3|||
160737290|NCT01340027|580419204|FG004|Overall Study|Withdrawal by Subject|3|||
160737291|NCT01340027|580419205|FG005|Overall Study|Withdrawal by Subject|2|||
160737292|NCT01340027|580419206|FG006|Overall Study|Withdrawal by Subject|3|||
160737293|NCT01340027|580419207|FG007|Overall Study|Withdrawal by Subject|4|||
160737294|NCT01340027|580419208|FG008|Overall Study|Withdrawal by Subject|1|||
160737295|NCT01340027|580419209|FG009|Overall Study|Withdrawal by Subject|2|||
160737296|NCT01340027|580419210|FG010|Overall Study|Withdrawal by Subject|0|||
160737297|NCT01340027|580419211|FG011|Overall Study|Withdrawal by Subject|1|||
160737298|NCT01340027|580419200|FG000|Overall Study|Miscellaneous|0|||
160737299|NCT01340027|580419201|FG001|Overall Study|Miscellaneous|0|||
160737300|NCT01340027|580419202|FG002|Overall Study|Miscellaneous|0|||
160737301|NCT01340027|580419203|FG003|Overall Study|Miscellaneous|1|||
160737302|NCT01340027|580419204|FG004|Overall Study|Miscellaneous|0|||
160737303|NCT01340027|580419205|FG005|Overall Study|Miscellaneous|0|||
160737304|NCT01340027|580419206|FG006|Overall Study|Miscellaneous|0|||
160737305|NCT01340027|580419207|FG007|Overall Study|Miscellaneous|0|||
160737306|NCT01340027|580419208|FG008|Overall Study|Miscellaneous|0|||
160737307|NCT01340027|580419209|FG009|Overall Study|Miscellaneous|0|||
160737308|NCT01340027|580419210|FG010|Overall Study|Miscellaneous|1|||
160737309|NCT01340027|580419211|FG011|Overall Study|Miscellaneous|0|||
160737310|NCT03005327|580419212|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
160737311|NCT03005327|580419213|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
160737312|NCT03005327|580419214|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
160737313|NCT03005327|580419215|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
160737314|NCT03005327|580419212|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160737315|NCT03005327|580419213|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
160737316|NCT03005327|580419214|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160737317|NCT03005327|580419215|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
160737318|NCT01794793|580419217|FG000|Treatment Period|Withdrawal by Subject|24|||
160737319|NCT01794793|580419217|FG000|Treatment Period|Lack of Efficacy|22|||
160737320|NCT01794793|580419217|FG000|Treatment Period|Adverse Event|17|||
160737321|NCT01794793|580419217|FG000|Treatment Period|Physician Decision|14|||
160737322|NCT01794793|580419217|FG000|Treatment Period|Lost to Follow-up|7|||
160737323|NCT01794793|580419217|FG000|Treatment Period|Death|6|||
160737324|NCT01794793|580419217|FG000|Treatment Period|Protocol Violation|5|||
160737325|NCT01794793|580419217|FG000|Treatment Period|administrative problem|3|||
160737326|NCT01794793|580419217|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
160737327|NCT01794793|580419217|FG000|Post-treatment Follow-up|Adverse Event|8|||
160737328|NCT01794793|580419217|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
160737329|NCT01794793|580419217|FG000|Post-treatment Follow-up|administrative problem|5|||
160737330|NCT01794793|580419217|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
160737331|NCT01794793|580419217|FG000|Post-treatment Follow-up|Protocol Violation|3|||
160737332|NCT04852679|580419218|FG000|Main Intervention Period|Withdrawal by Subject|3|||
160737333|NCT04852679|580419218|FG000|Main Intervention Period|Adverse Event|1|||
160737334|NCT04852679|580419218|FG000|Main Intervention Period|Progressive Disease|16|||
160737335|NCT04852679|580419218|FG000|Main Intervention Period|Refused study visit|1|||
160737336|NCT04852679|580419218|FG000|Independent Injection Period|Missed study visit|1|||
160737337|NCT03569293|580420478|FG000|Overall Study|Adverse Event|4|||
160737338|NCT03569293|580420479|FG001|Overall Study|Adverse Event|1|||
160737339|NCT03569293|580420480|FG002|Overall Study|Adverse Event|5|||
160737340|NCT03569293|580420481|FG003|Overall Study|Adverse Event|1|||
160737341|NCT03569293|580420482|FG004|Overall Study|Adverse Event|0|||
160737342|NCT03569293|580420483|FG005|Overall Study|Adverse Event|0|||
160737343|NCT03569293|580420478|FG000|Overall Study|Withdrawal by Subject|16|||
160737344|NCT03569293|580420479|FG001|Overall Study|Withdrawal by Subject|2|||
160737345|NCT03569293|580420480|FG002|Overall Study|Withdrawal by Subject|4|||
160737346|NCT03569293|580420481|FG003|Overall Study|Withdrawal by Subject|1|||
160737347|NCT03569293|580420482|FG004|Overall Study|Withdrawal by Subject|0|||
160737348|NCT03569293|580420483|FG005|Overall Study|Withdrawal by Subject|0|||
160737349|NCT03569293|580420478|FG000|Overall Study|Lost to Follow-up|1|||
160737350|NCT03569293|580420479|FG001|Overall Study|Lost to Follow-up|3|||
160737351|NCT03569293|580420480|FG002|Overall Study|Lost to Follow-up|1|||
160737352|NCT03569293|580420481|FG003|Overall Study|Lost to Follow-up|1|||
160737353|NCT03569293|580420482|FG004|Overall Study|Lost to Follow-up|0|||
160737354|NCT03569293|580420483|FG005|Overall Study|Lost to Follow-up|0|||
160737355|NCT03569293|580420478|FG000|Overall Study|Other|8|||
160737356|NCT03569293|580420479|FG001|Overall Study|Other|2|||
160737357|NCT03569293|580420480|FG002|Overall Study|Other|1|||
160737358|NCT03569293|580420481|FG003|Overall Study|Other|1|||
160737359|NCT03569293|580420482|FG004|Overall Study|Other|0|||
160737360|NCT03569293|580420483|FG005|Overall Study|Other|0|||
160737361|NCT03569293|580420478|FG000|Overall Study|Ongoing at Time of Analysis|8|||
160737362|NCT03569293|580420479|FG001|Overall Study|Ongoing at Time of Analysis|1|||
160737363|NCT03569293|580420480|FG002|Overall Study|Ongoing at Time of Analysis|3|||
160737364|NCT03569293|580420481|FG003|Overall Study|Ongoing at Time of Analysis|0|||
160737365|NCT03569293|580420482|FG004|Overall Study|Ongoing at Time of Analysis|0|||
160737366|NCT03569293|580420483|FG005|Overall Study|Ongoing at Time of Analysis|0|||
160737367|NCT05376241|580420494|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
160737368|NCT05376241|580420494|FG000|Overall Study|103 did not complete the survey|103|||
160737369|NCT05376241|580420494|FG000|Overall Study|17 failed 2 attention check questions|17|||
160737370|NCT03036098|580420495|FG000|Pre-Treatment|Other Reasons|1|||
160737371|NCT03036098|580420496|FG001|Pre-Treatment|Other Reasons|2|||
160737372|NCT03036098|580420497|FG002|Pre-Treatment|Other Reasons|0|||
160737373|NCT03036098|580420498|FG003|Pre-Treatment|Other Reasons|5|||
160737374|NCT03036098|580420495|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
160737375|NCT03036098|580420496|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
160737376|NCT03036098|580420497|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
160737377|NCT03036098|580420498|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
160737378|NCT03036098|580420495|FG000|Pre-Treatment|Withdrawal by Subject|1|||
160737379|NCT03036098|580420496|FG001|Pre-Treatment|Withdrawal by Subject|14|||
160737380|NCT03036098|580420497|FG002|Pre-Treatment|Withdrawal by Subject|0|||
160737381|NCT03036098|580420498|FG003|Pre-Treatment|Withdrawal by Subject|5|||
160737382|NCT03036098|580420495|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
160737383|NCT03036098|580420496|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
160737384|NCT03036098|580420497|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
160737385|NCT03036098|580420498|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
160737386|NCT03036098|580420495|FG000|Treatment|Disease Progression|130|||
160737387|NCT03036098|580420496|FG001|Treatment|Disease Progression|77|||
160737388|NCT03036098|580420497|FG002|Treatment|Disease Progression|168|||
160737389|NCT03036098|580420498|FG003|Treatment|Disease Progression|50|||
160737390|NCT03036098|580420495|FG000|Treatment|Study Drug Toxicity|95|||
160737391|NCT03036098|580420496|FG001|Treatment|Study Drug Toxicity|45|||
160737392|NCT03036098|580420497|FG002|Treatment|Study Drug Toxicity|26|||
160737393|NCT03036098|580420498|FG003|Treatment|Study Drug Toxicity|22|||
160737394|NCT03036098|580420495|FG000|Treatment|Death|9|||
160737395|NCT03036098|580420496|FG001|Treatment|Death|3|||
160737396|NCT03036098|580420497|FG002|Treatment|Death|1|||
160737397|NCT03036098|580420498|FG003|Treatment|Death|2|||
160737398|NCT03036098|580420495|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
160737399|NCT03036098|580420496|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
160737400|NCT03036098|580420497|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
160737401|NCT03036098|580420498|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
160737402|NCT03036098|580420495|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
160737403|NCT03036098|580420496|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
160737404|NCT03036098|580420497|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
160737405|NCT03036098|580420498|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
160737406|NCT03036098|580420495|FG000|Treatment|Withdrawal by Subject|2|||
160737407|NCT03036098|580420496|FG001|Treatment|Withdrawal by Subject|9|||
160737408|NCT03036098|580420497|FG002|Treatment|Withdrawal by Subject|2|||
160737409|NCT03036098|580420498|FG003|Treatment|Withdrawal by Subject|4|||
160737410|NCT03036098|580420495|FG000|Treatment|Maximum Clinical Benefit|6|||
160737411|NCT03036098|580420496|FG001|Treatment|Maximum Clinical Benefit|1|||
160737412|NCT03036098|580420497|FG002|Treatment|Maximum Clinical Benefit|6|||
160737413|NCT03036098|580420498|FG003|Treatment|Maximum Clinical Benefit|10|||
160737414|NCT03036098|580420495|FG000|Treatment|Poor/Non Compliance|1|||
160737415|NCT03036098|580420496|FG001|Treatment|Poor/Non Compliance|2|||
160737416|NCT03036098|580420497|FG002|Treatment|Poor/Non Compliance|0|||
160737417|NCT03036098|580420498|FG003|Treatment|Poor/Non Compliance|1|||
160737418|NCT03036098|580420495|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
160737419|NCT03036098|580420496|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
160737420|NCT03036098|580420497|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
160737421|NCT03036098|580420498|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
160737422|NCT03036098|580420495|FG000|Treatment|Administrative Reason by Sponsor|1|||
160737423|NCT03036098|580420496|FG001|Treatment|Administrative Reason by Sponsor|0|||
160737424|NCT03036098|580420497|FG002|Treatment|Administrative Reason by Sponsor|2|||
160737425|NCT03036098|580420498|FG003|Treatment|Administrative Reason by Sponsor|1|||
160737426|NCT03036098|580420495|FG000|Treatment|Other Reasons|31|||
160737427|NCT03036098|580420496|FG001|Treatment|Other Reasons|5|||
160737428|NCT03036098|580420497|FG002|Treatment|Other Reasons|21|||
160737429|NCT03036098|580420498|FG003|Treatment|Other Reasons|8|||
160737430|NCT03036098|580420495|FG000|Treatment|Ongoing Treatment|0|||
160737431|NCT03036098|580420496|FG001|Treatment|Ongoing Treatment|0|||
160737432|NCT03036098|580420497|FG002|Treatment|Ongoing Treatment|23|||
160737433|NCT03036098|580420498|FG003|Treatment|Ongoing Treatment|0|||
160737434|NCT02276053|580420501|FG000|Overall Study|Death|2|||
160737435|NCT02276053|580420501|FG000|Overall Study|Adverse Event|5|||
160737436|NCT02276053|580420501|FG000|Overall Study|Lack of Efficacy|2|||
160737437|NCT02276053|580420501|FG000|Overall Study|Withdrawal by Subject|1|||
160737438|NCT02276053|580420501|FG000|Overall Study|Patient does not meet selection criteria|3|||
160737439|NCT02276053|580420501|FG000|Overall Study|Patient needs to increase baseline AED|1|||
160737440|NCT01632904|580420502|FG000|Overall Study|Adverse Event|4|||
160737441|NCT01632904|580420503|FG001|Overall Study|Adverse Event|1|||
160737442|NCT01632904|580420502|FG000|Overall Study|Physician Decision|0|||
160737443|NCT01632904|580420503|FG001|Overall Study|Physician Decision|1|||
160737444|NCT01632904|580420502|FG000|Overall Study|Subject decision|3|||
160737445|NCT01632904|580420503|FG001|Overall Study|Subject decision|2|||
160737446|NCT01632904|580420502|FG000|Overall Study|Disease Progression|0|||
160737447|NCT01632904|580420503|FG001|Overall Study|Disease Progression|1|||
160737448|NCT01632904|580420502|FG000|Overall Study|Reason for discontinuation not available|0|||
160737449|NCT01632904|580420503|FG001|Overall Study|Reason for discontinuation not available|1|||
160737450|NCT02059434|580420504|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
160737451|NCT02059434|580420505|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
160737452|NCT02059434|580420506|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
160737453|NCT02059434|580420507|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
160737454|NCT02059434|580420508|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
160737455|NCT02059434|580420509|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
160737456|NCT02059434|580420510|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
160737457|NCT02059434|580420511|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
160737458|NCT02059434|580420512|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
160737459|NCT02059434|580420504|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
160737460|NCT02059434|580420505|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
160737461|NCT02059434|580420506|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
160737462|NCT02059434|580420507|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
160737463|NCT02059434|580420508|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
160737464|NCT02059434|580420509|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
160737465|NCT02059434|580420510|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
160737466|NCT02059434|580420511|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
160737467|NCT02059434|580420512|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
160737468|NCT02059434|580420504|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
160737469|NCT02059434|580420505|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
160737470|NCT02059434|580420506|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
160737471|NCT02059434|580420507|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
160737472|NCT02059434|580420508|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
160737473|NCT02059434|580420509|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
160737474|NCT02059434|580420510|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
160737475|NCT02059434|580420511|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
160737476|NCT02059434|580420512|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
160737477|NCT02059434|580420504|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
160737478|NCT02059434|580420505|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
160737479|NCT02059434|580420506|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
160737480|NCT02059434|580420507|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
160737481|NCT02059434|580420508|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
160737482|NCT02059434|580420509|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
160737483|NCT02059434|580420510|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
160737484|NCT02059434|580420511|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
160737485|NCT02059434|580420512|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
160737486|NCT02059434|580420504|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
160737487|NCT02059434|580420505|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
160737488|NCT02059434|580420506|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
160737489|NCT02059434|580420507|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
160737490|NCT02059434|580420508|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
160737491|NCT02059434|580420509|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
160737492|NCT02059434|580420510|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
160737493|NCT02059434|580420511|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
160737494|NCT02059434|580420512|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
160737495|NCT01004406|580420517|FG000|Overall Study|Withdrawal by Subject|2|||
160737496|NCT01004406|580420518|FG001|Overall Study|Withdrawal by Subject|0|||
160737497|NCT01004406|580420517|FG000|Overall Study|Lost to Follow-up|1|||
160737498|NCT01004406|580420518|FG001|Overall Study|Lost to Follow-up|0|||
160737499|NCT02928770|580420519|FG000|Overall Study|Withdrawal by Subject|2|||
160737500|NCT03201874|580420520|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
160737501|NCT03201874|580420521|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
160737502|NCT03201874|580420520|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
160737503|NCT03201874|580420521|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
160737504|NCT01944670|580420524|FG000|Overall Study|Lost to Follow-up|2|||
160737505|NCT02907593|580420525|FG000|Overall Study|Withdrawal by Subject|0|||
160737506|NCT02907593|580420526|FG001|Overall Study|Withdrawal by Subject|0|||
160737507|NCT02907593|580420527|FG002|Overall Study|Withdrawal by Subject|1|||
160737508|NCT02907593|580420528|FG003|Overall Study|Withdrawal by Subject|0|||
160737509|NCT05128773|580420537|FG000|Overall Study|Sponsor decision to terminate study|3|||
160737510|NCT05906836|580420539|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
160737511|NCT05906836|580420539|FG000|Overall Study|Lost to Follow-up|1|||
160737512|NCT04488497|580420540|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
160737513|NCT04488497|580420541|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
160737514|NCT04488497|580420540|FG000|Intervention|Physician Decision|2|||
160737515|NCT04488497|580420541|FG001|Intervention|Physician Decision|1|||
160737516|NCT04488497|580420540|FG000|Intervention|Withdrawal by Subject|5|||
160737517|NCT04488497|580420541|FG001|Intervention|Withdrawal by Subject|6|||
160737518|NCT04488497|580420540|FG000|Intervention|Lost to Follow-up|2|||
160737519|NCT04488497|580420541|FG001|Intervention|Lost to Follow-up|0|||
160737520|NCT04488497|580420540|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
160737521|NCT04488497|580420541|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
160737522|NCT04488497|580420540|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
160737523|NCT04488497|580420541|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
160737524|NCT00623597|580420542|FG000|Overall Study|Failed to return|1|||
160737525|NCT00623597|580420543|FG001|Overall Study|Failed to return|0|||
160737526|NCT01451164|580420544|FG000|Overall Study|Adverse Event|19|||
160737527|NCT01451164|580420545|FG001|Overall Study|Adverse Event|12|||
160737528|NCT01451164|580420546|FG002|Overall Study|Adverse Event|18|||
160737529|NCT01451164|580420547|FG003|Overall Study|Adverse Event|21|||
160737530|NCT01451164|580420544|FG000|Overall Study|Withdrawal Criteria|1|||
160737531|NCT01451164|580420545|FG001|Overall Study|Withdrawal Criteria|1|||
160737532|NCT01451164|580420546|FG002|Overall Study|Withdrawal Criteria|1|||
160737533|NCT01451164|580420547|FG003|Overall Study|Withdrawal Criteria|1|||
160737534|NCT01451164|580420544|FG000|Overall Study|Physician Decision|2|||
160737535|NCT01451164|580420545|FG001|Overall Study|Physician Decision|0|||
160737536|NCT01451164|580420546|FG002|Overall Study|Physician Decision|1|||
160737537|NCT01451164|580420547|FG003|Overall Study|Physician Decision|0|||
160737538|NCT01451164|580420544|FG000|Overall Study|Withdrawal by Subject|14|||
160737539|NCT01451164|580420545|FG001|Overall Study|Withdrawal by Subject|11|||
160737540|NCT01451164|580420546|FG002|Overall Study|Withdrawal by Subject|16|||
160737541|NCT01451164|580420547|FG003|Overall Study|Withdrawal by Subject|17|||
160737542|NCT01451164|580420544|FG000|Overall Study|Protocol Violation|0|||
160737543|NCT01451164|580420545|FG001|Overall Study|Protocol Violation|1|||
160737544|NCT01451164|580420546|FG002|Overall Study|Protocol Violation|0|||
160737545|NCT01451164|580420547|FG003|Overall Study|Protocol Violation|0|||
160737546|NCT01451164|580420544|FG000|Overall Study|Lack of Efficacy|7|||
160737547|NCT01451164|580420545|FG001|Overall Study|Lack of Efficacy|9|||
160737548|NCT01451164|580420546|FG002|Overall Study|Lack of Efficacy|9|||
160737549|NCT01451164|580420547|FG003|Overall Study|Lack of Efficacy|7|||
160737550|NCT01214252|580420551|FG000|Overall Study|Not eligible per protocol|82|||
160737551|NCT01877551|580420556|FG000|Overall Study|Physician Decision|0|||
160737552|NCT01877551|580420557|FG001|Overall Study|Physician Decision|1|||
160737553|NCT02659514|580420558|FG000|Overall Study|Adverse Event|3|||
160737554|NCT02659514|580420559|FG001|Overall Study|Adverse Event|12|||
160737555|NCT02659514|580420558|FG000|Overall Study|Disease Progression|23|||
160737556|NCT02659514|580420559|FG001|Overall Study|Disease Progression|13|||
160737557|NCT02659514|580420558|FG000|Overall Study|Withdrawal by Subject|0|||
160737558|NCT02659514|580420559|FG001|Overall Study|Withdrawal by Subject|4|||
160737559|NCT02659514|580420558|FG000|Overall Study|Lost to Follow-up|0|||
160737560|NCT02659514|580420559|FG001|Overall Study|Lost to Follow-up|1|||
160737561|NCT02659514|580420558|FG000|Overall Study|Death|6|||
160737562|NCT02659514|580420559|FG001|Overall Study|Death|1|||
160737563|NCT02659514|580420558|FG000|Overall Study|Reason Unspecified|0|||
160737564|NCT02659514|580420559|FG001|Overall Study|Reason Unspecified|3|||
160737565|NCT03409107|580420560|FG000|Overall Study|Withdrawal by Subject|4|||
160737566|NCT03409107|580420561|FG001|Overall Study|Withdrawal by Subject|2|||
160737567|NCT03409107|580420560|FG000|Overall Study|Physician Decision|1|||
160737568|NCT03409107|580420561|FG001|Overall Study|Physician Decision|0|||
160737569|NCT03409107|580420560|FG000|Overall Study|Lost to Follow-up|7|||
160737570|NCT03409107|580420561|FG001|Overall Study|Lost to Follow-up|2|||
160737571|NCT03409107|580420560|FG000|Overall Study|Adverse Event|5|||
160737572|NCT03409107|580420561|FG001|Overall Study|Adverse Event|3|||
160737573|NCT03687372|580420562|FG000|Overall Study|Lost to Follow-up|12|||
160737574|NCT03687372|580420563|FG001|Overall Study|Lost to Follow-up|21|||
160737575|NCT03687372|580420562|FG000|Overall Study|Withdrawal by Subject|4|||
160737576|NCT03687372|580420563|FG001|Overall Study|Withdrawal by Subject|17|||
160737577|NCT03687372|580420562|FG000|Overall Study|Investigator Decision|1|||
160737578|NCT03687372|580420563|FG001|Overall Study|Investigator Decision|1|||
160737579|NCT02370667|580420572|FG000|Overall Study|Lost to Follow-up|0|||
160737580|NCT02370667|580420573|FG001|Overall Study|Lost to Follow-up|1|||
160737581|NCT02370667|580420574|FG002|Overall Study|Lost to Follow-up|0|||
160737582|NCT03536949|580420575|FG000|Overall Study|Adverse Event|4|||
160737583|NCT03536949|580420576|FG001|Overall Study|Adverse Event|0|||
160737584|NCT03536949|580420575|FG000|Overall Study|Lost to Follow-up|2|||
160737585|NCT03536949|580420576|FG001|Overall Study|Lost to Follow-up|1|||
160737586|NCT03536949|580420575|FG000|Overall Study|Withdrawal by Subject|6|||
160737587|NCT03536949|580420576|FG001|Overall Study|Withdrawal by Subject|0|||
160737588|NCT03536949|580420575|FG000|Overall Study|Non-compliance|2|||
160737589|NCT03536949|580420576|FG001|Overall Study|Non-compliance|1|||
160737590|NCT00423189|580420578|FG000|Overall Study|Death|0|||
160737591|NCT00423189|580420579|FG001|Overall Study|Death|1|||
160737592|NCT00423189|580420580|FG002|Overall Study|Death|0|||
160737593|NCT03787303|580420581|FG000|Overall Study|Death|1|||
160737594|NCT03787303|580420581|FG000|Overall Study|Premature Termination of Study|1|||
160737595|NCT00381043|580420593|FG000|Overall Study|Lost to Follow-up|8|||
160737596|NCT00381043|580420594|FG001|Overall Study|Lost to Follow-up|6|||
160737597|NCT00381043|580420593|FG000|Overall Study|Withdrawal by Subject|3|||
160737598|NCT00381043|580420594|FG001|Overall Study|Withdrawal by Subject|1|||
160737599|NCT00381043|580420593|FG000|Overall Study|wanted more care|0|||
160737600|NCT00381043|580420594|FG001|Overall Study|wanted more care|1|||
160737601|NCT00381043|580420593|FG000|Overall Study|incarcerated|1|||
160737602|NCT00381043|580420594|FG001|Overall Study|incarcerated|0|||
160737603|NCT03045276|580420596|FG000|Intervention Phase|Withdrawal by Subject|7|||
160737604|NCT03045276|580420597|FG001|Intervention Phase|Withdrawal by Subject|2|||
160737605|NCT03045276|580420598|FG002|Intervention Phase|Withdrawal by Subject|3|||
160737606|NCT03045276|580420599|FG003|Intervention Phase|Withdrawal by Subject|7|||
160737607|NCT03045276|580420596|FG000|Intervention Phase|Developed exclusionary criteria|3|||
160737608|NCT03045276|580420597|FG001|Intervention Phase|Developed exclusionary criteria|3|||
160737609|NCT03045276|580420598|FG002|Intervention Phase|Developed exclusionary criteria|0|||
160737610|NCT03045276|580420599|FG003|Intervention Phase|Developed exclusionary criteria|0|||
160737611|NCT03045276|580420596|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
160737612|NCT03045276|580420597|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
160737613|NCT03045276|580420598|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
160737614|NCT03045276|580420599|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
160737615|NCT03045276|580420596|FG000|Follow-Up Phase|Lost to Follow-up|0|||
160737616|NCT03045276|580420597|FG001|Follow-Up Phase|Lost to Follow-up|1|||
160737617|NCT03045276|580420598|FG002|Follow-Up Phase|Lost to Follow-up|0|||
160737618|NCT03045276|580420599|FG003|Follow-Up Phase|Lost to Follow-up|1|||
160737619|NCT03045276|580420596|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
160737620|NCT03045276|580420597|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
160737621|NCT03045276|580420598|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
160737622|NCT03045276|580420599|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
160737623|NCT02496091|580420604|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
160737624|NCT02272842|580420605|FG000|Overall Study|Lost to Follow-up|8|||
160737625|NCT02272842|580420606|FG001|Overall Study|Lost to Follow-up|8|||
160737626|NCT02272842|580420605|FG000|Overall Study|Withdrawal by Subject|8|||
160737627|NCT02272842|580420606|FG001|Overall Study|Withdrawal by Subject|2|||
160737628|NCT01984892|580420609|FG000|Overall Study|Progressive disease|7|||
160737629|NCT02000882|580422054|FG000|Overall Study|Adverse Event|3|||
160737630|NCT02000882|580422054|FG000|Overall Study|Physician Decision|2|||
160737631|NCT02000882|580422054|FG000|Overall Study|Withdrawal by Subject|1|||
160737632|NCT02417961|580422058|FG000|Overall Study|Adverse Event|1|||
160737633|NCT02417961|580422058|FG000|Overall Study|Lost to Follow-up|1|||
160737634|NCT02417961|580422058|FG000|Overall Study|Withdrawal by Subject|2|||
160737635|NCT01390428|580422059|FG000|Overall Study|Elective Surgery|0|||
160737636|NCT01390428|580422060|FG001|Overall Study|Elective Surgery|0|||
160737637|NCT01390428|580422061|FG002|Overall Study|Elective Surgery|0|||
160737638|NCT01390428|580422062|FG003|Overall Study|Elective Surgery|0|||
160737639|NCT01390428|580422063|FG004|Overall Study|Elective Surgery|1|||
160737640|NCT01390428|580422064|FG005|Overall Study|Elective Surgery|0|||
160737641|NCT01390428|580422059|FG000|Overall Study|Withdrawal by Subject|0|||
160737642|NCT01390428|580422060|FG001|Overall Study|Withdrawal by Subject|0|||
160737643|NCT01390428|580422061|FG002|Overall Study|Withdrawal by Subject|1|||
160737644|NCT01390428|580422062|FG003|Overall Study|Withdrawal by Subject|0|||
160737645|NCT01390428|580422063|FG004|Overall Study|Withdrawal by Subject|0|||
160737646|NCT01390428|580422064|FG005|Overall Study|Withdrawal by Subject|0|||
160737647|NCT05079750|580422065|FG000|Overall Study|Lost to Follow-up|0|||
160737648|NCT05079750|580422066|FG001|Overall Study|Lost to Follow-up|0|||
160737649|NCT05079750|580422067|FG002|Overall Study|Lost to Follow-up|1|||
160737650|NCT05091346|580422070|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
160737651|NCT05091346|580422071|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
160737652|NCT05091346|580422072|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
160737653|NCT05091346|580422073|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
160737654|NCT05091346|580422074|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
160737655|NCT05091346|580422070|FG000|Overall Study|Death|6|||
160737656|NCT05091346|580422071|FG001|Overall Study|Death|5|||
160737657|NCT05091346|580422072|FG002|Overall Study|Death|8|||
160737658|NCT05091346|580422073|FG003|Overall Study|Death|16|||
160737659|NCT05091346|580422074|FG004|Overall Study|Death|26|||
160737660|NCT05091346|580422070|FG000|Overall Study|Lost to Follow-up|0|||
160737661|NCT05091346|580422071|FG001|Overall Study|Lost to Follow-up|0|||
160737662|NCT05091346|580422072|FG002|Overall Study|Lost to Follow-up|0|||
160737663|NCT05091346|580422073|FG003|Overall Study|Lost to Follow-up|1|||
160737664|NCT05091346|580422074|FG004|Overall Study|Lost to Follow-up|0|||
160737665|NCT05091346|580422070|FG000|Overall Study|Withdrawal by Subject|0|||
160737666|NCT05091346|580422071|FG001|Overall Study|Withdrawal by Subject|1|||
160737667|NCT05091346|580422072|FG002|Overall Study|Withdrawal by Subject|2|||
160737668|NCT05091346|580422073|FG003|Overall Study|Withdrawal by Subject|2|||
160737669|NCT05091346|580422074|FG004|Overall Study|Withdrawal by Subject|1|||
160737670|NCT05897827|580422075|FG000|Overall Study|Lost to Follow-up|33|||
160737671|NCT05897827|580422076|FG001|Overall Study|Lost to Follow-up|14|||
160737672|NCT05897827|580422075|FG000|Overall Study|Withdrawal by Subject|1|||
160737673|NCT05897827|580422076|FG001|Overall Study|Withdrawal by Subject|1|||
160737674|NCT01752634|580422077|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
160737675|NCT01752634|580422078|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
160737676|NCT01752634|580422079|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
160737677|NCT01752634|580422080|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
160737678|NCT01752634|580422081|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
160737679|NCT01752634|580422082|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
160737680|NCT01752634|580422077|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
160737681|NCT01752634|580422078|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
160737682|NCT01752634|580422079|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
160737683|NCT01752634|580422080|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
160737684|NCT01752634|580422081|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
160737685|NCT01752634|580422082|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
160737686|NCT01752634|580422077|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
160737687|NCT01752634|580422078|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
160737688|NCT01752634|580422079|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
160737689|NCT01752634|580422080|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
160737690|NCT01752634|580422081|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
160737691|NCT01752634|580422082|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
160737692|NCT01752634|580422077|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
160737693|NCT01752634|580422078|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
160737694|NCT01752634|580422079|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
160737695|NCT01752634|580422080|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
160737696|NCT01752634|580422081|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
160737697|NCT01752634|580422082|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
160737698|NCT01752634|580422077|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
160737699|NCT01752634|580422078|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
160737700|NCT01752634|580422079|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
160737701|NCT01752634|580422080|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
160737702|NCT01752634|580422081|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
160737703|NCT01752634|580422082|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
160737704|NCT01752634|580422077|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
160737705|NCT01752634|580422078|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
160737706|NCT01752634|580422079|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
160737707|NCT01752634|580422080|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
160737708|NCT01752634|580422081|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
160737709|NCT01752634|580422082|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
160737710|NCT01752634|580422077|FG000|Week 24 to Week 260|Physician Decision|1|||
160737711|NCT01752634|580422078|FG001|Week 24 to Week 260|Physician Decision|2|||
160737712|NCT01752634|580422079|FG002|Week 24 to Week 260|Physician Decision|4|||
160737713|NCT01752634|580422080|FG003|Week 24 to Week 260|Physician Decision|2|||
160737714|NCT01752634|580422081|FG004|Week 24 to Week 260|Physician Decision|1|||
160737715|NCT01752634|580422082|FG005|Week 24 to Week 260|Physician Decision|0|||
160737716|NCT01752634|580422077|FG000|Week 24 to Week 260|Death|0|||
160737717|NCT01752634|580422078|FG001|Week 24 to Week 260|Death|1|||
160737718|NCT01752634|580422079|FG002|Week 24 to Week 260|Death|0|||
160737719|NCT01752634|580422080|FG003|Week 24 to Week 260|Death|0|||
160737720|NCT01752634|580422081|FG004|Week 24 to Week 260|Death|0|||
160737721|NCT01752634|580422082|FG005|Week 24 to Week 260|Death|0|||
160737722|NCT01752634|580422077|FG000|Week 24 to Week 260|Pregnancy|0|||
160737723|NCT01752634|580422078|FG001|Week 24 to Week 260|Pregnancy|0|||
160737724|NCT01752634|580422079|FG002|Week 24 to Week 260|Pregnancy|1|||
160737725|NCT01752634|580422080|FG003|Week 24 to Week 260|Pregnancy|0|||
160737726|NCT01752634|580422081|FG004|Week 24 to Week 260|Pregnancy|0|||
160737727|NCT01752634|580422082|FG005|Week 24 to Week 260|Pregnancy|0|||
160737728|NCT01752634|580422077|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
160737729|NCT01752634|580422078|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
160737730|NCT01752634|580422079|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
160737731|NCT01752634|580422080|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
160737732|NCT01752634|580422081|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
160737733|NCT01752634|580422082|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
160737734|NCT01752634|580422077|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
160737735|NCT01752634|580422078|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
160737736|NCT01752634|580422079|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
160737737|NCT01752634|580422080|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
160737738|NCT01752634|580422081|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
160737739|NCT01752634|580422082|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
160737740|NCT01752634|580422077|FG000|Week 24 to Week 260|Adverse Event|4|||
160737741|NCT01752634|580422078|FG001|Week 24 to Week 260|Adverse Event|8|||
160737742|NCT01752634|580422079|FG002|Week 24 to Week 260|Adverse Event|8|||
160737743|NCT01752634|580422080|FG003|Week 24 to Week 260|Adverse Event|4|||
160737744|NCT01752634|580422081|FG004|Week 24 to Week 260|Adverse Event|2|||
160737745|NCT01752634|580422082|FG005|Week 24 to Week 260|Adverse Event|0|||
160737746|NCT04250714|580422086|FG000|Overall Study|Treatment - withdrawal by subject|14|||
160737747|NCT04250714|580422086|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
160737748|NCT04250714|580422086|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
160737749|NCT04250714|580422086|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
160737750|NCT04250714|580422086|FG000|Overall Study|Treatment - Death|1|||
160737751|NCT04250714|580422086|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
160737752|NCT04250714|580422086|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
160737753|NCT04250714|580422086|FG000|Overall Study|Attempt|2|||
160737754|NCT04250714|580422086|FG000|Overall Study|Intent|7|||
160737755|NCT04697056|580422087|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
160737756|NCT04697056|580422088|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
160737757|NCT03617861|580422089|FG000|Second Intervention (1 Day)|Adverse Event|0|||
160737758|NCT03617861|580422090|FG001|Second Intervention (1 Day)|Adverse Event|0|||
160737759|NCT03617861|580422091|FG002|Second Intervention (1 Day)|Adverse Event|1|||
160737760|NCT03617861|580422092|FG003|Second Intervention (1 Day)|Adverse Event|0|||
160737761|NCT01702532|580422093|FG000|Overall Study|Adverse Event|0|||
160737762|NCT01702532|580422094|FG001|Overall Study|Adverse Event|1|||
160737763|NCT02963558|580422097|FG000|Overall Study|Withdrawn by investigator|1|||
160737764|NCT02963558|580422098|FG001|Overall Study|Withdrawn by investigator|0|||
160737765|NCT02963558|580422097|FG000|Overall Study|Withdrawal by Subject|0|||
160737766|NCT02963558|580422098|FG001|Overall Study|Withdrawal by Subject|1|||
160737767|NCT01371877|580422099|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
160737768|NCT01371877|580422100|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
160737769|NCT05932225|580422103|FG000|Overall Study|Lost to Follow-up|0|||
160737770|NCT05932225|580422104|FG001|Overall Study|Lost to Follow-up|1|||
160737771|NCT05932225|580422105|FG002|Overall Study|Lost to Follow-up|0|||
160737772|NCT05932225|580422103|FG000|Overall Study|Withdrawal by Subject|1|||
160737773|NCT05932225|580422104|FG001|Overall Study|Withdrawal by Subject|0|||
160737774|NCT05932225|580422105|FG002|Overall Study|Withdrawal by Subject|0|||
160737775|NCT05932225|580422103|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
160737776|NCT05932225|580422104|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
160737777|NCT05932225|580422105|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
160737778|NCT00345878|580422108|FG000|Overall Study|Adverse Event|1|||
160737779|NCT00345878|580422109|FG001|Overall Study|Adverse Event|0|||
160737780|NCT00345878|580422108|FG000|Overall Study|Lost to Follow-up|2|||
160737781|NCT00345878|580422109|FG001|Overall Study|Lost to Follow-up|1|||
160737782|NCT00345878|580422108|FG000|Overall Study|Other|1|||
160737783|NCT00345878|580422109|FG001|Overall Study|Other|0|||
160737784|NCT00308750|580422110|FG000|Overall Study|Adverse Event|9|||
160737785|NCT00308750|580422111|FG001|Overall Study|Adverse Event|9|||
160737786|NCT00308750|580422112|FG002|Overall Study|Adverse Event|13|||
160737787|NCT00308750|580422110|FG000|Overall Study|Withdrawal by Subject|6|||
160737788|NCT00308750|580422111|FG001|Overall Study|Withdrawal by Subject|2|||
160737789|NCT00308750|580422112|FG002|Overall Study|Withdrawal by Subject|3|||
160737790|NCT00308750|580422110|FG000|Overall Study|Physician Decision|3|||
160737791|NCT00308750|580422111|FG001|Overall Study|Physician Decision|4|||
160737792|NCT00308750|580422112|FG002|Overall Study|Physician Decision|3|||
160737793|NCT00308750|580422110|FG000|Overall Study|Sponsor Decision|1|||
160737794|NCT00308750|580422111|FG001|Overall Study|Sponsor Decision|0|||
160737795|NCT00308750|580422112|FG002|Overall Study|Sponsor Decision|0|||
160737796|NCT00308750|580422110|FG000|Overall Study|Disease Progression|47|||
160737797|NCT00308750|580422111|FG001|Overall Study|Disease Progression|24|||
160737798|NCT00308750|580422112|FG002|Overall Study|Disease Progression|28|||
160737799|NCT00308750|580422110|FG000|Overall Study|Unrelated Complication|3|||
160737800|NCT00308750|580422111|FG001|Overall Study|Unrelated Complication|0|||
160737801|NCT00308750|580422112|FG002|Overall Study|Unrelated Complication|1|||
160737802|NCT00308750|580422110|FG000|Overall Study|Death|1|||
160737803|NCT00308750|580422111|FG001|Overall Study|Death|0|||
160737804|NCT00308750|580422112|FG002|Overall Study|Death|1|||
160737805|NCT00308750|580422110|FG000|Overall Study|Protocol Violation|1|||
160737806|NCT00308750|580422111|FG001|Overall Study|Protocol Violation|0|||
160737807|NCT00308750|580422112|FG002|Overall Study|Protocol Violation|0|||
160737808|NCT00308750|580422110|FG000|Overall Study|New Primary Disease Identified|1|||
160737809|NCT00308750|580422111|FG001|Overall Study|New Primary Disease Identified|1|||
160737810|NCT00308750|580422112|FG002|Overall Study|New Primary Disease Identified|0|||
160737811|NCT02045732|580422113|FG000|Overall Study|At the discretion of the investigator|1|||
160737812|NCT02045732|580422114|FG001|Overall Study|At the discretion of the investigator|1|||
160737813|NCT00348790|580422115|FG000|Completed Treatment|Withdrawal by Subject|4|||
160737814|NCT00348790|580422115|FG000|Completed Treatment|Disease progression|14|||
160737815|NCT00348790|580422115|FG000|Completed Treatment|Adverse Event|4|||
160737816|NCT00348790|580422115|FG000|Completed Treatment|Required surgery|2|||
160737817|NCT00348790|580422115|FG000|Completed Treatment|Unable to travel to study site|1|||
160737818|NCT01185509|580422119|FG000|Overall Study|Progression/Relapse|9|||
160737819|NCT01185509|580422120|FG001|Overall Study|Progression/Relapse|15|||
160737820|NCT01185509|580422119|FG000|Overall Study|Physician Decision|2|||
160737821|NCT01185509|580422120|FG001|Overall Study|Physician Decision|2|||
160737822|NCT01185509|580422119|FG000|Overall Study|Withdrawal by Subject|0|||
160737823|NCT01185509|580422120|FG001|Overall Study|Withdrawal by Subject|1|||
160737824|NCT01185509|580422119|FG000|Overall Study|Death|0|||
160737825|NCT01185509|580422120|FG001|Overall Study|Death|1|||
160737826|NCT01185509|580422119|FG000|Overall Study|Intercurrent Illness|0|||
160737827|NCT01185509|580422120|FG001|Overall Study|Intercurrent Illness|1|||
160737828|NCT01088243|580422122|FG000|Overall Study|Adverse Event|1|||
160737829|NCT01088243|580422123|FG001|Overall Study|Adverse Event|0|||
160737830|NCT04495816|580422126|FG000|Overall Study|Lost to Follow-up|10|||
160737831|NCT04495816|580422127|FG001|Overall Study|Lost to Follow-up|4|||
160737832|NCT04495816|580422126|FG000|Overall Study|Withdrawal by Subject|3|||
160737833|NCT04495816|580422127|FG001|Overall Study|Withdrawal by Subject|5|||
160737834|NCT01826370|580422130|FG000|Overall Study|Protocol Violation|6|||
160737835|NCT01826370|580422130|FG000|Overall Study|Lost to Follow-up|12|||
160737836|NCT01826370|580422130|FG000|Overall Study|Other reason not defined above|2|||
160737837|NCT04416737|580422131|FG000|Week 1 (First Injection)|Physician Decision|0|||
160737838|NCT04416737|580422132|FG001|Week 1 (First Injection)|Physician Decision|1|||
160737839|NCT03332628|580422133|FG000|Overall Study|Physician Decision|2|||
160737840|NCT04489381|580422145|FG000|Overall Study|Lost to Follow-up|2|||
160737841|NCT04489381|580422146|FG001|Overall Study|Lost to Follow-up|3|||
160737842|NCT04489381|580422145|FG000|Overall Study|Withdrawal by Subject|1|||
160737843|NCT04489381|580422146|FG001|Overall Study|Withdrawal by Subject|0|||
160737844|NCT01500213|580422149|FG000|Overall Study|Adverse Event|35|||
160737845|NCT01500213|580422150|FG001|Overall Study|Adverse Event|35|||
160737846|NCT01500213|580422149|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
160737847|NCT01500213|580422150|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
160737848|NCT01500213|580422149|FG000|Overall Study|Withdrawal by Subject|28|||
160737849|NCT01500213|580422150|FG001|Overall Study|Withdrawal by Subject|37|||
160737850|NCT01500213|580422149|FG000|Overall Study|Death|7|||
160737851|NCT01500213|580422150|FG001|Overall Study|Death|3|||
160737852|NCT01500213|580422149|FG000|Overall Study|Disease Progression|13|||
160737853|NCT01500213|580422150|FG001|Overall Study|Disease Progression|21|||
160737854|NCT01500213|580422149|FG000|Overall Study|Protocol Violation|19|||
160737855|NCT01500213|580422150|FG001|Overall Study|Protocol Violation|19|||
160737856|NCT01500213|580422149|FG000|Overall Study|Physician Decision|12|||
160737857|NCT01500213|580422150|FG001|Overall Study|Physician Decision|10|||
160737858|NCT01500213|580422149|FG000|Overall Study|Lack of Efficacy|9|||
160737859|NCT01500213|580422150|FG001|Overall Study|Lack of Efficacy|7|||
160737860|NCT01500213|580422149|FG000|Overall Study|Lost to Follow-up|3|||
160737861|NCT01500213|580422150|FG001|Overall Study|Lost to Follow-up|6|||
160737862|NCT01500213|580422149|FG000|Overall Study|Other Reasons|7|||
160737863|NCT01500213|580422150|FG001|Overall Study|Other Reasons|5|||
160737864|NCT00785213|580422151|FG000|Quinine Sulfate Alone|Adverse Event|4|||
160737865|NCT00785213|580422151|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
160737866|NCT02386345|580422152|FG000|Overall Study|Not treated|14|||
160737867|NCT02386345|580422152|FG000|Overall Study|Lost to Follow-up|1|||
160737868|NCT02386345|580422152|FG000|Overall Study|Adverse Event|5|||
160737869|NCT02386345|580422152|FG000|Overall Study|Repeat Procedure|10|||
160737870|NCT02386345|580422152|FG000|Overall Study|Did not complete 12-month follow-up|72|||
160737871|NCT01043705|580422153|FG000|Overall Study|Death|28|||
160737872|NCT01043705|580422154|FG001|Overall Study|Death|60|||
160737873|NCT01043705|580422155|FG002|Overall Study|Death|26|||
160737874|NCT01043705|580422153|FG000|Overall Study|Lost to Follow-up|27|||
160737875|NCT01043705|580422154|FG001|Overall Study|Lost to Follow-up|12|||
160737876|NCT01043705|580422155|FG002|Overall Study|Lost to Follow-up|0|||
160737877|NCT01043705|580422153|FG000|Overall Study|Multiple Reasons|4|||
160737878|NCT01043705|580422154|FG001|Overall Study|Multiple Reasons|7|||
160737879|NCT01043705|580422155|FG002|Overall Study|Multiple Reasons|0|||
160737880|NCT01043705|580422153|FG000|Overall Study|Protocol Violation|2|||
160737881|NCT01043705|580422154|FG001|Overall Study|Protocol Violation|1|||
160737882|NCT01043705|580422155|FG002|Overall Study|Protocol Violation|0|||
160737883|NCT01043705|580422153|FG000|Overall Study|Withdrawal by Subject|8|||
160737884|NCT01043705|580422154|FG001|Overall Study|Withdrawal by Subject|6|||
160737885|NCT01043705|580422155|FG002|Overall Study|Withdrawal by Subject|0|||
160737886|NCT01043705|580422153|FG000|Overall Study|Site Closure|8|||
160737887|NCT01043705|580422154|FG001|Overall Study|Site Closure|0|||
160737888|NCT01043705|580422155|FG002|Overall Study|Site Closure|0|||
160737889|NCT01043705|580422153|FG000|Overall Study|Subsequent Procedure|9|||
160737890|NCT01043705|580422154|FG001|Overall Study|Subsequent Procedure|24|||
160737891|NCT01043705|580422155|FG002|Overall Study|Subsequent Procedure|29|||
160737892|NCT01043705|580422153|FG000|Overall Study|Adverse Event|0|||
160737893|NCT01043705|580422154|FG001|Overall Study|Adverse Event|2|||
160737894|NCT01043705|580422155|FG002|Overall Study|Adverse Event|0|||
160737895|NCT01043705|580422153|FG000|Overall Study|Screen Fail|21|||
160737896|NCT01043705|580422154|FG001|Overall Study|Screen Fail|0|||
160737897|NCT01043705|580422155|FG002|Overall Study|Screen Fail|0|||
160737898|NCT01043705|580422153|FG000|Overall Study|Other|0|||
160737899|NCT01043705|580422154|FG001|Overall Study|Other|19|||
160737900|NCT01043705|580422155|FG002|Overall Study|Other|25|||
160737901|NCT05083923|580422161|FG000|Overall Study|Adverse Event|2|||
160737902|NCT05083923|580422162|FG001|Overall Study|Adverse Event|0|||
160737903|NCT05083923|580422161|FG000|Overall Study|Lack of Efficacy|1|||
160737904|NCT05083923|580422162|FG001|Overall Study|Lack of Efficacy|3|||
160737905|NCT05083923|580422161|FG000|Overall Study|Withdrawal by Subject|2|||
160737906|NCT05083923|580422162|FG001|Overall Study|Withdrawal by Subject|6|||
160737907|NCT05083923|580422161|FG000|Overall Study|Reason Not Specified|0|||
160737908|NCT05083923|580422162|FG001|Overall Study|Reason Not Specified|1|||
160737909|NCT02880865|580422163|FG000|Overall Study|Adverse Event|1|||
160737910|NCT02880865|580422164|FG001|Overall Study|Adverse Event|0|||
160737911|NCT02880865|580422163|FG000|Overall Study|Withdrawal by Subject|0|||
160737912|NCT02880865|580422164|FG001|Overall Study|Withdrawal by Subject|2|||
160737913|NCT02880865|580422163|FG000|Overall Study|Physician Decision|0|||
160737914|NCT02880865|580422164|FG001|Overall Study|Physician Decision|1|||
160737915|NCT01190267|580422167|FG000|Overall Study|Adverse Event|10|||
160737916|NCT01190267|580422168|FG001|Overall Study|Adverse Event|0|||
160737917|NCT01190267|580422167|FG000|Overall Study|Treatment Failure|8|||
160737918|NCT01190267|580422168|FG001|Overall Study|Treatment Failure|2|||
160737919|NCT01190267|580422167|FG000|Overall Study|Lost to Follow-up|2|||
160737920|NCT01190267|580422168|FG001|Overall Study|Lost to Follow-up|0|||
160737921|NCT01190267|580422167|FG000|Overall Study|Withdrawal by Subject|13|||
160737922|NCT01190267|580422168|FG001|Overall Study|Withdrawal by Subject|1|||
160737923|NCT01190267|580422167|FG000|Overall Study|Protocol Violation|8|||
160737924|NCT01190267|580422168|FG001|Overall Study|Protocol Violation|1|||
160737925|NCT04687072|580422179|FG000|Overall Study|Adverse Event|2|||
160737926|NCT04687072|580422180|FG001|Overall Study|Adverse Event|0|||
160737927|NCT04687072|580422179|FG000|Overall Study|Death|1|||
160737928|NCT04687072|580422180|FG001|Overall Study|Death|0|||
160737929|NCT04687072|580422179|FG000|Overall Study|Lack of Efficacy|2|||
160737930|NCT04687072|580422180|FG001|Overall Study|Lack of Efficacy|1|||
160737931|NCT04687072|580422179|FG000|Overall Study|Physician Decision|1|||
160737932|NCT04687072|580422180|FG001|Overall Study|Physician Decision|0|||
160737933|NCT04687072|580422179|FG000|Overall Study|Pregnancy|1|||
160737934|NCT04687072|580422180|FG001|Overall Study|Pregnancy|0|||
160737935|NCT04687072|580422179|FG000|Overall Study|Requires Prohibited Medication|2|||
160737936|NCT04687072|580422180|FG001|Overall Study|Requires Prohibited Medication|0|||
160737937|NCT04687072|580422179|FG000|Overall Study|Withdrawal of Consent|11|||
160737938|NCT04687072|580422180|FG001|Overall Study|Withdrawal of Consent|6|||
160737939|NCT04687072|580422179|FG000|Overall Study|Miscellaneous|4|||
160737940|NCT04687072|580422180|FG001|Overall Study|Miscellaneous|1|||
160737941|NCT01263782|580422181|FG000|Overall Study|Death|0|||
160737942|NCT01263782|580422182|FG001|Overall Study|Death|0|||
160737943|NCT01263782|580422183|FG002|Overall Study|Death|1|||
160737944|NCT01263782|580422184|FG003|Overall Study|Death|0|||
160737945|NCT01263782|580422181|FG000|Overall Study|Progressive disease|0|||
160737946|NCT01263782|580422182|FG001|Overall Study|Progressive disease|0|||
160737947|NCT01263782|580422183|FG002|Overall Study|Progressive disease|0|||
160737948|NCT01263782|580422184|FG003|Overall Study|Progressive disease|1|||
160737949|NCT01263782|580422181|FG000|Overall Study|Too early|0|||
160737950|NCT01263782|580422182|FG001|Overall Study|Too early|0|||
160737951|NCT01263782|580422183|FG002|Overall Study|Too early|1|||
160737952|NCT01263782|580422184|FG003|Overall Study|Too early|0|||
160737953|NCT01263782|580422181|FG000|Overall Study|Inevaluable|0|||
160737954|NCT01263782|580422182|FG001|Overall Study|Inevaluable|0|||
160737955|NCT01263782|580422183|FG002|Overall Study|Inevaluable|1|||
160737956|NCT01263782|580422184|FG003|Overall Study|Inevaluable|0|||
160737957|NCT00915876|580422185|FG000|Overall Study|Adverse Event|0|||
160737958|NCT00915876|580422186|FG001|Overall Study|Adverse Event|1|||
160737959|NCT04545567|580422191|FG000|Overall Study|tested positive for SARS-co-V2|1|||
160737960|NCT04545567|580422192|FG001|Overall Study|tested positive for SARS-co-V2|1|||
160737961|NCT04545567|580422191|FG000|Overall Study|Withdrawal by Subject|0|||
160737962|NCT04545567|580422192|FG001|Overall Study|Withdrawal by Subject|1|||
160737963|NCT04464720|580422195|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
160737964|NCT04413552|580422200|FG000|Overall Study|Adverse Event|0|||
160737965|NCT04413552|580422201|FG001|Overall Study|Adverse Event|0|||
160737966|NCT04413552|580422202|FG002|Overall Study|Adverse Event|0|||
160737967|NCT04413552|580422203|FG003|Overall Study|Adverse Event|0|||
160737968|NCT04413552|580422204|FG004|Overall Study|Adverse Event|0|||
160737969|NCT04413552|580422205|FG005|Overall Study|Adverse Event|0|||
160737970|NCT04413552|580422206|FG006|Overall Study|Adverse Event|1|||
160737971|NCT04413552|580422207|FG007|Overall Study|Adverse Event|0|||
160737972|NCT04413552|580422208|FG008|Overall Study|Adverse Event|0|||
160737973|NCT04413552|580422209|FG009|Overall Study|Adverse Event|0|||
160737974|NCT05723328|580422210|FG000|Overall Study|Investigator's Decision|5|||
160737975|NCT05723328|580422211|FG001|Overall Study|Investigator's Decision|2|||
160737976|NCT03495154|580422214|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
160737977|NCT03495154|580422214|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
160737978|NCT03495154|580422214|FG000|Overall Study|Screen Failures During Surgery|6|||
160737979|NCT03495154|580422214|FG000|Overall Study|Death|2|||
160737980|NCT03495154|580422214|FG000|Overall Study|Lost to Follow-up|16|||
160737981|NCT03495154|580422214|FG000|Overall Study|Withdrawal by Subject|2|||
160737982|NCT03495154|580422214|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
160737983|NCT01294696|580422222|FG000|Overall Study|Screening failures|7|||
160737984|NCT01294696|580422222|FG000|Overall Study|Protocol Violation|8|||
160737985|NCT01294696|580422222|FG000|Overall Study|Missing BPI Response|7|||
160737986|NCT01294696|580422222|FG000|Overall Study|Site closure|52|||
160737987|NCT01358578|580424217|FG000|Induction Period|Adverse Event|2|||
160737988|NCT01358578|580424218|FG001|Induction Period|Adverse Event|4|||
160737989|NCT01358578|580424219|FG002|Induction Period|Adverse Event|2|||
160737990|NCT01358578|580424220|FG003|Induction Period|Adverse Event|6|||
160737991|NCT01358578|580424221|FG004|Induction Period|Adverse Event|0|||
160737992|NCT01358578|580424222|FG005|Induction Period|Adverse Event|0|||
160737993|NCT01358578|580424217|FG000|Induction Period|Lack of Efficacy|0|||
160737994|NCT01358578|580424218|FG001|Induction Period|Lack of Efficacy|0|||
160737995|NCT01358578|580424219|FG002|Induction Period|Lack of Efficacy|9|||
160737996|NCT01358578|580424220|FG003|Induction Period|Lack of Efficacy|1|||
160737997|NCT01358578|580424221|FG004|Induction Period|Lack of Efficacy|0|||
160737998|NCT01358578|580424222|FG005|Induction Period|Lack of Efficacy|0|||
160737999|NCT01358578|580424217|FG000|Induction Period|Lost to Follow-up|0|||
160738000|NCT01358578|580424218|FG001|Induction Period|Lost to Follow-up|0|||
160738001|NCT01358578|580424219|FG002|Induction Period|Lost to Follow-up|1|||
160738002|NCT01358578|580424220|FG003|Induction Period|Lost to Follow-up|4|||
160738003|NCT01358578|580424221|FG004|Induction Period|Lost to Follow-up|0|||
160738004|NCT01358578|580424222|FG005|Induction Period|Lost to Follow-up|0|||
160738005|NCT01358578|580424217|FG000|Induction Period|Physician Decision|2|||
160738006|NCT01358578|580424218|FG001|Induction Period|Physician Decision|1|||
160738007|NCT01358578|580424219|FG002|Induction Period|Physician Decision|2|||
160738008|NCT01358578|580424220|FG003|Induction Period|Physician Decision|0|||
160738009|NCT01358578|580424221|FG004|Induction Period|Physician Decision|0|||
160738010|NCT01358578|580424222|FG005|Induction Period|Physician Decision|0|||
160738011|NCT01358578|580424217|FG000|Induction Period|Protocol Deviation|3|||
160738012|NCT01358578|580424218|FG001|Induction Period|Protocol Deviation|5|||
160738013|NCT01358578|580424219|FG002|Induction Period|Protocol Deviation|0|||
160738014|NCT01358578|580424220|FG003|Induction Period|Protocol Deviation|3|||
160738015|NCT01358578|580424221|FG004|Induction Period|Protocol Deviation|0|||
160738016|NCT01358578|580424222|FG005|Induction Period|Protocol Deviation|0|||
160738017|NCT01358578|580424217|FG000|Induction Period|technical problems|0|||
160738018|NCT01358578|580424218|FG001|Induction Period|technical problems|0|||
160738019|NCT01358578|580424219|FG002|Induction Period|technical problems|1|||
160738020|NCT01358578|580424220|FG003|Induction Period|technical problems|1|||
160738021|NCT01358578|580424221|FG004|Induction Period|technical problems|0|||
160738022|NCT01358578|580424222|FG005|Induction Period|technical problems|0|||
160738023|NCT01358578|580424217|FG000|Induction Period|Withdrawal by Subject|5|||
160738024|NCT01358578|580424218|FG001|Induction Period|Withdrawal by Subject|5|||
160738025|NCT01358578|580424219|FG002|Induction Period|Withdrawal by Subject|10|||
160738026|NCT01358578|580424220|FG003|Induction Period|Withdrawal by Subject|6|||
160738027|NCT01358578|580424221|FG004|Induction Period|Withdrawal by Subject|0|||
160738028|NCT01358578|580424222|FG005|Induction Period|Withdrawal by Subject|0|||
160738029|NCT01358578|580424217|FG000|Maintenance Period|Adverse Event|2|||
160738030|NCT01358578|580424218|FG001|Maintenance Period|Adverse Event|7|||
160738031|NCT01358578|580424219|FG002|Maintenance Period|Adverse Event|0|||
160738032|NCT01358578|580424220|FG003|Maintenance Period|Adverse Event|6|||
160738033|NCT01358578|580424221|FG004|Maintenance Period|Adverse Event|4|||
160738034|NCT01358578|580424222|FG005|Maintenance Period|Adverse Event|3|||
160738035|NCT01358578|580424217|FG000|Maintenance Period|Lack of Efficacy|10|||
160738036|NCT01358578|580424218|FG001|Maintenance Period|Lack of Efficacy|2|||
160738037|NCT01358578|580424219|FG002|Maintenance Period|Lack of Efficacy|0|||
160738038|NCT01358578|580424220|FG003|Maintenance Period|Lack of Efficacy|11|||
160738039|NCT01358578|580424221|FG004|Maintenance Period|Lack of Efficacy|3|||
160738040|NCT01358578|580424222|FG005|Maintenance Period|Lack of Efficacy|0|||
160738041|NCT01358578|580424217|FG000|Maintenance Period|Lost to Follow-up|4|||
160738042|NCT01358578|580424218|FG001|Maintenance Period|Lost to Follow-up|0|||
160738043|NCT01358578|580424219|FG002|Maintenance Period|Lost to Follow-up|0|||
160738044|NCT01358578|580424220|FG003|Maintenance Period|Lost to Follow-up|5|||
160738045|NCT01358578|580424221|FG004|Maintenance Period|Lost to Follow-up|1|||
160738046|NCT01358578|580424222|FG005|Maintenance Period|Lost to Follow-up|1|||
160738047|NCT01358578|580424217|FG000|Maintenance Period|Non-compliance with study treatment|3|||
160738048|NCT01358578|580424218|FG001|Maintenance Period|Non-compliance with study treatment|1|||
160738049|NCT01358578|580424219|FG002|Maintenance Period|Non-compliance with study treatment|0|||
160738050|NCT01358578|580424220|FG003|Maintenance Period|Non-compliance with study treatment|2|||
160738051|NCT01358578|580424221|FG004|Maintenance Period|Non-compliance with study treatment|1|||
160738052|NCT01358578|580424222|FG005|Maintenance Period|Non-compliance with study treatment|2|||
160738053|NCT01358578|580424217|FG000|Maintenance Period|Physician Decision|0|||
160738054|NCT01358578|580424218|FG001|Maintenance Period|Physician Decision|1|||
160738055|NCT01358578|580424219|FG002|Maintenance Period|Physician Decision|0|||
160738056|NCT01358578|580424220|FG003|Maintenance Period|Physician Decision|1|||
160738057|NCT01358578|580424221|FG004|Maintenance Period|Physician Decision|0|||
160738058|NCT01358578|580424222|FG005|Maintenance Period|Physician Decision|0|||
160738059|NCT01358578|580424217|FG000|Maintenance Period|Pregnancy|1|||
160738060|NCT01358578|580424218|FG001|Maintenance Period|Pregnancy|0|||
160738061|NCT01358578|580424219|FG002|Maintenance Period|Pregnancy|0|||
160738062|NCT01358578|580424220|FG003|Maintenance Period|Pregnancy|0|||
160738063|NCT01358578|580424221|FG004|Maintenance Period|Pregnancy|0|||
160738064|NCT01358578|580424222|FG005|Maintenance Period|Pregnancy|0|||
160738065|NCT01358578|580424217|FG000|Maintenance Period|Protocol deviation|7|||
160738066|NCT01358578|580424218|FG001|Maintenance Period|Protocol deviation|4|||
160738067|NCT01358578|580424219|FG002|Maintenance Period|Protocol deviation|0|||
160738068|NCT01358578|580424220|FG003|Maintenance Period|Protocol deviation|2|||
160738069|NCT01358578|580424221|FG004|Maintenance Period|Protocol deviation|2|||
160738070|NCT01358578|580424222|FG005|Maintenance Period|Protocol deviation|2|||
160738071|NCT01358578|580424217|FG000|Maintenance Period|Withdrawal by Subject|12|||
160738072|NCT01358578|580424218|FG001|Maintenance Period|Withdrawal by Subject|7|||
160738073|NCT01358578|580424219|FG002|Maintenance Period|Withdrawal by Subject|2|||
160738074|NCT01358578|580424220|FG003|Maintenance Period|Withdrawal by Subject|15|||
160738075|NCT01358578|580424221|FG004|Maintenance Period|Withdrawal by Subject|6|||
160738076|NCT01358578|580424222|FG005|Maintenance Period|Withdrawal by Subject|3|||
160738077|NCT01358578|580424217|FG000|Follow-up Period|Adverse Event|1|||
160738078|NCT01358578|580424218|FG001|Follow-up Period|Adverse Event|1|||
160738079|NCT01358578|580424219|FG002|Follow-up Period|Adverse Event|0|||
160738080|NCT01358578|580424220|FG003|Follow-up Period|Adverse Event|0|||
160738081|NCT01358578|580424221|FG004|Follow-up Period|Adverse Event|0|||
160738082|NCT01358578|580424222|FG005|Follow-up Period|Adverse Event|0|||
160738083|NCT01358578|580424217|FG000|Follow-up Period|Lack of Efficacy|3|||
160738084|NCT01358578|580424218|FG001|Follow-up Period|Lack of Efficacy|0|||
160738085|NCT01358578|580424219|FG002|Follow-up Period|Lack of Efficacy|4|||
160738086|NCT01358578|580424220|FG003|Follow-up Period|Lack of Efficacy|1|||
160738087|NCT01358578|580424221|FG004|Follow-up Period|Lack of Efficacy|0|||
160738088|NCT01358578|580424222|FG005|Follow-up Period|Lack of Efficacy|0|||
160738089|NCT01358578|580424217|FG000|Follow-up Period|Lost to Follow-up|0|||
160738090|NCT01358578|580424218|FG001|Follow-up Period|Lost to Follow-up|1|||
160738091|NCT01358578|580424219|FG002|Follow-up Period|Lost to Follow-up|0|||
160738092|NCT01358578|580424220|FG003|Follow-up Period|Lost to Follow-up|4|||
160738093|NCT01358578|580424221|FG004|Follow-up Period|Lost to Follow-up|0|||
160738094|NCT01358578|580424222|FG005|Follow-up Period|Lost to Follow-up|0|||
160738095|NCT01358578|580424217|FG000|Follow-up Period|non- compliance with study treatment|1|||
160738096|NCT01358578|580424218|FG001|Follow-up Period|non- compliance with study treatment|0|||
160738097|NCT01358578|580424219|FG002|Follow-up Period|non- compliance with study treatment|0|||
160738098|NCT01358578|580424220|FG003|Follow-up Period|non- compliance with study treatment|0|||
160738099|NCT01358578|580424221|FG004|Follow-up Period|non- compliance with study treatment|0|||
160738100|NCT01358578|580424222|FG005|Follow-up Period|non- compliance with study treatment|0|||
160738101|NCT01358578|580424217|FG000|Follow-up Period|Pregnancy|1|||
160738102|NCT01358578|580424218|FG001|Follow-up Period|Pregnancy|0|||
160738103|NCT01358578|580424219|FG002|Follow-up Period|Pregnancy|0|||
160738104|NCT01358578|580424220|FG003|Follow-up Period|Pregnancy|0|||
160738105|NCT01358578|580424221|FG004|Follow-up Period|Pregnancy|0|||
160738106|NCT01358578|580424222|FG005|Follow-up Period|Pregnancy|0|||
160738107|NCT01358578|580424217|FG000|Follow-up Period|Withdrawal by Subject|3|||
160738108|NCT01358578|580424218|FG001|Follow-up Period|Withdrawal by Subject|3|||
160738109|NCT01358578|580424219|FG002|Follow-up Period|Withdrawal by Subject|1|||
160738110|NCT01358578|580424220|FG003|Follow-up Period|Withdrawal by Subject|12|||
160738111|NCT01358578|580424221|FG004|Follow-up Period|Withdrawal by Subject|0|||
160738112|NCT01358578|580424222|FG005|Follow-up Period|Withdrawal by Subject|0|||
160738113|NCT01358578|580424217|FG000|Follow-up Period|Physician Decision|1|||
160738114|NCT01358578|580424218|FG001|Follow-up Period|Physician Decision|1|||
160738115|NCT01358578|580424219|FG002|Follow-up Period|Physician Decision|0|||
160738116|NCT01358578|580424220|FG003|Follow-up Period|Physician Decision|2|||
160738117|NCT01358578|580424221|FG004|Follow-up Period|Physician Decision|0|||
160738118|NCT01358578|580424222|FG005|Follow-up Period|Physician Decision|0|||
160738119|NCT01643798|580424223|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
160738120|NCT01643798|580424224|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
160738121|NCT03605849|580424225|FG000|Overall Study|Adverse Event|20|||
160738122|NCT03605849|580424226|FG001|Overall Study|Adverse Event|21|||
160738123|NCT03605849|580424227|FG002|Overall Study|Adverse Event|29|||
160738124|NCT03605849|580424228|FG003|Overall Study|Adverse Event|11|||
160738125|NCT03605849|580424225|FG000|Overall Study|Lack of Efficacy|4|||
160738126|NCT03605849|580424226|FG001|Overall Study|Lack of Efficacy|7|||
160738127|NCT03605849|580424227|FG002|Overall Study|Lack of Efficacy|9|||
160738128|NCT03605849|580424228|FG003|Overall Study|Lack of Efficacy|2|||
160738129|NCT03605849|580424225|FG000|Overall Study|Lost to Follow-up|8|||
160738130|NCT03605849|580424226|FG001|Overall Study|Lost to Follow-up|8|||
160738131|NCT03605849|580424227|FG002|Overall Study|Lost to Follow-up|14|||
160738132|NCT03605849|580424228|FG003|Overall Study|Lost to Follow-up|11|||
160738133|NCT03605849|580424225|FG000|Overall Study|Non-compliance With IMP|6|||
160738134|NCT03605849|580424226|FG001|Overall Study|Non-compliance With IMP|5|||
160738135|NCT03605849|580424227|FG002|Overall Study|Non-compliance With IMP|2|||
160738136|NCT03605849|580424228|FG003|Overall Study|Non-compliance With IMP|1|||
160738137|NCT03605849|580424225|FG000|Overall Study|Protocol Deviation|1|||
160738138|NCT03605849|580424226|FG001|Overall Study|Protocol Deviation|2|||
160738139|NCT03605849|580424227|FG002|Overall Study|Protocol Deviation|1|||
160738140|NCT03605849|580424228|FG003|Overall Study|Protocol Deviation|3|||
160738141|NCT03605849|580424225|FG000|Overall Study|Withdrawal by Subject|33|||
160738142|NCT03605849|580424226|FG001|Overall Study|Withdrawal by Subject|28|||
160738143|NCT03605849|580424227|FG002|Overall Study|Withdrawal by Subject|30|||
160738144|NCT03605849|580424228|FG003|Overall Study|Withdrawal by Subject|28|||
160738145|NCT03605849|580424225|FG000|Overall Study|Site Terminated by Sponsor|0|||
160738146|NCT03605849|580424226|FG001|Overall Study|Site Terminated by Sponsor|0|||
160738147|NCT03605849|580424227|FG002|Overall Study|Site Terminated by Sponsor|0|||
160738148|NCT03605849|580424228|FG003|Overall Study|Site Terminated by Sponsor|1|||
160738149|NCT03605849|580424225|FG000|Overall Study|Physician Decision|2|||
160738150|NCT03605849|580424226|FG001|Overall Study|Physician Decision|1|||
160738151|NCT03605849|580424227|FG002|Overall Study|Physician Decision|2|||
160738152|NCT03605849|580424228|FG003|Overall Study|Physician Decision|1|||
160738153|NCT03605849|580424225|FG000|Overall Study|Enrolled, but not Treated|2|||
160738154|NCT03605849|580424226|FG001|Overall Study|Enrolled, but not Treated|2|||
160738155|NCT03605849|580424227|FG002|Overall Study|Enrolled, but not Treated|3|||
160738156|NCT03605849|580424228|FG003|Overall Study|Enrolled, but not Treated|2|||
160738157|NCT03605849|580424225|FG000|Overall Study|Other (COVID-19 Related)|0|||
160738158|NCT03605849|580424226|FG001|Overall Study|Other (COVID-19 Related)|1|||
160738159|NCT03605849|580424227|FG002|Overall Study|Other (COVID-19 Related)|1|||
160738160|NCT03605849|580424228|FG003|Overall Study|Other (COVID-19 Related)|0|||
160738161|NCT03605849|580424225|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
160738162|NCT03605849|580424226|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
160738163|NCT03605849|580424227|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
160738164|NCT03605849|580424228|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
160738165|NCT01911780|580424231|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
160738166|NCT01911780|580424232|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
160738167|NCT01911780|580424231|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
160738168|NCT01911780|580424232|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
160738169|NCT01911780|580424231|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
160738170|NCT01911780|580424232|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
160738171|NCT01911780|580424231|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
160738172|NCT01911780|580424232|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
160738173|NCT01911780|580424231|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
160738174|NCT01911780|580424232|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
160738175|NCT01911780|580424231|FG000|Extension Period (52 Weeks)|Personal reason|1|||
160738176|NCT01911780|580424232|FG001|Extension Period (52 Weeks)|Personal reason|1|||
160738177|NCT05014815|580424235|FG000|Overall Study|Death|63|||
160738178|NCT05014815|580424236|FG001|Overall Study|Death|70|||
160738179|NCT05014815|580424235|FG000|Overall Study|Withdrawal by Subject|10|||
160738180|NCT05014815|580424236|FG001|Overall Study|Withdrawal by Subject|10|||
160738181|NCT05014815|580424235|FG000|Overall Study|Lost to Follow-up|4|||
160738182|NCT05014815|580424236|FG001|Overall Study|Lost to Follow-up|2|||
160738183|NCT05014815|580424235|FG000|Overall Study|Physician Decision|2|||
160738184|NCT05014815|580424236|FG001|Overall Study|Physician Decision|4|||
160738185|NCT06303167|580424247|FG000|Overall Study|Ineligible|1|||
160738186|NCT06303167|580424247|FG000|Overall Study|Never start protocol therapy|2|||
160738187|NCT06303167|580424247|FG000|Overall Study|Disease progression|16|||
160738188|NCT02677896|580424248|FG000|Double Blind Period (up to 35 Months)|Death|117|||
160738189|NCT02677896|580424249|FG001|Double Blind Period (up to 35 Months)|Death|197|||
160738190|NCT02677896|580424248|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
160738191|NCT02677896|580424249|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
160738192|NCT02677896|580424248|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
160738193|NCT02677896|580424249|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
160738194|NCT02677896|580424248|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
160738195|NCT02677896|580424249|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
160738196|NCT02677896|580424248|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
160738197|NCT02677896|580424249|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
160738198|NCT02677896|580424248|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
160738199|NCT02677896|580424249|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
160738200|NCT02677896|580424248|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
160738201|NCT02677896|580424249|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
160738202|NCT02677896|580424248|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
160738203|NCT02677896|580424249|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
160738204|NCT02677896|580424248|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
160738205|NCT02677896|580424249|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
160738206|NCT02677896|580424248|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
160738207|NCT02677896|580424249|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
160738208|NCT02677896|580424248|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
160738209|NCT02677896|580424249|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
160738210|NCT02677896|580424248|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
160738211|NCT02677896|580424249|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
160738212|NCT02677896|580424248|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
160738213|NCT02677896|580424249|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
160738214|NCT02677896|580424248|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
160738215|NCT02677896|580424249|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
160738216|NCT00916344|580424257|FG000|Overall Study|Death|2|||
160738217|NCT00916344|580424257|FG000|Overall Study|ICD upgrade|1|||
160738218|NCT00916344|580424257|FG000|Overall Study|Drop-out|5|||
160738219|NCT00655733|580424261|FG000|Overall Study|Lost to Follow-up|2|||
160738220|NCT00655733|580424262|FG001|Overall Study|Lost to Follow-up|2|||
160738221|NCT00655733|580424261|FG000|Overall Study|Adverse Event|2|||
160738222|NCT00655733|580424262|FG001|Overall Study|Adverse Event|2|||
160738223|NCT00655733|580424261|FG000|Overall Study|Withdrawal by Subject|3|||
160738224|NCT00655733|580424262|FG001|Overall Study|Withdrawal by Subject|3|||
160738225|NCT00655733|580424261|FG000|Overall Study|Physician Decision|0|||
160738226|NCT00655733|580424262|FG001|Overall Study|Physician Decision|1|||
160738227|NCT01482962|580424266|FG000|Overall Study|Progressive Disease|65|||
160738228|NCT01482962|580424267|FG001|Overall Study|Progressive Disease|53|||
160738229|NCT01482962|580424266|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
160738230|NCT01482962|580424267|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
160738231|NCT01482962|580424266|FG000|Overall Study|Adverse Event|18|||
160738232|NCT01482962|580424267|FG001|Overall Study|Adverse Event|22|||
160738233|NCT01482962|580424266|FG000|Overall Study|Withdrawal by Participant|8|||
160738234|NCT01482962|580424267|FG001|Overall Study|Withdrawal by Participant|13|||
160738235|NCT01482962|580424266|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
160738236|NCT01482962|580424267|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
160738237|NCT01482962|580424266|FG000|Overall Study|Other Reason|1|||
160738238|NCT01482962|580424267|FG001|Overall Study|Other Reason|5|||
160738239|NCT01482962|580424266|FG000|Overall Study|Study Terminated by Sponsor|5|||
160738240|NCT01482962|580424267|FG001|Overall Study|Study Terminated by Sponsor|2|||
160738241|NCT01482962|580424266|FG000|Overall Study|Did not Receive Study Drug|1|||
160738242|NCT01482962|580424267|FG001|Overall Study|Did not Receive Study Drug|6|||
160738243|NCT02407457|580424268|FG000|1 Month|Death|3|||
160738244|NCT02407457|580424269|FG001|1 Month|Death|0|||
160738245|NCT02407457|580424268|FG000|1 Month|Lost to Follow-up|1|||
160738246|NCT02407457|580424269|FG001|1 Month|Lost to Follow-up|1|||
160738247|NCT02407457|580424268|FG000|1 Month|missed visit|2|||
160738248|NCT02407457|580424269|FG001|1 Month|missed visit|5|||
160738249|NCT02407457|580424268|FG000|6-Month|Death|2|||
160738250|NCT02407457|580424269|FG001|6-Month|Death|8|||
160738251|NCT02407457|580424268|FG000|6-Month|Lost to Follow-up|2|||
160738252|NCT02407457|580424269|FG001|6-Month|Lost to Follow-up|2|||
160738253|NCT02407457|580424268|FG000|6-Month|missed visit|16|||
160738254|NCT02407457|580424269|FG001|6-Month|missed visit|14|||
160738255|NCT02407457|580424268|FG000|6-Month|Open Repair|0|||
160738256|NCT02407457|580424269|FG001|6-Month|Open Repair|1|||
160738257|NCT02407457|580424268|FG000|1 Year|Death|6|||
160738258|NCT02407457|580424269|FG001|1 Year|Death|11|||
160738259|NCT02407457|580424268|FG000|1 Year|Lost to Follow-up|3|||
160738260|NCT02407457|580424269|FG001|1 Year|Lost to Follow-up|2|||
160738261|NCT02407457|580424268|FG000|1 Year|Missed Visit|24|||
160738262|NCT02407457|580424269|FG001|1 Year|Missed Visit|14|||
160738263|NCT02407457|580424268|FG000|1 Year|Open Repair|0|||
160738264|NCT02407457|580424269|FG001|1 Year|Open Repair|1|||
160738265|NCT02407457|580424268|FG000|2-year|Death|14|||
160738266|NCT02407457|580424269|FG001|2-year|Death|8|||
160738267|NCT02407457|580424268|FG000|2-year|Lost to Follow-up|7|||
160738268|NCT02407457|580424269|FG001|2-year|Lost to Follow-up|10|||
160738269|NCT02407457|580424268|FG000|2-year|Missed Visit|13|||
160738270|NCT02407457|580424269|FG001|2-year|Missed Visit|15|||
160738271|NCT02407457|580424268|FG000|2-year|Open Repair|0|||
160738272|NCT02407457|580424269|FG001|2-year|Open Repair|2|||
160738273|NCT02407457|580424268|FG000|3-year|Death|11|||
160738274|NCT02407457|580424269|FG001|3-year|Death|10|||
160738275|NCT02407457|580424268|FG000|3-year|Lost to Follow-up|9|||
160738276|NCT02407457|580424269|FG001|3-year|Lost to Follow-up|10|||
160738277|NCT02407457|580424268|FG000|3-year|Missed Visit|19|||
160738278|NCT02407457|580424269|FG001|3-year|Missed Visit|16|||
160738279|NCT02407457|580424268|FG000|4-year|Death|18|||
160738280|NCT02407457|580424269|FG001|4-year|Death|10|||
160738281|NCT02407457|580424268|FG000|4-year|Lost to Follow-up|10|||
160738282|NCT02407457|580424269|FG001|4-year|Lost to Follow-up|12|||
160738283|NCT02407457|580424268|FG000|4-year|Missed Visit|18|||
160738284|NCT02407457|580424269|FG001|4-year|Missed Visit|16|||
160738285|NCT02407457|580424268|FG000|5-year|Death|10|||
160738286|NCT02407457|580424269|FG001|5-year|Death|3|||
160738287|NCT02407457|580424268|FG000|5-year|Lost to Follow-up|22|||
160738288|NCT02407457|580424269|FG001|5-year|Lost to Follow-up|13|||
160738289|NCT02407457|580424268|FG000|5-year|Missed Visit|9|||
160738290|NCT02407457|580424269|FG001|5-year|Missed Visit|1|||
160738291|NCT02954653|580424272|FG000|Overall Study|Death|3|||
160738292|NCT02954653|580424273|FG001|Overall Study|Death|1|||
160738293|NCT02954653|580424274|FG002|Overall Study|Death|0|||
160738294|NCT02954653|580424275|FG003|Overall Study|Death|0|||
160738295|NCT02954653|580424276|FG004|Overall Study|Death|0|||
160738296|NCT02954653|580424277|FG005|Overall Study|Death|0|||
160738297|NCT02954653|580424278|FG006|Overall Study|Death|0|||
160738298|NCT02954653|580424279|FG007|Overall Study|Death|0|||
160738299|NCT02954653|580424280|FG008|Overall Study|Death|0|||
160738300|NCT02954653|580424272|FG000|Overall Study|Randomized but did not receive treatment|1|||
160738301|NCT02954653|580424273|FG001|Overall Study|Randomized but did not receive treatment|0|||
160738302|NCT02954653|580424274|FG002|Overall Study|Randomized but did not receive treatment|0|||
160738303|NCT02954653|580424275|FG003|Overall Study|Randomized but did not receive treatment|0|||
160738304|NCT02954653|580424276|FG004|Overall Study|Randomized but did not receive treatment|0|||
160738305|NCT02954653|580424277|FG005|Overall Study|Randomized but did not receive treatment|0|||
160738306|NCT02954653|580424278|FG006|Overall Study|Randomized but did not receive treatment|0|||
160738307|NCT02954653|580424279|FG007|Overall Study|Randomized but did not receive treatment|0|||
160738308|NCT02954653|580424280|FG008|Overall Study|Randomized but did not receive treatment|0|||
160738309|NCT02954653|580424272|FG000|Overall Study|Started another anti-cancer therapy|0|||
160738310|NCT02954653|580424273|FG001|Overall Study|Started another anti-cancer therapy|1|||
160738311|NCT02954653|580424274|FG002|Overall Study|Started another anti-cancer therapy|0|||
160738312|NCT02954653|580424275|FG003|Overall Study|Started another anti-cancer therapy|0|||
160738313|NCT02954653|580424276|FG004|Overall Study|Started another anti-cancer therapy|0|||
160738314|NCT02954653|580424277|FG005|Overall Study|Started another anti-cancer therapy|0|||
160738315|NCT02954653|580424278|FG006|Overall Study|Started another anti-cancer therapy|0|||
160738316|NCT02954653|580424279|FG007|Overall Study|Started another anti-cancer therapy|0|||
160738317|NCT02954653|580424280|FG008|Overall Study|Started another anti-cancer therapy|0|||
160738318|NCT02954653|580424272|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
160738319|NCT02954653|580424273|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
160738320|NCT02954653|580424274|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
160738321|NCT02954653|580424275|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
160738322|NCT02954653|580424276|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
160738323|NCT02954653|580424277|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
160738324|NCT02954653|580424278|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
160738325|NCT02954653|580424279|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
160738326|NCT02954653|580424280|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
160738327|NCT03054064|580424281|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
160738328|NCT03054064|580424281|FG000|Overall Study|Investigator Decision|2|||
160738329|NCT03054064|580424281|FG000|Overall Study|Bladder Issue|1|||
160738330|NCT03054064|580424281|FG000|Overall Study|High Blood Pressure|1|||
160738331|NCT03054064|580424281|FG000|Overall Study|Change in Status|1|||
160738332|NCT04329091|580424284|FG000|Overall Study|Physician Decision|5|||
160738333|NCT01210495|580424287|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
160738334|NCT01210495|580424288|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
160738335|NCT01210495|580424289|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
160738336|NCT01210495|580424290|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
160738337|NCT01210495|580424287|FG000|Overall Study|Death|14|||
160738338|NCT01210495|580424288|FG001|Overall Study|Death|7|||
160738339|NCT01210495|580424289|FG002|Overall Study|Death|112|||
160738340|NCT01210495|580424290|FG003|Overall Study|Death|54|||
160738341|NCT01210495|580424287|FG000|Overall Study|Study Terminated by Sponsor|0|||
160738342|NCT01210495|580424288|FG001|Overall Study|Study Terminated by Sponsor|0|||
160738343|NCT01210495|580424289|FG002|Overall Study|Study Terminated by Sponsor|4|||
160738344|NCT01210495|580424290|FG003|Overall Study|Study Terminated by Sponsor|11|||
160738345|NCT01210495|580424287|FG000|Overall Study|Lost to Follow-up|0|||
160738346|NCT01210495|580424288|FG001|Overall Study|Lost to Follow-up|0|||
160738347|NCT01210495|580424289|FG002|Overall Study|Lost to Follow-up|1|||
160738348|NCT01210495|580424290|FG003|Overall Study|Lost to Follow-up|1|||
160738349|NCT01210495|580424287|FG000|Overall Study|Other unspecified|0|||
160738350|NCT01210495|580424288|FG001|Overall Study|Other unspecified|0|||
160738351|NCT01210495|580424289|FG002|Overall Study|Other unspecified|6|||
160738352|NCT01210495|580424290|FG003|Overall Study|Other unspecified|0|||
160738353|NCT01384019|580424291|FG000|Overall Study|Withdrawal by Subject|3|||
160738354|NCT01384019|580424292|FG001|Overall Study|Withdrawal by Subject|0|||
160738355|NCT01384019|580424291|FG000|Overall Study|Death|1|||
160738356|NCT01384019|580424292|FG001|Overall Study|Death|0|||
160738357|NCT01384019|580424291|FG000|Overall Study|MRI refusal|6|||
160738358|NCT01384019|580424292|FG001|Overall Study|MRI refusal|6|||
160738359|NCT03199612|580424297|FG000|Overall Study|Adverse Event|1|||
160738360|NCT03199612|580424298|FG001|Overall Study|Adverse Event|0|||
160738361|NCT02543892|580424299|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
160738362|NCT02543892|580424300|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
160738363|NCT02543892|580424301|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
160738364|NCT02543892|580424302|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
160738365|NCT02543892|580424303|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
160738366|NCT02543892|580424304|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
160738367|NCT02543892|580424305|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
160738368|NCT02543892|580424306|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
160738369|NCT02543892|580424299|FG000|Received Vaccination 2|Physician Decision|0|||
160738370|NCT02543892|580424300|FG001|Received Vaccination 2|Physician Decision|0|||
160738371|NCT02543892|580424301|FG002|Received Vaccination 2|Physician Decision|0|||
160738372|NCT02543892|580424302|FG003|Received Vaccination 2|Physician Decision|0|||
160738373|NCT02543892|580424303|FG004|Received Vaccination 2|Physician Decision|0|||
160738374|NCT02543892|580424304|FG005|Received Vaccination 2|Physician Decision|1|||
160738375|NCT02543892|580424305|FG006|Received Vaccination 2|Physician Decision|0|||
160738376|NCT02543892|580424306|FG007|Received Vaccination 2|Physician Decision|0|||
160738377|NCT02543892|580424299|FG000|Received Vaccination 2|Adverse Event|0|||
160738378|NCT02543892|580424300|FG001|Received Vaccination 2|Adverse Event|1|||
160738379|NCT02543892|580424301|FG002|Received Vaccination 2|Adverse Event|0|||
160738380|NCT02543892|580424302|FG003|Received Vaccination 2|Adverse Event|0|||
160738381|NCT02543892|580424303|FG004|Received Vaccination 2|Adverse Event|0|||
160738382|NCT02543892|580424304|FG005|Received Vaccination 2|Adverse Event|0|||
160738383|NCT02543892|580424305|FG006|Received Vaccination 2|Adverse Event|0|||
160738384|NCT02543892|580424306|FG007|Received Vaccination 2|Adverse Event|0|||
160738385|NCT02543892|580424299|FG000|Had Immunology Data|Withdrawal by Subject|0|||
160738386|NCT02543892|580424300|FG001|Had Immunology Data|Withdrawal by Subject|0|||
160738387|NCT02543892|580424301|FG002|Had Immunology Data|Withdrawal by Subject|0|||
160738388|NCT02543892|580424302|FG003|Had Immunology Data|Withdrawal by Subject|0|||
160738389|NCT02543892|580424303|FG004|Had Immunology Data|Withdrawal by Subject|0|||
160738390|NCT02543892|580424304|FG005|Had Immunology Data|Withdrawal by Subject|0|||
160738391|NCT02543892|580424305|FG006|Had Immunology Data|Withdrawal by Subject|1|||
160738392|NCT02543892|580424306|FG007|Had Immunology Data|Withdrawal by Subject|0|||
160738393|NCT01199822|580424307|FG000|Overall Study|Investigator discontinued therapy|0|||
160738394|NCT01199822|580424308|FG001|Overall Study|Investigator discontinued therapy|1|||
160738395|NCT01199822|580424309|FG002|Overall Study|Investigator discontinued therapy|0|||
160738396|NCT04027075|580424310|FG000|Overall Study|Lost to Follow-up|41|||
160738397|NCT04027075|580424311|FG001|Overall Study|Lost to Follow-up|22|||
160738398|NCT03448939|580424312|FG000|Overall Study|Adverse Event|5|||
160738399|NCT03448939|580424313|FG001|Overall Study|Adverse Event|1|||
160738400|NCT03448939|580424312|FG000|Overall Study|Lost to Follow-up|6|||
160738401|NCT03448939|580424313|FG001|Overall Study|Lost to Follow-up|6|||
160738402|NCT03448939|580424312|FG000|Overall Study|Pregnancy|1|||
160738403|NCT03448939|580424313|FG001|Overall Study|Pregnancy|1|||
160738404|NCT03448939|580424312|FG000|Overall Study|Withdrawal by Subject|9|||
160738405|NCT03448939|580424313|FG001|Overall Study|Withdrawal by Subject|3|||
160738406|NCT01259375|580424314|FG000|Overall Study|Adverse Event|1|||
160738407|NCT00986986|580424315|FG000|Overall Study|Lost to Follow-up|0|||
160738408|NCT00986986|580424316|FG001|Overall Study|Lost to Follow-up|1|||
160738409|NCT00628095|580424317|FG000|Overall Study|Adverse Event|5|||
160738410|NCT00628095|580424318|FG001|Overall Study|Adverse Event|3|||
160738411|NCT00628095|580424317|FG000|Overall Study|Lack of Efficacy|0|||
160738412|NCT00628095|580424318|FG001|Overall Study|Lack of Efficacy|3|||
160738413|NCT00628095|580424317|FG000|Overall Study|Withdrawal by Subject|2|||
160738414|NCT00628095|580424318|FG001|Overall Study|Withdrawal by Subject|0|||
160738415|NCT00628095|580424317|FG000|Overall Study|Other|0|||
160738416|NCT00628095|580424318|FG001|Overall Study|Other|1|||
160738417|NCT02003963|580424325|FG000|Overall Study|Lost to Follow-up|2|||
160738418|NCT02003963|580424326|FG001|Overall Study|Lost to Follow-up|1|||
160738419|NCT01195844|580424327|FG000|Overall Study|Fecal sample not collected|40|||
160738420|NCT01801280|580424328|FG000|Period 1|Withdrawal by Subject|0|||
160738421|NCT01801280|580424329|FG001|Period 1|Withdrawal by Subject|1|||
160738422|NCT01801280|580424330|FG002|Period 1|Withdrawal by Subject|0|||
160738423|NCT01801280|580424331|FG003|Period 1|Withdrawal by Subject|0|||
160738424|NCT01801280|580424328|FG000|Period 2|Withdrawal by Subject|1|||
160738425|NCT01801280|580424329|FG001|Period 2|Withdrawal by Subject|0|||
160738426|NCT01801280|580424330|FG002|Period 2|Withdrawal by Subject|0|||
160738427|NCT01801280|580424331|FG003|Period 2|Withdrawal by Subject|0|||
160738428|NCT01801280|580424328|FG000|Period 4|Protocol Violation|0|||
160738429|NCT01801280|580424329|FG001|Period 4|Protocol Violation|0|||
160738430|NCT01801280|580424330|FG002|Period 4|Protocol Violation|1|||
160738431|NCT01801280|580424331|FG003|Period 4|Protocol Violation|0|||
160738432|NCT00176644|580424332|FG000|Overall Study|Withdrawal by Subject|1|||
160738433|NCT00581542|580424333|FG000|Overall Study|they met an exclusion criteria|2|||
160738434|NCT00581542|580424334|FG001|Overall Study|they met an exclusion criteria|2|||
160738435|NCT00581542|580424333|FG000|Overall Study|Lost to Follow-up|9|||
160738436|NCT00581542|580424334|FG001|Overall Study|Lost to Follow-up|21|||
160738437|NCT05020366|580424335|FG000|Overall Study|Lost to Follow-up|2|||
160738438|NCT05020366|580424336|FG001|Overall Study|Lost to Follow-up|0|||
160738439|NCT05020366|580424335|FG000|Overall Study|Withdrawal by Subject|2|||
160738440|NCT05020366|580424336|FG001|Overall Study|Withdrawal by Subject|0|||
160738441|NCT00195494|580424341|FG000|Year 1|Adverse Event|0|||
160738442|NCT00195494|580424342|FG001|Year 1|Adverse Event|0|||
160738443|NCT00195494|580424343|FG002|Year 1|Adverse Event|0|||
160738444|NCT00195494|580424344|FG003|Year 1|Adverse Event|0|||
160738445|NCT00195494|580424345|FG004|Year 1|Adverse Event|34|||
160738446|NCT00195494|580424346|FG005|Year 1|Adverse Event|27|||
160738447|NCT00195494|580424341|FG000|Year 1|System Toxicity|0|||
160738448|NCT00195494|580424342|FG001|Year 1|System Toxicity|0|||
160738449|NCT00195494|580424343|FG002|Year 1|System Toxicity|0|||
160738450|NCT00195494|580424344|FG003|Year 1|System Toxicity|0|||
160738451|NCT00195494|580424345|FG004|Year 1|System Toxicity|0|||
160738452|NCT00195494|580424346|FG005|Year 1|System Toxicity|1|||
160738453|NCT00195494|580424341|FG000|Year 1|Lack of Efficacy|0|||
160738454|NCT00195494|580424342|FG001|Year 1|Lack of Efficacy|0|||
160738455|NCT00195494|580424343|FG002|Year 1|Lack of Efficacy|0|||
160738456|NCT00195494|580424344|FG003|Year 1|Lack of Efficacy|0|||
160738457|NCT00195494|580424345|FG004|Year 1|Lack of Efficacy|24|||
160738458|NCT00195494|580424346|FG005|Year 1|Lack of Efficacy|9|||
160738459|NCT00195494|580424341|FG000|Year 1|Compliance|0|||
160738460|NCT00195494|580424342|FG001|Year 1|Compliance|0|||
160738461|NCT00195494|580424343|FG002|Year 1|Compliance|0|||
160738462|NCT00195494|580424344|FG003|Year 1|Compliance|0|||
160738463|NCT00195494|580424345|FG004|Year 1|Compliance|5|||
160738464|NCT00195494|580424346|FG005|Year 1|Compliance|1|||
160738465|NCT00195494|580424341|FG000|Year 1|Lost to Follow-up|0|||
160738466|NCT00195494|580424342|FG001|Year 1|Lost to Follow-up|0|||
160738467|NCT00195494|580424343|FG002|Year 1|Lost to Follow-up|0|||
160738468|NCT00195494|580424344|FG003|Year 1|Lost to Follow-up|0|||
160738469|NCT00195494|580424345|FG004|Year 1|Lost to Follow-up|1|||
160738470|NCT00195494|580424346|FG005|Year 1|Lost to Follow-up|0|||
160738471|NCT00195494|580424341|FG000|Year 1|Missed >4 consecutive doses|0|||
160738472|NCT00195494|580424342|FG001|Year 1|Missed >4 consecutive doses|0|||
160738473|NCT00195494|580424343|FG002|Year 1|Missed >4 consecutive doses|0|||
160738474|NCT00195494|580424344|FG003|Year 1|Missed >4 consecutive doses|0|||
160738475|NCT00195494|580424345|FG004|Year 1|Missed >4 consecutive doses|3|||
160738476|NCT00195494|580424346|FG005|Year 1|Missed >4 consecutive doses|2|||
160738477|NCT00195494|580424341|FG000|Year 1|Protocol deviation|0|||
160738478|NCT00195494|580424342|FG001|Year 1|Protocol deviation|0|||
160738479|NCT00195494|580424343|FG002|Year 1|Protocol deviation|0|||
160738480|NCT00195494|580424344|FG003|Year 1|Protocol deviation|0|||
160738481|NCT00195494|580424345|FG004|Year 1|Protocol deviation|2|||
160738482|NCT00195494|580424346|FG005|Year 1|Protocol deviation|3|||
160738483|NCT00195494|580424341|FG000|Year 1|Physician Decision|0|||
160738484|NCT00195494|580424342|FG001|Year 1|Physician Decision|0|||
160738485|NCT00195494|580424343|FG002|Year 1|Physician Decision|0|||
160738486|NCT00195494|580424344|FG003|Year 1|Physician Decision|0|||
160738487|NCT00195494|580424345|FG004|Year 1|Physician Decision|1|||
160738488|NCT00195494|580424346|FG005|Year 1|Physician Decision|0|||
160738489|NCT00195494|580424341|FG000|Year 1|Withdrawal by Subject|0|||
160738490|NCT00195494|580424342|FG001|Year 1|Withdrawal by Subject|0|||
160738491|NCT00195494|580424343|FG002|Year 1|Withdrawal by Subject|0|||
160738492|NCT00195494|580424344|FG003|Year 1|Withdrawal by Subject|0|||
160738493|NCT00195494|580424345|FG004|Year 1|Withdrawal by Subject|8|||
160738494|NCT00195494|580424346|FG005|Year 1|Withdrawal by Subject|9|||
160738495|NCT00195494|580424341|FG000|Year 1|Protocol Violation|0|||
160738496|NCT00195494|580424342|FG001|Year 1|Protocol Violation|0|||
160738497|NCT00195494|580424343|FG002|Year 1|Protocol Violation|0|||
160738498|NCT00195494|580424344|FG003|Year 1|Protocol Violation|0|||
160738499|NCT00195494|580424345|FG004|Year 1|Protocol Violation|1|||
160738500|NCT00195494|580424346|FG005|Year 1|Protocol Violation|1|||
160738501|NCT00195494|580424341|FG000|Year 2|Adverse Event|3|||
160738502|NCT00195494|580424342|FG001|Year 2|Adverse Event|7|||
160738503|NCT00195494|580424343|FG002|Year 2|Adverse Event|5|||
160738504|NCT00195494|580424344|FG003|Year 2|Adverse Event|9|||
160738505|NCT00195494|580424345|FG004|Year 2|Adverse Event|0|||
160738506|NCT00195494|580424346|FG005|Year 2|Adverse Event|0|||
160738507|NCT00195494|580424341|FG000|Year 2|Lack of Efficacy|0|||
160738508|NCT00195494|580424342|FG001|Year 2|Lack of Efficacy|1|||
160738509|NCT00195494|580424343|FG002|Year 2|Lack of Efficacy|7|||
160738510|NCT00195494|580424344|FG003|Year 2|Lack of Efficacy|7|||
160738511|NCT00195494|580424345|FG004|Year 2|Lack of Efficacy|0|||
160738512|NCT00195494|580424346|FG005|Year 2|Lack of Efficacy|0|||
160738513|NCT00195494|580424341|FG000|Year 2|Compliance|1|||
160738514|NCT00195494|580424342|FG001|Year 2|Compliance|0|||
160738515|NCT00195494|580424343|FG002|Year 2|Compliance|0|||
160738516|NCT00195494|580424344|FG003|Year 2|Compliance|2|||
160738517|NCT00195494|580424345|FG004|Year 2|Compliance|0|||
160738518|NCT00195494|580424346|FG005|Year 2|Compliance|0|||
160738519|NCT00195494|580424341|FG000|Year 2|Lost to Follow-up|0|||
160738520|NCT00195494|580424342|FG001|Year 2|Lost to Follow-up|0|||
160738521|NCT00195494|580424343|FG002|Year 2|Lost to Follow-up|1|||
160738522|NCT00195494|580424344|FG003|Year 2|Lost to Follow-up|1|||
160738523|NCT00195494|580424345|FG004|Year 2|Lost to Follow-up|0|||
160738524|NCT00195494|580424346|FG005|Year 2|Lost to Follow-up|0|||
160738525|NCT00195494|580424341|FG000|Year 2|Missed >4 consecutive doses|1|||
160738526|NCT00195494|580424342|FG001|Year 2|Missed >4 consecutive doses|1|||
160738527|NCT00195494|580424343|FG002|Year 2|Missed >4 consecutive doses|1|||
160738528|NCT00195494|580424344|FG003|Year 2|Missed >4 consecutive doses|0|||
160738529|NCT00195494|580424345|FG004|Year 2|Missed >4 consecutive doses|0|||
160738530|NCT00195494|580424346|FG005|Year 2|Missed >4 consecutive doses|0|||
160738531|NCT00195494|580424341|FG000|Year 2|Protocol deviation|0|||
160738532|NCT00195494|580424342|FG001|Year 2|Protocol deviation|1|||
160738533|NCT00195494|580424343|FG002|Year 2|Protocol deviation|0|||
160738534|NCT00195494|580424344|FG003|Year 2|Protocol deviation|0|||
160738535|NCT00195494|580424345|FG004|Year 2|Protocol deviation|0|||
160738536|NCT00195494|580424346|FG005|Year 2|Protocol deviation|0|||
160738537|NCT00195494|580424341|FG000|Year 2|Physician Decision|1|||
160738538|NCT00195494|580424342|FG001|Year 2|Physician Decision|1|||
160738539|NCT00195494|580424343|FG002|Year 2|Physician Decision|0|||
160738540|NCT00195494|580424344|FG003|Year 2|Physician Decision|0|||
160738541|NCT00195494|580424345|FG004|Year 2|Physician Decision|0|||
160738542|NCT00195494|580424346|FG005|Year 2|Physician Decision|0|||
160738543|NCT00195494|580424341|FG000|Year 2|Withdrawal by Subject|1|||
160738544|NCT00195494|580424342|FG001|Year 2|Withdrawal by Subject|5|||
160738545|NCT00195494|580424343|FG002|Year 2|Withdrawal by Subject|4|||
160738546|NCT00195494|580424344|FG003|Year 2|Withdrawal by Subject|3|||
160738547|NCT00195494|580424345|FG004|Year 2|Withdrawal by Subject|0|||
160738548|NCT00195494|580424346|FG005|Year 2|Withdrawal by Subject|0|||
160738549|NCT00195494|580424341|FG000|Year 2|System toxicity|0|||
160738550|NCT00195494|580424342|FG001|Year 2|System toxicity|0|||
160738551|NCT00195494|580424343|FG002|Year 2|System toxicity|0|||
160738552|NCT00195494|580424344|FG003|Year 2|System toxicity|1|||
160738553|NCT00195494|580424345|FG004|Year 2|System toxicity|0|||
160738554|NCT00195494|580424346|FG005|Year 2|System toxicity|0|||
160738555|NCT03973918|580424352|FG000|Overall Study|Adverse Event|0|||
160738556|NCT03973918|580424353|FG001|Overall Study|Adverse Event|0|||
160738557|NCT03973918|580424354|FG002|Overall Study|Adverse Event|0|||
160738558|NCT03973918|580424355|FG003|Overall Study|Adverse Event|1|||
160738559|NCT03973918|580424352|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
160738560|NCT03973918|580424353|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
160738561|NCT03973918|580424354|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
160738562|NCT03973918|580424355|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
160738563|NCT04050124|580424356|FG000|Overall Study|Death|1|||
160738564|NCT04050124|580424357|FG001|Overall Study|Death|0|||
160738565|NCT04601103|580424360|FG000|Overall Study|Needed crown & cleaning|0|||
160738566|NCT04601103|580424361|FG001|Overall Study|Needed crown & cleaning|0|||
160738567|NCT04601103|580424362|FG002|Overall Study|Needed crown & cleaning|1|||
160738568|NCT04601103|580424360|FG000|Overall Study|study was terminated|18|||
160738569|NCT04601103|580424361|FG001|Overall Study|study was terminated|18|||
160738570|NCT04601103|580424362|FG002|Overall Study|study was terminated|16|||
160738571|NCT01068626|580424370|FG000|Overall Study|Adverse Event|3|||
160738572|NCT01068626|580424371|FG001|Overall Study|Adverse Event|0|||
160738573|NCT01068626|580424370|FG000|Overall Study|Withdrawal by Subject|0|||
160738574|NCT01068626|580424371|FG001|Overall Study|Withdrawal by Subject|2|||
160738575|NCT01785849|580424372|FG000|Overall Study|Death|7|||
160738576|NCT01785849|580424373|FG001|Overall Study|Death|9|||
160738577|NCT01785849|580424372|FG000|Overall Study|Protocol Specified Criteria|29|||
160738578|NCT01785849|580424373|FG001|Overall Study|Protocol Specified Criteria|1|||
160738579|NCT01785849|580424372|FG000|Overall Study|Withdrawal by Subject|15|||
160738580|NCT01785849|580424373|FG001|Overall Study|Withdrawal by Subject|12|||
160738581|NCT01785849|580424372|FG000|Overall Study|Sponsor Decision|0|||
160738582|NCT01785849|580424373|FG001|Overall Study|Sponsor Decision|1|||
160738583|NCT01785849|580424372|FG000|Overall Study|Lost to Follow-up|10|||
160738584|NCT01785849|580424373|FG001|Overall Study|Lost to Follow-up|11|||
160738585|NCT03932331|580424375|FG000|Overall Study|Death|0|||
160738586|NCT03932331|580424376|FG001|Overall Study|Death|7|||
160738587|NCT03932331|580424377|FG002|Overall Study|Death|2|||
160738588|NCT03932331|580424375|FG000|Overall Study|Withdrawal by Subject|0|||
160738589|NCT03932331|580424376|FG001|Overall Study|Withdrawal by Subject|3|||
160738590|NCT03932331|580424377|FG002|Overall Study|Withdrawal by Subject|0|||
160738591|NCT03932331|580424375|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
160738592|NCT03932331|580424376|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
160738593|NCT03932331|580424377|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
160738594|NCT03932331|580424375|FG000|Overall Study|Progressive disease|3|||
160738595|NCT03932331|580424376|FG001|Overall Study|Progressive disease|0|||
160738596|NCT03932331|580424377|FG002|Overall Study|Progressive disease|0|||
160738597|NCT03932331|580424375|FG000|Overall Study|Lung infection|1|||
160738598|NCT03932331|580424376|FG001|Overall Study|Lung infection|0|||
160738599|NCT03932331|580424377|FG002|Overall Study|Lung infection|0|||
160738600|NCT03932331|580424375|FG000|Overall Study|Other|0|||
160738601|NCT03932331|580424376|FG001|Overall Study|Other|0|||
160738602|NCT03932331|580424377|FG002|Overall Study|Other|58|||
160738603|NCT00347919|580424378|FG000|Overall Study|Lost to Follow-up|11|||
160738604|NCT00347919|580424379|FG001|Overall Study|Lost to Follow-up|13|||
160738605|NCT00347919|580424380|FG002|Overall Study|Lost to Follow-up|0|||
160738606|NCT00347919|580424378|FG000|Overall Study|Withdrawal by Subject|6|||
160738607|NCT00347919|580424379|FG001|Overall Study|Withdrawal by Subject|8|||
160738608|NCT00347919|580424380|FG002|Overall Study|Withdrawal by Subject|0|||
160738609|NCT00347919|580424378|FG000|Overall Study|Physician Decision|1|||
160738610|NCT00347919|580424379|FG001|Overall Study|Physician Decision|1|||
160738611|NCT00347919|580424380|FG002|Overall Study|Physician Decision|0|||
160738612|NCT00347919|580424378|FG000|Overall Study|Sponsor terminated study|15|||
160738613|NCT00347919|580424379|FG001|Overall Study|Sponsor terminated study|10|||
160738614|NCT00347919|580424380|FG002|Overall Study|Sponsor terminated study|16|||
160738615|NCT00347919|580424378|FG000|Overall Study|Death|35|||
160738616|NCT00347919|580424379|FG001|Overall Study|Death|42|||
160738617|NCT00347919|580424380|FG002|Overall Study|Death|19|||
160738618|NCT00347919|580424378|FG000|Overall Study|Par. Started Other Treatment|1|||
160738619|NCT00347919|580424379|FG001|Overall Study|Par. Started Other Treatment|1|||
160738620|NCT00347919|580424380|FG002|Overall Study|Par. Started Other Treatment|1|||
160738621|NCT00347919|580424378|FG000|Overall Study|Missing|2|||
160738622|NCT00347919|580424379|FG001|Overall Study|Missing|1|||
160738623|NCT00347919|580424380|FG002|Overall Study|Missing|2|||
160738624|NCT03379753|580424381|FG000|Overall Study|Withdrawal by Subject|2|||
160738625|NCT03379753|580424382|FG001|Overall Study|Withdrawal by Subject|1|||
160738626|NCT03379753|580424381|FG000|Overall Study|not having correct procedure|1|||
160738627|NCT03379753|580424382|FG001|Overall Study|not having correct procedure|2|||
160738628|NCT03379753|580424381|FG000|Overall Study|No primary outcome|12|||
160738629|NCT03379753|580424382|FG001|Overall Study|No primary outcome|22|||
160738630|NCT00533702|580424389|FG000|Overall Study|Withdrawal by Subject|3|||
160738631|NCT00533702|580424390|FG001|Overall Study|Withdrawal by Subject|1|||
160738632|NCT00533702|580424389|FG000|Overall Study|Found ineligible after randomization|2|||
160738633|NCT00533702|580424390|FG001|Overall Study|Found ineligible after randomization|1|||
160738634|NCT00960986|580424391|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
160738635|NCT00960986|580424392|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
160738636|NCT00960986|580424393|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
160738637|NCT00960986|580424394|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
160738638|NCT00960986|580424391|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
160738639|NCT00960986|580424392|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
160738640|NCT00960986|580424393|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
160738641|NCT00960986|580424394|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
160738642|NCT00960986|580424391|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
160738643|NCT00960986|580424392|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
160738644|NCT00960986|580424393|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
160738645|NCT00960986|580424394|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
160738646|NCT00960986|580424391|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
160738647|NCT00960986|580424392|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
160738648|NCT00960986|580424393|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
160738649|NCT00960986|580424394|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
160738650|NCT00960986|580424391|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
160738651|NCT00960986|580424392|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
160738652|NCT00960986|580424393|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
160738653|NCT00960986|580424394|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
160738654|NCT00960986|580424391|FG000|Period 3 (7-week Therapy Period)|Death|0|||
160738655|NCT00960986|580424392|FG001|Period 3 (7-week Therapy Period)|Death|0|||
160738656|NCT00960986|580424393|FG002|Period 3 (7-week Therapy Period)|Death|1|||
160738657|NCT00960986|580424394|FG003|Period 3 (7-week Therapy Period)|Death|0|||
160738658|NCT00960986|580424391|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
160738659|NCT00960986|580424392|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
160738660|NCT00960986|580424393|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
160738661|NCT00960986|580424394|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
160738662|NCT00960986|580424391|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
160738663|NCT00960986|580424392|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
160738664|NCT00960986|580424393|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
160738665|NCT00960986|580424394|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
160738666|NCT00960986|580424391|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
160738667|NCT00960986|580424392|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
160738668|NCT00960986|580424393|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
160738669|NCT00960986|580424394|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
160738670|NCT00960986|580424391|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
160738671|NCT00960986|580424392|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
160738672|NCT00960986|580424393|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
160738673|NCT00960986|580424394|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
160738674|NCT01077739|580424395|FG000|Overall Study|Premature withdrawal|1|||
160738675|NCT01077739|580424396|FG001|Overall Study|Premature withdrawal|3|||
160738676|NCT01077739|580424395|FG000|Overall Study|Withdrawal by Subject|1|||
160738677|NCT01077739|580424396|FG001|Overall Study|Withdrawal by Subject|0|||
160738678|NCT01077739|580424395|FG000|Overall Study|Death|0|||
160738679|NCT01077739|580424396|FG001|Overall Study|Death|3|||
160738680|NCT01077739|580424395|FG000|Overall Study|Unacceptable toxicity|1|||
160738681|NCT01077739|580424396|FG001|Overall Study|Unacceptable toxicity|2|||
160738682|NCT01077739|580424395|FG000|Overall Study|Other|2|||
160738683|NCT01077739|580424396|FG001|Overall Study|Other|2|||
160738684|NCT00877071|580424397|FG000|Overall Study|disease progression|2|||
160738685|NCT01317797|580424398|FG000|Overall Study|Other|0|||
160738686|NCT01317797|580424399|FG001|Overall Study|Other|1|||
160738687|NCT01317797|580424400|FG002|Overall Study|Other|0|||
160738688|NCT01317797|580424398|FG000|Overall Study|Withdrawal of Patient|0|||
160738689|NCT01317797|580424399|FG001|Overall Study|Withdrawal of Patient|0|||
160738690|NCT01317797|580424400|FG002|Overall Study|Withdrawal of Patient|1|||
160738691|NCT03026530|580424404|FG000|Overall Study|Lost to Follow-up|19|||
160738692|NCT03026530|580424405|FG001|Overall Study|Lost to Follow-up|24|||
160738693|NCT03026530|580424404|FG000|Overall Study|Protocol Violation|2|||
160738694|NCT03026530|580424405|FG001|Overall Study|Protocol Violation|5|||
160738695|NCT03721835|580424406|FG000|Overall Study|Participant not able to return|1|||
160738696|NCT03721835|580424406|FG000|Overall Study|Lost to Follow-up|1|||
160738697|NCT03721835|580424406|FG000|Overall Study|Revision of the components of the study device|2|||
160738698|NCT03721835|580424406|FG000|Overall Study|Sponsor terminated study|6|||
160738699|NCT03721835|580424406|FG000|Overall Study|Death|1|||
160738700|NCT03721835|580424406|FG000|Overall Study|Sponsor decision|1|||
160738701|NCT02100670|580424407|FG000|Overall Study|Adverse Event|10|||
160738702|NCT02100670|580424408|FG001|Overall Study|Adverse Event|3|||
160738703|NCT02100670|580424409|FG002|Overall Study|Adverse Event|3|||
160738704|NCT02100670|580424410|FG003|Overall Study|Adverse Event|0|||
160738705|NCT02100670|580424407|FG000|Overall Study|Lost to Follow-up|1|||
160738706|NCT02100670|580424408|FG001|Overall Study|Lost to Follow-up|0|||
160738707|NCT02100670|580424409|FG002|Overall Study|Lost to Follow-up|0|||
160738708|NCT02100670|580424410|FG003|Overall Study|Lost to Follow-up|0|||
160738709|NCT02100670|580424407|FG000|Overall Study|Protocol Violation|0|||
160738710|NCT02100670|580424408|FG001|Overall Study|Protocol Violation|1|||
160738711|NCT02100670|580424409|FG002|Overall Study|Protocol Violation|0|||
160738712|NCT02100670|580424410|FG003|Overall Study|Protocol Violation|1|||
160738713|NCT02100670|580424407|FG000|Overall Study|Withdrawal of Consent|0|||
160738714|NCT02100670|580424408|FG001|Overall Study|Withdrawal of Consent|1|||
160738715|NCT02100670|580424409|FG002|Overall Study|Withdrawal of Consent|1|||
160738716|NCT02100670|580424410|FG003|Overall Study|Withdrawal of Consent|0|||
160738717|NCT02100670|580424407|FG000|Overall Study|No swelling no pain|1|||
160738718|NCT02100670|580424408|FG001|Overall Study|No swelling no pain|0|||
160738719|NCT02100670|580424409|FG002|Overall Study|No swelling no pain|0|||
160738720|NCT02100670|580424410|FG003|Overall Study|No swelling no pain|0|||
160738721|NCT02100670|580424407|FG000|Overall Study|Poor Efficacy|0|||
160738722|NCT02100670|580424408|FG001|Overall Study|Poor Efficacy|1|||
160738723|NCT02100670|580424409|FG002|Overall Study|Poor Efficacy|0|||
160738724|NCT02100670|580424410|FG003|Overall Study|Poor Efficacy|0|||
160738725|NCT02100670|580424407|FG000|Overall Study|Physician Decision|0|||
160738726|NCT02100670|580424408|FG001|Overall Study|Physician Decision|1|||
160738727|NCT02100670|580424409|FG002|Overall Study|Physician Decision|0|||
160738728|NCT02100670|580424410|FG003|Overall Study|Physician Decision|0|||
160738729|NCT02100670|580424407|FG000|Overall Study|Withdrawal by Subject|1|||
160738730|NCT02100670|580424408|FG001|Overall Study|Withdrawal by Subject|0|||
160738731|NCT02100670|580424409|FG002|Overall Study|Withdrawal by Subject|0|||
160738732|NCT02100670|580424410|FG003|Overall Study|Withdrawal by Subject|0|||
160738733|NCT04599933|580425902|FG000|Overall Study|Adverse Event|4|||
160738734|NCT04599933|580425903|FG001|Overall Study|Adverse Event|1|||
160738735|NCT04599933|580425902|FG000|Overall Study|Withdrawal by Subject|4|||
160738736|NCT04599933|580425903|FG001|Overall Study|Withdrawal by Subject|2|||
160738737|NCT04599933|580425902|FG000|Overall Study|Lost to Follow-up|0|||
160738738|NCT04599933|580425903|FG001|Overall Study|Lost to Follow-up|1|||
160738739|NCT04599933|580425902|FG000|Overall Study|Physician Decision|0|||
160738740|NCT04599933|580425903|FG001|Overall Study|Physician Decision|1|||
160738741|NCT04599933|580425902|FG000|Overall Study|Screen Failure|1|||
160738742|NCT04599933|580425903|FG001|Overall Study|Screen Failure|2|||
160738743|NCT02339155|580425912|FG000|Overall Study|Adverse Event|0|||
160738744|NCT02339155|580425913|FG001|Overall Study|Adverse Event|6|||
160738745|NCT02339155|580425912|FG000|Overall Study|Death|1|||
160738746|NCT02339155|580425913|FG001|Overall Study|Death|1|||
160738747|NCT02339155|580425912|FG000|Overall Study|Lost to Follow-up|8|||
160738748|NCT02339155|580425913|FG001|Overall Study|Lost to Follow-up|9|||
160738749|NCT02339155|580425912|FG000|Overall Study|Physician Decision|2|||
160738750|NCT02339155|580425913|FG001|Overall Study|Physician Decision|1|||
160738751|NCT02339155|580425912|FG000|Overall Study|Withdrawal by Subject|4|||
160738752|NCT02339155|580425913|FG001|Overall Study|Withdrawal by Subject|4|||
160738753|NCT03226678|580425920|FG000|Part A (Core Study Phase)|Adverse Event|0|||
160738754|NCT03226678|580425921|FG001|Part A (Core Study Phase)|Adverse Event|1|||
160738755|NCT03226678|580425922|FG002|Part A (Core Study Phase)|Adverse Event|0|||
160738756|NCT03226678|580425923|FG003|Part A (Core Study Phase)|Adverse Event|0|||
160738757|NCT03226678|580425924|FG004|Part A (Core Study Phase)|Adverse Event|0|||
160738758|NCT03226678|580425925|FG005|Part A (Core Study Phase)|Adverse Event|0|||
160738759|NCT03226678|580425920|FG000|Part A (Core Study Phase)|Death|0|||
160738760|NCT03226678|580425921|FG001|Part A (Core Study Phase)|Death|0|||
160738761|NCT03226678|580425922|FG002|Part A (Core Study Phase)|Death|1|||
160738762|NCT03226678|580425923|FG003|Part A (Core Study Phase)|Death|0|||
160738763|NCT03226678|580425924|FG004|Part A (Core Study Phase)|Death|0|||
160738764|NCT03226678|580425925|FG005|Part A (Core Study Phase)|Death|0|||
160738765|NCT03226678|580425920|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
160738766|NCT03226678|580425921|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
160738767|NCT03226678|580425922|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
160738768|NCT03226678|580425923|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
160738769|NCT03226678|580425924|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
160738770|NCT03226678|580425925|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
160738771|NCT03226678|580425920|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
160738772|NCT03226678|580425921|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
160738773|NCT03226678|580425922|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
160738774|NCT03226678|580425923|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
160738775|NCT03226678|580425924|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
160738776|NCT03226678|580425925|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
160738777|NCT03226678|580425920|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
160738778|NCT03226678|580425921|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
160738779|NCT03226678|580425922|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
160738780|NCT03226678|580425923|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
160738781|NCT03226678|580425924|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
160738782|NCT03226678|580425925|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
160738783|NCT03226678|580425920|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
160738784|NCT03226678|580425921|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
160738785|NCT03226678|580425922|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
160738786|NCT03226678|580425923|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
160738787|NCT03226678|580425924|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
160738788|NCT03226678|580425925|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
160738789|NCT03226678|580425920|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
160738790|NCT03226678|580425921|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
160738791|NCT03226678|580425922|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
160738792|NCT03226678|580425923|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
160738793|NCT03226678|580425924|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
160738794|NCT03226678|580425925|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
160738795|NCT03226678|580425920|FG000|Part B (Long-Term Extension Phase)|Death|0|||
160738796|NCT03226678|580425921|FG001|Part B (Long-Term Extension Phase)|Death|0|||
160738797|NCT03226678|580425922|FG002|Part B (Long-Term Extension Phase)|Death|0|||
160738798|NCT03226678|580425923|FG003|Part B (Long-Term Extension Phase)|Death|0|||
160738799|NCT03226678|580425924|FG004|Part B (Long-Term Extension Phase)|Death|0|||
160738800|NCT03226678|580425925|FG005|Part B (Long-Term Extension Phase)|Death|1|||
160738801|NCT03226678|580425920|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
160738802|NCT03226678|580425921|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
160738803|NCT03226678|580425922|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
160738804|NCT03226678|580425923|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
160738805|NCT03226678|580425924|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
160738806|NCT03226678|580425925|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
160738807|NCT03226678|580425920|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
160738808|NCT03226678|580425921|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
160738809|NCT03226678|580425922|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
160738810|NCT03226678|580425923|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
160738811|NCT03226678|580425924|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
160738812|NCT03226678|580425925|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
160738813|NCT03226678|580425920|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
160738814|NCT03226678|580425921|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
160738815|NCT03226678|580425922|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
160738816|NCT03226678|580425923|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
160738817|NCT03226678|580425924|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
160738818|NCT03226678|580425925|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
160738819|NCT03602391|580425928|FG000|Overall Study|COVID-19|7|||
160738820|NCT03602391|580425929|FG001|Overall Study|COVID-19|6|||
160738821|NCT00108485|580425934|FG000|Overall Study|Withdrawal by Subject|3|||
160738822|NCT00108485|580425935|FG001|Overall Study|Withdrawal by Subject|0|||
160738823|NCT00108485|580425934|FG000|Overall Study|Lost to Follow-up|0|||
160738824|NCT00108485|580425935|FG001|Overall Study|Lost to Follow-up|2|||
160738825|NCT00878969|580425937|FG000|Overall Study|Physician Decision|5|||
160738826|NCT00878969|580425938|FG001|Overall Study|Physician Decision|3|||
160738827|NCT00878969|580425939|FG002|Overall Study|Physician Decision|2|||
160738828|NCT00878969|580425937|FG000|Overall Study|Withdrawal by Subject|1|||
160738829|NCT00878969|580425938|FG001|Overall Study|Withdrawal by Subject|6|||
160738830|NCT00878969|580425939|FG002|Overall Study|Withdrawal by Subject|3|||
160738831|NCT00878969|580425937|FG000|Overall Study|kidney transplant|2|||
160738832|NCT00878969|580425938|FG001|Overall Study|kidney transplant|3|||
160738833|NCT00878969|580425939|FG002|Overall Study|kidney transplant|2|||
160738834|NCT00878969|580425937|FG000|Overall Study|Adverse Event|3|||
160738835|NCT00878969|580425938|FG001|Overall Study|Adverse Event|1|||
160738836|NCT00878969|580425939|FG002|Overall Study|Adverse Event|2|||
160738837|NCT00878969|580425937|FG000|Overall Study|Lost to Follow-up|2|||
160738838|NCT00878969|580425938|FG001|Overall Study|Lost to Follow-up|1|||
160738839|NCT00878969|580425939|FG002|Overall Study|Lost to Follow-up|0|||
160738840|NCT00878969|580425937|FG000|Overall Study|Protocol Violation|2|||
160738841|NCT00878969|580425938|FG001|Overall Study|Protocol Violation|0|||
160738842|NCT00878969|580425939|FG002|Overall Study|Protocol Violation|0|||
160738843|NCT00878969|580425937|FG000|Overall Study|Death|0|||
160738844|NCT00878969|580425938|FG001|Overall Study|Death|0|||
160738845|NCT00878969|580425939|FG002|Overall Study|Death|2|||
160738846|NCT00878969|580425937|FG000|Overall Study|Pregnancy|0|||
160738847|NCT00878969|580425938|FG001|Overall Study|Pregnancy|1|||
160738848|NCT00878969|580425939|FG002|Overall Study|Pregnancy|0|||
160738849|NCT01701193|580425942|FG000|Overall Study|Withdrawal by Subject|2|||
160738850|NCT01701193|580425943|FG001|Overall Study|Withdrawal by Subject|2|||
160738851|NCT01701193|580425944|FG002|Overall Study|Withdrawal by Subject|1|||
160738852|NCT01701193|580425945|FG003|Overall Study|Withdrawal by Subject|2|||
160738853|NCT01701193|580425942|FG000|Overall Study|Adverse Event|1|||
160738854|NCT01701193|580425943|FG001|Overall Study|Adverse Event|0|||
160738855|NCT01701193|580425944|FG002|Overall Study|Adverse Event|0|||
160738856|NCT01701193|580425945|FG003|Overall Study|Adverse Event|0|||
160738857|NCT02122770|580425946|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
160738858|NCT02122770|580425947|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
160738859|NCT02122770|580425948|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
160738860|NCT02122770|580425949|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
160738861|NCT02122770|580425950|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
160738862|NCT02122770|580425951|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
160738863|NCT02122770|580425946|FG000|Part A: Drug-drug Interaction 2|Other|0|||
160738864|NCT02122770|580425947|FG001|Part A: Drug-drug Interaction 2|Other|0|||
160738865|NCT02122770|580425948|FG002|Part A: Drug-drug Interaction 2|Other|1|||
160738866|NCT02122770|580425949|FG003|Part A: Drug-drug Interaction 2|Other|0|||
160738867|NCT02122770|580425950|FG004|Part A: Drug-drug Interaction 2|Other|0|||
160738868|NCT02122770|580425951|FG005|Part A: Drug-drug Interaction 2|Other|0|||
160738869|NCT02122770|580425946|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
160738870|NCT02122770|580425947|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
160738871|NCT02122770|580425948|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
160738872|NCT02122770|580425949|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
160738873|NCT02122770|580425950|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
160738874|NCT02122770|580425951|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
160738875|NCT02122770|580425946|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
160738876|NCT02122770|580425947|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
160738877|NCT02122770|580425948|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
160738878|NCT02122770|580425949|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
160738879|NCT02122770|580425950|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
160738880|NCT02122770|580425951|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
160738881|NCT02122770|580425946|FG000|Part B: Standard of Care|Adverse Event|0|||
160738882|NCT02122770|580425947|FG001|Part B: Standard of Care|Adverse Event|0|||
160738883|NCT02122770|580425948|FG002|Part B: Standard of Care|Adverse Event|0|||
160738884|NCT02122770|580425949|FG003|Part B: Standard of Care|Adverse Event|0|||
160738885|NCT02122770|580425950|FG004|Part B: Standard of Care|Adverse Event|4|||
160738886|NCT02122770|580425951|FG005|Part B: Standard of Care|Adverse Event|1|||
160738887|NCT02122770|580425946|FG000|Part B: Standard of Care|Other|0|||
160738888|NCT02122770|580425947|FG001|Part B: Standard of Care|Other|0|||
160738889|NCT02122770|580425948|FG002|Part B: Standard of Care|Other|0|||
160738890|NCT02122770|580425949|FG003|Part B: Standard of Care|Other|0|||
160738891|NCT02122770|580425950|FG004|Part B: Standard of Care|Other|0|||
160738892|NCT02122770|580425951|FG005|Part B: Standard of Care|Other|2|||
160738893|NCT02122770|580425946|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
160738894|NCT02122770|580425947|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
160738895|NCT02122770|580425948|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
160738896|NCT02122770|580425949|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
160738897|NCT02122770|580425950|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
160738898|NCT02122770|580425951|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
160738899|NCT02122770|580425946|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
160738900|NCT02122770|580425947|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
160738901|NCT02122770|580425948|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
160738902|NCT02122770|580425949|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
160738903|NCT02122770|580425950|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
160738904|NCT02122770|580425951|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
160738905|NCT02122770|580425946|FG000|Part B: Standard of Care|Progressive Disease|0|||
160738906|NCT02122770|580425947|FG001|Part B: Standard of Care|Progressive Disease|0|||
160738907|NCT02122770|580425948|FG002|Part B: Standard of Care|Progressive Disease|0|||
160738908|NCT02122770|580425949|FG003|Part B: Standard of Care|Progressive Disease|0|||
160738909|NCT02122770|580425950|FG004|Part B: Standard of Care|Progressive Disease|10|||
160738910|NCT02122770|580425951|FG005|Part B: Standard of Care|Progressive Disease|8|||
160738911|NCT00250458|580425953|FG000|Overall Study|Lost to Follow-up|4|||
160738912|NCT00250458|580425954|FG001|Overall Study|Lost to Follow-up|2|||
160738913|NCT00250458|580425953|FG000|Overall Study|Protocol Violation|0|||
160738914|NCT00250458|580425954|FG001|Overall Study|Protocol Violation|1|||
160738915|NCT00250458|580425953|FG000|Overall Study|Withdrawal by Subject|4|||
160738916|NCT00250458|580425954|FG001|Overall Study|Withdrawal by Subject|2|||
160738917|NCT00250458|580425953|FG000|Overall Study|Lack of Migraine Attack|20|||
160738918|NCT00250458|580425954|FG001|Overall Study|Lack of Migraine Attack|9|||
160738919|NCT00250458|580425953|FG000|Overall Study|Qualifying migraine but did not treat|3|||
160738920|NCT00250458|580425954|FG001|Overall Study|Qualifying migraine but did not treat|3|||
160738921|NCT00250458|580425953|FG000|Overall Study|Other|1|||
160738922|NCT00250458|580425954|FG001|Overall Study|Other|0|||
160738923|NCT06137703|580425955|FG000|Overall Study|Other|0|||
160738924|NCT06137703|580425956|FG001|Overall Study|Other|1|||
160738925|NCT06137703|580425957|FG002|Overall Study|Other|0|||
160738926|NCT06137703|580425958|FG003|Overall Study|Other|0|||
160738927|NCT06137703|580425955|FG000|Overall Study|Adverse Event|0|||
160738928|NCT06137703|580425956|FG001|Overall Study|Adverse Event|0|||
160738929|NCT06137703|580425957|FG002|Overall Study|Adverse Event|1|||
160738930|NCT06137703|580425958|FG003|Overall Study|Adverse Event|0|||
160738931|NCT01527487|580425959|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
160738932|NCT01527487|580425960|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
160738933|NCT01527487|580425959|FG000|Overall Study|Disease Progression|4|||
160738934|NCT01527487|580425960|FG001|Overall Study|Disease Progression|1|||
160738935|NCT01527487|580425959|FG000|Overall Study|Adverse Event|1|||
160738936|NCT01527487|580425960|FG001|Overall Study|Adverse Event|1|||
160738937|NCT01527487|580425959|FG000|Overall Study|Death|0|||
160738938|NCT01527487|580425960|FG001|Overall Study|Death|1|||
160738939|NCT01472757|580425963|FG000|Overall Study|Withdrawal by Subject|1|||
160738940|NCT01472757|580425964|FG001|Overall Study|Withdrawal by Subject|2|||
160738941|NCT01472757|580425965|FG002|Overall Study|Withdrawal by Subject|2|||
160738942|NCT01472757|580425966|FG003|Overall Study|Withdrawal by Subject|0|||
160738943|NCT01472757|580425963|FG000|Overall Study|Asthma exacerbation|4|||
160738944|NCT01472757|580425964|FG001|Overall Study|Asthma exacerbation|1|||
160738945|NCT01472757|580425965|FG002|Overall Study|Asthma exacerbation|2|||
160738946|NCT01472757|580425966|FG003|Overall Study|Asthma exacerbation|1|||
160738947|NCT01472757|580425963|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
160738948|NCT01472757|580425964|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
160738949|NCT01472757|580425965|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
160738950|NCT01472757|580425966|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
160738951|NCT01472757|580425963|FG000|Overall Study|Protocol Violation|3|||
160738952|NCT01472757|580425964|FG001|Overall Study|Protocol Violation|2|||
160738953|NCT01472757|580425965|FG002|Overall Study|Protocol Violation|4|||
160738954|NCT01472757|580425966|FG003|Overall Study|Protocol Violation|4|||
160738955|NCT01472757|580425963|FG000|Overall Study|Other reasons|1|||
160738956|NCT01472757|580425964|FG001|Overall Study|Other reasons|0|||
160738957|NCT01472757|580425965|FG002|Overall Study|Other reasons|2|||
160738958|NCT01472757|580425966|FG003|Overall Study|Other reasons|2|||
160738959|NCT02505334|580425969|FG000|Main Treatment Period|Adverse Event|3|||
160738960|NCT02505334|580425970|FG001|Main Treatment Period|Adverse Event|3|||
160738961|NCT02505334|580425969|FG000|Main Treatment Period|Lack of Efficacy|7|||
160738962|NCT02505334|580425970|FG001|Main Treatment Period|Lack of Efficacy|17|||
160738963|NCT02505334|580425969|FG000|Main Treatment Period|Protocol Violation|0|||
160738964|NCT02505334|580425970|FG001|Main Treatment Period|Protocol Violation|1|||
160738965|NCT02505334|580425969|FG000|Main Treatment Period|Withdrawal by Subject|1|||
160738966|NCT02505334|580425970|FG001|Main Treatment Period|Withdrawal by Subject|8|||
160738967|NCT02505334|580425969|FG000|Main Treatment Period|Unclassified|4|||
160738968|NCT02505334|580425970|FG001|Main Treatment Period|Unclassified|10|||
160738969|NCT02505334|580425969|FG000|Extension Treatment Period|Adverse Event|5|||
160738970|NCT02505334|580425970|FG001|Extension Treatment Period|Adverse Event|0|||
160738971|NCT02505334|580425969|FG000|Extension Treatment Period|Lack of Efficacy|4|||
160738972|NCT02505334|580425970|FG001|Extension Treatment Period|Lack of Efficacy|0|||
160738973|NCT02505334|580425969|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
160738974|NCT02505334|580425970|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
160738975|NCT02505334|580425969|FG000|Extension Treatment Period|Unclassified|3|||
160738976|NCT02505334|580425970|FG001|Extension Treatment Period|Unclassified|0|||
160738977|NCT00081731|580425975|FG000|Overall Study|scientific integrity issue|8|||
160738978|NCT00081731|580425976|FG001|Overall Study|scientific integrity issue|8|||
160738979|NCT01629823|580425977|FG000|Trial Period|Missed visit|11|||
160738980|NCT01629823|580425978|FG001|Trial Period|Missed visit|9|||
160738981|NCT01629823|580425979|FG002|Trial Period|Missed visit|8|||
160738982|NCT01629823|580425977|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
160738983|NCT01629823|580425978|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
160738984|NCT01629823|580425979|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
160738985|NCT01629823|580425977|FG000|Trial Period|Pregnancy|1|||
160738986|NCT01629823|580425978|FG001|Trial Period|Pregnancy|0|||
160738987|NCT01629823|580425979|FG002|Trial Period|Pregnancy|0|||
160738988|NCT01629823|580425977|FG000|Trial Period|Adverse Event|0|||
160738989|NCT01629823|580425978|FG001|Trial Period|Adverse Event|1|||
160738990|NCT01629823|580425979|FG002|Trial Period|Adverse Event|0|||
160738991|NCT01629823|580425977|FG000|Trial Period|Out-of-window visit|0|||
160738992|NCT01629823|580425978|FG001|Trial Period|Out-of-window visit|2|||
160738993|NCT01629823|580425979|FG002|Trial Period|Out-of-window visit|0|||
160738994|NCT01629823|580425977|FG000|Trial Period|Failed to hold medication|0|||
160738995|NCT01629823|580425978|FG001|Trial Period|Failed to hold medication|0|||
160738996|NCT01629823|580425979|FG002|Trial Period|Failed to hold medication|1|||
160738997|NCT01629823|580425977|FG000|Washout Period|Safety|2|||
160738998|NCT01629823|580425978|FG001|Washout Period|Safety|5|||
160738999|NCT01629823|580425979|FG002|Washout Period|Safety|0|||
160739000|NCT01629823|580425977|FG000|Washout Period|Pregnancy|1|||
160739001|NCT01629823|580425978|FG001|Washout Period|Pregnancy|0|||
160739002|NCT01629823|580425979|FG002|Washout Period|Pregnancy|0|||
160739003|NCT01629823|580425977|FG000|Washout Period|Protocol Violation|0|||
160739004|NCT01629823|580425978|FG001|Washout Period|Protocol Violation|1|||
160739005|NCT01629823|580425979|FG002|Washout Period|Protocol Violation|0|||
160739006|NCT03747302|580425981|FG000|Overall Study|Withdrawal by Subject|1|||
160739007|NCT03747302|580425982|FG001|Overall Study|Withdrawal by Subject|2|||
160739008|NCT00738062|580425985|FG000|Open Label Treatment|Lack of Efficacy|5|||
160739009|NCT00738062|580425986|FG001|Open Label Treatment|Lack of Efficacy|0|||
160739010|NCT00738062|580425987|FG002|Open Label Treatment|Lack of Efficacy|0|||
160739011|NCT00738062|580425985|FG000|Open Label Treatment|Adverse Event|11|||
160739012|NCT00738062|580425986|FG001|Open Label Treatment|Adverse Event|0|||
160739013|NCT00738062|580425987|FG002|Open Label Treatment|Adverse Event|0|||
160739014|NCT00738062|580425985|FG000|Open Label Treatment|Protocol Violation|2|||
160739015|NCT00738062|580425986|FG001|Open Label Treatment|Protocol Violation|0|||
160739016|NCT00738062|580425987|FG002|Open Label Treatment|Protocol Violation|0|||
160739017|NCT00738062|580425985|FG000|Open Label Treatment|Withdrawal by Subject|9|||
160739018|NCT00738062|580425986|FG001|Open Label Treatment|Withdrawal by Subject|0|||
160739019|NCT00738062|580425987|FG002|Open Label Treatment|Withdrawal by Subject|0|||
160739020|NCT00738062|580425985|FG000|Open Label Treatment|Investigator Decision|1|||
160739021|NCT00738062|580425986|FG001|Open Label Treatment|Investigator Decision|0|||
160739022|NCT00738062|580425987|FG002|Open Label Treatment|Investigator Decision|0|||
160739023|NCT00738062|580425985|FG000|Open-Label Extension|Adverse Event|5|||
160739024|NCT00738062|580425986|FG001|Open-Label Extension|Adverse Event|0|||
160739025|NCT00738062|580425987|FG002|Open-Label Extension|Adverse Event|0|||
160739026|NCT00738062|580425985|FG000|Open-Label Extension|Physician Decision|1|||
160739027|NCT00738062|580425986|FG001|Open-Label Extension|Physician Decision|0|||
160739028|NCT00738062|580425987|FG002|Open-Label Extension|Physician Decision|0|||
160739029|NCT00738062|580425985|FG000|Open-Label Extension|Lack of Efficacy|2|||
160739030|NCT00738062|580425986|FG001|Open-Label Extension|Lack of Efficacy|0|||
160739031|NCT00738062|580425987|FG002|Open-Label Extension|Lack of Efficacy|0|||
160739032|NCT00738062|580425985|FG000|Open-Label Extension|Withdrawal by Subject|6|||
160739033|NCT00738062|580425986|FG001|Open-Label Extension|Withdrawal by Subject|0|||
160739034|NCT00738062|580425987|FG002|Open-Label Extension|Withdrawal by Subject|0|||
160739035|NCT00738062|580425985|FG000|Open-Label Extension|Protocol Violation|1|||
160739036|NCT00738062|580425986|FG001|Open-Label Extension|Protocol Violation|0|||
160739037|NCT00738062|580425987|FG002|Open-Label Extension|Protocol Violation|0|||
160739038|NCT00738062|580425985|FG000|Open-Label Extension|Study Terminated|2|||
160739039|NCT00738062|580425986|FG001|Open-Label Extension|Study Terminated|0|||
160739040|NCT00738062|580425987|FG002|Open-Label Extension|Study Terminated|0|||
160739041|NCT00526331|580425988|FG000|Overall Study|Sponsor Termination|55|||
160739042|NCT00455520|580425990|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
160739043|NCT00455520|580425991|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
160739044|NCT00455520|580425990|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
160739045|NCT00455520|580425991|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
160739046|NCT00455520|580425990|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
160739047|NCT00455520|580425991|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
160739048|NCT00455520|580425990|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
160739049|NCT00455520|580425991|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
160739050|NCT00455520|580425990|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
160739051|NCT00455520|580425991|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
160739052|NCT00455520|580425990|FG000|Open Label Tapentadol Extended Release|All other|33|||
160739053|NCT00455520|580425991|FG001|Open Label Tapentadol Extended Release|All other|0|||
160739054|NCT00455520|580425990|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
160739055|NCT00455520|580425991|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
160739056|NCT00455520|580425990|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
160739057|NCT00455520|580425991|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
160739058|NCT00455520|580425990|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
160739059|NCT00455520|580425991|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
160739060|NCT00455520|580425990|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
160739061|NCT00455520|580425991|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
160739062|NCT00455520|580425990|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
160739063|NCT00455520|580425991|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
160739064|NCT00455520|580425990|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
160739065|NCT00455520|580425991|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
160739066|NCT00033657|580425993|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
160739067|NCT00033657|580425994|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
160739068|NCT00033657|580425993|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
160739069|NCT00033657|580425994|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
160739070|NCT00033657|580425993|FG000|Neoadjuvant Chemotherapy|Death|1|||
160739071|NCT00033657|580425994|FG001|Neoadjuvant Chemotherapy|Death|1|||
160739072|NCT00033657|580425993|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
160739073|NCT00033657|580425994|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
160739074|NCT00033657|580425993|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
160739075|NCT00033657|580425994|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
160739076|NCT00033657|580425993|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
160739077|NCT00033657|580425994|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
160739078|NCT00033657|580425993|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
160739079|NCT00033657|580425994|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
160739080|NCT00033657|580425993|FG000|Surgical Resection|not complete resection|0|||
160739081|NCT00033657|580425994|FG001|Surgical Resection|not complete resection|3|||
160739082|NCT00033657|580425993|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
160739083|NCT00033657|580425994|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
160739084|NCT00033657|580425993|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
160739085|NCT00033657|580425994|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
160739086|NCT00033657|580425993|FG000|Adjuvant Chemotherapy|Death|2|||
160739087|NCT00033657|580425994|FG001|Adjuvant Chemotherapy|Death|1|||
160739088|NCT00033657|580425993|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
160739089|NCT00033657|580425994|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
160739090|NCT00033657|580425993|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
160739091|NCT00033657|580425994|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
160739092|NCT00033657|580425993|FG000|Adjuvant Chemotherapy|Other|0|||
160739093|NCT00033657|580425994|FG001|Adjuvant Chemotherapy|Other|2|||
160739094|NCT03235115|580425995|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
160739095|NCT03235115|580425996|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
160739096|NCT03235115|580425997|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
160739097|NCT03235115|580425998|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
160739098|NCT03235115|580425999|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
160739099|NCT03235115|580426000|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
160739100|NCT00503997|580426002|FG000|Overall Study|disease progression|1|||
160739101|NCT00503997|580426002|FG000|Overall Study|Adverse Event|5|||
160739102|NCT00503997|580426002|FG000|Overall Study|Death|1|||
160739103|NCT00503997|580426002|FG000|Overall Study|Withdrawal by Subject|1|||
160739104|NCT00656851|580426007|FG000|Overall Study|Withdrawal by Subject|0|||
160739105|NCT00656851|580426008|FG001|Overall Study|Withdrawal by Subject|4|||
160739106|NCT05020899|580426010|FG000|8 Week Follow-up|Lost to Follow-up|3|||
160739107|NCT05020899|580426011|FG001|8 Week Follow-up|Lost to Follow-up|6|||
160739108|NCT05020899|580426010|FG000|12 Week Follow-up|Lost to Follow-up|1|||
160739109|NCT05020899|580426011|FG001|12 Week Follow-up|Lost to Follow-up|0|||
160739110|NCT05020899|580426010|FG000|12 Week Follow-up|Death|0|||
160739111|NCT05020899|580426011|FG001|12 Week Follow-up|Death|1|||
160739112|NCT02225366|580426016|FG000|Overall Study|Lack of Efficacy|1|||
160739113|NCT02225366|580426017|FG001|Overall Study|Lack of Efficacy|0|||
160739114|NCT01382225|580426020|FG000|Overall Study|Adverse Event|3|||
160739115|NCT01382225|580426021|FG001|Overall Study|Adverse Event|2|||
160739116|NCT01382225|580426020|FG000|Overall Study|Protocol Violation|2|||
160739117|NCT01382225|580426021|FG001|Overall Study|Protocol Violation|1|||
160739118|NCT01382225|580426020|FG000|Overall Study|Subject Withdrew Consent|5|||
160739119|NCT01382225|580426021|FG001|Overall Study|Subject Withdrew Consent|2|||
160739120|NCT01382225|580426020|FG000|Overall Study|Other|4|||
160739121|NCT01382225|580426021|FG001|Overall Study|Other|2|||
160739122|NCT04450407|580426026|FG000|Overall Study|Withdrawal by Subject|10|||
160739123|NCT04450407|580426027|FG001|Overall Study|Withdrawal by Subject|1|||
160739124|NCT04450407|580426028|FG002|Overall Study|Withdrawal by Subject|4|||
160739125|NCT04450407|580426026|FG000|Overall Study|Adverse Event|0|||
160739126|NCT04450407|580426027|FG001|Overall Study|Adverse Event|0|||
160739127|NCT04450407|580426028|FG002|Overall Study|Adverse Event|1|||
160739128|NCT04450407|580426026|FG000|Overall Study|Lost to Follow-up|1|||
160739129|NCT04450407|580426027|FG001|Overall Study|Lost to Follow-up|0|||
160739130|NCT04450407|580426028|FG002|Overall Study|Lost to Follow-up|0|||
160739131|NCT04450407|580426026|FG000|Overall Study|Physician Decision|0|||
160739132|NCT04450407|580426027|FG001|Overall Study|Physician Decision|0|||
160739133|NCT04450407|580426028|FG002|Overall Study|Physician Decision|1|||
160739134|NCT04450407|580426026|FG000|Overall Study|Pregnancy|1|||
160739135|NCT04450407|580426027|FG001|Overall Study|Pregnancy|0|||
160739136|NCT04450407|580426028|FG002|Overall Study|Pregnancy|0|||
160739137|NCT04450407|580426026|FG000|Overall Study|Protocol Violation|2|||
160739138|NCT04450407|580426027|FG001|Overall Study|Protocol Violation|0|||
160739139|NCT04450407|580426028|FG002|Overall Study|Protocol Violation|0|||
160739140|NCT04450407|580426026|FG000|Overall Study|Investigational site terminated by sponsor|3|||
160739141|NCT04450407|580426027|FG001|Overall Study|Investigational site terminated by sponsor|0|||
160739142|NCT04450407|580426028|FG002|Overall Study|Investigational site terminated by sponsor|2|||
160739143|NCT00794040|580426030|FG000|Overall Study|Withdrawal by Subject|3|||
160739144|NCT00794040|580426031|FG001|Overall Study|Withdrawal by Subject|4|||
160739145|NCT00794040|580426030|FG000|Overall Study|Physician Decision|0|||
160739146|NCT00794040|580426031|FG001|Overall Study|Physician Decision|1|||
160739147|NCT04696354|580426034|FG000|Overall Study|Study termination|6|||
160739148|NCT04696354|580426035|FG001|Overall Study|Study termination|6|||
160739149|NCT03626363|580426039|FG000|Overall Study|Protocol Violation|4|||
160739150|NCT03626363|580426040|FG001|Overall Study|Protocol Violation|0|||
160739151|NCT03626363|580426039|FG000|Overall Study|Lost to Follow-up|5|||
160739152|NCT03626363|580426040|FG001|Overall Study|Lost to Follow-up|7|||
160739153|NCT01095978|580426041|FG000|Overall Study|Did not take Klacid SR|2|||
160739154|NCT01095978|580426041|FG000|Overall Study|Adverse Event|1|||
160739155|NCT00965341|580426042|FG000|Overall Study|Withdrew consent|1|||
160739156|NCT00965341|580426043|FG001|Overall Study|Withdrew consent|5|||
160739157|NCT00965341|580426042|FG000|Overall Study|Lost to Follow-up|1|||
160739158|NCT00965341|580426043|FG001|Overall Study|Lost to Follow-up|0|||
160739159|NCT00965341|580426042|FG000|Overall Study|Transportation issues|4|||
160739160|NCT00965341|580426043|FG001|Overall Study|Transportation issues|3|||
160739161|NCT01970475|580426049|FG000|Overall Study|Withdrawal by Subject|11|||
160739162|NCT01970475|580426050|FG001|Overall Study|Withdrawal by Subject|6|||
160739163|NCT01970475|580426049|FG000|Overall Study|Adverse Event|7|||
160739164|NCT01970475|580426050|FG001|Overall Study|Adverse Event|3|||
160739165|NCT01970475|580426049|FG000|Overall Study|Lost to Follow-up|2|||
160739166|NCT01970475|580426050|FG001|Overall Study|Lost to Follow-up|2|||
160739167|NCT01970475|580426049|FG000|Overall Study|Protocol Violation|1|||
160739168|NCT01970475|580426050|FG001|Overall Study|Protocol Violation|0|||
160739169|NCT00710684|580426053|FG000|Overall Study|Adverse Event|11|||
160739170|NCT00710684|580426054|FG001|Overall Study|Adverse Event|19|||
160739171|NCT00710684|580426055|FG002|Overall Study|Adverse Event|16|||
160739172|NCT00710684|580426053|FG000|Overall Study|Lack of Efficacy|4|||
160739173|NCT00710684|580426054|FG001|Overall Study|Lack of Efficacy|3|||
160739174|NCT00710684|580426055|FG002|Overall Study|Lack of Efficacy|5|||
160739175|NCT00710684|580426053|FG000|Overall Study|Protocol Violation|5|||
160739176|NCT00710684|580426054|FG001|Overall Study|Protocol Violation|5|||
160739177|NCT00710684|580426055|FG002|Overall Study|Protocol Violation|5|||
160739178|NCT00710684|580426053|FG000|Overall Study|Lost to Follow-up|4|||
160739179|NCT00710684|580426054|FG001|Overall Study|Lost to Follow-up|6|||
160739180|NCT00710684|580426055|FG002|Overall Study|Lost to Follow-up|7|||
160739181|NCT00710684|580426053|FG000|Overall Study|Physician Decision|0|||
160739182|NCT00710684|580426054|FG001|Overall Study|Physician Decision|2|||
160739183|NCT00710684|580426055|FG002|Overall Study|Physician Decision|4|||
160739184|NCT00710684|580426053|FG000|Overall Study|Withdrawal by Subject|24|||
160739185|NCT00710684|580426054|FG001|Overall Study|Withdrawal by Subject|18|||
160739186|NCT00710684|580426055|FG002|Overall Study|Withdrawal by Subject|11|||
160739187|NCT00710684|580426053|FG000|Overall Study|Missing|1|||
160739188|NCT00710684|580426054|FG001|Overall Study|Missing|0|||
160739189|NCT00710684|580426055|FG002|Overall Study|Missing|0|||
160739190|NCT00710684|580426053|FG000|Overall Study|Did not continue after week 24|25|||
160739191|NCT00710684|580426054|FG001|Overall Study|Did not continue after week 24|21|||
160739192|NCT00710684|580426055|FG002|Overall Study|Did not continue after week 24|16|||
160739193|NCT04778059|580426056|FG000|Overall Study|Death|2|||
160739194|NCT04778059|580426057|FG001|Overall Study|Death|2|||
160739195|NCT04778059|580426058|FG002|Overall Study|Death|1|||
160739196|NCT04778059|580426059|FG003|Overall Study|Death|1|||
160739197|NCT04778059|580426060|FG004|Overall Study|Death|1|||
160739198|NCT04778059|580426056|FG000|Overall Study|Lost to Follow-up|0|||
160739199|NCT04778059|580426057|FG001|Overall Study|Lost to Follow-up|0|||
160739200|NCT04778059|580426058|FG002|Overall Study|Lost to Follow-up|0|||
160739201|NCT04778059|580426059|FG003|Overall Study|Lost to Follow-up|0|||
160739202|NCT04778059|580426060|FG004|Overall Study|Lost to Follow-up|1|||
160739203|NCT04778059|580426056|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
160739204|NCT04778059|580426057|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
160739205|NCT04778059|580426058|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
160739206|NCT04778059|580426059|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
160739207|NCT04778059|580426060|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
160739208|NCT02832375|580426061|FG000|Overall Study|Lost to Follow-up|1|||
160739209|NCT02832375|580426062|FG001|Overall Study|Lost to Follow-up|0|||
160739210|NCT02832375|580426061|FG000|Overall Study|Withdrawal of Consent|1|||
160739211|NCT02832375|580426062|FG001|Overall Study|Withdrawal of Consent|0|||
160739212|NCT00514904|580426063|FG000|Overall Study|Withdrawal by Subject|3|||
160739213|NCT00514904|580426064|FG001|Overall Study|Withdrawal by Subject|2|||
160739214|NCT00514904|580426063|FG000|Overall Study|Lost to Follow-up|21|||
160739215|NCT00514904|580426064|FG001|Overall Study|Lost to Follow-up|3|||
160739216|NCT00084318|580426065|FG000|Overall Study|Withdrawal by Subject|5|||
160739217|NCT00084318|580426066|FG001|Overall Study|Withdrawal by Subject|2|||
160739218|NCT00084318|580426065|FG000|Overall Study|Protocol Violation|15|||
160739219|NCT00084318|580426066|FG001|Overall Study|Protocol Violation|11|||
160739220|NCT00084318|580426065|FG000|Overall Study|No protocol treatment|2|||
160739221|NCT00084318|580426066|FG001|Overall Study|No protocol treatment|0|||
160739222|NCT00549601|580427463|FG000|Randomized|Protocol Violation|0|||
160739223|NCT00549601|580427464|FG001|Randomized|Protocol Violation|0|||
160739224|NCT00549601|580427465|FG002|Randomized|Protocol Violation|1|||
160739225|NCT00549601|580427463|FG000|Randomized|Withdrawal by Subject|0|||
160739226|NCT00549601|580427464|FG001|Randomized|Withdrawal by Subject|1|||
160739227|NCT00549601|580427465|FG002|Randomized|Withdrawal by Subject|1|||
160739228|NCT00549601|580427463|FG000|Received Study Drug|Adverse Event|2|||
160739229|NCT00549601|580427464|FG001|Received Study Drug|Adverse Event|5|||
160739230|NCT00549601|580427465|FG002|Received Study Drug|Adverse Event|1|||
160739231|NCT00549601|580427463|FG000|Received Study Drug|Death|0|||
160739232|NCT00549601|580427464|FG001|Received Study Drug|Death|1|||
160739233|NCT00549601|580427465|FG002|Received Study Drug|Death|0|||
160739234|NCT00549601|580427463|FG000|Received Study Drug|Lost to Follow-up|0|||
160739235|NCT00549601|580427464|FG001|Received Study Drug|Lost to Follow-up|1|||
160739236|NCT00549601|580427465|FG002|Received Study Drug|Lost to Follow-up|1|||
160739237|NCT00549601|580427463|FG000|Received Study Drug|Protocol Violation|3|||
160739238|NCT00549601|580427464|FG001|Received Study Drug|Protocol Violation|4|||
160739239|NCT00549601|580427465|FG002|Received Study Drug|Protocol Violation|1|||
160739240|NCT00549601|580427463|FG000|Received Study Drug|Withdrawal by Subject|2|||
160739241|NCT00549601|580427464|FG001|Received Study Drug|Withdrawal by Subject|0|||
160739242|NCT00549601|580427465|FG002|Received Study Drug|Withdrawal by Subject|1|||
160739243|NCT05741346|580427477|FG000|Overall Study|Withdrawn due to termination of study|28|||
160739244|NCT04439357|580427481|FG000|Overall Study|Disease Progression|4|||
160739245|NCT01458951|580427496|FG000|Overall Study|Other|1|||
160739246|NCT01458951|580427497|FG001|Overall Study|Other|0|||
160739247|NCT01458951|580427498|FG002|Overall Study|Other|0|||
160739248|NCT01458951|580427496|FG000|Overall Study|Protocol Violation|5|||
160739249|NCT01458951|580427497|FG001|Overall Study|Protocol Violation|1|||
160739250|NCT01458951|580427498|FG002|Overall Study|Protocol Violation|0|||
160739251|NCT01458951|580427496|FG000|Overall Study|Withdrawal by Subject|2|||
160739252|NCT01458951|580427497|FG001|Overall Study|Withdrawal by Subject|0|||
160739253|NCT01458951|580427498|FG002|Overall Study|Withdrawal by Subject|2|||
160739254|NCT01458951|580427496|FG000|Overall Study|Adverse Event|7|||
160739255|NCT01458951|580427497|FG001|Overall Study|Adverse Event|0|||
160739256|NCT01458951|580427498|FG002|Overall Study|Adverse Event|2|||
160739257|NCT01458951|580427496|FG000|Overall Study|Insufficient Clinical Response|17|||
160739258|NCT01458951|580427497|FG001|Overall Study|Insufficient Clinical Response|0|||
160739259|NCT01458951|580427498|FG002|Overall Study|Insufficient Clinical Response|11|||
160739260|NCT01846221|580427503|FG000|Overall Study|Catheter Failure|2|||
160739261|NCT01846221|580427504|FG001|Overall Study|Catheter Failure|0|||
160739262|NCT01846221|580427503|FG000|Overall Study|Age Exclusion|1|||
160739263|NCT01846221|580427504|FG001|Overall Study|Age Exclusion|0|||
160739264|NCT01668966|580427505|FG000|Overall Study|Withdrawal by Subject|1|||
160739265|NCT01668966|580427505|FG000|Overall Study|Death|1|||
160739266|NCT01668966|580427505|FG000|Overall Study|Not treated|2|||
160739267|NCT04392167|580427506|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
160739268|NCT01573767|580427507|FG000|Overall Study|Adverse Event|0|||
160739269|NCT01573767|580427508|FG001|Overall Study|Adverse Event|1|||
160739270|NCT01573767|580427509|FG002|Overall Study|Adverse Event|0|||
160739271|NCT01573767|580427510|FG003|Overall Study|Adverse Event|1|||
160739272|NCT01573767|580427507|FG000|Overall Study|Lack of Efficacy|18|||
160739273|NCT01573767|580427508|FG001|Overall Study|Lack of Efficacy|15|||
160739274|NCT01573767|580427509|FG002|Overall Study|Lack of Efficacy|12|||
160739275|NCT01573767|580427510|FG003|Overall Study|Lack of Efficacy|17|||
160739276|NCT01573767|580427507|FG000|Overall Study|Protocol Violation|3|||
160739277|NCT01573767|580427508|FG001|Overall Study|Protocol Violation|1|||
160739278|NCT01573767|580427509|FG002|Overall Study|Protocol Violation|1|||
160739279|NCT01573767|580427510|FG003|Overall Study|Protocol Violation|3|||
160739280|NCT01573767|580427507|FG000|Overall Study|Lost to Follow-up|0|||
160739281|NCT01573767|580427508|FG001|Overall Study|Lost to Follow-up|1|||
160739282|NCT01573767|580427509|FG002|Overall Study|Lost to Follow-up|1|||
160739283|NCT01573767|580427510|FG003|Overall Study|Lost to Follow-up|1|||
160739284|NCT01573767|580427507|FG000|Overall Study|Physician Decision|1|||
160739285|NCT01573767|580427508|FG001|Overall Study|Physician Decision|2|||
160739286|NCT01573767|580427509|FG002|Overall Study|Physician Decision|0|||
160739287|NCT01573767|580427510|FG003|Overall Study|Physician Decision|2|||
160739288|NCT01573767|580427507|FG000|Overall Study|Withdrawal by Subject|0|||
160739289|NCT01573767|580427508|FG001|Overall Study|Withdrawal by Subject|1|||
160739290|NCT01573767|580427509|FG002|Overall Study|Withdrawal by Subject|0|||
160739291|NCT01573767|580427510|FG003|Overall Study|Withdrawal by Subject|0|||
160739292|NCT03427268|580427511|FG000|Overall Study|Progressive disease|25|||
160739293|NCT03427268|580427511|FG000|Overall Study|Never treated|2|||
160739294|NCT03427268|580427511|FG000|Overall Study|Compassionate use|1|||
160739295|NCT03427268|580427511|FG000|Overall Study|Withdrawal by Subject|1|||
160739296|NCT03427268|580427511|FG000|Overall Study|Adverse Event|3|||
160739297|NCT04247880|580427512|FG000|Overall Study|Lost to Follow-up|24|||
160739298|NCT04247880|580427513|FG001|Overall Study|Lost to Follow-up|17|||
160739299|NCT04247880|580427512|FG000|Overall Study|Withdrawal by Subject|3|||
160739300|NCT04247880|580427513|FG001|Overall Study|Withdrawal by Subject|0|||
160739301|NCT04076059|580427516|FG000|Double Blind Phase|Progressive disease|22|||
160739302|NCT04076059|580427517|FG001|Double Blind Phase|Progressive disease|26|||
160739303|NCT04076059|580427518|FG002|Double Blind Phase|Progressive disease|0|||
160739304|NCT04076059|580427516|FG000|Double Blind Phase|Withdrawal by Subject|4|||
160739305|NCT04076059|580427517|FG001|Double Blind Phase|Withdrawal by Subject|11|||
160739306|NCT04076059|580427518|FG002|Double Blind Phase|Withdrawal by Subject|0|||
160739307|NCT04076059|580427516|FG000|Double Blind Phase|Death|1|||
160739308|NCT04076059|580427517|FG001|Double Blind Phase|Death|1|||
160739309|NCT04076059|580427518|FG002|Double Blind Phase|Death|0|||
160739310|NCT04076059|580427516|FG000|Double Blind Phase|Lost to Follow-up|1|||
160739311|NCT04076059|580427517|FG001|Double Blind Phase|Lost to Follow-up|0|||
160739312|NCT04076059|580427518|FG002|Double Blind Phase|Lost to Follow-up|0|||
160739313|NCT04076059|580427516|FG000|Double Blind Phase|Adverse Event|5|||
160739314|NCT04076059|580427517|FG001|Double Blind Phase|Adverse Event|1|||
160739315|NCT04076059|580427518|FG002|Double Blind Phase|Adverse Event|0|||
160739316|NCT04076059|580427516|FG000|Double Blind Phase|Ongoing Participants|82|||
160739317|NCT04076059|580427517|FG001|Double Blind Phase|Ongoing Participants|18|||
160739318|NCT04076059|580427518|FG002|Double Blind Phase|Ongoing Participants|0|||
160739319|NCT04076059|580427516|FG000|Double Blind Phase|Miscellaneous|3|||
160739320|NCT04076059|580427517|FG001|Double Blind Phase|Miscellaneous|1|||
160739321|NCT04076059|580427518|FG002|Double Blind Phase|Miscellaneous|0|||
160739322|NCT04076059|580427516|FG000|Double Blind Phase|Protocol Deviation|1|||
160739323|NCT04076059|580427517|FG001|Double Blind Phase|Protocol Deviation|1|||
160739324|NCT04076059|580427518|FG002|Double Blind Phase|Protocol Deviation|0|||
160739325|NCT04076059|580427516|FG000|Double Blind Phase|Did not take study drug|1|||
160739326|NCT04076059|580427517|FG001|Double Blind Phase|Did not take study drug|1|||
160739327|NCT04076059|580427518|FG002|Double Blind Phase|Did not take study drug|0|||
160739328|NCT04076059|580427516|FG000|Open Label Phase|Progressive disease|0|||
160739329|NCT04076059|580427517|FG001|Open Label Phase|Progressive disease|0|||
160739330|NCT04076059|580427518|FG002|Open Label Phase|Progressive disease|7|||
160739331|NCT04076059|580427516|FG000|Open Label Phase|Withdrawal by Subject|0|||
160739332|NCT04076059|580427517|FG001|Open Label Phase|Withdrawal by Subject|0|||
160739333|NCT04076059|580427518|FG002|Open Label Phase|Withdrawal by Subject|3|||
160739334|NCT04076059|580427516|FG000|Open Label Phase|Death|0|||
160739335|NCT04076059|580427517|FG001|Open Label Phase|Death|0|||
160739336|NCT04076059|580427518|FG002|Open Label Phase|Death|2|||
160739337|NCT04076059|580427516|FG000|Open Label Phase|Ongoing Participants|0|||
160739338|NCT04076059|580427517|FG001|Open Label Phase|Ongoing Participants|0|||
160739339|NCT04076059|580427518|FG002|Open Label Phase|Ongoing Participants|11|||
160739340|NCT04186806|580427519|FG000|Period 1: 7 Days|Adverse Event|1|||
160739341|NCT04186806|580427520|FG001|Period 1: 7 Days|Adverse Event|0|||
160739342|NCT02720744|580427522|FG000|Overall Study|Protocol Violation|0|||
160739343|NCT02720744|580427523|FG001|Overall Study|Protocol Violation|2|||
160739344|NCT02720744|580427522|FG000|Overall Study|Pregnancy|2|||
160739345|NCT02720744|580427523|FG001|Overall Study|Pregnancy|0|||
160739346|NCT02720744|580427522|FG000|Overall Study|Lack of Efficacy|2|||
160739347|NCT02720744|580427523|FG001|Overall Study|Lack of Efficacy|8|||
160739348|NCT02720744|580427522|FG000|Overall Study|Adverse Event|21|||
160739349|NCT02720744|580427523|FG001|Overall Study|Adverse Event|3|||
160739350|NCT02720744|580427522|FG000|Overall Study|Withdrawal by Subject|11|||
160739351|NCT02720744|580427523|FG001|Overall Study|Withdrawal by Subject|11|||
160739352|NCT02720744|580427522|FG000|Overall Study|Lost to follow up|2|||
160739353|NCT02720744|580427523|FG001|Overall Study|Lost to follow up|0|||
160739354|NCT02720744|580427522|FG000|Overall Study|Non Compliance with Investigational Product|0|||
160739355|NCT02720744|580427523|FG001|Overall Study|Non Compliance with Investigational Product|1|||
160739356|NCT02720744|580427522|FG000|Overall Study|Excluded Concomitant Medication|0|||
160739357|NCT02720744|580427523|FG001|Overall Study|Excluded Concomitant Medication|1|||
160739358|NCT00741091|580427524|FG000|Overall Study|Death|13|||
160739359|NCT00741091|580427524|FG000|Overall Study|Lost to Follow-up|16|||
160739360|NCT00741091|580427524|FG000|Overall Study|Withdrawal by Subject|6|||
160739361|NCT00741091|580427524|FG000|Overall Study|Missed Visit|22|||
160739362|NCT01801358|580427525|FG000|Overall Study|Adverse Event|0|||
160739363|NCT01801358|580427526|FG001|Overall Study|Adverse Event|2|||
160739364|NCT01801358|580427527|FG002|Overall Study|Adverse Event|1|||
160739365|NCT01801358|580427528|FG003|Overall Study|Adverse Event|0|||
160739366|NCT01801358|580427529|FG004|Overall Study|Adverse Event|0|||
160739367|NCT01801358|580427530|FG005|Overall Study|Adverse Event|1|||
160739368|NCT01801358|580427525|FG000|Overall Study|Physician Decision|0|||
160739369|NCT01801358|580427526|FG001|Overall Study|Physician Decision|0|||
160739370|NCT01801358|580427527|FG002|Overall Study|Physician Decision|1|||
160739371|NCT01801358|580427528|FG003|Overall Study|Physician Decision|0|||
160739372|NCT01801358|580427529|FG004|Overall Study|Physician Decision|0|||
160739373|NCT01801358|580427530|FG005|Overall Study|Physician Decision|0|||
160739374|NCT01801358|580427525|FG000|Overall Study|Progressive Disease|6|||
160739375|NCT01801358|580427526|FG001|Overall Study|Progressive Disease|4|||
160739376|NCT01801358|580427527|FG002|Overall Study|Progressive Disease|4|||
160739377|NCT01801358|580427528|FG003|Overall Study|Progressive Disease|5|||
160739378|NCT01801358|580427529|FG004|Overall Study|Progressive Disease|6|||
160739379|NCT01801358|580427530|FG005|Overall Study|Progressive Disease|5|||
160739380|NCT01801358|580427525|FG000|Overall Study|Withdrawal by Subject|0|||
160739381|NCT01801358|580427526|FG001|Overall Study|Withdrawal by Subject|0|||
160739382|NCT01801358|580427527|FG002|Overall Study|Withdrawal by Subject|0|||
160739383|NCT01801358|580427528|FG003|Overall Study|Withdrawal by Subject|1|||
160739384|NCT01801358|580427529|FG004|Overall Study|Withdrawal by Subject|0|||
160739385|NCT01801358|580427530|FG005|Overall Study|Withdrawal by Subject|2|||
160739386|NCT00767039|580427531|FG000|Overall Study|Death|5|||
160739387|NCT00767039|580427532|FG001|Overall Study|Death|2|||
160739388|NCT01549041|580427534|FG000|Overall Study|Lack of Efficacy|2|||
160739389|NCT01549041|580427535|FG001|Overall Study|Lack of Efficacy|4|||
160739390|NCT01549041|580427534|FG000|Overall Study|Adverse Event|0|||
160739391|NCT01549041|580427535|FG001|Overall Study|Adverse Event|4|||
160739392|NCT00597506|580427536|FG000|Overall Study|Subject is being followed for survival|1|||
160739393|NCT00525902|580427541|FG000|Overall Study|Lack of Efficacy|1|||
160739394|NCT01032239|580427542|FG000|Overall Study|Lost to Follow-up|3|||
160739395|NCT01032239|580427543|FG001|Overall Study|Lost to Follow-up|2|||
160739396|NCT01032239|580427542|FG000|Overall Study|Withdrawal by Subject|2|||
160739397|NCT01032239|580427543|FG001|Overall Study|Withdrawal by Subject|3|||
160739398|NCT01032239|580427542|FG000|Overall Study|Death|1|||
160739399|NCT01032239|580427543|FG001|Overall Study|Death|0|||
160739400|NCT01032239|580427542|FG000|Overall Study|Protocol Violation|1|||
160739401|NCT01032239|580427543|FG001|Overall Study|Protocol Violation|0|||
160739402|NCT00204477|580427546|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
160739403|NCT00204477|580427547|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
160739404|NCT00204477|580427546|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
160739405|NCT00204477|580427547|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
160739406|NCT01940900|580427548|FG000|Overall Study|Physician Decision|4|||
160739407|NCT01940900|580427549|FG001|Overall Study|Physician Decision|0|||
160739408|NCT01940900|580427548|FG000|Overall Study|Adverse Event|10|||
160739409|NCT01940900|580427549|FG001|Overall Study|Adverse Event|15|||
160739410|NCT01940900|580427548|FG000|Overall Study|Withdrawal by Subject|11|||
160739411|NCT01940900|580427549|FG001|Overall Study|Withdrawal by Subject|15|||
160739412|NCT01940900|580427548|FG000|Overall Study|Lost to Follow-up|1|||
160739413|NCT01940900|580427549|FG001|Overall Study|Lost to Follow-up|0|||
160739414|NCT01940900|580427548|FG000|Overall Study|Sponsor Decision|1|||
160739415|NCT01940900|580427549|FG001|Overall Study|Sponsor Decision|0|||
160739416|NCT01940900|580427548|FG000|Overall Study|subject non-compliance|1|||
160739417|NCT01940900|580427549|FG001|Overall Study|subject non-compliance|1|||
160739418|NCT01940900|580427548|FG000|Overall Study|other|1|||
160739419|NCT01940900|580427549|FG001|Overall Study|other|0|||
160739420|NCT04713592|580427550|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
160739421|NCT04713592|580427551|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
160739422|NCT04713592|580427552|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
160739423|NCT04713592|580427553|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
160739424|NCT04713592|580427550|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
160739425|NCT04713592|580427551|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
160739426|NCT04713592|580427552|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
160739427|NCT04713592|580427553|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
160739428|NCT04713592|580427550|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
160739429|NCT04713592|580427551|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
160739430|NCT04713592|580427552|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
160739431|NCT04713592|580427553|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
160739432|NCT04713592|580427550|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160739433|NCT04713592|580427551|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160739434|NCT04713592|580427552|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
160739435|NCT04713592|580427553|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
160739436|NCT04713592|580427550|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
160739437|NCT04713592|580427551|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
160739438|NCT04713592|580427552|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
160739439|NCT04713592|580427553|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
160739440|NCT04713592|580427550|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160739441|NCT04713592|580427551|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160739442|NCT04713592|580427552|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
160739443|NCT04713592|580427553|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
160739444|NCT04713592|580427550|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
160739445|NCT04713592|580427551|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
160739446|NCT04713592|580427552|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
160739447|NCT04713592|580427553|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
160739448|NCT02431806|580427556|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
160739449|NCT02431806|580427557|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
160739450|NCT02431806|580427558|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
160739451|NCT02431806|580427559|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
160739452|NCT02431806|580427556|FG000|Double-blind Treatment Period|Adverse Event|4|||
160739453|NCT02431806|580427557|FG001|Double-blind Treatment Period|Adverse Event|7|||
160739454|NCT02431806|580427558|FG002|Double-blind Treatment Period|Adverse Event|11|||
160739455|NCT02431806|580427559|FG003|Double-blind Treatment Period|Adverse Event|7|||
160739456|NCT02431806|580427556|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
160739457|NCT02431806|580427557|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
160739458|NCT02431806|580427558|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
160739459|NCT02431806|580427559|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
160739460|NCT02431806|580427556|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
160739461|NCT02431806|580427557|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
160739462|NCT02431806|580427558|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
160739463|NCT02431806|580427559|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
160739464|NCT02431806|580427556|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
160739465|NCT02431806|580427557|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
160739466|NCT02431806|580427558|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
160739467|NCT02431806|580427559|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
160739468|NCT02431806|580427556|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
160739469|NCT02431806|580427557|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
160739470|NCT02431806|580427558|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
160739471|NCT02431806|580427559|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
160739472|NCT02431806|580427556|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
160739473|NCT02431806|580427557|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
160739474|NCT02431806|580427558|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
160739475|NCT02431806|580427559|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
160739476|NCT01797081|580427562|FG000|Overall Study|Adverse Event|1|||
160739477|NCT01797081|580427563|FG001|Overall Study|Adverse Event|0|||
160739478|NCT01797081|580427564|FG002|Overall Study|Adverse Event|1|||
160739479|NCT01797081|580427565|FG003|Overall Study|Adverse Event|0|||
160739480|NCT01797081|580427562|FG000|Overall Study|Pregnancy|1|||
160739481|NCT01797081|580427563|FG001|Overall Study|Pregnancy|0|||
160739482|NCT01797081|580427564|FG002|Overall Study|Pregnancy|0|||
160739483|NCT01797081|580427565|FG003|Overall Study|Pregnancy|0|||
160739484|NCT01797081|580427562|FG000|Overall Study|Personal Reasons|12|||
160739485|NCT01797081|580427563|FG001|Overall Study|Personal Reasons|4|||
160739486|NCT01797081|580427564|FG002|Overall Study|Personal Reasons|4|||
160739487|NCT01797081|580427565|FG003|Overall Study|Personal Reasons|8|||
160739488|NCT01797081|580427562|FG000|Overall Study|Protocol Violation|0|||
160739489|NCT01797081|580427563|FG001|Overall Study|Protocol Violation|0|||
160739490|NCT01797081|580427564|FG002|Overall Study|Protocol Violation|0|||
160739491|NCT01797081|580427565|FG003|Overall Study|Protocol Violation|1|||
160739492|NCT05513703|580427568|FG000|Overall Study|Death|4|||
160739493|NCT05513703|580427568|FG000|Overall Study|Study terminated by sponsor|5|||
160739494|NCT02484651|580427571|FG000|Overall Study|Patients' data files were corrupted.|1|||
160739495|NCT02484651|580427572|FG001|Overall Study|Patients' data files were corrupted.|1|||
160739496|NCT02484651|580427571|FG000|Overall Study|BIS monitoring failed.|1|||
160739497|NCT02484651|580427572|FG001|Overall Study|BIS monitoring failed.|1|||
160739498|NCT02484651|580427571|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
160739499|NCT02484651|580427572|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
160739500|NCT01419080|580427573|FG000|Overall Study|Withdrawal by Subject|75|||
160739501|NCT01419080|580427573|FG000|Overall Study|Death|30|||
160739502|NCT01419080|580427573|FG000|Overall Study|Lost to Follow-up|23|||
160739503|NCT01419080|580427573|FG000|Overall Study|Too Ill|3|||
160739504|NCT04972968|580427574|FG000|Overall Study|Adverse Event|3|||
160739505|NCT04972968|580427575|FG001|Overall Study|Adverse Event|1|||
160739506|NCT04972968|580427576|FG002|Overall Study|Adverse Event|1|||
160739507|NCT04972968|580427577|FG003|Overall Study|Adverse Event|7|||
160739508|NCT04972968|580427574|FG000|Overall Study|Lack of Efficacy|2|||
160739509|NCT04972968|580427575|FG001|Overall Study|Lack of Efficacy|1|||
160739510|NCT04972968|580427576|FG002|Overall Study|Lack of Efficacy|0|||
160739511|NCT04972968|580427577|FG003|Overall Study|Lack of Efficacy|0|||
160739512|NCT04972968|580427574|FG000|Overall Study|Withdrawal by Subject|7|||
160739513|NCT04972968|580427575|FG001|Overall Study|Withdrawal by Subject|4|||
160739514|NCT04972968|580427576|FG002|Overall Study|Withdrawal by Subject|3|||
160739515|NCT04972968|580427577|FG003|Overall Study|Withdrawal by Subject|2|||
160739516|NCT04972968|580427574|FG000|Overall Study|Study Terminated by Sponsor|25|||
160739517|NCT04972968|580427575|FG001|Overall Study|Study Terminated by Sponsor|28|||
160739518|NCT04972968|580427576|FG002|Overall Study|Study Terminated by Sponsor|32|||
160739519|NCT04972968|580427577|FG003|Overall Study|Study Terminated by Sponsor|27|||
160739520|NCT04972968|580427574|FG000|Overall Study|Other|1|||
160739521|NCT04972968|580427575|FG001|Overall Study|Other|0|||
160739522|NCT04972968|580427576|FG002|Overall Study|Other|1|||
160739523|NCT04972968|580427577|FG003|Overall Study|Other|1|||
160739524|NCT00150800|580427578|FG000|Overall Study|Adverse Event|89|||
160739525|NCT00150800|580427578|FG000|Overall Study|Death|18|||
160739526|NCT00150800|580427578|FG000|Overall Study|Lack of Efficacy|166|||
160739527|NCT00150800|580427578|FG000|Overall Study|Lost to Follow-up|58|||
160739528|NCT00150800|580427578|FG000|Overall Study|Subject's choice|90|||
160739529|NCT00150800|580427578|FG000|Overall Study|No compliance|18|||
160739530|NCT00150800|580427578|FG000|Overall Study|IP misshandling|1|||
160739531|NCT00150800|580427578|FG000|Overall Study|Site closure|24|||
160739532|NCT00150800|580427578|FG000|Overall Study|Protocol non-adherence|2|||
160739533|NCT00150800|580427578|FG000|Overall Study|Nobody to accompany patient|1|||
160739534|NCT00150800|580427578|FG000|Overall Study|Distance too long for patient|1|||
160739535|NCT00150800|580427578|FG000|Overall Study|Neurosurgery|2|||
160739536|NCT00150800|580427578|FG000|Overall Study|BRV monotherapy|1|||
160739537|NCT00150800|580427578|FG000|Overall Study|Visit refusal|3|||
160739538|NCT00150800|580427578|FG000|Overall Study|Sponsor's request|2|||
160739539|NCT00150800|580427578|FG000|Overall Study|Generalized Epilepsy|1|||
160739540|NCT00150800|580427578|FG000|Overall Study|Moved from area/country|8|||
160739541|NCT00150800|580427578|FG000|Overall Study|PI retiring|2|||
160739542|NCT00150800|580427578|FG000|Overall Study|PI leaving site|2|||
160739543|NCT00150800|580427578|FG000|Overall Study|Patient insurance|1|||
160739544|NCT00150800|580427578|FG000|Overall Study|Surgical intervention|4|||
160739545|NCT00150800|580427578|FG000|Overall Study|Pregnancy planned|1|||
160739546|NCT00150800|580427578|FG000|Overall Study|PI discontinuation request|1|||
160739547|NCT01698879|580427579|FG000|Overall Study|Withdrawal by Subject|1|||
160739548|NCT01698879|580427580|FG001|Overall Study|Withdrawal by Subject|0|||
160739549|NCT01698879|580427581|FG002|Overall Study|Withdrawal by Subject|0|||
160739550|NCT03649178|580427582|FG000|Overall Study|Adverse Event|1|||
160739551|NCT03649178|580427583|FG001|Overall Study|Adverse Event|2|||
160739552|NCT03649178|580427582|FG000|Overall Study|Withdrawal by Subject|0|||
160739553|NCT03649178|580427583|FG001|Overall Study|Withdrawal by Subject|2|||
160739554|NCT03649178|580427582|FG000|Overall Study|COVID regulation required halt in protocol|1|||
160739555|NCT03649178|580427583|FG001|Overall Study|COVID regulation required halt in protocol|0|||
160739556|NCT03619902|580427585|FG000|Overall Study|Termination of Study by Investigator|1|||
160739557|NCT03619902|580427585|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
160739558|NCT02419612|580427586|FG000|Short-term Treatment Period|Adverse Event|1|||
160739559|NCT02419612|580427587|FG001|Short-term Treatment Period|Adverse Event|1|||
160739560|NCT02419612|580427586|FG000|Short-term Treatment Period|Death|0|||
160739561|NCT02419612|580427587|FG001|Short-term Treatment Period|Death|2|||
160739562|NCT02419612|580427586|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
160739563|NCT02419612|580427587|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
160739564|NCT02419612|580427586|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
160739565|NCT02419612|580427587|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
160739566|NCT02419612|580427586|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
160739567|NCT02419612|580427587|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
160739568|NCT02419612|580427586|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
160739569|NCT02419612|580427587|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
160739570|NCT02419612|580427586|FG000|Short-term Treatment Period|Worsening of liver function|0|||
160739571|NCT02419612|580427587|FG001|Short-term Treatment Period|Worsening of liver function|1|||
160739572|NCT02419612|580427586|FG000|Short-term Treatment Period|Subject moved out of state|0|||
160739573|NCT02419612|580427587|FG001|Short-term Treatment Period|Subject moved out of state|1|||
160739574|NCT02419612|580427586|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
160739575|NCT02419612|580427587|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
160739576|NCT02419612|580427586|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
160739577|NCT02419612|580427587|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
160739578|NCT02419612|580427586|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
160739579|NCT02419612|580427587|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
160739580|NCT02419612|580427586|FG000|Long-term Treatment Period|Death|0|||
160739581|NCT02419612|580427587|FG001|Long-term Treatment Period|Death|1|||
160739582|NCT02419612|580427586|FG000|Long-term Treatment Period|Adverse Event|0|||
160739583|NCT02419612|580427587|FG001|Long-term Treatment Period|Adverse Event|5|||
160739584|NCT02419612|580427586|FG000|Long-term Treatment Period|Other|4|||
160739585|NCT02419612|580427587|FG001|Long-term Treatment Period|Other|4|||
160739586|NCT02419612|580427586|FG000|Long-term Treatment Period|Subject Decision|2|||
160739587|NCT02419612|580427587|FG001|Long-term Treatment Period|Subject Decision|4|||
160739588|NCT02419612|580427586|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
160739589|NCT02419612|580427587|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
160739590|NCT02135107|580427588|FG000|Treatment Period|Withdrawal by Subject|11|||
160739591|NCT02135107|580427589|FG001|Treatment Period|Withdrawal by Subject|0|||
160739592|NCT02135107|580427590|FG002|Treatment Period|Withdrawal by Subject|0|||
160739593|NCT02135107|580427591|FG003|Treatment Period|Withdrawal by Subject|0|||
160739594|NCT02135107|580427588|FG000|Treatment Period|Adverse Event|5|||
160739595|NCT02135107|580427589|FG001|Treatment Period|Adverse Event|2|||
160739596|NCT02135107|580427590|FG002|Treatment Period|Adverse Event|0|||
160739597|NCT02135107|580427591|FG003|Treatment Period|Adverse Event|0|||
160739598|NCT02135107|580427588|FG000|Treatment Period|Pregnancy|1|||
160739599|NCT02135107|580427589|FG001|Treatment Period|Pregnancy|0|||
160739600|NCT02135107|580427590|FG002|Treatment Period|Pregnancy|0|||
160739601|NCT02135107|580427591|FG003|Treatment Period|Pregnancy|0|||
160739602|NCT02135107|580427588|FG000|Treatment Period|Other|115|||
160739603|NCT02135107|580427589|FG001|Treatment Period|Other|24|||
160739604|NCT02135107|580427590|FG002|Treatment Period|Other|0|||
160739605|NCT02135107|580427591|FG003|Treatment Period|Other|0|||
160739606|NCT02135107|580427588|FG000|Maintenance Therapy Period|Adverse Event|0|||
160739607|NCT02135107|580427589|FG001|Maintenance Therapy Period|Adverse Event|0|||
160739608|NCT02135107|580427590|FG002|Maintenance Therapy Period|Adverse Event|3|||
160739609|NCT02135107|580427591|FG003|Maintenance Therapy Period|Adverse Event|7|||
160739610|NCT02135107|580427588|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
160739611|NCT02135107|580427589|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
160739612|NCT02135107|580427590|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
160739613|NCT02135107|580427591|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
160739614|NCT02135107|580427588|FG000|Maintenance Therapy Period|Pregnancy|0|||
160739615|NCT02135107|580427589|FG001|Maintenance Therapy Period|Pregnancy|0|||
160739616|NCT02135107|580427590|FG002|Maintenance Therapy Period|Pregnancy|0|||
160739617|NCT02135107|580427591|FG003|Maintenance Therapy Period|Pregnancy|1|||
160739618|NCT02135107|580427588|FG000|Maintenance Therapy Period|Other|0|||
160739619|NCT02135107|580427589|FG001|Maintenance Therapy Period|Other|0|||
160739620|NCT02135107|580427590|FG002|Maintenance Therapy Period|Other|7|||
160739621|NCT02135107|580427591|FG003|Maintenance Therapy Period|Other|8|||
160739622|NCT00474045|580427592|FG000|Overall Study|Adverse Event|18|||
160739623|NCT00474045|580427593|FG001|Overall Study|Adverse Event|8|||
160739624|NCT00474045|580427592|FG000|Overall Study|Unclassified|1|||
160739625|NCT00474045|580427593|FG001|Overall Study|Unclassified|3|||
160739626|NCT00474045|580427592|FG000|Overall Study|Lack of Efficacy|0|||
160739627|NCT00474045|580427593|FG001|Overall Study|Lack of Efficacy|9|||
160739628|NCT00474045|580427592|FG000|Overall Study|Lost to Follow-up|1|||
160739629|NCT00474045|580427593|FG001|Overall Study|Lost to Follow-up|1|||
160739630|NCT00474045|580427592|FG000|Overall Study|Protocol Violation|10|||
160739631|NCT00474045|580427593|FG001|Overall Study|Protocol Violation|12|||
160739632|NCT00474045|580427592|FG000|Overall Study|Withdrawal by Subject|16|||
160739633|NCT00474045|580427593|FG001|Overall Study|Withdrawal by Subject|18|||
160739634|NCT00474045|580427592|FG000|Overall Study|Withdrawal criteria|60|||
160739635|NCT00474045|580427593|FG001|Overall Study|Withdrawal criteria|50|||
160739636|NCT03197324|580427600|FG000|Overall Study|Adverse Event|0|||
160739637|NCT03197324|580427601|FG001|Overall Study|Adverse Event|1|||
160739638|NCT03589976|580427603|FG000|Overall Study|Death|5|||
160739639|NCT03589976|580427604|FG001|Overall Study|Death|1|||
160739640|NCT03589976|580427603|FG000|Overall Study|Adverse Event|5|||
160739641|NCT03589976|580427604|FG001|Overall Study|Adverse Event|1|||
160739642|NCT03589976|580427603|FG000|Overall Study|Withdrawal by Subject|4|||
160739643|NCT03589976|580427604|FG001|Overall Study|Withdrawal by Subject|1|||
160739644|NCT03589976|580427603|FG000|Overall Study|Lost to Follow-up|1|||
160739645|NCT03589976|580427604|FG001|Overall Study|Lost to Follow-up|0|||
160739646|NCT03589976|580427603|FG000|Overall Study|Other|4|||
160739647|NCT03589976|580427604|FG001|Overall Study|Other|3|||
160739648|NCT03117881|580429387|FG000|Baseline|Withdrawal by Subject|21|||
160739649|NCT03117881|580429388|FG001|Baseline|Withdrawal by Subject|10|||
160739650|NCT03117881|580429389|FG002|Baseline|Withdrawal by Subject|0|||
160739651|NCT03117881|580429387|FG000|Baseline|Lost to Follow-up|22|||
160739652|NCT03117881|580429388|FG001|Baseline|Lost to Follow-up|25|||
160739653|NCT03117881|580429389|FG002|Baseline|Lost to Follow-up|0|||
160739654|NCT03117881|580429387|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
160739655|NCT03117881|580429388|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
160739656|NCT03117881|580429389|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
160739657|NCT03117881|580429387|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
160739658|NCT03117881|580429388|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
160739659|NCT03117881|580429389|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
160739660|NCT03117881|580429387|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
160739661|NCT03117881|580429388|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
160739662|NCT03117881|580429389|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
160739663|NCT03117881|580429387|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
160739664|NCT03117881|580429388|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
160739665|NCT03117881|580429389|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
160739666|NCT03117881|580429387|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
160739667|NCT03117881|580429388|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
160739668|NCT03117881|580429389|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
160739669|NCT03117881|580429387|FG000|6-Month Follow-Up|Did not complete test|53|||
160739670|NCT03117881|580429388|FG001|6-Month Follow-Up|Did not complete test|25|||
160739671|NCT03117881|580429389|FG002|6-Month Follow-Up|Did not complete test|7|||
160739672|NCT03117881|580429387|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
160739673|NCT03117881|580429388|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
160739674|NCT03117881|580429389|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
160739675|NCT03117881|580429387|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
160739676|NCT03117881|580429388|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
160739677|NCT03117881|580429389|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
160739678|NCT03117881|580429387|FG000|12-Month Follow-Up|Did not complete test|40|||
160739679|NCT03117881|580429388|FG001|12-Month Follow-Up|Did not complete test|0|||
160739680|NCT03117881|580429389|FG002|12-Month Follow-Up|Did not complete test|0|||
160739681|NCT01892085|580429395|FG000|Overall Study|Death|4|||
160739682|NCT01892085|580429396|FG001|Overall Study|Death|1|||
160739683|NCT01892085|580429397|FG002|Overall Study|Death|3|||
160739684|NCT01892085|580429395|FG000|Overall Study|Withdrawal by Subject|2|||
160739685|NCT01892085|580429396|FG001|Overall Study|Withdrawal by Subject|0|||
160739686|NCT01892085|580429397|FG002|Overall Study|Withdrawal by Subject|2|||
160739687|NCT00480493|580429398|FG000|Overall Study|moved|2|||
160739688|NCT00480493|580429399|FG001|Overall Study|moved|7|||
160739689|NCT03769675|580429400|FG000|Overall Study|Lost to Follow-up|1|||
160739690|NCT02844907|580429401|FG000|With Dexamethasone|No IV access|1|||
160739691|NCT02772276|580429402|FG000|Overall Study|Lost to Follow-up|0|||
160739692|NCT02772276|580429403|FG001|Overall Study|Lost to Follow-up|0|||
160739693|NCT02772276|580429404|FG002|Overall Study|Lost to Follow-up|0|||
160739694|NCT02772276|580429405|FG003|Overall Study|Lost to Follow-up|0|||
160739695|NCT02772276|580429406|FG004|Overall Study|Lost to Follow-up|0|||
160739696|NCT02772276|580429407|FG005|Overall Study|Lost to Follow-up|0|||
160739697|NCT02772276|580429408|FG006|Overall Study|Lost to Follow-up|1|||
160739698|NCT02772276|580429409|FG007|Overall Study|Lost to Follow-up|0|||
160739699|NCT02772276|580429410|FG008|Overall Study|Lost to Follow-up|0|||
160739700|NCT02772276|580429411|FG009|Overall Study|Lost to Follow-up|0|||
160739701|NCT02772276|580429412|FG010|Overall Study|Lost to Follow-up|0|||
160739702|NCT02772276|580429413|FG011|Overall Study|Lost to Follow-up|0|||
160739703|NCT02772276|580429414|FG012|Overall Study|Lost to Follow-up|0|||
160739704|NCT02772276|580429402|FG000|Overall Study|Withdrew consent|0|||
160739705|NCT02772276|580429403|FG001|Overall Study|Withdrew consent|0|||
160739706|NCT02772276|580429404|FG002|Overall Study|Withdrew consent|0|||
160739707|NCT02772276|580429405|FG003|Overall Study|Withdrew consent|0|||
160739708|NCT02772276|580429406|FG004|Overall Study|Withdrew consent|0|||
160739709|NCT02772276|580429407|FG005|Overall Study|Withdrew consent|0|||
160739710|NCT02772276|580429408|FG006|Overall Study|Withdrew consent|0|||
160739711|NCT02772276|580429409|FG007|Overall Study|Withdrew consent|1|||
160739712|NCT02772276|580429410|FG008|Overall Study|Withdrew consent|0|||
160739713|NCT02772276|580429411|FG009|Overall Study|Withdrew consent|0|||
160739714|NCT02772276|580429412|FG010|Overall Study|Withdrew consent|0|||
160739715|NCT02772276|580429413|FG011|Overall Study|Withdrew consent|0|||
160739716|NCT02772276|580429414|FG012|Overall Study|Withdrew consent|0|||
160739717|NCT00550862|580429415|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
160739718|NCT00550862|580429416|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
160739719|NCT00550862|580429417|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
160739720|NCT00550862|580429418|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
160739721|NCT00550862|580429419|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
160739722|NCT00550862|580429415|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
160739723|NCT00550862|580429416|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
160739724|NCT00550862|580429417|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
160739725|NCT00550862|580429418|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
160739726|NCT00550862|580429419|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
160739727|NCT00550862|580429415|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
160739728|NCT00550862|580429416|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
160739729|NCT00550862|580429417|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
160739730|NCT00550862|580429418|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
160739731|NCT00550862|580429419|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
160739732|NCT00550862|580429415|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
160739733|NCT00550862|580429416|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
160739734|NCT00550862|580429417|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
160739735|NCT00550862|580429418|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
160739736|NCT00550862|580429419|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
160739737|NCT00550862|580429415|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
160739738|NCT00550862|580429416|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
160739739|NCT00550862|580429417|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
160739740|NCT00550862|580429418|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
160739741|NCT00550862|580429419|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
160739742|NCT00550862|580429415|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
160739743|NCT00550862|580429416|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
160739744|NCT00550862|580429417|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
160739745|NCT00550862|580429418|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
160739746|NCT00550862|580429419|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
160739747|NCT00550862|580429415|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
160739748|NCT00550862|580429416|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
160739749|NCT00550862|580429417|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
160739750|NCT00550862|580429418|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
160739751|NCT00550862|580429419|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
160739752|NCT00550862|580429415|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
160739753|NCT00550862|580429416|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
160739754|NCT00550862|580429417|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
160739755|NCT00550862|580429418|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
160739756|NCT00550862|580429419|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
160739757|NCT00550862|580429415|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
160739758|NCT00550862|580429416|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
160739759|NCT00550862|580429417|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
160739760|NCT00550862|580429418|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
160739761|NCT00550862|580429419|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
160739762|NCT00550862|580429415|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
160739763|NCT00550862|580429416|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
160739764|NCT00550862|580429417|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
160739765|NCT00550862|580429418|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
160739766|NCT00550862|580429419|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
160739767|NCT02248974|580429423|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
160739768|NCT02248974|580429424|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
160739769|NCT02248974|580429423|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
160739770|NCT02248974|580429424|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
160739771|NCT02248974|580429423|FG000|1-Day Follow-Up|Enrolled in another study|1|||
160739772|NCT02248974|580429424|FG001|1-Day Follow-Up|Enrolled in another study|0|||
160739773|NCT02248974|580429423|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
160739774|NCT02248974|580429424|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
160739775|NCT02248974|580429423|FG000|1-Week Follow-Up|Enrolled in another study|1|||
160739776|NCT02248974|580429424|FG001|1-Week Follow-Up|Enrolled in another study|1|||
160739777|NCT02248974|580429423|FG000|1-Week Follow-Up|Transferred to another facility|1|||
160739778|NCT02248974|580429424|FG001|1-Week Follow-Up|Transferred to another facility|0|||
160739779|NCT02248974|580429423|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
160739780|NCT02248974|580429424|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
160739781|NCT02248974|580429423|FG000|1-Week Follow-Up|Death|1|||
160739782|NCT02248974|580429424|FG001|1-Week Follow-Up|Death|1|||
160739783|NCT02248974|580429423|FG000|1-Week Follow-Up|Excluded because of age|0|||
160739784|NCT02248974|580429424|FG001|1-Week Follow-Up|Excluded because of age|1|||
160739785|NCT02248974|580429423|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
160739786|NCT02248974|580429424|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
160739787|NCT02248974|580429423|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
160739788|NCT02248974|580429424|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
160739789|NCT02248974|580429423|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
160739790|NCT02248974|580429424|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
160739791|NCT02248974|580429423|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
160739792|NCT02248974|580429424|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
160739793|NCT02248974|580429423|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
160739794|NCT02248974|580429424|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
160739795|NCT03488225|580429426|FG000|Overall Study|Off Protocol Therapy|2|||
160739796|NCT03488225|580429426|FG000|Overall Study|Stem Cell Transplant|2|||
160739797|NCT04093492|580429427|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
160739798|NCT04093492|580429428|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
160739799|NCT04093492|580429429|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
160739800|NCT04093492|580429430|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
160739801|NCT04093492|580429427|FG000|25 Weeks Gestational Age (GA)|No response|5|||
160739802|NCT04093492|580429428|FG001|25 Weeks Gestational Age (GA)|No response|5|||
160739803|NCT04093492|580429429|FG002|25 Weeks Gestational Age (GA)|No response|5|||
160739804|NCT04093492|580429430|FG003|25 Weeks Gestational Age (GA)|No response|2|||
160739805|NCT04093492|580429427|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
160739806|NCT04093492|580429428|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
160739807|NCT04093492|580429429|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
160739808|NCT04093492|580429430|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
160739809|NCT04093492|580429427|FG000|30 Weeks GA|Delivered before assessment|1|||
160739810|NCT04093492|580429428|FG001|30 Weeks GA|Delivered before assessment|2|||
160739811|NCT04093492|580429429|FG002|30 Weeks GA|Delivered before assessment|0|||
160739812|NCT04093492|580429430|FG003|30 Weeks GA|Delivered before assessment|0|||
160739813|NCT04093492|580429427|FG000|30 Weeks GA|No response|7|||
160739814|NCT04093492|580429428|FG001|30 Weeks GA|No response|5|||
160739815|NCT04093492|580429429|FG002|30 Weeks GA|No response|5|||
160739816|NCT04093492|580429430|FG003|30 Weeks GA|No response|2|||
160739817|NCT04093492|580429427|FG000|30 Weeks GA|Lost to Follow-up|0|||
160739818|NCT04093492|580429428|FG001|30 Weeks GA|Lost to Follow-up|1|||
160739819|NCT04093492|580429429|FG002|30 Weeks GA|Lost to Follow-up|0|||
160739820|NCT04093492|580429430|FG003|30 Weeks GA|Lost to Follow-up|0|||
160739821|NCT04093492|580429427|FG000|34 Weeks GA|Delivered before assessment|6|||
160739822|NCT04093492|580429428|FG001|34 Weeks GA|Delivered before assessment|3|||
160739823|NCT04093492|580429429|FG002|34 Weeks GA|Delivered before assessment|0|||
160739824|NCT04093492|580429430|FG003|34 Weeks GA|Delivered before assessment|0|||
160739825|NCT04093492|580429427|FG000|34 Weeks GA|No response|0|||
160739826|NCT04093492|580429428|FG001|34 Weeks GA|No response|7|||
160739827|NCT04093492|580429429|FG002|34 Weeks GA|No response|5|||
160739828|NCT04093492|580429430|FG003|34 Weeks GA|No response|3|||
160739829|NCT04093492|580429427|FG000|34 Weeks GA|Lost to Follow-up|0|||
160739830|NCT04093492|580429428|FG001|34 Weeks GA|Lost to Follow-up|1|||
160739831|NCT04093492|580429429|FG002|34 Weeks GA|Lost to Follow-up|0|||
160739832|NCT04093492|580429430|FG003|34 Weeks GA|Lost to Follow-up|0|||
160739833|NCT02945254|580429435|FG000|Overall Study|Lost to Follow-up|1|||
160739834|NCT02945254|580429436|FG001|Overall Study|Lost to Follow-up|0|||
160739835|NCT02945254|580429435|FG000|Overall Study|Withdrawal by Subject|1|||
160739836|NCT02945254|580429436|FG001|Overall Study|Withdrawal by Subject|0|||
160739837|NCT00783224|580429437|FG000|Overall Study|Adverse Event|0|||
160739838|NCT00783224|580429438|FG001|Overall Study|Adverse Event|0|||
160739839|NCT00783224|580429439|FG002|Overall Study|Adverse Event|1|||
160739840|NCT00783224|580429440|FG003|Overall Study|Adverse Event|0|||
160739841|NCT00783224|580429437|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
160739842|NCT00783224|580429438|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
160739843|NCT00783224|580429439|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
160739844|NCT00783224|580429440|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
160739845|NCT00783224|580429437|FG000|Overall Study|Inappropriate as a study subject|0|||
160739846|NCT00783224|580429438|FG001|Overall Study|Inappropriate as a study subject|0|||
160739847|NCT00783224|580429439|FG002|Overall Study|Inappropriate as a study subject|0|||
160739848|NCT00783224|580429440|FG003|Overall Study|Inappropriate as a study subject|1|||
160739849|NCT01711619|580429441|FG000|Overall Study|Early study termination|10|||
160739850|NCT01711619|580429442|FG001|Overall Study|Early study termination|14|||
160739851|NCT01711619|580429441|FG000|Overall Study|Withdrawal by Subject|3|||
160739852|NCT01711619|580429442|FG001|Overall Study|Withdrawal by Subject|7|||
160739853|NCT01711619|580429441|FG000|Overall Study|Protocol Violation|2|||
160739854|NCT01711619|580429442|FG001|Overall Study|Protocol Violation|3|||
160739855|NCT01711619|580429441|FG000|Overall Study|Adverse Event|2|||
160739856|NCT01711619|580429442|FG001|Overall Study|Adverse Event|0|||
160739857|NCT01711619|580429441|FG000|Overall Study|Lost to Follow-up|1|||
160739858|NCT01711619|580429442|FG001|Overall Study|Lost to Follow-up|0|||
160739859|NCT03422159|580429443|FG000|Overall Study|Exclusion due to terminal disease|2|||
160739860|NCT03422159|580429444|FG001|Overall Study|Exclusion due to terminal disease|1|||
160739861|NCT04631107|580429445|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
160739862|NCT04631107|580429445|FG000|Second Intervention (1 Night)|Adverse Event|1|||
160739863|NCT04631107|580429445|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
160739864|NCT04631107|580429445|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
160739865|NCT00087126|580429449|FG000|Overall Study|Ineligible - second primary|1|||
160739866|NCT00087126|580429449|FG000|Overall Study|Never treated|1|||
160739867|NCT01432275|580429450|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
160739868|NCT01432275|580429451|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
160739869|NCT01432275|580429450|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
160739870|NCT01432275|580429451|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
160739871|NCT01432275|580429450|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
160739872|NCT01432275|580429451|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
160739873|NCT01432275|580429450|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
160739874|NCT01432275|580429451|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
160739875|NCT01432275|580429450|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
160739876|NCT01432275|580429451|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
160739877|NCT01432275|580429450|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
160739878|NCT01432275|580429451|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
160739879|NCT01432275|580429450|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
160739880|NCT01432275|580429451|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
160739881|NCT01432275|580429450|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
160739882|NCT01432275|580429451|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
160739883|NCT01432275|580429450|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
160739884|NCT01432275|580429451|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
160739885|NCT01935700|580429456|FG000|Overall Study|Withdrawal by Subject|1|||
160739886|NCT01935700|580429457|FG001|Overall Study|Withdrawal by Subject|0|||
160739887|NCT01935700|580429456|FG000|Overall Study|Physician Decision|4|||
160739888|NCT01935700|580429457|FG001|Overall Study|Physician Decision|0|||
160739889|NCT00096993|580429458|FG000|Overall Study|Death|1|||
160739890|NCT00096993|580429459|FG001|Overall Study|Death|0|||
160739891|NCT00096993|580429458|FG000|Overall Study|Disease progression|56|||
160739892|NCT00096993|580429459|FG001|Overall Study|Disease progression|53|||
160739893|NCT00096993|580429458|FG000|Overall Study|Adverse Event|2|||
160739894|NCT00096993|580429459|FG001|Overall Study|Adverse Event|8|||
160739895|NCT00096993|580429458|FG000|Overall Study|Subject's decision|3|||
160739896|NCT00096993|580429459|FG001|Overall Study|Subject's decision|1|||
160739897|NCT00096993|580429458|FG000|Overall Study|Physician Decision|2|||
160739898|NCT00096993|580429459|FG001|Overall Study|Physician Decision|1|||
160739899|NCT00096993|580429458|FG000|Overall Study|Non-compliance|0|||
160739900|NCT00096993|580429459|FG001|Overall Study|Non-compliance|1|||
160739901|NCT00096993|580429458|FG000|Overall Study|Other unspecified|1|||
160739902|NCT00096993|580429459|FG001|Overall Study|Other unspecified|1|||
160739903|NCT01935128|580429462|FG000|Overall Study|Death|1|||
160739904|NCT01935128|580429462|FG000|Overall Study|Adverse Event|6|||
160739905|NCT01162122|580429465|FG000|Overall Study|Withdrawal by Subject|52|||
160739906|NCT01162122|580429466|FG001|Overall Study|Withdrawal by Subject|43|||
160739907|NCT01162122|580429465|FG000|Overall Study|Lost to Follow-up|73|||
160739908|NCT01162122|580429466|FG001|Overall Study|Lost to Follow-up|91|||
160739909|NCT01162122|580429465|FG000|Overall Study|Adverse Event|3|||
160739910|NCT01162122|580429466|FG001|Overall Study|Adverse Event|2|||
160739911|NCT01162122|580429465|FG000|Overall Study|Death|51|||
160739912|NCT01162122|580429466|FG001|Overall Study|Death|46|||
160739913|NCT01162122|580429465|FG000|Overall Study|Protocol Violation|2|||
160739914|NCT01162122|580429466|FG001|Overall Study|Protocol Violation|2|||
160739915|NCT01162122|580429465|FG000|Overall Study|Inappropriate enrollment|5|||
160739916|NCT01162122|580429466|FG001|Overall Study|Inappropriate enrollment|4|||
160739917|NCT01162122|580429465|FG000|Overall Study|Administrative reason|1|||
160739918|NCT01162122|580429466|FG001|Overall Study|Administrative reason|1|||
160739919|NCT01162122|580429465|FG000|Overall Study|Unable to classify|3|||
160739920|NCT01162122|580429466|FG001|Overall Study|Unable to classify|7|||
160739921|NCT01162122|580429465|FG000|Overall Study|Missing primary reason|1|||
160739922|NCT01162122|580429466|FG001|Overall Study|Missing primary reason|0|||
160739923|NCT02020512|580429467|FG000|Overall Study|Adverse Event|1|||
160739924|NCT02020512|580429467|FG000|Overall Study|Lost to Follow-up|3|||
160739925|NCT02020512|580429467|FG000|Overall Study|Protocol Violation|4|||
160739926|NCT00835679|580429468|FG000|Overall Study|Withdrawal by Subject|1|||
160739927|NCT00835679|580429469|FG001|Overall Study|Withdrawal by Subject|0|||
160739928|NCT00835679|580429470|FG002|Overall Study|Withdrawal by Subject|0|||
160739929|NCT00835679|580429471|FG003|Overall Study|Withdrawal by Subject|0|||
160739930|NCT00955968|580429476|FG000|Overall Study|Death|2|||
160739931|NCT00955968|580429477|FG001|Overall Study|Death|4|||
160739932|NCT00955968|580429476|FG000|Overall Study|Withdrawal by Subject|35|||
160739933|NCT00955968|580429477|FG001|Overall Study|Withdrawal by Subject|31|||
160739934|NCT00955968|580429476|FG000|Overall Study|Lost to Follow-up|45|||
160739935|NCT00955968|580429477|FG001|Overall Study|Lost to Follow-up|39|||
160739936|NCT00955968|580429476|FG000|Overall Study|Site closed|55|||
160739937|NCT00955968|580429477|FG001|Overall Study|Site closed|52|||
160739938|NCT03782298|580429480|FG000|Overall Study|Protocol Deviation|4|||
160739939|NCT00742508|580429481|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
160739940|NCT00742508|580429482|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
160739941|NCT00742508|580429481|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
160739942|NCT00742508|580429482|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
160739943|NCT00742508|580429481|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
160739944|NCT00742508|580429482|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
160739945|NCT00742508|580429481|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
160739946|NCT00742508|580429482|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
160739947|NCT00742508|580429481|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
160739948|NCT00742508|580429482|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
160739949|NCT01793688|580429483|FG000|Overall Study|Protocol Violation|2|||
160739950|NCT03814720|580429486|FG000|Overall Study|Lost to Follow-up|0|||
160739951|NCT03814720|580429487|FG001|Overall Study|Lost to Follow-up|1|||
160739952|NCT03814720|580429488|FG002|Overall Study|Lost to Follow-up|0|||
160739953|NCT03814720|580429489|FG003|Overall Study|Lost to Follow-up|0|||
160739954|NCT03814720|580429490|FG004|Overall Study|Lost to Follow-up|0|||
160739955|NCT02009397|580429497|FG000|Overall Study|Protocol Violation|6|||
160739956|NCT02009397|580429497|FG000|Overall Study|Death|8|||
160739957|NCT02009397|580429497|FG000|Overall Study|Lost to Follow-up|6|||
160739958|NCT02278120|580429501|FG000|Treatment Period|Progressive disease|234|||
160739959|NCT02278120|580429502|FG001|Treatment Period|Progressive disease|260|||
160739960|NCT02278120|580429501|FG000|Treatment Period|Subject/guardian decision|23|||
160739961|NCT02278120|580429502|FG001|Treatment Period|Subject/guardian decision|20|||
160739962|NCT02278120|580429501|FG000|Treatment Period|Adverse Event|16|||
160739963|NCT02278120|580429502|FG001|Treatment Period|Adverse Event|14|||
160739964|NCT02278120|580429501|FG000|Treatment Period|Physician Decision|14|||
160739965|NCT02278120|580429502|FG001|Treatment Period|Physician Decision|27|||
160739966|NCT02278120|580429501|FG000|Treatment Period|Death|3|||
160739967|NCT02278120|580429502|FG001|Treatment Period|Death|3|||
160739968|NCT02278120|580429501|FG000|Treatment Period|Lost to Follow-up|2|||
160739969|NCT02278120|580429502|FG001|Treatment Period|Lost to Follow-up|0|||
160739970|NCT02278120|580429501|FG000|Treatment Period|Protocol deviation|0|||
160739971|NCT02278120|580429502|FG001|Treatment Period|Protocol deviation|2|||
160739972|NCT02278120|580429501|FG000|Treatment Period|Study terminated as per protocol|43|||
160739973|NCT02278120|580429502|FG001|Treatment Period|Study terminated as per protocol|11|||
160739974|NCT02278120|580429501|FG000|Post-treatment Efficacy Follow-up|Death|0|||
160739975|NCT02278120|580429502|FG001|Post-treatment Efficacy Follow-up|Death|1|||
160739976|NCT02278120|580429501|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
160739977|NCT02278120|580429502|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
160739978|NCT02278120|580429501|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
160739979|NCT02278120|580429502|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
160739980|NCT02278120|580429501|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
160739981|NCT02278120|580429502|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
160739982|NCT02278120|580429501|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160739983|NCT02278120|580429502|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160739984|NCT00808639|580429503|FG000|Overall Study|Disease progression before surgery.|1|||
160739985|NCT01966068|580429504|FG000|Overall Study|Withdrawal by Subject|57|||
160739986|NCT01966068|580429504|FG000|Overall Study|Lost to Follow-up|81|||
160739987|NCT00191282|580429505|FG000|Overall Study|Adverse Event|5|||
160739988|NCT00191282|580429506|FG001|Overall Study|Adverse Event|6|||
160739989|NCT00191282|580429505|FG000|Overall Study|Death|51|||
160739990|NCT00191282|580429506|FG001|Overall Study|Death|51|||
160739991|NCT00191282|580429505|FG000|Overall Study|Lack of Efficacy|11|||
160739992|NCT00191282|580429506|FG001|Overall Study|Lack of Efficacy|6|||
160739993|NCT00191282|580429505|FG000|Overall Study|Noncompliance|14|||
160739994|NCT00191282|580429506|FG001|Overall Study|Noncompliance|17|||
160739995|NCT00191282|580429505|FG000|Overall Study|Patient moved|11|||
160739996|NCT00191282|580429506|FG001|Overall Study|Patient moved|14|||
160739997|NCT00191282|580429505|FG000|Overall Study|Withdrawal by Subject|59|||
160739998|NCT00191282|580429506|FG001|Overall Study|Withdrawal by Subject|44|||
160739999|NCT00191282|580429505|FG000|Overall Study|Physician Decision|18|||
160740000|NCT00191282|580429506|FG001|Overall Study|Physician Decision|15|||
160740001|NCT00191282|580429505|FG000|Overall Study|Protocol entry criteria not met|14|||
160740002|NCT00191282|580429506|FG001|Overall Study|Protocol entry criteria not met|9|||
160740003|NCT00191282|580429505|FG000|Overall Study|Protocol Violation|9|||
160740004|NCT00191282|580429506|FG001|Overall Study|Protocol Violation|12|||
160740005|NCT00191282|580429505|FG000|Overall Study|Severity of outcome|2|||
160740006|NCT00191282|580429506|FG001|Overall Study|Severity of outcome|5|||
160740007|NCT00191282|580429505|FG000|Overall Study|Sponsor's decision|2|||
160740008|NCT00191282|580429506|FG001|Overall Study|Sponsor's decision|2|||
160740009|NCT00191282|580429505|FG000|Overall Study|Lost to Follow-up|24|||
160740010|NCT00191282|580429506|FG001|Overall Study|Lost to Follow-up|31|||
160740011|NCT00102531|580429507|FG000|Overall Study|Adverse Event|0|||
160740012|NCT00102531|580429508|FG001|Overall Study|Adverse Event|1|||
160740013|NCT00102531|580429507|FG000|Overall Study|Disease Progression|5|||
160740014|NCT00102531|580429508|FG001|Overall Study|Disease Progression|9|||
160740015|NCT00102531|580429507|FG000|Overall Study|Physician Decision|0|||
160740016|NCT00102531|580429508|FG001|Overall Study|Physician Decision|1|||
160740017|NCT04756154|580429509|FG000|Overall Study|Did not meet treatment day baseline|30|||
160740018|NCT04756154|580429510|FG001|Overall Study|Did not meet treatment day baseline|28|||
160740019|NCT04756154|580429511|FG002|Overall Study|Did not meet treatment day baseline|7|||
160740020|NCT04756154|580429509|FG000|Overall Study|Did not return for final sample collection|1|||
160740021|NCT04756154|580429510|FG001|Overall Study|Did not return for final sample collection|1|||
160740022|NCT04756154|580429511|FG002|Overall Study|Did not return for final sample collection|0|||
160740023|NCT01790828|580429512|FG000|Overall Study|Other|34|||
160740024|NCT02089334|580429514|FG000|Overall Study|Withdrawal by Subject|0|||
160740025|NCT02089334|580429515|FG001|Overall Study|Withdrawal by Subject|0|||
160740026|NCT02089334|580429516|FG002|Overall Study|Withdrawal by Subject|0|||
160740027|NCT02089334|580429517|FG003|Overall Study|Withdrawal by Subject|2|||
160740028|NCT02089334|580429514|FG000|Overall Study|Adverse Event|0|||
160740029|NCT02089334|580429515|FG001|Overall Study|Adverse Event|0|||
160740030|NCT02089334|580429516|FG002|Overall Study|Adverse Event|0|||
160740031|NCT02089334|580429517|FG003|Overall Study|Adverse Event|2|||
160740032|NCT02089334|580429514|FG000|Overall Study|Progressive disease|0|||
160740033|NCT02089334|580429515|FG001|Overall Study|Progressive disease|0|||
160740034|NCT02089334|580429516|FG002|Overall Study|Progressive disease|0|||
160740035|NCT02089334|580429517|FG003|Overall Study|Progressive disease|2|||
160740036|NCT02089334|580429514|FG000|Overall Study|Physician Decision|0|||
160740037|NCT02089334|580429515|FG001|Overall Study|Physician Decision|0|||
160740038|NCT02089334|580429516|FG002|Overall Study|Physician Decision|1|||
160740039|NCT02089334|580429517|FG003|Overall Study|Physician Decision|1|||
160740040|NCT00954512|580429525|FG000|Overall Study|Withdrawal by Subject|0|||
160740041|NCT00954512|580429526|FG001|Overall Study|Withdrawal by Subject|0|||
160740042|NCT00954512|580429527|FG002|Overall Study|Withdrawal by Subject|0|||
160740043|NCT00954512|580429528|FG003|Overall Study|Withdrawal by Subject|0|||
160740044|NCT00954512|580429529|FG004|Overall Study|Withdrawal by Subject|0|||
160740045|NCT00954512|580429530|FG005|Overall Study|Withdrawal by Subject|1|||
160740046|NCT00954512|580429525|FG000|Overall Study|Adverse Event|0|||
160740047|NCT00954512|580429526|FG001|Overall Study|Adverse Event|0|||
160740048|NCT00954512|580429527|FG002|Overall Study|Adverse Event|0|||
160740049|NCT00954512|580429528|FG003|Overall Study|Adverse Event|0|||
160740050|NCT00954512|580429529|FG004|Overall Study|Adverse Event|1|||
160740051|NCT00954512|580429530|FG005|Overall Study|Adverse Event|2|||
160740052|NCT00954512|580429525|FG000|Overall Study|Physician Decision|0|||
160740053|NCT00954512|580429526|FG001|Overall Study|Physician Decision|1|||
160740054|NCT00954512|580429527|FG002|Overall Study|Physician Decision|0|||
160740055|NCT00954512|580429528|FG003|Overall Study|Physician Decision|1|||
160740056|NCT00954512|580429529|FG004|Overall Study|Physician Decision|0|||
160740057|NCT00954512|580429530|FG005|Overall Study|Physician Decision|0|||
160740058|NCT00954512|580429525|FG000|Overall Study|Symptomatic Deterioration|0|||
160740059|NCT00954512|580429526|FG001|Overall Study|Symptomatic Deterioration|1|||
160740060|NCT00954512|580429527|FG002|Overall Study|Symptomatic Deterioration|0|||
160740061|NCT00954512|580429528|FG003|Overall Study|Symptomatic Deterioration|0|||
160740062|NCT00954512|580429529|FG004|Overall Study|Symptomatic Deterioration|2|||
160740063|NCT00954512|580429530|FG005|Overall Study|Symptomatic Deterioration|0|||
160740064|NCT00954512|580429525|FG000|Overall Study|Progression of Disease|2|||
160740065|NCT00954512|580429526|FG001|Overall Study|Progression of Disease|1|||
160740066|NCT00954512|580429527|FG002|Overall Study|Progression of Disease|0|||
160740067|NCT00954512|580429528|FG003|Overall Study|Progression of Disease|1|||
160740068|NCT00954512|580429529|FG004|Overall Study|Progression of Disease|1|||
160740069|NCT00954512|580429530|FG005|Overall Study|Progression of Disease|1|||
160740070|NCT04814368|580429531|FG000|Overall Study|Study Terminated by Sponsor|0|||
160740071|NCT04814368|580429532|FG001|Overall Study|Study Terminated by Sponsor|3|||
160740072|NCT04814368|580429533|FG002|Overall Study|Study Terminated by Sponsor|0|||
160740073|NCT04814368|580429534|FG003|Overall Study|Study Terminated by Sponsor|2|||
160740074|NCT04814368|580429531|FG000|Overall Study|Subject Decision|1|||
160740075|NCT04814368|580429532|FG001|Overall Study|Subject Decision|2|||
160740076|NCT04814368|580429533|FG002|Overall Study|Subject Decision|0|||
160740077|NCT04814368|580429534|FG003|Overall Study|Subject Decision|0|||
160740078|NCT04216589|580429536|FG000|Overall Study|Withdrawal by Subject|2|||
160740079|NCT04216589|580429536|FG000|Overall Study|Protocol Violation|1|||
160740080|NCT04216589|580429536|FG000|Overall Study|Incarceration|1|||
160740081|NCT00908596|580432042|FG000|Overall Study|Other reasons|46|||
160740082|NCT00908596|580432043|FG001|Overall Study|Other reasons|6|||
160740083|NCT00908596|580432044|FG002|Overall Study|Other reasons|2|||
160740084|NCT00908596|580432045|FG003|Overall Study|Other reasons|0|||
160740085|NCT00908596|580432042|FG000|Overall Study|Lost to Follow-up|0|||
160740086|NCT00908596|580432043|FG001|Overall Study|Lost to Follow-up|1|||
160740087|NCT00908596|580432044|FG002|Overall Study|Lost to Follow-up|12|||
160740088|NCT00908596|580432045|FG003|Overall Study|Lost to Follow-up|4|||
160740089|NCT00908596|580432042|FG000|Overall Study|Death|0|||
160740090|NCT00908596|580432043|FG001|Overall Study|Death|5|||
160740091|NCT00908596|580432044|FG002|Overall Study|Death|57|||
160740092|NCT00908596|580432045|FG003|Overall Study|Death|32|||
160740093|NCT00908596|580432042|FG000|Overall Study|Protocol Violation|1|||
160740094|NCT00908596|580432043|FG001|Overall Study|Protocol Violation|0|||
160740095|NCT00908596|580432044|FG002|Overall Study|Protocol Violation|0|||
160740096|NCT00908596|580432045|FG003|Overall Study|Protocol Violation|0|||
160740097|NCT00908596|580432042|FG000|Overall Study|Withdrawal by Subject|0|||
160740098|NCT00908596|580432043|FG001|Overall Study|Withdrawal by Subject|1|||
160740099|NCT00908596|580432044|FG002|Overall Study|Withdrawal by Subject|3|||
160740100|NCT00908596|580432045|FG003|Overall Study|Withdrawal by Subject|1|||
160740101|NCT00224406|580432046|FG000|Overall Study|Re-transplant|0|||
160740102|NCT00224406|580432047|FG001|Overall Study|Re-transplant|2|||
160740103|NCT00224406|580432046|FG000|Overall Study|Death|0|||
160740104|NCT00224406|580432047|FG001|Overall Study|Death|1|||
160740105|NCT00224406|580432046|FG000|Overall Study|Transplant cancelled|0|||
160740106|NCT00224406|580432047|FG001|Overall Study|Transplant cancelled|4|||
160740107|NCT00224406|580432046|FG000|Overall Study|Drug not delivered|2|||
160740108|NCT00224406|580432047|FG001|Overall Study|Drug not delivered|0|||
160740109|NCT00224406|580432046|FG000|Overall Study|Other|4|||
160740110|NCT00224406|580432047|FG001|Overall Study|Other|0|||
160740111|NCT00224406|580432046|FG000|Overall Study|Transplant cancelled|3|||
160740112|NCT00224406|580432047|FG001|Overall Study|Transplant cancelled|0|||
160740113|NCT01556997|580432050|FG000|Overall Study|Adverse Event|10|||
160740114|NCT01556997|580432051|FG001|Overall Study|Adverse Event|12|||
160740115|NCT01556997|580432052|FG002|Overall Study|Adverse Event|12|||
160740116|NCT01556997|580432050|FG000|Overall Study|Lost to Follow-up|6|||
160740117|NCT01556997|580432051|FG001|Overall Study|Lost to Follow-up|6|||
160740118|NCT01556997|580432052|FG002|Overall Study|Lost to Follow-up|4|||
160740119|NCT01556997|580432050|FG000|Overall Study|Physician Decision|1|||
160740120|NCT01556997|580432051|FG001|Overall Study|Physician Decision|1|||
160740121|NCT01556997|580432052|FG002|Overall Study|Physician Decision|1|||
160740122|NCT01556997|580432050|FG000|Overall Study|Withdrawal by Subject|7|||
160740123|NCT01556997|580432051|FG001|Overall Study|Withdrawal by Subject|6|||
160740124|NCT01556997|580432052|FG002|Overall Study|Withdrawal by Subject|8|||
160740125|NCT01556997|580432050|FG000|Overall Study|Other|2|||
160740126|NCT01556997|580432051|FG001|Overall Study|Other|3|||
160740127|NCT01556997|580432052|FG002|Overall Study|Other|7|||
160740128|NCT05459558|580432056|FG000|Overall Study|Adverse Event|1|||
160740129|NCT05459558|580432057|FG001|Overall Study|Adverse Event|0|||
160740130|NCT05459558|580432058|FG002|Overall Study|Adverse Event|0|||
160740131|NCT05459558|580432056|FG000|Overall Study|Scheduling issue|0|||
160740132|NCT05459558|580432057|FG001|Overall Study|Scheduling issue|1|||
160740133|NCT05459558|580432058|FG002|Overall Study|Scheduling issue|3|||
160740134|NCT05459558|580432056|FG000|Overall Study|Withdrawal by Subject|0|||
160740135|NCT05459558|580432057|FG001|Overall Study|Withdrawal by Subject|0|||
160740136|NCT05459558|580432058|FG002|Overall Study|Withdrawal by Subject|2|||
160740137|NCT01250171|580432065|FG000|Overall Study|Administrative reasons|1|||
160740138|NCT01250171|580432066|FG001|Overall Study|Administrative reasons|0|||
160740139|NCT01250171|580432067|FG002|Overall Study|Administrative reasons|0|||
160740140|NCT04676412|580432068|FG000|Overall Study|Death|28|||
160740141|NCT04676412|580432069|FG001|Overall Study|Death|31|||
160740142|NCT04676412|580432068|FG000|Overall Study|Lost to Follow-up|1|||
160740143|NCT04676412|580432069|FG001|Overall Study|Lost to Follow-up|2|||
160740144|NCT04676412|580432068|FG000|Overall Study|Sponsor Decision|20|||
160740145|NCT04676412|580432069|FG001|Overall Study|Sponsor Decision|23|||
160740146|NCT04676412|580432068|FG000|Overall Study|Withdrawal by Subject|0|||
160740147|NCT04676412|580432069|FG001|Overall Study|Withdrawal by Subject|2|||
160740148|NCT04550832|580432070|FG000|Overall Study|Adverse Event|0|||
160740149|NCT04550832|580432071|FG001|Overall Study|Adverse Event|0|||
160740150|NCT04550832|580432072|FG002|Overall Study|Adverse Event|2|||
160740151|NCT04550832|580432073|FG003|Overall Study|Adverse Event|0|||
160740152|NCT04550832|580432074|FG004|Overall Study|Adverse Event|1|||
160740153|NCT04823130|580432075|FG000|Overall Study|Withdrawal by Subject|2|||
160740154|NCT04823130|580432076|FG001|Overall Study|Withdrawal by Subject|3|||
160740155|NCT04823130|580432075|FG000|Overall Study|Failure to meet inclusion criteria|6|||
160740156|NCT04823130|580432076|FG001|Overall Study|Failure to meet inclusion criteria|4|||
160740157|NCT04823130|580432075|FG000|Overall Study|Other-unspecified|1|||
160740158|NCT04823130|580432076|FG001|Overall Study|Other-unspecified|0|||
160740159|NCT02304380|580432082|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
160740160|NCT02304380|580432083|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
160740161|NCT02304380|580432084|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
160740162|NCT02304380|580432085|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
160740163|NCT02304380|580432086|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
160740164|NCT02304380|580432087|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
160740165|NCT01027897|580432088|FG000|Overall Study|Protocol Violation|1|||
160740166|NCT01027897|580432088|FG000|Overall Study|Withdrawal by Subject|1|||
160740167|NCT00328094|580432089|FG000|Overall Study|Physician Decision|3|||
160740168|NCT00328094|580432090|FG001|Overall Study|Physician Decision|3|||
160740169|NCT00473824|580432091|FG000|Overall Study|Virologic Breakthrough|1|||
160740170|NCT00473824|580432092|FG001|Overall Study|Virologic Breakthrough|0|||
160740171|NCT00473824|580432091|FG000|Overall Study|Adverse Event|1|||
160740172|NCT00473824|580432092|FG001|Overall Study|Adverse Event|0|||
160740173|NCT00473824|580432091|FG000|Overall Study|Death|1|||
160740174|NCT00473824|580432092|FG001|Overall Study|Death|0|||
160740175|NCT00473824|580432091|FG000|Overall Study|Lost to Follow-up|1|||
160740176|NCT00473824|580432092|FG001|Overall Study|Lost to Follow-up|0|||
160740177|NCT00473824|580432091|FG000|Overall Study|Withdrawal by physician|1|||
160740178|NCT00473824|580432092|FG001|Overall Study|Withdrawal by physician|0|||
160740179|NCT01349322|580432093|FG000|Overall Study|Protocol Violation|45|||
160740180|NCT01349322|580432094|FG001|Overall Study|Protocol Violation|47|||
160740181|NCT02453282|580432095|FG000|Overall Study|Death|275|||
160740182|NCT02453282|580432096|FG001|Overall Study|Death|277|||
160740183|NCT02453282|580432097|FG002|Overall Study|Death|296|||
160740184|NCT02453282|580432095|FG000|Overall Study|Lost to Follow-up|1|||
160740185|NCT02453282|580432096|FG001|Overall Study|Lost to Follow-up|0|||
160740186|NCT02453282|580432097|FG002|Overall Study|Lost to Follow-up|2|||
160740187|NCT02453282|580432095|FG000|Overall Study|Withdrawal by Subject|12|||
160740188|NCT02453282|580432096|FG001|Overall Study|Withdrawal by Subject|10|||
160740189|NCT02453282|580432097|FG002|Overall Study|Withdrawal by Subject|11|||
160740190|NCT02453282|580432095|FG000|Overall Study|Participants ongoing at data cut-off|85|||
160740191|NCT02453282|580432096|FG001|Overall Study|Participants ongoing at data cut-off|84|||
160740192|NCT02453282|580432097|FG002|Overall Study|Participants ongoing at data cut-off|62|||
160740193|NCT02453282|580432095|FG000|Overall Study|Other|1|||
160740194|NCT02453282|580432096|FG001|Overall Study|Other|1|||
160740195|NCT02453282|580432097|FG002|Overall Study|Other|1|||
160740196|NCT01143064|580432098|FG000|Overall Study|Death|109|||
160740197|NCT01143064|580432099|FG001|Overall Study|Death|91|||
160740198|NCT01143064|580432098|FG000|Overall Study|Adverse Event|0|||
160740199|NCT01143064|580432099|FG001|Overall Study|Adverse Event|1|||
160740200|NCT01143064|580432098|FG000|Overall Study|Withdrawal by Subject|7|||
160740201|NCT01143064|580432099|FG001|Overall Study|Withdrawal by Subject|5|||
160740202|NCT01143064|580432098|FG000|Overall Study|Lost to Follow-up|17|||
160740203|NCT01143064|580432099|FG001|Overall Study|Lost to Follow-up|14|||
160740204|NCT01143064|580432098|FG000|Overall Study|Physician Decision|0|||
160740205|NCT01143064|580432099|FG001|Overall Study|Physician Decision|4|||
160740206|NCT00985426|580432100|FG000|Overall Study|Adverse Event|0|||
160740207|NCT00985426|580432101|FG001|Overall Study|Adverse Event|1|||
160740208|NCT00985426|580432100|FG000|Overall Study|Subject Non-Compliance|3|||
160740209|NCT00985426|580432101|FG001|Overall Study|Subject Non-Compliance|3|||
160740210|NCT00985426|580432100|FG000|Overall Study|Withdrawal by Subject|12|||
160740211|NCT00985426|580432101|FG001|Overall Study|Withdrawal by Subject|16|||
160740212|NCT00985426|580432100|FG000|Overall Study|Lost to Follow-up|8|||
160740213|NCT00985426|580432101|FG001|Overall Study|Lost to Follow-up|10|||
160740214|NCT00985426|580432100|FG000|Overall Study|Death|7|||
160740215|NCT00985426|580432101|FG001|Overall Study|Death|3|||
160740216|NCT00985426|580432100|FG000|Overall Study|Protocol Violation|2|||
160740217|NCT00985426|580432101|FG001|Overall Study|Protocol Violation|0|||
160740218|NCT00985426|580432100|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
160740219|NCT00985426|580432101|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
160740220|NCT02327013|580432104|FG000|Overall Study|Adverse Event|4|||
160740221|NCT02327013|580432105|FG001|Overall Study|Adverse Event|4|||
160740222|NCT02327013|580432106|FG002|Overall Study|Adverse Event|3|||
160740223|NCT02327013|580432107|FG003|Overall Study|Adverse Event|0|||
160740224|NCT02327013|580432108|FG004|Overall Study|Adverse Event|1|||
160740225|NCT02327013|580432104|FG000|Overall Study|Lack of Efficacy|2|||
160740226|NCT02327013|580432105|FG001|Overall Study|Lack of Efficacy|0|||
160740227|NCT02327013|580432106|FG002|Overall Study|Lack of Efficacy|5|||
160740228|NCT02327013|580432107|FG003|Overall Study|Lack of Efficacy|0|||
160740229|NCT02327013|580432108|FG004|Overall Study|Lack of Efficacy|1|||
160740230|NCT02327013|580432104|FG000|Overall Study|Non-compliance with IMP|1|||
160740231|NCT02327013|580432105|FG001|Overall Study|Non-compliance with IMP|2|||
160740232|NCT02327013|580432106|FG002|Overall Study|Non-compliance with IMP|7|||
160740233|NCT02327013|580432107|FG003|Overall Study|Non-compliance with IMP|0|||
160740234|NCT02327013|580432108|FG004|Overall Study|Non-compliance with IMP|0|||
160740235|NCT02327013|580432104|FG000|Overall Study|Withdrawal of Consent|1|||
160740236|NCT02327013|580432105|FG001|Overall Study|Withdrawal of Consent|0|||
160740237|NCT02327013|580432106|FG002|Overall Study|Withdrawal of Consent|3|||
160740238|NCT02327013|580432107|FG003|Overall Study|Withdrawal of Consent|0|||
160740239|NCT02327013|580432108|FG004|Overall Study|Withdrawal of Consent|0|||
160740240|NCT02327013|580432104|FG000|Overall Study|Lost to Follow-up|2|||
160740241|NCT02327013|580432105|FG001|Overall Study|Lost to Follow-up|4|||
160740242|NCT02327013|580432106|FG002|Overall Study|Lost to Follow-up|5|||
160740243|NCT02327013|580432107|FG003|Overall Study|Lost to Follow-up|0|||
160740244|NCT02327013|580432108|FG004|Overall Study|Lost to Follow-up|0|||
160740245|NCT02327013|580432104|FG000|Overall Study|Administrative or other reason(s)|1|||
160740246|NCT02327013|580432105|FG001|Overall Study|Administrative or other reason(s)|5|||
160740247|NCT02327013|580432106|FG002|Overall Study|Administrative or other reason(s)|11|||
160740248|NCT02327013|580432107|FG003|Overall Study|Administrative or other reason(s)|1|||
160740249|NCT02327013|580432108|FG004|Overall Study|Administrative or other reason(s)|1|||
160740250|NCT02327013|580432104|FG000|Overall Study|Protocol Violation|0|||
160740251|NCT02327013|580432105|FG001|Overall Study|Protocol Violation|0|||
160740252|NCT02327013|580432106|FG002|Overall Study|Protocol Violation|3|||
160740253|NCT02327013|580432107|FG003|Overall Study|Protocol Violation|0|||
160740254|NCT02327013|580432108|FG004|Overall Study|Protocol Violation|1|||
160740255|NCT02327013|580432104|FG000|Overall Study|Withdrawal before treatment|2|||
160740256|NCT02327013|580432105|FG001|Overall Study|Withdrawal before treatment|1|||
160740257|NCT02327013|580432106|FG002|Overall Study|Withdrawal before treatment|5|||
160740258|NCT02327013|580432107|FG003|Overall Study|Withdrawal before treatment|0|||
160740259|NCT02327013|580432108|FG004|Overall Study|Withdrawal before treatment|0|||
160740260|NCT02380859|580432109|FG000|Overall Study|Withdrawal by Subject|2|||
160740261|NCT02380859|580432110|FG001|Overall Study|Withdrawal by Subject|0|||
160740262|NCT01661933|580432111|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
160740263|NCT01661933|580432111|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
160740264|NCT03385304|580432112|FG000|Overall Study|Death|19|||
160740265|NCT03385304|580432113|FG001|Overall Study|Death|7|||
160740266|NCT03385304|580432112|FG000|Overall Study|Lost to Follow-up|17|||
160740267|NCT03385304|580432113|FG001|Overall Study|Lost to Follow-up|14|||
160740268|NCT03385304|580432112|FG000|Overall Study|Withdrawal by Subject|3|||
160740269|NCT03385304|580432113|FG001|Overall Study|Withdrawal by Subject|2|||
160740270|NCT03385304|580432112|FG000|Overall Study|Incarceration|2|||
160740271|NCT03385304|580432113|FG001|Overall Study|Incarceration|3|||
160740272|NCT04258254|580432114|FG000|Overall Study|Withdrawal by Subject|0|||
160740273|NCT04258254|580432115|FG001|Overall Study|Withdrawal by Subject|1|||
160740274|NCT04258254|580432116|FG002|Overall Study|Withdrawal by Subject|0|||
160740275|NCT01120249|580432117|FG000|Overall Study|No protocol treatment received|21|||
160740276|NCT01120249|580432118|FG001|Overall Study|No protocol treatment received|15|||
160740277|NCT01120249|580432117|FG000|Overall Study|Disease recurrence|107|||
160740278|NCT01120249|580432118|FG001|Overall Study|Disease recurrence|57|||
160740279|NCT01120249|580432117|FG000|Overall Study|Death|1|||
160740280|NCT01120249|580432118|FG001|Overall Study|Death|0|||
160740281|NCT01120249|580432117|FG000|Overall Study|Adverse Event|40|||
160740282|NCT01120249|580432118|FG001|Overall Study|Adverse Event|276|||
160740283|NCT01120249|580432117|FG000|Overall Study|Participant refusal|34|||
160740284|NCT01120249|580432118|FG001|Overall Study|Participant refusal|42|||
160740285|NCT01120249|580432117|FG000|Overall Study|Other reasons, not protocol specified|29|||
160740286|NCT01120249|580432118|FG001|Overall Study|Other reasons, not protocol specified|22|||
160740287|NCT00723190|580432123|FG000|Overall Study|Withdrawal by Subject|45|||
160740288|NCT00723190|580432123|FG000|Overall Study|Lost to Follow-up|37|||
160740289|NCT00723190|580432123|FG000|Overall Study|Adverse Event|18|||
160740290|NCT00723190|580432123|FG000|Overall Study|Lack of Efficacy|16|||
160740291|NCT00723190|580432123|FG000|Overall Study|Protocol Violation|15|||
160740292|NCT00723190|580432123|FG000|Overall Study|Other-Premature Discontinuation|9|||
160740293|NCT00723190|580432123|FG000|Overall Study|Other-Not included in safety population|2|||
160740294|NCT04472026|580432127|FG000|Overall Study|Lost to Follow-up|5|||
160740295|NCT01404208|580432128|FG000|Overall Study|Discontinued|3|||
160740296|NCT01404208|580432129|FG001|Overall Study|Discontinued|0|||
160740297|NCT00772005|580432136|FG000|Overall Study|Adverse Event|9|||
160740298|NCT00772005|580432137|FG001|Overall Study|Adverse Event|14|||
160740299|NCT00772005|580432138|FG002|Overall Study|Adverse Event|10|||
160740300|NCT00772005|580432139|FG003|Overall Study|Adverse Event|13|||
160740301|NCT00772005|580432136|FG000|Overall Study|Lack of Efficacy|0|||
160740302|NCT00772005|580432137|FG001|Overall Study|Lack of Efficacy|1|||
160740303|NCT00772005|580432138|FG002|Overall Study|Lack of Efficacy|0|||
160740304|NCT00772005|580432139|FG003|Overall Study|Lack of Efficacy|0|||
160740305|NCT00772005|580432136|FG000|Overall Study|Withdrawal by Subject|3|||
160740306|NCT00772005|580432137|FG001|Overall Study|Withdrawal by Subject|7|||
160740307|NCT00772005|580432138|FG002|Overall Study|Withdrawal by Subject|10|||
160740308|NCT00772005|580432139|FG003|Overall Study|Withdrawal by Subject|2|||
160740309|NCT00772005|580432136|FG000|Overall Study|Protocol Violation|2|||
160740310|NCT00772005|580432137|FG001|Overall Study|Protocol Violation|4|||
160740311|NCT00772005|580432138|FG002|Overall Study|Protocol Violation|1|||
160740312|NCT00772005|580432139|FG003|Overall Study|Protocol Violation|6|||
160740313|NCT00772005|580432136|FG000|Overall Study|Lost to Follow-up|7|||
160740314|NCT00772005|580432137|FG001|Overall Study|Lost to Follow-up|3|||
160740315|NCT00772005|580432138|FG002|Overall Study|Lost to Follow-up|6|||
160740316|NCT00772005|580432139|FG003|Overall Study|Lost to Follow-up|3|||
160740317|NCT00772005|580432136|FG000|Overall Study|Non-compliance with study procedures|1|||
160740318|NCT00772005|580432137|FG001|Overall Study|Non-compliance with study procedures|1|||
160740319|NCT00772005|580432138|FG002|Overall Study|Non-compliance with study procedures|0|||
160740320|NCT00772005|580432139|FG003|Overall Study|Non-compliance with study procedures|1|||
160740321|NCT00772005|580432136|FG000|Overall Study|Non-compliance with drug administration|3|||
160740322|NCT00772005|580432137|FG001|Overall Study|Non-compliance with drug administration|0|||
160740323|NCT00772005|580432138|FG002|Overall Study|Non-compliance with drug administration|1|||
160740324|NCT00772005|580432139|FG003|Overall Study|Non-compliance with drug administration|1|||
160740325|NCT01273155|580432143|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
160740326|NCT01273155|580432144|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
160740327|NCT01273155|580432145|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
160740328|NCT01273155|580432146|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
160740329|NCT01273155|580432147|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
160740330|NCT01273155|580432148|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
160740331|NCT01273155|580432149|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
160740332|NCT01273155|580432143|FG000|Overall Study|Change in liver function/no longer eval.|0|||
160740333|NCT01273155|580432144|FG001|Overall Study|Change in liver function/no longer eval.|1|||
160740334|NCT01273155|580432145|FG002|Overall Study|Change in liver function/no longer eval.|0|||
160740335|NCT01273155|580432146|FG003|Overall Study|Change in liver function/no longer eval.|0|||
160740336|NCT01273155|580432147|FG004|Overall Study|Change in liver function/no longer eval.|1|||
160740337|NCT01273155|580432148|FG005|Overall Study|Change in liver function/no longer eval.|0|||
160740338|NCT01273155|580432149|FG006|Overall Study|Change in liver function/no longer eval.|0|||
160740339|NCT01273155|580432143|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
160740340|NCT01273155|580432144|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
160740341|NCT01273155|580432145|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
160740342|NCT01273155|580432146|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
160740343|NCT01273155|580432147|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
160740344|NCT01273155|580432148|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
160740345|NCT01273155|580432149|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
160740346|NCT01273155|580432143|FG000|Overall Study|Died during Cycle 1|0|||
160740347|NCT01273155|580432144|FG001|Overall Study|Died during Cycle 1|0|||
160740348|NCT01273155|580432145|FG002|Overall Study|Died during Cycle 1|1|||
160740349|NCT01273155|580432146|FG003|Overall Study|Died during Cycle 1|1|||
160740350|NCT01273155|580432147|FG004|Overall Study|Died during Cycle 1|0|||
160740351|NCT01273155|580432148|FG005|Overall Study|Died during Cycle 1|2|||
160740352|NCT01273155|580432149|FG006|Overall Study|Died during Cycle 1|2|||
160740353|NCT01273155|580432143|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
160740354|NCT01273155|580432144|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
160740355|NCT01273155|580432145|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
160740356|NCT01273155|580432146|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
160740357|NCT01273155|580432147|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
160740358|NCT01273155|580432148|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
160740359|NCT01273155|580432149|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
160740360|NCT01440569|580432150|FG000|Main Study|Enrolled but not treated|1|||
160740361|NCT01440569|580432151|FG001|Main Study|Enrolled but not treated|0|||
160740362|NCT01440569|580432150|FG000|Main Study|Adverse Event|9|||
160740363|NCT01440569|580432151|FG001|Main Study|Adverse Event|0|||
160740364|NCT01440569|580432150|FG000|Main Study|Pregnancy|1|||
160740365|NCT01440569|580432151|FG001|Main Study|Pregnancy|0|||
160740366|NCT01440569|580432150|FG000|Main Study|Investigator's Discretion|1|||
160740367|NCT01440569|580432151|FG001|Main Study|Investigator's Discretion|1|||
160740368|NCT01440569|580432150|FG000|Main Study|Withdrew Consent|7|||
160740369|NCT01440569|580432151|FG001|Main Study|Withdrew Consent|1|||
160740370|NCT01440569|580432150|FG000|Main Study|Lost to Follow-up|13|||
160740371|NCT01440569|580432151|FG001|Main Study|Lost to Follow-up|2|||
160740372|NCT01440569|580432150|FG000|Main Study|Subject Non-Compliance|3|||
160740373|NCT01440569|580432151|FG001|Main Study|Subject Non-Compliance|0|||
160740374|NCT01440569|580432150|FG000|Main Study|Protocol Violation|1|||
160740375|NCT01440569|580432151|FG001|Main Study|Protocol Violation|0|||
160740376|NCT01440569|580432150|FG000|Open-Label Rollover Phase|Adverse Event|3|||
160740377|NCT01440569|580432151|FG001|Open-Label Rollover Phase|Adverse Event|0|||
160740378|NCT01440569|580432150|FG000|Open-Label Rollover Phase|Pregnancy|1|||
160740379|NCT01440569|580432151|FG001|Open-Label Rollover Phase|Pregnancy|0|||
160740380|NCT01440569|580432150|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
160740381|NCT01440569|580432151|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
160740382|NCT01440569|580432150|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
160740383|NCT01440569|580432151|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
160740384|NCT01440569|580432150|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
160740385|NCT01440569|580432151|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
160740386|NCT01440569|580432150|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
160740387|NCT01440569|580432151|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
160740388|NCT01440569|580432150|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
160740389|NCT01440569|580432151|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
160740390|NCT01438814|580432153|FG000|Overall Study|Adverse Event|3|||
160740391|NCT01438814|580432154|FG001|Overall Study|Adverse Event|3|||
160740392|NCT01438814|580432153|FG000|Overall Study|Protocol Violation|1|||
160740393|NCT01438814|580432154|FG001|Overall Study|Protocol Violation|2|||
160740394|NCT01438814|580432153|FG000|Overall Study|Lost to Follow-up|4|||
160740395|NCT01438814|580432154|FG001|Overall Study|Lost to Follow-up|3|||
160740396|NCT01438814|580432153|FG000|Overall Study|Withdrawal by Subject|4|||
160740397|NCT01438814|580432154|FG001|Overall Study|Withdrawal by Subject|2|||
160740398|NCT01438814|580432153|FG000|Overall Study|Other|2|||
160740399|NCT01438814|580432154|FG001|Overall Study|Other|4|||
160740400|NCT03887117|580432162|FG000|Overall Study|Discontinued prematurely|0|||
160740401|NCT03887117|580432163|FG001|Overall Study|Discontinued prematurely|1|||
160740402|NCT03887117|580432164|FG002|Overall Study|Discontinued prematurely|1|||
160740403|NCT03887117|580432165|FG003|Overall Study|Discontinued prematurely|2|||
160740404|NCT02584959|580432166|FG000|Period 1|Withdrawn from study|3|||
160740405|NCT02584959|580432167|FG001|Period 1|Withdrawn from study|4|||
160740406|NCT02584959|580432168|FG002|Period 1|Withdrawn from study|0|||
160740407|NCT02584959|580432166|FG000|Period 2|Withdrawn from study|6|||
160740408|NCT02584959|580432167|FG001|Period 2|Withdrawn from study|1|||
160740409|NCT02584959|580432168|FG002|Period 2|Withdrawn from study|2|||
160740410|NCT04908475|580432169|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
160740411|NCT04908475|580432170|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160740412|NCT04908475|580432171|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160740413|NCT04908475|580432172|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160740414|NCT04908475|580432173|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160740415|NCT04908475|580432174|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160740416|NCT04908475|580432169|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
160740417|NCT04908475|580432170|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
160740418|NCT04908475|580432171|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
160740419|NCT04908475|580432172|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
160740420|NCT04908475|580432173|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
160740421|NCT04908475|580432174|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
160740422|NCT04908475|580432169|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
160740423|NCT04908475|580432170|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
160740424|NCT04908475|580432171|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
160740425|NCT04908475|580432172|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
160740426|NCT04908475|580432173|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
160740427|NCT04908475|580432174|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
160740428|NCT04908475|580432169|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
160740429|NCT04908475|580432170|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
160740430|NCT04908475|580432171|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
160740431|NCT04908475|580432172|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
160740432|NCT04908475|580432173|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
160740433|NCT04908475|580432174|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
160740434|NCT04908475|580432169|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
160740435|NCT04908475|580432170|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
160740436|NCT04908475|580432171|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
160740437|NCT04908475|580432172|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
160740438|NCT04908475|580432173|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
160740439|NCT04908475|580432174|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
160740440|NCT04908475|580432169|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
160740441|NCT04908475|580432170|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
160740442|NCT04908475|580432171|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
160740443|NCT04908475|580432172|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
160740444|NCT04908475|580432173|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
160740445|NCT04908475|580432174|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
160740446|NCT01739764|580432175|FG000|Overall Study|Adverse Event|0|||
160740447|NCT01739764|580432176|FG001|Overall Study|Adverse Event|3|||
160740448|NCT01739764|580432177|FG002|Overall Study|Adverse Event|4|||
160740449|NCT01739764|580432175|FG000|Overall Study|Death|4|||
160740450|NCT01739764|580432176|FG001|Overall Study|Death|6|||
160740451|NCT01739764|580432177|FG002|Overall Study|Death|38|||
160740452|NCT01739764|580432175|FG000|Overall Study|Lost to Follow-up|0|||
160740453|NCT01739764|580432176|FG001|Overall Study|Lost to Follow-up|0|||
160740454|NCT01739764|580432177|FG002|Overall Study|Lost to Follow-up|5|||
160740455|NCT01739764|580432175|FG000|Overall Study|Non-Compliance|0|||
160740456|NCT01739764|580432176|FG001|Overall Study|Non-Compliance|0|||
160740457|NCT01739764|580432177|FG002|Overall Study|Non-Compliance|1|||
160740458|NCT01739764|580432175|FG000|Overall Study|Multiple Reasons|3|||
160740459|NCT01739764|580432176|FG001|Overall Study|Multiple Reasons|2|||
160740460|NCT01739764|580432177|FG002|Overall Study|Multiple Reasons|3|||
160740461|NCT01739764|580432175|FG000|Overall Study|Physician Decision|2|||
160740462|NCT01739764|580432176|FG001|Overall Study|Physician Decision|2|||
160740463|NCT01739764|580432177|FG002|Overall Study|Physician Decision|4|||
160740464|NCT01739764|580432175|FG000|Overall Study|Progressive Disease|3|||
160740465|NCT01739764|580432176|FG001|Overall Study|Progressive Disease|5|||
160740466|NCT01739764|580432177|FG002|Overall Study|Progressive Disease|16|||
160740467|NCT01739764|580432175|FG000|Overall Study|Protocol Violation|0|||
160740468|NCT01739764|580432176|FG001|Overall Study|Protocol Violation|0|||
160740469|NCT01739764|580432177|FG002|Overall Study|Protocol Violation|2|||
160740470|NCT01739764|580432175|FG000|Overall Study|Study Terminated by Sponsor|8|||
160740471|NCT01739764|580432176|FG001|Overall Study|Study Terminated by Sponsor|13|||
160740472|NCT01739764|580432177|FG002|Overall Study|Study Terminated by Sponsor|26|||
160740473|NCT01739764|580432175|FG000|Overall Study|Withdrawal by Subject|6|||
160740474|NCT01739764|580432176|FG001|Overall Study|Withdrawal by Subject|5|||
160740475|NCT01739764|580432177|FG002|Overall Study|Withdrawal by Subject|27|||
160740476|NCT00404924|580432178|FG000|Overall Study|Adverse Event|75|||
160740477|NCT00404924|580432179|FG001|Overall Study|Adverse Event|16|||
160740478|NCT00404924|580432178|FG000|Overall Study|Condition under investigation worsened|475|||
160740479|NCT00404924|580432179|FG001|Overall Study|Condition under investigation worsened|264|||
160740480|NCT00404924|580432178|FG000|Overall Study|Lost to Follow-up|1|||
160740481|NCT00404924|580432179|FG001|Overall Study|Lost to Follow-up|1|||
160740482|NCT00404924|580432178|FG000|Overall Study|Withdrawal by Subject|26|||
160740483|NCT00404924|580432179|FG001|Overall Study|Withdrawal by Subject|13|||
160740484|NCT00404924|580432178|FG000|Overall Study|Other|25|||
160740485|NCT00404924|580432179|FG001|Overall Study|Other|11|||
160740486|NCT00404924|580432178|FG000|Overall Study|Randomised but not received treatment|1|||
160740487|NCT00404924|580432179|FG001|Overall Study|Randomised but not received treatment|1|||
160740488|NCT00513357|580432184|FG000|Overall Study|did not receive allocated placebo|2|||
160740489|NCT00513357|580432185|FG001|Overall Study|did not receive allocated placebo|3|||
160740490|NCT00513357|580432184|FG000|Overall Study|Adverse Event|4|||
160740491|NCT00513357|580432185|FG001|Overall Study|Adverse Event|2|||
160740492|NCT00513357|580432184|FG000|Overall Study|Death|2|||
160740493|NCT00513357|580432185|FG001|Overall Study|Death|0|||
160740494|NCT00513357|580432184|FG000|Overall Study|Withdrawal by Subject|5|||
160740495|NCT00513357|580432185|FG001|Overall Study|Withdrawal by Subject|4|||
160740496|NCT00513357|580432184|FG000|Overall Study|Disease Progression|2|||
160740497|NCT00513357|580432185|FG001|Overall Study|Disease Progression|1|||
160740498|NCT00435487|580432194|FG000|Overall Study|Death|3|||
160740499|NCT00435487|580432195|FG001|Overall Study|Death|4|||
160740500|NCT00435487|580432194|FG000|Overall Study|Adverse Event|0|||
160740501|NCT00435487|580432195|FG001|Overall Study|Adverse Event|3|||
160740502|NCT00435487|580432194|FG000|Overall Study|Lost to Follow-up|2|||
160740503|NCT00435487|580432195|FG001|Overall Study|Lost to Follow-up|2|||
160740504|NCT00435487|580432194|FG000|Overall Study|Other|5|||
160740505|NCT00435487|580432195|FG001|Overall Study|Other|2|||
160740506|NCT00435487|580432194|FG000|Overall Study|Withdrawal by Subject|2|||
160740507|NCT00435487|580432195|FG001|Overall Study|Withdrawal by Subject|1|||
160740508|NCT00435487|580432194|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
160740509|NCT00435487|580432195|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
160740510|NCT00435487|580432194|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
160740511|NCT00435487|580432195|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
160740512|NCT02537431|580432205|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
160740513|NCT05238025|580432206|FG000|Overall Study|Adverse Event|2|||
160740514|NCT05238025|580432207|FG001|Overall Study|Adverse Event|2|||
160740515|NCT05238025|580432206|FG000|Overall Study|Lost to Follow-up|334|||
160740516|NCT05238025|580432207|FG001|Overall Study|Lost to Follow-up|339|||
160740517|NCT05238025|580432206|FG000|Overall Study|Withdrawal by Subject|203|||
160740518|NCT05238025|580432207|FG001|Overall Study|Withdrawal by Subject|222|||
160740519|NCT05238025|580432206|FG000|Overall Study|Physician Decision|20|||
160740520|NCT05238025|580432207|FG001|Overall Study|Physician Decision|8|||
160740521|NCT05238025|580432206|FG000|Overall Study|Protocol Violation|6|||
160740522|NCT05238025|580432207|FG001|Overall Study|Protocol Violation|2|||
160740523|NCT05238025|580432206|FG000|Overall Study|Death|38|||
160740524|NCT05238025|580432207|FG001|Overall Study|Death|32|||
160740525|NCT05238025|580432206|FG000|Overall Study|Study terminated by Sponsor|6358|||
160740526|NCT05238025|580432207|FG001|Overall Study|Study terminated by Sponsor|6358|||
160740527|NCT05238025|580432206|FG000|Overall Study|Other Reason|669|||
160740528|NCT05238025|580432207|FG001|Overall Study|Other Reason|690|||
160740529|NCT01173055|580432213|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
160740530|NCT01173055|580432214|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
160740531|NCT01173055|580432213|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
160740532|NCT01173055|580432214|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
160740533|NCT04325698|580432216|FG000|Overall Study|Study Terminated By Sponsor|1|||
160740534|NCT04325698|580432217|FG001|Overall Study|Study Terminated By Sponsor|1|||
160740535|NCT04325698|580432216|FG000|Overall Study|Withdrawal by Subject|0|||
160740536|NCT04325698|580432217|FG001|Overall Study|Withdrawal by Subject|2|||
160740537|NCT04253782|580432218|FG000|Overall Study|Death|2|||
160740538|NCT04253782|580432219|FG001|Overall Study|Death|0|||
160740539|NCT02889835|580432224|FG000|Overall Study|Lost to Follow-up|13|||
160740540|NCT02889835|580432225|FG001|Overall Study|Lost to Follow-up|13|||
160740541|NCT02889835|580432226|FG002|Overall Study|Lost to Follow-up|13|||
160740542|NCT02889835|580432224|FG000|Overall Study|Withdrawal by Subject|2|||
160740543|NCT02889835|580432225|FG001|Overall Study|Withdrawal by Subject|2|||
160740544|NCT02889835|580432226|FG002|Overall Study|Withdrawal by Subject|2|||
160740545|NCT02889835|580432224|FG000|Overall Study|Protocol Violation|1|||
160740546|NCT02889835|580432225|FG001|Overall Study|Protocol Violation|1|||
160740547|NCT02889835|580432226|FG002|Overall Study|Protocol Violation|1|||
160740548|NCT02889835|580432224|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
160740549|NCT02889835|580432225|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
160740550|NCT02889835|580432226|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
160740551|NCT02889835|580432224|FG000|Overall Study|Death|1|||
160740552|NCT02889835|580432225|FG001|Overall Study|Death|1|||
160740553|NCT02889835|580432226|FG002|Overall Study|Death|1|||
160740554|NCT01047332|580432229|FG000|Overall Study|SEMS Obstruction|11|||
160740555|NCT01047332|580432230|FG001|Overall Study|SEMS Obstruction|20|||
160740556|NCT01047332|580432229|FG000|Overall Study|Died Unobstructed|38|||
160740557|NCT01047332|580432230|FG001|Overall Study|Died Unobstructed|41|||
160740558|NCT01047332|580432229|FG000|Overall Study|Lost to Follow-up|8|||
160740559|NCT01047332|580432230|FG001|Overall Study|Lost to Follow-up|3|||
160740560|NCT03315455|580433486|FG000|Overall Study|Ongoing in the Study|13|||
160740561|NCT03315455|580433487|FG001|Overall Study|Ongoing in the Study|24|||
160740562|NCT03315455|580433488|FG002|Overall Study|Ongoing in the Study|17|||
160740563|NCT03315455|580433489|FG003|Overall Study|Ongoing in the Study|15|||
160740564|NCT03315455|580433486|FG000|Overall Study|Withdrawal by Subject|0|||
160740565|NCT03315455|580433487|FG001|Overall Study|Withdrawal by Subject|1|||
160740566|NCT03315455|580433488|FG002|Overall Study|Withdrawal by Subject|0|||
160740567|NCT03315455|580433489|FG003|Overall Study|Withdrawal by Subject|0|||
160740568|NCT01125813|580433492|FG000|Overall Study|Death|1|||
160740569|NCT01125813|580433492|FG000|Overall Study|Withdrawal by Subject|1|||
160740570|NCT01125813|580433492|FG000|Overall Study|Screen Failures|4|||
160740571|NCT01565668|580433493|FG000|Overall Study|Death|2|||
160740572|NCT01565668|580433494|FG001|Overall Study|Death|1|||
160740573|NCT01565668|580433493|FG000|Overall Study|Lack of Efficacy|4|||
160740574|NCT01565668|580433494|FG001|Overall Study|Lack of Efficacy|2|||
160740575|NCT01565668|580433493|FG000|Overall Study|Participant went on Hospice Care|1|||
160740576|NCT01565668|580433494|FG001|Overall Study|Participant went on Hospice Care|0|||
160740577|NCT01565668|580433493|FG000|Overall Study|Adverse Event|6|||
160740578|NCT01565668|580433494|FG001|Overall Study|Adverse Event|1|||
160740579|NCT01565668|580433493|FG000|Overall Study|Randomized, but never received drug|0|||
160740580|NCT01565668|580433494|FG001|Overall Study|Randomized, but never received drug|2|||
160740581|NCT01565668|580433493|FG000|Overall Study|Progressive disease|13|||
160740582|NCT01565668|580433494|FG001|Overall Study|Progressive disease|14|||
160740583|NCT01565668|580433493|FG000|Overall Study|Withdrawal by Subject|1|||
160740584|NCT01565668|580433494|FG001|Overall Study|Withdrawal by Subject|3|||
160740585|NCT01565668|580433493|FG000|Overall Study|HSCT Transplant|11|||
160740586|NCT01565668|580433494|FG001|Overall Study|HSCT Transplant|15|||
160740587|NCT01097421|580433495|FG000|Overall Study|Adverse Event|8|||
160740588|NCT01097421|580433495|FG000|Overall Study|Protocol Violation|2|||
160740589|NCT01097421|580433495|FG000|Overall Study|Lost to Follow-up|1|||
160740590|NCT01097421|580433495|FG000|Overall Study|Withdrawal by Subject|3|||
160740591|NCT02258542|580433496|FG000|Overall Study|eg. not made to the visit|7|||
160740592|NCT02258542|580433497|FG001|Overall Study|eg. not made to the visit|4|||
160740593|NCT02258542|580433498|FG002|Overall Study|eg. not made to the visit|0|||
160740594|NCT02258542|580433499|FG003|Overall Study|eg. not made to the visit|1|||
160740595|NCT02258542|580433496|FG000|Overall Study|study specific discount. criteria|1|||
160740596|NCT02258542|580433497|FG001|Overall Study|study specific discount. criteria|1|||
160740597|NCT02258542|580433498|FG002|Overall Study|study specific discount. criteria|0|||
160740598|NCT02258542|580433499|FG003|Overall Study|study specific discount. criteria|0|||
160740599|NCT02258542|580433496|FG000|Overall Study|Withdrawal by Subject|20|||
160740600|NCT02258542|580433497|FG001|Overall Study|Withdrawal by Subject|20|||
160740601|NCT02258542|580433498|FG002|Overall Study|Withdrawal by Subject|7|||
160740602|NCT02258542|580433499|FG003|Overall Study|Withdrawal by Subject|1|||
160740603|NCT02258542|580433496|FG000|Overall Study|Lost to Follow-up|5|||
160740604|NCT02258542|580433497|FG001|Overall Study|Lost to Follow-up|12|||
160740605|NCT02258542|580433498|FG002|Overall Study|Lost to Follow-up|1|||
160740606|NCT02258542|580433499|FG003|Overall Study|Lost to Follow-up|2|||
160740607|NCT02258542|580433496|FG000|Overall Study|Death|5|||
160740608|NCT02258542|580433497|FG001|Overall Study|Death|4|||
160740609|NCT02258542|580433498|FG002|Overall Study|Death|0|||
160740610|NCT02258542|580433499|FG003|Overall Study|Death|1|||
160740611|NCT02258542|580433496|FG000|Overall Study|Adverse Event|3|||
160740612|NCT02258542|580433497|FG001|Overall Study|Adverse Event|4|||
160740613|NCT02258542|580433498|FG002|Overall Study|Adverse Event|0|||
160740614|NCT02258542|580433499|FG003|Overall Study|Adverse Event|0|||
160740615|NCT02258542|580433496|FG000|Overall Study|Protocol Violation|1|||
160740616|NCT02258542|580433497|FG001|Overall Study|Protocol Violation|2|||
160740617|NCT02258542|580433498|FG002|Overall Study|Protocol Violation|0|||
160740618|NCT02258542|580433499|FG003|Overall Study|Protocol Violation|0|||
160740619|NCT02258542|580433496|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160740620|NCT02258542|580433497|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
160740621|NCT02258542|580433498|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
160740622|NCT02258542|580433499|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
160740623|NCT00334802|580433502|FG000|Overall Study|Progressive Disease|2|||
160740624|NCT00334802|580433503|FG001|Overall Study|Progressive Disease|24|||
160740625|NCT00334802|580433502|FG000|Overall Study|Toxicity|1|||
160740626|NCT00334802|580433503|FG001|Overall Study|Toxicity|5|||
160740627|NCT00334802|580433502|FG000|Overall Study|Lack of Efficacy|1|||
160740628|NCT00334802|580433503|FG001|Overall Study|Lack of Efficacy|3|||
160740629|NCT00334802|580433502|FG000|Overall Study|Patient Condition Aggrevated|1|||
160740630|NCT00334802|580433503|FG001|Overall Study|Patient Condition Aggrevated|0|||
160740631|NCT00334802|580433502|FG000|Overall Study|Physician Decision|1|||
160740632|NCT00334802|580433503|FG001|Overall Study|Physician Decision|0|||
160740633|NCT00334802|580433502|FG000|Overall Study|Withdrawal by Subject|0|||
160740634|NCT00334802|580433503|FG001|Overall Study|Withdrawal by Subject|4|||
160740635|NCT00334802|580433502|FG000|Overall Study|Adverse Event|0|||
160740636|NCT00334802|580433503|FG001|Overall Study|Adverse Event|3|||
160740637|NCT00334802|580433502|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
160740638|NCT00334802|580433503|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
160740639|NCT03436199|580433504|FG000|Overall Study|Adverse Event|15|||
160740640|NCT03436199|580433505|FG001|Overall Study|Adverse Event|40|||
160740641|NCT03436199|580433506|FG002|Overall Study|Adverse Event|7|||
160740642|NCT03436199|580433504|FG000|Overall Study|Withdrawal by Subject|4|||
160740643|NCT03436199|580433505|FG001|Overall Study|Withdrawal by Subject|10|||
160740644|NCT03436199|580433506|FG002|Overall Study|Withdrawal by Subject|3|||
160740645|NCT03436199|580433504|FG000|Overall Study|Lost to Follow-up|1|||
160740646|NCT03436199|580433505|FG001|Overall Study|Lost to Follow-up|0|||
160740647|NCT03436199|580433506|FG002|Overall Study|Lost to Follow-up|2|||
160740648|NCT03436199|580433504|FG000|Overall Study|Protocol Violation|1|||
160740649|NCT03436199|580433505|FG001|Overall Study|Protocol Violation|1|||
160740650|NCT03436199|580433506|FG002|Overall Study|Protocol Violation|0|||
160740651|NCT03436199|580433504|FG000|Overall Study|Physician Decision|0|||
160740652|NCT03436199|580433505|FG001|Overall Study|Physician Decision|1|||
160740653|NCT03436199|580433506|FG002|Overall Study|Physician Decision|0|||
160740654|NCT03436199|580433504|FG000|Overall Study|Could not return to clinic|1|||
160740655|NCT03436199|580433505|FG001|Overall Study|Could not return to clinic|0|||
160740656|NCT03436199|580433506|FG002|Overall Study|Could not return to clinic|0|||
160740657|NCT03436199|580433504|FG000|Overall Study|Withdrawn per physician|0|||
160740658|NCT03436199|580433505|FG001|Overall Study|Withdrawn per physician|1|||
160740659|NCT03436199|580433506|FG002|Overall Study|Withdrawn per physician|0|||
160740660|NCT00085098|580433507|FG000|Overall Study|Withdrawal by Subject|0|||
160740661|NCT00085098|580433508|FG001|Overall Study|Withdrawal by Subject|1|||
160740662|NCT00085098|580433507|FG000|Overall Study|Ineligible|1|||
160740663|NCT00085098|580433508|FG001|Overall Study|Ineligible|1|||
160740664|NCT01886781|580433509|FG000|Overall Study|Protocol Violation|5|||
160740665|NCT01886781|580433510|FG001|Overall Study|Protocol Violation|0|||
160740666|NCT01886781|580433509|FG000|Overall Study|Adverse Event|1|||
160740667|NCT01886781|580433510|FG001|Overall Study|Adverse Event|0|||
160740668|NCT01886781|580433509|FG000|Overall Study|Lost to Follow-up|5|||
160740669|NCT01886781|580433510|FG001|Overall Study|Lost to Follow-up|0|||
160740670|NCT01886781|580433509|FG000|Overall Study|Withdrawal by Subject|2|||
160740671|NCT01886781|580433510|FG001|Overall Study|Withdrawal by Subject|1|||
160740672|NCT01886781|580433509|FG000|Overall Study|Worsening of symptoms|1|||
160740673|NCT01886781|580433510|FG001|Overall Study|Worsening of symptoms|1|||
160740674|NCT00926536|580433515|FG000|Overall Study|Physician Decision|1|||
160740675|NCT00926536|580433516|FG001|Overall Study|Physician Decision|2|||
160740676|NCT05087966|580433517|FG000|Overall Study|Lost to Follow-up|1|||
160740677|NCT05087966|580433517|FG000|Overall Study|Withdrawal by Subject|5|||
160740678|NCT01267201|580433519|FG000|First Intervention Period|Withdrawal by Subject|1|||
160740679|NCT01267201|580433520|FG001|First Intervention Period|Withdrawal by Subject|0|||
160740680|NCT01267201|580433521|FG002|First Intervention Period|Withdrawal by Subject|0|||
160740681|NCT01267201|580433522|FG003|First Intervention Period|Withdrawal by Subject|0|||
160740682|NCT01267201|580433523|FG004|First Intervention Period|Withdrawal by Subject|0|||
160740683|NCT01267201|580433524|FG005|First Intervention Period|Withdrawal by Subject|0|||
160740684|NCT01267201|580433519|FG000|Second Intervention Period|Withdrawal by Subject|0|||
160740685|NCT01267201|580433520|FG001|Second Intervention Period|Withdrawal by Subject|1|||
160740686|NCT01267201|580433521|FG002|Second Intervention Period|Withdrawal by Subject|0|||
160740687|NCT01267201|580433522|FG003|Second Intervention Period|Withdrawal by Subject|0|||
160740688|NCT01267201|580433523|FG004|Second Intervention Period|Withdrawal by Subject|0|||
160740689|NCT01267201|580433524|FG005|Second Intervention Period|Withdrawal by Subject|0|||
160740690|NCT00483704|580433525|FG000|Randomization|Withdrawal by Subject|19|||
160740691|NCT00483704|580433526|FG001|Randomization|Withdrawal by Subject|28|||
160740692|NCT00483704|580433527|FG002|Randomization|Withdrawal by Subject|18|||
160740693|NCT00483704|580433525|FG000|Randomization|Protocol Violation|14|||
160740694|NCT00483704|580433526|FG001|Randomization|Protocol Violation|25|||
160740695|NCT00483704|580433527|FG002|Randomization|Protocol Violation|22|||
160740696|NCT00483704|580433525|FG000|Randomization|Lost to Follow-up|14|||
160740697|NCT00483704|580433526|FG001|Randomization|Lost to Follow-up|14|||
160740698|NCT00483704|580433527|FG002|Randomization|Lost to Follow-up|19|||
160740699|NCT00483704|580433525|FG000|Randomization|Pregnancy|1|||
160740700|NCT00483704|580433526|FG001|Randomization|Pregnancy|0|||
160740701|NCT00483704|580433527|FG002|Randomization|Pregnancy|0|||
160740702|NCT00483704|580433525|FG000|Randomization|Physician Decision|2|||
160740703|NCT00483704|580433526|FG001|Randomization|Physician Decision|4|||
160740704|NCT00483704|580433527|FG002|Randomization|Physician Decision|0|||
160740705|NCT00483704|580433525|FG000|Randomization|Progressive disease|0|||
160740706|NCT00483704|580433526|FG001|Randomization|Progressive disease|0|||
160740707|NCT00483704|580433527|FG002|Randomization|Progressive disease|1|||
160740708|NCT00483704|580433525|FG000|Randomization|Lack of qualifying migraines|21|||
160740709|NCT00483704|580433526|FG001|Randomization|Lack of qualifying migraines|25|||
160740710|NCT00483704|580433527|FG002|Randomization|Lack of qualifying migraines|31|||
160740711|NCT00483704|580433525|FG000|Treatment|Lack of qualifying migraines|101|||
160740712|NCT00483704|580433526|FG001|Treatment|Lack of qualifying migraines|99|||
160740713|NCT00483704|580433527|FG002|Treatment|Lack of qualifying migraines|116|||
160740714|NCT00483704|580433525|FG000|Treatment|Adverse Event|3|||
160740715|NCT00483704|580433526|FG001|Treatment|Adverse Event|5|||
160740716|NCT00483704|580433527|FG002|Treatment|Adverse Event|4|||
160740717|NCT00483704|580433525|FG000|Treatment|Withdrawal by Subject|16|||
160740718|NCT00483704|580433526|FG001|Treatment|Withdrawal by Subject|12|||
160740719|NCT00483704|580433527|FG002|Treatment|Withdrawal by Subject|21|||
160740720|NCT00483704|580433525|FG000|Treatment|Protocol Violation|6|||
160740721|NCT00483704|580433526|FG001|Treatment|Protocol Violation|3|||
160740722|NCT00483704|580433527|FG002|Treatment|Protocol Violation|5|||
160740723|NCT00483704|580433525|FG000|Treatment|Lost to Follow-up|2|||
160740724|NCT00483704|580433526|FG001|Treatment|Lost to Follow-up|7|||
160740725|NCT00483704|580433527|FG002|Treatment|Lost to Follow-up|5|||
160740726|NCT00483704|580433525|FG000|Treatment|Lack of Efficacy|1|||
160740727|NCT00483704|580433526|FG001|Treatment|Lack of Efficacy|1|||
160740728|NCT00483704|580433527|FG002|Treatment|Lack of Efficacy|1|||
160740729|NCT00483704|580433525|FG000|Treatment|Pregnancy|0|||
160740730|NCT00483704|580433526|FG001|Treatment|Pregnancy|1|||
160740731|NCT00483704|580433527|FG002|Treatment|Pregnancy|0|||
160740732|NCT00483704|580433525|FG000|Treatment|Physician Decision|0|||
160740733|NCT00483704|580433526|FG001|Treatment|Physician Decision|1|||
160740734|NCT00483704|580433527|FG002|Treatment|Physician Decision|4|||
160740735|NCT04272606|580433528|FG000|Overall Study|Protocol Violation|1|||
160740736|NCT04272606|580433529|FG001|Overall Study|Protocol Violation|1|||
160740737|NCT04272606|580433528|FG000|Overall Study|Physician Decision|0|||
160740738|NCT04272606|580433529|FG001|Overall Study|Physician Decision|1|||
160740739|NCT03912428|580433530|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
160740740|NCT03912428|580433531|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
160740741|NCT03912428|580433532|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
160740742|NCT03912428|580433533|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
160740743|NCT03912428|580433530|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
160740744|NCT03912428|580433531|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
160740745|NCT03912428|580433532|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
160740746|NCT03912428|580433533|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
160740747|NCT03912428|580433530|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
160740748|NCT03912428|580433531|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
160740749|NCT03912428|580433532|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
160740750|NCT03912428|580433533|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
160740751|NCT03430895|580433537|FG000|Overall Study|Not Treated|2|||
160740752|NCT01645891|580433543|FG000|Overall Study|Adverse Event|6|||
160740753|NCT01645891|580433544|FG001|Overall Study|Adverse Event|10|||
160740754|NCT01645891|580433543|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
160740755|NCT01645891|580433544|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
160740756|NCT01645891|580433543|FG000|Overall Study|Withdrawal by Subject|3|||
160740757|NCT01645891|580433544|FG001|Overall Study|Withdrawal by Subject|3|||
160740758|NCT01645891|580433543|FG000|Overall Study|Protocol Violation|4|||
160740759|NCT01645891|580433544|FG001|Overall Study|Protocol Violation|0|||
160740760|NCT01645891|580433543|FG000|Overall Study|Lost to Follow-up|4|||
160740761|NCT01645891|580433544|FG001|Overall Study|Lost to Follow-up|1|||
160740762|NCT01645891|580433543|FG000|Overall Study|Death|0|||
160740763|NCT01645891|580433544|FG001|Overall Study|Death|2|||
160740764|NCT00138073|580433545|FG000|Overall Study|lack of resources|55|||
160740765|NCT03301740|580433546|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
160740766|NCT03301740|580433547|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
160740767|NCT03301740|580433546|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
160740768|NCT03301740|580433547|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
160740769|NCT01037127|580433549|FG000|Overall Study|Lost to Follow-up|2|||
160740770|NCT01037127|580433550|FG001|Overall Study|Lost to Follow-up|4|||
160740771|NCT01037127|580433549|FG000|Overall Study|Physician Decision|1|||
160740772|NCT01037127|580433550|FG001|Overall Study|Physician Decision|0|||
160740773|NCT01037127|580433549|FG000|Overall Study|Study Closed Terminated|2|||
160740774|NCT01037127|580433550|FG001|Overall Study|Study Closed Terminated|17|||
160740775|NCT02847182|580433551|FG000|Overall Study|Withdrawal by Subject|0|||
160740776|NCT02847182|580433552|FG001|Overall Study|Withdrawal by Subject|1|||
160740777|NCT02326298|580433553|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740778|NCT02326298|580433554|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740779|NCT02326298|580433555|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
160740780|NCT02326298|580433556|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740781|NCT02326298|580433557|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740782|NCT02326298|580433558|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740783|NCT02326298|580433559|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740784|NCT02326298|580433560|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740785|NCT02326298|580433561|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740786|NCT02326298|580433562|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740787|NCT02326298|580433563|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740788|NCT02326298|580433564|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740789|NCT02326298|580433565|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740790|NCT02326298|580433566|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
160740791|NCT02326298|580433553|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
160740792|NCT02326298|580433554|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740793|NCT02326298|580433555|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740794|NCT02326298|580433556|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740795|NCT02326298|580433557|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740796|NCT02326298|580433558|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740797|NCT02326298|580433559|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740798|NCT02326298|580433560|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740799|NCT02326298|580433561|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740800|NCT02326298|580433562|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740801|NCT02326298|580433563|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740802|NCT02326298|580433564|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740803|NCT02326298|580433565|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740804|NCT02326298|580433566|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
160740805|NCT02326298|580433553|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
160740806|NCT02326298|580433554|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
160740807|NCT02326298|580433555|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740808|NCT02326298|580433556|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740809|NCT02326298|580433557|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740810|NCT02326298|580433558|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740811|NCT02326298|580433559|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740812|NCT02326298|580433560|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740813|NCT02326298|580433561|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740814|NCT02326298|580433562|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740815|NCT02326298|580433563|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740816|NCT02326298|580433564|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740817|NCT02326298|580433565|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740818|NCT02326298|580433566|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
160740819|NCT02326298|580433553|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
160740820|NCT02326298|580433554|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
160740821|NCT02326298|580433555|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740822|NCT02326298|580433556|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740823|NCT02326298|580433557|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740824|NCT02326298|580433558|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740825|NCT02326298|580433559|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740826|NCT02326298|580433560|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740827|NCT02326298|580433561|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740828|NCT02326298|580433562|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740829|NCT02326298|580433563|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740830|NCT02326298|580433564|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740831|NCT02326298|580433565|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740832|NCT02326298|580433566|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160740833|NCT02326298|580433553|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740834|NCT02326298|580433554|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740835|NCT02326298|580433555|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
160740836|NCT02326298|580433556|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740837|NCT02326298|580433557|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740838|NCT02326298|580433558|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740839|NCT02326298|580433559|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740840|NCT02326298|580433560|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740841|NCT02326298|580433561|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740842|NCT02326298|580433562|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740843|NCT02326298|580433563|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740844|NCT02326298|580433564|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740845|NCT02326298|580433565|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740846|NCT02326298|580433566|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
160740847|NCT02326298|580433553|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160740848|NCT02326298|580433554|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160740849|NCT02326298|580433555|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160740850|NCT02326298|580433556|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160740851|NCT02326298|580433557|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160740852|NCT02326298|580433558|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160740853|NCT02326298|580433559|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
160740854|NCT02326298|580433560|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160740855|NCT02326298|580433561|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160740856|NCT02326298|580433562|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160740857|NCT02326298|580433563|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160740858|NCT02326298|580433564|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160740859|NCT02326298|580433565|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160740860|NCT02326298|580433566|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160740861|NCT02326298|580433553|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740862|NCT02326298|580433554|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740863|NCT02326298|580433555|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740864|NCT02326298|580433556|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740865|NCT02326298|580433557|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740866|NCT02326298|580433558|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
160740867|NCT02326298|580433559|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
160740868|NCT02326298|580433560|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740869|NCT02326298|580433561|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
160740870|NCT02326298|580433562|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740871|NCT02326298|580433563|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740872|NCT02326298|580433564|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740873|NCT02326298|580433565|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740874|NCT02326298|580433566|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
160740875|NCT02326298|580433553|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740876|NCT02326298|580433554|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740877|NCT02326298|580433555|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740878|NCT02326298|580433556|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740879|NCT02326298|580433557|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740880|NCT02326298|580433558|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
160740881|NCT02326298|580433559|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740882|NCT02326298|580433560|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740883|NCT02326298|580433561|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740884|NCT02326298|580433562|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740885|NCT02326298|580433563|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740886|NCT02326298|580433564|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740887|NCT02326298|580433565|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740888|NCT02326298|580433566|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
160740889|NCT02326298|580433553|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740890|NCT02326298|580433554|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740891|NCT02326298|580433555|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740892|NCT02326298|580433556|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740893|NCT02326298|580433557|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740894|NCT02326298|580433558|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740895|NCT02326298|580433559|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
160740896|NCT02326298|580433560|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740897|NCT02326298|580433561|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740898|NCT02326298|580433562|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740899|NCT02326298|580433563|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740900|NCT02326298|580433564|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740901|NCT02326298|580433565|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740902|NCT02326298|580433566|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
160740903|NCT02326298|580433553|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740904|NCT02326298|580433554|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740905|NCT02326298|580433555|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740906|NCT02326298|580433556|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740907|NCT02326298|580433557|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740908|NCT02326298|580433558|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740909|NCT02326298|580433559|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740910|NCT02326298|580433560|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
160740911|NCT02326298|580433561|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740912|NCT02326298|580433562|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740913|NCT02326298|580433563|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740914|NCT02326298|580433564|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740915|NCT02326298|580433565|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740916|NCT02326298|580433566|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
160740917|NCT02326298|580433553|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740918|NCT02326298|580433554|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740919|NCT02326298|580433555|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740920|NCT02326298|580433556|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740921|NCT02326298|580433557|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740922|NCT02326298|580433558|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740923|NCT02326298|580433559|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
160740924|NCT02326298|580433560|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
160740925|NCT02326298|580433561|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740926|NCT02326298|580433562|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740927|NCT02326298|580433563|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740928|NCT02326298|580433564|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740929|NCT02326298|580433565|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740930|NCT02326298|580433566|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160740931|NCT02326298|580433553|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740932|NCT02326298|580433554|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740933|NCT02326298|580433555|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740934|NCT02326298|580433556|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740935|NCT02326298|580433557|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740936|NCT02326298|580433558|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740937|NCT02326298|580433559|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740938|NCT02326298|580433560|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
160740939|NCT02326298|580433561|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740940|NCT02326298|580433562|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740941|NCT02326298|580433563|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740942|NCT02326298|580433564|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740943|NCT02326298|580433565|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740944|NCT02326298|580433566|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160740945|NCT02326298|580433553|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740946|NCT02326298|580433554|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740947|NCT02326298|580433555|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740948|NCT02326298|580433556|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740949|NCT02326298|580433557|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740950|NCT02326298|580433558|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
160740951|NCT02326298|580433559|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740952|NCT02326298|580433560|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740953|NCT02326298|580433561|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740954|NCT02326298|580433562|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740955|NCT02326298|580433563|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740956|NCT02326298|580433564|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740957|NCT02326298|580433565|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740958|NCT02326298|580433566|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
160740959|NCT02326298|580433553|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
160740960|NCT02326298|580433554|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
160740961|NCT02326298|580433555|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
160740962|NCT02326298|580433556|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
160740963|NCT02326298|580433557|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
160740964|NCT02326298|580433558|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
160740965|NCT02326298|580433559|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
160740966|NCT02326298|580433560|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
160740967|NCT02326298|580433561|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
160740968|NCT02326298|580433562|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
160740969|NCT02326298|580433563|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
160740970|NCT02326298|580433564|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
160740971|NCT02326298|580433565|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
160740972|NCT02326298|580433566|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
160740973|NCT02326298|580433553|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740974|NCT02326298|580433554|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740975|NCT02326298|580433555|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740976|NCT02326298|580433556|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740977|NCT02326298|580433557|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740978|NCT02326298|580433558|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740979|NCT02326298|580433559|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740980|NCT02326298|580433560|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740981|NCT02326298|580433561|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740982|NCT02326298|580433562|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740983|NCT02326298|580433563|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740984|NCT02326298|580433564|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
160740985|NCT02326298|580433565|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
160740986|NCT02326298|580433566|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
160740987|NCT02326298|580433553|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740988|NCT02326298|580433554|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740989|NCT02326298|580433555|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740990|NCT02326298|580433556|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740991|NCT02326298|580433557|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740992|NCT02326298|580433558|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740993|NCT02326298|580433559|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740994|NCT02326298|580433560|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740995|NCT02326298|580433561|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740996|NCT02326298|580433562|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740997|NCT02326298|580433563|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160740998|NCT02326298|580433564|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
160740999|NCT02326298|580433565|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
160741000|NCT02326298|580433566|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160741001|NCT02326298|580433553|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741002|NCT02326298|580433554|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741003|NCT02326298|580433555|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741004|NCT02326298|580433556|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741005|NCT02326298|580433557|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741006|NCT02326298|580433558|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741007|NCT02326298|580433559|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741008|NCT02326298|580433560|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741009|NCT02326298|580433561|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741010|NCT02326298|580433562|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741011|NCT02326298|580433563|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741012|NCT02326298|580433564|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741013|NCT02326298|580433565|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160741014|NCT02326298|580433566|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
160741015|NCT02326298|580433553|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741016|NCT02326298|580433554|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741017|NCT02326298|580433555|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741018|NCT02326298|580433556|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741019|NCT02326298|580433557|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741020|NCT02326298|580433558|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741021|NCT02326298|580433559|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741022|NCT02326298|580433560|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741023|NCT02326298|580433561|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741024|NCT02326298|580433562|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741025|NCT02326298|580433563|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160741026|NCT02326298|580433564|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
160741027|NCT02326298|580433565|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
160741028|NCT02326298|580433566|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
160741029|NCT02326298|580433553|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741030|NCT02326298|580433554|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741031|NCT02326298|580433555|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741032|NCT02326298|580433556|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741033|NCT02326298|580433557|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741034|NCT02326298|580433558|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741035|NCT02326298|580433559|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741036|NCT02326298|580433560|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741037|NCT02326298|580433561|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741038|NCT02326298|580433562|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741039|NCT02326298|580433563|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
160741040|NCT02326298|580433564|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
160741041|NCT02326298|580433565|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
160741042|NCT02326298|580433566|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
160741043|NCT02326298|580433553|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741044|NCT02326298|580433554|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741045|NCT02326298|580433555|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741046|NCT02326298|580433556|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741047|NCT02326298|580433557|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741048|NCT02326298|580433558|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741049|NCT02326298|580433559|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741050|NCT02326298|580433560|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741051|NCT02326298|580433561|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741052|NCT02326298|580433562|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741053|NCT02326298|580433563|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160741054|NCT02326298|580433564|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
160741055|NCT02326298|580433565|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
160741056|NCT02326298|580433566|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
160741057|NCT01306045|580433567|FG000|Met General Eligibility Criteria|Screen failures|193|||
160741058|NCT01306045|580433568|FG001|Met General Eligibility Criteria|Screen failures|11|||
160741059|NCT01306045|580433569|FG002|Met General Eligibility Criteria|Screen failures|8|||
160741060|NCT02044874|580433570|FG000|Overall Study|Adverse Event|5|||
160741061|NCT02044874|580433571|FG001|Overall Study|Adverse Event|6|||
160741062|NCT02044874|580433572|FG002|Overall Study|Adverse Event|6|||
160741063|NCT02044874|580433570|FG000|Overall Study|Withdrawal by Subject|8|||
160741064|NCT02044874|580433571|FG001|Overall Study|Withdrawal by Subject|16|||
160741065|NCT02044874|580433572|FG002|Overall Study|Withdrawal by Subject|23|||
160741066|NCT02044874|580433570|FG000|Overall Study|Physician Decision|0|||
160741067|NCT02044874|580433571|FG001|Overall Study|Physician Decision|2|||
160741068|NCT02044874|580433572|FG002|Overall Study|Physician Decision|1|||
160741069|NCT02044874|580433570|FG000|Overall Study|Lost to Follow-up|10|||
160741070|NCT02044874|580433571|FG001|Overall Study|Lost to Follow-up|27|||
160741071|NCT02044874|580433572|FG002|Overall Study|Lost to Follow-up|21|||
160741072|NCT02044874|580433570|FG000|Overall Study|Sponsor Decision|0|||
160741073|NCT02044874|580433571|FG001|Overall Study|Sponsor Decision|1|||
160741074|NCT02044874|580433572|FG002|Overall Study|Sponsor Decision|1|||
160741075|NCT02044874|580433570|FG000|Overall Study|Other|7|||
160741076|NCT02044874|580433571|FG001|Overall Study|Other|3|||
160741077|NCT02044874|580433572|FG002|Overall Study|Other|8|||
160741078|NCT05072964|580433575|FG000|Overall Study|Withdrawal by Subject|4|||
160741079|NCT05072964|580433575|FG000|Overall Study|Death|1|||
160741080|NCT02342548|580433576|FG000|Overall Study|Adverse Event|12|||
160741081|NCT02342548|580433577|FG001|Overall Study|Adverse Event|17|||
160741082|NCT02342548|580433578|FG002|Overall Study|Adverse Event|13|||
160741083|NCT02342548|580433576|FG000|Overall Study|Lost to Follow-up|0|||
160741084|NCT02342548|580433577|FG001|Overall Study|Lost to Follow-up|1|||
160741085|NCT02342548|580433578|FG002|Overall Study|Lost to Follow-up|0|||
160741086|NCT02342548|580433576|FG000|Overall Study|Study terminated by sponsor|20|||
160741087|NCT02342548|580433577|FG001|Overall Study|Study terminated by sponsor|39|||
160741088|NCT02342548|580433578|FG002|Overall Study|Study terminated by sponsor|25|||
160741089|NCT02342548|580433576|FG000|Overall Study|Protocol Violation|0|||
160741090|NCT02342548|580433577|FG001|Overall Study|Protocol Violation|1|||
160741091|NCT02342548|580433578|FG002|Overall Study|Protocol Violation|0|||
160741092|NCT02342548|580433576|FG000|Overall Study|Withdrawal by Subject|1|||
160741093|NCT02342548|580433577|FG001|Overall Study|Withdrawal by Subject|3|||
160741094|NCT02342548|580433578|FG002|Overall Study|Withdrawal by Subject|4|||
160741095|NCT02342548|580433576|FG000|Overall Study|Other|1|||
160741096|NCT02342548|580433577|FG001|Overall Study|Other|1|||
160741097|NCT02342548|580433578|FG002|Overall Study|Other|1|||
160741098|NCT02987972|580433579|FG000|Overall Study|Adverse Event|1|||
160741099|NCT02987972|580433580|FG001|Overall Study|Adverse Event|1|||
160741100|NCT02987972|580433581|FG002|Overall Study|Adverse Event|0|||
160741101|NCT02987972|580433579|FG000|Overall Study|Death|1|||
160741102|NCT02987972|580433580|FG001|Overall Study|Death|0|||
160741103|NCT02987972|580433581|FG002|Overall Study|Death|0|||
160741104|NCT02987972|580433579|FG000|Overall Study|Lack of Efficacy|9|||
160741105|NCT02987972|580433580|FG001|Overall Study|Lack of Efficacy|12|||
160741106|NCT02987972|580433581|FG002|Overall Study|Lack of Efficacy|12|||
160741107|NCT02987972|580433579|FG000|Overall Study|Lost to Follow-up|7|||
160741108|NCT02987972|580433580|FG001|Overall Study|Lost to Follow-up|8|||
160741109|NCT02987972|580433581|FG002|Overall Study|Lost to Follow-up|4|||
160741110|NCT02987972|580433579|FG000|Overall Study|Physician Decision|1|||
160741111|NCT02987972|580433580|FG001|Overall Study|Physician Decision|6|||
160741112|NCT02987972|580433581|FG002|Overall Study|Physician Decision|0|||
160741113|NCT02987972|580433579|FG000|Overall Study|Protocol Violation|2|||
160741114|NCT02987972|580433580|FG001|Overall Study|Protocol Violation|1|||
160741115|NCT02987972|580433581|FG002|Overall Study|Protocol Violation|5|||
160741116|NCT02987972|580433579|FG000|Overall Study|Withdrawal by Subject|22|||
160741117|NCT02987972|580433580|FG001|Overall Study|Withdrawal by Subject|17|||
160741118|NCT02987972|580433581|FG002|Overall Study|Withdrawal by Subject|21|||
160741119|NCT00787917|580433582|FG000|Blinded Treatment|Adverse Event|1|||
160741120|NCT00787917|580433583|FG001|Blinded Treatment|Adverse Event|0|||
160741121|NCT00787917|580433582|FG000|Blinded Treatment|Lack of Efficacy|1|||
160741122|NCT00787917|580433583|FG001|Blinded Treatment|Lack of Efficacy|0|||
160741123|NCT00787917|580433582|FG000|Blinded Treatment|Administrative problems|3|||
160741124|NCT00787917|580433583|FG001|Blinded Treatment|Administrative problems|2|||
160741125|NCT00787917|580433582|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
160741126|NCT00787917|580433583|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
160741127|NCT00787917|580433582|FG000|Open Label|Administrative problems|3|||
160741128|NCT00787917|580433583|FG001|Open Label|Administrative problems|0|||
160741129|NCT03521817|580433584|FG000|Overall Study|Protocol Violation|0|||
160741130|NCT03521817|580433585|FG001|Overall Study|Protocol Violation|1|||
160741131|NCT05685732|580433587|FG000|Overall Study|Withdrawal by Subject|2|||
160741132|NCT05685732|580433588|FG001|Overall Study|Withdrawal by Subject|0|||
160741133|NCT05685732|580433589|FG002|Overall Study|Withdrawal by Subject|2|||
160741134|NCT05685732|580433590|FG003|Overall Study|Withdrawal by Subject|3|||
160741135|NCT05685732|580433587|FG000|Overall Study|Protocol Violation|1|||
160741136|NCT05685732|580433588|FG001|Overall Study|Protocol Violation|2|||
160741137|NCT05685732|580433589|FG002|Overall Study|Protocol Violation|4|||
160741138|NCT05685732|580433590|FG003|Overall Study|Protocol Violation|1|||
160741139|NCT05685732|580433587|FG000|Overall Study|Lost to Follow-up|5|||
160741140|NCT05685732|580433588|FG001|Overall Study|Lost to Follow-up|1|||
160741141|NCT05685732|580433589|FG002|Overall Study|Lost to Follow-up|3|||
160741142|NCT05685732|580433590|FG003|Overall Study|Lost to Follow-up|1|||
160741143|NCT05685732|580433587|FG000|Overall Study|Adverse Event|2|||
160741144|NCT05685732|580433588|FG001|Overall Study|Adverse Event|1|||
160741145|NCT05685732|580433589|FG002|Overall Study|Adverse Event|0|||
160741146|NCT05685732|580433590|FG003|Overall Study|Adverse Event|0|||
160741147|NCT05685732|580433587|FG000|Overall Study|Physician Decision|1|||
160741148|NCT05685732|580433588|FG001|Overall Study|Physician Decision|0|||
160741149|NCT05685732|580433589|FG002|Overall Study|Physician Decision|0|||
160741150|NCT05685732|580433590|FG003|Overall Study|Physician Decision|0|||
160741151|NCT02640404|580433591|FG000|Overall Study|Protocol Violation|1|||
160741152|NCT02640404|580433592|FG001|Overall Study|Protocol Violation|0|||
160741153|NCT02640404|580433591|FG000|Overall Study|Withdrawal by Subject|1|||
160741154|NCT02640404|580433592|FG001|Overall Study|Withdrawal by Subject|0|||
160741155|NCT00778102|580433593|FG000|Overall Study|Adverse Event|8|||
160741156|NCT00778102|580433594|FG001|Overall Study|Adverse Event|5|||
160741157|NCT00778102|580433593|FG000|Overall Study|Death|1|||
160741158|NCT00778102|580433594|FG001|Overall Study|Death|1|||
160741159|NCT00778102|580433593|FG000|Overall Study|Lost to Follow-up|1|||
160741160|NCT00778102|580433594|FG001|Overall Study|Lost to Follow-up|0|||
160741161|NCT00778102|580433593|FG000|Overall Study|Violation of Selection Criteria|1|||
160741162|NCT00778102|580433594|FG001|Overall Study|Violation of Selection Criteria|1|||
160741163|NCT00778102|580433593|FG000|Overall Study|Protocol Violation|0|||
160741164|NCT00778102|580433594|FG001|Overall Study|Protocol Violation|1|||
160741165|NCT00778102|580433593|FG000|Overall Study|Refused Treatment|2|||
160741166|NCT00778102|580433594|FG001|Overall Study|Refused Treatment|3|||
160741167|NCT00778102|580433593|FG000|Overall Study|Withdrawal by Subject|1|||
160741168|NCT00778102|580433594|FG001|Overall Study|Withdrawal by Subject|1|||
160741169|NCT00778102|580433593|FG000|Overall Study|Administrative Reason|7|||
160741170|NCT00778102|580433594|FG001|Overall Study|Administrative Reason|10|||
160741171|NCT05397171|580433595|FG000|Overall Study|Death|2|||
160741172|NCT05397171|580433596|FG001|Overall Study|Death|3|||
160741173|NCT05397171|580433597|FG002|Overall Study|Death|3|||
160741174|NCT05397171|580433595|FG000|Overall Study|Study Terminated By Sponsor|1|||
160741175|NCT05397171|580433596|FG001|Overall Study|Study Terminated By Sponsor|2|||
160741176|NCT05397171|580433597|FG002|Overall Study|Study Terminated By Sponsor|3|||
160741177|NCT05397171|580433595|FG000|Overall Study|Withdrawal by Subject|0|||
160741178|NCT05397171|580433596|FG001|Overall Study|Withdrawal by Subject|1|||
160741179|NCT05397171|580433597|FG002|Overall Study|Withdrawal by Subject|1|||
160741180|NCT01328548|580433598|FG000|Overall Study|Death|3|||
160741181|NCT01328548|580433599|FG001|Overall Study|Death|0|||
160741182|NCT01328548|580433598|FG000|Overall Study|Protocol Violation|1|||
160741183|NCT01328548|580433599|FG001|Overall Study|Protocol Violation|0|||
160741184|NCT02824562|580435405|FG000|Overall Study|Lost to Follow-up|3|||
160741185|NCT02824562|580435406|FG001|Overall Study|Lost to Follow-up|4|||
160741186|NCT02824562|580435405|FG000|Overall Study|Death|0|||
160741187|NCT02824562|580435406|FG001|Overall Study|Death|1|||
160741188|NCT02921750|580435407|FG000|Overall Study|Adverse Event|1|||
160741189|NCT02921750|580435408|FG001|Overall Study|Adverse Event|2|||
160741190|NCT02921750|580435407|FG000|Overall Study|Withdrawal by Subject|1|||
160741191|NCT02921750|580435408|FG001|Overall Study|Withdrawal by Subject|1|||
160741192|NCT02921750|580435407|FG000|Overall Study|Lost to Follow-up|3|||
160741193|NCT02921750|580435408|FG001|Overall Study|Lost to Follow-up|3|||
160741194|NCT02921750|580435407|FG000|Overall Study|Wound healed|3|||
160741195|NCT02921750|580435408|FG001|Overall Study|Wound healed|3|||
160741196|NCT02921750|580435407|FG000|Overall Study|Serious Adverse Event|1|||
160741197|NCT02921750|580435408|FG001|Overall Study|Serious Adverse Event|2|||
160741198|NCT03309696|580435410|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
160741199|NCT03309696|580435411|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
160741200|NCT03309696|580435412|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
160741201|NCT03309696|580435413|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
160741202|NCT02638129|580435414|FG000|Overall Study|Study terminated|28|||
160741203|NCT02638129|580435415|FG001|Overall Study|Study terminated|30|||
160741204|NCT02368210|580435418|FG000|Overall Study|Withdrawal by Subject|1|||
160741205|NCT02368210|580435419|FG001|Overall Study|Withdrawal by Subject|0|||
160741206|NCT02368210|580435418|FG000|Overall Study|Adverse Event|0|||
160741207|NCT02368210|580435419|FG001|Overall Study|Adverse Event|1|||
160741208|NCT00078949|580435420|FG000|Overall Study|No treated|4|||
160741209|NCT00078949|580435421|FG001|Overall Study|No treated|5|||
160741210|NCT00078949|580435422|FG002|Overall Study|No treated|3|||
160741211|NCT00078949|580435423|FG003|Overall Study|No treated|3|||
160741212|NCT00577005|580435424|FG000|Overall Study|Lost to Follow-up|3|||
160741213|NCT00577005|580435425|FG001|Overall Study|Lost to Follow-up|2|||
160741214|NCT00577005|580435424|FG000|Overall Study|Withdrawal by Subject|2|||
160741215|NCT00577005|580435425|FG001|Overall Study|Withdrawal by Subject|1|||
160741216|NCT02667626|580435426|FG000|Overall Study|Withdrawal by Subject|0|||
160741217|NCT02667626|580435427|FG001|Overall Study|Withdrawal by Subject|1|||
160741218|NCT00590538|580435428|FG000|Overall Study|Study terminated before completed|2|||
160741219|NCT02309723|580435429|FG000|Overall Study|Withdrawal by Subject|24|||
160741220|NCT02309723|580435430|FG001|Overall Study|Withdrawal by Subject|23|||
160741221|NCT02309723|580435431|FG002|Overall Study|Withdrawal by Subject|24|||
160741222|NCT02560623|580435432|FG000|Overall Study|Unable to swallow sponge|0|||
160741223|NCT02560623|580435433|FG001|Overall Study|Unable to swallow sponge|1|||
160741224|NCT02560623|580435434|FG002|Overall Study|Unable to swallow sponge|0|||
160741225|NCT02560623|580435435|FG003|Overall Study|Unable to swallow sponge|0|||
160741226|NCT02560623|580435432|FG000|Overall Study|Intervention prior to sponge administration|0|||
160741227|NCT02560623|580435433|FG001|Overall Study|Intervention prior to sponge administration|1|||
160741228|NCT02560623|580435434|FG002|Overall Study|Intervention prior to sponge administration|0|||
160741229|NCT02560623|580435435|FG003|Overall Study|Intervention prior to sponge administration|0|||
160741230|NCT02539134|580435438|FG000|Overall Study|Lost to Follow-up|1|||
160741231|NCT02539134|580435439|FG001|Overall Study|Lost to Follow-up|0|||
160741232|NCT02539134|580435440|FG002|Overall Study|Lost to Follow-up|0|||
160741233|NCT02539134|580435441|FG003|Overall Study|Lost to Follow-up|0|||
160741234|NCT02539134|580435442|FG004|Overall Study|Lost to Follow-up|0|||
160741235|NCT02539134|580435443|FG005|Overall Study|Lost to Follow-up|0|||
160741236|NCT02255552|580435444|FG000|Overall Study|Participants enrolled into another study|0|||
160741237|NCT02255552|580435445|FG001|Overall Study|Participants enrolled into another study|11|||
160741238|NCT02255552|580435444|FG000|Overall Study|Withdrawal by Subject|1|||
160741239|NCT02255552|580435445|FG001|Overall Study|Withdrawal by Subject|4|||
160741240|NCT01447446|580435446|FG000|Overall Study|Death|6|||
160741241|NCT01447446|580435447|FG001|Overall Study|Death|3|||
160741242|NCT01447446|580435448|FG002|Overall Study|Death|2|||
160741243|NCT01447446|580435449|FG003|Overall Study|Death|1|||
160741244|NCT01447446|580435450|FG004|Overall Study|Death|7|||
160741245|NCT01447446|580435451|FG005|Overall Study|Death|0|||
160741246|NCT01447446|580435446|FG000|Overall Study|Adverse Event|3|||
160741247|NCT01447446|580435447|FG001|Overall Study|Adverse Event|0|||
160741248|NCT01447446|580435448|FG002|Overall Study|Adverse Event|1|||
160741249|NCT01447446|580435449|FG003|Overall Study|Adverse Event|0|||
160741250|NCT01447446|580435450|FG004|Overall Study|Adverse Event|2|||
160741251|NCT01447446|580435451|FG005|Overall Study|Adverse Event|0|||
160741252|NCT01447446|580435446|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
160741253|NCT01447446|580435447|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
160741254|NCT01447446|580435448|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
160741255|NCT01447446|580435449|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
160741256|NCT01447446|580435450|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
160741257|NCT01447446|580435451|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
160741258|NCT01447446|580435446|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
160741259|NCT01447446|580435447|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
160741260|NCT01447446|580435448|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
160741261|NCT01447446|580435449|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
160741262|NCT01447446|580435450|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
160741263|NCT01447446|580435451|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
160741264|NCT01447446|580435446|FG000|Overall Study|Administrative/Other|34|||
160741265|NCT01447446|580435447|FG001|Overall Study|Administrative/Other|9|||
160741266|NCT01447446|580435448|FG002|Overall Study|Administrative/Other|10|||
160741267|NCT01447446|580435449|FG003|Overall Study|Administrative/Other|2|||
160741268|NCT01447446|580435450|FG004|Overall Study|Administrative/Other|33|||
160741269|NCT01447446|580435451|FG005|Overall Study|Administrative/Other|4|||
160741270|NCT01447446|580435446|FG000|Overall Study|SVR12 Assessment|13|||
160741271|NCT01447446|580435447|FG001|Overall Study|SVR12 Assessment|1|||
160741272|NCT01447446|580435448|FG002|Overall Study|SVR12 Assessment|2|||
160741273|NCT01447446|580435449|FG003|Overall Study|SVR12 Assessment|1|||
160741274|NCT01447446|580435450|FG004|Overall Study|SVR12 Assessment|5|||
160741275|NCT01447446|580435451|FG005|Overall Study|SVR12 Assessment|5|||
160741276|NCT01447446|580435446|FG000|Overall Study|New Treatment Started|8|||
160741277|NCT01447446|580435447|FG001|Overall Study|New Treatment Started|2|||
160741278|NCT01447446|580435448|FG002|Overall Study|New Treatment Started|1|||
160741279|NCT01447446|580435449|FG003|Overall Study|New Treatment Started|0|||
160741280|NCT01447446|580435450|FG004|Overall Study|New Treatment Started|2|||
160741281|NCT01447446|580435451|FG005|Overall Study|New Treatment Started|0|||
160741282|NCT01447446|580435446|FG000|Overall Study|Reason not Specified|1|||
160741283|NCT01447446|580435447|FG001|Overall Study|Reason not Specified|1|||
160741284|NCT01447446|580435448|FG002|Overall Study|Reason not Specified|1|||
160741285|NCT01447446|580435449|FG003|Overall Study|Reason not Specified|1|||
160741286|NCT01447446|580435450|FG004|Overall Study|Reason not Specified|1|||
160741287|NCT01447446|580435451|FG005|Overall Study|Reason not Specified|0|||
160741288|NCT02052596|580435452|FG000|Active Phase|Adverse Event|3|||
160741289|NCT02052596|580435453|FG001|Active Phase|Adverse Event|2|||
160741290|NCT02052596|580435452|FG000|Active Phase|Lost to Follow-up|8|||
160741291|NCT02052596|580435453|FG001|Active Phase|Lost to Follow-up|11|||
160741292|NCT02052596|580435452|FG000|Active Phase|Protocol Violation|1|||
160741293|NCT02052596|580435453|FG001|Active Phase|Protocol Violation|2|||
160741294|NCT02052596|580435452|FG000|Active Phase|Withdrawal by Subject|3|||
160741295|NCT02052596|580435453|FG001|Active Phase|Withdrawal by Subject|4|||
160741296|NCT02052596|580435452|FG000|Active Phase|Enrolled in error|1|||
160741297|NCT02052596|580435453|FG001|Active Phase|Enrolled in error|0|||
160741298|NCT02052596|580435452|FG000|Active Phase|Lost due to Crohn's disease|0|||
160741299|NCT02052596|580435453|FG001|Active Phase|Lost due to Crohn's disease|1|||
160741300|NCT02052596|580435452|FG000|Safety Phase|Adverse Event|6|||
160741301|NCT02052596|580435453|FG001|Safety Phase|Adverse Event|3|||
160741302|NCT02052596|580435452|FG000|Safety Phase|Lost to Follow-up|11|||
160741303|NCT02052596|580435453|FG001|Safety Phase|Lost to Follow-up|18|||
160741304|NCT02052596|580435452|FG000|Safety Phase|Protocol Violation|1|||
160741305|NCT02052596|580435453|FG001|Safety Phase|Protocol Violation|2|||
160741306|NCT02052596|580435452|FG000|Safety Phase|Withdrawal by Subject|8|||
160741307|NCT02052596|580435453|FG001|Safety Phase|Withdrawal by Subject|11|||
160741308|NCT02052596|580435452|FG000|Safety Phase|Enrolled in error|1|||
160741309|NCT02052596|580435453|FG001|Safety Phase|Enrolled in error|0|||
160741310|NCT02052596|580435452|FG000|Safety Phase|Lost due to Crohn's disease|0|||
160741311|NCT02052596|580435453|FG001|Safety Phase|Lost due to Crohn's disease|1|||
160741312|NCT00943670|580435454|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
160741313|NCT00943670|580435454|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
160741314|NCT00943670|580435454|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
160741315|NCT00943670|580435454|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
160741316|NCT00943670|580435454|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
160741317|NCT00943670|580435454|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
160741318|NCT00943670|580435454|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
160741319|NCT00943670|580435454|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
160741320|NCT00943670|580435454|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
160741321|NCT00943670|580435454|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
160741322|NCT02382796|580435455|FG000|Overall Study|Global deterioration of health status|1|||
160741323|NCT02382796|580435455|FG000|Overall Study|Objective progression or relapse|3|||
160741324|NCT02382796|580435455|FG000|Overall Study|Commercial dacomitinib became available|3|||
160741325|NCT03077659|580435456|FG000|Overall Study|Withdrawal by Subject|0|||
160741326|NCT03077659|580435457|FG001|Overall Study|Withdrawal by Subject|0|||
160741327|NCT03077659|580435458|FG002|Overall Study|Withdrawal by Subject|1|||
160741328|NCT04526574|580435465|FG000|Overall Study|Protocol Violation|3|||
160741329|NCT04526574|580435466|FG001|Overall Study|Protocol Violation|1|||
160741330|NCT04526574|580435465|FG000|Overall Study|Withdrawal by Subject|12|||
160741331|NCT04526574|580435466|FG001|Overall Study|Withdrawal by Subject|9|||
160741332|NCT04526574|580435465|FG000|Overall Study|Other|1|||
160741333|NCT04526574|580435466|FG001|Overall Study|Other|2|||
160741334|NCT04526574|580435465|FG000|Overall Study|Adverse Event|1|||
160741335|NCT04526574|580435466|FG001|Overall Study|Adverse Event|1|||
160741336|NCT04526574|580435465|FG000|Overall Study|Death|2|||
160741337|NCT04526574|580435466|FG001|Overall Study|Death|3|||
160741338|NCT04526574|580435465|FG000|Overall Study|Lost to Follow-up|9|||
160741339|NCT04526574|580435466|FG001|Overall Study|Lost to Follow-up|9|||
160741340|NCT04526574|580435465|FG000|Overall Study|No longer meets eligibility criteria|8|||
160741341|NCT04526574|580435466|FG001|Overall Study|No longer meets eligibility criteria|8|||
160741342|NCT01032070|580435467|FG000|Overall Study|Disease progression|13|||
160741343|NCT01032070|580435468|FG001|Overall Study|Disease progression|8|||
160741344|NCT01032070|580435467|FG000|Overall Study|Medical or ethical reasons|0|||
160741345|NCT01032070|580435468|FG001|Overall Study|Medical or ethical reasons|2|||
160741346|NCT01032070|580435467|FG000|Overall Study|Withdrawal by Subject|0|||
160741347|NCT01032070|580435468|FG001|Overall Study|Withdrawal by Subject|2|||
160741348|NCT04068688|580435469|FG000|Overall Study|Lost to Follow-up|1|||
160741349|NCT04068688|580435470|FG001|Overall Study|Lost to Follow-up|1|||
160741350|NCT04068688|580435471|FG002|Overall Study|Lost to Follow-up|0|||
160741351|NCT04068688|580435472|FG003|Overall Study|Lost to Follow-up|0|||
160741352|NCT04068688|580435473|FG004|Overall Study|Lost to Follow-up|5|||
160741353|NCT04068688|580435474|FG005|Overall Study|Lost to Follow-up|5|||
160741354|NCT04068688|580435475|FG006|Overall Study|Lost to Follow-up|0|||
160741355|NCT04068688|580435476|FG007|Overall Study|Lost to Follow-up|0|||
160741356|NCT04068688|580435477|FG008|Overall Study|Lost to Follow-up|1|||
160741357|NCT04068688|580435478|FG009|Overall Study|Lost to Follow-up|0|||
160741358|NCT04068688|580435469|FG000|Overall Study|Withdrawal by Subject|1|||
160741359|NCT04068688|580435470|FG001|Overall Study|Withdrawal by Subject|1|||
160741360|NCT04068688|580435471|FG002|Overall Study|Withdrawal by Subject|0|||
160741361|NCT04068688|580435472|FG003|Overall Study|Withdrawal by Subject|0|||
160741362|NCT04068688|580435473|FG004|Overall Study|Withdrawal by Subject|0|||
160741363|NCT04068688|580435474|FG005|Overall Study|Withdrawal by Subject|0|||
160741364|NCT04068688|580435475|FG006|Overall Study|Withdrawal by Subject|0|||
160741365|NCT04068688|580435476|FG007|Overall Study|Withdrawal by Subject|0|||
160741366|NCT04068688|580435477|FG008|Overall Study|Withdrawal by Subject|0|||
160741367|NCT04068688|580435478|FG009|Overall Study|Withdrawal by Subject|0|||
160741368|NCT04068688|580435469|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
160741369|NCT04068688|580435470|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
160741370|NCT04068688|580435471|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
160741371|NCT04068688|580435472|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
160741372|NCT04068688|580435473|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
160741373|NCT04068688|580435474|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
160741374|NCT04068688|580435475|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
160741375|NCT04068688|580435476|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
160741376|NCT04068688|580435477|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
160741377|NCT04068688|580435478|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
160741378|NCT04679051|580435479|FG000|Overall Study|felt tired after restricted time in bed|3|||
160741379|NCT04679051|580435480|FG001|Overall Study|felt tired after restricted time in bed|0|||
160741380|NCT04679051|580435479|FG000|Overall Study|discomfort with blood pressure cuff|2|||
160741381|NCT04679051|580435480|FG001|Overall Study|discomfort with blood pressure cuff|0|||
160741382|NCT04679051|580435479|FG000|Overall Study|scheduling conflict|1|||
160741383|NCT04679051|580435480|FG001|Overall Study|scheduling conflict|1|||
160741384|NCT04679051|580435479|FG000|Overall Study|Protocol Violation|0|||
160741385|NCT04679051|580435480|FG001|Overall Study|Protocol Violation|4|||
160741386|NCT02554318|580435481|FG000|Overall Study|Withdrawal by Subject|10|||
160741387|NCT02554318|580435482|FG001|Overall Study|Withdrawal by Subject|8|||
160741388|NCT02332239|580435485|FG000|Overall Study|Lost to Follow-up|4|||
160741389|NCT02332239|580435486|FG001|Overall Study|Lost to Follow-up|6|||
160741390|NCT00894790|580435487|FG000|Overall Study|Protocol Violation|0|||
160741391|NCT00894790|580435488|FG001|Overall Study|Protocol Violation|1|||
160741392|NCT00894790|580435487|FG000|Overall Study|Lost to Follow-up|0|||
160741393|NCT00894790|580435488|FG001|Overall Study|Lost to Follow-up|1|||
160741394|NCT00894790|580435487|FG000|Overall Study|Did not meet entrance criteria|1|||
160741395|NCT00894790|580435488|FG001|Overall Study|Did not meet entrance criteria|0|||
160741396|NCT01472965|580435489|FG000|Overall Study|Withdrawal by Subject|1|||
160741397|NCT01472965|580435490|FG001|Overall Study|Withdrawal by Subject|0|||
160741398|NCT00980018|580435497|FG000|Overall Study|Adverse Event|8|||
160741399|NCT00980018|580435497|FG000|Overall Study|Patient withdrew consent|3|||
160741400|NCT00980018|580435497|FG000|Overall Study|Lost to Follow-up|1|||
160741401|NCT00551161|580435498|FG000|Overall Study|Withdrawal by Subject|1|||
160741402|NCT00934856|580435499|FG000|Feasibility Part|Progressive disease|4|||
160741403|NCT00934856|580435500|FG001|Feasibility Part|Progressive disease|4|||
160741404|NCT00934856|580435501|FG002|Feasibility Part|Progressive disease|2|||
160741405|NCT00934856|580435502|FG003|Feasibility Part|Progressive disease|3|||
160741406|NCT00934856|580435503|FG004|Feasibility Part|Progressive disease|0|||
160741407|NCT00934856|580435504|FG005|Feasibility Part|Progressive disease|0|||
160741408|NCT00934856|580435499|FG000|Feasibility Part|Physician Decision|0|||
160741409|NCT00934856|580435500|FG001|Feasibility Part|Physician Decision|0|||
160741410|NCT00934856|580435501|FG002|Feasibility Part|Physician Decision|1|||
160741411|NCT00934856|580435502|FG003|Feasibility Part|Physician Decision|0|||
160741412|NCT00934856|580435503|FG004|Feasibility Part|Physician Decision|0|||
160741413|NCT00934856|580435504|FG005|Feasibility Part|Physician Decision|0|||
160741414|NCT00934856|580435499|FG000|Feasibility Part|Adverse Event|1|||
160741415|NCT00934856|580435500|FG001|Feasibility Part|Adverse Event|1|||
160741416|NCT00934856|580435501|FG002|Feasibility Part|Adverse Event|0|||
160741417|NCT00934856|580435502|FG003|Feasibility Part|Adverse Event|1|||
160741418|NCT00934856|580435503|FG004|Feasibility Part|Adverse Event|0|||
160741419|NCT00934856|580435504|FG005|Feasibility Part|Adverse Event|2|||
160741420|NCT00934856|580435499|FG000|Feasibility Part|Withdrawal by Subject|0|||
160741421|NCT00934856|580435500|FG001|Feasibility Part|Withdrawal by Subject|0|||
160741422|NCT00934856|580435501|FG002|Feasibility Part|Withdrawal by Subject|0|||
160741423|NCT00934856|580435502|FG003|Feasibility Part|Withdrawal by Subject|1|||
160741424|NCT00934856|580435503|FG004|Feasibility Part|Withdrawal by Subject|0|||
160741425|NCT00934856|580435504|FG005|Feasibility Part|Withdrawal by Subject|1|||
160741426|NCT00934856|580435499|FG000|Extension Part|Adverse Event|0|||
160741427|NCT00934856|580435500|FG001|Extension Part|Adverse Event|0|||
160741428|NCT00934856|580435501|FG002|Extension Part|Adverse Event|0|||
160741429|NCT00934856|580435502|FG003|Extension Part|Adverse Event|1|||
160741430|NCT00934856|580435503|FG004|Extension Part|Adverse Event|4|||
160741431|NCT00934856|580435504|FG005|Extension Part|Adverse Event|4|||
160741432|NCT00934856|580435499|FG000|Extension Part|Progressive disease|0|||
160741433|NCT00934856|580435500|FG001|Extension Part|Progressive disease|0|||
160741434|NCT00934856|580435501|FG002|Extension Part|Progressive disease|0|||
160741435|NCT00934856|580435502|FG003|Extension Part|Progressive disease|1|||
160741436|NCT00934856|580435503|FG004|Extension Part|Progressive disease|0|||
160741437|NCT00934856|580435504|FG005|Extension Part|Progressive disease|0|||
160741438|NCT00934856|580435499|FG000|Extension Part|Non-compliance with drug|0|||
160741439|NCT00934856|580435500|FG001|Extension Part|Non-compliance with drug|0|||
160741440|NCT00934856|580435501|FG002|Extension Part|Non-compliance with drug|0|||
160741441|NCT00934856|580435502|FG003|Extension Part|Non-compliance with drug|0|||
160741442|NCT00934856|580435503|FG004|Extension Part|Non-compliance with drug|0|||
160741443|NCT00934856|580435504|FG005|Extension Part|Non-compliance with drug|1|||
160741444|NCT01256385|580435505|FG000|Overall Study|Physician Decision|1|||
160741445|NCT01256385|580435506|FG001|Overall Study|Physician Decision|1|||
160741446|NCT01256385|580435505|FG000|Overall Study|Withdrawal by Subject|2|||
160741447|NCT01256385|580435506|FG001|Overall Study|Withdrawal by Subject|2|||
160741448|NCT02273908|580435514|FG000|Overall Study|Adverse Event|16|||
160741449|NCT02273908|580435515|FG001|Overall Study|Adverse Event|0|||
160741450|NCT02273908|580435514|FG000|Overall Study|Lost to Follow-up|10|||
160741451|NCT02273908|580435515|FG001|Overall Study|Lost to Follow-up|1|||
160741452|NCT02273908|580435514|FG000|Overall Study|Did not meet entrance criteria|3|||
160741453|NCT02273908|580435515|FG001|Overall Study|Did not meet entrance criteria|2|||
160741454|NCT02273908|580435514|FG000|Overall Study|Withdrawal by Subject|4|||
160741455|NCT02273908|580435515|FG001|Overall Study|Withdrawal by Subject|2|||
160741456|NCT00422422|580435516|FG000|Overall Study|Lack of Efficacy|1|||
160741457|NCT00422422|580435516|FG000|Overall Study|Protocol Violation|1|||
160741458|NCT00422422|580435516|FG000|Overall Study|Withdrawal by Subject|2|||
160741459|NCT00422422|580435516|FG000|Overall Study|SAE, non-fatal|1|||
160741460|NCT00422422|580435516|FG000|Overall Study|AE, non-serious non-fatal|5|||
160741461|NCT03301844|580435517|FG000|Overall Study|suspected colon cancer|1|||
160741462|NCT03301844|580435518|FG001|Overall Study|suspected colon cancer|1|||
160741463|NCT03191864|580435525|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
160741464|NCT03191864|580435526|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
160741465|NCT03191864|580435527|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
160741466|NCT03191864|580435528|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
160741467|NCT03191864|580435529|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
160741468|NCT03191864|580435530|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
160741469|NCT03191864|580435525|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
160741470|NCT03191864|580435526|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
160741471|NCT03191864|580435527|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
160741472|NCT03191864|580435528|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
160741473|NCT03191864|580435529|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
160741474|NCT03191864|580435530|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
160741475|NCT03191864|580435525|FG000|Baseline Symptom Assessment|Adverse Event|0|||
160741476|NCT03191864|580435526|FG001|Baseline Symptom Assessment|Adverse Event|0|||
160741477|NCT03191864|580435527|FG002|Baseline Symptom Assessment|Adverse Event|0|||
160741478|NCT03191864|580435528|FG003|Baseline Symptom Assessment|Adverse Event|0|||
160741479|NCT03191864|580435529|FG004|Baseline Symptom Assessment|Adverse Event|0|||
160741480|NCT03191864|580435530|FG005|Baseline Symptom Assessment|Adverse Event|2|||
160741481|NCT03191864|580435525|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
160741482|NCT03191864|580435526|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
160741483|NCT03191864|580435527|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
160741484|NCT03191864|580435528|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
160741485|NCT03191864|580435529|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
160741486|NCT03191864|580435530|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
160741487|NCT03191864|580435525|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
160741488|NCT03191864|580435526|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
160741489|NCT03191864|580435527|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
160741490|NCT03191864|580435528|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
160741491|NCT03191864|580435529|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
160741492|NCT03191864|580435530|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
160741493|NCT03191864|580435525|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
160741494|NCT03191864|580435526|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
160741495|NCT03191864|580435527|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
160741496|NCT03191864|580435528|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
160741497|NCT03191864|580435529|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
160741498|NCT03191864|580435530|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
160741499|NCT03191864|580435525|FG000|Part 1 - Induction|Adverse Event|0|||
160741500|NCT03191864|580435526|FG001|Part 1 - Induction|Adverse Event|2|||
160741501|NCT03191864|580435527|FG002|Part 1 - Induction|Adverse Event|0|||
160741502|NCT03191864|580435528|FG003|Part 1 - Induction|Adverse Event|1|||
160741503|NCT03191864|580435529|FG004|Part 1 - Induction|Adverse Event|0|||
160741504|NCT03191864|580435530|FG005|Part 1 - Induction|Adverse Event|2|||
160741505|NCT03191864|580435525|FG000|Part 1 - Induction|Randomized but never dosed|0|||
160741506|NCT03191864|580435526|FG001|Part 1 - Induction|Randomized but never dosed|0|||
160741507|NCT03191864|580435527|FG002|Part 1 - Induction|Randomized but never dosed|1|||
160741508|NCT03191864|580435528|FG003|Part 1 - Induction|Randomized but never dosed|0|||
160741509|NCT03191864|580435529|FG004|Part 1 - Induction|Randomized but never dosed|0|||
160741510|NCT03191864|580435530|FG005|Part 1 - Induction|Randomized but never dosed|0|||
160741511|NCT03191864|580435525|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
160741512|NCT03191864|580435526|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
160741513|NCT03191864|580435527|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
160741514|NCT03191864|580435528|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
160741515|NCT03191864|580435529|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
160741516|NCT03191864|580435530|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
160741517|NCT03191864|580435525|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
160741518|NCT03191864|580435526|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
160741519|NCT03191864|580435527|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
160741520|NCT03191864|580435528|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
160741521|NCT03191864|580435529|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
160741522|NCT03191864|580435530|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
160741523|NCT03191864|580435525|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
160741524|NCT03191864|580435526|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
160741525|NCT03191864|580435527|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
160741526|NCT03191864|580435528|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
160741527|NCT03191864|580435529|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
160741528|NCT03191864|580435530|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
160741529|NCT03191864|580435525|FG000|Part 2 - Maintenance|Physician Decision|1|||
160741530|NCT03191864|580435526|FG001|Part 2 - Maintenance|Physician Decision|0|||
160741531|NCT03191864|580435527|FG002|Part 2 - Maintenance|Physician Decision|0|||
160741532|NCT03191864|580435528|FG003|Part 2 - Maintenance|Physician Decision|0|||
160741533|NCT03191864|580435529|FG004|Part 2 - Maintenance|Physician Decision|0|||
160741534|NCT03191864|580435530|FG005|Part 2 - Maintenance|Physician Decision|0|||
160741535|NCT03191864|580435525|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
160741536|NCT03191864|580435526|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
160741537|NCT03191864|580435527|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
160741538|NCT03191864|580435528|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
160741539|NCT03191864|580435529|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
160741540|NCT03191864|580435530|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
160741541|NCT03191864|580435525|FG000|Part 2 - Maintenance|Adverse Event|0|||
160741542|NCT03191864|580435526|FG001|Part 2 - Maintenance|Adverse Event|0|||
160741543|NCT03191864|580435527|FG002|Part 2 - Maintenance|Adverse Event|0|||
160741544|NCT03191864|580435528|FG003|Part 2 - Maintenance|Adverse Event|0|||
160741545|NCT03191864|580435529|FG004|Part 2 - Maintenance|Adverse Event|1|||
160741546|NCT03191864|580435530|FG005|Part 2 - Maintenance|Adverse Event|0|||
160741547|NCT03191864|580435525|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
160741548|NCT03191864|580435526|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
160741549|NCT03191864|580435527|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
160741550|NCT03191864|580435528|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
160741551|NCT03191864|580435529|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
160741552|NCT03191864|580435530|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
160741553|NCT03191864|580435525|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
160741554|NCT03191864|580435526|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
160741555|NCT03191864|580435527|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
160741556|NCT03191864|580435528|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
160741557|NCT03191864|580435529|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
160741558|NCT03191864|580435530|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
160741559|NCT00415597|580435531|FG000|Enrollment|Withdrawal by Subject|1|||
160741560|NCT00415597|580435531|FG000|Enrollment|Protocol Violation|1|||
160741561|NCT00415597|580435531|FG000|Treatment|Adverse Event|110|||
160741562|NCT00415597|580435531|FG000|Treatment|Lack of Efficacy|39|||
160741563|NCT00415597|580435531|FG000|Treatment|Protocol Violation|67|||
160741564|NCT00415597|580435531|FG000|Treatment|Physician Decision|3|||
160741565|NCT00415597|580435531|FG000|Treatment|Withdrawal by Subject|51|||
160741566|NCT00415597|580435531|FG000|Treatment|Lost to Follow-up|28|||
160741567|NCT00415597|580435531|FG000|Treatment|Drug Screen|2|||
160741568|NCT00415597|580435531|FG000|Treatment|Administrative|3|||
160741569|NCT00415597|580435531|FG000|Treatment|Sponsor Decision|1|||
160741570|NCT00415597|580435531|FG000|Treatment|Multiple Reasons|1|||
160741571|NCT02172040|580435537|FG000|Overall Study|Adverse Event|0|||
160741572|NCT02172040|580435538|FG001|Overall Study|Adverse Event|2|||
160741573|NCT02172040|580435539|FG002|Overall Study|Adverse Event|0|||
160741574|NCT02172040|580435540|FG003|Overall Study|Adverse Event|0|||
160741575|NCT02172040|580435537|FG000|Overall Study|Protocol Violation|0|||
160741576|NCT02172040|580435538|FG001|Overall Study|Protocol Violation|1|||
160741577|NCT02172040|580435539|FG002|Overall Study|Protocol Violation|0|||
160741578|NCT02172040|580435540|FG003|Overall Study|Protocol Violation|0|||
160741579|NCT02172040|580435537|FG000|Overall Study|Withdrawal by Subject|0|||
160741580|NCT02172040|580435538|FG001|Overall Study|Withdrawal by Subject|0|||
160741581|NCT02172040|580435539|FG002|Overall Study|Withdrawal by Subject|1|||
160741582|NCT02172040|580435540|FG003|Overall Study|Withdrawal by Subject|0|||
160741583|NCT02172040|580435537|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
160741584|NCT02172040|580435538|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
160741585|NCT02172040|580435539|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
160741586|NCT02172040|580435540|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
160741587|NCT02172040|580435537|FG000|Overall Study|Family emergency abroad|0|||
160741588|NCT02172040|580435538|FG001|Overall Study|Family emergency abroad|0|||
160741589|NCT02172040|580435539|FG002|Overall Study|Family emergency abroad|0|||
160741590|NCT02172040|580435540|FG003|Overall Study|Family emergency abroad|1|||
160741591|NCT04908202|580435541|FG000|Pre-Treatment Period|OTHER REASONS|3|||
160741592|NCT04908202|580435542|FG001|Pre-Treatment Period|OTHER REASONS|1|||
160741593|NCT04908202|580435543|FG002|Pre-Treatment Period|OTHER REASONS|0|||
160741594|NCT04908202|580435544|FG003|Pre-Treatment Period|OTHER REASONS|0|||
160741595|NCT04908202|580435541|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
160741596|NCT04908202|580435542|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
160741597|NCT04908202|580435543|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
160741598|NCT04908202|580435544|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
160741599|NCT04908202|580435541|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
160741600|NCT04908202|580435542|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
160741601|NCT04908202|580435543|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
160741602|NCT04908202|580435544|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
160741603|NCT04908202|580435541|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
160741604|NCT04908202|580435542|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
160741605|NCT04908202|580435543|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
160741606|NCT04908202|580435544|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
160741607|NCT04908202|580435541|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
160741608|NCT04908202|580435542|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
160741609|NCT04908202|580435543|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
160741610|NCT04908202|580435544|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
160741611|NCT04908202|580435541|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
160741612|NCT04908202|580435542|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
160741613|NCT04908202|580435543|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
160741614|NCT04908202|580435544|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
160741615|NCT04908202|580435541|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
160741616|NCT04908202|580435542|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
160741617|NCT04908202|580435543|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
160741618|NCT04908202|580435544|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
160741619|NCT04908202|580435541|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
160741620|NCT04908202|580435542|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
160741621|NCT04908202|580435543|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
160741622|NCT04908202|580435544|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
160741623|NCT04908202|580435541|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
160741624|NCT04908202|580435542|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
160741625|NCT04908202|580435543|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
160741626|NCT04908202|580435544|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
160741627|NCT04908202|580435541|FG000|Active Treatment Period|OTHER REASONS|0|||
160741628|NCT04908202|580435542|FG001|Active Treatment Period|OTHER REASONS|0|||
160741629|NCT04908202|580435543|FG002|Active Treatment Period|OTHER REASONS|1|||
160741630|NCT04908202|580435544|FG003|Active Treatment Period|OTHER REASONS|3|||
160741631|NCT04908202|580435541|FG000|Active Treatment Period|Lack of Efficacy|0|||
160741632|NCT04908202|580435542|FG001|Active Treatment Period|Lack of Efficacy|0|||
160741633|NCT04908202|580435543|FG002|Active Treatment Period|Lack of Efficacy|4|||
160741634|NCT04908202|580435544|FG003|Active Treatment Period|Lack of Efficacy|5|||
160741635|NCT04908202|580435541|FG000|Active Treatment Period|Adverse Event|0|||
160741636|NCT04908202|580435542|FG001|Active Treatment Period|Adverse Event|0|||
160741637|NCT04908202|580435543|FG002|Active Treatment Period|Adverse Event|5|||
160741638|NCT04908202|580435544|FG003|Active Treatment Period|Adverse Event|8|||
160741639|NCT04908202|580435541|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
160748721|NCT00303472|580465928|FG002|Treatment Extension (Optional)|Physician Decision|2|||
160741640|NCT04908202|580435542|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
160741641|NCT04908202|580435543|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
160741642|NCT04908202|580435544|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
160741643|NCT04908202|580435541|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
160741644|NCT04908202|580435542|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
160741645|NCT04908202|580435543|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
160741646|NCT04908202|580435544|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
160741647|NCT04908202|580435541|FG000|Active Treatment Period|Lost to Follow-up|0|||
160741648|NCT04908202|580435542|FG001|Active Treatment Period|Lost to Follow-up|0|||
160741649|NCT04908202|580435543|FG002|Active Treatment Period|Lost to Follow-up|2|||
160741650|NCT04908202|580435544|FG003|Active Treatment Period|Lost to Follow-up|2|||
160741651|NCT04908202|580435541|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
160741652|NCT04908202|580435542|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
160741653|NCT04908202|580435543|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
160741654|NCT04908202|580435544|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
160741655|NCT04908202|580435541|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
160741656|NCT04908202|580435542|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
160741657|NCT04908202|580435543|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
160741658|NCT04908202|580435544|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
160741659|NCT04908202|580435541|FG000|Active Treatment Period|ONGOING Treatment|0|||
160741660|NCT04908202|580435542|FG001|Active Treatment Period|ONGOING Treatment|0|||
160741661|NCT04908202|580435543|FG002|Active Treatment Period|ONGOING Treatment|117|||
160741662|NCT04908202|580435544|FG003|Active Treatment Period|ONGOING Treatment|114|||
160741663|NCT04506905|580435547|FG000|Overall Study|Lost to Follow-up|1|||
160741664|NCT04506905|580435548|FG001|Overall Study|Lost to Follow-up|0|||
160741665|NCT04506905|580435549|FG002|Overall Study|Lost to Follow-up|0|||
160741666|NCT04506905|580435550|FG003|Overall Study|Lost to Follow-up|1|||
160741667|NCT04506905|580435551|FG004|Overall Study|Lost to Follow-up|0|||
160741668|NCT04506905|580435552|FG005|Overall Study|Lost to Follow-up|0|||
160741669|NCT04506905|580435553|FG006|Overall Study|Lost to Follow-up|0|||
160741670|NCT04506905|580435554|FG007|Overall Study|Lost to Follow-up|0|||
160741671|NCT04506905|580435555|FG008|Overall Study|Lost to Follow-up|0|||
160741672|NCT04506905|580435547|FG000|Overall Study|Withdrawal by Subject|0|||
160741673|NCT04506905|580435548|FG001|Overall Study|Withdrawal by Subject|0|||
160741674|NCT04506905|580435549|FG002|Overall Study|Withdrawal by Subject|0|||
160741675|NCT04506905|580435550|FG003|Overall Study|Withdrawal by Subject|2|||
160741676|NCT04506905|580435551|FG004|Overall Study|Withdrawal by Subject|0|||
160741677|NCT04506905|580435552|FG005|Overall Study|Withdrawal by Subject|0|||
160741678|NCT04506905|580435553|FG006|Overall Study|Withdrawal by Subject|0|||
160741679|NCT04506905|580435554|FG007|Overall Study|Withdrawal by Subject|0|||
160741680|NCT04506905|580435555|FG008|Overall Study|Withdrawal by Subject|0|||
160741681|NCT02093390|580435556|FG000|Overall Study|Withdrawal by Subject|0|||
160741682|NCT02093390|580435557|FG001|Overall Study|Withdrawal by Subject|1|||
160741683|NCT00073983|580435558|FG000|Overall Study|not evaluable|1|||
160741684|NCT03976323|580435561|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
160741685|NCT03976323|580435562|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
160741686|NCT03976323|580435563|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
160741687|NCT03976323|580435561|FG000|Induction Phase|Death|80|||
160741688|NCT03976323|580435562|FG001|Induction Phase|Death|0|||
160741689|NCT03976323|580435563|FG002|Induction Phase|Death|0|||
160741690|NCT03976323|580435561|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
160741691|NCT03976323|580435562|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
160741692|NCT03976323|580435563|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
160741693|NCT03976323|580435561|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160741694|NCT03976323|580435562|FG001|Maintenance Phase|Withdrawal by Subject|9|||
160741695|NCT03976323|580435563|FG002|Maintenance Phase|Withdrawal by Subject|3|||
160741696|NCT03976323|580435561|FG000|Maintenance Phase|Physician Decision|0|||
160741697|NCT03976323|580435562|FG001|Maintenance Phase|Physician Decision|0|||
160741698|NCT03976323|580435563|FG002|Maintenance Phase|Physician Decision|1|||
160741699|NCT03976323|580435561|FG000|Maintenance Phase|Death|0|||
160741700|NCT03976323|580435562|FG001|Maintenance Phase|Death|228|||
160741701|NCT03976323|580435563|FG002|Maintenance Phase|Death|234|||
160741702|NCT02294461|580435564|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
160741703|NCT02294461|580435565|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
160741704|NCT02294461|580435566|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
160741705|NCT02294461|580435564|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
160741706|NCT02294461|580435565|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
160741707|NCT02294461|580435566|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
160741708|NCT02294461|580435564|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
160741709|NCT02294461|580435565|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
160741710|NCT02294461|580435566|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
160741711|NCT02294461|580435564|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
160741712|NCT02294461|580435565|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
160741713|NCT02294461|580435566|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
160741714|NCT02294461|580435564|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
160741715|NCT02294461|580435565|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
160741716|NCT02294461|580435566|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
160741717|NCT02294461|580435564|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
160741718|NCT02294461|580435565|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
160741719|NCT02294461|580435566|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
160741720|NCT02294461|580435564|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
160741721|NCT02294461|580435565|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
160741722|NCT02294461|580435566|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
160741723|NCT02294461|580435564|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
160741724|NCT02294461|580435565|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
160741725|NCT02294461|580435566|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
160741726|NCT02294461|580435564|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
160741727|NCT02294461|580435565|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
160741728|NCT02294461|580435566|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
160741729|NCT02294461|580435564|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
160741730|NCT02294461|580435565|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
160741731|NCT02294461|580435566|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
160741732|NCT02294461|580435564|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
160741733|NCT02294461|580435565|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
160741734|NCT02294461|580435566|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
160741735|NCT02294461|580435564|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
160741736|NCT02294461|580435565|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
160741737|NCT02294461|580435566|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
160741738|NCT02294461|580435564|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
160741739|NCT02294461|580435565|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
160741740|NCT02294461|580435566|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
160741741|NCT02294461|580435564|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
160741742|NCT02294461|580435565|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
160741743|NCT02294461|580435566|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
160741744|NCT03800836|580435567|FG000|Overall Study|Other|2|||
160741745|NCT03800836|580435568|FG001|Overall Study|Other|1|||
160741746|NCT03800836|580435569|FG002|Overall Study|Other|0|||
160741747|NCT03800836|580435570|FG003|Overall Study|Other|2|||
160741748|NCT03800836|580435571|FG004|Overall Study|Other|0|||
160741749|NCT03800836|580435572|FG005|Overall Study|Other|1|||
160741750|NCT03800836|580435567|FG000|Overall Study|Lost to Follow-up|2|||
160741751|NCT03800836|580435568|FG001|Overall Study|Lost to Follow-up|0|||
160741752|NCT03800836|580435569|FG002|Overall Study|Lost to Follow-up|1|||
160741753|NCT03800836|580435570|FG003|Overall Study|Lost to Follow-up|1|||
160741754|NCT03800836|580435571|FG004|Overall Study|Lost to Follow-up|3|||
160741755|NCT03800836|580435572|FG005|Overall Study|Lost to Follow-up|0|||
160741756|NCT03800836|580435567|FG000|Overall Study|Withdrawal by Subject|1|||
160741757|NCT03800836|580435568|FG001|Overall Study|Withdrawal by Subject|0|||
160741758|NCT03800836|580435569|FG002|Overall Study|Withdrawal by Subject|0|||
160741759|NCT03800836|580435570|FG003|Overall Study|Withdrawal by Subject|0|||
160741760|NCT03800836|580435571|FG004|Overall Study|Withdrawal by Subject|0|||
160741761|NCT03800836|580435572|FG005|Overall Study|Withdrawal by Subject|0|||
160741762|NCT03800836|580435567|FG000|Overall Study|Physician Decision|31|||
160741763|NCT03800836|580435568|FG001|Overall Study|Physician Decision|3|||
160741764|NCT03800836|580435569|FG002|Overall Study|Physician Decision|6|||
160741765|NCT03800836|580435570|FG003|Overall Study|Physician Decision|4|||
160741766|NCT03800836|580435571|FG004|Overall Study|Physician Decision|4|||
160741767|NCT03800836|580435572|FG005|Overall Study|Physician Decision|5|||
160741768|NCT03800836|580435567|FG000|Overall Study|Death|34|||
160741769|NCT03800836|580435568|FG001|Overall Study|Death|16|||
160741770|NCT03800836|580435569|FG002|Overall Study|Death|5|||
160741771|NCT03800836|580435570|FG003|Overall Study|Death|5|||
160741772|NCT03800836|580435571|FG004|Overall Study|Death|10|||
160741773|NCT03800836|580435572|FG005|Overall Study|Death|0|||
160741774|NCT03800836|580435567|FG000|Overall Study|Symptomatic Deterioration|1|||
160741775|NCT03800836|580435568|FG001|Overall Study|Symptomatic Deterioration|0|||
160741776|NCT03800836|580435569|FG002|Overall Study|Symptomatic Deterioration|1|||
160741777|NCT03800836|580435570|FG003|Overall Study|Symptomatic Deterioration|0|||
160741778|NCT03800836|580435571|FG004|Overall Study|Symptomatic Deterioration|0|||
160741779|NCT03800836|580435572|FG005|Overall Study|Symptomatic Deterioration|0|||
160741780|NCT01709864|580437038|FG000|Overall Study|Physician Decision|0|||
160741781|NCT01709864|580437039|FG001|Overall Study|Physician Decision|1|||
160741782|NCT01709864|580437038|FG000|Overall Study|subject/guardian decision|5|||
160741783|NCT01709864|580437039|FG001|Overall Study|subject/guardian decision|6|||
160741784|NCT01709864|580437038|FG000|Overall Study|Lost to Follow-up|1|||
160741785|NCT01709864|580437039|FG001|Overall Study|Lost to Follow-up|0|||
160741786|NCT01709864|580437038|FG000|Overall Study|non-compliance with study treatment|1|||
160741787|NCT01709864|580437039|FG001|Overall Study|non-compliance with study treatment|1|||
160741788|NCT01709864|580437038|FG000|Overall Study|Adverse Event|0|||
160741789|NCT01709864|580437039|FG001|Overall Study|Adverse Event|2|||
160741790|NCT01709864|580437038|FG000|Overall Study|Death|0|||
160741791|NCT01709864|580437039|FG001|Overall Study|Death|1|||
160741792|NCT01066793|580437040|FG000|Overall Study|Death|4|||
160741793|NCT01066793|580437041|FG001|Overall Study|Death|1|||
160741794|NCT01066793|580437042|FG002|Overall Study|Death|1|||
160741795|NCT01066793|580437043|FG003|Overall Study|Death|0|||
160741796|NCT01066793|580437044|FG004|Overall Study|Death|0|||
160741797|NCT01066793|580437045|FG005|Overall Study|Death|0|||
160741798|NCT01066793|580437040|FG000|Overall Study|Lack of Efficacy|2|||
160741799|NCT01066793|580437041|FG001|Overall Study|Lack of Efficacy|1|||
160741800|NCT01066793|580437042|FG002|Overall Study|Lack of Efficacy|0|||
160741801|NCT01066793|580437043|FG003|Overall Study|Lack of Efficacy|0|||
160741802|NCT01066793|580437044|FG004|Overall Study|Lack of Efficacy|0|||
160741803|NCT01066793|580437045|FG005|Overall Study|Lack of Efficacy|0|||
160741804|NCT01066793|580437040|FG000|Overall Study|Lost to Follow-up|180|||
160741805|NCT01066793|580437041|FG001|Overall Study|Lost to Follow-up|39|||
160741806|NCT01066793|580437042|FG002|Overall Study|Lost to Follow-up|82|||
160741807|NCT01066793|580437043|FG003|Overall Study|Lost to Follow-up|16|||
160741808|NCT01066793|580437044|FG004|Overall Study|Lost to Follow-up|0|||
160741809|NCT01066793|580437045|FG005|Overall Study|Lost to Follow-up|1|||
160741810|NCT01066793|580437040|FG000|Overall Study|Physician Decision|3|||
160741811|NCT01066793|580437041|FG001|Overall Study|Physician Decision|0|||
160741812|NCT01066793|580437042|FG002|Overall Study|Physician Decision|0|||
160741813|NCT01066793|580437043|FG003|Overall Study|Physician Decision|0|||
160741814|NCT01066793|580437044|FG004|Overall Study|Physician Decision|0|||
160741815|NCT01066793|580437045|FG005|Overall Study|Physician Decision|0|||
160741816|NCT01066793|580437040|FG000|Overall Study|Protocol Violation|3|||
160741817|NCT01066793|580437041|FG001|Overall Study|Protocol Violation|2|||
160741818|NCT01066793|580437042|FG002|Overall Study|Protocol Violation|2|||
160741819|NCT01066793|580437043|FG003|Overall Study|Protocol Violation|0|||
160741820|NCT01066793|580437044|FG004|Overall Study|Protocol Violation|0|||
160741821|NCT01066793|580437045|FG005|Overall Study|Protocol Violation|0|||
160741822|NCT01066793|580437040|FG000|Overall Study|Withdrawal by Subject|7|||
160741823|NCT01066793|580437041|FG001|Overall Study|Withdrawal by Subject|4|||
160741824|NCT01066793|580437042|FG002|Overall Study|Withdrawal by Subject|1|||
160741825|NCT01066793|580437043|FG003|Overall Study|Withdrawal by Subject|0|||
160741826|NCT01066793|580437044|FG004|Overall Study|Withdrawal by Subject|0|||
160741827|NCT01066793|580437045|FG005|Overall Study|Withdrawal by Subject|0|||
160741828|NCT01066793|580437040|FG000|Overall Study|Early Termination|3|||
160741829|NCT01066793|580437041|FG001|Overall Study|Early Termination|0|||
160741830|NCT01066793|580437042|FG002|Overall Study|Early Termination|0|||
160741831|NCT01066793|580437043|FG003|Overall Study|Early Termination|0|||
160741832|NCT01066793|580437044|FG004|Overall Study|Early Termination|0|||
160741833|NCT01066793|580437045|FG005|Overall Study|Early Termination|0|||
160741834|NCT01066793|580437040|FG000|Overall Study|Lab test not done|7|||
160741835|NCT01066793|580437041|FG001|Overall Study|Lab test not done|0|||
160741836|NCT01066793|580437042|FG002|Overall Study|Lab test not done|0|||
160741837|NCT01066793|580437043|FG003|Overall Study|Lab test not done|1|||
160741838|NCT01066793|580437044|FG004|Overall Study|Lab test not done|0|||
160741839|NCT01066793|580437045|FG005|Overall Study|Lab test not done|0|||
160741840|NCT01066793|580437040|FG000|Overall Study|Miscellaneous|4|||
160741841|NCT01066793|580437041|FG001|Overall Study|Miscellaneous|5|||
160741842|NCT01066793|580437042|FG002|Overall Study|Miscellaneous|6|||
160741843|NCT01066793|580437043|FG003|Overall Study|Miscellaneous|0|||
160741844|NCT01066793|580437044|FG004|Overall Study|Miscellaneous|0|||
160741845|NCT01066793|580437045|FG005|Overall Study|Miscellaneous|0|||
160741846|NCT01066793|580437040|FG000|Overall Study|Non-responders|104|||
160741847|NCT01066793|580437041|FG001|Overall Study|Non-responders|5|||
160741848|NCT01066793|580437042|FG002|Overall Study|Non-responders|11|||
160741849|NCT01066793|580437043|FG003|Overall Study|Non-responders|25|||
160741850|NCT01066793|580437044|FG004|Overall Study|Non-responders|0|||
160741851|NCT01066793|580437045|FG005|Overall Study|Non-responders|0|||
160741852|NCT01066793|580437040|FG000|Overall Study|Other|15|||
160741853|NCT01066793|580437041|FG001|Overall Study|Other|5|||
160741854|NCT01066793|580437042|FG002|Overall Study|Other|6|||
160741855|NCT01066793|580437043|FG003|Overall Study|Other|2|||
160741856|NCT01066793|580437044|FG004|Overall Study|Other|0|||
160741857|NCT01066793|580437045|FG005|Overall Study|Other|0|||
160741858|NCT01066793|580437040|FG000|Overall Study|Relapse|20|||
160741859|NCT01066793|580437041|FG001|Overall Study|Relapse|8|||
160741860|NCT01066793|580437042|FG002|Overall Study|Relapse|2|||
160741861|NCT01066793|580437043|FG003|Overall Study|Relapse|3|||
160741862|NCT01066793|580437044|FG004|Overall Study|Relapse|0|||
160741863|NCT01066793|580437045|FG005|Overall Study|Relapse|0|||
160741864|NCT01066793|580437040|FG000|Overall Study|Result Not Available|1|||
160741865|NCT01066793|580437041|FG001|Overall Study|Result Not Available|0|||
160741866|NCT01066793|580437042|FG002|Overall Study|Result Not Available|0|||
160741867|NCT01066793|580437043|FG003|Overall Study|Result Not Available|0|||
160741868|NCT01066793|580437044|FG004|Overall Study|Result Not Available|0|||
160741869|NCT01066793|580437045|FG005|Overall Study|Result Not Available|0|||
160741870|NCT01066793|580437040|FG000|Overall Study|Treatment Interrupted|1|||
160741871|NCT01066793|580437041|FG001|Overall Study|Treatment Interrupted|1|||
160741872|NCT01066793|580437042|FG002|Overall Study|Treatment Interrupted|0|||
160741873|NCT01066793|580437043|FG003|Overall Study|Treatment Interrupted|0|||
160741874|NCT01066793|580437044|FG004|Overall Study|Treatment Interrupted|0|||
160741875|NCT01066793|580437045|FG005|Overall Study|Treatment Interrupted|0|||
160741876|NCT01066793|580437040|FG000|Overall Study|Treatment Never Started|18|||
160741877|NCT01066793|580437041|FG001|Overall Study|Treatment Never Started|5|||
160741878|NCT01066793|580437042|FG002|Overall Study|Treatment Never Started|4|||
160741879|NCT01066793|580437043|FG003|Overall Study|Treatment Never Started|1|||
160741880|NCT01066793|580437044|FG004|Overall Study|Treatment Never Started|0|||
160741881|NCT01066793|580437045|FG005|Overall Study|Treatment Never Started|0|||
160741882|NCT01066793|580437040|FG000|Overall Study|Treatment Stopped|2|||
160741883|NCT01066793|580437041|FG001|Overall Study|Treatment Stopped|1|||
160741884|NCT01066793|580437042|FG002|Overall Study|Treatment Stopped|0|||
160741885|NCT01066793|580437043|FG003|Overall Study|Treatment Stopped|1|||
160741886|NCT01066793|580437044|FG004|Overall Study|Treatment Stopped|0|||
160741887|NCT01066793|580437045|FG005|Overall Study|Treatment Stopped|0|||
160741888|NCT02697916|580437047|FG000|Overall Study|Death|357|||
160741889|NCT02697916|580437048|FG001|Overall Study|Death|315|||
160741890|NCT02697916|580437047|FG000|Overall Study|Withdrawal by Subject|221|||
160741891|NCT02697916|580437048|FG001|Overall Study|Withdrawal by Subject|393|||
160741892|NCT02864316|580437049|FG000|Overall Study|Progressive Disease|2|||
160741893|NCT02864316|580437050|FG001|Overall Study|Progressive Disease|1|||
160741894|NCT02864316|580437049|FG000|Overall Study|Adverse Event|0|||
160741895|NCT02864316|580437050|FG001|Overall Study|Adverse Event|1|||
160741896|NCT05916131|580437055|FG000|Overall Study|Lost to Follow-up|0|||
160741897|NCT05916131|580437056|FG001|Overall Study|Lost to Follow-up|0|||
160741898|NCT05916131|580437057|FG002|Overall Study|Lost to Follow-up|1|||
160741899|NCT05916131|580437058|FG003|Overall Study|Lost to Follow-up|0|||
160741900|NCT03030118|580437059|FG000|Overall Study|Achieved SLE Diagnosis|11|||
160741901|NCT03030118|580437060|FG001|Overall Study|Achieved SLE Diagnosis|10|||
160741902|NCT03030118|580437059|FG000|Overall Study|Adverse Event|1|||
160741903|NCT03030118|580437060|FG001|Overall Study|Adverse Event|1|||
160741904|NCT03030118|580437059|FG000|Overall Study|Pregnancy|2|||
160741905|NCT03030118|580437060|FG001|Overall Study|Pregnancy|2|||
160741906|NCT03030118|580437059|FG000|Overall Study|Lost to Follow-up|5|||
160741907|NCT03030118|580437060|FG001|Overall Study|Lost to Follow-up|6|||
160741908|NCT03030118|580437059|FG000|Overall Study|Concomitant Medications|1|||
160741909|NCT03030118|580437060|FG001|Overall Study|Concomitant Medications|1|||
160741910|NCT03030118|580437059|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
160741911|NCT03030118|580437060|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
160741912|NCT03030118|580437059|FG000|Overall Study|Other|2|||
160741913|NCT03030118|580437060|FG001|Overall Study|Other|0|||
160741914|NCT03030118|580437059|FG000|Overall Study|Withdrawal by Subject|26|||
160741915|NCT03030118|580437060|FG001|Overall Study|Withdrawal by Subject|21|||
160741916|NCT03030118|580437059|FG000|Overall Study|Protocol Violation|1|||
160741917|NCT03030118|580437060|FG001|Overall Study|Protocol Violation|6|||
160741918|NCT04643964|580437061|FG000|Overall Study|Lost to Follow-up|55|||
160741919|NCT04643964|580437062|FG001|Overall Study|Lost to Follow-up|59|||
160741920|NCT04643964|580437063|FG002|Overall Study|Lost to Follow-up|54|||
160741921|NCT04643964|580437064|FG003|Overall Study|Lost to Follow-up|129|||
160741922|NCT04643964|580437065|FG004|Overall Study|Lost to Follow-up|48|||
160741923|NCT04643964|580437061|FG000|Overall Study|Failed attention check|1|||
160741924|NCT04643964|580437062|FG001|Overall Study|Failed attention check|8|||
160741925|NCT04643964|580437063|FG002|Overall Study|Failed attention check|2|||
160741926|NCT04643964|580437064|FG003|Overall Study|Failed attention check|14|||
160741927|NCT04643964|580437065|FG004|Overall Study|Failed attention check|11|||
160741928|NCT02949908|580437066|FG000|Overall Study|Study termination|2|||
160741929|NCT02607280|580437068|FG000|Overall Study|Adverse Event|4|||
160741930|NCT02607280|580437069|FG001|Overall Study|Adverse Event|0|||
160741931|NCT02607280|580437068|FG000|Overall Study|Decrease in CrCl <15|0|||
160741932|NCT02607280|580437069|FG001|Overall Study|Decrease in CrCl <15|1|||
160741933|NCT00558896|580437070|FG000|Overall Study|Adverse Event|1|||
160741934|NCT00558896|580437071|FG001|Overall Study|Adverse Event|1|||
160741935|NCT00558896|580437072|FG002|Overall Study|Adverse Event|1|||
160741936|NCT00558896|580437073|FG003|Overall Study|Adverse Event|3|||
160741937|NCT00558896|580437074|FG004|Overall Study|Adverse Event|4|||
160741938|NCT00558896|580437075|FG005|Overall Study|Adverse Event|10|||
160741939|NCT00558896|580437076|FG006|Overall Study|Adverse Event|3|||
160741940|NCT00558896|580437070|FG000|Overall Study|Death|3|||
160741941|NCT00558896|580437071|FG001|Overall Study|Death|0|||
160741942|NCT00558896|580437072|FG002|Overall Study|Death|2|||
160741943|NCT00558896|580437073|FG003|Overall Study|Death|3|||
160741944|NCT00558896|580437074|FG004|Overall Study|Death|2|||
160741945|NCT00558896|580437075|FG005|Overall Study|Death|2|||
160741946|NCT00558896|580437076|FG006|Overall Study|Death|6|||
160741947|NCT00558896|580437070|FG000|Overall Study|Withdrawal by Subject|2|||
160741948|NCT00558896|580437071|FG001|Overall Study|Withdrawal by Subject|1|||
160741949|NCT00558896|580437072|FG002|Overall Study|Withdrawal by Subject|1|||
160741950|NCT00558896|580437073|FG003|Overall Study|Withdrawal by Subject|1|||
160741951|NCT00558896|580437074|FG004|Overall Study|Withdrawal by Subject|1|||
160741952|NCT00558896|580437075|FG005|Overall Study|Withdrawal by Subject|5|||
160741953|NCT00558896|580437076|FG006|Overall Study|Withdrawal by Subject|5|||
160741954|NCT00558896|580437070|FG000|Overall Study|Alternative Treatment|2|||
160741955|NCT00558896|580437071|FG001|Overall Study|Alternative Treatment|2|||
160741956|NCT00558896|580437072|FG002|Overall Study|Alternative Treatment|0|||
160741957|NCT00558896|580437073|FG003|Overall Study|Alternative Treatment|2|||
160741958|NCT00558896|580437074|FG004|Overall Study|Alternative Treatment|6|||
160741959|NCT00558896|580437075|FG005|Overall Study|Alternative Treatment|7|||
160741960|NCT00558896|580437076|FG006|Overall Study|Alternative Treatment|1|||
160741961|NCT00558896|580437070|FG000|Overall Study|Physician discretion|3|||
160741962|NCT00558896|580437071|FG001|Overall Study|Physician discretion|2|||
160741963|NCT00558896|580437072|FG002|Overall Study|Physician discretion|1|||
160741964|NCT00558896|580437073|FG003|Overall Study|Physician discretion|2|||
160741965|NCT00558896|580437074|FG004|Overall Study|Physician discretion|1|||
160741966|NCT00558896|580437075|FG005|Overall Study|Physician discretion|3|||
160741967|NCT00558896|580437076|FG006|Overall Study|Physician discretion|3|||
160741968|NCT00558896|580437070|FG000|Overall Study|Continues on treatment|10|||
160741969|NCT00558896|580437071|FG001|Overall Study|Continues on treatment|1|||
160741970|NCT00558896|580437072|FG002|Overall Study|Continues on treatment|0|||
160741971|NCT00558896|580437073|FG003|Overall Study|Continues on treatment|1|||
160741972|NCT00558896|580437074|FG004|Overall Study|Continues on treatment|9|||
160741973|NCT00558896|580437075|FG005|Overall Study|Continues on treatment|25|||
160741974|NCT00558896|580437076|FG006|Overall Study|Continues on treatment|6|||
160741975|NCT04829331|580437079|FG000|Overall Study|Lost to Follow-up|1|||
160741976|NCT04829331|580437080|FG001|Overall Study|Lost to Follow-up|0|||
160741977|NCT05323994|580437081|FG000|Overall Study|Protocol Violation|1|||
160741978|NCT00454818|580437085|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
160741979|NCT00454818|580437086|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
160741980|NCT00454818|580437087|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
160741981|NCT00454818|580437088|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
160741982|NCT00454818|580437089|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
160741983|NCT00454818|580437085|FG000|Phase I: Open-label Dose-escalation|Death|0|||
160741984|NCT00454818|580437086|FG001|Phase I: Open-label Dose-escalation|Death|1|||
160741985|NCT00454818|580437087|FG002|Phase I: Open-label Dose-escalation|Death|0|||
160741986|NCT00454818|580437088|FG003|Phase I: Open-label Dose-escalation|Death|0|||
160741987|NCT00454818|580437089|FG004|Phase I: Open-label Dose-escalation|Death|0|||
160741988|NCT00454818|580437085|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
160741989|NCT00454818|580437086|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
160741990|NCT00454818|580437087|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
160741991|NCT00454818|580437088|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
160741992|NCT00454818|580437089|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
160741993|NCT00454818|580437085|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
160741994|NCT00454818|580437086|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
160741995|NCT00454818|580437087|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
160741996|NCT00454818|580437088|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
160741997|NCT00454818|580437089|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
160741998|NCT00454818|580437085|FG000|Phase 2: Randomized Double-blind|Death|0|||
160741999|NCT00454818|580437086|FG001|Phase 2: Randomized Double-blind|Death|1|||
160742000|NCT00454818|580437087|FG002|Phase 2: Randomized Double-blind|Death|0|||
160742001|NCT00454818|580437088|FG003|Phase 2: Randomized Double-blind|Death|0|||
160742002|NCT00454818|580437089|FG004|Phase 2: Randomized Double-blind|Death|1|||
160742003|NCT00454818|580437085|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
160742004|NCT00454818|580437086|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
160742005|NCT00454818|580437087|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
160742006|NCT00454818|580437088|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
160742007|NCT00454818|580437089|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
160742008|NCT00454818|580437085|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
160742009|NCT00454818|580437086|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
160742010|NCT00454818|580437087|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
160742011|NCT00454818|580437088|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
160742012|NCT00454818|580437089|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
160742013|NCT03181503|580437090|FG000|Overall Study|Adverse Event|2|||
160742014|NCT03181503|580437091|FG001|Overall Study|Adverse Event|2|||
160742015|NCT03181503|580437090|FG000|Overall Study|Protocol Violation|1|||
160742016|NCT03181503|580437091|FG001|Overall Study|Protocol Violation|0|||
160742017|NCT03181503|580437090|FG000|Overall Study|Withdrawal by Subject|3|||
160742018|NCT03181503|580437091|FG001|Overall Study|Withdrawal by Subject|0|||
160742019|NCT03181503|580437090|FG000|Overall Study|Lost to Follow-up|1|||
160742020|NCT03181503|580437091|FG001|Overall Study|Lost to Follow-up|1|||
160742021|NCT00766467|580437093|FG000|Overall Study|Withdrawal by Subject|7|||
160742022|NCT00766467|580437094|FG001|Overall Study|Withdrawal by Subject|2|||
160742023|NCT00766467|580437093|FG000|Overall Study|Adverse Event|1|||
160742024|NCT00766467|580437094|FG001|Overall Study|Adverse Event|1|||
160742025|NCT00766467|580437093|FG000|Overall Study|Protocol Violation|2|||
160742026|NCT00766467|580437094|FG001|Overall Study|Protocol Violation|4|||
160742027|NCT00766467|580437093|FG000|Overall Study|Tumor Progression on Study|0|||
160742028|NCT00766467|580437094|FG001|Overall Study|Tumor Progression on Study|1|||
160742029|NCT00766467|580437093|FG000|Overall Study|Physician Decision|1|||
160742030|NCT00766467|580437094|FG001|Overall Study|Physician Decision|0|||
160742031|NCT00908076|580437098|FG000|Overall Study|Lack of Efficacy|1|||
160742032|NCT00908076|580437099|FG001|Overall Study|Lack of Efficacy|1|||
160742033|NCT00662558|580437100|FG000|Overall Study|Adverse Event|21|||
160742034|NCT00662558|580437101|FG001|Overall Study|Adverse Event|59|||
160742035|NCT00662558|580437100|FG000|Overall Study|Lack of Efficacy|4|||
160742036|NCT00662558|580437101|FG001|Overall Study|Lack of Efficacy|7|||
160742037|NCT00662558|580437100|FG000|Overall Study|Lost to Follow-up|13|||
160742038|NCT00662558|580437101|FG001|Overall Study|Lost to Follow-up|10|||
160742039|NCT00662558|580437100|FG000|Overall Study|Other|9|||
160742040|NCT00662558|580437101|FG001|Overall Study|Other|14|||
160742041|NCT00662558|580437100|FG000|Overall Study|Withdrawal by Subject|7|||
160742042|NCT00662558|580437101|FG001|Overall Study|Withdrawal by Subject|12|||
160742043|NCT00662558|580437100|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
160742044|NCT00662558|580437101|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
160742045|NCT00396877|580437102|FG000|Overall Study|Lost to Follow-up|2|||
160742046|NCT00396877|580437103|FG001|Overall Study|Lost to Follow-up|1|||
160742047|NCT00396877|580437102|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
160742048|NCT00396877|580437103|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
160742049|NCT03329248|580437113|FG000|Overall Study|Progressive Disease|6|||
160742050|NCT00987402|580437114|FG000|Overall Study|Insufficient data entry|86|||
160742051|NCT00987402|580437115|FG001|Overall Study|Insufficient data entry|98|||
160742052|NCT03000530|580437119|FG000|Overall Study|Adverse Event|0|||
160742053|NCT03000530|580437120|FG001|Overall Study|Adverse Event|0|||
160742054|NCT03000530|580437121|FG002|Overall Study|Adverse Event|2|||
160742055|NCT03000530|580437119|FG000|Overall Study|Lost to Follow-up|0|||
160742056|NCT03000530|580437120|FG001|Overall Study|Lost to Follow-up|3|||
160742057|NCT03000530|580437121|FG002|Overall Study|Lost to Follow-up|1|||
160742058|NCT03000530|580437119|FG000|Overall Study|Withdrawal by Subject|0|||
160742059|NCT03000530|580437120|FG001|Overall Study|Withdrawal by Subject|2|||
160742060|NCT03000530|580437121|FG002|Overall Study|Withdrawal by Subject|1|||
160742061|NCT00306787|580437122|FG000|Overall Study|Discontinued without taking study drug|208|||
160742062|NCT00306787|580437123|FG001|Overall Study|Discontinued without taking study drug|215|||
160742063|NCT00306787|580437122|FG000|Overall Study|Adverse Event|1|||
160742064|NCT00306787|580437123|FG001|Overall Study|Adverse Event|1|||
160742065|NCT00306787|580437122|FG000|Overall Study|Lack of Efficacy|1|||
160742066|NCT00306787|580437123|FG001|Overall Study|Lack of Efficacy|0|||
160742067|NCT00306787|580437122|FG000|Overall Study|Protocol Violation|8|||
160742068|NCT00306787|580437123|FG001|Overall Study|Protocol Violation|10|||
160742069|NCT00306787|580437122|FG000|Overall Study|Withdrawal by Subject|2|||
160742070|NCT00306787|580437123|FG001|Overall Study|Withdrawal by Subject|9|||
160742071|NCT00306787|580437122|FG000|Overall Study|Lost to Follow-up|9|||
160742072|NCT00306787|580437123|FG001|Overall Study|Lost to Follow-up|6|||
160742073|NCT00306787|580437122|FG000|Overall Study|Administrative problems|4|||
160742074|NCT00306787|580437123|FG001|Overall Study|Administrative problems|0|||
160742075|NCT00306787|580437122|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160742076|NCT00306787|580437123|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160742077|NCT00369161|580437124|FG000|Overall Study|Adverse Event|15|||
160742078|NCT00369161|580437125|FG001|Overall Study|Adverse Event|13|||
160742079|NCT00369161|580437124|FG000|Overall Study|Abnormal laboratory value|0|||
160742080|NCT00369161|580437125|FG001|Overall Study|Abnormal laboratory value|1|||
160742081|NCT00369161|580437124|FG000|Overall Study|Lack of Efficacy|3|||
160742082|NCT00369161|580437125|FG001|Overall Study|Lack of Efficacy|1|||
160742083|NCT00369161|580437124|FG000|Overall Study|Protocol Violation|0|||
160742084|NCT00369161|580437125|FG001|Overall Study|Protocol Violation|2|||
160742085|NCT00369161|580437124|FG000|Overall Study|Withdrawal by Subject|2|||
160742086|NCT00369161|580437125|FG001|Overall Study|Withdrawal by Subject|3|||
160742087|NCT00369161|580437124|FG000|Overall Study|Death|1|||
160742088|NCT00369161|580437125|FG001|Overall Study|Death|2|||
160742089|NCT00369161|580437124|FG000|Overall Study|Graft loss|4|||
160742090|NCT00369161|580437125|FG001|Overall Study|Graft loss|0|||
160742091|NCT00369161|580437124|FG000|Overall Study|Administrative Problem|2|||
160742092|NCT00369161|580437125|FG001|Overall Study|Administrative Problem|2|||
160742093|NCT01870297|580437128|FG000|Overall Study|Adverse Event|0|||
160742094|NCT01870297|580437129|FG001|Overall Study|Adverse Event|0|||
160742095|NCT01870297|580437130|FG002|Overall Study|Adverse Event|0|||
160742096|NCT01870297|580437131|FG003|Overall Study|Adverse Event|0|||
160742097|NCT01870297|580437132|FG004|Overall Study|Adverse Event|2|||
160742098|NCT01870297|580437133|FG005|Overall Study|Adverse Event|0|||
160742099|NCT01870297|580437134|FG006|Overall Study|Adverse Event|0|||
160742100|NCT01870297|580437128|FG000|Overall Study|Lost to Follow-up|0|||
160742101|NCT01870297|580437129|FG001|Overall Study|Lost to Follow-up|1|||
160742102|NCT01870297|580437130|FG002|Overall Study|Lost to Follow-up|1|||
160742103|NCT01870297|580437131|FG003|Overall Study|Lost to Follow-up|0|||
160742104|NCT01870297|580437132|FG004|Overall Study|Lost to Follow-up|0|||
160742105|NCT01870297|580437133|FG005|Overall Study|Lost to Follow-up|0|||
160742106|NCT01870297|580437134|FG006|Overall Study|Lost to Follow-up|0|||
160742107|NCT01870297|580437128|FG000|Overall Study|Withdrawal by Subject|0|||
160742108|NCT01870297|580437129|FG001|Overall Study|Withdrawal by Subject|0|||
160742109|NCT01870297|580437130|FG002|Overall Study|Withdrawal by Subject|0|||
160742110|NCT01870297|580437131|FG003|Overall Study|Withdrawal by Subject|0|||
160742111|NCT01870297|580437132|FG004|Overall Study|Withdrawal by Subject|1|||
160742112|NCT01870297|580437133|FG005|Overall Study|Withdrawal by Subject|1|||
160742113|NCT01870297|580437134|FG006|Overall Study|Withdrawal by Subject|1|||
160742114|NCT01870297|580437128|FG000|Overall Study|Sponsor Decision|0|||
160742115|NCT01870297|580437129|FG001|Overall Study|Sponsor Decision|6|||
160742116|NCT01870297|580437130|FG002|Overall Study|Sponsor Decision|0|||
160742117|NCT01870297|580437131|FG003|Overall Study|Sponsor Decision|0|||
160742118|NCT01870297|580437132|FG004|Overall Study|Sponsor Decision|0|||
160742119|NCT01870297|580437133|FG005|Overall Study|Sponsor Decision|0|||
160742120|NCT01870297|580437134|FG006|Overall Study|Sponsor Decision|1|||
160742121|NCT00337779|580437135|FG000|Overall Study|Withdrawal by Subject|10|||
160742122|NCT00337779|580437136|FG001|Overall Study|Withdrawal by Subject|12|||
160742123|NCT00337779|580437135|FG000|Overall Study|Sponsor decision|1|||
160742124|NCT00337779|580437136|FG001|Overall Study|Sponsor decision|1|||
160742125|NCT00337779|580437135|FG000|Overall Study|Physician Decision|3|||
160742126|NCT00337779|580437136|FG001|Overall Study|Physician Decision|6|||
160742127|NCT00337779|580437135|FG000|Overall Study|Protocol Violation|1|||
160742128|NCT00337779|580437136|FG001|Overall Study|Protocol Violation|1|||
160742129|NCT00337779|580437135|FG000|Overall Study|Lost to Follow-up|6|||
160742130|NCT00337779|580437136|FG001|Overall Study|Lost to Follow-up|5|||
160742131|NCT00337779|580437135|FG000|Overall Study|Adverse Event|28|||
160742132|NCT00337779|580437136|FG001|Overall Study|Adverse Event|51|||
160742133|NCT00337779|580437135|FG000|Overall Study|Pregnancy|3|||
160742134|NCT00337779|580437136|FG001|Overall Study|Pregnancy|2|||
160742135|NCT00337779|580437135|FG000|Overall Study|Death|0|||
160742136|NCT00337779|580437136|FG001|Overall Study|Death|1|||
160742137|NCT00501059|580437139|FG000|Overall Study|Protocol Violation|80|||
160742138|NCT00501059|580437140|FG001|Overall Study|Protocol Violation|69|||
160742139|NCT00501059|580437139|FG000|Overall Study|Death|140|||
160742140|NCT00501059|580437140|FG001|Overall Study|Death|137|||
160742141|NCT00501059|580437139|FG000|Overall Study|Other|236|||
160742142|NCT00501059|580437140|FG001|Overall Study|Other|239|||
160742143|NCT00501059|580437139|FG000|Overall Study|Missing end-of-study page|91|||
160742144|NCT00501059|580437140|FG001|Overall Study|Missing end-of-study page|92|||
160742145|NCT00501059|580437139|FG000|Overall Study|Clinical endpoint reached|110|||
160742146|NCT00501059|580437140|FG001|Overall Study|Clinical endpoint reached|123|||
160742147|NCT00501059|580437139|FG000|Overall Study|Insufficient therapeutic effect|4|||
160742148|NCT00501059|580437140|FG001|Overall Study|Insufficient therapeutic effect|5|||
160742149|NCT00501059|580437139|FG000|Overall Study|Consent withdrawn by subject|817|||
160742150|NCT00501059|580437140|FG001|Overall Study|Consent withdrawn by subject|873|||
160742151|NCT00501059|580437139|FG000|Overall Study|Non-compliant with study treatment|23|||
160742152|NCT00501059|580437140|FG001|Overall Study|Non-compliant with study treatment|16|||
160742153|NCT00501059|580437139|FG000|Overall Study|Reason not given|3|||
160742154|NCT00501059|580437140|FG001|Overall Study|Reason not given|1|||
160742155|NCT00501059|580437139|FG000|Overall Study|Adverse Event|129|||
160742156|NCT00501059|580437140|FG001|Overall Study|Adverse Event|122|||
160742157|NCT00501059|580437139|FG000|Overall Study|Lost to Follow-up|210|||
160742158|NCT00501059|580437140|FG001|Overall Study|Lost to Follow-up|198|||
160742159|NCT00501059|580437139|FG000|Overall Study|Not treated|25|||
160742160|NCT00501059|580437140|FG001|Overall Study|Not treated|17|||
160742161|NCT04249622|580437141|FG000|Overall Study|Withdrawal by Subject|1|||
160742162|NCT04249622|580437142|FG001|Overall Study|Withdrawal by Subject|1|||
160742163|NCT04249622|580437141|FG000|Overall Study|Alternative therapy|1|||
160742164|NCT04249622|580437142|FG001|Overall Study|Alternative therapy|0|||
160742165|NCT04249622|580437141|FG000|Overall Study|Discontinuation of pertuzumab|1|||
160742166|NCT04249622|580437142|FG001|Overall Study|Discontinuation of pertuzumab|0|||
160742167|NCT03689543|580437143|FG000|Overall Study|Adverse Event|0|||
160742168|NCT03689543|580437144|FG001|Overall Study|Adverse Event|0|||
160742169|NCT03689543|580437145|FG002|Overall Study|Adverse Event|1|||
160742170|NCT00819780|580437149|FG000|Overall Study|Did not receive study drug|3|||
160742171|NCT00819780|580437150|FG001|Overall Study|Did not receive study drug|4|||
160742172|NCT00819780|580437149|FG000|Overall Study|Still in treatment|25|||
160742173|NCT00819780|580437150|FG001|Overall Study|Still in treatment|17|||
160742174|NCT02637713|580437152|FG000|Overall Study|Screen Failure|2|||
160742175|NCT02345889|580437153|FG000|Overall Study|Inadequate Bowel Prep|17|||
160742176|NCT02345889|580437154|FG001|Overall Study|Inadequate Bowel Prep|16|||
160742177|NCT02345889|580437155|FG002|Overall Study|Inadequate Bowel Prep|18|||
160742178|NCT02345889|580437156|FG003|Overall Study|Inadequate Bowel Prep|14|||
160742179|NCT02345889|580437153|FG000|Overall Study|Polyposis identified during procedure|1|||
160742180|NCT02345889|580437154|FG001|Overall Study|Polyposis identified during procedure|1|||
160742181|NCT02345889|580437155|FG002|Overall Study|Polyposis identified during procedure|0|||
160742182|NCT02345889|580437156|FG003|Overall Study|Polyposis identified during procedure|1|||
160742183|NCT02345889|580437153|FG000|Overall Study|Recognized ineligible post-randomization|1|||
160742184|NCT02345889|580437154|FG001|Overall Study|Recognized ineligible post-randomization|0|||
160742185|NCT02345889|580437155|FG002|Overall Study|Recognized ineligible post-randomization|2|||
160742186|NCT02345889|580437156|FG003|Overall Study|Recognized ineligible post-randomization|1|||
160742187|NCT02345889|580437153|FG000|Overall Study|Ulcerative Colitis identified|1|||
160742188|NCT02345889|580437154|FG001|Overall Study|Ulcerative Colitis identified|0|||
160742189|NCT02345889|580437155|FG002|Overall Study|Ulcerative Colitis identified|0|||
160742190|NCT02345889|580437156|FG003|Overall Study|Ulcerative Colitis identified|0|||
160742191|NCT02345889|580437153|FG000|Overall Study|Cecum not intubated|1|||
160742192|NCT02345889|580437154|FG001|Overall Study|Cecum not intubated|0|||
160742193|NCT02345889|580437155|FG002|Overall Study|Cecum not intubated|0|||
160742194|NCT02345889|580437156|FG003|Overall Study|Cecum not intubated|0|||
160742195|NCT00962091|580437157|FG000|Overall Study|Withdrawal by Subject|1|||
160742196|NCT00962091|580437158|FG001|Overall Study|Withdrawal by Subject|2|||
160742197|NCT00962091|580437159|FG002|Overall Study|Withdrawal by Subject|1|||
160742198|NCT00962091|580437160|FG003|Overall Study|Withdrawal by Subject|1|||
160742199|NCT00962091|580437161|FG004|Overall Study|Withdrawal by Subject|0|||
160742200|NCT00962091|580437162|FG005|Overall Study|Withdrawal by Subject|1|||
160742201|NCT00962091|580437163|FG006|Overall Study|Withdrawal by Subject|0|||
160742202|NCT00962091|580437157|FG000|Overall Study|Adverse Event|0|||
160742203|NCT00962091|580437158|FG001|Overall Study|Adverse Event|0|||
160742204|NCT00962091|580437159|FG002|Overall Study|Adverse Event|0|||
160742205|NCT00962091|580437160|FG003|Overall Study|Adverse Event|0|||
160742206|NCT00962091|580437161|FG004|Overall Study|Adverse Event|0|||
160742207|NCT00962091|580437162|FG005|Overall Study|Adverse Event|0|||
160742208|NCT00962091|580437163|FG006|Overall Study|Adverse Event|1|||
160742209|NCT03334422|580439096|FG000|Overall Study|Adverse Event|1|||
160742210|NCT03334422|580439097|FG001|Overall Study|Adverse Event|3|||
160742211|NCT03334422|580439098|FG002|Overall Study|Adverse Event|2|||
160742212|NCT03334422|580439099|FG003|Overall Study|Adverse Event|2|||
160742213|NCT03334422|580439096|FG000|Overall Study|Lack of Efficacy|10|||
160742214|NCT03334422|580439097|FG001|Overall Study|Lack of Efficacy|2|||
160742215|NCT03334422|580439098|FG002|Overall Study|Lack of Efficacy|7|||
160742216|NCT03334422|580439099|FG003|Overall Study|Lack of Efficacy|3|||
160742217|NCT03334422|580439096|FG000|Overall Study|Withdrawal by Subject|8|||
160742218|NCT03334422|580439097|FG001|Overall Study|Withdrawal by Subject|3|||
160742219|NCT03334422|580439098|FG002|Overall Study|Withdrawal by Subject|1|||
160742220|NCT03334422|580439099|FG003|Overall Study|Withdrawal by Subject|0|||
160742221|NCT03334422|580439096|FG000|Overall Study|Lost to Follow-up|0|||
160742222|NCT03334422|580439097|FG001|Overall Study|Lost to Follow-up|0|||
160742223|NCT03334422|580439098|FG002|Overall Study|Lost to Follow-up|0|||
160742224|NCT03334422|580439099|FG003|Overall Study|Lost to Follow-up|1|||
160742225|NCT03334422|580439096|FG000|Overall Study|Inability to obtain laboratory samples|0|||
160742226|NCT03334422|580439097|FG001|Overall Study|Inability to obtain laboratory samples|1|||
160742227|NCT03334422|580439098|FG002|Overall Study|Inability to obtain laboratory samples|0|||
160742228|NCT03334422|580439099|FG003|Overall Study|Inability to obtain laboratory samples|0|||
160742229|NCT03334422|580439096|FG000|Overall Study|Pregnancy|0|||
160742230|NCT03334422|580439097|FG001|Overall Study|Pregnancy|1|||
160742231|NCT03334422|580439098|FG002|Overall Study|Pregnancy|0|||
160742232|NCT03334422|580439099|FG003|Overall Study|Pregnancy|0|||
160742233|NCT03774394|580439100|FG000|Overall Study|Withdrawal by Subject|2|||
160742234|NCT03774394|580439101|FG001|Overall Study|Withdrawal by Subject|0|||
160742235|NCT01313221|580439102|FG000|Overall Study|Protocol Violation|0|||
160742236|NCT01313221|580439103|FG001|Overall Study|Protocol Violation|1|||
160742237|NCT01313221|580439104|FG002|Overall Study|Protocol Violation|1|||
160742238|NCT01313221|580439102|FG000|Overall Study|Non-compliance|3|||
160742239|NCT01313221|580439103|FG001|Overall Study|Non-compliance|0|||
160742240|NCT01313221|580439104|FG002|Overall Study|Non-compliance|2|||
160742241|NCT01313221|580439102|FG000|Overall Study|Withdrawal by Subject|2|||
160742242|NCT01313221|580439103|FG001|Overall Study|Withdrawal by Subject|3|||
160742243|NCT01313221|580439104|FG002|Overall Study|Withdrawal by Subject|5|||
160742244|NCT01313221|580439102|FG000|Overall Study|Requirement for alternative therapy|0|||
160742245|NCT01313221|580439103|FG001|Overall Study|Requirement for alternative therapy|1|||
160742246|NCT01313221|580439104|FG002|Overall Study|Requirement for alternative therapy|1|||
160742247|NCT01313221|580439102|FG000|Overall Study|Lost to Follow-up|6|||
160742248|NCT01313221|580439103|FG001|Overall Study|Lost to Follow-up|3|||
160742249|NCT01313221|580439104|FG002|Overall Study|Lost to Follow-up|1|||
160742250|NCT01313221|580439102|FG000|Overall Study|Other|1|||
160742251|NCT01313221|580439103|FG001|Overall Study|Other|0|||
160742252|NCT01313221|580439104|FG002|Overall Study|Other|0|||
160742253|NCT01313221|580439102|FG000|Overall Study|Adverse Event|0|||
160742254|NCT01313221|580439103|FG001|Overall Study|Adverse Event|0|||
160742255|NCT01313221|580439104|FG002|Overall Study|Adverse Event|7|||
160742256|NCT01313221|580439102|FG000|Overall Study|Disease progression|0|||
160742257|NCT01313221|580439103|FG001|Overall Study|Disease progression|0|||
160742258|NCT01313221|580439104|FG002|Overall Study|Disease progression|2|||
160742259|NCT01313221|580439102|FG000|Overall Study|Physician Decision|0|||
160742260|NCT01313221|580439103|FG001|Overall Study|Physician Decision|0|||
160742261|NCT01313221|580439104|FG002|Overall Study|Physician Decision|2|||
160742262|NCT01313221|580439102|FG000|Overall Study|Pregnancy|0|||
160742263|NCT01313221|580439103|FG001|Overall Study|Pregnancy|0|||
160742264|NCT01313221|580439104|FG002|Overall Study|Pregnancy|2|||
160742265|NCT00994214|580439105|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
160742266|NCT00994214|580439106|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
160742267|NCT00994214|580439107|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
160742268|NCT00994214|580439108|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
160742269|NCT00994214|580439105|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
160742270|NCT00994214|580439106|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
160742271|NCT00994214|580439107|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
160742272|NCT00994214|580439108|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
160742273|NCT00994214|580439105|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
160742274|NCT00994214|580439106|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
160742275|NCT00994214|580439107|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
160742276|NCT00994214|580439108|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
160742277|NCT00994214|580439105|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
160742278|NCT00994214|580439106|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
160742279|NCT00994214|580439107|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
160742280|NCT00994214|580439108|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
160742281|NCT00994214|580439105|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
160742282|NCT00994214|580439106|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
160742283|NCT00994214|580439107|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
160742284|NCT00994214|580439108|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
160742285|NCT00994214|580439105|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
160742286|NCT00994214|580439106|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
160742287|NCT00994214|580439107|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
160742288|NCT00994214|580439108|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
160742289|NCT03246061|580439109|FG000|Overall Study|Still in follow-up|15|||
160742290|NCT03246061|580439110|FG001|Overall Study|Still in follow-up|21|||
160742291|NCT04710368|580439115|FG000|Overall Study|Withdrawal by Subject|9|||
160742292|NCT04710368|580439115|FG000|Overall Study|Lost to Follow-up|4|||
160742293|NCT04710368|580439115|FG000|Overall Study|Death|2|||
160742294|NCT04710368|580439115|FG000|Overall Study|Patient preference|11|||
160742295|NCT04710368|580439115|FG000|Overall Study|Treatment discontinuation|1|||
160742296|NCT01777139|580439118|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
160742297|NCT01777139|580439119|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
160742298|NCT01777139|580439118|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
160742299|NCT01777139|580439119|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
160742300|NCT01777139|580439118|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
160742301|NCT01777139|580439119|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
160742302|NCT01777139|580439118|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
160742303|NCT01777139|580439119|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
160742304|NCT01777139|580439118|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
160742305|NCT01777139|580439119|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
160742306|NCT01777139|580439118|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
160742307|NCT01777139|580439119|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
160742308|NCT01777139|580439118|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
160742309|NCT01777139|580439119|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
160742310|NCT01777139|580439118|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
160742311|NCT01777139|580439119|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
160742312|NCT01887288|580439121|FG000|Overall Study|The study was terminated and the PI has|16|||
160742313|NCT05625477|580439122|FG000|Overall Study|Lost to Follow-up|2|||
160742314|NCT05625477|580439123|FG001|Overall Study|Lost to Follow-up|2|||
160742315|NCT05625477|580439124|FG002|Overall Study|Lost to Follow-up|1|||
160742316|NCT05625477|580439125|FG003|Overall Study|Lost to Follow-up|1|||
160742317|NCT05625477|580439126|FG004|Overall Study|Lost to Follow-up|0|||
160742318|NCT05625477|580439122|FG000|Overall Study|Covid quarantine|1|||
160742319|NCT05625477|580439123|FG001|Overall Study|Covid quarantine|0|||
160742320|NCT05625477|580439124|FG002|Overall Study|Covid quarantine|0|||
160742321|NCT05625477|580439125|FG003|Overall Study|Covid quarantine|0|||
160742322|NCT05625477|580439126|FG004|Overall Study|Covid quarantine|0|||
160742323|NCT04849416|580439127|FG000|Overall Study|Ongoing Treatment|12|||
160742324|NCT04849416|580439128|FG001|Overall Study|Ongoing Treatment|5|||
160742325|NCT04849416|580439129|FG002|Overall Study|Ongoing Treatment|3|||
160742326|NCT04849416|580439127|FG000|Overall Study|On Post-Treatment Follow-up|8|||
160742327|NCT04849416|580439128|FG001|Overall Study|On Post-Treatment Follow-up|9|||
160742328|NCT04849416|580439129|FG002|Overall Study|On Post-Treatment Follow-up|10|||
160742329|NCT04849416|580439127|FG000|Overall Study|Withdrawal by Subject|0|||
160742330|NCT04849416|580439128|FG001|Overall Study|Withdrawal by Subject|0|||
160742331|NCT04849416|580439129|FG002|Overall Study|Withdrawal by Subject|1|||
160742332|NCT04849416|580439127|FG000|Overall Study|Lost to Follow-up|1|||
160742333|NCT04849416|580439128|FG001|Overall Study|Lost to Follow-up|0|||
160742334|NCT04849416|580439129|FG002|Overall Study|Lost to Follow-up|0|||
160742335|NCT01092637|580439130|FG000|Overall Study|Death|47|||
160742336|NCT01092637|580439131|FG001|Overall Study|Death|49|||
160742337|NCT04105010|580439132|FG000|Overall Study|Death|3|||
160742338|NCT04105010|580439133|FG001|Overall Study|Death|1|||
160742339|NCT04105010|580439134|FG002|Overall Study|Death|1|||
160742340|NCT04105010|580439135|FG003|Overall Study|Death|54|||
160742341|NCT04105010|580439132|FG000|Overall Study|Lost to Follow-up|0|||
160742342|NCT04105010|580439133|FG001|Overall Study|Lost to Follow-up|0|||
160742343|NCT04105010|580439134|FG002|Overall Study|Lost to Follow-up|0|||
160742344|NCT04105010|580439135|FG003|Overall Study|Lost to Follow-up|4|||
160742345|NCT04105010|580439132|FG000|Overall Study|Withdrawal by Subject|8|||
160742346|NCT04105010|580439133|FG001|Overall Study|Withdrawal by Subject|1|||
160742347|NCT04105010|580439134|FG002|Overall Study|Withdrawal by Subject|1|||
160742348|NCT04105010|580439135|FG003|Overall Study|Withdrawal by Subject|4|||
160742349|NCT04105010|580439132|FG000|Overall Study|Other reason|4|||
160742350|NCT04105010|580439133|FG001|Overall Study|Other reason|7|||
160742351|NCT04105010|580439134|FG002|Overall Study|Other reason|0|||
160742352|NCT04105010|580439135|FG003|Overall Study|Other reason|19|||
160742353|NCT01675154|580439136|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
160742354|NCT01675154|580439137|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
160742355|NCT01675154|580439138|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
160742356|NCT01675154|580439139|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
160742357|NCT02971800|580439142|FG000|Overall Study|Protocol Violation|1|||
160742358|NCT02971800|580439142|FG000|Overall Study|Withdrawal by Subject|1|||
160742359|NCT02971800|580439142|FG000|Overall Study|Exclusion criteria prior intervention|1|||
160742360|NCT02971800|580439142|FG000|Overall Study|Number evaluable participant already reached|4|||
160742361|NCT01149421|580439144|FG000|Overall Study|Adverse Event|22|||
160742362|NCT01149421|580439145|FG001|Overall Study|Adverse Event|6|||
160742363|NCT01149421|580439146|FG002|Overall Study|Adverse Event|11|||
160742364|NCT01149421|580439144|FG000|Overall Study|Withdrawal by Subject|20|||
160742365|NCT01149421|580439145|FG001|Overall Study|Withdrawal by Subject|12|||
160742366|NCT01149421|580439146|FG002|Overall Study|Withdrawal by Subject|13|||
160742367|NCT01149421|580439144|FG000|Overall Study|Sponsor Decision|0|||
160742368|NCT01149421|580439145|FG001|Overall Study|Sponsor Decision|1|||
160742369|NCT01149421|580439146|FG002|Overall Study|Sponsor Decision|1|||
160742370|NCT01149421|580439144|FG000|Overall Study|Lost to Follow-up|2|||
160742371|NCT01149421|580439145|FG001|Overall Study|Lost to Follow-up|4|||
160742372|NCT01149421|580439146|FG002|Overall Study|Lost to Follow-up|5|||
160742373|NCT01149421|580439144|FG000|Overall Study|Physician Decision|5|||
160742374|NCT01149421|580439145|FG001|Overall Study|Physician Decision|3|||
160742375|NCT01149421|580439146|FG002|Overall Study|Physician Decision|6|||
160742376|NCT01149421|580439144|FG000|Overall Study|Entry Criteria Not Met|1|||
160742377|NCT01149421|580439145|FG001|Overall Study|Entry Criteria Not Met|1|||
160742378|NCT01149421|580439146|FG002|Overall Study|Entry Criteria Not Met|2|||
160742379|NCT01149421|580439144|FG000|Overall Study|Protocol Violation|2|||
160742380|NCT01149421|580439145|FG001|Overall Study|Protocol Violation|2|||
160742381|NCT01149421|580439146|FG002|Overall Study|Protocol Violation|6|||
160742382|NCT00616603|580439147|FG000|Overall Study|Physician Decision|2|||
160742383|NCT00616603|580439148|FG001|Overall Study|Physician Decision|0|||
160742384|NCT00616603|580439149|FG002|Overall Study|Physician Decision|2|||
160742385|NCT03738800|580439152|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
160742386|NCT03738800|580439153|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
160742387|NCT03738800|580439154|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160742388|NCT03738800|580439152|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
160742389|NCT03738800|580439153|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
160742390|NCT03738800|580439154|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
160742391|NCT03738800|580439152|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
160742392|NCT03738800|580439153|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
160742393|NCT03738800|580439154|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
160742394|NCT02223819|580439160|FG000|Overall Study|Lost to Follow-up|2|||
160742395|NCT03435224|580439164|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
160742396|NCT00367484|580439165|FG000|Overall Study|Adverse Event|7|||
160742397|NCT00367484|580439165|FG000|Overall Study|Withdrew informed consent|5|||
160742398|NCT00367484|580439165|FG000|Overall Study|Travel to USA|1|||
160742399|NCT00367484|580439165|FG000|Overall Study|Lost to Follow-up|1|||
160742400|NCT00367484|580439165|FG000|Overall Study|Protocol Violation|1|||
160742401|NCT00367484|580439165|FG000|Overall Study|The choice of the patient|1|||
160742402|NCT00367484|580439165|FG000|Overall Study|Lack of Efficacy|1|||
160742403|NCT02604550|580439166|FG000|Overall Study|Lost to Follow-up|7|||
160742404|NCT02604550|580439167|FG001|Overall Study|Lost to Follow-up|6|||
160742405|NCT02604550|580439166|FG000|Overall Study|Withdrawal by Subject|0|||
160742406|NCT02604550|580439167|FG001|Overall Study|Withdrawal by Subject|1|||
160742407|NCT02604550|580439166|FG000|Overall Study|Incomplete data using paper journal|18|||
160742408|NCT02604550|580439167|FG001|Overall Study|Incomplete data using paper journal|19|||
160742409|NCT02609724|580439168|FG000|Overall Study|Death|2|||
160742410|NCT02609724|580439169|FG001|Overall Study|Death|0|||
160742411|NCT02609724|580439170|FG002|Overall Study|Death|1|||
160742412|NCT02609724|580439168|FG000|Overall Study|Withdrawal by Subject|1|||
160742413|NCT02609724|580439169|FG001|Overall Study|Withdrawal by Subject|2|||
160742414|NCT02609724|580439170|FG002|Overall Study|Withdrawal by Subject|3|||
160742415|NCT02609724|580439168|FG000|Overall Study|Illness|2|||
160742416|NCT02609724|580439169|FG001|Overall Study|Illness|1|||
160742417|NCT02609724|580439170|FG002|Overall Study|Illness|0|||
160742418|NCT01672294|580439171|FG000|Overall Study|Withdrawal by Subject|4|||
160742419|NCT01672294|580439172|FG001|Overall Study|Withdrawal by Subject|4|||
160742420|NCT01672294|580439173|FG002|Overall Study|Withdrawal by Subject|4|||
160742421|NCT01672294|580439174|FG003|Overall Study|Withdrawal by Subject|4|||
160742422|NCT01672294|580439171|FG000|Overall Study|Excluded by study|1|||
160742423|NCT01672294|580439172|FG001|Overall Study|Excluded by study|1|||
160742424|NCT01672294|580439173|FG002|Overall Study|Excluded by study|0|||
160742425|NCT01672294|580439174|FG003|Overall Study|Excluded by study|0|||
160742426|NCT01672294|580439171|FG000|Overall Study|Lost to Follow-up|1|||
160742427|NCT01672294|580439172|FG001|Overall Study|Lost to Follow-up|16|||
160742428|NCT01672294|580439173|FG002|Overall Study|Lost to Follow-up|7|||
160742429|NCT01672294|580439174|FG003|Overall Study|Lost to Follow-up|9|||
160742430|NCT01285492|580439175|FG000|Overall Study|Adverse Event|11|||
160742431|NCT01285492|580439176|FG001|Overall Study|Adverse Event|0|||
160742432|NCT01285492|580439175|FG000|Overall Study|Protocol Violation|3|||
160742433|NCT01285492|580439176|FG001|Overall Study|Protocol Violation|0|||
160742434|NCT01285492|580439175|FG000|Overall Study|Withdrawal by Subject|2|||
160742435|NCT01285492|580439176|FG001|Overall Study|Withdrawal by Subject|1|||
160742436|NCT01285492|580439175|FG000|Overall Study|Death|1|||
160742437|NCT01285492|580439176|FG001|Overall Study|Death|0|||
160742438|NCT03379792|580439177|FG000|Overall Study|Physician Decision|0|||
160742439|NCT03379792|580439178|FG001|Overall Study|Physician Decision|0|||
160742440|NCT03379792|580439179|FG002|Overall Study|Physician Decision|0|||
160742441|NCT03379792|580439180|FG003|Overall Study|Physician Decision|1|||
160742442|NCT03379792|580439181|FG004|Overall Study|Physician Decision|0|||
160742443|NCT03379792|580439182|FG005|Overall Study|Physician Decision|0|||
160742444|NCT03379792|580439177|FG000|Overall Study|Withdrawal by Subject|0|||
160742445|NCT03379792|580439178|FG001|Overall Study|Withdrawal by Subject|0|||
160742446|NCT03379792|580439179|FG002|Overall Study|Withdrawal by Subject|0|||
160742447|NCT03379792|580439180|FG003|Overall Study|Withdrawal by Subject|0|||
160742448|NCT03379792|580439181|FG004|Overall Study|Withdrawal by Subject|1|||
160742449|NCT03379792|580439182|FG005|Overall Study|Withdrawal by Subject|1|||
160742450|NCT01121536|580439184|FG000|Overall Study|Adverse Event|63|||
160742451|NCT01121536|580439184|FG000|Overall Study|Lack of Efficacy|35|||
160742452|NCT01121536|580439184|FG000|Overall Study|Withdrawal by Subject|65|||
160742453|NCT01121536|580439184|FG000|Overall Study|Protocol Violation|20|||
160742454|NCT01121536|580439184|FG000|Overall Study|Noncompliance with study medication|12|||
160742455|NCT01121536|580439184|FG000|Overall Study|Noncompliance with study procedures|9|||
160742456|NCT01121536|580439184|FG000|Overall Study|Lost to Follow-up|39|||
160742457|NCT01121536|580439184|FG000|Overall Study|Other|118|||
160742458|NCT00401960|580439185|FG000|Overall Study|Lost to Follow-up|3|||
160742459|NCT00401960|580439186|FG001|Overall Study|Lost to Follow-up|0|||
160742460|NCT00401960|580439185|FG000|Overall Study|Death|2|||
160742461|NCT00401960|580439186|FG001|Overall Study|Death|0|||
160742462|NCT02649426|580439187|FG000|Overall Study|Follow-up on going|1|||
160742463|NCT02649426|580439188|FG001|Overall Study|Follow-up on going|26|||
160742464|NCT02649426|580439189|FG002|Overall Study|Follow-up on going|28|||
160742465|NCT02649426|580439190|FG003|Overall Study|Follow-up on going|31|||
160742466|NCT01606202|580439191|FG000|Overall Study|Adverse Event|5|||
160742467|NCT01606202|580439192|FG001|Overall Study|Adverse Event|0|||
160742468|NCT01606202|580439191|FG000|Overall Study|Withdrawal by Subject|2|||
160742469|NCT01606202|580439192|FG001|Overall Study|Withdrawal by Subject|1|||
160742470|NCT01606202|580439191|FG000|Overall Study|Personal problems|0|||
160742471|NCT01606202|580439192|FG001|Overall Study|Personal problems|1|||
160742472|NCT01606202|580439191|FG000|Overall Study|Problems with administration|0|||
160742473|NCT01606202|580439192|FG001|Overall Study|Problems with administration|1|||
160742474|NCT01593254|580439193|FG000|Overall Study|Disease progression|2|||
160742475|NCT01593254|580439194|FG001|Overall Study|Disease progression|7|||
160742476|NCT01593254|580439193|FG000|Overall Study|Study drug toxicity|6|||
160742477|NCT01593254|580439194|FG001|Overall Study|Study drug toxicity|20|||
160742478|NCT01593254|580439193|FG000|Overall Study|Death|3|||
160742479|NCT01593254|580439194|FG001|Overall Study|Death|3|||
160742480|NCT01593254|580439193|FG000|Overall Study|AE unrelated to study drug|0|||
160742481|NCT01593254|580439194|FG001|Overall Study|AE unrelated to study drug|1|||
160742482|NCT01593254|580439193|FG000|Overall Study|participant request to discontinue study treatment|1|||
160742483|NCT01593254|580439194|FG001|Overall Study|participant request to discontinue study treatment|3|||
160742484|NCT01593254|580439193|FG000|Overall Study|participant withdrew consent|0|||
160742485|NCT01593254|580439194|FG001|Overall Study|participant withdrew consent|9|||
160742486|NCT01593254|580439193|FG000|Overall Study|lost to follow up|1|||
160742487|NCT01593254|580439194|FG001|Overall Study|lost to follow up|6|||
160742488|NCT01593254|580439193|FG000|Overall Study|maximum clinical benefit|1|||
160742489|NCT01593254|580439194|FG001|Overall Study|maximum clinical benefit|2|||
160742490|NCT01593254|580439193|FG000|Overall Study|Poor/non compliance|1|||
160742491|NCT01593254|580439194|FG001|Overall Study|Poor/non compliance|1|||
160742492|NCT01593254|580439193|FG000|Overall Study|Pregnancy|0|||
160742493|NCT01593254|580439194|FG001|Overall Study|Pregnancy|3|||
160742494|NCT01593254|580439193|FG000|Overall Study|participant no longer meets study criteria|1|||
160742495|NCT01593254|580439194|FG001|Overall Study|participant no longer meets study criteria|1|||
160742496|NCT01593254|580439193|FG000|Overall Study|Admin reason by sponsor|7|||
160742497|NCT01593254|580439194|FG001|Overall Study|Admin reason by sponsor|3|||
160742498|NCT01593254|580439193|FG000|Overall Study|Imatinib treatment failure|2|||
160742499|NCT01593254|580439194|FG001|Overall Study|Imatinib treatment failure|0|||
160742500|NCT01593254|580439193|FG000|Overall Study|Other Reasons|61|||
160742501|NCT01593254|580439194|FG001|Overall Study|Other Reasons|115|||
160742502|NCT02124759|580439197|FG000|Overall Study|Withdrawal by Subject|3|||
160742503|NCT02124759|580439198|FG001|Overall Study|Withdrawal by Subject|1|||
160742504|NCT02124759|580439199|FG002|Overall Study|Withdrawal by Subject|1|||
160742505|NCT02124759|580439197|FG000|Overall Study|Screen Fail|2|||
160742506|NCT02124759|580439198|FG001|Overall Study|Screen Fail|2|||
160742507|NCT02124759|580439199|FG002|Overall Study|Screen Fail|3|||
160742508|NCT00932451|580439202|FG000|Overall Study|Withdrawal by Subject|69|||
160742509|NCT00932451|580439202|FG000|Overall Study|Lost to Follow-up|22|||
160742510|NCT00932451|580439202|FG000|Overall Study|Death|726|||
160742511|NCT00932451|580439202|FG000|Overall Study|Other reasons|5|||
160742512|NCT00586508|580439203|FG000|Overall Study|Progressive disease|52|||
160742513|NCT00586508|580439204|FG001|Overall Study|Progressive disease|8|||
160742514|NCT00586508|580439203|FG000|Overall Study|Death|0|||
160742515|NCT00586508|580439204|FG001|Overall Study|Death|1|||
160742516|NCT00586508|580439203|FG000|Overall Study|Adverse Event|12|||
160742517|NCT00586508|580439204|FG001|Overall Study|Adverse Event|4|||
160742518|NCT00586508|580439203|FG000|Overall Study|Withdrawal by Subject|4|||
160742519|NCT00586508|580439204|FG001|Overall Study|Withdrawal by Subject|0|||
160742520|NCT01294371|580439205|FG000|Overall Study|Adverse Event|1|||
160742521|NCT01294371|580439205|FG000|Overall Study|Withdrawal by Subject|12|||
160742522|NCT01294371|580439205|FG000|Overall Study|Lost to Follow-up|6|||
160742523|NCT01294371|580439205|FG000|Overall Study|Administrative Reason|1|||
160742524|NCT01294371|580439205|FG000|Overall Study|Other|14|||
160742525|NCT02968433|580439206|FG000|Overall Study|Withdrawal by Subject|1|||
160742526|NCT05619536|580439207|FG000|Overall Study|Withdrawal by Subject|0|||
160742527|NCT05619536|580439208|FG001|Overall Study|Withdrawal by Subject|1|||
160742528|NCT05619536|580439209|FG002|Overall Study|Withdrawal by Subject|0|||
160742529|NCT05619536|580439210|FG003|Overall Study|Withdrawal by Subject|1|||
160742530|NCT05619536|580439207|FG000|Overall Study|Lost to Follow-up|0|||
160742531|NCT05619536|580439208|FG001|Overall Study|Lost to Follow-up|1|||
160742532|NCT05619536|580439209|FG002|Overall Study|Lost to Follow-up|1|||
160742533|NCT05619536|580439210|FG003|Overall Study|Lost to Follow-up|0|||
160742534|NCT00875433|580439211|FG000|Overall Study|Progressive disease|41|||
160742535|NCT00875433|580439211|FG000|Overall Study|Other Adverse Event|14|||
160742536|NCT00875433|580439211|FG000|Overall Study|Withdrawal by Subject|2|||
160742537|NCT00875433|580439211|FG000|Overall Study|Other|3|||
160742538|NCT00725101|580439212|FG000|Overall Study|Death|3|||
160742539|NCT00725101|580439212|FG000|Overall Study|Lost to Follow-up|353|||
160742540|NCT00725101|580439212|FG000|Overall Study|Protocol Violation|1|||
160742541|NCT00725101|580439212|FG000|Overall Study|Withdrawal by Subject|127|||
160742542|NCT00725101|580439212|FG000|Overall Study|not specified/no reason given|11|||
160742543|NCT03325894|580439213|FG000|Overall Study|Adverse Event|2|||
160742544|NCT03325894|580439214|FG001|Overall Study|Adverse Event|3|||
160742545|NCT03325894|580439213|FG000|Overall Study|Protocol Violation|1|||
160742546|NCT03325894|580439214|FG001|Overall Study|Protocol Violation|2|||
160742547|NCT03325894|580439213|FG000|Overall Study|Withdrawal by Subject|10|||
160742548|NCT03325894|580439214|FG001|Overall Study|Withdrawal by Subject|6|||
160742549|NCT03325894|580439213|FG000|Overall Study|Lost to Follow-up|4|||
160742550|NCT03325894|580439214|FG001|Overall Study|Lost to Follow-up|9|||
160742551|NCT03325894|580439213|FG000|Overall Study|Lack of Efficacy|8|||
160742552|NCT03325894|580439214|FG001|Overall Study|Lack of Efficacy|14|||
160742553|NCT03325894|580439213|FG000|Overall Study|Study Terminated by Sponsor|38|||
160742554|NCT03325894|580439214|FG001|Overall Study|Study Terminated by Sponsor|43|||
160742555|NCT03325894|580439213|FG000|Overall Study|Other (Not received Treatment)|1|||
160742556|NCT03325894|580439214|FG001|Overall Study|Other (Not received Treatment)|0|||
160742557|NCT01592292|580439217|FG000|Overall Study|Follow-up loss|3|||
160742558|NCT01592292|580439218|FG001|Overall Study|Follow-up loss|3|||
160742559|NCT01592292|580439219|FG002|Overall Study|Follow-up loss|1|||
160742560|NCT01592292|580439220|FG003|Overall Study|Follow-up loss|0|||
160742561|NCT01592292|580439217|FG000|Overall Study|Withdrew consent|2|||
160742562|NCT01592292|580439218|FG001|Overall Study|Withdrew consent|1|||
160742563|NCT01592292|580439219|FG002|Overall Study|Withdrew consent|0|||
160742564|NCT01592292|580439220|FG003|Overall Study|Withdrew consent|0|||
160742565|NCT01592292|580439217|FG000|Overall Study|Other|1|||
160742566|NCT01592292|580439218|FG001|Overall Study|Other|1|||
160742567|NCT01592292|580439219|FG002|Overall Study|Other|2|||
160742568|NCT01592292|580439220|FG003|Overall Study|Other|1|||
160742569|NCT03482167|580439221|FG000|Allocated to Intervention|Physician Decision|1|||
160742570|NCT03482167|580439222|FG001|Allocated to Intervention|Physician Decision|2|||
160742571|NCT03482167|580439221|FG000|Received Intervention|Adverse Event|3|||
160742572|NCT03482167|580439222|FG001|Received Intervention|Adverse Event|1|||
160742573|NCT03482167|580439221|FG000|Received Intervention|Physician Decision|1|||
160742574|NCT03482167|580439222|FG001|Received Intervention|Physician Decision|1|||
160742575|NCT03482167|580439221|FG000|Received Intervention|Withdrawal by Subject|1|||
160742576|NCT03482167|580439222|FG001|Received Intervention|Withdrawal by Subject|0|||
160742577|NCT00622336|580439224|FG000|Treatment Phase|Progression of Disease|181|||
160742578|NCT00622336|580439224|FG000|Treatment Phase|Adverse Event|46|||
160742579|NCT00622336|580439224|FG000|Treatment Phase|Other|40|||
160742580|NCT00622336|580439224|FG000|Treatment Phase|Death|14|||
160742581|NCT00622336|580439224|FG000|Treatment Phase|Lack of therapeutic effect|13|||
160742582|NCT00622336|580439224|FG000|Treatment Phase|Withdrawal by Subject|13|||
160742583|NCT00622336|580439224|FG000|Treatment Phase|Lost to Follow-up|2|||
160742584|NCT00622336|580439224|FG000|Extension Phase|Adverse Event|2|||
160742585|NCT00622336|580439224|FG000|Extension Phase|Progressive Disease|6|||
160742586|NCT00622336|580439224|FG000|Extension Phase|Lack of therapeutic effect|2|||
160742587|NCT00622336|580439224|FG000|Extension Phase|Withdrawal by Subject|1|||
160742588|NCT00622336|580439224|FG000|Extension Phase|Lost to Follow-up|1|||
160742589|NCT00622336|580439224|FG000|Extension Phase|Other|9|||
160742590|NCT04148287|580439229|FG000|Overall Study|Death|2|||
160742591|NCT00106639|580439231|FG000|Overall Study|Adverse Event|3|||
160742592|NCT00106639|580439232|FG001|Overall Study|Adverse Event|4|||
160742593|NCT00106639|580439233|FG002|Overall Study|Adverse Event|1|||
160742594|NCT00106639|580439231|FG000|Overall Study|Protocol Violation|0|||
160742595|NCT00106639|580439232|FG001|Overall Study|Protocol Violation|1|||
160742596|NCT00106639|580439233|FG002|Overall Study|Protocol Violation|0|||
160742597|NCT00106639|580439231|FG000|Overall Study|Withdrawal by Subject|0|||
160742598|NCT00106639|580439232|FG001|Overall Study|Withdrawal by Subject|1|||
160742599|NCT00106639|580439233|FG002|Overall Study|Withdrawal by Subject|0|||
160742600|NCT00106639|580439231|FG000|Overall Study|Participant defaulted|0|||
160742601|NCT00106639|580439232|FG001|Overall Study|Participant defaulted|1|||
160742602|NCT00106639|580439233|FG002|Overall Study|Participant defaulted|1|||
160742603|NCT02923245|580439234|FG000|Overall Study|ultrasound order was cancelled|2|||
160742604|NCT02923245|580439235|FG001|Overall Study|ultrasound order was cancelled|1|||
160742605|NCT02680834|580439237|FG000|Overall Study|Physician Decision|5|||
160742606|NCT02680834|580439238|FG001|Overall Study|Physician Decision|2|||
160742607|NCT02680834|580439237|FG000|Overall Study|Withdrawal by Subject|6|||
160742608|NCT02680834|580439238|FG001|Overall Study|Withdrawal by Subject|0|||
160742609|NCT02680834|580439237|FG000|Overall Study|Lost to Follow-up|0|||
160742610|NCT02680834|580439238|FG001|Overall Study|Lost to Follow-up|1|||
160742611|NCT02520427|580439239|FG000|Overall Study|Decision by sponsor|0|||
160742612|NCT02520427|580439240|FG001|Overall Study|Decision by sponsor|0|||
160742613|NCT02520427|580439241|FG002|Overall Study|Decision by sponsor|0|||
160742614|NCT02520427|580439242|FG003|Overall Study|Decision by sponsor|0|||
160742615|NCT02520427|580439243|FG004|Overall Study|Decision by sponsor|0|||
160742616|NCT02520427|580439244|FG005|Overall Study|Decision by sponsor|0|||
160742617|NCT02520427|580439245|FG006|Overall Study|Decision by sponsor|0|||
160742618|NCT02520427|580439246|FG007|Overall Study|Decision by sponsor|0|||
160742619|NCT02520427|580439247|FG008|Overall Study|Decision by sponsor|1|||
160742620|NCT02520427|580439248|FG009|Overall Study|Decision by sponsor|1|||
160742621|NCT02520427|580439249|FG010|Overall Study|Decision by sponsor|0|||
160742622|NCT02520427|580439250|FG011|Overall Study|Decision by sponsor|0|||
160742623|NCT02520427|580439251|FG012|Overall Study|Decision by sponsor|0|||
160742624|NCT02520427|580439252|FG013|Overall Study|Decision by sponsor|0|||
160742625|NCT02520427|580439253|FG014|Overall Study|Decision by sponsor|0|||
160742626|NCT02520427|580439254|FG015|Overall Study|Decision by sponsor|0|||
160742627|NCT02520427|580439255|FG016|Overall Study|Decision by sponsor|0|||
160742628|NCT02520427|580439256|FG017|Overall Study|Decision by sponsor|0|||
160742629|NCT02520427|580439257|FG018|Overall Study|Decision by sponsor|0|||
160742630|NCT02520427|580439258|FG019|Overall Study|Decision by sponsor|0|||
160742631|NCT02520427|580439259|FG020|Overall Study|Decision by sponsor|0|||
160742632|NCT02520427|580439260|FG021|Overall Study|Decision by sponsor|0|||
160742633|NCT02520427|580439261|FG022|Overall Study|Decision by sponsor|0|||
160742634|NCT02520427|580439262|FG023|Overall Study|Decision by sponsor|0|||
160742635|NCT02520427|580439263|FG024|Overall Study|Decision by sponsor|0|||
160742636|NCT02520427|580439264|FG025|Overall Study|Decision by sponsor|0|||
160742637|NCT02520427|580439239|FG000|Overall Study|Withdrawal by Subject|0|||
160742638|NCT02520427|580439240|FG001|Overall Study|Withdrawal by Subject|0|||
160742639|NCT02520427|580439241|FG002|Overall Study|Withdrawal by Subject|1|||
160742640|NCT02520427|580439242|FG003|Overall Study|Withdrawal by Subject|0|||
160742641|NCT02520427|580439243|FG004|Overall Study|Withdrawal by Subject|0|||
160742642|NCT02520427|580439244|FG005|Overall Study|Withdrawal by Subject|0|||
160742643|NCT02520427|580439245|FG006|Overall Study|Withdrawal by Subject|0|||
160742644|NCT02520427|580439246|FG007|Overall Study|Withdrawal by Subject|0|||
160742645|NCT02520427|580439247|FG008|Overall Study|Withdrawal by Subject|0|||
160742646|NCT02520427|580439248|FG009|Overall Study|Withdrawal by Subject|0|||
160742647|NCT02520427|580439249|FG010|Overall Study|Withdrawal by Subject|0|||
160742648|NCT02520427|580439250|FG011|Overall Study|Withdrawal by Subject|0|||
160742649|NCT02520427|580439251|FG012|Overall Study|Withdrawal by Subject|1|||
160742650|NCT02520427|580439252|FG013|Overall Study|Withdrawal by Subject|1|||
160742651|NCT02520427|580439253|FG014|Overall Study|Withdrawal by Subject|1|||
160742652|NCT02520427|580439254|FG015|Overall Study|Withdrawal by Subject|0|||
160742653|NCT02520427|580439255|FG016|Overall Study|Withdrawal by Subject|1|||
160742654|NCT02520427|580439256|FG017|Overall Study|Withdrawal by Subject|0|||
160742655|NCT02520427|580439257|FG018|Overall Study|Withdrawal by Subject|0|||
160742656|NCT02520427|580439258|FG019|Overall Study|Withdrawal by Subject|3|||
160742657|NCT02520427|580439259|FG020|Overall Study|Withdrawal by Subject|2|||
160742658|NCT02520427|580439260|FG021|Overall Study|Withdrawal by Subject|0|||
160742659|NCT02520427|580439261|FG022|Overall Study|Withdrawal by Subject|0|||
160742660|NCT02520427|580439262|FG023|Overall Study|Withdrawal by Subject|0|||
160742661|NCT02520427|580439263|FG024|Overall Study|Withdrawal by Subject|0|||
160742662|NCT02520427|580439264|FG025|Overall Study|Withdrawal by Subject|0|||
160742663|NCT02520427|580439239|FG000|Overall Study|Death|1|||
160742664|NCT02520427|580439240|FG001|Overall Study|Death|0|||
160742665|NCT02520427|580439241|FG002|Overall Study|Death|0|||
160742666|NCT02520427|580439242|FG003|Overall Study|Death|0|||
160742667|NCT02520427|580439243|FG004|Overall Study|Death|0|||
160742668|NCT02520427|580439244|FG005|Overall Study|Death|0|||
160742669|NCT02520427|580439245|FG006|Overall Study|Death|0|||
160742670|NCT02520427|580439246|FG007|Overall Study|Death|0|||
160742671|NCT02520427|580439247|FG008|Overall Study|Death|0|||
160742672|NCT02520427|580439248|FG009|Overall Study|Death|0|||
160742673|NCT02520427|580439249|FG010|Overall Study|Death|0|||
160742674|NCT02520427|580439250|FG011|Overall Study|Death|0|||
160742675|NCT02520427|580439251|FG012|Overall Study|Death|0|||
160742676|NCT02520427|580439252|FG013|Overall Study|Death|0|||
160742677|NCT02520427|580439253|FG014|Overall Study|Death|0|||
160742678|NCT02520427|580439254|FG015|Overall Study|Death|0|||
160742679|NCT02520427|580439255|FG016|Overall Study|Death|2|||
160742680|NCT02520427|580439256|FG017|Overall Study|Death|1|||
160742681|NCT02520427|580439257|FG018|Overall Study|Death|3|||
160742682|NCT02520427|580439258|FG019|Overall Study|Death|2|||
160742683|NCT02520427|580439259|FG020|Overall Study|Death|0|||
160742684|NCT02520427|580439260|FG021|Overall Study|Death|0|||
160742685|NCT02520427|580439261|FG022|Overall Study|Death|1|||
160742686|NCT02520427|580439262|FG023|Overall Study|Death|0|||
160742687|NCT02520427|580439263|FG024|Overall Study|Death|1|||
160742688|NCT02520427|580439264|FG025|Overall Study|Death|0|||
160742689|NCT01712334|580439265|FG000|Treatment Period 1|Randomized in Error|0|||
160742690|NCT01712334|580439266|FG001|Treatment Period 1|Randomized in Error|2|||
160742691|NCT00232596|580439267|FG000|6-Week Titration Phase|Adverse Event|6|||
160742692|NCT00232596|580439268|FG001|6-Week Titration Phase|Adverse Event|19|||
160742693|NCT00232596|580439267|FG000|6-Week Titration Phase|Failed to Return|2|||
160742694|NCT00232596|580439268|FG001|6-Week Titration Phase|Failed to Return|1|||
160742695|NCT00232596|580439267|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
160742696|NCT00232596|580439268|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
160742697|NCT00232596|580439267|FG000|6-Week Titration Phase|Protocol Violation|1|||
160742698|NCT00232596|580439268|FG001|6-Week Titration Phase|Protocol Violation|3|||
160742699|NCT00232596|580439267|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
160742700|NCT00232596|580439268|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
160742701|NCT00232596|580439267|FG000|6-Week Titration Phase|Other|3|||
160742702|NCT00232596|580439268|FG001|6-Week Titration Phase|Other|3|||
160742703|NCT00232596|580439267|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
160742704|NCT00232596|580439268|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
160742705|NCT00232596|580439267|FG000|12-Week Maintenance Phase|Adverse Event|7|||
160742706|NCT00232596|580439268|FG001|12-Week Maintenance Phase|Adverse Event|22|||
160742707|NCT00232596|580439267|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
160742708|NCT00232596|580439268|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
160742709|NCT00232596|580439267|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
160742710|NCT00232596|580439268|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
160742711|NCT00232596|580439267|FG000|12-Week Maintenance Phase|Other|1|||
160742712|NCT00232596|580439268|FG001|12-Week Maintenance Phase|Other|3|||
160742713|NCT04102865|580439271|FG000|Overall Study|Adverse Event|4|||
160742714|NCT04102865|580439272|FG001|Overall Study|Adverse Event|0|||
160742715|NCT04102865|580439271|FG000|Overall Study|Lost to Follow-up|1|||
160742716|NCT04102865|580439272|FG001|Overall Study|Lost to Follow-up|0|||
160742717|NCT04102865|580439271|FG000|Overall Study|Withdrawal by Subject|2|||
160742718|NCT04102865|580439272|FG001|Overall Study|Withdrawal by Subject|0|||
160742719|NCT01764997|580439277|FG000|Run-in Period|Adverse Event|15|||
160742720|NCT01764997|580439278|FG001|Run-in Period|Adverse Event|0|||
160742721|NCT01764997|580439279|FG002|Run-in Period|Adverse Event|0|||
160742722|NCT01764997|580439280|FG003|Run-in Period|Adverse Event|0|||
160742723|NCT01764997|580439281|FG004|Run-in Period|Adverse Event|0|||
160742724|NCT01764997|580439277|FG000|Run-in Period|Lack of Efficacy|5|||
160742725|NCT01764997|580439278|FG001|Run-in Period|Lack of Efficacy|0|||
160742726|NCT01764997|580439279|FG002|Run-in Period|Lack of Efficacy|0|||
160742727|NCT01764997|580439280|FG003|Run-in Period|Lack of Efficacy|0|||
160742728|NCT01764997|580439281|FG004|Run-in Period|Lack of Efficacy|0|||
160742729|NCT01764997|580439277|FG000|Run-in Period|Poor compliance to protocol|1|||
160742730|NCT01764997|580439278|FG001|Run-in Period|Poor compliance to protocol|0|||
160742731|NCT01764997|580439279|FG002|Run-in Period|Poor compliance to protocol|0|||
160742732|NCT01764997|580439280|FG003|Run-in Period|Poor compliance to protocol|0|||
160742733|NCT01764997|580439281|FG004|Run-in Period|Poor compliance to protocol|0|||
160742734|NCT01764997|580439277|FG000|Run-in Period|Other than specified above|17|||
160742735|NCT01764997|580439278|FG001|Run-in Period|Other than specified above|0|||
160742736|NCT01764997|580439279|FG002|Run-in Period|Other than specified above|0|||
160742737|NCT01764997|580439280|FG003|Run-in Period|Other than specified above|0|||
160742738|NCT01764997|580439281|FG004|Run-in Period|Other than specified above|0|||
160742739|NCT01764997|580439277|FG000|Study Drug Treatment Period|Adverse Event|0|||
160742740|NCT01764997|580439278|FG001|Study Drug Treatment Period|Adverse Event|1|||
160742741|NCT01764997|580439279|FG002|Study Drug Treatment Period|Adverse Event|0|||
160742742|NCT01764997|580439280|FG003|Study Drug Treatment Period|Adverse Event|0|||
160742743|NCT01764997|580439281|FG004|Study Drug Treatment Period|Adverse Event|24|||
160742744|NCT01764997|580439277|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
160742745|NCT01764997|580439278|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
160742746|NCT01764997|580439279|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
160742747|NCT01764997|580439280|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
160742748|NCT01764997|580439281|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
160742749|NCT01764997|580439277|FG000|Study Drug Treatment Period|Other than specified above|0|||
160742750|NCT01764997|580439278|FG001|Study Drug Treatment Period|Other than specified above|0|||
160742751|NCT01764997|580439279|FG002|Study Drug Treatment Period|Other than specified above|0|||
160742752|NCT01764997|580439280|FG003|Study Drug Treatment Period|Other than specified above|0|||
160742753|NCT01764997|580439281|FG004|Study Drug Treatment Period|Other than specified above|10|||
160742754|NCT02168777|580441232|FG000|Overall Study|Withdrawal by Subject|1|||
160742755|NCT02168777|580441233|FG001|Overall Study|Withdrawal by Subject|0|||
160742756|NCT02168777|580441234|FG002|Overall Study|Withdrawal by Subject|2|||
160742757|NCT02168777|580441232|FG000|Overall Study|Adverse Event|1|||
160742758|NCT02168777|580441233|FG001|Overall Study|Adverse Event|0|||
160742759|NCT02168777|580441234|FG002|Overall Study|Adverse Event|1|||
160742760|NCT02168777|580441232|FG000|Overall Study|Disease recurrence|0|||
160742761|NCT02168777|580441233|FG001|Overall Study|Disease recurrence|0|||
160742762|NCT02168777|580441234|FG002|Overall Study|Disease recurrence|1|||
160742763|NCT02168777|580441232|FG000|Overall Study|Radiological disease progression|0|||
160742764|NCT02168777|580441233|FG001|Overall Study|Radiological disease progression|5|||
160742765|NCT02168777|580441234|FG002|Overall Study|Radiological disease progression|5|||
160742766|NCT02168777|580441232|FG000|Overall Study|Clinical disease progression|0|||
160742767|NCT02168777|580441233|FG001|Overall Study|Clinical disease progression|1|||
160742768|NCT02168777|580441234|FG002|Overall Study|Clinical disease progression|2|||
160742769|NCT02168777|580441232|FG000|Overall Study|Other reason|0|||
160742770|NCT02168777|580441233|FG001|Overall Study|Other reason|1|||
160742771|NCT02168777|580441234|FG002|Overall Study|Other reason|0|||
160742772|NCT05243563|580441235|FG000|Overall Study|Withdrawal by Subject|1|||
160742773|NCT05243563|580441236|FG001|Overall Study|Withdrawal by Subject|0|||
160742774|NCT05243563|580441235|FG000|Overall Study|Physician Decision|1|||
160742775|NCT05243563|580441236|FG001|Overall Study|Physician Decision|0|||
160742776|NCT00441363|580441237|FG000|Overall Study|Adverse Event|4|||
160742777|NCT00441363|580441238|FG001|Overall Study|Adverse Event|2|||
160742778|NCT00441363|580441237|FG000|Overall Study|Withdrawal by Subject|3|||
160742779|NCT00441363|580441238|FG001|Overall Study|Withdrawal by Subject|4|||
160742780|NCT00441363|580441237|FG000|Overall Study|Physician Decision|6|||
160742781|NCT00441363|580441238|FG001|Overall Study|Physician Decision|7|||
160742782|NCT00441363|580441237|FG000|Overall Study|Lost to Follow-up|2|||
160742783|NCT00441363|580441238|FG001|Overall Study|Lost to Follow-up|2|||
160742784|NCT00441363|580441237|FG000|Overall Study|Other|2|||
160742785|NCT00441363|580441238|FG001|Overall Study|Other|0|||
160742786|NCT02437188|580441241|FG000|Overall Study|Randomized but did not receive surgery|4|||
160742787|NCT02437188|580441242|FG001|Overall Study|Randomized but did not receive surgery|8|||
160742788|NCT02437188|580441241|FG000|Overall Study|Adverse Event|0|||
160742789|NCT02437188|580441242|FG001|Overall Study|Adverse Event|1|||
160742790|NCT01663857|580441243|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
160742791|NCT01663857|580441244|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
160742792|NCT01663857|580441245|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
160742793|NCT01663857|580441246|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
160742794|NCT01663857|580441243|FG000|Overall Study|Lost to Follow-up|0|||
160742795|NCT01663857|580441244|FG001|Overall Study|Lost to Follow-up|0|||
160742796|NCT01663857|580441245|FG002|Overall Study|Lost to Follow-up|3|||
160742797|NCT01663857|580441246|FG003|Overall Study|Lost to Follow-up|1|||
160742798|NCT01172808|580441249|FG000|Overall Study|Adverse Event|8|||
160742799|NCT01172808|580441250|FG001|Overall Study|Adverse Event|4|||
160742800|NCT01172808|580441251|FG002|Overall Study|Adverse Event|8|||
160742801|NCT01172808|580441252|FG003|Overall Study|Adverse Event|3|||
160742802|NCT01172808|580441249|FG000|Overall Study|Lack of Efficacy|1|||
160742803|NCT01172808|580441250|FG001|Overall Study|Lack of Efficacy|0|||
160742804|NCT01172808|580441251|FG002|Overall Study|Lack of Efficacy|0|||
160742805|NCT01172808|580441252|FG003|Overall Study|Lack of Efficacy|0|||
160742806|NCT01172808|580441249|FG000|Overall Study|Protocol Violation|2|||
160742807|NCT01172808|580441250|FG001|Overall Study|Protocol Violation|2|||
160742808|NCT01172808|580441251|FG002|Overall Study|Protocol Violation|2|||
160742809|NCT01172808|580441252|FG003|Overall Study|Protocol Violation|0|||
160742810|NCT01172808|580441249|FG000|Overall Study|Lost to Follow-up|0|||
160742811|NCT01172808|580441250|FG001|Overall Study|Lost to Follow-up|1|||
160742812|NCT01172808|580441251|FG002|Overall Study|Lost to Follow-up|1|||
160742813|NCT01172808|580441252|FG003|Overall Study|Lost to Follow-up|3|||
160742814|NCT01172808|580441249|FG000|Overall Study|Withdrawal by Subject|4|||
160742815|NCT01172808|580441250|FG001|Overall Study|Withdrawal by Subject|1|||
160742816|NCT01172808|580441251|FG002|Overall Study|Withdrawal by Subject|3|||
160742817|NCT01172808|580441252|FG003|Overall Study|Withdrawal by Subject|2|||
160742818|NCT01172808|580441249|FG000|Overall Study|Other|6|||
160742819|NCT01172808|580441250|FG001|Overall Study|Other|5|||
160742820|NCT01172808|580441251|FG002|Overall Study|Other|9|||
160742821|NCT01172808|580441252|FG003|Overall Study|Other|7|||
160742822|NCT02578940|580441259|FG000|Overall Study|Screening failure|5|||
160742823|NCT02578940|580441259|FG000|Overall Study|Lost to Follow-up|1|||
160742824|NCT01911793|580441260|FG000|Overall Study|Physician Decision|1|||
160742825|NCT01911793|580441261|FG001|Overall Study|Physician Decision|5|||
160742826|NCT00290693|580441268|FG000|Overall Study|Withdrawal by Subject|2|||
160742827|NCT01716520|580441275|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
160742828|NCT01716520|580441276|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
160742829|NCT01716520|580441277|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
160742830|NCT01716520|580441278|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
160742831|NCT01716520|580441279|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
160742832|NCT01716520|580441280|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
160742833|NCT01716520|580441275|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
160742834|NCT01716520|580441276|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
160742835|NCT01716520|580441277|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
160742836|NCT01716520|580441278|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
160742837|NCT01716520|580441279|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
160742838|NCT01716520|580441280|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
160742839|NCT01716520|580441275|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160742840|NCT01716520|580441276|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160742841|NCT01716520|580441277|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160742842|NCT01716520|580441278|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160742843|NCT01716520|580441279|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160742844|NCT01716520|580441280|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160742845|NCT01716520|580441275|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
160742846|NCT01716520|580441276|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
160742847|NCT01716520|580441277|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
160742848|NCT01716520|580441278|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
160742849|NCT01716520|580441279|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
160742850|NCT01716520|580441280|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
160742851|NCT01716520|580441275|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160742852|NCT01716520|580441276|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160742853|NCT01716520|580441277|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160742854|NCT01716520|580441278|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160742855|NCT01716520|580441279|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160742856|NCT01716520|580441280|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
160742857|NCT01716520|580441275|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
160742858|NCT01716520|580441276|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
160742859|NCT01716520|580441277|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
160742860|NCT01716520|580441278|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
160742861|NCT01716520|580441279|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
160742862|NCT01716520|580441280|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
160742863|NCT01716520|580441275|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
160742864|NCT01716520|580441276|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
160742865|NCT01716520|580441277|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
160742866|NCT01716520|580441278|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
160742867|NCT01716520|580441279|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
160742868|NCT01716520|580441280|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
160742869|NCT01716520|580441275|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160742870|NCT01716520|580441276|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160742871|NCT01716520|580441277|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160742872|NCT01716520|580441278|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160742873|NCT01716520|580441279|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
160742874|NCT01716520|580441280|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160742875|NCT01716520|580441275|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
160742876|NCT01716520|580441276|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
160742877|NCT01716520|580441277|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
160742878|NCT01716520|580441278|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
160742879|NCT01716520|580441279|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
160742880|NCT01716520|580441280|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
160742881|NCT01716520|580441275|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
160742882|NCT01716520|580441276|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
160742883|NCT01716520|580441277|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
160742884|NCT01716520|580441278|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
160742885|NCT01716520|580441279|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
160742886|NCT01716520|580441280|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
160742887|NCT01716520|580441275|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
160742888|NCT01716520|580441276|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
160742889|NCT01716520|580441277|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
160742890|NCT01716520|580441278|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
160742891|NCT01716520|580441279|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
160742892|NCT01716520|580441280|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
160742893|NCT01716520|580441275|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
160742894|NCT01716520|580441276|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
160742895|NCT01716520|580441277|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
160742896|NCT01716520|580441278|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
160742897|NCT01716520|580441279|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
160742898|NCT01716520|580441280|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
160742899|NCT01716520|580441275|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
160742900|NCT01716520|580441276|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
160742901|NCT01716520|580441277|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
160742902|NCT01716520|580441278|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
160742903|NCT01716520|580441279|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
160742904|NCT01716520|580441280|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
160742905|NCT01716520|580441275|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160742906|NCT01716520|580441276|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160742907|NCT01716520|580441277|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160742908|NCT01716520|580441278|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160742909|NCT01716520|580441279|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160742910|NCT01716520|580441280|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
160742911|NCT01716520|580441275|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160742912|NCT01716520|580441276|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160742913|NCT01716520|580441277|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
160742914|NCT01716520|580441278|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160742915|NCT01716520|580441279|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160742916|NCT01716520|580441280|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160742917|NCT01211483|580441283|FG000|Phase 1b|Death|6|||
160742918|NCT01211483|580441284|FG001|Phase 1b|Death|0|||
160742919|NCT01211483|580441285|FG002|Phase 1b|Death|0|||
160742920|NCT01211483|580441286|FG003|Phase 1b|Death|0|||
160742921|NCT01211483|580441283|FG000|Phase 1b|Withdrawal by Subject|1|||
160742922|NCT01211483|580441284|FG001|Phase 1b|Withdrawal by Subject|0|||
160742923|NCT01211483|580441285|FG002|Phase 1b|Withdrawal by Subject|0|||
160742924|NCT01211483|580441286|FG003|Phase 1b|Withdrawal by Subject|0|||
160742925|NCT01211483|580441283|FG000|Phase 2|Lost to Follow-up|0|||
160742926|NCT01211483|580441284|FG001|Phase 2|Lost to Follow-up|1|||
160742927|NCT01211483|580441285|FG002|Phase 2|Lost to Follow-up|1|||
160742928|NCT01211483|580441286|FG003|Phase 2|Lost to Follow-up|2|||
160742929|NCT01211483|580441283|FG000|Phase 2|Death|0|||
160742930|NCT01211483|580441284|FG001|Phase 2|Death|64|||
160742931|NCT01211483|580441285|FG002|Phase 2|Death|53|||
160742932|NCT01211483|580441286|FG003|Phase 2|Death|53|||
160742933|NCT01211483|580441283|FG000|Phase 2|Withdrawal by Subject|0|||
160742934|NCT01211483|580441284|FG001|Phase 2|Withdrawal by Subject|1|||
160742935|NCT01211483|580441285|FG002|Phase 2|Withdrawal by Subject|10|||
160742936|NCT01211483|580441286|FG003|Phase 2|Withdrawal by Subject|5|||
160742937|NCT01211483|580441283|FG000|Phase 2|Study terminated by Sponsor|0|||
160742938|NCT01211483|580441284|FG001|Phase 2|Study terminated by Sponsor|6|||
160742939|NCT01211483|580441285|FG002|Phase 2|Study terminated by Sponsor|8|||
160742940|NCT01211483|580441286|FG003|Phase 2|Study terminated by Sponsor|11|||
160742941|NCT03570554|580441287|FG000|Overall Study|Non-compliance with study drug|0|||
160742942|NCT03570554|580441288|FG001|Overall Study|Non-compliance with study drug|0|||
160742943|NCT03570554|580441289|FG002|Overall Study|Non-compliance with study drug|1|||
160742944|NCT03570554|580441290|FG003|Overall Study|Non-compliance with study drug|0|||
160742945|NCT03570554|580441287|FG000|Overall Study|Adverse Event|0|||
160742946|NCT03570554|580441288|FG001|Overall Study|Adverse Event|0|||
160742947|NCT03570554|580441289|FG002|Overall Study|Adverse Event|0|||
160742948|NCT03570554|580441290|FG003|Overall Study|Adverse Event|1|||
160742949|NCT02719353|580441294|FG000|First Intervention|Physician Decision|0|||
160742950|NCT02719353|580441295|FG001|First Intervention|Physician Decision|1|||
160742951|NCT01917344|580441297|FG000|Overall Study|Withdrawal by Subject|1|||
160742952|NCT00412217|580441298|FG000|Overall Study|Insufficient Data Available|8|||
160742953|NCT00412217|580441299|FG001|Overall Study|Insufficient Data Available|3|||
160742954|NCT00412217|580441298|FG000|Overall Study|Death|5|||
160742955|NCT00412217|580441299|FG001|Overall Study|Death|4|||
160742956|NCT00412217|580441298|FG000|Overall Study|Disease Progression|2|||
160742957|NCT00412217|580441299|FG001|Overall Study|Disease Progression|3|||
160742958|NCT00412217|580441298|FG000|Overall Study|Investigator Decision|1|||
160742959|NCT00412217|580441299|FG001|Overall Study|Investigator Decision|0|||
160742960|NCT00412217|580441298|FG000|Overall Study|Withdrawal by Subject|2|||
160742961|NCT00412217|580441299|FG001|Overall Study|Withdrawal by Subject|0|||
160742962|NCT00412217|580441298|FG000|Overall Study|Lost to Follow-up|1|||
160742963|NCT00412217|580441299|FG001|Overall Study|Lost to Follow-up|4|||
160742964|NCT00412217|580441298|FG000|Overall Study|Study Terminated by Sponsor|26|||
160742965|NCT00412217|580441299|FG001|Overall Study|Study Terminated by Sponsor|33|||
160742966|NCT00412217|580441298|FG000|Overall Study|Other|1|||
160742967|NCT00412217|580441299|FG001|Overall Study|Other|1|||
160742968|NCT01777295|580441300|FG000|Overall Study|Withdrawal by Subject|2|||
160742969|NCT01777295|580441301|FG001|Overall Study|Withdrawal by Subject|2|||
160742970|NCT01777295|580441300|FG000|Overall Study|Pregnancy|0|||
160742971|NCT01777295|580441301|FG001|Overall Study|Pregnancy|1|||
160742972|NCT01777295|580441300|FG000|Overall Study|Personal problem|1|||
160742973|NCT01777295|580441301|FG001|Overall Study|Personal problem|0|||
160742974|NCT01777295|580441300|FG000|Overall Study|Investigator call for AEs check|1|||
160742975|NCT01777295|580441301|FG001|Overall Study|Investigator call for AEs check|0|||
160742976|NCT04007107|580441306|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
160742977|NCT04007107|580441307|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
160742978|NCT04007107|580441308|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
160742979|NCT04007107|580441309|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
160742980|NCT00426660|580441315|FG000|Overall Study|Death|14|||
160742981|NCT00426660|580441315|FG000|Overall Study|Adverse Event|23|||
160742982|NCT00426660|580441315|FG000|Overall Study|Insufficient Clinical Response|22|||
160742983|NCT00426660|580441315|FG000|Overall Study|Lost to Follow-up|15|||
160742984|NCT00426660|580441315|FG000|Overall Study|Other|23|||
160742985|NCT00426660|580441315|FG000|Overall Study|Withdrawal by Subject|18|||
160742986|NCT00426660|580441315|FG000|Overall Study|Protocol Violation|1|||
160742987|NCT00426660|580441315|FG000|Overall Study|Enrolled Not Treated|15|||
160742988|NCT00006305|580441316|FG000|Overall Study|Withdrawal by Subject|17|||
160742989|NCT00006305|580441317|FG001|Overall Study|Withdrawal by Subject|10|||
160742990|NCT00006305|580441318|FG002|Overall Study|Withdrawal by Subject|15|||
160742991|NCT00006305|580441319|FG003|Overall Study|Withdrawal by Subject|14|||
160742992|NCT00329641|580441320|FG000|Overall Study|Did not start treatment|1|||
160742993|NCT00329641|580441320|FG000|Overall Study|Not eligible|1|||
160742994|NCT00329641|580441320|FG000|Overall Study|Adverse Event|3|||
160742995|NCT00329641|580441320|FG000|Overall Study|Other reason, not protocol specified|1|||
160742996|NCT00115037|580441321|FG000|Phase1|Lost to Follow-up|16|||
160742997|NCT00115037|580441322|FG001|Phase1|Lost to Follow-up|23|||
160742998|NCT00115037|580441323|FG002|Phase1|Lost to Follow-up|0|||
160742999|NCT00115037|580441324|FG003|Phase1|Lost to Follow-up|0|||
160743000|NCT00115037|580441325|FG004|Phase1|Lost to Follow-up|0|||
160743001|NCT00115037|580441326|FG005|Phase1|Lost to Follow-up|0|||
160743002|NCT00115037|580441321|FG000|Phase1|Withdrawal by Subject|9|||
160743003|NCT00115037|580441322|FG001|Phase1|Withdrawal by Subject|4|||
160743004|NCT00115037|580441323|FG002|Phase1|Withdrawal by Subject|0|||
160743005|NCT00115037|580441324|FG003|Phase1|Withdrawal by Subject|0|||
160743006|NCT00115037|580441325|FG004|Phase1|Withdrawal by Subject|0|||
160743007|NCT00115037|580441326|FG005|Phase1|Withdrawal by Subject|0|||
160743008|NCT00115037|580441321|FG000|Phase2|Death|0|||
160743009|NCT00115037|580441322|FG001|Phase2|Death|0|||
160743010|NCT00115037|580441323|FG002|Phase2|Death|1|||
160743011|NCT00115037|580441324|FG003|Phase2|Death|0|||
160743012|NCT00115037|580441325|FG004|Phase2|Death|0|||
160743013|NCT00115037|580441326|FG005|Phase2|Death|1|||
160743014|NCT00115037|580441321|FG000|Phase2|Withdrawal by Subject|0|||
160743015|NCT00115037|580441322|FG001|Phase2|Withdrawal by Subject|0|||
160743016|NCT00115037|580441323|FG002|Phase2|Withdrawal by Subject|2|||
160743017|NCT00115037|580441324|FG003|Phase2|Withdrawal by Subject|1|||
160743018|NCT00115037|580441325|FG004|Phase2|Withdrawal by Subject|2|||
160743019|NCT00115037|580441326|FG005|Phase2|Withdrawal by Subject|1|||
160743020|NCT00115037|580441321|FG000|Phase2|Lost to Follow-up|0|||
160743021|NCT00115037|580441322|FG001|Phase2|Lost to Follow-up|0|||
160743022|NCT00115037|580441323|FG002|Phase2|Lost to Follow-up|12|||
160743023|NCT00115037|580441324|FG003|Phase2|Lost to Follow-up|14|||
160743024|NCT00115037|580441325|FG004|Phase2|Lost to Follow-up|4|||
160743025|NCT00115037|580441326|FG005|Phase2|Lost to Follow-up|10|||
160743026|NCT01398410|580441327|FG000|Overall Study|Adverse Event|12|||
160743027|NCT01398410|580441328|FG001|Overall Study|Adverse Event|16|||
160743028|NCT01398410|580441327|FG000|Overall Study|Participants Choice|8|||
160743029|NCT01398410|580441328|FG001|Overall Study|Participants Choice|11|||
160743030|NCT01398410|580441327|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
160743031|NCT01398410|580441328|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
160743032|NCT01398410|580441327|FG000|Overall Study|Other|36|||
160743033|NCT01398410|580441328|FG001|Overall Study|Other|29|||
160743034|NCT02470403|580441329|FG000|Overall Study|Adverse Event|1|||
160743035|NCT02470403|580441330|FG001|Overall Study|Adverse Event|0|||
160743036|NCT02470403|580441331|FG002|Overall Study|Adverse Event|0|||
160743037|NCT02470403|580441332|FG003|Overall Study|Adverse Event|0|||
160743038|NCT02470403|580441333|FG004|Overall Study|Adverse Event|0|||
160743039|NCT02470403|580441329|FG000|Overall Study|Lost to Follow-up|0|||
160743040|NCT02470403|580441330|FG001|Overall Study|Lost to Follow-up|1|||
160743041|NCT02470403|580441331|FG002|Overall Study|Lost to Follow-up|0|||
160743042|NCT02470403|580441332|FG003|Overall Study|Lost to Follow-up|0|||
160743043|NCT02470403|580441333|FG004|Overall Study|Lost to Follow-up|0|||
160743044|NCT02470403|580441329|FG000|Overall Study|Subject/guardian decision|1|||
160743045|NCT02470403|580441330|FG001|Overall Study|Subject/guardian decision|0|||
160743046|NCT02470403|580441331|FG002|Overall Study|Subject/guardian decision|0|||
160743047|NCT02470403|580441332|FG003|Overall Study|Subject/guardian decision|4|||
160743048|NCT02470403|580441333|FG004|Overall Study|Subject/guardian decision|0|||
160743049|NCT02631070|580441334|FG000|Overall Study|Withdrawal by Subject|35|||
160743050|NCT02631070|580441335|FG001|Overall Study|Withdrawal by Subject|13|||
160743051|NCT02631070|580441334|FG000|Overall Study|Death|45|||
160743052|NCT02631070|580441335|FG001|Overall Study|Death|24|||
160743053|NCT02631070|580441334|FG000|Overall Study|Lost to Follow-up|5|||
160743054|NCT02631070|580441335|FG001|Overall Study|Lost to Follow-up|1|||
160743055|NCT02631070|580441334|FG000|Overall Study|Transition to rollover protocol|52|||
160743056|NCT02631070|580441335|FG001|Overall Study|Transition to rollover protocol|21|||
160743057|NCT02631070|580441334|FG000|Overall Study|Other reasons|12|||
160743058|NCT02631070|580441335|FG001|Overall Study|Other reasons|5|||
160743059|NCT03515629|580441336|FG000|Overall Study|Death|0|||
160743060|NCT03515629|580441337|FG001|Overall Study|Death|1|||
160743061|NCT03515629|580441338|FG002|Overall Study|Death|1|||
160743062|NCT03515629|580441336|FG000|Overall Study|Progressive disease|0|||
160743063|NCT03515629|580441337|FG001|Overall Study|Progressive disease|1|||
160743064|NCT03515629|580441338|FG002|Overall Study|Progressive disease|0|||
160743065|NCT01522235|580441339|FG000|Overall Study|Physician Decision|1|||
160743066|NCT01522235|580441340|FG001|Overall Study|Physician Decision|1|||
160743067|NCT03597022|580441343|FG000|Overall Study|Premature termination of the study|7|||
160743068|NCT03597022|580441344|FG001|Overall Study|Premature termination of the study|7|||
160743069|NCT03597022|580441345|FG002|Overall Study|Premature termination of the study|8|||
160743070|NCT03597022|580441343|FG000|Overall Study|Serious adverse event|1|||
160743071|NCT03597022|580441344|FG001|Overall Study|Serious adverse event|1|||
160743072|NCT03597022|580441345|FG002|Overall Study|Serious adverse event|0|||
160743073|NCT01430624|580441346|FG000|Overall Study|Lost to Follow-up|23|||
160743074|NCT01430624|580441347|FG001|Overall Study|Lost to Follow-up|29|||
160743075|NCT01430624|580441348|FG002|Overall Study|Lost to Follow-up|27|||
160743076|NCT01430624|580441346|FG000|Overall Study|technical or eligibility|5|||
160743077|NCT01430624|580441347|FG001|Overall Study|technical or eligibility|5|||
160743078|NCT01430624|580441348|FG002|Overall Study|technical or eligibility|2|||
160743079|NCT05385224|580441349|FG000|Overall Study|Unable to swallow capsule|2|||
160743080|NCT05385224|580441349|FG000|Overall Study|Withdrawal by Subject|2|||
160743081|NCT05385224|580441349|FG000|Overall Study|Did not meet study criteria|1|||
160743082|NCT04521114|580441350|FG000|Overall Study|Lost to Follow-up|1|||
160743083|NCT04521114|580441351|FG001|Overall Study|Lost to Follow-up|2|||
160743084|NCT04521114|580441352|FG002|Overall Study|Lost to Follow-up|0|||
160743085|NCT04521114|580441350|FG000|Overall Study|Withdrawal by Subject|1|||
160743086|NCT04521114|580441351|FG001|Overall Study|Withdrawal by Subject|2|||
160743087|NCT04521114|580441352|FG002|Overall Study|Withdrawal by Subject|2|||
160743088|NCT04521114|580441350|FG000|Overall Study|Adverse Event|1|||
160743089|NCT04521114|580441351|FG001|Overall Study|Adverse Event|0|||
160743090|NCT04521114|580441352|FG002|Overall Study|Adverse Event|0|||
160743091|NCT04521114|580441350|FG000|Overall Study|Sponsor Wish|1|||
160743092|NCT04521114|580441351|FG001|Overall Study|Sponsor Wish|0|||
160743093|NCT04521114|580441352|FG002|Overall Study|Sponsor Wish|0|||
160743094|NCT04521114|580441350|FG000|Overall Study|Withdrawal of Consent|2|||
160743095|NCT04521114|580441351|FG001|Overall Study|Withdrawal of Consent|2|||
160743096|NCT04521114|580441352|FG002|Overall Study|Withdrawal of Consent|0|||
160743097|NCT01362517|580441353|FG000|Overall Study|Protocol Violation|1|||
160743098|NCT01362517|580441353|FG000|Overall Study|Lost to Follow-up|1|||
160743099|NCT01133288|580441356|FG000|Eligibility Assessment|met exclusion criteria|5|||
160743100|NCT01133288|580441356|FG000|Intervention Allocation|study terminated|2|||
160743101|NCT03209518|580441360|FG000|Overall Study|Case Report Forms Uncollected|1|||
160743102|NCT03209518|580441360|FG000|Overall Study|Protocol Deviation|1|||
160743103|NCT02565706|580441365|FG000|Overall Study|Withdrawal by Subject|5|||
160743104|NCT02565706|580441366|FG001|Overall Study|Withdrawal by Subject|7|||
160743105|NCT02565706|580441367|FG002|Overall Study|Withdrawal by Subject|7|||
160743106|NCT02565706|580441368|FG003|Overall Study|Withdrawal by Subject|11|||
160743107|NCT02565706|580441365|FG000|Overall Study|Lost to Follow-up|72|||
160743108|NCT02565706|580441366|FG001|Overall Study|Lost to Follow-up|75|||
160743109|NCT02565706|580441367|FG002|Overall Study|Lost to Follow-up|82|||
160743110|NCT02565706|580441368|FG003|Overall Study|Lost to Follow-up|74|||
160743111|NCT01281956|580441374|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
160743112|NCT01281956|580441375|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
160743113|NCT01096589|580441397|FG000|Overall Study|Adverse Event|2|||
160743114|NCT01096589|580441398|FG001|Overall Study|Adverse Event|1|||
160743115|NCT01096589|580441399|FG002|Overall Study|Adverse Event|2|||
160743116|NCT01096589|580441400|FG003|Overall Study|Adverse Event|1|||
160743117|NCT01096589|580441397|FG000|Overall Study|Withdrawal by Subject|2|||
160743118|NCT01096589|580441398|FG001|Overall Study|Withdrawal by Subject|1|||
160743119|NCT01096589|580441399|FG002|Overall Study|Withdrawal by Subject|1|||
160743120|NCT01096589|580441400|FG003|Overall Study|Withdrawal by Subject|1|||
160743121|NCT01096589|580441397|FG000|Overall Study|Compliance with protocol|0|||
160743122|NCT01096589|580441398|FG001|Overall Study|Compliance with protocol|0|||
160743123|NCT01096589|580441399|FG002|Overall Study|Compliance with protocol|1|||
160743124|NCT01096589|580441400|FG003|Overall Study|Compliance with protocol|0|||
160743125|NCT01096589|580441397|FG000|Overall Study|found treatment exhausting|0|||
160743126|NCT01096589|580441398|FG001|Overall Study|found treatment exhausting|0|||
160743127|NCT01096589|580441399|FG002|Overall Study|found treatment exhausting|0|||
160743128|NCT01096589|580441400|FG003|Overall Study|found treatment exhausting|1|||
160743129|NCT00948506|580441401|FG000|Overall Study|Withdrawal by Subject|3|||
160743130|NCT00948506|580441402|FG001|Overall Study|Withdrawal by Subject|1|||
160743131|NCT03233204|580441403|FG000|Overall Study|Adverse Event|1|||
160743132|NCT03233204|580441403|FG000|Overall Study|Death|1|||
160743133|NCT03233204|580441403|FG000|Overall Study|Withdrawal by Subject|1|||
160743134|NCT03233204|580441403|FG000|Overall Study|Progressive Disease|3|||
160743135|NCT00793624|580441405|FG000|Overall Study|Adverse Event|18|||
160743136|NCT00793624|580441406|FG001|Overall Study|Adverse Event|16|||
160743137|NCT00793624|580441407|FG002|Overall Study|Adverse Event|15|||
160743138|NCT00793624|580441408|FG003|Overall Study|Adverse Event|20|||
160743139|NCT00793624|580441405|FG000|Overall Study|Lost to Follow-up|2|||
160743140|NCT00793624|580441406|FG001|Overall Study|Lost to Follow-up|2|||
160743141|NCT00793624|580441407|FG002|Overall Study|Lost to Follow-up|4|||
160743142|NCT00793624|580441408|FG003|Overall Study|Lost to Follow-up|0|||
160743143|NCT00793624|580441405|FG000|Overall Study|Withdrawal by Subject|20|||
160743144|NCT00793624|580441406|FG001|Overall Study|Withdrawal by Subject|9|||
160743145|NCT00793624|580441407|FG002|Overall Study|Withdrawal by Subject|11|||
160743146|NCT00793624|580441408|FG003|Overall Study|Withdrawal by Subject|14|||
160743147|NCT00793624|580441405|FG000|Overall Study|Lack of Efficacy|9|||
160743148|NCT00793624|580441406|FG001|Overall Study|Lack of Efficacy|2|||
160743149|NCT00793624|580441407|FG002|Overall Study|Lack of Efficacy|1|||
160743150|NCT00793624|580441408|FG003|Overall Study|Lack of Efficacy|3|||
160743151|NCT00793624|580441405|FG000|Overall Study|Non compliance with protocol|2|||
160743152|NCT00793624|580441406|FG001|Overall Study|Non compliance with protocol|3|||
160743153|NCT00793624|580441407|FG002|Overall Study|Non compliance with protocol|2|||
160743154|NCT00793624|580441408|FG003|Overall Study|Non compliance with protocol|3|||
160743155|NCT00793624|580441405|FG000|Overall Study|Other reason not described above|6|||
160743156|NCT00793624|580441406|FG001|Overall Study|Other reason not described above|4|||
160743157|NCT00793624|580441407|FG002|Overall Study|Other reason not described above|6|||
160743158|NCT00793624|580441408|FG003|Overall Study|Other reason not described above|3|||
160743159|NCT00157248|580441409|FG000|Overall Study|Adverse Event|36|||
160743160|NCT00157248|580441410|FG001|Overall Study|Adverse Event|25|||
160743161|NCT00157248|580441411|FG002|Overall Study|Adverse Event|13|||
160743162|NCT00157248|580441412|FG003|Overall Study|Adverse Event|33|||
160743163|NCT00157248|580441409|FG000|Overall Study|Protocol Violation|4|||
160743164|NCT00157248|580441410|FG001|Overall Study|Protocol Violation|0|||
160743165|NCT00157248|580441411|FG002|Overall Study|Protocol Violation|2|||
160743166|NCT00157248|580441412|FG003|Overall Study|Protocol Violation|2|||
160743167|NCT00157248|580441409|FG000|Overall Study|Lost to Follow-up|0|||
160743168|NCT00157248|580441410|FG001|Overall Study|Lost to Follow-up|1|||
160743169|NCT00157248|580441411|FG002|Overall Study|Lost to Follow-up|0|||
160743170|NCT00157248|580441412|FG003|Overall Study|Lost to Follow-up|0|||
160743171|NCT00157248|580441409|FG000|Overall Study|Withdrawal by Subject|1|||
160743172|NCT00157248|580441410|FG001|Overall Study|Withdrawal by Subject|4|||
160743173|NCT00157248|580441411|FG002|Overall Study|Withdrawal by Subject|3|||
160743174|NCT00157248|580441412|FG003|Overall Study|Withdrawal by Subject|3|||
160743175|NCT00157248|580441409|FG000|Overall Study|site closures, subject moving|7|||
160743176|NCT00157248|580441410|FG001|Overall Study|site closures, subject moving|7|||
160743177|NCT00157248|580441411|FG002|Overall Study|site closures, subject moving|3|||
160743178|NCT00157248|580441412|FG003|Overall Study|site closures, subject moving|9|||
160743179|NCT03467763|580441413|FG000|Overall Study|Lost to Follow-up|1|||
160743180|NCT03467763|580441413|FG000|Overall Study|Protocol Violation|2|||
160743181|NCT01447927|580441414|FG000|Overall Study|Adverse Event|4|||
160743182|NCT01447927|580441415|FG001|Overall Study|Adverse Event|3|||
160743183|NCT01447927|580441414|FG000|Overall Study|Withdrawal by Subject|1|||
160743184|NCT01447927|580441415|FG001|Overall Study|Withdrawal by Subject|0|||
160743185|NCT02073565|580441416|FG000|Cohort A|Withdrawal by Subject|1|||
160743186|NCT02073565|580441417|FG001|Cohort A|Withdrawal by Subject|0|||
160743187|NCT02073565|580441416|FG000|Cohort B|Withdrawal by Subject|1|||
160743188|NCT02073565|580441417|FG001|Cohort B|Withdrawal by Subject|2|||
160743189|NCT02073565|580441416|FG000|Cohort C|Withdrawal by Subject|0|||
160743190|NCT02073565|580441417|FG001|Cohort C|Withdrawal by Subject|2|||
160743191|NCT02073565|580441416|FG000|Cohort C|Lost to Follow-up|0|||
160743192|NCT02073565|580441417|FG001|Cohort C|Lost to Follow-up|2|||
160743193|NCT02913105|580443661|FG000|Overall Study|Adverse Event|11|||
160743194|NCT02913105|580443662|FG001|Overall Study|Adverse Event|0|||
160743195|NCT02913105|580443663|FG002|Overall Study|Adverse Event|4|||
160743196|NCT02913105|580443661|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160743197|NCT02913105|580443662|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160743198|NCT02913105|580443663|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160743199|NCT02913105|580443661|FG000|Overall Study|Reason Not Specified|3|||
160743200|NCT02913105|580443662|FG001|Overall Study|Reason Not Specified|1|||
160743201|NCT02913105|580443663|FG002|Overall Study|Reason Not Specified|1|||
160743202|NCT02913105|580443661|FG000|Overall Study|Physician Decision|1|||
160743203|NCT02913105|580443662|FG001|Overall Study|Physician Decision|1|||
160743204|NCT02913105|580443663|FG002|Overall Study|Physician Decision|0|||
160743205|NCT02913105|580443661|FG000|Overall Study|Withdrawal by Subject|0|||
160743206|NCT02913105|580443662|FG001|Overall Study|Withdrawal by Subject|3|||
160743207|NCT02913105|580443663|FG002|Overall Study|Withdrawal by Subject|1|||
160743208|NCT03959488|580443664|FG000|Season 1|Other|6|||
160743209|NCT03959488|580443665|FG001|Season 1|Other|7|||
160743210|NCT03959488|580443666|FG002|Season 1|Other|0|||
160743211|NCT03959488|580443667|FG003|Season 1|Other|0|||
160743212|NCT03959488|580443668|FG004|Season 1|Other|0|||
160743213|NCT03959488|580443664|FG000|Season 1|Withdrawal by parent/guardian|43|||
160743214|NCT03959488|580443665|FG001|Season 1|Withdrawal by parent/guardian|28|||
160743215|NCT03959488|580443666|FG002|Season 1|Withdrawal by parent/guardian|0|||
160743216|NCT03959488|580443667|FG003|Season 1|Withdrawal by parent/guardian|0|||
160743217|NCT03959488|580443668|FG004|Season 1|Withdrawal by parent/guardian|0|||
160743218|NCT03959488|580443664|FG000|Season 1|Due to COVID-19 pandemic|2|||
160743219|NCT03959488|580443665|FG001|Season 1|Due to COVID-19 pandemic|3|||
160743220|NCT03959488|580443666|FG002|Season 1|Due to COVID-19 pandemic|0|||
160743221|NCT03959488|580443667|FG003|Season 1|Due to COVID-19 pandemic|0|||
160743222|NCT03959488|580443668|FG004|Season 1|Due to COVID-19 pandemic|0|||
160743223|NCT03959488|580443664|FG000|Season 1|Lost to Follow-up|17|||
160743224|NCT03959488|580443665|FG001|Season 1|Lost to Follow-up|7|||
160743225|NCT03959488|580443666|FG002|Season 1|Lost to Follow-up|0|||
160743226|NCT03959488|580443667|FG003|Season 1|Lost to Follow-up|0|||
160743227|NCT03959488|580443668|FG004|Season 1|Lost to Follow-up|0|||
160743228|NCT03959488|580443664|FG000|Season 1|Death|5|||
160743229|NCT03959488|580443665|FG001|Season 1|Death|1|||
160743230|NCT03959488|580443666|FG002|Season 1|Death|0|||
160743231|NCT03959488|580443667|FG003|Season 1|Death|0|||
160743232|NCT03959488|580443668|FG004|Season 1|Death|0|||
160743233|NCT03959488|580443664|FG000|Season 2|Other|0|||
160743234|NCT03959488|580443665|FG001|Season 2|Other|0|||
160743235|NCT03959488|580443666|FG002|Season 2|Other|2|||
160743236|NCT03959488|580443667|FG003|Season 2|Other|0|||
160743237|NCT03959488|580443668|FG004|Season 2|Other|0|||
160743238|NCT03959488|580443664|FG000|Season 2|Withdrawal by parent/guardian|0|||
160743239|NCT03959488|580443665|FG001|Season 2|Withdrawal by parent/guardian|0|||
160743240|NCT03959488|580443666|FG002|Season 2|Withdrawal by parent/guardian|3|||
160743241|NCT03959488|580443667|FG003|Season 2|Withdrawal by parent/guardian|1|||
160743242|NCT03959488|580443668|FG004|Season 2|Withdrawal by parent/guardian|1|||
160743243|NCT03959488|580443664|FG000|Season 2|Lost to Follow-up|0|||
160743244|NCT03959488|580443665|FG001|Season 2|Lost to Follow-up|0|||
160743245|NCT03959488|580443666|FG002|Season 2|Lost to Follow-up|1|||
160743246|NCT03959488|580443667|FG003|Season 2|Lost to Follow-up|0|||
160743247|NCT03959488|580443668|FG004|Season 2|Lost to Follow-up|1|||
160743248|NCT03341936|580443669|FG000|Overall Study|Ineligible|1|||
160743249|NCT03341936|580443669|FG000|Overall Study|Disease Progression|2|||
160743250|NCT03341936|580443669|FG000|Overall Study|Withdrew Consent|4|||
160743251|NCT03341936|580443669|FG000|Overall Study|Non-Compliance|1|||
160743252|NCT03341936|580443669|FG000|Overall Study|Physician Decision|1|||
160743253|NCT03341936|580443669|FG000|Overall Study|Withdrawal by Subject|1|||
160743254|NCT03341936|580443669|FG000|Overall Study|Other|1|||
160743255|NCT00981058|580443676|FG000|Overall Study|Progressive Disease|38|||
160743256|NCT00981058|580443677|FG001|Overall Study|Progressive Disease|31|||
160743257|NCT00981058|580443676|FG000|Overall Study|Lost to Follow-up|3|||
160743258|NCT00981058|580443677|FG001|Overall Study|Lost to Follow-up|2|||
160743259|NCT00981058|580443676|FG000|Overall Study|Physician Decision|4|||
160743260|NCT00981058|580443677|FG001|Overall Study|Physician Decision|5|||
160743261|NCT00981058|580443676|FG000|Overall Study|Randomization Error|0|||
160743262|NCT00981058|580443677|FG001|Overall Study|Randomization Error|1|||
160743263|NCT00981058|580443676|FG000|Overall Study|Withdrawal by Subject|24|||
160743264|NCT00981058|580443677|FG001|Overall Study|Withdrawal by Subject|22|||
160743265|NCT02667587|580443678|FG000|Pre-Treatment|Not reported|1|||
160743266|NCT02667587|580443679|FG001|Pre-Treatment|Not reported|0|||
160743267|NCT02667587|580443678|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
160743268|NCT02667587|580443679|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
160743269|NCT02667587|580443678|FG000|Pre-Treatment|Participant withdrew consent|0|||
160743270|NCT02667587|580443679|FG001|Pre-Treatment|Participant withdrew consent|1|||
160743271|NCT02667587|580443678|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
160743272|NCT02667587|580443679|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
160743273|NCT02667587|580443678|FG000|End of Treatment|Disease Progression|193|||
160743274|NCT02667587|580443679|FG001|End of Treatment|Disease Progression|226|||
160743275|NCT02667587|580443678|FG000|End of Treatment|Study Drug Toxicity|75|||
160743276|NCT02667587|580443679|FG001|End of Treatment|Study Drug Toxicity|19|||
160743277|NCT02667587|580443678|FG000|End of Treatment|Death|2|||
160743278|NCT02667587|580443679|FG001|End of Treatment|Death|1|||
160743279|NCT02667587|580443678|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
160743280|NCT02667587|580443679|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
160743281|NCT02667587|580443678|FG000|End of Treatment|participant request to discontinue treatment|33|||
160743282|NCT02667587|580443679|FG001|End of Treatment|participant request to discontinue treatment|35|||
160743283|NCT02667587|580443678|FG000|End of Treatment|participant withdrew consent|5|||
160743284|NCT02667587|580443679|FG001|End of Treatment|participant withdrew consent|6|||
160743285|NCT02667587|580443678|FG000|End of Treatment|Lost to Follow-up|1|||
160743286|NCT02667587|580443679|FG001|End of Treatment|Lost to Follow-up|2|||
160743287|NCT02667587|580443678|FG000|End of Treatment|maximum clinical benefit|4|||
160743288|NCT02667587|580443679|FG001|End of Treatment|maximum clinical benefit|4|||
160743289|NCT02667587|580443678|FG000|End of Treatment|poor or non compliant|0|||
160743290|NCT02667587|580443679|FG001|End of Treatment|poor or non compliant|1|||
160743291|NCT02667587|580443678|FG000|End of Treatment|participant no longer meets study criteria|1|||
160743292|NCT02667587|580443679|FG001|End of Treatment|participant no longer meets study criteria|1|||
160743293|NCT02667587|580443678|FG000|End of Treatment|administrative reason by sponsor|1|||
160743294|NCT02667587|580443679|FG001|End of Treatment|administrative reason by sponsor|29|||
160743295|NCT02667587|580443678|FG000|End of Treatment|other reasonse|21|||
160743296|NCT02667587|580443679|FG001|End of Treatment|other reasonse|10|||
160743297|NCT02542293|580443680|FG000|Overall Study|Death|367|||
160743298|NCT02542293|580443681|FG001|Overall Study|Death|377|||
160743299|NCT02542293|580443680|FG000|Overall Study|Withdrawal by Subject|8|||
160743300|NCT02542293|580443681|FG001|Overall Study|Withdrawal by Subject|19|||
160743301|NCT04529850|580443682|FG000|Overall Study|Death|2|||
160743302|NCT04529850|580443682|FG000|Overall Study|Physician Decision|1|||
160743303|NCT04529850|580443682|FG000|Overall Study|Withdrawal by Subject|2|||
160743304|NCT00593606|580443687|FG000|Overall Study|Adverse Event|13|||
160743305|NCT00593606|580443687|FG000|Overall Study|Withdrawal by Subject|1|||
160743306|NCT00593606|580443687|FG000|Overall Study|Protocol Violation|3|||
160743307|NCT00593606|580443687|FG000|Overall Study|Lost to Follow-up|2|||
160743308|NCT00593606|580443687|FG000|Overall Study|Run-In Failure|5|||
160743309|NCT00593606|580443687|FG000|Overall Study|Screen Failure|3|||
160743310|NCT02278367|580443688|FG000|Overall Study|Physician Decision|5|||
160743311|NCT02278367|580443689|FG001|Overall Study|Physician Decision|0|||
160743312|NCT02278367|580443688|FG000|Overall Study|Withdrawal by Subject|5|||
160743313|NCT02278367|580443689|FG001|Overall Study|Withdrawal by Subject|0|||
160743314|NCT00869557|580443691|FG000|Randomized Phase|Lost to Follow-up|2|||
160743315|NCT00869557|580443692|FG001|Randomized Phase|Lost to Follow-up|1|||
160743316|NCT00869557|580443691|FG000|Randomized Phase|Investigator's Discretion|1|||
160743317|NCT00869557|580443692|FG001|Randomized Phase|Investigator's Discretion|0|||
160743318|NCT00869557|580443691|FG000|Randomized Phase|Withdrew Consent|0|||
160743319|NCT00869557|580443692|FG001|Randomized Phase|Withdrew Consent|1|||
160743320|NCT00869557|580443691|FG000|Extension Phase|Adverse Event|2|||
160743321|NCT00869557|580443692|FG001|Extension Phase|Adverse Event|2|||
160743322|NCT00869557|580443691|FG000|Extension Phase|Lack of Efficacy|1|||
160743323|NCT00869557|580443692|FG001|Extension Phase|Lack of Efficacy|0|||
160743324|NCT00869557|580443691|FG000|Extension Phase|Lost to Follow-up|3|||
160743325|NCT00869557|580443692|FG001|Extension Phase|Lost to Follow-up|1|||
160743326|NCT00869557|580443691|FG000|Extension Phase|Investigator's Discretion|2|||
160743327|NCT00869557|580443692|FG001|Extension Phase|Investigator's Discretion|0|||
160743328|NCT00869557|580443691|FG000|Extension Phase|Withdrew Consent|2|||
160743329|NCT00869557|580443692|FG001|Extension Phase|Withdrew Consent|0|||
160743330|NCT01472939|580443695|FG000|Overall Study|Adverse Event|3|||
160743331|NCT01472939|580443696|FG001|Overall Study|Adverse Event|7|||
160743332|NCT01472939|580443697|FG002|Overall Study|Adverse Event|7|||
160743333|NCT01472939|580443698|FG003|Overall Study|Adverse Event|14|||
160743334|NCT01472939|580443695|FG000|Overall Study|Lack of Efficacy|1|||
160743335|NCT01472939|580443696|FG001|Overall Study|Lack of Efficacy|0|||
160743336|NCT01472939|580443697|FG002|Overall Study|Lack of Efficacy|0|||
160743337|NCT01472939|580443698|FG003|Overall Study|Lack of Efficacy|1|||
160743338|NCT01472939|580443695|FG000|Overall Study|Lost to Follow-up|3|||
160743339|NCT01472939|580443696|FG001|Overall Study|Lost to Follow-up|0|||
160743340|NCT01472939|580443697|FG002|Overall Study|Lost to Follow-up|2|||
160743341|NCT01472939|580443698|FG003|Overall Study|Lost to Follow-up|0|||
160743342|NCT01472939|580443695|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
160743343|NCT01472939|580443696|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
160743344|NCT01472939|580443697|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
160743345|NCT01472939|580443698|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
160743346|NCT01472939|580443695|FG000|Overall Study|Prohibited Medication|0|||
160743347|NCT01472939|580443696|FG001|Overall Study|Prohibited Medication|1|||
160743348|NCT01472939|580443697|FG002|Overall Study|Prohibited Medication|0|||
160743349|NCT01472939|580443698|FG003|Overall Study|Prohibited Medication|0|||
160743350|NCT01472939|580443695|FG000|Overall Study|Withdrawal By PI|1|||
160743351|NCT01472939|580443696|FG001|Overall Study|Withdrawal By PI|0|||
160743352|NCT01472939|580443697|FG002|Overall Study|Withdrawal By PI|0|||
160743353|NCT01472939|580443698|FG003|Overall Study|Withdrawal By PI|0|||
160743354|NCT01472939|580443695|FG000|Overall Study|Protocol Violation|3|||
160743355|NCT01472939|580443696|FG001|Overall Study|Protocol Violation|3|||
160743356|NCT01472939|580443697|FG002|Overall Study|Protocol Violation|0|||
160743357|NCT01472939|580443698|FG003|Overall Study|Protocol Violation|1|||
160743358|NCT01472939|580443695|FG000|Overall Study|Withdrawal by Subject|9|||
160743359|NCT01472939|580443696|FG001|Overall Study|Withdrawal by Subject|3|||
160743360|NCT01472939|580443697|FG002|Overall Study|Withdrawal by Subject|1|||
160743361|NCT01472939|580443698|FG003|Overall Study|Withdrawal by Subject|4|||
160743362|NCT00114738|580443699|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
160743363|NCT00114738|580443700|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
160743364|NCT00114738|580443701|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
160743365|NCT00114738|580443699|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
160743366|NCT00114738|580443700|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
160743367|NCT00114738|580443701|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
160743368|NCT00114738|580443699|FG000|Screening for Randomization|Neuropathy|17|||
160743369|NCT00114738|580443700|FG001|Screening for Randomization|Neuropathy|0|||
160743370|NCT00114738|580443701|FG002|Screening for Randomization|Neuropathy|0|||
160743371|NCT00114738|580443699|FG000|Screening for Randomization|Progressive disease|2|||
160743372|NCT00114738|580443700|FG001|Screening for Randomization|Progressive disease|0|||
160743373|NCT00114738|580443701|FG002|Screening for Randomization|Progressive disease|0|||
160743374|NCT00114738|580443699|FG000|Screening for Randomization|CNS Hemorrhage|1|||
160743375|NCT00114738|580443700|FG001|Screening for Randomization|CNS Hemorrhage|0|||
160743376|NCT00114738|580443701|FG002|Screening for Randomization|CNS Hemorrhage|0|||
160743377|NCT00114738|580443699|FG000|Screening for Randomization|Other|1|||
160743378|NCT00114738|580443700|FG001|Screening for Randomization|Other|0|||
160743379|NCT00114738|580443701|FG002|Screening for Randomization|Other|0|||
160743380|NCT05940077|580443702|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
160743381|NCT00388297|580443703|FG000|Overall Study|Lost to Follow-up|16|||
160743382|NCT00388297|580443704|FG001|Overall Study|Lost to Follow-up|12|||
160743383|NCT00388297|580443705|FG002|Overall Study|Lost to Follow-up|11|||
160743384|NCT00388297|580443706|FG003|Overall Study|Lost to Follow-up|8|||
160743385|NCT01492101|580443709|FG000|Overall Study|Death|323|||
160743386|NCT01492101|580443710|FG001|Overall Study|Death|322|||
160743387|NCT01492101|580443709|FG000|Overall Study|Withdrawal by Subject|14|||
160743388|NCT01492101|580443710|FG001|Overall Study|Withdrawal by Subject|18|||
160743389|NCT01492101|580443709|FG000|Overall Study|Lost to Follow-up|0|||
160743390|NCT01492101|580443710|FG001|Overall Study|Lost to Follow-up|2|||
160743391|NCT01004432|580443711|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
160743392|NCT01004432|580443712|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
160743393|NCT01004432|580443713|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
160743394|NCT01004432|580443714|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
160743395|NCT01004432|580443715|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
160743396|NCT01004432|580443711|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
160743397|NCT01004432|580443712|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
160743398|NCT01004432|580443713|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
160743399|NCT01004432|580443714|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
160743400|NCT01004432|580443715|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
160743401|NCT01004432|580443711|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
160743402|NCT01004432|580443712|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
160743403|NCT01004432|580443713|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
160743404|NCT01004432|580443714|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
160743405|NCT01004432|580443715|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
160743406|NCT01004432|580443711|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
160743407|NCT01004432|580443712|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
160743408|NCT01004432|580443713|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
160743409|NCT01004432|580443714|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
160743410|NCT01004432|580443715|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
160743411|NCT01004432|580443711|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
160743412|NCT01004432|580443712|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
160743413|NCT01004432|580443713|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
160743414|NCT01004432|580443714|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
160743415|NCT01004432|580443715|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
160743416|NCT01004432|580443711|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
160743417|NCT01004432|580443712|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
160743418|NCT01004432|580443713|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
160743419|NCT01004432|580443714|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
160743420|NCT01004432|580443715|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
160743421|NCT01004432|580443711|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
160743422|NCT01004432|580443712|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
160743423|NCT01004432|580443713|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
160743424|NCT01004432|580443714|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
160743425|NCT01004432|580443715|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
160743426|NCT01004432|580443711|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
160743427|NCT01004432|580443712|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
160743428|NCT01004432|580443713|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
160743429|NCT01004432|580443714|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
160743430|NCT01004432|580443715|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
160743431|NCT01004432|580443711|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
160743432|NCT01004432|580443712|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
160743433|NCT01004432|580443713|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
160743434|NCT01004432|580443714|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
160743435|NCT01004432|580443715|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
160743436|NCT01004432|580443711|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
160743437|NCT01004432|580443712|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
160743438|NCT01004432|580443713|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
160743439|NCT01004432|580443714|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
160743440|NCT01004432|580443715|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
160743441|NCT01004432|580443711|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
160743442|NCT01004432|580443712|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
160743443|NCT01004432|580443713|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
160743444|NCT01004432|580443714|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
160743445|NCT01004432|580443715|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
160743446|NCT01004432|580443711|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
160743447|NCT01004432|580443712|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
160743448|NCT01004432|580443713|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
160743449|NCT01004432|580443714|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
160743450|NCT01004432|580443715|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
160743451|NCT01004432|580443711|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
160743452|NCT01004432|580443712|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
160743453|NCT01004432|580443713|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
160743454|NCT01004432|580443714|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
160743455|NCT01004432|580443715|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
160743456|NCT01004432|580443711|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
160743457|NCT01004432|580443712|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
160743458|NCT01004432|580443713|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
160743459|NCT01004432|580443714|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
160743460|NCT01004432|580443715|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
160743461|NCT01004432|580443711|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
160743462|NCT01004432|580443712|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
160743463|NCT01004432|580443713|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
160743464|NCT01004432|580443714|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
160743465|NCT01004432|580443715|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
160743466|NCT02696434|580443719|FG000|Overall Study|Adverse Event|3|||
160743467|NCT02696434|580443720|FG001|Overall Study|Adverse Event|1|||
160743468|NCT02696434|580443719|FG000|Overall Study|Lost to Follow-up|5|||
160743469|NCT02696434|580443720|FG001|Overall Study|Lost to Follow-up|4|||
160743470|NCT02696434|580443719|FG000|Overall Study|Withdrawal by Subject|14|||
160743471|NCT02696434|580443720|FG001|Overall Study|Withdrawal by Subject|12|||
160743472|NCT02696434|580443719|FG000|Overall Study|Physician Decision|0|||
160743473|NCT02696434|580443720|FG001|Overall Study|Physician Decision|1|||
160743474|NCT00316914|580443726|FG000|Overall Study|Withdrawal by Subject|5|||
160743475|NCT00316914|580443727|FG001|Overall Study|Withdrawal by Subject|3|||
160743476|NCT00316914|580443726|FG000|Overall Study|Adverse Event|8|||
160743477|NCT00316914|580443727|FG001|Overall Study|Adverse Event|7|||
160743478|NCT00316914|580443726|FG000|Overall Study|Other Problems|6|||
160743479|NCT00316914|580443727|FG001|Overall Study|Other Problems|11|||
160743480|NCT00316914|580443726|FG000|Overall Study|Missing end of treatment documentation|14|||
160743481|NCT00316914|580443727|FG001|Overall Study|Missing end of treatment documentation|15|||
160743482|NCT02284568|580443728|FG000|Overall Study|Adverse Event|2|||
160743483|NCT02284568|580443729|FG001|Overall Study|Adverse Event|9|||
160743484|NCT02284568|580443730|FG002|Overall Study|Adverse Event|4|||
160743485|NCT02284568|580443728|FG000|Overall Study|Withdrawal by Subject|22|||
160743486|NCT02284568|580443729|FG001|Overall Study|Withdrawal by Subject|21|||
160743487|NCT02284568|580443730|FG002|Overall Study|Withdrawal by Subject|1|||
160743488|NCT02284568|580443728|FG000|Overall Study|Noncompliance with study drug admin|1|||
160743489|NCT02284568|580443729|FG001|Overall Study|Noncompliance with study drug admin|2|||
160743490|NCT02284568|580443730|FG002|Overall Study|Noncompliance with study drug admin|0|||
160743491|NCT02284568|580443728|FG000|Overall Study|Noncompliance|1|||
160743492|NCT02284568|580443729|FG001|Overall Study|Noncompliance|0|||
160743493|NCT02284568|580443730|FG002|Overall Study|Noncompliance|0|||
160743494|NCT02284568|580443728|FG000|Overall Study|Protocol Violation|0|||
160743495|NCT02284568|580443729|FG001|Overall Study|Protocol Violation|1|||
160743496|NCT02284568|580443730|FG002|Overall Study|Protocol Violation|0|||
160743497|NCT02284568|580443728|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
160743498|NCT02284568|580443729|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
160743499|NCT02284568|580443730|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
160743500|NCT02284568|580443728|FG000|Overall Study|Lost to Follow-up|0|||
160743501|NCT02284568|580443729|FG001|Overall Study|Lost to Follow-up|3|||
160743502|NCT02284568|580443730|FG002|Overall Study|Lost to Follow-up|0|||
160743503|NCT02284568|580443728|FG000|Overall Study|Lack of Efficacy|4|||
160743504|NCT02284568|580443729|FG001|Overall Study|Lack of Efficacy|7|||
160743505|NCT02284568|580443730|FG002|Overall Study|Lack of Efficacy|0|||
160743506|NCT02284568|580443728|FG000|Overall Study|Other|1|||
160743507|NCT02284568|580443729|FG001|Overall Study|Other|2|||
160743508|NCT02284568|580443730|FG002|Overall Study|Other|0|||
160743509|NCT02284568|580443728|FG000|Overall Study|Withdrew before taking study drug|0|||
160743510|NCT02284568|580443729|FG001|Overall Study|Withdrew before taking study drug|1|||
160743511|NCT02284568|580443730|FG002|Overall Study|Withdrew before taking study drug|0|||
160743512|NCT00980174|580443734|FG000|Overall Study|Withdrawal by Subject|1|||
160743513|NCT00980174|580443735|FG001|Overall Study|Withdrawal by Subject|4|||
160743514|NCT00980174|580443734|FG000|Overall Study|Adverse Event|0|||
160743515|NCT00980174|580443735|FG001|Overall Study|Adverse Event|3|||
160743516|NCT00980174|580443734|FG000|Overall Study|Ineligibility determined|2|||
160743517|NCT00980174|580443735|FG001|Overall Study|Ineligibility determined|1|||
160743518|NCT00980174|580443734|FG000|Overall Study|Death|1|||
160743519|NCT00980174|580443735|FG001|Overall Study|Death|1|||
160743520|NCT00980174|580443734|FG000|Overall Study|Other|0|||
160743521|NCT00980174|580443735|FG001|Overall Study|Other|1|||
160743522|NCT03114657|580443736|FG000|Overall Study|Adverse Event|9|||
160743523|NCT03114657|580443737|FG001|Overall Study|Adverse Event|6|||
160743524|NCT03114657|580443736|FG000|Overall Study|Death|4|||
160743525|NCT03114657|580443737|FG001|Overall Study|Death|0|||
160743526|NCT03114657|580443736|FG000|Overall Study|Multiple Reasons|1|||
160743527|NCT03114657|580443737|FG001|Overall Study|Multiple Reasons|2|||
160743528|NCT03114657|580443736|FG000|Overall Study|Physician Decision|2|||
160743529|NCT03114657|580443737|FG001|Overall Study|Physician Decision|2|||
160743530|NCT03114657|580443736|FG000|Overall Study|Study Terminated By Sponsor|355|||
160743531|NCT03114657|580443737|FG001|Overall Study|Study Terminated By Sponsor|374|||
160743532|NCT03114657|580443736|FG000|Overall Study|Symptomatic Deterioration|0|||
160743533|NCT03114657|580443737|FG001|Overall Study|Symptomatic Deterioration|1|||
160743534|NCT03114657|580443736|FG000|Overall Study|Withdrawal by Subject|28|||
160743535|NCT03114657|580443737|FG001|Overall Study|Withdrawal by Subject|22|||
160743536|NCT01546038|580443738|FG000|Overall Study|Death|15|||
160743537|NCT01546038|580443739|FG001|Overall Study|Death|6|||
160743538|NCT01546038|580443740|FG002|Overall Study|Death|4|||
160743539|NCT01546038|580443741|FG003|Overall Study|Death|2|||
160743540|NCT01546038|580443742|FG004|Overall Study|Death|9|||
160743541|NCT01546038|580443743|FG005|Overall Study|Death|3|||
160743542|NCT01546038|580443744|FG006|Overall Study|Death|46|||
160743543|NCT01546038|580443745|FG007|Overall Study|Death|76|||
160743544|NCT01546038|580443746|FG008|Overall Study|Death|39|||
160743545|NCT01546038|580443738|FG000|Overall Study|Lost to Follow-up|0|||
160743546|NCT01546038|580443739|FG001|Overall Study|Lost to Follow-up|0|||
160743547|NCT01546038|580443740|FG002|Overall Study|Lost to Follow-up|0|||
160743548|NCT01546038|580443741|FG003|Overall Study|Lost to Follow-up|0|||
160743549|NCT01546038|580443742|FG004|Overall Study|Lost to Follow-up|1|||
160743550|NCT01546038|580443743|FG005|Overall Study|Lost to Follow-up|0|||
160743551|NCT01546038|580443744|FG006|Overall Study|Lost to Follow-up|2|||
160743552|NCT01546038|580443745|FG007|Overall Study|Lost to Follow-up|1|||
160743553|NCT01546038|580443746|FG008|Overall Study|Lost to Follow-up|0|||
160743554|NCT01546038|580443738|FG000|Overall Study|Withdrawal by Subject|1|||
160743555|NCT01546038|580443739|FG001|Overall Study|Withdrawal by Subject|0|||
160743556|NCT01546038|580443740|FG002|Overall Study|Withdrawal by Subject|0|||
160743557|NCT01546038|580443741|FG003|Overall Study|Withdrawal by Subject|1|||
160743558|NCT01546038|580443742|FG004|Overall Study|Withdrawal by Subject|0|||
160743559|NCT01546038|580443743|FG005|Overall Study|Withdrawal by Subject|1|||
160743560|NCT01546038|580443744|FG006|Overall Study|Withdrawal by Subject|3|||
160743561|NCT01546038|580443745|FG007|Overall Study|Withdrawal by Subject|3|||
160743562|NCT01546038|580443746|FG008|Overall Study|Withdrawal by Subject|1|||
160743563|NCT01546038|580443738|FG000|Overall Study|: Randomized, not treated|0|||
160743564|NCT01546038|580443739|FG001|Overall Study|: Randomized, not treated|0|||
160743565|NCT01546038|580443740|FG002|Overall Study|: Randomized, not treated|0|||
160743566|NCT01546038|580443741|FG003|Overall Study|: Randomized, not treated|0|||
160743567|NCT01546038|580443742|FG004|Overall Study|: Randomized, not treated|0|||
160743568|NCT01546038|580443743|FG005|Overall Study|: Randomized, not treated|0|||
160743569|NCT01546038|580443744|FG006|Overall Study|: Randomized, not treated|2|||
160743570|NCT01546038|580443745|FG007|Overall Study|: Randomized, not treated|4|||
160743571|NCT01546038|580443746|FG008|Overall Study|: Randomized, not treated|3|||
160743572|NCT04245202|580443747|FG000|Overall Study|Lack of Efficacy|10|||
160743573|NCT04245202|580443748|FG001|Overall Study|Lack of Efficacy|1|||
160743574|NCT00717275|580443749|FG000|Overall Study|Premature study termination.|3|||
160743575|NCT00424021|580443753|FG000|NCT00046319 Study Period|Adverse Event|1|||
160743576|NCT00424021|580443754|FG001|NCT00046319 Study Period|Adverse Event|0|||
160743577|NCT00424021|580443755|FG002|NCT00046319 Study Period|Adverse Event|1|||
160743578|NCT00424021|580443756|FG003|NCT00046319 Study Period|Adverse Event|1|||
160743579|NCT00424021|580443753|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
160743580|NCT00424021|580443754|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
160743581|NCT00424021|580443755|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
160743582|NCT00424021|580443756|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
160743583|NCT00424021|580443753|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
160743584|NCT00424021|580443754|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
160743585|NCT00424021|580443755|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
160743586|NCT00424021|580443756|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
160743587|NCT00424021|580443753|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
160743588|NCT00424021|580443754|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
160743589|NCT00424021|580443755|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
160743590|NCT00424021|580443756|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
160743591|NCT00424021|580443753|FG000|AMB-220-E Study Period|Adverse Event|1|||
160743592|NCT00424021|580443754|FG001|AMB-220-E Study Period|Adverse Event|1|||
160743593|NCT00424021|580443755|FG002|AMB-220-E Study Period|Adverse Event|3|||
160743594|NCT00424021|580443756|FG003|AMB-220-E Study Period|Adverse Event|7|||
160743595|NCT00424021|580443753|FG000|AMB-220-E Study Period|Death|0|||
160743596|NCT00424021|580443754|FG001|AMB-220-E Study Period|Death|0|||
160743597|NCT00424021|580443755|FG002|AMB-220-E Study Period|Death|1|||
160743598|NCT00424021|580443756|FG003|AMB-220-E Study Period|Death|1|||
160743599|NCT00424021|580443753|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
160743600|NCT00424021|580443754|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
160743601|NCT00424021|580443755|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
160743602|NCT00424021|580443756|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
160743603|NCT00424021|580443753|FG000|AMB-220-E Study Period|Physician Decision|0|||
160743604|NCT00424021|580443754|FG001|AMB-220-E Study Period|Physician Decision|0|||
160743605|NCT00424021|580443755|FG002|AMB-220-E Study Period|Physician Decision|0|||
160743606|NCT00424021|580443756|FG003|AMB-220-E Study Period|Physician Decision|1|||
160743607|NCT03769194|580443757|FG000|Overall Study|Withdrawal by Subject|0|||
160743608|NCT03769194|580443758|FG001|Overall Study|Withdrawal by Subject|7|||
160743609|NCT03769194|580443759|FG002|Overall Study|Withdrawal by Subject|4|||
160743610|NCT03769194|580443760|FG003|Overall Study|Withdrawal by Subject|1|||
160743611|NCT03769194|580443757|FG000|Overall Study|moved from study area|0|||
160743612|NCT03769194|580443758|FG001|Overall Study|moved from study area|2|||
160743613|NCT03769194|580443759|FG002|Overall Study|moved from study area|1|||
160743614|NCT03769194|580443760|FG003|Overall Study|moved from study area|1|||
160743615|NCT03769194|580443757|FG000|Overall Study|Lost to Follow-up|3|||
160743616|NCT03769194|580443758|FG001|Overall Study|Lost to Follow-up|6|||
160743617|NCT03769194|580443759|FG002|Overall Study|Lost to Follow-up|3|||
160743618|NCT03769194|580443760|FG003|Overall Study|Lost to Follow-up|6|||
160743619|NCT03769194|580443757|FG000|Overall Study|other|1|||
160743620|NCT03769194|580443758|FG001|Overall Study|other|3|||
160743621|NCT03769194|580443759|FG002|Overall Study|other|0|||
160743622|NCT03769194|580443760|FG003|Overall Study|other|1|||
160743623|NCT00312572|580443762|FG000|Overall Study|Adverse Event|10|||
160743624|NCT00312572|580443763|FG001|Overall Study|Adverse Event|16|||
160743625|NCT00312572|580443762|FG000|Overall Study|Lost to Follow-up|1|||
160743626|NCT00312572|580443763|FG001|Overall Study|Lost to Follow-up|1|||
160743627|NCT00312572|580443762|FG000|Overall Study|Administrative|4|||
160743628|NCT00312572|580443763|FG001|Overall Study|Administrative|2|||
160743629|NCT00312572|580443762|FG000|Overall Study|Lack of Efficacy|1|||
160743630|NCT00312572|580443763|FG001|Overall Study|Lack of Efficacy|2|||
160743631|NCT02614131|580443770|FG000|Overall Study|Withdrawal by Subject|1|||
160743632|NCT02614131|580443771|FG001|Overall Study|Withdrawal by Subject|0|||
160743633|NCT02614131|580443772|FG002|Overall Study|Withdrawal by Subject|0|||
160743634|NCT02614131|580443773|FG003|Overall Study|Withdrawal by Subject|0|||
160743635|NCT02614131|580443774|FG004|Overall Study|Withdrawal by Subject|0|||
160743636|NCT02614131|580443775|FG005|Overall Study|Withdrawal by Subject|0|||
160743637|NCT02614131|580443776|FG006|Overall Study|Withdrawal by Subject|0|||
160743638|NCT02614131|580443770|FG000|Overall Study|Adverse Event|0|||
160743639|NCT02614131|580443771|FG001|Overall Study|Adverse Event|0|||
160743640|NCT02614131|580443772|FG002|Overall Study|Adverse Event|0|||
160743641|NCT02614131|580443773|FG003|Overall Study|Adverse Event|0|||
160743642|NCT02614131|580443774|FG004|Overall Study|Adverse Event|0|||
160743643|NCT02614131|580443775|FG005|Overall Study|Adverse Event|0|||
160743644|NCT02614131|580443776|FG006|Overall Study|Adverse Event|1|||
160743645|NCT01832818|580443777|FG000|Overall Study|Lost to Follow-up|6|||
160743646|NCT00236899|580443778|FG000|Overall Study|Adverse Event (Study Related)|1|||
160743647|NCT00236899|580443779|FG001|Overall Study|Adverse Event (Study Related)|1|||
160743648|NCT00236899|580443780|FG002|Overall Study|Adverse Event (Study Related)|2|||
160743649|NCT00236899|580443781|FG003|Overall Study|Adverse Event (Study Related)|1|||
160743650|NCT00236899|580443778|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
160743651|NCT00236899|580443779|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
160743652|NCT00236899|580443780|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
160743653|NCT00236899|580443781|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
160743654|NCT00236899|580443778|FG000|Overall Study|Death (Study Disease)|1|||
160743655|NCT00236899|580443779|FG001|Overall Study|Death (Study Disease)|4|||
160743656|NCT00236899|580443780|FG002|Overall Study|Death (Study Disease)|0|||
160743657|NCT00236899|580443781|FG003|Overall Study|Death (Study Disease)|0|||
160743658|NCT00236899|580443778|FG000|Overall Study|Death (Not Study Related)|2|||
160743659|NCT00236899|580443779|FG001|Overall Study|Death (Not Study Related)|0|||
160743660|NCT00236899|580443780|FG002|Overall Study|Death (Not Study Related)|0|||
160743661|NCT00236899|580443781|FG003|Overall Study|Death (Not Study Related)|0|||
160743662|NCT00236899|580443778|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
160743663|NCT00236899|580443779|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
160743664|NCT00236899|580443780|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
160743665|NCT00236899|580443781|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
160743666|NCT00236899|580443778|FG000|Overall Study|Lost to Follow-up|0|||
160743667|NCT00236899|580443779|FG001|Overall Study|Lost to Follow-up|1|||
160743668|NCT00236899|580443780|FG002|Overall Study|Lost to Follow-up|0|||
160743669|NCT00236899|580443781|FG003|Overall Study|Lost to Follow-up|0|||
160743670|NCT00236899|580443778|FG000|Overall Study|Entry Criteria Exclusion|0|||
160743671|NCT00236899|580443779|FG001|Overall Study|Entry Criteria Exclusion|1|||
160743672|NCT00236899|580443780|FG002|Overall Study|Entry Criteria Exclusion|1|||
160743673|NCT00236899|580443781|FG003|Overall Study|Entry Criteria Exclusion|0|||
160743674|NCT00236899|580443778|FG000|Overall Study|Protocol Violation|1|||
160743675|NCT00236899|580443779|FG001|Overall Study|Protocol Violation|0|||
160743676|NCT00236899|580443780|FG002|Overall Study|Protocol Violation|0|||
160743677|NCT00236899|580443781|FG003|Overall Study|Protocol Violation|0|||
160743678|NCT00236899|580443778|FG000|Overall Study|Withdrawal by Subject|6|||
160743679|NCT00236899|580443779|FG001|Overall Study|Withdrawal by Subject|4|||
160743680|NCT00236899|580443780|FG002|Overall Study|Withdrawal by Subject|5|||
160743681|NCT00236899|580443781|FG003|Overall Study|Withdrawal by Subject|2|||
160743682|NCT00236899|580443778|FG000|Overall Study|Physician Decision|7|||
160743683|NCT00236899|580443779|FG001|Overall Study|Physician Decision|8|||
160743684|NCT00236899|580443780|FG002|Overall Study|Physician Decision|7|||
160743685|NCT00236899|580443781|FG003|Overall Study|Physician Decision|6|||
160743686|NCT00236899|580443778|FG000|Overall Study|Satisfactory Response|2|||
160743687|NCT00236899|580443779|FG001|Overall Study|Satisfactory Response|0|||
160743688|NCT00236899|580443780|FG002|Overall Study|Satisfactory Response|0|||
160743689|NCT00236899|580443781|FG003|Overall Study|Satisfactory Response|1|||
160743690|NCT00236899|580443778|FG000|Overall Study|Lack of Efficacy|18|||
160743691|NCT00236899|580443779|FG001|Overall Study|Lack of Efficacy|18|||
160743692|NCT00236899|580443780|FG002|Overall Study|Lack of Efficacy|25|||
160743693|NCT00236899|580443781|FG003|Overall Study|Lack of Efficacy|23|||
160743694|NCT01389258|580443784|FG000|Overall Study|Lost to Follow-up|5|||
160743695|NCT03313310|580443785|FG000|Phase 2|Lost to Follow-up|4|||
160743696|NCT03313310|580443786|FG001|Phase 2|Lost to Follow-up|0|||
160743697|NCT03313310|580443785|FG000|Phase 3|Lost to Follow-up|0|||
160743698|NCT03313310|580443786|FG001|Phase 3|Lost to Follow-up|1|||
160743699|NCT01904903|580443790|FG000|Overall Study|Withdrawal by Subject|1|||
160743700|NCT00314132|580443791|FG000|Overall Study|Lost to Follow-up|3|||
160743701|NCT00314132|580443792|FG001|Overall Study|Lost to Follow-up|13|||
160743702|NCT00314132|580443791|FG000|Overall Study|Withdrawal by Subject|3|||
160743703|NCT00314132|580443792|FG001|Overall Study|Withdrawal by Subject|5|||
160743704|NCT00314132|580443791|FG000|Overall Study|Adverse Event|1|||
160743705|NCT00314132|580443792|FG001|Overall Study|Adverse Event|0|||
160743706|NCT00314132|580443791|FG000|Overall Study|Physician Decision|1|||
160743707|NCT00314132|580443792|FG001|Overall Study|Physician Decision|0|||
160743708|NCT03677934|580443793|FG000|Overall Study|Adverse Event|1|||
160743709|NCT03677934|580443794|FG001|Overall Study|Adverse Event|1|||
160743710|NCT03677934|580443793|FG000|Overall Study|Death|8|||
160743711|NCT03677934|580443794|FG001|Overall Study|Death|4|||
160743712|NCT03677934|580443793|FG000|Overall Study|Lost to Follow-up|3|||
160743713|NCT03677934|580443794|FG001|Overall Study|Lost to Follow-up|0|||
160743714|NCT03677934|580443793|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160743715|NCT03677934|580443794|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160743716|NCT03677934|580443793|FG000|Overall Study|Physician Decision|0|||
160743717|NCT03677934|580443794|FG001|Overall Study|Physician Decision|1|||
160743718|NCT03677934|580443793|FG000|Overall Study|Withdrawal by Subject|1|||
160743719|NCT03677934|580443794|FG001|Overall Study|Withdrawal by Subject|7|||
160743720|NCT04769739|580443795|FG000|Overall Study|Colorectal cancer obstruction|2|||
160743721|NCT04769739|580443796|FG001|Overall Study|Colorectal cancer obstruction|0|||
160743722|NCT04769739|580443797|FG002|Overall Study|Colorectal cancer obstruction|0|||
160743723|NCT04769739|580443798|FG003|Overall Study|Colorectal cancer obstruction|0|||
160743724|NCT04769739|580443795|FG000|Overall Study|Failed cecal intubation|1|||
160743725|NCT04769739|580443796|FG001|Overall Study|Failed cecal intubation|0|||
160743726|NCT04769739|580443797|FG002|Overall Study|Failed cecal intubation|0|||
160743727|NCT04769739|580443798|FG003|Overall Study|Failed cecal intubation|1|||
160743728|NCT04769739|580443795|FG000|Overall Study|Poor bowel preparation|0|||
160743729|NCT04769739|580443796|FG001|Overall Study|Poor bowel preparation|0|||
160743730|NCT04769739|580443797|FG002|Overall Study|Poor bowel preparation|0|||
160743731|NCT04769739|580443798|FG003|Overall Study|Poor bowel preparation|1|||
160743732|NCT03627416|580443805|FG000|Overall Study|Adverse Event|0|||
160743733|NCT03627416|580443806|FG001|Overall Study|Adverse Event|1|||
160743734|NCT02079636|580443807|FG000|Overall Study|Death|2|||
160743735|NCT02079636|580443808|FG001|Overall Study|Death|1|||
160743736|NCT02079636|580443809|FG002|Overall Study|Death|0|||
160743737|NCT02079636|580443810|FG003|Overall Study|Death|5|||
160743738|NCT02079636|580443811|FG004|Overall Study|Death|1|||
160743739|NCT02079636|580443812|FG005|Overall Study|Death|2|||
160743740|NCT02079636|580443813|FG006|Overall Study|Death|1|||
160743741|NCT02079636|580443814|FG007|Overall Study|Death|0|||
160743742|NCT02079636|580443815|FG008|Overall Study|Death|0|||
160743743|NCT02079636|580443816|FG009|Overall Study|Death|0|||
160743744|NCT02079636|580443817|FG010|Overall Study|Death|0|||
160743745|NCT02079636|580443818|FG011|Overall Study|Death|1|||
160743746|NCT02079636|580443819|FG012|Overall Study|Death|1|||
160743747|NCT02079636|580443820|FG013|Overall Study|Death|0|||
160743748|NCT02079636|580443821|FG014|Overall Study|Death|2|||
160743749|NCT02079636|580443807|FG000|Overall Study|Adverse Event|1|||
160743750|NCT02079636|580443808|FG001|Overall Study|Adverse Event|1|||
160743751|NCT02079636|580443809|FG002|Overall Study|Adverse Event|0|||
160743752|NCT02079636|580443810|FG003|Overall Study|Adverse Event|1|||
160743753|NCT02079636|580443811|FG004|Overall Study|Adverse Event|1|||
160743754|NCT02079636|580443812|FG005|Overall Study|Adverse Event|2|||
160743755|NCT02079636|580443813|FG006|Overall Study|Adverse Event|0|||
160743756|NCT02079636|580443814|FG007|Overall Study|Adverse Event|0|||
160743757|NCT02079636|580443815|FG008|Overall Study|Adverse Event|0|||
160743758|NCT02079636|580443816|FG009|Overall Study|Adverse Event|0|||
160743759|NCT02079636|580443817|FG010|Overall Study|Adverse Event|0|||
160743760|NCT02079636|580443818|FG011|Overall Study|Adverse Event|0|||
160743761|NCT02079636|580443819|FG012|Overall Study|Adverse Event|0|||
160743762|NCT02079636|580443820|FG013|Overall Study|Adverse Event|0|||
160743763|NCT02079636|580443821|FG014|Overall Study|Adverse Event|0|||
160743764|NCT02079636|580443807|FG000|Overall Study|Progressive disease|0|||
160743765|NCT02079636|580443808|FG001|Overall Study|Progressive disease|0|||
160743766|NCT02079636|580443809|FG002|Overall Study|Progressive disease|0|||
160743767|NCT02079636|580443810|FG003|Overall Study|Progressive disease|2|||
160743768|NCT02079636|580443811|FG004|Overall Study|Progressive disease|0|||
160743769|NCT02079636|580443812|FG005|Overall Study|Progressive disease|0|||
160743770|NCT02079636|580443813|FG006|Overall Study|Progressive disease|0|||
160743771|NCT02079636|580443814|FG007|Overall Study|Progressive disease|0|||
160743772|NCT02079636|580443815|FG008|Overall Study|Progressive disease|0|||
160743773|NCT02079636|580443816|FG009|Overall Study|Progressive disease|0|||
160743774|NCT02079636|580443817|FG010|Overall Study|Progressive disease|0|||
160743775|NCT02079636|580443818|FG011|Overall Study|Progressive disease|0|||
160743776|NCT02079636|580443819|FG012|Overall Study|Progressive disease|1|||
160743777|NCT02079636|580443820|FG013|Overall Study|Progressive disease|0|||
160743778|NCT02079636|580443821|FG014|Overall Study|Progressive disease|0|||
160743779|NCT02079636|580443807|FG000|Overall Study|Withdrawal by Subject|0|||
160743780|NCT02079636|580443808|FG001|Overall Study|Withdrawal by Subject|0|||
160743781|NCT02079636|580443809|FG002|Overall Study|Withdrawal by Subject|0|||
160743782|NCT02079636|580443810|FG003|Overall Study|Withdrawal by Subject|4|||
160743783|NCT02079636|580443811|FG004|Overall Study|Withdrawal by Subject|0|||
160743784|NCT02079636|580443812|FG005|Overall Study|Withdrawal by Subject|1|||
160743785|NCT02079636|580443813|FG006|Overall Study|Withdrawal by Subject|0|||
160743786|NCT02079636|580443814|FG007|Overall Study|Withdrawal by Subject|0|||
160743787|NCT02079636|580443815|FG008|Overall Study|Withdrawal by Subject|0|||
160743788|NCT02079636|580443816|FG009|Overall Study|Withdrawal by Subject|2|||
160743789|NCT02079636|580443817|FG010|Overall Study|Withdrawal by Subject|1|||
160743790|NCT02079636|580443818|FG011|Overall Study|Withdrawal by Subject|1|||
160743791|NCT02079636|580443819|FG012|Overall Study|Withdrawal by Subject|1|||
160743792|NCT02079636|580443820|FG013|Overall Study|Withdrawal by Subject|0|||
160743793|NCT02079636|580443821|FG014|Overall Study|Withdrawal by Subject|2|||
160743794|NCT02079636|580443807|FG000|Overall Study|Physician Decision|0|||
160743795|NCT02079636|580443808|FG001|Overall Study|Physician Decision|0|||
160743796|NCT02079636|580443809|FG002|Overall Study|Physician Decision|0|||
160743797|NCT02079636|580443810|FG003|Overall Study|Physician Decision|0|||
160743798|NCT02079636|580443811|FG004|Overall Study|Physician Decision|0|||
160743799|NCT02079636|580443812|FG005|Overall Study|Physician Decision|1|||
160743800|NCT02079636|580443813|FG006|Overall Study|Physician Decision|0|||
160743801|NCT02079636|580443814|FG007|Overall Study|Physician Decision|0|||
160743802|NCT02079636|580443815|FG008|Overall Study|Physician Decision|0|||
160743803|NCT02079636|580443816|FG009|Overall Study|Physician Decision|1|||
160743804|NCT02079636|580443817|FG010|Overall Study|Physician Decision|1|||
160743805|NCT02079636|580443818|FG011|Overall Study|Physician Decision|0|||
160743806|NCT02079636|580443819|FG012|Overall Study|Physician Decision|0|||
160743807|NCT02079636|580443820|FG013|Overall Study|Physician Decision|0|||
160743808|NCT02079636|580443821|FG014|Overall Study|Physician Decision|1|||
160743809|NCT02079636|580443807|FG000|Overall Study|Lost to Follow-up|0|||
160743810|NCT02079636|580443808|FG001|Overall Study|Lost to Follow-up|0|||
160743811|NCT02079636|580443809|FG002|Overall Study|Lost to Follow-up|0|||
160743812|NCT02079636|580443810|FG003|Overall Study|Lost to Follow-up|0|||
160743813|NCT02079636|580443811|FG004|Overall Study|Lost to Follow-up|0|||
160743814|NCT02079636|580443812|FG005|Overall Study|Lost to Follow-up|0|||
160743815|NCT02079636|580443813|FG006|Overall Study|Lost to Follow-up|0|||
160743816|NCT02079636|580443814|FG007|Overall Study|Lost to Follow-up|1|||
160743817|NCT02079636|580443815|FG008|Overall Study|Lost to Follow-up|0|||
160743818|NCT02079636|580443816|FG009|Overall Study|Lost to Follow-up|0|||
160743819|NCT02079636|580443817|FG010|Overall Study|Lost to Follow-up|0|||
160743820|NCT02079636|580443818|FG011|Overall Study|Lost to Follow-up|0|||
160743821|NCT02079636|580443819|FG012|Overall Study|Lost to Follow-up|0|||
160743822|NCT02079636|580443820|FG013|Overall Study|Lost to Follow-up|0|||
160743823|NCT02079636|580443821|FG014|Overall Study|Lost to Follow-up|0|||
160743824|NCT00637806|580443822|FG000|Double-blind Phase|Study Discontinued|2|||
160743825|NCT00637806|580443823|FG001|Double-blind Phase|Study Discontinued|0|||
160743826|NCT00637806|580443824|FG002|Double-blind Phase|Study Discontinued|1|||
160743827|NCT00637806|580443825|FG003|Double-blind Phase|Study Discontinued|0|||
160743828|NCT00637806|580443822|FG000|Extension Phase|Study Discontinued|0|||
160743829|NCT00637806|580443823|FG001|Extension Phase|Study Discontinued|0|||
160743830|NCT00637806|580443824|FG002|Extension Phase|Study Discontinued|0|||
160743831|NCT00637806|580443825|FG003|Extension Phase|Study Discontinued|1|||
160743832|NCT00561470|580443826|FG000|Overall Study|Adverse Event|74|||
160743833|NCT00561470|580443827|FG001|Overall Study|Adverse Event|163|||
160743834|NCT00561470|580443826|FG000|Overall Study|Disease progression|437|||
160743835|NCT00561470|580443827|FG001|Overall Study|Disease progression|305|||
160743836|NCT00561470|580443826|FG000|Overall Study|poor compliance to protocol|4|||
160743837|NCT00561470|580443827|FG001|Overall Study|poor compliance to protocol|4|||
160743838|NCT00561470|580443826|FG000|Overall Study|Lost to Follow-up|2|||
160743839|NCT00561470|580443827|FG001|Overall Study|Lost to Follow-up|0|||
160743840|NCT00561470|580443826|FG000|Overall Study|Physician Decision|21|||
160743841|NCT00561470|580443827|FG001|Overall Study|Physician Decision|20|||
160743842|NCT00561470|580443826|FG000|Overall Study|Consent Withdrawn|2|||
160743843|NCT00561470|580443827|FG001|Overall Study|Consent Withdrawn|6|||
160743844|NCT00561470|580443826|FG000|Overall Study|Subject request|43|||
160743845|NCT00561470|580443827|FG001|Overall Study|Subject request|77|||
160743846|NCT00561470|580443826|FG000|Overall Study|Metastatic surgery|10|||
160743847|NCT00561470|580443827|FG001|Overall Study|Metastatic surgery|12|||
160743848|NCT00561470|580443826|FG000|Overall Study|Unauthorized procedure|3|||
160743849|NCT00561470|580443827|FG001|Overall Study|Unauthorized procedure|1|||
160743850|NCT00561470|580443826|FG000|Overall Study|Randomized but not treated|5|||
160743851|NCT00561470|580443827|FG001|Overall Study|Randomized but not treated|5|||
160743852|NCT00561470|580443826|FG000|Overall Study|Missed visit window|1|||
160743853|NCT00561470|580443827|FG001|Overall Study|Missed visit window|4|||
160743854|NCT00561470|580443826|FG000|Overall Study|Planning surgery|1|||
160743855|NCT00561470|580443827|FG001|Overall Study|Planning surgery|1|||
160743856|NCT00561470|580443826|FG000|Overall Study|Ongoing Treatment|11|||
160743857|NCT00561470|580443827|FG001|Overall Study|Ongoing Treatment|14|||
160743858|NCT00335959|580443828|FG000|Overall Study|Adverse Event|2|||
160743859|NCT00335959|580443828|FG000|Overall Study|Ineligible|1|||
160743860|NCT02028169|580443829|FG000|Overall Study|Lost to Follow-up|21|||
160743861|NCT02028169|580443829|FG000|Overall Study|Lack of Efficacy|2|||
160743862|NCT02028169|580443829|FG000|Overall Study|Withdrawal by Subject|2|||
160743863|NCT02028169|580443829|FG000|Overall Study|Adverse Event|1|||
160743864|NCT02028169|580443829|FG000|Overall Study|Cessation of Drug|1|||
160743865|NCT02028169|580443829|FG000|Overall Study|Concomitant Medication Usage|1|||
160743866|NCT02240069|580443834|FG000|Overall Study|Withdrawal by Subject|5|||
160743867|NCT02240069|580443835|FG001|Overall Study|Withdrawal by Subject|5|||
160743868|NCT02240069|580443836|FG002|Overall Study|Withdrawal by Subject|2|||
160743869|NCT01876979|580443837|FG000|Overall Study|Physician Decision|2|||
160743870|NCT01876979|580443838|FG001|Overall Study|Physician Decision|3|||
160743871|NCT00824382|580443840|FG000|Overall Study|Adverse Event|4|||
160743872|NCT00824382|580443841|FG001|Overall Study|Adverse Event|1|||
160743873|NCT00824382|580443842|FG002|Overall Study|Adverse Event|1|||
160743874|NCT00824382|580443843|FG003|Overall Study|Adverse Event|4|||
160743875|NCT00824382|580443840|FG000|Overall Study|Protocol Violation|1|||
160743876|NCT00824382|580443841|FG001|Overall Study|Protocol Violation|0|||
160743877|NCT00824382|580443842|FG002|Overall Study|Protocol Violation|0|||
160743878|NCT00824382|580443843|FG003|Overall Study|Protocol Violation|1|||
160743879|NCT00824382|580443840|FG000|Overall Study|Investigator's decision|0|||
160743880|NCT00824382|580443841|FG001|Overall Study|Investigator's decision|1|||
160743881|NCT00824382|580443842|FG002|Overall Study|Investigator's decision|2|||
160743882|NCT00824382|580443843|FG003|Overall Study|Investigator's decision|0|||
160743883|NCT02407054|580443844|FG000|Overall Study|Adverse Event|1|||
160743884|NCT02407054|580443845|FG001|Overall Study|Adverse Event|4|||
160743885|NCT02407054|580443846|FG002|Overall Study|Adverse Event|1|||
160743886|NCT02407054|580443844|FG000|Overall Study|Non-compliance with Study|0|||
160743887|NCT02407054|580443845|FG001|Overall Study|Non-compliance with Study|2|||
160743888|NCT02407054|580443846|FG002|Overall Study|Non-compliance with Study|1|||
160743889|NCT02407054|580443844|FG000|Overall Study|Physician Decision|1|||
160743890|NCT02407054|580443845|FG001|Overall Study|Physician Decision|3|||
160743891|NCT02407054|580443846|FG002|Overall Study|Physician Decision|3|||
160743892|NCT02407054|580443844|FG000|Overall Study|Withdrawal by Subject|5|||
160743893|NCT02407054|580443845|FG001|Overall Study|Withdrawal by Subject|9|||
160743894|NCT02407054|580443846|FG002|Overall Study|Withdrawal by Subject|2|||
160743895|NCT00932698|580443847|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
160743896|NCT00932698|580443848|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
160743897|NCT00932698|580443849|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
160743898|NCT00932698|580443850|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
160743899|NCT00932698|580443851|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
160743900|NCT00932698|580443852|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
160743901|NCT00932698|580443853|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
160743902|NCT00932698|580443854|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
160743903|NCT00932698|580443855|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
160743904|NCT00932698|580443856|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
160743905|NCT00932698|580443857|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
160743906|NCT00932698|580443847|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
160743907|NCT00932698|580443848|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
160743908|NCT00932698|580443849|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
160743909|NCT00932698|580443850|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
160743910|NCT00932698|580443851|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
160743911|NCT00932698|580443852|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
160743912|NCT00932698|580443853|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
160743913|NCT00932698|580443854|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
160743914|NCT00932698|580443855|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
160743915|NCT00932698|580443856|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
160743916|NCT00932698|580443857|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
160743917|NCT00932698|580443847|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
160743918|NCT00932698|580443848|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
160743919|NCT00932698|580443849|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
160743920|NCT00932698|580443850|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
160743921|NCT00932698|580443851|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
160743922|NCT00932698|580443852|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
160743923|NCT00932698|580443853|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
160743924|NCT00932698|580443854|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
160743925|NCT00932698|580443855|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
160743926|NCT00932698|580443856|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
160743927|NCT00932698|580443857|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
160743928|NCT00932698|580443847|FG000|Part 1 (Dose Escalation)|Other|0|||
160743929|NCT00932698|580443848|FG001|Part 1 (Dose Escalation)|Other|0|||
160743930|NCT00932698|580443849|FG002|Part 1 (Dose Escalation)|Other|1|||
160743931|NCT00932698|580443850|FG003|Part 1 (Dose Escalation)|Other|0|||
160743932|NCT00932698|580443851|FG004|Part 1 (Dose Escalation)|Other|0|||
160743933|NCT00932698|580443852|FG005|Part 1 (Dose Escalation)|Other|0|||
160743934|NCT00932698|580443853|FG006|Part 1 (Dose Escalation)|Other|1|||
160743935|NCT00932698|580443854|FG007|Part 1 (Dose Escalation)|Other|0|||
160743936|NCT00932698|580443855|FG008|Part 1 (Dose Escalation)|Other|0|||
160743937|NCT00932698|580443856|FG009|Part 1 (Dose Escalation)|Other|0|||
160743938|NCT00932698|580443857|FG010|Part 1 (Dose Escalation)|Other|0|||
160743939|NCT00932698|580443847|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
160743940|NCT00932698|580443848|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
160743941|NCT00932698|580443849|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
160743942|NCT00932698|580443850|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
160743943|NCT00932698|580443851|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
160743944|NCT00932698|580443852|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
160743945|NCT00932698|580443853|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
160743946|NCT00932698|580443854|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
160743947|NCT00932698|580443855|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
160743948|NCT00932698|580443856|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
160743949|NCT00932698|580443857|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
160743950|NCT00932698|580443847|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
160743951|NCT00932698|580443848|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
160743952|NCT00932698|580443849|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
160743953|NCT00932698|580443850|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
160743954|NCT00932698|580443851|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
160743955|NCT00932698|580443852|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
160743956|NCT00932698|580443853|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
160743957|NCT00932698|580443854|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
160743958|NCT00932698|580443855|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
160743959|NCT00932698|580443856|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
160743960|NCT00932698|580443857|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
160743961|NCT00932698|580443847|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
160743962|NCT00932698|580443848|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
160743963|NCT00932698|580443849|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
160743964|NCT00932698|580443850|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
160743965|NCT00932698|580443851|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
160743966|NCT00932698|580443852|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
160743967|NCT00932698|580443853|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
160743968|NCT00932698|580443854|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
160743969|NCT00932698|580443855|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
160743970|NCT00932698|580443856|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
160743971|NCT00932698|580443857|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
160743972|NCT02908074|580443860|FG000|Overall Study|sponsor/ICON decision|0|||
160743973|NCT02908074|580443861|FG001|Overall Study|sponsor/ICON decision|0|||
160743974|NCT02908074|580443862|FG002|Overall Study|sponsor/ICON decision|1|||
160743975|NCT02908074|580443863|FG003|Overall Study|sponsor/ICON decision|0|||
160743976|NCT02908074|580443864|FG004|Overall Study|sponsor/ICON decision|0|||
160743977|NCT02908074|580443865|FG005|Overall Study|sponsor/ICON decision|0|||
160743978|NCT02908074|580443860|FG000|Overall Study|Protocol Violation|0|||
160743979|NCT02908074|580443861|FG001|Overall Study|Protocol Violation|1|||
160743980|NCT02908074|580443862|FG002|Overall Study|Protocol Violation|0|||
160743981|NCT02908074|580443863|FG003|Overall Study|Protocol Violation|0|||
160743982|NCT02908074|580443864|FG004|Overall Study|Protocol Violation|0|||
160743983|NCT02908074|580443865|FG005|Overall Study|Protocol Violation|0|||
160743984|NCT02908074|580443860|FG000|Overall Study|Adverse Event|5|||
160743985|NCT02908074|580443861|FG001|Overall Study|Adverse Event|2|||
160743986|NCT02908074|580443862|FG002|Overall Study|Adverse Event|0|||
160743987|NCT02908074|580443863|FG003|Overall Study|Adverse Event|0|||
160743988|NCT02908074|580443864|FG004|Overall Study|Adverse Event|1|||
160743989|NCT02908074|580443865|FG005|Overall Study|Adverse Event|0|||
160743990|NCT02908074|580443860|FG000|Overall Study|AESI|1|||
160743991|NCT02908074|580443861|FG001|Overall Study|AESI|0|||
160743992|NCT02908074|580443862|FG002|Overall Study|AESI|1|||
160743993|NCT02908074|580443863|FG003|Overall Study|AESI|0|||
160743994|NCT02908074|580443864|FG004|Overall Study|AESI|1|||
160743995|NCT02908074|580443865|FG005|Overall Study|AESI|0|||
160743996|NCT02908074|580443860|FG000|Overall Study|Discontinuation criteria per protocol|0|||
160743997|NCT02908074|580443861|FG001|Overall Study|Discontinuation criteria per protocol|0|||
160743998|NCT02908074|580443862|FG002|Overall Study|Discontinuation criteria per protocol|1|||
160743999|NCT02908074|580443863|FG003|Overall Study|Discontinuation criteria per protocol|0|||
160744000|NCT02908074|580443864|FG004|Overall Study|Discontinuation criteria per protocol|0|||
160744001|NCT02908074|580443865|FG005|Overall Study|Discontinuation criteria per protocol|1|||
160744002|NCT02908074|580443860|FG000|Overall Study|Withdrawal by Subject|3|||
160744003|NCT02908074|580443861|FG001|Overall Study|Withdrawal by Subject|2|||
160744004|NCT02908074|580443862|FG002|Overall Study|Withdrawal by Subject|2|||
160744005|NCT02908074|580443863|FG003|Overall Study|Withdrawal by Subject|2|||
160744006|NCT02908074|580443864|FG004|Overall Study|Withdrawal by Subject|2|||
160744007|NCT02908074|580443865|FG005|Overall Study|Withdrawal by Subject|2|||
160744008|NCT02908074|580443860|FG000|Overall Study|Lost to Follow-up|0|||
160744009|NCT02908074|580443861|FG001|Overall Study|Lost to Follow-up|1|||
160744010|NCT02908074|580443862|FG002|Overall Study|Lost to Follow-up|1|||
160744011|NCT02908074|580443863|FG003|Overall Study|Lost to Follow-up|1|||
160744012|NCT02908074|580443864|FG004|Overall Study|Lost to Follow-up|0|||
160744013|NCT02908074|580443865|FG005|Overall Study|Lost to Follow-up|1|||
160744014|NCT02227368|580445219|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
160744015|NCT02227368|580445220|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
160744016|NCT02227368|580445219|FG000|Overall Study|Lost to Follow-up|1|||
160744017|NCT02227368|580445220|FG001|Overall Study|Lost to Follow-up|0|||
160744018|NCT02227368|580445219|FG000|Overall Study|Adverse Event|1|||
160744019|NCT02227368|580445220|FG001|Overall Study|Adverse Event|0|||
160744020|NCT03046056|580445222|FG000|Overall Study|Non-responder at Week 10|6|||
160744021|NCT03046056|580445223|FG001|Overall Study|Non-responder at Week 10|6|||
160744022|NCT03046056|580445224|FG002|Overall Study|Non-responder at Week 10|4|||
160744023|NCT03046056|580445222|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
160744024|NCT03046056|580445223|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
160744025|NCT03046056|580445224|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
160744026|NCT03046056|580445222|FG000|Overall Study|Adverse Event|1|||
160744027|NCT03046056|580445223|FG001|Overall Study|Adverse Event|5|||
160744028|NCT03046056|580445224|FG002|Overall Study|Adverse Event|0|||
160744029|NCT03046056|580445222|FG000|Overall Study|Non-compliance With Study Drug|0|||
160744030|NCT03046056|580445223|FG001|Overall Study|Non-compliance With Study Drug|0|||
160744031|NCT03046056|580445224|FG002|Overall Study|Non-compliance With Study Drug|2|||
160744032|NCT03046056|580445222|FG000|Overall Study|Protocol Violation|1|||
160744033|NCT03046056|580445223|FG001|Overall Study|Protocol Violation|1|||
160744034|NCT03046056|580445224|FG002|Overall Study|Protocol Violation|0|||
160744035|NCT03046056|580445222|FG000|Overall Study|Investigator's Discretion|0|||
160744036|NCT03046056|580445223|FG001|Overall Study|Investigator's Discretion|1|||
160744037|NCT03046056|580445224|FG002|Overall Study|Investigator's Discretion|0|||
160744038|NCT03046056|580445222|FG000|Overall Study|Withdrew Consent|1|||
160744039|NCT03046056|580445223|FG001|Overall Study|Withdrew Consent|0|||
160744040|NCT03046056|580445224|FG002|Overall Study|Withdrew Consent|0|||
160744041|NCT03089853|580445225|FG000|Overall Study|Lost to Follow-up|2|||
160744042|NCT03089853|580445226|FG001|Overall Study|Lost to Follow-up|1|||
160744043|NCT01317004|580445227|FG000|Overall Study|Withdrawal by Subject|1|||
160744044|NCT01317004|580445228|FG001|Overall Study|Withdrawal by Subject|4|||
160744045|NCT01317004|580445227|FG000|Overall Study|Protocol Violation|0|||
160744046|NCT01317004|580445228|FG001|Overall Study|Protocol Violation|2|||
160744047|NCT01317004|580445227|FG000|Overall Study|Adverse Event|3|||
160744048|NCT01317004|580445228|FG001|Overall Study|Adverse Event|3|||
160744049|NCT01344759|580445231|FG000|Overall Study|Patients failed to reach sedation level|0|||
160744050|NCT01344759|580445232|FG001|Overall Study|Patients failed to reach sedation level|2|||
160744051|NCT04114656|580445233|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
160744052|NCT04114656|580445234|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
160744053|NCT04114656|580445233|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
160744054|NCT04114656|580445234|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
160744055|NCT04114656|580445233|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
160744056|NCT04114656|580445234|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
160744057|NCT04114656|580445233|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
160744058|NCT04114656|580445234|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
160744059|NCT04114656|580445233|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
160744060|NCT04114656|580445234|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
160744061|NCT00703326|580445235|FG000|Overall Study|Lost to Follow-up|47|||
160744062|NCT00703326|580445236|FG001|Overall Study|Lost to Follow-up|18|||
160744063|NCT00703326|580445235|FG000|Overall Study|Withdrawal by Subject|54|||
160744064|NCT00703326|580445236|FG001|Overall Study|Withdrawal by Subject|20|||
160744065|NCT00703326|580445235|FG000|Overall Study|Adverse Event|1|||
160744066|NCT00703326|580445236|FG001|Overall Study|Adverse Event|0|||
160744067|NCT02661061|580445238|FG000|Overall Study|Lack of Efficacy|1|||
160744068|NCT02661061|580445239|FG001|Overall Study|Lack of Efficacy|1|||
160744069|NCT02661061|580445238|FG000|Overall Study|Withdrawal by Subject|1|||
160744070|NCT02661061|580445239|FG001|Overall Study|Withdrawal by Subject|1|||
160744071|NCT01393106|580445240|FG000|Overall Study|Adverse Event|3|||
160744072|NCT01393106|580445240|FG000|Overall Study|Withdrawal by Subject|1|||
160744073|NCT01393106|580445240|FG000|Overall Study|Lack of Efficacy|1|||
160744074|NCT02732015|580445241|FG000|Overall Study|Lost to Follow-up|0|||
160744075|NCT02732015|580445242|FG001|Overall Study|Lost to Follow-up|1|||
160744076|NCT03052920|580445243|FG000|Overall Study|Withdrawal by Subject|1|||
160744077|NCT01980628|580445244|FG000|Overall Study|Adverse Event|12|||
160744078|NCT01980628|580445244|FG000|Overall Study|Physician Decision|5|||
160744079|NCT01980628|580445244|FG000|Overall Study|Withdrawal by Subject|4|||
160744080|NCT01980628|580445244|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
160744081|NCT03015194|580445248|FG000|Overall Study|Death|10|||
160744082|NCT03015194|580445248|FG000|Overall Study|Withdrawal by Subject|2|||
160744083|NCT01698268|580445249|FG000|Overall Study|Physician Decision|2|||
160744084|NCT01698268|580445250|FG001|Overall Study|Physician Decision|1|||
160744085|NCT02263729|580445251|FG000|Overall Study|Lost to Follow-up|1|||
160744086|NCT02263729|580445252|FG001|Overall Study|Lost to Follow-up|1|||
160744087|NCT04591015|580445253|FG000|Overall Study|Death|6|||
160744088|NCT04591015|580445254|FG001|Overall Study|Death|4|||
160744089|NCT04591015|580445253|FG000|Overall Study|Withdrawal by Subject|6|||
160744090|NCT04591015|580445254|FG001|Overall Study|Withdrawal by Subject|3|||
160744091|NCT04591015|580445253|FG000|Overall Study|Lost to Follow-up|16|||
160744092|NCT04591015|580445254|FG001|Overall Study|Lost to Follow-up|11|||
160744093|NCT02509078|580445255|FG000|Overall Study|Protocol Violation|1|||
160744094|NCT02509078|580445256|FG001|Overall Study|Protocol Violation|1|||
160744095|NCT03594955|580445258|FG000|Overall Study|Adverse Event|1|||
160744096|NCT03594955|580445258|FG000|Overall Study|Progressive disease|5|||
160744097|NCT03594955|580445258|FG000|Overall Study|Sponsor's decision|1|||
160744098|NCT02131636|580445264|FG000|Overall Study|Personal Reasons|4|||
160744099|NCT02131636|580445265|FG001|Overall Study|Personal Reasons|4|||
160744100|NCT02131636|580445264|FG000|Overall Study|Lost to Follow-up|4|||
160744101|NCT02131636|580445265|FG001|Overall Study|Lost to Follow-up|0|||
160744102|NCT02131636|580445264|FG000|Overall Study|Adverse Event|4|||
160744103|NCT02131636|580445265|FG001|Overall Study|Adverse Event|1|||
160744104|NCT06226649|580445266|FG000|Overall Study|Withdrawal by Subject|4|||
160744105|NCT06226649|580445267|FG001|Overall Study|Withdrawal by Subject|1|||
160744106|NCT00631163|580445268|FG000|Number of Participants in Year 1|Adverse Event|12|||
160744107|NCT00631163|580445268|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
160744108|NCT00631163|580445268|FG000|Number of Participants in Year 1|Death|6|||
160744109|NCT00631163|580445268|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
160744110|NCT00631163|580445268|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
160744111|NCT00631163|580445268|FG000|Number of Participants in Year 1|Administrative problems|6|||
160744112|NCT00631163|580445268|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
160744113|NCT00631163|580445268|FG000|Number of Participants in Year 2|Adverse Event|1|||
160744114|NCT00631163|580445268|FG000|Number of Participants in Year 2|Protocol Violation|1|||
160744115|NCT00631163|580445268|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
160744116|NCT02290925|580445269|FG000|First Period of Three Months|Lost to Follow-up|2|||
160744117|NCT02290925|580445270|FG001|First Period of Three Months|Lost to Follow-up|1|||
160744118|NCT02290925|580445269|FG000|First Period of Three Months|Death|1|||
160744119|NCT02290925|580445270|FG001|First Period of Three Months|Death|0|||
160744120|NCT02290925|580445269|FG000|First Period of Three Months|Insulin Started|1|||
160744121|NCT02290925|580445270|FG001|First Period of Three Months|Insulin Started|1|||
160744122|NCT02290925|580445269|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
160744123|NCT02290925|580445270|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
160744124|NCT02290925|580445269|FG000|Second Period of 3 Months|insulin started|0|||
160744125|NCT02290925|580445270|FG001|Second Period of 3 Months|insulin started|1|||
160744126|NCT03956615|580445279|FG000|Overall Study|No multiple myeloma confirmed|2|||
160744127|NCT03956615|580445279|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
160744128|NCT03956615|580445279|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
160744129|NCT03956615|580445279|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
160744130|NCT01254721|580445282|FG000|Overall Study|Lost to Follow-up|0|||
160744131|NCT01254721|580445283|FG001|Overall Study|Lost to Follow-up|4|||
160744132|NCT01254721|580445282|FG000|Overall Study|Lack of Efficacy|4|||
160744133|NCT01254721|580445283|FG001|Overall Study|Lack of Efficacy|2|||
160744134|NCT01254721|580445282|FG000|Overall Study|Death|0|||
160744135|NCT01254721|580445283|FG001|Overall Study|Death|1|||
160744136|NCT01254721|580445282|FG000|Overall Study|technical problum|1|||
160744137|NCT01254721|580445283|FG001|Overall Study|technical problum|0|||
160744138|NCT01254721|580445282|FG000|Overall Study|Adverse Event|2|||
160744139|NCT01254721|580445283|FG001|Overall Study|Adverse Event|3|||
160744140|NCT01254721|580445282|FG000|Overall Study|Withdrawal by Subject|8|||
160744141|NCT01254721|580445283|FG001|Overall Study|Withdrawal by Subject|11|||
160744142|NCT01254721|580445282|FG000|Overall Study|Wrongly randomization|0|||
160744143|NCT01254721|580445283|FG001|Overall Study|Wrongly randomization|1|||
160744144|NCT00568334|580445284|FG000|Overall Study|Withdrawal by Subject|0|||
160744145|NCT00568334|580445285|FG001|Overall Study|Withdrawal by Subject|1|||
160744146|NCT00568334|580445284|FG000|Overall Study|Lost to Follow-up|1|||
160744147|NCT00568334|580445285|FG001|Overall Study|Lost to Follow-up|0|||
160744148|NCT01897571|580445286|FG000|Overall Study|Lost to Follow-up|3|||
160744149|NCT01897571|580445287|FG001|Overall Study|Lost to Follow-up|0|||
160744150|NCT01897571|580445288|FG002|Overall Study|Lost to Follow-up|0|||
160744151|NCT01897571|580445289|FG003|Overall Study|Lost to Follow-up|0|||
160744152|NCT01897571|580445290|FG004|Overall Study|Lost to Follow-up|2|||
160744153|NCT01897571|580445291|FG005|Overall Study|Lost to Follow-up|0|||
160744154|NCT01897571|580445292|FG006|Overall Study|Lost to Follow-up|0|||
160744155|NCT01897571|580445293|FG007|Overall Study|Lost to Follow-up|0|||
160744156|NCT01897571|580445294|FG008|Overall Study|Lost to Follow-up|1|||
160744157|NCT01897571|580445295|FG009|Overall Study|Lost to Follow-up|2|||
160744158|NCT01897571|580445296|FG010|Overall Study|Lost to Follow-up|4|||
160744159|NCT01897571|580445286|FG000|Overall Study|Withdrawal by Subject|0|||
160744160|NCT01897571|580445287|FG001|Overall Study|Withdrawal by Subject|0|||
160744161|NCT01897571|580445288|FG002|Overall Study|Withdrawal by Subject|0|||
160744162|NCT01897571|580445289|FG003|Overall Study|Withdrawal by Subject|0|||
160744163|NCT01897571|580445290|FG004|Overall Study|Withdrawal by Subject|0|||
160744164|NCT01897571|580445291|FG005|Overall Study|Withdrawal by Subject|0|||
160744165|NCT01897571|580445292|FG006|Overall Study|Withdrawal by Subject|0|||
160744166|NCT01897571|580445293|FG007|Overall Study|Withdrawal by Subject|1|||
160744167|NCT01897571|580445294|FG008|Overall Study|Withdrawal by Subject|4|||
160744168|NCT01897571|580445295|FG009|Overall Study|Withdrawal by Subject|3|||
160744169|NCT01897571|580445296|FG010|Overall Study|Withdrawal by Subject|1|||
160744170|NCT01897571|580445286|FG000|Overall Study|Other|1|||
160744171|NCT01897571|580445287|FG001|Overall Study|Other|0|||
160744172|NCT01897571|580445288|FG002|Overall Study|Other|0|||
160744173|NCT01897571|580445289|FG003|Overall Study|Other|3|||
160744174|NCT01897571|580445290|FG004|Overall Study|Other|3|||
160744175|NCT01897571|580445291|FG005|Overall Study|Other|4|||
160744176|NCT01897571|580445292|FG006|Overall Study|Other|7|||
160744177|NCT01897571|580445293|FG007|Overall Study|Other|0|||
160744178|NCT01897571|580445294|FG008|Overall Study|Other|0|||
160744179|NCT01897571|580445295|FG009|Overall Study|Other|0|||
160744180|NCT01897571|580445296|FG010|Overall Study|Other|0|||
160744181|NCT01897571|580445286|FG000|Overall Study|Enrolled in rollover study|0|||
160744182|NCT01897571|580445287|FG001|Overall Study|Enrolled in rollover study|0|||
160744183|NCT01897571|580445288|FG002|Overall Study|Enrolled in rollover study|0|||
160744184|NCT01897571|580445289|FG003|Overall Study|Enrolled in rollover study|0|||
160744185|NCT01897571|580445290|FG004|Overall Study|Enrolled in rollover study|0|||
160744186|NCT01897571|580445291|FG005|Overall Study|Enrolled in rollover study|0|||
160744187|NCT01897571|580445292|FG006|Overall Study|Enrolled in rollover study|0|||
160744188|NCT01897571|580445293|FG007|Overall Study|Enrolled in rollover study|9|||
160744189|NCT01897571|580445294|FG008|Overall Study|Enrolled in rollover study|7|||
160744190|NCT01897571|580445295|FG009|Overall Study|Enrolled in rollover study|9|||
160744191|NCT01897571|580445296|FG010|Overall Study|Enrolled in rollover study|1|||
160744192|NCT01897571|580445286|FG000|Overall Study|Death|2|||
160744193|NCT01897571|580445287|FG001|Overall Study|Death|2|||
160744194|NCT01897571|580445288|FG002|Overall Study|Death|3|||
160744195|NCT01897571|580445289|FG003|Overall Study|Death|6|||
160744196|NCT01897571|580445290|FG004|Overall Study|Death|7|||
160744197|NCT01897571|580445291|FG005|Overall Study|Death|9|||
160744198|NCT01897571|580445292|FG006|Overall Study|Death|5|||
160744199|NCT01897571|580445293|FG007|Overall Study|Death|22|||
160744200|NCT01897571|580445294|FG008|Overall Study|Death|23|||
160744201|NCT01897571|580445295|FG009|Overall Study|Death|129|||
160744202|NCT01897571|580445296|FG010|Overall Study|Death|59|||
160744203|NCT01797094|580445297|FG000|Overall Study|Adverse Event|1|||
160744204|NCT01797094|580445298|FG001|Overall Study|Adverse Event|1|||
160744205|NCT01797094|580445297|FG000|Overall Study|Personal Reasons|4|||
160744206|NCT01797094|580445298|FG001|Overall Study|Personal Reasons|0|||
160744207|NCT01797094|580445297|FG000|Overall Study|Protocol Violation|0|||
160744208|NCT01797094|580445298|FG001|Overall Study|Protocol Violation|1|||
160744209|NCT01797094|580445297|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160744210|NCT01797094|580445298|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160744211|NCT03217968|580445299|FG000|Overall Study|Withdrawal by Subject|4|||
160744212|NCT03217968|580445299|FG000|Overall Study|Lost to Follow-up|1|||
160744213|NCT03217968|580445299|FG000|Overall Study|Protocol Violation|6|||
160744214|NCT03003000|580445300|FG000|Overall Study|Adverse Event|1|||
160744215|NCT03003000|580445301|FG001|Overall Study|Adverse Event|2|||
160744216|NCT03003000|580445302|FG002|Overall Study|Adverse Event|3|||
160744217|NCT03003000|580445300|FG000|Overall Study|Lack of Efficacy|1|||
160744218|NCT03003000|580445301|FG001|Overall Study|Lack of Efficacy|0|||
160744219|NCT03003000|580445302|FG002|Overall Study|Lack of Efficacy|0|||
160744220|NCT03003000|580445300|FG000|Overall Study|Non-compliant with protocol|0|||
160744221|NCT03003000|580445301|FG001|Overall Study|Non-compliant with protocol|1|||
160744222|NCT03003000|580445302|FG002|Overall Study|Non-compliant with protocol|1|||
160744223|NCT03003000|580445300|FG000|Overall Study|Refused to continue medication|2|||
160744224|NCT03003000|580445301|FG001|Overall Study|Refused to continue medication|0|||
160744225|NCT03003000|580445302|FG002|Overall Study|Refused to continue medication|0|||
160744226|NCT03003000|580445300|FG000|Overall Study|Other than listed|1|||
160744227|NCT03003000|580445301|FG001|Overall Study|Other than listed|1|||
160744228|NCT03003000|580445302|FG002|Overall Study|Other than listed|1|||
160744229|NCT04933617|580445304|FG000|Dose Escalation|Early closure of study|0|||
160744230|NCT04933617|580445305|FG001|Dose Escalation|Early closure of study|3|||
160744231|NCT04933617|580445306|FG002|Dose Escalation|Early closure of study|0|||
160744232|NCT04933617|580445307|FG003|Dose Escalation|Early closure of study|0|||
160744233|NCT04933617|580445308|FG004|Dose Escalation|Early closure of study|0|||
160744234|NCT05268016|580445309|FG000|Overall Study|Unacceptable toxicity or AE|2|||
160744235|NCT05268016|580445310|FG001|Overall Study|Unacceptable toxicity or AE|2|||
160744236|NCT05268016|580445311|FG002|Overall Study|Unacceptable toxicity or AE|4|||
160744237|NCT05268016|580445312|FG003|Overall Study|Unacceptable toxicity or AE|3|||
160744238|NCT05268016|580445313|FG004|Overall Study|Unacceptable toxicity or AE|1|||
160744239|NCT05268016|580445309|FG000|Overall Study|Withdrawal by Subject|1|||
160744240|NCT05268016|580445310|FG001|Overall Study|Withdrawal by Subject|3|||
160744241|NCT05268016|580445311|FG002|Overall Study|Withdrawal by Subject|2|||
160744242|NCT05268016|580445312|FG003|Overall Study|Withdrawal by Subject|2|||
160744243|NCT05268016|580445313|FG004|Overall Study|Withdrawal by Subject|1|||
160744244|NCT05268016|580445309|FG000|Overall Study|Lost to Follow-up|4|||
160744245|NCT05268016|580445310|FG001|Overall Study|Lost to Follow-up|7|||
160744246|NCT05268016|580445311|FG002|Overall Study|Lost to Follow-up|1|||
160744247|NCT05268016|580445312|FG003|Overall Study|Lost to Follow-up|3|||
160744248|NCT05268016|580445313|FG004|Overall Study|Lost to Follow-up|5|||
160744249|NCT05268016|580445309|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
160744250|NCT05268016|580445310|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
160744251|NCT05268016|580445311|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
160744252|NCT05268016|580445312|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
160744253|NCT05268016|580445313|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
160744254|NCT05268016|580445309|FG000|Overall Study|Lack of Efficacy|0|||
160744255|NCT05268016|580445310|FG001|Overall Study|Lack of Efficacy|0|||
160744256|NCT05268016|580445311|FG002|Overall Study|Lack of Efficacy|0|||
160744257|NCT05268016|580445312|FG003|Overall Study|Lack of Efficacy|0|||
160744258|NCT05268016|580445313|FG004|Overall Study|Lack of Efficacy|4|||
160744259|NCT05268016|580445309|FG000|Overall Study|Physician Decision|0|||
160744260|NCT05268016|580445310|FG001|Overall Study|Physician Decision|0|||
160744261|NCT05268016|580445311|FG002|Overall Study|Physician Decision|0|||
160744262|NCT05268016|580445312|FG003|Overall Study|Physician Decision|1|||
160744263|NCT05268016|580445313|FG004|Overall Study|Physician Decision|0|||
160744264|NCT05268016|580445309|FG000|Overall Study|Other|1|||
160744265|NCT05268016|580445310|FG001|Overall Study|Other|0|||
160744266|NCT05268016|580445311|FG002|Overall Study|Other|1|||
160744267|NCT05268016|580445312|FG003|Overall Study|Other|2|||
160744268|NCT05268016|580445313|FG004|Overall Study|Other|0|||
160744269|NCT03008278|580445314|FG000|Overall Study|Progressive Disease|0|||
160744270|NCT03008278|580445315|FG001|Overall Study|Progressive Disease|0|||
160744271|NCT03008278|580445316|FG002|Overall Study|Progressive Disease|32|||
160744272|NCT03008278|580445314|FG000|Overall Study|Adverse Event|0|||
160744273|NCT03008278|580445315|FG001|Overall Study|Adverse Event|0|||
160744274|NCT03008278|580445316|FG002|Overall Study|Adverse Event|4|||
160744275|NCT03008278|580445314|FG000|Overall Study|Withdrawal by Subject|0|||
160744276|NCT03008278|580445315|FG001|Overall Study|Withdrawal by Subject|0|||
160744277|NCT03008278|580445316|FG002|Overall Study|Withdrawal by Subject|3|||
160744278|NCT03008278|580445314|FG000|Overall Study|Physician Decision|0|||
160744279|NCT03008278|580445315|FG001|Overall Study|Physician Decision|2|||
160744280|NCT03008278|580445316|FG002|Overall Study|Physician Decision|0|||
160744281|NCT01074255|580445317|FG000|Overall Study|Did not receive EMEND|2|||
160744282|NCT03170609|580445320|FG000|Overall Study|Death|0|||
160744283|NCT03170609|580445321|FG001|Overall Study|Death|0|||
160744284|NCT03170609|580445322|FG002|Overall Study|Death|1|||
160744285|NCT03170609|580445323|FG003|Overall Study|Death|0|||
160744286|NCT03170609|580445324|FG004|Overall Study|Death|0|||
160744287|NCT03170609|580445325|FG005|Overall Study|Death|0|||
160744288|NCT03170609|580445326|FG006|Overall Study|Death|0|||
160744289|NCT03170609|580445320|FG000|Overall Study|Withdrawal by Subject|1|||
160744290|NCT03170609|580445321|FG001|Overall Study|Withdrawal by Subject|2|||
160744291|NCT03170609|580445322|FG002|Overall Study|Withdrawal by Subject|0|||
160744292|NCT03170609|580445323|FG003|Overall Study|Withdrawal by Subject|0|||
160744293|NCT03170609|580445324|FG004|Overall Study|Withdrawal by Subject|0|||
160744294|NCT03170609|580445325|FG005|Overall Study|Withdrawal by Subject|0|||
160744295|NCT03170609|580445326|FG006|Overall Study|Withdrawal by Subject|1|||
160744296|NCT03170609|580445320|FG000|Overall Study|Lost to Follow-up|1|||
160744297|NCT03170609|580445321|FG001|Overall Study|Lost to Follow-up|0|||
160744298|NCT03170609|580445322|FG002|Overall Study|Lost to Follow-up|5|||
160744299|NCT03170609|580445323|FG003|Overall Study|Lost to Follow-up|2|||
160744300|NCT03170609|580445324|FG004|Overall Study|Lost to Follow-up|1|||
160744301|NCT03170609|580445325|FG005|Overall Study|Lost to Follow-up|1|||
160744302|NCT03170609|580445326|FG006|Overall Study|Lost to Follow-up|0|||
160744303|NCT03170609|580445320|FG000|Overall Study|Other|1|||
160744304|NCT03170609|580445321|FG001|Overall Study|Other|0|||
160744305|NCT03170609|580445322|FG002|Overall Study|Other|0|||
160744306|NCT03170609|580445323|FG003|Overall Study|Other|0|||
160744307|NCT03170609|580445324|FG004|Overall Study|Other|0|||
160744308|NCT03170609|580445325|FG005|Overall Study|Other|1|||
160744309|NCT03170609|580445326|FG006|Overall Study|Other|0|||
160744310|NCT00957905|580445337|FG000|Part B|Not Treated|0|||
160744311|NCT00957905|580445338|FG001|Part B|Not Treated|1|||
160744312|NCT00957905|580445337|FG000|Part B|Physician Decision|0|||
160744313|NCT00957905|580445338|FG001|Part B|Physician Decision|1|||
160744314|NCT00957905|580445337|FG000|Part B|Death|0|||
160744315|NCT00957905|580445338|FG001|Part B|Death|1|||
160744316|NCT00957905|580445337|FG000|Part B|Protocol Violation|0|||
160744317|NCT00957905|580445338|FG001|Part B|Protocol Violation|1|||
160744318|NCT01260584|580445355|FG000|Period 1|Protocol Violation|0|||
160744319|NCT01260584|580445356|FG001|Period 1|Protocol Violation|0|||
160744320|NCT01260584|580445357|FG002|Period 1|Protocol Violation|1|||
160744321|NCT01260584|580445358|FG003|Period 1|Protocol Violation|1|||
160744322|NCT01260584|580445355|FG000|Period 1|Adverse Event|0|||
160744323|NCT01260584|580445356|FG001|Period 1|Adverse Event|0|||
160744324|NCT01260584|580445357|FG002|Period 1|Adverse Event|1|||
160744325|NCT01260584|580445358|FG003|Period 1|Adverse Event|0|||
160744326|NCT01260584|580445355|FG000|Period 2|Protocol Violation|0|||
160744327|NCT01260584|580445356|FG001|Period 2|Protocol Violation|2|||
160744328|NCT01260584|580445357|FG002|Period 2|Protocol Violation|3|||
160744329|NCT01260584|580445358|FG003|Period 2|Protocol Violation|1|||
160744330|NCT01260584|580445355|FG000|Period 2|Adverse Event|1|||
160744331|NCT01260584|580445356|FG001|Period 2|Adverse Event|0|||
160744332|NCT01260584|580445357|FG002|Period 2|Adverse Event|2|||
160744333|NCT01260584|580445358|FG003|Period 2|Adverse Event|0|||
160744334|NCT01260584|580445355|FG000|Period 2|Withdrawal by Subject|0|||
160744335|NCT01260584|580445356|FG001|Period 2|Withdrawal by Subject|1|||
160744336|NCT01260584|580445357|FG002|Period 2|Withdrawal by Subject|0|||
160744337|NCT01260584|580445358|FG003|Period 2|Withdrawal by Subject|0|||
160744338|NCT00045734|580445359|FG000|Overall Study|Protocol Violation|1|||
160744339|NCT02069093|580445360|FG000|Overall Study|Disease progression|14|||
160744340|NCT02069093|580445360|FG000|Overall Study|New cancer therapy|1|||
160744341|NCT02069093|580445360|FG000|Overall Study|Death|1|||
160744342|NCT02069093|580445360|FG000|Overall Study|Administrative problems|1|||
160744343|NCT02069093|580445360|FG000|Overall Study|Withdrawal by Subject|2|||
160744344|NCT02069093|580445360|FG000|Overall Study|Abnormal laboratory values|1|||
160744345|NCT02069093|580445360|FG000|Overall Study|Adverse Event|10|||
160744346|NCT01634659|580445361|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
160744347|NCT01634659|580445362|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
160744348|NCT01634659|580445361|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
160744349|NCT01634659|580445362|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
160744350|NCT02918552|580445363|FG000|Overall Study|Failed Pharmacokinetics|1|||
160744351|NCT02918552|580445364|FG001|Overall Study|Failed Pharmacokinetics|0|||
160744352|NCT02918552|580445363|FG000|Overall Study|Withdrawal by Subject|0|||
160744353|NCT02918552|580445364|FG001|Overall Study|Withdrawal by Subject|1|||
160744354|NCT02918552|580445363|FG000|Overall Study|Lost to Follow-up|0|||
160744355|NCT02918552|580445364|FG001|Overall Study|Lost to Follow-up|1|||
160744356|NCT04395274|580445365|FG000|Overall Study|Lost to Follow-up|20|||
160744357|NCT04395274|580445366|FG001|Overall Study|Lost to Follow-up|11|||
160744358|NCT04395274|580445365|FG000|Overall Study|Withdrawal by Subject|13|||
160744359|NCT04395274|580445366|FG001|Overall Study|Withdrawal by Subject|10|||
160744360|NCT04395274|580445365|FG000|Overall Study|Moved Abroad|0|||
160744361|NCT04395274|580445366|FG001|Overall Study|Moved Abroad|1|||
160744362|NCT00642954|580447092|FG000|Overall Study|Progressive Disease|3|||
160744363|NCT00642954|580447093|FG001|Overall Study|Progressive Disease|3|||
160744364|NCT00642954|580447094|FG002|Overall Study|Progressive Disease|3|||
160744365|NCT00642954|580447095|FG003|Overall Study|Progressive Disease|3|||
160744366|NCT00642954|580447096|FG004|Overall Study|Progressive Disease|9|||
160744367|NCT00642954|580447092|FG000|Overall Study|Withdrawal by Subject|0|||
160744368|NCT00642954|580447093|FG001|Overall Study|Withdrawal by Subject|0|||
160744369|NCT00642954|580447094|FG002|Overall Study|Withdrawal by Subject|0|||
160744370|NCT00642954|580447095|FG003|Overall Study|Withdrawal by Subject|0|||
160744371|NCT00642954|580447096|FG004|Overall Study|Withdrawal by Subject|1|||
160744372|NCT00642954|580447092|FG000|Overall Study|Adverse Event|1|||
160744373|NCT00642954|580447093|FG001|Overall Study|Adverse Event|1|||
160744374|NCT00642954|580447094|FG002|Overall Study|Adverse Event|0|||
160744375|NCT00642954|580447095|FG003|Overall Study|Adverse Event|0|||
160744376|NCT00642954|580447096|FG004|Overall Study|Adverse Event|6|||
160744377|NCT01890759|580447097|FG000|Overall Study|Protocol Violation|0|||
160744378|NCT01890759|580447098|FG001|Overall Study|Protocol Violation|2|||
160744379|NCT01890759|580447097|FG000|Overall Study|Lost to Follow-up|0|||
160744380|NCT01890759|580447098|FG001|Overall Study|Lost to Follow-up|2|||
160744381|NCT01890759|580447097|FG000|Overall Study|Withdrawal by Subject|2|||
160744382|NCT01890759|580447098|FG001|Overall Study|Withdrawal by Subject|8|||
160744383|NCT05437640|580447101|FG000|Washout (1 Week)|Adverse Event|1|||
160744384|NCT05437640|580447102|FG001|Washout (1 Week)|Adverse Event|0|||
160744385|NCT02474355|580447103|FG000|Overall Study|Other|43|||
160744386|NCT02474355|580447103|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
160744387|NCT02474355|580447103|FG000|Overall Study|Lost to Follow-up|98|||
160744388|NCT02474355|580447103|FG000|Overall Study|Withdrawal by Subject|124|||
160744389|NCT02474355|580447103|FG000|Overall Study|Death|1361|||
160744390|NCT01937715|580447107|FG000|Overall Study|Death|0|||
160744391|NCT01937715|580447108|FG001|Overall Study|Death|0|||
160744392|NCT01937715|580447109|FG002|Overall Study|Death|0|||
160744393|NCT01937715|580447110|FG003|Overall Study|Death|1|||
160744394|NCT01937715|580447111|FG004|Overall Study|Death|0|||
160744395|NCT01937715|580447107|FG000|Overall Study|Withdrawal by Subject|0|||
160744396|NCT01937715|580447108|FG001|Overall Study|Withdrawal by Subject|1|||
160744397|NCT01937715|580447109|FG002|Overall Study|Withdrawal by Subject|0|||
160744398|NCT01937715|580447110|FG003|Overall Study|Withdrawal by Subject|0|||
160744399|NCT01937715|580447111|FG004|Overall Study|Withdrawal by Subject|2|||
160744400|NCT01937715|580447107|FG000|Overall Study|Other|0|||
160744401|NCT01937715|580447108|FG001|Overall Study|Other|0|||
160744402|NCT01937715|580447109|FG002|Overall Study|Other|0|||
160744403|NCT01937715|580447110|FG003|Overall Study|Other|3|||
160744404|NCT01937715|580447111|FG004|Overall Study|Other|0|||
160744405|NCT00433017|580447114|FG000|Overall Study|Adverse Event|5|||
160744406|NCT00433017|580447115|FG001|Overall Study|Adverse Event|3|||
160744407|NCT00433017|580447114|FG000|Overall Study|Withdrawal by Subject|4|||
160744408|NCT00433017|580447115|FG001|Overall Study|Withdrawal by Subject|5|||
160744409|NCT00433017|580447114|FG000|Overall Study|Lost to Follow-up|3|||
160744410|NCT00433017|580447115|FG001|Overall Study|Lost to Follow-up|4|||
160744411|NCT00433017|580447114|FG000|Overall Study|Administrative problems|80|||
160744412|NCT00433017|580447115|FG001|Overall Study|Administrative problems|86|||
160744413|NCT00433017|580447114|FG000|Overall Study|Protocol Violation|1|||
160744414|NCT00433017|580447115|FG001|Overall Study|Protocol Violation|0|||
160744415|NCT00433017|580447114|FG000|Overall Study|Death|2|||
160744416|NCT00433017|580447115|FG001|Overall Study|Death|2|||
160744417|NCT00433017|580447114|FG000|Overall Study|Subject no longer requires study drug|1|||
160744418|NCT00433017|580447115|FG001|Overall Study|Subject no longer requires study drug|1|||
160744419|NCT00153816|580447116|FG000|Overall Study|Death|6|||
160744420|NCT00153816|580447117|FG001|Overall Study|Death|5|||
160744421|NCT00153816|580447118|FG002|Overall Study|Death|4|||
160744422|NCT00153816|580447119|FG003|Overall Study|Death|6|||
160744423|NCT00153816|580447120|FG004|Overall Study|Death|0|||
160744424|NCT00153816|580447121|FG005|Overall Study|Death|2|||
160744425|NCT00153816|580447116|FG000|Overall Study|Lost to Follow-up|7|||
160744426|NCT00153816|580447117|FG001|Overall Study|Lost to Follow-up|8|||
160744427|NCT00153816|580447118|FG002|Overall Study|Lost to Follow-up|5|||
160744428|NCT00153816|580447119|FG003|Overall Study|Lost to Follow-up|8|||
160744429|NCT00153816|580447120|FG004|Overall Study|Lost to Follow-up|7|||
160744430|NCT00153816|580447121|FG005|Overall Study|Lost to Follow-up|9|||
160744431|NCT00153816|580447116|FG000|Overall Study|Withdrawal by Subject|9|||
160744432|NCT00153816|580447117|FG001|Overall Study|Withdrawal by Subject|9|||
160744433|NCT00153816|580447118|FG002|Overall Study|Withdrawal by Subject|9|||
160744434|NCT00153816|580447119|FG003|Overall Study|Withdrawal by Subject|4|||
160744435|NCT00153816|580447120|FG004|Overall Study|Withdrawal by Subject|1|||
160744436|NCT00153816|580447121|FG005|Overall Study|Withdrawal by Subject|5|||
160744437|NCT00153816|580447116|FG000|Overall Study|Follow-up exam not done|8|||
160744438|NCT00153816|580447117|FG001|Overall Study|Follow-up exam not done|7|||
160744439|NCT00153816|580447118|FG002|Overall Study|Follow-up exam not done|11|||
160744440|NCT00153816|580447119|FG003|Overall Study|Follow-up exam not done|10|||
160744441|NCT00153816|580447120|FG004|Overall Study|Follow-up exam not done|8|||
160744442|NCT00153816|580447121|FG005|Overall Study|Follow-up exam not done|9|||
160744443|NCT00153816|580447116|FG000|Overall Study|Follow-up exam done, histology missing|2|||
160744444|NCT00153816|580447117|FG001|Overall Study|Follow-up exam done, histology missing|3|||
160744445|NCT00153816|580447118|FG002|Overall Study|Follow-up exam done, histology missing|3|||
160744446|NCT00153816|580447119|FG003|Overall Study|Follow-up exam done, histology missing|3|||
160744447|NCT00153816|580447120|FG004|Overall Study|Follow-up exam done, histology missing|1|||
160744448|NCT00153816|580447121|FG005|Overall Study|Follow-up exam done, histology missing|2|||
160744449|NCT03539484|580447125|FG000|Overall Study|Death|1|||
160744450|NCT03539484|580447126|FG001|Overall Study|Death|0|||
160744451|NCT03539484|580447127|FG002|Overall Study|Death|0|||
160744452|NCT03539484|580447128|FG003|Overall Study|Death|2|||
160744453|NCT03539484|580447129|FG004|Overall Study|Death|8|||
160744454|NCT03539484|580447130|FG005|Overall Study|Death|3|||
160744455|NCT03539484|580447131|FG006|Overall Study|Death|0|||
160744456|NCT03539484|580447125|FG000|Overall Study|Lost to Follow-up|0|||
160744457|NCT03539484|580447126|FG001|Overall Study|Lost to Follow-up|1|||
160744458|NCT03539484|580447127|FG002|Overall Study|Lost to Follow-up|0|||
160744459|NCT03539484|580447128|FG003|Overall Study|Lost to Follow-up|0|||
160744460|NCT03539484|580447129|FG004|Overall Study|Lost to Follow-up|1|||
160744461|NCT03539484|580447130|FG005|Overall Study|Lost to Follow-up|0|||
160744462|NCT03539484|580447131|FG006|Overall Study|Lost to Follow-up|0|||
160744463|NCT03539484|580447125|FG000|Overall Study|Withdrawal by Subject|0|||
160744464|NCT03539484|580447126|FG001|Overall Study|Withdrawal by Subject|0|||
160744465|NCT03539484|580447127|FG002|Overall Study|Withdrawal by Subject|0|||
160744466|NCT03539484|580447128|FG003|Overall Study|Withdrawal by Subject|0|||
160744467|NCT03539484|580447129|FG004|Overall Study|Withdrawal by Subject|2|||
160744468|NCT03539484|580447130|FG005|Overall Study|Withdrawal by Subject|0|||
160744469|NCT03539484|580447131|FG006|Overall Study|Withdrawal by Subject|1|||
160744470|NCT03539484|580447125|FG000|Overall Study|Study Terminated by Sponsor|0|||
160744471|NCT03539484|580447126|FG001|Overall Study|Study Terminated by Sponsor|0|||
160744472|NCT03539484|580447127|FG002|Overall Study|Study Terminated by Sponsor|1|||
160744473|NCT03539484|580447128|FG003|Overall Study|Study Terminated by Sponsor|1|||
160744474|NCT03539484|580447129|FG004|Overall Study|Study Terminated by Sponsor|2|||
160744475|NCT03539484|580447130|FG005|Overall Study|Study Terminated by Sponsor|2|||
160744476|NCT03539484|580447131|FG006|Overall Study|Study Terminated by Sponsor|1|||
160744477|NCT02173379|580447132|FG000|Overall Study|Lost to Follow-up|89|||
160744478|NCT02173379|580447133|FG001|Overall Study|Lost to Follow-up|81|||
160744479|NCT02173379|580447132|FG000|Overall Study|Withdrawal by Subject|24|||
160744480|NCT02173379|580447133|FG001|Overall Study|Withdrawal by Subject|29|||
160744481|NCT02173379|580447132|FG000|Overall Study|Physician Decision|8|||
160744482|NCT02173379|580447133|FG001|Overall Study|Physician Decision|8|||
160744483|NCT02173379|580447132|FG000|Overall Study|Death|75|||
160744484|NCT02173379|580447133|FG001|Overall Study|Death|72|||
160744485|NCT02173379|580447132|FG000|Overall Study|Other Reason|1|||
160744486|NCT02173379|580447133|FG001|Overall Study|Other Reason|0|||
160744487|NCT02305446|580447139|FG000|Overall Study|Adverse Event|1|||
160744488|NCT01636947|580447140|FG000|Overall Study|Not Treated|2|||
160744489|NCT01636947|580447141|FG001|Overall Study|Not Treated|2|||
160744490|NCT01636947|580447140|FG000|Overall Study|Lost to Follow-up|4|||
160744491|NCT01636947|580447141|FG001|Overall Study|Lost to Follow-up|0|||
160744492|NCT01636947|580447140|FG000|Overall Study|Protocol Violation|1|||
160744493|NCT01636947|580447141|FG001|Overall Study|Protocol Violation|1|||
160744494|NCT01636947|580447140|FG000|Overall Study|Withdrawal by Subject|3|||
160744495|NCT01636947|580447141|FG001|Overall Study|Withdrawal by Subject|3|||
160744496|NCT01636947|580447140|FG000|Overall Study|Adverse Event|1|||
160744497|NCT01636947|580447141|FG001|Overall Study|Adverse Event|1|||
160744498|NCT01636947|580447140|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
160744499|NCT01636947|580447141|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
160744500|NCT00427999|580447146|FG000|Overall Study|Adverse Event|6|||
160744501|NCT00427999|580447146|FG000|Overall Study|Abnormal laboratory values|1|||
160744502|NCT00427999|580447146|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
160744503|NCT00427999|580447146|FG000|Overall Study|Protocol Violation|2|||
160744504|NCT00427999|580447146|FG000|Overall Study|Withdrawal by Subject|9|||
160744505|NCT00427999|580447146|FG000|Overall Study|Death|1|||
160744506|NCT00460265|580447147|FG000|Overall Study|Lost to Follow-up|14|||
160744507|NCT00460265|580447148|FG001|Overall Study|Lost to Follow-up|15|||
160744508|NCT00460265|580447147|FG000|Overall Study|Physician Decision|1|||
160744509|NCT00460265|580447148|FG001|Overall Study|Physician Decision|2|||
160744510|NCT00460265|580447147|FG000|Overall Study|Withdrawal by Subject|10|||
160744511|NCT00460265|580447148|FG001|Overall Study|Withdrawal by Subject|25|||
160744512|NCT00460265|580447147|FG000|Overall Study|Ongoing|60|||
160744513|NCT00460265|580447148|FG001|Overall Study|Ongoing|47|||
160744514|NCT02956057|580447160|FG000|Overall Study|Discontinued intervention|14|||
160744515|NCT02956057|580447161|FG001|Overall Study|Discontinued intervention|10|||
160744516|NCT02956057|580447162|FG002|Overall Study|Discontinued intervention|7|||
160744517|NCT02956057|580447163|FG003|Overall Study|Discontinued intervention|14|||
160744518|NCT02956057|580447164|FG004|Overall Study|Discontinued intervention|4|||
160744519|NCT02956057|580447165|FG005|Overall Study|Discontinued intervention|17|||
160744520|NCT02956057|580447160|FG000|Overall Study|Lost to Follow-up|0|||
160744521|NCT02956057|580447161|FG001|Overall Study|Lost to Follow-up|2|||
160744522|NCT02956057|580447162|FG002|Overall Study|Lost to Follow-up|1|||
160744523|NCT02956057|580447163|FG003|Overall Study|Lost to Follow-up|1|||
160744524|NCT02956057|580447164|FG004|Overall Study|Lost to Follow-up|1|||
160744525|NCT02956057|580447165|FG005|Overall Study|Lost to Follow-up|0|||
160744526|NCT01420679|580447170|FG000|Overall Study|Disease Progression|3|||
160744527|NCT01420679|580447171|FG001|Overall Study|Disease Progression|2|||
160744528|NCT01420679|580447170|FG000|Overall Study|Adverse Event|4|||
160744529|NCT01420679|580447171|FG001|Overall Study|Adverse Event|0|||
160744530|NCT01420679|580447170|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
160744531|NCT01420679|580447171|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
160744532|NCT01420679|580447170|FG000|Overall Study|Patient Decision|1|||
160744533|NCT01420679|580447171|FG001|Overall Study|Patient Decision|0|||
160744534|NCT01420679|580447170|FG000|Overall Study|Investigator Decision|1|||
160744535|NCT01420679|580447171|FG001|Overall Study|Investigator Decision|2|||
160744536|NCT01420679|580447170|FG000|Overall Study|Sponsor Decision|3|||
160744537|NCT01420679|580447171|FG001|Overall Study|Sponsor Decision|3|||
160744538|NCT01420679|580447170|FG000|Overall Study|Other|1|||
160744539|NCT01420679|580447171|FG001|Overall Study|Other|0|||
160744540|NCT01069419|580447172|FG000|Overall Study|Adverse Event|233|||
160744541|NCT01069419|580447172|FG000|Overall Study|Lack of Efficacy|332|||
160744542|NCT01069419|580447172|FG000|Overall Study|Lost to Follow-up|49|||
160744543|NCT01069419|580447172|FG000|Overall Study|Remission of disease|11|||
160744544|NCT01069419|580447172|FG000|Overall Study|Withdrawal by Subject|34|||
160744545|NCT01069419|580447172|FG000|Overall Study|Other Reason|43|||
160744546|NCT01069419|580447172|FG000|Overall Study|Missing termination information|13|||
160744547|NCT01179737|580447174|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
160744548|NCT01179737|580447175|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
160744549|NCT01179737|580447176|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
160744550|NCT01179737|580447177|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
160744551|NCT01179737|580447174|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
160744552|NCT01179737|580447175|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
160744553|NCT01179737|580447176|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
160744554|NCT01179737|580447177|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
160744555|NCT01179737|580447174|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
160744556|NCT01179737|580447175|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
160744557|NCT01179737|580447176|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
160744558|NCT01179737|580447177|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
160744559|NCT01179737|580447174|FG000|Cohort 1 & Cohort 2|Death|0|||
160744560|NCT01179737|580447175|FG001|Cohort 1 & Cohort 2|Death|0|||
160744561|NCT01179737|580447176|FG002|Cohort 1 & Cohort 2|Death|1|||
160744562|NCT01179737|580447177|FG003|Cohort 1 & Cohort 2|Death|0|||
160744563|NCT01179737|580447174|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
160744564|NCT01179737|580447175|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
160744565|NCT01179737|580447176|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
160744566|NCT01179737|580447177|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
160744567|NCT01179737|580447174|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
160744568|NCT01179737|580447175|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
160744569|NCT01179737|580447176|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
160744570|NCT01179737|580447177|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
160744571|NCT01179737|580447174|FG000|Extension|The study was terminated|3|||
160744572|NCT01179737|580447175|FG001|Extension|The study was terminated|0|||
160744573|NCT01179737|580447176|FG002|Extension|The study was terminated|0|||
160744574|NCT01179737|580447177|FG003|Extension|The study was terminated|0|||
160744575|NCT01955109|580447178|FG000|Overall Study|Adverse Event|2|||
160744576|NCT01955109|580447179|FG001|Overall Study|Adverse Event|0|||
160744577|NCT01955109|580447178|FG000|Overall Study|Participant unwilling to continue|35|||
160744578|NCT01955109|580447179|FG001|Overall Study|Participant unwilling to continue|7|||
160744579|NCT01955109|580447178|FG000|Overall Study|Physician Decision|2|||
160744580|NCT01955109|580447179|FG001|Overall Study|Physician Decision|0|||
160744581|NCT01955109|580447178|FG000|Overall Study|Lost to Follow-up|3|||
160744582|NCT01955109|580447179|FG001|Overall Study|Lost to Follow-up|1|||
160744583|NCT01955109|580447178|FG000|Overall Study|Non-compliance|3|||
160744584|NCT01955109|580447179|FG001|Overall Study|Non-compliance|1|||
160744585|NCT00904839|580447180|FG000|Overall Study|Adverse Event|0|||
160744586|NCT00904839|580447181|FG001|Overall Study|Adverse Event|5|||
160744587|NCT00904839|580447182|FG002|Overall Study|Adverse Event|4|||
160744588|NCT00904839|580447180|FG000|Overall Study|Protocol Violation|0|||
160744589|NCT00904839|580447181|FG001|Overall Study|Protocol Violation|1|||
160744590|NCT00904839|580447182|FG002|Overall Study|Protocol Violation|1|||
160744591|NCT00904839|580447180|FG000|Overall Study|Lost to Follow-up|0|||
160744592|NCT00904839|580447181|FG001|Overall Study|Lost to Follow-up|1|||
160744593|NCT00904839|580447182|FG002|Overall Study|Lost to Follow-up|2|||
160744594|NCT00904839|580447180|FG000|Overall Study|Withdrawal by Subject|0|||
160744595|NCT00904839|580447181|FG001|Overall Study|Withdrawal by Subject|2|||
160744596|NCT00904839|580447182|FG002|Overall Study|Withdrawal by Subject|0|||
160744597|NCT00904839|580447180|FG000|Overall Study|Not treated|1|||
160744598|NCT00904839|580447181|FG001|Overall Study|Not treated|0|||
160744599|NCT00904839|580447182|FG002|Overall Study|Not treated|1|||
160744600|NCT00904839|580447180|FG000|Overall Study|Other than above|0|||
160744601|NCT00904839|580447181|FG001|Overall Study|Other than above|9|||
160744602|NCT00904839|580447182|FG002|Overall Study|Other than above|7|||
160744603|NCT01853696|580447185|FG000|Overall Study|Withdrawal by Subject|1|||
160744604|NCT01853696|580447186|FG001|Overall Study|Withdrawal by Subject|1|||
160744605|NCT01853696|580447185|FG000|Overall Study|Lost to Follow-up|5|||
160744606|NCT01853696|580447186|FG001|Overall Study|Lost to Follow-up|4|||
160744607|NCT01167634|580447187|FG000|Overall Study|Lost to Follow-up|1|||
160744608|NCT01167634|580447188|FG001|Overall Study|Lost to Follow-up|3|||
160744609|NCT01167634|580447189|FG002|Overall Study|Lost to Follow-up|3|||
160744610|NCT01167634|580447190|FG003|Overall Study|Lost to Follow-up|4|||
160744611|NCT01167634|580447187|FG000|Overall Study|Withdrawal by Subject|1|||
160744612|NCT01167634|580447188|FG001|Overall Study|Withdrawal by Subject|1|||
160744613|NCT01167634|580447189|FG002|Overall Study|Withdrawal by Subject|0|||
160744614|NCT01167634|580447190|FG003|Overall Study|Withdrawal by Subject|0|||
160744615|NCT00553358|580447191|FG000|Overall Study|Randomized but did not receive treatment|3|||
160744616|NCT00553358|580447192|FG001|Overall Study|Randomized but did not receive treatment|3|||
160744617|NCT00553358|580447193|FG002|Overall Study|Randomized but did not receive treatment|1|||
160744618|NCT00553358|580447191|FG000|Overall Study|Lost to Follow-up|22|||
160744619|NCT00553358|580447192|FG001|Overall Study|Lost to Follow-up|26|||
160744620|NCT00553358|580447193|FG002|Overall Study|Lost to Follow-up|18|||
160744621|NCT00553358|580447191|FG000|Overall Study|Withdrew completely|23|||
160744622|NCT00553358|580447192|FG001|Overall Study|Withdrew completely|33|||
160744623|NCT00553358|580447193|FG002|Overall Study|Withdrew completely|34|||
160744624|NCT00553358|580447191|FG000|Overall Study|Died during clinical follow-up|25|||
160744625|NCT00553358|580447192|FG001|Overall Study|Died during clinical follow-up|29|||
160744626|NCT00553358|580447193|FG002|Overall Study|Died during clinical follow-up|32|||
160744627|NCT00553358|580447191|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
160744628|NCT00553358|580447192|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
160744629|NCT00553358|580447193|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
160744630|NCT00553358|580447191|FG000|Overall Study|Died after clinical follow-up ended|1|||
160744631|NCT00553358|580447192|FG001|Overall Study|Died after clinical follow-up ended|2|||
160744632|NCT00553358|580447193|FG002|Overall Study|Died after clinical follow-up ended|0|||
160744633|NCT00553358|580447191|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
160744634|NCT00553358|580447192|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
160744635|NCT00553358|580447193|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
160744636|NCT02854605|580447198|FG000|Overall Study|Adverse Event|1|||
160744637|NCT02854605|580447199|FG001|Overall Study|Adverse Event|5|||
160744638|NCT02854605|580447200|FG002|Overall Study|Adverse Event|2|||
160744639|NCT02854605|580447198|FG000|Overall Study|Lost to Follow-up|0|||
160744640|NCT02854605|580447199|FG001|Overall Study|Lost to Follow-up|2|||
160744641|NCT02854605|580447200|FG002|Overall Study|Lost to Follow-up|0|||
160744642|NCT02854605|580447198|FG000|Overall Study|Withdrew Consent|1|||
160744643|NCT02854605|580447199|FG001|Overall Study|Withdrew Consent|0|||
160744644|NCT02854605|580447200|FG002|Overall Study|Withdrew Consent|1|||
160744645|NCT02854605|580447198|FG000|Overall Study|Investigator's Discretion|1|||
160744646|NCT02854605|580447199|FG001|Overall Study|Investigator's Discretion|0|||
160744647|NCT02854605|580447200|FG002|Overall Study|Investigator's Discretion|0|||
160744648|NCT02854605|580447198|FG000|Overall Study|Protocol Violation|0|||
160744649|NCT02854605|580447199|FG001|Overall Study|Protocol Violation|0|||
160744650|NCT02854605|580447200|FG002|Overall Study|Protocol Violation|1|||
160744651|NCT02191046|580447201|FG000|Overall Study|low compliance|5|||
160744652|NCT02191046|580447202|FG001|Overall Study|low compliance|1|||
160744653|NCT01217385|580447204|FG000|Overall Study|Withdrawal by Subject|3|||
160744654|NCT01217385|580447204|FG000|Overall Study|DOSI not performed/not eval|12|||
160744655|NCT01217385|580447204|FG000|Overall Study|Central Path not Available|1|||
160744656|NCT01217385|580447204|FG000|Overall Study|Normal Breast TOI not available|10|||
160744657|NCT00090987|580447205|FG000|Overall Study|Adverse Event|5|||
160744658|NCT00090987|580447205|FG000|Overall Study|Lack of Efficacy|7|||
160744659|NCT00090987|580447205|FG000|Overall Study|Withdrawal by Subject|3|||
160744660|NCT00090987|580447205|FG000|Overall Study|alternative therapy|1|||
160744661|NCT00090987|580447205|FG000|Overall Study|Non-compliance|4|||
160744662|NCT00090987|580447205|FG000|Overall Study|Incarcerated|1|||
160744663|NCT00990665|580447206|FG000|Overall Study|Unsuccessful Implant|8|||
160744664|NCT00990665|580447206|FG000|Overall Study|Death|29|||
160744665|NCT00990665|580447206|FG000|Overall Study|Heart Transplant|1|||
160744666|NCT00990665|580447206|FG000|Overall Study|Withdrawal by Subject|6|||
160744667|NCT00990665|580447206|FG000|Overall Study|Lost to Follow-up|1|||
160744668|NCT00990665|580447206|FG000|Overall Study|System Explant|3|||
160744669|NCT00270231|580447207|FG000|First Intervention|Lost to Follow-up|1|||
160744670|NCT00270231|580447208|FG001|First Intervention|Lost to Follow-up|1|||
160744671|NCT00270231|580447207|FG000|Washout Period|Lost to Follow-up|1|||
160744672|NCT00270231|580447208|FG001|Washout Period|Lost to Follow-up|0|||
160744673|NCT00270231|580447207|FG000|Second Intervention|Lost to Follow-up|0|||
160744674|NCT00270231|580447208|FG001|Second Intervention|Lost to Follow-up|1|||
160744675|NCT02603562|580447209|FG000|Overall Study|Lost to Follow-up|1|||
160744676|NCT00574795|580447211|FG000|Infant Series|Withdrawal by Subject|2|||
160744677|NCT00574795|580447211|FG000|Infant Series|Protocol Violation|2|||
160744678|NCT00574795|580447211|FG000|Infant Series|Adverse Event|1|||
160744679|NCT00574795|580447211|FG000|After Infant Series|Withdrawal by Subject|1|||
160744680|NCT00574795|580447211|FG000|After Infant Series|Adverse Event|2|||
160744681|NCT00574795|580447211|FG000|Toddler Dose|Withdrawal by Subject|1|||
160744682|NCT02638259|580447212|FG000|Treatment Period 1|Adverse Event|1|||
160744683|NCT02638259|580447213|FG001|Treatment Period 1|Adverse Event|5|||
160744684|NCT02638259|580447212|FG000|Treatment Period 1|Death|0|||
160744685|NCT02638259|580447213|FG001|Treatment Period 1|Death|1|||
160744686|NCT02638259|580447212|FG000|Treatment Period 1|Lack of Efficacy|0|||
160744687|NCT02638259|580447213|FG001|Treatment Period 1|Lack of Efficacy|1|||
160744688|NCT02638259|580447212|FG000|Treatment Period 1|Protocol Violation|0|||
160744689|NCT02638259|580447213|FG001|Treatment Period 1|Protocol Violation|3|||
160744690|NCT02638259|580447212|FG000|Treatment Period 1|Withdrawal by Subject|4|||
160744691|NCT02638259|580447213|FG001|Treatment Period 1|Withdrawal by Subject|6|||
160744692|NCT02638259|580447212|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
160744693|NCT02638259|580447213|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
160744694|NCT02638259|580447212|FG000|Treatment Period 2|Adverse Event|5|||
160744695|NCT02638259|580447213|FG001|Treatment Period 2|Adverse Event|4|||
160744696|NCT02638259|580447212|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160744697|NCT02638259|580447213|FG001|Treatment Period 2|Withdrawal by Subject|7|||
160744698|NCT04299048|580447214|FG000|Overall Study|Death|1|||
160744699|NCT04299048|580447214|FG000|Overall Study|Global deterioration of health status|2|||
160744700|NCT04299048|580447214|FG000|Overall Study|Enrolled and not treated|1|||
160744701|NCT03434249|580447217|FG000|Overall Study|Adverse Event|1|||
160744702|NCT03434249|580447218|FG001|Overall Study|Adverse Event|0|||
160744703|NCT03434249|580447217|FG000|Overall Study|Lost to Follow-up|0|||
160744704|NCT03434249|580447218|FG001|Overall Study|Lost to Follow-up|1|||
160744705|NCT03434249|580447217|FG000|Overall Study|Non-compliance of family|2|||
160744706|NCT03434249|580447218|FG001|Overall Study|Non-compliance of family|1|||
160744707|NCT03434249|580447217|FG000|Overall Study|Difficulties in completing daily diary|2|||
160744708|NCT03434249|580447218|FG001|Overall Study|Difficulties in completing daily diary|1|||
160744709|NCT01001598|580447219|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
160744710|NCT01001598|580447219|FG000|Overall Study|Adverse Event|1|||
160744711|NCT01969084|580447220|FG000|Overall Study|Adverse Event|0|||
160744712|NCT01969084|580447221|FG001|Overall Study|Adverse Event|1|||
160744713|NCT02920177|580447222|FG000|Overall Study|Withdrawal by Subject|1|||
160744714|NCT02920177|580447223|FG001|Overall Study|Withdrawal by Subject|1|||
160744715|NCT02920177|580447222|FG000|Overall Study|Physician Decision|1|||
160744716|NCT02920177|580447223|FG001|Overall Study|Physician Decision|0|||
160744717|NCT02920177|580447222|FG000|Overall Study|Lost to Follow-up|0|||
160744718|NCT02920177|580447223|FG001|Overall Study|Lost to Follow-up|1|||
160744719|NCT03164265|580447224|FG000|Overall Study|Physician Decision|3|||
160744720|NCT01362244|580447225|FG000|Overall Study|Adverse Event|3|||
160744721|NCT01362244|580447226|FG001|Overall Study|Adverse Event|5|||
160744722|NCT01362244|580447225|FG000|Overall Study|Lack of Efficacy|5|||
160744723|NCT01362244|580447226|FG001|Overall Study|Lack of Efficacy|11|||
160744724|NCT01362244|580447225|FG000|Overall Study|Lost to Follow-up|0|||
160744725|NCT01362244|580447226|FG001|Overall Study|Lost to Follow-up|2|||
160744726|NCT01362244|580447225|FG000|Overall Study|Protocol Violation|5|||
160744727|NCT01362244|580447226|FG001|Overall Study|Protocol Violation|1|||
160744728|NCT01362244|580447225|FG000|Overall Study|Withdrawal by Subject|2|||
160744729|NCT01362244|580447226|FG001|Overall Study|Withdrawal by Subject|1|||
160744730|NCT01362244|580447225|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
160744731|NCT01362244|580447226|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
160744732|NCT01362244|580447225|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
160744733|NCT01362244|580447226|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
160744734|NCT01253174|580447227|FG000|Period 1|Randomized but not treated|0|||
160744735|NCT01253174|580447228|FG001|Period 1|Randomized but not treated|1|||
160744736|NCT01253174|580447229|FG002|Period 1|Randomized but not treated|1|||
160744737|NCT01253174|580447230|FG003|Period 1|Randomized but not treated|0|||
160744738|NCT01253174|580447231|FG004|Period 1|Randomized but not treated|1|||
160744739|NCT01253174|580447232|FG005|Period 1|Randomized but not treated|0|||
160744740|NCT01253174|580447227|FG000|Period 2|Adverse Event|0|||
160744741|NCT01253174|580447228|FG001|Period 2|Adverse Event|0|||
160744742|NCT01253174|580447229|FG002|Period 2|Adverse Event|1|||
160744743|NCT01253174|580447230|FG003|Period 2|Adverse Event|0|||
160744744|NCT01253174|580447231|FG004|Period 2|Adverse Event|0|||
160744745|NCT01253174|580447232|FG005|Period 2|Adverse Event|0|||
160744746|NCT01253174|580447227|FG000|Period 3|Withdrawal by Subject|0|||
160744747|NCT01253174|580447228|FG001|Period 3|Withdrawal by Subject|1|||
160744748|NCT01253174|580447229|FG002|Period 3|Withdrawal by Subject|0|||
160744749|NCT01253174|580447230|FG003|Period 3|Withdrawal by Subject|0|||
160744750|NCT01253174|580447231|FG004|Period 3|Withdrawal by Subject|1|||
160744751|NCT01253174|580447232|FG005|Period 3|Withdrawal by Subject|0|||
160744752|NCT01253174|580447227|FG000|Period 3|Pregnancy|0|||
160744753|NCT01253174|580447228|FG001|Period 3|Pregnancy|0|||
160744754|NCT01253174|580447229|FG002|Period 3|Pregnancy|1|||
160744755|NCT01253174|580447230|FG003|Period 3|Pregnancy|0|||
160744756|NCT01253174|580447231|FG004|Period 3|Pregnancy|0|||
160744757|NCT01253174|580447232|FG005|Period 3|Pregnancy|0|||
160744758|NCT02267135|580447233|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
160744759|NCT02267135|580447234|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
160744760|NCT02267135|580447233|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
160744761|NCT02267135|580447234|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
160744762|NCT02267135|580447233|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
160744763|NCT02267135|580447234|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
160744764|NCT02267135|580447233|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
160744765|NCT02267135|580447234|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
160744766|NCT02267135|580447233|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
160744767|NCT02267135|580447234|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
160744768|NCT03806231|580447235|FG000|Overall Study|Physician Decision|1|||
160744769|NCT03806231|580447236|FG001|Overall Study|Physician Decision|0|||
160744770|NCT03806231|580447235|FG000|Overall Study|Withdrawal by Subject|1|||
160744771|NCT03806231|580447236|FG001|Overall Study|Withdrawal by Subject|0|||
160744772|NCT02919267|580447237|FG000|Overall Study|Protocol Violation|0|||
160744773|NCT02919267|580447238|FG001|Overall Study|Protocol Violation|3|||
160744774|NCT02919267|580447239|FG002|Overall Study|Protocol Violation|3|||
160744775|NCT02919267|580447240|FG003|Overall Study|Protocol Violation|4|||
160744776|NCT00467961|580447241|FG000|Overall Study|Technical Failures|5|||
160744777|NCT00467961|580447241|FG000|Overall Study|Disease Progression|2|||
160744778|NCT00394433|580447243|FG000|Overall Study|Adverse Event|2|||
160744779|NCT00394433|580447243|FG000|Overall Study|Alternative Therapy|1|||
160744780|NCT02510820|580448743|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
160744781|NCT02510820|580448744|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160744782|NCT02510820|580448743|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160744783|NCT02510820|580448744|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
160744784|NCT01964716|580448746|FG000|Overall Study|Withdrawal by Subject|2|||
160744785|NCT01964716|580448747|FG001|Overall Study|Withdrawal by Subject|3|||
160744786|NCT01964716|580448746|FG000|Overall Study|Lost to Follow-up|1|||
160744787|NCT01964716|580448747|FG001|Overall Study|Lost to Follow-up|2|||
160744788|NCT01964716|580448746|FG000|Overall Study|No longer met eligibility criteria|1|||
160744789|NCT01964716|580448747|FG001|Overall Study|No longer met eligibility criteria|1|||
160744790|NCT01964716|580448746|FG000|Overall Study|Death|1|||
160744791|NCT01964716|580448747|FG001|Overall Study|Death|0|||
160744792|NCT02147067|580448748|FG000|Overall Study|Withdrawal by Subject|2|||
160744793|NCT02147067|580448749|FG001|Overall Study|Withdrawal by Subject|2|||
160744794|NCT00089635|580448750|FG000|Overall Study|Adverse Event|2|||
160744795|NCT00089635|580448750|FG000|Overall Study|Death|17|||
160744796|NCT00089635|580448750|FG000|Overall Study|Disease Progression|12|||
160744797|NCT00089635|580448750|FG000|Overall Study|Lost to Follow-up|3|||
160744798|NCT00089635|580448750|FG000|Overall Study|Withdrawal by Subject|6|||
160744799|NCT00089635|580448750|FG000|Overall Study|Ineligibility determined|1|||
160744800|NCT00089635|580448750|FG000|Overall Study|Other|2|||
160744801|NCT02943785|580448751|FG000|Overall Study|Adverse Event|112|||
160744802|NCT02943785|580448752|FG001|Overall Study|Adverse Event|97|||
160744803|NCT02943785|580448751|FG000|Overall Study|Withdrawal by Subject|63|||
160744804|NCT02943785|580448752|FG001|Overall Study|Withdrawal by Subject|126|||
160744805|NCT02943785|580448751|FG000|Overall Study|Physician Decision|23|||
160744806|NCT02943785|580448752|FG001|Overall Study|Physician Decision|47|||
160744807|NCT02943785|580448751|FG000|Overall Study|Death|46|||
160744808|NCT02943785|580448752|FG001|Overall Study|Death|46|||
160744809|NCT02943785|580448751|FG000|Overall Study|Lost to Follow-up|1|||
160744810|NCT02943785|580448752|FG001|Overall Study|Lost to Follow-up|0|||
160744811|NCT02943785|580448751|FG000|Overall Study|Other|16|||
160744812|NCT02943785|580448752|FG001|Overall Study|Other|19|||
160744813|NCT02943785|580448751|FG000|Overall Study|Did not receive any study medication|21|||
160744814|NCT02943785|580448752|FG001|Overall Study|Did not receive any study medication|28|||
160744815|NCT02603107|580448753|FG000|Randomized Phase|Withdrew consent|8|||
160744816|NCT02603107|580448754|FG001|Randomized Phase|Withdrew consent|15|||
160744817|NCT02603107|580448753|FG000|Randomized Phase|Lost to Follow-up|1|||
160744818|NCT02603107|580448754|FG001|Randomized Phase|Lost to Follow-up|3|||
160744819|NCT02603107|580448753|FG000|Randomized Phase|Adverse Event|2|||
160744820|NCT02603107|580448754|FG001|Randomized Phase|Adverse Event|0|||
160744821|NCT02603107|580448753|FG000|Randomized Phase|Death|1|||
160744822|NCT02603107|580448754|FG001|Randomized Phase|Death|1|||
160744823|NCT02603107|580448753|FG000|Randomized Phase|Non-compliance with study drug|1|||
160744824|NCT02603107|580448754|FG001|Randomized Phase|Non-compliance with study drug|1|||
160744825|NCT02603107|580448753|FG000|Randomized Phase|Investigator's discretion|0|||
160744826|NCT02603107|580448754|FG001|Randomized Phase|Investigator's discretion|1|||
160744827|NCT02603107|580448753|FG000|Randomized Phase|Lack of Efficacy|1|||
160744828|NCT02603107|580448754|FG001|Randomized Phase|Lack of Efficacy|0|||
160744829|NCT02603107|580448753|FG000|Randomized Phase|Protocol Violation|1|||
160744830|NCT02603107|580448754|FG001|Randomized Phase|Protocol Violation|0|||
160744831|NCT02603107|580448753|FG000|Optional Extension Phase|Lost to Follow-up|3|||
160744832|NCT02603107|580448754|FG001|Optional Extension Phase|Lost to Follow-up|3|||
160744833|NCT02603107|580448753|FG000|Optional Extension Phase|Withdrew consent|3|||
160744834|NCT02603107|580448754|FG001|Optional Extension Phase|Withdrew consent|2|||
160744835|NCT02603107|580448753|FG000|Optional Extension Phase|Investigator's discretion|2|||
160744836|NCT02603107|580448754|FG001|Optional Extension Phase|Investigator's discretion|2|||
160744837|NCT02603107|580448753|FG000|Optional Extension Phase|Pregnancy|0|||
160744838|NCT02603107|580448754|FG001|Optional Extension Phase|Pregnancy|3|||
160744839|NCT02603107|580448753|FG000|Optional Extension Phase|Adverse Event|0|||
160744840|NCT02603107|580448754|FG001|Optional Extension Phase|Adverse Event|2|||
160744841|NCT02603107|580448753|FG000|Optional Extension Phase|Not treated in extension phase|0|||
160744842|NCT02603107|580448754|FG001|Optional Extension Phase|Not treated in extension phase|1|||
160744843|NCT02603107|580448753|FG000|Optional Extension Phase|Protocol Violation|1|||
160744844|NCT02603107|580448754|FG001|Optional Extension Phase|Protocol Violation|0|||
160744845|NCT00821015|580448755|FG000|Overall Study|Lost to Follow-up|12|||
160744846|NCT03013985|580448763|FG000|Overall Study|Protocol Violation|2|||
160744847|NCT03013985|580448764|FG001|Overall Study|Protocol Violation|2|||
160744848|NCT03013985|580448763|FG000|Overall Study|Withdrawal by Subject|14|||
160744849|NCT03013985|580448764|FG001|Overall Study|Withdrawal by Subject|17|||
160744850|NCT01887678|580448765|FG000|Overall Study|Adverse Event|4|||
160744851|NCT01887678|580448766|FG001|Overall Study|Adverse Event|6|||
160744852|NCT01887678|580448765|FG000|Overall Study|Exceeded rescue medication dosage|4|||
160744853|NCT01887678|580448766|FG001|Overall Study|Exceeded rescue medication dosage|5|||
160744854|NCT01887678|580448765|FG000|Overall Study|Withdrawal of consent|3|||
160744855|NCT01887678|580448766|FG001|Overall Study|Withdrawal of consent|4|||
160744856|NCT01887678|580448765|FG000|Overall Study|Lost to Follow-up|4|||
160744857|NCT01887678|580448766|FG001|Overall Study|Lost to Follow-up|2|||
160744858|NCT01887678|580448765|FG000|Overall Study|Deterioration of clinical condition|0|||
160744859|NCT01887678|580448766|FG001|Overall Study|Deterioration of clinical condition|4|||
160744860|NCT01887678|580448765|FG000|Overall Study|Lack of Efficacy|1|||
160744861|NCT01887678|580448766|FG001|Overall Study|Lack of Efficacy|2|||
160744862|NCT01887678|580448765|FG000|Overall Study|Non-compliance|0|||
160744863|NCT01887678|580448766|FG001|Overall Study|Non-compliance|3|||
160744864|NCT01887678|580448765|FG000|Overall Study|Specified|1|||
160744865|NCT01887678|580448766|FG001|Overall Study|Specified|2|||
160744866|NCT00791492|580448770|FG000|Overall Study|Withdrawal by Subject|1|||
160744867|NCT00791492|580448771|FG001|Overall Study|Withdrawal by Subject|2|||
160744868|NCT00791492|580448770|FG000|Overall Study|Liver transplantation|5|||
160744869|NCT00791492|580448771|FG001|Overall Study|Liver transplantation|1|||
160744870|NCT00419159|580448776|FG000|Overall Study|Adverse Event|7|||
160744871|NCT00419159|580448777|FG001|Overall Study|Adverse Event|15|||
160744872|NCT00419159|580448776|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160744873|NCT00419159|580448777|FG001|Overall Study|Abnormal laboratory value(s)|2|||
160744874|NCT00419159|580448776|FG000|Overall Study|Subject's no longer requires study drug|0|||
160744875|NCT00419159|580448777|FG001|Overall Study|Subject's no longer requires study drug|1|||
160744876|NCT00419159|580448776|FG000|Overall Study|Protocol Violation|1|||
160744877|NCT00419159|580448777|FG001|Overall Study|Protocol Violation|0|||
160744878|NCT00419159|580448776|FG000|Overall Study|Withdrawal by Subject|10|||
160744879|NCT00419159|580448777|FG001|Overall Study|Withdrawal by Subject|3|||
160744880|NCT00419159|580448776|FG000|Overall Study|Lost to Follow-up|0|||
160744881|NCT00419159|580448777|FG001|Overall Study|Lost to Follow-up|1|||
160744882|NCT00419159|580448776|FG000|Overall Study|Death|2|||
160744883|NCT00419159|580448777|FG001|Overall Study|Death|2|||
160744884|NCT00419159|580448776|FG000|Overall Study|Disease progression|79|||
160744885|NCT00419159|580448777|FG001|Overall Study|Disease progression|76|||
160744886|NCT01693185|580448778|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
160744887|NCT01693185|580448779|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
160744888|NCT01857102|580448783|FG000|Period 1|No longer meets Eligibility Criteria|0|||
160744889|NCT01857102|580448784|FG001|Period 1|No longer meets Eligibility Criteria|2|||
160744890|NCT01857102|580448783|FG000|Period 1|Lost to Follow-up|0|||
160744891|NCT01857102|580448784|FG001|Period 1|Lost to Follow-up|3|||
160744892|NCT01857102|580448783|FG000|Period 1|Unsatisfactory Lens Fit|1|||
160744893|NCT01857102|580448784|FG001|Period 1|Unsatisfactory Lens Fit|0|||
160744894|NCT01857102|580448783|FG000|Period 1|Unsatisfactory Visual Response|1|||
160744895|NCT01857102|580448784|FG001|Period 1|Unsatisfactory Visual Response|0|||
160744896|NCT01857102|580448783|FG000|Period 1|Physician Decision|1|||
160744897|NCT01857102|580448784|FG001|Period 1|Physician Decision|0|||
160744898|NCT01857102|580448783|FG000|Period 2|Lens Discomfort|1|||
160744899|NCT01857102|580448784|FG001|Period 2|Lens Discomfort|0|||
160744900|NCT01857102|580448783|FG000|Period 2|Unsatisfactory Lens Fit|1|||
160744901|NCT01857102|580448784|FG001|Period 2|Unsatisfactory Lens Fit|0|||
160744902|NCT01080391|580448794|FG000|Overall Study|Randomized but not treated|7|||
160744903|NCT01080391|580448795|FG001|Overall Study|Randomized but not treated|4|||
160744904|NCT01534208|580448796|FG000|Overall Study|Lost to Follow-up|19|||
160744905|NCT01534208|580448797|FG001|Overall Study|Lost to Follow-up|14|||
160744906|NCT01534208|580448796|FG000|Overall Study|Withdrawal by Subject|6|||
160744907|NCT01534208|580448797|FG001|Overall Study|Withdrawal by Subject|20|||
160744908|NCT01534208|580448796|FG000|Overall Study|Adverse Event|15|||
160744909|NCT01534208|580448797|FG001|Overall Study|Adverse Event|8|||
160744910|NCT01534208|580448796|FG000|Overall Study|Physician Decision|2|||
160744911|NCT01534208|580448797|FG001|Overall Study|Physician Decision|0|||
160744912|NCT01534208|580448796|FG000|Overall Study|Lack of Efficacy|0|||
160744913|NCT01534208|580448797|FG001|Overall Study|Lack of Efficacy|3|||
160744914|NCT01534208|580448796|FG000|Overall Study|Protocol Violation|2|||
160744915|NCT01534208|580448797|FG001|Overall Study|Protocol Violation|2|||
160744916|NCT01534208|580448796|FG000|Overall Study|Sponsor decision|4|||
160744917|NCT01534208|580448797|FG001|Overall Study|Sponsor decision|1|||
160744918|NCT01534208|580448796|FG000|Overall Study|Subject relocation|2|||
160744919|NCT01534208|580448797|FG001|Overall Study|Subject relocation|0|||
160744920|NCT01534208|580448796|FG000|Overall Study|Lab assessment|2|||
160744921|NCT01534208|580448797|FG001|Overall Study|Lab assessment|1|||
160744922|NCT01534208|580448796|FG000|Overall Study|Eligibility error|3|||
160744923|NCT01534208|580448797|FG001|Overall Study|Eligibility error|0|||
160744924|NCT01534208|580448796|FG000|Overall Study|PCP decision|1|||
160744925|NCT01534208|580448797|FG001|Overall Study|PCP decision|0|||
160744926|NCT01534208|580448796|FG000|Overall Study|Needed prohibited meds|1|||
160744927|NCT01534208|580448797|FG001|Overall Study|Needed prohibited meds|0|||
160744928|NCT02117713|580448808|FG000|Week 48|Adverse Event|4|||
160744929|NCT02117713|580448808|FG000|Week 48|Withdrawal by caregiver|2|||
160744930|NCT02117713|580448808|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
160744931|NCT02117713|580448808|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
160744932|NCT02117713|580448808|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
160744933|NCT02117713|580448808|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
160744934|NCT03578146|580448809|FG000|Overall Study|Did Not Receive Treatment|1|||
160744935|NCT03578146|580448810|FG001|Overall Study|Did Not Receive Treatment|0|||
160744936|NCT03578146|580448811|FG002|Overall Study|Did Not Receive Treatment|0|||
160744937|NCT03578146|580448812|FG003|Overall Study|Did Not Receive Treatment|0|||
160744938|NCT03578146|580448813|FG004|Overall Study|Did Not Receive Treatment|0|||
160744939|NCT03578146|580448814|FG005|Overall Study|Did Not Receive Treatment|2|||
160744940|NCT03578146|580448809|FG000|Overall Study|Lost to Follow-up|0|||
160744941|NCT03578146|580448810|FG001|Overall Study|Lost to Follow-up|1|||
160744942|NCT03578146|580448811|FG002|Overall Study|Lost to Follow-up|1|||
160744943|NCT03578146|580448812|FG003|Overall Study|Lost to Follow-up|0|||
160744944|NCT03578146|580448813|FG004|Overall Study|Lost to Follow-up|0|||
160744945|NCT03578146|580448814|FG005|Overall Study|Lost to Follow-up|1|||
160744946|NCT01094782|580448816|FG000|Overall Study|Withdrawal by Subject|5|||
160744947|NCT01094782|580448817|FG001|Overall Study|Withdrawal by Subject|5|||
160744948|NCT01094782|580448818|FG002|Overall Study|Withdrawal by Subject|1|||
160744949|NCT01094782|580448819|FG003|Overall Study|Withdrawal by Subject|5|||
160744950|NCT01094782|580448820|FG004|Overall Study|Withdrawal by Subject|5|||
160744951|NCT01094782|580448821|FG005|Overall Study|Withdrawal by Subject|0|||
160744952|NCT01094782|580448816|FG000|Overall Study|Lost to Follow-up|1|||
160744953|NCT01094782|580448817|FG001|Overall Study|Lost to Follow-up|0|||
160744954|NCT01094782|580448818|FG002|Overall Study|Lost to Follow-up|0|||
160744955|NCT01094782|580448819|FG003|Overall Study|Lost to Follow-up|2|||
160744956|NCT01094782|580448820|FG004|Overall Study|Lost to Follow-up|1|||
160744957|NCT01094782|580448821|FG005|Overall Study|Lost to Follow-up|4|||
160744958|NCT01094782|580448816|FG000|Overall Study|Positive Drug Screen|2|||
160744959|NCT01094782|580448817|FG001|Overall Study|Positive Drug Screen|2|||
160744960|NCT01094782|580448818|FG002|Overall Study|Positive Drug Screen|1|||
160744961|NCT01094782|580448819|FG003|Overall Study|Positive Drug Screen|1|||
160744962|NCT01094782|580448820|FG004|Overall Study|Positive Drug Screen|3|||
160744963|NCT01094782|580448821|FG005|Overall Study|Positive Drug Screen|2|||
160744964|NCT01094782|580448816|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
160744965|NCT01094782|580448817|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
160744966|NCT01094782|580448818|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
160744967|NCT01094782|580448819|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
160744968|NCT01094782|580448820|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
160744969|NCT01094782|580448821|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
160744970|NCT01094782|580448816|FG000|Overall Study|Unable to Complete Questionnaires|0|||
160744971|NCT01094782|580448817|FG001|Overall Study|Unable to Complete Questionnaires|1|||
160744972|NCT01094782|580448818|FG002|Overall Study|Unable to Complete Questionnaires|0|||
160744973|NCT01094782|580448819|FG003|Overall Study|Unable to Complete Questionnaires|0|||
160744974|NCT01094782|580448820|FG004|Overall Study|Unable to Complete Questionnaires|0|||
160744975|NCT01094782|580448821|FG005|Overall Study|Unable to Complete Questionnaires|0|||
160744976|NCT01094782|580448816|FG000|Overall Study|Healthy Subject Had Pain|0|||
160744977|NCT01094782|580448817|FG001|Overall Study|Healthy Subject Had Pain|1|||
160744978|NCT01094782|580448818|FG002|Overall Study|Healthy Subject Had Pain|0|||
160744979|NCT01094782|580448819|FG003|Overall Study|Healthy Subject Had Pain|0|||
160744980|NCT01094782|580448820|FG004|Overall Study|Healthy Subject Had Pain|0|||
160744981|NCT01094782|580448821|FG005|Overall Study|Healthy Subject Had Pain|0|||
160744982|NCT01094782|580448816|FG000|Overall Study|Hypertension|0|||
160744983|NCT01094782|580448817|FG001|Overall Study|Hypertension|0|||
160744984|NCT01094782|580448818|FG002|Overall Study|Hypertension|1|||
160744985|NCT01094782|580448819|FG003|Overall Study|Hypertension|0|||
160744986|NCT01094782|580448820|FG004|Overall Study|Hypertension|0|||
160744987|NCT01094782|580448821|FG005|Overall Study|Hypertension|0|||
160744988|NCT01094782|580448816|FG000|Overall Study|Wrong Pain Condition|0|||
160744989|NCT01094782|580448817|FG001|Overall Study|Wrong Pain Condition|0|||
160744990|NCT01094782|580448818|FG002|Overall Study|Wrong Pain Condition|0|||
160744991|NCT01094782|580448819|FG003|Overall Study|Wrong Pain Condition|2|||
160744992|NCT01094782|580448820|FG004|Overall Study|Wrong Pain Condition|1|||
160744993|NCT01094782|580448821|FG005|Overall Study|Wrong Pain Condition|1|||
160744994|NCT01094782|580448816|FG000|Overall Study|Recent Interventional Injection|0|||
160744995|NCT01094782|580448817|FG001|Overall Study|Recent Interventional Injection|0|||
160744996|NCT01094782|580448818|FG002|Overall Study|Recent Interventional Injection|0|||
160744997|NCT01094782|580448819|FG003|Overall Study|Recent Interventional Injection|0|||
160744998|NCT01094782|580448820|FG004|Overall Study|Recent Interventional Injection|0|||
160744999|NCT01094782|580448821|FG005|Overall Study|Recent Interventional Injection|1|||
160745000|NCT01094782|580448816|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
160745001|NCT01094782|580448817|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
160745002|NCT01094782|580448818|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
160745003|NCT01094782|580448819|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
160745004|NCT01094782|580448820|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
160745005|NCT01094782|580448821|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
160745006|NCT01094782|580448816|FG000|Overall Study|Noncompliance With Study Schedule|0|||
160745007|NCT01094782|580448817|FG001|Overall Study|Noncompliance With Study Schedule|0|||
160745008|NCT01094782|580448818|FG002|Overall Study|Noncompliance With Study Schedule|0|||
160745009|NCT01094782|580448819|FG003|Overall Study|Noncompliance With Study Schedule|1|||
160745010|NCT01094782|580448820|FG004|Overall Study|Noncompliance With Study Schedule|0|||
160745011|NCT01094782|580448821|FG005|Overall Study|Noncompliance With Study Schedule|0|||
160745012|NCT00634049|580448824|FG000|Overall Study|Never received study drug|1|||
160745013|NCT00634049|580448824|FG000|Overall Study|Died prior to receiving study drug|1|||
160745014|NCT00634049|580448824|FG000|Overall Study|Screening failure|1|||
160745015|NCT01717391|580448825|FG000|Overall Study|Withdrawal by Subject|5|||
160745016|NCT01717391|580448825|FG000|Overall Study|Physician Decision|1|||
160745017|NCT01717391|580448825|FG000|Overall Study|FLT technical failure|3|||
160745018|NCT04907227|580448834|FG000|Overall Study|Death|12|||
160745019|NCT04907227|580448835|FG001|Overall Study|Death|8|||
160745020|NCT04907227|580448834|FG000|Overall Study|Withdrawal by Subject|2|||
160745021|NCT04907227|580448835|FG001|Overall Study|Withdrawal by Subject|2|||
160745022|NCT04907227|580448834|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
160745023|NCT04907227|580448835|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
160745024|NCT04907227|580448834|FG000|Overall Study|Sponsor Decision|25|||
160745025|NCT04907227|580448835|FG001|Overall Study|Sponsor Decision|30|||
160745026|NCT04907227|580448834|FG000|Overall Study|Physician Decision|1|||
160745027|NCT04907227|580448835|FG001|Overall Study|Physician Decision|0|||
160745028|NCT02208050|580448838|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
160745029|NCT02208050|580448839|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
160745030|NCT00721279|580448841|FG000|Overall Study|Lack of Efficacy|6|||
160745031|NCT00721279|580448842|FG001|Overall Study|Lack of Efficacy|3|||
160745032|NCT00721279|580448841|FG000|Overall Study|Tolerability insufficient|5|||
160745033|NCT00721279|580448842|FG001|Overall Study|Tolerability insufficient|2|||
160745034|NCT00721279|580448841|FG000|Overall Study|Withdrawal by Subject|13|||
160745035|NCT00721279|580448842|FG001|Overall Study|Withdrawal by Subject|3|||
160745036|NCT00721279|580448841|FG000|Overall Study|Other|12|||
160745037|NCT00721279|580448842|FG001|Overall Study|Other|16|||
160745038|NCT03673345|580448843|FG000|Overall Study|Lost to Follow-up|1|||
160745039|NCT03673345|580448844|FG001|Overall Study|Lost to Follow-up|0|||
160745040|NCT03673345|580448845|FG002|Overall Study|Lost to Follow-up|3|||
160745041|NCT03673345|580448846|FG003|Overall Study|Lost to Follow-up|3|||
160745042|NCT03673345|580448847|FG004|Overall Study|Lost to Follow-up|2|||
160745043|NCT03673345|580448848|FG005|Overall Study|Lost to Follow-up|1|||
160745044|NCT03673345|580448849|FG006|Overall Study|Lost to Follow-up|0|||
160745045|NCT03673345|580448850|FG007|Overall Study|Lost to Follow-up|0|||
160745046|NCT03673345|580448843|FG000|Overall Study|Withdrawal by Subject|1|||
160745047|NCT03673345|580448844|FG001|Overall Study|Withdrawal by Subject|0|||
160745048|NCT03673345|580448845|FG002|Overall Study|Withdrawal by Subject|4|||
160745049|NCT03673345|580448846|FG003|Overall Study|Withdrawal by Subject|2|||
160745050|NCT03673345|580448847|FG004|Overall Study|Withdrawal by Subject|0|||
160745051|NCT03673345|580448848|FG005|Overall Study|Withdrawal by Subject|0|||
160745052|NCT03673345|580448849|FG006|Overall Study|Withdrawal by Subject|0|||
160745053|NCT03673345|580448850|FG007|Overall Study|Withdrawal by Subject|0|||
160745054|NCT03673345|580448843|FG000|Overall Study|Physician Decision|0|||
160745055|NCT03673345|580448844|FG001|Overall Study|Physician Decision|0|||
160745056|NCT03673345|580448845|FG002|Overall Study|Physician Decision|2|||
160745057|NCT03673345|580448846|FG003|Overall Study|Physician Decision|0|||
160745058|NCT03673345|580448847|FG004|Overall Study|Physician Decision|0|||
160745059|NCT03673345|580448848|FG005|Overall Study|Physician Decision|0|||
160745060|NCT03673345|580448849|FG006|Overall Study|Physician Decision|0|||
160745061|NCT03673345|580448850|FG007|Overall Study|Physician Decision|0|||
160745062|NCT04608344|580448851|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
160745063|NCT04608344|580448852|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
160745064|NCT04608344|580448851|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
160745065|NCT04608344|580448852|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
160745066|NCT02429310|580448853|FG000|Overall Study|Lost to Follow-up|1|||
160745067|NCT02429310|580448854|FG001|Overall Study|Lost to Follow-up|2|||
160745068|NCT02429310|580448853|FG000|Overall Study|Protocol Violation|1|||
160745069|NCT02429310|580448854|FG001|Overall Study|Protocol Violation|1|||
160745070|NCT03646305|580448855|FG000|Overall Study|Lost to Follow-up|4|||
160745071|NCT03646305|580448856|FG001|Overall Study|Lost to Follow-up|2|||
160745072|NCT03646305|580448857|FG002|Overall Study|Lost to Follow-up|2|||
160745073|NCT03646305|580448858|FG003|Overall Study|Lost to Follow-up|1|||
160745074|NCT03646305|580448855|FG000|Overall Study|Withdrawal by Subject|1|||
160745075|NCT03646305|580448856|FG001|Overall Study|Withdrawal by Subject|0|||
160745076|NCT03646305|580448857|FG002|Overall Study|Withdrawal by Subject|0|||
160745077|NCT03646305|580448858|FG003|Overall Study|Withdrawal by Subject|1|||
160745078|NCT01554176|580448859|FG000|Treatment Phase|Protocol Violation|1|||
160745079|NCT01554176|580448860|FG001|Treatment Phase|Protocol Violation|2|||
160745080|NCT01554176|580448861|FG002|Treatment Phase|Protocol Violation|0|||
160745081|NCT01554176|580448862|FG003|Treatment Phase|Protocol Violation|0|||
160745082|NCT01554176|580448863|FG004|Treatment Phase|Protocol Violation|0|||
160745083|NCT01554176|580448859|FG000|Treatment Phase|Physician Decision|1|||
160745084|NCT01554176|580448860|FG001|Treatment Phase|Physician Decision|1|||
160745085|NCT01554176|580448861|FG002|Treatment Phase|Physician Decision|0|||
160745086|NCT01554176|580448862|FG003|Treatment Phase|Physician Decision|0|||
160745087|NCT01554176|580448863|FG004|Treatment Phase|Physician Decision|0|||
160745088|NCT01554176|580448859|FG000|Treatment Phase|Lack of Efficacy|0|||
160745089|NCT01554176|580448860|FG001|Treatment Phase|Lack of Efficacy|1|||
160745090|NCT01554176|580448861|FG002|Treatment Phase|Lack of Efficacy|0|||
160745091|NCT01554176|580448862|FG003|Treatment Phase|Lack of Efficacy|0|||
160745092|NCT01554176|580448863|FG004|Treatment Phase|Lack of Efficacy|0|||
160745093|NCT01554176|580448859|FG000|Treatment Phase|Adverse event, non-fatal|1|||
160745094|NCT01554176|580448860|FG001|Treatment Phase|Adverse event, non-fatal|1|||
160745095|NCT01554176|580448861|FG002|Treatment Phase|Adverse event, non-fatal|0|||
160745096|NCT01554176|580448862|FG003|Treatment Phase|Adverse event, non-fatal|0|||
160745097|NCT01554176|580448863|FG004|Treatment Phase|Adverse event, non-fatal|0|||
160745098|NCT01554176|580448859|FG000|Treatment Phase|Non-compliance with study drug|1|||
160745099|NCT01554176|580448860|FG001|Treatment Phase|Non-compliance with study drug|0|||
160745100|NCT01554176|580448861|FG002|Treatment Phase|Non-compliance with study drug|0|||
160745101|NCT01554176|580448862|FG003|Treatment Phase|Non-compliance with study drug|0|||
160745102|NCT01554176|580448863|FG004|Treatment Phase|Non-compliance with study drug|0|||
160745103|NCT01554176|580448859|FG000|Treatment Phase|Withdrawal by Subject|1|||
160745104|NCT01554176|580448860|FG001|Treatment Phase|Withdrawal by Subject|0|||
160745105|NCT01554176|580448861|FG002|Treatment Phase|Withdrawal by Subject|0|||
160745106|NCT01554176|580448862|FG003|Treatment Phase|Withdrawal by Subject|0|||
160745107|NCT01554176|580448863|FG004|Treatment Phase|Withdrawal by Subject|0|||
160745108|NCT01554176|580448859|FG000|Treatment Phase|Lost to Follow-up|3|||
160745109|NCT01554176|580448860|FG001|Treatment Phase|Lost to Follow-up|0|||
160745110|NCT01554176|580448861|FG002|Treatment Phase|Lost to Follow-up|0|||
160745111|NCT01554176|580448862|FG003|Treatment Phase|Lost to Follow-up|0|||
160745112|NCT01554176|580448863|FG004|Treatment Phase|Lost to Follow-up|0|||
160745113|NCT01554176|580448859|FG000|Run-out Phase|Protocol Violation|0|||
160745114|NCT01554176|580448860|FG001|Run-out Phase|Protocol Violation|0|||
160745115|NCT01554176|580448861|FG002|Run-out Phase|Protocol Violation|0|||
160745116|NCT01554176|580448862|FG003|Run-out Phase|Protocol Violation|1|||
160745117|NCT01554176|580448863|FG004|Run-out Phase|Protocol Violation|0|||
160745118|NCT02678000|580448866|FG000|PART 2|Adverse Event|0|||
160745119|NCT02678000|580448867|FG001|PART 2|Adverse Event|0|||
160745120|NCT02678000|580448868|FG002|PART 2|Adverse Event|2|||
160745121|NCT02678000|580448869|FG003|PART 2|Adverse Event|1|||
160745122|NCT02678000|580448870|FG004|PART 2|Adverse Event|0|||
160745123|NCT02678000|580448866|FG000|PART 2|Withdrawal by Subject|0|||
160745124|NCT02678000|580448867|FG001|PART 2|Withdrawal by Subject|0|||
160745125|NCT02678000|580448868|FG002|PART 2|Withdrawal by Subject|1|||
160745126|NCT02678000|580448869|FG003|PART 2|Withdrawal by Subject|0|||
160745127|NCT02678000|580448870|FG004|PART 2|Withdrawal by Subject|0|||
160745128|NCT03053427|580448871|FG000|Overall Study|Adverse Event|4|||
160745129|NCT03053427|580448872|FG001|Overall Study|Adverse Event|4|||
160745130|NCT03053427|580448871|FG000|Overall Study|Lack of Efficacy|1|||
160745131|NCT03053427|580448872|FG001|Overall Study|Lack of Efficacy|3|||
160745132|NCT03053427|580448871|FG000|Overall Study|Lost to Follow-up|2|||
160745133|NCT03053427|580448872|FG001|Overall Study|Lost to Follow-up|2|||
160745134|NCT03053427|580448871|FG000|Overall Study|Worsening of the target disease|0|||
160745135|NCT03053427|580448872|FG001|Overall Study|Worsening of the target disease|1|||
160745136|NCT03053427|580448871|FG000|Overall Study|Protocol Deviation|3|||
160745137|NCT03053427|580448872|FG001|Overall Study|Protocol Deviation|3|||
160745138|NCT03053427|580448871|FG000|Overall Study|Withdrawal by Subject|3|||
160745139|NCT03053427|580448872|FG001|Overall Study|Withdrawal by Subject|2|||
160745140|NCT03053427|580448871|FG000|Overall Study|Miscellaneous|0|||
160745141|NCT03053427|580448872|FG001|Overall Study|Miscellaneous|1|||
160745142|NCT03214679|580450910|FG000|Overall Study|Lost to Follow-up|12|||
160745143|NCT03214679|580450911|FG001|Overall Study|Lost to Follow-up|14|||
160745144|NCT03214679|580450910|FG000|Overall Study|not eligible|2|||
160745145|NCT03214679|580450911|FG001|Overall Study|not eligible|0|||
160745146|NCT02469168|580450917|FG000|Overall Study|Trial closed|1|||
160745147|NCT02469168|580450918|FG001|Overall Study|Trial closed|0|||
160745148|NCT01533688|580450919|FG000|Overall Study|Withdrawal by Subject|5|||
160745149|NCT01533688|580450920|FG001|Overall Study|Withdrawal by Subject|4|||
160745150|NCT01533688|580450921|FG002|Overall Study|Withdrawal by Subject|3|||
160745151|NCT01533688|580450919|FG000|Overall Study|Medically unstable|1|||
160745152|NCT01533688|580450920|FG001|Overall Study|Medically unstable|3|||
160745153|NCT01533688|580450921|FG002|Overall Study|Medically unstable|3|||
160745154|NCT01533688|580450919|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
160745155|NCT01533688|580450920|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
160745156|NCT01533688|580450921|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
160745157|NCT02190721|580450922|FG000|Overall Study|Patient was out of the city|0|||
160745158|NCT02190721|580450923|FG001|Overall Study|Patient was out of the city|1|||
160745159|NCT02190721|580450924|FG002|Overall Study|Patient was out of the city|0|||
160745160|NCT01760447|580450925|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
160745161|NCT01760447|580450926|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
160745162|NCT01760447|580450927|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
160745163|NCT01760447|580450928|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
160745164|NCT01760447|580450925|FG000|Weeks 0-20|Withdrawal by Subject|2|||
160745165|NCT01760447|580450926|FG001|Weeks 0-20|Withdrawal by Subject|0|||
160745166|NCT01760447|580450927|FG002|Weeks 0-20|Withdrawal by Subject|1|||
160745167|NCT01760447|580450928|FG003|Weeks 0-20|Withdrawal by Subject|0|||
160745168|NCT01760447|580450925|FG000|Weeks 0-20|Lost to Follow-up|1|||
160745169|NCT01760447|580450926|FG001|Weeks 0-20|Lost to Follow-up|0|||
160745170|NCT01760447|580450927|FG002|Weeks 0-20|Lost to Follow-up|1|||
160745171|NCT01760447|580450928|FG003|Weeks 0-20|Lost to Follow-up|1|||
160745172|NCT01760447|580450925|FG000|Weeks 0-20|Randomized but not treated|0|||
160745173|NCT01760447|580450926|FG001|Weeks 0-20|Randomized but not treated|0|||
160745174|NCT01760447|580450927|FG002|Weeks 0-20|Randomized but not treated|2|||
160745175|NCT01760447|580450928|FG003|Weeks 0-20|Randomized but not treated|0|||
160745176|NCT01760447|580450925|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
160745177|NCT01760447|580450926|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
160745178|NCT01760447|580450927|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
160745179|NCT01760447|580450928|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
160745180|NCT01760447|580450925|FG000|Weeks 20-54|Withdrawal by Subject|2|||
160745181|NCT01760447|580450926|FG001|Weeks 20-54|Withdrawal by Subject|1|||
160745182|NCT01760447|580450927|FG002|Weeks 20-54|Withdrawal by Subject|1|||
160745183|NCT01760447|580450928|FG003|Weeks 20-54|Withdrawal by Subject|2|||
160745184|NCT01760447|580450925|FG000|Weeks 20-54|Lost to Follow-up|0|||
160745185|NCT01760447|580450926|FG001|Weeks 20-54|Lost to Follow-up|0|||
160745186|NCT01760447|580450927|FG002|Weeks 20-54|Lost to Follow-up|1|||
160745187|NCT01760447|580450928|FG003|Weeks 20-54|Lost to Follow-up|2|||
160745188|NCT01214668|580450929|FG000|Overall Study|Adverse Event|0|||
160745189|NCT01214668|580450930|FG001|Overall Study|Adverse Event|1|||
160745190|NCT01214668|580450931|FG002|Overall Study|Adverse Event|0|||
160745191|NCT01214668|580450932|FG003|Overall Study|Adverse Event|2|||
160745192|NCT01214668|580450933|FG004|Overall Study|Adverse Event|1|||
160745193|NCT01214668|580450934|FG005|Overall Study|Adverse Event|1|||
160745194|NCT01214668|580450929|FG000|Overall Study|Death|0|||
160745195|NCT01214668|580450930|FG001|Overall Study|Death|0|||
160745196|NCT01214668|580450931|FG002|Overall Study|Death|1|||
160745197|NCT01214668|580450932|FG003|Overall Study|Death|0|||
160745198|NCT01214668|580450933|FG004|Overall Study|Death|0|||
160745199|NCT01214668|580450934|FG005|Overall Study|Death|0|||
160745200|NCT01214668|580450929|FG000|Overall Study|Progressive Disease|4|||
160745201|NCT01214668|580450930|FG001|Overall Study|Progressive Disease|2|||
160745202|NCT01214668|580450931|FG002|Overall Study|Progressive Disease|5|||
160745203|NCT01214668|580450932|FG003|Overall Study|Progressive Disease|4|||
160745204|NCT01214668|580450933|FG004|Overall Study|Progressive Disease|4|||
160745205|NCT01214668|580450934|FG005|Overall Study|Progressive Disease|5|||
160745206|NCT01214668|580450929|FG000|Overall Study|Withdrawal by Subject|0|||
160745207|NCT01214668|580450930|FG001|Overall Study|Withdrawal by Subject|0|||
160745208|NCT01214668|580450931|FG002|Overall Study|Withdrawal by Subject|0|||
160745209|NCT01214668|580450932|FG003|Overall Study|Withdrawal by Subject|0|||
160745210|NCT01214668|580450933|FG004|Overall Study|Withdrawal by Subject|1|||
160745211|NCT01214668|580450934|FG005|Overall Study|Withdrawal by Subject|0|||
160745212|NCT02907619|580450935|FG000|Overall Study|Study terminated by sponsor|18|||
160745213|NCT02907619|580450936|FG001|Overall Study|Study terminated by sponsor|18|||
160745214|NCT02907619|580450937|FG002|Overall Study|Study terminated by sponsor|19|||
160745215|NCT02907619|580450935|FG000|Overall Study|Death|0|||
160745216|NCT02907619|580450936|FG001|Overall Study|Death|0|||
160745217|NCT02907619|580450937|FG002|Overall Study|Death|1|||
160745218|NCT02907619|580450935|FG000|Overall Study|Withdrawal by Subject|1|||
160745219|NCT02907619|580450936|FG001|Overall Study|Withdrawal by Subject|1|||
160745220|NCT02907619|580450937|FG002|Overall Study|Withdrawal by Subject|0|||
160745221|NCT02907619|580450935|FG000|Overall Study|Other|0|||
160745222|NCT02907619|580450936|FG001|Overall Study|Other|1|||
160745223|NCT02907619|580450937|FG002|Overall Study|Other|0|||
160745224|NCT03326518|580450938|FG000|Overall Study|Protocol Violation|1|||
160745225|NCT03326518|580450939|FG001|Overall Study|Protocol Violation|0|||
160745226|NCT03326518|580450940|FG002|Overall Study|Protocol Violation|0|||
160745227|NCT03326518|580450938|FG000|Overall Study|Withdrawal by Subject|1|||
160745228|NCT03326518|580450939|FG001|Overall Study|Withdrawal by Subject|0|||
160745229|NCT03326518|580450940|FG002|Overall Study|Withdrawal by Subject|0|||
160745230|NCT03326518|580450938|FG000|Overall Study|Lost to Follow-up|1|||
160745231|NCT03326518|580450939|FG001|Overall Study|Lost to Follow-up|0|||
160745232|NCT03326518|580450940|FG002|Overall Study|Lost to Follow-up|1|||
160745233|NCT02065518|580450941|FG000|Overall Study|Lost to Follow-up|3|||
160745234|NCT02065518|580450942|FG001|Overall Study|Lost to Follow-up|4|||
160745235|NCT02065518|580450943|FG002|Overall Study|Lost to Follow-up|0|||
160745236|NCT02065518|580450944|FG003|Overall Study|Lost to Follow-up|3|||
160745237|NCT02065518|580450941|FG000|Overall Study|Withdrawal by Subject|3|||
160745238|NCT02065518|580450942|FG001|Overall Study|Withdrawal by Subject|4|||
160745239|NCT02065518|580450943|FG002|Overall Study|Withdrawal by Subject|9|||
160745240|NCT02065518|580450944|FG003|Overall Study|Withdrawal by Subject|2|||
160745241|NCT06439095|580450945|FG000|Overall Study|Lost to Follow-up|2|||
160745242|NCT03484403|580450947|FG000|Overall Study|Withdrawal by Subject|6|||
160745243|NCT03484403|580450948|FG001|Overall Study|Withdrawal by Subject|4|||
160745244|NCT01937884|580450949|FG000|Overall Study|Withdrawal by Subject|1|||
160745245|NCT01937884|580450950|FG001|Overall Study|Withdrawal by Subject|0|||
160745246|NCT02636699|580450955|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
160745247|NCT02636699|580450956|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
160745248|NCT02636699|580450957|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
160745249|NCT02636699|580450955|FG000|Screening Period|Withdrawal by Subject|0|||
160745250|NCT02636699|580450956|FG001|Screening Period|Withdrawal by Subject|0|||
160745251|NCT02636699|580450957|FG002|Screening Period|Withdrawal by Subject|23|||
160745252|NCT02636699|580450955|FG000|Screening Period|Adverse Event|0|||
160745253|NCT02636699|580450956|FG001|Screening Period|Adverse Event|0|||
160745254|NCT02636699|580450957|FG002|Screening Period|Adverse Event|1|||
160745255|NCT02636699|580450955|FG000|Screening Period|Other not specified|0|||
160745256|NCT02636699|580450956|FG001|Screening Period|Other not specified|0|||
160745257|NCT02636699|580450957|FG002|Screening Period|Other not specified|3|||
160745258|NCT02636699|580450955|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
160745259|NCT02636699|580450956|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
160745260|NCT02636699|580450957|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
160745261|NCT02636699|580450955|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
160745262|NCT02636699|580450956|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
160745263|NCT02636699|580450957|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
160745264|NCT02636699|580450955|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
160745265|NCT02636699|580450956|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
160745266|NCT02636699|580450957|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
160745267|NCT02636699|580450955|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
160745268|NCT02636699|580450956|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
160745269|NCT02636699|580450957|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
160745270|NCT02636699|580450955|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
160745271|NCT02636699|580450956|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
160745272|NCT02636699|580450957|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
160745273|NCT02636699|580450955|FG000|Treatment and Follow-up Periods|Other|3|||
160745274|NCT02636699|580450956|FG001|Treatment and Follow-up Periods|Other|1|||
160745275|NCT02636699|580450957|FG002|Treatment and Follow-up Periods|Other|0|||
160745276|NCT00624832|580450958|FG000|Overall Study|Adverse Event|0|||
160745277|NCT00624832|580450959|FG001|Overall Study|Adverse Event|1|||
160745278|NCT00624832|580450960|FG002|Overall Study|Adverse Event|0|||
160745279|NCT00624832|580450961|FG003|Overall Study|Adverse Event|1|||
160745280|NCT00624832|580450958|FG000|Overall Study|Abnormal Laboratory Value|2|||
160745281|NCT00624832|580450959|FG001|Overall Study|Abnormal Laboratory Value|0|||
160745282|NCT00624832|580450960|FG002|Overall Study|Abnormal Laboratory Value|0|||
160745283|NCT00624832|580450961|FG003|Overall Study|Abnormal Laboratory Value|0|||
160745284|NCT01939223|580450962|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
160745285|NCT01939223|580450963|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
160745286|NCT01939223|580450962|FG000|Overall Study|Disease recurrence (radiological)|1|||
160745287|NCT01939223|580450963|FG001|Overall Study|Disease recurrence (radiological)|3|||
160745288|NCT01939223|580450962|FG000|Overall Study|Study stopped by Sponsor|5|||
160745289|NCT01939223|580450963|FG001|Overall Study|Study stopped by Sponsor|7|||
160745290|NCT01939223|580450962|FG000|Overall Study|Withdrawal by Subject|6|||
160745291|NCT01939223|580450963|FG001|Overall Study|Withdrawal by Subject|0|||
160745292|NCT04379700|580450964|FG000|Overall Study|Withdrawal by Subject|10|||
160745293|NCT04379700|580450964|FG000|Overall Study|Screen Fail|4|||
160745294|NCT04379700|580450964|FG000|Overall Study|Lost to Follow-up|3|||
160745295|NCT03004924|580450993|FG000|Overall Study|Adverse Event|6|||
160745296|NCT03004924|580450994|FG001|Overall Study|Adverse Event|5|||
160745297|NCT03004924|580450995|FG002|Overall Study|Adverse Event|10|||
160745298|NCT03004924|580450993|FG000|Overall Study|Protocol Violation|4|||
160745299|NCT03004924|580450994|FG001|Overall Study|Protocol Violation|0|||
160745300|NCT03004924|580450995|FG002|Overall Study|Protocol Violation|1|||
160745301|NCT03004924|580450993|FG000|Overall Study|Withdrawal by Subject|5|||
160745302|NCT03004924|580450994|FG001|Overall Study|Withdrawal by Subject|3|||
160745303|NCT03004924|580450995|FG002|Overall Study|Withdrawal by Subject|5|||
160745304|NCT03004924|580450993|FG000|Overall Study|Lost to Follow-up|6|||
160745305|NCT03004924|580450994|FG001|Overall Study|Lost to Follow-up|1|||
160745306|NCT03004924|580450995|FG002|Overall Study|Lost to Follow-up|4|||
160745307|NCT03004924|580450993|FG000|Overall Study|Lack of Efficacy|2|||
160745308|NCT03004924|580450994|FG001|Overall Study|Lack of Efficacy|4|||
160745309|NCT03004924|580450995|FG002|Overall Study|Lack of Efficacy|2|||
160745310|NCT03004924|580450993|FG000|Overall Study|Physician Decision|1|||
160745311|NCT03004924|580450994|FG001|Overall Study|Physician Decision|0|||
160745312|NCT03004924|580450995|FG002|Overall Study|Physician Decision|1|||
160745313|NCT03004924|580450993|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160745314|NCT03004924|580450994|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160745315|NCT03004924|580450995|FG002|Overall Study|Withdrawal by parent/guardian|2|||
160745316|NCT03004924|580450993|FG000|Overall Study|Screen Failure|1|||
160745317|NCT03004924|580450994|FG001|Overall Study|Screen Failure|0|||
160745318|NCT03004924|580450995|FG002|Overall Study|Screen Failure|0|||
160745319|NCT03004924|580450993|FG000|Overall Study|Pregnancy|0|||
160745320|NCT03004924|580450994|FG001|Overall Study|Pregnancy|1|||
160745321|NCT03004924|580450995|FG002|Overall Study|Pregnancy|0|||
160745322|NCT03004924|580450993|FG000|Overall Study|Terminated by Sponsor|0|||
160745323|NCT03004924|580450994|FG001|Overall Study|Terminated by Sponsor|0|||
160745324|NCT03004924|580450995|FG002|Overall Study|Terminated by Sponsor|1|||
160745325|NCT03004924|580450993|FG000|Overall Study|Missed Study Visit|0|||
160745326|NCT03004924|580450994|FG001|Overall Study|Missed Study Visit|0|||
160745327|NCT03004924|580450995|FG002|Overall Study|Missed Study Visit|2|||
160745328|NCT03004924|580450993|FG000|Overall Study|HSV1 Positive|1|||
160745329|NCT03004924|580450994|FG001|Overall Study|HSV1 Positive|0|||
160745330|NCT03004924|580450995|FG002|Overall Study|HSV1 Positive|0|||
160745331|NCT03411902|580451011|FG000|Overall Study|Lost to Follow-up|3|||
160745332|NCT03411902|580451012|FG001|Overall Study|Lost to Follow-up|0|||
160745333|NCT01370616|580451013|FG000|Overall Study|Adverse Event|11|||
160745334|NCT01370616|580451014|FG001|Overall Study|Adverse Event|16|||
160745335|NCT01370616|580451013|FG000|Overall Study|Death|1|||
160745336|NCT01370616|580451014|FG001|Overall Study|Death|0|||
160745337|NCT01370616|580451013|FG000|Overall Study|Lack of Efficacy|6|||
160745338|NCT01370616|580451014|FG001|Overall Study|Lack of Efficacy|2|||
160745339|NCT01370616|580451013|FG000|Overall Study|Lost to Follow-up|0|||
160745340|NCT01370616|580451014|FG001|Overall Study|Lost to Follow-up|3|||
160745341|NCT01370616|580451013|FG000|Overall Study|Physician Decision|6|||
160745342|NCT01370616|580451014|FG001|Overall Study|Physician Decision|6|||
160745343|NCT01370616|580451013|FG000|Overall Study|Progressive Disease|0|||
160745344|NCT01370616|580451014|FG001|Overall Study|Progressive Disease|1|||
160745345|NCT01370616|580451013|FG000|Overall Study|Recovery|1|||
160745346|NCT01370616|580451014|FG001|Overall Study|Recovery|0|||
160745347|NCT01370616|580451013|FG000|Overall Study|Technical Problems|3|||
160745348|NCT01370616|580451014|FG001|Overall Study|Technical Problems|5|||
160745349|NCT01370616|580451013|FG000|Overall Study|Withdrawal by Subject|34|||
160745350|NCT01370616|580451014|FG001|Overall Study|Withdrawal by Subject|34|||
160745351|NCT01017601|580451015|FG000|Overall Study|Disease Progression|12|||
160745352|NCT01017601|580451016|FG001|Overall Study|Disease Progression|12|||
160745353|NCT01017601|580451015|FG000|Overall Study|Withdrawal by Subject|0|||
160745354|NCT01017601|580451016|FG001|Overall Study|Withdrawal by Subject|1|||
160745355|NCT00076999|580451017|FG000|Overall Study|Adverse Event|2|||
160745356|NCT00076999|580451018|FG001|Overall Study|Adverse Event|8|||
160745357|NCT00076999|580451019|FG002|Overall Study|Adverse Event|6|||
160745358|NCT00076999|580451020|FG003|Overall Study|Adverse Event|0|||
160745359|NCT00076999|580451021|FG004|Overall Study|Adverse Event|2|||
160745360|NCT00076999|580451017|FG000|Overall Study|Protocol Violation|0|||
160745361|NCT00076999|580451018|FG001|Overall Study|Protocol Violation|3|||
160745362|NCT00076999|580451019|FG002|Overall Study|Protocol Violation|4|||
160745363|NCT00076999|580451020|FG003|Overall Study|Protocol Violation|0|||
160745364|NCT00076999|580451021|FG004|Overall Study|Protocol Violation|9|||
160745365|NCT00076999|580451017|FG000|Overall Study|Lost to Follow-up|2|||
160745366|NCT00076999|580451018|FG001|Overall Study|Lost to Follow-up|1|||
160745367|NCT00076999|580451019|FG002|Overall Study|Lost to Follow-up|0|||
160745368|NCT00076999|580451020|FG003|Overall Study|Lost to Follow-up|0|||
160745369|NCT00076999|580451021|FG004|Overall Study|Lost to Follow-up|0|||
160745370|NCT00076999|580451017|FG000|Overall Study|Withdrawal by Subject|0|||
160745371|NCT00076999|580451018|FG001|Overall Study|Withdrawal by Subject|4|||
160745372|NCT00076999|580451019|FG002|Overall Study|Withdrawal by Subject|3|||
160745373|NCT00076999|580451020|FG003|Overall Study|Withdrawal by Subject|0|||
160745374|NCT00076999|580451021|FG004|Overall Study|Withdrawal by Subject|1|||
160745375|NCT00076999|580451017|FG000|Overall Study|Other reason (not specified)|8|||
160745376|NCT00076999|580451018|FG001|Overall Study|Other reason (not specified)|8|||
160745377|NCT00076999|580451019|FG002|Overall Study|Other reason (not specified)|4|||
160745378|NCT00076999|580451020|FG003|Overall Study|Other reason (not specified)|1|||
160745379|NCT00076999|580451021|FG004|Overall Study|Other reason (not specified)|13|||
160745380|NCT00803205|580451022|FG000|Overall Study|Adverse Event|7|||
160745381|NCT00803205|580451023|FG001|Overall Study|Adverse Event|2|||
160745382|NCT00803205|580451022|FG000|Overall Study|Lost to Follow-up|1|||
160745383|NCT00803205|580451023|FG001|Overall Study|Lost to Follow-up|0|||
160745384|NCT00803205|580451022|FG000|Overall Study|Withdrawal by Subject|9|||
160745385|NCT00803205|580451023|FG001|Overall Study|Withdrawal by Subject|9|||
160745386|NCT00803205|580451022|FG000|Overall Study|Physician Decision|1|||
160745387|NCT00803205|580451023|FG001|Overall Study|Physician Decision|0|||
160745388|NCT00803205|580451022|FG000|Overall Study|Protocol Violation|1|||
160745389|NCT00803205|580451023|FG001|Overall Study|Protocol Violation|1|||
160745390|NCT00803205|580451022|FG000|Overall Study|Medical Monitor Decision|1|||
160745391|NCT00803205|580451023|FG001|Overall Study|Medical Monitor Decision|0|||
160745392|NCT00803205|580451022|FG000|Overall Study|Acquired a Lung Infection|0|||
160745393|NCT00803205|580451023|FG001|Overall Study|Acquired a Lung Infection|1|||
160745394|NCT00803205|580451022|FG000|Overall Study|Sponsor Decision|0|||
160745395|NCT00803205|580451023|FG001|Overall Study|Sponsor Decision|1|||
160745396|NCT02735096|580451027|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
160745397|NCT00672841|580451031|FG000|Overall Study|Comfort care|1|||
160745398|NCT00672841|580451032|FG001|Overall Study|Comfort care|4|||
160745399|NCT00672841|580451031|FG000|Overall Study|icteric specimens|0|||
160745400|NCT00672841|580451032|FG001|Overall Study|icteric specimens|3|||
160745401|NCT00672841|580451031|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
160745402|NCT00672841|580451032|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
160745403|NCT00672841|580451031|FG000|Overall Study|Adverse Event|0|||
160745404|NCT00672841|580451032|FG001|Overall Study|Adverse Event|3|||
160745405|NCT00672841|580451031|FG000|Overall Study|Pregnancy|0|||
160745406|NCT00672841|580451032|FG001|Overall Study|Pregnancy|1|||
160745407|NCT02083653|580451033|FG000|Overall Study|Randomized but not Treated|0|||
160745408|NCT02083653|580451034|FG001|Overall Study|Randomized but not Treated|2|||
160745409|NCT02083653|580451035|FG002|Overall Study|Randomized but not Treated|7|||
160745410|NCT02083653|580451033|FG000|Overall Study|Adverse Event|12|||
160745411|NCT02083653|580451034|FG001|Overall Study|Adverse Event|5|||
160745412|NCT02083653|580451035|FG002|Overall Study|Adverse Event|4|||
160745413|NCT02083653|580451033|FG000|Overall Study|Lost to Follow-up|1|||
160745414|NCT02083653|580451034|FG001|Overall Study|Lost to Follow-up|0|||
160745415|NCT02083653|580451035|FG002|Overall Study|Lost to Follow-up|0|||
160745416|NCT02083653|580451033|FG000|Overall Study|Death|2|||
160745417|NCT02083653|580451034|FG001|Overall Study|Death|2|||
160745418|NCT02083653|580451035|FG002|Overall Study|Death|2|||
160745419|NCT02083653|580451033|FG000|Overall Study|Progressive Disease|65|||
160745420|NCT02083653|580451034|FG001|Overall Study|Progressive Disease|73|||
160745421|NCT02083653|580451035|FG002|Overall Study|Progressive Disease|63|||
160745422|NCT02083653|580451033|FG000|Overall Study|Withdrawal by Subject|2|||
160745423|NCT02083653|580451034|FG001|Overall Study|Withdrawal by Subject|1|||
160745424|NCT02083653|580451035|FG002|Overall Study|Withdrawal by Subject|2|||
160745425|NCT02083653|580451033|FG000|Overall Study|Other Events|0|||
160745426|NCT02083653|580451034|FG001|Overall Study|Other Events|2|||
160745427|NCT02083653|580451035|FG002|Overall Study|Other Events|2|||
160745428|NCT02083653|580451033|FG000|Overall Study|Reason Missing|0|||
160745429|NCT02083653|580451034|FG001|Overall Study|Reason Missing|0|||
160745430|NCT02083653|580451035|FG002|Overall Study|Reason Missing|4|||
160745431|NCT02073656|580451036|FG000|Primary Study|Lost to Follow-up|6|||
160745432|NCT02073656|580451036|FG000|Primary Study|Death|1|||
160745433|NCT02073656|580451036|FG000|Primary Study|Withdrew Consent|1|||
160745434|NCT02536781|580451037|FG000|Overall Study|Lost to Follow-up|2|||
160745435|NCT02536781|580451038|FG001|Overall Study|Lost to Follow-up|0|||
160745436|NCT03423147|580451039|FG000|Overall Study|Lost to Follow-up|5|||
160745437|NCT03423147|580451040|FG001|Overall Study|Lost to Follow-up|8|||
160745438|NCT03423147|580451039|FG000|Overall Study|Withdrawal by Subject|1|||
160745439|NCT03423147|580451040|FG001|Overall Study|Withdrawal by Subject|0|||
160745440|NCT03423147|580451039|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
160745441|NCT03423147|580451040|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
160745442|NCT03423147|580451039|FG000|Overall Study|Age < 18|1|||
160745443|NCT03423147|580451040|FG001|Overall Study|Age < 18|0|||
160745444|NCT03423147|580451039|FG000|Overall Study|No Trial of Labor|0|||
160745445|NCT03423147|580451040|FG001|Overall Study|No Trial of Labor|1|||
160745446|NCT02450552|580451042|FG000|Overall Study|Withdrawal by Subject|4|||
160745447|NCT02450552|580451043|FG001|Overall Study|Withdrawal by Subject|0|||
160745448|NCT02450552|580451044|FG002|Overall Study|Withdrawal by Subject|4|||
160745449|NCT02450552|580451042|FG000|Overall Study|Physician Decision|1|||
160745450|NCT02450552|580451043|FG001|Overall Study|Physician Decision|0|||
160745451|NCT02450552|580451044|FG002|Overall Study|Physician Decision|1|||
160745452|NCT02054910|580451049|FG000|Overall Study|Lost to Follow-up|4|||
160745453|NCT02054910|580451050|FG001|Overall Study|Lost to Follow-up|1|||
160745454|NCT01625689|580451051|FG000|Overall Study|Migration|2|||
160745455|NCT01625689|580451052|FG001|Overall Study|Migration|1|||
160745456|NCT03723070|580451057|FG000|Overall Study|Lost to Follow-up|2|||
160745457|NCT03723070|580451057|FG000|Overall Study|Physician Decision|1|||
160745458|NCT03723070|580451057|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
160745459|NCT05153148|580451058|FG000|Overall Study|Adverse Event|1|||
160745460|NCT05153148|580451059|FG001|Overall Study|Adverse Event|0|||
160745461|NCT05153148|580451060|FG002|Overall Study|Adverse Event|3|||
160745462|NCT05153148|580451061|FG003|Overall Study|Adverse Event|5|||
160745463|NCT05153148|580451058|FG000|Overall Study|Lost to Follow-up|1|||
160745464|NCT05153148|580451059|FG001|Overall Study|Lost to Follow-up|1|||
160745465|NCT05153148|580451060|FG002|Overall Study|Lost to Follow-up|2|||
160745466|NCT05153148|580451061|FG003|Overall Study|Lost to Follow-up|0|||
160745467|NCT05153148|580451058|FG000|Overall Study|Withdrawal by Subject|6|||
160745468|NCT05153148|580451059|FG001|Overall Study|Withdrawal by Subject|8|||
160745469|NCT05153148|580451060|FG002|Overall Study|Withdrawal by Subject|6|||
160745470|NCT05153148|580451061|FG003|Overall Study|Withdrawal by Subject|8|||
160745471|NCT05153148|580451058|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
160745472|NCT05153148|580451059|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
160745473|NCT05153148|580451060|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
160745474|NCT05153148|580451061|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
160745475|NCT05153148|580451058|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
160745476|NCT05153148|580451059|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
160745477|NCT05153148|580451060|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
160745478|NCT05153148|580451061|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
160745479|NCT05153148|580451058|FG000|Overall Study|Reason not Specified|1|||
160745480|NCT05153148|580451059|FG001|Overall Study|Reason not Specified|1|||
160745481|NCT05153148|580451060|FG002|Overall Study|Reason not Specified|1|||
160745482|NCT05153148|580451061|FG003|Overall Study|Reason not Specified|1|||
160745483|NCT01732471|580451062|FG000|Overall Study|Withdrawal by Subject|1|||
160745484|NCT00474786|580451063|FG000|Overall Study|Not Meeting Study Criteria|0|||
160745485|NCT00474786|580451064|FG001|Overall Study|Not Meeting Study Criteria|1|||
160745486|NCT00474786|580451063|FG000|Overall Study|Investigator Request|2|||
160745487|NCT00474786|580451064|FG001|Overall Study|Investigator Request|1|||
160745488|NCT00474786|580451063|FG000|Overall Study|Death|189|||
160745489|NCT00474786|580451064|FG001|Overall Study|Death|170|||
160745490|NCT00474786|580451063|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
160745491|NCT00474786|580451064|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
160745492|NCT00474786|580451063|FG000|Overall Study|Lost to Follow-up|4|||
160745493|NCT00474786|580451064|FG001|Overall Study|Lost to Follow-up|7|||
160745494|NCT00474786|580451063|FG000|Overall Study|Protocol Violation|2|||
160745495|NCT00474786|580451064|FG001|Overall Study|Protocol Violation|0|||
160745496|NCT00474786|580451063|FG000|Overall Study|Withdrawal by Subject|15|||
160745497|NCT00474786|580451064|FG001|Overall Study|Withdrawal by Subject|15|||
160745498|NCT00474786|580451063|FG000|Overall Study|Other|5|||
160745499|NCT00474786|580451064|FG001|Overall Study|Other|0|||
160745500|NCT02892513|580451065|FG000|Overall Study|Withdrawal by Subject|0|||
160745501|NCT02892513|580451066|FG001|Overall Study|Withdrawal by Subject|1|||
160745502|NCT00900731|580451067|FG000|Overall Study|Adverse Event|31|||
160745503|NCT00900731|580451068|FG001|Overall Study|Adverse Event|27|||
160745504|NCT00900731|580451067|FG000|Overall Study|Withdrawal by Subject|8|||
160745505|NCT00900731|580451068|FG001|Overall Study|Withdrawal by Subject|7|||
160745506|NCT00900731|580451067|FG000|Overall Study|Protocol Deviation|8|||
160745507|NCT00900731|580451068|FG001|Overall Study|Protocol Deviation|11|||
160745508|NCT00900731|580451067|FG000|Overall Study|Administrative Problems|5|||
160745509|NCT00900731|580451068|FG001|Overall Study|Administrative Problems|4|||
160745510|NCT00900731|580451067|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
160745511|NCT00900731|580451068|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
160745512|NCT00900731|580451067|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
160745513|NCT00900731|580451068|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
160745514|NCT00900731|580451067|FG000|Overall Study|Lost to Follow-up|2|||
160745515|NCT00900731|580451068|FG001|Overall Study|Lost to Follow-up|3|||
160745516|NCT00900731|580451067|FG000|Overall Study|Lack of Efficacy|1|||
160745517|NCT00900731|580451068|FG001|Overall Study|Lack of Efficacy|3|||
160745518|NCT00900731|580451067|FG000|Overall Study|Death|0|||
160745519|NCT00900731|580451068|FG001|Overall Study|Death|2|||
160745520|NCT00131365|580451069|FG000|Overall Study|Withdrawal by Subject|1|||
160745521|NCT00131365|580451069|FG000|Overall Study|Alternative treatment|3|||
160745522|NCT05249127|580451070|FG000|Overall Study|Protocol Violation|13|||
160745523|NCT05249127|580451070|FG000|Overall Study|Physician Decision|4|||
160745524|NCT05249127|580451070|FG000|Overall Study|Withdrawal by Subject|2|||
160745525|NCT05249127|580451070|FG000|Overall Study|Participant Non-compliance|1|||
160745526|NCT01324570|580451071|FG000|Overall Study|Adverse Event|4|||
160745527|NCT01324570|580451072|FG001|Overall Study|Adverse Event|7|||
160745528|NCT01324570|580451071|FG000|Overall Study|Withdrawal by Subject|0|||
160745529|NCT01324570|580451072|FG001|Overall Study|Withdrawal by Subject|3|||
160745530|NCT01324570|580451071|FG000|Overall Study|Lack of Efficacy|0|||
160745531|NCT01324570|580451072|FG001|Overall Study|Lack of Efficacy|1|||
160745532|NCT01324570|580451071|FG000|Overall Study|Confirmed or suspected diversion|0|||
160745533|NCT01324570|580451072|FG001|Overall Study|Confirmed or suspected diversion|1|||
160745534|NCT01324570|580451071|FG000|Overall Study|Administrative|0|||
160745535|NCT01324570|580451072|FG001|Overall Study|Administrative|2|||
160745536|NCT02607306|580451075|FG000|Overall Study|Adverse Event|8|||
160745537|NCT02607306|580451076|FG001|Overall Study|Adverse Event|6|||
160745538|NCT02607306|580451077|FG002|Overall Study|Adverse Event|6|||
160745539|NCT02607306|580451075|FG000|Overall Study|Unclassified|1|||
160633167|NCT01643928|580038006|FG004|Overall Study|Withdrawal by Subject|0|||
160633168|NCT01643928|580038002|FG000|Overall Study|Pregnancy|0|||
160633169|NCT01643928|580038003|FG001|Overall Study|Pregnancy|0|||
160633170|NCT01643928|580038004|FG002|Overall Study|Pregnancy|0|||
160633171|NCT01643928|580038005|FG003|Overall Study|Pregnancy|1|||
160633172|NCT01643928|580038006|FG004|Overall Study|Pregnancy|0|||
160633173|NCT01643928|580038002|FG000|Overall Study|Other|5|||
160633174|NCT01643928|580038003|FG001|Overall Study|Other|1|||
160633175|NCT01643928|580038004|FG002|Overall Study|Other|1|||
160633176|NCT01643928|580038005|FG003|Overall Study|Other|0|||
160633177|NCT01643928|580038006|FG004|Overall Study|Other|0|||
160633178|NCT01643928|580038002|FG000|Overall Study|Adverse Event|2|||
160633179|NCT01643928|580038003|FG001|Overall Study|Adverse Event|1|||
160633180|NCT01643928|580038004|FG002|Overall Study|Adverse Event|0|||
160633181|NCT01643928|580038005|FG003|Overall Study|Adverse Event|1|||
160633182|NCT01643928|580038006|FG004|Overall Study|Adverse Event|2|||
160633183|NCT03359473|580038008|FG000|Overall Study|Adverse Event|0|||
160633184|NCT03359473|580038009|FG001|Overall Study|Adverse Event|2|||
160633185|NCT03359473|580038010|FG002|Overall Study|Adverse Event|5|||
160633186|NCT03359473|580038011|FG003|Overall Study|Adverse Event|3|||
160633187|NCT03359473|580038008|FG000|Overall Study|Lost to Follow-up|0|||
160633188|NCT03359473|580038009|FG001|Overall Study|Lost to Follow-up|1|||
160633189|NCT03359473|580038010|FG002|Overall Study|Lost to Follow-up|0|||
160633190|NCT03359473|580038011|FG003|Overall Study|Lost to Follow-up|0|||
160633191|NCT03359473|580038008|FG000|Overall Study|Physician Decision|0|||
160633192|NCT03359473|580038009|FG001|Overall Study|Physician Decision|1|||
160633193|NCT03359473|580038010|FG002|Overall Study|Physician Decision|0|||
160633194|NCT03359473|580038011|FG003|Overall Study|Physician Decision|1|||
160633195|NCT03359473|580038008|FG000|Overall Study|Withdrawal by Subject|1|||
160633196|NCT03359473|580038009|FG001|Overall Study|Withdrawal by Subject|2|||
160633197|NCT03359473|580038010|FG002|Overall Study|Withdrawal by Subject|1|||
160633198|NCT03359473|580038011|FG003|Overall Study|Withdrawal by Subject|0|||
160633199|NCT03359473|580038008|FG000|Overall Study|Protocol-defined stopping criteria|1|||
160633200|NCT03359473|580038009|FG001|Overall Study|Protocol-defined stopping criteria|0|||
160633201|NCT03359473|580038010|FG002|Overall Study|Protocol-defined stopping criteria|0|||
160633202|NCT03359473|580038011|FG003|Overall Study|Protocol-defined stopping criteria|1|||
160633203|NCT02643394|580038013|FG000|Overall Study|Protocol Violation|4|||
160633204|NCT02643394|580038014|FG001|Overall Study|Protocol Violation|5|||
160633205|NCT00943384|580038015|FG000|Overall Study|Dispositioned prior to treatment|23|||
160633206|NCT00943384|580038015|FG000|Overall Study|Treated off protocol-protocol violation|5|||
160633207|NCT00943384|580038015|FG000|Overall Study|Lost to Follow-up|16|||
160633208|NCT00943384|580038015|FG000|Overall Study|Withdrawal by Subject|5|||
160633209|NCT00096200|580038016|FG000|Overall Study|Adverse Event|0|||
160633210|NCT00096200|580038017|FG001|Overall Study|Adverse Event|4|||
160633211|NCT00096200|580038018|FG002|Overall Study|Adverse Event|0|||
160745540|NCT02607306|580451076|FG001|Overall Study|Unclassified|4|||
160633212|NCT00096200|580038016|FG000|Overall Study|Withdrawal by Subject|1|||
160633213|NCT00096200|580038017|FG001|Overall Study|Withdrawal by Subject|2|||
160633214|NCT00096200|580038018|FG002|Overall Study|Withdrawal by Subject|0|||
160633215|NCT00096200|580038016|FG000|Overall Study|Ineligible pathology|0|||
160633216|NCT00096200|580038017|FG001|Overall Study|Ineligible pathology|1|||
160633217|NCT00096200|580038018|FG002|Overall Study|Ineligible pathology|0|||
160633218|NCT00938015|580038023|FG000|Overall Study|Death|2|||
160633219|NCT00938015|580038023|FG000|Overall Study|Lost to Follow-up|32|||
160633220|NCT00938015|580038023|FG000|Overall Study|Adverse Event|32|||
160633221|NCT00938015|580038023|FG000|Overall Study|Non-responder|52|||
160633222|NCT00938015|580038023|FG000|Overall Study|Reason not related to Etanercept|29|||
160633223|NCT02341482|580038024|FG000|Overall Study|Adverse Event|1|||
160633224|NCT03186794|580038025|FG000|Overall Study|Physician Decision|2|||
160633225|NCT03186794|580038025|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
160633226|NCT00111007|580038029|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
160633227|NCT00111007|580038030|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
160633228|NCT00111007|580038029|FG000|Double-blind (DB) Treatment|Death|5|||
160633229|NCT00111007|580038030|FG001|Double-blind (DB) Treatment|Death|2|||
160633230|NCT00111007|580038029|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
160633231|NCT00111007|580038030|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
160633232|NCT00111007|580038029|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
160633233|NCT00111007|580038030|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
160633234|NCT00111007|580038029|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
160633235|NCT00111007|580038030|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
160633236|NCT00111007|580038029|FG000|Double-blind (DB) Treatment|Relapse|1|||
160633237|NCT00111007|580038030|FG001|Double-blind (DB) Treatment|Relapse|0|||
160633238|NCT00111007|580038029|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
160633239|NCT00111007|580038030|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
160633240|NCT00111007|580038029|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
160633241|NCT00111007|580038030|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
160633242|NCT00111007|580038029|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
160633243|NCT00111007|580038030|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
160633244|NCT00111007|580038029|FG000|Active Follow-up|Adverse Event|1|||
160633245|NCT00111007|580038030|FG001|Active Follow-up|Adverse Event|0|||
160633246|NCT00111007|580038029|FG000|Active Follow-up|Death|2|||
160633247|NCT00111007|580038030|FG001|Active Follow-up|Death|0|||
160633248|NCT00111007|580038029|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
160633249|NCT00111007|580038030|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
160633250|NCT00111007|580038029|FG000|Long Term Follow-up|Death|34|||
160633251|NCT00111007|580038030|FG001|Long Term Follow-up|Death|39|||
160633252|NCT00111007|580038029|FG000|Long Term Follow-up|Lost to Follow-up|1|||
160633253|NCT00111007|580038030|FG001|Long Term Follow-up|Lost to Follow-up|1|||
160633254|NCT00111007|580038029|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
160633255|NCT00111007|580038030|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
160633256|NCT00111007|580038029|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
160633257|NCT00111007|580038030|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
160633258|NCT00111007|580038029|FG000|Long Term Follow-up|Missing|10|||
160633259|NCT00111007|580038030|FG001|Long Term Follow-up|Missing|3|||
160633260|NCT01495793|580038031|FG000|Overall Study|Lost to Follow-up|1|||
160633261|NCT01495793|580038031|FG000|Overall Study|Violation of inclusion criteria|1|||
160633262|NCT03014570|580038032|FG000|Overall Study|COVID-19 Restrictions|38|||
160633263|NCT03014570|580038033|FG001|Overall Study|COVID-19 Restrictions|24|||
160633264|NCT03014570|580038032|FG000|Overall Study|Death|70|||
160633265|NCT03014570|580038033|FG001|Overall Study|Death|79|||
160633266|NCT03014570|580038032|FG000|Overall Study|Transfer from facility|11|||
160633267|NCT03014570|580038033|FG001|Overall Study|Transfer from facility|14|||
160633268|NCT03014570|580038032|FG000|Overall Study|Hospitalized|5|||
160633269|NCT03014570|580038033|FG001|Overall Study|Hospitalized|3|||
160633270|NCT03014570|580038032|FG000|Overall Study|Transfer within facility|1|||
160633271|NCT03014570|580038033|FG001|Overall Study|Transfer within facility|0|||
160633272|NCT03014570|580038032|FG000|Overall Study|Site refusal|0|||
160633273|NCT03014570|580038033|FG001|Overall Study|Site refusal|11|||
160633274|NCT00090259|580038034|FG000|Overall Study|Lost to Follow-up|30|||
160633275|NCT00090259|580038035|FG001|Overall Study|Lost to Follow-up|26|||
160633276|NCT00090259|580038034|FG000|Overall Study|Withdrawal by Subject|21|||
160633277|NCT00090259|580038035|FG001|Overall Study|Withdrawal by Subject|15|||
160633278|NCT00090259|580038034|FG000|Overall Study|Investigator site closed|11|||
160633279|NCT00090259|580038035|FG001|Overall Study|Investigator site closed|7|||
160633280|NCT04797637|580038036|FG000|Overall Study|Lost to Follow-up|23|||
160633281|NCT04797637|580038037|FG001|Overall Study|Lost to Follow-up|32|||
160633282|NCT04797637|580038036|FG000|Overall Study|Withdrawal by Subject|0|||
160745541|NCT02607306|580451077|FG002|Overall Study|Unclassified|0|||
160633283|NCT04797637|580038037|FG001|Overall Study|Withdrawal by Subject|1|||
160633284|NCT03083639|580038038|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
160633285|NCT03083639|580038039|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
160633286|NCT03083639|580038038|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
160633287|NCT03083639|580038039|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
160633288|NCT00960687|580038043|FG000|Washout Period of 7 Days|Adverse Event|3|||
160633289|NCT00960687|580038044|FG001|Washout Period of 7 Days|Adverse Event|2|||
160633290|NCT00960687|580038043|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
160633291|NCT00960687|580038044|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
160633292|NCT03611751|580038048|FG000|Pre-treatment|Randomized but not treated|1|||
160633293|NCT03611751|580038049|FG001|Pre-treatment|Randomized but not treated|1|||
160633294|NCT03611751|580038050|FG002|Pre-treatment|Randomized but not treated|0|||
160633295|NCT03611751|580038048|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
160633296|NCT03611751|580038049|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
160633297|NCT03611751|580038050|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
160633298|NCT03611751|580038048|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
160633299|NCT03611751|580038049|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
160633300|NCT03611751|580038050|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
160633301|NCT03611751|580038048|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
160633302|NCT03611751|580038049|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
160633303|NCT03611751|580038050|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
160633304|NCT03611751|580038048|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
160633305|NCT03611751|580038049|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
160633306|NCT03611751|580038050|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
160633307|NCT03611751|580038048|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
160633308|NCT03611751|580038049|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
160633309|NCT03611751|580038050|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
160633310|NCT03611751|580038048|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
160633311|NCT03611751|580038049|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
160633312|NCT03611751|580038050|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
160633313|NCT03611751|580038048|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
160633314|NCT03611751|580038049|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
160633315|NCT03611751|580038050|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
160633316|NCT03611751|580038048|FG000|Treatment Week 0 - Week 16|Death|0|||
160633317|NCT03611751|580038049|FG001|Treatment Week 0 - Week 16|Death|0|||
160633318|NCT03611751|580038050|FG002|Treatment Week 0 - Week 16|Death|1|||
160633319|NCT03611751|580038048|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
160633320|NCT03611751|580038049|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
160633321|NCT03611751|580038050|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
160633322|NCT03611751|580038048|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
160633323|NCT03611751|580038049|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
160633324|NCT03611751|580038050|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
160633325|NCT03611751|580038048|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
160633326|NCT03611751|580038049|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
160633327|NCT03611751|580038050|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
160633328|NCT03611751|580038048|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
160633329|NCT03611751|580038049|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
160633330|NCT03611751|580038050|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
160633331|NCT03611751|580038048|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
160633332|NCT03611751|580038049|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
160633333|NCT03611751|580038050|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
160633334|NCT03611751|580038048|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
160633335|NCT03611751|580038049|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
160633336|NCT03611751|580038050|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
160633337|NCT03611751|580038048|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
160633338|NCT03611751|580038049|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
160633339|NCT03611751|580038050|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
160633340|NCT03611751|580038048|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
160633341|NCT03611751|580038049|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
160633342|NCT03611751|580038050|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
160633343|NCT03611751|580038048|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
160633344|NCT03611751|580038049|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
160633345|NCT03611751|580038050|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
160633346|NCT03611751|580038048|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
160633347|NCT03611751|580038049|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
160633348|NCT03611751|580038050|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
160633349|NCT03611751|580038048|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
160633350|NCT03611751|580038049|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
160633351|NCT03611751|580038050|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
160633352|NCT03611751|580038048|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
160633353|NCT03611751|580038049|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
160633354|NCT03611751|580038050|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
160633355|NCT03611751|580038048|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
160633356|NCT03611751|580038049|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
160633357|NCT03611751|580038050|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
160633358|NCT03611751|580038048|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
160633359|NCT03611751|580038049|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
160633360|NCT03611751|580038050|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
160633361|NCT02666768|580038053|FG000|Overall Study|Withdrawal by Subject|4|||
160633362|NCT03728257|580038054|FG000|Overall Study|Death|3|||
160633363|NCT03728257|580038055|FG001|Overall Study|Death|0|||
160633364|NCT03940742|580038056|FG000|Overall Study|Lost to Follow-up|0|||
160633365|NCT03940742|580038057|FG001|Overall Study|Lost to Follow-up|0|||
160633366|NCT03940742|580038058|FG002|Overall Study|Lost to Follow-up|0|||
160633367|NCT03940742|580038059|FG003|Overall Study|Lost to Follow-up|1|||
160633368|NCT03428217|580038061|FG000|Overall Study|Death|89|||
160633369|NCT03428217|580038062|FG001|Overall Study|Death|93|||
160633370|NCT03428217|580038061|FG000|Overall Study|Withdrawal by Subject|8|||
160633371|NCT03428217|580038062|FG001|Overall Study|Withdrawal by Subject|7|||
160633372|NCT03428217|580038061|FG000|Overall Study|Lost to Follow-up|1|||
160633373|NCT03428217|580038062|FG001|Overall Study|Lost to Follow-up|3|||
160633374|NCT03428217|580038061|FG000|Overall Study|Study terminated by sponsor|124|||
160633375|NCT03428217|580038062|FG001|Overall Study|Study terminated by sponsor|118|||
160633376|NCT03428217|580038061|FG000|Overall Study|Other, Not Specified|1|||
160633377|NCT03428217|580038062|FG001|Overall Study|Other, Not Specified|0|||
160633378|NCT00621309|580038063|FG000|Overall Study|Withdrawal by Subject|2|||
160633379|NCT00621309|580038064|FG001|Overall Study|Withdrawal by Subject|0|||
160633380|NCT00621309|580038065|FG002|Overall Study|Withdrawal by Subject|1|||
160633381|NCT00621309|580038066|FG003|Overall Study|Withdrawal by Subject|1|||
160633382|NCT00621309|580038067|FG004|Overall Study|Withdrawal by Subject|1|||
160633383|NCT00621309|580038068|FG005|Overall Study|Withdrawal by Subject|1|||
160633384|NCT00905437|580038069|FG000|Overall Study|Adverse Event|3|||
160633385|NCT00905437|580038070|FG001|Overall Study|Adverse Event|2|||
160633386|NCT00905437|580038069|FG000|Overall Study|Lost to Follow-up|0|||
160633387|NCT00905437|580038070|FG001|Overall Study|Lost to Follow-up|1|||
160633388|NCT00905437|580038069|FG000|Overall Study|Withdrawal by Subject|0|||
160633389|NCT00905437|580038070|FG001|Overall Study|Withdrawal by Subject|1|||
160633390|NCT00905437|580038069|FG000|Overall Study|Other|5|||
160633391|NCT00905437|580038070|FG001|Overall Study|Other|6|||
160633392|NCT05246111|580038071|FG000|Period 01|NOT ELIGIBLE IC5|1|||
160633393|NCT05246111|580038072|FG001|Period 01|NOT ELIGIBLE IC5|0|||
160633394|NCT01306968|580038073|FG000|Overall Study|Lost to Follow-up|1|||
160633395|NCT01306968|580038074|FG001|Overall Study|Lost to Follow-up|1|||
160633396|NCT01306968|580038075|FG002|Overall Study|Lost to Follow-up|0|||
160633397|NCT01306968|580038076|FG003|Overall Study|Lost to Follow-up|0|||
160633398|NCT01306968|580038073|FG000|Overall Study|Physician Decision|0|||
160633399|NCT01306968|580038074|FG001|Overall Study|Physician Decision|1|||
160633400|NCT01306968|580038075|FG002|Overall Study|Physician Decision|0|||
160633401|NCT01306968|580038076|FG003|Overall Study|Physician Decision|0|||
160633402|NCT01306968|580038073|FG000|Overall Study|Relocated and left active duty|0|||
160633403|NCT01306968|580038074|FG001|Overall Study|Relocated and left active duty|1|||
160633404|NCT01306968|580038075|FG002|Overall Study|Relocated and left active duty|1|||
160633405|NCT01306968|580038076|FG003|Overall Study|Relocated and left active duty|1|||
160633406|NCT01306968|580038073|FG000|Overall Study|Withdrew - time commitment|0|||
160633407|NCT01306968|580038074|FG001|Overall Study|Withdrew - time commitment|0|||
160633408|NCT01306968|580038075|FG002|Overall Study|Withdrew - time commitment|0|||
160633409|NCT01306968|580038076|FG003|Overall Study|Withdrew - time commitment|2|||
160633410|NCT01306968|580038073|FG000|Overall Study|Withdrew over privacy concerns|0|||
160633411|NCT01306968|580038074|FG001|Overall Study|Withdrew over privacy concerns|0|||
160633412|NCT01306968|580038075|FG002|Overall Study|Withdrew over privacy concerns|0|||
160633413|NCT01306968|580038076|FG003|Overall Study|Withdrew over privacy concerns|1|||
160633414|NCT03252015|580038079|FG000|Overall Study|Withdrawal by Subject|0|||
160633415|NCT03252015|580038080|FG001|Overall Study|Withdrawal by Subject|1|||
160633416|NCT03252015|580038081|FG002|Overall Study|Withdrawal by Subject|1|||
160633417|NCT03252015|580038082|FG003|Overall Study|Withdrawal by Subject|0|||
160633418|NCT03252015|580038079|FG000|Overall Study|Adverse Event|1|||
160633419|NCT03252015|580038080|FG001|Overall Study|Adverse Event|0|||
160633420|NCT03252015|580038081|FG002|Overall Study|Adverse Event|0|||
160633421|NCT03252015|580038082|FG003|Overall Study|Adverse Event|1|||
160633422|NCT01329562|580038083|FG000|Overall Study|Protocol Violation|5|||
160633423|NCT01329562|580038084|FG001|Overall Study|Protocol Violation|3|||
160633424|NCT01329562|580038083|FG000|Overall Study|Lost to Follow-up|1|||
160633425|NCT01329562|580038084|FG001|Overall Study|Lost to Follow-up|1|||
160633426|NCT01329562|580038083|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
160633427|NCT01329562|580038084|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
160633428|NCT01329562|580038083|FG000|Overall Study|Physician Decision|0|||
160633429|NCT01329562|580038084|FG001|Overall Study|Physician Decision|1|||
160633430|NCT00061568|580038085|FG000|Overall Study|Lost to Follow-up|12|||
160633431|NCT00061568|580038086|FG001|Overall Study|Lost to Follow-up|0|||
160633432|NCT00061568|580038085|FG000|Overall Study|Death|6|||
160633433|NCT00061568|580038086|FG001|Overall Study|Death|0|||
160633434|NCT00061568|580038085|FG000|Overall Study|Withdrawal by Subject|1|||
160633435|NCT00061568|580038086|FG001|Overall Study|Withdrawal by Subject|0|||
160633436|NCT01381068|580038087|FG000|Overall Study|Death|1|||
160633437|NCT01381068|580038088|FG001|Overall Study|Death|0|||
160633438|NCT00209560|580038094|FG000|Overall Study|Lack of Efficacy|1|||
160633439|NCT00209560|580038095|FG001|Overall Study|Lack of Efficacy|0|||
160633440|NCT01964898|580039237|FG000|Overall Study|ineligible post-randomization|1|||
160633441|NCT01964898|580039238|FG001|Overall Study|ineligible post-randomization|1|||
160633442|NCT01964898|580039237|FG000|Overall Study|did not receive the allocated interventi|2|||
160633443|NCT01964898|580039238|FG001|Overall Study|did not receive the allocated interventi|1|||
160633444|NCT01964898|580039237|FG000|Overall Study|Lost to Follow-up|3|||
160633445|NCT01964898|580039238|FG001|Overall Study|Lost to Follow-up|5|||
160633446|NCT01964898|580039237|FG000|Overall Study|Withdrawal by Subject|1|||
160633447|NCT01964898|580039238|FG001|Overall Study|Withdrawal by Subject|0|||
160633448|NCT02428231|580039241|FG000|Overall Study|Other|10|||
160633449|NCT02428231|580039242|FG001|Overall Study|Other|16|||
160633450|NCT02428231|580039241|FG000|Overall Study|Required Symptomatic Therapy|0|||
160633451|NCT02428231|580039242|FG001|Overall Study|Required Symptomatic Therapy|1|||
160633452|NCT02428231|580039241|FG000|Overall Study|Adverse Event|3|||
160633453|NCT02428231|580039242|FG001|Overall Study|Adverse Event|0|||
160633454|NCT02957682|580039245|FG000|Overall Study|Adverse Event|64|||
160633455|NCT02957682|580039246|FG001|Overall Study|Adverse Event|67|||
160633456|NCT02957682|580039245|FG000|Overall Study|Poor Compliance to Protocol|30|||
160633457|NCT02957682|580039246|FG001|Overall Study|Poor Compliance to Protocol|26|||
160633458|NCT02957682|580039245|FG000|Overall Study|Physician Decision|4|||
160633459|NCT02957682|580039246|FG001|Overall Study|Physician Decision|4|||
160633460|NCT02957682|580039245|FG000|Overall Study|Study Terminated by Sponsor|4|||
160633461|NCT02957682|580039246|FG001|Overall Study|Study Terminated by Sponsor|3|||
160633462|NCT02957682|580039245|FG000|Overall Study|Subject Moved|10|||
160633463|NCT02957682|580039246|FG001|Overall Study|Subject Moved|16|||
160633464|NCT02957682|580039245|FG000|Overall Study|Withdrawal by Subject|64|||
160633465|NCT02957682|580039246|FG001|Overall Study|Withdrawal by Subject|33|||
160633466|NCT02957682|580039245|FG000|Overall Study|Related to IMP Administration|3|||
160633467|NCT02957682|580039246|FG001|Overall Study|Related to IMP Administration|6|||
160633468|NCT02957682|580039245|FG000|Overall Study|Non-disclosed|16|||
160633469|NCT02957682|580039246|FG001|Overall Study|Non-disclosed|12|||
160633470|NCT02957682|580039245|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
160633471|NCT02957682|580039246|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
160633472|NCT02953262|580039254|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
160633473|NCT02953262|580039255|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
160633474|NCT02953262|580039256|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
160633475|NCT02953262|580039257|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
160633476|NCT00934622|580039258|FG000|Overall Study|Lost to Follow-up|7|||
160633477|NCT00934622|580039258|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
160633478|NCT03284424|580039259|FG000|Overall Study|Death|70|||
160633479|NCT03284424|580039260|FG001|Overall Study|Death|24|||
160633480|NCT03284424|580039259|FG000|Overall Study|Lost to Follow-up|3|||
160633481|NCT03284424|580039260|FG001|Overall Study|Lost to Follow-up|1|||
160633482|NCT03284424|580039259|FG000|Overall Study|Physician Decision|1|||
160633483|NCT03284424|580039260|FG001|Overall Study|Physician Decision|2|||
160633484|NCT03284424|580039259|FG000|Overall Study|Withdrawal by Subject|4|||
160633485|NCT03284424|580039260|FG001|Overall Study|Withdrawal by Subject|5|||
160633486|NCT03284424|580039259|FG000|Overall Study|Sponsor's decision|27|||
160633487|NCT03284424|580039260|FG001|Overall Study|Sponsor's decision|22|||
160633488|NCT00468312|580039261|FG000|Overall Study|Adverse Event|2|||
160633489|NCT00468312|580039262|FG001|Overall Study|Adverse Event|1|||
160633490|NCT00468312|580039261|FG000|Overall Study|Lack of Efficacy|0|||
160633491|NCT00468312|580039262|FG001|Overall Study|Lack of Efficacy|1|||
160633492|NCT00468312|580039261|FG000|Overall Study|Withdrawal by Subject|0|||
160633493|NCT00468312|580039262|FG001|Overall Study|Withdrawal by Subject|1|||
160633494|NCT00468312|580039261|FG000|Overall Study|Protocol Violation|2|||
160633495|NCT00468312|580039262|FG001|Overall Study|Protocol Violation|1|||
160633496|NCT00468312|580039261|FG000|Overall Study|Did not meet protocol eligibility|0|||
160633497|NCT00468312|580039262|FG001|Overall Study|Did not meet protocol eligibility|1|||
160633498|NCT03349437|580039263|FG000|Screening|Screen Fail|4|||
160633499|NCT03349437|580039264|FG001|Screening|Screen Fail|0|||
160633500|NCT03349437|580039265|FG002|Screening|Screen Fail|0|||
160633501|NCT03349437|580039263|FG000|Screening|Withdrawn|1|||
160633502|NCT03349437|580039264|FG001|Screening|Withdrawn|0|||
160633503|NCT03349437|580039265|FG002|Screening|Withdrawn|0|||
160633504|NCT03976076|580039266|FG000|Overall Study|Withdrawal by Subject|2|||
160633505|NCT05226286|580039270|FG000|Overall Study|Screen failures prior to implant|62|||
160633506|NCT05226286|580039270|FG000|Overall Study|Withdrawal by Subject|13|||
160633507|NCT05226286|580039270|FG000|Overall Study|Lost to Follow-up|3|||
160633508|NCT05226286|580039270|FG000|Overall Study|Physician Decision|1|||
160633509|NCT05226286|580039270|FG000|Overall Study|Adverse Event|1|||
160633510|NCT05226286|580039270|FG000|Overall Study|Death|1|||
160633511|NCT05226286|580039270|FG000|Overall Study|Device explant with no planned replacement|1|||
160633512|NCT05226286|580039270|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
160633513|NCT05226286|580039270|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
160633514|NCT02742818|580039271|FG000|Overall Study|Adverse Event|0|||
160633515|NCT02742818|580039272|FG001|Overall Study|Adverse Event|1|||
160633516|NCT02742818|580039271|FG000|Overall Study|Protocol Violation|0|||
160633517|NCT02742818|580039272|FG001|Overall Study|Protocol Violation|1|||
160633518|NCT00457418|580039273|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
160633519|NCT00457418|580039273|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
160633520|NCT00457418|580039273|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
160633521|NCT00457418|580039273|FG000|Post PK Maintenance|Adverse Event|10|||
160633522|NCT00457418|580039273|FG000|Post PK Maintenance|Progression of Disease|6|||
160633523|NCT00457418|580039273|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
160633524|NCT00457418|580039273|FG000|Post PK Maintenance|Lost to Follow-up|1|||
160633525|NCT05302414|580039275|FG000|Pretest to Posttest|Lost to Follow-up|12|||
160633526|NCT05302414|580039276|FG001|Pretest to Posttest|Lost to Follow-up|8|||
160633527|NCT05302414|580039277|FG002|Pretest to Posttest|Lost to Follow-up|8|||
160633528|NCT05302414|580039275|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
160633529|NCT05302414|580039276|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
160633530|NCT05302414|580039277|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
160633531|NCT01346501|580039282|FG000|Overall Study|Initiated Other Biological Agents|3|||
160633532|NCT01346501|580039283|FG001|Overall Study|Initiated Other Biological Agents|1|||
160633533|NCT01346501|580039282|FG000|Overall Study|Other|8|||
160633534|NCT01346501|580039283|FG001|Overall Study|Other|12|||
160633535|NCT03829462|580039284|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
160633536|NCT03829462|580039285|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
160633537|NCT03829462|580039284|FG000|Overall Study|No treatment due to progression disease|0|||
160633538|NCT03829462|580039285|FG001|Overall Study|No treatment due to progression disease|1|||
160633539|NCT00664066|580039289|FG000|Overall Study|Study terminated|3|||
160633540|NCT03332212|580039293|FG000|Overall Study|Not treated|0|||
160633541|NCT03332212|580039294|FG001|Overall Study|Not treated|1|||
160633542|NCT03332212|580039295|FG002|Overall Study|Not treated|0|||
160633543|NCT03332212|580039296|FG003|Overall Study|Not treated|0|||
160633544|NCT03332212|580039293|FG000|Overall Study|Adverse Event|0|||
160633545|NCT03332212|580039294|FG001|Overall Study|Adverse Event|0|||
160633546|NCT03332212|580039295|FG002|Overall Study|Adverse Event|0|||
160633547|NCT03332212|580039296|FG003|Overall Study|Adverse Event|1|||
160633548|NCT03332212|580039293|FG000|Overall Study|worsening of disease under study|1|||
160633549|NCT03332212|580039294|FG001|Overall Study|worsening of disease under study|1|||
160633550|NCT03332212|580039295|FG002|Overall Study|worsening of disease under study|0|||
160633551|NCT03332212|580039296|FG003|Overall Study|worsening of disease under study|0|||
160633552|NCT02362646|580039297|FG000|Overall Study|Death|15|||
160633553|NCT02362646|580039298|FG001|Overall Study|Death|8|||
160633554|NCT02362646|580039297|FG000|Overall Study|Withdrawal by Subject|2|||
160633555|NCT02362646|580039298|FG001|Overall Study|Withdrawal by Subject|2|||
160633556|NCT02362646|580039297|FG000|Overall Study|received transplant|21|||
160633557|NCT02362646|580039298|FG001|Overall Study|received transplant|14|||
160633558|NCT00929864|580039302|FG000|Overall Study|Death|1|||
160633559|NCT00929864|580039303|FG001|Overall Study|Death|1|||
160633560|NCT00929864|580039302|FG000|Overall Study|Adverse Event|11|||
160633561|NCT00929864|580039303|FG001|Overall Study|Adverse Event|30|||
160633562|NCT00929864|580039302|FG000|Overall Study|Lack of Efficacy|19|||
160633563|NCT00929864|580039303|FG001|Overall Study|Lack of Efficacy|16|||
160633564|NCT00929864|580039302|FG000|Overall Study|Lost to Follow-up|7|||
160633565|NCT00929864|580039303|FG001|Overall Study|Lost to Follow-up|12|||
160633566|NCT00929864|580039302|FG000|Overall Study|Withdrawal by Subject|20|||
160633567|NCT00929864|580039303|FG001|Overall Study|Withdrawal by Subject|9|||
160633568|NCT00929864|580039302|FG000|Overall Study|No longer met criteria|2|||
160633569|NCT00929864|580039303|FG001|Overall Study|No longer met criteria|1|||
160633570|NCT00929864|580039302|FG000|Overall Study|Poor or non-compliance|3|||
160633571|NCT00929864|580039303|FG001|Overall Study|Poor or non-compliance|3|||
160633572|NCT00929864|580039302|FG000|Overall Study|Pregnancy|0|||
160633573|NCT00929864|580039303|FG001|Overall Study|Pregnancy|3|||
160633574|NCT00929864|580039302|FG000|Overall Study|Administrative reason by Sponsor|1|||
160633575|NCT00929864|580039303|FG001|Overall Study|Administrative reason by Sponsor|1|||
160633576|NCT00929864|580039302|FG000|Overall Study|Non-specified|2|||
160633577|NCT00929864|580039303|FG001|Overall Study|Non-specified|7|||
160633578|NCT03889197|580039304|FG000|Overall Study|Withdrawal by Subject|1|||
160633579|NCT03889197|580039305|FG001|Overall Study|Withdrawal by Subject|0|||
160633580|NCT03889197|580039304|FG000|Overall Study|Physician Decision|0|||
160633581|NCT03889197|580039305|FG001|Overall Study|Physician Decision|1|||
160633582|NCT03889197|580039304|FG000|Overall Study|met exclusion criteria|0|||
160633583|NCT03889197|580039305|FG001|Overall Study|met exclusion criteria|1|||
160633584|NCT03889197|580039304|FG000|Overall Study|Protocol Violation|1|||
160633585|NCT03889197|580039305|FG001|Overall Study|Protocol Violation|0|||
160633586|NCT02736695|580039308|FG000|Overall Study|Ineligible|6|||
160633587|NCT02736695|580039309|FG001|Overall Study|Ineligible|0|||
160633588|NCT03193190|580039314|FG000|Stage 1|Arm Terminated by Sponsor|0|||
160633589|NCT03193190|580039315|FG001|Stage 1|Arm Terminated by Sponsor|0|||
160633590|NCT03193190|580039316|FG002|Stage 1|Arm Terminated by Sponsor|0|||
160633591|NCT03193190|580039317|FG003|Stage 1|Arm Terminated by Sponsor|1|||
160633592|NCT03193190|580039318|FG004|Stage 1|Arm Terminated by Sponsor|0|||
160633593|NCT03193190|580039319|FG005|Stage 1|Arm Terminated by Sponsor|2|||
160633594|NCT03193190|580039320|FG006|Stage 1|Arm Terminated by Sponsor|0|||
160633595|NCT03193190|580039321|FG007|Stage 1|Arm Terminated by Sponsor|0|||
160633596|NCT03193190|580039322|FG008|Stage 1|Arm Terminated by Sponsor|0|||
160633597|NCT03193190|580039323|FG009|Stage 1|Arm Terminated by Sponsor|0|||
160633598|NCT03193190|580039324|FG010|Stage 1|Arm Terminated by Sponsor|0|||
160633599|NCT03193190|580039325|FG011|Stage 1|Arm Terminated by Sponsor|0|||
160633600|NCT03193190|580039326|FG012|Stage 1|Arm Terminated by Sponsor|0|||
160633601|NCT03193190|580039327|FG013|Stage 1|Arm Terminated by Sponsor|0|||
160633602|NCT03193190|580039328|FG014|Stage 1|Arm Terminated by Sponsor|0|||
160633603|NCT03193190|580039329|FG015|Stage 1|Arm Terminated by Sponsor|0|||
160633604|NCT03193190|580039314|FG000|Stage 1|Death|22|||
160633605|NCT03193190|580039315|FG001|Stage 1|Death|8|||
160633606|NCT03193190|580039316|FG002|Stage 1|Death|23|||
160633607|NCT03193190|580039317|FG003|Stage 1|Death|14|||
160633608|NCT03193190|580039318|FG004|Stage 1|Death|34|||
160633609|NCT03193190|580039319|FG005|Stage 1|Death|28|||
160633610|NCT03193190|580039320|FG006|Stage 1|Death|19|||
160633611|NCT03193190|580039321|FG007|Stage 1|Death|21|||
160633612|NCT03193190|580039322|FG008|Stage 1|Death|14|||
160633613|NCT03193190|580039323|FG009|Stage 1|Death|10|||
160633614|NCT03193190|580039324|FG010|Stage 1|Death|59|||
160633615|NCT03193190|580039325|FG011|Stage 1|Death|14|||
160633616|NCT03193190|580039326|FG012|Stage 1|Death|14|||
160633617|NCT03193190|580039327|FG013|Stage 1|Death|0|||
160633618|NCT03193190|580039328|FG014|Stage 1|Death|0|||
160633619|NCT03193190|580039329|FG015|Stage 1|Death|0|||
160633620|NCT03193190|580039314|FG000|Stage 1|Lost to Follow-up|2|||
160633621|NCT03193190|580039315|FG001|Stage 1|Lost to Follow-up|1|||
160633622|NCT03193190|580039316|FG002|Stage 1|Lost to Follow-up|1|||
160633623|NCT03193190|580039317|FG003|Stage 1|Lost to Follow-up|0|||
160633624|NCT03193190|580039318|FG004|Stage 1|Lost to Follow-up|0|||
160633625|NCT03193190|580039319|FG005|Stage 1|Lost to Follow-up|0|||
160633626|NCT03193190|580039320|FG006|Stage 1|Lost to Follow-up|1|||
160633627|NCT03193190|580039321|FG007|Stage 1|Lost to Follow-up|0|||
160633628|NCT03193190|580039322|FG008|Stage 1|Lost to Follow-up|0|||
160633629|NCT03193190|580039323|FG009|Stage 1|Lost to Follow-up|0|||
160633630|NCT03193190|580039324|FG010|Stage 1|Lost to Follow-up|0|||
160633631|NCT03193190|580039325|FG011|Stage 1|Lost to Follow-up|0|||
160633632|NCT03193190|580039326|FG012|Stage 1|Lost to Follow-up|0|||
160633633|NCT03193190|580039327|FG013|Stage 1|Lost to Follow-up|0|||
160633634|NCT03193190|580039328|FG014|Stage 1|Lost to Follow-up|0|||
160633635|NCT03193190|580039329|FG015|Stage 1|Lost to Follow-up|0|||
160633636|NCT03193190|580039314|FG000|Stage 1|Reason not Specified|1|||
160633637|NCT03193190|580039315|FG001|Stage 1|Reason not Specified|0|||
160633638|NCT03193190|580039316|FG002|Stage 1|Reason not Specified|0|||
160633639|NCT03193190|580039317|FG003|Stage 1|Reason not Specified|1|||
160633640|NCT03193190|580039318|FG004|Stage 1|Reason not Specified|0|||
160633641|NCT03193190|580039319|FG005|Stage 1|Reason not Specified|1|||
160633642|NCT03193190|580039320|FG006|Stage 1|Reason not Specified|2|||
160633643|NCT03193190|580039321|FG007|Stage 1|Reason not Specified|2|||
160633644|NCT03193190|580039322|FG008|Stage 1|Reason not Specified|0|||
160633645|NCT03193190|580039323|FG009|Stage 1|Reason not Specified|1|||
160633646|NCT03193190|580039324|FG010|Stage 1|Reason not Specified|3|||
160633647|NCT03193190|580039325|FG011|Stage 1|Reason not Specified|0|||
160633648|NCT03193190|580039326|FG012|Stage 1|Reason not Specified|1|||
160633649|NCT03193190|580039327|FG013|Stage 1|Reason not Specified|0|||
160633650|NCT03193190|580039328|FG014|Stage 1|Reason not Specified|0|||
160633651|NCT03193190|580039329|FG015|Stage 1|Reason not Specified|0|||
160633652|NCT03193190|580039314|FG000|Stage 1|Physician Decision|0|||
160633653|NCT03193190|580039315|FG001|Stage 1|Physician Decision|0|||
160633654|NCT03193190|580039316|FG002|Stage 1|Physician Decision|0|||
160633655|NCT03193190|580039317|FG003|Stage 1|Physician Decision|0|||
160633656|NCT03193190|580039318|FG004|Stage 1|Physician Decision|0|||
160633657|NCT03193190|580039319|FG005|Stage 1|Physician Decision|0|||
160633658|NCT03193190|580039320|FG006|Stage 1|Physician Decision|0|||
160633659|NCT03193190|580039321|FG007|Stage 1|Physician Decision|0|||
160633660|NCT03193190|580039322|FG008|Stage 1|Physician Decision|0|||
160633661|NCT03193190|580039323|FG009|Stage 1|Physician Decision|0|||
160633662|NCT03193190|580039324|FG010|Stage 1|Physician Decision|0|||
160633663|NCT03193190|580039325|FG011|Stage 1|Physician Decision|1|||
160633664|NCT03193190|580039326|FG012|Stage 1|Physician Decision|0|||
160633665|NCT03193190|580039327|FG013|Stage 1|Physician Decision|0|||
160633666|NCT03193190|580039328|FG014|Stage 1|Physician Decision|0|||
160633667|NCT03193190|580039329|FG015|Stage 1|Physician Decision|0|||
160633668|NCT03193190|580039314|FG000|Stage 1|Progressive Disease|1|||
160633669|NCT03193190|580039315|FG001|Stage 1|Progressive Disease|0|||
160633670|NCT03193190|580039316|FG002|Stage 1|Progressive Disease|0|||
160633671|NCT03193190|580039317|FG003|Stage 1|Progressive Disease|0|||
160633672|NCT03193190|580039318|FG004|Stage 1|Progressive Disease|0|||
160633673|NCT03193190|580039319|FG005|Stage 1|Progressive Disease|0|||
160633674|NCT03193190|580039320|FG006|Stage 1|Progressive Disease|0|||
160633675|NCT03193190|580039321|FG007|Stage 1|Progressive Disease|0|||
160633676|NCT03193190|580039322|FG008|Stage 1|Progressive Disease|0|||
160633677|NCT03193190|580039323|FG009|Stage 1|Progressive Disease|0|||
160633678|NCT03193190|580039324|FG010|Stage 1|Progressive Disease|0|||
160633679|NCT03193190|580039325|FG011|Stage 1|Progressive Disease|0|||
160633680|NCT03193190|580039326|FG012|Stage 1|Progressive Disease|0|||
160633681|NCT03193190|580039327|FG013|Stage 1|Progressive Disease|0|||
160633682|NCT03193190|580039328|FG014|Stage 1|Progressive Disease|0|||
160633683|NCT03193190|580039329|FG015|Stage 1|Progressive Disease|0|||
160633684|NCT03193190|580039314|FG000|Stage 1|Study Terminated By Sponsor|3|||
160633685|NCT03193190|580039315|FG001|Stage 1|Study Terminated By Sponsor|0|||
160633686|NCT03193190|580039316|FG002|Stage 1|Study Terminated By Sponsor|0|||
160633687|NCT03193190|580039317|FG003|Stage 1|Study Terminated By Sponsor|0|||
160633688|NCT03193190|580039318|FG004|Stage 1|Study Terminated By Sponsor|6|||
160633689|NCT03193190|580039319|FG005|Stage 1|Study Terminated By Sponsor|0|||
160633690|NCT03193190|580039320|FG006|Stage 1|Study Terminated By Sponsor|0|||
160633691|NCT03193190|580039321|FG007|Stage 1|Study Terminated By Sponsor|0|||
160633692|NCT03193190|580039322|FG008|Stage 1|Study Terminated By Sponsor|0|||
160633693|NCT03193190|580039323|FG009|Stage 1|Study Terminated By Sponsor|0|||
160633694|NCT03193190|580039324|FG010|Stage 1|Study Terminated By Sponsor|0|||
160633695|NCT03193190|580039325|FG011|Stage 1|Study Terminated By Sponsor|0|||
160633696|NCT03193190|580039326|FG012|Stage 1|Study Terminated By Sponsor|0|||
160633697|NCT03193190|580039327|FG013|Stage 1|Study Terminated By Sponsor|0|||
160633698|NCT03193190|580039328|FG014|Stage 1|Study Terminated By Sponsor|0|||
160633699|NCT03193190|580039329|FG015|Stage 1|Study Terminated By Sponsor|0|||
160633700|NCT03193190|580039314|FG000|Stage 1|Withdrawal by Subject|6|||
160633701|NCT03193190|580039315|FG001|Stage 1|Withdrawal by Subject|0|||
160633702|NCT03193190|580039316|FG002|Stage 1|Withdrawal by Subject|1|||
160633703|NCT03193190|580039317|FG003|Stage 1|Withdrawal by Subject|0|||
160633704|NCT03193190|580039318|FG004|Stage 1|Withdrawal by Subject|2|||
160633705|NCT03193190|580039319|FG005|Stage 1|Withdrawal by Subject|0|||
160633706|NCT03193190|580039320|FG006|Stage 1|Withdrawal by Subject|3|||
160633707|NCT03193190|580039321|FG007|Stage 1|Withdrawal by Subject|2|||
160633708|NCT03193190|580039322|FG008|Stage 1|Withdrawal by Subject|2|||
160633709|NCT03193190|580039323|FG009|Stage 1|Withdrawal by Subject|4|||
160633710|NCT03193190|580039324|FG010|Stage 1|Withdrawal by Subject|9|||
160633711|NCT03193190|580039325|FG011|Stage 1|Withdrawal by Subject|1|||
160633712|NCT03193190|580039326|FG012|Stage 1|Withdrawal by Subject|0|||
160633713|NCT03193190|580039327|FG013|Stage 1|Withdrawal by Subject|0|||
160633714|NCT03193190|580039328|FG014|Stage 1|Withdrawal by Subject|0|||
160633715|NCT03193190|580039329|FG015|Stage 1|Withdrawal by Subject|0|||
160633716|NCT03193190|580039314|FG000|Stage 2|Death|0|||
160633717|NCT03193190|580039315|FG001|Stage 2|Death|0|||
160633718|NCT03193190|580039316|FG002|Stage 2|Death|0|||
160633719|NCT03193190|580039317|FG003|Stage 2|Death|0|||
160633720|NCT03193190|580039318|FG004|Stage 2|Death|0|||
160633721|NCT03193190|580039319|FG005|Stage 2|Death|0|||
160633722|NCT03193190|580039320|FG006|Stage 2|Death|0|||
160633723|NCT03193190|580039321|FG007|Stage 2|Death|0|||
160633724|NCT03193190|580039322|FG008|Stage 2|Death|0|||
160633725|NCT03193190|580039323|FG009|Stage 2|Death|0|||
160633726|NCT03193190|580039324|FG010|Stage 2|Death|0|||
160633727|NCT03193190|580039325|FG011|Stage 2|Death|0|||
160633728|NCT03193190|580039326|FG012|Stage 2|Death|0|||
160633729|NCT03193190|580039327|FG013|Stage 2|Death|14|||
160633730|NCT03193190|580039328|FG014|Stage 2|Death|4|||
160633731|NCT03193190|580039329|FG015|Stage 2|Death|1|||
160633732|NCT03193190|580039314|FG000|Stage 2|Lost to Follow-up|0|||
160633733|NCT03193190|580039315|FG001|Stage 2|Lost to Follow-up|0|||
160633734|NCT03193190|580039316|FG002|Stage 2|Lost to Follow-up|0|||
160633735|NCT03193190|580039317|FG003|Stage 2|Lost to Follow-up|0|||
160633736|NCT03193190|580039318|FG004|Stage 2|Lost to Follow-up|0|||
160633737|NCT03193190|580039319|FG005|Stage 2|Lost to Follow-up|0|||
160633738|NCT03193190|580039320|FG006|Stage 2|Lost to Follow-up|0|||
160633739|NCT03193190|580039321|FG007|Stage 2|Lost to Follow-up|0|||
160633740|NCT03193190|580039322|FG008|Stage 2|Lost to Follow-up|0|||
160633741|NCT03193190|580039323|FG009|Stage 2|Lost to Follow-up|0|||
160633742|NCT03193190|580039324|FG010|Stage 2|Lost to Follow-up|0|||
160633743|NCT03193190|580039325|FG011|Stage 2|Lost to Follow-up|0|||
160633744|NCT03193190|580039326|FG012|Stage 2|Lost to Follow-up|0|||
160633745|NCT03193190|580039327|FG013|Stage 2|Lost to Follow-up|0|||
160633746|NCT03193190|580039328|FG014|Stage 2|Lost to Follow-up|1|||
160633747|NCT03193190|580039329|FG015|Stage 2|Lost to Follow-up|0|||
160633748|NCT03193190|580039314|FG000|Stage 2|Withdrawal by Subject|0|||
160633749|NCT03193190|580039315|FG001|Stage 2|Withdrawal by Subject|0|||
160633750|NCT03193190|580039316|FG002|Stage 2|Withdrawal by Subject|0|||
160633751|NCT03193190|580039317|FG003|Stage 2|Withdrawal by Subject|0|||
160633752|NCT03193190|580039318|FG004|Stage 2|Withdrawal by Subject|0|||
160633753|NCT03193190|580039319|FG005|Stage 2|Withdrawal by Subject|0|||
160633754|NCT03193190|580039320|FG006|Stage 2|Withdrawal by Subject|0|||
160633755|NCT03193190|580039321|FG007|Stage 2|Withdrawal by Subject|0|||
160633756|NCT03193190|580039322|FG008|Stage 2|Withdrawal by Subject|0|||
160633757|NCT03193190|580039323|FG009|Stage 2|Withdrawal by Subject|0|||
160633758|NCT03193190|580039324|FG010|Stage 2|Withdrawal by Subject|0|||
160633759|NCT03193190|580039325|FG011|Stage 2|Withdrawal by Subject|0|||
160633760|NCT03193190|580039326|FG012|Stage 2|Withdrawal by Subject|0|||
160633761|NCT03193190|580039327|FG013|Stage 2|Withdrawal by Subject|1|||
160633762|NCT03193190|580039328|FG014|Stage 2|Withdrawal by Subject|1|||
160633763|NCT03193190|580039329|FG015|Stage 2|Withdrawal by Subject|0|||
160633764|NCT01907516|580039330|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
160633765|NCT01907516|580039331|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
160633766|NCT01907516|580039330|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
160633767|NCT01907516|580039331|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
160633768|NCT01907516|580039330|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
160633769|NCT01907516|580039331|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
160633770|NCT01907516|580039330|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
160633771|NCT01907516|580039331|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
160633772|NCT00975000|580039334|FG000|Overall Study|Other|1|||
160633773|NCT00975000|580039335|FG001|Overall Study|Other|0|||
160633774|NCT00975000|580039334|FG000|Overall Study|Adverse Event|1|||
160633775|NCT00975000|580039335|FG001|Overall Study|Adverse Event|1|||
160633776|NCT00975000|580039334|FG000|Overall Study|Withdrawal by Subject|2|||
160633777|NCT00975000|580039335|FG001|Overall Study|Withdrawal by Subject|2|||
160633778|NCT00975000|580039334|FG000|Overall Study|Lost to Follow-up|0|||
160633779|NCT00975000|580039335|FG001|Overall Study|Lost to Follow-up|1|||
160633780|NCT00975000|580039334|FG000|Overall Study|Protocol-specified Criteria|1|||
160633781|NCT00975000|580039335|FG001|Overall Study|Protocol-specified Criteria|0|||
160633782|NCT00975000|580039334|FG000|Overall Study|Non-compliance|0|||
160633783|NCT00975000|580039335|FG001|Overall Study|Non-compliance|1|||
160633784|NCT02392377|580039336|FG000|Overall Study|Withdrawal by Subject|0|||
160633785|NCT02392377|580039337|FG001|Overall Study|Withdrawal by Subject|1|||
160633786|NCT01126359|580039338|FG000|First Intervention (20-minutes)|Physician Decision|0|||
160633787|NCT01126359|580039339|FG001|First Intervention (20-minutes)|Physician Decision|1|||
160633788|NCT00902486|580039340|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
160633789|NCT00902486|580039341|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
160633790|NCT00902486|580039342|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
160633791|NCT00902486|580039343|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
160633792|NCT00902486|580039344|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
160633793|NCT00902486|580039345|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
160633794|NCT00902486|580039340|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
160633795|NCT00902486|580039341|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
160633796|NCT00902486|580039342|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
160633797|NCT00902486|580039343|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
160633798|NCT00902486|580039344|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
160633799|NCT00902486|580039345|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
160633800|NCT00902486|580039340|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
160633801|NCT00902486|580039341|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
160633802|NCT00902486|580039342|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
160633803|NCT00902486|580039343|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
160633804|NCT00902486|580039344|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
160633805|NCT00902486|580039345|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
160633806|NCT00902486|580039340|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
160633807|NCT00902486|580039341|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
160633808|NCT00902486|580039342|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
160633809|NCT00902486|580039343|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
160633810|NCT00902486|580039344|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
160633811|NCT00902486|580039345|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
160633812|NCT00902486|580039340|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
160633813|NCT00902486|580039341|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
160633814|NCT00902486|580039342|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
160633815|NCT00902486|580039343|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
160633816|NCT00902486|580039344|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
160633817|NCT00902486|580039345|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
160633818|NCT00902486|580039340|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
160633819|NCT00902486|580039341|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
160633820|NCT00902486|580039342|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
160633821|NCT00902486|580039343|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
160633822|NCT00902486|580039344|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
160633823|NCT00902486|580039345|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
160633824|NCT00902486|580039340|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
160633825|NCT00902486|580039341|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
160633826|NCT00902486|580039342|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
160633827|NCT00902486|580039343|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
160633828|NCT00902486|580039344|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
160633829|NCT00902486|580039345|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
160633830|NCT00902486|580039340|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
160633831|NCT00902486|580039341|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
160633832|NCT00902486|580039342|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
160633833|NCT00902486|580039343|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
160633834|NCT00902486|580039344|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
160633835|NCT00902486|580039345|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
160633836|NCT00902486|580039340|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
160633837|NCT00902486|580039341|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
160633838|NCT00902486|580039342|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
160633839|NCT00902486|580039343|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
160633840|NCT00902486|580039344|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
160633841|NCT00902486|580039345|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
160633842|NCT00902486|580039340|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
160633843|NCT00902486|580039341|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
160633844|NCT00902486|580039342|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
160633845|NCT00902486|580039343|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
160633846|NCT00902486|580039344|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
160633847|NCT00902486|580039345|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
160633848|NCT00902486|580039340|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
160633849|NCT00902486|580039341|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
160633850|NCT00902486|580039342|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
160633851|NCT00902486|580039343|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
160633852|NCT00902486|580039344|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
160633853|NCT00902486|580039345|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
160633854|NCT04439110|580039346|FG000|Overall Study|Ineligible|2|||
160633855|NCT04439110|580039346|FG000|Overall Study|Adverse Event|4|||
160633856|NCT04439110|580039346|FG000|Overall Study|Death|2|||
160633857|NCT04439110|580039346|FG000|Overall Study|Disease proression|25|||
160633858|NCT04439110|580039346|FG000|Overall Study|Withdrawal by Subject|1|||
160633859|NCT04439110|580039346|FG000|Overall Study|Alternative therapy|1|||
160633860|NCT04439110|580039346|FG000|Overall Study|Other complicating disease|1|||
160633861|NCT04439110|580039346|FG000|Overall Study|Personal reasons|1|||
160633862|NCT04439110|580039346|FG000|Overall Study|Still on treatment|1|||
160633863|NCT01298661|580039347|FG000|Overall Study|Withdrawal by Subject|2|||
160633864|NCT01298661|580039348|FG001|Overall Study|Withdrawal by Subject|0|||
160633865|NCT01298661|580039349|FG002|Overall Study|Withdrawal by Subject|2|||
160633866|NCT00526227|580039352|FG000|Overall Study|Device not implanted|1|||
160633867|NCT00526227|580039352|FG000|Overall Study|Death|1|||
160633868|NCT05257109|580039353|FG000|Overall Study|Withdrawal by Subject|1|||
160633869|NCT05257109|580039354|FG001|Overall Study|Withdrawal by Subject|0|||
160633870|NCT05257109|580039355|FG002|Overall Study|Withdrawal by Subject|0|||
160633871|NCT05257109|580039356|FG003|Overall Study|Withdrawal by Subject|0|||
160633872|NCT00858234|580040918|FG000|Overall Study|Adverse Event|6|||
160633873|NCT00858234|580040918|FG000|Overall Study|Progressive disease|2|||
160633874|NCT00858234|580040918|FG000|Overall Study|Status unknown|1|||
160633875|NCT01678924|580040919|FG000|Overall Study|Adverse Event|1|||
160633876|NCT01678924|580040920|FG001|Overall Study|Adverse Event|1|||
160633877|NCT01678924|580040921|FG002|Overall Study|Adverse Event|0|||
160633878|NCT01678924|580040922|FG003|Overall Study|Adverse Event|1|||
160633879|NCT01678924|580040919|FG000|Overall Study|Lack of Efficacy|7|||
160633880|NCT01678924|580040920|FG001|Overall Study|Lack of Efficacy|2|||
160633881|NCT01678924|580040921|FG002|Overall Study|Lack of Efficacy|0|||
160633882|NCT01678924|580040922|FG003|Overall Study|Lack of Efficacy|5|||
160633883|NCT01678924|580040919|FG000|Overall Study|Lost to Follow-up|0|||
160633884|NCT01678924|580040920|FG001|Overall Study|Lost to Follow-up|4|||
160633885|NCT01678924|580040921|FG002|Overall Study|Lost to Follow-up|0|||
160633886|NCT01678924|580040922|FG003|Overall Study|Lost to Follow-up|2|||
160633887|NCT01678924|580040919|FG000|Overall Study|Personal Reasons|2|||
160633888|NCT01678924|580040920|FG001|Overall Study|Personal Reasons|2|||
160633889|NCT01678924|580040921|FG002|Overall Study|Personal Reasons|2|||
160633890|NCT01678924|580040922|FG003|Overall Study|Personal Reasons|7|||
160633891|NCT01678924|580040919|FG000|Overall Study|Withdrawal by Subject|0|||
160633892|NCT01678924|580040920|FG001|Overall Study|Withdrawal by Subject|3|||
160633893|NCT01678924|580040921|FG002|Overall Study|Withdrawal by Subject|0|||
160633894|NCT01678924|580040922|FG003|Overall Study|Withdrawal by Subject|2|||
160633895|NCT01678924|580040919|FG000|Overall Study|Unable to attend scheduled visits|0|||
160633896|NCT01678924|580040920|FG001|Overall Study|Unable to attend scheduled visits|0|||
160633897|NCT01678924|580040921|FG002|Overall Study|Unable to attend scheduled visits|0|||
160633898|NCT01678924|580040922|FG003|Overall Study|Unable to attend scheduled visits|1|||
160633899|NCT02253654|580040923|FG000|Overall Study|Withdrawal by Subject|12|||
160633900|NCT02253654|580040924|FG001|Overall Study|Withdrawal by Subject|4|||
160633901|NCT02253654|580040923|FG000|Overall Study|Decision by Sponsor|1|||
160633902|NCT02253654|580040924|FG001|Overall Study|Decision by Sponsor|1|||
160633903|NCT02253654|580040923|FG000|Overall Study|Lost to Follow-up|2|||
160633904|NCT02253654|580040924|FG001|Overall Study|Lost to Follow-up|5|||
160633905|NCT02253654|580040923|FG000|Overall Study|Death|4|||
160633906|NCT02253654|580040924|FG001|Overall Study|Death|7|||
160633907|NCT02253654|580040923|FG000|Overall Study|Did Not Receive Study Treatment|4|||
160633908|NCT02253654|580040924|FG001|Overall Study|Did Not Receive Study Treatment|1|||
160633909|NCT01614925|580040925|FG000|Overall Study|Withdrawal by Subject|1|||
160633910|NCT01614925|580040926|FG001|Overall Study|Withdrawal by Subject|0|||
160633911|NCT01614925|580040925|FG000|Overall Study|Protocol Violation|3|||
160633912|NCT01614925|580040926|FG001|Overall Study|Protocol Violation|2|||
160633913|NCT01652573|580040930|FG000|Overall Study|Adverse Event|0|||
160633914|NCT01652573|580040931|FG001|Overall Study|Adverse Event|1|||
160633915|NCT01052038|580040934|FG000|Overall Study|Lost to Follow-up|2|||
160633916|NCT01052038|580040935|FG001|Overall Study|Lost to Follow-up|3|||
160633917|NCT01052038|580040936|FG002|Overall Study|Lost to Follow-up|1|||
160633918|NCT01052038|580040934|FG000|Overall Study|Protocol Violation|2|||
160633919|NCT01052038|580040935|FG001|Overall Study|Protocol Violation|3|||
160633920|NCT01052038|580040936|FG002|Overall Study|Protocol Violation|3|||
160633921|NCT03343054|580040937|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
160633922|NCT03343054|580040938|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
160633923|NCT03343054|580040939|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
160633924|NCT03343054|580040937|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
160633925|NCT03343054|580040938|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
160633926|NCT03343054|580040939|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
160633927|NCT03343054|580040937|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
160633928|NCT03343054|580040938|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
160633929|NCT03343054|580040939|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
160633930|NCT03343054|580040937|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
160633931|NCT03343054|580040938|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
160633932|NCT03343054|580040939|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
160633933|NCT00981409|580040944|FG000|Overall Study|Adverse Event|4|||
160633934|NCT00981409|580040945|FG001|Overall Study|Adverse Event|0|||
160633935|NCT00981409|580040944|FG000|Overall Study|Protocol Violation|0|||
160633936|NCT00981409|580040945|FG001|Overall Study|Protocol Violation|1|||
160633937|NCT00981409|580040944|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
160633938|NCT00981409|580040945|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
160633939|NCT00450177|580040946|FG000|Overall Study|Adverse Event|7|||
160633940|NCT00450177|580040947|FG001|Overall Study|Adverse Event|4|||
160633941|NCT00450177|580040946|FG000|Overall Study|Withdrawal by Subject|1|||
160633942|NCT00450177|580040947|FG001|Overall Study|Withdrawal by Subject|6|||
160633943|NCT00450177|580040946|FG000|Overall Study|Withdrawal by Primary Team|1|||
160633944|NCT00450177|580040947|FG001|Overall Study|Withdrawal by Primary Team|1|||
160633945|NCT03869684|580040950|FG000|Overall Study|Adverse Event|0|||
160633946|NCT03869684|580040951|FG001|Overall Study|Adverse Event|3|||
160633947|NCT03869684|580040952|FG002|Overall Study|Adverse Event|1|||
160633948|NCT03869684|580040950|FG000|Overall Study|Withdrawal by Subject|1|||
160633949|NCT03869684|580040951|FG001|Overall Study|Withdrawal by Subject|0|||
160633950|NCT03869684|580040952|FG002|Overall Study|Withdrawal by Subject|0|||
160633951|NCT03869684|580040950|FG000|Overall Study|Lost to Follow-up|1|||
160633952|NCT03869684|580040951|FG001|Overall Study|Lost to Follow-up|0|||
160633953|NCT03869684|580040952|FG002|Overall Study|Lost to Follow-up|0|||
160633954|NCT03869684|580040950|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
160633955|NCT03869684|580040951|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
160633956|NCT03869684|580040952|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
160633957|NCT05723835|580040957|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
160633958|NCT05723835|580040958|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
160633959|NCT05723835|580040959|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
160633960|NCT05723835|580040960|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
160633961|NCT05723835|580040961|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
160633962|NCT05723835|580040962|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
160633963|NCT05723835|580040963|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
160633964|NCT05723835|580040964|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
160633965|NCT00602641|580040965|FG000|Overall Study|Never started protocol therapy|6|||
160633966|NCT00602641|580040966|FG001|Overall Study|Never started protocol therapy|2|||
160633967|NCT00602641|580040965|FG000|Overall Study|Still on treatment at time of analysis|8|||
160633968|NCT00602641|580040966|FG001|Overall Study|Still on treatment at time of analysis|15|||
160633969|NCT00602641|580040965|FG000|Overall Study|Adverse Event|62|||
160633970|NCT00602641|580040966|FG001|Overall Study|Adverse Event|53|||
160633971|NCT00602641|580040965|FG000|Overall Study|Disease progression|38|||
160633972|NCT00602641|580040966|FG001|Overall Study|Disease progression|55|||
160633973|NCT00602641|580040965|FG000|Overall Study|Death|6|||
160633974|NCT00602641|580040966|FG001|Overall Study|Death|5|||
160633975|NCT00602641|580040965|FG000|Overall Study|Withdrawal by Subject|15|||
160633976|NCT00602641|580040966|FG001|Overall Study|Withdrawal by Subject|12|||
160633977|NCT00602641|580040965|FG000|Overall Study|Alternative therapy|5|||
160633978|NCT00602641|580040966|FG001|Overall Study|Alternative therapy|2|||
160633979|NCT00602641|580040965|FG000|Overall Study|Other Complicating Disease|5|||
160633980|NCT00602641|580040966|FG001|Overall Study|Other Complicating Disease|2|||
160633981|NCT00602641|580040965|FG000|Overall Study|Physician Decision|5|||
160633982|NCT00602641|580040966|FG001|Overall Study|Physician Decision|4|||
160633983|NCT00602641|580040965|FG000|Overall Study|Administrative Closure|1|||
160633984|NCT00602641|580040966|FG001|Overall Study|Administrative Closure|1|||
160633985|NCT00602641|580040965|FG000|Overall Study|Other|3|||
160633986|NCT00602641|580040966|FG001|Overall Study|Other|1|||
160633987|NCT03901352|580040967|FG000|Double-blind Phase|Adverse Event|6|||
160633988|NCT03901352|580040968|FG001|Double-blind Phase|Adverse Event|4|||
160633989|NCT03901352|580040967|FG000|Double-blind Phase|Death|1|||
160633990|NCT03901352|580040968|FG001|Double-blind Phase|Death|0|||
160633991|NCT03901352|580040967|FG000|Double-blind Phase|Lack of Efficacy|0|||
160633992|NCT03901352|580040968|FG001|Double-blind Phase|Lack of Efficacy|1|||
160633993|NCT03901352|580040967|FG000|Double-blind Phase|Protocol Violation|0|||
160633994|NCT03901352|580040968|FG001|Double-blind Phase|Protocol Violation|1|||
160633995|NCT03901352|580040967|FG000|Double-blind Phase|Withdrawal by Subject|10|||
160633996|NCT03901352|580040968|FG001|Double-blind Phase|Withdrawal by Subject|8|||
160633997|NCT03901352|580040967|FG000|Open-label Extension Phase|Adverse Event|24|||
160633998|NCT03901352|580040968|FG001|Open-label Extension Phase|Adverse Event|0|||
160633999|NCT03901352|580040967|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
160634000|NCT03901352|580040968|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
160634001|NCT03901352|580040967|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
160634002|NCT03901352|580040968|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
160634003|NCT03901352|580040967|FG000|Open-label Extension Phase|Other|1|||
160634004|NCT03901352|580040968|FG001|Open-label Extension Phase|Other|0|||
160634005|NCT01826201|580040971|FG000|Overall Study|Non compliance with protocol|4|||
160634006|NCT03901339|580040972|FG000|Overall Study|Death|220|||
160634007|NCT03901339|580040973|FG001|Overall Study|Death|192|||
160634008|NCT03901339|580040972|FG000|Overall Study|Informed consent withdrawn|13|||
160634009|NCT03901339|580040973|FG001|Overall Study|Informed consent withdrawn|40|||
160634010|NCT03901339|580040972|FG000|Overall Study|Sponsor request|30|||
160634011|NCT03901339|580040973|FG001|Overall Study|Sponsor request|23|||
160634012|NCT03901339|580040972|FG000|Overall Study|Reason not specified|5|||
160634013|NCT03901339|580040973|FG001|Overall Study|Reason not specified|7|||
160634014|NCT03901339|580040972|FG000|Overall Study|Lost to Follow-up|4|||
160634015|NCT03901339|580040973|FG001|Overall Study|Lost to Follow-up|7|||
160634016|NCT03901339|580040972|FG000|Overall Study|Covid19|0|||
160634017|NCT03901339|580040973|FG001|Overall Study|Covid19|2|||
160634018|NCT01988337|580040976|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
160634019|NCT04701658|580040977|FG000|Overall Study|Lost to Follow-up|6|||
160634020|NCT03387735|580040980|FG000|Overall Study|Lost to Follow-up|4|||
160634021|NCT03387735|580040981|FG001|Overall Study|Lost to Follow-up|8|||
160634022|NCT03387735|580040980|FG000|Overall Study|Death|4|||
160634023|NCT03387735|580040981|FG001|Overall Study|Death|8|||
160634024|NCT03099161|580040982|FG000|Overall Study|Adverse Event|0|||
160634025|NCT03099161|580040983|FG001|Overall Study|Adverse Event|0|||
160634026|NCT03099161|580040984|FG002|Overall Study|Adverse Event|2|||
160634027|NCT03099161|580040982|FG000|Overall Study|Physician Decision|2|||
160634028|NCT03099161|580040983|FG001|Overall Study|Physician Decision|0|||
160634029|NCT03099161|580040984|FG002|Overall Study|Physician Decision|0|||
160634030|NCT03099161|580040982|FG000|Overall Study|Progressive Disease|1|||
160634031|NCT03099161|580040983|FG001|Overall Study|Progressive Disease|4|||
160634032|NCT03099161|580040984|FG002|Overall Study|Progressive Disease|1|||
160634033|NCT00110084|580040987|FG000|Overall Study|Adverse Event|9|||
160634034|NCT00110084|580040987|FG000|Overall Study|Death|1|||
160634035|NCT00110084|580040987|FG000|Overall Study|Patient Refusal|10|||
160634036|NCT00110084|580040987|FG000|Overall Study|Alternate Therapy|5|||
160634037|NCT00110084|580040987|FG000|Overall Study|Intercurrent Illness|1|||
160634038|NCT00110084|580040987|FG000|Overall Study|Other|2|||
160634039|NCT04854707|580040989|FG000|Overall Study|Lack of Efficacy|78|||
160634040|NCT04854707|580040990|FG001|Overall Study|Lack of Efficacy|59|||
160634041|NCT04854707|580040991|FG002|Overall Study|Lack of Efficacy|30|||
160634042|NCT00742859|580040992|FG000|Overall Study|Adverse Event|5|||
160634043|NCT00742859|580040993|FG001|Overall Study|Adverse Event|6|||
160634044|NCT00742859|580040994|FG002|Overall Study|Adverse Event|3|||
160634045|NCT00742859|580040995|FG003|Overall Study|Adverse Event|1|||
160634046|NCT00742859|580040992|FG000|Overall Study|Death|1|||
160634047|NCT00742859|580040993|FG001|Overall Study|Death|0|||
160634048|NCT00742859|580040994|FG002|Overall Study|Death|0|||
160634049|NCT00742859|580040995|FG003|Overall Study|Death|1|||
160634050|NCT00742859|580040992|FG000|Overall Study|Physician Decision|1|||
160634051|NCT00742859|580040993|FG001|Overall Study|Physician Decision|2|||
160634052|NCT00742859|580040994|FG002|Overall Study|Physician Decision|0|||
160634053|NCT00742859|580040995|FG003|Overall Study|Physician Decision|0|||
160634054|NCT00742859|580040992|FG000|Overall Study|Withdrawal by Subject|4|||
160634055|NCT00742859|580040993|FG001|Overall Study|Withdrawal by Subject|2|||
160634056|NCT00742859|580040994|FG002|Overall Study|Withdrawal by Subject|4|||
160634057|NCT00742859|580040995|FG003|Overall Study|Withdrawal by Subject|1|||
160634058|NCT00742859|580040992|FG000|Overall Study|Endpoint|0|||
160634059|NCT00742859|580040993|FG001|Overall Study|Endpoint|1|||
160634060|NCT00742859|580040994|FG002|Overall Study|Endpoint|1|||
160634061|NCT00742859|580040995|FG003|Overall Study|Endpoint|2|||
160634062|NCT00742859|580040992|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
160634063|NCT00742859|580040993|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
160634064|NCT00742859|580040994|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
160634065|NCT00742859|580040995|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
160634066|NCT00742859|580040992|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
160634067|NCT00742859|580040993|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
160634068|NCT00742859|580040994|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
160634069|NCT00742859|580040995|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
160634070|NCT00742859|580040992|FG000|Overall Study|Sponsor request patient out of town|0|||
160634071|NCT00742859|580040993|FG001|Overall Study|Sponsor request patient out of town|0|||
160634072|NCT00742859|580040994|FG002|Overall Study|Sponsor request patient out of town|1|||
160634073|NCT00742859|580040995|FG003|Overall Study|Sponsor request patient out of town|1|||
160634074|NCT00742859|580040992|FG000|Overall Study|Site error|0|||
160634075|NCT00742859|580040993|FG001|Overall Study|Site error|0|||
160634076|NCT00742859|580040994|FG002|Overall Study|Site error|1|||
160634077|NCT00742859|580040995|FG003|Overall Study|Site error|1|||
160634078|NCT02564952|580040999|FG000|Overall Study|Adverse Event|6|||
160634079|NCT02564952|580040999|FG000|Overall Study|Lost to Follow-up|1|||
160634080|NCT02564952|580040999|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
160634081|NCT02564952|580040999|FG000|Overall Study|Withdrawal by Subject|1|||
160634082|NCT02564952|580040999|FG000|Overall Study|Low Efficacy|1|||
160634083|NCT02564952|580040999|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
160634084|NCT01071083|580041006|FG000|Overall Study|Adverse Event|1|||
160634085|NCT01071083|580041007|FG001|Overall Study|Adverse Event|0|||
160634086|NCT01071083|580041008|FG002|Overall Study|Adverse Event|1|||
160634087|NCT01071083|580041009|FG003|Overall Study|Adverse Event|0|||
160634088|NCT01071083|580041010|FG004|Overall Study|Adverse Event|1|||
160634089|NCT01071083|580041006|FG000|Overall Study|Withdrawal by Subject|3|||
160634090|NCT01071083|580041007|FG001|Overall Study|Withdrawal by Subject|0|||
160634091|NCT01071083|580041008|FG002|Overall Study|Withdrawal by Subject|2|||
160634092|NCT01071083|580041009|FG003|Overall Study|Withdrawal by Subject|0|||
160634093|NCT01071083|580041010|FG004|Overall Study|Withdrawal by Subject|3|||
160634094|NCT01071083|580041006|FG000|Overall Study|Physician Decision|1|||
160634095|NCT01071083|580041007|FG001|Overall Study|Physician Decision|0|||
160634096|NCT01071083|580041008|FG002|Overall Study|Physician Decision|0|||
160634097|NCT01071083|580041009|FG003|Overall Study|Physician Decision|1|||
160634098|NCT01071083|580041010|FG004|Overall Study|Physician Decision|1|||
160634099|NCT01071083|580041006|FG000|Overall Study|Early Rescue|1|||
160634100|NCT01071083|580041007|FG001|Overall Study|Early Rescue|0|||
160634101|NCT01071083|580041008|FG002|Overall Study|Early Rescue|0|||
160634102|NCT01071083|580041009|FG003|Overall Study|Early Rescue|0|||
160634103|NCT01071083|580041010|FG004|Overall Study|Early Rescue|1|||
160634104|NCT01071083|580041006|FG000|Overall Study|Subject Moved|0|||
160634105|NCT01071083|580041007|FG001|Overall Study|Subject Moved|1|||
160634106|NCT01071083|580041008|FG002|Overall Study|Subject Moved|0|||
160634107|NCT01071083|580041009|FG003|Overall Study|Subject Moved|0|||
160634108|NCT01071083|580041010|FG004|Overall Study|Subject Moved|0|||
160634109|NCT01071083|580041006|FG000|Overall Study|Images Not Usable (Motion)|0|||
160634110|NCT01071083|580041007|FG001|Overall Study|Images Not Usable (Motion)|1|||
160634111|NCT01071083|580041008|FG002|Overall Study|Images Not Usable (Motion)|0|||
160634112|NCT01071083|580041009|FG003|Overall Study|Images Not Usable (Motion)|0|||
160634113|NCT01071083|580041010|FG004|Overall Study|Images Not Usable (Motion)|0|||
160634114|NCT01071083|580041006|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
160634115|NCT01071083|580041007|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
160634116|NCT01071083|580041008|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
160634117|NCT01071083|580041009|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
160634118|NCT01071083|580041010|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
160634119|NCT01071083|580041006|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
160634120|NCT01071083|580041007|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
160634121|NCT01071083|580041008|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
160634122|NCT01071083|580041009|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
160634123|NCT01071083|580041010|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
160634124|NCT01071083|580041006|FG000|Overall Study|Subject Refused to Continue|1|||
160634125|NCT01071083|580041007|FG001|Overall Study|Subject Refused to Continue|0|||
160634126|NCT01071083|580041008|FG002|Overall Study|Subject Refused to Continue|0|||
160634127|NCT01071083|580041009|FG003|Overall Study|Subject Refused to Continue|0|||
160634128|NCT01071083|580041010|FG004|Overall Study|Subject Refused to Continue|0|||
160634129|NCT03972709|580041011|FG000|Overall Study|Withdrawal by Subject|18|||
160634130|NCT03972709|580041012|FG001|Overall Study|Withdrawal by Subject|7|||
160634131|NCT03972709|580041013|FG002|Overall Study|Withdrawal by Subject|14|||
160634132|NCT03972709|580041011|FG000|Overall Study|Study Terminated by Sponsor|48|||
160634133|NCT03972709|580041012|FG001|Overall Study|Study Terminated by Sponsor|25|||
160634134|NCT03972709|580041013|FG002|Overall Study|Study Terminated by Sponsor|50|||
160634135|NCT03972709|580041011|FG000|Overall Study|Physician Decision|1|||
160634136|NCT03972709|580041012|FG001|Overall Study|Physician Decision|0|||
160634137|NCT03972709|580041013|FG002|Overall Study|Physician Decision|0|||
160634138|NCT03972709|580041011|FG000|Overall Study|COVID-19|0|||
160634139|NCT03972709|580041012|FG001|Overall Study|COVID-19|1|||
160634140|NCT03972709|580041013|FG002|Overall Study|COVID-19|1|||
160634141|NCT03972709|580041011|FG000|Overall Study|Lost to Follow-up|6|||
160634142|NCT03972709|580041012|FG001|Overall Study|Lost to Follow-up|1|||
160634143|NCT03972709|580041013|FG002|Overall Study|Lost to Follow-up|2|||
160634144|NCT03972709|580041011|FG000|Overall Study|Death|5|||
160634145|NCT03972709|580041012|FG001|Overall Study|Death|1|||
160634146|NCT03972709|580041013|FG002|Overall Study|Death|4|||
160634147|NCT03972709|580041011|FG000|Overall Study|Adverse Event|3|||
160634148|NCT03972709|580041012|FG001|Overall Study|Adverse Event|1|||
160634149|NCT03972709|580041013|FG002|Overall Study|Adverse Event|4|||
160634150|NCT03972709|580041011|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
160634151|NCT03972709|580041012|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
160634152|NCT03972709|580041013|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
160634153|NCT03972709|580041011|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
160634154|NCT03972709|580041012|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
160634155|NCT03972709|580041013|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
160634156|NCT03972709|580041011|FG000|Overall Study|Subject Unable to be Contacted|0|||
160634157|NCT03972709|580041012|FG001|Overall Study|Subject Unable to be Contacted|1|||
160634158|NCT03972709|580041013|FG002|Overall Study|Subject Unable to be Contacted|0|||
160634159|NCT03972709|580041011|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
160634160|NCT03972709|580041012|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
160634161|NCT03972709|580041013|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
160634162|NCT03972709|580041011|FG000|Overall Study|Subject Moved|0|||
160634163|NCT03972709|580041012|FG001|Overall Study|Subject Moved|1|||
160634164|NCT03972709|580041013|FG002|Overall Study|Subject Moved|0|||
160634165|NCT03972709|580041011|FG000|Overall Study|Missed Study Visits|1|||
160634166|NCT03972709|580041012|FG001|Overall Study|Missed Study Visits|0|||
160634167|NCT03972709|580041013|FG002|Overall Study|Missed Study Visits|0|||
160634168|NCT01523301|580041014|FG000|Overall Study|Adverse Event|25|||
160634169|NCT01523301|580041015|FG001|Overall Study|Adverse Event|16|||
160634170|NCT01523301|580041014|FG000|Overall Study|Lack of Efficacy|0|||
160634171|NCT01523301|580041015|FG001|Overall Study|Lack of Efficacy|2|||
160634172|NCT01523301|580041014|FG000|Overall Study|Protocol Violation|3|||
160634173|NCT01523301|580041015|FG001|Overall Study|Protocol Violation|4|||
160634174|NCT01523301|580041014|FG000|Overall Study|Lost to Follow-up|1|||
160634175|NCT01523301|580041015|FG001|Overall Study|Lost to Follow-up|0|||
160634176|NCT01523301|580041014|FG000|Overall Study|Withdrawal by Subject|6|||
160634177|NCT01523301|580041015|FG001|Overall Study|Withdrawal by Subject|8|||
160634178|NCT01523301|580041014|FG000|Overall Study|Other Reason|0|||
160634179|NCT01523301|580041015|FG001|Overall Study|Other Reason|2|||
160634180|NCT01339000|580041016|FG000|Overall Study|study closed due to lack of drug supply|1|||
160634181|NCT01339000|580041017|FG001|Overall Study|study closed due to lack of drug supply|0|||
160634182|NCT00728988|580041020|FG000|Overall Study|Not Treated|2|||
160634183|NCT00728988|580041021|FG001|Overall Study|Not Treated|2|||
160634184|NCT00728988|580041020|FG000|Overall Study|Death|1|||
160634185|NCT00728988|580041021|FG001|Overall Study|Death|1|||
160634186|NCT00728988|580041020|FG000|Overall Study|Adverse Event|3|||
160634187|NCT00728988|580041021|FG001|Overall Study|Adverse Event|2|||
160634188|NCT00728988|580041020|FG000|Overall Study|Other|85|||
160634189|NCT00728988|580041021|FG001|Overall Study|Other|77|||
160634190|NCT00728988|580041020|FG000|Overall Study|Withdrawal by Subject|2|||
160634191|NCT00728988|580041021|FG001|Overall Study|Withdrawal by Subject|6|||
160634192|NCT02017535|580041022|FG000|Overall Study|Withdrawal by Subject|1|||
160634193|NCT02017535|580041023|FG001|Overall Study|Withdrawal by Subject|0|||
160634194|NCT02017535|580041024|FG002|Overall Study|Withdrawal by Subject|0|||
160634195|NCT02017535|580041025|FG003|Overall Study|Withdrawal by Subject|0|||
160634196|NCT05511428|580041026|FG000|Overall Study|Withdrawal by Subject|1|||
160634197|NCT05511428|580041026|FG000|Overall Study|Adverse Event|1|||
160634198|NCT04088734|580041027|FG000|Overall Study|Other, Not Specified|5|||
160634199|NCT03532295|580041035|FG000|Overall Study|Did not start treatment|0|||
160634200|NCT03532295|580041036|FG001|Overall Study|Did not start treatment|2|||
160634201|NCT05004181|580041040|FG000|Overall Study|Withdrawal of consent|0|||
160634202|NCT05004181|580041041|FG001|Overall Study|Withdrawal of consent|0|||
160634203|NCT05004181|580041042|FG002|Overall Study|Withdrawal of consent|1|||
160634204|NCT05004181|580041043|FG003|Overall Study|Withdrawal of consent|3|||
160634205|NCT05004181|580041044|FG004|Overall Study|Withdrawal of consent|3|||
160634206|NCT05004181|580041045|FG005|Overall Study|Withdrawal of consent|0|||
160634207|NCT05004181|580041046|FG006|Overall Study|Withdrawal of consent|30|||
160634208|NCT05004181|580041047|FG007|Overall Study|Withdrawal of consent|9|||
160634209|NCT05004181|580041048|FG008|Overall Study|Withdrawal of consent|3|||
160634210|NCT05004181|580041049|FG009|Overall Study|Withdrawal of consent|2|||
160634211|NCT05004181|580041050|FG010|Overall Study|Withdrawal of consent|5|||
160634212|NCT05004181|580041051|FG011|Overall Study|Withdrawal of consent|1|||
160634213|NCT05004181|580041040|FG000|Overall Study|Lost to Follow-up|2|||
160634214|NCT05004181|580041041|FG001|Overall Study|Lost to Follow-up|4|||
160634215|NCT05004181|580041042|FG002|Overall Study|Lost to Follow-up|2|||
160634216|NCT05004181|580041043|FG003|Overall Study|Lost to Follow-up|3|||
160634217|NCT05004181|580041044|FG004|Overall Study|Lost to Follow-up|5|||
160634218|NCT05004181|580041045|FG005|Overall Study|Lost to Follow-up|2|||
160634219|NCT05004181|580041046|FG006|Overall Study|Lost to Follow-up|15|||
160634220|NCT05004181|580041047|FG007|Overall Study|Lost to Follow-up|12|||
160634221|NCT05004181|580041048|FG008|Overall Study|Lost to Follow-up|38|||
160634222|NCT05004181|580041049|FG009|Overall Study|Lost to Follow-up|6|||
160634223|NCT05004181|580041050|FG010|Overall Study|Lost to Follow-up|6|||
160634224|NCT05004181|580041051|FG011|Overall Study|Lost to Follow-up|0|||
160634225|NCT05004181|580041040|FG000|Overall Study|Death|0|||
160634226|NCT05004181|580041041|FG001|Overall Study|Death|0|||
160634227|NCT05004181|580041042|FG002|Overall Study|Death|0|||
160634228|NCT05004181|580041043|FG003|Overall Study|Death|0|||
160634229|NCT05004181|580041044|FG004|Overall Study|Death|0|||
160634230|NCT05004181|580041045|FG005|Overall Study|Death|0|||
160634231|NCT05004181|580041046|FG006|Overall Study|Death|1|||
160634232|NCT05004181|580041047|FG007|Overall Study|Death|0|||
160634233|NCT05004181|580041048|FG008|Overall Study|Death|2|||
160634234|NCT05004181|580041049|FG009|Overall Study|Death|0|||
160634235|NCT05004181|580041050|FG010|Overall Study|Death|0|||
160634236|NCT05004181|580041051|FG011|Overall Study|Death|0|||
160634237|NCT05004181|580041040|FG000|Overall Study|Physician Decision|0|||
160634238|NCT05004181|580041041|FG001|Overall Study|Physician Decision|0|||
160634239|NCT05004181|580041042|FG002|Overall Study|Physician Decision|0|||
160634240|NCT05004181|580041043|FG003|Overall Study|Physician Decision|0|||
160634241|NCT05004181|580041044|FG004|Overall Study|Physician Decision|0|||
160634242|NCT05004181|580041045|FG005|Overall Study|Physician Decision|0|||
160634243|NCT05004181|580041046|FG006|Overall Study|Physician Decision|2|||
160634244|NCT05004181|580041047|FG007|Overall Study|Physician Decision|0|||
160634245|NCT05004181|580041048|FG008|Overall Study|Physician Decision|7|||
160634246|NCT05004181|580041049|FG009|Overall Study|Physician Decision|0|||
160634247|NCT05004181|580041050|FG010|Overall Study|Physician Decision|0|||
160634248|NCT05004181|580041051|FG011|Overall Study|Physician Decision|0|||
160634249|NCT05004181|580041040|FG000|Overall Study|Withdrawal by Subject|2|||
160634250|NCT05004181|580041041|FG001|Overall Study|Withdrawal by Subject|3|||
160634251|NCT05004181|580041042|FG002|Overall Study|Withdrawal by Subject|2|||
160634252|NCT05004181|580041043|FG003|Overall Study|Withdrawal by Subject|2|||
160634253|NCT05004181|580041044|FG004|Overall Study|Withdrawal by Subject|4|||
160634254|NCT05004181|580041045|FG005|Overall Study|Withdrawal by Subject|2|||
160634255|NCT05004181|580041046|FG006|Overall Study|Withdrawal by Subject|4|||
160634256|NCT05004181|580041047|FG007|Overall Study|Withdrawal by Subject|22|||
160634257|NCT05004181|580041048|FG008|Overall Study|Withdrawal by Subject|8|||
160634258|NCT05004181|580041049|FG009|Overall Study|Withdrawal by Subject|1|||
160634259|NCT05004181|580041050|FG010|Overall Study|Withdrawal by Subject|3|||
160634260|NCT05004181|580041051|FG011|Overall Study|Withdrawal by Subject|2|||
160634261|NCT05004181|580041040|FG000|Overall Study|Protocol Violation|2|||
160634262|NCT05004181|580041041|FG001|Overall Study|Protocol Violation|3|||
160634263|NCT05004181|580041042|FG002|Overall Study|Protocol Violation|0|||
160634264|NCT05004181|580041043|FG003|Overall Study|Protocol Violation|0|||
160634265|NCT05004181|580041044|FG004|Overall Study|Protocol Violation|1|||
160634266|NCT05004181|580041045|FG005|Overall Study|Protocol Violation|0|||
160634267|NCT05004181|580041046|FG006|Overall Study|Protocol Violation|16|||
160634268|NCT05004181|580041047|FG007|Overall Study|Protocol Violation|18|||
160634269|NCT05004181|580041048|FG008|Overall Study|Protocol Violation|2|||
160634270|NCT05004181|580041049|FG009|Overall Study|Protocol Violation|2|||
160634271|NCT05004181|580041050|FG010|Overall Study|Protocol Violation|2|||
160634272|NCT05004181|580041051|FG011|Overall Study|Protocol Violation|1|||
160634273|NCT05004181|580041040|FG000|Overall Study|Not further specified|1|||
160634274|NCT05004181|580041041|FG001|Overall Study|Not further specified|0|||
160634275|NCT05004181|580041042|FG002|Overall Study|Not further specified|0|||
160634276|NCT05004181|580041043|FG003|Overall Study|Not further specified|0|||
160634277|NCT05004181|580041044|FG004|Overall Study|Not further specified|0|||
160634278|NCT05004181|580041045|FG005|Overall Study|Not further specified|0|||
160634279|NCT05004181|580041046|FG006|Overall Study|Not further specified|1|||
160634280|NCT05004181|580041047|FG007|Overall Study|Not further specified|0|||
160634281|NCT05004181|580041048|FG008|Overall Study|Not further specified|2|||
160634282|NCT05004181|580041049|FG009|Overall Study|Not further specified|1|||
160634283|NCT05004181|580041050|FG010|Overall Study|Not further specified|0|||
160634284|NCT05004181|580041051|FG011|Overall Study|Not further specified|1|||
160634285|NCT02949219|580041059|FG000|Overall Study|Withdrawal by Subject|1|||
160634286|NCT04278872|580041060|FG000|Overall Study|Adverse Event|1|||
160634287|NCT04278872|580041061|FG001|Overall Study|Adverse Event|0|||
160634288|NCT04278872|580041060|FG000|Overall Study|Protocol Violation|0|||
160634289|NCT04278872|580041061|FG001|Overall Study|Protocol Violation|1|||
160634290|NCT04278872|580041060|FG000|Overall Study|Study Termination|2|||
160634291|NCT04278872|580041061|FG001|Overall Study|Study Termination|0|||
160634292|NCT02044094|580041070|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
160634293|NCT02044094|580041070|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
160634294|NCT02044094|580041070|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
160634295|NCT02044094|580041070|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
160634296|NCT02044094|580041070|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
160634297|NCT02044094|580041070|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
160634298|NCT02044094|580041070|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
160634299|NCT02044094|580041070|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
160745542|NCT02607306|580451075|FG000|Overall Study|Withdrawal by Subject|8|||
160745543|NCT02607306|580451076|FG001|Overall Study|Withdrawal by Subject|10|||
160745544|NCT02607306|580451077|FG002|Overall Study|Withdrawal by Subject|2|||
160745545|NCT02607306|580451075|FG000|Overall Study|Lack of Efficacy|0|||
160745546|NCT02607306|580451076|FG001|Overall Study|Lack of Efficacy|1|||
160745547|NCT02607306|580451077|FG002|Overall Study|Lack of Efficacy|1|||
160745548|NCT02607306|580451075|FG000|Overall Study|Protocol Violation|4|||
160745549|NCT02607306|580451076|FG001|Overall Study|Protocol Violation|2|||
160745550|NCT02607306|580451077|FG002|Overall Study|Protocol Violation|1|||
160745551|NCT02360475|580451078|FG000|Overall Study|Lost to Follow-up|4|||
160745552|NCT02360475|580451079|FG001|Overall Study|Lost to Follow-up|12|||
160745553|NCT02360475|580451080|FG002|Overall Study|Lost to Follow-up|6|||
160745554|NCT02360475|580451081|FG003|Overall Study|Lost to Follow-up|4|||
160745555|NCT02360475|580451078|FG000|Overall Study|Withdrawal by Subject|0|||
160745556|NCT02360475|580451079|FG001|Overall Study|Withdrawal by Subject|1|||
160745557|NCT02360475|580451080|FG002|Overall Study|Withdrawal by Subject|2|||
160745558|NCT02360475|580451081|FG003|Overall Study|Withdrawal by Subject|0|||
160745559|NCT02360475|580451078|FG000|Overall Study|Migrated/moved from study area|0|||
160745560|NCT02360475|580451079|FG001|Overall Study|Migrated/moved from study area|0|||
160745561|NCT02360475|580451080|FG002|Overall Study|Migrated/moved from study area|0|||
160745562|NCT02360475|580451081|FG003|Overall Study|Migrated/moved from study area|1|||
160745563|NCT00207727|580451083|FG000|Overall Study|Withdrawal by Subject|0|||
160745564|NCT00207727|580451084|FG001|Overall Study|Withdrawal by Subject|0|||
160745565|NCT00207727|580451085|FG002|Overall Study|Withdrawal by Subject|0|||
160745566|NCT00207727|580451086|FG003|Overall Study|Withdrawal by Subject|0|||
160745567|NCT00207727|580451087|FG004|Overall Study|Withdrawal by Subject|1|||
160745568|NCT00207727|580451083|FG000|Overall Study|Lost to Follow-up|0|||
160745569|NCT00207727|580451084|FG001|Overall Study|Lost to Follow-up|1|||
160745570|NCT00207727|580451085|FG002|Overall Study|Lost to Follow-up|0|||
160745571|NCT00207727|580451086|FG003|Overall Study|Lost to Follow-up|0|||
160745572|NCT00207727|580451087|FG004|Overall Study|Lost to Follow-up|0|||
160745573|NCT00207727|580451083|FG000|Overall Study|Other|38|||
160745574|NCT00207727|580451084|FG001|Overall Study|Other|41|||
160745575|NCT00207727|580451085|FG002|Overall Study|Other|41|||
160745576|NCT00207727|580451086|FG003|Overall Study|Other|37|||
160745577|NCT00207727|580451087|FG004|Overall Study|Other|33|||
160745578|NCT03759366|580451088|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
160745579|NCT03759366|580451088|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
160745580|NCT03759366|580451088|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
160745581|NCT03759366|580451088|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
160745582|NCT03759366|580451088|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
160745583|NCT03759366|580451088|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
160745584|NCT03759366|580451088|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
160745585|NCT00539032|580451089|FG000|Overall Study|Withdrawal by Subject|2|||
160745586|NCT00539032|580451090|FG001|Overall Study|Withdrawal by Subject|1|||
160745587|NCT04438499|580451091|FG000|Overall Study|Lack of Efficacy|3|||
160745588|NCT01859949|580453116|FG000|Overall Study|Family Matters|0|||
160745589|NCT01859949|580453117|FG001|Overall Study|Family Matters|1|||
160745590|NCT01859949|580453116|FG000|Overall Study|Physician Decision|2|||
160745591|NCT01859949|580453117|FG001|Overall Study|Physician Decision|4|||
160745592|NCT01859949|580453116|FG000|Overall Study|Withdrawal by Subject|11|||
160745593|NCT01859949|580453117|FG001|Overall Study|Withdrawal by Subject|10|||
160745594|NCT01859949|580453116|FG000|Overall Study|Protocol Violation|1|||
160745595|NCT01859949|580453117|FG001|Overall Study|Protocol Violation|1|||
160745596|NCT01859949|580453116|FG000|Overall Study|Adverse Event|0|||
160745597|NCT01859949|580453117|FG001|Overall Study|Adverse Event|1|||
160745598|NCT01153009|580453118|FG000|Overall Study|Adverse Event|4|||
160745599|NCT01153009|580453119|FG001|Overall Study|Adverse Event|14|||
160745600|NCT01153009|580453120|FG002|Overall Study|Adverse Event|14|||
160745601|NCT01153009|580453121|FG003|Overall Study|Adverse Event|10|||
160745602|NCT01153009|580453118|FG000|Overall Study|Lack of Efficacy|9|||
160745603|NCT01153009|580453119|FG001|Overall Study|Lack of Efficacy|0|||
160745604|NCT01153009|580453120|FG002|Overall Study|Lack of Efficacy|2|||
160745605|NCT01153009|580453121|FG003|Overall Study|Lack of Efficacy|1|||
160745606|NCT01153009|580453118|FG000|Overall Study|Noncompliance with Study Medication|1|||
160745607|NCT01153009|580453119|FG001|Overall Study|Noncompliance with Study Medication|3|||
160745608|NCT01153009|580453120|FG002|Overall Study|Noncompliance with Study Medication|4|||
160745609|NCT01153009|580453121|FG003|Overall Study|Noncompliance with Study Medication|1|||
160745610|NCT01153009|580453118|FG000|Overall Study|Protocol Deviations|4|||
160745611|NCT01153009|580453119|FG001|Overall Study|Protocol Deviations|3|||
160745612|NCT01153009|580453120|FG002|Overall Study|Protocol Deviations|3|||
160745613|NCT01153009|580453121|FG003|Overall Study|Protocol Deviations|2|||
160745614|NCT01153009|580453118|FG000|Overall Study|Withdrawal of Consent|5|||
160745615|NCT01153009|580453119|FG001|Overall Study|Withdrawal of Consent|5|||
160745616|NCT01153009|580453120|FG002|Overall Study|Withdrawal of Consent|4|||
160745617|NCT01153009|580453121|FG003|Overall Study|Withdrawal of Consent|6|||
160745618|NCT01153009|580453118|FG000|Overall Study|Lost to Follow-up|8|||
160745619|NCT01153009|580453119|FG001|Overall Study|Lost to Follow-up|8|||
160745620|NCT01153009|580453120|FG002|Overall Study|Lost to Follow-up|11|||
160745621|NCT01153009|580453121|FG003|Overall Study|Lost to Follow-up|15|||
160745622|NCT01153009|580453118|FG000|Overall Study|Other|1|||
160745623|NCT01153009|580453119|FG001|Overall Study|Other|1|||
160745624|NCT01153009|580453120|FG002|Overall Study|Other|3|||
160745625|NCT01153009|580453121|FG003|Overall Study|Other|2|||
160745626|NCT04494425|580453122|FG000|Overall Study|Death|160|||
160745627|NCT04494425|580453123|FG001|Overall Study|Death|166|||
160745628|NCT04494425|580453122|FG000|Overall Study|Withdrawal by Subject|10|||
160745629|NCT04494425|580453123|FG001|Overall Study|Withdrawal by Subject|40|||
160745630|NCT04494425|580453122|FG000|Overall Study|Other|1|||
160745631|NCT04494425|580453123|FG001|Overall Study|Other|1|||
160745632|NCT04494425|580453122|FG000|Overall Study|Ongoing at the time of PCD|265|||
160745633|NCT04494425|580453123|FG001|Overall Study|Ongoing at the time of PCD|223|||
160745634|NCT04003623|580453125|FG000|Overall Study|Withdrawal by Subject|1|||
160745635|NCT04003623|580453126|FG001|Overall Study|Withdrawal by Subject|0|||
160745636|NCT03307837|580453132|FG000|Overall Study|Withdrawal by Subject|0|||
160745637|NCT03307837|580453133|FG001|Overall Study|Withdrawal by Subject|0|||
160745638|NCT03307837|580453134|FG002|Overall Study|Withdrawal by Subject|1|||
160745639|NCT03307837|580453135|FG003|Overall Study|Withdrawal by Subject|0|||
160745640|NCT03307837|580453136|FG004|Overall Study|Withdrawal by Subject|0|||
160745641|NCT03307837|580453137|FG005|Overall Study|Withdrawal by Subject|1|||
160745642|NCT03307837|580453132|FG000|Overall Study|Lost to Follow-up|1|||
160745643|NCT03307837|580453133|FG001|Overall Study|Lost to Follow-up|1|||
160745644|NCT03307837|580453134|FG002|Overall Study|Lost to Follow-up|0|||
160745645|NCT03307837|580453135|FG003|Overall Study|Lost to Follow-up|0|||
160745646|NCT03307837|580453136|FG004|Overall Study|Lost to Follow-up|0|||
160745647|NCT03307837|580453137|FG005|Overall Study|Lost to Follow-up|1|||
160745648|NCT01744483|580453138|FG000|Overall Study|Death|9|||
160745649|NCT01744483|580453139|FG001|Overall Study|Death|4|||
160745650|NCT01744483|580453140|FG002|Overall Study|Death|11|||
160745651|NCT01744483|580453138|FG000|Overall Study|Lost to Follow-up|8|||
160745652|NCT01744483|580453139|FG001|Overall Study|Lost to Follow-up|9|||
160745653|NCT01744483|580453140|FG002|Overall Study|Lost to Follow-up|11|||
160745654|NCT01744483|580453138|FG000|Overall Study|Protocol Violation|1|||
160745655|NCT01744483|580453139|FG001|Overall Study|Protocol Violation|2|||
160745656|NCT01744483|580453140|FG002|Overall Study|Protocol Violation|1|||
160745657|NCT01744483|580453138|FG000|Overall Study|Withdrawal by Subject|4|||
160745658|NCT01744483|580453139|FG001|Overall Study|Withdrawal by Subject|6|||
160745659|NCT01744483|580453140|FG002|Overall Study|Withdrawal by Subject|2|||
160745660|NCT01744483|580453138|FG000|Overall Study|No ICU Admit|5|||
160745661|NCT01744483|580453139|FG001|Overall Study|No ICU Admit|1|||
160745662|NCT01744483|580453140|FG002|Overall Study|No ICU Admit|2|||
160745663|NCT01744483|580453138|FG000|Overall Study|Routed to OSH|2|||
160745664|NCT01744483|580453139|FG001|Overall Study|Routed to OSH|0|||
160745665|NCT01744483|580453140|FG002|Overall Study|Routed to OSH|1|||
160745666|NCT03041467|580453141|FG000|Overall Study|Death|46|||
160745667|NCT03041467|580453142|FG001|Overall Study|Death|39|||
160745668|NCT03041467|580453141|FG000|Overall Study|Withdrawal by Subject|36|||
160745669|NCT03041467|580453142|FG001|Overall Study|Withdrawal by Subject|37|||
160745670|NCT03041467|580453141|FG000|Overall Study|Lost to Follow-up|6|||
160745671|NCT03041467|580453142|FG001|Overall Study|Lost to Follow-up|8|||
160745672|NCT03041467|580453141|FG000|Overall Study|Declined consent for study extension|21|||
160745673|NCT03041467|580453142|FG001|Overall Study|Declined consent for study extension|33|||
160745674|NCT03041467|580453141|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
160745675|NCT03041467|580453142|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
160745676|NCT01190189|580453143|FG000|Overall Study|Lost to Follow-up|4|||
160745677|NCT01190189|580453143|FG000|Overall Study|Withdrawal by Subject|1|||
160745678|NCT01190189|580453143|FG000|Overall Study|Migrated/moved from study area|1|||
160745679|NCT00734656|580453147|FG000|Lab Session 1|Withdrawal by Subject|2|||
160745680|NCT00734656|580453148|FG001|Lab Session 1|Withdrawal by Subject|0|||
160745681|NCT00734656|580453149|FG002|Lab Session 1|Withdrawal by Subject|0|||
160745682|NCT00734656|580453150|FG003|Lab Session 1|Withdrawal by Subject|0|||
160745683|NCT00734656|580453147|FG000|Washout 1|Withdrawal by Subject|1|||
160745684|NCT00734656|580453148|FG001|Washout 1|Withdrawal by Subject|5|||
160745685|NCT00734656|580453149|FG002|Washout 1|Withdrawal by Subject|2|||
160745686|NCT00734656|580453150|FG003|Washout 1|Withdrawal by Subject|3|||
160745687|NCT00734656|580453147|FG000|Lab Session 2|Withdrawal by Subject|1|||
160745688|NCT00734656|580453148|FG001|Lab Session 2|Withdrawal by Subject|0|||
160745689|NCT00734656|580453149|FG002|Lab Session 2|Withdrawal by Subject|0|||
160745690|NCT00734656|580453150|FG003|Lab Session 2|Withdrawal by Subject|1|||
160745691|NCT00734656|580453147|FG000|Washout 2|Withdrawal by Subject|1|||
160745692|NCT00734656|580453148|FG001|Washout 2|Withdrawal by Subject|1|||
160745693|NCT00734656|580453149|FG002|Washout 2|Withdrawal by Subject|1|||
160745694|NCT00734656|580453150|FG003|Washout 2|Withdrawal by Subject|0|||
160745695|NCT00734656|580453147|FG000|Washout 3|Withdrawal by Subject|1|||
160745696|NCT00734656|580453148|FG001|Washout 3|Withdrawal by Subject|0|||
160745697|NCT00734656|580453149|FG002|Washout 3|Withdrawal by Subject|0|||
160745698|NCT00734656|580453150|FG003|Washout 3|Withdrawal by Subject|1|||
160745699|NCT00734656|580453147|FG000|Lab Session 4|Withdrawal by Subject|0|||
160745700|NCT00734656|580453148|FG001|Lab Session 4|Withdrawal by Subject|0|||
160745701|NCT00734656|580453149|FG002|Lab Session 4|Withdrawal by Subject|0|||
160745702|NCT00734656|580453150|FG003|Lab Session 4|Withdrawal by Subject|1|||
160745703|NCT01754766|580453156|FG000|Overall Study|Personal reasons|1|||
160745704|NCT01754766|580453157|FG001|Overall Study|Personal reasons|1|||
160745705|NCT01754766|580453158|FG002|Overall Study|Personal reasons|0|||
160745706|NCT00298363|580453159|FG000|Overall Study|Lost to Follow-up|0|||
160745707|NCT00298363|580453160|FG001|Overall Study|Lost to Follow-up|0|||
160745708|NCT00298363|580453161|FG002|Overall Study|Lost to Follow-up|1|||
160745709|NCT00298363|580453159|FG000|Overall Study|Physician Decision|4|||
160745710|NCT00298363|580453160|FG001|Overall Study|Physician Decision|1|||
160745711|NCT00298363|580453161|FG002|Overall Study|Physician Decision|0|||
160745712|NCT00298363|580453159|FG000|Overall Study|Protocol Violation|1|||
160745713|NCT00298363|580453160|FG001|Overall Study|Protocol Violation|1|||
160745714|NCT00298363|580453161|FG002|Overall Study|Protocol Violation|0|||
160745715|NCT00298363|580453159|FG000|Overall Study|Withdrawal by Subject|5|||
160745716|NCT00298363|580453160|FG001|Overall Study|Withdrawal by Subject|1|||
160745717|NCT00298363|580453161|FG002|Overall Study|Withdrawal by Subject|3|||
160745718|NCT00298363|580453159|FG000|Overall Study|Adverse Event|5|||
160745719|NCT00298363|580453160|FG001|Overall Study|Adverse Event|2|||
160745720|NCT00298363|580453161|FG002|Overall Study|Adverse Event|2|||
160745721|NCT00298363|580453159|FG000|Overall Study|Lack of Efficacy|2|||
160745722|NCT00298363|580453160|FG001|Overall Study|Lack of Efficacy|3|||
160745723|NCT00298363|580453161|FG002|Overall Study|Lack of Efficacy|0|||
160745724|NCT00135356|580453162|FG000|Overall Study|Adverse Event|6|||
160745725|NCT00135356|580453163|FG001|Overall Study|Adverse Event|2|||
160745726|NCT00135356|580453162|FG000|Overall Study|Lack of Efficacy|2|||
160745727|NCT00135356|580453163|FG001|Overall Study|Lack of Efficacy|0|||
160745728|NCT00135356|580453162|FG000|Overall Study|Lost to Follow-up|3|||
160745729|NCT00135356|580453163|FG001|Overall Study|Lost to Follow-up|1|||
160745730|NCT00135356|580453162|FG000|Overall Study|Surgery for abdominal fat|1|||
160745731|NCT00135356|580453163|FG001|Overall Study|Surgery for abdominal fat|0|||
160745732|NCT00135356|580453162|FG000|Overall Study|Change in antiviral regimen|0|||
160745733|NCT00135356|580453163|FG001|Overall Study|Change in antiviral regimen|1|||
160745734|NCT00135356|580453162|FG000|Overall Study|Poor/noncompliance|1|||
160745735|NCT00135356|580453163|FG001|Overall Study|Poor/noncompliance|1|||
160745736|NCT00135356|580453162|FG000|Overall Study|No longer meets study criteria|2|||
160745737|NCT00135356|580453163|FG001|Overall Study|No longer meets study criteria|0|||
160745738|NCT00135356|580453162|FG000|Overall Study|Withdrawal by Subject|2|||
160745739|NCT00135356|580453163|FG001|Overall Study|Withdrawal by Subject|4|||
160745740|NCT02412878|580453164|FG000|Overall Study|Withdrawal by Subject|19|||
160745741|NCT02412878|580453165|FG001|Overall Study|Withdrawal by Subject|10|||
160745742|NCT02412878|580453164|FG000|Overall Study|Lost to Follow-up|2|||
160745743|NCT02412878|580453165|FG001|Overall Study|Lost to Follow-up|3|||
160745744|NCT04676152|580453167|FG000|Overall Study|screen fail|9|||
160745745|NCT01306214|580453168|FG000|Overall Study|Death|0|||
160745746|NCT01306214|580453169|FG001|Overall Study|Death|0|||
160745747|NCT01306214|580453170|FG002|Overall Study|Death|1|||
160745748|NCT01306214|580453168|FG000|Overall Study|Lost to Follow-up|3|||
160745749|NCT01306214|580453169|FG001|Overall Study|Lost to Follow-up|5|||
160745750|NCT01306214|580453170|FG002|Overall Study|Lost to Follow-up|4|||
160745751|NCT01306214|580453168|FG000|Overall Study|Withdrawal by Subject|24|||
160745752|NCT01306214|580453169|FG001|Overall Study|Withdrawal by Subject|22|||
160745753|NCT01306214|580453170|FG002|Overall Study|Withdrawal by Subject|16|||
160745754|NCT01306214|580453168|FG000|Overall Study|Not treated|1|||
160745755|NCT01306214|580453169|FG001|Overall Study|Not treated|1|||
160745756|NCT01306214|580453170|FG002|Overall Study|Not treated|1|||
160745757|NCT02686814|580453171|FG000|Overall Study|Physician Decision|14|||
160745758|NCT02686814|580453171|FG000|Overall Study|Withdrawal by Subject|4|||
160745759|NCT02686814|580453171|FG000|Overall Study|Death|1|||
160745760|NCT01026818|580453179|FG000|Screening Period|Entry Criteria Not Met|105|||
160745761|NCT01026818|580453180|FG001|Screening Period|Entry Criteria Not Met|0|||
160745762|NCT01026818|580453181|FG002|Screening Period|Entry Criteria Not Met|0|||
160745763|NCT01026818|580453182|FG003|Screening Period|Entry Criteria Not Met|0|||
160745764|NCT01026818|580453179|FG000|Screening Period|Withdrawal by Subject|49|||
160745765|NCT01026818|580453180|FG001|Screening Period|Withdrawal by Subject|0|||
160745766|NCT01026818|580453181|FG002|Screening Period|Withdrawal by Subject|0|||
160745767|NCT01026818|580453182|FG003|Screening Period|Withdrawal by Subject|0|||
160745768|NCT01026818|580453179|FG000|Screening Period|Protocol Deviation|3|||
160745769|NCT01026818|580453180|FG001|Screening Period|Protocol Deviation|0|||
160745770|NCT01026818|580453181|FG002|Screening Period|Protocol Deviation|0|||
160745771|NCT01026818|580453182|FG003|Screening Period|Protocol Deviation|0|||
160745772|NCT01026818|580453179|FG000|Screening Period|Adverse Event|2|||
160745773|NCT01026818|580453180|FG001|Screening Period|Adverse Event|0|||
160745774|NCT01026818|580453181|FG002|Screening Period|Adverse Event|0|||
160745775|NCT01026818|580453182|FG003|Screening Period|Adverse Event|0|||
160745776|NCT01026818|580453179|FG000|Screening Period|Physician Decision|1|||
160745777|NCT01026818|580453180|FG001|Screening Period|Physician Decision|0|||
160745778|NCT01026818|580453181|FG002|Screening Period|Physician Decision|0|||
160745779|NCT01026818|580453182|FG003|Screening Period|Physician Decision|0|||
160745780|NCT01026818|580453179|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
160745781|NCT01026818|580453180|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
160745782|NCT01026818|580453181|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
160745783|NCT01026818|580453182|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
160745784|NCT01026818|580453179|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
160745785|NCT01026818|580453180|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
160745786|NCT01026818|580453181|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
160745787|NCT01026818|580453182|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
160745788|NCT01026818|580453179|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
160745789|NCT01026818|580453180|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
160745790|NCT01026818|580453181|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
160745791|NCT01026818|580453182|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
160745792|NCT01026818|580453179|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
160745793|NCT01026818|580453180|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
160745794|NCT01026818|580453181|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
160745795|NCT01026818|580453182|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
160745796|NCT01026818|580453179|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
160745797|NCT01026818|580453180|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
160745798|NCT01026818|580453181|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
160745799|NCT01026818|580453182|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
160745800|NCT01026818|580453179|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
160745801|NCT01026818|580453180|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
160745802|NCT01026818|580453181|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
160745803|NCT01026818|580453182|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
160745804|NCT01026818|580453179|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
160745805|NCT01026818|580453180|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
160745806|NCT01026818|580453181|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
160745807|NCT01026818|580453182|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
160745808|NCT01026818|580453179|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
160745809|NCT01026818|580453180|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
160745810|NCT01026818|580453181|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
160745811|NCT01026818|580453182|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
160745812|NCT01026818|580453179|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
160745813|NCT01026818|580453180|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
160745814|NCT01026818|580453181|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
160745815|NCT01026818|580453182|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
160745816|NCT01026818|580453179|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
160745817|NCT01026818|580453180|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
160745818|NCT01026818|580453181|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
160745819|NCT01026818|580453182|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
160745820|NCT01026818|580453179|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
160745821|NCT01026818|580453180|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
160745822|NCT01026818|580453181|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
160745823|NCT01026818|580453182|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
160745824|NCT01026818|580453179|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
160745825|NCT01026818|580453180|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
160745826|NCT01026818|580453181|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
160745827|NCT01026818|580453182|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
160745828|NCT01026818|580453179|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
160745829|NCT01026818|580453180|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
160745830|NCT01026818|580453181|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
160745831|NCT01026818|580453182|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
160745832|NCT01026818|580453179|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
160745833|NCT01026818|580453180|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
160745834|NCT01026818|580453181|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
160745835|NCT01026818|580453182|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
160745836|NCT01026818|580453179|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
160745837|NCT01026818|580453180|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
160745838|NCT01026818|580453181|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
160745839|NCT01026818|580453182|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
160745840|NCT01026818|580453179|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
160745841|NCT01026818|580453180|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
160745842|NCT01026818|580453181|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
160745843|NCT01026818|580453182|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
160745844|NCT01026818|580453179|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
160745845|NCT01026818|580453180|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
160745846|NCT01026818|580453181|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
160745847|NCT01026818|580453182|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
160745848|NCT01026818|580453179|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
160745849|NCT01026818|580453180|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
160745850|NCT01026818|580453181|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
160745851|NCT01026818|580453182|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
160745852|NCT01026818|580453179|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
160745853|NCT01026818|580453180|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
160745854|NCT01026818|580453181|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
160745855|NCT01026818|580453182|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
160745856|NCT03300050|580453185|FG000|Overall Study|Lost to Follow-up|2|||
160745857|NCT03300050|580453186|FG001|Overall Study|Lost to Follow-up|1|||
160745858|NCT03300050|580453187|FG002|Overall Study|Lost to Follow-up|0|||
160745859|NCT03300050|580453188|FG003|Overall Study|Lost to Follow-up|0|||
160745860|NCT03300050|580453189|FG004|Overall Study|Lost to Follow-up|1|||
160745861|NCT03300050|580453185|FG000|Overall Study|Withdrawal by Subject|1|||
160745862|NCT03300050|580453186|FG001|Overall Study|Withdrawal by Subject|1|||
160745863|NCT03300050|580453187|FG002|Overall Study|Withdrawal by Subject|1|||
160745864|NCT03300050|580453188|FG003|Overall Study|Withdrawal by Subject|0|||
160745865|NCT03300050|580453189|FG004|Overall Study|Withdrawal by Subject|0|||
160745866|NCT03300050|580453185|FG000|Overall Study|Death|0|||
160745867|NCT03300050|580453186|FG001|Overall Study|Death|0|||
160745868|NCT03300050|580453187|FG002|Overall Study|Death|1|||
160745869|NCT03300050|580453188|FG003|Overall Study|Death|0|||
160745870|NCT03300050|580453189|FG004|Overall Study|Death|0|||
160745871|NCT03300050|580453185|FG000|Overall Study|Not Eligible at Randomization|0|||
160745872|NCT03300050|580453186|FG001|Overall Study|Not Eligible at Randomization|0|||
160745873|NCT03300050|580453187|FG002|Overall Study|Not Eligible at Randomization|1|||
160745874|NCT03300050|580453188|FG003|Overall Study|Not Eligible at Randomization|1|||
160745875|NCT03300050|580453189|FG004|Overall Study|Not Eligible at Randomization|0|||
160745876|NCT01375374|580453190|FG000|Overall Study|Adverse Event|1|||
160745877|NCT01908582|580453191|FG000|Period 2|Physician Decision|1|||
160745878|NCT01908582|580453191|FG000|Period 2|Withdrawal by Subject|1|||
160745879|NCT00424593|580453192|FG000|Acute Double-Blind Period|Adverse Event|16|||
160745880|NCT00424593|580453193|FG001|Acute Double-Blind Period|Adverse Event|7|||
160745881|NCT00424593|580453192|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
160745882|NCT00424593|580453193|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
160745883|NCT00424593|580453192|FG000|Acute Double-Blind Period|Protocol Violation|2|||
160745884|NCT00424593|580453193|FG001|Acute Double-Blind Period|Protocol Violation|2|||
160745885|NCT00424593|580453192|FG000|Acute Double-Blind Period|Physician Decision|1|||
160745886|NCT00424593|580453193|FG001|Acute Double-Blind Period|Physician Decision|2|||
160745887|NCT00424593|580453192|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
160745888|NCT00424593|580453193|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
160745889|NCT00424593|580453192|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
160745890|NCT00424593|580453193|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
160745891|NCT00424593|580453192|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
160745892|NCT00424593|580453193|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
160745893|NCT00424593|580453192|FG000|Dose-Blind Extension Period|Adverse Event|18|||
160745894|NCT00424593|580453193|FG001|Dose-Blind Extension Period|Adverse Event|0|||
160745895|NCT00424593|580453192|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
160745896|NCT00424593|580453193|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
160745897|NCT00424593|580453192|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
160745898|NCT00424593|580453193|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
160745899|NCT00424593|580453192|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
160745900|NCT00424593|580453193|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
160745901|NCT00424593|580453192|FG000|Dose-Blind Extension Period|Physician Decision|3|||
160745902|NCT00424593|580453193|FG001|Dose-Blind Extension Period|Physician Decision|0|||
160745903|NCT01066663|580453195|FG000|Overall Study|Adverse Event|0|||
160745904|NCT01066663|580453196|FG001|Overall Study|Adverse Event|0|||
160745905|NCT01066663|580453197|FG002|Overall Study|Adverse Event|1|||
160745906|NCT01090050|580453198|FG000|Overall Study|Lost to Follow-up|0|||
160745907|NCT01090050|580453199|FG001|Overall Study|Lost to Follow-up|1|||
160745908|NCT01090050|580453198|FG000|Overall Study|Lack of Efficacy|1|||
160745909|NCT01090050|580453199|FG001|Overall Study|Lack of Efficacy|5|||
160745910|NCT01090050|580453198|FG000|Overall Study|Physician Decision|0|||
160745911|NCT01090050|580453199|FG001|Overall Study|Physician Decision|1|||
160745912|NCT02232061|580453200|FG000|Overall Study|Administrative problems|1|||
160745913|NCT02232061|580453200|FG000|Overall Study|Withdrawal by Subject|1|||
160745914|NCT00571103|580453201|FG000|Overall Study|Withdrawal by Subject|1|||
160745915|NCT00571103|580453201|FG000|Overall Study|Lost to Follow-up|1|||
160745916|NCT02368886|580453202|FG000|Overall Study|Cancel|1|||
160745917|NCT02368886|580453203|FG001|Overall Study|Cancel|1|||
160745918|NCT02368886|580453204|FG002|Overall Study|Cancel|1|||
160745919|NCT02368886|580453205|FG003|Overall Study|Cancel|3|||
160745920|NCT02368886|580453202|FG000|Overall Study|Ineligible|0|||
160745921|NCT02368886|580453203|FG001|Overall Study|Ineligible|0|||
160745922|NCT02368886|580453204|FG002|Overall Study|Ineligible|0|||
160745923|NCT02368886|580453205|FG003|Overall Study|Ineligible|1|||
160745924|NCT04278924|580453207|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
160745925|NCT04278924|580453208|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
160745926|NCT04278924|580453209|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
160745927|NCT04278924|580453210|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
160745928|NCT04278924|580453211|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
160745929|NCT04278924|580453212|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
160745930|NCT04278924|580453213|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
160745931|NCT04278924|580453207|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
160745932|NCT04278924|580453208|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
160745933|NCT04278924|580453209|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
160745934|NCT04278924|580453210|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
160745935|NCT04278924|580453211|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
160745936|NCT04278924|580453212|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
160745937|NCT04278924|580453213|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
160745938|NCT04767529|580453214|FG000|Overall Study|Adverse Event|0|||
160745939|NCT04767529|580453215|FG001|Overall Study|Adverse Event|4|||
160745940|NCT04767529|580453216|FG002|Overall Study|Adverse Event|3|||
160745941|NCT04767529|580453214|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
160745942|NCT04767529|580453215|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
160745943|NCT04767529|580453216|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
160745944|NCT04767529|580453214|FG000|Overall Study|Required use of a prohibited medication|0|||
160745945|NCT04767529|580453215|FG001|Overall Study|Required use of a prohibited medication|1|||
160745946|NCT04767529|580453216|FG002|Overall Study|Required use of a prohibited medication|0|||
160745947|NCT04767529|580453214|FG000|Overall Study|Withdrawal by Subject|7|||
160745948|NCT04767529|580453215|FG001|Overall Study|Withdrawal by Subject|5|||
160745949|NCT04767529|580453216|FG002|Overall Study|Withdrawal by Subject|4|||
160745950|NCT04767529|580453214|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
160745951|NCT04767529|580453215|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
160745952|NCT04767529|580453216|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
160745953|NCT04767529|580453214|FG000|Overall Study|Lost to Follow-up|0|||
160745954|NCT04767529|580453215|FG001|Overall Study|Lost to Follow-up|2|||
160745955|NCT04767529|580453216|FG002|Overall Study|Lost to Follow-up|3|||
160745956|NCT04847232|580453217|FG000|Overall Study|Death|123|||
160745957|NCT04847232|580453218|FG001|Overall Study|Death|115|||
160745958|NCT04847232|580453217|FG000|Overall Study|Lost to Follow-up|3|||
160745959|NCT04847232|580453218|FG001|Overall Study|Lost to Follow-up|10|||
160745960|NCT04847232|580453217|FG000|Overall Study|Withdrawal by Subject|73|||
160745961|NCT04847232|580453218|FG001|Overall Study|Withdrawal by Subject|101|||
160745962|NCT04847232|580453217|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
160745963|NCT04847232|580453218|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
160745964|NCT02476916|580453219|FG000|Core Period|Adverse Event|2|||
160745965|NCT02476916|580453220|FG001|Core Period|Adverse Event|2|||
160745966|NCT02476916|580453219|FG000|Core Period|Investigator decision|1|||
160745967|NCT02476916|580453220|FG001|Core Period|Investigator decision|1|||
160745968|NCT02476916|580453219|FG000|Core Period|Withdrawal by Subject|3|||
160745969|NCT02476916|580453220|FG001|Core Period|Withdrawal by Subject|0|||
160745970|NCT02476916|580453219|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
160745971|NCT02476916|580453220|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
160745972|NCT02476916|580453219|FG000|Extension Period|On Treatment|12|||
160745973|NCT02476916|580453220|FG001|Extension Period|On Treatment|17|||
160745974|NCT06010732|580453221|FG000|Crossover Period 1|Protocol Violation|0|||
160745975|NCT06010732|580453222|FG001|Crossover Period 1|Protocol Violation|0|||
160745976|NCT06010732|580453223|FG002|Crossover Period 1|Protocol Violation|1|||
160745977|NCT06010732|580453224|FG003|Crossover Period 1|Protocol Violation|0|||
160745978|NCT06010732|580453225|FG004|Crossover Period 1|Protocol Violation|1|||
160745979|NCT06010732|580453226|FG005|Crossover Period 1|Protocol Violation|0|||
160745980|NCT06010732|580453221|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
160745981|NCT06010732|580453222|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
160745982|NCT06010732|580453223|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
160745983|NCT06010732|580453224|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
160745984|NCT06010732|580453225|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
160745985|NCT06010732|580453226|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
160745986|NCT06010732|580453221|FG000|Crossover Period 2|Adverse Event|0|||
160745987|NCT06010732|580453222|FG001|Crossover Period 2|Adverse Event|1|||
160745988|NCT06010732|580453223|FG002|Crossover Period 2|Adverse Event|0|||
160745989|NCT06010732|580453224|FG003|Crossover Period 2|Adverse Event|0|||
160745990|NCT06010732|580453225|FG004|Crossover Period 2|Adverse Event|0|||
160745991|NCT06010732|580453226|FG005|Crossover Period 2|Adverse Event|0|||
160745992|NCT06010732|580453221|FG000|Crossover Period 2|broken denture|0|||
160745993|NCT06010732|580453222|FG001|Crossover Period 2|broken denture|0|||
160745994|NCT06010732|580453223|FG002|Crossover Period 2|broken denture|1|||
160745995|NCT06010732|580453224|FG003|Crossover Period 2|broken denture|0|||
160745996|NCT06010732|580453225|FG004|Crossover Period 2|broken denture|0|||
160745997|NCT06010732|580453226|FG005|Crossover Period 2|broken denture|0|||
160745998|NCT00253370|580453228|FG000|Overall Study|Adverse Event|18|||
160745999|NCT00253370|580453228|FG000|Overall Study|Disease progression|13|||
160746000|NCT00253370|580453228|FG000|Overall Study|Death|2|||
160746001|NCT00253370|580453228|FG000|Overall Study|Withdrawal by Subject|6|||
160746002|NCT00253370|580453228|FG000|Overall Study|Non-protocol therapy|1|||
160746003|NCT00253370|580453228|FG000|Overall Study|Physician Decision|1|||
160746004|NCT00253370|580453228|FG000|Overall Study|Protocol Violation|1|||
160746005|NCT00253370|580453228|FG000|Overall Study|Abdominal pain due to disease|1|||
160746006|NCT03699540|580453229|FG000|Overall Study|Lost to Follow-up|1|||
160746007|NCT02697591|580453230|FG000|Overall Study|Lost to Follow-up|0|||
160746008|NCT02697591|580453231|FG001|Overall Study|Lost to Follow-up|0|||
160746009|NCT02697591|580453232|FG002|Overall Study|Lost to Follow-up|0|||
160746010|NCT02697591|580453233|FG003|Overall Study|Lost to Follow-up|0|||
160746011|NCT02697591|580453234|FG004|Overall Study|Lost to Follow-up|0|||
160746012|NCT02697591|580453235|FG005|Overall Study|Lost to Follow-up|1|||
160746013|NCT02697591|580453236|FG006|Overall Study|Lost to Follow-up|1|||
160746014|NCT02697591|580453237|FG007|Overall Study|Lost to Follow-up|0|||
160746015|NCT02697591|580453238|FG008|Overall Study|Lost to Follow-up|0|||
160746016|NCT02697591|580453239|FG009|Overall Study|Lost to Follow-up|1|||
160746017|NCT02697591|580453230|FG000|Overall Study|Withdrawal by Subject|1|||
160746018|NCT02697591|580453231|FG001|Overall Study|Withdrawal by Subject|1|||
160746019|NCT02697591|580453232|FG002|Overall Study|Withdrawal by Subject|2|||
160746020|NCT02697591|580453233|FG003|Overall Study|Withdrawal by Subject|1|||
160746021|NCT02697591|580453234|FG004|Overall Study|Withdrawal by Subject|7|||
160746022|NCT02697591|580453235|FG005|Overall Study|Withdrawal by Subject|6|||
160746023|NCT02697591|580453236|FG006|Overall Study|Withdrawal by Subject|9|||
160746024|NCT02697591|580453237|FG007|Overall Study|Withdrawal by Subject|1|||
160746025|NCT02697591|580453238|FG008|Overall Study|Withdrawal by Subject|6|||
160746026|NCT02697591|580453239|FG009|Overall Study|Withdrawal by Subject|10|||
160746027|NCT02697591|580453230|FG000|Overall Study|Physician Decision|1|||
160746028|NCT02697591|580453231|FG001|Overall Study|Physician Decision|0|||
160746029|NCT02697591|580453232|FG002|Overall Study|Physician Decision|0|||
160746030|NCT02697591|580453233|FG003|Overall Study|Physician Decision|0|||
160746031|NCT02697591|580453234|FG004|Overall Study|Physician Decision|1|||
160746032|NCT02697591|580453235|FG005|Overall Study|Physician Decision|2|||
160746033|NCT02697591|580453236|FG006|Overall Study|Physician Decision|0|||
160746034|NCT02697591|580453237|FG007|Overall Study|Physician Decision|0|||
160746035|NCT02697591|580453238|FG008|Overall Study|Physician Decision|1|||
160746036|NCT02697591|580453239|FG009|Overall Study|Physician Decision|1|||
160746037|NCT02697591|580453230|FG000|Overall Study|Death|2|||
160746038|NCT02697591|580453231|FG001|Overall Study|Death|3|||
160746039|NCT02697591|580453232|FG002|Overall Study|Death|1|||
160746040|NCT02697591|580453233|FG003|Overall Study|Death|1|||
160746041|NCT02697591|580453234|FG004|Overall Study|Death|4|||
160746042|NCT02697591|580453235|FG005|Overall Study|Death|5|||
160746043|NCT02697591|580453236|FG006|Overall Study|Death|3|||
160746044|NCT02697591|580453237|FG007|Overall Study|Death|1|||
160746045|NCT02697591|580453238|FG008|Overall Study|Death|1|||
160746046|NCT02697591|580453239|FG009|Overall Study|Death|5|||
160746047|NCT02697591|580453230|FG000|Overall Study|Reason not Specified|0|||
160746048|NCT02697591|580453231|FG001|Overall Study|Reason not Specified|0|||
160746049|NCT02697591|580453232|FG002|Overall Study|Reason not Specified|0|||
160746050|NCT02697591|580453233|FG003|Overall Study|Reason not Specified|1|||
160746051|NCT02697591|580453234|FG004|Overall Study|Reason not Specified|1|||
160746052|NCT02697591|580453235|FG005|Overall Study|Reason not Specified|2|||
160746053|NCT02697591|580453236|FG006|Overall Study|Reason not Specified|3|||
160746054|NCT02697591|580453237|FG007|Overall Study|Reason not Specified|1|||
160746055|NCT02697591|580453238|FG008|Overall Study|Reason not Specified|1|||
160746056|NCT02697591|580453239|FG009|Overall Study|Reason not Specified|3|||
160746057|NCT00004088|580453241|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
160746058|NCT00004088|580453241|FG000|Overall Study|Withdrawal by Subject|1|||
160746059|NCT00004088|580453241|FG000|Overall Study|Protocol Violation|3|||
160746060|NCT00004088|580453241|FG000|Overall Study|Physician Decision|1|||
160746061|NCT03624569|580453243|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160746062|NCT03624569|580453244|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
160746063|NCT03624569|580453243|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
160746064|NCT03624569|580453244|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
160746065|NCT01618916|580453245|FG000|Overall Study|Adverse Event|1|||
160746066|NCT01618916|580453246|FG001|Overall Study|Adverse Event|0|||
160746067|NCT01618916|580453247|FG002|Overall Study|Adverse Event|0|||
160746068|NCT01618916|580453248|FG003|Overall Study|Adverse Event|0|||
160746069|NCT01618916|580453249|FG004|Overall Study|Adverse Event|0|||
160746070|NCT01618916|580453250|FG005|Overall Study|Adverse Event|0|||
160746071|NCT01618916|580453245|FG000|Overall Study|Withdrawal by Subject|0|||
160746072|NCT01618916|580453246|FG001|Overall Study|Withdrawal by Subject|1|||
160746073|NCT01618916|580453247|FG002|Overall Study|Withdrawal by Subject|1|||
160746074|NCT01618916|580453248|FG003|Overall Study|Withdrawal by Subject|0|||
160746075|NCT01618916|580453249|FG004|Overall Study|Withdrawal by Subject|1|||
160746076|NCT01618916|580453250|FG005|Overall Study|Withdrawal by Subject|0|||
160746077|NCT01618916|580453245|FG000|Overall Study|Lost to Follow-up|1|||
160746078|NCT01618916|580453246|FG001|Overall Study|Lost to Follow-up|0|||
160746079|NCT01618916|580453247|FG002|Overall Study|Lost to Follow-up|0|||
160746080|NCT01618916|580453248|FG003|Overall Study|Lost to Follow-up|2|||
160746081|NCT01618916|580453249|FG004|Overall Study|Lost to Follow-up|0|||
160746082|NCT01618916|580453250|FG005|Overall Study|Lost to Follow-up|0|||
160746083|NCT00090584|580453254|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
160746084|NCT00090584|580453255|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
160746085|NCT00090584|580453254|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
160746086|NCT00090584|580453255|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
160746087|NCT00379808|580453256|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
160746088|NCT00379808|580453257|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
160746089|NCT01048099|580453264|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
160746090|NCT01048099|580453264|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
160746091|NCT00508157|580453265|FG000|Overall Study|Adverse Event|0|||
160746092|NCT00508157|580453266|FG001|Overall Study|Adverse Event|1|||
160746093|NCT00508157|580453265|FG000|Overall Study|Subject Withdrew Consent|1|||
160746094|NCT00508157|580453266|FG001|Overall Study|Subject Withdrew Consent|0|||
160746095|NCT00508157|580453265|FG000|Overall Study|Lost to Follow-up|1|||
160746096|NCT00508157|580453266|FG001|Overall Study|Lost to Follow-up|0|||
160746097|NCT00508157|580453265|FG000|Overall Study|Subject no longer met study criteria|0|||
160746098|NCT00508157|580453266|FG001|Overall Study|Subject no longer met study criteria|1|||
160746099|NCT00508157|580453265|FG000|Overall Study|Other known cause|0|||
160746100|NCT00508157|580453266|FG001|Overall Study|Other known cause|1|||
160746101|NCT01731470|580453268|FG000|Overall Study|Withdrawal by Subject|1|||
160746102|NCT01731470|580453268|FG000|Overall Study|Did not meet study criteria|1|||
160746103|NCT02258334|580453269|FG000|Overall Study|Adverse Event|1|||
160746104|NCT02258334|580453270|FG001|Overall Study|Adverse Event|0|||
160746105|NCT02258334|580453271|FG002|Overall Study|Adverse Event|0|||
160746106|NCT02258334|580453272|FG003|Overall Study|Adverse Event|0|||
160746107|NCT05079230|580453273|FG000|Overall Study|Study Terminated by Sponsor|101|||
160746108|NCT05079230|580453274|FG001|Overall Study|Study Terminated by Sponsor|102|||
160746109|NCT05079230|580453273|FG000|Overall Study|Death|72|||
160746110|NCT05079230|580453274|FG001|Overall Study|Death|66|||
160746111|NCT05079230|580453273|FG000|Overall Study|Withdrew Consent|16|||
160746112|NCT05079230|580453274|FG001|Overall Study|Withdrew Consent|18|||
160746113|NCT05079230|580453273|FG000|Overall Study|Lost to Follow-up|0|||
160746114|NCT05079230|580453274|FG001|Overall Study|Lost to Follow-up|3|||
160746115|NCT01524783|580453275|FG000|Blinded Period|Adverse Event|64|||
160746116|NCT01524783|580453276|FG001|Blinded Period|Adverse Event|7|||
160746117|NCT01524783|580453277|FG002|Blinded Period|Adverse Event|0|||
160746118|NCT01524783|580453275|FG000|Blinded Period|Disease Progression|89|||
160746119|NCT01524783|580453276|FG001|Blinded Period|Disease Progression|75|||
160746120|NCT01524783|580453277|FG002|Blinded Period|Disease Progression|0|||
160746121|NCT01524783|580453275|FG000|Blinded Period|Withdrawal by Subject|19|||
160746122|NCT01524783|580453276|FG001|Blinded Period|Withdrawal by Subject|6|||
160746123|NCT01524783|580453277|FG002|Blinded Period|Withdrawal by Subject|0|||
160746124|NCT01524783|580453275|FG000|Blinded Period|Protocol deviation|2|||
160746125|NCT01524783|580453276|FG001|Blinded Period|Protocol deviation|1|||
160746126|NCT01524783|580453277|FG002|Blinded Period|Protocol deviation|0|||
160746127|NCT01524783|580453275|FG000|Blinded Period|Death|5|||
160746128|NCT01524783|580453276|FG001|Blinded Period|Death|2|||
160746129|NCT01524783|580453277|FG002|Blinded Period|Death|0|||
160746130|NCT01524783|580453275|FG000|Open-label Period|Disease progression|13|||
160746131|NCT01524783|580453276|FG001|Open-label Period|Disease progression|0|||
160746132|NCT01524783|580453277|FG002|Open-label Period|Disease progression|2|||
160746133|NCT01524783|580453275|FG000|Open-label Period|Administrative problems|5|||
160746134|NCT01524783|580453276|FG001|Open-label Period|Administrative problems|0|||
160746135|NCT01524783|580453277|FG002|Open-label Period|Administrative problems|2|||
160746136|NCT01524783|580453275|FG000|Open-label Period|Adverse Event|5|||
160746137|NCT01524783|580453276|FG001|Open-label Period|Adverse Event|0|||
160746138|NCT01524783|580453277|FG002|Open-label Period|Adverse Event|1|||
160746139|NCT01524783|580453275|FG000|Open-label Period|Withdrawal by Subject|2|||
160746140|NCT01524783|580453276|FG001|Open-label Period|Withdrawal by Subject|0|||
160746141|NCT01524783|580453277|FG002|Open-label Period|Withdrawal by Subject|1|||
160746142|NCT01524783|580453275|FG000|Open-label Period|Protocol deviation|1|||
160746143|NCT01524783|580453276|FG001|Open-label Period|Protocol deviation|0|||
160746144|NCT01524783|580453277|FG002|Open-label Period|Protocol deviation|0|||
160746145|NCT00477607|580453279|FG000|Overall Study|Lost to Follow-up|7|||
160746146|NCT00477607|580453280|FG001|Overall Study|Lost to Follow-up|7|||
160746147|NCT01687283|580455175|FG000|Overall Study|Adverse Event|11|||
160746148|NCT01687283|580455176|FG001|Overall Study|Adverse Event|4|||
160746149|NCT01687283|580455175|FG000|Overall Study|Lack of Efficacy|3|||
160746150|NCT01687283|580455176|FG001|Overall Study|Lack of Efficacy|1|||
160746151|NCT01687283|580455175|FG000|Overall Study|Protocol Violation|1|||
160746152|NCT01687283|580455176|FG001|Overall Study|Protocol Violation|3|||
160746153|NCT01687283|580455175|FG000|Overall Study|protocol defined stopping criteria|8|||
160746154|NCT01687283|580455176|FG001|Overall Study|protocol defined stopping criteria|10|||
160746155|NCT01687283|580455175|FG000|Overall Study|Lost to Follow-up|1|||
160746156|NCT01687283|580455176|FG001|Overall Study|Lost to Follow-up|1|||
160746157|NCT01687283|580455175|FG000|Overall Study|Investigator discretion|2|||
160746158|NCT01687283|580455176|FG001|Overall Study|Investigator discretion|0|||
160746159|NCT01687283|580455175|FG000|Overall Study|Withdrawal by Subject|9|||
160746160|NCT01687283|580455176|FG001|Overall Study|Withdrawal by Subject|8|||
160746161|NCT00410072|580455180|FG000|Day 1 to Week 48|Adverse Event|1|||
160746162|NCT00410072|580455181|FG001|Day 1 to Week 48|Adverse Event|2|||
160746163|NCT00410072|580455180|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
160746164|NCT00410072|580455181|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
160746165|NCT00410072|580455180|FG000|Day 1 to Week 48|Other|0|||
160746166|NCT00410072|580455181|FG001|Day 1 to Week 48|Other|1|||
160746167|NCT00410072|580455180|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
160746168|NCT00410072|580455181|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
160746169|NCT00410072|580455180|FG000|Day 1 to Week 48|Pregnancy|0|||
160746170|NCT00410072|580455181|FG001|Day 1 to Week 48|Pregnancy|2|||
160746171|NCT00410072|580455180|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
160746172|NCT00410072|580455181|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
160746173|NCT00410072|580455180|FG000|After Week 48 to Week 96|Adverse Event|1|||
160746174|NCT00410072|580455181|FG001|After Week 48 to Week 96|Adverse Event|2|||
160746175|NCT00410072|580455180|FG000|After Week 48 to Week 96|Death|0|||
160746176|NCT00410072|580455181|FG001|After Week 48 to Week 96|Death|1|||
160746177|NCT00410072|580455180|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
160746178|NCT00410072|580455181|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
160746179|NCT00410072|580455180|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
160746180|NCT00410072|580455181|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
160746181|NCT00410072|580455180|FG000|After Week 48 to Week 96|Other|2|||
160746182|NCT00410072|580455181|FG001|After Week 48 to Week 96|Other|0|||
160746183|NCT00410072|580455180|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
160746184|NCT00410072|580455181|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
160746185|NCT00410072|580455180|FG000|After Week 48 to Week 96|Pregnancy|0|||
160746186|NCT00410072|580455181|FG001|After Week 48 to Week 96|Pregnancy|2|||
160746187|NCT00410072|580455180|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
160746188|NCT00410072|580455181|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
160746189|NCT01270321|580455184|FG000|Overall Study|Death|3|||
160746190|NCT01270321|580455185|FG001|Overall Study|Death|1|||
160746191|NCT01270321|580455186|FG002|Overall Study|Death|4|||
160746192|NCT01270321|580455184|FG000|Overall Study|Adverse Event|7|||
160746193|NCT01270321|580455185|FG001|Overall Study|Adverse Event|9|||
160746194|NCT01270321|580455186|FG002|Overall Study|Adverse Event|5|||
160746195|NCT00762034|580455193|FG000|Induction Period|Protocol Violation|1|||
160746196|NCT00762034|580455194|FG001|Induction Period|Protocol Violation|2|||
160746197|NCT00762034|580455193|FG000|Induction Period|Entry Criterion Not Met|12|||
160746198|NCT00762034|580455194|FG001|Induction Period|Entry Criterion Not Met|11|||
160746199|NCT00762034|580455193|FG000|Induction Period|Adverse Event|27|||
160746200|NCT00762034|580455194|FG001|Induction Period|Adverse Event|38|||
160746201|NCT00762034|580455193|FG000|Induction Period|Lost to Follow-up|1|||
160746202|NCT00762034|580455194|FG001|Induction Period|Lost to Follow-up|1|||
160746203|NCT00762034|580455193|FG000|Induction Period|Progressive Disease|73|||
160746204|NCT00762034|580455194|FG001|Induction Period|Progressive Disease|55|||
160746205|NCT00762034|580455193|FG000|Induction Period|Physician Decision|21|||
160746206|NCT00762034|580455194|FG001|Induction Period|Physician Decision|20|||
160746207|NCT00762034|580455193|FG000|Induction Period|Withdrawal by Subject|15|||
160746208|NCT00762034|580455194|FG001|Induction Period|Withdrawal by Subject|19|||
160746209|NCT00762034|580455193|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
160746210|NCT00762034|580455194|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
160746211|NCT00762034|580455193|FG000|Induction Period|Deaths Due to Study Disease|9|||
160746212|NCT00762034|580455194|FG001|Induction Period|Deaths Due to Study Disease|9|||
160746213|NCT00762034|580455193|FG000|Maintenance Period|Protocol Violation|1|||
160746214|NCT00762034|580455194|FG001|Maintenance Period|Protocol Violation|3|||
160746215|NCT00762034|580455193|FG000|Maintenance Period|Entry Criterion Not Met|0|||
160746216|NCT00762034|580455194|FG001|Maintenance Period|Entry Criterion Not Met|2|||
160746217|NCT00762034|580455193|FG000|Maintenance Period|Adverse Event|42|||
160746218|NCT00762034|580455194|FG001|Maintenance Period|Adverse Event|26|||
160746219|NCT00762034|580455193|FG000|Maintenance Period|Progressive Disease|186|||
160746220|NCT00762034|580455194|FG001|Maintenance Period|Progressive Disease|224|||
160746221|NCT00762034|580455193|FG000|Maintenance Period|Physician Decision|25|||
160746222|NCT00762034|580455194|FG001|Maintenance Period|Physician Decision|20|||
160746223|NCT00762034|580455193|FG000|Maintenance Period|Withdrawal by Subject|34|||
160746224|NCT00762034|580455194|FG001|Maintenance Period|Withdrawal by Subject|14|||
160746225|NCT00762034|580455193|FG000|Maintenance Period|Death not due to study disease|2|||
160746226|NCT00762034|580455194|FG001|Maintenance Period|Death not due to study disease|5|||
160746227|NCT00762034|580455193|FG000|Maintenance Period|Death due to study disease|3|||
160746228|NCT00762034|580455194|FG001|Maintenance Period|Death due to study disease|3|||
160746229|NCT00762034|580455193|FG000|Maintenance Period|Other|1|||
160746230|NCT00762034|580455194|FG001|Maintenance Period|Other|1|||
160746231|NCT04228965|580455195|FG000|Overall Study|Lost to Follow-up|26|||
160746232|NCT04228965|580455196|FG001|Overall Study|Lost to Follow-up|11|||
160746233|NCT04228965|580455195|FG000|Overall Study|Withdrawal by Subject|18|||
160746234|NCT04228965|580455196|FG001|Overall Study|Withdrawal by Subject|5|||
160746235|NCT02442206|580455197|FG000|Period 1|Adverse Event|1|||
160746236|NCT02442206|580455198|FG001|Period 1|Adverse Event|1|||
160746237|NCT02442206|580455197|FG000|Period 1|withdrew consent|0|||
160746238|NCT02442206|580455198|FG001|Period 1|withdrew consent|1|||
160746239|NCT02442206|580455197|FG000|Period 1|COPD exacerbation|0|||
160746240|NCT02442206|580455198|FG001|Period 1|COPD exacerbation|1|||
160746241|NCT02442206|580455197|FG000|Period 2|Adverse Event|1|||
160746242|NCT02442206|580455198|FG001|Period 2|Adverse Event|0|||
160746243|NCT01471444|580455199|FG000|Overall Study|Physician Decision|3|||
160746244|NCT01471444|580455200|FG001|Overall Study|Physician Decision|2|||
160746245|NCT01471444|580455199|FG000|Overall Study|Withdrawal by Subject|0|||
160746246|NCT01471444|580455200|FG001|Overall Study|Withdrawal by Subject|1|||
160746247|NCT03915626|580455201|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
160746248|NCT01709409|580455204|FG000|Overall Study|Protocol Violation|1|||
160746249|NCT01709409|580455205|FG001|Overall Study|Protocol Violation|0|||
160746250|NCT04571385|580455206|FG000|Overall Study|Participant non-compliance|1|||
160746251|NCT04571385|580455207|FG001|Overall Study|Participant non-compliance|0|||
160746252|NCT04571385|580455208|FG002|Overall Study|Participant non-compliance|0|||
160746253|NCT04571385|580455206|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
160746254|NCT04571385|580455207|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
160746255|NCT04571385|580455208|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
160746256|NCT04571385|580455206|FG000|Overall Study|Screen failure|0|||
160746257|NCT04571385|580455207|FG001|Overall Study|Screen failure|0|||
160746258|NCT04571385|580455208|FG002|Overall Study|Screen failure|1|||
160746259|NCT05025332|580455209|FG000|Screening|Screen failure|12|||
160746260|NCT05025332|580455209|FG000|Treatment & Follow Up|Protocol Violation|1|||
160746261|NCT05025332|580455209|FG000|Treatment & Follow Up|Adverse Event|4|||
160746262|NCT01928199|580455212|FG000|Overall Study|Lost to Follow-up|2|||
160746263|NCT01928199|580455213|FG001|Overall Study|Lost to Follow-up|1|||
160746264|NCT01928199|580455212|FG000|Overall Study|Withdrawal by Subject|3|||
160746265|NCT01928199|580455213|FG001|Overall Study|Withdrawal by Subject|5|||
160746266|NCT01108237|580455214|FG000|Overall Study|No alignment data|2|||
160746267|NCT01108237|580455215|FG001|Overall Study|No alignment data|15|||
160746268|NCT01108237|580455214|FG000|Overall Study|Did not meet criteria for analysis|7|||
160746269|NCT01108237|580455215|FG001|Overall Study|Did not meet criteria for analysis|0|||
160746270|NCT03297021|580455216|FG000|Overall Study|Incomplete/illegible data sheet|4|||
160746271|NCT03297021|580455217|FG001|Overall Study|Incomplete/illegible data sheet|2|||
160746272|NCT03297021|580455218|FG002|Overall Study|Incomplete/illegible data sheet|3|||
160746273|NCT03297021|580455216|FG000|Overall Study|Missing Post-Op Data|1|||
160746274|NCT03297021|580455217|FG001|Overall Study|Missing Post-Op Data|2|||
160746275|NCT03297021|580455218|FG002|Overall Study|Missing Post-Op Data|1|||
160746276|NCT02784288|580455220|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
160746277|NCT02734862|580455221|FG000|Part A|Death|3|||
160746278|NCT02734862|580455222|FG001|Part A|Death|4|||
160746279|NCT02734862|580455223|FG002|Part A|Death|6|||
160746280|NCT02734862|580455221|FG000|Part A|Lost to Follow-up|2|||
160746281|NCT02734862|580455222|FG001|Part A|Lost to Follow-up|1|||
160746282|NCT02734862|580455223|FG002|Part A|Lost to Follow-up|1|||
160746283|NCT02734862|580455221|FG000|Part A|Withdrawal by Subject|1|||
160746284|NCT02734862|580455222|FG001|Part A|Withdrawal by Subject|1|||
160746285|NCT02734862|580455223|FG002|Part A|Withdrawal by Subject|2|||
160746286|NCT02734862|580455221|FG000|Part A|Physician Decision|2|||
160746287|NCT02734862|580455222|FG001|Part A|Physician Decision|0|||
160746288|NCT02734862|580455223|FG002|Part A|Physician Decision|1|||
160746289|NCT02734862|580455221|FG000|Part A|Adverse Event|2|||
160746290|NCT02734862|580455222|FG001|Part A|Adverse Event|0|||
160746291|NCT02734862|580455223|FG002|Part A|Adverse Event|1|||
160746292|NCT02734862|580455221|FG000|Part A|Noncompliance|1|||
160746293|NCT02734862|580455222|FG001|Part A|Noncompliance|1|||
160746294|NCT02734862|580455223|FG002|Part A|Noncompliance|0|||
160746295|NCT02734862|580455221|FG000|Part A|Other|1|||
160746296|NCT02734862|580455222|FG001|Part A|Other|1|||
160746297|NCT02734862|580455223|FG002|Part A|Other|3|||
160746298|NCT02734862|580455221|FG000|Part B|Death|8|||
160746299|NCT02734862|580455222|FG001|Part B|Death|3|||
160746300|NCT02734862|580455223|FG002|Part B|Death|5|||
160746301|NCT02734862|580455221|FG000|Part B|Lost to Follow-up|2|||
160746302|NCT02734862|580455222|FG001|Part B|Lost to Follow-up|2|||
160746303|NCT02734862|580455223|FG002|Part B|Lost to Follow-up|0|||
160746304|NCT02734862|580455221|FG000|Part B|Withdrawal by Subject|3|||
160746305|NCT02734862|580455222|FG001|Part B|Withdrawal by Subject|1|||
160746306|NCT02734862|580455223|FG002|Part B|Withdrawal by Subject|0|||
160746307|NCT02734862|580455221|FG000|Part B|Other|0|||
160746308|NCT02734862|580455222|FG001|Part B|Other|1|||
160746309|NCT02734862|580455223|FG002|Part B|Other|0|||
160746310|NCT02757625|580455224|FG000|Overall Study|Investigator's discretion|0|||
160746311|NCT02757625|580455225|FG001|Overall Study|Investigator's discretion|0|||
160746312|NCT02757625|580455226|FG002|Overall Study|Investigator's discretion|1|||
160746313|NCT02757625|580455227|FG003|Overall Study|Investigator's discretion|0|||
160746314|NCT02757625|580455224|FG000|Overall Study|Adverse Event|0|||
160746315|NCT02757625|580455225|FG001|Overall Study|Adverse Event|0|||
160746316|NCT02757625|580455226|FG002|Overall Study|Adverse Event|1|||
160746317|NCT02757625|580455227|FG003|Overall Study|Adverse Event|0|||
160746318|NCT00564278|580455228|FG000|Overall Study|Lost to Follow-up|35|||
160746319|NCT00564278|580455229|FG001|Overall Study|Lost to Follow-up|33|||
160746320|NCT00564278|580455228|FG000|Overall Study|Physician Decision|1|||
160746321|NCT00564278|580455229|FG001|Overall Study|Physician Decision|2|||
160746322|NCT00564278|580455228|FG000|Overall Study|Withdrawal by Subject|11|||
160746323|NCT00564278|580455229|FG001|Overall Study|Withdrawal by Subject|7|||
160746324|NCT00560703|580455230|FG000|Overall Study|Adverse Event|0|||
160746325|NCT00560703|580455231|FG001|Overall Study|Adverse Event|2|||
160746326|NCT00560703|580455230|FG000|Overall Study|Protocol Violation|0|||
160746327|NCT00560703|580455231|FG001|Overall Study|Protocol Violation|2|||
160746328|NCT00560703|580455230|FG000|Overall Study|Withdrawal by Subject|0|||
160746329|NCT00560703|580455231|FG001|Overall Study|Withdrawal by Subject|1|||
160746330|NCT00560703|580455230|FG000|Overall Study|non-compliance|0|||
160746331|NCT00560703|580455231|FG001|Overall Study|non-compliance|1|||
160746332|NCT02095197|580455232|FG000|Overall Study|Lost to Follow-up|0|||
160746333|NCT02095197|580455233|FG001|Overall Study|Lost to Follow-up|3|||
160746334|NCT02779075|580455234|FG000|Overall Study|Withdrawal by Subject|1|||
160746335|NCT02779075|580455235|FG001|Overall Study|Withdrawal by Subject|3|||
160746336|NCT02779075|580455234|FG000|Overall Study|IV lost during 2nd study|1|||
160746337|NCT02779075|580455235|FG001|Overall Study|IV lost during 2nd study|0|||
160746338|NCT00790556|580455236|FG000|Treatment Period 1|Physician Decision|1|||
160746339|NCT00790556|580455237|FG001|Treatment Period 1|Physician Decision|0|||
160746340|NCT00790556|580455236|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160746341|NCT00790556|580455237|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160746342|NCT02714036|580455238|FG000|Overall Study|Adverse Event|9|||
160746343|NCT02714036|580455239|FG001|Overall Study|Adverse Event|2|||
160746344|NCT02714036|580455238|FG000|Overall Study|Withdrawal by Subject|3|||
160746345|NCT02714036|580455239|FG001|Overall Study|Withdrawal by Subject|2|||
160746346|NCT05697627|580455243|FG000|Overall Study|Adverse Event|1|||
160746347|NCT04122625|580455244|FG000|Part A (up to 2.92 Years)|Death|2|||
160746348|NCT04122625|580455245|FG001|Part A (up to 2.92 Years)|Death|4|||
160746349|NCT04122625|580455246|FG002|Part A (up to 2.92 Years)|Death|0|||
160746350|NCT04122625|580455247|FG003|Part A (up to 2.92 Years)|Death|0|||
160746351|NCT04122625|580455248|FG004|Part A (up to 2.92 Years)|Death|0|||
160746352|NCT04122625|580455249|FG005|Part A (up to 2.92 Years)|Death|0|||
160746353|NCT04122625|580455244|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
160746354|NCT04122625|580455245|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
160746355|NCT04122625|580455246|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
160746356|NCT04122625|580455247|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
160746357|NCT04122625|580455248|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
160746358|NCT04122625|580455249|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
160746359|NCT04122625|580455244|FG000|Part B (up to 2.33 Years)|Death|0|||
160746360|NCT04122625|580455245|FG001|Part B (up to 2.33 Years)|Death|0|||
160746361|NCT04122625|580455246|FG002|Part B (up to 2.33 Years)|Death|5|||
160746362|NCT04122625|580455247|FG003|Part B (up to 2.33 Years)|Death|7|||
160746363|NCT04122625|580455248|FG004|Part B (up to 2.33 Years)|Death|6|||
160746364|NCT04122625|580455249|FG005|Part B (up to 2.33 Years)|Death|7|||
160746365|NCT02722746|580455250|FG000|Overall Study|Withdrawal by Subject|0|||
160746366|NCT02722746|580455251|FG001|Overall Study|Withdrawal by Subject|1|||
160746367|NCT02722746|580455252|FG002|Overall Study|Withdrawal by Subject|0|||
160746368|NCT02722746|580455250|FG000|Overall Study|Protocol Violation|8|||
160746369|NCT02722746|580455251|FG001|Overall Study|Protocol Violation|4|||
160746370|NCT02722746|580455252|FG002|Overall Study|Protocol Violation|6|||
160746371|NCT04165135|580455253|FG000|Overall Study|Protocol Violation|10|||
160746372|NCT04165135|580455253|FG000|Overall Study|Participants withdrawal of consent|5|||
160746373|NCT00530790|580455254|FG000|Overall Study|Adverse Event|2|||
160746374|NCT00530790|580455254|FG000|Overall Study|Withdrawal by Subject|2|||
160746375|NCT00530790|580455254|FG000|Overall Study|Physician Decision|1|||
160746376|NCT05053035|580455261|FG000|Overall Study|Withdrawal by Subject|1|||
160746377|NCT05053035|580455262|FG001|Overall Study|Withdrawal by Subject|0|||
160746378|NCT00055497|580455267|FG000|Overall Study|Adverse Event|1|||
160746379|NCT00055497|580455268|FG001|Overall Study|Adverse Event|1|||
160746380|NCT00055497|580455269|FG002|Overall Study|Adverse Event|1|||
160746381|NCT00055497|580455270|FG003|Overall Study|Adverse Event|28|||
160746382|NCT00055497|580455267|FG000|Overall Study|Withdrawal by Subject|3|||
160746383|NCT00055497|580455268|FG001|Overall Study|Withdrawal by Subject|1|||
160746384|NCT00055497|580455269|FG002|Overall Study|Withdrawal by Subject|1|||
160746385|NCT00055497|580455270|FG003|Overall Study|Withdrawal by Subject|15|||
160746386|NCT00055497|580455267|FG000|Overall Study|Lost to Follow-up|0|||
160746387|NCT00055497|580455268|FG001|Overall Study|Lost to Follow-up|1|||
160746388|NCT00055497|580455269|FG002|Overall Study|Lost to Follow-up|0|||
160746389|NCT00055497|580455270|FG003|Overall Study|Lost to Follow-up|5|||
160746390|NCT00055497|580455267|FG000|Overall Study|Protocol Violation|0|||
160746391|NCT00055497|580455268|FG001|Overall Study|Protocol Violation|0|||
160746392|NCT00055497|580455269|FG002|Overall Study|Protocol Violation|0|||
160746393|NCT00055497|580455270|FG003|Overall Study|Protocol Violation|3|||
160746394|NCT00055497|580455267|FG000|Overall Study|Lack of Efficacy|1|||
160746395|NCT00055497|580455268|FG001|Overall Study|Lack of Efficacy|0|||
160746396|NCT00055497|580455269|FG002|Overall Study|Lack of Efficacy|0|||
160746397|NCT00055497|580455270|FG003|Overall Study|Lack of Efficacy|27|||
160746398|NCT00055497|580455267|FG000|Overall Study|Administrative Reasons|0|||
160746399|NCT00055497|580455268|FG001|Overall Study|Administrative Reasons|0|||
160746400|NCT00055497|580455269|FG002|Overall Study|Administrative Reasons|0|||
160746401|NCT00055497|580455270|FG003|Overall Study|Administrative Reasons|1|||
160746402|NCT00055497|580455267|FG000|Overall Study|Other|0|||
160746403|NCT00055497|580455268|FG001|Overall Study|Other|0|||
160746404|NCT00055497|580455269|FG002|Overall Study|Other|0|||
160746405|NCT00055497|580455270|FG003|Overall Study|Other|11|||
160746406|NCT00048165|580455271|FG000|Completed 6 Months Study|Administration/Other|8|||
160746407|NCT00048165|580455272|FG001|Completed 6 Months Study|Administration/Other|8|||
160746408|NCT00048165|580455271|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
160746409|NCT00048165|580455272|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
160746410|NCT00048165|580455271|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
160746411|NCT00048165|580455272|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
160746412|NCT00048165|580455271|FG000|Completed 6 Months Study|Death|12|||
160746413|NCT00048165|580455272|FG001|Completed 6 Months Study|Death|6|||
160746414|NCT00048165|580455271|FG000|Completed 6 Months Study|Insufficient therapy|1|||
160746415|NCT00048165|580455272|FG001|Completed 6 Months Study|Insufficient therapy|4|||
160746416|NCT00048165|580455271|FG000|Completed 6 Months Study|Other violation|4|||
160746417|NCT00048165|580455272|FG001|Completed 6 Months Study|Other violation|6|||
160746418|NCT00048165|580455271|FG000|Completed 6 Months Study|Refused treatment|5|||
160746419|NCT00048165|580455272|FG001|Completed 6 Months Study|Refused treatment|5|||
160746420|NCT00048165|580455271|FG000|Completed 6 Months Study|Violation criteria|0|||
160746421|NCT00048165|580455272|FG001|Completed 6 Months Study|Violation criteria|2|||
160746422|NCT00048165|580455271|FG000|Completed 6 Months Study|Did not receive study drug|6|||
160746423|NCT00048165|580455272|FG001|Completed 6 Months Study|Did not receive study drug|6|||
160746424|NCT00048165|580455271|FG000|Completed 12 Months Study|Administration/Other|0|||
160746425|NCT00048165|580455272|FG001|Completed 12 Months Study|Administration/Other|2|||
160746426|NCT00048165|580455271|FG000|Completed 12 Months Study|Death|2|||
160746427|NCT00048165|580455272|FG001|Completed 12 Months Study|Death|1|||
160746428|NCT00048165|580455271|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
160746429|NCT00048165|580455272|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
160746430|NCT00731731|580455273|FG000|Overall Study|Protocol Violation|0|||
160746431|NCT00731731|580455274|FG001|Overall Study|Protocol Violation|0|||
160746432|NCT00731731|580455275|FG002|Overall Study|Protocol Violation|1|||
160746433|NCT00731731|580455273|FG000|Overall Study|Cancel prior to treatment|0|||
160746434|NCT00731731|580455274|FG001|Overall Study|Cancel prior to treatment|0|||
160746435|NCT00731731|580455275|FG002|Overall Study|Cancel prior to treatment|2|||
160746436|NCT01084538|580455276|FG000|Overall Study|Drug not available|30|||
160746437|NCT01084538|580455276|FG000|Overall Study|Adverse Event|9|||
160746438|NCT01084538|580455276|FG000|Overall Study|Kidney transplant|6|||
160746439|NCT01084538|580455276|FG000|Overall Study|Serious Adverse Event|3|||
160746440|NCT01084538|580455276|FG000|Overall Study|Lack of effectiveness|2|||
160746441|NCT01084538|580455276|FG000|Overall Study|Patient noncompliance|2|||
160746442|NCT01084538|580455276|FG000|Overall Study|Hyperphosphatemia|2|||
160746443|NCT01084538|580455276|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
160746444|NCT01084538|580455276|FG000|Overall Study|Change of residence|2|||
160746445|NCT01084538|580455276|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
160746446|NCT01084538|580455276|FG000|Overall Study|Reason unknown|8|||
160746447|NCT01490697|580455283|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
160746448|NCT01490697|580455284|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
160746449|NCT01987232|580455287|FG000|Overall Study|Ongoing in Study|0|||
160746450|NCT01987232|580455288|FG001|Overall Study|Ongoing in Study|0|||
160746451|NCT01987232|580455289|FG002|Overall Study|Ongoing in Study|0|||
160746452|NCT01987232|580455290|FG003|Overall Study|Ongoing in Study|1|||
160746453|NCT01987232|580455291|FG004|Overall Study|Ongoing in Study|0|||
160746454|NCT03564795|580455301|FG000|Overall Study|Withdrawal by Subject|3|||
160746455|NCT03564795|580455301|FG000|Overall Study|Lost to Follow-up|6|||
160746456|NCT03564795|580455301|FG000|Overall Study|Physician Decision|2|||
160746457|NCT00564395|580455302|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
160746458|NCT00564395|580455303|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
160746459|NCT00564395|580455302|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
160746460|NCT00564395|580455303|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
160746461|NCT02134353|580455308|FG000|Overall Study|Adverse Event|10|||
160746462|NCT02134353|580455309|FG001|Overall Study|Adverse Event|6|||
160746463|NCT02134353|580455308|FG000|Overall Study|Lost to Follow-up|1|||
160746464|NCT02134353|580455309|FG001|Overall Study|Lost to Follow-up|1|||
160746465|NCT02134353|580455308|FG000|Overall Study|Lack of Efficacy|2|||
160746466|NCT02134353|580455309|FG001|Overall Study|Lack of Efficacy|1|||
160746467|NCT02134353|580455308|FG000|Overall Study|Withdrawal by Subject|12|||
160746468|NCT02134353|580455309|FG001|Overall Study|Withdrawal by Subject|13|||
160746469|NCT02134353|580455308|FG000|Overall Study|Death|0|||
160746470|NCT02134353|580455309|FG001|Overall Study|Death|1|||
160746471|NCT02134353|580455308|FG000|Overall Study|Pregnancy|0|||
160746472|NCT02134353|580455309|FG001|Overall Study|Pregnancy|1|||
160746473|NCT02134353|580455308|FG000|Overall Study|Relocation|1|||
160746474|NCT02134353|580455309|FG001|Overall Study|Relocation|0|||
160746475|NCT02134353|580455308|FG000|Overall Study|Other - Patient's Choice|0|||
160746476|NCT02134353|580455309|FG001|Overall Study|Other - Patient's Choice|1|||
160746477|NCT00432276|580455312|FG000|Overall Study|Hyperglycemic Rescue|44|||
160746478|NCT00432276|580455313|FG001|Overall Study|Hyperglycemic Rescue|87|||
160746479|NCT00432276|580455312|FG000|Overall Study|Adverse Event|13|||
160746480|NCT00432276|580455313|FG001|Overall Study|Adverse Event|16|||
160746481|NCT00432276|580455312|FG000|Overall Study|Protocol Violation|25|||
160746482|NCT00432276|580455313|FG001|Overall Study|Protocol Violation|20|||
160746483|NCT00432276|580455312|FG000|Overall Study|Lost to Follow-up|6|||
160746484|NCT00432276|580455313|FG001|Overall Study|Lost to Follow-up|2|||
160746485|NCT00432276|580455312|FG000|Overall Study|Withdrawal by Subject|25|||
160746486|NCT00432276|580455313|FG001|Overall Study|Withdrawal by Subject|20|||
160746487|NCT00432276|580455312|FG000|Overall Study|Physician Decision|6|||
160746488|NCT00432276|580455313|FG001|Overall Study|Physician Decision|8|||
160746489|NCT00432276|580455312|FG000|Overall Study|Other|2|||
160746490|NCT00432276|580455313|FG001|Overall Study|Other|3|||
160746491|NCT00594386|580455314|FG000|Overall Study|Major protocol violation|2|||
160746492|NCT00594386|580455314|FG000|Overall Study|Lack of Efficacy|12|||
160746493|NCT00594386|580455314|FG000|Overall Study|Adverse Event|68|||
160746494|NCT00594386|580455314|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
160746495|NCT00594386|580455314|FG000|Overall Study|Subject withdrew consent|35|||
160746496|NCT00594386|580455314|FG000|Overall Study|Study ended per sponsor|115|||
160746497|NCT00594386|580455314|FG000|Overall Study|Lost to Follow-up|6|||
160746498|NCT00594386|580455314|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
160746499|NCT00594386|580455314|FG000|Overall Study|Other: Subject moved to Seattle|1|||
160746500|NCT00594386|580455314|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
160746501|NCT00594386|580455314|FG000|Overall Study|Other: Study terminated per investigator|2|||
160746502|NCT00594386|580455314|FG000|Overall Study|Other: Sponsor closure of study|1|||
160746503|NCT00594386|580455314|FG000|Overall Study|Other: Site terminated participation|1|||
160746504|NCT00594386|580455314|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
160746505|NCT00594386|580455314|FG000|Overall Study|Other: Loss of drivers license|1|||
160746506|NCT03611582|580455321|FG000|Overall Study|Adverse Event|26|||
160746507|NCT03611582|580455322|FG001|Overall Study|Adverse Event|6|||
160746508|NCT03611582|580455321|FG000|Overall Study|Protocol Violation|0|||
160746509|NCT03611582|580455322|FG001|Overall Study|Protocol Violation|1|||
160746510|NCT03611582|580455321|FG000|Overall Study|Pregnancy|1|||
160746511|NCT03611582|580455322|FG001|Overall Study|Pregnancy|2|||
160746512|NCT03611582|580455321|FG000|Overall Study|Lack of Efficacy|0|||
160746513|NCT03611582|580455322|FG001|Overall Study|Lack of Efficacy|1|||
160746514|NCT03611582|580455321|FG000|Overall Study|At the discretion of the investigator|1|||
160746515|NCT03611582|580455322|FG001|Overall Study|At the discretion of the investigator|0|||
160746516|NCT03611582|580455321|FG000|Overall Study|Safety concern as judged by the investigator|1|||
160746517|NCT03611582|580455322|FG001|Overall Study|Safety concern as judged by the investigator|2|||
160746518|NCT03611582|580455321|FG000|Overall Study|Withdrawal by Subject|4|||
160746519|NCT03611582|580455322|FG001|Overall Study|Withdrawal by Subject|3|||
160746520|NCT03611582|580455321|FG000|Overall Study|Lost to Follow-up|18|||
160746521|NCT03611582|580455322|FG001|Overall Study|Lost to Follow-up|7|||
160746522|NCT03611582|580455321|FG000|Overall Study|other|17|||
160746523|NCT03611582|580455322|FG001|Overall Study|other|16|||
160746524|NCT00463840|580455323|FG000|Overall Study|Disease progression|7|||
160746525|NCT00463840|580455323|FG000|Overall Study|Withdrawal by Subject|2|||
160746526|NCT00463840|580455323|FG000|Overall Study|Adverse Event|3|||
160746527|NCT00866333|580455324|FG000|Overall Study|Withdrawal of consent|0|||
160746528|NCT00866333|580455325|FG001|Overall Study|Withdrawal of consent|1|||
160746529|NCT00866333|580455326|FG002|Overall Study|Withdrawal of consent|2|||
160746530|NCT00866333|580455324|FG000|Overall Study|Reason not Specified|3|||
160746531|NCT00866333|580455325|FG001|Overall Study|Reason not Specified|1|||
160746532|NCT00866333|580455326|FG002|Overall Study|Reason not Specified|1|||
160746533|NCT00866333|580455324|FG000|Overall Study|Study Terminated by Sponsor|2|||
160746534|NCT00866333|580455325|FG001|Overall Study|Study Terminated by Sponsor|5|||
160746535|NCT00866333|580455326|FG002|Overall Study|Study Terminated by Sponsor|9|||
160746536|NCT01653327|580455327|FG000|Overall Study|Withdrawal by Subject|1|||
160746537|NCT00422292|580455328|FG000|Overall Study|Serious adverse events|1|||
160746538|NCT00422292|580455329|FG001|Overall Study|Serious adverse events|4|||
160746539|NCT00422292|580455330|FG002|Overall Study|Serious adverse events|0|||
160746540|NCT00422292|580455331|FG003|Overall Study|Serious adverse events|0|||
160746541|NCT00422292|580455328|FG000|Overall Study|Adverse Event|1|||
160746542|NCT00422292|580455329|FG001|Overall Study|Adverse Event|0|||
160746543|NCT00422292|580455330|FG002|Overall Study|Adverse Event|1|||
160746544|NCT00422292|580455331|FG003|Overall Study|Adverse Event|0|||
160746545|NCT00422292|580455328|FG000|Overall Study|Protocol Violation|4|||
160746546|NCT00422292|580455329|FG001|Overall Study|Protocol Violation|25|||
160746547|NCT00422292|580455330|FG002|Overall Study|Protocol Violation|8|||
160746548|NCT00422292|580455331|FG003|Overall Study|Protocol Violation|5|||
160746549|NCT00422292|580455328|FG000|Overall Study|Lost to Follow-up|6|||
160746550|NCT00422292|580455329|FG001|Overall Study|Lost to Follow-up|12|||
160746551|NCT00422292|580455330|FG002|Overall Study|Lost to Follow-up|6|||
160746552|NCT00422292|580455331|FG003|Overall Study|Lost to Follow-up|6|||
160746553|NCT00422292|580455328|FG000|Overall Study|Withdrawal by Subject|6|||
160746554|NCT00422292|580455329|FG001|Overall Study|Withdrawal by Subject|25|||
160746555|NCT00422292|580455330|FG002|Overall Study|Withdrawal by Subject|7|||
160746556|NCT00422292|580455331|FG003|Overall Study|Withdrawal by Subject|13|||
160746557|NCT02243046|580455332|FG000|Overall Study|Lost to Follow-up|1|||
160746558|NCT02243046|580455333|FG001|Overall Study|Lost to Follow-up|1|||
160746559|NCT02243046|580455334|FG002|Overall Study|Lost to Follow-up|4|||
160746560|NCT04683939|580455338|FG000|Overall Study|Study termination by the sponsor|0|||
160746561|NCT04683939|580455339|FG001|Overall Study|Study termination by the sponsor|1|||
160746562|NCT04683939|580455340|FG002|Overall Study|Study termination by the sponsor|2|||
160746563|NCT04683939|580455341|FG003|Overall Study|Study termination by the sponsor|2|||
160746564|NCT04683939|580455338|FG000|Overall Study|Death|1|||
160746565|NCT04683939|580455339|FG001|Overall Study|Death|1|||
160746566|NCT04683939|580455340|FG002|Overall Study|Death|2|||
160746567|NCT04683939|580455341|FG003|Overall Study|Death|1|||
160746568|NCT04683939|580455338|FG000|Overall Study|Withdrawal by Subject|1|||
160746569|NCT04683939|580455339|FG001|Overall Study|Withdrawal by Subject|0|||
160746570|NCT04683939|580455340|FG002|Overall Study|Withdrawal by Subject|0|||
160746571|NCT04683939|580455341|FG003|Overall Study|Withdrawal by Subject|0|||
160746572|NCT04683939|580455338|FG000|Overall Study|Physician Decision|1|||
160746573|NCT04683939|580455339|FG001|Overall Study|Physician Decision|0|||
160746574|NCT04683939|580455340|FG002|Overall Study|Physician Decision|0|||
160746575|NCT04683939|580455341|FG003|Overall Study|Physician Decision|0|||
160746576|NCT04683939|580455338|FG000|Overall Study|Lost to Follow-up|0|||
160746577|NCT04683939|580455339|FG001|Overall Study|Lost to Follow-up|1|||
160746578|NCT04683939|580455340|FG002|Overall Study|Lost to Follow-up|0|||
160746579|NCT04683939|580455341|FG003|Overall Study|Lost to Follow-up|0|||
160746580|NCT04852276|580455342|FG000|Overall Study|Death|2|||
160746581|NCT04852276|580455343|FG001|Overall Study|Death|0|||
160746582|NCT04852276|580455342|FG000|Overall Study|Lost to Follow-up|15|||
160746583|NCT04852276|580455343|FG001|Overall Study|Lost to Follow-up|9|||
160746584|NCT04852276|580455342|FG000|Overall Study|Withdrawal by Subject|26|||
160746585|NCT04852276|580455343|FG001|Overall Study|Withdrawal by Subject|6|||
160746586|NCT02107313|580456973|FG000|Overall Study|One participant did not do the FED cohor|0|||
160746587|NCT02107313|580456974|FG001|Overall Study|One participant did not do the FED cohor|1|||
160746588|NCT01031004|580456975|FG000|Overall Study|Protocol Violation|0|||
160746589|NCT01031004|580456976|FG001|Overall Study|Protocol Violation|1|||
160746590|NCT01031004|580456975|FG000|Overall Study|Lost to Follow-up|1|||
160746591|NCT01031004|580456976|FG001|Overall Study|Lost to Follow-up|0|||
160746592|NCT01641471|580456977|FG000|Overall Study|Withdrawal by Subject|19|||
160746593|NCT01641471|580456978|FG001|Overall Study|Withdrawal by Subject|19|||
160746594|NCT01641471|580456977|FG000|Overall Study|Lost to Follow-up|2|||
160746595|NCT01641471|580456978|FG001|Overall Study|Lost to Follow-up|4|||
160746596|NCT01641471|580456977|FG000|Overall Study|Protocol Violation|2|||
160746597|NCT01641471|580456978|FG001|Overall Study|Protocol Violation|4|||
160746598|NCT02335346|580456979|FG000|Overall Study|Adverse Event|11|||
160746599|NCT02335346|580456979|FG000|Overall Study|Withdrawal by Subject|1|||
160746600|NCT01548768|580456980|FG000|Overall Study|Withdrawal by Subject|0|||
160746601|NCT01548768|580456981|FG001|Overall Study|Withdrawal by Subject|2|||
160746602|NCT01548768|580456982|FG002|Overall Study|Withdrawal by Subject|1|||
160746603|NCT01548768|580456983|FG003|Overall Study|Withdrawal by Subject|0|||
160746604|NCT01548768|580456980|FG000|Overall Study|Physician Decision|1|||
160746605|NCT01548768|580456981|FG001|Overall Study|Physician Decision|0|||
160746606|NCT01548768|580456982|FG002|Overall Study|Physician Decision|0|||
160746607|NCT01548768|580456983|FG003|Overall Study|Physician Decision|0|||
160746608|NCT01548768|580456980|FG000|Overall Study|Adverse Event|0|||
160746609|NCT01548768|580456981|FG001|Overall Study|Adverse Event|0|||
160746610|NCT01548768|580456982|FG002|Overall Study|Adverse Event|0|||
160746611|NCT01548768|580456983|FG003|Overall Study|Adverse Event|1|||
160746612|NCT01548768|580456980|FG000|Overall Study|Non-Compliance|0|||
160746613|NCT01548768|580456981|FG001|Overall Study|Non-Compliance|0|||
160746614|NCT01548768|580456982|FG002|Overall Study|Non-Compliance|0|||
160746615|NCT01548768|580456983|FG003|Overall Study|Non-Compliance|3|||
160746616|NCT02499263|580456984|FG000|Overall Study|Lost to Follow-up|9|||
160746617|NCT02499263|580456984|FG000|Overall Study|Participant's withdrawal of consent|4|||
160746618|NCT02499263|580456984|FG000|Overall Study|Lack of Efficacy|22|||
160746619|NCT02499263|580456984|FG000|Overall Study|investigator's judgment|12|||
160746620|NCT02499263|580456984|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
160746621|NCT02499263|580456984|FG000|Overall Study|Participant's decision|3|||
160746622|NCT02499263|580456984|FG000|Overall Study|Pregnancy|1|||
160746623|NCT02178358|580456987|FG000|Overall Study|Withdrawal by Subject|0|||
160746624|NCT02178358|580456988|FG001|Overall Study|Withdrawal by Subject|2|||
160746625|NCT02178358|580456989|FG002|Overall Study|Withdrawal by Subject|2|||
160746626|NCT02178358|580456987|FG000|Overall Study|Lost to Follow-up|1|||
160746627|NCT02178358|580456988|FG001|Overall Study|Lost to Follow-up|0|||
160746628|NCT02178358|580456989|FG002|Overall Study|Lost to Follow-up|0|||
160746629|NCT00645671|580456991|FG000|Overall Study|Protocol Violation|1|||
160746630|NCT00645671|580456992|FG001|Overall Study|Protocol Violation|0|||
160746631|NCT00645671|580456991|FG000|Overall Study|Withdrawal by Subject|0|||
160746632|NCT00645671|580456992|FG001|Overall Study|Withdrawal by Subject|4|||
160746633|NCT00645671|580456991|FG000|Overall Study|Adverse Event|0|||
160746634|NCT00645671|580456992|FG001|Overall Study|Adverse Event|1|||
160746635|NCT00645671|580456991|FG000|Overall Study|Physician Decision|0|||
160746636|NCT00645671|580456992|FG001|Overall Study|Physician Decision|1|||
160746637|NCT00493311|580456993|FG000|Overall Study|Need for rescue medication|2|||
160746638|NCT00493311|580456994|FG001|Overall Study|Need for rescue medication|2|||
160746639|NCT05600036|580457002|FG000|Overall Study|Adverse Event|0|||
160746640|NCT05600036|580457003|FG001|Overall Study|Adverse Event|2|||
160746641|NCT05600036|580457004|FG002|Overall Study|Adverse Event|1|||
160746642|NCT05600036|580457005|FG003|Overall Study|Adverse Event|0|||
160746643|NCT05600036|580457006|FG004|Overall Study|Adverse Event|1|||
160746644|NCT05600036|580457007|FG005|Overall Study|Adverse Event|0|||
160746645|NCT05600036|580457002|FG000|Overall Study|Lost to Follow-up|0|||
160746646|NCT05600036|580457003|FG001|Overall Study|Lost to Follow-up|2|||
160746647|NCT05600036|580457004|FG002|Overall Study|Lost to Follow-up|1|||
160746648|NCT05600036|580457005|FG003|Overall Study|Lost to Follow-up|1|||
160746649|NCT05600036|580457006|FG004|Overall Study|Lost to Follow-up|0|||
160746650|NCT05600036|580457007|FG005|Overall Study|Lost to Follow-up|0|||
160746651|NCT05600036|580457002|FG000|Overall Study|Protocol Violation|0|||
160746652|NCT05600036|580457003|FG001|Overall Study|Protocol Violation|0|||
160746653|NCT05600036|580457004|FG002|Overall Study|Protocol Violation|2|||
160746654|NCT05600036|580457005|FG003|Overall Study|Protocol Violation|0|||
160746655|NCT05600036|580457006|FG004|Overall Study|Protocol Violation|0|||
160746656|NCT05600036|580457007|FG005|Overall Study|Protocol Violation|0|||
160746657|NCT05600036|580457002|FG000|Overall Study|Withdrawal by Subject|0|||
160746658|NCT05600036|580457003|FG001|Overall Study|Withdrawal by Subject|1|||
160746659|NCT05600036|580457004|FG002|Overall Study|Withdrawal by Subject|2|||
160746660|NCT05600036|580457005|FG003|Overall Study|Withdrawal by Subject|0|||
160746661|NCT05600036|580457006|FG004|Overall Study|Withdrawal by Subject|3|||
160746662|NCT05600036|580457007|FG005|Overall Study|Withdrawal by Subject|5|||
160746663|NCT05600036|580457002|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
160746664|NCT05600036|580457003|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
160746665|NCT05600036|580457004|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
160746666|NCT05600036|580457005|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
160746667|NCT05600036|580457006|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
160746668|NCT05600036|580457007|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
160746669|NCT05600036|580457002|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
160746670|NCT05600036|580457003|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
160746671|NCT05600036|580457004|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
160746672|NCT05600036|580457005|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
160746673|NCT05600036|580457006|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
160746674|NCT05600036|580457007|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
160746675|NCT05600036|580457002|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
160746676|NCT05600036|580457003|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
160746677|NCT05600036|580457004|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
160746678|NCT05600036|580457005|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
160746679|NCT05600036|580457006|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
160746680|NCT05600036|580457007|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
160746681|NCT04401202|580457008|FG000|Overall Study|Lost to Follow-up|2|||
160746682|NCT04401202|580457009|FG001|Overall Study|Lost to Follow-up|2|||
160746683|NCT04401202|580457008|FG000|Overall Study|Adverse Event|0|||
160746684|NCT04401202|580457009|FG001|Overall Study|Adverse Event|1|||
160746685|NCT04401202|580457008|FG000|Overall Study|Hospitalized|4|||
160746686|NCT04401202|580457009|FG001|Overall Study|Hospitalized|1|||
160746687|NCT00715520|580457010|FG000|Overall Study|Screen failure|8|||
160746688|NCT00715520|580457011|FG001|Overall Study|Screen failure|1|||
160746689|NCT00715520|580457012|FG002|Overall Study|Screen failure|1|||
160746690|NCT00715520|580457010|FG000|Overall Study|Withdrawal by Subject|2|||
160746691|NCT00715520|580457011|FG001|Overall Study|Withdrawal by Subject|0|||
160746692|NCT00715520|580457012|FG002|Overall Study|Withdrawal by Subject|1|||
160746693|NCT01006590|580457013|FG000|Overall Study|Adverse Event|2|||
160746694|NCT01006590|580457014|FG001|Overall Study|Adverse Event|3|||
160746695|NCT01006590|580457013|FG000|Overall Study|Death|1|||
160746696|NCT01006590|580457014|FG001|Overall Study|Death|1|||
160746697|NCT01006590|580457013|FG000|Overall Study|Lost to Follow-up|1|||
160746698|NCT01006590|580457014|FG001|Overall Study|Lost to Follow-up|1|||
160746699|NCT01006590|580457013|FG000|Overall Study|Protocol Violation|1|||
160746700|NCT01006590|580457014|FG001|Overall Study|Protocol Violation|0|||
160746701|NCT01006590|580457013|FG000|Overall Study|Withdrawal by Subject|4|||
160746702|NCT01006590|580457014|FG001|Overall Study|Withdrawal by Subject|2|||
160746703|NCT01006590|580457013|FG000|Overall Study|Study specific discontinuation criteria|16|||
160746704|NCT01006590|580457014|FG001|Overall Study|Study specific discontinuation criteria|23|||
160746705|NCT01006590|580457013|FG000|Overall Study|Other|3|||
160746706|NCT01006590|580457014|FG001|Overall Study|Other|2|||
160746707|NCT03332095|580457015|FG000|Overall Study|Lost to Follow-up|1|||
160746708|NCT03332095|580457016|FG001|Overall Study|Lost to Follow-up|0|||
160746709|NCT03332095|580457015|FG000|Overall Study|Pregnancy|0|||
160746710|NCT03332095|580457016|FG001|Overall Study|Pregnancy|1|||
160746711|NCT04942210|580457020|FG000|Overall Study|Adverse Event|0|||
160746712|NCT04942210|580457021|FG001|Overall Study|Adverse Event|1|||
160746713|NCT04942210|580457020|FG000|Overall Study|Protocol Deviation|4|||
160746714|NCT04942210|580457021|FG001|Overall Study|Protocol Deviation|1|||
160746715|NCT04942210|580457020|FG000|Overall Study|Withdrawal by Subject|5|||
160746716|NCT04942210|580457021|FG001|Overall Study|Withdrawal by Subject|2|||
160746717|NCT04942210|580457020|FG000|Overall Study|Lost to Follow-up|16|||
160746718|NCT04942210|580457021|FG001|Overall Study|Lost to Follow-up|7|||
160746719|NCT04942210|580457020|FG000|Overall Study|Ongoing at the time of DBL date|60|||
160746720|NCT04942210|580457021|FG001|Overall Study|Ongoing at the time of DBL date|25|||
160746721|NCT04942210|580457020|FG000|Overall Study|Randomized but did not receive vaccination|3|||
160746722|NCT04942210|580457021|FG001|Overall Study|Randomized but did not receive vaccination|0|||
160746723|NCT04348500|580457022|FG000|Overall Study|Death|2|||
160746724|NCT04348500|580457023|FG001|Overall Study|Death|2|||
160746725|NCT04348500|580457022|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
160746726|NCT04348500|580457023|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
160746727|NCT02776670|580457024|FG000|Overall Study|Adverse Event|0|||
160746728|NCT02776670|580457025|FG001|Overall Study|Adverse Event|2|||
160746729|NCT02776670|580457024|FG000|Overall Study|Protocol Violation|0|||
160746730|NCT02776670|580457025|FG001|Overall Study|Protocol Violation|2|||
160746731|NCT02776670|580457024|FG000|Overall Study|Withdrawal by Subject|0|||
160746732|NCT02776670|580457025|FG001|Overall Study|Withdrawal by Subject|1|||
160746733|NCT02776670|580457024|FG000|Overall Study|Other - Reason not given|0|||
160746734|NCT02776670|580457025|FG001|Overall Study|Other - Reason not given|1|||
160746735|NCT01038752|580457026|FG000|Overall Study|Tumor Progression|2|||
160746736|NCT01038752|580457027|FG001|Overall Study|Tumor Progression|2|||
160746737|NCT01038752|580457026|FG000|Overall Study|Lost to Follow-up|3|||
160746738|NCT01038752|580457027|FG001|Overall Study|Lost to Follow-up|3|||
160746739|NCT02700698|580457034|FG000|Overall Study|Withdrawal by Subject|1|||
160746740|NCT02700698|580457035|FG001|Overall Study|Withdrawal by Subject|0|||
160746741|NCT00703118|580457036|FG000|Overall Study|Adverse Event|1|||
160746742|NCT00703118|580457037|FG001|Overall Study|Adverse Event|2|||
160746743|NCT00703118|580457038|FG002|Overall Study|Adverse Event|2|||
160746744|NCT00703118|580457036|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
160746745|NCT00703118|580457037|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
160746746|NCT00703118|580457038|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
160746747|NCT00703118|580457036|FG000|Overall Study|Lost to Follow-up|6|||
160746748|NCT00703118|580457037|FG001|Overall Study|Lost to Follow-up|4|||
160746749|NCT00703118|580457038|FG002|Overall Study|Lost to Follow-up|4|||
160746750|NCT00703118|580457036|FG000|Overall Study|Withdrawal by Subject|8|||
160746751|NCT00703118|580457037|FG001|Overall Study|Withdrawal by Subject|7|||
160746752|NCT00703118|580457038|FG002|Overall Study|Withdrawal by Subject|13|||
160746753|NCT00703118|580457036|FG000|Overall Study|Other|0|||
160746754|NCT00703118|580457037|FG001|Overall Study|Other|0|||
160746755|NCT00703118|580457038|FG002|Overall Study|Other|1|||
160746756|NCT00438256|580457041|FG000|Overall Study|Ineligible for Resection|2|||
160746757|NCT00438256|580457042|FG001|Overall Study|Ineligible for Resection|1|||
160746758|NCT00438256|580457043|FG002|Overall Study|Ineligible for Resection|1|||
160746759|NCT00438256|580457044|FG003|Overall Study|Ineligible for Resection|7|||
160746760|NCT00438256|580457041|FG000|Overall Study|Excluded final Diagnosis|0|||
160746761|NCT00438256|580457042|FG001|Overall Study|Excluded final Diagnosis|0|||
160746762|NCT00438256|580457043|FG002|Overall Study|Excluded final Diagnosis|0|||
160746763|NCT00438256|580457044|FG003|Overall Study|Excluded final Diagnosis|2|||
160746764|NCT02005627|580457045|FG000|Overall Study|Lost to Follow-up|1|||
160746765|NCT02005627|580457046|FG001|Overall Study|Lost to Follow-up|2|||
160746766|NCT02005627|580457045|FG000|Overall Study|Withdrawal by Subject|1|||
160746767|NCT02005627|580457046|FG001|Overall Study|Withdrawal by Subject|2|||
160746768|NCT00849290|580457052|FG000|Overall Study|Adverse Event|3|||
160746769|NCT00849290|580457052|FG000|Overall Study|Death|14|||
160746770|NCT00849290|580457052|FG000|Overall Study|Withdrawal by Subject|11|||
160746771|NCT00849290|580457052|FG000|Overall Study|Lost to Follow-up|2|||
160746772|NCT00849290|580457052|FG000|Overall Study|Protocol Violation|5|||
160746773|NCT00849290|580457052|FG000|Overall Study|Disease Progression|20|||
160746774|NCT00938587|580457053|FG000|Overall Study|Adverse Event|2|||
160746775|NCT00938587|580457054|FG001|Overall Study|Adverse Event|0|||
160746776|NCT00938587|580457055|FG002|Overall Study|Adverse Event|0|||
160746777|NCT00938587|580457056|FG003|Overall Study|Adverse Event|2|||
160746778|NCT00938587|580457053|FG000|Overall Study|Did not meet entrance criteria|0|||
160746779|NCT00938587|580457054|FG001|Overall Study|Did not meet entrance criteria|0|||
160746780|NCT00938587|580457055|FG002|Overall Study|Did not meet entrance criteria|1|||
160746781|NCT00938587|580457056|FG003|Overall Study|Did not meet entrance criteria|0|||
160746782|NCT00938587|580457053|FG000|Overall Study|Withdrawal by Subject|1|||
160746783|NCT00938587|580457054|FG001|Overall Study|Withdrawal by Subject|1|||
160746784|NCT00938587|580457055|FG002|Overall Study|Withdrawal by Subject|0|||
160746785|NCT00938587|580457056|FG003|Overall Study|Withdrawal by Subject|0|||
160746786|NCT01464619|580457063|FG000|Overall Study|Lost to Follow-up|3|||
160746787|NCT01464619|580457064|FG001|Overall Study|Lost to Follow-up|4|||
160746788|NCT02819440|580457067|FG000|Overall Study|Adverse Event|3|||
160746789|NCT02819440|580457068|FG001|Overall Study|Adverse Event|1|||
160746790|NCT02819440|580457067|FG000|Overall Study|Lost to Follow-up|1|||
160746791|NCT02819440|580457068|FG001|Overall Study|Lost to Follow-up|3|||
160746792|NCT02819440|580457067|FG000|Overall Study|Withdrawal by Subject|9|||
160746793|NCT02819440|580457068|FG001|Overall Study|Withdrawal by Subject|8|||
160746794|NCT03304184|580457074|FG000|Overall Study|Withdrawal by Subject|1|||
160746795|NCT03304184|580457075|FG001|Overall Study|Withdrawal by Subject|2|||
160746796|NCT03420222|580457078|FG000|Overall Study|Withdrawal by Subject|5|||
160746797|NCT03420222|580457079|FG001|Overall Study|Withdrawal by Subject|0|||
160746798|NCT03420222|580457078|FG000|Overall Study|Physician Decision|0|||
160746799|NCT03420222|580457079|FG001|Overall Study|Physician Decision|1|||
160746800|NCT02334384|580457082|FG000|Overall Study|Lost to Follow-up|1|||
160746801|NCT02334384|580457083|FG001|Overall Study|Lost to Follow-up|1|||
160746802|NCT03742258|580457084|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
160746803|NCT03742258|580457085|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
160746804|NCT03742258|580457086|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
160746805|NCT03742258|580457084|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
160746806|NCT03742258|580457085|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
160746807|NCT03742258|580457086|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
160746808|NCT03742258|580457084|FG000|Survival Follow-Up|Still in Follow-up|0|||
160746809|NCT03742258|580457085|FG001|Survival Follow-Up|Still in Follow-up|0|||
160746810|NCT03742258|580457086|FG002|Survival Follow-Up|Still in Follow-up|2|||
160746811|NCT01952080|580457088|FG000|Overall Study|Withdrawal by Subject|0|||
160746812|NCT01952080|580457089|FG001|Overall Study|Withdrawal by Subject|0|||
160746813|NCT01952080|580457090|FG002|Overall Study|Withdrawal by Subject|0|||
160746814|NCT01952080|580457091|FG003|Overall Study|Withdrawal by Subject|1|||
160746815|NCT01952080|580457088|FG000|Overall Study|Protocol Non-compliance|0|||
160746816|NCT01952080|580457089|FG001|Overall Study|Protocol Non-compliance|1|||
160746817|NCT01952080|580457090|FG002|Overall Study|Protocol Non-compliance|0|||
160746818|NCT01952080|580457091|FG003|Overall Study|Protocol Non-compliance|0|||
160746819|NCT01333956|580457092|FG000|Overall Study|Lost to Follow-up|1|||
160746820|NCT01333956|580457093|FG001|Overall Study|Lost to Follow-up|2|||
160746821|NCT01333956|580457094|FG002|Overall Study|Lost to Follow-up|0|||
160746822|NCT01333956|580457095|FG003|Overall Study|Lost to Follow-up|1|||
160746823|NCT01333956|580457092|FG000|Overall Study|Unable to complete study procedure|1|||
160746824|NCT01333956|580457093|FG001|Overall Study|Unable to complete study procedure|0|||
160746825|NCT01333956|580457094|FG002|Overall Study|Unable to complete study procedure|0|||
160746826|NCT01333956|580457095|FG003|Overall Study|Unable to complete study procedure|1|||
160746827|NCT01333956|580457092|FG000|Overall Study|Withdrawal by Subject|0|||
160746828|NCT01333956|580457093|FG001|Overall Study|Withdrawal by Subject|2|||
160746829|NCT01333956|580457094|FG002|Overall Study|Withdrawal by Subject|1|||
160746830|NCT01333956|580457095|FG003|Overall Study|Withdrawal by Subject|0|||
160746831|NCT03426436|580457096|FG000|Overall Study|Incorrect lead placement|12|||
160746832|NCT03426436|580457096|FG000|Overall Study|Withdrawal by Subject|2|||
160746833|NCT03426436|580457096|FG000|Overall Study|Consent issue|1|||
160746834|NCT03426436|580457096|FG000|Overall Study|ECGs not saved|4|||
160746835|NCT01210144|580457100|FG000|Overall Study|Lack of ovarian response|1|||
160746836|NCT01210144|580457101|FG001|Overall Study|Lack of ovarian response|0|||
160746837|NCT01210144|580457100|FG000|Overall Study|No fertilization|1|||
160746838|NCT01210144|580457101|FG001|Overall Study|No fertilization|0|||
160746839|NCT01210144|580457100|FG000|Overall Study|No transfer|1|||
160746840|NCT01210144|580457101|FG001|Overall Study|No transfer|0|||
160746841|NCT02655419|580457106|FG000|Overall Study|Enrolled but not treated|1|||
160746842|NCT02655419|580457107|FG001|Overall Study|Enrolled but not treated|5|||
160746843|NCT02655419|580457106|FG000|Overall Study|Withdrawal by Subject|4|||
160746844|NCT02655419|580457107|FG001|Overall Study|Withdrawal by Subject|1|||
160746845|NCT02655419|580457106|FG000|Overall Study|Other|0|||
160746846|NCT02655419|580457107|FG001|Overall Study|Other|1|||
160746847|NCT04226495|580457111|FG000|Overall Study|Withdrawal by Subject|3|||
160746848|NCT04226495|580457112|FG001|Overall Study|Withdrawal by Subject|3|||
160746849|NCT04226495|580457111|FG000|Overall Study|PI discretion|3|||
160746850|NCT04226495|580457112|FG001|Overall Study|PI discretion|4|||
160746851|NCT00505661|580457115|FG000|Overall Study|Not Eligible|4|||
160746852|NCT01783821|580457116|FG000|Overall Study|Screen Failure|1|||
160746853|NCT01783821|580457117|FG001|Overall Study|Screen Failure|1|||
160746854|NCT02333383|580457119|FG000|Overall Study|Adalimumab discontinuation|21|||
160746855|NCT02333383|580457119|FG000|Overall Study|Lost to Follow-up|15|||
160746856|NCT02333383|580457119|FG000|Overall Study|Withdrawal by Subject|3|||
160746857|NCT02333383|580457119|FG000|Overall Study|Transfer to another hospital|2|||
160746858|NCT01573754|580457120|FG000|Overall Study|Noncompliance or remission not achieved|3|||
160746859|NCT01573754|580457121|FG001|Overall Study|Noncompliance or remission not achieved|15|||
160746860|NCT04459598|580457122|FG000|Overall Study|Adverse Event|1|||
160746861|NCT04459598|580457123|FG001|Overall Study|Adverse Event|1|||
160746862|NCT02440854|580457130|FG000|Overall Study|Relocation of patient|1|||
160746863|NCT02440854|580457130|FG000|Overall Study|Death|6|||
160746864|NCT02440854|580457130|FG000|Overall Study|Lost to Follow-up|10|||
160746865|NCT02440854|580457130|FG000|Overall Study|Afatinib discontinuation|46|||
160746866|NCT02440854|580457130|FG000|Overall Study|stopped study at earlier timepoint|14|||
160746867|NCT02440854|580457130|FG000|Overall Study|Study medication not received|1|||
160746868|NCT02440854|580457130|FG000|Overall Study|Violation of inclusion criteria|2|||
160746869|NCT02669082|580457131|FG000|Overall Study|Adverse Event|1|||
160746870|NCT04918355|580457132|FG000|Overall Study|no qualifying health encounter|497|||
160746871|NCT04918355|580457133|FG001|Overall Study|no qualifying health encounter|192|||
160746872|NCT04918355|580457134|FG002|Overall Study|no qualifying health encounter|438|||
160746873|NCT04918355|580457135|FG003|Overall Study|no qualifying health encounter|424|||
160746874|NCT00904917|580459114|FG000|Overall Study|Lost to Follow-up|2|||
160746875|NCT00904917|580459115|FG001|Overall Study|Lost to Follow-up|2|||
160746876|NCT00904917|580459116|FG002|Overall Study|Lost to Follow-up|2|||
160746877|NCT00904917|580459117|FG003|Overall Study|Lost to Follow-up|2|||
160746878|NCT00497146|580459118|FG000|Treatment Period|Adverse Event|6|||
160746879|NCT00497146|580459119|FG001|Treatment Period|Adverse Event|2|||
160746880|NCT00497146|580459118|FG000|Treatment Period|Withdrawal by Subject|5|||
160746881|NCT00497146|580459119|FG001|Treatment Period|Withdrawal by Subject|9|||
160746882|NCT00497146|580459118|FG000|Treatment Period|Lost to Follow-up|1|||
160746883|NCT00497146|580459119|FG001|Treatment Period|Lost to Follow-up|3|||
160746884|NCT00497146|580459118|FG000|Treatment Period|Required dialysis|4|||
160746885|NCT00497146|580459119|FG001|Treatment Period|Required dialysis|1|||
160746886|NCT00497146|580459118|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
160746887|NCT00497146|580459119|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
160746888|NCT00497146|580459118|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
160746889|NCT00497146|580459119|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
160746890|NCT00497146|580459118|FG000|Treatment Period|Other Reason|2|||
160746891|NCT00497146|580459119|FG001|Treatment Period|Other Reason|3|||
160746892|NCT00497146|580459118|FG000|Long-term Follow-up Period|Adverse Event|2|||
160746893|NCT00497146|580459119|FG001|Long-term Follow-up Period|Adverse Event|2|||
160746894|NCT00497146|580459118|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
160746895|NCT00497146|580459119|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
160746896|NCT00497146|580459118|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
160746897|NCT00497146|580459119|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
160746898|NCT00497146|580459118|FG000|Long-term Follow-up Period|Other|0|||
160746899|NCT00497146|580459119|FG001|Long-term Follow-up Period|Other|1|||
160746900|NCT04575584|580459124|FG000|Overall Study|Death|6|||
160746901|NCT04575584|580459125|FG001|Overall Study|Death|4|||
160746902|NCT04575584|580459126|FG002|Overall Study|Death|6|||
160746903|NCT04575584|580459127|FG003|Overall Study|Death|2|||
160746904|NCT04575584|580459128|FG004|Overall Study|Death|0|||
160746905|NCT04575584|580459129|FG005|Overall Study|Death|0|||
160746906|NCT04575584|580459124|FG000|Overall Study|Lost to Follow-up|1|||
160746907|NCT04575584|580459125|FG001|Overall Study|Lost to Follow-up|1|||
160746908|NCT04575584|580459126|FG002|Overall Study|Lost to Follow-up|1|||
160746909|NCT04575584|580459127|FG003|Overall Study|Lost to Follow-up|1|||
160746910|NCT04575584|580459128|FG004|Overall Study|Lost to Follow-up|0|||
160746911|NCT04575584|580459129|FG005|Overall Study|Lost to Follow-up|0|||
160746912|NCT04575584|580459124|FG000|Overall Study|Physician Decision|0|||
160746913|NCT04575584|580459125|FG001|Overall Study|Physician Decision|1|||
160746914|NCT04575584|580459126|FG002|Overall Study|Physician Decision|1|||
160746915|NCT04575584|580459127|FG003|Overall Study|Physician Decision|1|||
160746916|NCT04575584|580459128|FG004|Overall Study|Physician Decision|0|||
160746917|NCT04575584|580459129|FG005|Overall Study|Physician Decision|0|||
160746918|NCT04575584|580459124|FG000|Overall Study|Withdrawal by Subject|7|||
160746919|NCT04575584|580459125|FG001|Overall Study|Withdrawal by Subject|9|||
160746920|NCT04575584|580459126|FG002|Overall Study|Withdrawal by Subject|5|||
160746921|NCT04575584|580459127|FG003|Overall Study|Withdrawal by Subject|3|||
160746922|NCT04575584|580459128|FG004|Overall Study|Withdrawal by Subject|0|||
160746923|NCT04575584|580459129|FG005|Overall Study|Withdrawal by Subject|0|||
160746924|NCT04575584|580459124|FG000|Overall Study|Not recorded|0|||
160746925|NCT04575584|580459125|FG001|Overall Study|Not recorded|0|||
160746926|NCT04575584|580459126|FG002|Overall Study|Not recorded|0|||
160746927|NCT04575584|580459127|FG003|Overall Study|Not recorded|1|||
160746928|NCT04575584|580459128|FG004|Overall Study|Not recorded|0|||
160746929|NCT04575584|580459129|FG005|Overall Study|Not recorded|0|||
160746930|NCT02634801|580459130|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
160746931|NCT02634801|580459131|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
160746932|NCT02634801|580459132|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
160746933|NCT02634801|580459130|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
160746934|NCT02634801|580459131|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
160746935|NCT02634801|580459132|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
160746936|NCT02634801|580459130|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
160746937|NCT02634801|580459131|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
160746938|NCT02634801|580459132|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
160746939|NCT02634801|580459130|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
160746940|NCT02634801|580459131|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
160746941|NCT02634801|580459132|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
160746942|NCT02634801|580459130|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
160746943|NCT02634801|580459131|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
160746944|NCT02634801|580459132|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
160746945|NCT02634801|580459130|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
160746946|NCT02634801|580459131|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
160746947|NCT02634801|580459132|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
160746948|NCT02634801|580459130|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
160746949|NCT02634801|580459131|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
160746950|NCT02634801|580459132|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
160746951|NCT02634801|580459130|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
160746952|NCT02634801|580459131|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
160746953|NCT02634801|580459132|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
160746954|NCT02634801|580459130|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
160746955|NCT02634801|580459131|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
160746956|NCT02634801|580459132|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
160746957|NCT02634801|580459130|FG000|Follow-up Period|Lost to Follow-up|3|||
160746958|NCT02634801|580459131|FG001|Follow-up Period|Lost to Follow-up|1|||
160746959|NCT02634801|580459132|FG002|Follow-up Period|Lost to Follow-up|2|||
160746960|NCT02634801|580459130|FG000|Follow-up Period|Physician Decision|0|||
160746961|NCT02634801|580459131|FG001|Follow-up Period|Physician Decision|0|||
160746962|NCT02634801|580459132|FG002|Follow-up Period|Physician Decision|1|||
160746963|NCT02634801|580459130|FG000|Follow-up Period|Withdrawal by Subject|1|||
160746964|NCT02634801|580459131|FG001|Follow-up Period|Withdrawal by Subject|2|||
160746965|NCT02634801|580459132|FG002|Follow-up Period|Withdrawal by Subject|5|||
160746966|NCT02634801|580459130|FG000|Follow-up Period|Adverse Event|1|||
160746967|NCT02634801|580459131|FG001|Follow-up Period|Adverse Event|5|||
160746968|NCT02634801|580459132|FG002|Follow-up Period|Adverse Event|0|||
160746969|NCT00582426|580459140|FG000|Overall Study|Lost to Follow-up|0|||
160746970|NCT00582426|580459141|FG001|Overall Study|Lost to Follow-up|2|||
160746971|NCT00582426|580459140|FG000|Overall Study|Adverse Event|4|||
160746972|NCT00582426|580459141|FG001|Overall Study|Adverse Event|2|||
160746973|NCT00582426|580459140|FG000|Overall Study|Protocol Violation|6|||
160746974|NCT00582426|580459141|FG001|Overall Study|Protocol Violation|2|||
160746975|NCT00582426|580459140|FG000|Overall Study|Death|4|||
160746976|NCT00582426|580459141|FG001|Overall Study|Death|3|||
160746977|NCT00582426|580459140|FG000|Overall Study|Withdrawal by Subject|3|||
160746978|NCT00582426|580459141|FG001|Overall Study|Withdrawal by Subject|2|||
160746979|NCT00582426|580459140|FG000|Overall Study|Disease Progression|2|||
160746980|NCT00582426|580459141|FG001|Overall Study|Disease Progression|2|||
160746981|NCT00582426|580459140|FG000|Overall Study|Use of illicit drugs|1|||
160746982|NCT00582426|580459141|FG001|Overall Study|Use of illicit drugs|0|||
160746983|NCT00199849|580459144|FG000|Overall Study|Unrelated illness or complication|0|||
160746984|NCT00199849|580459145|FG001|Overall Study|Unrelated illness or complication|1|||
160746985|NCT00199849|580459146|FG002|Overall Study|Unrelated illness or complication|0|||
160746986|NCT00199849|580459144|FG000|Overall Study|Progressive disease requiring intervention|0|||
160746987|NCT00199849|580459145|FG001|Overall Study|Progressive disease requiring intervention|0|||
160746988|NCT00199849|580459146|FG002|Overall Study|Progressive disease requiring intervention|1|||
160746989|NCT00199849|580459144|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
160746990|NCT00199849|580459145|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
160746991|NCT00199849|580459146|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
160746992|NCT02164318|580459147|FG000|Overall Study|Withdrawal by Subject|0|||
160746993|NCT02164318|580459148|FG001|Overall Study|Withdrawal by Subject|1|||
160746994|NCT02164318|580459149|FG002|Overall Study|Withdrawal by Subject|0|||
160746995|NCT02164318|580459150|FG003|Overall Study|Withdrawal by Subject|1|||
160746996|NCT00662311|580459151|FG000|Overall Study|Respiratory Infection|1|||
160746997|NCT00662311|580459152|FG001|Overall Study|Respiratory Infection|0|||
160746998|NCT00662311|580459153|FG002|Overall Study|Respiratory Infection|0|||
160746999|NCT04727528|580459154|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
160747000|NCT04727528|580459155|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
160747001|NCT04727528|580459154|FG000|Open-label Period|Randomized who did not receive treatment|1|||
160747002|NCT04727528|580459155|FG001|Open-label Period|Randomized who did not receive treatment|0|||
160747003|NCT04727528|580459154|FG000|Double-blind Treatment Phase|Adverse Event|0|||
160747004|NCT04727528|580459155|FG001|Double-blind Treatment Phase|Adverse Event|1|||
160747005|NCT04727528|580459154|FG000|Double-blind Treatment Phase|Death|0|||
160747006|NCT04727528|580459155|FG001|Double-blind Treatment Phase|Death|1|||
160747007|NCT04727528|580459154|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
160747008|NCT04727528|580459155|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
160747009|NCT04727528|580459154|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
160747010|NCT04727528|580459155|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
160747011|NCT04727528|580459154|FG000|Double-blind Treatment Phase|Physician Decision|0|||
160747012|NCT04727528|580459155|FG001|Double-blind Treatment Phase|Physician Decision|1|||
160747013|NCT04727528|580459154|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
160747014|NCT04727528|580459155|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160747015|NCT01964989|580459159|FG000|Overall Study|Protocol Violation|3|||
160747016|NCT01964989|580459160|FG001|Overall Study|Protocol Violation|4|||
160747017|NCT01964989|580459159|FG000|Overall Study|Administrative Reason|103|||
160747018|NCT01964989|580459160|FG001|Overall Study|Administrative Reason|95|||
160747019|NCT01964989|580459159|FG000|Overall Study|Adverse Event|0|||
160747020|NCT01964989|580459160|FG001|Overall Study|Adverse Event|1|||
160747021|NCT01964989|580459159|FG000|Overall Study|Death|1|||
160747022|NCT01964989|580459160|FG001|Overall Study|Death|3|||
160747023|NCT01964989|580459159|FG000|Overall Study|Withdrawal by Subject|156|||
160747024|NCT01964989|580459160|FG001|Overall Study|Withdrawal by Subject|160|||
160747025|NCT01964989|580459159|FG000|Overall Study|Lost to Follow-up|254|||
160747026|NCT01964989|580459160|FG001|Overall Study|Lost to Follow-up|232|||
160747027|NCT01964989|580459159|FG000|Overall Study|Other|267|||
160747028|NCT01964989|580459160|FG001|Overall Study|Other|252|||
160747029|NCT02769312|580459161|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
160747030|NCT02769312|580459162|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
160747031|NCT02769312|580459161|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
160747032|NCT02769312|580459162|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
160747033|NCT02769312|580459161|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
160747034|NCT02769312|580459162|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
160747035|NCT02769312|580459161|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
160747036|NCT02769312|580459162|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
160747037|NCT02769312|580459161|FG000|Follow-up|Lost to Follow-up|1|||
160747038|NCT02769312|580459162|FG001|Follow-up|Lost to Follow-up|1|||
160747039|NCT01148459|580459165|FG000|Overall Study|Serious Adverse Event|5|||
160747040|NCT01148459|580459166|FG001|Overall Study|Serious Adverse Event|4|||
160747041|NCT01148459|580459165|FG000|Overall Study|Withdrawal by Subject|1|||
160747042|NCT01148459|580459166|FG001|Overall Study|Withdrawal by Subject|0|||
160747043|NCT01148459|580459165|FG000|Overall Study|Migrated/moved from study area|3|||
160747044|NCT01148459|580459166|FG001|Overall Study|Migrated/moved from study area|6|||
160747045|NCT01148459|580459165|FG000|Overall Study|Lost to Follow-up|2|||
160747046|NCT01148459|580459166|FG001|Overall Study|Lost to Follow-up|0|||
160747047|NCT01148459|580459165|FG000|Overall Study|Refusal|1|||
160747048|NCT01148459|580459166|FG001|Overall Study|Refusal|0|||
160747049|NCT01148459|580459165|FG000|Overall Study|Failure to comply with study procedures|0|||
160747050|NCT01148459|580459166|FG001|Overall Study|Failure to comply with study procedures|1|||
160747051|NCT02496039|580459167|FG000|Overall Study|Adverse Event|3|||
160747052|NCT02496039|580459167|FG000|Overall Study|Protocol Violation|1|||
160747053|NCT02131233|580459168|FG000|Overall Study|Not Treated|2|||
160747054|NCT02131233|580459169|FG001|Overall Study|Not Treated|3|||
160747055|NCT02131233|580459168|FG000|Overall Study|Adverse Event|7|||
160747056|NCT02131233|580459169|FG001|Overall Study|Adverse Event|6|||
160747057|NCT02131233|580459168|FG000|Overall Study|Death|0|||
160747058|NCT02131233|580459169|FG001|Overall Study|Death|1|||
160747059|NCT02131233|580459168|FG000|Overall Study|Lack of Efficacy|6|||
160747060|NCT02131233|580459169|FG001|Overall Study|Lack of Efficacy|3|||
160747061|NCT02131233|580459168|FG000|Overall Study|Lost to Follow-up|14|||
160747062|NCT02131233|580459169|FG001|Overall Study|Lost to Follow-up|13|||
160747063|NCT02131233|580459168|FG000|Overall Study|Non-Compliance With Study Drug|8|||
160747064|NCT02131233|580459169|FG001|Overall Study|Non-Compliance With Study Drug|5|||
160747065|NCT02131233|580459168|FG000|Overall Study|Physician Decision|7|||
160747066|NCT02131233|580459169|FG001|Overall Study|Physician Decision|0|||
160747067|NCT02131233|580459168|FG000|Overall Study|Pregnancy|4|||
160747068|NCT02131233|580459169|FG001|Overall Study|Pregnancy|0|||
160747069|NCT02131233|580459168|FG000|Overall Study|Withdrawal by Subject|18|||
160747070|NCT02131233|580459169|FG001|Overall Study|Withdrawal by Subject|11|||
160747071|NCT00255840|580459170|FG000|Overall Study|Lost to Follow-up|10|||
160747072|NCT00255840|580459171|FG001|Overall Study|Lost to Follow-up|14|||
160747073|NCT00255840|580459170|FG000|Overall Study|Discontinued intervention|53|||
160747074|NCT00255840|580459171|FG001|Overall Study|Discontinued intervention|56|||
160747075|NCT03077607|580459172|FG000|Period 1 (15 Days)|Adverse Event|1|||
160747076|NCT03077607|580459173|FG001|Period 1 (15 Days)|Adverse Event|0|||
160747077|NCT03077607|580459172|FG000|Period 1 (15 Days)|Death|1|||
160747078|NCT03077607|580459173|FG001|Period 1 (15 Days)|Death|0|||
160747079|NCT03077607|580459172|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
160747080|NCT03077607|580459173|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
160747081|NCT03077607|580459172|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
160747082|NCT03077607|580459173|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
160747083|NCT01005901|580459174|FG000|Overall Study|Withdrawal by Subject|38|||
160747084|NCT01005901|580459175|FG001|Overall Study|Withdrawal by Subject|14|||
160747085|NCT01005901|580459174|FG000|Overall Study|Adverse Event|30|||
160747086|NCT01005901|580459175|FG001|Overall Study|Adverse Event|16|||
160747087|NCT01005901|580459174|FG000|Overall Study|Administrative problems|21|||
160747088|NCT01005901|580459175|FG001|Overall Study|Administrative problems|13|||
160747089|NCT01005901|580459174|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
160747090|NCT01005901|580459175|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
160747091|NCT01005901|580459174|FG000|Overall Study|Protocol Violation|4|||
160747092|NCT01005901|580459175|FG001|Overall Study|Protocol Violation|3|||
160747093|NCT01005901|580459174|FG000|Overall Study|Death|2|||
160747094|NCT01005901|580459175|FG001|Overall Study|Death|3|||
160747095|NCT01005901|580459174|FG000|Overall Study|Lost to Follow-up|1|||
160747096|NCT01005901|580459175|FG001|Overall Study|Lost to Follow-up|2|||
160747097|NCT01005901|580459174|FG000|Overall Study|Patient's inability to use the device|1|||
160747098|NCT01005901|580459175|FG001|Overall Study|Patient's inability to use the device|1|||
160747099|NCT01005901|580459174|FG000|Overall Study|No longer requires study drug|0|||
160747100|NCT01005901|580459175|FG001|Overall Study|No longer requires study drug|1|||
160747101|NCT00957424|580459184|FG000|Overall Study|Lost to Follow-up|19|||
160747102|NCT00957424|580459184|FG000|Overall Study|Protocol Violation|3|||
160747103|NCT00957424|580459184|FG000|Overall Study|Withdrawal by Subject|1|||
160747104|NCT00431067|580459188|FG000|Overall Study|Other Adverse Event|9|||
160747105|NCT00431067|580459188|FG000|Overall Study|Progressive disease|30|||
160747106|NCT00431067|580459188|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
160747107|NCT00548249|580459189|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
160747108|NCT00548249|580459190|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
160747109|NCT00548249|580459191|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
160747110|NCT00548249|580459192|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
160747111|NCT00548249|580459193|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
160747112|NCT00548249|580459189|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
160747113|NCT00548249|580459190|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
160747114|NCT00548249|580459191|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
160747115|NCT00548249|580459192|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
160747116|NCT00548249|580459193|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
160747117|NCT00548249|580459189|FG000|Overall Study|Protocol Violation|1|||
160747118|NCT00548249|580459190|FG001|Overall Study|Protocol Violation|1|||
160747119|NCT00548249|580459191|FG002|Overall Study|Protocol Violation|4|||
160747120|NCT00548249|580459192|FG003|Overall Study|Protocol Violation|0|||
160747121|NCT00548249|580459193|FG004|Overall Study|Protocol Violation|3|||
160747122|NCT00548249|580459189|FG000|Overall Study|Miscellaneous|2|||
160747123|NCT00548249|580459190|FG001|Overall Study|Miscellaneous|3|||
160747124|NCT00548249|580459191|FG002|Overall Study|Miscellaneous|2|||
160747125|NCT00548249|580459192|FG003|Overall Study|Miscellaneous|0|||
160747126|NCT00548249|580459193|FG004|Overall Study|Miscellaneous|2|||
160747127|NCT00548249|580459189|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
160747128|NCT00548249|580459190|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
160747129|NCT00548249|580459191|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
160747130|NCT00548249|580459192|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
160747131|NCT00548249|580459193|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
160747132|NCT00548249|580459189|FG000|Overall Study|Adverse Event|2|||
160747133|NCT00548249|580459190|FG001|Overall Study|Adverse Event|2|||
160747134|NCT00548249|580459191|FG002|Overall Study|Adverse Event|0|||
160747135|NCT00548249|580459192|FG003|Overall Study|Adverse Event|1|||
160747136|NCT00548249|580459193|FG004|Overall Study|Adverse Event|1|||
160747137|NCT00548249|580459189|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
160747138|NCT00548249|580459190|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
160747139|NCT00548249|580459191|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
160747140|NCT00548249|580459192|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
160747141|NCT00548249|580459193|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
160747142|NCT00548249|580459189|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
160747143|NCT00548249|580459190|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
160747144|NCT00548249|580459191|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
160747145|NCT00548249|580459192|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
160747146|NCT00548249|580459193|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
160747147|NCT00548249|580459189|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
160747148|NCT00548249|580459190|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
160747149|NCT00548249|580459191|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
160747150|NCT00548249|580459192|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
160747151|NCT00548249|580459193|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
160747152|NCT00548249|580459189|FG000|Overall Study|Prolonged hospitalization|0|||
160747153|NCT00548249|580459190|FG001|Overall Study|Prolonged hospitalization|0|||
160747154|NCT00548249|580459191|FG002|Overall Study|Prolonged hospitalization|2|||
160747155|NCT00548249|580459192|FG003|Overall Study|Prolonged hospitalization|1|||
160747156|NCT00548249|580459193|FG004|Overall Study|Prolonged hospitalization|0|||
160747157|NCT00548249|580459189|FG000|Overall Study|Withdrawal by Subject|2|||
160747158|NCT00548249|580459190|FG001|Overall Study|Withdrawal by Subject|0|||
160747159|NCT00548249|580459191|FG002|Overall Study|Withdrawal by Subject|0|||
160747160|NCT00548249|580459192|FG003|Overall Study|Withdrawal by Subject|0|||
160747161|NCT00548249|580459193|FG004|Overall Study|Withdrawal by Subject|0|||
160747162|NCT00548249|580459189|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
160747163|NCT00548249|580459190|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
160747164|NCT00548249|580459191|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
160747165|NCT00548249|580459192|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
160747166|NCT00548249|580459193|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
160747167|NCT00548249|580459189|FG000|Overall Study|Sponsor's request|0|||
160747168|NCT00548249|580459190|FG001|Overall Study|Sponsor's request|0|||
160747169|NCT00548249|580459191|FG002|Overall Study|Sponsor's request|0|||
160747170|NCT00548249|580459192|FG003|Overall Study|Sponsor's request|1|||
160747171|NCT00548249|580459193|FG004|Overall Study|Sponsor's request|0|||
160747172|NCT03760458|580459195|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
160747173|NCT03760458|580459196|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
160747174|NCT03760458|580459197|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
160747175|NCT03760458|580459198|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
160747176|NCT03760458|580459199|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
160747177|NCT00750919|580459200|FG000|Overall Study|Adverse Event|9|||
160747178|NCT00750919|580459200|FG000|Overall Study|Withdrawal by Subject|1|||
160747179|NCT00750919|580459200|FG000|Overall Study|Lack of Efficacy|8|||
160747180|NCT00750919|580459200|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
160747181|NCT00750919|580459200|FG000|Overall Study|Other|36|||
160747182|NCT00080483|580459205|FG000|Overall Study|Lost to Follow-up|1|||
160747183|NCT00080483|580459206|FG001|Overall Study|Lost to Follow-up|1|||
160747184|NCT00080483|580459205|FG000|Overall Study|Physician Decision|1|||
160747185|NCT00080483|580459206|FG001|Overall Study|Physician Decision|1|||
160747186|NCT03913104|580459209|FG000|Overall Study|Lost to Follow-up|20|||
160747187|NCT03913104|580459209|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
160747188|NCT03913104|580459209|FG000|Overall Study|Withdrawal by Subject|2|||
160747189|NCT00048997|580459210|FG000|Overall Study|Protocol Violation|7|||
160747190|NCT00048997|580459211|FG001|Overall Study|Protocol Violation|2|||
160747191|NCT00048997|580459210|FG000|Overall Study|Withdrawal by Subject|6|||
160747192|NCT00048997|580459211|FG001|Overall Study|Withdrawal by Subject|1|||
160747193|NCT00002525|580459218|FG000|Overall Study|Adverse Event|36|||
160747194|NCT00002525|580459219|FG001|Overall Study|Adverse Event|0|||
160747195|NCT00002525|580459218|FG000|Overall Study|Death|5|||
160747196|NCT00002525|580459219|FG001|Overall Study|Death|0|||
160747197|NCT00002525|580459218|FG000|Overall Study|Withdrawal by Subject|11|||
160747198|NCT00002525|580459219|FG001|Overall Study|Withdrawal by Subject|0|||
160747199|NCT00002525|580459218|FG000|Overall Study|Start non-protocol therapy|1|||
160747200|NCT00002525|580459219|FG001|Overall Study|Start non-protocol therapy|0|||
160747201|NCT00002525|580459218|FG000|Overall Study|Other complicating disease|1|||
160747202|NCT00002525|580459219|FG001|Overall Study|Other complicating disease|0|||
160747203|NCT00002525|580459218|FG000|Overall Study|Duke's A, B1, D disease|92|||
160747204|NCT00002525|580459219|FG001|Overall Study|Duke's A, B1, D disease|0|||
160747205|NCT00002525|580459218|FG000|Overall Study|Error|6|||
160747206|NCT00002525|580459219|FG001|Overall Study|Error|0|||
160747207|NCT00002525|580459218|FG000|Overall Study|Other|26|||
160747208|NCT00002525|580459219|FG001|Overall Study|Other|0|||
160747209|NCT00002525|580459218|FG000|Overall Study|Never start protocol therapy|8|||
160747210|NCT00002525|580459219|FG001|Overall Study|Never start protocol therapy|0|||
160747211|NCT04527978|580459221|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
160747212|NCT04527978|580459222|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
160747213|NCT02112877|580459224|FG000|Overall Study|Withdrawal by Subject|1|||
160747214|NCT02112877|580459225|FG001|Overall Study|Withdrawal by Subject|7|||
160747215|NCT02112877|580459224|FG000|Overall Study|Visit Missed|1|||
160747216|NCT02112877|580459225|FG001|Overall Study|Visit Missed|6|||
160747217|NCT00187278|580459234|FG000|Overall Study|Protocol Violation|10|||
160747218|NCT00187278|580459235|FG001|Overall Study|Protocol Violation|13|||
160747219|NCT01578499|580459236|FG000|Overall Study|Reason not Specified|0|||
160747220|NCT01578499|580459237|FG001|Overall Study|Reason not Specified|1|||
160747221|NCT01578499|580459236|FG000|Overall Study|Lost to Follow-up|2|||
160747222|NCT01578499|580459237|FG001|Overall Study|Lost to Follow-up|1|||
160747223|NCT01578499|580459236|FG000|Overall Study|Withdrawal by Subject|10|||
160747224|NCT01578499|580459237|FG001|Overall Study|Withdrawal by Subject|16|||
160747225|NCT01578499|580459236|FG000|Overall Study|Death|20|||
160747226|NCT01578499|580459237|FG001|Overall Study|Death|25|||
160747227|NCT01578499|580459236|FG000|Overall Study|Died and End of Study Page not Completed|2|||
160747228|NCT01578499|580459237|FG001|Overall Study|Died and End of Study Page not Completed|0|||
160747229|NCT00862459|580459239|FG000|Overall Study|Lost to Follow-up|1|||
160747230|NCT00862459|580459240|FG001|Overall Study|Lost to Follow-up|2|||
160747231|NCT00862459|580459241|FG002|Overall Study|Lost to Follow-up|2|||
160747232|NCT00862459|580459239|FG000|Overall Study|Protocol Violation|1|||
160747233|NCT00862459|580459240|FG001|Overall Study|Protocol Violation|0|||
160747234|NCT00862459|580459241|FG002|Overall Study|Protocol Violation|0|||
160747235|NCT00862459|580459239|FG000|Overall Study|Withdrawal by Subject|1|||
160747236|NCT00862459|580459240|FG001|Overall Study|Withdrawal by Subject|1|||
160747237|NCT00862459|580459241|FG002|Overall Study|Withdrawal by Subject|3|||
160747238|NCT00862459|580459239|FG000|Overall Study|Adverse Event|0|||
160747239|NCT00862459|580459240|FG001|Overall Study|Adverse Event|1|||
160747240|NCT00862459|580459241|FG002|Overall Study|Adverse Event|0|||
160747241|NCT00862459|580459239|FG000|Overall Study|Personal reasons|1|||
160747242|NCT00862459|580459240|FG001|Overall Study|Personal reasons|0|||
160747243|NCT00862459|580459241|FG002|Overall Study|Personal reasons|0|||
160747244|NCT00862459|580459239|FG000|Overall Study|Operation|1|||
160747245|NCT00862459|580459240|FG001|Overall Study|Operation|1|||
160747246|NCT00862459|580459241|FG002|Overall Study|Operation|0|||
160747247|NCT00862459|580459239|FG000|Overall Study|Intravenous (IV) site problems|1|||
160747248|NCT00862459|580459240|FG001|Overall Study|Intravenous (IV) site problems|0|||
160747249|NCT00862459|580459241|FG002|Overall Study|Intravenous (IV) site problems|1|||
160747250|NCT00862459|580459239|FG000|Overall Study|Unable to hold still for imaging|0|||
160747251|NCT00862459|580459240|FG001|Overall Study|Unable to hold still for imaging|1|||
160747252|NCT00862459|580459241|FG002|Overall Study|Unable to hold still for imaging|0|||
160747253|NCT00862459|580459239|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
160747254|NCT00862459|580459240|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
160747255|NCT00862459|580459241|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
160747256|NCT00862459|580459239|FG000|Overall Study|Administrative problems|0|||
160747257|NCT00862459|580459240|FG001|Overall Study|Administrative problems|1|||
160747258|NCT00862459|580459241|FG002|Overall Study|Administrative problems|0|||
160747259|NCT02906033|580459242|FG000|Baseline|Protocol Violation|37|||
160747260|NCT02906033|580459243|FG001|Baseline|Protocol Violation|33|||
160747261|NCT02906033|580459242|FG000|Follow-up|Lost to Follow-up|46|||
160747262|NCT02906033|580459243|FG001|Follow-up|Lost to Follow-up|62|||
160747263|NCT00358956|580459254|FG000|Overall Study|Adverse Event|3|||
160747264|NCT00358956|580459254|FG000|Overall Study|condition under investigation worsened|4|||
160747265|NCT00358956|580459254|FG000|Overall Study|Withdrawal by Subject|1|||
160747266|NCT00655681|580459255|FG000|Overall Study|Lost to Follow-up|1|||
160747267|NCT00655681|580459256|FG001|Overall Study|Lost to Follow-up|1|||
160747268|NCT03168919|580459257|FG000|Overall Study|Withdrawal by Subject|2|||
160747269|NCT01085136|580459258|FG000|Part A|Other Adverse event|223|||
160747270|NCT01085136|580459259|FG001|Part A|Other Adverse event|0|||
160747271|NCT01085136|580459260|FG002|Part A|Other Adverse event|0|||
160747272|NCT01085136|580459258|FG000|Part A|Protocol Violation|3|||
160747273|NCT01085136|580459259|FG001|Part A|Protocol Violation|0|||
160747274|NCT01085136|580459260|FG002|Part A|Protocol Violation|0|||
160747275|NCT01085136|580459258|FG000|Part A|Lost to Follow-up|3|||
160747276|NCT01085136|580459259|FG001|Part A|Lost to Follow-up|0|||
160747277|NCT01085136|580459260|FG002|Part A|Lost to Follow-up|0|||
160747278|NCT01085136|580459258|FG000|Part A|Refusal to continue trial medication|64|||
160747279|NCT01085136|580459259|FG001|Part A|Refusal to continue trial medication|0|||
160747280|NCT01085136|580459260|FG002|Part A|Refusal to continue trial medication|0|||
160747281|NCT01085136|580459258|FG000|Part A|Other reason not defined above|30|||
160747282|NCT01085136|580459259|FG001|Part A|Other reason not defined above|0|||
160747283|NCT01085136|580459260|FG002|Part A|Other reason not defined above|0|||
160747284|NCT01085136|580459258|FG000|Part B|Other AE|0|||
160747285|NCT01085136|580459259|FG001|Part B|Other AE|29|||
160747286|NCT01085136|580459260|FG002|Part B|Other AE|8|||
160747287|NCT01085136|580459258|FG000|Part B|Refusal to continue trial medication|0|||
160747288|NCT01085136|580459259|FG001|Part B|Refusal to continue trial medication|12|||
160747289|NCT01085136|580459260|FG002|Part B|Refusal to continue trial medication|7|||
160747290|NCT01085136|580459258|FG000|Part B|Not treated|0|||
160747291|NCT01085136|580459259|FG001|Part B|Not treated|4|||
160747292|NCT01085136|580459260|FG002|Part B|Not treated|8|||
160747293|NCT01085136|580459258|FG000|Part B|Other reason not defined above|0|||
160747294|NCT01085136|580459259|FG001|Part B|Other reason not defined above|6|||
160747295|NCT01085136|580459260|FG002|Part B|Other reason not defined above|3|||
160747296|NCT03782974|580459261|FG000|Overall Study|Withdrawal by Subject|7|||
160747297|NCT03782974|580459262|FG001|Overall Study|Withdrawal by Subject|7|||
160747298|NCT03782974|580459261|FG000|Overall Study|Pregnancy|1|||
160747299|NCT03782974|580459262|FG001|Overall Study|Pregnancy|0|||
160747300|NCT00385827|580460573|FG000|Part 1|Adverse Event|1|||
160747301|NCT00385827|580460574|FG001|Part 1|Adverse Event|0|||
160747302|NCT00385827|580460575|FG002|Part 1|Adverse Event|0|||
160747303|NCT00385827|580460573|FG000|Part 1|Death|2|||
160747304|NCT00385827|580460574|FG001|Part 1|Death|0|||
160747305|NCT00385827|580460575|FG002|Part 1|Death|0|||
160747306|NCT00385827|580460573|FG000|Part 1|Lack of Efficacy|5|||
160747307|NCT00385827|580460574|FG001|Part 1|Lack of Efficacy|0|||
160747308|NCT00385827|580460575|FG002|Part 1|Lack of Efficacy|0|||
160747309|NCT00385827|580460573|FG000|Part 1|Other|1|||
160747310|NCT00385827|580460574|FG001|Part 1|Other|0|||
160747311|NCT00385827|580460575|FG002|Part 1|Other|0|||
160747312|NCT00385827|580460573|FG000|Part 2|Adverse Event|0|||
160747313|NCT00385827|580460574|FG001|Part 2|Adverse Event|6|||
160747314|NCT00385827|580460575|FG002|Part 2|Adverse Event|10|||
160747315|NCT00385827|580460573|FG000|Part 2|Death|0|||
160747316|NCT00385827|580460574|FG001|Part 2|Death|0|||
160747317|NCT00385827|580460575|FG002|Part 2|Death|2|||
160747318|NCT00385827|580460573|FG000|Part 2|Lack of Efficacy|0|||
160747319|NCT00385827|580460574|FG001|Part 2|Lack of Efficacy|14|||
160747320|NCT00385827|580460575|FG002|Part 2|Lack of Efficacy|13|||
160747321|NCT00385827|580460573|FG000|Part 2|Randomized but not treated|0|||
160747322|NCT00385827|580460574|FG001|Part 2|Randomized but not treated|2|||
160747323|NCT00385827|580460575|FG002|Part 2|Randomized but not treated|2|||
160747324|NCT00385827|580460573|FG000|Part 2|Other|0|||
160747325|NCT00385827|580460574|FG001|Part 2|Other|11|||
160747326|NCT00385827|580460575|FG002|Part 2|Other|21|||
160747327|NCT01421147|580460576|FG000|Treatment Period|Adverse Event|2|||
160747328|NCT01421147|580460577|FG001|Treatment Period|Adverse Event|3|||
160747329|NCT01421147|580460576|FG000|Treatment Period|Lost to Follow-up|2|||
160747330|NCT01421147|580460577|FG001|Treatment Period|Lost to Follow-up|1|||
160747331|NCT01421147|580460576|FG000|Treatment Period|Physician Decision|2|||
160747332|NCT01421147|580460577|FG001|Treatment Period|Physician Decision|2|||
160747333|NCT01421147|580460576|FG000|Treatment Period|Withdrawal by Subject|10|||
160747334|NCT01421147|580460577|FG001|Treatment Period|Withdrawal by Subject|5|||
160747335|NCT01421147|580460576|FG000|Extension Period|Adverse Event|0|||
160747336|NCT01421147|580460577|FG001|Extension Period|Adverse Event|2|||
160747337|NCT01421147|580460576|FG000|Extension Period|Death|0|||
160747338|NCT01421147|580460577|FG001|Extension Period|Death|1|||
160747339|NCT01421147|580460576|FG000|Extension Period|Lost to Follow-up|2|||
160747340|NCT01421147|580460577|FG001|Extension Period|Lost to Follow-up|5|||
160747341|NCT01421147|580460576|FG000|Extension Period|Physician Decision|1|||
160747342|NCT01421147|580460577|FG001|Extension Period|Physician Decision|0|||
160747343|NCT01421147|580460576|FG000|Extension Period|Withdrawal by Subject|5|||
160747344|NCT01421147|580460577|FG001|Extension Period|Withdrawal by Subject|3|||
160747345|NCT04985942|580460578|FG000|Overall Study|Adverse Event|14|||
160747346|NCT04985942|580460579|FG001|Overall Study|Adverse Event|2|||
160747347|NCT04985942|580460578|FG000|Overall Study|Lack of Efficacy|0|||
160747348|NCT04985942|580460579|FG001|Overall Study|Lack of Efficacy|3|||
160747349|NCT04985942|580460578|FG000|Overall Study|Lost to Follow-up|1|||
160747350|NCT04985942|580460579|FG001|Overall Study|Lost to Follow-up|1|||
160747351|NCT04985942|580460578|FG000|Overall Study|Protocol Violation|1|||
160747352|NCT04985942|580460579|FG001|Overall Study|Protocol Violation|1|||
160747353|NCT04985942|580460578|FG000|Overall Study|Withdrawal by Subject|5|||
160747354|NCT04985942|580460579|FG001|Overall Study|Withdrawal by Subject|4|||
160747355|NCT01467271|580460580|FG000|Overall Study|Death|84|||
160747356|NCT01467271|580460580|FG000|Overall Study|Lost to Follow-up|83|||
160747357|NCT01467271|580460580|FG000|Overall Study|Retraction of patient's consent|21|||
160747358|NCT01467271|580460580|FG000|Overall Study|Other reason|14|||
160747359|NCT02815267|580460600|FG000|Double-Blind Phase|Adverse Event|0|||
160747360|NCT02815267|580460601|FG001|Double-Blind Phase|Adverse Event|3|||
160747361|NCT02815267|580460600|FG000|Double-Blind Phase|Lost to Follow-up|17|||
160747362|NCT02815267|580460601|FG001|Double-Blind Phase|Lost to Follow-up|9|||
160747363|NCT02815267|580460600|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
160747364|NCT02815267|580460601|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
160747365|NCT02815267|580460600|FG000|Double-Blind Phase|Protocol Violation|3|||
160747366|NCT02815267|580460601|FG001|Double-Blind Phase|Protocol Violation|2|||
160747367|NCT02815267|580460600|FG000|Double-Blind Phase|Site withdrawal|1|||
160747368|NCT02815267|580460601|FG001|Double-Blind Phase|Site withdrawal|6|||
160747369|NCT02815267|580460600|FG000|Double-Blind Phase|Received a disallowed medication|1|||
160747370|NCT02815267|580460601|FG001|Double-Blind Phase|Received a disallowed medication|1|||
160747371|NCT02815267|580460600|FG000|Open-Label Phase|Adverse Event|1|||
160747372|NCT02815267|580460601|FG001|Open-Label Phase|Adverse Event|1|||
160747373|NCT02815267|580460600|FG000|Open-Label Phase|Lost to Follow-up|23|||
160747374|NCT02815267|580460601|FG001|Open-Label Phase|Lost to Follow-up|9|||
160747375|NCT02815267|580460600|FG000|Open-Label Phase|Withdrawal by Subject|24|||
160747376|NCT02815267|580460601|FG001|Open-Label Phase|Withdrawal by Subject|13|||
160747377|NCT02815267|580460600|FG000|Open-Label Phase|Protocol Violation|0|||
160747378|NCT02815267|580460601|FG001|Open-Label Phase|Protocol Violation|1|||
160747379|NCT02815267|580460600|FG000|Open-Label Phase|Administrative|21|||
160747380|NCT02815267|580460601|FG001|Open-Label Phase|Administrative|12|||
160747381|NCT02815267|580460600|FG000|Open-Label Phase|Other|2|||
160747382|NCT02815267|580460601|FG001|Open-Label Phase|Other|5|||
160747383|NCT04126317|580460602|FG000|Overall Study|Adverse Event|0|||
160747384|NCT04126317|580460603|FG001|Overall Study|Adverse Event|1|||
160747385|NCT04126317|580460602|FG000|Overall Study|Withdrawal by Subject|4|||
160747386|NCT04126317|580460603|FG001|Overall Study|Withdrawal by Subject|1|||
160747387|NCT00660595|580460604|FG000|Overall Study|Lost to Follow-up|0|||
160747388|NCT00660595|580460605|FG001|Overall Study|Lost to Follow-up|1|||
160747389|NCT00660595|580460604|FG000|Overall Study|Did not consent to participate in study|12|||
160747390|NCT00660595|580460605|FG001|Overall Study|Did not consent to participate in study|8|||
160747391|NCT00660595|580460604|FG000|Overall Study|Participant left hospital|1|||
160747392|NCT00660595|580460605|FG001|Overall Study|Participant left hospital|0|||
160747393|NCT00660595|580460604|FG000|Overall Study|Non Specified reasons|5|||
160747394|NCT00660595|580460605|FG001|Overall Study|Non Specified reasons|0|||
160747395|NCT00948922|580460608|FG000|Overall Study|Did not start study treatment|2|||
160747396|NCT00948922|580460609|FG001|Overall Study|Did not start study treatment|5|||
160747397|NCT00948922|580460610|FG002|Overall Study|Did not start study treatment|0|||
160747398|NCT00948922|580460608|FG000|Overall Study|Withdrawal by Subject|0|||
160747399|NCT00948922|580460609|FG001|Overall Study|Withdrawal by Subject|2|||
160747400|NCT00948922|580460610|FG002|Overall Study|Withdrawal by Subject|1|||
160747401|NCT00948922|580460608|FG000|Overall Study|Death|3|||
160747402|NCT00948922|580460609|FG001|Overall Study|Death|0|||
160747403|NCT00948922|580460610|FG002|Overall Study|Death|0|||
160747404|NCT00948922|580460608|FG000|Overall Study|Disease progression|0|||
160747405|NCT00948922|580460609|FG001|Overall Study|Disease progression|1|||
160747406|NCT00948922|580460610|FG002|Overall Study|Disease progression|0|||
160747407|NCT00948922|580460608|FG000|Overall Study|Insurance issues|1|||
160747408|NCT00948922|580460609|FG001|Overall Study|Insurance issues|0|||
160747409|NCT00948922|580460610|FG002|Overall Study|Insurance issues|0|||
160747410|NCT00948922|580460608|FG000|Overall Study|Transplant eligibility issues|2|||
160747411|NCT00948922|580460609|FG001|Overall Study|Transplant eligibility issues|3|||
160747412|NCT00948922|580460610|FG002|Overall Study|Transplant eligibility issues|0|||
160747413|NCT00948922|580460608|FG000|Overall Study|Not evaluable at time of analysis|0|||
160747414|NCT00948922|580460609|FG001|Overall Study|Not evaluable at time of analysis|3|||
160747415|NCT00948922|580460610|FG002|Overall Study|Not evaluable at time of analysis|0|||
160747416|NCT04854057|580460611|FG000|Overall Study|Adverse Event|0|||
160747417|NCT04854057|580460612|FG001|Overall Study|Adverse Event|1|||
160748722|NCT00303472|580465929|FG003|Treatment Extension (Optional)|Physician Decision|3|||
160747418|NCT05114564|580460614|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
160747419|NCT05114564|580460615|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
160747420|NCT05114564|580460614|FG000|First Intervention|Adverse Event|0|||
160747421|NCT05114564|580460615|FG001|First Intervention|Adverse Event|1|||
160747422|NCT00339833|580460624|FG000|Overall Study|Withdrawal by Subject|1|||
160747423|NCT00339833|580460625|FG001|Overall Study|Withdrawal by Subject|2|||
160747424|NCT00339833|580460624|FG000|Overall Study|toothache|0|||
160747425|NCT00339833|580460625|FG001|Overall Study|toothache|1|||
160747426|NCT00339833|580460624|FG000|Overall Study|indigestion|0|||
160747427|NCT00339833|580460625|FG001|Overall Study|indigestion|1|||
160747428|NCT00339833|580460624|FG000|Overall Study|Chest pain|0|||
160747429|NCT00339833|580460625|FG001|Overall Study|Chest pain|1|||
160747430|NCT00339833|580460624|FG000|Overall Study|minor infection|0|||
160747431|NCT00339833|580460625|FG001|Overall Study|minor infection|1|||
160747432|NCT00339833|580460624|FG000|Overall Study|Poor venous access|2|||
160747433|NCT00339833|580460625|FG001|Overall Study|Poor venous access|2|||
160747434|NCT00339833|580460624|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
160747435|NCT00339833|580460625|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
160747436|NCT00339833|580460624|FG000|Overall Study|Error in data records|1|||
160747437|NCT00339833|580460625|FG001|Overall Study|Error in data records|0|||
160747438|NCT00217581|580460626|FG000|Overall Study|Withdrawal by Subject|1|||
160747439|NCT02829047|580460627|FG000|Overall Study|Withdrawal by Subject|1|||
160747440|NCT01280682|580460628|FG000|Overall Study|Lost to Follow-up|0|||
160747441|NCT01280682|580460629|FG001|Overall Study|Lost to Follow-up|6|||
160747442|NCT01280682|580460628|FG000|Overall Study|Withdrawal by Subject|0|||
160747443|NCT01280682|580460629|FG001|Overall Study|Withdrawal by Subject|7|||
160747444|NCT01119846|580460635|FG000|Overall Study|Adverse Event|1|||
160747445|NCT01119846|580460636|FG001|Overall Study|Adverse Event|0|||
160747446|NCT01119846|580460637|FG002|Overall Study|Adverse Event|6|||
160747447|NCT01119846|580460635|FG000|Overall Study|Physician Decision|1|||
160747448|NCT01119846|580460636|FG001|Overall Study|Physician Decision|0|||
160747449|NCT01119846|580460637|FG002|Overall Study|Physician Decision|0|||
160747450|NCT01119846|580460635|FG000|Overall Study|Protocol Violation|0|||
160747451|NCT01119846|580460636|FG001|Overall Study|Protocol Violation|0|||
160747452|NCT01119846|580460637|FG002|Overall Study|Protocol Violation|1|||
160747453|NCT01119846|580460635|FG000|Overall Study|Withdrawal by Subject|0|||
160747454|NCT01119846|580460636|FG001|Overall Study|Withdrawal by Subject|0|||
160747455|NCT01119846|580460637|FG002|Overall Study|Withdrawal by Subject|4|||
160747456|NCT02651688|580460638|FG000|Overall Study|Non-compliance|0|||
160747457|NCT02651688|580460639|FG001|Overall Study|Non-compliance|0|||
160747458|NCT02651688|580460640|FG002|Overall Study|Non-compliance|1|||
160747459|NCT02651688|580460638|FG000|Overall Study|Principal Investigator (PI) decision|0|||
160747460|NCT02651688|580460639|FG001|Overall Study|Principal Investigator (PI) decision|2|||
160747461|NCT02651688|580460640|FG002|Overall Study|Principal Investigator (PI) decision|0|||
160747462|NCT02651688|580460638|FG000|Overall Study|Lost to Follow-up|1|||
160747463|NCT02651688|580460639|FG001|Overall Study|Lost to Follow-up|3|||
160747464|NCT02651688|580460640|FG002|Overall Study|Lost to Follow-up|0|||
160747465|NCT02651688|580460638|FG000|Overall Study|Withdrawal by Subject|1|||
160747466|NCT02651688|580460639|FG001|Overall Study|Withdrawal by Subject|0|||
160747467|NCT02651688|580460640|FG002|Overall Study|Withdrawal by Subject|2|||
160747468|NCT00625183|580460641|FG000|Overall Study|Disease Progression|1|||
160747469|NCT01606748|580460647|FG000|Overall Study|Adverse Event|1|||
160747470|NCT01606748|580460648|FG001|Overall Study|Adverse Event|0|||
160747471|NCT01606748|580460647|FG000|Overall Study|Progressive Disease|1|||
160747472|NCT01606748|580460648|FG001|Overall Study|Progressive Disease|0|||
160747473|NCT01606748|580460647|FG000|Overall Study|Withdrawal by Subject|1|||
160747474|NCT01606748|580460648|FG001|Overall Study|Withdrawal by Subject|0|||
160747475|NCT02670382|580460650|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
160747476|NCT02670382|580460651|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
160747477|NCT03244618|580460652|FG000|Overall Study|Lost to Follow-up|3|||
160747478|NCT03244618|580460653|FG001|Overall Study|Lost to Follow-up|4|||
160747479|NCT03244618|580460652|FG000|Overall Study|Protocol Violation|4|||
160747480|NCT03244618|580460653|FG001|Overall Study|Protocol Violation|3|||
160747481|NCT03244618|580460652|FG000|Overall Study|Withdrawal by Subject|0|||
160747482|NCT03244618|580460653|FG001|Overall Study|Withdrawal by Subject|2|||
160747483|NCT01380691|580460654|FG000|Washout (7 Days)|Protocol Violation|0|||
160747484|NCT01380691|580460655|FG001|Washout (7 Days)|Protocol Violation|0|||
160747485|NCT01380691|580460656|FG002|Washout (7 Days)|Protocol Violation|0|||
160747486|NCT01380691|580460657|FG003|Washout (7 Days)|Protocol Violation|1|||
160747487|NCT01380691|580460654|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
160747488|NCT01380691|580460655|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
160747489|NCT01380691|580460656|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
160747490|NCT01380691|580460657|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
160747491|NCT03084315|580460658|FG000|Overall Study|Lost to Follow-up|8|||
160747492|NCT03084315|580460659|FG001|Overall Study|Lost to Follow-up|7|||
160747493|NCT03084315|580460658|FG000|Overall Study|Withdrawal by Subject|2|||
160747494|NCT03084315|580460659|FG001|Overall Study|Withdrawal by Subject|2|||
160747495|NCT04424914|580460662|FG000|Overall Study|Other|0|||
160747496|NCT04424914|580460663|FG001|Overall Study|Other|0|||
160747497|NCT04424914|580460664|FG002|Overall Study|Other|28|||
160747498|NCT04424914|580460662|FG000|Overall Study|Withdrawal by Subject|3|||
160747499|NCT04424914|580460663|FG001|Overall Study|Withdrawal by Subject|0|||
160747500|NCT04424914|580460664|FG002|Overall Study|Withdrawal by Subject|0|||
160747501|NCT04424914|580460662|FG000|Overall Study|Study terminated by sponsor|23|||
160747502|NCT04424914|580460663|FG001|Overall Study|Study terminated by sponsor|7|||
160747503|NCT04424914|580460664|FG002|Overall Study|Study terminated by sponsor|0|||
160747504|NCT04424914|580460662|FG000|Overall Study|Lost to Follow-up|0|||
160747505|NCT04424914|580460663|FG001|Overall Study|Lost to Follow-up|0|||
160747506|NCT04424914|580460664|FG002|Overall Study|Lost to Follow-up|1|||
160747507|NCT04424914|580460662|FG000|Overall Study|Death|3|||
160747508|NCT04424914|580460663|FG001|Overall Study|Death|1|||
160747509|NCT04424914|580460664|FG002|Overall Study|Death|0|||
160747510|NCT00460746|580460665|FG000|Overall Study|Adverse Event|1|||
160747511|NCT00460746|580460665|FG000|Overall Study|Lost to Follow-up|1|||
160747512|NCT02791438|580460666|FG000|Treatment Period|Adverse Event|1|||
160747513|NCT02791438|580460667|FG001|Treatment Period|Adverse Event|0|||
160747514|NCT02791438|580460666|FG000|Treatment Period|Withdrawal by Subject|0|||
160747515|NCT02791438|580460667|FG001|Treatment Period|Withdrawal by Subject|1|||
160747516|NCT02791438|580460666|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
160747517|NCT02791438|580460667|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
160747518|NCT01603394|580460669|FG000|Overall Study|Adverse Event|1|||
160747519|NCT00394771|580460670|FG000|Overall Study|Did not meet protocol requirements|1|||
160747520|NCT00394771|580460671|FG001|Overall Study|Did not meet protocol requirements|0|||
160747521|NCT00394771|580460672|FG002|Overall Study|Did not meet protocol requirements|2|||
160747522|NCT00394771|580460673|FG003|Overall Study|Did not meet protocol requirements|0|||
160747523|NCT00394771|580460670|FG000|Overall Study|Protocol Violation|2|||
160747524|NCT00394771|580460671|FG001|Overall Study|Protocol Violation|4|||
160747525|NCT00394771|580460672|FG002|Overall Study|Protocol Violation|9|||
160747526|NCT00394771|580460673|FG003|Overall Study|Protocol Violation|7|||
160747527|NCT00394771|580460670|FG000|Overall Study|Withdrawal by Subject|10|||
160747528|NCT00394771|580460671|FG001|Overall Study|Withdrawal by Subject|6|||
160747529|NCT00394771|580460672|FG002|Overall Study|Withdrawal by Subject|8|||
160747530|NCT00394771|580460673|FG003|Overall Study|Withdrawal by Subject|12|||
160747531|NCT00394771|580460670|FG000|Overall Study|Adverse Event|10|||
160747532|NCT00394771|580460671|FG001|Overall Study|Adverse Event|5|||
160747533|NCT00394771|580460672|FG002|Overall Study|Adverse Event|12|||
160747534|NCT00394771|580460673|FG003|Overall Study|Adverse Event|8|||
160747535|NCT00394771|580460670|FG000|Overall Study|Participant pregnant|0|||
160747536|NCT00394771|580460671|FG001|Overall Study|Participant pregnant|1|||
160747537|NCT00394771|580460672|FG002|Overall Study|Participant pregnant|2|||
160747538|NCT00394771|580460673|FG003|Overall Study|Participant pregnant|2|||
160747539|NCT00394771|580460670|FG000|Overall Study|Lost to Follow-up|15|||
160747540|NCT00394771|580460671|FG001|Overall Study|Lost to Follow-up|15|||
160747541|NCT00394771|580460672|FG002|Overall Study|Lost to Follow-up|13|||
160747542|NCT00394771|580460673|FG003|Overall Study|Lost to Follow-up|10|||
160747543|NCT00394771|580460670|FG000|Overall Study|Other|3|||
160747544|NCT00394771|580460671|FG001|Overall Study|Other|3|||
160747545|NCT00394771|580460672|FG002|Overall Study|Other|1|||
160747546|NCT00394771|580460673|FG003|Overall Study|Other|0|||
160747547|NCT04776018|580460676|FG000|Overall Study|Death|0|||
160747548|NCT04776018|580460677|FG001|Overall Study|Death|1|||
160747549|NCT04776018|580460678|FG002|Overall Study|Death|4|||
160747550|NCT04776018|580460679|FG003|Overall Study|Death|1|||
160747551|NCT04776018|580460680|FG004|Overall Study|Death|4|||
160747552|NCT04776018|580460681|FG005|Overall Study|Death|0|||
160747553|NCT04776018|580460682|FG006|Overall Study|Death|0|||
160747554|NCT04776018|580460676|FG000|Overall Study|Study terminated by sponsor|2|||
160747555|NCT04776018|580460677|FG001|Overall Study|Study terminated by sponsor|1|||
160747556|NCT04776018|580460678|FG002|Overall Study|Study terminated by sponsor|4|||
160747557|NCT04776018|580460679|FG003|Overall Study|Study terminated by sponsor|0|||
160747558|NCT04776018|580460680|FG004|Overall Study|Study terminated by sponsor|3|||
160747559|NCT04776018|580460681|FG005|Overall Study|Study terminated by sponsor|0|||
160747560|NCT04776018|580460682|FG006|Overall Study|Study terminated by sponsor|0|||
160747561|NCT04776018|580460676|FG000|Overall Study|Withdrawal by Subject|1|||
160747562|NCT04776018|580460677|FG001|Overall Study|Withdrawal by Subject|0|||
160747563|NCT04776018|580460678|FG002|Overall Study|Withdrawal by Subject|0|||
160747564|NCT04776018|580460679|FG003|Overall Study|Withdrawal by Subject|2|||
160747565|NCT04776018|580460680|FG004|Overall Study|Withdrawal by Subject|1|||
160747566|NCT04776018|580460681|FG005|Overall Study|Withdrawal by Subject|0|||
160747567|NCT04776018|580460682|FG006|Overall Study|Withdrawal by Subject|0|||
160747568|NCT04776018|580460676|FG000|Overall Study|Other|0|||
160747569|NCT04776018|580460677|FG001|Overall Study|Other|1|||
160747570|NCT04776018|580460678|FG002|Overall Study|Other|1|||
160747571|NCT04776018|580460679|FG003|Overall Study|Other|0|||
160747572|NCT04776018|580460680|FG004|Overall Study|Other|0|||
160747573|NCT04776018|580460681|FG005|Overall Study|Other|0|||
160747574|NCT04776018|580460682|FG006|Overall Study|Other|0|||
160747575|NCT04776018|580460676|FG000|Overall Study|Lost to Follow-up|0|||
160747576|NCT04776018|580460677|FG001|Overall Study|Lost to Follow-up|0|||
160747577|NCT04776018|580460678|FG002|Overall Study|Lost to Follow-up|1|||
160747578|NCT04776018|580460679|FG003|Overall Study|Lost to Follow-up|0|||
160747579|NCT04776018|580460680|FG004|Overall Study|Lost to Follow-up|0|||
160747580|NCT04776018|580460681|FG005|Overall Study|Lost to Follow-up|0|||
160747581|NCT04776018|580460682|FG006|Overall Study|Lost to Follow-up|0|||
160747582|NCT03417024|580460685|FG000|Overall Study|Study Termination prior to follow-up|11|||
160747583|NCT03417024|580460685|FG000|Overall Study|Physician Decision|2|||
160747584|NCT02195427|580460686|FG000|Overall Study|Did not consent to study extension|13|||
160747585|NCT02195427|580460687|FG001|Overall Study|Did not consent to study extension|9|||
160747586|NCT02195427|580460686|FG000|Overall Study|Withdrawal by Subject|4|||
160747587|NCT02195427|580460687|FG001|Overall Study|Withdrawal by Subject|2|||
160747588|NCT02195427|580460686|FG000|Overall Study|Lost to Follow-up|0|||
160747589|NCT02195427|580460687|FG001|Overall Study|Lost to Follow-up|1|||
160747590|NCT02195427|580460686|FG000|Overall Study|Protocol Violation|7|||
160747591|NCT02195427|580460687|FG001|Overall Study|Protocol Violation|14|||
160747592|NCT02195427|580460686|FG000|Overall Study|Conditional re-treatment at W52|2|||
160747593|NCT02195427|580460687|FG001|Overall Study|Conditional re-treatment at W52|1|||
160747594|NCT00386425|580460688|FG000|Overall Study|Physician Decision|3|||
160747595|NCT00386425|580460689|FG001|Overall Study|Physician Decision|0|||
160747596|NCT00386425|580460690|FG002|Overall Study|Physician Decision|0|||
160747597|NCT00386425|580460688|FG000|Overall Study|Withdrawal by Subject|0|||
160747598|NCT00386425|580460689|FG001|Overall Study|Withdrawal by Subject|1|||
160747599|NCT00386425|580460690|FG002|Overall Study|Withdrawal by Subject|0|||
160747600|NCT01907217|580460693|FG000|Overall Study|Withdrawal by Subject|0|||
160747601|NCT01907217|580460694|FG001|Overall Study|Withdrawal by Subject|2|||
160747602|NCT04607980|580460699|FG000|Overall Study|Adverse Event|3|||
160747603|NCT04607980|580460700|FG001|Overall Study|Adverse Event|4|||
160747604|NCT04607980|580460699|FG000|Overall Study|Death|0|||
160747605|NCT04607980|580460700|FG001|Overall Study|Death|1|||
160747606|NCT04607980|580460699|FG000|Overall Study|Withdrawal by Subject|2|||
160747607|NCT04607980|580460700|FG001|Overall Study|Withdrawal by Subject|5|||
160747608|NCT04607980|580460699|FG000|Overall Study|Lost to Follow-up|4|||
160747609|NCT04607980|580460700|FG001|Overall Study|Lost to Follow-up|8|||
160747610|NCT04607980|580460699|FG000|Overall Study|Protocol Violation|0|||
160747611|NCT04607980|580460700|FG001|Overall Study|Protocol Violation|3|||
160747612|NCT04607980|580460699|FG000|Overall Study|Other|3|||
160747613|NCT04607980|580460700|FG001|Overall Study|Other|0|||
160747614|NCT00448812|580460701|FG000|Year 2|Missed visit but remained in study|4|||
160747615|NCT00448812|580460702|FG001|Year 2|Missed visit but remained in study|1|||
160747616|NCT00448812|580460701|FG000|Year 3|Withdrawal by Subject|1|||
160747617|NCT00448812|580460702|FG001|Year 3|Withdrawal by Subject|3|||
160747618|NCT00448812|580460701|FG000|Year 3|Lost to Follow-up|1|||
160747619|NCT00448812|580460702|FG001|Year 3|Lost to Follow-up|0|||
160747620|NCT00448812|580460701|FG000|Year 3|Missed visit but remained in study|2|||
160747621|NCT00448812|580460702|FG001|Year 3|Missed visit but remained in study|0|||
160747622|NCT00448812|580460701|FG000|Year 5|Missed visit but remained in study|1|||
160747623|NCT00448812|580460702|FG001|Year 5|Missed visit but remained in study|0|||
160747624|NCT01854879|580460703|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
160747625|NCT01854879|580460703|FG000|Overall Study|screen fail|3|||
160747626|NCT01854879|580460703|FG000|Overall Study|incomplete data set|1|||
160747627|NCT02012959|580460704|FG000|Treatment Phase A|Adverse Event|2|||
160747628|NCT02012959|580460705|FG001|Treatment Phase A|Adverse Event|0|||
160747629|NCT02012959|580460706|FG002|Treatment Phase A|Adverse Event|0|||
160747630|NCT02012959|580460707|FG003|Treatment Phase A|Adverse Event|0|||
160747631|NCT02012959|580460708|FG004|Treatment Phase A|Adverse Event|0|||
160747632|NCT03630705|580462400|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
160747633|NCT03630705|580462401|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
160747634|NCT03630705|580462402|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
160747635|NCT03630705|580462403|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160747636|NCT03630705|580462400|FG000|Overall Study|Lost to Follow-up|1|||
160747637|NCT03630705|580462401|FG001|Overall Study|Lost to Follow-up|2|||
160747638|NCT03630705|580462402|FG002|Overall Study|Lost to Follow-up|0|||
160747639|NCT03630705|580462403|FG003|Overall Study|Lost to Follow-up|0|||
160747640|NCT01212159|580462404|FG000|Overall Study|Withdrawal by Subject|12|||
160747641|NCT01212159|580462405|FG001|Overall Study|Withdrawal by Subject|12|||
160747642|NCT03782571|580462409|FG000|Period 1|Withdrawal by Subject|1|||
160747643|NCT03782571|580462410|FG001|Period 1|Withdrawal by Subject|0|||
160747644|NCT03782571|580462411|FG002|Period 1|Withdrawal by Subject|0|||
160747645|NCT03782571|580462412|FG003|Period 1|Withdrawal by Subject|0|||
160747646|NCT03782571|580462409|FG000|Period 3|Subject Unable to Attend V5|1|||
160747647|NCT03782571|580462410|FG001|Period 3|Subject Unable to Attend V5|0|||
160747648|NCT03782571|580462411|FG002|Period 3|Subject Unable to Attend V5|0|||
160747649|NCT03782571|580462412|FG003|Period 3|Subject Unable to Attend V5|0|||
160747650|NCT03782571|580462409|FG000|Period 3|Adverse Event|1|||
160747651|NCT03782571|580462410|FG001|Period 3|Adverse Event|0|||
160747652|NCT03782571|580462411|FG002|Period 3|Adverse Event|0|||
160747653|NCT03782571|580462412|FG003|Period 3|Adverse Event|0|||
160747654|NCT03488563|580462413|FG000|Overall Study|Lost to Follow-up|7|||
160747655|NCT03488563|580462414|FG001|Overall Study|Lost to Follow-up|6|||
160747656|NCT03488563|580462415|FG002|Overall Study|Lost to Follow-up|7|||
160747657|NCT03488563|580462413|FG000|Overall Study|Withdrawal by Subject|8|||
160747658|NCT03488563|580462414|FG001|Overall Study|Withdrawal by Subject|7|||
160747659|NCT03488563|580462415|FG002|Overall Study|Withdrawal by Subject|7|||
160747660|NCT03488563|580462413|FG000|Overall Study|Physician Decision|0|||
160747661|NCT03488563|580462414|FG001|Overall Study|Physician Decision|0|||
160747662|NCT03488563|580462415|FG002|Overall Study|Physician Decision|1|||
160747663|NCT03488563|580462413|FG000|Overall Study|Protocol Violation|3|||
160747664|NCT03488563|580462414|FG001|Overall Study|Protocol Violation|2|||
160747665|NCT03488563|580462415|FG002|Overall Study|Protocol Violation|6|||
160747666|NCT03488563|580462413|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
160747667|NCT03488563|580462414|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
160747668|NCT03488563|580462415|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
160747669|NCT03488563|580462413|FG000|Overall Study|Use of prohibited medication|2|||
160747670|NCT03488563|580462414|FG001|Overall Study|Use of prohibited medication|0|||
160747671|NCT03488563|580462415|FG002|Overall Study|Use of prohibited medication|0|||
160747672|NCT03488563|580462413|FG000|Overall Study|Adverse Event|1|||
160747673|NCT03488563|580462414|FG001|Overall Study|Adverse Event|0|||
160747674|NCT03488563|580462415|FG002|Overall Study|Adverse Event|1|||
160747675|NCT03488563|580462413|FG000|Overall Study|Subject returned for ET visit|0|||
160747676|NCT03488563|580462414|FG001|Overall Study|Subject returned for ET visit|1|||
160747677|NCT03488563|580462415|FG002|Overall Study|Subject returned for ET visit|0|||
160747678|NCT03488563|580462413|FG000|Overall Study|Sponsor's decision|0|||
160747679|NCT03488563|580462414|FG001|Overall Study|Sponsor's decision|0|||
160747680|NCT03488563|580462415|FG002|Overall Study|Sponsor's decision|1|||
160747681|NCT01411319|580462434|FG000|Overall Study|Lost to Follow-up|1|||
160747682|NCT01597492|580462472|FG000|Overall Study|Withdrawal by Subject|1|||
160747683|NCT01597492|580462473|FG001|Overall Study|Withdrawal by Subject|2|||
160747684|NCT01597492|580462472|FG000|Overall Study|Adverse Event|3|||
160747685|NCT01597492|580462473|FG001|Overall Study|Adverse Event|0|||
160747686|NCT01597492|580462472|FG000|Overall Study|Lost to Follow-up|0|||
160747687|NCT01597492|580462473|FG001|Overall Study|Lost to Follow-up|2|||
160747688|NCT01597492|580462472|FG000|Overall Study|Other Reason|2|||
160747689|NCT01597492|580462473|FG001|Overall Study|Other Reason|0|||
160747690|NCT02570750|580462474|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
160747691|NCT02570750|580462475|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
160747692|NCT02570750|580462474|FG000|Overall Study|Protocol deviation|4|||
160747693|NCT02570750|580462475|FG001|Overall Study|Protocol deviation|2|||
160747694|NCT02570750|580462474|FG000|Overall Study|Withdrawal by Subject|5|||
160747695|NCT02570750|580462475|FG001|Overall Study|Withdrawal by Subject|0|||
160747696|NCT02570750|580462474|FG000|Overall Study|Lost to Follow-up|2|||
160747697|NCT02570750|580462475|FG001|Overall Study|Lost to Follow-up|2|||
160747698|NCT02570750|580462474|FG000|Overall Study|Adverse Event|2|||
160747699|NCT02570750|580462475|FG001|Overall Study|Adverse Event|1|||
160747700|NCT01884545|580462476|FG000|Overall Study|Lost to Follow-up|6|||
160747701|NCT01884545|580462477|FG001|Overall Study|Lost to Follow-up|4|||
160747702|NCT01884545|580462478|FG002|Overall Study|Lost to Follow-up|9|||
160747703|NCT01884545|580462479|FG003|Overall Study|Lost to Follow-up|4|||
160747704|NCT01884545|580462476|FG000|Overall Study|Patient withdrawn|7|||
160747705|NCT01884545|580462477|FG001|Overall Study|Patient withdrawn|12|||
160747706|NCT01884545|580462478|FG002|Overall Study|Patient withdrawn|5|||
160747707|NCT01884545|580462479|FG003|Overall Study|Patient withdrawn|5|||
160747708|NCT01884545|580462476|FG000|Overall Study|Non-adherence|0|||
160747709|NCT01884545|580462477|FG001|Overall Study|Non-adherence|2|||
160747710|NCT01884545|580462478|FG002|Overall Study|Non-adherence|0|||
160747711|NCT01884545|580462479|FG003|Overall Study|Non-adherence|0|||
160747712|NCT00496587|580462480|FG000|Overall Study|Adverse Event|2|||
160747713|NCT00496587|580462480|FG000|Overall Study|Progressive Disease|24|||
160747714|NCT00496587|580462480|FG000|Overall Study|Withdrawal by Subject|2|||
160747715|NCT00496587|580462480|FG000|Overall Study|Death|1|||
160747716|NCT00496587|580462480|FG000|Overall Study|Complications unrelated|2|||
160747717|NCT00482170|580462482|FG000|Overall Study|Adverse Event|5|||
160747718|NCT00482170|580462483|FG001|Overall Study|Adverse Event|14|||
160747719|NCT00482170|580462482|FG000|Overall Study|Withdrawal by Subject|6|||
160747720|NCT00482170|580462483|FG001|Overall Study|Withdrawal by Subject|1|||
160747721|NCT00482170|580462482|FG000|Overall Study|Protocol Violation|2|||
160747722|NCT00482170|580462483|FG001|Overall Study|Protocol Violation|3|||
160747723|NCT00482170|580462482|FG000|Overall Study|Lost to Follow-up|2|||
160747724|NCT00482170|580462483|FG001|Overall Study|Lost to Follow-up|0|||
160747725|NCT00482170|580462482|FG000|Overall Study|Unspecified reason|0|||
160747726|NCT00482170|580462483|FG001|Overall Study|Unspecified reason|2|||
160747727|NCT01134263|580462484|FG000|Overall Study|Serious adverse event|2|||
160747728|NCT01134263|580462485|FG001|Overall Study|Serious adverse event|1|||
160747729|NCT01134263|580462486|FG002|Overall Study|Serious adverse event|1|||
160747730|NCT01134263|580462487|FG003|Overall Study|Serious adverse event|1|||
160747731|NCT01134263|580462488|FG004|Overall Study|Serious adverse event|1|||
160747732|NCT01134263|580462484|FG000|Overall Study|Other adverse event|1|||
160747733|NCT01134263|580462485|FG001|Overall Study|Other adverse event|2|||
160747734|NCT01134263|580462486|FG002|Overall Study|Other adverse event|5|||
160747735|NCT01134263|580462487|FG003|Overall Study|Other adverse event|3|||
160747736|NCT01134263|580462488|FG004|Overall Study|Other adverse event|0|||
160747737|NCT01134263|580462484|FG000|Overall Study|Protocol Violation|8|||
160747738|NCT01134263|580462485|FG001|Overall Study|Protocol Violation|7|||
160747739|NCT01134263|580462486|FG002|Overall Study|Protocol Violation|2|||
160747740|NCT01134263|580462487|FG003|Overall Study|Protocol Violation|4|||
160747741|NCT01134263|580462488|FG004|Overall Study|Protocol Violation|2|||
160747742|NCT01134263|580462484|FG000|Overall Study|Lost to Follow-up|4|||
160747743|NCT01134263|580462485|FG001|Overall Study|Lost to Follow-up|3|||
160747744|NCT01134263|580462486|FG002|Overall Study|Lost to Follow-up|5|||
160747745|NCT01134263|580462487|FG003|Overall Study|Lost to Follow-up|3|||
160747746|NCT01134263|580462488|FG004|Overall Study|Lost to Follow-up|1|||
160747747|NCT01134263|580462484|FG000|Overall Study|Withdrawal by Subject|8|||
160747748|NCT01134263|580462485|FG001|Overall Study|Withdrawal by Subject|6|||
160747749|NCT01134263|580462486|FG002|Overall Study|Withdrawal by Subject|16|||
160747750|NCT01134263|580462487|FG003|Overall Study|Withdrawal by Subject|7|||
160747751|NCT01134263|580462488|FG004|Overall Study|Withdrawal by Subject|5|||
160747752|NCT01134263|580462484|FG000|Overall Study|Enrolled, but not treated|1|||
160747753|NCT01134263|580462485|FG001|Overall Study|Enrolled, but not treated|1|||
160747754|NCT01134263|580462486|FG002|Overall Study|Enrolled, but not treated|0|||
160747755|NCT01134263|580462487|FG003|Overall Study|Enrolled, but not treated|1|||
160747756|NCT01134263|580462488|FG004|Overall Study|Enrolled, but not treated|0|||
160747757|NCT01204918|580462489|FG000|Overall Study|Withdrawal by Subject|4|||
160747758|NCT01204918|580462490|FG001|Overall Study|Withdrawal by Subject|10|||
160747759|NCT01204918|580462491|FG002|Overall Study|Withdrawal by Subject|5|||
160747760|NCT00269477|580462496|FG000|Overall Study|Protocol Violation|5|||
160747761|NCT00269477|580462497|FG001|Overall Study|Protocol Violation|5|||
160747762|NCT00269477|580462498|FG002|Overall Study|Protocol Violation|1|||
160747763|NCT00269477|580462499|FG003|Overall Study|Protocol Violation|0|||
160747764|NCT00269477|580462496|FG000|Overall Study|Missed post-vaccination blood draw|0|||
160747765|NCT00269477|580462497|FG001|Overall Study|Missed post-vaccination blood draw|1|||
160747766|NCT00269477|580462498|FG002|Overall Study|Missed post-vaccination blood draw|0|||
160747767|NCT00269477|580462499|FG003|Overall Study|Missed post-vaccination blood draw|0|||
160747768|NCT02007278|580462500|FG000|Overall Study|Failure to comply with an eligibility|0|||
160747769|NCT02007278|580462501|FG001|Overall Study|Failure to comply with an eligibility|1|||
160747770|NCT02007278|580462500|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
160747771|NCT02007278|580462501|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
160747772|NCT02007278|580462500|FG000|Overall Study|Incorrect medication administration|1|||
160747773|NCT02007278|580462501|FG001|Overall Study|Incorrect medication administration|0|||
160747774|NCT02007278|580462500|FG000|Overall Study|Mis-randomization|1|||
160747775|NCT02007278|580462501|FG001|Overall Study|Mis-randomization|1|||
160747776|NCT01404949|580462502|FG000|Overall Study|Not Treated|1|||
160747777|NCT02886884|580462506|FG000|Follow-up|Withdrawal by Subject|0|||
160747778|NCT02886884|580462507|FG001|Follow-up|Withdrawal by Subject|0|||
160747779|NCT02886884|580462508|FG002|Follow-up|Withdrawal by Subject|0|||
160747780|NCT02886884|580462509|FG003|Follow-up|Withdrawal by Subject|1|||
160747781|NCT01429441|580462512|FG000|Overall Study|Adverse Event|5|||
160747782|NCT01429441|580462513|FG001|Overall Study|Adverse Event|1|||
160747783|NCT01429441|580462512|FG000|Overall Study|Death|0|||
160747784|NCT01429441|580462513|FG001|Overall Study|Death|2|||
160747785|NCT01429441|580462512|FG000|Overall Study|Lost to Follow-up|5|||
160747786|NCT01429441|580462513|FG001|Overall Study|Lost to Follow-up|2|||
160747787|NCT01429441|580462512|FG000|Overall Study|Physician Decision|1|||
160747788|NCT01429441|580462513|FG001|Overall Study|Physician Decision|0|||
160747789|NCT01429441|580462512|FG000|Overall Study|Withdrawal by Subject|27|||
160747790|NCT01429441|580462513|FG001|Overall Study|Withdrawal by Subject|18|||
160747791|NCT03469999|580462520|FG000|Overall Study|Lost to Follow-up|2|||
160747792|NCT01863732|580462522|FG000|Overall Study|Adverse Event|2|||
160747793|NCT01863732|580462523|FG001|Overall Study|Adverse Event|0|||
160747794|NCT01863732|580462524|FG002|Overall Study|Adverse Event|3|||
160747795|NCT01863732|580462525|FG003|Overall Study|Adverse Event|3|||
160747796|NCT01863732|580462522|FG000|Overall Study|Lack of Efficacy|1|||
160747797|NCT01863732|580462523|FG001|Overall Study|Lack of Efficacy|0|||
160747798|NCT01863732|580462524|FG002|Overall Study|Lack of Efficacy|2|||
160747799|NCT01863732|580462525|FG003|Overall Study|Lack of Efficacy|1|||
160747800|NCT01863732|580462522|FG000|Overall Study|Lost to Follow-up|2|||
160747801|NCT01863732|580462523|FG001|Overall Study|Lost to Follow-up|2|||
160747802|NCT01863732|580462524|FG002|Overall Study|Lost to Follow-up|1|||
160747803|NCT01863732|580462525|FG003|Overall Study|Lost to Follow-up|1|||
160747804|NCT01863732|580462522|FG000|Overall Study|Physician Decision|1|||
160747805|NCT01863732|580462523|FG001|Overall Study|Physician Decision|0|||
160747806|NCT01863732|580462524|FG002|Overall Study|Physician Decision|1|||
160747807|NCT01863732|580462525|FG003|Overall Study|Physician Decision|0|||
160747808|NCT01863732|580462522|FG000|Overall Study|Pregnancy|0|||
160747809|NCT01863732|580462523|FG001|Overall Study|Pregnancy|0|||
160747810|NCT01863732|580462524|FG002|Overall Study|Pregnancy|0|||
160747811|NCT01863732|580462525|FG003|Overall Study|Pregnancy|1|||
160747812|NCT01863732|580462522|FG000|Overall Study|Technical problems|0|||
160747813|NCT01863732|580462523|FG001|Overall Study|Technical problems|1|||
160747814|NCT01863732|580462524|FG002|Overall Study|Technical problems|1|||
160747815|NCT01863732|580462525|FG003|Overall Study|Technical problems|0|||
160747816|NCT01863732|580462522|FG000|Overall Study|Subject/guardian decision|6|||
160747817|NCT01863732|580462523|FG001|Overall Study|Subject/guardian decision|9|||
160747818|NCT01863732|580462524|FG002|Overall Study|Subject/guardian decision|3|||
160747819|NCT01863732|580462525|FG003|Overall Study|Subject/guardian decision|1|||
160747820|NCT01863732|580462522|FG000|Overall Study|Death|1|||
160747821|NCT01863732|580462523|FG001|Overall Study|Death|0|||
160747822|NCT01863732|580462524|FG002|Overall Study|Death|0|||
160747823|NCT01863732|580462525|FG003|Overall Study|Death|1|||
160747824|NCT02155322|580462529|FG000|Overall Study|Adverse Event|1|||
160747825|NCT02155322|580462529|FG000|Overall Study|Physician Decision|1|||
160747826|NCT02155322|580462529|FG000|Overall Study|Relapse/Recurrence|8|||
160747827|NCT02155322|580462529|FG000|Overall Study|Withdrawal by Subject|4|||
160747828|NCT03383692|580462538|FG000|Overall Study|Progressive disease as per RECIST|3|||
160747829|NCT03383692|580462539|FG001|Overall Study|Progressive disease as per RECIST|3|||
160747830|NCT03383692|580462538|FG000|Overall Study|Clinical progression|0|||
160747831|NCT03383692|580462539|FG001|Overall Study|Clinical progression|1|||
160747832|NCT03383692|580462538|FG000|Overall Study|Adverse Event|3|||
160747833|NCT03383692|580462539|FG001|Overall Study|Adverse Event|0|||
160747834|NCT03816007|580462541|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
160747835|NCT03816007|580462542|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
160747836|NCT03816007|580462541|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
160747837|NCT03816007|580462542|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
160747838|NCT03816007|580462541|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
160747839|NCT03816007|580462542|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
160747840|NCT00630747|580462543|FG000|Overall Study|Death|1|||
160747841|NCT00630747|580462543|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
160747842|NCT00630747|580462543|FG000|Overall Study|Returned to country of origin|1|||
160747843|NCT01210352|580462545|FG000|Overall Study|Adverse Event|0|||
160747844|NCT01210352|580462546|FG001|Overall Study|Adverse Event|0|||
160747845|NCT01210352|580462547|FG002|Overall Study|Adverse Event|0|||
160747846|NCT01210352|580462548|FG003|Overall Study|Adverse Event|0|||
160747847|NCT01210352|580462549|FG004|Overall Study|Adverse Event|0|||
160747848|NCT01210352|580462550|FG005|Overall Study|Adverse Event|0|||
160747849|NCT01210352|580462551|FG006|Overall Study|Adverse Event|0|||
160747850|NCT01210352|580462552|FG007|Overall Study|Adverse Event|2|||
160747851|NCT01210352|580462553|FG008|Overall Study|Adverse Event|1|||
160747852|NCT01210352|580462545|FG000|Overall Study|Lack of Efficacy|0|||
160747853|NCT01210352|580462546|FG001|Overall Study|Lack of Efficacy|0|||
160747854|NCT01210352|580462547|FG002|Overall Study|Lack of Efficacy|0|||
160747855|NCT01210352|580462548|FG003|Overall Study|Lack of Efficacy|0|||
160747856|NCT01210352|580462549|FG004|Overall Study|Lack of Efficacy|0|||
160747857|NCT01210352|580462550|FG005|Overall Study|Lack of Efficacy|0|||
160747858|NCT01210352|580462551|FG006|Overall Study|Lack of Efficacy|1|||
160747859|NCT01210352|580462552|FG007|Overall Study|Lack of Efficacy|0|||
160747860|NCT01210352|580462553|FG008|Overall Study|Lack of Efficacy|0|||
160747861|NCT01210352|580462545|FG000|Overall Study|Physician Decision|0|||
160747862|NCT01210352|580462546|FG001|Overall Study|Physician Decision|0|||
160747863|NCT01210352|580462547|FG002|Overall Study|Physician Decision|0|||
160747864|NCT01210352|580462548|FG003|Overall Study|Physician Decision|0|||
160747865|NCT01210352|580462549|FG004|Overall Study|Physician Decision|0|||
160747866|NCT01210352|580462550|FG005|Overall Study|Physician Decision|0|||
160747867|NCT01210352|580462551|FG006|Overall Study|Physician Decision|0|||
160747868|NCT01210352|580462552|FG007|Overall Study|Physician Decision|1|||
160747869|NCT01210352|580462553|FG008|Overall Study|Physician Decision|2|||
160747870|NCT01210352|580462545|FG000|Overall Study|Withdrawal by Subject|0|||
160747871|NCT01210352|580462546|FG001|Overall Study|Withdrawal by Subject|0|||
160747872|NCT01210352|580462547|FG002|Overall Study|Withdrawal by Subject|1|||
160747873|NCT01210352|580462548|FG003|Overall Study|Withdrawal by Subject|0|||
160747874|NCT01210352|580462549|FG004|Overall Study|Withdrawal by Subject|0|||
160747875|NCT01210352|580462550|FG005|Overall Study|Withdrawal by Subject|0|||
160747876|NCT01210352|580462551|FG006|Overall Study|Withdrawal by Subject|1|||
160747877|NCT01210352|580462552|FG007|Overall Study|Withdrawal by Subject|0|||
160747878|NCT01210352|580462553|FG008|Overall Study|Withdrawal by Subject|1|||
160747879|NCT01210352|580462545|FG000|Overall Study|Patient Discharged Early|0|||
160747880|NCT01210352|580462546|FG001|Overall Study|Patient Discharged Early|0|||
160747881|NCT01210352|580462547|FG002|Overall Study|Patient Discharged Early|1|||
160747882|NCT01210352|580462548|FG003|Overall Study|Patient Discharged Early|0|||
160747883|NCT01210352|580462549|FG004|Overall Study|Patient Discharged Early|0|||
160747884|NCT01210352|580462550|FG005|Overall Study|Patient Discharged Early|0|||
160747885|NCT01210352|580462551|FG006|Overall Study|Patient Discharged Early|0|||
160747886|NCT01210352|580462552|FG007|Overall Study|Patient Discharged Early|0|||
160747887|NCT01210352|580462553|FG008|Overall Study|Patient Discharged Early|0|||
160747888|NCT03338569|580462554|FG000|Overall Study|Physician Decision|8|||
160747889|NCT03338569|580462555|FG001|Overall Study|Physician Decision|3|||
160747890|NCT03338569|580462554|FG000|Overall Study|Withdrawal by Subject|0|||
160747891|NCT03338569|580462555|FG001|Overall Study|Withdrawal by Subject|1|||
160747892|NCT03338569|580462554|FG000|Overall Study|Lost to Follow-up|0|||
160747893|NCT03338569|580462555|FG001|Overall Study|Lost to Follow-up|1|||
160747894|NCT04227405|580463977|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
160747895|NCT04227405|580463978|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
160747896|NCT04227405|580463977|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
160747897|NCT04227405|580463978|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
160747898|NCT04227405|580463977|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
160747899|NCT04227405|580463978|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
160747900|NCT03396822|580463981|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
160747901|NCT03396822|580463981|FG000|Overall Study|Physician Decision|1|||
160747902|NCT00171158|580463982|FG000|Core Study|Death|27|||
160747903|NCT00171158|580463982|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
160747904|NCT00171158|580463982|FG000|Core Study|Protocol Violation|4|||
160747905|NCT00171158|580463982|FG000|Core Study|Administrative problems|1|||
160747906|NCT00171158|580463982|FG000|Core Study|Adverse event, non-fatal|21|||
160747907|NCT00171158|580463982|FG000|Core Study|Consent withdrawn by subject|6|||
160747908|NCT00171158|580463982|FG000|Core Study|No longer required drug (BMT)|14|||
160747909|NCT00171158|580463982|FG000|Core Study|Abnormal Laboratory Values|2|||
160747910|NCT00171158|580463982|FG000|Core Study|Lost to Follow-up|1|||
160747911|NCT00171158|580463982|FG000|E2 Extension|Other|7|||
160747912|NCT02757352|580463983|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
160747913|NCT02757352|580463984|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
160747914|NCT02757352|580463985|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
160747915|NCT02757352|580463986|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
160747916|NCT02757352|580463987|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
160747917|NCT02757352|580463988|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
160747918|NCT02757352|580463989|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
160747919|NCT02757352|580463990|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
160747920|NCT02757352|580463991|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
160747921|NCT02757352|580463992|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
160747922|NCT02757352|580463983|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
160747923|NCT02757352|580463984|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
160747924|NCT02757352|580463985|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
160747925|NCT02757352|580463986|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
160747926|NCT02757352|580463987|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
160747927|NCT02757352|580463988|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
160747928|NCT02757352|580463989|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
160747929|NCT02757352|580463990|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
160747930|NCT02757352|580463991|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
160747931|NCT02757352|580463992|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
160747932|NCT02757352|580463983|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
160747933|NCT02757352|580463984|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
160747934|NCT02757352|580463985|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
160747935|NCT02757352|580463986|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
160747936|NCT02757352|580463987|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
160747937|NCT02757352|580463988|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
160747938|NCT02757352|580463989|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
160747939|NCT02757352|580463990|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
160747940|NCT02757352|580463991|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
160747941|NCT02757352|580463992|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
160747942|NCT02757352|580463983|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
160747943|NCT02757352|580463984|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
160747944|NCT02757352|580463985|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
160747945|NCT02757352|580463986|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
160747946|NCT02757352|580463987|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
160747947|NCT02757352|580463988|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
160747948|NCT02757352|580463989|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
160747949|NCT02757352|580463990|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
160747950|NCT02757352|580463991|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
160747951|NCT02757352|580463992|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
160747952|NCT02757352|580463983|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747953|NCT02757352|580463984|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
160747954|NCT02757352|580463985|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747955|NCT02757352|580463986|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747956|NCT02757352|580463987|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747957|NCT02757352|580463988|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747958|NCT02757352|580463989|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747959|NCT02757352|580463990|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747960|NCT02757352|580463991|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747961|NCT02757352|580463992|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747962|NCT02757352|580463983|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
160747963|NCT02757352|580463984|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
160747964|NCT02757352|580463985|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
160747965|NCT02757352|580463986|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160747966|NCT02757352|580463987|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160747967|NCT02757352|580463988|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160747968|NCT02757352|580463989|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160747969|NCT02757352|580463990|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160747970|NCT02757352|580463991|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160747971|NCT02757352|580463992|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160747972|NCT02757352|580463983|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
160747973|NCT02757352|580463984|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
160747974|NCT02757352|580463985|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
160747975|NCT02757352|580463986|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
160747976|NCT02757352|580463987|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
160747977|NCT02757352|580463988|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
160747978|NCT02757352|580463989|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
160747979|NCT02757352|580463990|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
160747980|NCT02757352|580463991|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
160747981|NCT02757352|580463992|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
160747982|NCT02757352|580463983|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
160747983|NCT02757352|580463984|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
160747984|NCT02757352|580463985|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
160747985|NCT02757352|580463986|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
160747986|NCT02757352|580463987|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
160747987|NCT02757352|580463988|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
160747988|NCT02757352|580463989|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
160747989|NCT02757352|580463990|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
160747990|NCT02757352|580463991|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
160747991|NCT02757352|580463992|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
160747992|NCT02757352|580463983|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747993|NCT02757352|580463984|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747994|NCT02757352|580463985|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747995|NCT02757352|580463986|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
160747996|NCT02757352|580463987|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
160747997|NCT02757352|580463988|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
160747998|NCT02757352|580463989|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160747999|NCT02757352|580463990|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160748000|NCT02757352|580463991|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160748001|NCT02757352|580463992|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
160748002|NCT02757352|580463983|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
160748003|NCT02757352|580463984|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
160748004|NCT02757352|580463985|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
160748005|NCT02757352|580463986|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
160748006|NCT02757352|580463987|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
160748007|NCT02757352|580463988|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
160748008|NCT02757352|580463989|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
160748009|NCT02757352|580463990|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
160748010|NCT02757352|580463991|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
160748011|NCT02757352|580463992|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
160748012|NCT02757352|580463983|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
160748013|NCT02757352|580463984|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
160748014|NCT02757352|580463985|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
160748015|NCT02757352|580463986|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
160748016|NCT02757352|580463987|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
160748017|NCT02757352|580463988|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
160748018|NCT02757352|580463989|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
160748019|NCT02757352|580463990|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
160748020|NCT02757352|580463991|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
160748021|NCT02757352|580463992|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
160748022|NCT02757352|580463983|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160748023|NCT02757352|580463984|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160748024|NCT02757352|580463985|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160748025|NCT02757352|580463986|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
160748026|NCT02757352|580463987|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
160748027|NCT02757352|580463988|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
160748028|NCT02757352|580463989|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160748029|NCT02757352|580463990|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160748030|NCT02757352|580463991|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160748031|NCT02757352|580463992|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
160748032|NCT02757352|580463983|FG000|Follow-Up Period|Adverse Event|0|||
160748033|NCT02757352|580463984|FG001|Follow-Up Period|Adverse Event|0|||
160748034|NCT02757352|580463985|FG002|Follow-Up Period|Adverse Event|0|||
160748035|NCT02757352|580463986|FG003|Follow-Up Period|Adverse Event|0|||
160748036|NCT02757352|580463987|FG004|Follow-Up Period|Adverse Event|0|||
160748037|NCT02757352|580463988|FG005|Follow-Up Period|Adverse Event|0|||
160748038|NCT02757352|580463989|FG006|Follow-Up Period|Adverse Event|1|||
160748039|NCT02757352|580463990|FG007|Follow-Up Period|Adverse Event|0|||
160748040|NCT02757352|580463991|FG008|Follow-Up Period|Adverse Event|2|||
160748041|NCT02757352|580463992|FG009|Follow-Up Period|Adverse Event|0|||
160748042|NCT02757352|580463983|FG000|Follow-Up Period|Lost to Follow-up|0|||
160748043|NCT02757352|580463984|FG001|Follow-Up Period|Lost to Follow-up|0|||
160748044|NCT02757352|580463985|FG002|Follow-Up Period|Lost to Follow-up|0|||
160748045|NCT02757352|580463986|FG003|Follow-Up Period|Lost to Follow-up|0|||
160748046|NCT02757352|580463987|FG004|Follow-Up Period|Lost to Follow-up|0|||
160748047|NCT02757352|580463988|FG005|Follow-Up Period|Lost to Follow-up|0|||
160748048|NCT02757352|580463989|FG006|Follow-Up Period|Lost to Follow-up|0|||
160748049|NCT02757352|580463990|FG007|Follow-Up Period|Lost to Follow-up|0|||
160748050|NCT02757352|580463991|FG008|Follow-Up Period|Lost to Follow-up|1|||
160748051|NCT02757352|580463992|FG009|Follow-Up Period|Lost to Follow-up|0|||
160748052|NCT02757352|580463983|FG000|Follow-Up Period|Lack of Efficacy|0|||
160748053|NCT02757352|580463984|FG001|Follow-Up Period|Lack of Efficacy|0|||
160748054|NCT02757352|580463985|FG002|Follow-Up Period|Lack of Efficacy|0|||
160748055|NCT02757352|580463986|FG003|Follow-Up Period|Lack of Efficacy|0|||
160748056|NCT02757352|580463987|FG004|Follow-Up Period|Lack of Efficacy|0|||
160748057|NCT02757352|580463988|FG005|Follow-Up Period|Lack of Efficacy|0|||
160748058|NCT02757352|580463989|FG006|Follow-Up Period|Lack of Efficacy|0|||
160748059|NCT02757352|580463990|FG007|Follow-Up Period|Lack of Efficacy|0|||
160748060|NCT02757352|580463991|FG008|Follow-Up Period|Lack of Efficacy|1|||
160748061|NCT02757352|580463992|FG009|Follow-Up Period|Lack of Efficacy|1|||
160748062|NCT02757352|580463983|FG000|Follow-Up Period|Withdrawal by Subject|0|||
160748063|NCT02757352|580463984|FG001|Follow-Up Period|Withdrawal by Subject|0|||
160748064|NCT02757352|580463985|FG002|Follow-Up Period|Withdrawal by Subject|0|||
160748065|NCT02757352|580463986|FG003|Follow-Up Period|Withdrawal by Subject|0|||
160748066|NCT02757352|580463987|FG004|Follow-Up Period|Withdrawal by Subject|0|||
160748067|NCT02757352|580463988|FG005|Follow-Up Period|Withdrawal by Subject|0|||
160748068|NCT02757352|580463989|FG006|Follow-Up Period|Withdrawal by Subject|0|||
160748069|NCT02757352|580463990|FG007|Follow-Up Period|Withdrawal by Subject|1|||
160748070|NCT02757352|580463991|FG008|Follow-Up Period|Withdrawal by Subject|6|||
160748071|NCT02757352|580463992|FG009|Follow-Up Period|Withdrawal by Subject|2|||
160748072|NCT03536663|580463993|FG000|Endexo|Protocol Violation|1|||
160748073|NCT01128400|580463994|FG000|Overall Study|Lost to Follow-up|1|||
160748074|NCT01128400|580463995|FG001|Overall Study|Lost to Follow-up|0|||
160748075|NCT01128400|580463996|FG002|Overall Study|Lost to Follow-up|1|||
160748076|NCT01128400|580463994|FG000|Overall Study|Screening failure|1|||
160748077|NCT01128400|580463995|FG001|Overall Study|Screening failure|0|||
160748078|NCT01128400|580463996|FG002|Overall Study|Screening failure|0|||
160748079|NCT01128400|580463994|FG000|Overall Study|were not invited to participate on taste|0|||
160748080|NCT01128400|580463995|FG001|Overall Study|were not invited to participate on taste|0|||
160748081|NCT01128400|580463996|FG002|Overall Study|were not invited to participate on taste|15|||
160748082|NCT01128400|580463994|FG000|Overall Study|Excluded due to sinus problems|0|||
160748083|NCT01128400|580463995|FG001|Overall Study|Excluded due to sinus problems|1|||
160748084|NCT01128400|580463996|FG002|Overall Study|Excluded due to sinus problems|0|||
160748085|NCT04750278|580463997|FG000|Overall Study|Death|9|||
160748086|NCT04750278|580463998|FG001|Overall Study|Death|10|||
160748087|NCT04750278|580463999|FG002|Overall Study|Death|10|||
160748088|NCT04750278|580463997|FG000|Overall Study|Withdrawal by Subject|4|||
160748089|NCT04750278|580463998|FG001|Overall Study|Withdrawal by Subject|1|||
160748090|NCT04750278|580463999|FG002|Overall Study|Withdrawal by Subject|2|||
160748091|NCT04750278|580463997|FG000|Overall Study|Lost to Follow-up|1|||
160748092|NCT04750278|580463998|FG001|Overall Study|Lost to Follow-up|1|||
160748093|NCT04750278|580463999|FG002|Overall Study|Lost to Follow-up|1|||
160748094|NCT04750278|580463997|FG000|Overall Study|Pregnancy|1|||
160748095|NCT04750278|580463998|FG001|Overall Study|Pregnancy|0|||
160748096|NCT04750278|580463999|FG002|Overall Study|Pregnancy|0|||
160748097|NCT04750278|580463997|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
160748098|NCT04750278|580463998|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
160748099|NCT04750278|580463999|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
160748100|NCT04750278|580463997|FG000|Overall Study|Non-compliance|0|||
160748101|NCT04750278|580463998|FG001|Overall Study|Non-compliance|0|||
160748102|NCT04750278|580463999|FG002|Overall Study|Non-compliance|1|||
160748103|NCT04750278|580463997|FG000|Overall Study|Transfer to Outside Facility|0|||
160748104|NCT04750278|580463998|FG001|Overall Study|Transfer to Outside Facility|2|||
160748105|NCT04750278|580463999|FG002|Overall Study|Transfer to Outside Facility|1|||
160748106|NCT04750278|580463997|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
160748107|NCT04750278|580463998|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
160748108|NCT04750278|580463999|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
160748109|NCT04750278|580463997|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
160748110|NCT04750278|580463998|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
160748111|NCT04750278|580463999|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
160748112|NCT01299896|580464000|FG000|Overall Study|Withdrawal by Subject|1|||
160748113|NCT01299896|580464001|FG001|Overall Study|Withdrawal by Subject|7|||
160748114|NCT01299896|580464000|FG000|Overall Study|Lost to Follow-up|0|||
160748115|NCT01299896|580464001|FG001|Overall Study|Lost to Follow-up|11|||
160748116|NCT01502956|580464004|FG000|Overall Study|Death|0|||
160748117|NCT01502956|580464005|FG001|Overall Study|Death|2|||
160748118|NCT01502956|580464004|FG000|Overall Study|Lost to Follow-up|14|||
160748119|NCT01502956|580464005|FG001|Overall Study|Lost to Follow-up|11|||
160748120|NCT01502956|580464004|FG000|Overall Study|Physician Decision|2|||
160748121|NCT01502956|580464005|FG001|Overall Study|Physician Decision|3|||
160748122|NCT01502956|580464004|FG000|Overall Study|Withdrawal by Subject|8|||
160748123|NCT01502956|580464005|FG001|Overall Study|Withdrawal by Subject|10|||
160748124|NCT01616758|580464006|FG000|Overall Study|Adverse Event|1|||
160748125|NCT01616758|580464006|FG000|Overall Study|Withdrawal by Subject|2|||
160748126|NCT01616758|580464006|FG000|Overall Study|Disease progression|18|||
160748127|NCT01616758|580464006|FG000|Overall Study|Study termination by Sponsor|1|||
160748128|NCT04076319|580464011|FG000|Overall Study|Withdrawal by Subject|2|||
160748129|NCT04076319|580464012|FG001|Overall Study|Withdrawal by Subject|0|||
160748130|NCT04076319|580464011|FG000|Overall Study|Death|1|||
160748131|NCT04076319|580464012|FG001|Overall Study|Death|0|||
160748132|NCT01054222|580464013|FG000|Overall Study|Lack of Efficacy|1|||
160748133|NCT01054222|580464013|FG000|Overall Study|Lost to Follow-up|4|||
160748134|NCT01054222|580464013|FG000|Overall Study|Withdrawal by Subject|6|||
160748135|NCT03504189|580464017|FG000|Overall Study|Withdrawal by Subject|1|||
160748136|NCT03504189|580464017|FG000|Overall Study|Screening Failure|1|||
160748137|NCT03504189|580464017|FG000|Overall Study|Device Failure|2|||
160748138|NCT02626000|580464018|FG000|Overall Study|Decision by Sponsor|1|||
160748139|NCT02626000|580464018|FG000|Overall Study|Death|29|||
160748140|NCT01796301|580464023|FG000|Overall Study|Withdrawal by Subject|15|||
160748141|NCT01796301|580464024|FG001|Overall Study|Withdrawal by Subject|15|||
160748142|NCT01796301|580464023|FG000|Overall Study|Lost to Follow-up|3|||
160748143|NCT01796301|580464024|FG001|Overall Study|Lost to Follow-up|3|||
160748144|NCT01796301|580464023|FG000|Overall Study|Death|0|||
160748145|NCT01796301|580464024|FG001|Overall Study|Death|1|||
160748146|NCT01796301|580464023|FG000|Overall Study|Decision by Sponsor|0|||
160748147|NCT01796301|580464024|FG001|Overall Study|Decision by Sponsor|1|||
160748148|NCT01410240|580464025|FG000|Overall Study|Physician Decision|0|||
160748149|NCT01410240|580464026|FG001|Overall Study|Physician Decision|0|||
160748150|NCT01410240|580464027|FG002|Overall Study|Physician Decision|1|||
160748151|NCT01410240|580464025|FG000|Overall Study|Missed week 6 assessments|1|||
160748152|NCT01410240|580464026|FG001|Overall Study|Missed week 6 assessments|1|||
160748153|NCT01410240|580464027|FG002|Overall Study|Missed week 6 assessments|1|||
160748154|NCT00592592|580464031|FG000|Overall Study|Patient found ineligible upon chart review|1|||
160748155|NCT01557517|580464032|FG000|Overall Study|Death|1|||
160748156|NCT01557517|580464033|FG001|Overall Study|Death|0|||
160748157|NCT01557517|580464032|FG000|Overall Study|Refused further treatment|0|||
160748158|NCT01557517|580464033|FG001|Overall Study|Refused further treatment|2|||
160748159|NCT01557517|580464032|FG000|Overall Study|Adverse Event|0|||
160748160|NCT01557517|580464033|FG001|Overall Study|Adverse Event|2|||
160748161|NCT01557517|580464032|FG000|Overall Study|Pt declined before treatment started|1|||
160748162|NCT01557517|580464033|FG001|Overall Study|Pt declined before treatment started|0|||
160748163|NCT00162097|580464034|FG000|Overall Study|Participant no longer met study criteria|0|||
160748164|NCT00162097|580464035|FG001|Overall Study|Participant no longer met study criteria|0|||
160748165|NCT00162097|580464036|FG002|Overall Study|Participant no longer met study criteria|0|||
160748166|NCT00162097|580464037|FG003|Overall Study|Participant no longer met study criteria|1|||
160748167|NCT00770913|580464038|FG000|Overall Study|Adverse Event|1|||
160748168|NCT00770913|580464039|FG001|Overall Study|Adverse Event|3|||
160748169|NCT00770913|580464040|FG002|Overall Study|Adverse Event|6|||
160748170|NCT00770913|580464038|FG000|Overall Study|Refusal to continue participation|6|||
160748171|NCT00770913|580464039|FG001|Overall Study|Refusal to continue participation|4|||
160748172|NCT00770913|580464040|FG002|Overall Study|Refusal to continue participation|5|||
160748173|NCT00770913|580464038|FG000|Overall Study|Physician Decision|0|||
160748174|NCT00770913|580464039|FG001|Overall Study|Physician Decision|1|||
160748175|NCT00770913|580464040|FG002|Overall Study|Physician Decision|1|||
160748176|NCT00770913|580464038|FG000|Overall Study|Protocol Violation|3|||
160748177|NCT00770913|580464039|FG001|Overall Study|Protocol Violation|0|||
160748178|NCT00770913|580464040|FG002|Overall Study|Protocol Violation|1|||
160748179|NCT00770913|580464038|FG000|Overall Study|Incorrect drug was allocated|1|||
160748180|NCT00770913|580464039|FG001|Overall Study|Incorrect drug was allocated|0|||
160748181|NCT00770913|580464040|FG002|Overall Study|Incorrect drug was allocated|0|||
160748182|NCT03585712|580464046|FG000|Treatment Period 1|Protocol Violation|1|||
160748183|NCT03585712|580464047|FG001|Treatment Period 1|Protocol Violation|0|||
160748184|NCT03585712|580464048|FG002|Treatment Period 1|Protocol Violation|0|||
160748185|NCT03585712|580464046|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
160748186|NCT03585712|580464047|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
160748187|NCT03585712|580464048|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
160748188|NCT03585712|580464046|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
160748189|NCT03585712|580464047|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
160748190|NCT03585712|580464048|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
160748191|NCT03585712|580464046|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
160748192|NCT03585712|580464047|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
160748193|NCT03585712|580464048|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
160748194|NCT03517449|580464051|FG000|Overall Study|Death|184|||
160748195|NCT03517449|580464052|FG001|Overall Study|Death|236|||
160748196|NCT03517449|580464051|FG000|Overall Study|Lost to Follow-up|0|||
160748197|NCT03517449|580464052|FG001|Overall Study|Lost to Follow-up|2|||
160748198|NCT03517449|580464051|FG000|Overall Study|Withdrawal by Subject|7|||
160748199|NCT03517449|580464052|FG001|Overall Study|Withdrawal by Subject|26|||
160748200|NCT03517449|580464051|FG000|Overall Study|Participants Ongoing|220|||
160748201|NCT03517449|580464052|FG001|Overall Study|Participants Ongoing|152|||
160748202|NCT02347072|580464056|FG000|Overall Study|Adverse Event|2|||
160748203|NCT02347072|580464056|FG000|Overall Study|Withdrawal by Subject|6|||
160748204|NCT02347072|580464056|FG000|Overall Study|Physician Decision|1|||
160748205|NCT02347072|580464056|FG000|Overall Study|Lost to Follow-up|2|||
160748206|NCT02347072|580464056|FG000|Overall Study|Protocol Violation|1|||
160748207|NCT02347072|580464056|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
160748208|NCT01134393|580464061|FG000|Overall Study|Adverse Event|18|||
160748209|NCT01134393|580464061|FG000|Overall Study|Lack of Efficacy|2|||
160748210|NCT01134393|580464061|FG000|Overall Study|Protocol Violation|12|||
160748211|NCT01134393|580464061|FG000|Overall Study|Lost to Follow-up|3|||
160748212|NCT01134393|580464061|FG000|Overall Study|Withdrawal by Subject|11|||
160748213|NCT01134393|580464061|FG000|Overall Study|Other|6|||
160748214|NCT03230838|580464066|FG000|Overall Study|Withdrawal by Subject|3|||
160748215|NCT03230838|580464067|FG001|Overall Study|Withdrawal by Subject|0|||
160748216|NCT03230838|580464066|FG000|Overall Study|Temperature excursion|1|||
160748217|NCT03230838|580464067|FG001|Overall Study|Temperature excursion|0|||
160748218|NCT00575510|580464070|FG000|Overall Study|Lost to Follow-up|4|||
160748219|NCT00575510|580464071|FG001|Overall Study|Lost to Follow-up|6|||
160748220|NCT00575510|580464072|FG002|Overall Study|Lost to Follow-up|9|||
160748221|NCT00575510|580464070|FG000|Overall Study|Withdrawal by Subject|1|||
160748222|NCT00575510|580464071|FG001|Overall Study|Withdrawal by Subject|0|||
160748223|NCT00575510|580464072|FG002|Overall Study|Withdrawal by Subject|0|||
160748224|NCT00575510|580464070|FG000|Overall Study|Clinic Called Patient|7|||
160748225|NCT00575510|580464071|FG001|Overall Study|Clinic Called Patient|7|||
160748226|NCT00575510|580464072|FG002|Overall Study|Clinic Called Patient|7|||
160748227|NCT00575510|580464070|FG000|Overall Study|Pregnancy|0|||
160748228|NCT00575510|580464071|FG001|Overall Study|Pregnancy|0|||
160748229|NCT00575510|580464072|FG002|Overall Study|Pregnancy|1|||
160748230|NCT02697734|580464073|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
160748231|NCT02697734|580464074|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
160748232|NCT02697734|580464073|FG000|Core Phase - up to Week 48|Adverse Event|1|||
160748233|NCT02697734|580464074|FG001|Core Phase - up to Week 48|Adverse Event|2|||
160748234|NCT02697734|580464073|FG000|Core Phase - up to Week 48|Physician Decision|1|||
160748235|NCT02697734|580464074|FG001|Core Phase - up to Week 48|Physician Decision|0|||
160748236|NCT02697734|580464073|FG000|Optional Extension Phase|Adverse Event|5|||
160748237|NCT02697734|580464074|FG001|Optional Extension Phase|Adverse Event|1|||
160748238|NCT02697734|580464073|FG000|Optional Extension Phase|Physician Decision|0|||
160748239|NCT02697734|580464074|FG001|Optional Extension Phase|Physician Decision|1|||
160748240|NCT03970200|580464075|FG000|Overall Study|Death|2|||
160748241|NCT03970200|580464076|FG001|Overall Study|Death|2|||
160748242|NCT03970200|580464077|FG002|Overall Study|Death|1|||
160748243|NCT03970200|580464075|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
160748244|NCT03970200|580464076|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
160748245|NCT03970200|580464077|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
160748246|NCT01607346|580464078|FG000|Overall Study|Adverse Event|3|||
160748247|NCT01098162|580464079|FG000|Overall Study|Adverse Event|37|||
160748248|NCT01098162|580464079|FG000|Overall Study|Lack of Efficacy|4|||
160748249|NCT01098162|580464079|FG000|Overall Study|Wish of Patient|7|||
160748250|NCT01098162|580464079|FG000|Overall Study|Lost to Follow-up|9|||
160748251|NCT01098162|580464079|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
160748252|NCT01098162|580464079|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
160748253|NCT01098162|580464079|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
160748254|NCT01098162|580464079|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
160748255|NCT01098162|580464079|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
160748256|NCT01098162|580464079|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
160748257|NCT01098162|580464079|FG000|Overall Study|Other Reason|1|||
160748258|NCT01098162|580464079|FG000|Overall Study|Reason Unknown|26|||
160748259|NCT01605825|580464080|FG000|Overall Study|Adverse Event|4|||
160748260|NCT01605825|580464081|FG001|Overall Study|Adverse Event|2|||
160748261|NCT01605825|580464080|FG000|Overall Study|Withdrawal by Subject|0|||
160748262|NCT01605825|580464081|FG001|Overall Study|Withdrawal by Subject|1|||
160748263|NCT01605825|580464080|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
160748264|NCT01605825|580464081|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
160748265|NCT01605825|580464080|FG000|Overall Study|Non-Compliance with Protocol|3|||
160748266|NCT01605825|580464081|FG001|Overall Study|Non-Compliance with Protocol|0|||
160748267|NCT02279745|580464082|FG000|Overall Study|Adverse Event|7|||
160748268|NCT02279745|580464082|FG000|Overall Study|Death|6|||
160748269|NCT02279745|580464082|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
160748270|NCT02279745|580464082|FG000|Overall Study|Withdrawal by Subject|2|||
160748271|NCT02279745|580464082|FG000|Overall Study|Pregnancy|1|||
160748272|NCT02279745|580464082|FG000|Overall Study|Study Non-compliance|1|||
160748273|NCT02279745|580464082|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
160748274|NCT00380718|580464083|FG000|Overall Study|Adverse Event|1|||
160748275|NCT00380718|580464083|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
160748276|NCT01706575|580464085|FG000|Overall Study|Participant Withdrew Consent|4|||
160748277|NCT01706575|580464085|FG000|Overall Study|Lost to Follow-up|2|||
160748278|NCT01706575|580464085|FG000|Overall Study|Started but not Treated|6|||
160748279|NCT00840034|580464089|FG000|Acute Treatment Phase|Adverse Event|6|||
160748280|NCT00840034|580464090|FG001|Acute Treatment Phase|Adverse Event|8|||
160748281|NCT00840034|580464089|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
160748282|NCT00840034|580464090|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
160748283|NCT00840034|580464089|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
160748284|NCT00840034|580464090|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
160748285|NCT00840034|580464089|FG000|Acute Treatment Phase|Physician Decision|0|||
160748286|NCT00840034|580464090|FG001|Acute Treatment Phase|Physician Decision|1|||
160748287|NCT00840034|580464089|FG000|Acute Treatment Phase|Protocol Violation|2|||
160748288|NCT00840034|580464090|FG001|Acute Treatment Phase|Protocol Violation|4|||
160748289|NCT00840034|580464089|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
160748290|NCT00840034|580464090|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
160748291|NCT00840034|580464089|FG000|Taper Phase|Adverse Event|1|||
160748292|NCT00840034|580464090|FG001|Taper Phase|Adverse Event|0|||
160748293|NCT00840034|580464089|FG000|Taper Phase|Lost to Follow-up|1|||
160748294|NCT00840034|580464090|FG001|Taper Phase|Lost to Follow-up|1|||
160748295|NCT00840034|580464089|FG000|Taper Phase|Withdrawal by Subject|1|||
160748296|NCT00840034|580464090|FG001|Taper Phase|Withdrawal by Subject|1|||
160748297|NCT01215435|580464091|FG000|Overall Study|Adverse Event|1|||
160748298|NCT01215435|580464092|FG001|Overall Study|Adverse Event|0|||
160748299|NCT01215435|580464091|FG000|Overall Study|Protocol Violation|2|||
160748300|NCT01215435|580464092|FG001|Overall Study|Protocol Violation|0|||
160748301|NCT01215435|580464091|FG000|Overall Study|Withdrawal Criteria|8|||
160748302|NCT01215435|580464092|FG001|Overall Study|Withdrawal Criteria|11|||
160748303|NCT01215435|580464091|FG000|Overall Study|Lost to Follow-up|3|||
160748304|NCT01215435|580464092|FG001|Overall Study|Lost to Follow-up|0|||
160748305|NCT01215435|580464091|FG000|Overall Study|Unclassified|5|||
160748306|NCT01215435|580464092|FG001|Overall Study|Unclassified|5|||
160748307|NCT02839876|580464093|FG000|Overall Study|Protocol Violation|10|||
160748308|NCT02839876|580464094|FG001|Overall Study|Protocol Violation|11|||
160748309|NCT01156051|580464095|FG000|Overall Study|Lost to Follow-up|1|||
160748310|NCT01156051|580464096|FG001|Overall Study|Lost to Follow-up|0|||
160748311|NCT01156051|580464095|FG000|Overall Study|patient not compliant with protocol|0|||
160748312|NCT01156051|580464096|FG001|Overall Study|patient not compliant with protocol|1|||
160748313|NCT02179749|580464100|FG000|Overall Study|Adverse Event|0|||
160748314|NCT02179749|580464101|FG001|Overall Study|Adverse Event|0|||
160748315|NCT02179749|580464102|FG002|Overall Study|Adverse Event|1|||
160748316|NCT02179749|580464100|FG000|Overall Study|Withdrawal by Subject|0|||
160748317|NCT02179749|580464101|FG001|Overall Study|Withdrawal by Subject|0|||
160748318|NCT02179749|580464102|FG002|Overall Study|Withdrawal by Subject|1|||
160748319|NCT01810783|580464103|FG000|Overall Study|Adverse Event|32|||
160748320|NCT01810783|580464103|FG000|Overall Study|Withdrawal by Subject|22|||
160748321|NCT01810783|580464103|FG000|Overall Study|Lack of Efficacy|12|||
160748322|NCT01810783|580464103|FG000|Overall Study|Lost to Follow-up|10|||
160748323|NCT01810783|580464103|FG000|Overall Study|Protocol Violation|5|||
160748324|NCT01810783|580464103|FG000|Overall Study|Non-compliance with IMP|4|||
160748325|NCT01810783|580464103|FG000|Overall Study|Adminstrative or other reason(s)|23|||
160748326|NCT01810783|580464103|FG000|Overall Study|Enrolled, not treated|1|||
160748327|NCT00793546|580464104|FG000|Overall Study|Death|3|||
160748328|NCT00793546|580464105|FG001|Overall Study|Death|0|||
160748329|NCT00793546|580464104|FG000|Overall Study|Lost to Follow-up|1|||
160748330|NCT00793546|580464105|FG001|Overall Study|Lost to Follow-up|0|||
160748331|NCT00793546|580464104|FG000|Overall Study|Withdrawal by Subject|1|||
160748332|NCT00793546|580464105|FG001|Overall Study|Withdrawal by Subject|1|||
160748333|NCT00793546|580464104|FG000|Overall Study|Study Terminated by Sponsor|8|||
160748334|NCT00793546|580464105|FG001|Overall Study|Study Terminated by Sponsor|27|||
160748335|NCT00793546|580464104|FG000|Overall Study|Other|1|||
160748336|NCT00793546|580464105|FG001|Overall Study|Other|0|||
160748337|NCT00094536|580464106|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
160748338|NCT00094536|580464106|FG000|Treatment and Follow-up|Adverse Event|4|||
160748339|NCT00094536|580464106|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
160748340|NCT00094536|580464106|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
160748341|NCT00094536|580464106|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
160748342|NCT00094536|580464106|FG000|Treatment and Follow-up|Subject non-compliance|9|||
160748343|NCT00094536|580464106|FG000|Treatment and Follow-up|Unable to attend visits|1|||
160748344|NCT02620384|580464107|FG000|Overall Study|Adverse Event|2|||
160748345|NCT02620384|580464108|FG001|Overall Study|Adverse Event|1|||
160748346|NCT02620384|580464107|FG000|Overall Study|Discharged prior to 2nd dose|2|||
160748347|NCT02620384|580464108|FG001|Overall Study|Discharged prior to 2nd dose|5|||
160748348|NCT02620384|580464107|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
160748349|NCT02620384|580464108|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
160748350|NCT01841567|580464109|FG000|Overall Study|Adverse Event|3|||
160748351|NCT01078298|580464110|FG000|Overall Study|Lost to Follow-up|12|||
160748352|NCT01078298|580464111|FG001|Overall Study|Lost to Follow-up|13|||
160748353|NCT01078298|580464110|FG000|Overall Study|Withdrawal by Subject|31|||
160748354|NCT01078298|580464111|FG001|Overall Study|Withdrawal by Subject|33|||
160748355|NCT01078298|580464110|FG000|Overall Study|Protocol Violation|6|||
160748356|NCT01078298|580464111|FG001|Overall Study|Protocol Violation|6|||
160748357|NCT01078298|580464110|FG000|Overall Study|Adverse Event|6|||
160748358|NCT01078298|580464111|FG001|Overall Study|Adverse Event|5|||
160748359|NCT01078298|580464110|FG000|Overall Study|Death|2|||
160748360|NCT01078298|580464111|FG001|Overall Study|Death|0|||
160748361|NCT01078298|580464110|FG000|Overall Study|Did not meet entrance criteria|0|||
160748362|NCT01078298|580464111|FG001|Overall Study|Did not meet entrance criteria|1|||
160748363|NCT01078298|580464110|FG000|Overall Study|Other|24|||
160748364|NCT01078298|580464111|FG001|Overall Study|Other|32|||
160748365|NCT00742027|580464112|FG000|Overall Study|Disease Progression|76|||
160748366|NCT00742027|580464112|FG000|Overall Study|New Cancer Therapy|19|||
160748367|NCT00742027|580464112|FG000|Overall Study|Withdrawal by Subject|18|||
160748368|NCT00742027|580464112|FG000|Overall Study|Death|7|||
160748369|NCT00742027|580464112|FG000|Overall Study|Lost to Follow-up|4|||
160748370|NCT00742027|580464112|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
160748371|NCT00742027|580464112|FG000|Overall Study|Missing|2|||
160748372|NCT00742027|580464112|FG000|Overall Study|Administrative Problems|1|||
160748373|NCT01764659|580464113|FG000|Overall Study|Death|1|||
160748374|NCT01764659|580464113|FG000|Overall Study|Physician Decision|1|||
160748375|NCT02526160|580465828|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
160748376|NCT02526160|580465829|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
160748377|NCT02526160|580465828|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
160748378|NCT02526160|580465829|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
160748379|NCT02526160|580465828|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
160748380|NCT02526160|580465829|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
160748381|NCT02526160|580465828|FG000|Open-Label Treatment Extension Period I|Death|0|||
160748382|NCT02526160|580465829|FG001|Open-Label Treatment Extension Period I|Death|1|||
160748383|NCT02526160|580465828|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
160748384|NCT02526160|580465829|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
160748385|NCT02526160|580465828|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
160748386|NCT02526160|580465829|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
160748387|NCT02526160|580465828|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
160748388|NCT02526160|580465829|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
160748389|NCT02526160|580465828|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
160748390|NCT02526160|580465829|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
160748391|NCT00398216|580465830|FG000|Overall Study|Adverse Event|4|||
160748392|NCT00398216|580465831|FG001|Overall Study|Adverse Event|2|||
160748393|NCT00398216|580465832|FG002|Overall Study|Adverse Event|5|||
160748394|NCT00398216|580465833|FG003|Overall Study|Adverse Event|7|||
160748395|NCT00398216|580465834|FG004|Overall Study|Adverse Event|2|||
160748396|NCT00398216|580465830|FG000|Overall Study|Protocol Violation|2|||
160748397|NCT00398216|580465831|FG001|Overall Study|Protocol Violation|4|||
160748398|NCT00398216|580465832|FG002|Overall Study|Protocol Violation|5|||
160748399|NCT00398216|580465833|FG003|Overall Study|Protocol Violation|7|||
160748400|NCT00398216|580465834|FG004|Overall Study|Protocol Violation|5|||
160748401|NCT00398216|580465830|FG000|Overall Study|Lost to Follow-up|1|||
160748402|NCT00398216|580465831|FG001|Overall Study|Lost to Follow-up|6|||
160748403|NCT00398216|580465832|FG002|Overall Study|Lost to Follow-up|4|||
160748404|NCT00398216|580465833|FG003|Overall Study|Lost to Follow-up|4|||
160748405|NCT00398216|580465834|FG004|Overall Study|Lost to Follow-up|1|||
160748406|NCT00398216|580465830|FG000|Overall Study|Death|0|||
160748407|NCT00398216|580465831|FG001|Overall Study|Death|3|||
160748408|NCT00398216|580465832|FG002|Overall Study|Death|0|||
160748409|NCT00398216|580465833|FG003|Overall Study|Death|0|||
160748410|NCT00398216|580465834|FG004|Overall Study|Death|0|||
160748411|NCT00398216|580465830|FG000|Overall Study|Withdrawal by Subject|1|||
160748412|NCT00398216|580465831|FG001|Overall Study|Withdrawal by Subject|0|||
160748413|NCT00398216|580465832|FG002|Overall Study|Withdrawal by Subject|3|||
160748414|NCT00398216|580465833|FG003|Overall Study|Withdrawal by Subject|1|||
160748415|NCT00398216|580465834|FG004|Overall Study|Withdrawal by Subject|2|||
160748416|NCT00398216|580465830|FG000|Overall Study|administrative reasons|3|||
160748417|NCT00398216|580465831|FG001|Overall Study|administrative reasons|4|||
160748418|NCT00398216|580465832|FG002|Overall Study|administrative reasons|4|||
160748419|NCT00398216|580465833|FG003|Overall Study|administrative reasons|3|||
160748420|NCT00398216|580465834|FG004|Overall Study|administrative reasons|3|||
160748421|NCT00398216|580465830|FG000|Overall Study|entrance criteria|0|||
160748422|NCT00398216|580465831|FG001|Overall Study|entrance criteria|0|||
160748423|NCT00398216|580465832|FG002|Overall Study|entrance criteria|0|||
160748424|NCT00398216|580465833|FG003|Overall Study|entrance criteria|0|||
160748425|NCT00398216|580465834|FG004|Overall Study|entrance criteria|2|||
160748426|NCT02207400|580465835|FG000|Overall Study|Adverse Event|1|||
160748427|NCT02207400|580465836|FG001|Overall Study|Adverse Event|1|||
160748428|NCT02207400|580465835|FG000|Overall Study|Lost to Follow-up|6|||
160748429|NCT02207400|580465836|FG001|Overall Study|Lost to Follow-up|7|||
160748430|NCT02207400|580465835|FG000|Overall Study|Protocol Violation|1|||
160748431|NCT02207400|580465836|FG001|Overall Study|Protocol Violation|1|||
160748432|NCT02207400|580465835|FG000|Overall Study|Withdrawal by Subject|8|||
160748433|NCT02207400|580465836|FG001|Overall Study|Withdrawal by Subject|4|||
160748434|NCT02207400|580465835|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
160748435|NCT02207400|580465836|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
160748436|NCT04304508|580465837|FG000|Overall Study|Subject Decision|29|||
160748437|NCT04304508|580465838|FG001|Overall Study|Subject Decision|39|||
160748438|NCT04304508|580465839|FG002|Overall Study|Subject Decision|37|||
160748439|NCT04304508|580465840|FG003|Overall Study|Subject Decision|48|||
160748440|NCT04304508|580465837|FG000|Overall Study|Death|6|||
160748441|NCT04304508|580465838|FG001|Overall Study|Death|1|||
160748442|NCT04304508|580465839|FG002|Overall Study|Death|8|||
160748443|NCT04304508|580465840|FG003|Overall Study|Death|5|||
160748444|NCT04304508|580465837|FG000|Overall Study|Non-compliance With Study Drug|3|||
160748445|NCT04304508|580465838|FG001|Overall Study|Non-compliance With Study Drug|1|||
160748446|NCT04304508|580465839|FG002|Overall Study|Non-compliance With Study Drug|2|||
160748447|NCT04304508|580465840|FG003|Overall Study|Non-compliance With Study Drug|0|||
160748448|NCT04304508|580465837|FG000|Overall Study|Switching To Other Therapy|1|||
160748449|NCT04304508|580465838|FG001|Overall Study|Switching To Other Therapy|1|||
160748450|NCT04304508|580465839|FG002|Overall Study|Switching To Other Therapy|1|||
160748451|NCT04304508|580465840|FG003|Overall Study|Switching To Other Therapy|2|||
160748452|NCT04304508|580465837|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
160748453|NCT04304508|580465838|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
160748454|NCT04304508|580465839|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
160748455|NCT04304508|580465840|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
160748456|NCT04304508|580465837|FG000|Overall Study|Withdrawal by Subject|7|||
160748457|NCT04304508|580465838|FG001|Overall Study|Withdrawal by Subject|5|||
160748458|NCT04304508|580465839|FG002|Overall Study|Withdrawal by Subject|11|||
160748459|NCT04304508|580465840|FG003|Overall Study|Withdrawal by Subject|6|||
160748460|NCT04304508|580465837|FG000|Overall Study|Logistical Difficulties|2|||
160748461|NCT04304508|580465838|FG001|Overall Study|Logistical Difficulties|2|||
160748462|NCT04304508|580465839|FG002|Overall Study|Logistical Difficulties|3|||
160748463|NCT04304508|580465840|FG003|Overall Study|Logistical Difficulties|2|||
160748464|NCT04304508|580465837|FG000|Overall Study|Missing Information|1|||
160748465|NCT04304508|580465838|FG001|Overall Study|Missing Information|2|||
160748466|NCT04304508|580465839|FG002|Overall Study|Missing Information|1|||
160748467|NCT04304508|580465840|FG003|Overall Study|Missing Information|3|||
160748468|NCT04304508|580465837|FG000|Overall Study|Other|7|||
160748469|NCT04304508|580465838|FG001|Overall Study|Other|6|||
160748470|NCT04304508|580465839|FG002|Overall Study|Other|5|||
160748471|NCT04304508|580465840|FG003|Overall Study|Other|4|||
160748472|NCT04304508|580465837|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
160748473|NCT04304508|580465838|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
160748474|NCT04304508|580465839|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
160748475|NCT04304508|580465840|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
160748476|NCT04304508|580465837|FG000|Overall Study|Physician Decision|3|||
160748477|NCT04304508|580465838|FG001|Overall Study|Physician Decision|4|||
160748478|NCT04304508|580465839|FG002|Overall Study|Physician Decision|9|||
160748479|NCT04304508|580465840|FG003|Overall Study|Physician Decision|7|||
160748480|NCT04304508|580465837|FG000|Overall Study|Study drug never administered|10|||
160748481|NCT04304508|580465838|FG001|Overall Study|Study drug never administered|4|||
160748482|NCT04304508|580465839|FG002|Overall Study|Study drug never administered|4|||
160748483|NCT04304508|580465840|FG003|Overall Study|Study drug never administered|4|||
160748484|NCT04304508|580465837|FG000|Overall Study|Adverse Event|49|||
160748485|NCT04304508|580465838|FG001|Overall Study|Adverse Event|50|||
160748486|NCT04304508|580465839|FG002|Overall Study|Adverse Event|51|||
160748487|NCT04304508|580465840|FG003|Overall Study|Adverse Event|56|||
160748488|NCT04304508|580465837|FG000|Overall Study|Lost to Follow-up|1|||
160748489|NCT04304508|580465838|FG001|Overall Study|Lost to Follow-up|5|||
160748490|NCT04304508|580465839|FG002|Overall Study|Lost to Follow-up|2|||
160748491|NCT04304508|580465840|FG003|Overall Study|Lost to Follow-up|3|||
160748492|NCT02113007|580465841|FG000|Overall Study|Progressive disease|2|||
160748493|NCT00885378|580465842|FG000|Overall Study|Lack of Efficacy|2|||
160748494|NCT00885378|580465843|FG001|Overall Study|Lack of Efficacy|2|||
160748495|NCT00885378|580465842|FG000|Overall Study|Withdrawal by Subject|1|||
160748496|NCT00885378|580465843|FG001|Overall Study|Withdrawal by Subject|2|||
160748497|NCT00885378|580465842|FG000|Overall Study|Lost to Follow-up|1|||
160748498|NCT00885378|580465843|FG001|Overall Study|Lost to Follow-up|2|||
160748499|NCT00885378|580465842|FG000|Overall Study|Poor/Noncompliance|2|||
160748500|NCT00885378|580465843|FG001|Overall Study|Poor/Noncompliance|2|||
160748501|NCT00885378|580465842|FG000|Overall Study|Protocol Violation|2|||
160748502|NCT00885378|580465843|FG001|Overall Study|Protocol Violation|0|||
160748503|NCT03252145|580465844|FG000|Overall Study|Withdrawal by Subject|1|||
160748504|NCT03252145|580465845|FG001|Overall Study|Withdrawal by Subject|0|||
160748505|NCT03252145|580465844|FG000|Overall Study|Complicating Disease|1|||
160748506|NCT03252145|580465845|FG001|Overall Study|Complicating Disease|2|||
160748507|NCT01763827|580465849|FG000|Overall Study|Withdrawal by Subject|1|||
160748508|NCT01763827|580465850|FG001|Overall Study|Withdrawal by Subject|0|||
160748509|NCT01763827|580465851|FG002|Overall Study|Withdrawal by Subject|0|||
160748510|NCT01763827|580465852|FG003|Overall Study|Withdrawal by Subject|0|||
160748511|NCT01763827|580465853|FG004|Overall Study|Withdrawal by Subject|2|||
160748512|NCT01763827|580465854|FG005|Overall Study|Withdrawal by Subject|0|||
160748513|NCT01763827|580465849|FG000|Overall Study|Decision by sponsor|2|||
160748514|NCT01763827|580465850|FG001|Overall Study|Decision by sponsor|0|||
160748515|NCT01763827|580465851|FG002|Overall Study|Decision by sponsor|3|||
160748516|NCT01763827|580465852|FG003|Overall Study|Decision by sponsor|0|||
160748517|NCT01763827|580465853|FG004|Overall Study|Decision by sponsor|2|||
160748518|NCT01763827|580465854|FG005|Overall Study|Decision by sponsor|1|||
160748519|NCT01763827|580465849|FG000|Overall Study|Lost to Follow-up|0|||
160748520|NCT01763827|580465850|FG001|Overall Study|Lost to Follow-up|1|||
160748521|NCT01763827|580465851|FG002|Overall Study|Lost to Follow-up|1|||
160748522|NCT01763827|580465852|FG003|Overall Study|Lost to Follow-up|1|||
160748523|NCT01763827|580465853|FG004|Overall Study|Lost to Follow-up|2|||
160748524|NCT01763827|580465854|FG005|Overall Study|Lost to Follow-up|1|||
160748525|NCT02187029|580465857|FG000|Overall Study|Adverse Event|0|||
160748526|NCT02187029|580465858|FG001|Overall Study|Adverse Event|1|||
160748527|NCT02187029|580465859|FG002|Overall Study|Adverse Event|1|||
160748528|NCT02187029|580465860|FG003|Overall Study|Adverse Event|0|||
160748529|NCT02187029|580465857|FG000|Overall Study|Study Terminated by Sponsor|0|||
160748530|NCT02187029|580465858|FG001|Overall Study|Study Terminated by Sponsor|0|||
160748531|NCT02187029|580465859|FG002|Overall Study|Study Terminated by Sponsor|10|||
160748532|NCT02187029|580465860|FG003|Overall Study|Study Terminated by Sponsor|3|||
160748533|NCT02187029|580465857|FG000|Overall Study|Withdrawal by Subject|1|||
160748534|NCT02187029|580465858|FG001|Overall Study|Withdrawal by Subject|0|||
160748535|NCT02187029|580465859|FG002|Overall Study|Withdrawal by Subject|0|||
160748536|NCT02187029|580465860|FG003|Overall Study|Withdrawal by Subject|0|||
160748537|NCT02985021|580465861|FG000|Overall Study|Inability to comply with study procedures|1|||
160748538|NCT04105842|580465862|FG000|Overall Study|Withdrawal by Subject|2|||
160748539|NCT04399889|580465864|FG000|Overall Study|Death|5|||
160748540|NCT04399889|580465865|FG001|Overall Study|Death|1|||
160748541|NCT04399889|580465866|FG002|Overall Study|Death|1|||
160748542|NCT00707980|580465870|FG000|Overall Study|Adverse Event|49|||
160748543|NCT00707980|580465870|FG000|Overall Study|Lack of Efficacy|35|||
160748544|NCT00707980|580465870|FG000|Overall Study|Non-Compliance with Study Drug|28|||
160748545|NCT00707980|580465870|FG000|Overall Study|Protocol Deviations|19|||
160748546|NCT00707980|580465870|FG000|Overall Study|Withdrawal of Consent|81|||
160748547|NCT00707980|580465870|FG000|Overall Study|Lost to Follow-up|59|||
160748548|NCT00707980|580465870|FG000|Overall Study|Other|39|||
160748549|NCT01152996|580465871|FG000|Overall Study|Withdrawal by Subject|142|||
160748550|NCT01152996|580465871|FG000|Overall Study|Adverse Event|115|||
160748551|NCT01152996|580465871|FG000|Overall Study|Lost to Follow-up|112|||
160748552|NCT01152996|580465871|FG000|Overall Study|Lack of Efficacy|68|||
160748553|NCT01152996|580465871|FG000|Overall Study|Noncompliance|41|||
160748554|NCT01152996|580465871|FG000|Overall Study|Other|36|||
160748555|NCT01152996|580465871|FG000|Overall Study|Protocol Violation|22|||
160748556|NCT01152996|580465871|FG000|Overall Study|Elevated liver enzymes|1|||
160748557|NCT00460239|580465873|FG000|Overall Study|Physician Decision|0|||
160748558|NCT00460239|580465874|FG001|Overall Study|Physician Decision|1|||
160748559|NCT00460239|580465875|FG002|Overall Study|Physician Decision|0|||
160748560|NCT00460239|580465876|FG003|Overall Study|Physician Decision|0|||
160748561|NCT00460239|580465877|FG004|Overall Study|Physician Decision|0|||
160748562|NCT00460239|580465878|FG005|Overall Study|Physician Decision|2|||
160748563|NCT00460239|580465879|FG006|Overall Study|Physician Decision|0|||
160748564|NCT00460239|580465880|FG007|Overall Study|Physician Decision|0|||
160748565|NCT00460239|580465881|FG008|Overall Study|Physician Decision|0|||
160748566|NCT00460239|580465873|FG000|Overall Study|Withdrawal by Subject|0|||
160748567|NCT00460239|580465874|FG001|Overall Study|Withdrawal by Subject|0|||
160748568|NCT00460239|580465875|FG002|Overall Study|Withdrawal by Subject|0|||
160748569|NCT00460239|580465876|FG003|Overall Study|Withdrawal by Subject|0|||
160748570|NCT00460239|580465877|FG004|Overall Study|Withdrawal by Subject|0|||
160748571|NCT00460239|580465878|FG005|Overall Study|Withdrawal by Subject|1|||
160748572|NCT00460239|580465879|FG006|Overall Study|Withdrawal by Subject|0|||
160748573|NCT00460239|580465880|FG007|Overall Study|Withdrawal by Subject|0|||
160748574|NCT00460239|580465881|FG008|Overall Study|Withdrawal by Subject|0|||
160748575|NCT01535443|580465884|FG000|Overall Study|Physician Decision|3|||
160748576|NCT00760487|580465886|FG000|Overall Study|Unilateral implantation|3|||
160748577|NCT02260817|580465890|FG000|Overall Study|Lost to Follow-up|0|||
160748578|NCT02260817|580465891|FG001|Overall Study|Lost to Follow-up|14|||
160748579|NCT02260817|580465890|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
160748580|NCT02260817|580465891|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
160748581|NCT02260817|580465890|FG000|Overall Study|Observation, no biopsy|0|||
160748582|NCT02260817|580465891|FG001|Overall Study|Observation, no biopsy|1|||
160748583|NCT02260817|580465890|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
160748584|NCT02260817|580465891|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
160748585|NCT02260817|580465890|FG000|Overall Study|Protocol Violation|0|||
160748586|NCT02260817|580465891|FG001|Overall Study|Protocol Violation|14|||
160748587|NCT03299101|580465892|FG000|Overall Study|Lost to Follow-up|1|||
160748588|NCT03299101|580465892|FG000|Overall Study|Withdrawal by Subject|5|||
160748589|NCT03299101|580465892|FG000|Overall Study|Surgery was changed|3|||
160748590|NCT03299101|580465892|FG000|Overall Study|Not enough time to complete prehab|1|||
160748591|NCT04217317|580465895|FG000|Overall Study|Lack of Efficacy|4|||
160748592|NCT04217317|580465895|FG000|Overall Study|Physician Decision|1|||
160748593|NCT01882803|580465896|FG000|Overall Study|Disease Progression|1|||
160748594|NCT01882803|580465896|FG000|Overall Study|Withdrawal by Subject|9|||
160748595|NCT01882803|580465896|FG000|Overall Study|Death|68|||
160748596|NCT01882803|580465896|FG000|Overall Study|Physician Decision|3|||
160748597|NCT01882803|580465896|FG000|Overall Study|Lost to Follow-up|3|||
160748598|NCT01882803|580465896|FG000|Overall Study|Follow-up Completed|39|||
160748599|NCT01882803|580465896|FG000|Overall Study|Study Terminated by the Sponsor|6|||
160748600|NCT02869893|580465897|FG000|Overall Study|participant aversion to IV|5|||
160748601|NCT02869893|580465897|FG000|Overall Study|participant fear of MRI scanner|2|||
160748602|NCT01563913|580465898|FG000|Overall Study|Physician Decision|1|||
160748603|NCT01563913|580465899|FG001|Overall Study|Physician Decision|0|||
160748604|NCT01563913|580465898|FG000|Overall Study|Spouse Passed Away|1|||
160748605|NCT01563913|580465899|FG001|Overall Study|Spouse Passed Away|0|||
160748606|NCT03066778|580465900|FG000|Overall Study|Death|195|||
160748607|NCT03066778|580465901|FG001|Overall Study|Death|205|||
160748608|NCT03066778|580465900|FG000|Overall Study|Withdrawal by Subject|5|||
160748609|NCT03066778|580465901|FG001|Overall Study|Withdrawal by Subject|7|||
160748610|NCT00329745|580465902|FG000|Overall Study|Protocol Violation|1|||
160748611|NCT00329745|580465903|FG001|Overall Study|Protocol Violation|0|||
160748612|NCT00329745|580465902|FG000|Overall Study|Withdrawal by Subject|0|||
160748613|NCT00329745|580465903|FG001|Overall Study|Withdrawal by Subject|1|||
160748614|NCT00329745|580465902|FG000|Overall Study|Lost to Follow-up|86|||
160748615|NCT00329745|580465903|FG001|Overall Study|Lost to Follow-up|101|||
160748616|NCT03146741|580465904|FG000|Overall Study|Txp with non-HCV+ heart|4|||
160748617|NCT03146741|580465904|FG000|Overall Study|Listeted for MOT|2|||
160748618|NCT03146741|580465904|FG000|Overall Study|Physician Decision|2|||
160748619|NCT03146741|580465904|FG000|Overall Study|Awaiting txp|2|||
160748620|NCT03224624|580465905|FG000|Overall Study|Lost to Follow-up|9|||
160748621|NCT03224624|580465906|FG001|Overall Study|Lost to Follow-up|4|||
160748622|NCT03224624|580465905|FG000|Overall Study|Death|1|||
160748623|NCT03224624|580465906|FG001|Overall Study|Death|0|||
160748624|NCT01424241|580465909|FG000|Overall Study|Withdrawal by Subject|1|||
160748625|NCT01424241|580465909|FG000|Overall Study|Time constraints|2|||
160748626|NCT00551525|580465910|FG000|Overall Study|Protocol Violation|5|||
160748627|NCT05259917|580465916|FG000|Overall Study|Protocol Violation|0|||
160748628|NCT05259917|580465917|FG001|Overall Study|Protocol Violation|0|||
160748629|NCT05259917|580465918|FG002|Overall Study|Protocol Violation|1|||
160748630|NCT05259917|580465919|FG003|Overall Study|Protocol Violation|0|||
160748631|NCT05259917|580465920|FG004|Overall Study|Protocol Violation|0|||
160748632|NCT05259917|580465921|FG005|Overall Study|Protocol Violation|0|||
160748633|NCT05259917|580465916|FG000|Overall Study|Lost to Follow-up|0|||
160748634|NCT05259917|580465917|FG001|Overall Study|Lost to Follow-up|0|||
160748635|NCT05259917|580465918|FG002|Overall Study|Lost to Follow-up|1|||
160748636|NCT05259917|580465919|FG003|Overall Study|Lost to Follow-up|0|||
160748637|NCT05259917|580465920|FG004|Overall Study|Lost to Follow-up|0|||
160748638|NCT05259917|580465921|FG005|Overall Study|Lost to Follow-up|1|||
160748639|NCT05259917|580465916|FG000|Overall Study|Physician Decision|0|||
160748640|NCT05259917|580465917|FG001|Overall Study|Physician Decision|1|||
160748641|NCT05259917|580465918|FG002|Overall Study|Physician Decision|0|||
160748642|NCT05259917|580465919|FG003|Overall Study|Physician Decision|0|||
160748643|NCT05259917|580465920|FG004|Overall Study|Physician Decision|0|||
160748644|NCT05259917|580465921|FG005|Overall Study|Physician Decision|0|||
160748645|NCT05259917|580465916|FG000|Overall Study|Withdrawal by Subject|0|||
160748646|NCT05259917|580465917|FG001|Overall Study|Withdrawal by Subject|1|||
160748647|NCT05259917|580465918|FG002|Overall Study|Withdrawal by Subject|0|||
160748648|NCT05259917|580465919|FG003|Overall Study|Withdrawal by Subject|0|||
160748649|NCT05259917|580465920|FG004|Overall Study|Withdrawal by Subject|1|||
160748650|NCT05259917|580465921|FG005|Overall Study|Withdrawal by Subject|1|||
160748651|NCT05259917|580465916|FG000|Overall Study|Trial Termination by Sponsor|7|||
160748652|NCT05259917|580465917|FG001|Overall Study|Trial Termination by Sponsor|2|||
160748653|NCT05259917|580465918|FG002|Overall Study|Trial Termination by Sponsor|3|||
160748654|NCT05259917|580465919|FG003|Overall Study|Trial Termination by Sponsor|5|||
160748655|NCT05259917|580465920|FG004|Overall Study|Trial Termination by Sponsor|11|||
160748656|NCT05259917|580465921|FG005|Overall Study|Trial Termination by Sponsor|4|||
160748657|NCT05259917|580465916|FG000|Overall Study|Other|1|||
160748658|NCT05259917|580465917|FG001|Overall Study|Other|0|||
160748659|NCT05259917|580465918|FG002|Overall Study|Other|2|||
160748660|NCT05259917|580465919|FG003|Overall Study|Other|0|||
160748661|NCT05259917|580465920|FG004|Overall Study|Other|0|||
160748662|NCT05259917|580465921|FG005|Overall Study|Other|0|||
160748663|NCT00303472|580465926|FG000|Treatment Period|Adverse Event|0|||
160748664|NCT00303472|580465927|FG001|Treatment Period|Adverse Event|0|||
160748665|NCT00303472|580465928|FG002|Treatment Period|Adverse Event|0|||
160748666|NCT00303472|580465929|FG003|Treatment Period|Adverse Event|0|||
160748667|NCT00303472|580465930|FG004|Treatment Period|Adverse Event|1|||
160748668|NCT00303472|580465931|FG005|Treatment Period|Adverse Event|0|||
160748669|NCT00303472|580465932|FG006|Treatment Period|Adverse Event|0|||
160748670|NCT00303472|580465926|FG000|Treatment Period|Death|0|||
160748671|NCT00303472|580465927|FG001|Treatment Period|Death|0|||
160748672|NCT00303472|580465928|FG002|Treatment Period|Death|0|||
160748673|NCT00303472|580465929|FG003|Treatment Period|Death|1|||
160748674|NCT00303472|580465930|FG004|Treatment Period|Death|0|||
160748675|NCT00303472|580465931|FG005|Treatment Period|Death|0|||
160748676|NCT00303472|580465932|FG006|Treatment Period|Death|1|||
160748677|NCT00303472|580465926|FG000|Treatment Period|Withdrawal by Subject|0|||
160748678|NCT00303472|580465927|FG001|Treatment Period|Withdrawal by Subject|0|||
160748679|NCT00303472|580465928|FG002|Treatment Period|Withdrawal by Subject|0|||
160748680|NCT00303472|580465929|FG003|Treatment Period|Withdrawal by Subject|1|||
160748681|NCT00303472|580465930|FG004|Treatment Period|Withdrawal by Subject|0|||
160748682|NCT00303472|580465931|FG005|Treatment Period|Withdrawal by Subject|1|||
160748683|NCT00303472|580465932|FG006|Treatment Period|Withdrawal by Subject|0|||
160748684|NCT00303472|580465926|FG000|Treatment Period|Other|0|||
160748685|NCT00303472|580465927|FG001|Treatment Period|Other|0|||
160748686|NCT00303472|580465928|FG002|Treatment Period|Other|0|||
160748687|NCT00303472|580465929|FG003|Treatment Period|Other|0|||
160748688|NCT00303472|580465930|FG004|Treatment Period|Other|1|||
160748689|NCT00303472|580465931|FG005|Treatment Period|Other|0|||
160748690|NCT00303472|580465932|FG006|Treatment Period|Other|1|||
160748691|NCT00303472|580465926|FG000|Treatment Period|Disease Progression (to AML)|0|||
160748692|NCT00303472|580465927|FG001|Treatment Period|Disease Progression (to AML)|0|||
160748693|NCT00303472|580465928|FG002|Treatment Period|Disease Progression (to AML)|0|||
160748694|NCT00303472|580465929|FG003|Treatment Period|Disease Progression (to AML)|0|||
160748695|NCT00303472|580465930|FG004|Treatment Period|Disease Progression (to AML)|1|||
160748696|NCT00303472|580465931|FG005|Treatment Period|Disease Progression (to AML)|0|||
160748697|NCT00303472|580465932|FG006|Treatment Period|Disease Progression (to AML)|0|||
160748698|NCT00303472|580465926|FG000|Treatment Extension (Optional)|Adverse Event|1|||
160748699|NCT00303472|580465927|FG001|Treatment Extension (Optional)|Adverse Event|0|||
160748700|NCT00303472|580465928|FG002|Treatment Extension (Optional)|Adverse Event|1|||
160748701|NCT00303472|580465929|FG003|Treatment Extension (Optional)|Adverse Event|0|||
160748702|NCT00303472|580465930|FG004|Treatment Extension (Optional)|Adverse Event|0|||
160748703|NCT00303472|580465931|FG005|Treatment Extension (Optional)|Adverse Event|0|||
160748723|NCT00303472|580465930|FG004|Treatment Extension (Optional)|Physician Decision|2|||
160748724|NCT00303472|580465931|FG005|Treatment Extension (Optional)|Physician Decision|0|||
160748725|NCT00303472|580465932|FG006|Treatment Extension (Optional)|Physician Decision|0|||
160748726|NCT00303472|580465926|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
160748727|NCT00303472|580465927|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
160748728|NCT00303472|580465928|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
160748729|NCT00303472|580465929|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
160748730|NCT00303472|580465930|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
160748731|NCT00303472|580465931|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
160748732|NCT00303472|580465932|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
160748733|NCT00303472|580465926|FG000|Treatment Extension (Optional)|Other|0|||
160748734|NCT00303472|580465927|FG001|Treatment Extension (Optional)|Other|2|||
160748735|NCT00303472|580465928|FG002|Treatment Extension (Optional)|Other|4|||
160748736|NCT00303472|580465929|FG003|Treatment Extension (Optional)|Other|2|||
160748737|NCT00303472|580465930|FG004|Treatment Extension (Optional)|Other|1|||
160748738|NCT00303472|580465931|FG005|Treatment Extension (Optional)|Other|0|||
160748739|NCT00303472|580465932|FG006|Treatment Extension (Optional)|Other|0|||
160748740|NCT00303472|580465926|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
160748741|NCT00303472|580465927|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
160748742|NCT00303472|580465928|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
160748743|NCT00303472|580465929|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
160748744|NCT00303472|580465930|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
160748745|NCT00303472|580465931|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
160748746|NCT00303472|580465932|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
160748747|NCT01808222|580465933|FG000|Overall Study|mpMR scan was not performed|1|||
160748748|NCT02324699|580465934|FG000|Overall Study|study terminated|1|||
160748749|NCT03628716|580465941|FG000|Overall Study|Adverse Event|1|||
160748750|NCT03628716|580465942|FG001|Overall Study|Adverse Event|1|||
160748751|NCT03628716|580465941|FG000|Overall Study|Death|1|||
160748752|NCT03628716|580465942|FG001|Overall Study|Death|0|||
160748753|NCT03628716|580465941|FG000|Overall Study|Lack of Efficacy|15|||
160748754|NCT03628716|580465942|FG001|Overall Study|Lack of Efficacy|20|||
160748755|NCT03628716|580465941|FG000|Overall Study|Withdrawal by Subject|1|||
160748756|NCT03628716|580465942|FG001|Overall Study|Withdrawal by Subject|2|||
160748757|NCT03628716|580465941|FG000|Overall Study|Study Terminated by Sponsor|1|||
160748758|NCT03628716|580465942|FG001|Overall Study|Study Terminated by Sponsor|0|||
160748759|NCT02071082|580465943|FG000|Overall Study|Enrolled and Never Treated|1|||
160748760|NCT02071082|580465944|FG001|Overall Study|Enrolled and Never Treated|1|||
160748761|NCT02071082|580465943|FG000|Overall Study|Adverse Event|0|||
160748762|NCT02071082|580465944|FG001|Overall Study|Adverse Event|1|||
160748763|NCT02071082|580465943|FG000|Overall Study|Withdrew Consent|0|||
160748764|NCT02071082|580465944|FG001|Overall Study|Withdrew Consent|4|||
160748765|NCT02071082|580465943|FG000|Overall Study|Lost to Follow-up|1|||
160748766|NCT02071082|580465944|FG001|Overall Study|Lost to Follow-up|1|||
160748767|NCT02101359|580465945|FG000|Overall Study|Not included|23|||
160748768|NCT02101359|580465946|FG001|Overall Study|Not included|13|||
160748769|NCT02101359|580465945|FG000|Overall Study|Withdrawal by Subject|5|||
160748770|NCT02101359|580465946|FG001|Overall Study|Withdrawal by Subject|4|||
160748771|NCT02101359|580465945|FG000|Overall Study|Lost to Follow-up|1|||
160748772|NCT02101359|580465946|FG001|Overall Study|Lost to Follow-up|0|||
160748773|NCT02101359|580465945|FG000|Overall Study|Protocol Violation|0|||
160748774|NCT02101359|580465946|FG001|Overall Study|Protocol Violation|2|||
160748775|NCT00494221|580465947|FG000|Overall Study|Death|15|||
160748776|NCT00494221|580465948|FG001|Overall Study|Death|9|||
160748777|NCT00494221|580465949|FG002|Overall Study|Death|14|||
160748778|NCT00494221|580465947|FG000|Overall Study|Withdrawal by Subject|1|||
160748779|NCT00494221|580465948|FG001|Overall Study|Withdrawal by Subject|2|||
160748780|NCT00494221|580465949|FG002|Overall Study|Withdrawal by Subject|0|||
160748781|NCT01900431|580465950|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
160748782|NCT01900431|580465951|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
160748783|NCT01900431|580465952|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
160748784|NCT01900431|580465950|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
160748785|NCT01900431|580465951|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
160748786|NCT01900431|580465952|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
160748787|NCT01900431|580465950|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
160748788|NCT01900431|580465951|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
160748789|NCT01900431|580465952|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
160748790|NCT01900431|580465950|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
160748791|NCT01900431|580465951|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
160748792|NCT01900431|580465952|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
160748793|NCT01900431|580465950|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
160748794|NCT01900431|580465951|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
160748795|NCT01900431|580465952|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
160748796|NCT01900431|580465950|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
160748797|NCT01900431|580465951|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
160748798|NCT01900431|580465952|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
160748799|NCT01900431|580465950|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
160748800|NCT01900431|580465951|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
160748801|NCT01900431|580465952|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
160748802|NCT01900431|580465950|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
160748803|NCT01900431|580465951|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
160748804|NCT01900431|580465952|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
160748805|NCT01900431|580465950|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
160748806|NCT01900431|580465951|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
160748807|NCT01900431|580465952|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
160748808|NCT02732327|580465959|FG000|Overall Study|Protocol Violation|0|||
160748809|NCT02732327|580465960|FG001|Overall Study|Protocol Violation|1|||
160748810|NCT00435019|580465961|FG000|Overall Study|Adverse Event|1|||
160748811|NCT00435019|580465962|FG001|Overall Study|Adverse Event|0|||
160748812|NCT00435019|580465961|FG000|Overall Study|Lack of Efficacy|1|||
160748813|NCT00435019|580465962|FG001|Overall Study|Lack of Efficacy|2|||
160748814|NCT00435019|580465961|FG000|Overall Study|Protocol Violation|3|||
160748815|NCT00435019|580465962|FG001|Overall Study|Protocol Violation|1|||
160748816|NCT00435019|580465961|FG000|Overall Study|Personal reasons for withdrawal|8|||
160748817|NCT00435019|580465962|FG001|Overall Study|Personal reasons for withdrawal|7|||
160748818|NCT04503668|580465963|FG000|Overall Study|Incomplete data|4|||
160748819|NCT04503668|580465964|FG001|Overall Study|Incomplete data|3|||
160748820|NCT04503668|580465963|FG000|Overall Study|Withdrawal by Subject|1|||
160748821|NCT04503668|580465964|FG001|Overall Study|Withdrawal by Subject|1|||
160748822|NCT04503668|580465963|FG000|Overall Study|Adverse Event|2|||
160748823|NCT04503668|580465964|FG001|Overall Study|Adverse Event|0|||
160748824|NCT02306694|580465965|FG000|Overall Study|Withdrawal by Subject|3|||
160748825|NCT02306694|580465965|FG000|Overall Study|Lost to Follow-up|1|||
160748826|NCT00603382|580465966|FG000|Overall Study|Adverse Event|0|||
160748827|NCT00603382|580465967|FG001|Overall Study|Adverse Event|1|||
160748828|NCT00603382|580465968|FG002|Overall Study|Adverse Event|1|||
160748829|NCT00603382|580465969|FG003|Overall Study|Adverse Event|2|||
160748830|NCT00603382|580465970|FG004|Overall Study|Adverse Event|1|||
160748831|NCT00603382|580465971|FG005|Overall Study|Adverse Event|2|||
160748832|NCT00603382|580465966|FG000|Overall Study|Lack of Efficacy|14|||
160748833|NCT00603382|580465967|FG001|Overall Study|Lack of Efficacy|9|||
160748834|NCT00603382|580465968|FG002|Overall Study|Lack of Efficacy|3|||
160748835|NCT00603382|580465969|FG003|Overall Study|Lack of Efficacy|6|||
160748836|NCT00603382|580465970|FG004|Overall Study|Lack of Efficacy|6|||
160748837|NCT00603382|580465971|FG005|Overall Study|Lack of Efficacy|11|||
160748838|NCT00603382|580465966|FG000|Overall Study|Protocol Violation|1|||
160748839|NCT00603382|580465967|FG001|Overall Study|Protocol Violation|0|||
160748840|NCT00603382|580465968|FG002|Overall Study|Protocol Violation|1|||
160748841|NCT00603382|580465969|FG003|Overall Study|Protocol Violation|2|||
160748842|NCT00603382|580465970|FG004|Overall Study|Protocol Violation|1|||
160748843|NCT00603382|580465971|FG005|Overall Study|Protocol Violation|0|||
160748844|NCT00603382|580465966|FG000|Overall Study|Lost to Follow-up|0|||
160748845|NCT00603382|580465967|FG001|Overall Study|Lost to Follow-up|1|||
160748846|NCT00603382|580465968|FG002|Overall Study|Lost to Follow-up|1|||
160748847|NCT00603382|580465969|FG003|Overall Study|Lost to Follow-up|1|||
160748848|NCT00603382|580465970|FG004|Overall Study|Lost to Follow-up|0|||
160748849|NCT00603382|580465971|FG005|Overall Study|Lost to Follow-up|1|||
160748850|NCT00603382|580465966|FG000|Overall Study|Physician Decision|0|||
160748851|NCT00603382|580465967|FG001|Overall Study|Physician Decision|0|||
160748852|NCT00603382|580465968|FG002|Overall Study|Physician Decision|2|||
160748853|NCT00603382|580465969|FG003|Overall Study|Physician Decision|0|||
160748854|NCT00603382|580465970|FG004|Overall Study|Physician Decision|1|||
160748855|NCT00603382|580465971|FG005|Overall Study|Physician Decision|3|||
160748856|NCT00603382|580465966|FG000|Overall Study|Withdrawal by Subject|3|||
160748857|NCT00603382|580465967|FG001|Overall Study|Withdrawal by Subject|3|||
160748858|NCT00603382|580465968|FG002|Overall Study|Withdrawal by Subject|1|||
160748859|NCT00603382|580465969|FG003|Overall Study|Withdrawal by Subject|1|||
160748860|NCT00603382|580465970|FG004|Overall Study|Withdrawal by Subject|0|||
160748861|NCT00603382|580465971|FG005|Overall Study|Withdrawal by Subject|1|||
160748862|NCT00659776|580465974|FG000|Overall Study|Withdrawal by Subject|12|||
160748863|NCT00659776|580465975|FG001|Overall Study|Withdrawal by Subject|2|||
160748864|NCT00659776|580465976|FG002|Overall Study|Withdrawal by Subject|0|||
160748865|NCT01180049|580465977|FG000|Overall Study|Other|9|||
160748866|NCT01180049|580465978|FG001|Overall Study|Other|7|||
160748867|NCT01180049|580465977|FG000|Overall Study|Lost to Follow-up|8|||
160748868|NCT01180049|580465978|FG001|Overall Study|Lost to Follow-up|6|||
160748869|NCT01180049|580465977|FG000|Overall Study|Death|36|||
160748870|NCT01180049|580465978|FG001|Overall Study|Death|35|||
160748871|NCT01738191|580465979|FG000|Overall Study|Withdrawal by Subject|4|||
160748872|NCT01738191|580465980|FG001|Overall Study|Withdrawal by Subject|1|||
160748873|NCT00350779|580465981|FG000|Overall Study|Adverse Event|4|||
160748874|NCT00350779|580465982|FG001|Overall Study|Adverse Event|2|||
160748875|NCT00350779|580465981|FG000|Overall Study|Lack of Efficacy|0|||
160748876|NCT00350779|580465982|FG001|Overall Study|Lack of Efficacy|4|||
160748877|NCT00350779|580465981|FG000|Overall Study|Lost to Follow-up|2|||
160748878|NCT00350779|580465982|FG001|Overall Study|Lost to Follow-up|0|||
160748879|NCT00350779|580465981|FG000|Overall Study|Physician Decision|2|||
160748880|NCT00350779|580465982|FG001|Overall Study|Physician Decision|4|||
160748881|NCT00350779|580465981|FG000|Overall Study|Protocol Violation|3|||
160748882|NCT00350779|580465982|FG001|Overall Study|Protocol Violation|1|||
160748883|NCT00350779|580465981|FG000|Overall Study|Withdrawal by Subject|9|||
160748884|NCT00350779|580465982|FG001|Overall Study|Withdrawal by Subject|8|||
160748885|NCT00350779|580465981|FG000|Overall Study|Patient Moved|2|||
160748886|NCT00350779|580465982|FG001|Overall Study|Patient Moved|1|||
160748887|NCT00350779|580465981|FG000|Overall Study|Non-compliance with study procedures|0|||
160748888|NCT00350779|580465982|FG001|Overall Study|Non-compliance with study procedures|1|||
160748889|NCT00958412|580465985|FG000|Overall Study|Study prematurely terminated|18|||
160748890|NCT02552888|580465986|FG000|Overall Study|Lost to Follow-up|1|||
160748891|NCT02552888|580465987|FG001|Overall Study|Lost to Follow-up|1|||
